(in-package :sparser)

(defparameter *biochemical-names*
  '(("BE:ACAD" (("Acad" 6)))
    ("BE:ACC"
     (("ACCs" 160) ("sporadic ACCs" 6) ("adult sporadic ACCs" 2)
      ("histologically equivocal ACCs" 1) ("fusion-negative ACCs" 1)
      ("85% fusion-positive ACCs" 1)))
    ("BE:ACSL"
     (("ACSL" 6) ("long-chain acyl-CoA synthetase" 4)
      ("long-chain acyl-CoA synthetase (ACSL)" 2) ("ACSLs" 1)))
    ("BE:ACTN"
     (("actinin" 54) ("Actinin" 10) ("-actinin" 3)
      ("cardiac contractile proteins alpha actinin" 2) ("–actinin" 2)
      ("actinIn" 1) ("actinins" 1)
      ("3 stretch-activated focal adhesion proteins, FAK, p130Cas, and alpha actinin"
       1)))
    ("BE:ADCY"
     (("adenylate cyclase" 68) ("adenylate cyclase protein" 4)
      ("the associated adenylate cyclase" 2)
      ("a calcium/calmodulin-dependent adenylate cyclase" 2)
      ("adenylate cyclase (AC)" 1) ("Adenylate cyclase" 1)
      ("adenylate cyclases" 1)))
    ("BE:ADRB" (("beta-adrenergic receptor" 5) ("beta-adrenergic receptors" 4)))
    ("BE:AKT"
     (("AKT" 23315) ("p-AKT" 1464) ("pAKT" 1003) ("pAkt" 902) ("P-AKT" 319)
      ("-AKT" 150) ("AKTs" 50) ("-pAkt" 41) ("AKT protein" 40) ("AKT-" 25)
      ("AKT family" 22) ("–AKT" 17) ("akt" 12) ("pAkt-" 10) ("than AKT" 9)
      ("dominant-negative AKT" 7) ("pAKt" 5) ("a dominant-negative AKT" 4)
      ("PI3KAkt" 4) ("membrane-associated AKT" 4) ("available pTyr176-AKT" 4)
      ("AKt" 3) ("AKT’s" 3) ("constitutively-activated AKT" 3)
      ("prosurvival phospho-AKT" 3) ("overexpressed pAkt" 3)
      ("Overexpressed pAkt" 3) ("strong phospho-AKT" 3)
      ("overexpressed p110α presented significantly activated AKT" 3) ("p-AKt" 2)
      ("AkT" 2) ("AKT molecule" 2) ("PAkt" 2) ("AKT's" 2)
      ("NF-κB-associated AKT" 2) ("−AKT" 2) ("more AKT" 2)
      ("monoclonal rabbit anti-human p-AKT" 2)
      ("the multifunctional oncogenic kinase AKT" 2)
      ("the prosurvival pathway AKT" 2) ("mouse monoclonal anti- total AKT" 2)
      ("rabbit monoclonal anti-phospho AKT" 2) ("AktS" 2)
      ("Dominant-negative AKT" 2) ("the dominant-negative AKT" 2)
      ("adenoviral FAK-CD decreased AKT" 2) ("endogeneous AKT" 2)
      ("conditional AKT" 2) ("endogenous IGF-I increased pAkt" 2)
      ("further activating AKT" 2) ("concurrent pAkt" 2) ("-pAKT" 2)
      ("than AKT ( xref )" 1) ("so AKT K179M" 1) ("than p-AKT ( P  = 0.002)" 1)
      ("caveolin-1 and cavin-1 increased pAkt" 1)
      ("the serine/threonine-specific protein kinase AKT" 1)
      ("PTEN-competent 293T cells displayed increased phospho-AKT" 1)
      ("phospho/total- AKT" 1)
      ("The dominant-negative Δp85α and Myc-His–tagged dominant-negative AKT" 1)
      ("the constitutively-activated AKT" 1)
      ("substantially more basal phospho-AKT" 1) ("exogenously expressed AKT" 1)
      ("expressed AKT" 1) ("“pAkt”" 1) ("Monoclonal mouse anti-human AKT" 1)
      ("LY294002 decreased p-AKT" 1) ("we first examined endogenous p-AKT" 1)
      ("AKT‐" 1) ("p-AKT (CST)" 1) ("API-2 abrogated miR-221&222–activated AKT" 1)
      ("AKTi decreased P-AKT" 1) ("dominant-negative AKT (AAA)" 1)
      ("the constitutively activity AKT" 1)
      ("transfected dominant-negative AKT" 1) ("Dual targeting reduced P-AKT" 1)
      ("targeting reduced P-AKT" 1) ("membranous P-AKT" 1)
      ("essentially all the AKT" 1) ("strong p-AKT" 1)
      ("correspondingly less AKT" 1) ("total and phosphorylated AKT" 1)
      ("residual Ser473-phosphorylated AKT" 1) ("the previously reported AKT" 1)
      ("PI3KAKT" 1) ("Most studies view AKT" 1) ("“FLT3L→p-AKT”" 1)
      ("Spry1 increased pAkt" 1)))
    ("BE:ALDH"
     (("aldehyde dehydrogenase" 115) ("Aldehyde dehydrogenase" 24)
      ("aldehyde dehydrogenase (ALDH)" 18) ("Aldh" 11)
      ("aldehyde dehydrogenases" 7)
      ("aldehyde
                    dehydrogenases"
       2)))
    ("BE:AMPK"
     (("AMPK" 10181) ("AMPK-" 184) ("p-AMPK" 176) ("pAMPK" 107) ("-AMPK" 16)
      ("AMP activated protein kinase" 15) ("AMPK family" 14) ("AMPK protein" 13)
      ("AMPK-CA" 13) ("P-AMPK" 6) ("AMPK (AMP-activated protein kinase) family" 6)
      ("Ampk" 5) ("heterotrimeric AMPK" 4) ("targeting AMPK" 3) ("AMPK’s" 3)
      ("AMPKs" 3) ("AMP activated protein kinase (AMPK)" 3)
      ("energy stress-induced pAMPK" 2) ("dominant-negative AMPK" 2) ("-Ampk" 2)
      ("UV-induced AMPK" 2) ("exercise-activated AMPK" 2)
      ("a dominant-negative AMPK" 2) ("AMPK molecule" 2)
      ("the heterotrimeric AMPK" 2) ("-AMP activated protein kinase" 2)
      ("Given AMPK's" 1) ("given AMPK's" 1) ("treated AMPK −/−" 1)
      ("phospho-AMPK/total AMPK" 1) ("hypothalamic AMPK" 1)
      ("Rabbit monoclonal anti-phospho-Thr 172 AMPK" 1)
      ("FOXO3 mediated AMPK's" 1) ("Ad-XBP1-spliced showed increased pAMPK" 1)
      ("cerebral AMPK" 1) ("AMPK (KD)" 1) ("AMPK's" 1)
      ("-AMP activated protein kinase (AMPK)" 1)))
    ("BE:AP1"
     (("AP-1" 6031) ("AP-1 family" 107) ("AP-1 protein" 16) ("AP-1–" 13)
      ("AP-1-" 10) ("pAP-1" 7) ("heterodimeric AP-1" 5) ("AP-1’s" 3)
      ("Activating protein-1" 2) ("AP−1" 2)
      ("the heterodimeric transcription factor complex AP-1" 2)
      ("dominant-negative AP-1" 2)
      ("the heterodimeric transcription factor AP-1" 1) ("Activating Protein-1" 1)
      ("further address AP-1’s" 1) ("further address AP-1" 1)
      ("The transcriptional factor AP-1" 1) ("homologous AP-1" 1)
      ("contiguous AP-1–" 1) ("AP-1 (activator protein-1) protein" 1)
      ("more AP-1" 1) ("some transcriptional factor AP-1" 1)))
    ("BE:APC_C"
     (("APC/C" 4016) ("APC-C" 174) ("the mitotic APC/C" 16) ("APC/Cs" 13)
      ("APC/C-" 10) ("APC/C’s" 8) ("mitotic APC/C" 4) ("Cdc20-associated APC/C" 2)
      ("the Cdc20-associated APC/C" 2) ("-APC/C" 2) ("the APC/C's" 1) ("—APC/C" 1)
      ("monomeric APC/C" 1) ("dimeric APC/C" 1) ("most APC/C" 1)
      ("that APC/C’s" 1) ("mitotic exit APC/C" 1)))
    ("BE:APOA" (("apoA" 19) ("ApoA" 8)))
    ("BE:Actin"
     (("actin" 12742) ("Actin" 1158) ("-actin" 812) ("SMA" 117)
      ("cortical actin" 86) ("ACTIN" 56) ("-Actin" 46) ("polymerized actin" 35)
      ("actin (SMA)" 35) ("actin-" 30) ("junctional actin" 24)
      ("monomeric actin" 17) ("actins" 16) ("actin protein" 14)
      ("the cortical actin" 10) ("-SMA" 10) ("globular actin" 8) ("-ACTIN" 6)
      ("intense actin" 4) ("perijunctional actin" 4)
      ("Mouse monoclonal anti- β -actin" 4) ("–actin" 4)
      ("FITC-conjugated mouse monoclonal anti-α-smooth muscle actin" 4)
      ("the junctional actin" 4) ("Filamentous (F)-actin" 4)
      ("particle-mediated actin" 4) ("monoclonal β actin" 4)
      ("circumferential actin" 3) ("20% Atto-488–labeled actin" 3)
      ("monoclonal anti- β -actin" 3) ("Junctional actin" 3)
      ("the circumferential actin" 3) ("Mouse monoclonal antibodies Actin" 3)
      ("sequestering monomeric actin" 3) ("filamentous (F) actin" 3)
      ("α-sarcomeric actin" 3) ("mouse monoclonal anti- β -actin" 3)
      ("strong sub-apical actin" 3) ("apical actin" 2) ("most intense actin" 2)
      ("cortical  actin" 2) ("Cortical Actin" 2)
      ("internal reference genes (beta-actin" 2) ("filamentous (F-) actin" 2)
      ("actin (ACTB)" 2) ("The static cortical actin" 2) ("peripheral actin" 2)
      ("Sma" 2) ("The monomeric rabbit skeletal muscle actin" 2)
      ("intense β actin" 2) ("the pol I-associated actin" 2)
      ("muscle-specific actin" 2) ("–Actin" 2)
      ("more pronounced cortical actin" 2) ("more actin" 2)
      ("Nap1-positive actin" 2)
      ("myoepithelial cell marker α-smooth muscle actin" 2) ("monoclonal actin" 2)
      ("subcortical actin" 2) ("filamentous (F)-actin" 2) ("absent actin" 2)
      ("cortical filamentous (F)-actin" 2) ("ROS-associated actin" 2)
      ("Arp2/3-associated actin" 2) ("more robust actin" 2)
      ("no circumferential actin" 2) ("serum deprivation-dependent actin" 2)
      ("few actin" 2) ("aberrant cortical actin" 2)
      ("adherens junction–driven actin" 2)
      ("LPA exhibited less concentrated cortical actin" 2)
      ("the pan-cardiac marker α-cardiac actin" 2)
      ("more compact cortical actin" 2) ("subsequent actin" 2)
      ("dynamic cortical actin" 2) ("increased cortical actin" 2)
      ("fibrillar actin" 2) ("Monoclonal mouse anti- β -actin" 2)
      ("expressing alpha-smooth muscle actin" 2) ("actin ( ACTB )" 2)
      ("filamentous and globular actin" 2) ("pSMA" 2) ("monomeric (G) actin" 2)
      ("clone 1 showed less actin" 2)
      ("silenced cells displayed cortical actin" 2)
      ("the profibrotic markers collagen and alpha smooth muscle actin" 2)
      ("excessively polymerized actin" 2) ("precise control actin" 2)
      ("mitotic actin" 2)
      ("the mesenchymal markers vimentin and α-smooth muscle actin" 2)
      ("both intense actin" 2) ("α-smooth Muscle Actin" 2)
      ("slightly  aberrant cortical actin" 1) ("The polymerized actin" 1)
      ("perinuclear actin" 1) ("highly polymerized actin" 1)
      ("the internal control gene ACTIN" 1) ("their well-defined actin" 1)
      ("Actin-" 1) ("focal actin" 1) ("endosome-associated actin" 1) ("sma" 1)
      ("membrane-associated β actin" 1) ("perimarginal actin" 1)
      ("Mouse monoclonal β -actin" 1) ("cardiac actin" 1)
      ("their correspondent actin" 1) ("pol I-associated actin" 1)
      ("Atto-488–labeled actin" 1) ("Actin (ACTB)" 1) ("global actin" 1)
      ("calibrated skeletal actin" 1) ("γ-enteric actin" 1)
      ("Rac1-dependent actin" 1) ("three internal controls (beta-actin" 1)
      ("free monomeric actin" 1)
      ("No other tested formin exhibited disregulated junctional actin" 1)
      ("LifeAct-GFP revealed stable junctional actin" 1)
      ("than actin remodelling" 1) ("5 min polymerized actin" 1)
      ("displayed pronounced circumferential actin" 1)
      ("prominent cortical actin" 1) ("respective actin" 1)
      ("Large fluorescent actin" 1) ("previously reported actin" 1)
      ("monomeric (globular) actin" 1) ("MyoGEF-induced massive actin" 1)
      ("total globular (G)-actin" 1)
      ("Growth Factor-β1-induced α-smooth muscle actin" 1)
      ("Fibrillar (F) actin" 1) ("filopodial actin" 1) ("directly bind actin" 1)
      ("parallel cortical actin" 1) ("thin cortical actin" 1)
      ("junctional-associated cortical actin" 1)
      ("cell contact-initiated cortical actin" 1)
      ("mesenchymal markers desmin and alpha-smooth muscle actin" 1)
      ("α cardiac actin" 1) ("Cortical actin" 1)
      ("binding both filamentous and globular actin" 1) ("radial actin" 1)
      ("less discernable circumferential actin" 1)
      ("less peri-junctional short actin" 1)
      ("brightly stained longitudinal actin" 1) ("fibular actin" 1)
      ("already polymerized actin" 1) ("protrusive actin" 1)
      ("Monomeric (G-) actin" 1) ("predominantly cortical actin" 1)
      ("a correct actin" 1) ("dense cytoplasmic Actin" 1)
      ("each internal control β -actin" 1) ("binds filamentous (F)-actin" 1)
      ("the internal standard β -actin" 1)
      ("more pronounced linear organised junctional actin" 1)
      ("myofibroblast-associated smooth muscle actin" 1) ("Polymerized actin" 1)
      ("an internal control (beta actin" 1) ("concentrated polymerized actin" 1)
      ("Actin protein" 1) ("motility-associated actin" 1)
      ("the cytoskeleton undergoes dynamic cortical actin" 1)
      ("postsynaptic actin" 1) ("GABPA accumulated subcortical actin" 1)
      ("dendritic actin" 1)
      ("the characteristic prominent circumferential actin" 1)
      ("The cortical actin" 1)
      ("monoclonal anti- β -actin and anti- α -actin" 1)))
    ("BE:Activin_A" (("activin A" 101)))
    ("BE:Activin_B" (("Activin B" 120) ("activin-B" 8)))
    ("BE:Adaptor_protein_III"
     (("AP-3" 208) ("-AP-3" 4) ("AP-3-" 2) ("the latter bound AP-3" 2)
      ("AP-3–" 1)))
    ("BE:BIRC" (("BIRC family" 3) ("BIRC" 1)))
    ("BE:BRCA"
     (("BRCA" 2787) ("BrCa" 237) ("BrCas" 59) ("pBRCA" 41) ("BRCA−" 22)
      ("BRCAs" 14) ("BRCA protein" 10) ("BRCA-" 9) ("underwent BRCA" 6)
      ("bilateral BrCa" 4) ("-BRCA" 3) ("CIMBA" 2) ("had uninformative BRCA" 2)
      ("uninformative BRCA" 2) ("than BRCA" 1) ("BrCA" 1) ("most BrCa" 1)
      ("benign BrCa" 1) ("most luminal BrCas" 1) ("the thorough BRCA" 1)
      ("“FA/BRCA”" 1) ("hereditary BrCa" 1) ("“BRCA”" 1)))
    ("BE:C1"
     (("C1" 1602) ("-C1" 19) ("C1s" 5) ("C1-" 4) ("C1 protein" 2) ("C1 peptide" 2)
      ("shorter fragment C1" 2) ("than clone C1" 1) ("His-Sumo–tagged L2-C1" 1)
      ("C1+C2-" 1) ("\"C1\"" 1) ("than C1" 1) ("conserved modular C1" 1)
      ("than peptide C1" 1)
      ("The atypical PKCs (PKCζ and PKCλ) lack both functional C1" 1)))
    ("BE:CAMK2_family" (("CAMKII" 18)))
    ("BE:CAPN"
     (("calpain" 840) ("calpains" 113) ("Calpain" 92) ("-calpain" 40)
      ("Calpains" 22) ("calpain family" 4) ("ubiquitous calpains" 3)
      ("endogeneous calcium-activated cytosolic calpain" 2) ("residual calpain" 1)
      ("proteases called calpains" 1) ("calpain-" 1) ("than calpain" 1)))
    ("BE:CCT_complex"
     (("chaperonin" 80) ("chaperonins" 15) ("oligomeric eukaryotic chaperonin" 3)
      ("a bacterial chaperonin" 2) ("Chaperonins" 1) ("chaperonin (CCT)" 1)
      ("Chaperonin" 1)))
    ("BE:CDK"
     (("CDK" 2404) ("cdks" 184) ("pCDK" 109) ("CDK family" 31) ("-CDK" 5)
      ("CDK6224Y protein" 2) ("CDK-" 2) ("CDK’s" 2) ("the predominant CDK" 2)
      ("most cdks" 2) ("Transcriptional cdks" 2) ("-pCDK1" 1) ("p-CDK" 1)
      ("the atypical CDK" 1) ("CDKS" 1) ("cyclin binding most cdks" 1)
      ("mitotic CDK" 1) ("the only mitotic CDK" 1)))
    ("BE:CDKN"
     (("cyclin-dependent kinase inhibitor" 437)
      ("cyclin-dependent kinase inhibitors" 183)
      ("cyclin-dependent kinase inhibitor (CKI)" 8)
      ("cyclin-dependent kinase inhibitor (CDKI)" 4)
      ("cyclin-dependent kinase inhibitors (CKI)" 3)
      ("cyclin-dependent kinase inhibitor (CDKI) family" 3)
      ("cyclin-dependent kinase inhibitor (CKI) family" 3)
      ("cyclin-dependent kinase inhibitor protein" 3)
      ("a universal cyclin-dependent kinase inhibitor" 2)
      ("a universal cyclin-dependent kinase inhibitor (CDKI)" 2)
      ("a stress-inducible
                        cyclin-dependent kinase inhibitor"
       2)
      ("cyclin-dependent kinase inhibitors (CDKI)" 1)
      ("cyclin-dependent kinase inhibitors-" 1)
      ("cyclin-dependent kinase
 inhibitor"
       1)
      ("cyclin-dependent kinase inhibitor (CDKN)" 1)))
    ("BE:CDKN2" (("CDKN2" 19)))
    ("BE:CEBP"
     (("C/EBP" 602) ("CEBP" 110) ("CCAAT/enhancer binding protein" 41)
      ("C/EBPs" 33) ("C/EBP family" 19) ("c/EBP" 8) ("CEBP family" 6)
      ("CCAAT/enhancer binding proteins" 5)
      ("biallelic CCAAT/enhancer binding protein" 3) ("C/EBP-" 3)
      ("CCAAT/enhancer binding protein-" 2) ("CEBP protein" 2)))
    ("BE:CHEK"
     (("checkpoint kinase" 199) ("checkpoint kinases" 196) ("Checkpoint kinase" 2)
      ("checkpoint kinase (CHEK)" 2)
      ("multiple possible downstream effector checkpoint kinases" 2)
      ("the principal checkpoint kinases" 2) ("Checkpoint kinases" 1) ("CHEK" 1)))
    ("BE:CHRN"
     (("nAChRs" 319) ("nAChR" 103) ("nicotinic acetylcholine receptors" 26)
      ("nicotinic acetylcholine receptor" 23) ("nAchR" 8) ("Neuronal nAChRs" 4)
      ("Neuronal nicotinic acetylcholine receptors" 4) ("nACHRs" 3)
      ("Nicotinic acetylcholine receptors" 2)
      ("Nicotinic acetylcholine receptor" 2)
      ("nicotinic acetylcholine receptor nicotinic acetylcholine receptor" 2)
      ("neuronal nAChRs" 2) ("denervation-induced synaptic nAChR" 1) ("nAChR-" 1)
      ("NAChRs" 1) ("heteromeric neuronal nAChRs" 1)
      ("Heteromeric neuronal nAChRs" 1)))
    ("BE:CREB"
     (("CREB" 1492) ("pCREB" 111) ("p-CREB" 38)
      ("cAMP response element-binding protein" 36)
      ("cAMP response element-binding protein (CREB)" 13) ("P-CREB" 8)
      ("phospho-CREB" 6) ("CREB peptide" 3)
      ("cAMP response element–binding protein" 2) ("CREBs" 2)
      ("ultra-pure LPS-induced P-CREB" 2)
      ("cAMP response element-binding protein-" 2)
      ("cAMP response element-binding protein (CBP)" 2) ("CREB family" 2)
      ("CREB (cAMP response element binding) protein" 2)
      ("the PGC1-α-regulated genes cAMP response element-binding protein (CREB)"
       1)
      ("CREB protein" 1)
      ("The basic leucine zipper transcription factor p-CREB" 1) ("Creb" 1)
      ("cAMP response element-binding proteins" 1)
      ("Transfected exogenous CREB" 1) ("dimeric CREB" 1)))
    ("BE:CSNK2" (("CSNK2" 4))) ("BE:CUL" (("Cul" 25) ("CUL" 5) ("cul" 3)))
    ("BE:Caspase" (("caspase domain" 11)))
    ("BE:Caspase_3_7"
     (("caspase-3/7" 234) ("Caspase-3/7" 81) ("expressing caspase-3/7" 1)))
    ("BE:Clathrin"
     (("clathrin" 1776) ("Clathrin" 87) ("clathrin-" 72) ("p-clathrin" 2)
      ("virion associated clathrin" 2) ("Clathrin-" 1) ("the residual clathrin" 1)
      ("Given clathrin's" 1) ("much or more clathrin" 1)))
    ("BE:Cofilin"
     (("cofilin" 3232) ("Cofilin" 283) ("cofilins" 79) ("P-cofilin" 39)
      ("p-cofilin" 34) ("cofilin molecule" 16) ("cofilin-" 10)
      ("cofilin protein" 5) ("cofilin's" 4) ("overexpressed cofilins" 3)
      ("a non-phosphorylatable mutant cofilin" 3) ("Cofilin's" 2)
      ("Half helical pitch around sparsely bound cofilin" 2) ("Cofilin-" 2)
      ("an inactive Ser-3–phosphorylated cofilin" 2)
      ("active/non-active cofilin" 2) ("total and phosphorylated cofilin" 2)
      ("cofilin family" 2) ("exogenous WT cofilin" 2)
      ("exogenous phosphorylated cofilin" 2) ("than cofilin" 1)
      ("subsequent full-length mouse cofilin" 1) ("stoichiometric cofilin" 1)
      ("cofilin–" 1) ("the ubiquitous actin depolymerizing factor cofilin" 1)
      ("cofil-ins" 1) ("Only one cofilin" 1)
      ("than cofilin [ xref , xref , xref , xref , xref ]" 1)
      ("otherwise inhibited cofilin" 1) ("quantitatively more active cofilin" 1)
      ("the amino acids of cofilin" 1) ("DTT-treated cofilin" 1)
      ("cofilin (PDB)" 1) ("IAA-treated recombinant cofilin" 1)
      ("those observed around cofilin" 1) ("shorter cofilin" 1)
      ("only Cys oxidation causes cofilin" 1) ("other cofilin’s" 1)
      ("Four cofilin’s" 1) ("Previously non-phosphorylated cofilin" 1)
      ("either exogenous cofilin" 1) ("Exogenous wild type cofilin" 1)
      ("exogenous cofilin" 1) ("-cofilin" 1) ("more cofilin" 1)
      ("the less P-cofilin" 1) ("Cofilins" 1)))
    ("BE:Cyclin_D"
     (("Cyclin D" 632) ("Cyclin Ds" 10) ("-Cyclin D3" 2)
      ("the PIM inhibitor SGI-1773 (10 µM) somewhat reduced Cyclin D1" 1)))
    ("BE:Cyclophilin"
     (("cyclophilin" 114) ("Cyclophilin" 23)
      ("the internal control gene cyclophilin" 2)
      ("a further QC round, Cyclophilin" 1)
      ("TaqMan Pre-Developed Assay Reagent human cyclophilin" 1)))
    ("BE:DDR" (("discoidin domain receptors" 3)))
    ("BE:DNA_polymerase_delta" (("DNA polymerase delta" 4)))
    ("BE:DRD"
     (("dopamine receptors" 53) ("dopamine receptor" 36) ("Dopamine receptor" 2)))
    ("BE:DUSP"
     (("DUSP" 186) ("DUSPs" 95) ("pDUSP" 12) ("DUSP family" 7) ("DuSP" 3)
      ("the atypical DUSPs" 3) ("DuSPs" 2) ("overexpressed DUSP" 2)
      ("typical DUSPs" 2) ("the so-called ‘atypical’ DUSPs" 2) ("Dusp" 1)
      ("the other more weakly expressed DUSPs" 1)
      ("the most prominently overexpressed DUSP" 1) ("9 typical DUSPs" 1)
      ("several typical DUSPs" 1) ("another MAPK-associated DUSP" 1)
      ("at least ten MAPK-associated DUSPs" 1)))
    ("BE:Death_receptor"
     (("death receptor" 618) ("death receptors" 503) ("Death receptor" 14)
      ("“death receptors”" 11) ("death receptor-" 7) ("death receptor family" 6)
      ("Death Receptor" 6) ("death receptors (DR)" 4) ("Death Receptors" 4)
      ("death receptor (DR)" 3) ("Death receptors" 3)
      ("so-called death receptors" 2) ("a prototypic death receptor" 2)
      ("than death receptors" 1) ("external death receptors" 1)
      ("weak death receptor" 1) ("one or more death receptors" 1)))
    ("BE:Desmoglein" (("desmogleins" 23) ("desmoglein" 18) ("Desmogleins" 3)))
    ("BE:E2F"
     (("E2F" 3689) ("E2Fs" 567) ("E2f" 121) ("E2fs" 21) ("repressive E2Fs" 9)
      ("e2f" 6) ("pro-apoptotic E2Fs" 4) ("E2f family" 3) ("targeted E2Fs" 3)
      ("the repressive E2Fs" 2) ("the repressive E2fs" 1)
      ("biological processes E2Fs" 1)))
    ("BE:EGR" (("Egr" 87) ("pEgr" 1) ("Egr-" 1)))
    ("BE:EIF4EBP" (("EIF4EBP" 2) ("EIF4EBPs" 2) ("eIF4EBP" 1)))
    ("BE:ENO" (("eNOS" 2121) ("eno" 6) ("ENO" 5) ("eNO" 1) ("eNos" 1)))
    ("BE:ERK"
     (("ERK1/2" 9940) ("Erk1/2" 2105) ("p-ERK1/2" 499) ("pERK1/2" 386)
      ("ERK 1/2" 374) ("ERK-1/2" 161) ("Erk 1/2" 157)
      ("extracellular signal-regulated kinase 1/2" 103) ("pErk1/2" 76)
      ("p-Erk1/2" 73) ("P-ERK1/2" 65) ("pTpYERK" 58)
      ("extracellular signal regulated kinase" 54) ("pERK-1/2" 53) ("-ERK1/2" 22)
      ("ERK1/2 protein" 19) ("Erk-1/2" 18)
      ("extracellular signal regulated kinase 1/2" 13)
      ("extracellular signal–regulated kinase 1/2" 10) ("p-ERK 1/2" 10)
      ("Erk1/2 protein" 9) ("extracellular signal regulated kinases" 8)
      ("Extracellular signal-regulated kinase 1/2" 6)
      ("Extracellular signal regulated kinases" 4)
      ("extracellular signal regulated kinase (ERK)" 4)
      ("extracellular signal regulated kinases 1 and 2" 4)
      ("total and activated ERK1/2" 4) ("p-Erk 1/2" 3) ("ERK1/2-" 3)
      ("Extracellular signal regulated kinase" 3) ("Erk1/2 (MAPK)" 2)
      ("than ERK1/2" 2) ("extracellular signal regulated kinase (MEK)" 2)
      ("total and phosphorylated ERK1/2" 2) ("Erk1/2-" 2) ("ERk1/2" 2)
      ("-ERK 1/2" 2) ("its immediate downstream target ERK1/2" 2)
      ("pERK1/2 protein" 2) ("ERK1/2 family" 2) ("α-total ERK1/2" 2)
      ("dual-phosphorylated ERK1/2" 2)
      ("growth factors activated both the ERK1/2" 2)
      ("lacked ΔNp63α expression exhibited strong nuclear phosphorylated Erk1/2"
       2)
      ("stress-activated ERK1/2" 2) ("the dual-phosphorylated active ERK1/2" 1)
      ("analysis showed Erk1/2" 1) ("than p-ERK1/2" 1)
      ("extracellular signal regulated kinases (ERK)" 1)
      ("monoclonal mouse anti-human STAT5 and phosphotyrosine STAT5, AKT and phosphoserine AKT, ERK-1/2 and phosphotyrosine ERK-1/2"
       1)
      ("P-Erk1/2" 1) ("dominant negative (DN) Erk1/2" 1) ("–Erk1/2" 1)
      ("P-Erk 1/2" 1) ("ERK1/2 (MEK)" 1) ("erk 1/2" 1) ("the classical ERK1/2" 1)
      ("the precise role Erk1/2" 1) ("ErK1/2" 1) ("ERK1/2 (MAPK)" 1)
      ("more ERK1/2" 1) ("relatively more pERK1/2" 1) ("less ERK1/2" 1)
      ("exogenous 1 µM H 2 O 2 activated endothelial cell ERK1/2" 1)
      ("the precise role ERK1/2" 1)
      ("extracellular signal regulated kinases 1 and 2 (ERK)" 1) ("p-ERK-1/2" 1)
      ("ERK1/2’s" 1) ("directly binding ERK1/2" 1)))
    ("BE:ETS" (("ETS-domain" 24)))
    ("BE:EXOC"
     (("exocyst complex" 479) ("EXOC" 145) ("Exocyst complexes" 22)
      ("exocyst complexes" 15) ("Exocyst complex" 13)
      ("the octameric exocyst complex" 4) ("the octomeric exocyst complex" 2)
      ("exocyst complex (EXOC)" 2) ("the full octameric exocyst complex" 1)
      ("the heteroctomeric exocyst complex" 1)
      ("the highly-conserved eight protein exocyst complex" 1)))
    ("BE:Ephrin_receptor"
     (("Eph receptors" 70) ("Eph receptor" 34) ("Eph receptor family" 9)
      ("Eph Receptor" 1)))
    ("BE:FANC" (("FANC" 65) ("Fanc" 10)))
    ("BE:FGF"
     (("fibroblast growth factor" 227) ("fibroblast growth factors" 74)
      ("Fibroblast Growth Factor" 33) ("fibroblast growth factor (FGF)" 28)
      ("fibroblast growth factor (FGF) family" 13) ("Fibroblast Growth Factors" 5)
      ("fibroblast growth factor family" 3)
      ("There are 18 known fibroblast growth factors" 2)
      ("basic fibroblast growth factors" 2) ("basic Fibroblast Growth Factor" 1)))
    ("BE:FGFR"
     (("FGFRs" 463) ("Fgfrs" 12) ("Fgfr" 10) ("FgfR" 9) ("FgfRs" 3)
      ("FGFRs family" 2) ("dominant-negative Fgfrs" 1)))
    ("BE:FLOT" (("pFlot" 2) ("FLOT" 1)))
    ("BE:FNT"
     (("farnesyltransferase" 69) ("Farnesyltransferase" 8)
      ("farnesyltransferases" 3)))
    ("BE:FOXO" (("Foxo" 59) ("Foxo family" 8) ("Foxos" 2) ("pFoxo" 1)))
    ("BE:FSH"
     (("follicle-stimulating hormone" 26) ("Follicle-stimulating hormone" 3)))
    ("BE:FZD" (("FZD" 110) ("Fzd" 12) ("FZDs" 3) ("fzd" 2) ("FzD" 1) ("Fzds" 1)))
    ("BE:Fibrinogen"
     (("fibrinogen" 767) ("Fibrinogen" 40) ("soluble fibrinogen" 3)
      ("using Alexa Fluor 647–labeled fibrinogen" 3)
      ("Alexa Fluor 488–labeled human fibrinogen" 2)
      ("surface-bound fibrinogen" 2) ("fibrinogen-" 2)
      ("than fibrinogen ( xref )" 1) ("soluble and immobilized fibrinogen" 1)
      ("than unmodified fibrinogen [ xref ]" 1) ("–fibrinogen" 1)))
    ("BE:GABR"
     (("GABA receptor" 17) ("postsynaptic GABA receptor" 2) ("GABA receptors" 2)))
    ("BE:GPCR"
     (("GPCR" 718) ("GPCRs" 714) ("GPCR family" 19) ("GPCR-" 12) ("most GPCRs" 4)
      ("classical GPCRs" 4) ("a classical G q/11 -coupled GPCR" 4) ("GPCR's" 2)
      ("a viral GPCR" 2)
      ("all current therapeutic agents directly or indirectly target GPCRs" 2)
      ("GPCRs family" 2) ("a typical GPCR" 2) ("-linked GPCRs" 1)
      ("a few GPCRs" 1) ("class A GPCRs" 1) ("most other adhesion GPCRs" 1)
      ("the most pharmacologically relevant GPCRs" 1) ("one or more GPCRs" 1)
      ("The P2Y 1 purinergic GPCR" 1) ("specifically target GPCRs" 1)
      ("a classical GPCR" 1) ("atypical GPCRs" 1) ("Numerous neuronal GPCRs" 1)))
    ("BE:GPIb_IX_V" (("GPIb-IX-V" 1)))
    ("BE:GRIA"
     (("AMPA receptor" 64) ("AMPA receptors" 52) ("AMPAR" 15) ("AMPARs" 7)
      ("synaptic AMPARs" 4) ("synaptic AMPA receptors" 2)
      ("fewer surface AMPA receptors" 1) ("Ca 2+ -permeable AMPA receptors" 1)
      ("calcium-permeable AMPA receptors" 1) ("AMPAR-" 1)
      ("Synaptic AMPA receptors" 1) ("than AMPA receptors" 1)))
    ("BE:GRK" (("GRKs" 13)))
    ("BE:GSK3"
     (("GSK3" 3745) ("Gsk3" 62) ("p-GSK3" 38) ("pGSK3" 18) ("GSK3s" 18)
      ("GSK3-" 10) ("-GSK3" 8) ("GSk3" 6) ("GSK3 protein" 5) ("gsk3" 4)
      ("GSK3 family" 4) ("P-GSK3" 3) ("the N-terminal serine of GSK3" 2)
      ("pGsk3" 1) ("more GSK3s" 1) ("overexpressing GSK3" 1)))
    ("BE:GST" (("Gst" 35)))
    ("BE:GUCY"
     (("guanylyl cyclase" 14) ("soluble guanylyl cyclase" 9) ("Gucy" 3)
      ("Soluble guanylyl cyclase" 2) ("less soluble guanylyl cyclase protein" 1)
      ("guanylyl cyclase protein" 1) ("guanylyl cyclase (GC)" 1)))
    ("BE:G_12"
     (("G12" 940) ("-G12" 2) ("G12-" 2) ("whose tumors expressed G12" 1)
      ("whose tumors lack G12" 1)))
    ("BE:G_q"
     (("Gq/11" 130) ("the cancer-associated mutant Gq/11" 2) ("Gq/11-" 2)))
    ("BE:HDAC_I"
     (("class I HDACs" 263) ("Class I HDACs" 75)
      ("class I histone deacetylases" 16) ("HDAC I" 2)
      ("the classical class
I HDACs"
       1)
      ("class
I HDACs"
       1)
      ("than those containing class I HDACs" 1)
      ("class I histone deacetylases (HDAC)" 1) ("targeting class I HDACs" 1)
      ("most class I HDACs" 1)))
    ("BE:HDAC_II"
     (("class II HDACs" 124) ("Class II HDACs" 32) ("than class II HDACs" 2)
      ("than Class II HDACs" 2) ("specifically target class II HDACs" 2)
      ("most class II HDACs" 1)))
    ("BE:HDAC_III" (("class III HDACs" 55) ("Class III HDACs" 19) ("HDACIII" 2)))
    ("BE:HES"
     (("ES" 2024) ("ESEs" 110) ("targeted ES" 4) ("ES-" 3) ("Targeted ES" 2)
      ("theoretical ESEs" 2) ("pES" 2) ("these computer-identified ESEs" 2)
      ("The human ovarian clear cell carcinoma cell line ES-2" 1)
      ("their associated ESEs" 1) ("Most ESEs" 1) ("8 correctly targeted ES" 1)
      ("Correctly targeted ES" 1)
      ("Unresectable locally advanced and metastatic ES" 1)))
    ("BE:HIF1"
     (("hypoxia-inducible factor-1" 104) ("hif-1" 20)
      ("Hypoxia-inducible factor-1" 14) ("Hif-1" 5)))
    ("BE:HMOX"
     (("heme oxygenase" 19) ("heme oxygenase family" 3) ("haem oxygenase" 3)
      ("heme oxygenase-" 1) ("Haem oxygenase" 1)))
    ("BE:HSP90" (("Hsp-90" 9))) ("BE:HSP90AA" (("HSP90AA" 1)))
    ("BE:HSPA"
     (("HSPA" 21) ("HSPA family" 14) ("HSPA protein" 3) ("HSPAs" 3)
      ("HSPA (HSP70) family" 3) ("Hspa" 2)))
    ("BE:HSPB"
     (("HSPB" 53) ("HSPB family" 20) ("HspB" 6) ("HSPBs" 6) ("most HSPBs" 1)))
    ("BE:Histone_H3"
     (("histone H3" 2936) ("Histone H3" 419) ("p-histone H3" 14)
      ("the mitotic marker phospho-histone H3" 8) ("histone H3 protein" 8)
      ("histone H3 peptide" 6) ("-histone H3" 4) ("P-histone H3" 4)
      ("trimethyl (Lys9)-phospho (Ser10)-Histone H3" 3)
      ("the mitotic marker phosphorylated histone H3" 3)
      ("previously known histone H3" 2) ("monomeric histone H3" 2)
      ("-Histone H3" 2) ("a mitotic marker histone H3" 2)
      ("the chromatin-associated histone H3" 2)
      ("the mitotic marker phospho-Histone H3" 2)
      ("the mitotic marker phospho-serine 10 histone H3" 2)
      ("Histone
H3"
       2)
      ("the mitotic marker mouse anti-phospho S10 Histone H3" 2)
      ("Di-Methylated Histone H3" 2)
      ("a well-known mitotic marker phospho-histone H3" 2)
      ("using another mitotic marker phosphorylated histone H3" 2)
      ("soluble histone H3" 1) ("than those showing pSer10-histone H3" 1)
      ("histone
H3"
       1)
      ("nucleosomal histone H3" 1) ("the repressive histone H3" 1)
      ("Histone H3 peptide" 1) ("Histone H3 protein" 1)))
    ("BE:IFNA" (("IFN-a" 4)))
    ("BE:IGFBP"
     (("IGFBPs" 152) ("IGFBP" 103) ("Insulin-like growth factor binding" 21)
      ("IGFBP family" 9) ("insulin-like growth factor-binding" 4)
      ("insulin-like growth factor binding" 3)
      ("insulin-like growth factor-binding protein" 2)
      ("the most abundantly expressed IGFBP" 2)
      ("Insulin-like growth factor binding protein" 2)
      ("Insulin-like growth factor-binding" 2)
      ("insulin-like
growth factor binding"
       1)
      ("Most IGFBPs" 1) ("the predominant IGFBP" 1)
      ("than full-length IGFBPs [ xref – xref ]" 1) ("IGFBP-" 1)))
    ("BE:IKK_family"
     (("IKKs" 257) ("IkK-" 3) ("IkK" 3) ("so-called non-canonical IKKs" 1)
      ("than the canonical IKKs ( xref )" 1)))
    ("BE:IL12"
     (("IL-12" 888) ("IL-12p70" 89) ("IL12" 57) ("Il12" 18) ("interleukin-12" 13)
      ("interleukin 12" 7) ("IL12p70" 4) ("Interleukin 12" 4) ("IL12 protein" 2)
      ("simultaneous high IL12" 2) ("Interleukin-12" 1) ("than IL-12p70" 1)))
    ("BE:Interferon"
     (("interferon" 1196) ("interferons" 246) ("Interferon" 92) ("Interferons" 26)
      ("interferon-" 16) ("interferon (IFN)" 6) ("interferon (IFN) family" 5)
      ("Interferon-" 4) ("interferon (TRIF)" 2) ("antiviral interferon" 2)
      ("soluble type-1 interferon (IFN)" 1) ("interferon’s" 1)
      ("interferons (IFN)" 1)))
    ("BE:JNK"
     (("JNK" 7805) ("c-Jun N-terminal kinase" 259) ("p-JNK" 134) ("pJNK" 132)
      ("Jnk" 119) ("c-Jun N-terminal kinases" 60) ("JNK MAPK" 48)
      ("c-Jun N-terminal kinase (JNK)" 29) ("c-Jun NH2-terminal kinase" 27)
      ("c-jun N-terminal kinase" 26) ("JNK MAPKs" 9)
      ("c-jun N-terminal kinases" 8) ("P-JNK" 7)
      ("c-jun N-terminal kinase (JNK)" 6) ("c-JNK" 5)
      ("c-Jun NH2-terminal kinases" 5) ("JNK protein" 5)
      ("c-Jun NH2-terminal kinase (JNK)" 4) ("c-jun NH2-terminal kinase" 4)
      ("c-Jun N-terminal kinases (JNK)" 3) ("JNK family" 3)
      ("C-Jun N-terminal kinases" 3) ("p-Jnk" 3)
      ("1/2000 rabbit monoclonal antihuman phospho–c-Jun N-terminal kinase (JNK)"
       3)
      ("c-Jun N-terminal
kinase"
       2)
      ("radiation-induced MKP1 specifically targets JNK" 2)
      ("radiation-induced MKP1 particularly targets JNK" 2)
      ("c-JUN N-terminal kinase" 2) ("c-Jun N-terminal kinase-" 2) ("JNK (APF)" 2)
      ("the pro-apoptotic c-Jun N-terminal kinases" 2)
      ("adenoviral dominant negative JNK" 2) ("Jnk-" 1)
      ("C-Jun N-terminal kinase" 1) ("“pJNK”" 1) ("than JNK" 1)
      ("the M itogen- A ctivated P rotein K inase (MAPK) JNK" 1)
      ("-c-Jun N-terminal kinase" 1) ("further activating p-JNK" 1)
      ("total or phosphorylated c-Jun N-terminal kinase (JNK)" 1) ("p-JNK MAPK" 1)
      ("C-jun NH2-terminal kinase" 1) ("pJnk" 1)))
    ("BE:LH"
     (("luteinizing hormone" 40) ("luteinizing hormone (LH)" 4)
      ("Luteinizing hormone" 2) ("luteinizing hormone-" 1)))
    ("BE:Laminin_332"
     (("laminin-5" 34) ("laminin 332" 19) ("laminin-332" 14) ("Laminin-332" 7)
      ("Laminin-5" 6) ("laminin 332 chains" 2)
      ("the heterotrimeric Laminin-332 (LM-332) molecule" 1)
      ("Laminin-332 (LM-332) molecule" 1) ("less laminin-5" 1)))
    ("BE:MAC" (("MAC" 103) ("MACs" 5))) ("BE:MAP1LC3" (("MAP1LC3" 21)))
    ("BE:MAP3K"
     (("MAP3K" 55) ("MAPKKK" 54) ("MEKK" 30) ("MAPK kinase kinase" 29)
      ("mitogen-activated protein kinase kinase kinase" 25) ("MAP3Ks" 24)
      ("MEK1 kinase" 21) ("mitogen-activated protein kinase kinase kinases" 14)
      ("MAP kinase kinase kinases" 12) ("MAPK kinase kinases" 9) ("MEKK family" 8)
      ("MAP kinase kinase kinase" 8) ("MAPKKK family" 7)
      ("mitogen-activated protein kinase kinase kinase (MAP3K) family" 5)
      ("MEKK protein" 4) ("MAPK kinase kinase (MAPKKK)" 4)
      ("mitogen-activated protein kinase kinase kinase family" 4)
      ("MAP kinase kinase kinase (MAPKKK) family" 4) ("MAP3K family" 3)
      ("MAP kinase kinase kinase (MAP3K) family" 2)
      ("MAPK kinase kinases (MEKK)" 1) ("MAPK kinase kinase (MAP3K) family" 1)
      ("MAP kinase kinase kinase (MAPKKK)" 1) ("MAP3K (NIK)" 1)
      ("Mitogen-activated protein kinase kinase kinase" 1)))
    ("BE:MEK"
     (("MEK" 6379) ("MEK1/2" 1433) ("Mek" 234) ("p-MEK" 163) ("pMEK" 155)
      ("MAPKK" 88) ("Mek1/2" 77) ("MEKs" 57)
      ("mitogen-activated protein kinase kinase" 53) ("p-MEK1/2" 34) ("MAPKKs" 32)
      ("MEK 1/2" 31) ("pMEK1/2" 29) ("MEK-1/2" 24) ("pMEK-1/2" 20) ("MEK-" 10)
      ("P-MEK" 9) ("mitogen-activated protein kinase kinases" 8)
      ("mitogen activated protein kinase kinase" 6) ("-MEK1/2" 6) ("pMek" 5)
      ("targeting MEK" 5) ("MEKDD" 5)
      ("Mitogen-activated protein kinase kinase" 4)
      ("mitogen-activated protein kinase kinase (MEK)" 4) ("P-MEK1/2" 3)
      ("mitogen-activated protein kinase kinase family" 3)
      ("Mitogen-activated protein kinase kinases" 3) ("-MEK" 3) ("than MEK" 2)
      ("pMek1/2" 2) ("MAPKK family" 2) ("MEK family" 2) ("p-MEK 1/2" 2)
      ("residual pMEK" 2) ("a noncompetitive MEK" 1) ("associated MEK" 1)
      ("dual specificity kinases MEK1/2" 1)
      ("Mitogen activated protein kinase kinase" 1) ("MEK1/2-" 1)
      ("the dual specificity kinases MEK1/2" 1) ("their respective MAPKKs" 1)
      ("two respective MEKs" 1) ("than MEKs" 1)
      ("mitogen activated ERK kinases" 1)
      ("mitogen-activated protein kinase kinases (MKK)" 1)
      ("relatively little MEK" 1) ("Similarly immunoprecipitated active MEKs" 1)
      ("mitotic MEKs" 1) ("MEK's" 1) ("MEk1/2" 1)
      ("classical upstream activator MEK1/2" 1) ("than MEK1/2" 1) ("dual MEK" 1)))
    ("BE:MMP" (("MMP" 1740) ("pMMP" 64) ("Mmps" 2)))
    ("BE:MYH"
     (("myosin heavy chain" 103) ("Myosin heavy chain" 9)
      ("myosin heavy chains" 5) ("-myosin heavy chain" 5)
      ("myosin heavy chain (MHC)" 2) ("myosin heavy chain (NMHC)" 2)
      ("myosin heavy chain protein" 2) ("-myosin heavy chain (MHC)" 1)))
    ("BE:MYL"
     (("MLC" 804) ("myosin light chain" 211) ("pMLC" 74) ("P-MLC" 21) ("p-MLC" 19)
      ("myosin light chains" 12) ("myosin light chain (MLC)" 10)
      ("Myosin light chain" 5) ("the stress fiber-associated protein MLC" 2)
      ("MLCs" 2) ("Mlc" 2) ("mLCS" 2) ("enhanced perijunctional pMLC" 1)
      ("myosin light chains (MYL)" 1)))
    ("BE:MYL_regulatory"
     (("regulatory myosin light chain" 3)
      ("regulatory myosin light chain (RMLC)" 2)
      ("regulatory myosin light chains" 2)))
    ("BE:MYST"
     (("MYST" 41) ("MYST family" 28)
      ("MYST (MOZ, YBF2, SAS2, and TIP60) family" 3)))
    ("BE:NCOA"
     (("NCoA" 25) ("NCOAs" 23) ("NCOA" 14) ("p160/SRC" 7) ("p160/SRC family" 3)
      ("NCOA family" 2) ("NcoA" 1)))
    ("BE:NCOR"
     (("NCoR" 258) ("NcoR" 13) ("NCoRs" 1) ("receptor corepressor" 1)
      ("its closely-related paralog NCoR" 1) ("receptor corepressors" 1)
      ("Transcriptional corepressor NCoR" 1)))
    ("BE:NDRG" (("NDR family" 6))) ("BE:NFY" (("NFY" 50) ("NFY family" 2)))
    ("BE:NFkappaB"
     (("NF-κB" 29385) ("NF-kB" 1323) ("kappa B" 631) ("NFkB" 489)
      ("NF-kappaB" 460) ("NFκ" 351) ("NF-κB family" 152) ("NFKB" 96)
      ("factor-kappaB" 86) ("kB" 79) ("NFkappaB" 63) ("NF-κB-" 48) ("NF–κB" 42)
      ("NF-KB" 40) ("NF-κB protein" 36) ("astroglial NF-κB" 35) ("p-NF-κB" 22)
      ("Kappa B" 19) ("pNF-κB" 16) ("NF-κB’s" 13) ("NF-kB family" 10) ("Nfκb" 9)
      ("Factor-kappaB" 8) ("NF-κBs" 8) ("-NF-κB" 8) ("pNFkB" 7) ("than NF-κB" 7)
      ("Relish" 7) ("NF-KappaB" 6) ("factor-kappaB (NF-κB) family" 6)
      ("Nuclear factor-kappaB" 6) ("factor kappa-b" 6) ("NF-kb" 5)
      ("NF-kappabeta" 5) ("Factor kappaB" 5) ("NF-κB (p65) protein" 4)
      ("NF-κB Family" 4) ("NF-kB-" 3) ("p-NFkB" 3) ("overexpressed NF-κB" 3)
      ("Nfκ" 3) ("nfκb" 3) ("NF-κB (RELA)" 3) ("NF-κB (RANK)" 3) ("-NFkB" 3)
      ("NF-κB−" 3) ("low-dose UVB exposure reduced chromosomal-bound NF-κB" 2)
      ("NFkB family" 2) ("NFkB-" 2) ("nonspecific nucleotide NF-κB" 2)
      ("NF-kappaB protein" 2) ("both the classical NF-κB" 2)
      ("transcriptionally competent NF-κB" 2) ("NF-κB–" 2)
      ("hypoxia increased NF-κB" 2) ("the well-documented NF-κB" 2)
      ("the stress-responsive transcription factor NF-κB" 2)
      ("the ubiquitous mammalian transcription factor NF-κB" 2) ("NFk-B" 2)
      ("viral protein synthesis rendered NF-κB" 2) ("heterodimeric NF-κB" 2)
      ("the now-liberated NF-κB" 2)
      ("AlexaFluor 488-labeled mouse anti-human NF-κB" 2) ("Endogeous NF-κB" 2)
      ("placental NF-κB" 2) ("transiently overexpressed Zfra sequestered NF-κB" 2)
      ("overexpressed Zfra sequestered NF-κB" 2) ("almost all NF-κB" 2)
      ("kappa B (RANK)" 2) ("NF-κB family protein" 2)
      ("Factor-kappaB (NF-κB) family" 2) ("IHC NF-κB" 2)
      ("strong nuclear NF-κB" 2) ("NF-kappaB (NF-κB) family" 2)
      ("NF-κB (nuclear factor of kappa light polypeptide gene enhancer in B-cells) family"
       2)
      ("at least two biochemically distinct p65-p50 NF-κB" 1)
      ("a brain injury model astroglial NF-κB" 1) ("the classical NF-κB" 1)
      ("a major O-GlcNAcylated NF-κB protein" 1) ("NF-κB (IκB) family" 1)
      ("classical NF-κB" 1) ("Noncanonical NF-κB" 1) ("noncanonical NF-κB" 1)
      ("than NF-κB (Fig. xref )" 1) ("“NF-κB”" 1) ("−NF-κB" 1)
      ("both heterodimeric and homodimeric NF-κB" 1) ("Radiation-induced NF-kB" 1)
      ("NF-κB (IKK)" 1) ("the heterodimeric NF-kB" 1) ("The NF-κB’s" 1)
      ("dimeric NF-κB" 1) ("the former increased IKKβ-induced NF-κB" 1)
      ("further epigenetic regulators control NF-κB" 1) ("p65-associated NF-κB" 1)
      ("balance NF-κB’s" 1) ("also known as classical NF-κB" 1)
      ("Mammary NF-κB" 1) ("than mutII NF-κB" 1) ("than mutII NF-κB (p<0.05)" 1)
      ("than mutII NF-κB ( xref )" 1) ("than mutI NF-κB" 1)
      ("than NF-κB ( xref ; xref )" 1) ("the membrane diffusible NF-κB" 1)
      ("most cells NF-κB" 1) ("astrocytic NF-κB" 1) ("the recurrent NF-κB" 1)
      ("representative NF-κB" 1) ("NF−κB" 1) ("in turn releases NF-κB" 1)
      ("STAT3-associated NF-κB" 1) ("NF-κB's" 1) ("Less NF-κB" 1)
      ("p65-deficient mice lack synaptic NF-κB" 1)
      ("whose
                laboratory NF-κB"
       1)
      ("its transcriptional partner canonical NF-κB" 1) ("neuronal NF-κB" 1)
      ("Placental NF-κB" 1) ("previously identified motifs -NFkB" 1) ("-NF-kB" 1)
      ("the noncanonical NF-κB" 1) ("NFKB-" 1) ("Nf-kB" 1)
      ("the prosurvival factor NF-κB" 1) ("most unstimulated cells NF-κB" 1)
      ("NF-Kb" 1)))
    ("BE:NRG"
     (("neuregulins" 29) ("NRGs" 11) ("Neuregulins" 8) ("Immature NRGs" 1)))
    ("BE:NTRK"
     (("Trk receptors" 15) ("NTRK" 5) ("Trk receptor" 3) ("NTRK family" 2)
      ("neuronal Trk receptors" 1)))
    ("BE:Na_K_ATPase"
     (("Na,K-ATPase" 113) ("Na/K-ATPase" 10)
      ("neuronal, vascular, muscular and renal Na,K-ATPase" 1)))
    ("BE:Notch"
     (("NOTCH" 292) ("notch" 58) ("the suprasternal notch" 3)
      ("the sciatic notch" 2) ("narrow sciatic notches" 1) ("notches" 1)
      ("NOTCH-" 1)))
    ("BE:P2RX" (("P2X" 15) ("P2X receptors" 5) ("P2X family" 2)))
    ("BE:P70RSK" (("p70RSK" 2)))
    ("BE:P90RSK"
     (("p90RSK" 190) ("p90 RSK" 121) ("p-p90RSK" 26) ("P90RSK" 15) ("RPS6KA" 6)
      ("p90 RSK family" 5) ("P-p90RSK" 4) ("p90Rsk" 4) ("P90 RSK" 4) ("p90rsk" 3)
      ("p90RSK family" 3) ("pp90rsk" 1) ("p90 Rsk" 1)))
    ("BE:PAK"
     (("PAK" 918) ("Pak" 548) ("Paks" 323) ("PAKs" 285)
      ("p21-activated kinases" 111) ("p21-activated kinase" 106) ("PAK family" 43)
      ("p-PAK" 23) ("p21-activated kinase (PAK)" 19) ("Pak family" 12)
      ("P21-activated kinases" 8) ("pPAK" 8) ("Pak's" 5) ("Pak protein" 5)
      ("p21-activated kinase (PAK) family" 4) ("PAK-" 4) ("P-Pak" 3)
      ("Nef-associated serine kinase Pak" 2) ("PAK protein" 2)
      ("p21-activated kinases (PAKs) family" 2) ("Pak molecule" 2)
      ("p21-activated kinase (Pak) family" 2) ("LD4 associated PAK" 1)
      ("exogenous BRAF and Group I PAKs" 1) ("P21-activated kinase" 1)
      ("targeting PAKs" 1) ("centrosomal Pak" 1)
      ("their other mitotic roles xref  xref  xref Paks" 1) ("Pak’s" 1)
      ("than Group I Paks" 1) ("the more distantly group II Paks" 1)
      ("this full-length dominant-negative Pak" 1) ("PAK's" 1)))
    ("BE:PBX" (("PBX" 19) ("Pbx" 18)))
    ("BE:PDC"
     (("DC" 1906) ("dC" 43) ("pDC" 11) ("-DC" 11) ("mature DC" 7) ("treated DC" 6)
      ("IL-15-treated DC" 4) ("autologous DC" 3) ("immature DC" 3)
      ("Immature DC" 3) ("tolerogenic DC" 2) ("more classical DC" 2)
      ("CD11c + splenic DC" 2) ("dc" 2) ("immature CD1a+ langerin/CD207+ DC" 2)
      ("the immature DC" 2) ("“Sine-DC”" 1) ("than murine DC" 1)
      ("The absolute DC" 1) ("Dc" 1) ("peripheral DC" 1) ("the pathological DC" 1)
      ("lesional CD207 + DC" 1) ("DC's" 1) ("immature DC–" 1) ("DC–" 1)
      ("IFN-β–treated DC" 1) ("non-reoTCM-treated tumour-loaded DC" 1)
      ("“AML-DC”" 1) ("the LPS-primed mature DC" 1)
      ("10^6 peptide-pulsed autologous DC" 1) ("decidual DC" 1)
      ("received autologous DC" 1) ("peptide-loaded irradiated autologous DC" 1)
      ("IL-15/p38 inhibitor-treated DC" 1) ("a mature DC" 1)))
    ("BE:PDE"
     (("phosphodiesterase" 79) ("-phosphodiesterase" 14) ("Phosphodiesterase" 3)
      ("Phosphodiesterase (PDE)" 2) ("phosphodiesterase (PDE)" 1)))
    ("BE:PDGF"
     (("PDGF" 2193) ("PDGFs" 36) ("Pdgf" 25) ("PDGF family" 20) ("pPDGF" 1)
      ("PDGF (AB)" 1) ("than the PDGFs ( xref ; xref )" 1)))
    ("BE:PDGFR_AA" (("PDGFRαa" 3))) ("BE:PDGFR_AB" (("PDGFRαb" 1)))
    ("BE:PDGF_AA" (("PDGF-AA" 261) ("PDGFAA" 11) ("PDGF-AA–" 2)))
    ("BE:PDGF_AB" (("PDGF-AB" 65) ("The PDGF-AB" 1)))
    ("BE:PDGF_BB"
     (("PDGF-BB" 1112) ("exogenous PDGF-BB" 27) ("PDGFBB" 26) ("PDGFbb" 7)
      ("soluble PDGF-BB" 4) ("PDGF-BB-" 3) ("yet another mediator PDGF-BB" 2)
      ("Exogenous PDGF-BB" 1) ("FNIII 8–11 required exogenous PDGF-BB" 1)
      ("astrocytic PDGF-BB" 1) ("PDGF-BB protein" 1) ("than soluble PDGF-BB" 1)
      ("The fibrogenic PDGF-BB" 1)))
    ("BE:PDGF_CC"
     (("PDGF-CC" 138) ("the neurotrophic protein PDGF-CC" 1)
      ("PDGF-CC protein" 1)))
    ("BE:PDGF_DD" (("PDGF-DD" 15)))
    ("BE:PDK" (("PDK" 31) ("PDKs" 6) ("Pdks" 4) ("Pdk" 4)))
    ("BE:PFN"
     (("Fn" 856) ("profilin" 55) ("pFn" 10) ("Profilins" 4) ("profilins" 4)
      ("Profilin" 4) ("Fns" 3) ("Fn molecule" 2) ("PFN" 2) ("Pfns" 2)
      ("24-well plate Fn" 2) ("little mesenchymal marker Fn" 2)
      ("than Fn in the plasma" 1) ("The soluble pFn" 1)))
    ("BE:PI3K"
     (("PI 3" 322) ("phosphatidylinositol-3 kinase" 192) ("PI-3-kinase" 36)
      ("phosphatidyl-inositol-3-kinase" 11) ("phosphatidyl-inositol 3-kinase" 11)
      ("Phosphatidylinositol-3 kinases" 10) ("phosphatidyl-inositol-3 kinase" 9)
      ("Phosphatidylinositol-3 kinase" 7) ("phosphatidylinositol-3 kinases" 5)
      ("phosphatidylinositol-3’-kinase" 4) ("PI-3Ks" 4)
      ("phosphatidylinositol–3 kinase" 4)
      ("the only Class III phosphatidylinositol-3 kinase" 3)
      ("phosphatidyl inositol-3-kinase" 3) ("PI 3-" 2)
      ("phosphatidylinositol-3'-kinase" 2)
      ("phosphatidylinositol-3 kinase (PI3K) family" 2)
      ("phosphatidylinositol-3
            kinase"
       2)
      ("Phosphatidyl inositol-3-kinase" 2) ("Phosphatidyl Inositol-3-Kinase" 2)
      ("“phosphatidylinositol-3 kinase”" 1) ("PI-3k" 1)))
    ("BE:PI3K_p110" (("PI3K p110 subunit" 12) ("PI3K p110 subunits" 2)))
    ("BE:PI3K_p85"
     (("p85" 3059) ("p85 protein" 50) ("P85" 42) ("monomeric p85" 21) ("p-p85" 6)
      ("p85 peptide" 5) ("study monomeric p85" 3) ("p85 family" 3)
      ("primarily monomeric p85" 3) ("LAT-associated p85" 2) ("p85-" 1) ("-p85" 1)
      ("mouse monoclonal p85" 1) ("abrogated hepatic p85" 1)
      ("monomeric p85 protein" 1) ("Dominant-negative PI-3K p85" 1)
      ("mouse monoclonal anti-human PI3K p85" 1)
      ("total and phospho-specific PI3k p85" 1)))
    ("BE:PIK3R_I" (("PIK3R" 10))) ("BE:PKA" (("kinase A" 11) ("Kinase A" 2)))
    ("BE:PKC" (("kinase C" 48) ("kinase C family" 2) ("kinase C (PKC)" 1)))
    ("BE:PKI"
     (("PKI" 80) ("PKIs" 36) ("pkIs" 23) ("PKI peptide" 2)
      ("cAMP-dependent protein kinase inhibitor" 1) ("PKI-" 1)))
    ("BE:PLC" (("phospholipase-C" 8) ("phospholipase-C-" 2)))
    ("BE:PLCB"
     (("PLCβ" 78) ("PLC-β" 18) ("phospholipase Cβ" 9) ("PLCb" 3) ("-PLCβ" 1)
      ("Phospholipase Cβ" 1)))
    ("BE:PLCG"
     (("PLCg" 11) ("LCG" 5) ("PLC-gamma" 4) ("PLCg family" 4) ("PLCG" 2)))
    ("BE:PLD" (("Phospholipase D" 19))) ("BE:PPP1" (("PPP1" 8)))
    ("BE:PPP1R" (("PP1R" 2)))
    ("BE:PPP2"
     (("PP2A" 3071) ("protein phosphatase 2A" 249) ("phosphatase 2" 116)
      ("Phosphatase 2A" 22) ("protein phosphatase 2" 21)
      ("Protein phosphatase 2A" 20) ("PP2A family" 14) ("PPP2" 9) ("PP2a" 6)
      ("PP-2A" 5) ("-PP2A" 4) ("than PP2A" 4) ("less PP2A" 2) ("more PP2A" 2)
      ("Heterotrimeric protein phosphatase 2A" 2) ("the haplodeficient PP2A" 2)
      ("-phosphatase 2" 2) ("pPP2A" 2) ("microtubule-associated PP2A" 1)
      ("Phosphatase 2" 1) ("different trimeric PP2A" 1)
      ("forcibly-expressed exogenous PP2A" 1) ("four times less PP2A" 1)
      ("than PP2A (Fig. xref )" 1) ("Protein phosphatase 2" 1)
      ("heterotrimeric PP2A" 1) ("multiple heterotrimeric PP2A" 1)
      ("than protein phosphatase 2A (PP2A)" 1) ("PP2A-" 1) ("PP2A protein" 1)
      ("GSK-3–associated PP2A" 1)))
    ("BE:PPP2C" (("PPP2C" 3) ("PPP2c" 1)))
    ("BE:PRC1_complex"
     (("polycomb repressive complex 1" 23) ("Polycomb repressive complex 1" 16)
      ("the histone-H2A-specific ubiquitin ligase complex Polycomb repressive complex 1"
       2)))
    ("BE:PRDX" (("PRDX" 2)))
    ("BE:PRKAC"
     (("PKA catalytic subunit" 25) ("PKA catalytic subunits" 5)
      ("using pure PKA catalytic subunit" 1)))
    ("BE:PRKAR" (("PKA regulatory subunits" 3))) ("BE:PRKC" (("PRKC" 40)))
    ("BE:Pertussis_toxin"
     (("pertussis toxin" 117) ("Pertussis toxin" 30) ("pertussis toxin (PTX)" 17)
      ("Pertussis toxin (PTX)" 2) ("pertussis toxin (PT)" 1)
      ("pertussis toxins" 1)))
    ("BE:Protease"
     (("protease" 7985) ("Protease" 635) ("protease family" 46)
      ("the viral protease" 27) ("protease (caspase) family" 9)
      ("an active viral protease" 4) ("sarcoma-associated herpesvirus protease" 4)
      ("protease (OTU) family" 3) ("protease (MSP)" 3) ("an external protease" 3)
      ("protease (SENP)" 3)
      ("the sequence-specific HRV 3C (human rhinovirus 3C) protease" 2)
      ("the ovarian tumour domain protease (OTU) family" 2)
      ("an apical protease" 2) ("the only relevant protease" 2)
      ("largest surface protease family" 2) ("the viral protease 3C" 2)
      ("apical protease" 2) ("The neutral protease" 2) ("protease-" 2)
      ("a large multimeric protease" 2)
      ("a cytosolic Ca ++ -activated neutral protease" 2) ("Protease (HAUSP)" 2)
      ("protease (MJD)" 2) ("this lysosomal aspartic protease" 2)
      ("viral protease" 2) ("the virus-associated protease" 2)
      ("the collagenolytic protease" 1) ("a viral protease" 1)
      ("this protease's" 1) ("the protease's" 1) ("Protease-" 1)
      ("protease ( PR)" 1) ("protease (PR)" 1) ("this unique viral protease" 1)
      ("the active site serine of the protease" 1) ("Protease (GE)" 1)
      ("Cysteine-aspartic specific protease" 1) ("excess soluble protease" 1)
      ("a membrane-associated protease" 1) ("an intermediary protease" 1)
      ("a protease" 1) ("exogenous protease" 1) ("a pro-apoptotic protease" 1)
      ("a zymogenic protease" 1)
      ("the deubiquitinating enzyme Herpesvirus-Associated Ubiquitin-Specific Protease"
       1)
      ("This viral protease" 1) ("a MEK/MKK-specific protease" 1)
      ("Herpes-Specific Ubiquitin Specific Protease (HAUSP)" 1)
      ("herpes virus-associated ubiquitin specific protease" 1)
      ("protease (OTU)" 1) ("virally-encoded protease" 1)
      ("the virally-encoded 3C pro protease" 1)
      ("the virally-encoded 3C pro cysteine protease" 1)
      ("virion-associated HIV-1 protease" 1)
      ("the virion-associated viral protease" 1)
      ("a single virion-associated protease" 1)
      ("virus-associated HIV-1 protease" 1) ("virtually any protease" 1)
      ("a vitamin-K-dependent serine protease" 1) ("protease µ" 1)
      ("protease (GE)" 1) ("a massive multi-subunit protease" 1)
      ("an aspartic protease" 1)))
    ("BE:RAPGEF" (("RapGEFs" 7) ("RAPGEF" 2) ("Rapgef" 1)))
    ("BE:RAR" (("retinoic acid receptors" 27)))
    ("BE:RAS"
     (("gene family" 1286) ("gene families" 192) ("Ras family" 188)
      ("RAS family" 82) ("ras family" 14) ("SIRT" 9)
      ("gene
family"
       6)
      ("gene family-" 3) ("largest V H gene family" 3) ("larger gene family" 3)
      ("the highly homologous p21 Ras family" 2) ("gene family ( SIRT )" 2)
      ("the highly homologous Ras family" 2) ("at least one gene family" 2)
      ("Ras Family" 2) ("membrane-associated gene families" 2)
      ("RAS family protein" 1) ("-gene family" 1) ("a very large gene family" 1)
      ("heterogeneous gene families" 1)
      ("the mitotic arrest deficiency (MAD) gene family" 1)
      ("a previously unannotated gene family" 1)
      ("the caudal-related homeobox gene family" 1)
      ("the predominant gene families" 1) ("gene family—" 1) ("Gene families" 1)
      ("largest gene families" 1)))
    ("BE:RASGRF" (("RasGRF" 21) ("RasGRFs" 11) ("specific RasGRF's" 1)))
    ("BE:RASSF"
     (("RASSF" 186) ("RASSFs" 60) ("RASSF family" 59) ("pRASSF" 8) ("Rassf" 6)
      ("the only RASSF protein" 2) ("RASSF family protein" 2)
      ("all classical RASSFs" 2) ("six classical RASSFs" 2) ("RASSF protein" 1)
      ("the classical RASSF family" 1) ("the other classical RASSFs" 1)
      ("The classical RASSFs" 1)))
    ("BE:RNApo_I" (("RNA polymerase 1" 4)))
    ("BE:RNApo_II"
     (("RNAP II" 226) ("the promoter-paused RNAP II’s" 1)
      ("virtually no downstream RNAP II" 1)))
    ("BE:ROCK"
     (("ROCK" 2938) ("ROCKs" 133) ("ROCK family" 5) ("p-ROCK" 4) ("-ROCK" 3)
      ("ROCK-" 3) ("only GST-MBS bound ROCK" 2) ("than ROCK" 2)
      ("the Rho-associated kinase ROCK" 2) ("ROCK protein" 1)
      ("other essential ROCK" 1) ("ROCK (WT)" 1)
      ("than ROCK (e.g., MLC kinase and MRCK)" 1) ("than ROCK ( xref )" 1)))
    ("BE:ROR" (("RoR" 4) ("RORs" 4) ("Pluripotency-associated lnc-RoR" 1)))
    ("BE:RasGAP"
     (("RasGAP" 659) ("Ras-GAP" 291) ("RasGAPs" 123) ("RASGAPs" 26) ("RAS-GAP" 13)
      ("RasGAP family" 6) ("Ras-GAP protein" 5) ("RasGAPS" 5) ("rasGAP" 4)
      ("RasGAP protein (DTRLNTVWMW)" 4) ("RASGAP" 3) ("Ras-GAPs" 3)
      ("Ras-GAP family" 3) ("RAS–GAP" 3) ("RASGap" 2) ("RasGAP protein" 2)
      ("RAS-Gap" 1) ("RAS-GAPs" 1) ("dominant-negative Ras-GAP" 1) ("Ras-GAP-" 1)
      ("‐RASGAP" 1) ("expressing Ras-GAP" 1) ("most RasGAPs" 1)
      ("At least 10 different RasGAPs" 1)))
    ("BE:RhoGDI" (("RhoGDIs" 64) ("RHOGDI" 2)))
    ("BE:S1PR" (("S1PR" 4) ("S1PRs" 3)))
    ("BE:SCD" (("Stearoyl-CoA desaturase" 3))) ("BE:SLC2A" (("SLC2A" 1)))
    ("BE:SMAD"
     (("Smad" 1714) ("Smads" 697) ("SMAD" 435) ("pSMAD" 50) ("smad" 23)
      ("Smad protein" 10) ("SMAD family" 8) ("SMAD-" 7) ("Smad family" 7)
      ("SMADS" 5) ("ligand binding cytoplasmic receptor-associated Smads" 3)
      ("p-SMAD" 2) ("SMAD protein" 2) ("the respective phospho-Smads" 2)
      ("heteromeric
Smad"
       1)
      ("smads" 1) ("the two predominant Smads" 1) ("an alternate SMAD-" 1)
      ("the functional heteromeric Smad" 1) ("-Smad" 1) ("than Smads" 1)
      ("The heteromeric Smad" 1) ("the respective Smads" 1)
      ("signal-driven Smads" 1) ("pSmad" 1)))
    ("BE:SMAD2_3"
     (("Smad2/3" 927) ("SMAD2/3" 197) ("P-Smad2/3" 102) ("smad2/3" 32)
      ("p-Smad2/3" 24) ("Smad 2/3" 19) ("smad-2/3" 7) ("Smad2/3 protein" 4)
      ("pSMAD2/3" 3) ("-Smad2/3" 3) ("the hypoactive P-Smad2/3" 3)
      ("all available P-Smad2/3" 2) ("p-SMAD2/3" 1) ("p-Smad2/3 protein" 1)
      ("the accumulated hypoactive P-Smad2/3" 1) ("pSmad2/3" 1) ("SMAD 2/3" 1)))
    ("BE:SNAI" (("SNAI" 6) ("SNAIs" 1)))
    ("BE:SOS" (("Sos" 201) ("pSos" 15) ("SoS" 6) ("Sos family" 2)))
    ("BE:SPRED"
     (("Spred" 27) ("SPREDs" 22) ("SPRED" 15) ("Spreds" 14) ("Spreds family" 1)))
    ("BE:SPRY"
     (("Spry" 107) ("overexpressed Spry" 4) ("pSpry" 3) ("Spry protein" 2)))
    ("BE:SRC"
     (("Src-kinases" 9) ("Src-kinases family" 2) ("the predominant Src-kinases" 2)
      ("GEM-associated Src-kinases" 1)))
    ("BE:STAT5" (("STAT-5" 195) ("p-STAT-5" 1)))
    ("BE:SWI_SNF"
     (("SWI/SNF complex" 113) ("SWI/SNF complexes" 58) ("than SWI/SNF complex" 1)
      ("potentially links SWI/SNF complexes" 1)))
    ("BE:TAP"
     (("TAP" 873) ("TAP family" 6) ("TAP protein" 2)
      ("proteins underwent TAP" 1)))
    ("BE:TCF-LEF"
     (("TCF-LEF" 56) ("Tcf-Lef family" 5) ("Tcf-Lef" 5) ("TCF-LEF family" 3)))
    ("BE:TCF_LEF"
     (("Tcf" 232) ("Tcf/Lef" 147) ("Tcfs" 22) ("Tcf/Lef family" 14)
      ("Tcf family" 9) ("Tcf protein" 6) ("Tcf/LEF" 4) ("TcF/LEF" 1)))
    ("BE:TGFB" (("TGFb" 27) ("TGFBs" 2) ("TGF-B" 1) ("Tgf-beta" 1)))
    ("BE:TGFBR"
     (("TGF beta receptor" 27) ("TGF-beta receptors" 4) ("TGF beta receptors" 2)
      ("TGF-beta receptor" 1)))
    ("BE:THR"
     (("thyroid hormone receptor" 75) ("thyroid hormone receptors" 25)
      ("thyroid hormone receptor (TR)" 5) ("Thyroid hormone receptors" 3)
      ("thyroid hormone receptors (TR)" 1)
      ("the classic nuclear thyroid hormone receptor (TR)" 1)
      ("Thyroid hormone receptor" 1)))
    ("BE:TLR"
     (("TLR" 1268) ("TLRs" 580) ("TLR family" 17) ("most TLRs" 8)
      ("TLR protein" 8) ("Tlr" 5) ("than single TLR" 1) ("exogenous TLRs" 1)))
    ("BE:TN" (("tenascin" 57) ("Tenascin" 5) ("matrix-associated tenascin" 1)))
    ("BE:TNFRSF" (("TNFR family" 23) ("TNF-receptor family" 5)))
    ("BE:TSC"
     (("tuberous sclerosis" 230) ("Tuberous sclerosis" 51)
      ("Tuberous Sclerosis" 26)))
    ("BE:TUBA" (("Tuba" 5)))
    ("BE:TXNRD"
     (("thioredoxin reductase" 114) ("Thioredoxin reductase" 16)
      ("thioredoxin reductases" 9)
      ("at least two potential Klf9 target genes thioredoxin reductases" 2)
      ("Thioredoxin Reductases" 2) ("Thioredoxin reductases" 1)))
    ("BE:Troponin_C"
     (("cTnI" 278) ("TNC" 251) ("TNCs" 19) ("TnC" 13) ("cTnC" 11) ("Tnc" 1)
      ("Mst1 specifically targets cTnI" 1)))
    ("BE:Troponin_T"
     (("troponin T" 27) ("cardiac troponin T" 5) ("the cardiac troponin T" 2)))
    ("BE:Tryptase" (("tryptase" 62) ("Tryptase" 9)))
    ("BE:Ubiquitin"
     (("ubiquitin" 9354) ("Ub" 3846) ("Ubiquitin" 504) ("ubiquitins" 129)
      ("ubiquitin molecule" 67) ("UB" 55) ("ub" 54) ("-Ub" 42) ("-ubiquitin" 35)
      ("UBS" 27) ("ubiquitin protein" 23) ("–Ub" 23) ("Ub molecule" 20)
      ("ubiquitin-" 19) ("Ub’s" 16) ("Ubs" 13) ("ubiquitin peptide" 11) ("ATCC" 9)
      ("–ubiquitin" 6) ("exogenous ubiquitin" 5) ("Lys-63–linked Ub" 5)
      ("soluble ubiquitin" 4) ("polymeric ubiquitin" 4) ("Ub-" 3)
      ("pTyr363 directly contacts Ub" 3) ("at least four ubiquitins" 3)
      ("the proximal Ub" 3) ("overexpressed His 6 -Ub" 3) ("Ubiquitin (WT)" 2)
      ("optimal Ub" 2) ("the more Ub" 2) ("ubiquitin family" 2)
      ("exogenous free ubiquitin" 2) ("a well-studied E3 Ub" 2) ("Ubiquitins" 2)
      ("TRIM6-synthesized multimeric Ub" 2) ("monomeric ubiquitin" 2)
      ("fluorescent Ub" 2) ("proteome-wide ubiquitin" 2)
      ("receptor-associated ubiquitin" 2) ("four or more ubiquitins" 2)
      ("4 or more ubiquitins" 2) ("longer ubiquitin" 2) ("than ubiquitin" 2)
      ("ubiquitin’s" 2) ("equimolar ubiquitin" 2)
      ("the seven lysines of the previously cross-linked ubiquitin molecule" 2)
      ("chromatin-associated conjugated ubiquitin" 2) ("-Ubiquitin" 2)
      ("ubiquitin (BIOMOL)" 2) ("Ubiquitin-" 2)
      ("non-degradative K63-linked ubiquitin" 2)
      ("containing at least four ubiquitins" 2)
      ("lysine-63 (K63)-linked ubiquitin" 1)
      ("Flag-tagged TRAF3 and haemagglutinin A (HA)-tagged ubiquitin" 1)
      ("available free ubiquitin" 1) ("flag-tagged ubiquitin" 1)
      ("position Ub’s" 1) ("precisely position Ub" 1)
      ("monomeric RING E3-mediated Ub" 1) ("the terminal glycine of Ub" 1)
      ("monomeric RING-mediated Ub" 1) ("pTyr363 directly contacts Ub’s" 1)
      ("the C-terminal glycine of Ub" 1)
      ("the C-terminal Gly of the preceding Ub" 1) ("the C-terminal Gly of Ub" 1)
      ("HDAC6-associated unanchored ubiquitin" 1)
      ("non-degradable forked ubiquitin" 1) ("the distal ubiquitin" 1)
      ("longer Ub" 1) ("UBIQUITIN" 1) ("Lys 48 -linked ubiquitin" 1)
      ("lysine 63 (Lys 63 )–linked ubiquitin" 1)
      ("a deubiquitinase-resistant monomeric ubiquitin" 1)
      ("the C-terminal glycine of a ubiquitin" 1) ("longer K48-linked poly-Ub" 1)
      ("JAK1-associated Ub" 1) ("IKKε-associated Ub" 1) ("ub-" 1)
      ("the distal Ub" 1) ("a few Ubs" 1) ("robust Ub" 1) ("unique Ub" 1)
      ("subsequent Ub" 1) ("The human-specific tryptic ubiquitin peptide" 1)
      ("global ubiquitin" 1) ("−Ub" 1)
      ("the C-terminal glycine of another ubiquitin molecule [ xref ]" 1)
      ("covalently bound ubiquitins" 1) ("physiologically relevant ubiquitin" 1)
      ("associated ubiquitin" 1) ("S7-Ub’s" 1) ("unique ubiquitin" 1)
      ("the associated ubiquitin" 1) ("exclusively forms K63-linked ubiquitin" 1)
      ("internal lysines of ubiquitin" 1) ("nondegradative ubiquitin" 1)
      ("than endogenous ubiquitin" 1) ("a previously attached ubiquitin" 1)
      ("Lys 63 -linked ubiquitin" 1) ("the polymeric ubiquitin" 1)
      ("more polymeric ubiquitin" 1)
      ("the C-terminal glycine of ubiquitin (G76)" 1) ("monomeric Ub" 1)
      ("the lysine of one Ub" 1) ("regenerate free ubiquitin" 1)
      ("than WT ubiquitin" 1) ("subsequent ubiquitin" 1) ("fewer ubiquitin" 1)
      ("HHARI-catalyzed Ub" 1) ("non-reducible isopeptide-linked Ub" 1)
      ("reducible thioester-linked Ub" 1) ("at least 4 ubiquitins" 1)
      ("the previously cross-linked ubiquitin molecule" 1) ("the associated Ub" 1)
      ("the last three amino acids of ubiquitin" 1) ("sequential ubiquitin" 1)
      ("Lys-63–linked ubiquitin" 1) ("at least two types ubiquitin" 1)
      ("the remaining 6 lysines of ubiquitin" 1)
      ("exogenous Myc-tagged ubiquitin" 1) ("Less Ub" 1)
      ("more K63-linked ubiquitin" 1) ("less K63-linked ubiquitin" 1)
      ("less total ubiquitin" 1) ("a sequential mechanism, Ub and FLAG Ub" 1)
      ("the flexible ubiquitin" 1)
      ("the active site cysteine of the ubiquitin activating enzyme (E1)" 1)
      ("Neuronal Ub" 1) ("higher–molecular weight poly-Ub" 1)
      ("simultaneously binding ubiquitin" 1) ("The resin-bound Ub" 1)
      ("than four Ubs" 1)))
    ("BE:VEGF"
     (("VEGF" 8121) ("vascular endothelial growth factor" 684)
      ("vascular endothelial growth factor (VEGF)" 87)
      ("Vascular endothelial growth factor" 73)
      ("vascular endothelial growth factors" 11)
      ("vascular endothelial growth factor (VEGF) family" 10) ("VEGFs" 9)
      ("Vascular endothelial growth factor (VEGF)" 5)
      ("targeting vascular endothelial growth factor (VEGF)" 2)
      ("vascular endothelial growth factor family" 2)
      ("vascular endothelial growth factor-" 2)
      ("vascular endothelial growth
factors"
       1)
      ("“vascular endothelial growth factor”" 1)
      ("vascular endothelial growth factors (VEGF)" 1)
      ("vascular endothelial growth
factor"
       1)
      ("vascular endothelial growth factor ( VEGF )" 1)))
    ("BE:VEGFR"
     (("VEGFR" 292) ("VEGF receptor" 132) ("VEGF receptors" 85) ("pVEGFR" 75)
      ("VEGFRs" 71) ("Vascular endothelial growth factor receptor" 9) ("VEGFrs" 2)
      ("VEGFr" 1) ("soluble VEGF receptor 2" 1) ("VEGF receptor (VEGFR)" 1)))
    ("BE:Wnt"
     (("Wnt" 8582) ("WNT" 893) ("Wnts" 297) ("Wnt family" 50) ("Wnt protein" 24)
      ("WNTs" 19) ("Wnt-" 10) ("-WNT" 9) ("WNT-" 5) ("Wnt–" 5) ("WNT family" 4)
      ("only two Wnts" 4) ("exogenous Wnt" 3)
      ("a well-discussed non-canonical Wnt protein" 2) ("at least some Wnts" 2)
      ("at least 19 Wnts" 1) ("19 identified soluble secreted Wnts" 1) ("-Wnt" 1)
      ("relapsed MB WNT" 1) ("WNTs family" 1) ("the exogenous Wnt" 1)
      ("a noncanonical Wnt" 1) ("strong Wnt" 1) ("external Wnt" 1)
      ("a dominant-negative Wnt" 1) ("our previous model Wnt" 1)))
    ("BE:mTORC1"
     (("mTORC1" 8067) ("mTORc1" 28) ("mTORC1-" 6) ("neuronal mTORC1" 5)
      ("mTorc1" 5) ("mTORC1’s" 4) ("than mTORC1" 4) ("mTORC1's" 4)
      ("mTORC1 protein" 3) ("highly pure and intact mTORC1" 3)
      ("dimeric mTORC1" 2) ("targeted mTORC1" 2)
      ("than mTORC1 possibly underlying elevated IL-4 production" 1)
      ("experiments further supports mTORC1" 1)
      ("serum withdrawal inhibited mTORC1" 1)
      ("the translational regulators downstream mTORC1" 1)
      ("Western diet overactivates mTORC1" 1)))
    ("BE:mTORC2"
     (("mTORC2" 2825) ("mTORc2" 16) ("targeting mTORC2" 4) ("mTORC2-" 2)
      ("Mtorc2" 2) ("mTorc2" 2) ("mTORC2’s" 1) ("mTORC2's" 1)
      ("specifically target mTORC2" 1) ("the previously reported mTORC2" 1)))
    ("BE:p14_3_3"
     (("14-3-3" 3331) ("14-3-3 proteins" 761) ("14-3-3 protein" 129)
      ("14-3-3 family" 59) ("p-14-3-3" 21) ("14-3-3s" 18)
      ("14-3-3 protein family" 15) ("14–3–3" 11) ("14–3-3" 11)
      ("14–3-3 proteins" 9) ("14–3–3 proteins" 8) ("-14-3-3" 5)
      ("14–3–3 protein" 3) ("mouse monoclonal anti 14-3-3" 2) ("dimeric 14-3-3" 2)
      ("indeed no p-14-3-3" 2) ("heterodimeric 14-3-3" 1) ("14-3-3-" 1)
      ("the ubiquitous phosphoserine/threonine-binding protein 14-3-3 family" 1)
      ("than 100 14-3-3 interacting" 1) ("Monomeric 14-3-3" 1)
      ("than 14-3-3 that would be relevant" 1) ("the relevant 14-3-3 proteins" 1)
      ("directly bind 14-3-3" 1)))
    ("BE:p38"
     (("p38" 7832) ("p38 MAPK" 4463) ("p38MAPK" 686) ("p38 MAP kinase" 423)
      ("p38-MAPK" 297) ("p38 mitogen-activated protein kinase" 152) ("P38" 148)
      ("p38 MAP kinases" 94) ("p38mapk" 85) ("p-p38" 60) ("MAPK p38" 37)
      ("p38 mitogen activated protein kinase" 30) ("p38-" 30) ("p-38" 17)
      ("p38 protein" 15) ("p38 mitogen-activated protein kinase (MAPK)" 14)
      ("p38 MAPK protein" 14) ("P38 MAPK" 12) ("MAPK-p38" 11) ("pp38" 11)
      ("-p38" 11) ("p38 MAPK family" 10) ("p-p38MAPK" 9) ("p38 MAPK-" 9)
      ("p38 family" 8) ("p38 mitogen-activated protein kinases" 6) ("P38MAPK" 6)
      ("p38 mitogen activated protein kinases" 4) ("LMP1 1-231-mediated p38" 4)
      ("p38s" 4) ("p38MAPKs" 4) ("p38-MAPKs" 4)
      ("p38 mitogen activated protein kinase (MAPK)" 3) ("p38 µ" 3) ("p38 (AF)" 3)
      ("p38 MAP kinase family" 3)
      ("p38 mitogen-activated protein kinase (MAPK) family" 3)
      ("the stress-activated p38 MAP kinase" 2) ("p38 MAP kinase–" 2)
      ("MAPK p38s" 2) ("Mouse monoclonal phospho-p38 MAPK" 2) ("-p38MAPK" 2)
      ("a HA-tagged dominant-negative p38" 2) ("−p38" 2)
      ("normal human keratinocytes differentiation further implicating p38MAPK" 2)
      ("P-p38" 2) ("neuronal p38 MAPK" 2) ("DTT-treated p38" 2) ("p38 molecule" 2)
      ("p38 MapK" 2) ("“p38”" 1) ("systemic p38" 1) ("simultaneous p38" 1)
      ("An alternate p38" 1) ("Targeting p38 MAPK" 1)
      ("the M itogen- A ctivated P rotein K inase p38" 1)
      ("-p38 mitogen-activated protein kinase (MAPK)" 1)
      ("-p38 mitogen-activated protein kinase" 1)
      ("the noncanonical signals p38MAPK" 1)
      ("P38 mitogen activated protein kinases" 1)
      ("P38 mitogen-activated protein kinase" 1)
      ("293 TRAF1 cells impaired LMP1 1-231-mediated p38" 1) ("P38-" 1)
      ("total and activated p38" 1)
      ("the stress-activated mitogen-activated protein (MAP) kinase p38" 1)
      ("p38 Map kinase" 1) ("-p38 MAPK" 1) ("here report p38 MAPK" 1)
      ("the previously described Rac1→ p38" 1)
      ("osmotic shock activated p38 MAPK" 1)
      ("the stress-responsive MAP kinase p38" 1)
      ("stress-associated kinase p38" 1)
      ("the stress-activated kinases (SAPK) p38 MAPK" 1)
      ("The stress-activated p38 MAPK" 1)
      ("The stress-regulated mitogen activated protein kinase (MAPK) p38" 1)
      ("Essentially no p38" 1) ("Minimal oxidized p38" 1)
      ("p38 Mitogen-activated protein kinase" 1)
      ("total and phosphorylated p38" 1)
      ("P38 mitogen-activated protein kinases" 1) ("microglial phospho-p38" 1)
      ("p38 mitogen activated protein kinases (MAPK)" 1)
      ("the stress-induced p38 MAP kinase" 1) ("pp38MAPK" 1)
      ("less phospho-p38" 1) ("MAPK-p38-" 1) ("pro-apoptotic effector p38" 1)
      ("pro-apoptotic effector phospho-p38" 1)
      ("The stress-inducible kinase p38" 1)
      ("activated stress-associated p38 MAP kinase" 1)
      ("the stress-associated p38 MAP kinase" 1) ("p38 MAP kinase" 1)
      ("p38-MAPK-" 1)))
    ("BE:p53_family"
     (("p53 DNA-binding domain" 61) ("p53 DNA binding domain" 44)
      ("p53 DNA-binding domain (DBD)" 7)
      ("p53 DNA binding
domain"
       4)
      ("p53 DNA-binding domains" 4) ("p53 DNA binding domains" 3)
      ("p53
DNA binding domain"
       2)
      ("p53
DNA-binding domain"
       2)
      ("p53 DNA-binding
domain"
       1)))
    ("CHEBI:101278" (("diltiazem" 6) ("Diltiazem" 5)))
    ("CHEBI:101355" (("IPA-3" 125))) ("CHEBI:101381" (("E64d" 64)))
    ("CHEBI:104120" (("α-methylene-γ-butyrolactone" 6)))
    ("CHEBI:10545"
     (("electron" 1973) ("Electron" 550) ("electrons" 124) ("Electrons" 2)
      ("more electron" 1) ("-electron" 1) ("the highly nucleophilic electrons" 1)
      ("much more electron" 1) ("Inefficient electron" 1) ("more electrons" 1)
      ("secondary electrons" 1) ("respiratory electron" 1)))
    ("CHEBI:107736" (("intravenous metoclopramide" 1) ("metoclopramide" 1)))
    ("CHEBI:114785"
     (("erlotinib" 6152) ("Erlotinib" 609) ("erlotinib-" 28) ("than erlotinib" 11)
      ("Erlotinib-" 4) ("than erlotinib ( xref )" 3) ("erlotinib’s" 3)
      ("daily low-dose erlotinib" 3)
      ("the traditional EGFR inhibitor erlotinib" 2) ("just erlotinib" 2)
      ("daily oral erlotinib" 2) ("Erlotinib’s" 2) ("—erlotinib" 1)
      ("concurrent erlotinib" 1) ("than single-agent erlotinib ( xref )" 1)
      ("“erlotinib”" 1) ("than EGFR specific reversible TKI erlotinib" 1)
      ("Eighty-six percent received erlotinib" 1) ("weekly high-dose erlotinib" 1)
      ("than erlotinib (or bexarotene) alone in lung cancer ( xref , xref , xref )"
       1)
      ("The orally available small molecule EGFR inhibitor erlotinib" 1)
      ("than erlotinib in vivo" 1) ("tested erlotinib’s" 1)
      ("than this deemed erlotinib" 1)))
    ("CHEBI:115196" (("HOBt" 14))) ("CHEBI:11684" (("RT3" 14)))
    ("CHEBI:131189"
     (("glass" 2659) ("glasses" 127) ("Glass" 115)
      ("poly-L-lysine-coated glass" 3) ("Glasses" 3) ("glass (WPI)" 2)
      ("glasses (BD)" 2) ("Laboratory-Tek II 4-well chambered cover glasses" 2)
      ("than glass" 1) ("Eight-chambered RS glass" 1) ("adhesive-coated glass" 1)
      ("positively charged microscopic glass" 1) ("adhesive‐coated glass" 1)
      ("poly-lysine-coated glass" 1) ("10 4 cells/collagen IV-coated glass" 1)
      ("8-well chamber glass" 1) ("Chase Scientific Glass" 1)
      ("treated glass" 1)))
    ("CHEBI:131196" (("OSU-03012" 92))) ("CHEBI:131326" (("JSH-23" 53)))
    ("CHEBI:131802" (("SKF38393" 21) ("acute SKF38393" 2)))
    ("CHEBI:131822" (("sulfamate" 5))) ("CHEBI:131850" (("PR-39" 2)))
    ("CHEBI:131902" (("LDN" 9) ("LDN’s" 1))) ("CHEBI:132084" (("SU11652" 6)))
    ("CHEBI:132120" (("resolvin" 64) ("resolvins" 18) ("Resolvin" 10)))
    ("CHEBI:132153"
     (("hyaluronan" 288) ("Hyaluronan" 20) ("hyaluronan (HA)" 5) ("hyaluronate" 2)
      ("Hyaluronan (HA)" 1) ("we first measured hyaluronan" 1)))
    ("CHEBI:132554"
     (("oligomer" 572) ("Oligomer" 5) ("the duplex siRNA oligomer" 3)
      ("a trimeric Smad2 oligomer" 2) ("a mutated Bcl-xL oligomer" 2)
      ("-oligomer" 2) ("-biotinylated DNA complementary oligomer" 2)
      ("a trimeric oligomer" 1) ("a unique dimer-based CTLA-4 oligomer" 1)
      ("BLOCK-iT Fluorescent oligomer" 1)
      ("than the native oligomer ( xref , xref , xref )" 1)))
    ("CHEBI:132950"
     (("tartrate" 63) ("Tartrate" 8) ("TARTRATE" 2) ("tartrate molecule" 1)))
    ("CHEBI:132951" (("maleate" 17) ("maleate (DEM)" 1) ("Maleate" 1)))
    ("CHEBI:132952"
     (("oxalate" 70) ("Oxalate" 5) ("saturated aqueous uranyl oxalate" 2)
      ("Most oxalate" 1) ("oxalate (PO)" 1)))
    ("CHEBI:132953" (("suberate" 70) ("suberate (DSS)" 15)))
    ("CHEBI:132986"
     (("sapitinib" 8)
      ("the equipotent reversible pan-HER inhibitor sapitinib" 1)))
    ("CHEBI:133021" (("venetoclax" 2)))
    ("CHEBI:133151"
     (("Methyl-beta-cyclodextrin" 6) ("methyl-beta-cyclodextrin" 2)))
    ("CHEBI:13389"
     (("NAD" 2224) ("-NAD" 4) ("NAD-" 3) ("Nad" 3) ("nad" 2)
      ("Pyruvic Acid + NADH ←----→ Lactic Acid + NAD" 1)
      ("essentially no NAD" 1)))
    ("CHEBI:13392" (("NAD(P)H" 289)))
    ("CHEBI:13643"
     (("glycol" 441) ("glycol (PEG)" 24) ("Glycol" 4) ("glycol (EG)" 2)
      ("glycols" 2)))
    ("CHEBI:13850"
     (("apoprotein" 14) ("apoproteins" 14) ("than the apoprotein" 1)))
    ("CHEBI:13941" (("carbamate" 12)))
    ("CHEBI:15035"
     (("retinal" 1041) ("Retinal" 66) ("-retinal" 2) ("fetal retinal" 2)
      ("human telomerase-expressing retinal" 2) ("VHL-associated retinal" 1)
      ("macular hole or giant retinal" 1) ("internal nuclear retinal" 1)
      ("diabetic retinal" 1) ("the distal retinal" 1) ("All digital retinal" 1)
      ("mature retinal" 1) ("telomerase-immortalized retinal" 1)
      ("The immortalized normal retinal" 1)))
    ("CHEBI:15036" (("retinoate" 5))) ("CHEBI:15075" (("selenate" 7)))
    ("CHEBI:15076" (("selenide" 4)))
    ("CHEBI:15318" (("xanthine" 25) ("Xanthine" 7)))
    ("CHEBI:15339"
     (("acceptor" 1410) ("acceptors" 216) ("Acceptor" 30) ("EYFP" 6)
      ("acceptor molecule" 5) ("potential Michael acceptors" 2)
      ("an intronic acceptor" 2) ("acceptor (TMR)" 1) ("‘acceptor’" 1)
      ("the ultimate electron acceptor" 1) ("the two available acceptors" 1)
      ("acceptor (TAMRA)" 1) ("essential acceptors" 1)
      ("essential ubiquitin acceptors" 1) ("a nucleophilic acceptor" 1)
      ("the nucleophilic acceptor" 1) ("“acceptor”" 1) ("acceptor (SA)" 1)))
    ("CHEBI:15347"
     (("acetone" 687) ("ice-cold acetone" 29) ("Acetone" 24) ("-acetone" 17)
      ("acetone-" 3) ("pure acetone" 2) ("pre-cooled acetone" 2)
      ("ice-cold 100% acetone" 1)
      ("50:50 (v/v) resin (Lowicryl K4M):100% acetone" 1)
      ("ice-cold 0.1% HCl/ acetone" 1) ("100% ice-cold acetone" 1)
      ("absolute acetone" 1) ("dry ice-chilled acetone" 1) ("the crude acetone" 1)
      ("acetones" 1) ("80% ice-cold acetone" 1) ("ice-cold (−20 °C) acetone" 1)
      ("using ice-cold 100% acetone" 1)))
    ("CHEBI:15354"
     (("choline" 74) ("cholines" 2) ("choline (PC)" 2) ("Choline" 1)))
    ("CHEBI:15368" (("acrolein" 68) ("than acrolein" 1) ("Acrolein" 1)))
    ("CHEBI:15369"
     (("actinomycin" 75) ("Actinomycin" 9) ("amino actinomycin" 2)
      ("the transcriptional blocker actinomycin" 1)))
    ("CHEBI:15373" (("biopterin" 14) ("Biopterin" 2)))
    ("CHEBI:15377"
     (("water" 6918) ("Waters" 206) ("water molecule" 174) ("Water" 94)
      ("waters" 81) ("CURH" 57) ("treated water" 22) ("double-distilled water" 18)
      ("explicit water" 12) ("DEPC-treated water" 10) ("pure water" 8)
      ("ice-cold water" 5) ("water-" 5) ("than CURH" 5) ("ultra-pure water" 4)
      ("DEPC treated water" 3)
      ("water
molecule"
       3)
      ("RNase/DNase-free water" 3) ("Solvent A contained 98.9% water" 3)
      ("the peripheral water" 3) ("no crystallographic water" 2)
      ("associated water" 2) ("WATER" 2) ("water (DDW)" 2)
      ("only one water molecule" 2) ("ice-cold double distilled water" 2)
      ("mild soapy water" 2) ("opaque water" 2) ("water (NFW)" 2) ("than water" 2)
      ("hydrobromic acid water" 2) ("the residual water" 2) ("internal water" 2)
      ("treated and RNAse-free water" 2) ("warm tap water" 1)
      ("automatic recirculating water" 1) ("supplied bacteriostatic water" 1)
      ("8.5 μl nuclease-free double-distilled water" 1)
      ("extravascular lung water" 1) ("the osmotic water" 1)
      ("finally double distilled water (DDW)" 1) ("12 μl Ultra-distilled water" 1)
      ("distilled-deionized water" 1) ("an ascending ethanol:distilled water" 1)
      ("the nucleophilic water" 1) ("warm soapy water" 1)
      ("xref  incorporated all crystallographic
waters"
       1)
      ("sterile triple distilled water" 1) ("ultra-pure RNase-free water" 1)
      ("Barnstead NANO-pure water" 1) ("diethylpyrocarbonate-treated water" 1)
      ("triple distilled water" 1) ("double-deionized water" 1)
      ("Doxycycline-supplemental drinking water" 1) ("finally distilled water" 1)
      ("warm water" 1) ("Waters-" 1) ("20  μ L DEPC-treated water" 1)
      ("residual water" 1) ("lukewarm water" 1) ("treated deionised water" 1)
      ("the residual non deuterated water" 1)
      ("explicit flexible three-center waters" 1)
      ("using sterile
                    RNase/DNase-free water"
       1)
      ("treated distilled water" 1) ("RNAse-free pure water" 1)
      ("the explicit water" 1) ("crystallographic water" 1)
      ("white opaque water" 1) ("sterile-filtered water" 1) ("favorable water-" 1)
      ("ice-cold distilled water" 1) ("water and half dirty water" 1)
      ("water (MQ)" 1) ("sterile ultra-pure water" 1) ("the internal water" 1)
      ("bacteriostatic water" 1)))
    ("CHEBI:15378" (("hydron" 2) ("Hydron" 1)))
    ("CHEBI:15429" (("hydroxylamine" 42) ("Hydroxylamine" 3)))
    ("CHEBI:15440" (("squalene" 9))) ("CHEBI:15443" (("inulin" 9) ("Inulin" 3)))
    ("CHEBI:15538" (("phytanoyl-CoA" 1)))
    ("CHEBI:15541" (("stearoyl-CoA" 18) ("stearoyl-coA" 2)))
    ("CHEBI:15551"
     (("PGE2" 494) ("prostaglandin E2" 108) ("Prostaglandin E2" 26)
      ("exogenous PGE2" 5) ("The highly pleiotropic PGE2" 1)
      ("COPD produced more PGE2" 1)
      ("the predominant eicosanoid inflammatory metabolite PGE2" 1)
      ("Activated FGFR1 increased intracellular PGE2" 1)))
    ("CHEBI:15552"
     (("prostacyclin" 67) ("Prostacyclin" 8) ("prostaglandin I2" 5)
      ("prostacyclins" 4) ("less prostacyclin" 1)))
    ("CHEBI:15553" (("PGF2-alpha" 1)))
    ("CHEBI:15554"
     (("PGH2" 22) ("prostaglandin H2" 19) ("further isomerizing PGH2" 1)))
    ("CHEBI:15603"
     (("L-leucine" 34) ("Essential amino acids (EAA) such as L-leucine" 2)
      ("water-soluble L-leucine" 2)
      ("branched side-chain amino acids such as L-leucine" 1) ("-L-leucine" 1)))
    ("CHEBI:15611" (("sarcosine" 103) ("exogenous sarcosine" 3) ("Sarcosine" 2)))
    ("CHEBI:15627" (("TxA2" 41) ("thromboxane A2" 23) ("TXA2" 15)))
    ("CHEBI:15713"
     (("UTP" 288) ("UTPs" 7) ("biotinylated UTP" 7) ("-UTP" 3)
      ("uridine triphosphate" 2) ("Utp" 2) ("utp" 2)
      ("biotinylated uridine triphosphate" 1) ("amino allyl modified UTP" 1)))
    ("CHEBI:15719" (("ferricytochrome" 9)))
    ("CHEBI:15729" (("L-ornithine" 33) ("l-ornithine" 3)))
    ("CHEBI:15740" (("formate" 94)))
    ("CHEBI:15746" (("spermine" 73) ("Spermine" 6) ("than spermine" 1)))
    ("CHEBI:15773" (("cyclohexylamine" 1)))
    ("CHEBI:15817"
     (("semiquinone" 10) ("semiquinones" 9) ("Semiquinones" 2)
      ("a long-lived semiquinone" 1)))
    ("CHEBI:15846"
     (("NAD+" 310) ("NAD(+)" 8) ("NAD+-" 1) ("available NAD+" 1)
      ("regenerate NAD+" 1)))
    ("CHEBI:15858"
     (("bromide" 811) ("bromide (MTT)" 144) ("Bromide" 37) ("Bromide (MTT)" 16)
      ("5 mg/ml colorimetric 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT)"
       2)
      ("fresh medium, and hexadimethrine bromide" 2) ("bromide(MTT)" 2)
      ("the vital dye 3-(4,5-dimethylthiazol-2-yl)-2,4-diphenyltetrazolium bromide"
       2)
      ("-lysine hydro bromide" 2)
      ("the peripheral ganglionic blocker hexamethonium bromide" 2)
      ("bromide (DDAB)" 1)))
    ("CHEBI:15864" (("luteolin" 291) ("Luteolin" 71) ("Dietary luteolin" 2)))
    ("CHEBI:15882"
     (("phenol" 709) ("Phenol" 25) ("Residual phenol" 2) ("-phenol" 2)
      ("phenol-" 1)))
    ("CHEBI:15891" (("taurine" 26) ("Taurine" 2)))
    ("CHEBI:15904"
     (("long-chain fatty acids" 12) ("long-chain fatty acid" 4) ("LCFA" 2)
      ("LCFAs" 1)))
    ("CHEBI:15930" (("atrazine" 1)))
    ("CHEBI:15956"
     (("biotin" 2662) ("Biotin" 488) ("-biotin" 48) ("biotin-" 21) ("-Biotin" 9)
      ("biotin molecule" 9) ("–biotin" 7) ("non-biotin" 4) ("BIOTIN" 3)
      ("Biotin-" 2) ("exogenous biotin" 2) ("surface-bound biotin" 1)
      ("a secondary anti-rabbit biotin" 1) ("a cleavable biotin" 1)
      ("4°C. Nonreactive biotin" 1) ("Non-endocytosed surface biotin" 1)
      ("than PGA 1 -biotin" 1) ("BIOTIN-" 1) ("residual surface NH-SS biotin" 1)
      ("available free biotin" 1) ("using cleavable biotin" 1)
      ("cell-impermeable EZ-LinkTM Sulfo- NHS-SS Biotin" 1)))
    ("CHEBI:15986"
     (("polynucleotide" 8) ("Polynucleotide" 6) ("polynucleotides" 3)))
    ("CHEBI:15996"
     (("GTP" 5368) ("GTP-" 39) ("-GTP" 8) ("the fractional GTP" 4)
      ("cellular GTP" 4) ("nonhydrolyzable GTP" 4) ("flow-induced GTP" 3)
      ("GTP molecule" 3) ("global GTP" 2) ("stress–induced Rac1 GTP" 2)
      ("60–70% fractional GTP" 2) ("GEF-catalyzed GTP" 2) ("GTPs" 2)
      ("their relatively weak intrinsic GTP" 2) ("a poor GTP" 2)
      ("its optimal GTP" 2) ("normal GTP" 2) ("a nonhydrolyzable GTP" 2)
      ("GTP nucleotide" 2) ("GTPγS-" 1) ("the RagA/B-bound GTP" 1)
      ("proteins increased GTP" 1) ("exogenous GTP" 1) ("GMPS decreased GTP" 1)
      ("replete GTP" 1) ("a new GTP" 1) ("non-hydrolizable GTP" 1)
      ("the already-bound GTP" 1) ("–GTP" 1) ("a permanent active GTP" 1)
      ("postlytic GTP" 1)))
    ("CHEBI:15997" (("IBA" 41) ("Iba" 4))) ("CHEBI:16007" (("methanethiol" 12)))
    ("CHEBI:16024" (("D-mannose" 18) ("the soluble receptor analog D-mannose" 2)))
    ("CHEBI:16038"
     (("phosphatidylethanolamine" 104) ("Phosphatidylethanolamine" 4)
      ("phosphatidylethanolamines (PE)" 3) ("phosphatidylethanolamine (PE)" 2)
      ("phosphatidylethanolamine (DOPE)" 2) ("phosphatidylethanolamines" 1)
      ("neutral colipid dioleoyl phosphatidylethanolamine (DOPE)" 1)))
    ("CHEBI:16042" (("halide" 7) ("Halide" 1)))
    ("CHEBI:16069"
     (("imidazol" 20) ("1H-imidazole" 8) ("Imidazol" 8)
      ("4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole"
       4)
      ("The p38 α and β inhibitor 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole"
       2)
      ("4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole"
       2)
      ("-imidazol-1-yl" 1)))
    ("CHEBI:16091" (("dolichol" 2))) ("CHEBI:16108" (("DHAP" 14)))
    ("CHEBI:16113"
     (("cholesterol" 3837) ("Cholesterol" 193) ("-cholesterol" 38)
      ("cholesterol (TC)" 26) ("cholesterol-" 15) ("cholesterol (HDL)" 5)
      ("more cholesterol" 4) ("cholesterol (FC)" 4) ("–cholesterol" 4)
      ("exogenous cholesterol" 3) ("cholesterol molecule" 3)
      ("postprandial blood biochemical parameters included high density lipoprotein cholesterol"
       3)
      ("a dietary cholesterol" 3) ("virion-associated cholesterol" 3)
      ("-cholesterol cholesterol" 2) ("most excess cellular cholesterol" 2)
      ("the percent cholesterol" 2) ("cholesterol (LDLC)" 2) ("non-cholesterol" 2)
      ("“cholesterol”" 1) ("caveolar cholesterol" 1) ("cholesterol (CHOL)" 1)
      ("cholesterol–" 1) ("less cholesterol" 1)
      ("the late endosomal pathway cholesterol" 1)
      ("hypercholesterolemia:total cholesterol (TC)" 1)
      ("borderline hypercholesterolemia:total cholesterol (TC)" 1)
      ("Almost all the cholesterol" 1) ("efficiently efflux cholesterol" 1)
      ("cholesterol (HDLC)" 1) ("-Cholesterol" 1) ("-linked cholesterol" 1)
      ("dietary cholesterol" 1) ("the fluorescent cholesterol" 1)
      ("than cholesterol" 1) ("cholesterol’s" 1)
      ("equally extract cholesterol" 1)))
    ("CHEBI:16118" (("berberine" 258) ("Berberine" 149) ("berberine (BRB)" 2)))
    ("CHEBI:16134"
     (("ammonia" 176) ("Ammonia" 15) ("NH3" 5) ("the much more inert ammonia" 1)
      ("more ammonia" 1) ("exogenous ammonia" 1)
      ("glutamine withdrawal lowered ammonia" 1)
      ("25% (vol/vol) aqueous ammonia" 1) ("aqueous ammonia" 1)))
    ("CHEBI:16136"
     (("sulfane" 6) ("Sulfane" 4) ("Hydrogen sulfide" 3) ("hydrogen sulfide" 2)))
    ("CHEBI:16137" (("chondroitin" 6)))
    ("CHEBI:16150"
     (("benzoate" 6)
      ("Methyl 4-(dimethylamino)-2-hydroxy-5-(phenylethynyl)benzoate" 4)
      ("benzoate (DB)" 1)))
    ("CHEBI:16183"
     (("methane" 19) ("1,1-Bis(3'-indoly)-1-(p-substituted phenyl)methanes" 2)
      ("methanes" 2) ("1,1-Bis(3′-indolyl)-1-( p -substituted phenyl)methanes" 2)
      ("1,1-Bis(3′-indolyl)-1-( p -hydroxyphenyl)methane" 2)))
    ("CHEBI:16199"
     (("urea" 1348) ("Urea" 126) ("ureas" 8) ("ureA" 3) ("UREA" 3)
      ("a symmetrical sulfonated urea" 2) ("Hu" 2) ("-urea" 1) ("UreA" 1) ("hu" 1)
      ("urea (HU)" 1)))
    ("CHEBI:16208" (("mercaptopyruvate" 1)))
    ("CHEBI:16219"
     (("cucurbitacin" 90) ("cucurbitacins" 29) ("Cucurbitacin" 27)
      ("Cucurbitacins" 8) ("than one hundred cucurbitacins" 1)))
    ("CHEBI:16236"
     (("ethanol" 6442) ("alcohol" 3589) ("EtOH" 521) ("Ethanol" 196)
      ("Alcohol" 176) ("ice-cold 70% ethanol" 86) ("ethanols" 58)
      ("70% ice-cold ethanol" 41) ("absolute ethanol" 39) ("ETOH" 33)
      ("ice-cold ethanol" 27) ("alcohol-" 18) ("absolute alcohol" 7)
      ("75% ice-cold ethanol" 6) ("alcohol's" 6) ("gradient alcohol" 5)
      ("ice-cold 75% ethanol" 5) ("ice-cold 70% (v/v) ethanol" 5) ("ethanol-" 5)
      ("Absolute ethanol" 4) ("ice-cold 80% ethanol" 4)
      ("ice-cold absolute ethanol" 4) ("absolute EtOH" 4) ("aqueous ethanol" 3)
      ("80% ice-cold ethanol" 3) ("absolute ethyl alcohol" 3)
      ("ice-cold 80% (v/v) ethanol" 3) ("ice-cold 96% ethanol" 3)
      ("consumed more alcohol" 3) ("EtOH’s" 3) ("cold absolute ethanol" 3)
      ("less alcohol" 3) ("residual ethanol" 3) ("1 ml ice-cold 70% ethanol" 2)
      ("ice cold absolute ethanol" 2) ("any residual ethanol" 2)
      ("retrograde alcohol" 2) ("than one alcohol" 2) ("EtoH" 2)
      ("voluntary excessive alcohol" 2) ("ice-cold 100% ethanol" 2)
      ("consumed less alcohol" 2) ("90% aqueous ethanol" 2) ("EtOH-" 2)
      ("9 ml ice-cold 80% ethanol" 2) ("chilled absolute ethanol" 2)
      ("followed 100% ethanol" 2) ("The long-term voluntary alcohol" 2)
      ("tertiary alcohol" 2) ("more alcohol" 2) ("pure alcohol" 2)
      ("habitual alcohol" 2) ("those consuming less alcohol" 2)
      ("strong alcohol-" 2) ("more ethanol" 2) ("Seventy percent ethanol" 2)
      ("decreased gradient ethanol" 2) ("voluntary alcohol" 2) ("ethanol (EOH)" 2)
      ("65% ice-cold ethanol" 1) ("serial graded alcohol" 1)
      ("95% absolute alcohol" 1) ("parental alcohol" 1)
      ("ice-cold 75% (v/v) ethanol" 1) ("ice-cold 50% ethanol" 1)
      ("70% aqueous ethanol" 1) ("anhydrous ethanol" 1) ("ice‐cold ethanol" 1)
      ("500 μl ice-cold 70% ethanol" 1) ("an ice-cold 70% ethanol" 1)
      ("70% v/v ice-cold ethanol" 1) ("70% ice-cold alcohol" 1)
      ("ice-cold PBS/80% ethanol" 1) ("gradient ethanol" 1)
      ("10 mL ice-cold ethanol" 1) ("100% ice-cold ethanol" 1) ("than EtOH" 1)
      ("ice-cold 70% EtOH" 1) ("fresh 100% ethanol" 1)
      ("absolute methyl alcohol" 1) ("70% ice-cold (−20°C) ethanol" 1)
      ("ice-cold 85% Ethanol" 1) ("ice-cold 95% ethanol" 1)
      ("ice-cold 90% ethanol" 1) ("100% ice-cold alcohol" 1)
      ("1mL ice-cold 70% ethanol" 1) ("ice-cold 85% ethanol" 1) ("than ethanol" 1)
      ("0.9% (w/v) NaCl/95% (v/v) ethanol" 1) ("glacial alcohol" 1)
      ("2 L 95% aqueous ethanol" 1) ("0.5 ml/tube ice-cold absolute ethanol" 1)
      ("dry ice/isopropyl alcohol" 1) ("1.4 mL cold absolute ethanol" 1)
      ("3 ml ice-cold 70% ethanol" 1) ("1 ml 75% ice-cold ethanol" 1)
      ("3 ml ice-cold ethanol" 1) ("50 μl absolute ethanol" 1)
      ("200 proof absolute ethanol" 1) ("ice-cold EtOH" 1) ("serial ethanol" 1)
      ("concentration gradient ethanols" 1) ("co-morbid alcohol" 1)
      ("Ice-cold 95% ethanol" 1) ("5% absolute ethanol" 1)
      ("acute and chronic alcohol" 1) ("sequential ethanol" 1)
      ("70% ice-cold EtOH" 1) ("The absolute ethanol" 1)))
    ("CHEBI:16238"
     (("FAD" 73) ("fad" 3) ("FAD molecule" 3) ("fads" 2)
      ("humanized mouse mammary fad" 1) ("the mammary fad" 1) ("Fad" 1)
      ("the mammary fat fads" 1)))
    ("CHEBI:16243"
     (("quercetin" 498) ("Quercetin" 72) ("QUE" 15) ("quercetin-" 4)
      ("concentrated QUE" 1) ("quercetin (QTN)" 1)))
    ("CHEBI:16261" (("chitosan" 65) ("Chitosan" 25) ("water-soluble chitosan" 1)))
    ("CHEBI:16301" (("nitrite" 82) ("Nitrite" 16) ("nitrites" 4)))
    ("CHEBI:16335"
     (("adenosine" 305) ("Adenosine" 16) ("adenosines" 16) ("adenosine-" 10)
      ("-adenosine" 1) ("than AP-sites opposite adenosine ( xref )" 1)))
    ("CHEBI:16337"
     (("pA" 238) ("phosphatidic acid" 143) ("Pa" 108)
      ("phosphatidic acid (PA)" 15) ("Phosphatidic acid" 8)
      ("water soluble phosphatidic acid" 2)
      ("cell permeable 1,2-dioctanoyl phosphatidic acid" 2) ("typically 0.2 pA" 1)
      ("respiratory epithelial cells (and, perhaps, resident macrophages) sense Pa"
       1)
      ("pa" 1)))
    ("CHEBI:16385" (("RSRS" 3) ("rsrs" 1)))
    ("CHEBI:16411"
     (("IES" 10) ("ies" 3) ("Ies" 2) ("significantly less iEs" 1) ("iEs" 1)))
    ("CHEBI:16450"
     (("deoxyuridine" 208) ("-deoxyuridine" 193) ("2’-deoxyuridine" 13)
      ("Deoxyuridine" 9) ("2'-deoxyuridine" 6) ("-Deoxyuridine" 6)
      ("deoxyuridines" 2) ("–deoxyuridine" 1)))
    ("CHEBI:16452"
     (("oxaloacetate" 47) ("oxaloacetate (OAA)" 6)
      ("oxaloacetate using Ellman’s" 1)))
    ("CHEBI:16454" (("pantothenate" 8)))
    ("CHEBI:16467" (("L-arginine" 213) ("-L-arginine" 59) ("l-arginine" 1)))
    ("CHEBI:16469" (("beta-estradiol" 41) ("17beta-estradiol" 2)))
    ("CHEBI:16474"
     (("NADPH" 913) ("more NADPH" 2) ("The enzyme specifically uses NADPH" 1)))
    ("CHEBI:16482" (("naphthalene" 13) ("naphthalen" 3) ("Naphthalene" 2)))
    ("CHEBI:16581" (("pregnenolone" 12)))
    ("CHEBI:16586" (("6-aminohexanoic acid" 4) ("εACA" 1)))
    ("CHEBI:16598" (("DDE" 62) ("-DDE" 46) ("Dde" 4)))
    ("CHEBI:16602" (("TCE" 15)))
    ("CHEBI:16610"
     (("spermidine" 115) ("Spermidine" 6) ("exogenous spermidine" 4)))
    ("CHEBI:16628" (("MGX" 2)))
    ("CHEBI:16646"
     (("carbohydrate" 287) ("carbohydrates" 83) ("dietary carbohydrate" 7)
      ("saccharides" 5) ("Carbohydrate" 4) ("saccharide" 3)
      ("tumor-associated carbohydrates" 1) ("non-carbohydrate" 1)
      ("the most vital carbohydrate" 1) ("less carbohydrate" 1)
      ("the more complex carbohydrates" 1)))
    ("CHEBI:16680"
     (("S-adenosylhomocysteine" 9) ("S-adenosyl-L-homocysteine" 3)
      ("S-adenosylhomocysteine (SAH)" 2)
      ("its demethylated byproducts S-adenosylhomocysteine (SAH)" 1)))
    ("CHEBI:16684"
     (("atropine" 35) ("Concomitant medication included subcutaneous atropine" 2)
      ("the muscarinic ACh receptor antagonist atropine" 2) ("atropin" 1)
      ("the muscarinic inhibitor atropine" 1)))
    ("CHEBI:16688" (("ecdysone" 20) ("Ecdysone" 3)))
    ("CHEBI:16731" (("cinnamaldehyde" 1)))
    ("CHEBI:16750"
     (("guanosine" 216) ("Guanosine" 7) ("exogenous guanosine" 3) ("guanosines" 2)
      ("guanosine's" 1) ("20–40 kDa monomeric guanosine" 1)
      ("Exogenous guanosine" 1) ("methylated guanosine" 1)))
    ("CHEBI:16755"
     (("CDCA" 184) ("chenodeoxycholic acid" 29) ("Chenodeoxycholic acid" 7)
      ("than CDCA ( xref )" 1)))
    ("CHEBI:16796"
     (("melatonin" 166) ("Melatonin" 105) ("Melatonin's" 2)
      ("preoperative Melatonin" 1) ("The pineal gland hormone melatonin" 1)))
    ("CHEBI:16810"
     (("α-ketoglutarate" 113) ("α–ketoglutarate" 2)
      ("the oxidative substrate α-ketoglutarate" 1)))
    ("CHEBI:16827"
     (("corticosterone" 145) ("Corticosterone" 13) ("acute corticosterone" 1)))
    ("CHEBI:16828" (("L-tryptophan" 10) ("L-Tryptophan" 2)))
    ("CHEBI:16838"
     (("polyphosphates" 13) ("polyphosphate" 13) ("Polyphosphate" 1)))
    ("CHEBI:16865"
     (("GABA" 214) ("gamma-aminobutyric acid" 11) ("Gamma-aminobutyric acid" 1)))
    ("CHEBI:16881" (("indol" 49) ("1H-indole" 16) ("Indol" 1)))
    ("CHEBI:16908" (("NADH" 483) ("external NADH" 1)))
    ("CHEBI:16910" (("mandeloniTRILE" 1) ("mandelonitrile" 1)))
    ("CHEBI:16918"
     (("gallate" 46) ("Gallate" 3) ("gallate (EG)" 3) ("gallate (EGCG)" 3)))
    ("CHEBI:16958" (("β-alanine" 4) ("β-Alanine" 1)))
    ("CHEBI:16960" (("ADPribose" 7)))
    ("CHEBI:16961" (("lysophospholipids" 16) ("lysophospholipid" 10)))
    ("CHEBI:16973" (("deoxycorticosterone" 2))) ("CHEBI:16978" (("LTC4" 28)))
    ("CHEBI:16998" (("D-phenylalanine" 8) ("D-phenylala-nine" 1)))
    ("CHEBI:17012" (("N-acetylneuraminic acid" 3) ("Neu5Ac" 1)))
    ("CHEBI:17029" (("chitin" 44) ("Chitin" 3) ("chitin-" 1)))
    ("CHEBI:17033" (("biliverdin" 44) ("Biliverdin" 3)))
    ("CHEBI:17045" (("NNO" 5)))
    ("CHEBI:17051"
     (("fluoride" 854) ("PVDF" 443) ("fluoride (PMSF)" 117) ("fluoride (PVDF)" 12)
      ("Fluoride" 11) ("fluoride (AEBSF)" 9) ("fluoride (TBAF)" 2)
      ("fluoride (TMAF)" 1) ("fluoride (HF)" 1)))
    ("CHEBI:17087"
     (("ketone" 155) ("ketone (TPCK)" 19) ("ketones" 15) ("Ketone" 7)
      ("ketone (BAF)" 4) ("ketone (TLCK)" 4)
      ("Carbobenzyloxy-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethyl ketone" 2)
      ("ketone (NNK)" 2)))
    ("CHEBI:17097" (("biphenyl" 12) ("Biphenyl" 1)))
    ("CHEBI:17111" (("phosphoribosylpyrophosphate" 4)))
    ("CHEBI:17126"
     (("carnitine" 49) ("carnitines" 6) ("-carnitine" 3) ("Carnitine" 2)))
    ("CHEBI:17137"
     (("bisulphite" 230) ("Bisulphite" 71) ("oxidative bisulphite" 2)
      ("bisulphite (SIGMA)" 1)))
    ("CHEBI:17138"
     (("glyceraldehyde 3-phosphate" 155) ("Glyceraldehyde 3-phosphate" 38)
      ("glyceraldehyde-3-phosphate" 9) ("Glyceraldehyde-3-phosphate" 5)))
    ("CHEBI:17141"
     (("MeA" 9) ("cysteamine" 6) ("Cysteamine" 4) ("-meA" 3) ("Mea" 1) ("mea" 1)
      ("than the MeA" 1) ("the highly cytotoxic N 3 -meA" 1) ("meA" 1)))
    ("CHEBI:17148" (("putrescine" 29) ("Putrescine" 2)))
    ("CHEBI:17172"
     (("deoxyguanosine" 54) ("-deoxyguanosine" 35) ("2'-deoxyguanosine" 2)
      ("principally 8-OH deoxyguanosine" 2) ("2’-deoxyguanosine" 1)))
    ("CHEBI:171741" (("cerulenin" 14) ("Cerulenin" 3)))
    ("CHEBI:17196" (("L-asparagine" 7) ("L-Asparagine" 2)))
    ("CHEBI:17202" (("IMP" 34) ("Imp" 4)))
    ("CHEBI:17230"
     (("homocysteine" 315) ("Homocysteine" 33) ("raised homocysteine" 1)))
    ("CHEBI:17234"
     (("glucose" 12331) ("Glucose" 612) ("-glucose" 120) ("glucose-" 20)
      ("glucose (FPG)" 16) ("glucose (HG)" 12) ("more glucose" 12)
      ("glucose (NG)" 7) ("glucose (PAA)" 6) ("glucose (FBG)" 6)
      ("glucose molecule" 4) ("Glucose (DMEM)" 4) ("-Glucose" 4) ("GLUCOSE" 4)
      ("stimulatory glucose" 4) ("exogenous glucose" 3) ("glucose (KRPG)" 3)
      ("glucose (SD)" 3) ("Glucose (HG)" 3) ("substimulatory glucose" 3)
      ("dietary glucose" 2) ("glucoses" 2) ("Intraperitoneal glucose" 2)
      ("Glucose-" 2) ("glucose (PGG)" 2) ("uniformly 13 C enriched glucose" 2)
      ("Arterial Plasma Glucose" 2) ("residual glucose" 2) ("than glucose" 2)
      ("available glucose" 2) ("glucose (IFG)" 2) ("the hypothalamic glucose" 2)
      ("increased post-prandial glucose" 2) ("intravenous glucose" 2)
      ("Sirt6 KO/H-RasV12/shp53 transformed MEFs uptake more glucose" 2)
      ("biphasic glucose" 1) ("approximately tenfold more glucose" 1)
      ("isotope-labeled glucose" 1) ("cancer cells uptake more glucose" 1)
      ("whose glucose" 1) ("than normal glucose ( xref )" 1)
      ("than either fasting glucose" 1) ("maternal and elevated glucose" 1)
      ("pre-warmed DPBS containing glucose" 1) ("1 mM nonradioactive glucose" 1)
      ("exogeneous glucose" 1) ("non-glucose" 1)
      ("non–insulin-mediated glucose" 1) ("Basal arterial plasma glucose" 1)
      ("plasmatic glucose" 1) ("the available glucose" 1)
      ("the excess dietary glucose" 1) ("less 13 C glucose" 1)
      ("physical fitness and whole-body glucose" 1)
      ("nonoxidative (26.31 ± 12.08 vs. 34.94 ± 12.24 vs. 43.38 ± 15.16 μmol/kg LBM/min, P = 3.6 × 10 −13 ) glucose"
       1)
      ("nonoxidative (30.31 ± 12.81 vs. 34.06 ± 13.24 vs. 40.68 ± 16.52 μmol/kg LBM/min, P = 1.2 × 10 −5 ) glucose"
       1)
      ("nonoxidative glucose" 1) ("glucose (YNBD)" 1) ("even more glucose" 1)
      ("only mAkt required glucose" 1) ("adequate glucose" 1)
      ("α(1,4)-linked glucoses" 1) ("systemic blood glucose" 1)
      ("ample glucose" 1) ("uptake more glucose" 1)
      ("the same dose (0.25 mU g −1 ) markedly lowered blood glucose" 1)
      ("glucose (YPD)" 1) ("unbuffered 5 mM glucose containing Dulbecco’s" 1)
      ("1 g/l glucose (5.5 mmol/l) containing Dulbecco’s" 1) ("Glucose (FPG)" 1)
      ("Glucose (IFG)" 1) ("a mild glucose" 1) ("glucose (LDMIIIG)" 1)
      ("intraperitoneal glucose (IPGTT)" 1) ("glutamine but not glucose" 1)
      ("a more moderate glucose" 1) ("submaximal glucose" 1)
      ("postprandial blood glucose (PBG)" 1) ("glucose (PBG)" 1)
      ("EA displayed significantly lower blood glucose" 1)
      ("than glucose ( xref )" 1) ("acute glucose" 1) ("postprandial glucose" 1)))
    ("CHEBI:17263" (("estrone" 41) ("Estrone" 2)))
    ("CHEBI:17276"
     (("phloretin" 15) ("Phloretin" 4) ("ice-cold 0.3 mM phloretin" 2)))
    ("CHEBI:17295" (("L-phenylalanine" 9) ("-L-phenylalanine" 1)))
    ("CHEBI:17306" (("maltose" 101) ("Maltose" 10) ("-maltose" 1)))
    ("CHEBI:17326"
     (("NTPs" 19) ("NTP" 18) ("nucleoside triphosphates" 5)
      ("nucleoside triphosphate" 3)
      ("nucleoside
 triphosphate"
       1)))
    ("CHEBI:17334"
     (("penicillin" 6867) ("Penicillin" 222) ("penicillin (PAA)" 4)
      ("penicillin-" 2) ("10% fetal bovine serum (Hyclone) 100 U/ml penicillin" 1)
      ("10% fetal bovine serum (FBS, Invitrogen) 100 units/mL penicillin" 1)
      ("penicillins" 1)))
    ("CHEBI:17347"
     (("testosterone" 1036) ("Testosterone" 40) ("salivary testosterone" 15)
      ("exogenous testosterone" 4) ("Salivary testosterone" 4) ("testosterone-" 2)
      ("pure testosterone" 2) ("than testosterone" 1)
      ("Yet neither testosterone" 1) ("testosterone's" 1)
      ("higher salivary testosterone" 1) ("testosterone (ELISA)" 1)
      ("so prostatic testosterone" 1) ("testicular testosterone" 1)))
    ("CHEBI:17376"
     (("cystine" 60) ("Cystine" 4) ("cystines" 2) ("-cystine" 1) ("–cystine" 1)))
    ("CHEBI:17408" (("monoacylglycerol" 2) ("monoacylglycerols" 1)))
    ("CHEBI:17431" (("agmatine" 9) ("-agmatine" 2)))
    ("CHEBI:17440"
     (("nitrophenylphosphate" 14) ("-Nitrophenylphosphate" 3)
      ("4-nitrophenyl phosphate" 3) ("Nitrophenylphosphate" 2)
      ("The chromogenic substrate 4-nitrophenyl phosphate" 2)
      ("-nitrophenylphosphate" 2) ("p -nitrophenylphosphate" 1)))
    ("CHEBI:17478"
     (("aldehyde" 206) ("aldehydes" 172) ("Aldehyde" 14) ("Aldehydes" 8)
      ("β-unsaturated aldehydes" 3) ("β-unsaturated aldehyde" 3)
      ("toxic aldehydes" 2) ("endogeneous aldehydes" 2)
      ("an amphiphilic aldehyde" 2) ("amphiphilic aldehydes" 2)
      ("chemiluminescent aldehyde" 1) ("a biotinylated aldehyde" 1)
      ("The consequent aldehydes" 1) ("384-well GA3 aldehyde" 1)
      ("10% paraformic aldehyde" 1) ("a toxic aldehyde" 1)
      ("residual aldehydes" 1) ("the atheronal aldehydes" 1)
      ("certain inflammatory-derived lipidic aldehydes" 1)
      ("all biologically relevant aldehydes" 1)))
    ("CHEBI:17484" (("BITC" 2)))
    ("CHEBI:17489"
     (("cAMP" 1707) ("cyclic adenosine monophosphate" 32) ("cyclic-AMP" 16)
      ("-cyclic adenosine monophosphate" 4) ("Cyclic adenosine monophosphate" 2)))
    ("CHEBI:17544" (("HCO3" 6)))
    ("CHEBI:17552"
     (("GDP" 1361) ("GDP-" 46) ("-GDP" 26) ("GDP nucleotide" 3) ("GDP molecule" 2)
      ("than [ 32 P]GDP" 1) ("than GDP" 1) ("p21 rapidly exchange GDP" 1)
      ("locally exchange GDP" 1)))
    ("CHEBI:17562"
     (("cytidine" 134) ("CYD" 23) ("cytidines" 12) ("Cytidine" 10) ("-cytidine" 7)
      ("The deaminated cytidines" 1)))
    ("CHEBI:17578" (("toluene" 38) ("Toluene" 1)))
    ("CHEBI:17596" (("inosine" 15) ("Inosine" 1) ("inosines" 1)))
    ("CHEBI:17598" (("PDBu" 196) ("PdBu" 8)))
    ("CHEBI:17625"
     (("dUTP" 671) ("deoxyuridine triphosphate" 36) ("dUTPs" 27)
      ("biotinylated dUTP" 6) ("biotinylated deoxyuridine triphosphate" 2)
      ("dUTP nucleotide" 2) ("fluorescent dUTPs" 2)
      ("spectrum orange-labelled dUTP" 2) ("the fluorescence-conjugated dUTP" 1)
      ("Excess biotinylated dUTPs" 1)))
    ("CHEBI:17634" (("D-glucose" 189) ("d-glucose" 8) ("-D-glucose" 6)))
    ("CHEBI:17642" (("pentachlorophenol" 2)))
    ("CHEBI:17650"
     (("cortisol" 144) ("Cortisol" 6)
      ("midnight serum cortisol and 24-h urinary free cortisol" 2)
      ("Urinary free cortisol" 1)))
    ("CHEBI:17701" (("benzenediol" 2)))
    ("CHEBI:17716"
     (("lactose" 64) ("-lactose" 27) ("Lactose" 4) ("-Lactose" 2)
      ("the disaccharidic competitor lactose" 2)))
    ("CHEBI:17741"
     (("dimethylformamide" 45) ("-dimethylformamide" 13) ("DMF" 5)
      ("Dimethylformamide" 4) ("N,N-dimethylformamide" 4)
      ("anhydrous dimethylformamide" 2) ("-dimethylformamide (DMF)" 1)
      ("dimethylformamide (DMF)" 1) ("dimethylformamide-" 1)))
    ("CHEBI:17750" (("betaine" 41) ("Betaine" 8)))
    ("CHEBI:17755" (("cystathionine" 24) ("Cystathionine" 4)))
    ("CHEBI:17761"
     (("ceramide" 894) ("-ceramide" 175) ("Ceramide" 72) ("ceramides" 12)
      ("-ceramides" 5) ("Ceramides" 4) ("exogenous C 16 -ceramide" 4)
      ("the radiation-generated ceramide" 3)
      ("approximately 0.2 µM C 16 -ceramide" 2) ("exogenous ceramide" 2)
      ("the pro-apoptotic sphingolipid metabolite ceramide" 2)
      ("ceramide synthase inhibitor and cell permeable ceramide" 1)
      ("than the ceramide in resting HeLa cells" 1)
      ("this latter observation ceramide" 1) ("gp120 increased ceramide" 1)
      ("the pro-apoptotic lipid ceramide" 1) ("the pro-apoptotic ceramide" 1)))
    ("CHEBI:17790"
     (("methanol" 3095) ("ice-cold methanol" 108) ("Methanol" 63)
      ("absolute methanol" 21) ("100% ice-cold methanol" 13)
      ("ice-cold 100% methanol" 12) ("–methanol" 12) ("-methanol" 9)
      ("90% ice-cold methanol" 5) ("anhydrous methanol" 4)
      ("ice-cold 90% methanol" 3) ("150  μ L ice-cold methanol" 2)
      ("ice-cold 70% methanol" 2) ("methanol-" 2) ("pure methanol" 2)
      ("using 100% ice-cold methanol" 1) ("ice-cold 100% (v/v) methanol" 1)
      ("ice-cold Methanol" 1) ("dry methanol" 1) ("100% ice-cold Methanol" 1)
      ("using absolute methanol" 1) ("either 100% ice-cold methanol" 1)
      ("ice-cold 60% methanol" 1) ("ice-cold 80% methanol" 1)
      ("1:4 (vol/vol) ice-cold methanol" 1) ("ice-cold anhydrous methanol" 1)
      ("50% aqueous methanol" 1) ("70% ice-cold methanol" 1)
      ("100% (v/v) ice-cold methanol" 1) ("3mL 80% ice-cold methanol" 1)
      ("chilled absolute methanol" 1)
      ("82.5∶17.5 (v/v) 30 mM monobasic potassium phosphate (pH 3.6)-methanol"
       1)))
    ("CHEBI:17802" (("pseudouridine" 5)))
    ("CHEBI:17823" (("calcitriol" 50) ("Calcitriol" 4)))
    ("CHEBI:17840" (("indoxyl" 3)))
    ("CHEBI:17855"
     (("triglycerides" 381) ("triglyceride" 249) ("triacylglycerol" 25)
      ("Triglycerides" 15) ("IMTG" 14) ("Triglyceride" 12)
      ("triglycerides (TG)" 11) ("Triacylglycerol" 3) ("triacylglycerol (TAG)" 3)
      ("triacylglycerols" 3) ("intramuscular triglyceride (IMTG)" 3)
      ("neutral triglycerides" 2) ("triglyceride (TG)" 2)
      ("microsomal triglyceride" 1) ("“triglycerides”" 1)
      ("triglycerides using Friedewald's" 1) ("intramuscular triglyceride" 1)))
    ("CHEBI:17898" (("all-trans-retinal" 1)))
    ("CHEBI:17905" (("com" 65) ("COM" 29) ("Com" 11) ("CoM" 1)))
    ("CHEBI:17909"
     (("sulfur" 62) ("Sulfur" 8) ("sulfur molecule" 2)
      ("the polarizable sulfur" 1)))
    ("CHEBI:17984"
     (("acyl-CoA" 67) ("acyl-CoAs" 9) ("Acyl-CoA" 7)
      ("saturated fatty acyl-CoA" 2) ("a few other short-chain acyl-CoAs" 1)
      ("fatty acyl-CoAs" 1) ("transports fatty acyl-CoA" 1)
      ("long-chain fatty acyl-CoAs" 1)))
    ("CHEBI:17992"
     (("sucrose" 2636) ("Sucrose" 142) ("sucrose molecule" 2)
      ("the irrelevant sugar sucrose" 2)
      ("ice-cold artificial cerebrospinal fluid (ACSF)-sucrose" 2) ("-sucrose" 2)
      ("a discontinuous sucrose" 2) ("LDMIIIS" 2) ("ice-cold 80% sucrose" 2)
      ("ice-cold 80% (wt/vol) sucrose" 1)
      ("hyperglycemic high fat/ high sucrose" 1)
      ("A 5–40% discontinuous sucrose" 1) ("finally 8% sucrose" 1)
      ("a 17/40% (w/v) discontinuous sucrose" 1)
      ("25-mg/ml fluorescent gelatin and 20-mg/ml sucrose" 1)))
    ("CHEBI:17996"
     (("chloride" 897) ("Chloride" 83) ("chloride (TTC)" 13) ("chloride (DPI)" 9)
      ("–chloride" 8) ("TTC" 8) ("chloride (VC)" 4) ("the respective chloride" 4)
      ("chloride (DAKO)" 3) ("chloride (PMSF)" 3)
      ("2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (INT)"
       2)
      ("chloride (INT)" 2) ("chloride (DOTAP)" 1) ("ferric chloride" 1)
      ("chloride (TEA)" 1) ("chelerythrine chloride’s" 1)
      ("96-well polyvinyl chloride" 1)
      ("2-(p-iodophenyl)-3-(p-nitropheyl)-5-phenyl tetrazolium chloride" 1)
      ("the chaotropic agent guanidinium chloride" 1)
      ("the lysosomotropic agent Ammonium Chloride" 1)
      ("528 mM 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (INT)"
       1)
      ("Chloride (BDH)" 1)))
    ("CHEBI:18009" (("NADP+" 15))) ("CHEBI:18021" (("phosphoenolpyruvate" 34)))
    ("CHEBI:18022" (("thiocyanate" 84) ("GTC" 1)))
    ("CHEBI:18036"
     (("triphosphate" 564) ("triphosphates" 213) ("-triphosphate" 118)
      ("triphosphate (GTP)" 4) ("TriPhosphate" 2) ("-triphosphate (ATP)" 2)
      ("triphosphate (ATP)" 2) ("Triphosphate" 2) ("triphosphate (PIP)" 2)
      ("Inositol (1,3,4,5)-tetraphosphate and Inositol (1,4,5)-triphosphate" 1)
      ("-triphosphates" 1)))
    ("CHEBI:18066"
     (("UDP-D-glucose" 8) ("the glycogenic precursor UDP-D-glucose" 1)))
    ("CHEBI:18075"
     (("Tdp" 97) ("TDP" 12) ("dTDP" 6) ("thymidine diphosphate" 2) ("DTPPs" 1)
      ("TDPs" 1)))
    ("CHEBI:18077" (("dTTP" 215) ("-dTTP" 4)))
    ("CHEBI:18085"
     (("glycosaminoglycans" 52) ("glycosaminoglycan" 46)
      ("urinary glycosaminoglycans" 3) ("specific sulfated glycosaminoglycans" 2)
      ("Sulfated glycosaminoglycans" 2) ("glycosaminoglycan (GAG)" 2)
      ("contained more sulfated glycosaminoglycans" 2) ("Glycosaminoglycan" 2)
      ("glycosamino-glycans" 1) ("the sulfated glycosaminoglycan" 1)))
    ("CHEBI:18132" (("phosphocholine" 25)))
    ("CHEBI:18133" (("hexose" 3) ("hexoses" 1)))
    ("CHEBI:18211" (("citrulline" 65) ("citrullines" 18) ("-citrulline" 12)))
    ("CHEBI:18220"
     (("isoflavones" 139) ("isoflavone" 105) ("Isoflavone" 5)
      ("dietary soy isoflavones" 5) ("Isoflavones" 4) ("dietary isoflavones" 3)
      ("a dietary isoflavone" 2) ("a typical isoflavone" 1) ("Most isoflavones" 1)
      ("the principal isoflavone" 1) ("a well-studied isoflavone" 1)
      ("Soy-derived isoflavones" 1) ("the principal soy isoflavones" 1)))
    ("CHEBI:18243"
     (("DA" 1057) ("Da" 782) ("dopamine" 646) ("dA" 167) ("da" 39) ("Dopamine" 37)
      ("dopamine (DA)" 4) ("-biotinylated poly-dA" 2) ("than 1500 Da ( xref )" 1)
      ("only 0.18 Da" 1) ("than 3 Da" 1) ("than 5 Da" 1) ("Da (GGUCU)" 1)
      ("the important modulatory role DA" 1) ("than 500 Da" 1)))
    ("CHEBI:18246"
     (("cellulose" 210) ("Cellulose" 3) ("-cellulose" 2)
      ("sterile-filtered 1% carboxymethyl cellulose" 2)))
    ("CHEBI:18254"
     (("ribonucleoside" 40) ("ribonucleosides" 9) ("ribonucleoside (AICAR)" 8)
      ("-ribonucleoside" 4)
      ("AMPK pharmacologic activators 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR)"
       1)))
    ("CHEBI:18257" (("ornithine" 46) ("-ornithine" 19)))
    ("CHEBI:18319" (("SAICAR" 153)))
    ("CHEBI:18347"
     (("L-norleucine" 5) ("caprine" 5) ("ALLN" 2) ("-L-norleucine (ALLN)" 1)
      ("-L-norleucine" 1)))
    ("CHEBI:18349" (("GAR" 47) ("GaR" 1)))
    ("CHEBI:18361"
     (("diphosphate" 67) ("diphosphates" 13) ("-diphosphate" 6)
      ("diphosphate (GGPP)" 4) ("diphosphate (UDP)" 3) ("AOPCP" 2)
      ("highly energetic diphosphate" 1) ("diphosphate (GDP)" 1)))
    ("CHEBI:18379" (("CNRS" 33) ("nitrile" 2) ("cnr" 1)))
    ("CHEBI:18388"
     (("apigenin" 408) ("Apigenin" 104) ("apigenin's" 4)
      ("~1000 -fold more apigenin" 2) ("Dietary Apigenin" 2)
      ("log-transformed plasma free apigenin" 2)
      ("log-transformed pancreas total apigenin" 2) ("apigenin (APG)" 2)
      ("a translational perspective apigenin" 1) ("the most apigenin" 1)))
    ("CHEBI:18401" (("Phenylacetate" 1) ("phenylacetate" 1)))
    ("CHEBI:18420" (("Mg2+" 12) ("Mg2+-" 1)))
    ("CHEBI:18421"
     (("superoxide" 1414) ("Superoxide" 77) ("superoxides" 27) ("Superoxides" 3)
      ("monocytic superoxide" 2) ("exogenous superoxide" 2)
      ("self-produced superoxide" 2)
      ("comparatively less reactive hydrogen superoxide" 1)
      ("high-glucose-induced superoxide" 1) ("L-NAME-inhibitable superoxide" 1)
      ("more superoxide" 1) ("than superoxide" 1) ("microvascular superoxide" 1)
      ("BK increased superoxide" 1) ("more mitochondrial superoxide" 1)
      ("increased monocytic superoxide" 1) ("superoxide-" 1)
      ("Nox4 increased mitochondrial superoxide" 1)))
    ("CHEBI:20506"
     (("THF" 307) ("–THF" 13) ("-THF" 3) ("anhydrous THF" 3) ("dry THF" 2)
      ("The residual THF" 1) ("THFs" 1)))
    ("CHEBI:20680" (("dihydrobiopterin" 4)))
    ("CHEBI:20794" (("7-methylguanosine" 21)))
    ("CHEBI:209807" (("CFX" 155) ("cfx" 1)))
    ("CHEBI:21547" (("NAA" 10) ("NaA" 2) ("Naa" 1)))
    ("CHEBI:217301"
     (("benz" 7) ("-benz" 6) ("Benz" 4)
      ("Tetracyclic pyridone 2- tert -butyl-9-fluoro-3,6-dihydro-7 H -benz" 2)))
    ("CHEBI:21858" (("hypusine" 3)))
    ("CHEBI:22259" (("ADP-ribosyl" 442) ("ADP–ribosyl" 1)))
    ("CHEBI:22271"
     (("aflatoxin" 87) ("Aflatoxin" 5) ("aflatoxins" 1) ("Aflatoxins" 1)))
    ("CHEBI:22315" (("alkaloid" 122) ("alkaloids" 93)))
    ("CHEBI:22339" (("alkyne" 28)))
    ("CHEBI:22470"
     (("Alpha-Tocopherol" 15) ("alpha-tocopherol" 5) ("Alpha-tocopherol" 1)))
    ("CHEBI:22496" (("aminobiphenyl" 3) ("Aminobiphenyl" 1)))
    ("CHEBI:22512" (("aminoimidazole" 12) ("Aminoimidazole" 2)))
    ("CHEBI:22525" (("aminopropionitrile" 4)))
    ("CHEBI:22563"
     (("anion" 219) ("anions" 24) ("Anion" 8)
      ("SLCO4A1 (solute carrier organic anion transporter family, member 4A1) transports organic anions"
       2)
      ("mono-anion" 2) ("toxic organic anion" 1)))
    ("CHEBI:22565" (("ansamycin" 9) ("ansamycins" 1)))
    ("CHEBI:22580" (("anthraquinone" 9)))
    ("CHEBI:22586"
     (("antioxidant" 2739) ("antioxidants" 678) ("Antioxidant" 105)
      ("Antioxidants" 24) ("antioxidant molecule" 13) ("exogenous antioxidants" 5)
      ("phenolic antioxidants" 4) ("a polyphenolic antioxidant" 2)
      ("an indirect antioxidant" 2) ("strong antioxidant" 2) ("-antioxidant" 2)
      ("both exogenous and endogenous antioxidants" 2)
      ("chemical and enzymatic antioxidants" 2)
      ("cellular defensive antioxidants" 2)
      ("the most abundant nonenzymatic antioxidant" 2)
      ("a synthetic phenolic antioxidant" 1) ("potentially use antioxidants" 1)
      ("statins or more general antioxidants" 1) ("cytoprotective antioxidant" 1)
      ("a dietary antioxidant" 1) ("the principal antioxidant" 1)
      ("antioxidant (NAC)" 1) ("an important organic antioxidant" 1)
      ("an organic antioxidant" 1) ("dietary antioxidant" 1)
      ("dietary antioxidants" 1) ("a mitochondrial-targeted antioxidant" 1)
      ("the natural polyphenolic antioxidant" 1)
      ("probably more efficiently endogenous and exogenous (for example from the diet) antioxidants"
       1)
      ("a strong antioxidant" 1) ("Phenolic antioxidants" 1)
      ("nonenzymatic antioxidants" 1)))
    ("CHEBI:22610" (("arachidonoyl" 10)))
    ("CHEBI:22612" (("arachidonyl" 12) ("Arachidonyl" 3)))
    ("CHEBI:22614" (("eicosanoyl" 1)))
    ("CHEBI:22629"
     (("arsenate" 30) ("inorganic arsenate" 2) ("Arsenate" 1)
      ("pentavalent arsenate" 1)))
    ("CHEBI:22637" (("arsine" 3) ("Arsine" 2)))
    ("CHEBI:22651" (("ascorbate" 153) ("Ascorbate" 2) ("-ascorbate" 1)))
    ("CHEBI:22676" (("auxin" 25) ("exogenous auxin" 2)))
    ("CHEBI:22680"
     (("azide" 517) ("Azide" 33) ("azides" 3)
      ("ice-cold 10 mM sodium fluoride/sodium azide" 1)
      ("using AlexaFluor 647-conjugated azide" 1)
      ("Alexa Fluro 594 azide according the manufacturer’s" 1) ("azide (PBA)" 1)
      ("a small fluorescent azide" 1) ("a photoactivatable aryl azide" 1)
      ("fetal bovine serum and sodium azide" 1) ("azide-" 1)
      ("Pacific blue azide" 1)))
    ("CHEBI:22727" (("benzopyran" 20))) ("CHEBI:22729" (("benzoquinones" 1)))
    ("CHEBI:22733" (("benzoyl" 21) ("Benzoyl" 1) ("-benzoyl" 1)))
    ("CHEBI:22744"
     (("phenylmethyl" 50) ("benzyl group" 29) ("benzyl groups" 1)
      ("Phenylmethyl" 1)))
    ("CHEBI:22788" (("paragloboside" 2) ("paragloboside (SGPG)" 1)))
    ("CHEBI:22832"
     (("isoaspartyl" 25) ("isoaspartyls" 2)
      ("the actual methylatable isoaspartyls" 1)))
    ("CHEBI:22885" (("biotinoyl" 3) ("-biotinoyl" 2)))
    ("CHEBI:22901" (("bisphenol" 20) ("bisphenols" 7) ("Bisphenol" 4)))
    ("CHEBI:22905"
     (("blasticidin" 602) ("Blasticidin" 161) ("Blasticidin-" 3)
      ("blasticidin-" 1) ("blasticidin (WT)" 1)))
    ("CHEBI:22908" (("borate" 239) ("Borate" 24) ("borate (TBE)" 2)))
    ("CHEBI:22951"
     (("butanone" 7)
      ("nitrosamine 4-(methylnitrosamino)-1-(3-pyri-dyl)-1- butanone (NNK)" 1)
      ("butanone (NNK)" 1)))
    ("CHEBI:22972" (("butyryl" 8))) ("CHEBI:22977" (("cds" 7) ("Cds" 1)))
    ("CHEBI:23019"
     (("carbonyl" 438) ("carbonyls" 137) ("carbonyl group" 95)
      ("carbonyl groups" 33) ("Carbonyl" 30)
      ("carbonyl
groups"
       3)
      ("the seven-membered ring lactone carbonyl group" 3)
      ("β-unsaturated carbonyl group" 2) ("carbonyl (PC)" 2) ("carbonyl-" 1)
      ("-carbonyl" 1) ("β-unsaturated carbonyl groups" 1) ("carbonyl (CO)" 1)))
    ("CHEBI:23042" (("carotene" 13) ("Carotene" 10) ("-carotene" 3)))
    ("CHEBI:23044"
     (("carotenoid" 17) ("carotenoids" 13)
      ("the major non-provitamin A carotenoid" 1)))
    ("CHEBI:23053"
     (("catechin" 31) ("catechins" 29) ("-Catechin" 3) ("monomeric catechins" 3)
      ("Catechin" 2) ("-catechin" 2) ("Catechins" 1)
      ("green tea-derived catechins" 1) ("-catechin (CA)" 1)))
    ("CHEBI:23123" (("chloroacetate" 4) ("Chloroacetate" 2)))
    ("CHEBI:23229" (("chromanol" 1)))
    ("CHEBI:23240"
     (("chromophores" 33) ("chromophore" 25) ("chromophore (AE)" 12)))
    ("CHEBI:23354"
     (("coenzyme" 212) ("Coenzyme" 20) ("coenzymes" 7)
      ("an essential coenzyme" 2)))
    ("CHEBI:23357"
     (("cofactor" 1388) ("a transcriptional cofactor" 23)
      ("an essential cofactor" 13) ("a key transcriptional cofactor" 4)
      ("Cofactor" 3) ("a TCRdependent cofactor" 2)
      ("the two proteins alone lacks cofactor" 2)
      ("a stress-inducible transcription cofactor" 2) ("cooperative cofactor" 1)
      ("a translational cofactor" 1)
      ("a
pivotal cofactor"
       1)
      ("an essential enzyme cofactor" 1) ("the cofactor's" 1)
      ("an essential cellular cofactor" 1) ("a pivotal cofactor" 1)
      ("a pro-apoptotic cofactor" 1) ("the etiologic cofactor" 1)
      ("stimulatory GR cofactor" 1) ("the co-expressed TPR cofactor" 1)
      ("an essential anti-oxidant cofactor" 1)
      ("an essential structural cofactor" 1) ("AN ESSENTIAL COFACTOR" 1)
      ("COFACTOR" 1) ("a nucleolar-confined c-Jun cofactor" 1)
      ("a p53 transcriptional cofactor" 1)))
    ("CHEBI:23403" (("coumarins" 4) ("Coumarins" 2)))
    ("CHEBI:2341" (("AACOCF3" 31))) ("CHEBI:23410" (("cumate" 8)))
    ("CHEBI:23456"
     (("cyclodextrin" 167) ("-cyclodextrin" 18) ("Cyclodextrin" 8)
      ("cyclodextrins" 6) ("Cyclodextrins" 1)))
    ("CHEBI:23492" (("cyclopentane" 5)))
    ("CHEBI:23528" (("cytochalasin" 42) ("Cytochalasin" 9) ("cytochalasins" 1)))
    ("CHEBI:23614"
     (("deoxycholate" 457) ("Deoxycholate" 52) ("deoxycholate (DOC)" 2)))
    ("CHEBI:23623" (("deoxyglucose" 20) ("-deoxyglucose" 2) ("Deoxyglucose" 2)))
    ("CHEBI:23636"
     (("deoxyribonucleosides" 20) ("deoxyribonucleoside" 10)
      ("Deoxyribonucleoside" 4) ("than purine deoxyribonucleosides ( xref )" 1)
      ("exogenous deoxyribonucleosides" 1)))
    ("CHEBI:23666"
     (("diamine" 66) ("Diamine" 12) ("diamine (TMPD)" 4) ("diamine (TEMED)" 2)
      ("aliphatic diamines" 2) ("diamines" 1)))
    ("CHEBI:23704" (("diepoxybutane" 4) ("diepoxybutane (DEB)" 2)))
    ("CHEBI:23765" (("quinolone" 4))) ("CHEBI:23798" (("dimethoxyflavone" 2)))
    ("CHEBI:23818" (("dimethylxanthines" 3))) ("CHEBI:2382" (("acerosin" 9)))
    ("CHEBI:23824" (("diol" 47) ("diols" 3)))
    ("CHEBI:23849"
     (("diterpenoid" 25) ("diterpenoids" 9) ("a lipophilic diterpenoid" 2)))
    ("CHEBI:23853" (("dithiol" 7) ("vicinal dithiols" 1) ("dithiols" 1)))
    ("CHEBI:23870" (("lauryl" 10)))
    ("CHEBI:23899"
     (("eicosanoids" 87) ("eicosanoid" 34) ("Eicosanoids" 5) ("Eicosanoid" 2)
      ("a prohypertensive eicosanoid" 1) ("a proatherogenic eicosanoid" 1)))
    ("CHEBI:23916" (("enoyl" 3) ("Enoyl" 1)))
    ("CHEBI:23965"
     (("estradiol" 1632) ("Estradiol" 127) ("-estradiol" 90) ("estradiols" 15)
      ("-Estradiol" 11) ("Estradiols" 6) ("exogenous estradiol" 5)
      ("supplemental estradiol" 3) ("estradiol molecule" 3)
      ("the residual estradiol" 2)
      ("The parent unsubstituted phenylvinyl estradiol" 2)
      ("transvaginal ultrasound and serum estradiol" 2)
      ("girls produced less estradiol" 1)
      ("1% charcoal dextran-treated FBS, and estrogen (beta-estradiol" 1)
      ("estradiol-" 1) ("estradiol's" 1) ("than estradiol" 1)
      ("the ovarian hormones estradiol" 1) ("Most estradiol" 1)
      ("Bioavailable plasma estradiol" 1) ("bioavailable estradiol" 1)))
    ("CHEBI:23995"
     (("N-ethyl-N-nitrosourea" 11) ("N-Ethyl-N-nitrosourea (ENU)" 1)
      ("N-Ethyl-N-nitrosourea" 1)))
    ("CHEBI:24017"
     (("farnesyl" 93) ("farnesyl group" 51) ("Farnesyl" 8) ("farnesyl groups" 3)
      ("shorter 15-carbon farnesyl group" 2) ("farnesyl-" 1)))
    ("CHEBI:24061"
     (("Fluor" 4986) ("fluor" 273) ("Fluors" 16) ("fluors" 8) ("Fluor (AF)" 7)
      ("secondary Alexa Fluor" 5) ("fluorine atom" 5) ("fluorine atoms" 5)
      ("the appropriate secondary goat anti-mouse Alexa Fluor" 3) ("Fluor-" 3)
      ("the fluorescently labeled secondary antibodies Alexa Fluor" 3)
      ("-Fluor" 2) ("FLUOR" 2) ("a secondary anti-rabbit Alexa Fluor" 2)
      ("FluorS" 2) ("secondary antibody Alexa Fluor" 2)
      ("secondary goat-anti-mouse and Alexa Fluor" 2)
      ("the water-soluble dyes Alexa Fluor" 2)
      ("secondary anti–rabbit Alexa Fluor" 2)
      ("Highly cross-absorbed secondary reagents Alexa Fluor" 2)
      ("namely goat anti-mouse IgG Alexa Fluor" 2)
      ("secondary goat anti-mouse IgG Alexa Fluor" 2) ("Alexa Fluor" 2)
      ("secondary goat antibodies anti-rabbit Alexa Fluor" 2)
      ("the secondary antibody Alexa Fluor" 2)
      ("488-conjugated anti-rabbit and Alexa Fluor" 1) ("using Alexa Fluor" 1)
      ("Secondary detection employed Anti-IgG Alexa Fluor" 1)))
    ("CHEBI:24128" (("furanocoumarins" 9) ("furanocoumarin" 7)))
    ("CHEBI:24163"
     (("galactoside" 41) ("-galactoside" 6) ("galactosides" 3) ("Galactoside" 1)))
    ("CHEBI:24190" (("γ-glutamyl" 27)))
    ("CHEBI:24195" (("Gamma-glutamylcysteine" 1)))
    ("CHEBI:24215" (("gentiobioside" 1)))
    ("CHEBI:2423"
     (("N-acetyl-leucyl-leucyl-norleucinal (ALLN)" 7)
      ("N-acetyl-leucyl-leucyl-norleucinal" 3)))
    ("CHEBI:24265" (("gluconate" 11) ("-gluconate" 3)))
    ("CHEBI:24278" (("glucoside" 50) ("-glucoside" 11) ("glucosides" 4)))
    ("CHEBI:24279" (("glucosinolate" 13) ("glucosinolates" 6)))
    ("CHEBI:24302"
     (("glucuronide" 57) ("-glucuronide" 15) ("glucuronides" 10)
      ("SYF −/− generated 3-fold more E 2 glucuronide" 1)))
    ("CHEBI:24329"
     (("glutarate" 56) ("-glutarate" 16) ("Glutarate" 5)
      ("isotopic D 4 -glutarate" 4)
      ("we first treated HeLa cells non-isotopic glutarate" 1)
      ("glutarate (DSG)" 1)))
    ("CHEBI:24346"
     (("glycerophosphate" 575) ("-glycerophosphate" 69) ("Glycerophosphate" 15)
      ("–glycerophosphate" 5) ("phosphoglyceric acid" 2)))
    ("CHEBI:24364" (("glyceryl" 3) ("Glyceryl" 1)))
    ("CHEBI:24366" (("glycidyl" 1)))
    ("CHEBI:24396" (("glycopeptide" 2) ("glycopeptides" 1)))
    ("CHEBI:24400"
     (("glycosides" 46) ("glycoside" 13) ("cardiac glycosides" 4)
      ("a cardiac glycoside" 2)))
    ("CHEBI:24410" (("glycosylphosphatidylinositol" 29)))
    ("CHEBI:24500" (("heparans" 15) ("heparan" 7)))
    ("CHEBI:24536" (("hexachlorocyclohexane" 5)))
    ("CHEBI:24586" (("hexosamine" 22) ("hexosamines" 6) ("Hexosamine" 4)))
    ("CHEBI:24593"
     (("hexyl" 8) ("-hexyl" 1) ("-hexyl group" 1) ("hexyl group" 1) ("Hexyl" 1)))
    ("CHEBI:24621"
     (("hormone" 4873) ("hormones" 1239) ("Hormone" 168) ("Hormones" 22)
      ("hormone-" 19) ("exogenous hormones" 15) ("menopausal hormones" 13)
      ("reproductive hormones" 11) ("lactogenic hormones" 11)
      ("ovarian hormones" 8) ("hormone (MSH)" 8) ("PMH" 8)
      ("postmenopausal hormones" 6) ("female-specific hormones" 5)
      ("sexual hormones" 5) ("hormone (AMH)" 5) ("hormone (TSH)" 4)
      ("placental hormones" 4) ("had used menopausal hormones" 4)
      ("androgenic hormones" 3) ("pMH" 3)
      ("contraceptive and menopausal hormones" 3) ("hormone (PTHLH)" 3)
      ("hormone (TH)" 3) ("hormone (TRH)" 3) ("The mammotrophic hormone" 2)
      ("lipophilic hormones" 2) ("a classical endocrine hormone" 2)
      ("a reproductive hormone" 2) ("exogenous sex hormones" 2)
      ("natriuretic hormones" 2) ("HORMONE" 2) ("thyroid-stimulatory hormone" 2)
      ("an exercise-stimulated hormone" 2) ("a tropic hormone" 2)
      ("thyroidal effector hormones" 2) ("dual hormone" 2)
      ("a bile acid/FXR induced intestinal hormone" 2) ("systemic hormones" 2)
      ("the hypothalamic hormone" 2) ("exogenous reproductive hormones" 2)
      ("hormone (GHRH)" 2) ("the human placental hormone" 2)
      ("the lactogenic hormones" 2) ("Hormone-" 2) ("an orexigenic hormone" 2)
      ("Nonandrogenic hormones" 2) ("nonandrogenic hormones" 2)
      ("the first mouse placental hormone" 2) ("essential placental hormones" 2)
      ("progestational hormone (PR)" 2) ("Hormone (HGH)" 2)
      ("the ovarian hormone" 2) ("an adipose-derived hormone" 2)
      ("primarily female-specific hormones" 2) ("several systemic hormones" 2)
      ("a systemic hormone" 2) ("an important calciophosphoregulatory hormone" 2)
      ("adipogenic hormones" 1) ("a residual hormone" 1)
      ("given exogenous hormones" 1) ("follicular stimulating hormone (FSH)" 1)
      ("hormone (FSH)" 1) ("the androgenic hormone" 1)
      ("the most influential and prominent hormones" 1) ("than hormone" 1)
      ("female sexual hormones" 1) ("rhythmically-produced hormones" 1)
      ("decidual hormones" 1) ("Exogenous hormones" 1)
      ("many classical hormones" 1) ("postmenopausal hormone" 1)
      ("both delivering reproductive hormones" 1) ("the ‘female’ hormone" 1)
      ("a fat soluble hormone" 1)
      ("the stimulatory effect of pregnancy-related hormones" 1)
      ("the constituent hormones" 1) ("a multifunctional hormone" 1)
      ("a gaseous hormone (NO)" 1) ("Hormone (FSH)" 1) ("Diffusible hormones" 1)
      ("the previously diminished Anti-Müllerian hormone" 1)
      ("a pleiotropic hormone" 1) ("ever use menopausal hormones" 1)
      ("a controversial insulin-mimetic hormone" 1)
      ("phenol red-free media + 10% charcoal-stripped Nuserum +/− hormone" 1)
      ("current exogenous reproductive hormones" 1)
      ("gender-dependent hormones" 1) ("hormone (ACTH)" 1) ("hormones (GH)" 1)
      ("a pluripotent hormone" 1) ("adrenocorticotrophic hormone" 1)
      ("the ancestral hormone" 1) ("post-menopausal hormones" 1)
      ("contraceptive or menopausal hormones" 1) ("aggressive hormone" 1)
      ("immunoregulatory hormones" 1) ("sufficient placental hormone" 1)
      ("insufficient placental hormone" 1) ("other placental hormones" 1)
      ("the first placental hormone" 1) ("“hormones”" 1)
      ("We first added back various hormones" 1) ("exogenous thyroid hormone" 1)
      ("an anabolic hormone" 1) ("curable hormone-" 1)
      ("a commonly known androgenic or reproductive hormone" 1)
      ("adenohypophysial hormones" 1) ("the predominant sex hormone" 1)
      ("surplus exogenous hormones" 1)
      ("multiple stimulatory G protein-coupled hormones" 1) ("external hormone" 1)
      ("the ovarian hormones" 1) ("other lipophilic hormones" 1)
      ("this hormone's" 1) ("anabolic hormones" 1)))
    ("CHEBI:24632"
     (("hydrocarbon" 91) ("hydrocarbons" 73)
      ("polycyclic aromatic hydrocarbons" 52)
      ("polycyclic aromatic hydrocarbons (PAH)" 6)
      ("halogenated aromatic hydrocarbons" 3)
      ("carcinogenic polycyclic aromatic hydrocarbons" 3)
      ("polycyclic hydrocarbons" 2) ("poly aromatic hydrocarbons" 2)
      ("polyhalogenated aromatic hydrocarbons" 2)
      ("polycyclic aromatic hydrocarbon (PAH)" 2)
      ("Polycyclic aromatic hydrocarbons" 2)
      ("a carcinogenic polycyclic aromatic hydrocarbon (PAH)" 2)
      ("the polycyclic aromatic hydrocarbons (PAH)" 2)
      ("polycyclic aromatic hydrocarbon" 2)
      ("the polycyclic aromatic hydrocarbons" 2)
      ("Polyhalogenated aromatic hydrocarbon" 1)
      ("Polycyclic aromatic hydrocarbon" 1) ("Hydrocarbon" 1)
      ("aromatic hydrocarbons" 1) ("Polycyclic aromatic hydrocarbons (PAH)" 1)
      ("a polycyclic aromatic hydrocarbon" 1) ("the polycyclic hydrocarbons" 1)))
    ("CHEBI:24644" (("HpETE" 2) ("HPETE" 1)))
    ("CHEBI:24648" (("hydroxamate" 55) ("hydroxamates" 9) ("hydroxamate-" 2)))
    ("CHEBI:24651"
     (("hydroxide" 104) ("hydroxides" 7) ("XTT" 5) ("hydroxide (KOH)" 1)
      ("ferric hydroxides" 1)))
    ("CHEBI:24675"
     (("hydroxybenzoate" 4) ("2 μg/ml butyl- p -hydroxybenzoate" 1)
      ("-hydroxybenzoate" 1)))
    ("CHEBI:24698" (("Hydroxyflavone" 3)))
    ("CHEBI:24712"
     (("hydroxymethyl" 45) ("Hydroxymethyl" 3) ("hydroxymethyl group" 2)))
    ("CHEBI:24741"
     (("hydroxyproline" 57) ("Hydroxyproline" 11)
      ("significantly more hydroxyproline" 1)))
    ("CHEBI:24750"
     (("reticulin" 43) ("Reticulin" 5) ("intercellular reticulin" 1)))
    ("CHEBI:24751" (("hydroxytoluene" 32) ("hydroxytoluene (BHT)" 7)))
    ("CHEBI:24753" (("hygromycin" 684) ("Hygromycin" 95) ("-Hygromycin" 2)))
    ("CHEBI:24757" (("HOCl" 115) ("hypochlorous acid" 11) ("HOCl-" 1)))
    ("CHEBI:24783"
     (("imine" 3) ("N-acetyl- p -benzoquinone imine" 2) ("imine (PEI)" 2)))
    ("CHEBI:24786"
     (("di-glycine" 15) ("iminodiacetic acid" 5) ("-iminodiacetic acid" 1)))
    ("CHEBI:24853" (("intercalator" 43) ("the fluorescent intercalator" 1)))
    ("CHEBI:24858"
     (("iodide" 5158) ("iodide (PI)" 965) ("Iodide" 298) ("Iodide (PI)" 57)
      ("iodides" 10) ("iodide(PI)" 3)
      ("the red fluorescent DNA dye propidium iodide" 2)
      ("a mitotic marker and propidium iodide" 2)
      ("the membrane-impermeable propidium iodide" 2)
      ("Alexa Fluor 488-conjugated annexin V and propidium iodide (PI)" 2)
      ("subsequently propidium iodide" 2) ("the vital dye propidium iodide" 2)
      ("the corresponding isomeric di-methylphenyl iodides" 2)
      ("Iodide (SIGMA)" 1) ("more Annexin V/propidium iodide" 1)
      ("flow cytometric Annexin V/propidium iodide (PI)" 1) ("iodide ( PI )" 1)
      ("cold (4 °C) hypotonic propidium iodide (PI)" 1)
      ("the membrane impermeable DNA-binding dye propidium iodide" 1)
      ("iodide
                    (PI)"
       1)
      ("Iodide (IP)" 1) ("more propidium iodide" 1)
      ("live and necrotic cells 10 mg/ml Hoechst 33342 and 1 mg/ml propidium iodide"
       1)
      ("the nuclear vital dye propidium iodide (PI)" 1)))
    ("CHEBI:24859"
     (("IOD" 119) ("iodine atoms" 3) ("iod" 2)
      ("the semi quantitative analysis tool IOD" 2)
      ("western blotting and standardizing IOD" 1)
      ("concordant α-tubulin or β-actin IOD" 1)))
    ("CHEBI:24864" (("iodothyronine" 8) ("iodothyronines" 2)))
    ("CHEBI:24865" (("iodotyrosine" 1)))
    ("CHEBI:24866"
     (("salt" 2686) ("Salt" 251) ("salts" 161) ("sel" 37) ("Salts" 13) ("WST" 6)
      ("SEL" 5) ("unusual cationic salts" 3) ("chaotropic salts" 3)
      ("salts (BME)" 3) ("kosmotropic salts" 3) ("salt (MTS)" 3) ("salt (LPA)" 3)
      ("salt (PDTC)" 3)
      ("glycodeoxycholic acid, glycochenodeoxycholic acid, and deoxycholic acid sodium salts"
       2)
      ("weak salt" 2) ("100 mM monovalent salt" 2) ("salt-" 2)
      ("3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt"
       2)
      ("salt (ABTS)" 2) ("inorganic salts" 2) ("water-soluble acid salts" 2)
      ("Salt (HBSS)" 2) ("salts (HBSS)" 2)
      ("1 m M ethylenediaminetetraacetic acid (EDTA) disodium salt" 2)
      ("salt (DDTC)" 2) ("water-soluble tetrazolium salt" 2) ("salt–" 1)
      ("at least 25 mM salt" 1)
      ("bathocuproine disulfonic acid (BCS) disodium salt" 1) ("sALT" 1)
      ("3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt"
       1)
      ("Sel" 1) ("monovalent salts" 1) ("typical monovalent salts" 1)
      ("a strong salt" 1) ("a red-coloured formazan salt" 1)
      ("a highly water-soluble tetrazolium salt" 1) ("iodine added salt" 1)
      ("the nSH3 domain employs only two intermolecular salt" 1)
      ("only two intermolecular salt" 1) ("residual salt" 1)
      ("E627 and K688 form strong salt" 1) ("forms strong salt" 1)
      ("the strong salt" 1) ("benzamide-mesylate methane sulfonic acid salt" 1)
      ("the nonnative salt" 1) ("one or more intermolecular salt" 1)
      ("salt (MTT)" 1) ("insoluble formazan salt" 1) ("approximate 150mM salt" 1)
      ("the respective metal chloride salts" 1)
      ("3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2 H -tetrazolium inner salt"
       1)
      ("several interchangeable salt" 1)
      ("the filament and forms intermittent salt" 1) ("reproducible salt" 1)
      ("salts (GAS)" 1) ("strong salt" 1)
      ("than other tetrazolium salts such as MTT" 1)
      ("highly water-soluble tetrazolium salt" 1)
      ("the previously characterized short RNAs ACE sel" 1)
      ("p -nitrophenyl phosphate disodium salt" 1) ("salt (PNPP)" 1)
      ("Water-soluble tetrazolium salt" 1)
      ("p -nitrophenyl phosphate (PNPP) disodium salt" 1)))
    ("CHEBI:24869"
     (("ionophore" 187) ("ionophores" 43) ("Ionophore" 5)
      ("a carboxylic polyether ionophore" 1) ("-ionophore" 1)))
    ("CHEBI:24983" (("ketoxime" 2))) ("CHEBI:24995" (("lactam" 10) ("lactams" 1)))
    ("CHEBI:25000"
     (("lactone" 119) ("lactones" 14) ("Lactone" 10) ("-lactone" 6)
      ("a steroidal lactone" 3) ("the five-membered ring lactone" 2)
      ("lactone (BEL)" 1) ("a macrocyclic lactone" 1) ("C28 steroidal lactone" 1)
      ("an immunosuppressive macrocyclic lactone" 1)))
    ("CHEBI:25013" (("Lanthionine" 1)))
    ("CHEBI:25029"
     (("leukotriene" 61) ("leukotrienes" 50) ("Leukotriene" 18)
      ("Leukotrienes" 1)))
    ("CHEBI:25036"
     (("lignan" 60) ("lignans" 35) ("dietary lignans" 3) ("Lignan" 3)
      ("Lignans" 3) ("a pure mammalian lignan" 1)))
    ("CHEBI:25078" (("luciferin" 218) ("Luciferin" 42) ("-luciferin" 22)))
    ("CHEBI:25115"
     (("malate" 131) ("-malate" 10) ("exogenous cell permeable malate" 1)
      ("exogenous malate" 1)))
    ("CHEBI:25166" (("mannosamine" 8) ("Mannosamine" 4)))
    ("CHEBI:25212"
     (("metabolites" 1789) ("metabolite" 1040) ("Metabolites" 47)
      ("Metabolite" 45) ("DHBMA" 11) ("bacterial metabolites" 9)
      ("a fungal metabolite" 8) ("the urinary metabolites" 6)
      ("metabolite (PGEM)" 5) ("genotoxic metabolites" 5) ("toxic metabolites" 4)
      ("an essential metabolite" 4) ("Urinary Metabolite" 4)
      ("a toxic metabolite" 3) ("metabolites ( COMT )" 3)
      ("The biologically most active vitamin D metabolite" 3)
      ("vitamin A metabolite" 3) ("the immediate upstream metabolite" 2)
      ("oxidative metabolites" 2) ("The global metabolite" 2)
      ("anabolic metabolites" 2) ("an anabolic metabolite" 2)
      ("genotoxic and mutagenic metabolites" 2)
      ("succinyl-CoA and malonyl-CoA intermediary metabolites" 2)
      ("a weakly-oestrogenic (100 to 1000-fold less compared to natural oestradiol) mammalian metabolite"
       2)
      ("Only 2 measured metabolites" 2) ("pivotal metabolites" 2)
      ("139 soluble metabolites" 2) ("only three metabolites" 2)
      ("a novel secondary metabolite" 2) ("secondary metabolites" 2)
      ("the respective metabolites" 2) ("essential metabolites" 2)
      ("their secondary metabolites" 2) ("genotoxic estrogen metabolites" 2)
      ("urinary arsenic metabolites" 2) ("urinary metabolites" 2)
      ("multifunctional lipid metabolites" 2) ("its N -hydroxylated metabolite" 2)
      ("a chemopreventive metabolite" 2) ("targeted metabolites" 2)
      ("cardiotoxic anthracycline alcohol metabolites" 2)
      ("bioactive secondary metabolites" 2) ("most other metabolites" 2)
      ("some bacterial metabolites" 2) ("major bacterial metabolites" 2)
      ("Bacterial metabolites" 2) ("cytokines increased NO metabolites" 2)
      ("the most ubiquitous secondary metabolites" 2)
      ("potentially toxic fluoro-cytidine metabolites" 1)
      ("various oxidative metabolites" 1)
      ("The three incident HF-related metabolites" 1)
      ("previously reported HF-related metabolites" 1)
      ("a blue redox-active secondary metabolite" 1)
      ("anabolic precursor metabolites" 1) ("Nicotinic acid metabolites" 1)
      ("organic metabolites" 1) ("their own toxic metabolites" 1)
      ("The carboxylic acid metabolite" 1) ("The dry metabolite" 1)
      ("downstream anabolic metabolites" 1)
      ("a potential carcinogenic estrogen metabolite" 1)
      ("a genotoxic metabolite" 1) ("urinary PGE 2 metabolite" 1)
      ("specific unique metabolites" 1)
      ("separate aqueous and lipid-soluble metabolites" 1)
      ("tolerogenic kynurenine metabolites" 1) ("its methylated metabolite" 1)
      ("its methylated metabolites" 1) ("the only TCA cycle metabolites" 1)
      ("the essential metabolite" 1) ("urinary catecholamine metabolites" 1)
      ("candidal 5-hydroxytryptophan metabolites" 1)
      ("this secondary metabolite" 1) ("this bacterial-produced metabolite" 1)
      ("Microbial secondary metabolites" 1) ("smoking-associated metabolites" 1)
      ("The polar metabolites" 1) ("pure secondary metabolites" 1)
      ("toxic metabolite" 1) ("the main urinary metabolites" 1)
      ("approximately 100 metabolites" 1) ("intermediary metabolites" 1)
      ("Their respective metabolites" 1)
      ("endogenously generated toxic metabolites" 1) ("anionic metabolites" 1)
      ("higher urinary nitric oxide metabolites" 1)
      ("multiple distal metabolites" 1) ("electrophilic metabolites" 1)
      ("a urinary metabolite" 1) ("oxidative estrogen metabolites" 1)
      ("These oxidative metabolites" 1) ("urinary arsenic metabolite" 1)
      ("methylated arsenic metabolites" 1)
      ("Several reative carbonyl metabolites" 1) ("promutagenic metabolites" 1)
      ("inactive excretable metabolites" 1) ("toxic estrogen metabolites" 1)
      ("a gastrointestinal metabolite" 1) ("its N -hydroxylated metabolites" 1)
      ("promitogenic sphingosine metabolites" 1)
      ("the promitogenic phosphorylated metabolite" 1)
      ("potential active metabolites" 1)
      ("several essential secondary metabolites" 1)
      ("water-soluble metabolites" 1) ("transformed parental cell metabolite" 1)
      ("one or more other metabolites" 1) ("Many genotoxic metabolites" 1)
      ("microbial metabolites" 1) ("these microbial metabolites" 1)
      ("bacterial bioactive metabolites" 1) ("its immediate metabolites" 1)
      ("more toxic metabolites" 1) ("other bacterial metabolites" 1)
      ("the bacterial metabolites" 1) ("single bacterial metabolites" 1)
      ("appropriate intermediary metabolites" 1)
      ("genotoxic cellular metabolites" 1)))
    ("CHEBI:25224" (("methanesulfonate" 4)))
    ("CHEBI:25272" (("methyladenine" 11) ("-methyladenine" 5)))
    ("CHEBI:25294" (("methylcytidine" 4))) ("CHEBI:25296" (("Medina" 5)))
    ("CHEBI:25297"
     (("methylenetetrahydrofolate" 19) ("Methylenetetrahydrofolate" 4)
      ("methylenetetrahydrofolate (MTHF)" 2)))
    ("CHEBI:25305"
     (("-methylguanine" 197) ("methylguanine" 167) ("Methylguanine" 7)
      ("-methylguanines" 7) ("-Methylguanine" 4) ("methylguanines" 3)))
    ("CHEBI:25345" (("methyltetrahydrofolate" 14)))
    ("CHEBI:25348"
     (("methylxanthine" 29) ("methylxanthines" 5) ("methylxanthine (DCI)" 3)))
    ("CHEBI:25350" (("mevalonate" 178) ("Mevalonate" 3)))
    ("CHEBI:25354"
     (("mineralocorticoid" 12) ("mineralocorticoids" 2) ("Mineralocorticoid" 1)))
    ("CHEBI:25357"
     (("mitomycin" 87) ("Mitomycin" 7) ("mitomycins" 4) ("mitomycin-" 2)))
    ("CHEBI:25399" (("methylphenol" 4) ("Cresol" 2)))
    ("CHEBI:25413"
     (("MUFA" 64) ("monounsaturated fatty acids" 22) ("dietary MUFA" 4)
      ("monounsaturated fatty acid" 3) ("exogenous MUFA" 2)
      ("endogenously-synthesized MUFA" 1) ("monounsaturated fatty acids (MUFA)" 1)
      ("MUFAs" 1) ("dietary monounsaturated fatty acids" 1)))
    ("CHEBI:25433" (("muramyl" 22) ("Muramyl" 1)))
    ("CHEBI:25442" (("mycotoxin" 7) ("mycotoxins" 3) ("a fungal mycotoxin" 1)))
    ("CHEBI:25456"
     (("myr" 253) ("Myr" 217) ("myr-" 16) ("MYR" 8) ("Myr-" 3)
      ("a stable hESC line expressing myr" 1)
      ("the highly PKA-selective cell-permeable peptide inhibitor myr" 1)))
    ("CHEBI:25482" (("naphthoate" 1)))
    ("CHEBI:25512"
     (("neurotransmitter" 222) ("neurotransmitters" 118) ("Neurotransmitters" 2)
      ("the principal inhibitory neurotransmitter" 2)
      ("a predominant neurotransmitter" 2)
      ("the predominant excitatory neurotransmitter" 2) ("neurotransmitter-" 2)
      ("the excitatory neurotransmitter" 1) ("excitatory neurotransmitters" 1)
      ("oxidative
catecholaminergic neurotransmitters"
       1)
      ("most neurotransmitters" 1) ("Neurotransmitter" 1)
      ("toxic neurotransmitters" 1) ("the major excitatory neurotransmitter" 1)
      ("a classical neurotransmitter" 1)
      ("neural/non-neural neurotransmitters" 1)))
    ("CHEBI:25523"
     (("NADP" 314) ("observable bound NADP" 1) ("exogenous NADP" 1)))
    ("CHEBI:25555"
     (("nitrogen" 2921) ("nitrogen atoms" 30) ("nitrogen atom" 27)
      ("nitrogens" 25) ("Nitrogen" 21) ("nitrogen (BUN)" 14)
      ("basic nitrogen atoms" 4) ("-nitrogen" 4) ("a basic nitrogen" 2)
      ("dry nitrogen" 2) ("two critically positioned nitrogen atoms" 2)
      ("Nonprotein urinary nitrogen" 1) ("an available nitrogen atom" 1)
      ("pure nitrogen" 1)))
    ("CHEBI:25562"
     (("nitrophenol" 29) ("-nitrophenol" 9) ("p -nitrophenol" 3)
      ("product p -nitrophenol" 1) ("released p -nitrophenol" 1)))
    ("CHEBI:25589" (("nonyl" 11) ("Nonyl" 1)))
    ("CHEBI:25650" (("octanoyl" 4) ("di-octanoyl" 2)))
    ("CHEBI:25657" (("octyl" 58) ("-octyl" 6) ("Octyl" 5)))
    ("CHEBI:25667" (("oleoyl" 17) ("Oleoyl" 5) ("oleoyl-" 1)))
    ("CHEBI:25675"
     (("oligomycin" 317) ("Oligomycin" 45)
      ("the respiratory chain inhibitor oligomycin" 2)))
    ("CHEBI:25682" (("SDMA" 25) ("only R111/113 SDMA" 1) ("sDMA" 1) ("SDMAs" 1)))
    ("CHEBI:25698"
     (("ether" 191) ("ethers" 3) ("ether (MTBE)" 3) ("residual ether" 2)
      ("Ether" 1) ("anhydrous ether" 1) ("ether (NE)" 1)))
    ("CHEBI:25728"
     (("osmolytes" 14) ("osmolyte" 11) ("small organic osmolytes" 4)
      ("organic osmolytes" 1)))
    ("CHEBI:25741"
     (("oxide" 149) ("oxides" 6) ("oxyde" 4) ("oxide (PEO)" 3) ("Oxide" 3)
      ("oxide (PAO)" 3) ("secondary oxides" 3) ("oxide (NO)" 1) ("oxide (PO)" 1)))
    ("CHEBI:25750"
     (("BIO" 155) ("oxime" 41) ("-oxime" 28) ("0.5 µM BIO" 2) ("2μM BIO" 2)
      ("-oxime (BIO)" 2) ("the chemical inhibitor BIO" 1)
      ("the unrelated inhibitor BIO" 1) ("oximes" 1) ("–oxime" 1)))
    ("CHEBI:25805"
     (("oxygen" 4367) ("Oxygen" 166) ("oxygens" 77) ("atmospheric oxygen" 64)
      ("oxygen atom" 59) ("oxygen atoms" 41) ("ambient oxygen" 11)
      ("low ambient oxygen" 10) ("5% ambient oxygen" 8) ("oxygen-" 8)
      ("1% ambient oxygen" 7) ("oxygen molecule" 6) ("21% ambient oxygen" 6)
      ("supplemental oxygen" 5) ("adequate oxygen" 4) ("Supplemental oxygen" 2)
      ("hyperbaric oxygen" 2) ("21% and 5% ambient oxygen" 2)
      ("Inspiratory oxygen" 2) ("ambient normal oxygen" 2)
      ("oxygen
atom"
       2)
      ("available oxygen" 2) ("continuous atmospheric oxygen" 2)
      ("newly developed oxygen" 2) ("ample oxygen" 2)
      ("the electronegative substrate oxygen" 2) ("2% actual oxygen" 2)
      ("our experiments control ambient oxygen" 1)
      ("21%, 5% or 1% ambient oxygen" 1) ("approximately 21 percent oxygen" 1)
      ("3 percent oxygen" 1) ("the equatorial oxygens" 1) ("the apical oxygen" 1)
      ("whose main chain carbonyl oxygens" 1) ("-oxygen" 1) ("less oxygen" 1)
      ("intimately links oxygen" 1) ("the available oxygen" 1)
      ("3% ambient oxygen" 1) ("the proximal oxygen" 1)
      ("five additional electronegative oxygen atoms" 1) ("lowered oxygen" 1)
      ("phenolic oxygen" 1) ("more oxygen" 1) ("1% atmospheric oxygen" 1)
      ("20% atmospheric oxygen" 1) ("The 1% and 4% atmospheric oxygen" 1)
      ("1% and 4% atmospheric oxygen" 1) ("4% atmospheric oxygen" 1)
      ("than 2% oxygen [ xref ]" 1)))
    ("CHEBI:25879" (("pENT" 2) ("pent" 2)))
    ("CHEBI:25901" (("pentose" 141) ("Pentose" 6)))
    ("CHEBI:25902" (("pentyl" 9) ("-pentyl" 5)))
    ("CHEBI:25941"
     (("peroxynitrite" 127) ("Peroxynitrite" 16) ("peroxynitrites" 7)
      ("exogenous peroxynitrite" 2) ("d-flow–mediated peroxynitrite" 2)
      ("the resultant peroxynitrite" 1)))
    ("CHEBI:25944"
     (("pesticides" 81) ("pesticide" 67) ("Pesticide" 4) ("Pesticides" 3)
      ("just one pesticide" 2) ("agricultural pesticides" 1)
      ("xenoestrogenic pesticides" 1)))
    ("CHEBI:26013" (("pheromone" 27)))
    ("CHEBI:26020"
     (("phosphate" 6368) ("phosphates" 331) ("Phosphate" 223) ("-phosphate" 62)
      ("ice-cold phosphate" 30) ("inorganic phosphate" 26) ("phosphate-" 21)
      ("p -nitrophenyl phosphate" 15) ("-phosphates" 7)
      ("20 mM monobasic potassium phosphate" 6)
      ("the released inorganic phosphate" 4) ("phosphate (NAPDH)" 3)
      ("mono-phosphate (IMP)" 3) ("phosphate (PTP)" 3) ("Phosphate (TRAP)" 3)
      ("Free inorganic phosphate" 2) ("dual specificity phosphates" 2)
      ("Phosphates" 2) ("32 P inorganic phosphate" 2) ("phosphate (BMP)" 2)
      ("Inorganic Phosphate" 2) ("phosphate (BCIP)" 2) ("mono-phosphate" 2)
      ("p -Nitrophenyl phosphate" 2) ("10 mM p -nitrophenol phosphate" 2)
      ("a low molecular weight compound p -nitrophenyl phosphate" 2)
      ("phosphate (OMFP)" 2) ("Inorganic phosphate" 2)
      ("3 mM inorganic phosphate" 2) ("fewer phosphates" 1)
      ("pre-cold phosphate" 1) ("acyclic nucleoside phosphates" 1)
      ("inorganic phosphates" 1) ("using p -nytrophenyl phosphate" 1)
      ("seven or more phosphates" 1) ("many more phosphate" 1)
      ("more phosphates" 1) ("ice-cold 70% ethanol/30% phosphate" 1)
      ("residual phosphate" 1) ("10 m m  p -nitrophenyl phosphate" 1)
      ("than 2.0 mole phosphate" 1) ("than 1 mole phosphate" 1)
      ("mono-phosphate (AMP)" 1) ("phosphate (DHAP)" 1)
      ("an ice-cold phosphate" 1) ("residual free phosphates" 1)
      ("phosphate (SIP)" 1) ("intracellular inorganic phosphate" 1)
      ("phosphate (NP)" 1) ("32 P-labeled inorganic phosphate" 1)
      ("a negatively-charged phosphate molecule" 1) ("phosphate molecule" 1)
      ("50% acetonitrile/0.1% trifluoroacetic acid/10 mM ammonium phosphate" 1)
      ("-inorganic phosphate" 1) ("possibly subsequent phosphate" 1)
      ("20 mM p -nitrophenyl phosphate" 1) ("10 mM p -nitrophenyl phosphate" 1)
      ("di-phosphate" 1) ("warm phosphate" 1) ("than phosphates" 1)
      ("three consecutive phosphates" 1) ("organic phosphate" 1)
      ("phosphate (MVAP)" 1)
      ("the chromogenic substrate para -nitrophenyl phosphate" 1)
      ("minimal phosphate" 1) ("approximately 30 mL Phosphate" 1)))
    ("CHEBI:26025" (("PTD" 69) ("-PTD" 3) ("ptd" 3) ("pTD" 1)))
    ("CHEBI:26034"
     (("phosphatidylinositol 3-phosphate" 45)
      ("Phosphatidylinositol 3-phosphate" 5)))
    ("CHEBI:26095"
     (("PHTS" 136) ("PHT" 3) ("“PHTS”" 2) ("PHTs" 2) ("severe PHTS" 1)))
    ("CHEBI:26115"
     (("phytoalexin" 21) ("phytoalexins" 17) ("a polyphenolic phytoalexin" 2)
      ("occurring polyphenolic phytoalexin" 1)
      ("a naturally polyphenolic phytoalexin" 1) ("Phytoalexins" 1)))
    ("CHEBI:26188" (("polyketide" 4))) ("CHEBI:26191" (("polyol" 2)))
    ("CHEBI:26195"
     (("polyphenols" 213) ("polyphenol" 127) ("Polyphenols" 12)
      ("Dietary polyphenols" 6) ("dietary polyphenols" 6)
      ("an estrogenic polyphenol" 2) ("cinnamon-derived polyphenols" 2)
      ("naturally-occurring plant polyphenols" 2)
      ("than isolated individual polyphenols in all three cell lines suggesting"
       1)
      ("a water soluble polyphenol" 1) ("plant based polyphenols" 1)
      ("approximately 300 polyphenols" 1) ("Polyphenol" 1)
      ("the most polyphenols" 1) ("other dietary polyphenols" 1)))
    ("CHEBI:26197"
     (("polyphosphates" 32) ("the water-soluble inositol polyphosphates" 1)))
    ("CHEBI:26214" (("porphyrins" 8) ("Porphyrins" 1)))
    ("CHEBI:26294" (("propionyl" 10) ("propionyl-" 3) ("propionyl group" 2)))
    ("CHEBI:26307"
     (("-propionitrile" 15) ("propionitrile" 9) ("propionitrile (DPN)" 9)
      ("propanenitrile" 2) ("–propionitrile (DPN)" 1) ("–propionitrile" 1)
      ("-propionitrile (DPN)" 1)))
    ("CHEBI:26308" (("propyl" 58) ("Propyl" 7) ("-propyl" 6) ("propyl group" 2)))
    ("CHEBI:26333"
     (("prostaglandin" 538) ("prostaglandins" 362) ("Prostaglandin" 62)
      ("Prostaglandins" 41) ("prostaglandin (PG)" 6) ("exogenic prostaglandins" 2)
      ("cytoprotective prostaglandins" 1) ("prostaglandins (PG)" 1)
      ("prostaglandin (TP)" 1) ("the predominant prostaglandins" 1)))
    ("CHEBI:26335" (("pGBS" 16) ("pGB" 4)))
    ("CHEBI:2634" (("amidine" 17) ("Amidine" 9) ("amidines" 2)))
    ("CHEBI:26347"
     (("prostanoids" 115) ("prostanoid" 63) ("Prostanoids" 3)
      ("endothelial-derived prostanoids" 2) ("than other prostanoids" 1)
      ("Prostanoid" 1) ("the major vasoprotective prostanoid" 1)))
    ("CHEBI:26374" (("pterin" 6))) ("CHEBI:26414" (("pyridazinones" 3)))
    ("CHEBI:26519"
     (("radical" 1485) ("radicals" 709) ("Radical" 61) ("free-radical" 19)
      ("non-radical" 3) ("free-radicals" 2)
      ("The former uses toxic reactive radicals" 2) ("oxidative free radicals" 2)
      ("more radical" 2) ("a diatomic free radical" 2) ("radicals (ROS)" 2)
      ("a more radical" 1) ("toxic radicals" 1) ("than the tyrosyl radical" 1)
      ("the only other tyrosyl radical" 1) ("the alternate radical" 1)
      ("a torsionally-relaxed radical" 1)
      ("the torsionally-strained Tyr385 radical" 1)
      ("an essential tyrosine radical" 1) ("even more radical" 1)
      ("long-lived lipid radicals" 1)))
    ("CHEBI:26541" (("retinyl" 3))) ("CHEBI:26546" (("rhamnose" 11)))
    ("CHEBI:26547" (("rhamnosides" 17) ("rhamnoside" 11)))
    ("CHEBI:26561"
     (("ribonucleotide" 55) ("ribonucleotides" 44) ("ribonucleotide (AICAR)" 4)
      ("Ribonucleotides" 4) ("Ribonucleotide" 4)
      ("biotinylated ribonucleotides" 2) ("ribonucleotide (RNA)" 1)
      ("approximately four times more ribonucleotides" 1)))
    ("CHEBI:26565" (("ribosyl" 10) ("Ribosyl" 1) ("-ribosyl" 1)))
    ("CHEBI:26587" (("rutinoside" 8) ("-rutinoside" 6)))
    ("CHEBI:26607"
     (("saturated fatty acids" 52) ("saturated fatty acid" 49) ("SFAs" 24)
      ("sFas" 20) ("Saturated fatty acids" 3) ("SFa" 3)
      ("Dietary saturated fatty acids" 2)
      ("Stearic saturated fatty acids (SFA)" 2)
      ("dietary saturated fatty acids" 1) ("more saturated fatty acids" 1)))
    ("CHEBI:26643" (("semialdehyde" 1)))
    ("CHEBI:26658"
     (("sesquiterpenoid" 5) ("sesquiterpenoids" 3)
      ("than the sesquiterpenoids (Figures xref )" 1)))
    ("CHEBI:26666"
     (("SCFAs" 196) ("SCFA" 22) ("short-chain fatty acids" 13)
      ("short-chain fatty acid" 6) ("bacterial SCFAs" 2) ("the volatile SCFAs" 2)
      ("the pure SCFAs" 1) ("at least five different SCFAs" 1)
      ("Short-chain fatty acid" 1)))
    ("CHEBI:26708"
     (("sodium" 3576) ("Sodium" 183) ("sodium (DSS)" 6)
      ("required intraliposomal sodium" 2)
      ("2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H tetrazolium sodium"
       2)
      ("a rectal diclofenac sodium" 1) ("increased dietary sodium" 1)
      ("dietary sodium" 1) ("external sodium" 1) ("sodium-" 1) ("-sodium" 1)
      ("di-sodium" 1)))
    ("CHEBI:26753" (("stearoyl" 5) ("Stearoyl" 1) ("stearoyl-" 1)))
    ("CHEBI:26755" (("octadecyl" 2) ("Octadecyl" 1)))
    ("CHEBI:26764"
     (("steroid hormones" 220) ("steroid hormone" 182) ("Steroid hormones" 18)
      ("steroid-hormone" 9) ("ovarian steroid hormones" 2) ("Steroid hormone" 2)
      ("sexual steroid hormones" 1) ("Sexual steroid hormones" 1)
      ("some anabolic steroid hormones" 1) ("nonandrogenic steroid hormones" 1)
      ("respective steroid hormones" 1)
      ("ablate endogenous testicular steroid hormones" 1) ("steroid hormone-" 1)))
    ("CHEBI:26775"
     (("stilbene" 13) ("stilbenes" 7) ("-stilbene" 1)
      ("the well-studied stilbene" 1)))
    ("CHEBI:26776" (("stilbenoid" 4)))
    ("CHEBI:26806"
     (("succinate" 219) ("Succinate" 18) ("succinate (VES)" 4)
      ("succinate (EGS)" 3) ("-succinate" 1)))
    ("CHEBI:26810" (("succinyl" 58) ("succinyl-" 2) ("Succinyl" 1)))
    ("CHEBI:26822" (("sulfide" 24) ("sulfide (BPTES)" 12) ("Sulfides" 2)))
    ("CHEBI:26921" (("tetrahydropyridine" 1))) ("CHEBI:26948" (("thiamine" 12)))
    ("CHEBI:26978" (("thiouridine" 6)))
    ("CHEBI:26995"
     (("thromboxane" 128) ("thromboxanes" 19) ("Thromboxane" 13)
      ("more thromboxane" 1) ("more thromboxane (TX)" 1)))
    ("CHEBI:2700" (("AEA" 218) ("anandamide" 24)))
    ("CHEBI:27007" (("tin" 9) ("TIN" 5) ("Tin" 4) ("Tins" 2)))
    ("CHEBI:27013"
     (("tocopherol" 255) ("tocopherols" 99) ("-tocopherol" 44) ("Tocopherol" 10)
      ("Tocopherols" 6) ("tocopherol-" 3) ("tocopherols (TP)" 1)
      ("Dietary tocopherols" 1) ("tocopherol's" 1)))
    ("CHEBI:27023" (("tosylate" 9)))
    ("CHEBI:27026"
     (("toxin" 2024) ("toxins" 422) ("Toxin" 59) ("bacterial toxins" 25)
      ("uremic toxins" 6) ("Toxins" 4) ("exogenous toxins" 4) ("toxin (CT)" 3)
      ("toxin (CDT)" 3) ("the bacterial toxins" 3)
      ("Cytolethal distending toxins" 2) ("a bacterial AB 5 toxin" 2)
      ("the few toxins" 2) ("Viral toxins" 2) ("viral toxins" 2)
      ("viral and cellular toxins" 2) ("the traditional biotoxin cholera toxin" 2)
      ("a cytolethal distending toxin (CDT)" 2) ("Bacterial toxins" 2)
      ("PD-associated toxins" 2) ("a cell-permeable C3 toxin" 2)
      ("two different bacterial toxins" 2) ("the cell permeable C3 toxin" 2)
      ("the superantigen toxic shock syndrome toxin (TSST)" 2) ("toxin (TSST)" 2)
      ("several different bacterial toxins" 2)
      ("an unusual hybrid peptide-polyketide toxin" 2) ("the key viral toxins" 1)
      ("toxin (PMT)" 1) ("the bacterial cytolethal distending toxin (CDT)" 1)
      ("bacterial cytotoxic necrotizing factor (CNF) toxin" 1)
      ("a unique oral toxin" 1) ("Several other bacterial toxins" 1)
      ("most simple PP1 molecular toxin" 1) ("a typical single-chain AB toxin" 1)
      ("bacterial protein toxins" 1) ("these viral toxins" 1)
      ("known viral toxins" 1) ("The cytolethal distending toxin (CDT)" 1)
      ("the toxin's" 1) ("Recently bacterial toxins" 1)
      ("α-helical pore-forming toxins" 1)
      ("exogenous and endogenous chemical toxins" 1)
      ("The cell-permeable C3 fusion toxin" 1)
      ("a cell-permeable C3 fusion toxin" 1) ("most toxins" 1)
      ("cytolethal distending toxins" 1) ("the potent viral toxins" 1)))
    ("CHEBI:27027"
     (("micronutrients" 17) ("micronutrient" 7)
      ("maternal vital micronutrients" 2) ("an essential micronutrient" 1)
      ("dietary micronutrients" 1)))
    ("CHEBI:27082" (("trehalose" 16) ("Trehalose" 6)))
    ("CHEBI:27110" (("trifluoroacetate" 8) ("trifluoroacetate (TFA)" 1)))
    ("CHEBI:27116" (("trihydroxyflavone" 8)))
    ("CHEBI:27136" (("triol" 36) ("triol (PPT)" 7) ("triols" 6)))
    ("CHEBI:27300"
     (("vitamin D" 972) ("Vitamin D" 99) ("-vitamin D" 20)
      ("vitamin D molecule" 3) ("exogenous vitamin D" 1) ("vitamin D’s" 1)))
    ("CHEBI:27338"
     (("xylene" 1080) ("Xylene" 53) ("xylenes" 39) ("xylene (DPX)" 3)
      ("thorough xylene" 1) ("residual xylene" 1)))
    ("CHEBI:27353" (("xylulose" 4) ("Xylulose" 3)))
    ("CHEBI:27363"
     (("zinc" 1338) ("Zinc" 138) ("zinc atom" 16) ("ZINC" 11) ("zinc atoms" 10)
      ("zinc-" 4) ("exogenous zinc" 3) ("the last zinc" 3) ("zinc molecule" 2)
      ("the coordinating cysteines of the two zinc" 2)
      ("eight consecutive C2H2 zinc" 1) ("2 highly-conserved zinc" 1)
      ("Myc-associated zinc" 1) ("myc-associated zinc ( MAZ )" 1)
      ("two unusual
“PARP-like” zinc"
       1)
      ("2 well known structurally and functionally unique zinc" 1)
      ("special CCCH type zinc" 1) ("two unique C4 type zinc" 1) ("dual zinc" 1)
      ("the first cysteine of the first zinc coordinating complex of LIM2 (C287A) or the first cysteine of the second zinc coordinating complex of LIM2 (C313A)"
       1)
      ("classical zinc" 1)))
    ("CHEBI:27385"
     (("tetra" 114) ("Tetra" 16) ("tetra-" 15) ("-tetraacetic acid tetra" 2)
      ("the relevant tetra-" 1) ("-tetra" 1)))
    ("CHEBI:27443" (("deoxycytosine" 3) ("-deoxycytosine" 3)))
    ("CHEBI:27485" (("PGJ2" 37) ("prostaglandin J2" 25) ("Prostaglandin J2" 4)))
    ("CHEBI:27510" (("umbelliferone" 3)))
    ("CHEBI:27518" (("HCCH" 21) ("acetylene" 3))) ("CHEBI:27539" (("isatin" 6)))
    ("CHEBI:27547" (("Zeaxanthin" 4)))
    ("CHEBI:27563"
     (("arsenic" 605) ("Arsenic" 47) ("inorganic arsenic" 19)
      ("Inorganic arsenic" 6) ("ARSENIC" 6) ("Acute arsenic" 2)
      ("than inorganic arsenic" 2) ("Methylated arsenic" 1) ("arsenic’s" 1)
      ("chemotherapeutic arsenic" 1)))
    ("CHEBI:27568"
     (("selenium" 201) ("Selenium" 23) ("organic selenium" 21)
      ("selenium atoms" 8) ("selenium (ITS)" 5) ("selenium (ITES)" 3)
      ("the antioxidant organic selenium" 2) ("selenium-" 2)
      ("the organic selenium" 1)))
    ("CHEBI:27584" (("aldosterone" 160) ("Aldosterone" 24)))
    ("CHEBI:27585"
     (("selenomethionine" 43) ("Selenomethionine" 1) ("-selenomethionine" 1)))
    ("CHEBI:27601" (("pteridine" 2)))
    ("CHEBI:27638" (("cobalt" 92) ("Cobalt" 14)))
    ("CHEBI:27647" (("PGG2" 4) ("prostaglandin G2" 2)))
    ("CHEBI:2766"
     (("aphidicolin" 880) ("Aphidicolin" 31) ("aphidicolin (APH)" 12)
      ("aphidicolin (EMD)" 3) ("aphidicolin-" 2)))
    ("CHEBI:27666"
     (("actinomycin D" 846) ("ActD" 259) ("Actinomycin D" 235)
      ("the transcriptional inhibitor actinomycin D" 6) ("ActD-" 6)
      ("actinomycin D–" 2) ("the classical TNF sensitizer actinomycin D" 2)
      ("the transcriptional repressor actinomycin D" 2)
      ("7-amino actinomycin D" 2) ("Actinomycin D (SIGMA)" 1)
      ("a transcriptional inhibitor Actinomycin D" 1)
      ("transcriptional inhibitor actinomycin D" 1)
      ("Our preliminary data using actinomycin D" 1)
      ("than actinomycin D suggesting an additional non-transcriptional level of regulation"
       1)
      ("the two different chemotherapeutic treatments Actinomycin D" 1)
      ("the transcriptional inhibitor ActD" 1)))
    ("CHEBI:27727" (("androstanediol" 4)))
    ("CHEBI:27729" (("digitonin" 304) ("Digitonin" 23) ("digitonin (EMD)" 2)))
    ("CHEBI:27780"
     (("detergent" 1025) ("detergents" 144) ("Detergent" 88) ("mild detergents" 9)
      ("a mild detergent" 6) ("detergent-" 4) ("nonionic detergent" 4)
      ("detergent molecule (CTAB)" 4) ("“detergent”" 4) ("Detergents" 3)
      ("the mild detergents" 2) ("Mild Detergents" 2)
      ("the nonionic detergents" 2) ("nonionic detergents" 2)
      ("a mild nonionic  detergent" 2) ("a nonionic detergent" 2)
      ("gentle detergents" 2) ("a weak nonionic detergent" 2)
      ("0.5% IGEPAL detergent" 2) ("harsh detergent" 1)
      ("mild nonionic detergents" 1) ("nonioinic detergent" 1)
      ("No harsh detergent" 1) ("non-detergent" 1) ("Most detergents" 1)
      ("other industrial detergents" 1) ("-detergent" 1) ("mild detergent" 1)))
    ("CHEBI:2781" (("apocynin" 300) ("Apocynin" 30) ("apocynin (APO)" 2)))
    ("CHEBI:27889" (("PBN" 14) ("pBn" 5)))
    ("CHEBI:27899"
     (("cisplatin" 7910) ("CDDP" 561) ("Cisplatin" 531) ("cDDP" 328)
      ("cisplatin-" 45) ("cisplatin (CDDP)" 14)
      ("the chemotherapeutic agent cisplatin" 11)
      ("the chemotherapeutic drug cisplatin" 8) ("than cisplatin" 7) ("Cis-DDP" 6)
      ("CDDP-" 3) ("the pro-apoptotic agent cisplatin" 3)
      ("the genotoxic agent cisplatin" 3) ("preoperative cisplatin" 3) ("cddp" 3)
      ("cisplatin’s" 2) ("the front line chemotherapeutic drug cisplatin" 2)
      ("the chemotherapeutic agent cisplatin (CDDP)" 2)
      ("concurrent intravenous cisplatin" 2) ("CISPLATIN" 2) ("cis-DDP" 2)
      ("the genotoxic drug cisplatin (CDDP)" 1)
      ("than those receiving cisplatin" 1)
      ("the well-established anticancer drug cisplatin" 1) ("cisplatin (DDP)" 1)
      ("The chemotherapeutic drug cisplatin" 1)
      ("the chemotherapeutic compound cisplatin" 1) ("high equitoxic cisplatin" 1)
      ("The pro-apoptotic agent cisplatin" 1)
      ("the cytotoxic chemotherapeutic agent cisplatin" 1) ("longer cisplatin" 1)
      ("concurrent cisplatin" 1) ("cisplatin's" 1)
      ("chemotherapeutic cisplatin" 1) ("intravenous cisplatin" 1)
      ("chemotherapeutic agent cisplatin" 1)
      ("the chemotherapeutic reagent cisplatin" 1)
      ("the latter cases cisplatin" 1) ("Cisplatin-" 1)
      ("surgically unresectable or metastatic disease received cisplatin-" 1)
      ("underwent first-line cisplatin-" 1)))
    ("CHEBI:27928"
     (("dNTP" 1166) ("dNTPs" 1067) ("dNTPS" 9) ("dNTP (NEB)" 3) ("DNTP" 3)
      ("dNTP’s" 2) ("-dNTPs" 2) ("adequate dNTP" 1) ("0.5 mM dNTP’s" 1)
      ("1 mM dNTP's" 1) ("0.17 mM dNTP's" 1) ("dNTps" 1) ("10 mM dNTP’s" 1)
      ("incorrect dNTPs" 1) ("binding correct dNTP" 1) ("the absent dNTP" 1)
      ("0.2 mM dNTP’s" 1) ("available dNTPs" 1)))
    ("CHEBI:27938" (("asialoGM1" 1))) ("CHEBI:27986" (("NOB" 7)))
    ("CHEBI:28009" (("betaGlcNAc" 1)))
    ("CHEBI:28017" (("starch" 9) ("starches" 1)))
    ("CHEBI:28077" (("rifampicin" 14) ("Rifampicin" 8)))
    ("CHEBI:28087" (("glycogen" 487) ("Glycogen" 59)))
    ("CHEBI:28088"
     (("genistein" 780) ("Genistein" 167) ("genistein (GEN)" 3)
      ("than genistein" 1) ("genistein (EMD)" 1) ("genistein's" 1)
      ("the dietary chemo preventive agent genistein" 1)))
    ("CHEBI:28102" (("amylose" 54) ("Amylose" 8))) ("CHEBI:28229" (("L-NMMA" 23)))
    ("CHEBI:28240"
     (("dichloroacetate (DCA)" 14) ("dichloroacetate" 9) ("Dichloroacetate" 1)))
    ("CHEBI:28260"
     (("galactose" 240) ("Galactose" 6)
      ("terminally α-glycosidically bound galactose" 3) ("galactose-" 2)
      ("galactose (GAL)" 1) ("-galactose" 1)))
    ("CHEBI:28328" (("D-galactosamine" 11) ("D-galactosamine (GLN)" 2)))
    ("CHEBI:28424" (("GD3" 262) ("exogenous GD3" 7)))
    ("CHEBI:28494"
     (("cardiolipin" 97) ("Cardiolipin" 18) ("immature cardiolipin" 2)
      ("no mature cardiolipin (CL)" 1) ("intact mature cardiolipin" 1)))
    ("CHEBI:28527" (("rutin" 4) ("Rutin" 1)))
    ("CHEBI:28545" (("valinomycin" 28) ("Valinomycin" 6)))
    ("CHEBI:28626" (("indoleamine" 2))) ("CHEBI:28648" (("GD2" 10)))
    ("CHEBI:28659"
     (("phosphor" 377) ("Phosphor" 34) ("PhosphoRS" 6) ("phosphorus atom" 4)
      ("phosphoRS" 4) ("phosphor-" 3) ("Phosphors" 1)))
    ("CHEBI:28666" (("leukotriene D4" 2) ("LTD4" 1)))
    ("CHEBI:28675" (("dextrin" 4) ("isocaloric dextrin" 1)))
    ("CHEBI:28683"
     (("kynurenine" 49) ("kynurenines" 5) ("Kynurenines" 3) ("Kynurenine" 1)
      ("-kynurenine" 1)))
    ("CHEBI:28685" (("molybdenum" 2))) ("CHEBI:28721" (("ribulose" 6)))
    ("CHEBI:28727" (("TVA" 21) ("TvA" 10) ("Tva" 7) ("tva" 5) ("TVAs" 1)))
    ("CHEBI:28757" (("fructose" 43))) ("CHEBI:28775" (("hesperidin" 7)))
    ("CHEBI:28790"
     (("serotonin" 325) ("Serotonin" 31) ("Peripheral serotonin" 2)
      ("serotonin's" 1) ("peripheral serotonin" 1)
      ("especially peripheral serotonin" 1)))
    ("CHEBI:28800" (("GalNAc" 44) ("N-acetylgalactosamine" 6) ("GalNac" 3)))
    ("CHEBI:28808"
     (("mannan" 7) ("mannans" 3) ("Mannan" 1) ("than mannan" 1)
      ("soluble mannans" 1)))
    ("CHEBI:28816"
     (("deoxyribose" 26) ("2-deoxy-D-ribose" 3) ("-deoxyribose" 3)
      ("deoxyriboses" 1) ("Deoxyribose" 1)))
    ("CHEBI:28838" (("lutein" 3) ("Lutein" 2)))
    ("CHEBI:28869" (("menadione" 69) ("Menadione" 4)))
    ("CHEBI:28892"
     (("ganglioside" 44) ("gangliosides" 21)
      ("the resident raft lipid marker GM1 ganglioside" 2)
      ("less complex gangliosides" 1) ("Gangliosides" 1) ("than ganglioside" 1)))
    ("CHEBI:28915" (("FCM" 126) ("FCMs" 11)))
    ("CHEBI:28938"
     (("ammonium" 516) ("Ammonium" 24) ("ammonium (PDTC)" 5)
      ("ammonium molecule" 2) ("two sequential ammonium" 1)))
    ("CHEBI:28939"
     (("N-acetyl-L-cysteine" 58) ("N-acetyl-L-cysteine (NAC)" 19)
      ("N-acetyl-l-cysteine (NAC)" 3) ("N-acetyl-l-cysteine" 2)
      ("n-acetyl-l-cysteine" 1)))
    ("CHEBI:28940" (("VitaminD3" 1) ("vitaminD3" 1)))
    ("CHEBI:29005" (("cyclohexane" 16) ("hexamethylene" 5)))
    ("CHEBI:29007" (("ceftriaxone" 3)))
    ("CHEBI:29009" (("methylhistamine" 3) ("-methylhistamine" 2)))
    ("CHEBI:29021" (("hexane" 60) ("hexanes" 21) ("Hexane" 5)))
    ("CHEBI:29033" (("Fe(II)" 5)))
    ("CHEBI:29034" (("Fe(III)" 9) ("mimetic Fe(III)" 1) ("Fe(III)-" 1)))
    ("CHEBI:29063" (("L-mimosine" 4)))
    ("CHEBI:29075"
     (("mononucleotide" 188) ("mononucleotides" 12) ("Mononucleotide" 8)
      ("intronic mononucleotide" 3) ("nicotinic acid mononucleotide" 2)
      ("quasimonomorphic mononucleotide" 1)))
    ("CHEBI:29101" (("Na+" 24))) ("CHEBI:29105" (("Zn2+" 7)))
    ("CHEBI:29120" (("nitrosonium" 1)))
    ("CHEBI:29146" (("-ethenoadenine" 15) ("ethenoadenine" 6)))
    ("CHEBI:29191"
     (("hydroxyl" 373) ("-hydroxyl" 32) ("hydroxyls" 10) ("targeted hydroxyl" 4)
      ("the phenolic hydroxyl" 4) ("the second phenolic hydroxyl" 2)
      ("Hydroxyl" 1) ("one catecholic hydroxyl" 1) ("-hydroxyls" 1)
      ("its polar hydroxyl" 1) ("the first phenolic hydroxyl" 1)
      ("This phenolic hydroxyl" 1) ("The second phenolic hydroxyl" 1)
      ("The phenolic hydroxyl" 1) ("the phenolic hydroxyls" 1)))
    ("CHEBI:29202" (("ICAs" 13)))
    ("CHEBI:29234"
     (("Triton" 6287) ("triton" 245) ("TBST" 7) ("TRITON" 4) ("0.1% TBST" 3)
      ("Triton (PBST)" 2) ("“Triton”" 1) ("15 ml TBST" 1) ("PBST" 1)))
    ("CHEBI:29237"
     (("deuterium" 226) ("Deuterium" 19) ("deuterium atoms" 5) ("deuteriums" 2)
      ("approximately 4-5 deuterium atoms" 2) ("than 50% deuterium" 2)
      ("less deuterium" 1) ("one more deuterium" 1)
      ("a small amount more deuterium" 1)))
    ("CHEBI:29239"
     (("hydride" 74) ("hydride (NADPH)" 1) ("the ecDHFR-catalyzed hydride" 1)
      ("hsDHFR-catalyzed hydride" 1)))
    ("CHEBI:29256"
     (("thiol" 459) ("thiols" 179) ("Thiol" 13) ("Thiols" 7)
      ("biotinylated thiols" 6) ("thiol molecule" 4) ("the nucleophilic thiol" 3)
      ("Plasmatic Total Thiols" 2)
      ("both nitrosylated and oxidized thiols (SOX)" 2) ("macrocyclic thiols" 2)
      ("the nucleophilic thiols" 2) ("plasmatic total thiols" 1)
      ("redox potential and quantified free thiols" 1) ("thiol-" 1)
      ("the relevant cysteine thiols" 1) ("the residual thiols" 1)
      ("the newly-reduced thiols" 1)))
    ("CHEBI:29309"
     (("methyl" 1478) ("Methyl" 179) ("methyl-" 55) ("-methyl" 36) ("methyls" 21)
      ("di-methyl" 18) ("Methyl-" 6) ("-methyl--aspartate" 5) ("most methyls" 2)
      ("a propargylic methyl" 1) ("-Methyl" 1) ("non-methyl" 1)
      ("the 120 possible methyl" 1)))
    ("CHEBI:29312" (("mercapto" 30) ("sulfanyl" 6)))
    ("CHEBI:29315" (("phosphoryl" 87) ("most phosphoryl" 1)))
    ("CHEBI:29342" (("imino" 57) ("Imino" 3) ("the exchangeable imino" 1)))
    ("CHEBI:29354" (("Oxy" 34) ("oxy" 6)))
    ("CHEBI:29355" (("oxido" 6) ("Oxido" 1)))
    ("CHEBI:29357"
     (("methylene" 264) ("Methylene" 13) ("methylenes" 9) ("-methylene" 4)))
    ("CHEBI:29361" (("Ch2" 6) ("ch2" 3) ("cH2" 1)))
    ("CHEBI:29365" (("CoCl2" 5) ("Cocl2" 2) ("CoCL2" 1)))
    ("CHEBI:29426"
     (("SCN" 425) ("Scn" 4) ("SCNS" 3) ("the dorsomedial SCN" 2)
      ("the ventrolateral SCN" 2) ("each unilateral SCN" 1)))
    ("CHEBI:29432" (("methine" 9) ("methines" 4)))
    ("CHEBI:29438"
     (("CH3" 222) ("ch3" 3) ("-CH3" 1) ("associated WT CBP CH3" 1) ("Ch3" 1)))
    ("CHEBI:2955" (("azithromycin" 2) ("Azithromycin" 1)))
    ("CHEBI:29598" (("GA5" 12)))
    ("CHEBI:29678"
     (("sodium arsenite" 54) ("Sodium arsenite" 8) ("Sodium Arsenite" 2)))
    ("CHEBI:29699"
     (("tunicamycin" 394) ("Tunicamycin" 38) ("tunicamycin-" 2)
      ("tunicamycin (TM)" 2) ("tunicamycin (TN)" 1)))
    ("CHEBI:29767"
     (("nitroxide" 81) ("nitroxides" 37) ("commercially available nitroxide" 2)
      ("Cell-associated nitroxide" 2) ("Zwitterionic nitroxides" 1)
      ("more nitroxide" 1) ("cell-associated nitroxide" 1) ("Nitroxide" 1)))
    ("CHEBI:29769" (("hydroxyamino" 1)))
    ("CHEBI:29785"
     (("nitro" 137) ("Nitro" 18) ("nitro group" 14) ("-nitro" 4)
      ("nitro groups" 2) ("nitros" 1)))
    ("CHEBI:29792" (("hydroperoxy" 3)))
    ("CHEBI:29806"
     (("fumarate" 42) ("fumarates" 8) ("Fumarate" 5) ("Fumarates" 1)))
    ("CHEBI:29810" (("NCO" 61) ("Nco" 42))) ("CHEBI:29825" (("sulfonyl group" 2)))
    ("CHEBI:29826" (("dithio" 12))) ("CHEBI:29828" (("OS2" 28)))
    ("CHEBI:29829" (("HNS" 8)))
    ("CHEBI:29830"
     (("thio" 75) ("Thio" 4) ("-thio" 1) ("-thio-2-nitrobenzoic" 1) ("thio-" 1)))
    ("CHEBI:29857" (("benzylidene" 13) ("-benzylidene" 3)))
    ("CHEBI:29879"
     (("OCLs" 186) ("OCl" 2) ("Csk KD -expressing OCLs" 1) ("Pagetic OCLs" 1)
      ("pagetic OCLs" 1)))
    ("CHEBI:29920" (("phosphoramidate" 6)))
    ("CHEBI:29922"
     (("sulfo" 22) ("Sulfo" 15) ("SULFO" 2) ("sulfo-" 1) ("Sulfo-" 1)))
    ("CHEBI:29987"
     (("glutamate" 1173) ("glutamates" 66) ("Glutamate" 53) ("-glutamate" 17)
      ("the excitatory neurotransmitter glutamate" 5) ("excitotoxic glutamate" 4)
      ("extracellular excitatory glutamate" 2) ("glutamate-" 2)
      ("the non-essential fatty acid glutamate" 2)
      ("the phosphomimetic amino acid glutamate" 1)
      ("2008-Ets1 cells released more glutamate" 1)
      ("lysines but not glutamates" 1)
      ("the four glutamates replaced by alanines" 1)
      ("the negatively-charged glutamate (GAA)" 1)))
    ("CHEBI:29988" (("L-glutamate" 16) ("L-glutamate (GIBCO)" 1)))
    ("CHEBI:30066" (("thioglycollate" 36) ("Thioglycollate" 9)))
    ("CHEBI:30085" (("ethynyl" 78) ("Ethynyl" 8)))
    ("CHEBI:30087" (("guanidinium" 129) ("Guanidinium" 2)))
    ("CHEBI:30089"
     (("acetate" 2250) ("acetate (PMA)" 133) ("Acetate" 87) ("-acetate" 6)
      ("acetate (CA)" 4) ("acetate (CPA)" 4) ("di-acetate" 3)
      ("2% aqueous uranyl acetate" 3) ("acetate (TPA)" 3) ("acetate molecule" 3)
      ("acetate (TEAA)" 3) ("acetate (APMA)" 3)
      ("the membrane‐permeable 4,5‐diaminofluoresceine acetate" 2)
      ("4-aminophenylmercuric acetate (APMA)" 2)
      ("the membrane-permeable 4,5-diaminofluoresceine acetate" 2)
      ("neutral uranyl acetate" 2) ("Ice-cold ammonium acetate" 2)
      ("1% (w/v) aqueous uranyl acetate" 2) ("acetate (NCA)" 2)
      ("phorbal myristate acetate (PMA)" 1)
      ("p -aminophenylmercuric acetate (APMA)" 1) ("acetate (BZA)" 1)
      ("4% aqueous uranyl acetate" 1) ("ice‐cold 2  m sodium acetate" 1)
      ("disposable 0.45 μ m cellulose acetate" 1)
      ("disposable 0.45 μM cellulose acetate" 1)
      ("100μl ice-cold 2M ammonium acetate" 1)
      ("50 μM 4-aminophenylmercuric acetate" 1) ("neutral uranyl acetate (UA)" 1)
      ("acetate (UA)" 1) ("using tannic acid and uranyl acetate" 1)
      ("aminophenylmercuric acetate (APMA)" 1) ("4-aminophenylmercuric acetate" 1)
      ("saturated aqueous uranyl acetate" 1) ("Acetate (APMA)" 1)
      ("aqueous uranyl acetate" 1)
      ("1 mM p -aminophenylmercuric acetate (APMA)" 1)
      ("2.0% aqueous uranyl acetate" 1) ("1% aqueous uranyl acetate" 1)))
    ("CHEBI:30105" (("diazo" 4))) ("CHEBI:30106" (("Azo" 1)))
    ("CHEBI:30124" (("Clf2" 1)))
    ("CHEBI:30146"
     (("HLI" 8) ("its insoluble parent compound HLI" 2)
      ("than its insoluble parent compound HLI 98" 1)))
    ("CHEBI:3015" (("benomyl" 21))) ("CHEBI:30216" (("alpha-particles" 4)))
    ("CHEBI:30217" (("Helio" 1))) ("CHEBI:30236" (("fluorine" 19) ("Fluorine" 1)))
    ("CHEBI:30245" (("linoleate" 9))) ("CHEBI:30248" (("LNT" 15)))
    ("CHEBI:30278" (("Ph3" 25) ("ph3" 1))) ("CHEBI:30351" (("bpy" 3)))
    ("CHEBI:30353"
     (("isopropyl" 224) ("Isopropyl" 18) ("isopropyl-" 10) ("isopropyl group" 6)
      ("-isopropyl" 1)))
    ("CHEBI:30355" (("t-butyl" 16) ("T-butyl" 2) ("t-Butyl" 1)))
    ("CHEBI:30356" (("isobutyl" 32))) ("CHEBI:30360" (("TPE" 56)))
    ("CHEBI:30364" (("Cyclopropyl" 7) ("cyclopropyl" 6) ("-cyclopropyl" 1)))
    ("CHEBI:30366" (("imidazolide" 2) ("Imidazolide" 1)))
    ("CHEBI:30376" (("cyclobutyl" 12) ("cyclobutyl group" 2) ("-cyclobutyl" 1)))
    ("CHEBI:30377" (("cyclobutane" 53)))
    ("CHEBI:30396"
     (("phenyl" 401) ("-phenyl" 28) ("Phenyl" 17) ("phenyl group" 12)
      ("phenyl-" 2) ("phenyl groups" 1)))
    ("CHEBI:30408"
     (("iron-sulfur cluster" 13) ("iron-sulfur clusters" 10) ("iron-sulfur" 7)
      ("Iron-sulfur" 2) ("iron–sulfur" 2)))
    ("CHEBI:30413"
     (("heme" 412) ("Heme" 161) ("haem" 22) ("HEME" 6) ("non-heme" 4) ("hemes" 2)
      ("heme molecule" 2) ("a more accessible heme" 1) ("Haem" 1)
      ("exogenous heme" 1) ("the pro-oxidative heme" 1)))
    ("CHEBI:30415" (("astato" 1))) ("CHEBI:30418" (("ath" 3)))
    ("CHEBI:30430" (("indium" 4))) ("CHEBI:30458" (("Teh" 2) ("teh" 2)))
    ("CHEBI:30496" (("sf6" 7))) ("CHEBI:30514" (("cesium" 50) ("Cesium" 15)))
    ("CHEBI:30527" (("flavin" 11) ("Flavin" 2))) ("CHEBI:30541" (("siH3" 3)))
    ("CHEBI:30580" (("siH" 13)))
    ("CHEBI:30588" (("SIO" 83) ("SiO" 13) ("siO" 3) ("SIO-" 1)))
    ("CHEBI:30598" (("si4" 7) ("Si4" 5)))
    ("CHEBI:30660" (("thyroxine" 15) ("Thyroxine" 4) ("thyroxine's" 1)))
    ("CHEBI:30682"
     (("ruthenium" 104) ("Ruthenium" 11) ("ruthenium(II)" 8) ("ruthenium atoms" 3)
      ("ruthenium ruthenium(II)" 2)
      ("ruthenium
atom"
       2)
      ("Most ruthenium atoms" 1)))
    ("CHEBI:30687" (("osmium" 91) ("Osmium" 2)))
    ("CHEBI:3070" (("bestatin" 76) ("Bestatin" 11)))
    ("CHEBI:30721" (("epoxy" 41) ("Epoxy" 16) ("epoxy group" 7)))
    ("CHEBI:30744" (("OAA" 43) ("OAA-" 1))) ("CHEBI:30753" (("PABA" 6)))
    ("CHEBI:30762" (("salicylate" 20) ("salicylates" 8)))
    ("CHEBI:30769"
     (("citrate" 1227) ("citric acid" 214) ("Citrate" 46) ("citrate (SSC)" 7)
      ("Citric acid" 6) ("ferric ammonium citrate (FAC)" 3)
      ("triply 13 C labeled citrate" 3) ("100 μmol/L ferric citrate" 3) ("SSC" 2)
      ("citrate (FAC)" 2) ("the iron donor ferric ammonium citrate" 2)
      ("antigen retrieval using citrate" 2)
      ("Antigen retrieval using citric acid" 2) ("ferric ammonium citrate" 2)
      ("-citrate" 1) ("AR increased citrate" 1) ("Ferric citrate" 1)
      ("ferric citrate" 1)))
    ("CHEBI:30775"
     (("HFAs" 84) ("HFA" 35) ("rVpr-treated HFAs" 3) ("Vpr-treated HFAs" 2)
      ("Vpr-treated primary HFAs" 1)))
    #+ignore("CHEBI:30780" ; removed erroneous def
     (("male" 4803) ("males" 3260) ("Male" 302) ("Males" 28) ("than males" 21)
      ("MalE" 13) ("Caucasian males" 7) ("more males" 6) ("homozygous males" 3)
      ("only anosmic males" 3) ("infertile males" 3) ("than males ( xref )" 3)
      ("more male" 3) ("Egyptian males" 3) ("healthy male" 3)
      ("8 young healthy males" 2) ("otherwise normal males" 2) ("anosmic males" 2)
      ("a 24-year-old Caucasian male" 2) ("unrelated healthy AA and CA males" 2)
      ("females outlive males" 2) ("a 27 yo Caucasian male" 2)
      ("Young and adult male" 2) ("a 68–year-old Caucasian male" 2)
      ("a sexually active homosexual male" 2) ("a previously reported male" 2)
      ("Healthy males" 2) ("four sporadic males" 2) ("BRASTO males" 2)
      ("a 70y old Australian male" 2)
      ("compound heterozygous Arf  Cre/Flox male" 2)
      ("MMTV-PyMT heterozygous male" 2) ("both triple transgenic male" 2)
      ("a 21-month-old Caucasian American male" 2)
      ("Middle-aged glucose-tolerant Danish males" 2)
      ("an X-linked disorder hemizygous males" 1) ("hemizygous males" 1)
      ("heterozygous IκBα-dn males" 1) ("sporadic male" 1) ("obese human male" 1)
      ("never smoker males" 1) ("a 36-year-old young Caucasian male" 1)
      ("than their fellow males" 1) ("10 healthy male" 1) ("neonatal male" 1)
      ("male-" 1) ("166 healthy male" 1) ("than male" 1)
      ("female and unscreened male" 1) ("12 year old Caucasian male" 1)
      ("124 unrelated healthy AA and CA males" 1) ("approximately 2,200 males" 1)
      ("older obese males" 1) ("Eight healthy male" 1) ("230 normotensive male" 1)
      ("‘male’" 1)
      ("the most common non-cutaneous cancer affecting Western males" 1)
      ("two healthy males" 1) ("48 healthy Norwegian males" 1)
      ("95‐year‐old male" 1) ("a 10 yo Caucasian male" 1)
      ("benign prostate tissue African-American males" 1)
      ("78 healthy fertile male" 1) ("the Italian male" 1) ("a homosexual male" 1)
      ("than control males" 1) ("a Caucasian male" 1) ("an autistic male" 1)
      ("3 times more males" 1) ("Nf1flox/wt/Prx1Cre males" 1)
      ("Sixteen healthy males" 1) ("thymic BALB/c male" 1) ("healthy males" 1)
      ("clinically non-metastatic males" 1) ("71 Egyptian males" 1)
      ("than males (47.7% vs 37.1%, P  = 0.004)" 1)
      ("randomly selected healthy volunteer male" 1) ("approximately 3–5 males" 1)
      ("than males (p < 0.001)" 1) ("treated iBRAF* males" 1)
      ("FVB nontransgenic males" 1) ("Caucasian population control males" 1)
      ("affected Caucasian males" 1) ("a Russian male" 1) ("11 Caucasian males" 1)
      ("Several Caucasian males" 1) ("16 Russian alcohol-dependent males" 1)
      ("heterozygous GFAP-IκBα-dn males" 1) ("obese male" 1) ("Montreal male" 1)
      ("Montreal males" 1) ("4 alcoholic male" 1) ("250 healthy males" 1)
      ("at least one healthy male" 1) ("than wt males" 1)
      ("than wt males [ xref , xref ]" 1) ("predominantly young males" 1)
      ("the referent male" 1) ("Most males" 1)
      ("than males (26 of 49, 53.1%; p = 0.003)" 1)
      ("421 unrelated healthy adult males" 1) ("too few males" 1)
      ("azoospermic/severely oligospermic males" 1)
      ("than the males (3.36, p = 0.040)" 1) ("primarily young males" 1)
      ("than males ( xref ; xref ; xref )" 1) ("All diabetic males" 1)
      ("than normal 46XY males [ xref , xref ]" 1) ("43 Egyptian males" 1)
      ("postnatal day 0 (P0) male" 1) ("53bp1 homozygous mutant males" 1)
      ("few males" 1) ("hemizygous Mdm2 transgenic males" 1)
      ("six healthy male" 1) ("than males (RR=22)" 1) ("than male ( P =0.0272)" 1)
      ("a 40-year-old Caucasian male" 1) ("a healthy male" 1)
      ("p53  −/− doubly-deficient males" 1) ("young fertile males" 1)
      ("the healthy young males" 1)
      ("than normal 46XY males [ xref , xref , xref ]" 1)
      ("than Moroccan males" 1) ("724 Argentinean healthy male" 1)
      ("more aggressive dominant males" 1) ("bred heterozygous Lck-cre males" 1)
      ("ENU-treated (ethylnitrosourea) males" 1) ("a universal HCC male" 1)
      ("Australian males" 1) ("the hemizygous males" 1) ("Caucasian male" 1)
      ("than males (p=0.18)" 1) ("A 48-year-old Caucasian male" 1)))
    ("CHEBI:30785" (("methylmercury" 1)))
    ("CHEBI:30802"
     (("IPA" 635) ("ipA" 3) ("iPA" 2) ("IPA's" 2) ("IPA’s" 2) ("ipa" 2)
      ("IPA using a Fisher's" 1) ("Ipa" 1)
      ("IPA using the right-tailed Fisher’s" 1)))
    ("CHEBI:30807"
     (("myristate" 267) ("Myristate" 2) ("myristate-" 2) ("tetradecanoate" 1)))
    ("CHEBI:30823" (("oleate" 46) ("Oleate" 1)))
    ("CHEBI:30839" (("orotate" 10) ("Orotate" 3)))
    ("CHEBI:30856" (("thiophene" 14)))
    ("CHEBI:3088"
     (("PTT" 80) ("Ptt" 35) ("painful PTT" 4) ("pTT" 2) ("the painful PTT" 1)
      ("Painful PTT" 1)))
    ("CHEBI:3092" (("bicuculline" 29)))
    ("CHEBI:30953" (("pyrazin" 3) ("pyrazine" 1)))
    ("CHEBI:30954" (("pyridazin" 3) ("pyridazine" 2)))
    ("CHEBI:30968" (("azetidine" 1)))
    ("CHEBI:31206"
     (("ammonium chloride" 118) ("NH4Cl" 16) ("Ammonium chloride" 5)))
    ("CHEBI:31445" (("cADPR" 31) ("cyclic ADP-ribose" 5)))
    ("CHEBI:31488" (("-dihydroceramide" 34) ("dihydroceramide" 17)))
    ("CHEBI:31498" (("PDMS" 71) ("oxygen plasma-treated PDMS" 2)))
    ("CHEBI:31624"
     (("fluorescein" 536) ("Fluorescein" 97) ("fluorescein-" 9)
      ("Fluorescein (FITC)" 4) ("fluorescein (FITC)" 3) ("fluorescein (FAM)" 2)
      ("FL" 2) ("-fluorescein" 2) ("tertiary streptavidin fluorescein" 2)
      ("fluorescein(APC)" 1) ("Fl" 1)
      ("Blue-labelled albumin and sodium fluorescein" 1)
      ("fluorescein conjugated goat anti-rabbit immunoglobulin (AQ132F) secondary fluorescein"
       1)
      ("a secondary fluorescein" 1) ("fluorescein (APF)" 1)))
    ("CHEBI:31711" (("iopamidol" 1)))
    ("CHEBI:31730" (("isopaque" 1) ("Isopaque" 1)))
    ("CHEBI:31794" (("MGO" 162) ("MgO" 1))) ("CHEBI:3181" (("bromocriptine" 15)))
    ("CHEBI:31811" (("meglumine" 2)))
    ("CHEBI:31824" (("MesNa" 19) ("MESNA" 13) ("Mesna" 1)))
    ("CHEBI:31856"
     (("Mithramycin" 47) ("mithramycin" 44) ("mithramycin (MTH)" 5)
      ("the fetal hemoglobin (HbF) inducer mithramycin (MTH)" 2)))
    ("CHEBI:31882" (("N-methyl-D-aspartic acid" 5) ("N-methyl-d-aspartate" 1)))
    ("CHEBI:31941"
     (("oxaliplatin" 1106) ("Oxaliplatin" 82) ("oxaliplatin-" 24)
      ("intravenous oxaliplatin" 2)
      ("this study received preoperative oxaliplatin-" 1) ("Oxaliplatin’s" 1)
      ("oxaliplatin (FOLFOX)" 1) ("than oxaliplatin" 1)
      ("than oxaliplatin ( xref )" 1)))
    ("CHEBI:31991"
     (("phenol red" 737) ("phenol-red" 123) ("Phenol Red" 13) ("Phenol red" 13)
      ("Phenol-red" 2) ("phenol red (PR)" 2) ("Phenol-Red" 1) ("phenol red-" 1)))
    ("CHEBI:32026" (("poloxamer" 7)))
    ("CHEBI:32145" (("NaOH" 945) ("sodium hydroxide" 54) ("Sodium hydroxide" 6)))
    ("CHEBI:32155" (("stigmatellin" 7) ("Stigmatellin" 1)))
    ("CHEBI:32234" (("titanium dioxide" 10) ("Titanium dioxide" 3) ("TiO2" 1)))
    ("CHEBI:32359" (("Lau" 21) ("LAU" 2)))
    ("CHEBI:32361"
     (("DETANO" 64) ("NONOate" 57) ("NONOate (DTNO)" 3) ("NONOate (DETANO)" 1)))
    ("CHEBI:32372" (("palmitoleate" 13) ("Palmitoleate" 4)))
    ("CHEBI:32387" (("linolenate" 1))) ("CHEBI:32395" (("arachidonate" 17)))
    ("CHEBI:32548"
     (("LUTS" 15) ("LUT" 7) ("severe LUTS" 2) ("mild and moderate LUTS" 1)))
    ("CHEBI:32588"
     (("KCl" 4684) ("KCL" 96) ("potassium chloride" 61) ("Potassium chloride" 6)
      ("KCl (LK)" 3) ("KCl (HK)" 2) ("KCL (LK)" 2) ("KCL (HK)" 2)
      ("Ice-cold 0.6 M potassium chloride" 2) ("high external KCl" 1) ("Kcl" 1)))
    ("CHEBI:32599"
     (("MgSO4" 29) ("magnesium sulfate" 16) ("anhydrous magnesium sulfate" 3)
      ("Magnesium Sulfate" 1)))
    ("CHEBI:32878" (("alkene" 11) ("-alkene" 1)))
    ("CHEBI:32879"
     (("propane" 22) ("Propane" 19) ("propan" 10) ("-propan-1-one" 1)))
    ("CHEBI:32900" (("und" 86))) ("CHEBI:32903" (("GA7" 7)))
    ("CHEBI:32952"
     (("amine" 297) ("amines" 73) ("Amine" 55) ("heterocyclic amines" 7)
      ("the tertiary amine" 3) ("carcinogenic heterocyclic amines (HCA)" 3)
      ("the only available primary amines" 2) ("dietary amines" 2) ("AMINE" 2)
      ("amine molecule" 2) ("an amphiphilic amine" 2) ("a tertiary amine" 2)
      ("The tertiary amine" 2) ("the secondary amine" 2)
      ("affording crude free amine" 1) ("xref  Most amines" 1)
      ("covalently links amine" 1)
      ("The large abiotic nondegradable poly(amido)amine molecule" 1)
      ("exocyclic amine" 1) ("available primary amines" 1) ("biogenic amines" 1)
      ("Gly-Gly-modified amines" 1) ("other biogenic amines" 1)
      ("the biogenic amine" 1) ("The biogenic amine" 1)
      ("no available primary amines" 1) ("an available amine" 1)))
    ("CHEBI:32955"
     (("epoxide" 60) ("epoxides" 7) ("epoxide (BDPE)" 3) ("epoxides (BPDE)" 2)
      ("epoxide (BPDE)" 2) ("Epoxide" 1)))
    ("CHEBI:32988"
     (("amide" 690) ("amides" 182) ("Amide" 15) ("-amide" 12) ("gambogic amide" 6)
      ("Myristoylated PKA inhibitor 14-22 amide" 3)
      ("but-2-enedioic acid(3-morpholin-4-propyl)-amide" 2)
      ("TrkA agonist gambogic amide" 2)
      ("PTHrP receptor antagonist (Nle 8,18 , Tyr 34 )-pTH( xref - xref )amide" 2)
      ("KLH conjugated Ac- CSRKLPGTTLTALEAAANPAL -amide" 2)
      ("their available backbone amides" 1) ("the non-methylated amide" 1)
      ("1-(2-Indol-1-yl-acetyl)-piperidine-4-carboxylic acid (5-methyl-isoxazol-3-yl)-amide"
       1)
      ("\"Biotin-SGSG-PEPTIDE-amide\"" 1) ("exchangeable amides" 1)
      ("its activator dihydro-CDDO-trifluoroethyl amide (Dh404)" 1)
      ("most amide" 1) ("Amides" 1) ("slowest exchanging backbone amides" 1)
      ("explicit Gly-rich loop amide" 1) ("approximately 85–105 amide" 1)))
    ("CHEBI:33098" (("ONT" 1) ("Ont" 1)))
    ("CHEBI:33100" (("carbamoyl" 32) ("Carbamoyl" 2) ("-carbamoyl" 1)))
    ("CHEBI:33224" (("chroman" 14) ("chromane" 1)))
    ("CHEBI:33228" (("TOAC" 42) ("rigid amino acid spin-label TOAC" 3)))
    ("CHEBI:33235" (("tocotrienols" 4) ("tocotrienol" 3)))
    ("CHEBI:33281"
     (("antimicrobial agent" 8) ("antimicrobial agents" 4) ("microbicides" 3)))
    ("CHEBI:33284"
     (("nutrient" 1574) ("nutrients" 708) ("Nutrient" 87) ("Nutrients" 15)
      ("nutrient-" 12) ("essential nutrients" 6) ("an essential nutrient" 5)
      ("acute nutrient" 3) ("dietary one-carbon nutrients" 3)
      ("adequate nutrients" 3) ("plentiful nutrients" 2)
      ("the essential nutrients" 2) ("vital nutrients" 2)
      ("favourable nutrient" 2) ("sufficient external nutrients" 1)
      ("lipid-soluble nutrients" 1)
      ("Multiple electrophilic bioactive nutrients" 1) ("internal nutrients" 1)
      ("adequate nutrient" 1) ("the major nutrients utilized by the brain" 1)
      ("reliable dietary nutrient" 1) ("non-nutrient" 1)
      ("still need sufficient nutrients" 1) ("oxidizable nutrients" 1)
      ("dietary nutrients" 1) ("acute and chronic nutrient" 1)
      ("favorable nutrient" 1) ("more favorable nutrient" 1)
      ("properly use nutrients" 1) ("basic nutrients" 1)
      ("rapidly exhaust available glucose, and perhaps other nutrients" 1)
      ("most nutrients" 1) ("external nutrient" 1)))
    ("CHEBI:33290"
     (("food" 969) ("Food" 257) ("foods" 240) ("salty food" 11) ("Foods" 6)
      ("fiber-rich foods" 3) ("40% less food" 2) ("cereal foods" 2)
      ("soy-based foods" 2) ("cheap high-calorie foods" 2) ("very hot foods" 2)
      ("energy-dense foods" 2) ("the energy-dense foods" 2) ("most foods" 2)
      ("Western foods" 2) ("ruminant-based foods" 1) ("ruminant-produced foods" 1)
      ("these fiber-rich foods" 1) ("fiber-containing foods" 1)
      ("calorie-rich foods" 1) ("highly variable food" 1)
      ("approximately 120 foods" 1) ("Brazilian food" 1) ("approximate food" 1)
      ("these energy-dense foods" 1) ("characteristic food" 1)
      ("well-cooked food" 1) ("Canadian food" 1) ("charcoal-grilled food" 1)
      ("available food" 1) ("fresh fly food" 1) ("commercial rat food" 1)
      ("ethnic foods" 1) ("readily available food" 1) ("some salty food" 1)
      ("salty foods" 1) ("indeed many foods" 1) ("20–30% more food" 1)))
    ("CHEBI:33324" (("strontium" 2)))
    ("CHEBI:33325"
     (("radio" 513) ("radio-" 118) ("Radio" 38) ("radios" 3) ("Radio-" 2)
      ("radio−" 1) ("No enrolled patients underwent radio-" 1)
      ("preoperative radio-" 1) ("the diagnostic odds radio" 1)
      ("postoperative radio-" 1) ("thermal radio" 1)))
    ("CHEBI:33331" (("yttrium" 4) ("Yttrium" 2)))
    ("CHEBI:33336" (("lanthanum" 1)))
    ("CHEBI:33353" (("technetium" 3) ("Technetium" 1)))
    ("CHEBI:33363" (("palladium" 17) ("Palladium" 2)))
    ("CHEBI:33364"
     (("platinum" 2115) ("Platinum" 350) ("platinum-" 21) ("platinums" 7)
      ("platinum(II)" 5) ("non-platinum" 4) ("-platinum" 4)
      ("the Super Script™ III Platinum" 2) ("fewer platinum" 1) ("PLATINUM" 1)
      ("platinum (IV)" 1) ("survive conventional platinum-" 1)
      ("platinum(II) (CDDP)" 1) ("aggressive platinum" 1) ("platinum (II)" 1)
      ("postoperative platinum" 1)
      ("polynuclear
platinum"
       1)
      ("traditional platinum" 1) ("even third line platinum" 1)
      ("bifunctional or monofunctional platinum" 1)
      ("potentially other platinum" 1) ("than platinum" 1)))
    ("CHEBI:33374" (("samarium" 1)))
    ("CHEBI:33375" (("gadolinium" 15) ("Gadolinium" 1)))
    ("CHEBI:33397" (("uNTX" 3) ("uNTx" 2))) ("CHEBI:33416" (("fullerenes" 2)))
    ("CHEBI:33478" (("SIR3" 6) ("Sir3" 5) ("siR3" 2)))
    ("CHEBI:33505"
     (("adenosyl" 39) ("Adenosyl" 7) ("-adenosyl" 4) ("-Adenosyl" 2)))
    ("CHEBI:33563"
     (("glycolipids" 32) ("glycolipid" 23) ("Glycolipid" 2) ("Glycolipids" 2)
      ("Detergent-insoluble glycolipid (DIG)" 1)))
    ("CHEBI:33567"
     (("catecholamine" 51) ("catecholamines" 19) ("Catecholamine" 1)))
    ("CHEBI:33569" (("noradrenaline" 10)))
    ("CHEBI:33573" (("tetrols" 5) ("tetrol" 3) ("Tetrols" 2)))
    ("CHEBI:33601"
     (("dimethyl" 270) ("Dimethyl" 48) ("Safranin O" 11) ("-dimethyl" 4)
      ("safranin O" 4) ("dimethyl-" 3) ("The resultant dimethyl" 1)))
    ("CHEBI:33607"
     (("BH2" 127) ("at least one other BH2" 1) ("any considerable BH2-" 1)
      ("BH2-" 1)))
    ("CHEBI:33609" (("boron" 28) ("Boron" 13)))
    ("CHEBI:33624" (("bromophenol" 399) ("Bromophenol" 33)))
    ("CHEBI:33629"
     (("ALNs" 207) ("ALN" 78) ("aln" 4) ("Aln" 3) ("preoperative ALN" 2)
      ("bilateral metastatic ALNs" 2) ("the concordant metastatic ALNs" 1)
      ("the benign ALNs" 1) ("The 29 benign ALNs" 1)
      ("ipsilateral and contralateral ALNs" 1) ("bilateral ALNs" 1)
      ("ultrasonographically suspicious ALNs" 1)
      ("FNA-HER2-positive metastatic ALNs" 1) ("All 29 benign ALNs" 1)
      ("benign and metastatic ALNs" 1)))
    ("CHEBI:33658" (("arene" 6)))
    ("CHEBI:33690" (("HHE" 64) ("β-unsaturated inflammatory aldehydes HHE" 1)))
    ("CHEBI:33694"
     (("biopolymer" 9) ("biopolymers" 7) ("Biopolymer" 7) ("Biopolymers" 3)
      ("biomacromolecules" 2) ("a macromolecular biopolymer" 2)
      ("Such thermally responsive macromolecular biopolymers" 1)))
    ("CHEBI:33811" (("HTO" 46))) ("CHEBI:33823" (("enol" 5)))
    ("CHEBI:33839"
     (("macromolecules" 337) ("macromolecule" 96) ("damaged macromolecules" 2)
      ("a negatively-charged plasma membrane macromolecule" 2)
      ("biological macromolecules" 2) ("a proteinaceous macromolecule" 2)
      ("soluble macromolecules" 2) ("a highly glycosylated macromolecule" 2)
      ("collagenous and noncollagenous extracellular matrix macromolecules" 2)
      ("matrix-associated macromolecules" 1) ("other biological macromolecules" 1)
      ("the biological macromolecules" 1) ("two biological macromolecules" 1)
      ("damage many biological macromolecules" 1) ("associated macromolecules" 1)
      ("essential macromolecules" 1) ("Macromolecule" 1)
      ("soluble native macromolecules" 1)))
    ("CHEBI:33860"
     (("aromatic amines" 21) ("arylamine" 5) ("arylamines" 3)
      ("industrial aromatic amines" 1)
      ("Lilla et al. reported heterocyclic aromatic amines" 1)
      ("Aromatic amine" 1)))
    ("CHEBI:33871" (("glycerate" 2)))
    ("CHEBI:33893"
     (("reagent" 20850) ("reagents" 9063) ("Reagent" 5657) ("Reagents" 3417)
      ("Qiagen" 55) ("QIAGEN" 44) ("reagent (QIAGEN)" 31) ("Reagent (QIAGEN)" 19)
      ("Western Blotting Detection Reagent" 18)
      ("ECL Western blotting detection reagents" 17) ("REAGENTS" 14)
      ("REAGENT" 14) ("chemiluminescent reagent" 13)
      ("ECL Western Blotting Detection Reagents" 12)
      ("Western Blotting Detection Reagents" 12)
      ("ECL western blotting detection reagents" 10) ("Dako" 10)
      ("Western blotting detection reagents" 8)
      ("Western Lightning Chemiluminescence Reagent" 8)
      ("using ECL Western blotting detection reagents" 8)
      ("Alamar Blue reagent" 7) ("a secondary reagent" 6) ("reagents (QIAGEN)" 6)
      ("western blotting detection reagents" 6) ("using TriReagent reagent" 6)
      ("overnight using LipofectaminePlus reagent" 6)
      ("DOTAP liposomal transfection reagent" 5) ("a chemiluminescent reagent" 5)
      ("biochemical reagents" 5) ("Reagents (QIAGEN)" 5)
      ("chemiluminescent reagents" 4)
      ("CellTiter 96® AQueous One Solution Reagent" 4) ("Reagent (ECL)" 4)
      ("CelLytic M cell Lysis Reagent" 4) ("available reagents" 4)
      ("reagent (USB)" 4) ("western blotting detection reagent" 4)
      ("Biochemical Reagents" 4) ("the chemiluminescent reagents" 4)
      ("the Western Lightning® Enhanced Chemiluminescence Reagent" 4)
      ("using Western Lightning Chemiluminescence Reagent" 4)
      ("a commercial reagent" 4) ("reagent (DAKO)" 4)
      ("using SuperSignal Chemiluminescent reagent" 4) ("commercial reagents" 4)
      ("Aqueous One Solution Reagent" 4) ("the respective blocking reagents" 4)
      ("Amersham ECL Western blotting detection reagent" 4) ("reagent (ROCHE)" 4)
      ("using Western blot chemiluminescence reagent" 4)
      ("JetPEI Cationic Polymer Transfection reagent" 4)
      ("using Amersham ECL Western blotting detection reagents" 4)
      ("reagent (CGS)" 4) ("using detergent-compatible protein assay reagents" 4)
      ("fluorescent reagents" 3) ("osteogenic reagents" 3)
      ("osteogenic induction reagent" 3) ("Secondary reagents" 3)
      ("Biochemical reagents" 3) ("ice-cold PhosphoSafe Extraction Reagent" 3)
      ("reagent (GIBCO)" 3) ("CellTiter-Blue reagent" 3)
      ("the Immunostar LD western blotting detection reagent" 3)
      ("Kinase-Glo® Luminescent Kinase Assay reagent" 3)
      ("the CellTiter 96 Aqueous One Solution Reagent" 3)
      ("Western blotting detection reagent" 3)
      ("2 µM CellEvent Caspase-3/7 green detection reagent" 3)
      ("reagents (ECL)" 3) ("biological reagents" 3)
      ("the enhanced chemiluminescent substrate reagents" 3) ("Reagent (MPER)" 3)
      ("SuperSignal reagent" 3) ("chemotherapeutic reagents" 3)
      ("bacterial protein extraction reagent" 3) ("few reagents" 3)
      ("reagent (ECL)" 3) ("Reagent (LAR)" 3)
      ("a Qiagen RNeasy Mini Kit or TRIzol reagent" 3)
      ("the ECL® (enhanced chemiluminescence) western blotting detection reagents"
       3)
      ("nonliposomal FuGene-6 reagent" 2)
      ("using peroxidase-conjugated secondary reagents" 2)
      ("Universal PCR Master Reagent" 2)
      ("Western Blotting System Detection Reagents" 2)
      ("the CellTiter 96 Aqueous MTS Reagent" 2)
      ("using Dual Luciferase reagents" 2) ("Chemiluminescent reagents" 2)
      ("the ECL Western blotting detection reagent" 2) ("Commercial reagents" 2)
      ("the Western Lighting Chemiluminescence Reagent" 2)
      ("well-characterized reagents" 2) ("chromogenic reagent" 2)
      ("enhanced chemiluminescent reagent" 2) ("CAS universal blocking reagent" 2)
      ("Signalstain boost IHC detection reagent" 2)
      ("using ECL Western Blotting Detection Reagents" 2)
      ("enhanced chemiluminescence (ECL) western blotting reagents" 2)
      ("BrightStar BioDetect chemiluminescence reagent" 2)
      ("neural induction reagents" 2) ("osteogenic induction reagents" 2)
      ("osteogenic, myoblastic, or neural induction reagents" 2)
      ("a cell impermeable reagent" 2)
      ("the Amersham ECL™ Western Blot Detection Reagents" 2)
      ("relevant monoclonal reagent" 2) ("a radiomimetic reagent" 2)
      ("Chemiluminescent Substrate Reagents" 2) ("a bicinchoninic acid reagent" 2)
      ("the anti-fade Pro-long reagent" 2) ("using chemiluminescent reagent" 2)
      ("pharmacologic reagents" 2)
      ("Duoset enzyme-linked immunosorbent assay (ELISA) reagents" 2)
      ("using CelLytic Mammalian Cell Lysis Reagent" 2)
      ("Western Blotting Luminal Reagent" 2)
      ("bacterial protein extraction reagents" 2)
      ("B-PER bacterial protein extraction reagent" 2)
      ("Western Lighting Plus-ECL chemiluminescence reagents" 2)
      ("Special Reagents" 2) ("five percent MTT reagent" 2)
      ("secondary antibody reagent" 2)
      ("using enhanced chemiluminescent (ECL) reagent" 2)
      ("Western Lightning Enhanced Chemiluminescence Reagent" 2)
      ("using B-PER bacterial protein extraction reagent" 2)
      ("Western Blot detection reagent" 2)
      ("a CellTiter 96 AQueous One Solution Cell Proliferation Assay Reagent" 2)
      ("the Western Lightning chemiluminescence reagent" 2) ("reagent (PIERCE)" 2)
      ("using Western Lightning™ chemiluminescence reagents" 2)
      ("Western Lightning Plus-ECL reagents" 2)
      ("Amersham ECL Western Blotting Detection Reagent" 2)
      ("Chemiluminescent detection reagents" 2)
      ("a Western Blotting Luminol Reagent" 2)
      ("the ECL Western Blotting Detection reagents" 2)
      ("the colorimetric Bradford reagent" 2) ("reagent (DCS)" 2)
      ("ice-cold T-PER Tissue Protein Extraction Reagent" 2)
      ("using Trizol Reagent" 2)
      ("using NE-PER nuclear and cytoplasmic extraction reagents" 2)
      ("using Trizol reagent" 2)
      ("using West-Pico or West-Dura enhanced chemiluminescent detection reagents"
       2)
      ("a commercial Immobilon Western Chemiluminescent HRP Substrate detection reagent"
       2)
      ("western blotting luminal reagent" 2) ("all biochemical reagents" 2)
      ("SuperSignal WestPico chemiluminescence reagent" 2)
      ("ice-cold Nuclear Extraction Reagent" 2)
      ("many chemotherapeutic reagents" 2)
      ("Femto Chemiluminiscent detection reagents" 2)
      ("using chemiluminescence western blotting detection reagents" 2)
      ("Western Lightning Chemiluminescense Reagent" 2)
      ("CelLytic TM M Cell Lysis Reagent" 2) ("1X Universal Blocking Reagent" 2)
      ("hydrochloride-based RiboClear reagent" 2) ("secondary reagents" 2)
      ("a known bifunctional reagent" 2) ("chemotoxic reagents" 2)
      ("a trifunctional reagent" 2) ("the chaotropic reagent" 2)
      ("reagent (SIGMA)" 2) ("Aqueous MTS reagent" 2)
      ("microscopy dual detection reagent" 2)
      ("ice-cold tissue protein extraction reagent" 2)
      ("Alcian blue/Nuclear Fast Red Kernechtrot reagents" 2)
      ("Colorimetric detection reagent" 2)
      ("the enhanced chemiluminescent Reagent" 2)
      ("a CellTiter-Glo Luminescent Cell Viability Assay reagent" 2)
      ("Amersham™ ECL™ Western Blotting detection reagent" 2)
      ("using Chemiluminescent ECL reagent" 2) ("CelLytic M Cell lysis reagent" 2)
      ("two different pharmacologic reagents" 2)
      ("PTEN IHC using 6H2.1 and DAKO-based reagents" 2)
      ("FEMTO chemiluminescent reagent" 2) ("CelLytic M lysis reagent" 2)
      ("using Human β-actin Pre-developed TaqMan assay reagents" 2)
      ("reagent (NER)" 2) ("Enhanced Chemiluminescent Reagents" 2)
      ("CellTiter 96 AQueous One Solution Reagent" 2)
      ("the CellTiter 96 AQueous One Solution Reagent" 2)
      ("The 488-nm excitable Cyto-ID Green Autophagy Detection Reagent" 2)
      ("HRP-conjugated secondary antibodies and Immobilon Western Chemiluminescent HRP Substrate Detection Reagent"
       2)
      ("The enhanced chemiluminescence western blotting detection reagents" 2)
      ("Reagents (ASR)" 2) ("Periodic acid/Schiff reagent" 2)
      ("the FastStart Universal SYBR Green Master reagent" 2)
      ("a polymer-HRP IHC detection reagent" 2) ("Western Blotting reagent" 2)
      ("CellTiter-Glo luminescent cell viability assay reagent" 2)
      ("using ECL Western blot reagents" 2) ("Most reagents" 2)
      ("Western Blot Luminol Reagent" 2) ("TriReagent reagent" 2)
      ("the cationic lipid reagent" 2)
      ("the ECL™ Western blotting detection reagent" 2)
      ("Multiplex PCR reagent" 2)
      ("environmental toxicants and cancer chemotherapeutic reagents" 2)
      ("SuperSignal Ultra Chemiluminescent reagent" 2)
      ("Pico Chemiluminescent reagents" 2)
      ("the Dual- Luciferase Reporter Assay System reagents" 2)
      ("ECL chemiluminescent reagents" 2)
      ("an irreversible thiol-specific homobifunctional cross-linking reagent" 2)
      ("ECL western blotting reagents" 2) ("fluorescent reagent" 2)
      ("75 nM siRNA duplex using Dharmafect 1 reagent" 2)
      ("Western blotting reagents" 2) ("Pharmaceutical reagents" 2)
      ("fresh Vector Red reagent" 2) ("fresh ABC-Alkyline Phosphatase reagent" 2)
      ("Enhanced chemiluminescent reagent" 2)
      ("pre-developed 18S rRNA (VICTM-dye labeled probe) TaqMan® assay reagent" 2)
      ("a nonenzymatic cell dissociation reagent" 2)
      ("the ECL Western Blot Chemiluminescence Reagent" 2)
      ("using Western Lightning™ chemiluminescence reagent" 2)
      ("ice-cold Trizol reagent" 2)
      ("horseradish peroxidase (HRP)-conjugated secondary reagents" 2)
      ("using enhanced chemiluminescent reagents" 2)
      ("the dual luciferase assay reagents" 2) ("Western Detection Reagent" 2)
      ("the cationic polymer LipofectaminePlus reagent" 2)
      ("a potent chemopreventive reagent" 2)
      ("50 μl dual (firefly and sea pansy) luciferase assay reagents" 2)
      ("an enhanced chemilumiscent (ECL) detection reagent" 2)
      ("enhanced chemiluminescence Western Blot Reagent" 2)
      ("cytotoxic chemotherapeutic reagents" 2)
      ("ECL-Plus Western Blotting Detection Reagents" 2)
      ("All other biochemical reagents" 2) ("Hi-Perfect Transfection Reagent" 2)
      ("EBM-2–diluted Oligofectamine reagent" 2)
      ("RNAi duplex using Oligofectamine Reagent" 2)
      ("peroxidase-conjugated secondary antibody and DAB reagents" 2)
      ("using ECL™ Western Blotting Detection Reagents" 2)
      ("Pico Dura chemiluminescent reagent" 2)
      ("using ECL Western blotting Detection Reagents" 2)
      ("Biotinylated Link reagent" 2)
      ("using Amersham ECL western blot detection reagents" 2)
      ("a magnetic bead dextran reagent" 2)
      ("ECL western blotting detection reagent" 2)
      ("enhanced chemoluminescent detection reagents" 2)
      ("Western Lightning™ chemiluminescence reagents" 2)
      ("pico chemiluminescent substrate reagents" 2)
      ("the chemioluminescent ECL reagent" 2) ("immunological reagents" 2)
      ("a cysteine alkylating reagent" 2)
      ("the JetSI-ENDO Cationic Transfection reagent" 2)
      ("Enhanced chemiluminescence (ECL) Western blot detection reagents" 2)
      ("enhanced chemiluminescence (ECL) western detection reagents" 2)
      ("using Blotfresh Western Stripping Reagent" 2) ("linking reagent" 2)
      ("Taqman universal PCR master mix reagents" 2)
      ("peroxidase coupled secondary reagent" 2)
      ("the bicinchoninic acid protein assay reagent" 2)
      ("fluorescently conjugated secondary reagents" 2)
      ("enhanced chemiluminescence system Western Blotting Detection Reagents" 2)
      ("the Chariot-mediated peptide transduction reagent" 2)
      ("p -dimethylaminobenzaldehyde reagent" 2)
      ("using Pre-Developed TaqMan® Assay Reagents" 2) ("luminescent reagents" 2)
      ("the ECL Western Blotting Detection Reagents" 2)
      ("horseradish peroxidase (HRP)-conjugated secondary antibodies and Immobilon Western Chemiluminescent HRP Substrate detection reagent"
       2)
      ("WestPico chemiluminescent detection reagents" 2)
      ("bicinchoninic acid (BCA) reagents" 2) ("using RNAble reagent" 2)
      ("aqueous tissue storage reagents" 2)
      ("B-PER™ Bacterial Protein Extraction Reagent" 2)
      ("the CellTiter 96® AQueous MTS-based Reagent" 2) ("a unique reagent" 2)
      ("reagent (LAR)" 2) ("Retrieval Reagent" 2)
      ("dual luciferase assay reagent" 2) ("using Western blot luminol reagent" 2)
      ("the CellTiter 96® AQueous One Solution Cell Proliferation Assay reagent"
       2)
      ("chemiluminescent detection reagents" 2)
      ("enhanced chemiluminescence Western blotting detection reagents" 2)
      ("using Western blot Luminol reagent" 2)
      ("biotinylated secondary antibodies and sABC reagent" 2)
      ("the Immunostar LD Western blotting detection reagent" 2)
      ("10% v/v Alamar Blue reagent" 2) ("antibiotic-antimycotic reagent" 2)
      ("using western blot chemiluminescence reagents" 2)
      ("HyGLO Chemiluminescent HRP Detection Reagent" 2)
      ("using chemiluminescence ECL Western blotting detection reagents" 2)
      ("Pico Chemiluminescent Reagent" 2) ("Pro-Long anti-fade reagent" 2)
      ("usingCellTiter-Glo Luminescent reagent" 2)
      ("a Bicinchoninic Acid Protein Assay Reagent" 2)
      ("DOTAP Liposomal Transfection Reagent" 2)
      ("CelLytic M mammalian cell lysis reagent" 2)
      ("using DOTAP Liposomal Transfection Reagent" 2)
      ("using B-Per bacterial cell lysis reagent" 2)
      ("a membrane-impermeable thiol-cleavable reagent" 2)
      ("ECL Western blotting detection reagent" 2) ("Reagents (GE)" 2)
      ("Immobilon Western HRP substrate Luminol Reagent" 2)
      ("ImmunoStar LD reagents" 2) ("ECL Western blotting Detection Reagent" 2)
      ("Western Blot Detection reagents" 2)
      ("Bacterial Protein Extraction Reagent" 2)
      ("Enhanced chemiluminescence Western blotting detection reagents" 2)
      ("ECL Western blot detection reagents" 2)
      ("B-PER II Bacterial Protein Extraction Reagent" 2)
      ("appropriate, and visualized using enhanced chemiluminescence (ECL) Western blot detection reagents"
       2)
      ("ECL-Advanced western blot reagents" 2) ("reagent (SUPEX)" 2)
      ("only transfection reagent" 2) ("cleavable biotinylation reagent" 2)
      ("p NPP reagent" 2) ("a freshly prepared 2 ml clonogenic reagent" 2)
      ("bicinchoninic acid assay reagents" 2) ("ECL Western Blotting Reagents" 2)
      ("Amersham ECL Western Blotting Detection Reagents" 2)
      ("any reliable immunohistochemical reagents" 2)
      ("Thermo Scientific DharmaFECT 1 transfection reagent" 2)
      ("Western Blotting Luminol Reagent" 2)
      ("primary antibody overnight and visualized using ECL Detection Reagents" 2)
      ("Western Lightning reagent" 2)
      ("the Cell-titer 96 Aqueous One Solution Cell Proliferation Assay MTS reagent"
       2)
      ("a peroxidase-conjugated secondary reagent" 2) ("Biologic Reagents" 2)
      ("the enhanced chemiluminescence Western blotting detection reagents" 2)
      ("Western Lightening ECL reagent" 2) ("Miscellaneous Reagents" 2)
      ("the Amersham™ ECL™ Western Blot Detection Reagents" 2)
      ("antigen retrieval reagent" 2)
      ("using Immun-Star WesternC chemilluminescent reagent" 2)
      ("Western Blotting Chemiluminescence Luminol Reagent" 2)
      ("using Easy-Blue reagent" 2) ("a convenient reagent" 1)
      ("Two secondary reagents" 1) ("various biochemical reagents" 1)
      ("using ECL Western Blotting Detection Reagent" 1)
      ("otherwise stated tissue culture reagents" 1) ("relevant reagents" 1)
      ("the Bio-Rad Laboratories detergent-compatible protein reagent" 1)
      ("jetPEI cationic polymer transfection reagent" 1)
      ("the Oligofectamine transfection reagent (Invitrogen, Paisley, UK) according the manufacturer's"
       1)
      ("streptavidin-biotinylated peroxidase-conjugated reagents" 1)
      ("the Pre-Developed TaqMan® Assay Reagent" 1)
      ("the iTRAQ isobaric reagent" 1) ("diagnostic reagents" 1)
      ("commercially-available reagents" 1)
      ("the Supervision TM Universal (Anti-Mouse/Rabbit) Detection Reagent (HRP)"
       1)
      ("Reagent (HRP)" 1) ("Western blot reagents" 1) ("neurogenic reagents" 1)
      ("the myoblastic induction reagents" 1) ("the neural induction reagents" 1)
      ("the osteogenic reagent" 1) ("The osteogenic induction reagent" 1)
      ("infinite reagent" 1) ("reagent (GE)" 1) ("reagent (EMD)" 1)
      ("an Agilent 2100 Bioanalyzer and DNA 1000 reagents" 1)
      ("oxidative stress-inducing reagents" 1) ("the DAB chromogenic reagent" 1)
      ("the optimal reagent" 1)
      ("Enhanced chemiluminescence (ECL) western blot detection reagents" 1)
      ("alamar Blue reagent" 1) ("a bicinchoninic acid protein assay reagent" 1)
      ("Enhanced chemiluminescent detection reagents" 1)
      ("good immunological reagents" 1) ("secondary labeling reagent" 1)
      ("Femto Chemiluminescent substrate (Pierce) detection reagents" 1)
      ("Alamar Blue cell viability reagent" 1) ("the Alamar Blue reagent" 1)
      ("the CellLytic TM M Cell Lysis Reagent" 1)
      ("respective transfection reagents" 1) ("commercial antibody reagents" 1)
      ("biotinylated secondary antibody and RTU ABC reagent" 1)
      ("an antimetastatic reagent" 1) ("five pharmaceutical reagents" 1)
      ("only HiPerFect reagent" 1) ("using TRIZOL Reagent" 1)
      ("Lipofectamine 2000 reagent (Life Technologies) adopting the manufacturer's"
       1)
      ("chemiluminescence western blotting detection reagents" 1)
      ("Western Lighting Chemiluminescence Reagent" 1)
      ("pre-developed assay reagent" 1) ("a pre-developed assay reagent (PDAR)" 1)
      ("reagent (PDAR)" 1) ("than reagents" 1)
      ("Ventana Ultra View HRP reagent" 1)
      ("100 μL luminogenic ATP detection reagent" 1)
      ("ECL Western blot detection reagent" 1)
      ("commercially available reagents" 1) ("cell permeable reagents" 1)
      ("western blot detection reagents" 1) ("the most favorable reagent" 1)
      ("applicable respective reagents" 1)
      ("the latter received transfection reagent" 1)
      ("the secondary
reagent"
       1)
      ("MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) (Sigma-Aldrich) reagent"
       1)
      ("the secondary reagent" 1)
      ("using western blotting detection reagents (ECL)" 1)
      ("transfection reagent (Invitorgen, Carlsbad, CA) according the manufacturer's"
       1)
      ("vital reagents" 1)
      ("biotinylated “universal” secondary antibody and VECTASTAIN RT Elite ABC reagent"
       1)
      ("using ECL™ Western blotting detection reagents" 1)
      ("CellTiter 96 Aqueous One Solution reagent" 1)
      ("using TRIzol reagent (Life Technologies) according manufacturer’s" 1)
      ("Lipofectamine 2000 reagent (Life Technologies, Invitrogen) adopting the manufacturer's"
       1)
      ("fixative reagents" 1)
      ("Epitope Retrieval 2 (Leica, Buffalo, IL) reagents" 1)
      ("dual glo stop and glo reagent" 1) ("dual glo luciferase reagent" 1)
      ("a cationic liposome based reagent" 1) ("bicinchoninic acid reagent" 1)
      ("western
blotting detection reagent"
       1)
      ("the Western Breeze reagents" 1)
      ("CellTiter 96® AQueous One Solution Cell Proliferation reagent" 1)
      ("Upstate EZ ChIP (17–371) reagents" 1) ("a proprietary reagent" 1)
      ("the fluorescent reagents" 1) ("a chemotactic reagent" 1)
      ("robust reagents" 1) ("the available reagents" 1)
      ("Micro bicinchoninic acid protein assay reagents" 1)
      ("three related thiol-specific homobifunctional cross-linking reagents" 1)
      ("LumoGlo chemiluminescent reagent" 1) ("immunofluorescent reagents" 1)
      ("Western Lightning Chemiluninescence Reagent" 1)
      ("Chemiluninescent detection reagent" 1) ("ice-cold reagents" 1)
      ("low toxic reagents" 1) ("SuperSignal (Pierce) detection reagents" 1)
      ("Several recently developed reagents" 1)
      ("the supersignal pico reagent (PIERCE)" 1)
      ("LumiSensor Chemiluminescent HRP Substrate ECL Western Blot Detection Reagent"
       1)
      ("SuperSignal WestPico (Pierce Biotechnology) reagents" 1)
      ("alkylating reagents" 1) ("using chemiluminescent reagents" 1)
      ("more specific/sensitive reagents" 1)
      ("using TaqMan pre-developed assay reagents" 1)
      ("Qiagen Multiplex PCR reagent" 1)
      ("chemiluminescent detection reagents (ECL)" 1)
      ("relative and absolute quantitation (iTRAQ) reagents" 1)
      ("ECL Supersignal reagents" 1) ("ECL western blot detection reagents" 1)
      ("more potent chemopreventive reagents" 1)
      ("stable diploid non transformed cell reagents" 1)
      ("Bicinchoninic acid protein assay reagent" 1)
      ("the Western blotting Luminol Reagent" 1)
      ("Enhanced chemiluminescence western blotting detection reagents" 1)
      ("the monoclonal reagent" 1) ("the relevant RNAi reagents" 1)
      ("diphenylamine-aniline phosphoric acid reagent" 1)
      ("the respective GTPase assay reagent" 1)
      ("a non-permeable biotinylating reagent" 1) ("Noncommercial reagents" 1)
      ("suitable commercially available reagents" 1)
      ("the Western Lightning Chemiluminescence Reagent" 1)
      ("commercial luminescence reagents" 1) ("Western Lightning™ ECL reagents" 1)
      ("using commercial reagents" 1) ("Biotinylated reagents" 1)
      ("the ECL Western Blotting Detection Reagent" 1)
      ("the ECL chemiluminescent detection reagent" 1)
      ("FEMTO SuperSignal Chemiluminescence Reagent" 1)
      ("a reducible biotin reagent" 1)
      ("HRP-conjugated secondary antibodies and SuperSignal™ ECL reagents" 1)
      ("targeting reagents" 1) ("“Reagents”" 1) ("“Reagent”" 1)
      ("the EnVision+ Dual Link detection reagent" 1)
      ("the secondary antibody reagents" 1)
      ("the commercially available NE-PER Nuclear and Cytoplasmic Extraction Reagents"
       1)
      ("Enhanced chemiluminescent (ECL) reagent and bovine serum albumin (BSA) protein assay reagent"
       1)
      ("two chemotherapeutic reagents" 1)
      ("the chemiluminescent
                    detection reagent"
       1)
      ("ECL Western Blotting Detection Kit Reagent" 1)
      ("a peroxidase-conjugated secondary antibody and
                    DAB reagents"
       1)
      ("the currently available reagents" 1) ("Envison+ Dual link reagent" 1)
      ("a thiolcleavable amine-reactive biotinylation reagent" 1)
      ("using GalactoStar reagent" 1) ("reagent-" 1) ("the secondary reagents" 1)
      ("All retroviral reagents" 1) ("secondary detection reagents" 1)
      ("Western Blotting detection reagent" 1) ("Available reagents" 1)
      ("Agilent blocking reagents" 1)
      ("The ECL Western Blotting Detection Reagents" 1)
      ("using enhanced chemiluminescent reagent" 1)
      ("CellTiter 96 Aqueous One Solution Reagent" 1)
      ("biotinylated antibody reagent" 1)
      ("Enhanced chemiluminescence reagents" 1)
      ("CellTiter 96 Aqueous One reagent" 1)
      ("biotin-conjugated secondary Abs and ABC-AP color development reagents" 1)
      ("phosphomolybdic acid reagent" 1) ("paramagnetic reagent" 1)
      ("75 -μl dual luciferase reagent" 1) ("∼4-fold less reagent" 1)
      ("the same D 0 -propionic anhydride reagent" 1)
      ("fresh media and XTT reagent" 1) ("anhydrous reagents" 1)
      ("Western Blotting detection Reagents (GE)" 1)
      ("other essential reagents" 1) ("QIAgen" 1)
      ("ECL chemiluminiscent reagent" 1)
      ("a well-known chemotherapeutic reagent" 1)
      ("secondary antibodies and Far-Red Detection Reagents" 1)
      ("Commercially available reagents" 1) ("proprietary reagents" 1)
      ("Dual Stop and Glo reagent" 1)
      ("SuperSignal WestPico enhanced chemiluminescence western blotting detection reagent"
       1)
      ("Amplex-red reagent" 1) ("All other inorganic reagents" 1)
      ("as yet no reagents" 1) ("Western Lightning™ Chemiluminescence Reagent" 1)
      ("Commercially available DNA synthesis reagents" 1)
      ("Western blot detection reagent (SUPEX)" 1)
      ("the cleavable biotinylation reagent" 1)
      ("CellTiter 96 AQueous One Solution reagent" 1)
      ("100 µL dual detection reagent" 1)
      ("Supersignal Femto (Pierce) reagents" 1)
      ("Goat anti-rabbit horseradish peroxidase secondary antibody and TransFectin™ lipid reagent"
       1)
      ("a dual luciferase assay reagent" 1) ("Promega Dual Luciferase reagents" 1)
      ("the ECL-plus chemiluminescent detection reagents" 1)
      ("ice-cold nuclear extraction reagent" 1) ("AQueous One Solution Reagent" 1)
      ("GIBCO" 1) ("ECF Western blotting reagents" 1)
      ("the commercial transfection reagent" 1)))
    ("CHEBI:33937" (("macronutrients" 12) ("macronutrient" 7)))
    ("CHEBI:33942"
     (("ribose" 339) ("Ribose" 28) ("-ribose" 25) ("ribose (AICAR)" 6)
      ("ribose-" 3) ("ribose (PAR)" 3) ("nucleic acid ribose" 2) ("-Ribose" 2)
      ("-ribose (PAR)" 1) ("ribose (ADPR)" 1)))
    ("CHEBI:33979" (("LiOH" 12)))
    ("CHEBI:33984" (("fucose" 6) ("fucoses" 2) ("Fucose" 1)))
    ("CHEBI:3435" (("carrageenan" 26) ("Carrageenan" 3)))
    ("CHEBI:34444" (("PtBP" 3) ("ptbp" 1)))
    ("CHEBI:34623" (("chlordanes" 14) ("chlordane" 6)))
    ("CHEBI:34636" (("pGL3b" 11) ("PGL3b" 1))) ("CHEBI:34690" (("dichlorvos" 2)))
    ("CHEBI:34725"
     (("MK-801" 7) ("the non-competitive NMDA receptor antagonist MK-801" 2)))
    ("CHEBI:34756"
     (("DPCs" 110) ("dpc" 61) ("DPC" 40) ("luteolin and apigenin treated DPCs" 1)
      ("Dpc" 1) ("than DPC" 1)))
    ("CHEBI:3478" (("CCL" 138) ("CCl" 133) ("Ccl" 4) ("ccl" 2) ("ccL" 1)))
    ("CHEBI:34827"
     (("M2" 2651) ("M2-" 13) ("M+2" 11) ("m+2" 8) ("-M2" 7)
      ("mouse monoclonal anti-Flag M2" 3) ("25 μl monoclonal anti-FLAG M2" 2)
      ("a 96-well plate reader SpectraMax M2" 2)
      ("highly active tetrameric pyruvate kinase M2" 2)
      ("mouse monoclonal Flag M2" 2) ("mouse monoclonal anti–Flag M2" 2)
      ("mouse monoclonal ANTI-FLAG M2" 2) ("mouse monoclonal FLAG M2" 2)
      ("the monoclonal anti-Flag antibody M2" 1) ("than M2 ( xref )" 1)
      ("pre-conjugated EZview Red anti-FLAG M2" 1)
      ("mouse monoclonal Flag antibody M2" 1) ("mouse monoclonal anti-FLAG M2" 1)
      ("\"M2\"" 1) ("“M2”" 1) ("than M2" 1)))
    ("CHEBI:34905"
     (("paraquat" 87) ("Paraquat" 28) ("paraquat (PQ)" 3) ("Paraquat-" 2)
      ("an oxidative stress-inducing agent paraquat" 1)
      ("Post-confluent ARPE-19 cells required more paraquat" 1)))
    ("CHEBI:34941" (("PPADS" 9))) ("CHEBI:34968" (("SR95531" 8)))
    ("CHEBI:35095" (("DDFS" 60) ("ddf" 1)))
    ("CHEBI:35134"
     (("metalloprotein" 10) ("metalloproteins" 3)
      ("a small globular metalloprotein" 1)))
    ("CHEBI:35143"
     (("hemoglobin" 411) ("haemoglobin" 73) ("Hemoglobin" 23) ("hemoglobins" 14)
      ("Haemoglobin" 7) ("fetal haemoglobin" 6) ("glycosylated haemoglobin" 4)
      ("Fetal haemoglobin" 2) ("fetal hemoglobins" 1) ("Hemoglobins" 1)
      ("lower hemoglobin’s" 1) ("haemoglobin (MCH)" 1)))
    ("CHEBI:35154" (("MNN" 9)))
    ("CHEBI:35189"
     (("sesquiterpene" 16) ("sesquiterpenes" 4) ("Sesquiterpene" 1)))
    ("CHEBI:35190" (("diterpenes" 12) ("diterpene" 11) ("diterpene molecule" 2)))
    ("CHEBI:35191"
     (("triterpene" 32) ("triterpenes" 8) ("tetracyclic triterpenes" 2)
      ("pentacyclic triterpenes" 2) ("occurring dietary pentacyclic triterpene" 1)
      ("a pentacyclic triterpene" 1) ("occurring pentacyclic triterpene" 1)))
    ("CHEBI:35195"
     (("surfactant" 86) ("Surfactant" 11) ("surfactants" 5)
      ("Pulmonary surfactants" 1)))
    ("CHEBI:35204"
     (("tracer" 326) ("tracers" 58) ("targeted tracer" 14) ("Tracer" 7)
      ("Tracers" 6) ("endocytic tracers" 4) ("the respective tracers" 2)
      ("The fluorescent membrane tracer" 2) ("\"tracer\"" 2)
      ("fluorescent tracers" 1) ("an endocytic tracer" 1)
      ("cell impermeable avidin-conjugated FITC-labeled tracer" 1)
      ("a single fluorescent tracer" 1)
      ("a membrane potential-independent tracer" 1) ("a fluorescent tracer" 1)
      ("an isotopic tracer" 1) ("lipophilic tracer" 1)
      ("stable isotopic tracers" 1) ("macromolecular tracers" 1)
      ("a nontoxic and broad neuronal tracer" 1)))
    ("CHEBI:35218" (("anthocyanins" 7) ("anthocyanin" 4)))
    ("CHEBI:35313" (("-hexoside" 9) ("hexoside" 5)))
    ("CHEBI:35341"
     (("steroid" 908) ("steroids" 386) ("Steroid" 51) ("Steroids" 10)
      ("systemic steroids" 10) ("non-steroid" 9) ("ovarian steroids" 7)
      ("reproductive steroids" 4) ("non-androgenic steroids" 4) ("steroid-" 4)
      ("exogenous steroids" 3) ("nonandrogenic steroids" 3)
      ("exogenous serum steroids" 2) ("various non-androgenic steroids" 2)
      ("oestrogenic steroids" 2) ("cardiotonic steroids" 2) ("sexual steroids" 2)
      ("the other major adrenal steroids" 2) ("adrenal steroids" 1)
      ("adrenal-derived steroids" 1) ("Estrogenic steroids" 1)
      ("contraceptive steroids" 1) ("topical steroids" 1)))
    ("CHEBI:35350" (("hydroxysteroid" 26))) ("CHEBI:35358" (("sulfonamide" 19)))
    ("CHEBI:35366"
     (("fatty acid" 1210) ("fatty acids" 981) ("Fatty acid" 44) ("fatty-acid" 20)
      ("Fatty acids" 18) ("Fatty Acids" 8) ("very long chain fatty acids" 6)
      ("fatty acid (FFA)" 4) ("fatty acids (PUFA)" 4) ("fatty acids (LCFA)" 3)
      ("essential fatty acids" 3) ("the dietary long-chain omega-3 fatty acids" 3)
      ("fatty acid (PUFA)" 2) ("exogenous essential fatty acids" 2)
      ("fatty
acid"
       2)
      ("at least five different short chain fatty acids" 2)
      ("BODIPY-dodecanoic acid fluorescent fatty acid" 2)
      ("serum-derived essential fatty acids" 2) ("FATTY ACIDS" 2)
      ("the respective fatty acids" 2) ("fatty-acids" 2)
      ("dietary omega-3 fatty acids" 2) ("linoleic fatty acids" 2)
      ("linolenic polyunsaturated fatty acids (PUFA)" 2)
      ("tumor cells most fatty acid" 2) ("exogenous fatty acid" 2)
      ("fatty acid (NEFA)" 1) ("fatty acids (FFA)" 1) ("occurring fatty acid" 1)
      ("BODIPY-labeled fluorescent free fatty acid" 1) ("fatty acids-" 1)
      ("a very long-chain omega-3 fatty acid" 1)
      ("exogenous unsaturated fatty acids" 1)
      ("dietary long-chain omega-3 fatty acids" 1)
      ("short chain organic fatty-acids" 1) ("dietary fatty acids" 1)
      ("than other fatty acids [ xref ]" 1) ("Exogenous fatty acids" 1)
      ("sebacic (SA) fatty acids" 1) ("neutral fatty acids" 1)
      ("Further omega 3 fatty acids" 1) ("this system exogenous fatty acid" 1)
      ("exogenous 16∶0 and 18∶1 fatty acid" 1)
      ("specifically ω-6 polyunsaturated fatty acids" 1) ("fatty-acids (SCFA)" 1)
      ("fatty acids (NEFA)" 1) ("Dietary fatty acids" 1)))
    ("CHEBI:35369" (("pentasaccharide" 16) ("pentasaccharides" 4)))
    ("CHEBI:35371"
     (("Los" 275) ("lipooligosaccharide" 8) ("LOS" 5) ("los" 4)
      ("Lipooligosaccharide" 2) ("Lipooligosaccharide (LOS)" 1)))
    ("CHEBI:35381" (("monosaccharides" 10) ("monosaccharide" 8)))
    ("CHEBI:35404" (("chromate" 19) ("Chromate" 4)))
    ("CHEBI:35455" (("anit" 6) ("ANIT" 2) ("Anit" 1)))
    ("CHEBI:35469"
     (("antidepressant" 126) ("antidepressant drug" 8) ("Antidepressant" 3)
      ("subchronic antidepressant" 2) ("at least one antidepressant" 1)
      ("Triciclic antidepressant" 1)))
    ("CHEBI:35475"
     (("NSAIDs" 601) ("non-steroidal anti-inflammatory drugs" 95) ("NSAIDS" 21)
      ("non-steroidal anti-inflammatory drug" 16)
      ("Non-steroidal anti-inflammatory drugs" 16) ("nonselective NSAIDs" 6)
      ("non-steroidal anti-inflammatory drugs (NSAID)" 2)
      ("Non-steroidal anti-inflammatory drug" 2)
      ("non-steroidal anti-inflammatory drugs (NSAIDS)" 1) ("most NSAIDs" 1)
      ("most other NSAIDs" 1) ("Traditional NSAIDs" 1)
      ("the early non-steroidal anti-inflammatory drugs (NSAIDs) known to inhibit the activities of cyclooxygenases (COXs)"
       1)
      ("more NSAIDs" 1) ("the nonselective NSAIDs" 1)
      ("both traditional NSAIDs" 1) ("traditional NSAIDs" 1)
      ("possibly other NSAIDs" 1) ("than standard NSAIDs" 1)))
    ("CHEBI:35476" (("neuroleptic" 5) ("antipsychotic agent" 3)))
    ("CHEBI:35480"
     (("analgesic" 54) ("an effective postoperative analgesic" 3)
      ("the sole intravenous analgesic" 1)))
    ("CHEBI:35493" (("antipyretic" 8))) ("CHEBI:35499" (("hallucinogen" 3)))
    ("CHEBI:35509" (("androstane" 6)))
    ("CHEBI:35526" (("anti-diabetic" 58) ("anti-diabetic drug" 36)))
    ("CHEBI:35556" (("pyrrole" 12))) ("CHEBI:35595" (("isoxazole" 5)))
    ("CHEBI:35602" (("chromene" 63)))
    ("CHEBI:35607" (("Na3VO4" 138) ("fresh 1 mM Na3VO4" 1)))
    ("CHEBI:35623" (("anticonvulsant" 9))) ("CHEBI:35640" (("NRI" 32)))
    ("CHEBI:35666" (("thiopurines" 20) ("thiopurine" 17)))
    ("CHEBI:35674" (("antihypertensive" 50) ("antihypertensive agent" 2)))
    ("CHEBI:35682" (("naphthol" 26) ("-naphthol" 4) ("Naphthol" 3)))
    ("CHEBI:35701"
     (("ester" 1142) ("esters" 477) ("MIAM" 73) ("ester (CFSE)" 60) ("CFSE" 48)
      ("Ester" 37) ("ester (DAPT)" 17) ("ester (TMRE)" 13) ("ester-" 9)
      ("Ester (DAPT)" 8) ("ester (GME)" 7) ("ester (PMA)" 6) ("ester (CE)" 6)
      ("ester (TMRM)" 5) ("esters (FAME)" 5) ("LME" 5)
      ("2-(4-Pyren-1-yl-butyrylamino)-propionic Acid
Methyl Ester"
       4)
      ("ester (MIAM)" 4) ("ester (AME)" 3) ("ester (CAPE)" 3)
      ("a diacylglycerol-mimetic phorbol ester" 2)
      ("ultraviolet (UV) irradiation or phorbol esters" 2) ("the acetic ester" 2)
      ("the lysosomotropic reagent L-leucyl-L-leucine methyl ester" 2)
      ("-tetraacetic acid tetraacetoxymethyl ester" 2)
      ("1-HMP subsequently forms reactive sulphuric acid ester" 2)
      ("Trifluoromethanesulfonic acid 1-methyl-cyclohexylmethyl ester" 2)
      ("esters (TMRE)" 2) ("ester (LME)" 2) ("Ester (TAME)" 2)
      ("the nontumorigenic phorbol ester" 2) ("Ester (CFSE)" 2)
      ("ester (DCFDA)" 2) ("-ester" 2)
      ("the fluorescent Ca 2+ indicator fura-2-acetoxymethyl ester" 2)
      ("ester (TAME)" 2)
      ("-bis(2-carboxyethel)-5(6)-carboxyfluorescein acetoxymethyl ester" 2)
      ("ESTER" 1) ("bulky phenyl ester" 1)
      ("the cell permeable Ca 2+ sensitive fluorescent dye Fluo- 3 acetoxymethyl ester"
       1)
      ("than Pro esters" 1) ("its mimetic phorbol esters" 1)
      ("-tetraacetic acid acetoxymethyl ester" 1) ("ester (CFDA)" 1)
      ("the crude L -theanine ester" 1) ("a nontumorigenic phorbol ester" 1)
      ("suberic acid monomethyl ester" 1) ("azelaic acid monomethyl ester" 1)
      ("D-2,3-O-Isopropylidene-6-O-(2-nitro-4,5-dimethoxy)benzyl-myo-Inositol 1,4,5-trisphosphate-Hexakis (propionoxymethyl) Ester"
       1)
      ("the mitochondria-specific fluorescent dye tetramethyl rhodamine ethyl ester (TMRE)"
       1)
      ("substituted phenoxyacetic acid ethyl esters" 1) ("esters (TPA)" 1)
      ("acrylic acid N-hydrosuccinimide (NHS) ester" 1)
      ("-tetraacetic acid/tetra(acetoxymethyl)-ester" 1)
      ("The cationic fluorescent dye tetramethylrhodamine methyl ester (TMRM)" 1)
      ("the fluorescent dye Alexafluor 633 succinimidyl ester" 1)
      ("Residual activated esters" 1)
      ("an orally bioavailable fumaric acid ester" 1)
      ("phospho-aminophosphonic acid-adenylate ester (ANP)" 1) ("ester (ANP)" 1)))
    ("CHEBI:35703"
     (("xenobiotic" 126) ("xenobiotics" 122) ("Xenobiotic" 5) ("Xenobiotics" 2)
      ("toxic xenobiotics" 1)))
    ("CHEBI:35738" (("MAA" 11) ("Maas" 5)))
    ("CHEBI:35741" (("glycerolipids" 7) ("glycerolipid" 3)))
    ("CHEBI:35757" (("monocarboxylates" 2) ("Monocarboxylate" 1)))
    ("CHEBI:35785" (("sphingoid" 8) ("Sphingoid" 1)))
    ("CHEBI:35790" (("oxazoles" 3) ("oxazole" 2) ("-oxazole" 1)))
    ("CHEBI:35801"
     (("nitroso" 60) ("-nitroso" 8) ("Nitroso" 4)
      ("two newly-described acyloxy nitroso" 1)))
    ("CHEBI:35803" (("nitrosamines" 53) ("nitrosamine" 33) ("-nitrosamines" 2)))
    ("CHEBI:35850"
     (("sulfone" 37) ("cysteic acid and methionine sulfone" 1)
      ("Cysteic acid and methionine sulfone" 1) ("sulfones" 1)))
    ("CHEBI:35923"
     (("hydroperoxide" 57) ("hydroperoxides" 30) ("hydroperoxide (CH)" 1)
      ("hydroperoxide (TBHP)" 1) ("organic hydroperoxide" 1)))
    ("CHEBI:36200" (("hepoxilin" 2) ("Hepoxilin" 1)))
    ("CHEBI:36233"
     (("disaccharide" 16) ("disaccharides" 11) ("amino disaccharides" 1)))
    ("CHEBI:36257" (("taurocholate" 7)))
    ("CHEBI:36264" (("molybdate" 59) ("Molybdate" 1)))
    ("CHEBI:36275"
     (("HETE" 313) ("-HETE" 102) ("HETEs" 5)
      ("the pro-migratory factor 12(S)-HETE" 1)))
    ("CHEBI:36328" (("HODE" 67) ("-HODE" 3) ("HODEs" 1)))
    ("CHEBI:36405" (("norleucine" 7) ("-norleucine" 2) ("-norleucine (DON)" 1)))
    ("CHEBI:36417"
     (("phenanthroline" 46) ("-phenanthroline" 10) ("-phenanthroline (OPT)" 1)))
    ("CHEBI:36420" (("acridine" 15) ("Acridine" 1)))
    ("CHEBI:36498" (("galactosylceramide" 10)))
    ("CHEBI:36500"
     (("glucosylceramide" 17) ("-glucosylceramide" 9) ("glucosylceramides" 1)
      ("Glucosylceramide" 1) ("GlucosylCeramide" 1)))
    ("CHEBI:36540" (("ent-kaurane" 6))) ("CHEBI:36560" (("ZnO" 1)))
    ("CHEBI:36592" (("pyrrolidin-2-one" 8) ("butyrolactam" 1)))
    ("CHEBI:36615"
     (("triterpenoid" 65) ("triterpenoids" 42) ("Triterpenoids" 4)
      ("highly oxidized tetracyclic triterpenoids" 1)
      ("the oleanolic triterpenoids" 1) ("a semisynthetic triterpenoids" 1)))
    ("CHEBI:36616" (("quinoxaline" 14)))
    ("CHEBI:36621"
     (("quinazoline" 55) ("quinazoline (QNZ)" 7) ("Quinazoline" 3)
      ("quinazolines" 2)))
    ("CHEBI:36655" (("glyoxylate" 19) ("Glyoxylate" 1)))
    ("CHEBI:36671" (("indazole" 2) ("-indazole" 1)))
    ("CHEBI:36722"
     (("-hexachlorobiphenyl" 2) ("-Hexachlorobiphenyl" 1) ("Hexachlorobiphenyl" 1)
      ("hexachlorobiphenyl" 1)))
    ("CHEBI:36807"
     (("hydrochloride" 698) ("DAPI" 64) ("hydrochloride (AEBSF)" 35)
      ("hydrochloride (TCEP)" 12) ("AEBSF" 11) ("Hydrochloride" 9)
      ("-Hydrochloride" 8) ("hydrochloride (DAB)" 7) ("hydrochloride (DAPI)" 4)
      ("-5,7-Dihydroxy-8-(3-hydroxy-1-methyl-4-piperidinyl)-2-(5-methylisoxazole)-4 H -1-benzopyran-4-one hydrochloride"
       4)
      ("2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride" 3)
      ("hydrochloride (BV)" 2) ("hydrochloride-" 2) ("hydrochloride (ACNU)" 2)
      ("the chaotropic agent guanidine hydrochloride" 2)
      ("hydrochloride (BAPNA)" 1)
      ("the chaotropic agent guanidinium hydrochloride" 1)))
    ("CHEBI:36825" (("azido" 12) ("Azido" 3)))
    ("CHEBI:36916"
     (("cation" 353) ("cations" 114) ("divalent cations" 21) ("Cation" 14)
      ("the divalent cation" 13) ("divalent cation" 7) ("monovalent cations" 4)
      ("bivalent cations" 4) ("cation-" 3) ("a divalent cation" 3)
      ("different divalent cations" 3) ("a lipophilic cation" 3)
      ("divalent magnesium (Mg 2+ ) cations" 2) ("nonselective cation" 2)
      ("Divalent cations" 2) ("the most abundant divalent cation" 2)
      ("the divalent cations" 2)
      ("the dominant intracellular monovalent cation" 2)
      ("chelated paramagnetic cations" 2) ("this divalent cation" 1) ("Cations" 1)
      ("using divalent cations" 1) ("the second‐messenger‐operated cation" 1)
      ("Ca 2+ permeable nonselective cation" 1)
      ("highly Na + -selective cation" 1) ("one divalent cation" 1)
      ("several polyvalent cations" 1) ("more massive cation" 1)
      ("Ca 2+ permeable cation" 1) ("Ca 2+ -permeable nonselective cation" 1)
      ("various divalent cations" 1) ("chelates divalent cations" 1)))
    ("CHEBI:36973" (("graphene" 10)))
    ("CHEBI:37163"
     (("glucans" 7) ("glucan" 6) ("insoluble glucans" 2)
      ("fungal cell wall glucans" 1) ("-glucan" 1)))
    ("CHEBI:37256" (("Zn2" 14)))
    ("CHEBI:37395" (("mucopolysaccharide" 4) ("mucopolysaccharides" 3)))
    ("CHEBI:37409" (("corona" 13) ("Corona" 3) ("CoroNa" 2) ("coronas" 1)))
    ("CHEBI:37415" (("alpha-amanitin" 6))) ("CHEBI:37511" (("thiophosphate" 4)))
    ("CHEBI:37537"
     (("phorbol-12-myristate-13-acetate" 35)
      ("phorbol-12-myristate-13-acetate (PMA)" 10)
      ("Phorbol-12-myristate-13-acetate" 5)
      ("Phorbol-12-Myristate-13-Acetate" 1)))
    ("CHEBI:37548" (("phenyl phosphate" 6) ("phenyl-phosphate" 1)))
    ("CHEBI:37550"
     (("sphingosine-1-phosphate" 104) ("sphingosine 1-phosphate" 27)
      ("Sphingosine-1-phosphate" 27) ("-sphingosine-1-phosphate" 8)
      ("Sphingosine 1-phosphate" 8)
      ("The pleiotropic lipid mediator sphingosine-1-phosphate" 2)
      ("promitogenic sphingosine-1-phosphate" 1)))
    ("CHEBI:37603"
     (("vinyl" 69) ("vinyl group" 3) ("-vinyl" 2) ("vinyl groups" 2) ("Vinyl" 1)))
    ("CHEBI:37622"
     (("carboxamide" 62) ("-carboxamide" 30) ("Carboxamide" 4)
      ("N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3 carboxamide"
       1)
      ("carboxamides" 1)))
    ("CHEBI:37671" (("zymosan" 110) ("Zymosan" 36)))
    ("CHEBI:37684"
     (("mannose" 128) ("mannoses" 14) ("Mannose" 10) ("α-linked mannose" 1)))
    ("CHEBI:37710" (("Tal" 3)))
    ("CHEBI:37739"
     (("glycerophospholipid" 14) ("glycerophospholipids" 8)
      ("phosphoglycerides" 4)))
    ("CHEBI:37868" (("octanol" 4))) ("CHEBI:37903" (("Lysyl" 5) ("lysyl" 4)))
    ("CHEBI:37926"
     (("FITC" 4088) ("fluorescein isothiocyanate" 411) ("FITC-" 92) ("-FITC" 84)
      ("fluorescein isothiocyanate (FITC)" 48) ("Fluorescein isothiocyanate" 40)
      ("fitc" 11) ("–FITC" 5) ("secondary FITC-" 4)
      ("fluorescein isothiocyanate–" 4) ("secondary antibody anti mouse-FITC" 4)
      ("Fluorescein Isothiocyanate" 3) ("FITC molecule" 3)
      ("secondary anti-mouse FITC" 2) ("FitC" 2)
      ("-fluorescein isothiocyanate (FITC)" 2) ("Fluorescein isothiocyanate-" 2)
      ("fluorescein isothiocyanate-" 2) ("secondary FITC" 2)
      ("fluorescent dye FITC" 1)
      ("fluorescein
isothiocyanate"
       1)
      ("-fluorescein isothiocyanate" 1)
      ("monoclonal anti-Hck, and anti-mouse FITC" 1) ("Fluorescent FITC-" 1)
      ("Fitc" 1) ("Fluorescent secondary antibodies FITC" 1) ("Relevant FITC-" 1)
      ("appropriate secondary FITC" 1) ("showed less Annexin-V FITC" 1)))
    ("CHEBI:37952" (("Suc" 26) ("succinyl group" 9) ("suc" 1)))
    ("CHEBI:37963" (("pyranones" 3) ("23 structure-related pyranones" 1)))
    ("CHEBI:379896" (("methyltrienolone" 32) ("Methyltrienolone" 14)))
    ("CHEBI:37991" (("thiophenyl" 4))) ("CHEBI:37997" (("homopolymer" 24)))
    ("CHEBI:38034" (("aminonaphthalene" 1))) ("CHEBI:38056" (("triazine" 4)))
    ("CHEBI:38081" (("dithiole" 9) ("dithioles" 2)))
    ("CHEBI:38161"
     (("chelator" 293) ("chelators" 237) ("Chelator" 4) ("chelator (EGTA)" 2)
      ("divalent cation chelators" 2) ("a membrane permeable Zn chelator" 2)
      ("bifunctional chelators" 2) ("-chelator" 2) ("Chelators" 2)
      ("a nonspecific metal chelator" 2)))
    ("CHEBI:38178" (("strophanthidin" 2) ("Strophanthidin" 1)))
    ("CHEBI:38193" (("phenylpyridine" 1))) ("CHEBI:38207" (("aminopyridine" 6)))
    ("CHEBI:38224" (("fumonisin" 11) ("Fumonisin" 8)))
    ("CHEBI:38254" (("pheophorbide" 3) ("Pheophorbide" 1)))
    ("CHEBI:38272" (("borono" 2))) ("CHEBI:38327" (("oxazoline" 1)))
    ("CHEBI:38333" (("thiazolidine" 6)))
    ("CHEBI:38337" (("pyrimidone" 17) ("pyrimidones" 3)))
    ("CHEBI:38338"
     (("aminopyrimidine" 6) ("an orally available aminopyrimidine" 1)))
    ("CHEBI:38339" (("formamidopyrimidines" 2) ("Formamidopyrimidine" 1)))
    ("CHEBI:38518" (("benzophenanthridine" 3)))
    ("CHEBI:38532"
     (("hydrazone" 37) ("hydrazone (FCCP)" 10) ("hydrazone (CCCP)" 7)))
    ("CHEBI:38571" (("XMC" 2)))
    ("CHEBI:38597" (("triazole" 22) ("Triazole" 3) ("5 mM 3-amino triazole" 1)))
    ("CHEBI:38630" (("Steward" 1)))
    ("CHEBI:38669"
     (("pyrazolopyrimidine" 8)
      ("3-(3-Thienyl)-6-(4-methoxyphenyl)pyrazolopyrimidine" 1)
      ("pyrazolopyrimi-dine" 1)))
    ("CHEBI:38691" (("flavans" 1) ("flavan" 1)))
    ("CHEBI:38722"
     (("aurothiomalate" 16) ("aurothiomalate (ATM)" 5)
      ("antirheumatic drug aurothiomalate" 1)))
    ("CHEBI:38755" (("Hydroxyisoflavone" 4)))
    ("CHEBI:38776" (("imidazoquinoline" 3)))
    ("CHEBI:38867"
     (("anesthetic" 33) ("anaesthetic" 14) ("Anesthetic" 3) ("anaesthetic drug" 3)
      ("a topical anesthetic" 1)))
    ("CHEBI:38934" (("purvalanol" 98) ("Purvalanol" 14)))
    ("CHEBI:39010" (("MES" 286) ("Mes" 27) ("mes" 2)))
    ("CHEBI:39027"
     (("VLDL" 48) ("very-low-density lipoprotein" 7) ("VLDLs" 1)
      ("very-low-density lipoprotein (VLDL)" 1)))
    ("CHEBI:39054" (("NTA" 572) ("-NTA" 58) ("–NTA" 1)))
    ("CHEBI:39074" (("MOPS" 311) ("Mops" 24) ("MOPs" 6) ("finally 25 mM MOPS" 2)))
    ("CHEBI:3908" (("coumestrol" 20)))
    ("CHEBI:39146"
     (("trichostatin" 22) ("Trichostatin" 10) ("trichostatin (TSA)" 8)
      ("Trichostatin (TSA)" 1)))
    ("CHEBI:39178" (("Clo" 88) ("CLO" 3)))
    ("CHEBI:39282"
     (("Mei" 22) ("MEIS" 18) ("mei" 12) ("MEI" 7) ("Meis" 4) ("MeiS" 1)))
    ("CHEBI:39299" (("polo" 96) ("Polo" 67)))
    ("CHEBI:39321" (("tetrazine" 5) ("tetrazines" 2)))
    ("CHEBI:39352" (("dinitrophenol" 5) ("Dinitrophenol" 5)))
    ("CHEBI:39421" (("PFOS" 21)))
    ("CHEBI:39479" (("butadiene" 25) ("Butadiene" 1)))
    ("CHEBI:39867"
     (("VPA" 560) ("valproic acid" 156) ("Valproic acid" 17)
      ("valproic acid (VPA)" 12) ("VPA’s" 4) ("VPA-" 4) ("than VPA" 2)
      ("Valproic acid (VPA)" 1) ("valproic acid-" 1)
      ("its parent compound VPA" 1)))
    ("CHEBI:4031"
     (("cyclosporin A" 67) ("Cyclosporin A" 35) ("cyclosporin A (CSA)" 1)))
    ("CHEBI:40356" (("GalNAcα" 4) ("N-acetyl-alpha-D-galactosamine" 2)))
    ("CHEBI:40618"
     (("aminoguanidine" 8) ("aminoguanidine (AG)" 3) ("Aminoguanidine" 1)))
    ("CHEBI:40953" (("BIRB-796" 30)))
    ("CHEBI:41045"
     (("actinonin" 47) ("Actinonin" 3) ("actinonin's" 1) ("actinonins" 1)
      ("the peptidomimetic actinonin" 1)))
    ("CHEBI:41218"
     (("mercaptoethanol" 1041) ("-mercaptoethanol" 107)
      ("beta-mercaptoethanol" 86) ("Mercaptoethanol" 34)
      ("Beta-Mercaptoethanol" 8) ("fresh 5% beta-mercaptoethanol" 2)
      ("mercaptoethanol (BME)" 2) ("-Mercaptoethanol" 1)))
    ("CHEBI:41250"
     (("Bis-Tris" 82) ("bis-tris" 26) ("Bis-tris" 8) ("bis-Tris" 2) ("Bis–Tris" 2)
      ("bis–tris" 1) ("BIS-TRIS" 1)))
    ("CHEBI:412516"
     (("HMFs" 121) ("HMF" 39) ("resident HMFs" 5) ("than HMFs" 1)
      ("102CM-treated HMFs" 1) ("normal resident HMFs" 1)
      ("primary normal resident HMFs" 1)))
    ("CHEBI:41264"
     (("butyl" 77) ("-butyl" 31) ("Butyl" 7) ("-Butyl" 6) ("butyl-" 3)
      ("-butyl group" 1) ("butyl group" 1)))
    ("CHEBI:41402"
     (("carboxymethyl" 24) ("carboxymethyl group" 5) ("Carboxymethyl" 3)))
    ("CHEBI:41470" (("chymostatin" 42) ("Chymostatin" 4)))
    ("CHEBI:41609"
     (("carbonate" 192) ("anhydrous sodium carbonate" 2) ("Carbonate" 1)
      ("0.28 M anydrous sodium carbonate" 1)))
    ("CHEBI:41774"
     (("tamoxifen" 3893) ("Tamoxifen" 428) ("OHT" 161) ("tamoxifen (TAM)" 15)
      ("OHT-" 5) ("tamoxifen-" 5) ("receive tamoxifen" 4) ("than tamoxifen" 4)
      ("tamoxifen (OHT)" 3) ("−OHT" 3)
      ("aromatase transfected MCF-7 cells made tamoxifen" 2)
      ("the hormonal
agent tamoxifen"
       2)
      ("Tamoxifen (OHT)" 2) ("tamoxifen's" 2) ("the hormonal drug tamoxifen" 2)
      ("tamoxifen (TMX)" 1) ("Tamoxifen (TMX)" 1) ("less tamoxifen" 1)
      ("TAMOXIFEN" 1) ("Only 23 mutation carriers took tamoxifen" 1)
      ("the non-steroidal anti-estrogen tamoxifen" 1) ("Tamoxifen (TAM)" 1)
      ("tamoxifen (TM)" 1) ("the commonly used chemotherapeutic drug tamoxifen" 1)
      ("tamoxifen’s" 1)))
    ("CHEBI:41791" (("CalyculinA" 1))) ("CHEBI:41846" (("ddTTP" 10)))
    ("CHEBI:42098"
     (("digoxigenin" 133) ("Digoxigenin" 25) ("digoxigenin (DIG)" 5) ("DIG" 5)
      ("digoxigenins" 4) ("digoxigenin-" 3) ("dig" 3) ("Digoxigenin-" 1)
      ("-digoxigenin" 1)))
    ("CHEBI:42160"
     (("dithionite" 13)
      ("the membrane-impermeable reductant sodium dithionite" 1)))
    ("CHEBI:42266"
     (("ethane" 33) ("methyl-methane" 3) ("ethane-" 3)
      ("liquid-nitrogen-cooled liquified ethane" 1) ("-ethane" 1)))
    ("CHEBI:42478"
     (("ethidium" 60) ("Ethidium" 5) ("the red fluorescent ethidium" 1)
      ("red fluorescent ethidium" 1)))
    ("CHEBI:42485" (("formyl" 33) ("formyl group" 11) ("-formyl" 5) ("Formyl" 1)))
    ("CHEBI:42645"
     (("fluoro" 92) ("Fluoro" 47) ("fluoro-" 3) ("fluoro-2-deoxy-" 1)))
    ("CHEBI:42768" (("geneticin" 266) ("Geneticin" 256) ("GENETICIN" 7)))
    ("CHEBI:4285"
     (("DCIS" 1788) ("pure DCIS" 58) ("DCI" 19) ("HER2-positive DCIS" 12)
      ("ErbB2-overexpressing DCIS" 9) ("the pure DCIS" 4) ("dCI" 3)
      ("HER2-overexpressing DCIS" 3) ("these women developed DCIS" 3)
      ("around DCIS" 3) ("ErbB2 over expressing DCIS" 2) ("Her2-positive DCIS" 2)
      ("aggressive DCIS" 2) ("pre-operative tumour biopsies displaying DCIS" 2)
      ("HER-2-positive DCIS" 2) ("normal ducts around DCIS" 2) ("Pure DCIS" 2)
      ("preinvasive DCIS" 2) ("had bilateral synchronous DCIS" 2)
      ("IHC confirmed DCIS" 2) ("ErbB2-positive DCIS" 1)
      ("triple-negative DCIS" 1) ("ER-positive or HER2-positive DCIS" 1)
      ("35 pure DCIS" 1) ("this HER2-positive DCIS" 1)
      ("histologically confirmed HER2-positive DCIS" 1)
      ("prognostic and predictive DCIS" 1) ("a previous DCIS" 1)
      ("non-invasive DCIS" 1) ("the diffusely growing DCIS" 1)
      ("than either DCIS" 1) ("the ErbB2-overexpressing DCIS" 1)
      ("HER-2-positive/COX-2-positive DCIS" 1) ("Samples comprised pure DCIS" 1)
      ("had pure DCIS" 1) ("bilateral DCIS" 1) ("had unilateral DCIS" 1)
      ("an FHIT -negative DCIS" 1) ("pre-invasive DCIS" 1) ("multifocal DCIS" 1)
      ("high-grade pure DCIS" 1) ("175 pure DCIS" 1) ("179 pure DCIS" 1)
      ("papillary DCIS" 1) ("“DCIS”" 1) ("classical DCIS" 1)
      ("ductal carcinoma in situ DCIS" 1)))
    ("CHEBI:43176"
     (("hydroxy" 255) ("Hydroxy" 22) ("-hydroxy" 18) ("hydroxy group" 13)
      ("hydroxy groups" 4)
      ("a methylated
hydroxy group"
       1)
      ("namely 13(S)-hydroxy" 1)))
    ("CHEBI:43295" (("indoline" 16)))
    ("CHEBI:43448" (("iodo" 16) ("IODO" 11) ("Iodo" 3)))
    ("CHEBI:4356" (("DFO" 182) ("than DFO" 2) ("Dfo" 1)))
    ("CHEBI:43616" (("K252a" 47) ("the membrane-permeable inhibitor K252a" 1)))
    ("CHEBI:43732"
     (("thiazole" 37) ("thiazoles" 3)
      ("the sphingosine kinase inhibitor 2-( p -Hydroxyanilino)-4-( p -chlorophenyl)thiazole"
       2)
      ("Thiazole" 1) ("2-( p -Hydroxyanilino)-4-( p -chlorophenyl)thiazole" 1)
      ("2-(p-Hydroxyanilino)-4-(p-chlorophenyl) thiazole" 1)
      ("nonpeptidic thiazole" 1)
      ("2-( p -Hydroxyanilino)-4-( p -chlorophenyl) thiazole" 1)))
    ("CHEBI:4393" (("colcemid" 165) ("Colcemid" 75)))
    ("CHEBI:439819" (("phenylglycine" 12) ("-phenylglycine" 3)))
    ("CHEBI:44209"
     (("methylamino" 58) ("-methylamino group" 2)
      ("a basic N -methylamino group" 1) ("methylamino group" 1)
      ("Methylamino" 1)))
    ("CHEBI:44296" (("tetraethylammonium" 3)))
    ("CHEBI:44485"
     (("N-ethylmaleimide" 103) ("N-Ethylmaleimide" 22) ("NEM" 22)
      ("N-ethylmaleimide (NEM)" 17) ("n-ethylmaleimide" 9)
      ("N-Ethylmaleimide (NEM)" 4) ("N-EthylMaleimide" 1)))
    ("CHEBI:44520"
     (("methoxy" 86) ("Methoxy" 7) ("-methoxy" 6) ("methoxy group" 6)))
    ("CHEBI:44548" (("Orn" 2)))
    ("CHEBI:44658"
     (("OA" 2745) ("OAS" 162) ("radiographic OA" 16) ("severe OA" 10)
      ("mild knee OA" 9) ("p53 overexpressing OA" 8) ("Oa" 6) ("mild OA" 5)
      ("-OA" 5) ("severe knee OA" 4) ("oas" 3) ("idiopathic OA" 3)
      ("more severe knee OA" 3) ("radiographically mild OA" 3)
      ("post-traumatic OA" 3) ("oA" 3) ("Oa-" 3)
      ("Joint instability-induced OA" 2) ("targeting OA" 2)
      ("radiographic knee OA" 2) ("symptomatic OA" 2) ("-OAS" 2) ("OA-" 2)
      ("early-onset polyarticular OA" 2) ("chemically-induced OA" 2)
      ("late stage OA" 2) ("radiographically severe OA" 2) ("medial knee OA" 2)
      ("OAs" 2) ("primary symptomatic OA" 2) ("Oas" 1) ("OA’s" 1)
      ("Radiographic OA" 1) ("primary symptomatic knee OA" 1) ("had mild OA" 1)
      ("asymptomatic OA" 1) ("different anatomic OA" 1)
      ("hip, or generalized OA" 1) ("symptomatic and radiographic knee OA" 1)
      ("idiopathic generalized OA" 1) ("single-joint OA" 1)
      ("hip, or polyarticular OA" 1)
      ("self-reported and physician-diagnosed OA" 1)
      ("idiopathic generalized OA (GOA)" 1) ("OA (GOA)" 1)
      ("surgical instability–induced OA" 1) ("posttraumatic OA" 1)
      ("than the end stage OA" 1) ("“OA”" 1) ("radiographical knee OA" 1)
      ("than 75 yr old present OA ( xref )" 1) ("late onset OA" 1)
      ("than OA ( xref )" 1) ("secondary OA" 1) ("3 anaplastic OAs" 1)
      ("painful knee joint OA" 1) ("‘OAS’" 1) ("metabolomic included OA" 1)))
    ("CHEBI:44785"
     (("peroxide" 330) ("peroxides" 87) ("Peroxide" 23) ("exogenous peroxide" 4)
      ("0.3% methanolic peroxide" 2) ("Peroxides" 2) ("more lipid peroxides" 2)
      ("peroxide-" 1) ("some cells peroxisomal peroxides" 1)
      ("externally-produced peroxide" 1) ("peroxide (HRP)" 1)))
    ("CHEBI:44926" (("triethylene glycol" 3) ("Teg" 2)))
    ("CHEBI:44975"
     (("1,10-phenanthroline" 30) ("phen" 19) ("Phen" 6) ("pHEN" 5)
      ("1,10-Phenanthroline" 1)))
    ("CHEBI:45021"
     (("palmitoyl" 70) ("palmitoyl group" 13) ("palmitoyl groups" 5)
      ("Palmitoyl" 3)))
    ("CHEBI:45127"
     (("phorbol-13-acetate" 19) ("phorbol-13-acetate (TPA)" 7)
      ("phorbol 13-acetate (TPA)" 4) ("phorbol 13-acetate" 3)
      ("Phorbol-13-acetate" 1)))
    ("CHEBI:45353" (("phosphoramidon" 16)))
    ("CHEBI:45888" (("trifluoroacetyl" 4) ("trifluoroacetyl-" 1)))
    ("CHEBI:45927" (("TEPs" 32) ("TEP" 22)))
    ("CHEBI:45951" (("trifluoperazine" 9) ("trifluoperazine (TFP)" 3)))
    ("CHEBI:46195" (("Paracetamol" 2) ("paracetamol" 2) ("“Paracetamol”" 1)))
    ("CHEBI:4640" (("DPA" 21) ("Dpa" 1) ("diphenylamine" 1)))
    ("CHEBI:46442" (("vanadate" 180) ("Vanadate" 39)))
    ("CHEBI:46502" (("tungstate" 9)))
    ("CHEBI:46557"
     (("ZOL" 152) ("ZA" 49) ("zoledronic acid" 44) ("zol" 8) ("Zoledronic acid" 8)
      ("zoledronic acid (ZA)" 3) ("zoledronic acid (ZOL)" 3)
      ("low concentration (5 μM) ZA" 1) ("25μM ZA" 1) ("Pure crystalline ZOL" 1)
      ("Zol" 1)))
    ("CHEBI:46629" (("oxo" 132) ("Oxo" 12) ("oxo group" 2) ("oxo-" 1) ("-oxo" 1)))
    ("CHEBI:46640" (("diketone" 6) ("diketones" 2)))
    ("CHEBI:46661" (("asbestos" 317) ("Asbestos" 26) ("wide-used asbestos" 1)))
    ("CHEBI:46664" (("chrysotile" 98) ("Chrysotile" 17)))
    ("CHEBI:46666" (("crocidolite asbestos" 2) ("crocidolite" 1)))
    ("CHEBI:46677" (("amphiboles" 1)))
    ("CHEBI:46678" (("amosite asbestos" 4) ("amosite" 1)))
    ("CHEBI:46685" (("oxadiazoles" 1))) ("CHEBI:46695" (("HFC" 5) ("hFc" 3)))
    ("CHEBI:46711" (("pSH" 17) ("pSh" 4)))
    ("CHEBI:46740" (("glycyl" 9) ("Glycyl" 3) ("glycyl-" 2)))
    ("CHEBI:46741"
     (("Nutlin" 891) ("nutlin" 205) ("Nutlin’s" 2) ("nutlin-" 2)
      ("than Nutlin" 1)))
    ("CHEBI:46742"
     (("Nutlin-3" 1527) ("nutlin-3" 359) ("than Nutlin-3" 4)
      ("Racemic nutlin-3" 3) ("-Nutlin-3" 2) ("only 2μM nutlin-3" 2)
      ("Racemic Nutlin-3" 2) ("Nutlin-3-" 2)
      ("the nongenotoxic p53 activator Nutlin-3" 1) ("racemic nutlin-3" 1)
      ("NUTLIN-3" 1) ("than Nutlin-3 (K i =36 nM)" 1)
      ("than the positive controls Nutlin-3" 1) ("than Nutlin-3 in cell lines" 1)
      ("than Nutlin-3 in both cell lines" 1) ("than Nutlin-3 in this cell line" 1)
      ("than Nutlin-3 (p = 0.001)" 1) ("archetypical Nutlin-3" 1)
      ("the well-studied Nutlin-3" 1)))
    ("CHEBI:46751" (("quinolizidine" 2)))
    ("CHEBI:46756"
     (("HEPES" 5734) ("Hepes" 2281) ("hepes" 4) ("-Hepes" 3)
      ("ice-cold 20 mM Hepes" 3) ("ice-cold HEPES" 3) ("HEPES (PAA)" 2)
      ("–HEPES" 2) ("HEPES molecule" 2) ("Hepes-" 1) ("HEPEs" 1)))
    ("CHEBI:46787"
     (("solvent" 1732) ("solvents" 144) ("Solvent" 48) ("organic solvents" 12)
      ("Solvents" 12) ("explicit solvent" 11) ("solvent molecule" 9)
      ("solvent (DMSO)" 8) ("co-solvent" 6) ("more solvent" 4)
      ("the organic solvents" 4) ("the aqueous solvent" 4)
      ("any organic solvents" 4) ("residual solvent" 2)
      ("acidic aqueous-organic solvents" 2) ("significantly more solvent" 2)
      ("the organic solvent" 2) ("toxic organic solvent" 2)
      ("slightly more solvent" 2) ("aqueous solvents" 2)
      ("different organic solvents" 2) ("organic solvent" 2)
      ("anhydrous solvents" 1) ("the basic nitrogen and bulk solvent" 1)
      ("Explicit TIP3P solvents" 1) ("acidic or basic LC-compatible solvent" 1)
      ("auxiliary solvent" 1) ("The organic solvent" 1)
      ("Analytical grade solvents" 1) ("complete organic vapour solvent" 1)
      ("toxic organic solvents" 1) ("a highly polar solvent" 1) ("less solvent" 1)
      ("A spherical solvent" 1) ("one organic solvent molecule" 1)
      ("Very little solvent" 1) ("Dry solvents" 1)
      ("appropriate organic solvents" 1) ("the explicit solvent" 1)))
    ("CHEBI:46819" (("urate" 184) ("Urate" 3) ("cerebrospinal fluid urate" 1)))
    ("CHEBI:46881" (("propoxy" 4))) ("CHEBI:46882" (("primary amino groups" 2)))
    ("CHEBI:46883"
     (("carboxy" 763) ("Carboxy" 23) ("carboxy group" 15) ("carboxy-" 8)
      ("carboxy groups" 2) ("CARBOXY" 2) ("δ-catenin just carboxy" 1)
      ("the non-fluorescent carboxy" 1)))
    ("CHEBI:46887"
     (("acetyl" 1097) ("Acetyl" 120) ("-acetyl" 22) ("acetyl-" 3) ("-Acetyl" 2)
      ("-acetyl-5-methoxytryptamine" 1)
      ("euchromatic markers histone H3K9 acetyl" 1) ("than acetyl" 1)
      ("Acetyl-" 1)))
    ("CHEBI:46908" (("imidazopyridine" 4)))
    ("CHEBI:46923" (("dioxane" 9) ("Dioxane" 1)))
    ("CHEBI:46979" (("C2-ceramide" 4) ("C2-Ceramide" 1)))
    ("CHEBI:47042" (("hydroxycholecalciferol" 13) ("Hydroxycholecalciferol" 8)))
    ("CHEBI:47265" (("bromo" 222) ("Bromo" 89) ("BROMO" 6) ("bromo-" 3)))
    ("CHEBI:472805"
     (("ouabain" 70) ("Ouabain" 10) ("ouabain-" 2)
      ("the cardiac glycoside ouabain" 1)))
    ("CHEBI:47322" (("CKI-7" 18)))
    ("CHEBI:47499" (("imipramine" 54) ("Imipramine" 10)))
    ("CHEBI:47774"
     (("low-density lipoprotein cholesterol" 31) ("LDL-c" 11)
      ("Low-density lipoprotein cholesterol" 7)
      ("low-density lipoprotein cholesterol (LDLC)" 3)))
    ("CHEBI:47775"
     (("HDL-cholesterol" 88) ("high-density lipoprotein cholesterol" 35)
      ("High-density lipoprotein cholesterol" 2) ("HDL–cholesterol" 1)
      ("high-density lipoprotein cholesterol (HDL)" 1)))
    ("CHEBI:47779" (("aminoglycoside" 11)))
    ("CHEBI:47785"
     (("AMP-PNP" 176) ("the nonhydrolyzable analogue AMP-PNP" 2) ("-AMP-PNP" 2)
      ("AMP-PNP molecule" 2) ("the nonhydrolyzable ATP analog AMP-PNP" 2)))
    ("CHEBI:47853" (("chloro" 113) ("Chloro" 9) ("-chloro" 2)))
    ("CHEBI:47885"
     (("dinucleotides" 562) ("dinucleotide" 450) ("Dinucleotide" 8)
      ("methylated CpG dinucleotides" 7) ("the nearly invariant dinucleotides" 6)
      ("methylated CpG dinucleotide" 4) ("Methylated CpG Dinucleotide" 2)
      ("dinucleotide (CA)" 2) ("only one dinucleotide" 2)
      ("the polymorphic dinucleotide (CA)" 2) ("Dinucleotides" 2)
      ("particularly TG dinucleotides" 2)
      ("nearly invariant GT/AG dinucleotides" 2)
      ("fully methylated CG dinucleotides" 1)
      ("highly methylated CpG dinucleotides" 1) ("a critic CC dinucleotide" 1)
      ("intronic dinucleotides" 1) ("about eight methylated dinucleotides" 1)
      ("at least two CpG dinucleotides" 1) ("-dinucleotide" 1)
      ("approximately 20 CpG dinucleotides" 1)
      ("highly mutable CpG dinucleotides" 1)
      ("the methylated CpG dinucleotides" 1) ("the dense CG dinucleotides" 1)
      ("other unusual dinucleotides" 1) ("over-represented dinucleotides" 1)
      ("The methylated CpG dinucleotides" 1)))
    ("CHEBI:47898" (("Epirubicine" 4) ("epirubicine" 3)))
    ("CHEBI:47916"
     (("flavonoids" 162) ("flavonoid" 118) ("Flavonoids" 18)
      ("a major dietary flavonoid" 2) ("non-toxic flavonoids" 2)
      ("a natural dietary flavonoid" 2) ("dietary flavonoids" 2)
      ("another polyphenolic flavonoid" 2) ("diet-derived flavonoids" 2)
      ("these two polyphenolic flavonoids" 1) ("two potent dietary flavonoids" 1)
      ("a structurally-related flavonoid" 1)
      ("a representative antioxidant flavonoid" 1)
      ("a yellow crystalline flavonoid" 1) ("at least some flavonoids" 1)
      ("a dietary polyphenolic flavonoid" 1) ("various oligomeric flavonoids" 1)))
    ("CHEBI:47922" (("MV1" 2) ("Mv1" 1)))
    ("CHEBI:47924"
     (("BV6" 29) ("than BV6" 1)
      ("the second mitochondria-derived activator of caspase mimetic BV6" 1)))
    ("CHEBI:48041"
     (("microcystin" 95) ("Microcystin" 11) ("microcystins" 2)
      ("microcystin (EMD)" 2)))
    ("CHEBI:48051" (("acetoacetyl" 2)))
    ("CHEBI:4806"
     (("EGCG" 1079) ("approximately 53% EGCG" 4) ("EGCG molecule" 4)
      ("that EGCG’s" 1)))
    ("CHEBI:48076" (("acetoxy" 4))) ("CHEBI:48110" (("trinitrobenzene" 3)))
    ("CHEBI:48120"
     (("anthracycline" 387) ("anthracycline-" 15) ("Anthracycline" 3)
      ("a chemotherapeutic anthracycline" 2) ("non-anthracycline" 1)))
    ("CHEBI:48140" (("silicone" 30) ("Silicone" 3)))
    ("CHEBI:48141" (("disiloxane" 2)))
    ("CHEBI:48285" (("anilino" 24) ("anilino group" 2)))
    ("CHEBI:48343"
     (("disulfide" 743) ("disulfides" 47) ("Disulfide" 21)
      ("biologically irrelevant disulfide" 4) ("oxidative disulfide" 2)
      ("a possible disulfide" 1) ("at least one disulfide" 1)
      ("incorrect disulfide" 1) ("than disulfide trapping" 1)
      ("potential disulfide" 1) ("apparently form intramolecular disulfides" 1)
      ("Disulfides" 1)))
    ("CHEBI:48374" (("acetamido" 9) ("acetamido groups" 1)))
    ("CHEBI:48548" (("trifluoromethanesulfonyl" 24)))
    ("CHEBI:48551"
     (("guanidino" 14) ("guanidino group" 8) ("guanidino groups" 2)
      ("Guanidino" 1)))
    ("CHEBI:48559"
     (("phenylindole" 281) ("DAPI" 53) ("phenylindole (DAPI)" 7)
      ("-phenylindole" 6) ("Phenylindole" 1)))
    ("CHEBI:48605" (("Fmoc" 141) ("FMOC" 10) ("Fmoc-" 7) ("fmoc" 1)))
    ("CHEBI:48607"
     (("LiCl" 1164) ("lithium chloride" 133) ("LiCL" 23) ("Lithium chloride" 22)
      ("LiCl-" 2) ("the psychiatric drug LiCl" 1)))
    ("CHEBI:48631" (("pyridocarbazole" 2)))
    ("CHEBI:48706"
     (("antagonist" 4158) ("antagonists" 2264) ("Antagonists" 37)
      ("Antagonist" 16) ("a competitive antagonist" 14)
      ("a pure estrogen antagonist" 9) ("antagonist (CHAVDIC)" 7)
      ("a soluble antagonist" 6) ("a pure antagonist" 4) ("a strong antagonist" 4)
      ("antagonist (TPP)" 4) ("antagonist (CHAVC)" 4) ("a special antagonist" 4)
      ("a unique antagonist" 3) ("a weak AR antagonist" 3)
      ("a neutral MC1R antagonist" 3)
      ("a competitive leptin receptor antagonist" 3)
      ("a well-characterized antagonist" 2) ("antagonist (PHTPP)" 2)
      ("a well-characterized PR antagonist" 2) ("pure antagonists" 2)
      ("parenteral ligand-mimetic antagonists" 2) ("a steroidal AR antagonist" 2)
      ("a novel metastasis-suppressing antagonist" 2) ("viral antagonists" 2)
      ("other viral antagonists" 2) ("pharmacologic antagonists" 2)
      ("other viral immune antagonists" 2)
      ("a selective pharmacologic antagonist" 2) ("non steroidal AR antagonist" 2)
      ("a neutral antagonist" 2) ("the previously reported menin antagonist" 2)
      ("namely survival antagonists" 2) ("the muscarinic specific antagonist" 2)
      ("both non-competitive antagonists" 2)
      ("the principal cellular antagonist" 2)
      ("a competitive rat leptin antagonist" 2)
      ("Non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists" 2)
      ("the relatively newly developed MDM2 antagonists" 2)
      ("recently developed MDM2 antagonists" 2) ("one or more Wnt antagonists" 2)
      ("rather IAP antagonists" 2) ("Dapper antagonist" 2)
      ("soluble TNF receptors and IL-1 receptor antagonist" 2)
      ("antagonist (CSC)" 2) ("an A 2A R-selective antagonist" 2)
      ("a soluble competitive antagonist" 2)
      ("a potent competitive VEGF antagonist" 2)
      ("selective competitive antagonist" 2)
      ("especially β-catenin overactivation and WNT antagonist" 2)
      ("a ‘pure’ antagonist" 2) ("currently only one MDM2 antagonist" 2)
      ("a newly developed AR antagonist" 2)
      ("inhalable small-molecule antagonists" 1) ("a pure ER antagonist" 1)
      ("ANTagonist" 1) ("using nonselective pharmacological antagonists" 1)
      ("a noncompetitive NMDA receptor antagonist" 1)
      ("a potent noncompetitive antagonist" 1) ("no RGD-based pure antagonists" 1)
      ("RGD-based pure antagonists" 1) ("a classical AR antagonist" 1)
      ("novel non-steroidal AR antagonists" 1)
      ("The commercially available androgen receptor (AR) antagonists" 1)
      ("a relatively pure direct AR antagonist" 1)
      ("a direct AR competitive antagonist" 1)
      ("a steroidal type II ER antagonist" 1)
      ("a newly developed CXCR4 antagonist" 1)
      ("dual Mcl-1 and Bcl-xL antagonists" 1) ("Fewer Mcl-1 antagonists" 1)
      ("an SR A antagonist" 1) ("dual p53-Mdm2 and p53-Mdm4 antagonists" 1)
      ("a previously
reported small molecule p53-Mdm4 antagonist"
       1)
      ("thromboxane (Tx) A 2 /PGH 2 receptor antagonist" 1)
      ("a neural nAChR antagonist" 1) ("pure ER antagonists" 1)
      ("synthetic cell-permeable IAP antagonists" 1)
      ("a soluble Wnt antagonist" 1) ("any pro-apoptotic Bcl2/BclXL antagonist" 1)
      ("a dual endothelin receptor antagonist" 1)
      ("GABA A receptor antagonists" 1) ("Soluble antagonists" 1)
      ("dominant-negative PI3K, or Mdm2 antagonist" 1)
      ("clinically available antagonists" 1) ("known viral antagonists" 1)
      ("currently available P-gp antagonists" 1) ("CHAVC" 1)
      ("a potential endogenous antagonist" 1) ("a cell-permeable antagonist" 1)
      ("an uncompetitive NMDA receptor antagonist" 1)
      ("the respective antagonist" 1) ("the soluble wnt antagonist" 1)
      ("a pivotal antagonist" 1) ("an A 2A antagonist (CSC)" 1)
      ("more robust AR antagonists" 1) ("muscarinic antagonists" 1)
      ("The absolute estrogen antagonist" 1)
      ("the intrinsic dominant-negative antagonist" 1)
      ("a dominant-negative antagonist" 1)
      ("an intrinsic dominant-negative antagonist" 1)
      ("the first identified intrinsic dominant-negative antagonist" 1)
      ("dominant-negative antagonist" 1) ("larger HGF-derived antagonists" 1)
      ("selective competitive antagonists" 1)
      ("two previously described STAT3 antagonists" 1)
      ("the singular universal prosurvival protein antagonist" 1)
      ("the universal prosurvival antagonist" 1)
      ("Phosphatidyl inositol 3-kinase or interleukin receptor-associated kinase 1/4 antagonists"
       1)
      ("dual antagonists" 1) ("their viral antagonists" 1)))
    ("CHEBI:48819" (("cyano" 47) ("Cyano" 3) ("cyano group" 3)))
    ("CHEBI:48839" (("selenite" 252) ("Selenite" 13)))
    ("CHEBI:48958" (("diamide" 71) ("Diamide" 1)))
    ("CHEBI:49043" (("β-lactone" 20) ("β-Lactone" 3))) ("CHEBI:4907" (("HEDP" 1)))
    ("CHEBI:49168"
     (("DOPA" 27) ("-DOPA" 3) ("dopa" 2) ("-Dopa" 2) ("Dopa" 1) ("-dopa" 1)))
    ("CHEBI:49248" (("ionone" 1)))
    ("CHEBI:49298" (("formylmethionyl" 2) ("Formylmethionyl" 1)))
    ("CHEBI:495055" (("beta-cyclodextrin" 5)))
    ("CHEBI:49603"
     (("lapatinib" 2831) ("Lapatinib" 519) ("than lapatinib" 13) ("lapatinib-" 4)
      ("the dual kinase inhibitor Lapatinib" 4)
      ("the dual tyrosine kinase inhibitor lapatinib" 4)
      ("the dual EGFR/HER2 kinase inhibitor lapatinib" 3)
      ("the reversible dual EGFR and HER-2 inhibitor lapatinib" 3)
      ("the FDA-approved dual HER2/EGFR TKI lapatinib" 2)
      ("Dual kinase inhibitor Lapatinib" 2)
      ("the dual Her-1/2 inhibitor lapatinib" 2)
      ("the small molecule dual EGFR and HER2 inhibitor lapatinib" 2)
      ("The dual EGFR/Her2 inhibitor lapatinib" 2)
      ("The dual HER1/HER2-TKI1 lapatinib" 2) ("LapR cells underwent lapatinib" 1)
      ("the dual EGFR/HER2 TKI lapatinib" 1) ("than lapatinib [ xref ]" 1)
      ("The dual EGFR/HER2 tyrosine kinase inhibitor lapatinib" 1)
      ("the ErbB1/ErbB2 dual kinase inhibitor lapatinib" 1)
      ("the dual ErbB1/ErbB2 kinase inhibitor lapatinib" 1)
      ("the dual tyrosine kinase inhibitor Lapatinib" 1)
      ("ERBB2/EGFR-positive pancreatic cancer cell lines lapatinib" 1)
      ("lapatanib" 1) ("lapatinib's" 1)
      ("than the dual tyrosine kinase inhibitor lapatinib" 1)
      ("the dual EGFR and HER2 inhibitor lapatinib" 1)
      ("than lapatinib alone in BT474 cells" 1)
      ("The EGFR/HER2 dual kinase inhibitor lapatinib" 1)
      ("a dual HER1/HER2 inhibitor lapatinib" 1) ("the global lapatinib" 1)
      ("A global lapatinib" 1) ("a global lapatinib" 1)
      ("The HER2-predominant HER kinase inhibitor lapatinib" 1) ("Lapatinib's" 1)
      ("conceivable lapatinib" 1) ("the EGFR-ERBB2 dual inhibitor lapatinib" 1)))
    ("CHEBI:49637"
     (("hydrogen" 2452) ("hydrogens" 75) ("Hydrogen" 65) ("hydrogen atoms" 52)
      ("hydrogen atom" 22) ("Hydrogen atoms" 6) ("strong hydrogen" 6)
      ("internal hydrogen" 4) ("less hydrogen" 4) ("potential hydrogen" 3)
      ("Hydrogens" 3) ("favorable hydrogen" 3) ("polar hydrogen atoms" 3)
      ("a strong hydrogen" 2) ("more hydrogen" 2)
      ("its available backbone amide hydrogens" 2) ("fewer potential hydrogen" 2)
      ("Essential hydrogen atoms" 2) ("Non-polar hydrogen atoms" 2)
      ("possible hydrogen" 2) ("optimal hydrogen" 2) ("non-hydrogen" 2)
      ("no observable hydrogen" 2) ("the interfacial hydrogen" 2)
      ("the Hη phenolic hydrogen" 2) ("mostly backbone hydrogen" 2)
      ("two intramolecular polar hydrogen" 1) ("shorter hinge forms hydrogen" 1)
      ("the 2-amino group form hydrogen" 1) ("two more hydrogen" 1)
      ("polar hydrogen" 1) ("Phe of peptide forms 2 and 1 hydrogen" 1)
      ("whereby gefitinib forms hydrogen" 1)
      ("its main-chain carbonyl forms strong hydrogen" 1)
      ("at least three amide hydrogens" 1) ("their available amide hydrogens" 1)
      ("Other polar interactions such hydrogen" 1)
      ("the exchangeable hydrogens" 1) ("weak hydrogen" 1)
      ("the nonpolar hydrogen atoms" 1) ("archetypal backbone hydrogen" 1)
      ("two strong hydrogen" 1) ("a few hydrogen" 1)
      ("H587 normally forms hydrogen" 1) ("Hydrogen atom" 1)
      ("polar protein backbone groups form hydrogen" 1)
      ("The internal hydrogen" 1) ("only two hydrogen" 1)
      ("intermittent hydrogen" 1) ("181 exchangeable backbone amide hydrogen" 1)
      ("the hinge (N549, E565, and K641) form strong hydrogen" 1)
      ("the two potential hydrogen" 1) ("a potential hydrogen" 1)))
    ("CHEBI:49668"
     (("gefitinib" 4571) ("Gefitinib" 544) ("gefinitib" 17)
      ("preoperative gefitinib" 8) ("gefitinib-" 5) ("than gefitinib" 5)
      ("Gefinitib" 5) ("than Gefitinib" 5) ("“gefitinib”" 2)
      ("pre-operative gefitinib" 2) ("perioperative gefitinib" 2)
      ("receive adjuvant gefitinib" 2) ("systemic Gefitinib" 1)
      ("than gefitinib (Index SUM  = 423)" 1) ("than either gefitinib" 1)
      ("-gefitinib" 1)
      ("than gefitinib in MGH131-1 and MGH131-2 cells ( xref )" 1)
      ("gefitinib’s" 1) ("post-operative gefitinib" 1)
      ("targeted therapy drug gefitinib" 1)
      ("than 20 µM gefitinib in CL1-5 and A549 cells ( xref )" 1)
      ("gefitinib's" 1)))
    ("CHEBI:49706"
     (("perchlorate" 35) ("perchlorate (TMRE)" 7) ("perchlorate (TMRM)" 5)
      ("Perchlorate (DIL)" 4) ("Perchlorate" 3) ("Perchlorate (TMRM)" 3)
      ("TMRM" 1) ("perchlorate (DIL)" 1) ("DIL" 1) ("perchlorate–" 1)))
    ("CHEBI:49709" (("chlorate" 1))) ("CHEBI:49828" (("praseodymium" 2)))
    ("CHEBI:49882" (("rhenium" 1)))
    ("CHEBI:50075" (("dihydropyridine" 2) ("non-dihydropyridine" 1)))
    ("CHEBI:50076" (("Chromium-51" 4)))
    ("CHEBI:50091"
     (("S-nitrosoglutathione" 14) ("S-nitrosoglutathione (GSNO)" 11)))
    ("CHEBI:50102"
     (("MNU" 13) ("N-methyl-N-nitrosourea" 11)
      ("N-methyl-N-nitrosourea (MNU)" 4)))
    ("CHEBI:50113"
     (("androgen" 7054) ("androgens" 1250) ("Androgen" 318) ("Androgens" 94)
      ("androgen-" 49) ("ANDROGEN" 17) ("adrenal androgens" 11) ("non-androgen" 9)
      ("testicular androgens" 8) ("weak adrenal androgens" 6)
      ("exogenous androgen" 5) ("residual androgens" 5) ("exogenous androgens" 5)
      ("Androgen-" 4) ("weak androgens" 4) ("circulatory androgens" 3)
      ("androgen (PSA)" 3) ("more androgen" 2) ("the respective androgen" 2)
      ("weak circulating androgens" 2) ("other adrenal androgens" 2)
      ("the nonaromatizable androgens" 2) ("further characterized androgen-" 2)
      ("ovarian androgen" 2) ("than androgens" 2) ("available androgen" 2)
      ("androgen−" 1) ("prenatal androgen" 1) ("postnatal androgen" 1)
      ("non-androgens" 1) ("precisely androgen" 1) ("adrenal-derived androgens" 1)
      ("a synthetic non-metabolizable androgen" 1)
      ("systemic testicular androgens" 1) ("than androgen" 1)
      ("systematically suppresses/reduces androgen" 1) ("adrenal androgen" 1)
      ("murine adrenal androgens" 1) ("androgen (AR)" 1)
      ("nongenomic and classical AR-mediated androgen" 1) ("systemic androgen" 1)
      ("intraprostatic androgens" 1) ("androgen (DT)" 1) ("urinary androgen" 1)
      ("intra-tumoral androgens" 1) ("adrenal and testicular androgens" 1)
      ("some classical androgen" 1) ("testicular- androgen" 1)
      ("testicular androgen" 1) ("testicular and non-testicular androgens" 1)
      ("adrenal derived androgens" 1) ("no exogenous androgen" 1)
      ("than 0.1 pM androgen in 5% bovine" 1) ("bio-available androgens" 1)
      ("undetectable adrenal androgen" 1) ("this residual androgen" 1)
      ("permit weak androgens" 1) ("Ovarian androgens" 1)
      ("Hormonal evaluations showed undetectable androgens" 1)))
    ("CHEBI:50114"
     (("estrogen" 6686) ("estrogens" 852) ("Estrogen" 460) ("Estrogens" 91)
      ("estrogen-" 27) ("exogenous estrogen" 13) ("residual estrogens" 9)
      ("estrogen (ER)" 7) ("acute estrogen" 5) ("estrogen’s" 4)
      ("the weak estrogen" 4) ("luteal phase urinary estrogens" 3)
      ("exogenous estrogens" 3) ("a weak estrogen" 3)
      ("rapid nongenomic estrogen" 3) ("residual estrogen" 2)
      ("intratissular estrogens" 2) ("frontal cortex estrogen" 2)
      ("non-estrogen" 2) ("obviously not estrogen" 2) ("estrogens (CEE)" 1)
      ("than estrogens" 1) ("placental estrogen" 1) ("than estrogen" 1)
      ("continous combined estrogen" 1) ("exogenous or endogenous estrogens" 1)
      ("premenopausal estrogen" 1) ("rats showed estrogens" 1)
      ("biologically available estrogens" 1) ("abrupt estrogen" 1) ("estrogen–" 1)
      ("only medium potency estrogen" 1) ("specifically bind estrogens" 1)
      ("nongenomic estrogen" 1) ("indirect estrogen" 1)
      ("aromatic C18 estrogens" 1) ("ovarian estrogen" 1)
      ("post-menopausal estrogens" 1) ("residual endogenous estrogens" 1)
      ("the mouse mammary gland estrogen" 1) ("toxic estrogens" 1)
      ("human neoplastic mammary cells estrogens" 1) ("“estrogen”" 1)
      ("steroidal estrogens" 1) ("biological effects estrogen" 1)
      ("mammary estrogen" 1) ("Estrogen’s" 1)
      ("exogenous pharmacological or dietary estrogens" 1)
      ("The hydroxylated estrogens" 1) ("Classical estrogen" 1)
      ("than the physiologic estrogens" 1) ("all competent estrogens" 1)
      ("the steroidal estrogens" 1) ("a plasma membrane impermeable estrogen" 1)
      ("Excess intratesticular estrogens" 1) ("estrogen's" 1)
      ("just estrogen" 1)))
    ("CHEBI:50127"
     (("trifluoromethyl" 54) ("trifluoromethyl group" 8) ("Trifluoromethyl" 1)))
    ("CHEBI:50188" (("provitamin" 1)))
    ("CHEBI:50211" (("retinol" 21) ("Retinol" 3)))
    ("CHEBI:50249"
     (("anticoagulant" 94) ("ethylenediaminetetraacetic acid anticoagulant" 2)
      ("Anticoagulant" 1)))
    ("CHEBI:50264" (("thiazide" 2)))
    ("CHEBI:50316" (("Brh2" 86) ("fungal Brh2" 2) ("brh2" 1)))
    ("CHEBI:50317" (("iodonium" 30) ("iodonium (DPI)" 10)))
    ("CHEBI:50376" (("nitroalkene" 16) ("nitroalkenes" 9) ("Nitroalkenes" 1)))
    ("CHEBI:50385" (("hemin" 140) ("Hemin" 32) ("hemin-" 1)))
    ("CHEBI:50453"
     (("desferrioxamine" 26) ("desferrioxamine (DFO)" 4)
      ("desferrioxamine (DFX)" 3) ("ferric ammonium citrate + desferrioxamine" 2)
      ("Desferrioxamine" 2)))
    ("CHEBI:50459" (("PPF" 4)))
    ("CHEBI:50539"
     (("thiolate" 53) ("thiolate anion" 21) ("thiolates" 6)
      ("the negatively-charged thiolate anion" 1)))
    ("CHEBI:5054" (("fibrin" 239) ("Fibrin" 20))) ("CHEBI:50697" (("arestin" 1)))
    ("CHEBI:50699"
     (("oligosaccharides" 40) ("oligosaccharide" 35)
      ("one or more N-linked high-mannose oligosaccharides" 1)))
    ("CHEBI:50745" (("progestogen" 16) ("progestogens" 11)))
    ("CHEBI:50751"
     (("anti-estrogen" 236) ("anti-oestrogen" 40) ("Anti-estrogen" 4)
      ("anti-estrogen drug" 4) ("anti-estrogen-" 2) ("a pure anti-estrogen" 2)
      ("a pure anti-oestrogen" 1) ("another clinically relevant anti-estrogen" 1)
      ("a “pure” anti-estrogen" 1) ("a steroidal pure anti-oestrogen" 1)))
    ("CHEBI:50753" (("isoflavonoids" 18) ("isoflavonoid" 1)))
    ("CHEBI:5078"
     (("flavonols" 40) ("flavonol" 31) ("Flavonols" 5) ("flavonol's" 1)
      ("pure flavonols" 1)))
    ("CHEBI:50796"
     (("nanotubes" 114) ("nanotube" 20) ("notably carbon nanotubes" 3)
      ("Single-walled carbon nanotubes" 2) ("Nanotube" 1) ("Nanotubes" 1)))
    ("CHEBI:50803"
     (("nanoparticles" 420) ("nanoparticle" 168) ("LENA" 37) ("Nanoparticle" 26)
      ("Nanoparticles" 13) ("nanoparticles (CURN)" 4)
      ("‘smart’ hydrogel nanoparticles" 3) ("6-coumarin-loaded nanoparticles" 2)
      ("fluorescent nanoparticles" 2) ("nanoparticles (NP)" 2)
      ("Inorganic nanoparticle" 2) ("Commercially available gold nanoparticles" 2)
      ("Magnetic Nanoparticles" 2) ("bait-loaded nanoparticles" 2)
      ("anionic nanoparticles" 2) ("nanoparticle (LENA)" 2)
      ("nanoparticle
(NP)"
       1)
      ("nanoparticles (LNP)" 1) ("showed no observable nanoparticles" 1)
      ("gambogic acid-loaded magnetic Fe 3 O 4 nanoparticles" 1)
      ("liposomal nanoparticles" 1) ("nontoxic 20 nm gold nanoparticles" 1)
      ("xref inorganic nanoparticles" 1) ("miR-132–containing nanoparticles" 1)
      ("A new class ‘smart’ nanoparticles" 1) ("nanoparticle (GNP)" 1)
      ("EasySep CD138(+) magnetic nanoparticles" 1) ("Non-enveloped LENA" 1)
      ("VSV-G-pseudotyped LENA" 1)))
    ("CHEBI:50805" (("nanorods" 2) ("nanorod" 2)))
    ("CHEBI:50826" (("silver nanoparticles" 10) ("AgNPs" 5)))
    ("CHEBI:50858"
     (("corticosteroids" 152) ("ICS" 70) ("corticosteroid" 63)
      ("Corticosteroids" 14) ("Corticosteroid" 6) ("corticosteroids (ICS)" 4)
      ("systemic corticosteroids" 2) ("systemic corticosteroid" 1)
      ("those receiving concurrent corticosteroids" 1)
      ("topical corticosteroids" 1) ("oral or intravenous corticosteroids" 1)))
    ("CHEBI:50864" (("insulin-sensitizing drug" 3)))
    ("CHEBI:50902"
     (("genotoxin" 100) ("genotoxins" 86) ("Genotoxin" 12)
      ("exogenous genotoxins" 2) ("other ubiquitous genotoxins" 2)
      ("than other genotoxins" 1) ("Genotoxins" 1) ("ubiquitous genotoxins" 1)))
    ("CHEBI:50904"
     (("allergen" 205) ("allergens" 110) ("Allergen" 6) ("Allergens" 3)
      ("at least one allergen" 2) ("segmental allergen" 2) ("a unique allergen" 2)
      ("only one outdoor allergen" 2) ("at least one common allergen" 1)
      ("clinically relevant allergens" 1) ("a clinically relevant allergen" 1)
      ("fungal allergens" 1) ("most allergens" 1) ("classical allergens" 1)
      ("allergen-" 1) ("Allergen-" 1) ("one or more specific allergens" 1)
      ("than the other outdoor allergens" 1)
      ("perennial ryegrass and Bermuda grass outdoor allergens" 1)))
    ("CHEBI:50924"
     (("sorafenib" 1435) ("Sorafenib" 444) ("BAY43-9006" 5) ("sorafinib" 3)
      ("sorafenib-" 3) ("Sorafinib" 3) ("receive sorafenib" 2)
      ("than sorafenib" 2) ("the approved systemic therapeutic drug sorafenib" 2)
      ("multispecific kinase inhibitors sorafenib" 2)
      ("failed either sorafenib" 1) ("sorafenib's" 1)
      ("previously treated non-small–cell lung cancer (NSCLC) received sorafenib"
       1)
      ("sorafenib’s" 1)))
    ("CHEBI:50978" (("boronate" 4)))
    ("CHEBI:5098" (("Flucloxacillin" 1) ("flucloxacillin" 1)))
    ("CHEBI:51026" (("macrocycle" 41) ("macrocycles" 4) ("planar macrocycles" 1)))
    ("CHEBI:51068" (("meiotic" 240) ("Meiotic" 15) ("non-meiotic" 1)))
    ("CHEBI:5107" (("Fluo-3" 30) ("fluo3" 2)))
    ("CHEBI:51088" (("trimethylsilyl" 16)))
    ("CHEBI:51097"
     (("CBZ" 22) ("benzyloxycarbonyl group" 1) ("-CBZ" 1) ("CBz" 1)))
    ("CHEBI:51118" (("-indacene" 4) ("indacene" 4)))
    ("CHEBI:51214"
     (("diamminedichloroplatinum" 15) ("-diamminedichloroplatinum" 5)
      ("diamminedichloridoplatinum" 2) ("-diamminedichloroplatinum(II)" 2)
      ("-diamminedichloroplatinum (II)" 1)))
    ("CHEBI:51217"
     (("fluorochrome" 265) ("fluorochromes" 109) ("Fluorochrome" 18)
      ("Fluorochromes" 8) ("fluorochrome-" 5) ("–fluorochrome" 3)
      ("a lipophilic fluorochrome" 2) ("fluorochrome (MEF)" 2)
      ("equivalent soluble fluorochrome" 1)
      ("a cationic lipophilic fluorochrome" 1)))
    ("CHEBI:51224" (("YOYO-1" 16) ("yoyo-1" 1))) ("CHEBI:51225" (("YO-PRO1" 3)))
    ("CHEBI:51232" (("bis-benzimide" 16)))
    ("CHEBI:51246"
     (("propidium" 2145) ("Propidium" 269) ("Cells underwent propidium" 2)))
    ("CHEBI:51277"
     (("thioester" 240) ("thioesters" 28) ("Thioester" 3) ("-thioester" 2)
      ("the respective thioester" 1)))
    ("CHEBI:51338"
     (("dendrimer" 25) ("dendrimers" 12) ("dendrimer (EDC)" 4)
      ("dendrimer macromolecules" 2)
      ("Large abiotic non-degradable polyamidoamine (PAMAM) dendrimer macromolecules"
       1)
      ("-dendrimer" 1) ("Dendrimer" 1)))
    ("CHEBI:51403" (("PPDA" 3)))
    ("CHEBI:51467"
     (("PicoGreen" 114) ("Picogreen" 33) ("picogreen" 7) ("picoGreen" 3)
      ("the fluorescent DNA dye PicoGreen" 1)))
    ("CHEBI:51474" (("FUN-1" 8) ("FUN1" 1)))
    ("CHEBI:51580"
     (("phthalocyanines" 11) ("phthalocyanine (DIGP)" 1) ("phthalocyanine" 1)))
    ("CHEBI:51602"
     (("resorufin" 33) ("highly fluorescent resorufin" 2)
      ("pink fluorescent resorufin" 1)
      ("the red fluorescent oxidation product resorufin" 1)
      ("the fluorescent compound resorufin" 1) ("fluorescent resorufin" 1)
      ("red-fluorescent resorufin" 1)))
    ("CHEBI:51625" (("indolinone" 5)))
    ("CHEBI:51686"
     (("haematoxylin" 546) ("Haematoxylin" 87) ("haematoxylin-" 4)
      ("haematoxylin (DAKO)" 3) ("DAKO" 2) ("Haematoxylin-" 2)))
    ("CHEBI:51688" (("enals" 3) ("enal" 2)))
    ("CHEBI:51689" (("enone" 8) ("enones" 7))) ("CHEBI:51874" (("Auramine" 1)))
    ("CHEBI:51903"
     (("calcein" 203) ("Calcein" 109) ("strongly green fluorescent calcein" 3)
      ("the green-fluorescent protein calcein" 2) ("dual calcein" 2)
      ("extramitochondrial calcein" 2)
      ("the gap junction-permeable dye calcein" 1)
      ("the fluorescent dye calcein" 1) ("fluorescent calcein" 1)))
    ("CHEBI:51999" (("fulvene" 1)))
    ("CHEBI:52029"
     (("DiI" 76) ("diI" 5) ("Dii" 3) ("diI-" 2) ("dII" 2)
      ("the lipophilic dye DiI" 1)))
    ("CHEBI:52032"
     (("DiO" 26) ("DIO" 10) ("Dio" 8) ("diO" 7) ("DIo" 4)
      ("cytoplasm live dye Vybrant DIO" 2)))
    ("CHEBI:52084"
     (("Indo-1" 47) ("indo-1" 11) ("the fluorescent Ca indicator Indo-1" 2)))
    ("CHEBI:52097"
     (("JC-1" 378) ("mitochondrial potential sensor JC-1" 3)
      ("The unique cationic dye JC-1" 2) ("The lipophilic cationic dye JC-1" 1)
      ("the potentiometric mitochondrial dye JC-1" 1)
      ("the cationic membrane potential indicator JC-1" 1)
      ("the potentiometric dye JC-1" 1)))
    ("CHEBI:52109" (("ethoxycarbonyl" 2)))
    ("CHEBI:52156"
     (("CMXRos" 126) ("MitoTracker Red" 53) ("Mitotracker Red" 14) ("CMXROS" 6)
      ("acidic vesicular organelles xref , and MitoTracker Red CMXRos" 1)))
    ("CHEBI:52221"
     (("isothiocyanate" 117) ("isothiocyanates" 33) ("isothiocyanate (TRITC)" 12)
      ("isothiocyanate (FITC)" 12) ("isothiocyanate (PEITC)" 6)
      ("isothiocyanate-" 4) ("a dietary isothiocyanate" 2)
      ("secondary tetramethyl rhodamine isothiocyanate-" 2)
      ("a natural dietary isothiocyanate" 2) ("Isothiocyanate (PEITC)" 2)
      ("Isothiocyanate" 2) ("the fluorescent isothiocyanate (FITC)" 1)
      ("-isothiocyanate" 1) ("A structurally-related isothiocyanate" 1)
      ("Isothiocyanates" 1)))
    ("CHEBI:52254" (("hydroxyapatite" 20) ("Hydroxyapatite" 8)))
    ("CHEBI:52282"
     (("TAMRA" 250) ("tetramethylrhodamine" 80) ("-TAMRA" 25) ("Tamra" 15)
      ("Tetramethylrhodamine" 13) ("TAMRA−" 6) ("tetramethylrhodamine (TRITC)" 2)
      ("-Tamra" 2) ("tetramethylrhodamine (TAMRA)" 1)
      ("the fluorescent dye TAMRA" 1)))
    ("CHEBI:52286" (("norbornene" 1) ("Norbornene" 1)))
    ("CHEBI:52295"
     (("cyanine" 63) ("Cyanine" 22) ("Thionine" 1) ("cyanine (ECRC)" 1)))
    ("CHEBI:52297" (("TOPRO-3" 25) ("To-Pro-3" 12) ("ToPro-3" 4)))
    ("CHEBI:52299" (("TOTO-3" 13) ("Toto-3" 2)))
    ("CHEBI:52336" (("TRITC" 306) ("TRITC-" 6)))
    ("CHEBI:52360" (("DOPC" 97) ("essentially pure DOPC" 1)))
    ("CHEBI:52479" (("imidate" 7)))
    ("CHEBI:52497" (("maneb" 8) ("Maneb" 1) ("maneb (MB)" 1)))
    ("CHEBI:52552" (("cyclohexyl" 6) ("cyclohexyl group" 1)))
    ("CHEBI:52553" (("methylphenyl" 20) ("di-methylphenyl" 4)))
    ("CHEBI:52592" (("A2PE" 5) ("the immediate precursor A2PE" 2)))
    ("CHEBI:52732" (("phallacidin" 21))) ("CHEBI:52754" (("Qdot 525" 2)))
    ("CHEBI:52755" (("QD565" 1))) ("CHEBI:52756" (("QD585" 4)))
    ("CHEBI:52757" (("QD605" 7))) ("CHEBI:52759" (("QD655" 4) ("Qdot 655" 3)))
    ("CHEBI:52760" (("QD705" 4) ("Qdot 705" 1)))
    ("CHEBI:52770" (("Succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin" 1)))
    ("CHEBI:52880" (("cyclopentyl" 15) ("cyclopentyl-" 2)))
    ("CHEBI:52884"
     (("pyridine ring" 33) ("the newly-introduced pyridine ring" 1)
      ("a 6-membered pyridine ring" 1)))
    ("CHEBI:52916" (("phenylsulfonyl" 5)))
    ("CHEBI:529996"
     (("cytochalasin D" 240) ("Cytochalasin D" 56) ("cytochalasin D–" 3)
      ("cytochalasin D-" 1)))
    ("CHEBI:53049" (("dinitrofluorobenzene" 1)))
    ("CHEBI:53063" (("TNBS" 29) ("2,4,6-trinitrobenzenesulfonic acid" 1)))
    ("CHEBI:53067" (("Tnp" 229) ("TNPs" 2)))
    ("CHEBI:53076"
     (("phox" 623) ("PHOX" 112) ("Phox" 22) ("phox (PX)" 1) ("Phox (PX)" 1)))
    ("CHEBI:53090" (("dicyclohexylcarbodiimide" 1)))
    ("CHEBI:53094" (("imidazoline" 9) ("-imidazoline" 5) ("imidazolines" 1)))
    ("CHEBI:53199" (("PAMAM" 13)))
    ("CHEBI:53213"
     (("diisocyanate" 14) ("Diisocyanates" 3) ("diisocyanates" 2)
      ("diisocyanate (HDI)" 1) ("diisocyanate (MDI)" 1) ("diisocyanate (TDI)" 1)))
    ("CHEBI:53218" (("MDI" 15)))
    ("CHEBI:53226" (("polyethylene" 134) ("Polyethylene" 5)))
    ("CHEBI:53231"
     (("polyethyleneimine" 61) ("Polyethyleneimine" 6)
      ("polyethyleneimine (PEI)" 3) ("cationic polyethyleneimine" 1) ("PEI" 1)))
    ("CHEBI:53233"
     (("MTT" 4478)
      ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide" 204)
      ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide" 44)
      ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)" 30)
      ("3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide" 14)
      ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)" 4)
      ("20% sterile-filtered 5 mg/ml MTT" 3)
      ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide" 2)
      ("a standard colorimetric MTT" 2) ("overnight using 1mg/ml MTT" 1)
      ("the colorimetric MTT" 1) ("exogenous MTT" 1) ("soluble MTT" 1) ("MTT-" 1)
      ("the yellow-colored MTT" 1)))
    ("CHEBI:53244" (("PVF" 7) ("Pvf" 3) ("PVFs" 1)))
    ("CHEBI:53245" (("PVP" 35) ("Our previous study utilized PVP" 1)))
    ("CHEBI:53248" (("polyvinylpyrrolidone" 39) ("Polyvinylpyrrolidone" 2)))
    ("CHEBI:53249"
     (("polyvinylidene" 823) ("PVDF" 29) ("Polyvinylidene" 19)
      ("PolyVinylidene" 1)))
    ("CHEBI:53251" (("Teflon" 29) ("teflon" 8)))
    ("CHEBI:53261" (("PPV" 254) ("PPVs" 11) ("“1-PPV”" 1)))
    ("CHEBI:53272" (("enediyne" 12))) ("CHEBI:53309" (("polyanions" 9)))
    ("CHEBI:53310" (("heteropolymers" 9) ("soluble tetrameric heteropolymers" 2)))
    ("CHEBI:53325"
     (("nitrocellulose" 2535) ("Nitrocellulose" 81)
      ("Hybond enhanced chemiluminescent (ECL) nitrocellulose" 2)
      ("a Western Blot nitrocellulose" 1) ("pure nitrocellulose" 1)))
    ("CHEBI:53369"
     (("polyelectrolyte" 3) ("fluorescent polyelectrolytes" 2)
      ("polyelectrolytes" 1)))
    ("CHEBI:53371"
     (("PFA" 1142) ("ice-cold 4% PFA" 1) ("fresh 4% PFA" 1)
      ("IFN-γ–treated PFA" 1) ("warm 1.85% PFA" 1)))
    ("CHEBI:53376" (("polyglutamate" 30) ("polyglutamates" 1)))
    ("CHEBI:53383"
     (("polyglycine" 12) ("the internal non-conserved polyglycine" 1)))
    #+ignore("CHEBI:53387" ;fixed to make the "PHAS" case-sensitive to hopefully block the erroneous plural 
     (("phases" 2190) ("Phases" 32) ("PHAS" 13) ("-phases" 8)
      ("all mitotic phases" 6) ("specific circadian phases" 4)
      ("different mitotic phases" 3) ("the subsequent phases" 3)
      ("both the follicular and luteal phases" 3) ("two unique phases" 3)
      ("subsequent phases" 2) ("two sequential phases" 2)
      ("aqueous and organic phases" 2)
      ("acute “inflammatory” and delayed “repair/fibrotic” phases" 2)
      ("the organic and aqueous phases" 2) ("the mid and late secretory phases" 2)
      ("allelic phases" 2) ("light and dark phases" 2)
      ("premenstrual and preovulatory phases" 2) ("progressive phases" 2)
      ("lower phases" 2) ("later mitotic phases" 2) ("four sequential phases" 2)
      ("Subsequent phases" 2) ("all circadian phases" 2) ("the latter phases" 1)
      ("secretory phases" 1) ("liquid crystalline phases" 1)
      ("more radiosensitive phases" 1) ("preparatory phases" 1)
      ("the progressive phases" 1) ("accelerated phases" 1)
      ("the stationary phases" 1) ("stationary and mobile phases" 1)
      ("the four menstrual phases" 1) ("this review confirmed menstrual phases" 1)
      ("the relative phases" 1) ("both pain behavioral phases" 1)
      ("the aqueous and organic phases" 1) ("leukemic phases" 1)
      ("the follicular and luteal phases" 1) ("menstrual phases" 1)
      ("the pathological phases" 1) ("two separate phases" 1)
      ("monitor mitotic phases" 1) ("different pathogenic phases" 1)
      ("both the acute and convalescent phases" 1) ("the secretory phases" 1)
      ("separate phases" 1) ("The premenstrual and preovulatory phases" 1)
      ("acute phases" 1) ("latter phases" 1) ("three distinct thermal phases" 1)
      ("late-secretory phases" 1)
      ("the proliferative and early secretory phases" 1) ("exponential phases" 1)
      ("the post-mitotic phases" 1) ("Six mitotic phases" 1) ("Mitotic phases" 1)
      ("mitotic phases" 1) ("posttranscriptional phases" 1)
      ("two distinct thermal phases" 1) ("two thermal phases" 1)
      ("underwent two phases" 1) ("the advanced invasive and metastatic phases" 1)
      ("later strict fibrosis-associated phases" 1) ("similar circadian phases" 1)
      ("the acute phases" 1)))
    ("CHEBI:53413"
     (("PDL" 286) ("Pdls" 16) ("PDLs" 11) ("15 more PDLs" 2) ("than 90 PDL" 1)
      ("than 20 PDL" 1) ("much fewer PDL" 1)))
    ("CHEBI:53508" (("T4s" 2)))
    ("CHEBI:53534" (("polyarginine" 8) ("Polyarginine" 4) ("polyarginines" 2)))
    ("CHEBI:53691" (("diatrizoate" 6)))
    ("CHEBI:53692" (("Hypaque" 127) ("hypaque" 12))) ("CHEBI:53705" (("axo" 1)))
    ("CHEBI:53758" (("PAP" 275) ("PAP-" 4) ("PAPs" 2) ("PAP’s" 1)))
    ("CHEBI:5385" (("gliotoxin" 30) ("Gliotoxin" 3) ("gliotoxin-" 3)))
    ("CHEBI:5417" (("glucosamine" 14) ("-glucosamine" 8) ("Glucosamine" 2)))
    ("CHEBI:5445"
     (("glyceraldehyde" 35) ("glyceraldehydes" 24) ("Glyceraldehyde" 12)
      ("Glyceraldehydes" 2) ("Glyceraldehyd" 1) ("glyceraldehyd" 1)))
    ("CHEBI:545959"
     (("HVA" 13) ("homovanillic acid" 3) ("homovanillic acid (HVA)" 3)))
    ("CHEBI:55310"
     (("PEF" 10) ("pEFS" 3)
      ("the previously described macromolecular cytosolic factor termed PEF" 2)))
    ("CHEBI:55443" (("glycin" 13) ("Glycin" 10))) ("CHEBI:55444" (("THz" 44)))
    ("CHEBI:5588" (("HBA" 4))) ("CHEBI:5626" (("harringtonine" 10)))
    ("CHEBI:566274" (("malonaldehyde" 1))) ("CHEBI:5691" (("hCBD" 51)))
    ("CHEBI:5699"
     (("polybrene" 1466) ("Polybrene" 225) ("Hexadimethrine bromide" 6)
      ("Hexadimethrine Bromide" 1)))
    ("CHEBI:57739" (("phosphatidate" 5)))
    ("CHEBI:5775" (("hydralazine" 41) ("Hydralazine" 9) ("hydralazine’s" 1)))
    ("CHEBI:58178" (("phosphatidylinositol-4-phosphate" 5)))
    ("CHEBI:58187" (("alginate" 41) ("three-dimensional chondrocyte-alginate" 2)))
    ("CHEBI:58389" (("trimethylammonium" 7) ("-trimethylammonium" 3)))
    ("CHEBI:5852"
     (("ibogaine" 9) ("than ibogaine (data not shown)" 1) ("Ibogaine" 1)))
    ("CHEBI:59062" (("polymyxin" 32) ("Polymyxin" 6) ("polymixin" 4)))
    ("CHEBI:59123" (("iodobenzoate" 3)))
    ("CHEBI:59135" (("IMDM" 381) ("fresh medium IMDM" 3) ("IMDM (ATCC)" 1)))
    ("CHEBI:59163"
     (("biomarkers" 5682) ("biomarker" 5682) ("a predictive biomarker" 132)
      ("a prognostic biomarker" 131) ("Biomarkers" 118)
      ("predictive biomarkers" 114) ("a potential biomarker" 83) ("Biomarker" 76)
      ("prognostic biomarkers" 59) ("potential biomarkers" 58)
      ("an independent prognostic biomarker" 21) ("prognostic biomarker" 20)
      ("a valuable biomarker" 19) ("predictive biomarker" 16)
      ("a diagnostic biomarker" 15) ("a potential prognostic biomarker" 15)
      ("a reliable biomarker" 14) ("reliable biomarkers" 12)
      ("robust biomarkers" 11) ("a possible biomarker" 11)
      ("a pharmacodynamic biomarker" 10) ("a potential predictive biomarker" 9)
      ("diagnostic and prognostic biomarkers" 9)
      ("a novel prognostic biomarker" 8) ("a robust biomarker" 8)
      ("potential predictive biomarkers" 8) ("a useful predictive biomarker" 7)
      ("IHC biomarkers" 6) ("diagnostic biomarkers" 6) ("relevant biomarkers" 6)
      ("Prognostic biomarkers" 6) ("contemporary biomarkers" 6)
      ("clinically relevant biomarkers" 6)
      ("prognostic and predictive biomarkers" 5) ("new predictive biomarkers" 5)
      ("few biomarkers" 5) ("new prognostic biomarkers" 5)
      ("a novel predictive biomarker" 5) ("BIOMARKERS" 5)
      ("a negative predictive biomarker" 4) ("novel prognostic biomarkers" 4)
      ("potential biomarker" 4) ("possible biomarkers" 4)
      ("a good prognostic biomarker" 4) ("a reliable prognostic biomarker" 4)
      ("oxidative stress biomarkers" 4) ("urinary biomarkers" 4)
      ("classical molecular biomarkers" 4) ("the traditional biomarker" 3)
      ("a powerful prognostic biomarker" 3) ("a possible early biomarker" 3)
      ("a valuable prognostic biomarker" 3) ("a poor prognostic biomarker" 3)
      ("mesenchymal biomarkers" 3) ("relevant protein biomarkers" 3)
      ("non-invasive imaging biomarkers" 3) ("effective prognostic biomarkers" 3)
      ("an excellent biomarker" 3) ("a few biomarkers" 3)
      ("reliable prognostic biomarkers" 3) ("an early diagnostic biomarker" 3)
      ("a serological biomarker" 3) ("no predictive biomarker" 3)
      ("a prognostic and predictive biomarker" 3)
      ("an adverse prognostic biomarker" 3) ("potential auxiliary biomarker" 3)
      ("an important prognostic biomarker" 3)
      ("potential prognostic biomarkers" 3)
      ("predictive or prognostic biomarkers" 3)
      ("an important predictive biomarker" 3)
      ("prognostic or predictive biomarkers" 3)
      ("diagnostic and prognostic molecular biomarkers" 3)
      ("a diagnostic and prognostic biomarker" 3) ("BiomARKers" 3)
      ("Predictive biomarkers" 3) ("an attractive biomarker" 3)
      ("the potential biomarkers" 3) ("new potential interacting biomarkers" 3)
      ("a prognostic and predictive NSCLC biomarker" 3)
      ("potential prognostic and predictive biomarkers" 3)
      ("robust predictive biomarkers" 3) ("cardiac biomarkers" 3)
      ("negative prognostic biomarkers" 3) ("negative predictive biomarkers" 3)
      ("diagnostic cancer biomarkers" 3)
      ("Prognostic and predictive biomarkers" 3)
      ("additional predictive biomarkers" 3) ("Few biomarkers" 2)
      ("a non-invasive and quantifiable biomarker" 2)
      ("novel diagnostic biomarkers" 2)
      ("novel prognostic and predictive biomarkers" 2)
      ("potential diagnostic and predictive biomarkers" 2)
      ("a positive predictive biomarker" 2) ("a relevant predictive biomarker" 2)
      ("very few serological biomarkers" 2)
      ("oncomorphic p53-associated biomarkers" 2) ("a relevant biomarker" 2)
      ("mechanistically-based biomarkers" 2)
      ("prespecified predictive biomarkers" 2) ("potential clinical biomarkers" 2)
      ("a gene-specific prognostic or diagnostic biomarker" 2)
      ("a cancer diagnostic biomarker" 2) ("a strong biomarker" 2)
      ("an early pharmacodynamic biomarker" 2) ("representative CSC biomarkers" 2)
      ("Reliable biomarkers" 2) ("a predictive and prognostic biomarker" 2)
      ("each biomarker’s" 2) ("a novel diagnostic and prognostic biomarker" 2)
      ("a favorable prognostic biomarker" 2) ("valuable biomarkers" 2)
      ("no available biomarkers" 2) ("still no validated biomarkers" 2)
      ("both prognostic and predictive biomarkers" 2) ("the IHC biomarkers" 2)
      ("new predictive and prognostic biomarkers" 2)
      ("a useful predictive and prognostic biomarker" 2)
      ("new diagnostic biomarkers" 2) ("treatment predictive biomarkers" 2)
      ("possible biomarker" 2) ("a potential diagnostic biomarker" 2)
      ("a
prognostic and predictive biomarker"
       2)
      ("well-characterized biomarkers" 2) ("aberrantly expressed biomarkers" 2)
      ("all the blood-based biomarkers" 2) ("a fairly new prognostic biomarker" 2)
      ("oxidative metabolic biomarkers" 2) ("a systemic biomarker" 2)
      ("an informative prognostic biomarker" 2)
      ("prognostic molecular biomarkers" 2)
      ("a recognized predictive biomarker" 2) ("well-defined biomarkers" 2)
      ("the most famous biomarker" 2) ("a urinary biomarker" 2)
      ("a circulatory prognostic biomarker" 2)
      ("candidate predictive biomarkers" 2)
      ("clinically useful prognostic biomarkers" 2)
      ("numerous well-established biomarkers" 2) ("attractive biomarkers" 2)
      ("a promising prognostic biomarker" 2) ("a diagnostic cancer biomarker" 2)
      ("a noninvasive biomarker" 2) ("causative biomarkers" 2)
      ("standard breast cancer prognostic biomarkers" 2)
      ("diagnostic and prognostic cancer biomarkers" 2)
      ("serological biomarker" 2) ("novel diagnostic and prognostic biomarkers" 2)
      ("a potential noninvasive biomarker" 2)
      ("the pathological angiogenesis biomarker" 2)
      ("a well-established biomarker" 2) ("Adequate biomarkers" 2)
      ("a negative diagnostic biomarker" 2) ("a clinically relevant biomarker" 2)
      ("targeted biomarker" 2) ("Newly developed biomarkers" 2)
      ("pleomorphic ILC biomarkers" 2) ("another prognostic biomarker" 2)
      ("correlative biomarkers" 2) ("these predictive biomarkers" 2)
      ("the immunohistochemical biomarkers" 2)
      ("a reliable predictive biomarker" 2) ("Candidate prognostic biomarkers" 2)
      ("either prognostic or predictive biomarkers" 2)
      ("Valid Genomic Biomarkers" 2)
      ("non-invasive molecular imaging biomarkers" 2)
      ("any diagnostic biomarker" 2) ("potential modifiable biomarkers" 2)
      ("modifiable biomarkers" 2) ("HER2 prognostic biomarker" 2)
      ("an independent prognostic genetic biomarker" 2)
      ("More objective biomarkers" 2) ("a valid biomarker" 2)
      ("currently no biomarkers" 2) ("potential gene biomarkers" 2)
      ("rational biomarkers" 2) ("more sensitive urinary biomarkers" 2)
      ("a potential novel melanoma biomarker" 2)
      ("a predictive or prognostic biomarker" 2) ("reproducible biomarkers" 2)
      ("a robust aging biomarker" 2) ("the most relevant molecular biomarker" 2)
      ("the most appropriate predictive biomarker" 2)
      ("better predictive biomarkers" 2) ("an early prognostic biomarker" 2)
      ("molecular-based prognostic biomarkers" 2) ("a possible new biomarker" 2)
      ("most biomarkers" 2) ("a relevant protein biomarker" 2)
      ("a diagnostic or prognostic biomarker" 2) ("“biomarkers”" 2)
      ("more reliable prognostic or predictive biomarkers" 2) ("‘biomarker’" 2)
      ("Clinically relevant biomarkers" 2)
      ("a potential diagnostic or prognostic biomarker" 2)
      ("a better predictive biomarker" 2) ("a general prognostic biomarker" 2)
      ("no prognostic biomarkers" 2) ("manual biomarker" 2)
      ("elevated cardiac biomarkers" 2) ("a Useful Non-invasive Biomarker" 2)
      ("peripheral biomarkers" 2) ("histogenetic biomarkers" 2)
      ("robust blood-based biomarkers" 2) ("the most relevant biomarkers" 2)
      ("the investigated fibrogenic EMT biomarkers" 2)
      ("the potentially useful prognostic biomarkers" 2)
      ("Typical biochemical biomarkers" 2)
      ("40 potentially prognostic biomarkers" 1)
      ("robust predictive and prognostic biomarkers" 1)
      ("a well-characterized biomarker" 1)
      ("novel diagnostic, prognostic, and predictive biomarkers" 1)
      ("important oncological biomarkers" 1) ("microbial biomarkers" 1)
      ("a novel unfavorable and independent tumor biomarker" 1)
      ("another potential biomarker" 1) ("reliable tissue biomarkers" 1)
      ("Several potential NPC biomarkers" 1) ("a prognostic tumor biomarker" 1)
      ("a new potential biomarker" 1) ("important predictive biomarkers" 1)
      ("a definitive biomarker" 1) ("even diagnostic biomarker" 1)
      ("than several other candidate biomarkers previously reported" 1)
      ("multiple autophagic biomarkers" 1) ("an archetypal biomarker" 1)
      ("no definitive tissue biomarkers" 1)
      ("finding reliable predictive biomarkers" 1)
      ("the traditional prostate cancer biomarker" 1)
      ("other static biomarkers" 1) ("a pathogenetically relevant biomarker" 1)
      ("traditional lupus-relevant serological biomarkers" 1)
      ("additional relevant biomarkers" 1) ("an oxidative stress biomarker" 1)
      ("this cytogenetic biomarker" 1) ("synergistic biomarkers" 1)
      ("One such representative biomarker" 1) ("a useful urinary biomarker" 1)
      ("a previously established WT biomarker" 1)
      ("a peripheral tumor biomarker" 1) ("no definitive predictive biomarkers" 1)
      ("the potential epigenetic biomarkers" 1)
      ("a cancer-associated biomarker" 1)
      ("a potential early pharmacodynamic biomarker" 1)
      ("very few predictive biomarkers" 1)
      ("an effective pharmacodynamic biomarker" 1)
      ("a possible early predictive biomarker" 1) ("a reasonable biomarker" 1)
      ("available biomarkers" 1) ("a clinically relevant prognostic biomarker" 1)
      ("serological biomarkers" 1) ("adverse prognostic biomarker" 1)
      ("a useful companion diagnostic biomarker" 1)
      ("finding predictive biomarkers" 1) ("accurate prognostic biomarkers" 1)
      ("novel targetable biomarkers" 1)
      ("Our findings highlight possible new biomarkers" 1)
      ("a potentially translatable biomarker" 1)
      ("Clinically robust molecular imaging biomarkers" 1)
      ("potentially translatable biomarker" 1) ("few predictive biomarkers" 1)
      ("a robust pharmacodynamic biomarker" 1) ("locally expressed biomarkers" 1)
      ("the first available plaque biomarker" 1)
      ("a relatively quantitative biomarker" 1) ("useful prognostic biomarker" 1)
      ("a minimally-invasive (as well as cell-based) biomarker" 1)
      ("minimally-invasive predictive biomarker" 1)
      ("diagnostic, prognostic and predictive biomarkers" 1)
      ("a more biologically relevant biomarker" 1)
      ("no accurate predictive biomarkers" 1) ("predictive genomic biomarkers" 1)
      ("The few proven genetic biomarkers" 1) ("this prognostic biomarker" 1)
      ("an alternative predictive biomarker" 1) ("the only mRNA biomarker" 1)
      ("alternative predictive biomarkers" 1) ("a Potential Biomarker" 1)
      ("the assessed peripheral oxidative stress biomarkers" 1)
      ("these peripheral oxidative stress biomarkers" 1)
      ("some oxidative damage plasmatic biomarkers" 1)
      ("the oxidative stress biomarkers" 1)
      ("oxidative damage peripheral biomarkers" 1)
      ("extremely complex biomarkers" 1) ("any IHC biomarker" 1)
      ("any other IHC biomarker" 1) ("Immunohistochemical biomarkers" 1)
      ("simple prognostic molecular biomarkers" 1)
      ("PDGFR pathway IHC biomarkers" 1)
      ("the senescence-associated β-galactosidase (SA-βGal) biomarker" 1)
      ("the most reproducible biomarker" 1) ("several prognostic biomarkers" 1)
      ("specific mesenchymal biomarker" 1)
      ("biomarkers that objectively identify each tumor's" 1)
      ("no robust predictive biomarkers" 1)
      ("the most relevant predictive biomarkers" 1)
      ("the most important predictive biomarker" 1)
      ("an unfavorable prognostic biomarker" 1) ("the predictive biomarker" 1)
      ("strong prognostic biomarkers" 1) ("Only 15 biomarkers" 1)
      ("a potential SOC prognostic biomarker" 1) ("mutational biomarkers" 1)
      ("A well-characterized biomarker" 1)
      ("a prognostic and
predictive biomarker"
       1)
      ("one or more biomarkers" 1)
      ("a few predictive and prognostic biomarkers" 1)
      ("predictable biomarkers" 1) ("a potential diagnostic blood biomarker" 1)
      ("predictive efficacy biomarkers" 1)
      ("a potential prognostic and predictive biomarker" 1)
      ("a strong prognosis biomarker" 1) ("glioma-specific biomarkers" 1)
      ("as well-defined biomarkers" 1) ("relevant prognostic biomarkers" 1)
      ("many actionable biomarkers" 1) ("better prognostic biomarkers" 1)
      ("the only previously noted biomarkers" 1) ("Potential Biomarkers" 1)
      ("pre-treatment predictive pharmacodynamics biomarkers" 1)
      ("treatment response pharmacodynamic biomarkers" 1)
      ("a novel promising prognostic biomarker" 1)
      ("a relevant prognostic biomarker" 1) ("selective oxidative biomarkers" 1)
      ("the most commonly studied predictive biomarkers" 1)
      ("an alternate and useful biomarker" 1) ("the first prognostic biomarker" 1)
      ("potential novel diagnostic and prognostic biomarkers" 1)
      ("the prognostic biomarker" 1) ("the univariate prognostic biomarker" 1)
      ("the optimal biomarker" 1) ("potential powerful biomarkers" 1)
      ("valuable independent biomarkers" 1) ("a novel diagnostic biomarker" 1)
      ("A reliable biomarker" 1) ("candidate potential biomarkers" 1)
      ("Various potentially predictive biomarkers" 1)
      ("a strong independent biomarker" 1) ("strongest predictive biomarker" 1)
      ("the first predictive biomarker" 1) ("a reasonable candidate biomarker" 1)
      ("a sensitive pretreatment negative predictive biomarker" 1)
      ("a valuable diagnostic biomarker" 1)
      ("a more important prognostic biomarker" 1)
      ("novel molecular prognostic biomarkers" 1)
      ("a novel prognostic and therapeutic biomarker" 1)
      ("a novel cancer pharmacogenetic biomarker" 1)
      ("no approved predictive biomarker" 1) ("potential predictive biomarker" 1)
      ("a sensitive and specific diagnostic biomarker" 1)
      ("no valid biomarkers" 1) ("xref potential biomarkers" 1)
      ("No previously defined melanoma biomarkers" 1)
      ("no minimally invasive pharmacodynamic biomarkers" 1)
      ("possible associated biomarkers" 1)
      ("a predictive therapeutic biomarker" 1)
      ("a convenient and reliable biomarker" 1) ("poor prognostic biomarkers" 1)
      ("prognostically relevant biomarkers" 1) ("other prognostic biomarkers" 1)
      ("a prognostic or theranostic biomarker" 1)
      ("a potential useful prognostic biomarker" 1)
      ("the most important established predictive biomarker" 1)
      ("an alternative diagnostic biomarker" 1) ("dependable biomarker" 1)
      ("additional clinically relevant biomarkers" 1)
      ("both a prognostic and predictive biomarker" 1) ("a typical biomarker" 1)
      ("earliest identifiable pre-neoplastic biomarkers" 1)
      ("a positive prognostic biomarker" 1) ("relevant pathway biomarkers" 1)
      ("a more reliable predictive biomarker" 1)
      ("a potential negative predictive biomarker" 1)
      ("a reproducible prognostic biomarker" 1)
      ("numerous other contemporary biomarkers" 1)
      ("the well-established biomarkers" 1)
      ("a novel and powerful prognostic biomarker" 1)
      ("the selection traditional biomarkers" 1)
      ("the respective log transformed biomarker" 1)
      ("a well-known diagnostic biomarker" 1)
      ("an important HCC-specific diagnostic biomarker" 1)
      ("more reliable molecular biomarkers" 1)
      ("a diagnostic, prognostic, or predictive biomarker" 1)
      ("specific prognostic biomarker" 1) ("potentially relevant biomarkers" 1)
      ("a reliable and robust prognostic and predictive biomarker" 1)
      ("reliable, predictive and prognostic biomarkers" 1)
      ("reliable predictive biomarkers" 1)
      ("robust
prognostic and predictive biomarker"
       1)
      ("predictive and prognostic biomarkers" 1) ("New diagnostic biomarkers" 1)
      ("novel diagnostic or predictive biomarkers" 1)
      ("diagnostic or prognostic cancer biomarkers" 1)
      ("immunohistochemical biomarker" 1) ("A predictive biomarker" 1)
      ("a valuable predictive and prognostic biomarker" 1)
      ("a potential urinary biomarker" 1) ("a solitary biomarker" 1)
      ("a possible predictive biomarker" 1) ("Cardiac biomarkers" 1)
      ("more convenient and reliable biomarkers" 1)
      ("a valuable prognosis biomarker" 1) ("a preferential biomarker" 1)
      ("further molecular prognostic biomarkers" 1)
      ("the MGMT promoter methylation status predictive biomarker" 1)
      ("an attractive candidate biomarker" 1)
      ("reliable diagnostic or prognostic biomarkers" 1)
      ("novel predictive biomarkers" 1) ("the potential predictive biomarkers" 1)
      ("these prognostic biomarkers" 1)
      ("potential common inherited biomarkers" 1) ("any prognostic biomarkers" 1)
      ("robust prognostic biomarkers" 1) ("a potential new biomarker" 1)
      ("account collective biomarker" 1) ("potential new biomarkers" 1)
      ("applicable biomarkers" 1) ("absolutely reliable biomarker" 1)
      ("a helpful biomarker" 1) ("genome-based biomarkers" 1)
      ("potential circulating biomarkers" 1) ("naive pluripotency biomarkers" 1)
      ("at least two biomarkers" 1) ("predictive tumour biomarkers" 1)
      ("a clinical prognostic biomarker" 1) ("an elegant biomarker" 1)
      ("a tumor-associated endothelial biomarker" 1)
      ("new predictive prognostic biomarkers" 1) ("a prototypic biomarker" 1)
      ("a long-term prognostic biomarker" 1)
      ("a potentially useful prognostic biomarker" 1)
      ("better predictive and prognostic biomarkers" 1)
      ("a promising predictive and prognostic biomarker" 1)
      ("a novel potential biomarker" 1) ("potential surrogate biomarkers" 1)
      ("the most commonly available biomarkers" 1)
      ("diagnostic or prognostic biomarkers" 1)
      ("clinical predictive biomarker" 1)
      ("validated prognostic molecular biomarkers" 1)
      ("the potential DNA methylation biomarkers" 1)
      ("possibly predictive biomarkers" 1)
      ("Many potential predictive biomarkers" 1) ("predicative biomarkers" 1)
      ("an important negative prognostic biomarker" 1)
      ("one strong emerging candidate biomarker" 1)
      ("surprisingly few such biomarkers" 1)
      ("a potential early warning biomarker" 1)
      ("an applicable prognostic biomarker" 1)
      ("an applicable early warning biomarker" 1) ("reliable HCC biomarkers" 1)
      ("more biomarkers" 1) ("a noninvasive prognostic biomarker" 1)
      ("systemic inflammation biomarkers" 1) ("helpful biomarkers" 1)
      ("simulation-based biomarkers" 1) ("These multicomponent biomarkers" 1)
      ("the newly developed biomarkers" 1) ("an internal exposure biomarker" 1)
      ("a new prognostic biomarker" 1) ("reliable early biomarkers" 1)
      ("finding reliable biomarkers" 1) ("pharmacodynamic (PD) biomarkers" 1)
      ("the prognostic biomarkers" 1) ("as yet no objective biomarkers" 1)
      ("a candidate prognostic biomarker" 1)
      ("an established predictive biomarker" 1)
      ("potentially useful diagnostic and prognostic biomarkers" 1)
      ("a potential additional biomarker" 1)
      ("another potential prostate cancer biomarker" 1)
      ("a potential urine biomarker" 1) ("currently no cancer cell biomarkers" 1)
      ("than other candidate biomarkers such as RNA" 1)
      ("the clinically relevant biomarkers" 1) ("at least one biomarker" 1)
      ("three potential predictive biomarkers" 1)
      ("using each potential predictive biomarker" 1)
      ("one or more CHD-related biomarkers" 1)
      ("an excellent candidate biomarker" 1) ("a clinically valuable biomarker" 1)
      ("a very attractive biomarker" 1) ("objective and precise biomarkers" 1)
      ("a “universal” or “widely-applicable” biomarker" 1)
      ("a well-established tumor biomarker" 1)
      ("putative MS IFN-β pharmacogenomic biomarkers" 1)
      ("a new DNA-based diagnostic biomarker" 1)
      ("relevant molecular biomarkers" 1) ("a generally employed biomarker" 1)
      ("employed biomarker" 1) ("a potential candidate biomarker" 1)
      ("a powerful independent predictive biomarker" 1)
      ("an accurate and independent predictive biomarker" 1)
      ("a specific histological biomarker" 1) ("more robust biomarkers" 1)
      ("a powerful negative predictive biomarker" 1)
      ("a competitive surrogate biomarker" 1) ("robust molecular biomarkers" 1)
      ("This predictive biomarker" 1)
      ("clinically relevant “pathway-specific” biomarkers" 1)
      ("inert biomarkers" 1) ("a pre-operative diagnostic biomarker" 1)
      ("no currently accepted pre-neoplastic biomarkers" 1)
      ("a potential negative biomarker" 1) ("ovarian biomarkers" 1)
      ("standard prognostic biomarkers" 1) ("a good “theranostic” biomarker" 1)
      ("such a prognostic biomarker" 1)
      ("functionally relevant molecular biomarker" 1)
      ("established predictive biomarkers" 1)
      ("a critically important diagnostic biomarker" 1)
      ("predictive (as well as prognostic) biomarkers" 1)
      ("an early diagnostic lung cancer biomarker" 1)
      ("specific reliable biomarkers" 1) ("209 potential gene biomarkers" 1)
      ("a promising predictive biomarker" 1)
      ("a candidate diagnostic biomarker" 1)
      ("pre-treatment predictive biomarkers" 1) ("a systemic blood biomarker" 1)
      ("less obvious biomarkers" 1) ("the potential prognostic biomarker" 1)
      ("a potentially valuable biomarker" 1)
      ("oncogenes present excellent biomarkers" 1)
      ("the currently developed urine biomarkers" 1) ("systemic biomarkers" 1)
      ("currently no predictive biomarkers" 1) ("associated biomarkers" 1)
      ("an important prognostic and mechanistic biomarker" 1)
      ("excellent candidate biomarkers" 1)
      ("Current leading cerebrospinal fluid (CSF) biomarkers" 1)
      ("the imaging-based vascular biomarkers" 1)
      ("imaging-based quantifiable biomarkers" 1)
      ("employing quantifiable imaging-based biomarkers" 1)
      ("a few protein biomarkers" 1) ("a predictive tissue biomarker" 1)
      ("a clinically usable biomarker" 1) ("an unexpected prognostic biomarker" 1)
      ("Easily assessable biomarkers" 1) ("cardiometabolic biomarkers" 1)
      ("potential cancer biomarkers" 1) ("these potential biomarkers" 1)
      ("Potential biomarkers" 1) ("a potent prognostic biomarker" 1)
      ("dedifferentiation-associated biomarkers" 1)
      ("a novel MPNST prognostic biomarker" 1) ("a potential MPNST biomarker" 1)
      ("one or more tissue biomarkers" 1) ("the principal biomarkers" 1)
      ("a new possible biomarker" 1) ("three different prognostic biomarkers" 1)
      ("a potential breast cancer early detection biomarker" 1)
      ("important diagnostic, prognostic and therapeutic biomarkers" 1)
      ("potential protein biomarkers" 1) ("\"biomarker\"" 1)
      ("clinically relevant biomarker" 1) ("possible predictive biomarkers" 1)
      ("an effective negative predictive biomarker" 1)
      ("ARE KRAS MUTATIONS NEGATIVE PREDICTIVE BIOMARKERS" 1)
      ("POTENTIAL PREDICTIVE BIOMARKERS" 1) ("the only potential biomarker" 1)
      ("the latter biomarkers" 1) ("excellent biomarkers" 1)
      ("a statistically independent prognostic biomarker" 1)
      ("a key determinant and putative biomarker" 1) ("this elusive biomarker" 1)
      ("several potential molecular biomarkers" 1)
      ("potential blood-based biomarkers" 1)
      ("the most investigated predictive biomarkers" 1)
      ("new progression predictive biomarkers" 1) ("a plausible biomarker" 1)
      ("immunohistochemical (IHC) biomarkers" 1)
      ("immunohistochemical biomarkers" 1) ("currently used biomarkers" 1)
      ("a vital prognostic biomarker" 1) ("the predictive biomarkers" 1)
      ("treated, and prognostic biomarkers" 1)
      ("most DNA damage response biomarkers" 1)
      ("functional biological response biomarkers" 1)
      ("the current histological biomarkers" 1)
      ("the current diagnostic and prognostic biomarkers" 1)
      ("a clinically relevant HCC biomarker" 1)
      ("a possible diagnostic biomarker" 1)
      ("clinically relevant predictive biomarkers" 1)
      ("Clinical diagnostic biomarkers" 1)
      ("no known clinically relevant biomarkers" 1)
      ("accurate predictive biomarkers" 1) ("Noninvasive biomarkers" 1)
      ("HER2over-activationare two important predictive biomarkers" 1)
      ("an easily evaluable biomarker" 1) ("than biomarkers" 1)
      ("Each IHC biomarker" 1) ("Various immunohistochemical (IHC) biomarkers" 1)
      ("a novel prognostic and predictive biomarker" 1)
      ("stronger prognostic biomarker" 1) ("a putative prognostic biomarker" 1)
      ("an available predictive biomarker" 1) ("cytogenetic biomarkers" 1)
      ("New objective diagnostic, prognostic and predictive biomarkers" 1)
      ("previously unrecognized biomarkers" 1) ("some cardiac biomarkers" 1)
      ("promising non-invasive biomarkers" 1)
      ("a clinically useful molecular prognostic biomarker" 1)
      ("a non-invasive biomarker" 1) ("several peripheral biomarkers" 1)
      ("MDD peripheral biomarkers" 1) ("this potential diagnostic biomarker" 1)
      ("a predictive cancer biomarker" 1)
      ("potential diagnostic and prognostic biomarkers" 1)
      ("potential diagnostic biomarkers" 1)
      ("a potential lung cancer biomarker" 1)
      ("a potentially important prognostic biomarker" 1)
      ("a predictive molecular biomarker" 1)
      ("diagnostic, prognostic and therapeutic biomarkers" 1)
      ("the potential biomarker" 1) ("a strong potential biomarker" 1)
      ("new potential biomarkers" 1) ("these pharmacogenetic biomarkers" 1)
      ("a potential functional SNP biomarker" 1)
      ("possible susceptibility biomarkers" 1) ("a few biomarker" 1)
      ("the most reliable biomarker" 1) ("the diagnostic biomarker" 1)
      ("diagnostic biomarker" 1) ("this predictive biomarker" 1)
      ("a minimally invasive biomarker" 1)
      ("a reliable type 2 diabetes biomarker" 1)
      ("particularly attractive biomarkers" 1)
      ("potential susceptibility biomarkers" 1)
      ("candidate prognostic and predictive biomarkers" 1)
      ("predictive and prognostic biomarker" 1) ("more potential biomarkers" 1)
      ("blood-based biomarkers" 1) ("molecular predictive biomarkers" 1)
      ("classical disease biomarkers" 1) ("a few well established biomarkers" 1)
      ("investigative CRC biomarkers" 1) ("blood-based peripheral biomarkers" 1)
      ("any peripheral biomarker" 1) ("Additional prognostic biomarkers" 1)
      ("a potential early biomarker" 1) ("potential early biomarker" 1)
      ("still lacks enough appropriate biomarkers" 1)
      ("Gpc3 as well-established HCC biomarkers" 1)
      ("more robust prognostic biomarkers" 1)
      ("immoderate serum cancer-related biomarkers" 1)
      ("virtually no biomarkers" 1) ("most tumor biomarkers" 1)))
    ("CHEBI:5922" (("ingenols" 2)))
    ("CHEBI:59520"
     (("N-glycans" 60) ("N-glycan" 6) ("only immature N-glycans" 1)))
    ("CHEBI:59521"
     (("O-glycans" 24) ("O-glycan" 8) ("Aberrantly expressed O-glycans" 1)
      ("The resultant short core region O-glycans" 1)))
    ("CHEBI:59640"
     (("N-acetylglucosamine" 29) ("-N-acetylglucosamine" 3)
      ("O -linked β -N-acetylglucosamine" 3) ("N-Acetylglucosamine" 1)))
    ("CHEBI:59681" (("lipophosphoglycan" 5)))
    ("CHEBI:59739"
     (("electrophiles" 146) ("electrophile" 70) ("Electrophile" 3)
      ("Electrophiles" 3) ("–electrophile" 3) ("larger electrophile" 2)
      ("bifunctional electrophiles" 2) ("These bifunctional electrophiles" 2)
      ("improved neuroprotective electrophiles" 1)
      ("toxic reactive electrophiles" 1)))
    ("CHEBI:59740" (("nucleophiles" 11) ("biological nucleophiles" 1)))
    ("CHEBI:59826"
     (("progestin" 256) ("progestins" 46) ("Progestin" 6) ("Progestins" 1)))
    ("CHEBI:59941"
     (("amphiphiles" 116) ("amphiphile" 41) ("Amphiphiles" 4)
      ("single-tailed amphiphiles" 2) ("a cationic amphiphile molecule" 2)
      ("single-tailed peptide amphiphiles" 1) ("monomeric peptide amphiphiles" 1)
      ("endolysosomal-disrupting peptide amphiphiles" 1)
      ("amphiphile molecule" 1)))
    ("CHEBI:59962" (("argpyrimidine" 4)))
    ("CHEBI:60004"
     (("mixture" 12406) ("mixtures" 1862) ("Mixture" 126) ("Mixtures" 29)
      ("a heterogeneous mixture" 18) ("an equimolar mixture" 11)
      ("the combined osteogenic mixture" 7) ("the resultant mixture" 5)
      ("a racemic mixture" 4) ("compatible packaging plasmids mixture" 4)
      ("The resultant mixture" 4) ("a highly complex mixture" 4)
      ("2× TaqMan® Universal Master Mixture" 3) ("subclonal mixtures" 3)
      ("mixture (PSN)" 3) ("Resultant mixture" 3) ("mixture (PSA)" 3)
      ("Complete Mini Protease Inhibitor Mixture" 3)
      ("an inspiratory gas mixture" 3) ("compatible packaging plasmid mixture" 3)
      ("a 20 µM equimolar mixture" 2)
      ("a proprietary fibronectin/collagen (FNC) mixture" 2)
      ("1% complete medium agar mixture" 2) ("racemic mixtures" 2)
      ("the peptic peptide mixture" 2) ("The secondary antibody mixture" 2)
      ("glacial acetic acid mixture" 2) ("lentiviral packaging plasmid mixture" 2)
      ("The soluble mixtures" 2) ("fluorescent-tagged antibody mixtures" 2)
      ("Equimolar mixtures" 2) ("antibiotic-antimycotic mixture" 2)
      ("a commercial protease inhibitor mixture" 2)
      ("a 25 ml quantitative PCR reaction mixture" 2)
      ("80 nmol/L siRNA duplex mixture" 2)
      ("The resulting tryptic peptide mixtures" 2)
      ("a quantitative PCR reaction mixture" 2)
      ("Complete Mini protease inhibitor mixture" 2) ("a gaseous mixture" 2)
      ("a well-standardized decaffeinated green tea catechin mixture" 2)
      ("a green tea-derived catechin mixture" 2)
      ("an internal standard mixture" 2) ("An equimolar mixture" 2)
      ("co-mixture" 2) ("Typical assay mixtures" 2)
      ("ice-cold methanol-acetone mixture" 2)
      ("non-essential amino-acid mixture" 2)
      ("Matrigel—a proteinaceous mixture" 2) ("the Basic Mixture" 2)
      ("an irregular mixture" 2) ("A typical incubation mixture" 2)
      ("mixtures (QIAGEN)" 2) ("the exogenous mixture" 2)
      ("the Ultra SYBR Mixture" 2) ("a genome-wide mixture" 2)
      ("polymorphic mixtures" 1) ("1:1 mixture of DME and Ham's" 1)
      ("a 1:1 mixture of DME and Ham's" 1) ("a 1:1 mixture of Ham’s" 1)
      ("quantitative PCR reaction mixture" 1)
      ("the combined neural induction mixture" 1)
      ("The combined neural induction mixture" 1)
      ("the combined myoblastic induction mixture" 1)
      ("The combined osteogenic induction mixture" 1)
      ("A typical acetylation reaction mixture" 1) ("mixture (TOYOBO)" 1)
      ("beta-uniform mixture" 1) ("a beta-uniform mixture (BUM)" 1)
      ("mixtures (CM)" 1) ("8-peak fluorescent bead mixtures" 1)
      ("The tryptic peptide mixtures" 1)
      ("soluble and insoluble protein mixture" 1)
      ("ice-cold 50% methanol–50% acetone mixtures" 1)
      ("the secondary antibody mixture" 1) ("a homogenous mixture" 1)
      ("viral supernatant/DOTAP mixture" 1) ("a tri-hybrid ethnic mixture" 1)
      ("the unique mixture" 1) ("a 1:1 mixture of Ham's" 1)
      ("growth medium 1:1 mixture of Ham's" 1)
      ("antibiotic–antimycotic mixture" 1) ("pure JNKs reaction mixture" 1)
      ("a potentially nonphysiological mixture" 1) ("PI-pure lipid mixtures" 1)
      ("the BUM (beta-uniform mixture" 1) ("The soluble peptide mixtures" 1)
      ("the subclonal mixture" 1)
      ("cryogenically cold 80% methanol/water mixture" 1)
      ("the protein/compound/substrate mixture" 1)
      ("the former plasmid mixture" 1)
      ("an optimized quantitative reverse transcription-PCR (qRT-PCR) mixture" 1)
      ("the respective isotype‐labeled mixture" 1)
      ("a well-standardized green tea catechin mixture" 1)
      ("a well-defined green tea-derived catechin mixture" 1)
      ("a crude mixture" 1) ("an antibiotic –antimycotic mixture" 1)
      ("the heterogeneous mixture" 1)
      ("×200)/Control siRNA (200 nM) mixture and siIMPORTER (×200)/CTNNB1 (200 nM) mixture"
       1)
      ("racial mixture" 1) ("a neutral lipid mixture" 1)
      ("p NPP reaction mixture" 1) ("serial dilution mixtures" 1)
      ("no commercially available mixture" 1)
      ("1:1 (v/v) DMSO/NaHCO 3 buffer (50 mM, pH 8.5) mixture" 1)
      ("the magnetic bead-RNA mixture" 1) ("their spectral mixture" 1)
      ("the tryptic peptide mixtures" 1)
      ("2 mM glutamine and 10% (v/v) of a 2:1 mixture" 1)
      ("nutrient mixture of Ham’s" 1) ("crude reaction mixture" 1)
      ("the much more complex protein mixtures" 1)
      ("400 μl blood-saline mixture" 1) ("This conformational mixture" 1)
      ("heterogeneous tumor cell mixtures" 1) ("a commercial siRNA mixture" 1)
      ("Tryptic peptide mixtures" 1) ("this heterogenous mixture" 1)
      ("the resulting aqueous mixture" 1) ("an unremarkable mixture" 1)
      ("the resulting pale-yellow mixture" 1)
      ("a typical real-time PCR reaction mixture" 1)
      ("The resultant cDNA mixtures" 1) ("1% Amphotericin B. A mixture" 1)
      ("an approximate 50/50 mixture" 1) ("Inconsistent mixtures" 1)
      ("The deglycosylated peptide mixture" 1)
      ("mutant p53 form heterogeneous mixtures" 1) ("biological mixtures" 1)
      ("stoichiometric mixtures" 1) ("tryptic peptide mixtures" 1)
      ("tryptic peptides mixtures" 1) ("the nucleolar protein mixture" 1)
      ("The resultant reaction mixture" 1) ("separate mixtures" 1)
      ("The extracted tryptic peptide mixtures" 1)
      ("highly heterogeneous mixtures" 1) ("a β-uniform mixture" 1)
      ("a 1∶1 mixture of Ham’s" 1)))
    ("CHEBI:60027"
     (("polymer" 906) ("polymers" 377) ("Polymer" 211) ("Polymers" 6)
      ("4.5% POP Conformational Analysis Polymer" 3) ("brown polymer" 2)
      ("had fewer microtubule polymers" 2) ("polymers (PARP)" 2) ("-polymer" 2)
      ("polymer (PAR)" 2) ("a rigid polymer" 2) ("polymer-" 2)
      ("a tertiary anti-rabbit polymer" 2) ("the negatively-charged polymer" 2)
      ("a dense intermediate filament polymer" 2)
      ("two different poly(methyl methacrylate)-graft-poly(ethylene oxide) (PMMA-g-PEO) comb polymers"
       2)
      ("cationic polymer" 2) ("single stranded nucleic acid polymers" 2)
      ("acetylated α-tubulin polymers" 2) ("a flexible polymer" 2)
      ("4 °C. A horseradish peroxidase-labeled polymer" 2)
      ("cationic polyethylenimine polymer" 2) ("a strong hydrophilic polymer" 2)
      ("an artificial polymer" 1) ("osmiophilic DAB polymer" 1)
      ("an osmiophilic electron-dense polymer" 1)
      ("its associated branched PAR polymer" 1)
      ("GSK-3β pre-phosphorylated tau polymers" 1)
      ("biodegradable cationic polymers" 1)
      ("a biocompatible and biodegradable polymer" 1)
      ("Dako EnVision-labeled polymer" 1) ("polymers (PAR)" 1)
      ("PMMA-g-PEO diluent polymer" 1)
      ("xref macromolecular synthetic polymers" 1) ("a filamentous polymer" 1)
      ("than PAR polymer" 1) ("a capillary containing POP-4 polymer" 1)
      ("fluorescent polymer" 1) ("Exogenous HA polymer" 1)
      ("a flexible 9.5 nm-long PEG polymer" 1) ("a pure β-(1,3)-glucan polymer" 1)
      ("MACH 2 Universal HRP-labeled polymer" 1)))
    ("CHEBI:60029" (("homopolymers" 12) ("Homopolymers" 2)))
    ("CHEBI:60151" (("oxLDLs" 15) ("oxidised LDL" 1)))
    ("CHEBI:60320" (("PEIPC" 21)))
    ("CHEBI:60325" (("XMD8-92" 40) ("XMD8-92 (XMD)" 1)))
    ("CHEBI:60430" (("monolyso-CL" 1)))
    ("CHEBI:60479"
     (("lysophosphatidylcholine" 16) ("Lysophosphatidylcholine" 6)
      ("lyso-phosphatidylcholine" 4) ("lysophosphatidylcholine (LPC)" 1)))
    ("CHEBI:60567"
     (("TMA" 3302) ("TMAs" 1210) ("available TMA" 12) ("One custom-made TMA" 3)
      ("the recipient TMA" 2) ("Commercially available human prostate TMA" 2)
      ("the commercial TMA" 2) ("Previously constructed TMAs" 2) ("smaller TMA" 2)
      ("a commercial glioma TMA" 2) ("serial TMA" 2) ("a recipient TMA" 2)
      ("Haematoxylin–eosin-stained TMA" 2) ("no more TMA" 1)
      ("the minimum and maximum TMA" 1) ("Previously assembled TMAs" 1)
      ("TMA (CT)" 1) ("the four TMA's" 1) ("consecutive 4-μm FFPE TMA" 1)
      ("the commercial TMAs" 1) ("IHC stained TMA" 1) ("The digital TMA" 1)
      ("9 colorectal TMAs" 1) ("13 gastric TMAs" 1) ("the ovarian tumor TMA" 1)
      ("the high-grade serous ovarian TMA" 1) ("an endometrial carcinoma TMA" 1)
      ("freshly cut TMA" 1) ("a retrospective prostate cancer TMA" 1)
      ("Freshly cut TMA" 1) ("At least 2 TMA" 1) ("A commercial TMA" 1)
      ("the non-adenoid cystic salivary gland TMA" 1)
      ("two commercially available TMAs" 1) ("representative TMA" 1)
      ("benign TMA" 1) ("our TMA’s" 1) ("four commercial TMAs" 1)
      ("two custom-made TMAs" 1) ("previously described  xref  Index TMAs" 1)
      ("a commercial TMA" 1) ("each recipient TMA" 1) ("IHC-stained human TMA" 1)
      ("lost TMA" 1) ("Two commercial PCa TMAs" 1) ("commercial TMAs" 1)
      ("the TMA's" 1) ("previously described single-patient TMAs" 1)
      ("ten previously generated HGA TMAs" 1)))
    ("CHEBI:60604"
     (("RITC" 65) ("rhodamine B isothiocyanate" 2)
      ("Rhodamine B isothiocyanate-" 1) ("Rhodamine B isothiocyanate" 1)))
    ("CHEBI:60657" (("dAPC" 44))) ("CHEBI:60739" (("SGPG" 107)))
    ("CHEBI:60809"
     (("adjuvant" 3094) ("Adjuvant" 120) ("co-adjuvant" 2)
      ("a possible adjuvant" 1) ("a potential chemotherapeutic adjuvant" 1)
      ("adjuvant (CFA)" 1) ("auto-adjuvant" 1) ("a potential adjuvant" 1)
      ("a diagnostic adjuvant" 1)
      ("a relatively universal therapeutic adjuvant" 1)))
    ("CHEBI:60815"
     (("lysobisphosphatidic acid (LBPA)" 3) ("lysobisphosphatidic acid" 3)
      ("the unconventional phospholipid lysobisphosphatidic acid (LBPA)" 2)))
    ("CHEBI:60816"
     (("immunogen" 134) ("immunogens" 32) ("the representative immunogens" 2)
      ("whose immunogen" 1) ("harmful exogenous immunogens" 1)
      ("harmless immunogens" 1) ("the respective immunogen" 1)
      ("the unique immunogens" 1) ("some other vaccine-relevant immunogens" 1)
      ("an unusually problematic immunogen" 1)))
    ("CHEBI:60831" (("epothilone" 17) ("epothilones" 8)))
    ("CHEBI:60888" (("BAPTA" 215) ("Bapta" 4) ("BAPTA-" 2)))
    ("CHEBI:60911" (("racemate" 3))) ("CHEBI:61000" (("erythrosine" 5)))
    ("CHEBI:61014" (("PD123319" 5))) ("CHEBI:6102" (("kallidin" 3)))
    ("CHEBI:61049" (("FK-506" 8)))
    ("CHEBI:61115"
     (("HDACi" 484) ("HDACIs" 235) ("HDACis" 225) ("HDACI" 175)
      ("A far more potent HDACI" 2) ("Hydroxamic acid HDACis" 2)
      ("the optimal HDACI" 2) ("most HDACIs" 2) ("the clinic HDACi" 1)
      ("the so-called HDACi" 1) ("than 25 HDACis" 1)
      ("a novel cinnamic hydroxamic acid HDACi" 1) ("many more HDACi" 1)
      ("HDACi's" 1) ("classical HDACis" 1) ("a widely use HDACi" 1)
      ("traditional HDACIs" 1) ("at least 11 other HDACIs" 1) ("Most HDACIs" 1)))
    ("CHEBI:61151" (("pADPr" 44) ("biotinylated pADPr" 1)))
    ("CHEBI:61311" (("RB5" 4) ("Rb5" 1))) ("CHEBI:61353" (("PDPA" 6)))
    ("CHEBI:61360" (("Globoside" 3) ("globoside" 1)))
    ("CHEBI:61448" (("IPTG" 1167)))
    ("CHEBI:61595" (("p-nitrophenyl" 21) ("p-Nitrophenyl" 5)))
    ("CHEBI:61822" (("PGPC" 33)))
    ("CHEBI:62034"
     (("-CMG" 122) ("CMG" 71)
      ("the presumed promutagenic lesion ( xref ) O  6 -CMG" 1)))
    ("CHEBI:62107"
     (("CMH" 36) ("cmH" 9) ("a one-sided CMH" 1) ("a two-tailed CMH" 1)
      ("a one-tailed CMH" 1)))
    ("CHEBI:62167" (("TAME" 85) ("TAME’s" 1)))
    ("CHEBI:62501"
     (("folate" 938) ("Folate" 33) ("dietary folate" 20) ("folates" 14)
      ("total dietary folate" 3) ("Dietary folate" 2) ("acute folate" 2)
      ("only total folate" 2) ("Folates" 2) ("maternal serum folate" 1)
      ("Adequate dietary folate" 1) ("Folate-" 1) ("Dietary folates" 1)
      ("High dietary folate" 1)))
    ("CHEBI:62571" (("SSEA3" 17)))
    ("CHEBI:62801"
     (("ethyl" 264) ("Ethyl" 11) ("-ethyl" 6) ("-Ethyl" 3) ("ethyl-" 2)))
    ("CHEBI:62913"
     (("PARP inhibitors" 660) ("PARP inhibitor" 591)
      ("a clinically relevant PARP inhibitor" 4) ("PARP Inhibitor" 3)
      ("PARP
inhibitors"
       2)
      ("Parp inhibitor" 2) ("brain permeable PARP inhibitors" 1)
      ("two potent competitive PARP inhibitors" 1)
      ("their next generation PARP inhibitor" 1) ("the PARP inhibitor's" 1)
      ("most PARP inhibitors" 1)))
    ("CHEBI:62932" (("mycophenolate" 23)))
    ("CHEBI:63016"
     (("NP40" 1151) ("nonyl phenoxypolyethoxylethanol" 3)
      ("Nonyl phenoxypolyethoxylethanol" 2) ("NP40-" 1) ("Np40" 1)))
    ("CHEBI:63080" (("PBS57" 3)))
    ("CHEBI:63134" (("GAAAA" 32) ("the PD-associated haplotype GAAAA" 2)))
    ("CHEBI:63153" (("N-acetyl-D-mannosamine" 1) ("ManNAc" 1)))
    ("CHEBI:63213" (("TCEP" 310) ("resin-bound TCEP" 2)))
    ("CHEBI:63247"
     (("reducing agent" 154) ("reducing agents" 42) ("Reducing Agent" 39)
      ("reductant" 34) ("DTE" 29) ("reductants" 24) ("Reducing Agents" 3)
      ("a strong reducing agent" 2) ("a nonpermeable reducing agent" 2)
      ("the principal intracellular reductant" 2) ("water soluble reductants" 1)
      ("membrane-impermeable reducing agents" 1) ("reducing agent (DTE)" 1)))
    ("CHEBI:63248"
     (("oxidant" 713) ("oxidants" 308) ("Oxidant" 13) ("Oxidants" 11)
      ("membrane permeable oxidants" 2) ("phagocytic oxidants" 1)
      ("hypohalous acid oxidants" 1) ("The anti oxidant molecule" 1)
      ("strong oxidants" 1) ("deliberate oxidants" 1)
      ("inhaled cigarette smoke-derived oxidants" 1) ("exogenous oxidants" 1)
      ("organometallic oxidants" 1)))
    ("CHEBI:63533" (("GnRHa" 26)))
    ("CHEBI:63534" (("monoamine" 16) ("monoamines" 7) ("Monoamine" 6)))
    ("CHEBI:63618" (("pravastatin" 25) ("Pravastatin" 3)))
    ("CHEBI:63744" (("NBE" 4) ("NbE" 1))) ("CHEBI:63747" (("nPE1" 8)))
    ("CHEBI:63959"
     (("celastrol" 276) ("Celastrol" 200) ("Celastrol’s" 2)
      ("we first used TAK1 inhibitor Celastrol" 1) ("the Celastrol’s" 1)
      ("further highlights Celastrol’s" 1) ("further highlights Celastrol" 1)
      ("even 0.05 µM Celastrol" 1) ("evaluated Celastrol’s" 1)))
    ("CHEBI:64090"
     (("t-BHP" 47) ("TBH" 24) ("tert-Butyl hydroperoxide" 11)
      ("tert-butyl hydroperoxide" 10) ("10 mM TBH" 5) ("Exogenous t-BHP" 1)
      ("the exogenous oxidant t-BHP" 1) ("Tert-butyl hydroperoxide" 1)
      ("tert-butyl hydroperoxide (TBH)" 1)))
    ("CHEBI:641" (("MPP+" 26))) ("CHEBI:6415" (("LLY" 5)))
    ("CHEBI:64210" (("AM580" 53) ("Am580" 4)))
    ("CHEBI:64213" (("cantharidin" 38) ("Cantharidin" 6)))
    ("CHEBI:64276"
     (("glutaraldehyde" 804) ("Glutaraldehyde" 19)
      ("0.5% ice-cold glutaraldehyde" 2) ("2.5% neutral glutaraldehyde" 2)
      ("4% paraformaldehyde/0.2% picric acid/0.05% glutaraldehyde" 2)
      ("ice-cold glutaraldehyde" 2) ("glutaraldehyde (GLD)" 1)
      ("2% (v/v) formaldehyde/0.2%  (v/v) glutaraldehyde" 1)
      ("residual glutaraldehyde" 1)))
    ("CHEBI:64317" (("isoprenaline" 26)))
    ("CHEBI:6432" (("levamisole" 24) ("aqueous 0.2 mM levamisole" 1)))
    ("CHEBI:64459" (("biaryl" 5)))
    ("CHEBI:6446"
     (("letter" 235) ("letters" 200) ("Letters" 6) ("Letter" 4)
      ("capital letters" 3) ("bold letters" 2) ("the rebuttal letter" 2)
      ("an introductory letter" 2) ("Bold letters" 2) ("bold uppercase letters" 1)
      ("mails annual follow-up letters" 1) ("Capital letters" 1)
      ("referral letter" 1) ("the capital letters" 1)))
    ("CHEBI:64482"
     (("phosphatidylcholine" 105) ("phosphatidylcholine (PC)" 9)
      ("Phosphatidylcholine" 5) ("phosphatidylcholines" 2)
      ("Phosphatidylcholines" 2) ("radioactively-labeled phosphatidylcholine" 2)
      ("only neutral lipids phosphatidylcholine (PC)" 2)
      ("phosphatidylcholines (PC)" 1) ("C-14-labeled phosphatidylcholine" 1)))
    ("CHEBI:64583"
     (("sphingomyelin" 78) ("Sphingomyelin" 10) ("sphingomyelin-" 1)
      ("Sphingomyelin (SFM)" 1) ("-Sphingomyelin" 1)))
    ("CHEBI:64645"
     (("amyloid-β" 89) ("beta-amyloid" 39) ("Amyloid-β" 8) ("soluble amyloid-β" 2)
      ("pathologic amyloid-β" 1) ("insoluble amyloid-β" 1)
      ("the neurotoxic
                            peptide amyloid-β"
       1)
      ("Beta-amyloid" 1)))
    ("CHEBI:64743" (("MLCL" 9)))
    ("CHEBI:64909"
     (("poison" 201) ("topo II poison" 4) ("Topo II poison" 2) ("Poison" 1)
      ("any mitotic poison" 1) ("mitotic poison" 1)
      ("a transcriptional poison" 1)))
    ("CHEBI:64911"
     (("antimitotic" 88) ("anti-mitotic" 42) ("Antimitotic" 16) ("antimitotics" 8)
      ("anti-mitotics" 2)))
    ("CHEBI:6497" (("lipoxins" 16) ("Lipoxin" 14) ("lipoxin" 7)))
    ("CHEBI:6498" (("Lipoxin A4" 2)))
    ("CHEBI:65308"
     (("S-nitrosothiols" 13) ("S-nitrosothiol" 2) ("S-Nitrosothiol" 1)))
    ("CHEBI:6617"
     (("mega" 37) ("Mega" 18) ("MEGA" 11) ("a few mega" 1)
      ("the typical mega" 1)))
    ("CHEBI:6636"
     (("MgCl2" 745) ("MgCL2" 9) ("Mgcl2" 3) ("magnesium dichloride" 3)
      ("mgCl2" 2)))
    ("CHEBI:67011" (("folates" 27) ("Folates" 2)))
    ("CHEBI:67016"
     (("tetrahydrofolate" 58) ("-tetrahydrofolate" 2) ("Tetrahydrofolate" 1)))
    ("CHEBI:67194"
     (("cannabinoids" 33) ("cannabinoid" 19) ("non-psychoactive cannabinoid" 2)
      ("Cannabinoids" 1) ("Cannabinoid" 1) ("neutral cannabinoids" 1)))
    ("CHEBI:67197"
     (("endocannabinoid" 23) ("endocannabinoids" 11) ("Endocannabinoid" 4)
      ("Endocannabinoids" 3)))
    ("CHEBI:67559"
     (("5Z-7-oxozeaenol" 71) ("5z-7-oxozeaenol" 9)
      ("the commercially available inhibitor 5Z-7-oxozeaenol" 3)
      ("The resorcylic acid lactone 5Z-7-oxozeaenol" 2)))
    ("CHEBI:68481"
     (("mTOR inhibitors" 1509) ("mTOR inhibitor" 923) ("MTOR inhibitor" 25)
      ("MTOR inhibitors" 16) ("an ATP-competitive mTOR inhibitor" 8)
      ("mTor inhibitor" 7) ("ATP-competitive mTOR inhibitors" 5)
      ("the ATP-competitive mTOR inhibitors" 4)
      ("a novel clinically relevant mTOR inhibitor" 4)
      ("currently used mTOR inhibitors" 3)
      ("mTOR
inhibitors"
       3)
      ("a selective ATP-competitive mTOR inhibitor" 2)
      ("an orally bioavailable mTOR inhibitor" 2) ("dual mTOR inhibitors" 2)
      ("the only first-generation mTOR inhibitor" 2)
      ("the ATP-competitive mTOR inhibitor" 2)
      ("indirect (e.g., metformin) mTOR inhibitors" 2)
      ("a second-generation ATP-competitive mTOR inhibitor" 2)
      ("pharmacologic mTOR inhibitors" 2) ("mTOR INHIBITOR" 2)
      ("the potent and specific pharmacologic mTor inhibitor" 2)
      ("recently developed potent and specific mTOR inhibitors" 2)
      ("mTor inhibitors" 2) ("than the conventional allosteric mTOR inhibitor" 1)
      ("than mTOR inhibitors" 1) ("this dual mTOR inhibitor" 1)
      ("targeted mTOR inhibitors" 1)
      ("ATP-competitive and selective mTOR inhibitors" 1)
      ("pyrazolopyrimidine ATP-competitive mTOR inhibitors" 1)
      ("a prototypic mTOR inhibitor" 1)
      ("endometrial tumors several mTOR inhibitors" 1)
      ("a recently developed mTOR inhibitor" 1)
      ("all non-mTORC2-specific mTOR inhibitors" 1) ("pure mTOR inhibitors" 1)))
    ("CHEBI:68686" (("PRPN" 3) ("Prpn" 1)))
    ("CHEBI:69120"
     (("WA" 707) ("wA" 19) ("Withaferin A" 17) ("Wa" 12) ("wa" 10)
      ("withaferin A" 9) ("Withaferin A (WA)" 2)
      ("The 28-carbon steroidal lactone withaferin A" 2) ("Hummerdal wa" 2)))
    ("CHEBI:6925" (("microcystin-LR" 45) ("Microcystin-LR" 5)))
    ("CHEBI:6980"
     (("monocrotaline" 24) ("Monocrotaline" 8) ("monocrotaline (MCTP)" 1)))
    ("CHEBI:69818" (("prostratin" 118) ("Prostratin" 20) ("the prostratin's" 1)))
    ("CHEBI:70851" (("Opa" 75) ("opa" 1) ("OPAs" 1) ("Opa-" 1)))
    ("CHEBI:71212" (("prohormone" 24) ("prohormones" 4)))
    ("CHEBI:71223" (("pralatrexate" 6))) ("CHEBI:71429" (("KDN" 15) ("kdN" 1)))
    ("CHEBI:71464" (("PEA" 23) ("peas" 2))) ("CHEBI:71543" (("rotenoid" 3)))
    ("CHEBI:72010" (("flavanols" 9) ("flavanol" 6) ("Flavanols" 2)))
    ("CHEBI:72564"
     (("TMZ" 2042) ("temozolomide" 794) ("Temozolomide" 82)
      ("temozolomide (TMZ)" 28) ("concurrent temozolomide" 6) ("concurrent TMZ" 3)
      ("the chemotherapeutic agent temozolomide" 2) ("dose-dense TMZ" 2)
      ("the standard chemotherapeutic agent TMZ" 2)
      ("the AAV-hIFN-β treated cohorts received 2.5 mg TMZ" 2)
      ("Temozolomide (TMZ)" 2) ("the chemotherapeutic agents temozolomide" 2)
      ("TMZ-" 2) ("concurrent and sequential TMZ" 1)
      ("The DNA methylating agent temozolomide (TMZ)" 1)
      ("sequential non-therapeutic low dose TMZ" 1)
      ("than the currently used chemotherapeutic drug TMZ" 1)
      ("the currently used chemotherapeutic drug TMZ" 1) ("sequential TMZ" 1)
      ("most studies employed 200 μM TMZ" 1) ("TMZ’s" 1)
      ("empiric temozolomide" 1) ("further demonstrated TMZ" 1)
      ("DNA methylating agent Temozolomide" 1)
      ("all glioblastoma patients receive TMZ" 1) ("at least concomitant TMZ" 1)
      ("subsequent in vivo TMZ" 1) ("‘TMZ’" 1)
      ("whose treatment regimen included TMZ" 1)))
    ("CHEBI:72568" (("MTIC" 8))) ("CHEBI:72583" (("WR1065" 1)))
    ("CHEBI:72598" (("Ga13" 1))) ("CHEBI:72813" (("exopolysaccharide" 1)))
    ("CHEBI:7307" (("NMP" 28)))
    ("CHEBI:73156"
     (("TCO" 14) ("trans-cyclooctene" 12) ("trans-cyclooctenes" 2) ("TcO" 2)))
    ("CHEBI:73195" (("concanamycin" 22) ("Concanamycin" 7)))
    ("CHEBI:73283" (("CGS21680" 1))) ("CHEBI:73284" (("NECA" 22)))
    ("CHEBI:73321" (("AAS" 16) ("Aas" 2) ("aas" 1)))
    ("CHEBI:73458" (("NS-398" 429)))
    ("CHEBI:73493" (("EEE" 71) ("Glu-Glu-Glu" 1)))
    ("CHEBI:73516" (("Gly-Ser" 9) ("GlySer" 3) ("Gly–Ser" 1)))
    ("CHEBI:73563" (("LDS" 178) ("lds" 1))) ("CHEBI:73569" (("LLS" 26)))
    ("CHEBI:73576" (("LVD" 35) ("“LVD”" 1))) ("CHEBI:73577" (("LVG" 2)))
    ("CHEBI:73600" (("Lys-Gln" 4))) ("CHEBI:73611" (("Met-Gly" 9)))
    ("CHEBI:73646" (("ProPro" 19) ("Pro-Pro" 3)))
    ("CHEBI:73656" (("TAH" 2) ("Tah" 1)))
    ("CHEBI:73662" (("Thr-Pro" 80) ("Thr–Pro" 3) ("Thr-pro" 1) ("thr-pro" 1)))
    ("CHEBI:73669" (("LTQ" 307)))
    ("CHEBI:73702"
     (("wax" 225) ("Wax" 5) ("orthodontic wax" 2) ("waxes" 2)
      ("a pre-molded recipient paraffin wax" 1) ("a recipient paraffin wax" 1)
      ("Representative paraffin wax" 1)))
    ("CHEBI:73811"
     (("ArgArg" 45) ("Arg-Arg" 12) ("the homozygous Arg-Arg" 2) ("Arg-Arg-" 1)))
    ("CHEBI:73816" (("Arg-Lys" 5) ("Arg-Lys ( RK )" 1)))
    ("CHEBI:73828" (("Asp-Glu" 48) ("Asp–Glu" 1)))
    ("CHEBI:73837"
     (("AGG" 757) ("-AGG" 40) ("agg" 37) ("-agg" 5) ("‘AGG’" 4) ("AGg" 1)))
    ("CHEBI:73890" (("Gly-Cys" 2)))
    ("CHEBI:73899"
     (("GGA" 968) ("-GGA" 87) ("gga" 36) ("GGa" 7) ("-gga" 6) ("GGAs" 6)
      ("ggA" 1)))
    ("CHEBI:73902" (("GGI" 21)))
    ("CHEBI:73913"
     (("antifolate" 90) ("antifolates" 67) ("Antifolates" 4)
      ("a novel antimalarial antifolate" 2)
      ("the first highly-targeted antifolate" 1)
      ("a selective antifungal antifolate" 1) ("Antifolate" 1)
      ("high-dose polyglutamable antifolates" 1)))
    ("CHEBI:73965"
     (("PGE 2" 2462) ("exogenous PGE 2" 48) ("Exogenous PGE 2" 8) ("PGEM" 6)
      ("systemic PGE 2" 2) ("the antifibrotic mediator PGE 2" 1)
      ("COX-2 transgenic mice produced significantly more PGE 2" 1) ("PGE 2 ’s" 1)
      ("MEFs produced approximately twofold more prostaglandin PGE 2" 1)
      ("the PGE 2" 1) ("Our laboratory previously observed PGE 2" 1)
      ("more PGE 2" 1) ("subsequent PGE 2" 1) ("showed strong PGE 2" 1)
      ("a monoclonal PGE 2" 1)
      ("15-PGDH overexpressed cells exhibited decreased PGE 2" 1)))
    ("CHEBI:74052" (("His-Lys" 9)))
    ("CHEBI:74538"
     (("LGGs" 120) ("LGG" 25) ("lgG" 11) ("LgG" 8) ("pediatric LGGs" 7)
      ("Pediatric LGGs" 3) ("89 pediatric LGGs" 1) ("pediatric grade II LGGs" 1)
      ("adult and pediatric LGGs" 1) ("Fifty-seven pediatric LGGs" 1)
      ("38 representative LGGs" 1) ("Sixteen representative LGGs" 1)
      ("pediatric LGG" 1) ("57 pediatric LGGs" 1)))
    ("CHEBI:74541" (("LLL" 45))) ("CHEBI:74553" (("Lys-Arg" 9)))
    ("CHEBI:7459" (("naloxone" 15))) ("CHEBI:74634" (("cardenolides" 9)))
    ("CHEBI:74856" (("SBCl3" 31))) ("CHEBI:74858" (("GCB" 329)))
    ("CHEBI:74978"
     (("ginsenosides" 13) ("Ginsenoside" 10) ("ginsenoside" 8)
      ("Ginsenosides" 2)))
    ("CHEBI:75041" (("DT3" 27)))
    ("CHEBI:75044"
     (("phleomycin" 39) ("the radiomimetic agent phleomycin" 2) ("Phleomycin" 1)))
    ("CHEBI:75047"
     (("RAF inhibitors" 218) ("Raf inhibitors" 38)
      ("ATP-competitive RAF inhibitors" 4) ("weak RAF inhibitors" 3)
      ("“next-generation” ATP-competitive or allosteric RAF inhibitors" 2)
      ("RAF
inhibitors"
       2)
      ("Numerous ATP-competitive Raf inhibitors" 1)))
    ("CHEBI:75050"
     (("chromogen" 741) ("Chromogen" 71) ("chromogens" 6) ("chromogen (AEC)" 3)
      ("Permanent Red chromogen" 2) ("thereafter DAB substrate chromogen" 2)
      ("chromogen (DAKO)" 2) ("a fluorescent chromogen" 2)
      ("brown chromogens" 1)))
    ("CHEBI:75055"
     (("X-gal" 216) ("X-Gal" 75) ("x-Gal" 1) ("x-GAL" 1)
      ("the chromogenic substrate X-gal" 1) ("x-gal" 1) ("X-GAL" 1)))
    ("CHEBI:75221" (("NaVO3" 15) ("sodium metavanadate" 1)))
    ("CHEBI:75389" (("U0125" 3))) ("CHEBI:75390" (("MK886" 2)))
    ("CHEBI:75401" (("quinpirole" 50) ("Quinpirole" 1)))
    ("CHEBI:75430" (("GHK" 9)))
    ("CHEBI:7549" (("L-NAME" 105) ("L-Name" 4) ("l-NAME" 2)))
    ("CHEBI:75602" (("dT4" 3))) ("CHEBI:75648" (("DO3" 6) ("DO3-" 2)))
    ("CHEBI:7569" (("nigericin" 70) ("Nigericin" 8) ("-nigericin" 1)))
    ("CHEBI:75701" (("Sarin" 1)))
    ("CHEBI:75958"
     (("solution" 24656) ("solutions" 2254) ("Solution" 1309) ("Solutions" 156)
      ("HBSS" 156) ("solution (HBSS)" 99) ("Solution (HBSS)" 52)
      ("solution (PBS)" 45) ("Target Retrieval Solution" 45) ("DAKO" 45)
      ("SPSS" 33) ("a hypotonic solution" 27) ("hypotonic solution" 26)
      ("an aqueous solution" 25) ("aqueous solution" 24)
      ("antigen retrieval solution" 24) ("target retrieval solution" 21)
      ("fixative solution" 19) ("solution (DAKO)" 15)
      ("1% antibiotic-antimycotic solution" 12) ("solution (EBSS)" 11)
      ("Upstate Cell Signaling Solutions" 11)
      ("the secondary antibody solution" 9) ("solution (SIGMA)" 9)
      ("Dako Target Retrieval Solution" 9) ("BD" 9) ("an isotonic solution" 8)
      ("aqueous solutions" 8) ("antibiotic-antimycotic solution" 8)
      ("Epitope Retrieval Solution" 7) ("Target Retrieval solution" 7)
      ("retrieval solution" 7) ("an antigen retrieval solution" 7)
      ("an ice-cold solution" 7) ("Solution (EBSS)" 6)
      ("Antigen Retrieval Citra Solution" 6) ("-solution" 6)
      ("internal solution" 5) ("solution (PI)" 5)
      ("secondary antibody solution" 5) ("CellTiter 96 Aqueous One Solution" 5)
      ("solution (ERS)" 5) ("EnVision FLEX Target Retrieval Solution" 5)
      ("a fixative solution" 5) ("Solution (BD)" 5) ("the fixative solution" 5)
      ("using Enhanced Chemiluminescent (ECL) solution" 4)
      ("a hypotonic propidium iodide solution" 4)
      ("SuperSignal chemiluminescent substrate-stable peroxide solution" 4)
      ("1% antibiotic–antimycotic solution" 4)
      ("using Target retrieval solution" 4) ("a secondary antibody solution" 4)
      ("The internal pipette solution" 4) ("solution (SSC)" 4)
      ("a concentrated bacterial solution" 4) ("Diff-Quick Fixative Solutions" 4)
      ("a homogeneous solution" 4) ("antibody diluent solution" 4)
      ("the antibiotic antimycotic solution" 4) ("a fresh substrate solution" 4)
      ("the Antigen Retrieval Solution" 4) ("appropriate DakoREAL solutions" 4)
      ("solution (DAB)" 3) ("an internal solution" 3) ("One possible solution" 3)
      ("5% non-fat dry milk solution" 3) ("hypotonic PI solution" 3)
      ("aqueous stock solutions" 3) ("solution (DMSO)" 3)
      ("0.6% bactoagar media solution" 3) ("CellTiter 96 AQueous One Solution" 3)
      ("External bath solution" 3) ("GIBCO" 3) ("retrieval solutions" 3)
      ("saline (PBS) solution" 3) ("AQueous One Solution" 3)
      ("homogeneous solution" 3) ("fresh acellular collagen matrix solution" 3)
      ("a weak solution" 3) ("Retrieval Solution" 3) ("a possible solution" 3)
      ("10% aqueous NaS 2 O 3 solution" 3) ("An aqueous solution" 3)
      ("an isotonic phosphate buffer solution" 3) ("the resultant solution" 3)
      ("1 mL hypotonic fluorochrome solution" 3) ("solution (MTS)" 3)
      ("Coomassie blue fixative solution" 2)
      ("the standard antigen TBE-buffer-based antigen retrieval solution" 2)
      ("TriReagent solution" 2) ("ice-cold isotonic lysis solution" 2)
      ("37°C. Chemiluminescent HRP substrate solution" 2)
      ("ice-cold dissection solution" 2) ("sodium citric solution" 2)
      ("enhanced chemiluminescent reagent solution" 2)
      ("consecutive ethanol solutions" 2) ("Target retrieval solution" 2)
      ("using Target Retrieval Solution" 2) ("Solution (DAKO)" 2)
      ("the 7 representative solutions" 2) ("CC1 high pH retrieval solution" 2)
      ("Lentiviral particle solution" 2)
      ("fresh prepared alkaline buffer solution" 2) ("a potential solution" 2)
      ("Dako EnVision FLEX Target Retrieval Solution" 2)
      ("retrieval
solution"
       2)
      ("Coomassie Brilliant Blue R-250 solution" 2)
      ("300 μl hypotonic fluorochrome solution" 2)
      ("MTT (methylthiazolyldiphenyl-tetrazolium ) (Sigma-Aldrich ® ) solution" 2)
      ("0.1 mM MEM nonessential amino-acid solution" 2)
      ("a freshly made bisulfite solution" 2) ("isotonic solution" 2)
      ("fresh-filtered oil red O solution" 2) ("the viral solution" 2)
      ("2-(N-morpholino) ethanesulfonic acid (MES)-buffered solution" 2)
      ("hypotonic sucrose solutions" 2) ("Hypotonic solutions" 2)
      ("the EnVision™ FLEX target retrieval solution" 2) ("HBSS solution" 2)
      ("reproducible solution" 2)
      ("A commercially made ELISA blocking solution" 2)
      ("a low pH target retrieval solution" 2)
      ("optimal cutting temperature solution" 2)
      ("hypotonic propidium iodide (PI) solution" 2) ("hypothetical solutions" 2)
      ("heat-induced epitope retrieval solution" 2) ("Artificial tear solution" 2)
      ("100 μL 10 mM aqueous unbuffered Tris solution" 2)
      ("the sodium tripolyphosphate (TPP in sodium citrate, 238503, Sigma-Aldrich) aqueous solution"
       2)
      ("1× antibiotic-antimycotic solution" 2) ("Solutions (SPSS)" 2)
      ("a 0.5% cystal violet solution" 2) ("two gradient solutions" 2)
      ("ice-cold isotonic NHCI solution" 2) ("ECL western blotting solution" 2)
      ("secondary antibody goat‐anti‐mouse‐HRP solution" 2)
      ("fresh 4% paraformaldehyde solution" 2) ("antigen-retrieval solution" 2)
      ("using 4% paraformaldehyde solution" 2) ("freshly made ECL solution" 2)
      ("10% neutral formalin solution" 2) ("Antibiotic antimycotic solution" 2)
      ("EDTA antigen retrieval solution" 2) ("boric acid solution" 2)
      ("10% commercial blocking solution" 2)
      ("Histofine antigen retrieval solution" 2) ("Western HRP Solution" 2)
      ("nitro-blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt (NBT/BCIP) solution"
       2)
      ("solution (BSA)" 2) ("a cryoprotective solution" 2) ("solution (GIBCO)" 2)
      ("16% paraformaldehyde (formaldehyde) aqueous solution" 2)
      ("high pH/low pH target retrieval solution" 2)
      ("serial ethanol solutions" 2) ("the viral preservation solution" 2)
      ("a citrate buffer retrieval solution" 2)
      ("-benzene sulfonic acid hydrate (XTT) solution" 2)
      ("a hypotonic
solution"
       2)
      ("hyperosmotic, hyperglycemic and acidic dialysis solutions" 2)
      ("using fixative solution" 2) ("EnVision FLEX target retrieval solution" 2)
      ("a hypotonic lysis solution" 2) ("300 μL pre-warmed pepsin solution" 2)
      ("a 10% formalin neutral buffer solution" 2)
      ("nonenzymatic cell dissociation solution" 2) ("viral solution" 2)
      ("three-dimensional solution" 2) ("the optimal solution" 2)
      ("a twofold vitamin solution" 2) ("Cell Titer 96 Aqueous One Solution" 2)
      ("solution (TBS)" 2) ("stationary solution" 2)
      ("warm Hepes-buffered saline solution" 2) ("CanGetSignal solution" 2)
      ("enhanced chemiluminiscent (ECL) solution" 2) ("an hypotonic solution" 2)
      ("glacial acetic acid solution" 2) ("0.005% neutral red solution" 2)
      ("Western blocker solution" 2) ("Trilogy antigen retrieval solution" 2)
      ("glycerol vinyl alcohol aqueous mounting solution" 2)
      ("2:1 hypotonic solution" 2) ("ice-cold paraformaldehyde solution" 2)
      ("an eluent solution" 2)
      ("heat-induced epitope antigen retrieval solution" 2)
      ("0.52% (pH 3.5) aqueous solution" 2) ("Mild Antibody Stripping Solution" 2)
      ("ice-cold fixation solution" 2)
      ("the relevant Vybrant® Cell-Labeling Solution" 2)
      ("the fresh mannitol solution" 2)
      ("various antigen different retrieval solutions" 2)
      ("an antibody diluent solution" 2)
      ("Universal Immuno-peroxidase polymer (UIP) solution" 2)
      ("400 μl hypotonic fluorochrome solution" 2)
      ("soluble chromatin solutions" 2) ("pre-warmed hypotonic solution" 2)
      ("isoelectric focusing (IEF) solution" 2) ("post-primary solution" 2)
      ("a citrate-based antigen retrieval solution" 2)
      ("0.1 M Citrate Buffer Antigen Retrieval Solution" 2)
      ("The methanolic solution" 2) ("1X antibiotic-antimycotic solution" 2)
      ("a rapidly stirred aqueous solution" 2)
      ("prewarmed (37°C) hypotonic solution" 2)
      ("0.01 M citrate retrieval solution" 2)
      ("1% non-essential amino acid solution" 2) ("Reversing Solution" 2)
      ("Dako antigen retrieval solution" 2)
      ("DMEM and 100x antibiotic antimycotic solution" 2)
      ("1% MEM non-essential amino acid solution" 2)
      ("DAKO antigen retrieval solution" 2) ("an elegant solution" 2)
      ("a 9 p M solution" 2) ("antimycotic solution" 2)
      ("2 mM L-Glutamine and 1× antibiotic-antimycotic solution" 2)
      ("monovalent cation-containing solution" 2) ("solution (PAA)" 2)
      ("10% buffered neutral formalin solution" 2) ("Alamar Blue solution" 2)
      ("traceable standard solutions" 2) ("Hypertonic saline solution" 2)
      ("hypertonic saline solution (HTS)" 2) ("solution (HTS)" 2)
      ("the aqueous working solution" 2)
      ("50% artificial cerebrospinal fluid solution" 2)
      ("Alcian blue/Alizarin red solution" 2) ("Antigen Retrieval Solution" 2)
      ("hypotonic labeled solution" 2) ("a 5% perchloric acid solution" 2)
      ("siRNA duplex solution" 2) ("serial alcohol solutions" 2)
      ("the most parsimonious solution" 2) ("mild antibody solution" 2)
      ("refrigerated hypotonic staining solution" 2)
      ("10% formalin neutral buffer solution" 2) ("charcoal solution" 2)
      ("CellTiter96 Aqueous One solution" 2)
      ("heated Target Retrieval Solution" 2) ("1 ml hypotonic solution" 2)
      ("-bis-(2-carboxyethyl)-5,6-carboxyfluorescein-acetoxymethylester (BCECF-AM) solution"
       2)
      ("one potential solution" 2) ("10% neutral-buffered formalin solution" 2)
      ("the tissue culture plastic using trypsin solution" 2)
      ("ice-cold glycine solution" 2) ("100× antibiotic-antimycotic solution" 2)
      ("1X antigen retrieval solution" 2)
      ("10 ml/L 100x antibiotic antimycotic solution" 2)
      ("a commercially available blocking buffer solution" 2)
      ("Gel-Blue staining solution" 2) ("Gold colloidal solution" 2)
      ("hypertonic solution" 2) ("0.5% periodic acid solution" 2)
      ("100× Antibiotic-Antimycotic solution" 2) ("a methanolic solution" 2)
      ("Dako High-pH Target Retrieval Solution" 2)
      ("diluted Target Retrieval Solution" 2)
      ("antigen retrieval using ficin solution" 2)
      ("epitope retrieval solution" 2) ("ice-cold glutathione solution" 2)
      ("ethanolic solutions" 2) ("solution (EMEM)" 2)
      ("HybClear blocking solution" 2) ("fresh ECL-Plus solution" 2)
      ("Mild Solution" 2) ("a commercially available unmasking solution" 2)
      ("neutral lysis solution" 2) ("a Super Signal chemiluminescent solution" 2)
      ("MEM non-essential amino acid solution" 2)
      ("Alexa fluor 488 secondary antibody solutions" 2)
      ("0.1% (v/v) antibiotic–antimycotic solution" 2)
      ("an EDTA-containing Target Retrieval Solution" 2)
      ("a citrate-based Target Retrieval Solution" 2)
      ("The standard isotonic solution" 2) ("a hypotonic Ca 2+ -rich solution" 2)
      ("DAKO Target Retrieval Solution" 2) ("optimal solutions" 2)
      ("Quantitative PCR solution" 2) ("the pre-made amplifier solutions" 2)
      ("ice-cold 0.5% Triton X-100 solution" 2)
      ("using Dako antigen retrieval solution" 2)
      ("20 µL CellTiter 96® AQueous One solution" 2)
      ("the Bond Epitope Retrieval Solution" 2) ("pH Target Retrieval solution" 2)
      ("an ice-cold lysis solution" 2) ("dual blocker HP/AP solution" 2)
      ("hypotonic fluorochrome solution" 2) ("fresh staining solution" 2)
      ("an Alamar Blue solution" 2) ("fresh MTT solution" 2)
      ("1× fixative solution" 2) ("Antibody Diluent Solution" 2)
      ("solution (BSS)" 2) ("10% formaldehyde Neutral Buffer Solution" 2)
      ("3 ml 1.8% (w/v) BactoAgar solution" 2)
      ("Nucleic Acid Purification Lysis Solution" 2)
      ("Stochastic steady state solutions" 2)
      ("Deterministic steady state solutions" 2)
      ("dual endogenous HP/AP enzyme blocker solution" 2)
      ("1X Target Retrieval Solution" 2) ("solution (TBST)" 2)
      ("10% neutral buffered-formalin solution" 2)
      ("The crystallographic solution" 1) ("soluble REDV solutions" 1)
      ("Diluted soluble chromatin solution" 1) ("The internal solution" 1)
      ("using 2 N NaOH aqueous solution" 1) ("an aqueous solution (PBS)" 1)
      ("an aqueous 100 mg/ml recombinant human EGF solution" 1)
      ("a 50 mM ethylenediamine tetraacetic acid/PBS solution" 1)
      ("nucleic acid solution" 1) ("using homemade solutions" 1)
      ("Target Retrieval Solution (DAKO)" 1) ("The aqueous solution" 1)
      ("heat-mediated antigen retrieval solution" 1)
      ("the globally optimal solution" 1) ("external solution" 1)
      ("neutral aqueous solution" 1)
      ("10% fetal bovine serum, and antibiotic solution" 1)
      ("The Manumycin A stock solution" 1)
      ("using Envision Flex Target Retrieval solution" 1)
      ("0.075 M KCl hypotonic solution" 1)
      ("JNK1 (1.5 × 10 8 PFU/ml) adenoviral stock solutions" 1)
      ("90% PEG (polyethylene glycol, molecular weight 300) (Wako) solution" 1)
      ("standard internal solution" 1) ("standard external solution" 1)
      ("a retroviral vector solution" 1)
      ("hypotonic inositol and sucrose solutions" 1)
      ("Dako target-retrieval solution" 1)
      ("a proprietary EDTA-based retrieval solution" 1)
      ("the probable solution" 1) ("ice-cold 2% BSA/PBS solutions" 1)
      ("an obvious potential solution" 1) ("10% fetal bovine solution (FBS)" 1)
      ("solution (FBS)" 1) ("possible solutions" 1) ("solution (HHSS)" 1)
      ("“in-solution”" 1) ("1 X antibiotic-antimycotic solution" 1)
      ("naphthol blue-black solution" 1) ("fluorescent protein solution" 1)
      ("a nonenzymatic solution" 1) ("EnVision Target Retrieval Solution" 1)
      ("0.25% trypsin-0.02% ethylenediaminetetravacetic acid (EDTA) solution" 1)
      ("Thermo Scientific Cellomics HCS Solution" 1)
      ("secondary universal antibody solution" 1) ("an unambiguous solution" 1)
      ("0.5% Alcian blue 8GX solution" 1) ("histoclear solution" 1)
      ("a 1% aqueous solution" 1) ("a 100 μL p NPP solution" 1)
      ("a potential therapeutic solution" 1)
      ("primary antibody diluent solution" 1)
      ("95∶2.5∶2.5 trifluoroacetic acid/triisopropylsilane/water solution" 1)
      ("Diaminobenzidine colorimetric reagent solution" 1)
      ("antibiotic–antimycotic solution" 1)
      ("4°C. Data fitting used numerical solutions" 1)
      ("Western Blotting Detection Reagent solution" 1)
      ("Dako antibody diluent solution" 1) ("0.67  M KCL hypotonic solution" 1)
      ("basic alcohol solution" 1) ("SSC" 1) ("CellTiter 96 Aqueous solution" 1)
      ("Antibody Diluent Background Reducing Solution (DAKO)" 1)
      ("the basic lysis solution" 1) ("The basic lysis solution" 1)
      ("the neutral lysis solution" 1)
      ("1% antibiotic-antimycotic (anti-anti) solution" 1)
      ("4% neutral buffered paraformaldehyde solution" 1)
      ("The internal (pipette) solution" 1)
      ("0.015% collagenase II (Sigma) solution" 1) ("target-retrieval solution" 1)
      ("trypsin- ethylenediaminetetraacetic acid (EDTA) solution" 1)
      ("most assay solutions" 1) ("the least preferable solution" 1)
      ("Bond Epitope Retrieval Solution" 1)
      ("The fluorescent protein solutions" 1)
      ("freezable 20 mM stock solutions" 1) ("fresh xylene solution" 1)
      ("senescence-associated betagalactosidase (SA-β-gal) Detection Solution" 1)
      ("the basolateral bath solution" 1) ("the apical bathing solution" 1)
      ("the apical bath solution" 1)
      ("a Dako PT-link and EnVision Flex target retrieval solution" 1)
      ("1% trifluoroacetic acid solution" 1)
      ("the CellTiter 96® AQueous One Solution" 1)
      ("a 3% phosphoric acid solution" 1) ("more legitimate solution" 1)
      ("fresh low ovomucoid solution" 1) ("pH 9 Dako Target Retrieval Solution" 1)
      ("1% Antibiotic-Antimycotic Solution (ATB)" 1)
      ("20μl CellTiter 96 AQueous One Solution" 1)
      ("secondary Alexa Fluor antibodies (594 488; Invitrogen) solution" 1)
      ("DaKo" 1)
      ("Phosphate Buffered Saline (PBS, 137 mM NaCl, 2.7 mM KCl and 10 mM phosphate buffer solution, pH 7.4) (Sigma-Aldrich, Carlsbad, CA, USA) solution"
       1)
      ("2N sulphuric acid stop solution" 1)
      ("The vehicle treated group received both 5% β-cyclodextrin solution" 1)
      ("an on-exchanged solution" 1) ("1.25M sulfuric acid stop solution" 1)
      ("a biotinylated secondary antibody solution" 1)
      ("the previous ligand solution" 1) ("a more universal solution" 1)
      ("pre-cold phosphate buffer solution" 1) ("the liposomal solution" 1)
      ("senescence-associated beta-galactosidase (SA-β-gal) solution" 1)
      ("Complete Cell Fixative Solution" 1) ("25% trichloric acid solution" 1)
      ("20% pluronic F-127 solution" 1) ("the AQueous One solution" 1)
      ("EtBr (Promega) (5 μg/ml) solution" 1)
      ("a 0.03% diaminobenzidine chromogenic solution" 1)
      ("a citrate buffer target retrieval solution" 1)
      ("0.1 mM nonessential amino acids solution" 1)
      ("heated antigen retrieval solution" 1) ("All aqueous solutions" 1)
      ("the organic solutions" 1)
      ("sodium citrate–Triton X100 hypotonic solution" 1) ("solution (EPEI)" 1)
      ("black Indian ink and Bouins solution" 1) ("cost-effective solutions" 1)
      ("10 mM MEM Non-Essential Amino Acids Solution" 1)
      ("the hypotonic solution" 1) ("SA-β-gal-staining solution" 1)
      ("The retrieval solution" 1) ("5% milk-Tris-buffered saline solution" 1)
      ("CC1 retrieval solution" 1) ("the DAKO Antigen Retrieval Solution" 1)
      ("saturated aqueous NaHCO 3 solution" 1) ("an insoluble cloudy solution" 1)
      ("their respective blocking solutions" 1)
      ("the originalmolecular replacement solution" 1) ("cardioplegic solution" 1)
      ("MEM vitamin mixture and MEM nonessential amino acid solution" 1)
      ("The herbal solution" 1) ("The media-duplex solution" 1)
      ("the EnVision™FLEX Target Retrieval Solution (DAKO)" 1)
      ("warm (45 ºC) hybridization solution" 1)
      ("freshly made 0.2% SDS/0.1 M NaHCO 3 solution" 1)
      ("a 0.06 M KCl hypotonic solution" 1)
      ("serial aqueous-increased ethanol solutions" 1)
      ("both stable and unstable (subcritically bifurcating solutions) oscillatory solutions"
       1)
      ("The stable oscillatory solution" 1) ("the numerical solutions" 1)
      ("oscillatory solutions" 1)
      ("antigen retrieval using DAKO target retriever solution" 1)
      ("1% antibiotic antimycotic solution" 1)
      ("a trypsin (0.25 %) EDTA (1 mM) solution" 1) ("solution (BIOMOL)" 1)
      ("Solution (CHEMICON)" 1) ("Re-Blot Plus-strong stripping solution" 1)
      ("100 μl Basic Nucleofector Solution" 1) ("the correct solution" 1)
      ("ice-cold alkaline lysis solution" 1) ("monovalent cation solution" 1)
      ("soluble target protein solutions" 1) ("A possible new solution" 1)
      ("1× hypotonic solution" 1) ("10 8 CFU ml -1 bacterial solution" 1)
      ("cross-validating gravimetric standard solutions" 1)
      ("a 0.4% aqueous solution" 1) ("Antigen retrieval solution" 1)
      ("hypertonic saline solutions" 1)
      ("tetrazolium dye 3-(4,5-dimethylthiazole-2-yl)-2,5- diphenyltetrazolium bromide (MTT) (Sigma, USA) solution"
       1)
      ("25 µL internal standard solution" 1) ("fluorescent gelatin solution" 1)
      ("ice-cold oxygenated Krebs-Ringer bicarbonate solution" 1)
      ("working solution" 1) ("5 mM perfluoropentanoic acid aqueous solution" 1)
      ("ice-cold solution" 1) ("ice-cold PBS solution" 1)
      ("purified fluorescent protein solutions" 1) ("treated DNA solution" 1)
      ("fluorescent carbocyanine dye Di-I solution" 1)
      ("Basic Salt Solution (EBSS)" 1)
      ("secondary detection reagent and TMB solution" 1)
      ("biotinylated secondary antibody solution" 1) ("Two possible solutions" 1)
      ("ice-cold Triton X-100 solution" 1) ("commercial 8M GuHCl solution" 1)
      ("than anti-Stat3 assay solution" 1) ("the viral solutions" 1)
      ("1 μl okadaic acid stock solutions" 1)
      ("1 ml ice-cold 10% (w/v) TCA solution" 1) ("the respective solutions" 1)
      ("one possible solution" 1) ("DAKO Epitope Retireval Solution" 1)
      ("solutions bathing a smoker's" 1)
      ("the EnVision Flex Target Retrieval Solution (DAKO)" 1)
      ("a 50 mmol/L injectable solution" 1) ("a 60-mmol/L injectable solution" 1)
      ("The secondary antibody solution" 1)
      ("the all-timescale analytical solution" 1) ("aqueous solution (XLINK)" 1)
      ("EnVision™ Flex target retrieval solution" 1)
      ("fresh trypsin/EDTA solution" 1) ("0.5% trifluoroacetic acid solution" 1)
      ("0.05M Tris Triton epitope retrieval solution" 1) ("ice-cold (4°C) HBSS" 1)
      ("ice-cold HBSS" 1) ("a valid solution" 1) ("a unique solution" 1)
      ("The ultimate solution" 1) ("respective primary Ab solutions" 1)
      ("ethanol aqueous solutions" 1) ("the same hypertonic solution" 1)
      ("Alcian Blue (pH 2.5) solution" 1) ("the trivial solutions" 1)
      ("ice-cold M199 Hanks solution" 1) ("rectal dialysis solution" 1)
      ("an epitope retrieval solution" 1) ("ice-cold solutions" 1)
      ("a 2.5 N sulfuric acid solution" 1)
      ("3% bovine serum albumin-phosphate-buffered saline solution" 1)
      ("the respective precipitant solutions" 1)
      ("Five representative solutions" 1) ("Bacterial solution" 1)
      ("the resultant clear solution" 1) ("neutral red solution" 1)
      ("the slightly turbid solution" 1)
      ("pH 9.0 TRIS target retrieval solution (TRS)" 1)
      ("well secondary antibody solutions" 1) ("a more comprehensive solution" 1)
      ("intravital buffer solution" 1)
      ("10% neutral buffered formalin solution" 1)
      ("the Epitope Retrieval Solution" 1) ("a chromogenic solution" 1)
      ("20 µL CellTiter 96 Aqueous One Solution" 1)
      ("a prewarmed 75 mM KCl hypotonic solution" 1)
      ("many mathematical solutions" 1) ("every single clustering solution’s" 1)
      ("than any single clustering solution" 1)
      ("than a single clustering solution" 1)
      ("at least one clustering solution" 1) ("disparate solutions" 1)
      ("ice-cold 10% (wt/vol) TCA solution" 1) ("Neutral collagen solution" 1)
      ("an optimal solution" 1) ("1% MEM non-essential amino acids solution" 1)
      ("An obvious solution" 1) ("an exact mathematical solution" 1)
      ("One potential solution" 1) ("cryopreservative solution" 1)
      ("5% non-fat dry milk TBST solution" 1)
      ("0.5 mg/ml 3-(4,5-dimethyl-thia-zol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT, Sigma) solution"
       1)
      ("Antibiotic Antimycotic solution" 1) ("this fluorescent solution" 1)
      ("10% neutral buffered formaldehyde solution" 1)
      ("tryptic peptide solutions" 1) ("Universal IHC blocking solution" 1)
      ("ice cold isotonic saline solution" 1)
      ("Fast Flow® (GE Life Sciences) 1:1 (v:v) slurry solution" 1)
      ("pure buffer solution" 1) ("the antibody diluent solution" 1)
      ("aqueous NaCl solutions" 1) ("the slightly yellow solution" 1)
      ("The resultant solution" 1)
      ("50% (v/v) methanol/0.01% (w/v) crystal violet solution" 1)
      ("The potential solution" 1)
      ("diluted anti-NF-κB (p65) antibody (1:100) solution" 1)
      ("a stictic acid solution" 1) ("a 3.3% (w/v) BactoAgar solution" 1)
      ("37°C. Alamar blue solution" 1) ("saturated NH 4 Cl aqueous solution" 1)
      ("saturated NaHCO 3 aqueous solution" 1) ("Aqueous solutions" 1)
      ("their respective deterministic solutions" 1)
      ("three different antigen retrieval solutions" 1)
      ("secondary antibody (Alexa 350/405/488/ 594) (Invitrogen) solution" 1)
      ("the Leica Epitope Retrieval 2 solution" 1)
      ("Leica Bond epitope retrieval solution" 1)
      ("a commercial Giemsa solution" 1)
      ("neutral buffered 10% formalin solution" 1)
      ("target retrieval solution (DAKO)" 1)))
    ("CHEBI:75984" (("flecainide" 3)))
    ("CHEBI:76023"
     (("ThT" 22) ("THT" 1) ("WT p53C bound more ThT" 1)
      ("The R248Q aggregate bound more ThT" 1) ("Tht" 1)))
    ("CHEBI:76072" (("NAADP" 37))) ("CHEBI:76274" (("SC560" 15)))
    ("CHEBI:76451" (("alloxan" 2)))
    ("CHEBI:76567"
     (("PUFAs" 237) ("dietary n-6 PUFAs" 10) ("dietary PUFAs" 1)
      ("Dietary LC n-3 PUFAs" 1) ("high dietary n-6 PUFAs" 1)))
    ("CHEBI:76721" (("OHE" 55)))
    ("CHEBI:76983" (("sulphonylurea" 4) ("sulphonylureas" 2)))
    ("CHEBI:76988"
     (("xenoestrogens" 42) ("xenoestrogen" 6) ("Xenoestrogens" 2)
      ("nonphysiologic xenoestrogens" 1)))
    ("CHEBI:76995"
     (("α-naphthoflavone" 14) ("α-naphthoflavone (ANF)" 4)
      ("α-Naphthoflavone" 1)))
    ("CHEBI:77066" (("MPLA" 6)))
    ("CHEBI:77383"
     (("bisphosphonates" 74) ("bisphosphonate" 48) ("Bisphosphonates" 7)
      ("a heterocyclic nitrogen-containing bisphosphonate" 2) ("Bisphosphonate" 1)
      ("non-nitrogen-containing bisphosphonates" 1)))
    ("CHEBI:7754"
     (("oligonucleotides" 7573) ("oligonucleotide" 5673) ("oligos" 2356)
      ("oligo" 2191) ("Oligonucleotides" 357) ("Oligo" 317)
      ("Oligonucleotide" 254) ("AON" 91) ("Oligos" 48) ("SSO" 30) ("-oligo" 27)
      ("oligo-" 21) ("STGM" 21) ("biotinylated oligonucleotides" 20)
      ("oligonucleotide (ASO)" 18) ("MSO" 17) ("oligonucleotides (ASO)" 15)
      ("oligonucleotide (AMO)" 13) ("OLIGO" 12)
      ("a biotinylated oligonucleotide" 11) ("Biotinylated oligonucleotides" 9)
      ("Alexa Fluor® Red Fluorescent Oligo" 8)
      ("The biotinylated oligonucleotides" 8)
      ("the biotinylated oligonucleotides" 8) ("custom-made oligonucleotide" 8)
      ("biotinylated double-stranded oligonucleotides" 6)
      ("biotinylated oligonucleotide" 6) ("Fluorescent Oligo" 6)
      ("-biotinylated double-stranded oligonucleotides" 5)
      ("oligonucleotide (MO)" 5) ("OLIGONUCLEOTIDE" 5)
      ("oligonucleotides (ASRO)" 5)
      ("reverse and nested reverse oligonucleotides" 4) ("oligo (PMO)" 4)
      ("the duplex oligonucleotide" 4) ("siRNA duplex oligonucleotides" 4)
      ("the biotinylated oligonucleotide" 4)
      ("sequence-specific oligonucleotide" 4) ("complimentary oligonucleotides" 4)
      ("32 P end-labelled complementary 43-mer oligonucleotide" 4)
      ("The mutated oligo" 4) ("TAF6δ-inducing SSO" 4)
      ("shorter oligonucleotides" 4)
      ("the biotinylated double-stranded oligonucleotide" 4)
      ("oligonucleotides (AON)" 4) ("duplex oligonucleotides" 4)
      ("biotinylated RNA oligonucleotide" 4)
      ("High-density custom-made oligonucleotide" 4)
      ("oligonucleotide (TTAGGG)" 3) ("Oligo-" 3)
      ("RNA-based duplex oligonucleotides" 3) ("oligo ( CTGATTGGCTAA )" 3)
      ("oligo (MSO)" 3) ("The biotinylated oligonucleotide" 3)
      ("-biotinylated oligonucleotide" 3) ("oligonucleotides (TTAGGG)" 3)
      ("competitive oligonucleotides" 3) ("The duplex oligonucleotides" 3)
      ("using biotinylated oligonucleotides" 3) ("-phosphorylated oligo" 3)
      ("a previously described oligonucleotide" 3) ("a mutated oligonucleotide" 3)
      ("The biotinylated double-stranded oligonucleotides" 3) ("oligo (SO)" 3)
      ("Two 64-mere oligonucleotides" 3)
      ("biotinylated double-stranded oligonucleotide" 3)
      ("nonspecific oligonucleotide" 3) ("MEEBO" 3) ("IDT" 3)
      ("oligonucleotide (CGGGGCGGGGCGGGGC)" 3) ("DPO" 3) ("-biotinylated oligo" 3)
      ("An end-labeled ( 32 P[γ-ATP]) double-stranded oligonucleotide" 2)
      ("Oligonucleotides (AMO)" 2) ("oligonucleotides (MM)" 2)
      ("annealed biotinylated oligonucleotides" 2)
      ("oligonucleotide ( TCTCGCTTGGGCGAGAGTAAG )" 2)
      ("siGlo fluorescent oligonucleotides" 2)
      ("the respective unlabeled oligonucleotides" 2)
      ("unlabeled Mut I or Mut II oligo" 2) ("-Mut I and -Mut II oligos" 2)
      ("two double-stranded mutated DNA oligos" 2)
      ("Universal control oligonucleotides" 2)
      ("a cold competitive oligonucleotide" 2) ("oligonucleotides (CSO)" 2)
      ("biotinylated double-stranded 20 mer oligos" 2) ("smaller ssDNA oligos" 2)
      ("annealed duplex oligonucleotides" 2)
      ("using color-coded oligonucleotides" 2)
      ("fluorescently-labeled DNA oligonucleotides" 2) ("oligonucleotide (AS)" 2)
      ("50 μg·mL −1 double‐stranded activator oligonucleotide" 2)
      ("an irrelevant oligonucleotide" 2)
      ("precursor-negative control oligonucleotides" 2)
      ("Further siRNA oligonucleotides" 2)
      ("targeted small interfering RNA (siRNA) oligonucleotides" 2)
      ("Double-strained oligonucleotides" 2)
      ("a nonspecific duplex oligonucleotide" 2) ("GC duplex oligonucleotides" 2)
      ("oligonucleotides (AATCCC)" 2)
      ("a telomerase antagonistic oligonucleotide" 2)
      ("a competitive oligonucleotide" 2) ("oligonucleotides (QIAGEN)" 2)
      ("-biotinylated scrambled oligonucleotide" 2)
      ("-biotinylated short oligonucleotides" 2)
      ("previously published siRNA oligonucleotides" 2)
      ("a WT biotinylated oligonucleotide" 2) ("shorter 29 bp oligonucleotide" 2)
      ("a second universal DNA oligonucleotide" 2) ("A nonspecific oligo" 2)
      ("the biotinylated WT oligonucleotides" 2)
      ("non-biotinylated WT oligonucleotides" 2)
      ("fluorescent-labeled oligonucleotides" 2)
      ("dATP end-labeled oligonucleotides" 2)
      ("previously used Cl-I oligonucleotide" 2)
      ("biotinylated κB consensus sequence oligonucleotides" 2)
      ("using duplex oligonucleotides" 2) ("Bispecific AS oligonucleotides" 2)
      ("siRNA duplex oligo" 2) ("I. A double-stranded oligonucleotide" 2)
      ("triplex-forming oligonucleotides" 2) ("a mutated oligo" 2)
      ("20 nM siRNA duplex oligos" 2) ("oligonucleotide (GGGGTGAATTCTTTGCCA)" 2)
      ("the nonspecific oligonucleotide" 2)
      ("biotinylated 50-mer oligonucleotides" 2) ("oligos (NSC)" 2)
      ("the relevant oligonucleotides" 2) ("the labeled duplex oligonucleotide" 2)
      ("Block-it fluorescent oligonucleotide" 2)
      ("Complementary biotinylated oligonucleotides" 2)
      ("using four different siRNA duplex oligonucleotides" 2)
      ("The pol α-associated primase subunits synthesise oligonucleotides" 2)
      ("mutated SKP2 oligonucleotide" 2) ("Biotin end-labeled oligonucleotides" 2)
      ("a biotinylated telomerase substrate oligonucleotide" 2)
      ("transcript-specific oligonucleotides" 2)
      ("a unique nested forward oligonucleotide" 2)
      ("21-nucleotide duplex RNAi oligonucleotides" 2)
      ("nonspecific oligonucleotides" 2) ("using RNA Fluorescent Oligo" 2)
      ("a biotin-tagged irrelevant control oligonucleotide" 2)
      ("previously used HER2/neu AON" 2)
      ("short interfering (siRNA) duplex oligonucleotides" 2)
      ("the homologous AP-1#1 oligonucleotide" 2)
      ("the mutated AP-1 consensus oligonucleotide" 2)
      ("homologous and heterologous oligonucleotides" 2)
      ("the unlabeled homologous AP-1#1 oligonucleotide" 2)
      ("the biotinylated RNA oligonucleotide" 2)
      ("Biotinylated RNA oligonucleotide" 2) ("a biotinylated oligo" 2)
      ("-Biotinylated oligos" 2) ("well-established siRNA oligonucleotides" 2)
      ("50 nM siRNA (Dharmacon, Fisher Scientific, Wohlen, Switzerland) duplex oligonucleotides"
       2)
      ("mutated FHRE oligonucleotides" 2) ("targeting oligonucleotide" 2)
      ("mature miR-34a oligonucleotide" 2) ("oligo (ODN)" 2)
      ("ATP end-labeled oligonucleotides" 2)
      ("oligonucleotide (UCUCGCUUGGGCGAGAGUAAG)" 2) ("oligonucleotide (WT)" 2)
      ("shorter oligonucleotide" 2) ("-IRD700–labeled oligonucleotide" 2)
      ("two YAP1 siRNA duplex oligonucleotides" 2)
      ("The mutated κPU oligonucleotides" 2) ("oligonucleotide (MTS)" 2)
      ("Duplex oligonucleotides" 2) ("Dephosphorylated oligonucleotides" 2)
      ("the GC-box III oligonucleotide" 2)
      ("cRNA biotinylated oligonucleotides" 2) ("oligonucleotides (FBCO)" 2)
      ("the mutated oligonucleotide" 2)
      ("using SMARTpool duplex RNA oligonucleotides" 2)
      ("Four pooled small interfering RNA (siRNA) duplex oligos" 2)
      ("oligonucleotide (GGGCGGGCGGGCGGGC)" 2)
      ("end-labeled ( 32 P-γATP) double-stranded oligonucleotides" 2)
      ("the mutated consensus oligonucleotide" 2)
      ("a cell-permeable antisense oligonucleotide (ASO)" 2)
      ("C152T mutated oligonucleotide" 2)
      ("Biotin end-labeled double-stranded oligonucleotides" 2)
      ("double-stranded biotinylated oligonucleotide" 2)
      ("DEP-1 siRNA duplex oligonucleotides" 2) ("a previously described oligo" 1)
      ("the fluorescent oligonucleotides" 1)
      ("32 P γ-ATP-labelled oligonucleotide" 1)
      ("17-mer THF-containing duplex oligonucleotides" 1)
      ("than oligos 2 and 3 (∼4–6 fold)" 1)
      ("blunt-ended dsDNA oligonucleotides" 1) ("a lipidated oligonucleotide" 1)
      ("Non-labeled oligos" 1) ("phosphorylated annealed oligonucleotide" 1)
      ("commercial oligonucleotide" 1) ("oligo−" 1) ("than oligonucleotides" 1)
      ("A double-stranded mutated sis -inducible element (SIE) oligo" 1)
      ("a few more antisense oligonucleotides" 1) ("two or more oligo’s" 1)
      ("two or more oligo" 1) ("2130 unique siRNA oligos" 1)
      ("Biotinylated ds oligonucleotides" 1)
      ("Stealth RNAi™ siRNA Duplex Oligonucleotides" 1)
      ("Stealth™ RNAi siRNA Duplex Oligonucleotides" 1)
      ("Previously published siRNA oligonucleotides" 1)
      ("the relevant DNA oligonucleotides" 1)
      ("the predicted optimal oligonucleotide" 1)
      ("end-labeled oligonucleotides" 1)
      ("The nonspecific siRNA oligonucleotides" 1) ("CSO" 1)
      ("exogenous synthetic small ssDNA oligos" 1)
      ("biotinylated pA 70 /pT 70 oligos" 1) ("the Oligo’s" 1)
      ("RNA expressing plasmid or siRNA oligonucleotides" 1)
      ("-biotinylated complementary oligonucleotides" 1)
      ("biotin end-labeled oligonucleotides" 1)
      ("the free GATA-motif-containing oligonucleotide" 1)
      ("the ‘sense’ oligos (which detect antisense transcripts), contiguous transcripts"
       1)
      ("a non-fluorescent p21 promoter oligonucleotide" 1)
      ("sequence-based synthetic oligos" 1) ("sequence-based oligos" 1)
      ("biotinylated double-strand oligonucleotides" 1)
      ("the dye-labeled oligos" 1) ("A double-stranded mutated oligonucleotide" 1)
      ("Blunt-ended double-stranded oligonucleotides" 1)
      ("the biotinylated duplex oligonucleotide" 1) ("oligonucleotide (STGM)" 1)
      ("we first inserted UCA1 DNA oligonucleotides" 1)
      ("32 P-labeled duplex oligonucleotides" 1)
      ("nonspecific competitor oligonucleotides" 1)
      ("fluorescently-labelled siRNA oligonucleotides" 1)
      ("exogenous oligonucleotide" 1) ("longer oligonucleotide" 1)
      ("mutated oligonucleotide" 1) ("a complimentary oligonucleotide" 1)
      ("biotinylated or unlabeled oligonucleotides" 1)
      ("STAT3 (5′-GATCCTTCTGGGAATTCCTAGATC-3′) (Biometra) oligonucleotides" 1)
      ("scrambled biotinylated oligos" 1)
      ("negative oligomeric single-stranded oligonucleotides" 1)
      ("oligomeric single-stranded oligonucleotides" 1)
      ("an internal Sμ oligonucleotide" 1) ("GC-duplex oligonucleotides" 1)
      ("a bridged nucleic acid (BNA) RNA oligonucleotide" 1)
      ("its complimentary control oligonucleotide" 1)
      ("random hexameric oligos" 1) ("than normal oligonucleotides" 1)
      ("a mutated SIE oligonucleotide" 1)
      ("the Pak siRNA oligos compared with a non-target control ( xref )" 1)
      ("only IFNγ or CpG oligonucleotides" 1)
      ("the respective oligonucleotides" 1)
      ("five Alexa Fluor 488-labelled anti-hTR oligonucleotides" 1)
      ("nonameric oligonucleotides" 1) ("an internal PNA oligo" 1)
      ("the radioactively-labelled oligonucleotide" 1)
      ("the fluorescently-labelled oligonucleotides" 1)
      ("non-biotinylated Mut oligonucleotides" 1)
      ("the unlabelled nonspecific GAGA oligonucleotide" 1)
      ("Traditional antisense oligonucleotides" 1)
      ("The nonspecific short hairpin dsDNA oligonucleotide" 1)
      ("than previously used Cl-I oligonucleotide ( xref )" 1)
      ("cold mutated oligonucleotide" 1)
      ("small-interfering RNA (siRNA) oligonucleotides" 1)
      ("A 30 bp blunt-ended oligonucleotide" 1) ("oligonucleotide-" 1)
      ("the biotin end-labeled oligonucleotides" 1) ("mutated oligonucleotides" 1)
      ("further Bcl-x L antisense oligonucleotides" 1)
      ("an internal control oligonucleotide" 1)
      ("O -methoxyethyl chimerical phosphorothioate oligonucleotides" 1)
      ("bcl-2/bcl-x L bispecific oligonucleotides" 1)
      ("dCTP end-labelled oligonucleotide" 1) ("4 independent oligo's" 1)
      ("32 P end-labeled AP-1 oligo" 1) ("end-labeled 72-mer oligonucleotide" 1)
      ("an end-labeled 72-mer oligonucleotide" 1)
      ("We first tested two different siRNA oligos" 1)
      ("-biotinylated ssDNA oligos" 1) ("oligonucleotide (CGGAATTCCG)" 1)
      ("biotinylated 8-oxodG oligonucleotide" 1)
      ("8-dihydro-8-oxoguanine duplex oligonucleotide" 1)
      ("Mutated labeled oligonucleotide" 1)
      ("the respective unlabeled oligonucleotide" 1) ("Fluorescent oligos" 1)
      ("A locked nucleic acids (LNA)-antisense oligonucleotide" 1)
      ("at least two different siRNA oligos" 1)
      ("around 30- 40% confluency and siRNA oligonucleotides" 1)
      ("The mutated κAP-l oligonucleotides" 1)
      ("The mutated κNF-κB oligonucleotides" 1)
      ("The nonspecific oligonucleotides" 1)
      ("a specific locked nucleic acid (LNA) oligonucleotide" 1)
      ("a PCR-Sequence-Specific Oligonucleotide" 1)
      ("The siRNA duplex oligonucleotides" 1)
      ("the fluorogenic oligonucleotide" 1) ("The resuspended crude oligo" 1)
      ("The crude oligos" 1) ("we first tested two different siRNA oligos" 1)
      ("a previously validated double-stranded RNA oligo" 1)
      ("the TAF6δ-inducing SSO" 1) ("any non-specific SSO" 1)
      ("The improved SSO" 1) ("splice-switching oligonucleotides (SSO)" 1)
      ("two heterologous oligonucleotides" 1)
      ("small interfering RNA (siRNA) duplex oligos" 1)
      ("Fluorogenic oligonucleotide" 1) ("custom made oligonucleotides" 1)
      ("methylated oligonucleotides" 1)
      ("synthetic mature miR-504 oligonucleotides" 1)
      ("their respective complementary oligonucleotides" 1)
      ("RNA duplex oligonucleotide" 1)
      ("Chen et al. treated prostate cancer cell lines antisense oligonucleotides"
       1)
      ("at least 2 independent siRNA oligonucleotides" 1)
      ("artificial oligonucleotides" 1) ("a duplex oligo" 1)
      ("overhang-specific DNA oligonucleotides" 1)
      ("-phospho group-containing downstream labeled oligonucleotides" 1)
      ("cold competitive oligonucleotides" 1) ("fluorescent RNA oligos" 1)
      ("chemically-modified antisense oligonucleotides" 1)
      ("homologous unlabeled AP-1 oligonucleotide" 1)
      ("15 μg ml −1 Cy3-conjugated peptide nucleic acid (PNA) oligonucleotide" 1)
      ("a 32 P end-labelled 100-nt oligonucleotide" 1)
      ("The ASPE sequence-specific oligos" 1)
      ("an irrelevant control (miRN367) oligonucleotide" 1)
      ("end-labelled (γ- 32 P) NF-κB oligonucleotide" 1)
      ("the biotinylated E2F1 promoter consensus oligonucleotide" 1)
      ("the nonspecific control oligonucleotide" 1)
      ("unlabeled (cold) consensus and mutant (5′-CACTGGGAGCCCTCT GCTAGC CCACACACCCGCCTG-3′) oligonucleotides"
       1)
      ("sense-specific oligonucleotides" 1) ("34 based-paired oligonucleotides" 1)
      ("brief, wild-type and mutated 32 P-labeled oligonucleotides" 1)
      ("pull-down biotinylated oligonucleotides" 1)
      ("γ- 32 P-ATP end-labelled anti-miR oligonucleotide" 1)
      ("a heterologous oligonucleotide" 1)
      ("The synthetic polynucleic acid (PNA) oligonucleotide" 1)
      ("a mutated consensus NFκB oligonucleotide" 1)
      ("60 K Agilent oligonucleotide" 1) ("At least two individual siRNA oligo" 1)
      ("mutated FHRE2 oligonucleotides" 1)
      ("The small inhibitory duplex shRNA oligo" 1) ("more oligo-" 1)
      ("synthetic duplex RNA oligonucleotides" 1) ("siRNA duplex oligos" 1)
      ("unique 60-mer oligonucleotide" 1)
      ("using synthetic duplex RNA oligonucleotides" 1)
      ("unlabeled nonspecific oligonucleotide" 1) ("oligonucleotide (ODN)" 1)
      ("a nonspecific scrambled small inhibitory RNA (siScr) oligonucleotide" 1)
      ("the complimentary oligos" 1) ("fluorescent oligonucleotide" 1)
      ("20 fmol biotinylated oligonucleotide" 1)
      ("biotinylated MRE oligonucleotide" 1)
      ("The biotinylated MRE oligonucleotides" 1)
      ("end–labeled c4ESE or p4ESE RNA oligonucleotide" 1)
      ("locked nucleic acid oligonucleotides" 1)
      ("its homologous double-stranded oligonucleotide" 1)
      ("-biotinylated oligonucleotides" 1)
      ("the 1024 possible 5-mer oligonucleotides" 1)
      ("infrared dye-labeled CRE oligonucleotides" 1)
      ("NC siRNA oligos according the manufacturer’s" 1)
      ("subsequent oligonucleotide" 1)
      ("control (scrambled, CyclophilinB, GAPDH) small interfering RNA (siRNA) oligonucleotides"
       1)
      ("than specific siRNA oligos" 1) ("all respective siRNA oligonucleotides" 1)
      ("oligonucleotides (MO)" 1)
      ("Matrigel-spot–embedded small interfering RNA (siRNA) oligos" 1)
      ("fluorescent oligonucleotides" 1)
      ("Nonspecific competitor oligonucleotides" 1)
      ("biotin end-labeled (BrightStar BioDetect Kit, Ambion) double-stranded oligonucleotides"
       1)
      ("oligonucleotides (IDT)" 1) ("the duplex oligonucleotides" 1)
      ("32 P end-labeled NF-κB oligonucleotide" 1)
      ("the un-methylated oligonucleotide" 1) ("this mutated oligonucleotide" 1)
      ("siRNA oligo’s" 1) ("the duplex oligo" 1)
      ("the respective complementary oligonucleotide" 1)
      ("than a scrambled 15-bp oligonucleotide ( xref )" 1)
      ("the constituent oligonucleotides" 1)
      ("a mutated half-PRE oligonucleotide" 1)
      ("a differently targeted siWT1 RNA oligonucleotide" 1)
      ("targeted siWT1 RNA oligonucleotide" 1)
      ("a cell-permeable antisense oligonucleotide" 1)
      ("cell-permeable antisense oligonucleotides" 1)
      ("the biotinylated -199/-150 oligonucleotide" 1)
      ("a biotinylated ssDNA oligonucleotide" 1)
      ("nonspecific FAM-conjugated oligonucleotides" 1)))
    ("CHEBI:7757"
     (("oligoribonucleotides" 77) ("oligoribonucleotide" 62)
      ("Oligoribonucleotides" 6) ("a standard siRNA duplex oligoribonucleotide" 4)
      ("A stealth siRNA duplex oligoribonucleotide" 4)
      ("siRNA duplex oligoribonucleotides" 2)
      ("Three different Stealth-RNAi siRNA duplex oligoribonucleotides" 1)
      ("-phosphorylated miRNA oligoribonucleotides" 1)))
    ("CHEBI:77760" (("KP1019" 4)))
    ("CHEBI:77761" (("piperidinones" 2) ("piperidinone" 2)))
    ("CHEBI:77853"
     (("POP" 121) ("POPs" 97) ("POPS" 29) ("pop" 16)
      ("persistent organic pollutants" 14) ("severe POP" 7) ("mild POP" 6)
      ("Persistent organic pollutants" 5) ("The lipophilic plasma legacy POPs" 2)
      ("Pop" 2) ("Persistent organic pollutant" 1) ("symptomatic POP" 1)))
    ("CHEBI:77963" (("sequestrant" 11)))
    ("CHEBI:77966"
     (("stabilizer" 152) ("stabilizers" 107) ("carboxylated comb stabilizer" 1)
      ("an amphiphilic comb copolymer stabilizer" 1)
      ("systemic immunosuppressants or mast cell stabilizers" 1)
      ("a well-characterized microtubule stabilizer" 1)
      ("a humeral head stabilizer" 1) ("a secondary stabilizer" 1)))
    ("CHEBI:78004"
     (("filler" 18) ("fillers" 5) ("dermal filler" 2) ("HA dermal fillers" 2)
      ("‘filler'" 2) ("“filler”" 2)
      ("artificial collagens or HA dermal fillers" 1)
      ("Hyaluronic acid (HA) dermal fillers" 1)))
    ("CHEBI:78018" (("dodecylphosphocholine" 7)))
    ("CHEBI:78510" (("Dorsomorphin" 27) ("dorsomorphin" 7)))
    ("CHEBI:78511" (("mPB" 1)))
    ("CHEBI:78518"
     (("MPM" 649) ("MPMs" 24) ("mpm" 7) ("biphasic MPM" 4) ("MPM’s" 2)
      ("more
aggressive MPM"
       2)
      ("a biphasic MPM" 2) ("sarcomatous MPM" 1) ("thoracoscopic MPM" 1) ("Mpm" 1)
      ("pathologically proven MPM" 1) ("histological MPM" 1)))
    ("CHEBI:78519" (("MPV" 209))) ("CHEBI:7861" (("oxyhemoglobin" 1)))
    ("CHEBI:78708"
     (("Nonidet P-40" 1006) ("Nonidet p-40" 7)
      ("Nonidet
P-40"
       1)
      ("nonidet p-40" 1) ("ice-cold Nonidet P-40" 1)))
    ("CHEBI:78761" (("ML-7" 48)))
    ("CHEBI:7896"
     (("palmitate" 338) ("Palmitate" 28) ("palmitate molecule" 3)
      ("palmitate (RP)" 3) ("palmitates" 2)))
    ("CHEBI:79056" (("plasticizer" 1)))
    ("CHEBI:79091"
     (("ERK inhibitors" 70) ("Erk inhibitors" 11) ("PD98509" 8)
      ("no therapeutically nontoxic ERK inhibitors" 1)))
    ("CHEBI:79208"
     (("-lactosylceramide" 11) ("lactosylceramide" 8) ("lactosylceramides" 1)
      ("Lactosylceramide" 1)))
    ("CHEBI:79381" (("a-factor" 4)))
    ("CHEBI:7956"
     (("PCV" 52) ("pCV" 19) ("pcv" 5) ("an idiopathic PCV" 2) ("PCV-" 1)))
    ("CHEBI:8005"
     (("peptidoglycan" 58) ("bacterial peptidoglycan" 3) ("peptidoglycans" 2)
      ("Peptidoglycan" 2) ("15 µg/ml insoluble peptidoglycan" 2)
      ("peptidoglycan (PGN)" 1) ("Peptidoglycan (PGN)" 1)
      ("bacterial cell wall derived peptidoglycan" 1)
      ("bacterial peptidoglycan (PGN)" 1)))
    ("CHEBI:80146" (("Kemptide" 7) ("kemptide" 2)))
    ("CHEBI:80236" (("uroguanylin" 1)))
    ("CHEBI:80244"
     (("urotensin-II" 3) ("Urotensin-II" 2)
      ("The vasoactive peptide urotensin-II" 2)))
    ("CHEBI:80307"
     (("C-terminal amidated Kisspeptin-10" 2) ("Kisspeptin-10" 1)
      ("kisspeptin-10" 1)))
    ("CHEBI:80332" (("C-peptide" 167) ("c-peptide" 10)))
    ("CHEBI:80552"
     (("NPC" 3228) ("NPCs" 973) ("locoregional NPC" 8) ("endemic NPC" 7)
      ("EBV-associated NPC" 5) ("nPC" 4) ("incident NPC" 4)
      ("Human cortical NPCs" 2) ("the matched relapsed NPC" 2)
      ("loco-regional advanced NPC" 2) ("previously untreated NPC" 2)
      ("we first generated NPCs" 2) ("had more variable NPC" 2)
      ("EGFR-expressing NPCs" 2) ("the enhanced self-renewal ofp53 (-/-) NPCs" 2)
      ("NPCS" 2) ("rat hippocampal NPCs" 1) ("premature embryonic NPCs" 1)
      ("siCon-treated NPCs" 1) ("histological confirmed NPC" 1) ("adherent NPC" 1)
      ("Additionally Pten null NPCs" 1) ("than the matched primary NPC" 1)
      ("TFEB-expressing SBMA NPCs" 1) ("CNP -expressing NPCs" 1)
      ("Human fetal cortical NPCs" 1) ("human fetal cortical NPCs" 1)
      ("fewer adult NPCs" 1) ("Multipotent NPCs" 1) ("multipotent adult NPCs" 1)
      ("adult hippocampal NPCs" 1) ("X-Gal-positive NPCs" 1)
      ("hippocampal NPCs" 1) ("than normal NPC [ xref ]" 1)))
    ("CHEBI:8069"
     (("luminal" 4194) ("Luminal" 407) ("phenobarbital" 33) ("non-luminal" 22)
      ("luminal-" 14) ("Phenobarbital" 7) ("mature luminal" 2) ("LUMINAL" 2)
      ("acinar luminal" 2) ("weak luminal" 2)
      ("these DCIS-like structures underwent luminal" 2) ("“luminal”" 2)
      ("proliferating luminal" 2) ("CC reverted AP-induced luminal" 2)
      ("luminal- (LEP)" 2) ("than luminal" 1) ("more mature luminal" 1)
      ("either committed unipotent luminal" 1) ("the so-called luminal" 1)
      ("mostly empty luminal" 1) ("Most luminal" 1) ("‘luminal’" 1)
      ("\"luminal\"" 1) ("the BRCA1-mutated tumors expressed non-luminal" 1)
      ("'luminal'" 1) ("than luminal (including ZR75-1)" 1)
      ("intraperitoneal Phenobarbital" 1) ("phenobarbital-" 1)
      ("benign luminal" 1) ("rudimentary luminal" 1)
      ("mid-secretory phase luminal" 1) ("unequivocal luminal" 1)))
    ("CHEBI:80806" (("cinobufotalin" 3)))
    ("CHEBI:8093"
     (("phenylephrine" 51) ("phenylephrine (PE)" 5) ("Phenylephrine" 2)))
    ("CHEBI:8113" (("phlorizin" 2))) ("CHEBI:81351" (("Activin A" 106)))
    ("CHEBI:81555" (("enterolactone" 13) ("Enterolactone" 3)))
    ("CHEBI:81556" (("enterodiol" 13) ("Enterodiol" 2)))
    ("CHEBI:81664" (("LL-37" 93) ("LL37" 5))) ("CHEBI:81825" (("TDL" 21)))
    ("CHEBI:82128" (("PB1-F2" 5)))
    ("CHEBI:82415" (("chloramine" 15) ("chloramines" 6) ("Chloramines" 1)))
    ("CHEBI:82625" (("Trolox" 89) ("trolox" 68) ("TROLOX" 2)))
    ("CHEBI:82713" (("SB220025" 12)))
    ("CHEBI:82755" (("mertansine" 9) ("Mertansine" 1)))
    ("CHEBI:8337"
     (("porphyrin" 81) ("porphyrins" 8) ("cationic porphyrins" 6)
      ("a cationic porphyrin" 2) ("the cationic porphyrin" 2) ("Porphyrin" 1)
      ("Porphyrins" 1)))
    ("CHEBI:83405" (("GDC-0879" 44))) ("CHEBI:83406" (("MS417" 1)))
    ("CHEBI:83967" (("bufadienolides" 1)))
    ("CHEBI:84327"
     (("Torin 1" 92) ("Torin-1" 25) ("torin 1" 8)
      ("torin
1"
       1)
      ("the dual mTOR inhibitor Torin 1" 1)))
    ("CHEBI:84444" (("TXB3" 1))) ("CHEBI:84622" (("RP-cAMPs" 4) ("Rp-cAMPs" 2)))
    ("CHEBI:85044" (("H3K27Ac" 99) ("H3k27ac" 1)))
    ("CHEBI:85045" (("H3K27Me3" 9)))
    ("CHEBI:85103"
     (("phenyl isothiocyanate (CPITC)" 2) ("phenyl isothiocyanate" 2)
      ("Phenyl isothiocyanate" 1)))
    ("CHEBI:85174" (("pMD2" 174) ("PMD2" 9)))
    ("CHEBI:85259" (("DEA" 6) ("diethylamine" 3)))
    ("CHEBI:85309" (("isoaspartate" 1)))
    ("CHEBI:85429" (("phosphatidylethanol" 1)))
    ("CHEBI:85572"
     (("Ku-0063794" 165) ("KU-0063794" 17) ("than Ku-0063794" 1)
      ("the ATP-competitive mTOR inhibitor Ku-0063794" 1) ("than KU-0063794" 1)))
    ("CHEBI:8616" (("psoralidin" 1)))
    ("CHEBI:86180" (("HNa" 1) ("HNA" 1) ("hNA" 1))) ("CHEBI:86195" (("DEAB" 37)))
    ("CHEBI:86497" (("hydroxykynurenine" 2))) ("CHEBI:87158" (("SU1498" 3)))
    ("CHEBI:87159" (("SU5614" 9))) ("CHEBI:87192" (("phloxine" 1)))
    ("CHEBI:87359" (("LY411575" 1)))
    ("CHEBI:87631"
     (("statins" 514) ("statin" 373) ("Statins" 69) ("Statin" 23) ("statin-" 5)
      ("another lipophilic statin" 2) ("a hydrophilic statin" 2)
      ("hydrophilic statins" 1) ("lipophilic statins" 1) ("Statin's" 1)
      ("non-statin" 1) ("a lipophilic statin" 1) ("than statins" 1) ("'statin'" 1)
      ("lipophilic and hydrophilic statins" 1)))
    ("CHEBI:87668" (("carbolfuchsin" 2)))
    ("CHEBI:87897" (("succinylacetone" 16) ("succinylacetone (SA)" 4)))
    ("CHEBI:88061"
     (("polyamine" 92) ("polyamines" 88) ("Polyamine" 9) ("Polyamines" 2)
      ("than the other polyamines" 1)))
    ("CHEBI:88212" (("pBCL2" 1)))
    ("CHEBI:88286"
     (("MEK inhibitor" 1614) ("MEK inhibitors" 1323) ("Mek inhibitor" 55)
      ("Mek inhibitors" 9) ("MEK Inhibitor" 8)
      ("MEK
inhibitors"
       2)
      ("an orally available MEK inhibitor" 2) ("than MEK Inhibitor" 2)
      ("alternate MEK inhibitors" 2) ("two clinically relevant MEK inhibitors" 2)
      ("targeted compounds identified MEK inhibitors" 2)
      ("a second non-ATP-competitive MEK inhibitor" 1)
      ("non-ATP-competitive MEK inhibitors" 1)
      ("clinically available MEK inhibitors" 1)
      ("this 1st generation MEK inhibitor" 1)
      ("a clinically applicable MEK inhibitor" 1) ("than the MEK inhibitor" 1)
      ("MEK inhibitor-" 1) ("an ATP-noncompetitive allosteric MEK inhibitor" 1)
      ("previously known MEK inhibitors" 1)))
    ("CHEBI:88294" (("Gallein" 1)))
    ("CHEBI:88339"
     (("BMS-754807" 132)
      ("the dual anti-IGF-IR/InsR tyrosine kinase inhibitor BMS-754807" 1)
      ("than BMS-754807" 1) ("the dual IGF-IR/InsR inhibitor BMS-754807" 1)
      ("a new dual IGF-IR/InsR small molecule inhibitor BMS-754807" 1)
      ("a dual anti-IGF-IR/InsR inhibitor BMS-754807" 1)))
    ("CHEBI:88353"
     (("bryostatin-1" 7) ("bryostatin 1" 3) ("Bryostatin-1" 2)
      ("the clinically-available macrolide bryostatin 1" 2)
      ("Authentic bryostatin-1" 1)))
    ("CHEBI:88795" (("cholesteryl" 10) ("Cholesteryl" 1)))
    ("CHEBI:89634"
     (("melanin" 146) ("Melanin" 11)
      ("extensive microscopic or macroscopic melanin" 1) ("than melanin" 1)
      ("melanin's" 1)))
    ("CHEBI:89701" (("glutamylcysteine" 18) ("-glutamylcysteine" 3)))
    ("CHEBI:8988" (("SN-38" 215) ("SN-38-" 3)))
    ("CHEBI:90180" (("CL-387,785" 20)))
    ("CHEBI:90197" (("PHA-665752" 276) ("PHA-665752 (PHA)" 6)))
    ("CHEBI:90234" (("spiruchostatin" 4))) ("CHEBI:9024" (("Santin" 2)))
    ("CHEBI:90414" (("secretagogue" 15) ("secretagogues" 4)))
    ("CHEBI:90624" (("SGX523" 12) ("SGX-523" 2)))
    ("CHEBI:90681" (("SB-239063" 1)))
    ("CHEBI:90682" (("Torin2" 65) ("Torin 2" 10) ("torin2" 1) ("Torin2’s" 1)))
    ("CHEBI:90686" (("IC87114" 32))) ("CHEBI:90687" (("BIIB021" 40)))
    ("CHEBI:90690" (("U-73122" 29))) ("CHEBI:90724" (("AM251" 20) ("AM-251" 13)))
    ("CHEBI:90766"
     (("PMP" 151) ("PMPs" 86) ("Pmp" 1) ("pmp" 1) ("PMP's" 1) ("pMP" 1)))
    ("CHEBI:91091" (("CHIR-99021" 20) ("CHIR 99021" 7) ("CHIR-99021 (EMD)" 4)))
    ("CHEBI:91192" (("Ki16425" 38)))
    ("CHEBI:91224"
     (("S3I-201" 216) ("S3i-201" 7) ("S3I-201 (NCI)" 3)
      ("The amidosalicylic acid S3I-201" 1)))
    ("CHEBI:91275"
     (("BBN" 45) ("N-butyl-N-(4-hydroxybutyl)nitrosamine" 5)
      ("a well-established chemical carcinogen regimen BBN" 1)))
    ("CHEBI:9141"
     (("silver" 593) ("Silver" 248) ("-silver" 8) ("MS compatible silver" 2)
      ("either nonradioactive silver" 2) ("only faint silver" 2)
      ("a previously described silver" 2) ("a MS-compatible silver" 1)
      ("black metallic silver" 1) ("a typical silver" 1) ("metallic silver" 1)
      ("silver-" 1)))
    ("CHEBI:9144"
     (("silibinin" 207) ("Silibinin" 45) ("silibinin’s" 3)
      ("the cancer chemopreventive agent Silibinin" 1) ("dietary silibinin" 1)))
    ("CHEBI:91460" (("KN-93" 21) ("KN93" 20))) ("CHEBI:92211" (("SL327" 7)))
    ("CHEBI:9242"
     (("impulse" 43) ("impulses" 8) ("muscle cells receive electrical impulses" 1)
      ("electric impulses" 1)))
    ("CHEBI:9505" (("NBT" 129) ("NBT-" 1))) ("CHEBI:9509" (("TBL" 7)))
    ("CHEBI:9516"
     (("thapsigargin" 339) ("Thapsigargin" 40) ("thapsigargin (TG)" 8)
      ("Thapsigargin (TG)" 3)
      ("the well-characterized ER stress agent thapsigargin" 2)
      ("We first perfused 1 µM thapsigargin" 1)
      ("The proteostatic stress inducer thapsigargin" 1)
      ("thapsigargin (THAP)" 1)))
    ("CHEBI:9552"
     (("thiogalactoside" 46) ("-thiogalactoside" 41)
      ("-thiogalactoside (IPTG)" 4)))
    ("CHEBI:9555" (("THG" 1)))
    ("CHEBI:9607" (("Tiron" 53) ("tiron" 5) ("TIRON" 2)))
    ("CHEBI:9642" (("TPCK" 71)))
    ("CHEBI:9765"
     (("trypsin" 2700) ("Trypsin" 273) ("“Trypsin”" 5) ("trypsin-" 4)
      ("treated trypsin" 2) ("0.05% crude trypsin" 2) ("grade-modified trypsin" 2)
      ("TPCK-treated trypsin" 2) ("ice-cold trypsin" 2) ("trypsin (HAT)" 2)
      ("2 µg/ml TPCK-treated trypsin" 2) ("overnight using modified trypsin" 2)
      ("warm trypsin" 2) ("1  μ g/ml TPCK-treated Trypsin" 2)
      ("crystalline  trypsin" 1)
      ("The CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay kit and sequencing-grade trypsin"
       1)
      ("either exogenous trypsin" 1) ("trypsins" 1) ("residual trypsin" 1)
      ("subsequent trypsin" 1) ("trypsin–" 1) ("trypsin using McCoy's" 1)))
    ("EBI:2606881"
     (("9-1-1 complex" 297) ("9-1-1" 125) ("Rad9-Rad1-Hus1" 21) ("9–1–1" 10)
      ("9-1-1 complexes" 4) ("9–1–1 complex" 4) ("Rad9-Hus1-Rad1 complex" 3)
      ("9-1–1" 3) ("Rad9–Hus1–Rad1 complex" 2)
      ("the heterotrimeric 9-1-1 complex" 1)
      ("the heterotrimeric complex 9-1-1" 1)))
    ("EC:1.15.1.1" (("1.15.1.1" 1))) ("EC:2.7.10.1" (("2.7.10.1" 1)))
    ("FA:00048" (("ABCC" 12) ("ABCCs" 4) ("ABCC family" 3) ("abcc" 3) ("aBCC" 2)))
    ("FA:00067"
     (("ARD1" 298) ("Ard1" 2) ("protein G–agarose–bound ARD1" 1) ("ard1" 1)))
    ("FA:00080" (("ARP2" 14)))
    ("FA:00081"
     (("Arp3" 72) ("ARP3" 2)
      ("the lamellipodia-associated signal protein Arp3" 2)))
    ("FA:00087" (("GMF" 6))) ("FA:00123" (("AF4" 20) ("–AF4" 2)))
    ("FA:00149"
     (("adducin" 132) ("Adducin" 44) ("P-adducin" 11) ("p-adducin" 3)
      ("adducins" 2)))
    ("FA:00158" (("AlkB" 18) ("alkB" 2)))
    ("FA:00250"
     (("Argonaute" 57) ("argonaute" 17) ("argonautes" 3) ("Argonaute protein" 2)
      ("argonaute (Ago) family" 2) ("Argonaute (Ago) family" 2)
      ("Argonaute (AGO)" 1)))
    ("FA:00261" (("aros" 3) ("Aros" 2))) ("FA:00267" (("ARS2" 1)))
    ("FA:00330" (("flotillins" 56) ("Flotillins" 16)))
    ("FA:00348" (("Beclin" 22) ("beclin" 8)))
    ("FA:00361" (("beta-catenin" 1012) ("Beta-catenin" 68)))
    ("FA:00404"
     (("bZIP" 387) ("bZIPs" 115) ("bZIP family" 43) ("bZip" 32)
      ("bZIP families" 24) ("bZip family" 5) ("HLH-bZIP protein" 4)
      ("bZIP protein" 4) ("bZIP peptide" 4) ("BZIPs" 2) ("Several viral bZIPs" 2)
      ("Four unique bZIPs" 2) ("viral bZIPs" 2) ("Four viral bZIPs" 2)
      ("33 representative human bZIPs" 2) ("bZIP-" 2) ("the viral bZIPs" 1)
      ("almost all human bZIPs" 1) ("the 4 viral bZIPs" 1)
      ("all four viral bZIPs" 1) ("These homologous viral bZIPs" 1)
      ("most human bZIPs" 1) ("these four viral bZIPs" 1)
      ("the ancestral bZIP families" 1)))
    ("FA:00407" (("CNC" 88) ("CNC family" 2) ("pCNC" 2) ("CNCs" 1)))
    ("FA:00408"
     (("Fos" 536) ("fos" 159) ("Fos family" 34) ("fos-" 3) ("Fos peptide" 2)
      ("‘Fos’" 1) ("-Fos" 1)))
    ("FA:00409"
     (("Jun" 854) ("jun" 89) ("Jun family" 31) ("p-jun" 9) ("-jun" 5) ("Jun-" 4)
      ("p-Jun" 3) ("jun-" 2) ("jun family" 2) ("junS" 1) ("-Jun" 1)))
    ("FA:00412" (("PARs" 120)))
    ("FA:00475"
     (("cathelicidin" 80) ("CRAMP" 24) ("Cathelicidin" 5) ("cathelicidins" 2)
      ("Cathelicidins" 1) ("cathelicidin (CRAMP)" 1) ("exogenous cathelicidin" 1)
      ("than human cathelicidin (LL-37)" 1)))
    ("FA:00493" (("CBP3" 1)))
    ("FA:00722"
     (("connexin" 55) ("connexins" 35) ("Connexins" 6) ("cardiac connexins" 2)
      ("vascular specific connexins" 2) ("connexin family" 1) ("the connexin's" 1)
      ("vascular connexins" 1)))
    ("FA:00739" (("CoREST" 356) ("coREST" 5) ("CoRest" 3)))
    ("FA:00771" (("Csn7" 6) ("CSN7" 1)))
    ("FA:00787"
     (("cullin" 255) ("cullins" 161) ("Cullin" 127) ("Cullins" 14)
      ("cullin family" 13) ("Cullin family" 13) ("CULLINs" 4) ("Cullin protein" 4)
      ("cullin family protein" 3) ("cullin protein" 3) ("exogenous cullins" 2)
      ("RBX2-associated cullins" 2) ("A cullin’s" 2) ("than other cullins" 1)
      ("the 190 unique cullin" 1) ("multiple RBX1-associated cullins" 1)
      ("un-neddylated cullins" 1) ("the cullin’s" 1)))
    ("FA:00801" (("PDE1" 7))) ("FA:00802" (("PDE2" 3))) ("FA:00803" (("PDE3" 4)))
    ("FA:00807" (("PDE9" 4)))
    ("FA:00815"
     (("cyclin" 2744) ("cyclins" 2098) ("Cyclin" 417) ("Cyclins" 164)
      ("cyclin family" 34) ("mitotic cyclins" 20) ("Cyclin protein" 7)
      ("-cyclin" 6) ("cyclin protein" 5) ("cyclin-" 4)
      ("regulatory subunits called cyclins" 4) ("the predominant D-type cyclin" 4)
      ("one or more D-type cyclins" 3) ("a mitotic cyclin" 3)
      ("secondary cyclins" 3) ("mitotic Cyclins" 2) ("proteins called cyclins" 2)
      ("the predominant cyclin" 2) ("a key mitotic cyclin" 2)
      ("cyclin molecule" 2) ("the mitotic B cyclins" 2) ("Viral cyclin" 2)
      ("the principal mitotic cyclins" 2) ("Secondary cyclins" 2)
      ("one or more cyclins" 2) ("an atypical cyclin" 2) ("associated cyclins" 2)
      ("many more cyclins" 2) ("the G2-associated cyclin" 2) ("Cyclin family" 2)
      ("the principal G 1 -phase cyclin" 1)
      ("cells not expressing exogenous cyclin" 1) ("the archetypical cyclins" 1)
      ("at least 11 cyclins" 1) ("the retroviral cyclin protein" 1) ("–cyclin" 1)
      ("than the other D-type cyclins" 1) ("two five-helical cyclin" 1)
      ("the most frequently expressed cyclin" 1) ("their associated cyclins" 1)
      ("than other cyclins" 1) ("this mitotic cyclin" 1) ("the residual cyclin" 1)
      ("the main mitotic cyclins" 1) ("various candidate mitotic cyclins" 1)
      ("a relevant cyclin" 1) ("both mitotic cyclins" 1)
      ("all three flag-tagged D-type Cyclins" 1) ("the relevant cyclins" 1)
      ("their respective cyclins" 1) ("mitotic cyclin" 1)
      ("pre-ubiquitinated cyclin" 1) ("typical cyclins" 1)
      ("at least 16 cyclins" 1)))
    ("FA:00837" (("CYFIP" 41) ("Cyfip" 3)))
    ("FA:00839" (("cystatin" 43) ("cystatins" 2) ("Cystatin" 1)))
    ("FA:00874" (("dans" 5) ("DAN family" 3)))
    ("FA:00880" (("DCP1" 16) ("Dcp-1" 6) ("Dcp1" 6)))
    ("FA:00914" (("DEAH" 12) ("DEAH family" 3)))
    ("FA:00950"
     (("Dickkopf" 19) ("Dickkopf family" 11) ("Dickkopfs" 2)
      ("Dickkopf (Dkk) family" 2)))
    ("FA:01047" (("Dystrobrevin" 2))) ("FA:01051" (("EAF" 6) ("EAF family" 1)))
    ("FA:01106" (("Endosulfines" 3) ("endosulfine" 2) ("Endosulfine" 1)))
    ("FA:01142"
     (("ETS" 1204) ("Ets" 532) ("ETS family" 146) ("Ets family" 57)
      ("ETS protein" 26) ("pETS" 17) ("Ets protein" 5) ("ETS-" 4)
      ("ETS (E26 transformation-specific) family" 2)
      ("ETS ( E-twenty six ) family" 2) ("Ets family protein" 2)
      ("ETS ( E 26 T ransformed S pecific) family" 2) ("targeted ETS" 1)
      ("Ets (E-twenty-six) family" 1) ("\"Ets\"" 1) ("than 25 mammalian Ets" 1)))
    ("FA:01183"
     (("Exo84" 394) ("EXO84" 4) ("“sh-Exo84”" 1) ("–Exo84" 1) ("-Exo84" 1)))
    ("FA:01185" (("TRex" 22) ("TREx" 15)))
    ("FA:01249" (("Abraxas" 176) ("Abraxas-" 1) ("the recurrent Abraxas" 1)))
    ("FA:01347" (("fibrillin" 59) ("fibrillins" 27) ("Fibrillins" 4)))
    ("FA:01349"
     (("fibulin" 5) ("fibulin family" 5) ("fibulins" 4) ("FIBULIN family" 2)
      ("Fibulins" 1)))
    ("FA:01352"
     (("filamin" 144) ("filamins" 8) ("Filamin" 6) ("Filamins" 2)
      ("filamin (Fln) family" 2)
      ("control carrier-treated cells contained filamin" 2)))
    ("FA:01356" (("Fit" 32) ("Fits" 9)))
    ("FA:01359" (("FKBP-1" 18) ("FKBP-1–" 2) ("FKBP1" 1)))
    ("FA:01383" (("diaphanous" 16) ("Diaphanous" 11)))
    ("FA:01385" (("FPG" 88) ("FPG protein" 1))) ("FA:01426" (("Mas" 24)))
    ("FA:01441" (("Gab" 20) ("Gab family" 6) ("pGab" 5) ("GAB family" 3)))
    ("FA:01442" (("GADD45" 254) ("GADD45-" 3) ("-GADD45" 2) ("GADD45 protein" 1)))
    ("FA:01443" (("Gauge" 78) ("GAGE" 2)))
    ("FA:01627"
     (("glypican" 7) ("glypican family" 5) ("glypicans" 2) ("Glypicans" 2)))
    ("FA:01630" (("GnRH" 431) ("GnRHs" 12) ("GnRh" 4) ("hypothalamic GnRH" 1)))
    ("FA:01638" (("gonadal" 97) ("Gonadal" 1))) ("FA:01658" (("CP2" 7)))
    ("FA:01659" (("grainyhead" 4) ("Grainyhead" 2) ("Grainyhead (GRH)" 1)))
    ("FA:01671" (("Kappa" 95)))
    ("FA:01673" (("Omega" 139) ("Clustal Omega" 3) ("The Clustal Omega" 2)))
    ("FA:01677"
     (("zeta" 181) ("Zeta" 30) ("BMS" 26) ("-zeta ( PRKCZ )" 4)
      ("-zeta ( PRKCZ)" 4) ("Zeta (PRKCZ)" 2) ("18 mm bare metal Zeta (BMS)" 2)
      ("the atypical PKC isoform zeta" 2) ("-zeta" 2) ("RSG treated BMS" 1)
      ("Zeta (BMS)" 1)))
    ("FA:01729"
     (("Hedgehog" 313) ("hedgehog" 128) ("Hedgehog (SHH)" 6) ("Hedgehog (HH)" 6)
      ("Hedgehog (Hh) family" 3) ("hedgehog protein" 2) ("hedgehog (HH)" 1)))
    ("FA:01734" (("RecQ" 107) ("RecQ family" 21) ("recQ" 6)))
    ("FA:01747" (("HEXIM" 4)))
    ("FA:01749" (("Hey" 37) ("HEY family" 9) ("HEY families" 1)))
    ("FA:01753" (("HIN-200 family" 9) ("HIN200" 7) ("HIN200 family" 6)))
    ("FA:01763"
     (("histone H2B" 205) ("Histone H2B" 42) ("histone 2B" 15) ("Histone 2B" 3)
      ("histone H2B protein" 2) ("A fluorescently-tagged histone H2B" 1)))
    ("FA:01775" (("Hits" 34) ("Hit" 33) ("HIT family" 3)))
    ("FA:01780" (("HMGA family" 2) ("Hmga" 1)))
    ("FA:01786"
     (("Homer" 62) ("homer" 2) ("Homer family" 2) ("Homer (TPPSPF)" 1)))
    ("FA:01788" (("HOOK" 4) ("Hook family" 2) ("hook family" 1)))
    ("FA:01805"
     (("IAN" 48) ("IAN family" 7)
      ("IAN (immune-associated nucleotide-binding protein) family" 2)))
    ("FA:01820" (("IL-1" 1255) ("IL1" 80) ("pIL1" 10) ("Il-1" 3) ("Il1" 1)))
    ("FA:01833"
     (("immunoglobulin" 1408) ("immunoglobulin superfamily" 53)
      ("Immunoglobulin" 45) ("IVIG" 36) ("immunoglobulin family" 8)
      ("Immunoglobulin superfamily" 6) ("immunoglobulin (Ig) family" 6)
      ("intravenous immunoglobulin" 5) ("intravenous immunoglobulin (IVIG)" 4)
      ("immunoglobulin protein" 4) ("nonspecific immunoglobulin" 3)
      ("complete monoclonal immunoglobulin" 2)
      ("a structurally stable C-terminal immunoglobulin" 2)
      ("than an intact immunoglobulin (IgG)" 1)
      ("horseradish peroxidase-labeled appropriate secondary immunoglobulin" 1)
      ("secondary anti-mouse immunoglobulin" 1)
      ("light-chain-restricted surface immunoglobulin" 1)
      ("monoclonal immunoglobulin" 1)
      ("horseradish peroxidase-conjugated secondary immunoglobulin" 1)
      ("secondary anti-rabbit horseradish peroxidase–conjugated immunoglobulin" 1)
      ("appropriate secondary biotinylated immunoglobulin" 1)
      ("than immunoglobulin (150 kDa, 12.0 ml, xref )" 1)
      ("non-immunogenic immunoglobulin" 1)))
    ("FA:01836"
     (("CEA" 457) ("preoperative CEA" 10) ("preoperative serum CEA" 3)
      ("an elevated preoperative CEA" 2) ("postoperative CEA" 1)
      ("The pre-operative CEA" 1) ("serum preoperative CEA" 1)))
    ("FA:01840" (("ICAM" 110) ("ICAMs" 10))) ("FA:01844" (("MyBP" 25)))
    ("FA:01845" (("Robo" 31) ("Robos" 12) ("Robo family" 2)))
    ("FA:01856" (("ING family" 9))) ("FA:01867" (("Insig" 7) ("Insigs" 5)))
    ("FA:01924" (("ITIH" 12) ("ITIHs" 1))) ("FA:01930" (("Jade" 11) ("Jade-" 1)))
    ("FA:01933"
     (("Janus" 353) ("Janus family" 25) ("janus" 23) ("Janus family (JAK)" 4)
      ("Janus (JAK) family" 3) ("the two-faced Roman god Janus" 2) ("-Janus" 1)
      ("JANUS" 1) ("the receptor-associated Janus" 1)))
    ("FA:01961" (("Kin17" 3)))
    ("FA:01962" (("Kindlin" 4) ("kindlin family" 2) ("Kindlins" 1)))
    ("FA:01967"
     (("chromokinesin" 13) ("chromokinesins" 1)
      ("at least one additional chromokinesin" 1) ("Chromokinesins" 1)))
    ("FA:01968" (("Kif26" 17))) ("FA:01974" (("NCD" 12) ("“NCD”" 1)))
    ("FA:01978" (("Kizuna" 8)))
    ("FA:02002"
     (("Ku70" 1357) ("Ku-70" 8) ("Ku70 protein" 7) ("a strong nuclear Ku70" 2)
      ("-Ku70" 2) ("both virus-associated and cell-associated Ku70" 1)
      ("exogenous Ku70" 1) ("contained more Ku70" 1)
      ("its heterodimeric partner Ku70" 1)))
    ("FA:02009" (("Lamp" 93) ("LAMP family" 1))) ("FA:02014" (("LARP" 4)))
    ("FA:02020" (("LDB" 8)))
    ("FA:02022"
     (("LDH" 858) ("maximal neuronal LDH" 1)
      ("the known prognostic factor LDH" 1)))
    ("FA:02030" (("LEM" 20)))
    ("FA:02093" (("Lin28" 134) ("lin-28" 7) ("Lin-28" 1)))
    ("FA:02096" (("Lin7" 6)))
    ("FA:02101"
     (("lipoxygenase" 57) ("lipooxygenase" 34) ("lipoxygenases" 14)
      ("-Lipoxygenase" 7) ("Lipoxygenase" 6) ("lipoxygenase family" 4)
      ("-lipoxygenase" 4) ("Lipoxygenases" 3) ("lipoxygenase (LOX) family" 2)))
    ("FA:02102" (("liprin" 26) ("Liprin" 2) ("liprins" 2)))
    ("FA:02122"
     (("Lst2" 23) ("Lst2 protein" 5) ("Lst2s" 2)
      ("evolutionarily distant Lst2s" 1)))
    ("FA:02124" (("LTBP" 7) ("LTBPs" 1)))
    ("FA:02147" (("MAGUK family" 16) ("MAGuKs" 12) ("MAGuK" 11) ("MAGUKs" 2)))
    ("FA:02180"
     (("mask" 501) ("masks" 129) ("Mask" 75) ("‘masks’" 5)
      ("the Basic Analyzer segmentation mask" 3) ("Binary masks" 3)
      ("binary masks" 2) ("a stringent CD3 mask" 1) ("cyoplasmic masks" 1)
      ("Masks" 1)))
    ("FA:02181" (("Mastermind" 25) ("mastermind" 6) ("Mastermind family" 4)))
    ("FA:02189" (("MCTP" 8))) ("FA:02225" (("mEGF" 12))) ("FA:02236" (("Mesd" 1)))
    ("FA:02239" (("metallo-β-lactamase family" 3) ("metallo-β-lactamase" 2)))
    ("FA:02253" (("Metaxin" 3))) ("FA:02295" (("MIC" 56) ("MICs" 54)))
    ("FA:02310" (("Mis18" 58))) ("FA:02319" (("MLFs" 36)))
    ("FA:02331" (("Mo25" 7))) ("FA:02358" (("MRL" 24)))
    ("FA:02363" (("MS4A" 13) ("MS4A family" 10))) ("FA:02382" (("Musashi" 13)))
    ("FA:02383" (("muscleblind" 4) ("Muscleblind" 1)))
    ("FA:02385" (("mut7" 6) ("Mut7" 3) ("Mut-7" 1))) ("FA:02391" (("Myeov2" 149)))
    ("FA:02396" (("myozenin" 6)))
    ("FA:02431" (("NDRG family" 6) ("pNDRG" 4) ("NDRG" 2)))
    ("FA:02442" (("Nesprins" 13) ("Nesprin" 3) ("perinuclear Nesprins" 1)))
    ("FA:02445" (("neurexins" 4) ("Neurexins" 3)))
    ("FA:02453" (("Neuropilins" 4) ("Neuropilin" 2))) ("FA:02467" (("Niban" 4)))
    ("FA:02472" (("Nip3" 1))) ("FA:02475" (("NIPSNAP" 2)))
    ("FA:02482" (("NLRP" 2) ("NLRPs" 1)))
    ("FA:02506"
     (("Notch" 4163) ("Notch family" 19) ("Notch protein" 8) ("NOTCH family" 5)
      ("ICNX" 5) ("ICN" 4) ("Notch molecule" 3) ("Notch's" 3) ("Notch-" 3)
      ("moderate and high Notch" 3) ("constitutively intracellular Notch" 2)
      ("Notch (ICN)" 1) ("stage-specific physiologic and pathologic Notch" 1)
      ("Notch (NICD)" 1) ("Notch’s" 1) ("“on-Notch”" 1)))
    ("FA:02511" (("NPIP" 4))) ("FA:02517" (("NRAMP" 1) ("nramp" 1)))
    ("FA:02523" (("Nse4" 1))) ("FA:02525" (("NSG" 224)))
    ("FA:02541" (("Nucleobindin" 10))) ("FA:02562" (("NudF" 4)))
    ("FA:02571" (("Nxf" 3)))
    ("FA:02586"
     (("OKL38" 179) ("OKL38 protein" 7) ("His6-OKL38 protein" 2)
      ("The p53 R72 Polymorphic Allele More Efficiently Targets OKL38" 2)))
    ("FA:02595" (("Orai" 9))) ("FA:02613" (("Ost1" 1)))
    ("FA:02631" (("P4HAs" 4) ("P4HA" 1))) ("FA:02635" (("PA28" 6)))
    ("FA:02636" (("PACS" 22) ("PACS-" 1)))
    ("FA:02641" (("bicoid" 3) ("bicoid subfamily" 2) ("Bicoid" 1)))
    ("FA:02656" (("paraoxonase" 5) ("paraoxonases" 1) ("paraoxonase (PON)" 1)))
    ("FA:02660" (("Parvin" 7) ("parvin" 6) ("-parvin" 5) ("parvins" 3)))
    ("FA:02661" (("PAT1" 5) ("Pat1" 5))) ("FA:02718" (("secernin" 1)))
    ("FA:02754" (("BRCC36" 53)))
    ("FA:02763" (("granzymes" 36) ("granzyme" 21) ("Granzyme" 2) ("granzyme-" 1)))
    ("FA:02764"
     (("kallikrein" 23) ("kallikreins" 12) ("Kallikreins" 6)
      ("kallikrein (KLK) family" 4) ("kallikrein family" 3) ("Kallikrein" 2)))
    ("FA:02787" (("DPPIV" 9)))
    ("FA:02794" (("perilipin" 24) ("Perilipin" 2) ("most perilipin" 1)))
    ("FA:02795"
     (("peroxidase" 6521) ("peroxidase (HRP)" 632) ("Peroxidase" 323)
      ("peroxidases" 152) ("Peroxidase (HRP)" 16)
      ("the secondary antibody and streptavidin-biotin peroxidase" 4)
      ("peroxidase ( HRP )" 3) ("peroxidase (DAKO)" 2) ("Peroxidase (HRPO)" 2)
      ("using indirect horseradish peroxidase" 2)
      ("secondary goat anti-mouse antibody IgG-horseradish peroxidase (HRP)" 2)
      ("Secondary antibody goat anti-rabbit horseradish peroxidase" 2)
      ("secondary horseradish peroxidase" 2)
      ("antibody-conjugated proprietary micropolymer peroxidase" 2)
      ("peroxidase (DAB)" 2) ("peroxidase (POD)" 2) ("peroxidase (HP)" 2)
      ("biotinylated secondary antibody and streptavidinhorseradish peroxidase (HRP)"
       2)
      ("a proprietary antibody-conjugated micropolymer peroxidase" 2)
      ("peroxidases (HRP)" 2)
      ("the appropriate secondary antibody-horseradish peroxidase" 2)
      ("correspondent horseradish peroxidase" 1) ("peroxidase (PO)" 1)
      ("a secondary goat anti–mouse horseradish peroxidase" 1)
      ("peroxidase families" 1) ("peroxidase (KPL)" 1)
      ("secondary biotinylated antibody and streptavidin-horseradish peroxidase"
       1)
      ("the biotinylated secondary antibody peroxidase" 1)
      ("secondary antibodies (1:10,000) horseradish peroxidase" 1)
      ("biotinylated secondary antibodies and streptavidin-biotin peroxidase" 1)
      ("secondary immunoglobulin-G-horseradish peroxidase" 1)
      ("using peroxidase" 1) ("Secondary horseradish peroxidase (HRP)" 1)
      ("secondary goat anti-IgG horseradish peroxidase" 1)
      ("multifunctional antioxidant thioredoxin-dependent peroxidases" 1)
      ("Peroxidases" 1) ("Secondary antibodies horseradish peroxidase" 1)
      ("peroxidase (SP)" 1) ("secondary antibody–horseradish peroxidase" 1)
      ("a biotinylated goat anti-rabbit secondary antibody and streptavidin-horseradish peroxidase"
       1)
      ("the appropriate secondary antibody horseradish peroxidase" 1)
      ("using secondary biotinylated antibodies and streptavidin/horseradish peroxidase"
       1)
      ("The secondary horseradish peroxidase" 1) ("Peroxidase (DAB)" 1)
      ("appropriate secondary antibody-horseradish peroxidase" 1)
      ("peroxidase (CST)" 1) ("peroxidase (HPR)" 1) ("peroxidase (POX)" 1)
      ("Peroxidase (TPO)" 1)
      ("its redox soluble partner cytochrome c peroxidase" 1)
      ("respective horseradish peroxidase" 1)
      ("Respective horseradish peroxidase" 1)
      ("the secondary horseradish peroxidase" 1)))
    ("FA:02859"
     (("PIAS" 112) ("PIAS family" 26) ("the only PIAS protein" 1)
      ("PIAS protein" 1)))
    ("FA:02884" (("PKIs" 31) ("pkIs" 11) ("pKI" 3) ("PKi" 1)))
    ("FA:02889"
     (("plexin" 66) ("Plexin" 30) ("plexin family" 8) ("plexin molecule" 3)
      ("PLEXIN" 1) ("Plexin families" 1)
      ("this trimeric arrangement each plexin molecule" 1)))
    ("FA:02983" (("class1" 4) ("Class1" 1)))
    ("FA:02994" (("prune" 41) ("we first prune" 1)))
    ("FA:03001"
     (("PP1" 3514) ("PP-1" 72) ("associated PP1" 8) ("NIPP1-associated PP1" 8)
      ("-PP1" 6) ("intranuclear PP1" 5) ("PP1’s" 3) ("overexpressed PP1" 3)
      ("exogenous PP1" 2) ("PP1 protein" 2)
      ("the most extensively studied neuronal PP1" 2)
      ("the nonselective kinase inhibitor PP1" 2) ("the neuronal PP1" 2)
      ("AKAP149 not only anchors PP1" 1) ("Exogenous PP1" 1)
      ("chromatin-associated PP1" 1) ("at least some PP1" 1) ("well-folded PP1" 1)
      ("previously published PP1" 1) ("previously studied PP1" 1)
      ("soluble PP1" 1) ("direct PP1’s" 1) ("than PP1 (Fig. xref )" 1)
      ("about RNAPII-associated PP1" 1)
      ("the C-terminal 134 amino acids of PP1" 1) ("than PP1" 1)
      ("all previously reported PP1" 1) ("than native PP1" 1) ("PP1-" 1)
      ("than free PP1" 1) ("all other available PP1" 1)))
    ("FA:03002" (("PP2B" 57)))
    ("FA:03015"
     (("prion" 125) ("prion protein" 50) ("prions" 23) ("Prion" 12)
      ("Prion protein" 4) ("Prion Protein" 3) ("exogenous prion protein" 2)
      ("prion-" 1) ("“prion”" 1) ("transmissible prion" 1)
      ("than typical prions" 1) ("typical prions" 1)))
    ("FA:03028" (("prominin" 8) ("prominins" 8) ("Prominin" 7) ("Prominins" 1)))
    ("FA:03061" (("cGMP" 214) ("we first measured intracellular cGMP" 1)))
    ("FA:03066"
     (("Akt" 31999) ("Rac" 4159) ("PKB" 1253) ("pAkt" 1172) ("p-Akt" 972)
      ("pAKT" 516) ("protein kinase B" 423) ("P-Akt" 277) ("RAC" 209) ("-Akt" 103)
      ("Akt-" 75) ("Akt protein" 56) ("rac" 38) ("Protein kinase B" 34)
      ("AKTs" 32) ("Akt family" 25) ("pkbA" 21) ("protein kinase B (PKB)" 19)
      ("PkbA" 19) ("Protein Kinase B" 15) ("PKBA" 14) ("pRac" 13)
      ("RAC family" 10) ("–Akt" 10) ("Rac protein" 10) ("Akt peptide" 9)
      ("PKBs" 9) ("dominant-negative Akt" 8) ("-protein kinase B" 7)
      ("dominant-negative Rac" 7) ("raft-associated Akt" 7) ("-Rac" 6) ("Akt’s" 6)
      ("total and phosphorylated Akt" 6) ("protein kinase B (AKT)" 6) ("Rac-" 6)
      ("Rac family" 6) ("pAkt-" 6) ("p-Akt protein" 5) ("Akts" 5)
      ("pAkt (Ser-473) pAkt" 4) ("Racs" 4) ("p-PKB" 4)
      ("both total and phosphorylated Akt" 3) ("RAC protein" 3)
      ("rabbit monoclonal Akt" 3) ("—protein kinase B" 3) ("protein kinase b" 3)
      ("–protein kinase B" 3) ("partially active glu-glu–tagged PKB" 2)
      ("“Akt”" 2) ("pAKt" 2) ("overexpressed Akt" 2) ("monoclonal Akt" 2)
      ("Akt's" 2) ("Intense (grade 2 and 3) p-Akt" 2)
      ("overexpressed constitutively active Rac" 2) ("phospho-PKB" 2) ("PKBa" 2)
      ("AktS" 2) ("than Akt" 2)
      ("β-arrestin 2 coprecipitated full-activated Akt" 2)
      ("LPS increased phosphorylated Akt" 2) ("rac-" 2)
      ("the prosurvival kinase Akt" 2) ("Cytoplasmatic phospho-Akt" 2)
      ("only TLC activated Akt" 2) ("neuronal pAkt" 2)
      ("monoclonal mouse antibody phospho-Akt" 2) ("so all Rac" 2) ("-Akt(PKB)" 2)
      ("Akt (DA)" 2) ("less Akt" 2) ("PKB protein" 1) ("dominant-negative  Rac" 1)
      ("“pAkt”" 1) ("pPKB" 1) ("-protein kinase B (PKB)" 1)
      ("protein kinase B-" 1) ("dominant-negative RAC" 1)
      ("monoclonal phospho-Akt" 1) ("the pivotal cell survival kinase Akt" 1)
      ("than the myristoylated Akt ( xref , xref )" 1)
      ("protein
kinase B"
       1)
      ("than the myristoylated Akt" 1) ("transiently increases p-Akt" 1)
      ("a dominant-negative Akt" 1) ("exogenous Akt" 1)
      ("a kinase-dead dominant-negative (DN) Akt" 1) ("more Akt" 1)
      ("Sal increased pAkt" 1) ("p-Akt (pS473) protein" 1)
      ("the latter PI3K(Pten)-Akt" 1) ("instead endogenous Rac" 1) ("“p-Akt”" 1)
      ("pAkt's" 1) ("pAkt (Ser-473) protein" 1)
      ("slightly stronger phospho-Akt" 1)
      ("β-catenin decreased phosphorylated Akt" 1) ("pAkt protein" 1) ("RACs" 1)
      ("previously-published reports demonstrated Akt" 1) ("undetectable pAkt" 1)
      ("subsequent Akt" 1) ("—Akt" 1) ("than WT Akt ( xref )" 1)
      ("Ample evidence links Akt" 1) ("PBD–GST-reactive Rac" 1)
      ("Dominant-negative Akt" 1) ("Akt (CST)" 1)
      ("serine (S)/threonine (T) protein kinase Akt" 1)
      ("hypertonic conditions Akt" 1) ("predominantly uses Rac" 1) ("pkbA-" 1)
      ("more Rac" 1) ("residual Akt" 1) ("Rac's" 1)
      ("Similarly phosphorylated and total Akt" 1) ("than non-raft Akt" 1)
      ("increased Akt's" 1) ("down twofold more active Rac" 1) ("Rac (WT)" 1)
      ("even highly purified constitutively active Akt" 1) ("more total Akt" 1)
      ("Akt–" 1) ("membrane-associated Akt" 1) ("Akt (HA)" 1)
      ("pAkt (Thr308) protein" 1)))
    ("FA:03072"
     (("CaMK" 137) ("CaMKs" 25) ("CaM kinase" 12) ("CAMK" 9) ("CaM kinases" 2)
      ("CaM-K" 2) ("CamK" 2) ("CaM-kinase" 1)))
    ("FA:03074" (("DAP-kinase" 2)))
    ("FA:03078"
     (("PIM" 162) ("Pim" 122) ("PIM family" 8) ("PIM−" 3) ("Pim family" 2)))
    ("FA:03080" (("SNF1" 22))) ("FA:03081" (("Tribbles" 10) ("tribbles" 8)))
    ("FA:03093" (("NIMA" 32) ("the mitotic kinase NIMA" 1)))
    ("FA:03097"
     (("Aurora" 1398) ("aurora" 95) ("Aurora family" 12) ("AURORA" 3)
      ("aurora family" 2) ("Auroras" 1)))
    ("FA:03101"
     (("CK2" 1271) ("CKII" 89) ("casein kinase 2" 88) ("casein kinase II" 39)
      ("Casein kinase 2" 13) ("Casein kinase II" 11) ("CK2 protein" 4) ("Ck2" 2)
      ("a potential CK2" 2) ("namely protein kinase CK2" 2) ("pure CK2" 1)
      ("the FACT-associated kinase CK2" 1) ("ERK-interacted CK2" 1)))
    ("FA:03103" (("haspin" 20) ("Haspin" 2) ("Haspin-" 1)))
    ("FA:03108" (("WNK" 10) ("WNK family" 4) ("WNK subfamily" 3)))
    ("FA:03111" (("STE20" 33) ("Ste-20" 7) ("STe-20" 3)))
    ("FA:03114"
     (("Raf" 2248) ("RAF" 1501) ("RAFs" 41) ("RAF family" 28) ("Raf family" 24)
      ("Rafs" 13) ("rAFS" 9) ("RAF protein" 7) ("p-RAF" 6)
      ("Raf family protein" 3) ("pRaf" 3) ("Raf-" 2) ("“RAF”" 1)
      ("dominant-negative Raf" 1) ("dominant-negative Raf-S621A" 1) ("Raf's" 1)
      ("monomeric RAF" 1)))
    ("FA:03115" (("ROCO family" 6) ("ROCO" 5) ("ROCO protein" 5)))
    ("FA:03125"
     (("FAK" 11064) ("pFAK" 376) ("Fak" 321) ("p-FAK" 140) ("fak" 15) ("FAKs" 12)
      ("P-FAK" 8) ("p-FAK protein" 3) ("Fak protein" 3) ("Fak-" 3) ("pFAKs" 2)
      ("p-FAKs" 2) ("less continuous p-FAK" 1) ("pFAK protein" 1)))
    ("FA:03130" (("Ror" 12) ("Ror protein" 1)))
    ("FA:03134"
     (("ties" 34) ("tie" 20) ("Tie" 18) ("TiE" 14) ("a strong tie" 1) ("Ties" 1)))
    ("FA:03160" (("PROTOR" 7)))
    ("FA:03208" (("R-spondin" 11) ("R-spondin family" 6) ("R-spondins" 2)))
    ("FA:03214" (("rabaptin" 1)))
    ("FA:03219"
     (("Rad23" 87) ("Rad23 protein" 6)
      ("the otherwise unrelated Saccharomyces cerevisiae Rad23 protein" 2)
      ("Given Rad23’s" 1) ("Rad23's" 1) ("rad23" 1)))
    ("FA:03221"
     (("Rad9" 463) ("RAD9" 97) ("rad9" 4) ("than Rad9" 3) ("Rad9 peptide" 2)
      ("Rad9 protein" 1) ("Rad9’s" 1)))
    ("FA:03263" (("Reprimo" 15) ("reprimo" 4)))
    ("FA:03281" (("rh-PN" 10) ("rhPN" 1))) ("FA:03414" (("RNA1" 8)))
    ("FA:03419"
     (("eukaryotic" 736) ("Eukaryotic" 85) ("eukaryotic protein" 5)
      ("a ubiquitous eukaryotic protein" 2)))
    ("FA:03474" (("Ruvb" 3) ("ruvb" 1)))
    ("FA:03480" (("S-100" 49) ("S-100 protein" 9))) ("FA:03495" (("SAPAP" 1)))
    ("FA:03513"
     (("SCF" 3693) ("SCFs" 43) ("-SCF~N8" 8) ("exogenous SCF" 5) ("soluble SCF" 5)
      ("SCF−" 4) ("SCF-" 2) ("Scf" 2)
      ("SCF (Skp1, Cullin, F-box protein) family" 2) ("“SCF”" 2) ("more SCF" 1)
      ("Cullin-1 based SCF" 1) ("than 100 ng/ml SCF (compare xref )" 1)
      ("Exogenous SCF" 1) ("non severe asthma serum SCF" 1) ("a dimerized SCF" 1)
      ("stably bind fully assembled SCFs" 1) ("a catalytically-competent SCF" 1)))
    ("FA:03516"
     (("SCM" 90) ("SCMs" 8) ("Cytoprotective SCM" 2)
      ("cytoprotective HS-5-derived SCM" 1)))
    ("FA:03529"
     (("Sec15" 198) ("sec15" 12) ("Sec15-D700K protein" 2) ("SEC15" 1)))
    ("FA:03534" (("Sec23" 10)))
    ("FA:03563"
     (("semaphorins" 144) ("semaphorin" 112) ("Semaphorins" 47) ("Semaphorin" 20)
      ("semaphorin family" 14) ("Semaphorin family" 3)
      ("proteins called Semaphorins" 2) ("Most class 3 semaphorins" 1)
      ("most class 3 semaphorins" 1) ("semaphorin families" 1)))
    ("FA:03572" (("SerB" 44) ("serB" 7)))
    ("FA:03578"
     (("serpins" 169) ("serpin" 108) ("Serpins" 45) ("SERPIN" 24) ("SERPINS" 20)
      ("Serpin" 9) ("SERPINs" 4)
      ("serpin ( ser  ine  p  rotease  in  hibitor ) family" 3)
      ("both a soluble as well matrix-anchored SERPIN" 2)
      ("most extracellular serpins" 2) ("serpin molecule" 2)
      ("the noninhibitory serpins" 2) ("Clade A serpins" 1) ("‘serpin’" 1)
      ("most serpins" 1)))
    ("FA:03580"
     (("Sestrins" 19) ("Sestrin" 15) ("sestrins" 15) ("sestrin" 13)
      ("sestrin family" 5) ("Sestrin family" 5) ("sestrin protein" 2)
      ("sestrins (SESN)" 1)))
    ("FA:03592" (("Sgf11" 2))) ("FA:03617" (("siD1" 6)))
    ("FA:03623"
     (("sirtuins" 1120) ("sirtuin" 626) ("Sirtuins" 273) ("sirtuin family" 232)
      ("Sirtuin" 153) ("Sirtuin family" 63) ("SIRT" 31)
      ("sirtuin (SIRT) family" 11) ("sirtuin families" 11)
      ("Sirtuin (SIRT) family" 10) ("sirtuin (SIRT)" 5) ("sirtuins family" 5)
      ("SIRTUINS" 4) ("SIRT family" 3) ("most other sirtuins" 2)
      ("Sirtuins family" 2) ("Sirtuin (SIRT)" 2) ("bacterial sirtuins" 2)
      ("Sirtuin protein" 2) ("at least one sirtuin" 2) ("sirtuin protein" 2)
      ("One well-studied sirtuin" 2) ("most Class III sirtuins" 2)
      ("only Class I sirtuins" 2) ("the mitochondrial-localized sirtuin" 2)
      ("the three mitochondrial-localized sirtuins" 1) ("Most sirtuins" 1)
      ("sirtuin's" 1) ("the above-mentioned ternary sirtuin" 1)
      ("ternary sirtuin" 1) ("-sirtuin" 1) ("sirtuins ( SIRT )" 1)
      ("the seven mammalian sirtuins, which are a conserved family of proteins possessing NAD + -dependent deacetylase activity"
       1)
      ("the seven mammalian sirtuins, which are homologs of the yeast Sir2 gene"
       1)
      ("tight-binding sirtuin" 1) ("Sirt" 1) ("the homologous sirtuin" 1)
      ("Presumably all Class III sirtuins" 1)
      ("the mainly prokaryotic class III Sirtuins" 1)))
    ("FA:03654" (("Slx1" 8)))
    ("FA:03659"
     (("Arf" 1371) ("Arfs" 17) ("ARFs" 15) ("arf" 14) ("Arf-" 11)
      ("Arf protein" 9) ("ARf" 2) ("peripheral ARFs" 2) ("highly basic p19 Arf" 2)
      ("the pro-apoptotic factor Arf" 2) ("Arf’s" 1) ("so exogenous Arf" 1)
      ("normally lack Arf" 1) ("most Arf protein" 1)
      ("nucleolar stress releases Arf" 1) ("exogenous Arf" 1) ("most Arfs" 1)))
    ("FA:03660" (("DIRAS" 17)))
    ("FA:03661"
     (("Rab" 354) ("Rabs" 140) ("RAB" 38) ("RasB" 33) ("Rab protein" 10) ("rab" 9)
      ("rAb" 4) ("the vesicle-associated rab" 3) ("rasB" 3) ("rASB" 2)
      ("an exocytic rab" 1) ("RaB" 1)))
    ("FA:03663"
     (("Ras" 11993) ("RAS" 6810) ("ras" 1090) ("Ras protein" 130)
      ("RAS protein" 66) ("Ras-" 55) ("-ras" 53) ("ras protein" 33) ("RAS-" 22)
      ("ras peptide" 15) ("intrarenal RAS" 14) ("Ras-family" 10) ("RasGTP" 9)
      ("-Ras" 8) ("a dominant-negative Ras" 7) ("pRAS" 6) ("ras-" 3)
      ("an activated cardiac RAS" 3) ("–Ras" 3) ("nigral intraneuronal RAS" 3)
      ("substantially more V12-Ras" 2) ("ras (KRAS)" 2) ("soluble Ras" 2)
      ("As-purified Ras" 2)
      ("the retroviral vector pBabe-hygro encoding constitutive active RAS" 2)
      ("possible confounding RAS" 2) ("dominant-negative (S17N) Ras" 2)
      ("more RAS" 2) ("mut(K)RAS and wtBRAF/(K)RAS" 2)
      ("constitutively-activated p21 Ras" 2) ("'RAS'" 2) ("neuronal Ras" 2)
      ("than non-ubiquitinated Ras" 2) ("Dominant-negative Ras" 2)
      ("a retrovirus-expressing dominant-negative Ras" 2) ("Ras (KSR)" 2)
      ("mouse monoclonal anti-pan Ras" 1) ("optimal Ras" 1)
      ("MEFs expressing RAS" 1) ("2 large collaborative Kirsten Ras" 1)
      ("particularly p21 ras" 1) ("Ras (KSR) family" 1) ("oncognic RAS" 1)
      ("directly target oncogenic RAS" 1)
      ("specifically immunoprecipitate active Ras" 1)
      ("than dipalmitolyated Ras" 1) ("the peripheral RAS" 1)
      ("efficiently target RAS" 1) ("systemic RAS" 1) ("paracrine tubular RAS" 1)
      ("more Ras" 1) ("accessible RasGTP" 1) ("point-mutated ras" 1)
      ("oncogeneic Ras" 1) ("than RAS (39 vs 13%, p=0.04)" 1) ("RAS–" 1)
      ("than farnesylated Ras ( xref )" 1)
      ("the principal RAF isoform linking Ras" 1) ("less Ras" 1)
      ("selectively target Ras" 1) ("ras (KSR)" 1) ("‘ras'" 1)
      ("investigated amino acids of RAS" 1) ("RAS ( KRAS )" 1)
      ("There activated Ras" 1) ("the membrane-associated Ras" 1) ("Ras’s" 1)
      ("targeting RAS" 1) ("sensitive cells typically display wild-type K- Ras" 1)
      ("we first examined RAS" 1) ("the Ras" 1)
      ("than codon 13 mutated or wild-type RAS" 1) ("dominant-negative Ras" 1)
      ("colon carcinomas and melanomas frequently harbour activated RAS" 1)
      ("than WT- Ras [Feig, xref ]" 1)))
    ("FA:03668"
     (("Rho" 4777) ("Rho-kinase" 533) ("rho" 252) ("RHO" 95) ("Rho protein" 36)
      ("Rho-" 18) ("Rho-kinases" 14) ("Rho associated kinase" 7) ("-Rho" 4)
      ("–Rho" 4) ("dominant–negative Rho" 3) ("the exact Rho protein" 3)
      ("rho-" 2) ("Membrane-permeable active Rho" 2)
      ("Rho (Ras homologue) family" 2) ("Rho-kinase (CAT)" 1) ("The distal Rho" 1)
      ("the distal Rho" 1) ("–RHO" 1) ("rho-kinase" 1)
      ("the predominant Rho protein" 1) ("Rho-kinase (ROCK)" 1) ("Rho’s" 1)))
    ("FA:03684"
     (("SMCs" 1361) ("SMC" 901) ("vascular SMCs" 58) ("human aortic SMCs" 27)
      ("vascular SMC" 23) ("CASMC" 23) ("arterial SMCs" 7) ("aortic SMCs" 5)
      ("cultured vascular SMCs" 5) ("visceral SMC" 4) ("Aortic SMCs" 4)
      ("human vascular SMCs" 4) ("neointimal SMCs" 4) ("PDGF-treated SMC" 3)
      ("SMC family" 3) ("medial SMCs" 3) ("SMCs (CASMC)" 3) ("human aortic SMC" 3)
      ("Human arterial SMC" 2) ("adherent SMC" 2) ("fewer SMC" 2)
      ("systemic vascular SMCs" 2) ("contractile intestinal SMC" 2)
      ("the degenerated vascular SMCs" 2) ("Human Arterial SMCs" 2)
      ("the vascular SMCs" 2) ("adherent human SMCs" 2)
      ("the Ad-FRNK-infected SMCs" 2)
      ("either Ad-PN-infected wildtype SMCs or Ad-PN-infected PN−/− SMCs" 2)
      ("the vascular wall SMCs" 2) ("rat aortic vascular SMCs" 2)
      ("asymptomatic plaque SMCs" 2) ("the highly proliferative neointimal SMC" 2)
      ("SMC (ASMC)" 2) ("pulmonary SMCs" 2) ("neointimal SMC" 2)
      ("apoptotic (TUNEL+) SMCs" 2) ("SMC protein" 2) ("both vascular SMC" 1)
      ("adherent vascular SMC" 1)
      ("either untreated or degraded collagen-treated SMC" 1)
      ("Human newborn arterial SMC" 1) ("cultured human arterial SMC" 1)
      ("human and rat aortic SMC" 1)
      ("Neil et al. used commercially available SMC" 1)
      ("both aortic and venous SMC" 1) ("coronary SMC" 1)
      ("Murine aortic SMC (MOVAS)" 1) ("Rat aortic SMCs" 1)
      ("human visceral SMC" 1) ("Pathologic SMC" 1) ("CD44-expressing SMCs" 1)
      ("cultured arterial SMCs" 1) ("calphostin C. Isolated aortic SMCs" 1)
      ("human arterial SMCs" 1) ("the SMC's" 1)
      ("than the adjacent SMC ( xref , xref )" 1) ("proliferating SMCs" 1)
      ("Vascular SMCs" 1) ("few SMCs" 1)
      ("the Ad-PN-infected wildtype SMCs and PN−/− SMCs" 1) ("rat aortic SMCs" 1)
      ("saphenous vein SMCs" 1) ("migrated SMCs" 1) ("arterial SMC" 1)
      ("venous SMC" 1) ("aortic SMC" 1) ("PDGF-BB-treated human aortic SMCs" 1)
      ("Human aortic SMCs" 1) ("predominantly vascular SMCs" 1)
      ("human coronary SMCs" 1) ("De-differentiated SMCs" 1)
      ("Normal human bronchial SMC" 1) ("medial SMC" 1)))
    ("FA:03696" (("SMN" 76) ("SMN protein" 8) ("the more severe SMN" 1)))
    ("FA:03701"
     (("SNAP" 388) ("SNAP (CYS)" 3) ("the web-based software SNAP" 2) ("SNAPs" 2)
      ("than SNAP" 1) ("exogenous NO/RNS donor SNAP" 1)))
    ("FA:03708" (("SWR1" 11) ("Swr1" 9))) ("FA:03709" (("SNF5" 24)))
    ("FA:03800" (("spectrins" 16))) ("FA:03804" (("SPF27" 2)))
    ("FA:03814"
     (("Sprouty" 194) ("Sprouty family" 19) ("Sprouty (Spry) family" 3)
      ("sprouty family" 3) ("pSprouty" 3) ("Sprouty (SPRY) family" 2)))
    ("FA:03817" (("Spt4" 5)))
    ("FA:03825"
     (("SREBP" 162) ("SREBPs" 26) ("transcriptional factor SREBP" 5)
      ("SREBP family" 4) ("SREBP protein" 4) ("mature SREBP" 2) ("pSREBP" 2)))
    ("FA:03840" (("SSX" 116) ("SSX protein" 2)))
    ("FA:03855"
     (("STOP" 132) ("FS-alternative STOP" 2) ("“STOP”" 1) ("the parent STOP" 1)
      ("sTOP" 1)))
    ("FA:03871" (("SUI1" 3))) ("FA:03872" (("sulfatase" 8) ("sulfatases" 1)))
    ("FA:03898" (("synaptojanins" 7))) ("FA:03901" (("synaptotagmin" 6)))
    ("FA:03905" (("syntrophin" 3)))
    ("FA:03908" (("TACC" 50) ("TACC family" 7) ("TACC families" 2)))
    ("FA:03909" (("tachykinin" 5) ("tachykinins" 2) ("Tachykinins" 1)))
    ("FA:03935" (("taxilin family" 2) ("taxilin" 2)))
    ("FA:03943"
     (("TCF/LEF" 681) ("TCF/Lef" 99) ("TCF/LEF family" 76) ("TCF/lef" 8)
      ("TCF/LEF-" 6) ("TCF/LEFs" 3) ("TCF/Lef family" 1) ("TCF/LEF's" 1)))
    ("FA:03988"
     (("TFA" 427) ("TFAs" 175) ("0.05% aqueous TFA" 4) ("methanolic TFA" 2)
      ("residual TFA" 1) ("a standard gradient using 0.1% TFA" 1)
      ("Other tissue-type-specific regulated TFAs" 1)
      ("their associated prostate cancer-associated TFAs" 1)
      ("we first compared each TFA" 1)
      ("the transcriptional network-inferred PTEN-controlled TFAs" 1)
      ("whose inferred TFAs" 1)))
    ("FA:03989"
     (("TGF-β" 6902) ("TGFβ" 4523) ("TGF-beta" 98) ("Tgfβ" 36) ("TGFβ family" 31)
      ("−TGF-β" 28) ("TGFbeta" 26) ("TGF-βs" 22) ("exogenous TGF-β" 22)
      ("TGF-β family" 19) ("TGF-β’s" 19) ("TGFβs" 13) ("TGF-β–" 8) ("TGF-β-" 7)
      ("TGF–β" 7) ("TGFβ’s" 5) ("TGF-β's" 4) ("TGFβ's" 3) ("TGFβ-" 3)
      ("exogenous TGFβ-1" 3) ("exogenous TGFβ" 2)
      ("pro-fibrotic growth factor TGFβ" 2) ("overactive TGFβ" 2) ("than TGFβ" 2)
      ("than TGF-β" 2) ("more TGF-β" 2) ("TGF-Beta" 2)
      ("the fibrotic growth factor TGF-β" 2) ("bioavailable TGF-β" 2)
      ("the fibrotic cytokine TGFβ" 2) ("microglial TGFβ-1" 2)
      ("pro-fibrotic TGF-β" 1)
      ("metastatic serous ovarian cancers highlighted TGFβ's" 1)
      ("metastatic serous ovarian cancers highlighted TGFβ" 1)
      ("these noncanonical TGFβ" 1)
      ("miR-181 and miR-21 most effectively abolished TGFβ's" 1)
      ("cerebral endothelium-derived TGF-β" 1) ("Cells perceive TGF-β" 1)
      ("targeting TGF-β" 1) ("14-3-3ζ switches TGF-β’s" 1)
      ("the specific Smad partners determining TGF-β’s" 1)
      ("ECM-associated TGFβ" 1) ("–TGF-β" 1)
      ("Resident fibroblasts not only secret TGFβ" 1)
      ("exogenously added and autocrine TGF-β's" 1) ("disable TGFβ’s" 1)
      ("disable TGFβ" 1) ("10% serum -/+ supplemental TGF-β" 1)
      ("a noncovalently linked mature TGF-β" 1)))
    ("FA:03997" (("thioesterases" 9)))
    ("FA:04006"
     (("TSP" 50) ("thrombospondin" 42) ("thrombospondins" 9) ("TSPs" 6)
      ("thrombospondin (TSP) family" 2) ("thrombospondin (TSP)" 2) ("THBS" 2)
      ("external TSP" 2) ("characteristic seven thrombospondin" 1) ("Tsp" 1)))
    ("FA:04014" (("Tiam" 19))) ("FA:04021" (("Tim50" 110) ("Tim50 protein" 6)))
    ("FA:04022" (("Timeless" 11) ("Timeless (hTim) protein" 3) ("timeless" 1)))
    ("FA:04027" (("TM2" 12)))
    ("FA:04071" (("NEMP" 20) ("NEMPs" 17) ("around 904 known human NEMPs" 1)))
    ("FA:04134" (("TORC" 47) ("TORCs" 15)))
    ("FA:04154"
     (("transglutaminase" 24) ("Transglutaminase" 5) ("transglutaminases" 5)
      ("transglutaminase family" 2) ("Transglutaminases" 1)))
    ("FA:04179" (("TRPV" 1))) ("FA:04199" (("sedlin" 2)))
    ("FA:04220" (("TRS85" 2))) ("FA:04300" (("UNC-5" 11)))
    ("FA:04571" (("vasohibin" 8) ("Vasohibin" 1))) ("FA:04577" (("vestigial" 10)))
    ("FA:04687" (("Wntless" 10) ("wntless" 2) ("WNTLESS" 2)))
    ("FA:04707" (("XPG" 59))) ("FA:04726" (("classII" 2)))
    ("FA:04805" (("mms22" 3) ("MMS22" 2) ("Mms22" 1)))
    ("FA:04809" (("TONSOKU" 2))) ("FA:04811" (("humanin" 5) ("Humanin" 4)))
    ("FA:04857" (("METTL20" 2))) ("FA:04861" (("Mieap" 5)))
    ("FA:04921"
     (("GATA" 398) ("Gata" 87) ("GATA family" 36) ("gata" 8) ("Gata family" 4)
      ("GATA protein" 2) ("pGATA" 2) ("GATAs" 1)))
    ("FA:04969" (("nYAP" 31) ("nYap" 26) ("intense nYap" 2)))
    ("FA:04971" (("asterix" 5) ("asterixes" 1))) ("FA:04980" (("mical" 2)))
    ("FA:05057" (("glycogenins" 4) ("glycogenin" 2) ("Glycogenins" 1)))
    ("FA:05157" (("Mvb12" 2)))
    ("FA:05162"
     (("polycomb-like" 9) ("polycomb-like protein" 5)
      ("polycomb-like (Pcl) protein" 4)))
    ("FA:05183" (("ATG8" 148) ("Atg8" 83) ("Atg8s" 11) ("Atg8 protein" 9)))
    ("FA:05184" (("Blm10" 7)))
    ("FA:05216" (("Eco" 372) ("pEco" 2) ("–Eco" 1) ("-Eco" 1)))
    ("GO:0000145"
     (("exocyst" 845) ("Exocyst" 274) ("Exocyst Complex" 10) ("“exocyst”" 9)
      ("exocyst’s" 1) ("the exocyst’s" 1) ("The exocyst’s" 1)
      ("the heterooctomeric exocyst (aka Sec6/8) complex" 1)
      ("exocyst (aka Sec6/8) complex" 1)))
    ("GO:0000502"
     (("proteasomal" 2477) ("proteasome complex" 59) ("Proteasomal" 55)
      ("non-proteasomal" 11) ("proteasome complexes" 2)))
    ("GO:0000791"
     (("euchromatin" 79) ("active euchromatin" 2) ("Euchromatin" 2)
      ("transcriptionally active euchromatin" 2) ("euchromatin-" 1)))
    ("GO:0000792"
     (("heterochromatin" 667) ("Heterochromatin" 8) ("heterochromatin complex" 2)
      ("apparently undergoes heterochromatin" 1)
      ("centromere-associated constitutive heterochromatin" 1)))
    ("GO:0000808"
     (("ORC" 108) ("origin recognition complex" 29) ("ORC complex" 13) ("orC" 3)
      ("ORCs" 1) ("orc" 1) ("a dimeric ORC" 1)))
    ("GO:0003796" (("lysozyme" 203) ("Lysozyme" 37) ("lysozyme (HEL)" 8)))
    ("GO:0004016" (("adenylylcyclases" 3)))
    ("GO:0004040" (("acylase" 4) ("de-long-chain fatty acylase" 2)))
    ("GO:0004053"
     (("arginase activity" 52) ("Arginase activity" 9) ("Arginase Activity" 6)
      ("vascular arginase activity" 3)
      ("TSA increased both total arginase activity" 1)))
    ("GO:0004148" (("Diaphorase" 4) ("diaphorase" 2)))
    ("GO:0004167"
     (("DCF" 354) ("the strongly fluorescent DCF" 4) ("highly fluorescent DCF" 2)
      ("the strongly fluorescent derivative DCF" 2)
      ("the fluorescent product DCF" 1) ("fluorescent DCF" 1)
      ("the highly fluorescent DCF" 1) ("more DCF" 1) ("-DCF ( DCF )" 1)
      ("-DCF" 1) ("the florescent H 2 DCF" 1) ("a highly fluorescent DCF" 1)))
    ("GO:0004175"
     (("endopeptidases" 90) ("endopeptidase" 50) ("endopeptidase activity" 4)
      ("homologous zinc-dependent endopeptidases" 2)
      ("a secretory endopeptidase" 1)
      ("membrane-associated zinc endopeptidases" 1)
      ("a probable endopeptidase" 1)))
    ("GO:0004177" (("aminopeptidase activity" 9)))
    ("GO:0004345" (("G6PDH" 15) ("G6PDH protein" 2)))
    ("GO:0004359"
     (("glutaminase" 146) ("glutaminase (GLS)" 9) ("Glutaminase" 6)
      ("glutaminases" 4) ("glutaminases (GLS)" 1) ("glutaminase (KGA)" 1)))
    ("GO:0004396"
     (("hexokinase" 66) ("Hexokinase" 20) ("hexokinase activity" 10)
      ("Hexokinase activity" 4)))
    ("GO:0004430" (("PI4Ks" 1))) ("GO:0004435" (("PI-PLCs" 10) ("PIPLC" 2)))
    ("GO:0004451"
     (("ICLs" 386) ("duplex ICLs" 9) ("iCL" 2) ("the duplex ICLs" 1)
      ("laser-activated ICLs" 1)))
    ("GO:0004497"
     (("monooxygenase" 26) ("monooxygenases" 10) ("monooxygenase activity" 2)))
    ("GO:0004519"
     (("endonuclease activity" 278) ("endonucleases" 234)
      ("structure-specific endonucleases" 6)
      ("a somewhat weak AP endonuclease activity" 2) ("bacterial endonucleases" 2)
      ("the abasic endonuclease activity" 2)
      ("the respective restriction endonucleases" 2)
      ("an intrinsic endonuclease activity" 2)
      ("structure-specific endonuclease activity" 2)
      ("a functional endonuclease activity" 1)
      ("apurinic-apyrimidinic endonucleases" 1)
      ("SLX4-associated MUS81-EME1 endonucleases" 1)
      ("several DNA structure-specific endonucleases" 1)
      ("multiple DNA structure-specific endonucleases" 1)
      ("its very week AP endonuclease activity" 1)
      ("a weak AP endonuclease activity" 1)
      ("structurally related heterodimeric flap endonucleases" 1)
      ("Structure-specific endonucleases" 1) ("endonuclease activity (FEN)" 1)
      ("rare-cutting endonucleases" 1)))
    ("GO:0004527"
     (("exonuclease activity" 197) ("exonucleases" 22)
      ("-exonuclease activity" 20) ("major cellular exonucleases" 4)
      ("-Exonuclease activity" 1) ("Exonuclease activity" 1)))
    ("GO:0004532"
     (("exoribonucleases" 5) ("Exoribonuclease activity" 2)
      ("exoribonuclease activity" 2) ("the two major exoribonucleases" 1)))
    ("GO:0004563" (("β-hexosaminidase" 21))) ("GO:0004565" (("βgalactosidase" 7)))
    ("GO:0004566"
     (("β-glucuronidase" 32) ("β-glucuronidase ( GUSB )" 4)
      ("β-GLUCURONIDASE" 4)))
    ("GO:0004616"
     (("6PGD" 228) ("6PGD protein" 3) ("dimeric 6PGD" 3) ("Monomeric 6PGD" 1)))
    ("GO:0004620"
     (("phospholipases" 42) ("phospholipase activity" 4) ("Phospholipases" 3)
      ("phospholipases (PLC)" 2)))
    ("GO:0004645"
     (("phosphorylase" 98) ("Phosphorylase" 10)
      ("Bacterial nucleoside phosphorylase" 2) ("P-phosphorylase" 2)))
    ("GO:0004660" (("FTase" 17)))
    ("GO:0004709" (("MAP3Ks" 45) ("MAPKKKs" 9) ("MEKKs" 6)))
    ("GO:0004725" (("PTPases" 10) ("cellular PTPases" 1)))
    ("GO:0004908" (("IL-1Rs" 6))) ("GO:0004921" (("IL11R" 1)))
    ("GO:0004930" (("G-protein coupled receptor activity" 1)))
    ("GO:0004935"
     (("adrenergic receptor" 80) ("adrenergic receptors" 33)
      ("-adrenergic receptor" 29) ("-adrenergic receptors" 20)
      ("adrenoreceptor" 5) ("-adrenoreceptor" 2) ("-adrenoreceptor (AR)" 2)
      ("adrenergic  receptor" 1) ("Adrenergic receptors" 1)))
    ("GO:0005024" (("TGFβR" 67) ("TGF-βR" 14) ("TGF-βRs" 3) ("TGFβRs" 2)))
    ("GO:0005089" (("RhoGEF" 256) ("RhoGEFs" 86) ("rhoGEF" 5)))
    ("GO:0005092"
     (("GDI" 157) ("GDI protein" 14) ("GDI molecule" 9)
      ("a previously characterized GDI" 1) ("a weak GDI" 1)))
    ("GO:0005184" (("neurohormone" 3)))
    ("GO:0005215"
     (("transporters" 569) ("transporter activity" 35)
      ("transmembrane transporters" 6) ("Transporters" 5)
      ("transmembrane transporter activity" 2)
      ("the above-mentioned transporters" 1) ("the major transporters" 1)
      ("transporters, enzymes involved in glutathione metabolism" 1)
      ("endoplasmic reticulum-resident transporters" 1)
      ("calcium ion transmembrane transporter activity" 1)
      ("48 distinct transporters" 1) ("anionic transporters" 1)))
    ("GO:0005484"
     (("SNARE" 132) ("t-SNAREs" 13) ("SNARE protein" 2) ("-SNARE" 2)
      ("the multiproteic SNARE" 1)))
    ("GO:0005643"
     (("nuclear pore" 204) ("nuclear pore complex" 93) ("nuclear pores" 38)
      ("nuclear pore complex (NPC)" 33) ("nucleopore" 6) ("Nucleopore complex" 4)
      ("Nuclear Pore" 2) ("Nuclear Pore Complex (NPC)" 2) ("Nucleopore" 2)
      ("nucleopore complex" 2) ("Nuclear pore" 2)
      ("the supramolecular nuclear pore complex (NPC)" 1) ("Nuclear pores" 1)))
    ("GO:0005681"
     (("spliceosome" 268) ("spliceosomal complex" 15) ("spliceosomes" 13)
      ("Spliceosome" 9) ("spliceosome complex" 6)
      ("the associated mRNA binding spliceosome" 2) ("Spliceosomal complex" 2)
      ("spliceosomal complexes" 2) ("the associated spliceosome" 1)
      ("the cotranscriptional spliceosome" 1) ("Spliceosomes" 1)
      ("active spliceosomes" 1) ("Spliceosomal complexes" 1)))
    ("GO:0005732"
     (("snoRNPs" 17) ("snoRNP" 8)
      ("small nucleolar ribonucleoprotein complexes" 3) ("snoRNP complex" 2)))
    ("GO:0005818"
     (("asters" 122) ("aster" 54) ("Aster" 21)
      ("a distinct centrosomal MT aster" 3) ("the few asters" 2) ("Asters" 2)
      ("monopolar asters" 2) ("a signal around mitotic asters" 1)
      ("rare huge asters" 1) ("no mitotic asters" 1) ("mitotic asters" 1)
      ("a radial aster" 1)))
    ("GO:0005840"
     (("ribosomal" 1459) ("ribosome" 1131) ("ribosomes" 306) ("Ribosome" 75)
      ("Ribosomal" 46) ("ribosome complex" 9) ("“Ribosome”" 6)
      ("mature ribosomes" 6) ("non-ribosomal" 5) ("stalled ribosomes" 2)
      ("genome-wide ribosome" 2) ("monomeric 80S ribosomes" 2)
      ("A genome-wide ribosome" 2) ("Genome-wide ribosome" 2) ("RIBOSOMAL" 2)
      ("Ribosomes" 2) ("co-translational ribosome" 2)
      ("a monomolecular ribosome" 2) ("more ribosomes" 2)
      ("an elongation-competent 80S ribosome" 1) ("active polysomal ribosomes" 1)
      ("“ribosome”" 1) ("than the ribosome" 1) ("the bacterial ribosome" 1)
      ("the translation-competent 80S ribosome" 1)
      ("the elongation-competent 80S ribosome" 1) ("-ribosomal" 1)
      ("translationally inactive ribosomes" 1) ("membrane-associated ribosomes" 1)
      ("soluble ribosomes" 1) ("internal mRNA ribosome" 1) ("non–ribosome" 1)))
    ("GO:0005844"
     (("polysomes" 222) ("polysome" 215) ("Polysome" 73) ("polyribosomes" 41)
      ("polyribosome" 17) ("Polyribosome" 10) ("Polysomes" 6)
      ("light and heavy polysomes" 2) ("active polysomes" 2)
      ("the highly translationally active polysomes" 1) ("largest polysomes" 1)
      ("soluble polysomes" 1)))
    ("GO:0005850"
     (("eIF2" 1593) ("CUGBP1-eIF2 complex" 24) ("the translational CUGBP1-eIF2" 2)
      ("the heterotrimeric factor eIF2" 2) ("Eif2s" 2) ("eIF2 complex" 1)
      ("eiF2" 1) ("eIf2" 1)))
    ("GO:0005852"
     (("eIF3" 670) ("eIF3 complex" 38) (NIL 30) ("EIF3" 17)
      ("eukaryotic
translation initiation factor 3 complex"
       7)
      ("EIF3 complex" 5) ("the multimeric complex eIF3" 2) ("eIF3s" 2)
      ("the translational initiation complex eIF3" 2)
      ("dramatically more purified eIF3" 1) ("We first determined eIF3" 1)
      ("a concurrent eIF3" 1) ("the translational initiation factor eIF3" 1)))
    ("GO:0005922" (("connexons" 3)))
    ("GO:0008081" (("PDE" 85) ("phosphodiesterases" 30) ("Phosphodiesterases" 2)))
    ("GO:0008146" (("sulfotransferases" 6)))
    ("GO:0008168"
     (("methyltransferase" 871) ("methyltransferases" 634)
      ("methyltransferase activity" 277) ("methylase" 128) ("methylases" 37)
      ("Methyltransferase" 37) ("-methyltransferase" 33) ("Methyltransferases" 18)
      ("methyl-transferases" 16) ("methyltransferase (MGMT)" 10)
      ("methyltransferase family" 8) ("methyltransferases (PRMT)" 7)
      ("MethylTransferase" 6) ("methyltransferase (PRMT)" 6)
      ("methyltransferase protein" 5) ("Methyltransferase activity" 5)
      ("methyltransferase (HMT)" 5) ("methyltransferase activities" 4)
      ("Methyltransferase Activity" 4) ("methyltransferase (LSMT)" 4)
      ("the predominant methyltransferase" 3)
      ("bacterial DNA adenine methyltransferase" 3) ("methyltransferase (HKMT)" 3)
      ("their respective modifying enzymes G9a, EZH2, and DNA methyltransferases"
       2)
      ("-methyltransferase (COMT)" 2) ("methyltransferase ( MTR )" 2)
      ("-methyltransferase (PEMT)" 2) ("Sss bacterial methylase" 2)
      ("methylase (NEB)" 2) ("especially HDAC1, and histone methyltransferases" 2)
      ("Methylase" 2) ("the most expressed methyltransferase" 2)
      ("methyltransferase (GNMT)" 2)
      ("the distributive methyltransferase activity" 2)
      ("-methyltransferase ( PNMT )" 2) ("the prokaryotic Dam methylase" 2)
      ("methyltransferase (NEB)" 2)
      ("GSK-3β–associated methyltransferase activity" 2)
      ("most methyltransferases" 2)
      ("its inherent histone methyltransferase activity" 1)
      ("one or more DNA methyltransferases" 1) ("-methyltransferases" 1)
      ("the principal H3K9 methyltransferases" 1) ("methyltransferases (DNMT)" 1)
      ("methyltransferase (DNMT)" 1) ("only histone methyl-transferases" 1)
      ("the most predominant methyltransferase" 1)
      ("Methyltransferase activities" 1)
      ("G9a reported previously involved histone methyltransferase activity" 1)
      ("the authentic α-N-RCC1 methyltransferase" 1)
      ("at least three different DNA methyltransferases" 1)
      ("methyltransferase (BHMT)" 1) ("respective methyltransferases" 1)
      ("bacterial Sss1 CpG methyltransferase (NEB)" 1)
      ("SssI bacterial methylase" 1) ("most other protein methyltransferases" 1)
      ("in fact protein methyltransferases" 1)
      ("previously uncharacterized methyltransferases" 1)))
    ("GO:0008171" (("omethyltransferase" 1)))
    ("GO:0008180"
     (("signalosome" 338) ("COP9 signalosome" 65) ("signalosomes" 53)
      ("Signalosome (CSN)" 10) ("COP9 Signalosome" 3) ("‘signalosomes’" 3)
      ("Signalosome" 3) ("“signalosomes”" 2) ("an active EGFR signalosome" 2)))
    ("GO:0008233"
     (("peptidase" 121) ("peptidase activity" 43) ("Peptidase" 9)
      ("peptidase (MPP)" 5) ("arhgdia, and methionyl amino peptidase" 2)
      ("an important placental peptidase" 2) ("Peptidase Activity" 2)
      ("the specific proteasomal peptidase activity" 2)
      ("SUMO1/sentrin-specific peptidase" 2) ("methionine amino peptidase" 1)
      ("Proteasome-specific chymotryptic peptidase activity" 1)))
    ("GO:0008237"
     (("metallopeptidase" 109) ("Metallopeptidase" 3)
      ("metallopeptidase activity" 2) ("metallopeptidase (MMP)" 2)))
    ("GO:0008238" (("exoproteases" 2)))
    ("GO:0008239" (("dipeptidyl-peptidase" 4)))
    ("GO:0008274" (("γ-TuRC" 3) ("γ-TuRCs" 2) ("γ-TuRC complex" 2)))
    ("GO:0008376"
     (("acetylgalactosaminyltransferase" 5)
      ("-acetylgalactosaminyltransferase" 5)))
    ("GO:0008483"
     (("transaminase" 79) ("transaminase (ALT)" 13) ("transaminase (AST)" 10)
      ("aminotransferases" 8) ("transaminase activity" 4)
      ("normal aminotransferases" 2) ("serum glutamic oxaloacetic transaminase" 2)
      ("aspartate amino transaminase (AST)" 1) ("abnormal aminotransferases" 1)
      ("serum glutamic pyruvic transaminase" 1)))
    ("GO:0008568"
     (("Katanin" 109) ("katanin" 16) ("Katanin protein" 4) ("katanin protein" 3)
      ("microtubule-severing heterodimeric ATPase katanin" 1)))
    ("GO:0008623" (("CHRAC" 4) ("the nucleosome-mobilizing complexes CHRAC" 1)))
    ("GO:0008753" (("NADPH-oxidase" 28) ("NADPHoxidase" 1)))
    ("GO:0008800"
     (("β-lactamase" 10) ("virion-associated β-lactamase" 2) ("β–lactamase" 1)))
    ("GO:0008861" (("pFL" 15)))
    ("GO:0009975"
     (("cyclases" 26) ("cyclase activity" 5)
      ("negligible CD38 cyclase activity" 2)
      ("soluble
guanyl cyclase activity"
       1)))
    ("GO:0015020" (("glucuronosyltransferases" 3)))
    ("GO:0015026"
     (("co-receptor" 400) ("co-receptors" 228) ("coreceptors" 160)
      ("\"co-receptor\"" 6) ("Co-Receptor" 4) ("viral co-receptors" 2)
      ("an essential co-receptor" 2) ("neuronal or astrocytic HIV coreceptors" 2)
      ("the respective HIV coreceptors" 2) ("a multifunctional co-receptor" 2)
      ("the major co-receptors" 1) ("the principal co-receptors" 1)
      ("the primary co-receptor" 1) ("the two major coreceptors" 1)
      ("Potential coreceptors" 1) ("transmembrane coreceptors" 1)
      ("an efficient co-receptor" 1) ("the viral coreceptors" 1)
      ("these principal gp120 co-receptors" 1) ("Co-receptor" 1)))
    ("GO:0015292" (("uniporter" 18)))
    ("GO:0015293"
     (("symporter" 32) ("cotransporter" 13) ("symporter (NIS)" 8)
      ("cotransporters" 4) ("cotransporter (SMIT)" 2) ("symporter protein" 2)
      ("an electrogenic amino acid symporter" 1)))
    ("GO:0015297"
     (("antiporter" 61) ("antiporters" 8)
      ("a heterodimeric bidirectional antiporter" 2) ("antiporter activity" 2)
      ("a heterodimeric bidirectional amino acid antiporter" 2)))
    ("GO:0015923" (("mannosidase" 30) ("-mannosidase" 6) ("Mannosidase" 4)))
    ("GO:0015926" (("glucosidase" 7) ("glucosidases" 2)))
    ("GO:0016015"
     (("morphogens" 30) ("morphogen" 27) ("an embryonic morphogen" 3)
      ("a potent embryonic morphogen" 2) ("the classic morphogen activity" 2)
      ("soluble morphogens" 1) ("morphogen activity" 1)
      ("gradient morphogens" 1)))
    ("GO:0016160" (("amylase" 42) ("the acinar marker amylase" 2) ("Amylase" 1)))
    ("GO:0016231"
     (("β-N-acetyl-glucosaminidase" 5) ("β-N-acetyl-glucosaminidase (NAG)" 1)))
    ("GO:0016274" (("PRMT" 17) ("PRmt" 7)))
    ("GO:0016281" (("eukaryotic translation initiation factor 4F complex" 2)))
    ("GO:0016298"
     (("lipase activity" 67) ("lipases" 17) ("LD-associated lipases" 2)))
    ("GO:0016301"
     (("phospho-kinase" 15) ("Phospho-kinase" 9) ("phospho-kinases" 9)
      ("Phospho-kinases" 2)))
    ("GO:0016308" (("PIP5Ks" 37))) ("GO:0016309" (("PIP4Ks" 1)))
    ("GO:0016407"
     (("acetyltransferases" 673) ("acetyltransferase" 532) ("acetylase" 146)
      ("acetylases" 88) ("acetyl-transferase" 41) ("acetyl-transferases" 24)
      ("Acetyltransferase" 20) ("acetyltransferase family" 10)
      ("acetyltransferases (HAT)" 7) ("acetyltransferase (DLAT)" 5)
      ("acetylase (HAT)" 5) ("-acetyltransferase" 4)
      ("acetyltransferase protein" 4) ("Acetyltransferases" 3)
      ("a multifunctional acetyltransferase" 3)
      ("acetyltransferases (HAT) family" 3) ("-acetyltransferases" 3)
      ("acetylase (INHAT)" 3)
      ("nicotinic receptors, cyclin D3, and histone acetyltransferases" 2)
      ("acetylase protein" 2)
      ("a well known transcriptional co-activator and histone acetylase" 2)
      ("Acetylase" 2) ("at least four acetyltransferases" 2)
      ("the only lysine acetyltransferase" 2) ("potential acetyltransferases" 2)
      ("-acetyltransferase (SSAT)" 2) ("Acetylases" 1)
      ("directly CBP and p300 acetyltransferases" 1)
      ("other non-essential acetyltransferases" 1)
      ("a very weak acetyltransferase" 1)))
    ("GO:0016462" (("pyrophosphatase" 12) ("pyrophosphatases" 1)))
    ("GO:0016491"
     (("redox" 1782) ("Redox" 81) ("oxidoreductase activity" 25)
      ("cellular redox" 6) ("“oxidoreductase activity”" 5) ("redox protein" 4)
      ("Oxidoreductase activity" 4) ("futile redox" 2) ("robust futile redox" 2)
      ("NQO1-driven futile redox" 2) ("the cellular redox" 2) ("a major redox" 2)
      ("redox-" 2) ("extensive redox" 2) ("oxido-reductases" 2)
      ("Cellular redox" 2) ("an NQO1-dependent futile redox" 1)
      ("a futile redox" 1) ("Sequential redox" 1) ("monitor subcellular redox" 1)
      ("a favorable redox" 1) ("the principal redox" 1)
      ("MIF-associated protein oxidoreductase activity" 1) ("vascular redox" 1)
      ("toxic redox" 1) ("general cellular redox" 1) ("proper redox" 1)
      ("environmental redox" 1) ("“redox”" 1) ("subsequent redox" 1)))
    ("GO:0016530" (("metallochaperones" 9) ("metallochaperone" 3)))
    ("GO:0016779" (("nucleotidyltransferase" 1)))
    ("GO:0016787"
     (("hydrolase" 209) ("hydrolases" 153) ("hydrolase (HLAL)" 12) ("Hydrolase" 8)
      ("hydrolases (UCH)" 5) ("hydrolase (UCH) family" 5) ("-hydrolase" 3)
      ("-hydrolases" 3) ("hydrolase (EPHX)" 2) ("resident hydrolases" 2)
      ("vacuolar hydrolase" 2) ("hydrolase (TH)" 2) ("hydrolase (UCH)" 2)
      ("e.g. soluble acid hydrolases" 1) ("Hydrolases" 1) ("hydrolase ( GGH )" 1)
      ("than 50 hydrolases" 1)))
    ("GO:0016829"
     (("lyase" 71) ("lyase activity" 27) ("lyase (ACLY)" 5) ("lyase (ACL)" 5)
      ("“lyase activity”" 1)
      ("an extramitochondrial hydroxymethylglutaryl-CoA lyase (HMGCL)" 1)
      ("lyase (HMGCL)" 1) ("-lyase" 1)))
    ("GO:0016831"
     (("decarboxylase" 53) ("aromatic L-amino acid decarboxylase (AADC)" 2)
      ("decarboxylase (MCD)" 2) ("decarboxylase (AADC)" 1)
      ("decarboxylase (MVD)" 1) ("decarboxylase (HDC)" 1)))
    ("GO:0016874"
     (("ligase activity" 413) ("synthetase" 375) ("Ligase Activity" 36)
      ("Synthetase" 9) ("synthetase ( MTHFS )" 3) ("synthetase (PTGS)" 3)
      ("Acetyl-coenzyme A synthetase" 2)
      ("mitochondrial butyryl coenzyme A synthetase 1" 2)
      ("sub-optimal ligase activity" 2) ("synthetase (GCL)" 2)
      ("acetyl- coenzyme A synthetase 2" 2) ("the major ligase activity" 2)
      ("synthetase (FPGS)" 2) ("synthetase (CTPS)" 2) ("synthetase (FASN)" 1)
      ("butyryl coenzyme A synthetase" 1) ("robust ligase activity" 1)
      ("polyketide synthase-non-ribosomal peptide synthetase" 1)
      ("synthetase (NRPS)" 1) ("synthetase (ASNS)" 1)
      ("an intrinsic ligase activity" 1)))
    ("GO:0016887"
     (("ATPase" 1135) ("ATPase activity" 736) ("-ATPase" 292) ("ATPases" 97)
      ("ATPase activities" 39) ("-ATPase activity" 25) ("ATPase Activity" 8)
      ("-ATPases" 7) ("ATPase (SERCA)" 5) ("the weak ATPase activity" 4)
      ("microsomal Ca 2+ -ATPase" 3) ("AT-Pase" 3)
      ("coexpressed RAD51-binding ATPases" 3) ("ATPase family" 3)
      ("ATPase (PMCA)" 3) ("ATPase protein" 3) ("the vacuolar H + -ATPase" 3)
      ("-ATPase (NKA)" 2) ("vacuolar ATPase" 2) ("a homohexameric ATPase" 2)
      ("ATPases (SERCA)" 2)
      ("ATPase
activity"
       2)
      ("a higher-than-normal constitutive ATPase activity" 2)
      ("a modular ATPase" 2) ("myosin II ATPase activity" 2)
      ("the sarcoplasmic reticulum Ca 2+ ATPase" 2) ("a weak ATPase activity" 2)
      ("an apical v-H + -ATPase" 2) ("a basolateral vacuolar H + -ATPase" 2)
      ("non-muscle myosin II ATPase activity" 2) ("Histochemical ATPase" 2)
      ("the vacuolar type H(+)-ATPase" 1) ("ATPase-" 1)
      ("the vacuolar H + ATPase" 1) ("vacuolar H+ ATPase" 1)
      ("the predominant mammalian force-generating ATPase" 1)
      ("the predominant force-generating ATPase" 1) ("modest ATPase activity" 1)
      ("the basolateral membrane Na + /K + -ATPase" 1)
      ("vesicular ATPase activity" 1) ("minimal ATPase activity" 1)
      ("the associated Hsp70 ATPase activity" 1)
      ("vesicle associated H + -ATPase" 1)
      ("the sarcoplasmic reticulum Ca 2+ /Mg 2+ ATPase" 1) ("ATPAses" 1)
      ("the latter increases myosin ATPase activity" 1)
      ("the oligomeric F 1 F o ATPase" 1) ("than the F 1 F o ATPase (>1.2 MDa)" 1)
      ("inherent ATPase activity" 1)))
    ("GO:0016909" (("SAPKs" 31)))
    ("GO:0019035" (("PIK" 179) ("pIK" 6) ("PIKs" 4)))
    ("GO:0019107"
     (("myristoyltransferase" 7) ("-myristoyltransferase (NMT)" 2)
      ("-myristoyltransferase" 1)))
    ("GO:0019213"
     (("deacetylase activity" 1374) ("deacetylases" 320)
      ("Deacetylase Activity" 18) ("Deacetylase activity" 6)
      ("robust deacetylase activity" 5) ("very weak deacetylase activity" 5)
      ("weak deacetylase activity" 4) ("subsequent deacetylase activity" 3)
      ("than its deacetylase activity" 3)
      ("hSIRT3 showed mitochondrial deacetylase activity" 2)
      ("deacetylase
activity"
       2)
      ("the intrinsic deacetylase activity" 2)
      ("intrinsic deacetylase activity" 2) ("efficient deacetylase activity" 2)
      ("Deacetylases" 2) ("virion-associated deacetylase activity" 2)
      ("the global deacetylase activity" 2) ("a major deacetylase activity" 2)
      ("a surprisingly low deacetylase activity" 2)
      ("the most robust deacetylases" 2)
      ("MPP showed NAD-dependent deacetylase activity" 1)
      ("a residual deacetylase activity" 1)
      ("relatively weak deacetylase activity" 1)
      ("DAC2 displayed strong deacetylase activity" 1)
      ("metal-dependent deacetylases" 1) ("than deacetylase activity" 1)
      ("SIRTs1-3 display robust deacetylase activity" 1)
      ("than the deacetylase activity" 1)
      ("very weak in vitro deacetylase activity" 1)
      ("p53-associated deacetylase activity" 1)
      ("more efficient deacetylase activity" 1)
      ("Reptin-associated deacetylase activity" 1)
      ("the HIV-1-associated deacetylase activity" 1)
      ("APPL1-associated deacetylase activity" 1)
      ("further suggested active tubulin deacetylase activity" 1)
      ("most known deacetylases" 1) ("only weak deacetylase activity" 1)
      ("the most robust deacetylase activity" 1)
      ("very little deacetylase activity" 1) ("deacetylase activity (ESA)" 1)
      ("N-CoR associated HDAC3 deacetylase activity" 1)
      ("NAD-dependent deacetylases" 1)))
    ("GO:0019767" (("IgE-receptor" 5)))
    ("GO:0022623" (("pan" 1750) ("Pan" 220) ("PAN" 188) ("Duojia Pan’s" 1)))
    ("GO:0030126" (("coatomer" 21) ("coatomer complex" 11) ("Coatomer" 1)))
    ("GO:0030284"
     (("oestrogen-receptor" 25) ("estrogen receptor activity" 11)
      ("Estrogen Receptor Activity" 2)))
    ("GO:0030290" (("Saposin" 9) ("saposin" 5)))
    ("GO:0030532"
     (("snRNP" 434) ("snRNPs" 35) ("snRNP complex" 30)
      ("the inactive 7SK snRNP" 3) ("the spliceosomal snRNPs" 3)
      ("tri-snRNP complex" 2) ("SNRNP" 2) ("an inactive 7SK snRNP" 1)
      ("the inactive 7SK snRNP complex" 1)))
    ("GO:0030894"
     (("replisome" 113) ("replisomes" 7) ("Replisome" 2)
      ("FANCD2-associated replisomes" 1)))
    ("GO:0030895" (("APOBEC" 52) ("APOBECs" 10)))
    ("GO:0031264"
     (("DISC" 944) ("disc" 662) ("discs" 607)
      ("death-inducing signaling complex" 83) ("Discs" 51)
      ("death-inducing signaling complex (DISC)" 48) ("DISCs" 28)
      ("the optic disc" 25) ("Disc" 22) ("DISC complex" 21) ("imaginal discs" 13)
      ("optic disc" 11) ("the intervertebral disc" 10)
      ("death-inducing signaling complexes" 9) ("the intervertebral discs" 5)
      ("wing imaginal discs" 5) ("the imaginal discs" 5)
      ("the eye imaginal disc" 4) ("the intervertebral disc (IVD)" 4)
      ("different imaginal discs" 3) ("all imaginal discs" 3)
      ("larval imaginal discs" 3) ("intervertebral disc" 3) ("an absent disc" 3)
      ("the larval imaginal discs" 2) ("disc complex" 2)
      ("other imaginal discs" 2) ("the wing imaginal disc" 2)
      ("ey>hid-p35 eye imaginal discs" 2) ("eye imaginal discs" 2)
      ("usually wing and eye discs" 2) ("Drosophila imaginal discs" 2)
      ("most imaginal discs" 2) ("the developing wing imaginal discs" 2)
      ("DiSc" 2) ("“death-inducing signaling complex” (DISC)" 2)
      ("the imaginal disc" 2) ("imaginal disc" 2)
      ("skeletally mature rat discs" 2) ("the neonatal disc" 2)
      ("larger optic discs" 2) ("DiSC" 2) ("TMJ disc" 2)
      ("the BioCoat Osteologic Discs" 2) ("hyperopic discs" 2)
      ("the receptor-associated death-inducing signaling complex (DISC)" 2)
      ("Imaginal wing discs" 1) ("wild type third instar wing discs" 1)
      ("Imaginal discs" 1) ("the control dorsal discs" 1)
      ("p35 eye imaginal discs" 1) ("Eye and wing imaginal discs" 1)
      ("D. melanogaster imaginal wing discs" 1) ("surgically-obtained discs" 1)
      ("severely degenerate discs" 1) ("Optic discs" 1) ("The lumbar discs" 1)
      ("McNamee and Brodsky xref treated larval wing discs" 1)
      ("larval imaginal eye and wing discs" 1)
      ("the developing wing imaginal disc" 1) ("tumorous imaginal disc" 1)
      ("“death-inducing signaling complex”" 1) ("embryonic imaginal disc" 1)
      ("the wing imaginal discs" 1) ("the resultant DISC" 1)
      ("drosophila imaginal discs" 1) ("wt larval eye discs" 1)
      ("eye and wing imaginal discs" 1) ("wing imaginal disc" 1)
      ("highly cellular neonatal discs" 1) ("mature rat discs" 1)
      ("The intervertebral disc" 1) ("the skeletally mature rat disc" 1)
      ("optic discs" 1)
      ("the Drosophila melanogaster  lethal(2)tumorous imaginal discs" 1)
      ("In contrast diseased disc" 1) ("randomly selected TMJ disc" 1)
      ("human TMJ discs" 1) ("whole TMJ discs" 1) ("15 displaced TMJ discs" 1)
      ("internal derangement TMJ disc" 1) ("disc displacement TMJ discs" 1)
      ("Adult human temporomandibular joint (TMJ) disc" 1) ("this minimal DISC" 1)
      ("basolateral junction proteins discs" 1) ("absent optic discs" 1)
      ("disc-" 1) ("than lower grade discs" 1)
      ("idiopathic scoliosis MRI grade 2 discs" 1)
      ("sav-mutated eye imaginal disc" 1) ("the hematopoetic DISC" 1)
      ("approximately ten times less TRAIL DISC" 1) ("an active DISC" 1)
      ("the entire wing imaginal disc" 1)
      ("using 3-mm cloning discs (Sigma-Aldrich) folllowing the manufacturer's" 1)
      ("normal intervertebral disc" 1)))
    ("GO:0031389" (("Rad17–Rfc" 3)))
    ("GO:0031510"
     (("SAEs" 13) ("Sae" 2) ("No fatal SAEs" 1) ("more SAEs" 1)
      ("a further 6 SAEs" 1) ("SaE" 1)))
    ("GO:0031931" (("TORC1 complex" 30)))
    ("GO:0031941"
     (("F-actin" 3057) ("filamentous actin" 147) ("F-Actin" 54) ("f-actin" 26)
      ("cortical F-actin" 25) ("Filamentous actin" 17) ("junctional F-actin" 8)
      ("filamentary F-actin" 6) ("Cortical F-actin" 6)
      ("circumferential F-actin" 6) ("cortical filamentous actin" 5)
      ("polymerized F-actin" 4) ("strong F-actin" 4) ("the cortical F-actin" 4)
      ("the circumferential F-actin" 4) ("glucose-induced cortical F-actin" 4)
      ("more F-actin" 3) ("filamentous F-actin" 3) ("F-actin-" 3)
      ("peripheral F-actin" 3) ("sub membranous filamentous actin" 2)
      ("Fluorescent F-actin" 2) ("prominent cortical F-actin" 2) ("F-ACTIN" 2)
      ("fewer filopodia and thinner cortical filamentous actin" 2)
      ("an intense F-actin" 2) ("less filamentous actin" 2)
      ("increased cortical F-actin" 2) ("intense F-actin" 2)
      ("a pre-polymerized F-actin" 2) ("polymerized filamentous actin" 2)
      ("ERM–F-actin complex" 2) ("increased perijunctional f-actin" 2)
      ("stress-induced F-actin" 2) ("protrusive filamentous actin" 2)
      ("thinner circumferential F-actin" 2) ("strong cortical F-actin" 2)
      ("minimal F-actin" 2) ("mild F-actin" 2) ("cortical F-actins" 2)
      ("characteristic large F-actin" 1) ("residual F-actin" 1)
      ("filamentous  actin" 1) ("polymeric F-actin" 1) ("Peripheral F-actin" 1)
      ("than F-actin" 1) ("N-WASP–dependent invadopodial F-actin" 1)
      ("the “old” F-actin" 1) ("than F-actin in Sep15-deficient cells (+Dox)" 1)
      ("localized F-actin" 1)
      ("TSAd WT-mCherry transfected cells displayed significantly more F-actin" 1)
      ("little peripheral F-actin" 1) ("pronounced circumferential F-actin" 1)
      ("perijunctional F-actin" 1) ("perijunctional circumferential F-actin" 1)
      ("significantly better preserved hepatocyte F-actin" 1)
      ("bile canalicular membrane F-actin" 1)
      ("Both basolateral hepatocyte membrane F-actin" 1) ("A dense F-actin" 1)
      ("less F-actin" 1) ("tensile F-actin" 1) ("characteristic F-actin" 1)
      ("perijunctional f-actin" 1) ("protrusive F-actin" 1) ("F-actin's" 1)
      ("membrane E-cadherin and thicker circumferential F-actin" 1)
      ("FAM40B increased cortical F-actin" 1)
      ("very few thick cortical F-actin" 1)
      ("histological assessment and assessed F-actin" 1) ("F-actins" 1)
      ("lost CCL2 induced F-actin" 1) ("characteristic F-Actin" 1)
      ("Nef/CIHPs showed cortical F-actin" 1) ("no cortical F-actin" 1)
      ("Nef/CIHP displayed enhanced cortical F-actin" 1)
      ("blunted glucose-induced cortical F-actin" 1)
      ("discontinuous cortical F-actin" 1)
      ("glucose-stimulated cortical F-actin" 1)
      ("Glucose-induced cortical F-actin" 1)
      ("the glucose-induced cortical F-actin" 1) ("apical F-actin" 1)))
    ("GO:0032542" (("sulfiredoxin" 4)))
    ("GO:0035369"
     (("pre-BCR" 62) ("pre–BCR" 14) ("pre-Bcr" 2) ("pre–BCR complex" 2)))
    ("GO:0035586" (("purinoceptors" 6)))
    ("GO:0036284"
     (("TBC" 81) ("TSC-TBC complex" 30) ("Tbc" 2) ("TBCs" 1) ("TBCS" 1)))
    ("GO:0036387"
     (("pre-RC" 272) ("pre-replicative complex" 38) ("pre-RCs" 15)
      ("pre-replicative complexes" 11) ("pre-RC complex" 6) ("Pre-RC" 5)
      ("the essential pre-RC" 1) ("Pre-RCs" 1) ("pre–replicative complex (RC)" 1)
      ("pre–replicative complex" 1)))
    ("GO:0042008" (("Il18R" 1))) ("GO:0042016" (("IL-20R" 6)))
    ("GO:0042056"
     (("chemoattractants" 178) ("attractant" 122) ("chemo-attractant" 91)
      ("attractants" 13) ("chemo-attractants" 11) ("Chemoattractants" 9)
      ("their major attractant" 2) ("host-or pathogen-derived chemoattractants" 2)
      ("chemoattractant activity" 2) ("external chemoattractants" 1)
      ("haptotactic attractant" 1) ("chemo-attractant (FBS)" 1)
      ("the nutritional attractant" 1) ("the major attractant" 1)
      ("exogenous chemoattractants" 1) ("a strong chemo-attractant" 1)
      ("1.0% fetal bovine serum attractant" 1)
      ("the fetal bovine serum attractant" 1) ("diverse chemoattractants" 1)
      ("Attractants" 1) ("prototypic chemoattractants" 1)
      ("the same surface-bound chemoattractants" 1)
      ("surface-bound chemoattractants" 1) ("chemotactic attractants" 1)))
    ("GO:0043293"
     (("apoptosome" 831) ("apoptosomes" 114) ("apoptosome complex" 29)
      ("Apoptosome" 13) ("‘apoptosome’" 9) ("“apoptosome”" 5) ("‘apoptosome'" 3)
      ("an active apoptosome" 2) ("the oligomeric apoptosome" 2)
      ("a large multimeric complex “apoptosome”" 2)
      ("the heptameric apoptosome" 2) ("\"apoptosome\"" 1)
      ("the oligomeric apoptosome complex" 1) ("The active apoptosome" 1)
      ("Apoptosomes" 1) ("active apoptosomes" 1) ("the active apoptosome" 1)
      ("than pc-9 apoptosomes ( xref )" 1)))
    ("GO:0043739" (("μgs" 7) ("MUG" 6)))
    ("GO:0045499" (("chemorepellent" 19) ("chemorepellent activity" 10)))
    ("GO:0046480" (("GGGT" 3)))
    ("GO:0046930"
     (("pore" 1749) ("pores" 996) ("pore (PTP)" 69) ("Pore" 35) ("pore (MPTP)" 26)
      ("pore complex" 23) ("pore complex (PTPC)" 16) ("Pores" 10) ("“pore”" 6)
      ("pores (PTP)" 5) ("Bax directly forms pores" 3)
      ("ion conductive membrane pores" 3) ("an aqueous pore" 3)
      ("tight slit pores" 3) ("pores pores" 3) ("pore (MTP)" 3)
      ("an ion-conductive pore" 3) ("Bax and Bak form oligomeric pores" 3)
      ("pore complex (NPC)" 3) ("a lipidic pore" 2) ("lipidic pores" 2)
      ("irregular mixed protein-lipidic pores" 2)
      ("the mature MOMP-inducing pore" 2) ("aqueous pore" 2)
      ("especially large pores" 2) ("the lipidic pore" 2)
      ("a mitochondrial homo-oligomeric pore" 2) ("an asymmetrical pore" 2)
      ("pores (BD)" 2) ("Bax oligomeric pores" 1) ("the lipidic pores" 1)
      ("than pores requiring adjoining protein-lined pores" 1)
      ("monomer-induced lipidic pores" 1) ("large protein-lipidic pores" 1)
      ("Bax-monomer-mediated pore" 1) ("protein-lipidic pores" 1)
      ("the observed Bax-monomer-mediated pores" 1) ("an aqueous MOMP pore" 1)
      ("Tight slit pores" 1) ("a secretory pore" 1)
      ("a cytochrome c competent pore" 1) ("The tetrameric pore" 1)
      ("proteolipidic pores" 1) ("a nonspecific pore" 1)
      ("approximately 20–30% more pores" 1) ("a putative homo-oligomeric pore" 1)
      ("“pre-pore”" 1) ("the active pore" 1) ("an active Bax pore" 1)
      ("a functional Bax “lipidic” pore" 1) ("a “lipidic” pore" 1)
      ("a toxic mitochondrial pore" 1) ("an intramembrane oligomeric pore" 1)
      ("micro scale pores" 1) ("Transendothelial pores" 1)
      ("transendothelial pores" 1) ("supramolecular membrane pores" 1)
      ("a supramolecular pore" 1) ("supramolecular pores" 1) ("PORE" 1)
      ("an active pore" 1) ("the aqueous pore" 1)))
    ("GO:0047290" (("ST6GALNAC" 2) ("ST6GalNAc" 1)))
    ("GO:0050105"
     (("Glo" 688) ("glo" 23) ("GLO" 21) ("Glo (CTG)" 2)
      ("adherent cell lines or cell titer glo" 2)))
    ("GO:0050248" (("aequorin" 23) ("Aequorin" 2)))
    ("GO:0050321"
     (("glycogen synthase kinase-3beta" 6) ("Glycogen synthase kinase-3beta" 1)))
    ("GO:0050355"
     (("triphosphatase" 127) ("triphosphatases" 110) ("triphosphatase (GTP)" 4)
      ("the vacuolar H(+)-adenosine triphosphatase" 3)
      ("vacuolar adenosine triphosphatase" 2) ("-triphosphatase" 2)
      ("triphosphatase (TERA)" 2)
      ("Transitional endoplasmic reticulum adenosine triphosphatase (TERA)" 1)))
    ("GO:0051920"
     (("peroxiredoxins" 48) ("peroxiredoxin" 35) ("Peroxiredoxins" 7)
      ("peroxiredoxin family" 3) ("peroxiredoxin (PRX) family" 3)
      ("the catalytic cysteines of all the 2-Cys peroxiredoxins" 1)
      ("peroxiredoxins (PRX)" 1)))
    ("GO:0052664" (("NaO" 23)))
    ("GO:0070122"
     (("isopeptidases" 15) ("isopeptidase activity" 6)
      ("cellular isopeptidases" 1)))
    ("GO:0070187" (("telosome" 3) ("telosomes" 2)))
    ("GO:0070330" (("aromatases" 3))) ("GO:0070566" (("adenylyltransferase" 10)))
    ("GO:0071735"
     (("IgG1" 882) ("IgG1-" 5) ("monoclonal mouse IgG1" 4) ("IgG1 (SCBT)" 4)
      ("fluorochrome-conjugated secondary goat anti-mouse IgG1" 3)
      ("mouse monoclonal IgG1" 3) ("Alexa 633-labeled goat anti-mouse-IgG1" 2)
      ("a monoclonal mouse IgG1" 2)
      ("Alexa Fluor 647-conjugated goat anti-mouse IgG1" 2)
      ("control Armenian hamster IgG1" 2) ("a mouse monoclonal anti-FITC IgG1" 2)
      ("Alexa Fluor 555-labeled goat anti-mouse IgG1" 2) ("The monoclonal IgG1" 1)
      ("goat anti-rabbit IgG and Dylight 649-conjugated goat anti-mouse IgG1" 1)
      ("irrelevant anti-human IgG1" 1) ("Using monoclonal Mouse IgG1" 1)
      ("Isotypic mouse IgG1" 1)
      ("secondary antibodies HRP-conjugated goat anti-rabbit and anti-mouse IgG1"
       1)
      ("an irrelevant murine IgG1" 1) ("non-specific mouse monoclonal IgG1" 1)
      ("secondary AlexaFluor-647 anti-mouse IgG1" 1)))
    ("GO:0071762" (("HCAbs" 5)))
    ("GO:0089701"
     (("U2AF" 45) ("the accessory factor U2AF" 2) ("U2AFs" 2) ("U2af" 1)))
    ("GO:0097342"
     (("Ripoptosome" 172) ("“Ripoptosome”" 3) ("a strong Ripoptosome" 1)))
    ("GO:0097747"
     (("RNA-polymerase" 6) ("RNA polymerase activity" 5)
      ("viral RNA polymerase activity" 1)))
    ("GO:1990124"
     (("mRNPs" 124) ("messenger ribonucleoprotein complexes" 2)
      ("polysomal mRNPs" 2) ("associated mRNPs" 1)
      ("translationally inactive mRNPs" 1) ("Hypothetical gemin5 mRNPs" 1)
      ("the viral mRNPs" 1) ("the gigantic Balbiani ring mRNPs" 1)
      ("translated polysomal mRNPs" 1)))
    ("GO:1990404" (("ribosylase" 8)))
    ("GO:1990779" (("Cd42" 5) ("cd42" 4) ("CD42" 2)))
    ("GO:1990904"
     (("ribonucleoprotein complex" 131) ("ribonucleoprotein complexes" 70)
      ("viral ribonucleoprotein complexes" 5)
      ("multimeric ribonucleoprotein complexes" 3)
      ("targeted ribonucleoprotein complex" 2)
      ("the viral ribonucleoprotein complex" 2)
      ("a viral ribonucleoprotein complex" 2)
      ("The active telomerase ribonucleoprotein complex" 1)
      ("“ribonucleoprotein complex”" 1) ("Rnp" 1)))
    ("HGNC:12027" (("TRA" 86) ("pTRA" 6)))
    ("HGNC:25438" (("SgK223" 142) ("the ectopically-expressed SgK223" 2)))
    ("HGNC:5853"
     (("IGL" 64) ("IgL" 58) ("Igl" 17) ("IgL protein" 2) ("the 3rd Igl" 1)))
    ("HMDB10147" (("PIP-3" 21)))
    ("IPR000025"
     (("melatonin receptors" 7) ("Melatonin receptors" 2)
      ("melatonin receptor" 2)))
    ("IPR000148" (("papillomavirus E7" 4)))
    ("IPR000248"
     (("angiotensin II receptor" 19) ("angiotensin II receptors" 9)
      ("Angiotensin II receptor" 5) ("angiotensin II  receptor" 1)))
    ("IPR000277"
     (("CGS" 60) ("CGs" 6)
      ("the specific cell-permeable CaM antagonist CGS9343B" 2)))
    ("IPR000307" (("S16" 86) ("S16-" 1)))
    ("IPR000324"
     (("vitamin D receptor" 131) ("vitamin D receptor (VDR)" 34)
      ("Vitamin D Receptor" 10) ("Vitamin D receptor" 9)
      ("vitamin D receptor ( VDR )" 5) ("vitamin D receptors" 5)
      ("Vitamin D receptor (VDR)" 1) ("Vitamin D Receptor (VDR)" 1)
      ("Vitamin D receptors" 1)))
    ("IPR000460" (("neuroligin" 3) ("neuroligins" 3) ("Neuroligins" 2)))
    ("IPR000499"
     (("endothelin receptor" 16) ("endothelin receptors" 9)
      ("Endothelin receptor" 1)))
    ("IPR000663"
     (("natriuretic peptide" 24) ("natriuretic peptides" 11)
      ("natriuretic peptide (BNP)" 3) ("the cardiac natriuretic peptides" 1)
      ("natriuretic peptide (NCP)" 1) ("Natriuretic peptides" 1)))
    ("IPR000698"
     (("arrestin" 341) ("arrestins" 185) ("Arrestin" 13) ("-arrestin" 11)
      ("Arrestins" 10) ("arrestin molecule" 6) ("arrestin protein" 5)
      ("arrestin peptide" 4) ("visual arrestins" 3) ("overexpressed arrestin" 3)
      ("ubiquitously expressed non-visual arrestins" 2) ("arrestin family" 2)
      ("visual arrestin" 2) ("expressed non-visual arrestins" 1)
      ("than parental WT arrestins" 1) ("parental WT arrestins" 1)
      ("exclusively non-visual arrestins" 1)))
    ("IPR000837"
     (("AP-1 transcription factor" 202) ("AP-1 transcription factors" 83)
      ("AP-1 transcription factor family" 14)
      ("the dimeric AP-1 transcription factors" 2)
      ("dimeric AP-1 transcription factor" 2)
      ("Immediate Early Genes (IEGs) AP-1 transcription factors" 2)
      ("the dimeric AP-1 transcription factor" 1)))
    ("IPR000972"
     (("octamer-binding transcription factor" 9)
      ("Octamer-binding transcription factor" 5)))
    ("IPR000981"
     (("NH" 2372) ("-NH" 22) ("nH" 2) ("unique NH" 1)
      ("d-Arg(6)-Azagly(10)-NH2" 1) ("-NH2" 1)))
    ("IPR000995"
     (("-muscarinic receptor" 109) ("muscarinic receptor" 93)
      ("muscarinic receptors" 37) ("-muscarinic receptors" 30)
      ("muscarinic acetylcholine receptors" 7)
      ("muscarinic acetylcholine receptor" 5) ("muscarinic receptor peptide" 3)
      ("than the M 3 -muscarinic receptor" 1) ("Muscarinic receptor" 1)
      ("Muscarinic receptors" 1)))
    ("IPR001067"
     (("translocator" 70) ("translocator (ANT)" 26) ("translocator (ARNT)" 15)
      ("Translocator" 1) ("a so-called “translocator”" 1) ("“translocator”" 1)))
    ("IPR001089"
     (("CXC chemokine" 39) ("CXC chemokines" 10) ("CXC chemokine family" 4)
      ("angiostatic CXC chemokines" 2)))
    ("IPR001112" (("endothelin receptor B" 5)))
    ("IPR001164"
     (("Arf GTPase-activating" 4) ("Arf GTPase-activating protein (GAP)" 3)))
    ("IPR001277" (("CXC chemokine receptor 4" 22)))
    ("IPR001292"
     (("era" 464) ("ERa" 141) ("ERA" 38) ("eras" 4)
   ("the modern cardiac surgical era" 2) ("Era" 2) ("ERa protein" 1)
   ("the post-antiretroviral therapy era" 1) ("Eras" 1)
   ("the new postgenomic era" 1) ("the postgenomic era" 1) ("SCOPE" 1)
   ("pre-IHC era" 1)))
 ("IPR001321"
  (("hypoxia inducible factor-1 alpha" 9)
   ("hypoxia-inducible factor-1 alpha" 1)))
 ("IPR001395"
  (("aldo–keto reductase" 10) ("aldo-keto reductase" 7)
   ("aldo–keto reductases" 6) ("aldo-keto reductases" 4)
   ("aldo–keto reductase family" 3) ("Aldo-keto reductase" 2)
   ("aldo-keto reductase ( AKR )" 1)))
 ("IPR001418"
  (("opioid receptor" 31) ("opioid receptors" 23) ("Opioid receptors" 1)
   ("Opioid receptor" 1) ("-opioid receptor" 1)))
 ("IPR001461" (("pepsin" 137) ("Pepsin" 15)))
 ("IPR001525"
  (("DCM" 203) ("dry DCM" 8) ("non-syndromic DCM" 2) ("Indian DCM" 1)
   ("RAF1-associated DCM" 1)))
 ("IPR001588"
  (("casein" 296) ("Casein" 95) ("-casein" 11) ("caseins" 3)
   ("namely three caseins" 1) ("FWCS treated casein" 1)
   ("casein protein (DAKO)" 1)))
 ("IPR001630" (("cAMP response element–binding (CREB)" 1)))
 ("IPR001634" (("adenosine receptor" 21) ("adenosine receptors" 13)))
 ("IPR001697"
  (("pyruvate kinase" 131) ("Pyruvate kinase" 12) ("pyruvate kinases" 4)
   ("pyruvate kinase (PK)" 2) ("Most pyruvate kinases" 1)))
 ("IPR001723"
  (("steroid hormone receptors" 163) ("steroid hormone receptor" 86)
   ("steroid hormone receptor family" 11) ("Steroid hormone receptors" 9)
   ("classical steroid hormone receptors" 3)
   ("the classical steroid hormone receptors" 1)
   ("steroid hormone receptors (SR)" 1) ("most steroid hormone receptors" 1)
   ("transmembrane classic steroid hormone receptors" 1)))
 ("IPR001757" (("P-type ATPase" 5) ("type ATPase" 5) ("type ATPases" 2)))
 ("IPR001908" (("Melanocortin receptors" 1) ("melanocortin receptor" 1)))
 ("IPR001941" (("melanocortin" 21) ("Melanocortin" 2) ("melanocortins" 1)))
 ("IPR001951"
  (("H4" 1801) ("-H4" 20) ("nucleosomal H4" 18) ("H4 peptide" 12)
   ("Htt exon 1(97)-H4 and HttQC(97)-H4" 3) ("H4 ( xref ) peptide" 3) ("–H4" 2)
   ("monoclonal anti-acetylated H4" 2) ("the nucleosomal H4" 2)
   ("Htt exon 1(97)-H4 or HttQC(97)-H4" 2) ("new-synthesized H4" 1) ("pH4" 1)))
 ("IPR002038" (("osteo" 13) ("osteo-" 2) ("Osteo" 1)))
 ("IPR002041" (("Ran GTPase" 30) ("Ran GTPases" 9)))
 ("IPR002070"
  (("Brachyury" 327) ("brachyury" 16) ("Brachyury-" 12)
   ("mesodermal marker Brachyury" 4) ("BRACHYURY" 3) ("pBrachyury" 2)
   ("-Brachyury" 2) ("mesodermal marker Brachyury (BRA)" 1)
   ("Brachyury (BRA)" 1)))
 ("IPR002117"
  (("p53 tumour suppressor" 110) ("p53 tumour suppressor protein" 26)
   ("p53
                        tumour suppressor"
    4)
   ("p53 tumour
suppressor"
    2)
   ("p53 tumour
                            suppressor protein"
    2)
   ("P53 tumour suppressor" 2) ("p53 tumour suppressors" 2)
   ("p53 tumour
                            suppressor"
    1)))
 ("IPR002151" (("kinesin light chain" 3) ("kinesin light chains" 2)))
 ("IPR002230"
  (("cannabinoid receptor" 13) ("cannabinoid receptors" 11)
   ("Cannabinoid receptor" 2)))
 ("IPR002233"
  (("adrenoceptor" 16) ("adrenoceptors" 8) ("-Adrenoceptors" 8)
   ("-adrenoceptors" 3) ("-adrenoceptor" 2) ("Adrenoceptors" 2)))
 ("IPR002281" (("protease-activated receptor 2" 5)))
 ("IPR002298"
  (("DNA polymerase as" 5) ("DNA polymerase a" 1)
   ("Pfu -turbo DNA polymerase as" 1)))
 ("IPR002475" (("BCL2-like" 34)))
 ("IPR002959" (("tumour necrosis factor alpha" 10) ("Eiger" 6) ("Eiger-" 1)))
 ("IPR002972"
  (("prostaglandin D synthase ( PGDS )" 1) ("prostaglandin D synthase" 1)))
 ("IPR003017" (("amphiphysin1" 2)))
 ("IPR003020"
  (("AE" 164) ("Ae" 13) ("ae" 4) ("1 fatal AE" 2) ("grade 4 hematologic AE" 2)
   ("a serious AE (SAE)" 1) ("One fatal AE" 1) ("AE-" 1) ("at least 1 AE" 1)))
 ("IPR003070"
  (("orphan nuclear receptor" 56) ("orphan nuclear receptors" 16)
   ("orphan
                            nuclear receptor"
    1)))
 ("IPR003074"
  (("peroxisome proliferator-activated receptor" 103)
   ("peroxisome proliferator–activated receptor" 24)
   ("peroxisome proliferator-activated receptors" 23)
   ("Peroxisome proliferator-activated receptor" 19)
   ("peroxisome proliferator activated receptor" 10)
   ("Peroxisome proliferator-activated receptors" 10)
   ("peroxisome proliferator-activated receptors (PPAR)" 5)
   ("peroxisome proliferator-activated receptor-" 4)
   ("peroxisome proliferator–activated receptors" 4)
   ("peroxisome proliferator-activated receptor (PPAR) family" 3)
   ("peroxisome proliferator-activated receptor (PPAR)" 2)
   ("Peroxisome proliferator–activated receptor" 1)
   ("Peroxisome Proliferator-activated receptor" 1)
   ("peroxisome proliferator activated receptors" 1)))
 ("IPR003078"
  (("retinoic acid receptor" 91) ("retinoic acid receptors" 49)
   ("Retinoic acid receptor" 4) ("retinoic acid receptor (RAR)" 3)
   ("retinoic acid receptor-" 2)))
 ("IPR003548" (("claudin1" 15) ("Claudin1" 3) ("insoluble claudin1" 1)))
 ("IPR003635" (("neurokinin" 7) ("Neurokinin" 1)))
 ("IPR003840"
  (("DNA helicase" 226) ("DNA helicases" 40) ("DNA helicase family" 12)
   ("DNA helicase protein (WRN)" 3)
   ("the viral origin recognition complex/replicative DNA helicase" 2)
   ("a hexameric DNA helicase" 1)
   ("the MCM4-6-7 complex-associated DNA helicase" 1)))
 ("IPR003912"
  (("activated receptor" 259) ("activated receptors" 155)
   ("protease-activated receptor" 43) ("protease-activated receptors" 27)
   ("activated Receptor" 14) ("Protease-activated receptor" 6)
   ("Activated Receptor" 6) ("-activated receptor" 6)
   ("activated receptor (PAR)" 4) ("Activated receptors" 3)
   ("protease-activated receptor (PAR)" 1)
   ("at least two activated receptors" 1) ("Activated Receptors" 1)
   ("Protease-activated receptors" 1) ("Activated Receptor-" 1)))
 ("IPR003918" (("NADH:ubiquinone oxidoreductase" 6)))
 ("IPR003989"
  (("vascular cell adhesion molecule 1" 27)
   ("soluble vascular cell adhesion molecule 1" 2)
   ("Vascular cell adhesion molecule 1" 1)))
 ("IPR004061" (("sphingosine 1-phosphate receptor" 3)))
 ("IPR004065"
  (("lysophosphatidic acid receptor" 6) ("lysophosphatidic acid receptors" 2)))
 ("IPR004269" (("folate receptor" 14) ("folate receptors" 2)))
 ("IPR004709" (("Na+/H+ exchanger" 5)))
 ("IPR004724"
  (("ENaC" 255) ("exogenous ENaC" 5) ("epithelial sodium channel" 4)
   ("-ENaC" 3) ("endometrial ENaC" 1) ("ENaC's" 1)))
 ("IPR004729" (("transient receptor potential channel" 6)))
 ("IPR004743"
  (("monocarboxylate transporters" 8) ("Monocarboxylate transporters" 2)
   ("monocarboxylate transporter" 2)))
 ("IPR005331"
  (("sulfotransferase" 25) ("Sulfotransferase" 6)
   ("sulfotransferase ( UST )" 2) ("-sulfotransferase" 2) ("Sult" 1)))
 ("IPR005708" (("HMGA" 10)))
 ("IPR005792" (("disulphide isomerase" 5) ("disulphide isomerase (PDI)" 4)))
 ("IPR005938" (("cdc48" 12) ("Cdc48" 8) ("CDC48" 3) ("soluble cdc48" 1)))
 ("IPR006053"
  (("tumour necrosis factor" 106) ("Tumour necrosis factor" 12)
   ("tumour necrosis factor (TNF)" 3) ("tumour necrosis factor-" 1)
   ("tumour necrosis
factor"
    1)))
 ("IPR006183" (("6-phosphogluconate dehydrogenase" 11)))
 ("IPR006201" (("LIC" 146) ("pLIC" 10) ("‘LIC’" 1)))
 ("IPR006329" (("AMP deaminase" 1)))
 ("IPR006687" (("SAR" 189) ("Sar" 2) ("-SAR" 1) ("SARs" 1)))
 ("IPR007768" (("suppressor of fused" 12) ("suppressor of fused (SUFU)" 1)))
 ("IPR008063"
  (("Fas receptor" 168) ("Fas receptors" 12) ("FAS receptor" 5)
   ("Fas Receptor" 2)))
 ("IPR008080" (("parvalbumin" 9)))
 ("IPR008096"
  (("cytotoxic T-lymphocyte antigen-4" 4)
   ("Cytotoxic T-lymphocyte antigen-4" 3)))
 ("IPR008294" (("meprin" 3)))
 ("IPR008343" (("Mitogen-activated protein (MAP) kinase phosphatases" 2)))
 ("IPR008365" (("prostanoid receptor" 25) ("prostanoid receptors" 10)))
 ("IPR008366"
  (("factor of activated T cells (NFAT)" 44)
   ("factor of activated T cells (NFAT)-" 6)
   ("Nuclear Factor of Activated T Cells (NFAT)" 3)
   ("factor of activated T cells (NFAT) family" 3)))
 ("IPR008431"
  (("cyclic nucleotide phosphodiesterases" 1)
   ("cyclic nucleotide phosphodiesterase" 1)))
 ("IPR008606"
  (("eukaryotic translation initiation factor 4E-binding" 16)
   ("eukaryotic translation initiation factor 4E-binding protein" 5)
   ("eukaryotic translation initiation factor 4E–binding" 4)
   ("eukaryotic translation initiation factor 4E–binding protein" 3)
   ("eukaryotic translation initiation factor 4E binding" 1)
   ("eukaryotic translation-initiation factor 4E-binding" 1)
   ("eukaryotic translation initiation factor 4E Binding" 1)))
 ("IPR008653" (("immediate early response" 21) ("Immediate early response" 2)))
 ("IPR009122"
  (("desmosomal cadherins" 92) ("desmosomal cadherin" 55)
   ("Desmosomal cadherins" 6) ("desmosomal cadherin family" 2)
   ("Desmosomal cadherin" 1)))
 ("IPR009136" (("vascular endothelial growth factor receptor 2 (VEGFR2)" 15)))
 ("IPR009138" (("neural cell adhesion" 4) ("neural cell adhesion protein" 2)))
 ("IPR009146" (("Groucho/Transducin-like enhancer" 2)))
 ("IPR010796"
  (("B9" 188) ("B9 protein" 3) ("the water-soluble Vitamin B9" 1)
   ("shorter lifespan ofPINK1 B9" 1) ("than B9" 1)))
 ("IPR011174"
  (("ezrin/radixin/moesin" 25) ("ezrin-radixin-moesin" 19)
   ("Ezrin/Radixin/Moesin" 8) ("ezrin/radixin/moesin (ERM) family" 5)
   ("ezrin-radixin-moesin (ERM)" 4) ("ezrin-radixin-moesin (ERM) family" 3)
   ("Ezrin-radixin-moesin (ERM) family" 3) ("ezrin/radixin/moesin family" 3)
   ("Ezrin/radixin/moesin" 2) ("ezrin–radixin–moesin" 2)
   ("Ezrin-radixin-moesin" 1) ("Ezrin–radixin–moesin" 1)))
 ("IPR011407" (("10-formyltetrahydrofolate dehydrogenase" 13)))
 ("IPR011822" (("Meth" 116) ("meth" 15) ("MetH" 10) ("Meth-" 2)))
 ("IPR012163"
  (("sialyltransferases" 25) ("sialyltransferase" 21) ("-sialyltransferase" 3)
   ("-sialyltransferases" 1)))
 ("IPR012233"
  (("PKC" 8109) ("PKCs" 941) ("PKC family" 194) ("PKC-" 167)
   ("Protein kinase C" 137) ("Protein Kinase C" 66) ("atypical PKCs" 45)
   ("PKcs" 33) ("atypical PKC" 24) ("pPKC" 23) ("p-PKC" 19)
   ("the atypical PKCs" 18) ("classical PKCs" 10) ("the classical PKCs" 8)
   ("P-PKC" 8) ("the atypical PKC" 7) ("Atypical PKCs" 6)
   ("classical and novel PKCs" 5) ("Protein kinase Cs" 5)
   ("both classical and novel PKC" 5) ("The atypical PKCs" 4)
   ("Protein kinase C (PKC)" 4) ("Protein Kinase Cs" 4) ("an atypical PKC" 4)
   ("PKC molecule" 4) ("the atypical PKC family" 4)
   ("at least one Ca 2+ -independent PKC" 3) ("classic PKC" 3)
   ("classical PKC" 3) ("Pkc" 3) ("Protein Kinase C (PKC) family" 3)
   ("a C. elegans atypical PKC" 2) ("immunoreactive PKC" 2)
   ("two atypical PKCs" 2) ("the only calcium-dependent classical PKC" 2)
   ("Kinase C" 2) ("atypical (aPKCζ and λ/ι) PKCs" 2)
   ("several atypical PKCs" 2) ("atypical Protein Kinase C" 2)
   ("classic PKCs" 2) ("The classic PKCs" 2) ("the classic PKC" 2)
   ("calcium-independent DAG-non-resposive atypical PKC" 2)
   ("calcium-dependent diacylglycerol (DAG)-activated classical PKC" 2)
   ("the calcium-dependent classical PKCs" 2) ("the Drosophila atypical PKC" 2)
   ("a kinase-dead Drosophila atypical PKC" 2)
   ("a catalytically competent and stable mature PKC" 2)
   ("typical PKC family" 2) ("PKC protein" 2) ("–PKC" 2)
   ("The polarity complex atypical PKC" 2)
   ("the apical polarity complex Par6–atypical PKC" 2)
   ("both the classical and novel PKCs" 1)
   ("untypical Ca ++ -independent PKCs" 1)
   ("Protein
Kinase C"
    1)
   ("Protein
kinase C"
    1)
   ("PKC's" 1) ("the classic or conventional PKCs" 1)
   ("The classic and novel PKCs" 1) ("atypical (a) PKCs" 1)
   ("than the PKC family" 1) ("at least some PKCs" 1)
   ("classical or novel PKC" 1) ("calcium-dependent classical PKC" 1)
   ("Atypical PKC" 1) ("PKC (PKC)" 1) ("we first inhibited PKC" 1)
   ("cellular atypical PKCs" 1) ("a classical PKC" 1)
   ("PKC (protein kinase C) family" 1) ("atypical PKC family" 1)
   ("Protein Kinase C" 1) ("most PKCs" 1)
   ("The serine/threonine-specific protein kinase PKC" 1)))
 ("IPR012725"
  (("DnaK" 121) ("DnaK protein" 4) ("the bacterial HSP70 homologue DnaK" 2)
   ("than DnaK" 1) ("bacterial DnaK" 1)))
 ("IPR013020" (("Rad3" 189) ("RAD3" 23) ("rad3" 21) ("Rad3-" 2)))
 ("IPR013126"
  (("heat shock protein 70" 50) ("Heat shock protein 70" 6)
   ("heat shock protein 70 (Hsp70) family" 4)
   ("heat shock protein 70 (HSP70) family" 3)
   ("heat shock protein 70 family" 1)))
 ("IPR013178" (("Kat11" 1)))
 ("IPR013333"
  (("ryanodine receptor" 14) ("ryanodine receptors" 14)
   ("Ryanodine receptor" 2) ("neuronal ryanodine receptors" 1)))
 ("IPR014492"
  (("poly(A) polymerase" 30) ("Poly(A) polymerase" 4)
   ("poly(A) polymerase (NEB)" 3) ("a noncanonical poly(A) polymerase" 1)
   ("poly(A) polymerase (PAPT)" 1)))
 ("IPR014615" (("Extracellular Sulfatase" 2)))
 ("IPR015433"
  (("phosphatidylinositol kinase" 16) ("phosphatidylinositol kinases" 3)))
 ("IPR015451"
  (("cyclin D" 686) ("cyclin Ds" 21) ("cyclin D-" 7) ("cyclin D family" 6)
   ("the predominant cyclin D" 4) ("cyclin D protein" 3) ("CYCLIN D" 2)
   ("At least one cyclin D" 2) ("cyclin D–" 2) ("\"cyclin D\"" 1)
   ("cyclin D's" 1)))
 ("IPR015476"
  (("Calcitonin gene related peptide" 1)
   ("calcitonin gene related peptide" 1)))
 ("IPR015496" (("ubiquilin" 1)))
 ("IPR015497"
  (("epidermal growth factor receptor ligand" 6)
   ("epidermal growth factor receptor ligand family" 3)
   ("epidermal growth factor receptor ligands" 2)))
 ("IPR015617" (("growth differentiation factor-9" 3)))
 ("IPR015621"
  (("interleukin-1 receptor" 23) ("Interleukin-1 receptor" 8)
   ("interleukin-1 receptors" 1)))
 ("IPR015664" (("p53 induced" 100) ("-p53 induced" 2)))
 ("IPR015679" (("phospholipase D" 45) ("phospholipase D (PLD)" 4)))
 ("IPR015812" (("integrin beta subunit" 3) ("integrin beta subunits" 2)))
 ("IPR016202"
  (("DNaseI" 309) ("DNAseI" 60) ("DnaseI" 5) ("we first DNaseI" 2)))
 ("IPR016245" (("EGF Receptors" 3) ("p-EGF Receptor" 2)))
 ("IPR016319"
  (("transforming growth factor-beta" 80)
   ("Transforming growth factor-beta" 14)
   ("transforming growth factor-beta (TGF-β) family" 3)))
 ("IPR016468"
  (("CCAAT/enhancer-binding" 28) ("CCAAT/enhancer-binding protein" 5)
   ("CCAAT/enhancer-binding protein (CEBP)" 1)))
 ("IPR017096"
  (("BTB-Kelch proteins" 15) ("BTB-Kelch protein" 10) ("BTB-Kelch family" 6)
   ("BTB-Kelch" 5) ("BTB-KELCH" 3) ("BTB-Kelch protein family" 3)
   ("few BTB-Kelch proteins" 1) ("most BTB-Kelch proteins" 1)))
 ("IPR017241"
  (("Toll-like receptors" 218) ("Toll-like receptor" 139)
   ("toll-like receptors" 43) ("toll-like receptor" 41)
   ("Toll like receptor" 17) ("Toll-like receptor (TLR)" 13)
   ("Toll-Like Receptors" 11) ("Toll-like receptors (TLR)" 11)
   ("Toll like receptors" 10) ("Toll-Like Receptor" 6)
   ("Toll-like
                    receptor (TLR)"
    6)
   ("Toll-like receptor (TLR) family" 4) ("Toll-like Receptor" 3)
   ("Toll-Like receptor (TLR) family" 2) ("Toll like receptor (TLR)" 2)
   ("Toll-like receptor-" 2) ("Toll like Receptor (TLR)" 2)
   ("most human Toll-like receptors" 2)
   ("the membrane-associated toll-like receptors" 2) ("Toll Like Receptors" 2)
   ("Toll-Like receptor" 1) ("Toll-Like Receptors (TLR)" 1)
   ("toll-like receptor-" 1) ("toll-like receptor (TLR)" 1)
   ("Toll-like
                    receptor"
    1)
   ("Toll Like Receptor" 1) ("Toll like Receptor" 1)
   ("membrane-associated toll-like receptors (TLR)" 1)))
 ("IPR017347" (("Heterogeneous nuclear ribonucleoprotein C" 3)))
 ("IPR017862" (("Ski-interacting protein, SKIP" 2)))
 ("IPR020471" (("AKR" 11) ("AKRs" 1)))
 ("IPR021151"
  (("GINS complex" 129)
   ("than the human GINS complex (see previous section)" 1)
   ("than one human GINS complex" 1)
   ("rotary-shadowed Xenopus GINS complex" 1)))
 ("IPR022034"
  (("Fragile X Mental Retardation Protein (FMRP)" 3)
   ("Fragile X Mental Retardation Protein" 2)))
 ("IPR022350"
  (("Insulin like growth factors" 9) ("insulin like growth factor" 9)
   ("Insulin like growth factor" 5) ("insulin like growth factors" 1)))
 ("IPR023257"
  (("liver X receptor" 24) ("liver X receptors" 16) ("Liver X receptor" 5)
   ("liver X receptor (LXR)" 2) ("liver X Receptor" 2)
   ("Liver X receptor (LXR)" 1) ("Liver X receptors" 1)))
 ("IPR023274" (("aquaporin 1" 4) ("Aquaporin 1" 3))) ("IPR023426" (("FEN" 7)))
 ("IPR024706" (("AhpC" 5) ("bacterial thiol peroxidase AhpC" 2)))
 ("IPR024786" (("transducer of regulated CREB activity" 8)))
 ("IPR024950"
  (("dual specificity phosphatase" 89) ("dual specificity phosphatases" 35)
   ("Dual specificity phosphatase" 29)
   ("dual specificity phosphatase family" 8)
   ("Dual specificity phosphatases" 4)
   ("dual specificity phosphatase (VHR)" 1)))
 ("IPR025602" (("BCP1" 19)))
 ("IPR026074"
  (("microtubule-associated protein 1" 36)
   ("Microtubule-associated protein 1" 4)))
 ("IPR026117" (("prostate apoptosis response-4" 10)))
 ("IPR026280"
  (("tissue plasminogen activator" 67) ("Tissue plasminogen activator" 11)
   ("tissue plasminogen activators" 1)))
 ("IPR026752"
  (("cavins" 109) ("cavin" 85) ("Cavin" 73) ("Cavins" 16)
   ("fluorescent cavins" 1)))
 ("IPR026791"
  (("dedicator of cytokinesis" 3) ("dedicator of cytokinesis protein" 2)))
 ("IPR026818"
  (("adenomatous polyposis coli (APC)" 162)
   ("adenomatous polyposis coli (APC) protein" 10)
   ("Adenomatous Polyposis Coli (APC)" 7)
   ("Adenomatous polyposis coli (APC)" 7)
   ("Adenomatous Polyposis Coli (Apc)" 4)
   ("adenomatous
polyposis coli (APC)"
    2)
   ("Adenomatous polyposis coli (APC) protein" 1)
   ("Adenomatous polyposis coli (Apc)" 1)))
 ("IPR026836"
  (("Adenomatous polyposis coli" 16) ("Adenomatous Polyposis Coli" 6)
   ("Adenomatous Polyposis Coli Protein (APC)" 3)
   ("Adenomatous polyposis coli protein" 1) ("Adenomatous Polyposis coli" 1)))
 ("IPR026983"
  (("dynein heavy chain" 9) ("dynein heavy chain (DHC)" 4)
   ("dynein heavy chains" 3)))
 ("IPR027340" (("Coronin 1b" 4)))
 ("IPR027640"
  (("kinesin-like" 26) ("mitotic kinesin-like protein" 4)
   ("kinesin-like protein (MKlp)" 1) ("kinesin-like protein" 1)))
 ("IPR028288" (("SCAR/WAVE" 17) ("Scar/WAVE" 2)))
 ("IPR028309"
  (("retinoblastoma protein" 535) ("Retinoblastoma protein" 67)
   ("retinoblastoma proteins" 14) ("Retinoblastoma Protein" 9)
   ("retinoblastoma protein (pRb) family" 4) ("retinoblastoma protein (RB)" 4)
   ("Retinoblastoma proteins" 3)
   ("resultant inactive retinoblastoma protein" 2)
   ("retinoblastoma protein (Rb) family" 2) ("retinoblastoma protein family" 2)
   ("retinoblastoma
                protein"
    2)))
 ("IPR028325"
  (("voltage-gated potassium channel" 6)
   ("voltage-gated potassium channels" 1)))
 ("IPR028858"
  (("cyclin E" 3194) ("Cyclin E" 727) ("cyclin E protein" 29) ("cyclin e" 18)
   ("overexpressed cyclin E" 12) ("cyclin E (EL)" 7) ("cyclin E peptide" 6)
   ("cyclin E-" 5) ("-cyclin E" 5) ("cyclin E–" 4) ("Exogenous cyclin E" 3)
   ("cyclin E's" 3) ("exogenous cyclin E" 2)
   ("cyclin E (Neomarkers Ab-1, RB-012, 2 ug per immunoprecipitation) cyclin E"
    2)
   ("overexpressed Cyclin E" 2) ("targeted gene Cyclin E" 2)
   ("monoclonal mouse cyclin E" 2) ("than full-length cyclin E" 2)
   ("Cyclin E peptide" 2) ("the associated cyclin E" 1)
   ("Monomeric (or “free”) Cyclin E" 1) ("overexpressing cyclin E" 1)
   ("more cyclin E protein" 1) ("Cyclin E protein" 1)
   ("CMV promoter driven-FLAG-tagged cyclin E" 1) ("the exogenous cyclin E" 1)
   ("the E2F1-dependent target cyclin E" 1)
   ("a full-length nondegradable cyclin E" 1) ("promitotic cyclin E" 1)
   ("significantly more cyclin E" 1) ("PARK2 normally targets cyclin E" 1)
   ("cyclin
                        E"
    1)
   ("Cyclin E's" 1) ("adenoviral cyclin E" 1) ("asynchronous cyclin E" 1)))
 ("IPR029177" (("interferon lambda" 1)))
 ("IPR029539" (("calpain-2" 14) ("Calpain-2" 1)))
 ("IPR029643" (("calpain-1" 66) ("calpain-1 protein" 1) ("Calpain-1" 1)))
 ("IPR029866"
  (("steroidogenic acute regulatory protein" 10)
   ("steroidogenic acute regulatory" 8)))
 ("IPR030146" (("fascin-1" 10)))
 ("IPR030616"
  (("Aurora kinases" 131) ("Aurora kinase" 124) ("aurora kinase" 16)
   ("Aurora kinase family" 13) ("aurora kinases" 5) ("Aurora kinases family" 4)
   ("the mitotic Aurora kinases" 2)
   ("than those inhibiting Aurora kinases ( xref )" 1)))
 ("MESH:C000188" (("LASSO" 25) ("lasso" 12) ("Lasso" 1)))
 ("MESH:C000541" (("cyclopamine" 147) ("Cyclopamine" 13)))
 ("MESH:C000589383" (("pS210" 7))) ("MESH:C000589651" (("LEE011" 65)))
 ("MESH:C000589977" (("CO-1686" 16) ("CO1686" 13)))
 ("MESH:C000591235" (("spautin-1" 95) ("Spautin-1" 8) ("“spautin-1”" 5)))
 ("MESH:C000592275" (("PSB603" 1))) ("MESH:C000592454" (("AZ628" 94)))
 ("MESH:C000592878" (("UMI-77" 1))) ("MESH:C000593797" (("SAR405838" 184)))
 ("MESH:C000594637" (("HLM006474" 33))) ("MESH:C000595177" (("OGX-427" 6)))
 ("MESH:C000595831" (("HJC0149" 5))) ("MESH:C000596358" (("pS315" 1)))
 ("MESH:C000598331" (("VE-822" 18))) ("MESH:C000598436" (("ETP-46464" 31)))
 ("MESH:C000598597" (("YM024" 31)))
 ("MESH:C000598831" (("phenazine" 20) ("phenazines" 4)))
 ("MESH:C000599304" (("JNJ38877605" 15))) ("MESH:C000599963" (("OSU-53" 96)))
 ("MESH:C000600809" (("GSK2256098" 1))) ("MESH:C000601814" (("PD169540" 18)))
 ("MESH:C000602444" (("SAR125844" 2)))
 ("MESH:C001123" (("dopachrome" 5) ("-dopachrome" 2) ("Dopachrome" 1)))
 ("MESH:C001426"
  (("N-hydroxysuccinimide" 25) ("N-Hydroxysuccinimide (NHS)" 3)
   ("N-Hydroxysuccinimide" 1)))
 ("MESH:C001569" (("aeroplysinin" 1)))
 ("MESH:C001598" (("chetomin" 19) ("Chetomin" 1)))
 ("MESH:C001652" (("homoharringtonine" 3) ("Homoharringtonine" 1)))
 ("MESH:C001803"
  (("tempol" 48) ("Tempol" 29) ("TEMPOL" 15)
   ("the superoxide dismutase mimetic tempol" 1)))
 ("MESH:C001899" (("triptolide" 303) ("Triptolide" 20) ("triptolide’s" 1)))
 ("MESH:C002471" (("cinobufagin" 2) ("Cinobufagin" 2)))
 ("MESH:C002602" (("costunolide" 2)))
 ("MESH:C003043"
  (("paraformaldehyde" 5836) ("paraformaldehyde (PFA)" 123)
   ("Paraformaldehyde" 67) ("ice-cold 4% paraformaldehyde" 10)
   ("Paraformaldehyde (PFA)" 7) ("fresh 4% paraformaldehyde" 4)
   ("warm 4% paraformaldehyde" 3) ("4% neutral buffered paraformaldehyde" 2)
   ("4% neutral-buffered paraformaldehyde" 2) ("paraformaldehyde (PF)" 2)
   ("paraformaldehyde (PFH)" 2) ("Residual paraformaldehyde" 1)
   ("preheated (37°C) 4% (wt./vol) paraformaldehyde (PFA)" 1)
   ("fresh 1% paraformaldehyde (PFA)" 1)
   ("freshly made 4% (w/v) paraformaldehyde" 1)
   ("ice-cold 3% paraformaldehyde" 1)
   ("ice-cold 60% Acetone/3.7% paraformaldehyde" 1)
   ("PBS residual paraformaldehyde" 1) ("ice-cold 4% paraformaldehyde (PFA)" 1)
   ("paraformaldehyde (PAF)" 1) ("10% neutral buffered paraformaldehyde" 1)
   ("Two percent paraformaldehyde (PFA)" 1) ("ice-cold 2% paraformaldehyde" 1)
   ("3% ice-cold paraformaldehyde" 1) ("fresh 4% Paraformaldehyde (PFA)" 1)
   ("cold 4% neutral paraformaldehyde" 1) ("4% ice-cold paraformaldehyde" 1)
   ("ice-cold 2% buffered paraformaldehyde" 1)))
 ("MESH:C003402" (("tetrahydrobiopterin" 11) ("Tetrahydrobiopterin" 7)))
 ("MESH:C003466"
  (("thymoquinone" 5) ("Dietary phytochemical thymoquinone (TQ)" 1)
   ("thymoquinone (TQ)" 1) ("Thymoquinone" 1)))
 ("MESH:C003741" (("ubiquinol" 13) ("Ubiquinol" 1)))
 ("MESH:C003915" (("trypan" 831) ("Trypan" 370) ("the vital dye Trypan" 1)))
 ("MESH:C003959" (("tempo" 18) ("-TEMPO" 10) ("TEMPO" 9) ("Tempo" 3)))
 ("MESH:C004363" (("alantolactone" 142) ("Alantolactone" 28)))
 ("MESH:C004547" (("thyronamine" 1))) ("MESH:C004774" (("dimedone" 26)))
 ("MESH:C004820"
  (("Immobilon" 485) ("immobilon" 18)
   ("The chemiluminescent substrate HRP Immobilon" 1)))
 ("MESH:C005134"
  (("Juglone" 88) ("juglone" 70) ("an organic compound Juglone" 2)))
 ("MESH:C005273"
  (("naringenin" 49) ("Naringenin" 6) ("than naringenin" 1)
   ("dietary naringenin" 1)))
 ("MESH:C005274" (("naringin" 4)))
 ("MESH:C005391" (("diethylenetriamine" 6) ("Diethylenetriamine" 2)))
 ("MESH:C005448" (("phosphorylethanolamine" 7) ("-phosphorylethanolamine" 5)))
 ("MESH:C005499" (("HNK" 90) ("honokiol" 34) ("Honokiol" 18)))
 ("MESH:C005542" (("mb2" 1))) ("MESH:C005543" (("MB3" 6) ("mb3" 3)))
 ("MESH:C005703"
  (("sham" 471) ("Sham" 37) ("sham-" 4) ("“sham”" 1) ("‘sham'" 1)
   ("underwent sham" 1)))
 ("MESH:C005705" (("Sanguinarine" 15)))
 ("MESH:C005746"
  (("sulfoxide" 15) ("sulfoxide (DMSO)" 2) ("SulfOxide" 1) ("Sulfoxide" 1)))
 ("MESH:C005843"
  (("resazurin" 73) ("AlamarBlue" 39) ("alamarBlue" 36) ("Resazurin" 14)
   ("Alamarblue" 2) ("non-fluorescent resazurin" 2)
   ("cell-permeable resazurin" 1)))
 ("MESH:C006009" (("IA3" 2))) ("MESH:C006014" (("TMB-8" 10) ("TMB–8" 1)))
 ("MESH:C006068" (("propylparaben" 16)))
 ("MESH:C006552"
  (("kaempferol" 89) ("Kaempferol" 10) ("kaempferol-3-O-" 2)
   ("kaempferol (KF)" 1)))
 ("MESH:C006680" (("baicalein" 14))) ("MESH:C007160" (("cryptopleurine" 7)))
 ("MESH:C007392" (("DiOC6" 31))) ("MESH:C007619" (("eriodictyol" 3)))
 ("MESH:C007638" (("ethanethiol" 6))) ("MESH:C007789" (("fucoidan" 1)))
 ("MESH:C007834" (("genipin" 2)))
 ("MESH:C008047" (("3-hydroxy-3-methylglutaryl-coenzyme A" 4) ("HMGCoA" 1)))
 ("MESH:C008281" (("limonene" 1))) ("MESH:C008390" (("methional" 1)))
 ("MESH:C008449" (("O-6-methylguanine" 3)))
 ("MESH:C008542"
  (("monodansylcadaverine" 34) ("monodansylcadaverine (MDC)" 6)
   ("Monodansylcadaverine" 2)
   ("the membrane-permeable dye monodansylcadaverine (MDC)" 1)
   ("Monodansylcadaverine (MDC)" 1)
   ("the autophagic vesicle marker monodansylcadaverine" 1)))
 ("MESH:C008661" (("nobiletin" 1)))
 ("MESH:C008699"
  (("Octylamine" 4) ("octylamine" 3) ("octylamine (OA)" 1) ("-octylamine" 1)))
 ("MESH:C008743" (("oxychlordane" 9)))
 ("MESH:C008881" (("phosphocellulose" 52))) ("MESH:C008936" (("Platycodin" 3)))
 ("MESH:C008976" (("polidocanol" 27) ("Polidocanol" 1)))
 ("MESH:C009042" (("pristane" 38) ("Pristane" 2)))
 ("MESH:C009043"
  (("pristimerin" 13) ("Pristimerin" 10) ("pristimerin (PM)" 1)))
 ("MESH:C009405" (("tetrabutylammonium" 6) ("Tetrabutylammonium" 1)))
 ("MESH:C009560" (("trigonelline" 23) ("Trigonelline" 7)))
 ("MESH:C009689" (("xanthones" 4) ("xanthone" 1)))
 ("MESH:C010013" (("doxorubicinol" 2)))
 ("MESH:C010078" (("alizarin" 5) ("Alizarin" 2)))
 ("MESH:C010272" (("palytoxin" 10)))
 ("MESH:C010480" (("lupeol" 134) ("Lupeol" 41) ("lupeol's" 1) ("lupeol-" 1)))
 ("MESH:C010574"
  (("diphenyl" 155) ("biphenyls" 33) ("coplanar polychlorinated biphenyls" 2)
   ("biphenyls (PCB)" 1) ("diphenyl-" 1)))
 ("MESH:C010777" (("quinomycin" 2)))
 ("MESH:C010920"
  (("dihydrofolate" 30) ("than dihydrofolate (DHF)" 1)
   ("dihydrofolate (DHF)" 1) ("Dihydrofolate" 1)))
 ("MESH:C011126"
  (("tetrac" 17) ("Tetrac" 2) ("tetraiodothyroacetic acid" 2)
   ("Tetraiodothyroacetic acid" 2)))
 ("MESH:C011452" (("salen" 5) ("Salen" 3) ("-salen" 1)))
 ("MESH:C011700" (("carbogen" 12)))
 ("MESH:C011959"
  (("oridonin" 97) ("Oridonin" 38) ("oridonin-" 1) ("treated oridonin" 1)))
 ("MESH:C012393" (("AHP" 12)))
 ("MESH:C012526" (("quercitrin" 7) ("Quercitrin" 1)))
 ("MESH:C012867" (("decane" 2) ("-decane" 1)))
 ("MESH:C013091" (("lipoamide" 23))) ("MESH:C013221" (("proanthocyanidin" 1)))
 ("MESH:C013411" (("biocytin" 6) ("-biocytin" 2) ("Biocytin" 1)))
 ("MESH:C013418" (("Talon" 50) ("TALON" 34) ("“Talon”" 1) ("talon" 1)))
 ("MESH:C013515"
  (("ellagitannins" 5) ("Monomeric and oligomeric ellagitannins" 1)
   ("monomeric and oligomeric ellagitannins" 1) ("ellagitannin" 1)))
 ("MESH:C013592" (("mangiferin" 10)))
 ("MESH:C013830"
  (("polydimethylsiloxane" 12) ("polydimethylsiloxane (PDMS)" 3)
   ("Polydimethylsiloxane" 2)))
 ("MESH:C013874" (("chloroacetamide" 18) ("Chloroacetamide" 1)))
 ("MESH:C013905" (("cyclopentenone" 12) ("Cyclopentenone" 4)))
 ("MESH:C014175" (("A-420983" 2))) ("MESH:C014499" (("alar" 2)))
 ("MESH:C014641" (("LidA" 8) ("Lida" 2)))
 ("MESH:C015001"
  (("arsenite" 316) ("Arsenite" 5) ("inorganic arsenite" 4)
   ("acute arsenite" 1) ("arsenite-" 1) ("trivalent arsenite" 1)))
 ("MESH:C015367" (("mevalonolactone" 1)))
 ("MESH:C015423" (("PF" 128) ("paeoniflorin" 6) ("Paeoniflorin" 6)))
 ("MESH:C015591" (("TX61" 19)))
 ("MESH:C015620" (("brimonidine" 2) ("Brimonidine" 1)))
 ("MESH:C016039"
  (("Percoll" 145) ("percoll" 10) ("a discontinuous Percoll" 2)
   ("a 17% isotonic Percoll" 1) ("the 17% isotonic Percoll" 1)
   ("isotonic Percoll" 1) ("a discontinuous plasma-Percoll" 1)
   ("residual Percoll" 1) ("discontinuous Percoll" 1)))
 ("MESH:C016101" (("shikonin" 264) ("Shikonin" 41)))
 ("MESH:C016299"
  (("chelerythrine" 108) ("Chelerythrine" 33) ("chelerythrine’s" 2)
   ("chelerythrine's" 1) ("the cell-permeable alkaloid chelerythrine" 1)))
 ("MESH:C016517" (("Indole-3-carbinol" 23) ("indole-3-carbinol" 13)))
 ("MESH:C016679"
  (("polyacrylamide" 1928) ("Polyacrylamide" 24) ("-polyacrylamide" 20)
   ("–polyacrylamide" 2)))
 ("MESH:C017092"
  (("bromopyruvate" 6) ("Bromopyruvate" 1) ("bromopyruvate (BP)" 1)))
 ("MESH:C017154" (("cyanidin" 3) ("Cyanidin" 1)))
 ("MESH:C017160" (("cypermethrin" 7))) ("MESH:C017185" (("delphinidin" 2)))
 ("MESH:C017501" (("AME" 130))) ("MESH:C017506" (("methylcholine" 17)))
 ("MESH:C017573" (("nonane" 1))) ("MESH:C017662" (("Udel" 7)))
 ("MESH:C017875"
  (("fisetin" 197) ("Fisetin" 47)
   ("every alternate day with/without fisetin" 2) ("than fisetin" 1)
   ("our previous observations fisetin" 1)))
 ("MESH:C018855"
  (("tert-butylhydroquinone" 43) ("Tert-butylhydroquinone" 3)
   ("tert-Butylhydroquinone" 3) ("Tert-Butylhydroquinone" 2)))
 ("MESH:C019248" (("pamidronate" 9))) ("MESH:C020175" (("ORG2058" 1)))
 ("MESH:C020237" (("brusatol" 26) ("Brusatol" 8)))
 ("MESH:C020491" (("Rhein" 3) ("rhein" 1)))
 ("MESH:C020753" (("haemozoin" 3) ("hemozoin" 1) ("Haemozoin" 1)))
 ("MESH:C020754" (("herbimycin" 35) ("Herbimycin" 3)))
 ("MESH:C020809" (("tetrathiomolybdate" 8) ("tetrathiomolybdate (TTM)" 5)))
 ("MESH:C021096"
  (("TMPyP4" 146) ("the cationic porphyrin TMPyP4" 6) ("TMPYP4" 2)
   ("The cationic porphyrin TMPyP4" 2) ("The cationic porphyrine TMPyP4" 1)))
 ("MESH:C021183" (("paraxanthine" 2)))
 ("MESH:C021304" (("hyperoside" 4) ("Hyperoside" 1)))
 ("MESH:C022777"
  (("bufalin" 85) ("Bufalin" 10) ("bufalin’s" 1)
   ("the cardiac glycoside (CG) bufalin" 1)
   ("the cardiac
glycoside bufalin"
    1)))
 ("MESH:C023617"
  (("guggulsterone" 59) ("Guggulsterone" 19) ("Guggulsterone (GS)" 1)))
 ("MESH:C023650" (("aniline" 18)))
 ("MESH:C023666" (("pyridine" 121) ("Pyridine" 4) ("-pyridine" 2)))
 ("MESH:C024098"
  (("6-carboxyfluorescein" 33) ("carboxy-fluorescein" 16)
   ("-carboxy-fluorescein" 11) ("Carboxy-fluorescein" 4)
   ("6-carboxyfluorescein (FAM)" 3) ("6-Carboxyfluorescein" 1)))
 ("MESH:C024132" (("flavins" 2))) ("MESH:C024714" (("caryophyllene" 1)))
 ("MESH:C024942" (("S-nitrosopenicillamine" 4)))
 ("MESH:C024989" (("ubisemiquinone" 4) ("coenzyme Q10" 2) ("Coenzyme Q10" 1)))
 ("MESH:C025164" (("fucoxanthin" 127) ("Fucoxanthin" 26)))
 ("MESH:C025430" (("LY117018" 4) ("LY 117018" 2)))
 ("MESH:C025614" (("Sephadex" 76) ("sephadex" 8)))
 ("MESH:C026058" (("NiEDDA" 10)))
 ("MESH:C026166"
  (("theanine" 33) ("-Theanine" 3) ("Theanine" 3)
   ("their parental compound theanine" 3) ("-theanine" 1)))
 ("MESH:C027185" (("indirubin" 35) ("Indirubin" 16) ("indirubin molecule" 1)))
 ("MESH:C027451" (("methylamine" 17) ("Methylamine" 1)))
 ("MESH:C027681" (("isonicotinamide" 3) ("Isonicotinamide" 1)))
 ("MESH:C027870" (("berbamine" 2)))
 ("MESH:C027982" (("RID" 46) ("rid" 34) ("“rid”" 2)))
 ("MESH:C028210" (("mPEG" 32) ("MPEG" 2)))
 ("MESH:C028610" (("flavanones" 5) ("flavanone" 2)))
 ("MESH:C028858" (("MDAMD" 3)))
 ("MESH:C029569"
  (("DCFDA" 542) ("-DCFDA" 21) ("DCFDA-" 3) ("the fluorescent dye H 2 DCFDA" 2)
   ("the general oxidative stress indicator CM-H 2 DCFDA" 2) ("using DCFDA" 2)
   ("10 µmol/L nonfluorescent indicator H 2 DCFDA" 2)
   ("the fluorescent dye CM-H 2 DCFDA" 2)
   ("the fluorescent carboxy-H 2 DCFDA" 1) ("Non-fluorescent H 2 DCFDA" 1)
   ("the cell-permeable indicator dye DCFDA" 1)))
 ("MESH:C029743" (("alpha-ketoglutarate" 6)))
 ("MESH:C029899"
  (("imidazole" 1345) ("Imidazole" 102) ("-imidazole" 3)
   ("imidazole molecule" 2) ("imidazole-" 2)
   ("-1-(4-hydroxy-cyclohexyl)-4-(4-fluorophenyl)-5-(2-methoxypyridimidin-4-yl)-imidazole"
    1)
   ("DEPC-treated H 2 O. Imidazole" 1)))
 ("MESH:C030290" (("malonate" 26))) ("MESH:C030299" (("phenylhydrazine" 7)))
 ("MESH:C030374" (("indole" 135) ("-indole-5-sulphonamide" 4) ("Indole" 3)))
 ("MESH:C030517" (("myxothiazol" 85))) ("MESH:C030686" (("acetamide" 35)))
 ("MESH:C030820" (("tryptamine" 7) ("the aromatic tryptamine" 1)))
 ("MESH:C030935" (("benz(a)anthracene" 3)))
 ("MESH:C030985"
  (("purine" 338) ("purines" 55) ("Purine" 10) ("purine-" 4)
   ("oxidatively damaged purines" 2) ("purine (TNP)" 2)
   ("a 2,6,9-tri-substituted purine" 1)))
 ("MESH:C030986"
  (("pyrimidine" 435) ("Pyrimidine" 5)
   ("low dose 4-amino-3-(p-fluorophenylamino)pyrazolo (3,4-d)pyrimidine" 2)
   ("Src family kinase inhibitor 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo(3,4-d)-pyrimidine"
    2)
   ("-pyrimidine" 1) ("pyrimidine (ABDP)" 1)))
 ("MESH:C031000"
  (("benzimidazole" 20) ("benzimidazoles" 5) ("Benzimidazole" 2)
   ("Benzimidazoles" 1)))
 ("MESH:C031066" (("formamide" 405) ("Formamide" 35)))
 ("MESH:C031181" (("phenanthrene" 5)))
 ("MESH:C031234"
  (("ethylenediamine" 82) ("ethylenediamine (TPEN)" 4) ("-ethylenediamine" 1)))
 ("MESH:C031280"
  (("pyrazole" 68) ("4-amino-5- (4-chlorophenyl)-7-( t -butyl) pyrazole" 2)
   ("-pyrazole" 2)))
 ("MESH:C031463" (("beta-glycerophosphate" 94)))
 ("MESH:C031534" (("imperatorin" 1)))
 ("MESH:C031655"
  (("TUDCA" 67) ("Tudca" 18) ("tauroursodeoxycholic acid (TUDCA)" 5)
   ("tauroursodeoxycholic acid" 5) ("Tauroursodeoxycholic acid" 1)))
 ("MESH:C032159"
  (("acetonitrile" 939) ("Acetonitrile" 27) ("acetonitrile (ACN)" 17)
   ("Acetonitrile (ACN)" 2) ("neat acetonitrile" 2)
   ("5 mL anhydrous acetonitrile" 2) ("pure acetonitrile" 2)
   ("aqueous 50% acetonitrile" 1) ("ice-cold 80% acetonitrile" 1)
   ("10–30% aqueous acetonitrile" 1) ("eluent B −80% acetonitrile" 1)
   ("aqueous 80% (volume/volume)
acetonitrile"
    1)
   ("aqueous 2% acetonitrile" 1)))
 ("MESH:C032456" (("antimycin" 107) ("Antimycin" 25) ("antimycin-" 3)))
 ("MESH:C032519" (("pyrrolidine" 74) ("-pyrrolidine" 20) ("Pyrrolidine" 2)))
 ("MESH:C032620" (("succinimide" 6) ("succinimide (NHS)" 4)))
 ("MESH:C032727" (("piperidine" 49)))
 ("MESH:C032854"
  (("leupeptin" 2233) ("Leupeptin" 107)
   ("the distal authophagy inhibitor leupeptin" 1)))
 ("MESH:C033085" (("phorbol" 545) ("Phorbol" 49) ("study phorbol" 2)))
 ("MESH:C033110" (("PDMP" 11))) ("MESH:C033132" (("aziridine" 4)))
 ("MESH:C033353" (("pentane" 8) ("anhydrous pentane" 2)))
 ("MESH:C033472"
  (("lucigenin" 57) ("Lucigenin" 5) ("Dark-adapted lucigenin" 2)))
 ("MESH:C033502" (("HTB" 237) ("HTb" 9) ("Htb" 2)))
 ("MESH:C033607" (("puerarin" 3)))
 ("MESH:C034020"
  (("anthracene" 33) ("anthracene (DMBA)" 12) ("-anthracene" 1)))
 ("MESH:C034219" (("isocitrate" 74) ("Isocitrate" 19)))
 ("MESH:C034248" (("MTSSL" 6)))
 ("MESH:C034657"
  (("Texas Red" 358) ("Texas red" 180) ("Texas-Red" 34) ("Texas-red" 22)
   ("Texas-Red-" 6) ("Texas red-" 3) ("Texas Red-" 3) ("Texas  red" 1)
   ("Texas red–" 1) ("Texas Red–" 1) ("fluorescent Texas Red" 1)
   ("-Texas-Red" 1)))
 ("MESH:C034807" (("TAPP" 2))) ("MESH:C035456" (("MOSE" 12) ("MOSE-" 1)))
 ("MESH:C037032"
  (("galangin" 87) ("Galangin" 14) ("One log less galangin" 1)
   ("galangin's" 1)))
 ("MESH:C037067"
  (("latrunculin A" 44) ("Latrunculin A" 26) ("latrunculin A (LA)" 8)))
 ("MESH:C037068"
  (("latrunculin B" 78) ("Latrunculin B" 48) ("LatB" 19)
   ("latrunculin B (LB)" 2)))
 ("MESH:C037219" (("quinoline" 9) ("Quinoline" 2)))
 ("MESH:C037304"
  (("sentinel" 177) ("Sentinel" 9) ("\"sentinel\"" 1) ("‘sentinel’" 1)))
 ("MESH:C037689"
  (("benzamide" 44) ("Benzamide" 3) ("benzamide (BZ)" 3) ("BZ" 2)
   ("-benzamide" 1)))
 ("MESH:C038044" (("baicalin" 1)))
 ("MESH:C038106" (("JSI-124" 131) ("cucurbitacin I" 45) ("Cucurbitacin I" 19)))
 ("MESH:C038491" (("diallylsulfide" 2) ("diallylsulfide (DAS)" 1)))
 ("MESH:C038518"
  (("acrylodan" 12) ("the environmentally-sensitive fluorophore acrylodan" 2)))
 ("MESH:C038699"
  (("acetophenone" 11) ("the chiral acetophenone" 2)
   ("The key intermediate chiral acetophenone" 2)))
 ("MESH:C038905" (("elemene" 71) ("Elemene" 18)))
 ("MESH:C039109"
  (("isoquinoline" 23) ("-isoquinoline" 6) ("-isoquinoline (DPQ)" 2)))
 ("MESH:C039163" (("safran" 3))) ("MESH:C039614" (("EIPA" 32)))
 ("MESH:C040015" (("myricetin" 27))) ("MESH:C040115" (("shogaol" 1)))
 ("MESH:C040617" (("PRISMA" 53) ("Prisma" 2)))
 ("MESH:C040929"
  (("bafilomycin A1" 175) ("Bafilomycin A1" 98)
   ("the vesicular H + -ATPase inhibitor bafilomycin A1" 2)
   ("the vacuolar type H + -ATPase inhibitor bafilomycin A1" 1)))
 ("MESH:C041509" (("fluorene" 1)))
 ("MESH:C041514"
  (("carbazole" 35) ("FICZ" 14) ("carbazole (FICZ)" 4) ("-carbazole" 4)
   ("carbazole (AEC)" 2) ("-carbazole-3-methanamine" 1)
   ("amino ethyl carbazole" 1)))
 ("MESH:C041564" (("-ethylamine" 9) ("ethylamine" 6) ("ethylamine (DIEA)" 1)))
 ("MESH:C042198"
  (("nimbolide" 61) ("Nimbolide" 4)
   ("its principal cytotoxic component nimbolide" 2) ("pure nimbolide" 1)
   ("than nimbolide" 1)))
 ("MESH:C042855" (("Mono Q" 33)))
 ("MESH:C043042" (("pMDM" 11) ("PMDM" 6) ("pMdm" 4)))
 ("MESH:C043099" (("GT12" 1))) ("MESH:C043243" (("MTBE" 6) ("mTBE" 6)))
 ("MESH:C043435" (("PLGA" 79) ("a microfluidic PLGA" 1)))
 ("MESH:C043592"
  (("maleimide" 151) ("maleimide (NEM)" 8) ("NEM" 7) ("-maleimide" 7)
   ("maleimide (BIM)" 5) ("Maleimide" 4)
   ("Near-infrared fluorescent dye Alexa Fluor 680 C2 maleimide" 1)))
 ("MESH:C044295"
  (("diC8" 17) ("DiC8" 8) ("–diC8" 4) ("1,2-dioctanoylglycerol" 2)
   ("the cell-permeable DAG analog diC8" 1)))
 ("MESH:C044387" (("TPEN" 63))) ("MESH:C044697" (("trifluoromethylbenzene" 2)))
 ("MESH:C044834" (("iodixanol" 71) ("Iodixanol" 4)))
 ("MESH:C045000" (("SBDP" 24))) ("MESH:C045400" (("NBDG" 25)))
 ("MESH:C045651"
  (("epigallocatechin-3-gallate" 33) ("epigallocatechin gallate" 22)
   ("-epigallocatechin-3-gallate" 11) ("-epigallocatechin-3-gallate (EGCG)" 4)
   ("Epigallocatechin-3-gallate" 3) ("epigallocatechin-3-gallate (EGCG)" 3)
   ("epigallocatechin gallate (EGCG)" 3) ("Epigallocatechin gallate" 2)
   ("Epigallocatechin-3-gallate (EGCG)" 1)))
 ("MESH:C046594" (("mCCD" 3))) ("MESH:C047254" (("PPHP" 16)))
 ("MESH:C047723" (("benzophenone" 25)))
 ("MESH:C049538"
  (("streptavidin-agarose" 86) ("streptavidin–agarose" 18)
   ("Streptavidin-agarose" 12) ("Streptavidin–agarose" 2)
   ("Streptavidin-Agarose" 2)))
 ("MESH:C051175" (("Fe-SP" 157) ("the previous sections Fe-SP" 1)))
 ("MESH:C051329" (("HMQC" 17))) ("MESH:C052246" (("EMCA" 114)))
 ("MESH:C052464" (("siNC" 51)))
 ("MESH:C052518" (("WEB2086" 75) ("WEB 2086" 5)))
 ("MESH:C053400" (("cafestol" 96) ("Cafestol" 6) ("cafestol-" 1)))
 ("MESH:C053876" (("AH-6809" 16)))
 ("MESH:C055492" (("endoxifen" 16) ("-endoxifen" 1)))
 ("MESH:C055869" (("dichlobenil" 5))) ("MESH:C056218" (("ML-9" 11)))
 ("MESH:C056507"
  (("gemcitabine" 1812) ("Gemcitabine" 129) ("gemcitabine-" 6)
   ("than gemcitabine" 5) ("the chemotherapeutic gemcitabine" 4)
   ("pharmaceutical grade gemcitabine" 2) ("non-gemcitabine" 2)
   ("at least one gemcitabine" 2) ("than the gemcitabine" 1)
   ("The chemotherapeutic agent gemcitabine" 1)
   ("than gemcitabine in variable cancers" 1) ("gemcitabine's" 1)
   ("more gemcitabine" 1)))
 ("MESH:C057299" (("fumagillol" 4)))
 ("MESH:C057416" (("KT-5720" 2) ("KT 5720" 2))) ("MESH:C057536" (("p536" 43)))
 ("MESH:C057580"
  (("-epigallocatechin" 9) ("epigallocatechin" 6) ("Epigallocatechin" 2)))
 ("MESH:C058024" (("lidamycin" 11) ("lidamycin (LDM)" 3) ("Lidamycin" 2)))
 ("MESH:C058189" (("HepII" 3))) ("MESH:C058744" (("tautomycetin" 29)))
 ("MESH:C059141" (("MK571" 16))) ("MESH:C059368" (("pp56" 2)))
 ("MESH:C059896" (("Miglustat" 3)))
 ("MESH:C061481" (("dibenzoylmethane" 11) ("Dibenzoylmethane" 1)))
 ("MESH:C061492" (("isomangiferin" 6))) ("MESH:C061730" (("TSQ" 18)))
 ("MESH:C061896" (("triphenylphosphine" 9))) ("MESH:C062112" (("CDE3" 3)))
 ("MESH:C062198" (("LGD1550" 18)))
 ("MESH:C062669"
  (("epicatechin-3-gallate" 5) ("-epicatechin-3-gallate" 2)
   ("epicatechin gallate" 2) ("-epicatechin gallate" 1)))
 ("MESH:C062916" (("-protopanaxadiol" 8) ("protopanaxadiol" 5)))
 ("MESH:C063155"
  (("violacein" 109) ("Violacein" 6) ("violacein’s" 1)
   ("the secondary metabolite violacein" 1)))
 ("MESH:C063159" (("SKF-96365" 1))) ("MESH:C063302" (("KN62" 36)))
 ("MESH:C063471" (("PEG-SOD" 17)))
 ("MESH:C063998" (("nodularin" 29) ("Nodularin" 4) ("nodularins" 2)))
 ("MESH:C064764" (("penta" 18) ("Penta" 7)))
 ("MESH:C065179"
  (("atorvastatin" 264) ("Atorvastatin" 33)
   ("the lipophilic statin atorvastatin" 1)
   ("intensive (80 mg/d) dose atorvastatin" 1)))
 ("MESH:C065580" (("Laurdan" 33) ("the membrane fluorescent Laurdan" 1)))
 ("MESH:C066957" (("pelargonidin" 1))) ("MESH:C067113" (("SKF81297" 18)))
 ("MESH:C067713"
  (("lactacystin" 270) ("Lactacystin" 52) ("-lactacystin" 9)
   ("the proteasomal inhibitor lactacystin" 1) ("-Lactacystin" 1)))
 ("MESH:C068457" (("SKF97541" 9))) ("MESH:C068559" (("propanesulfonate" 17)))
 ("MESH:C068718" (("dETS" 3)))
 ("MESH:C070080"
  (("PKH26" 54) ("the far red fluorescent membrane linker PKH26" 1)
   ("the fluorescent cell membrane dye PKH26" 1) ("red fluorescent PKH26" 1)
   ("PKH26-" 1)))
 ("MESH:C070081"
  (("fulvestrant" 641) ("Fulvestrant" 65) ("ICI-182780" 22)
   ("fulvestrant (FUL)" 3) ("the pure antiestrogen fulvestrant" 2)
   ("the nonselective ERα/ERβ antagonist fulvestrant" 2)
   ("The pure anti-oestrogen fulvestrant" 1) ("fulvestrant-" 1)
   ("the pure steroidal antiestrogen fulvestrant (ICI)" 1)
   ("fulvestrant (ICI)" 1) ("the pure steroidal antiestrogen fulvestrant" 1)))
 ("MESH:C070423" (("TAAD" 50)))
 ("MESH:C070515"
  (("Bisindolylmaleimide I" 32) ("bisindolylmaleimide I" 30) ("GF109203x" 16)
   ("bisindolylmaleimide I (BIM)" 4) ("Bisindolylmaleimide I (BIMI)" 3)
   ("Bisindolylmaleimide I (BIM)" 1)))
 ("MESH:C070646" (("HCAP18" 2)))
 ("MESH:C070899" (("ICRF-193" 78) ("Topo II Inhibitor ICRF-193" 2)))
 ("MESH:C070966" (("OCT43" 1))) ("MESH:C071423" (("capsazepine" 2)))
 ("MESH:C071924" (("Ro31-8425" 34))) ("MESH:C072251" (("depudecin" 5)))
 ("MESH:C073601" (("KT5823" 7)))
 ("MESH:C073608" (("perfluorooctane" 2) ("Perfluorooctane" 1)))
 ("MESH:C074502"
  (("methanethiosulfonate" 21) ("methanethiosulfonate (MMTS)" 4)
   ("Methanethiosulfonate" 1)))
 ("MESH:C074589" (("pirodavir" 16) ("Pirodavir" 2)))
 ("MESH:C074975" (("M15" 49) ("m15" 7) ("M15 (QIAGEN)" 2)))
 ("MESH:C075295" (("toto" 21) ("TOTO" 2)))
 ("MESH:C076196" (("Org 31710" 5) ("Org31710" 3)))
 ("MESH:C077910" (("margatoxin" 6))) ("MESH:C078131" (("GM6001" 370)))
 ("MESH:C078903" (("EB1089" 63) ("seocalcitol" 2) ("Seocalcitol" 1)))
 ("MESH:C079087" (("SR48692" 101))) ("MESH:C079110" (("YM3" 8)))
 ("MESH:C079391" (("PTIO" 21))) ("MESH:C079393" (("cPTIO" 15)))
 ("MESH:C079694" (("LY367385" 6)))
 ("MESH:C080625"
  (("taxane" 518) ("Taxane" 14) ("taxane drug" 7) ("taxane-" 4)
   ("The semisynthetic taxane" 2) ("non-taxane" 2) ("–taxane" 2)
   ("a semisynthetic taxane" 1) ("a representative taxane" 1) ("‘taxane’" 1)
   ("sequential taxane" 1) ("Sequential taxane" 1)))
 ("MESH:C081020" (("AG879" 31)))
 ("MESH:C081021" (("Go 6976" 27) ("Go-6976" 4) ("GO-6976" 1)))
 ("MESH:C081648" (("pp36" 1)))
 ("MESH:C082026"
  (("mimics" 3205) ("Mimics" 47) ("“mimics”" 4) ("mimics-" 3)
   ("benign mimics" 3) ("viral RNA and DNA mimics" 3)
   ("the morphologic mimics" 2) ("MIRIDIAN miRNA mimics" 2)
   ("Longer PIP Box peptide mimics" 2) ("mimics (NC)" 2) ("‘mimics’" 2)
   ("reasonable mimics" 2) ("Ras-expressing keratinocytes mimics" 2)
   ("four chemically-modified miRNA mimics" 2) ("histological mimics" 2)
   ("miRNA duplex mimics" 1) ("chemically-synthesized mimics" 1)
   ("chemical-engineered mimics" 1) ("miRIDIAN miR Mimics" 1)
   ("this pathogenic mutation mimics" 1) ("just mimics" 1)
   ("only miRNA mimics" 1)
   ("exogenous cell permeable dimethyl-malate (DMM) mimics" 1)
   ("Commercial miR-149 mimics" 1) ("miRIDIAN miRNA mimics" 1)
   ("Exogenous H 2 O 2 mimics" 1) ("only FGF2 mimics" 1)
   ("nonpolar thymidine mimics" 1) ("use nonpolar nucleoside mimics" 1)
   ("benign histological mimics" 1) ("Non-phosphorylated CagA mimics" 1)
   ("The pre-designed miRIDIAN miRNA mimics" 1) ("nonnative mimics" 1)
   ("The last mutation mimics" 1)))
 ("MESH:C082246" (("ZD7288" 2))) ("MESH:C082887" (("PD145065" 5)))
 ("MESH:C084904" (("Ro41-5253" 2))) ("MESH:C085348" (("Tau1" 7)))
 ("MESH:C085514" (("wogonin" 125) ("Wogonin" 21) ("wogonin's" 1)))
 ("MESH:C085586"
  (("pemetrexed" 638) ("Pemetrexed" 52) ("pemetrexed-" 3)
   ("the chemotherapeutic pemetrexed" 2) ("pemetrexed (PMX)" 1)
   ("than monoglutamyl pemetrexed" 1)))
 ("MESH:C085746"
  (("rottlerin" 406) ("Rottlerin" 96) ("BIOMOL" 2) ("than rottlerin" 1)))
 ("MESH:C086501" (("L-NAC" 20)))
 ("MESH:C086566" (("glycitein" 12) ("Glycitein" 1)))
 ("MESH:C086836" (("SC-51089" 1)))
 ("MESH:C087030"
  (("melt" 206) ("MELT" 67) ("Melt" 30) ("melt (HRM)" 9) ("Melt (HRM)" 4)
   ("phosphorylated MELT" 1) ("the mutated MELT" 1)
   ("The phosphorylated MELT" 1) ("numerous so-called MELT" 1)
   ("Guanine–cytosine-rich sequences (resulting from methylated CpG dinucleotides) melt"
    1)))
 ("MESH:C087123" (("romidepsin" 62) ("Romidepsin" 22)))
 ("MESH:C087130" (("SR11237" 4))) ("MESH:C088015" (("benzothiophene" 3)))
 ("MESH:C088060"
  (("bisindolylmaleimide" 50) ("Bisindolylmaleimide" 16)
   ("the nonspecific PKC inhibitor bisindolylmaleimide" 3)
   ("an acyclic bisindolylmaleimide" 2)))
 ("MESH:C089032" (("rimonabant" 11))) ("MESH:C089486" (("MG115" 31)))
 ("MESH:C089946"
  (("thiazolidinedione" 24) ("-2,4-thiazolidinedione" 5)
   ("2,4-thiazolidinedione" 5)
   ("3-(2-aminoethyl)5-([4-ethoxyphenyl]methylene)-2,4-thiazolidinedione" 2)
   ("exogenous synthetic thiazolidinedione" 1)))
 ("MESH:C090046" (("olomoucine" 34) ("Olomoucine" 4) ("olomoucine-" 1)))
 ("MESH:C090413" (("Way100635" 7))) ("MESH:C090438" (("NIM811" 2)))
 ("MESH:C090662" (("GR144053" 5))) ("MESH:C091666" (("SNARF-1" 11)))
 ("MESH:C093285" (("NOC-18" 12))) ("MESH:C093850" (("thioanisole" 9)))
 ("MESH:C095489"
  (("BODIPY" 94) ("Bodipy" 21) ("bodipy" 6) ("the fluorescent dye BODIPY" 1)
   ("its fluorescent product BODIPY" 1)))
 ("MESH:C095512" (("AG-490" 47)))
 ("MESH:C096713"
  (("z-vad-FMK" 2) ("z-Vad-fmk" 2) ("Z-Vad-FMK" 1) ("Z-vad-fmk" 1)))
 ("MESH:C098214" (("AG825" 113))) ("MESH:C098981" (("AG556" 3)))
 ("MESH:C099150"
  (("trabectedin" 45) ("Trabectedin" 4)
   ("the new chemotherapeutic compound trabectedin" 2)))
 ("MESH:C099154" (("LY333531" 37) ("ruboxistaurin" 10)))
 ("MESH:C100058" (("vanillin" 8) ("Vanillin" 4)))
 ("MESH:C100148" (("tylocrebrine" 3)))
 ("MESH:C100184" (("Tricine" 65) ("tricine" 17)))
 ("MESH:C101044" (("AG-1478" 61)))
 ("MESH:C101954" (("C6-ceramide" 8) ("exogenous C6-ceramide" 2)))
 ("MESH:C102521" (("GGTI-298" 43)))
 ("MESH:C104201" (("gimeracil" 4) ("Gimeracil" 1)))
 ("MESH:C104586"
  (("roscovitine" 556) ("Roscovitine" 134) ("than roscovitine" 2)
   ("induced neuronal apoptosis Roscovitine" 2)))
 ("MESH:C104727" (("Moxifloxacin" 1))) ("MESH:C105430" (("benzofuran" 9)))
 ("MESH:C106250" (("AG1296" 44))) ("MESH:C106538" (("abacavir" 5)))
 ("MESH:C106592" (("CEP-1347" 6))) ("MESH:C107428" (("Oregovomab" 2)))
 ("MESH:C107773" (("pterostilbene" 3))) ("MESH:C107820" (("SB242084" 3)))
 ("MESH:C107832" (("Kar2" 2))) ("MESH:C107875" (("PD158780" 18)))
 ("MESH:C108637" (("DEVD-cho" 2))) ("MESH:C109145" (("SJA6017" 4)))
 ("MESH:C110258" (("NF449" 8)))
 ("MESH:C110400"
  (("H2DCFDA" 40) ("2',7'-dichlorodihydrofluorescein diacetate" 13)
   ("2’,7’-dichlorodihydrofluorescein diacetate" 10) ("H2DCFDA molecule" 2)))
 ("MESH:C110621" (("isoindolone" 2)))
 ("MESH:C110630" (("SR144528" 30) ("than SR144528" 1)))
 ("MESH:C111237"
  (("vorinostat" 271) ("Vorinostat" 102) ("vorinostat (SAHA)" 6)
   ("than Vorinostat (reviewed in [ xref ])" 1)))
 ("MESH:C111914" (("MRS2179" 32))) ("MESH:C112019" (("SB225002" 10)))
 ("MESH:C112276" (("MACH2" 19) ("mach2" 9) ("Mach2" 4) ("MaCH2" 1)))
 ("MESH:C112381" (("CysLT" 2)))
 ("MESH:C112765" (("Tanespimycin" 6) ("tanespimycin" 6)))
 ("MESH:C113580" (("UO126" 321) ("U 0126" 6) ("UO126's" 1)))
 ("MESH:C116572" (("CMTMR" 22))) ("MESH:C116917" (("acylcarnitine" 2)))
 ("MESH:C117197" (("hydroimidazolone" 21) ("Hydroimidazolone" 1)))
 ("MESH:C117329" (("vicenin" 5))) ("MESH:C119130" (("SC236" 45)))
 ("MESH:C119285"
  (("DiFMUP" 23) ("6,8-difluoro-4-methylumbelliferyl phosphate" 10)
   ("using fluorogenic 6,8-difluoro-4-methylumbelliferyl phosphate" 2)
   ("DifMUP" 1) ("the generic substrate DiFMUP" 1)))
 ("MESH:C119341" (("KOD" 71) ("Kod" 1)))
 ("MESH:C119369"
  (("Tak779" 9) ("the CCR5-specific pharmacologic antagonist Tak779" 2)))
 ("MESH:C119494" (("glucoraphanin" 14)))
 ("MESH:C121565"
  (("pifithrin" 167) ("Pifithrin" 82) ("Pifithrin-" 17) ("pifithrin-alpha" 11)
   ("Pifithrin-alpha" 6) ("pifithrin-" 4) ("pifithrin-µ" 2)))
 ("MESH:C121825" (("ZM336372" 4)))
 ("MESH:C122096" (("salvicine" 6) ("Salvicine" 2) ("than salvicine" 1)))
 ("MESH:C122148" (("ONO-8711" 1)))
 ("MESH:C400223" (("monastrol" 214) ("Monastrol" 29)))
 ("MESH:C400277" (("RWJ67657" 1))) ("MESH:C401312" (("GMX1778" 1)))
 ("MESH:C402665" (("CP-31398" 36)))
 ("MESH:C403008" (("-dihydroquinones" 3) ("dihydroquinones" 3)))
 ("MESH:C403585"
  (("ctn" 405) ("-ctn" 14) ("This  phosphatase-treated p120 ctn" 1)
   ("the  NH 2 -terminally deleted p120 ctn" 1)
   ("the NH 2 -terminal 346  amino acids (aa) of p120 ctn" 1)
   ("NH 2 -terminally deleted p120 ctn" 1)
   ("the classical cadherin-associated protein p120 ctn" 1) ("Ctn" 1)
   ("p120 ctn ’s" 1)))
 ("MESH:C403753" (("z-IETD-fmk" 47) ("Z-IETD-FMK" 17) ("Z-IETD-fmk" 4)))
 ("MESH:C403754" (("Z-LEHD-FMK" 14) ("z-LEHD-fmk" 1)))
 ("MESH:C404329" (("SB218078" 33) ("SB 218078" 5)))
 ("MESH:C405103" (("CA-ME" 11)))
 ("MESH:C406082" (("MMA(III)" 59) ("monomethylarsonous acid" 12)))
 ("MESH:C407689" (("AG1295" 36))) ("MESH:C408502" (("GaQ3" 3)))
 ("MESH:C408604" (("PD169316" 27) ("PD 169316" 1)))
 ("MESH:C409004" (("GW274150" 18)))
 ("MESH:C409648" (("Fluo-4" 58) ("fluo-4" 3) ("Fluo 4" 2) ("FLUO-4" 2)))
 ("MESH:C410027" (("KNK437" 27))) ("MESH:C410732" (("PD180970" 4)))
 ("MESH:C410733" (("scriptaid" 17) ("Scriptaid" 14)))
 ("MESH:C411652" (("IC261" 63) ("the ATP competitive inhibitor IC261" 2)))
 ("MESH:C412815" (("GW4064" 85))) ("MESH:C413246" (("oleanane" 4)))
 ("MESH:C413408" (("Atazanavir" 3) ("atazanavir" 2)))
 ("MESH:C414409" (("penetratin" 13) ("Penetratin" 8)))
 ("MESH:C415250" (("ICL670" 2) ("deferasirox" 1)))
 ("MESH:C415424" (("SCH79797" 33)))
 ("MESH:C416827"
  (("rasfonin" 128) ("Rasfonin" 22) ("than rasfonin" 1)
   ("Even 10  μ M rasfonin" 1)))
 ("MESH:C417520" (("SB-415286" 34) ("SB-415286-" 1)))
 ("MESH:C417521" (("SB-216763" 84) ("SB 216763" 5)))
 ("MESH:C418216" (("AH109" 127) ("a pre-transformed AH109" 2)))
 ("MESH:C418570" (("SB258585" 19))) ("MESH:C420324" (("LR12" 2)))
 ("MESH:C421311" (("trithiacyclononane" 4)))
 ("MESH:C423062" (("BIBX1382BS" 8)))
 ("MESH:C423915" (("TO-901317" 18) ("TO901317" 8)))
 ("MESH:C423917"
  (("MG262" 20) ("a proteosomal inhibitor MG262" 2) ("Mg262" 1)))
 ("MESH:C424882" (("LG101305" 11)))
 ("MESH:C425931" (("GW1516" 45) ("simultaneous GW1516" 1)))
 ("MESH:C426883" (("UCS15A" 4))) ("MESH:C429014" (("MitoQ" 12)))
 ("MESH:C429533" (("SB-3CT" 11)))
 ("MESH:C431126" (("rhapontigenin" 6) ("Rhapontigenin" 2)))
 ("MESH:C431888" (("telomestatin" 3)))
 ("MESH:C432307" (("isorhapontigenin" 16) ("Isorhapontigenin" 1)))
 ("MESH:C432343" (("hypoestoxide" 13)))
 ("MESH:C432807"
  (("PMC" 84) ("Pramanicin" 4) ("pramanicin" 3) ("Its Precursor PMC" 2)
   ("100 µM PMC" 1) ("the previously reported natural products PMC" 1)))
 ("MESH:C433928"
  (("Euk134" 15) ("EUK-134" 11) ("the catalase mimetic Euk134" 3)
   ("The synthetic superoxide dismutase-SOD-/catalase mimetic EUK134" 3)
   ("EUK134" 3) ("Euk-134" 1)))
 ("MESH:C433985" (("SU9516" 22)))
 ("MESH:C434003"
  (("Bay-117082" 12) ("BAY-117082" 4)
   ("-3-(4-Methylphenylsulfonyl)-2-propenenitrile" 1)
   ("3-(4-Methylphenylsulfonyl)-2-propenenitrile" 1)))
 ("MESH:C434605" (("LY379196" 12))) ("MESH:C434926" (("PJ-34" 78) ("Pj-34" 2)))
 ("MESH:C435606" (("RWJ-56110" 20) ("RWJ56110" 7)))
 ("MESH:C435946"
  (("DMMB" 7) ("dimethylmethylene blue" 4) ("Dimethylmethylene blue" 2)))
 ("MESH:C437084" (("pbsa" 2))) ("MESH:C438269" (("HX531" 16)))
 ("MESH:C438613" (("PSB11" 1)))
 ("MESH:C438920" (("Coronin" 45) ("coronin" 28)))
 ("MESH:C438937" (("SGMIB" 63)))
 ("MESH:C439060" (("sirtinol" 278) ("Sirtinol" 91) ("Sirtinol–" 1)))
 ("MESH:C440869" (("PD0166285" 6))) ("MESH:C442856" (("FK-3000" 138)))
 ("MESH:C444299"
  (("-diindolylmethane" 13) ("diindolylmethane" 8) ("Diindolylmethane" 1)))
 ("MESH:C444426" (("splitomicin" 16) ("Splitomicin" 3)))
 ("MESH:C446518" (("PD42" 1))) ("MESH:C446540" (("thienopyridine" 2)))
 ("MESH:C446799" (("dinitrophenylhydrazine" 12)))
 ("MESH:C447031" (("AG1024" 118)))
 ("MESH:C447082" (("CORM-2" 58) ("tricarbonyldichlororuthenium (II) dimer" 3)))
 ("MESH:C448619" (("octaarginine" 9))) ("MESH:C449302" (("GW6471" 16)))
 ("MESH:C452139" (("BIRB796" 138) ("BIRB 796" 44) ("BIRB796 (BIRB)" 1)))
 ("MESH:C452539" (("diazeniumdiolates" 3) ("diazeniumdiolate" 2)))
 ("MESH:C453899" (("GW7647" 3))) ("MESH:C456319" (("PS1145" 29) ("PS-1145" 3)))
 ("MESH:C456800" (("HA14-1" 7))) ("MESH:C457499" (("GW9662" 149)))
 ("MESH:C458139" (("scolymoside" 7) ("more scolymoside" 3) ("Scolymoside" 1)))
 ("MESH:C458523"
  (("BIBR 1532" 11) ("BIBR1532" 10)
   ("the pharmacological nonnucleosidic compound BIBR1532" 2)))
 ("MESH:C458525" (("STO-609" 38)))
 ("MESH:C463061" (("AP20187" 50) ("AP20187 (CID)" 2) ("AP20187 (AP)" 2)))
 ("MESH:C464577" (("Palladia" 6))) ("MESH:C465539" (("SB202474" 64)))
 ("MESH:C465543" (("Sulfo-NHS" 40) ("sulfo-NHS" 33)))
 ("MESH:C465664" (("Go6983" 26) ("GO6983" 4))) ("MESH:C466090" (("PD98058" 5)))
 ("MESH:C466913" (("NU2058" 2)))
 ("MESH:C466914" (("NU6102" 21) ("than NU6102" 1)))
 ("MESH:C466997" (("CGP57380" 83))) ("MESH:C467767" (("catenanes" 16)))
 ("MESH:C468549" (("Bz-423" 104)))
 ("MESH:C468566" (("abatacept" 4) ("Abatacept" 2)))
 ("MESH:C468773" (("GW4869" 17))) ("MESH:C469298" (("CEP-11004" 20)))
 ("MESH:C469818" (("GW406381X" 2))) ("MESH:C471109" (("BMS-345541" 79)))
 ("MESH:C471392" (("sulphenamide" 8))) ("MESH:C471998" (("JTE013" 14)))
 ("MESH:C473027" (("GW3965" 123))) ("MESH:C473711" (("CT99021" 63)))
 ("MESH:C474722"
  (("ZM447439" 86) ("ZM" 15) ("ZM447439 (ZM)" 3)
   ("the aurora A inhibitor ZM447439" 1)))
 ("MESH:C475455" (("YM-254890" 16) ("YM254890" 1)))
 ("MESH:C475622" (("NU6027" 69) ("Nu6027" 1)))
 ("MESH:C475919" (("hydroxytamoxifen" 10) ("-hydroxytamoxifen" 2)))
 ("MESH:C476105" (("SHetA2" 1)))
 ("MESH:C476916" (("-linked eudesmanolide" 1) ("eudesmanolide" 1)))
 ("MESH:C477224" (("erastin" 93) ("Erastin" 8)))
 ("MESH:C477361" (("LAQ824" 2)))
 ("MESH:C477523" (("SC-514" 55) ("sc-514" 5) ("Sc-514" 1)))
 ("MESH:C477524" (("GTP14564" 2))) ("MESH:C477694" (("BDE-99" 2)))
 ("MESH:C477954" (("afzelin" 3) ("Afzelin" 1)))
 ("MESH:C478479"
  (("SU11274" 507) ("SU11274 (SU)" 1) ("concurrent dual SU11274" 1)
   ("the preclinical MET inhibitor SU11274" 1)))
 ("MESH:C479234"
  (("AG14361" 169) ("than AG14361" 1)
   ("the potent cell membrane-permeable PARP1 inhibitor AG14361" 1)))
 ("MESH:C479235" (("NU-7026" 15)))
 ("MESH:C479831" (("N-(4-Methoxybenzyl)-N’-(5-nitro-1,3-thiazol-2-yl)urea" 2)))
 ("MESH:C482404" (("SB612111" 9)))
 ("MESH:C484810" (("VX-680" 59) ("VX680" 49) ("VX-680-" 1)))
 ("MESH:C487081" (("belinostat" 121) ("Belinostat" 4)))
 ("MESH:C487214" (("IC86621" 17)))
 ("MESH:C487513"
  (("NSC23766" 641) ("NSC 23766" 19) ("NSC23766 (NSC)" 3)
   ("the pharmacologic inhibitor NSC23766" 1) ("NSC23766-" 1)))
 ("MESH:C487735"
  (("dimethyl-arginine" 7) ("dimethylarginine" 5)
   ("symmetric dimethylarginine" 2) ("Dimethylarginine" 1)))
 ("MESH:C488103" (("PAI-039" 31) ("tiplaxtinin" 2) ("than tiplaxtinin" 1)))
 ("MESH:C488185" (("PD184161" 9))) ("MESH:C488234" (("XCT790" 4)))
 ("MESH:C489138" (("AS601245" 9)))
 ("MESH:C489251"
  (("GW5074" 172) ("than GW5074" 2) ("effectively combination GW5074" 1)))
 ("MESH:C489897" (("silvestrol" 22) ("Silvestrol" 7) ("silvestrol’s" 1)))
 ("MESH:C492448"
  (("ICG-001" 101) ("elsewhere (Miranda-Carboni et al, xref ) ICG-001" 2)))
 ("MESH:C492546" (("GW280264X" 7))) ("MESH:C492806" (("apogossypol" 3)))
 ("MESH:C492919" (("IMD-0354" 45))) ("MESH:C493272" (("YC137" 5)))
 ("MESH:C493330"
  (("LysoTracker" 111) ("Lysotracker" 38) ("lysotracker" 34) ("Red DND-99" 14)
   ("LysoTracker-" 3) ("the acidotropic dye LysoTracker" 2)
   ("the fluorescent plasma membrane-permeable dye Lysotracker" 1)))
 ("MESH:C494356"
  (("TDZD-8" 33) ("4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione" 1)))
 ("MESH:C495818"
  (("KU55933" 530) ("Ku55933" 41)
   ("2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one" 9) ("KU55933 (KU)" 5)
   ("2-Morpholin-4-yl-6-thianthren-1-yl-pyran-4-one" 3)))
 ("MESH:C496827" (("salubrinal" 189) ("Salubrinal" 46)))
 ("MESH:C496906" (("dansyl" 13) ("mono-dansyl" 1) ("Dansyl" 1)))
 ("MESH:C497449"
  (("SL0101" 180) ("SL0101 molecule" 5)
   ("The RSK1/RSK2-specific inhibitor SL0101" 2) ("SL0101-" 2)
   ("than SL0101" 1) ("Sl0101" 1)))
 ("MESH:C498077" (("Piperlongumine" 15) ("piperlongumine" 10)))
 ("MESH:C499326" (("TPCA1" 9)))
 ("MESH:C500109" (("deschloroflavopiridol" 4) ("Deschloroflavopiridol" 1)))
 ("MESH:C500947" (("STA-21" 60) ("the previously characterized STA-21" 2)))
 ("MESH:C501048" (("CAY10404" 13))) ("MESH:C501177" (("NVP-AEW541" 59)))
 ("MESH:C501332"
  (("ABT-737" 1244) ("Abt-737" 13) ("the BH3 mimetic ABT-737" 11)
   ("a BAD-mimetic ABT-737" 2) ("the BH3 Mimetic ABT-737" 2)
   ("BH3 mimetic drug ABT-737" 2) ("the BH3 mimetic agent ABT-737" 2)
   ("the BH3-mimetic molecule ABT-737" 2) ("ABT-737-" 2)
   ("The BH3 mimetic ABT-737" 2) ("the BH3-mimetic drug ABT-737" 2)
   ("the previously mentioned compound ABT-737" 1)
   ("the pro-apoptotic ABT-737" 1) ("only 10 µM ABT-737" 1)
   ("the BH3 (Bcl-2-homology domain 3)-mimetic ABT-737" 1)
   ("The BH3 mimetic compound ABT-737" 1)
   ("the BH3 mimetic compound ABT-737" 1) ("the BH3-only mimetic ABT-737" 1)
   ("a BAD mimetic ABT-737" 1)))
 ("MESH:C501656" (("WAY163909" 94))) ("MESH:C502971" (("GW6604" 2)))
 ("MESH:C503557" (("NC1153" 17))) ("MESH:C503964" (("SEW2871" 3)))
 ("MESH:C504035"
  (("A-443654" 14)
   ("a structurally distinct ATP-competitive AKT catalytic inhibitor A-443654"
    1)))
 ("MESH:C504217" (("CYL-26z" 61)))
 ("MESH:C504718" (("TGX-221" 83) ("TGX 221" 2)))
 ("MESH:C505226" (("SM7368" 8))) ("MESH:C505241" (("FR180204" 71)))
 ("MESH:C506121" (("JNJ-7706621" 16) ("JNJ7706621" 6)))
 ("MESH:C506187" (("RO4383596" 13)))
 ("MESH:C506645"
  (("GW2974" 33) ("the EGFR/HER2 dual kinase inhibitor GW2974" 2)))
 ("MESH:C506907" (("EHT1864" 69) ("EHT 1864" 47)))
 ("MESH:C506918" (("Bafetinib" 42) ("bafetinib" 11)))
 ("MESH:C506932" (("KU0058948" 19))) ("MESH:C507623" (("KRIBB3" 12)))
 ("MESH:C507866" (("dihydrodiol" 7) ("Dihydrodiol" 1)))
 ("MESH:C508198" (("oxindole" 7) ("Oxindole" 1)))
 ("MESH:C509204" (("PD168393" 63))) ("MESH:C509374" (("Protandim" 3)))
 ("MESH:C510150" (("ZSTK474" 201))) ("MESH:C510342" (("RS5444" 116)))
 ("MESH:C510621" (("KCC009" 2)))
 ("MESH:C510718" (("cambinol" 67) ("Cambinol" 55)))
 ("MESH:C511179" (("VAS2870" 33))) ("MESH:C511621" (("CH223191" 1)))
 ("MESH:C511626" (("NF110" 25) ("larger alternative splice variant NF110" 1)))
 ("MESH:C511991" (("PD173952" 4)))
 ("MESH:C512273" (("CGK-733" 13) ("CGK 733" 1)))
 ("MESH:C512408"
  (("A-769662" 110) ("pharmacologic AMPK activator A-769662" 1)))
 ("MESH:C512438" (("AS252424" 17)))
 ("MESH:C512715"
  (("NSC-87877" 87) ("The pharamacologic inhibitor NSC-87877" 1)))
 ("MESH:C512868" (("isochaihulactone" 139) ("Isochaihulactone" 19)))
 ("MESH:C512984"
  (("RO-3306" 236) ("RO 3306" 7) ("Ro-3306" 3) ("RO-3306 (RO)" 1)))
 ("MESH:C514153"
  (("Phos-tag" 51) ("phos-tag" 11) ("-Phos-tag" 11) ("Phos-Tag" 8)))
 ("MESH:C514241"
  (("dihydroethidine" 13) ("DHE" 13) ("dihydroethidine (DHE)" 4)
   ("Dihydroethidine (DHE)" 1) ("Dihydroethidine" 1)
   ("the oxidative fluorescent dye dihydroethidine (DHE)" 1)))
 ("MESH:C514334" (("NSC606985" 68) ("NSC606985-" 1)))
 ("MESH:C514526" (("SD282" 3)))
 ("MESH:C515074" (("ridaforolimus" 16) ("Ridaforolimus" 2)))
 ("MESH:C515425" (("Ki23057" 2))) ("MESH:C515783" (("DAP81" 6)))
 ("MESH:C516025" (("SecinH3" 116)))
 ("MESH:C516714"
  (("TAE684" 158) ("NVP-TAE684" 31) ("the previous inhibitor TAE684" 1)))
 ("MESH:C516783" (("SD1029" 4)))
 ("MESH:C517016" (("aspalathin" 7) ("Aspalathin" 1)))
 ("MESH:C517222" (("PY957" 56)))
 ("MESH:C517409"
  (("Stattic" 371) ("STATTIC" 57) ("stattic" 56) ("than Stattic" 3)
   ("Stattic-" 2) ("than Stattic (−5.6 Kcal/mol)" 1) ("STATtic" 1)
   ("We first used stattic" 1)))
 ("MESH:C517771" (("VX702" 6))) ("MESH:C518299" (("BIX-01294" 52)))
 ("MESH:C518471" (("silybin-phytosome" 1)))
 ("MESH:C518477" (("BI 2536" 473) ("BI-2536" 151) ("BI 2536's" 1)))
 ("MESH:C518940" (("MLN8054" 15))) ("MESH:C519132" (("SB505124" 11)))
 ("MESH:C519562" (("imetelstat" 171) ("Imetelstat" 150) ("than imetelstat" 1)))
 ("MESH:C519751" (("WP1130" 36))) ("MESH:C519885" (("WP1066" 324)))
 ("MESH:C519899" (("AS602868" 2))) ("MESH:C520284" (("LY364947" 7)))
 ("MESH:C520337" (("NSC74859" 9) ("NSC 74859" 2)))
 ("MESH:C520390" (("PF-2341066" 159) ("Racemic PF-2341066" 1)))
 ("MESH:C520468" (("VRX0466617" 9))) ("MESH:C521047" (("MP470" 1)))
 ("MESH:C521104"
  (("CP724714" 65) ("dual EGFR/ErbB2 tyrosine kinase inhibitor CP724714" 1)))
 ("MESH:C521108" (("PF-228" 82)))
 ("MESH:C521281"
  (("MitoSOX" 159) ("MitoSox" 36) ("Mitosox" 20) ("mitoSOX" 18) ("mitosox" 8)))
 ("MESH:C521641" (("phenanthroquinolizidine" 4)))
 ("MESH:C522839" (("PF670462" 14) ("PF-670462" 11)))
 ("MESH:C522865"
  (("TG101209" 211) ("TG101209 (TG)" 4) ("TG101209's" 1) ("than TG101209" 1)))
 ("MESH:C522924" (("BIBW2992" 136) ("BIBW 2992" 6)))
 ("MESH:C522973"
  (("PI-103" 243) ("PI103" 72) ("the dual PI3K-mTOR inhibitor PI103" 2)
   ("The dual PI3K/mTOR inhibitor PI-103" 2)
   ("newly developed PI3K inhibitor PI103" 1)
   ("the PIK3CA/mTOR dual inhibitor PI-103" 1)
   ("The dual PI3K and mTOR inhibitor PI-103" 1)
   ("the ATP-competitive PI3K-mTOR kinase inhibitor PI-103" 1)
   ("the dual PI3K and mTOR inhibitor PI-103" 1)
   ("the dual PI3K-mTOR inhibitor PI-103" 1)))
 ("MESH:C523184" (("mocetinostat" 13) ("Mocetinostat" 3)))
 ("MESH:C523280" (("AD101" 13)))
 ("MESH:C523797"
  (("danusertib" 51) ("Danusertib" 14) ("clinically relevant danusertib" 1)))
 ("MESH:C523799" (("MRK-003" 7))) ("MESH:C524513" (("HDAC42" 4)))
 ("MESH:C524543" (("PHA680632" 1))) ("MESH:C524632" (("TAE226" 22)))
 ("MESH:C525086"
  (("LDN57444" 3) ("the commercially available UCH-L1 inhibitor LDN57444" 1)))
 ("MESH:C525422" (("SRT1720" 61))) ("MESH:C525423" (("SRT2183" 86)))
 ("MESH:C525424" (("SRT1460" 5))) ("MESH:C527196" (("BODIPY-LacCer" 21)))
 ("MESH:C527741" (("pyrrolopyrimidine" 12) ("pyrrolo-pyrimidine" 4)))
 ("MESH:C527766" (("diapocynin" 4))) ("MESH:C527797" (("PF562,271" 1)))
 ("MESH:C527817" (("DBZ" 6) ("dibenzazepine" 5) ("dibenzazepine (DBZ)" 3)))
 ("MESH:C528178" (("ISCK03" 13)))
 ("MESH:C528327" (("TG101348" 156) ("TG101348-" 2)))
 ("MESH:C528969" (("OSU-03013" 5)))
 ("MESH:C529490" (("locostatin" 152) ("Locostatin" 35) ("locostatin's" 2)))
 ("MESH:C530108" (("LY2109761" 32)))
 ("MESH:C530481" (("anthothecol" 5) ("Anthothecol" 2)))
 ("MESH:C530494" (("sagopilone" 28) ("Sagopilone" 8)))
 ("MESH:C530802" (("LS104" 7))) ("MESH:C531198" (("dactolisib" 1)))
 ("MESH:C531200" (("ST1968" 4)))
 ("MESH:C531237" (("PHA767491" 7) ("PHA 767491" 4)))
 ("MESH:C531315" (("RM4819" 56)))
 ("MESH:C531549" (("rucaparib" 124) ("Rucaparib" 32)))
 ("MESH:C532252" (("oncrasin-1" 1)))
 ("MESH:C532254" (("GSK650394" 29) ("GSK 650394" 4)))
 ("MESH:C532368" (("HLI373" 7))) ("MESH:C533467" (("SM-164" 1)))
 ("MESH:C533793" (("fasentin" 6))) ("MESH:C534391" (("AZ960" 13)))
 ("MESH:C534628" (("SCH23390" 14))) ("MESH:C534922" (("SNX2112" 4)))
 ("MESH:C538949" (("PKF115-584" 41) ("PKF115–584" 25)))
 ("MESH:C539263"
  (("Dp44mT" 18) ("di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone" 2)))
 ("MESH:C539427" (("salermide" 11) ("Salermide" 1)))
 ("MESH:C539629"
  (("AP21967" 24) ("nonimmunosuppressive rapamycin analogue AP21967" 2)))
 ("MESH:C540383" (("INCB018424" 57) ("INCB018424 (INCB)" 3) ("INCB-018424" 1)))
 ("MESH:C540576" (("YM201636" 7))) ("MESH:C541444" (("IPI-926" 39)))
 ("MESH:C543332" (("obinutuzumab" 1))) ("MESH:C543534" (("GW856553" 45)))
 ("MESH:C544261" (("XAV939" 91)))
 ("MESH:C545186"
  (("florbetapir" 18) ("Florbetapir" 4)
   ("approximately 370 MBq florbetapir" 1)))
 ("MESH:C545733" (("Fatostatin" 2) ("fatostatin" 1)))
 ("MESH:C545735" (("PV1019" 32))) ("MESH:C545763" (("JSM6427" 4)))
 ("MESH:C545823" (("intralipid" 29) ("Intralipid" 11)))
 ("MESH:C546193" (("KU-60019" 135)))
 ("MESH:C547078"
  (("NC2213" 36) ("-3-oxopropylsulfanyl} ethanesulfonic acid NC2213" 3)))
 ("MESH:C547688" (("TWS119" 1))) ("MESH:C547875" (("RO5068760" 3)))
 ("MESH:C548901" (("FLLL31" 3))) ("MESH:C548902" (("FLLL32" 68)))
 ("MESH:C548961" (("MI-319" 12)))
 ("MESH:C549075" (("LY290042" 39) ("LY 290042" 2)))
 ("MESH:C549211" (("PIK-75" 186) ("systemic PIK-75" 1)))
 ("MESH:C549231" (("INCB16562" 6))) ("MESH:C549556" (("TM5275" 1)))
 ("MESH:C550243" (("inter-gel" 4)))
 ("MESH:C550547"
  (("EX-527" 116) ("Ex-527" 56)
   ("6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide" 2)))
 ("MESH:C550923" (("PF-3758309" 85) ("PF-3758309 (PF)" 4)))
 ("MESH:C551027" (("GANT61" 120)))
 ("MESH:C551282"
  (("TX-100" 143) ("Tx-100" 15) ("Tx-100 (PBST)" 3) ("TX-100 (PBST)" 1)))
 ("MESH:C551527" (("WP1193" 43) ("WP1193's" 1)))
 ("MESH:C551538" (("GW583340" 2)))
 ("MESH:C551619"
  (("CCT137690" 51) ("The dual FLT3-Aurora kinase inhibitor CCT137690" 1)
   ("the dual FLT3-Aurora inhibitor CCT137690" 1)))
 ("MESH:C551788" (("CL075" 10))) ("MESH:C552206" (("BXL0124" 97)))
 ("MESH:C552362" (("QLT0267" 63)))
 ("MESH:C552719"
  (("PF-4708671" 62) ("PF-4708671 (PF)" 2)
   ("p70 ribosomal S6 kinase (S6K1) inhibitor PF-4708671" 1)))
 ("MESH:C552861" (("tigatuzumab" 5))) ("MESH:C553194" (("NVP-BSK805" 40)))
 ("MESH:C554430" (("LDN-193189" 33) ("LDN 193189" 3)))
 ("MESH:C554645" (("iBET762" 1))) ("MESH:C554850" (("GKT136901" 50)))
 ("MESH:C555257" (("GSK2334470" 30))) ("MESH:C555916" (("Mitotempo" 1)))
 ("MESH:C556458" (("MRT67307" 13))) ("MESH:C556690" (("STF-083010" 1)))
 ("MESH:C556907" (("RRD-251" 131))) ("MESH:C557799" (("LY2157299" 11)))
 ("MESH:C558330" (("WAY208466" 8)))
 ("MESH:C559019"
  (("RAF265" 49)
   ("Novartis International (Basel, Switzerland) kindly provided RAF265" 1)))
 ("MESH:C559138" (("CH4987655" 7))) ("MESH:C559815" (("MK-8776" 183)))
 ("MESH:C560272" (("JCC76" 2))) ("MESH:C560580" (("VE-821" 230)))
 ("MESH:C561435" (("LDE225" 52))) ("MESH:C568210" (("Serdemetan" 61)))
 ("MESH:C568452" (("importazole" 5) ("Importazole" 4)))
 ("MESH:C568713" (("IBET151" 6)))
 ("MESH:C569433" (("Poloxin" 69) ("further studies Poloxin" 1)))
 ("MESH:C570121" (("chrysosplenetin" 8))) ("MESH:C570122" (("penduletin" 9)))
 ("MESH:C570630" (("LCH-7749944" 1))) ("MESH:C570636" (("TOK-001" 4)))
 ("MESH:C570663" (("LY2874455" 3))) ("MESH:C570853" (("INCB28060" 6)))
 ("MESH:C571149" (("PRT062607" 5)))
 ("MESH:C571178"
  (("NVP-BKM120" 190) ("the dual PI3K/mTOR inhibitor NVP-BKM120" 2)
   ("NVP-BKM120’s" 1)))
 ("MESH:C571455" (("WZ4002" 121) ("than WZ4002" 1)))
 ("MESH:C571826" (("XL647" 55)))
 ("MESH:C572449"
  (("INK128" 316) ("than INK128" 3) ("INK128’s" 3)
   ("the dual mTORC1/2 inhibitor INK128" 1)))
 ("MESH:C572919"
  (("PP242" 397) ("pp242" 55) ("the ATP-competitive MTOR inhibitor PP242" 1)))
 ("MESH:C572947" (("G28UCM" 30)))
 ("MESH:C573921"
  (("INZ" 179) ("Inauhzin" 16) ("inauhzin" 3)
   ("Inauhzin inactive analogue INZ" 2) ("Inauhzin's" 2) ("2 μM INZ" 1)
   ("Inauhzin (INZ)" 1)))
 ("MESH:C573930" (("Lys05" 1))) ("MESH:C574276" (("GDC-0973" 5)))
 ("MESH:C574650" (("NSC751382" 1))) ("MESH:C574798" (("III-10" 6)))
 ("MESH:C574808" (("KL001" 18)))
 ("MESH:C574930" (("MI-219" 177) ("MI–219" 15) ("than MI-219" 1)))
 ("MESH:C575085" (("Quad" 171) ("quad" 19) ("“Quad”" 2)))
 ("MESH:C575430" (("FH535" 19))) ("MESH:C575445" (("DC120" 166)))
 ("MESH:C575625" (("PIK-108" 24))) ("MESH:C576403" (("GSK2606414" 1)))
 ("MESH:C576678" (("fusaruside" 13)))
 ("MESH:C576808" (("XL765" 9) ("the dual PI3K/mTOR inhibitor XL765" 2)))
 ("MESH:C576809" (("KU0060648" 5))) ("MESH:C577431" (("RTC13" 10)))
 ("MESH:C577554" (("MC1568" 59))) ("MESH:C577756" (("MHY1485" 3)))
 ("MESH:C577920" (("GSK126" 27) ("GSK126 molecule" 2)))
 ("MESH:C577924" (("CH5126766" 36) ("RO5126766" 1)))
 ("MESH:C578515" (("FL118" 192))) ("MESH:C578561" (("emtansine" 56)))
 ("MESH:C579117" (("RS504393" 18))) ("MESH:C579148" (("NU9056" 3)))
 ("MESH:C579556" (("PBS-1086" 58))) ("MESH:C579675" (("BX795" 52)))
 ("MESH:C579783" (("RG7112" 16))) ("MESH:C581039" (("LY2784544" 7)))
 ("MESH:C581157" (("XL147" 5)))
 ("MESH:C581313"
  (("MEK162" 189) ("MEK-162" 3) ("currently ongoing comparing MEK162" 1)))
 ("MESH:C582229" (("Tanic" 3))) ("MESH:C582792" (("MC1293" 6)))
 ("MESH:C582858" (("EMD1214063" 66)))
 ("MESH:C582966"
  (("BIO-acetoxime" 10) ("BIO-Acetoxime" 3) ("Bio-acetoxime" 1)))
 ("MESH:C584571" (("GLPG0634" 1)))
 ("MESH:C584676" (("Frax597" 19) ("FRAX597" 11)))
 ("MESH:C585271" (("VU0155069" 7))) ("MESH:C585656" (("OTSSP167" 20)))
 ("MESH:C585956"
  (("GT13072" 20) ("the Smac mimetic GT13072" 1)
   ("The active Smac mimetic GT13072" 1)))
 ("MESH:C586365" (("Talazoparib" 2))) ("MESH:C586458" (("LGK974" 5)))
 ("MESH:C586755" (("WZ4003" 16))) ("MESH:C587178" (("SCH772984" 14)))
 ("MESH:C588406"
  (("CC214-1" 68) ("Active site dual mTORC1/mTORC2 inhibitor CC214-1" 2)
   ("the dual mTOR inhibitor CC214-1" 1)
   ("the next generation dual mTOR inhibitor CC214-1" 1)
   ("the active-site dual mTOR inhibitor CC214-1" 1)))
 ("MESH:D003094"
  (("collagen" 6570) ("Collagen" 429) ("collagens" 256)
   ("polymerized collagen" 55) ("fibrillar collagen" 35) ("collagen-" 14)
   ("soluble type-I collagen" 10) ("collagen peptide" 10)
   ("fibrillar collagens" 9) ("interstitial collagens" 9) ("Collagens" 8)
   ("collagen (COLX)" 8) ("dermal collagen" 7) ("3D fibrillar collagen" 7)
   ("monomeric collagen" 5) ("fresh monomeric collagen" 5)
   ("the interstitial collagens" 5) ("subendothelial collagen" 5)
   ("the triple-helical collagen" 5) ("collagen protein" 5)
   ("Polymerized Collagen" 4) ("interstitial collagen" 4)
   ("native fibrillar collagens" 4) ("3 H-labeled polymerized collagen" 3)
   ("soluble collagen" 3) ("other fibrillar collagens" 3)
   ("immunoreactive collagen" 3) ("three-dimensional collagen" 3)
   ("aggrecan and type II collagen" 3) ("interstitial fibrillar collagen" 3)
   ("insoluble triple helical collagens" 3)
   ("0.6 ml fibrillar bovine dermal collagen" 3) ("collagen protein  (SHC)" 2)
   ("native triple helical collagen" 2) ("the predominant collagen" 2)
   ("insoluble type-I collagen" 2) ("insoluble collagen" 2)
   ("mineralized fibrillar type-I collagen" 2)
   ("the soluble positive control collagen" 2)
   ("namely SOX9 and type II collagen" 2) ("aggrecan, and type II collagen" 2)
   ("dermal collagens" 2) ("reticular dermis collagen" 2)
   ("a subendothelial collagen" 2) ("submesothelial collagen" 2)
   ("2.5 mg/mL bovine dermal collagen" 2)
   ("the stage-specific marker type X collagen" 2)
   ("disease-associated collagen" 2) ("2.5 mg/ml bovine dermal collagen" 2)
   ("Three-dimensional (3-D) collagen" 2) ("Monomeric collagen" 2)
   ("the fibrillar collagens" 2) ("or more cross-linked collagen" 2)
   ("more mature collagen" 2)
   ("fibroblast fibronectin and type III collagen" 2)
   ("0.6 ml (2.3 mg/ml) fibrillar bovine dermal collagen" 2)
   ("reticular collagen" 2) ("Aggrecan and type II collagen" 2)
   ("100 μl serum-free dermal collagen" 2)
   ("0.5 ml fibrillar bovine dermal collagen" 2)
   ("The interstitial collagens" 2) ("MMP-1-digested fibrilar collagen" 2)
   ("3D Fibrillar Collagen" 2) ("the polymerized cross-linked collagen" 2)
   ("the non-fibrillar collagens" 2) ("the labeled polymerized collagen" 1)
   ("monomeric collagen-" 1) ("native triple-helical collagen" 1)
   ("Total soluble collagen" 1) ("collagen (BD)" 1)
   ("the fibrillar collagen" 1)
   ("more
interstitial collagen"
    1)
   ("“collagen”" 1) ("the major amino acid of collagen" 1)
   ("Significantly less collagen" 1) ("perivascular collagen" 1)
   ("fibrillary eosinophilic collagen" 1)
   ("vimentin, alpha-enolase and type II collagen" 1) ("-Collagen" 1)
   ("approximately 10 μg/ml DQ collagen" 1) ("insoluble fibrillar collagens" 1)
   ("dense 3D collagen" 1) ("Fibrillar horm collagen" 1)
   ("the 3-dimentional type-I collagen" 1) ("3-dimensional type-I collagen" 1)
   ("Rigid collagen" 1) ("3D flexible collagen" 1)
   ("fibrous mesenchymal collagen" 1) ("decreased gingival collagen" 1)
   ("membranes forming pseudomesaxons around collagen" 1) ("than collagen" 1)
   ("less collagen" 1) ("Dab2-deficient cells internalized less collagen" 1)
   ("all SSc cell strains produced more collagen" 1)
   ("equine-tendon-derived Type-I collagen" 1)
   ("190 u g/mL calf-skin-derived Type-I collagen" 1) ("3D dermal collagen" 1)
   ("multidirectional collagen" 1) ("triple helical collagens" 1)
   ("cross-linked fibrillar collagen" 1) ("more collagen" 1)
   ("fibroblast-derived fibronectin and type III collagen" 1)
   ("triple-helical fibril collagens" 1) ("Triple helical collagen" 1)
   ("tendon-associated collagens" 1) ("PG and type II collagen" 1)
   ("aggrecan/type II collagen" 1) ("the triple-helical collagens" 1)
   ("Interstitial collagen" 1) ("three-dimensional (3D) collagen" 1)
   ("monomeric collagen 1" 1) ("83 µL fluorescent (CF633, Biotium) collagen" 1)
   ("the moist 1.5 mL collagen" 1) ("fluorescent collagen" 1)
   ("the 3D fibrillar collagen" 1)
   ("IPF fibroblast interaction polymerized collagen" 1)
   ("triple-helical collagen" 1) ("a suitably long collagen peptide" 1)
   ("-collagen" 1)))
 ("MI0000263"
  (("miR-7" 805) ("MiR-7" 19) ("mIR-7" 2) ("Mature miR-7" 1)
   ("potentially decrease miR-7" 1) ("miRIDIAN shMIMIC miR-7" 1) ("mir-7" 1)))
 ("MIPF0000033" (("miR-10" 599) ("MiR-10" 26) ("mir-10" 1)))
 ("MIPF0000038"
  (("miR-1" 205) ("mir-1" 4) ("a mutated miR-1" 1) ("Muscle-specific miR-1" 1)
   ("mature miR-1" 1) ("immature (pri- and pre-) miR-1" 1) ("MiR-1" 1)))
 ("MIPF0000157" (("miR155" 29) ("MIR155" 7) ("microRNA 155" 5)))
 ("NCIT:C1014"
  (("verteporfin" 67) ("Verteporfin" 25) ("Verteporfin (VP)" 2)
   ("the aromatic heterocyclic small-molecule verteporfin" 1)
   ("we first used Verteporfin (VP)" 1) ("verteporfin (VP)" 1)))
 ("NCIT:C101532" (("WX-554" 1)))
 ("NCIT:C101788"
  (("LPS" 6481) ("lipopolysaccharide" 382) ("LPS-" 88)
   ("lipopolysaccharide (LPS)" 49) ("Lipopolysaccharide" 35)
   ("ultra-pure LPS" 21) ("bacterial lipopolysaccharide (LPS)" 10)
   ("bacterial LPS" 9) ("lipopolysaccharide-" 7)
   ("bacterial lipopolysaccharide" 7) ("-LPS" 4) ("than LPS" 4)
   ("Bacterial lipopolysaccharide (LPS)" 3) ("Lipopolysaccharide (LPS)" 3)
   ("100 μM ultra-pure LPS" 3) ("Gram negative bacterial lipopolysaccharide" 3)
   ("gram-negative bacterial lipopolysaccharide (LPS)" 2)
   ("enteric microbe-derived LPS" 2) ("LPS (MRC)" 2)
   ("possible residual LPS" 2)
   ("treated with/without lipopolysaccharide (LPS)" 2) ("atypical LPS" 1)
   ("The bacterial lipopolysaccharide" 1) ("chlamydial LPS" 1)
   ("bacterial endotoxin LPS" 1) ("bacterial product LPS" 1)
   ("the TLR4 ligand bacterial endotoxin LPS" 1)
   ("the TLR4 ligand bacterial lipopolysaccharide (LPS)" 1)
   ("intrahepatic LPS" 1) ("The bacterial product LPS" 1) ("Ultra pure LPS" 1)
   ("the microbial component lipopolysaccharide (LPS)" 1)
   ("bacterial product lipopolysaccharide (LPS)" 1) ("LPS−" 1)
   ("Ultra-pure LPS" 1)
   ("the strain-specific leptospiral lipopolysaccharide" 1)
   ("the Gram-negative bacterial cell wall component lipopolysaccharide (LPS)"
    1)
   ("bacterial-derived LPS" 1) ("residual LPS" 1) ("intraperitoneal LPS" 1)
   ("residual lipopolysaccharide (LPS)" 1) ("Bacterial endotoxin LPS" 1)
   ("than LPS ( xref )" 1) ("Bacterial lipopolysaccharide" 1)
   ("subsequent LPS" 1) ("the bacterial endotoxin LPS" 1)))
 ("NCIT:C101790" (("ALK inhibitor CH5424802" 3) ("RO5424802" 1)))
 ("NCIT:C103147" (("ABT-199" 205) ("acute ABT-199" 1)))
 ("NCIT:C103298" (("OTX015" 1)))
 ("NCIT:C103999"
  (("Hsp72" 985) ("HSP72" 435) ("HSPA1A" 233) ("HSPA1" 110)
   ("HSPA1 protein" 11) ("HSP72 protein" 6) ("hsp72" 5) ("Hspa1" 2)
   ("overexpressed HSP72" 2) ("bladder and prostate epithelia strong HSPA1" 2)
   ("strong HSPA1" 2) ("mitochondrial-associated HSP72" 1)
   ("the detected esophageal squamous cell carcinomas expressed HSP72" 1)
   ("Hsp70–1" 1) ("cytosolic stress-inducible HSPA1 protein" 1)
   ("stress-inducible HSPA1" 1)))
 ("NCIT:C104193" (("LDH5" 13) ("LD5" 2)))
 ("NCIT:C104197"
  (("cyclinE" 55) ("CyclinE" 35) ("cyclin-E" 20) ("Cyclin-E" 6)
   ("cyclin E family" 4) ("cyclin-E–" 2) ("cyclinEs" 1) ("CYCLIN-E" 1)))
 ("NCIT:C104199"
  (("IKK" 2377) ("IKKs" 203) ("IKK-" 18) ("pIKK" 15) ("p-IKK" 9) ("IKK’s" 4)
   ("IKK—" 3) ("-IKK" 3) ("the respective IKK molecule" 3) ("IkappaB kinase" 3)
   ("P-IKK" 3) ("IKappaB kinase" 2) ("dual IKK" 2) ("IKK family" 1)
   ("than IKK ( xref ; xref )" 1) ("the atypical IKKs" 1) ("Ikk" 1)
   ("IKK molecule" 1) ("respective IKK" 1) ("the atypical IKK" 1)
   ("the principal IKK" 1) ("the TBK1 atypical IkappaB kinase" 1) ("IKK's" 1)))
 ("NCIT:C104224" (("cTnI" 234)))
 ("NCIT:C104414" (("geranylgeranyltransferase I inhibitor" 2)))
 ("NCIT:C104675"
  (("FcγR" 121) ("FcγRs" 21) ("Fc-gamma receptor" 1) ("than the FcγR" 1)))
 ("NCIT:C104678" (("CD158" 1))) ("NCIT:C104732" (("volitinib" 3)))
 ("NCIT:C104791" (("phosphofructokinase-1" 4)))
 ("NCIT:C1051" (("Cilostazol" 2))) ("NCIT:C105365" (("miR29b" 3) ("MiR29b" 1)))
 ("NCIT:C1054" (("clarithromycin" 2)))
 ("NCIT:C1055" (("OGX-011" 30) ("OGX011" 2))) ("NCIT:C1056" (("cpv" 2)))
 ("NCIT:C1057" (("cordycepin" 7) ("Cordycepin" 1)))
 ("NCIT:C105821" (("HoxA" 6))) ("NCIT:C105822" (("HOXB" 6)))
 ("NCIT:C105947"
  (("MAPK kinase" 105) ("MAPK kinases" 48) ("MAP kinase kinase" 35)
   ("MAP2K" 32) ("MAP kinase kinases" 15) ("MAP2Ks" 13)
   ("MAPK kinase family" 6) ("MAPK kinases (MKK)" 4)
   ("MAP kinase kinase (MEK)" 2) ("dual kinases MAP2Ks" 2) ("MAP2K family" 2)
   ("MAPK kinase (MEK)" 2) ("the dual specificity MAPK kinases" 2)
   ("MAP kinase kinase family" 2) ("-MAPK kinase" 1)
   ("MAPK kinases (MAPKK)" 1)))
 ("NCIT:C1060"
  (("daidzein" 82) ("Daidzein" 12) ("Daidzein molecule" 2)
   ("daidzein molecule" 2)))
 ("NCIT:C106407" (("MIR124" 16) ("miR124" 7) ("MiR124" 1)))
 ("NCIT:C107149" (("AMPKβ" 109)))
 ("NCIT:C107238" (("VS-4718" 118) ("FAK inhibitor VS-4718" 7)))
 ("NCIT:C107430" (("HARA" 48) ("Hara" 13)))
 ("NCIT:C1106" (("fotemustine" 5) ("Fotemustine (FM)" 2) ("Fotemustine" 1)))
 ("NCIT:C1108" (("gabapentin" 2)))
 ("NCIT:C1112"
  (("geldanamycin" 164) ("Geldanamycin" 26) ("geldanamycin (GA)" 22)
   ("Geldanamycin (GA)" 3)
   ("The less toxic geldanamycin-derivative 17-allylamino-demethoxy geldanamycin"
    2)))
 ("NCIT:C111298" (("precursor mRNA" 23) ("precursor mRNAs" 11)))
 ("NCIT:C111316"
  (("snoRNAs" 269) ("snoRNA" 150) ("small nucleolar RNA" 26)
   ("small nucleolar RNAs" 25) ("-snoRNAs" 3) ("most snoRNAs" 2)
   ("polycistronic C/D box snoRNAs" 2) ("several intronic snoRNAs" 2)
   ("SnoRNAs" 1) ("the GAS5 gene hosts ten intronic snoRNAs" 1)
   ("ten intronic C/D box snoRNAs" 1) ("mature snoRNAs" 1)
   ("polycistronic snoRNAs" 1)
   ("the most abundantly expressed SNHG1-derived snoRNA" 1)))
 ("NCIT:C111790"
  (("lamin B" 199) ("Lamin B" 129) ("LaminB" 12) ("laminB" 4) ("-lamin B" 2)
   ("monoclonal mouse anti-human lamin B" 1)))
 ("NCIT:C111799"
  (("TG-3" 525) ("tg-3" 34) ("TG3" 25) ("mitotic proteins TG-3" 1)
   ("TCNGG(A/G)AANCCCCA(A/G)CA(A/G)TG-3" 1)))
 ("NCIT:C1119" (("ondansetron" 17))) ("NCIT:C1123" (("hepsulfam" 4)))
 ("NCIT:C1125"
  (("hexamethylene bisacetamide" 10) ("Hexamethylene bisacetamide" 3)
   ("the hybrid polar compound hexamethylene bisacetamide (HMBA)" 2)
   ("HexaMethylene BisAcetamide" 1) ("hexamethylenebisacetamide" 1)
   ("hexamethylene bisacetamide (HMBA)" 1)
   ("Hexamethylene bisacetamide (HMBA)" 1)))
 ("NCIT:C1128" (("leflunomide" 18) ("Leflunomide" 2)))
 ("NCIT:C113245" (("CPK" 1)))
 ("NCIT:C113246" (("angiokine" 2) ("angiokines" 2)))
 ("NCIT:C113247" (("EphrinA" 5) ("ephrinA" 3) ("ephrin-A" 3) ("Ephrin-A" 2)))
 ("NCIT:C113248"
  (("receptor-activated Smads" 17) ("receptor-activated SMADs" 5)
   ("receptor-activated Smad" 3) ("receptor-activated SMADS" 2)
   ("receptor-activated SMAD" 1) ("Receptor-activated Smads" 1)))
 ("NCIT:C113655"
  (("PF-06463922" 3) ("the macrocyclic inhibitor PF-06463922" 2)))
 ("NCIT:C1138" (("itraconazole" 5) ("Itraconazole" 2)))
 ("NCIT:C113839" (("HIFs" 88)))
 ("NCIT:C1139"
  (("KLH" 73) ("keyhole limpet hemocyanin" 30)
   ("keyhole limpet hemocyanin (KLH)" 1) ("Keyhole limpet hemocyanin" 1)))
 ("NCIT:C114317"
  (("Kcnq1ot1" 3) ("LIT-1 protein" 2) ("LIT-1" 2) ("KCNQ1OT1" 2) ("lit1" 1)))
 ("NCIT:C114489"
  (("LNA" 645) ("LANA" 375) ("LANA-1" 95) ("LNAs" 68) ("LANA protein" 14)
   ("LANA-1 protein" 4) ("-LNA" 2)
   ("KSHV latency associated LANA-1 (ORF73) protein" 2) ("latent LANA-1" 2)
   ("LANA1" 2) ("Two fluorogenic LNA" 1) ("latency-associated LANA-1" 1)
   ("viral latency associated LANA-1 protein" 1) ("Lana-1" 1) ("lnA" 1)
   ("LANA-1 (ORF73) protein" 1) ("the subsequent LANA" 1)
   ("the latency-associated nuclear antigen LANA" 1)
   ("the viral protein LANA" 1)))
 ("NCIT:C114490" (("orf71" 1))) ("NCIT:C114730" (("PMCA" 24)))
 ("NCIT:C114982" (("ASV" 140) ("unique ASV" 1) ("asV" 1)))
 ("NCIT:C114984" (("entrectinib" 9) ("Entrectinib" 2)))
 ("NCIT:C114985" (("XACT" 7) ("bi-allelic XACT" 1)))
 ("NCIT:C1150" (("mafosfamide" 4)))
 ("NCIT:C1154" (("MBC" 845) ("HER2-positive refractory MBC" 2) ("Mbc" 1)))
 ("NCIT:C1156" (("megestrol acetate" 3) ("Megace" 1)))
 ("NCIT:C116019"
  (("AMPKα" 845) ("PRKAA" 65) ("p-AMPKα" 35) ("pAMPKα" 26) ("P-AMPKα" 4)
   ("AMPKα protein" 3) ("AMPKα–" 1) ("AMPK-alpha" 1)
   ("the myc-tagged AMPKα2" 1)
   ("cell lysates targeting total and phosphorylated AMPKα" 1) ("–AMPKα" 1)))
 ("NCIT:C116021" (("miRs181" 12)))
 ("NCIT:C116285" (("HOTAIR" 906) ("tumoral HOTAIR" 1) ("intrinsic HOTAIR" 1)))
 ("NCIT:C1163" (("NMF" 27))) ("NCIT:C116850" (("AR42" 60) ("AR42-" 3)))
 ("NCIT:C116858" (("KW2449" 11))) ("NCIT:C116868" (("p53MVA" 40)))
 ("NCIT:C116963" (("P1NP" 29) ("PINP" 8))) ("NCIT:C1173" (("nilutamide" 6)))
 ("NCIT:C1177" (("oltipraz" 41) ("Oltipraz" 6) ("oltipraz (OPZ)" 2)))
 ("NCIT:C118113" (("C13orf25" 25) ("c13orf25" 6)))
 ("NCIT:C118125"
  (("PINT" 69) ("LINC-PINT" 6) ("We first stably overexpressed PINT" 2)
   ("overexpressed PINT" 2)))
 ("NCIT:C118203" (("SChLAP1" 3)))
 ("NCIT:C1183" (("onconase" 22) ("Onconase" 1) ("ranpirnase" 1)))
 ("NCIT:C118452"
  (("CBD" 314) ("-CBD" 4) ("CBd" 1) ("autopsy-confirmed CBD" 1) ("CBD’s" 1)
   ("cannabidiol" 1) ("Cannabidiol" 1)))
 ("NCIT:C118457"
  (("NMDAR" 207) ("NMDARs" 110) ("NMDA receptor" 95) ("NMDA receptors" 91)
   ("N-methyl-D-aspartate receptor" 10) ("NMDA-R" 8)
   ("N-methyl-D-aspartate receptors" 4) ("extrasynaptic NMDA receptors" 3)
   ("N-methyl-D-aspartate Receptor" 2) ("extra-synaptic NMDA receptors" 2)
   ("extrasynaptic NR2B-containing NMDARs" 2) ("extrasynaptic NMDARs" 2)
   ("NMDA-Rs" 1) ("NMDA Receptor" 1) ("synaptic NMDAR" 1)
   ("synaptic NMDARs" 1)))
 ("NCIT:C118473"
  (("ZEBRA" 172) ("ZEBRA protein" 43) ("tumor associated ZEBRA" 2)
   ("the dimerized ZEBRA protein" 1) ("The EBV viral protein ZEBRA" 1)))
 ("NCIT:C118479"
  (("PcG" 340) ("pCG" 22) ("PcG protein" 18) ("PcGs" 7)
   ("polycomb-group protein" 5) ("PcG family" 4) ("pcG" 2)
   ("polycomb-group proteins" 1) ("Polycomb-group proteins" 1)
   ("Polycomb-group protein" 1)))
 ("NCIT:C118492"
  (("CD45RA" 228) ("CD45RA-" 2) ("-CD45RA" 2) ("CD45RA+CD20−" 2)
   ("CD45RA+CD27−" 1) ("CD45RA−" 1)))
 ("NCIT:C118795"
  (("shelterin" 189) ("Shelterin" 5) ("shelterin protein" 4)
   ("“shelterin”" 1)))
 ("NCIT:C1188"
  (("pen" 134) ("Pen" 91) ("PEN" 6) ("pEN" 6)
   ("a liquid-repellent slide marker pen" 1)))
 ("NCIT:C118892"
  (("FOXO" 1391) ("FOXOs" 186) ("FOXO family" 147) ("FoxOs" 112) ("pFOXO" 53)
   ("FOXO protein" 7) ("p-FOXO" 6) ("dominant-negative FOXO" 3) ("FOXO’s" 3)
   ("FOXO family protein" 2) ("FOXO families" 1)
   ("endogenous cyclin D1 increased FOXO’s" 1)
   ("endogenous cyclin D1 increased FOXO" 1) ("FOXO’S" 1) ("FOXO-" 1)
   ("differentially control FOXOs" 1) ("the characteristic FOXO" 1)))
 ("NCIT:C1195" (("piceatannol" 166) ("Piceatannol" 26)))
 ("NCIT:C1196" (("pimonidazole" 41) ("Pimonidazole" 12)))
 ("NCIT:C119617" (("Telomelysin" 3))) ("NCIT:C119619" (("SAIT301" 89)))
 ("NCIT:C119656"
  (("FAL1" 173) ("specifically targets FAL1" 1) ("the 1,019 FAL1 -induced" 1)))
 ("NCIT:C1197" (("pirarubicin" 53)))
 ("NCIT:C1199" (("Pep" 17) ("pep" 13) ("pEP" 5)))
 ("NCIT:C1202"
  (("predates" 22) ("This arbitrarily-selected criterion predates" 1)))
 ("NCIT:C1212"
  (("sirolimus" 118) ("RAPA" 59) ("Sirolimus" 44) ("Rapa" 18) ("rapa" 1)
   ("Sirolimus-" 1)))
 ("NCIT:C121332"
  (("DMARD" 18) ("a biological DMARD" 2)
   ("disease-modifying antirheumatic drug" 2)))
 ("NCIT:C121977"
  (("HLA" 1115) ("HLA complex" 11) ("HLA-" 4) ("HLA molecule" 4)
   ("classical HLA" 3) ("accurate HLA" 2) ("Hospital HLA" 2)
   ("the classical HLA" 1) ("than HLA" 1) ("the relevant HLA molecule" 1)
   ("actual HLA" 1) ("a rare HLA" 1)))
 ("NCIT:C121993" (("α4β7" 14))) ("NCIT:C122395" (("SmD" 1)))
 ("NCIT:C122769" (("Lig" 26) ("LRIG" 2)))
 ("NCIT:C1233" (("SHM" 85) ("shM" 1) ("ShM" 1)))
 ("NCIT:C1237"
  (("staurosporine" 928) ("Staurosporine" 114) ("staurosporine (STS)" 17)
   ("staurosporine-" 6)
   ("the  mechanistically disparate agents staurosporine" 2)
   ("the ATP-competitive kinase inhibitor staurosporine" 2)
   ("the pro-apoptotic pan-tyrosine kinase inhibitor staurosporine (STS)" 2)
   ("staurosporine molecule" 2) ("staurosporine- (STS)" 2)
   ("the broad-based kinase inhibitor staurosporine" 2)
   ("the proapoptotic global kinase inhibitor staurosporine" 2)
   ("than staurosporine" 1)
   ("the nonspecific kinase inhibitor
staurosporine"
    1)
   ("the non-hydrolysable ATP-competitive kinase inhibitor staurosporine" 1)
   ("bacterial staurosporine" 1) ("the pro-apoptotic agent staurosporine" 1)
   ("a bacterial alkaloid staurosporine (STS)" 1)))
 ("NCIT:C123810"
  (("adipokine" 77) ("adipokines" 58) ("Adipokines" 3) ("Adipokine" 3)
   ("a multifunctional adipokine" 2) ("a newly-identified adipokine" 2)
   ("a pleiotropic adipokine" 1)
   ("than other adipokines such as PDGF-BB (210 pg/ml), IL-6sR (110 pg/ml) and TNF-a (529 pg/ml)"
    1)))
 ("NCIT:C123893"
  (("shRNA" 23723) ("shRNAs" 5219) ("short hairpin RNA" 1153)
   ("short hairpin RNAs" 328) ("ShRNA" 201) ("-shRNA" 105)
   ("Short hairpin RNA" 95) ("lentiviral shRNA" 59) ("ShRNAs" 37)
   ("Lentiviral shRNA" 34) ("shRNA-" 33) ("Short Hairpin RNA" 28)
   ("lentiviral shRNAs" 21) ("shRNA molecule" 18) ("Short hairpin RNAs" 16)
   ("a lentiviral shRNA" 10) ("Lentiviral shRNAs" 9)
   ("lentiviral short hairpin RNA" 9) ("shRNA (NTC)" 9) ("targeted shRNAs" 9)
   ("targeting shRNA" 8) ("Genome-wide shRNA" 8) ("Short Hairpin RNAs" 8)
   ("lentiviral-mediated shRNA" 7) ("lentiviral short hairpin RNAs" 6)
   ("shRNA (KD)" 6) ("a retroviral shRNA" 5) ("targeted shRNA" 5)
   ("Lentiviral short hairpin RNAs" 5) ("the lentiviral shRNA" 5) ("-shRNAs" 5)
   ("at least two shRNAs" 4) ("ShRNA-" 4) ("two separate shRNAs" 4)
   ("short
hairpin RNA"
    4)
   ("a lentivirally-delivered shRNA" 4) ("ABCB1 lentiviral shRNA" 4)
   ("shRNA (NT)" 4) ("two lentiviral shRNAs" 4)
   ("tetracycline inducible H1 lentiviral shRNA" 4)
   ("lentiviral PICT1 -shRNA" 3) ("nonspecific shRNA" 3)
   ("using lentiviral-mediated shRNA" 3) ("non-isogenic shRNAs" 3)
   ("the respective shRNAs" 3) ("a genome-wide shRNA" 3)
   ("an adenoviral short hairpin RNA" 3) ("irrelevant shRNA" 3)
   ("a previously described short hairpin RNA" 3)
   ("4 separate short hairpin RNA" 3) ("lentiviral IL-6 shRNA" 3)
   ("Lentiviral-mediated shRNA" 3) ("shRNA ( TCAACATCAAACATGATCTGC )" 3)
   ("HER2 lentiviral short hairpin RNA" 2)
   ("lentiviral-mediated short hairpin RNA" 2) ("shRNA (PKCB)" 2)
   ("a doxycycline (dox)-inducible lentiviral shRNA" 2) ("Two unique shRNAs" 2)
   ("control (NS) shRNAs" 2) ("78 432 unique shRNAs" 2)
   ("lentiviral delivered shRNAs" 2) ("the lentivious AR shRNA" 2)
   ("than shRNA" 2) ("three unique shRNAs" 2)
   ("RNA1-Ready pSIREN-RetroQ-scramble shRNA" 2) ("Autophagy-focused shRNA" 2)
   ("a stably control shRNA" 2) ("lentiviral PKCθ shRNA" 2)
   ("lentiviral PKCθ and KIT short hairpin RNA" 2) ("viral shRNA" 2)
   ("parallel genome-wide shRNA" 2) ("reporter-validated shRNAs" 2)
   ("we first introduced shRNAs" 2) ("Lentiviral plasmids encoding shRNAs" 2)
   ("Micro-RNA–adapted short hairpin RNA" 2) ("unspecific control shRNAs" 2)
   ("CD9 lentiviral shRNA" 2) ("Lentiviral short hairpin RNA" 2)
   ("a microRNA 30-embedded shRNA" 2)
   ("using lentiviral-based short hairpin RNA" 2)
   ("two previously validated IKKε shRNAs" 2)
   ("two lentiviral short hairpin RNAs" 2) ("-lentiviral shRNA" 2)
   ("-lentiviral shRNAs" 2) ("genome-wide shRNA" 2)
   ("lentiviral vector short hairpin RNA" 2)
   ("TRIPZ tetracycline-inducible lentiviral shRNAs" 2)
   ("Four individual pGIPZ lentiviral shRNAs" 2)
   ("TRIPZ Inducible Lentiviral Human shRNAs" 2) ("GIPZ Lentiviral shRNAs" 2)
   ("an independent Sgk3- specfic shRNA" 2)
   ("doxycycline controllable EWS-FLI1 shRNA" 2)
   ("lentiviral transduced shRNAs" 2)
   ("two previously validated short hairpin RNAs" 2)
   ("Lentiviral plasmid encoding shRNA" 2)
   ("A universal scrambled negative control shRNA" 2)
   ("endoG targeted shRNAs" 2) ("lentiviral pGV248-puro-RKIP shRNA" 2)
   ("50 nM lentiviral Smac shRNA" 2) ("lentivirus-expressing shRNA" 2)
   ("the respective scrambled shRNAs" 2) ("respective shRNAs" 2)
   ("The same unspecific shRNA" 2) ("Inducible lentiviral shRNA" 2)
   ("FUGW-H1-scrambled control shRNA" 2) ("targeted short hairpin RNAs" 2)
   ("a lentiviral p53 shRNA" 2)
   ("two independent p53-specific lentiviral shRNAs" 2)
   ("Five pre-made lentiviral LKB1 short hairpin RNA" 2)
   ("retroviral-encoded shRNA" 2) ("a previously described shRNA" 2)
   ("lentivirally-transduced shRNA" 2) ("30 randomly-selected shRNAs" 2)
   ("shRNA (TTCTCCGAACGTGTCACGT)" 2) ("lentiviral PTEN shRNA" 2)
   ("Relaxed statistical criteria identified 1,741 RSL shRNAs" 2)
   ("–short hairpin RNA" 2) ("retroviral-encoded short hairpin RNAs" 2)
   ("a novel genome-wide shRNA" 2) ("two independent lentiviral shRNA" 2)
   ("Lentiviral pLKO shRNAs" 2) ("a unique shRNA" 2)
   ("We first used short hairpin RNA" 2)
   ("the GIPZ Lentiviral microRNA-adapted short hairpin RNA" 2)
   ("targeting control shRNA" 2) ("using lentiviral shRNA" 2)
   ("-based lentiviral shRNAs" 2)
   ("both a commercially available control shRNA" 2) ("shRNA’s" 2)
   ("a conditional short hairpin RNA" 2) ("at least two different shRNA" 2)
   ("shRNA (CAACAAGATGAAGAGCACCAA)" 2)
   ("the micro-RNA–adapted short hairpin RNA" 2) ("than the shRNAs" 2)
   ("The lentiviral shRNA" 2)
   ("We first identified PI3Kγ short hairpin RNAs" 2)
   ("Next previously validated shRNAs" 2) ("relevant ShRNAs" 2)
   ("sequence-verified shRNAs" 2) ("retroviral shRNA" 2)
   ("EpCAM-specific lentiviral shRNA" 2) ("Commercially available shRNAs" 2)
   ("lentivirus based shRNA" 2) ("Foxo3a-lentiviral shRNA" 2)
   ("Skp2-lentiviral shRNA" 2) ("a controllable lentiviral based shRNA" 2)
   ("targeting shRNAs" 2) ("Two lentiviral shRNAs" 2) ("commercial shRNA" 2)
   ("a non-silencing-GIPZ lentiviral shRNA" 2)
   ("We first generated three short hairpin RNA" 2) ("vector-driven shRNA" 2)
   ("Lentiviral Mediated pGIPZ shRNA" 2)
   ("Lentiviral plasmids each encoding shRNAs" 2)
   ("lentiviral-based short hairpin RNA" 2)
   ("noneffective scrambled control shRNA" 2) ("short hairpin RNA–" 2)
   ("3 different lentiviral shRNAs" 2) ("two lentiviral based shRNA" 2)
   ("A universal non-targeting negative control shRNA" 2)
   ("−20°C. Lentiviral shRNAs" 2)
   ("a previously characterized non-specific shRNA" 2) ("The shRNA's" 1)
   ("three different HER2-specific lentiviral shRNAs" 1)
   ("Brk lentiviral shRNA" 1) ("lentivirus-expressing shRNAs" 1)
   ("Surprisingly, 53bp1 shRNA" 1) ("Lentiviral pSIH1-puro-STAT3 shRNA" 1)
   ("shRNA (NS)" 1) ("different lentiviral shRNAs" 1)
   ("Lentiviral PICT1 -shRNA" 1) ("two previously described shRNAs" 1)
   ("respective shRNA" 1) ("The CD147 lentiviral shRNA" 1)
   ("The survivin lentiviral shRNA" 1) ("pGIPZ and pTRIPZ lentiviral shRNA" 1)
   ("the indicated lentiviral shRNAs" 1) ("Lentiviral pGIPZ shRNA" 1)
   ("Lentiviral pSIH1-puro-control shRNA" 1) ("lentiviral TRAF3IP2 shRNA" 1)
   ("than control shRNA in two different cell lines (Fig. xref )" 1)
   ("a well-recognized shRNA" 1) ("ShRNA (NTC)" 1)
   ("treated OVCA 420 Scr and OVCA p53 shRNA" 1)
   ("-80°C. Two well-validated shRNAs" 1) ("KIT lentiviral shRNA" 1)
   ("pGIPZ RIP2 lentiviral shRNA" 1)
   ("multiple lentiviral
shRNA"
    1)
   ("All lentiviral shRNA" 1) ("their respective shRNA’s" 1)
   ("their respective shRNA" 1) ("potential shRNA" 1)
   ("Tet-On TRIPZ inducible lentiviral human cyclin D1 shRNAs" 1)
   ("two independent lentiviral shRNAs" 1)
   ("the commercial pTRIPZ Inducible Lentiviral Human DGKA shRNA" 1)
   ("retroviral-mediated shRNA" 1) ("Lentiviral nonsilencing control shRNA" 1)
   ("Lentiviral-delivered MIF and D-DT shRNA" 1)
   ("the Thermo Scientific GIPZ lentiviral shRNA" 1) ("shRNA's" 1)
   ("an integrin β 1-specific shRNA" 1) ("using two-independent shRNAs" 1)
   ("scrambled control (Ctr) lentiviral shRNA" 1) ("the lentiviral shRNAs" 1)
   ("individual lentival shRNAs" 1) ("the most efficient lentiviral shRNAs" 1)
   ("at least one BMI1 shRNA" 1) ("multiple lentiviral shRNAs" 1)
   ("an ~2.5-fold more ETS-1 shRNA" 1) ("A lentiviral-based shRNA" 1)
   ("five different SIRT1-pecific shRNAs" 1)
   ("MCF7 cells ( PIK3CA E545K, high SGK3, and high INPP4B, xref ) whereby SGK3 and INPP4B shRNA"
    1)
   ("than MSCs expressing control shRNAs" 1) ("dual shRNAs" 1)
   ("The lentiviral vector shRNA" 1) ("lentiviral BMCC1 shRNAs" 1)
   ("2 different lentiviral VCAN shRNAs" 1) ("at least 2 independent shRNAs" 1)
   ("a previously validated shRNA" 1) ("most shRNAs" 1)
   ("Lentiviral-based AchRα7 shRNA" 1)
   ("this screen human kinome-wide shRNA" 1)
   ("The lentivirus-expressing GFP-target shRNA" 1)
   ("RbAp46 lentiviral shRNA" 1) ("lenti-viral shRNA" 1)
   ("pre-validated shRNA" 1)
   ("V3LHS_346941 Dharmacon plasmid-based CFLAR (c-FLIP) shRNA" 1)
   ("respective scrambled shRNA" 1) ("a lentiviral short hairpin RNA" 1)
   ("TO/H1 promoter-driven shRNA" 1) ("TO/H1-driven shRNAs" 1)
   ("a tetracycline-inducible-H1 (TO/H1) promoter-driven shRNA" 1)
   ("an independent adenoviral shRNA" 1) ("independent adenoviral shRNA" 1)
   ("lentiviral DOT1L shRNA" 1) ("p53 lentiviral shRNA" 1)
   ("their respective NDRG1 shRNA" 1) ("The lentiviral pLVUT-KRAB p53 shRNA" 1)
   ("Commercially available pGIPZ shRNAs" 1) ("lentiviral-transduced shRNA" 1)
   ("short
 hairpin RNA"
    1)
   ("phospho-proteomic shRNA" 1)
   ("plasmid-based U6 promoter-driven DP5 shRNA" 1)
   ("the 30 randomly-selected shRNAs" 1) ("the relevant shRNA" 1)
   ("74,905 retroviral shRNAs" 1)
   ("a retroviral derivative vector pSUPER shRNA" 1)
   ("nonspecific control shRNA" 1) ("two or more shRNAs" 1)
   ("lentiviral vector-expressed shRNA" 1) ("13,609 lentiviral shRNAs" 1)
   ("Lentiviral mediated shRNA" 1) ("a genome-wide human shRNA" 1)
   ("at least one shRNA" 1) ("at least 2 shRNAs" 1) ("the shRNA’s" 1)
   ("The following GSK3β-targeted shRNA’s" 1) ("Lentiviral based shRNAs" 1)
   ("approximately five shRNAs" 1) ("c- CBL lentiviral shRNA" 1)
   ("than one shRNA" 1) ("than 3982 shRNA" 1)
   ("two previously validated NF1 shRNA" 1)
   ("at least two independent shRNAs" 1) ("the representative shRNA" 1)
   ("the previously described shRNA" 1) ("Commercially available shRNA" 1)
   ("24 Class 1 shRNA’s" 1) ("21 Class 2 shRNA’s" 1)
   ("Five independent shRNA’s" 1) ("multiple shRNA’s" 1) ("single shRNA’s" 1)
   ("shRNA (WT)" 1) ("–shRNA" 1) ("two unique RAC3 shRNAs" 1)
   ("non-coding shRNA" 1) ("two different DEK-specific lentiviral shRNA" 1)
   ("Lentiviral Hax1 and RhoA shRNA" 1) ("the shRNA's" 1)
   ("targeted lentiviral shRNA" 1)
   ("we first screened several anti-MET shRNA" 1) ("than the shRNA" 1)
   ("five unique shRNA" 1) ("shRNA (SCR)" 1) ("lentiviral control shRNA" 1)
   ("lentiviral GDF15 shRNA" 1)
   ("mature myeloid surface marker expression comparedtoFOXO3 shRNA" 1)
   ("“shRNA”" 1) ("Three potential shRNAs" 1)
   ("encoded both a RasGRP1 shRNA" 1) ("lentiviral mediated shRNA" 1)
   ("The retroviral shRNA" 1) ("non-targeted lentiviral shRNA (NT)" 1)
   ("specific lentiviral shRNAs" 1) ("eight different lentiviral shRNA" 1)
   ("a nonspecific shRNA" 1) ("lentiviral-based shRNAs" 1)
   ("the α-specific shRNA" 1) ("sh2 lentiviral shRNA" 1)
   ("Lentiviral delivered shRNA" 1)
   ("triple transfection adenovirus mTOR shRNA" 1) ("a CBF-β-specific shRNA" 1)
   ("shRNA (ACUCCCCAGUGAGACCAUU)" 1) ("previously characterized shRNA" 1)
   ("The lentiviral vector carryed luciferase shRNA" 1) ("than ERK1 shRNA" 1)
   ("whose shRNA" 1) ("The following lentiviral shRNAs" 1)
   ("four unique shRNA" 1)
   ("SMARTvector 2.0 (Thermo Scientific) lentiviral shRNA" 1)
   ("lentiviral survivin shRNA" 1)
   ("Western blot +/− either CXCR4-targeted shRNA" 1)
   ("virally-transduced shRNAs" 1) ("Lentiviral plasmids producing shRNAs" 1)
   ("control (NC) shRNA" 1) ("anti-Filamin A lentiviral shRNAs" 1)
   ("a controllable shRNA" 1) ("Doxy-controllable c-Myb-specific shRNA" 1)
   ("Lentiviral shRNA (CHOP)" 1)
   ("the shRNA experiments each retroviral and lentiviral shRNA" 1)
   ("Retroviral shRNA" 1) ("sHRNA" 1) ("we first used shRNAs" 1)
   ("isogenic cell lines H1299-LKB1 shRNA" 1) ("using short hairpin RNA’s" 1)
   ("lentivrial shRNA" 1)
   ("We first used two different SGTA specific shRNAs" 1)
   ("two commercially available shRNA" 1)
   ("a lentiviral plasmid encoding shRNA" 1) ("2 or more shRNAs" 1)
   ("a lentiviral expressed shRNA" 1) ("Lentiviral-based shRNA" 1)
   ("the following amino acid sequences (ΔNHL, 421-734; NHL, 1-420; ΔABP, 290-420; ΔCC, 150-280; ΔB, 115-146, and ΔR, 22-62) Lentiviral TRIM3 shRNA"
    1)
   ("8 unique shRNA" 1) ("Lentiviral-based HMGA2 shRNAs" 1)
   ("lentivrial shRNAs" 1) ("E-Cadherin knockdown lentiviral shRNA" 1)
   ("previously unpublished shRNAs" 1) ("than hTERT shRNA" 1)
   ("than scrambled shRNA in both cell lines" 1)
   ("use lentiviral delivered shRNAs" 1) ("the lentiviral based shRNA" 1)
   ("than ARNT shRNA" 1) ("lentiviral-delivered shRNA" 1)))
 ("NCIT:C124258" (("αvβ6" 26)))
 ("NCIT:C125480"
  (("curcuminoids" 8) ("“curcuminoids”" 3) ("the principal curcuminoid" 2)
   ("pure curcuminoids" 2) ("curcuminoid" 1)))
 ("NCIT:C126114"
  (("PLCγ" 657) ("phospholipase C gamma" 21) ("pPLCγ" 6) ("PLCγ family" 4)
   ("PLCγ-" 4) ("PLCγ molecule" 3) ("phospholipase-Cγ" 2)
   ("the Rac-nonresponsive
 PLCγ"
    2)
   ("phospholipase-C-γ" 1) ("PlCγ" 1)))
 ("NCIT:C126122" (("GPIb-V-IX" 2)))
 ("NCIT:C126567" (("vasopressors" 4) ("vasopressor" 1)))
 ("NCIT:C126712" (("fluoroquinolone" 13)))
 ("NCIT:C126954" (("Sep15" 70) ("SEP15" 2)))
 ("NCIT:C1270" (("adozelesin" 15) ("Adozelesin" 3) ("than adozelesin" 1)))
 ("NCIT:C127012" (("LY3009104" 1))) ("NCIT:C127014" (("V-H" 3) ("IGHV3-21" 1)))
 ("NCIT:C1271"
  (("UCN-01" 747) ("7-hydroxystaurosporine" 21) ("7-Hydroxystaurosporine" 3)
   ("than UCN-01" 1) ("the multitudinous ways UCN-01" 1)))
 ("NCIT:C1275"
  (("vinorelbine" 199) ("Vinorelbine" 10) ("even single-agent vinorelbine" 1)))
 ("NCIT:C1282"
  (("carboplatin" 831) ("Carboplatin" 33) ("carboplatin-" 12)
   ("intravenous carboplatin" 2) ("intravenous (IV) carboplatin" 2)
   ("the cumulative carboplatin" 1) ("11.5 cumulative carboplatin" 1)
   ("cumulative prior carboplatin" 1) ("400 mg intraperitoneal carboplatin" 1)
   ("-carboplatin" 1) ("intraperitoneal injected carboplatin" 1)
   ("the chemotherapeutic drugs carboplatin" 1) ("Carboplatin-" 1)
   ("than carboplatin" 1) ("Carboplatin (CBDCA)" 1)))
 ("NCIT:C128275" (("LXR" 230) ("LXRs" 28) ("Lxr" 2)))
 ("NCIT:C128285" (("platelet-derived growth factor-AA" 2)))
 ("NCIT:C128286" (("platelet-derived growth factor-AB" 5)))
 ("NCIT:C128287"
  (("platelet-derived growth factor-BB" 21)
   ("Platelet-derived growth factor-BB" 7)
   ("Platelet-derived growth factor-BB (PDGF)" 2)))
 ("NCIT:C128309" (("HLA-B44" 3)))
 ("NCIT:C128319"
  (("δ-catenin" 405) ("Overexpressed δ-catenin" 4) ("δ-catenin peptide" 3)
   ("-δ-catenin" 3) ("Neuronal synaptic junction protein δ-catenin" 2)
   ("δ-catenin protein" 1)))
 ("NCIT:C129396"
  (("TC" 2214) ("TC‐" 5) ("-TC" 4) ("transcobalamin" 3) ("normal TC" 2)
   ("the myometrial TC" 2) ("than TC" 2) ("the possible TC" 1)
   ("the PDGFRα-positive TC" 1) ("the intramuscular TC" 1)
   ("intramuscular TC" 1) ("decreased primary TC" 1)
   ("The heterozygous genotype TC" 1) ("than the TC 50" 1)
   ("than TC (EC 50  = ∼10 to 20 µM)" 1) ("endogenous TC48" 1)
   ("Transcobalamin" 1)))
 ("NCIT:C129400"
  (("antineutrophil cytoplasmic antibody" 2)
   ("Antineutrophil cytoplasmic antibody" 1)))
 ("NCIT:C129416" (("miRNA-16" 3) ("microRNA 16" 1)))
 ("NCIT:C129655"
  (("beta-tubulin" 24) ("beta tubulin" 12) ("Beta-tubulin" 5)
   ("Beta tubulin" 1)))
 ("NCIT:C1298" (("TNP470" 16) ("TNP-470" 8)))
 ("NCIT:C1300"
  (("Dolastatin-10" 12) ("the antineoplastic drug Dolastatin-10" 3)
   ("dolastatin-10" 2) ("the antivascular agent dolastatin-10" 1)))
 ("NCIT:C1306" (("O6-benzylguanine" 12) ("O 6 benzylguanine" 1)))
 ("NCIT:C1310"
  (("Ro31-8220" 78) ("Ro 31-8220" 25) ("submaximal Ro31-8220" 15)
   ("Ro 31–8220" 5) ("Submaximal Ro31-8220" 2)))
 ("NCIT:C1311" (("tacrolimus" 30) ("Tacrolimus" 1)))
 ("NCIT:C1313" (("misoprostol" 3) ("Misoprostol" 2)))
 ("NCIT:C1318"
  (("lithium" 454) ("Lithium" 45) ("lithium carbonate" 17) ("lithium's" 1)
   ("the classical mood stabilizer lithium" 1) ("than lithium" 1)))
 ("NCIT:C1326"
  (("Dox" 1458) ("DOX" 1393) ("dox" 500) ("DOX-" 25) ("−dox" 21)
   ("doxorubicin hydrochloride" 20) ("Doxorubicin hydrochloride" 12) ("−Dox" 7)
   ("-Dox" 5) ("Dox-" 5) ("−DOX" 4) ("ICN" 2) ("Dox (ICN)" 2)
   ("chemotherapeutic agent DOX" 2) ("–dox" 2)
   ("p53 null Saos-2 cells made DOX" 1)
   ("E17.5 cortical and thalamic DT −dox" 1) ("cellular residual DOX" 1)
   ("“Dox”" 1) ("–Dox" 1) ("the chemotherapeutic agents Dox" 1) ("-dox" 1)
   ("-DOX" 1)))
 ("NCIT:C1331" (("epipodophyllotoxins" 3))) ("NCIT:C1333" (("ICRF187" 6)))
 ("NCIT:C1368" (("ENA-78" 13))) ("NCIT:C1374" (("goserelin" 3)))
 ("NCIT:C1377"
  (("photofrin" 8) ("than the first-generation photosensitizer photofrin" 1)))
 ("NCIT:C1395" (("navelbine" 4) ("Navelbine" 3)))
 ("NCIT:C1401" (("PZD" 4) ("piperazinedione" 1)))
 ("NCIT:C1418" (("clodronate" 25)))
 ("NCIT:C1420" (("photosensitizer" 48) ("photosensitizer molecule" 7)))
 ("NCIT:C1423" (("hydroperoxycyclophosphamide" 2)))
 ("NCIT:C1424"
  (("sulforaphane" 379) ("Sulforaphane" 63) ("sulforaphane (SFN)" 12)
   ("sulforaphane (SF)" 4) ("Sulforaphane (SFN)" 2)
   ("the cancer chemoprotective agent sulforaphane (SFN)" 2)
   ("the dietary isothiocyantes sulforaphane" 2)
   ("the dietary isothiocyanate sulforaphane (SFN)" 1)
   ("potential cancer-prevention drug Sulforaphane (SFN)" 1)))
 ("NCIT:C1428" (("stavudine" 7) ("Stavudine" 1)))
 ("NCIT:C1431" (("imiquimod" 42) ("Imiquimod" 8))) ("NCIT:C1437" (("gp39" 1)))
 ("NCIT:C1440"
  (("4-phenylbutyrate" 12) ("phenylbutyrate" 4) ("4-phenylbutyrate (PB)" 2)
   ("Phenylbutyrate" 1)))
 ("NCIT:C1446"
  (("radiopharmaceuticals" 9) ("Nanobody-based radiopharmaceuticals" 1)))
 ("NCIT:C1454"
  (("BsAb" 213) ("bispecific antibody" 35) ("bsAb" 19)
   ("Bispecific Antibody" 6) ("BsAb molecule" 6)
   ("the fully human recombinant scFv BsAb" 1) ("a fully human BsAb" 1)
   ("a fully human recombinant single chain BsAb" 1)
   ("stably expressed HER2/CD3 BsAb" 1) ("a fully human HER2/CD3 BsAb" 1)
   ("a fully human recombinant single-chain HER2/CD3 BsAb" 1)
   ("a fully human recombinant single chain variable fragment BsAb" 1)))
 ("NCIT:C1456"
  (("superantigen" 63) ("superantigens" 14)
   ("the staphylococcal enterotoxin E (SEE) superantigen" 1) ("Superantigen" 1)
   ("microbial superantigens" 1)))
 ("NCIT:C1461" (("POH" 13) ("Poh" 1) ("perillyl alcohol" 1)))
 ("NCIT:C1462" (("radicicol" 21) ("Radicicol" 4)))
 ("NCIT:C1471" (("lamivudine" 6) ("Lamivudine" 2)))
 ("NCIT:C1472" (("bizelesin" 8)))
 ("NCIT:C1476" (("denileukin diftitox" 8) ("Ontak" 6)))
 ("NCIT:C1478" (("QS21" 2)))
 ("NCIT:C1509"
  (("neuroprotective agent" 18) ("a potential neuroprotective agent" 1)
   ("neuroprotectants" 1)))
 ("NCIT:C1518"
  (("raloxifene" 209) ("Raloxifene" 16) ("than raloxifene" 1)
   ("than 10 μM raloxifene (Figure xref )" 1)))
 ("NCIT:C1527"
  (("letrozole" 240) ("Letrozole" 25) ("preoperative letrozole (POL)" 2)
   ("letrozole-" 1) ("preoperative letrozole" 1)
   ("only 20% received letrozole" 1)))
 ("NCIT:C1529" (("batimastat" 24) ("Batimastat" 19)))
 ("NCIT:C1544"
  (("FK228" 80) ("depsipeptide" 45) ("a macrocyclic depsipeptide" 6)
   ("Depsipeptide" 2) ("the macrocyclic depsipeptide" 1)
   ("the bulky depsipeptide" 1)))
 ("NCIT:C1568"
  (("dihydrosphingosine" 12) ("-dihydrosphingosine" 3)
   ("Dihydrosphingosine" 2)))
 ("NCIT:C1571"
  (("flavopiridol" 291) ("Flavopiridol" 54) ("than flavopiridol" 12)
   ("flavopiridol (FP)" 4) ("than flavopiridol in vitro" 2)
   ("The key representative flavonoid molecule flavopiridol" 1)))
 ("NCIT:C1583" (("daunomycin" 5))) ("NCIT:C1586" (("levofloxacin" 1)))
 ("NCIT:C1594"
  (("anthracyclines" 235) ("Anthracyclines" 18) ("anthracycline antibiotic" 12)
   ("\"anthracyclines\"" 3) ("monomeric anthracyclines" 2)
   ("than monomeric anthracyclines in human cancer cell lines" 1)
   ("parent anthracyclines" 1) ("the parent anthracyclines" 1)))
 ("NCIT:C1599"
  (("bicalutamide" 541) ("Bicalutamide" 83)
   ("the commercially available AR antagonist bicalutamide" 2)
   ("the antiandrogenic compound bicalutamide" 2) ("bicalutamide-" 2)
   ("bicalutamide (CDX)" 1)))
 ("NCIT:C1607" (("anastrozole" 108) ("Arimidex" 20) ("Anastrozole" 4)))
 ("NCIT:C16259"
  (("acyltransferases" 33) ("acyltransferase" 30) ("acyltransferase (PAT)" 4)
   ("acyltransferase (ACAT)" 2)))
 ("NCIT:C16285" (("pN2" 21)))
 ("NCIT:C16302"
  (("T-antigen" 297) ("T-antigens" 5) ("t-antigen" 4) ("T-antigen (JCVT)" 3)
   ("T-antigen protein" 2) ("the Simian Virus 40 Large T-antigen" 1)
   ("Human Mammary Large T-antigen" 1) ("t-antigens" 1)
   ("simian virus 40 (SV-40) large T-antigen" 1)
   ("temperature-sensitive SV40 T-antigen" 1)
   ("simian virus (SV)40 large T-antigen" 1)))
 ("NCIT:C1635"
  (("bexarotene" 135) ("Bexarotene" 43) ("LGD1069" 2)
   ("than Bexarotene (Figure xref )" 1) ("bexarotene’s" 1)))
 ("NCIT:C16383"
  (("capsid protein" 109) ("capsid proteins" 30) ("viral capsid protein" 6)
   ("viral capsid proteins" 5) ("The viral capsid protein" 3)
   ("capsid protein (CA)" 2) ("the viral capsid protein" 2)
   ("the EV71 viral capsid protein" 2) ("3–4 viral capsid proteins" 2)
   ("the free viral capsid proteins" 2) ("Capsid protein" 1)
   ("a retroviral capsid protein" 1) ("a viral capsid protein" 1)
   ("Mature capsid proteins" 1)
   ("a red-labeled Sindbis virus (SIN) capsid protein" 1)
   ("cytoplasmatic viral capsid proteins" 1)))
 ("NCIT:C16389" (("cathepsins" 184) ("Cathepsins" 22) ("whose cathepsins" 1)))
 ("NCIT:C16436" (("chromogranin" 61) ("Chromogranin" 25)))
 ("NCIT:C16479"
  (("PKA" 2369) ("pKa" 68) ("PKA-" 23) ("PKA protein" 3) ("exogenous PKA" 2)
   ("protein kinase-A" 2) ("Pka" 2) ("Gravin-associated PKA" 2)
   ("proportionally less PKA" 2) ("the well-studied PKA" 2) ("PKA’s" 1)
   ("than PKA" 1) ("mechanistically link PKA" 1) ("p-PKA" 1)
   ("synergistic PKA-" 1) ("-PKA" 1) ("pPKA" 1) ("we first inhibited PKA" 1)))
 ("NCIT:C1652"
  (("Marimastat" 44) ("marimastat" 15) ("marimastat (MM)" 4) ("BB2516" 1)))
 ("NCIT:C16614" (("GAG" 815) ("-GAG" 57) ("GAG GAG" 7) ("pGAG" 2)))
 ("NCIT:C1662" (("indinavir" 6)))
 ("NCIT:C1665" (("trapoxin" 3) ("Trapoxin" 2)))
 ("NCIT:C16672"
  (("heat shock proteins" 383) ("HSPs" 320) ("heat shock protein" 285)
   ("HSP" 256) ("Hsp" 134) ("Hsps" 107) ("pHSP" 86) ("Heat shock protein" 46)
   ("Heat shock proteins" 36) ("pHsp" 23) ("heat shock protein (HSP)" 18)
   ("Heat Shock Protein" 18) ("heat shock protein family" 16) ("HSP family" 13)
   ("Heat Shock Proteins" 11) ("heat shock protein (sHSP) family" 8)
   ("Heat shock protein (HSP)" 4) ("Heat shock protein (HSP) family" 4)
   ("heat shock protein (sHSP or HSPB in mammals) family" 4)
   ("heat shock protein (Hsp) family" 3) ("heat shock protein (HSP) family" 3)
   ("HSPs (HSPB)" 2) ("the homologous Hsp" 2)
   ("proteins called heat shock proteins" 2) ("stress-inducible HSP" 2)
   ("sHSP" 2) ("The most stress-inducible Hsp" 2) ("Hsps family" 2)
   ("the ubiquitous small heat shock proteins" 2) ("underwent reduced HSP" 2)
   ("associated heat shock proteins" 1) ("the heat shock protein Hsp83" 1)
   ("than one HSP" 1) ("possibly other heat shock proteins" 1)
   ("cytoprotective heat shock proteins" 1)
   ("cytoprotective heat shock proteins (HSP)" 1) ("HSPs-" 1)))
 ("NCIT:C16682"
  (("HDAC" 3637) ("HDACs" 3142) ("histone deacetylase" 1080)
   ("histone deacetylases" 811) ("Histone deacetylases" 113) ("HDAC family" 92)
   ("Histone deacetylase" 70) ("histone deacetylase (HDAC)" 67)
   ("histone deacetylase family" 32) ("pHDAC" 28) ("Hdacs" 19)
   ("Histone Deacetylases" 15) ("Hdac" 15) ("HDAC protein" 12)
   ("histone deacetylase (HDAC) family" 9) ("histone deacetylases (HDAC)" 6)
   ("HDACS" 6) ("HDAC-" 5) ("–HDAC" 5) ("HDAC peptide" 4) ("hdac" 3)
   ("histone deacetylase
family"
    3)
   ("associated HDACs" 3)
   ("histone
                        deacetylase"
    3)
   ("histone deacetylase (Hdac) family" 3) ("larger HDAC family" 2)
   ("a prototypic class II HDAC" 2) ("the less well-characterized HDACs" 2)
   ("the well-characterized HDACs" 2) ("possibly other HDACs" 2)
   ("traditional histone deacetylases" 2) ("a unique class 1 HDAC" 2)
   ("histone deacetylase (HDAC) protein" 2) ("HDACs family" 2)
   ("targeted HDAC" 2) ("the respective HDACs" 2)
   ("the most representative HDACs" 2) ("these classical HDACs" 2)
   ("most classical HDACs" 2) ("clinically relevant histone deacetylases" 2)
   ("expressing tagged HDACs" 1) ("the lone class IV HDAC" 1)
   ("the associated HDAC" 1) ("the less well-studied HDACs" 1)
   ("less well-studied HDACs" 1) ("HDAC's" 1) ("at least 18 HDACs" 1)
   ("Classic HDACs" 1) ("The classical HDACs" 1) ("the possible role HDAC" 1)
   ("The classical HDACs family" 1)
   ("the zinc-dependent classical HDACs family" 1)
   ("purified human recombinant HDAC’s" 1) ("most HDACs" 1) ("HDAC–" 1)
   ("a special class IIb histone deacetylase" 1) ("the only Class IV HDAC" 1)
   ("their associated HDACs" 1) ("than HDAC 1 and 2" 1)
   ("at least some HDACs" 1) ("associated repressive HDACs" 1)
   ("virion-associated HDAC" 1) ("Classical HDACs" 1)
   ("the classical HDAC family" 1) ("classical HDACs" 1) ("Most HDACs" 1)
   ("than these HDACs" 1) ("At least 18 HDACs" 1)
   ("probably biologically most relevant HDACs" 1) ("Class I HDAC's" 1)
   ("‘classical' histone deacetylases" 1) ("the class I HDAC’s" 1)
   ("targetable HDACs" 1) ("most other HDACs" 1)
   ("Histone deacetylases (HDAC)" 1)
   ("the previously determined class I HDAC" 1) ("most class I–II HDACs" 1)
   ("selectively address individual HDACs" 1) ("the antagonistic HDACs" 1)
   ("the α-actinin-associated HDACs" 1) ("one or more HDACs" 1)
   ("non-NuRD associated HDACs" 1) ("NuRD-associated HDACs" 1)))
 ("NCIT:C16685"
  (("Histone-H3" 29) ("histone-H3" 28) ("histoneH3" 8) ("HistoneH3" 7)))
 ("NCIT:C16687"
  (("histone" 6137) ("histones" 2482) ("Histone" 409) ("Histones" 45)
   ("histone protein" 19) ("nucleosomal histones" 18) ("repressive histone" 15)
   ("histone peptide" 11) ("histone-" 6) ("parental histones" 5)
   ("than histones" 4) ("histone family" 3) ("the repressive histone" 3)
   ("a repressive histone" 2) ("nucleosomal histone" 2)
   ("repressive (H3K27me3) histone" 2) ("the only histone protein" 2)
   ("parental histone" 2) ("toxic excess histones" 2)
   ("nucleosomal core histones" 2) ("than histones [ xref , xref ]" 2)
   ("a red fluorescent protein (RFP)-tagged histone-2B" 2)
   ("enhancer and promoter associated histone" 2) ("the residual histone" 2)
   ("around histone" 2) ("fewer histones" 2) ("around histones" 2)
   ("the amino terminal histone" 2) ("the testes-specific histone" 2)
   ("the core
                            nucleosomal histones"
    2)
   ("any known Snai1-associated histone" 2) ("a fluorescent histone" 2)
   ("Histone protein" 2) ("nucleosomal H3-H4 histones" 2) ("Dual Histone" 2)
   ("a Dual Histone" 2) ("a genome-wide histone" 2)
   ("target chromatin-associated histones" 2) ("even isolated histones" 2)
   ("promoter-associated histone" 2) ("bivalent histone" 1)
   ("Soluble histones" 1) ("soluble histones" 1) ("global histone" 1)
   ("transcriptional regulation-associated histone" 1)
   ("than histones suggesting that these proteins are critical in the regulation"
    1)
   ("a transcriptionally repressive histone" 1)
   ("the four nucleosomal histones" 1) ("repressive histones" 1)
   ("assay global histone" 1) ("the very C-terminal amino acid of histone" 1)
   ("both the global histone" 1) ("basic histones" 1)
   ("exogenous H4 histone" 1) ("suppressive histone" 1)
   ("the repressive H3K27me3 histone" 1) ("repressive linker histones" 1)
   ("very little histones" 1) ("the euchromatic histone" 1)
   ("the mitotic histone" 1) ("the octomeric histone" 1) ("most histones" 1)
   ("respective histone" 1) ("DNA-associated histones" 1)
   ("specifically targets histones" 1) ("less histones" 1)
   ("soluble chromatinized histones" 1)
   ("than hyperacetylated histones [ xref ]" 1)
   ("subsequently exchanges histones" 1) ("the basic amino-terminal histone" 1)
   ("the globular histone" 1)
   ("important regulatory lysines of the core histone" 1)
   ("repressive (H3K27me3 or H3K9me3) histone" 1) ("That soluble histones" 1)
   ("pure histones" 1) ("soluble histone" 1)
   ("pre-existing nucleosomal histones" 1) ("phospho-acetylated histone" 1)
   ("other repressive histone" 1) ("DNA wrapped around core histones" 1)
   ("Other previously characterized repressive histones" 1)
   ("one or more histones" 1) ("the enhancer element-specific histone" 1)
   ("activation-associated histone" 1) ("chromatin-associated histones" 1)
   ("directly bind histones" 1) ("this repressive histone" 1)
   ("the Ezh2-catalyzed histone" 1) ("the active transcriptional histone" 1)))
 ("NCIT:C16692" (("HLA-DR" 257) ("HLA-DR protein" 3) ("HLA-DR-" 2)))
 ("NCIT:C1670" (("ibandronate" 9)))
 ("NCIT:C16748"
  (("integrin" 11295) ("integrins" 3268) ("-integrin" 613) ("Integrin" 528)
   ("Integrins" 228) ("integrin family" 65) ("integrin-" 42) ("integrin–" 33)
   ("-Integrin" 20) ("-integrins" 16) ("integrin protein" 15)
   ("integrin molecule" 12) ("the predominant integrin" 4)
   ("integrin peptide" 4) ("Integrin–" 3) ("its associated LB integrins" 3)
   ("its associated α3β1 integrin" 3) ("most integrins" 3)
   ("The principal integrin" 3) ("specifically knockdown (kd) each integrin" 2)
   ("the more promiscuous alpha integrins" 2) ("minimal α v β 3 -integrin" 2)
   ("CD151-associated α3β1 integrin" 2) ("its associated α3 integrin" 2)
   ("endocytic integrin" 2) ("at least 24 distinct integrins" 2)
   ("Integrin-" 2) ("the FN-competent β1 integrin" 2) ("Integrin Protein" 2)
   ("significantly more integrin" 2) ("namely β1 integrins" 2)
   ("possibly other integrins" 2) ("than αvβ3 integrin" 2)
   ("immature intracellular β1 integrin" 2) ("CDCP1-associated β1 integrin" 2)
   ("the associated integrins" 1) ("previously inactive integrins" 1)
   ("only α5β1 integrin" 1)
   ("Internalized soluble fibronectin and β1 integrins" 1)
   ("healthy pancreas, and β1 integrin" 1) ("their associated integrins" 1)
   ("the cancer stem cell-associated α2β1 integrin" 1)
   ("very late antigen-4 (VLA-4) integrins" 1)
   ("CD151-associated α3 and α6 integrins" 1)
   ("CD151-associated α3 integrin" 1) ("particularly LB integrins" 1)
   ("at least three key integrins" 1) ("than the integrin" 1)
   ("less internal β1 integrin" 1) ("only α4 integrin" 1)
   ("Invasive Hs578T cells upregulated β 1 integrin" 1)
   ("CMAC-associated integrins" 1)
   ("Hyal1 transfectants expressed slightly more β1 integrin" 1)
   ("the most ubiquitous integrin" 1)
   ("PDGFRβ-associated tTG and PDGFRβ-β 1 integrin" 1)
   ("proteins called integrins" 1) ("an integrin" 1)
   ("the most enigmatic integrin" 1)
   ("predominant co-localization MMP-2 and α5β1 integrin" 1)
   ("the respective integrins" 1) ("surface-localized β1 integrin" 1)
   ("at least 24 different heterodimeric integrin" 1)
   ("static conditions allowed β 2 integrins" 1)
   ("expressing (i) α 6 integrin" 1) ("mature 130-kDa β1 integrin" 1)
   ("mechanistically β1 integrin" 1) ("the mature β1 integrin" 1)
   ("namely β1 integrin" 1)))
 ("NCIT:C16819"
  (("manganese superoxide dismutase" 103)
   ("Manganese superoxide dismutase" 5)))
 ("NCIT:C16843"
  (("metalloproteases" 474) ("metalloproteinase" 278)
   ("metalloproteinases" 265) ("metalloprotease" 247) ("Metalloproteases" 13)
   ("Metalloproteinases" 12) ("Metalloproteinase" 12)
   ("metalloproteinase family" 5) ("metalloprotease (MMP)" 5)
   ("Metalloprotease" 5) ("metalloprotease-" 4) ("metalloproteases (MMP)" 3)
   ("metalloproteinase (MP)" 2) ("a membrane-associated metalloprotease" 2)
   ("particularly matrix metalloproteases" 2) ("a soluble metalloproteinase" 2)
   ("one or more metalloproteinases" 2) ("neuronal metalloproteases" 1)
   ("the cell-associated metalloprotease" 1)
   ("the 1,10-PT-inhibitable metalloproteases" 1)
   ("the cell-associated metalloproteases" 1) ("metalloproteinases (MMP)" 1)
   ("metalloproteinases (TIMP)" 1) ("metalloproteinases (TIMPS)" 1)
   ("e.g. HGF, vascular endothelial growth factor and matrix metalloproteases"
    1)
   ("metalloproteinase's" 1) ("metalloprotease (ADAM)" 1)
   ("the invasive metalloproteinase" 1)
   ("than 300 catalytically active Zn metalloproteinase" 1)))
 ("NCIT:C16883"
  (("mucin" 553) ("mucins" 97) ("mucin family" 15) ("Mucin" 14)
   ("mucin protein" 9) ("Mucins" 8) ("only intracytoplasmic mucin" 4)
   ("The copious mucin" 2) ("abundant supranuclear mucin" 2)
   ("secretary mucin" 2) ("overexpressed mucins" 2)
   ("membrane-associated mucins" 2)
   ("a hetero-dimeric O-glycosylated transmembrane mucin" 2)
   ("such antiadhesive mucins" 1) ("abdominal mucin" 1) ("gelatinous mucin" 1)
   ("mucin-" 1) ("histochemical mucin" 1) ("than one mucin" 1)
   ("largest known transmembrane mucin" 1) ("these predominant mucins" 1)
   ("a gastric foveolar mucin" 1) ("PAS-positive apical mucin" 1)
   ("AB-negative/PAS-positive apical mucin" 1) ("the secretary mucins" 1)
   ("associated mucin" 1) ("minimal mucin" 1) ("intracytoplasmic mucin" 1)
   ("Polymeric mucins" 1) ("produced basophilic mucin" 1)
   ("intestinal phenotype mucins" 1) ("focal cytoplasmic mucin" 1)))
 ("NCIT:C1689" (("DDB" 66) ("ddb" 1)))
 ("NCIT:C16934"
  (("oncoproteins" 924) ("viral oncoproteins" 50) ("Oncoproteins" 7)
   ("several viral oncoproteins" 5) ("other viral oncoproteins" 4)
   ("the major oncoproteins" 4) ("Cellular oncoproteins" 4)
   ("cellular oncoproteins" 2) ("powerful oncoproteins" 2)
   ("key oncoproteins" 2) ("several cellular oncoproteins" 2)
   ("Rb-inactivating viral oncoproteins" 2) ("client oncoproteins" 2)
   ("MLL chimeric oncoproteins" 2) ("the classic oncoproteins" 2)
   ("a few oncoproteins" 2) ("most notably viral oncoproteins" 2)
   ("well-known oncoproteins" 2) ("several key oncoproteins" 1)
   ("Multiple haematological disorder-associated oncoproteins" 1)
   ("new oncoproteins" 1) ("E7 viral oncoproteins" 1)
   ("several well-known oncoproteins" 1) ("than one oncoproteins" 1)
   ("the above-mentioned oncoproteins" 1) ("different viral oncoproteins" 1)
   ("the viral oncoproteins" 1) ("both viral oncoproteins" 1)
   ("the ETS1 and ETS2 transcriptional oncoproteins" 1)
   ("viral small T oncoproteins" 1) ("the viral Tax and HBx oncoproteins" 1)
   ("multiple well-known oncoproteins" 1) ("2 primary oncoproteins" 1)
   ("Nine viral oncoproteins" 1) ("clinically relevant oncoproteins" 1)
   ("many viral oncoproteins" 1) ("one or more HPV-16 oncoproteins" 1)
   ("several other viral oncoproteins" 1)
   ("these viral and cellular oncoproteins" 1)
   ("cellular and viral oncoproteins" 1)
   ("intrinsically unstable cellular and viral oncoproteins" 1)
   ("than the related SV40 oncoproteins" 1)
   ("other sarcoma-associated fusion oncoproteins" 1)
   ("several well-defined oncoproteins" 1) ("their respective oncoproteins" 1)
   ("other key oncoproteins" 1) ("the essential KIT/PDGFRA oncoproteins" 1)))
 ("NCIT:C16970" (("permease" 7) ("permeases" 2)))
 ("NCIT:C17015"
  (("cyclooxygenase" 268) ("Cyclooxygenase" 62) ("cyclooxygenases" 47)
   ("cyclooxygenase (COX)" 40) ("Cyclooxygenases" 33)
   ("Cyclooxygenase (COX)" 11) ("cyclo-oxygenase" 6) ("Cyclo-oxygenases" 3)
   ("cyclooxygenase-" 2) ("cyclooxygenase ( COX )" 2)
   ("cyclooxygenases (COX)" 1)
   ("than its pharmacological target cyclooxygenase (COX)" 1)
   ("‘cyclooxygenase'" 1) ("cyclo-oxygenase (COX)" 1) ("Cyclo-oxygenase" 1)))
 ("NCIT:C17022"
  (("proteoglycans" 263) ("proteoglycan" 184) ("Proteoglycans" 7)
   ("proteoglycan family" 6) ("Proteoglycan" 5) ("proteoglycan (MPG)" 3)
   ("a ubiquitously expressed cell-surface proteoglycan" 2)
   ("particularly small leucine-rich proteoglycans" 2)
   ("expressed cell-surface proteoglycan" 1) ("an atypical proteoglycan" 1)
   ("intimal proteoglycans" 1) ("Accumulated cell-associated proteoglycan" 1)
   ("a small connective tissue proteoglycan" 1)
   ("potentially heparin sulfate proteoglycans" 1)))
 ("NCIT:C17062" (("beta adrenergic receptor" 3) ("Ad-Rb" 1)))
 ("NCIT:C17070"
  (("FcR" 69) ("Fc receptor" 52) ("Fc receptors" 42) ("Fc receptor family" 3)
   ("Fc Receptor" 2) ("FcRs" 1)))
 ("NCIT:C1720" (("KRN7000" 1))) ("NCIT:C1725" (("SU5402" 102)))
 ("NCIT:C17274"
  (("BMP" 758) ("BMPs" 134) ("bone morphogenetic protein" 65)
   ("bone morphogenetic proteins" 53) ("bone morphogenetic protein (BMP)" 10)
   ("Bone morphogenetic proteins" 9) ("BMP family" 5) ("exogenous BMP" 4)
   ("BMP-" 4)
   ("bone
 morphogenetic proteins"
    3)
   ("one or more BMPs" 2) ("Bone morphogenetic protein" 2) ("Exogenous BMP" 1)
   ("BMP’s" 1) ("than other BMP" 1) ("Bone morphogenetic protein (BMP)" 1)))
 ("NCIT:C17275"
  (("calcineurin" 273) ("Calcineurin" 30) ("calcineurin (CN)" 6)
   ("–calcineurin" 4)
   ("the calcium-calmodulin-dependent protein serine phosphatase calcineurin"
    3)
   ("the Calm-dependent serine/threonine phosphatase Calcineurin" 2)
   ("KSR2-associated calcineurin" 2) ("-calcineurin" 2) ("calcineurin's" 1)))
 ("NCIT:C17297"
  (("FGFR" 1737) ("FGFRs" 340) ("FGF receptor" 111) ("FGF receptors" 110)
   ("FGFR family" 96) ("pFGFR" 55) ("Fibroblast growth factor receptor" 54)
   ("fibroblast growth factor receptor family" 14)
   ("Fibroblast growth factor receptors" 5) ("FGF Receptor" 5) ("-FGFR" 3)
   ("p-FGFR" 2) ("FgfRs" 2) ("FGF receptors (FGFR)" 2) ("FGF receptor (CFR)" 2)
   ("FGF receptor (FGFR)" 1) ("“FGFR”" 1)
   ("Fibroblast growth factor receptor (FGFR)" 1)
   ("soluble high affinity decoy FGF receptors" 1) ("soluble FGFRs" 1)
   ("dominant-negative FGFRs" 1) ("endocytic FGFR" 1)
   ("target both the FGFR" 1) ("FGFR’s" 1)
   ("a soluble dominant-negative FGFR" 1) ("an optimal FGFR" 1)
   ("more selectively target FGFR" 1)))
 ("NCIT:C17307"
  (("lamins" 217) ("lamin" 122) ("Lamin" 26) ("Lamins" 8) ("lamin family" 4)
   ("LAMIN ( LMNA )" 3) ("LAMIN" 1) ("only A-type lamins" 1)))
 ("NCIT:C17322"
  (("PDGFRs" 139) ("PDGF receptor" 107) ("Pdgfr" 23) ("PDGF-R" 17) ("PDGR" 5)
   ("PDGF Receptor" 3) ("targeting PDGFRs" 2) ("PDGF receptor family" 2)
   ("Pdgfrs" 2) ("PDGF receptor (PDGFR)" 2) ("PDGFr" 2)
   ("PDGF receptor ( PDGFRB )" 1) ("derived growth factor-receptor" 1)
   ("the most well-documented PDGF receptor" 1) ("the respective PDGFRs" 1)))
 ("NCIT:C17333"
  (("somatostatin receptors" 5) ("somatostatin receptor" 3) ("SSTR" 2)))
 ("NCIT:C17335" (("syndecans" 15) ("Syndecans" 1)))
 ("NCIT:C1742"
  (("anti-angiogenic" 415) ("angiogenesis inhibitor" 67) ("Anti-angiogenic" 7)
   ("anti-angiogenic drug" 7) ("Anti-Angiogenic" 4)
   ("a well-characterized endogenous angiogenesis inhibitor" 2)
   ("synergistic anti-angiogenic" 1) ("antagonistic anti-angiogenic" 1)
   ("the well-described robust CD36-dependent anti-angiogenic" 1)
   ("a highly anti-angiogenic molecule" 1) ("anti-angiogenic molecule" 1)))
 ("NCIT:C17420" (("PEA-3" 22) ("Pea3" 3)))
 ("NCIT:C17434"
  (("glycosyltransferases" 25) ("diverse glycosyltransferases" 2)
   ("the correspondent glycosyltransferases" 1)))
 ("NCIT:C1744" (("chemosensitizer" 23) ("a potential chemosensitizer" 2)))
 ("NCIT:C17458"
  (("G protein" 794) ("G proteins" 427) ("G-protein" 373) ("g protein" 289)
   ("heterotrimeric G proteins" 43) ("g proteins" 36)
   ("vesicular stomatitis virus G protein" 8) ("trimeric G proteins" 8)
   ("G Protein" 6)
   ("G
 protein"
    6)
   ("monomeric G proteins" 4) ("G protein family" 4) ("G–protein" 3)
   ("a stimulatory heterotrimeric G protein" 3) ("G-protein family" 3)
   ("G protein-" 3) ("-G protein" 3) ("–G protein" 3)
   ("several heterotrimeric G proteins" 3) ("G-protein-" 2)
   ("vesicular stomatitis virus G–protein" 2)
   ("the vesicular stomatitis virus G-protein" 2)
   ("constitutively active stimulatory G protein" 2)
   ("the heterotrimeric G protein" 2) ("G-Protein" 2)
   ("specific heterotrimeric G proteins" 2)
   ("the vesicular stomatitis virus (VSV) G protein" 2)
   ("αβγ-trimeric G proteins" 2) ("a monomeric membrane-localized G protein" 2)
   ("a plasmid encoding vesicular stomatitis virus G protein" 2)
   ("the trimeric G proteins" 2) ("canonical heterotrimeric G protein" 2)
   ("heterotrimeric G protein" 2) ("other possible G proteins" 2)
   ("different heterotrimeric G proteins" 2)
   ("the appropriate trimeric G proteins" 2)
   ("vesicular stomatitis virus envelope G protein" 2) ("G-protein (VSVG)" 2)
   ("classic G proteins" 2) ("the monomeric G-protein" 2)
   ("a heterotrimeric G protein" 1) ("vesicular stomatitis virus G-protein" 1)
   ("previously incubated 500 µg protein" 1) ("G-protein (ARF)" 1)
   ("the heterotrimeric G-protein family" 1) ("Trimeric G proteins" 1)
   ("Approximately 10 µg protein" 1) ("a heterotrimeric G-protein" 1)
   ("receptor-coupled trimeric G proteins" 1) ("G protein–" 1)
   ("hetero trimeric G proteins" 1) ("trimeric G-protein" 1)
   ("Vesicular stomatitis virus (VSV)-G protein" 1)
   ("the receptor-catalyzed G-protein" 1) ("the heterotrimeric G-protein" 1)
   ("the vesicular stomatitis virus (VSV)–G protein" 1)
   ("associated G proteins" 1) ("than other small G proteins ( xref  A )" 1)
   ("the viral G protein" 1)
   ("several possible seven transmembrane G protein" 1)
   ("the trimeric G protein" 1) ("the heterotrimeric G proteins" 1)
   ("a trimeric G protein" 1) ("both heterotrimeric G proteins" 1)
   ("Ras and perhaps other small monomeric G proteins" 1)
   ("the stimulatory G protein" 1) ("the coupled heterotrimeric G proteins" 1)
   ("this G protein’s" 1) ("vesicular stomatitis G-protein" 1)
   ("different heterotrimeric G protein" 1) ("different trimeric G proteins" 1)
   ("the basolateral G protein" 1) ("most G proteins" 1)
   ("activated trimeric G proteins" 1) ("Most G proteins" 1)
   ("most Ras superfamily G proteins" 1) ("Most Ras superfamily G proteins" 1)
   ("trimeric G protein" 1) ("G Protein (SIGMA)" 1) ("g Protein" 1)))
 ("NCIT:C17530"
  (("insulin-like growth factor receptor" 130) ("IGF-R" 10)
   ("Insulin-like growth factor receptor" 3)
   ("insulin-like growth factor receptor (IGFR)" 3)
   ("insulin-like growth factor receptor ( IGFR )" 1)))
 ("NCIT:C17548" (("cANCA" 2)))
 ("NCIT:C17583"
  (("IκB" 1657) ("IκBs" 194) ("I-κB" 148) ("IkB" 75) ("IκB protein" 61)
   ("IκB family" 55) ("IKB" 30) ("IkappaB" 17) ("pIκB" 15) ("IκBS" 8)
   ("p-IκB" 7) ("IkappaBs" 6) ("I-κBs" 6) ("IκB (A238L) protein" 6)
   ("IkB family" 5) ("pI-κB" 4) ("CXCL1 activated more IκB" 3) ("IkBs" 3)
   ("p-IKB" 3) ("IKBs" 3) ("IkB protein" 2) ("I-kappa-B proteins" 2) ("iκB" 2)
   ("I-κB family" 2) ("classical IκBs" 2) ("both classical IκBs" 2)
   ("an unusual IκB" 2) ("pIkB" 2) ("a dominant-negative IκB" 2)
   ("IκB (IKK)" 1) ("IKappaB" 1) ("I-kappaB" 1) ("this unusual IκB protein" 1)
   ("IκB’s" 1) ("a “typical” IκB" 1) ("IκB-" 1) ("the atypical IκB" 1)))
 ("NCIT:C17660"
  (("RTKs" 2833) ("RTK" 2682) ("receptor tyrosine kinases" 1998)
   ("receptor tyrosine kinase" 1837) ("receptor tyrosine kinase (RTK)" 119)
   ("receptor tyrosine kinase family" 112) ("Receptor tyrosine kinases" 89)
   ("RTK family" 44) ("receptor tyrosine kinase (RTK) family" 36) ("TKR" 30)
   ("Receptor tyrosine kinase" 28) ("receptor tyrosine kinases (RTK)" 24)
   ("receptor-tyrosine kinases" 11) ("TKRs" 8) ("RTK-" 7)
   ("receptor tyrosine kinase (TK)" 7) ("receptor-tyrosine kinase" 7)
   ("receptor tyrosine kinase (TK) family" 7)
   ("most receptor tyrosine kinases" 6) ("p-RTK" 5) ("an alternate RTK" 5)
   ("a typical RTK" 4) ("RTKs family" 4) ("pRTK" 4)
   ("receptor
tyrosine kinases"
    4)
   ("RTK peptide" 4) ("RTK’s" 3) ("receptor tyrosine kinases (RTKs) family" 3)
   ("most RTKs" 3) ("vascular-specific receptor tyrosine kinases" 3)
   ("exogenous receptor tyrosine kinases" 3) ("RTK family protein" 3)
   ("receptor tyrosine kinases family" 3) ("“receptor tyrosine kinase”" 3)
   ("receptor tyrosine kinase ( MET )" 3)
   ("receptor tyrosine kinase (HER) family" 3) ("compensatory RTKs" 2)
   ("fewer RTKs" 2) ("classical growth factor-activated RTKs" 2)
   ("targeted RTK" 2)
   ("These findings directly link receptor tyrosine kinases" 2)
   ("a well-characterized cell surface receptor tyrosine kinase" 2)
   ("a tetrameric transmembrane RTK" 2)
   ("most notably PDGF-β receptor tyrosine kinase" 2) ("possibly other RTKs" 2)
   ("well-characterized adaptor-specific RTK" 2)
   ("receptor tyrosine
kinases"
    2)
   ("potentially other RTKs" 2)
   ("an essential receptor tyrosine kinase (RTK)" 2)
   ("the secondary active RTKs" 2) ("classical receptor tyrosine kinases" 2)
   ("a well-established oncogenic driver RTK" 2)
   ("the so called receptor tyrosine kinases" 2)
   ("two or more positive RTKs" 2)
   ("an archetypal receptor tyrosine kinase (TK)" 2)
   ("the most commonly overexpressed receptor tyrosine kinase" 2)
   ("overexpressed receptor tyrosine kinase" 2)
   ("spatially contact receptor tyrosine kinases" 2)
   ("a typical receptor tyrosine kinase" 2)
   ("RTK Bis-Phosphorylated Peptide" 2) ("at least 13 different RTKs" 2)
   ("secondary RTK" 2) ("other leukemogenic receptor tyrosine kinases" 2)
   ("receptor tyrosine kinase protein" 2) ("nearly all RTKs" 2)
   ("wider role regulating receptor tyrosine kinases" 2) ("P-RTK" 2)
   ("the predominant receptor tyrosine kinase" 1)
   ("The most differentially expressed RTK" 1)
   ("the potential miR-34-regulated RTKs" 1) ("1 or more additional RTKs" 1)
   ("Drosophila both the Ret-like receptor tyrosine kinase" 1)
   ("at least several RTKs" 1) ("than the other RTKs" 1) ("singular RTKs" 1)
   ("than receptor tyrosine kinases" 1)
   ("the presumptive upstream receptor tyrosine kinase" 1)
   ("receptor-tyrosine kinases (RTK)" 1) ("other RTK’s" 1) ("ternary RTK" 1)
   ("stably binding RTKs" 1) ("more RTKs" 1) ("their respective RTKs" 1)
   ("a cell-surface neural receptor tyrosine kinase (RTK)" 1)
   ("possibly other receptor tyrosine kinases" 1)
   ("other ligand-driven RTKs" 1) ("other resistance-enriched RTKs" 1)
   ("-receptor tyrosine kinase" 1) ("than other RTKs" 1)
   ("three or more strongly positive RTKs" 1)
   ("at least one strongly or weakly positive RTK" 1)
   ("a heterodimeric transmembrane receptor tyrosine kinase" 1)
   ("the receptor tyrosine kinases (RTK), which leads to activation of the PI3K pathway"
    1)
   ("a drug targetable RTK" 1) ("typical receptor tyrosine kinases" 1)
   ("the Tek/Tie2 endothelial-specific receptor tyrosine kinase" 1)
   ("This monomeric receptor tyrosine kinase" 1) ("yet another RTK" 1)
   ("Abl, Arg, and class III receptor tyrosine kinases" 1)
   ("the most consistently overexpressed and activated RTK" 1)
   ("than one receptor tyrosine kinase" 1)
   ("a unique transmembrane receptor tyrosine kinase" 1) ("the RTK's" 1)
   ("RTK protein" 1) ("its associated RTKs" 1)
   ("the only other receptor tyrosine kinase (RTK)" 1)
   ("lapatinib-treated GC cells phosphorylated MET RTK" 1)
   ("the first receptor tyrosine kinases, EGFR" 1)
   ("a well-established promigratory RTK" 1) ("alternate RTKs" 1)
   ("than the RTKs" 1) ("receptor tyrosine kinases (TK)" 1)
   ("the respective RTKs" 1)))
 ("NCIT:C17692" (("nsps" 3)))
 ("NCIT:C17746"
  (("P-glycoprotein" 209) ("p-glycoprotein" 15) ("P-glycoprotein (PGP)" 3)
   ("less P-glycoprotein" 2)))
 ("NCIT:C17763"
  (("ErbBs" 48) ("ERBBs" 19) ("than other ErbBs ( xref )" 1)
   ("than the other ErbBs ( xref )" 1)))
 ("NCIT:C17764"
  (("chaperone" 2046) ("chaperone protein" 77) ("Chaperone" 44)
   ("an essential molecular chaperone" 8) ("a Homodimeric Chaperone" 4)
   ("chaperone peptide" 3) ("an ER-resident chaperone" 2)
   ("a stress-activated cytoprotective chaperone" 2)
   ("a classical ER chaperone" 2) ("“chaperone”" 2)
   ("ubiquitous cytoplasmic chaperone" 2)
   ("a ubiquitous ATP-dependent molecular chaperone" 2)
   ("a multifunctional chaperone" 2) ("the ER-resident chaperone" 2)
   ("The classical histone chaperone" 2) ("a multi-functional chaperone" 2)
   ("cytoprotective small heat-shock chaperone" 2)
   ("cytoprotective chaperone" 2) ("chaperone molecule" 2)
   ("The last chaperone" 2) ("a new chaperone" 2) ("well known chaperone" 2)
   ("a ubiquitous molecular chaperone" 2) ("an antiapoptotic chaperone" 2)
   ("a stress-induced molecular chaperone" 2) ("a nucleic acid chaperone" 1)
   ("a transmembrane chaperone" 1) ("the stress-inducible protein chaperone" 1)
   ("a resident endoplasmic reticulum chaperone" 1) ("the two chaperone’s" 1)
   ("biologically coherent chaperone" 1) ("an alternative chaperone" 1)
   ("chaperone (BSG)" 1) ("this potential chemical chaperone" 1)
   ("this versatile chaperone" 1)
   ("a stress-inducible cytosolic molecular chaperone" 1)
   ("this importin-4-associated chaperone" 1)
   ("an abundant cellular chaperone" 1) ("a classic molecular chaperone" 1)
   ("a stress-activated chaperone" 1)
   ("A plausible candidate ARV chaperone" 1)))
 ("NCIT:C17765"
  (("Hsp70" 1568) ("HSP70" 895) ("HSP70" 765) ("hsp70" 113)
   ("HSP70 protein" 16) ("Hsp70 family" 16) ("Hsp70s" 12) ("Hsp70 protein" 11)
   ("HSP-70" 7) ("Hsp70s" 6) ("HSP-70" 6) ("HSP70s" 5) ("Hsp70’s" 4)
   ("Hsp-70" 4) ("Hsp70-" 4) ("Hsp-70" 3) ("Hsp70 peptide" 3)
   ("hsp70 family" 3) ("than Hsp70" 2) ("HSP70-" 2) ("monoclonal anti Hsp70" 2)
   ("IF-associated Hsp70" 2) ("pleural fluid HSP70" 1)
   ("pleural mesothelial cells release HSP70" 1)
   ("the biochemical stress indicator Hsp70" 1) ("Hsps70" 1) ("Hsps70" 1)
   ("its transcriptional target Hsp70" 1)
   ("the stress-inducible human HSP70" 1) ("immunomodulatory factor Hsp70" 1)
   ("the mitochondrial matrix-resident protein Hsp70" 1)))
 ("NCIT:C17767"
  (("CDKs" 1775) ("cyclin-dependent kinases" 586)
   ("cyclin-dependent kinase" 411) ("Cdks" 248) ("cyclin dependent kinases" 98)
   ("cyclin dependent kinase" 63) ("Cyclin-dependent kinases" 39)
   ("Cyclin-dependent kinase" 26) ("cyclin-dependent kinase (CDK)" 21)
   ("cyclin-dependent kinase family" 14) ("Cyclin dependent kinases" 12)
   ("cyclin-dependent kinases (CDK)" 8) ("CdKs" 8) ("CDks" 3)
   ("cyclin-dependent kinase (CDK) family" 3)
   ("their associated cyclin-dependent kinases" 2)
   ("their respective cyclin-dependent kinases" 2)
   ("constitutively-expressed cyclin-dependent kinases" 2)
   ("cyclin-dependent
kinase"
    2)
   ("a ubiquitous cyclin-dependent kinase" 2)
   ("phase-specific cyclin-dependent kinases" 2)
   ("spesific cyclin-dependent kinase" 2) ("Cyclin dependent kinase" 2)
   ("monomeric CDKs" 2) ("their associated cyclin dependent kinases" 2)
   ("a few CDKs" 2) ("at least nine different CDKs" 2)
   ("associated cyclin-dependent kinases" 2) ("the associated CDKs" 1)
   ("the post-mitotic cyclin-dependent kinase (CDK) 5" 1) ("overactive CDKs" 1)
   ("the CDKs had little" 1) ("Most CDKs" 1)
   ("cell cycle–associated cyclin-dependent kinases" 1)
   ("their respective CDKs" 1) ("cyclin-dependent kinase(CDK)" 1)
   ("cyclin dependent kinase (CDK)" 1) ("mitotic cyclin-dependent kinase" 1)
   ("their associated cyclin-dependent kinases(CDK)" 1) ("Monomeric CDKs" 1)
   ("mitotic Cdks" 1)
   ("cyclin-dependent
                kinase"
    1)
   ("the mitotic cyclin-dependent kinase" 1)
   ("p27C bound cyclin-associated CDKs" 1) ("transcriptional CDKs" 1)))
 ("NCIT:C1777" (("AMD3100" 367)))
 ("NCIT:C17897"
  (("P-selectin" 30) ("selectin" 28) ("selectins" 17) ("Selectin" 12)
   ("selectin family" 5) ("Selectins" 1) ("-selectin" 1) ("p-selectin" 1)))
 ("NCIT:C17903"
  (("NFAT" 1056) ("NF-AT" 163) ("NFAT family" 24) ("pNFAT" 7)
   ("NFAT protein" 6) ("NFAT (nuclear factor of activated T cells) family" 5)
   ("a predominant NFAT protein" 5) ("–NFAT" 4) ("NF-AT-" 3) ("GGAAA" 2)
   ("NF-AT–" 2) ("NFAT-" 1) ("transcriptional factor NFAT" 1)
   ("other NFAT’s" 1) ("PEDF-driven NFAT" 1) ("than NFAT" 1) ("-NFAT" 1)))
 ("NCIT:C17981" (("cyclin-B1" 18) ("Cyclin-B1" 16)))
 ("NCIT:C17988"
  (("cyclin D1a" 267) ("cyclin-D1" 151) ("cyclin D1a" 3) ("CCND1a" 3)
   ("cyclinsD1" 1) ("cyclin D1a-" 1) ("-cyclin D1a" 1) ("than cyclin D1a" 1)
   ("strong cyclin-D1" 1)))
 ("NCIT:C1802"
  (("cigarette" 1338) ("Cigarette" 186) ("both habitual cigarette" 4)
   ("water soluble cigarette" 2) ("Ever smokers included cigarette" 2)
   ("at least 1 cigarette" 2) ("at least one cigarette" 2)
   ("cumulative cigarette" 2) ("a commercial cigarette" 2)
   ("than cigarette smoking" 1)))
 ("NCIT:C1804"
  (("raltitrexed" 39) ("Raltitrexed" 5) ("than raltitrexed (MW 458)" 1)))
 ("NCIT:C18049" (("GST-PI" 3) ("GST-pi" 1)))
 ("NCIT:C18153"
  (("caspase" 4933) ("caspases" 3449) ("Caspase" 585) ("Caspases" 182)
   ("caspase family" 63) ("caspase-" 28) ("regulative apoptotic caspases" 8)
   ("the mature caspase" 7) ("Caspase-" 6) ("the apical caspases" 6)
   ("the regulative apoptotic caspases" 4) ("FLICA" 4) ("an apical caspase" 4)
   ("caspases-" 4) ("Fluorometric caspase" 4) ("most caspases" 3)
   ("one or more caspases" 3) ("the acute proapoptotic markers caspases" 3)
   ("the mitochondrial-independent caspases" 3) ("apical caspases" 2)
   ("further effector caspases" 2) ("proteases called caspases" 2)
   ("regulative caspases" 2) ("an immediate caspase" 2)
   ("the pro-apoptotic fragment p40Met caspase" 2)
   ("at least one other inflammatory caspase" 2)
   ("only P102L V inhibited caspases" 2) ("FLICA-" 2)
   ("a unique caspase family" 2) ("pro-apoptotic caspases" 2)
   ("mature IL-1β and active caspase" 2) ("whereupon effector caspases" 1)
   ("these unique microenvironments place individual caspases" 1)
   ("caspases (DEXD)" 1) ("‘caspases’" 1) ("other relevant caspases" 1)
   ("the apical caspase" 1) ("a death receptor-associated initiator caspase" 1)
   ("a strong caspase" 1) ("apoptotic regulative caspases" 1)
   ("the apoptotic regulative caspases" 1) ("a regulative apoptotic caspase" 1)
   ("a mysterious caspase" 1) ("apoptotic and non-apoptotic caspases" 1)
   ("the primarily initiator caspase" 1) ("therapy-induced caspases" 1)
   ("here called p40Met caspase" 1) ("the pro-apoptotic Caspase" 1)
   ("effectively target caspases" 1) ("several potential caspase" 1)
   ("Caspase (CASP)" 1) ("‘caspase’" 1) ("an Apical Caspase" 1)
   ("monomeric caspases" 1) ("the pro-apoptotic caspases" 1)
   ("the so-called caspases" 1) ("a proximal caspase" 1)
   ("than caspases such as caspase-3 ( xref )" 1)
   ("ultimately either caspase" 1) ("Caspase family" 1) ("Most caspases" 1)
   ("caspase’s" 1) ("plural caspases" 1)
   ("both apoptotic and inflammatory caspases" 1)))
 ("NCIT:C18164"
  (("MMP" 1905) ("matrix metalloproteinase" 347)
   ("matrix metalloproteinase (MMP)" 40) ("Matrix metalloproteinase" 25)
   ("Matrix Metalloproteinase" 19) ("those distinct MMP" 2) ("the key MMP" 2)
   ("a minimal domain MMP" 2) ("matrix metalloproteinase-" 2)
   ("a transmembrane collagenolytic MMP" 2)
   ("stromal matrix metalloproteinase" 2) ("Matrix metalloproteinase (MMP)" 2)
   ("a particular MMP" 2) ("their respective MMP" 2)
   ("smallest matrix metalloproteinase (MMP)" 2)
   ("the most widely expressed MMP" 1) ("the best studied MMP's" 1)
   ("consecutive MMP" 1) ("than one MMP" 1) ("Matrix metalloproteinase" 1)
   ("only total MMP" 1) ("matrix metalloproteinase-(MMP)" 1)
   ("The membrane-associated MMP" 1) ("a mesenchymal MMP" 1)
   ("subsequent MMP" 1) ("spontaneous MMP" 1) ("the primary MMP" 1)
   ("“Matrix Metalloproteinase1”" 1)))
 ("NCIT:C1820"
  (("mitomycin C" 465) ("Mitomycin C" 68) ("mitomycin C (MMC)" 24)
   ("mitomycin C (MMC)" 3) ("mitomycin C-" 2)
   ("the chemotherapeutic mitomycin C" 1)
   ("the mitotic inhibitor mitomycin C" 1)
   ("chemotherapeutic agent mitomycin C" 1) ("mitomycin C" 1)
   ("mitomycin C (MC)" 1) ("the chemotherapeutic agent mitomycin C" 1)
   ("mitomycin-c" 1)))
 ("NCIT:C1834" (("cilengitide" 18) ("Cilengitide" 1)))
 ("NCIT:C1844" (("CCI-779" 106)))
 ("NCIT:C1863"
  (("MS-275" 244) ("MS-275’s" 1) ("pharmacologic inhibitor MS-275" 1)))
 ("NCIT:C1868" (("PTK787" 7))) ("NCIT:C1869" (("valdecoxib" 4)))
 ("NCIT:C1871"
  (("PKI166" 20) ("PKI-166" 3) ("the ATP-competitive EGFR inhibitor PKI166" 2)
   ("the preclinical HER2 inhibitor PKI-166" 1)))
 ("NCIT:C1872"
  (("PKC412" 270) ("midostaurin" 135) ("Midostaurin" 33) ("\"midostaurin\"" 4)
   ("targeted kinase inhibitor PKC412" 3) ("midostaurin molecule" 2)
   ("than midostaurin" 1) ("than PKC412" 1)))
 ("NCIT:C1878" (("NESP" 17) ("darbepoetin alfa" 1)))
 ("NCIT:C1884" (("SU6668" 2)))
 ("NCIT:C1893" (("dolastatins" 1) ("Dolastatins" 1)))
 ("NCIT:C18930" (("peptide MHC complexes" 3)))
 ("NCIT:C19104" (("vAbl" 1) ("V-ABL" 1))) ("NCIT:C19106" (("vsrc" 8)))
 ("NCIT:C19285" (("TNFRs" 5)))
 ("NCIT:C1932"
  (("modifiers" 1057) ("modifier" 740) ("Modifiers" 73) ("modifier (SUMO)" 32)
   ("Modifier" 18) ("potential modifiers" 10) ("Modifier (SUMO)" 8)
   ("modifiers (SUMO)" 6) ("a potential effect modifier" 5)
   ("possible effect modifiers" 4) ("potential genetic modifiers" 4)
   ("repressive chromatin modifiers" 4) ("Potential modifiers" 4)
   ("modifier (SERM)" 4) ("‘modifier’" 3) ("a dramatic modifier" 2)
   ("a nonselective modifier" 2) ("no known EMT transcriptional modifier" 2)
   ("Snail/Slug transcriptional modifiers" 2)
   ("post-translational modifiers" 2)
   ("the main post-translational modifier" 2) ("a potential modifier" 2)
   ("previously identified modifiers" 2) ("potential disease modifiers" 2)
   ("more subtle genetic modifiers" 2) ("MOdifier" 2)
   ("post-transcriptional modifiers" 2)
   ("downstream post-transcriptional modifiers" 2)
   ("significant gender associated modifiers" 2) ("phenotypic modifiers" 2)
   ("possible cancer susceptibility modifiers" 2) ("possible modifiers" 1)
   ("these autosomal genomic modifiers" 1) ("a clinically-relevant modifier" 1)
   ("“modifier”" 1) ("\"modifier\"" 1)
   ("additional repressive chromatin modifiers" 1)
   ("a potential risk modifier" 1) ("at least one modifier" 1)
   ("the stress-inducible alternative splice forms MDM2-ALT1 and MDMX-ALT2 are important modifiers"
    1)
   ("biologic modifiers" 1) ("nongenetic modifiers" 1)
   ("a possible risk modifier" 1) ("possible risk modifiers" 1)
   ("chemical modifiers" 1) ("BRCA1 and BRCA2 carrier-specific modifiers" 1)
   ("the biological modifiers" 1)
   ("a well-established selective estrogen response modifier" 1)
   ("multiple transcriptional and epigenetic modifiers" 1)
   ("many more modifiers" 1) ("the possible modifier" 1)
   ("transcriptional corepressors and chromatin modifiers" 1)
   ("few OvCa risk modifiers" 1) ("a strong effect modifier" 1)
   ("a mild cancer-risk modifier" 1) ("possible upstream modifiers" 1)
   ("disparate genetic modifiers" 1)
   ("a cyclin D1 posttranslational modifier" 1) ("nongenetic risk modifiers" 1)
   ("potential effect modifiers" 1) ("a more plausible genetic modifier" 1)
   ("further genetic modifiers" 1) ("the more proximal modifier" 1)
   ("the predominant modifiers" 1)
   ("the regulatory NF-κB essential modifier" 1)
   ("biologically plausible modifiers" 1)
   ("various transcriptional modifiers" 1) ("a pleiotropic modifier" 1)
   ("a strong modifier" 1) ("a pivotal modifier" 1)
   ("negative posttranslational modifiers" 1) ("a polygenic risk modifier" 1)
   ("the adapter protein NFκB essential modifier (NEMO)" 1)
   ("posttranslational modifiers" 1)))
 ("NCIT:C19384"
  (("admixture" 406) ("admixtures" 18) ("Admixture" 10) ("ADMIXTURE" 6)
   ("ethnic admixture" 4) ("approximately 7% European admixture" 3)
   ("heterogeneous racial admixture" 3) ("intercontinental admixture" 2)
   ("relatively recent genetic admixture" 2)
   ("potential confounders and population admixture" 2)
   ("an ancestral admixture" 1) ("Amerindian admixture" 1)
   ("The Brazilian population admixture" 1) ("ancestry-specific admixture" 1)
   ("than 15% admixture" 1) ("than 20% admixture" 1) ("too much admixture" 1)
   ("minimal African admixture" 1) ("more European admixture" 1)
   ("possible ethnic admixture" 1) ("racial admixture" 1)
   ("possible admixture" 1) ("global admixture" 1)
   ("possible remaining population admixture" 1)))
 ("NCIT:C195" (("mercaptopurine" 15)))
 ("NCIT:C1955" (("vanilloid" 10) ("Vanilloid" 1))) ("NCIT:C196" (("BPDE" 75)))
 ("NCIT:C198"
  (("acetaminophen" 66) ("Acetaminophen" 7)
   ("received no preoperative acetaminophen" 1)))
 ("NCIT:C19801" (("NURF" 46)))
 ("NCIT:C19802"
  (("RSCs" 160) ("RSC" 13) ("rsc" 2) ("sh-SirT1-treated RSCs" 2) ("pRSC" 1)
   ("self-renewal RSCs" 1) ("oxidative stress-treated RSCs" 1)
   ("RV-treated RSCs" 1) ("than group 1 RSCs" 1)))
 ("NCIT:C19808" (("Swi3p" 1)))
 ("NCIT:C19817" (("HSVTK" 29) ("HSV-TK" 7) ("HSV-tk" 2)))
 ("NCIT:C19850" (("TAF30" 2))) ("NCIT:C19856" (("SNR1" 2)))
 ("NCIT:C19862"
  (("OSA" 275) ("severe OSA" 5) ("pediatric OSA" 4) ("radiation-induced OSA" 2)
   ("spontaneous OSA" 2) ("fresh frozen OSA" 1) ("appendicular OSA" 1)
   ("the malignant OSA" 1) ("we first evaluated OSA" 1)))
 ("NCIT:C19863" (("Moira" 1)))
 ("NCIT:C19864"
  (("Mediator complex" 109) ("mediator complex" 52) ("Mediator complexes" 10)
   ("mediator of activation" 6) ("mediator complexes" 5)
   ("the transcriptional mediator complex" 2)
   ("Mediator
 complex"
    2)
   ("a transcriptionally inactive mediator complex" 1)
   ("the transcriptional MEDIATOR complex" 1) ("MEDIATOR complex" 1)
   ("the thyroid hormone receptor-associated proteins/the vitamin D receptor-interacting proteins (TRAP/DRIP) mediator complex"
    1)))
 ("NCIT:C19868" (("Polyhomeotic" 2) ("polyhomeotic" 1)))
 ("NCIT:C19885" (("mSin3" 18)))
 ("NCIT:C200"
  (("-acetylcysteine" 50) ("-acetylcysteine (NAC)" 25) ("N-acetyl-cysteine" 24)
   ("acetylcysteine" 23) ("N-acetyl-cysteine (NAC)" 10)))
 ("NCIT:C20076"
  (("RNA polymerase" 296) ("RdRP" 114) ("RNA polymerases" 89) ("RdRPs" 30)
   ("RNA
polymerase"
    3)
   ("the three well-recognized RNA polymerases" 2) ("viral RNA polymerases" 2)
   ("the influenza A virus RNA polymerase" 1) ("stalled RNA polymerase" 1)
   ("bacterial RNA polymerase" 1)))
 ("NCIT:C20141"
  (("SGCs" 25) ("soluble guanylate cyclase" 16) ("erbB2-expressing SGCs" 1)
   ("incurable SGCs" 1)))
 ("NCIT:C20186" (("CTF" 164) ("CTFs" 30) ("NF-I" 1) ("CTF's" 1)))
 ("NCIT:C202" (("aclarubicin" 14)))
 ("NCIT:C20401"
  (("monoclonal antibody" 9338) ("Monoclonal antibody" 90)
   ("Monoclonal Antibody" 29) ("targeted monoclonal antibody" 10) ("DAKO" 6)
   ("monoclonal antibody (DAKO)" 5)
   ("phospho-specific ( Ser -139) histone H2AX (γ-H2AX) mouse monoclonal antibody"
    4)
   ("monoclonal
                    antibody"
    4)
   ("anti-phospho-p44/42 ERK (Thr202/Tyr204) (197G2) mouse monoclonal antibody"
    4)
   ("α-phosphorylated TDP-43 (409/410–1) mouse monoclonal antibody" 4)
   ("an irrelevant mouse IgG2a monoclonal antibody" 3)
   ("a novel commercially available rabbit monoclonal antibody" 3)
   ("monovalent monoclonal antibody" 3) ("a fully human monoclonal antibody" 3)
   ("a commercial monoclonal antibody" 2)
   ("a representative monoclonal antibody" 2)
   ("the phospho-Histone H2A.X (Ser139) (20E3) rabbit monoclonal antibody" 2)
   ("anti-phospho-(S235/236)S6 ribosomal protein (S235/236) rabbit monoclonal antibody"
    2)
   ("a configuration-specific monoclonal antibody" 2)
   ("rabbit anti-poly (ADP-ribose) polymerase (PARP)-1 (p25) monoclonal antibody"
    2)
   ("anti-MDM2 (N-20) polyclonal antibody (sc-813, Santa Cruz Biotechnology) anti-Cyclin G1 monoclonal antibody"
    2)
   ("biotinylated anti-PCNA monoclonal antibody" 2)
   ("targeted humanized monoclonal antibody" 2)
   ("uses biotinylated anti-MMP monoclonal antibody" 2)
   ("monoclonal antibody (UBI)" 2)
   ("a monoclonal anti-HA monoclonal antibody" 2)
   ("an HER-2/neu-specific monoclonal antibody" 2)
   ("a biotinylated secondary anti-human-IFN- γ monoclonal antibody" 2)
   ("an Armenian hamster monoclonal antibody" 2)
   ("phospho-MAPK-specific mouse monoclonal antibody" 2)
   ("an irrelevant mouse monoclonal antibody" 2)
   ("an agonistic anti-DR5 monoclonal antibody" 2)
   ("the recently developed monoclonal antibody" 2)
   ("an agonistic monoclonal antibody" 2)
   ("CT2 Armenian Hamster monoclonal antibody" 2)
   ("a newly-developed monoclonal antibody" 2)
   ("a chick-specific monoclonal antibody" 2)
   ("a molecularly targeted monoclonal antibody" 2)
   ("Blotto containing anti-FOXO1 rabbit monoclonal antibody" 2)
   ("a fully human IgG1 agonistic monoclonal antibody" 2)
   ("An irrelevant murine IgG1 monoclonal antibody" 2)
   ("a single Fab-armed monoclonal antibody" 2)
   ("the ATM-p monoclonal antibody" 2)
   ("the polyubiquitinated protein-specific monoclonal antibody" 1)
   ("soluble CD4 or VRC01 monoclonal antibody" 1)
   ("The developed monoclonal antibody" 1)
   ("a home-made FGFR-2-IIIb-specific monoclonal antibody" 1)
   ("a matched isotypic monoclonal antibody" 1)
   ("monoclonal
antibody"
    1)
   ("a newly developed rabbit monoclonal antibody" 1)
   ("an irrelevant monoclonal antibody" 1)
   ("monoclonal anti-Flag monoclonal antibody" 1) ("monoclonal Antibody" 1)
   ("Immunohistochemical reagent c-myc monoclonal antibody" 1)
   ("a labeled secondary monoclonal antibody" 1)
   ("a M1-pUb-specific monoclonal antibody" 1) ("monoclonal antibody-" 1)
   ("20ul biotinylated anti-active caspase-3 rabbit monoclonal antibody" 1)
   ("A similarly named monoclonal antibody" 1)
   ("Alexa Fluor 568-conjugated anti-HA mouse monoclonal antibody" 1)
   ("generic mouse monoclonal antibody" 1)
   ("a phospho-STAT5-specific monoclonal antibody" 1)
   ("This sequence-specific pTyr monoclonal antibody" 1)
   ("the well-validated mAb414 monoclonal antibody" 1)
   ("a phospho-JAK2-specific monoclonal antibody" 1)
   ("anti-Akt 1/2 (H-136, Santa Cruz Biotechnology) polyclonal antibodies or anti-actin (Sigma) monoclonal antibody"
    1)
   ("a one-armed monoclonal antibody" 1)
   ("a MET-specific monovalent monoclonal antibody" 1)
   ("a newly-established monoclonal antibody" 1)
   ("a proprietary monoclonal antibody" 1)
   ("a commercially available monoclonal antibody" 1)
   ("than either monoclonal antibody" 1)))
 ("NCIT:C2045" (("MMI270" 6)))
 ("NCIT:C20464"
  (("cytokines" 11770) ("cytokine" 7070) ("Cytokine" 408) ("Cytokines" 215)
   ("cytokine family" 96) ("a pleiotropic cytokine" 39)
   ("a multifunctional cytokine" 36) ("cytokine-" 36)
   ("exogenous cytokines" 15) ("chemotactic cytokines" 11)
   ("an immunoregulatory cytokine" 10) ("immunoregulatory cytokines" 7)
   ("non-T cell-derived cytokines" 7) ("immunomodulatory cytokines" 6)
   ("soluble cytokines" 5) ("cytokine protein" 5) ("neurotoxic cytokines" 5)
   ("Most cytokines" 4) ("a pleiotropic pro-inflammatory cytokine" 4)
   ("an essential cytokine" 4) ("exogenous cytokine" 4)
   ("a pleiotropic inflammatory cytokine" 4) ("immune-suppressive cytokines" 4)
   ("cytokine (KC)" 4) ("an immunomodulatory cytokine" 4)
   ("systemic cytokines" 4) ("most cytokines" 3)
   ("senescence-associated cytokines" 3) ("profibrotic cytokines" 3)
   ("immune-modulatory cytokines" 3)
   ("the most differentially-expressed cytokines" 3)
   ("the principal neutrophil chemotactic cytokine" 3) ("cytokine molecule" 3)
   ("the primary antiviral cytokines" 3)
   ("immunoregulatory and proinflammatory cytokines" 2)
   ("Predominant Th1 cytokines" 2)
   ("a multi-functional pleiotropic cytokine" 2)
   ("a potential STAT3-activating cytokine" 2) ("the respective cytokines" 2)
   ("this latter cytokine" 2) ("a β-chemotactic cytokine" 2)
   ("intracytoplasmic cytokine" 2) ("than cytokines" 2)
   ("a ubiquitously expressed pleiotropic
cytokine"
    2)
   ("the sole supplemental cytokine" 2) ("a pivotal cytokine" 2)
   ("stimulatory cytokines" 2) ("tumor-associated cytokines" 2)
   ("a suppressive cytokine" 2) ("a profibrotic cytokine" 2)
   ("a modulatory cytokine" 2) ("a novel cardioprotective cytokine" 2)
   ("a multifunctional regulatory cytokine" 2) ("osteoinductive cytokines" 2)
   ("the crucial fibrogenic cytokine" 2) ("a potent fibrogenic cytokine" 2)
   ("microenvironmental cytokines" 2) ("a ubiquitous cytokine" 2)
   ("a pleiotropic proinflammatory cytokine" 2) ("CYTOKINE" 2)
   ("an essential proinflammatory cytokine" 2)
   ("differentially-upregulated cytokines" 2) ("the fibrogenic cytokine" 2)
   ("a neurotrophic cytokine" 2) ("most differentially-expressed cytokines" 2)
   ("an inflammation-associated pleiotropic cytokine" 2)
   ("immune modulatory cytokines" 2) ("several neurotoxic cytokines" 2)
   ("a pleiotropic glycoprotein cytokine" 2)
   ("many inflammatory-related cytokines" 2)
   ("carcinogenically-relevant cytokine" 2) ("a heterodimeric cytokine" 2)
   ("respective cytokines" 2) ("important antiviral cytokines" 2)
   ("T H 1-produced cytokines" 2) ("a principal proinflammatory cytokine" 2)
   ("pivotal proinflammatory cytokines" 2)
   ("low molecular weight (8–14 kDa) chemotactic cytokines" 2)
   ("a covalently linked heterodimeric cytokine" 2)
   ("ECM-bound pro-invasive cytokines" 2)
   ("inflammation-associated cytokines" 2) ("a classical cytokine" 2)
   ("angiostatic cytokines" 2) ("a pro-apoptotic cytokine" 2)
   ("the multifunctional potent immunosuppressive cytokines" 2)
   ("infiltrated mononuclear cells not only release inflammatory cytokines" 2)
   ("the main specific granulopoietic cytokine" 2) ("a fibrogenic cytokine" 2)
   ("a soluble cytokine" 2) ("a tumor suppressive cytokine" 2)
   ("nearly twenty secreted NF-κB-regulated cytokines" 2)
   ("multifunctional cytokines" 2)
   ("IFN-alpha increases cerebrospinal fluid (CSF) cytokines" 2)
   ("the neurotoxic TNFα cytokine" 2) ("an antiviral cytokine" 2)
   ("an important pro-fibrogenic cytokine" 2) ("representative cytokines" 2)
   ("the predominant effector cytokine" 2) ("proinflammamtory cytokines" 2)
   ("a classical pro-inflammatory cytokine" 2)
   ("a highly complex biologic cascade-involving cytokines" 2)
   ("a 20-kDa pleiotropic cytokine" 2) ("antiinflammatory cytokines" 2)
   ("other Th2-associated cytokines" 2) ("osteotropic cytokines" 2)
   ("many profibrotic cytokines" 2) ("its associated cytokines" 2)
   ("Non-T cell-derived cytokines" 2) ("the most profibrogenic cytokine" 2)
   ("the essential cytokine" 2)
   ("a well-described immunosuppressive cytokine" 2)
   ("T H 17-related cytokines" 2) ("newly-synthesised cytokines" 2)
   ("the major pro-fibrotic cytokine" 2) ("myeloma-derived cytokines" 2)
   ("gastric mucosal inflammation cytokine" 2) ("osteoclastogenic cytokines" 2)
   ("the major profibrogenic cytokine" 2)
   ("other psoriasis-associated cytokines" 2)
   ("its potential relevant cytokines" 1)
   ("the cytokines secreted by Th17 cells" 1) ("Relevant Th1 cytokines" 1)
   ("Two other chemotactic cytokines" 1)
   ("the archetypal proinflammatory cytokine" 1)
   ("other disease-associated cytokines" 1)
   ("neutrophil-mobilizing cytokines" 1) ("a vasculopathic cytokine" 1)
   ("the immunosuppressive cytokines, which is elevated" 1)
   ("the antiviral cytokine" 1) ("primary antiviral cytokines" 1)
   ("an important immunoregulatory cytokine" 1)
   ("a pleiotropic IL6-like cytokine" 1) ("cognate haematopoietic cytokines" 1)
   ("proinvasive and inflammatory cytokines" 1)
   ("Intestinal Hsp72 overexpression reversed toll-like receptor (TLR)-4-induced cytokines"
    1)
   ("exogenous recombinant cytokines" 1) ("the diverse peritoneal cytokine" 1)
   ("the most potent cytokines capable of initiating and maintaining this process"
    1)
   ("profibrotic and proinflammatory cytokines" 1)
   ("various profibrotic and antifibrotic cytokines" 1)
   ("a potent pleiotropic cytokine" 1) ("a few cytokines" 1)
   ("the most important antiviral cytokines" 1)
   ("two potentially pathogenic cytokines" 1) ("a pluripotent cytokine" 1)
   ("relevant pro-inflammatory cytokines" 1) ("pleiotropic cytokine" 1)
   ("antiviral cytokines" 1) ("suppressive cytokines" 1)
   ("we first compared cytokine" 1) ("most other cytokines" 1)
   ("a multipotent cytokine" 1) ("a stress-responsive cytokine" 1)
   ("the fibrotic cytokines" 1)
   ("AIM-V media not containing any exogenous cytokines" 1)
   ("both chemotactic cytokines" 1)
   ("antifungal interleukin-17 (IL-17) cytokines" 1)
   ("the predominant pro-inflammatory cytokine" 1) ("at least one cytokine" 1)
   ("classical anti-inflammatory cytokine" 1)
   ("an acute proinflammatory cytokine" 1)
   ("the most potent hepatic pro-fibrogenic cytokine" 1)
   ("the chemotactic cytokine" 1)
   ("the quintessential innate immune cytokines" 1)
   ("a strictly NF-κB dependent cytokine" 1) ("this antiviral cytokine" 1)
   ("a strong profibrogenic cytokine" 1)
   ("the prototypic proinflammatory cytokine" 1) ("heterodimeric cytokines" 1)
   ("the lineage-specific cytokine" 1) ("a presumptive cytokine" 1)
   ("soluble recombinant cytokines" 1) ("an antiproliferative cytokine" 1)
   ("inflammation-induced mesothelial cell injury cytokines" 1)
   ("peritoneal inflammation numerous cytokines" 1)
   ("These latter anti-inflammatory cytokines" 1)
   ("a classical T H 1 cytokine" 1) ("a potent profibrotic cytokine" 1)
   ("exogenous human cytokines" 1) ("this pleiotropic cytokine" 1)
   ("the same soluble cytokines" 1) ("than angiostatic cytokines [ xref ]" 1)
   ("Th1-associated cytokines" 1) ("a few other cytokines" 1)
   ("the important inflammatory cytokines secreted by immune-activated monocytes/macrophages"
    1)
   ("a key proinflamatory cytokine" 1) ("probably other cytokines" 1)
   ("short chain helical cytokines" 1) ("intrahepatic cytokines" 1)
   ("even single cytokines" 1) ("a mesenchymal cytokine" 1)
   ("this fibrogenic cytokine" 1) ("atheroma-associated cytokines" 1)
   ("at least eight different cytokines" 1) ("pleiotropic cytokines" 1)
   ("proinflammatory/counter-inflammatory cytokines" 1)
   ("further enhancing cytokine" 1)
   ("detrimental and hepatoprotective cytokines" 1)
   ("hepatoprotective cytokines" 1)
   ("two cytokines known to prime eosinophil’s" 1)
   ("a key pro-fibrotic cytokine" 1) ("this multifunctional cytokine" 1)
   ("prototypic Th1 and Th17 cytokines" 1) ("Th2-associated cytokine" 1)
   ("p53 −/− microglia release significantly less pro-inflammatory cytokines"
    1)
   ("residual cytokines" 1) ("the latter two cytokines" 1)
   ("moderately less proinflammatory cytokines" 1)
   ("a macrophage-derived chemotactic cytokine" 1) ("a chemotactic cytokine" 1)
   ("the principal cytokine" 1) ("immunoregulatory cytokine" 1)
   ("the inductive cytokine" 1) ("cytokine (CLC)" 1) ("“cytokines”" 1)
   ("a representative pro-inflammatory cytokine" 1)
   ("an intermediary cytokine" 1) ("the well-known profibrotic cytokine" 1)
   ("antiviral and proinflammatory cytokines" 1)
   ("various chemotactic cytokines" 1) ("profibrogenic cytokines" 1)
   ("the most relevant cytokine" 1) ("gastric inflammatory cytokines" 1)
   ("non-T cell–derived cytokines" 1) ("an immune-stimulatory cytokine" 1)
   ("senescence associated cytokines" 1) ("psoriasis-related cytokines" 1)
   ("all psoriasis-related cytokines" 1)
   ("multiple senescence-associated cytokines" 1)
   ("IL-17 associated cytokines" 1) ("a biphasic T-helper cytokine" 1)
   ("special cytokines" 1) ("10 osteoclastogenesis-associated cytokines" 1)
   ("several neuroinflammatory cytokines" 1)
   ("the cytokines induced by IL-1β" 1) ("-cytokine" 1)
   ("a secretory cytokine" 1) ("pyrogenic cytokines" 1)
   ("these immunomodulatory cytokines" 1) ("other secondary cytokines" 1)
   ("stromal-derived cytokines" 1) ("cytoprotective cytokines" 1)
   ("stromal-secreted cytokines" 1) ("directional cytokine" 1)
   ("a growth suppressive cytokine" 1) ("even other cytokines" 1)
   ("high-throughput Luminex Multiplex Cytokine" 1)
   ("the predominant cytokine" 1)))
 ("NCIT:C20494"
  (("IFN-α" 932) ("IFNα" 453) ("IFN-alpha" 80) ("IFNA" 32)
   ("interferon alpha" 29) ("IFNα-" 13) ("IFNalpha" 3) ("IFN-α-" 3)
   ("than IFN-α which correlates" 2) ("exogenous IFNα" 2) ("IFN-α–" 2)
   ("Interferon Alpha" 1) ("IFN-α’s" 1) ("than IFN-α" 1) ("yet more IFNα" 1)
   ("Interferon alpha" 1) ("exogenous recombinant human IFN-α" 1)))
 ("NCIT:C20497"
  (("IL" 3940) ("interleukin" 329) ("interleukin (IL)" 134) ("Interleukin" 41)
   ("ILs" 27) ("IL-" 19) ("Il" 16) ("Interleukin (IL)" 14) ("interleukin-" 14)
   ("Interleukin-" 7) ("viral interleukin" 3) ("interleukine" 3)
   ("chemotactic interleukin (IL)" 2) ("interleukin(IL)" 2)
   ("interleukin family" 1) ("interleukin-(IL)" 1) ("ILs-" 1) ("iLS" 1)))
 ("NCIT:C20498" (("lymphokine" 16) ("lymphokines" 12)))
 ("NCIT:C205"
  (("acyclovir" 9) ("outpatient acyclovir" 1)
   ("the antiviral drug acyclovir" 1)))
 ("NCIT:C20514"
  (("IL-12" 1012) ("interleukin-12" 23) ("than IL-12" 2) ("Interleukin-12" 2)
   ("exogenous IL-12" 2)
   ("Th1-type T cell responses need inflammatory IL-12" 2)
   ("proinflammatory IL-12" 2)
   ("PEMs overexpressing HDAC11 produced more IL-12" 1) ("IL-12-" 1)))
 ("NCIT:C20519" (("interleukin-17" 17) ("Interleukin-17" 2)))
 ("NCIT:C20586" (("colony-stimulating-factor" 6)))
 ("NCIT:C20593" (("TFIIH" 122) ("functional TFIIH" 1)))
 ("NCIT:C20693"
  (("cytokeratin" 460) ("cytokeratins" 266) ("Cytokeratin" 47)
   ("cytokeratin (CK)" 8) ("Cytokeratins" 6) ("cytokeratins (CK)" 3)
   ("cytokeratin (HMWCK)" 3) ("more luminal cytokeratins" 2)
   ("triple immunostaining comprised cytokeratin" 2)
   ("only “luminal” cytokeratins" 2) ("cytokeratin peptide" 2)
   ("Cytokeratin (CK)" 1)))
 ("NCIT:C20694"
  (("intermediate filament protein" 65) ("IFP" 38)
   ("the most widely expressed intermediate filament protein" 2)
   ("the predominant intermediate filament protein" 2)
   ("a well-characterized intermediate filament protein" 2)
   ("the major intermediate filament protein" 2)
   ("a major intermediate filament protein" 1)
   ("internexin neuronal intermediate filament protein" 1)
   ("The only other intermediate filament protein" 1)))
 ("NCIT:C2095"
  (("Lopinavir" 37) ("lopinavir" 13) ("than standard Lopinavir" 3)
   ("than lopinavir" 2) ("the previously available standard drug Lopinavir" 2)
   ("than the standard Lopinavir" 2) ("lopinavir (LPV)" 1)
   ("than Lopinavir [ xref ]" 1)
   ("than the previously available standard drug Lopinavir [ xref ]" 1)
   ("Lopinavir drug" 1)))
 ("NCIT:C20959" (("cyclinE2" 12)))
 ("NCIT:C2097"
  (("hTERC" 123) ("telomerase RNA component" 34)
   ("telomerase RNA component (TERC)" 4) ("telomerase RNA component (TER)" 2)))
 ("NCIT:C20972"
  (("autoantigen" 79) ("autoantigens" 55) ("Autoantigen" 3)
   ("a peripheral Golgi membrane-associated autoantigen" 1)
   ("dense fine speckled autoantigen" 1) ("autoantigens (CREST)" 1)
   ("potential autoantigens" 1) ("aberrantly expressed autoantigens" 1)))
 ("NCIT:C2108" (("ImmunoCyt" 4)))
 ("NCIT:C21183"
  (("nucleoporins" 117) ("nucleoporin" 79) ("Nucleoporin" 9)
   ("nucleoporin protein" 6) ("roughly 30 distinct nucleoporins" 3)
   ("Nucleoporins" 3) ("key nucleoporins" 1)))
 ("NCIT:C212" (("adrenocorticotropin" 5)))
 ("NCIT:C2139" (("immunostimulants" 2) ("nonspecific immunostimulants" 1)))
 ("NCIT:C21483" (("DNAPK" 25) ("XRCC7" 1)))
 ("NCIT:C2165"
  (("Mbo" 15) ("mixed-backbone oligonucleotide" 8)
   ("Mixed-backbone oligonucleotide" 2)))
 ("NCIT:C2188" (("alkylphosphocholine" 3)))
 ("NCIT:C2191"
  (("siRNA" 62274) ("siRNAs" 12717) ("small interfering RNA" 2057)
   ("small interfering RNAs" 523) ("Small interfering RNA" 444) ("SiRNA" 431)
   ("Small Interfering RNA" 169) ("siRNA-" 123) ("-siRNA" 116)
   ("Small interfering RNAs" 108) ("nonspecific siRNA" 62) ("SiRNAs" 57)
   ("targeted siRNA" 44) ("Small Interfering RNAs" 38)
   ("a nonspecific siRNA" 22) ("targeted siRNAs" 17)
   ("the respective siRNAs" 16) ("their respective siRNAs" 15) ("si-RNAs" 14)
   ("nonspecific control siRNA" 13) ("siRNA (QIAGEN)" 13)
   ("irrelevant siRNA" 11) ("siRNA (NC)" 11) ("Nonspecific siRNA" 10)
   ("siRNA–" 9) ("A nonspecific control siRNA" 8) ("their respective siRNA" 8)
   ("commercially available siRNA" 7) ("duplex siRNAs" 7)
   ("control nonspecific siRNA" 7) ("two or more siRNAs" 6)
   ("respective siRNA" 6) ("at least two siRNAs" 6) ("siRNA (NT)" 6)
   ("the respective siRNA" 6) ("Si-RNAs" 6) ("siRNA molecule" 6)
   ("targeting siRNA" 5) ("we first used siRNA" 5) ("targeting siRNAs" 5)
   ("a commercial siRNA" 5) ("a nonspecific control siRNA" 5) ("QIAGEN" 5)
   ("100 nM nonspecific control siRNA" 4) ("AllStar negative control siRNA" 4)
   ("duplex siRNA" 4) ("an irrelevant siRNA" 4) ("the nonspecific siRNA" 4)
   ("employed siRNA" 4) ("-siRNAs" 4) ("universal control siRNA" 4)
   ("Duplex siRNAs" 4) ("2 or more siRNAs" 4) ("a fluorescent siRNA" 4)
   ("targeting SMARTpool-designed siRNA" 4) ("the irrelevant siRNA" 3)
   ("two pre-validated siRNAs" 3) ("the nonspecific control siRNA" 3)
   ("at least two different siRNAs" 3) ("The universal control siRNA" 3)
   ("-small interfering RNA" 3) ("sequence-specific siRNAs" 3)
   ("each respective siRNA" 3) ("a control duplex siRNA" 3)
   ("four duplex siRNAs" 3) ("siRNA (GGACGAGGACTATTACAAA)" 3)
   ("siRNA (SCRAM)" 3) ("Silencer-validated small interfering RNA" 3)
   ("unspecific control siRNA" 3) ("the relevant siRNA" 3)
   ("A 21-nucleotide duplex siRNA" 3) ("the optimal siRNA" 3)
   ("Commercial STAT3 siRNA" 3)
   ("hnRNP K SMARTpool multiplex or scrambled control siRNA" 3)
   ("previously validated siRNAs" 3) ("using lentiviral mediated siRNA" 2)
   ("the custom-made siRNA" 2) ("–siRNA" 2) ("genome-wide siRNA" 2)
   ("nonspecific control (NC) siRNA" 2) ("A nonspecific non-silencing siRNA" 2)
   ("4 target-special 19–25 nt siRNAs" 2)
   ("commercially available HDAC1 siRNA" 2)
   ("genome-wide small interfering RNA" 2) ("previously described siRNAs" 2)
   ("4 sequence-specific siRNAs" 2)
   ("non-silencing/sequence-scrambled control siRNA" 2) ("mature siRNA" 2)
   ("a previously characterized siRNA" 2) ("the relevant siRNAs" 2)
   ("siRNA ( GGAACAAUCAUGUGAGGAA )" 2) ("Specific BARD1 fluorescent siRNA" 2)
   ("the nonspecific (scrambled) control siRNA" 2)
   ("Allstar negative control siRNA" 2) ("Non-targeted control siRNA" 2)
   ("the Alexa Fluor 488-labelled control siRNA" 2)
   ("lentiviral vector-mediated MMP-7 siRNA" 2) ("the pre-designed siRNA" 2)
   ("siRNA (SCX)" 2) ("systemic siRNA" 2) ("gefitinib treated NT siRNA" 2)
   ("an irrelevant control siRNA" 2) ("commercially available control siRNA" 2)
   ("previously validated small interfering RNA" 2)
   ("at least two different RPS6KB1 siRNAs" 2) ("The E2-E10-specific siRNA" 2)
   ("more siRNAs" 2) ("Only 1 siRNA" 2) ("A nonspecific scrambled siRNA" 2)
   ("more siRNA" 2) ("the previously described siRNA" 2)
   ("the mock and scrambled siRNA" 2) ("using pre-made siRNA" 2)
   ("approximately 90% using NAMPT siRNA" 2) ("a control nonspecific siRNA" 2)
   ("negative universal control siRNA" 2)
   ("universal control small interfering RNA" 2)
   ("at least two independent siRNAs" 2) ("multiple unique siRNAs" 2)
   ("a previously validated siRNA" 2) ("nonspecific (NS)-siRNA" 2)
   ("control (CON)-siRNA" 2) ("a custom made siRNA" 2)
   ("A universal non-targeting siRNA" 2) ("siRNA ( GGAGACUGUUGGAAGCGAAGU )" 2)
   ("a previously reported siRNA" 2) ("siRNA (NS)" 2)
   ("targeted C-Raf siRNA" 2) ("siRNA's" 2) ("siRNA µ" 2)
   ("a previously published siRNA" 2) ("a fluorescent control siRNA" 2)
   ("MWG" 2) ("siRNA (MWG)" 2) ("ON-TARGETplus Duplex siRNA" 2)
   ("ARD1 ON-TARGETplus SMARTpool duplex siRNAs" 2) ("siRNA (NSC)" 2)
   ("a Silencer-validated Rad9 siRNA" 2) ("siRNA (GAACATGGCTGACCTCATATT)" 2)
   ("their cognate mutated siRNAs" 2) ("mutated siRNA" 2)
   ("simultaneous siRNA" 2)
   ("either Reptin or Pontin sequence-specific siRNA" 2)
   ("Reptin sequence-specific siRNA" 2) ("nonspecific control siRNAs" 2)
   ("The following duplex siRNAs" 2) ("two or more independent siRNAs" 2)
   ("multiplex siRNA" 2) ("Hsp27 II siRNA" 2) ("nonfunctional siRNA" 2)
   ("at least 1 siRNA" 2) ("either nonspecific siRNA" 2) ("than siRNA" 2)
   ("dual-targeting siRNA" 2) ("lentiviral vector-mediated siRNA" 2)
   ("an essentially non-functional PML siRNA" 2) ("A nonspecific siRNA" 2)
   ("66.7 nM duplex siRNA" 2) ("exogenous siRNAs" 2) ("an alternate siRNA" 2)
   ("Non-silencing control (NS) siRNA" 2) ("control (NTC) siRNA" 2)
   ("nonspecific GAPD control siRNA" 2) ("Non-specific siRNA" 2)
   ("100 nM nonspecific siRNA" 2) ("a commercially available human siRNA" 2)
   ("a previously described siRNA" 2) ("the previously used siRNAs" 2)
   ("Custom made ER small interfering RNA" 2)
   ("trilencer-27 universal scrambled negative control siRNA" 2)
   ("small
interfering RNA"
    2)
   ("IGF-IRspecific siRNAs" 2) ("two-independent siRNAs" 2)
   ("a previously reported siRNA (GAAGGAGAUAACCUAUUGA)" 2) ("siRNA (SC)" 2)
   ("two validated commercially available FGFR4-specific siRNAs" 2)
   ("two separate siRNAs" 2) ("control Luciferase GL2 Duplex siRNA" 2)
   ("2,168 unique siRNAs" 2) ("Lentiviral mediated siRNA" 1)
   ("a luciferase GL2 duplex siRNA" 1) ("Meanwhile, LKB1 siRNA" 1)
   ("In contrast, LKB1 siRNA" 1) ("these genome-wide siRNA" 1)
   ("recent genome-wide siRNA" 1) ("two separate siRNA" 1)
   ("Commercially available STAT3 siRNA" 1)
   ("At least two individual siRNAs" 1) ("3 target-special 19–25 nt siRNAs" 1)
   ("control (NC) siRNA" 1) ("An irrelevant siRNA" 1)
   ("Lpd ON-TARGETplus siRNA's" 1) ("nonspecific siRNA (NSC)" 1)
   ("We first transfected three different siRNA" 1)
   ("-OMe–modified immunostimulatory siRNA" 1) ("than single siRNA" 1)
   ("than control nontargeting siRNA (N)" 1)
   ("soluble double-stranded siRNAs" 1) ("All siRNA's" 1)
   ("our two most efficacious siRNAs" 1)
   ("these two siRNAs resulted in significantly reduced basal levels of ERIC RNA"
    1)
   ("Stealth-modified 25-bp duplex siRNAs" 1)
   ("siRNA ( GAACAAGAGACCCUGGUUA )" 1) ("yet not Control siRNA" 1)
   ("the two siRNAs specific for independent sites" 1) ("Syndecan-1 siRNA’s" 1)
   ("The following nonspecific siRNAs" 1) ("than a specific siRNA" 1)
   ("only Smad2/3 siRNA" 1) ("two further FGFR4 siRNA" 1)
   ("using two further FGFR4 siRNA" 1) ("fluorescent labeled siRNA" 1)
   ("three separate siRNAs" 1) ("The genome-wide siRNA" 1)
   ("the previously used siRNA" 1) ("four unique siRNAs" 1) ("siRNA (NEB)" 1)
   ("an unspecific control siRNA" 1) ("control (CTR) siRNAs" 1)
   ("whose siRNAs" 1) ("finally cyclin D1 siRNA" 1)
   ("Commercial NON-TARGET small interfering RNA" 1) ("using 100 nM siRNA" 1)
   ("using COX-2-specific siRNA" 1) ("at least 21 siRNAs" 1)
   ("adequate 1 nM siRNA" 1) ("exogenous siRNA" 1)
   ("their respective sequence-scrambled siRNA" 1)
   ("a nonspecific targeting (Scr) siRNA" 1) ("Nonspecific control siRNA" 1)
   ("The Trilencer-27 Universal Scrambled Negative Control siRNA" 1)
   ("fusion-specific siRNA" 1) ("The control nonspecific siRNA" 1)
   ("than ERK1 siRNA" 1) ("the custom made siRNA" 1) ("siRNa" 1)
   ("only RB and p53 siRNA" 1) ("each gene target at least two siRNA" 1)
   ("than a single siRNA" 1) ("transcript-specific siRNAs" 1)
   ("at least 2 different siRNAs" 1) ("Comparative siRNA" 1)
   ("Alexa Fluor 488-labeled negative control siRNA" 1)
   ("Scrambled duplex siRNAs" 1) ("commercially available HPV16 E6 siRNA" 1)
   ("two sequence-specific siRNAs" 1) ("siRNA (GGUCCGGCUCCCCCAAAUG)" 1)
   ("than negative control siRNA (Fig. xref )" 1)
   ("their respective specific siRNAs" 1) ("At least 2 different siRNAs" 1)
   ("targeted HIF-1α siRNA" 1) ("targeting ATXN10 siRNA" 1)
   ("particularly 24 nt long siRNAs" 1) ("than other siRNAs" 1)
   ("than other siRNAs (Figure xref )" 1)
   ("we first introduced three siRNAs" 1) ("than ERK siRNA(s)" 1)
   ("a pre-validated commercial Rea siRNA" 1)
   ("A nonspecific scramble siRNA" 1)
   ("the computer-identified multicellular siRNA" 1)
   ("we first screened various siRNAs" 1) ("control (CTL) siRNA" 1)
   ("two more siRNA" 1) ("well-established siRNA" 1)
   ("PHD3-depletion well-characterized siRNA" 1)
   ("EGFR-L858R-specific siRNA" 1) ("the EGFR-L858R–specific siRNAs" 1)
   ("a previously validated second siRNA" 1) ("the GFP siRNA's" 1) ("siRNAS" 1)
   ("nonspecific (ns) siRNA" 1) ("Negative unspecific siRNA" 1)
   ("possible siRNA" 1) ("Custom-made validated siRNAs" 1) ("than siRNAs" 1)
   ("alternate Pin1 siRNAs" 1) ("a control lentiviral siRNA" 1)
   ("than IKKβ siRNA" 1) ("SiRNA-" 1)
   ("the siRNAs resulted in a comparable reduction in protein levels in U251MG cells ( xref )"
    1)
   ("Non-specific (Scramble) siRNA" 1) ("we first used PALB2 siRNA" 1)
   ("the latter siRNA" 1) ("only cdc6 siRNA" 1) ("just cdc6 or cdt1 siRNA" 1)
   ("irrelevant control siRNA" 1) ("potential siRNA" 1)
   ("nonspecific siRNA (NC)" 1) ("only ErbB-2 specific siRNA" 1)
   ("universal negative control (UNC) siRNA" 1)
   ("siSTABLE Non-Targeting siRNA" 1) ("quickly escape siRNAs" 1)
   ("seven unique anti-HSV-2 siRNAs" 1) ("nonspecific scrambled siRNA" 1)
   ("Non-specific scrambled siRNA" 1) ("using fluorescent control siRNA" 1)
   ("an Alexa-488-labeled control siRNA" 1) ("the siRNA's" 1)
   ("commercially available siRNAs" 1)
   ("the universal negative control siRNA" 1) ("using two available siRNA" 1)
   ("GL-3–targeted siRNA" 1) ("MMC damaged non-target siRNA" 1)
   ("MMC treated Nt siRNA" 1) ("a nonspecific scrambled siRNA" 1)
   ("subsequent assays 75 nM siRNA" 1) ("than synthesized siRNA [ xref ]" 1)
   ("respective Si-RNAs" 1) ("Pre designad SMARTpool siRNA's" 1)
   ("Two separate siRNAs" 1) ("commercial siRNA" 1)
   ("small interfering RNA’s" 1) ("than the Rictor siRNA" 1)
   ("a dominant-negative p38 MAPK mutant or p38 MAPK siRNA" 1)
   ("A commercially available siRNA" 1)
   ("The cofilin-1 specific duplex siRNAs" 1) ("than Tiam1 siRNAs" 1)
   ("than p300 siRNA" 1) ("Non-targeting siRNA" 1) ("the fluorescent siRNA" 1)
   ("The universal negative siRNA" 1) ("a universal negative siRNA" 1)
   ("3 individual siRNA’s" 1) ("Allstar Negative Control siRNA" 1)
   ("a duplex siRNA" 1) ("the commercially available caveolin-1 siRNA" 1)
   ("Both the commercially available siRNA" 1)
   ("a commercially available siRNA" 1) ("2 commercially available siRNAs" 1)
   ("two unique commercially available siRNAs" 1)
   ("non-coding sequence siRNA" 1) ("previously published siRNA" 1)
   ("an irrelevant (green fluorescent protein-specific) control siRNA" 1)
   ("pooled targeted siRNA’s" 1) ("Scrambled siRNA’s" 1)
   ("their control-scrambled siRNA" 1) ("using both the siRNA" 1)
   ("nonspecific control pooled siRNAs" 1)
   ("siGENOME SMARTpool duplex siRNA" 1) ("the irrelevant control siRNA" 1)
   ("the four constituent siRNAs" 1) ("dual siRNAs" 1) ("siRNA’s" 1)
   ("only RSK2 specific siRNA" 1) ("The nonspecific siRNAs (NS)" 1)
   ("at least 2 siRNAs" 1) ("than siRNA 2 ( xref )" 1) ("than c-Jun siRNA" 1)
   ("oligo duplex siRNA" 1)
   ("universal negative (nonspecific) control siRNA" 1)
   ("nonspecific (NS) control siRNA" 1) ("Previously published siRNA" 1)
   ("two unique siRNAs" 1) ("respectively miR-130a and c-Jun siRNA" 1)
   ("two recent comprehensive and independent siRNA" 1) ("adenoviral siRNA" 1)
   ("using adenoviral CCN2 siRNA" 1)
   ("PAGE-purified 21-nucleotide-long siRNAs" 1)
   ("A scrambled nonspecific siRNA" 1) ("more standard siRNA" 1)
   ("than control siRNA ( xref )" 1)
   ("the respective scrambled non-silencing control siRNA" 1)
   ("control (CTL) SiRNA" 1) ("The control irrelevant siRNA" 1)
   ("A genome-wide siRNA" 1) ("each individual siRNA’s" 1)
   ("Two or more siRNAs" 1)
   ("a human siGenome library containing 21,215 siRNA" 1)
   ("a non-targeting random sequence-inserted siRNA" 1)
   ("Indeed all 4 siRNAs" 1) ("at least 2 individual siRNAs" 1)
   ("at least one siRNA" 1)
   ("than Mirk siRNA alone in all three lines ( xref )" 1)
   ("OV2008, OVCAR5 or OVCAR8 treated with/without Mirk siRNA" 1)
   ("showed at least two different siRNA" 1)
   ("had at least two different siRNA" 1) ("Artificial synthetic siRNAs" 1)
   ("SiRNas" 1) ("low-density GCs negative universal control siRNA" 1)
   ("control (NS) siRNA" 1) ("using two sequence-specific siRNAs" 1)
   ("each comprising four proprietary siRNA" 1)
   ("an AR Exon 1-targeted siRNA" 1) ("an AR Exon 7-targeted siRNA" 1)
   ("the strong scoring Ambion siRNAs" 1)
   ("our strong scoring Dharmacon siRNAs" 1) ("Strong siRNAs" 1)
   ("IGF1R sequence-specific siRNAs" 1) ("the respective specific siRNAs" 1)
   ("a universal negative control siRNA" 1) ("Smart pool duplex siRNA" 1)
   ("A PML-IV-specific siRNA" 1) ("At least two different siRNAs" 1)
   ("whereby 40 nM siRNA" 1) ("20 p moles/ml control siRNA" 1)
   ("a fluorescent-tagged control siRNA" 1)
   ("control scrambled nonspecific siRNA" 1)
   ("Commercially available mouse BLM siRNA" 1) ("A commercial siRNA" 1)
   ("the control nonspecific siRNA" 1)
   ("A commercial (Applied Biosystems) siRNA" 1) ("scrambled siRNA’s" 1)
   ("only Sp3 siRNA" 1)
   ("human E2F1 or trilencer-27 universal scrambled negative control siRNA" 1)
   ("Approximately 50 nM HBx/CyclinD1 siRNA" 1) ("pLKO/non-targeting siRNA" 1)
   ("2 separate siRNA" 1) ("four SMART selection-designed siRNAs" 1)
   ("Pg-treated Cdh1 siRNA" 1) ("both mock and scrambled (Scr) siRNA" 1)
   ("than WNT10A siRNA ( xref )" 1) ("Commercially available siRNAs" 1)
   ("LPS treated NS siRNA" 1) ("nonspecific (NS) siRNA" 1) ("“LSP1-siRNA”" 1)
   ("“NT-siRNA”" 1) ("a chemically-synthesized siRNA" 1)
   ("p65/RelA-specific siRNA" 1) ("their respective control siRNAs" 1)
   ("pSuper-based siRNA" 1) ("fluorescently labelled nonspecific siRNA" 1)
   ("other genome-wide siRNA" 1) ("siRNA (GAAGGAGAUAACCUAUUGA)" 1)
   ("universal nontargeting siRNA" 1) ("the 2 sequence‐independent siRNAs" 1)
   ("the control-negative siRNA" 1) ("all treated siRNA" 1)
   ("a pre-validated siRNA" 1) ("Three separate 21-nucleotide siRNA" 1)))
 ("NCIT:C222"
  (("sulfonate" 38) ("sulfonate (MMS)" 18) ("sulfonate (EMS)" 3)
   ("sulfonate (PFOS)" 2) ("Sulfonate" 1) ("sulfonate (CHAPS)" 1)))
 ("NCIT:C2220"
  (("interferon-alpha" 13) ("Interferon-alpha" 4)
   ("than interferon-alpha [ xref ]" 1)))
 ("NCIT:C223"
  (("alkylating agents" 566) ("alkylating agent" 283) ("-alkylating agents" 30)
   ("alkylator" 26) ("alkylators" 21) ("Alkylating agents" 18)
   ("chemotherapeutic alkylating agents" 5)
   ("chemotherapeutic O  6 -alkylating agents" 3)
   ("The chemotherapeutic O  6 -alkylating agents" 2)
   ("dietary alkylating agents" 2)
   ("ubiquitous and environmental alkylating agents" 2)
   ("a monofunctional alkylating agent" 2)
   ("a chemotherapeutic alkylating agent" 2) ("than the alkylating agent" 1)
   ("brain-permeable alkylating agent" 1)
   ("the bifunctional alkylating agents" 1) ("one or more alkylating agents" 1)
   ("Alkylator" 1) ("currently used alkylating agents" 1) ("non-alkylator" 1)
   ("strong alkylating agents" 1)))
 ("NCIT:C224" (("allopurinol" 49)))
 ("NCIT:C2246" (("Tariquidar" 5) ("tariquidar" 4) ("XR9576" 2)))
 ("NCIT:C225" (("α-interferon" 1)))
 ("NCIT:C226" (("difluoromethylornithine" 2) ("eflornithine" 1)))
 ("NCIT:C2265"
  (("DHEA" 348) ("DHEA-" 6) ("Dietary DHEA" 2) ("the adrenal androgen DHEA" 2)
   ("adrenal derived DHEA" 2) ("dietary DHEA" 1)
   ("the weak adrenal androgens DHEA" 1)))
 ("NCIT:C2273"
  (("gonadotrophins" 14) ("gonadotrophin" 8) ("Gonadotrophin" 2)
   ("recombinant human pituitary gonadotrophins" 2)
   ("more exogenous gonadotrophins" 1)
   ("pregnant mare serum gonadotropin and human chorionic gonadotrophin" 1)
   ("Key regulatory gonadotrophins" 1)))
 ("NCIT:C2276" (("inhibin" 50) ("Inhibin" 17)))
 ("NCIT:C2280"
  (("TSH" 264) ("thyroid stimulating hormone" 5) ("tsh" 1)
   ("Thyroid stimulating hormone" 1)))
 ("NCIT:C2284" (("thymosins" 3))) ("NCIT:C2300" (("androstenedione" 83)))
 ("NCIT:C2327" (("niacinamide" 2)))
 ("NCIT:C235" (("aminopterin" 15) ("Aminopterin" 4)))
 ("NCIT:C236" (("amiodarone" 44) ("Amiodarone" 10)))
 ("NCIT:C2363" (("aminoglycoside antibiotic" 5) ("aminoglycosides" 4)))
 ("NCIT:C238" (("Ambs" 5))) ("NCIT:C2386" (("gp100" 12) ("GP100" 2)))
 ("NCIT:C239"
  (("ampicillin" 356) ("Ampicillin" 8) ("-ampicillin" 2)
   ("completely awake, and oral ampicillin" 1)))
 ("NCIT:C240" (("amsacrine" 23)))
 ("NCIT:C242"
  (("anti-androgen" 207) ("Anti-androgen" 6) ("a more recent anti-androgen" 2)
   ("the clinically more relevant anti-androgen" 1)))
 ("NCIT:C2453" (("erb-38" 9) ("erb-38 molecule" 2)))
 ("NCIT:C2471" (("Ad-p53" 20)))
 ("NCIT:C2478"
  (("dinitrophenyl" 16) ("Dinitrophenyl" 2) ("dinitrophenyl (DNP)" 1)))
 ("NCIT:C2513" (("LMB-2" 6))) ("NCIT:C25186" (("HDLs" 3)))
 ("NCIT:C25187"
  (("LDL" 1053) ("low density lipoprotein" 45) ("LDLs" 18)
   ("low-density-lipoprotein" 7) ("LDL-" 5) ("Low density lipoprotein" 5)
   ("low density lipoprotein (LDL)" 3) ("LDL protein" 3)
   ("Fluorescently-labeled LDL" 2) ("proatherogenic oxidized LDLs" 2)
   ("proatherogenic LDLs" 2) ("low density lipoprotein (LRP)" 2) ("“LDL”" 1)
   ("atherogenic LDL" 1) ("than oxidized LDL (7.95±0.60 μ M )" 1)
   ("Commercial LDL" 1) ("than native LDL" 1) ("minimally-oxidized LDL" 1)
   ("Low Density Lipoprotein" 1)))
 ("NCIT:C25202" (("SGOT" 5)))
 ("NCIT:C25278"
  (("fluid" 1821) ("fluids" 361) ("BALF" 63) ("Fluid" 45)
   ("cerebrospinal fluid" 34) ("synovial fluid" 31) ("amniotic fluid" 24)
   ("cerebrospinal fluid (CSF)" 23) ("bronchoalveolar lavage fluid" 19)
   ("fluid (BALF)" 17) ("pleural fluid" 16) ("biological fluids" 16)
   ("peritoneal fluid" 13) ("the cerebrospinal fluid" 12)
   ("the synovial fluid" 11) ("the axillary fluid" 11)
   ("the amniotic fluid" 10) ("bronchoalveolar lavage (BAL) fluid" 9)
   ("ascitic fluid" 6) ("the pleural fluid" 6) ("fluid (NAF)" 6)
   ("bronchoalveolar lavage fluid (BALF)" 5) ("the peritoneal fluid" 5)
   ("interstitial fluid" 5) ("fluids (BALF)" 5)
   ("Ready-Safe scintillation fluid" 4) ("artificial cerebrospinal fluid" 4)
   ("the cerebral spinal fluid (CSF)" 4) ("mucosal fluid" 4)
   ("seminal fluid" 4) ("seminal vesicle fluid" 4) ("RA synovial fluid" 4)
   ("the vitreous fluids" 4) ("vitreous fluids" 4)
   ("Artificial Cerebrospinal Fluid" 4) ("intravenous fluids" 3)
   ("pleural fluids" 3) ("Cerebrospinal fluid" 3) ("human seminal fluid" 3)
   ("intestinal fluid" 3) ("bronchioalveolar lavage fluid (BALF)" 3)
   ("Peritoneal fluid" 3) ("the pleural fluids" 3)
   ("the cerebrospinal fluid (CSF)" 3) ("the gingival crevicular fluid" 3)
   ("pulmonary edema fluid" 3) ("gingival crevicular fluid" 3)
   ("fluid (CSF)" 3) ("human amniotic fluid" 3) ("synovial fluid (SF)" 3)
   ("arthritic synovial fluid" 2) ("all human pleural fluids" 2)
   ("intraperitoneal fluid" 2) ("synovial fluids" 2) ("biologic fluids" 2)
   ("fluid (NLF)" 2) ("the bronchoalveolar lavage fluid (BALF)" 2)
   ("the ascitic fluid" 2)
   ("anti-c-Myc clone 9E10 mouse monoclonal ascites fluid" 2)
   ("The human pleural fluids" 2) ("other biological fluids" 2)
   ("peritoneal lavage fluid" 2) ("sucrose-artificial cerebrospinal fluid" 2)
   ("pPROM amniotic fluid" 2) ("amniotic fluid (AF)" 2) ("alveolar fluid" 2)
   ("ascetic fluid" 2) ("the cerebral spinal fluid" 2)
   ("the peritoneal tumour fluid" 2) ("most pathophysiological fluids" 2)
   ("bronchoalveolar lavage fluids" 2) ("the lymphatic fluid" 2)
   ("lymphatic fluid" 2) ("their lymphatic fluid" 2) ("duodenal fluid" 2)
   ("ovarian peritoneal fluid" 2) ("unfractioned biological fluids" 2)
   ("Synovial fluid (SF)" 2) ("fetal lung fluid" 2)
   ("the pseudocoelomic fluid" 2) ("cerebral spinal fluid" 2)
   ("cystic fluid" 2) ("their cerebrospinal fluids" 2) ("Interstitial fluid" 2)
   ("intravascular fluids" 2) ("osteoarthritic synovial fluids" 2)
   ("peritoneal ascitic fluid" 2) ("the tumor interstitial fluid (TIF)" 2)
   ("the bronchoalveolar lavages (BAL) fluid" 2)
   ("bronchoalveolar lavage (BAL) fluids" 2) ("ductal fluid" 2)
   ("Artificial cerebrospinal fluid" 2)
   ("monoclonal anti-α-tubulin clone B-5-1-2 mouse ascites fluid" 2)
   ("pleural and cerebrospinal fluids" 2) ("hydrosalpingeal fluid" 2)
   ("the broncheoalveolar lavage fluid (BALF)" 2) ("uterine fluid" 2)
   ("fluids (HWF)" 2) ("The human amniotic fluid" 2)
   ("the artificial cerebral spinal fluid" 2)
   ("subsequently obtained bronchoalveolar lavage (BAL) fluid" 1)
   ("human pleural fluid" 1) ("273 pleural fluid" 1) ("human pleural fluids" 1)
   ("the uterine fluid" 1)
   ("sucrose substituted artificial cerebrospinal fluid (ACSF)" 1)
   ("broncholaveolar lavage fluid" 1) ("ascitic fluids" 1)
   ("OA synovial fluid" 1) ("laminar fluid" 1)
   ("Bronchoalveolar lavage (BAL) fluids" 1)
   ("gingival crevicular fluid (GCF)" 1) ("subretinal fluid" 1)
   ("Seminal vesicle fluid" 1) ("native peritoneal fluid" 1)
   ("Allantoic fluid" 1) ("PARP activation—in cerebrospinal fluid (CSF)" 1)
   ("intraocular fluid" 1)
   ("typically (although not always) interstitial fluid" 1)
   ("interstitial fluids" 1) ("this amniotic fluid" 1) ("a Newtonian fluid" 1)
   ("32 pleural fluid" 1) ("pancreatic cystic fluid" 1)
   ("the peritoneal lavage fluid" 1) ("amniotic fluids" 1)
   ("The gingival crevicular fluids" 1) ("tracheal lavage fluid" 1)
   ("peritoneal dialysis fluids" 1) ("viral fluid" 1)
   ("Bronchoalveolar lavage (BAL) fluid" 1) ("the residual fluid" 1)
   ("bronchiolar fluids" 1) ("the gingival crevicular fluid (GCF)" 1)
   ("the daily intake fluids" 1) ("bronchoalveolar fluids" 1)
   ("peritoneal or ascitic fluid" 1) ("a viscous fluid (PDMS)" 1)
   ("other mucosal fluids" 1) ("mucosal fluids" 1) ("Pleural fluid" 1)
   ("various biological fluids" 1) ("an ideal biological fluid" 1)
   ("several pathophysiological fluids" 1)
   ("Vascular endothelial cells (ECs) constantly experience fluid" 1)
   ("the axillary drainage fluid" 1) ("The axillary fluid" 1)
   ("their axillary fluid" 1) ("the lymphatic fluids" 1)
   ("The collected axillary fluids" 1) ("axillary lymphatic fluid" 1)
   ("the axillary fluids" 1) ("the pulmonary edema fluid" 1)
   ("Cerebrospinal Fluid (CSF)" 1) ("cystic fluids" 1) ("spinal fluid" 1)
   ("the bronchioalveolar lavage fluid" 1) ("Bronchoalveolar lavage fluid" 1)
   ("bronchoalveolar fluid" 1) ("cystic and ascitic fluids" 1)
   ("ACS II scintillation fluid" 1) ("two immiscible fluids" 1)
   ("5 ml aqueous scintillation fluid" 1) ("The recovered peritoneal fluid" 1)
   ("267 amniotic fluid" 1) ("This honey bee-excreted biological fluid" 1)
   ("clone Dm1a mouse monoclonal ascites fluid" 1)
   ("collagenase-treated bone marrow fluid" 1) ("circulatory fluid" 1)
   ("the biological fluids" 1) ("16 pleural fluid (PF)" 1)
   ("nasal and bronchioalveolar lavage fluids" 1)
   ("osteoarthritic synovial fluid" 1)
   ("Recovered bronchoalveolar lavage fluids (BALF)" 1)
   ("animal bronchoalveolar lavage fluids (BALF)" 1)
   ("the central spinal fluid (CSF)" 1) ("Synovial fluid" 1)
   ("OA-derived synovial fluid" 1) ("the interstitial fluid" 1)
   ("the seminal fluid" 1) ("33–37°C. Harvested allantoic fluid" 1)
   ("aminiotic fluid" 1) ("rectal dialysis fluid" 1) ("Breast ductal fluid" 1)
   ("the ductal fluid" 1) ("breast ductal fluid" 1)
   ("ductal lavage (DL) fluid" 1) ("active fluid" 1) ("The synovial fluid" 1)
   ("The allantoic fluid" 1) ("both synovial fluid" 1)
   ("the synovial fluids" 1) ("RA patient synovial fluid" 1)
   ("oxygenated artificial cerebrospinal fluid" 1)
   ("bronchoalveolar lavage fluids (BALF)" 1)
   ("Bronchoalveolar lavage fluid (BALF)" 1)
   ("virus-containing allantoic fluid" 1)
   ("the brochoalveolar lavage fluid (BAL)" 1) ("fluid (BAL)" 1)
   ("Peritoneal fluids" 1) ("HGF-containing vitreous fluids" 1)
   ("all the vitreous fluids" 1) ("Clinical vitreous fluids" 1)
   ("Vitreous fluids" 1) ("Hydrosalpingeal fluid" 1) ("Human synovial fluid" 1)
   ("human synovial fluid" 1) ("De-identified synovial fluid" 1)
   ("the bronchial lavage fluids" 1) ("apical fluid" 1)
   ("cell-free clarified pleural fluid" 1) ("the mucosal fluid" 1)
   ("bronchial lavage fluids" 1) ("the effusive fluid" 1)
   ("more thermodynamically favorable bulk biological fluid" 1) ("Fluids" 1)
   ("A healthy pleural fluid" 1) ("the peritoneal ascites fluids" 1)
   ("proximal fluids" 1) ("both bronchioalveolar lavage fluid (BALF)" 1)
   ("the colourless fluid" 1) ("The cerebrospinal fluid (CSF)" 1)
   ("The bronchoalveolar lavage fluid" 1)))
 ("NCIT:C25293" (("SGPT" 4))) ("NCIT:C253" (("anthracenedione" 3)))
 ("NCIT:C25773"
  (("G2/mitotic-specific cyclin-B2" 2) ("cyclinB2" 2) ("cyclin-B2" 1)))
 ("NCIT:C258"
  (("antibiotic" 901) ("antimicrobial" 191) ("Antibiotic" 53)
   ("Antimicrobial" 10) ("antibiotic-" 8) ("an antifungal antibiotic" 3)
   ("a macromolecular chromoprotein enediyne antibiotic" 2)
   ("a cationic antibiotic" 2) ("an agricultural antibiotic" 1)
   ("a lipophilic macrolide antibiotic" 1)
   ("a natural antifungal antibiotic" 1)
   ("a monocarboxylic polyether antibiotic" 1)))
 ("NCIT:C2583"
  (("rosiglitazone" 359) ("Rosiglitazone" 57) ("rosiglitazone (RSG)" 4)
   ("rosiglitazone (RGZ)" 2) ("Rosiglitazone (RSG)" 2)
   ("Rosiglitazone (ROSI)" 1) ("rosiglitazone's" 1)))
 ("NCIT:C2586"
  (("psoralen" 180) ("Psoralen" 29) ("psoralens" 4)
   ("laser-activated psoralen" 2) ("psoralen-" 1) ("-psoralen" 1)))
 ("NCIT:C2588" (("gadopentetate dimeglumine" 5) ("GdDTPA" 3)))
 ("NCIT:C2591"
  (("benzaldehyde" 10) ("benzaldehyde (DEAB)" 2)
   ("3-(4-Methoxy-2-nitrophenylamino)-1-(4-nitrophenyl)-3-phenylpropan-1-one benzaldehyde"
    2)))
 ("NCIT:C25967"
  (("pri-miRNA" 127) ("pri-miRNAs" 113) ("Pri-miRNA" 4) ("Most pri-miRNAs" 1)
   ("pri-miRna" 1) ("discrete polycistronic pri-miRNAs" 1)))
 ("NCIT:C25968"
  (("pre-miRNA" 129) ("pre-miRNAs" 92) ("premiRNAs" 8) ("Pre-miRNAs" 6)
   ("premiRNA" 5) ("Pre-miRNA" 2) ("shorter hairpin-shaped pre-miRNAs" 2)
   ("pre-MiRNA" 1) ("polymorphic pre-miRNAs" 1)
   ("artificial engineered pre-miRNA" 1)
   ("the above-identified pre-miRNAs" 1)))
 ("NCIT:C25975"
  (("mitochondrial RNA" 12) ("mitochondrial RNAs" 10) ("mtRNAs" 5)
   ("mtRNA" 1)))
 ("NCIT:C26233"
  (("GRK" 40) ("GRKs" 12) ("G protein-coupled receptor kinases" 9)
   ("GPCR kinases" 5) ("G protein–coupled receptor kinases" 4)
   ("GPCR kinase family" 2) ("GPCR kinase" 1)))
 ("NCIT:C263" (("anticoagulants" 7))) ("NCIT:C2634" (("digitoxin" 8)))
 ("NCIT:C2635" (("pirfenidone" 1)))
 ("NCIT:C26360"
  (("ERK" 18498) ("Erk" 2968) ("pERK" 1730) ("p-ERK" 626)
   ("extracellular signal-regulated kinase" 439) ("ERKs" 304) ("P-ERK" 205)
   ("extracellular signal-regulated kinases" 169) ("pErk" 137)
   ("extracellular signal–regulated kinase" 61)
   ("extracellular regulated kinase" 45)
   ("extracellular-signal-regulated kinase" 40)
   ("extracellular signal-regulated kinase (ERK)" 34)
   ("extracellular-signal-regulated kinases" 29) ("ERK-" 26) ("-ERK" 23)
   ("Extracellular signal-regulated kinase" 18) ("ERK protein" 16) ("Erks" 15)
   ("signal regulated kinase" 13)
   ("extracellular signal–regulated kinase (ERK)" 11)
   ("extracellular regulated kinases" 10)
   ("Extracellular signal-regulated kinases" 10) ("ERK family" 8)
   ("extracellular signal-regulated kinases (ERK)" 6) ("–ERK" 6)
   ("extracellular signal–regulated kinases" 5) ("“pERK”" 5) ("erk" 4)
   ("ERK molecule" 4) ("extra-cellular signal regulated kinase" 4)
   ("Extracellular signal–regulated kinase" 3)
   ("–extracellular signal-regulated kinase" 3)
   ("-extracellular signal-regulated kinase" 3)
   ("extracellular-signal-regulated kinase (ERK)" 3)
   ("P-extracellular signal-regulated kinase" 3)
   ("dominant negative (DN) ERK" 3) ("pERK protein" 3) ("ERK’s" 3)
   ("extracellular signal related kinases" 3) ("Erk molecule" 3)
   ("Erk protein" 3) ("-pERK" 3) ("IER3-B56γ1-phosphorylated ERK" 2)
   ("extracellular regulated protein kinases" 2) ("pERK-" 2)
   ("extracellular regulated protein kinase" 2) ("residual pERK" 2)
   ("extracellular-signal-regulated kinases (ERK)" 2)
   ("RAS increased phospho-ERK" 2) ("−ERK" 2)
   ("extracellular
 signal-regulated kinase"
    2)
   ("18 (22%) normal adjacent colonic crypts demonstrated pERK" 2)
   ("strong pERK" 2) ("extracellular regulated kinase (ERK)" 2) ("Erk-" 2)
   ("mouse monoclonal anti phospho-Erk" 2) ("Extracellular regulated kinase" 2)
   ("the mitogen-associated protein kinase (MAPK) Erk" 2)
   ("pallial VZ/SVZ pErk" 2) ("strong p-ERK" 2) ("dual phosphorylated ERK" 2)
   ("total and activated ERK" 2) ("less Erk" 2) ("the residual pERK" 2)
   ("–extracellular signal–regulated kinase" 2) ("than Erk" 1)
   ("than Erk in fibroblast cells" 1) ("dual-phosphorylated ERK" 1) ("“ERK”" 1)
   ("than ERK ( xref ; xref )" 1)
   ("extracellular signal regulated protein kinases (ERK)" 1)
   ("extracellular signal regulated protein kinases" 1)
   ("-extracellular regulated protein kinase" 1) ("much less pERK" 1)
   ("phospho/total- ERK" 1)
   ("mutant Shp2-expressing macrophage progenitors demonstrated constitutively active Erk"
    1)
   ("completely abrogated extracellular-signal-regulated kinase (ERK)" 1)
   ("Extracellular regulated protein kinase" 1) ("ErK" 1) ("at least ERK" 1)
   ("the well-characterized extracellular-signal-regulated kinase (ERK)" 1)
   ("granular pERK" 1) ("Extracellular signal Regulated Kinases (ERK)" 1)
   ("Extracellular signal Regulated Kinases" 1)
   ("the classical extracellular signal-regulated kinase (ERK)" 1)
   ("β-arrestin-dependent ERK" 1) ("both total and phosphorylated ERK" 1)
   ("having less total ERK" 1) ("study ERK’s" 1)
   ("Extracellular signal–regulated kinase (ERK)" 1)
   ("mitogenic-induced ERKs" 1) ("absolute phospho-ERK" 1)
   ("Extracellular signal regulated protein kinase" 1) ("weak ERK" 1)
   ("cardiac activation ERK" 1) ("than ERK" 1) ("more pERK" 1)
   ("-extracellular regulated kinase" 1) ("AS increased phospho-ERK" 1)
   ("promoter-associated ERK" 1) ("ERK's" 1) ("-Erk" 1)
   ("Extracellular regulated protein kinases" 1)
   ("Extracellular-signal-regulated kinase" 1)
   ("counteractive CagA-dependent SHP2-(Ras)-ERK" 1)
   ("total and activated Erk" 1) ("nonradioactive ERK" 1)
   ("a pivotal Met canonical signaling protein ERK" 1)
   ("increased residual pERK" 1) ("Extracellular signal Regulated Kinase" 1)
   ("Erk’s" 1) ("residual phospho-ERK" 1)))
 ("NCIT:C264" (("anticonvulsants" 3)))
 ("NCIT:C26418"
  (("TCRβ" 167) ("TCRβ-" 2) ("Tcrβ" 2) ("“useless” revised TCRβ" 1)))
 ("NCIT:C26421" (("TCRG" 5)))
 ("NCIT:C26549"
  (("ncRNAs" 193) ("ncRNA" 169) ("functional RNA" 7)
   ("subnuclear structure-specific ncRNAs" 2) ("intronic ncRNA" 1)
   ("the long intragenic ncRNA" 1) ("the cancer-associated MALAT1 ncRNA" 1)
   ("we first screened known ncRNAs" 1) ("functional RNAs" 1) ("NCRNA" 1)))
 ("NCIT:C26563" (("ENU" 117) ("ethylnitrosourea" 2)))
 ("NCIT:C26638" (("clofarabine" 37) ("Clofarabine" 2)))
 ("NCIT:C26653" (("GW572016" 10))) ("NCIT:C26658" (("LY317615" 4)))
 ("NCIT:C26659"
  (("marijuana" 71) ("cannabis" 27) ("non-marijuana" 3) ("Cannabis" 2)
   ("Schizophrenia patients frequently abuse cannabis" 1)
   ("patients often use cannabis" 1) ("non-cannabis" 1) ("Marijuana" 1)))
 ("NCIT:C26662" (("noni" 7) ("Morinda citrifolia" 4) ("Noni" 2)))
 ("NCIT:C26666" (("R-flurbiprofen" 5))) ("NCIT:C26667" (("zileuton" 18)))
 ("NCIT:C26671" (("silymarin" 4) ("Silymarin" 2)))
 ("NCIT:C26673" (("SU11248" 17)))
 ("NCIT:C2668" (("Revlimid" 1) ("revlimid" 1)))
 ("NCIT:C2682" (("aflibercept" 9) ("VEGF trap" 2)))
 ("NCIT:C2713" (("EKB-569" 7))) ("NCIT:C2720" (("ICR62" 111)))
 ("NCIT:C2736" (("ZD6126" 3))) ("NCIT:C2737" (("ZD6474" 6)))
 ("NCIT:C274"
  (("anti-neoplastic" 137) ("antineoplastic agent" 12) ("Anti-neoplastic" 1)))
 ("NCIT:C281"
  (("antivirals" 20) ("antiviral agent" 6)
   ("direct acting antiviral antivirals" 2)))
 ("NCIT:C28156"
  (("hydrogen peroxide" 1905) ("Hydrogen peroxide" 79) ("Hydrogen Peroxide" 26)
   ("exogenous hydrogen peroxide" 7) ("fresh 3% hydrogen peroxide" 4)
   ("hydrogen peroxide–" 4)
   ("hydrogen
peroxide"
    3)
   ("strong oxidant hydrogen peroxide" 2) ("3% aqueous hydrogen peroxide" 1)
   ("hydrogen peroxide (VWR)" 1)))
 ("NCIT:C28269"
  (("phytochemicals" 127) ("phytochemical" 67) ("dietary phytochemicals" 7)
   ("Phytochemicals" 6) ("a polyphenolic stilbene phytochemical" 2)
   ("cancer preventive phytochemicals" 2) ("non-toxic phytochemicals" 2)
   ("common dietary phytochemicals" 2)
   ("Many chemopreventive phytochemicals" 1)
   ("antiinflammatory phytochemical" 1) ("other soy-derived phytochemicals" 1)
   ("the most common and abundant dietary phytochemicals" 1)
   ("many stress-induced phytochemicals" 1)
   ("a dietary and medicinal phytochemical" 1)
   ("chemopreventive phytochemicals" 1)
   ("many chemopreventive phytochemicals" 1)
   ("cancer chemopreventive phytochemicals" 1) ("the dietary phytochemicals" 1)
   ("clinically-useful dietary phytochemicals" 1)
   ("an attractive dietary bioactive phytochemical" 1)
   ("bioactive dietary phytochemicals" 1)))
 ("NCIT:C28459" (("oxygenase" 21) ("Oxygenase" 4)))
 ("NCIT:C286" (("asparaginase" 14) ("Asparaginase" 1)))
 ("NCIT:C28725" (("TRP-1" 8)))
 ("NCIT:C288"
  (("azacytidine" 29) ("azacitidine" 17) ("-azacytidine" 12) ("Azacytidine" 4)
   ("Azacitidine" 1)))
 ("NCIT:C28816" (("PGE1" 14)))
 ("NCIT:C28822" (("amphetamine" 28) ("Amphetamine" 5) ("Amphet-amine" 1)))
 ("NCIT:C28833" (("argatroban" 6)))
 ("NCIT:C28883" (("Retronectin" 12) ("retronectin" 11) ("RetroNectin" 8)))
 ("NCIT:C28898" (("CTLA4-Ig" 17)))
 ("NCIT:C28904"
  (("somata" 43) ("neuronal somata" 2) ("visual cortical neuron somata" 1)
   ("visual neuron somata" 1)))
 ("NCIT:C28936" (("clozapine" 20) ("Clozapine" 2)))
 ("NCIT:C28952" (("Tetrandrine" 1))) ("NCIT:C28982" (("diazepam" 8)))
 ("NCIT:C28990"
  (("digoxin" 46) ("Digoxin" 15) ("than digoxin" 2) ("digoxin-" 1)))
 ("NCIT:C290"
  (("aza" 444) ("Aza" 287) ("AZA" 172) ("azathioprine" 26) ("-aza" 3)
   ("Azathioprine" 1) ("than AZA" 1)
   ("both the DNA demethylating agent AZA" 1)))
 ("NCIT:C29027" (("efavirenz" 12) ("Efavirenz" 1)))
 ("NCIT:C29071" (("gemfibrozil" 4)))
 ("NCIT:C29076" (("glyburide" 12) ("glibenclamide" 6) ("Glyburide" 1)))
 ("NCIT:C29097" (("hydrazine (CCCP)" 16) ("hydrazine" 14)))
 ("NCIT:C29105"
  (("hypoxanthine" 98) ("Hypoxanthine" 16) ("hypoxanthine (HX)" 2)))
 ("NCIT:C29115" (("Imexon" 4)))
 ("NCIT:C29149" (("laetrile" 2) ("Laetrile" 1) ("“laetrile”" 1)))
 ("NCIT:C29150" (("lansoprazole" 12) ("Lansoprazole" 4)))
 ("NCIT:C29151" (("latanoprost" 1) ("Latanoprost" 1)))
 ("NCIT:C29249" (("mesalamine" 6) ("Mesalamine" 5)))
 ("NCIT:C29253"
  (("methylcellulose" 420) ("Methylcellulose" 31) ("methyl-cellulose" 8)
   ("ice-cold PBS/0.1% methylcellulose" 2) ("methylcellulose (MC)" 1)))
 ("NCIT:C29277" (("NVP" 507) ("nevirapine" 11)))
 ("NCIT:C29285"
  (("nelfinavir" 22) ("nelfinavir (NFV)" 22) ("NFV" 15) ("Nelfinavir" 3)))
 ("NCIT:C29290" (("nifedipine" 40) ("Nifedipine" 1)))
 ("NCIT:C29294" (("nitroglycerin" 4) ("Nitroglycerin" 3)))
 ("NCIT:C29307" (("oxaprozin" 8)))
 ("NCIT:C29309" (("oxycodone" 9) ("Oxycodone" 1)))
 ("NCIT:C29329" (("pPD" 2) ("purified protein derivative" 1)))
 ("NCIT:C29341" (("pT523" 2))) ("NCIT:C29355" (("perphenazine" 6)))
 ("NCIT:C29411" (("ramipril" 8) ("Ramipril" 2)))
 ("NCIT:C29412" (("ranitidine" 19))) ("NCIT:C29416" (("risperidone" 17)))
 ("NCIT:C29444" (("Saquinavir" 10) ("saquinavir" 6) ("saquinavir (SQV)" 2)))
 ("NCIT:C29454"
  (("simvastatin" 309) ("Simvastatin" 94) ("daily low-dose simvastatin" 2)
   ("the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor simvastatin"
    2)
   ("Simvastatin's" 1) ("simvastatin’s" 1)))
 ("NCIT:C29457"
  (("sodium bicarbonate" 391) ("NaHCO3" 86) ("Sodium Bicarbonate" 8)
   ("Sodium bicarbonate" 6) ("5% aqueous sodium bicarbonate" 1)))
 ("NCIT:C29475" (("TAS106" 127))) ("NCIT:C29576" (("β-blockers" 12)))
 ("NCIT:C29618"
  (("dihydrotestosterone" 186) ("dihydrotestosterone (DHT)" 41)
   ("Dihydrotestosterone" 22) ("Dihydrotestosterone (DHT)" 4)
   ("less dihydrotestosterone" 1) ("dihydrotestosterone ( AR )" 1)
   ("tenfold more active dihydrotestosterone" 1)))
 ("NCIT:C29707"
  (("vasodilators" 20) ("pulmonary vasodilators" 1)
   ("than vasodilators such as acetylcholine" 1)))
 ("NCIT:C29723"
  (("PPI" 561) ("pPI" 24) ("PPi" 18) ("proton pump inhibitor" 4) ("PpI" 1)
   ("the traditional reference-based PPI" 1)
   ("~25,000 pre dicted binary PPI" 1) ("“PPI”" 1) ("the PPI’s" 1)))
 ("NCIT:C29739"
  (("sulfonamides" 8) ("than the corresponding methyl sulfonamides 19" 1)
   ("Sulfonamides" 1)))
 ("NCIT:C29744"
  (("formaldehyde" 3535) ("Formaldehyde" 89) ("-formaldehyde" 6)
   ("10% neutral buffered formaldehyde" 3) ("formaldehyde (FA)" 3)
   ("fresh 1% formaldehyde" 2) ("3% p -formaldehyde" 2)
   ("mild in vivo formaldehyde" 2)
   ("using 1% ice-cold methanol-free formaldehyde" 1)
   ("neutral 10% buffered formaldehyde" 1) ("2% p -formaldehyde" 1)
   ("1090 neutral buffered formaldehyde" 1) ("residual formaldehyde" 1)
   ("ice-cold 3.7% formaldehyde" 1)
   ("4.5 mL ice-cold 1% methanol-free formaldehyde" 1)
   ("One percent formaldehyde" 1) ("freshly made 3.7% formaldehyde" 1)
   ("fresh 4% formaldehyde" 1) ("4% neutral formaldehyde" 1)
   ("ice-cold 4% formaldehyde" 1)))
 ("NCIT:C29773"
  (("ECG" 140) ("pregnant mare serum gonadotropin" 4) ("retrospective ECG" 2)
   ("eCG" 2) ("underwent ECG" 2) ("simultaneous ECG" 2) ("ECG-" 1)
   ("exogenous eCG" 1) ("Subsequent ECG" 1)))
 ("NCIT:C29783" (("androsterone" 10)))
 ("NCIT:C298"
  (("BCG" 252) ("intravesical BCG" 6) ("BCG vaccine" 3) ("than M. bovis BCG" 2)
   ("than BCG" 2) ("intravesical (Connaught strain) BCG" 1) ("Bcg" 1)
   ("virulent M. leprae and non-pathogenic BCG" 1)
   ("had received intravesical BCG" 1)))
 ("NCIT:C29801" (("NNK" 244)))
 ("NCIT:C29815"
  (("chloroform" 798) ("Chloroform" 47) ("ice-cold chloroform" 1)))
 ("NCIT:C29823"
  (("hydroquinone" 101) ("hydroquinones" 7) ("Hydroquinone" 2)
   ("hydroquinone (TBHQ)" 2) ("less toxic hydroquinone" 1)))
 ("NCIT:C29849" (("pBOS" 1) ("pBos" 1)))
 ("NCIT:C29853"
  (("silica" 242) ("Silica" 17) ("crystalline silica" 4) ("SILICA" 1)))
 ("NCIT:C29858" (("triethylenemelamine" 2)))
 ("NCIT:C29866" (("pirinixic acid" 1)))
 ("NCIT:C29983"
  (("anti-MUC1" 28) ("anti–MUC1" 2) ("mouse monoclonal anti-MUC1" 2)
   ("Anti-MUC1" 1)))
 ("NCIT:C302"
  (("benzene" 124) ("Benzene" 11) ("-benzene" 3) ("Benzene-" 2)
   ("benzene (TCPOBOP)" 1)))
 ("NCIT:C306"
  (("bioflavonoid" 15) ("bioflavonoids" 3) ("non-toxic bioflavonoid" 2)
   ("this non-toxic bioflavonoid" 1) ("a polyphenolic bioflavonoid" 1)))
 ("NCIT:C307"
  (("biological agent" 7) ("Bio-pharmaceuticals" 1) ("Bio-Pharmaceuticals" 1)))
 ("NCIT:C308"
  (("Brm" 71) ("BrM" 21) ("an essential biological response modifier" 2)
   ("biological response modifier" 1)))
 ("NCIT:C310" (("dicoumarol" 29) ("dicumarol" 6) ("Dicoumarol" 5)))
 ("NCIT:C313"
  (("bleomycin" 609) ("Bleomycin" 82) ("bleomycin-" 7) ("bleomycin drug" 5)
   ("the radiomimetic drug bleomycin" 3) ("intra-tracheal bleomycin" 2)
   ("the radio-mimetic compound Bleomycin" 2) ("the radiomimetic bleomycin" 2)
   ("The chemotherapeutic agent bleomycin" 1) ("bleomycin (BLM)" 1)))
 ("NCIT:C318"
  (("BrdU" 4834) ("bromodeoxyuridine" 321) ("Bromodeoxyuridine" 140)
   ("BrDU" 51) ("Brdu" 49) ("BRDU" 34) ("brdU" 14) ("BrdU drug" 7)
   ("Cumulative BrdU" 6) ("BrdU-" 5) ("-bromodeoxyuridine" 4)
   ("virtually no BrdU" 4) ("BrDu" 4) ("-BrdU" 3) ("BromodeoxyUridine" 3)
   ("mouse monoclonal BrdU" 3)
   ("the artificial thymidine nucleotide analog BrdU" 2)
   ("The cumulative BrdU" 2) ("the cumulative BrdU" 2) ("A cumulative BrdU" 2)
   ("pulse-labeled BrdU" 2) ("both intense BrdU" 2)
   ("indirect immunofluorescent BrdU" 2) ("late S-phase BrdU" 2)
   ("fewer BrdU" 1) ("exclusively late stage BrdU" 1)
   ("the characteristic BrdU" 1) ("very short BrdU" 1)
   ("these mid-to-late S-phase BrdU" 1) ("significantly more BrdU" 1)
   ("the percent BrdU" 1)
   ("the mock-transfected control cells incorporated BrdU" 1) ("less BrdU" 1)))
 ("NCIT:C32345"
  (("colloid" 53) ("eosinophilic colloid" 2) ("Colloid" 1)
   ("relatively less colloid" 1)
   ("PD325901 treated mice contained readily detectable eosinophilic colloid"
    1)
   ("a magnetic colloid" 1)))
 ("NCIT:C325"
  (("CA-125" 93) ("preoperative CA-125" 1) ("specifically serum CA-125" 1)))
 ("NCIT:C32650" (("gamma-tubulin" 10) ("gamma tubulin" 9) ("γtubulin" 7)))
 ("NCIT:C327" (("CA-19-9" 2)))
 ("NCIT:C328"
  (("caffeine" 815) ("Caffeine" 85) ("caffeine’s" 5) ("than caffeine" 2)
   ("caffeine-" 2) ("than 3 mM caffeine" 1) ("oral or topical caffeine" 1)
   ("the dual ATM/ATR inhibitor caffeine" 1) ("caffeine's" 1) ("-caffeine" 1)
   ("their potential inhibitory effect 4 mM caffeine" 1)))
 ("NCIT:C335" (("cgt" 11)))
 ("NCIT:C338"
  (("camptothecin" 668) ("Camptothecin" 91) ("camptothecin (CPT)" 58)
   ("camptothecin(CPT)" 5) ("Camptothecin (CPT)" 3)
   ("the apoptogenic drug camptothecin (CPT)" 1)
   ("the chemotherapeutic Camptothecin" 1) ("than camptothecin" 1)
   ("the genotoxic agent camptothecin (CPT)" 1)
   ("the chemotherapeutic agent camptothecin" 1) ("camptothecin-" 1)
   ("the chemotherapeutic drug camptothecin (CPT)" 1)))
 ("NCIT:C339"
  (("capsaicin" 356) ("Capsaicin" 54) ("capsaicin's" 6) ("capsaicin (CAP)" 3)
   ("Capsaicin (CAP)" 1)
   ("the pungent chili pepper component capsaicin (CAP)" 1)))
 ("NCIT:C341"
  (("carbamazepine" 13) ("carbamazepine-" 1)
   ("another classic antiepileptic drug carbamazepine (CBZ)" 1)
   ("carbamazepine (CBZ)" 1) ("Carbamazepine" 1)))
 ("NCIT:C362" (("chlorambucil" 37)))
 ("NCIT:C363"
  (("chloramphenicol" 74) ("Chloramphenicol" 7)
   ("the bacterial protein
synthesis inhibitor chloramphenicol"
    2)))
 ("NCIT:C367"
  (("chlorpromazine" 28) ("Chlorpromazine" 3) ("chlorpromazine (CPZ)" 2)
   ("the antipsychotic drug chlorpromazine (CPZ)" 1)
   ("The cationic amphiphilic drug chlorpromazine (CPZ)" 1)))
 ("NCIT:C374" (("cimetidine" 28) ("Cimetidine" 1)))
 ("NCIT:C37452" (("ixabepilone" 2)))
 ("NCIT:C375" (("ciprofloxacin" 48) ("Ciprofloxacin" 14)))
 ("NCIT:C378" (("Clofibrate" 12) ("clofibrate" 4)))
 ("NCIT:C37899"
  (("17-Allylamino 17-demethoxygeldanamycin" 5)
   ("17-allylamino 17-demethoxygeldanamycin" 5) ("KOS-953" 3)))
 ("NCIT:C379" (("clomiphene" 3) ("Clomiphene" 1)))
 ("NCIT:C381" (("CLT" 8) ("clotrimazole" 2) ("clotrimazole (CLT)" 1)))
 ("NCIT:C38713" (("BMS-354825" 10) ("Sprycel" 10) ("SPRYCEL" 2)))
 ("NCIT:C38717" (("anakinra" 2)))
 ("NCIT:C38897"
  (("CD3" 1806) ("CD3 complex" 31) ("CD3-" 10) ("-CD3 complex" 4)
   ("CD3 complexes" 4) ("targeting human CD3" 3) ("soluble anti CD3" 3)
   ("CD3 molecule" 3) ("CD3 (APC)" 2)
   ("Alexa Fluor 700-conjugated CD14, and APC-Cy7-conjugated CD3" 2)
   ("mouse monoclonal CD3" 2) ("targeting CD3" 2) ("cD3" 2)
   ("The mouse monoclonal anti- human CD3" 2)
   ("the TCR-associated CD3 complex" 1) ("colon-associated CD45 + CD3" 1)))
 ("NCIT:C38958"
  (("elongation factor-1" 2) ("Elongation factor-1" 2) ("eF1" 2)))
 ("NCIT:C394" (("cfr" 4) ("Cfr" 1)))
 ("NCIT:C397"
  (("coumarin" 51) ("AFC" 7) ("-coumarin" 6) ("AMC" 3) ("coumarin (AMC)" 2)
   ("coumarin (AFC)" 2) ("Coumarin" 1)))
 ("NCIT:C401"
  (("curcumin" 1107) ("Curcumin" 173) ("curcumin-" 6)
   ("the pharmacologic inhibitor curcumin" 3) ("receive either curcumin" 2)
   ("than curcumin" 2) ("Commercially available curcumin" 1)
   ("approximately 5 μg/mL curcumin" 1) ("than pure curcumin" 1)
   ("pure curcumin" 1) ("the nontoxic phytochemical curcumin" 1)
   ("insoluble curcumin (CURH)" 1)))
 ("NCIT:C405"
  (("cyclophosphamide" 353) ("Cyclophosphamide" 12)
   ("metronomic cyclophosphamide" 2) ("cyclophosphamide-" 2)
   ("cyclophosphamide (FAC)" 1) ("cyclophosphamide (FC)" 1)))
 ("NCIT:C406"
  (("cyclosporine" 118) ("Cyclosporine" 15) ("cyclosporin" 11)
   ("Cyclosporin" 2) ("than cyclosporine" 1)))
 ("NCIT:C408" (("cytosine arabinoside" 55) ("Cytosine arabinoside" 6)))
 ("NCIT:C412"
  (("dactinomycin" 8) ("Dactinomycin" 3)
   ("the chemotherapeutic agent Dactinomycin" 2)))
 ("NCIT:C415" (("dapsone" 2)))
 ("NCIT:C416"
  (("deferoxamine" 36) ("deferoxamine (DFO)" 6) ("Deferoxamine" 5)
   ("deferoxamine (DFX)" 3)))
 ("NCIT:C419" (("demecolcine" 7) ("Demecolcine" 3)))
 ("NCIT:C429"
  (("-dideoxyadenosine" 2) ("dideoxyadenosine" 2)
   ("dideoxyadenosine (DDA)" 1)))
 ("NCIT:C432" (("diethyldithiocarbamate" 5)))
 ("NCIT:C44297"
  (("PDB" 1206) ("pdb" 80) ("PDBs" 13) ("PDB-" 13) ("pDB" 8) ("Pdb" 2)
   ("pdbs" 1) ("respective pdb" 1) ("the protein PDB's" 1)))
 ("NCIT:C44324"
  (("DAB" 1502) ("DAKO" 18) ("Dab" 7) ("“DAB”" 4) ("-DAB" 2) ("the pure DAB" 2)
   ("strong brown DAB" 1)
   ("the secondary polyperoxidase-anti-rabbit IgG antibody, and chromogen substrate reagent DAB"
    1)
   ("DAB (DAKO)" 1) ("than DAB" 1) ("most DAB" 1)))
 ("NCIT:C44328"
  (("acetaldehyde" 131) ("Acetaldehyde" 10) ("more acetaldehyde" 2)
   ("acetaldehyde-" 2) ("exogenous acetaldehyde" 2)))
 ("NCIT:C44329"
  (("acrylamide" 491) ("Acrylamide" 26) ("-acrylamide" 3)
   ("monomeric acrylamide" 1)))
 ("NCIT:C44331" (("atas" 24) ("the information available atas" 1)))
 ("NCIT:C44335"
  (("benzidine" 79) ("Benzidine" 5) ("neutral benzidine" 4)
   ("benzidine (DAB)" 2)))
 ("NCIT:C44348"
  (("cadmium" 274) ("Cadmium" 51) ("cadmium-" 2) ("cadmium’s" 1)))
 ("NCIT:C44352" (("chlordecone" 2)))
 ("NCIT:C44364"
  (("DDT" 102) ("dichlorodiphenyltrichloroethane" 16)
   ("dichlorodiphenyltrichloroethane (DDT)" 4) ("ddT" 2)
   ("dichlorodiphenyltrichloroethane (DTT)" 2)))
 ("NCIT:C44365" (("dianisidine" 7) ("-dianisidine" 6)))
 ("NCIT:C44383"
  (("EDC" 65) ("EDCs" 3) ("Edc" 3) ("Ethylene dichloride" 1)
   ("ethylene dichloride" 1)))
 ("NCIT:C44385" (("furan" 12) ("Furan" 1)))
 ("NCIT:C44388" (("hexachlorobenzene" 1))) ("NCIT:C44404" (("mirex" 5)))
 ("NCIT:C44414" (("nitrosonornicotine" 2)))
 ("NCIT:C44417"
  (("NDMA" 46) ("N-Nitrosodimethylamine" 1) ("exogenous NDMA" 1)))
 ("NCIT:C44453"
  (("TNM" 1529) ("pathological TNM" 6) ("pathologic TNM" 5) ("TNMs" 3)
   ("the pathological TNM" 3) ("Pathologic TNM" 2)
   ("The 7th Union International Cancer Control (UICC) TNM" 2)
   ("the 7th UICC TNM" 2) ("than TNM staging" 2) ("post-operative TNM" 2)
   ("the international TNM" 1) ("than the TNM staging" 1)
   ("the currently used TNM" 1)
   ("than TNM staging (AUC for STMN1-E/P model: 0.775; AUC for TNM stage: 0.698; Figure xref )"
    1)))
 ("NCIT:C44454" (("thioacetamide" 12) ("thioacetamide (TAA)" 6)))
 ("NCIT:C44455" (("thiourea" 65) ("Thiourea" 6)))
 ("NCIT:C44459" (("trichloroethylene" 1))) ("NCIT:C445" (("dipyridamole" 10)))
 ("NCIT:C45298"
  (("liquid" 1924) ("Liquid" 132) ("liquids" 27) ("viscoelastic liquids" 3)
   ("1 pleural liquid" 2) ("manual liquid" 2)
   ("4 ml Ready-safe liquid scintillation liquid" 2) ("residual liquid" 2)
   ("a stationary phase culture liquid" 1) ("Liquids" 1)
   ("a compressive force revealed both liquid" 1) ("ordinary liquids" 1)))
 ("NCIT:C45299"
  (("GAS" 494) ("gas" 384) ("Gas" 35) ("gases" 22) ("noxious gases" 2)
   ("a diatomic free-radical gas" 2) ("gas (CUR)" 1) ("arterial blood gases" 1)
   ("The parental M3 GAS" 1) ("an invasive M3 GAS" 1)))
 ("NCIT:C45303" (("MiST" 20) ("MIST" 1)))
 ("NCIT:C45304"
  (("suspension" 4274) ("suspensions" 1610) ("Suspension" 42)
   ("Suspensions" 41) ("re-suspension" 27) ("viral suspension" 5)
   ("the bacterial suspensions" 4) ("viral suspensions" 3)
   ("bacterial suspension" 3) ("the treated cell suspensions" 2)
   ("The resultant suspension" 2) ("a homogenous suspension" 2)
   ("the resultant suspension" 2) ("50% aqueous suspension" 2)
   ("the exponential growth phase and single-cell suspensions" 2)
   ("The viral vector suspension" 2) ("The swollen cell suspension" 2)
   ("raloxifene-treated cell suspensions" 2)
   ("Three-dimensional (3D) cell suspensions" 2) ("Viral suspensions" 2)
   ("The carboxylated latex suspension" 1)
   ("JY-1-106-treated cell suspensions" 1) ("The peritoneal cell suspension" 1)
   ("Treated viral suspensions" 1) ("bacterial suspensions" 1)
   ("10% active carbon suspension" 1) ("soft nutrient agar suspension" 1)
   ("the viral suspension" 1) ("mononuclear single-cell suspensions" 1)
   ("The trioxsalen-treated virus suspension" 1)
   ("flowing single cell suspension" 1) ("The aqueous suspension" 1)
   ("a predominantly single-cell suspension" 1) ("the crude cell suspension" 1)
   ("the aqueous suspension" 1) ("The resulting milky suspension" 1)
   ("this organellar suspension" 1) ("three-dimensional suspension" 1)
   ("Bacterial suspensions" 1) ("The resultant single-cell suspensions" 1)
   ("only single-cell suspensions" 1) ("The myometrial tissues suspension" 1)
   ("homogenous suspension" 1) ("the resultant cell suspension" 1)
   ("cervical cell suspensions" 1) ("a homogeneous cell suspension" 1)
   ("Exponentially growing cell suspensions" 1)
   ("splenic mononucleated cell suspension" 1) ("The bacterial suspension" 1)
   ("Lentiviral suspension" 1)))
 ("NCIT:C45487" (("cyclinD2" 55) ("CyclinD2" 12) ("cyclinsD2" 3)))
 ("NCIT:C45506" (("E1b" 28) ("e1b" 3) ("the adenoviral oncoprotein E1b55K" 2)))
 ("NCIT:C457"
  (("doxycycline" 2892) ("Doxycycline" 215) ("doxycycline (DOX)" 8)
   ("Recomb A ON doxycycline" 2) ("diet-containing doxycycline" 1)
   ("doxycycline (DXC)" 1) ("Doxycycline (DOX)" 1)))
 ("NCIT:C466" (("emodin" 27) ("Emodin" 4)))
 ("NCIT:C468" (("enalapril" 5) ("Enalapril" 1)))
 ("NCIT:C473" (("adrenals" 42) ("NL" 4) ("adrenals (NL)" 3)))
 ("NCIT:C47380" (("acetohexamide" 24) ("Acetohexamide" 2)))
 ("NCIT:C47381" (("AHA" 40) ("aha" 4)))
 ("NCIT:C47395" (("amlexanox" 29) ("Amlexanox" 1)))
 ("NCIT:C474"
  (("epirubicin" 375) ("Epirubicin" 21) ("epirubicin-" 6)
   ("perioperative epirubicin" 2) ("the chemotherapeutic agent epirubicin" 1)))
 ("NCIT:C47428" (("cabergoline" 7)))
 ("NCIT:C47430"
  (("carbachol" 43) ("the cholinergic agonist carbachol" 4) ("Carbachol" 2)
   ("carbachol-" 1) ("Carbachol's" 1)
   ("positive control muscarinic agonist carbachol" 1)))
 ("NCIT:C47431" (("carbidopa" 17))) ("NCIT:C47466" (("cycloserine" 2)))
 ("NCIT:C47479" (("dexmedetomidine" 49)))
 ("NCIT:C47503" (("dutasteride" 12) ("Dutasteride" 2)))
 ("NCIT:C47516" (("eptifibatide" 16) ("integrilin" 15) ("Integrilin" 4)))
 ("NCIT:C47526" (("etodolac" 8) ("Etodolac" 5)))
 ("NCIT:C47529" (("ezetimibe" 8)))
 ("NCIT:C47554" (("halothane" 12) ("Halothane" 1)))
 ("NCIT:C47577" (("isradipine" 2))) ("NCIT:C47581" (("levetiracetam" 4)))
 ("NCIT:C47585"
  (("levonorgestrel" 10) ("Levonorgestrel" 2) ("Levonorgestrel (LNG)" 1)
   ("intrauterine levonorgestrel" 1)))
 ("NCIT:C47616" (("methyldopa" 1)))
 ("NCIT:C47672" (("pimozide" 38) ("Pimozide" 1)))
 ("NCIT:C47680" (("Pima" 38) ("potassium iodide" 1)))
 ("NCIT:C47683" (("praziquantel" 8))) ("NCIT:C47712" (("scopolamine" 11)))
 ("NCIT:C47717" (("Sevoflurane" 2) ("sevoflurane" 1)))
 ("NCIT:C47735" (("sulphadoxine" 3) ("Sulphadoxine" 2) ("sulfadoxine" 1)))
 ("NCIT:C47743" (("tadalafil" 3) ("Tadalafil" 1)))
 ("NCIT:C47746" (("telmisartan" 12) ("Telmisartan" 6)))
 ("NCIT:C47776" (("tropicamide" 12))) ("NCIT:C47788" (("ziprasidone" 15)))
 ("NCIT:C47795"
  (("stimulant" 90) ("CNS stimulant" 3) ("a pro-apoptotic stimulant" 3)
   ("co-stimulant" 2) ("a mild stimulant" 1) ("stimulant-" 1) ("Stimulant" 1)
   ("atherosclerotic stimulant" 1)))
 ("NCIT:C48183"
  (("let-7" 1594) ("Let-7" 109) ("hsa-let-7" 15) ("mature let-7" 2)
   ("cloning mature let-7" 1) ("some indirect let-7" 1)
   ("further establishing let-7" 1) ("robust let-7" 1) ("Let-7s" 1)
   ("SIRT1 increased anti- let-7" 1) ("we first detected miRNA let-7" 1)
   ("“let-7”" 1) ("Tumour suppressive let-7" 1)
   ("previously characterized let-7" 1) ("tumor-suppressive let-7" 1)
   ("than let-7 that could be repressed by both Lin28 and Myc ( xref )" 1)))
 ("NCIT:C483"
  (("oestrogens" 58) ("Oestrogens" 3) ("exogenous oestrogens" 1)
   ("peripherally-generated oestrogens" 1)))
 ("NCIT:C48369" (("AEE788" 86)))
 ("NCIT:C48382" (("CDDO" 237) ("biotinylated CDDO" 3) ("bardoxolone" 1)))
 ("NCIT:C48397" (("iloprost" 76) ("Iloprost" 18)))
 ("NCIT:C48404"
  (("MLN518" 106) ("than the selective FLT3 inhibitor MLN518" 1)))
 ("NCIT:C48406" (("hCD20" 2)))
 ("NCIT:C48409"
  (("RasV12" 222) ("RASV12" 31) ("rasV12" 15) ("rasv12" 4) ("RASV12-" 2)
   ("RasV12-" 2)))
 ("NCIT:C486" (("ethinyl estradiol" 4))) ("NCIT:C48812" (("PXD101" 119)))
 ("NCIT:C48966"
  (("autoantibodies" 534) ("autoantibody" 264) ("TPOA" 59)
   ("Autoantibodies" 38) ("Autoantibody" 11) ("-TPOA" 10)
   ("autoantibodies (CCPA)" 3) ("pathogenic autoantibodies" 2)
   ("a previously characterized human autoantibody" 2) ("TPOA-" 2)
   ("autoantibodies (TPOA)" 2) ("antinuclear autoantibodies" 2)
   ("autoantibodies-" 1) ("particular autoantibodies" 1)
   ("more autoantibodies" 1) ("More new autoantibodies" 1)
   ("had measureable anti-p53 autoantibodies" 1)
   ("two distinct autoantibodies" 1)
   ("two T1D-associated anti-islet autoantibodies" 1)
   ("T1D-associated autoantibodies" 1) ("at least one autoantibody" 1)
   ("nucleic acid-containing autoantibody" 1) ("stimulatory autoantibodies" 1)
   ("agonistic anti-PDGFR autoantibodies" 1)
   ("these stimulatory autoantibodies" 1) ("agonistic autoantibodies" 1)
   ("maternal autoantibodies" 1)))
 ("NCIT:C49061" (("AP23573" 13))) ("NCIT:C49094" (("HKI-272" 106)))
 ("NCIT:C49176"
  (("PD-0332991" 261) ("PD-0332991 (PD)" 13) ("PD332991" 6)
   ("the cytostatic agent PD-0332991" 1)))
 ("NCIT:C494" (("fentanyl" 9)))
 ("NCIT:C49436" (("WT2" 33) ("WT-2" 5) ("wt-2" 1)))
 ("NCIT:C495" (("interferon-beta" 9) ("interferon-beta (TRIF)" 3)))
 ("NCIT:C504" (("FUDR" 3) ("floxuridine" 1) ("FUdR" 1)))
 ("NCIT:C505"
  (("fluorouracil" 760) ("5FU" 540) ("Fluorouracil" 72) ("-Fluorouracil" 4)
   ("-5FU" 3) ("fluorouracil-" 3) ("than 5FU" 1) ("5FU (FUIRI)" 1)
   ("the traditional genotoxic agent 5FU" 1)
   ("the chemotherapeutic agent 5FU" 1)))
 ("NCIT:C506" (("fluoxetine" 68) ("Fluoxetine" 4) ("subchronic fluoxetine" 2)))
 ("NCIT:C508" (("-flurbiprofen" 32) ("flurbiprofen" 19) ("Flurbiprofen" 1)))
 ("NCIT:C509" (("flutamide" 111) ("Flutamide" 28) ("flutamide-" 2)))
 ("NCIT:C50918"
  (("endotoxin" 297) ("Endotoxin" 50) ("endotoxins" 32)
   ("bacterial endotoxin" 8) ("contaminated bacterial endotoxins" 3)
   ("endotoxin (LPS)" 3) ("bacterial endotoxins" 3) ("endotoxin-" 2)
   ("a unique atypical endotoxin" 2) ("systemic endotoxin" 2)
   ("Bacterial endotoxin" 2) ("bacterial endotoxin (LPS)" 2)
   ("pathogenic endotoxins" 1) ("Gram-negative endotoxin" 1)
   ("the bacterial lipopolysaccharide (LPS) endotoxin" 1)))
 ("NCIT:C513" (("tegafur" 19) ("Tegafur" 1))) ("NCIT:C51443" (("HTR" 152)))
 ("NCIT:C515" (("FRS" 6) ("furosemide" 3)))
 ("NCIT:C517"
  (("ganciclovir" 59) ("DHPG" 43) ("Ganciclovir" 13)
   ("the antiviral compound ganciclovir" 1)))
 ("NCIT:C519"
  (("gentamicin" 580) ("Gentamicin" 27) ("gentamicin (GIBCO)" 3)
   ("Gentamicin (GIBCO)" 2)
   ("the host membrane-impermeable bacteriocidal agent gentamicin" 2)))
 ("NCIT:C52188" (("etoricoxib" 4)))
 ("NCIT:C52195"
  (("PD0325901" 589) ("PD-0325901" 12) ("than PD0325901" 7)
   ("than either PD0325901" 1) ("than PD0325901 in NF1-null melanoma cells" 1)
   ("than 20nM PD0325901 ( xref )" 1)))
 ("NCIT:C52200"
  (("XL184" 94) ("the orally available tyrosine kinase inhibitor XL184" 1)
   ("XL184’s" 1)))
 ("NCIT:C523"
  (("glutathione" 2187) ("GSH" 1555) ("Glutathione" 389) ("glutathione-" 37)
   ("glutathione (GSH)" 30) ("Glutathione-" 12) ("-glutathione" 8)
   ("Glutathione (GSH)" 4) ("glutathione (EB)" 3) ("exogenous glutathione" 2)
   ("astrocytic glutathione" 2) ("than glutathione" 1)
   ("Quantitative total GSH" 1) ("exogenous GSH" 1)
   ("conversely oxidative glutathione (GSSG)" 1)
   ("reductive glutathione (GSH)" 1) ("GSH-" 1) ("striatal GSH" 1) ("Gsh" 1)
   ("Oxidated glutathione (GSSG)" 1) ("–glutathione" 1)))
 ("NCIT:C52435" (("SLI" 37) ("SLIs" 4)))
 ("NCIT:C52491" (("Terc" 33) ("-Terc" 1)))
 ("NCIT:C52588" (("antibacterials" 3) ("antimicrobial solution" 2)))
 ("NCIT:C52877" (("LDs" 69) ("smaller LDs" 2) ("a complete LDs" 2) ("LdS" 1)))
 ("NCIT:C529"
  (("gossypol" 178) ("Gossypol" 17) ("The BH3-mimetic drug gossypol" 2)
   ("gossypol’s" 1)))
 ("NCIT:C53148" (("RNR1" 2))) ("NCIT:C53306" (("cryoprotectant" 34)))
 ("NCIT:C53398" (("PF00299804" 51) ("PF-00299804" 1)))
 ("NCIT:C537" (("haloperidol" 47) ("Haloperidol" 2) ("haloperidol-" 1)))
 ("NCIT:C54377"
  (("BRCAX" 243) ("BRCA3" 11) ("a third hypothetical gene BRCA3" 2)
   ("BRCAX-" 1) ("”" 1)))
 ("NCIT:C544" (("HMM" 136) ("their associated HMM" 1)))
 ("NCIT:C54422" (("PVT1" 368) ("Pvt1" 78)))
 ("NCIT:C54435" (("DLEU2" 67) ("dleu2" 6)))
 ("NCIT:C555"
  (("hydrocortisone" 1019) ("Hydrocortisone" 31) ("hydrocortisone (SIGMA)" 2)
   ("2 mM glutamine and 0.4 μg/mL of hydrocortisone" 1)))
 ("NCIT:C557"
  (("hydroxychloroquine" 45) ("HCQ" 22) ("hydroxychloroquine (HCQ)" 4)
   ("the HCQ" 2) ("Hydroxychloroquine" 1)))
 ("NCIT:C560"
  (("hydroxyurea" 588) ("HU" 585) ("hydroxyurea (HU)" 63) ("Hydroxyurea" 47)
   ("Hu" 47) ("low dose HU" 12) ("Hu−" 10) ("2 mM HU" 10) ("hu" 7)
   ("high dose HU" 4) ("20 mM HU" 3) ("Hydroxyurea (HU)" 3) ("1 mM HU" 3)
   ("3 mM HU" 2) ("5 mM HU" 2) ("low-dose HU" 2) ("10 mM HU" 2)
   ("100 mg/kg HU" 2) ("−HU" 2) ("4 mM HU" 2)
   ("the neuronal mRNA binding protein Hu" 2) ("HU-" 2) ("hydroxyurea- (HU)" 1)
   ("hydroxyurea-" 1) ("3λmmol/l HU" 1) ("using HU" 1) ("hU" 1)
   ("in vivo HU" 1) ("2 hours HU" 1) ("an HU" 1) ("the HU" 1)
   ("the neuronal marker Hu" 1) ("the pan-neuronal markers Hu" 1) ("than HU" 1)
   ("2mM HU" 1)))
 ("NCIT:C562" (("idarubicin" 31) ("Idarubicin" 4)))
 ("NCIT:C563" (("IdU" 217) ("IdU-" 2) ("Idu" 2)))
 ("NCIT:C564" (("ifosfamide" 22) ("Ifosfamide" 1))) ("NCIT:C567" (("IgEs" 5)))
 ("NCIT:C575"
  (("immunotoxin" 78) ("Immunotoxin" 1)
   ("an irrelevant IL2-PE immunotoxin" 1)))
 ("NCIT:C576"
  (("indomethacin" 249) ("Indomethacin" 22)
   ("the nonselective COX inhibitor indomethacin" 2)
   ("the nonselective COX-1/-2 inhibitor indomethacin" 2)
   ("prophylactic indomethacin" 1) ("received prophylactic indomethacin" 1)
   ("than indomethacin" 1)
   ("the nonsteroidal anti-inflammatory drug indomethacin" 1)))
 ("NCIT:C582" (("intercalators" 34) ("intercalating agent" 12)))
 ("NCIT:C583" (("γ-interferon" 14)))
 ("NCIT:C600" (("isoniazid" 2) ("Isoniazid" 2) ("isoniazid (INH)" 1)))
 ("NCIT:C603" (("isotretinoin" 2) ("Isotretinoin's" 1) ("Isotretinoin" 1)))
 ("NCIT:C605" (("ketoconazole" 15) ("Ketoconazole" 1)))
 ("NCIT:C60768" (("ABT-888" 238) ("ABT-888's" 1)))
 ("NCIT:C61070" (("intetumumab" 4)))
 ("NCIT:C61083"
  (("SSG" 13) ("sodium stibogluconate" 3)
   ("an evolutionally degenerate phospho-degron variant SSG" 2)
   ("Sodium Stibogluconate" 1)))
 ("NCIT:C61099" (("nedaplatin" 13)))
 ("NCIT:C611" (("levodopa" 7) ("Levodopa" 2))) ("NCIT:C61102" (("XL844" 5)))
 ("NCIT:C61303"
  (("crystal" 3384) ("crystals" 1380) ("crystallized" 292) ("Crystals" 150)
   ("Crystal" 149) ("co-crystal" 59) ("co-crystallized" 43) ("CRYSTAL" 34)
   ("co-crystals" 16) ("fewer CaOx crystals" 3) ("well-ordered crystals" 2)
   ("The heterotrimeric protein-peptide complex crystallized" 2)
   ("the divergent crystal" 2) ("internal deletions crystallized" 2)
   ("whose crystal" 2) ("bigger crystals" 2)
   ("the water-insoluble purple formazan crystals" 2) ("residual crystal" 2)
   ("CRYSTAL-" 2) ("this unique crystal" 2) ("The monoclinic crystals" 1)
   ("previously reported crystal" 1) ("the isomorphic monoclinic crystals" 1)
   ("thin hexagonal rod-shaped crystals" 1) ("All five ternary crystals" 1)
   ("well-characterized crystal" 1) ("A3F-CTD asymmetric tetrameric crystal" 1)
   ("the ternary complex crystal" 1) ("other Ets1 ternary complex crystal" 1)
   ("the previously reported crystal" 1) ("currently no crystal" 1)
   ("insoluble formazon crystals" 1) ("insoluble CaOx crystals" 1)
   ("a periodically poled MgO:LiNbO 3 nonlinear‐optical crystal" 1)
   ("Most crystals" 1) ("three-dimensional co-crystal" 1)
   ("well-diffracting crystals" 1) ("Available crystal" 1)
   ("the previously published crystal" 1) ("previously published crystal" 1)
   ("4°C. Mature crystals" 1) ("the dark-coloured crystals" 1)
   ("the phosphorylated IR kinase domain crystallized" 1)
   ("a well-resolved crystal" 1) ("the insoluble formazan crystals" 1)
   ("the available p85α SH3 crystal" 1)
   ("both methylated and unmethylated crystals" 1)
   ("All subsequent crystals" 1) ("Tiny crystals" 1)
   ("more soluble and yielded crystals" 1) ("few crystal" 1)
   ("colorless crystal" 1) ("insoluble purple formazan crystals" 1)
   ("larger crystals" 1) ("homologous crystal" 1) ("available crystal" 1)
   ("cubic Nef crystals" 1) ("hexagonal crystals" 1)
   ("the blue-purple crystals" 1) ("the orthorhombic crystals" 1)
   ("A solitary crystal" 1) ("brilliant crystal (MSB)" 1)
   ("The most recent crystal" 1) ("a few crystals" 1)
   ("the available crystal" 1) ("sure all the crystals" 1)
   ("around 50 crystal" 1) ("all available crystal" 1)
   ("at least 40 crystal" 1) ("only two crystal" 1) ("the complex A crystal" 1)
   ("dark-blue formazan crystals" 1)))
 ("NCIT:C61318" (("MZM" 3))) ("NCIT:C61319" (("MK-0457" 3) ("MK0457" 2)))
 ("NCIT:C61326" (("TLK199" 9)))
 ("NCIT:C61363"
  (("granules" 1185) ("granule" 684) ("secretory granules" 26) ("Granules" 20)
   ("Granule" 19) ("brown granules" 14) ("cytolytic granules" 10)
   ("neurosecretory granules" 9) ("dense granules" 8)
   ("insulin secretory granules" 5) ("brownish yellow granules" 5)
   ("PIN1 immunoreactive granules" 5) ("membrane-associated granules" 4)
   ("membrane-associated secretory granules" 4) ("than predocked granules" 3)
   ("dense-core secretory granules" 3) ("azurophilic granules" 3)
   ("a mild granule" 2) ("more releasable and primed newcomer granules" 2)
   ("previously docked granules" 2)
   ("labeled cells showed brown yellow granules" 2)
   ("very small (<1 μm3) granules" 2) ("Brown-yellow granules" 2)
   ("the membrane-associated granule" 2) ("NPY-mCherry–labeled granules" 2)
   ("the readily releasable granule" 2)
   ("larger obviously membrane-bound granules" 2)
   ("apparently non-membrane bound granules" 2) ("neuronal PIN1 granules" 2)
   ("neuronal granules" 2) ("yellowish or brownish granules" 2)
   ("the secretory granules" 2) ("distinctive perinuclear granules" 2)
   ("bulky granules" 2) ("the DEDD-positive granules" 1)
   ("disable insulin granules" 1) ("IAPP-mCherry-tagged insulin granules" 1)
   ("DIV6 cerebellar granule" 1) ("a few pigment granules" 1)
   ("immature secretory granules" 1) ("the yellowish or brownish granules" 1)
   ("translationally inactive small granules" 1) ("-granule" 1)
   ("LC3-positive granules" 1) ("brown intracytoplasmic granules" 1)
   ("lysosome-related cortical granules" 1) ("“granules”" 1)
   ("dense core (mature) secretory granules" 1) ("platelet dense granules" 1)
   ("Platelet dense granules" 1) ("large secretory granules" 1)
   ("preexisting membrane-associated granules" 1)
   ("a reduced membrane-localized insulin granule" 1)
   ("membrane-associated insulin granules" 1)
   ("a few fine azurophilic granules" 1) ("dense granule" 1)
   ("revealed numerous metachromatic cytoplasmic granules" 1)
   ("smaller individual granules" 1) ("scarce PIN1 granules" 1)
   ("discrete 0.5–5 µm basophilic granules" 1)
   ("cortical regions either lacked PIN1 granules" 1)
   ("cortical neuronal PIN1 granules" 1) ("PIN immunoreactive granules" 1)
   ("numerous secretory granules" 1) ("the cytolytic granules" 1)
   ("discrete 0.5-5 μm basophilic granules" 1)
   ("than neighboring pyramidal neurons not containing pS6-positive granules"
    1)
   ("phase-dense cytoplasmic granules" 1) ("Cytolytic granules" 1)
   ("released cytolytic granules" 1) ("the specialized secretory granules" 1)
   ("no secretory granules" 1) ("monocyte secretory granules" 1)
   ("These neurosecretory granules" 1) ("than the pigment granules" 1)
   ("PM-localized granules" 1) ("separate PM-localized granules" 1)))
 ("NCIT:C61436"
  (("licorice" 18) ("Licorice" 5) ("Licorice root extract" 1)
   ("licorice root extract" 1)))
 ("NCIT:C61439" (("meloxicam" 63) ("Meloxicam" 5)))
 ("NCIT:C61533"
  (("conjugate" 2125) ("conjugates" 1002) ("Conjugate" 76) ("Conjugates" 17)
   ("-conjugate" 9) ("targeted conjugates" 4) ("nanobiopolymeric conjugate" 4)
   ("-conjugates" 4) ("the resin-bound conjugates" 4)
   ("the percent conjugates" 3) ("fluorescent conjugates" 2)
   ("BODIPY-compound 5-1 conjugates" 2)
   ("secondary antibody IgG-linked horseradish peroxidase conjugate" 2)
   ("conjugate (EDC)" 2)
   ("biotinylated secondary antibody and streptavidin-peroxidase conjugate" 2)
   ("the secondary antibody fluorochrome conjugate" 2)
   ("secondary Ab goat anti-mouse IgG (H+L) horseradish peroxidase (HRP) conjugate"
    2)
   ("novel water-soluble N-mustard-benzene conjugates" 2)
   ("secondary anti-mouse or anti-rabbit Ig-horseradish peroxidase conjugate"
    2)
   ("an exogenous BSA–nuclear localization signal conjugate" 2)
   ("mouse monoclonal HA-probe (F-7) agarose conjugate" 2)
   ("conjugate (SAPE)" 2) ("the polyubiquitinated conjugates" 2)
   ("both ubiquitinated and neddylated conjugates" 2)
   ("secondary anti-mouse IgG-HRP conjugate" 2)
   ("secondary anti-human Alexa Fluor 488 conjugate" 2)
   ("PTEN-SUMO2-purified conjugates" 2) ("BODIPY-compound 5-1 conjugate" 1)
   ("a biotinylated secondary antibody and avidin-peroxidase conjugate" 1)
   ("Fluorescein isothiocyanate-conjugated secondary antibodies and rhodamine-phalloidin conjugate"
    1)
   ("the newly developed conjugate" 1)
   ("monoclonal anti-HA peroxidase conjugate" 1)
   ("specific fluorescent conjugates" 1)
   ("bound CF-750 fluorescent dye conjugate" 1)
   ("goat anti-rabbit IgG FITC conjugate" 1) ("Secondary conjugates" 1)
   ("Monoclonal anti-mouse IgG horseradish peroxidase conjugate" 1)
   ("mouse monoclonal anti-FLAG M2 Peroxidase Conjugate" 1)
   ("conjugate (ADC)" 1)
   ("Alexa Fluor 488 nm secondary antibody conjugate and rabbit anti-Dsg3 and Alexa Fluor 555 nm conjugate"
    1)
   ("our nanobiopolymeric conjugate" 1) ("this nanobiopolymeric conjugate" 1)
   ("the nanobiopolymeric conjugates" 1) ("in fact MN-PLT conjugates" 1)
   ("ubiquitinated conjugates" 1) ("His-6-ubiquitinated conjugates" 1)
   ("the resultant more water-soluble GSH conjugate" 1) ("de-conjugate" 1)
   ("The secondary biotinylated antibody and streptavidin-peroxidase conjugate"
    1)
   ("Mouse monoclonal vimentin antibody and antimouse IgG-tetramethylrhodamine isothiocyanate conjugate"
    1)
   ("most SUMO conjugate" 1)))
 ("NCIT:C61612"
  (("metformin" 1859) ("Metformin" 203) ("metformin's" 9) ("metformin’s" 6)
   ("the antidiabetic drug metformin" 6) ("than metformin" 4)
   ("metformin (MF)" 4) ("metformin (MET)" 4) ("metformin-" 2)
   ("the clinically available antidiabetic drug metformin" 2)
   ("diabetic patients not receiving metformin" 2)
   ("the antidiabetic agent metformin" 2) ("The antidiabetic drug metformin" 1)
   ("184 diabetic patients not receiving metformin" 1)
   ("N-cadherin expressing cancer cells metformin" 1)
   ("than metformin in other cell types" 1)))
 ("NCIT:C61639" (("apomorphine" 7) ("-apomorphine" 3)))
 ("NCIT:C61645" (("benazepril" 28) ("Benazepril" 1)))
 ("NCIT:C61677"
  (("ciclopirox" 74) ("Ciclopirox" 12) ("the antifungal agent ciclopirox" 1)
   ("the antifungal drug ciclopirox" 1)))
 ("NCIT:C61680" (("citalopram" 6))) ("NCIT:C61686" (("clopidogrel" 7)))
 ("NCIT:C61688" (("cloxacillin" 2)))
 ("NCIT:C617" (("lomustine" 10) ("Lomustine" 1)))
 ("NCIT:C61700" (("desipramine" 19) ("Desipramine" 2)))
 ("NCIT:C61728" (("diphenhydramine" 5) ("intravenous diphenhydramine" 2)))
 ("NCIT:C61733" (("dobutamine" 5) ("Dobutamine" 2)))
 ("NCIT:C61737" (("doxazosin" 102) ("Doxazosin" 27)))
 ("NCIT:C61754" (("escitalopram" 4)))
 ("NCIT:C61756" (("ethanolamine" 91) ("Ethanolamine" 1)))
 ("NCIT:C61768" (("fluvastatin" 11) ("Fluvastatin" 2)))
 ("NCIT:C61797"
  (("ketamine" 143) ("Ketamine" 20) ("intraperitoneal ketamine" 2)))
 ("NCIT:C61806" (("levocabastine" 3)))
 ("NCIT:C61823" (("MnCl2" 26) ("manganese chloride" 4)))
 ("NCIT:C61879" (("paroxetine" 10) ("Paroxetine" 1)))
 ("NCIT:C61885"
  (("pentobarbital" 175) ("intraperitoneal pentobarbital" 4)
   ("intraperitoneal sodium pentobarbital" 2) ("Pentobarbital" 1)))
 ("NCIT:C61888" (("phenelzine" 7) ("Phenelzine" 1)))
 ("NCIT:C61892" (("piperazine" 26) ("piperazine-" 5)))
 ("NCIT:C61905" (("procainamide" 4))) ("NCIT:C61917" (("quetiapine" 26)))
 ("NCIT:C61931" (("ropinirole" 2)))
 ("NCIT:C61940" (("sildenafil" 26) ("Sildenafil" 2)))
 ("NCIT:C61952"
  (("streptomycin" 7353) ("Streptomycin" 263) ("GIBCO" 19) ("-streptomycin" 18)
   ("streptomycin (PAA)" 9) ("streptomycin (GIBCO)" 6) ("–streptomycin" 3)
   ("DMEM/F12 + 10% fetal bovine serum + penicillin + streptomycin" 1)))
 ("NCIT:C61961" (("tacrine" 4)))
 ("NCIT:C61979" (("tranylcypromine" 52) ("Tranylcypromine" 6)))
 ("NCIT:C620"
  (("lovastatin" 113) ("Lovastatin" 21)
   ("severe MKD—i.e. classic mevalonic aciduria—with lovastatin" 2)))
 ("NCIT:C62056" (("mechlorethamine" 6)))
 ("NCIT:C62073"
  (("propranolol" 185) ("Propranolol" 18) ("propranolol (TOCRIS)" 2)))
 ("NCIT:C62091"
  (("DNR" 184) ("daunorubicin" 172) ("Daunorubicin" 31) ("Dnr" 8)
   ("chemotherapeutic agent daunorubicin" 2) ("The polymorphic DNR" 2)
   ("the chemotherapeutic drug daunorubicin" 2) ("DNR-" 1)
   ("a 5′-UTR polymorphic DNR" 1) ("The SZ-causative polymorphic DNR" 1)
   ("the polymorphic DNR" 1) ("a SZ-associated polymorphic DNR" 1)
   ("Daunorubicin-" 1)))
 ("NCIT:C62098"
  (("norepinephrine" 44) ("Norepinephrine" 5)
   ("hypertrophic agonists norepinephrine" 3)
   ("Twenty-four hour urinary norepinephrine" 1)))
 ("NCIT:C622"
  (("lymphotoxin" 17) ("lymphotoxin (LT)" 3) ("Lymphotoxin" 2)
   ("lymphotoxin-" 1)))
 ("NCIT:C62435"
  (("TKI258" 79) ("CHIR-258" 4) ("than TKI258" 4)
   ("the rather broad-spectrum tyrosine kinase inhibitor TKI258" 2)
   ("than the rather broad-spectrum tyrosine kinase inhibitor TKI258 also sustaining"
    1)
   ("the more broad-spectrum tyrosine kinase inhibitor TKI258" 1)))
 ("NCIT:C62492" (("rIL-21" 8)))
 ("NCIT:C625" (("mannitol" 153) ("Mannitol" 12)))
 ("NCIT:C62514" (("ATN-224" 1))) ("NCIT:C62516" (("INNO-406" 1)))
 ("NCIT:C62521" (("MGCD0103" 86))) ("NCIT:C62523" (("SNS-032" 62)))
 ("NCIT:C62526" (("BSI-201" 12) ("SAR240550" 1)))
 ("NCIT:C626" (("maytansine" 12)))
 ("NCIT:C62624" (("GSSG" 256) ("oxidized glutathione" 62)))
 ("NCIT:C62763" (("PM00104" 1)))
 ("NCIT:C62765" (("BIBF1120" 47) ("BIBF 1120" 9)))
 ("NCIT:C62786"
  (("HBsAg" 98) ("hepatitis B surface antigen" 22) ("HbsAg" 3) ("HBsAg-" 1)))
 ("NCIT:C629" (("medroxyprogesterone" 3) ("Medroxyprogesterone" 1)))
 ("NCIT:C630" (("MEG" 25) ("Meg" 4) ("meg" 2)))
 ("NCIT:C63661"
  (("S-adenosylmethionine" 27) ("S-adenosylmethionine (SAM)" 8)
   ("S-Adenosylmethionine" 7) ("S-adenosylmethionine (NEB)" 4)
   ("the universal methyl donor S-adenosylmethionine (SAM)" 2)
   ("S-AdenosylMethionine" 1) ("s-adenosylmethionine" 1)))
 ("NCIT:C63670" (("dimethyl fumarate" 7) ("Tecfidera" 1)))
 ("NCIT:C63927"
  (("scFv" 561) ("scFvs" 166) ("ScFv" 36) ("the chimeric scFv" 8)
   ("scFv molecule" 6) ("single chain variable fragment" 4) ("ScFvs" 3)
   ("scFV" 2) ("soluble scFvs" 2) ("this particular scFv" 2)
   ("Six distinct scFvs" 1) ("Unique scFvs" 1) ("Monoclonal scFv" 1)
   ("Pure scFvs" 1) ("Soluble scFv" 1) ("Monoclonal phage-displayed scFvs" 1)
   ("than the scFv molecule (130 kDa versus 27 kDa)" 1)
   ("their parental scFv" 1)))
 ("NCIT:C64175" (("thiolutin" 83) ("Thiolutin" 12) ("than thiolutin" 1)))
 ("NCIT:C64185"
  (("PDTC" 456) ("the pharmacologic NFκB inhibitor PDTC" 2) ("PDTC’s" 1)
   ("the PET-positive PDTC" 1) ("36 primary or metastatic PDTC" 1)
   ("PET-positive metastatic PDTC" 1)))
 ("NCIT:C642"
  (("methotrexate" 282) ("Methotrexate" 17) ("methotrexate (MTX)" 6)
   ("Methotrexate (MTX)" 5) ("chemotherapeutic agent methotrexate (MTX)" 1)
   ("-methotrexate" 1) ("high-dose systemic methotrexate" 1)))
 ("NCIT:C645"
  (("methylnitrosourea" 6) ("the DNA methylating agent methylnitrosourea" 3)))
 ("NCIT:C64634" (("NPI-0052" 24) ("NPI0052" 5)))
 ("NCIT:C647"
  (("methylprednisolone" 17) ("MPS" 6) ("pulsed iv methylprednisolone" 1)
   ("intravenous methylprednisolone" 1)))
 ("NCIT:C64761" (("AT7519" 2)))
 ("NCIT:C64768"
  (("PLX4032" 590) ("Zelboraf" 7)
   ("targeted drug therapy program identified PLX4032" 3)
   ("using both the Plexxikon BRAF V600E specific inhibitor PLX4032" 2)))
 ("NCIT:C64776"
  (("ABT-263" 199) ("the orally bivalent Bcl-2/Bcl-xL inhibitor ABT-263" 2)
   ("its more bioavailable analogue ABT-263" 2)
   ("its orally-available ABT-263" 1) ("Abt-263" 1)
   ("orally bioavailable ABT-263" 1)))
 ("NCIT:C648" (("android" 2) ("a more android" 1) ("methyltestosterone" 1)))
 ("NCIT:C65242" (("auranofin" 21))) ("NCIT:C65284" (("candesartan" 2)))
 ("NCIT:C65337" (("clioquinol" 2) ("Clioquinol" 1)))
 ("NCIT:C654" (("midazolam" 5) ("intravenous midazolam" 2)))
 ("NCIT:C655"
  (("mifepristone" 73) ("RU-486" 51) ("Mifepristone" 11)
   ("The pharmaceutical grade mifepristone" 2)))
 ("NCIT:C65624"
  (("fasudil" 103) ("Fasudil" 12) ("-Fasudil" 1) ("than fasudil" 1)))
 ("NCIT:C65629" (("febuxostat" 77) ("Febuxostat" 23)))
 ("NCIT:C65754" (("formoterol" 1))) ("NCIT:C65819" (("griseofulvin" 2)))
 ("NCIT:C65877" (("AR100" 29))) ("NCIT:C66041" (("lumiracoxib" 2)))
 ("NCIT:C66063" (("mecamylamine (MEC)" 4) ("mecamylamine" 3)))
 ("NCIT:C661" (("-methylG" 11) ("methylG" 4)))
 ("NCIT:C66172" (("mizoribine" 2))) ("NCIT:C66189" (("montelukast" 8)))
 ("NCIT:C66212" (("Mubritinib" 6)))
 ("NCIT:C66240" (("niclosamide" 155) ("Niclosamide" 115)))
 ("NCIT:C66456" (("pramipexole" 4)))
 ("NCIT:C66470" (("probucol" 133) ("Probucol" 31) ("probucol's" 2)))
 ("NCIT:C66510" (("rasagiline" 2)))
 ("NCIT:C66515" (("repertaxin" 10) ("reparixin" 2) ("Reparixin" 1)))
 ("NCIT:C66519" (("rivastigmine" 1))) ("NCIT:C66523" (("rosuvastatin" 7)))
 ("NCIT:C66531" (("secretin" 3)))
 ("NCIT:C66558" (("spiperone" 80) ("Spiperone" 11) ("spiperone's" 1)))
 ("NCIT:C66584" (("LDTs" 10) ("telbivudine" 1)))
 ("NCIT:C66610" (("tolbutamide" 15))) ("NCIT:C66633" (("trientine" 7)))
 ("NCIT:C66643" (("Tao" 21) ("TAO" 3) ("Tao's" 1)))
 ("NCIT:C66711" (("Zoniporide" 9)))
 ("NCIT:C66822"
  (("wine" 149) ("Wine" 2) ("wines" 1)
   ("the lateral venous anomaly or port wine" 1)))
 ("NCIT:C66877" (("IDV" 23)))
 ("NCIT:C66934"
  (("oil" 1539) ("Oil" 169) ("mineral oil" 24) ("oils" 17) ("OIL" 10)
   ("a colorless oil" 3) ("essential oil" 3) ("dietary fish oil" 2)
   ("Apo Neofluar 63X NA 1.25 oil" 2) ("a crude brown oil" 2)
   ("light mineral oil" 2) ("the volatile oil" 2) ("500 μl mineral oil" 2)
   ("a lambda blue 63×1.35 numerical aperture oil" 1) ("1.25 ml mineral oil" 1)
   ("vegetable oil" 1) ("the resulting colorless oil" 1)
   ("enough mineral oil" 1) ("the mineral oil" 1) ("vegetable oils" 1)
   ("Oil-" 1) ("Sigma mineral oil" 1) ("a brown oil" 1)))
 ("NCIT:C66937" (("XRP6258" 2)))
 ("NCIT:C66948" (("LBH589" 137) ("LBH-589" 12)))
 ("NCIT:C66961" (("AZD7762" 212) ("AZD7762 (AZD)" 1)))
 ("NCIT:C67043" (("APO866" 3) ("FK-866" 3)))
 ("NCIT:C67099"
  (("SNP309" 1403) ("-SNP309" 4)
   ("the well-studied single nucleotide polymorphism (SNP) SNP309" 2)
   ("the ancient SNP309" 1) ("the discordant MDM2 SNP309" 1)))
 ("NCIT:C67342"
  (("ice" 6757) ("dry ice" 56) ("ICEs" 21) ("Ice" 15) ("ice-" 1)
   ("ethanol-dry ice" 1)))
 ("NCIT:C67562"
  (("ranibizumab" 7) ("ranibizumab molecule" 3)
   ("intravitreal ranibizumab" 1)))
 ("NCIT:C683"
  (("neomycin" 442) ("Neomycin" 35) ("-Neomycin" 3) ("-neomycin" 1)))
 ("NCIT:C68820" (("PF-00477736" 63)))
 ("NCIT:C68845"
  (("abiraterone acetate" 39) ("Abiraterone acetate" 5) ("Zytiga" 4)
   ("Abiraterone acetate (AA)" 1)))
 ("NCIT:C68936" (("AC220" 115)))
 ("NCIT:C690"
  (("Ni" 858) ("nickel" 423) ("Nickel" 70) ("Ni(II)" 18) ("Ni-" 9)
   ("nickel-" 7) ("Nis" 3) ("nickel(II)" 3)
   ("DGS-nitrilotriacetic acid (NTA)-Ni" 3) ("-Ni" 2)
   ("The potential nickel-" 2) ("water-soluble nickel" 1)
   ("the water-soluble nickel" 1) ("water-insoluble nickel" 1) ("Ni–" 1)
   ("aqueous Raney Nickel" 1) ("potential nickel-" 1) ("potential nickel" 1)
   ("nongenotoxic Ni(II)" 1) ("nonmutagenic Ni(II)" 1)))
 ("NCIT:C691"
  (("nicotine" 700) ("Nicotine" 64) ("vehicle-treated mice nicotine" 1)))
 ("NCIT:C699"
  (("nitrosourea" 29) ("-nitrosourea" 12) ("-nitrosourea (NMU)" 8)
   ("-nitrosourea (MNU)" 6) ("Nitrosourea (NMU)" 1) ("Nitrosourea" 1)))
 ("NCIT:C70547" (("Ana" 117) ("antinuclear antibody" 22) ("ana" 5) ("ana-" 1)))
 ("NCIT:C70620" (("LA" 588) ("LACs" 9) ("pLA" 2) ("more LACs" 2) ("LA-" 1)))
 ("NCIT:C70741" (("GA101" 1))) ("NCIT:C70941" (("cotinine" 29) ("Cotinine" 2)))
 ("NCIT:C70982"
  (("OSI-906" 117) ("the ATP-competitive dual InsR/IGF-1R TKIs OSI-906" 2)
   ("The dual IGF-IR/IR inhibitor OSI-906" 1)
   ("the dual tyrosine kinase inhibitor OSI-906" 1)))
 ("NCIT:C711" (("octreotide" 5) ("Octreotide" 1)))
 ("NCIT:C71132" (("BR-DIM" 114)))
 ("NCIT:C71467" (("AUY922" 195) ("than AUY922" 1)))
 ("NCIT:C716" (("omeprazole" 95) ("Omeprazole" 22)))
 ("NCIT:C71631" (("leucovorin" 92) ("leucovorin (LC)" 1)))
 ("NCIT:C71704" (("SAR245409" 1))) ("NCIT:C71716" (("ITF2357" 3)))
 ("NCIT:C71717"
  (("MLN8237" 263) ("MLN8237-" 1)
   ("AURKA investigational inhibitor MLN8237" 1)))
 ("NCIT:C71734" (("Nifurtimox" 7)))
 ("NCIT:C71744"
  (("MDV3100" 356) ("than MDV3100" 1)
   ("an investigational anti-androgen MDV3100" 1)))
 ("NCIT:C71750" (("amuvatinib" 38) ("Amuvatinib" 2)))
 ("NCIT:C72560" (("pomalidomide" 13))) ("NCIT:C72628" (("linsidomine" 7)))
 ("NCIT:C72629" (("piperine" 1)))
 ("NCIT:C72726" (("ciglitazone" 126) ("Ciglitazone" 11)))
 ("NCIT:C72837" (("raltegravir" 6) ("Raltegravir" 5) ("raltegravir (RAL)" 1)))
 ("NCIT:C729" (("penicillamine" 5) ("-penicillamine" 4)))
 ("NCIT:C72982" (("acipimox" 18) ("Acipimox" 4)))
 ("NCIT:C73030" (("CP20" 27) ("deferiprone" 4)))
 ("NCIT:C731" (("pentamidine" 4)))
 ("NCIT:C73144" (("Maraviroc" 67) ("maraviroc" 52)))
 ("NCIT:C73261" (("bendamustine" 11))) ("NCIT:C73269" (("memantine" 9)))
 ("NCIT:C733"
  (("PTX" 212) ("PTx" 17) ("Ptx" 15) ("Pentoxifylline" 3) ("pentoxifylline" 2)
   ("Pentoxifylline (PTX)" 1) ("pTx" 1)))
 ("NCIT:C73302" (("siramesine" 4))) ("NCIT:C73305" (("belotecan" 1)))
 ("NCIT:C73318" (("Elacridar" 3) ("GF120918" 1)))
 ("NCIT:C73489" (("sol" 43) ("Sol" 10) ("sols" 3) ("Sols" 1)))
 ("NCIT:C73589" (("vicriviroc" 2)))
 ("NCIT:C73598" (("bazedoxifene" 5) ("Bazedoxifene" 2)))
 ("NCIT:C738"
  (("phencyclidine" 7) ("Phencyclidine" 1)
   ("the psychotomimetic phencyclidine (PCP)" 1)))
 ("NCIT:C740" (("phenothiazine" 12)))
 ("NCIT:C74012" (("apatinib" 1) ("Apatinib" 1)))
 ("NCIT:C74038" (("GDC-0449" 58)))
 ("NCIT:C74059"
  (("RDEA119" 117) ("MEK inhibitor RDEA119" 28) ("than RDEA119 ( xref )" 1)))
 ("NCIT:C74061" (("PF-02341066" 19)))
 ("NCIT:C74072"
  (("BEZ-235" 45) ("PI3K inhibitor BEZ235" 8)
   ("the dual phosphoinostitide 3- kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor BEZ-235"
    2)))
 ("NCIT:C74077" (("KX-01" 2)))
 ("NCIT:C74080" (("Tasquinimod" 18) ("tasquinimod" 11) ("Tasquinimod‘s" 2)))
 ("NCIT:C741" (("phenytoin" 14))) ("NCIT:C74158" (("idebenone" 2)))
 ("NCIT:C74177" (("aminothiazole" 14)))
 ("NCIT:C74369" (("butaprost" 19) ("Butaprost" 3)))
 ("NCIT:C74547" (("GW786034" 8))) ("NCIT:C74594" (("nutlin-3a" 180)))
 ("NCIT:C75049" (("xylazine" 117) ("Xylazine" 16) ("-Xylazine" 3)))
 ("NCIT:C751"
  (("piroxicam" 45) ("Piroxicam" 4)
   ("the non steroidal anti-inflammatory drugs (NSAIDs) piroxicam" 1)))
 ("NCIT:C75285" (("Telenzepine" 3) ("telenzepine" 2)))
 ("NCIT:C75291" (("elesclomol" 1))) ("NCIT:C755" (("rPDGF" 13)))
 ("NCIT:C75595"
  (("XIST" 223) ("Xist" 100) ("XIC" 21) ("Xic" 7) ("than XIST" 1)
   ("significantly fewer XIST" 1)))
 ("NCIT:C75963" (("fumagillin" 9)))
 ("NCIT:C75979"
  (("hexon" 16) ("Hexon" 9) ("adenoviral capsid protein Hexon" 1)
   ("hexamethonium" 1)))
 ("NCIT:C76395" (("cangrelor" 7)))
 ("NCIT:C76752" (("ethylene" 142) ("Ethylene" 16)))
 ("NCIT:C76882" (("Senicapoc" 2))) ("NCIT:C76896" (("Beraprost" 2)))
 ("NCIT:C769" (("prednisolone" 61) ("Prednisolone" 2)))
 ("NCIT:C76917" (("oteracil" 3))) ("NCIT:C76994" (("benzestrol" 3)))
 ("NCIT:C770" (("prednisone" 137) ("Prednisone" 5)))
 ("NCIT:C77023" (("aminoacridine" 5))) ("NCIT:C77056" (("resorcinol" 1)))
 ("NCIT:C77153"
  (("nitroprusside" 73) ("nitroprusside (SNP)" 14) ("nitroprusside-" 3)))
 ("NCIT:C772" (("Probenecid" 12) ("probenecid" 4)))
 ("NCIT:C773" (("pCZ" 24) ("procarbazine" 8) ("Procarbazine" 2)))
 ("NCIT:C77330" (("pyrvinium" 9) ("Pyrvinium" 7)))
 ("NCIT:C774" (("prochlorperazine" 7)))
 ("NCIT:C77840"
  (("acetylcholine" 151) ("Acetylcholine" 14)
   ("the nicotinic acetylcholine" 1)))
 ("NCIT:C77853" (("M5a" 9) ("monocytic M5a" 1))) ("NCIT:C77861" (("XL139" 2)))
 ("NCIT:C77876" (("MGCD265" 4)))
 ("NCIT:C77906" (("MLN4924" 351) ("NAE inhibitor MLN4924" 9)))
 ("NCIT:C78030" (("cyclofenil" 2)))
 ("NCIT:C78056" (("colesevelam" 39) ("colesevelam’s" 2)))
 ("NCIT:C78084"
  (("methoxyamine" 17) ("Methoxyamine" 6) ("methoxyamine (MX)" 3)
   ("the indirect APE1 inhibitor methoxyamine" 1)))
 ("NCIT:C78093" (("artemisinin" 9) ("Artemisinin" 3)))
 ("NCIT:C78126" (("dapagliflozin" 2))) ("NCIT:C78186" (("PF-01367338" 2)))
 ("NCIT:C78227" (("IgG4" 35))) ("NCIT:C78348" (("AT-101" 7)))
 ("NCIT:C78483" (("PF04217903" 6)))
 ("NCIT:C787"
  (("puromycin" 4063) ("Puromycin" 246) ("puroMycin" 4) ("-puromycin" 3)
   ("low glucose DMEM (Gibco) +10% tetracycline-free fetal bovine serum (Clontech) + puromycin"
    2)
   ("significantly more puromycin" 2) ("puromycin (EMD)" 2) ("puromycin-" 1)))
 ("NCIT:C788" (("pyrimethamine" 16) ("Pyrimethamine" 1)))
 ("NCIT:C78825" (("CAL101" 5))) ("NCIT:C78837" (("SB1518" 18)))
 ("NCIT:C78853" (("U3-1287" 2))) ("NCIT:C78859" (("MM-121" 27)))
 ("NCIT:C798" (("radio-sensitizer" 10) ("radiosensitizing agent" 3)))
 ("NCIT:C79825" (("Olaratumab" 2)))
 ("NCIT:C79835" (("XL888" 97) ("Hsp90 inhibitor XL888" 3)))
 ("NCIT:C79867" (("SCH900776" 141) ("only 200 nmol/L SCH900776" 1)))
 ("NCIT:C80014" (("combretastatin" 5))) ("NCIT:C80038" (("Sotatercept" 2)))
 ("NCIT:C80059" (("MK4827" 2)))
 ("NCIT:C80152"
  (("MDA" 1048) ("mda" 91) ("MDa" 80) ("mda-" 23) ("Mda" 6) ("MDA-" 4)
   ("approximately 1 MDa" 2)
   ("the human aggressive breast cancer cell lines MDA" 1) ("mDa" 1)
   ("around 1 MDa" 1) ("the ductal adenocarcinoma MDA" 1)
   ("expressing mda" 1)))
 ("NCIT:C80153"
  (("cocaine" 479) ("Cocaine" 29) ("acute cocaine" 2)
   ("simultaneous cocaine" 1) ("non-cocaine" 1) ("Acute cocaine" 1)
   ("we first performed cocaine" 1)))
 ("NCIT:C804"
  (("retinoids" 126) ("Retinoids" 13) ("clinically relevant retinoids" 5)
   ("classical retinoids" 2)
   ("carboxylic acid group (-COOH)-substituted retinoids" 1)
   ("than retinoids" 1)))
 ("NCIT:C80589" (("Noscapine" 93))) ("NCIT:C80679" (("lasofoxifene" 4)))
 ("NCIT:C807" (("ribavirin" 53) ("Ribavirin" 16) ("ribavirin (RBV)" 1)))
 ("NCIT:C80787" (("epiestriol" 1))) ("NCIT:C809" (("ricin" 4) ("Ricin" 1)))
 ("NCIT:C81109" (("benserazide" 65) ("Benserazide" 6)))
 ("NCIT:C81111" (("etomoxir" 40) ("Etomoxir" 3)))
 ("NCIT:C813"
  (("mRNA" 65986) ("mRNAs" 8069) ("messenger RNA" 459) ("messenger RNAs" 153)
   ("Messenger RNA" 50) ("mRNA molecule" 41) ("targeted mRNAs" 32)
   ("targeted mRNA" 28) ("viral mRNA" 15) ("mRNA-" 14) ("the mature mRNA" 12)
   ("most mRNAs" 11) ("polyadenylated mRNAs" 11)
   ("targeting human cyclin D1 mRNA" 10) ("weak mRNAs" 9) ("mature mRNA" 9)
   ("polysomal mRNA" 8) ("-mRNA" 7) ("NCBI" 7) ("mature mRNAs" 7)
   ("their respective mRNAs" 6) ("the respective mRNAs" 6)
   ("polysome-associated mRNA" 5) ("protein-coding mRNAs" 5)
   ("a bicistronic mRNA" 5) ("previously published mRNA" 5)
   ("polyadenylated histone mRNAs" 5) ("whose mRNA" 4) ("bicistronic mRNAs" 4)
   ("than mRNA" 4) ("Messenger RNAs" 4) ("digital mRNA" 4)
   ("targeting Bcl2 or WT1 mRNA" 4) ("homologous mRNA" 4) ("many more mRNAs" 4)
   ("dicistronic mRNAs" 4) ("translatable mRNAs" 4) ("relative mRNA" 4)
   ("mature p21 mRNA" 4) ("fetal human brain mRNA" 3) ("shorter mRNA" 3)
   ("mRNA’s" 3) ("the mature mRNAs" 3) ("the authentic mRNAs" 3)
   ("viral M1 mRNA" 3) ("a polycistronic mRNA" 3) ("nearly all mRNAs" 3)
   ("we first measured VHR mRNA" 3) ("messenger RNA molecule" 3)
   ("mRNA (GCTTTGAACTGAAGACTAT)" 3) ("whose mRNAs" 3) ("the respective mRNA" 3)
   ("directly target CYP1B1 mRNA" 3) ("miR-130a directly targets c-myc mRNA" 3)
   ("only PARP-1 mRNA" 3) ("than mRNAs" 3)
   ("plasmid-expressed β-globin mRNA" 3) ("faecal COX-2 mRNA" 3)
   ("the distal mRNA" 3) ("the predominant splice variant mRNA" 3)
   ("Weak mRNAs" 3) ("mature MDM2 mRNA" 3) ("more sPLA 2 IIa messenger RNA" 3)
   ("the two allelic mRNAs" 3) ("the viral mRNAs" 2)
   ("mRNA (AAAGACCTCTCACAATATT)" 2)
   ("a minor and transient increase inBim EL andBim L mRNA" 2)
   ("75 kPa hydrogels produced significantly less YAP mRNA" 2)
   ("a single bicistronic mRNA" 2) ("a specific viral mRNA" 2)
   ("influenza A virus M1 mRNA" 2)
   ("TERT promoter overexpressed less frequently TERT messenger RNA" 2)
   ("amplifiable mRNA" 2) ("the protein-coding RASSF1A mRNA" 2)
   ("ribosomal 18S mRNA" 2) ("mature MIR155HG mRNA" 2) ("secondary mRNA" 2)
   ("gp120 increased FCRL4 mRNA" 2)
   ("a monocistronic firefly luciferase mRNA" 2)
   ("polysome-associated mRNAs" 2) ("121 exon-deleted ESR1 mRNAs" 2)
   ("exon-deleted ESR1 mRNAs" 2) ("cortical ESR1 mRNA" 2) ("Global mRNA" 2)
   ("these weak mRNAs" 2) ("mRNA (PCR)" 2) ("U/AU-Rich mRNAs" 2)
   ("nef -IRES- eGFP bicistronic mRNA" 2) ("more PCNA mRNA" 2)
   ("0.5-fold more cyclin B1 mRNA" 2)
   ("fibrogenic genes α-SMA and α1-collagen mRNA" 2)
   ("Western blot and slug mRNA" 2) ("PTC mutated p53 mRNA" 2)
   ("the mutated p53 mRNA" 2) ("chondrogenic marker mRNA" 2)
   ("osteogenic marker mRNA" 2) ("comprehensive mRNA" 2)
   ("polysomal PAK1 mRNA" 2) ("polycistronic mRNAs" 2) ("Percent mRNA" 2)
   ("1350 unique mRNAs" 2) ("at least eight different mRNAs" 2)
   ("mitotic Stau1 55 -bound mRNAs" 2)
   ("indomethacin (10  μ M) completely inhibited apoptotic cell-induced HGF mRNA"
    2)
   ("lipogenic mRNAs" 2) ("the miR-221-targeted p27Kip1 mRNAs" 2)
   ("targeting hdmX mRNA" 2) ("multiple spliced viral mRNAs" 2)
   ("the most highly expressed mRNAs" 2)
   ("we first analysed MMP-2 , MMP-9 , and MMP-12 mRNA" 2)
   ("the mutated TP53 mRNA" 2) ("altogether 1015 mRNAs" 2)
   ("associated mRNAs" 2) ("targeting cyclin D1 mRNA" 2) ("Few mRNAs" 2)
   ("incompletely spliced viral mRNA" 2) ("unspliced viral mRNA" 2)
   ("Rev/RRE-dependent mRNA" 2) ("incompletely spliced viral mRNAs" 2)
   ("ROS increased CCN1 mRNA" 2) ("polyadenylated mRNA" 2)
   ("intronless viral mRNA" 2) ("the mutated mRNA" 2)
   ("an alternative doubly-spliced pX mRNA" 2)
   ("leptin increased beclin-1 mRNA" 2) ("the DNA damage-dependent mRNA" 2)
   ("targeting Rictor mRNA" 2) ("YB-1–associated mRNAs" 2)
   ("SG-associated poly(A) + mRNAs" 2) ("non-polysome-bound mRNAs" 2)
   ("the intracellular viral mRNA" 2) ("potential mRNA" 2) ("mRNA (NCBI)" 2)
   ("mature p53 mRNA" 2) ("directly binding c-Cbl and Cbl-b mRNA" 2)
   ("quantitative mRNA" 2) ("directly target MYC mRNA" 2)
   ("p53 increased IGFBP-3 mRNA" 2) ("immature mRNA" 2)
   ("Only variable mRNAs" 2)
   ("targeted
 mRNAs"
    2)
   ("even more strongly suppressed Oct1 mRNA" 2) ("larger Bcl-x mRNA" 2)
   ("an RNAi-resistant exogenous Bub1-wt mRNA" 2) ("targeting hLst2 mRNA" 2)
   ("poxviral mRNA" 2) ("“weak” mRNAs" 2)
   ("Pre-Developed TaqMan Assay Reagents Human GAPDH (20×) mRNA" 2)
   ("precursor intronic Lats2 mRNA" 2) ("directly Lats2 mRNA" 2)
   ("polyadenylated histone H3 mRNA" 2)
   ("miRNA-125a translationally arrests p53 mRNA" 2)
   ("miRNA-125 (miRNA-125a) translationally arrests mRNA" 2)
   ("Forskolin increased MMP-2 mRNA" 2) ("we first measured AREG mRNA" 2)
   ("previously identified TAF6δ-dependent mRNAs" 2) ("faecal B2M mRNA" 2)
   ("media increased BCL6 mRNA" 2) ("most eukaryotic mRNAs" 2)
   ("further reduced CTGF mRNA" 2) ("targeting human APC3 mRNA" 2)
   ("bi-directional mRNA" 2) ("that hyperosmolar stress induced Csh1 mRNA" 2)
   ("shorter mRNAs" 2) ("70 percent less IL-6 mRNA" 2)
   ("ribosomal subunit mRNAs" 2) ("less MMP-1 mRNA" 2) ("exogenic p53 mRNA" 2)
   ("exogenic MCT-1 mRNA" 2) ("AGs capture polyadenylated mRNAs" 2)
   ("an otherwise labile reporter mRNA" 2) ("targeted PKCδ mRNA" 2)
   ("more mdmx-S mRNA" 2) ("associated p21 mRNA" 2)
   ("a barely detectable p21 mRNA" 2)
   ("unable preferential translation viral mRNA" 2)
   ("targeted cytokine mRNAs" 2) ("purified poly A + mRNA" 2)
   ("maternal mRNA" 2) ("the mutated mRNAs" 2) ("internal control mRNA" 2)
   ("largest to-date mRNA" 2) ("mycobacterial RNA or rabbit mRNA" 2)
   ("targeting Pax3 mRNA" 2) ("heterologous lacZ mRNA" 2)
   ("predominantly full-length AR mRNA" 2) ("four mesenchymal marker mRNAs" 2)
   ("three neural marker mRNAs" 2) ("completely spliced viral mRNAs" 2)
   ("completely-spliced viral and cellular mRNAs" 2) ("the previous mRNA" 2)
   ("Bcl-xl and Mcl-1 mRNA’s" 2)
   ("the human neuronal nitric-oxide sythase (nNOS) mRNA" 2)
   ("the final mature mRNA" 2) ("functionally target many Hox mRNAs" 2)
   ("cell-cycle–associated mRNAs" 2) ("orthotopic tumor-derived mRNA" 2)
   ("more TNF and IL6 mRNA" 2)
   ("long (~35–40 kB) Chironomus tentans salivary gland mRNAs" 2)
   ("their resident mRNAs" 2) ("nonsense-mediated mRNA" 2)
   ("‘total’ Sirt3 mRNA" 2) ("endothelial-specific VE-cadherin mRNA" 2)
   ("indirect miR-124 target mRNAs" 2) ("solely YB-1 mRNA" 2)
   ("respective mRNAs" 2) ("Argonaute 2-associated mRNA" 2)
   ("increased tumoural mRNA" 2) ("only 16% mRNA" 2)
   ("biotinylated FOS mRNA" 2) ("each contributory mRNA" 2)
   ("weak gp30/ 40 mRNA" 1) ("6-fold or more increased USP14 mRNA" 1)
   ("potential downstream mRNA" 1) ("Potential downstream mRNA" 1)
   ("the most differentially expressed mRNAs" 1) ("yet Spy1 mRNA" 1)
   ("less TAZ mRNA" 1) ("subgenomic mRNAs" 1) ("respective mRNA" 1)
   ("Poly-adenylated mRNA" 1) ("previously reported ( xref ), c-MYC mRNA" 1)
   ("directly targeted STAT3 mRNA" 1) ("targeted STAT3 mRNA" 1)
   ("Viral mRNA" 1) ("moDC decreased p35 mRNA" 1)
   ("namely Mdm2 and miR-34a mRNAs" 1) ("relevant mRNA" 1)
   ("only one human RSK4 mRNA" 1) ("CT-1 increased MMP-1 mRNA" 1)
   ("than the protein-coding RASSF1A and RASSF1C mRNAs" 1)
   ("the protein-coding RASSF1A and RASSF1C mRNAs" 1)
   ("cancer directly targets mRNAs" 1)
   ("significantly (p<0.05) more PP6c mRNA" 1) ("a respective mRNA molecule" 1)
   ("more mRNA" 1) ("the differentially-regulated mRNAs" 1)
   ("in turn EGFR mRNA" 1) ("possibly vegf mRNA" 1) ("more vegf mRNA" 1)
   ("the long-sized mRNA" 1) ("especially long-sized mRNA" 1)
   ("-capped bicistronic luciferase reporter mRNA" 1)
   ("than ERα mRNA ( xref , xref )" 1) ("cortical ERα mRNA" 1)
   ("pro-apoptotic factor mRNAs" 1) ("A bicistronic reporter mRNA" 1)
   ("several pro-apoptotic mRNAs" 1) ("change secondary mRNA" 1)
   ("whose ESR1 transcript pool contained specific exon 7-deleted mRNAs" 1)
   ("hippocampal ESR1 mRNA" 1) ("L1 bicistronic mRNA" 1)
   ("bicistronic L1 mRNA" 1) ("ET A receptor mRNA" 1)
   ("Chromogranin A mRNA (PCR)" 1) ("AU-Rich element-containing mRNA" 1)
   ("~2-fold more PIK3CA mRNA" 1) ("monoamine oxidase (MAO) A mRNA" 1)
   ("0.2-fold more cyclin A2 mRNA" 1) ("less SLC34A2-ROS1 mRNA" 1)
   ("than AR mRNA" 1) ("significantly more TF mRNA" 1)
   ("most studies COX-2 mRNA" 1)
   ("absolute
mRNA"
    1)
   ("profibrotic mRNAs" 1) ("These viral mRNA" 1) ("more Rac1 mRNA" 1)
   ("spliced viral mRNAs" 1) ("significantly less Prkcb2 mRNA" 1)
   ("than CXCR3 mRNA" 1) ("more substrate mRNA" 1) ("mutated mRNAs" 1)
   ("PTC mutated mRNAs" 1) ("endogenous mutated mRNAs" 1)
   ("mutated endogenously expressed mRNAs" 1) ("PTC mutated mRNA" 1)
   ("375 unique mRNAs" 1) ("72 unique mRNAs" 1)
   ("We first analyzed global mRNA" 1) ("a unique Akt1 mRNA" 1)
   ("significantly less IL8 mRNA" 1) ("Relative target mRNA" 1)
   ("specifically target human cyclin D1 mRNA" 1)
   ("several cancer-relevant mRNAs" 1) ("cancer-relevant 3′-UTR mRNAs" 1)
   ("multiple mature mRNAs" 1) ("less interferon-γ mRNA" 1)
   ("more IL-4 mRNA" 1) ("HuD-associated mRNAs" 1) ("we first isolated mRNA" 1)
   ("MID1 complex-associated mRNAs" 1)
   ("divalent metal transporter 1 (DMT1) (+ IRE) mRNA" 1) ("relevant mRNAs" 1)
   ("a potential Stau1-associated mRNA" 1) ("than PAI-1 mRNA ( xref )" 1)
   ("expressed more cytokine mRNA" 1)
   ("we first overlapped differential expression mRNAs" 1)
   ("gain(Myc, Pvt1, Ccdc26, Gsdmc) mammary glands showed approximately 3.5-fold more Myc mRNA"
    1)
   ("than IR-B mRNA" 1) ("rectal biopsy mRNAs" 1)
   ("about 10-folds more AR mRNA" 1) ("meanwhile DLC2 mRNA" 1)
   ("exogenous mRNAs" 1) ("those expressing exogenous mRNAs" 1)
   ("typical cartilage mRNAs" 1) ("CpG-DNA-induced S100A8 and IL-10 mRNAs" 1)
   ("decreased CpG-DNA-induced S100A8 mRNA" 1) ("8,537 unique mRNAs" 1)
   ("synaptic mRNA" 1) ("than 30,000 mRNAs ( xref , xref )" 1)
   ("unique mRNAs" 1) ("mature miR-146a and EGFR mRNA" 1)
   ("the associated mRNA" 1) ("pro-apoptotic mRNA" 1)
   ("than those showing low- MET mRNA" 1) ("non-reverse transcribed mRNA" 1)
   ("than the positive control—the IL-2 mRNA 3" 1) ("more STK33 mRNA" 1)
   ("than Smad2 mRNA (Figure  xref C)" 1) ("neuronal mRNAs" 1)
   ("synaptic plasticity-related mRNAs" 1) ("specifically target SIRT1 mRNA" 1)
   ("well-designed sgRNAs targeting human cyclin D1 mRNA" 1)
   ("total and unspliced viral mRNA" 1) ("RRE-containing viral mRNA" 1)
   ("total viral mRNA" 1) ("Rev-dependent viral mRNA" 1)
   ("singly spliced viral mRNA" 1) ("a bi-cistronic Nef-IRES-eGFP mRNA" 1)
   ("Cyclo A mRNA" 1) ("amplifiable PTEN mRNA" 1) ("than ERβ mRNA" 1)
   ("than OGG1 mRNA" 1) ("only intronless viral mRNAs" 1)
   ("an exogenous mRNA" 1) ("correct mutant target mRNAs" 1)
   ("the bicistronic mRNA" 1) ("mature miR-130b and PTEN mRNA" 1)
   ("less CTGF mRNA" 1) ("than PKCζ mRNA" 1)
   ("at least 10 times more PKCι mRNA" 1) ("SG-resident mRNAs" 1)
   ("polysomal fractionated (ribosome-bound) mRNAs" 1)
   ("Western blot and BRCA1 mRNA" 1) ("the respective F-Luc mRNA" 1)
   ("possible mRNA" 1) ("fewer mRNAs" 1)
   ("actively translated polysomal mRNA" 1) ("monosomal mRNA" 1)
   ("We first examined mRNA" 1) ("we first examined mRNA" 1)
   ("many previously unappreciated mRNAs" 1) ("in turn target Ets1 mRNA" 1)
   ("the residual mRNA" 1) ("target homologous mRNA" 1)
   ("directly target ROCK mRNAs" 1) ("buccal swab Pgc-1 α mRNA" 1)
   ("pro-apoptotic effector caspase-3 mRNA" 1) ("399 temporal cortex mRNA" 1)
   ("than 20 variant mRNAs [ xref – xref ]" 1)
   ("key transcriptionally-controlled autophagy gene mRNAs" 1)
   ("significantly less CDA mRNA" 1) ("had several potential target mRNAs" 1)
   ("potential target mRNAs" 1) ("some mTORC1-dependent mRNAs" 1)
   ("p53 mature mRNA" 1) ("its representative target NQO1 mRNAs" 1)
   ("Intriguingly ASF2 and U2AF65 mRNA" 1) ("exogenous mRNA" 1)
   ("than its mRNA" 1) ("the exon 15-skipped HER2 mRNA" 1)
   ("cell-cycle-associated mRNAs" 1)
   ("Glomerular and tubulointerstitial mRNAs" 1) ("more IL-12 mRNA" 1)
   ("less IL-10 mRNA" 1) ("than one mRNA" 1) ("mRNA (UGAGAAGUCUCCCAGUCAG)" 1)
   ("mRNA (CGUACGCGGAAUACUUCGA)" 1) ("only IGFBP-2a mRNA" 1) ("a few mRNAs" 1)
   ("very little p21 mRNA" 1) ("Polyadenylated mRNA" 1) ("larger p53 mRNA" 1)
   ("yield viral mRNA" 1) ("the stress-induced mRNAs" 1)
   ("this study expressed at least 50% more BRCA1 mRNA" 1) ("more ACC2 mRNA" 1)
   ("the resultant mRNA" 1) ("about 100-fold more hTERT mRNA" 1)
   ("slightly more hTERT mRNA" 1) ("9-fold less mTERT mRNA" 1)
   ("about 100-fold less hTERT mRNA" 1) ("than the full-length hTERT mRNA" 1)
   ("EGF decreased AR mRNA" 1) ("less CCHCR1 mRNA" 1)
   ("whose tumors expressed below-median EpoR mRNA" 1) ("less BHLHB3 mRNA" 1)
   ("Xenopus (x)TERT ci (D770A) mRNA" 1) ("2.5 times less TPM1 mRNA" 1)
   ("100-1000-fold more hTERT mRNA" 1) ("monocistronic mRNAs" 1)
   ("Western blot and β-catenin mRNA" 1) ("the sequence-tagged mRNA" 1)
   ("subunit increased endogenous Neph3 mRNA" 1)
   ("subunits increased Neph3 mRNA" 1) ("no expressed protein-coding mRNAs" 1)
   ("most highly expressed EGFR mRNA" 1) ("endometrial carcinomas mRNAs" 1)
   ("an mRNA's" 1) ("The resultant histone mRNA" 1) ("10-fold more Myb mRNA" 1)
   ("Eyes absent 4 (EYA4) mRNA" 1) ("endogeneous Nrf2 mRNAs" 1)
   ("a monocistronic Fluc mRNA" 1) ("than the p131 mRNA" 1)
   ("hypoxia decreased CXCR4 mRNA" 1) ("the potential mRNA" 1)
   ("bicistronic mRNA" 1) ("faecal B2M, CEA, E-cad, or CD45 mRNAs" 1)
   ("than the endogenous β-catenin mRNA" 1)
   ("Hyperglycemia increased iNOS mRNA" 1)
   ("the untranslatable cellular mRNAs" 1)
   ("a more stringent dicistronic mRNA" 1) ("longer COX-2 mRNA" 1)
   ("longer mRNA" 1) ("nearly every fully processed eukaryotic mRNA" 1)
   ("only HDAC1 mRNA" 1) ("IL-4-driven GATA-3 mRNA" 1)
   ("internal control GAPDH mRNA" 1)
   ("120 ng/well (12 well plate) m7GpppG-capped renilla-let-7(8x) mRNA" 1)
   ("120 ng/well (12 well plate) m7GpppG-capped renilla-let-7(8x) (Addgene) mRNA"
    1)
   ("polysomal mRNAs" 1) ("most e2f1 and dp mRNAs" 1)
   ("exon IV-containing BDNF mRNA" 1) ("more SmgGDS-607 mRNA" 1)
   ("than SmgGDS-558 mRNA ( xref  D )" 1)
   ("MiTF-WT increased p21 WAF1/CIP1 mRNA" 1) ("their client mRNAs" 1)
   ("10 times more S100A7 and DEFB4 mRNA" 1)
   ("subconfluent NHK expressed 6 times more mRNA" 1)
   ("a subconfluent cell density showed relatively little inducible DEFB4 mRNA"
    1)
   ("than the full-length mRNA" 1) ("RT–PCR-quantified CLU mRNA" 1)
   ("Stat3 shRNA expressed less IL-6 mRNA" 1) ("4 times more IL-6 mRNA" 1)
   ("protein-coding messenger RNAs" 1) ("only MMP9 mRNA" 1)
   ("more IL8 and MYC mRNA" 1) ("six times more mRNA" 1)
   ("the associated mRNAs" 1) ("Polyadenylated mRNAs" 1)
   ("minimal detectable TNF-α mRNA" 1)
   ("HuR-associated IFN-γ and TNF-α mRNA" 1)
   ("Src transformed cells contained less Robo1 mRNA" 1)
   ("4 times more Slit2 mRNA" 1) ("relative amounts mRNA" 1)
   ("than 40-fold more CCNE1 mRNA" 1) ("40-fold more CCNE1 mRNA" 1)
   ("Similarly IL8 mRNA" 1) ("their respective mRNA" 1)
   ("post-translational mRNA" 1)
   ("PCR-amplified reverse-transcribed PTK6 mRNA" 1)
   ("reverted Bax and Bak mRNA" 1) ("the long-lived TP53 mRNA" 1)
   ("than the ARfl mRNA" 1) ("undetectable AR-V7 mRNA" 1)
   ("a single polycistronic mRNA" 1) ("than Elk-1 mRNA" 1) ("viral mRNAs" 1)
   ("the associated p21 mRNA" 1) ("its associated p21 mRNA" 1)
   ("nearly full length Atm mRNA" 1) ("mutated mRNA" 1)
   ("memory CD4 T cells produced >10-fold more IFN-γ mRNA" 1)
   ("the internal control mRNAs" 1) ("less cyclin D1b mRNA" 1)
   ("than cav-1 mRNA" 1) ("eight times more FGFR2 mRNA" 1)
   ("50% and 40% less PRL-2 mRNA" 1) ("than mRNA testing" 1)
   ("the MYCN mRNA’s" 1) ("These “weak” mRNAs" 1)
   ("an aberrantly spliced mature mRNA" 1) ("more hRasGRP4 mRNA" 1)
   ("more INSR-B mRNA" 1) ("potentially any mRNAs" 1)
   ("AKT increased ADAM12 mRNA" 1) ("targeted XAP2 mRNA" 1)
   ("mature XBP-1 mRNA" 1) ("TNFα increased SP1 mRNA" 1)
   ("the two primary study endpoints cervical COX-2 mRNA" 1)
   ("cervical COX-2 mRNA" 1) ("Approximately 3 μg mRNA" 1)
   ("GDF1 bi-cistronic mRNA" 1) ("a bi-cistronic mRNA" 1)
   ("post-transcriptional mRNA" 1) ("intron-containing mRNA's" 1)
   ("binary high HER2 mRNA" 1) ("the only in-frame Pax-3 mRNA" 1)
   ("at least some mRNAs" 1) ("the Ad-IRF3-induced mRNA" 1) ("mRNA (NMD)" 1)
   ("a few target mRNAs" 1) ("the newly identified target mRNAs, Pim-1" 1)
   ("than bulk mRNA" 1) ("than other mRNAs" 1)
   ("pro-apoptotic BAX, BAD and BIK mRNAs" 1) ("the endogeneous mRNA" 1)
   ("the endogeneous neuronal N-Bak mRNA" 1)
   ("PD-PANC-1s expressed four-fold less vimentin mRNA" 1)
   ("PinX1 decreased hTERT mRNA" 1) ("Mature actin mRNA" 1)
   ("Mature p21 mRNA" 1) ("Mature HDAC8 mRNA" 1)
   ("six times more PAI-1 messenger RNA" 1)
   ("SRY (sex determining region Y)-box 2 ( SOX2 ) mRNA" 1)
   ("5,333 (replicate 2) unique mRNAs" 1) ("the CBC-associated mRNAs" 1)
   ("the unspliced viral mRNA" 1) ("most host mRNAs" 1)
   ("picornaviral mRNAs" 1) ("several potential mRNA" 1)
   ("specifically binds mRNAs" 1) ("DNAse-treated mRNA" 1)
   ("a reverse-transcribed JMJD2 mRNA" 1) ("the four ubiquitin-coding mRNAs" 1)
   ("two alternate HuR mRNAs" 1) ("the expressed mRNA's" 1)
   ("the mature MDM2 mRNA" 1) ("anti-apoptotic gene Bcl-xl and Mcl-1 mRNA’s" 1)
   ("pro-apoptotic gene Bak mRNA" 1) ("Bak, Bcl-xl, and Mcl-1 mRNA’s" 1)
   ("total or polysomal mRNA" 1) ("mesenchymal marker mRNA" 1)
   ("mRNA (GGACGTTCATTGTGATTGA)" 1) ("than A2V6 mRNA" 1)
   ("than A2WT mRNA in some differentiated adult tissues" 1)
   ("the mature cyclin A2 (A2WT) mRNA" 1) ("at least 8 mRNAs" 1)
   ("in turn targets E-cad mRNA" 1) ("only 283 mRNAs" 1)
   ("less TNF and IL6 mRNA" 1) ("the IFN-I-dependent MxA protein mRNA" 1)
   ("At least one EMT-TF mRNA" 1) ("absent ATM mRNA" 1)
   ("41 (32%) colorectal adenomas expressed both SNAI1 and TWIST1 mRNA" 1)
   ("normal colonic mucosa, SNAI1, TWIST1 and CDH2 mRNA" 1)
   ("cellular Fas-associated death domain-like interleukin-1β-converting enzyme-like inhibitory protein mRNA"
    1)
   ("nucleocytoplasmic mRNA" 1) ("approximately 70% FGFR2-IIIc mRNA" 1)
   ("in fact both MYC mRNA" 1) ("these viral mRNAs" 1)
   ("than 30 distinct mRNAs that are grouped" 1) ("approximately 1–2 mRNAs" 1)
   ("approximately 20–40 mRNAs" 1) ("a potential mRNA" 1)
   ("solid tumors expressed significantly more ERBB2 mRNA" 1)
   ("mature (spliced) IL-6 mRNA" 1) ("CD55 mRNA’s" 1)
   ("newly synthesized polyadenylated mRNA" 1)
   ("nearly all (99.8 %) cellular mRNAs" 1)
   ("5-fold (P = 0.00011) more hTERT mRNA" 1)
   ("serous ovarian cancer patient mRNA" 1)
   ("multiple hepatic lipogenic enzyme mRNAs" 1)
   ("the bicistronic transcript mRNA" 1) ("other weak mRNAs" 1)
   ("the weak mRNA" 1) ("The inducible microsomal PGE 2 synthase mRNA" 1)
   ("peritoneal lavage fluid all contained E-cadherin mRNA" 1)
   ("High EREG tumoural mRNA" 1)
   ("whose tumors expressed TAZ, AXL and CTGF mRNA" 1)
   ("X-linked immune-related mRNAs" 1) ("pro-apoptotic Bax mRNA" 1)
   ("target protein-coding mRNAs" 1) ("only p21 mRNA" 1)
   ("its long muscle-specific isoforms increases p21 mRNA" 1)
   ("Very few specific target mRNAs" 1) ("CDKN1B allelic mRNAs" 1)
   ("FoxO1, FoxO3a or FoxO4 increased Myocd mRNA" 1)
   ("the bona fide NMD targeted (and therefore poorly translated) SRSF3 PTC+ mRNA"
    1)
   ("endogenous miR-21-targeted mRNAs" 1) ("cleavage-dependent mRNA" 1)
   ("the biotinylated mRNA" 1) ("possible non specific mRNA" 1)
   ("less CCND1/2 mRNA" 1) ("oxidative stress up-regulated Nrf2 mRNA" 1)))
 ("NCIT:C81344" (("xamoterol" 3)))
 ("NCIT:C814"
  (("rRNA" 1788) ("ribosomal RNA" 297) ("rRNAs" 91) ("ribosomal RNAs" 36)
   ("Ribosomal RNA" 10) ("-rRNA" 5) ("the mature rRNAs" 3) ("potential rRNA" 2)
   ("mature 28S and 18S rRNA" 2) ("pre-ribosomal rRNA" 2)
   ("the mature 28S, 18S, and 5.8S rRNA" 1)
   ("mature
rRNAs"
    1)
   ("the mature 5.8S rRNA" 1) ("the mature 28S rRNA" 1)
   ("Pol III-transcribed 5S rRNAs" 1)
   ("RPS9 knockdown cultures very little mature 18S rRNA" 1)
   ("mature 18S ribosomal RNA" 1) ("rRNA (ABI)" 1) ("the mature rRNA" 1)
   ("The traditional loading control 18S rRNA" 1) ("the chlamydial 16s rRNA" 1)
   ("chlamydial 16s rRNA" 1) ("rRNA (VIC)" 1)
   ("the mature 28S and 18S rRNAs" 1) ("membrane-associated ribosomal RNA" 1)))
 ("NCIT:C81404" (("cyclopropane" 1))) ("NCIT:C81418" (("fenfluramine" 1)))
 ("NCIT:C815"
  (("snRNA" 425) ("small nuclear RNA" 139) ("small nuclear RNAs" 8)
   ("Small nuclear RNA" 3) ("snRNA (GGCCGAGAAGCGAT)" 3)
   ("snRNA (TGCCAGGTAAGTAT)" 3) ("an approximately 60-nucleotide U7 snRNA" 1)))
 ("NCIT:C81566" (("prasugrel" 1)))
 ("NCIT:C81578" (("emetine" 112) ("Emetine" 22)))
 ("NCIT:C816"
  (("tRNA" 594) ("tRNAs" 221) ("transfer RNA" 13) ("transfer RNAs" 6)
   ("Transfer RNA" 5) ("tRNA molecule" 4) ("mature tRNAs" 2)
   ("deacylated tRNA" 2) ("the near-cognate transfer RNAs" 2)
   ("the nuclear aminoacylation-dependent tRNA" 1) ("than tRNAs" 1) ("-tRNA" 1)
   ("at least some cytosolic tRNAs" 1) ("virtually all tRNAs" 1) ("tRNA’s" 1)
   ("than telomerase use cellular tRNAs" 1)
   ("amino acids or surrogates such as cognate tRNAs" 1)))
 ("NCIT:C81604" (("pleconaril" 3) ("than pleconaril" 1)))
 ("NCIT:C81700" (("phenformin" 154) ("Phenformin" 14) ("than phenformin" 1)))
 ("NCIT:C81859" (("Mirlet7e" 1))) ("NCIT:C81878" (("miR10b" 2)))
 ("NCIT:C81888" (("miR17" 22) ("miRNA17" 1) ("miRs-17" 1) ("mir17" 1)))
 ("NCIT:C81915" (("miR-29b2" 15) ("miR29b2" 1)))
 ("NCIT:C81917" (("miR-29c" 42) ("miR29c" 1) ("than miR-29c" 1)))
 ("NCIT:C81934" (("PCI-32765" 7) ("BTK inhibitor PCI-32765" 3)))
 ("NCIT:C81937" (("LY2603618" 54)))
 ("NCIT:C81938"
  (("rhEGF" 22) ("recombinant human epidermal growth factor" 18) ("RhEGF" 18)
   ("exogenous rhEGF" 3) ("recombinant human epidermal growth factor (EGF)" 3)
   ("Recombinant human epidermal growth factor" 3)))
 ("NCIT:C82052" (("miRs-106a" 1)))
 ("NCIT:C82053" (("miRs-106b" 13) ("MiR-106b" 7) ("miR106b" 3)))
 ("NCIT:C82055" (("MIR107" 1))) ("NCIT:C82077" (("miR130a" 4) ("MiR-130a" 2)))
 ("NCIT:C82080" (("miR132" 3)))
 ("NCIT:C82156" (("MiR-200b" 19) ("miR200b" 13)))
 ("NCIT:C82157"
  (("miR-200c" 699) ("MiR-200c" 18) ("mir-200c" 12) ("miR200c" 9) ("mir200c" 3)
   ("MIR200C" 1) ("mature miR-200c" 1) ("potential miR-200c" 1)
   ("its transcriptional target miR-200c" 1)))
 ("NCIT:C82158" (("miR203" 72) ("MiR203" 8) ("miR203-" 2)))
 ("NCIT:C82171" (("miR221" 25) ("miRNA221" 9) ("miRs-221" 2) ("mir221" 1)))
 ("NCIT:C82172" (("miR222" 9)))
 ("NCIT:C82211"
  (("hsa-miR-196a2" 11) ("miR-196a2" 3) ("Hsa-miR-196a2" 3) ("miR196a2" 1)))
 ("NCIT:C82239" (("Liraglutide" 9) ("myocardial infarction Liraglutide" 2)))
 ("NCIT:C82254" (("NTBC" 4))) ("NCIT:C82258" (("A1AT" 3) ("A1AT(NHK)" 1)))
 ("NCIT:C82273" (("prothrombin" 42) ("Prothrombin" 7)))
 ("NCIT:C823" (("saponin" 418) ("Saponin" 38)))
 ("NCIT:C82364" (("AlloDerm" 12))) ("NCIT:C82387" (("HSP990" 11)))
 ("NCIT:C82404" (("SGI-1776" 29) ("PIM kinase inhibitor SGI-1776" 6)))
 ("NCIT:C82415" (("huachansu" 8) ("Huachansu" 4)))
 ("NCIT:C82653" (("MLN9708" 11) ("proteasome inhibitor MLN9708" 10)))
 ("NCIT:C82659" (("PEGPH20" 5))) ("NCIT:C82696" (("RO4987655" 2)))
 ("NCIT:C827" (("Semustine" 1)))
 ("NCIT:C83573" (("calcimycin" 79) ("Calcimycin" 3) ("calcimycin-" 1)))
 ("NCIT:C83740" (("guanabenz" 15) ("Guanabenz" 1)))
 ("NCIT:C83782" (("ifenprodil" 18) ("Ifenprodil" 2)))
 ("NCIT:C83887" (("Linagliptin" 1)))
 ("NCIT:C84191" (("Sulprostone" 6) ("sulprostone" 3)))
 ("NCIT:C84280"
  (("contaminants" 254) ("contaminant" 108)
   ("these represented probable contaminants" 3) ("Contaminant" 2)
   ("nonspecific contaminants" 2) ("a non-specific bacterial contaminant" 2)
   ("Contaminants" 2) ("other compartmental contaminants" 2)
   ("common nonspecific contaminants" 2)
   ("mesenchymal, endothelial or haematopoietic (Lin − ) contaminants" 2)
   ("external sample contaminants" 1)
   ("a ubiquitous environmental contaminant" 1)
   ("an omnipotent environmental contaminant" 1)
   ("fluorescent
contaminants"
    1)
   ("any organic contaminants" 1) ("residual ionic contaminants" 1)
   ("microbial contaminants" 1) ("nucleic acid contaminants" 1)
   ("mesenchymal contaminants" 1) ("an estrogenic environmental contaminant" 1)
   ("many nonspecific contaminants" 1) ("possible contaminants" 1)))
 ("NCIT:C845"
  (("streptozotocin" 110) ("Streptozotocin" 12) ("streptozotocin (STZ)" 7)
   ("streptozotocin-" 3) ("streptozocin" 2)))
 ("NCIT:C84616"
  (("MSM" 189) ("dimethyl sulfone" 2) ("msm" 2) ("the hierarchical MSM" 2)
   ("MSM's" 1)))
 ("NCIT:C84841" (("PF03758309" 20)))
 ("NCIT:C84858" (("TAK-733" 5) ("MEK inhibitor TAK-733" 4)))
 ("NCIT:C84865" (("Binimetinib" 20) ("binimetinib" 8)))
 ("NCIT:C84866" (("galeterone" 113) ("Galeterone" 29)))
 ("NCIT:C851" (("sunscreen" 41) ("Sunscreen" 2)))
 ("NCIT:C853" (("suramin" 20) ("Suramin" 1)))
 ("NCIT:C85465" (("APR-246" 6) ("Apr-246" 2)))
 ("NCIT:C85469"
  (("SF1126" 136) ("than SF1126 alone in all resistant cells" 1)))
 ("NCIT:C85484" (("SRT501" 41) ("than SRT501" 2)))
 ("NCIT:C857" (("teniposide" 12) ("pTG" 4)))
 ("NCIT:C859" (("teratogens" 6) ("teratogen" 3)))
 ("NCIT:C864"
  (("dioxin" 52) ("-dioxin" 8) ("Dioxin" 5) ("dioxins" 5)
   ("2,3,7,8-tetrachlorodibenzo- p -dioxin (TCDD)" 3)
   ("2,3,7,8-Tetrachlorodibenzo- p -dioxin (TCDD)" 1)
   ("2,3,7,8-tetrachlorodibenzo- p -dioxin" 1)))
 ("NCIT:C865"
  (("tetracycline" 1300) ("Tetracycline" 72) ("tetracycline-" 3)
   ("The most tetracycline" 2) ("fetal bovine serum tetracycline" 1)
   ("overnight using 2 μg/ml tetracycline" 1)))
 ("NCIT:C867"
  (("Tetrahydrocannabinol" 2) ("-tetrahydrocannabinol" 2)
   ("Tetrahydrocannabinol (THC)" 1) ("tetrahydrocannabinol" 1)))
 ("NCIT:C868" (("THU" 7) ("tetrahydrouridine" 5)))
 ("NCIT:C86976" (("glycophorins" 2) ("glycophorin" 1)))
 ("NCIT:C872" (("theophylline" 18) ("Theophylline" 3)))
 ("NCIT:C87294" (("oxypurinol" 14)))
 ("NCIT:C87435" (("aurothioglucose" 6) ("aurothioglucose (ATG)" 3)))
 ("NCIT:C87449" (("bezafibrate" 10))) ("NCIT:C87471" (("ciprofibrate" 4)))
 ("NCIT:C875" (("thiotepa" 5)))
 ("NCIT:C87576"
  (("hyaluronidase" 91) ("hyaluronidases" 31) ("Hyaluronidase" 11)))
 ("NCIT:C876" (("thioguanine" 29)))
 ("NCIT:C87652" (("IP6" 194) ("than IP6" 3) ("phytic acid" 1)))
 ("NCIT:C87656" (("quinacrine" 113) ("Quinacrine" 15) ("than quinacrine" 2)))
 ("NCIT:C87736"
  (("PPP" 102) ("picropodophyllin" 15) ("Picropodophyllin" 4) ("500 nM PPP" 3)
   ("picropodophyllin (PPP)" 2) ("Picropodophyllin (PPP)" 2)
   ("the IGF-1R inhibitor PPP" 1)))
 ("NCIT:C87751" (("pitavastatin" 12))) ("NCIT:C88271" (("AR-12" 3)))
 ("NCIT:C88293" (("JAK2 inhibitor TG101348" 29) ("SAR302503" 7)))
 ("NCIT:C88303" (("PLX3397" 8)))
 ("NCIT:C887"
  (("thyrotropin" 10) ("than thyrotropin (TSH)" 1)
   ("recombinant thyroid-stimulating hormone" 1)))
 ("NCIT:C88774" (("concanavalin A" 28) ("CONA" 2)))
 ("NCIT:C88789"
  (("PWM" 162) ("pokeweed mitogen" 3) ("Pokeweed mitogen" 1)
   ("than a single PWM (see xref )" 1)))
 ("NCIT:C88791"
  (("phytohemagglutinin" 57) ("phytohemagglutinin (PHA)" 24)
   ("Phytohemagglutinin" 2)))
 ("NCIT:C88924"
  (("lncRNAs" 1374) ("lncRNA" 970) ("lincRNA" 522) ("lincRNAs" 270)
   ("PACER" 75) ("LincRNA" 58) ("LncRNA" 20) ("LncRNAs" 17) ("LincRNAs" 6)
   ("most lncRNAs" 5) ("lncRNA PACER" 3) ("PACER lncRNA" 3)
   ("a potential oncogenic lncRNA" 3) ("intergenic lncRNAs" 3)
   ("unspliced intronic lncRNAs" 2) ("the intergenic lncRNA" 2)
   ("intronic unspliced lncRNA" 2) ("the well-studied intergenic lncRNAs" 2)
   ("abundant intergenic lncRNAs" 2)
   ("a novel unspliced antisense intronic lncRNA" 2) ("intronic lncRNAs" 2)
   ("cancer-associated lncRNAs" 2) ("Most lncRNAs" 2)
   ("a previously unreported lncRNA" 2) ("-lncRNAs" 2) ("The few lncRNA" 2)
   ("lncRNA (PACER)" 2) ("a tumor-suppressive lncRNA" 2)
   ("targeting bystander lncRNAs" 2) ("140 intergenic lncRNAs" 2)
   ("1,314 and 1,399 intergenic lncRNAs" 2)
   ("a non-annotated monoexonic intergenic lncRNA" 2)
   ("their nearest respective lincRNA" 2) ("only 1 down-regulated lincRNA" 2)
   ("a few lncRNAs" 2) ("associated lncRNAs" 2)
   ("pseudogene-expressed lncRNAs" 2) ("these unspliced intronic lncRNAs" 1)
   ("this intronic unspliced lncRNA" 1) ("an unspliced intronic lncRNA" 1)
   ("than these lincRNAs in HeLa cells ( xref )" 1) ("Intergenic lncRNAs" 1)
   ("the few biologically well-documented lncRNAs" 1)
   ("a previously unannotated lncRNA" 1)
   ("at least two uncharacterized promoter lncRNAs" 1)
   ("a muscle-specific lncRNA" 1) ("PACER RNA" 1) ("means most lncRNAs" 1)
   ("very few lncRNAs" 1) ("a heart-associated murine lncRNA" 1)
   ("two well-characterized oncogenic lncRNAs" 1) ("few lncRNAs" 1)
   ("the well-characterized lncRNAs" 1)
   ("the putatively ERα-regulated intergenic lncRNAs" 1)
   ("6,850 intergenic lncRNAs" 1) ("two representative lncRNAs" 1)
   ("sense-intronic lncRNAs" 1) ("Few lncRNAs" 1)
   ("the cancer-relevant lncRNA" 1) ("the most well characterized lncRNAs" 1)
   ("down significantly more HOTAIR lncRNA" 1) ("lncRNA-" 1)
   ("GC-associated lncRNAs" 1) ("a well-characterized lncRNA" 1)
   ("the respective antisense lncRNAs" 1) ("targeting antisense lncRNAs" 1)))
 ("NCIT:C88929" (("Tarp" 156) ("the bacterial effector protein Tarp" 1)))
 ("NCIT:C890" (("TDZ" 1)))
 ("NCIT:C891"
  (("tobacco" 1292) ("Tobacco" 127) ("non-tobacco" 5) ("“tobacco”" 2)
   ("–tobacco" 1) ("more tobacco" 1) ("smokeless tobacco" 1)))
 ("NCIT:C900"
  (("ATRA" 664) ("atRA" 140) ("AtRA" 3) ("longer half-life ATRA" 1)
   ("than ATRA" 1)))
 ("NCIT:C901" (("triamcinolone" 3)))
 ("NCIT:C90548"
  (("MLN0128" 204) ("the investigational drug MLN0128" 2) ("than MLN0128" 1)))
 ("NCIT:C90564" (("INC280" 2)))
 ("NCIT:C90565"
  (("PI3K inhibitor BKM120" 35) ("buparlisib" 3)
   ("than the selective PI3K inhibitor BKM120" 1)))
 ("NCIT:C90573" (("XL019" 11))) ("NCIT:C90574" (("AT-406" 2)))
 ("NCIT:C90585" (("MK5108" 3))) ("NCIT:C90591" (("MK2461" 20)))
 ("NCIT:C907" (("triiodothyronine" 62) ("Triiodothyronine" 5)))
 ("NCIT:C908"
  (("trimethoprim" 19) ("trimethoprim (TMP)" 3) ("-trimethoprim" 1)))
 ("NCIT:C90982" (("nifuroxazide" 113) ("Nifuroxazide" 12)))
 ("NCIT:C91039" (("MCE" 14) ("Mce" 1)))
 ("NCIT:C91072"
  (("GDC0068" 16) ("Akt inhibitor GDC-0068" 7)
   ("another new ATP- competitive inhibitor GDC0068" 2)))
 ("NCIT:C91089" (("LEQ506" 4)))
 ("NCIT:C912"
  (("tumor antigen" 102) ("taa" 12) ("Taa" 5) ("tumor antigen ( PKKKRKV )" 3)
   ("tumor antigen (ST)" 3) ("targeted tumor antigen" 3)
   ("a model ovarian tumor antigen" 3) ("-taa" 2)
   ("simian virus 40 large tumor antigen" 2) ("Tumor antigen" 2)
   ("the simian virus 40 (SV40) large tumor antigen ( PKKKRKV )" 1)))
 ("NCIT:C91392" (("LY2606368" 8)))
 ("NCIT:C91394" (("AZD1480" 322) ("JAK2 inhibitor AZD1480" 4)))
 ("NCIT:C91399" (("bidi" 12)))
 ("NCIT:C916" (("ubiquinone" 32) ("Ubiquinone" 2) ("coenzyme-Q" 1)))
 ("NCIT:C91724" (("RO5045337" 2)))
 ("NCIT:C91725" (("WEE1 inhibitor MK-1775" 2)))
 ("NCIT:C91731" (("GDC-0980" 52) ("the dual PI3K/mTOR inhibitor GDC-0980" 1)))
 ("NCIT:C91732" (("PKI-587" 12)))
 ("NCIT:C920" (("urethane" 80) ("Urethane" 3)))
 ("NCIT:C922"
  (("uridine" 175) ("uridine (EU)" 10) ("Uridine" 7) ("uridine (ENU)" 4)
   ("Uridine (EU)" 1)))
 ("NCIT:C925" (("vancomycin" 5)))
 ("NCIT:C92559" (("PCA3" 33) ("prostate cancer antigen 3" 3)))
 ("NCIT:C930" (("vinblastine" 190) ("Vinblastine" 27)))
 ("NCIT:C93260"
  (("pro-oxidant" 116) ("prooxidant" 26) ("pro-oxidants" 20) ("prooxidants" 2)
   ("Pro-oxidant" 2)))
 ("NCIT:C933"
  (("vincristine" 396) ("Vincristine" 33)
   ("the mitotic inhibitor vincristine" 2) ("vincristine (VIN)" 1)))
 ("NCIT:C94214" (("BYL719" 376) ("PI3K inhibitor BYL719" 9)))
 ("NCIT:C94220" (("PankoMab" 9)))
 ("NCIT:C945" (("warfarin" 57) ("Warfarin" 4)))
 ("NCIT:C94553"
  (("buildup" 125) ("build-up" 76) ("buildups" 5) ("the immediate build-up" 1)
   ("an otherwise toxic build-up" 1) ("The consequent buildup" 1)
   ("resultant build-up" 1) ("Buildup" 1) ("Oxidative stress—a build-up" 1)
   ("a more noticeable build-up" 1) ("the toxic build-up" 1)
   ("a similar global buildup" 1)))
 ("NCIT:C94600"
  (("BCR-ABL" 1500) ("BCR-Abl" 59) ("BCR–ABL" 44) ("BCR-ABL fusion gene" 19)
   ("BCR-ABL protein" 9) ("BCR–ABL fusion gene" 4) ("expressing BCR-ABL" 2)
   ("targeted BCR-ABL" 2) ("than wild type BCR-ABL" 1)
   ("triple mutant BCR-ABL" 1) ("the triple mutant BCR-ABL" 1)
   ("BCR-ABL (WT)" 1)))
 ("NCIT:C947"
  (("azidothymidine" 18) ("zidovudine" 12) ("azidothymidine (AZT)" 7)
   ("Zidovudine (AZT)" 3)
   ("the first antiretroviral active drug azidothymidine" 2) ("Zidovudine" 1)
   ("zidovudine (AZT)" 1) ("Azidothymidine" 1)))
 ("NCIT:C94725"
  (("SSRI" 8) ("selective serotonin reuptake inhibitor" 6)
   ("selective serotonin reuptake inhibitor (SSRI)" 5)))
 ("NCIT:C94728"
  (("fluoropyrimidine" 125) ("fluoropyrimidines" 27) ("Fluoropyrimidines" 4)
   ("fluoropyrimidine drug" 2) ("Fluoropyrimidine" 2) ("fluoropyrimidine-" 1)))
 ("NCIT:C9506" (("UFT" 22)))
 ("NCIT:C95114"
  (("gamma-secretase" 40) ("gamma secretase" 14) ("Gamma-Secretase" 2)
   ("Gamma-secretase" 1) ("Gamma secretase" 1)))
 ("NCIT:C95196"
  (("avid" 44) ("less avid" 2) ("non-avid" 2) ("-avid" 2) ("Avid" 1)
   ("much more avid" 1) ("slightly less avid" 1) ("AVID" 1)))
 ("NCIT:C95244"
  (("Elongin" 154) ("elongin" 24) ("Elongins" 20) ("elongins" 11)))
 ("NCIT:C95407" (("macroH2A" 26) ("mH2A" 12)))
 ("NCIT:C95408"
  (("ACA" 904) ("aca" 58) ("-ACA" 26) ("Aca" 6) ("-aca" 4)
   ("the invasive ACA" 3) ("smoking history and mutation-negative ACA" 2)
   ("the ‘classical’ ACA" 2) ("normal and benign ACA" 1)
   ("the deeper invasive ACA" 1) ("the adjacent invasive ACA" 1)
   ("the more deeply invasive ACA" 1) ("ACA-" 1) ("acA" 1)))
 ("NCIT:C956"
  (("edelfosine" 20) ("than edelfosine ( xref )" 1) ("Edelfosine" 1)))
 ("NCIT:C95702"
  (("BMS-911543" 75) ("JAK2 inhibitor BMS-911543" 15)
   ("orally bioavailable JAK2 inhibitor BMS-911543" 1)))
 ("NCIT:C95740" (("LY2275796" 7))) ("NCIT:C95800" (("tasocitinib" 4)))
 ("NCIT:C95938"
  (("dsRNA" 666) ("double-stranded RNA" 198) ("dsRNAs" 98)
   ("double-stranded RNAs" 37) ("Double-stranded RNA" 9) ("viral dsRNA" 6)
   ("viral double-stranded RNA" 5) ("Double-stranded RNAs" 3) ("-dsRNA" 3)
   ("respective dsRNA" 2) ("the respective dsRNAs" 2) ("Double-Stranded RNA" 2)
   ("a nonspecific control dsRNA" 2) ("double-stranded RNA molecule" 2)
   ("an approximately 22-nt double-stranded RNA (dsRNA) molecule" 2)
   ("double-stranded RNA (dsRNA) molecule" 2) ("the viral by-product dsRNA" 1)
   ("Biotinylated dsRNA" 1) ("this dsRNA's" 1) ("a homologous dsRNA" 1)
   ("their respective dsRNAs" 1)
   ("a 6-FAM-labeled inactive double-stranded RNA" 1) ("two separate dsRNA" 1)
   ("binding viral dsRNA" 1) ("300 NM dsRNA’s" 1)
   ("other viral and bacterial dsRNAs" 1) ("viral dsRNAs" 1)
   ("double-stranded RNA-" 1) ("dsRNA-" 1) ("targeted dsRNA" 1)))
 ("NCIT:C95939"
  (("ssRNA" 66) ("single-stranded RNA" 65) ("single-stranded RNAs" 49)
   ("single-stranded RNA molecule" 4) ("ssRNAs" 3) ("viral ssRNA" 2)
   ("Single-stranded RNAs" 1) ("Single-stranded RNA" 1)))
 ("NCIT:C95943"
  (("rDNA" 530) ("ribosomal RNA gene" 9) ("extrachromosomal rDNA" 6)
   ("form growth-associated higher-order rDNA" 1)
   ("self-replicating extrachromosomal rDNA" 1) ("the ribosomal rDNA" 1)
   ("toxic rDNA" 1) ("extra-chromosomal rDNA" 1)))
 ("NCIT:C95952"
  (("gRNA" 33) ("guide RNA" 26) ("gRNAs" 15) ("guide RNAs" 13)
   ("an artificial small guide RNA" 4) ("chimaeric guide RNA" 2)
   ("The chimaeric gRNA" 1)))
 ("NCIT:C95953"
  (("piRNAs" 11) ("piRNA" 10) ("PIWI-interacting RNAs" 4)
   ("Piwi-interacting RNAs" 3) ("Piwi-interacting RNA" 3)
   ("piwi-interacting RNAs" 2)))
 ("NCIT:C95979" (("androstenediol" 4)))
 ("NCIT:C96232" (("NG-nitro-L-arginine" 1)))
 ("NCIT:C96285" (("compactin" 9) ("Mevastatin" 3) ("mevastatin" 2)))
 ("NCIT:C96286" (("Ilomastat" 12) ("ilomastat" 8) ("Ilomastat's" 1)))
 ("NCIT:C96295" (("pepstatin" 925) ("Pepstatin" 57)))
 ("NCIT:C96314" (("MTORC1" 73) ("MTORC2" 64) ("Rictor-mTOR" 4) ("pMTORC1" 1)))
 ("NCIT:C96401" (("OPVs" 1))) ("NCIT:C96531" (("SB681323" 4)))
 ("NCIT:C96898" (("CD15" 83)))
 ("NCIT:C970" (("metaiodobenzylguanidine" 2) ("meta-iodobenzylguanidine" 1)))
 ("NCIT:C97127"
  (("vis" 90) ("Vis" 34) ("VIs" 3) ("our conservative approaches vis" 1)))
 ("NCIT:C97356" (("AEDs" 4))) ("NCIT:C97383" (("cyclinsD3" 1)))
 ("NCIT:C97452" (("NRTIs" 7)))
 ("NCIT:C97453"
  (("NNRTI" 11) ("non-nucleoside reverse transcriptase inhibitor" 1)))
 ("NCIT:C97560" (("HB9" 126) ("Hb9" 37) ("Hb9-" 1)))
 ("NCIT:C97660" (("abemaciclib" 2)))
 ("NCIT:C97713" (("harmine" 24) ("Harmine" 18)))
 ("NCIT:C97745" (("VLA-4" 187) ("VLA4" 6) ("appreciably expressed VLA-4" 1)))
 ("NCIT:C97940" (("MLN2238" 132) ("than MLN2238" 1)))
 ("NCIT:C97997" (("BAMPER" 4)))
 ("NCIT:C981"
  (("decitabine" 134) ("Decitabine" 17)
   ("the DNA demethylating agent decitabine" 1)))
 ("NCIT:C98213" (("GS-9450" 52)))
 ("NCIT:C98250"
  (("CDDO-Me" 224) ("bardoxolone methyl" 9) ("Bardoxolone methyl" 3)))
 ("NCIT:C983" (("acarbose" 2))) ("NCIT:C985" (("acitretin" 1)))
 ("NCIT:C986" (("acivicin" 4))) ("NCIT:C99562" (("paraoxon" 2)))
 ("NCIT:C99905" (("rociletinib" 89) ("Rociletinib" 2)))
 ("PCID:10085693" (("zebularine" 40) ("Zebularine" 2)))
 ("PCID:10113978" (("pazopanib" 79) ("Pazopanib" 11)))
 ("PCID:101179"
  (("HG" 907) ("Hg" 251) ("hg" 195) ("HG-" 3) ("hG" 2) ("than 20 mm Hg" 1)
   ("at least 140/90 mm Hg" 1) ("than 21 mm Hg" 1)
   ("than 21 mm Hg using a Goldmann applanation tomometer" 1)
   ("than 28 mm Hg" 1) ("than 22 mm Hg" 1)
   ("normal optic nerve head appearance and IOP ≤21 mm Hg" 1)))
 ("PCID:10127622" (("AZD-6244" 18)))
 ("PCID:10133" (("chenodeoxycholate (CDC)" 2) ("chenodeoxycholate" 2)))
 ("PCID:1014" (("phosphorylcholine" 11))) ("PCID:1017" (("m2" 119)))
 ("PCID:10205"
  (("plumbagin" 321) ("Plumbagin" 104)
   ("5-hydroxy-2-methyl-1,4-naphthoquinone" 4) ("Plumbagin (PLB)" 2)))
 ("PCID:10206" (("cepharanthine" 6))) ("PCID:10207" (("aloe-emodin" 1)))
 ("PCID:1021"
  (("porphobilinogen (PBGD)" 1) ("porphobilinogen" 1) ("Porphobilinogen" 1)))
 ("PCID:10214" (("3'-phosphoadenosine-5'-phosphosulfate" 3)))
 ("PCID:102212"
  (("uM" 731) ("UM" 718) ("um" 121) ("UMs" 11) ("UMS" 5) ("Um" 3)
   ("most UMs" 2) ("UM-" 2) ("than 100 um" 1) ("than 0.25 uM" 1)
   ("local intraocular UM" 1) ("an IC50 around 15 uM" 1) ("at least 10 um" 1)
   ("roughly 12 uM" 1) ("serial 6 um" 1)))
 ("PCID:10255"
  (("kainic acid" 17) ("Kainic acid" 2)
   ("intraperitoneal kainic acid (KA)" 1)))
 ("PCID:10258" (("indoxyl sulfate" 1)))
 ("PCID:10281" (("TQ" 235) ("the active ingredient TQ" 1) ("TQs" 1)))
 ("PCID:10288191" (("MEK 162" 1)))
 ("PCID:10296883" (("AEB071" 14) ("sotrastaurin" 1)))
 ("PCID:1031"
  (("propanol" 27) ("1-propanol" 9)
   ("erythro -2-(4-Benzylpiperidino)-1-(4-hydroxyphenyl)-1-propanol" 1)
   ("-1-propanol" 1)))
 ("PCID:10341154" (("VX-702" 4))) ("PCID:10436839" (("NH125" 12)))
 ("PCID:10445608" (("Ft" 50) ("ft" 5) ("FTs" 1)))
 ("PCID:10460379"
  (("HDAC inhibitors" 923) ("HDAC inhibitor" 814) ("HDAC Inhibitor" 10)
   ("HDI" 7) ("a nonselective HDAC inhibitor" 4) ("HDAC inhibitors (HDI)" 2)
   ("valproic acid or more potent HDAC inhibitors" 2)
   ("HDAC inhibitor (TSA)" 1) ("a hybrid-polar HDAC inhibitor" 1)
   ("a clinically relevant HDAC inhibitor" 1) ("an unselective HDI" 1)
   ("HDAC
 inhibitor"
    1)
   ("a classical HDAC inhibitor" 1) ("a classic HDAC inhibitor" 1)
   ("Most HDAC inhibitors" 1) ("a weak HDAC inhibitor" 1)
   ("HDAC inhibitor (HDACI)" 1) ("relatively non-toxic HDAC inhibitors" 1)
   ("a well-characterized HDAC inhibitor" 1)))
 ("PCID:10461508" (("volasertib" 40) ("Volasertib" 12)))
 ("PCID:10461815"
  (("PHA665752" 81)
   ("than the Met antagonist PHA665752 (IC 50 = 60 nM; xref , triangles)" 1)))
 ("PCID:104727"
  (("al" 23805) ("AL" 504) ("aluminum" 76) ("Al" 72) ("Pekovic et al" 9)
   ("Goldgar et al" 5) ("Riely et al" 4) ("alloys" 4) ("Brown et al" 4)
   ("Gully et al" 4) ("Bahmanyar et al" 4) ("Scully et al" 3)
   ("Torlakovic et al" 3) ("Rafnar et al" 3) ("Cieply et al" 3)
   ("Truhlar et al" 3) ("alloy" 3) ("Valent et al" 3) ("Aluminum" 2)
   ("Reilly et al" 2) ("For instance, Gao et al" 2) ("Connolly et al" 2)
   ("Mosoian et al" 2) ("Gasparian et al" 2) ("Sanyal et al" 2) ("al (STM)" 2)
   ("Horcic et al" 2) ("Armanious et al" 2) ("Terzian et al" 2)
   ("Latinkic BV et al" 2) ("Ozuysal et al" 2) ("Freedman et al's" 2)
   ("Zerjavic et al" 2) ("Lovly et al" 2) ("Futreal et al" 2)
   ("Varambally et al" 2) ("Gujral et al" 2) ("Recently Wang et al" 2)
   ("Subramanian et al" 2) ("Gealy et al" 2) ("Jolly et al" 2)
   ("Ruhparwar et al" 2) ("-Al" 2) ("In fact Wang et al" 2)
   ("Kapitanovic et al" 2) ("Recently Orimo et al" 2) ("Abrial et al" 2)
   ("Jaiswal et al" 2) ("Harlaar et al" 1) ("Duggal et al" 1)
   ("Stankovic et al" 1) ("Here Johansson et al" 1) ("Here Daugaard et al" 1)
   ("similarly Lohr et al" 1) ("Rong Y et al’s" 1)
   ("Interestingly Rong et al" 1) ("Recently Ma et al" 1)
   ("Recently Sourbier et al" 1) ("Janjigian et al" 1) ("Kostic et al" 1)
   ("Here Ali et al" 1) ("Ozretic et al" 1) ("Agopian et al" 1)
   ("Gregory-Bass et al" 1) ("Orsulic et al" 1) ("Skrgatic et al" 1)
   ("both Lievre et al's" 1) ("Bhatavdekar et al" 1) ("Katiyar et al" 1)
   ("our study and Sakamoto et al’s" 1) ("Sankar et al" 1)
   ("than Bastus et al" 1) ("Finally Weisenberger et al" 1) ("Kovacic et al" 1)
   ("Recently Cuozzo et al" 1) ("Zhang et al ‘s" 1) ("Golden et al" 1)
   ("Potokar et al" 1) ("Recently Faggi et al" 1) ("70 μl Al’s" 1)
   ("Fabian AK et al" 1) ("Girard et al's" 1) ("Urosevic et al" 1)
   ("Grewal et al" 1) ("Cox et al's" 1) ("Drab et al" 1) ("Barbalic et al" 1)
   ("Parmar et al" 1) ("Puissant et al" 1) ("Modest et al" 1)
   ("Rosenthal et al" 1) ("Korpal et al" 1) ("Recently Helsen C. et al" 1)
   ("Barkhordarian et al" 1) ("previously ZhuGe et al" 1) ("Here Hong et al" 1)
   ("Trifunovic et al" 1) ("Safdar et al" 1) ("Bayraktar et al" 1)
   ("Here Zhang et al" 1) ("indeed Kueh et al" 1) ("Nair A K et al" 1)
   ("Here Whalley et al" 1) ("Here Zuckermann et al" 1) ("Here Tomas et al" 1)
   ("Gogly et al" 1) ("Yoshioka A et al" 1) ("Tabary et al" 1)
   ("Here Cao et al" 1) ("Shirley et al’s" 1) ("Recently Chen et al" 1)
   ("Ji et al's" 1) ("Pourazar et al" 1) ("Chaudary et al" 1)
   ("Recently Kim et al" 1) ("Fingar et al" 1) ("Recently Koide et al" 1)
   ("Originally Berger et al" 1) ("Long et al 's" 1)
   ("further conclusions Subramanian et al" 1) ("Badalian et al" 1)
   ("Pinto et al  's" 1) ("Pantic et al" 1) ("a previous work Ng et al" 1)
   ("Harris et al's" 1) ("Agrawal et al" 1) ("Very recently Lu et al" 1)
   ("Charalambous et al" 1) ("Shelly et al" 1) ("Hardy et al" 1)
   ("Gastpar et al" 1) ("Aggarwal et al" 1) ("Fabian et al" 1)
   ("Kendal et al" 1) ("Recently Gupta et al" 1) ("Boorjian et al" 1)
   ("et al 's" 1) ("recently Reichelt et al" 1) ("Le et al's" 1)
   ("Recently Benassi et al" 1) ("Ali et al's" 1) ("Recently Marti et al" 1)
   ("a previous study Michelotti et al" 1) ("Recently Bond et al" 1)
   ("Mujawar et al" 1) ("Interestingly Ahmad et al" 1) ("Hébert et al's" 1)
   ("ultra-sensitive methods Lassen et al" 1) ("Recently Gallastegui et al" 1)
   ("Fachal et al" 1) ("Sensintaffar et al" 1) ("Frank et al" 1)
   ("Sarkar et al" 1) ("Haughian J.M. et al" 1) ("More recently Kato et al" 1)
   ("Mandal et al" 1) ("Recently Bonora et al" 1) ("Recently Zhu et al" 1)
   ("Actually DeNicola GM et al" 1)))
 ("PCID:104745"
  (("propionate" 58) ("-propionate" 4) ("propionate (DSP)" 2)
   ("Propionate" 1)))
 ("PCID:104748"
  (("bisulfite" 1087) ("Bisulfite" 503) ("Quantitative bisulfite" 6)
   ("quantitative bisulfite" 6) ("traditional bisulfite" 2)
   ("a comprehensive bisulfite" 2) ("non-bisulfite" 1)))
 ("PCID:104755"
  (("Ag" 335) ("AGs" 107) ("ag" 47) ("Ags" 22) ("ag ( EST )" 5) ("most AGs" 3)
   ("exogenous Ags" 2) ("the original viral Ag" 2) ("-ag" 1)
   ("both exogenous and endogenous Ags" 1)
   ("a nonpolymorphic MHC class I Ag" 1) ("4 consecutive AGs" 1) ("aG" 1)))
 ("PCID:104810"
  (("BA" 381) ("Ba" 21) ("ba" 18) ("barium" 10) ("Bas" 5) ("BAs" 3)
   ("methylated and unmethylated BA" 1)
   ("an Agilent DNA microarray scanner BA" 1) ("bA" 1) ("exogenous BA" 1)))
 ("PCID:104842" (("7-ethyl-10-hydroxycamptothecin" 7)))
 ("PCID:104858" (("GSNO" 87) ("than GSNO" 1)))
 ("PCID:104865"
  (("bosentan" 19) ("Bosentan" 3)
   ("A dual endothelin receptor antagonist bosentan" 1)))
 ("PCID:104894"
  (("SB" 564) ("SBS" 127) ("Sb" 5) ("sb" 3) ("one potential SBS" 1)
   ("than the SBS" 1) ("“SBS”" 1)))
 ("PCID:1049" (("PY" 370) ("Py" 19) ("py" 14) ("PY-" 10) ("than 10 PY" 1)))
 ("PCID:10494"
  (("oleanolic acid" 21) ("Oleanolic acid" 8) ("Oleanolic acid (OA)" 1)))
 ("PCID:104978" (("fluo-3" 3)))
 ("PCID:105021" (("fructose 2,6-bisphosphate" 2)))
 ("PCID:1051" (("pyridoxal phosphate" 3))) ("PCID:105153" (("Rb(+)" 1)))
 ("PCID:10603"
  (("hematoxylin" 2111) ("Hematoxylin" 376) ("hematoxylin-" 15)
   ("simultaneous hematoxylin" 2) ("ferric hematoxylin" 2)
   ("aqueous hematoxylin" 1) ("All archival hematoxylin" 1)
   ("all available hematoxylin" 1) ("DAKO" 1) ("Hematoxylin-" 1)
   ("sour hematoxylin" 1)))
 ("PCID:1066" (("quinolinic acid" 13)))
 ("PCID:10663" (("malonyl-CoA" 51) ("Malonyl-CoA" 5)))
 ("PCID:10680" (("flavone" 88) ("flavones" 12) ("flavone-" 1)))
 ("PCID:10685" (("IEA" 3)))
 ("PCID:107689"
  (("lactic acid" 75) ("-lactic acid" 3) ("Lactic acid" 2) ("lactic acids" 2)))
 ("PCID:107807" (("perindopril" 2))) ("PCID:107969" (("FTY720" 20)))
 ("PCID:108156"
  (("platelet-activating factor" 12) ("platelet activating factor" 11)
   ("platelet-activating factor (PAF)" 5) ("Platelet activating factor" 3)
   ("Platelet-activating factor" 2) ("platelet activating factor (PAF)" 2)
   ("platelet-activating factor’s" 1) ("platelet activating factors" 1)))
 ("PCID:10836" (("methamphetamine" 23) ("Methamphetamine" 7)))
 ("PCID:1084" (("thiosulphate" 21)))
 ("PCID:10964"
  (("malondialdehyde" 66) ("malondialdehyde (MDA)" 9) ("Malondialdehyde" 7)
   ("the oxidative damage markers malondialdehyde" 1)))
 ("PCID:11" (("DCE" 43) ("-DCE" 2)))
 ("PCID:11005"
  (("C14" 121) ("myristic acid" 19) ("myristic acid (PMA)" 4)
   ("myristic acids" 3) ("c14" 2) ("-myristic acid" 1) ("C14’s" 1)
   ("than C14" 1)))
 ("PCID:11006"
  (("CNS" 3072) ("Cns" 6) ("the postnatal CNS" 6) ("CNs" 5)
   ("the mature CNS" 3) ("infratentorial CNS" 2) ("supratentorial CNS" 2)
   ("stroke-induced CNS" 2) ("postnatal CNS" 1) ("a damaged CNS" 1)
   ("the developed CNS" 1) ("“pan-CNS”" 1) ("the fatal CNS" 1)
   ("adult, and injured CNS" 1) ("CNS (PNET)" 1) ("presumably human CNS" 1)
   ("cNS" 1) ("mild CNS" 1) ("the ischemic CNS" 1) ("mature CNS" 1)
   ("either non-leptomeningeal CNS" 1) ("CNS-" 1) ("neonatal CNS" 1)))
 ("PCID:11025495" (("cholesterols" 9)))
 ("PCID:11057"
  (("crystal violet" 1976) ("Crystal Violet" 94) ("Crystal violet" 71)
   ("BD" 43) ("CV" 3) ("Crystal Violet (CV)" 3) ("Amresco" 3)
   ("crystal
                        violet"
    2)
   ("0.05% CV" 1) ("fresh prepared 0.2% crystal violet" 1)
   ("crystal violet (AMRESCO)" 1) ("crystal violets" 1)))
 ("PCID:11161"
  (("GGG" 641) ("-GGG" 84) ("ggg" 32) ("‘GGG’" 6) ("GGGS" 5) ("GGg" 4)
   ("GGG(T/C)GGG" 3) ("GGG (GGT)" 2) ("-ggg" 2) ("GGG(GGT)" 1) ("ggG" 1)
   ("triple GGGS" 1)))
 ("PCID:11167602" (("regorafenib" 11)))
 ("PCID:1117"
  (("sulphate" 325) ("sulphate (SDS)" 36) ("sulfate ion" 21)
   ("sulfate ions" 15) ("sulphate (DSS)" 6) ("SULPHATE" 4)
   ("sulphate (DHEAS)" 4) ("Sulphate" 2) ("0.445 μg/ml ferrous sulphate" 2)
   ("1,6  μ M ferrous sulphate" 2) ("sulphate (DMS)" 1)))
 ("PCID:11175137" (("AT7867" 4))) ("PCID:11213558" (("R406" 39)))
 ("PCID:11228183" (("Bcl2 inhibitors" 1))) ("PCID:11237762" (("E7080" 111)))
 ("PCID:11254" (("DEB" 20) ("Deb" 9) ("dEBS" 3)))
 ("PCID:11327430" (("NU7441" 156) ("Nu7441" 30)))
 ("PCID:11343137" (("DM1" 578) ("Dm1" 3) ("dm1" 2)))
 ("PCID:11347535" (("Marizomib" 2) ("marizomib" 2)))
 ("PCID:11389353"
  (("nitrosothiols" 3) ("-nitrosothiols (SNO)" 1) ("-nitrosothiols" 1)))
 ("PCID:11433190"
  (("nutlin 3a" 34) ("Nutlin 3a" 8)
   ("than nutlin 3a (IC 50 values of 17.3 nM and 18.7 nM, respectively)" 1)))
 ("PCID:1145" (("TMAO" 1)))
 ("PCID:11476171"
  (("AEW541" 47) ("AEW" 12) ("AEW541 (AEW)" 5) ("AEW541-" 2) ("75 nM AEW" 1)
   ("the AEW" 1)))
 ("PCID:11485656" (("Linifanib" 85) ("linifanib" 4)))
 ("PCID:114880" (("dodecyl maltoside" 40) ("Dodecyl maltoside" 1)))
 ("PCID:114942" (("Titanium" 45) ("titanium" 19)))
 ("PCID:115175" (("TOFA" 57))) ("PCID:115239" (("SC-58125" 1)))
 ("PCID:11524144"
  (("AMPK inhibitor" 89) ("AMPK inhibitors" 15)
   ("AMPK
                        inhibitor"
    2)
   ("AMPK Inhibitor" 1) ("Compound c" 1) ("compound c" 1)))
 ("PCID:11612883"
  (("PF-573228" 40) ("PF 573228" 19)
   ("the commercially available PF-573228" 2)))
 ("PCID:11625818" (("GS-1101" 69) ("CAL-101" 24)))
 ("PCID:11640390" (("linsitinib" 8) ("Linsitinib" 2)))
 ("PCID:11696609" (("AT9283" 45))) ("PCID:11713159" (("PF562271" 31)))
 ("PCID:11740284"
  (("lithocholic acid" 5) ("Lithocholic acid (LCA)" 1) ("Lithocholic acid" 1)))
 ("PCID:1175" (("uric acid" 71) ("Uric acid" 5)))
 ("PCID:11754511" (("BX-912" 10))) ("PCID:1176" (("ure" 4)))
 ("PCID:119065" (("lactosamine" 1)))
 ("PCID:119434"
  (("[3H]" 28) ("tritium" 10)
   ("shRNA E2F1-A or E2F1-B incorporated less [3H]" 1) ("Tritium" 1)))
 ("PCID:1195" (("IPR" 7))) ("PCID:11953884" (("nystatin" 32) ("Nystatin" 11)))
 ("PCID:11966255" (("in2" 1)))
 ("PCID:11966311"
  (("agarose" 7424) ("Sepharose" 2355) ("sepharose" 1059) ("Agarose" 527)
   ("-agarose" 39) ("soft agarose" 18) ("-Sepharose" 17) ("–agarose" 16)
   ("agarose (QIAGEN)" 8) ("agarose (KPL)" 6)
   ("using nickel–nitrilotriacetic acid agarose" 5) ("Agarose-" 4)
   ("sepharose (GE)" 4) ("–Sepharose" 4) ("0.6% soft agarose" 3)
   ("using nickel-nitrilotriacetic acid (NiNTA) magnetic agarose" 2)
   ("anti-HA-antibody-conjugated agarose" 2)
   ("anti-Flag-antibody-conjugated agarose" 2) ("agaroses" 2)
   ("40 µL protein A agarose" 2)
   ("mouse monoclonal Anti-HA-agarose, and anti-FLAG (M2)-agarose" 2)
   ("–Agarose" 2) ("40 µl Protein A agarose" 2) ("Sepharose (GE)" 2)
   ("nickel–nitrilotriacetic acid (Ni–NTA)–agarose" 2) ("agarose (MBL)" 2)
   ("Agarose (CST)" 1) ("agarose (GE)" 1)
   ("using salmon-sperm DNA/protein A agarose" 1) ("40 µl protein A agarose" 1)
   ("Agarose (QIAGEN)" 1) ("fresh protein G Sepharose" 1) ("1% soft agarose" 1)
   ("traditional agarose" 1) ("the immunoprecipitate-bound agarose" 1)
   ("using 0.4% soft agarose" 1)
   ("anti-GFP antibody or anti-HA antibody and rProtein A sepharose" 1)
   ("-sepharose" 1) ("monoclonal anti-HA agarose" 1)
   ("50µl protein A agarose" 1) ("mouse monoclonal anti-HA agarose" 1)
   ("prepared cylindrical agarose" 1) ("Sepharoses" 1)
   ("One or more agarose" 1) ("nonadhesive agarose" 1) ("Sepharose (IBA)" 1)
   ("Ni + 2 nitrilotriacetic acid agarose" 1)
   ("nickel-nitrilotriacetic acid agarose (QIAGEN)" 1)))
 ("PCID:11977753"
  (("BEZ235" 1125) ("the dual PI3K/mTOR inhibitor BEZ235" 7)
   ("the dual PI3K–TORC inhibitor BEZ235" 2)
   ("the dual PI3K/mTORC inhibitor BEZ235" 2)
   ("the already mentioned dual p110/mTOR inhibitor BEZ235" 2) ("BEZ235-" 2)
   ("the PI3K/mTOR dual kinase inhibitor BEZ235" 1)
   ("the dual PI3K/mammalian target of rapamycin (mTOR) inhibitor BEZ235" 1)
   ("The dual pan-PI3K/mTORC1/2 inhibitors BEZ235" 1)
   ("the dual PI3K p110α/mTOR inhibitor BEZ235" 1)
   ("the dual PI3K-mTOR inhibitor BEZ235" 1) ("the dual inhibitor BEZ235" 1)
   ("dual PI3K and MTOR inhibitor BEZ235" 1)
   ("the dual PI3K/MTOR inhibitors BEZ235" 1) ("BeZ235" 1)))
 ("PCID:11998575" (("P529" 27)))
 ("PCID:12035"
  (("N-acetylcysteine" 102) ("N-acetylcysteine (NAC)" 36)
   ("N-Acetylcysteine" 5) ("the classical ROS scavenger N-acetylcysteine" 2)
   ("Exogenous N-acetylcysteine (NAC)" 1) ("n-acetylcysteine" 1)
   ("The exogenous antioxidant N-acetylcysteine" 1)))
 ("PCID:122158" (("chitobiose" 1)))
 ("PCID:122297"
  (("CMFDA" 48) ("the membrane-permeable fluorescent dye CMFDA" 2)))
 ("PCID:123596"
  (("Gleevec" 179) ("imatinib mesylate" 140) ("Imatinib mesylate" 47)
   ("Imatinib Mesylate" 2) ("gleevec" 1) ("imatinib mesilate" 1)
   ("Gleevec's" 1) ("Imatinib mesylate (IM)" 1)))
 ("PCID:123600" (("salbutamol" 30))) ("PCID:123743" (("HCO" 386)))
 ("PCID:123831"
  (("ADMA" 44) ("asymmetric dimethylarginine" 5)
   ("asymmetric dimethylarginine (ADMA)" 2) ("almost halved medium ADMA" 1)
   ("-ADMA" 1) ("aDMA" 1)))
 ("PCID:12388" (("TRD" 31)))
 ("PCID:123913"
  (("GQ" 136) ("Gq" 123) ("Gq-" 5)
   ("-biotin-TGG GGA GGG TG A GGA GGG TGG GGA AGGmutant-2 GQ" 1)
   ("isomorphic GQ" 1)))
 ("PCID:123976" (("27-hydroxycholesterol" 34)))
 ("PCID:124072" (("tetrahydrocurcumin" 1)))
 ("PCID:124886"
  (("reduced glutathione" 257) ("reduced glutathione (GSH)" 7)
   ("Reduced glutathione" 5) ("L-glutathione" 5)))
 ("PCID:12594" (("DHEAS" 121) ("log transformed DHEAS" 1)))
 ("PCID:12599"
  (("DAMP" 36) ("DAMP molecule" 15) ("damp" 5) ("damps" 3)
   ("the principal DAMP" 2) ("a principal DAMP" 1)))
 ("PCID:127757" (("Ro 32-0432" 28) ("Ro 32–0432" 11)))
 ("PCID:128837"
  (("KK" 121) ("KKs" 3) ("KKS" 2) ("targeting motif KK" 2) ("“KK”" 1)))
 ("PCID:129211" (("Tamsulosin" 1)))
 ("PCID:13019211" (("m1" 1346) ("-m1" 2) ("m1 µ" 1)))
 ("PCID:132841" (("G*" 48) ("G°" 8) ("g*" 3)))
 ("PCID:132971" (("abiraterone" 201) ("Abiraterone" 17)))
 ("PCID:135103" (("AGs" 126) ("Ags" 35))) ("PCID:13526" (("DSM" 122)))
 ("PCID:135269"
  (("valeryl salicylate" 2) ("Valeryl salicylate" 1)
   ("valeryl salicylate (VSA)" 1)))
 ("PCID:13588" (("PGJ" 69) ("-PGJ" 6)))
 ("PCID:137" (("delta-aminolevulinic acid" 1) ("5-aminolevulinic acid" 1)))
 ("PCID:13730"
  (("DA" 944) ("Da" 453) ("dA" 129) ("da" 34) ("-DA" 13) ("most DA" 2)
   ("“DA”" 2) ("−dA" 2) ("The peripheral DA" 1) ("the predominant DA" 1)
   ("a more intensive DA" 1) ("striatal DA" 1) ("DA’s" 1) ("a cerebral DA" 1)
   ("relatively reduced synaptic DA" 1) ("-dA" 1)))
 ("PCID:1388"
  (("1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine" 18)
   ("1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" 5)))
 ("PCID:14135916" (("YW" 32) ("yw" 3)))
 ("PCID:14180"
  (("nicotinamide mononucleotide" 20) ("nicotinamide mononucleotide (NMN)" 3)))
 ("PCID:143" (("folinic acid" 51) ("-folinic acid" 2)))
 ("PCID:14403" (("AFB1" 25)))
 ("PCID:145068"
  (("nitric oxide" 481) ("Nitric oxide" 61) ("Nitric Oxide" 36)
   ("nitric oxide (NO)" 16) ("nitroxyl" 6) ("Nitric oxide (NO)" 4)
   ("the important vasoprotective molecule nitric oxide (NO)" 2)
   ("core-generated nitric oxide (NO)" 2)
   ("the vasoactive molecule nitric oxide (NO)" 1)
   ("endothelial-derived nitric oxide (NO)" 1)
   ("bioavailable vascular nitric oxide" 1)))
 ("PCID:1456" (("ODQ" 37)))
 ("PCID:14710"
  (("ethidium bromide" 1321) ("Ethidium Bromide" 21) ("Ethidium bromide" 9)
   ("ethidium bromide (EB)" 3) ("Ethidium Bromide (EB)" 1)))
 ("PCID:14797" (("KOH" 391) ("Koh" 10) ("-KOH" 1) ("ice-cold KOH" 1)))
 ("PCID:148191"
  (("temsirolimus" 468) ("Temsirolimus" 44)
   ("than temsirolimus ( p = 0.044)" 1) ("TEMSIROLIMUS" 1)))
 ("PCID:148192" (("ATZ" 1) ("atZ" 1)))
 ("PCID:148879" (("1,2-dioctanoyl-sn-glycerol" 1)))
 ("PCID:14945"
  (("iron oxide" 8) ("superparamagnetic iron oxide" 1) ("iron oxides" 1)))
 ("PCID:150855" (("deoxycytidine diphosphate" 2)))
 ("PCID:15103"
  (("SeMet" 41) ("SeMet (GSHM)" 4) ("SeMET" 3)
   ("the organic selenium compound SeMet" 1)))
 ("PCID:151134"
  (("Fe" 297) ("FE" 71) ("Fe(CN)" 54) ("Fes" 10) ("FEs" 2) ("FeS" 2) ("FE−" 1)
   ("FE-" 1) ("fe" 1)))
 ("PCID:151148"
  (("DG" 549) ("dG" 115) ("DGS" 46) ("d–g" 4) ("-dG" 3) ("−dg^2" 2) ("DG-" 1)
   ("dg" 1) ("−dG" 1)))
 ("PCID:151410" (("KF" 159)))
 ("PCID:1548887"
  (("Sulindac" 123) ("sulindac" 42) ("than Sulindac" 3) ("Sulindac’s" 2)))
 ("PCID:1549111"
  (("caffeic acid" 11) ("Caffeic acid" 2) ("Caffeic acid (CA)" 1)
   ("caffeic acids" 1) ("caffeic acid (CA)" 1)))
 ("PCID:156391" (("naproxen" 13))) ("PCID:15667" (("palmitoyl-CoA" 3)))
 ("PCID:1570" (("pyrithione" 19))) ("PCID:158781" (("olmesartan" 6)))
 ("PCID:15940185"
  (("Novobiocin" 5) ("novobiocin" 1)
   ("the antibacterial compound Novobiocin" 1)))
 ("PCID:15951529" (("enzalutamide" 279) ("Enzalutamide" 77) ("MDV 3100" 3)))
 ("PCID:1598" (("2-APB" 33) ("two pharmaceutical inhibitors 2-APB" 1)))
 ("PCID:159881"
  (("BB" 256) ("-BB" 27) ("BBs" 15) ("bb" 12) ("Bb" 7) ("the ciliary BB" 2)
   ("more severe BB" 2) ("Bbs" 2) ("The homozygous genotype bb" 2)
   ("the zwitterionic detergent Empigen BB" 2) ("bB" 1) ("’BB’" 1)))
 ("PCID:15993" (("deoxyadenosine triphosphate" 2)))
 ("PCID:16019996" (("OMFP" 4)))
 ("PCID:160355"
  (("R-roscovitine" 28) ("CYC202" 12) ("R-Roscovitine" 4) ("Cyc202" 2)))
 ("PCID:160435"
  (("carbodiimide" 17) ("carbodiimide (EDC)" 4)
   ("water soluble carbodiimide" 2)))
 ("PCID:1606" (("DETA NONOate" 12))) ("PCID:160637" (("VLA" 3)))
 ("PCID:16079005"
  (("specific inhibitor of SMAD3" 2) ("specific inhibitor of Smad3" 2)
   ("Specific inhibitor of SMAD3" 1) ("Specific Inhibitor of SMAD3" 1)))
 ("PCID:160913" (("glycinamide ribonucleotide" 7)))
 ("PCID:16122509"
  (("Dr" 5503) ("Drs" 197) ("dR" 43) ("dr" 19) ("Dr’s" 1)
   ("CEIC del Hospital de Gran Canaria Dr" 1) ("personal communication Dr" 1)
   ("a generous gift form Dr" 1) ("Hospital Universitari de Girona Dr" 1)))
 ("PCID:16122514" (("N-NS" 1))) ("PCID:16130199" (("T-20" 13)))
 ("PCID:161368"
  (("inositol phosphate" 37) ("inositol phosphates" 13)
   ("Inositol phosphates" 2) ("phosphorylated inositol phosphates" 1)
   ("soluble inositol phosphates" 1) ("Inositol phosphate" 1)))
 ("PCID:16149436" (("T8" 142)))
 ("PCID:161500"
  (("air" 2532) ("AIR" 59) ("Air" 54) ("ambient air" 28) ("humid air" 8)
   ("SSFA" 4) ("air (RA)" 3) ("95% ambient air" 3)
   ("cultivated limbal epithelial cells pre/post air" 3) ("focal air" 2)
   ("subcutaneous air" 2) ("air-" 2) ("ethanol vapor∶humidified air" 2)
   ("subsequent air" 2) ("their respective room air" 1)
   ("high efficiency particle accumulation-filtered air" 1) ("-air" 1)
   ("IAV or ambient air" 1) ("150 mM phosphoric acid (3x, 15 min each) air" 1)
   ("external air" 1) ("included 3M organic vapour air" 1)
   ("dilated distal air" 1) ("these cells underwent room air (RA)" 1)
   ("confocal system and Olympus 10×/0.40 air" 1) ("normoxic air" 1)))
 ("PCID:16219440" (("BDI" 14) ("than BDI" 1)))
 ("PCID:16231"
  (("amiloride" 170) ("-amiloride" 8) ("Amiloride" 5) ("amiloride (NSC)" 2)
   ("amiloride (HSC)" 2) ("amiloride (EIPA)" 1) ("amiloride (HMA)" 1)))
 ("PCID:16315" (("DATS" 75) ("DATs" 2) ("DATS-" 2)))
 ("PCID:1645"
  (("3-aminobenzamide" 103) ("3-Aminobenzamide" 17) ("–3-aminobenzamide" 5)))
 ("PCID:165271" (("histidinol" 28)))
 ("PCID:165491"
  (("nicotinic acid adenine dinucleotide phosphate (NAADP)" 3)
   ("nicotinic acid adenine dinucleotide phosphate" 2)))
 ("PCID:16590" (("diallyl disulfide" 2))) ("PCID:165914" (("CUS" 29)))
 ("PCID:16654980" (("BKM-120" 42) ("the dual PI3K inhibitor BKM-120" 1)))
 ("PCID:16682999" (("Dermatol" 1)))
 ("PCID:16684434" (("thimerosal" 7) ("Thimerosal" 1)))
 ("PCID:16685708" (("lead acetate" 3)))
 ("PCID:1673"
  (("3-methyladenine" 184) ("3-Methyladenine" 47)
   ("an autophagic inhibitor 3-methyladenine" 2)))
 ("PCID:16736978" (("KU0063794" 14)))
 ("PCID:1674"
  (("MC" 958) ("Mc" 17) ("3-methylcholanthrene" 8) ("mc" 7) ("3-MC" 2)
   ("pure random MC" 2) ("other cys-LT-induced MC" 1) ("“MC”" 1)
   ("MC (BMMC)" 1) ("several leukemic MC" 1) ("than MC" 1)))
 ("PCID:16741"
  (("PEITC" 244) ("phenylethyl isothiocyanate" 5)
   ("-phenylethyl isothiocyanate (PEITC)" 2) ("-phenylethyl isothiocyanate" 2)
   ("approximately 9.2±0.6 µM PEITC" 2) ("Phenylethyl isothiocyanate" 2)
   ("beta-phenylethyl isothiocyanate (PEITC)" 1)
   ("beta-phenylethyl isothiocyanate" 1) ("approximately 928±250 nM PEITC" 1)
   ("PEITC-" 1)))
 ("PCID:16750408" (("PF477736" 46)))
 ("PCID:167551" (("anacardic acid" 46) ("Anacardic acid" 10)))
 ("PCID:16755649" (("Nutlin 3" 24) ("nutlin 3" 9)))
 ("PCID:16757548"
  (("AdoMet" 39) ("-AdoMet" 8)
   ("Approximately 20% more radioactive AdoMet" 1)))
 ("PCID:16760412" (("epoxomicin" 60) ("Epoxomicin" 16)))
 ("PCID:1678" (("3-nitropropionic acid" 24) ("3-Nitropropionic acid" 2)))
 ("PCID:168928"
  (("Boswellic Acids" 9) ("boswellic acids" 7) ("-boswellic acid(KBA)" 6)
   ("boswellic acid" 6) ("Boswellic acids" 4) ("-boswellic acid" 2)
   ("Boswellic acid" 1)))
 ("PCID:1712093" (("oxa" 8) ("Oxa" 5) ("oxazolone" 2) ("OXA" 1)))
 ("PCID:1727" (("4-AP" 31)))
 ("PCID:17513"
  (("Acadesine" 7) ("5-aminoimidazole-4-carboxamide ribonucleoside" 3)
   ("Acadesine
                        (AICAR)"
    1)
   ("“Acadesine”" 1)))
 ("PCID:17596" (("HMX" 3) ("hmx" 1)))
 ("PCID:176"
  (("acetic acid" 1122) ("glacial acetic acid" 8) ("Acetic acid" 7)
   ("acetic acid (EGTA)" 6) ("10% glacial acetic acid" 4)
   ("methanol-glacial acetic acid" 4) ("1% glacial acetic acid" 4)
   ("acetic acid(EDTA)" 4) ("acetic acid (EDTA)" 3)
   ("33% glacial acetic acid" 2) ("methanol∶glacial acetic acid" 2)
   ("ice-cold acetic acid" 2) ("using glacial acetic acid" 2)
   ("5% glacial acetic acid" 2) ("3:1 methanol:glacial acetic acid" 1)
   ("0.12% Sulforhodamine B/1% glacial acetic acid" 1)
   ("5%(v/v) glacial acetic acid" 1) ("5 M glacial acetic acid" 1)
   ("3∶1 methanol∶glacial acetic acid" 1)
   ("95% ethanol/5% glacial acetic acid" 1) ("methanol:glacial acetic acid" 1)
   ("0.4% (v/v) glacial acetic acid" 1) ("-acetic acid" 1)
   ("pure acetic acid" 1) ("3% glacial acetic acid" 1)
   ("6 μl glacial acetic acid" 1)))
 ("PCID:176155" (("SB 203580" 72)))
 ("PCID:176167"
  (("enzastaurin" 85) ("Enzastaurin" 35)
   ("the pharmacologic inhibitor enzastaurin" 1)))
 ("PCID:17755052" (("GDC-0941" 269) ("than GDC-0941" 1)))
 ("PCID:1794427" (("chlorogenic acid" 4) ("chlorogenic acids" 2)))
 ("PCID:18058"
  (("thymine glycol" 8) ("-thymine glycol" 3) ("thymine glycols" 1)))
 ("PCID:18085" (("DPE" 9) ("DPEs" 2))) ("PCID:1809" (("5-CT" 7)))
 ("PCID:1826" (("5-HIAA" 13)))
 ("PCID:18526330"
  (("glycyrrhetinic acid" 7) ("-glycyrrhetinic acid (AGA)" 2)
   ("-glycyrrhetinic acid" 1)))
 ("PCID:18601100" (("deoxyuridylate" 7))) ("PCID:188959" (("G-m" 3)))
 ("PCID:19001"
  (("DTT" 6476) ("DTT (dithiothreitol) molecule" 4) ("−DTT" 2)
   ("DTT molecule" 2) ("DTT (GIBCO)" 2) ("DTTs" 1) ("dTT" 1)
   ("ice-cold buffer B+ DTT" 1)))
 ("PCID:19188" (("POA" 7) ("Poa" 1)))
 ("PCID:192"
  (("ADP-ribose" 1201) ("ADP–ribose" 5) ("ADP-ribose (PAR)" 4)
   ("polymeric ADP-ribose (PAR)" 2) ("ADP-riboses" 2)))
 ("PCID:192590" (("acetyllysine" 17)))
 ("PCID:192866" (("1,2-diacylglycerol" 9)))
 ("PCID:1967" (("AA861" 18) ("AA-861" 14)))
 ("PCID:1983"
  (("triad" 188) ("triads" 167) ("APAP" 51) ("momentum" 21)
   ("the portal triad" 8) ("Triad" 6) ("the Norwegian control-parent triads" 5)
   ("the Norwegian triads" 4) ("Case-parent triads" 3)
   ("616 case-parental triads" 2) ("Momentum" 2) ("irregular triads" 2)
   ("the typical active site triad" 2) ("a mucocutaneous triad" 2)
   ("the portal triads" 2)
   ("the Icelandic genealogical database 1,034 triads" 2)
   ("the diagnostic triad" 2)
   ("inflammation-driven cancer (e.g. colorectal cancer) gains momentum" 2)
   ("1,645 control-parental triads" 1) ("the classic triad" 1) ("Triads" 1)
   ("425 case-parent triads" 1) ("missing triads" 1)
   ("733 case-parent triads" 1) ("a tremendous momentum" 1)
   ("WT andStat3 hep−/− portal triads" 1) ("portal triads" 1)
   ("134 Italian triads" 1) ("Caucasian triads" 1)
   ("2,000 case-parent triads" 1)))
 ("PCID:1993" (("methacholine" 22)))
 ("PCID:20057320"
  (("globotriaosylceramide" 6)
   ("the neutral glycosphingolipid Globotriaosylceramide" 3)
   ("Globotriaosylceramide" 3) ("globotriaosylceramides" 1)))
 ("PCID:20057331" (("ganglioside GD3" 4)))
 ("PCID:2051"
  (("AG1478" 1625) ("AG 1478" 20) ("AG1478-" 9) ("tyrphostin AG-1478" 6)
   ("AG1478 (AG)" 4) ("Tyrphostin AG 1478" 2)
   ("the commercially available AG1478" 1)
   ("Commercially available EGFR inhibitor AG1478" 1)))
 ("PCID:206042" (("Orantinib" 1))) ("PCID:208898" (("Dronedarone" 1)))
 ("PCID:21157"
  (("buthionine sulfoximine" 6) ("buthionine sulfoximine (BSO)" 3)
   ("-buthionine sulfoximine (BSO)" 1) ("-buthionine sulfoximine" 1)))
 ("PCID:2141" (("amifostine" 1)))
 ("PCID:21618712"
  (("sulfonylureas" 12) ("sulfonylurea" 8) ("Sulfonylureas" 1)))
 ("PCID:2162" (("amlodipine" 2)))
 ("PCID:216326"
  (("lenalidomide" 341) ("Lenalidomide" 25) ("lenalidomide’s" 5)
   ("antagonized lenalidomide’s" 1)))
 ("PCID:2165" (("amodiaquine" 1))) ("PCID:21881944" (("TAPI-0" 25)))
 ("PCID:221493" (("cholic acid" 27) ("Cholic acid" 1)))
 ("PCID:222284" (("sitosterol" 2)))
 ("PCID:222528"
  (("deoxycholic acid" 186) ("Deoxycholic acid" 9) ("deoxycholic acid (DCA)" 3)
   ("deoxycholic acid (SDC)" 1)
   ("secondary deconjugated bile acids deoxycholic acid (DCA)" 1)))
 ("PCID:2236"
  (("aristolochic acid" 10) ("“aristolochic acid”" 1)
   ("aristolochic acid (AA)" 1)))
 ("PCID:2244"
  (("aspirin" 1154) ("Aspirin" 63) ("acetylsalicylic acid" 25)
   ("non-aspirin" 7) ("aspirin’s" 3) ("than aspirin" 3) ("“Aspirin”" 1)
   ("aspirin's" 1) ("‘aspirin’" 1) ("aspirin-" 1) ("Acetylsalicylic acid" 1)))
 ("PCID:2247" (("astemizole" 6))) ("PCID:2249" (("atenolol" 4)))
 ("PCID:227939" (("AHE" 1)))
 ("PCID:22833540"
  (("glycochenodeoxycholic acid" 3) ("Glycochenodeoxycholate" 2)
   ("glycochenodeoxycholate" 2)))
 ("PCID:22833565"
  (("heparin sulfate" 27) ("heparin sulphate" 11) ("heparin sulfate (HS)" 3)
   ("heparin sulfates" 1)))
 ("PCID:22833608" (("fructan" 2))) ("PCID:22833648" (("fluticasone" 9)))
 ("PCID:22833655" (("eriocitrin" 5) ("Eriocitrin" 1)))
 ("PCID:2284" (("baclofen" 2) ("Baclofen" 1)))
 ("PCID:22880" (("NMDA" 287) ("focal NMDA" 2)))
 ("PCID:23253564"
  (("morphine" 296) ("Morphine" 11) ("morphine's" 2)
   ("Subcutaneous morphine" 1) ("88.2 mcg/kg intraoperative morphine" 1)
   ("postoperative morphine" 1)
   ("postoperative and total (intraoperative plus postoperative) morphine" 1)))
 ("PCID:2336"
  (("benzo(a)pyrene" 24) ("Benzo(a)pyrene" 1) ("benzo(a) pyrene" 1)))
 ("PCID:234" (("arsenic acid" 2))) ("PCID:23557187" (("POVPC" 24)))
 ("PCID:235719"
  (("3-nitrotyrosine" 41) ("the oxidative stress marker 3-nitrotyrosine" 2)))
 ("PCID:23624255" (("ganetespib" 95) ("Ganetespib" 12)))
 ("PCID:23644584" (("12d" 46)))
 ("PCID:23665763"
  (("sodium bisulfite" 181) ("Sodium bisulfite" 51) ("Sodium Bisulfite" 4)))
 ("PCID:23666345" (("sodium taurocholate" 4))) ("PCID:23666711" (("CMZ" 1)))
 ("PCID:23667635" (("sodium metaperiodate" 1)))
 ("PCID:23668196"
  (("sodium deoxycholate" 937) ("Sodium deoxycholate" 44)
   ("Sodium Deoxycholate" 15) ("sodium deoxycholate (DOC)" 4)
   ("sodium Deoxycholate" 1)))
 ("PCID:237" (("mepacrine" 6))) ("PCID:23724666" (("DMI" 90)))
 ("PCID:23725625"
  (("olaparib" 531) ("Olaparib" 260) ("OLA" 8) ("olaparib (OLA)" 4)
   ("the clinically relevant PARP inhibitor olaparib" 2)
   ("we first used olaparib" 2) ("10 μM OLA" 1)
   ("the clinically relevant PARPi olaparib" 1)
   ("the clinically relevant PARP-1 inhibitor olaparib" 1)
   ("than Olaparib" 1)))
 ("PCID:23925"
  (("iron" 1050) ("Iron" 54) ("iron-" 8) ("ferrous iron" 7) ("iron (LPI)" 3)
   ("more iron" 2) ("exogenous iron" 2) ("colloidal iron" 2)
   ("cause hereditary iron" 1) ("dietary iron" 1) ("transfusional iron" 1)
   ("the mild hepatic iron" 1) ("intracellular redoxactive iron" 1)
   ("di-iron" 1) ("a common autosomal recessive iron" 1) ("less iron" 1)
   ("Nearly all extracellular iron" 1) ("hereditary iron" 1)))
 ("PCID:23930"
  (("manganese" 30) ("Manganese" 7) ("the binuclear manganese" 1)))
 ("PCID:23932"
  (("MO" 4907) ("mo" 438) ("approximately every 6 mo" 2) ("at least 2 mo" 1)
   ("than MO (3.8 vs 1.9)" 1) ("quit smoking at least 12 mo" 1)
   ("at least 6–8 mo" 1) ("primary chemotherapy—thus approximately 3 mo" 1)
   ("than 6 mo (two cases)" 1) ("at least 3 mo" 1)))
 ("PCID:23948"
  (("Rh" 142) ("RH" 99) ("rH" 61) ("rh" 56) ("-RH" 3) ("RHs" 1)
   ("associated RH" 1)))
 ("PCID:23957"
  (("TCS" 295) ("TCs" 128) ("Tc" 57) ("tc" 26)
   ("Matrigel-embedded luminescent TCs" 2) ("Tcs" 1)
   ("very few metastatic (Hmb-45 + ) TCs" 1) ("perivascular TCs" 1)
   ("c-kit-positive TCs" 1)))
 ("PCID:23963" (("Ti" 301) ("TI" 135) ("ti" 13) ("Tis" 12) ("TiS" 4) ("tI" 1)))
 ("PCID:23964" (("Wolfram" 6)))
 ("PCID:23974"
  (("CE" 252) ("CEs" 18) ("CES" 15) ("ce" 8) ("Cɛ" 6) ("cE" 6) ("ces-" 4)
   ("Ce" 3)
   ("the C. elegans pro-apoptotic cell death specification gene ces-" 3)
   ("approximately 0.01 ce" 1) ("ces" 1) ("than CE" 1) ("“CE”" 1) ("-CE" 1)
   ("the on-line automatic µCE" 1) ("Ces" 1)))
 ("PCID:23976" (("chromium" 39) ("Chromium" 9) ("hexavalent chromium" 4)))
 ("PCID:23978"
  (("copper" 187) ("Copper" 13) ("copper(II)" 6) ("copper (II)" 2)
   ("37°C. A copper" 1)))
 ("PCID:23981"
  (("EU" 143) ("Eu" 91) ("Eu-" 17) ("eu" 7) ("eu-" 6) ("EUS" 5)
   ("average nucleolar EU" 1)))
 ("PCID:23985"
  (("AU" 291) ("AUS" 48) ("au" 47) ("colloidal gold" 27) ("Au" 26)
   ("Colloidal gold" 8) ("AU-" 6) ("colloidal Gold" 2) ("Au-" 1) ("Aus" 1)
   ("AUs" 1) ("aU" 1)))
 ("PCID:23990" (("vanadium" 5) ("Vanadium" 1)))
 ("PCID:23994"
  (("Zn" 920) ("ZN" 9) ("Zn-" 4) ("systemic Zn" 2) ("zn" 2)
   ("extra exogenous Zn" 1) ("bioavailable Zn" 1) ("Zn(II)" 1)))
 ("PCID:23995" (("ZR" 117) ("Zr" 9) ("ZRS" 1) ("ZR-" 1)))
 ("PCID:240" (("BEZ" 12))) ("PCID:24085" (("mercuric chloride" 4)))
 ("PCID:24154"
  (("galactosamine" 8) ("-galactosamine" 7) ("Galactosamine" 2)
   ("the transcriptional inhibitor D(+)-galactosamine" 1)))
 ("PCID:24180719" (("PLX-4720" 49) ("PLX 4720" 2)))
 ("PCID:24261" (("silicon dioxide" 1)))
 ("PCID:243"
  (("benzoic acid" 38) ("-benzoic acid" 6) ("the RAR-specific ligand TTNPB" 2)
   ("TTNPB" 2) ("-benzoic acid (TTNPB)" 1) ("-benzoic acid (NPPB)" 1)))
 ("PCID:24385" (("nickel chloride" 11) ("Nickel chloride" 2)))
 ("PCID:24411"
  (("VO" 2790) ("Vo" 25) ("Vos" 5) ("vo" 4) ("VOS" 4) ("using absolute VO" 1)))
 ("PCID:24424" (("zinc sulfate" 6)))
 ("PCID:24436"
  (("sodium sulfate" 53) ("sodium sulfate (DSS)" 10)
   ("anhydrous sodium sulfate" 8) ("Sodium Sulfate" 3)))
 ("PCID:24456"
  (("calcium phosphate" 422) ("Calcium phosphate" 16)
   ("calcium
phosphate"
    2)
   ("calcium phosphates" 1)))
 ("PCID:24470" (("silver nitrate" 37) ("2% aqueous silver nitrate" 1)))
 ("PCID:24642"
  (("TL" 581) ("TLs" 6) ("shorter TL" 3)
   ("an extended heptad ( xref ) motif YA 374 X 2 L 377 X 2 G 380 X 2 FF 384 X 2 IL 388 X 2 A 391 X 2 TL"
    2)
   ("longer TL" 2) ("relative TL" 2) ("-TL" 1) ("shortest TL" 1) ("Tl" 1)
   ("Shorter TL" 1)))
 ("PCID:247304"
  (("ECs" 2628) ("ECS" 64) ("vascular ECs" 35) ("microvascular ECs" 16)
   ("human microvascular ECs" 9) ("XAV-treated A 100 /B 5 ECs" 6)
   ("mature ECs" 5) ("the A 100 /B 5 ECs" 5) ("SPSB" 5)
   ("VE-cadherin–expressing ECs" 4) ("normal human dermal microvascular ECs" 4)
   ("human dermal microvascular ECs" 4) ("human aortic ECs" 3) ("than ECs" 3)
   ("anterior-derived ECs" 3) ("lung microvascular ECs" 3)
   ("Human dermal microvascular ECs" 3) ("a self-contained ECS" 3)
   ("CD31-positive ECs" 3) ("brain microvascular ECs" 2) ("TNFα-treated ECs" 2)
   ("Ecs" 2) ("oral and vaginal ECs" 2) ("mock-infected ECs" 2)
   ("human arterial ECs" 2) ("bovine aortic ECs" 2)
   ("primary bovine aortic ECs" 2) ("mouse pulmonary ECs" 2)
   ("10 5 primary human brain microvascular ECs" 2) ("HCC-associated ECs" 2)
   ("liver sinusoidal ECs" 2) ("aortic ECs" 2)
   ("the XAV-treated posterior A 50 /B 40 ECs" 2) ("anterior A 100 /B 5 ECs" 2)
   ("hemogenic ECs" 2) ("the day 5 A 100 /B 5 ECs" 2)
   ("the non-sprouting A 50 /B 40 ECs" 2) ("human vascular ECs" 2)
   ("human cerebromicrovascular ECs" 2)
   ("both well-differatiated and early-stage ECs" 2)
   ("human lung microvascular ECs" 2) ("static ECs" 2)
   ("using bovine aortic ECs" 2) ("human Aortic ECs" 2) ("Bovine Aortic ECs" 2)
   ("Human umbilical vascular ECs" 2) ("human retinal vascular ECs" 2)
   ("VASH1 made ECs" 2) ("Human venular ECs" 2)
   ("aortic and microvascular ECs" 2) ("both immature and mature ECs" 1)
   ("control (PBS)-treated ECs" 1) ("migrated ECs" 1) ("corneal ECs" 1)
   ("Human aortic ECs" 1) ("vehicle-treated ECs" 1) ("than matured ECs" 1)
   ("target vascular ECs" 1) ("vascular lung ECs" 1) ("the vascular ECs" 1)
   ("human dermal microvascular (HDM)ECs" 1) ("PI3KCA E545K–expressing ECs" 1)
   ("posterior-derived ECs" 1) ("XAV-treated A 50 /B 40 ECs" 1)
   ("the XAV-treated A 100 /B 5 ECs" 1) ("the anterior A 100 /B 5 ECs" 1)
   ("posterior A 50 /B 40 ECs" 1) ("day 5 A 100 /B 5 ECs" 1)
   ("the A 50 /B 40 ECs" 1) ("the day 5 A 50 /B 40 ECs" 1)
   ("than A 50 /B 40 ECs ( xref E)" 1) ("than 95% pure CD31 (PECAM1) + ECs" 1)
   ("95% pure CD31 (PECAM1) + ECs" 1) ("OxPAPC-treated human ECs" 1)
   ("OxPAPC-treated ECs" 1) ("human pulmonary ECs" 1) ("solitary ECs" 1)
   ("a transformed brain ECs" 1) ("Quer-treated ECs" 1)
   ("mouse lung microvascular ECs" 1) ("the PECAM-1 expressing ECs" 1)
   ("PECAM-1-expressing ECs" 1) ("an entire self-contained ECS" 1)
   ("otherwise unstimulated ECs" 1) ("hypoxia treated ECs" 1)
   ("PDK1-overexpressing ECs" 1) ("pre-treated ECs" 1)
   ("blood vessel–associated ECs" 1) ("almost all ECs" 1) ("Arterial ECs" 1)
   ("arterial ECs" 1) ("the most reliable ECs" 1) ("ECS(SPSB)" 1)
   ("the venular ECs" 1) ("Activated venular ECs" 1)
   ("than aortic and microvascular ECs ( xref  A )" 1) ("fetal ECs" 1)))
 ("PCID:24759"
  (("hyaluronic acid" 50) ("hyaluronic acid (HA)" 5) ("Hyaluronic acid" 1)))
 ("PCID:24766"
  (("chondroitin sulfate" 34) ("chondroitin sulphate" 6)
   ("Chondroitin sulphate" 3) ("Chondroitin sulfate" 2)))
 ("PCID:24776445" (("vismodegib" 91) ("Vismodegib" 3)))
 ("PCID:24788740" (("GDC-0068" 37))) ("PCID:24794418" (("BMS-777607" 3)))
 ("PCID:24821094"
  (("ibrutinib" 212) ("Ibrutinib" 74) ("than ibrutinib" 3)
   ("the recently developed BTK inhibitor Ibrutinib" 1) ("ibrutinib-" 1)))
 ("PCID:24823" (("O3" 25) ("ozone" 19))) ("PCID:24826799" (("AP24534" 12)))
 ("PCID:24864821" (("AMG 208" 68)))
 ("PCID:24883429"
  (("deferoxamine mesylate" 9) ("deferoxamine mesylate (DFOM)" 2)))
 ("PCID:24906273"
  (("AS605240" 69) ("the ATP-competitive inhibitor AS605240" 2)))
 ("PCID:24934"
  (("sodium selenite" 88) ("Sodium selenite" 10) ("Sodium Selenite" 1)))
 ("PCID:24947" (("cadmium chloride" 28) ("Cadmium chloride" 1)))
 ("PCID:24964624"
  (("Akt inhibitor" 579) ("AKT inhibitor" 416) ("Akt inhibitors" 226)
   ("AKT inhibitors" 220) ("Akt Inhibitor" 29) ("AKT Inhibitor" 14)
   ("ATP-competitive AKT inhibitors" 10) ("AKT INHIBITOR" 8)
   ("vs ATP-competitive AKT inhibitors" 4)
   ("AKT
inhibitor"
    2)
   ("the ATP-competitive AKT inhibitors" 2)
   ("another new ATP-competitive AKT inhibitor" 2)
   ("an orally bioavailable AKT inhibitor" 2) ("a potential AKT inhibitor" 2)
   ("AKt inhibitor" 1) ("AKT inhibitor (AKTI)" 1)
   ("than ATP-competitive AKT inhibitors" 1)
   ("several ATP-competitive and allosteric AKT inhibitors" 1)
   ("-Akt inhibitor" 1) ("noncompetitive Akt inhibitor" 1)
   ("an orally available Akt inhibitor" 1)))
 ("PCID:25074887" (("cetrorelix" 1))) ("PCID:25102846" (("XL-184" 12)))
 ("PCID:25145403"
  (("ND" 594) ("nd" 581) ("Nd" 7) ("-ND" 3) ("NDS" 2) ("than ND" 1)
   ("than inDmp1 wt ND" 1) ("than inDmp1 wt ND ( P < 0.0001)" 1)))
 ("PCID:251636"
  (("mibolerone" 90) ("Mibolerone" 15) ("mibolerone (MB)" 3)
   ("ER beta knockdown reverses mibolerone’s" 2)
   ("the synthetic non-metabolizable androgen mibolerone" 2)))
 ("PCID:25188" (("acrylate" 3)))
 ("PCID:2520" (("verapamil" 81) ("Verapamil" 5)))
 ("PCID:25200834" (("lipid as" 8) ("diet-derived lipid as" 1)))
 ("PCID:25202697" (("acacetin" 151) ("Acacetin" 47)))
 ("PCID:25257557" (("CX-5461" 100))) ("PCID:252682" (("S31-201" 17)))
 ("PCID:25670"
  (("counter" 2351) ("Counter" 594) ("counters" 52)
   ("the ADAM automatic cell counter" 13) ("-counter" 9)
   ("an automatic cell counter" 6) ("an electronic cell counter" 6)
   ("COUNTER" 5) ("a 2D electronic counter" 2) ("ESCC" 2)
   ("automatic cell counter" 2) ("a TC-10 automatic cell counter" 2)
   ("the cellometer mini cell counter" 2) ("an automatic counter" 2)
   ("a fluorescent based automatic cell counter" 2)
   ("a Victor 2 1420 Multilable counter" 2)
   ("Envision HRP secondary antibodies and hematoxylin counter" 2)
   ("the Wallac WinSpectral liquid scintillation counter" 2)
   ("using multipurpose scintillation counter" 2)
   ("Series Automatic Gamma Counter" 2)
   ("a Perkin Elmer 96-well plate gamma counter" 1)
   ("the Bio-Rad TC10 automatic cell counter" 1)
   ("a Countstar Automated cell counter" 1) ("Counters" 1) ("counter (CPM)" 1)
   ("a basic counter" 1) ("a mitotic counter" 1)
   ("an electronic Coulter Counter" 1) ("manual counter" 1)))
 ("PCID:2578" (("BCNU" 54) ("carmustine" 45) ("Carmustine" 2)))
 ("PCID:25796439" (("ITP" 17))) ("PCID:259331" (("estramustine" 6)))
 ("PCID:2603" (("CCCP" 261)))
 ("PCID:261000"
  (("R1881" 1972) ("R1881-" 18) ("-R1881" 6) ("exogenous R1881" 3)
   ("optimal R1881" 2) ("the non-aromatizable agonist R1881" 2)
   ("bolizable androgen R1881" 1) ("−R1881" 1) ("–R1881" 1)))
 ("PCID:26250" (("potassium ferricyanide" 55) ("Potassium Ferricyanide" 1)))
 ("PCID:263"
  (("butanol" 44) ("1-butanol" 42) ("1-Butanol" 12) ("Butanol" 7)
   ("-butanol" 6) ("tertiary butanol" 1)))
 ("PCID:264"
  (("butyric acid" 36) ("butyric acid (PBA)" 3) ("γ-amino butyric acid" 1)
   ("Butyric acid" 1) ("-butyric acid" 1)
   ("gamma-amino butyric acid ( GABA )" 1)))
 ("PCID:2662" (("Celebrex" 25) ("celebrex" 8)))
 ("PCID:26623"
  (("mercury" 44) ("Mercury" 6) ("a Varian Mercury" 3) ("MERCURY" 1)))
 ("PCID:26757" (("selegiline" 4))) ("PCID:26840" (("phytanic acids" 1)))
 ("PCID:26987" (("clemastine" 3)))
 ("PCID:27099"
  (("Cu" 514) ("CUS" 32) ("CU" 20) ("exchangeable Cu" 5) ("Cu-" 3)
   ("cupric Cu" 2) ("cuprous Cu" 2) ("cu" 2) ("-CU" 1) ("available Cu" 1)
   ("than Cu" 1)))
 ("PCID:271"
  (("CA" 29628) ("Ca" 524) ("ca" 193) ("-CA" 10) ("“CA”" 9) ("cA" 8) ("CA-" 8)
   ("Ca-" 2) ("pelletable CA" 2) ("soluble CA" 2) ("more severe CA" 2)
   ("silencing abrogated CA" 2) ("the universal CA" 2)
   ("most breast cancers display CA" 2) ("laryngeal CA" 2) ("than ca" 1)
   ("−Ca" 1) ("CA molecule" 1) ("CA’s" 1)
   ("The cell-impermeable cathepsin B inhibitor CA" 1) ("endometrial CA" 1)
   ("the cardiac Ca" 1) ("“Non-ca”" 1) ("“Ca”" 1) ("a polymorphic CA" 1)
   ("residual input p24 CA" 1) ("nearly no p24 CA" 1) ("mild CA" 1)
   ("oncogene-driven CA" 1) ("H-Ras G12V abrogated Ras-induced CA" 1)
   ("“non-specific” paramagnetic CA" 1) ("the viral CA" 1) ("“pik3ca”" 1)
   ("papillary ca" 1) ("mucinous ca" 1) ("metaplastic ca" 1) ("lobular ca" 1)))
 ("PCID:2722" (("CHQ" 1))) ("PCID:2723601" (("6-TG" 59) ("6-TG-" 1)))
 ("PCID:2723628" (("thiobarbituric acid" 10) ("Thiobarbituric acid" 1)))
 ("PCID:2724480" (("L-carnitine" 9)))
 ("PCID:2724807" (("GV" 62) ("gvs" 3) ("GVS" 3) ("GVs" 1)))
 ("PCID:273"
  (("cadaverine" 6) ("cadaverine (MDC)" 3)
   ("autophagic vacuoles monodansyl cadaverine (MDC)" 2)))
 ("PCID:2733490" (("H-89 Dihydrochloride" 1)))
 ("PCID:2733504"
  (("diphenyleneiodonium chloride" 14) ("diphenyleneiodonium chloride (DPI)" 6)
   ("Diphenyleneiodonium chloride" 2)
   ("Diphenyleneiodonium chloride (DPI)" 1)))
 ("PCID:2733531"
  (("G418" 2781) ("G418-" 4) ("G418 (EMD)" 2) ("G418 (VWR)" 1)
   ("G418 (MERCK)" 1)))
 ("PCID:2733768"
  (("TDCA" 70) ("taurodeoxycholic acid" 2) ("Taurodeoxycholic acid" 1)))
 ("PCID:2761171" (("ETPs" 1)))
 ("PCID:2762683" (("TMRE" 128) ("TMRE-" 2) ("the cationic dye TMRE" 1)))
 ("PCID:27668" (("chrome" 3) ("Chrome" 3)))
 ("PCID:27854" (("Mn2+" 5) ("the activating bivalent cation Mn2+" 2)))
 ("PCID:280" (("carbon dioxide" 190) ("5% carbon dioxide using Ham’s" 1)))
 ("PCID:281"
  (("carbon monoxide" 65) ("Carbon monoxide" 4)
   ("percent predicted carbon monoxide" 3) ("Carbon Monoxide" 2)
   ("carbon monoxide (DLCO)" 2) ("carbon monoxide (CO)" 1)))
 ("PCID:2828334"
  (("necrostatin-1" 114) ("Necrostatin-1" 72)
   ("necroptosis-specific inhibitor necrostatin-1" 1)))
 ("PCID:283" (("a short-chain fatty acid" 8)))
 ("PCID:2830" (("coelenterazine" 34) ("Coelenterazine" 6)))
 ("PCID:284"
  (("formic acid" 693) ("Formic acid" 16) ("formic acid (FA)" 10)
   ("0.05% aqueous formic acid" 2) ("e.g. 0.1% formic acid" 1)
   ("ice-cold 50 mM formic acid" 1)))
 ("PCID:2871948" (("C646" 57))) ("PCID:2879" (("p-cresol" 1)))
 ("PCID:29131" (("Chromium (VI)" 1))) ("PCID:2946601" (("JW55" 8)))
 ("PCID:297" (("6c" 33) ("Carbone" 10)))
 ("PCID:29936"
  (("ferric ions" 24) ("ferric ion" 10) ("ferric iron" 7) ("Ferric ion" 1)))
 ("PCID:3006531" (("U-0126" 14)))
 ("PCID:3007855" (("zinc chloride" 16) ("Zinc chloride" 1)))
 ("PCID:3017661" (("Oxamate" 1)))
 ("PCID:3019" (("diazoxide" 39) ("Diazoxide" 1)))
 ("PCID:3025961" (("MPEP" 17)))
 ("PCID:3031"
  (("DBN" 128) ("flag-tagged DBN" 2) ("spine associated DBN" 1)
   ("bacterially expressed (phosphorylation-deficient) DBN" 1)))
 ("PCID:3032536" (("cobalt chloride" 63) ("Cobalt chloride" 8)))
 ("PCID:3033" (("diclofenac" 61) ("Diclofenac" 4)))
 ("PCID:3038525" (("VX-745" 1)))
 ("PCID:304590"
  (("5-FU" 2538) ("5-Fu" 338) ("5-FU-" 15) ("infusional 5-FU" 9)
   ("weekly timed-flat-infusion 5-FU" 4) ("chemotherapeutic agent 5-Fu" 3)
   ("-5-FU" 2) ("intravenous bolus 5-FU" 2) ("intravenous 5-FU" 2)
   ("the genotoxic drug 5-FU" 1)
   ("only 2 articles reported patients received standard 5-FU" 1)
   ("5-FU (FIRI)" 1) ("the chemotherapeutic 5-FU" 1)
   ("the chemotherapeutic agent 5-FU" 1) ("daily bolus 5-FU" 1)
   ("commonly used chemotherapeutic agent 5-FU" 1) ("5-FU’s" 1)
   ("standard preoperative 5-FU" 1)))
 ("PCID:3080870"
  (("MW" 522) ("mW" 219) ("MWs" 14) ("Mw" 13) ("the theoretical MW" 4)
   ("Centricon centrifugal concentrators MW" 2)
   ("Texas Red®-lysine fixable dextran 70,000 MW" 2) ("mw" 1)
   ("a relative MW" 1)))
 ("PCID:3081361"
  (("vandetanib" 143) ("Vandetanib" 15)
   ("The orally available TKI vandetanib" 2)))
 ("PCID:3101"
  (("diphenyleneiodonium" 25) ("diphenyleneiodonium (DPI)" 3)
   ("Diphenyleneiodonium" 1)))
 ("PCID:3117" (("Disulfiram" 10) ("disulfiram" 3)))
 ("PCID:31192"
  (("LR" 694) ("LRS" 21) ("LRs" 16) ("Unt" 10) ("“LR”" 3)
   ("the composite LR" 2) ("LR−" 2) ("the mock-treated LR" 1)
   ("composite LR" 1) ("the LR’s" 1) ("UNT" 1) ("than LR ( P  = 0.003)" 1)
   ("quantitative LR" 1) ("Unconditional multivariate LR" 1) ("LR-" 1)
   ("using unconditional LR" 1)))
 ("PCID:31193"
  (("CD" 2775) ("Cd" 229) ("-CD" 37) ("cd" 25) ("mild CD" 6)
   ("Montreal B2 CD" 4) ("indolent CD" 2) ("Indolent CD" 2) ("Aggressive CD" 2)
   ("either particularly aggressive or indolent CD" 2)
   ("Montreal B2 phenotype CD" 2) ("cD" 2) ("pediatric CD" 2)
   ("ileo-colonic CD" 2) ("than CD" 1) ("a clear typical CD" 1)
   ("-CD79alpha" 1) ("“aggressive” CD" 1) ("“indolent”/“mild” CD" 1)
   ("early “aggressive” CD" 1) ("aggressive CD" 1) ("than USP4 CD" 1)
   ("colonic CD" 1) ("Montreal B3 phenotype CD" 1)
   ("Montreal B1 phenotype CD" 1)
   ("3-TYP (50 μM) + melatonin (1 μM) +10 μM Cd" 1)
   ("than CD (1.11 vs. 0.67, P<0.05)" 1)))
 ("PCID:312" (("chloride ions" 14) ("chloride ion" 10)))
 ("PCID:3121"
  (("valproate" 64) ("Valproate" 4) ("only sodium valproate" 1)
   ("The proteasomal inhibitor MG132, BrdU and sodium valproate" 1)))
 ("PCID:313"
  (("Cl" 1592) ("CL" 683) ("cl" 75) ("hydrochloric acid" 56) ("−CL" 12)
   ("Cl (EMM)" 4) ("Cl-" 4) ("CL molecule" 4) ("-Cl" 3) ("CLs" 3)
   ("mature CL" 3) ("Ellington CL’s" 3) ("anhydrous CH 2 Cl" 2)
   ("saturated aqueous NH 4 Cl" 2) ("Hydrochloric acid" 2)
   ("an apical membrane Cl" 1) ("rilotumumab systemic CL" 1)
   ("the lysosomotropic amine NH 4 Cl" 1) ("typical Cl" 1) ("CL-" 1) ("Cl−" 1)
   ("distal colnic epithelail Cl" 1) ("2 mL ice-cold NH 4 Cl" 1)
   ("ice-cold 50 mM NH 4 Cl" 1) ("-hydrochloric acid" 1) ("an apical Cl" 1)))
 ("PCID:3136" (("DMNQ" 1)))
 ("PCID:31401"
  (("UDCA" 114) ("ursodeoxycholic acid" 20) ("UDCA's" 5)
   ("Ursodeoxycholic acid" 4) ("ursodeoxycholic acid (UDCA)" 2)
   ("the hydrophilic bile acid ursodeoxycholic acid" 1)
   ("caveolin-1 augmented UDCA's" 1) ("caveolin-1 augmented UDCA" 1)
   ("caveolin-1 enhanced UDCA's" 1) ("caveolin-1 enhanced UDCA" 1)))
 ("PCID:31404" (("BHT" 27) ("preservative BHT" 2)))
 ("PCID:3194" (("ebselen" 9) ("Ebselen" 4))) ("PCID:32014" (("8-Br-cAMP" 44)))
 ("PCID:32051" (("zinc ion" 117) ("zinc ions" 80) ("one or more zinc ions" 1)))
 ("PCID:3213" (("ellipticine" 8) ("Ellipticine" 2)))
 ("PCID:3218" (("embelin" 104) ("Embelin" 34)))
 ("PCID:32744"
  (("Poly(I:C)" 31) ("polyinosinic-polycytidylic acid" 19) ("pI-pC" 14)
   ("Poly(I∶C)" 12) ("pIpC" 7)))
 ("PCID:3278"
  (("ethacrynic acid" 3) ("the competitive inhibitors ethacrynic acid (EA)" 1)
   ("ethacrynic acid (EA)" 1)))
 ("PCID:33005" (("calcium oxalate" 8) ("Calcium oxalate" 3)))
 ("PCID:3301"
  (("en" 208) ("EN" 114) ("En" 36) ("ens" 2) ("even organoid EN" 1)
   ("these keratinocytic EN" 1) ("The keratinocytic EN" 1)))
 ("PCID:3330" (("FCCP" 130) ("FCCPS" 3) ("the proton gradient using FCCP" 2)))
 ("PCID:3339" (("fenofibrate" 7) ("Fenofibrate" 5)))
 ("PCID:3365" (("fluconazole" 2))) ("PCID:3373" (("flumazenil" 2)))
 ("PCID:338"
  (("salicylic acid" 55) ("Salicylic acid" 4)
   ("irregularly low-dose acetyl salicylic acid" 2)
   ("the bicyclic salicylic acid" 1) ("salicylic acids" 1)))
 ("PCID:3386966" (("Im" 39) ("im" 10) ("IMs" 3) ("ims" 1)))
 ("PCID:3415" (("foscarnet (PFA)" 1) ("foscarnet" 1)))
 ("PCID:3423265"
  (("sodium dodecyl sulfate" 707) ("sodium dodecyl sulfate (SDS)" 99)
   ("Sodium dodecyl sulfate" 24) ("Sodium Dodecyl Sulfate" 10)
   ("Sodium Dodecyl Sulfate (SDS)" 3) ("Sodium dodecyl sulfate (SDS)" 3)
   ("sodium dodecyl sulfates" 2) ("sodium Dodecyl sulfate" 1)
   ("sodium dodecyl
                        sulfate"
    1)))
 ("PCID:3440"
  (("nephron" 105) ("nephrons" 37) ("the distal nephron" 11) ("Nephron" 2)
   ("distal nephron" 1) ("fewer immature nephrons" 1) ("Nephrons" 1)))
 ("PCID:3473" (("6-gingerol" 2))) ("PCID:3474584" (("lithium acetate" 23)))
 ("PCID:34755"
  (("SAMs" 46) ("Sam" 15) ("sam" 6) ("using GAP-associated protein Sam" 2)
   ("sam-" 1)))
 ("PCID:3476" (("glimepiride" 2) ("than glimepiride" 1)))
 ("PCID:3499" (("Go 6983" 13))) ("PCID:3501" (("Go6976" 78) ("GO6976" 48)))
 ("PCID:3520"
  (("guanidine" 176) ("Guanidine" 10) ("guanidines" 3) ("guanidine (MNNG)" 1)))
 ("PCID:3532632" (("pyocyanin (PCN)" 3) ("pyocyanin" 3)))
 ("PCID:35370" (("Azt" 106) ("AZT" 88) ("-AZT" 1)))
 ("PCID:3541" (("H89" 338) ("H-89" 117) ("H89-" 1)))
 ("PCID:3542" (("H7" 113) ("h7" 23) ("H-7" 19)))
 ("PCID:36314"
  (("taxol" 958) ("Taxol" 410) ("TAXOL" 9) ("taxol-" 6)
   ("the chemotherapeutic agent taxol" 4) ("abraxane" 3) ("Abraxane" 2)
   ("Semisynthetic taxol" 2) ("than taxol" 1) ("cells treated 400 nM Taxol" 1)
   ("taxol's" 1) ("both TNF-α and taxol further supporting taxol's" 1)
   ("both TNF-α and taxol further supporting taxol" 1) ("TAXOL-" 1)
   ("taxols" 1) ("Taxol (TAX)" 1)))
 ("PCID:36462" (("VP-16" 198)))
 ("PCID:3672"
  (("ibuprofen" 133) ("-ibuprofen" 51) ("Ibuprofen" 15) ("“Ibuprofen”" 1)
   ("than ibuprofen" 1) ("the classic NSAID ibuprofen" 1) ("ibuprofen-" 1)))
 ("PCID:3676" (("lidocaine" 12) ("topical lidocaine" 2)))
 ("PCID:3681305" (("biphosphate" 50) ("-biphosphate" 8)))
 ("PCID:370" (("gallic acid" 2))) ("PCID:3730" (("iohexol" 2)))
 ("PCID:3749" (("irbesartan" 6))) ("PCID:37542" (("RBV" 35) ("RBV's" 1)))
 ("PCID:3763" (("isoflurane" 256) ("Isoflurane" 10) ("isoflurane-" 1)))
 ("PCID:37783"
  (("phorbol 12,13-dibutyrate" 13) ("Phorbol 12,13-dibutyrate" 2)))
 ("PCID:3779"
  (("isoproterenol" 228) ("Isoproterenol" 11) ("isoproterenol (ISO)" 2)))
 ("PCID:379077" (("NSC 663284" 1))) ("PCID:38103" (("CED" 41) ("ced" 18)))
 ("PCID:3825" (("ketoprofen" 3))) ("PCID:3837" (("KN 93" 1)))
 ("PCID:3845" (("kynurenic acid" 13) ("Kynurenic acid" 3)))
 ("PCID:387447"
  (("PS-341" 44) ("Velcade" 33) ("velcade" 4) ("VELCADE" 2)
   ("the proteasomal inhibitor PS-341" 1)))
 ("PCID:3893" (("lauric acid" 2)))
 ("PCID:39214" (("nimustine" 4) ("Nimustine" 3)))
 ("PCID:392622" (("ritonavir" 21) ("ritonavir (RTV)" 1) ("Ritonavir" 1)))
 ("PCID:39484"
  (("1-methyl-4-phenylpyridinium" 9)
   ("its toxic metabolite 1-methyl-4-phenylpyridinium" 2)))
 ("PCID:3973" (("LY 294002" 87) ("Ly 294002" 16)))
 ("PCID:4033" (("nitrogen mustard" 12) ("nitrogen mustards" 11)))
 ("PCID:406563" (("Nexavar" 13) ("nexavar" 1)))
 ("PCID:4075" (("5-ASA" 99) ("5-ASA's" 1) ("blocked 5-ASA's" 1)))
 ("PCID:4082203" (("silicon" 62) ("Silicon" 25)))
 ("PCID:4156"
  (("methyl methanesulfonate" 42) ("methyl methanesulfonate (MMS)" 22)
   ("Methyl methanesulfonate" 4) ("Methyl methanesulfonate (MMS)" 3)
   ("the monofunctional DNA methylating agent methyl methanesulfonate (MMS)" 2)
   ("the genotoxic drug Methyl methanesulfonate (MMS)" 1)))
 ("PCID:4174" (("metyrapone" 51) ("Metyrapone" 10)))
 ("PCID:4205" (("mirtazapine" 82) ("Mirtazapine" 8) ("mirtazapine-" 2)))
 ("PCID:4210951" (("SB415286" 53))) ("PCID:42113" (("desflurane" 1)))
 ("PCID:4212"
  (("mitoxantrone" 144) ("Mitoxantrone" 29)
   ("the chemotherapeutic drug mitoxantrone" 1)
   ("the chemotherapeutic agent mitoxantrone" 1)))
 ("PCID:4261" (("entinostat" 30) ("Entinostat" 13) ("than Entinostat" 1)))
 ("PCID:42636535" (("A66" 46)))
 ("PCID:42642645" (("foretinib" 36) ("Foretinib" 4) ("than foretinib" 2)))
 ("PCID:42786" (("anagrelide" 6))) ("PCID:4299" (("W-13" 12) ("W13" 4)))
 ("PCID:4369359" (("sitagliptin" 1) ("Sitagliptin" 1)))
 ("PCID:439161" (("succinyl-CoA" 18) ("Succinyl-CoA" 3)))
 ("PCID:439167" (("ribose-5-phosphate" 31)))
 ("PCID:439176" (("MTA" 149) ("Mta" 43) ("MTAs" 8) ("Mta’s" 1)))
 ("PCID:439195" (("arabinose" 23) ("-arabinose" 1)))
 ("PCID:439218"
  (("HMG-CoA" 19) ("3-hydroxy-3-methylglutaryl-CoA" 8) ("HMG–CoA" 2)))
 ("PCID:439232" (("AOR" 54) ("aOR" 22) ("AORs" 9) ("Aor" 1)))
 ("PCID:439268"
  (("2-deoxy-d-glucose" 8) ("the calorie mimetic agent 2-deoxy-d-glucose" 2)))
 ("PCID:439352"
  (("DTE" 8) ("dithioerythritol (DTE)" 4) ("dithioerythritol" 3)
   ("Dithioerythritol" 1)))
 ("PCID:439456"
  (("inositol 1,4,5-trisphosphate" 73) ("Inositol 1,4,5-trisphosphate" 5)
   ("-inositol 1,4,5-trisphosphate" 5) ("Inositol 1,4,5-Trisphosphate" 2)
   ("the secondary messengers inositol 1,4,5-trisphosphate" 2) ("InsP3" 1)))
 ("PCID:439498" (("-cysteinylglycine" 1) ("cysteinylglycine" 1)))
 ("PCID:439520"
  (("bile salts" 104) ("Bile salts" 11)
   ("Hydrophilic and hydrophobic bile salts" 4) ("hydrophilic bile salts" 3)
   ("hepatotoxic bile salts" 2) ("the predominant hydrophobic bile salts" 2)
   ("hydrophilic and hydrophobic bile salts" 1)
   ("hepatotoxic and cholestatic bile salts" 1)))
 ("PCID:439924" (("nicotinamide riboside (NR)" 5) ("nicotinamide riboside" 4)))
 ("PCID:440567" (("taurocholic acid" 1)))
 ("PCID:440869"
  (("CRMs" 64) ("CRM" 37) ("Crm" 3) ("p53 homotypic CRMs" 2) ("-CRM" 1)
   ("at least one instance such CRMs" 1)))
 ("PCID:441145"
  (("monensin" 146) ("Monensin" 26)
   ("endocytic recycling inhibitor monensin" 1) ("monensin-" 1)))
 ("PCID:441203" (("cis-platin" 26) ("Cis-platin" 1)))
 ("PCID:441542"
  (("phalloidin" 1509) ("Phalloidin" 323) ("fluorescent phalloidin" 14)
   ("Alexa Fluor 488–conjugated phalloidin" 8)
   ("Alexa Fluor 488-conjugated phalloidin" 6) ("-phalloidin" 5)
   ("Alexa 568-conjugated phalloidin" 5) ("Alexa 594-conjugated phalloidin" 4)
   ("phalloidins" 4) ("Alexa 488–conjugated phalloidin" 4)
   ("Alexa 594–conjugated phalloidin" 3)
   ("Alexa Fluor 594–conjugated phalloidin" 3)
   ("texas red-conjugated phalloidin" 3)
   ("fluorescent rhodamine-labeled phalloidin" 3)
   ("Alexa-Fluor 488-conjugated Phalloidin" 2) ("–phalloidin" 2)
   ("Alexa Fluor 568-labeled phalloidin" 2)
   ("ALEXAFluor-568-labeled phalloidin" 2)
   ("Alexa Fluor 488-conjugated phalloidin or Alexa Fluor 647-conjugated phalloidin"
    2)
   ("Alexa Fluor dye-conjugated phalloidin" 2)
   ("Alexa 568-labeled phalloidin" 2)
   ("Rhodamine- and Alexa Fluor 488–conjugated phalloidin" 2)
   ("Alexa fluor-647-conjugated phalloidin" 2)
   ("Oregon Green 488-conjugated phalloidin" 2)
   ("Alexa Fluor 568-conjugated phalloidin" 2)
   ("using Alexa Fluor 568-conjugated phalloidin" 2)
   ("568–conjugated phalloidin" 2) ("Alexa 568–conjugated phalloidin" 2)
   ("using Alexafluor 594-tagged phalloidin" 2)
   ("Alexa-Fluor 568-conjugated phalloidin" 2)
   ("N-WASp ( xref B, GFP-CA) largely abolished circumferential phalloidin" 2)
   ("Alexa Fluor 633–conjugated phalloidin" 2)
   ("Alexa 568-labelled phalloidin" 2) ("Alexa 546-conjugated phalloidin" 2)
   ("fluorescent Oregon Green-conjugated phalloidin" 2)
   ("fluor-594-conjugated phalloidin" 2) ("phalloidin-" 2)
   ("0.1% Triton X-100, and Alexa 647–conjugated phalloidin" 2)
   ("Alexa flour 555-conjugated phalloidin" 2)
   ("keratinocytes showed some weak phalloidin" 2)
   ("Alexa Fluor 596-conjugated phalloidin" 2)
   ("Alexa Fluor 488–labeled phalloidin" 2)
   ("Alexa fluor 594-labeled phalloidin" 2)
   ("Alexa Fluor 488/647–conjugated phalloidin" 2)
   ("Alexa-fluor 488-conjugated phalloidin" 2)
   ("Rhodamine-labeled phalloidin and Alexa Fluor 647–labeled phalloidin" 1)
   ("Texas red- or Alexa 350-conjugated phalloidin" 1)
   ("an Alexa Fluor 660-labeled phalloidin" 1)
   ("TexasRed-coupled phalloidin" 1)
   ("Alexa 594-conjugated goat anti-mouse IgG and Alexa Fluor 488 phalloidin"
    1)
   ("Alexa Fluor 647-conjugated phalloidin" 1)
   ("Alexa 488-conjugated phalloidin" 1) ("fluorescently-labeled phalloidin" 1)
   ("Alexafluor 594-tagged phalloidin" 1) ("Oregon-green phalloidin" 1)
   ("568–labeled phalloidin" 1)
   ("anti–β-catenin/Alexa Fluor 546–conjugated anti–rabbit, and Alexa Fluor 633–conjugated phalloidin"
    1)
   ("Fluorescent phalloidin" 1) ("using fluorescent phalloidin" 1)
   ("Alexa Flour 594–conjugated phalloidin" 1)
   ("Alexa Fluor 647–conjugated phalloidin" 1)
   ("Oregon Green-conjugated phalloidin" 1)
   ("fluorescent (Oregon Green 514) phalloidin" 1)
   ("Fluorescent (Oregon Green 514) phalloidin" 1)
   ("Fluoro-594-conjugated phalloidin" 1)
   ("rhodamine- or Alexa 647–conjugated phalloidin" 1)
   ("Rhodamine- and Alexa 647–conjugated phalloidin" 1)
   ("rhodamine and Alexa-Fluor 633–labeled phalloidin" 1)
   ("0.5 μM Alexa Fluor 488-conjugated phalloidin" 1)
   ("Alexa Fluor red–conjugated phalloidin" 1)
   ("Alexa 633–labeled phalloidin" 1)
   ("Alexa Fluor 555–conjugated phalloidin" 1)))
 ("PCID:44259"
  (("staurosporin" 72) ("Staurosporin" 5) ("staurosporin (STS)" 2)))
 ("PCID:443247" (("IP7" 49) ("these cells most IP7" 1)))
 ("PCID:443295" (("fMLF" 38) ("f-Met-Leu-Phe" 15) ("N-formyl-Met-Leu-Phe" 6)))
 ("PCID:443872" (("eplerenone" 1)))
 ("PCID:444036"
  (("fluticasone propionate" 6) ("fluticasone propionate (FP)" 1)))
 ("PCID:444212"
  (("acid" 5002) ("acids" 841) ("Acid" 327) ("nucleic acids" 191)
   ("okadaic acid" 183) ("acid (HEPES)" 74) ("nucleic acid" 54)
   ("stictic acid" 39) ("Okadaic acid" 31) ("Acids" 30)
   ("the tricarboxylic acid (TCA)" 26) ("okadaic acid (OA)" 25)
   ("phosphoric acid" 19) ("KA" 19) ("0.1% trifluoroacetic acid" 17)
   ("ethylenediaminetetraacetic acid (EDTA)" 17) ("Nucleic acids" 17)
   ("lipoteichoic acid" 12) ("Corosolic acid" 12) ("trifluoroacetic acid" 11)
   ("0.75% phosphoric acid" 11)
   ("1 mM ethylenediaminetetraacetic acid (EDTA)" 10) ("acid (CDDO)" 10)
   ("1 μM okadaic acid" 9) ("ethylenediaminetetraacetic acid" 9)
   ("-tetraacetic acid (EGTA)" 9) ("the nucleic acids" 8) ("tannic acid" 8)
   ("5 mM ethylenediaminetetraacetic acid (EDTA)" 8)
   ("1 mM ethylene glycol tetraacetic acid" 8)
   ("50mM hydroxyethyl piperazineethanesulfonic acid (HEPES)" 8)
   ("acid (TOFA)" 8) ("the phosphatase inhibitor okadaic acid" 7)
   ("tricarboxylic acid (TCA)" 7) ("γ-aminobutyric acid" 7) ("acid (BA)" 7)
   ("sulfinic acid" 7) ("isovaleric acid" 7) ("corosolic acid (CA)" 7)
   ("acid-" 7) ("Okadaic acid (OA)" 7) ("the PP2A inhibitor okadaic acid" 6)
   ("Total nucleic acid" 6) ("3-mercaptopropionic acid" 6)
   ("75 mM phosphoric acid" 6) ("phosphonoacetic acid (PAA)" 6)
   ("nicotinic acid" 6) ("-acid" 6) ("-tetraacetic acid" 6) ("ACID" 6)
   ("Stictic acid" 6) ("lysophophatidic acid" 5) ("5-fluoroorotic acid" 5)
   ("the nucleic acid" 5) ("isobutyric acid" 5) ("a hydroxamic acid" 5)
   ("MTOB" 5) ("1% phosphoric acid" 5) ("toxic bile acid" 5) ("CHES" 5)
   ("dimethylarsinic acid" 5) ("dimethylarsinous acid" 5)
   ("monomethylarsonic acid" 5) ("gastric acid" 5)
   ("50 mM 4-morpholine ethane sulfonic acid (MES)" 5)
   ("80 mM 1,4-piperazinediethanesulfonic acid" 5) ("total nucleic acid" 4)
   ("10 nM okadaic acid" 4) ("10% trichloracetic acid (TCA)" 4)
   ("0.3 µM okadaic acid" 4) ("bicinchoninic acid" 4)
   ("phosphotungstic acid" 4) ("hydroxamic acids" 4)
   ("Locked nucleic acid (LNA)" 4) ("locked nucleic acids (LNA)" 4)
   ("0.1% trifluoroacetic acid (TFA)" 4) ("Fatty Acid" 4)
   ("nucleic acid (LNA)" 4) ("trifluoroacetic acid (TFA)" 4)
   ("Sulfuric acid" 4) ("sulfonic acid" 4)
   ("5 mM ethylenediaminetetraacetic acid" 4) ("lysophosphatic acid (LPA)" 4)
   ("arachadonic acid" 4) ("Nucleic Acids" 4) ("phenylbutyric acid" 4)
   ("methoxyacetic acid" 4) ("with/without okadaic acid" 4)
   ("using perchloric acid" 4) ("peptide nucleic acid (PNA)" 4)
   ("toxic bile acids" 4) ("CHES molecule" 4)
   ("15(S)-hydroxyeicosatetraenoic acids" 4)
   ("the PP2A inhibitor okadaic acid (OA)" 4)
   ("1.5 mM ethylenediaminetetraacetic acid (EDTA)" 4)
   ("0.1 μM okadaic acid" 4) ("substrates arachadonic acid" 4)
   ("12(S)-hydroxyeicosatetraenoic acid (HETE)" 4) ("aminoisobutyric acid" 4)
   ("0.2% picric acid" 3) ("bongkrekic acid" 3) ("foreign nucleic acids" 3)
   ("dihydroxy docosatrienoic acid" 3) ("acid (DSS)" 3) ("boric acid" 3)
   ("5-aminosalicylic acid" 3) ("0.05% trifluoroacetic acid" 3)
   ("-disulfonic acid (IASD)" 3) ("phenolic acids" 3) ("gambogic acid" 3)
   ("hydroxyeicosatetraenoic acid" 3) ("the Nucleic Acid" 3)
   ("1% tannic acid" 3) ("perchloric acid" 3) ("acid (TNB)" 3)
   ("0.5% phosphoric acid" 3) ("95% trifluoroacetic acid (TFA)" 3)
   ("Periodic acid" 3) ("PE-conjugated 15-hydroxyeicosatetraenoic acid" 3)
   ("2% phosphoric acid" 3) ("chebulagic acid" 3) ("Bongkrekic acid" 3)
   ("synthetic antisense locked-nucleic acids" 3)
   ("1 mM ethylene glycol tetraacetic acid (EGTA)" 3)
   ("62.5% isobutyric acid" 3) ("locked nucleic acid (LNA)" 3)
   ("0.05% trifluoracetic acid" 3) ("dihydrolipoic acid" 3)
   ("any nucleic acids" 3) ("0.5 mm aminophenylmercuric acid" 3)
   ("viral nucleic acids" 3) ("farnesylthiosalicylic acid (FTS)" 3)
   ("0.5% trifluoroacetic acid" 3) ("5 nM okadaic acid" 3)
   ("2,5-dihydroxybenzoic acid" 3) ("0.02% pluronic acid" 3)
   ("0.15% picric acid" 3) ("chilled 0.1 M perchloric acid" 3)
   ("the serine/threonine phosphatase inhibitor okadaic acid" 3)
   ("locked nucleic acid" 3) ("40.76 mM propionic acid" 3) ("acid (ATRA)" 3)
   ("4-aminosalicylic acid" 3)
   ("0.1 M 2-( N -morpholino)-ethanesulfonic acid (MES)" 3)
   ("100 nM okadaic acid" 3) ("the okadaic acid" 3)
   ("100 μM ethylenediaminetetraacetic acid" 3)
   ("5 mM 3-(N-morpholino)-propanesulfonic acid" 3) ("carboxylic acid" 3)
   ("a locked nucleic acid (LNA)" 3) ("sebacic acid" 3)
   ("nitroarachidonic acid" 3) ("nitrolinoleic acid" 3)
   ("1-pyrrolidinecarbodithioic acid" 3) ("lanilide hydroxamic acid" 3)
   ("acid (PNA)" 3)
   ("ice-cold 40 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid" 3)
   ("organic acids" 3) ("either scrambled Exiqon miRCURY Lock Nucleic Acid" 3)
   ("ε-aminocaproic acid" 3) ("AMINO ACID" 3)
   ("the bile component glycocholic acid" 3)
   ("100 mM 2-(N-morpholino) ethanesulphonic acid" 3) ("carboxylic acids" 3)
   ("100 mM phosphoric acid" 2) ("iodohexanoic acid" 2)
   ("iodohexadecanoic acid" 2)
   ("10 mM N -tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid" 2)
   ("0.425% phosphoric acid" 2) ("glycocholic acid" 2) ("sulfuric acid" 2)
   ("L(+)-tartaric acid" 2) ("20 mM ethylenediamine-tetraacetic acid" 2)
   ("the ANT-binding bongkrekic acid" 2)
   ("1 mM ethylenediaminetetraacetic acid" 2)
   ("5mM ethylenediaminetetraacetic acid" 2) ("methylseleninic acid" 2)
   ("diethylenetriaminepentaacetic acid (DETAPAC)" 2) ("100 µM tannic acid" 2)
   ("ethylenediamine tetraacetic acid" 2) ("suberoylanilide hydroxanic acid" 2)
   ("Peptide nucleic acid (PNA)" 2)
   ("0.2 ml ice cold 0.01 mM perchloric acid" 2)
   ("ethylene-diamine- tetraacetic acid" 2) ("a coding nucleic acid" 2)
   ("sulfosalicylic acid" 2) ("1 µM okadaic acid" 2)
   ("5% metaphosphoric acid" 2) ("2% oxalic acid" 2) ("tetrahydrofolic acid" 2)
   ("50 mM 2-morpholinoethanesulfonic acid" 2)
   ("5 mM ethylenediamine tetraacetic acid" 2)
   ("N -Boc-protected m -aminomethylbenzoic acid" 2)
   ("a lipid-soluble weak acid" 2) ("cysteine sulfinic and sulfonic acid" 2)
   ("100 nM okadaic acid" 2) ("-disulfonic acid (DIDS)" 2)
   ("Trifluoroacetic acid (TFA)" 2) ("suberoylanilidehydroxamic acid" 2)
   ("the fluorochrome 3,5-diaminobenzoic acid" 2) ("30°C. Okadaic acid" 2)
   ("1 mM ethylene glycol tetraacetic acid (EGTA)" 2)
   ("1 mM ethylenediaminetetraacetic acid (EDTA)" 2)
   ("ethylene glycol tetraacetic acid (EGTA)" 2) ("0.1 M phosphoric acid" 2)
   ("Their nucleic acid" 2) ("ethylene glycol tetraacetic acid" 2)
   ("60 mM Na–1,4-piperazinediethanesulfonic acid" 2)
   ("perfluorooctanoic acid (PFOA)" 2) ("the hydroxamic acid" 2)
   ("the viral nucleic acids" 2) ("molybdic acid" 2) ("Viral nucleic acids" 2)
   ("viral nucleic acid" 2) ("residual nucleic acids" 2)
   ("pathological nucleic acids" 2)
   ("0.02% ethylenediaminetetraacetic acid (EDTA)" 2)
   ("30% trichloracetic acid" 2)
   ("0.25% trypsin–ethylenediaminetetraacetic acid" 2)
   ("75 mM phosphoric acid" 2) ("S. aureus lipoteichoic acid (LTA)" 2)
   ("dipicolinic acid (DPA)" 2) ("ophthalmic acid" 2) ("pyroglutamic acid" 2)
   ("chloroauric acid" 2) ("30 ml trifluoroacetic acid (TFA)" 2)
   ("sulphonic acid" 2) ("inhibitory neurons γ -aminobutyric acid" 2)
   ("2-Fluoropalmitic acid" 2) ("Farnesyl thiosalicylic acid" 2)
   ("10 mM ethylenediamine tetraacetic acid" 2)
   ("ethylenedinitrotetraacetic acid" 2) ("direct nucleic acid" 2)
   ("0.02 μM bathocuproinedisulfonic acid" 2) ("Glutamic Acid" 2)
   ("cytochrome P450-derived epoxyeicosatrienoic acids" 2)
   ("Locked nucleic acids" 2) ("The carboxylic acids" 2)
   ("m -chloroperbenzoic acid" 2)
   ("6-Nitro-2-oxo-2H-chromene-3- carboxylic acid" 2)
   ("concentrated sulfuric acid" 2)
   ("3,3,4,4,4-D 5 (3-position 97% D, 4-position 50–70% D) 2-ketobutyric acid"
    2)
   ("Fragmented nucleic acid" 2) ("mild acid" 2) ("Perchloric acid" 2)
   ("polyriboinosinic polyribocytidylic acid" 2)
   ("double-stranded locked nucleic acid (LNA)" 2)
   ("using 6-( p -toluidinyl) naphthalene-2-sulfonic acid" 2)
   ("aminooxyacetic acid" 2)
   ("ethylenediamine tetraacetatic
acid"
    2)
   ("50μg/mL L-Ascorbic Acid" 2) ("0.015% pluronic acid" 2)
   ("trans-farnesylthiosalicylic acid" 2) ("propionic acid" 2)
   ("25mM 2-( N -morpholino) ethanesulfonic acid" 2)
   ("3-( N -morpholino)propanesulfonic acid (MOPS)" 2)
   ("5-sulfosalicylic acid (SSA)" 2) ("3,4-dimethoxycinnamic acid (DMCA)" 2)
   ("dimethylcaffeic acid (DMCA)" 2) ("dihydrocaffeic acid (HCA)" 2)
   ("25 mmol/L L(+)-tartaric acid" 2) ("1-piperazineethanesulfonic acid" 2)
   ("Alexa Fluor 594 carboxylic acid" 2) ("15 hydroxyeicosatetraenoic acid" 2)
   ("S-farnesylthiosalicylic acid" 2) ("10nM Okadoic acid" 2)
   ("Suberoyl anilide hydroxamic acid" 2)
   ("the Pck1/Pck2 inhibitor 3-mercaptopicolinic acid" 2)
   ("0.05% trypsin-ethylenediaminetetraacetic acid" 2)
   ("10% trifluoroacetic acid" 2)
   ("0.2 mM ethylenediaminetetraacetic acid (EDTA)" 2)
   ("evolutionary conserved phosphoamino acids" 2) ("glycyrrhetic acid (GA)" 2)
   ("eicosopanthenoic acid (EPA)" 2)
   ("5 mM ethylene glycol tetraacetic acid (EGTA)" 2)
   ("100 mM Tris/HCl pH 8.8 and 0.2 mM para-coumaric acid" 2)
   ("1 m M ethylenediaminetetraacetic acid" 2)
   ("antisense locked-nucleic acids" 2) ("0.1% aqueous trifluoroacetic acid" 2)
   ("a polyphenol antioxidant carboxylic acid" 2) ("a Locked Nucleic Acid" 2)
   ("5-aminosalicyclic acid" 2) ("peptide nucleic acids" 2)
   ("locked nucleic acids" 2) ("piperazineethanesulfonic acid (HEPES)" 2)
   ("microbial nucleic acids" 2) ("1 mM edetic acid" 2)
   ("tetrabromocinnamic acid (TBCA)" 2) ("fenofibric acid (FA)" 2)
   ("ethylenediamine tetraacetic acid (EDTA)" 2) ("dehydroascorbic acid" 2)
   ("0.2 mM ethylenediaminetetraacetic acid" 2)
   ("ethanesulfonic acid (HEPES)" 2)
   ("0.1 mM ethylene glycol tetraacetic acid" 2)
   ("25% methanol/20% acetonitrile/55% (0.3%) phosphoric acid" 2)
   ("mercapturic acids" 2) ("1 m M Tris/ethylene diamine tetraacetic acid" 2)
   ("2 mM ethylene diamine tetraacetic acid" 2) ("Toxic bile acids" 2)
   ("the Sc-BUB1 2-(n-cyclohexylamino)ethane sulfonic acid (CHES)" 2)
   ("2 M oxalic acid" 2) ("0.1% trifluoracetic acid" 2)
   ("82.5% trifluoroacetic acid (TFA)" 2) ("epoxyeicosatrienoic acids" 2)
   ("0.1 M Tris-HCl (pH7.4,) 0.1 M epsilon amino caproic acid" 2)
   ("15(S)-hydroxyeicosatetraenoic acid (HETE)" 2) ("acid (DCA)" 2)
   ("use nicotinic acid" 2) ("10 mM ethylenediaminetetraacetic acid (EDTA)" 2)
   ("ethylenediaminetetracetic acid (EDTA)" 2)
   ("a terminal sulfated carbohydrate acid" 2) ("-orthophosphoric acid" 2)
   ("isodialuric acid" 2)
   ("using trypsin-ethylenediaminetetraacetic acid (EDTA)" 2)
   ("Heptadecanoic acid" 2) ("Basic Amino Acid" 2)
   ("2mM ethylenediaminetetraacetic acid (EDTA)" 2) ("acid (EDTA)" 2)
   ("trans -farnesylthiosalicylic acid" 2) ("free 1-pyrenylcarboxylic acid" 2)
   ("3-( N -morpholino)propanesulfonic acid" 2)
   ("the phosphatase inhibitor okadaic acid (OA)" 2)
   ("a dimeric cyanine nucleic acid" 2) ("2,5 dihydroxybenzoic acid" 2)
   ("ethacrinic acid" 2) ("aurintricarboxylic acid" 2)
   ("either 100 nM okadaic acid" 2) ("palmitoleic acid" 2)
   ("1 mM nitrilotriacetic acid (NTA)" 2) ("sinapinic acid" 2)
   ("1% phosphowolframic acid" 2) ("methylseleninic acid (MSA)" 2)
   ("the sialic acid N -glycolylneuraminic acid" 2)
   ("any contaminating nucleic acids" 2)
   ("a non-sequence specific nucleic acid" 2) ("neat trifluoroacetic acid" 2)
   ("the terminal sulphonic acids" 2) ("sulphinic acid" 2)
   ("1 μg deoxyinosinic deoxycytidylic acid" 2)
   ("the intermediary (15R) hydroxyeicosotetraenoic acid" 2)
   ("Isobutyric acid" 2) ("antiporter inhibitors DL-amino adipic acid" 2)
   ("0.4 μl 2,5-dihydroxybenzoic acid (DHB)" 2)
   ("aflatoxin-mercapturic acid" 2) ("3-amino-3-(1-napthyl)-propionic acid" 2)
   ("aminolevulinic acid" 2) ("acid (AMPA)" 2)
   ("5 mM perfluoropentanoic acid" 2)
   ("the arginase inhibitor 2(S)-amino-6-boronohexonic acid (ABH)" 2)
   ("4-Hydroxymethylphenoxyacetic acid" 2) ("90% trifluoroacetic acid (TFA)" 2)
   ("Nordihydroguayaretic acid" 2) ("polydeoxyinosinic-deoxycytidylic acid" 2)
   ("cellular nucleic acids" 2)
   ("either 1 m M ethylenediaminetetraacetic acid" 2)
   ("20-hydroxyeiscosatetraenoic acid" 2) ("sebacic (SA) acids" 2)
   ("zaragozic acid" 2) ("Zaragozic acid" 2)
   ("25 mM 2-N-morpholine ethanesulfonic acid" 2)
   ("chemically characterized nitroarachidonic acid" 2)
   ("a bisphosphonic acid" 2) ("10 mM Butyric Acid" 2)
   ("ethylene-diaminetetraacetic acid (EDTA)" 2)
   ("complex single-stranded nucleic acid" 2)
   ("glycochenodeoxyocholic acid (GCDA)" 2)
   ("-2-naphthalene carboxylic acid (AHPN)" 2) ("1,3,7-trimethyluric acid" 2)
   ("ethanesulfonic acid" 2) ("saturated sinapinic acid" 2)
   ("orthophosphoric acid" 2)
   ("20 mM 3-(N-morpholino)propanesulfonic acid (MOPS)" 2)
   ("ethylenediaminetetracetic acid" 2) ("dimerumic acid (DMA)" 2)
   ("Nucleic acid" 2) ("12 nucleic acids" 2)
   ("-2-naphthalene carboxylic acid" 2)
   ("trichloracetic acid/phosphotungstic acid" 2)
   ("Tris-ethylenediaminetetraacetic acid (EDTA) (TE)" 2)
   ("peptide nucleic acid" 2) ("0.1–1 µM okadaic acid" 2)
   ("0.2 µM okadaic acid" 2) ("its precursor nucleic acids" 2)
   ("the specific PP2A inhibitor cantharidic acid" 2) ("uronic acids" 2)
   ("90 mM boric acid" 2) ("20 nM bathocuproine disulfonic acid" 2)
   ("Aspartic Acid" 2) ("arachindonic acid" 2) ("Kainic Acid (KA)" 2)
   ("0.1 M 4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid (HEPES)" 2)
   ("The nucleic acid" 2) ("0.1 M cacodylic acid" 2)
   ("RedSafe™ Nucleic Acid" 2) ("2 mM ethylene glycol tetraacetic acid" 2)
   ("150 µg/ml pyruvic acid" 2) ("2,4-Dihydroxybenzoic acid" 2)
   ("cannabidiolic acid (CBDA)" 2) ("13- S -hydroxyoctadecadienoic acid" 2)
   ("0.5% Deoxycholic Acid" 2) ("chenodeoxycolic acid (CDCA)" 2)
   ("0.3 nM Okadaic acid (OA)" 2) ("Locked nucleic acid" 2)
   ("2M sulphuric acid" 2)
   ("0.05% trypsin/0.02% ethylenediaminetetraacetic acid" 2)
   ("amino-isobutyric acid" 2)
   ("1 mM ethylenediamine tetraacetic acid (EDTA)" 2) ("Ocadaic acid" 2)
   ("2 mM ethylene glycol tetraacetic acid (EGTA)" 2) ("L (+)-tartaric acid" 2)
   ("4-(2-hydroxyethyl)-1-piperazineethane sulfonic acid (HEPES)" 2)
   ("0.45 N sulfuric acid" 2)
   ("hydroxyeicosatetraenoic or hydroxyoctadecadienoic acids" 2)
   ("0.1 M boric acid" 2)
   ("trypsin/disodium ethylenediaminetetraacetic acid" 2)
   ("trans- farnesylthiosalicylic acid" 2) ("heptacosanoic acid" 2)
   ("the PALB2-nucleic acid" 2) ("AF488 carboxylic acid" 2)
   ("performic acid" 1) ("180 mM phosphoric acid" 1)
   ("containing 0.2% (wt/vol) fluoroorotic acid (FOA)" 1)
   ("0.19% picric acid" 1) ("duodenal bile acids (BA)" 1) ("acids (BA)" 1)
   ("The triflouroacetic acid" 1) ("0.4 mM ethylenediaminetetraacetic acid" 1)
   ("2,4,6-trinitrobenzenesulphonic acid (TNBS)" 1) ("0.1 μM okadaic acid" 1)
   ("1 μM okadaic acid" 1) ("using bicinchoninic acid" 1)
   ("1% Sodium Deoxycholic Acid" 1)
   ("Tris-borate ethylenediaminetetraacetic acid" 1)
   ("polyinosinic-cytidylic acid" 1) ("Valproic Acid" 1)
   ("10% trichloracetic acid" 1)
   ("Complete Protease Inhibitor ethylenediaminetetraacetic acid" 1)
   ("the six dispersed locked nucleic acid (LNA)" 1)
   ("10 μM deuterated phosphoric acid" 1) ("1-piperidinecarboxylic acid" 1)
   ("Ethylene-diamine tetraacetic acid" 1) ("the PARG inhibitor tannic acid" 1)
   ("2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid" 1)
   ("8 mM oxalic acid" 1)
   ("this study, pyroglutamine and dihydroxy docosatrienoic acid" 1)
   ("the bacteriostatic TB drug para-aminosalicyclic acid" 1)
   ("docosahexanoic acid (DHA)" 1) ("-octanoic acid" 1)
   ("3,4-dihydroxyphenylacetic acid (DOPAC)" 1) ("80nM okadaic Acid" 1)
   ("small aptameric nucleic acids" 1) ("4% performic acid" 1)
   ("500 nM okadaic acid (OA)" 1) ("acid (CHCA)" 1)
   ("50% ACN/2% trifluoroacetic acid (TFA)" 1)
   ("pyrrolidinedithiocarbamic acid (PDTC)" 1) ("44.5 mM boric acid" 1)
   ("0.01 M critic acid" 1)
   ("The polymerase inhibitor phosphonoacetic acid (PAA)" 1)
   ("1 mM ethylenediaminetetraacetic acid" 1)
   ("2-( N -morpholino)ethanesulfonic acid" 1) ("propanesulfonic acid" 1)
   ("4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid" 1)
   ("6% meta-phosphoric acid" 1) ("miR-7 locked nucleic acids (LNA)" 1)
   ("3-hydroxypicolinic acid" 1) ("250 nM okadaic acid" 1)
   ("either 30 μM arachadonic acid" 1) ("EthyleneDiamineTetraacetic acid" 1)
   ("single-stranded nucleic acid" 1) ("the retroviral nucleic acids" 1)
   ("using phosphoric acid" 1) ("cysteine sulfinic acid" 1)
   ("0.06% sulfosalicylic acid" 1) ("Peptide nucleic acid" 1)
   ("template DNA, primer and peptide nucleic acid(PNA)" 1)
   ("100 µM diethylenetriaminepentaacetic acid" 1)
   ("the phenolic carboxylic acid" 1)
   ("The phosphatase inhibitor okadaic acid (OA)" 1)
   ("Ni 2+ nitrilotriacetic acid" 1) ("PP2A inhibitor okadaic acid" 1)
   ("Hoechst nucleic acid" 1) ("the CyQUANT Direct Nucleic Acid" 1)
   ("chemically modified single stranded nucleic acids" 1)
   ("70 mM 2,6,4-trinitrobenzenesulfonic acid (TNBS)" 1)
   ("oxidatively decarboxylates malic acid" 1)
   ("2% CH 3 CN/0.1% trifluoroacetic acid" 1)
   ("1 mM ethyleneglycoltetraacetic acid" 1)
   ("trypsin-ethylenediaminotetraacetic acid (EDTA)" 1)
   ("using
phosphoric acid"
    1)
   ("pyruvic acid" 1) ("labeled Locked Nucleic Acid (LNA)" 1)
   ("chendeoxycholic acid (CDCA)" 1) ("PIK3CA nucleic acid" 1)
   ("-3-Methyl-7-(4-methylphenyl)-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid"
    1)
   ("1.0 mM ethylenediaminetetraacetic acid" 1)
   ("methylene tetrahydrofolic acid" 1) ("5% phosphoric acid" 1)
   ("its potent inhibitor okadaic acid (OA)" 1)
   ("concentrated hydrofluoric acid" 1) ("ethylene diamine tetraacetic acid" 1)
   ("the major secondary bile acids" 1)
   ("a potent tumor-promoting secondary bile acid" 1)
   ("the secondary bile acids" 1) ("a secondary bile acid" 1) ("acid (DNA)" 1)
   ("0.04% pluronic acid" 1) ("10 mM Na–ethylene glycol tetraacetic acid" 1)
   ("a fluorescent nucleic acid" 1) ("Indeed bile acids" 1)
   ("Perfluorooctanoic acid" 1)
   ("Ca 2+ chelators BAPTA-AM and ethylene glycol bis(2-aminoethyl) tetraacetic acid (EGTA)"
    1)
   ("dicarboxylic acids" 1) ("2,2-dithiobisnitrobenzoic acid (DTNB)" 1)
   ("fluorescein (fluorescein isothiocyanate)-labeled peptide nucleic acid" 1)
   ("2.5% trifluoroacetic acid" 1)
   ("0.53 mM ethylenediaminetetraacetic acid (EDTA)" 1)
   ("virus derived nucleic acids" 1) ("excess nucleic acids" 1)
   ("excess HIV-derived nucleic acids" 1) ("abnormal self-nucleic acids" 1)
   ("virus-derived nucleic acids" 1)
   ("foreign or pathological nucleic acids" 1)
   ("1 mM ethylenediamineteraacetic acid (EDTA)" 1) ("galbanic acid" 1)
   ("10 mM ethylenediaminetetraacetic acid" 1)
   ("aurin trycarboxylic acid (ATA)" 1) ("2% (w/v) phosphotungstic acid" 1)
   ("4-Aminophenylmercuric acid" 1) ("a telomere peptide nucleic acid" 1)
   ("a telomere-specific peptide nucleic acid" 1)
   ("Ethylene Diamine Tetraacetic Acid" 1)
   ("20 mM ethylenediaminetetraacetic acid" 1) ("3% phosphoric acid" 1)
   ("numerous polymerase-nucleic acid" 1) ("either lipoteichoic acid (LTA)" 1)
   ("1% molybdophosphoric acid" 1) ("ophthalmic acid (OPA)" 1)
   ("Mycophenolic Acid (MPA)" 1) ("changed four nucleic acids" 1)
   ("Syto60 nucleic acid" 1) ("a Cy3-labeled peptide nucleic acid (PNA)" 1)
   ("single stranded nucleic acids" 1) ("1 μ M okadaic acid" 1)
   ("0.5 mM ethylenediaminetetraacetic acid" 1)
   ("farnesythiosalicylic acid (FTS)" 1) ("available extracted nucleic acid" 1)
   ("1-napthohydroxamic acid" 1) ("-tetraacetic acid (DOTA)" 1)
   ("Tannic acid" 1) ("the non-permeable fixative tannic acid" 1)
   ("using 0.4 N perchloric acid" 1)
   ("the oxygen-dependent tricarboxylic acid (TCA)" 1)
   ("mercaptoacetic acid" 1) ("6-substituted coumarin-3-carboxylic acid" 1)
   ("coumarin-3-carboxylic acid" 1) ("lipoteichoic acid (LTA)" 1)
   ("lipotechoic acid (LTA)" 1) ("ethylenediamine-tetraacetic acid" 1)
   ("the squalene synthase inhibitor zaragozic acid (ZGA)" 1)
   ("the TLR2 ligand lipoteichoic acid" 1) ("50 mM orthophosphoric acid" 1)
   ("0.5 M (3%) orthophosphoric acid" 1)
   ("the tumor-associated 2-aminoadipic acid" 1)
   ("arachidonic and docosahexaenoic (DHA) acids" 1) ("2-aminoadipic acid" 1)
   ("oleanic acid (OA)" 1) ("Oleanic acid (OA)" 1) ("Nicotinic acid" 1)
   ("Locked Nucleic Acid" 1)
   ("50 µL diluted (1∶149) trinitrobenzenesulfonic acid (TNBA)" 1)
   ("a galacturonic acid" 1)
   ("0.1%
tannic acid"
    1)
   ("10 μL 0.5 M ethylendiaminetetraacetic acid" 1) ("20 nM okadaic acid" 1)
   ("class-1/2 HDACs inhibitor suberoyanilide hydroxamic acid (SAHA)" 1)
   ("Pyruvic acid" 1) ("SYBR® Gold nucleic acid" 1)
   ("5 mmol/l ethylene diaminetetraacetic acid" 1)
   ("a specific inhibitor Okadaic Acid" 1) ("3,4-dihydrocinnamic acid (HCA)" 1)
   ("tumor cell-free nucleic acids" 1)
   ("A fluorescently labeled nucleic acid" 1)
   ("tannic
acid"
    1)
   ("0.5 µM okadaic acid" 1) ("farnesyl thiosalicylic acid" 1)
   ("Arachidonic Acid" 1) ("most famously nucleic acids" 1)
   ("pH 8.0 and 1 mM ethylenediamine tetraacetic acid (EDTA)" 1)
   ("0.5 µM Okadaic acid" 1) ("hydrofluoric acid" 1)
   ("5 mmoll −1 ethylenediaminetetraacetic acid (EDTA)" 1)
   ("Total nucleic acids" 1) ("homocysteic acid (HCA)" 1)
   ("1 mM homocysteic acid (HCA)" 1) ("ice-cold 70% perchloric acid" 1)
   ("using pan-telomeric peptide nucleic acid" 1)
   ("1 mmol/L ethylene diamine tetraacetic acid (EDTA)" 1)
   ("neuronal nucleic acids" 1) ("acid (MTOB)" 1) ("glutamic (OSU-EE) acid" 1)
   ("a peptide nucleic acid (PNA)" 1)
   ("0.01 mmol/l ethylenediamine-tetraacetic acid" 1)
   ("15(R)-hydroxyeicosatetraenoic acid" 1)
   ("12.5 mM 2-(N-Morpholino)ethanesulfonic acid (MES)" 1)
   ("10 nM okadaic acid" 1) ("2 mM ethylenediaminetetraacetic acid (EDTA)" 1)
   ("2,4,6 trinitrobenzene sulfonic acid (TNBS)" 1)
   ("Methoxyacetic acid (MAA)" 1) ("the carboxylic acid" 1)
   ("trans-3-(3-pyridyl) acrylic acid" 1) ("6% sulphosalicylic acid" 1)
   ("molybdenic acid" 1)
   ("membrane-bound Toll-like receptors (TLRs) sense nucleic acids" 1)
   ("the mitochondria-stabilizing agent bongkrekic acid" 1)
   ("aliphatic acids" 1) ("a highly sensitive locked nucleic acid (LNA)" 1)
   ("0.05% aqueous trifluoroacetic acid" 1) ("2% trifluoroacetic acid (TFA)" 1)
   ("glycyrrhizic acid" 1) ("glyccyrrhetinic acid" 1)
   ("\"Biotin-SGSG-PEPTIDE-acid\"" 1) ("fluorescent bile acids" 1)
   ("corosolic acid" 1) ("ice-cold 0.4N perchloric acid" 1)
   ("an asparatic acid" 1) ("DAPI nucleic acid" 1)
   ("0.5% v/v trifluoroacetic acid (TFA)" 1) ("efficient nucleic acid" 1)
   ("oylalanide hydroxamic acid (SAHA)" 1)
   ("trypsin-ethylenediaminetetraacetic acid" 1)
   ("SUMOylation- Ginkgolic acid" 1) ("0.1M boric acid" 1)
   ("2 mM sodium heptanesulfonic acid" 1) ("The periodic acid" 1)
   ("using tricholoroacetic acid" 1) ("a salicyclic acid" 1)
   ("The lyophilized tricarboxylic acid (TCA)" 1)
   ("2-(N-morpholino)ethanesulfonic acid" 1) ("soft Lewis acids" 1)
   ("0.1% tannic acid" 1) ("any nucleic acid" 1) ("specific nucleic acid" 1)
   ("nucleic acids (NA)" 1) ("2 mM ethylenediamine tetraacetic acid (EDTA)" 1)
   ("phosphoenolpyruvic acid" 1)
   ("0.5M ethylene glycol tetraacetic acid (EGTA)" 1)
   ("0.5M ethylenediaminetetraacetic acid (EDTA)" 1)
   ("fetal cell-free nucleic acids" 1)
   ("FITC-labeled oligo(dT) 25 locked nucleic acid (LNA)" 1)
   ("bis-hydroxamic acid (SBHA)" 1) ("8% Trifluoroacetic acid (TFA)" 1)
   ("2 M sulphuric acid" 1) ("10mM ethylenediaminetetraacetic acid (EDTA)" 1)
   ("50 μL perchloric acid" 1) ("exotic nucleic acids" 1)
   ("2 mM ethylenediamine tetraacetic acid" 1) ("-dienoic acid" 1)
   ("belizeanic acid" 1)
   ("the magnetic particles (Siemens Healthcare Diagnostics, Cologne, Germany) nucleic acids"
    1)
   ("the herbicide 2,4-dichlorophenoxyacetic acid" 1) ("100 μl Oxalic acid" 1)
   ("pharmaceutical agents- okadaic acid" 1) ("a toxic bile acid" 1)
   ("the most toxic bile acid" 1) ("muricholic acids" 1)
   ("2.5 mM ethylene glycol tetraacetic acid" 1)
   ("2.5 mM ethylenediaminetetraacetic acid" 1) ("2.5 nM okadaic acid" 1)
   ("0.2M Citric Acid" 1) ("a specific nucleic acid" 1) ("both okadaic acid" 1)
   ("Trifluoroacetic acid" 1)
   ("2-aminobicyclo-(2,2,1)heptanecarboxylic acid (BCH)" 1)
   ("hydroxy octadecadienoic acid" 1)
   ("13(S)-hydroxy octadecadienoic acid (HODE)" 1) ("linoeic acid" 1)
   ("4-(2-hydroxethyl)-1-piperazineethanesulfonic acid" 1)
   ("double-stranded nucleic acids" 1)
   ("the related molecule nicotinic acid" 1)
   ("using trypsin and ethylenediamine tetraacetic acid (EDTA)" 1)
   ("no nucleic acid" 1) ("a nucleic acid" 1) ("Acid (RA)" 1)
   ("lipotechoic acid" 1) ("10% (v/v) ethanoic (acetic) acid" 1)
   ("2M sulfuric acid" 1) ("1.0 mM 1-octanesulfonic acid" 1)
   ("4.0 mM 1-octanesulfonic acid" 1) ("5 M perchloric acid" 1)
   ("0.85 mM 1-octanesulfonic acid" 1)
   ("its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC)" 1)
   ("0.1 µM okadaic acid" 1) ("esophageal acid" 1) ("70% 12 N sulfuric acid" 1)
   ("Höechst 33342 nucleic acid" 1)
   ("0.02% ethyl-enediaminetetraacetic acid" 1)
   ("2- O -sulfated iduronic acid" 1) ("2-hydroxymyristic acid" 1)
   ("control locked nucleic acids (LNA)" 1)
   ("4-methoxy-6-nitroobenzene sulfonic acid" 1)
   ("saturated -cyanocinnamic acid" 1) ("0.1% trifluroacetic acid (TFA)" 1)
   ("100 mM Bis-2-aminoethanesulfonic acid (BES)" 1)
   ("two or more nucleic acid" 1) ("50 μL/well 1 M sulfuric acid" 1)
   ("methylpyrenyl mercapturic acid (MPMA)" 1)
   ("monovalent conjugated bile acids" 1) ("2 μM ocadaic acid" 1)
   ("0.125% trifluoroacetic acid" 1) ("1% trifluoroacetic acid (TFA)" 1)
   ("icecold 5% perchloric acid" 1)
   ("0.5 M ethylene-diaminetetraacetic acid" 1)
   ("using Ni 2+ -nitrilotriacetic acid" 1) ("than primary bile acids" 1)
   ("Locked Nucleic Acid (LNA)" 1) ("phosphoric acid’s" 1)
   ("SYTO 9 green fluorescent nucleic acid" 1) ("0.8 M perchloric acid" 1)
   ("1-methylcyclohexanecarboxylic acid" 1)
   ("the anti-miR-138 peptide nucleic acid (PNA)" 1)
   ("10 μ M dipicolinic acid" 1) ("α-aminobutyric acid" 1)
   ("50°C. Nucleic acids" 1) ("2% paraphormaldehyde/0.21% picric acid" 1)
   ("1μM okadaic acid" 1) ("5 ng/ml selenous acid" 1)
   ("20% tri-chloroacetic acid (TCA)" 1) ("contaminating nucleic acid" 1)
   ("50 mM phosphoric acid" 1)
   ("both containing 0.001% (v/v) trifluoroacetic acid" 1)
   ("2 m tetrahydrofolic acid" 1) ("acid (FTS)" 1)
   ("superoylanilide hydroxamic acid" 1) ("hydroxamic acid (SAHA)" 1)
   ("2-mercaptoethane sulfonic acid (MESNA)" 1) ("exogenous bile acids" 1)
   ("both nucleic acids" 1) ("a nalidixic acid" 1) ("2 µM ocadaic acid" 1)
   ("10% Acetic Acid" 1) ("acid (ANTS)" 1) ("DL-2-aminoadipic acid" 1)
   ("450nM Syto9 green-fluorescent nucleic acid" 1)
   ("a red fluorescent nucleic acid" 1)
   ("containing ethylenediaminetetraacetic acid (EDTA)" 1)
   ("1% sulfuric acid" 1) ("acid (ADCB)" 1) ("acid (RA)" 1)
   ("hyodeoxycholic acid" 1) ("0.1 N perchloric acid" 1)
   ("5-S-hydroperoxy eicosatetraenoic acid" 1)
   ("15(S)-hydroxyeicosatetraenoic acid" 1)
   ("12(S)-hydroxyeicosatetraenoic acid" 1) ("sulfonic (R-SO 3 H) acids" 1)
   ("strong acid" 1) ("contaminant bacterial nucleic acids" 1)
   ("-locked digoxigenin-labeled nucleic acid (LNA)" 1)
   ("Biotin-bound nucleic acids" 1)
   ("acetonitrile/0.1% trifluoroacetic acid" 1)
   ("75 mM orthophosphoric acid" 1) ("50 mM ortho-phosphoric acid" 1)
   ("6 mM ethylenediamine tetraacetic acid" 1)
   ("3,10-dihydroxydecanoic and sebacic acid" 1) ("5 μM zaragozic acid" 1)
   ("using 10 m ethylenediaminetetraacetic acid (EDTA)" 1)
   ("50% acetonitrile/0.1% trifluoroacetic acid (TFA)" 1)
   ("15-hydroperoxyeicosatetraenoic acid" 1)
   ("15-Hydroperoxyeicosatetraenoic acid" 1) ("nitrooleic acid" 1)
   ("pristanic acid" 1) ("the obtained nucleic acids" 1)
   ("100 μM ethylenediaminetetraacetic acid (EDTA)" 1) ("phosphatydic acid" 1)
   ("the vesicular γ-aminobutyric acid" 1) ("acid (ANS)" 1)
   ("template nucleic acids" 1) ("Purified nucleic acid" 1)
   ("10 μl 2% ACN/0.1% trifluoroacetic acid (TFA)" 1)
   ("7% phosphomolybdic acid" 1) ("0.5 mM ethylene glycol tetraacetic acid" 1)
   ("pH 7.2)/100 mM NaCl/1 mM ethylenediaminetetraacetic acid" 1)
   ("0.2 µM okadaic acid (OA)" 1) ("3-(N-morpholino)-propanesulfonic acid" 1)
   ("6M perchloric acid" 1) ("Okadaic Acid" 1) ("0.1 M okadaic acid" 1)
   ("the published nucleic acid" 1) ("foreign nucleic acid" 1)
   ("A hydroxamic acid" 1) ("-disolfonic acid" 1)
   ("naphthalene sulfonic acid" 1) ("64.6 mM boric acid" 1)
   ("45 nM selenious acid" 1) ("mitochondrial nucleic acids" 1) ("acid (OA)" 1)
   ("polyinosinic-polycitidilic acid (PIC)" 1)
   ("agents glycyrrhizic acid (GA)" 1)
   ("2.5 mM ethylene glycol tetraacetic acid (EGTA)" 1) ("tienilic acid" 1)
   ("0.1N trifluoroacetic acid" 1) ("host-derived nucleic acid" 1)
   ("0.05% ethylenediaminetetraacetic acid (EDTA)" 1)
   ("10-camphorsulphonic acid" 1) ("1 m M ethylene glycol tetraacetic acid" 1)
   ("1 m M ethylene diamine tetraacetic acid" 1)
   ("10 mM 3-( N -morpholino)propanesulfonic acid" 1)
   ("an FITC-conjugated peptide nucleic acid (PNA)" 1)
   ("isolated nucleic acids" 1) ("1% Non Essential Amino Acid" 1)
   ("2% phosphotungstic acid" 1) ("0.5 M sulfuric acid" 1)
   ("than okadaic acid" 1) ("bacterial nucleic acids" 1)
   ("These nucleic acids" 1) ("diethyldithiocarbamic acid (DETC)" 1)
   ("15 mM 2-( N -morpholino)ethanesulfonic acid" 1)
   ("a 0.1% trifluoroacetic acid (TFA)" 1)
   ("the PP1/PP2A inhibitor Okadaic acid" 1) ("PFA)/0.2% picric acid" 1)
   ("N 9-tetraacetic acid" 1) ("this experiment no okadaic acid" 1)
   ("perchloric acid (PCA)" 1) ("about okadaic acid" 1)
   ("50 mM ethylene glycol tetraacetic acid" 1)
   ("the PP2A inhibitor cantharidic acid" 1)
   ("lysobiophosphatidic acid (LBPA)" 1)
   ("0.7 μM ethylene glycol tetraacetic acid (EGTA)" 1)
   ("0.16 M sulfuric acid" 1) ("Antisense nucleic acid" 1)
   ("a carboxylic acid" 1) ("the OSU Nucleic Acid" 1)
   ("0.2 mM ethylenediaminetetraacetic acid" 1) ("iduronic acid" 1)
   ("ethylenediaminetetraacetic
acid"
    1)
   ("myristoylic acid" 1)
   ("These therapeutic approaches target nucleic acids" 1)
   ("urinary vanillylmandelic acid" 1) ("amino and organic acids" 1)
   ("0.1 M 2-( N -morpholino)ethanesulfonic acid (MES)" 1)
   ("a fluorescein-conjugated (CCCTAA) 3 peptide nucleic acid (PNA)" 1)
   ("fluorescently labeled peptide nucleic acid (PNA)" 1)
   ("0.1% trypsin-ethylenediaminetetraacetic acid" 1) ("-coumaric acid" 1)
   ("a Cy3-conjugated telomere-specific peptide nucleic acid (PNA)" 1)
   ("the specific nucleic acids" 1)
   ("5 mM ethylenediamine tetraacetic acid (EDTA)" 1)
   ("peptide nucleic acid-locked nucleic acid" 1)
   ("the appropriate amino carboxylic acids" 1)
   ("2-(N-morpholino)-ethanesulfonic acid (MES)" 1)
   ("0.5 mmol/l ethylenediaminetetraacetic acid (EDTA)" 1)
   ("Nickel-nitrilotriacetic acid" 1) ("Lipoteichoic acid" 1)
   ("Lipoteichoic acid (LTA)" 1) ("1 mM toluic acid" 1)
   ("0.1 mM ethylenediaminetetraacetic acid (EDTA)" 1)
   ("protein–nucleic acid" 1)
   ("0.25% trypsin-0.03% ethylendiaminetetraacetic acid" 1)
   ("single-stranded nucleic acids" 1)
   ("a Cy3-labled (CCCTAA) 3 peptide nucleic acid" 1)
   ("telomere repeat–specific peptide nucleic acid" 1)
   ("the activating nucleic acid" 1) ("flufenamic acid (FFA)" 1)
   ("Carboxylic acid" 1) ("0.04% trifluoroacetic acid" 1)
   ("using trifluoroacetic acid" 1) ("farnesylthiosalicylic acid" 1)
   ("Farnesylthiosalicylic acid (FTS)" 1)
   ("6-diamidino-2-phenylindole (DAPI) Nucleic Acid" 1)
   ("decreased gastric acid" 1) ("1µM okadaic acid" 1)
   ("chemically modified single-stranded nucleic acids" 1)
   ("15% picric acid" 1) ("tricarboxcylic acid (TCA)" 1)
   ("0.1 M perchloric acid" 1)
   ("using ethylene diamine tetraacetic acid (EDTA)" 1)
   ("0.02 N Acetic Acid" 1) ("ice-cold 0.4 M perchloric acid" 1)
   ("60% acetonitrile/0.1%
trifluoroacetic acid"
    1)
   ("nucleic
acids"
    1)
   ("a single stranded nucleic acid" 1)
   ("blue-fluorescent DAPI nucleic acid" 1)
   ("N-acetylneuraminic (sialic) acids" 1) ("fenofibric acid" 1)
   ("Rhodamine conjugated peptide nucleic acid (PNA)" 1)
   ("a cell-permeable nucleic acid" 1)
   ("1 mM ethylenediamine tetraacetic acid" 1)
   ("rapamycin-42,2,2-bis(hydroxymethyl)-propionic acid" 1)
   ("EDTA Ethylene Diamine Tetraacetic Acid" 1)
   ("5( S )-hydroperoxyeicosatetraenoic acid" 1)
   ("Cy3-(CCCTAA) 3 peptide nucleic acid (PNA)" 1)
   ("using 0.67 M sulfuric acid" 1) ("elevated secondary bile acids" 1)
   ("The organic acids" 1) ("15 mM ethylenediaminetetraacetic acid (EDTA)" 1)
   ("a Cy3-OO-(CCCTAA) 3 -peptide nucleic acid (PNA)" 1)
   ("a telomeric protein nucleic acid (PNA)" 1) ("the stictic acid" 1)
   ("250 μ g/ml camphor sulfonic acid" 1)
   ("the nitrosated bile acid N -nitrosoglycocholic acid (NOGC)" 1)
   ("1 M perchloric acid (PCA)" 1) ("aqueous acid" 1)
   ("nitrophenanthrene carboxylic acids" 1)
   ("a nitrophenathrene carboxylic acid" 1) ("0.02N Acetic Acid" 1)
   ("1.5 mL 0.06 N Acetic Acid" 1) ("1 µM CF633 (Biotium) carboxylic acid" 1)
   ("25 mM hydroxyethyl piperazineethanesulfonic acid" 1)
   ("5-fluoroorotic acid (FOA)" 1) ("an aspartatic acid" 1)
   ("10 mM p -nitrophenyl phosphoric acid" 1) ("lysophosphotidic acid (LPA)" 1)
   ("protein-nucleic acid" 1) ("1mM ethylenediaminetetraacetic acid" 1)))
 ("PCID:444266" (("Mae" 3) ("maleic acid" 3)))
 ("PCID:444305"
  (("TAR" 312) ("tar" 42) ("TARs" 12) ("\"tar\"" 8) ("Tar" 6) ("TarS" 2)
   ("Only two TARs" 1) ("aqueous cigarette tar" 1)
   ("The viral transcriptional elements TAR" 1) ("'tar'" 1)))
 ("PCID:444493"
  (("acetyl-CoA" 352) ("Acetyl-CoA" 33) ("acetyl-coA" 11) ("Ac-CoA" 4)
   ("Acetyl-coA" 3) ("-acetyl-CoA" 2) ("more acetyl-CoA" 1)))
 ("PCID:444791" (("glucuronic acid" 26)))
 ("PCID:444795"
  (("all-trans-retinoic acid" 16) ("All-trans-retinoic acid" 4)
   ("exogenous all-trans-retinoic acid (ATRA)" 1)
   ("all-trans-retinoic acid (ATRA)" 1)))
 ("PCID:444796"
  (("poly(dT)" 60) ("-poly(dT)" 12) ("Poly(dT)" 1) ("poly (dT)" 1)
   ("regular filament around poly(dT)" 1)))
 ("PCID:444885" (("polysialic acid" 4) ("Polysialic acids" 1)))
 ("PCID:444899"
  (("arachidonic acid" 567) ("Arachidonic acid" 32)
   ("arachidonic acid (AA)" 16) ("exogenous arachidonic acid" 4)
   ("-arachidonic acid" 3) ("arachidonic acid (ARA)" 3)
   ("the dietary fatty acid arachidonic acid" 2) ("arachidonic acid-" 1)
   ("Arachidonic acid (AA)" 1) ("arachidonic acids" 1)))
 ("PCID:445063"
  (("sialic acid" 118) ("-sialic acid" 35) ("sialic acids" 18)
   ("Sialic acids" 3) ("Sialic acid" 1)))
 ("PCID:445154"
  (("resveratrol" 2275) ("Resveratrol" 326) ("-resveratrol" 135)
   ("resveratrol (RES)" 8) ("resveratrol’s" 7) ("resveratrol's" 7)
   ("resveratrol (RSV)" 6) ("Resveratrol’s" 4) ("than resveratrol" 3)
   ("trans-resveratrol" 2) ("The natural polyphenolic compound resveratrol" 2)
   ("dietary polyphenol resveratrol" 1) ("than 5 μM resveratrol" 1)
   ("Resveratrol's" 1) ("resveratrol-" 1)
   ("approximately 14 mg/day resveratrol" 1)
   ("PDCD4 attenuated resveratrol’s" 1)
   ("the calorie restriction mimetic resveratrol (RES)" 1)))
 ("PCID:44516822" (("GSK-2118436" 2))) ("PCID:445354" (("vitamin as" 1)))
 ("PCID:445420" (("LatA" 10) ("lata" 2)))
 ("PCID:445557" (("fructose 1,6-diphosphate" 4)))
 ("PCID:445580"
  (("docosahexaenoic acid" 23) ("docosahexaenoic acid (DHA)" 9)
   ("Docosahexaenoic acid" 9) ("docosahexaenoic acids" 2)
   ("Docosahexaenoic acid (DHA)" 1)
   ("the essential omega-3 fatty acid docosahexaenoic acid (DHA)" 1)))
 ("PCID:445639"
  (("oleic acid" 60) ("Oleic acid" 8) ("oleic acids" 4)
   ("adding exogenous oleic acid" 1)))
 ("PCID:445643" (("FK506" 101) ("the closely-related FK506" 1)))
 ("PCID:445713" (("farnesyl pyrophosphate" 18) ("Farnesyl pyrophosphate" 1)))
 ("PCID:445858" (("ferulic acid" 6) ("ferulic acids" 1)))
 ("PCID:446284"
  (("eicosapentaenoic acid" 12) ("eicosapentaenoic acid (EPA)" 2)
   ("Eicosapentaenoic acid" 1)))
 ("PCID:446378" (("thapsigargine" 2)))
 ("PCID:446541"
  (("mycophenolic acid" 37) ("mycophenolic acid (MPA)" 11)
   ("Mycophenolic acid" 1)))
 ("PCID:446925" (("lycopene" 6)))
 ("PCID:447466"
  (("CRD" 383) ("CRDs" 11) ("the atypical CRD" 5) ("CrD" 2)
   ("only one CRD" 1)))
 ("PCID:447587"
  (("sulfenic acid" 64) ("sulphenic acid" 22) ("sulfenic acids" 11)
   ("Sulfenic acid" 5) ("initially yields sulphenic acid" 2) ("Soh" 1)))
 ("PCID:447638" (("monothioglycerol" 24)))
 ("PCID:44795"
  (("ATRA" 629) ("atRA" 139) ("ATRA-" 4) ("ATRA’s" 4) ("-ATRA" 3)
   ("concurrent ATRA" 1) ("liposomal ATRA" 1) ("AtRA" 1)
   ("intermittent ATRA" 1)))
 ("PCID:447966" (("LY-364947" 9)))
 ("PCID:448013" (("patupilone" 5) ("EpoB" 2)))
 ("PCID:448042"
  (("Y-27632" 606) ("y-27632" 6) ("Y-27632 (EMD)" 3)
   ("10 μM Rho-associated protein kinase inhibitor Y-27632" 2) ("-Y-27632" 1)
   ("than Y-27632" 1)))
 ("PCID:448043" (("H-1152" 180) ("H1152" 16) ("than H-1152" 1)))
 ("PCID:448537"
  (("diethylstilbestrol" 15) ("diethylstilbestrol (DES)" 3)
   ("the non-steroidal full ER agonist diethylstilbestrol (DES)" 2)
   ("the nonphysiological ligand diethylstilbestrol" 2)))
 ("PCID:449"
  (("MVA" 138) ("MVs" 54) ("mevalonic acid" 20) ("Mva" 18) ("MVS" 7)
   ("Mevalonic acid" 2) ("MVA-" 2) ("Mvs" 2) ("UV-treated MVA" 1)
   ("MVAΔE3L-" 1) ("MVA’s" 1) ("exogenous MVA" 1)))
 ("PCID:449171"
  (("tretinoin" 5) ("trans-retinoic acid" 3) ("trans-retinoic acid (RA)" 2)
   ("Tretinoin" 2) ("9-cis-retinoic acid" 1)))
 ("PCID:449291" (("polycytidylic acid" 2)))
 ("PCID:452110" (("DPPC" 8) ("dipalmitoylphosphatidylcholine" 1)))
 ("PCID:4521392"
  (("SB 431542" 14)
   ("SB
431542"
    3)
   ("SB 431542 (SB)" 1)))
 ("PCID:4534"
  (("NDGA" 27) ("nordihydroguaiaretic acid" 6)
   ("nordihydroguaiaretic acid (NDGA)" 4)
   ("the exogenous 15-HETE inhibitor NDGA" 2)))
 ("PCID:454202" (("KT5720" 45))) ("PCID:45479435" (("DHM" 92)))
 ("PCID:455260" (("carnosic acid" 12))) ("PCID:4553" (("NS398" 170)))
 ("PCID:455658" (("haemin" 25) ("Haemin" 7))) ("PCID:4583" (("ofloxacin" 1)))
 ("PCID:4585" (("olanzapine" 47) ("Olanzapine" 1)))
 ("PCID:45933887"
  (("D-glucosamine" 11) ("-D-glucosamine" 2)
   ("a linear β (1 → 4)-D-glucosamine and acetyl- β (1 → 4)-D-glucosamine" 1)))
 ("PCID:460612"
  (("melphalan" 150) ("Melphalan" 6) ("chemotherapeutic agent melphalan" 1)
   ("than melphalan ( xref )" 1)))
 ("PCID:4609868" (("2-hydroxyglutarate" 26)))
 ("PCID:46173720" (("semiquinone radical" 5) ("semiquinone radicals" 1)))
 ("PCID:46224516" (("UNC0638" 1))) ("PCID:46224594" (("K-80003" 38)))
 ("PCID:462382"
  (("MG-132" 761) ("MG 132" 33) ("Mg-132" 9)
   ("the proteasomal inhibitor MG-132" 9) ("MG–132" 8)
   ("the proteosomal inhibitor MG-132" 3)
   ("the proteasomal degradation inhibitor MG-132" 2)
   ("proteasomal inhibitors MG 132" 2) ("MG 132-" 1)
   ("proteasomal inhibitor MG-132" 1)
   ("nonspecific proteasome inhibitor MG-132" 1)))
 ("PCID:4624"
  (("6-OHDA" 164) ("6-hydroxydopamine" 32) ("6-Hydroxydopamine" 2)
   ("the dopaminergic toxin 6-hydroxydopamine" 2)))
 ("PCID:4650" (("semiquinone radicals" 1)))
 ("PCID:46878529"
  (("Gold" 992) ("gold" 748) ("GOLD" 123) ("“Gold”" 5)
   ("the ImageQuant LAS 4000 MINI GOLD" 4) ("-gold" 4) ("“gold”" 4)
   ("coloidal gold" 2) ("gold-" 2) ("gold (PAA)" 2)
   ("20% fetal bovine serum gold" 2) ("Competent yeast Gold" 1) ("a gold" 1)
   ("10% foetal calf serum (FCS) gold (PAA)" 1)
   ("using Sybr Gold (Invitrogen) according the manufacturer’s" 1)
   ("than the gold" 1) ("Gold (ABI)" 1)
   ("10% fetal bovine serum (FBS) “gold”" 1)))
 ("PCID:46907787" (("JQ1" 509) ("-JQ1" 10) ("JQ1-" 10)))
 ("PCID:46926350" (("dinaciclib" 56) ("Dinaciclib" 9)))
 ("PCID:46943432" (("I-BET" 4) ("I-Bet" 1))) ("PCID:4705" (("PD 153035" 10)))
 ("PCID:4713"
  (("PD 98059" 75) ("PD-98059" 37) ("2'-amino-3'-methoxyflavone" 2)
   ("2’-amino-3’-methoxyflavone" 1)
   ("the phospho(p)ERK1/2-inhibitor PD 98059" 1)))
 ("PCID:471583"
  (("DD" 978) ("dd" 190) ("DDS" 26) ("Dd" 11) ("-DD" 4) ("a deleted DD" 2)
   ("–DD" 2) ("similarly activated MEK1 DD" 2) ("the DD’s" 1)
   ("Fas associated DD (FADD)" 1) ("DD-" 1)))
 ("PCID:472335" (("9-nitrocamptothecin" 1)))
 ("PCID:47289"
  (("4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone" 17)
   ("4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)" 7)
   ("4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone" 2)))
 ("PCID:4746" (("perhexiline" 36) ("Perhexiline" 15)))
 ("PCID:47528" (("nicorandil" 35) ("Nicorandil" 2)))
 ("PCID:4775" (("4-phenylbutyric acid" 9) ("4-phenylbutyric acid (PBA)" 2)))
 ("PCID:4784"
  (("PMSF" 3277) ("phenylmethylsulfonyl fluoride" 1091)
   ("phenylmethylsulfonyl fluoride (PMSF)" 138)
   ("Phenylmethylsulfonyl fluoride" 8)
   ("Phenylmethylsulfonyl fluoride (PMSF)" 6)
   ("phenylmethylsulfonyl  fluoride" 3)
   ("Phenylmethylsulfonyl Fluoride (PMSF)" 1)
   ("Phenylmethylsulfonyl Fluoride" 1)
   ("phenylmethylsulfonyl fluoride (PMFS)" 1)
   ("phenylmethylsulfonyl
fluoride"
    1)))
 ("PCID:47936" (("colforsin" 2)))
 ("PCID:4875"
  (("KI" 464) ("ki" 144) ("Ki" 132) ("Kis" 4) ("Ki-" 3) ("‘KI’" 2)
   ("hippocampal slices fromEif4e ki" 1)
   ("CA1 dendritic morphology inEif4e ki" 1)))
 ("PCID:4908" (("primaquine" 25) ("Primaquine" 2)))
 ("PCID:4914" (("procaine" 4)))
 ("PCID:4943"
  (("propofol" 211) ("Propofol" 29) ("propofol's" 1)
   ("intravenous general anesthetic propofol" 1)
   ("intravenous anesthetic propofol" 1)))
 ("PCID:4971" (("-PPIX" 6) ("PPIX" 5))) ("PCID:49806720" (("CH5424802" 56)))
 ("PCID:49830557"
  (("dovitinib" 204) ("Dovitinib" 20) ("dovitinib’s" 2) ("–dovitinib" 1)
   ("dovitinib-" 1)))
 ("PCID:49836027"
  (("Torin1" 236) ("torin1" 70) ("the ATP-competitive inhibitor Torin1" 1)
   ("than Torin1" 1) ("mTOR ATP-competitive inhibitors Torin1" 1)))
 ("PCID:5034" (("GW 5074" 2)))
 ("PCID:50599" (("ddI" 15) ("DDIs" 3) ("Ddi" 1) ("DDI" 1)))
 ("PCID:5090" (("Vioxx" 8) ("VIOXX" 2)))
 ("PCID:50909810" (("Lewis x" 5) ("lewis x" 2))) ("PCID:509554" (("QNZ" 13)))
 ("PCID:50992434" (("Mekinist" 1))) ("PCID:5143" (("LSA" 50) ("than LSA" 1)))
 ("PCID:51537604" (("minocycline" 12) ("Minocycline" 3) ("minocycline-" 1)))
 ("PCID:5166" (("SB 239063" 60) ("SB239063" 12)))
 ("PCID:5234" (("sodium chloride" 339) ("Sodium chloride" 5)))
 ("PCID:5235"
  (("sodium fluoride" 558) ("Sodium fluoride" 14) ("Sodium Fluoride" 11)
   ("sodium Fluoride" 1)))
 ("PCID:5237030" (("CBDCA" 33)))
 ("PCID:5238" (("NaI" 24) ("NAI" 19) ("sodium iodide" 13) ("Nai" 1)))
 ("PCID:5240" (("iodoacetic acid" 23) ("iodoacetic acid (IAA)" 3)))
 ("PCID:5280352"
  (("bilirubin" 130) ("Bilirubin" 2) ("indirect bilirubin" 2)
   ("bilirubin (BR)" 1) ("bilirubin-" 1)))
 ("PCID:5280378" (("formononetin" 80) ("Formononetin" 16)))
 ("PCID:5280450"
  (("linoleic acid" 130) ("Linoleic acid" 10) ("linoleic acids" 4)
   ("linoleic acid (LA)" 1)))
 ("PCID:5280453" (("1,25-dihydroxycholecalciferol" 2)))
 ("PCID:5280489" (("beta-carotene" 2)))
 ("PCID:5280497" (("TXA 2" 79) ("TxA 2" 22)))
 ("PCID:5280567" (("4-methylumbelliferone" 11) ("4-MU" 3)))
 ("PCID:5280934"
  (("linolenic acid" 27) ("linolenic acids" 13) ("Linolenic acid" 2)))
 ("PCID:5280965" (("amphotericin b" 2)))
 ("PCID:5281"
  (("stearic acid" 28) ("stearate" 12) ("stearic acids" 4)
   ("stearic acids (SFA)" 3) ("stearic acid (SA)" 1) ("Stearic acid" 1)))
 ("PCID:5281004" (("budesonide" 3)))
 ("PCID:5281007"
  (("dacarbazine" 152) ("DTIC" 77) ("Dacarbazine" 7) ("dacarbazine (DTIC)" 7)
   ("Dacarbazine (DTIC)" 2) ("only 7.7% dacarbazine" 1)
   ("the conventional chemotherapeutic agent dacarbazine (DTIC)" 1)))
 ("PCID:5281051" (("hypericin" 5)))
 ("PCID:5281104" (("paricalcitol" 28) ("Paricalcitol" 3)))
 ("PCID:5281303" (("Azadirachtin" 1)))
 ("PCID:5281365" (("geranylgeraniol (GGOH)" 5) ("geranylgeraniol" 2)))
 ("PCID:5281680" (("quercetagetin" 53) ("Quercetagetin" 2)))
 ("PCID:5281787"
  (("caffeic acid phenethyl ester" 15)
   ("caffeic acid phenethyl ester (CAPE)" 11)
   ("Caffeic acid phenethyl ester" 4)))
 ("PCID:5281792" (("rosmarinic acid" 11) ("Rosmarinic acid" 5)))
 ("PCID:5281813" (("Wedelolactone" 25) ("wedelolactone" 13)))
 ("PCID:5281855" (("ellagic acid" 6)))
 ("PCID:5281877" (("13-cis-retinoic acid (RA)" 3) ("13-cis-retinoic acid" 2)))
 ("PCID:5281951" (("DIDS" 13)))
 ("PCID:5282165" (("JM" 545) ("Jm" 25) ("JMS" 4) ("-JM" 2) ("jm" 1)))
 ("PCID:5282199" (("geranylgeranylacetone" 7) ("Geranylgeranylacetone" 1)))
 ("PCID:5282263" (("8-isoprostanes" 9) ("8-isoprostane" 3)))
 ("PCID:5282280" (("2-AG" 44)))
 ("PCID:5282309" (("DMS" 237) ("DMs" 153) ("idiopathic DMS" 2) ("dMS" 1)))
 ("PCID:5282379"
  (("retinoic acid" 597) ("-retinoic acid" 68) ("retinoic acid (RA)" 44)
   ("Retinoic acid" 40) ("retinoic acid (ATRA)" 33) ("retinoic acids" 17)
   ("-retinoic acid (ATRA)" 4) ("cis-RA" 3)
   ("than 13-cis retinoic acid (cis - RA)" 1) ("Retinoic acid (RA)" 1)
   ("topical retinoic acid" 1)
   ("The vitamin A metabolite retinoic acid (RA)" 1) ("Retinoic Acids" 1)))
 ("PCID:5282796"
  (("conjugated linoleic acid" 2) ("Conjugated linoleic acid" 1)))
 ("PCID:5283157"
  (("20-hydroxyeicosatetraenoic acid" 4)
   ("20-Hydroxyeicosatetraenoic acid" 1)))
 ("PCID:5283344"
  (("4-hydroxynonenal" 52) ("4-hydroxy-2-nonenal" 27)
   ("4-hydroxy-2-nonenal (HNE)" 8) ("4-hydroxynonenal (HNE)" 6)
   ("-4-hydroxy-2-nonenal" 6) ("4-Hydroxynonenal" 2)
   ("β-unsaturated aldehyde 4-hydroxynonenal (HNE)" 1)))
 ("PCID:5283454"
  (("NOEs" 185) ("NOE" 175) ("the heteronuclear NOE" 3)
   ("heteronuclear 15 N-{ 1 H} NOEs" 2)
   ("only intraresidual or sequential NOEs" 2) ("strong NOEs" 2)
   ("unambiguous intermolecular NOEs" 2)
   ("The heteronuclear 15 N-{ 1 H} NOEs" 2) ("sequential H N -H N NOEs" 1)
   ("The heteronuclear steady-state NOE" 1) ("Noe" 1)
   ("1 H}- 15 N heteronuclear NOE" 1) ("1 H}- 15 N heteronuclear NOEs" 1)
   ("the heteronuclear NOEs" 1) ("a heteronuclear NOE" 1)
   ("the 15 N-{ 1 H} heteronuclear NOE" 1)
   ("The 15 N-{ 1 H} heteronuclear NOE" 1)
   ("the heteronuclear 1 H- 15 N NOE" 1) ("29 detected several weak NOEs" 1)))
 ("PCID:5283637" (("campesterol" 1)))
 ("PCID:5284359" (("calcium chloride" 86) ("Calcium chloride" 1)))
 ("PCID:5288209"
  (("fenretinide" 147) ("4-HPR" 13) ("Fenretinide" 9)
   ("N-(4-hydroxyphenyl) retinamide" 2) ("fenretinide-" 1)))
 ("PCID:5288674" (("17-DMAG" 113)))
 ("PCID:5291"
  (("imatinib" 2208) ("Imatinib" 444) ("imatinib (IM)" 12) ("imatinib-" 8)
   ("than imatinib" 8) ("IMATINIB" 6) ("imatinib molecule" 3) ("imatinib's" 3)
   ("Imanitib" 2) ("only modest imatinib" 1) ("Imatinib’s" 1)
   ("treated with/without imatinib" 1) ("“imatinib”" 1) ("Imatinib (IM)" 1)
   ("than imatinib in wild-type BCR/ABL expressing cells" 1)
   ("than imatinib in cell lines (KBM5, KBM7)" 1)
   ("than imatinib (IC 50 > 3000 nM)" 1)
   ("than imatinib (Table xref ; Figure xref )" 1)
   ("the pharmacologic inhibitor Imatinib" 1)))
 ("PCID:52912189"
  (("I-BET151" 12) ("the structurally-related BET inhibitor I-BET151" 2)
   ("I-Bet151" 1)))
 ("PCID:52921583"
  (("Dsg" 66) ("Dsgs" 10) ("the continuous junction-associated Dsg" 3)
   ("DSGs" 1)))
 ("PCID:5311"
  (("suberoylanilide hydroxamic acid" 76)
   ("suberoylanilide hydroxamic acid (SAHA)" 22)
   ("Suberoylanilide hydroxamic acid" 8) ("SuberoylAnilide hydroxamic acid" 1)
   ("suberoylanilide hydroxamic
acid"
    1)
   ("than suberoylanilide hydroxamic acid (SAHA)" 1)))
 ("PCID:5311211" (("15d-PGJ2" 21))) ("PCID:5312120" (("Ro-41-5253" 13)))
 ("PCID:5312529" (("ETE" 34) ("minimal ETE" 2)))
 ("PCID:5318532"
  (("ICI" 982) ("the pure antiestrogen ICI" 14)
   ("the pure anti-estrogen ICI" 5) ("ICT" 4) ("the pure ER antagonist ICI" 4)
   ("Pure anti-oestrogen drug ICI" 3) ("the steroidal antiestrogen ICI" 2)
   ("pure anti-estrogen ICI" 2) ("ICIS" 2)
   ("the nonspecific ER antagonist ICI" 2)))
 ("PCID:53235510"
  (("BGJ398" 266) ("the highly FGFR specific compound BGJ398" 1)))
 ("PCID:53262369" (("Lewis y antigen" 25) ("soluble Lewis y antigen" 2)))
 ("PCID:53262376" (("a type 2" 22) ("A type 2" 2)))
 ("PCID:5326397"
  (("Hoechst 33258" 354) ("the fluorescent dye Hoechst 33258" 3)
   ("fluorescent Hoechst 33258" 2)))
 ("PCID:5326637" (("MNX" 2))) ("PCID:5329" (("sulfamethoxazole" 8)))
 ("PCID:5329098" (("SU5416" 26) ("SU-5416" 3)))
 ("PCID:5329102"
  (("sunitinib" 521) ("Sunitinib" 97) ("sunitinib-" 3)
   ("receive blinded sunitinib" 2) ("receive sunitinib" 2)
   ("targeted oral TKI sunitinib" 1)))
 ("PCID:5330286" (("palbociclib" 18) ("PD 0332991" 3) ("Palbociclib" 2)))
 ("PCID:53356667" (("ruthenium red" 4))) ("PCID:53477559" (("GlcCer" 4)))
 ("PCID:53477696" (("7-ketocholesterol" 4)))
 ("PCID:53477705"
  (("extrinsic factors" 61) ("extrinsic factor" 8) ("factor II" 6)
   ("Factor II" 6) ("Extrinsic factors" 4) ("factor II (TRFII)" 1)))
 ("PCID:53477708" (("dermatan sulfate" 2)))
 ("PCID:53477714"
  (("heparan sulfate" 119) ("heparan sulfates" 21) ("Heparan sulfate" 8)
   ("heparan sulphate" 7) ("heparan sulfate (HS)" 6) ("-heparan sulfate" 3)
   ("Heparan sulfates" 2) ("Heparan Sulfate" 1) ("soluble heparan sulfates" 1)
   ("heparan sulfate–" 1) ("3- O -sulfated heparan sulfate" 1)
   ("tumor-membrane-associated heparan sulfate (HS)" 1)))
 ("PCID:53477739" (("antidiuretic hormone" 4)))
 ("PCID:53477764" (("HEM" 26) ("Hem" 5) ("HEMs" 4) ("hem" 2)))
 ("PCID:53481001" (("LacCer" 15) ("-LacCer" 1)))
 ("PCID:53481404"
  (("sulfatide" 2) ("oligodendrocytic sulfatide" 1)
   ("the oligodendrocytic sulfatide" 1)))
 ("PCID:53481441" (("Qi" 36) ("QI" 16) ("qi" 1)))
 ("PCID:53481561"
  (("protoporphyrin" 33) ("Protoporphyrin" 2) ("-protoporphyrin" 2)
   ("protoporphyrins" 1)))
 ("PCID:53481562" (("luteinizing hormone-releasing hormone" 6)))
 ("PCID:53481581" (("NMC" 49) ("NMCs" 7)))
 ("PCID:53481793"
  (("endotoxin lipopolysaccharide" 5)
   ("bacterial endotoxin lipopolysaccharide (LPS)" 1)
   ("0.5 mg/kg bacterial endotoxin lipopolysaccharide" 1)
   ("endotoxin lipopolysaccharide (LPS)" 1)
   ("the bacterial endotoxin lipopolysaccharide (LPS)" 1)))
 ("PCID:5352062" (("FR901228" 2)))
 ("PCID:5352624" (("sulindac sulfide" 18) ("Sulindac sulfide" 4)))
 ("PCID:5353431"
  (("BAY-11-7082" 14) ("BAY" 11) ("Bay-11-7082" 10) ("10 μM BAY" 3)))
 ("PCID:5353940" (("SB 202190" 136) ("SB 202190-" 1)))
 ("PCID:5353955" (("sphingosine" 108) ("-sphingosine" 4)))
 ("PCID:5358" (("Sumatriptan" 1)))
 ("PCID:5359476"
  (("sulfasalazine" 53) ("Sulfasalazine" 7)
   ("the unspecific NF-κB inhibitor sulfasalazine" 2)))
 ("PCID:5359597"
  (("superoxide anion" 121) ("superoxide anions" 62) ("superoxide radicals" 18)
   ("superoxide radical" 13) ("Superoxide anion" 7)
   ("superoxide anion radical" 7) ("superoxide anion radicals" 4)
   ("superoxide
anions"
    1)
   ("a SOD mimetic scavenging superoxide anion" 1) ("Superoxide anions" 1)))
 ("PCID:5362119" (("lpr" 74) ("LPR" 20)))
 ("PCID:5362449"
  (("hold" 743) ("holds" 727) ("DXM" 92) ("Hold" 5) ("targeting holds" 3)
   ("adoptive T cell therapy hold" 2)
   ("targeting PAK1/HER-2/EGFR network holds" 2)
   ("the Cox proportional hazards assumption holds" 2)
   ("measured and theoretical ΔC p values holds" 2)
   ("Targeted therapy holds" 2) ("quantitative imaging phenotypes holds" 2)
   ("laboratories world-wide holds" 1)
   ("the proportional hazards assumption holds" 1)
   ("antigen-binding clefts hold" 1) ("regenerative medicine holds" 1)
   ("Autologous CD34 + cells hold" 1) ("targeted molecular therapies holds" 1)
   ("the approximate equality holds" 1) ("fork reversal in vivo holds" 1)
   ("multispecific antibodies hold" 1) ("leukemic cells hold" 1)
   ("viral suppression hold" 1)
   ("autoinhibitory interdomain interactions hold" 1)
   ("A popular model holds" 1) ("targeted anticancer agents holds" 1)
   ("indirect and direct BAX activators holds" 1)
   ("antiestrogenic activities hold" 1) ("Dxm" 1)))
 ("PCID:5372954"
  (("cinnamic acid" 9) ("Cinnamic acid" 1)
   ("half-saturated alpha-cyano-4-hydroxy cinnamic acid" 1)))
 ("PCID:5379" (("Gatifloxacin" 104) ("gatifloxacin" 1) ("Gatifloxacin-" 1)))
 ("PCID:5403" (("terbutaline" 10)))
 ("PCID:545"
  (("arsenic trioxide" 157) ("Arsenic trioxide" 21)
   ("Arsenic Trioxide (ATO)" 3) ("receive arsenic trioxide (ATO)" 1)
   ("arsenic trioxide (ATO)" 1) ("Arsenic Trioxide" 1)))
 ("PCID:5452"
  (("thioridazine" 59) ("Thioridazine" 12)
   ("the antipsychotic drug thioridazine" 1)))
 ("PCID:54532705" (("C-s" 1))) ("PCID:5459377" (("DMPC" 30)))
 ("PCID:5460161" (("L-lactate" 26) ("L-Lactate" 3) ("-L-lactate" 1)))
 ("PCID:5460305" (("Glycyrrhizin" 12) ("than Glycyrrhizin (Gc)" 2)))
 ("PCID:5460751" (("ATTA" 80) ("than ATTA" 1) ("the ATTA 1, 2," 1) ("Atta" 1)))
 ("PCID:5460975" (("alaninate" 3))) ("PCID:5462222" (("19k" 1)))
 ("PCID:5462311" (("5b" 197) ("-5b" 2)))
 ("PCID:54670067"
  (("ascorbic acid" 284) ("Ascorbic acid" 4) ("-ascorbic acid" 4)
   ("ascorbic acid (AA)" 4) ("-Ascorbic acid" 1)))
 ("PCID:54675768" (("Coumermycin" 2)))
 ("PCID:54682463" (("cyclopiazonic acid" 7) ("cyclopiazonic acid (CPA)" 4)))
 ("PCID:54690394" (("vitamin c" 7)))
 ("PCID:547" (("Haas" 9) ("DOPAC" 9) ("haa" 3) ("HAA" 2)))
 ("PCID:5470187" (("zerumbone" 75) ("Zerumbone" 27)))
 ("PCID:5484352"
  (("AA" 5208) ("aa" 3329) ("Aa" 89) ("-AA" 33) ("aA" 19) ("AAS" 16) ("AA-" 11)
   ("than AA" 8) ("“AA”" 7) ("intramitochondrial AA" 6) ("more AA" 4)
   ("aa (SDPEEDDE)" 3) ("homozygous AA" 3) ("exogenous AA" 3) ("‘AA’" 3)
   ("the last 570 aa" 2) ("around 70 aa" 2) ("homozygous variant AA" 2)
   ("the mutated homozygous AA" 2) ("had homozygous genotype aa" 2)
   ("the last 12- aa" 2) ("the last 100 aa" 2)
   ("GGGGATCCATGTC(I)GA(CT)AA(AG)AG-(CT)GA(I)(CT)T(I)AA" 1) ("bulky AA" 1)
   ("only 50 aa" 1) ("aas" 1) ("the C-terminal last 24–44 aa" 1)
   ("previously untreated AA" 1) ("than their AA" 1)
   ("the essential fatty acid AA" 1) ("unrelated healthy AA" 1)
   ("mutated homozygous variant AA" 1) ("approximately 1,000 aa" 1)
   ("Eligible participants included English-speaking AA" 1)
   ("36 membrane-proximal aa" 1) ("Aas" 1) ("the last aa" 1) ("\"AA\"" 1)
   ("the last 138 aa" 1) ("the last 99 aa" 1) ("those homozygous AA" 1)
   ("this basic aa" 1) ("the available AA" 1)
   ("particularly branched chain AA" 1) ("exogeneous AA" 1) ("More AA" 1)
   ("the amino terminal 142 aa" 1) ("The homozygous genotype AA" 1)
   ("constitutional AA" 1) ("either idiopathic AA" 1)
   ("variant homozygous AA" 1) ("the last 22 aa" 1) ("the last 50–60 aa" 1)
   ("the last 24 aa" 1) ("only 1 aa" 1) ("the basic aa" 1)
   ("The homozygous TNF-α AA" 1) ("pediatric AA" 1)
   ("the homozygous genotype ‘AA’" 1)))
 ("PCID:54900" (("Evista" 2) ("Evista (CORE)" 1)))
 ("PCID:5494425"
  (("P6" 298) ("p6" 94) ("-P6" 3) ("around P6" 2) ("Monozygotic twins P6" 1)
   ("P6–" 1)))
 ("PCID:5494449" (("Tozasertib" 1))) ("PCID:5496455" (("Ya" 12) ("ya" 3)))
 ("PCID:5526" (("tranexamic acid" 5) ("Tranexamic acid" 2)))
 ("PCID:5590" (("Triton x-100" 20) ("triton x-100" 5)))
 ("PCID:5591"
  (("troglitazone" 75) ("Troglitazone" 2) ("troglitazone (TZD)" 2)))
 ("PCID:56069"
  (("Casodex" 339) ("casodex" 77) ("casodex (CDX)" 8) ("Casodex (CSDX)" 4)
   ("Casodex (CDX)" 4) ("the non-steroidal anti-androgen Casodex" 2)
   ("the antiandrogenic compound Casodex" 1) ("than Casodex" 1)))
 ("PCID:56649450" (("BYL-719" 6)))
 ("PCID:56927919"
  (("exendin-4" 25) ("Exendin-4" 4) ("long-acting analog exendin-4" 1)))
 ("PCID:56951715"
  (("RF" 483) ("rf" 14) ("Rf" 5) ("RFs" 3) ("−RF" 3) ("–RF" 1) ("rF" 1)
   ("traditional RF" 1)))
 ("PCID:56951717" (("Sg" 28) ("Sgs" 10) ("sgs" 10) ("sg" 2)))
 ("PCID:56965966"
  (("OSI-027" 24) ("the ATP-competitive mTOR inhibitor OSI-027" 1)
   ("The dual mTORC1/TORC2 inhibitor OSI-027" 1)))
 ("PCID:5702613"
  (("C6 ceramide" 8) ("C6-Cer" 3) ("C6 Ceramide" 2)
   ("the short-chain cell permeable C6 ceramide" 1)
   ("short-chain cell permeable C6 ceramide" 1)))
 ("PCID:57347681"
  (("TORKinibs" 77) ("TORKinib" 8) ("TORkinibs" 2)
   ("a representative TORKinib" 1)))
 ("PCID:57390074" (("AP26113" 41) ("a dual ALK/EGFR inhibitor AP26113" 2)))
 ("PCID:5746" (("mitomycin c" 5) ("Mitomycin c" 1)))
 ("PCID:5756"
  (("E3" 2289) ("E3s" 649) ("RING" 118) ("e3" 6) ("monomeric RING E3s" 5)
   ("a monomeric RING E3" 4) ("ɛ3" 4) ("E3 (FUS)" 3) ("RING E3" 3) ("-E3" 3)
   ("other monomeric E3s" 2) ("several dimeric and monomeric RING E3s" 2)
   ("other monomeric RING E3s" 2) ("the dimeric RING E3s" 2) ("E3-" 2)
   ("a well-established SUMO E3" 2) ("the relevant E3" 2)
   ("bacterial HECT-like E3s" 2) ("the relevant E3s" 2)
   ("Mcl-1-ubiquitinating ligase E3 (MULE)" 2)
   ("other monomeric RING and U-box E3s" 1) ("the dimeric RING E3" 1)
   ("Several monomeric RING and U-box E3s" 1) ("dimeric RING E3" 1)
   ("these two dimeric RING E3s" 1) ("dimeric RING E3s" 1)
   ("both monomeric and dimeric RING E3s" 1) ("possibly other E3s" 1)
   ("the latter two E3s" 1) ("more E3s" 1) ("presumably other E3s" 1)
   ("most E3s" 1) ("some well-characterized E3s" 1) ("well-connected E3s" 1)
   ("at least one E3" 1) ("RING type E3’s" 1) ("nearly 600 E3s" 1)
   ("mitotic E3" 1) ("potential E3s" 1) ("The heterodimeric RING-type E3s" 1)
   ("mammalian ERAD-associated E3s" 1) ("these two principal ERAD E3s" 1)
   ("other ER-resident E3s" 1) ("at least 10 different E3s" 1)
   ("the interacting E3's" 1) ("a relatively weak E3" 1) ("this viral E3" 1)
   ("“-E3”" 1) ("E3 (MULE)" 1) ("the resin-bound E3" 1)))
 ("PCID:5757"
  (("E2" 7868) ("E2s" 524) ("oestradiol" 102) ("E2-" 45) ("e2" 43) ("-E2" 8)
   ("E2’s" 4) ("Oestradiol" 4) ("exogenous E2" 4) ("-oestradiol" 4)
   ("than E2" 3) ("all possible E2s" 3) ("-Oestradiol" 3) ("E2's" 3) ("−E2" 3)
   ("postmenopausal circulating E2" 2) ("potentially other E2s" 2)
   ("almost every human E2" 2) ("the homologous E2s" 2)
   ("highly homologous E2s" 2) ("lysine-unreactive E2s" 2)
   ("an associated Ub E2" 2) ("a mutated E2" 2) ("the promiscuous E2" 2)
   ("the unique E2" 1) ("than 0.5 nM E2" 1) ("only BPA mimics E2" 1)
   ("than E2 ( xref )" 1) ("than E2 in the ERβ-U2OS system" 1)
   ("than E2 ( xref , left panel)" 1) ("Meanwhile five other E2s" 1)
   ("other potential E2s" 1) ("Most E2s" 1) ("its associated E2" 1)
   ("only one E2" 1) ("so many different E2s" 1)
   ("the active monoubiquitinating E2" 1) ("the correct E2" 1)
   ("than one E2" 1) ("an ER-resident E2" 1) ("a heterodimeric E2" 1)
   ("at least one E2" 1) ("roughly 50 E2s" 1) ("a cysteine of E2" 1)
   ("than 25 E2" 1) ("an E2’s" 1)
   ("the first 126 amino acids of the human UBC9 (UBE2I) SUMO E2 conjugating enzyme ( xref )"
    1)
   ("than E2 in either Hs578T-ERαLuc or Hs578T-ERβLuc cells" 1)
   ("two popular E2s" 1) ("other E2's" 1) ("the available E2" 1) ("the E2’s" 1)
   ("In contrast neither E2" 1) ("associated E2s" 1)))
 ("PCID:5780"
  (("sorbitol" 181) ("Sorbitol" 3) ("hyperosmotic sorbitol" 3)
   ("Hyperosmotic sorbitol" 1)))
 ("PCID:5789"
  (("thymidine" 2649) ("Thymidine" 176) ("-thymidine" 136) ("thymidines" 17)
   ("deoxythymidine" 12) ("-Thymidine" 12) ("supplemental thymidine" 5)
   ("-deoxythymidine" 5) ("thymidine-" 5) ("THYMIDINE" 4) ("thymidine (DT)" 4)
   ("exogenous thymidine" 3) ("thymidine (CALBIOCHEM)" 2)
   ("Supplemental thymidine" 2) ("10 µM supplemental thymidine" 2)
   ("thymidine (TT)" 2) ("the last 10-hours ( 3 H)-thymidine" 2)
   ("thymidine (TDR)" 1) ("deoxythymidines" 1) ("sequential thymidine" 1)
   ("than natural thymidine" 1) ("polar thymidine" 1)
   ("a previously described double thymidine (DT)" 1) ("secondary thymidine" 1)
   ("salvageable thymidine" 1)))
 ("PCID:5790" (("fluorodeoxyuridine" 10)))
 ("PCID:5816" (("epinephrine" 74) ("Epinephrine" 3)))
 ("PCID:5819"
  (("T4" 797) ("L-thyroxine" 9) ("t4" 5) ("levothyroxine" 3) ("T4−" 3)
   ("T4s" 2) ("“T3–T4”" 1) ("-T4" 1)))
 ("PCID:5833" (("spironolactone" 15) ("Spironolactone" 1)))
 ("PCID:5862" (("L-cysteine" 18) ("l-cysteine" 1)))
 ("PCID:5881"
  (("dehydroepiandrosterone" 27) ("dehydroepiandrosterone (DHEA)" 6)
   ("Dehydroepiandrosterone" 4)))
 ("PCID:5886"
  (("nicotinamide adenine dinucleotide phosphate" 25)
   ("Nicotinamide adenine dinucleotide phosphate" 4)
   ("nicotinamide adenine dinucleotide phosphate (NADPH)" 3)
   ("nicotinamide adenine dinucleotide
phosphate (NADPH)"
    2)
   ("nicotinamide
adenine dinucleotide phosphate"
    1)
   ("nicotinamide adenine dinucleotide
phosphate"
    1)))
 ("PCID:589075" (("CK-666" 1)))
 ("PCID:5893"
  (("nicotinamide adenine dinucleotide" 212)
   ("Nicotinamide adenine dinucleotide" 9)
   ("nicotinamide adenine dinucleotide-" 4)
   ("nicotinamide adenine dinucleotide (NAD)" 4)
   ("Nicotinamide Adenine Dinucleotide" 3)
   ("nicotinamide
adenine dinucleotide"
    2)
   ("reductive nicotinamide adenine dinucleotide (NADH)" 1)
   ("nicotinamide adenine dinucleotides" 1)))
 ("PCID:5910" (("pilocarpine" 15) ("the cholinomimetic pilocarpine" 1)))
 ("PCID:5920"
  (("T3" 948) ("t3" 14) ("exogenous T3" 2) ("pathologic stage T3" 2)
   ("pathological T3" 1) ("-T3" 1)))
 ("PCID:5921"
  (("diethylnitrosamine" 35) ("diethylnitrosamine (DEN)" 10)
   ("Diethylnitrosamine" 3)
   ("the potent genotoxic carcinogen diethylnitrosamine" 2)
   ("N-nitrosodiethylamine" 1)
   ("the genotoxic carcinogen diethylnitrosamine (DEN)" 1)
   ("N-Nitrosodiethylamine" 1)))
 ("PCID:5936"
  (("diisopropyl fluorophosphate" 9) ("Diisopropyl fluorophosphate" 2)
   ("Diisopropyl fluorophosphates" 1)))
 ("PCID:5937" (("DMM" 70) ("Exogenous DMM" 1)))
 ("PCID:5939" (("biguanides" 33) ("biguanide" 7)))
 ("PCID:5943" (("R10" 165) ("r10" 2)))
 ("PCID:5957"
  (("ATP" 11262) ("-ATP" 227) ("adenosine triphosphate" 133) ("ATP-" 27)
   ("adenosine triphosphate (ATP)" 18) ("Atp" 18) ("ATP molecule" 13)
   ("exogenous ATP" 10) ("atp" 9) ("more ATP" 8)
   ("adenosine 5'-triphosphate" 7) ("Adenosine triphosphate" 5) ("than ATP" 4)
   ("adenosine 5’-triphosphate" 4) ("exogenous (d)ATP" 4) ("ATPs" 3)
   ("luminescent ATP" 3) ("purinergic agonist ATP" 3) ("nearly 100% ATP" 2)
   ("reached ∼40% initial ATP" 2) ("detachment-induced ATP" 2)
   ("the residual ATP" 2) ("hydrolyzable ATP" 2) ("cell-associated ATP" 2)
   ("oxidative ATP" 2) ("10 μCi 32 p γ ATP" 1) ("the ATP's" 1)
   ("Adenosine TriPhosphate" 1) ("γ-p 32 labeled ATP" 1)
   ("These typical protein kinases use ATP" 1) ("damaged cells leak ATP" 1)
   ("nonradioactive ATP" 1) ("instead 2 mM ATP" 1)
   ("Adenosine 5’-triphosphate" 1) ("more ATPs" 1) ("subcellular ATP" 1)
   ("larger ATP" 1)
   ("the four different F buffer-based observation buffers each containing (i) 1 mM ATP"
    1)
   ("ATP (or dATP) molecule" 1)
   ("than ATP (-15.2 kcal/mol versus -12.3 kcal/mol)" 1)
   ("the resultant ATP" 1) ("adenosine 5’-triphosphate (ATP)" 1)
   ("The actual ATP" 1) ("available ATP" 1) ("residual ATP" 1) ("aTP" 1)
   ("adenosine triphosphates" 1) ("adenosine 5'-triphosphate (ATP)" 1)
   ("Exogenous (d)ATP" 1) ("5 µCi 32 P- ATP" 1) ("γ- 32 P- ATP" 1)
   ("Adenosine Triphosphate" 1) ("50 μM “cold” ATP" 1) ("‘bulky’ ATP" 1)
   ("-adenosine triphosphate" 1) ("well-oriented ATP" 1)
   ("regenerate intracellular ATP" 1) ("ATP (ERS)" 1)
   ("either exogenous ATP" 1)))
 ("PCID:5958"
  (("glucose-6-phosphate" 63) ("glucose 6-phosphate" 13)
   ("Glucose 6-phosphate" 5) ("Glucose-6-phosphate" 1)))
 ("PCID:5961"
  (("L-glutamine" 3182) ("polyglutamine" 239) ("l-glutamine" 127) ("Gibco" 12)
   ("L-glutamine (GIBCO)" 6) ("GIBCO" 3) ("Polyglutamine" 3)
   ("L-glutamine (PAA)" 2) ("exogenous L-glutamine" 2) ("L-glutamine (SF)" 2)
   ("intracellular amino acids such as L-glutamine ( xref ; xref )" 1)
   ("polyglutamines" 1) ("10% fetal bovine serum and 2X L-glutamine" 1)
   ("longer AR polyglutamine" 1)))
 ("PCID:5962"
  (("L-lysine" 324) ("-L-lysine" 56) ("l-lysine" 29) ("L-Lys" 5)
   ("amino acids such as L-lysine" 1) ("l-Lys" 1)))
 ("PCID:5988"
  (("sugar" 201) ("sugars" 69) ("Sugar" 6) ("sugar (FBS)" 2) ("sugar-" 1)
   ("a fluorescent-tagged sugar" 1) ("the abasic site sugar" 1)
   ("any residual sugars" 1) ("very few (10 and 14) solvent-exposed sugars" 1)
   ("only high-mannose N-linked sugars" 1) ("otherwise resistant sugars" 1)))
 ("PCID:6"
  (("CDNB" 47) ("1-chloro-2,4-dinitrobenzene" 10)
   ("1-chloro-2,4-dinitrobenzene (CDNB)" 4)))
 ("PCID:60167550" (("JNJ-26854165" 15)))
 ("PCID:60198"
  (("exemestane" 78) ("Exemestane" 3) ("the nonsteroidal AI exemestane" 2)
   ("than exemestane alone in the third-line setting" 1)
   ("the steroidal aromatase inhibitor exemestane" 1)
   ("receive
exemestane"
    1)))
 ("PCID:6020" (("puromycin aminonucleoside" 5)))
 ("PCID:6021" (("INO" 17) ("inO" 5) ("iNO" 4) ("INOS" 1)))
 ("PCID:6030"
  (("pU" 55) ("Pu" 15) ("pU-" 6) ("pus" 4) ("pu" 3) ("PUS" 1) ("pUS" 1)))
 ("PCID:6035"
  (("5-bromodeoxyuridine" 30) ("5-bromo-2'-deoxyuridine" 22)
   ("5-bromo-2’-deoxyuridine" 10) ("5-Bromo-2’-deoxyuridine" 10)
   ("5-Bromodeoxyuridine" 8) ("5-Bromo-2'-deoxyuridine" 7)))
 ("PCID:6037"
  (("folic acid" 234) ("Folic acid" 15) ("PteGlu" 10) ("than folic acid" 1)
   ("folic acid (FA)" 1) ("maternal folic acid" 1)
   ("folic
acid"
    1)
   ("folic acid's" 1) ("peri-conceptional folic acid" 1)
   ("Increased dietary folic acid" 1) ("supplemental folic acid" 1)))
 ("PCID:6047" (("L-dopa" 20) ("L-DOPA" 9) ("L-Dopa" 1) ("l-DOPA" 1)))
 ("PCID:6049"
  (("EDTA" 12806) ("−EDTA" 8) ("EDTA (TE)" 7) ("-EDTA" 6) ("EDTA (RIPA)" 3)
   ("EDTA (TBE)" 2) ("90 mM Tris/64.6 mM boric acid/2.5 mM EDTA" 2)
   ("ice-cold EDTA" 2) ("ice-cold PBS/0.3 mM EDTA" 1) ("Complete Mini EDTA" 1)
   ("EDTA-" 1) ("edta" 1)))
 ("PCID:60613" (("cidofovir" 4)))
 ("PCID:60700"
  (("topotecan" 151) ("Topotecan" 11) ("topotecan (TPT)" 6)
   ("the DNA-damaging cancer chemotherapeutic agent topotecan" 1)
   ("topotecan-" 1)))
 ("PCID:6076"
  (("cyclic AMP" 165) ("Cyclic AMP" 19)
   ("Nf1 protein (neurofibromin)-mediated neuronal cyclic AMP" 3)
   ("-cyclic AMP" 1)))
 ("PCID:6083"
  (("AMP" 825) ("adenosine monophosphate" 39) ("adenylate" 22) ("AMP-" 9)
   ("Adenosine monophosphate" 8) ("-AMP" 8) ("AMP molecule" 5) ("adenylate-" 4)
   ("than AMP" 4) ("5'-AMP" 3) ("5’-AMP" 2) ("5'-adenosine monophosphate" 2)
   ("cellular cyclical AMP" 2) ("other skin-derived AMP" 2)
   ("-Adenosine monophosphate" 1) ("this short-sized AMP" 1)
   ("than the prototypic human skin AMP" 1) ("the prototypic human skin AMP" 1)
   ("less AMP" 1) ("Adenosine Monophosphate" 1) ("-adenosine monophosphate" 1)
   ("skin-derived AMP" 1) ("other skin-relevant AMP" 1)
   ("an important skin-derived AMP" 1)))
 ("PCID:60837" (("CPT-11" 89))) ("PCID:60846" (("valsartan" 1)))
 ("PCID:60947" (("tirofiban" 4) ("Tirofiban" 3))) ("PCID:60953" (("Xeloda" 8)))
 ("PCID:6097028" (("ammonium sulphate" 28) ("residual ammonium sulphate" 1)))
 ("PCID:610479" (("tolfenamic acid" 5) ("Tolfenamic acid" 1)))
 ("PCID:6112"
  (("RLA" 40) ("lipoic acid" 14) ("Lipoic acid" 7) ("alpha-lipoic acid" 3)
   ("lipoic acid (LA) molecule" 1) ("Alpha-Lipoic acid" 1)
   ("Alpha-lipoic acid" 1)))
 ("PCID:6113" (("ethyl methanesulfonate" 1)))
 ("PCID:6137"
  (("S-methionine" 144) ("L-methionine" 22) ("-L-methionine" 4)
   ("S–methionine" 3) ("S-methionine-" 2)))
 ("PCID:61486" (("gadolinium chloride" 9))) ("PCID:6166" (("DOCA" 1)))
 ("PCID:61668"
  (("boronic acid" 8) ("boronic acids" 3) ("whose boronic acid" 1)))
 ("PCID:61671"
  (("sodium vanadate" 359) ("Sodium Vanadate" 6) ("Sodium vanadate" 2)
   ("sodium  vanadate" 1)))
 ("PCID:61739" (("hypochlorite" 13)))
 ("PCID:6212"
  (("CF" 841) ("TCM" 221) ("cf" 116) ("TcM" 18) ("CFs" 8) ("Cf" 3)
   ("anionic CF" 1) ("parent TcM" 1) ("than TcM" 1) ("cF" 1)
   ("very feeble intracellular CF" 1) ("than TCM" 1) ("CF-" 1) ("-CF" 1)
   ("most CF" 1) ("both resident CF" 1)))
 ("PCID:6213"
  (("Methylsulfonylmethane" 2) ("methylsulfonylmethane" 1)
   ("Methylsulfonylmethane (MSM)" 1)))
 ("PCID:6230" (("norethindrone" 1))) ("PCID:6234" (("DCS" 134)))
 ("PCID:62344"
  (("acridine orange" 172) ("Acridine orange" 22) ("Acridine Orange" 10)
   ("acridine orange (AO)" 6) ("Acridine orange (AO)" 3)
   ("supravital acridine orange" 2)
   ("lysosomotropic agent acridine orange (AO)" 1)))
 ("PCID:62389" (("6-BAP" 25))) ("PCID:6264" (("DNFB" 1)))
 ("PCID:6279"
  (("medroxyprogesterone acetate" 28) ("medroxyprogesterone acetate (MPA)" 2)))
 ("PCID:6293"
  (("AZ" 632) ("alizarin red" 57) ("Alizarin Red" 53) ("Alizarin red" 42)
   ("Az" 10) ("Alizarin Red-" 3) ("ALIZARIN RED" 2) ("az" 1)))
 ("PCID:63090" (("PCB 126" 18) ("coplanar PCB 126" 2)))
 ("PCID:6322" (("L-Arg" 16)))
 ("PCID:6324668"
  (("tetrodotoxin" 11) ("tetrodotoxin (TTX)" 3) ("Tetrodotoxin" 1)))
 ("PCID:6326969" (("phosphonate" 2))) ("PCID:6327182" (("tellurium" 1)))
 ("PCID:6329"
  (("methyl group" 328) ("methyl groups" 159) ("NME" 110) ("NMEs" 38)
   ("-methyl group" 3) ("Methyl group" 2) ("the dietary methyl groups" 2)
   ("whose methyl groups" 2) ("the propargylic methyl group" 1)
   ("than the NME" 1) ("nme" 1) ("whose methyl group" 1) ("the NME’s" 1)
   ("“NMEs”" 1)))
 ("PCID:6331" (("borane" 2)))
 ("PCID:6338"
  (("VC" 257) ("Vc" 72) ("vC" 20) ("VCs" 12) ("VCS" 7)
   ("1NM-PP1-treated VC" 2)))
 ("PCID:6347" (("isocyanate" 7) ("isocyanate (TRITC)" 4) ("isocyanates" 1)))
 ("PCID:637511" (("cinnamic aldehyde" 2)))
 ("PCID:638015" (("retinaldehyde" 2) ("retinaldehydes" 1) ("Retinaldehyde" 1)))
 ("PCID:6410"
  (("tBHP" 39) ("t-butylhydroperoxide" 13) ("TBHP" 10)
   ("t-butyl hydroperoxide" 2) ("tert-butylhydroperoxide" 2)))
 ("PCID:64147" (("valganciclovir" 1))) ("PCID:6419746" (("TX-1918" 16)))
 ("PCID:6421"
  (("trichloroacetic acid" 308) ("trichloroacetic acid (TCA)" 31)
   ("Trichloroacetic acid" 9) ("ice-cold 10% trichloroacetic acid" 3)
   ("3ml ice-cold trichloroacetic acid" 2) ("Trichloroacetic acid (TCA)" 2)
   ("500 µL ice-cold Trichloroacetic acid (TCA)" 1)
   ("ice‐cold trichloroacetic acid (TCA)" 1)
   ("using 10% trichloroacetic acid" 1)
   ("ice-cold 10% trichloroacetic acid (TCA)" 1)
   ("100 μl ice-cold 40% trichloroacetic acid (TCA)" 1)
   ("either 10% ice-cold trichloroacetic acid" 1)
   ("5% ice-cold trichloroacetic acid" 1)
   ("ice-cold 12% (wt/vol) trichloroacetic acid" 1)
   ("ice-cold 5% trichloroacetic acid (TCA)" 1)
   ("10% ice-cold trichloroacetic acid" 1)
   ("1 ml ice-cold 25% (w/v) trichloroacetic acid" 1)))
 ("PCID:6426709"
  (("pg" 574) ("Pg" 165) ("pG" 33) ("PGS" 4) ("the periodontal pathogens Pg" 1)
   ("than 20 pg" 1) ("routinely 20 pg" 1)
   ("than 5 pg of human Aβ ( xref )" 1)))
 ("PCID:6426942" (("WF" 28) ("Wf" 1)))
 ("PCID:6426943"
  (("kd" 437) ("Kd" 185) ("Kds" 3) ("concentrations approximately kd" 2)
   ("fractional kd" 1) ("a less tight dimerization Kd" 1) ("than the Kd" 1)
   ("sub-nanomolar Kd’s" 1)))
 ("PCID:6426949"
  (("Em" 138) ("em" 90) ("em (FRET)" 7) ("em (CFP)" 6) ("Ems" 2) ("EMs" 1)
   ("560 nm(20) Ex /590 nm(10) Em" 1)))
 ("PCID:6427003" (("DK" 78) ("DKs" 39) ("dk" 4) ("Dks" 1) ("than DK" 1)))
 ("PCID:6427052" (("e–g" 9) ("e-g" 4))) ("PCID:6432248" (("eans" 1)))
 ("PCID:6433194"
  (("filipin" 111) ("Filipin" 27)
   ("PKCα, PKCε, or PKCβII showed significantly less filipin" 2)
   ("more heterogeneous filipin" 1)))
 ("PCID:6436043" (("VA2" 2))) ("PCID:6438156" (("cobalamin" 11)))
 ("PCID:6438330" (("Manumycin" 47) ("manumycin" 17)))
 ("PCID:6438372" (("farnesylcysteine" 6))) ("PCID:6438639" (("DOPS" 131)))
 ("PCID:6439500" (("YO-PRO-1" 24)))
 ("PCID:643975"
  (("flavin adenine dinucleotide" 12) ("flavin adenine dinucleotide (FAD)" 3)))
 ("PCID:643976" (("flavin mononucleotide" 1)))
 ("PCID:644073"
  (("buprenorphine" 6) ("Buprenorphine" 4) ("systemic buprenorphine" 1)))
 ("PCID:644102"
  (("pyrophosphate" 1027) ("pyrophosphates" 17) ("Pyrophosphate" 12)
   ("pyrophosphate (GGPP)" 11) ("pyrophosphate (TPP)" 2) ("-pyrophosphate" 2)
   ("the essential co-factor thiamine pyrophosphate (TPP)" 1)))
 ("PCID:6443065" (("PC(18:0/20:4)" 1))) ("PCID:6454188" (("DHPE" 13)))
 ("PCID:64689" (("curdlan" 7) ("Curdlan" 4)))
 ("PCID:64945" (("ursolic acid" 7) ("Ursolic acid" 3)))
 ("PCID:64968"
  (("thymidine triphosphate" 9) ("deoxythymidine triphosphate" 7)
   ("Thymidine triphosphate" 2)))
 ("PCID:64971" (("betulinic acid" 22) ("Betulinic acid" 3)))
 ("PCID:6503"
  (("Tris base" 156) ("Tris-base" 90) ("Tris Base" 27) ("tris base" 13)
   ("Tris-Base" 8) ("tris-base" 2)))
 ("PCID:65040"
  (("5-methylcytosine" 78) ("5-methylcytosines" 3)
   ("about one-fifth less 5-methylcytosine" 2)
   ("hypermutable 5-methylcytosine" 1)))
 ("PCID:6505803" (("17-(allylamino)-17-demethoxygeldanamycin" 5)))
 ("PCID:65063" (("deoxyuridine monophosphate" 12)))
 ("PCID:65064"
  (("tea catechins" 8) ("tea catechin" 4)
   ("(-)-epigallocatechin gallate (EGCG)" 3) ("(−)-epigallocatechin gallate" 3)
   ("epigallocatechin 3-gallate" 2) ("(-)-epigallocatechin gallate" 2)
   ("(-)-Epigallocatechin Gallate" 1)))
 ("PCID:65076" (("cholesterol sulfate" 3) ("Cholesterol sulfate" 2)))
 ("PCID:65094" (("25-hydroxycholesterol" 21) ("25-Hydroxycholesterol" 2)))
 ("PCID:65110"
  (("aminoimidazole carboxamide ribonucleotide" 7)
   ("Aminoimidazole carboxamide ribonucleotide" 1)
   ("5-amino-4-imidazolecarboxamide ribotide (AICAR)" 1)
   ("5-amino-4-imidazolecarboxamide ribotide" 1)))
 ("PCID:65154" (("8-oxoguanine" 43)))
 ("PCID:6518" (("Pentaerithrityl tetranitrate" 1)))
 ("PCID:65217"
  (("rhodamine 123" 52) ("Rhodamine 123" 44) ("rhodamine-123" 14)
   ("Rhodamine-123" 4) ("fluorescent rhodamine 123" 1)
   ("the fluorescent dye rhodamine 123 (RH)" 1) ("rhodamine 123 (RH)" 1)))
 ("PCID:65359" (("glutathione disulphide" 3)))
 ("PCID:65399" (("triciribine" 121) ("Triciribine" 18) ("TCN" 3)))
 ("PCID:654" (("DPF" 51) ("dpf" 47))) ("PCID:6557" (("isoprene" 1)))
 ("PCID:65576" (("tomatidine" 3))) ("PCID:657356" (("R59949" 25)))
 ("PCID:6579"
  (("optimum" 210) ("Optimum" 11) ("the global optimum" 2)
   ("the stoichiometric optimum" 1) ("than optimum" 1)))
 ("PCID:66025" (("NPG" 19) ("NPGs" 17) ("nPG" 2) ("Ras-transformed NPGs" 1)))
 ("PCID:6605258" (("CGK733" 15)))
 ("PCID:66414" (("2-methoxyestradiol" 35) ("2-Methoxyestradiol" 15)))
 ("PCID:66524294" (("BIX02188" 8)))
 ("PCID:667490" (("6-MP" 26) ("most study groups intensively use 6-MP" 1)))
 ("PCID:668" (("dihydroxyacetone phosphate" 7)))
 ("PCID:6724"
  (("AQ" 182) ("Aq" 7) ("aq" 5) ("aQ" 2) ("AqS" 1) ("ice-cold aq" 1)))
 ("PCID:67701" (("guanidinopropionic acid" 1)))
 ("PCID:679"
  (("DMSO" 6614) ("dimethyl sulfoxide" 647) ("dimethyl sulfoxide (DMSO)" 75)
   ("DMSO-" 57) ("Dimethyl sulfoxide" 53) ("Dimethyl sulfoxide (DMSO)" 9)
   ("dmso" 8) ("Dimethyl Sulfoxide" 8) ("anhydrous DMSO" 2) ("-DMSO" 2)
   ("Dimethyl sulfoxide(DMSO)" 1) ("optical grade DMSO" 1)
   ("their respective DMSO" 1) ("Mock treated wells received DMSO" 1)
   ("than 20% DMSO" 1) ("respective DMSO" 1) ("than the 300-day DMSO" 1)
   ("Subsequently 150  μ L DMSO" 1) ("Dimethyl Sulfoxide (DMSO)" 1)))
 ("PCID:6802" (("Guo" 78)))
 ("PCID:6804"
  (("GMP" 136) ("guanosine monophosphate" 28) ("guanylate" 14)
   ("-guanosine monophosphate" 3) ("double tomato/GFP-positive GMP" 1)
   ("GMP-" 1) ("guanosine monophosphate (GMP)" 1) ("Guanylate" 1)))
 ("PCID:68077" (("tangeretin" 3) ("the dietary phytochemical tangeretin" 1)))
 ("PCID:6816"
  (("CoA" 163) ("CoAs" 9) ("coA" 4)
   ("3 hydroxy3methylglutaryl Coenzyme A HMG CoA" 1)))
 ("PCID:6830"
  (("GTG" 729) ("guanosine triphosphate" 51) ("-GTG" 42) ("gtg" 38)
   ("guanosine triphosphate (GTP)" 13) ("-gtg" 3) ("guanosine triphosphates" 3)
   ("Guanosine Triphosphate" 1) ("the classic GTG" 1)
   ("–guanosine triphosphate" 1) ("gTg" 1)
   ("Rab-associated guanosine triphosphate (GTP)" 1)))
 ("PCID:6842" (("acriflavine" 2)))
 ("PCID:6857385"
  (("T antigen" 793) ("T antigens" 71) ("T antigen (LT)" 14) ("t antigens" 7)
   ("simian virus 40 large T antigen" 5) ("T antigen (ST)" 5)
   ("a temperature-sensitive SV40 Large T antigen" 4)
   ("T antigen (DPKKKKRKV)" 3) ("T antigen (MT)" 3)
   ("the simian virus 40 large T antigen" 2)
   ("interferon-inducible temperature-sensitive SV-40 T antigen" 2)
   ("simian virus 40 (SV40) large T antigen" 2)
   ("the polyoma viral middle T antigen" 2)
   ("simian virus 40 (SV40) T antigen" 2) ("expressing SV40 large T antigen" 2)
   ("t antigen" 2) ("replication competent SV40 large T antigen" 2)
   ("viral T antigen" 2) ("Simian virus large T antigen" 2)
   ("pSV40Tag encoding simian virus 40 large T antigen" 1)
   ("a thermosensitive T antigen" 1) ("simian virus 40 T antigen" 1)
   ("the first 121 amino acids of the SV40 T antigen (see xref ) that encodes a J domain"
    1)
   ("a temperature-sensitive simian virus 40 large T antigen" 1)
   ("human kidney epithelial cell line expressing SV40 large T antigen" 1)
   ("CMV-SV40-large T antigen" 1)
   ("simian virus 40 (SV40) large T antigen (LT)" 1)
   ("The monoclonal mouse anti-SV40 large T antigen" 1)
   ("the MCV viral T antigens" 1) ("the viral large T antigen" 1)
   ("temperature-sensitive SV40-T antigen" 1)
   ("the only available p53-proficient ALT cell lines not expressing SV40 T antigens"
    1)
   ("the polyomaviral T antigen" 1)))
 ("PCID:6857597"
  (("bases" 1994) ("damaged bases" 29) ("Bas" 10) ("BAs" 8)
   ("targeted bases" 8) ("Bases" 5) ("the mutated bases" 4)
   ("alkylated bases" 4) ("at least 15 intronic bases" 4)
   ("the damaged bases" 3) ("consecutive bases" 3) ("only nine bases" 2)
   ("damaged DNA bases" 2) ("a few bases" 2) ("its negative emotional bases" 2)
   ("intronic alteration approximately 50 bases" 2)
   ("Miseq covered nearly 3000 bases" 2) ("the last three bases" 2)
   ("oxidatively damaged bases" 2) ("weak bases" 2)
   ("non-bulky damaged bases" 2) ("at least six bases" 2)
   ("both damaged bases" 2) ("nucleic bases" 2) ("the proximal bases" 2)
   ("the biological bases" 2) ("protecting bases" 2) ("bases (GAGACAAA)" 1)
   ("methylated, oxidized, or reduced bases" 1)
   ("two or more alternative bases" 1) ("nitrogenous bases" 1)
   ("damaged or mismatched bases" 1) ("The deleted 4 bases" 1)
   ("the 10 most common mutated bases" 1)
   ("nearby damaged
bases"
    1)
   ("the potential molecular bases" 1) ("than 20 bases" 1) ("than 25 bases" 1)
   ("the π-stacked bases" 1) ("five villous bases" 1) ("more rational bases" 1)
   ("than 70 bases" 1) ("at least 40 bases" 1) ("various damaged bases" 1)
   ("approximately 550 bases" 1) ("morphologic bases" 1)
   ("The alkylated bases" 1) ("the C13orf25 gene and span nearly 800 bases" 1)
   ("only 150 bases" 1) ("at least 60 bases" 1)
   ("the separate molecular bases" 1) ("the pathogenetic bases" 1)
   ("the alkylated bases" 1) ("Pharmacogenomic knowledge bases" 1)
   ("The biochemical bases" 1) ("several incorrect bases" 1)
   ("these methylated bases" 1) ("at least 15 bases" 1) ("deaminated bases" 1)
   ("nonbulky damaged bases" 1)
   ("reactive oxygen species (ROS) damaged bases" 1) ("around 100 bases" 1)
   ("we first discarded all intronic bases" 1) ("at least 2 unpaired bases" 1)
   ("CFH/CFHL1 unique bases" 1) ("than 6 bases" 1) ("the last 5 bases" 1)
   ("extrahelical bases" 1) ("than 15 bases (MW ∼5000 Da)" 1)
   ("deleted bases" 1) ("the deleted bases" 1) ("the neurobiological bases" 1)
   ("than 50 bases" 1) ("than 3 uncalled bases" 1) ("bases (TT)" 1)
   ("different damaged bases" 1) ("than two of the substituted bases" 1)))
 ("PCID:68602" (("medetomidine" 3))) ("PCID:68682" (("ABK" 4)))
 ("PCID:68853159" (("SSR" 39) ("SSRs" 1)))
 ("PCID:68925359" (("BMS-536924" 23))) ("PCID:6917907" (("LMB" 411)))
 ("PCID:6918837"
  (("panobinostat" 311) ("Panobinostat" 48)
   ("intraperitoneal injection panobinostat" 1)))
 ("PCID:69362" (("hMB" 19) ("HMB" 18) ("Hmb" 2) ("HMb" 1)))
 ("PCID:69435" (("DTH" 12) ("dTh" 6) ("DTH-" 1)))
 ("PCID:69507"
  (("FPC" 81) ("fructose-6-phosphate" 9) ("fructose 6-phosphate" 4)))
 ("PCID:69602" (("Ahn" 18) ("AHN" 6))) ("PCID:6971017" (("acetoacetate" 4)))
 ("PCID:6989" (("thymol" 4))) ("PCID:6992076" (("LLS" 18) ("ll" 8) ("lL" 8)))
 ("PCID:6992304"
  (("Fg" 229) ("FG" 117) ("fg" 45) ("Fg-" 29) ("f–g" 1) ("f-g" 1)
   ("soluble Fg" 1) ("intact dimeric Fg" 1) ("FG-" 1) ("immobilized Fg" 1)
   ("exogenous Fg" 1)))
 ("PCID:6992638" (("Va" 37) ("vas" 13) ("va" 3) ("VAs" 2) ("Vas" 1) ("vA" 1)))
 ("PCID:6992643" (("Fd" 135) ("FD" 50) ("fd" 4) ("FDS" 2)))
 ("PCID:6992654"
  (("Rv" 192) ("rv" 49) ("RVs" 21) ("Rvs" 20) ("rvs" 8) ("RVS" 1) ("rV" 1)))
 ("PCID:6992830"
  (("Hs" 1785) ("HS" 1146) ("hs" 165) ("HS-" 20) ("-Hs" 16)
   ("-Hs00932330_m1" 8) ("HSEs" 6) ("-Hs00200394_m1" 3) ("-Hs00200725_m1" 3)
   ("burn-induced HS" 3) ("-Hs00171876_m1" 2) ("-Hs00945875_m1" 2)
   ("-Hs00198012_m1" 2) ("distal HSEs" 2) ("preliminary DNaseI HS" 1)
   ("-hS6K1" 1) ("hS" 1) ("than HS (36.7 versus 31.3%, OR = 1.27, P = 0.04)" 1)
   ("a sublethal HS" 1) ("Hs-" 1) ("homogeneous HS" 1) ("-Hs99999905_m1" 1)
   ("severe HS" 1)))
 ("PCID:6993039"
  (("VM" 293) ("More VM" 6) ("VMS" 6) ("Vm" 2) ("the most VM" 2) ("‘vm'" 2)
   ("vm" 1)))
 ("PCID:6993105"
  (("Hh" 733) ("HHS" 16) ("hHS" 14) ("hh" 6) ("Indian Hh" 2)
   ("namely Sonic Hh" 2) ("hH" 1)))
 ("PCID:6993116"
  (("LV" 575) ("Lv" 70) ("Lv-" 3) ("the late (A wave) LV" 2) ("LV-" 1) ("lV" 1)
   ("pathologic LV" 1) ("adverse LV" 1)))
 ("PCID:6993118" (("vl" 1))) ("PCID:6995653" (("es" 72) ("Es" 5)))
 ("PCID:6997510" (("WL" 33) ("Wl" 3) ("wl" 1)))
 ("PCID:7009577"
  (("IA" 909) ("Ia" 110) ("ia" 12) ("IAS" 4) ("IAs" 4) ("adherent PorB IA" 1)
   ("IA-" 1) ("pathological stage IIB/FIGO stage IA" 1) ("Even stage IA" 1)
   ("most CD4+ IA" 1)))
 ("PCID:7009579"
  (("SA" 1407) ("SA-" 74) ("Sa" 37) ("SAs" 34) ("sa" 12) ("sas" 6)
   ("VWR international SA" 6) ("sA" 2) ("VWR International SA" 2) ("Sas" 2)
   ("traditional SAs" 2) ("idiopathic SA" 1) ("‘SA’" 1)
   ("The non-polar energy ΔG SA" 1) ("than either SAs (33%)" 1)
   ("colorectal SA" 1) ("than SA" 1) ("SaS" 1)))
 ("PCID:7009600" (("YF" 230) ("YFS" 16)))
 ("PCID:7009608" (("VD" 35) ("VDS" 6) ("Vd" 1)))
 ("PCID:7009610"
  (("MD" 5072) ("Md" 22) ("bilateral MD" 6) ("unilateral MD" 5) ("MDs" 3)
   ("definite MD" 2) ("md" 2) ("generalized Born MD" 1)
   ("at least 3 independent MD" 1) ("sporadic MD" 1) ("the accelerated MD" 1)
   ("Subsequent free MD" 1) ("the parental MD" 1) ("Mock-transduced MD" 1)
   ("divided MD" 1) ("benign MD" 1)
   ("benign (all other noncancer diagnoses) MD" 1) ("–mds" 1) ("mds" 1)
   ("explicit solvent MD" 1) ("explicit water MD" 1) ("MD-" 1)
   ("very long explicit-solvent MD" 1) ("classical MD" 1) ("mD" 1)))
 ("PCID:7009616" (("DV" 166) ("dV" 2) ("Dv" 1)))
 ("PCID:7009623"
  (("VE" 367) ("ve" 254) ("−ve" 42) ("–VE" 33) ("VES" 15) ("-ve" 10) ("VE-" 8)
   ("–ve" 6) ("Ve" 3)))
 ("PCID:7010502"
  (("KE" 336) ("ke" 10) ("Ke" 9) ("than ke" 2) ("the highly immunogenic KE" 1)
   ("“KE”" 1) ("exogenous cyclin D1 KE" 1) ("treated KE" 1)
   ("than KE ( p = 0.01, paired t-test)" 1) ("than KE (Fig xref )" 1)
   ("than KE ( p = 0.03, paired t-test)" 1)))
 ("PCID:7010529"
  (("LMs" 21) ("lm" 16) ("Lm" 7) ("lM" 3)
   ("than 10 000 LMs (Petsalaki & Russell, 2008 xref )" 1)))
 ("PCID:7010532"
  (("VI" 851) ("vi" 89) ("vis" 76) ("Vi" 47) ("Vis" 34) ("VIs" 3) ("vI" 2)
   ("-VI" 1) ("the randomized controlled phase III trial Nordic VI" 1)
   ("the dominant-negative myosin VI" 1) ("myosin VI's" 1)
   ("the bioinformatics-based classifier VI" 1) ("Only model VI" 1)
   ("those SCs expressed myosins VI" 1) ("infragranular layer VI" 1)))
 ("PCID:7010534"
  (("Li" 1033) ("LI" 874) ("LIs" 47) ("li" 20) ("lI" 4) ("vs acute Li" 3)
   ("Lis" 3) ("Li's" 2) ("Pui-Kai Li’s" 2) ("the Li’s" 1) ("Li’s" 1)
   ("Li-" 1)))
 ("PCID:7010718"
  (("KT" 281) ("KTs" 99) ("KTS" 66) ("kt" 13) ("Kt" 8) ("−KTS" 5) ("KT-" 3)
   ("dynactin-1–positive KT" 3) ("most KT" 1) ("−kt" 1)
   ("clinically diagnosis KTS" 1) ("kT" 1) ("spindle-distal KT" 1)
   ("Most KTs" 1) ("-KTS" 1) ("–KTS" 1)))
 ("PCID:7016067" (("TDS" 45) ("td" 35) ("Td" 27) ("Tds" 2) ("-TDS" 1)))
 ("PCID:7016078"
  (("ln" 153) ("LNs" 101) ("Ln" 16) ("LNS" 12)
   ("199 synchronous metastatic LNs" 4) ("-ln" 2) ("3.6 more LNs" 2)
   ("ln(OR)" 1) ("regional LNs" 1) ("inguinal LNs" 1) ("two fewer LNs" 1)
   ("positive-to-total LNs" 1) ("1.2 more LNs" 1) ("inguinal draining LNs" 1)
   ("mesenteric LNs" 1) ("positive axillary LNs" 1)))
 ("PCID:7016082"
  (("SQ" 212) ("sq" 22) ("Sq" 20) ("weekly LY294002 SQ" 2) ("weekly DMSO SQ" 2)
   ("than Sq" 2) ("“SQ”" 2) ("sQ" 1) ("−SQ" 1)))
 ("PCID:7016094" (("S-Hs" 1))) ("PCID:7019" (("9AA" 39) ("9aa" 1)))
 ("PCID:7019081"
  (("IH" 237) ("IHS" 64) ("IHs" 23) ("iHS" 15) ("iHs" 8) ("iH" 1)
   ("most IHs" 1)))
 ("PCID:7019108"
  (("WD" 462) ("WDS" 3) ("reiterated motifs called WD" 1) ("two atypical WD" 1)
   ("tandemly-arrayed WD" 1) ("Insulinotropic WD" 1) ("insulinotropic WD" 1)))
 ("PCID:7019985"
  (("RQ" 417) ("Rq" 3) ("RQs" 3) ("RQ-" 2) ("RQS" 1)
   ("IHC showed HER-2 gene RQ" 1)))
 ("PCID:7019993" (("NV" 59) ("nv" 2)))
 ("PCID:702"
  (("alcohols" 273) ("aliphatic amino alcohols" 2)
   ("two diastereomeric alcohols" 1) ("gradient alcohols" 1)
   ("secondary alcohols" 1)))
 ("PCID:7020001" (("DW" 49) ("DWS" 1))) ("PCID:7020029" (("QE" 13) ("Qe" 1)))
 ("PCID:7020114" (("MQ" 35) ("mq" 3) ("than MQ" 1)))
 ("PCID:7020159"
  (("SV" 421) ("SVs" 238) ("Sv" 43) ("healthy SV" 24) ("sv" 19) ("SVS" 9)
   ("the healthy SV" 3) ("Expressed SVs" 2) ("varicose (n = 5) SV" 2)
   ("non-used healthy SV" 2) ("subsequent SVs" 2) ("using Golden Helix SVS" 2)
   ("Golden Helix SVS" 2) ("Fifteen healthy SV" 1) ("so all SVs" 1)
   ("recurrent SVs" 1)))
 ("PCID:7020181" (("YH" 24) ("YHS" 3) ("yH" 2)))
 ("PCID:7021454"
  (("rs" 11943) ("Rs" 228) ("rS" 3) ("rs2834167*G–" 2) ("mutant A 1 Rs" 1)
   ("presynaptic A 1 Rs" 1) ("rs5110r-" 1) ("“rs”" 1) ("'rs'" 1)))
 ("PCID:7021871" (("HVS" 32) ("HV" 31)))
 ("PCID:7022320"
  (("kg" 1475) ("KG" 137) ("Kg" 37) ("-KG" 10) ("KGS" 1) ("kG" 1)))
 ("PCID:70335" (("Edaravone" 10)))
 ("PCID:70410"
  (("lies" 1142) ("LY" 332) ("Ly" 92) ("ly" 12) ("glucose disposal lies" 2)
   ("The serine/threonine (Ser/Thr) kinase mammalian target of rapamycin (mTOR) lies"
    2)
   ("acquired lies" 2) ("Their biological activity lies" 1)
   ("only one (rs7705526) lies" 1) ("−LY" 1)
   ("The proximal BRCA1 promoter lies" 1) ("Yet one clue lies" 1)
   ("NPM-associated cell growth control lies" 1)
   ("here (scrambled and shp38γ) lies" 1) ("the favorable proneural lies" 1)
   ("Another possible mechanism lies" 1)))
 ("PCID:70590" (("YY" 50))) ("PCID:70678708" (("DLPs" 4)))
 ("PCID:70678892" (("CBDA" 62) ("CBDA’s" 2)))
 ("PCID:70678897" (("HOE-140" 11))) ("PCID:70698771" (("lecithin" 12)))
 ("PCID:7071"
  (("3,3'-diaminobenzidine" 58) ("3,3’-diaminobenzidine" 33)
   ("3,3'-Diaminobenzidine" 9) ("3,3’-Diaminobenzidine" 6)
   ("3,3’-diaminobenzidine (DAB)" 3) ("DAKO" 3) ("3,3‘-diaminobenzidine" 3)
   ("3,3'-Diaminobenzidine (DAB)" 1)))
 ("PCID:70751" (("5-hydroxymethylcytosine" 19)))
 ("PCID:7097402"
  (("PCA" 887) ("Pca" 49) ("pca" 6) ("ablation-resistant PCA" 6)
   ("invasive PCA" 3) ("Fluorescent PCA" 2) ("1.5 ml 5% ice-cold PCA" 2)
   ("PCA-" 2) ("PCAS" 1) ("possibly aggressive Pca" 1)
   ("our previously published firefly luciferase PCA" 1)))
 ("PCID:712" (("formol" 10) ("Formol" 3))) ("PCID:71360" (("iloperidone" 1)))
 ("PCID:71464518" (("ALLs" 69) ("most Ph + ALLs" 1)))
 ("PCID:71464665" (("EFV" 7)))
 ("PCID:71474"
  (("sodium citrate" 793) ("Sodium Citrate" 30) ("SSC" 19)
   ("Sodium citrate" 11) ("sodium citrate (SSC)" 4) ("sodium Citrate" 3)
   ("sodium citrates" 3) ("antigen retrieval using 10 mM sodium citrate" 1)))
 ("PCID:71491931" (("cobimetinib" 15) ("Cobimetinib" 2)))
 ("PCID:71583" (("CDCl3" 5))) ("PCID:71728368" (("tw" 2) ("TWS" 1)))
 ("PCID:72" (("protocatechuic acid" 5))) ("PCID:7220" (("BTA" 2)))
 ("PCID:72276"
  (("epicatechin" 12) ("-epicatechin" 6) ("epicatechins" 2)
   ("-epicatechin (EC)" 2) ("-epicatechins" 1)))
 ("PCID:724"
  (("3-phosphoglycerate" 34) ("evidenced 3-phosphoglycerate" 2)
   ("a recent metabolomic study evidenced 3-phosphoglycerate" 1)
   ("study evidenced 3-phosphoglycerate" 1)))
 ("PCID:7251185"
  (("parthenolide" 184) ("Parthenolide" 28) ("parthenolide (PTN)" 7)
   ("parthenolide (PTL)" 3) ("parthenolide-" 1)))
 ("PCID:727"
  (("HCH" 136) ("hCh" 67) ("TNFα treated OA hCh" 2) ("HCH-" 1)
   ("TNFα-treated OA hCh" 1) ("ALLN/TNFα treated OA hCh" 1)
   ("TNFα-treated hCh" 1) ("relatively mild HCH" 1)))
 ("PCID:72715807"
  (("bias" 4837) ("Bias" 163) ("BIA" 104) ("potential bias" 23)
   ("possible bias" 16) ("a strong bias" 9) ("a potential bias" 9)
   ("the potential publication bias" 9) ("potential publication bias" 9)
   ("referral bias" 8) ("a possible publication bias" 7) ("a referral bias" 6)
   ("the possible bias" 6) ("the potential bias" 6) ("this potential bias" 6)
   ("any potential bias" 5) ("potential confounding bias" 4)
   ("inherent bias" 4) ("BIAS" 4) ("possible publication bias" 4)
   ("possible selection bias" 4) ("technical bias" 4)
   ("serious confounding bias" 3) ("no obvious publication bias" 3)
   ("analytical bias" 3) ("significant bias" 3)
   ("Potential publication bias" 3) ("potential selection bias" 3)
   ("possible survival bias" 3) ("a possible selection bias" 3)
   ("the known pericentromeric and subtelomeric positional bias" 3)
   ("a possible bias" 3) ("a potential selection bias" 3) ("A possible bias" 2)
   ("possible recall bias" 2) ("so potential language bias" 2)
   ("mild publication bias" 2) ("expressional bias" 2)
   ("revealed no obvious publication bias" 2)
   ("The quantitative transcriptional bias" 2)
   ("our cytogenetic database and disease selection bias" 2)
   ("potential institutional bias" 2) ("considerable bias" 2)
   ("a small angular bias" 2) ("minimal bias" 2)
   ("a possible experimental bias" 2) ("The strong bias" 2)
   ("subtle sequence bias" 2) ("the characteristic G→A mutational bias" 2)
   ("residual bias" 2) ("a strong orientation bias" 2) ("a technical bias" 2)
   ("the potential selection bias" 2) ("The potential publication bias" 2)
   ("negligible publication bias" 2) ("the possible publication bias" 2)
   ("any inherent bias" 2)
   ("an asymmetric plot suggested possible publication bias" 2)
   ("weak stochastic bias" 1) ("gender-specific methylation bias" 1)
   ("possible reporting bias" 1) ("unavoidable bias" 1)
   ("Accordingly, no significant bias" 1)
   ("publication bias using either Begg’s" 1)
   ("prostate cancer risk suggested some possible bias" 1)
   ("No visual publication bias" 1) ("no discernable bias" 1)
   ("a proportionate bias" 1) ("some possible bias" 1)
   ("An asymmetric plot suggested possible publication bias" 1)
   ("an obvious date bias" 1) ("potential survivor-ship bias" 1)
   ("One conceivable size bias" 1) ("clinic bias" 1)
   ("A very mild publication bias" 1) ("the possible recall bias" 1)
   ("unavoidable selection bias" 1) ("displayed no statistical bias" 1)
   ("loading bias" 1) ("The possible publication bias" 1)
   ("The only potential bias" 1) ("inherent selection bias" 1)
   ("our pooled data contained no potential publication bias" 1)
   ("suggested possible publication bias" 1) ("a probable bias" 1)
   ("the inherent bias" 1) ("an inevitable recall bias" 1)
   ("a consequent referral bias" 1) ("this inherent bias" 1)
   ("Possible publication bias" 1) ("systemic bias" 1)
   ("the directional bias" 1) ("a tertiary care practice referral bias" 1)
   ("given possible bias" 1) ("a serious confounding bias" 1)
   ("minimal inspection bias" 1) ("systematic non-biological bias" 1)
   ("the obvious selection bias" 1) ("The main predictable bias" 1)
   ("any technical bias" 1) ("than publication bias" 1)
   ("a strong sequence bias" 1) ("no strong bias" 1)
   ("less misclassification bias" 1)
   ("the heterozygous mutant cell lines HepG2, SK-N-SH, and GBM1 all showed significant bias"
    1)
   ("Probable significant publication bias" 1)
   ("a marked cardiogenic lineage bias" 1) ("a cardiogenic lineage bias" 1)
   ("potential survival bias" 1) ("any potential observation bias" 1)
   ("This quantitative transcriptional bias" 1) ("negligible bias" 1)
   ("minimized possible misclassification bias" 1) ("a diagnostic bias" 1)
   ("prognostic selection bias" 1) ("an attentional bias" 1)
   ("attentional bias" 1) ("minimal selection bias" 1)
   ("minimal patient selection bias" 1) ("a conservative bias" 1)
   ("any potential selection bias" 1)
   ("deployment status introducedsubstantial bias" 1)
   ("so participation bias" 1) ("an allelic bias" 1)
   ("well-characterized relatively homogeneous populations limiting selection bias"
    1)
   ("a substantial histological subtype bias" 1) ("a severe bias" 1)
   ("subsequent potential bias" 1) ("a potential sample bias" 1)
   ("a methodical bias" 1) ("a potential publication bias" 1)
   ("a gender-specific bias" 1) ("histological bias" 1)
   ("potential PCR bias" 1) ("the regional bias" 1) ("an inherent bias" 1)
   ("an epigenetic-mediated Wnt bias" 1) ("a possible dye-specific bias" 1)
   ("predominant bias" 1) ("the technical bias" 1)
   ("the secondary structure bias" 1) ("The oligodendrocytic bias" 1)
   ("cause mutational bias" 1) ("unspecific bias" 1)
   ("the possible selection bias" 1) ("considerable selection bias" 1)
   ("visual bias" 1) ("obvious bias" 1) ("potential print run specific bias" 1)
   ("potential language bias" 1) ("obvious publication bias" 1)
   ("subjective bias" 1) ("no obvious bias" 1) ("global labeling bias" 1)
   ("a possible sampling bias" 1) ("positional bias" 1)
   ("this potential testing bias" 1) ("any possible sample size bias" 1)
   ("the inherent selection bias" 1) ("a potential survival bias" 1)
   ("A potential bias" 1) ("2 statistic xref , and publication bias" 1)
   ("some referral bias" 1) ("systematic technical bias" 1)
   ("any dye-specific staining bias" 1)
   ("multiple population-based cohorts reduced bias" 1)
   ("potential ascertainment (Neyman) bias" 1)
   ("the previously reported ∼20% orientation bias" 1)))
 ("PCID:72899" (("indole-2-carboxylic acid" 1)))
 ("PCID:73293" (("fascaplysin" 62) ("Fascaplysin" 3) ("fascaplysin (FAS)" 2)))
 ("PCID:73318"
  (("8-OHdG" 170) ("8-oxodG" 73) ("8-oxo-dG" 47) ("8-Oxo-dG" 17) ("8-OxodG" 10)
   ("8-oxo-7,8-dihydro-2'-deoxyguanosine" 7) ("urinary 8-OHdG" 4)
   ("8-hydroxy-2'-deoxyguanosine" 3) ("8-Oxo-7,8-dihydro-2'-deoxyguanosine" 2)
   ("extranuclear 8-oxo-dG" 2) ("western blot and DNA 8-OHdG" 1)
   ("Urinary 8-Oxo-dG" 1)))
 ("PCID:73357" (("gramicidin" 31) ("Gramicidin" 3)))
 ("PCID:7339" (("PRPP" 43) ("almost all PRPP" 1)))
 ("PCID:73568"
  (("gallotannin" 68) ("Gallotannin" 18) ("gallotannins" 3)
   ("Gallotannin (GLTN)" 1)))
 ("PCID:7359122" (("FV" 216) ("Fv" 77) ("a confocal microscope FV" 2)))
 ("PCID:73659"
  (("maslinic acid" 22) ("Maslinic acid" 8) ("maslinic acid (MA)" 3)))
 ("PCID:7408104"
  (("HM" 416) ("hM" 7) ("HMS" 5) ("Hm" 4) ("the phosphorylated HM" 2) ("HMs" 2)
   ("hm" 1) ("\"Hm\"" 1) ("phosphorylated HM" 1)))
 ("PCID:7408110"
  (("PQ" 326) ("pQ" 26) ("pq" 11) ("pQs" 4) ("the last PQ" 1) ("than PQ" 1)
   ("PQS" 1)))
 ("PCID:7408258"
  (("PS" 1261) ("pS" 1078) ("ps" 554) ("Ps" 57) ("missing PS" 6)
   ("PS molecule" 6) ("favourable PS" 3) ("than PS" 2) ("the last 10 ps" 2)
   ("Cooperative Oncology Group (ECOG) PS" 2)
   ("an Eastern Cooperative Oncology Group (ECOG) PS" 2) ("exogenous PS" 2)
   ("apparently nonsyndromic PS" 2) ("the cell permeable peptide PS" 2)
   ("additionally negatively-charged lipids PS" 2) ("PS (ECOG)" 1)
   ("at least
one additional PS molecule"
    1)
   ("a significantly worse PS" 1) ("intrallular PS" 1) ("the last 4.0 ps" 1)
   ("history and poor PS" 1) ("Both anionic lipids PS" 1) ("the last 500 ps" 1)
   ("PS-" 1) ("nearly 95 ps" 1) ("Eastern Cooperative Oncology Group PS" 1)))
 ("PCID:7409"
  (("alpha" 2246) ("Alpha" 263) ("-alpha" 24) ("alphas" 6) ("non-alpha" 6)
   ("Alpha (RARA)" 5) ("Minimum Essential Medium Alpha" 5) ("alpha (NFYA)" 5)
   ("alpha (ER)" 4) ("Minimum Essential Medium (MEM) Alpha" 3)
   ("minimal Eagle medium alpha" 3) ("alpha (TNF)" 2)
   ("Deoxyribose nucleic acid (DNA) (cytosine-5)-methyltransferase 3 alpha" 2)
   ("Tripartite Motif 5 alpha" 2) ("e.g. tumor necrosis factor alpha" 2)
   ("alpha ( TNF )" 2) ("alpha (PDGFA)" 2)
   ("the organic solute transporter alpha" 2) ("alpha ( ACACA )" 2)
   ("lobular neoplasia demonstrated ER alpha" 2) ("alpha (NFKBIA)" 2)
   ("mouse monoclonal anti-smooth muscle actin alpha" 2)
   ("acetyl-coenzyme A carboxylase alpha" 2)
   ("phenol red-free minimum essential medium alpha" 2)
   ("phenol red-containing minimum essential medium alpha" 2)
   ("namely BAX alpha" 1) ("alpha ( PDGFA )" 1)
   ("a highly reactive lipophilic alpha" 1) ("A two-sided alpha" 1)
   ("a traditional alpha" 1) ("alpha (VEGFA)" 1) ("ALPHA" 1)
   ("the BLM helicase, or Topoisomerase III alpha" 1) ("a two-sided alpha" 1)
   ("acetyl-coenzyme A carboxylase alpha ( ACACA )" 1)
   ("Protein kinase C alpha (PKCα) in both in HN2-5 cells (a mouse hippocampal neuron-derived cell line [ xref ])"
    1)
   ("some residual alpha" 1) ("Prolyl-hydroxylated HIF-1 alpha" 1)
   ("namely IFN alpha" 1) ("Phosphorylated eIF2 alpha" 1)
   ("alpha (PDGFRA)" 1)))
 ("PCID:74267" (("DPPE" 2))) ("PCID:743" (("glutaric acid" 9)))
 ("PCID:755673" (("CID755673" 13))) ("PCID:757" (("glycolic acid" 15)))
 ("PCID:76044" (("S-trityl-l-cysteine" 5))) ("PCID:76516568" (("JNK-IN-8" 2)))
 ("PCID:767" (("Soda" 19) ("sodas" 8) ("soda" 4)))
 ("PCID:769"
  (("bicarbonate" 677) ("bicarbonate (ABC)" 7) ("bicarbonate (KRB)" 5)
   ("bicarbonate (AMBIC)" 4) ("Bicarbonate" 4) ("KRB" 2)
   ("Bicarbonate (KRB)" 2) ("bicarbonate (TEAB)" 1)))
 ("PCID:774" (("HSM" 3) ("Hsm" 1))) ("PCID:778" (("Hcy" 235) ("HCY" 7)))
 ("PCID:783"
  (("proton" 495) ("protons" 342) ("Proton" 294) ("exchangeable protons" 4)
   ("the amino proton" 4) ("the exchangeable proton" 2)
   ("four well-dispersed imino protons" 2) ("the respective H6 protons" 2)
   ("exchanging guanine imino protons" 2) ("nonexchangeable protons" 2)
   ("proton ( PT )" 2) ("residual solvent protons" 1) ("the phenolic proton" 1)
   ("non-proton" 1) ("an electrochemical proton" 1) ("aromatic ring protons" 1)
   ("the only amino proton" 1)
   ("12 partially resolved exchangeable imino protons" 1)
   ("12 exchangeable imino protons" 1) ("amino protons" 1)
   ("the nonexchangeable protons" 1)
   ("Cyanide p -trifluoromethoxy-phenylhydrazone (FCCP; injection 2) causes protons"
    1)
   ("fastest exchanging amide protons" 1)
   ("these few more resistant amide protons" 1) ("the amidic protons" 1)
   ("The aliphatic protons" 1) ("a low-field olefinic proton" 1)
   ("an olefinic proton" 1) ("all carbon-bound protons" 1)
   ("the vinylic protons" 1)))
 ("PCID:784" (("organic hydroperoxides" 1)))
 ("PCID:7918" (("acetic anhydride" 17) ("Acetic anhydride" 1)))
 ("PCID:807"
  (("iodine" 209) ("I2" 66) ("i2" 54) ("Iodine" 17) ("iodine (PI)" 9) ("-I2" 4)
   ("Iodine (PI)" 2) ("I2-" 2) ("I2–" 1)))
 ("PCID:8103" (("hexanol" 2))) ("PCID:8110" (("BIC" 443) ("Bic" 19)))
 ("PCID:813"
  (("potassium" 459) ("K+" 32) ("Potassium" 18) ("potassium cation" 4)
   ("mono-potassium" 1) ("the hyperpolarization-activated potassium (HCN)" 1)
   ("30 mM external potassium" 1) ("the cardiac fast transient outward K+" 1)
   ("di-potassium" 1)))
 ("PCID:8330"
  (("arena" 112) ("a square-shaped open-field arena" 3) ("arenas" 3)
   ("Arena" 2) ("a unique arena" 2) ("a large circular arena" 2)
   ("the public health arena" 1) ("the cardiovascular arena" 1) ("Arenas" 1)))
 ("PCID:83525"
  (("AP" 1432) ("Ap" 77) ("ap" 19) ("aP" 10) ("AP-" 6) ("-AP" 2)
   ("objective AP" 2) ("biotinylated AP" 2) ("ap-" 1) ("weak AP-" 1)))
 ("PCID:8468" (("vanillic acid" 4)))
 ("PCID:8515" (("SP 600125" 29) ("SP-600125" 19)))
 ("PCID:8530" (("naphthoquinone" 27) ("naphthoquinones" 3)))
 ("PCID:85362" (("aw" 6) ("AWS" 5) ("aws" 2) ("aW" 1) ("Aw" 1)))
 ("PCID:8582" (("inosine monophosphate" 6) ("Inosine monophosphate" 1)))
 ("PCID:8583"
  (("ITT" 182) ("ITTs" 5) ("ITT-" 2) ("the phosphorylated ITT" 2)
   ("Inosine-5" 1) ("an intraperitoneal ITT" 1)))
 ("PCID:86" (("3-hydroxyanthranilic acid" 1)))
 ("PCID:86289077"
  (("Tween 20" 2100) ("TBST" 190) ("Tween 20 (TBST)" 52) ("tween 20" 43)
   ("Tween 20 (PBST)" 23) ("PBST" 16) ("polysorbate 20" 13)
   ("Tween 20 (TTBS)" 9) ("TWEEN 20" 8) ("-Tween 20" 6) ("Polysorbate 20" 5)
   ("Tween
20"
    2)
   ("Tween 20 (PBSGAT)" 1)
   ("Tris buffered-saline containing 0.1% Tween 20 (TBST)" 1) ("three TBST" 1)
   ("Tween 20 (PBT)" 1) ("–Tween 20" 1)
   ("Tris-buffer-saline containing 0.1% Tween 20 (TBST)" 1)
   ("tween 20 (PBST)" 1) ("saline (PBS) + 0.1% Tween 20" 1)
   ("Tween 20 (TPBS)" 1)))
 ("PCID:86289106" (("EEG" 34) ("paroxysmal EEG" 2) ("EEGs" 1)))
 ("PCID:86289426" (("Isoliquiritigenin" 1) ("isoliquiritigenin" 1)))
 ("PCID:86289562"
  (("GppNHp" 66) ("the non-hydrolyzable GTP analogue GppNHp" 2) ("GppNHP" 1)
   ("the nonhydrolyzable GTP-analogue GppNHp" 1)))
 ("PCID:86289906" (("alpha-factor" 2) ("Alpha-factor" 1)))
 ("PCID:86583374"
  (("poly IC" 25) ("polyinosinic:polycytidylic acid" 17) ("Poly IC" 7)
   ("poly IC (PIC)" 3) ("poly IC-" 1)))
 ("PCID:8682" (("Oxythiamine" 1)))
 ("PCID:880" (("methylglyoxal" 9) ("Methylglyoxal" 5)))
 ("PCID:88184" (("WY" 28))) ("PCID:8857" (("EtOAc" 36)))
 ("PCID:888"
  (("magnesium" 265) ("Magnesium" 14) ("magnesium ions" 8) ("Magnesium ions" 4)
   ("magnesium-" 1)))
 ("PCID:8892" (("hexanoic acid" 1)))
 ("PCID:892"
  (("MI" 1903) ("inositol" 426) ("mis" 211) ("acute MI" 44) ("Mi" 33) ("mi" 29)
   ("Inositol" 25) ("myo-inositol" 21) ("incident MI" 15) ("Mis" 14)
   ("the acute MI" 9) ("inositol-" 4) ("acute hospitalized MI" 4) ("mI" 4)
   ("first-time acute MI" 3) ("-inositol" 3) ("experimentally-induced MI" 2)
   ("more severe MI" 2) ("Acute MI" 2) ("315 incident MI" 2)
   ("-myo-inositol" 2) ("the 351 acute MI" 1)
   ("hypertrophic remolding post MI" 1)
   ("both reparative and detrimental fibrotic responses post MI" 1)
   ("recurrent MI" 1) ("only nonfatal MI" 1) ("incident nonfatal MI" 1)
   ("a definite or probable MI" 1) ("premature MI" 1) ("smaller MI" 1)
   ("than MI" 1) ("acute MI (INTERHEART)" 1) ("MI-" 1)))
 ("PCID:8977" (("guanosine diphosphate" 35) ("guanosine diphosphate (GDP)" 6)))
 ("PCID:9061" (("5-hydroxyindoleacetic acid" 2)))
 ("PCID:9062"
  (("2-deoxyglucose" 164) ("2-Deoxyglucose" 18) ("-2-deoxyglucose" 8)
   ("-2-Deoxyglucose" 1)))
 ("PCID:91469"
  (("equol" 202) ("Equol" 20) ("than R- (+)equol" 1) ("racemic equol" 1)
   ("Only S- (-)equol" 1)))
 ("PCID:91486" (("sphinganine" 4)))
 ("PCID:91498"
  (("Ct" 2249) ("CTS" 231) ("ct" 92) ("−Ct" 27) ("-Ct" 22) ("cT" 15) ("Cts" 10)
   ("Ct (GAPDH)−Ct" 4) ("–Ct" 3) ("Ct(KIF2)-Ct" 3) ("Ct(gene)-Ct" 3)
   ("Ct( miR-195 )–Ct" 2) ("-ct" 2) ("Ct (gene of interest)—Ct" 2)
   ("Ct( p21 )-Ct" 2) ("-CTS" 2) ("the Comparative Ct" 2) ("Ct(target)−Ct" 2)
   ("Ct(IP)−Ct" 2) ("Ct (gene of interest)−Ct" 2) ("comparative Ct" 1)
   ("−Ct (GAPDH)" 1)
   ("internal control genes (geometric average of Actin and 18S) Ct" 1)
   ("Ct-" 1) ("nonneuropathic Ct" 1) ("Ct (EGFR)-Ct (GAPDH)" 1) ("—Ct" 1)
   ("Ct (sample) −Ct (GAPDH)" 1)))
 ("PCID:91636" (("8-CPT-cAMP" 43) ("8-Cpt-cAMP" 1)))
 ("PCID:91657" (("ACNU" 71) ("ACNU-" 3)))
 ("PCID:91825631" (("complex b" 15) ("Complex b" 1)))
 ("PCID:91825658" (("satraplatin" 26) ("Satraplatin" 9)))
 ("PCID:92135" (("D-beta-hydroxybutyrate" 6)))
 ("PCID:92136103" (("C23" 45) ("c23" 5)))
 ("PCID:92136114" (("C24" 33) ("c24" 1) ("than C24" 1)))
 ("PCID:92136150" (("NBD-PS" 3)))
 ("PCID:92136181"
  (("MA" 10657) ("Ma" 116) ("MA-" 5) ("ma" 5) ("mas" 4)
   ("the only other published large MA" 2) ("V600E-negative MA" 2)
   ("BRAF V600E-negative MA" 2) ("pediatric MA" 2) ("myristoylated MA" 1)
   ("than either MA (41.8±4.4%)" 1) ("H Ma’s" 1)
   ("particularly differentiating MA" 1) ("all available MA" 1)
   ("the viral MA" 1) ("viral MA" 1) ("MA's" 1) ("adult MA’s" 1)
   ("the combined 78 MA’s" 1) ("pediatric MA’s" 1) ("orthotopic MA" 1)
   ("“3-MA”" 1) ("than either MA" 1)))
 ("PCID:9214" (("diphenylene" 12) ("Diphenylene" 2)))
 ("PCID:92829"
  (("Gy" 2932) ("GY" 20) ("gy" 9) ("at least 100 Gy" 2)
   ("approximately 2.3 Gy" 2) ("at least further 25 Gy" 1) ("than 2 Gy" 1)
   ("than 80 Gy" 1)))
 ("PCID:92946" (("AY" 69) ("ay" 4) ("aY" 3) ("Ay" 2)))
 ("PCID:934"
  (("NI" 96) ("NIs" 36) ("ni" 13) ("nIs" 2) ("most NIs" 1) ("‘ni’" 1)))
 ("PCID:93460"
  (("voltage" 569) ("voltages" 21) ("Voltage" 12) ("capillary voltage" 6)
   ("a capillary voltage" 5) ("-voltage" 3) ("voltage-" 2)
   ("200°C. A spray voltage" 2) ("a distal 2.4-kV spray voltage" 1)
   ("170°C. A voltage" 1) ("5% B. A nanospray voltage" 1) ("Voltage-" 1)
   ("a 2.5 kV distal voltage" 1) ("The capillary voltage" 1)
   ("increased ventricular voltages" 1) ("a distal 2.5 kV spray voltage" 1)
   ("a 1.8 kV distal voltage" 1) ("the capillary voltage" 1)
   ("optimal photomultiplier voltages (PMT)" 1) ("voltages (PMT)" 1)))
 ("PCID:936" (("trans -farnesylthiosalicylic acid amide" 2) ("acid amide" 2)))
 ("PCID:938" (("niacin" 85) ("Niacin" 7)))
 ("PCID:943"
  (("nitrate" 67) ("nitrates" 6) ("Nitrate" 2) ("ferric nitrate" 2)
   ("24.8 μM ferric nitrate" 2) ("The total transformed nitrate (III)" 1)
   ("1.5 g/L argent nitrate" 1) ("1.0 g/L argent nitrate" 1)))
 ("PCID:9444"
  (("5-azacytidine" 140) ("5-Azacytidine" 32) ("5-azacytidine (AZA)" 2)
   ("than 5-Azacytidine" 1)))
 ("PCID:9500" (("6-aminonicotinamide" 8)))
 ("PCID:9543762" (("diacyl glycerol" 4) ("diacyl glycerol (DAG)" 3)))
 ("PCID:9548826" (("TXA" 8)))
 ("PCID:96"
  (("diacetate" 535) ("diacetate (DCFDA)" 14) ("diacetate (DCF)" 7)
   ("Diacetate" 5) ("diacetate (SFDA)" 5) ("-diacetate" 3)
   ("the membrane-permeable 4,5-diaminofluoresceine diacetate" 2)
   ("the membrane-permeable 4,5-diamino-fluoresceine diacetate" 2)
   ("the H 2 O 2 ‐sensitive fluoresent dye dichlorofluorescein diacetate (DCFDA)"
    2)
   ("−diacetate" 1) ("diacetate (FA)" 1) ("diacetate (CMFDA)" 1)
   ("diacetate (FDA)" 1)))
 ("PCID:961"
  (("OH" 1985) ("-OH" 87) ("hydroxyl radical" 66) ("hydroxyl radicals" 30)
   ("Oh" 26) ("–OH" 5) ("Hydroxyl radical" 4) ("hydroxyl anion" 3)
   ("the extremely toxic hydroxyl radical" 1) ("ice-cold CH 3 OH" 1)
   ("Hydroxyl radicals" 1) ("OH-" 1) ("oh" 1)))
 ("PCID:96215" (("IAA" 143)))
 ("PCID:9679"
  (("5-aminoimidazole-4-carboxamide" 30) ("AICA" 27)
   ("5-Aminoimidazole-4-carboxamide" 3)))
 ("PCID:96799"
  (("AV" 112) ("av" 46) ("AVS" 28) ("AVs" 27) ("Av" 20) ("av−" 2) ("Av-" 1)
   ("degradative AVs" 1) ("larger AVs" 1)))
 ("PCID:9687" (("dibutyryl cAMP" 23) ("dibutyryl cyclic AMP" 4)))
 ("PCID:969491" (("dieldrin" 2)))
 ("PCID:969516"
  (("turmeric" 143) ("Turmeric" 52) ("Curcuma" 14) ("diferuloylmethane" 5)
   ("dietary turmeric" 3) ("the popular Indian spice turmeric" 2) ("curcuma" 1)
   ("turmeric’s" 1) ("Turmeric’s" 1) ("The golden spice turmeric" 1)
   ("curcumin-free aqueous turmeric" 1)))
 ("PCID:9700"
  (("dTMP" 80) ("thymidylate" 23) ("deoxythymidine monophosphate" 14)
   ("Thymidylate" 6) ("dTMPs" 2)))
 ("PCID:97054"
  (("WGS" 172) ("WG" 151) ("Wg" 80) ("wg" 25) ("severe WG" 2)
   ("comparative WGS" 1) ("wgs" 1) ("underwent WGS" 1) ("than WGS" 1)))
 ("PCID:97364" (("LG" 189) ("lg" 13) ("lgs" 1) ("LGs" 1) ("Lg" 1)))
 ("PCID:975" (("glutathione disulfide" 14) ("glutathione disulfide (GSSG)" 3)))
 ("PCID:9750"
  (("L-citrulline" 8) ("The effluent containing [3H]L-citrulline" 1)))
 ("PCID:977" (("molecular oxygen" 62) ("atmospheric molecular oxygen" 2)))
 ("PCID:9803963" (("GW501516" 33))) ("PCID:9812916" (("box as" 7)))
 ("PCID:9813758" (("BMS345541" 24))) ("PCID:9818200" (("Vpp" 11)))
 ("PCID:9826528" (("PD 0325901" 2)))
 ("PCID:9829523"
  (("Flt3 inhibitors" 12) ("Flt3 inhibitor" 5) ("benzoylstaurosporine" 4)
   ("PKC-412" 4)))
 ("PCID:9831419" (("AMG655" 1)))
 ("PCID:9831636" (("jasplakinolide" 30) ("Jasplakinolide" 7)))
 ("PCID:9837455"
  (("AH" 219) ("Ah" 5) ("aH" 4) ("AHS" 2) ("ah" 1) ("incident AH" 1)
   ("developed incident AH" 1)))
 ("PCID:9847290" (("sphingosylphosphorylcholine" 3)))
 ("PCID:985"
  (("palmitic acid" 86) ("Palmitic acid" 9) ("palmitic acid (PA)" 3)
   ("-palmitic acid" 1)))
 ("PCID:9858135" (("LVs" 5) ("LVS" 1))) ("PCID:9858940" (("SB-505124" 1)))
 ("PCID:9860529" (("NU7026" 115) ("Nu7026" 73)))
 ("PCID:9860744"
  (("dehydroisoandrosterone (DHEA)" 3) ("dehydroisoandrosterone (SIGMA)" 2)
   ("dehydroisoandrosterone" 2)))
 ("PCID:9877608"
  (("BEC" 86) ("BECs" 62) ("Bec" 10) ("the approximate peak BECs" 2)
   ("venous BECs" 1) ("mock-infected BEC" 1) ("than BEC" 1)
   ("than the 80 mg/dl (0.08%) BECs typically achieved" 1)))
 ("PCID:98792" (("dihydrofolic acid" 1)))
 ("PCID:9898279" (("Ginsenoside Rb1" 1)))
 ("PCID:9900771" (("NY" 3091) ("Ny" 2) ("ny" 1) ("nY" 1)))
 ("PCID:9903786" (("TPCA-1" 17))) ("PCID:9907093" (("TGX221" 72)))
 ("PCID:991"
  (("phosphorothioate" 84) ("Phosphorothioate" 6) ("phosphorothioates" 3)))
 ("PCID:9918693"
  (("ginsenoside Rg3" 5)
   ("than the ginsenoside Rg3 in HCT116 and SW480 colorectal cancer cells" 1)))
 ("PCID:9920715" (("DEA NONOate" 6)))
 ("PCID:99278"
  (("GE" 3616) ("Ge" 15) ("ge" 13) ("Ges" 3)
   ("the Agilent Human SurePrint G3 Human GE" 2) ("Agilent GE" 2)
   ("the medial and caudal GE" 1) ("gE" 1) ("genome-wide GE" 1)))
 ("PCID:99282" (("Gn" 16) ("gN" 5) ("Gn’s" 1)))
 ("PCID:9952773" (("TAK-715" 1))) ("PCID:9956119" (("CHIR99021" 306)))
 ("PCID:996"
  (("tea polyphenols" 35) ("tea polyphenol" 20) ("IPH" 4) ("IPHS" 1)))
 ("PCID:9966640" (("leukotoxins" 1)))
 ("PCID:9969021" (("Chk2 inhibitor II" 35)))
 ("PCID:99716"
  (("ED" 411) ("ed" 66) ("EDs" 61) ("EDS" 29) ("Ed" 14) ("ED-" 2)
   ("Log-transformed dexmedetomidine ED" 2) ("completely reduc ed" 1)
   ("subclinical EDs" 1) ("the log-transformed dexmedetomidine ED" 1)
   ("log-transformed dexmedetomidine ED" 1)))
 ("PCID:9999" (("cyanogen" 12) ("Cyanogen" 1)))
 ("PR:000000019"
  (("MAPK" 12202) ("MAP kinase" 1629) ("MAPKs" 1375)
   ("mitogen-activated protein kinase" 1054) ("MAP kinases" 717)
   ("mitogen-activated protein kinases" 358)
   ("mitogen activated protein kinase" 150) ("MAPK family" 142) ("pMAPK" 92)
   ("mitogen-activated protein kinase (MAPK)" 90) ("p-MAPK" 85)
   ("mitogen-activated protein (MAP) kinase" 74) ("P-MAPK" 73)
   ("Mitogen-activated protein kinase" 61)
   ("mitogen activated protein kinases" 54)
   ("Mitogen-activated protein kinases" 54)
   ("mitogen-activated protein (MAP) kinases" 41) ("MAP kinase family" 34)
   ("mitogen-activated protein kinase (MAPK) family" 34) ("-MAPK" 24)
   ("Mapk" 18) ("Map kinase" 17) ("mitogen activated protein kinase (MAPK)" 16)
   ("mitogen-activated protein kinases (MAPK)" 16) ("MAPK-" 14)
   ("map kinase" 9) ("mitogen-activated protein kinase family" 8)
   ("overexpressed MAPKs" 7)
   ("mitogen activated protein kinase (MAPK) family" 7)
   ("Mitogen activated protein kinase" 6)
   ("mitogen activated protein kinases (MAPK)" 6) ("stress-responsive MAPKs" 6)
   ("stress-activated MAPKs" 5)
   ("mitogen-activated protein (MAP) kinase family" 5)
   ("mitogen-activated protein kinase (MAPK) protein" 5)
   ("Mitogen-activated protein (MAP) kinases" 5) ("MAPK protein" 4)
   ("Mitogen activated protein kinases" 4) ("mapk" 4) ("MAP kinase (MAPK)" 4)
   ("Mitogen-activated protein kinase (MAPK)" 4)
   ("mitogen-activated protein kinases (MAPK) family" 4) ("typical MAPKs" 3)
   ("an atypical MAP kinase" 3) ("other stress-activated MAPKs" 3)
   ("mitogen-activated protein (MAP) kinase (MAPK)" 3)
   ("one or more MAP kinases" 2)
   ("mitogen-activated protein kinase (MAPK) family protein" 2)
   ("mouse monoclonal anti-phospho44/42 MAPK" 2) ("monoclonal pMAPK" 2)
   ("significantly more activated (phosphorylated) MAPK" 2)
   ("The monoclonal anti-phospho-p44/42 MAPK" 2) ("MAP kinases (MAPK)" 2)
   ("previously annotated MAPK" 2) ("MAPKs family" 2)
   ("coexpressed TACE, and p38β MAPK" 2) ("dominant-negative p38αAF MAPK" 2)
   ("an epithelial-specific MAPK" 2) ("MAPK (AF)" 2) ("MAP kinase-" 2)
   ("Monoclonal mouse antibody phospho-p44/42 MAPK" 2)
   ("Mitogen-activated protein (MAP) kinase" 2)
   ("the classical ERK1/2 MAPKs" 2) ("rabbit monoclonal anti-p44/42 MAPK" 2)
   ("mouse monoclonal anti-p42/44 MAP kinase" 2)
   ("Alexa Fluor 488-conjugated anti-phospho-p44/42 MAPK" 2) ("–MAPK" 2)
   ("the classical ERK1 and ERK2 MAPKs" 2) ("Stress-responsive MAPKs" 2)
   ("the stress-responsive MAP kinases" 2)
   ("dually-phosphorylated ERK MAP kinase" 1) ("than other MAPKs" 1)
   ("these mitogen-activated protein kinase (MAPK), NF-κB," 1)
   ("the atypical MAP kinases" 1) ("MAP kinase (ERK)" 1) ("dual MAPK" 1)
   ("than the MAPK" 1) ("mitogen activated protein kinase (MKK)" 1)
   ("TRAF1 enhanced LMP1 1-231-mediated MAP kinase" 1)
   ("larger MAP kinase family" 1) ("significantly more activated MAPK" 1)
   ("The classic MAP kinase family" 1) ("further increased P-MAPK" 1)
   ("\"MAPK\"" 1) ("-MAP kinase" 1)
   ("Mitogen-activated protein kinases (MAPK)" 1)
   ("The currently known MAPKs" 1) ("immunoreactive pp38 MAPK" 1)
   ("both these pro-apoptotic MAPKs" 1) ("pro-apoptotic MAPK" 1)
   ("variant 6 barely activated P44/42 MAPK" 1) ("“non-MAPK”" 1) ("MAPK's" 1)
   ("the classical MAP kinases" 1) ("–mitogen-activated protein kinase" 1)
   ("‘atypical’ MAPKs" 1) ("MAPks" 1) ("the stress-responsive MAPKs" 1)
   ("the respective MAPKs" 1) ("MAPK’s" 1)
   ("classical mitogen-activated protein kinases (MAPK)" 1)
   ("a symmetry-related MAPK molecule" 1) ("MAPK molecule" 1)
   ("a stress-dependent MAPK" 1)))
 ("PR:000006572" (("tid" 91) ("Tid" 12) ("TID" 3) ("tid-" 2)))
 ("PR:000007607" (("FOXC1" 212) ("FoxC1" 3)))
 ("PR:000021998"
  (("neurotrophins" 91) ("neurotrophin" 73) ("Neurotrophins" 11)
   ("neurotrophin family" 3) ("Neurotrophin" 2)
   ("neuroprotective neurotrophins" 2) ("a well-recognized neurotrophin" 1)
   ("the prototypic neurotrophin" 1)))
 ("PR:000023165" (("Methionine aminopeptidase" 3)))
 ("PR:000028799"
  (("tubulin" 3078) ("Tubulin" 555) ("-tubulin" 438) ("tubulins" 37)
   ("TUBULIN" 37) ("polymerized tubulin" 34) ("-Tubulin" 32)
   ("soluble tubulin" 19) ("-TUBULIN" 18) ("37.5 µM pure tubulin" 3)
   ("soluble and polymerized tubulin" 3) ("Neuronal beta-III tubulin" 3)
   ("monomeric tubulin" 3) ("tubulin molecule" 3) ("tubulin protein" 3)
   ("monoclonal anti- β -tubulin" 3) ("Monoclonal antiacetylated tubulin" 3)
   ("Soluble Tubulin" 2) ("characteristic acetylated tubulin" 2)
   ("anti- β -III tubulin" 2) ("soluble and polymeric tubulin" 2)
   ("Soluble and polymerized tubulin" 2) ("densely polymerized tubulin" 2)
   ("Tubulins" 2) ("polymerized and acetylated tubulin" 2)
   ("treated tubulin" 2) ("keratinocytes showed strong tubulin" 2)
   ("β III tubulin" 2) ("sequestering soluble tubulin" 2)
   ("cold-induced tubulin" 1) ("both polymerized and nonpolymerized tubulin" 1)
   ("subtilisin-treated tubulin" 1) ("pure tubulin" 1)
   ("about 2.5-fold more ac- α -tubulin" 1) ("monomeric (soluble) tubulin" 1)
   ("only centrosomal tubulin" 1) ("β -III Tubulin" 1)
   ("Mouse monoclonal anti- α -tubulin" 1) ("polymerized tubulins" 1)
   ("The soluble tubulin" 1) ("cellular soluble tubulin" 1)
   ("the phosphomimetic mutant MCAK SS/DD displayed 34% less polymerized tubulin"
    1)
   ("polymeric tubulin" 1) ("–tubulin" 1)
   ("kinetochore-associated cold-stable tubulin" 1) ("the mitotic tubulins" 1)
   ("2 μl polymerized tubulin" 1) ("—Tubulin" 1)
   ("all experiments X-Rhodamine–labeled tubulin" 1)
   ("X-Rhodamine–labeled tubulin" 1) ("soluble (cytosolic) tubulin" 1)
   ("sedimented polymerized tubulin" 1)
   ("TUBB3 (beta
                III tubulin"
    1)
   ("0.8 μM polymerized tubulin" 1) ("anti-beta III tubulin" 1)
   ("anti-β III tubulin" 1) ("hand-tracking fluorescent tubulin" 1)))
 ("PR:000037068"
  (("selenoprotein" 24) ("selenoproteins" 22) ("Selenoprotein" 2)))
 ("PR:000044374"
  (("TAp63" 354) ("TAp63-" 4) ("p28 increased TAp63" 1)
   ("than inhibiting TAp63" 1) ("overactive TAp63" 1)
   ("the p53-relative TAp63" 1) ("potentially toxic TAp63" 1) ("than TAp63" 1)
   ("than TAp63 ( xref , middle row)" 1) ("the basal TAp63" 1)))
 ("Raf CAAX" (("Raf CAAX" 1))) ("RasG12V" (("RasG12V" 70)))
 ("RasGEF"
  (("Ras GEF" 14) ("RasGEF" 14) ("Ras-GEF" 7) ("a new RasGEF" 1)
   ("a prominent RasGEF" 1)))
 ("UP:"
  (("Ki-67" 2634) ("Vif" 1761) ("Vif protein" 51) ("up:" 35)
   ("Ki-67 protein" 8) ("Vif-" 4) ("the viral protein Vif" 4) ("PKCzeta" 4)
   ("Ki-67-" 4) ("than Ki-67" 3) ("the viral Vif protein" 3)
   ("rabbit monoclonal Ki-67" 3) ("overexpressed Vif protein" 3)
   ("HIF-alpha" 2) ("MDM2 only targets Vif" 2) ("epidermal Ki-67" 2)
   ("the accessory factor Vif" 2) ("the lentiviral accessory protein Vif" 2)
   ("viral protein Vif" 1) ("Ki-67–" 1) ("than Ki-67 [ xref ]" 1)
   ("significant less Ki-67" 1) ("Mouse monoclonal anti Ki-67" 1)
   ("proviral Vif" 1) ("HIV-1 proviral Vif" 1)
   ("proviral (Figure  xref c) Vif" 1) ("E1–E4" 1) ("less Ki-67" 1)
   ("atypical PKCzeta" 1) ("strong positive Ki-67" 1)
   ("than Ki-67 ( xref , xref ; xref )" 1) ("full-length soluble Vif" 1)
   ("a sub-stoichiometric Vif" 1) ("that Vif’s" 1)
   ("The viral infectivity factor Vif" 1) ("less functional Vif" 1)
   ("simian immunodeficiency virus (SIV) Vif" 1) ("Ki-67−" 1) ("E1-E4" 1)
   ("an absent HIV Vif protein" 1) ("than full-length Vif ( xref )" 1)
   ("primate lentiviral Vif" 1) ("The HIV-1 accessory protein Vif" 1)))
 ("UP:A0A024R4B6" (("ATG16" 11))) ("UP:A0A089N7W1" (("IR4" 12)))
 ("UP:A0A0B5H903" (("301a" 91) ("hexon" 12) ("Hexon" 5) ("-301a" 3)))
 ("UP:A0A0K2S2V0" (("Sey" 2) ("SEY" 1))) ("UP:A0AVF1" (("TTC26" 1)))
 ("UP:A0AVI4" (("TMEM129" 2)))
 ("UP:A0AVK6" (("E2F8" 22) ("E2F-8" 3) ("E2f8" 2)))
 ("UP:A0AVT1" (("ubiquitin-activating enzyme E1" 12) ("Uba6" 4)))
 ("UP:A0C767" (("T4b" 1)))
 ("UP:A0FKN4" (("MMTV" 908) ("MMTV-" 99) ("Mmtv" 5) ("MMTV–" 1)))
 ("UP:A0JMN8" (("oxysterol" 46) ("the principal oxysterol" 2)))
 ("UP:A0JNA2" (("Sez-6" 1)))
 ("UP:A0KFJ6"
  (("meta" 478) ("Meta" 261) ("meta-" 16) ("“meta”" 7) ("Meta-" 3) ("MetA" 2)
   ("several new-ly-publicated meta" 1) ("than Meta 1" 1)))
 ("UP:A0KKL4" (("ProQ" 16))) ("UP:A0LU49" (("pup" 35) ("pUP" 26)))
 ("UP:A0MZ66" (("KIAA1598" 1))) ("UP:A0PJY2" (("FEZF1" 1)))
 ("UP:A0PK00" (("TMEM120B" 2)))
 ("UP:A0QZ48" (("PRCs" 34) ("replicated DNA lacks functional PRCs" 2)))
 ("UP:A0R3F9" (("protein acetyltransferase" 9)))
 ("UP:A0R5N1" (("EGTA" 3073) ("-EGTA" 1))) ("UP:A0R6E0" (("MTase" 5)))
 ("UP:A1A4Y4" (("IRGM" 15) ("IRGM1" 3))) ("UP:A1A5B4" (("ANO9" 3)))
 ("UP:A1C6B4" (("mPDA" 1))) ("UP:A1CE97" (("CBHA" 60)))
 ("UP:A1CFS2"
  (("PLA" 1049) ("PLAs" 39) ("Plas" 5) ("plas" 2)
   ("a well-characterized PLA" 2) ("chromogenic PLA" 1)
   ("negative and positive PLA" 1) ("in situ double sequential PLA" 1)
   ("a sequential PLA" 1) ("very few IFI16 and ASC PLA" 1)
   ("more IFI16-ASC PLA" 1) ("double sequential PLAs" 1) ("appropriate PLA" 1)
   ("secondary PLA" 1) ("qualitative in situ PLA" 1) ("at least two PLA" 1)
   ("so-called PLA" 1)))
 ("UP:A1CP85"
  (("Arom" 74)
   ("MCF-7 YFP-WT and YFP-K303R ERα-expressing cells or MCF-7 Arom" 2)
   ("arom" 2)))
 ("UP:A1CPG1" (("SAGA" 31))) ("UP:A1CTE6" (("CREC" 3)))
 ("UP:A1CUJ5" (("CPY" 17)))
 ("UP:A1E959"
  (("ODAM" 142) ("odontogenic" 66) ("ODAM protein" 5)
   ("odontogenic ameloblast-associated protein" 3) ("Odontogenic" 2)
   ("ODAM-" 1) ("odontogenic ameloblast-associated protein (ODAM)" 1)
   ("APIN" 1) ("apin" 1)))
 ("UP:A1KXE4" (("Mani" 16) ("Sridhar Mani" 2))) ("UP:A1KZ92" (("PXDNL" 2)))
 ("UP:A1L3X0" (("ELOVL7" 2))) ("UP:A1L3X4" (("MTM" 7)))
 ("UP:A1L4H1" (("SSc5D" 2)))
 ("UP:A1TP97"
  (("TAM" 754) ("Tam" 459) ("tam" 32) ("-TAM" 12) ("TAM-" 1) ("TAm" 1)))
 ("UP:A1X283"
  (("Tks4" 232) ("Tks4-" 4) ("Tks4 protein" 3) ("SH3PXD2B" 2)
   ("The SH3-domain-rich proteins Tks4" 2) ("fad49" 1) ("only Tks4 Y508F" 1)))
 ("UP:A1YCA5" (("NPT" 53) ("NpT" 2) ("Npt" 1)))
 ("UP:A1YGR5" (("galactosyltransferase" 11))) ("UP:A1Z1Q3" (("MACROD2" 2)))
 ("UP:A1Z6E0" (("GUS" 18)))
 ("UP:A1Z746"
  (("CN" 1172) ("cN" 3) ("Cn" 3) ("embryonic spinal CN" 3) ("CN-" 2)
   ("embryonic CN" 2) ("pCN" 1) ("log transformed CN" 1) ("continuous CN" 1)
   ("Log transformed CN" 1) ("maximal CN" 1) ("Somatic CN" 1) ("normal CN" 1)
   ("rat primary CN" 1)))
 ("UP:A2A2Y4" (("FRMD3" 3))) ("UP:A2AVJ3" (("cGMP" 206)))
 ("UP:A2BHN0"
  (("Annexin" 94) ("annexin" 66) ("annexins" 10) ("Annexins" 2) ("Annexin-" 1)
   ("ANNEXIN" 1) ("Most annexin" 1)))
 ("UP:A2N4P8"
  (("IL-2R" 268) ("IL2R" 53) ("interleukin-2 receptor" 16) ("IL2r" 3)
   ("Il2r" 2) ("the high-affinity heterotrimeric IL-2R" 2) ("-IL2R" 1)
   ("Interleukin-2 Receptor" 1) ("IL-2R–" 1)))
 ("UP:A2PYH4" (("HFM1" 6) ("Mer3" 1)))
 ("UP:A2Q6Z4"
  (("U0126" 3508) ("Env protein" 26) ("ENV protein" 14) (NIL 4)
   ("commercially-available small molecules U0126" 3) ("env protein" 2)
   ("a retroviral Env protein" 2) ("“U0126”" 1)
   ("the dual MEK1/MEK2 inhibitor U0126" 1)
   ("The non-competitive MEK inhibitor U0126" 1) ("than U0126" 1)
   ("the well-characterized selective MEK inhibitor U0126" 1)
   ("MEK called U0126" 1)
   ("the MEK1/2-specific non-competitive inhibitor U0126" 1)
   ("than the MEK inhibitor U0126" 1)))
 ("UP:A2RRP1" (("NBAS" 12) ("neuroblastoma amplified sequence" 1)))
 ("UP:A2RU49" (("LOC123688" 2) ("AGPHD1" 1))) ("UP:A2RU54" (("HMX2" 1)))
 ("UP:A2RUC4" (("TYW5" 1) ("C2orf60" 1)))
 ("UP:A2VDU1" (("Spry4" 282) ("exogenous Spry4" 2) ("spry4" 1)))
 ("UP:A2XFC7" (("aPXA" 14))) ("UP:A2XHZ9" (("BC1" 37)))
 ("UP:A2XVG1" (("PXG" 1))) ("UP:A2XX39" (("RFL" 5) ("pRFL" 2)))
 ("UP:A2Y7D9" (("pSIH" 13)))
 ("UP:A2YH64" (("CATB" 83) ("preoperative serum CATB" 2)))
 ("UP:A2YN56" (("shR1" 67))) ("UP:A3AZ88" (("MTE" 1)))
 ("UP:A3KMH1" (("KIAA0564" 8))) ("UP:A3KN83" (("SBNO1" 1)))
 ("UP:A3KNL5" (("PNT" 5) ("pPNT" 3)))
 ("UP:A3KQ55" (("MePCE" 10) ("7SK snRNA methylphosphate capping enzyme" 3)))
 ("UP:A3LX99" (("PDZ1" 107))) ("UP:A3M3H0" (("ATA" 381) ("-ATA" 17)))
 ("UP:A3N2T3" (("NGT" 130) ("obese NGT" 3))) ("UP:A4D0S4" (("LAMB4" 1)))
 ("UP:A4D1B5" (("GSAP" 66) ("gamma-secretase activating protein" 1)))
 ("UP:A4D1E1" (("ZNF804B" 2))) ("UP:A4D1S5" (("RAB19" 4)))
 ("UP:A4GXA9" (("EME2" 1))) ("UP:A4IFH5" (("ALT1" 123) ("alt1" 6)))
 ("UP:A4IFM7" (("MLCK2" 5)))
 ("UP:A4IG59" (("WASH" 159) ("WASH-" 12) ("WASH protein" 3)))
 ("UP:A4II20" (("EGR" 43) ("“EGR”" 1))) ("UP:A4UGR9" (("XIRP2" 1)))
 ("UP:A4W5B8" (("RSD" 2))) ("UP:A4X3Q0" (("SALL" 4))) ("UP:A4ZJ37" (("D35" 8)))
 ("UP:A4ZNR4" (("Naked2" 6))) ("UP:A5D6W6" (("FITM1" 1)))
 ("UP:A5D8V6" (("VPS37C" 71) ("overexpressed VPS37C" 2)))
 ("UP:A5D992"
  (("Spry1" 419) ("Spry1 protein" 7) ("than Spry1  −/− ( P < 0.01)" 1)
   ("Spry1-" 1)))
 ("UP:A5FVT7"
  (("AAD" 623) ("AAD-" 3) ("spontaneous AAD" 2)
   ("mice developed spontaneous AAD" 2) ("almost 2,000 AAD" 1)
   ("human thoracic AAD" 1) ("thoracic AAD" 1)))
 ("UP:A5FVZ7"
  (("PANC" 1119) ("Panc" 613) ("PanC" 20)
   ("than the erlotinib-sensitive tumor PANC410" 1) ("than PANC-1" 1)
   ("panc" 1) ("than Panc-1" 1)))
 ("UP:A5FZ25"
  (("HK" 193) ("HK-" 9) ("HSK" 2)
   ("the follicular dendritic cell line (FDC) HK" 2)
   ("The follicular dendritic cell line (FDC) HK" 2)))
 ("UP:A5FZ47"
  (("CTC" 1265) ("-CTC" 47) ("CTC-" 1)
   ("The only commercially available CTC" 1) ("a microfluidic CTC" 1)
   ("-C T GT A CTC-3" 1)))
 ("UP:A5FZN7" (("bioD" 4) ("BioD" 3))) ("UP:A5G020" (("NQO" 11) ("pNQO" 2)))
 ("UP:A5G2J1"
  (("LexA" 334) ("lexA" 24) ("pLexA" 12) ("the viral repressor LexA" 1)))
 ("UP:A5HJM1" (("IL-7Rα" 30) ("IL7Rα" 18) ("IL7RA" 3) ("IL7Ra" 3)))
 ("UP:A5HZ59" (("CEO" 2)))
 ("UP:A5PKW4"
  (("PSD" 245) ("EFA6" 27) ("PSDs" 12) ("PSD protein" 5) ("smaller PSDs" 2)
   ("well-defined PSD" 2) ("the nascent PSD" 2) ("Representative PSD" 2)
   ("smaller PSD" 1) ("an obvious PSD" 1) ("normal PSDs" 1)))
 ("UP:A5PLL7" (("KUA" 3) ("TMEM189" 1))) ("UP:A5X5Y0" (("family member E" 8)))
 ("UP:A5YKK6" (("Not1" 216) ("CNOT1" 11) ("CCR4-NOT transcription complex" 2)))
 ("UP:A6BM72" (("MEGF11" 4))) ("UP:A6H712" (("K26" 11) ("k26" 1)))
 ("UP:A6H8Y1" (("TfnR" 60) ("BDP1" 9) ("Bdp1" 3) ("TFnR" 1)))
 ("UP:A6NC42" (("DPPA5" 3))) ("UP:A6ND01" (("Folr4" 3)))
 ("UP:A6ND48" (("subfamily I" 1)))
 ("UP:A6NDG6"
  (("P-gp" 696) ("Pgp" 102) ("pGP" 10) ("P-gp protein" 7) ("PGP" 7) ("p-gp" 6)
   ("pgp" 4) ("PgP" 3) ("endothelial Pgp" 2) ("functional P-gp" 1)))
 ("UP:A6NDP7" (("MYADML2" 6))) ("UP:A6NEK1" (("ARRDC5" 1)))
 ("UP:A6NER0" (("TBC1D3F" 2)))
 ("UP:A6NER3" (("G antigen 12J" 2) ("GAGE12J" 1))) ("UP:A6NFH5" (("FABP12" 1)))
 ("UP:A6NFY7" (("Sdhaf1" 16))) ("UP:A6NHA9" (("OR4C46" 2)))
 ("UP:A6NHC0" (("CAPN8" 1))) ("UP:A6NHJ4" (("ZNF860" 1)))
 ("UP:A6NHR9"
  (("SMCHD1" 5)
   ("structural maintenance of chromosomes flexible hinge domain containing 1"
    1)))
 ("UP:A6NI15" (("MSGN1" 2) ("mesogenin 1" 1))) ("UP:A6NIH7" (("UNC119b" 9)))
 ("UP:A6NIX2" (("WTIP" 16)))
 ("UP:A6NK06"
  (("CAD" 1431) ("-CAD" 6) ("diabetic CAD" 3) ("severe CAD" 2)
   ("angiographically proven CAD" 2) ("newly-diagnosed stable CAD" 2)
   ("three Caucasian CAD" 1) ("incident CAD" 1)
   ("the first 1864 amino acids of CAD" 1) ("late onset CAD" 1)
   ("A multifunctional protein CAD" 1)))
 ("UP:A6NK89" (("RASSF10" 97) ("Rassf10" 4) ("RASSF10 protein" 2)))
 ("UP:A6NKF1" (("shD1" 2))) ("UP:A6NKG5" (("RTL1" 10) ("Rtl1" 3) ("Mart1" 1)))
 ("UP:A6NKT7" (("RGPD3" 2))) ("UP:A6NKX4" (("SLC22A31" 1)))
 ("UP:A6NLJ0" (("NLF2" 1))) ("UP:A6NMZ7" (("COL6A6" 1)))
 ("UP:A6NN14" (("ZNF729" 1))) ("UP:A6NP61" (("ZAR1L" 2)))
 ("UP:A6PVL3" (("Kino" 6))) ("UP:A6PVS8" (("LRRIQ3" 1) ("LRRC44" 1)))
 ("UP:A6QNY1" (("TCblR" 17))) ("UP:A6QP57" (("TGase-3" 9)))
 ("UP:A6QTX7" (("Atg18" 13))) ("UP:A6QX61" (("ERB1" 3) ("Erb1" 3) ("erB1" 1)))
 ("UP:A6R3L3" (("DED1" 28)))
 ("UP:A6R3R5" (("eukaryotic initiation factor 4A" 2)))
 ("UP:A6R6E3" (("ATG2" 1))) ("UP:A6R7B8" (("Mca1" 4) ("mca1" 2) ("MCA1" 2)))
 ("UP:A6R7F0" (("Rtt106" 3))) ("UP:A6RBB0" (("Nop7" 4)))
 ("UP:A6RFP4" (("End3" 7))) ("UP:A6RG85" (("NMA111" 1)))
 ("UP:A6RGF3"
  (("MPDs" 10) ("the classical MPDs" 2) ("BCR/ABL-negative MPDs" 1)))
 ("UP:A6TT15" (("DAPH" 4))) ("UP:A6VL53" (("Lamb" 14) ("lamb" 6)))
 ("UP:A6VM24" (("FIS" 4))) ("UP:A6YIH8" (("HPO" 650)))
 ("UP:A6ZL17" (("DNA topoisomerase" 13))) ("UP:A6ZNC8" (("ATG19" 2)))
 ("UP:A6ZS83" (("Nrm1" 2))) ("UP:A6ZV85" (("Yph1" 3)))
 ("UP:A6ZY34" (("mut4" 29) ("-mut4" 7) ("MUT4" 2) ("Mut4" 2)))
 ("UP:A6ZYQ3" (("APH1" 2))) ("UP:A6ZZG1" (("PIR3" 9)))
 ("UP:A6ZZJ1" (("myo-3" 11))) ("UP:A6ZZK4" (("Rad27" 7) ("rad27" 1)))
 ("UP:A6ZZZ8" (("Caf4" 4)))
 ("UP:A7A061"
  (("silent information regulator 1" 27) ("siR1" 20)
   ("Silent information regulator 1" 12) ("Sir1" 2) ("SIR1" 2)))
 ("UP:A7A0P0" (("sCD25" 12))) ("UP:A7A1P0" (("Ste11" 12) ("Ste11-" 1)))
 ("UP:A7KAX9"
  (("p250GAP" 10) ("RICS" 8) ("grit" 6) ("p200RhoGAP" 3) ("Grit" 2) ("Rics" 1)
   ("p200Rho-GAP" 1) ("a stainless steel wire grit" 1)
   ("200 Stainless steel wire grit" 1) ("GRIT" 1) ("GC-GAP" 1)))
 ("UP:A7MB80" (("TFII-I" 122)))
 ("UP:A7MBM2" (("DISP2" 3) ("dispatched homolog 2" 2)))
 ("UP:A7MCY6" (("Sintbad" 42) ("SINTBAD" 37) ("TBKBP1" 12) ("than Sintbad" 1)))
 ("UP:A7MD48" (("SRRM4" 1)))
 ("UP:A7MLT4"
  (("ASR" 51) ("the log-transformed incidence or mortality ASR" 1)))
 ("UP:A7UL74" (("Eco1" 15) ("ECO1" 3) ("eco1" 1)))
 ("UP:A7VLV1" (("SGR" 55) ("pSGR" 2))) ("UP:A7YWC4" (("ATAD3" 4)))
 ("UP:A7Z1T2" (("CFR" 118) ("Federal Regulation 45 CFR" 2)))
 ("UP:A7Z7F5" (("SspI" 7))) ("UP:A8AD95" (("HDA" 7)))
 ("UP:A8ADW5" (("RbN" 10)))
 ("UP:A8AGR9" (("Marc" 23) ("0.1x Marc’s" 1) ("MARC" 1)))
 ("UP:A8ALR4" (("CAIA" 3)))
 ("UP:A8AP56"
  (("AAs" 350) ("aaS" 4) ("than AAs" 2) ("163 non-diabetic AAs" 2)
   ("92 previously untreated AAs" 1) ("than AAs ( P = 0.002)" 1)
   ("than AAs ( P < 0.001)" 1) ("pediatric AAs" 1)))
 ("UP:A8AQX2" (("MALT" 52))) ("UP:A8CG34" (("POM121C" 1)))
 ("UP:A8DRH7" (("GAAC" 17))) ("UP:A8DYE2" (("TRPM" 5)))
 ("UP:A8FNH9" (("NSPC" 1)))
 ("UP:A8HTM2" (("CPCs" 31) ("early-disseminated CPCs" 1)))
 ("UP:A8K4G0" (("CD300b" 2) ("LMIR5" 1))) ("UP:A8K7I4" (("hCLCA1" 1)))
 ("UP:A8MQ03" (("C9ORF169" 1) ("C9orf169" 1))) ("UP:A8MQT2" (("Golgin-67" 7)))
 ("UP:A8MT69" (("MHF2" 3) ("CENP-X" 1))) ("UP:A8MUP2" (("METTL12" 2)))
 ("UP:A8MVW5" (("Miki" 13) ("HEPACAM2" 1))) ("UP:A8MW92" (("PHF20L1" 3)))
 ("UP:A8MX76" (("CAPN14" 26) ("calpain 14" 2)))
 ("UP:A8MXU0" (("pseudogene 1" 4) ("pseudogene 2" 2)))
 ("UP:A8MYZ6" (("FOXO6" 32) ("FoxO6" 11))) ("UP:A8MZH6" (("Oosp1" 1)))
 ("UP:A8W7M4" (("Ama1" 12))) ("UP:A8WJR8" (("MBK-2" 3) ("MBK2" 2)))
 ("UP:A8WL06" (("UNC62" 1)))
 ("UP:A8WUG4" (("PKC-3" 59) ("pkc-3" 3) ("PKC3" 1)))
 ("UP:A8WUV1" (("CpG5" 20))) ("UP:A8WVU7" (("CpG1" 2) ("CpG-1" 1)))
 ("UP:A8X0L9" (("lex1" 2))) ("UP:A8X7F0" (("CpG8" 16)))
 ("UP:A8X811" (("Wrm-1" 4) ("WRM-1" 3))) ("UP:A8X9H4" (("CpG 4" 12)))
 ("UP:A8XAD0" (("Rheb1" 120))) ("UP:A8XEH1" (("WNT protein" 1)))
 ("UP:A8XI74" (("CED-2" 7) ("ced-2" 2)))
 ("UP:A8XT88" (("FSN-1" 13) ("Fsn-1" 5) ("FSN–1" 5)))
 ("UP:A8XWX5" (("CpG2" 5)))
 ("UP:A8Y181"
  (("CpG 3" 10) ("CpG3" 4) ("encompassing CpG 3" 2) ("-CpG-3" 1) ("CpG-3" 1)))
 ("UP:A8ZNR6" (("ATPB" 5) ("Atpb" 1))) ("UP:A8ZNS4" (("ATPA2" 1)))
 ("UP:A9A1T2"
  (("MPNs" 601) ("Ph-negative MPNs" 12) ("BCR-ABL -negative MPNs" 12)
   ("V617F -negative MPNs" 7) ("the Ph-negative MPNs" 5)
   ("JAK2 V617F-negative MPNs" 3) ("JAK2-V617F-negative MPNs" 2)
   ("JAK2-V617F-positive MPNs" 2) ("classic MPNs" 2)
   ("adult Chinese classic MPNs" 2) ("the 120 classic MPNs" 2)
   ("V617F -postive MPNs" 2)
   ("the Philadelphia chromosome (Ph)-negative MPNs" 2) ("bona fide MPNs" 1)
   ("classical Ph-negative MPNs" 1) ("the 120 Ph-negative MPNs" 1)
   ("JAK2V617F-associated MPNs" 1) ("the classical Ph-negative MPNs" 1)
   ("JAK2-driven MPNs" 1) ("These three non-leukaemic MPNs" 1)
   ("BCR-ABL1 -negative MPNs" 1) ("JAK2  V617F -negative MPNs" 1)
   ("177 heterozygous JAK2  V617F -positive MPNs" 1)
   ("JAK2V617F-positive MPNs" 1)
   ("The classic Philadelphia-chromosome negative MPNs" 1) ("most MPNs" 1)
   ("Classical MPNs" 1) ("BCR/ABL -negative MPNs" 1)))
 ("UP:A9CEQ8" (("GCI" 13) ("pGCI" 1)))
 ("UP:A9CIM3"
  (("PCs" 619) ("pCS" 140) ("malignant PCs" 16) ("normal PCs" 9)
   ("recurrent PCs" 2) ("long-lived PCs" 2) ("the long-lived PCs" 1)
   ("The first few PCs" 1) ("pcS" 1) ("The first 2 ancestry informative PCs" 1)
   ("some long-lived PCs" 1) ("the respective PCs" 1)
   ("their respective PCs" 1) ("more PCs" 1) ("H2AX positive abnormal PCs" 1)
   ("yet 15% BM-PCs" 1) ("primary malignant PCs" 1)
   ("than 10% BM clonal PCs" 1) ("10% BM clonal PCs" 1) ("abnormal PCs" 1)
   ("highly invasive and metastatic PCs" 1) ("AR-positive PCs" 1)
   ("than usual PCs" 1) ("usual PCs" 1) ("larger PCs" 1)
   ("MYC/CD138-positive malignant PCs" 1) ("normal and malignant PCs" 1)))
 ("UP:A9MJD1" (("SseL" 8))) ("UP:A9UHW6" (("MIF4GD" 8) ("SLIP1" 1)))
 ("UP:A9UL14" (("RBR" 15)))
 ("UP:A9YLD1" (("AA8" 26) ("XRCC1-proficient AA8" 1)))
 ("UP:A9YTQ3"
  (("AHRR" 23) ("AhRR" 9) ("AhR repressor" 3)
   ("aryl hydrocarbon receptor repressor" 2)))
 ("UP:A9YWH3" (("pSTMN" 2)))
 ("UP:B0BNY0"
  (("AGS" 1204) ("AGS (ATCC)" 6) ("TFF1-expressing AGS" 6)
   ("the gastric carcinoma cell line AGS" 4)
   ("the human gastric adenocarcinoma cell line AGS" 3)
   ("A gastric epithelial cell line AGS" 2)
   ("The human gastric adenocarcinoma cell line AGS" 2)
   ("Stable fluorescent gastric cell lines AGS" 2)
   ("The human gastric carcinoma cell line AGS" 2)
   ("Human p53-null esophageal adenocarcinoma cell line SK-GT-4 xref and human gastric cancer cell line AGS (ATCC)"
    1)
   ("the Cav1-negative gastric cancer cell line AGS" 1)
   ("alisertib-treated AGS" 1) ("the malignant human gastric cell line AGS" 1)
   ("Pontin-specific siRNA-treated AGS" 1)
   ("the human gastric carcinoma cell line AGS" 1)
   ("The gastric carcinoma cell line AGS" 1)))
 ("UP:B0BP37" (("RNB" 10))) ("UP:B0BP80" (("PCK" 15)))
 ("UP:B0BQ64"
  (("phosphofructokinase" 15) ("phosphofructokinase (PFK)" 4)
   ("phosphofructokinase activity" 2) ("Phosphofructokinase" 1)))
 ("UP:B0BZS9"
  (("RPMI" 6168) ("complete RPMI" 73) ("GIBCO" 6) ("fresh complete RPMI" 4)
   ("incomplete RPMI" 4) ("5% charcoal stripped FBS RPMI" 3)
   ("cold incomplete RPMI" 3) ("serum free (SF)-RPMI" 3)
   ("fresh buffered RPMI" 2) ("warm RPMI" 2) ("RPMI (GIBCO)" 1)
   ("2 mL RPMI1640" 1) ("750  μ L complete RPMI" 1) ("RPMI (LONZA)" 1)
   ("fresh 10% FBS RPMI" 1) ("ice-cold RPMI" 1) ("RPMI1640 (GIBCO)" 1)
   ("supplemental RPMI" 1) ("Fresh serum-free RPMI" 1) ("RPMI-" 1)
   ("5% Dextran Charcoal (DCC) treated RPMI" 1) ("-RPMI" 1)
   ("excess complete RPMI" 1)))
 ("UP:B0C0A5" (("CTAB" 9))) ("UP:B0C0B6" (("bacterial RecO" 1) ("RecO" 1)))
 ("UP:B0C1D3" (("RPLC" 9))) ("UP:B0C1P2" (("der" 56) ("DER" 13) ("Der" 7)))
 ("UP:B0C2D5" (("RuvB" 2))) ("UP:B0C321" (("PanD" 4)))
 ("UP:B0C3C2" (("RPMA" 33))) ("UP:B0C424" (("pRFA" 1)))
 ("UP:B0C5D4"
  (("fpg" 7) ("Fpg" 5) ("the bacterial Fpg protein" 1) ("Fpg protein" 1)))
 ("UP:B0C6V3" (("SURE" 4) ("pSURE" 3))) ("UP:B0C8J3" (("DXS" 56) ("DxS" 18)))
 ("UP:B0C9G3" (("HisG" 11) ("hisG" 1))) ("UP:B0CAC6" (("RPLs" 1)))
 ("UP:B0CAI3" (("COAD" 17))) ("UP:B0CB42" (("psiC" 1)))
 ("UP:B0CB57" (("RecF" 1))) ("UP:B0CBC9" (("ISPF" 2)))
 ("UP:B0CD21"
  (("DXR" 299) ("DXR-" 4) ("most cases DXR-" 1) ("than DXR" 1)
   ("the DNA-damaging chemotherapeutic agent DXR" 1) ("DxR" 1) ("dxr" 1)))
 ("UP:B0CD95" (("pgk" 13) ("Pgk" 11) ("pGK" 6))) ("UP:B0CDA5" (("CCSB" 10)))
 ("UP:B0CDM2" (("DNAa" 1))) ("UP:B0CE09" (("UvrB" 1)))
 ("UP:B0CEI9" (("GlyA" 4)))
 ("UP:B0CEU2"
  (("TRPC" 100) ("pTRPC" 3) ("the canonical TRPC" 1)
   ("Possibly another TRPC" 1)))
 ("UP:B0CF30" (("MutS" 918) ("MUTs" 17) ("mutS" 5)))
 ("UP:B0F2B4"
  (("NL4" 445) ("T-cell tropic HIV-1 NL4" 3)
   ("The CCR5-tropic Wild type NL4" 2) ("infectious HIV-1 NL4-3" 1) ("nl4" 1)))
 ("UP:B0V349"
  (("claudin" 206) ("claudins" 102) ("Claudin" 30) ("Claudins" 8)
   ("“leaky” claudins" 2) ("TJ-associated claudins" 2)
   ("transmembrane claudins" 2) ("a major claudin" 1)
   ("other colonic claudins" 1)))
 ("UP:B0VXM6" (("PH–EF" 22))) ("UP:B0Y8H9" (("Gel2" 1)))
 ("UP:B0YCL3" (("pelB" 2)))
 ("UP:B0YJ81"
  (("cap" 1775) ("CaP" 703) ("Cap" 150) ("“cap”" 43) ("-cap" 17)
   ("castration-recurrent CaP" 15) ("the fibrous cap" 13) ("metastatic CaP" 13)
   ("aggressive CaP" 3) ("‘cap’" 3) ("cap-" 3)
   ("m 7 G(5′)ppp-(5′)N termed cap" 2) ("castration-resistant CaP (CRPC)" 2)
   ("castration-resistant CaP" 2) ("fibrous cap" 2) ("CaP (CRPC)" 2)
   ("an adhesive cap" 2) ("a protective ‘cap’" 2)
   ("a chromosome-protective cap" 2) ("Pten -null CaP" 2)
   ("bone metastatic CaP" 1) ("CAp" 1) ("a crescent shaped “cap”" 1)
   ("progressive CaP" 1) ("a physical cap" 1) ("an overlying fibrous cap" 1)
   ("the entire fibrous cap" 1) ("a thick fibrous cap" 1)
   ("the protective cap" 1) ("focal CaP" 1) ("minimal CaP" 1)
   ("a supranuclear melanin cap" 1) ("a predominantly fibrous cap" 1)
   ("AR-low/negative CaP" 1) ("Pten null CaP" 1)
   ("Several well-established transgenic CaP" 1) ("Primary CaP" 1)
   ("the primary CaP" 1) ("Metastatic CaP" 1) ("the comparative groups CaP" 1)
   ("‘cap'" 1)))
 ("UP:B1AH88" (("MBR" 83) ("TSPO" 13) ("PBSs" 8) ("TSPO protein" 1)))
 ("UP:B1AKI9" (("ISM" 75) ("typical ISM" 1))) ("UP:B1AUH1" (("PTPλ" 6)))
 ("UP:B1B557" (("NSL" 8))) ("UP:B1N1A2" (("HSPA" 24)))
 ("UP:B1PBZ7" (("Sprouty1" 26))) ("UP:B1Q2B6" (("OLs" 14) ("OLS" 11)))
 ("UP:B2CW77" (("KLLN" 129) ("KILLIN" 69))) ("UP:B2RXF5" (("ZBTB42" 25)))
 ("UP:B2RXH2" (("JMJD2E" 4))) ("UP:B2TT54" (("IpaH9.8" 3)))
 ("UP:B3DH20" (("Seahorse" 101) ("seahorse" 2))) ("UP:B3EWH1" (("SifA" 4)))
 ("UP:B3EWJ2" (("DSL" 17))) ("UP:B3F211" (("IGFBP-2b" 34) ("igfbp-2b" 21)))
 ("UP:B3GQR3" (("Ple" 3) ("ple" 2) ("pLe" 1))) ("UP:B3KRT9" (("mSin3a" 29)))
 ("UP:B3LV44"
  (("HH" 554) ("pHH" 48) ("congenital HH" 12) ("normosmic HH" 9)
   ("severe congenital HH" 4) ("a severe congenital HH" 2)
   ("both canonical HH" 2) ("Indian (IHH) HH" 1) ("than HH" 1) ("more T HH" 1)
   ("CD4(+) T lymphocytic cell lines HH" 1) ("HH-" 1)
   ("the mitotic marker pHH3" 1) ("severe HH" 1) ("Congenital HH" 1)))
 ("UP:B3LVB0" (("BAI" 1))) ("UP:B3M0Y8" (("JUPITER" 2) ("Jupiter" 1)))
 ("UP:B3M185" (("Ras85D" 7)))
 ("UP:B3MF39" (("ADAM" 228) ("ADAM-" 5) ("Adam" 5))) ("UP:B3MH43" (("OTK" 3)))
 ("UP:B3MM49" (("DBE" 28))) ("UP:B3MPN6" (("chico" 4) ("Chico" 1)))
 ("UP:B3MRI9" (("SWS" 3)))
 ("UP:B3MTS8"
  (("ECA" 104) ("ECa" 4) ("the 14 primary ECA" 2) ("primary ECA" 1)
   ("concurrent ECA" 1)))
 ("UP:B3VML1" (("RNA dependent RNA polymerase" 5)))
 ("UP:B4DLR8"
  (("Nqo1" 156) ("nqo1" 3) ("the classical Nrf2 target genes Nqo1" 2)
   ("NAD(P)H dehydrogenase [quinone] 1" 2)))
 ("UP:B4DRY8" (("3-NT" 35))) ("UP:B4EUL1" (("ARNT1" 13) ("Arnt1" 1)))
 ("UP:B4RYN9"
  (("Panc1" 227) ("PANC1" 137)
   ("immortalized pancreas cell line HPDE6C7 and pancreas carcinoma derived cell line PANC1"
    1)
   ("than pancreas carcinoma derived cell line PANC1" 1)))
 ("UP:B4S201" (("Rph1" 1))) ("UP:B4YPW6" (("AP1A" 4)))
 ("UP:B5MC53"
  (("transgene" 3357) ("Transgene" 46) ("overexpressed EGFP-bcl2 transgene" 4)
   ("transgene (AND)" 4) ("conditional human c- Myc transgene" 3)
   ("a conditional transgene" 3)
   ("a tetracycline (tet)-repressible MYC transgene" 2)
   ("an autosomal transgene" 2)
   ("a bacterial artificial chromosome transgene" 2)
   ("the mammary tumor virus (MMTV) driven ErbB/Neu/Her2 transgene" 2)
   ("expressing GFP transgene" 2) ("only one oncogenic transgene" 2)
   ("the dominant-negative transgene" 2)
   ("heterozygous or homozygous transgene" 2)
   ("a WAP-driven Brk/PTK6 transgene" 2)
   ("a distal Lck promoter-Cre transgene" 2)
   ("a mammary epithelium–specific cyclin E transgene" 2)
   ("The chimeric transgene" 2) ("gag-pol proviral transgene" 1)
   ("the flag-tagged transgene" 1) ("the muscle-specific transgene" 1)
   ("a doxycycline-repressible MYC transgene" 1) ("only one transgene" 1)
   ("the phospho-mimetic CENP-Q S50D –eGFP transgene" 1)
   ("the lentiviral-expressed Flag-Polβ transgene" 1)
   ("The retroviral transgene" 1) ("than the hNox4 transgene" 1)
   ("the tetracycline (tet)-repressible Myc transgene" 1)
   ("a
tetracycline-repressible MYC transgene"
    1)
   ("the respective transgene" 1) ("than the transgene [ xref ]" 1)
   ("the p53 transgene's" 1) ("a regulatable c- myc transgene" 1)
   ("a bidirectional GFP<-tetO ->myc-GLI1 transgene" 1)
   ("the exogenous transgene" 1)
   ("a MMTV promoter-driven human HER2 transgene" 1)
   ("than either transgene" 1)
   ("an ubiquitin-promoter-driven ert2-cre transgene" 1)
   ("a tetracycline repressible MYC transgene" 1) ("a few transgene" 1)
   ("our relatively weak constitutively active STAT5b transgene" 1)
   ("than the Villin-Cre transgene" 1) ("a telomeric transgene" 1)
   ("a telomere-proximal transgene" 1)
   ("both an integrated telomeric transgene" 1) ("the proviral transgene" 1)
   ("the temperature-sensitive large T antigen-SV40 transgene" 1)
   ("a conditional dominant negative transformation related protein 53 ( Trp53 ) transgene"
    1)
   ("the homologous human AMPK γ 3 transgene" 1)))
 ("UP:B5TKC2"
  (("gyrus" 525) ("SFG" 57) ("gyrus (DG)" 21)
   ("the left parietal inferior supramarginal gyrus" 5)
   ("left posterior superior temporal gyrus" 4) ("the middle frontal gyrus" 3)
   ("the parahippocampal gyrus" 3) ("superior temporal gyrus" 3)
   ("the hippocampal dentate gyrus" 3)
   ("the left hemisphere parietal inferior supramarginal gyrus" 3)
   ("gyrus (CG)" 2) ("postcentral gyrus" 2) ("the precentral gyrus" 2)
   ("angular gyrus" 2) ("midfrontal gyrus" 2)
   ("The superior frontal gyrus (SFG)" 2)
   ("The superior temporal gyrus (STG)" 2) ("parahippocampal gyrus" 2)
   ("left inferior temporal gyrus" 2) ("mouse hippocampal dentate gyrus" 2)
   ("Right Middle Frontal Gyrus" 2) ("Gyrus" 2) ("occipital fusiform gyrus" 2)
   ("the left inferior parietal supramarginal gyrus" 2)
   ("the inferior temporal gyrus" 2) ("gyrus (HG)" 2) ("the semilunar gyrus" 1)
   ("the middle temporal gyrus" 1) ("right inferior temporal gyrus" 1)
   ("alcoholic cingulate gyrus" 1)
   ("the cerebellar vermis and anterior cingulate gyrus" 1)
   ("the postcentral gyrus" 1) ("precentral gyrus" 1)
   ("the superior temporal gyrus" 1) ("right superior frontal gyrus" 1)
   ("bilateral SFG" 1) ("hippocampal CA1, CA3 and dentate gyrus (DG)" 1)
   ("The superior temporal gyrus" 1) ("inferior and superior temporal gyrus" 1)
   ("posterior orbital gyrus" 1) ("the temporal cortex and fusiform gyrus" 1)
   ("mid frontal gyrus" 1) ("the supramarginal gyrus" 1)
   ("the left parietal supramarginal gyrus" 1) ("Gyrus (HG)" 1)
   ("the superior temporal gyrus (STG)" 1)))
 ("UP:B5TVM2"
  (("LL" 289) ("pLL" 79) ("“LL”" 10) ("LL peptide" 2) ("”" 1)
   ("a lentivirus-based vector pLL3.7" 1) ("pLL5.0(GFP)" 1)
   ("the lentiviral shRNA expression vector pLL3.7" 1) ("LL-" 1)))
 ("UP:B6EMS7"
  (("AD" 4198) ("sporadic AD" 19) ("AD-" 12) ("AOAD" 12) ("probable AD" 11)
   ("incident AD" 8) ("probable or definite AD" 4) ("more severe AD" 4)
   ("definite or probable AD" 4) ("late onset AD" 3) ("AD (LOAD)" 3)
   ("than AD" 3) ("a strong AD" 2) ("previously designated AD" 2)
   ("AD (AAD)" 2) ("the central AD" 2) ("probable or possible AD" 2)
   ("AD (EOFAD)" 2) ("mild AD" 2) ("complex inherited sporadic AD" 2)
   ("68 neuropathologically-confirmed AD" 2) ("possible or probable AD" 2)
   ("pAD" 2) ("quiescent AD" 2) ("definite (CERAD  xref  ) AD" 2)
   ("AD (EOSAD)" 2) ("preclinical AD" 1) ("developed AD" 1) ("AD (LBVAD)" 1)
   ("the highly fibroblast-adapted HCMV strain AD169" 1)
   ("mild and advanced AD" 1) ("the probable AD" 1)
   ("late-onset sporadic AD" 1) ("the incident AD" 1)
   ("the GAL4 transcriptional activation domain AD" 1) ("50 Italian AD" 1)
   ("an Electronic RID Plate Reader AD001" 1) ("We first genotyped all AD" 1)
   ("Sporadic AD" 1) ("serial AD" 1) ("more AD" 1) ("severe AD" 1)
   ("“definite” AD" 1) ("sporadic AD (SAD)" 1) ("incipient AD" 1)
   ("neuropathologically confirmed sporadic AD" 1) ("accelerated AD" 1)))
 ("UP:B6EXY6" (("BAS" 47))) ("UP:B6KAM0" (("TgAMA1" 4)))
 ("UP:B7GGV9" (("Arab" 1))) ("UP:B7GL49" (("p-PAX" 4)))
 ("UP:B7I3P0" (("FadA" 77) ("fadA" 12) ("the secreted mature FadA" 3)))
 ("UP:B7I420" (("UR" 20) ("Ur" 1))) ("UP:B7ICG5" (("ALC" 83)))
 ("UP:B7J5X3" (("HscA" 8) ("hSca" 7) ("hSCA" 2))) ("UP:B7JAR2" (("HtpG" 5)))
 ("UP:B7JBI2" (("TPs" 1))) ("UP:B7L425" (("MATa" 32)))
 ("UP:B7S4N9" (("TSPI" 2))) ("UP:B7TEU4" (("pS170" 13)))
 ("UP:B7ZA85"
  (("Brca1" 1142) ("BrCa1" 86) ("brca1" 29) ("Brca1 protein" 12)
   ("BrCa1 protein" 7) ("Brca1-" 2) ("conditional Brca1" 2) ("BrcA1" 1)
   ("microglial Brca1" 1) ("functional Brca1" 1) ("brca1-" 1)))
 ("UP:B7ZAQ6" (("GPR89" 3))) ("UP:B7ZC32" (("KLP6" 1) ("Klp6" 1)))
 ("UP:B7ZLG1" (("FOXP-3" 7))) ("UP:B8QG00" (("hdcA" 7) ("HdcA" 1)))
 ("UP:B8YNW1" (("HNF-1α" 111))) ("UP:B9A0M5" (("Chibby" 22)))
 ("UP:B9EKR1" (("Rptpζ" 65) ("RPTPζ" 4) ("Rptpζ protein" 2)))
 ("UP:B9MPL7" (("REx" 132) ("Rex" 72) ("rEX" 7) ("rex" 6) ("rEx" 2)))
 ("UP:C0HJM6" (("chitinase" 4) ("Chitinase" 3))) ("UP:C0JAT4" (("PLDs" 3)))
 ("UP:C0JAU3" (("dermonecrotic toxin" 1))) ("UP:C0LGT6" (("EFR" 2)))
 ("UP:C0NTV7" (("LCL2" 29) ("an EBV transformed B-cell line LCL2" 1)))
 ("UP:C0RM12"
  (("glycerol" 4712) ("Glycerol" 298) ("-glycerol" 19) ("glycerol molecule" 13)
   ("6 ml Neat glycerol" 2) ("spectrophotometric grade glycerol" 2)
   ("glycerol (SG)" 2) ("frozen bacterial glycerol" 1)
   ("intravenous glycerol" 1) ("bacterial glycerol" 1) ("Bacterial glycerol" 1)
   ("archival glycerol" 1) ("Archival glycerol" 1) ("glycerol (YPG)" 1)
   ("glycerol (TBSG)" 1)))
 ("UP:C0SQ93" (("ERRγ" 13)))
 ("UP:C0SVZ5"
  (("DCs" 2257) ("pDCs" 44) ("immature DCs" 22) ("mature DCs" 15)
   ("Immature DCs" 5) ("tolerogenic DCs" 5) ("pathological DCs" 5)
   ("LPS-treated DCs" 5) ("Mature DCs" 4) ("The LPS/TNFα-treated IL-15 DCs" 4)
   ("regulatory DCs" 4) ("the rapamycin-treated DCs" 4)
   ("mainly MHC II + CD11c + DCs" 3)
   ("adherent PBMC-derived IL-4 and IL-15 DCs" 3)
   ("the LPS/TNFα-treated IL-15 DCs" 3) ("than IL-4 DCs" 3)
   ("si-G9-1-treated DCs" 3) ("rapamycin-treated DCs" 3)
   ("the control mature DCs" 3) ("dermal DCs" 3) ("inflammatory DCs" 2)
   ("blood-derived DCs" 2) ("Autologous matured DCs" 2)
   ("proTα(100–109)-matured HER-2(9 369 )-pulsed DCs" 2)
   ("immunocompetent DCs" 2) ("mock-treated DCs" 2)
   ("mature immunostimulatory DCs" 2) ("MHC II + CD11c + DCs" 2)
   ("differentiated tissue-resident DCs" 2) ("autologous mature DCs" 2)
   ("than mIL-4 DCs" 2) ("mature IL-4 DCs" 2) ("Tyk2-competent DCs" 2)
   ("IL-10 treated DCs" 2) ("the resident DCs" 2)
   ("GM-CSF+IL-4-induced immature DCs" 2) ("splenic plasmacytoid DCs" 2)
   ("human primary pDCs" 2) ("received rapamycin-treated DCs" 2)
   ("mature control DCs" 2) ("sorting viable DCs" 2) ("IL-6-treated pDCs" 1)
   ("available thymic DCs" 1) ("Thymic DCs" 1) ("viable DCs" 1)
   ("human mature DCs" 1) ("similarly matured autologous DCs" 1)
   ("functionally competent mature DCs" 1)
   ("proTα(100–109) efficiently mature human DCs" 1) ("immature myeloid DCs" 1)
   ("pre-treated DCs" 1) ("lesional MHC II + CD11c + DCs" 1)
   ("HLA-DR + CD11c + classical DCs" 1) ("the pathological infiltrating DCs" 1)
   ("pathological langerin + DCs" 1) ("treated DCs" 1)
   ("stimulated splenic DCs" 1) ("LAMP3+ (CD208+) mature DCs" 1)
   ("than IL-4 DCs ( xref and xref and xref )" 1)
   ("previously described stem-cell-derived IL-15 DCs" 1) ("typical DCs" 1)
   ("the previously characterized IL-15 DCs" 1)
   ("than the donor-matched IL-15 DCs ( n =6, P =0.03; xref )" 1)
   ("than mIL-4 DCs ( xref )" 1) ("than the donor-matched mIL-4 DCs" 1)
   ("The LPS/TNFα-treated DCs" 1) ("than mIL-15 DCs ( n =7, P =0.02)" 1)
   ("mIL-4 DCs" 1) ("the immature IL-15 (I'm-IL-15) DCs" 1)
   ("functional DCs" 1) ("so-called tolerogenic human DCs" 1)
   ("Stat3  −/− splenic DCs" 1) ("Normal splenic DCs" 1) ("splenic DCs" 1)
   ("CD11c + immature DCs" 1) ("contact-dependent induced regulatory DCs" 1)
   ("CCR7-expressing immature DCs" 1) ("functionally regulatory DCs" 1)
   ("Tolerogenic DCs" 1) ("neighboring DCs" 1)
   ("terminally differentiated mature DCs" 1) ("c-kit-negative DCs" 1)
   ("c-kit-expressing DCs" 1) ("myelocytic DCs" 1) ("the immature DCs" 1)
   ("the mature DCs" 1) ("mouse mature DCs" 1)
   ("mature bone marrow-derived DCs" 1) ("most DCs" 1) ("than control DCs" 1)
   ("injected rapamycin-treated DCs" 1) ("Rapamycin-treated DCs" 1)
   ("gp120—the gp120-treated DCs" 1) ("peripheral human myeloid DCs" 1)
   ("both immature and mature DCs" 1) ("more mature DCs" 1)
   ("more immunogenic DCs" 1)
   ("primary acute myeloid leukemia (AML)-derived DCs" 1)))
 ("UP:C1F1S6" (("Carb" 8) ("carB" 4) ("CARB" 1) ("carb" 1)))
 ("UP:C1F4K1" (("AhpD" 3)))
 ("UP:C1JJY3"
  (("envelope protein" 194) ("the viral envelope protein" 8)
   ("Envelope protein" 5) ("M-tropic HIV-1 envelope protein" 2)
   ("vesicular stomatitis virus G envelope protein" 2)
   ("vesicular stomatitis virus envelope protein" 2)
   ("vesicular stomatitis virus G (VSV-G) envelope protein" 1)
   ("viral envelope protein" 1) ("the appropriate envelope protein" 1)
   ("vesicular stomatitis virus (VSV) G envelope protein" 1)
   ("a highly glycosylated hydrophilic envelope protein" 1)))
 ("UP:C1P615" (("IBS-C" 49))) ("UP:C1P616" (("IBS-D" 38)))
 ("UP:C3VI15" (("IR3" 12))) ("UP:C5J894" (("ITx" 7)))
 ("UP:C5MKY7"
  (("EGFP" 4348) ("eGFP" 869) ("enhanced green fluorescent protein" 169)
   ("-EGFP" 49) ("egfp" 34) ("EGFP-" 28) ("–eGFP" 26)
   ("enhanced green fluorescent protein (EGFP)" 18) ("EGFP–" 16)
   ("Enhanced green fluorescent protein" 12) ("EGFP protein" 12) ("–EGFP" 10)
   ("eGFP-" 8) ("-eGFP" 8) ("Enhanced Green Fluorescent Protein" 6) ("EGFP−" 5)
   ("Egfp" 4) ("expressing eGFP" 4)
   ("enhanced green fluorescent protein (GFP)" 3) ("expressing EGFP" 3)
   ("coexpressed EGFP" 3) ("eGFP protein" 3)
   ("the plasmids encoding packageable enhanced green fluorescent protein" 2)
   ("soluble EGFP" 2) ("enhanced Green Fluorescent Protein" 2)
   ("CAV1–monomeric EGFP" 2) ("Enhanced Green Fluorescent Protein (GFP)" 2)
   ("-enhanced green fluorescent protein" 2) ("functional EGFP" 1)
   ("“cyclin A1-pCMS-EGFP”" 1) ("“pCMS-EGFP”" 1)
   ("a LEF-1/TCF-responsive promoter upstream d2-eGFP" 1) ("FUGW" 1)
   ("Each lentiviral vector coexpressed EGFP" 1) ("either soluble EGFP" 1)
   ("than the EGFP" 1)
   ("enhanced green
                        fluorescent protein (EGFP)"
    1)
   ("enhanced green
                        fluorescent protein"
    1)
   ("minimal EGFP" 1) ("exogenous EGFP-" 1) ("the control soluble EGFP" 1)
   ("EGFP (siEGFP) using DharmaFECT transfection reagent according the manufacturer's"
    1)
   ("a transgenic line expressing both the EGFP" 1)
   ("confusing extrinsic eGFP" 1) ("fortuitously targets EGFP" 1)))
 ("UP:C5P3T4" (("metalloproteinase 7" 1)))
 ("UP:C5PE62" (("metalloproteinase 2" 8)))
 ("UP:C6FX96"
  (("18h" 63) ("envelope glycoprotein gp160" 4) ("approximately 18h" 1)))
 ("UP:C6HFQ7" (("Sho1" 1))) ("UP:C6Y4C2" (("SPO2" 2)))
 ("UP:C6Y4C5" (("ECL2" 6)))
 ("UP:C7LYP8"
  (("PrCa" 743) ("PRCA" 65) ("metastatic PrCa" 7) ("hereditary PRCA" 3)
   ("primary PrCa" 3) ("advanced metastatic PrCa" 2) ("targeted PrCa" 2)
   ("578 sporadic PRCA" 1) ("590 consecutive AJ PRCA" 1)
   ("castration-resistant PrCa (CRPC)" 1) ("mimic human aggressive PrCa" 1)
   ("publicly available human PrCa" 1)
   ("androgen-independent metastatic PrCa" 1) ("nearly 2000 PrCa" 1)
   ("radiation-sensitive PrCa" 1)))
 ("UP:C9JY79" (("β-spectrin" 6)))
 ("UP:C9K2Q3"
  (("GGs" 65) ("GGS" 63) ("pediatric GGs" 3) ("Pediatric brainstem GGs" 2)
   ("non-brainstem (45%) pediatric GGs" 1) ("most GGs" 1)
   ("14/31 pediatric GGs" 1) ("pediatric brainstem GGs" 1)
   ("collective GGs" 1)))
 ("UP:D0ZRB2" (("SLRP" 4)))
 ("UP:D1FP53"
  (("Lin" 636) ("lin" 104) ("LIN" 20) ("Lin-" 9) ("lin-" 6)
   ("Ly5.1 + normal Lin" 1) ("the primitive Lin" 1) ("Lin−" 1)
   ("We first sorted Lin" 1) ("more Lin" 1) ("donor-derived Lin" 1) ("lin−" 1)
   ("the Lin's" 1) ("the more primitive subsets Lin" 1) ("primitive Lin" 1)
   ("primitive GFP + Lin" 1)
   ("BCR-ABL-Blk-expressing (transduced with the BCR-ABL - GFP or BCR-ABL - Blk - GFP , respectively) GFP + Lin"
    1)
   ("LiN" 1)))
 ("UP:D1KF50"
  (("Srs2" 151) ("srs2" 6) ("SRS2" 5) ("than Srs2" 1) ("than yeast Srs2" 1)))
 ("UP:D2D3P4" (("Rab27a" 35) ("RAb27a" 1)))
 ("UP:D2IE15" (("K54" 12) ("at least K54" 1)))
 ("UP:D2IE16"
  (("K63" 1423) ("K63-" 47) ("-K63" 9) ("k63" 2) ("only lysine K63" 1)
   ("the diGly-linked K63 peptide" 1) ("K63 peptide" 1)
   ("resin-bound K63-" 1)))
 ("UP:D2KZ36" (("MHC class I antigen" 6) ("JMDP" 4)))
 ("UP:D2NZ73"
  (("Listeriolysin O" 5) ("LLO" 5) ("listeriolysin O" 2) ("listeriolysin" 1)))
 ("UP:D2XWF1" (("P286" 1))) ("UP:D2XYZ5" (("VP1 protein" 8) ("IMI" 2)))
 ("UP:D3JV05" (("MCL-2" 2) ("MCL2" 1) ("Mcl-2" 1)))
 ("UP:D3YVF0" (("AKAP150" 2)))
 ("UP:D4ADM6"
  (("alkaline" 305) ("Alkaline" 96) ("ALKALINE" 2)
   ("anti-rabbit AP (1 : 5000) alkaline" 1)))
 ("UP:D4GTL2" (("mSHs" 22))) ("UP:D4GUZ4" (("CyO" 5)))
 ("UP:D4GXZ3"
  (("pMD" 167) ("PMD" 18) ("PMDs" 8) ("Pmd" 6) ("envelope plasmid pMD2" 2)
   ("plasmids pMD2" 1) ("vectors pMD2" 1)
   ("vector psPAX2 and envelope plasmid pMD2" 1) ("the pMD2" 1)
   ("viral packaging vectors pMD2" 1)
   ("plasmid psPAX2 and envelope plasmid pMD2" 1) ("plasmid pMD2" 1)
   ("the envelope plasmid pMD2" 1) ("1.0μg pMD2" 1)))
 ("UP:D5IGG6"
  (("FDR" 1690) ("pFDR" 37) ("FDR-" 4) ("the actual FDR" 3)
   ("at least one FDR" 3) ("at least two affected FDR" 2) ("FDR (BH)" 2)
   ("a negligible average FDR" 2) ("the local FDR" 2)
   ("A highly conservative FDR" 2) ("the more conservative 1% Benjamini FDR" 1)
   ("than the IRF5/TNPO3 region multiple-family FDR (2.22×10 −4 )" 1)
   ("the global FDR" 1) ("an empirical FDR" 1)
   ("an empirical
FDR"
    1)
   ("had at least one additional FDR" 1) ("Construction-wide FDR" 1)
   ("an experiment-wide 84% FDR" 1) ("a study-wide 33% FDR" 1)
   ("a conservative FDR" 1) ("an acceptable FDR" 1) ("than FDR" 1)))
 ("UP:D6RGH6"
  (("MCI" 229) ("amnestic MCI" 8) ("non-amnestic MCI" 2) ("mild MCI" 1)
   ("fewer MCI" 1) ("amnestic (memory-affecting) MCI" 1) ("Amnestic MCI" 1)
   ("“MCI”" 1) ("MCI (EMCI)" 1)))
 ("UP:D7UQM5" (("AUR" 46) ("\"UT-AUR\"" 1))) ("UP:D8KY57" (("SSP" 34)))
 ("UP:E1VBK2" (("TEAB" 21) ("consecutive 50% acetonitrile/50 mM TEAB" 2)))
 ("UP:E1VBK4" (("TEAD" 530) ("TEAD protein" 2) ("Tead" 2)))
 ("UP:E1XUJ2" (("LDI" 11)))
 ("UP:E2ERX5" (("Y28" 21) ("Latent membrane protein 2A" 4)))
 ("UP:E2RYF7"
  (("G 2" 1552) ("synchronous G 2" 2) ("profound G 2" 1) ("late S-and G 2" 1)
   ("G  2" 1) ("subsequent G 2" 1)))
 ("UP:E3SXU4" (("bHLH" 249) ("bHLH protein" 4))) ("UP:E5RQL4" (("Fong" 9)))
 ("UP:E9AFX2" (("IPCs" 35) ("Tbr2-positive IPCs" 1)))
 ("UP:E9Q7N4"
  (("diacylglycerol" 272) ("diacylglycerol (DAG)" 7) ("Diacylglycerol" 5)
   ("diacylglycerol (DAG), calcium," 1) ("diacylglycerol, calcium," 1)
   ("‘diacylglycerol’" 1)))
 ("UP:E9QYP0" (("SidA" 2)))
 ("UP:F1CKJ1" (("SSS" 127) ("Sss" 38) ("SSs" 19) ("apical SSS" 2) ("SSS-" 1)))
 ("UP:F1MMS9" (("integrin-α3" 3)))
 ("UP:F1P167"
  (("chemokine" 1653) ("chemokines" 1527) ("Chemokine" 98) ("Chemokines" 77)
   ("inflammatory chemokines" 19) ("a pro-inflammatory chemokine" 6)
   ("a proinflammatory chemokine" 6) ("stromal-derived chemokines" 5)
   ("inflammatory chemokine" 4) ("IL-1β-induced pro-inflammatory chemokines" 4)
   ("pro-inflammatory chemokines" 4) ("chemokine (KC)" 4)
   ("homeostatic chemokines" 4) ("a key chemokine" 3)
   ("this neurotoxic chemokine" 3) ("the neurotoxic chemokine" 3)
   ("chemokine-" 3) ("proinflammatory chemokines" 3)
   ("a multifunctional chemokine" 2) ("atherosclerotic chemokines" 2)
   ("a major chemokine" 2) ("a natural chemokine" 2)
   ("the inflammatory chemokines" 2) ("the neurotoxic chemokines" 2)
   ("soluble chemokines" 2) ("a neurotoxic chemokine" 2) ("viral chemokines" 2)
   ("the key chemokines" 2) ("a major pro-inflammatory chemokine" 2)
   ("a strong chemokine" 2) ("the CXCL8-orthologous murine chemokine" 2)
   ("a given chemokine" 1) ("than one chemokine" 1)
   ("some proinflammatory chemokines" 1) ("the key chemokine" 1)
   ("the first chemokines found in the brain" 1)
   ("pro-atherogenic chemokines" 1) ("the CXCR4–CXCR7-unrelated chemokine" 1)
   ("these stromal-derived chemokines" 1) ("the stromal-derived chemokine" 1)
   ("stromal-derived chemokine" 1) ("stromal chemokines" 1)
   ("numerous proinflammatory chemokines" 1)
   ("two pro-inflammatory chemokines" 1)
   ("hypoxia induced inflammatory chemokines" 1) ("a soluble chemokine" 1)
   ("apical chemokine" 1) ("\"chemokine\"" 1) ("a few chemokines" 1)
   ("chemokines called angiogenic chemokines" 1) ("Inflammatory chemokines" 1)
   ("M1 pro-inflammatory chemokines" 1) ("the potent chemotactic chemokine" 1)
   ("these viral chemokines" 1) ("a known proinflammatory chemokine" 1)
   ("several pro-inflammatory chemokines" 1) ("possibly other chemokines" 1)
   ("an inflammatory chemokine" 1) ("pro-apoptotic chemokines" 1)
   ("a pleiotropic chemokine" 1) ("the pro-inflammatory chemokine" 1)
   ("intact (+) chemokines" 1) ("the surface-bound chemokine" 1)
   ("a prototypic chemokine" 1) ("this prototypic chemokine" 1)
   ("the other principal PCa-associated chemokines" 1)
   ("three principal chemokines" 1) ("a structurally unique chemokine" 1)
   ("these inflammatory chemokines" 1)))
 ("UP:F1REV3" (("Santa" 15685) ("santa" 4) ("-Santa" 1)))
 ("UP:F2Z266" (("BEL" 59) ("Bel" 16) ("bel" 2))) ("UP:F4DAE8" (("RMF" 11)))
 ("UP:F4HTM3" (("MUC" 9) ("muc" 6) ("pMUC" 3) ("MUC molecule" 2)))
 ("UP:F4HVW5"
  (("Vad1" 41) ("VAD1" 18) ("vad1" 4) ("-Vad1" 1)
   ("the RCK yeast cryptococcal member Vad1" 1)))
 ("UP:F4I096"
  (("GCT" 930) ("-GCT" 57) ("GCT-" 8) ("their granulosa cells developed GCT" 2)
   ("ovarian GCT" 1) ("metastasized GCT" 1) ("inoperable stage IIIc GCT" 1)))
 ("UP:F4I4K5" (("LPR1" 1))) ("UP:F4I507" (("VIIIa" 11)))
 ("UP:F4I5Q6" (("XIa" 2))) ("UP:F4I907" (("GR2" 4)))
 ("UP:F4IBV4" (("glycosyltransferase" 52)))
 ("UP:F4IMQ0"
  (("FLX" 145) ("flx" 46) ("FLx" 3) ("massively parallel 454 FLX" 2)
   ("only 454 FLX" 2) ("Flx" 1)))
 ("UP:F4IV99" (("chr5" 41) ("Chr5" 10))) ("UP:F4IW47" (("TKL2" 9)))
 ("UP:F4IYM4" (("dex1" 1))) ("UP:F4IZC5" (("CAN1" 13) ("can1" 5)))
 ("UP:F4J2K2" (("DFC" 63) ("the nucleolar DFC" 1)))
 ("UP:F4J9M5" (("chr12" 9) ("Chr12" 4))) ("UP:F4JQZ3" (("Ren1" 6)))
 ("UP:F4JYZ8" (("Idd13" 1)))
 ("UP:F4K0C4"
  (("club" 11) ("Club" 8) ("Midosuji Rotary Club" 2) ("“club”" 1)
   ("the Spanish Urological Club" 1) ("the Rotary Club" 1)))
 ("UP:F4K2A1" (("DFB" 1))) ("UP:F5H9G3" (("K11" 93) ("k11" 4)))
 ("UP:F5HCM1" (("UL123" 6) ("pUL123" 3))) ("UP:F5HDD3" (("US7" 20)))
 ("UP:F5HEZ4" (("vFLIPs" 3)))
 ("UP:F5HF62"
  (("US28" 41) ("US28 protein" 9) ("The viral US28 protein" 2) ("US-28" 1)))
 ("UP:F5HF68"
  (("vIRF-1" 143) ("vIRF1" 3)
   ("Kaposi sarcoma associated herpesvirus (KSHV) vIRF1" 2)
   ("glutathione-S-transferase (GST)-fused bacterially-derived recombinant vIRF-1"
    1)))
 ("UP:F5HFA5"
  (("pUL117" 148) ("UL117" 23)
   ("pUL117, a novel viral protein that we recently identified," 1)
   ("pUL117, a viral protein that we recently identified," 1)))
 ("UP:F5HGC2" (("UL30" 24))) ("UP:F5HGQ8" (("UL138" 1)))
 ("UP:F5HHZ3" (("UL42" 1))) ("UP:F5HIC6" (("vIRF3" 7)))
 ("UP:F6IBC7" (("CARD" 293))) ("UP:F6M8H7" (("STpS" 1)))
 ("UP:F6M8I0" (("MTPS" 1))) ("UP:G0WXL9" (("cSH" 8) ("CsH" 6) ("CSh" 2)))
 ("UP:G3CCC1" (("NTABs" 1))) ("UP:G3FA30" (("K56" 302)))
 ("UP:G3FA67" (("K33" 77) ("k33" 3) ("The basic residues K33" 1)))
 ("UP:G3FNQ9" (("pII" 51) ("PII" 45))) ("UP:G3GBK0" (("COs" 1)))
 ("UP:G3GCR0" (("S130" 104))) ("UP:G3GCV8" (("S178" 9)))
 ("UP:G3LTJ9"
  (("LSCs" 355) ("the largely quiescent LSCs" 3) ("we first isolated LSCs" 2)
   ("IKK inhibition negatively impacts LSCs" 1) ("Confluent LSCs" 1)
   ("the dormant LSCs" 1) ("largely quiescent LSCs" 1)
   ("BCR-ABL/Blk-expressing LSCs" 1) ("significantly fewer LSCs" 1)
   ("STAT5 deficiency drives more LSCs" 1)))
 ("UP:G3V7P1" (("Syntaxin 13" 1)))
 ("UP:G5EDB9" (("Rap guanine nucleotide exchange factor" 3) ("RAGEF" 1)))
 ("UP:G5EGD2"
  (("hypoxia-inducible factor 1" 79) ("hypoxia inducible factor-1" 33)
   ("hypoxia inducible factor 1" 31) ("Hypoxia-inducible factor 1" 25)
   ("Hypoxia inducible factor-1" 10) ("Hypoxia inducible factor 1" 9)
   ("hypoxia-induced factor-1" 5) ("hypoxia induced factor 1" 3)
   ("Hypoxia-induced factor-1" 2) ("Hypoxia inducible factor -1" 2)))
 ("UP:H2KZM6" (("Clr-1" 1) ("CLR-1" 1))) ("UP:H3JQW0" (("MO2" 11)))
 ("UP:H8ZPX2" (("SAPD" 12) ("the fluorescent phorbol ester SAPD" 1)))
 ("UP:H9IWW7" (("Shu" 25) ("SHU" 1))) ("UP:H9T8G7" (("cdII" 3)))
 ("UP:I3L0S3" (("Pycard" 14))) ("UP:I6V1W0" (("BMB" 14)))
 ("UP:J3F2B0" (("Cas9" 93) ("CAS9" 3) ("cas9" 1) ("CAS9-" 1)))
 ("UP:J3S836" (("VF" 94) ("earliest available reliable VF" 1) ("Vf" 1)))
 ("UP:J3SDX8" (("LAL" 19)))
 ("UP:K1SWR3"
  (("chaperones" 978) ("Chaperones" 21) ("cellular chaperones" 5)
   ("most canonical chaperones" 2) ("Paralogous chaperones" 2)
   ("the canonical chaperones" 2)
   ("various chemical and pharmacological chaperones" 2)
   ("homologous histone chaperones" 2) ("more classical chaperones" 2)
   ("stress-inducible chaperones" 2) ("alternative chaperones" 2)
   ("possibly other chaperones" 1) ("so many chaperones" 1)
   ("ER xref -resident chaperones" 1) ("applicable chaperones" 1)
   ("perinuclear 4ICD chaperones" 1) ("-chaperones" 1)
   ("major cellular chaperones" 1)
   ("these chaperones, heat shock protein 27 (Hsp27)" 1)
   ("controls all stress-inducible chaperones" 1)
   ("ER resident protein chaperones" 1) ("Key chaperones" 1)))
 ("UP:K1V7I5" (("Tfx" 10) ("employing Tfx" 1) ("TFX" 1)))
 ("UP:K9NBS6"
  (("AAM" 21) ("post-menopausal AAM" 1)
   ("xref (upper panel) pre-menopausal ER (−) AAM" 1)
   ("pre- post-menopausal (ER−) AAM" 1)))
 ("UP:L0GCW2" (("Scl2" 6))) ("UP:M0QXZ8" (("elegans" 102)))
 ("UP:O00115" (("DNL" 14))) ("UP:O00116" (("AGPS" 1)))
 ("UP:O00124" (("UBXN8" 1)))
 ("UP:O00139"
  (("KIF2A" 68) ("kinesin-2" 8) ("Kif2a" 6) ("KIF2 protein" 3)
   ("KIF2A protein" 3) ("KIF2" 2) ("kinesin 2" 1)))
 ("UP:O00141"
  (("SGK1" 338) ("SGK" 158) ("SGK-1" 69) ("regulated kinase" 63) ("p-SGK1" 15)
   ("serum/glucocorticoid regulated kinase 1" 13) ("regulated kinase 1" 12)
   ("Sgk1" 12) ("serum/glucocorticoid-regulated kinase 1" 5)
   ("aberrant SGK1" 4) ("SGK1 protein" 3) ("overexpressed full-length SGK1" 3)
   ("-regulated kinase (MAPKKK)" 3) ("the p53-responsive prosurvival SGK1" 2)
   ("the well-described mTORC2 effector SGK1" 2)
   ("the established GR transcriptional target serum/glucocorticoid regulated kinase 1"
    2)
   ("sgk1" 2) ("the GR-regulated prosurvival gene SGK1" 1)
   ("the 22Rv1 xenografts expressed much less SGK1" 1) ("the aberrant SGK1" 1)
   ("the exon11-lacking aberrant SGK1" 1) ("pSGK" 1)
   ("extra-cellular regulated kinase" 1) ("-regulated kinase" 1)))
 ("UP:O00142" (("TK2" 51) ("SCA31" 1)))
 ("UP:O00144" (("FZD3" 4) ("Fzd9" 1) ("Frizzled 9" 1) ("FZD9" 1)))
 ("UP:O00148" (("49 kDa" 4) ("DDX39" 4) ("URH49" 1)))
 ("UP:O00151"
  (("PDLIM1" 64) ("CLP-36" 4) ("hCLIM1" 2) ("PDLIM1 protein" 2)
   ("Given PDLIM1’s" 1) ("Given PDLIM1" 1)
   ("the cytoskeleton-associated protein PDLIM1" 1)))
 ("UP:O00154" (("Bach" 6) ("BACH" 6))) ("UP:O00159" (("Myo1c" 3)))
 ("UP:O00161" (("SNAP-23" 31) ("SNAP23" 6)))
 ("UP:O00165"
  (("Hax1" 156) ("HAX1" 85) ("HAX1-" 2) ("HCLS1-associated protein X-1" 2)
   ("Hax-1" 1) ("the N-terminal 113 amino acids of Hax1" 1)
   ("the N-terminal 113 amino acids of Hax1 (GFP–Hax1 1–113)" 1) ("HAX-1" 1)))
 ("UP:O00167"
  (("EYA2" 166) ("EYA2 protein" 36) ("EAB1" 13) ("overexpressed EYA2" 2)
   ("slightly more EYA2 protein" 2) ("EAB1 peptide" 2)
   ("the pro-mitotic EYA2 molecule" 1) ("EYA2 molecule" 1)
   ("less EYA2 protein" 1)))
 ("UP:O00168" (("phospholemman" 2) ("PLM" 2)))
 ("UP:O00170"
  (("XAP2" 187) ("AiP" 141) ("AIP" 69) ("‘genuine’ AiP" 10) ("XAP2 protein" 9)
   ("pAIP" 2) ("no functional XAP2" 2) ("even more AiP" 1)
   ("‘genuine’ (p35-independent) AiP" 1) ("the ‘genuine’ AiP" 1)))
 ("UP:O00175" (("Eotaxin-2" 1)))
 ("UP:O00178" (("GP1" 9) ("surface-bound protein GP1" 1) ("gp1" 1) ("Gp1" 1)))
 ("UP:O00180" (("KCNK1" 9) ("Kcnk1" 9) ("subfamily K" 1)))
 ("UP:O00182"
  (("Gal-9" 175) ("galectin-9" 40) ("LGALS9" 37) ("Galectin-9" 5)
   ("Gal-9 protein" 2) ("exogenous recombinant LGALS9" 2) ("galectin 9" 1)))
 ("UP:O00187" (("MASP2" 2))) ("UP:O00189" (("Mu4" 3)))
 ("UP:O00192"
  (("ARVCF" 5)
   ("armadillo repeat gene deleted in velocardiofacial syndrome" 1)))
 ("UP:O00194" (("RAB27B" 9) ("Rab27b" 2) ("RaB27B" 1)))
 ("UP:O00198" (("Hrk" 54) ("DP5" 49) ("HRK" 25) ("Hrk peptide" 6)))
 ("UP:O00204" (("2B1" 11)))
 ("UP:O00206"
  (("TLR4" 1605) ("TLR-4" 152) ("Toll-like receptor 4" 55)
   ("toll-like receptor 4" 36) ("TLR4-" 7) ("toll-like receptor-4" 6)
   ("Toll-like receptor-4" 5) ("overexpressed TLR4" 4) ("Tlr4" 3)
   ("TLR4 molecule" 2) ("stromal TLR4" 2) ("toll like receptor 4" 2)
   ("Toll-like Receptor 4" 2) ("the abnormal TLR4" 2)
   ("toll like receptor-4" 1) ("TLR-4-" 1) ("relatively little TLR4" 1)
   ("TGX-221 increased TLR4-" 1) ("CD284" 1)))
 ("UP:O00212" (("Rhod" 82) ("RhoD" 56) ("ARHD" 3)))
 ("UP:O00213"
  (("FE65" 168) ("family B" 18) ("Family B" 10) ("Fe65" 4) ("RIR" 2) ("RIRs" 1)
   ("the exogenous FE65" 1)))
 ("UP:O00214" (("LGALS8" 2) ("galectin-8" 1))) ("UP:O00217" (("NDUFS8" 1)))
 ("UP:O00219" (("HAS3" 85)))
 ("UP:O00220"
  (("DR4" 652) ("TRAIL-R1" 301) ("TRAILR1" 29) ("TRAIL receptor 1" 23)
   ("death receptor 4" 19) ("TNFRSF10A" 17) ("APO 2" 7) ("DR4 protein" 5)
   ("member 10a" 4) ("TRAIL-R1-" 2) ("Death Receptor 4" 2)
   ("the pro-apoptotic TRAIL receptors DR4" 2) ("-TRAIL-R1" 2) ("than DR4" 1)
   ("Trail-R1" 1) ("Apo 2" 1) ("DR4-" 1)
   ("APO
                        2"
    1)
   ("more TRAIL-R1" 1) ("soluble TRAIL-R1" 1)
   ("recombinant soluble TRAIL-R1" 1)))
 ("UP:O00221"
  (("NFKBIE" 102) ("IκBε" 69) ("IkappaBepsilon protein" 3) ("IκBε molecule" 3)
   ("ikbe" 3) ("IkappaBepsilon" 2) ("IkBε" 1)))
 ("UP:O00222" (("mGluR8" 1) ("GRM8" 1))) ("UP:O00230" (("CORT" 24)))
 ("UP:O00231" (("PSMD11" 10))) ("UP:O00232" (("PSMD12" 2) ("Psmd12" 1)))
 ("UP:O00233" (("PSMD9" 9)))
 ("UP:O00238"
  (("BMPR-IB" 133) ("BMPR-1B" 10) ("BMPR1B" 10) ("–BMPR-IB" 7) ("BMPRIB" 2)
   ("Bmpr-Ib" 1) ("Bmpr1b" 1) ("BMPR-IB protein" 1)))
 ("UP:O00244" (("ATOX1" 15) ("Atox1" 1)))
 ("UP:O00253"
  (("ART" 201) ("AGRP" 19) ("AgRP" 11) ("suppressive ART" 3)
   ("efficient ART" 1)))
 ("UP:O00254"
  (("PAR3" 291) ("Par3" 132) ("pAR3" 12) ("PAR3 protein" 6)
   ("the strong PAR3" 2) ("the strong and aberrant PAR3" 1)
   ("correctly positioning PAR3" 1) ("Par3–" 1) ("PAR3 (SSAA)" 1)
   ("than PAR3 ( xref )" 1) ("par3" 1)))
 ("UP:O00255"
  (("MEN1" 293) ("Men1" 125) ("MEN1-" 7) ("SCG2" 1) ("highly frequent MEN1" 1)
   ("Men1-" 1)))
 ("UP:O00257" (("PC2" 64) ("PC-2" 23) ("CBX4" 10) ("Cbx4" 3) (NIL 2)))
 ("UP:O00264" (("MPR" 44) ("MPRs" 2) ("MpR" 2)))
 ("UP:O00267"
  (("Spt5" 55) ("DSIF" 50) ("SPT5" 18) ("hSpt5" 4) ("-Spt5" 2) ("SUPT5H" 1)))
 ("UP:O00268" (("TAF4" 6) ("130kD" 2)))
 ("UP:O00270"
  (("Ten14" 31) ("monomeric ten14" 2) ("than the predimerized Ten14" 1)
   ("ten14" 1)))
 ("UP:O00273"
  (("ICAD" 115) ("DFFA" 63) ("Ser-315" 51) ("DFF45" 46) ("inhibitor of CAD" 11)
   ("DNA fragmentation factor-45" 3) ("particular DFFA" 1)
   ("noncleavable ICAD" 1) ("control cells showed no cleaved ICAD" 1)))
 ("UP:O00291"
  (("HIP1" 367) ("Huntingtin interacting protein 1" 6)
   ("huntingtin interacting protein 1" 2)
   ("the endocytic oncoprotein Huntingtin interacting protein 1" 2)
   ("than wild-type HIP1 under conditions of androgen stimulation ( xref A)" 1)
   ("the previously described carboxy-terminal HIP1" 1)))
 ("UP:O00292" (("Lefty2" 6) ("LEFTY2" 3))) ("UP:O00299" (("CLIC1" 13)))
 ("UP:O00300"
  (("OPG" 125) ("osteoprotegerin" 35) ("TNFRSF11B" 35) ("11b" 24) ("Opg" 8)
   ("Osteoprotegerin" 8) ("NF1-associated OPG" 2) ("osteoprotegerin (OPG)" 2)
   ("the osteoblast-derived soluble Rankl decoy receptor Osteoprotegerin" 2)
   ("A symptomatic OPG" 1) ("an asymptomatic OPG" 1) ("a symptomatic OPG" 1)
   ("the most OPG" 1) ("EGF produced more osteoprotegerin (OPG)" 1)
   ("the soluble decoy receptor osteoprotegerin" 1)
   ("osteoprotegerin ( OPG )" 1) ("osteoclastogenesis inhibitory factor" 1)
   ("the TRAIL-binding soluble decoy receptor OPG" 1)))
 ("UP:O00303"
  (("47kDa" 13) ("eIF3f" 5) ("47kDa protein" 2) ("EIF3S5" 1) ("EIF3F" 1)
   ("eIF3ε" 1)))
 ("UP:O00305" (("CACNB4" 2)))
 ("UP:O00308"
  (("WWP2" 775) ("WW domain containing E3 ubiquitin protein ligase 2" 5)
   ("monomeric WWP2" 4) ("Retroviral-based WWP2" 2) ("AIP2" 1)
   ("heterodimeric WWP2" 1) ("cellular WWP2" 1) ("-WWP2" 1)
   ("flag-tagged WWP2" 1) ("WWP2-" 1) ("HA–Flag–tagged WWP2" 1)
   ("intact WWP2" 1) ("expressing WWP2" 1)))
 ("UP:O00311"
  (("Cdc7" 47) ("CDC7" 20) ("cdc7" 14) ("cell division cycle 7" 3)))
 ("UP:O00321" (("ETV2" 1)))
 ("UP:O00327"
  (("BMAL1" 223) ("ARNTL" 92) ("Bmal1" 54) ("T-ICs" 19) ("BMAL1 ( ARNTL )" 2)
   ("weakening BMAL1's" 1) ("the TAZ driven BC T-ICs" 1)
   ("selectively targets TAZ-induced T-ICs" 1) ("selectively targets T-ICs" 1)
   ("Mop3" 1) ("the circadian core component ARNTL" 1)))
 ("UP:O00329"
  (("p110δ" 698) ("PIK3CD" 233) ("anti-IgM" 213) ("PI3Kδ" 132)
   ("p110δ protein" 22) ("Pik3cd" 17) ("p110δ-" 6) ("PI3-Kδ" 6) ("anti–IgM" 5)
   ("PI3-K-delta" 4) ("soluble anti-IgM" 3) ("p110δ molecule" 3) ("Anti-IgM" 2)
   ("p110delta" 2) ("PI3K-delta" 2) ("PI3K-δ" 2) ("maximal anti-IgM" 1)
   ("the class I A PI3K isoform p110δ" 1)
   ("a healthy control subject and immunoprecipitated p110δ" 1)
   ("soluble or immobilized anti-IgM" 1) ("soluble and immobilized anti-IgM" 1)
   ("than p110δ ( xref )" 1) ("further implicated p110δ" 1)
   ("the only well described p110δ molecule" 1)
   ("the hematopoietic-selective isoform p110δ" 1)))
 ("UP:O00330" (("PDHX" 11) ("MODY4" 2) ("IDX1" 2) ("E3bp" 1) ("Prox" 1)))
 ("UP:O00337" (("hCNT1" 24) ("HCNT1" 1)))
 ("UP:O00339" (("MATN2" 3) ("matrilin-2" 2)))
 ("UP:O00358"
  (("FOXE1" 181) ("forkhead box E1" 5) ("FOXE1 protein" 2)
   ("Thyroid Transcription Factor 2" 2) ("FoxE1" 1)))
 ("UP:O00370"
  (("reverse transcriptase" 2953) ("endonuclease" 1010)
   ("Reverse Transcriptase" 962) ("Reverse transcriptase" 180) ("ORF2p" 118)
   ("reverse-transcriptase" 80) ("reverse transcriptase (RT)" 25)
   ("Reverse-transcriptase" 20) ("Endonuclease" 14)
   ("Reverse-Transcriptase" 10) ("endonuclease (APE)" 8)
   ("SuperScript® III Reverse Transcriptase" 8)
   ("Reverse Transcriptase (RT)" 5) ("endonuclease (UVDE)" 4)
   ("a structure-specific endonuclease" 4)
   ("SuperScript™ III reverse transcriptase" 4)
   ("the viral reverse transcriptase" 4) ("reverse transcriptase (TERT)" 4)
   ("a latent endonuclease" 4) ("SuperTranscript™ III Reverse Transcriptase" 4)
   ("-endonuclease" 3) ("Reverse transcriptase-" 3)
   ("reverse transcriptase protein" 3)
   ("SuperScript™ II reverse transcriptase" 3) ("endonuclease (APEX)" 3)
   ("reverse transcriptase peptide" 3) ("reverse transcriptase (INVITROGEN)" 3)
   ("the SuperScript® II Reverse Transcriptase" 2)
   ("another structure-specific endonuclease" 2)
   ("a previously published DNA endonuclease" 2)
   ("Superscript® III Reverse Transcriptase" 2)
   ("Quantitative Reverse-Transcriptase" 2) ("viral reverse transcriptase" 2)
   ("Superscript® III reverse transcriptase" 2) ("-reverse transcriptase" 2)
   ("reverse transcriptase (NEB)" 2)
   ("SuperScript TM II Reverse Transcriptase" 2)
   ("10 U Superscript™ III Reverse transcriptase" 2) ("even more ORF2p" 2)
   ("SuperScript® III Reverse transcriptase" 2)
   ("a thermostable restriction endonuclease" 2)
   ("a special cellular reverse transcriptase" 2)
   ("genotoxic stress-induced cytidine deaminase and LINE-1 repeat-encoded ORF2 endonuclease"
    2)
   ("the SuperScript™ II Reverse Transcriptase" 2)
   ("a specialized cellular reverse transcriptase (RT)" 2)
   ("a special reverse transcriptase" 2)
   ("Superscript II RNase H-negative reverse transcriptase" 2)
   ("reverse transcriptase (PROMEGA)" 2) ("Reverse Transcriptase-" 2)
   ("UVDE" 2)
   ("Reverse
transcriptase"
    1)
   ("than ORF2p ( xref and xref )" 1) ("endonuclease (EN)" 1)
   ("a major structure-specific endonuclease" 1)
   ("a placental poly-U endonuclease" 1)
   ("apurinic apyrimidinic endonuclease (APEX)" 1) ("reverse Transcriptase" 1)
   ("apurinic–apyrimidinic endonuclease" 1)
   ("Dual luciferase reporter assay kit and AMV Reverse Transcriptase" 1)
   ("a DNA structure–specific recombination endonuclease" 1)
   ("RNAsin, and Superscript II reverse transcriptase" 1)
   ("this multifunctional endonuclease" 1)
   ("Apurinic-apyrimidinic endonuclease" 1)
   ("murine myelogenous leukemia reverse transcriptase" 1)
   ("viral reverse transcriptase (RT)" 1)
   ("an inducible rare-cutting endonuclease" 1)
   ("diagnostic restriction endonuclease (RE)" 1) ("endonuclease (RE)" 1)
   ("reverse transcriptase ( TERT )" 1)
   ("the viral reverse transcriptase (RT)" 1) ("invitrogen" 1)
   ("a cellular reverse transcriptase" 1) ("reverse transcriptase–" 1)
   ("the UV damage endonuclease (UVDE)" 1)))
 ("UP:O00400" (("AT 1" 92) ("AT-1" 7)))
 ("UP:O00401"
  (("N-WASP" 323) ("N-WASp" 73) ("NWASP" 36) ("VCA" 18) ("p-NWASP" 6)
   ("IcsA" 6) ("N-Wasp" 4) ("N-WASP protein" 3) ("N-WASp molecule" 3)
   ("N-WASP-" 3) ("Neural Wiskott-Aldrich syndrome protein" 2) ("WASL" 2)))
 ("UP:O00410" (("IMP5" 4) ("importin-5" 2) ("RanBP5" 2) ("IPO5" 1)))
 ("UP:O00411" (("POLRMT" 2)))
 ("UP:O00418"
  (("EEF2K" 228) ("eEF2K" 87) ("eef2k" 1) ("Eef2k" 1) ("peEF2K" 1)
   ("eEF-2K" 1)))
 ("UP:O00421" (("CRAM" 1))) ("UP:O00422" (("SAP18" 89) ("-SAP18" 2)))
 ("UP:O00425" (("KOC" 12) ("IGF2BP3" 11) ("O00425" 1)))
 ("UP:O00429"
  (("DLP1" 99) ("DRP1" 84) ("dynamin-related protein 1" 10) ("HdynIV" 2)
   ("neither mitochondria-associated DRP1" 1)))
 ("UP:O00442"
  (("RPC" 82) ("RTCA" 79) ("mutation-positive RPC" 2)
   ("mutation-negative RPC" 1)))
 ("UP:O00443"
  (("PI3K-C2α" 221) ("PIK3C2A" 35) ("PI3KC2α" 4) ("endothelial PI3K-C2α" 1)))
 ("UP:O00444"
  (("HCT116" 7432) ("Plk4" 260) ("PLK4" 109) (NIL 68) ("SAK" 21) ("HCT116-" 10)
   ("p53-null HCT116" 9) ("Plk4 protein" 6) ("parental HCT116" 5)
   ("PLK4 protein" 4) ("the parental HCT116" 4) ("Polo-like kinase 4" 4)
   ("Nutlin 3-treated HCT116" 2)
   ("two isogenic human colon carcinoma cell lines HCT116" 2)
   ("isogenic colorectal carcinoma cell lines HCT116" 2)
   ("Nutlin-3-treated HCT116" 2) ("the p53 null HCT116" 2)
   ("the parental human colon carcinoma cell line HCT116" 2) ("−HCT116" 2)
   ("etoposide-treated HCT116" 2) ("isogenic HCT116" 1)
   ("our primary HCT116" 1) ("previously described drug-resistant HCT116" 1)
   ("CIMP-positive HCT116" 1) ("reovirus treated and untreated HCT116" 1)
   ("the parental p53+/+ colon cancer cell line HCT116" 1)
   ("thymidine-treated HCT116" 1) ("MYC-driven colon cancer line HCT116" 1)
   ("sphere-cultured colon carcinoma HCT116" 1)
   ("either mock-treated HCT116" 1) ("HCT116 (CRC)" 1)
   ("than the p53 null HCT116 ( TP53  -/- )" 1) ("than HCT116 (p53 − / − )" 1)
   ("the p53-positive HCT116" 1) ("CYL compound-treated HCT116" 1)
   ("isogenic cell lines HCT116" 1)
   ("the isogenic p53-null cell line HCT116" 1)
   ("The PIK3CA isogenic HCT116" 1) ("than HCT116" 1)
   ("the colorectal cell line HCT116" 1) ("p53-positive HCT116" 1) ("“SAK”" 1)
   ("the colorectal tumor cell line HCT116" 1) ("hPTTG1 -null HCT116" 1)
   ("both parental HCT116" 1) ("p53 parental and null HCT116" 1) ("HCt116" 1)
   ("HCT116Bax+Bak−" 1) ("human colon carcinoma parental HCT116" 1)
   ("Parental HCT116" 1) ("Isogenic p53+ and p53− HCT116" 1)))
 ("UP:O00445" (("synaptotagmin V" 2))) ("UP:O00451" (("GFRA2" 3) ("Gfra2" 1)))
 ("UP:O00453" (("LST1" 1))) ("UP:O00458" (("IFRD1" 3)))
 ("UP:O00459"
  (("p85β" 444) ("PIK3R2" 163) ("MPPH" 37) ("pik3R2" 9) ("Pik3r2" 4)
   ("both exogenous and endogenous p85β" 2) ("O00459" 1) ("p85beta" 1)
   ("pik3r2" 1) ("than wild-type p85β( xref )" 1) ("more p85β" 1)))
 ("UP:O00462" (("beta A" 4))) ("UP:O00463" (("TRAF5" 26)))
 ("UP:O00468"
  (("agrin" 44) ("Agrin" 4) ("neural agrin" 2) ("Neural agrin" 1)
   ("its arrival agrin" 1)))
 ("UP:O00469"
  (("PLOD2" 29) ("lysyl hydroxylase 2" 4) ("Plod2" 3)
   ("2-oxoglutarate 5-dioxygenase 2" 1)))
 ("UP:O00470"
  (("MEIS1" 268) ("Meis1" 27) ("meis1" 8) ("Meis-1" 5)
   ("showed hemi-methylated MEIS1" 1) ("MEIS1-" 1)))
 ("UP:O00471"
  (("Sec10" 188) ("EXOC5" 6) ("Sec10 peptide" 5)
   ("Exocyst complex component 5" 3) ("dominant-negative Sec10" 2)
   ("perinuclear Sec10" 2) ("dominant-inhibitory Sec10" 1) ("SEC10" 1)))
 ("UP:O00472"
  (("ELL2" 31) ("the transcriptional elongation factors ELL2" 3)
   ("more ELL2" 1)))
 ("UP:O00476" (("SLC17A3" 3))) ("UP:O00478" (("BTN3A3" 6)))
 ("UP:O00479" (("NHC" 12)))
 ("UP:O00482"
  (("LRH-1" 483) ("NR5A2" 60) ("CPF" 11) ("LRH1" 5)
   ("liver receptor homolog-1" 5) ("HB-1" 5) ("receptor homolog" 5) ("B1F" 4)
   ("liver receptor homolog 1" 4) ("Nr5a2" 3) ("LRH1-" 1) ("LRH-1 protein" 1)))
 ("UP:O00483" (("NDUFA4" 2)))
 ("UP:O00487"
  (("Poh1" 85) ("POH1" 48) ("PSMD14" 12) ("RPN11" 4) ("Psmd14" 4)
   ("proteasomal Poh1" 3) ("the proteasomal deubiquitinating enzyme Poh1" 2)
   ("proteasome-associated Poh1" 1) ("Pad1" 1)))
 ("UP:O00499"
  (("Amphiphysin II" 37) ("BIN1" 23) ("Bin1" 4) ("bridging integrator 1" 3)))
 ("UP:O00501" (("claudin 5" 7) ("Cldn5" 6) ("CLDN5" 4) ("Claudin 5" 1)))
 ("UP:O00505" (("Kpna3" 1)))
 ("UP:O00506"
  (("oxidant" 648) ("Oxidant" 13) ("STK25" 11) ("Ste20-like kinase" 7)
   ("YSK1" 2) ("SOK1" 2) ("serine/threonine kinase 25" 2)
   ("a strong oxidant" 1) ("oxidant-" 1) ("diet-derived oxidant" 1)))
 ("UP:O00512" (("BCL9" 282) ("BCL-9" 6) ("Legless" 2) ("Bcl-9" 1) ("Bcl9" 1)))
 ("UP:O00515" (("LAD-I" 5) ("LADA" 3) ("ladinin 1" 3) ("LAD1" 2) ("Lad1" 1)))
 ("UP:O00519"
  (("fatty acid amide hydrolase" 5) ("FAAH" 3)
   ("epithelial fatty acid amide hydrolase" 1)))
 ("UP:O00522"
  (("KRIT1" 34) ("krit1" 11) ("CCM1" 7) ("Krit1" 6) ("KRIT1 protein" 2)))
 ("UP:O00526" (("Uroplakin II" 1)))
 ("UP:O00533"
  (("call" 1139) ("CHL1" 18) ("Call" 16) ("the automatic call" 2)
   ("an absolute call" 1) ("correct call" 1) ("CALL" 1)
   ("marginal (M) detection call" 1) ("an absent call" 1) ("cALL" 1)
   ("an equivocal call" 1) ("a heterozygous copy-number deletion call" 1)
   ("a statistically significant absolute call" 1)))
 ("UP:O00541"
  (("PES1" 209) ("Pes1" 9) ("PES1 protein" 2)
   ("lymph nodes showed positive PES1" 2)))
 ("UP:O00548"
  (("delta" 475) ("Delta" 203) ("DLL1" 88) ("DLL" 77) ("DLL-" 37)
   ("Delta 1" 23) ("Dll" 21) ("Dll1" 17) ("DELTA" 9) ("delta 1" 7) ("δ-1" 5)
   ("hDelta1" 5) ("the lentiviral packaging plasmid delta" 4) ("dll" 3)
   ("-Delta" 3) ("delTA" 3) ("Delta 1 ligand" 2) ("DLL-1" 2) ("−delta" 2)
   ("delta delta" 2) ("triple mutants PTAP- (PTAP/LTAL) PY-(PY/LS) DLL-" 2)
   ("a meaningful delta" 2) ("−Delta" 1) ("-delta" 1) ("‘DLL’" 1)))
 ("UP:O00555"
  (("calcium channel" 122) ("voltage-dependent" 54) ("CACNA1A" 54) ("SCA6" 13)
   ("voltage dependent" 6) ("EA2" 3) ("Calcium channel" 3)
   ("calcium channel peptide" 2) ("the pro-apoptotic TRPC6 calcium channel" 1)
   ("EA2 peptide" 1) ("the previous network included CACNA1A" 1)))
 ("UP:O00559" (("RCAS1" 54) ("EBAG9" 5)))
 ("UP:O00560" (("MDA-9" 95) ("mda-9" 31) ("syntenin-1" 7)))
 ("UP:O00562" (("NIR2-" 1) ("NIR2" 1))) ("UP:O00566" (("MPHOSPH10" 1)))
 ("UP:O00567" (("NOL5A" 5) ("Nol5a" 2) ("NOP56" 2)))
 ("UP:O00570"
  (("Sox1" 56) ("SOX1" 53) ("Neural markers Sox1" 2)
   ("the neural marker Sox1" 2) ("the early neural marker Sox1" 2) ("sox1" 1)))
 ("UP:O00571"
  (("DDX3X" 272) ("DDX3" 58) ("-DDX3X" 3) ("overexpressed DDX3X" 3)
   ("GS-TAP-tagged DDX3X" 1)))
 ("UP:O00574" (("CXCR6" 10)))
 ("UP:O00584" (("ribonuclease T2" 2) ("RNASET2" 2)))
 ("UP:O00585"
  (("CCL21" 104) ("SLC" 66) ("CCL21 protein" 2) ("ccl21" 1) ("ccL21" 1)))
 ("UP:O00587" (("MFNG" 1))) ("UP:O00590" (("CCR10" 3)))
 ("UP:O00592"
  (("PC" 3392) ("CRPC" 181) ("Pc" 65) ("metastatic PC" 24) ("podocalyxin" 24)
   ("PODXL" 23) ("aggressive PC" 13) ("primary PC" 9) ("pc" 7)
   ("ischemic PC" 7) ("more aggressive PC" 7) ("Podxl" 7)
   ("less aggressive PC" 5) ("pC" 4) ("PC-" 4) ("Podocalyxin" 4) ("pc-" 3)
   ("PC (CRPC)" 3) ("mirror primary PC" 2)
   ("termed castration-resistant PC (CRPC)" 2) ("spontaneous PC" 2)
   ("primary and metastatic PC" 2) ("the castration-resistant PC" 2)
   ("Metastatic PC" 2) ("hereditary PC" 2)
   ("more aggressive PC (mean=2.91 ± 6.7) or less aggressive PC" 2)
   ("The apical marker podocalyxin" 2)
   ("the apical transmembrane protein podocalyxin" 2)
   ("myocardial ischemic PC" 1) ("late ischemic PC" 1) ("Ischemic PC" 1)
   ("metastatic CRPC" 1) ("each successive PC" 1) ("other AR-expressing PC" 1)
   ("resectable PC" 1) ("the different available in vitro PC" 1) ("“PC”" 1)
   ("the apical marker podocalyxin" 1) ("lethal metastatic PC" 1)
   ("233,000 new PC" 1) ("Trp53 mutant primary and metastatic PC" 1)
   ("most PC" 1) ("malignant and metastatic PC" 1) ("More aggressive PC" 1)
   ("the top ten PC's" 1) ("non-BRCA associated PC" 1) ("developed PC" 1)
   ("primary malignant PC" 1) ("malignant PC" 1) ("normal PC" 1)
   ("operable PC" 1) ("the normal PC" 1) ("-CRPC" 1) ("164 primary PC" 1)
   ("Progressive PC" 1) ("exogenous 30∶0 PC" 1) ("the top 10 PC’s" 1)
   ("the first two PC’s" 1) ("the metastatic PC" 1)
   ("the apical protein podocalyxin" 1) ("invasive and metastatic PC" 1)
   ("recognizable cyclin D1+ PC" 1) ("previously identified cyclin D1+ PC" 1)
   ("orthotopic PC" 1)))
 ("UP:O00602" (("FCN1" 9) ("ficolin 1" 4)))
 ("UP:O00622" (("Cyr61" 83) ("CYR61" 75) ("IGFBP10" 2) ("cyr61" 1)))
 ("UP:O00623" (("PEX12" 2)))
 ("UP:O00625"
  (("PIR" 142) ("pirin" 28) ("Pirin" 4) ("PIR peptide" 3) ("Pir" 1) ("pir" 1)))
 ("UP:O00626"
  (("mDCs" 250) ("CCL22" 23) ("human primary mDCs" 9) ("MDCs" 3)
   ("macrophage-derived chemokine" 2) ("intestinal mDCs" 1)
   ("peptide-loaded autologous mDCs" 1)
   ("macrophage derived chemokine (MDC)" 1) ("macrophage derived chemokine" 1)
   ("macrophage-derived chemokine (MDC)" 1)
   ("staphylococcal enterotoxin superantigen (SEA)–pulsed mDCs" 1)))
 ("UP:O00629" (("KPNA4" 6)))
 ("UP:O00631"
  (("SLN" 104) ("metastatic SLN" 84) ("the metastatic SLN" 4)
   ("only one SLN" 1)))
 ("UP:O00635" (("TRIM38" 5)))
 ("UP:O00712"
  (("NFIB" 126) ("Nfib" 7) ("nuclear factor I/B" 4) ("Nuclear factor I/B" 1)))
 ("UP:O00716"
  (("E2F3" 893) ("E2f3" 64) ("E2F-3" 14) ("E2F3 protein" 4)
   ("conditional E2F3" 1) ("transcription factor E2F3" 1)
   ("miR-377 directly targets E2F3" 1)))
 ("UP:O00743"
  (("PP6" 145) ("PPP6C" 30) ("protein phosphatase 6" 8)
   ("serine/threonine protein phosphatase 6 catalytic subunit" 3) ("pP6" 2)
   ("Protein phosphatase 6" 1)))
 ("UP:O00744"
  (("Wnt10b" 96) ("WNT10B" 77) ("Wnt-10b" 12) ("-Wnt10b" 3) ("Wnt10B" 2)
   ("WNT-10B" 1) ("particular Wnt-10b" 1) ("WNT10B protein" 1)))
 ("UP:O00746"
  (("protein expressed in" 123) ("NME4" 69) ("non-metastatic cells 4" 2)
   ("NME4 molecule" 2) ("a soluble photoreceptor protein expressed in" 1)
   ("a ubiquitous cytoplasmic protein expressed in" 1) ("NME4 protein" 1)
   ("nm23-H4" 1) ("both exogenous ΔNp63α protein expressed in" 1)
   ("a unique protein expressed in" 1)
   ("a multifunctional protein expressed in" 1)))
 ("UP:O00748" (("ICE" 61) ("‘ICE’" 2) ("ICE-" 1) ("Ces-2" 1)))
 ("UP:O00750"
  (("PI3KC2β" 175) ("PIK3C2B" 67) ("PI3K-C2β" 65) ("PI3KC2β protein" 2)))
 ("UP:O00754" (("class 2B" 1)))
 ("UP:O00755"
  (("WNT7A" 222) ("Wnt7a" 6) ("Wnt7A" 5) ("WNT-7a" 3)
   ("serous adenocarcinomas expressed WNT7A" 1) ("Wnt-7a" 1)))
 ("UP:O00757" (("6-bisphosphatase" 1)))
 ("UP:O00762"
  (("UBE2C" 144) ("UBCH10" 143) ("Ube2C" 129) ("UbcH10" 66) ("-Ube2C" 26)
   ("UBE2C protein" 8) ("E2-C" 4) ("strong UBE2C" 2)
   ("ubiquitin-conjugating enzyme E2C" 2) ("Ube2c" 2)
   ("the first 27 amino acids of Ube2C" 1) ("UbcX" 1)))
 ("UP:O00763"
  (("ACC2" 210) ("ACACB" 194) ("Acacb" 16) ("ACC2 protein" 8) ("ACCB" 4)
   ("more ACC2" 2) ("than ACC2 in liver" 1) ("than ACC2" 1)
   ("than ACC2 in brain, prostate, and ovary" 1) ("biotin carboxylase" 1)
   ("ACACB–" 1)))
 ("UP:O00764" (("PKH" 22)))
 ("UP:O00767"
  (("SCD" 509) ("SCD-1" 153) ("SCD1" 148) ("SCDs" 19) ("SCD protein" 18)
   ("Scd" 8) ("Scds" 3) ("the lipogenic enzyme SCD" 2) ("SCD-1 protein" 2)
   ("included more heterogeneous SCD" 1) ("functional SCDs" 1)
   ("a given SCD" 1)
   ("than one SCD (Figure xref and Additional file xref : Table S1)" 1)))
 ("UP:O00910"
  (("Stata" 417) ("STATA" 381) ("stata" 3) ("The statistical software STATA" 2)
   ("the statistical software programme STATA" 1)
   ("statistical software Stata" 1) ("the Statistical package STATA" 1)
   ("the statistical software STATA" 1)))
 ("UP:O01352" (("DJ" 53) ("-DJ" 23))) ("UP:O01382" (("DrICE" 12) ("drICE" 6)))
 ("UP:O01391" (("uch" 25) ("Uch" 2)))
 ("UP:O01673"
  (("tropomyosin" 64) ("Tropomyosin" 4) ("tropomyosins" 3) ("Tropomyosins" 2)
   ("-tropomyosin" 1) ("tropomyosins (TPM)" 1)))
 ("UP:O01833" (("hIL-5" 1))) ("UP:O01991" (("p-eEF2k" 3) ("eEF2k" 1)))
 ("UP:O02019"
  (("RBP-Jκ" 22) ("RBPJκ" 8) ("targeted RBP-Jκ" 2) ("RBP-Jkappa" 2)
   ("RBPjκ" 1)))
 ("UP:O02373" (("SGL" 5)))
 ("UP:O02755"
  (("C/EBP-β" 132) ("C/EBP- β" 45)
   ("This particle-mediated phosphorylated C/EBP-β" 1) ("pC/EBP-β" 1)))
 ("UP:O02775" (("EBD" 60))) ("UP:O03978" (("DPH" 5)))
 ("UP:O03979" (("lysin" 10) ("-lysin" 6) ("Lysin" 2)))
 ("UP:O04151" (("CRT1" 4) ("the transcriptional repressor Crt1" 2) ("Crt1" 2)))
 ("UP:O04211" (("ARR19" 1))) ("UP:O04309" (("JR1" 1)))
 ("UP:O04425" (("FCA" 4))) ("UP:O04846" (("ACA1" 1)))
 ("UP:O05151" (("ETBF" 9))) ("UP:O05251" (("MaLR" 1)))
 ("UP:O05982"
  (("Cdk" 751) ("cdk" 361) ("Cdk-" 6) ("CdK" 6) ("mitotic Cdk" 3)
   ("cdk molecule" 2) ("a neuronal cdk" 2) ("an atypical cdk" 2)
   ("their relevant cdk" 1) ("both Cdk’s" 1) ("this transcriptional cdk" 1)))
 ("UP:O06865" (("AMPA" 98) ("-AMPA" 22) ("AMPA-" 3)))
 ("UP:O06949" (("SopE" 189) ("sopE" 12) ("the bacterial GEF SopE" 1)))
 ("UP:O07006" (("PADC" 1))) ("UP:O07008" (("LacR" 11) ("lacR" 4)))
 ("UP:O07009" (("CycB" 6) ("cycB" 2))) ("UP:O07366" (("MELB" 1)))
 ("UP:O07582"
  (("IgM" 966) ("sIgM" 51) ("IgM-" 8) ("sIgM−" 7) ("more IgM" 3)
   ("normal IgM" 2)
   ("secondary antibody Alexa Fluor 594 goat anti-mouse IgM" 2)
   ("the secondary antibody HRP (horseradish peroxidase)-conjugated rabbit anti-mouse IgM"
    2)
   ("IgM protein" 2) ("Mouse monoclonal IgM" 1) ("than IgM" 1) ("-IgM" 1)
   ("segmental IgM" 1)))
 ("UP:O07917" (("YRAL" 6)))
 ("UP:O08715"
  (("AKAP" 49) ("A-kinase anchor protein" 9) ("A-kinase anchoring protein" 6)
   ("a-kinase anchor protein" 3) ("Another nuclear matrix–associated AKAP" 2)
   ("centrosomal matrix A-kinase anchoring protein" 2) ("AKAP-" 2)
   ("A-kinase anchoring protein (AKAP)" 2) ("a bona fide AKAP" 1)))
 ("UP:O08747" (("RCM" 23) ("\"RCM\"" 1) ("dynamic RCM" 1)))
 ("UP:O08764" (("CCA-3" 118))) ("UP:O08782" (("Akr1b8" 2)))
 ("UP:O08900" (("Aiolos" 211) ("strong Aiolos" 2)))
 ("UP:O08919"
  (("NBL" 169) ("aggressive NBL" 3) ("hereditary NBL" 3)
   ("the International NBL" 2) ("sporadic NBL" 2) ("unfavorable NBL" 1)))
 ("UP:O08966" (("LX1" 9) ("LX-1" 7)))
 ("UP:O08976" (("probasin" 87) ("Probasin" 15) ("Pbsn" 5)))
 ("UP:O09029" (("beta-3" 3) ("beta3" 1))) ("UP:O09131" (("pGST-X" 1)))
 ("UP:O12976" (("PSα" 1))) ("UP:O13048" (("NR4" 4)))
 ("UP:O13065" (("COL4" 7) ("Col4" 2))) ("UP:O13127" (("Reg2" 3)))
 ("UP:O13146" (("EK1" 1))) ("UP:O13310" (("Orb6" 2) ("orb6" 2)))
 ("UP:O13329" (("FOB1" 18) ("Fob1" 14))) ("UP:O13849" (("cpY" 1)))
 ("UP:O14064" (("PbH1" 1))) ("UP:O14126" (("PAM2" 24)))
 ("UP:O14363" (("L10a" 1)))
 ("UP:O14368" (("Hsp16" 45) ("hsp16" 9) ("the archeal Hsp16" 4) ("HSP16" 2)))
 ("UP:O14490" (("GKAP" 10) ("DAP1" 6) ("DLGAP1" 2) ("dAP-1" 2) ("DAP-1" 1)))
 ("UP:O14492"
  (("APs" 39) ("ApS" 3) ("Nine displayed spontaneous APs" 1)
   ("typical cardiac-type APs" 1) ("estrogenic APs" 1)))
 ("UP:O14493"
  (("CLDN4" 129) ("claudin-4" 102) ("Cldn4" 28) ("claudin 4" 15) ("claudin4" 4)
   ("Claudin 4" 4) ("claudin-4 protein" 3) ("Claudin-4" 3) ("than CLDN4" 1)))
 ("UP:O14494" (("LPP1" 2) ("PPAP2A" 1)))
 ("UP:O14495"
  (("LPP3" 120) ("Lpp3" 6) ("LPP3 protein" 5) ("LPP3 Protein" 2) ("PPAP2B" 2)))
 ("UP:O14497"
  (("held" 636) ("ARID1A" 442) ("BAF250a" 63) ("BAF250A" 12)
   ("BAF250a protein" 8) ("SWI1" 5) ("Baf250" 5) ("BAF250a−" 5) ("Held" 4)
   ("BAF250" 3) ("pathological response and mutation status held" 2)
   ("ARID1A protein" 2) ("two heterologous proteins (p65 and p50) held" 2)
   ("ARID1a" 1) ("BAF250A protein" 1) ("ARID domain-containing protein 1A" 1)
   ("a three-turn β spiral held" 1) ("dry nitrogen vapor held" 1) ("hOsa1" 1)
   ("Arid1a" 1)))
 ("UP:O14498" (("ISLR" 4)))
 ("UP:O14503"
  (("chondrocytes" 2820) ("Chondrocytes" 65) ("normal chondrocytes" 29)
   ("hypertrophic chondrocytes" 24) ("DEC1" 19) ("class B" 13) ("SHARP-2" 13)
   ("BHLHE40" 11) ("Class B" 9) ("osteoarthritic chondrocytes" 8) ("BHLHB2" 8)
   ("primary chondrocytes" 5) ("late-hypertrophic chondrocytes" 5)
   ("proliferative chondrocytes" 5) ("newborn sternal chondrocytes" 5)
   ("sternal chondrocytes" 5) ("apoptotic chondrocytes" 5)
   ("prehypertrophic chondrocytes" 3) ("early-hypertrophic chondrocytes" 3)
   ("the hypertrophic chondrocytes" 3) ("basic helix-loop-helix family" 3)
   ("cultured human knee osteoarthritic chondrocytes" 2)
   ("than chondrocytes" 2) ("mild OA chondrocytes" 2)
   ("the normal chondrocytes" 2)
   ("enhancer-of-split and hairy-related protein 2" 2)
   ("Col2a1-Smurf2 transgenic sternal chondrocytes" 2)
   ("sternal murine chondrocytes" 2) ("arthritic articular chondrocytes" 2)
   ("other zonal articular chondrocytes" 2)
   ("anti-CD95 treated chondrocytes" 2) ("viable chondrocytes" 2)
   ("human fetal chondrocytes" 2) ("chondrocytes (ATCC)" 1)
   ("human primary chondrocytes" 1) ("CoPP-IX treated C-20/A4 chondrocytes" 1)
   ("than primary chondrocytes (Additional file xref : Figure S4)" 1)
   ("postnatal growth plate chondrocytes" 1) ("human normal chondrocytes" 1)
   ("Primary chondrocytes" 1) ("some hypertrophic chondrocytes" 1)
   ("IL-1 β -stimulated osteoarthritic chondrocytes" 1)
   ("dysfunctional chondrocytes" 1)
   ("proliferative and hypertrophic chondrocytes" 1)
   ("pre-hypertrophic and early-hypertrophic chondrocytes" 1)
   ("both mature and immature chondrocytes" 1)
   ("Both COLX-positive and COLX-negative chondrocytes" 1)
   ("COLX-positive chondrocytes" 1) ("late stage hypertrophic chondrocytes" 1)
   ("proliferative or hypertrophic chondrocytes" 1)
   ("terminally-differentiated chondrocytes" 1)
   ("osteoarthritic articular chondrocytes" 1) ("IGF2-treated chondrocytes" 1)
   ("IL-beta-treated chondrocytes" 1) ("Prehypertrophic chondrocytes" 1)
   ("Hypertrophic chondrocytes" 1) ("than normal chondrocytes [ xref ]" 1)
   ("senescent chondrocytes" 1) ("The senescent chondrocytes" 1)
   ("TGF-β-positive staining chondrocytes" 1)
   ("Only first passaged chondrocytes" 1) ("Confluent chondrocytes" 1)
   ("the pericelluar network around hypertrophic chondrocytes" 1)
   ("WT sternal chondrocytes" 1)
   ("MG132-treated murine sternal chondrocytes" 1)
   ("the Col2a1-Smurf2 transgenic sternal chondrocytes" 1)
   ("transgenic newborn sternal chondrocytes" 1)
   ("murine sternal chondrocytes" 1) ("Newborn sternal chondrocytes" 1)
   ("zonal articular chondrocytes" 1)
   ("terminally differentiated hypertrophic chondrocytes" 1)
   ("Pfn1-null chondrocytes" 1) ("osteoarthritic human chondrocytes" 1)
   ("normal and osteoarthritic chondrocytes" 1) ("healthy chondrocytes" 1)
   ("meniscal chondrocytes" 1) ("human osteoarthritic chondrocytes" 1)
   ("pre-hypertrophic and hypertrophic chondrocytes" 1)
   ("fewer Ihh-generating prehypertrophic chondrocytes" 1)
   ("post-mitotic chondrocytes" 1) ("early hypertrophic chondrocytes" 1)
   ("type X collagen expressing hypertrophic chondrocytes" 1)
   ("than nontransfected chondrocytes" 1) ("than ORA chondrocytes" 1)
   ("than the nontransfected chondrocytes" 1) ("Proliferative chondrocytes" 1)
   ("Dexa-treated chondrocytes" 1) ("tibial growth plate chondrocytes" 1)
   ("nearby chondrocytes" 1)))
 ("UP:O14508"
  (("SOCS2" 168) ("Socs2" 14) ("SOCS-2" 4) ("SOC-2" 2) ("SOCS2-" 1)
   ("than SOCS2 ( xref , xref )" 1) ("than SOCS2 suggesting the formation" 1)))
 ("UP:O14511" (("NRG2" 38) ("neuregulin 2" 7) ("neuregulin-2" 4) ("NRG-2" 1)))
 ("UP:O14512" (("SOCS7" 29) ("SOCS-7" 2))) ("UP:O14513" (("NCKAP5" 11)))
 ("UP:O14514" (("BAI1" 10) ("brain-specific angiogenesis inhibitor 1" 3)))
 ("UP:O14519"
  (("CDK2AP1" 191) ("DOC-1" 8) ("exogenous CDK2AP1" 2) ("Cdk2ap1" 1)))
 ("UP:O14520" (("AQP7" 9) ("aquaporin 7" 1)))
 ("UP:O14521" (("SDHD" 169) ("SDHD-" 4)))
 ("UP:O14522" (("PTPRT" 105) ("RPTPρ" 2) ("Rptpρ" 1)))
 ("UP:O14526" (("FCHO1" 26) ("FCHo1" 2) ("its close relative FCHO1" 1)))
 ("UP:O14543"
  (("SOCS3" 1774) ("SOCS-3" 352) ("SOCS3 protein" 42) ("Socs3" 37) ("SSI-3" 31)
   ("suppressor of cytokine signaling 3" 29)
   ("Suppressor of cytokine signaling 3" 8)
   ("suppressor of cytokine signaling-3" 8) ("socs3" 5) ("SOCS-3 protein" 4)
   ("Mouse monoclonal SOCS-3" 3) ("pSOCS3" 3) ("Cytokine Signaling-3" 3)
   ("Suppressor of cytokine signaling-3" 2) ("exogenous SOCS3" 2)
   ("suppressor of cytokine signaling-3 (SOCS-3) protein" 2) ("than SOCS3" 2)
   ("SOCS3-" 1) ("-Socs3" 1) ("exogenous SOCS-3" 1)
   ("exogenous
 SOCS-3"
    1)
   ("neuronal SOCS3" 1)))
 ("UP:O14544" (("suppressor of cytokine signaling 6" 5) ("SOCS-6" 5)))
 ("UP:O14545" (("TRAFD1" 3))) ("UP:O14556" (("GAPDHS" 2) ("Gapdhs" 2)))
 ("UP:O14558" (("HSPB6" 50) ("HspB6" 33)))
 ("UP:O14559" (("sorting nexin 26" 4)))
 ("UP:O14561" (("ACP" 29) ("aCP" 9) ("aCPs" 7) ("ACPs" 2)))
 ("UP:O14576" (("DYNC1I1" 5)))
 ("UP:O14578"
  (("Cit" 58) ("citron" 25) ("CIT" 12) ("Citron" 11) ("cit" 8) ("—citron" 1)
   ("CRIK" 1) ("CITRON" 1)))
 ("UP:O14579" (("COPE" 5)))
 ("UP:O14594" (("NCAN" 3) ("neurocan ( NCAN )" 1) ("neurocan" 1)))
 ("UP:O14595" (("CTDSP2" 163) ("SCp2" 3) ("CTDSP2-" 1) ("OS4" 1)))
 ("UP:O14603" (("PRY" 22))) ("UP:O14607" (("UTY" 2)))
 ("UP:O14613" (("CEP2" 13) ("CDC42EP2" 2) ("BORG1" 1)))
 ("UP:O14617" (("AP3D1" 5)))
 ("UP:O14618" (("CCS" 74) ("the Cdh1 orthologs CCS52A2" 1)))
 ("UP:O14625"
  (("CXCL11" 118) ("I-TAC" 19) ("CXCL11-" 6) ("ITAC" 4) ("Cxcl11" 3)
   ("βR1" 3)))
 ("UP:O14638"
  (("nucleotide pyrophosphatase" 2) ("Alkaline phosphodiesterase I" 1)))
 ("UP:O14639" (("Actin-binding LIM protein 1" 1)))
 ("UP:O14640"
  (("DVL1" 48) ("Dvl1" 28) ("Dvl-1" 12) ("DVL-1" 6) ("DVL1 protein" 1)))
 ("UP:O14641"
  (("DVL2" 120) ("Dvl2" 111) ("Dsh" 98) ("Dvl-2" 57) ("dsh" 48) ("dSH" 43)
   ("protein Dishevelled" 19) ("DSH" 15) ("protein dishevelled" 9)
   ("DVL2 protein" 2) ("overexpressed DVL2 S143A" 2) ("Dvl-2 protein" 2)
   ("Dishevelled 2" 2) ("dishevelled-2" 2) ("Dishevelled-2" 2)
   ("exogenous Dsh" 1)))
 ("UP:O14645"
  (("dynein" 822) ("Dynein" 51) ("dynein protein" 5)
   ("the retrograde motor protein dynein" 5) ("dynein molecule" 2)
   ("we first depleted dynein" 2) ("the minus-end-directed motor dynein" 2)
   ("The minus-end-directed motor protein Dynein" 2)
   ("Overexpressed BICD2-N prevented dynein" 2) ("cytoplasmic dynein's" 1)
   ("so cytoplasmic dynein" 1) ("virtually all cytoplasmic dynein" 1)
   ("-dynein" 1) ("the microtubule-associated motor dynein" 1) ("dynein-" 1)
   ("end–directed motor cytoplasmic dynein" 1)
   ("dimeric targets—either dynein" 1) ("the viral core uses dynein" 1)
   ("the microtubular motor dynein" 1)
   ("the retrograde microtubule motor dynein" 1)
   ("the ciliary protein 13S dynein" 1) ("ciliary 13S dynein protein" 1)
   ("DNALI1" 1) ("the cargo-bound dynein" 1) ("dynein (DHC)" 1)))
 ("UP:O14646" (("CHD1" 34) ("Chd1" 5) ("ChD1" 2)))
 ("UP:O14647" (("CHD2" 1) ("Chd2" 1)))
 ("UP:O14649"
  (("task" 607) ("Task" 47) ("TASK-1" 33) ("KCNK3" 18) ("a trivial task" 9)
   ("a difficult task" 7) ("Task (COWA)" 5) ("a straightforward task" 4)
   ("Task (DSST)" 4) ("a formidable task" 4) ("the difficult task" 3)
   ("an essential task" 3) ("an urgent task" 3) ("task (MET)" 3)
   ("Another major task" 2) ("Y maze reversal task" 2)
   ("an inhibitory avoidance-learning task" 2) ("a major task" 2)
   ("a very difficult task" 2) ("no trivial task" 2) ("a tedious task" 2)
   ("an expressive vocabulary task" 2) ("a hippocampal-dependent task" 2)
   ("retrieval task" 2) ("an instrumental task" 2) ("a multistep task" 2)
   ("a hippocampal-dependent cognitive task" 2)
   ("one-choice serial reaction time (1-CSRT) task" 2) ("the mundane task" 1)
   ("the Rey Auditory-Verbal Learning Task (RAVLT)" 1) ("Task (RAVLT)" 1)
   ("the Rey Auditory-Verbal Learning Task" 1)
   ("an unreasonably difficult task" 1) ("crucial task" 1)
   ("a particularly complex task" 1) ("A major task" 1) ("a prioritary task" 1)
   ("the major task" 1) ("effectively address such a complex task" 1)
   ("the primary task" 1) ("mandatory task" 1) ("a demanding physical task" 1)
   ("this ambitious task" 1) ("the vital task" 1) ("a huge task" 1)
   ("a specific cognitive task" 1) ("a notoriously difficult task" 1)
   ("a clear and immediate task" 1) ("an imperative task" 1)
   ("The latter task" 1) ("a feasible task" 1) ("Our immediate task" 1)
   ("the principal biological task" 1) ("the more burdensome task" 1)
   ("a distinct task" 1) ("a computationally intractable task" 1)
   ("a rather difficult task" 1)
   ("a hippocampal-independent reference memory acquisition task" 1)
   ("the laborious task" 1) ("this visual task" 1) ("a risky task" 1)
   ("a behavioral task" 1)))
 ("UP:O14653" (("GOSR2" 4)))
 ("UP:O14654"
  (("IRS-4" 27) ("pY160" 22) ("IRS4" 19) ("IRS 4" 5) ("substrate-4" 3)
   ("insulin receptor substrate-4" 2) ("insulin receptor substrate 4" 1)
   ("Irs-4" 1) ("insulin-receptor substrate-4" 1)))
 ("UP:O14656" (("DYT1" 5) ("DQ2" 5) ("Tora" 2) ("TOR1A" 1)))
 ("UP:O14657" (("DQ1" 3) ("torsin family 1 member B" 2) ("TOR1B" 1)))
 ("UP:O14662" (("STX16" 3)))
 ("UP:O14672"
  (("ADAM10" 567) ("ADAM-10" 113) ("ADAM 10" 12) ("Adam10" 4)
   ("ADAM10 protein" 2) ("the defective ADAM10" 2) ("finely tune ADAM10" 2)
   ("ADAM10-" 2) ("local ADAM10" 1) ("MADM" 1)))
 ("UP:O14678" (("PMP69" 1)))
 ("UP:O14681"
  (("etoposide" 3370) ("Etoposide" 415) ("etoposide-" 53)
   ("etoposide (ETO)" 12) ("EI24" 7) ("PIG8" 6)
   ("the chemotherapeutic drug etoposide" 5)
   ("the chemotherapeutic agents etoposide" 3) ("than etoposide" 3)
   ("etoposide (ETP)" 2) ("EI24 protein" 2) ("the genotoxic agent etoposide" 2)
   ("Teva" 2) ("the genotoxic agent etoposide (ETP)" 1)
   ("the chemotherapeutic drug Etoposide" 1) ("Ei24" 1)
   ("1 μM (γH2AX) 10 μM (RAD51, 53BP1) etoposide" 1) ("ei24" 1)
   ("Etoposide-" 1) ("Pig8" 1) ("the chemotherapeutic reagent etoposide" 1)
   ("etoposide (ETOP)" 1) ("the chemotherapeutic agent etoposide" 1)))
 ("UP:O14682"
  (("ENC1" 147) ("ectodermal-neural cortex 1" 9) ("hENC1" 3) ("ENC-1" 1)))
 ("UP:O14684"
  (("mPGES-1" 442) ("PGES" 71) ("mPGES1" 28) ("prostaglandin E synthase" 11)
   ("PTGES" 8) ("microsomal prostaglandin E synthase-1" 6)
   ("mPGES-1 protein" 5) ("Microsomal prostaglandin E synthase-1" 4)
   ("the microsomal PGES" 2) ("prostaglandin E synthase ( PTGES )" 2)
   ("Prostaglandin E synthase" 1)))
 ("UP:O14686" (("KMT2D" 5) ("kmt2d" 2)))
 ("UP:O14713"
  (("β1-integrin" 365) ("ICAP-1" 149)
   ("significantly more active β1-integrin" 2)
   ("Integrin cytoplasmic domain–associated protein 1" 1)))
 ("UP:O14715" (("RGPD8" 3)))
 ("UP:O14717" (("DNMT2" 14) ("TRDMT1" 5) ("Dnmt2" 2)))
 ("UP:O14727"
  (("Apaf-1" 993) ("procaspase-9" 200) ("APAF-1" 198) ("APAF1" 140)
   ("Apaf1" 28) ("apoptotic protease-activating factor 1" 23)
   ("apoptotic protease activating factor-1" 21) ("Apaf-1 protein" 14)
   ("Procaspase-9" 13) ("apoptotic protease activating factor 1" 12)
   ("Apaf-1 molecule" 4) ("apoptotic peptidase activating factor 1" 3)
   ("apoptotic protease activating factor" 3)
   ("Apoptotic protease activating factor" 2)
   ("apoptotic protease-activating factor-1" 2) ("APAF-1 protein" 2)
   ("Apoptotic protease-activating factor 1" 2)
   ("two cases showed weak Apaf-1" 2) ("strong (3+) Apaf-1" 2)
   ("Apaf1 protein" 2) ("SVT016426 specifically targets Apaf-1" 1)
   ("amino acids of Apaf-1" 1) ("O14727" 1) ("Apaf 1" 1) ("new procaspase-9" 1)
   ("flexibly-bound Apaf-1" 1) ("Apoptotic protease activating factor-1" 1)))
 ("UP:O14730" (("RIOK3" 1))) ("UP:O14732" (("IMPA2" 1)))
 ("UP:O14733"
  (("MKK7" 208) ("MKK-7" 7) ("MAP2K7" 5) ("MEK7" 3)
   ("mitogen-activated protein kinase kinase 7" 2) ("JNKK2" 1) ("p-MKK7" 1)
   ("MKK 7" 1) ("amino acids of MKK7" 1)
   ("the last 20 amino acid of human MKK7" 1)))
 ("UP:O14734" (("hTE" 1) ("ACOT8" 1)))
 ("UP:O14735"
  (("PIs" 196) ("new PIs" 7) ("pIs" 6) ("potential PIs" 4) ("pIS" 2)
   ("mature PIs" 1) ("phosphatidylinositol synthase" 1) ("than other PIs" 1)))
 ("UP:O14737" (("TF-1" 164) (NIL 4) ("PDCD5" 2) ("programmed cell death 5" 1)))
 ("UP:O14744"
  (("PRMT5" 697) ("PRMT5 protein" 9) ("SKB1" 3)
   ("protein arginine methyltransferase 5" 3)
   ("overexpressed HA-tagged wild-type PRMT5" 2)
   ("symmetric dimethylating PRMT5" 1) ("less phospho-PRMT5" 1)
   ("down significantly more endogenous PRMT5 protein" 1)
   ("the commercially available anti-PRMT5 antibodies efficiently immunoprecipitate PRMT5"
    1)
   ("JBP1" 1)))
 ("UP:O14745"
  (("NHERF1" 290) ("EBP50" 214) ("NHERF" 12) ("SLC9A3R1" 12)
   ("EBP50 protein" 11) ("overexpressed NHERF1" 3)
   ("the submembranous scaffolding protein EBP50" 2)
   ("Overexpressed control NHERF1" 2) ("overexpressed FLAG-tagged NHERF1" 2)
   ("monomeric NHERF1" 2) ("Subapical EBP50 protein" 1)))
 ("UP:O14746"
  (("hTERT" 8726) ("telomerase" 6604) ("TERT" 6232) ("Telomerase" 643)
   ("telomerase reverse transcriptase" 593) ("hTERT protein" 137) ("Tert" 120)
   ("TERT protein" 92) ("mTERT" 78) ("h-TERT" 65)
   ("telomerase catalytic subunit" 46) ("hTert" 45) ("hTERT-" 45) ("pTERT" 36)
   ("-hTERT" 32) ("TRT" 23) ("telomerase reverse transcriptase (TERT)" 22)
   ("overexpressed telomerase" 21) ("herbimycin" 20) ("telomerase molecule" 19)
   ("Est2" 13) ("Telomerase reverse transcriptase" 11) ("telomerase protein" 9)
   ("p-hTERT" 8) ("phTERT" 6) ("telomerase reverse transcriptase ( TERT )" 6)
   ("Telomerase Reverse Transcriptase" 6) ("expressing DN hTERT" 6) ("TCS1" 5)
   ("overexpressed hTERT" 5) ("than hTERT-V791Y" 5) ("-TERT" 4)
   ("overexpressed 293T telomerase" 4) ("exogenous hTERT" 4) ("TERT-" 4)
   ("BJ" 4) ("Telomerase Reverse transcriptase" 4) ("p-TERT" 4)
   ("targeting TERT" 3) ("Herbimycin" 3) ("mTert" 3)
   ("insufficient telomerase" 3) ("overexpressed cellular +170 telomerase" 3)
   ("overexpressed WT hTERT" 3) ("telomerase reverse transcriptase protein" 3)
   ("overexpressed telomerase/endogenous telomerase" 2)
   ("we first treated hTERT" 2) ("telomere-associated hTERT" 2)
   ("telomerase reverse
transcriptase"
    2)
   ("telomerase reverse transcriptase (TERT) protein" 2)
   ("overexpressed TERT protein" 2) ("than hTERT" 2)
   ("functional telomerase" 2) ("treated SQ20B NES- hTERT" 2)
   ("the normal esophageal epithelial cell line EPC-hTERT" 2)
   ("Less processive telomerase" 2) ("Overexpressed telomerase" 2)
   ("organellar telomerase" 2) ("oxidative stress hTERT" 2) ("EST2" 2)
   ("expressing dominant-negative (DN) hTERT" 2)
   ("TERT (telomerase reverse transcriptase) protein" 2)
   ("exogenous telomerase" 2) ("overexpressed TERT" 2) ("hTert (NHF)" 2)
   ("hTERT-W930F's" 2) ("expressing hTERT-WT" 2)
   ("telomere recruitment-defective hTERT" 2) ("elongation-defective hTERT" 2)
   ("exogenous factors influencing TERT" 1)
   ("telomerase reverse transcriptase(TERT)" 1)
   ("bladder urothelial line h-TERT" 1)
   ("the 20 C-terminal amino acids of hTERT ()" 1) ("expressing h-TERT" 1)
   ("the pulmonary vascular TERT protein" 1)
   ("Telomerase reverse transcriptase (TERT)" 1) ("less hTERT" 1)
   ("the neural lineage telomerase" 1) ("benign TERT" 1)
   ("the monomeric telomerase" 1) ("than telomerase" 1)
   ("doubly-labeled telomerase" 1) ("h-Tert" 1)
   ("than endogenous telomerase" 1) ("fewer telomerase" 1)
   ("the fluorescent telomerase" 1)
   ("the urinary bladder bear TERT promoter mutation C228T" 1) ("hTERT(AR)" 1)
   ("the mature telomerase protein" 1) ("hTert-" 1) ("“TERT”" 1)
   ("Telomerase reverse Transcriptase" 1) ("–TERT" 1) ("O14746" 1)
   ("telomerase (NHBET)" 1) ("telomerase ( TERT )" 1)
   ("than mTERT ( xref , xref )" 1) ("pmTERT" 1) ("normal h-TERT" 1)
   ("stably overexpressed TERT protein" 1)
   ("than WT hTERT ( i.e. greater conformational flexibility)" 1)
   ("than WT hTERT ( xref )" 1) ("functionally-competent telomerase" 1)
   ("the regulatory hTERT" 1) ("asynchronously growing hTERT" 1)
   ("the classical telomerase" 1)
   ("barely detectable using recombinant mutant +170 telomerase" 1)
   ("endogenously-assembled human telomerase" 1)
   ("The N-terminal 200 amino acids of TERT [known as region I ( xref ) or the GQ ( xref ), RID1 ( xref ) or TEN ( xref ) domain]"
    1)
   ("diffusible telomerase" 1) ("exogenous overexpressed telomerase" 1)
   ("than the endogenously expressed telomerase" 1)
   ("the first 33 N-terminal amino acids of hTERT (including the MTS)" 1)
   ("\"telomerase reverse transcriptase\"" 1) ("Functional telomerase" 1)
   ("a karyotypically normal hTERT" 1) ("the hTERT" 1)
   ("the first 300 amino acids of hTERT" 1)
   ("The first 325 amino acids of hTERT, encoded by exon" 1)
   ("The first 325 amino acids of hTERT" 1) ("secondary telomerase" 1)
   ("the first 73 amino acids of hTERT" 1) ("Almost all hTERT" 1) ("”" 1)
   ("late generation TgTRF2/ Tert" 1) ("Tert–" 1) ("hTERT peptide" 1)
   ("telomerase-" 1) ("hTERT-V791Y's" 1) ("expressing hTERT-W930F" 1)
   ("both basal and phosphorylated hTERT" 1)
   ("full length functional telomerase" 1)
   ("large long-lived mammals regulated telomerase" 1)
   ("cancer cells almost universally upregulate/reactivate telomerase" 1)
   ("non-canonical hTERT" 1)))
 ("UP:O14753"
  (("Ovol1" 248) ("Ovol1 protein" 14) ("–Ovol1 protein" 10) ("–Ovol1" 8)
   ("OVOL1" 4) ("Ovol1–" 1) ("consistently Ovol1D bound Ovol1" 1)))
 ("UP:O14756"
  (("HSE" 189) ("HSD17B6" 6) ("HSE-" 1) ("no functional HSE" 1)
   ("a distal HSE" 1) ("Functional HSE" 1)))
 ("UP:O14757"
  (("Chk1" 7238) ("CHK1" 1915) ("CHEK1" 555) ("Chk1 protein" 137) ("pCHK1" 110)
   ("CHK1 protein" 84) ("chk1" 72) ("checkpoint kinase 1" 70) ("ChK1" 64)
   ("p-CHK1" 40) ("cell cycle checkpoint kinase" 38) ("Chek1" 18) ("Chk1-" 17)
   ("-Chk1" 16) ("Chk1 (WT)" 12) ("p-chk1" 9) ("-CHK1" 6)
   ("centrosomal Chk1" 6) ("Chk1(WT)" 6) ("–Chk1 peptide" 6)
   ("CHEK1 protein" 5) ("CHK 1" 5) ("pCHK1 protein" 4)
   ("Checkpoint kinase 1" 3) ("pCHEK1" 3) ("CHK1 (pCHK1) protein" 3)
   ("nucleoplasmic Chk1" 3) ("centrosome-associated Chk1" 3)
   ("the exogenous CHK1" 3) ("Ser-280–phosphorylated Chk1" 3)
   ("Chk1 molecule" 3) ("than the Chk1" 3)
   ("the downstream DNA-damage-induced kinases Chk1" 2)
   ("Cell cycle checkpoint kinase" 2) ("CHK1-" 2) ("targeted CHEK1" 2)
   ("likely represented total and phosphorylated Chk1" 2) ("Chk1 peptide" 2)
   ("checkpoint kinase 1" 2) ("overexpressed CHEK1" 2) ("α-phospho Chk1" 2)
   ("Centrosome-associated Chk1" 2) ("more total active Chk1" 2)
   ("down most 35 S-labeled Chk1" 2) ("cellular Chk1" 2)
   ("than WT Chk1 ( xref )" 2) ("functional Chk1" 2) ("chk 1" 2)
   ("than Chk1" 2) ("residual Chk1" 2) ("Chk 1" 2) ("Checkpoint kinase-1" 2)
   ("–checkpoint kinase 1" 2) ("using flag-tagged Chk1" 1)
   ("these cell lines more Chk1" 1) ("total and phosphorylated Chk1 protein" 1)
   ("centrosomal ChK1" 1) ("ChK1 protein" 1) ("soluble Chk1" 1)
   ("than wild type Chk1" 1) ("UV-activated Chk1" 1)
   ("Stress-activated Chk1" 1) ("stress-activated Chk1" 1)
   ("The essential cell cycle component CHEK1" 1)
   ("centrosome-associated checkpoint kinase Chk1" 1) ("than Chk1 ( xref )" 1)
   ("less Chk1" 1) ("Cul1-associated Chk1" 1) ("than either the Chk1" 1)
   ("than non-phosphorylated Chk1" 1) ("partial exogenous CHK1" 1)
   ("checkpoint kinase-1" 1) ("un-phosphorylated Chk1" 1)
   ("than endogenous Chk1" 1)
   ("than endogenous Chk1 (endogenous 64%, GFP-labelled 16%)" 1)
   ("asynchronously growing Chk1-" 1) ("the Chk2-relative Chk1" 1)
   ("exogenous FLAG-tagged CHK1" 1) ("more p-CHK1" 1)
   ("display overactive CHK1" 1) ("–Chk1" 1)
   ("Chk1 that is likely to promote Chk1’s" 1) ("cHK1" 1)
   ("two major Chk1" 1)))
 ("UP:O14763"
  (("SW480" 2054) ("killer" 247) ("TRAIL-R2" 240) ("NK" 132) ("TNFRSF10B" 51)
   ("Killer" 44) ("CIK" 31) ("death receptor 5" 23) ("TRAIL receptor 2" 12)
   ("KILLER" 11) ("TRAILR2" 9) ("killer (BIK)" 7) ("Dr5" 5)
   ("natural killer" 5) ("member 10b" 5) ("natural killer (NK)" 4)
   ("Death receptor 5" 4) ("-TRAIL-R2" 3) ("Bcl-2-associated killer" 2)
   ("killer (BAK)" 2) ("Human colorectal tumor cell lines SW480" 2)
   ("death receptor 5 (DR5) protein" 2) ("Death Receptor 5" 2)
   ("an efficient killer" 2) ("Sw480" 2) ("killer protein" 2)
   ("a silent killer" 2) ("killer (LAK)" 1) ("killer (NK)" 1) ("TRAIL-R2-" 1)
   ("Bcl-2 homologous antagonist killer" 1) ("Ad-S100A4-infected SW480" 1)
   ("migrated SW480" 1) ("we first infected two CRC cell lines SW480" 1)
   ("killer ( BIK )" 1) ("Bcl-2 homologous antagonist killer (BAK)" 1)
   ("Trail-R2" 1) ("naive SW480" 1)
   ("Human colorectal tumour cell lines SW480" 1) ("autologous NK" 1)
   ("particularly natural killer (NK)" 1) ("all MMR-proficient SW480" 1)
   ("the colorectal cell lines SW480" 1) ("the colorectal cell line SW480" 1)
   ("Natural Killer" 1) ("TRICK2" 1) ("than SW480" 1)
   ("dsRed-expressing SW480" 1) ("decidual NK" 1)
   ("The BH3-only protein natural born killer (NBK)" 1) ("than TRAIL-R2" 1)
   ("the number 1 genetic killer" 1) ("“killer”" 1) ("-TRAIL-R2ΔC" 1)
   ("The human colonic carcinoma-derived cell line SW480" 1)
   ("CX3CR1-expressing natural killer" 1)))
 ("UP:O14770" (("MRG1" 18) ("MEIS2" 7) ("Meis2" 1)))
 ("UP:O14773"
  (("TPP1" 639) ("Tpp1" 18) ("Cln2" 4) ("CLN2" 3) ("TPP1 protein" 2)
   ("TPP1(WT)" 1) ("cln2" 1) ("residual TPP1" 1)))
 ("UP:O14775" (("Gβ5" 4) ("Gb5" 2))) ("UP:O14776" (("CA150" 1) ("Tcerg1" 1)))
 ("UP:O14777"
  (("HEC" 473) ("Hec1" 119) ("hEC1" 55) ("NDC80" 50) ("Ndc80" 40) ("hECs" 30)
   ("highly expressed in cancer" 18) ("HEC1" 17) ("HECs" 7) ("HeCs" 6)
   ("KLRG1 Asn157(O)–Leu95(N) hEC1, and KLRG1 Asn157(N δ2 )–Leu95(O) hEC1" 2)
   ("primary hECs" 2)
   ("The human endometrial adenocarcinoma cell lines HEC-1A" 2) ("–Hec1" 2)
   ("KNTC2" 2) ("treated HEC-1A" 1) ("KLRG1 Ser158(O γ )–Glu93(O) hEC1" 1)
   ("hECS" 1)))
 ("UP:O14786"
  (("NRP1" 478) ("NRP" 219) ("NRP-1" 27) ("neuropilin" 16) ("Nrp1" 8)
   ("Neuropilin1" 7) ("neuropilin 1" 3) ("Nrp-1" 3) ("nrp1" 2)
   ("NRP protein" 2) ("NRP1 protein" 2) ("more NRP1" 1) ("endothelial NRP1" 1)
   ("CD304" 1) ("neuropilin (NRP)" 1)))
 ("UP:O14787" (("TNPO2" 1) ("Tnpo2" 1)))
 ("UP:O14788"
  (("RANKL" 870) ("Rankl" 26) ("TNFSF11" 21) ("nuclear factor kappaB" 18)
   ("Tnfsf11" 16) ("soluble RANKL" 11) ("RANK-L" 11) ("sRANKL" 10)
   ("nuclear factor kappa-B ligand" 5)
   ("tumor necrosis factor ligand superfamily member 11" 3) ("RankL" 3)
   ("Nuclear factor kappaB" 3) ("TRANCE" 2)
   ("nuclear factor kappa-B ligand (RANKL)" 2) ("RANKL-" 2)
   ("osteoclast differentiation factor" 2)
   ("recombinant soluble human RANKL" 2)
   ("the osteoclastogenic factor RANKL" 2) ("OPGL" 2) ("CD254" 2)
   ("RANKL protein" 1) ("Higher soluble RANKL" 1) ("a soluble RANKL" 1)
   ("nuclear factor-kappaB ligand" 1) ("Soluble RANKL" 1) ("the most RANKL" 1)
   ("than RANKL" 1) ("soluble recombinant RANKL" 1) ("TNFSF11 ( RANKL )" 1)
   ("exogenous RANKL" 1) ("The two cortical vBMD RANKL" 1)
   ("Receptor Activator" 1)))
 ("UP:O14791"
  (("APOL1" 103) ("ApoL1" 12) ("APOL" 8) ("apolipoprotein L1" 6)
   ("ApoL1 protein" 4) ("Apolipoprotein L1" 2) ("APOL1-" 1)))
 ("UP:O14793"
  (("myostatin" 14) ("MYOSTATIN" 3) ("Mstn" 2) ("GDF8" 1) ("GDF-8" 1)))
 ("UP:O14795"
  (("munc13" 5) ("Munc-13" 3) ("Unc-13" 2) ("UNC13" 2) ("Munc 13" 2)
   ("Munc13" 1) ("MUNC13" 1)))
 ("UP:O14796"
  (("EAT-2" 131) ("SH2D1B" 11) ("EAT-2 molecule" 4) ("Sh2d1b" 3) ("EAT2" 2)
   ("than EAT-2" 1) ("than EAT-2 in NK92 cells" 1) ("Eat-2" 1)))
 ("UP:O14798"
  (("DcR1" 68) ("TNFRSF10C" 17) ("TRID" 17) ("LIT" 17) ("TRAIL-R3" 14)
   ("decoy receptor 1" 10) ("lit" 10) ("Lit" 9) ("DCR1" 6)
   ("TRAIL receptor 3" 3) ("mainly decoy receptors DcR1" 2)
   ("Decoy receptors 1" 2) ("lit-" 1)))
 ("UP:O14802" (("POLR3A" 20)))
 ("UP:O14807"
  (("M-Ras" 53) ("MRAS" 18) ("MRAs" 16) ("M-ras" 6) ("M-RAS" 4)
   ("M-ras protein" 2) ("their dominant-negative mutants M-Ras" 2) ("MRas" 1)
   ("R-Ras3" 1)))
 ("UP:O14813" (("PHOX2A" 43) ("Phox2a" 1))) ("UP:O14815" (("CAPN9" 1)))
 ("UP:O14817"
  (("tetraspan" 25) ("tetraspan (4-transmembrane) protein" 3)
   ("tetraspan protein" 2) ("Tetraspan" 1)))
 ("UP:O14818" (("PSMA7" 7))) ("UP:O14827" (("RasGRF2" 6)))
 ("UP:O14828" (("SCAMP3" 1))) ("UP:O14829" (("PP7" 19)))
 ("UP:O14832" (("PHYH" 5))) ("UP:O14836" (("TACI" 5) ("TNFRSF13B" 3)))
 ("UP:O14841" (("OPLAH" 3))) ("UP:O14842" (("free fatty acid receptor 1" 1)))
 ("UP:O14843" (("GPR41" 4)))
 ("UP:O14862" (("AIM2" 98) ("Aim2" 6) ("absent in melanoma 2" 1)))
 ("UP:O14867"
  (("BACH1" 598) ("Bach1" 340) ("BACH1 peptide" 15) ("Bach-1" 9)
   ("bach1 peptide" 4) ("its heterodimeric partner BACH1" 3)
   ("BACH1 protein" 3) ("the transcriptional repressor Bach1" 2) ("-BACH1" 2)
   ("the transcriptional repressor BACH1" 2) ("BACH1-" 2) ("bach1" 2)
   ("transcriptional repressor Bach1" 1) ("residual BACH1" 1)
   ("Bach1 protein" 1) ("a phosphorylated Thr instead of Ser of Bach1" 1)
   ("the mammalian transcriptional repressor Bach1" 1)))
 ("UP:O14879" (("IFIT3" 17) ("ISG60" 15) ("rIgG" 8) ("RIgG" 1)))
 ("UP:O14880" (("GST–III" 185) ("MGST3" 1) ("Mgst3" 1)))
 ("UP:O14893" (("Sip1" 15) ("Gemin2" 1)))
 ("UP:O14896"
  (("IRF6" 48) ("interferon regulatory factor 6" 7)
   ("Interferon regulatory factor 6" 2)
   ("the previously identified susceptibility gene IRF6" 2)))
 ("UP:O14901" (("KLF11" 11) ("TIEG2" 1)))
 ("UP:O14904" (("Wnt9a" 7) ("Wnt-14" 1) ("WNT9A" 1) ("Wnt-9a" 1)))
 ("UP:O14905"
  (("WNT9B" 45) ("Wnt9B" 4) ("Wnt9b" 2) ("WNT14B" 1) ("WNT15" 1) ("Wnt-9b" 1)))
 ("UP:O14907" (("TIP-1" 5) ("Tip1" 1) ("TAX1BP3" 1)))
 ("UP:O14908" (("GIPC" 14) ("synectin" 1) ("Synectin" 1)))
 ("UP:O14910" (("LIN7A" 3))) ("UP:O14917" (("PCDH17" 1)))
 ("UP:O14920"
  (("IKKβ" 2093) ("IKK2" 459) ("Ikkβ" 118) ("IKK-2" 57) ("IKBKB" 51)
   ("IKK-β" 33) ("IKKβ protein" 13) ("IKKB" 10) ("IKKβ-" 9)
   ("overexpressed IKKβ" 8) ("IKKbeta" 7) ("Ikk2" 7) ("IKK-beta" 6) ("IKBkB" 6)
   ("SSAA" 5) ("SSEE" 5) ("Ikkβ protein" 5) ("IKKβ (SSAA) protein" 4)
   ("-IKKβ" 3) ("flag-tagged IKK2" 3) ("IkKβ" 3)
   ("overexpressed wild-type or kinase-dead IKKβ" 3) ("IKKb" 2)
   ("13-197 principally targets IKKβ" 2) ("a functional IKKβ" 2) ("IKKβ(AA)" 2)
   ("IKKβ (SE)" 2) ("flag-tagged wildtype or mutant IKK2" 2) ("intact Ikkβ" 2)
   ("IKKβ (KM)" 1) ("pIKKb" 1) ("Ikbkb" 1) ("IKKβ(WT)" 1)
   ("than IKKβ ( xref )" 1) ("dominant-negative (DN) IKKβ" 1)
   ("dominant-negative IKKβ" 1) ("IKK2-" 1) ("a non-epitope-tagged IKKβ" 1)
   ("constitutively-activated IKKβ" 1)
   ("than the kinase-dead IKKβ (SSAA) protein ( xref )" 1) ("IKKβ (SSEE)" 1)
   ("systemic targeting Ikkβ" 1) ("targeting Ikkβ" 1)
   ("inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta"
    1)
   ("Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta"
    1)))
 ("UP:O14924" (("RGS12" 16))) ("UP:O14925" (("TIM23" 11) ("Tim23" 4)))
 ("UP:O14929"
  (("HAT1" 52) ("Hat1" 13) ("histone acetyltransferase 1" 4)
   ("Histone acetyltransferase 1" 2) ("hat1" 1)))
 ("UP:O14931" (("NKp30" 37) ("NCR3" 10)))
 ("UP:O14933"
  (("UBCH8" 36) ("UbcH8" 31) ("UBE2L6" 9) ("the SIAH2-associated UBCH8" 2)
   ("its associated E2 ubiquitin conjugase UBCH8" 1)))
 ("UP:O14936"
  (("CASK" 57) ("LIN-2" 2) ("Cask" 2)
   ("calcium/calmodulin-dependent serine protein kinase" 1) ("Lin2" 1)))
 ("UP:O14939"
  (("PLD2" 230) ("phospholipase D2" 9) ("PLD2-" 4) ("PLD-2" 3)
   ("PLD2 protein" 2) ("Purified baculoviral PLD2" 1)))
 ("UP:O14944"
  (("EREG" 579) ("EPR" 236) ("epiregulin" 219) ("Epiregulin" 27) ("Ereg" 16)
   ("epiregulin (EREG)" 7) ("exogenous EREG" 2) ("soluble EREG" 1)
   ("an intense 24-26G NS EPR" 1) ("essentially no radical EPR" 1)
   ("epiregulin (EPI)" 1) ("epiregulin protein" 1)
   ("cell-associated epiregulin" 1)))
 ("UP:O14948" (("TFEC" 6))) ("UP:O14949" (("UQCRQ" 1)))
 ("UP:O14950"
  (("MLC-2" 24) ("MRLC2" 6) ("P-MLC-2" 4) ("myosin regulatory light chain 2" 3)
   ("MYL12B" 2) ("MLC2A" 2)))
 ("UP:O14960" (("Lect2" 8)))
 ("UP:O14964"
  (("HGS" 155) ("H-RS" 6) ("HGs" 6) ("late stage HGS" 2)
   ("hepatocyte growth factor–regulated tyrosine kinase substrate" 2)
   ("hepatocyte growth factor-regulated tyrosine kinase substrate" 2)
   ("Hgs" 1)))
 ("UP:O14965"
  (("Aurora A" 1342) ("AURKA" 1193) ("Aur A" 162) ("aura" 94)
   ("Aurora kinase A" 45) ("STK15" 37) ("aurora kinase A" 22) ("ARK1" 14)
   ("AurA" 13) ("ARK-1" 12) ("p-AURKA" 11) ("STK6" 9) ("Aurora A (AURKA)" 8)
   ("AURA" 7) ("Aurka" 7) ("Ark1" 7) ("IAK1" 6) ("Aurora Kinase A" 6) ("AIK" 5)
   ("AURKA protein" 5) ("protein kinase Aurora A" 5) ("Aurora A–" 4) ("BTAK" 3)
   ("–Aurora A" 3) ("exogenous AURKA protein" 2)
   ("the mitotic centrosome marker Aurora A" 2)
   ("centrosome-associated Aurora A" 2)
   ("the mitotic kinases Aurora A (AURKA)" 2) ("exogenous AURKA" 2)
   ("aurora kinase A (AURKA)" 2) ("atypical aura" 2) ("Aurora A protein" 2)
   ("the residual 50% active AURKA" 1) ("spindle-associated Aurora A" 1)
   ("most Aurora A" 1) ("mitotic protein kinase Aurora A" 1)
   ("the mitotic protein kinase Aurora A" 1) ("p-Aurora A" 1)
   ("centrosomal Aurora A" 1) ("AURORA KINASE A" 1) ("aura (MO)" 1)
   ("aura (MA)" 1) ("AurkA" 1) ("The mitotic kinase Aurora A" 1)
   ("the mitotic kinase Aurora A" 1) ("pAURKA" 1)))
 ("UP:O14966" (("Rab7L1" 20))) ("UP:O14972" (("DSCR3" 3) ("DSCR3 protein" 2)))
 ("UP:O14974"
  (("MYPT1" 815) ("PPP1R12A" 99) ("Mypt1" 93) ("myosin-binding subunit" 37)
   ("pMYPT1" 26) ("MBs" 22) ("MYPT-1" 18) ("myosin binding subunit" 17)
   ("myosin phosphatase target subunit 1" 17) ("MyPT1" 15) ("MYPT1-" 10)
   ("regulatory subunit 12A" 8) ("myosin phosphatase targeting subunit 1" 7)
   ("myosin phosphatase-targeting subunit 1" 6) ("MYPT1 protein" 6)
   ("myosin binding subunit (MBS)" 5) ("P-MYPT-1" 5) ("p-MYPT1" 4)
   ("myosin-binding subunit (MBS)" 3) ("myosin-binding  subunit (MBS)" 3)
   ("myosin-binding  subunit" 2) ("P-MYPT1" 2) ("pMypt1" 2)
   ("a large 110–130 kDa regulatory myosin-binding subunit" 2) ("than MYPT1" 1)
   ("–MYPT1" 1) ("myosin phosphatase target subunit-1" 1)
   ("targeting subunit MYPT1" 1) ("than pMYPT1 (Thr696)" 1)
   ("Phosphoproteomic screening identified MYPT1" 1)
   ("myosin phosphatase–targeting subunit 1" 1)
   ("we first immunoprecipitated PPP1R12A" 1)
   ("than wild-type Mypt1 (data not shown)" 1)))
 ("UP:O14975" (("SLC27A2" 2) ("VLACS" 1))) ("UP:O14976" (("GAK" 7)))
 ("UP:O14977"
  (("AZI" 62) ("antizyme" 5) ("antizyme inhibitor" 5) ("AZI protein" 2)
   ("-AZI" 1) ("Antizyme inhibitor" 1) ("antizyme (AZ)" 1) ("Antizyme" 1)))
 ("UP:O14978" (("ZNF263" 1))) ("UP:O14979" (("HNRPDL" 6)))
 ("UP:O14980"
  (("CRM1" 517) ("Crm1" 207) ("exportin" 38) ("CRM-1" 20) ("exportin 1" 19)
   ("Exportin 1" 17) ("XPO1" 14) ("Exp1" 12) ("Exportin" 11) ("-CRM1" 6)
   ("crm1" 5) ("exportin1" 4) ("Xpo1" 3) ("Exportin1" 2) ("CRM1 protein" 1)
   ("Crm-1" 1) ("exp1" 1) ("subsequent Crm1" 1) ("soluble Crm1" 1)
   ("cellular Crm1" 1) ("CRM1-" 1)))
 ("UP:O14981" (("MOT1" 1)))
 ("UP:O14983"
  (("cardiac muscle" 97) ("fast twitch 1" 3) ("Ca++ transporting" 3)
   ("ATP2A" 2)
   ("cardiac
muscle"
    1)))
 ("UP:O14986" (("PIP5K1B" 3))) ("UP:O14994" (("SYN3" 1)))
 ("UP:O15013"
  (("ARHGEF10" 147) ("GEF10" 8) ("ARHGEF10-" 4) ("ArhGEF10" 2) ("KIAA0294" 1)
   ("Rho guanine nucleotide exchange factor 10" 1)))
 ("UP:O15016" (("Trim66" 1))) ("UP:O15018" (("AIPC" 11)))
 ("UP:O15020" (("KIAA0302" 1)))
 ("UP:O15027"
  (("Sec16A" 89) ("P250" 11) ("p250" 1) ("Sec16" 1) ("KIAA0310" 1)))
 ("UP:O15031"
  (("MM1" 166) ("Plexin-B2" 4) ("plexin-B2" 3) ("PLXNB2" 1)
   ("chimeric plexin-B2" 1) ("bortezomibsensitive MM1" 1) ("viable MM1" 1)
   ("MM1-" 1)))
 ("UP:O15033" (("KIAA0317" 1))) ("UP:O15040" (("TECPR2" 5)))
 ("UP:O15041" (("Sema3E" 3) ("SEMA3E" 1)))
 ("UP:O15042"
  (("140 kDa" 50) ("140 kDa" 14) ("140 kDa protein" 9) ("140 kDa protein" 5)
   ("140 kDa" 4) ("140 KDa" 3) ("around 140 kDa" 2)
   ("the native eGFP-PARP-1 band around 140 kDa" 1)
   ("approximately 140 kDa" 1)))
 ("UP:O15047"
  (("SET1" 41) ("Set1" 23) ("SET1A" 18) ("Set1A" 7) ("Setd1A" 5) ("set1" 3)
   ("hSET1A" 1) ("\"Set1\"" 1)))
 ("UP:O15050" (("TRANK1" 1)))
 ("UP:O15054"
  (("Jmjd3" 46) ("JMJD3" 35) ("KDM6B" 9) ("histone lysine demethylase" 5)))
 ("UP:O15055"
  (("hPer2" 445) ("Per2" 204) ("PER2" 192) ("-hPer2" 35) ("PER2 protein" 16)
   ("hPer2 protein" 12) ("Period 2" 11) ("period 2" 4) ("per2" 4) ("hPER2" 4)
   ("overexpressed full-length PER2" 3) ("-hp53(ch)hPer2, or -hp53(ch)hPer2" 2)
   ("-NLS-hp53(ch)GST, or -NLS-hp53(ch)hPer2" 2)
   ("FLAG-hp53(ch)hPer2, or FLAG-hp53(ch)hPer2" 2)
   ("significantly more PER2" 2) ("functional PER2" 1) ("than PER2" 1)
   ("-Per2" 1) ("myc -hp53(ch)hPer2, and hp53(ch)hPer2" 1) ("rhythmic hPer2" 1)
   ("the circadian factor hPer2" 1) ("PERIOD 2" 1) ("PER2 peptide" 1)
   ("the circadian clock protein Per2" 1)))
 ("UP:O15056"
  (("synaptojanin" 20) ("synaptojanin 2" 11) ("synaptojanin-2" 4) ("synj2" 2)
   ("SYNJ2" 2) ("Synj2" 1)))
 ("UP:O15061" (("synemin" 155) ("DMN" 34) ("Synemin" 26)))
 ("UP:O15062" (("ZBTB5" 4)))
 ("UP:O15066" (("KIF3B" 64) ("kinesin family member 3B" 2) ("KIAA0359" 1)))
 ("UP:O15067" (("PFASs" 36) ("PFAS" 16) ("Pfas" 3)))
 ("UP:O15068" (("MCF2L" 6) ("DBL's big sister" 1)))
 ("UP:O15072" (("ADAMTS-4" 20) ("ADAMTS3" 4) ("ADAMTS-4 protein" 1)))
 ("UP:O15075" (("DCLK1" 41) ("Dcamkl1" 31) ("DCAMKL-1" 4)))
 ("UP:O15078"
  (("type 4" 85) ("NPHP6" 33) ("CEP290" 28) ("Type 4" 6) ("Nphp6" 6)
   ("type 4" 3) ("BBS14" 1) ("nphp6" 1)))
 ("UP:O15083" (("Spc110" 1)))
 ("UP:O15085"
  (("PDZ-RhoGEF" 48) ("PDZRhoGEF" 12) ("the eponymic PDZ-RhoGEF" 2) ("GEF11" 2)
   ("ARHGEF11" 1)))
 ("UP:O15090" (("ZNF536" 4)))
 ("UP:O15105"
  (("Smad7" 537) ("SMAD7" 138) ("Smad7 peptide" 37) ("Smad 7" 5)
   ("SMAD7 protein" 4) ("Smad7 protein" 3)
   ("mothers against decapentaplegic homolog 7" 2) ("SMAD-7" 1) ("SMAD 7" 1)
   ("smad7" 1) ("Smad7-" 1)))
 ("UP:O15111"
  (("IKKα" 1221) ("IKK1" 76) ("IKK-α" 44) ("Ikkα" 31) ("CHUK" 22) ("IKKα-" 19)
   ("IKKA" 10) ("Ikka" 9) ("IKKα protein" 8) ("IKKa" 6) ("IKK-alpha" 5)
   ("IKKalpha" 4) ("IKKα (KM)" 3) ("IKK-1" 3) ("p-IKKα" 3)
   ("I-kappaB kinase" 3) ("IKKα(EE)" 3) ("transfected exogenous IKKα" 2)
   ("silent IKKα" 2) ("Ikkα protein" 2) ("Ikk1" 2) ("dominant-negative IKKα" 2)
   ("-IKKα" 2) ("wild-type B cells more phospho-IKKα" 1) ("IKBKA" 1)
   ("PMA-treated IKKα −/−" 1) ("pIKKα" 1)
   ("conserved helix-loop-helix ubiquitous kinase" 1) ("IKK−α" 1)
   ("proximal CHUK" 1) ("IKKα(KM)" 1) ("IKK1-" 1) ("than IKK1" 1)
   ("dual IKKα" 1) ("than IKKα ( xref and xref )" 1) ("than IKKα" 1)
   ("IKKα(AA)" 1)))
 ("UP:O15116" (("Lsm1" 65) ("LSM1" 31)))
 ("UP:O15117"
  (("ADAP" 22) ("FYB" 11) ("SLAP-130" 7) ("Fyb" 3)
   ("SLP-76–associated phosphoprotein" 2)
   ("SLP-76–associated phosphoprotein (SLAP)" 1)))
 ("UP:O15118"
  (("liposomes" 692) ("NPC1" 109) ("Liposomes" 56) ("artificial liposomes" 12)
   ("intact liposomes" 5) ("multivesicular liposomes" 4) ("Npc1" 4)
   ("-liposomes" 3) ("cationic liposomes" 2) ("Giant unilamellar liposomes" 2)
   ("inert liposomes" 2) ("cholesterol artificial liposomes" 2)
   ("Synthetic unilamellar 100 nm liposomes" 2) ("P-liposomes" 2)
   ("mimetic liposomes" 2) ("Lipofectamine 2000-based liposomes" 1)
   ("Loosely associated liposomes" 1) ("neutral liposomes" 1)
   ("larger liposomes" 1) ("using cationic liposomes" 1) ("most liposomes" 1)
   ("artificial membrane liposomes" 1) ("NPC1-" 1)
   ("synthetic 100 μm unilamellar liposomes" 1) ("Unilamellar liposomes" 1)
   ("than liposomes" 1)))
 ("UP:O15119"
  (("Tbx3" 257) ("TBX3" 59) ("Tbx3 protein" 13) ("XHL" 6)
   ("the transcriptional repressor Tbx3" 1)))
 ("UP:O15120"
  (("beta)" 44) ("BSCL" 8) ("Beta)" 4) ("AGPAT2" 4)
   ("Berardinelli–Seip congenital lipodystrophy" 2)
   ("the
logistic regression beta)"
    1)))
 ("UP:O15121" (("MLD" 47) ("DEGS1" 1) ("DES1" 1)))
 ("UP:O15123"
  (("Ang2" 109) ("Ang-2" 36) ("ANGPT2" 8) ("Angiopoietin-2" 7)
   ("angiopoietin-2" 6) ("Angpt2" 5) ("ANG-2" 3) ("angiopoietin 2" 2)
   ("Ang-2 protein" 2) ("angiopoietin2" 2)))
 ("UP:O15126" (("SCAMP" 4))) ("UP:O15127" (("SCAMP2" 1)))
 ("UP:O15131" (("KPNA5" 8) ("importin subunit alpha-6" 4)))
 ("UP:O15143"
  (("Arp2/3" 466) ("p41-Arc" 7) ("p41-ARC" 6) ("ARPC1B" 3) ("Arp2/3-" 2)
   ("p41-Arc protein" 1)))
 ("UP:O15144" (("p34-Arc" 2) ("ARPC2" 1) ("34kDa" 1)))
 ("UP:O15145"
  (("P21-Arc" 8) ("21kDa protein" 4) ("a doublet around 21KDa" 1) ("21KDa" 1)
   ("ARPC3" 1) ("21kDa" 1)))
 ("UP:O15146"
  (("MuSK" 53) ("muscle-specific kinase MuSK" 2)
   ("the muscle-specific receptor tyrosine kinase MuSK" 1) ("P-MuSK" 1)))
 ("UP:O15151"
  (("MDMX" 1217) ("Mdmx" 1203) ("MdmX" 926) ("MDM4" 859) ("Mdm4" 311)
   ("HDMX" 168) ("mdmx" 111) ("MDMx" 71) ("p53 regulator" 40)
   ("MDMX protein" 38) ("MDM4 protein" 34) ("mdmX" 22) ("mdm4" 15)
   ("Mdmx protein" 11) ("MdmX protein" 5) ("protein Mdmx" 5) ("Mdmx-" 3)
   ("the potential downstream targets MDM4" 2) ("overexpressed Mdm4" 2)
   ("mouse double minute 4" 2) ("MdmX (HdmX) protein" 2)
   ("overexpressed MDM4" 2) ("fatty tissue lack Mdmx" 2)
   ("the negative transcriptional modulator MDM4" 2)
   ("in turn increases ubiquitinated MdmX" 2) ("mdmx-" 2) ("only Mdmx F488A" 2)
   ("than MDMX" 2) ("Cloning flag-tagged MDM4" 2)
   ("still significantly more MDM4 protein" 2) ("MDM4 (MDMX) protein" 2)
   ("MDM4 (HDMX)" 2) ("a key p53 regulator" 1) ("clear Mdmx" 1)
   ("than human MDM4" 1) ("than MDM4" 1)
   ("Mdm2-like p53-binding protein (HDMX)" 1)
   ("Mdm2-like p53-binding protein" 1) ("the major p53 regulator" 1)
   ("a stapled p53 helix preferentially targets HDMX" 1)
   ("than full-length mdmx" 1) ("these ruthless conditions MDMX protein" 1)
   ("than full-length MDMX    [ xref ]" 1)
   ("DNA breaks not only targets MDMX" 1) ("than MdmX" 1) ("exogenous Mdmx" 1)
   ("than MDMX [ xref ]" 1) ("resident HDMX" 1) ("than full length MDM4" 1)
   ("than wildtype Mdmx" 1) ("MDMX-" 1)))
 ("UP:O15155" (("BET1" 1))) ("UP:O15160" (("AC40" 8) ("POLR1C" 4)))
 ("UP:O15162" (("PLSCR1" 8)))
 ("UP:O15164"
  (("TRIM24" 37) ("TIF1A" 6) ("Factor 1A" 5) ("TIF1" 5) ("TIF-1" 3)
   ("TIF1α" 2)))
 ("UP:O15169"
  (("Axin" 1686) ("axin" 290) ("Axin1" 259) ("AXIN1" 134) ("AXIN" 30)
   ("Axin1 protein" 25) ("Axin protein" 13) ("-axin" 9) ("Axin 1" 8)
   ("Axin-1" 7) ("axin-1" 6) ("overexpressed Axin" 5) ("AXIN protein" 4)
   ("hAxin" 4) ("Axin–" 2) ("N-terminal flag-tagged Axin" 2)
   ("than those expressing Axin" 2) ("axin peptide" 2)
   ("almost no detectable AXIN1" 2) ("the cellular axin" 1)
   ("N-terminal flag-tagged mouse Axin" 1) ("20R2-bound Axin" 1)
   ("Drosophila Axin:endogenous hAxin1" 1) ("AXIN-1" 1) ("axin protein" 1)
   ("axin1" 1) ("intestinal Axin" 1) ("intestinal Axin1" 1) ("Axin1-" 1)
   ("forms around Axin" 1)))
 ("UP:O15173" (("pMBP" 5)))
 ("UP:O15178"
  (("tGFP" 20) ("TFT" 13) ("protein T" 5) ("-tGFP" 3) ("SAVA" 3)
   ("autocrine TGFp" 1) ("TGFp" 1) ("protein t" 1)))
 ("UP:O15182" (("CEN3" 4) ("centrin 3" 1)))
 ("UP:O15194"
  (("RBSP3" 161) ("CTDSPL" 35) ("S/CP3" 27) ("HYA22" 4) ("Scp3" 3)))
 ("UP:O15197"
  (("Hep" 210) ("hep" 113) ("HEp" 27) ("EPHB6" 16) ("HEP" 12) ("HeP" 5)
   ("hEP" 4) ("EphB6" 2)))
 ("UP:O15198" (("SMAD9" 4) ("SMAD8" 1)))
 ("UP:O15205"
  (("UBD" 308) ("UBDs" 122) ("FAT10" 122) ("diubiquitin" 43)
   ("previously described UBDs" 3) ("UBD- protein" 3) ("a heterologous UBD" 2)
   ("canonical UBDs" 2) ("two distinct UBDs" 1)
   ("The Myc-6xHis-tagged FAT10" 1) ("an intact UBD" 1)
   ("any previously known UBDs" 1) ("a canonical UBD" 1)
   ("isolated α-helical UBDs" 1) ("an additional α-helical UBD" 1)
   ("These α-helical UBDs" 1) ("UBD-" 1)))
 ("UP:O15209" (("ZBTB22" 1))) ("UP:O15211" (("RGL2" 34) ("Rgl2" 1)))
 ("UP:O15212" (("PFDN6" 1)))
 ("UP:O15217"
  (("GSTA4" 4) ("glutathione S-transferase alpha 4" 2) ("GSTA4-4" 1)))
 ("UP:O15226"
  (("pNrf" 97) ("Nrf" 11) ("NRF" 11) ("NRF protein" 2)
   ("HMVEC-d cells increases nuclear pNrf2" 2)))
 ("UP:O15229" (("KMO" 1) ("pKMO" 1))) ("UP:O15230" (("LAMA5" 9)))
 ("UP:O15232" (("HOA" 2)))
 ("UP:O15234" (("Btz" 78) ("CASC3" 5) ("MLN51" 2) ("BTZ" 1)))
 ("UP:O15235"
  (("RPS12" 2) ("mitochondrial ribosomal protein S12" 2) ("Mrps12" 1)
   ("MRPS12" 1)))
 ("UP:O15239" (("NDUFA1" 1)))
 ("UP:O15240" (("VGF" 16) ("vgf" 4) ("neurosecretory protein VGF" 1)))
 ("UP:O15243" (("LEPROT" 4) ("OBRs" 3)))
 ("UP:O15244"
  (("creatinine" 344) ("Oct2" 6) ("Creatinine" 5) ("SLC22A2" 5)
   ("urinary creatinine" 3)
   ("a urinary albumin/creatinine ratio (ACR) ≥300 mg/g creatinine" 2)
   ("a urinary albumin/creatinine ratio (ACR) ≥300 mg/g creatinine" 2)
   ("raised serum creatinine" 1)
   ("cerebrovascular disease, and serum creatinine" 1) ("Urinary creatinine" 1)
   ("creatinine (CREA)" 1)))
 ("UP:O15245"
  (("SLC22A1" 18) ("OCT-1" 16) ("organic cation transporter 1" 12)))
 ("UP:O15247" (("CLIC2" 4))) ("UP:O15258" (("RER1" 4)))
 ("UP:O15259"
  (("NPHP1" 142) ("nephrocystin-1" 17) ("Nphp1" 4) ("Nephrocystin-1" 3)))
 ("UP:O15260" (("SURF4" 3)))
 ("UP:O15263"
  (("hBD-2" 45) ("beta 2" 19) ("Sap1" 9) ("Beta 2" 5) ("beta defensin-2" 5)
   ("BD2" 4) ("beta-defensin 2" 3) ("beta defensin 2" 3) ("hBD2" 2)
   ("hBD-2 protein" 2) ("hBD-2 peptide" 2) ("DEFB4B" 1) ("DEFB4A" 1) ("HBD2" 1)
   ("bD2" 1)))
 ("UP:O15264"
  (("p38δ" 284) ("MAPK13" 3) ("mitogen-activated protein kinase 13" 1)
   ("SAPK4" 1) ("O15264" 1)))
 ("UP:O15265"
  (("ataxin-7" 77) ("Ataxin-7" 28) ("SCA7" 23) ("ATXN7" 21) ("Atxn7" 3)
   ("ataxin 7" 1) ("ATXN7-" 1)))
 ("UP:O15266" (("SHOX" 3) ("short stature homeobox" 2)))
 ("UP:O15269" (("Spt-1" 5) ("hereditary sensory neuropathy" 3) ("HSN1" 1)))
 ("UP:O15270" (("SPTLC2" 1)))
 ("UP:O15273"
  (("telethonin" 8) ("TCAP" 7) ("titin-cap" 2) ("Telethonin" 1) ("T-Cap" 1)
   ("titin-cap ( TCAP )" 1)))
 ("UP:O15287"
  (("X-ray repair" 131) ("FANCG" 129) ("FA-G" 29) ("in Chinese hamster" 28)
   ("x-ray repair" 11) ("Fancg" 9) ("complementing defective" 7)
   ("in Chinese Hamster" 4) ("X-ray Repair" 2) ("X-Ray Repair" 2)
   ("than FANCG" 1) ("FAG" 1) ("XRCC9" 1) ("In Chinese hamster" 1)
   ("FANCG-" 1)))
 ("UP:O15294"
  (("OGT" 241) ("Ogt" 18) ("Ogt protein" 9) ("ogt" 5) ("OGT protein" 3)
   ("OGT-" 2) ("more OGT" 1) ("cellular OGT" 1)))
 ("UP:O15296"
  (("type B" 123) ("second type" 64) ("15-LOX-2" 12) ("Type B" 4)
   ("manual occupation, and blood group type B" 3) ("ALOX15B" 3)
   ("Acute lymphoblastic leukemia type B" 2) ("type B (CSB)" 2)
   ("aortic arch type B" 1) ("interrupted aortic arch type B" 1)
   ("atrophic gastritis type B" 1)))
 ("UP:O15297"
  (("Wip1" 475) ("WIP1" 141) ("PPM1D" 92) ("Wip1 protein" 6)
   ("protein phosphatase 1D" 6) ("-Wip1" 3) ("PP2Cδ" 2)
   ("a
hyperactive Wip1"
    2)
   ("Wip1-" 1) ("more Wip1" 1)))
 ("UP:O15304"
  (("SIVA1" 247) ("Siva1" 198) ("Siva2" 11) ("Siva" 11) ("SIVA1 protein" 3)
   ("using GST-fused SIVA1" 1) ("exogenous SIVA1" 1)))
 ("UP:O15305" (("PMI" 124) ("PMM2" 2) ("CDGS" 1) ("PMI-" 1)))
 ("UP:O15315"
  (("paralogs" 523) ("RAD51B" 110) ("RAD51L1" 24) ("Rad51B" 9)
   ("DsRed-Monomer-tagged RAD51B" 5) ("rec2" 3) ("RAD51B-" 2)
   ("only two MDM paralogs" 2) ("one or more paralogs" 2) ("Rad51L1" 1)
   ("around twenty Exo70 paralogs" 1) ("functionally redundant paralogs" 1)
   ("two ( xref ) MVB12 (MVB12A and MVB12B) paralogs" 1)
   ("indeed both paralogs" 1) ("whose paralogs" 1) ("“rec2”" 1) ("rEC2" 1)))
 ("UP:O15318" (("POLR3G" 1)))
 ("UP:O15327"
  (("inositol polyphosphate 4-phosphatase type II" 38)
   ("Inositol Polyphosphate 4-phosphatase type II" 2)
   ("inositol polyphosphate 4-phosphatase
type II"
    1)))
 ("UP:O15335" (("chondroadherin" 2) ("CHAD" 1))) ("UP:O15342" (("ATP6V0E1" 2)))
 ("UP:O15344"
  (("MID1" 188) ("Osx" 78) ("OSX" 21) ("MID1 protein" 4) ("mId1" 2) ("Mid1" 2)
   ("Midline 1" 2)))
 ("UP:O15347" (("HMGB3" 8)))
 ("UP:O15350"
  (("p73" 6194) ("TAp73" 2419) ("TP73" 253) ("p73 protein" 73) ("P73" 69)
   ("Tp73" 38) ("TAp73 protein" 32) ("p53-related protein" 10)
   ("overexpressed p73" 7) ("than p73" 6) ("p73-" 4) ("–p73" 4)
   ("targeting p73" 4) ("TAp73-" 3) ("pro-apoptotic TAp73" 3)
   ("p73 (HA-p73) protein" 3) ("overexpressed TAp73" 3) ("-TAp73" 2)
   ("P73 protein" 2) ("-p73" 2) ("logistic regression analyses TP73" 2)
   ("the pro-apoptotic gene p73" 2)
   ("endogenous Cul1 indeed binds Flag-tagged TAp73" 2) ("simian p73" 2)
   ("its transcriptional target p73" 2) ("than p73 ( xref )" 2)
   ("monoclonal p73" 2) ("strong cytoplasmic p73" 2)
   ("expressing dominant negative p73" 2) ("a dominant-negative p73" 1)
   ("P73-" 1) ("transcriptional p73" 1) ("the proapoptotic p73" 1)
   ("disable p73" 1) ("apoptotic TAp73" 1) ("the exogenous p73" 1)
   ("bona fide p73" 1) ("previously reported p73" 1) ("particular p73" 1)
   ("perhaps less definitive model implicating p73" 1) ("exogenous p73" 1)
   ("phosphor-mimetic mutant p73" 1) ("phosphor-mimetic p73" 1) ("p73-WT’s" 1)
   ("more TAp73" 1) ("slightly more TAp73" 1) ("than either TAp73" 1)
   ("282-fold (± 65) more TAp73" 1) ("further activated p73" 1)
   ("further phosphorylated p73" 1) ("These findings not only support p73" 1)
   ("Functional p73" 1) ("strong p73" 1)))
 ("UP:O15353"
  (("Foxn1" 51) ("WHN" 24) ("FOXN1" 4)
   ("6-week-old female immune-deficient Athymic Nude FOXN1" 1)
   ("Five-week-old female athymic nude Foxn1" 1) ("foxn1" 1)))
 ("UP:O15354" (("PAEL-R" 1)))
 ("UP:O15355" (("PPM1G" 147) ("PP2Cγ" 6) ("PPM1G protein" 2)))
 ("UP:O15357" (("SHIP2" 30) ("SHIP-2" 15) ("INPPL1" 9) ("Ship2" 2)))
 ("UP:O15360"
  (("FANCA" 494) ("FA-A" 101) ("mouse monoclonal FANCA" 3)
   ("defective FANCA" 2) ("exogenous FANCA" 2) ("FANCA-" 2) ("-FANCA" 1)
   ("5 more FANCA point mutations" 1)))
 ("UP:O15370" (("SOX12" 1))) ("UP:O15371" (("eIF3d" 13) ("EIF3D" 2)))
 ("UP:O15372"
  (("EIF3H" 82) ("eukaryotic translation initiation factor 3 subunit H" 3)
   ("EIF3S3" 2) ("than EIF3H" 1)))
 ("UP:O15379"
  (("HDAC3" 3041) ("histone deacetylase 3" 28) ("HDAC3 protein" 28)
   ("HDAC-3" 21) ("Hdac3" 17) ("histone deacetylase-3" 13)
   ("Histone deacetylase 3" 12) ("pHDAC3" 6) ("ZBP-89 diminished HDAC3" 4)
   ("HDAC3 molecule" 3) ("overexpressed HDAC3" 2) ("ZBP-89 decreased HDAC3" 2)
   ("p-HDAC3" 2) ("specifically target HDAC3" 1) ("flow-induced HDAC3" 1)
   ("histone deacetylase 3 (HDAC3) protein" 1) ("HDAC3-" 1)
   ("a known transcriptional repressor HDAC3" 1)
   ("the transcriptional repressor HDAC3" 1) ("traffic HDAC3" 1)
   ("weak HDAC3" 1) ("strong HDAC3" 1) ("-HDAC3" 1)))
 ("UP:O15382" (("BCATM" 2) ("bcat2" 1))) ("UP:O15389" (("Siglec-5" 3)))
 ("UP:O15391" (("YY2" 1)))
 ("UP:O15392"
  (("survivin" 2347) ("Survivin" 762) ("BIRC5" 189) ("survivin protein" 32)
   ("Birc5" 27) ("SURVIVIN" 8) ("birc5" 6) ("Apoptosis Inhibitor Survivin" 6)
   ("-survivin" 3) ("BIRC5 ( SURVIVIN)" 3)
   ("baculoviral IAP repeat containing 5" 2) ("Survivin protein" 2)
   ("pre-constructed Survivin" 2) ("the Survivin" 2)
   ("baculoviral IAP repeat-containing 5" 2)
   ("smallest IAP family member survivin" 1) ("particular Survivin’s" 1)
   ("particular Survivin" 1) ("stably knockdown Survivin" 1) ("a Survivin" 1)
   ("STAT3-regulated antapoptotic gene products survivin" 1)
   ("all benign and malignant SGTs expressed survivin" 1) ("that survivin’s" 1)
   ("After survivin’s" 1) ("survivin-" 1) ("Multifunctional survivin" 1)
   ("Survivin (QIAGEN)" 1) ("selectively knock-down endogenous survivin" 1)))
 ("UP:O15393"
  (("TMPRSS2" 494) ("transmembrane protease, serine 2" 7) ("Tmprss2" 2)
   ("than TMPRSS2" 1)))
 ("UP:O15394" (("NCAM2" 7) ("neural cell adhesion molecule 2" 3)))
 ("UP:O15397" (("IPO8" 15) ("Importin 8" 3) ("Ipo8" 2) ("importin 8" 1)))
 ("UP:O15399" (("GRIN2D" 10) ("NR2D" 1))) ("UP:O15403" (("SLC16A6" 5)))
 ("UP:O15405" (("TOX3" 127) ("TNRC9" 85)))
 ("UP:O15409" (("FOXP2" 79) ("FoxP2" 2) ("Foxp2" 2)))
 ("UP:O15431" (("CTR1" 48) ("Ctr1" 32) ("-CTR1" 3) ("copper transporter 1" 2)))
 ("UP:O15432" (("SLC31A2" 2)))
 ("UP:O15438"
  (("MRP3" 227) ("ABCC3" 84) ("Mrp3" 18) ("Abcc3" 7) ("MRP3 protein" 3)
   ("Mlp2" 2)))
 ("UP:O15439"
  (("ABCC4" 64) ("MRP4" 23) ("ATP-binding cassette sub-family C member 4" 4)
   ("multidrug resistance-associated protein 4" 3) ("member 4)" 2) ("Mrp4" 1)))
 ("UP:O15440" (("MRP5" 52) ("ABCC5" 25) ("ABCC5 protein" 1)))
 ("UP:O15444" (("CCL25" 2) ("Ccl25" 1)))
 ("UP:O15446"
  (("cast" 141) ("CAST" 45) ("Cast" 2) ("a fragile enzyme cast" 1) ("ASE-1" 1)
   ("the pre-synaptic active zone protein CAST" 1) ("an entirely new cast" 1)))
 ("UP:O15453" (("NBR2" 31)))
 ("UP:O15455"
  (("TLR3" 854) ("TLR-3" 31) ("TLR3-" 16) ("Toll-like receptor 3" 11)
   ("toll-like receptor 3" 6) ("Tlr3" 2) ("than TLR3" 1)
   ("than endosomal TLR3 ( xref , xref )" 1)))
 ("UP:O15460" (("P4HA2" 19)))
 ("UP:O15467" (("LMC" 27) ("member 16" 4) ("representative LMC" 1)))
 ("UP:O15492" (("RGS16" 12) ("Rgs16" 2))) ("UP:O15498" (("Ykt6" 1)))
 ("UP:O15503"
  (("Insig-1" 12) ("INSIG1" 5) ("CL-6" 4) ("INSIG-1" 3) ("insig-1" 2)
   ("Insulin induced gene 1" 1)))
 ("UP:O15504" (("hCG1" 18) ("nucleoporin hCG1" 8) ("NLP1" 4)))
 ("UP:O15511" (("16kDa" 1)))
 ("UP:O15516"
  (("clock" 553) ("CLOCK" 345) ("the circadian clock" 89) ("Clock" 44)
   ("the mammalian circadian clock" 19) ("“clock”" 7) ("circadian clock" 4)
   ("clock protein" 4) ("the SCN circadian clock" 4) ("a mitotic clock" 3)
   ("the biological clock" 2) ("The mammalian circadian clock" 2)
   ("The circadian clock" 2) ("a biological “clock”" 2) ("optimal clock" 2)
   ("the mitotic clock" 2) ("The cellular clock" 1) ("the circadian clock's" 1)
   ("mammalian circadian clock" 1) ("possible clock" 1)
   ("an internal circadian clock" 1) ("the cardiomyocyte circadian clock" 1)
   ("the clock's" 1) ("the molecular circadian clock" 1)
   ("a multilevel cellular clock" 1) ("a functional clock" 1)
   ("the human circadian clock" 1) ("clock—" 1) ("this circadian clock" 1)
   ("the internal viability “clock”" 1)
   ("a pre-established intracellular clock" 1)
   ("the cell-autonomous circadian clock" 1) ("this mitotic clock" 1)
   ("a replicative clock" 1) ("The SCN circadian clock" 1)
   ("biological clock" 1) ("clock circadian regulator" 1) ("Clock-" 1)))
 ("UP:O15519"
  (("c-FLIP" 810) ("cFLIP" 458) ("CFLAR" 32) ("flame" 25) ("c-Flip" 20)
   ("CAsH" 18) ("cFlip" 8) ("c-FLIP protein" 8) ("CASH" 7) ("c-FLIPs" 5)
   ("casper" 5) ("c-flip" 4) ("cash" 3) ("antiapoptotic CFLAR" 2)
   ("the pro-apoptotic E3 ligase Itch and anti-apoptotic c-FLIP" 2)
   ("CASP8 and FADD-like apoptosis regulator (CFLAR)" 2)
   ("cellular FLICElike inhibitory protein" 2) ("antiapoptotic c-FLIP" 2)
   ("Casper" 2) ("C-FLIP" 1) ("than cFLIP" 1) ("c-FLIP-" 1) ("MRIT" 1)
   ("caspase-like apoptosis regulatory protein" 1)
   ("CASP8 and FADD-like apoptosis regulator" 1) ("caspase homolog" 1)
   ("Cash" 1)))
 ("UP:O15520"
  (("FGF10" 220) ("FGF-10" 79) ("Fgf10" 67) ("FGFR2IIIb" 15)
   ("fibroblast growth factor 10" 10) ("FGF 10" 4) ("Fgf10 protein" 3)
   ("the epithelial-specific isoform FGFR2IIIb" 2)
   ("fibroblast growth factor-10" 2) ("than FGF10" 1)))
 ("UP:O15522" (("NKX2.8" 9) ("Nkx2.8" 5) ("NKX2.8 protein" 4)))
 ("UP:O15523" (("DDX3Y" 12)))
 ("UP:O15524"
  (("SOCS1" 768) ("SSI-1" 131) ("SOCS-1" 63) ("TIP3" 49)
   ("suppressor of cytokine signaling 1" 29) ("SOCS1 protein" 9) ("JAB" 8)
   ("socs1" 7) ("Suppressor of cytokine signaling 1" 4) ("SOCS1-" 3)
   ("suppressor of
                cytokine signaling 1"
    3)
   ("IFNAR1-associated SOCS1" 3) ("SSI-1 protein" 2) ("SOCS-1 protein" 2)
   ("CIS1" 2) ("Jab" 1) ("than SOCS-1" 1) ("Socs1" 1)))
 ("UP:O15525"
  (("MAFG" 221) ("MafG" 205) ("-MafG" 6) ("MafG protein" 2) ("than MafG" 1)
   ("MAFG protein" 1) ("the transcriptional repressor MAFG" 1)))
 ("UP:O15527"
  (("OGG1" 780) ("MMH" 93) ("hOGG1" 71) ("OGG1 protein" 34)
   ("8-oxoguanine DNA glycosylase" 22) ("AP lyase" 18) ("Ogg1" 14)
   ("8-Oxoguanine DNA glycosylase" 11) ("8-oxoguanine-DNA glycosylase" 10)
   ("hOGG1-" 5) ("hOGG1 protein" 4) ("“OGG1\"" 4) ("polymorphic OGG1" 3)
   ("AP-lyase-" 2) ("renal OGG1" 2) ("ogg1" 2) ("AP-lyase" 1)))
 ("UP:O15528"
  (("CYP27B1" 21) ("CYP27B" 6) ("CYP27b1" 3)
   ("25-hydroxyvitamin D-1 alpha hydroxylase" 1)))
 ("UP:O15530"
  (("PDK1" 3200) ("PDPK1" 97)
   ("phosphoinositide-dependent protein kinase 1" 28)
   ("3-phosphoinositide-dependent protein kinase 1" 27)
   ("3-phosphoinositide-dependent protein kinase-1" 23)
   ("phosphoinositide-dependent protein kinase-1" 11)
   ("3-phosphoinositide dependent protein kinase-1" 10) ("pPDK1" 9)
   ("phosphoinositide-dependent protein kinase" 8) ("PDK1 protein" 7)
   ("3-phosphoinositide–dependent protein kinase-1" 6) ("-PDK1" 6) ("PDK1−" 4)
   ("Phosphoinositide-dependent protein kinase 1" 3) ("PDK1 molecule" 3)
   ("3-Phosphoinositide-Dependent-Protein-Kinase 1" 3)
   ("-phosphoinositide-dependent protein kinase-1" 2) ("total cellular PDK1" 2)
   ("36-fold more PDK1" 2) ("3-Phosphoinositide-dependent protein kinase 1" 1)
   ("particular PDK1" 1) ("exogenous PDK1" 1) ("overexpressing PDK1" 1)
   ("a constitutively-activated PDK1 protein" 1)
   ("therapeutically target PDK1" 1) ("pure PDK1" 1)
   ("phosphoinositide dependent protein kinase" 1)
   ("we first expressed V5-tagged PDK1" 1) ("soluble recombinant PDK1" 1)
   ("vesicle-associated PDK1" 1) ("intestinal crypt enterocytes PDK1" 1)
   ("the more PDK1" 1)))
 ("UP:O15533" (("TAPBP" 5) ("TPN" 1)))
 ("UP:O15534"
  (("period" 5371) ("PER" 454) ("longer period" 44) ("PER1" 39) ("Per1" 38)
   ("Period" 36) ("the neonatal period" 22) ("the perioperative period" 13)
   ("the circadian period" 12) ("the neurogenic period" 10)
   ("the perinatal period" 9) ("shorter period" 8)
   ("the peri-conceptional period" 8) ("the postnatal period" 8)
   ("Canalicular period" 8) ("Pseudoglandular period" 8)
   ("the reproductive period" 7) ("PERIOD" 7) ("circadian period" 7)
   ("the pseudoglandular period" 7) ("period 1" 6) ("last menstrual period" 6)
   ("Period 1" 6) ("the postoperative period" 5) ("resting period" 5)
   ("The referent period" 4) ("perinatal period" 4)
   ("the periconceptional period" 4) ("PERs" 4) ("the latter period" 4)
   ("the immediate postoperative period" 4) ("the referent period" 4)
   ("alveolar period" 4) ("Alveolar (weeks 36 to 40) period" 4)
   ("Saccular (weeks 28 to 36) period" 4) ("longer free-running period" 4)
   ("the perimenopausal period" 3) ("the ischaemic period" 3)
   ("the ischemic period" 3) ("the pre-ischemic period" 3)
   ("the canalicular period" 3) ("early postoperative period" 3)
   ("the fertile period" 2) ("an early fetal period" 2)
   ("the accrual period" 2) ("PSA demonstrated nominally significant period" 2)
   ("cells demonstrated period" 2) ("RORA showed period" 2)
   ("the postmenopausal period" 2) ("the prenatal period" 2)
   ("postovulatory period" 2) ("exponential period" 2)
   ("the circadian clock
gene Per1"
    2)
   ("Per1-" 2) ("their short reproductive period" 2) ("The accrual period" 2)
   ("the post-operative period" 2) ("Hausp increased circadian period" 2)
   ("considerable period" 2) ("calendar period" 2) ("the gestational period" 2)
   ("their reproductive period" 2) ("the last menstrual period" 2)
   ("the menstrual period" 2) ("the foetal period" 2) ("Foetal period" 2)
   ("the subsequent sustained period" 2) ("an optimal period" 2)
   ("the first menstrual period" 2) ("the preclinical period" 2)
   ("the alveolar period" 2) ("longest period" 2)
   ("a 60 day postnatal period" 2) ("a considerable period" 2)
   ("an asymptomatic period" 2) ("an adequate period" 2)
   ("the examined postnatal period" 2) ("the second accrual period" 2)
   ("the first accrual period" 2) ("the Neolithic period" 1)
   ("the optimal period" 1) ("the peri-operative period" 1)
   ("the post-menopausal period" 1) ("the peri-menopausal period" 1)
   ("shorter disease-free period" 1) ("the menopausal period" 1)
   ("the immediate period" 1) ("a clear circadian period" 1)
   ("Typical developmental period" 1) ("the acute period" 1)
   ("a subsequent period" 1) ("shorter circadian period" 1) ("per1" 1)
   ("this midgestational period" 1) ("a prolonged mitotic period" 1)
   ("the immediate post-operative period" 1)
   ("a 15-minute normoxic resting period" 1) ("The reproductive period" 1)
   ("the prepubertal period" 1) ("occurring menstrual period" 1) ("pER1" 1)
   ("foetal period" 1) ("Interestingly both Period 1" 1)
   ("a median asymptomatic period" 1) ("observational period" 1)
   ("the post-ischemic period" 1) ("their perinatal period" 1)
   ("the early-mid neurogenic period" 1) ("longer relapse-free period" 1)
   ("neonatal period" 1) ("the previously described period" 1)
   ("the early neonatal period" 1)
   ("the postnatal
period"
    1)
   ("the convalescent period" 1) ("four week-long period" 1)
   ("The most problematic period" 1) ("pseudoglandular period" 1)
   ("pseudo-glandular period" 1) ("a typical period" 1)
   ("the sample accrual period" 1) ("the patient accrual period" 1)
   ("The first menstrual period" 1) ("the embryonal period" 1)
   ("the lengthy period" 1) ("a significantly lengthened circadian period" 1)
   ("Precise period" 1) ("whose characteristic period" 1) ("-period" 1)
   ("stimulatory period" 1) ("the immediate post-natal period" 1)
   ("calendar period-" 1) ("period-" 1) ("the approximate period" 1)
   ("the fetal period" 1) ("the early postnatal period" 1)
   ("longer fasting period" 1) ("the premenopausal period" 1)
   ("longer predicted period" 1) ("a finite period" 1)
   ("the same observational period" 1) ("altered circadian period" 1)
   ("peri-operative period" 1)))
 ("UP:O15537" (("RS1" 36) ("the associated reference set RS1" 2)))
 ("UP:O15539" (("RGS5" 5)))
 ("UP:O15540"
  (("Blbp" 37) ("mRG" 17) ("BLBP" 15) ("brain lipid binding protein" 6)
   ("FABP7" 2) ("“FACS-mRG”" 1) ("B-FABP" 1) ("Fabp7" 1) ("MRG" 1)
   ("BFABP" 1)))
 ("UP:O15544" (("GR6" 2)))
 ("UP:O15547" (("orphan receptor" 93) ("P2R" 11) ("orphan receptor (TLX)" 2)))
 ("UP:O15550"
  (("KDM6A" 99) ("UTX" 28) ("lysine (K)-specific demethylase 6A" 4) ("Utx" 2)
   ("intact KDM6A" 1)))
 ("UP:O15551"
  (("claudin-3" 38) ("Cldn3" 12) ("Claudin-3" 10) ("CLDN3" 9) ("claudin 3" 4)
   ("claudin3" 3) ("Claudin 3" 2) ("Cldn 3" 1) ("insoluble claudin3" 1)
   ("Claudin3" 1)))
 ("UP:O15552"
  (("FFA" 314) ("Fetal Serum FFA" 2) ("toxic saturated FFA" 2) ("GPR43" 1)
   ("The remarkably increased fetal blood FFA" 1)
   ("The elevated fetal serum FFA" 1) ("unfortunately plasma FFA" 1)
   ("cytototoxic FFA" 1) ("than unsaturated FFA [ xref ]" 1) ("toxic FFA" 1)
   ("nonoxidative FFA" 1)))
 ("UP:O15553"
  (("MEFs" 7128) ("primary MEFs" 68) ("MEFV" 38) ("Primary MEFs" 27)
   ("p53-null MEFs" 23) ("pyrin" 17) ("Src-transformed MEFs" 16)
   ("Tsc2-null MEFs" 14) ("immortalized MEFs" 13) ("Mdm2 null MEFs" 13)
   ("Mediterranean fever" 12) ("doxorubicin-treated MEFs" 12)
   ("Gravin null MEFs" 12) ("PYRIN" 11) ("mEFs" 10) ("—MEFs" 9)
   ("Mdm2-null MEFs" 8) ("p53 null MEFs" 8) ("senescent MEFs" 7)
   ("caveolin-1–null MEFs" 6) ("Immortalized MEFs" 5) ("p110β-null MEFs" 5)
   ("SIRT1 null MEFs" 5) ("IKK-null MEFs" 4) ("pan-p85 null MEFs" 4)
   ("Pak1-expressing MEFs" 4) ("the V-Src-transformed MEFs" 4)
   ("lamin A/C–null MEFs" 4) ("SIRT1-null MEFs" 4) ("normal MEFs" 4)
   ("v-Src–transformed MEFs" 4) ("Bim -null MEFs" 4) ("γ-irradiated MEFs" 3)
   ("p53 -null MEFs" 3) ("the normal MEFs" 3) ("TSC2 null MEFs" 3)
   ("the TSC2 null MEFs" 3) ("menin-null MEFs" 3) ("Menin-null MEFs" 3)
   ("bleomycin-treated MEFs" 3) ("Keap1-null MEFs" 3) ("the treated MEFs" 2)
   ("Patz1-null MEFs" 2) ("Plk4 heterozygous MEFs" 2)
   ("the heterozygous MEFs" 2) ("Mediterranean Fever" 2)
   ("GSK-3 β- null MEFs" 2) ("GSK-3 β null MEFs" 2) ("GSK-3 β -null MEFs" 2)
   ("mitomycin C-treated MEFs" 2) ("Pten null MEFs" 2)
   ("TSC2-expressing or deficient MEFs" 2) ("paxillin-null MEFs" 2)
   ("EGFR null MEFs" 2) ("Transformed MEFs" 2) ("Pml -null MEFs" 2)
   ("vehicle treated MEFs" 2)
   ("SV40 TAg-transformed or 3T9-immortalized MEFs" 2)
   ("wild type MEFs and Mdm2 null MEFs" 2)
   ("wild type MEFs or Mdm2 null MEFs" 2) ("Pten -null MEFs" 2)
   ("mitomycin C treated MEFs" 2) ("Rad18 -null MEFs" 2)
   ("irradiated primary MEFs" 2) ("APAF-1 –null MEFs" 2)
   ("P53DD-immortalized MEFs" 2) ("adenoviral E1A-transformed MEFs" 2)
   ("autophagy-deficient Atg5 null MEFs" 2) ("MFN1 null MEFs" 2)
   ("Lig4-defective MEFs" 2) ("appropriately treated MEFs" 2)
   ("staurosporine-treated MEFs" 2) ("Subconfluent MEFs" 2)
   ("PAK4-null MEFs" 2) ("telomerase-negative MEFs" 2)
   ("both menin-null MEFs" 2) ("immortalized menin-null MEFs" 2)
   ("SirT3 −/− primary and immortalized MEFs" 2) ("Crebbp/Ep300 null MEFs" 2)
   ("cyclin D-null MEFs" 2) ("Mitotic MEFs" 2) ("FAK-null MEFs" 2)
   ("the immortalized MEFs" 2) ("CDK2-null MEFs" 2)
   ("STAT5a/STAT5b null MEFs" 2) ("mitotically inactivated MEFs" 2)
   ("passage 3 primary MEFs" 2) ("Cre-ERT2/floxed/floxed MEFs" 2)
   ("fl/fl or Δ/Δ primary MEFs" 2) ("treated MEFs" 2)
   ("etoposide-treated primary MEFs" 2) ("p110β-RBD-DM primary MEFs" 1)
   ("Mediterranean fever (FMF)" 1) ("MYC-transformed MEFs" 1)
   ("KO primary MEFs" 1) ("3T3-L1 preadipocytes and Fyn null MEFs" 1)
   ("293T cells or p53- null MEFs" 1) ("non-immortalized MEFs" 1)
   ("Pten+/- immortalized MEFs" 1) ("MUS81-null MEFs" 1) ("Patz1- null MEFs" 1)
   ("Ras-expressing MEFs" 1) ("p65-null MEFs" 1)
   ("the respective IKK-null MEFs" 1) ("Pan-p85 null MEFs" 1)
   ("ROS-treated heterozygous MEFs" 1) ("treated Plk4 heterozygous MEFs" 1)
   ("-negative MEFs" 1) ("Pak1-expressing primary MEFs" 1)
   ("PARP-1 null MEFs" 1)
   ("GSK-3 β -null
MEFs"
    1)
   ("KO transformed MEFs" 1) ("unperturbed Fancd2-null MEFs" 1)
   ("the Fancd2-null MEFs" 1) ("Fancd2-null MEFs" 1) ("Tsc2 null MEFs" 1)
   ("cyclin D1  −/− primary MEFs" 1) ("Paxillin-null MEFs" 1)
   ("The paxillin-null (paxillin −/− ) MEFs" 1) ("TRIM20" 1)
   ("both Tsc2-null MEFs" 1) ("Tsc2-expressing MEFs" 1) ("p73-null MEFs" 1)
   ("TAp73 −/− primary MEFs" 1) ("athymic mice primary MEFs" 1)
   ("Ambra1 -defective MEFs" 1) ("APL and Pml -null MEFs" 1)
   ("littermate primary MEFs" 1) ("wildtype primary MEFs" 1) ("−MEFs" 1)
   ("MondoA or Mlx null primary MEFs" 1) ("both p53-null MEFs" 1)
   ("pharmacologically treated MEFs" 1) ("rapamycin treated MEFs" 1)
   ("Trp53 -null MEFs" 1) ("congenic MEFs" 1)
   ("wild type E1A and Ras V12 transformed MEFs" 1) ("3T9-immortalized MEFs" 1)
   ("healthy MEFs" 1) ("both SV40 TAg-transformed and 3T9-immortalized MEFs" 1)
   ("SV40 TAg-transformed MEFs" 1) ("Bax/Bax-deficient MEFs" 1)
   ("The p53 −/− Mdm2 −/− double null MEFs" 1)
   ("Mdm2 −/− p53 −/− double null MEFs" 1) ("the parental MEFs (DKO)" 1)
   ("SV40 large T antigen transformed MEFs" 1) ("RICTOR-null MEFs" 1)
   ("using immortalized MEFs" 1) ("the primary MEFs" 1)
   ("Caveolin null MEFs" 1) ("Pten null Rictor heterozygous MEFs" 1)
   ("Rictor -null MEFs" 1) ("immortalized Rictor -null MEFs" 1)
   ("the 53BP1 -null MEFs" 1) ("53BP1 -null MEFs" 1) ("Rad18-null MEFs" 1)
   ("53BP1-null MEFs" 1) ("p110α-null MEFs" 1)
   ("both MDC1-proficient and MDC1-deficient MEFs" 1)
   ("H-Ras V12 -transformed MEFs" 1) ("hsf1  −/− SV-40 transformed MEFs" 1)
   ("ARF-arrested p21-null MEFs" 1) ("immortalized or primary MEFs" 1)
   ("vector-infected MEFs" 1) ("primary p53-null MEFs" 1) ("Adherent MEFs" 1)
   ("the nullizygous MEFs" 1) ("nullizygous MEFs" 1) ("TRAIL-treated MEFs" 1)
   ("young and senescent MEFs" 1) ("Recipient MEFs" 1)
   ("Primary p53 null MEFs" 1) ("POLG exonuclease null MEFs" 1)
   ("MFN2 null MEFs" 1) ("Near-confluent MEFs" 1) ("RelA-null MEFs" 1)
   ("immortalized pan-p85 null MEFs" 1) ("IKKγΔ-expressing MEFs" 1)
   ("the SIRT1 null MEFs" 1) ("Akt-null MEFs" 1) ("‘MEFs’" 1)
   ("mock-transfected MEFs" 1) ("HSF-1-null MEFs" 1)
   ("Brca1 -defective MEFs" 1) ("BRCA2-defective MEFs" 1)
   ("generateBrca2 ex11−- LT-immortalized MEFs" 1) ("p85α-null MEFs" 1)
   ("null MEFs" 1) ("p53/Mdm2-double null MEFs" 1) ("the transformed MEFs" 1)
   ("SIRT3 null (KO) MEFs" 1) ("YFP + conditional (dKO) MEFs" 1)
   ("The genetically unstable MEFs" 1) ("Mad2 null MEFs" 1)
   ("caspase-2 null MEFs" 1) ("immortalized and primary MEFs" 1)
   ("subconfluent MEFs" 1) ("FoxM1-null immortalized MEFs" 1)
   ("confluent MEFs" 1) ("quiescent MEFs" 1) ("E1A transformed MEFs" 1)
   ("normal (FAK +/+ ) MEFs" 1) ("STAT5a/b null MEFs" 1)
   ("these immortalized MEFs" 1) ("FAK null MEFs" 1) ("than normal MEFs" 1)
   ("FOXM1-null MEFs" 1) ("GFP-expressing MEFs" 1) ("residual MEFs" 1)
   ("Pin1-expressing (WT) MEFs" 1) ("H-RasV12/shp53 transformed MEFs" 1)
   ("p400-defective MEFs" 1) ("70% confluent MEFs" 1)
   ("sodium pervanadate-treated MEFs" 1) ("wild-type primary MEFs" 1)
   ("TBK1-null MEFs" 1) ("CIRBP null MEFs" 1) ("FAK-null (FAK −/− ) MEFs" 1)
   ("Ethanol-treated MEFs" 1) ("etoposide-treated MEFs" 1)
   ("caveolin-1 null MEFs" 1)))
 ("UP:O15554" (("KCa3.1" 7) ("KCNN4" 6) ("SK4" 2))) ("UP:O15945" (("TGO" 1)))
 ("UP:O15991" (("LK" 64) ("Lk" 1)))
 ("UP:O16011"
  (("MM" 3292) ("USA" 249) ("primary MM" 6) ("symptomatic MM" 5) ("MM (USA)" 4)
   ("than MM" 4) ("SMM" 3) ("extramedullary MM" 3) ("previously treated MM" 2)
   ("untreated symptomatic MM" 2) ("most MM" 2) ("extra-medullary MM" 2)
   ("relapsed or refractory MM" 2) ("intramedullary MM" 2) ("diagnostic MM" 2)
   ("credible MM" 1) ("less-aggressive MM" 1) ("metastatic MM" 1)
   ("overt MM" 1) ("vulvar MM" 1) ("Only five vulvar MM" 1)
   ("than MM which is indicative" 1) ("residual MM" 1) ("MM-" 1)
   ("the respective MM" 1) ("9 primary MM" 1) ("new MM" 1)
   ("relapsed and refractory MM" 1) ("isogenic cell lines Dex-sensitive MM" 1)
   ("e.g. dexamethasone-resistant MM" 1) ("spontaneous MM" 1)
   ("FGFR3-driven MM" 1) ("consecutive (non-selected) MM" 1) ("cutaneous MM" 1)
   ("“MM”" 1)))
 ("UP:O16140" (("TopoII" 80) ("topoII" 55))) ("UP:O16277" (("hIL-6" 10)))
 ("UP:O16850"
  (("DAF-16" 178) ("potential DAF-16" 1) ("DAF-16-" 1) ("DAF16" 1)))
 ("UP:O17468" (("SSM" 53) ("than SSM" 1))) ("UP:O17536" (("hIL-4" 6)))
 ("UP:O17966" (("TopoI" 8) ("topoI" 2) ("Topo-I" 1)))
 ("UP:O18158"
  (("O-GlcNAc" 119) ("In vitro chemoenzymatic O-GlcNAc" 4) ("O-GlcNac" 2)))
 ("UP:O18404" (("SCU" 1))) ("UP:O18412" (("Fzo" 5)))
 ("UP:O18413"
  (("ug" 146) ("UG" 33) ("approximately 250 ug" 2) ("approximately 20 ug" 1)
   ("the natural UG" 1)))
 ("UP:O18602" (("RPG" 3))) ("UP:O18778" (("LN1" 3)))
 ("UP:O18836" (("MH" 108) ("pMH" 7))) ("UP:O18979" (("NESP55" 3)))
 ("UP:O21947" (("gp32" 2))) ("UP:O22056" (("SigmaA" 1)))
 ("UP:O22152" (("AT" 1068) ("FIL" 2)))
 ("UP:O22194" (("Rat1" 95) (NIL 3) ("rat1" 1))) ("UP:O22265" (("CaO" 2)))
 ("UP:O22267" (("CKI-1" 6)))
 ("UP:O22287" (("CYT-1" 29) ("Cyt1" 24) ("CYT1" 3)))
 ("UP:O22315" (("SR-1" 9) ("SR1" 8) ("sR1" 1) ("Sr1" 1)))
 ("UP:O22446" (("Hda1" 59) ("HDA1" 20) ("hda1 protein" 3) ("hda1" 1)))
 ("UP:O22585" (("beta-amylase" 2))) ("UP:O22646" (("pLOC" 5)))
 ("UP:O22752" (("ntA" 1))) ("UP:O22781" (("Set3" 1))) ("UP:O22824" (("FH2" 6)))
 ("UP:O22881" (("kt2" 5))) ("UP:O22886" (("UPD2" 1)))
 ("UP:O23404" (("pPDK" 2))) ("UP:O23530" (("Snc1" 5) ("SNC1" 4) ("snc1" 1)))
 ("UP:O23651"
  (("TS1" 86) ("bicistronic reporter constructs TS1-wt" 2)
   ("the β 2 integrin–blocking mAb TS1.18" 1)))
 ("UP:O23702" (("CtBPs" 8))) ("UP:O23708" (("PRC3" 1)))
 ("UP:O24006"
  (("Amp" 196) ("amp" 37) ("amp-" 6)
   ("the undivided group displayed high Amp" 1)))
 ("UP:O24520" (("AHB1" 1)))
 ("UP:O24562" (("BM1" 36) ("REVRF" 6) ("BM1 (REVRF)" 4)))
 ("UP:O24585" (("CR4" 8) ("pCR4" 4))) ("UP:O24646" (("HY5" 11) ("Hy5" 7)))
 ("UP:O24743" (("SDSA" 22))) ("UP:O24821" (("PPM" 29)))
 ("UP:O26325"
  (("CpGs" 672) ("most CpGs" 3) ("consecutive CpGs" 2) ("almost all CpGs" 2)
   ("potential transcriptionally important CpGs" 2)
   ("Potential transcriptionally important CpGs" 2)
   ("two closely adjacent CpGs" 2) ("targeted CpGs" 2) ("the proximal CpGs" 2)
   ("adjacent CpGs" 1) ("approximately 4 methylated CpGs" 1)
   ("approximately three million CpGs" 1) ("exonic CpGs" 1)
   ("1367 autosomal CpGs" 1) ("than 5% CpGs" 1) ("very few CpGs" 1)
   ("discrete CpGs" 1) ("only 2 CpGs" 1) ("a few CpGs" 1)
   ("the neighboring CpGs" 1)))
 ("UP:O27438" (("RPAs" 7)))
 ("UP:O27848" (("HTA" 24) ("HTAs" 5) ("“HTA”" 1) ("most HTAs" 1)))
 ("UP:O28088" (("DHS-1" 10))) ("UP:O28383" (("AF3" 10) ("Af3" 1)))
 ("UP:O28484"
  (("Pol II" 1119) ("Polymerase II" 125) ("polymerase II" 36) ("p-Pol II" 28)
   ("POLII" 5) ("Polymerase II ( RPII )" 3) ("soluble Pol II" 2)
   ("causes genome-wide Pol II" 2)
   ("Pol
 II"
    2)
   ("stalled Pol II" 2) ("RNAPII" 2)
   ("monoclonal mouse anti-human RNA Polymerase II" 2)
   ("Polymerase II (POLII)" 1)
   ("nearly all the promoter-proximally paused Pol II" 1)
   ("causes widespread Pol II" 1) ("–Pol II" 1)
   ("chromatin-associated Pol II" 1) ("Polymerase II (RNAPII)" 1)))
 ("UP:O28783" (("IOR" 16)))
 ("UP:O29425" (("DFX" 89) ("the hypoxia mimetic DFX" 1)))
 ("UP:O29749" (("hMEC" 56))) ("UP:O29911" (("pRIL" 1)))
 ("UP:O30124" (("Sir2Af2" 28))) ("UP:O30709" (("C-sos1" 15)))
 ("UP:O30808"
  (("TME" 125) ("pTME" 5) ("a pro-tumorigenic TME" 1) ("“TME”" 1)
   ("“CAV-TME”" 1) ("the hypoxic TME" 1)))
 ("UP:O31466" (("rtPA" 1)))
 ("UP:O31509" (("YEEI" 67) ("pYEEI" 14) ("“YEEI”" 3)))
 ("UP:O31631" (("METi" 89))) ("UP:O31928" (("YopJ" 3)))
 ("UP:O31930" (("YopH" 7) ("whose virulence factor YopH" 1)))
 ("UP:O32028"
  (("PFS" 4482) ("OS" 247) ("longer PFS" 100) ("shorter PFS" 93)
   ("longer median PFS" 25) ("longest PFS" 14) ("shorter median PFS" 14)
   ("longer OS" 12) ("poor PFS" 11) ("significantly worse PFS" 9)
   ("longer first-line PFS" 4) ("a favorable PFS" 4) ("shortest PFS" 3)
   ("only 14.3% 5-year OS" 2) ("Shorter PFS" 2) ("adverse PFS" 2)
   ("a significantly worse median PFS" 2) ("other potential PFS" 2)
   ("further shortened PFS" 2) ("a poor PFS" 2) ("favorable PFS" 2)
   ("significantly inferior PFS" 2)
   ("shorter PFS (2.4 vs. 4.2 months) than those" 1) ("“PFS”" 1)
   ("remarkably favorable PFS" 1) ("shorter OS" 1)
   ("a significantly worse PFS" 1)
   ("elderly patients significantly increased PFS" 1)
   ("the chemorefractory patient subgroup demonstrated improved PFS" 1)
   ("only median PFS" 1)
   ("longer PFS than wild-type EGFR patients (5 versus 3 months, P =0.040 )" 1)
   ("previously reported PFS" 1)
   ("shorter
PFS"
    1)
   ("Independently-assessed PFS" 1) ("survival indicated PFS" 1)
   ("PDGFRL showed poorer PFS" 1) ("than one year PFS" 1)
   ("only EGFR GCN ( P =0.0003, HR: 0.16, 95% CI: 0.06–0.43) independently predicted PFS"
    1)
   ("longer PFS than those" 1)
   ("longer PFS than the mutation-negative patients (n = 14)" 1)
   ("targeted agents PFS" 1) ("than the PFS" 1) ("a good PFS" 1)
   ("a significantly poorer PFS" 1) ("longest median PFS" 1)
   ("monophasic subtype and inferior PFS" 1) ("monophasic 34% 10-year PFS" 1)))
 ("UP:O32091" (("PNCA" 2))) ("UP:O32140" (("Puck" 1)))
 ("UP:O32150" (("Yuri" 3)))
 ("UP:O32264" (("2KR" 158) ("than those overexpressing 2KR" 1)))
 ("UP:O32323" (("HSs" 4) ("HsS" 4)))
 ("UP:O33672"
  (("CSP" 176) ("Csp" 13) ("bacterial CSP" 3) ("csp" 3) ("CSP peptide" 2)
   ("the bacterial CSP" 1) ("the presynaptic vesicle marker CSP" 1)))
 ("UP:O34389" (("MALS" 29))) ("UP:O34527" (("CymR" 1)))
 ("UP:O34605" (("YopM" 1))) ("UP:O34642" (("YOTB" 4)))
 ("UP:O34664"
  (("thin" 693) ("Thin" 34) ("thin-" 2) ("a precast thin" 1) ("“thin”" 1)
   ("typical thin" 1) ("just thin" 1) ("serial thin" 1)
   ("Serial 3  μ m thin" 1)))
 ("UP:O34676" (("KAM" 18))) ("UP:O34697" (("BARC" 3)))
 ("UP:O34741" (("BARD" 6))) ("UP:O34748" (("RecQ" 97) ("recQ" 2)))
 ("UP:O34757" (("DesK" 1)))
 ("UP:O34798"
  (("PDAC" 2523) ("invasive PDAC" 17) ("primary PDAC" 11) ("metastatic PDAC" 5)
   ("nearly all PDAC" 3) ("invasive and metastatic PDAC" 2)
   ("invasive and malignant PDAC" 2) ("almost all PDAC" 2)
   ("moderately-differentiated PDAC" 2)
   ("mainly features moderately-differentiated and poorly-differentiated PDAC"
    2)
   ("fully developed PDAC" 2) ("sporadic PDAC" 2) ("most PDAC" 1)
   ("associated invasive PDAC" 1) ("than the conventional PDAC" 1)
   ("the aforementioned PDAC" 1) ("had developed PDAC" 1) ("Nearly all PDAC" 1)
   ("at least some PDAC" 1) ("invasive or metastatic PDAC" 1)
   ("widespread (>10) metastatic PDAC" 1) ("clinically more aggressive PDAC" 1)
   ("particularly glycolytic PDAC" 1) ("fully developed invasive PDAC" 1)
   ("KRAS-driven PDAC" 1) ("a primary PDAC" 1)
   ("hereditary pancreatitis related PDAC" 1)
   ("eventually invasive and metastatic PDAC" 1) ("unresectable PDAC" 1)
   ("The ‘classical’ PDAC" 1) ("hereditary PDAC" 1)
   ("BRCA1 /2-associated PDAC" 1)))
 ("UP:O34819"
  (("pNL" 179) ("the viral molecular clones pNL4.3" 4) ("a pNL4.3" 1)))
 ("UP:O34946"
  (("ADCC" 252) ("AdCC" 72)
   ("3 additional HNC patients demonstrated appreciable cetuximab-mediated ADCC"
    1)
   ("further enhancing ADCC" 1)))
 ("UP:O34966"
  (("AdCa" 33) ("human endometrial serous AdCa" 3) ("serous AdCa" 2)
   ("‘pure’ tubulo-cystic clear cell AdCa" 2) ("either serous AdCa" 2)
   ("endometrial serous AdCa" 2) ("AdCa-" 2) ("papillary AdCa" 1)
   ("serous or clear cell AdCa" 1) ("concurrent serous AdCa" 1)))
 ("UP:O35129" (("Bcap37" 2) ("BCap37" 1)))
 ("UP:O35149"
  (("LM" 465) ("LM-" 4) ("L M" 3) ("LM peptide" 3) ("microcystic LM" 1)))
 ("UP:O35188" (("CX3C" 5))) ("UP:O35290" (("MR3" 4)))
 ("UP:O35381" (("ANP32" 2) ("Anp32" 2))) ("UP:O35469" (("HSD3b6" 2)))
 ("UP:O35622"
  (("FGF15" 39) ("Fgf15" 16) ("fibroblast growth factor 15" 3)
   ("intestinal FGF15" 1)))
 ("UP:O35660" (("GSTM6" 1)))
 ("UP:O35698" (("RBM" 41) ("rBM" 29) ("about 20-fold more RBM" 1)))
 ("UP:O35711" (("CCLP1" 34))) ("UP:O35728" (("Cyp4A14" 1)))
 ("UP:O35744" (("Ym1" 18))) ("UP:O35949" (("CIN2" 51)))
 ("UP:O36362" (("gB" 63) ("rabbit monoclonal anti-KSHV gB" 1)))
 ("UP:O36363" (("DNA polymerase catalytic subunit" 1)))
 ("UP:O36367" (("PPR" 24))) ("UP:O36373" (("E-23" 6) ("e-23" 1)))
 ("UP:O36403" (("GN" 40) ("immunoglobulin A (IgA) GN" 1)))
 ("UP:O36414" (("deneddylase" 9))) ("UP:O41515" (("MAP1LC3" 21)))
 ("UP:O41637" (("V30" 4)))
 ("UP:O42043"
  (("transmembrane protein" 588) ("Su" 124) ("SU" 123) ("surface protein" 86)
   ("K110" 25) ("Surface Protein" 12) ("pSU" 12) ("Transmembrane Protein" 5)
   ("programmed death-1 surface protein" 3)
   ("a homodimeric transmembrane protein" 3) ("pSU6H-" 3) ("Surface protein" 3)
   ("a cellular transmembrane protein" 2)
   ("mouse monoclonal anti-fibroblast surface protein(FSP)" 2)
   ("The lysosomal-associated transmembrane protein 4B" 2)
   ("an apical transmembrane protein" 2)
   ("a large presynaptic transmembrane protein" 2) ("pSu" 1)
   ("surface protein (FSP)" 1)
   ("an
essential surface protein"
    1)
   ("surface protein(FSP)" 1) ("an integral transmembrane protein" 1)
   ("a leaderless transmembrane protein" 1)
   ("a bacterial leucine-rich repeat surface protein" 1)
   ("the major transmembrane protein" 1) ("than K110" 1)
   ("the p38 inhibitor SU203580" 1)
   ("the apically targeted transmembrane protein" 1)
   ("targeted transmembrane protein" 1)
   ("yet another transmembrane protein" 1)))
 ("UP:O42145" (("CYP19A" 1))) ("UP:O42173" (("PV.1" 7)))
 ("UP:O42201" (("rx1" 3) ("RX1" 1))) ("UP:O42202" (("NRD" 4)))
 ("UP:O42252"
  (("NSIP" 32) ("fibrotic NSIP" 6) ("4 cellular NSIP" 2)
   ("11 fibrotic NSIP" 2)))
 ("UP:O42409" (("GFI" 22) ("Gfi" 9))) ("UP:O42567" (("RX2" 8) ("Rx2" 7)))
 ("UP:O42580" (("KDEL-R" 5) ("KDELR" 2)))
 ("UP:O42690" (("CDR3" 20) ("particular CDR3" 1)))
 ("UP:O42720" (("calcium-binding protein" 42)))
 ("UP:O42781" (("pCMS" 101) ("PCMs" 6)))
 ("UP:O42993"
  (("FK506 binding protein" 33) ("FK506 binding protein (FKBP)" 1)))
 ("UP:O43125" (("cSH3" 214) ("C-SH3" 45) ("CSH3" 8)))
 ("UP:O43143" (("DEAH" 11) ("HRH2" 11))) ("UP:O43148" (("hMET" 7) ("hMet" 1)))
 ("UP:O43150"
  (("Pap" 67) ("pAP" 14) ("pap" 6) ("a normal cervical Pap" 2)
   ("normal cervical Pap" 2) ("morphologically normal Pap" 1)
   ("periodic pap" 1) ("59 previously stained Pap" 1) ("Pap-" 1)))
 ("UP:O43151" (("TET3" 14) ("Tet3" 1))) ("UP:O43156" (("Tti1" 94) ("TTI1" 1)))
 ("UP:O43157"
  (("Plexin-B1" 415) ("plexinB1" 286) ("Plexin B1" 278) ("plexin-B1" 157)
   ("plexin B1" 114) ("plexins" 87) ("Plexins" 33) ("PlexinB1" 29)
   ("plexinB1 protein" 14) ("Plex-B1" 12) ("targeting Plexin-B1" 4)
   ("Plexin-B1 protein" 4) ("class A Plexins" 3) ("Plexin B1 protein" 3)
   ("PLXNB1" 2) ("expressing Plexin B1" 2)
   ("mouse monoclonal anti-human Plexin-B1" 2) ("exogenous plexinB1" 2)
   ("had functional Plexin-B1" 1) ("endothelial plexins" 1)
   ("than plexin B1 ( xref )" 1) ("more Plexin B1" 1)
   ("two adjacent Plexin-B1" 1)))
 ("UP:O43164" (("PJA2" 1))) ("UP:O43166" (("SIPA1L1" 2) ("E6TP1" 1)))
 ("UP:O43167" (("ZBTB24" 2))) ("UP:O43169" (("cytochrome b5 type B" 1)))
 ("UP:O43172" (("PRPF4" 2)))
 ("UP:O43174"
  (("CYP26A1" 17) ("Cyp26a1" 6) ("CYP26" 5) ("subfamily XXVIA" 5) ("Cyp26" 2)
   ("CP26" 2)))
 ("UP:O43175" ; added other def for sera
  (#+ignore("sera" 1632) #+ignore("Sera" 97) ("PHGDH" 82) ("normal sera" 16) ("sera (NHS)" 8)
   ("PDG" 5) ("SerA" 4) ("Immune sera" 3) ("crude sera" 3)
   ("control non-immune sera" 3) ("pre-immune sera" 2)
   ("representative cancer sera" 2) ("the pre-immune sera" 2)
   ("matched normal sera" 2) ("10% fetal bovine sera (FBS)" 2)
   ("than the corresponding sera" 1) ("using normal sera" 1)
   ("De-identified high titer PRA sera" 1) ("postoperative sera" 1)
   ("the corresponding pre-immune sera" 1) ("phosphoglycerate dehydrogenase" 1)
   ("fetal calf sera" 1) ("the 8 normal sera" 1) ("the 135 normal sera" 1)
   ("pre immune sera" 1) ("The post-immune sera" 1) ("the post-immune sera" 1)
   ("the immune sera" 1) ("Post-immune sera" 1) ("Rabbit immune sera" 1)
   ("mouse and rabbit non-immune sera" 1) ("pre-diagnostic sera" 1)
   ("preoperative sera" 1) ("sera (FBS)" 1) ("acute sera" 1)
   ("5% new born bovine sera" 1) ("fetal bovine and horse sera" 1)
   ("mouse monoclonal sera" 1) ("10 uninfected non-endemic control sera" 1)
   ("than sera ( xref )" 1) ("immune sera" 1) ("fetal bovine sera" 1)
   ("the reactive sera" 1) ("healthy sera" 1)
   ("a mouse anti- A. baumannii Tnp immune sera" 1)
   ("monoclonal antibodies polyclonal sera" 1) ("than sera" 1)))
 ("UP:O43181" (("NdufS4" 4) ("NDUFS4" 1)))
 ("UP:O43182"
  (("ARHGAP6" 5) ("Arhgap6" 3) ("Rho GTPase-activating protein 6" 2)
   ("O43182" 1)))
 ("UP:O43184"
  (("ADAM12" 161) ("ADAM-12" 18) ("syndecans" 15) ("ADAM12 protein" 5)
   ("ADAM metallopeptidase domain 12" 2) ("ADAM12 revealed ADAM12 protein" 2)
   ("Syndecans" 1)))
 ("UP:O43186" (("Otx3" 22) ("CRX" 11) ("Crx" 5) ("cone–rod homeobox" 1)))
 ("UP:O43187" (("IRAK2" 11) ("IRAK-2" 1)))
 ("UP:O43189"
  (("PHF1" 300) ("PHF-1" 73) ("monoclonal PHF-1" 1)
   ("exogenous FLAG-tagged PHF1" 1)))
 ("UP:O43194" (("GPR39" 2)))
 ("UP:O43196"
  (("hMSH5" 213) ("MSH5" 19) ("Msh5" 14) ("hMSH5 protein" 8)
   ("mutS homolog 5" 6) ("flag-tagged hMSH5" 1)
   ("N-terminal-truncated flag-tagged hMSH5" 1)))
 ("UP:O43236"
  (("SEPT4" 5) ("ARTS" 2) ("septin 4" 2)
   ("the mitochondrial pro-apoptotic protein ARTS" 1) ("ARTs" 1)))
 ("UP:O43240"
  (("NES1" 95) ("KLK10" 12) ("kallikrein 10" 2) ("the functional NES1" 2)))
 ("UP:O43242" (("PSMD3" 36))) ("UP:O43248" (("HOXC11" 7)))
 ("UP:O43251"
  (("Rta" 302) ("RTA" 236) ("Rta protein" 7) ("RTA protein" 7) ("FOX2" 6)
   ("Rta-" 2) ("EBV transcriptional transactivators Rta" 2) ("Fox-2" 2)
   ("RBFox2" 1) ("Rta protein’s" 1) ("RBFOX2" 1) ("viral RTA protein" 1)))
 ("UP:O43252" (("SAT" 37) ("PAPSS1" 31) ("abdominal SAT" 1) ("sat" 1)))
 ("UP:O43255"
  (("seven" 4037) ("Siah2" 445) ("SIAH2" 319) ("Siah2 protein" 7)
   ("Siah2 (RM)" 5) ("Seven in Absentia homolog 2" 3) ("Siah-2" 2)
   ("Seven in absentia homolog 2" 2)
   ("seven in absentia homolog 2 (SIAH2) protein" 2)
   ("seven in absentia homolog 2" 2) ("miR-335 directly targets SIAH2" 1)
   ("SIAH2protein" 1)))
 ("UP:O43261" (("DLEU1" 4))) ("UP:O43264" (("ZW10" 76) ("Zw10" 1)))
 ("UP:O43272" (("proline oxidase" 3) ("PRODH" 1)))
 ("UP:O43278"
  (("serine protease inhibitor" 91) ("HAI-1" 37)
   ("Serine protease inhibitor" 5) ("SPINT1" 3) ("cellular HAI-1" 2)
   ("its cognate transmembrane serine protease inhibitor" 1)
   ("serine peptidase inhibitor" 1)))
 ("UP:O43280" (("TREs" 39) ("TREH" 8) ("functional TREs" 1) ("trehalase" 1)))
 ("UP:O43281"
  (("EFS" 353) ("shorter EFS" 3) ("P-EFS" 3)
   ("significantly worse 3-year EFS" 1) ("poor EFS" 1) ("pEFS" 1)))
 ("UP:O43283"
  (("MLKs" 36) ("MLK" 34) ("pMLK" 2) ("MLK protein" 1) ("than MLKs" 1)))
 ("UP:O43291" (("HAI-2" 2) ("Kunitz type" 1))) ("UP:O43292" (("GPAA1" 1)))
 ("UP:O43293"
  (("ZIPK" 166) ("DAPK3" 4) ("cellular ZIPK" 1) ("DAPK3 (ZIPK)" 1)))
 ("UP:O43294"
  (("Hic-5" 210) ("ARA55" 5) ("Hic5" 4) ("Hic-5 protein" 4) ("HIC5" 2)
   ("TGFB1I1" 1) ("approximately 200nM Hic-5" 1) ("TGFb1I1" 1)))
 ("UP:O43295"
  (("srGAP2" 29) ("srGAP3" 24) ("SRGAP3" 5) ("SRGAP2" 3) ("WRP" 2) ("MEGAP" 2)
   ("MeGAP" 1)))
 ("UP:O43298" (("ZNFX" 14))) ("UP:O43301" (("HSPA12A" 3)))
 ("UP:O43303" (("CP110" 59) ("much less CP110" 2)))
 ("UP:O43309" (("ZSCAN12" 2)))
 ("UP:O43312"
  (("MIM" 417) ("Mtss1" 83) ("mim" 22) ("an explicit MIM" 7) ("MTSS1" 3)
   ("a heuristic MIM" 3) ("the heuristic MIM" 1) ("the explicit MIM" 1)
   ("The heuristic MIM" 1)))
 ("UP:O43313" (("ATMIN" 1))) ("UP:O43316" (("PAX4" 29) ("Pax4" 4) ("Pax-4" 3)))
 ("UP:O43318"
  (("MAP3K7" 76) ("Tak1" 14)
   ("transforming growth factor-β-activated kinase 1" 13)
   ("transforming growth factor beta-activated kinase 1" 5)
   ("transforming growth factor-beta-activated kinase 1" 3)
   ("miR-377 directly targets MAP3K7" 2) ("TGF-beta-activated kinase 1" 2)
   ("MAP3K7 protein" 1)))
 ("UP:O43320"
  (("FGF16" 4) ("fibroblast growth factor 16" 4) ("MF4" 4) ("Fgf16" 1)))
 ("UP:O43323"
  (("Dhh" 19) ("DHH" 6) ("Desert Hedgehog" 4) ("desert hedgehog" 2)
   ("Desert hedgehog" 1) ("Desert Hedgehog (DHH)" 1)))
 ("UP:O43324"
  (("INK4C" 139) ("wherein p18 INK4C" 1)
   ("a compensatory upregulation ofp18 INK4C" 1) ("EEF1E1" 1)))
 ("UP:O43345" (("ZNF208" 1)))
 ("UP:O43347"
  (("MSI1" 33) ("Musashi-1" 23) ("Msi1" 19) ("MSI-1" 14) ("musashi" 8)
   ("musashi1" 6) ("Musashi1" 4) ("MSI1 protein" 2) ("musashi homolog 1" 2)
   ("the neural progenitor RNA binding protein musashi1" 2) ("Msi-1" 2)
   ("Musashi 1" 1) ("musashi-1" 1)))
 ("UP:O43353"
  (("RIP2" 273) ("Rip2" 163) ("RIPK2" 30) ("RICK" 15) ("CARDIAK" 5)
   ("receptor-interacting protein 2" 3) ("p-RIP2" 2) ("Ripk2" 2)
   ("receptor interacting protein 2" 2) ("Rip2-" 1) ("RIPK2-" 1)))
 ("UP:O43364" (("HOXA2" 5) ("homeobox A2" 1) ("HoxA2" 1)))
 ("UP:O43365" (("HOXA3" 3) ("Hoxa3" 1)))
 ("UP:O43374" (("CAPRI" 100) ("RASA4" 2)))
 ("UP:O43379"
  (("WDR62" 179) ("WDR62 protein" 2) ("WD repeat domain 62" 2)
   ("the last 239 amino acids of WDR62" 1)))
 ("UP:O43390" (("HNRPR" 1))) ("UP:O43395" (("PRP3" 16) ("RP18" 1) ("PRPF3" 1)))
 ("UP:O43396" (("TXNL1" 72) ("TXL" 32) ("TXL-" 1)))
 ("UP:O43426" (("SYNJ1" 2) ("synaptojanin 1" 2))) ("UP:O43427" (("FIBP" 2)))
 ("UP:O43432" (("eIF4GII" 14) ("EIF4G3" 14)))
 ("UP:O43435"
  (("TGA" 750) ("-TGA" 46) ("TGAs" 6) ("TBX1" 6) ("Tbx1" 3)
   ("AC G AAT TC A TGA ATA AAA TAT TGT TGT TGA" 1)))
 ("UP:O43439" (("EHT" 19))) ("UP:O43447" (("PPIH" 1) ("cyclophilin H" 1)))
 ("UP:O43448" (("KCNAB3" 2)))
 ("UP:O43451" (("MGA" 6) ("Mga" 4) ("glucoamylase" 1)))
 ("UP:O43462" (("S2P" 15)))
 ("UP:O43463"
  (("SUV39H1" 257) ("Suv39h1" 73) ("H3K9me 1" 28) ("Suv39H1" 18) ("Suv39h" 8)
   ("SUV39H" 5) ("suppressor of variegation 3–9 homolog 1" 4)
   ("we first silenced SUV39H1" 2)
   ("Suppressor of variegation 3–9 homolog 1" 1)
   ("Suppressor of variegation 3-9 homolog 1" 1) ("SUV39h1" 1)))
 ("UP:O43464"
  (("Omi" 198) ("HtrA2" 39) ("OmI" 11) ("HTRA2" 6) ("pulled His-tagged Omi" 3)
   ("OMI" 2) ("Htra2" 2) ("His-tagged mature Omi" 1) ("omi" 1)
   ("protease HtrA2" 1)))
 ("UP:O43474"
  (("KLF4" 949) ("Klf4" 254) ("factor 4" 90) ("Factor 4" 9) ("KLF-4" 6)
   ("Krueppel-like factor 4" 4) ("KLF4 protein" 4) ("Klf-4" 3)
   ("the more promiscuous STAT-3 and IFN regulatory factor 4" 2)
   ("Kruppel like factor 4" 2) ("HDAC1 specifically targets Klf4" 1)
   ("KLF4-" 1) ("GKLF" 1) ("substantially more recombinant human Klf4" 1)
   ("monomeric KLF4" 1)))
 ("UP:O43482" (("OIP5" 1))) ("UP:O43488" (("AKR7A2" 1)))
 ("UP:O43490"
  (("CD133" 1977) ("CD133−" 107) ("AC133" 29) ("prominin-1" 23) ("PROM1" 22)
   ("CD133 protein" 19) ("Prominin1" 17) ("Prominin-1" 12) ("Prominin 1" 9)
   ("CD133-" 9) ("Prom1" 8) ("AFP and stemness associated genes CD133" 4)
   ("prominin 1" 3) ("CD133 molecule" 3) ("than CD133" 2)
   ("using fluorescein isothiocyanate (FITC)-conjugated monocloncal mouse anti-human CD133"
    2)
   ("the neural precursor cell surface marker CD133" 2)
   ("CD133 (prominin-1) protein" 2) ("Cd133" 2)
   ("than CD133 [ xref , xref ]" 1) ("cytometry showed CD133" 1)))
 ("UP:O43493"
  (("TGN" 633) ("TGN46" 81) ("TGN38" 15) ("TgN" 11) ("TGN protein" 2)
   ("the GFP-MPR tail-positive TGN" 2) ("tgn" 2)))
 ("UP:O43497" (("CACNA1G" 47) ("Cav3.1" 4) ("T type" 2)))
 ("UP:O43502"
  (("RAD51C" 545) ("FANCO" 13) ("RAD51c" 13) ("Rad51C" 9) ("RAD51C protein" 6)
   ("Rad51c" 4) ("RAD51 homolog C" 2) ("The HELQ-associated protein RAD51C" 1)
   ("Rad51L2" 1)))
 ("UP:O43504" (("HBXIP" 4) ("XIP" 1)))
 ("UP:O43508"
  (("TWEAK" 113) ("tumor necrosis factor ligand superfamily member 12" 5)
   ("TNFSF12" 4) ("TWEAK-" 3) ("soluble TWEAK" 2) ("tweak" 1)))
 ("UP:O43511"
  (("PDs" 135) ("pds" 23) ("PDS" 17) ("pendrin" 17) ("SLC26A4" 9) ("pDS" 6)
   ("solute carrier family 26 member 4" 3) ("the first approximately 80 pds" 2)
   ("pDs" 2) ("approximately every 20 pds" 1)
   ("BRCA1  mut/+ cells underwent comparable PDs" 1) ("progressive PDs" 1)
   ("subset underwent fewer PDs" 1) ("Cumulative PDs" 1) ("SLC26" 1)
   ("Slc26a4" 1) ("Slc26" 1)))
 ("UP:O43513"
  (("subunit 9" 10) ("CRSP9" 6) ("33kDa protein" 2) ("33kDa" 2) ("MED7" 2)
   ("Crsp9" 1)))
 ("UP:O43516" (("WIP" 27) ("WIPF1" 7)))
 ("UP:O43520"
  (("FIC1" 93) ("Type 8B" 3) ("BRIC" 3)
   ("Progressive familial intrahepatic cholestasis type 1" 2) ("PFIC1" 2)
   ("familial intrahepatic cholestasis type 1" 2)))
 ("UP:O43521"
  (("Bim" 6677) ("BIM" 2868) ("BCL2L11" 372) ("BimEL" 231) ("Bim protein" 101)
   ("bim" 92) ("BimS" 43) ("BIM peptide" 29) ("BIM protein" 28)
   ("the pro-apoptotic protein Bim" 26) ("Bim-" 26)
   ("BIM (I155R/E158S) peptide" 23) ("Bcl2l11" 16) ("Bim peptide" 14)
   ("the pro-apoptotic protein BIM" 14) ("pro-apoptotic Bim" 12)
   ("the pro-apoptotic BH3-only protein Bim" 10) ("BIM-" 8)
   ("pro-apoptotic protein Bim" 7) ("proapoptotic BIM" 6)
   ("BIM (R154S/I155R/E158S) peptide" 6) ("Bcl2L11" 6) ("BimS protein" 6)
   ("the BH3-only pro-apoptotic protein Bim" 5)
   ("pro-apoptotic BH3-only protein Bim" 4) ("pro-apoptotic BIM" 4) ("-Bim" 4)
   ("Bim-L" 3) ("Bcl2-interacting mediator of cell death" 3) ("BOD" 3)
   ("BIM (I155R/E158S) protein" 3) ("BCL2L11 ( BIM )" 3) ("–Bim" 3)
   ("Mcl1L delGly158-Asp172 bound significantly more pro-apoptotic Bim" 2)
   ("proapoptotic Bim" 2) ("than BIM" 2) ("the pro-apoptotic gene BIM" 2)
   ("BCL2L11 (BIM) protein" 2) ("the pro-apoptotic Bim" 2)
   ("pro-apoptotic protein BIM" 2) ("BCL2L11 (BIM)" 2)
   ("less mitochondrial Bim" 2) ("more mitochondrial Bim" 2)
   ("these two possible Bim" 2) ("than Bim" 2) ("a pre-mature Bim protein" 2)
   ("the pro-apoptotic BH3-containing Bim" 2) ("phospho-BimEL" 2)
   ("the pro-apoptotic gene BCL2L11 ( BIM )" 2)
   ("the pro-apoptotic BH3-only protein BIM" 2) ("Pro-apoptotic Bim" 2)
   ("Bcl-2-homology domain 3 (BH3)-only family proteins Bim" 2)
   ("the pro-apoptotic proteins Bim" 2)
   ("the pro-apoptotic extra long (EL) BIM protein" 2)
   ("the Bcl-2 homology domain 3 only (BH3-only) protein Bim" 2)
   ("the Bcl-2 family pro-apoptotic protein Bim" 2)
   ("the pro-apoptotic gene Bim" 2) ("O43521" 2) ("-BIM" 2)
   ("than BIM( xref )" 1) ("than BIM peptide ( xref )" 1)
   ("The pro-apoptotic protein BIM" 1) ("bim-" 1) ("pro-apoptotic BCL2L11" 1)
   ("the pro-apoptotic factor BCL2L11" 1) ("otherwise elevated Bim" 1)
   ("the associated BimEL" 1) ("Bim−" 1) ("residual Bim" 1)
   ("30–80% more BIM protein" 1)
   ("the Bcl-2-family pro-apoptotic protein BIM" 1) ("more BIM" 1)
   ("the pro-apoptotic gene BCL2L11 (BIM)" 1) ("functional BIM" 1)
   ("The pro-apoptotic Bcl-2-family protein Bim" 1)
   ("its transcriptional target Bim" 1) ("bcl2l11" 1) ("–BIM" 1)
   ("lymphoid cells pre-made Bim" 1) ("the rapid available pre-made Bim" 1)
   ("both the pro-apoptotic Bim" 1) ("all three canonical Bim" 1)
   ("Drg1-expressing control cells Bim" 1)
   ("the pro-apoptotic Bcl-2 family member Bim" 1)
   ("the pro-apoptotic Bcl-2 relative Bim" 1)
   ("the pro-apoptotic Bcl-2 protein Bim" 1)
   ("BH3-only pro-apoptotic Bcl-2 family member Bim" 1)
   ("poly-HEMA displayed heightened Bim" 1) ("less Bim" 1) ("bimEL" 1)
   ("the pro-apoptotic Bcl-2 family protein Bim" 1)
   ("the pro-apoptotic Bim protein" 1)
   ("the selective GRPR antagonist BIM26226" 1) ("cellular BIM" 1)
   ("the pro-apoptotic Bcl-2 family member BIM" 1)
   ("the BH3-only pro-apoptotic BIM" 1)
   ("the pro-apoptotic BH3-only Bcl2 family member BIM" 1)
   ("the highly apoptogenic Bim" 1) ("Proapoptotic Bim" 1) ("p4.10-bim800" 1)
   ("-bim800" 1) ("nonapoptotic Bim" 1)
   ("apoptosis-inactive LC8-associated Bim" 1) ("Bim (EL)" 1) ("more Bim" 1)
   ("BH3-only proapoptotic Bim" 1)))
 ("UP:O43524"
  (("FOXO3a" 3470) ("FOXO3" 2383) ("FoxO3a" 1662) ("FoxO3" 1475) ("FoxO" 762)
   ("FOXO3A" 617) ("Foxo3a" 572) ("FoxO3A" 278) ("FKHRL1" 113) ("Foxo3" 108)
   ("FOXO3 protein" 68) ("Foxo3A" 53) ("p-FOXO3a" 44) ("FOXO3a protein" 38)
   ("pFOXO3a" 36) ("FoxO3 protein" 31) ("-FOXO3a" 26) ("FoxO3a protein" 23)
   ("pFOXO3A" 21) ("p-FoxO3a" 19) ("forkhead box O3" 17) ("FOXO3A protein" 14)
   ("FKHR-L1" 13) ("pFoxO" 12) ("P-FOXO3a" 11) ("Forkhead box O3" 8)
   ("p-FOXO3A" 7) ("FOXO3-" 6) ("foxo3a" 6)
   ("the transcriptional factor FOXO3a" 6) ("FOXO3-S644A protein" 5)
   ("FoxO protein" 4) ("-Foxo3a" 4) ("foxo3" 4) ("FOXO-3" 4)
   ("prominent FoxO3a" 4) ("FoxO3a-" 3) ("foxO3" 3)
   ("significantly less cytoplasmic pFOXO3a" 3) ("FoxO3A protein" 3)
   ("exogenous FOXO3" 3) ("pFoxO3a" 3) ("FOXO3a-" 2)
   ("forkhead box protein O3" 2) ("foxo3a protein" 2)
   ("Forkhead box protein O" 2) ("−FOXO3a" 2)
   ("Forkhead (FKHD) transcriptional factor FKHRL1" 2) ("Forkhead Box O3a" 2)
   ("Forkhead Box O3" 2) ("P-FOXO3A" 2) ("TNF-α increased FoxO protein" 2)
   ("FOX-O3a" 2) ("p-FoxO" 2) ("O43524" 2)
   ("the transcriptional factor Foxo3a" 2) ("FoxO3 molecule" 2)
   ("than Wild Type FoxO3" 2) ("Wild Type FoxO3" 2) ("-FoxO3a" 2)
   ("intergenic FOXO3" 2) ("overexpressed active FOXO3a" 2) ("FoxO3a (DF)" 2)
   ("p-FoxO3A" 2) ("than FOXO3a-S644A ( xref )" 1) ("than FOXO3a ( xref )" 1)
   ("than wild-type FOXO3" 1) ("particular FOXO3" 1) ("potential FOXO3" 1)
   ("both exogenous FOXO3" 1) ("very little nuclear FOXO3" 1) ("most FOXO3" 1)
   ("the tumor suppressive transcription factor FOXO3a" 1) ("FoXO3a" 1)
   ("BBR increased FOXO3a" 1) ("The exogenous FOXO3a" 1) ("exporting FOXO3A" 1)
   ("than WT FOXO3" 1) ("FOXO3 (WT)" 1)
   ("previously constructed recombinant adenovirus vectors Ad-TM (triple mutant)-FOXO3a"
    1)
   ("conditional FoxO" 1) ("the well-studied FOXO3" 1)
   ("FOXK1 translocated FOXO3" 1) ("foxO3a" 1) ("functional FOXO3a" 1)
   ("intestinal tissue Foxo3" 1)
   ("total and phosphorylated endogenous FOXO3a" 1)
   ("inactivated (phosphorylated) FOXO3A" 1)
   ("total and phosphorylated FOXO3A protein" 1) ("cellular FoxO3a" 1)
   ("FKHRL1 protein" 1) ("βTrCP1 increased FOXO3 protein" 1)
   ("predominant nuclear-targeted FOXO3a" 1) ("triple mutant FOXO3a" 1)
   ("Non-phosphorylated FOXO3a" 1) ("FKHRL-1" 1) ("stably binding FoxO3" 1)
   ("mock-infected cells unphosphorylated FoxO" 1) ("FOXO3_HUMAN" 1)
   ("particular FOXO3a" 1) ("than WT FoxO3 (Fig. xref )" 1)
   ("very little FoxO3" 1) ("9 lysines of FoxO3" 1) ("particular FoxO3" 1)
   ("the predominant FoxO" 1) ("distal FOXO3" 1)
   ("slightly around other FOXO3" 1) ("four intergenic FOXO3" 1)
   ("the distal intergenic endogenous and exogenous FOXO3" 1)
   ("distant FOXO3" 1) ("triple mutant FoxO3a (TM)" 1) ("FoxO3a (TM)" 1)))
 ("UP:O43525" (("KCNQ3" 1))) ("UP:O43526" (("KCNQ2" 1)))
 ("UP:O43529" (("HNK-1ST" 41) ("than HNK-1ST" 1)))
 ("UP:O43541"
  (("SMAD6" 49) ("Smad6" 12) ("Smad 6" 2) ("SMAD family member 6" 1)))
 ("UP:O43542"
  (("XRCC3" 683) ("XRCC3 protein" 7) ("Xrcc3" 6) ("XRCC3-" 2) ("”" 1)
   ("at least XRCC3" 1)))
 ("UP:O43543"
  (("XRCC2" 168) ("Xrcc2" 14) ("RAD51-like" 3) ("DSBR" 3)
   ("X-ray repair complementing defective repair in Chinese hamster cells 2" 2)
   ("the accessory factors XRCC2" 1)))
 ("UP:O43548" (("TGX" 59) ("–TGX" 4) ("Transglutaminase 5" 2) ("TGM5" 1)))
 ("UP:O43555" (("GnRH-II" 36) ("than GnRH-II" 1))) ("UP:O43556" (("pESG" 1)))
 ("UP:O43557"
  (("light" 6392) ("Light" 457) ("UV" 456) ("UV light" 120)
   ("ultraviolet light" 89) ("LIGHT" 64) ("dynamic light" 44) ("“light”" 44)
   ("Dynamic Light" 32) ("new light" 32) ("Dynamic light" 22)
   ("ultraviolet (UV) light" 19) ("shed new light" 18) ("Analytical light" 17)
   ("ultraviolet light (UV)" 16) ("‘light’" 16) ("light-" 15)
   ("light peptide" 11) ("TNFSF14" 11) ("‘light'" 10) ("more light" 9)
   ("a new light" 9) ("a Wyatt miniDAWN TREOS triple-angle static light" 9)
   ("-LTg" 9) ("UVB" 9) ("LTg" 7) ("-light" 6) ("static light" 6)
   ("Our results shed new light" 5) ("our study sheds new light" 5)
   ("further shed light" 4) ("relative light" 4) ("shed more light" 4)
   ("light protein" 3) ("sheds new light" 3) ("cast new light" 3)
   ("Ultraviolet (UV) light" 3) ("International Light" 3) ("visible light" 3)
   ("These results shed new light" 3) ("the incident light" 3) ("‘light‘" 3)
   ("forward light" 3) ("light (UV)" 2) ("a distant light" 2)
   ("Our study sheds new light" 2) ("using ultraviolet light" 2)
   ("These findings shed new light" 2) ("very light diffuse or focal light" 2)
   ("ultra violet light" 2) ("flexible cold light" 2)
   ("1 J/cm 2 solar-simulated light" 2)
   ("green fluorescent light and ordinary light" 2) ("former light" 2)
   ("UV 365-nm monochromatic light" 2) ("”light”" 2) ("Light-" 2)
   ("dim cyclic light" 2) ("considerable light" 2)
   ("predominantly 254-nm UV-C light" 2)
   ("these observations shed new light" 2) ("classical light" 2)
   ("Static light" 2) ("Our findings shed new light" 2) ("“light” peptide" 2)
   ("solar ultraviolet light" 2)
   ("analytical ultracentrifugation and multiangle light" 2) ("Static Light" 2)
   ("Static and Dynamic Light" 2) ("detector and Wyatt QELS dynamic light" 2)
   ("a representative dynamic light" 2) ("e.g. UV light" 2)
   ("an Axiophot digital light" 2) ("short-wavelength ultraviolet light" 2)
   ("UVB-" 2) ("our previous static light" 2) ("a QELS dynamic light" 2)
   ("cast more light" 1) ("The seven loci shed new light" 1) ("light (NFL)" 1)
   ("Monoclonal immunoglobulin Free Light" 1) ("Our studies shed new light" 1)
   ("2 regulatory light" 1) ("2 essential light" 1)
   ("Our observations shed new light" 1) ("these results shed new light" 1)
   ("the HGF/c-Met pathway sheds some mechanistic light" 1)
   ("The collective observations shed light" 1) ("shed mechanistic light" 1)
   ("this comprehensive genetic study sheds light" 1)
   ("This work sheds new light" 1) ("dual light" 1)
   ("chordoma and shed new light" 1) ("artificial light" 1)
   ("an ultraviolet light" 1) ("nocturnal light" 1)
   ("our findings collectively shed light" 1) ("two regulatory light" 1)
   ("two essential light" 1) ("than LIGHT ( xref )" 1)
   ("ultraviolet C light (UVC)" 1) ("light (UVC)" 1)
   ("ultraviolet B light (UVB)" 1) ("light (UVB)" 1) ("Light peptide" 1)
   ("sheds some new light" 1) ("IPM sheds new light" 1)
   ("ultraviolet
light"
    1)
   ("A monochromatic light" 1) ("the 20-kDa regulatory light" 1)
   ("our experiments shed new light" 1) ("herein shed light" 1)
   ("previously described human diseases shed light" 1)
   ("a recent study sheds new light" 1) ("myofibroblasts sheds new light" 1)
   ("20 J cm −2 ultraviolet light" 1) ("myosin II regulatory light" 1)
   ("this study sheds new light" 1) ("together shed light" 1)
   ("biological networks experimentally shed light" 1)
   ("20 Jm −2 ultraviolet light (UV)" 1) ("either ultraviolet light (UV)" 1)
   ("10 6 distinct light" 1) ("shed no functional light" 1)
   ("the solar light" 1) ("myosin regulatory light" 1) ("14% visible light" 1)
   ("this study shed new light" 1) ("equivalent artificial light" 1)
   ("1.8 J/cm 2 ultraviolet A light" 1)
   ("the CK2-SIRT1 link sheds new light" 1) ("our data shed new light" 1)
   ("DNA-PK regulation sheds new light" 1) ("recently shed light" 1)
   ("Our results further shed light" 1) ("shed less light" 1)
   ("here sheds new light" 1)
   ("than emitted light from cells transfected with ECFP- or EYFP-tagged proteins alone (i.e. background levels)"
    1)
   ("the ECM composition and shed new light" 1) ("Ultraviolet light (UV)" 1)
   ("solar UV light" 1) ("these findings shed new light" 1)
   ("ChIP analysis sheds new light" 1) ("A green brilliant light" 1)
   ("A red brilliant light" 1)
   ("other transcription factors throws new light" 1) ("excessive light" 1)
   ("a p62-associated protein sheds light" 1) ("using dynamic light" 1)
   ("incident light" 1) ("back-scattered light" 1) ("dynamic (DLS) light" 1)
   ("The UV light" 1) ("either intense blue light" 1)
   ("ciliogenesis sheds new light" 1) ("ultraviolent light (UV)" 1)
   ("our biophysical analysis sheds new light" 1)
   ("three unrelated Italian patients, and sheds light" 1)
   ("the associated myosin regulatory light" 1) ("environmental light" 1)
   ("dim red light" 1) ("computer-controlled light" 1) ("254-nm UV light" 1)
   ("Ultraviolet light" 1) ("these bacterial SMUG1 orthologs shed new light" 1)
   ("these observations and sheds new light" 1) ("distinct light" 1)
   ("low ambient light" 1) ("our results shed new light" 1)
   ("than the light emitted by CFP or YFP-tagged proteins alone" 1)
   ("minimal light" 1) ("The associated emission light" 1) ("UV light (UVB)" 1)
   ("short wavelength ultraviolet light (UVC)" 1)
   ("These data shed new light" 1)
   ("the radiant heat (Hargreaves) assay focuses radiant light" 1)))
 ("UP:O43559"
  (("FRS3" 13) ("fibroblast growth factor receptor substrate 3" 2)))
 ("UP:O43561"
  (("LAT" 1141) ("LATS" 211) ("Lat" 170) ("Lats" 167) ("LAT molecule" 25)
   ("trivalent LAT" 20) ("bivalent LAT" 13) ("monovalent and bivalent LAT" 10)
   ("Lats protein" 8) ("LATs" 8) ("monovalent LAT" 7) ("Monovalent LAT" 4)
   ("bivalent and monovalent LAT" 3) ("LAT-" 2) ("pLAT" 2) ("-LAT" 2)
   ("than bivalent LAT" 2) ("only bivalent and trivalent LAT" 2)
   ("only monovalent and trivalent LAT" 2) ("a trivalent LAT" 2)
   ("monovalent, bivalent and trivalent LAT" 2) ("a trivalent LAT molecule" 2)
   ("cellular LAT" 2) ("sub-synaptic LAT" 2) ("P-LAT" 2) ("pp36" 1)
   ("the YAP/TAZ canonic kinase Lats" 1)
   ("a single phosphorylated tyrosine of LAT" 1) ("Lat protein" 1)
   ("phospho-Lats protein" 1) ("only trivalent LAT" 1) ("the bivalent LAT" 1)
   ("increase bivalent LAT" 1) ("no monovalent LAT" 1)
   ("increase monovalent LAT" 1) ("no bivalent LAT" 1) ("the monovalent LAT" 1)
   ("a homogeneous population oftrivalent LAT" 1) ("two monovalent LAT" 1)
   ("three monovalent LAT" 1) ("four trivalent LATs" 1)
   ("only one trivalent LAT molecule" 1) ("free monovalent LAT" 1)
   ("membrane associated trivalent, bivalent and monovalent LAT" 1)
   ("smaller LAT" 1) ("a separate LAT" 1) ("received surgical LAT" 1)
   ("p-LAT" 1)))
 ("UP:O43566" (("RGS-14" 35) ("RGS-14 protein" 10) ("RGS14" 5)))
 ("UP:O43567" (("RNF13" 1))) ("UP:O43570" (("CA12" 30) ("xii" 5) ("CAXII" 2)))
 ("UP:O43572" (("AKAP10" 2)))
 ("UP:O43581" (("synaptotagmin 7" 7) ("SYT7" 6) ("Syt7" 1)))
 ("UP:O43583"
  (("dRP" 21) ("protein Drp1" 7) ("DRP" 4) ("-dRP" 3) ("protein DRP1" 1)))
 ("UP:O43586"
  (("PSTPIP" 68) ("PSTPIP1" 43) ("CD2BP1" 4)
   ("Proline-serine-threonine phosphatase-interacting protein 1" 3)
   ("the cleavage furrow–associated protein PSTPIP" 1) ("hPIP" 1)))
 ("UP:O43592" (("XPOT" 21) ("exportin-t" 3)))
 ("UP:O43593"
  (("HR" 11524) ("H/R" 197) ("HR-" 38) ("pHR" 30) ("defective HR" 18)
   ("HR protein" 9) ("efficient HR" 5) ("HR−" 5) ("dysfunctional HR" 4)
   ("conservative HR" 4) ("than HR" 3) ("RAD51-driven HR" 3) ("“HR”" 3)
   ("replication-associated HR" 3) ("spontaneous HR" 3) ("a protective HR" 3)
   ("multivariable HR" 2) ("Mutant IDH1-driven transformation increases HR" 2)
   ("chromosomal HR" 2) ("proficient HR" 2) ("functional HR" 2)
   ("multivariable-adjusted HR" 2) ("a multivariable-adjusted HR" 2)
   ("only 15% HR" 2) ("an essential HR protein" 2) ("the age-specific HR" 2)
   ("successful HR" 2) ("sub-optimal HR" 2) ("intact HR" 2) ("Functional HR" 2)
   ("key HR" 2) ("an associated multivariate HR" 2) ("somatic HR" 1)
   ("the lentiviral backbone pHR" 1) ("Proficient HR" 1)
   ("DNA double-strand break-induced HR" 1)
   ("mutant IDH1-driven transformation increases HR" 1) ("Defective HR" 1)
   ("HC-associated HR" 1) ("competent HR" 1)
   ("the ER-negative breast cancer log HR" 1)
   ("The ER-negative breast cancer log HR" 1) ("BRCA1-dependent HR" 1)
   ("the multivariable-adjusted HR" 1) ("the defective HR" 1) ("aberrant HR" 1)
   ("the lentiviral pHR" 1) ("classical RAD51-dependent HR" 1)
   ("otherwise high-fidelity HR" 1) ("a global role promoting HR" 1)
   ("separate HR" 1) ("the lentiviral helper pHR" 1) ("a modest HR" 1)
   ("somewhat attenuated HR" 1) ("fully efficient HR" 1)
   ("The lentiviral helper plasmids pHR" 1) ("inappropriate HR" 1)
   ("Most HR" 1) ("optimal HR" 1) ("caused defective HR" 1) ("accurate HR" 1)
   ("particular HR" 1) ("incomplete HR" 1) ("stress-induced HR" 1)
   ("the HR’s" 1) ("a significant crude HR" 1)
   ("double-strand break-induced HR" 1) ("larger HR" 1)
   ("Country-specific HR" 1)))
 ("UP:O43597"
  (("Spry2" 573) ("SPRY2" 526) ("Sprouty2" 412) ("sprouty-2" 134)
   ("Sprouty-2" 52) ("hSpry2" 38) ("Spry2 protein" 25) ("sprouty homolog 2" 11)
   ("sprouty2" 10) ("SPRY2 protein" 5) ("Sprouty2 protein" 5)
   ("Spry2 peptide" 5) ("overexpressed Sprouty2" 4) ("-Sprouty2" 3)
   ("pSPRY2" 3) ("particular Spry2" 2) ("Spry 2" 2) ("SPRY2-" 2)
   ("than Y55F Spry2 (HA-hSpry2)" 1) ("than WT Spry2" 1) ("spry2" 1)
   ("SPRY 2" 1) ("Spry2-" 1) ("slower migrating Sprouty2" 1)
   ("sprouty-2 protein" 1) ("HSpry2" 1) ("regulatory elements around SPRY2" 1)
   ("the pregnant mammary gland SPRY2" 1)))
 ("UP:O43598" (("RCL" 53) ("Rcl" 4) ("rcl" 2)))
 ("UP:O43602"
  (("DCX" 305) ("Dcx" 41) ("doublecortin" 28) ("Doublecortin" 7) ("pDCX" 6)
   ("doublecortin (DCX)" 5) ("P-DCX" 4) ("doublecortin ( DCX )" 2)
   ("the immature neuronal marker Dcx" 2) ("sequential DCX" 1)
   ("DCX protein" 1) ("Doublecortin (DCX)" 1) ("SCLH" 1)
   ("its associated protein doublecortin ( DCX )" 1)))
 ("UP:O43609"
  (("SPRY1" 349) ("Spry 1" 3) ("SPRY1-" 2) ("SPRY 1" 2)
   ("Sprouty homolog 1" 2)))
 ("UP:O43610" (("SPRY3" 3) ("Spry3" 2)))
 ("UP:O43612"
  (("Ox" 139) ("OX" 75) ("orexin" 21) ("hypocretin" 3) ("Orexin" 2)
   ("an alternate Ox" 1) ("An alternative Ox" 1) ("the Ox, Ox" 1) ("HCRT" 1)))
 ("UP:O43613" (("Ox1r" 1) ("HCRTR1" 1))) ("UP:O43614" (("Ox2r" 33)))
 ("UP:O43615" (("TIM44" 3)))
 ("UP:O43617" (("Bet3" 4) ("BET3" 1) ("TRAPPC3" 1)))
 ("UP:O43623"
  (("Slug" 1371) ("SNAI2" 388) ("SLUG" 359) ("slug" 226) ("Snail2" 35)
   ("Snai2" 25) ("SNAIL2" 20) ("Slug protein" 18) ("snai2" 4)
   ("overexpressed Slug" 4) ("SNAI2 (SLUG)" 4) ("-Slug" 4)
   ("nondegradable Slug" 3) ("Overexpressed Slug" 3)
   ("the transcriptional factor Slug" 3)
   ("Ectopically-produced Flag-tagged Slug" 2)
   ("rabbit monoclonal anti Slug" 2) ("expressing Slug" 2) ("SNAI2 protein" 2)
   ("Snail-2" 2) ("the regulatory elements around SLUG" 2)
   ("Nonphosphorylatable Slug" 1) ("nonphosphorylatable Slug" 1)
   ("ectopically-expressed Flag-tagged Slug" 1) ("than Slug-WT ( xref )" 1)
   ("than those expressing high SNAI2" 1) ("Transiently overexpressed Slug" 1)
   ("snail2" 1) ("miR-675 indirectly targets slug" 1)
   ("than SLUG that have been reported" 1)
   ("the transcriptional repressor Slug" 1) ("Slug-" 1)))
 ("UP:O43633"
  (("BC2" 4) ("Chromatin Modifying Protein 2A" 2) ("Chmp2" 2) ("CHMP2A" 1)))
 ("UP:O43639" (("LD4" 86) ("Nck2" 14) ("NCK2" 12) ("Nck-2" 2) ("NCKβ" 1)))
 ("UP:O43641" (("CACO-2" 11) ("caco-2" 4)))
 ("UP:O43653"
  (("PSCA" 33) ("prostate stem cell antigen" 5) ("Psca" 3)
   ("prostate stem cell antigen (PSCA)" 2)))
 ("UP:O43660" (("PLRG1" 3)))
 ("UP:O43663"
  (("PRC1" 537) ("Prc1" 61) ("the canonical PRC1" 3)
   ("the histone-H2A-specific ubiquitin ligase PRC1" 2) ("particular PRC1" 2)
   ("Some non-canonical PRC1" 2) ("O43663" 1)
   ("than the canonical PRC1 ( xref )" 1) ("very few PRC1" 1)))
 ("UP:O43665" (("RGS10" 1))) ("UP:O43670" (("ZNF207" 61)))
 ("UP:O43674" (("NDUFB5" 1)))
 ("UP:O43676" (("B12)" 23) ("b12)" 1) ("NDUFB3" 1)))
 ("UP:O43678" (("B8)" 14) ("NDUFA2" 3)))
 ("UP:O43679"
  (("Clim1" 13) ("CLIM1" 9) ("than Clim1" 2) ("Ldb2" 1) ("LDB2" 1)))
 ("UP:O43680"
  (("TCF21" 73) ("Tcf21" 13) ("tcf21" 2) ("TCF21 protein" 1) ("Pod1" 1)))
 ("UP:O43681" (("ARSA" 2) ("Get3" 2)))
 ("UP:O43683"
  (("Bub1" 2548) ("BUB1" 443) ("Hs-BUB1" 56) ("FL" 21) ("Bub1 protein" 10)
   ("overexpressed Bub1" 4) ("exogenous Bub1" 3) ("mitotic exit Bub1" 2)
   ("exogenous and endogenous Bub1" 2) ("bub1" 2) ("FL-" 2)
   ("exogenous Venus-tagged Bub1" 1) ("expressed exogenous Bub1" 1)
   ("than Bub1-WT" 1) ("than Bub1-WT ( xref )" 1)
   ("dimeric full-length Hs-BUB1" 1) ("exogenous Bub1-wt" 1)
   ("aberrant Bub1" 1) ("BUB1-" 1) ("kinetochore-associated Bub1" 1)
   ("sevenfold more Bub1" 1) ("1.84-fold less Bub1" 1)))
 ("UP:O43684"
  (("Bub3" 405) ("BUB3" 47) ("BUB family proteins" 19)
   ("mitotic checkpoint protein" 18) ("-Bub3" 15)
   ("an essential mitotic checkpoint protein" 2) ("more Bub3" 2)
   ("Bub3 protein" 2) ("bub3" 2) ("The mitotic regulators BUB3" 2)
   ("the mitotic regulator BUB3" 1)
   ("a defective mitotic checkpoint protein" 1)))
 ("UP:O43687" (("AKAP7" 2) ("AKAP18" 1))) ("UP:O43688" (("LPP2" 5)))
 ("UP:O43699"
  (("CD33L1" 7) ("the placental CD33L1 protein" 1) ("CD33L1 protein" 1)))
 ("UP:O43707"
  (("α-actinin-4" 39) ("ACTN4" 20) ("alpha-actinin-4" 4) ("FSGS1" 1)
   ("actinin-4" 1)))
 ("UP:O43708" (("MAI" 66) ("Mai" 2) ("GSTZ1" 1)))
 ("UP:O43711" (("TLX3" 18) ("HOX11L2" 2))) ("UP:O43715" (("TRIAP1" 12)))
 ("UP:O43716" (("GATC" 22)))
 ("UP:O43734"
  (("TRAF3IP2" 182) ("act1" 52) ("ACT1" 25) ("activator 1" 16) ("Act1" 7)
   ("Act-1" 2) ("TRAF3IP2 protein" 1) (NIL 1)))
 ("UP:O43736" (("ITM2A" 1)))
 ("UP:O43739"
  (("GRP1" 43) ("Grp1" 10) ("cytohesin-3" 3)
   ("general receptor of phosphoinositides 1" 1)))
 ("UP:O43741" (("PRKAB2" 22))) ("UP:O43747" (("AP1G1" 1)))
 ("UP:O43752" (("Syntaxin 6" 16) ("STX6" 8) ("syntaxin 6" 1)))
 ("UP:O43759" (("SYNGR1" 5))) ("UP:O43763" (("TLX2" 3) ("NCX" 1)))
 ("UP:O43765"
  (("SGT" 160) ("SGTA" 124) ("UBP" 64) ("UBPs" 9)
   ("PTEN and APC developed spontaneous SGT" 2)
   ("well-annotated malignant SGT" 1) ("malignant SGT" 1) ("a few UBPs" 1)
   ("the N-terminal 80 amino acids of SGTA (SGTA-N)" 1)
   ("these chain-specific UBPs" 1)))
 ("UP:O43766"
  (("LS" 1056) ("LAS" 510) ("LS-" 17) ("LAS (GE)" 3) ("pLS" 3)
   ("a FujiFilm LAS4000" 2) ("”" 1) ("colon-cancer cell line LS174" 1)
   ("positive colon tumor cell line LS174" 1) ("adjacent LS" 1)
   ("anogenital LS" 1) ("a LAS3000" 1)))
 ("UP:O43768" (("ENSA" 4) ("Ensa" 1)))
 ("UP:O43772"
  (("CAC" 1084) ("C-A-C" 4) ("Cac" 4) ("-CAC" 3) ("UC-associated CAC" 1)
   ("CACs" 1)))
 ("UP:O43781" (("DYRK3" 4))) ("UP:O43790" (("KRT86" 1)))
 ("UP:O43791"
  (("SPOP" 664) ("speckle-type POZ protein" 3)
   ("the prostate-cancer-associated SPOP mutant F133V" 2) ("residual SPOP" 2)
   ("SPOP protein" 2) ("-SPOP" 2) ("Speckle-type POZ protein" 2)
   ("more SPOP" 1) ("the Cul3-associated ligase SPOP" 1) ("TEF2" 1)
   ("speckle-type POZ protein (SPOP)" 1)))
 ("UP:O43795" (("MYO1B" 5))) ("UP:O43805" (("N14" 10)))
 ("UP:O43808" (("peroxisomal membrane protein PMP34" 2) ("34kDa)" 2)))
 ("UP:O43809"
  (("25 kDa" 81) ("25 kDa protein" 14) ("25 kDa" 13) ("25 kDa" 3) ("Nudt21" 2)
   ("roughly 25 kDa" 1) ("bands around 25 kDa" 1)
   ("than 25 kDa (see Fig. xref lanes 2-4)" 1) ("25 Kda" 1) ("than 25 kDa" 1)
   ("Cleavage and polyadenylation specificity factor subunit 5" 1)))
 ("UP:O43815"
  (("STRN" 10) ("striatins" 7) ("striatin" 4) ("Striatin" 3) ("Strn" 1)))
 ("UP:O43819" (("SCO2" 62))) ("UP:O43820" (("HYAL3" 3)))
 ("UP:O43823" (("AKAP95" 72))) ("UP:O43827" (("Cdt6" 1)))
 ("UP:O43829" (("zinc finger protein 161 homolog" 3)))
 ("UP:O43837" (("IDH3B" 1))) ("UP:O43847" (("Nardilysin" 5) ("NRDc" 3)))
 ("UP:O43852" (("CALU" 12) ("calumenin" 1)))
 ("UP:O43854"
  (("Del1" 44) ("del1" 12) ("the most distal del1" 2) ("EDIL3" 2) ("Del-1" 1)
   ("DEL1" 1)))
 ("UP:O43865" (("AHCYL1" 2))) ("UP:O43866" (("Spα" 1)))
 ("UP:O43868" (("SLC28A2" 1))) ("UP:O43869" (("OR2T1" 1)))
 ("UP:O43889"
  (("transcriptionally active form" 74) ("CREB3" 16) ("luman" 7) ("Luman" 7)
   ("LZIP" 3)))
 ("UP:O43895"
  (("membrane-bound" 708) ("membrane-bound protein" 40) ("Membrane-bound" 31)
   ("mAmp" 10) ("XPNPEP2" 7) ("Membrane-Bound" 3)
   ("distinctive membrane-bound" 2) ("membrane–bound protein" 2)
   ("membrane-bound peptide" 2) ("membrane–bound" 1)
   ("membrane-bound (MB)" 1)))
 ("UP:O43896" (("pSPAX2" 10) ("pSAX2" 1) ("sPax2" 1)))
 ("UP:O43897" (("TLL1" 24) ("TLL" 11)))
 ("UP:O43903"
  (("GAS2" 20) ("Gas2" 3) ("growth arrest specific 2" 2) ("Gas2 protein" 1)))
 ("UP:O43913"
  (("subunit 5" 11) ("Constitutive photomorphogenic homolog subunit 5" 1)
   ("ORC5" 1) ("Subunit 5" 1)))
 ("UP:O43914" (("DAP12" 17) ("KARAP" 1)))
 ("UP:O43915"
  (("VEGF-D" 34) ("Vegfd" 8) ("VEGFD" 6) ("FIGF" 5)
   ("c-fos induced growth factor" 5) ("fIGF" 5) ("Figf" 3) ("FIGF (VEGFD)" 2)
   ("very little VEGF-D" 1)))
 ("UP:O43916" (("carbohydrate sulfotransferase 1" 1)))
 ("UP:O43918" (("AIRE" 10) ("autoimmune regulator" 2) ("Aire" 1)))
 ("UP:O43921"
  (("EphrinA2" 6) ("Ephrin A2" 3)
   ("human dermal endothelial cell surface tyrosine kinase EphrinA2" 2)
   ("ephrinA2" 1)))
 ("UP:O43924"
  (("protein p17" 34) ("ARV nonstructural protein p17" 1) ("PDE6D" 1)))
 ("UP:O43927"
  (("CXCL13" 191) ("BLC" 40) ("BCA-1" 10) ("CXCL1-3" 10) ("sporadic BLC" 4)
   ("Angie" 2) ("cxcl13" 1)))
 ("UP:O43929" (("ORC4" 17) ("ORC4L" 3))) ("UP:O43933" (("PEX1" 9)))
 ("UP:O43934"
  (("ET" 1100) ("et" 1072) ("Et" 35) ("pET" 4) ("Similarly Puigdecanet et" 1)
   ("MFSD11" 1)))
 ("UP:O44081" (("MFL" 10))) ("UP:O44326" (("HMP-2" 1)))
 ("UP:O44552" (("cdc-25.1" 2)))
 ("UP:O44783" (("SPRY" 125) ("pSPRY" 5) ("SPRY protein" 1)))
 ("UP:O45797" (("WTS-1" 3))) ("UP:O46037" (("VINC" 2)))
 ("UP:O46072" (("KZ" 68))) ("UP:O46084" (("dPGAM5" 84)))
 ("UP:O46631" (("SHPS-1" 6))) ("UP:O46675" (("GROγ" 1)))
 ("UP:O46676" (("GROα" 17))) ("UP:O46677" (("Gro-β" 10)))
 ("UP:O48639" (("pT4" 59) ("more pT4" 1))) ("UP:O48890" (("rpb4" 1)))
 ("UP:O48963" (("phototropin 1" 3)))
 ("UP:O49065" (("Raps" 3) ("rAPS" 2) ("monomeric G protein Raps" 2)))
 ("UP:O49139" (("CMT1" 4)))
 ("UP:O49169" (("EF1" 249) ("elongation factor 1" 19) ("pEF1" 13)))
 ("UP:O49286" (("Skp2B" 9))) ("UP:O49482" (("CADD" 11) ("cadd" 1)))
 ("UP:O49835" (("PAL-1" 13) ("Pals-1" 4) ("PAL-1 protein" 2)))
 ("UP:O50008" (("MS1" 91)))
 ("UP:O50055" (("Col1" 29) ("col1" 13) ("COL1" 8) ("Col1-" 3)))
 ("UP:O50061" (("cl4" 12) ("CL4" 4) ("Cl4" 3)))
 ("UP:O50258"
  (("superoxide dismutase activity" 5) ("superoxide-dismutase (SOD)" 3)
   ("superoxide-dismutase" 3) ("superoxide dismutase activity (SOD)" 3)))
 ("UP:O50651" (("NoRC" 5))) ("UP:O50657" (("LDCs" 5)))
 ("UP:O54088" (("cBSA" 4) ("CBSA" 1))) ("UP:O54749" (("CYP2J5" 2)))
 ("UP:O54775" (("Elm1" 4) ("elm1" 1)))
 ("UP:O54922"
  (("rExo70" 14) ("expressed exogenous wild-type or mutated rExo70" 2)))
 ("UP:O54923" (("rSec15" 1))) ("UP:O54943" (("mPer2" 11) ("mPER2" 2)))
 ("UP:O54990" (("pPROM" 136) ("PROM" 12))) ("UP:O55047" (("TLK" 2)))
 ("UP:O55082" (("typ" 2) ("Typ" 1))) ("UP:O55233" (("Cerl" 5)))
 ("UP:O57166" (("vaccinia growth factor" 1))) ("UP:O57314" (("SPM2" 8)))
 ("UP:O57409"
  (("LB" 620) ("DLB" 14) ("a microplate luminometer Tristar LB" 5) ("Lb" 2)
   ("ice-cold LB" 2) ("pLB" 2) ("a Berthold luminometer LB953" 1)))
 ("UP:O57415" (("Ras-responsive element-binding protein 1" 2) ("RREB-1" 1)))
 ("UP:O57460" (("MFN" 23) ("Mfn" 17) ("mFN" 1) ("mfn" 1)))
 ("UP:O57474" (("SOF" 8))) ("UP:O57685" (("pax2a" 2)))
 ("UP:O59196"
  (("TET" 209) ("TETs" 76) ("pTET" 2) ("-TET" 1) ("than low-grade TETs" 1)
   ("we first divided TETs" 1) ("the invasive TET" 1)))
 ("UP:O59755" (("Cut12" 1))) ("UP:O60016" (("CLR4" 2)))
 ("UP:O60187" (("siD4" 1)))
 ("UP:O60216"
  (("RAD21" 320) ("SCC1" 124) ("Rad21" 23) ("RAD21 protein" 3) ("–SCC1" 3)
   ("kleisin" 2)
   ("as well-differentiated Squamous Cell Carcinomas (SCC)–SCC1" 2)
   ("RAD21-" 2) ("reduced functional RAD21" 1) ("“kleisin”" 1)
   ("experimental RAD21-" 1)))
 ("UP:O60218"
  (("AKR1B10" 92) ("Arp" 25) ("1B10" 10) ("Akr1b10" 5) ("HSI" 5)
   ("aldose reductase-like 1" 4)))
 ("UP:O60220" (("DDP" 377) ("dDP" 54) ("dDp" 2) ("DDp" 2)))
 ("UP:O60224" (("SSX4" 6)))
 ("UP:O60229"
  (("Duo" 122) ("kalirin" 89) ("Kalirin" 56) ("KALRN" 41) ("duo" 25)
   ("Duet" 18) ("Kalrn" 11) ("kalirin protein" 4) ("kalrn" 1)
   ("the kalirin protein's" 1) ("a functional duo" 1) ("KALIRIN" 1) ("DUO" 1)
   ("-Duo" 1)))
 ("UP:O60232" (("SSSCA1" 1)))
 ("UP:O60235"
  (("HAT" 744) ("HATs" 371) ("HAT−" 7) ("HAT-" 5) ("HAT protein" 4)
   ("airway trypsin-like protease" 2) ("exogenous HATs" 2)
   ("at least five different HATs" 2) ("a major HAT" 1) ("at least 15 HATs" 1)
   ("The relevant yeast HAT" 1) ("a key HAT" 1)))
 ("UP:O60237"
  (("myosin phosphatase" 121) ("MYLP" 16) ("Myosin phosphatase" 8)
   ("PPP1R12B" 2) ("MYPT2" 1) ("Mypt2" 1) ("Ppp1r12b" 1)))
 ("UP:O60238" (("Nix" 152) ("NIX" 27) ("BNIP3L" 11) ("Bnip3L" 8)))
 ("UP:O60239" (("SAB" 99) ("SH3BP5" 1)))
 ("UP:O60240" (("PLIN1" 8) ("PLIN" 1) ("PERI" 1))) ("UP:O60242" (("BAI3" 6)))
 ("UP:O60243" (("HS6ST1" 2))) ("UP:O60244" (("MED14" 4)))
 ("UP:O60245" (("protocadherin" 21) ("Protocadherin" 1) ("PCDH7" 1)))
 ("UP:O60258" (("Fgf17" 6) ("FGF17" 4))) ("UP:O60259" (("KLK8" 7) ("hK8" 3)))
 ("UP:O60260"
  (("parkin" 993) ("Parkin" 535) ("PARK2" 178) ("Parkin protein" 19)
   ("parkin protein" 13) ("PARKIN" 10) ("-PARK2" 4) ("PARK2 protein" 4)
   ("Park2" 3) ("Parkin Protein" 2) ("exogenously-expressed parkin" 1)
   ("cellular Parkin" 1) ("more Parkin" 1) ("significantly more Parkin" 1)
   ("parkin RBR E3 ubiquitin protein ligase" 1)
   ("the PD-associated gene PARK2" 1) ("cancer decrease PARK2's" 1)
   ("arrestin-associated parkin" 1) ("receptor-associated parkin" 1)
   ("associated parkin" 1)
   ("anti-parkin antibody readily immunoprecipitates endogenous parkin" 1)
   ("functional parkin" 1)))
 ("UP:O60264"
  (("ISWI" 33) ("SNF2h" 21) ("SMARCA5" 15) ("SNF2H" 11) ("Snf2h" 6)))
 ("UP:O60266"
  (("AC-3" 434) ("AC3" 23) ("ac-3" 13)
   ("-CAA ATA ATG ACA AGC AGA AGT AT G A  T C TGA AAA TCA ACC ATG AC-3" 1)
   ("5-CTT CTG C CC TT A A C A GCC ATA AAA AC-3" 1)))
 ("UP:O60268" (("KIAA0513" 2)))
 ("UP:O60271"
  (("HSs" 9) ("SYD1" 7) ("JLP" 7) ("JIP4" 7) ("HsS" 4) ("SYD1 protein" 3)))
 ("UP:O60279" (("SUSD5" 2))) ("UP:O60281" (("ZNF292" 5)))
 ("UP:O60284" (("ST18" 1)))
 ("UP:O60285"
  (("NUAK1" 323) ("ARK5" 21) ("Nuak1" 8) ("overexpressed NUAK1" 5)
   ("NUAK family" 4) ("Ark5" 4) ("overexpressed WT NUAK1" 3)
   ("stably overexpressed NUAK1" 2) ("–NUAK1" 2)
   ("than endogenous NUAK1 in these experiments (Supplementary Figure S1 at)"
    1)
   ("-NUAK1" 1) ("NuaK1" 1) ("SNF1-like kinase" 1)))
 ("UP:O60291" (("RING finger 1" 2) ("MGRN1" 1))) ("UP:O60293" (("ZFC3H1" 1)))
 ("UP:O60306" (("AQR" 2))) ("UP:O60312" (("Class V" 2) ("ATP10A" 1)))
 ("UP:O60313" (("NTg" 9) ("Opa1" 4)))
 ("UP:O60315"
  (("ZEB2" 371) ("ZFHX1B" 48) (NIL 9) ("ZEB-2" 7)
   ("Smad interacting protein 1" 2) ("Smad interacting protein-1" 2)
   ("the transcriptional inhibitor ZEB2" 1)
   ("the transcriptional repressor ZEB2" 1) ("SMAD-interacting protein" 1)))
 ("UP:O60318" (("MCM3AP" 7) ("MCM3AP protein" 4)))
 ("UP:O60331"
  (("PIPKIγ" 552) ("PIP5Kγ" 97) ("PIPKIγi5-" 3) ("-PIPKIγi5" 3)
   ("PIPKIγ protein" 2) ("PIP5K1C" 1) ("A dominant-negative PIPKIγ" 1)
   ("than PIPKIγ" 1) ("functional PIPKIγ" 1)))
 ("UP:O60333" (("CMT2" 21) ("KLP" 9) ("KIF1B" 4) ("CMT2A" 1)))
 ("UP:O60337" (("TEB4" 3)))
 ("UP:O60341"
  (("LSD1" 1662) ("KDM1" 93) ("KDM1A" 57) ("pLSD1" 14) ("-LSD1" 9) ("AOF2" 8)
   ("BHC110" 4) ("KDM1a" 4) ("LSD1 protein" 3) ("KDM1-" 3) ("KIAA0601" 2)
   ("the transcriptional repressor LSD1" 1) ("the cellular LSD1" 1)
   ("the first 171 amino acids of LSD1 (NΔ-LSD1)" 1)
   ("I-PpoI–induced DSBs recruited LSD1" 1) ("targeting human LSD1" 1)))
 ("UP:O60343"
  (("AS160" 59) ("TBC1D4" 11) ("p-AS160" 5) ("Akt substrate of 160 kDa" 3)
   ("AS160 protein" 2) ("p-Akt substrate of 160 kDa" 2)
   ("AKT substrate of 160 kDa" 1) ("As160" 1) ("p-TBC1D4" 1)))
 ("UP:O60346"
  (("PHLPP1" 607) ("PHLPP" 393) ("Phlpp1" 77) ("SCOP" 11)
   ("the antagonistic phosphatase PHLPP1" 3) ("PHLPP1 protein" 3)
   ("especially membrane-associated PHLPP" 2) ("Phlpp1 protein" 2)
   ("new PHLPP" 1) ("FKBP51 not only scaffolds PHLPP" 1) ("PHLPP protein" 1)))
 ("UP:O60353" (("FZD6" 11) ("Fz6" 1)))
 ("UP:O60356"
  (("NUPR1" 19) ("nuclear protein 1" 10)
   ("tumor protein 53-induced nuclear protein 1" 8) ("Nupr1" 2)
   ("Nuclear Protein 1" 1)))
 ("UP:O60381"
  (("HBP1" 167) ("HMG-box transcription factor 1" 7) ("HBP1 protein" 4)
   ("HMG box-containing protein 1" 2)
   ("the HMG box transcriptional repressor HBP1" 2) ("Hbp1" 1)))
 ("UP:O60383" (("GDF9" 5) ("GDF-9" 2) ("Gdf9" 1)))
 ("UP:O60393" (("OG2" 16) ("pOG2" 1))) ("UP:O60427" (("FADS1" 12)))
 ("UP:O60437" (("pPL" 7) ("PPL" 7) ("periplakin" 7) ("PPl" 2)))
 ("UP:O60443" (("DFNA5" 6)))
 ("UP:O60447"
  (("EVI5" 37) ("EVI-5" 3) ("Evi5" 2)
   ("Ecotropic viral integration site 5" 1)))
 ("UP:O60462"
  (("NRP2" 83) ("Neuropilin-2" 6) ("NRP-2" 6) ("neuropilin 2" 5)
   ("neuropilin-2" 3) ("nrp2" 2)))
 ("UP:O60469"
  (("DSCAM" 5) ("Down syndrome cell adhesion molecule" 2)
   ("Down syndrome cell adhesion molecule (DSCAM)" 1)))
 ("UP:O60479" (("DLX3" 4) ("Dlx3" 3) ("dlx3" 1))) ("UP:O60481" (("zic3" 1)))
 ("UP:O60486" (("Plexin C1" 6) ("plexin-C1" 3)))
 ("UP:O60487" (("EVA1" 10) ("MPZL2" 1)))
 ("UP:O60488" (("ACSL4" 292) ("ACSL4 protein" 1) ("FACL4" 1)))
 ("UP:O60493" (("SNX3" 63))) ("UP:O60494" (("CUBN" 6)))
 ("UP:O60496"
  (("DOK2" 116) ("Dok2" 41) ("Dok-2" 15) ("docking protein 2" 3)
   ("downstream of tyrosine kinase 2" 2) ("DOK-2" 2) ("dok2" 2)))
 ("UP:O60500" (("nephrin" 75) ("Nephrin" 8) ("NPHS1" 5) ("Nphs1" 1)))
 ("UP:O60502" (("MGEA5" 14) ("O-GlcNAcase" 11)))
 ("UP:O60503"
  (("AC9" 112) ("ADCY9" 11) ("adenylyl cyclase 9" 8)
   ("adenylate cyclase 9" 2)))
 ("UP:O60504" (("SORBS3" 1))) ("UP:O60512" (("polypeptide 3" 3)))
 ("UP:O60513" (("B4GALT4" 1))) ("UP:O60519" (("CREBL2" 1)))
 ("UP:O60522" (("TDRD6" 1))) ("UP:O60524" (("SDCCAG1" 1)))
 ("UP:O60542" (("persephin" 1)))
 ("UP:O60543" (("CIDEA" 28) ("Cidea" 4) ("cidea" 1)))
 ("UP:O60547" (("GMDS" 11) ("GDP-mannose 4,6-dehydratase" 2)))
 ("UP:O60551" (("NMT2" 4)))
 ("UP:O60563"
  (("cyclin T1" 327) ("CycT1" 92) ("Cyclin T1" 46) ("Cyclin T" 14)
   ("—cyclin T1" 5) ("phosphomimetic mutant cyclin T1 S564D" 1) ("CCNT1" 1)
   ("cycT1" 1) ("the regulatory CYCLIN T1" 1) ("CYCLIN T1" 1) ("new CycT1" 1)
   ("more cyclin T1" 1)))
 ("UP:O60565"
  (("DRM" 78) ("DRMs" 72) ("GREM1" 18) ("gremlin-1" 2) ("gremlin" 1)
   ("The V82A beneficial DRM" 1) ("The K20I beneficial DRM" 1)
   ("the beneficial and primary DRMs" 1)
   ("Our refactored database contained 671 unique DRMs" 1) ("Gremlin1" 1)))
 ("UP:O60566"
  (("BubR1" 1684) ("BUBR1" 234) ("PCS" 77) ("BUB1B" 32) ("Hs-BUBR1" 23)
   ("BubR1-" 6) ("Bubr1" 6) ("-BubR1" 3) ("1.66-fold less BubR1" 3)
   ("strong BubR1" 2) ("the available BubR1" 2) ("BUBR1 protein" 2)
   ("pBUBR1" 2) ("Bub1b" 2) ("Bub1B" 2)
   ("the kinetochore-associated checkpoint kinase BUBR1" 2)
   ("3-fold more BubR1" 1) ("Insufficient BubR1" 1) ("BubR1 protein" 1)
   ("PCS-" 1) ("than Hs-BUBR1" 1) ("particular BubR1" 1) ("bubR1" 1)
   ("MAD3L" 1)))
 ("UP:O60568" (("lysyl hydroxylase 3" 2)))
 ("UP:O60573" (("eIF4E2" 2) ("IF4e" 1))) ("UP:O60575" (("SPINK4" 1)))
 ("UP:O60583" (("cyclin T2" 6)))
 ("UP:O60602"
  (("TLR5" 271) ("Sle1" 62) ("toll-like receptor 5" 5) ("TLR-5" 3)
   ("Toll-like receptor 5" 2) ("tlr5" 1) ("functional TLR5" 1) ("TLR5-" 1)
   ("TLR5 protein" 1) ("the treated Sle1" 1)))
 ("UP:O60603"
  (("TLR2" 1057) ("TLR-2" 48) ("TLR2-" 17) ("Toll-like receptor 2" 12)
   ("TIL4" 10) ("toll-like receptor 2" 8) ("Tlr2" 7) ("soluble TLR2" 7)
   ("TLR2 protein" 4)))
 ("UP:O60610"
  (("mDia1" 88) ("DIAPH1" 26) ("DIAP1" 23) ("diap1" 18) ("p140mDia" 11)
   ("Diap1" 5) ("Drosophila IAP1" 2) ("mDia1 protein" 1) ("DRF1" 1)
   ("antiapoptotic DIAP1" 1)))
 ("UP:O60636" (("TSPAN2" 76) ("tetraspanin 2" 1)))
 ("UP:O60645"
  (("Sec6" 103) ("Exoc3" 9) ("EXOC3" 6) ("exocyst complex component 3" 2)
   ("sec6" 1)))
 ("UP:O60656" (("UGT1A9" 23))) ("UP:O60662" (("sarcosin" 6) ("Krp1" 1)))
 ("UP:O60663" (("LMX1B" 1)))
 ("UP:O60664" (("TIP47" 10) ("PLIN3" 3) ("perilipin 3" 2) ("Perilipin 3" 1)))
 ("UP:O60667" (("FAIM3" 3) ("Faim3" 3) ("TOSO" 2)))
 ("UP:O60669" (("SLC16A7" 6) ("MCT2" 2)))
 ("UP:O60671" (("hRad1" 38) ("RAD1" 18) ("rec1" 5) ("hRAD1" 1) ("“rec1”" 1)))
 ("UP:O60673"
  (("REV3" 24) ("Rev3" 21) ("rev3" 4) ("Rev3L" 1) ("hREV3" 1) ("REV3L" 1)))
 ("UP:O60674"
  (("JAK2" 8269) ("Jak2" 2259) ("JAK" 1849) ("pJAK" 220) ("pJAK2" 135)
   ("Janus kinase 2" 124) ("Jak" 122) ("JAK2 protein" 88) ("Jak-2" 59)
   ("pJak2" 26) ("JAK-2" 24) ("JAK2-" 22) ("P-JAK2" 19) ("p-JAK2" 16)
   ("Janus kinase-2" 12) ("JAK2 molecule" 11) ("Jak2 protein" 11)
   ("Janus-kinase 2" 9) ("pJak" 7) ("JAK-" 7) ("JAK molecule" 5) ("jak2" 5)
   ("p-Jak2" 4) ("than JAK2" 4) ("than wild-type JAK2" 4) ("JAk2" 4)
   ("Jak2 molecule" 4) ("JAK protein" 4) ("janus kinase 2" 3)
   ("overexpressed activated JAK2" 3) ("intact Jak2" 3) ("exogenous Jak2" 3)
   ("p-JAK" 3) ("-JAK2" 2) ("Jak 2" 2)
   ("monoclonal mouse anti-human JAK2 and phosphotyrosine JAK2" 2)
   ("MiR-375-regulated JAK2" 2) ("intact JAK2" 2)
   ("rabbit monoclonal anti-total JAK2" 2) ("strong Jak-2" 2)
   ("functional Jak2" 2) ("serial JAK2" 2) ("JAK2 Protein" 2)
   ("Exogenous Jak2" 2) ("an entirely new JAK2" 2)
   ("allosterically binding JAK2" 1) ("pathological mutant JAK2" 1)
   ("less JAK2" 1) ("only mutant Jak2" 1)
   ("either exclusively mutant or wildtype JAK2" 1) ("normal Jak2" 1)
   ("Jak2-" 1) ("the relevant Jak protein" 1) ("Jak protein" 1)
   ("particular Jak2" 1) ("most notably JAK2 -V617F" 1)
   ("the previously identified JAK2" 1)
   ("These receptors primarily use JAK2" 1) ("tubulointerstitial Jak-2" 1)
   ("normal JAK2" 1) ("alternate activating JAK2" 1)
   ("homozygous JAK2  V617F" 1) ("cytokine-associated Jak2" 1)
   ("had two or more sequential JAK2" 1)
   ("than those containing wild type JAK2 ( xref )" 1)
   ("the MPN-associated JAK2-V617F" 1)
   ("The receptor-associated tyrosine kinase Jak2" 1)
   ("the receptor-associated kinase Jak2" 1)
   ("than Jak2 coupled with our analysis" 1) ("functional JAK2" 1)
   ("hematopoietic cell growth predominantly use JAK2" 1)
   ("cytokine receptors preferentially use one JAK" 1)
   ("than wild-type JAK2 ( xref )" 1) ("normal and mutated JAK2" 1)
   ("at least one JAK" 1) ("“pre-JAK2”" 1) ("less Jak2" 1) ("cellular Jak2" 1)
   ("the fever range irreversibly aggregate Jak2" 1)
   ("This mutation effectively leaves JAK2" 1)
   ("Western blots confirmed decreased pJAK2" 1)))
 ("UP:O60675"
  (("MafK" 153) ("MAFK" 7) ("MafK protein" 2)
   ("nuclear factor erythroid-2" 1)))
 ("UP:O60676"
  (("CREs" 29) ("cellular CREs" 4) ("functional CREs" 2)
   ("the respective CREs" 2) ("enhancer elements called viral CREs" 2)
   ("four consecutive CREs" 1)))
 ("UP:O60678" (("PRMT3" 44)))
 ("UP:O60682"
  (("MSC" 790) ("transformed MSC" 8) ("hypoxic MSC" 5) ("multipotent MSC" 4)
   ("primary MSC" 2) ("sphere-initiating MSC" 2) ("etoposide-treated MSC" 2)
   ("MSc" 2) ("adherent MSC" 1) ("non-transformed MSC" 1)
   ("the accelerated aging phenotypein MSC" 1) ("ABF-1" 1)
   ("consecutive MSC" 1) ("migrated MSC" 1) ("the multipotent MSC" 1)
   ("permanent and stable human MSC" 1) ("MSC-" 1)))
 ("UP:O60683" (("PEX10" 2))) ("UP:O60684" (("KPNA6" 8)))
 ("UP:O60687" (("SRPX2" 7)))
 ("UP:O60701" (("UDP-glucose 6-dehydrogenase" 3) ("UGDH" 1)))
 ("UP:O60706" (("ABCC9" 4) ("Sur2" 1))) ("UP:O60711" (("LPXN" 3)))
 ("UP:O60716"
  (("p120ctn" 670) ("p120-catenin" 589) ("Cas" 319) ("p120 catenin" 66)
   ("p120-ctn" 58) ("CTNND1" 56) ("cas" 27) ("CAs" 27) ("p120-Catenin" 18)
   ("Cas protein" 7) ("Cas molecule" 7) ("p120cas" 5) ("p120ctn protein" 4)
   ("p120catenin" 4) ("p120-catenin protein" 2)
   ("overexpressed p120ctn isoforms 1A" 2) ("P120-catenin" 2)
   ("P120 catenin" 2) ("Cas(SD)" 1) ("exogenous p120ctn-1A" 1)
   ("cadherin-associated p120ctn" 1) ("targeting p120ctn" 1) ("p120ctn-" 1)
   ("p120-catenin–" 1)))
 ("UP:O60725"
  (("Icmt" 64) ("isoprenylcysteine carboxylmethyltransferase" 5) ("pcCMT" 4)
   ("ICMT" 4) ("isoprenylcysteine carboxyl methyltransferase" 3) ("Icmt-" 1)))
 ("UP:O60729"
  (("hCdc14B" 212) ("Cdc14B" 52) ("CDC14B" 2)
   ("asynchronous cells hCdc14B" 1)))
 ("UP:O60732" (("MAGE-C1" 2) ("MAGEC1" 1)))
 ("UP:O60733" (("PLA2G6" 4) ("iPLA2" 1))) ("UP:O60739" (("GC20" 9)))
 ("UP:O60741" (("HCN1" 12))) ("UP:O60749" (("SNX2" 7)))
 ("UP:O60759" (("CYBR" 2)))
 ("UP:O60760"
  (("glutathione S-transferase" 221) ("Glutathione S-transferase" 47)
   ("PGD2" 18) ("Glutathione S-Transferase" 16)
   ("glutathione S-transferase (GST)" 16) ("PGDS" 7) ("HPGDS" 6) ("H-PGDS" 5)
   ("glutathione S-transferase (GST) protein" 3) ("hpgds" 2)
   ("hematopoietic prostaglandin D synthase" 2) ("Glutathione S–transferase" 1)
   ("glutathione S-transferase ( GST )" 1) ("glutathione S-transferase-" 1)
   ("glutathione-S transferase" 1)
   ("glutathione
S-transferase"
    1)))
 ("UP:O60762"
  (("catalytic subunit" 2643) ("catalytic subunit (GCLC)" 6)
   ("catalytic subunit (TERT)" 5) ("catalytic subunit protein" 4)
   ("the principal catalytic subunit" 4) ("targeted PI3-K catalytic subunit" 3)
   ("Catalytic subunit" 3)
   ("catalytic
                            subunit"
    3)
   ("2500 U cAMP-dependent protein kinas A (PKA) catalytic subunit" 2)
   ("the predominant catalytic subunit" 2) ("Catalytic subunit (GCLC)" 2)
   ("the key catalytic subunit" 2)
   ("hemagglutinin (HA)-tagged dominant-negative (dn) PP2A catalytic subunit"
    2)
   ("a key catalytic subunit" 2) ("the class I A catalytic subunit" 2)
   ("potentially functional catalytic subunit" 2)
   ("catalytic
subunit"
    1)
   ("DPM1" 1) ("the only class IB PI3K catalytic subunit" 1)
   ("catalytic subunit ( TERT )" 1)))
 ("UP:O60763"
  (("Tap" 57) ("USO1" 5) ("Tap protein" 2) ("vesicle docking protein" 1)
   ("Uso1" 1) ("Tap–" 1) ("VDP" 1)))
 ("UP:O60784" (("TOM1" 33) ("Tom1" 27) ("tom1" 1))) ("UP:O60806" (("Tpit" 7)))
 ("UP:O60814" (("H2BK" 19) ("H2Bk" 13)))
 ("UP:O60825" (("PFK-2/FBPase-2" 8) ("PFKFB" 6)))
 ("UP:O60826" (("CCDC22" 6) ("Given CCDC22’s" 1) ("Given CCDC22" 1)))
 ("UP:O60829"
  (("PAGE4" 336) ("PAGE4 protein" 22) ("PAGE4 molecule" 10) ("page 4" 2)
   ("mitochondrial-associated PAGE4" 1) ("PAGE 4" 1)))
 ("UP:O60831" (("Praf2" 130)))
 ("UP:O60832"
  (("dyskerin" 82) ("DKC1" 65) ("Dyskerin" 8) ("dyskerin protein" 5)
   ("dyskeratosis congenita 1" 2) ("CBF5" 2)
   ("the accessory protein dyskerin" 2) ("Cbf5" 1)))
 ("UP:O60840" (("JM8" 2))) ("UP:O60841" (("IF2" 10) ("iF2" 5) ("EIF5B" 1)))
 ("UP:O60858" (("Leu5" 4) ("TRIM13" 1))) ("UP:O60861" (("GAS7" 11)))
 ("UP:O60869" (("Endothelial differentiation-related factor 1" 3) ("EDF1" 2)))
 ("UP:O60870"
  (("subdomains" 430) ("kin" 109) ("Kin" 53) ("KIN" 48)
   ("peripheral recycling endosome subdomains" 4)
   ("two potential paxillin-binding subdomains" 2) ("subdomains (PBS)" 2)
   ("WASH-positive subdomains" 2) ("two well-defined functional subdomains" 2)
   ("peripheral recycling endosomal subdomains" 2) ("distinct subdomains" 2)
   ("KIN protein" 2) ("cortactin-positive subdomains" 1)
   ("functional subdomains" 1) ("than the isolated AD1 and AD2 subdomains" 1)
   ("basolateral membrane subdomains" 1) ("key chromosomal subdomains" 1)
   ("chromosomal subdomains" 1) ("the Hrs-positive subdomains" 1)
   ("than KIN" 1)))
 ("UP:O60879" (("DIAPH2" 1)))
 ("UP:O60880"
  (("XLP" 53) ("SH2D1A" 49) ("lymphoproliferative syndrome" 15)
   ("lymphoproliferative syndrome (ALPS)" 4) ("SH2D1A protein" 2)
   ("Sh2d1a (SAP)" 2) ("Sh2d1a" 2) ("SH2D1A molecule" 1) ("MTCP1" 1)))
 ("UP:O60882" (("matrix metalloproteinase 20" 6)))
 ("UP:O60883" (("pLP2" 10) ("LP2" 5)))
 ("UP:O60884" (("cochaperones" 48) ("DNAJA2" 1)))
 ("UP:O60885"
  (("BRD4" 743) ("Brd4" 95) ("Brd4 protein" 3) ("specifically target BRD4" 2)
   ("bromodomain containing protein 4" 2) ("bromodomain containing 4" 2)
   ("BRD4 protein" 2) ("STAT3-associated BRD4" 1) ("-BRD4" 1) ("BRD4-" 1)
   ("normal BRD4" 1)))
 ("UP:O60890" (("OPHN1" 10) ("Oligophrenin-1" 2) ("oligophrenin-1" 1)))
 ("UP:O60902"
  (("shot" 38) ("Shot" 36) ("SHOX2" 8) ("shOT" 3)
   ("miR-375 directly targets SHOX2" 1)))
 ("UP:O60906"
  (("N-SMase" 47) ("nSMase" 35) ("neutral sphingomyelinase" 15) ("N-SMases" 10)
   ("N-Smase" 4) ("Neutral sphingomyelinase" 2)))
 ("UP:O60907" (("TBL1X" 12)))
 ("UP:O60909"
  (("polypeptide 2" 14) ("lamina-associated polypeptide 2" 2)
   ("Polypeptide 2" 1)))
 ("UP:O60911" (("CTSL2" 3) ("CTSU" 1)))
 ("UP:O60921"
  (("Hus1" 80) ("HUS1" 35) ("hHus1" 32) ("Ber" 11) ("hus1" 2) ("hHUS1" 1)))
 ("UP:O60925" (("PFD1" 1))) ("UP:O60930" (("RNaseH1" 12) ("RNase H1" 1)))
 ("UP:O60931" (("nephropathic" 2) ("cystinosis" 2)))
 ("UP:O60934"
  (("NBS1" 1029) ("p95" 212) ("NBN" 175) ("NBS" 118) ("Nibrin" 16)
   ("nibrin" 13) ("Nijmegen breakage syndrome protein 1" 9) ("p95 protein" 8)
   ("P95" 7) ("NBS1-" 7) ("NBS1 protein" 6) ("pp95" 3) ("pNBS" 2) ("“p95”" 2)
   ("p-NBS1" 1) ("pNBS1" 1) ("-NBS1" 1) ("exogenous mutated NBS1" 1)
   ("NBS1 (NBN)" 1) ("functional NBS1" 1)))
 ("UP:O60936" (("NOL3" 3) ("MYP" 1))) ("UP:O60941" (("DTNB" 18)))
 ("UP:O60942" (("HCE" 52) ("TPase" 9) ("TPase-" 4) ("RNGTT" 1)))
 ("UP:O60950" (("GOL" 5))) ("UP:O60993" (("TRS" 76))) ("UP:O61307" (("odz" 6)))
 ("UP:O61366" (("GPRs" 1))) ("UP:O61374" (("SXL" 4) ("Sxl" 2) ("sxl" 1)))
 ("UP:O61460" (("VAB-1" 2)))
 ("UP:O61608"
  (("NOS" 412) ("nitric oxide synthase" 406)
   ("endothelial nitric oxide synthase" 92)
   ("Endothelial nitric oxide synthase" 14) ("DLBCL" 11)
   ("neuronal nitric oxide synthase" 9) ("nitric oxide synthase (NOS)" 9)
   ("pNOS" 3) ("nitric oxide synthase protein" 3)
   ("the endothelial nitric oxide synthase" 3) ("NOS (ACNOS)" 3) ("NOSs" 3)
   ("Nitric oxide synthase" 2)
   ("the enzyme endothelial nitric oxide synthase" 2) ("another major NOS" 2)
   ("the AMPK substrates endothelial nitric oxide synthase" 2)
   ("cerebellar ataxia NOS" 2) ("ductal NOS" 2)
   ("nitric oxide synthase ( NOS )" 1) ("ductal carcinoma NOS" 1)))
 ("UP:O61955" (("IFE-3" 41))) ("UP:O61967" (("LET-413" 2)))
 ("UP:O62618" (("p38a" 8) ("P38a" 2)))
 ("UP:O62696" (("NAT" 28) ("pNAT" 2) ("adjacent NAT" 1)))
 ("UP:O62826" (("TRPC2" 1))) ("UP:O64253" (("gp61" 10)))
 ("UP:O64258" (("gp66" 2))) ("UP:O64267" (("p86" 1)))
 ("UP:O64319"
  (("gene 4" 37) ("Prostate-associated gene 4" 4)
   ("prostate-associated
gene 4"
    3)
   ("defective gene 4" 2) ("Prostate-associated Gene 4" 2)
   ("The neural precursor cell-expressed developmentally downregulated gene 4"
    2)
   ("Gene 4" 1) ("esophageal cancer related gene 4" 1)))
 ("UP:O64392" (("RNases" 10) ("double-strand-specific RNAses" 2) ("RNAses" 2)))
 ("UP:O64404" (("Ag4" 1))) ("UP:O64470" (("shT" 7)))
 ("UP:O64503" (("UTR1" 21))) ("UP:O64530" (("ST1" 72)))
 ("UP:O64645" (("SOC-1" 4)))
 ("UP:O64728" (("STI" 113) ("the Abl kinase inhibitor STI571" 1)))
 ("UP:O64937"
  (("EF1α" 350) ("EF-1α" 21) ("elongation factor 1-alpha" 20)
   ("EF1α protein" 11) ("eF1α" 5) ("EF-1alpha" 4) ("elongation factor-1α" 4)
   ("EF1α peptide" 2)))
 ("UP:O64953" (("LF1" 27) ("telomerase-immortalized human fibroblasts LF1" 1)))
 ("UP:O64982" (("pS7" 6) ("Rpt1" 4) ("Rpt-1" 3))) ("UP:O64988" (("BEAT" 1)))
 ("UP:O65020" (("ETO1" 1))) ("UP:O65268" (("Taspase1" 2)))
 ("UP:O65323"
  (("EAs" 145) ("EAS" 50) ("nearly 2000 EAs" 3) ("peas" 2)
   ("440 non-diabetic EAs" 2) ("the self-reported EAs" 1)
   ("than EAs ( xref )" 1) ("eas" 1)))
 ("UP:O65517" (("Sty2" 1))) ("UP:O65572" (("NC1" 23) ("Nc1" 1)))
 ("UP:O66188"
  (("SCNC" 82) ("a pure SCNC" 1) ("pure SCNC" 1) ("the resultant SCNC" 1)))
 ("UP:O66520" (("talc" 7) ("TALC" 4)))
 ("UP:O66761"
  (("LAM" 387) ("sporadic LAM" 3) ("“LAM”" 1) ("TSC-associated LAM" 1)))
 ("UP:O66874" (("PonA" 15))) ("UP:O67221" (("LysC" 2)))
 ("UP:O67332" (("HsK" 4)))
 ("UP:O67480"
  (("ICD" 1218) ("ICD protein" 13) ("N3-ICD protein" 4)
   ("coexpressed wild-type ICD" 3) ("N1-ICD protein" 2)
   ("overexpressed N1-ICD" 2) ("a soluble 80 kDa ICD" 2) ("the entire ICD" 2)
   ("at least 2 ICD" 1) ("Pin1 accelerated N4-ICD's" 1)
   ("Pin1 accelerated N4-ICD" 1) ("soluble N3-ICD" 1) ("larger ICD" 1)
   ("overexpressing Notch1 ICD" 1)
   ("Ectopically expressed ErbB4 soluble ICD" 1) ("The soluble ErbB4 ICD" 1)
   ("procedural ICD-9" 1) ("an isolated soluble gp130 ICD" 1)))
 ("UP:O67781" (("ASPC" 9))) ("UP:O67802" (("DLH" 1)))
 ("UP:O67866"
  (("flox" 1271) ("Flox" 36) ("FLOX" 4) ("Nordic FLOX" 4) ("-flox" 3)
   ("we first crossed theShp2 flox" 1) ("Mice homozygous forSpry1-2 flox" 1)
   ("-Flox" 1)))
 ("UP:O68006" (("GluA" 4))) ("UP:O68007" (("ba2" 2)))
 ("UP:O68900"
  (("toxin" 1074) ("PET" 944) ("Toxin" 44) ("a cell-permeable fungal toxin" 4)
   ("dynamic PET" 3) ("good PET" 2) ("affibody-based PET" 2)
   ("noninvasive PET" 2) ("One-hour dynamic PET" 2) ("a relatively poor PET" 2)
   ("an attractive PET" 2) ("a bacterial toxin" 2) ("choleric toxin" 2)
   ("a natural dopaminergic toxin" 2) ("Twenty primary sporadic PET" 2)
   ("a fungal toxin" 2) ("Decay-corrected coronal PET" 1) ("correlative PET" 1)
   ("dopaminergic toxin" 1) ("a unique toxin" 1)
   ("Attenuation-corrected PET" 1) ("a specific SubAB bacterial toxin" 1)
   ("a uremic toxin" 1) ("than FDG PET" 1)
   ("a natural dopaminergic toxin frequently used to trigger phenotypes resembling Parkinson’s"
    1)
   ("instead thymidine PET" 1) ("a binary toxin" 1) ("than PET" 1)
   ("the bacterial toxin" 1) ("-toxin" 1) ("oligomeric toxin" 1)
   ("monomeric toxin" 1)))
 ("UP:O69199"
  (("adenylyl cyclase" 60) ("adenylate cyclase activity" 4) ("crac" 4)
   ("Adenylyl cyclase" 3) ("adenylyl-cyclase" 1) ("Crac" 1)
   ("adenylyl cyclase (AC)" 1) ("adenylyl cyclase (CRAC)" 1)
   ("Adenylate cyclase activity" 1)))
 ("UP:O70022" (("FBE" 7))) ("UP:O70138" (("collagenase 2" 1)))
 ("UP:O70239" (("rAxin" 4))) ("UP:O70453" (("HO3" 4)))
 ("UP:O70566" (("mDia3" 6)))
 ("UP:O73683"
  (("a beta" 55) ("amyloid beta" 20) ("amyloid beta peptide" 7)
   ("Amyloid beta" 6) ("a Beta" 3) ("beta amyloid" 3) ("A  beta" 1)
   ("A beta" 1)))
 ("UP:O73688" (("Hmox" 5) ("HMOX" 3) ("HMOX protein" 1)))
 ("UP:O73689" (("OPL" 148) ("an OPL's" 1)))
 ("UP:O74187"
  (("ALDH" 875) ("than ALDH" 9) ("ALDH-" 5) ("ALDH protein" 2)
   ("than their ALDH" 2) ("than either ALDH" 1) ("ALDH+HER2−" 1)))
 ("UP:O74196" (("ChIP-1" 2))) ("UP:O74213" (("PG1" 1)))
 ("UP:O74453" (("Skb15" 7))) ("UP:O74737" (("RID1" 87)))
 ("UP:O74845"
  (("HIF2" 183) ("HIF-2" 146) ("than HIF2 ( xref )" 1) ("than HIF2" 1)
   ("HIF-2-" 1)))
 ("UP:O74952"
  (("MFS" 194) ("MFs" 34) ("FN-null MFs" 11) ("poor MFS" 5) ("distant MFS" 4)
   ("more favorable MFS" 4) ("shorter MFS" 3) ("a significantly better MFS" 2)
   ("significantly worse MFS" 2) ("weak power frequency MFs" 1)
   ("parental FN-null MFs" 1) ("FN null MFs" 1) ("markedly better MFS" 1)))
 ("UP:O75015" (("Fcgr3" 2) ("FCGR3" 1) ("FCGR3B" 1)))
 ("UP:O75019" (("leukocyte immunoglobulin-like receptor" 1)))
 ("UP:O75027" (("member 7" 14) ("asat" 2)))
 ("UP:O75030"
  (("MITF" 1316) ("MiTF" 270) ("Mitf" 199) ("MITF protein" 17)
   ("microphthalmia-associated transcription factor" 15) ("MiTF protein" 11)
   ("Mitf protein" 11) ("Microphthalmia-associated transcription factor" 10)
   ("Microphthalmia associated transcription factor" 5)
   ("microphthalmia-associated transcription factor (MITF)" 4) ("mitf" 4)
   ("the basic helix-loop-helix leucine zipper transcription factor MITF" 2)
   ("Microphthalmia-associated transcription factor (MITF)" 2)
   ("called microphthalmia-associated transcription factor (MITF)" 2)
   ("accumulated undetectable MiTF protein" 2) ("Mitf-" 2) ("MITFs" 1)
   ("significantly less MITF" 1) ("exogenous MITF" 1)
   ("MEK1 (MEK1 DD ) similarly suppressed MITF" 1) ("MITF-" 1)
   ("the melanocytic lineage transcription factor MITF" 1)
   ("sumoylation-defective microphthalmia-associated transcription factor (MITF)"
    1)
   ("previously unknown MITF" 1) ("The transcription factor MITF’s" 1)
   ("MiTF-S73A protein" 1) ("MiTF-WT protein" 1) ("than Mitf" 1)
   ("The basic helix-loop-helix leucine zipper transcriptional factor MITF"
    1)))
 ("UP:O75031" (("HSF2BP" 5)))
 ("UP:O75037" (("KIF21B" 15) ("Kinesin family member 21B" 1)))
 ("UP:O75038" (("eta 2" 1) ("Eta 2" 1)))
 ("UP:O75051"
  (("OCT" 227) ("PlexinA2" 58) ("Plexin A2" 41) ("OCTs" 3) ("Plexin-A2" 3)
   ("-Plexin A2" 1) ("PlexinA2-" 1) ("PLXNA2" 1)))
 ("UP:O75052"
  (("NOS1AP" 167) ("NOS1AP protein" 5)
   ("the neuronal nitric oxide synthase adaptor protein NOS1AP" 2)
   ("nitric oxide synthase 1 adaptor protein" 2) ("CAPON" 2)
   ("Nitric oxide synthase 1 adaptor protein" 1)))
 ("UP:O75056" (("SDC3" 4) ("N-syndecan" 4) ("syndecan-3" 4)))
 ("UP:O75061" (("auxilin" 10) ("DNAJC6" 5) ("Auxilin" 1)))
 ("UP:O75069" (("TMCC2" 6))) ("UP:O75071" (("KIAA0494" 3)))
 ("UP:O75077" (("ADAM23" 3)))
 ("UP:O75078"
  (("cysteine-rich protein" 25) ("Cysteine-rich protein" 5)
   ("a unique cysteine-rich protein" 2) ("disintegrin-like" 1)))
 ("UP:O75083"
  (("Actin interacting protein 1" 5) ("WDR1" 4)
   ("actin-interacting protein 1" 4) ("Actin-interacting protein 1" 3)))
 ("UP:O75084"
  (("FZD7" 99) ("Fzd7" 6) ("Fzd7 protein" 4) ("FZD7 protein" 3) ("Fz7" 1)
   ("Frizzled-7" 1) ("prometastatic genes FZD7" 1)))
 ("UP:O75093" (("slit1" 2) ("Slit1" 2)))
 ("UP:O75094" (("SLIT3" 15) ("Slit3" 3)))
 ("UP:O75096"
  (("LRP4" 25) ("low-density lipoprotein receptor-related protein 4" 2)
   ("Lrp4" 1)))
 ("UP:O75106" (("Rao" 20)))
 ("UP:O75112"
  (("ZASP" 162) ("ZASP protein" 10) ("ldb3" 4) ("LIM domain binding 3" 2)
   ("LDB3" 1)))
 ("UP:O75113" (("N4BP1" 6)))
 ("UP:O75116"
  (("ROCK2" 918) ("ROCKII" 485) ("Rho kinase" 262) ("ROCK II" 123)
   ("ROCK-2" 52) ("ROCK-II" 26) ("Rock II" 19) ("Rho kinase (ROCK)" 14)
   ("ROKα" 11) ("ROCK2-" 8) ("Rock2" 5) ("ROCK2 peptide" 4) ("KIAA0619" 4)
   ("rho kinase" 3) ("Rho kinase (ROK)" 3) ("Rho kinase 2" 3)
   ("the primary Rho kinase" 2) ("a dominant-negative Rho kinase" 1)
   ("two fold more ROCK2" 1) ("Uncleavable ROCK II" 1) ("than WT ROCK II" 1)
   ("exogenous ROCK II" 1) ("Exogenous ROCK II" 1)
   ("efficiently target ROCKII" 1) ("targeted ROCKII" 1) ("Rock-II" 1)))
 ("UP:O75122"
  (("CLASP2" 394) ("CLASP2 protein" 5) ("nonphosphorylatable 9×S/A CLASP2" 3)
   ("longer CLASP2" 1) ("KIAA0627" 1) ("yet total CLASP2" 1)
   ("KT-associated protein CLASP2" 1)))
 ("UP:O75128" (("Cordon-Bleu ( COBL )" 3) ("COBL" 3) ("Cordon-Bleu" 1)))
 ("UP:O75140" (("DEPDC5" 1)))
 ("UP:O75143"
  (("ATG13" 85) ("Atg13" 35) ("KIAA0652" 2) ("ATG13-" 2) ("ATG13 protein" 2)
   ("atg13" 1)))
 ("UP:O75144"
  (("ICOS-L" 90) ("ICOSLG" 12) ("ICOSL" 4) ("functional ICOS-L" 3)
   ("ICOS ligand" 1) ("B7-H2" 1)))
 ("UP:O75146" (("HIP1R" 19) ("Hip1R" 3))) ("UP:O75147" (("OBSL1" 41)))
 ("UP:O75150" (("RNF40" 66) ("Bre1b" 1)))
 ("UP:O75151" (("PHF2" 50) ("CENP-35" 2)))
 ("UP:O75152" (("Zc3h11a" 1) ("ZC3H11A" 1)))
 ("UP:O75154" (("Rab11-FIP3" 4) ("Rab11–FIP3" 1) ("Eferin" 1) ("eferin" 1)))
 ("UP:O75155" (("CAND2" 2))) ("UP:O75157" (("TSC22D2" 1)))
 ("UP:O75159"
  (("SOCS5" 276) ("SOCS-5" 5) ("SOCS5 protein" 2) ("JAK-associated SOCS5" 1)))
 ("UP:O75161"
  (("NPHP4" 118) ("Nphp4" 4) ("nephrocystin-4" 2) ("barely detectable NPHP4" 1)
   ("associated protein NPHP4" 1)))
 ("UP:O75164"
  (("JMJD2A" 146) ("KDM4A" 95) ("JMJD2" 18) ("Jmjd2A" 4)
   ("at least moderate JMJD2A" 2) ("JHDM3A" 1)
   ("the homologous protein JMJD2A" 1) ("jmjd2" 1)))
 ("UP:O75170" (("PP6R2" 12) ("KIAA0685" 5) ("SAPS2" 2)))
 ("UP:O75173"
  (("ADAMTS4" 12) ("aggrecanase 1" 1)
   ("a disintegrin and metalloproteinase with thrombospondin motifs 4" 1)))
 ("UP:O75175"
  (("orthologs" 624) ("CNOT3" 91) ("Cnot3" 14) ("subunit 3" 7) ("Orthologs" 3)
   ("NOT3" 3) ("functional orthologs" 2) ("syntenic orthologs" 2)
   ("whose orthologs" 2) ("CNOT3 protein" 2) ("obvious orthologs" 2)
   ("Clear orthologs" 2) ("only Bax orthologs" 2) ("identifiable orthologs" 2)
   ("lack clear orthologs" 2) ("the most probable orthologs" 1)
   ("several established functional orthologs" 1)
   ("only C. trachomatis TARP orthologs" 1) ("viral CDK orthologs" 1)
   ("their bacterial orthologs" 1) ("CNOT3-" 1) ("two mitotic orthologs" 1)
   ("SERINE/THREONINE-PROTEIN PHOSPHATASE 6 REGULATORY SUBUNIT 3" 1)
   ("SUBUNIT 3" 1) ("whose TRIM5 orthologs" 1)))
 ("UP:O75177"
  (("crest" 93) ("CREST" 86) ("the centromeric marker CREST" 2)
   ("the longitudinal mitochondrial crest" 2) ("CreSt" 2) ("Crest" 1)
   ("CrEST" 1) ("SS18L1" 1)))
 ("UP:O75179" (("MASK2" 3)))
 ("UP:O75182"
  (("Sin3B" 240) ("Sin3B protein" 6) ("SIN3B" 4) ("Sin3b" 3) ("–Sin3B" 1)))
 ("UP:O75185" (("ATP2C2" 7) ("SPCA2" 1))) ("UP:O75190" (("DNAJB6" 4)))
 ("UP:O75192" (("Pex11a" 1) ("PEX11" 1)))
 ("UP:O75197"
  (("LRP5" 228) ("Lrp5" 69)
   ("low-density lipoprotein receptor-related protein 5" 11)
   ("low-density lipoprotein receptor–related protein 5" 7) ("LRP 5" 6)
   ("LRP-5" 5) ("LRP5 protein" 5) ("lipoprotein receptor-related protein 5" 1)
   ("Low-density lipoprotein receptor-related protein 5" 1)
   ("smaller LRP5 protein" 1) ("a shorter-than-normal LRP5" 1)))
 ("UP:O75223"
  (("GGC" 815) ("-GGC" 75) ("ggc" 26) ("GCTG" 8) ("GGCT" 5) ("-ggc" 5)
   ("-ggC" 3) ("ggC" 3) ("-GCTG" 2) ("GGc" 2) ("G-G-C" 1) ("–GGC" 1)
   ("-GGCT" 1) ("Ggc" 1)))
 ("UP:O75293" (("GADD45B" 23) ("Gadd45b" 5) ("GADD45b" 1)))
 ("UP:O75306" (("NDUFS2" 1)))
 ("UP:O75309" (("KSP-cadherin" 12) ("CDH16" 8) ("cadherin 16" 3)))
 ("UP:O75312" (("ZNF259" 9)))
 ("UP:O75317" (("Usp12" 103) ("USP12" 11) ("Usp12 protein" 1)))
 ("UP:O75319" (("DUSP11" 3) ("dual specificity phosphatase 11" 2)))
 ("UP:O75323" (("GBAS" 3))) ("UP:O75325" (("LRRN2" 6)))
 ("UP:O75326" (("α1β1" 61) ("Sema7A" 2) ("Semaphorin 7A" 1) ("Sema7a" 1)))
 ("UP:O75330"
  (("RHAMM" 129) ("HMMR" 115)
   ("HMMR (hyaluronan-mediated motility receptor) protein" 3) ("-RHAMM" 3)
   ("receptor for hyaluronan-mediated motility" 3) ("CD168" 2)
   ("HMMR ( RHAMM )" 1) ("IHABP" 1)))
 ("UP:O75333" (("TBX10" 17))) ("UP:O75334" (("PPFIA2" 6)))
 ("UP:O75335" (("PPFIA4" 3))) ("UP:O75342" (("ALOX12B" 7)))
 ("UP:O75344"
  (("FKBP36" 12) ("the highly homologous co-chaperone FKBP36" 2) ("FKBP6" 1)))
 ("UP:O75347" (("TBCA" 24))) ("UP:O75348" (("ATP6V1G1" 11)))
 ("UP:O75351" (("VPS4B" 2) ("vacuolar protein sorting 4 homolog B" 2)))
 ("UP:O75352" (("MPDU1" 1)))
 ("UP:O75356"
  (("PCPH" 114) ("PCPH protein" 14) ("CD39L4" 2) ("PCPH-" 1) ("normal PCPH" 1)
   ("ENTPD5" 1) ("Entpd5" 1)))
 ("UP:O75360" (("PROP1" 32) ("Prop1" 4)))
 ("UP:O75362" (("ZNF217" 231) ("Znf217" 3) ("ZNF217-" 1)))
 ("UP:O75363"
  (("BCAS1" 9) ("NABC1" 2) ("breast carcinoma amplified sequence 1" 1)))
 ("UP:O75364" (("Ptx3" 4) ("Pitx3" 3) ("PITX3" 1)))
 ("UP:O75365"
  (("PRL-3" 623) ("hPRL" 209) ("PRL3" 37) ("PTP4A3" 11) ("PRL-3 protein" 10)
   ("Phosphatase of regenerating liver-3" 5) ("hPrl" 4)
   ("the potent angiostatic agent 16 K hPRL" 2)
   ("the angiostatic compound 16 K hPRL" 2) ("specifically knockdown PRL-3" 2)
   ("pRL-3" 1) ("the angiostatic protein 16 K hPRL" 1)
   ("previously reported 16 K hPRL" 1) ("PRL3 protein" 1)))
 ("UP:O75366" (("P92" 2)))
 ("UP:O75367"
  (("macroH2A1" 476) ("MacroH2A1" 52) ("H2AFY" 21) ("mac-roH2A1" 2)
   ("histone macroH2A1" 2) ("the repressive H2A variant macroH2A1" 1)
   ("the repressive histone variant macroH2A1" 1)
   ("facultative heterochromatin macroH2A1" 1) ("ectopic macroH2A1.1" 1)))
 ("UP:O75368" (("SH3BGRL" 1)))
 ("UP:O75369" (("FLNB" 23) ("FH1" 7) ("FlnB" 2) ("thyroid autoantigen" 1)))
 ("UP:O75376"
  (("N-CoR" 433) ("NCoR" 243) ("NCOR1" 85) ("NCoR1" 56)
   ("nuclear receptor corepressor" 32) ("NCOR" 14) ("NcoR" 13)
   ("N-CoR protein" 13) ("NcoR1" 10) ("N-Cor" 8)
   ("the transcriptional co-repressor NCoR1" 4)
   ("Nuclear receptor corepressor" 3) ("nuclear receptor co-repressor 1" 3)
   ("Ncor1" 3) ("nuclear receptor corepressor 1" 2)
   ("recombinant full length flag-tagged N-CoR" 2) ("Given N-CoR's" 1)
   ("Given N-CoR" 1)))
 ("UP:O75379" (("Vamp4" 4) ("VAMP4" 2))) ("UP:O75380" (("NDUFS6" 1)))
 ("UP:O75381" (("PEX14" 18) ("peroxisomal biogenesis factor 14" 1)))
 ("UP:O75382"
  (("TRIM3" 215) ("Trim3" 19) ("BERP" 2) ("TRIM3-" 1) ("RNF22" 1)
   ("TRIM3 protein" 1)))
 ("UP:O75385"
  (("ULK1" 878) ("Ulk1" 284) ("Atg1" 52) ("ATG1" 43) ("p-ULK1" 20) ("ULK-1" 16)
   ("unc-51-like kinase 1" 6) ("atg1" 5)
   ("unc-51 like autophagy activating kinase 1" 4) ("ULK1 protein" 3)
   ("pULK-1" 2) ("Unc-51 like autophagy activating kinase 1" 2)
   ("Unc-51-like kinase 1" 2) ("UNC-51-like kinase 1" 1)
   ("only Exo84-associated ULK1" 1)
   ("than the Ulk1 prepared from the cells cultured in nutrient-rich conditions ( xref )"
    1)
   ("hATG1" 1)))
 ("UP:O75387" (("SLC43A1" 2)))
 ("UP:O75390"
  (("CS" 2153) ("Cs" 144) ("AECS" 90) ("citrate synthase" 19) ("cs" 16)
   ("Citrate synthase" 9) ("severe CS" 8) ("ICs" 4) ("classic CS" 4)
   ("Severe CS" 4) ("benign CS" 3) ("severe neonatal CS" 3)
   ("using Adobe Photoshop CS5" 2) ("Adobe Photoshop CS5" 2)
   ("classical protein kinase Cs" 2) ("Elective CS" 2) ("a previous CS" 2)
   ("neonatal CS" 2) ("syndromic CS" 2) ("−CS" 1) ("a typical CS" 1)
   ("1 or more CS" 1) ("the client protein CS" 1) ("Citrate synthase (CS)" 1)
   ("-CS" 1) ("CS (ICS)" 1) ("three benign CS" 1)
   ("particular malignant and benign CS" 1) ("benign and malignant CS" 1)
   ("even 1μM CS" 1) ("“CS”" 1) ("CS-" 1) ("Classic CS" 1)
   ("non-malignant CS" 1) ("any Mayo Clinic CS" 1) ("all classic CS" 1)
   ("PTEN mutation negative classic CS" 1) ("chronic CS" 1)))
 ("UP:O75396" (("SEC22B" 1) ("Sec22b" 1)))
 ("UP:O75400"
  (("FNBP3" 26) ("HYPC" 6) ("PRP40" 4) ("FBP11" 3) ("PRPF40A" 2) ("Prp40" 1)
   ("HYPA" 1) ("HIP10" 1)))
 ("UP:O75410" (("TACC1" 22)))
 ("UP:O75417"
  (("POLQ" 179) ("Polq" 14) ("POLQ protein" 1)
   ("POLQ (CGGGCCTCTTTAGATATAAAT)" 1) ("Poleta" 1)))
 ("UP:O75419"
  (("Cdc45" 251) ("CDC45" 80) ("S.cerevisiae" 28) ("CDC45L" 12)
   ("Cdc45 protein" 3) ("Cdc45L" 2) ("cdc45" 1) ("human Cdc45" 1)))
 ("UP:O75426" (("FBXO24" 3) ("Fbxo24" 2))) ("UP:O75427" (("L R/N" 16)))
 ("UP:O75436" (("Vps26" 6) ("vps26" 2) ("VPS26A" 1) ("Hbeta58" 1)))
 ("UP:O75439"
  (("p52" 806) ("P52" 28) ("p52 protein" 5) ("LTβ increased p52" 2) ("p-p52" 2)
   ("others demonstrated p52's" 1) ("p52-" 1)))
 ("UP:O75444"
  (("MAF" 1834) ("tBHQ" 650) ("Maf" 149) ("Maf protein" 38) ("c-Maf" 32)
   ("c-MAF" 24) ("TBHQ" 14) ("mAF" 12) ("maf" 7) ("c-maf" 3) ("MAF protein" 3)
   ("the maximal MAF" 2) ("the minimal MAF" 2)
   ("v-maf musculoaponeurotic fibrosarcoma oncogene homolog" 2)
   ("musculoaponeurotic fibrosarcoma" 2) ("the respective SNP309 MAF" 1)
   ("the food preservative tBHQ" 1) ("tBHQ-" 1)
   ("musculoaponeurotic fibrosarcoma oncogene" 1) ("“maf”" 1)
   ("its transcriptional partner MAF" 1)
   ("another T H 2-specific transcription factor c-Maf" 1)
   ("the total Caucasian MAF" 1) ("very small MAF" 1) ("than 0.10 MAF" 1)
   ("at least 0.10 MAF" 1) ("whose MAF" 1)
   ("v-maf musculoaponeurotic fibrosarcoma oncogene homolog (MAF)" 1)))
 ("UP:O75446"
  (("SAP30" 66) ("SAP30 protein" 2) ("than SAP30" 2)
   ("myc-his-tagged SAP30" 2)))
 ("UP:O75448" (("MED24" 2) ("THRAP4" 1)))
 ("UP:O75460"
  (("serine/threonine protein kinase" 409) ("IRE1" 343) ("RMRP" 243)
   ("IRE1α" 215) ("endoribonuclease" 55) ("serine/threonine-protein kinase" 25)
   ("ire1" 24) ("IRE-1" 20) ("Ire1" 14) ("ERN1" 14)
   ("inositol-requiring protein 1" 9) ("IRE1a" 8) ("endoribonuclease (RMRP)" 6)
   ("a multifunctional serine/threonine protein kinase" 3)
   ("a ubiquitous serine/threonine protein kinase" 3)
   ("endoribonuclease ( RMRP )" 3) ("p-IRE1" 2) ("Endoribonuclease" 2)
   ("a pleiotropic serine/threonine protein kinase" 2)
   ("a heterotrimeric serine/threonine protein kinase" 2)
   ("a nucleolar endoribonuclease" 2)
   ("serine/threonine-protein kinase (ATM)" 2)
   ("a multimeric nuclear serine/threonine protein kinase" 2)
   ("the complementary RMRP" 2)
   ("a conserved heterotrimeric serine/threonine protein kinase" 2)
   ("the distal IRE1" 2) ("a combined nuclease and kinase called IRE1" 2)
   ("serine/threonine-protein kinase (MNK)" 2)
   ("a multifunctional cyclic nucleotide-independent serine/threonine protein kinase"
    1)
   ("highly conserved pleiotropic serine/threonine protein kinase" 1)
   ("heterotrimeric serine/threonine protein kinase" 1)
   ("serine/threonine-protein kinase (ATR)" 1) ("than RMRP that serve" 1)
   ("than RMRP in these cells ( xref ; xref )" 1) ("ire1α" 1)
   ("endoplasmic reticulum-to-nucleus signaling 1" 1) ("Ire-1" 1)
   ("a multi-functional serine/threonine protein kinase" 1)
   ("Serine/threonine protein kinase" 1)
   ("an atypical serine/threonine protein kinase" 1) ("IRE1alpha" 1)
   ("P-IRE1" 1)))
 ("UP:O75461"
  (("E2F6" 170) ("E2F6 protein" 2) ("The transcriptional repressor E2F6" 2)
   ("the transcriptional repressor E2F6" 2)))
 ("UP:O75462"
  (("CRLF1" 103) ("cytokine receptor-like factor 1" 8) ("Crlf1" 4) ("CISS1" 2)
   ("Exogenous CRLF1" 2) ("FN3" 2) ("exogenous CRLF1" 1)
   ("cold-induced sweating syndrome" 1)))
 ("UP:O75469"
  (("PXR" 211) ("group I" 209) ("Group I" 122) ("NR1I2" 33)
   ("pregnane X receptor" 15) ("group I protein" 4) ("group I (FANCI)" 3)
   ("pregnane X receptor (PXR)" 2) ("than group I" 2) ("SXR" 1)
   ("steroid and xenobiotic receptor" 1)
   ("than PXR immunoprecipitated from DMSO-treated cells ( xref , panels E and F)"
    1)
   ("Pregnane X receptor" 1) ("Pregnane X Receptor (PXR)" 1)
   ("Pregnane X Receptor" 1)))
 ("UP:O75473" (("Lgr5" 97) ("LGR5" 34) ("lgr5" 2) ("LGr5" 1)))
 ("UP:O75474" (("FRAT2" 4)))
 ("UP:O75475"
  (("LEDGF" 345) ("lens epithelium-derived growth factor" 7) ("-LEDGF" 5)
   ("LEDGF protein" 4) ("Lens epithelium-derived growth factor" 3)
   ("lens epithelium-derived growth factor (LEDGF)" 2)
   ("Lens-epithelium-derived growth factor" 1) ("DFS70" 1)
   ("PC4 and SFRS1 interacting protein" 1)
   ("lens epithelium derived growth factor" 1)
   ("transcriptional protein LEDGF" 1) ("further supports LEDGF" 1)
   ("DFS 70" 1)))
 ("UP:O75477" (("SPFH1" 18) ("Erlin-1" 1) ("ERLIN1" 1)))
 ("UP:O75478" (("ADA2A" 8) ("TADA2L" 1)))
 ("UP:O75486"
  (("SPT3" 11) ("spt3" 4) ("a HeLa cell line expressing Flag-tagged SPT3" 2)
   ("SUPT3H" 2) ("Spt3" 1)))
 ("UP:O75489"
  (("NDUFS3" 6) ("NADH–ubiquinone oxidoreductase 30 kDa subunit" 5)
   ("Ndufs3" 4)))
 ("UP:O75494" (("FUSIP1" 3)))
 ("UP:O75496"
  (("geminin" 592) ("Geminin" 55) ("-geminin" 14) ("GMNN" 13)
   ("geminin protein" 10) ("geminin-" 6) ("–geminin" 6) ("mitotic geminin" 2)
   ("cellular geminin" 2) ("somatic geminin" 2)
   ("FLAG-tagged exogenous geminin" 1) ("chromatin-associated geminin" 1)
   ("exogenous geminin" 1) ("stabilized mitotic geminin" 1)
   ("mitotic geminin-" 1) ("than wild-type geminin" 1) ("only geminin T25D" 1)
   ("nondegradable geminin" 1) ("this nondegradable geminin" 1)
   ("the spindle checkpoint support geminin’s" 1) ("Gmnn" 1)
   ("than geminin" 1)))
 ("UP:O75506" (("HSBP1" 2)))
 ("UP:O75508"
  (("Osp" 9) ("osp" 7) ("claudin-11" 3) ("CLDN11" 3) ("OSp" 2) ("OSP" 1)))
 ("UP:O75509" (("DR6" 25) ("TNFRSF21" 3)))
 ("UP:O75521"
  (("PECI" 19) ("peroxisomal D3,D2-enoyl-CoA isomerase ( PECI )" 2)
   ("peroxisomal D3,D2-enoyl-CoA isomerase" 2)))
 ("UP:O75525"
  (("RNA binding" 226) ("T-STAR" 85) ("RNA-binding protein T-STAR" 6)
   ("T-STAR protein" 4) ("Etoile" 3) ("KH domain containing" 2)
   ("an efficient RNA binding" 1) ("than T-STAR" 1)
   ("unquantifiable RNA binding" 1) ("SLM2" 1) ("Slm2" 1) ("SLM-2" 1)))
 ("UP:O75529" (("65 kD" 14) ("TAF5L" 2)))
 ("UP:O75530"
  (("Polycomb" 332) ("polycomb" 205) ("EED" 121) ("polycomb protein" 13)
   ("embryonic ectoderm development" 10) ("Eed" 9) ("Polycomb protein" 5)
   ("Embryonic Ectoderm Development" 1)
   ("embryonic ectoderm development (EED) protein" 1)
   ("embryonic ectoderm development protein (EED)" 1)))
 ("UP:O75531"
  (("barrier" 3490) ("BAF" 409) ("BBB" 184) ("Baf" 151) ("BaF" 111)
   ("barrier (BBB)" 64) ("Barrier" 50) ("the endothelial barrier" 23)
   ("the epithelial barrier" 16) ("a major barrier" 16)
   ("endothelial barrier" 13) ("the intestinal barrier" 13)
   ("a physical barrier" 11) ("the intestinal epithelial barrier" 10)
   ("the lymphatic barrier" 10) ("the mucosal barrier" 8)
   ("a dynamic barrier" 6) ("barrier (BRB)" 6) ("“barrier”" 5)
   ("a protective barrier" 5) ("a formidable barrier" 5) ("BAFs" 5)
   ("a functional barrier" 5) ("the inner barrier" 5)
   ("the vascular barrier" 4) ("the outer barrier" 4) ("a potential barrier" 3)
   ("an immiscible barrier" 3) ("epithelial barrier" 3)
   ("human cerebral barrier" 3) ("the glomerular filtration barrier" 3)
   ("an RB-mediated stress associated senescence barrier" 3)
   ("a steric barrier" 3) ("the mechanical barrier" 3)
   ("the placental barrier" 3) ("the restrictive endothelial barrier" 3)
   ("the lymphatic endothelial barrier" 3) ("the transendothelial barrier" 2)
   ("a crucial defensive barrier" 2) ("an intrinsic barrier" 2)
   ("the intestinal permeability barrier" 2) ("a natural barrier" 2)
   ("a mechanical barrier" 2) ("the limbal barrier" 2) ("intestinal barrier" 2)
   ("cerebral barrier" 2) ("a more stringent barrier" 2) ("a key barrier" 2)
   ("the antiapoptotic barrier" 2) ("a crucial barrier" 2)
   ("a permeable barrier" 2) ("a strong barrier" 2)
   ("a compromised gastrointestinal barrier" 2) ("barrier (BTB)" 2)
   ("the primary physical barrier" 2) ("barrier (RFB)" 2) ("BAF protein" 2)
   ("barrier-to-autointegration factor (BAF)" 2)
   ("barrier-to-autointegration factor" 2) ("the paracellular barrier" 2)
   ("paracellular barrier" 2) ("alveolar epithelial barrier" 2)
   ("inducible barrier" 2) ("the epidermal barrier" 2)
   ("an (autoinhibitory) energetic barrier" 2) ("the blood-aqueous barrier" 2)
   ("the characteristic restrictive endothelial barrier" 2)
   ("a restrictive endothelial barrier" 2) ("BAF-" 2)
   ("a substantial barrier" 2) ("barrier (HBEC)" 2) ("a global barrier" 2)
   ("the permeability electrical barrier" 2)
   ("the microvascular endothelial barrier" 2) ("the antiangiogenic barrier" 2)
   ("the functional glomerular filtration barrier" 2) ("Barrier (BBB)" 2)
   ("the airway epithelial barrier" 2) ("a bona fide barrier" 1)
   ("a substantial energetic barrier" 1) ("The immiscible barrier" 1)
   ("the local immune barrier" 1) ("a unique barrier" 1)
   ("an electrical barrier" 1) ("a perpetual self-renewal barrier" 1)
   ("the cell–cell adhesive barrier" 1) ("an important biological barrier" 1)
   ("the damaged alveolar blood/air barrier" 1) ("an epithelial barrier" 1)
   ("the gingival epithelial barrier" 1) ("the most formidable barrier" 1)
   ("the follicular barrier" 1) ("an innate barrier" 1)
   ("an important outer barrier" 1)
   ("the disrupted intestinal epithelial barrier" 1)
   ("the intestinal mucosal surface barrier" 1) ("a plausible barrier" 1)
   ("a tumorigenic barrier" 1) ("a robust barrier" 1)
   ("the tumorigenic barrier" 1) ("one potential cellular barrier" 1)
   ("A formidable barrier" 1) ("the cerebral barrier" 1)
   ("this repressive chromatin conformation barrier" 1) ("the epileptic BBB" 1)
   ("the energetic barrier" 1) ("a persistently defective barrier" 1)
   ("a polarized epithelial junctional barrier" 1)
   ("a protective tight junctional barrier" 1)
   ("an effective antiviral barrier" 1) ("the natural barrier" 1)
   ("endothelial junctional barrier" 1) ("the primary restrictive barrier" 1)
   ("a semi-permeable barrier" 1) ("mucosal barrier" 1)
   ("their biological barrier" 1) ("a continuous barrier" 1)
   ("a selectively permeable barrier" 1)
   ("monkey kidney cells form more robust cell-cell barrier" 1)
   ("a strong antitumorigenic barrier" 1) ("a cell-autonomous barrier" 1)
   ("higher energetic barrier" 1) ("an endothelial barrier" 1)
   ("the local endothelial barrier" 1) ("the alveolar–capillary barrier" 1)
   ("the basilar membrane barrier" 1)
   ("SIRT1-dependent infrastructural barrier" 1) ("an appreciable barrier" 1)
   ("the telomere-dependent proliferative barrier" 1)
   ("the proliferative barrier" 1) ("an immobile barrier" 1)
   ("a defensive barrier" 1) ("a semiselective barrier" 1)
   ("chromatin-associated BAF" 1) ("the first protective barrier" 1)
   ("a high resistance paracellular barrier" 1) ("the nucleosomal barrier" 1)
   ("Positive-Charged Barrier" 1) ("the cortical actin barrier" 1) ("“BAF”" 1)
   ("Barrier-to-autointegration factor" 1) ("a contact-inhibited barrier" 1)
   ("a powerful antiviral barrier" 1) ("a potent innate barrier" 1)
   ("a unique physiological barrier" 1)
   ("the immature blood-brain
barrier"
    1)
   ("a topological barrier" 1) ("the gut epithelial barrier" 1)
   ("the AJ endothelial barrier" 1) ("the glomerular barrier" 1)
   ("a strong physiological barrier" 1) ("BaF-" 1)
   ("a virtually impermeable barrier" 1) ("The epithelial barrier" 1)
   ("the tight junctional barrier" 1) ("a well-developed barrier" 1)
   ("the injured epidermal barrier" 1)
   ("the epidermal
                barrier"
    1)
   ("the alkaline protective barrier" 1) ("a secondary barrier" 1)
   ("the lung gas-exchange barrier" 1) ("epidermal barrier" 1)
   ("a significant physical barrier" 1) ("size-selective barrier" 1)
   ("the TJ size-selective barrier" 1) ("a potential treatment barrier" 1)
   ("higher genetic barrier" 1) ("the protective barrier" 1)
   ("the potential barrier" 1) ("an impenetrable barrier" 1)
   ("The resulting “leaky” barrier" 1) ("an intact lymphatic barrier" 1)
   ("An impaired lymphatic barrier" 1) ("a “normal” barrier" 1) ("‘barrier’" 1)
   ("the peritoneal mesothelial barrier" 1) ("a large energetic barrier" 1)
   ("an energetic barrier" 1)
   ("the VE-cadherin–controlled endothelial barrier" 1)
   ("a dysfunctional endothelial barrier" 1)
   ("the epithelial junctional barrier" 1) ("Monomeric BAF protein" 1)
   ("the leaky barrier" 1) ("a leaky barrier" 1) ("a “leaky” barrier" 1)
   ("vascular barrier" 1) ("a three-dimensional protein-rich barrier" 1)
   ("a biological barrier" 1) ("The genetic barrier" 1) ("Banf1" 1)
   ("The respiratory epithelial barrier" 1)))
 ("UP:O75533" (("SF3B1" 108) ("SAP155" 75) ("SAP 155" 2) ("Sap155" 1)))
 ("UP:O75534" (("CSDE1" 4)))
 ("UP:O75553"
  (("Dab1" 138) ("pDab1" 8) ("DAB1" 7) ("Dab1 protein" 3)
   ("disabled homolog 1" 2) ("total and phosphorylated Dab1" 2) ("DAB-1" 2)
   ("Dab-1" 1)))
 ("UP:O75558" (("STX11" 1) ("syntaxin 11" 1)))
 ("UP:O75563"
  (("SAPS" 17) ("SKAP2" 5) ("SKAP55R" 4) ("PRAP" 2)
   ("the pY+1 Asp of SKAP-HOM" 1) ("SKAP-HOM" 1) ("Skap2" 1)))
 ("UP:O75564" (("JRK" 6))) ("UP:O75569" (("pACT" 125) ("pAct" 6) ("PRKRA" 1)))
 ("UP:O75578" (("ITGA10" 1)))
 ("UP:O75581"
  (("LRP6" 692) ("Lrp6" 49) ("LRP-6" 29) ("P-LRP6" 21) ("LRP6 peptide" 9)
   ("low-density lipoprotein receptor-related protein 6" 6)
   ("low-density lipoprotein receptor–related protein 6" 4) ("LRP6 protein" 2)
   ("pLRP6" 2) ("LRP6-" 2) ("Lrp6 protein" 1)))
 ("UP:O75582"
  (("MSK1" 233) ("stress activated protein kinase" 12) ("MSK-1" 6) ("SAPK" 6)
   ("Msk1" 6) ("pMSK1" 2) ("pMsk1" 2) ("dominant-negative MSK1" 2)
   ("stress activated protein kinase (SAPK)" 1) ("-MSK1" 1)))
 ("UP:O75586" (("MED6" 8))) ("UP:O75592" (("MYCBP2" 8)))
 ("UP:O75593"
  (("fast" 1262) ("Fast" 769) ("FAST" 113) ("FAST1" 34) ("FoxH1" 26)
   ("Fast1" 12) ("FAST1 peptide" 11) ("forkhead activin signal transducer 1" 5)
   ("FAST-1" 5) ("Foxh1" 3) ("FAST2" 3) ("FAST1 (LDALFQGVPPNKSIYDVWVSHPRDL)" 2)
   ("Fast-1" 2) ("subsequent fast" 2) ("forkhead box H1" 1) ("less fast" 1)))
 ("UP:O75594" (("TAG7" 5) ("tag7" 2))) ("UP:O75600" (("GCAT" 6) ("KBL" 3)))
 ("UP:O75603" (("GCMb" 3))) ("UP:O75604" (("USP2" 69) ("Usp2" 8)))
 ("UP:O75607" (("NPM3" 3)))
 ("UP:O75610"
  (("Lefty1" 30) ("visceral endoderm markers Lefty1" 2)
   ("left-right determination factor 1" 1) ("LEFTY1" 1) ("lefty1" 1)))
 ("UP:O75616" (("HERA" 8)))
 ("UP:O75618"
  (("DEDD" 395) ("nucleolar DEDD" 4) ("death effector domain containing" 4)
   ("death effector domain containing protein" 3) ("total cellular DEDD" 2)
   ("filamentous DEDD" 2) ("apoptotic DEDD" 2) ("larger structures DEDD" 1)
   ("all filamentous DEDD" 1) ("than unmodified DEDD (unpublished data)" 1)))
 ("UP:O75626"
  (("Blimp1" 141) ("PRDM1" 101) ("BLIMP1" 95) ("Blimp-1" 25) ("BLIMP-1" 15)
   ("Blimp1 protein" 8) ("PRDI-BF1" 7) ("Prdm1" 3) ("with ZNF domain" 3)
   ("PR domain containing 1" 3) ("the transcriptional repressor PRDM1" 2)
   ("Positive-Regulatory Domain I Binding Factor 1" 2) ("more PRDM1" 1)
   ("Blimp 1" 1)))
 ("UP:O75628"
  (("REM" 108) ("GES" 35) ("the normal gastric epithelium cell line GES" 1)))
 ("UP:O75629" (("CREG1" 1) ("CREG" 1))) ("UP:O75631" (("Uroplakin III" 14)))
 ("UP:O75636"
  (("zymosan" 96) ("Zymosan" 32) ("zymosan-" 4) ("Intravitreal Zymosan" 2)
   ("intraocular Zymosan" 2) ("Fc OxyBURST Green–opsonized zymosan" 1)))
 ("UP:O75643" (("200 kD" 15) ("small nuclear ribonucleoprotein" 12)))
 ("UP:O75663" (("TIP" 21) ("TIPs" 13)))
 ("UP:O75665"
  (("RP23" 15) ("OFD1" 11) ("the centriole distal appendage marker OFD1" 2)))
 ("UP:O75674"
  (("Tom1L1" 264) ("Srcasm" 7) ("exogenous Tom1L1" 5) ("TOM1L1" 4)
   ("the early endosome-associated Tom1L1" 1)
   ("than unphosphorylated Tom1L1 ( xref , first panel, lane 2)" 1)))
 ("UP:O75676" (("MSK2" 11) ("RPS6KA4" 5))) ("UP:O75677" (("RFPL1" 2)))
 ("UP:O75679" (("RFPL3" 144) ("RFPL3 protein" 5)))
 ("UP:O75688" (("PPM1B" 23) ("PP2Cβ" 2) ("protein phosphatase 1B" 1)))
 ("UP:O75691" (("1A6/DRIM" 3) ("UTP20" 1)))
 ("UP:O75694" (("Nup155" 50) ("nucleoporin 155" 7) ("N155" 2) ("NUP155" 2)))
 ("UP:O75698" (("HUG1" 2)))
 ("UP:O75712" (("CX31" 7) ("EKV" 3) ("Cx31" 2) ("31kDa" 1)))
 ("UP:O75715" (("GPX5" 2))) ("UP:O75716" (("STK16" 1)))
 ("UP:O75717" (("and1" 6) ("ctf4" 5) ("Ctf4" 4) ("WDHD1" 1) ("And1" 1)))
 ("UP:O75718" (("CRTAP" 1)))
 ("UP:O75746" (("solute carrier family 25 (mitochondrial carrier" 2)))
 ("UP:O75747"
  (("class 2" 88) ("Class 2" 18) ("PIK3C2G" 8)
   ("phosphatidylinositol-4-phosphate 3-kinase" 2) ("larger class 2" 1)
   ("PI3KC2γ" 1)))
 ("UP:O75751" (("OCT3" 27) ("SLC22A3" 2))) ("UP:O75752" (("glob" 5)))
 ("UP:O75762"
  (("transient receptor potential cation channel" 7)
   ("Transient receptor potential cation channel" 5) ("TRPA1" 3)))
 ("UP:O75764" (("TCEA3" 1)))
 ("UP:O75771"
  (("RAD51D" 106) ("Rad51D" 14) ("Rad51d" 1) ("Rad51L3" 1)
   ("a Homologous Recombination repair protein" 1)
   ("Recombination repair protein" 1) ("Rad51l3" 1)
   ("recombination repair protein" 1)))
 ("UP:O75781"
  (("PalM" 33) ("PALM" 31) ("Palm" 29) ("palm" 24) ("paralemmin" 7) ("pALM" 2)
   ("Paralemmin" 1) ("‘palm’" 1)))
 ("UP:O75783" (("RRP" 99))) ("UP:O75787" (("renin receptor" 2) ("ATP6AP2" 1)))
 ("UP:O75791"
  (("Grf40" 131) ("GrpL" 67) ("Gads" 34) ("Mona" 24)
   ("growth factor receptor binding protein" 18) ("Grap2" 6)
   ("growth factor receptor-binding protein" 5) ("GRID" 5) ("GRAP2" 3)
   ("-GrpL" 3) ("GRB2L" 2) ("Growth factor receptor-binding protein" 2)
   ("MONA" 2) ("MonA" 2) ("mona" 1)))
 ("UP:O75792" (("RNASEH2A" 2)))
 ("UP:O75794"
  (("HT1080" 545) ("HT-1080" 88) ("HT 1080" 38) ("CDC123" 30) (NIL 9)
   ("Human telomerase-positive cell lines HT1080" 3) ("adherent HT1080" 2)))
 ("UP:O75795" (("UGT2B17" 104) ("UGT2B17-" 5) ("polypeptide B17" 4)))
 ("UP:O75800" (("ZMYND10" 1)))
 ("UP:O75807"
  (("GADD34" 111) ("Gadd34" 38) ("gadd34" 5) ("PPP1R15A" 3)
   ("growth arrest and DNA-damage-inducible 34" 2)
   ("pro-apoptotic GADD34 protein" 2) ("PP1R15A" 1) ("GADD34 protein" 1)))
 ("UP:O75815" (("BCAR3" 14) ("NSP2" 1) ("nsP2" 1)))
 ("UP:O75817" (("POP7" 6) ("rpP2" 3)))
 ("UP:O75818" (("RNaseP1" 2) ("RNASEP1" 1)))
 ("UP:O75820"
  (("ZNF189" 11) ("Zinc finger protein 189" 2) ("zinc finger protein 189" 2)))
 ("UP:O75821"
  (("factor-3" 23) ("eIF3g" 4)
   ("Tumor Necrosis Factor receptor-associated factor-3" 4)
   ("IFN regulatory factor-3" 2) ("EIF3S4" 1)))
 ("UP:O75822" (("35kDa" 5) ("eIF3j" 1) ("eIF3α" 1)))
 ("UP:O75828"
  (("CBR3" 141) ("CBR3 protein" 4) ("Cbr3" 2) ("polymorphic CBR3" 1)))
 ("UP:O75829"
  (("chemotaxin" 14) ("LECT1" 1) ("chondromodulin" 1) ("ChM-1" 1) ("Lect1" 1)))
 ("UP:O75830" (("SERPINI2" 4) ("Serpini2" 1)))
 ("UP:O75832"
  (("gankyrin" 125) ("Gankyrin" 24) ("PSMD10" 3)
   ("26S proteasome non-ATPase regulatory subunit 10" 1) ("Psmd10" 1)))
 ("UP:O75838" (("CIB2" 6))) ("UP:O75840" (("KLF7" 5) ("Klf7" 1)))
 ("UP:O75843" (("AP1G2" 9)))
 ("UP:O75844"
  (("Zmpste24" 10) ("ZMPSTE24" 5) ("Ste24p" 3)
   ("the competitive CAAX protease Ste24p" 1)))
 ("UP:O75845" (("SC5DL" 1)))
 ("UP:O75874"
  (("IDH1" 1054) ("IDH" 595) ("IDPs" 138) ("isocitrate" 72) ("IDP" 70)
   ("Isocitrate" 19) ("several relatively small IDPs" 2) ("most IDPs" 1)
   ("Normally both cytosolic IDH1" 1) ("homozygous IDH1" 1)
   ("the IDH1 , exon 4 of the IDH2 , and exons" 1) ("exogenous mutant IDH1" 1)
   ("than those expressing WT IDH1 ( xref )" 1) ("the mutant IDH1" 1)
   ("IDH-" 1) ("-isocitrate" 1) ("the clinically secondary IDH1" 1)))
 ("UP:O75880" (("SCO1" 1))) ("UP:O75881" (("CYP7B1" 6)))
 ("UP:O75886"
  (("STAM2" 15) ("signal transducing adaptor molecule 2" 3) ("Stam2" 1)))
 ("UP:O75888"
  (("APRIL" 23) ("a proliferation inducing ligand (APRIL)" 1)
   ("a proliferation inducing ligand" 1) ("A proliferation-inducing ligand" 1)
   ("TNFSF13" 1)))
 ("UP:O75891" (("ALDH1L1" 64) ("aldehyde dehydrogenase 1 family member L1" 1)))
 ("UP:O75896"
  (("TUSC2" 274) ("FUS1" 71) ("TUSC2 protein" 5) ("Fus1" 5) ("–TUSC2" 3)
   ("tumor suppressor candidate 2" 2) ("intravenous TUSC2" 1)
   ("FUS1 protein" 1)))
 ("UP:O75899" (("GB2" 6) ("GABBR2" 2))) ("UP:O75900" (("MMP23B" 28)))
 ("UP:O75901" (("RASSF9" 6) ("PAMCI" 1)))
 ("UP:O75907" (("DGAT1" 4) ("diacylglycerol O-acyltransferase 1" 2)))
 ("UP:O75909" (("CCNK" 5) ("cyclin K" 4) ("CYCLIN K" 4)))
 ("UP:O75911" (("DHRS3" 1))) ("UP:O75912" (("DGKI" 3)))
 ("UP:O75914"
  (("PAK3" 194) ("Pak3" 136) ("βPAK" 3) ("p21-activated kinase 3" 2)
   ("PAK3 protein" 1) ("P21-activated kinase 3" 1) ("than Pak3" 1) ("βPak" 1)))
 ("UP:O75915"
  (("JWA" 352) ("Arl6IP5" 10) ("ARL6ip5" 8) ("JWA protein" 5) ("ARL6IP5" 1)
   ("GTRAP3-18" 1)))
 ("UP:O75916" (("RGS9-1" 8)))
 ("UP:O75923"
  (("dysferlin" 132) ("Dysferlin" 17) ("DYSF" 14) ("dysferlin (WT)" 6)
   ("LGMD2B" 1)))
 ("UP:O75925"
  (("PIAS1" 817) ("PIAS1 protein" 7) ("shorter version PIAS1" 4) ("Pias1" 4)
   ("PIAS-1" 3) ("Gbp" 2) ("PIAS1-" 1) ("further decreased PIAS1’s" 1)
   ("further decreased PIAS1" 1)
   ("the first 20 amino acids of PIAS1 ( xref )" 1)
   ("protein inhibitor of activated STAT 1" 1) ("the PIAS1’s" 1)))
 ("UP:O75928"
  (("Miz1" 262) ("DIP" 118) ("PIASx" 32) ("PIAS2" 17)
   ("DAB2 interacting protein" 2) ("Pias2" 2) ("exogenous PIASx" 1)
   ("the Myc-associated zinc finger protein Miz1" 1) ("ARIP3" 1)))
 ("UP:O75934" (("BCAS2" 223) ("Dam1" 3) ("BCAS2 protein" 2) ("DAM1" 1)))
 ("UP:O75935" (("p22" 290) (NIL 39) ("P22" 8) ("-p22" 5) ("-p22.1" 1)))
 ("UP:O75936"
  (("B-box" 42) ("Bbox" 8) ("B-Box" 5) ("BBH" 4) ("its autoinhibitory B-box" 1)
   ("b-box" 1)))
 ("UP:O75940" (("SMNDC1" 1)))
 ("UP:O75943"
  (("Rad17" 228) ("RAD17" 108) ("rad17" 11) ("Rad24" 11) ("Rad17 protein" 5)
   ("Rad17 peptide" 3) ("Rad17-" 2) ("hRAD17" 2) ("hRad17" 2)
   ("Rad24 protein" 2) ("than Rad17" 1) ("RAD17 protein" 1)
   ("the ATR-associated molecules Rad17" 1)))
 ("UP:O75947" (("ATP5H" 2) ("subunit d" 1))) ("UP:O75949" (("TED" 4)))
 ("UP:O75952" (("CABYR" 1))) ("UP:O75953" (("DnaJb5" 3)))
 ("UP:O75955"
  (("flotillin" 46) ("Flot-1" 34) ("flotillin 1" 19) ("Flotillin 1" 8)
   ("flotillin1" 7) ("flotillin-" 5) ("Flotillin1" 5) ("Flotillin" 4)
   ("FLOT1" 3) ("FLOT-1" 2) ("the primary ployclonal antibody Flotillin 1" 2)))
 ("UP:O75956"
  (("DOC-1R" 117) ("DOC-1R protein" 9) ("overexpressed DOC-1R protein" 3)
   ("We first overexpressed DOC-1R protein" 2)))
 ("UP:O75962"
  (("Trio" 374) ("trio" 111) ("TRIO" 31) ("Trio peptide" 7) ("“trio”" 5)
   ("the archetypal trio" 2) ("Trio-" 1) ("triple functional domain protein" 1)
   ("the well-characterized Rac1-GEF Trio" 1) ("60 anonymous Finnish trio" 1)
   ("PTPRF-interacting protein" 1) ("a phenotypically diverse trio" 1)))
 ("UP:O75964" (("subunit G" 12) ("ATP5L" 3) ("subunit g" 1)))
 ("UP:O75970"
  (("MUPP1" 14) ("MPDZ" 13) ("Mupp1" 5) ("MPDZ protein" 2) ("MUPP-1" 1)))
 ("UP:O75973" (("CRF" 20)))
 ("UP:O75976"
  (("CPD" 337) ("CPDs" 162) ("cpd" 10) ("UV-induced CPDs" 4) ("Cpd" 3)
   ("weak CPDs" 3) ("contained more CPDs" 2) ("than lifetime CPD" 1)
   ("lifetime average and current CPD" 1) ("CPD-" 1) ("more CPDs" 1)
   ("at least six phosphorylated CPDs" 1) ("a CPD's" 1)
   ("All currently known mammalian CPDs" 1) ("than CPDs" 1) ("-CPD" 1)))
 ("UP:O76003" (("GLRX3" 2))) ("UP:O76011" (("keratin 34" 2) ("KRT34" 1)))
 ("UP:O76014" (("K-37" 2)))
 ("UP:O76021" (("L12" 38) ("RSL1D1" 2) ("ribosomal L1 domain containing 1" 1)))
 ("UP:O76024" (("WFS1" 11) ("WFS" 1))) ("UP:O76027" (("ANXA9" 5)))
 ("UP:O76031" (("CLPX" 5)))
 ("UP:O76036" (("NKp46" 47) ("NK cell activating receptor" 14)))
 ("UP:O76038" (("secret" 40))) ("UP:O76039" (("CDKL5" 2)))
 ("UP:O76041" (("NEBL" 10) ("nebulette" 1) ("Nebulette" 1)))
 ("UP:O76054" (("SPF" 78) ("SEC14L2" 8)))
 ("UP:O76061" (("STC2" 19) ("Stanniocalcin 2" 3) ("stanniocalcin 2" 1)))
 ("UP:O76064"
  (("RNF8" 713) ("Rnf8" 25) ("RNF8-" 10) ("RING finger protein 8" 5)
   ("RNF8 protein" 2) ("the other damage-associated E3 ligase RNF8" 1)
   ("ring finger protein 8" 1)))
 ("UP:O76070"
  (("SR" 757) ("SR protein" 60) ("SNCG" 21) ("scavenger receptors" 15) ("sr" 7)
   ("pSR" 6) ("Scavenger receptors" 2) ("S R" 2) ("junctional SR" 1)
   ("adenoviral IκB SR" 1) ("the adenoviral IκB SR" 1) ("“SR”" 1)
   ("231-Empty cells SR" 1)))
 ("UP:O76071" (("CIAO1" 11) ("Ciao1" 1)))
 ("UP:O76074" (("PDE5" 96) ("PDE5A" 4) ("than PDE5" 1)))
 ("UP:O76075"
  (("DFF40" 21) ("caspase-activated DNase" 15) ("DFFB" 12) ("40kDa" 6)
   ("caspase-activated DNase (ICAD)" 2) ("Caspase-activated DNAse" 2)
   ("CPAN" 1) ("DNA fragmentation factor subunit beta" 1) ("than 40kDa" 1)
   ("the apoptosis-associated nuclease caspase-activated DNase (CAD)" 1)
   ("caspase-activated DNase (CAD)" 1) ("Caspase-activated DNase" 1)))
 ("UP:O76076"
  (("WISP2" 16) ("CCN5" 7) ("Wisp2" 5) ("WISP-2" 4)
   ("WNT1 inducible signaling pathway protein 2" 1) ("Wisp-2" 1)))
 ("UP:O76081" (("RGS20" 2))) ("UP:O76082" (("SLC22A5" 14) ("OCTN2" 2)))
 ("UP:O76087" (("AL4" 5)))
 ("UP:O76093"
  (("FGF18" 78) ("Fgf18" 4) ("exogenous FGF18" 2)
   ("The anabolic growth factor FGF18" 1)))
 ("UP:O76094" (("SRP72" 97) ("SRP72 protein" 2)))
 ("UP:O76095" (("PAR protein" 8) ("JTB" 2) ("Par protein" 1)))
 ("UP:O76096" (("CMap" 2))) ("UP:O76324" (("Dco" 2)))
 ("UP:O76840" (("papilin" 1))) ("UP:O77051" (("dE2F2" 1)))
 ("UP:O77203" (("piaA" 28) ("PiaA" 10) ("piaA-" 7))) ("UP:O77506" (("pp40" 3)))
 ("UP:O77783" (("HS polymerase" 7) ("pfu-Ultra II fusion HS polymerase" 2)))
 ("UP:O78258" (("RbCl" 5) ("rBcl" 4))) ("UP:O78497" (("PBSA" 94)))
 ("UP:O80400" (("VPS" 8))) ("UP:O80642" (("GGB" 1)))
 ("UP:O80932" (("Exp3" 2) ("exp3" 1))) ("UP:O80939" (("LRK-1" 4)))
 ("UP:O81191"
  (("SCs" 242) ("SCS" 25) ("striolar SCs" 11) ("epidermal SCs" 8)
   ("extrastriolar SCs" 7) ("the extrastriolar SCs" 5) ("Striolar SCs" 5)
   ("the striolar SCs" 4) ("mammalian quiescent hematopoietic SCs" 2)
   ("mammary SCs" 2) ("mature SCs" 2) ("than extrastriolar SCs" 2)
   ("differentiated striolar SCs" 2) ("apical SCs" 2)
   ("mammalian proliferative neuronal SCs" 1) ("than other SCs" 1)
   ("E. coli SCS1" 1) ("longer SCs" 1) ("human embryonic SCs" 1)
   ("its resident SCs" 1) ("even striolar SCs" 1)
   ("striolar and extrastriolar SCs" 1) ("young utricular SCs" 1)
   ("Such E-cadherin-expressing SCs" 1) ("scattered striolar SCs" 1)
   ("differentiated vestibular SCs" 1) ("than the striola SCs" 1)
   ("some extrastriolar SCs" 1) ("almost all the SCs" 1) ("most SCs" 1)
   ("a few SCs" 1) ("Most striolar SCs" 1) ("than the extrastriolar SCs" 1)
   ("many striolar SCs" 1) ("most extrastriolar SCs" 1) ("utricular SCs" 1)
   ("immature SCs" 1) ("than SCs" 1) ("Extrastriolar SCs" 1)
   ("γ-secretase inhibitor (GSI) treatments cause striolar SCs" 1)
   ("some scattered striolar SCs" 1)))
 ("UP:O81208" (("OHP" 78))) ("UP:O81223" (("SOS3" 2)))
 ("UP:O81313" (("IND" 30) ("pIND" 14) ("pIND-" 4))) ("UP:O81796" (("IDH3" 2)))
 ("UP:O81851" (("Boi" 1))) ("UP:O82089" (("CCh" 44)))
 ("UP:O82491" (("Spt16" 17) ("SPT16" 14)))
 ("UP:O82656" (("protein tyrosine phosphatase-1" 5) ("PTP1" 3) ("PTP-1" 1)))
 ("UP:O82811" (("Lin1" 1)))
 ("UP:O84120"
  (("IncG" 22) ("the chlamydial protein IncG" 3) ("IncG protein" 2)))
 ("UP:O84462"
  (("TARP" 72) ("Tarp protein" 2) ("the bacterially-encoded TARP" 1)))
 ("UP:O87008" (("TFTC" 10))) ("UP:O87120" (("CdtA" 2)))
 ("UP:O87873" (("DCH" 35)))
 ("UP:O88382"
  (("scaffolding molecule" 30) ("synaptic scaffolding molecule" 8)))
 ("UP:O88466" (("SIRM" 2))) ("UP:O88514" (("RBD2" 5)))
 ("UP:O88705" (("HA-C3" 3))) ("UP:O88792" (("JCam1" 3)))
 ("UP:O88833" (("Cyp4A10" 2))) ("UP:O88940" (("MyoR" 4) ("myoR" 1)))
 ("UP:O89343"
  (("glycoprotein G" 13) ("the vesicular stomatitis virus glycoprotein G" 3)
   ("the viral glycoprotein G" 2) ("a unique glycoprotein G" 1)))
 ("UP:O93182"
  (("Gag polyprotein" 27) ("Retroviral Gag polyprotein" 1)
   ("the viral Gag polyprotein" 1)))
 ("UP:O93327"
  (("mH2A1" 81) ("Lentiviral shRNA plasmids targeting mH2A1" 2)
   ("targeting mH2A1" 2)))
 ("UP:O93436" (("STAM-2" 1))) ("UP:O93470" (("Mmp" 30) ("mmp" 5)))
 ("UP:O93610" (("Cdc1" 7))) ("UP:O93844" (("nup" 2)))
 ("UP:O93885" (("Prtb" 2) ("PRTB" 1))) ("UP:O93980" (("COX5" 5)))
 ("UP:O94198" (("ICL1" 4))) ("UP:O94374" (("importin 1" 1) ("Importin1" 1)))
 ("UP:O94399" (("twinfilin" 11) ("Twinfilin" 1)))
 ("UP:O94494" (("SIM4" 10) ("Sim4" 5) ("sim4" 1))) ("UP:O94526" (("PTN1" 3)))
 ("UP:O94534" (("Alp14" 45) ("alp14" 3))) ("UP:O94742" (("DSH1" 3)))
 ("UP:O94759" (("TRPM2" 39) ("TRPC7" 1)))
 ("UP:O94760" (("DDAH-1" 23) ("DDAH" 14) ("DDAH1" 2)))
 ("UP:O94761"
  (("RTS" 196) ("rTS" 101) ("RTs" 88) ("RECQL4" 60) ("pRTS" 17)
   ("retroviral RTs" 14) ("Recql4" 6) ("rTS protein" 5) ("RECQ4" 4)
   ("other retroviral RTs" 3) ("other lentiviral RTs" 2)
   ("other closely-related lentiviral RTs" 2) ("RecQ4" 1)
   ("the retroviral RTs" 1) ("both highly divergent RTs" 1)
   ("than oncoretroviral RTs" 1) ("oncoretroviral RTs" 1) ("lentiviral RTs" 1)
   ("purified retroviral RTs" 1) ("Retroviral RTs" 1) ("viral RTs" 1)))
 ("UP:O94762"
  (("RECQ5" 174) ("RECQL5" 18) ("RECQ5 protein" 8) ("Recql5" 4) ("RecQ5" 1)
   ("potential RECQ5" 1) ("RecQL5" 1)))
 ("UP:O94763" (("URI" 9) ("C19orf2" 5) ("their most recent URI" 1) ("RMP" 1)))
 ("UP:O94768" (("DRAK2" 85) ("DRAK2 protein" 1) ("STK17B" 1)))
 ("UP:O94776"
  (("MTA2" 110) ("PID" 83) ("PiD" 20) ("MTA-2" 7) ("MTA2 protein" 3)
   ("chronic PID" 3) ("additionally MTA2 protein" 2) ("This new PID" 1)
   ("an identifiable PID" 1) ("unique components MTA2" 1) ("pid" 1)))
 ("UP:O94782"
  (("USP1" 461) ("Usp1" 40) ("USP1 protein" 1)
   ("The internal deletion 295–342 amino acids of USP1" 1) ("usp1" 1)))
 ("UP:O94788" (("RALDH2" 22) ("Raldh2" 4) ("Aldh1a2" 2) ("ALDH1A2" 1)))
 ("UP:O94804" (("Lok" 7) ("STK10" 1) ("LOK" 1)))
 ("UP:O94805" (("ACTL6B" 1) ("Baf53/b" 1) ("Actin-like 6" 1)))
 ("UP:O94806" (("protein kinase D3" 7) ("PRKD3" 3)))
 ("UP:O94808" (("GFPT2" 2))) ("UP:O94810" (("RGS11" 1)))
 ("UP:O94811" (("TPPP" 4)))
 ("UP:O94813"
  (("Slit2" 367) ("SLIT2" 43) ("Slit2 protein" 11)
   ("the secretory glycoprotein Slit2" 2) ("the secretory protein Slit2" 1)
   ("O94813" 1) ("less Slit2 protein" 1)))
 ("UP:O94817"
  (("ATG12" 137) ("Atg12" 50) ("autophagic vesicle formation ATG12" 2)
   ("autophagy related 12" 1) ("the essential autophagy gene ATG12" 1)))
 ("UP:O94822" (("Listerin" 4) ("LTN1" 1)))
 ("UP:O94826" (("Tom70" 50) ("TOMM70A" 9) ("TOM70" 7) ("tom70" 3)))
 ("UP:O94827"
  (("Tech" 274) ("USA" 201) ("tech" 14) ("PLEKHG5" 9) ("TECH" 5)
   ("Tech (USA)" 2)))
 ("UP:O94829"
  (("IPO13" 23) ("importin 13" 3) ("importin13" 3) ("Importin 13" 2)))
 ("UP:O94830" (("DDHD2" 10) ("DDHD domain containing 2" 3)))
 ("UP:O94832" (("MYO1D" 2) ("myosin ID" 1))) ("UP:O94842" (("TOX4" 1)))
 ("UP:O94844" (("RhoBTB1" 5)))
 ("UP:O94856"
  (("NFs" 207) ("NFASC" 4) ("than NFs" 4) ("neurofascin" 2)
   ("two sequential NFs" 2) ("than NFs (Figure  xref A)" 1)
   ("than NFs ( xref )" 1) ("Neurofascin ( NFASC )" 1) ("Neurofascin" 1)))
 ("UP:O94864" (("STAF65γ" 10)))
 ("UP:O94874"
  (("UFL1" 4) ("KIAA0776" 3) ("RCAD" 3) ("NLBP" 2)
   ("a hypothetical protein also known as UFL1" 1)))
 ("UP:O94875" (("Abl/Arg" 28) ("SORBS2" 2) ("sorbin" 1)))
 ("UP:O94887" (("Farp2" 9) ("FARP2" 5) ("FIR" 2))) ("UP:O94889" (("KLHL18" 3)))
 ("UP:O94898" (("LRIG2" 1))) ("UP:O94900" (("TOX" 9)))
 ("UP:O94901" (("SUN1" 1)))
 ("UP:O94905"
  (("SPFH2" 113) ("ERLIN2" 5) ("targeting SPFH2" 4) ("C8orf2" 3)
   ("an additional siRNA duplex targeting SPFH2" 2) ("Erlin-2" 1)))
 ("UP:O94906" (("ANT-1" 4)))
 ("UP:O94907"
  (("SK" 1122) ("DKK1" 598) ("DKK-1" 324) ("Dkk1" 273) ("Dickkopf-1" 65)
   ("LRP5/6" 59) ("Lrp5/6" 42) ("Dkk-1" 25) ("Sk" 22) ("dickkopf-1" 19)
   ("DKK" 18) ("DKK1 protein" 11) ("pDkk1" 11) ("Dickkopf 1" 9)
   ("DKK-1 protein" 6) ("DICKKOPF-1" 5) ("Dkk" 3) ("hDKK1" 3)
   ("Soluble dickkopf-1" 2) ("SK-" 2) ("Dickkopf-related protein 1" 2)
   ("LRP5/6-" 2) ("Dickkopf1" 2) ("the soluble Wnt signaling inhibitor Dkk1" 2)
   ("exogenous DKK-1" 2) ("the soluble Wnt inhibitor DKK1" 1)
   ("Dickkopf-1 (DKK)" 1) ("-LRP5/6" 1) ("Soluble Dkk1" 1)
   ("Dickkopf-1 (DKK1) protein" 1) ("the soluble Wnt inhibitor Dkk1" 1)
   ("the soluble Wnt/β-catenin inhibitor Dkk1" 1)))
 ("UP:O94910" (("LPHN1" 1))) ("UP:O94911" (("member 8" 4) ("ABCA8" 4)))
 ("UP:O94916"
  (("TonEBP" 157) ("NFAT5" 81) ("TonEBP protein" 5)
   ("Nuclear factor of activated T-cells 5" 5) ("TonEBP-" 2)
   ("the osmolarity-sensitive promoter Nuclear factor of activated T-cells 5"
    2)
   ("hypertonicity-activated TonEBP" 1) ("OREBP" 1) ("Nfat5" 1)))
 ("UP:O94919" (("ENDOD1" 1))) ("UP:O94923" (("GLCE" 1)))
 ("UP:O94925" (("GLS" 242) ("GLS1" 175) ("Gls1" 21) ("GLS1 protein" 2)))
 ("UP:O94929" (("Ablim3" 5))) ("UP:O94952" (("FBXO21" 1) ("Fbxo21" 1)))
 ("UP:O94953"
  (("KDM4B" 86) ("JMJD2B" 9)
   ("than KDM4B in normal endometrial cells ( xref and xref )" 1)))
 ("UP:O94955"
  (("RhoBTB3" 204) ("RhoBTB3 protein" 4) ("that RhoBTB3’s" 1) ("RHOBTB3" 1)))
 ("UP:O94966" (("USP19" 153)))
 ("UP:O94972"
  (("TRIM37" 9) ("RING-B-box-coiled-coil protein" 3)
   ("tripartite motif containing 37" 2)))
 ("UP:O94973" (("AP2A2" 3)))
 ("UP:O94979" (("Sec31A" 7) ("Sec31a" 6) ("SEC31A" 4) ("SEC31L1" 2)))
 ("UP:O94985" (("CS-1" 11)))
 ("UP:O94986"
  (("CEP152" 66) ("SCKL5" 4) ("Cep152" 3) ("Asterless" 1) ("CEP152 protein" 1)
   ("focal CEP152" 1)))
 ("UP:O94988" (("FAM13A" 26) ("family with sequence similarity 13" 1)))
 ("UP:O94989" (("Ephexin5" 32) ("ArhGEF15" 2) ("ARHGEF15" 1)))
 ("UP:O94992"
  (("HEXIM1" 260) ("HEXIM-1" 14) ("HEXIM1 protein" 10) ("MAQ1" 1)
   ("about 50% less HEXIM1" 1)))
 ("UP:O94993" (("SOX30" 217) ("Sox30" 4) ("SOX30-" 1) ("exogenous SOX30" 1)))
 ("UP:O95025" (("SEMA3D" 2))) ("UP:O95045" (("UPP2" 6)))
 ("UP:O95049" (("ZO-3" 18) ("TJP3" 3))) ("UP:O95057" (("DIRAS1" 5)))
 ("UP:O95067"
  (("cyclin B2" 117) ("CCNB2" 69) ("Cyclin B2" 15) ("Ccnb2" 3) ("O95067" 1)
   ("Ccnb2 (TTTGAA)" 1) ("the ubiquitously-expressed cyclin B2" 1)))
 ("UP:O95069" (("TREK" 2) ("KCNK2" 1)))
 ("UP:O95071"
  (("EDD" 258) ("UBR5" 125) ("EDD1" 9) ("EDD protein" 7)
   ("overexpressed UBR5" 3) ("Hyd" 2) ("hHyd" 1) ("hHYD" 1) ("KIAA0896" 1)
   ("compromised EDD's" 1)))
 ("UP:O95072" (("Rec8" 2) ("REC8L1" 2))) ("UP:O95076" (("ALX3" 1)))
 ("UP:O95081" (("HRBL" 23)))
 ("UP:O95084" (("PRSS23" 160) ("Prss23" 3) ("PRSS23 protein" 2)))
 ("UP:O95096"
  (("NKX2.2" 52) ("Nkx2.2" 7) ("NK2 transcription factor related" 2)
   ("NKX2-2" 1) ("a few high-grade samples expressed NKX2.2" 1)
   ("most samples expressed NKX2.2" 1) ("Nkx2-2" 1)))
 ("UP:O95136" (("S1P 2" 149) ("S1PR2" 11))) ("UP:O95139" (("NDUFB6" 3)))
 ("UP:O95140"
  (("Mfn2" 218) ("MFN2" 34) ("mitofusin 2" 19) ("mArf" 10) ("Mfn2 protein" 3)
   ("increased mitochondrial fusion-related proteins Mfn2" 1) ("Mitofusin 2" 1)
   ("mARF" 1) ("non-phosphorylatable Mfn2" 1) ("exogenous Mfn2" 1)
   ("than Mfn2 ( xref )" 1)))
 ("UP:O95147" (("DUSP14" 8)))
 ("UP:O95149"
  (("SNUPN" 4) ("snurportin 1 (SNUPN)" 2) ("Snurportin 1" 1)
   ("snurportin 1" 1)))
 ("UP:O95150"
  (("TNFSF15" 45) ("Tnfsf15" 15) ("TL1A" 11)
   ("The positive internal control TNFSF15" 2) ("VEGI" 1)))
 ("UP:O95153" (("BZRAP1" 5)))
 ("UP:O95155" (("UBE4B" 88) ("Ufd2" 35) ("Ufd2 protein" 3)))
 ("UP:O95163"
  (("ELP1" 31) ("dys" 22) ("DYS" 17) ("Elp1" 17) ("ABL1 tyrosine kinase" 4)
   ("IKBKAP" 4) ("Dys" 4) ("hVps15" 2) ("Ikbkap" 1) ("IKAP" 1) ("dys-" 1)))
 ("UP:O95166" (("GABARAP" 83) ("ATG8a" 2) ("Atg8a" 1)))
 ("UP:O95167" (("9kDa" 1))) ("UP:O95168" (("15kDa" 3) ("NDUFB4" 1) ("B15)" 1)))
 ("UP:O95169" (("NDUFB8" 12))) ("UP:O95171" (("Scel" 3) ("sciellin" 1)))
 ("UP:O95178" (("AGGG" 31))) ("UP:O95180" (("CACNA1H" 1)))
 ("UP:O95185" (("UNC-5H3" 5) ("UNC5H3" 1) ("UNC5C" 1)))
 ("UP:O95196" (("NGC" 2) ("neuroglycan C" 1)))
 ("UP:O95197" (("HAP" 26) ("RTN3" 6) ("reticulon" 2) ("Reticulon" 1)))
 ("UP:O95198" (("MAV" 7))) ("UP:O95199" (("“RLG”" 1) ("RLG" 1)))
 ("UP:O95201" (("ZNF205" 1)))
 ("UP:O95206"
  (("PAPC" 29) ("PCDH8" 7) ("Pcdh8" 5) ("protocadherin 8" 2)
   ("Authentic PAPC" 1)))
 ("UP:O95208" (("epsin2" 5) ("O95208" 1))) ("UP:O95214" (("LEPROTL1" 1)))
 ("UP:O95219" (("SNX4" 3))) ("UP:O95229" (("Zwint" 62) ("ZWINT" 2)))
 ("UP:O95231" (("VentX" 1))) ("UP:O95232" (("Crop" 5)))
 ("UP:O95235"
  (("MKlp2" 195) ("KIF20A" 26) ("MKLP2" 13) ("Mklp2" 11) ("rabkinesin-6" 5)
   ("MKLP-2" 5) ("The mitotic kinesin KIF20A" 2) ("RAB6-KIFL" 1)))
 ("UP:O95238"
  (("SPDEF" 50) ("PDEF" 17) ("PSEs" 11) ("Spdef" 5) ("SPDEF protein" 2)))
 ("UP:O95239"
  (("Kif4A" 129) ("KIF4" 15) ("KIF4A" 14) ("Kif4" 8)
   ("kinesin family member 4A" 2) ("kif4A" 1)))
 ("UP:O95243"
  (("DNA glycosylase" 240) ("MBD4" 20) ("DNA glycosylase (UNG)" 6)
   ("DNA glycosylase (TDG)" 6) ("DNA Glycosylase (TDG)" 4)
   ("DNA glycosylase (UDG)" 4)
   ("DNA
glycosylase"
    2)
   ("DNA glycosylase ( UNG )" 2) ("DNA glycosylase (AAG)" 2)
   ("single-strand selective monofunctional uracil DNA glycosylase" 2)
   ("a central DNA glycosylase" 2) ("DNA Glycosylase" 1)
   ("DNA glycosylase (OGG)" 1)))
 ("UP:O95248" (("SBF1" 1)))
 ("UP:O95249" (("GOS-28" 7) ("GS28" 6) ("than GOS-28" 1)))
 ("UP:O95251"
  (("Hbo1" 147) ("HBO1" 117) ("Hbo1 protein" 3) ("HBO1 protein" 2)
   ("intense HBO1" 2) ("histone acetyltransferase binding to ORC1" 2)
   ("MYST2" 1)))
 ("UP:O95255" (("ARA" 61) ("ABCC6" 5) ("MRP6" 4)))
 ("UP:O95256" (("IL18RAP" 11) ("Il18rap" 2)))
 ("UP:O95257" (("GADD45γ" 5) ("GADD45g" 2))) ("UP:O95258" (("UCP5" 25)))
 ("UP:O95259"
  (("myoblasts" 1046) ("hEAG1" 47) ("EAG" 21) ("Myoblasts" 14) ("EAG1" 8)
   ("skeletal myoblasts" 8) ("human primary myoblasts" 7)
   ("myoblasts (HSMM)" 5) ("normal myoblasts" 4) ("primary myoblasts" 3)
   ("KCNH1" 3) ("Eag" 3) ("proliferating myoblasts" 2) ("eag" 2)
   ("myoblasts (ATCC)" 2) ("C2C12 skeletal myoblasts" 2)
   ("developmentally arrested primitive myoblasts" 2)
   ("normal skeletal myoblasts" 2)
   ("healthy primary human skeletal myoblasts" 2)
   ("step-wise converted normal human skeletal muscle myoblasts" 2)
   ("the exponentially growing myoblasts" 1) ("Primary myoblasts" 1)
   ("cardiac myoblasts" 1) ("mononuclear myoblasts" 1) ("Kv10.1" 1)
   ("normal proliferating myoblasts" 1) ("human normal myoblasts" 1)
   ("Human primary myoblasts" 1) ("than C2C12 myoblasts" 1)
   ("Asynchronous cycling C2C12 myoblasts" 1) ("fusion competent myoblasts" 1)
   ("parental C2C12 myoblasts" 1) ("mouse pluripotent C2C12 myoblasts" 1)
   ("non-transformed human myoblasts" 1) ("myogenesis—in normal myoblasts" 1)
   ("Pooled primary human skeletal myoblasts" 1)
   ("FSHD-derived myopathic myoblasts" 1)))
 ("UP:O95263" (("PDE8B" 13) ("phosphodiesterase 8B" 3)))
 ("UP:O95267"
  (("RasGRP1" 701) ("RasGRP" 244) ("RASGRP1" 46) ("Rasgrp1" 7)
   ("RAS guanyl-releasing protein" 4) ("RASGRP1-" 4) ("RasGRP protein" 3)
   ("RAS guanyl releasing protein" 3) ("RasGRP1 protein" 3) ("hRasGRP1" 3)
   ("-RasGRP" 2) ("RasGRP-" 2) ("dimeric RasGRP1" 1) ("RASGRP" 1)
   ("the intracellularly-localized RasGRP1" 1)))
 ("UP:O95271"
  (("TNKS" 48) ("tankyrase-1" 33) ("Tankyrase 1" 20) ("tankyrase" 15)
   ("tankyrase 1" 10) ("Tankyrase-1" 7) ("ARTD5" 7) ("Tankyrase" 6)
   ("tankyrases" 5) ("PARP-5a" 5) ("TNKS1" 4) ("Tankyrases" 3) ("TIN1" 1)
   ("Tnks1" 1)))
 ("UP:O95273" (("HHM" 13)))
 ("UP:O95274"
  (("Matrigel" 4024) ("matrigel" 1076) ("BD" 407) ("MATRIGEL" 8)
   ("three-dimensional Matrigel" 7) ("Matrigel (BD)" 7) ("LYPD3" 5)
   ("ice-cold Matrigel" 4) ("MatriGel" 3) ("residual matrigel" 2)
   ("sequential Matrigel" 2) ("subcutaneous Matrigel" 2)
   ("three-dimensional matrigel" 2) ("BD Matrigel" 2)
   ("commercially available growth factor reduced Matrigel" 2)
   ("high-concentrated Matrigel" 2) ("matrigel (BD)" 1)
   ("the polymerized Matrigel" 1) ("the three-dimensional (3D) Matrigel" 1)
   ("LY6/PLAUR domain containing 3" 1)
   ("the bipotent progenitor-initiated matrigel" 1) ("Matrigel-" 1)
   ("siRNA-transfected HCC1937 cells migrated trough Matrigel" 1)
   ("Five percent matrigel" 1)
   ("a trans-well chamber assay system coated matrigel" 1)
   ("Three-dimensional Matrigel" 1) ("than Matrigel" 1)))
 ("UP:O95278"
  (("laforin" 341) ("Laforin" 12) ("EPM2A" 7) ("laforin molecule" 2)))
 ("UP:O95279" (("KCNK5" 6))) ("UP:O95292" (("VAPB" 10)))
 ("UP:O95294" (("RASAL" 34) ("RASAL-" 1))) ("UP:O95295" (("Snapin" 6)))
 ("UP:O95297" (("Mpzl1" 2) ("PZR" 1))) ("UP:O95298" (("NDUFC2" 1)))
 ("UP:O95299" (("42KDa protein" 3) ("42kDa" 2) ("NDUFA10" 1) ("42KDa" 1)))
 ("UP:O95319"
  (("CUGBP2" 9) ("CUGBP-2" 4) ("CUG triplet repeat RNA-binding protein 2" 3)))
 ("UP:O95336" (("PGLs" 10) ("PGLS" 1)))
 ("UP:O95340"
  (("PAPSS2" 25) ("3'-phosphoadenosine 5'-phosphosulfate synthase 2" 4)
   ("non-functional PAPSS2" 2) ("SK-2" 1)))
 ("UP:O95342"
  (("BSEP" 140) ("Bsep" 19) ("bile salt export pump" 17) ("ABCB11" 12)
   ("member 11" 5) ("BSEP protein" 2) ("Abcb11" 1)
   ("The canalicular bile salt export pump (BSEP)" 1) ("PFIC2" 1)
   ("severe BSEP" 1)))
 ("UP:O95343" (("Six3" 16) ("SIX3" 1)))
 ("UP:O95347"
  (("CAPE" 263) ("SMC2" 30) ("Cape" 14) ("Smc2" 4) ("hCAP-E" 1) ("SMC2L1" 1)))
 ("UP:O95352"
  (("Atg7" 345) ("ATG7" 211) ("atg7" 5) ("ATG7 protein" 4)
   ("the central autophagic gene ATG7" 2) ("lentiviral ATG7" 2)
   ("the essential autophagic molecule ATG7" 1)
   ("the essential autophagy gene product Atg7" 1)))
 ("UP:O95359" (("TACC2" 10) ("AZU1" 2)))
 ("UP:O95361"
  (("TRIM16" 195) ("EBBP" 6) ("TRIM16 protein" 6) ("overexpressed TRIM16" 5)
   ("overall cellular TRIM16" 1)))
 ("UP:O95363" (("FARS2" 1) ("phenylalanyl-tRNA synthetase 2" 1)))
 ("UP:O95365"
  (("erythroid" 1451) ("Pokemon" 163) ("FBI-1" 151) ("Erythroid" 62) ("LRF" 12)
   ("ZBTB7" 4) ("Lrf" 4) ("zinc finger and BTB domain containing 7A" 4)
   ("primitive erythroid" 3) ("Pokemon protein" 3) ("Zbtb7a" 2)
   ("The erythroid myeloid ontogenic factor Pokemon" 2)
   ("POK erythroid myeloid ontogenic factor" 1)
   ("leukemia/lymphoma-related factor" 1) ("Pokemon-" 1) ("larger erythroid" 1)
   ("mature erythroid" 1) ("immortal erythroid" 1) ("normal erythroid" 1)
   ("erythroid-" 1) ("exogenous Pokemon" 1)
   ("named long intergenic non-coding RNA erythroid" 1)))
 ("UP:O95373"
  (("importin 7" 27) ("Importin-7" 4) ("Importin7" 3) ("IPO7" 2) ("IMP7" 1)
   ("Importin 7" 1) ("Imp7" 1)))
 ("UP:O95377" (("GJB5" 6) ("beta 5" 4) ("Cx31.1" 3) ("Beta 5" 2)))
 ("UP:O95379" (("TNFAIP8" 4))) ("UP:O95382" (("MAP3K6" 3)))
 ("UP:O95388"
  (("WISP1" 156) ("CCN4" 7) ("WISP-1" 6) ("Wisp1" 3) ("WISP1 protein" 2)
   ("Wisp 1" 2) ("WISP1 increased endogenous WISP1 protein" 1) ("WISP 1" 1)
   ("Wisp-1" 1)))
 ("UP:O95389" (("CCN6" 5) ("WISP3" 4))) ("UP:O95390" (("GDF11" 5) ("gdf11" 1)))
 ("UP:O95391" (("9G8" 43) ("hSlu7" 4) ("hSlu7 protein" 3) ("SLU7" 1)))
 ("UP:O95393" (("BMP10" 18)))
 ("UP:O95394" (("PGM3" 4) ("phosphoglucomutase 3" 2)))
 ("UP:O95395" (("GCNT3" 1) ("mucin type" 1)))
 ("UP:O95398"
  (("Epac1" 123) ("Epac" 85) ("EPAC1" 46) ("EPAC" 43) ("EPAC1 PROTEIN" 4)
   ("RAPGEF3" 4) ("Epac-1" 2) ("RapGEF3" 2)
   ("Rap guanine nucleotide exchange factor 3" 2)
   ("activated Rap1 (Ras-proximate-1 or Ras-related protein 1) GTPase and Rap1GEF (guanylate exchange factor) Epac1"
    2)
   ("Rapgef3" 1) ("Epac protein" 1) ("specifically targets Epac" 1)))
 ("UP:O95399" (("U-II" 139) ("U-II–" 3) ("urotensin II" 1)))
 ("UP:O95400" (("LIN1" 1)))
 ("UP:O95402" (("70kDa" 27) ("CRSP70" 7) ("70kDa protein" 5) ("70KDa" 1)))
 ("UP:O95405"
  (("NSP" 29) ("ZFYVE9" 18) ("SMAD anchor for receptor activation" 1) ("Nsp" 1)
   ("Smad anchor for receptor activation" 1)))
 ("UP:O95406" (("CNIL" 18) ("CNIH" 2)))
 ("UP:O95407"
  (("DcR3" 99) ("TNFRSF6B" 6) ("DcR3 protein" 5) ("TR6" 5)
   ("Decoy receptor 3" 5) ("decoy receptor 3" 1)))
 ("UP:O95409" (("ZIC2" 1))) ("UP:O95415" (("BRI3" 2)))
 ("UP:O95424" (("DEXI" 9)))
 ("UP:O95425"
  (("supervillin" 200) ("Supervillin" 20) ("Archvillin" 6) ("“supervillin”" 3)
   ("residual supervillin" 1)))
 ("UP:O95429"
  (("BAG4" 27) ("SODD" 4) ("Bag-4 (SODD)" 2) ("Bag-4" 1) ("Bag4" 1)))
 ("UP:O95433" (("Aha1" 51) ("AHA1" 3)))
 ("UP:O95436" (("SLC34A2" 53) ("SLC34A2-" 1)))
 ("UP:O95445"
  (("apoM" 9) ("APOM" 5) ("apolipoprotein M" 3) ("ApoM" 2)
   ("the HDL-associated apolipoprotein M" 1)))
 ("UP:O95452" (("beta 6" 4) ("GJB6" 3) ("connexin 30" 1)))
 ("UP:O95453"
  (("PARN" 59) ("Dan" 21) ("DAN" 6) ("dan" 1)
   ("poly(A)-specific ribonuclease" 1) ("exogenous wildtype PARN" 1)))
 ("UP:O95456"
  (("PAC-1" 46) ("BD" 40) ("PAC1" 13) ("Pac1" 8) ("PAC 1" 7) ("PSMG1" 4)
   ("PAC-1 (BD)" 1) ("the monoclonal antiboby PAC-1" 1)))
 ("UP:O95466"
  (("FMNL1" 17) ("FMNL" 4) ("formin-like" 3) ("formin-like protein 1" 3)
   ("FMNL protein" 2) ("Formin-like" 1)))
 ("UP:O95467"
  (("GNAS" 257) ("GSPs" 242) ("dietary GSPs" 11) ("Dietary GSPs" 9) ("Gnas" 5)
   ("given GSPs" 3) ("gnas" 2) ("GNAS1" 1) ("recurrent GNAS" 1)))
 ("UP:O95470" (("SGPL1" 3)))
 ("UP:O95471"
  (("Claudin 7" 47) ("claudin-7" 22) ("CLDN7" 16) ("Claudin-7" 11)
   ("claudin 7" 9) ("claudin7" 3) ("aberrant Claudin 7" 2) ("Cldn7" 1)
   ("Claudin7" 1)))
 ("UP:O95475" (("SIX6" 20) ("Optx2" 2) ("Six6" 1)))
 ("UP:O95477" (("ABCA1" 280) ("ABCA-1" 66) ("ABC1" 24) ("Abca1" 7)))
 ("UP:O95479" (("H6PD" 6) ("hexose-6-phosphate dehydrogenase" 5)))
 ("UP:O95484" (("claudin 9" 1))) ("UP:O95497" (("vanin" 1)))
 ("UP:O95500" (("claudin-14" 25) ("Claudin-14" 1) ("CLDN14" 1)))
 ("UP:O95503" (("CBX6" 4) ("chromobox homolog 6" 4)))
 ("UP:O95528" (("SLC2A10" 2)))
 ("UP:O95551"
  (("TTRAP" 7) ("TRAF and TNF receptor-associated protein" 2)
   ("DJ-1(M26I) bind more TTRAP" 1)))
 ("UP:O95568" (("METTL18" 6)))
 ("UP:O95573" (("ACSL3" 110) ("ACSL3 protein" 2) ("ACSL3-" 1) ("ACS3" 1)))
 ("UP:O95598" (("Fas/Apo1" 7))) ("UP:O95600" (("KLF8" 423) ("KLF8 protein" 5)))
 ("UP:O95602" (("POLR1A" 25) ("RPA194" 6)))
 ("UP:O95613"
  (("PCNT" 205) ("pericentrin" 183) ("KEN" 136) ("PCNTB" 75) ("Pericentrin" 14)
   ("-PCNTB" 6) ("Ken" 5) ("ken" 4) ("pericentrin (PCNT)" 4)
   ("centrosomal PCNT" 3) ("PCNTB protein" 3) ("The centrosomal PCNT" 3)
   ("KEN-" 2) ("kendrin" 2) ("PERICENTRIN" 2) ("PCNT protein" 2)
   ("the centrosomal PCNT" 2) ("Pericentrin (PCNT)" 2) ("bona fide KEN-" 1)
   ("the centrosomal marker pericentrin" 1) ("only weak pericentrin" 1)
   ("less PCNT" 1) ("Cep215 depleted cells centrosomal pericentrin" 1)
   ("than phospho-PCNT" 1)))
 ("UP:O95619" (("YEATS4" 5))) ("UP:O95622" (("ADCY5" 2)))
 ("UP:O95628"
  (("ligases" 289) ("CNOT4" 39) ("subunit 4" 23) ("Ligases" 9) ("Not4" 4)
   ("NOT4" 2) ("“ligases”" 2) ("active dimeric ligases" 1)))
 ("UP:O95630" (("α-MSH" 47) ("AMSH" 39) ("AMSH  protein" 5) ("STAMBP" 1)))
 ("UP:O95631"
  (("Netrin-1" 117) ("netrin-1" 98) ("NTN1" 11) ("netrin 1" 2)
   ("that netrin-1’s" 1) ("netrin-1 protein" 1)))
 ("UP:O95633" (("FLRG" 4)))
 ("UP:O95639"
  (("NAR" 149) ("Nar" 87) ("30kDa" 7) ("CPSF30" 6) ("CPSF4" 3) ("nar" 1)
   ("nAR" 1)))
 ("UP:O95644"
  (("NFATC1" 41) ("NFATc" 28) ("cytoplasmic 1" 19) ("NFAT2" 13) ("NFATC" 7)
   ("NFATC1-" 4)))
 ("UP:O95661"
  (("ARHI" 361) ("ARHI protein" 9) ("DIRAS3" 2) ("NOEY2" 1) ("ARHI-" 1)))
 ("UP:O95665" (("NTSR2" 2) ("NTR2" 1))) ("UP:O95677" (("EYA4" 45)))
 ("UP:O95684" (("FGFR1 oncogene partner" 2)))
 ("UP:O95696"
  (("BRL" 758) ("BRD1" 3)
   ("the heterotrimeric G-protein coupled receptor BRL1" 1)))
 ("UP:O95707" (("POP4" 3))) ("UP:O95711" (("MD1" 4)))
 ("UP:O95714"
  (("HERC2" 304) ("Herc2" 31) ("HERC2 protein" 6)
   ("HERC2
protein"
    5)
   ("biological
knowledge-based HERC2"
    1)))
 ("UP:O95715" (("CXCL14" 3)))
 ("UP:O95716" (("gov" 72) ("RAB3D" 2) ("GOV" 1) ("RAB3D-" 1) ("Gov" 1)))
 ("UP:O95718" (("ERRB2" 24) ("Esrrb" 8) ("ESRRB" 5) ("ERR2" 1)))
 ("UP:O95727" (("CRTAM" 1))) ("UP:O95747" (("OSR1" 3)))
 ("UP:O95749" (("GGPS1" 2)))
 ("UP:O95750"
  (("FGF19" 473) ("FGFs" 293) ("autocrine FGFs" 10) ("Fgfs" 8)
   ("fibroblast growth factor 19" 6) ("the canonic FGFs" 3) ("FGF-19" 2)
   ("key mitogenic FGFs" 2) ("canonic FGFs" 2) ("The postprandial FGF19" 2)
   ("at least 22 distinct FGFs" 2) ("available FGFs" 1) ("fgf-19" 1)
   ("alternative FGFs" 1) ("Almost all FGFs" 1) ("Fgf19" 1)
   ("exogenous FGFs" 1) ("canonic FGFs and endocrine FGFs" 1)
   ("the heparin-binding canonic FGFs" 1) ("these hormonal FGFs" 1)
   ("Most FGFs" 1)))
 ("UP:O95751" (("LDOC1" 1))) ("UP:O95757" (("HSPA4L" 12)))
 ("UP:O95758" (("Rod1" 3) ("ROD1" 2) ("PTBP3" 1))) ("UP:O95759" (("TBC1D8" 1)))
 ("UP:O95760"
  (("IL-33" 174) ("IL33" 43) ("IL-33 protein" 8) ("interleukin 33" 6)
   ("Interleukin 33" 1) ("interleukin-33" 1)))
 ("UP:O95777" (("U6 small nuclear RNA associated" 1)))
 ("UP:O95782" (("AP2A1" 2))) ("UP:O95785" (("Wiz" 6) ("WIZ" 5)))
 ("UP:O95786"
  (("RIG-I" 866) ("DDX58" 25) ("RIG-1" 16) ("RIG-I-" 15)
   ("retinoic acid inducible gene I" 6) ("RIG-I–" 5) ("RIG-I protein" 4)
   ("RIGI" 2) ("RNA helicase RIG-I" 2)
   ("the cytoplasmic viral RNA sensor RIG-I" 1)
   ("The cytoplasmic viral RNA sensor RIG-I" 1) ("O95786" 1) ("Ddx58" 1)
   ("Rig-I" 1) ("Rig-1" 1) ("antiviral genes RIG-1" 1)))
 ("UP:O95789" (("ZNF258" 4)))
 ("UP:O95793"
  (("Stau1" 314) ("Staufen" 26) ("Stau1 protein" 5)
   ("the first 88 N-terminal amino acids of Stau1" 4) ("STAU1" 3)
   ("the first N-terminal 88 amino acids of Stau1" 1)
   ("the multifunctional RNA-binding protein Stau1" 1) ("Stau1-" 1)
   ("targeted Stau1" 1)))
 ("UP:O95807" (("Smp1" 1)))
 ("UP:O95810"
  (("cavin 2" 47) ("cavin-2" 32) ("SDPR" 9) ("serum deprivation response" 6)
   ("Cavin 2" 5) ("Cavin-2" 3) ("cavin-2-" 1) ("relatively more cavin 2" 1)
   ("than endogenous cavin 2 in the cavin-2-GFP cell line" 1) ("Sdpr" 1)))
 ("UP:O95813" (("Cer1" 16) ("CER1" 4) ("cerberus" 2) ("Cerberus" 2)))
 ("UP:O95816" (("BAG2" 17) ("Bag2" 1)))
 ("UP:O95817"
  (("Bis" 403) ("bis" 330) ("BAG3" 204) ("BIS" 166) ("-bis" 42) ("bis-" 10)
   ("bag3" 6) ("Bcl-2-associated athanogene 3" 6)
   ("Another SOX2-associated protein BAG3" 3) ("Bis-" 2)
   ("the contrary BAG3" 1) ("BAG3 protein" 1)))
 ("UP:O95819"
  (("MAP4K4" 9) ("Nck-interacting kinase" 3)
   ("mitogen-activated protein kinase kinase kinase kinase 4" 1)))
 ("UP:O95822" (("MLYCD" 4) ("hmCD" 2)))
 ("UP:O95831"
  (("AIF" 800) ("-AIF" 7) ("a 62 kDa mature AIF" 3) ("immunodetectable AIF" 2)
   ("drived AIF" 2) ("AIF protein" 2) ("AIFM1" 1) ("strong AIF" 1)
   ("mature AIF" 1) ("AIF-" 1)))
 ("UP:O95832"
  (("claudin-1" 245) ("Claudin-1" 127) ("CLDN1" 84) ("Claudin 1" 10)
   ("claudin 1" 10) ("Cldn1" 8) ("Claudin-1 protein" 4)
   ("glomerular Claudin-1" 2) ("claudin-1 protein" 1)))
 ("UP:O95834" (("EML2" 3)))
 ("UP:O95835"
  (("LATS1" 564) ("Lats1" 192) ("Warts" 52) ("warts" 49) ("genital warts" 9)
   ("pLATS1" 7) ("WARTS" 7) ("LATS1 protein" 6) ("benign warts" 5)
   ("Lats1 protein" 5) ("p-LATS1" 3) ("h-warts" 3) ("Genital benign warts" 2)
   ("wart" 2) ("coexpressed FLAG-tagged Lats1" 2) ("LATS1-" 2)
   ("forskolin increased Lats1" 2) ("than LATS1" 1) ("5 genital warts" 1)
   ("Persistent genital warts" 1) ("five genital warts" 1)
   ("Large tumor suppressor homolog 1" 1) ("Lats1-" 1) ("UV-exposed warts" 1)
   ("plantar warts" 1) ("H-warts" 1) ("the bead-bound LATS1" 1)
   ("both exogenous and endogenous LATS1" 1) ("non-genital warts" 1)
   ("extragenital cutaneous viral warts" 1) ("induced genital warts" 1)))
 ("UP:O95838" (("GLP2R" 1)))
 ("UP:O95841" (("angiopoietin" 17) ("Angiopoietin" 4) ("ANGPTL1" 3)))
 ("UP:O95847" (("UCP4" 4) ("SLC25A27" 2)))
 ("UP:O95857" (("Tetraspanin 13" 2) ("Tspan13" 1) ("TSPAN13" 1)))
 ("UP:O95859"
  (("TSPAN12" 21) ("insufficient TSPAN12" 1) ("TSPAN12 protein" 1)))
 ("UP:O95863"
  (("Snail" 2879) ("Snail1" 476) ("SNAI1" 414) ("SNAIL" 256) ("snail" 186)
   ("Snai1" 163) ("SNAIL1" 132) ("Snail protein" 51) ("snai1" 18)
   ("Snail1 protein" 15) ("the pro-invasive gene Snail1" 7)
   ("the transcriptional repressor Snail" 6)
   ("its downstream transcriptional target SNAIL" 3)
   ("transcriptional marker Snail" 3) ("Snail-" 3)
   ("its transcriptional repressor SNAI1" 2) ("selectively targets snai1" 2)
   ("snail1" 2) ("transcriptional factor Snail" 2)
   ("transcriptional repressor Snail" 2) ("-Snail" 2)
   ("the EMT-associated transcription factor Snail" 2)
   ("absent nuclear Snail1" 2) ("Transcriptional factor Snail" 1)
   ("the E-cadherin-related transcriptional repressor Snail" 1)
   ("the transcriptional repressor SNAIL" 1)
   ("the E-cadherin transcriptional repressor Snail" 1)
   ("the EMT-associated transcription suppressor Snail" 1)
   ("The zinc finger transcriptional repressor Snail" 1)
   ("the EMT-associated transcription repressor Snail" 1)
   ("the transcriptional factor Snail" 1)
   ("the pro-invasive transcription factor Snail1" 1)
   ("the pro-invasive Snail1" 1) ("exogenous Snail" 1) ("SNAIL protein" 1)
   ("transcriptional factor snail" 1) ("the associated endogenous Snail" 1)
   ("exogenous Snai1" 1) ("amino-terminal fusions disrupted Snai1’s" 1)
   ("the proinvasive transcriptional regulator Snail" 1) ("than SNAIL 1" 1)
   ("Snail1-" 1) ("the essential EMT inducer Snail1" 1)
   ("human triple-tagged Snail" 1)))
 ("UP:O95864"
  (("FADS2" 33) ("fatty acid desaturase 2" 8) ("D6D" 3)
   ("delta-6 desaturase" 1)))
 ("UP:O95865"
  (("DDAH2" 43) ("DDAH-2" 7) ("dimethylarginine dimethylaminohydrolase 2" 1)))
 ("UP:O95866" (("G6B" 2))) ("UP:O95872" (("GPANK1" 1)))
 ("UP:O95886" (("DAP3" 8)))
 ("UP:O95905"
  (("ECD" 858) ("E-CD" 61) ("ECDs" 23) ("ECD protein" 8) ("hECD" 7) ("HeCd" 2)
   ("negative membranous E-CD" 2) ("structurally intact ECD" 2)
   ("serial ECD" 1) ("preoperative HER2 ECD" 1)
   ("the C-terminal membrane proximal ECD" 1)
   ("the archetypal dimeric GHR ECD" 1) ("the ECD’s" 1)))
 ("UP:O95918" (("OR2H2" 5))) ("UP:O95922" (("TTLL1" 1)))
 ("UP:O95925" (("Eppin" 95) ("eppin" 5) ("SPINLW1" 1)))
 ("UP:O95926" (("Syf2" 1))) ("UP:O95931" (("CBX7" 12) ("chromobox protein" 1)))
 ("UP:O95932" (("TGY" 7) ("TG6" 1)))
 ("UP:O95936" (("Tbr2" 81) ("EOMES" 30) ("Eomes" 19) ("TBR2" 5)))
 ("UP:O95944" (("NKp44" 247) ("NCR2" 5) ("CD336" 1)))
 ("UP:O95947" (("TBX6" 3) ("Tbx6" 3))) ("UP:O95948" (("OC2" 3) ("Onecut 2" 1)))
 ("UP:O95965" (("ITGBL1" 5)))
 ("UP:O95967"
  (("EFEMP2" 62) ("Tyr-267" 46)
   ("EGF-containing fibulin-like extracellular matrix protein 2" 3) ("FBLN4" 1)
   ("fibulin 4" 1) ("Efemp2" 1) ("fibulin-4" 1)
   ("longest interacting EFEMP2" 1)))
 ("UP:O95970"
  (("partial" 3958) ("Partial" 199) ("LGI1" 4) ("at least partial" 2)
   ("“partial”" 2) ("weak partial" 2) ("NAC showed dose-dependent partial" 1)
   ("underwent either partial" 1) ("these therapies only offer partial" 1)
   ("than partial unfolding by puling" 1) ("Etl1" 1) ("EPT" 1)
   ("Partial protein" 1) ("Mcl-1 underwent partial" 1) ("partial (PR)" 1)
   ("atomic partial" 1) ("mostly complex partial" 1) ("underwent partial" 1)))
 ("UP:O95971" (("CD160" 2))) ("UP:O95972" (("BMP15" 5) ("BMP-15" 1)))
 ("UP:O95980"
  (("RECK" 450) ("RECK protein" 23) ("Reck" 9) ("overexpressed RECK" 2)
   ("stably overexpressed RECK" 1)
   ("Reversion-inducing cysteine-rich protein with Kazal motifs (RECK)" 1)
   ("Reversion-inducing cysteine-rich protein with Kazal motifs" 1)))
 ("UP:O95983" (("MBD3" 22) ("than MBD3 (or MBD2)" 1)))
 ("UP:O95988" (("TCL1" 146) ("Tcl1" 11) ("TCL1B" 1)))
 ("UP:O95990" (("FAM107A" 2)))
 ("UP:O95992" (("cholesterol 25-hydroxylase" 4) ("CH25H" 2) ("Ch25h" 1)))
 ("UP:O95994" (("AG2" 2)))
 ("UP:O95996"
  (("APCL" 255) ("hAPC1" 53) ("APC-like" 8) ("a functional APCL" 3)
   ("APCL protein" 2)))
 ("UP:O95997"
  (("securin" 350) ("Securin" 97) ("PTTG1" 85) ("hPTTG" 12) ("Pttg1" 6)
   ("securin protein" 4) ("PTTG" 2) ("nondegradable securin" 2)
   ("around PTTG1" 1)
   ("the first 88 amino acids of the mitotic Cdc20-APC substrate securin" 1)
   ("the mitotic Cdc20-APC substrate securin" 1) ("fluorescent securin" 1)))
 ("UP:O95998" (("IL18BP" 9) ("IL-18BP" 7)))
 ("UP:O95999"
  (("BCL10" 375) ("Bcl10" 174) ("BCL10 molecule" 4) ("Bcl-10" 3)
   ("Bcl10 protein" 2) ("11 amino acids of BCL10" 1) ("BCL10 protein" 1)))
 ("UP:O96000" (("22KDa" 1)))
 ("UP:O96004"
  (("HAND1" 21) ("Hand1" 4)
   ("heart and neural crest derivatives expressed 1" 3)))
 ("UP:O96005" (("CLPTM1" 14))) ("UP:O96006" (("ALT-E" 29) ("Alt-E" 2)))
 ("UP:O96008" (("Tom40" 51) ("TOM40" 12) ("TOMM40" 6)))
 ("UP:O96009" (("Napsin A" 15) ("napsin A" 14) ("napa" 1)))
 ("UP:O96013"
  (("PAK4" 2158) ("Pak4" 143) ("p-Pak4" 25) ("p21-activated kinase 4" 24)
   ("overexpressed PAK4" 11) ("-PAK4" 8) ("PAK4 protein" 5)
   ("p21–activated kinase 4" 4) ("kinase-defective PAK4" 4) ("PAK4-" 3)
   ("P21-activated kinase 4" 3) ("PAK4 (WT)" 2)
   ("In contrast both the N-terminal fragments PAK4" 2) ("p-PAK4" 2)
   ("than PAK4" 1) ("down more PAK4" 1) ("hyperactive PAK4" 1)
   ("we first expressed PAK4" 1) ("pPak4" 1)
   ("than endogenous PAK4 ( xref , C and D)" 1)
   ("than wildtype PAK4 ( xref lanes 4 and 7 and 4D)" 1)
   ("0.5μM Purvalanol A PAK4 E329K" 1) ("-PAK4ΔKinase" 1) ("minimal PAK4" 1)))
 ("UP:O96014"
  (("WNT11" 98) ("Wnt11" 24) ("Wnt-11" 7)
   ("both total and secreted WNT11 protein" 2) ("WNT11 protein" 2)
   ("the ERRα/β-cat-dependent target WNT11" 1)))
 ("UP:O96015" (("axonemal" 5) ("complete axonemal" 1)))
 ("UP:O96017"
  (("Chk2" 3022) ("CHEK2" 2180) ("CHK2" 1672) ("Rad53" 107)
   ("checkpoint kinase 2" 102) ("CHEK2 protein" 50) ("pCHK2" 39)
   ("Chk2 protein" 37) ("chk2" 27) ("RAD53" 24) ("CHK2 protein" 23)
   ("pCHEK2" 21) ("CDS1" 19) ("Checkpoint kinase 2" 17) ("p-CHK2" 13)
   ("-CHK2" 12) ("rad53" 11) ("ChK2" 8) ("Chk2 molecule" 7) ("Chek2" 5)
   ("CHEK2-" 5) ("chek2" 5) ("CHK-2" 5) ("CHK2 checkpoint homolog" 5)
   ("Chk2-" 3) ("CHK2 molecule" 3) ("Chk-2" 3) ("checkpointkinase 2" 3)
   ("CHK2(KD)" 3) ("CHEK2 molecule" 2) ("exogenous CHK2" 2)
   ("using either cellular CHEK2" 2) ("point kinase-2" 2) ("CHK2 (WT)" 2)
   ("total and phosphorylated CHK2" 2) ("flag-tagged full-length human Chk2" 1)
   ("O96017" 1) ("than CHEK2" 1)
   ("the previously characterized CHEK2 germline mutants variants Arg117His" 1)
   ("only few CHEK2" 1) ("than Chk2 (IC50, 0.7μM)" 1) ("exogenous Chk2" 1)
   ("oligomeric activated Chk2" 1) ("P-CHK2" 1)
   ("the other placental mammalian CHK2" 1) ("–Chk2" 1) ("functional CHK2" 1)
   ("than Chk2 ( xref )" 1) ("CHK2-" 1) ("cHK2" 1)
   ("checkpoint
kinase 2"
    1)
   ("Chk2 (CAGTGTCCACTCAGGAACTCT)" 1)))
 ("UP:O96018" (("APBA3" 3) ("MINT3" 2)))
 ("UP:O96019"
  (("Baf53" 136) ("BAF53A" 10) ("BAF53" 10) ("BRG1-associated factor" 4)
   ("ACTL6A" 4) ("BAF53a" 2) ("much less Baf53" 1) ("Baf53a" 1) ("INO80K" 1)))
 ("UP:O96020" (("CCNE2" 131) ("cyclin E2" 126) ("cyclin E2 protein" 7)))
 ("UP:O96024" (("B3GALT4" 1)))
 ("UP:O96028" (("MMSET" 263) ("WHSC1" 11) ("NSD2" 6)))
 ("UP:O96042" (("dia2" 10) ("Dia2" 9) ("DIA2" 2)))
 ("UP:O96530" (("hyaline" 57) ("Hyaline" 2) ("contiguous hyaline" 1)))
 ("UP:O96623" (("ARPE" 12) ("ARPE-" 2))) ("UP:O97148" (("MTH" 118) ("MTH-" 1)))
 ("UP:O97159" (("Mi2" 13) ("mi2" 1))) ("UP:O97936" (("MspA" 26)))
 ("UP:P00106" (("CC4" 5))) ("UP:P00137" (("CyD" 5)))
 ("UP:P00154" (("cycA" 108) ("CycA" 43) ("pCycA" 4) ("than cycA" 1)))
 ("UP:P00156"
  (("cytochrome b" 48) ("cytochrome B" 4) ("CYTB" 3)
   ("mitochondrial-encoded cytochrome b" 2) ("Cytochrome b" 2)
   ("G-CSF increased plasma membrane cytochrome b" 2) ("Cytochrome B" 1)
   ("the heterodimeric cytochrome b" 1)))
 ("UP:P00167"
  (("cytochrome b5" 16) ("CYB5A" 2) ("CYB5" 2)
   ("the microsomal cytochrome b5" 2) ("microsomal cytochrome b5" 1)))
 ("UP:P00191" (("Cyp21a1" 2))) ("UP:P00238" (("ferredoxin" 5)))
 ("UP:P00259"
  (("PDX" 340) ("PDXs" 134) ("late passage PDX" 4)
   ("respective OCTT2 and LNT14 PDXs" 1) ("this particular lumenal PDX" 1)
   ("Four lumenal PDX" 1) ("the counterpart lumenal PDX" 1)
   ("yielded 22 serially transplantable PDXs" 1) ("subcutaneous PCa PDXs" 1)
   ("primary pancreatic ductal adenocarcinoma (PDAC) PDX" 1)
   ("the above-mentioned PDXs" 1)))
 ("UP:P00280" (("azurin" 41) ("Azurin" 1)))
 ("UP:P00299"
  (("PCa" 7106) ("CRPC" 124) ("metastatic PCa" 61) ("PCas" 59)
   ("primary PCa" 54) ("HRPC" 28) ("pCa" 21) ("castration-resistant PCa" 20)
   ("PCAs" 14) ("sporadic PCa" 14) ("pCA" 12) ("hereditary PCa" 12)
   ("PCa (CRPC)" 11) ("recurrent PCa" 8) ("aggressive PCa" 8)
   ("castration-resistant PCa (CRPC)" 7) ("indolent PCa" 5)
   ("more aggressive PCa" 5) ("sporadic or familial PCa" 5) ("invasive PCa" 4)
   ("untreated primary PCa" 4) ("primary and metastatic PCa" 4)
   ("PCa (HRPC)" 4) ("late stage PCa" 4) ("PTEN-null PCa" 3)
   ("castration-tolerant PCa" 3) ("late-stage castration-resistant PCa" 2)
   ("the primary PCa" 2) ("PCa termed castration-resistant PCa (CRPC)" 2)
   ("castration-recurrent PCa" 2) ("metastatic CRPC" 2)
   ("advanced metastatic CRPC" 2) ("131 primary PCa" 2)
   ("clinically significant and insignificant PCa" 2)
   ("matched primary and metastatic PCa" 2) ("PCa (ERPC)" 2) ("PCa (JHASPC)" 2)
   ("bone metastatic PCa" 2) ("neoplastic and invasive PCa" 2)
   ("especially early-onset PCa" 2) ("both sporadic and familial PCa" 2)
   ("more advanced metastatic and recurrent PCa" 2) ("clinical primary PCa" 2)
   ("lethal castration-resistant PCa" 2) ("50 primary PCa" 2)
   ("bone-metastatic PCa" 2) ("developed PCa" 2) ("Castration-resistant PCa" 2)
   ("PC-A" 1) ("this metastatic CRPC" 1) ("Only biopsy confirmed PCa" 1)
   ("localized primary PCa" 1) ("most recurrent PCa" 1)
   ("an incurable castration-resistant metastatic PCa (CRMPC)" 1)
   ("the early stage recurrent PCa" 1) ("latent or indolent PCa" 1)
   ("2571 unrelated European-descent PCa" 1) ("primarily older PCa" 1)
   ("intraosseous PCa" 1) ("whose PCa" 1) ("pCAS" 1) ("Most PCas" 1)
   ("castrate-recurrent or resistant (CR) PCa" 1)
   ("a biologically more aggressive PCa" 1) ("Most PCa" 1)
   ("particularly bone metastatic PCa" 1)
   ("aggressive and non-aggressive PCa" 1) ("most patients PCa" 1)
   ("progressive metastatic CRPC" 1) ("aggressive and metastatic PCa" 1)
   ("symptomatic metastatic CR PCa" 1)
   ("than untreated primary PCa (merely 3% overlap)" 1)
   ("19 metastasized PCa" 1) ("AR-dependent PCa" 1) ("metastasized PCa" 1)
   ("Nearly all PCas" 1) ("curatively treatable PCa" 1) ("150 primary PCa" 1)
   ("clinically significant and indolent PCa" 1) ("aggressive lethal PCa" 1)
   ("senescence-competent PCa" 1) ("human primary PCa" 1)
   ("the CD44 + human primary PCa" 1) ("these RAS-expressing PCa" 1)
   ("highly metastatic PCa" 1) ("benign, localized, and metastatic PCa" 1)
   ("malignant PCa" 1) ("most late stage PCa" 1) ("ablation-resistant PCAs" 1)
   ("annual PCa" 1) ("These castration-resistant PCas (CRPC)" 1)
   ("rapidly fatal PCa" 1) ("than primary PCa" 1)
   ("poorly-differentiated primary PCa" 1) ("recurrent PCas" 1)
   ("Paraffin-embedded human primary PCas" 1) ("a primary PCa" 1)
   ("benign prostate tissue and hormone naive PCa" 1) ("44 primary PCa" 1)
   ("an additional 1527 sporadic PCa" 1) ("than 400 PCas" 1)
   ("primary or metastatic PCa" 1) ("most PCa’s" 1) ("most PCa" 1)
   ("a more aggressive hormone-independent PCa" 1)
   ("the castration-resistant PCa" 1) ("experimental PCa" 1)
   ("both primary PCas" 1) ("primary PCas" 1) ("clinically relevant PCa" 1)
   ("AR-positive PCa" 1) ("aggressive invasive PCa" 1) ("aggressive PCas" 1)
   ("both benign and localized PCa" 1)
   ("prostate epithelial cells developed increased metastatic PCa" 1)
   ("the naive PCa" 1) ("58 primary PCa" 1)
   ("androgen-dependent metastatic PCa" 1)))
 ("UP:P00305" (("insA" 42) ("InsA" 2)))
 ("UP:P00325"
  (("ADH1B" 116) ("beta polypeptide" 4) ("alcohol dehydrogenase 1B" 2)))
 ("UP:P00326" (("ADH1C" 10)))
 ("UP:P00338"
  (("LDHA" 203) ("lactate dehydrogenase A" 24) ("LDH-A" 19) ("Ldha" 12)
   ("lactate dehydrogenase A (LDHA)" 7) ("lactate dehydrogenase A ( LDHA )" 5)
   ("Lactate dehydrogenase A" 2) ("Ldha protein" 2) ("LDHa" 2)
   ("Lactate dehydrogenase A (LDHA)" 1) ("p-LDHA" 1)))
 ("UP:P00352"
  (("ALDH1" 595) ("ALDH1A1" 128) ("ALDH-1" 19) ("ALDH1-" 4) ("ALDH1 protein" 3)
   ("ALDH1−" 3) ("the overall epithelial ALDH1" 2) ("aldh1" 1) ("Aldh1" 1)))
 ("UP:P00367" (("GDH-1" 103) ("GLUD1" 71) ("GDH-1 in it’s" 1) ("GDH -1" 1)))
 ("UP:P00374"
  (("DHFR" 951) ("DHF" 100) ("dihydrofolate reductase" 85) ("dHF" 39)
   ("dihydrofolate" 28) ("dhfr" 28) ("Dihydrofolate reductase" 10)
   ("dihydrofolate reductase (DHFR)" 8)
   ("dihydrofolate
reductase"
    6)
   ("DHFR protein" 4) ("Pure human DHFR" 2) ("–DHFR" 2)
   ("hospitalized possible DHF" 2) ("available DHFR" 1) ("endothelial DHFR" 1)
   ("For example C. elegans DHFR" 1) ("the other extant DHFR" 1)
   ("an ancestral DHFR" 1) ("Region B. Bacterial DHFR" 1)
   ("all available DHFR" 1) ("Dhfr" 1) ("acute dHF" 1)
   ("This observation highlighted DHFR’s" 1)
   ("the probable and possible DHF" 1) ("the hospitalized possible DHF" 1)
   ("possible DHF" 1) ("probable DHF" 1) ("hospitalized probable DHF" 1)
   ("Dihydrofolate" 1)
   ("An alternate purification strategy yields highly pure DHFR" 1)
   ("pure DHFR" 1)))
 ("UP:P00386"
  (("nos" 135) ("Nos" 44) ("100 microscopic fields/total nos" 1)
   ("our previous study xref examined Case Nos" 1)))
 ("UP:P00387"
  (("Dia1" 20) ("DIA1" 12) ("cytochrome b5 reductase" 2) ("b5R" 1) ("CYB5R3" 1)
   ("-cytochrome b5 reductase" 1)))
 ("UP:P00390"
  (("glutathione reductase" 65) ("GSR" 31) ("Glutathione reductase" 4)
   ("glutathione reductase (GR)" 3) ("GluR" 2)
   ("glutathione reductase (GRD)" 2) ("glutathione reductase ( GSR )" 1)
   ("Gsr" 1)))
 ("UP:P00395"
  (("COI" 12) ("COX-I" 2) ("COXI" 2) ("cytochrome c oxidase subunit 1" 2)
   ("cytochrome c oxidase I" 1) ("Cox-I" 1) ("MTCO1" 1)))
 ("UP:P00403"
  (("CO2" 811) ("CoxII" 18) ("COX II" 16) ("COXII" 6) ("COII" 4)
   ("cytochrome c oxidase II" 4) ("-CoxII" 1) ("coxII" 1)))
 ("UP:P00414" (("CO3" 4) ("CoIII" 3) ("CoxIII" 1) ("COX3" 1)))
 ("UP:P00439"
  (("PAH" 505) ("PAHs" 100) ("IPAH" 48) ("HPAH" 7) ("experimental PAH" 5)
   ("idiopathic PAH" 4) ("idiopathic PAH (IPAH)" 3) ("PAH-" 2)
   ("Purely aromatic PAHs" 2) ("CH developed PAH" 2) ("severe PAH" 2)
   ("mild PAH" 2) ("mild early PAH" 2) ("Rat Experimental PAH" 2)
   ("nonfamilial PAH" 2) ("parent PAHs" 2) ("heritable PAH (PAH)" 2)
   ("idiopathic or heritable PAH" 1) ("PAH (HRPAH)" 1) ("a prominent PAH" 1)
   ("refractory idiopathic PAH" 1) ("sporadic (I) PAH" 1)
   ("possibly human PAH" 1) ("autosomal dominant heritable PAH (HPAH)" 1)
   ("pediatric PAH" 1)))
 ("UP:P00441"
  (("SOD" 338) ("SOD1" 251) ("hSOD1" 51) ("CuZnSOD" 34)
   ("superoxide dismutase 1" 33) ("SOD-1" 12) ("Sod1" 6)
   ("Superoxide dismutase 1" 3) ("superoxide dismutase-1" 3) ("normal SOD1" 2)
   ("soluble superoxide dismutase 1" 2) ("SOD1 protein" 2) ("renal SOD" 2)
   ("superoxide dismutase 1, soluble" 1)
   ("manganese (Mn) SOD, and copper/zinc (Cu/Zn) SOD" 1)
   ("the mitochondrial-targeted SOD" 1) ("exogenous SOD" 1)
   ("than SOD1 ( xref ; xref )" 1) ("pSOD" 1)))
 ("UP:P00450"
  (("CP" 1035) ("Cp" 262) ("CPs" 65) ("ceruloplasmin" 26) ("CP-s" 22) ("C/P" 9)
   ("pCPs" 8) ("Cp-" 6) ("ferroxidase" 4) ("the nascent CP" 4)
   ("Ceruloplasmin" 3) ("severe CP" 3) ("a 20S proteolytic CP" 2) ("cP" 2)
   ("a dozen clinical trials underway testing CP" 2) ("cp" 2) ("CP-" 2)
   ("pCP" 1) ("relatively small CPs" 1) ("a local CP" 1)
   ("than CP (p<0.001)" 1) ("Exponential CP" 1) ("poorly proliferative CPs" 1)
   ("the available CP" 1) ("both alcoholic and idiopathic CP" 1)
   ("than a dozen clinical trials underway testing CP 690,550" 1)
   ("unresectable and received CP" 1) ("the upper CP" 1)
   ("its cisplatin-resistant subline CP70" 1) ("most CP" 1)))
 ("UP:P00451"
  (("FVIII" 49) ("coagulation factor VIII" 5) ("hemophilia A" 5) ("AHF" 2)
   ("coagulation factor VIII (FVIII)" 2)))
 ("UP:P00480" (("OTC" 41) ("OTC peptide" 8) ("ornithine transcarbamylase" 7)))
 ("UP:P00488"
  (("F13A1" 21) ("coagulation factor XIII" 8) ("A1 polypeptide" 2)
   ("F13a1" 1)))
 ("UP:P00491" (("purine nucleoside phosphorylase" 5)))
 ("UP:P00492"
  (("HPRT" 307) ("HPRT1" 229) ("hypoxanthine phosphoribosyltransferase 1" 34)
   ("Hprt" 33) ("hypoxanthine-guanine phosphoribosyltransferase" 25)
   ("HGPRT" 18) ("hprt" 15) ("Hprt1" 14) ("T/D" 12)
   ("hypoxanthine-guanine phosphoribosyltransferase (HPRT)" 6)
   ("HGPRT protein" 4) ("hypoxanthine phosphoribosyltransferase 1 ( HPRT )" 3)
   ("Hypoxanthine-guanine phosphoribosyltransferase" 2)
   ("hypoxanthine phosphoribosyltransferase 1 (HPRT)" 1)
   ("hypoxanthine-guanine phosphoribosyltransferase ( HPRT )" 1)
   ("the internal housekeeping control genes hypoxanthine phosphoribosyltransferase 1 ( HPRT )"
    1)
   ("Hypoxanthine phosphoribosyltransferase 1" 1) ("Lesch–Nyhan syndrome" 1)))
 ("UP:P00505" (("GOT2" 12) ("fatty acid binding protein" 8) ("FABPpm" 2)))
 ("UP:P00509"
  (("aspartate aminotransferase" 50) ("aspartate aminotransferase (AST)" 9)
   ("AsPC" 8) ("AsPc" 3) ("AsPC-" 1)))
 ("UP:P00519"
  (("c-Abl" 761) ("ABL" 711) ("ABL1" 278) ("c-abl" 107) ("c-ABL" 76)
   ("Abl1" 32) ("c-Abl protein" 15) ("cAbl" 14) ("ABL protein" 9) ("cABL" 6)
   ("c-ABL protein" 4) ("C-abl" 4) ("ABL-1" 4) ("-c-Abl" 4) ("than ABL1" 2)
   ("C-ABL" 2) ("total and phosphorylated c-abl protein" 2) ("ABL-" 2)
   ("C-Abl" 1) ("ABL1-" 1) ("normal ABL" 1) ("–c-abl" 1) ("P00519" 1)
   ("the pro–apoptotic tyrosine kinase ABL1" 1)
   ("relatively little additional phosphorylated ABL" 1)
   ("the ubiquitous protein tyrosine kinase c-Abl" 1) ("Abl-1" 1)
   ("c-abl protein" 1) ("P-c-abl" 1) ("-ABL1" 1)))
 ("UP:P00521" (("vAbl" 1))) ("UP:P00522" (("DASH" 5)))
 ("UP:P00524" (("vSrc" 54)))
 ("UP:P00527" (("v-Yes" 2) ("the viral v-Yes protein" 1) ("v-Yes protein" 1)))
 ("UP:P00528" (("Src64B" 1))) ("UP:P00529" (("v-ros" 2)))
 ("UP:P00532" (("V-Raf" 3) ("v-Raf" 2) ("V-RAF" 1)))
 ("UP:P00533"
  (("EGFR" 80137) ("epidermal growth factor receptor" 2294) ("ErbB" 1790)
   ("EGF receptor" 1232) ("EGFRs" 756) ("HER1" 725) ("pEGFR" 675)
   ("epidermal growth factor receptor (EGFR)" 497) ("sEGFR" 466) ("erbB" 385)
   ("Epidermal growth factor receptor" 366) ("EGFr" 349) ("EGFR protein" 313)
   ("ErbB1" 289) ("ERBB" 288) ("Egfr" 242) ("erbB1" 232) ("EGF-R" 203)
   ("p-EGFR" 183) ("hEGFR" 152) ("Epidermal Growth Factor Receptor" 141)
   ("pErbB" 137) ("eGFR" 107) ("ErbB-1" 93) ("nEGFR" 76) ("ERBB1" 71)
   ("phospho-EGFR" 70) ("HER-1" 61) ("pERBB" 61) ("-hEGFR" 51)
   ("EGF receptor (EGFR)" 46) ("Erbb" 41)
   ("epidermal growth factor receptor ( EGFR )" 37)
   ("Epidermal Growth Factor Receptor (EGFR)" 33) ("overexpressed EGFR" 31)
   ("pHER1" 28) ("EGFR peptide" 27) ("IHC" 27) ("EGF Receptor" 26) ("EGFR-" 24)
   ("lz-EGFR" 21) ("P-EGFR" 21) ("targeting EGFR" 19)
   ("stress-induced EGFR" 19) ("EGFR molecule" 18)
   ("stress-internalized EGFR" 17)
   ("epidermal growth factor receptor (HER)" 15)
   ("Epidermal growth factor Receptor" 14) ("ErbB protein" 13)
   ("membranous EGFR" 13) ("Her-1" 12) ("than EGFR" 11) ("EGFR (WT)" 10)
   ("targeted EGFR" 8) ("total cellular EGFR" 8) ("most EGFR" 8) ("Erb-B" 8)
   ("EGFR-ErbB" 8) ("urinary EGFR" 8) ("Urinary EGFR" 8) ("EGFR ( CA )" 8)
   ("pEGFR−" 8) ("Epidermal growth factor receptor (EGFR)" 7)
   ("the normally-expressed EGFR" 7)
   ("epidermal growth factor receptor protein" 6) ("phosphorylated-EGFR" 6)
   ("-pEGFR" 6) ("functional EGFR" 5) ("erbB-1" 5) ("normal EGFR" 5)
   ("EGFR-ERBB" 5) ("intact EGFR" 5) ("ErbB1 (EGFR)" 5) ("ERbB" 5)
   ("the membranous EGFR" 5) ("endocytic EGFR" 5) ("EGF receptor protein" 5)
   ("NSCLC-associated mutant EGFRs" 5) ("HER1 (EGFR)" 4) ("more EGFR" 4)
   ("Overexpressed EGFR" 4) ("monomeric EGFR" 4) ("hyperactive EGFR" 4)
   ("monomeric sEGFR" 4) ("intact hEGFR" 4) ("-EGF receptor" 4)
   ("total and phosphorylated EGFR" 4) ("EGFR–erbB" 4) ("EGFrs" 4)
   ("less EGFR protein" 4) ("erbB protein" 3) ("-EGFR" 3)
   ("commercial recombinant epidermal growth factor receptor" 3)
   ("employed sEGFR" 3) ("dimeric sEGFR" 3) ("soluble urinary EGFR" 3)
   ("traffic ligand-stimulated EGFR" 3) ("the cellular EGFR" 3)
   ("surface-biotinylated EGFR" 3) ("Somatic EGFR" 3) ("apical EGFR" 3)
   ("phEGFR" 3) ("overexpressed wild-type EGFR" 3) ("pEGFR protein" 3)
   ("P00533" 3) ("Interestingly AP1B resistant EGFR" 3)
   ("Apically-localized EGFR" 3) ("a signaling competent EGFR" 2)
   ("EGF receptor (DER)" 2) ("TGFα induced more robust EGFR" 2)
   ("only 58.4% (90 out of 154) HNSCCs expressed phosphorylated EGFR" 2)
   ("dominant-negative EGFR" 2) ("previously reported EGFR" 2)
   ("Epidermal growth factor-receptor" 2) ("almost all EGFR" 2)
   ("epithelial epidermal growth factor receptor (EGFR)" 2)
   ("down much more EGFR" 2) ("EGFR (TD)" 2)
   ("total and phosphorylated mutant EGFR" 2) ("mouse monoclonal EGFR" 2)
   ("epidermal growth factor receptor (EGFR) protein" 2)
   ("doxycycline-inducible bitransgenic EGFR" 2)
   ("the total and activated EGFR" 2) ("residual EGFR" 2)
   ("mutant K-Ras-dependent autocrine-activated EGFR" 2)
   ("than wild-type EGFR" 2)
   ("epidermal growth
factor receptor"
    2)
   ("an intense plasma-membrane EGFR" 2) ("phospho/total- EGFR" 2)
   ("monoclonal mouse anti-human EGFR" 2) ("than wild type EGFR" 2)
   ("EGFR ”" 2) ("sEGFR molecule" 2) ("pre-dimerized sEGFR" 2)
   ("dimeric and monomeric sEGFR" 2) ("a prospective EGFR" 2)
   ("suboptimal EGFR" 2) ("radiation-induced EGFR" 2) ("only EGFR L858R" 2)
   ("the kinase activity nearly full length mutant EGFR" 2)
   ("‘soluble' EGFR" 2) ("the total cellular EGFR" 2) ("Soluble EGFR" 2)
   ("A constitutively dimerized EGFR" 2) ("stromal EGFR" 2)
   ("Our institutional EGFR" 2) ("stress-stimulated EGFR" 2)
   ("stress-activated EGFR" 2) ("Stress-internalized EGFR" 2)
   ("progressive EGFR" 2) ("ErBb" 2) ("soluble EGFR" 2)
   ("a dominant-negative EGFR" 2) ("moderate and strong EGFR" 2)
   ("still significantly fewer EGFR" 2) ("very little EGFR" 2) ("EGFR (CA)" 2)
   ("strong membranous EGFR" 2) ("membranous EGFR protein" 2)
   ("the well-known traditional EGFR" 2)
   ("virtually no tyrosine phosphorylated EGFRs" 2)
   ("predominantly surface-localized EGFR" 2) ("predominantly punctate EGFR" 2)
   ("total and activated EGFR" 2) ("-ErbB" 2)
   ("internalization-defective EGFR" 2)
   ("stably expressed heterologous EGFR" 2) ("strong EGFR" 2)
   ("a secreted 60/80 kDa soluble EGFR protein" 2)
   ("Adenosquamous carcinomas usually harbour EGFR" 2)
   ("Epidermal Growth Factor Receptor (HER)" 2)
   ("histological apocrine features expressed EGFR" 2) ("a strong EGFR" 2)
   ("representative EGFR" 2) ("EGF bound dimerized EGFR" 2)
   ("dimerized EGFR" 2) ("our previous EGFR" 2)
   ("gefitinib or erlotinib showed negative EGFR" 2)
   ("the most frequent EGFR" 2) ("HER1-" 2)
   ("this harsh treatment stripped EGFR" 2) ("EGFR (TDL)" 2)
   ("near-full length EGFR" 2) ("strong nEGFR" 2) ("strong nuclear EGFR" 2)
   ("selectively target EGFR" 2) ("the dimerized EGF receptor" 2)
   ("continuous membranous EGFR" 2) ("∼20% more intracellular EGFR" 2)
   ("the predominant activating EGFR" 2)
   ("relatively less intrinsic EGFR protein" 2)
   ("soluble epidermal growth factor receptor" 2)
   ("the soluble epidermal growth factor receptor" 2) ("proper EGFR" 2)
   ("late endosomal EGFR" 2) ("proper postendocytic EGFR" 2)
   ("cellular EGFR" 2) ("the major EGFR" 2)
   ("the same way as well-characterized EGFR" 2) ("a homogeneous EGFR" 2)
   ("abnormal EGFR" 2) ("overexpressed human EGFRs" 2)
   ("In contrast biotinylated EGFR" 2) ("basolateral EGFR" 2)
   ("phospho-EGFR protein" 2) ("P-epidermal growth factor receptor" 2)
   ("pEGFR peptide" 2) ("EGF receptor-" 2) ("nEGFR protein" 2)
   ("10 times more EGFR" 1) ("kinase-defective EGFR" 1)
   ("six-fold more EGFR" 1) ("membranous wild-type EGFR" 1)
   ("than the EGFR ( xref ; xref )" 1) ("EGFR–" 1)
   ("the first 4 amino acids of mature sEGFR (LEEK)" 1)
   ("mature sEGFR (LEEK)" 1) ("two arginines of EGFR (R403 and 405)" 1)
   ("targeted Epidermal Growth Factor Receptor (EGFR)" 1)
   ("conversely, EGFR" 1) ("associated EGFR" 1) ("than the EGFR" 1)
   ("previously overexpressed EGFR" 1) ("functional EGFRs" 1)
   ("fluorescein isothiocyanate-conjugated rat monoclonal EGFR" 1)
   ("the residual total and activated EGFR" 1)
   ("the residual cell surface-associated activated EGFR" 1)
   ("CXCR2 positive cells transactivated more EGFR" 1) ("EGFR–ERBB" 1)
   ("than other single/dual erbB targeting agents" 1)
   ("multiple non-EGFR preferential erbB" 1) ("perbB" 1) ("the major erbB" 1)
   ("subsequent EGFR" 1) ("adaptor-bound EGFR" 1)
   ("physically
link phosphorylated
EGFR"
    1)
   ("dimeric EGFR" 1) ("tetrameric EGFR" 1) ("the internal EGFR" 1)
   ("than the ubiquitous EGFR" 1) ("the ubiquitous EGFR" 1) ("chimeric EGFR" 1)
   ("expressing high levels phosphorylated-EGFR" 1)
   ("undetectable ERBB1 (EGFR)" 1) ("ERBB1 (EGFR)" 1) ("HER1 protein" 1)
   ("Strong phospho-EGFR" 1) ("Erbb1" 1) ("dense EGFR" 1) ("‘EGFR’" 1)
   ("than the wild-type (WT) EGFR protein" 1)
   ("anaplastic thyroid cancers EGFR" 1) ("than EGFR in glioblastoma" 1)
   ("EGF-R (GGTCATACCCAGGAAAGCAA)" 1) ("the respective EGFR" 1)
   ("than EGFR-L858R" 1) ("we first co-expressed EGFR" 1) ("”" 1)
   ("than EGFR ( xref , xref )" 1) ("far less EGFR" 1)
   ("an order of magnitude less EGFR" 1) ("an order of magnitude more EGFR" 1)
   ("cell surface-associated EGFR" 1) ("than wild-type sEGFR" 1)
   ("than monomeric sEGFR" 1) ("intact detergent-soluble EGFR" 1) ("ErbB-" 1)
   ("Re-expressed EGFR-WT" 1) ("alternate short EGFR" 1)
   ("than WT EGFR ( xref )" 1) ("than WT EGFR" 1)
   ("than WT EGFR in unstimulated cells" 1) ("elevated urinary EGFR" 1)
   ("targeted-treated EGFR" 1)
   ("the Spectrum Orange locus-specific identifier EGFR" 1)
   ("sHB-EGF-stimulated retrograde EGFR" 1)
   ("secondary EGFR point mutations" 1) ("some stress-internalized EGFR" 1)
   ("perinuclear EGFR" 1) ("than EGFR that render cells" 1)
   ("both the membranous EGFR" 1) ("-ERBB" 1)
   ("un-ubiquitylated recyclable EGFRs" 1) ("internal EGFR" 1)
   ("total and activated (phosphorylated) EGFR" 1) ("plasma membranous EGFR" 1)
   ("flag-tagged EGFR" 1) ("both EGFR's" 1)
   ("Secondary EGFR T790M point mutations" 1)
   ("BRCA1 mutation carriers showed strong EGFR" 1) ("eGFRs" 1)
   ("2.7-fold more EGFR" 1) ("particular EGFRs" 1)
   ("expressing mutant EGFRs" 1) ("EGFR 211551_at aberrant EGFR" 1)
   ("natural EGFR" 1) ("new EGFR" 1) ("relatively few free EGFR" 1)
   ("fewer EGFR" 1) ("fewer total EGFR" 1) ("clear EGFR" 1)
   ("the transmembrane EGF receptor" 1) ("Longer EGFR ( CA )" 1)
   ("a possible ancestral EGF receptor" 1)
   ("essentially all surface-biotinylated EGFR" 1) ("aberrant EGF receptor" 1)
   ("expressing endogenous EGFR" 1) ("nearby EGFRs" 1)
   ("DEP-1 tightly controls EGFR’s" 1) ("DEP-1 tightly controls EGFR" 1)
   ("further determined activated full-length EGFR" 1) ("differential EGFR" 1)
   ("H1650, HCC827 and HCC4006 showed much more mutant EGFR" 1)
   ("mutationally-activated EGFRs" 1) ("most prominent EGFR" 1)
   ("the cellular epidermal growth factor receptor (EGFR)" 1)
   ("than EGFR in prostate cancer tissues" 1) ("In contrast human EGFR" 1)
   ("radiolabeled apical EGFRs" 1) ("the dimerized EGFR" 1)
   ("the three distal Lys of EGFR" 1) ("metastatic EGFR" 1)
   ("more sEGFR protein" 1) ("sEGFR protein" 1)
   ("the transformed composite EGFR" 1) ("potential EGFR" 1)
   ("particularly EGFR -216G>T" 1) ("only EGFR -216G>T" 1)
   ("a nuclear localization sequence-tagged EGFR" 1)
   ("Ara-C-treated CNP -hEGFR" 1) ("than IHC" 1) ("any associated EGFR" 1)
   ("current E+P users EGFR's" 1) ("the human wild- type EGFR" 1)
   ("Membrane-associated EGFR" 1) ("an irreversible HER1" 1)
   ("than erbB1 in this model system" 1) ("overexpressing EGFR" 1)
   ("Arg-1175-methylated EGFR" 1) ("than 7x10 5 HER1" 1)
   ("approximately 2x10 5 HER1" 1) ("\"HER1\"" 1) ("the heteromeric EGFR" 1)
   ("ZD" 1)
   ("epidermal
                growth factor receptor"
    1)
   ("approximately 200 000 EGFR" 1) ("80% specificity EGFR’s" 1)
   ("ox-stress-activated EGFR" 1) ("the hetero-dimer EGFR-ErbB2" 1)
   ("the ox-stress-activated EGFR" 1)
   ("nearly full-length epidermal growth factor receptor (EGFR)" 1)
   ("VHL-expressing cells stabilized activated EGFR" 1)
   ("the already more stable EGFR" 1) ("no new EGFR" 1)
   ("the symmetric EGFR-WT" 1) ("alternative EGFR" 1) ("intact erbB1’s" 1)
   ("intact erbB1" 1) ("both total and phosphorylated EGFR" 1)
   ("Tyrosine kinase inhibitors (TKI) gefitinib and erlotinib effectively target EGFR"
    1)
   ("a typical EGFR" 1) ("the actual EGFR" 1) ("than ubiquitinated EGFR" 1)
   ("the singly-occupied Drosophila EGF receptor" 1) ("4 or more EGFR" 1)
   ("a Spectrum Orange-labeled EGFR" 1) ("Mitochondrial-localized EGFR" 1)
   ("exogenous EGFR" 1) ("the dual epidermal growth factor receptor (EGFR)" 1)
   ("than EGFR under serum starved condition" 1) ("More EGFR" 1)
   ("less EGFR" 1) ("the tumor-associated overexpressed EGFR" 1)
   ("than EGFR that mediate drug response need to be identified" 1)
   ("than EGFR [ xref , xref ]" 1)
   ("Epidermal Growth Factor Receptor ( EGFR )" 1) ("lack functional EGFR" 1)
   ("than EGFR that encode components" 1) ("uncommon EGFR" 1)
   ("the heterodimerized EGFR" 1) ("EGFR, IL-6R," 1) ("the apical EGFR" 1)
   ("EGF induced endocytic EGFR" 1) ("ErBb1" 1)
   ("conversely AP1B-defective EGFRs" 1) ("a concurrent EGFR -T790M" 1)
   ("a more frequent EGFR" 1) ("anionic POPS lipids around EGFR" 1)
   ("concurrent EGFR" 1) ("a functional EGFR" 1) ("than the EGFR-WT" 1)
   ("These constructs efficiently knocked-down EGFR" 1)
   ("epidermal growth factor receptor ( EGFR ) protein" 1)))
 ("UP:P00534" (("v-ErbB" 5) ("v-Erb-B" 1) ("vErbB" 1)))
 ("UP:P00540"
  (("mOS" 97) ("MOs" 21) ("mos" 12) ("Mos" 10) ("longer mOS" 5)
   ("combinatorial splice-blocking MOs" 1)))
 ("UP:P00541" (("v-Fps" 1))) ("UP:P00545" (("v-fms" 1)))
 ("UP:P00546" (("cdc28" 28) ("Cdc28" 20)))
 ("UP:P00558"
  (("PGK1" 203) ("phosphoglycerate kinase 1" 15) ("MIG-10" 8)
   ("Phosphoglycerate kinase 1" 4) ("Pgk1" 3) ("MIG10" 1)))
 ("UP:P00588" (("diphtheria toxin" 28) ("Diphtheria toxin" 5)))
 ("UP:P00599" (("dei" 28) ("DEI" 7) ("Dei" 2))) ("UP:P00632" (("CATD" 1)))
 ("UP:P00635" (("PHO5" 8)))
 ("UP:P00644" (("staphylococcal nuclease" 2) ("Staphylococcal nuclease" 1)))
 ("UP:P00709" (("alpha-" 303) ("Alpha-" 27) ("lactalbumin" 6) ("alpha–" 1)))
 ("UP:P00734"
  (("F 2" 67) ("prothrombin" 42) ("Prothrombin" 7) ("coagulation factor II" 5)
   ("F  2" 3)))
 ("UP:P00736" (("complement C1r" 3) ("C1R" 2)))
 ("UP:P00738"
  (("HP" 595) ("Hp" 161) ("haptoglobin" 16) ("HP-" 8) ("microvesicular HP" 7)
   ("Zonulin" 3) ("a conventional microvesicular HP" 2) ("chronic HP" 1)))
 ("UP:P00739" (("HPr" 282) ("HPR" 24)))
 ("UP:P00740" (("fix" 79) ("Fix" 47) ("FIX" 8) ("hemophilia B" 2) ("‘fix’" 1)))
 ("UP:P00742" (("F10" 158) ("FXa" 9) ("fXa" 3) ("FxA" 3) ("f10" 1)))
 ("UP:P00746"
  (("DF" 119) ("df" 103) ("D–F" 69) ("Df" 24) ("D-F" 23) ("CFD" 5) ("dsF" 5)
   ("-DF" 4) ("DFs" 3) ("the outpatient DF" 2) ("ADN" 1) ("adipsin" 1)
   ("df-" 1) ("probable DF" 1) ("outpatient DF" 1)))
 ("UP:P00747"
  (("plasminogen" 351) ("Plasminogen" 31) ("angiostatin" 12)
   ("activation peptide" 12) ("PLG" 8) ("cell-associated plasminogen" 2)
   ("the fibrinolytic proenzyme plasminogen" 1)))
 ("UP:P00748"
  (("F12" 1220) ("-F12" 12) ("the mammary epithelial growth medium DMEM-F12" 3)
   ("modified essential medium/Ham F12" 3) ("coagulation factor XII" 3)
   ("F12 (GIBCO)" 3) ("–F12" 3) ("pf12" 1) ("modified essential medium/ F12" 1)
   ("syncytium showed nuclear-specific F12" 1) ("F12 (PAA)" 1)))
 ("UP:P00749"
  (("uPA" 2182) ("plasmin" 343) ("u-PA" 173) ("urokinase" 168) ("PLAU" 120)
   ("urokinase-type plasminogen activator" 116) ("Plasmin" 19) ("uPA-" 18)
   ("uPA protein" 14) ("Urokinase" 13) ("urokinase type" 12) ("UPA" 11)
   ("Urokinase-type plasminogen activator" 10) ("–uPA" 3)
   ("uPAR-associated uPA" 3) ("uPa" 3) ("u-PA protein" 3)
   ("plasminogen activator, urokinase" 3) ("cell-associated uPA" 2)
   ("total cellular uPA" 2) ("exogenous uPA" 2) ("the proteolytic uPA" 2)
   ("binding uPAR-associated two-chain uPA" 1) ("local plasmin" 1)
   ("urokinase (UPA)" 1) ("endothelial u-PA" 1) ("basal u-PA" 1)
   ("than uPA ( xref )" 1) ("cell-surface-bound uPA" 1)
   ("the blood-derived protease plasmin" 1) ("than uPA" 1)
   ("urokinase (PLAU)" 1) ("Urokinase type" 1)
   ("than plasmin that cleave CDCP1 in vivo" 1)))
 ("UP:P00750"
  (("TPA" 1113) ("plasminogen activator" 370) ("tPA" 212) ("t-PA" 206)
   ("PLAT" 94) ("tissue-type plasminogen activator" 50)
   ("Plasminogen activator" 30) ("pLAT" 5) ("plasminogen activator ( PLAT )" 4)
   ("p-LATS" 3) ("plasminogen activator (uPA) protein" 3) ("Plat" 3)
   ("log-transformed tPA" 2) ("Tissue-type plasminogen activator" 2)
   ("the primary plasminogen activator" 2)
   ("plasminogen activator, tissue type" 2) ("exogenous tPA" 1)
   ("tPA protein" 1) ("the urinary plasminogen activator" 1)
   ("than TPA (Figure xref )" 1)
   ("plasminogen activator, tissue type (PLAT)" 1) ("Patients given TPA" 1)
   ("tPa" 1)))
 ("UP:P00751"
  (("BF" 114) ("B-factor" 29) ("CFB" 17) ("Bf" 15) ("bf" 3)
   ("Complement factor B" 1) ("b-factor" 1) ("GBG" 1) ("-Bf" 1)
   ("individual restrained isotropic B-factor" 1)))
 ("UP:P00758" (("RK1" 1))) ("UP:P00759" (("Tonin" 3) ("tonin" 1)))
 ("UP:P00779" (("SKC" 6))) ("UP:P00784" (("papain" 73) ("Papain" 3)))
 ("UP:P00796" (("Ren2" 3)))
 ("UP:P00797"
  (("REN" 143) ("renin" 80) ("Ren" 37) ("Renin" 3) ("rennin" 2)
   ("juxtaglomerular renin" 1) ("RENIN" 1) ("than the epithelioid REN" 1)))
 ("UP:P00808" (("BLAP" 13)))
 ("UP:P00813"
  (("ADA" 186) ("Ada" 12) ("ada" 5) ("ada protein" 4)
   ("two macrophage tropic strains (M-tropic) HIV-1 ADA" 2)
   ("non-treated HIV-1 ADA" 1) ("The R5 tropic virus HIV-1 ADA" 1)))
 ("UP:P00814" (("CD-" 147) ("Cd-" 23) ("CD–" 4) ("cd-" 1)))
 ("UP:P00816" (("CNT" 13))) ("UP:P00830" (("atp2" 2)))
 ("UP:P00842" (("OLI" 19)))
 ("UP:P00846"
  (("RPs" 337) ("RPS" 31) ("protein 6" 29) ("rpS" 18) ("RpS" 14) ("Rps" 8)
   ("rps" 3) ("ATP synthase 6" 3) ("Protein 6" 3) ("ATP6" 2)
   ("proximal Wnt signaling components low density lipoprotein receptor-related protein 6"
    2)
   ("protein 6 ( DAXX )" 2) ("Protein 6 (DAXX)" 2) ("than the other RPs" 1)
   ("so many different RPs" 1) ("the aforementioned RPs" 1)
   ("mammalian cells need so many RPs" 1) ("more RPs" 1) ("protein 6 (DAXX)" 1)
   ("ATPase6" 1) ("cells need so many RPs" 1)))
 ("UP:P00864" (("glu" 96) ("GLU" 50) ("pPC" 18) ("glu-" 4)))
 ("UP:P00879" (("RBC" 296) ("external RBC" 1) ("mature RBC" 1)))
 ("UP:P00915"
  (("CA1" 232) ("CAB" 18) (NIL 17) ("CAI" 9) ("hippocampal area CA1" 8)
   ("Cai" 3) ("CA1-" 3) ("cAb" 1) ("hippocampal region CA1" 1)
   ("the hippocampal CA1" 1)))
 ("UP:P00918"
  (("CA2" 32) ("Ca2" 13) ("CAII" 6) ("carbonic anhydrase II" 5)
   ("carbonic anhydrase 2" 2) ("Carbonic anhydrase II" 1)))
 ("UP:P00956" (("ILVs" 84) ("fewer ILVs" 1)))
 ("UP:P00966"
  (("ASS" 15) ("ASs" 10) ("argininosuccinate synthetase" 5) ("ASS1" 4)
   ("radiation-induced ASs" 1) ("than ASs (Guo et al., xref )" 1)
   ("Twenty-two primary and secondary ASs" 1) ("Most secondary ASs" 1)))
 ("UP:P00973"
  (("OAS1" 66) ("-OAS1" 6) ("2'-5'-oligoadenylate synthetase 1" 4) ("oas1" 3)))
 ("UP:P00974" (("aprotinin" 1938) ("Aprotinin" 96) ("BPTI" 1)))
 ("UP:P00995"
  (("SPINK1" 106) ("PstI" 80) ("TATI" 51) ("TATI−" 8) ("SPINK1 protein" 6)
   ("SPINK 1" 2) ("Mitochondrial-targeted PstI" 2) ("heterogeneous SPINK1" 2)
   ("PSTI" 1) ("pancreatic secretory trypsin inhibitor" 1)
   ("tumor-associated trypsinogen inhibitor TATI" 1) ("SPINK1-" 1)
   ("serine peptidase inhibitor, Kazal type 1" 1)))
 ("UP:P01007" (("PSN" 26)))
 ("UP:P01008"
  (("AT3" 29) ("SERPINC1" 22) ("antithrombin III" 4) ("antithrombin-III" 3)
   ("Serpinc1" 2) ("Antithrombin-III" 2)))
 ("UP:P01009"
  (("PI" 6026) ("PI-" 26) ("pI" 26) ("SERPINA1" 17) ("-PI" 10)
   ("alpha-1-antitrypsin" 10) ("α1-antitrypsin" 8) ("PI−" 5) ("hypotonic PI" 4)
   ("P-PI" 4) ("PI (DIABLO)" 4) ("Experimental pI" 4) ("the experimental pI" 3)
   ("α1-AT" 3) ("The experimental pI" 2) ("the actual pI" 2)
   ("theoretical pI" 2) ("PI peptide" 2) ("acute PI" 2)
   ("the membrane impermeable PI" 1) ("Serpina1" 1) ("disparate PI" 1)
   ("alpha1-antitrypsin" 1) ("serpinA1" 1) ("than the PI" 1)
   ("its theoretical pI" 1) ("a theoretical pI" 1)
   ("than PI(3,4) in quiescent cells" 1) ("the centrosomal PI" 1)
   ("There are currently several cell-based PI" 1) ("a distinct PI" 1)))
 ("UP:P01011"
  (("ACT" 553) ("SERPINA3" 32) ("serpin peptidase inhibitor" 9) ("AACT" 7)
   ("pACT" 6) ("Serpina3" 6) ("antitrypsin)" 4) ("alpha-1-antichymotrypsin" 3)
   ("Serpin peptidase inhibitor" 2) ("clade A (alpha-1 antiproteinase" 2)
   ("α1-antichymotrypsin" 1) ("α1–antichymotrypsin" 1)))
 ("UP:P01012"
  (("ovalbumin" 115) ("Ovalbumin" 8) ("ovalbumin peptide" 3)
   ("ovalbumin (OVA)" 2) ("soluble ovalbumin" 2)
   ("H-2 Kb-restricted ovalbumin (OVA) (257–264) (SIINFEKL) peptide" 1)
   ("ovalbumin (OVA) (257–264) (SIINFEKL) peptide" 1) ("Ovalbumin (OVA)" 1)
   ("–ovalbumin" 1)))
 ("UP:P01019"
  (("AngII" 514) ("Ang II" 321) ("angiotensin II" 285) ("Angiotensin II" 65)
   ("angiotensinogen" 23) ("AGTs" 18) ("angiotensin-II" 10) ("angiotensin I" 9)
   ("-Ang II" 7) ("Angiotensin I" 6) ("Angiotensinogen" 5)
   ("-angiotensin II" 4) ("angiotensinogen (AGT)" 3) ("angiotensin III" 3)
   ("Angiotensin-II" 3) ("angiotensin II (AGII)" 2)
   ("selectively decreased representative white genes Angiotensinogen" 2)
   ("AngII-" 1) ("renal interstitial and tubular fluid AngII" 1)
   ("angiotensin IV" 1)
   ("the angiotensinogen (AGT), ACE, t-PA and PAI-1 genes" 1)
   ("angiotensin II–" 1) ("angII" 1) ("angiotensin 1" 1)))
 ("UP:P01023"
  (("α2-macroglobulin" 23) ("α2M" 13) ("A2M" 6) ("alpha2-macroglobulin" 5)
   ("alpha-2-macroglobulin" 4)))
 ("UP:P01024"
  (("asp" 27) ("complement C3" 23) ("C3a" 8) ("Complement C3" 4)
   ("Complement component 3" 2) ("complement component 3" 2) ("C3a-" 1)
   ("ASp" 1)))
 ("UP:P01031" (("C5a" 160) ("C5b" 84) ("complement C5" 1)))
 ("UP:P01033"
  (("TIMP-1" 556) ("EPA" 248) ("TIMP1" 173) ("TIMPs" 144) ("TIMP" 121)
   ("TIMP-1 protein" 28) ("tissue inhibitor of metalloproteinases" 23)
   ("metalloproteinase inhibitor 1" 11)
   ("tissue inhibitor of metalloproteinases 1" 5) ("P01033" 4) ("Timp1" 3)
   ("-EPA" 2) ("tissue inhibitor of metalloproteinases (TIMP)" 2)
   ("tissue inhibitor of metalloproteinases-1" 2) ("than EPA" 1)
   ("their associated TIMPs" 1) ("TIMP metallopeptidase inhibitor 1" 1)
   ("TIMP1 protein" 1) ("than EPA ( xref , xref )" 1)
   ("multifunctional TIMP-1" 1) ("Tissue Inhibitor of Metalloproteinases-1" 1)
   ("Tissue inhibitor of metalloproteinases" 1)))
 ("UP:P01034" (("Cystatin C" 7) ("cystatin C" 2)))
 ("UP:P01036" (("cystatin family" 3))) ("UP:P01040" (("AREI" 15) ("STF1" 2)))
 ("UP:P01042"
  (("bradykinin" 129) ("Bradykinin" 17) ("KNG1" 9) ("kininogen" 7) ("Kng1" 6)
   ("high molecular weight kininogen" 4) ("kallidin" 3)
   ("high molecular weight kininogen (HK)" 3) ("Hmwk" 2) ("kininogen 1" 1)))
 ("UP:P01060" (("BBI" 4))) ("UP:P01065" (("VAI" 2))) ("UP:P01068" (("B-i" 2)))
 ("UP:P01087" (("RBI" 4))) ("UP:P01097" (("INH1" 13)))
 ("UP:P01100"
  (("c-Fos" 2093) ("c-fos" 776) ("FOS" 636) ("cFos" 186) ("c-FOS" 98)
   ("c-Fos protein" 38) ("cFOS" 30) ("CFOS" 11) ("cfos" 9) ("C-FOS" 7)
   ("ER-associated c-Fos" 4) ("normal c-fos" 4) ("c-Fos (FOS)" 4) ("C-fos" 3)
   ("C-Fos" 3) ("the immediate-early genes c-fos" 2)
   ("ERNF-associated c-Fos-wt" 2) ("c-Fos peptide" 2) ("Foss" 2)
   ("c-fos protein" 2) ("cFos protein" 2) ("pc-fos" 1)
   ("The immediate-early gene c-fos" 1) ("G0S7" 1)
   ("both total and phosphorylated CFOS" 1) ("Total and phosphorylated CFOS" 1)
   ("the C-terminal 21 amino acids of c-Fos" 1) ("than wild-type c-Fos" 1)
   ("FOS
protein"
    1)
   ("GST-lamin A–bound c-Fos" 1) ("ERNF-associated c-Fos" 1) ("than c-Fos" 1)
   ("both HPV-positive and HPV-negative tumors cFos" 1)
   ("an augmented colorectal distension-induced elevated c-fos" 1)
   ("basic c-Fos" 1) ("c-Fo" 1) ("c-Fos-" 1)))
 ("UP:P01104"
  (("v-Myb" 28) ("v-myb" 5) ("v-Myb protein" 4) ("V-MYB" 1) ("V-myb" 1)
   ("than v-Myb" 1)))
 ("UP:P01106"
  (("MYC" 12059) ("Myc" 10078) ("c-Myc" 9913) ("c-MYC" 3578) ("myc" 2850)
   ("c-myc" 2318) ("C-MYC" 841) ("cMyc" 288) ("c-Myc protein" 207) ("cMYC" 204)
   ("C-Myc" 102) ("C-myc" 74) ("-Myc" 73) ("c-MYC protein" 55) ("-myc" 53)
   ("-MYC" 48) ("CMYC" 46) ("–c-Myc" 41) ("Myc-" 39) ("MYC-" 39) ("myc-" 29)
   ("-c-Myc" 19) ("p-c-Myc" 16) ("c-Myc-" 14) ("cmyc" 14)
   ("overexpressed c-Myc" 13) ("Myc peptide" 13) ("MycS" 12)
   ("nucleolar c-Myc" 9) ("c-myc protein" 9) ("overexpressed Myc" 9)
   ("c-Myc Protein" 8) ("exogenous Myc" 8)
   ("v-myc avian myelocytomatosis viral oncogene homolog" 7) ("Myc–" 5)
   ("pMYC" 5) ("exogenous c-Myc" 5) ("targeting MYC" 4) ("than MYC" 4)
   ("overexpressed c-myc" 4) ("C-MYC protein" 4) ("targeting Myc" 4) ("pMyc" 4)
   ("P-c-Myc" 4) ("myc peptide" 4) ("c-myc-" 3) ("acetylated-c-MYC protein" 3)
   ("exogenous c-MYC" 3) ("c-Myc ( MYC )" 3) ("MYCs" 3)
   ("dominant-negative MYC" 3) ("mouse monoclonal myc" 3)
   ("coexpressed ectopic c-Myc" 3) ("transcriptional factor c-Myc" 3)
   ("mouse monoclonal c-myc" 3) ("Myc (wtMyc) protein" 3) ("cMYC protein" 3)
   ("c-myc molecule" 2) ("MYC proto-oncogene protein" 2)
   ("c-Myc
 protein"
    2)
   ("mycS" 2) ("parental CD2- MYC" 2)
   ("Gleason pattern 4 lesions showed less MYC" 2) ("than Myc" 2)
   ("we first silenced c-Myc" 2) ("targeting c-Myc" 2) ("“Myc”" 2)
   ("exogenous total C-MYC" 2)
   ("the P493-6 human B cell line expressing c-Myc" 2)
   ("c-Myc
protein"
    2)
   ("overexpressed MYC" 2) ("its transcriptional target Myc" 2) ("-c-MYC" 2)
   ("we first depleted MYC" 2) ("a lentiviral MYC" 2)
   ("Interestingly Myc V394D" 2) ("positive epithelial MYC" 2)
   ("positive stromal MYC" 2) ("heavily overexpressed Myc" 2)
   ("reliable c-Myc" 2) ("than WT c-Myc" 2)
   ("The monoclonal antibodies mouse anti- myc" 2) ("around MYC" 2)
   ("miR-145 directly targets c-Myc" 2) ("targeting c-myc" 2)
   ("the similarly sized MycS protein" 2) ("MycS protein" 2)
   ("so cytoplasmic c-myc" 2) ("mitogenic c-myc" 2) ("cellular MYC" 2)
   ("MYC ( MYC )" 2) ("targeted c-Myc" 2) ("mature acini overexpressing Myc" 2)
   ("ectopically expressed functional c-Myc" 2)
   ("Specific 14q32 miRNAs cooperatively target cMYC" 2) ("coexpressed MYC" 2)
   ("anti rat monoclonal c-Myc" 2) ("MYC peptide (EQKLISEEDL)" 2)
   ("therapeutically target Myc" 2) ("-Myc peptide" 2) ("abnormal MYC" 2)
   ("discrete MYC" 2) ("a triple myc" 1) ("c–Myc" 1) ("that c-Myc ’s" 1)
   ("the ProFound c-Myc" 1) ("the critical transcriptional factor c-Myc" 1)
   ("-c-myc" 1) ("polysomic or disomic c-myc" 1) ("double fluorescent c-myc" 1)
   ("a dual color MYC" 1) ("alternative MYC" 1) ("c-Myc (KD)" 1)
   ("the pleiotropic oncogene c-Myc" 1) ("c-myc–" 1)
   ("slightly increases c-Myc" 1) ("this in turn releases c-Myc" 1)
   ("the proliferative MYC" 1) ("“Lo-MYC”" 1) ("exogenous MYC" 1)
   ("Many additional potential MYC" 1) ("c-MYC (MYC)" 1)
   ("gene desert around MYC" 1) ("its transcriptional repressor MYC" 1)
   ("directly target C-Myc" 1) ("c myc" 1) ("than those expressing WT MYC" 1)
   ("than WT MYC" 1) ("lymph node positive and overexpressed c-Myc" 1)
   ("essentially no MYC" 1) ("C-MYC-" 1) ("bona fide C-MYC" 1)
   ("Skp2 not only targets c-Myc" 1)
   ("the unique and irreplaceable role Myc" 1) ("for example all Myc" 1)
   ("than Myc even in tumors" 1) ("suprahysiological Myc" 1)
   ("encompassed MYC" 1) ("MYC (EV)" 1) ("we first examined c-MYC" 1)
   ("many bona fide c-Myc" 1) ("miR-130a directly targets c-Myc" 1)
   ("6 or more c-MYC" 1) ("than four c-MYC" 1) ("‘Myc’" 1)
   ("elevated cellular c-MYC" 1)
   ("a subsequent transcriptome analysis
+/- Myc"
    1)
   ("far
more Myc"
    1)
   ("a subsequent transcriptome analysis +/- Myc" 1) ("far more Myc" 1)
   ("The ectopically overexpressed c-Myc" 1)
   ("even ectopically expressed c-Myc" 1) ("than endogenous MYC" 1)
   ("Given c-MYC’s" 1) ("Given c-MYC" 1) ("monomeric Myc" 1)
   ("directly target Myc" 1) ("c MYC" 1) ("Proto-oncogene c-MYC" 1)
   ("the inhibitor specifically targets MYC" 1) ("three or more MYC" 1)
   ("epithelial MYC" 1) ("stromal MYC" 1) ("the normal and oncogenic MYC" 1)
   ("an N-terminal triple MYC" 1) ("triple MYC" 1)
   ("transcriptional factors c-Myc" 1) ("than c-MYC" 1) ("than c-Myc" 1)
   ("c-Myc (EQKLISEEDL)" 1) ("Exogenous Myc" 1)
   ("The transformed SIRT3 −/− Myc" 1) ("than overexpressed Myc ( xref )" 1)
   ("promiscuous c-MYC" 1) ("splenic Eμ- Myc" 1)
   ("the well-characterized model Eμ- myc" 1) ("shorter c-Myc protein" 1)
   ("full-length Myc’s" 1) ("highly conserved regions termed Myc" 1)
   ("target increased MYC" 1) ("distal 8q included MYC" 1)
   ("simultaneous high MYC" 1) ("than either high MYC" 1)
   ("total and exogenous c-MYC" 1) ("the last amino acid of c-Myc" 1)
   ("The Thr58/Ser62 dual phosphorylated Myc" 1) ("the Profound c-myc" 1)
   ("than endogenous Myc in 2D cell" 1)
   ("both constitutively overexpressed Myc" 1)
   ("retrovirally transduced exogenous Myc" 1) ("exogenous cMYC" 1)
   ("The WT c-Myc protein’s" 1) ("similarly reduced c-Myc protein" 1)
   ("c-Myc (TGR)" 1) ("more c-myc" 1) ("functional c-Myc" 1)
   ("ectopically-expressed MYC" 1) ("linking MYC" 1)
   ("V-myc avian myelocytomatosis viral oncogene homolog" 1)
   ("exogenous c-myc" 1) ("Transiently-expressed wild-type Myc-" 1)
   ("exogenous and endogenous c-Myc" 1) ("less myc" 1)
   ("its transcriptional target c-Myc" 1)
   ("miR-33b specifically targets MYC" 1)
   ("-negative RPMI-8226 cell line increased c-MYC" 1)
   ("conditional oncogenic c-MYC" 1) ("the transcriptional factor c-Myc" 1)
   ("weak Myc" 1) ("more Myc" 1)
   ("c-Myc (hereafter referred to as Myc) protein" 1)
   ("than full-length Myc ( xref , black arrowheads )" 1)
   ("only full-length Myc" 1) ("Pin1 augmented Myc's" 1)
   ("amplification or more frequent MYC" 1) ("indirectly targets MYC" 1)
   ("excess cellular MYC" 1)))
 ("UP:P01111"
  (("NRAS" 3812) ("N-Ras" 700) ("N-RAS" 380) ("N-ras" 286) ("NRas" 106)
   ("Nras" 57) ("NRAS-" 17) ("nras" 15) ("NRAS protein" 14)
   ("N-Ras protein" 13) ("NRA" 11) ("GTPase NRAS" 5) ("-NRAS" 5) ("N-RAS-" 4)
   ("most NRAS" 2) ("M249 SDR-DDR up-expressed mutant NRAS" 2)
   ("directly target N-RAS" 1) ("arginine in exon 2 of NRAS" 1)
   ("than monopalmitoylated N-Ras" 1) ("concurrent heterozygous Q61K  NRAS" 1)
   ("specifically target NRAS" 1) ("-N-Ras" 1) ("than NRAS" 1)
   ("unique NRAS" 1) ("HRAS-1" 1) ("NRAS (MN)" 1) ("the exogenous wt N-ras" 1)
   ("hras-1" 1) ("than endogenous N-Ras" 1) ("pN-Ras" 1)
   ("than the NRAS (p= 0.0047)" 1) ("“NRAS”" 1) ("our homogeneous NRAS" 1)
   ("NRAS (HA)" 1) ("N-Ras-" 1)))
 ("UP:P01112"
  (("H-Ras" 1918) ("HRAS" 1186) ("HRas" 626) ("H-RAS" 327) ("hras" 190)
   ("H-RasV12" 176) ("Ha-Ras" 110) ("H-ras" 64) ("transforming protein" 50)
   ("H- ras" 49) ("Hras" 47) ("Ha-ras" 36) ("H−RasV12" 23) ("h-Ras" 18)
   ("H-Ras protein" 15) ("pHRAS" 14) ("H- Ras" 11) ("h-RAS" 8)
   ("transforming protein (SHC)" 8) ("-transforming protein" 7)
   ("HRas protein" 6) ("HA-Ras" 5) ("Ha-RAS" 5) ("c-H-ras" 5)
   ("dominant-negative H-Ras" 4) ("HA-RAS" 4) ("-Ha-ras" 4) ("-H-Ras" 3)
   ("H-RAS protein" 3) ("targeting H-Ras" 3) ("H-RASV12" 3) ("HRAS protein" 3)
   ("HA-ras" 3) ("H- RAS" 3) ("H-Ras-" 3) ("GTPase HRAS" 3)
   ("a dominant transforming protein" 2) ("a concurrent HRAS" 2)
   ("than wt HRas" 2) ("coexpressed H-RAS" 2) ("H-rasV12" 2) ("ha-RAS" 2)
   ("dominant-negative h-RAS" 2) ("H-Rasv12" 2) ("-HRAS" 2) ("H-Ras–" 2)
   ("p21-ras" 2) ("a rare H- ras" 2) ("Dominant-negative HRAS" 2)
   ("the normal H-Ras" 2) ("overexpressed H-Ras" 2)
   ("H-Ras (V12Ras; 0.5 μg/μl) protein" 1) ("c-H-Ras" 1)
   ("expressed dominant-negative H-Ras" 1) ("either dominant-negative H-Ras" 1)
   ("the 18 COOH-terminal amino acids of H-Ras" 1) ("somatic HRAS" 1)
   ("A somatic heterozygous HRAS" 1)
   ("an unusual HRas NKCD-motif mutant K117R" 1) ("P01112" 1)
   ("AACOCF3 increased acylated H-RAS" 1)
   ("the well-characterized GFAP-V  12  Ha-Ras" 1) ("than H-Ras [ xref ]" 1)
   ("the dominant-negative H-Ras" 1) ("H−Ras" 1) ("than H-Ras ( xref )" 1)
   ("h-ras" 1) ("a weak transforming protein" 1) ("one conditional HRAS" 1)
   ("so oncogenic HRAS" 1) ("the heterozygous HRAS" 1)
   ("a paternal germline-derived HRAS" 1) ("the rare HRAS" 1)
   ("expressing both H-RasV12" 1) ("lipid-raft associated H-RAS" 1)
   ("p21-Ras" 1)))
 ("UP:P01116"
  (("KRAS" 24075) ("K-Ras" 3767) ("K-ras" 2196) ("Kras" 2054) ("K-RAS" 977)
   ("KRAS2" 249) ("KRAS-" 190) ("KRas" 127) ("KRAS protein" 120) ("Ki-ras" 102)
   ("kras" 101) ("k-ras" 68) ("Ki- ras" 55) ("K-RAS protein" 45)
   ("K-Ras protein" 35) ("Kras protein" 33) ("K-ras protein" 21) ("Ki-Ras" 19)
   ("Kra" 16) ("k-Ras" 15) ("kRas" 14) ("Kras2" 11) ("Ki-ras peptide" 10)
   ("pKRAS" 7) ("KRAS1" 7) ("Kras-" 6) ("exogenous KRAS" 5) ("KRAS Protein" 5)
   ("C/Kras" 4) ("KRAS–" 4) ("genomic KRAS" 3) ("than KRAS" 3)
   ("particular KRAS" 3) ("normal KRAS" 3) ("than K-Ras" 3) ("c-ki-ras" 3)
   ("GTPase KRAS" 3) ("EGFR analysis underwent KRAS" 2)
   ("Smad4 accelerated K-Ras" 2) ("KRas protein" 2) ("c-K-ras" 2)
   ("an abnormal KRAS" 2) ("more KRAS" 2) ("a well-known KRAS" 2)
   ("possessing neither KRAS" 2) ("codon 12-mutated KRAS" 2)
   ("overexpressed wt Kras" 2) ("a somatic KRAS" 2)
   ("overexpressed wild-type KRAS" 2) ("overexpressed KRAS" 2)
   ("K-Ras4B protein" 2) ("overexpressed mutant K-ras" 2)
   ("isogenic HCT116 WT KRAS" 2) ("overexpressed oncogenic K-Ras" 2)
   ("slightly less ubiquitinated K-Ras" 2) ("dominant-negative Kras" 2)
   ("expressing mutant KRAS" 2) ("expressing mutant K-Ras" 2) ("K-Ras-" 2)
   ("representative mut K-Ras" 2) ("weak KRAS" 2) ("at least three KRAS" 2)
   ("targeting KRAS" 2) ("hyperactive K-Ras" 2) ("K ras" 2)
   ("simultaneous KRAS" 2)
   ("the last 21 amino acids of human K-ras ( xref )" 1) ("distinct K-Ras" 1)
   ("KRAS ( WT )" 1) ("ki-ras" 1) ("KRAS (WT)" 1) ("c-K-Ras" 1) ("K-RAS-" 1)
   ("hyperactive K-RAS" 1) ("particular K-Ras" 1) ("only 3 KRAS" 1)
   ("a conclusive KRAS" 1) ("K-ras-" 1) ("than standard KRAS testing" 1)
   ("too much KRAS" 1) ("“KRAS”" 1) ("membranous bound Kras protein" 1)
   ("hyperactive KRAS" 1) ("-K-Ras" 1) ("Ki-ras-" 1) ("Ki- ras-" 1)
   ("Representative KRAS2" 1) ("K RAS" 1) ("most KRAS" 1)
   ("whose tumors display wildtype KRAS" 1) ("than oncogenic KRAS ( xref )" 1)
   ("four commercially available KRAS" 1) ("the KRAS -positive" 1)
   ("than G12D KRAS" 1)
   ("notably pancreatic adenocarcinomas predominantly harbour KRAS" 1)
   ("the predominant splice variant KRAS4B" 1) ("‘KRAS’" 1)
   ("particularly KRAS F156L" 1) ("far less ubiquitinated-K-Ras" 1)
   ("very little wild-type K-Ras" 1) ("the Flag-His-tagged K-Ras" 1)
   ("than WT Kras" 1) ("K Ras" 1) ("Ki-RAS" 1) ("whereby Kras protein" 1)
   ("KRAs" 1) ("the C-terminal 18 amino acids of Kras" 1) ("optimal KRAS" 1)
   ("chimeric KRAS" 1) ("targeting oncogenic KRAS" 1)
   ("than K-Ras in the cell lines" 1)
   ("than those carrying wt K-Ras (n = 5)" 1) ("the homologous KRAS" 1)
   ("metachronous WT KRAS" 1) ("synchronous WT KRAS" 1) ("aberrant K-Ras" 1)
   ("an aberrant K-ras" 1) ("aberrant K-ras" 1) ("respective KRAS" 1)
   ("our study ordered at least one KRAS" 1) ("at least one KRAS" 1)
   ("than K-RAS in BHK cells" 1) ("the transformed cells active K-Ras" 1)
   ("homozygous mutant KRAS" 1) ("only mutant KRAS" 1)
   ("heterozygous mutant/wild type KRAS" 1)
   ("specifically targets mutant KRAS" 1) ("KRAS−" 1)
   ("therapeutically target mutant KRAS" 1)))
 ("UP:P01119" (("Ras1" 9) ("RAS1" 7) ("ras1" 1)))
 ("UP:P01120" (("RAS2" 6) ("Ras2" 4))) ("UP:P01123" (("YPT1" 3) ("ypT1" 1)))
 ("UP:P01126"
  (("v-Rel" 46) ("the viral oncoprotein v-Rel" 2)
   ("the potent viral Rel/NF-κB oncoprotein v-Rel" 1)))
 ("UP:P01127"
  (("PDGF-B" 379) ("PDGFB" 99) ("SIS" 51) ("Pdgfb" 20)
   ("derived growth factor-B" 15) ("derived growth factor beta" 13)
   ("PdgfB" 13) ("Pdgf-b" 7) ("PDGF-B protein" 6) ("pdgf-b" 5) ("PDGFb" 3)
   ("PDGF2" 2) ("platelet-derived growth factor beta polypeptide" 2)
   ("the tropic factor PDGF-B" 1) ("available PDGF-B" 1) ("PDGF subunit B" 1)
   ("secretory protein Pdgf-b" 1) ("endothelial-derived PDGF-B" 1)
   ("the SMC/PC-attracting factor PDGF-B" 1)))
 ("UP:P01128" (("v-sis" 2) ("v-Sis" 1)))
 ("UP:P01130"
  (("LDLr" 182) ("LDLR" 166) ("LDL receptor" 102)
   ("low-density lipoprotein receptor" 43)
   ("low density lipoprotein receptor" 25) ("LDL-receptor" 7)
   ("LDLR protein" 6) ("low-density lipoprotein receptor (LDLR)" 5)
   ("low density lipoprotein receptor (LDLR)" 2) ("functional LDLR" 2)
   ("low
 density lipoprotein receptor"
    1)
   ("low-density Lipoprotein Receptor" 1)
   ("Low-density lipoprotein receptor" 1)))
 ("UP:P01132" (("mEGF" 12)))
 ("UP:P01133"
  (("EGF" 16639) ("epidermal growth factor" 1546)
   ("epidermal growth factor (EGF)" 169) ("EGF-" 115)
   ("Epidermal growth factor" 88) ("exogenous EGF" 73) ("hEGF" 51) ("-EGF" 34)
   ("soluble EGF" 18) ("EGF–" 9) ("Epidermal growth factor (EGF)" 8)
   ("than EGF" 8) ("fluorescent EGF" 8) ("EGF molecule" 8)
   ("epidermal growth factor (EGFR)" 5) ("continuous EGF" 5) ("EGF protein" 4)
   ("Fluorescent EGF" 4) ("the exogenous EGF" 3)
   ("epidermal growth
factor"
    3)
   ("triple negative and human epidermal growth factor" 3)
   ("epidermal growth
factor (EGF)"
    3)
   ("Soluble EGF" 3) ("Egf" 3) ("Alexa 647-conjugated EGF" 3)
   ("Alexa Fluor 488–conjugated EGF" 3) ("fully functional EGF" 2)
   ("anti-hVPS28 retained substantial EGF" 2) ("surprisingly not EGF" 2)
   ("Epidermal growth factor (EGF)" 2) ("EGF+HGF-" 2)
   ("epidermal growth factor (EFG)" 2) ("EGF (SFIHE)" 2)
   ("epidermal growth
 factor"
    2)
   ("−EGF" 2) ("pEGF" 2) ("fluorescently-labeled EGF" 2)
   ("exogenous epidermal growth factor (EGF)" 2) ("basolateral EGF" 2)
   ("maternal epidermal growth factor" 2)
   ("0.5% BSA and Alexa Fluor 488-labeled EGF" 2) ("Exogenous EGF" 2)
   ("50 ng/ml Alexa 488-labeled EGF" 2)
   ("internalized Alexa 488-labeled EGF" 2) ("Alexa 488-labeled EGF" 2)
   ("488-conjugated EGF" 2) ("human-EGF protein" 2)
   ("Alexa Fluor 488-labelled EGF" 2) ("the exogenously-added EGF" 1)
   ("Alexa-488-labeled EGF" 1) ("EGF (CST)" 1) ("37°C. Free TX-Red EGF" 1)
   ("specifically 30 ng/ml EGF" 1) ("additional exogenous EGF" 1)
   ("22 amino acids of EGF" 1) ("EGF (EGF)" 1) ("an EGF" 1)
   ("just 60 nM EGF" 1) ("than EGF that are present in the serum" 1)
   ("Alexa Fluor 488-conjugated EGF" 1) ("more EGF protein" 1)
   ("exogenous soluble EGF" 1) ("labeled soluble EGF" 1)
   ("than EGF ( xref )" 1) ("epidermal growth factor–" 1)
   ("the absence exogenous EGF" 1) ("supplemental EGF" 1)
   ("chemotactic stimulus EGF" 1) ("autocrine EGF" 1) ("more EGF" 1)
   ("both the ALDH1-positive and ALDH1-negative population bound EGF" 1)
   ("epidermal growth factor-" 1) ("chimeric EGF" 1)
   ("Alexa 488-conjugated EGF" 1) ("particular EGF" 1)))
 ("UP:P01135"
  (("TGF-α" 643) ("TGFα" 423) ("TGFA" 263)
   ("transforming growth factor alpha" 30) ("TGF-alpha" 25) ("TGFa" 23)
   ("transforming growth factor-alpha" 20) ("transmembrane TGF-α" 9)
   ("soluble TGF-α" 8) ("Tgfa" 6) ("transforming growth factor-a" 4)
   ("the constitutively active Src(E378G) further increased TGFα" 4)
   ("Transforming growth factor alpha" 3) ("TGF–α" 3) ("Transmembrane TGF-α" 3)
   ("TGF-a" 2) ("autocrine TGFα" 2) ("UV light induced TGF-α" 2) ("Tgfα" 2)
   ("TGFalpha" 2) ("transforming growth factor alpha ( TGFA )" 1)
   ("transforming growth factor-alpha (TGFA)" 1) ("than transmembrane TGF-α" 1)
   ("than TGF-α ( xref )" 1) ("very little TGF-α" 1)
   ("releases soluble TGF-α" 1) ("TGF-α protein" 1) ("autocrine TGF-α" 1)
   ("latent TGFα" 1)))
 ("UP:P01137"
  (("TGF-β1" 3589) ("TGFβ1" 1027) ("TGFB1" 310)
   ("transforming growth factor beta" 108) ("TGFB" 85)
   ("transforming growth factor-β1" 53) ("TGF beta" 26) ("TGF-β1 protein" 20)
   ("Transforming growth factor beta" 19) ("Transforming growth factor-β1" 19)
   ("exogenous TGF-β1" 18) ("TGF-β1-" 10)
   ("transforming growth factor beta 1" 9) ("TGF-beta1" 8)
   ("Transforming growth factor beta 1" 7) ("bioactive TGF-β1" 7) ("TGFβ1-" 6)
   ("Tgfb1" 6) ("TGF-b" 6) ("transforming growth factor beta-1" 6)
   ("transforming growth factor-beta1" 5) ("TGFb1" 5) ("exogenous TGFβ1" 4)
   ("Transforming growth factor beta1" 4) ("−TGF-β1" 4) ("Bioactive TGF-β1" 4)
   ("the names placental transforming growth factor beta" 3)
   ("secreted bioactive TGF-β1" 3) ("Transforming growth factor beta-1" 2)
   ("Recombinant human latent TGF-β1" 2) ("than TGF-β1" 2)
   ("the main transcriptional effectors downstream TGF-β1" 2)
   ("the profibrotic cytokine transforming growth factor-β1" 2) ("TGF-b1" 2)
   ("specific TGF-β1" 2) ("latent TGF-β1" 2) ("TGF-β1 molecule" 2)
   ("overactive TGFB" 2) ("transforming growth factor beta-1 (TGFB)" 2)
   ("fibrogenic factors TGF-β1" 2) ("Transforming growth factor-beta1" 2)
   ("the
multifunctional cytokine TGFβ1"
    2)
   ("approximately 2.6 fold more bioactive TGF-β1" 2)
   ("HCV-induced bioactive TGF-β1" 2) ("an adequate immune response TGF-β1" 1)
   ("transforming growth factor–β1" 1) ("the TGFβ1's" 1)
   ("an α 4 β 7 -reactive gp120 produced significantly more TGF-β1" 1)
   ("TGF-beta1-" 1) ("Recombinant mature TGFβ1" 1) ("cytostatic TGF-β1" 1)
   ("TGF-beta-1" 1) ("particular TGFB1" 1) ("maternal Tgfb1" 1)
   ("supplemental TGF-β1" 1) ("the fibrogenic cytokine TGF-β1" 1)
   ("simultaneous low TGFB" 1) ("exogenous (pre-activated) TGF-β1" 1)
   ("TGF-β-1" 1) ("TGF-β1–" 1) ("functional TGF-β1" 1) ("latent TGFβ1" 1)
   ("Secreted bioactive TGF-β1" 1) ("The bioactive TGF-β1" 1)
   ("Transforming growth factor -β1" 1)))
 ("UP:P01138"
  (("NGF" 914) ("NGF-" 4) ("beta-NGF" 3) ("exogenous NGF" 1) ("than NGF" 1)
   ("NGF protein" 1) ("more NGF" 1)))
 ("UP:P01148"
  (("gonadotropin" 68) ("GNRH1" 24) ("LHRH" 15)
   ("human chorionic gonadotropin" 15) ("Gonadotropin" 3)
   ("5.0 IU human chorionic gonadotropin" 3) ("GRH" 2)
   ("sufficient human chorionic gonadotropin" 2)
   ("“two-cell-two-gonadotropin”" 2) ("Hypothalamic Gonadotropin" 2)
   ("human chorionic gonadotropin (CG)" 1)
   ("Luteinizing-hormone-releasing hormone" 1) ("human chronic gonadotropin" 1)
   ("urine β-human chorionic gonadotropin" 1) ("Gnrh1" 1)
   ("Human chorionic gonadotropin" 1)))
 ("UP:P01160"
  (("NF" 3294) ("NF-" 2128) ("pNF" 84) ("PND" 70) ("CDP" 32) ("CDD" 24)
   ("atrial natriuretic peptide" 9) ("NPPA" 8) ("pNF-" 6) ("discrete NF" 6)
   ("atrial natriuretic peptide (ANP)" 3) ("Hospital NF" 2) ("CDP-" 2)
   ("panp" 1) ("Atrial natriuretic peptide" 1) ("Faulty NF-" 1)
   ("a primarily pediatric NF" 1) ("nF" 1)
   ("invasive cancers exhibited 53BP1 NF" 1) ("occasional discrete 53BP1 NF" 1)
   ("three or more discrete NF" 1) ("one or two discrete NF" 1)
   ("In contrast only one NF" 1) ("a personal history NF" 1)
   ("than NF ( xref )" 1)
   ("the cardiac hypertrophic marker atrial natriuretic peptide (ANP)" 1)))
 ("UP:P01178" (("OT" 221) ("OXT" 55) ("pOT" 4) ("OT-" 1)))
 ("UP:P01185"
  (("VP" 480) ("pVP" 32) ("Vps" 29) ("AVP" 21) ("vasopressin" 19) ("vps" 18)
   ("vp" 5) ("the prospective VP" 3) ("vasopressin (AVP)" 2)
   ("the viral transactivator VP16" 1)
   ("the fusion protein GAL4 147 ERt2 VP16" 1) ("Gal4-DBD-tagged VP16" 1)))
 ("UP:P01189"
  (("ACTH" 239) ("POMC" 123) ("CLIP" 99) ("adrenocorticotropic hormone" 16)
   ("proopiomelanocortin" 15) ("Pomc" 11) ("pro-opiomelanocortin" 5)
   ("adrenocorticotropic hormone (ACTH)" 5) ("Adrenocorticotropic hormone" 3)
   ("CLIP peptide" 3) ("ACTH-" 2) ("alpha-melanocyte stimulating hormone" 2)
   ("proopiomelanocortin (POMC)" 2)
   ("chronic adrenocorticotropic hormone (ACTH)" 1) ("potential peptide" 1)
   ("Adrenocorticotropic hormone (ACTH)" 1) ("ProOpiomelanocortin" 1)
   ("alpha-MSH" 1)))
 ("UP:P01197" (("corticotrophin" 19)))
 ("UP:P01210" (("opioid growth factor" 1) ("PENK" 1)))
 ("UP:P01213"
  (("ADCA" 11) ("dynorphin" 7) ("prodynorphin" 4) ("pDyn" 2)
   ("cervical ADCA" 1) ("pDYN" 1) ("“DRE-pDyn”" 1)))
 ("UP:P01215" (("CGA" 424) ("-CGA" 21) ("Broad CGA" 1)))
 ("UP:P01222" (("TSHβ" 10) ("TSHb" 3)))
 ("UP:P01225"
  (("gonadotropins" 29) ("FSHB" 9) ("the pituitary-derived gonadotropins" 2)
   ("follicle-stimulating hormone beta" 2) ("Human chorionic gonadotropins" 2)
   ("the pituitary gonadotropins" 1)))
 ("UP:P01229"
  (("LHB" 62) ("the intraarticular and extraarticular LHB" 1)
   ("the intraarticular LHB" 1)))
 ("UP:P01233" (("hCGβ" 107) ("β-hCG" 6)))
 ("UP:P01236"
  (("pRL" 797) ("PRL" 585) ("prolactin" 479) ("Prolactin" 49) ("Prl" 41)
   ("PRLs" 30) ("prolactin (PRL)" 9) ("PRL-" 5)
   ("an internal control construct pRL" 4) ("exogenous human prolactin" 2)
   ("exogenous prolactin" 2) ("PrL" 2) ("pRL-" 2)
   ("the angiostatic agent 16 K prolactin" 2)
   ("The lactogenic hormone prolactin (PRL)" 2) ("prolactin (SIGMA)" 2)
   ("mammary PRL" 1) ("epidemiologic data link PRL" 1) ("the prolactin's" 1)
   ("the first 139 amino acids of PRL" 1) ("STAT3 increased PRL" 1) ("prl" 1)))
 ("UP:P01241"
  (("GH" 622) ("growth hormone" 158) ("GH-" 25) ("gH" 14)
   ("growth hormone (GH)" 12) ("GH1" 8) ("Growth hormone" 4)
   ("pituitary growth hormone" 3) ("growth hormone (BGH)" 3) ("exogenous GH" 2)
   ("somatotropin" 2) ("placental growth hormone" 2) ("GHR showed no Cy3-GH" 2)
   ("pGH" 2) ("acidosis-resistant growth hormone" 1)
   ("the testicular cancer cells GH" 1) ("underwent GH-" 1)
   ("growth
hormone"
    1)
   ("the pituitary GH" 1) ("less Cy3-GH" 1)
   ("the first 11 amino acids of porcine growth hormone" 1)))
 ("UP:P01258"
  (("CALCA" 63) ("calcitonin" 34) ("Calcitonin" 10) ("calcitonin-" 1)))
 ("UP:P01266"
  (("Tg" 1893) ("TG" 1376) ("T/G" 182) ("thyroglobulin" 88) ("-Tg" 59)
   ("tg" 43) ("T-G" 31) ("-TG" 9) ("TG-" 8) ("“TG”" 7) ("Thyroglobulin" 6)
   ("Tg-" 2) ("Placental TG" 2) ("bona fide TG" 2) ("T/G-" 1)
   ("Postsurgical serum thyroglobulin" 1) ("the ipsilateral TG" 1)
   ("the accelerated tumorigenesis inMdm2 Tg" 1) ("shorter forMdm2 Tg" 1)
   ("7/7 (100%) p73−/− and 4/4 (100%)Mdm2 Tg" 1)
   ("thyrocyte-specific differentiating markers thyroglobulin" 1) ("–Tg" 1)
   ("than TG" 1) ("than TG (compare xref with xref )" 1) ("\"TG\"" 1)
   ("unusual TG" 1) ("Pol IV incorporated all four nucleotides opposite Tg" 1)
   ("than Tg" 1) ("T–G" 1)))
 ("UP:P01270"
  (("PTH" 81) ("parathyroid hormone" 64) ("Parathyroid hormone" 3)
   ("parathyroid hormone (PTH)" 2) ("Parathormone" 2)
   ("intermittent parathyroid hormone" 2) ("intact PTH" 1) ("parathormone" 1)
   ("both intermittent and continuous PTH" 1)))
 ("UP:P01275"
  (("GCG" 400) ("GLP-1" 279) ("glucagon" 187) ("-GCG" 39) ("Oxy" 32)
   ("Glucagon" 17) ("glucagon-like peptide 1" 16)
   ("glucagon-like peptide-1" 12) ("GLP1" 8) ("oxy" 6)
   ("glucagon-like peptide 1-" 5) ("Glucagon-like peptide-1" 3)
   ("oxyntomodulin" 3) ("the intestinal incretin glucagon-like peptide-1" 2)
   ("Glp1" 2) ("glucagon-" 2) ("than GLP-1" 1) ("than native GLP-1 ( xref )" 1)
   ("exogenous GLP-1" 1) ("Glucagon-like peptide 1" 1) ("incretin hormone" 1)
   ("OXM" 1) ("GLP1 peptide" 1)))
 ("UP:P01282"
  (("VIP" 53) ("Vasoactive intestinal polypeptide" 4)
   ("vasoactive intestinal peptide" 3)
   ("a more recently identified enzyme termed VIP" 1) ("Vip" 1)))
 ("UP:P01286"
  (("GHRH" 48) ("GRF" 3)
   ("hypothalamic growth hormone releasing hormone (GHRH)" 1)
   ("growth hormone releasing hormone" 1) ("tumoral GHRH" 1) ("GRFs" 1)))
 ("UP:P01298"
  (("PP" 596) ("Ph" 264) ("PPY" 56) ("Ph−" 20) ("-Ph" 18) ("pp" 16) ("Pp" 15)
   ("-PP" 14) ("P-P" 9) ("pancreatic polypeptide" 7) ("“PP”" 4) ("Ph-" 4)
   ("“PP” (TT)" 3) ("P–P" 2) ("avian pancreatic polypeptide" 2) ("pPP" 1)))
 ("UP:P01303"
  (("NPY" 35) ("neuropeptide Y" 11) ("Neuropeptide Y" 4)
   ("neuropeptide Y (NPY)" 1)))
 ("UP:P01308"
  (("insulin" 10088) ("Insulin" 691) ("INS" 246) ("insulin-" 21)
   ("than insulin" 7) ("human regular insulin" 5) ("insulin molecule" 5)
   ("basal insulin" 4) ("less insulin" 4) ("Penfil neutral insulin" 3)
   ("exogenous insulin" 3) ("raised insulin" 3)
   ("significantly more insulin" 3) ("incremental insulin" 2)
   ("regular insulin" 2) ("insulin (FPI)" 2) ("more insulin" 2)
   ("mature insulin" 2) ("properly process insulin" 2)
   ("crystalline human insulin" 2) ("insulin B chain" 1)
   ("insufficient insulin" 1) ("insulin ( INS )" 1) ("insulin (FINS)" 1)
   ("Knockout islets released more insulin" 1) ("much more insulin" 1)
   ("central insulin" 1) ("intracerebroventricular insulin" 1)
   ("residual intracellular insulin" 1) ("insulin (IR)" 1)
   ("log transformed insulin" 1) ("The anabolic hormone Insulin" 1)))
 ("UP:P01344"
  (("IGF2" 534) ("IGF-II" 417) ("Igf2" 39) ("insulin-like growth factor II" 18)
   ("Igf-2" 14) ("IGFII" 6) ("Insulin-like growth factor II" 5)
   ("mature IGF-II" 4) ("insulin like growth factor 2" 3) ("than IGF-II" 3)
   ("IGF II" 2) ("IGF2 protein" 2)
   ("YAP-infected CGNPs expressed and secreted significantly more IGF2" 2)
   ("pure IGF2" 1) ("recombinant mature IGF-II" 1)
   ("than Glu12Ala IGF-II ( xref )" 1)
   ("than wild-type IGF-II (a rightward shift of ∼2 fold and >80% of maximal response)"
    1)
   ("than IGF-II ( xref )" 1) ("Interestingly both IGF-II" 1)))
 ("UP:P01350"
  (("GAS" 405) ("gas" 285) ("gastrin" 71) ("Gas" 23) ("Gastrin" 9) ("-GAS" 4)
   ("dry gas" 3) ("GAST" 3) ("an environmental toxic gas" 2)
   ("raised plasma gastrin" 1) ("gastrins" 1) ("gastrin ( GAST )" 1)
   ("inert gas" 1) ("a highly diffusible gas" 1) ("The auxiliary gas" 1)))
 ("UP:P01374"
  (("LTA" 183) ("TNF-beta" 9) ("TNFβ" 7) ("lymphotoxin-alpha" 5)
   ("lymphotoxin-α" 4) ("lymphotoxin alpha" 4) ("TNFB" 3)))
 ("UP:P01375"
  (("TNFα" 5592) ("TNF" 4695) ("tumor necrosis factor" 763) ("TNF-" 666)
   ("TNF-alpha" 185) ("Casp8p41" 95) ("Tumor necrosis factor" 89)
   ("tumor necrosis factor-alpha" 58) ("TNFa" 46) ("Tumor Necrosis Factor" 44)
   ("TNFα-" 44) ("TNFA" 42) ("Tnf" 39) ("TNFalpha" 37) ("TNF-a" 30)
   ("tumor necrosis factor (TNF)" 25) ("tumor necrosis factor-" 22) ("NTF" 12)
   ("tnf" 10) ("Tumor necrosis factor-alpha" 9) ("TNFα protein" 9)
   ("less TNFα" 5) ("Tumor necrosis factor-" 5) ("TNF protein" 4)
   ("TNF-Alpha" 4) ("soluble TNF" 3) ("autocrine TNF" 3) ("TNFA-" 3) ("Tnfa" 2)
   ("than TNFα" 2) ("the well-characterized NF-κB activator TNFα" 2)
   ("Tumor Necrosis Factor-" 2) ("soluble TNFα" 2)
   ("the biological effects TNF" 2) ("pure human TNFα" 2) ("synovial TNFα" 2)
   ("TNFs" 2) ("exogenous TNFα" 2) ("more TNFα" 2) ("exogenous TNF" 2)
   ("the pleiotropic cytokine TNF" 2)
   ("stimulated monocytes produced less TNFα" 1) ("producing less TNFα" 1)
   ("further study TNFα-" 1) ("the pleiotropic cytokine TNFα" 1)
   ("glioblastoma cell–autonomous EGFR and paracrine TNFα" 1)
   ("microenvironment-derived TNFα" 1) ("intracellular domain 1" 1)
   ("Tumor necrosis factor (TNF)" 1) ("most TNF" 1) ("pro-inflammatory TNFα" 1)
   ("P01375" 1) ("hyperalgesic TNF-alpha" 1) ("TNFα–" 1)
   ("The immunostimulatory cytokine TNFα" 1)
   ("tumor necrosis
factor-"
    1)
   ("tumor necrosis
factor"
    1)
   ("tumor necrosis
                factor"
    1)
   ("than TNF" 1) ("hyperglycemic culturing conditions increased TNFα" 1)
   ("linking TNFα" 1) ("Only membrane-bound TNF" 1)
   ("The proinflammtory cytokine tumor necrosis factor (TNF)" 1) ("tnf-" 1)
   ("Tumor Necrosis Factor (TNF)" 1)
   ("than TNFα from the control KD cells ( xref )" 1)
   ("than TNFα from cells" 1)))
 ("UP:P01446" (("CX3" 10)))
 ("UP:P01478" (("RBX" 11) ("Rbx" 7) ("RBX protein" 2) ("the RBX protein’s" 1)))
 ("UP:P01528"
  (("AS2" 223) ("pAS2" 9) ("the parental AS2" 2) ("an Eksigent AS2" 2)
   ("as2" 2) ("As2" 1) ("than AS2" 1) ("AS2-" 1) ("an Eksigent AS-2" 1)
   ("AS-2" 1)))
 ("UP:P01529" (("AS5" 6))) ("UP:P01533" (("AS1" 219) ("pAS1" 1)))
 ("UP:P01549" (("MCRs" 29) ("substantially fewer MCRs" 1)))
 ("UP:P01552"
  (("staphylococcal enterotoxin B" 3)
   ("staphylococcal enterotoxin B (SEB)" 2)))
 ("UP:P01560"
  (("STB" 93) ("StB" 2) ("the FMR1 -specific dig-labelled StB12.3" 1)))
 ("UP:P01562" (("IFL" 55) ("IFNA1" 22) ("post-operative IFL" 1)))
 ("UP:P01563"
  (("IFN-α2b" 34) ("IFN-alpha2" 6) ("IFN-α2" 5) ("IFNα2" 3) ("IFNA2" 1)))
 ("UP:P01569" (("IFNA5" 8)))
 ("UP:P01574"
  (("IFN-β" 1410) ("IFNβ" 964) ("IFNB1" 106) ("IFN-B" 50) ("IFN-beta" 20)
   ("IFNB" 15) ("IFN-β protein" 12) ("interferon beta" 11) ("IFNβ-" 9)
   ("IFN-β (TRIF)" 8) ("Ifnβ" 8) ("pIFNB" 6) ("ifnβ" 5) ("Ifnb" 5) ("IFN-β-" 4)
   ("fibroblast interferon" 3) ("interferon beta 1" 2) ("IFNβ protein" 2)
   ("IFN Beta" 2) ("IFN beta" 2) ("Interferon beta" 2) ("less IFNβ" 2)
   ("IFNβ (TRIF)" 2) ("IFN-β–" 1) ("ifnb1" 1) ("ifnb" 1) ("pIFNβ" 1) ("IFB" 1)
   ("these cells produced more IFNβ" 1) ("the antiviral regulator IFN-β" 1)
   ("IFF" 1) ("reverse-transcribed IFNβ" 1)
   ("Toll/IL-1R domain–containing adapter-inducing IFN-β (TRIF)" 1)
   ("IFNb" 1)))
 ("UP:P01579"
  (("IFNγ" 1193) ("interferon gamma" 72) ("IFNG" 55) ("interferon-gamma" 36)
   ("IFN-gamma" 23) ("IFG" 23) ("Ifng" 22) ("Interferon gamma" 14)
   ("IFN gamma" 11) ("IFNγ-" 9) ("IFNgamma" 4) ("IFNg" 4)
   ("Interferon-gamma" 3) ("Interferon gamma protein" 2)
   ("interferon-gamma (IFNG)" 2) ("the classic pathway IFNγ" 1)
   ("dimeric IFNγ" 1) ("IFN-Gamma" 1) ("IFNγ protein" 1) ("exogenous IFNγ" 1)
   ("interferon gamma (IFNG)" 1)))
 ("UP:P01583"
  (("IL1A" 153) ("IL-1alpha" 70) ("interleukin-1α" 12) ("IL1α" 11) ("IL-1a" 10)
   ("IL1A protein" 10) ("IL1a" 5) ("IL-1 α" 4) ("Il1a" 4)
   ("interleukin-1 alpha" 3) ("IL-1A" 2) ("IL1A-" 2) ("interleukin-1alpha" 2)
   ("Interleukin 1 alpha" 2) ("Interleukin-1alpha" 2)
   ("10-fold more IL-1alpha" 1) ("markedly more IL-1alpha" 1)
   ("IL-1alpha protein" 1) ("Interleukin-1α" 1)))
 ("UP:P01584"
  (("IL-1β" 4333) ("IL1B" 286) ("interleukin-1β" 210) ("Il-1β" 65)
   ("IL-1beta" 45) ("IL-1B" 40) ("mature IL-1β" 38) ("IL-1β-" 37)
   ("IL-1β protein" 26) ("Interleukin-1β" 22) ("interleukin-1 beta" 22)
   ("IL-1b" 20) ("IL-1 beta" 19) ("Il1b" 17) ("interleukin-1beta" 12)
   ("Interleukin-1 beta" 8) ("interleukin-1-beta" 6) ("interleukin 1 beta" 5)
   ("IL-1-β" 5) ("pIL-1β" 4) ("IL1-Beta" 4) ("IL-1β (GIBCO)" 4)
   ("overexpressed IL-1β" 3) ("IL1b" 3) ("Il1B" 3) ("P01584" 2)
   ("31 previously implicated candidate genes— IL1B" 2) ("Mature IL-1β" 2)
   ("biological active IL-1β" 2) ("Interleukin 1 beta" 2)
   ("Interleukin-1beta" 2) ("interleukin 1beta" 2) ("TNIL" 2)
   ("Interleukin-1-β" 2) ("IL1-beta" 1) ("these findings support Il-1β’s" 1)
   ("increased placental IL-1β" 1) ("functional IL-1β" 1)
   ("interleukin 1 beta" 1) ("more IL-1β" 1) ("Il-1b" 1)
   ("pro-inflammatory IL-1β" 1)
   ("the colonic proinflammatory cytokine IL-1β" 1) ("subsequent IL-1β" 1)
   ("the pro-inflammatory IL-1β" 1) ("pro-inﬂammatory cytokine IL-1β" 1)
   ("Interleukin1β" 1)))
 ("UP:P01588"
  (("EPO" 641) ("Epo" 564) ("erythropoietin" 211) ("Erythropoietin" 28)
   ("erythropoietin (EPO)" 16) ("epoetin" 13) ("than EPO" 7) ("hemopoietin" 6)
   ("Epo-" 6) ("exogenous EPO" 5) ("−EPO" 5) ("erythropoietin-" 2) ("EPO-" 2)
   ("than EPO (n=4; xref , xref )" 1) ("erythro-poietin" 1) ("exogenous Epo" 1)
   ("Epoetin" 1) ("exogenous erythropoietin (EPO)" 1)))
 ("UP:P01589"
  (("CD25" 1144) ("IL2RA" 97) ("Il2ra" 12) ("IL-2RA" 8) ("CD25-" 4) ("-CD25" 4)
   ("circulating soluble CD25" 3) ("Naive CD4 + CD25" 3)
   ("interleukin-2 receptor alpha" 2) ("IL2ra" 2) ("IL2Ra" 2)
   ("particular CD25" 1) ("soluble CD25" 1) ("CD25 protein" 1) ("IL-2Ra" 1)
   ("peripheral naive CD4 + CD25" 1) ("Interleukin-2 receptor alpha" 1)
   ("TIEG1 –/– naive CD4 + CD25" 1)))
 ("UP:P01591" (("IGJ" 6) ("pJCH" 2) ("JCH" 1))) ("UP:P01594" (("O18" 2)))
 ("UP:P01730"
  (("CD4" 8176) ("Cd4" 29) ("CD4 molecule" 21) ("soluble CD4" 16) ("-CD4" 14)
   ("CD4-" 11) ("Soluble CD4" 6) ("absolute CD4" 2) ("than CD4" 2)
   ("a chimeric CD4 molecule" 1) ("CD4+CD103-" 1)
   ("the viral entry receptor CD4" 1) ("a few CD4" 1) ("CD4−" 1)
   ("than CD4 that blocks the function of Env in the virion" 1) ("Cd4-" 1)
   ("immature CD4" 1) ("undetectable CD4" 1) ("the thymic CD4" 1)))
 ("UP:P01731" (("LyT2" 4) ("LYT2" 1) ("Lyt-2" 1)))
 ("UP:P01732"
  (("CD8" 2866) ("MAL" 141) ("leu2" 87) ("LEU2" 28) ("pMAL" 27) ("CD8a" 14)
   ("CD8-" 10) ("CD8−" 5) ("-CD8" 3) ("CD8A" 3) ("CD8 molecule" 3) ("leu2-" 2)
   ("-MAL" 1) ("pMal" 1) ("-LEU2" 1) ("Leu2" 1) ("CD8 antigen" 1)
   ("mature CD4 + CD8" 1)))
 ("UP:P01833"
  (("pIgR" 11) ("polymeric immunoglobulin receptor" 4) ("PIgR" 1) ("PIGR" 1)
   ("intact pIgR" 1) ("so-called secretory component" 1)
   ("secretory component" 1)))
 ("UP:P01848" (("Tcra" 6) ("TCRA" 2))) ("UP:P01857" (("IGHG1" 1)))
 ("UP:P01858" (("tuftsin" 1)))
 ("UP:P01859"
  (("immunoglobulins" 308) ("Immunoglobulins" 10)
   ("monoclonal immunoglobulins" 2)
   ("Secondary horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit immunoglobulins"
    2)
   ("complete immunoglobulins" 2) ("intact immunoglobulins" 1)
   ("our previous study several immunoglobulins" 1)
   ("milk-derived immunoglobulins" 1) ("immunoglobulins (DAKO)" 1)
   ("using secondary affinity-purified goat anti-mouse or anti-rabbit immunoglobulins"
    1)))
 ("UP:P01860" (("HDC" 66))) ("UP:P01864" (("B-allele" 11)))
 ("UP:P01871" (("IGHM" 8)))
 ("UP:P01880"
  (("IgD" 164) ("IGD" 3) ("immature IgM + IgD" 1)
   ("predominantly B220 low/− IgM +/low IgD" 1) ("less surface IgD" 1)
   ("IgD−" 1) ("IgD+CD38−" 1)))
 ("UP:P01889"
  (("class I" 1688) (NIL 65) ("MHCI" 57) ("class I molecule" 15)
   ("class I-" 11) ("than class I" 3) ("class I protein" 3)
   ("targeting 11 class I" 1) ("most class I" 1)
   ("individual catalytic class I" 1) ("Classical MHC class I" 1)
   ("full-sized transmembrane major histocompatibility complex (MHC) class I protein"
    1)
   ("the highly polymorphic HLA class I" 1)
   ("HER2-negative ESCC showed preserved MHC class I" 1) ("class I" 1)
   ("a non-classical MHC class I molecule" 1) ("class I (MHCI)" 1)
   ("class I ( FANCL )" 1)))
 ("UP:P01901" (("H-2k" 4) ("H2-K" 1) ("H-2 k" 1)))
 ("UP:P01903"
  (("HLA-DRA" 29) ("major histocompatibility complex, class II, DR alpha" 2)))
 ("UP:P01906" (("HLA-DQA2" 16))) ("UP:P01909" (("HLA-DQA1" 29) ("HLADQA1" 4)))
 ("UP:P01911"
  (("DRB" 194) ("HLA-DRB1" 153) ("HLA–DRB1" 4) ("DRB-" 2) ("-DRB" 1)))
 ("UP:P01920"
  (("HLA-DQB1" 80) ("HLADQB1" 1) ("the MHC II DQ beta subunit HLA-DQB1" 1)))
 ("UP:P01939" (("αII" 8)))
 ("UP:P02008"
  (("fetuses" 159) ("HBZ" 118) ("HBZ protein" 6) ("Fetuses" 5)
   ("gestational age (SGA) fetuses" 1) ("gestational day 15–16 fetuses" 1)
   ("heteromeric HBZ" 1)))
 ("UP:P02042" (("HBD" 47) ("hBD" 12)))
 ("UP:P02100"
  (("HBE" 223) ("HBE1" 59) ("ε-globin" 54) ("epsilon 1" 8) ("HBE41o-" 1)
   ("the three primary HBE" 1)))
 ("UP:P02144" (("MB" 1205) ("myoglobin" 15) ("Myoglobin" 4) ("pMB" 1)))
 ("UP:P02238"
  (("N 2" 700) ("N  2" 18) ("n 2" 14) ("-N 2" 5) ("n  2" 3) ("-n 2" 1)
   ("N 2-" 1)))
 ("UP:P02241" (("hCds" 4))) ("UP:P02273" (("H2A1" 7)))
 ("UP:P02406" (("cyh2" 4) ("Cyh2" 2) ("CYH2" 2))) ("UP:P02448" (("HGT" 2)))
 ("UP:P02452"
  (("type I collagen" 484) ("COL1A1" 106) ("Type I collagen" 33) ("Col1a1" 25)
   ("Col1A1" 23) ("BD" 13) ("ColIA1" 10) ("polymerized type I collagen" 7)
   ("fibrous type I collagen" 4) ("fibrillar type I collagen" 3) ("ColIa1" 3)
   ("COLIA1" 2) ("Alexa Fluor 647–conjugated type I collagen" 2)
   ("IL-6 increased COL1A1" 2) ("type I collagen" 2)
   ("soluble rat tail type I collagen" 2) ("monomeric type I collagen" 1)
   ("dermal type I collagen" 1) ("dermal fibrillar type I collagen" 1)
   ("AlexaFluor 549-conjugated type I collagen (BD)" 1)
   ("type I collagen (CI)" 1) ("acid-insoluble fibrillar type I collagen" 1)))
 ("UP:P02458"
  (("AOM" 145) ("COL2A1" 49) ("Col2a1" 40) ("col2a1" 3) ("Col2A1" 2)))
 ("UP:P02461" (("COL3A1" 25) ("Col3A1" 5)))
 ("UP:P02462"
  (("type IV" 195) ("COL4A1" 23) ("Type IV" 13) ("type IV (MLIV)" 9)
   ("type IV" 3) ("exogenous collagen type IV" 1) ("type IV (CIV)" 1)))
 ("UP:P02489" (("HSPB4" 147) ("HspB4" 2) ("Hspb4" 1) ("HSPB4 protein" 1)))
 ("UP:P02511" (("CryAB" 133) ("HSPB5" 34) ("CRYAB" 20) ("HspB5" 13)))
 ("UP:P02518" (("heat shock protein 27" 73) ("Heat shock protein 27" 24)))
 ("UP:P02533"
  (("K14" 442) ("CK14" 173) ("KRT14" 34) ("keratin 14" 32) ("keratin-14" 31)
   ("cytokeratin 14" 26) ("EBS3" 17) ("keratin–14" 10) ("Keratin 14" 9)
   ("Cytokeratin 14" 8) ("Krt14" 7) ("k14" 3) ("Cytokeratin-14" 3) ("CK 14" 2)
   ("myoepithelial cytokeratin 14" 2) ("K14-" 1) ("Keratin-14" 1)
   ("basal K14" 1) ("myoepithelial Cytokeratin 14" 1)
   ("its heterodimeric partner K14" 1) ("CK-14" 1) ("-K14" 1) ("keratin14" 1)
   ("Ck14" 1)))
 ("UP:P02538"
  (("KRT6A" 3) ("K6a" 2) ("keratin 6" 2) ("Keratin 6" 1) ("keratin 6A" 1)))
 ("UP:P02545"
  (("lamin A/C" 259) ("lamin A" 168) ("Lamin A/C" 144) ("LMNA" 57)
   ("Lamin A" 41) ("Lmna" 33) ("lamin A protein" 4)
   ("Lamin
                            A/C"
    3)
   ("lamin A/C protein" 3) ("lmna" 2)
   ("targeting lamin A ( CCTGGACTTCCAGAAGAACA )" 2) ("-lamin A/C" 1) ("LmnA" 1)
   ("lamin A ( CCTGGACTTCCAGAAGAACA )" 1) ("LAMIN A/C" 1) ("-Lamin A/C" 1)))
 ("UP:P02549" (("SPTA1" 21) ("SPTA" 3)))
 ("UP:P02647"
  (("apoA-I" 126) ("APOA1" 23) ("apoA" 19) ("apolipoprotein A-I" 15)
   ("apoAI" 13) ("ApoA1" 11) ("apo A-I" 11) ("ApoA" 9) ("apolipoprotein A1" 8)
   ("apoA–I" 7) ("ApoAI" 4) ("ApoA-I" 3) ("Apolipoprotein A–I" 2) ("Apo A-I" 2)
   ("apolipoprotein A–I" 2) ("ABCA-1 expression markedly increases apoA-I" 2)
   ("apoA1" 1)))
 ("UP:P02649"
  (("ApoE" 833) ("APOE" 423) ("AD2" 91) ("apoE" 83) ("apolipoprotein E" 63)
   ("apoe" 20) ("Apolipoprotein E" 16) ("ApoE4" 14) ("Apoe" 13)
   ("apolipoprotein E (APOE)" 7) ("apolipoprotein-E" 4) ("ApoE protein" 3)
   ("apolipoprotein E4" 3) ("Apo E" 3) ("Ad2" 3) ("ApoE-" 2)
   ("Apolipoprotein-E" 1) ("APOE–" 1) ("Apolipoprotein E ( APOE )" 1)
   ("apolipoprotein E ( APOE )" 1) ("than APOE" 1)
   ("the extensive linkage disequilibrium (LD) structure around APOE" 1)
   ("the well-established genetic factor APOE" 1)))
 ("UP:P02652"
  (("apolipoproteins" 22) ("Apolipoproteins" 3) ("APOA2" 1)
   ("apolipoprotein A-II" 1)))
 ("UP:P02654" (("APOC1" 17)))
 ("UP:P02655" (("APOC2" 4) ("apolipoprotein C-II" 1)))
 ("UP:P02656"
  (("ApoCIII" 72) ("APOC3" 17) ("apo C-III" 6) ("ApoC-III" 2)
   ("apolipoprotein C3" 2) ("Apo C-III peptide" 2) ("ApocIII" 2)
   ("Apo C-III" 1)))
 ("UP:P02671" (("FGA" 21) ("fibrinogen alpha chain" 1)))
 ("UP:P02675"
  (("FGB" 9) ("Fibrinopeptide" 4) ("-Fibrinopeptide" 3) ("fibrinopeptide" 1)
   ("‐Fibrinopeptide" 1) ("fibrinogen beta chain" 1)))
 ("UP:P02679" (("FGG" 6) ("fibrinogen gamma chain" 1)))
 ("UP:P02686"
  (("MBP" 869) ("myelin basic protein" 112) ("Mbp" 30) ("-MBP" 26)
   ("Myelin basic protein" 8) ("myelin basic protein (MBP)" 7) ("pMBP" 5)
   ("MBp" 4) ("MBP protein" 4) ("the artificial substrate MBP" 3)
   ("Myelin basic protein (MBP)" 2) ("MBP-" 1) ("−MBP" 1)
   ("myelin
basic protein"
    1)
   ("Soluble MBP" 1) ("mature myelin protein MBP" 1) ("mature OL marker MBP" 1)
   ("mature myelin marker MBP" 1)))
 ("UP:P02689"
  (("MP2" 101) ("PMP2" 2) ("peripheral myelin protein 2" 2)
   ("Peripheral myelin protein 2" 1)))
 ("UP:P02701"
  (("avidin" 499) ("AVD" 73) ("Avidin" 69) ("using Monomeric Avidin" 2)
   ("biotinylated secondary antibody and streptavidin–horseradish peroxidase (HRP) avidin"
    2)
   ("avidin-" 2) ("using immobilized monomeric avidin" 1) ("AVd" 1) ("AvD" 1)
   ("avidin (DAKO)" 1)))
 ("UP:P02708"
  (("cholinergic receptor" 5) ("CHRNA1" 2)
   ("the M3 muscarinic cholinergic receptor" 2) ("CHRNA" 1) ("CHNRA" 1)))
 ("UP:P02724"
  (("MNs" 165) ("CD235a" 78) ("GpA" 43) ("GPA" 35) ("GPa" 24) ("GpA-" 21)
   ("MNS" 10) ("GYPA" 10) ("spinal MNs" 9) ("functional MNs" 5) ("GpA-(GGS)" 5)
   ("gpa" 3) ("Gpa" 2) ("embryonic spinal MNs" 1) ("primary MNs" 1)
   ("Glycophorin-A" 1) ("-purity functional MNs" 1)
   ("a mature CD36 low CD235a" 1) ("brachial MNs" 1) ("more MNs" 1)))
 ("UP:P02730"
  (("WR" 64) ("AE1" 53) ("band 3" 20) ("Slc4a1" 11) ("D  i" 7) ("d i" 5)
   ("WD1" 5) ("D i" 2) ("d i-" 1) ("WR-" 1) ("anion exchanger 1" 1)
   ("Band 3" 1) ("SLC4A1" 1)))
 ("UP:P02741"
  (("CRP" 1035) ("C-reactive protein" 217) ("Crp" 41) ("CRp" 30)
   ("C-reactive protein (CRP)" 20) ("CRP protein" 7) ("-CRP" 3)
   ("c-reactive protein" 3) ("cRP" 3) ("CRP-" 2) ("strong human CRP" 2)
   ("very weak or undetectable human CRP" 2) ("CrP" 2)
   ("C-reactive protein ( CRP )" 2) ("c-reactive protein (CRP)" 2)
   ("preoperative serum CRP" 1)
   ("C-reactive
protein"
    1)
   ("more CRP" 1) ("only 1 CRp" 1) ("than CRP" 1)
   ("incident diabetes, or plasma CRP" 1) ("raised C-reactive protein" 1)))
 ("UP:P02743"
  (("serum amyloid P-component" 1) ("pentraxin-related" 1) ("APCS" 1)))
 ("UP:P02745"
  (("a chain" 42) ("A chain" 18) ("C1QA" 6) ("complement component 1" 2)
   ("C1qa" 1)))
 ("UP:P02746" (("B chain" 20) ("C1QB" 2) ("C1qb" 1) ("-B chain" 1)))
 ("UP:P02747" (("c chain" 6) ("C chain" 3) ("C1QC" 2) ("C1qc" 1)))
 ("UP:P02749"
  (("BG" 328) ("-BG" 131) ("BGs" 52) ("APC inhibitor" 9) ("APOH" 4)
   ("the more intracellular BGs" 2) ("bg" 2) ("than bGS" 1) ("bGS" 1)
   ("Bg" 1)))
 ("UP:P02750" (("LRGs" 38) ("LRG1" 31) ("LRG" 6)))
 ("UP:P02751"
  (("fibronectin" 4928) ("FN" 2817) ("Fn" 780) ("Fibronectin" 382) ("FN1" 164)
   ("anastellin" 73) ("ED-B" 57) ("BD" 57) ("FN 1" 52) ("FN-1" 50) ("pFN" 47)
   ("intact FN" 41) ("fibronectin (FN)" 31) ("-fibronectin" 31)
   ("fibronectin 1" 27) ("fibronectin-" 25) ("soluble fibronectin" 17)
   ("FN molecule" 15) ("FN-" 12) ("FN peptide" 12) ("cellular fibronectin" 11)
   ("soluble FN" 10) ("Fn1" 9) ("exogenous FN" 8) ("FIBRONECTIN" 8)
   ("fibronectin peptide" 8) ("Fibronectins" 7) ("fibronectins" 7)
   ("Fusobacterium nucleatum" 6) ("Fibronectin 1" 6) ("soluble Fn" 6)
   ("exogenous plasma fibronectin" 5) ("more fibronectin" 5) ("fn 1" 5)
   ("intact fibronectin" 5) ("mesenchymal marker fibronectin" 4)
   ("FN protein" 4) ("the mesenchymal marker fibronectin" 4)
   ("oncofoetal fibronectin" 4) ("The bacterial cell surface fibronectin" 3)
   ("Anastellin" 3) ("Soluble Fn" 3)
   ("The most frequently targeted FN peptide" 3) ("oncofoetal fibronectins" 2)
   ("commercially available plasma fibronectin" 2)
   ("dermis fibroblasts release much more soluble fibronectin" 2)
   ("Gal-1 increased FN protein" 2)
   ("exogenous
 FN"
    2)
   ("functional FN" 2)
   ("the physiologically relevant macromolecular ligand fibronectin" 2)
   ("fibronectin (EMD)" 2) ("pCIG" 2) ("-FN1" 2)
   ("diabetes-induced increased FN protein" 2) ("Fibronectin (FN)" 2)
   ("oncofetal fibronectin" 2) ("exogenous fibronectin" 2)
   ("Briefly human plasma fibronectin" 2)
   ("30 µg/ml soluble rat plasma fibronectin" 2) ("fibroblastic fibronectin" 2)
   ("human plasmatic fibronectin" 2) ("oncofetal FN" 2) ("CIG" 2)
   ("a cellular fibronectin" 2) ("fibronectin (BD)" 2)
   ("the micro-printed fibronectin" 2) ("so called “normal” FN" 2)
   ("concequently total FN" 2) ("human oncofetal fibronectin" 2)
   ("lipid-associated FN" 1) ("associated FN" 1) ("either intact FN" 1)
   ("soluble fibronectin (FN)" 1)
   ("previously described oncofoetal fibronectins" 1)
   ("The ubiquitous matrix macromolecule fibronectin" 1)
   ("less total fibronectin" 1) ("more FN" 1) ("fetal fibronectin" 1)
   ("soluble plasma fibronectin" 1) ("heparin-treated Fn" 1) ("FN1 ( FN )" 1)
   ("than soluble fibronectin ( xref )" 1) ("protomeric fibronectin" 1)
   ("fluorescently-labeled fibronectin" 1)
   ("the modular matrix protein fibronectin (FN)" 1)
   ("Immunoreactive fibronectin" 1) ("the soluble Cy5-fibronectin" 1)
   ("fluorescent fibronectin" 1) ("full-length recombinant cellular FN" 1)
   ("Fibronectin-" 1) ("2 mg/ml Alexa Fluor 488-conjugated fibronectin" 1)
   ("fetal marker oncofetal fibronectin" 1) ("Fn 1" 1) ("than anastellin" 1)
   ("these MSCRAMMs target soluble Fn" 1) ("the compact soluble Fn" 1)
   ("the angiogenesis-associated ED-B" 1)
   ("the alternatively spliced angiogenesis-associated ED-B" 1)
   ("than FN (Fig. xref )" 1) ("than FN" 1) ("surface-bound FN" 1)
   ("surface-bound intact FN" 1) ("local FN" 1) ("fibronectin protein" 1)
   ("the pro-atherogenic protein fibronectin" 1) ("Defective FN" 1)
   ("available fibronectin" 1)
   ("20 ng/ml Alexa Fluor 488–conjugated fibronectin" 1)
   ("Alexa Fluor 488–conjugated fibronectin" 1) ("human seminal fibronectin" 1)
   ("Leukocytospermic seminal fibronectin" 1) ("monomeric fibronectin" 1)
   ("targeted FN peptide" 1) ("linking (citrullinated) FN" 1)
   ("plasmatic fibronectin" 1) ("the endogenous cellular fibronectin" 1)
   ("the fluorescent fibronectin" 1) ("astrocytic fibronectin" 1)
   ("we first prepared citrullinated fibronectin" 1) ("exogenous labeled FN" 1)
   ("The micro-printed fibronectin" 1)
   ("a highly clustered module around fibronectin" 1)))
 ("UP:P02753"
  (("RBPs" 93) ("RBP" 65) ("retinol binding protein 4" 3) ("new RBPs" 2)
   ("Such CNOT3-associated RBPs" 1)))
 ("UP:P02754" (("lactoglobulin" 9) ("beta-lactoglobulin" 1)))
 ("UP:P02760"
  (("iTILs" 78) ("UTI" 73) ("iTIL" 29) ("AMBP" 23) ("bikunin" 8) ("HI30" 4)
   ("At least one FOXP3+ iTIL" 2) ("EDC1" 2) ("Bikunin" 1)
   ("concurrent cytotoxic CD8+ iTILs" 1)))
 ("UP:P02763" (("Orm1" 7) ("orosomucoid 1" 2) ("agp1" 1)))
 ("UP:P02765" (("Ahsg" 1)))
 ("UP:P02766"
  (("TTR" 249) ("transthyretin" 9) ("shorter TTR" 4) ("tTR" 3) ("longer TTR" 2)
   ("significantly worse TTR" 2) ("shorter median TTR" 2) ("Transthyretin" 1)))
 ("UP:P02767"
  (("TT" 2132) ("“TT”" 12) ("-TT" 12) ("TT-" 10) ("‘TT’" 3)
   ("the Stat3 consensus sequences AA (N4) TT and AA (N5) TT" 2)
   ("homozygous TT" 1) ("the CC( c-kit2 T21)AG and TT( c-kit2 T21)TT" 1)
   ("-CTG CTT TGT ATT TC A CAA TGT TTT CAT TT-3" 1)))
 ("UP:P02768" (("Alb" 67) ("ALB" 41) ("Alb-" 3)))
 ("UP:P02771"
  (("AFP" 383) ("alpha-fetoprotein" 34) ("α-fetoprotein" 25)
   ("alpha fetoprotein" 9) ("Alpha-fetoprotein" 9)
   ("alpha-fetoprotein (AFP)" 8) ("α-fetoprotein (AFP)" 5)
   ("alphafetoprotein" 3) ("α-Fetoprotein" 3) ("AFP molecule" 2)
   ("preoperative alpha-fetoprotein (AFP)" 1) ("than serum AFP" 1)
   ("α-fetoprotein ( AFP )" 1) ("alpha fetoprotein (AFP)" 1)
   ("AFP protein" 1)))
 ("UP:P02774" (("G/C" 251) ("GC, vitamin D binding protein" 1) ("g/c" 1)))
 ("UP:P02775"
  (("TGB" 7) ("Cxcl7" 3) ("macrophage-derived growth factor" 3) ("Ppbp" 1)
   ("pro-platelet basic protein" 1)))
 ("UP:P02776"
  (("PF4" 33) ("platelet factor 4" 4) ("CXCL4" 2) ("PF-4" 2) ("Cxcl4" 2)
   ("PF-4 peptide" 1) ("PF4 (ELISA)" 1) ("Pf4" 1)))
 ("UP:P02778"
  (("CXCL10" 380) ("IP-10" 113) ("Cxcl10" 29) ("CXCL-10" 9) ("Ip10" 4)
   ("the angiostatic chemokine CXCL10" 3) ("CXCL10-" 1) ("CXCL10 protein" 1)
   ("exogenous CXCL10" 1)))
 ("UP:P02786"
  (("TfR" 220) ("transferrin receptor" 218) ("TfR1" 143) ("CD71" 82)
   ("TFRC" 37) ("TFR" 21) ("Transferrin Receptor" 13) ("TfRs" 10) ("TFR1" 9)
   ("Trf-R" 9) ("Transferrin receptor" 5) ("CD71)" 4) ("TrfR" 4)
   ("transferrin receptor-1" 3) ("CD71−" 3) ("Tfr1" 2) ("more TfR1" 2)
   ("transferrin receptor protein 1" 2) ("CD71+CD36-" 2) ("Tfrc" 2)
   ("the non-lipid raft-associated transferrin receptor" 2)
   ("the surface-localized TfR" 1) ("Transferrin Receptor (TR)" 1)
   ("more mature GpA+ CD71−" 1) ("Transferrin receptor protein 1" 1)
   ("P02786" 1)))
 ("UP:P02787"
  (("transferrin" 794) ("Tf" 245) ("Transferrin" 65) ("T/F" 51)
   ("fluorescent transferrin" 10) ("fluorescently-labeled transferrin" 5)
   ("–transferrin" 5) ("-transferrin" 3)
   ("Alexa Fluor 488–conjugated transferrin" 3) ("Transferrin-" 3)
   ("-Transferrin" 2) ("less Tf" 2) ("serotransferrin" 2) ("Tf-" 2)
   ("efficient Tf" 2) ("slightly more rapid Tf" 2) ("Fluorescent Tf" 2)
   ("Alexa Fluor 546-conjugated transferrin" 2)
   ("perinuclear labeled transferrin" 2)
   ("25 μg ml −1 Alexa Fluor 564-labeled transferrin" 2)
   ("diferric transferrin" 2) ("fluorescent human transferrin" 2)
   ("non-fluorescent transferrin" 2)
   ("clathrin dependent endocytic marker transferrin" 1)
   ("any residual transferrin" 1) ("the endocytosed fluorescent Tf" 1)
   ("fluorescent Tf" 1) ("endocytosed fluorescent Tf" 1) ("transferrin-" 1)
   ("488–labeled human Tf" 1) ("546–conjugated human Tf" 1)
   ("488–labeled Tf" 1) ("Alexa Fluor 564-labeled transferrin" 1)
   ("the endosomal marker Alexa-568–coupled transferrin" 1)
   ("total cell-associated (endocytosed and surface-bound) transferrin" 1)
   ("transferrin (TF)" 1) ("Surface-bound transferrin" 1)))
 ("UP:P02788"
  (("lactoferrin" 62) ("LTF" 17) ("Lactoferrin" 6) ("lactotransferrin" 3)
   ("lactoferrin (LTF)" 1)))
 ("UP:P02790" (("hemopexin" 24) ("HPX" 6) ("Hemopexin" 1)))
 ("UP:P02792" (("FTL" 25) ("ferritin light chain" 3)))
 ("UP:P02794"
  (("FHC" 60) ("FTH1" 28) ("ferritin heavy chain" 9) ("apoferritin" 5)
   ("heavy polypeptide 1" 5) ("ferritin heavy chain 1" 2) ("FTH" 1)
   ("any suspicious FHC" 1)))
 ("UP:P02795"
  (("MT2" 136) ("MT-2" 92) ("MT2A" 36) ("MT-2A" 11) ("-MT2" 6) ("pMT2" 5)
   ("mt-2" 3) ("metallothionein 2A" 2)
   ("the immortalized ErbB2-induced mammary cancer cell line MT2" 2)
   ("Metallothionein 2A" 1) ("the previous MT2A" 1) ("metallothionein 2" 1)
   ("the Human T lymphotropic virus type 1 (HTLV-1) in vitro transformed CD4 + T-cell line MT-2"
    1)))
 ("UP:P02807" (("CMT" 56) ("axonal CMT type 2F" 2) ("hyperactive CMT" 2)))
 ("UP:P02808"
  (("STRs" 55) ("three novel polymorphic STRs" 3) ("statherin" 1)
   ("multi-allelic STRs" 1) ("23 highly informative STRs" 1)
   ("autosomal STRs" 1)))
 ("UP:P02810"
  (("protein A" 1340) ("Protein A" 562) ("protein C" 130) ("Dbs" 35)
   ("protein a" 25) ("protein c" 24) ("protein A-" 22) ("protein A–" 8)
   ("Protein C" 7) ("Protein A-" 5) ("protein C (APC)" 5)
   ("protein A (HMGA)" 5) ("protein A (CSDA)" 4) ("Protein A (PAPPA)" 3)
   ("Helicobacter pylori-cytotoxin-associated protein A" 2)
   ("actor-induced protein C" 2) ("protein  A" 1)
   ("The metalloprotease Pregnancy-Associated Plasma Protein A (PAPPA)" 1)
   ("our causal analysis uncovered Pregnancy-Associated Plasma Protein A (PAPPA)"
    1)
   ("The microbial virulence factor protein A" 1) ("Protein A–" 1)
   ("paramagnetic protein A" 1)))
 ("UP:P02812" (("pRb2" 1)))
 ("UP:P02818"
  (("osteocalcin" 237) ("OCs" 227) ("OCN" 80) ("BGP" 61) ("Osteocalcin" 50)
   ("osteocalcin protein" 3) ("late osteogenic markers osteocalcin" 2)
   ("most OCs" 2) ("serous OCs" 2) ("mucinous OCs" 2) ("bone Gla protein" 2)
   ("nonfamilial HGS OCs" 2) ("7 glucose-tolerant OCs" 1)
   ("BRCA-associated OCs" 1) ("osteocalcin (OC)" 1) ("Hereditary OCs" 1)
   ("Most OCs" 1) ("epithelial OCs" 1) ("osteocalcin (OCN)" 1)
   ("Osteocalcin (OCN)" 1) ("primary OCs" 1) ("Osteocalcin (OC)" 1)
   ("primary epithelial OCs" 1) ("than BRCA1 and BRCA2 wild-type OCs" 1)
   ("High-grade serous (HGS) OCs" 1) ("than wild-type BRCA OCs" 1)))
 ("UP:P02855"
  (("type A" 124) ("Type A" 10) ("microfluidic card type A" 2)
   ("Ohshima type A2" 1)))
 ("UP:P02867" (("LECA" 5)))
 ("UP:P02872" (("PNA" 467) ("-PNA" 6) ("pNA" 5) ("a telomeric PNA" 2)))
 ("UP:P02879" (("ricin" 1) ("Ricin" 1))) ("UP:P02964" (("sIgH" 12)))
 ("UP:P03018" (("UvrD" 14)))
 ("UP:P03036" (("cRO" 12) ("CrO" 11) ("CRO" 10) ("pure cRO" 1)))
 ("UP:P03038" (("TetR" 22) ("tetR" 4))) ("UP:P03046" (("CIM" 51)))
 ("UP:P03076" (("Middle T antigen" 8)))
 ("UP:P03135"
  (("VP1" 86) ("capsid protein VP1" 6) ("viral capsid protein VP1" 1)))
 ("UP:P03230"
  (("LMP1" 2142) ("LMP1 protein" 24) ("LMP1-" 6)
   ("unrelated viral proteins—Epstein-Barr virus (EBV) LMP1" 2)
   ("conditional LMP1" 2) ("their parental cells HNE2-LMP1" 2)
   ("their parental cell line HNE2-LMP1" 2) ("cytoplasm-positive LMP1" 2)
   ("protein p63" 2) ("-LMP1" 2) ("the viral oncoprotein LMP1" 1)
   ("the viral protein LMP1" 1) ("here indicated LMP1" 1)
   ("Bay11-7082-treated HNE2-LMP1" 1) ("The retroviral vector pMX LMP1" 1)
   ("the prototypic B95-8 LMP1" 1)))
 ("UP:P03244"
  (("E1B" 112) ("E1B-55K" 26) ("-E1B" 5) ("E1B-55K protein" 3)
   ("the adenoviral protein E1B55K" 2) ("adenoviral protein E1B-55K" 1)))
 ("UP:P03247" (("E1B-19K" 9))) ("UP:P03269" (("pT-P" 8) ("pT–P" 1)))
 ("UP:P03274" (("pVI" 14))) ("UP:P03280" (("pVIII" 11)))
 ("UP:P03333"
  (("Gag" 890) ("gag" 228) ("HIV-gag (77–85) (SLYNTYATL) peptide" 4) ("-gag" 3)
   ("gAg" 2) ("viral precursor Gag" 2) ("GAg" 1) ("more gag" 1)
   ("NM-tropic viral Gag" 1) ("non-CD3-associated cytoplasmic Gag" 1)
   ("released viral p24 Gag" 1) ("relatively little Gag" 1)
   ("The former targets Gag" 1) ("gag-" 1) ("the viral protein Gag" 1)))
 ("UP:P03372"
  (("ER" 24652) ("ERα" 17755) ("ESR1" 4214) ("estrogen receptor" 2563)
   ("ER-α" 1753) ("ER-" 739) ("ER−" 469) ("estrogen receptors" 466)
   ("estrogen receptor alpha" 336) ("ERα protein" 277) ("ESR" 253)
   ("Estrogen receptor" 183) ("estrogen receptor (ER)" 176) ("ER-alpha" 146)
   ("-ERα" 143) ("E/R" 133) ("ERα-" 77) ("Estrogen Receptor" 75)
   ("estrogen receptor 1" 72) ("ER protein" 58) ("estrogen-receptor" 50)
   ("ERalpha" 45) ("estrogen receptor-alpha" 42) ("Estrogen receptors" 38)
   ("pERα" 28) ("-ER" 25) ("Estrogen Receptor alpha" 25)
   ("Estrogen receptor alpha" 24) ("ESRs" 24) ("ERα−" 20) ("ER–" 17)
   ("ESR1 protein" 17) ("ESR1−" 17) ("ESR1-" 16) ("Estrogen receptor-alpha" 14)
   ("Erα" 13) ("estrogen receptor-" 13) ("Estrogen Receptors" 12)
   ("ER-α protein" 12) ("estrogen receptors (ER)" 11) ("overexpressed ERα" 10)
   ("Esr1" 7) ("estradiol receptor" 7) ("membrane-associated ERα" 6)
   ("estrogen receptor protein" 6) ("ER-alpha-" 6) ("ERα Protein" 6) ("p-ER" 5)
   ("than ER" 5) ("E/R protein" 5) ("p-ERα" 5) ("exogenous ERα" 5)
   ("estrogen–receptor" 5) ("the classical estrogen receptors" 5)
   ("Estrogen-receptor" 4) ("ER-α-" 4) ("robust ERα" 4) ("than ERα" 4)
   ("erα" 4) ("Estrogen Receptor 1" 4) ("classical estrogen receptors" 4)
   ("directly target ESR1" 4) ("P03372" 4) ("Estrogen Receptor Alpha" 4)
   ("the strong nuclear expression (score 12) ERα" 4) ("the epithelial ERα" 4)
   ("ERα (HEGO)" 4) ("Estrogen receptor (ER)" 3) ("exogenous ER-α" 3)
   ("functional ER" 3) ("Estrogen Receptor (ER)" 3) ("extranuclear ERα" 3)
   ("the classical ER" 3) ("the classical ER-α" 3) ("ER-αs" 3)
   ("estrogen receptor alpha (ERα) protein" 3) ("whose tumors expressed ER" 3)
   ("NR3A1" 2) ("ERα–" 2) ("clear distinguishable ER" 2)
   ("functional membrane-associated ERα" 2) ("membrane-associated ER" 2)
   ("than wild-type ESR1" 2)
   ("ESR1
protein"
    2)
   ("the latter type E2-bound ERα" 2) ("a functional ER" 2)
   ("the classical ERα" 2) ("Cellular ERα" 2) ("the predominant ER" 2)
   ("coactivator-bound ER D538G" 2) ("functional ERα" 2) ("central ER" 2)
   ("five ERα-regulating miRNAs (e.g. miR-18a, miR-18b, miR-193b, miR-302c, and miR-206) directly targeted ERα"
    2)
   ("MiR-222-3p directly targets ERα" 2) ("more ERα" 2)
   ("Endogenously-expressed ERα" 2) ("stromal ER" 2)
   ("tested biomarkers showed ER" 2) ("The two distinct estrogen receptors" 2)
   ("the breast epithelial-associated transcript ESR1" 2)
   ("heterogeneous ER" 2)
   ("Cyclin D1 co-precipitated cytoplasmic membrane-associated ERα" 2)
   ("transitional ER" 2) ("the 444–456 amino acids of ERα" 2)
   ("-estrogen receptor" 2)
   ("the conventional breast cancer pathological markers ER" 2)
   ("oestrogen-bound ER" 2) ("“estrogen receptor”" 2)
   ("the membraneous estrogen receptor" 2)
   ("the well-studied modulator gene estrogen receptor 1" 2)
   ("A nuclear-localization defective ER" 2) ("ERα (PPT)" 2)
   ("Estrogen Receptor-alpha" 2) ("expressing YFP-K303R ERα" 2)
   ("exogenous and endogenous ERα" 2) ("estrogen-receptor (ER)" 2)
   ("strong nuclear ERα" 2) ("ER+PR−" 2) ("the associated ER" 2)
   ("than ESR1" 2) ("only negative ER" 2) ("very little ERα" 2)
   ("functional estrogen receptors" 2) ("estrogen receptor–" 2)
   ("the normal-sized ERα" 2) ("\"faint\" or \"low\" ER" 2)
   ("strong (2+ or 3+) positive ER" 2)
   ("the hypersensitive ER-α A908G point mutation" 2)
   ("multiple known and novel ERα" 2) ("both known and unknown ERα" 2)
   ("both percent ER" 2) ("ALH showed less ER" 2)
   ("its relevant receptor ERα" 2) ("ERα+/ERβ−" 2)
   ("so-called non-genomic or alternative estrogen receptors" 2) ("new ERα" 2)
   ("known prognostic and predictive factors such ER" 2)
   ("estrogen receptor ( ER )" 2) ("whose ERα" 2)
   ("normal MECs expressing exogenous ERα" 2)
   ("microdissected samples yield more homogeneous ERα" 2)
   ("subcompartment-resident ERα" 2) ("the classic estrogen receptor" 2)
   ("classical ER-α" 2) ("the classical 67-kDa ER-α protein" 2)
   ("its classical estrogen receptors" 2) ("the only functional ER" 2)
   ("these therapies directly target ERα" 2) ("expressing ERα" 2)
   ("cells showed ER" 2) ("a fully functional ERα" 2) ("ER (RER)" 1)
   ("undetectable endogenous ER" 1) ("endogeneous ERα" 1)
   ("estrogen receptor (GPER)" 1) ("genomic ER-" 1) ("functional ESR1" 1)
   ("five or more ESR1" 1) ("than ER-" 1)
   ("than
wild-type ER"
    1)
   ("than wild-type ESR1 ( xref )" 1)
   ("very few breast cancer PDXs expressing ER" 1)
   ("the former type nuclear ERα" 1) ("than wild-type ERα ( xref )" 1)
   ("the amino acid(s) of ERα that is phosphorylated by Aurora-A" 1)
   ("prominent ERα" 1) ("neuronal ERα" 1) ("the approximately 65 kDa ERα" 1)
   ("robust ERα protein" 1) ("showed strong ERα" 1) ("Neuronal ERα" 1)
   ("neuronal ERα protein" 1) ("cortical ERα protein" 1)
   ("than wild-type ERα" 1) ("than mutant ER ( xref )" 1) ("than WT ER" 1)
   ("weak ERα" 1) ("primary E/R" 1) ("a nonfunctional estrogen receptor" 1)
   ("aberrant ER" 1) ("Two major estrogen receptor" 1) ("targeted ERα" 1)
   ("expressing ER" 1) ("the last 138 amino acids of ER-α66" 1)
   ("plasma membrane-associated ER-α" 1) ("still significant residual ERα" 1)
   ("expressing full-length ERα" 1) ("had greater residual ERα" 1)
   ("significantly more ERα" 1) ("other key ERα" 1) ("Nongenomic ERα" 1)
   ("The classical ERα" 1) ("proapoptotic ER" 1)
   ("the subsequent ERα protein" 1) ("The dimeric ERα" 1) ("invasive ER-" 1)
   ("unique ER" 1) ("ERalpha-" 1) ("namely two ESR1" 1)
   ("Most reports consolidated ERα" 1) ("“estrogen receptors”" 1)
   ("a highly developed ER" 1) ("the two ER's" 1) ("estrogen receptor—alpha" 1)
   ("er" 1) ("both somatic ER" 1) ("eR" 1)
   ("a functional estrogen receptor (ER)" 1) ("genomic ERα" 1)
   ("Estrogen receptor-" 1) ("ER+/HER2-" 1)
   ("the well-studied modulator gene ESR1" 1)
   ("than ER (PTPH1 IP, Figures xref )" 1)
   ("a nuclear-localization defective ER" 1) ("the respective ER" 1)
   ("the principal estrogen receptor" 1) ("than wild type ERα suggesting" 1)
   ("whose tumors exploit ERα" 1) ("basal and non-basal ER−" 1)
   ("the villous CT expressed ERα" 1) ("showed very weak nuclear ERα" 1)
   ("placental ERα" 1) ("estrogen receptor alpha (ER-alpha) protein" 1)
   ("either strong ERα" 1) ("ER-alpha protein" 1)
   ("practical purpose no ERα" 1) ("the original ER-α" 1)
   ("DACH1-associated ERα" 1) ("the hypersensitive K303R ERα" 1)
   ("mutant ERα‘s" 1) ("than WT ERα" 1) ("mutant ERα’s" 1)
   ("the predominant ER protein" 1) ("than ERα [ xref ]" 1)
   ("exogenous ERα protein" 1) ("enough exogenous ERα protein" 1)
   ("a membranous estrogen receptor" 1) ("adjacent ESR1" 1) ("the ER’s" 1)
   ("FoxO3a(A3)-ER and FoxO1(A3)-ER" 1) ("only one ER" 1) ("the major ER" 1)
   ("The total cellular ER-α" 1) ("a unique ER" 1) ("nearly all ESR1" 1)
   ("estrogen receptor ( ESR )" 1) ("smaller molecular weight ERα" 1)
   ("normal ERα" 1) ("than the normal-sized ERα (66 kDa)" 1)
   ("estrogen receptor-α (ER)" 1) ("Our selection held more ER-" 1)
   ("the previously identified ERα" 1) ("around ERα" 1) ("Nr3a1" 1)
   ("the dimeric ER" 1) ("SIAH2-positive samples expressed ER" 1)
   ("these non-classical estrogen receptors" 1) ("Estrogen receptors-" 1)
   ("For instance miR-193b (5.5 fold higher in ESR1+ cells in our study) directly targets ESR1"
    1)
   ("than ERα bound to the same site" 1) ("associated ER" 1) ("given ERα's" 1)
   ("given ERα" 1) ("Er" 1) ("Endogenous ERα's" 1) ("further support ERα" 1)
   ("P-ER" 1) ("less ERα" 1) ("estrogen receptor alpha (ER)" 1)
   ("the classical “nuclear” ERα" 1) ("proproliferative ERα" 1)
   ("a functional estrogen receptor" 1)
   ("pBridge(Mod)-ERα-ΔLBD or pBridge(Mod)-ERα" 1)
   ("tamoxifen-treated K5cre  ER" 1) ("secondary ERα" 1)
   ("estrogen receptor(ER)" 1) ("the nongenomic ER-α" 1)
   ("full length heterodimerized ER" 1) ("stromal ERα" 1)
   ("estrogen receptor-alpha-" 1) ("cellular ERα" 1)
   ("453-397 C allele secret more variant ESR1" 1) ("“ER”" 1) ("than ER-α" 1)
   ("than ERα ( xref )" 1) ("than ERα in both gastric tumors" 1)
   ("the benign samples ESR1" 1) ("than 70% ER labeling" 1)
   ("a hypomorphic ERα" 1) ("the principal ER" 1) ("“ESR1”" 1)
   ("“Estrogen Receptor 1”" 1) ("“ERα”" 1) ("“estrogen receptor alpha”" 1)))
 ("UP:P03399" (("gp22" 2)))
 ("UP:P03406"
  (("Nef" 8218) ("Nef protein" 385) ("Nef-" 43) ("Nef Protein" 15)
   ("soluble Nef" 10) ("soluble Nef protein" 7) ("“Nef”" 5)
   ("the viral Nef protein" 3) ("amino acids of Nef" 3) ("that Nef’s" 2)
   ("HIV-1 Nef’s" 2) ("-Nef" 2) ("the HIV viral Nef protein" 2)
   ("The retroviral vector LZRS-NA7-IRES-eGFP encoding Nef" 2)
   ("membrane-associated Nef" 2) ("flag-tagged Nef" 2) ("triple-labeled Nef" 2)
   ("the previously studied truncated Nef" 2) ("viral Nef protein" 2)
   ("even simian immunodeficiency virus Nef" 2)
   ("the myristoylation defective Nef" 2) ("exclusively transport Nef" 2)
   ("21 novel cellular Nef" 2) ("study Nef's" 2)
   ("the early viral gene product Nef" 1) ("‘Nef’" 1)
   ("than the wild-type Nef protein" 1) ("Soluble Nef" 1)
   ("than HIV-1/SIVcpz Nef [ xref ]" 1) ("than 171 Nef (TGR 0.6)" 1)
   ("targeting HIV-1 Nef" 1) ("the viral pathogenicity factor HIV-1 Nef" 1)
   ("recombinant soluble Nef" 1) ("Recombinant soluble Nef protein" 1)
   ("soluble and ectopic Nef" 1) ("than the HJ162 Nef ( xref and xref )" 1)
   ("this latter conformation Nef" 1) ("a uniquely defective Nef" 1)
   ("previously mentioned Nef" 1)
   ("Many simian immunodeficiency viruses (SIVs) use Nef" 1)
   ("its simian precursors employ Nef" 1) ("More recently HIV-1 Nef" 1)
   ("exogenous HIV-1 Nef" 1) ("HAECs exogenous Nef" 1) ("Nef−" 1)
   ("the second proline of Nef’s" 1) ("the second proline of Nef" 1)
   ("weakened Nef’s" 1) ("the strong impact Nef" 1)
   ("the HIV accessory gene product Nef" 1) ("the viral gene Nef" 1)
   ("recombinant His-6-tagged Nef" 1) ("primate lentiviral Nef" 1)
   ("the last five amino acids of Nef" 1) ("these latter Nef" 1)
   ("the so called Nef" 1) ("than cells not expressing Nef" 1)
   ("The lentiviral Nef protein" 1) ("intact Nef" 1) ("particular Nef" 1)
   ("2c directly target Nef" 1) ("a strong Nef" 1) ("these primary Nef" 1)
   ("primary Nef" 1) ("The HIV-1 accessory factor Nef" 1)
   ("at least four Nef" 1) ("than Nef" 1) ("the respective Nef" 1)
   ("representative Nef" 1) ("SIVcpz and SIVgor clearly use Nef" 1)
   ("Exogenous Nef" 1)))
 ("UP:P03409"
  (("Tax" 2081) ("TAX" 52) ("tax" 28) ("Tax peptide" 19)
   ("Tax peptide (LLFGYPVYV)" 4) ("the viral protein Tax" 3) ("Tax molecule" 3)
   ("the viral regulatory protein Tax" 3) ("coexpressed WT Tax" 2)
   ("the viral oncoprotein Tax" 2) ("Tax–" 2)
   ("purified hexa-histidine-tagged Tax" 2) ("than Tax" 2)
   ("Tax (LLFGYPVYV)" 2) ("the viral oncoprotein TAX" 2)
   ("the secreted viral protein Tax" 2) ("the viral transactivator Tax" 2)
   ("viral transactivator Tax" 2) ("the N-terminal 40 amino acids of Tax" 1)
   ("the 20 C-terminal amino acids of Tax" 1)
   ("the viral transactivating protein Tax" 1) ("viral oncoprotein Tax" 1)
   ("than non-fused Tax" 1)
   ("than the wild-type Tax (Fig. xref right panel)" 1)
   ("than the wild-type Tax" 1) ("hexa-histidine-tagged Tax" 1)
   ("PDLIM2 directly shuttles Tax" 1)))
 ("UP:P03528" (("sigma-1" 1)))
 ("UP:P03548"
  (("protein 2" 441) ("Protein 2" 35) ("S phase kinase-associated protein 2" 4)
   ("cullin-associated NEDD8-dissociated protein 2" 3)
   ("the cytoskeleton-associated protein 2" 3) ("bone morphogenic protein 2" 3)
   ("the S phase kinase–associated protein 2" 3) ("protein 2 (IRP)" 2)
   ("the spermatogenesis-associated protein 2" 2)
   ("the TGF-β family member bone morphogenic protein 2" 2)
   ("metastasis associated protein 2" 2) ("boneless morphogenic protein 2" 2)
   ("The heterotetrameric clathrin-associated adaptor protein 2" 2)
   ("Fragile X related protein 2" 2)
   ("sterol-regulatory element-binding protein 2" 2)
   ("enhanced blue fluorescent protein 2" 1)
   ("leukemia inhibitor factor, and bone morphogenic protein 2" 1)))
 ("UP:P03552" (("virion-associated protein" 7)))
 ("UP:P03609"
  (("L protein" 77) ("l protein" 68) ("l Protein" 17) ("L Protein" 2)
   ("than BIM L protein" 1)))
 ("UP:P03657"
  (("MHC-I" 387) ("collagen-I" 83) ("GGTI" 70) ("Collagen-I" 13)
   ("topoisomerase-I" 6) ("overexpressed MHC-I" 3)
   ("Asthma derived ASM cells produced more collagen-I" 2)
   ("six-well Bioflex Collagen-I" 1) ("collagen­I" 1) ("MHC-I–" 1)))
 ("UP:P03679"
  (("protein-1" 413) ("TAPI-1" 107) ("Protein-1" 35) ("sirtuin-1" 28)
   ("Sirtuin-1" 14) ("sirtuin-1 (SIRT1) protein" 13) ("Cancer-1" 4)
   ("IL-1 family" 4) ("monocyte chemoattractive protein-1" 4) ("PROTEIN-1" 4)
   ("cancer-1" 3) ("protein–1" 2)
   ("Cyclin Dependent Kinase-2 Associated Protein-1" 2) ("JNK1-1" 2)
   ("cysteine-histidine-rich protein-1" 2)
   ("the mammalian α-tocopherol associated protein-1" 2)
   ("latent transforming growth factor-β-binding protein-1" 2)
   ("the scaffolding molecule Grb-2-associated binding protein-1" 2)
   ("Ras-associated protein-1" 2) ("yes-associated protein-1" 2)
   ("Lysosomal membrane–associated protein-1" 2)
   ("The streptococcal collagen-like protein-1" 2)
   ("the streptococcal collagen-like protein-1" 2)
   ("membrane-associated guanylate kinase (MAGUK) protein-1" 2)
   ("multidrug-resistance-associated protein-1" 2)
   ("caspase recruitment domain-containing membrane-associated guanylate kinase protein-1"
    1)))
 ("UP:P03702"
  (("IB" 724) ("GAM" 18) ("pIB" 8) ("a K48-ubiquitin-specific IB" 2)
   ("than stage IB (N = 1/42, 2.4%)" 1)))
 ("UP:P03709" (("FI" 132) ("Fi" 2)))
 ("UP:P03732" (("pGPU" 22) ("GPU" 6) ("GPU (NVIDIA)" 3)))
 ("UP:P03734" (("TAC" 541) ("-TAC" 30) ("namely both TAC" 2) ("TAC-" 1)))
 ("UP:P03762" (("GIT" 75) ("GIT-" 2) ("the human foetal GIT" 1)))
 ("UP:P03764" (("STF" 38))) ("UP:P03869" (("TMR" 111)))
 ("UP:P03870"
  (("Flp" 235) ("FLP" 53) ("flp" 5) ("FLp" 5) ("eyeless -FLP" 2) ("-FLP" 1)))
 ("UP:P03882"
  (("I-SceI" 480) ("omega" 50) ("OMEGA" 6) ("targeted I-SceI" 2) ("I-sceI" 1)
   ("exogenous I-SceI" 1) ("pkn-1 mutants display more frequent omega" 1)
   ("expressing endonuclease I-SceI" 1) ("I-SceI-" 1) ("I–SceI" 1)))
 ("UP:P03886"
  (("rotenone" 510) ("Rotenone" 54) ("ND1" 44) ("NADH dehydrogenase 1" 6)
   ("NADH dehydrogenase subunit 1" 3)
   ("rotenone and thenoyltrifluoroacetone (TTFA)" 2) ("NAD1" 1)))
 ("UP:P03891" (("ND2" 30) ("nd2" 1) ("NADH2" 1) ("mtND2" 1)))
 ("UP:P03897" (("ND3" 15) ("mt-ND3" 7))) ("UP:P03901" (("ND4L" 1)))
 ("UP:P03905" (("ND4" 8) ("NADH dehydrogenase 4" 3)))
 ("UP:P03915" (("ND5" 89) ("MT-ND5" 2) ("NADH dehydrogenase 5" 2)))
 ("UP:P03923"
  (("ND6" 15) ("NADH dehydrogenase 6" 3) ("NADH dehydrogenase subunit 6" 2)))
 ("UP:P03928" (("A6L" 2)))
 ("UP:P03950"
  (("angiogenin" 281) ("Angiogenin" 37) ("ANG" 1) ("that angiogenin’s" 1)
   ("p53 showed decreased angiogenin" 1)
   ("the multi-functional angiogenin" 1)))
 ("UP:P03951" (("PTA" 25))) ("UP:P03952" (("KLKB1" 4) ("plasma kallikrein" 3)))
 ("UP:P03956"
  (("MMP-1" 5732) ("MMPs" 2334) ("MMP1" 1842) ("matrix metalloproteinase-1" 90)
   ("interstitial collagenase" 62) ("MMP-1 protein" 57) ("MMP 1" 50)
   ("matrix metalloproteinase 1" 29) ("Matrix metalloproteinase-1" 29)
   ("Matrix metalloproteinase 1" 11) ("mmp1" 11) ("Mmp1" 10) ("MMP1-" 8)
   ("MMP1 protein" 7) ("most MMPs" 7) ("exogenous MMP-1" 6) ("MMP-1-" 5)
   ("-MMP1" 5) ("increased stromal MMP-1" 4) ("Most MMPs" 4)
   ("only four MMPs" 4) ("activated exogenous MMP-1" 3) ("MMP­1" 3)
   ("latent MMPs" 3) ("exogenous MMP1" 3) ("Matrix Metalloproteinase-1" 3)
   ("immunoreactive MMP-1" 3) ("some other soluble MMPs" 2)
   ("exogenously-supplemented purified MMP-1" 2) ("exogenous active MMP-1" 2)
   ("tissue-destructive MMPs" 2) ("MMP-1 Protein" 2) ("soluble factors MMPs" 2)
   ("the key MMPs" 2) ("approximately two-fold greater MMP-1" 2)
   ("Exogenous MMP-1" 2) ("soluble MMPs" 2) ("Gelatinolytic soluble MMPs" 2)
   ("‘classical’ MMPs" 2) ("the collagenolytic MMP-1" 2)
   ("independently increases MMP1" 2) ("more MMP-1" 2)
   ("high glucose increases more MMP-1" 2) ("Matrix Metallopeptidase 1" 2)
   ("a prototypic interstitial collagenase" 2) ("cellular MMPs" 2)
   ("metalloproteinase 1" 2) ("the few MMPs" 2) ("at least 24 MMPs" 2)
   ("the so-called membrane-type MMPs" 2) ("A few MMPs" 2)
   ("all soluble MMPs" 1) ("the most widely expressed MMPs" 1)
   ("exogenously-supplied human recombinant MMP-1" 1)
   ("90% less MMP-1 protein" 1) ("almost all MMPs" 1)
   ("than other MMPs (data not shown and [ xref ])" 1)
   ("particularly membrane-type (MT) MMPs" 1) ("than other MMPs" 1)
   ("than MMP-1" 1) ("the secretary MMP1" 1) ("most well-characterized MMPs" 1)
   ("distinct MMPs" 1) ("CLG" 1) ("the key collagenolytic MMPs MMP-1" 1)
   ("the key collagenolytic MMPs" 1) ("-MMP-1" 1) ("representative MMPs" 1)
   ("stromal MMPs" 1) ("here link MMP-1" 1) ("exogenously-added MMP-1" 1)
   ("Stromal-derived MMP1" 1) ("stromal-derived MMP-1" 1) ("latent MMP-1" 1)
   ("latent MMP1" 1) ("collagenolytic MMPs" 1) ("matrix metallopeptidase 1" 1)
   ("the elastolytic MMPs" 1) ("subsequent MMP1" 1) ("more MMP-1 protein" 1)
   ("membrane-associated matrix metalloproteinase-1" 1)
   ("than 20 MMPs that have been identified [ xref ]" 1)
   ("endothelial MMP-1" 1) ("invasion-associated MMPs" 1)
   ("the most ubiquitously expressed interstitial collagenase" 1)
   ("the entire MMP1" 1) ("membrane-associated MMPs" 1)
   ("basal and induced MMP1" 1) ("line produced significantly less MMP-1" 1)
   ("Metalloproteinase 1" 1) ("exogenous human MMP-1" 1)
   ("exogenous human (h)MMP-1" 1) ("excessive MMP-1" 1) ("pro-invasive MMPs" 1)
   ("“MMP1”" 1) ("“matrix metalloproteinase-1”" 1)))
 ("UP:P03971"
  (("AMH" 223) ("mIS" 82) ("MIS" 26) ("anti-Mullerian hormone" 3) ("MIs" 3)
   ("anti-Mullerian hormone (AMH)" 2) ("The Normal mIS" 1)
   ("than MIS (Table  xref )" 1) ("intrafollicular AMH" 1)))
 ("UP:P03973"
  (("ALP" 366) ("SLPI" 31) ("Alp" 31) ("Slpi" 24)
   ("secretory leukocyte peptidase inhibitor" 6)
   ("tEGF increases osteogenic differentiation markers ALP" 2)
   ("skin-derived antileukoproteinase (SKALP)" 2)
   ("samples showed complete ALP" 2) ("EMD surfaces displayed intense ALP" 2)
   ("antileukoproteinase" 1)))
 ("UP:P03979" (("Tcrb" 3) ("TCRb" 1)))
 ("UP:P03989"
  (("subtypes" 5320) ("histological subtypes" 76) ("Subtypes" 61)
   ("histologic subtypes" 40) ("different histological subtypes" 32)
   ("triple-negative subtypes" 19) ("the histological subtypes" 14)
   ("other histological subtypes" 11) ("other histologic subtypes" 11)
   ("all histological subtypes" 10) ("different histologic subtypes" 10)
   ("Histologic Subtypes" 10) ("aggressive subtypes" 9) ("mucinous subtypes" 8)
   ("Histological subtypes" 7) ("the breast cancer intrinsic subtypes" 7)
   ("the monocytic subtypes" 6) ("the histologic subtypes" 5)
   ("multiple histologic subtypes" 5) ("the different histological subtypes" 5)
   ("all histologic subtypes" 5) ("two major histological subtypes" 5)
   ("HER2-positive subtypes" 5) ("the major histological subtypes" 5)
   ("histopathologic subtypes" 5) ("neuronal subtypes" 5)
   ("more aggressive subtypes" 4) ("several histological subtypes" 4)
   ("pathological subtypes" 4) ("each histological subtypes" 4)
   ("two histological subtypes" 4) ("the two histological subtypes" 4)
   ("macroscopic subtypes" 4) ("morphologic subtypes" 4) ("SUBTYPES" 4)
   ("the two major histological subtypes" 4) ("most subtypes" 4)
   ("two or more subtypes" 4) ("certain histologic subtypes" 4)
   ("lung cancer histological subtypes" 3) ("two predominant subtypes" 3)
   ("four histological subtypes" 3) ("the most aggressive subtypes" 3)
   ("-negative subtypes" 3) ("The histological subtypes" 3)
   ("predominant subtypes" 3) ("nonmucinous subtypes" 3)
   ("the predominant histological subtypes" 3)
   ("smaller histological subtypes" 3) ("the different histologic subtypes" 3)
   ("the major histologic subtypes" 3) ("breast cancer biological subtypes" 3)
   ("estrogen receptor–positive subtypes" 3) ("clinically relevant subtypes" 3)
   ("various histological subtypes" 3) ("the other histological subtypes" 3)
   ("the various histological subtypes" 3)
   ("the most frequent histological subtypes" 3) ("the intrinsic subtypes" 3)
   ("diffuse and intestinal subtypes" 2) ("specific histological subtypes" 2)
   ("the NSCLC histologic subtypes" 2)
   ("pemetrexed-resistant histological subtypes" 2)
   ("different pathologic subtypes" 2) ("three phenotypic subtypes" 2)
   ("five surrogate intrinsic subtypes" 2)
   ("the Mesenchymal and Neural subtypes" 2) ("five major subtypes" 2)
   ("the less frequent pleomorphic subtypes" 2)
   ("IDC triple-negative subtypes" 2) ("the main histological subtypes" 2)
   ("biologic subtypes" 2) ("Histologic subtypes" 2)
   ("the estrogen receptor (ER)-negative subtypes" 2) ("basal subtypes" 2)
   ("at least two histologic subtypes" 2)
   ("The most common histologic subtypes" 2) ("acinar predominant subtypes" 2)
   ("micropapillary-predominant subtypes" 2)
   ("two major histologic subtypes" 2) ("Three histological subtypes" 2)
   ("the other predominant subtypes" 2)
   ("197 different histological subtypes" 2) ("certain serological subtypes" 2)
   ("the two histologic subtypes" 2) ("the 2 histologic subtypes" 2)
   ("outer subventricular (oRG) subtypes" 2)
   ("intestinal and diffuse subtypes" 2)
   ("Three different macroscopic subtypes" 2)
   ("different morphologic subtypes" 2) ("cytogenetic subtypes" 2)
   ("the mutational subtypes" 2)
   ("had classic papillary or follicular variant histologic subtypes" 2)
   ("50 different histologic subtypes" 2)
   ("clinically more aggressive subtypes" 2)
   ("HER2-negative (HER2−) subtypes" 2) ("lobular or tubular subtypes" 2)
   ("HISTOLOGIC AND MOLECULAR SUBTYPES" 2) ("three transcriptional subtypes" 2)
   ("the various examined histopathologic subtypes" 2)
   ("2 mucinous subtypes" 2) ("the more mature subtypes" 2)
   ("their data included other histological subtypes" 2)
   ("comparable transcriptional subtypes" 2)
   ("two major NSCLC histological subtypes" 2)
   ("the atypical histologic subtypes" 2) ("the three major subtypes" 2)
   ("distinct subtypes" 2) ("cryptic cytogenetic subtypes" 2)
   ("both cardiac subtypes" 2) ("the two cardiac subtypes" 2)
   ("specialized cardiac subtypes" 2)
   ("Acute Myeloid Leukemia (AML) disease subtypes" 2)
   ("Other Histological Subtypes" 2)
   ("both the ER-/basal and ER-/HER2+ subtypes" 2)
   ("novel prognostic subtypes" 2) ("mucosal subtypes" 2)
   ("all morphologic subtypes" 2)
   ("the different FTLD histological subtypes" 2)
   ("individual phenotypic subtypes" 2) ("two major subtypes" 2)
   ("visual subtypes" 2) ("different cytogenetic subtypes" 2)
   ("diverse subtypes" 2) ("12 different histological subtypes" 2)
   ("serous subtypes" 2) ("several STS histological subtypes" 2)
   ("six distinct subtypes" 2) ("the following clinicopathological subtypes" 2)
   ("ER-negative subtypes" 2) ("all three classic subtypes" 2)
   ("Several discriminative subtypes" 2)
   ("GBM neural, classical, and mesenchymal subtypes" 2)
   ("unfavorable subtypes" 2) ("adenocarcinoma histological subtypes" 2)
   ("anatomical subtypes" 2) ("three clinically relevant subtypes" 2)
   ("The most common histological subtypes" 2) ("specific biologic subtypes" 2)
   ("three different histological subtypes" 2)
   ("the non-adenocarcinoma histological subtypes" 2)
   ("the Lauren histological subtypes" 2)
   ("The major lung cancer histologic subtypes" 2)
   ("The histologic subtypes" 2)
   ("the clinically indolent or questionable subtypes" 2)
   ("all other histologic subtypes" 2)
   ("the classical and mesenchymal subtypes" 2)
   ("both alveolar and embryonal subtypes" 2)
   ("particular histopathologic subtypes" 2) ("EGFR mutational subtypes" 2)
   ("previously published prognostic subtypes" 2) ("intrinsic subtypes" 2)
   ("the two TGCT histological subtypes" 2)
   ("Both diffuse and intestinal subtypes" 1) ("its histological subtypes" 1)
   ("the heterogeneous subtypes" 1) ("numerous histologic subtypes" 1)
   ("established histologic subtypes" 1) ("NHL overall and common subtypes" 1)
   ("various histologic subtypes" 1) ("distinct invasive subtypes" 1)
   ("various predominant subtypes" 1) ("than 50 histological subtypes" 1)
   ("50 histological subtypes" 1) ("five intrinsic subtypes" 1)
   ("tumour cell morphological subtypes" 1) ("well-defined subtypes" 1)
   ("one or more subtypes" 1) ("No DCIS triple-negative subtypes" 1)
   ("gastric, intestinal and pancreatobiliary histological subtypes" 1)
   ("the diverse histological subtypes" 1) ("‘mesenchymal’ subtypes" 1)
   ("two highly pathogenic subtypes" 1) ("the same histologic subtypes" 1)
   ("other neuronal subtypes" 1) ("the cytogenetic subtypes" 1)
   ("intestinal and diffused subtypes" 1) ("Transcriptomal subtypes" 1)
   ("their biological subtypes" 1) ("the other biological subtypes" 1)
   ("all representative subtypes" 1)
   ("more malignant morphological subtypes" 1) ("micropapillary subtypes" 1)
   ("the papillary and micropapillary subtypes" 1) ("neural subtypes" 1)
   ("the three histologic subtypes" 1) ("the four histologic subtypes" 1)
   ("aggressive histologic subtypes" 1) ("Mesothelioma histologic subtypes" 1)
   ("gene expression–defined subtypes" 1)
   ("papillary predominant, and acinar-predominant subtypes" 1)
   ("the IASLC/ATS/ERS histologic subtypes" 1) ("the prognostic subtypes" 1)
   ("the less common histological subtypes" 1) ("respective subtypes" 1)
   ("the respective subtypes" 1) ("specific viral subtypes" 1)
   ("the intestinal and pancreatobiliary subtypes" 1)
   ("GABA) neuronal subtypes" 1) ("three major histologic subtypes" 1)
   ("the other mucinous subtypes" 1) ("specific histologic subtypes" 1)
   ("triple-negative (MDA-MB-231) subtypes" 1)
   ("indolent and aggressive subtypes" 1) ("indolent subtypes" 1)
   ("human epidermal growth factor receptor 2-positive
subtypes"
    1)
   ("specific KRAS mutational subtypes" 1) ("KRAS mutational subtypes" 1)
   ("some KRAS mutational subtypes" 1) ("KRAS and LKB1 predominant subtypes" 1)
   ("The three major clinicopathologic subtypes" 1)
   ("the histological and molecular subtypes" 1) ("pathologic subtypes" 1)
   ("their respective subtypes" 1) ("the more aggressive subtypes" 1)
   ("endometrial tumour histological subtypes" 1)
   ("specific OC histologic subtypes" 1) ("different macroscopic subtypes" 1)
   ("nongranular (LST-NG) subtypes" 1) ("Both histologic subtypes" 1)
   ("distinct histologic subtypes" 1) ("two distinct histologic subtypes" 1)
   ("mucinous and nonmucinous subtypes" 1)
   ("three major histological subtypes" 1)
   ("than other histologic subtypes (mutation rate, 44.4% vs. 80.4%; p = 0.090)"
    1)
   ("than other histologic subtypes" 1) ("4 major histologic subtypes" 1)
   ("Minor and rare subtypes" 1) ("ductal and lobular morphologic subtypes" 1)
   ("non-ductal subtypes" 1) ("lobular morphologic subtypes" 1)
   ("both sarcomatous and epithelial subtypes" 1)
   ("the most common histological subtypes" 1)
   ("4 clinically- relevant subtypes" 1)
   ("NSCLC histolopathological subtypes" 1)
   ("the most predominant histological subtypes" 1)
   ("the mesodermal subtypes" 1) ("all mesodermal subtypes" 1)
   ("the different NSCLC histologic subtypes" 1) ("Two distinct subtypes" 1)
   ("all other collective subtypes" 1) ("intestinal gastric subtypes" 1)
   ("the aggressive subtypes" 1)
   ("a therapeutic agent targeting aggressive subtypes" 1)
   ("environmental subtypes" 1) ("all three histologic subtypes" 1)
   ("the other histologic subtypes" 1)
   ("the examined histopathologic subtypes" 1)
   ("all SGT histological subtypes" 1) ("their histological subtypes" 1)
   ("some papillary subtypes" 1) ("this group more subtypes" 1)
   ("more subtypes" 1) ("the principal histologic subtypes" 1)
   ("intrinsic breast cancer biological subtypes" 1)
   ("luminal–HER2-positive subtypes" 1) ("NHL histological subtypes" 1)
   ("subtypes-" 1) ("these different ovarian epithelial tumor subtypes" 1)
   ("papillary and follicular subtypes" 1) ("distinct histological subtypes" 1)
   ("the intestinal subtypes" 1) ("the predominant histologic subtypes" 1)
   ("seven clinically more homogeneous subtypes" 1)
   ("several distinct morphologic subtypes" 1)
   ("than 15 histological subtypes" 1) ("15 histological subtypes" 1)
   ("the different PTC histological subtypes" 1)
   ("all non–small cell lung cancer histologic subtypes" 1)
   ("two different histological subtypes" 1) ("than specific subtypes" 1)
   ("four major histological subtypes" 1)
   ("several different histologic subtypes" 1)
   ("the Classical and Mesenchymal subtypes" 1)
   ("Mesenchymal (HR=0.54, p =0.02) subtypes" 1)
   ("Proneural, Classical and Mesenchymal subtypes" 1)
   ("Proneural, Neural, Classical and Mesenchymal subtypes" 1)
   ("numerous other malignant histologic subtypes" 1)
   ("homogeneous subtypes" 1) ("the benign histologic subtypes" 1)
   ("distinct immunohistopathological subtypes" 1)
   ("immunohistopathologic subtypes" 1) ("the different mutational subtypes" 1)
   ("specific mutational subtypes" 1) ("cardiac subtypes" 1)
   ("these specialized cardiac subtypes" 1)
   ("than 50 distinct histological subtypes" 1)
   ("50 distinct histological subtypes" 1) ("the major subtypes" 1)
   ("novel clinically relevant subtypes" 1) ("common pathologic subtypes" 1)
   ("breast cancer pathological subtypes" 1)
   ("the main pathological subtypes" 1) ("two biologic subtypes" 1)
   ("five distinct subtypes" 1) ("the traditional histological subtypes" 1)
   ("both DLBCL phenotypic subtypes" 1) ("major phenotypic subtypes" 1)
   ("unique subtypes" 1) ("the other two histologic subtypes" 1)
   ("UC pathological subtypes" 1) ("prognostic subtypes" 1)
   ("diverse histological subtypes" 1) ("the distinct histological subtypes" 1)
   ("more rare subtypes" 1) ("the two most common histological subtypes" 1)
   ("two reproducible subtypes" 1)
   ("triple-negative (ERα-, PR-, HER2-) subtypes" 1)
   ("the intestinal and diffuse histological subtypes" 1)
   ("the more aggressive proximal subtypes" 1)
   ("Several distinct histological subtypes" 1)
   ("biologically and clinically relevant subtypes" 1)
   ("mesenchymal/basal B/claudin-low subtypes" 1) ("subtypes—" 1)
   ("molecularly-defined breast cancer subtypes" 1)
   ("many histological subtypes" 1) ("certain histological subtypes" 1)
   ("Different histological subtypes" 1) ("certain viral subtypes" 1)
   ("early stage or less aggressive subtypes" 1) ("19 pleomorphic subtypes" 1)
   ("especially histological subtypes" 1)
   ("the variable histologic subtypes" 1) ("The two histologic subtypes" 1)
   ("major NHL histological subtypes" 1) ("SGC histological subtypes" 1)
   ("all the pathologic subtypes" 1)
   ("non-adenocarcinoma histological subtypes" 1)
   ("three histological subtypes" 1) ("these histologic subtypes" 1)
   ("residual tumour, and Lauren histologic subtypes" 1)
   ("the triple subtypes" 1) ("The triple subtypes" 1) ("triple subtypes" 1)
   ("invasive subtypes" 1) ("three other histologic subtypes" 1)
   ("Common histopathologic subtypes" 1)
   ("the four major histologic subtypes" 1)
   ("the dominant histologic subtypes" 1) ("nonbasal subtypes" 1)
   ("3 predominant subtypes" 1) ("discrete cellular subtypes" 1)
   ("some aggressive subtypes" 1) ("histological or molecular subtypes" 1)
   ("traditional histological subtypes" 1) ("HER2-overexpressing subtypes" 1)
   ("subtypes, both Hdm2 amplification" 1)
   ("included different histological subtypes" 1)
   ("the primary histologic subtypes" 1)
   ("The most common primary histologic subtypes" 1)
   ("several pathologic subtypes" 1)
   ("the serous cystadenocarcinoma and endometriod adenocarcinoma subtypes" 1)
   ("five histological subtypes" 1) ("the rarer histologic subtypes" 1)
   ("special histological subtypes" 1) ("the different intrinsic subtypes" 1)
   ("triple-negative (p<0.001, OR: 24.44, 95% CI: 7.887–75.759) subtypes" 1)
   ("the morphologic subtypes" 1) ("monophasic and biphasic subtypes" 1)
   ("vulnerable subtypes" 1)))
 ("UP:P03999" (("BCP" 18) ("BCP-" 1)))
 ("UP:P04000" (("RCP" 63) ("ROP" 4) ("color blindness" 4) ("Protan" 3)))
 ("UP:P04001" (("Opn" 42) ("GCP" 10) ("GOP" 2) ("pGCP" 1)))
 ("UP:P04003" (("proline-rich protein" 7) ("C4BPA" 2) ("C4bp" 1)))
 ("UP:P04004"
  (("VN" 486) ("vitronectin" 450) ("VTN" 81) ("S protein" 71) ("S-protein" 61)
   ("Vitronectin" 21) ("s protein" 20) ("Vn" 16) ("S Protein" 13)
   ("vitronectin (VN)" 10) ("vitronectin-" 5) ("vitronectin protein" 5)
   ("V75" 4) ("supplemental VN" 3) ("vitronectin (VTN)" 3) ("stromal VN" 2)
   ("the stromal VN" 1) ("mouse multimeric VN" 1) ("s Protein" 1)
   ("S protein-" 1) ("S-Protein" 1)))
 ("UP:P04035"
  (("HMG-CoA reductase" 123) ("HMGCR" 115) ("HMGCoA reductase" 8)
   ("3-hydroxy-3-methylglutaryl-coenzyme A reductase" 7)
   ("HMG-CoA reductase (HMGCR)" 6) ("HMG-coA reductase" 2) ("HMGCR-" 1)))
 ("UP:P04040"
  (("cat" 2078) ("Cat" 1612) ("catalase" 702) ("Catalase" 51) ("CaT" 32)
   ("-cat" 30) ("overexpressed HSPB members changed CaT" 5)
   ("7 consecutive CaT" 4) ("catalase (CAT)" 3) ("caT" 3)
   ("than RasGRP1 cat" 2) ("the peroxisomal protein catalase" 2)
   ("5000 U/ml exogenous catalase" 2) ("Upstate cat" 2)
   ("exogenous catalase" 2) ("self-reported cat" 1) ("Exogenous catalase" 1)
   ("than SOS cat" 1) ("catalase ( CAT )" 1) ("catalase protein" 1) ("CAt" 1)
   ("catalase-" 1) ("than catalase" 1)
   ("than catalase (260 kDa, 10.8 ml, xref )" 1)
   ("peroxisomal catalase ( CAT )" 1) ("overexpressing catalase" 1)
   ("expressing transfected catalase" 1)))
 ("UP:P04046" (("ade4" 2)))
 ("UP:P04049"
  (("Raf-1" 1057) ("CRAF" 955) ("C-Raf" 669) ("RAF1" 622) ("c-Raf" 531)
   ("Raf1" 506) ("C-RAF" 369) ("raf" 113) ("RAF-1" 86) ("mIL" 72) ("cRaf" 52)
   ("p-CRAF" 22) ("c-RAF" 20) ("Craf" 13) ("cRAF" 12) ("C-raf" 8)
   ("RAF1 protein" 7) ("raf-1" 7) ("Raf-1 protein" 7) ("C-Raf protein" 6)
   ("c-raf" 6) ("pCRAF" 6) ("C-Raf (GST-C-RafDD) protein" 5) ("p-C-RAF" 5)
   ("RAF-1-" 5) ("-Raf1" 5) ("raf1" 5) ("MIL" 4) ("c-Raf protein" 4) ("-raf" 3)
   ("p-c-Raf" 3) ("Raf 1" 2) ("C-RAF protein" 2) ("p-c-RAF" 2)
   ("recombinant bacterial Raf-1" 2) ("CRAF protein" 2)
   ("the mitochondria-associated CRAF" 2) ("RAF1-" 2) ("particular c-Raf" 2)
   ("pC-RAF" 2) ("myc-epitope-tagged C-Raf" 2) ("more pS621 Raf-1" 1)
   ("DCM-associated mutant RAF1" 1) ("RAf" 1) ("Raf1-" 1) ("pc-Raf" 1)
   ("the library-derived Raf1" 1) ("the plasma membrane-associated CRAF" 1)
   ("p-RAF1" 1) ("mil" 1) ("Raf-1 (RBD)" 1) ("–c-Raf" 1)
   ("a client protein kinase Raf-1" 1) ("kinase-negative Raf-1" 1)
   ("RAF1 (RBD)" 1) ("than wild-type C-RAF" 1) ("P-C-RAF" 1)
   ("directly binding C-Raf" 1) ("CA-RAF" 1)))
 ("UP:P04053"
  (("TdT" 188) ("TDT" 130) ("terminal deoxynucleotidyltransferase" 25)
   ("terminal deoxyribonucleotidyl transferase" 8)
   ("Terminal deoxynucleotidyltransferase" 6) ("DNTT" 3)
   ("Terminal deoxynucleotidyl-transferase" 3)
   ("Terminal deoxyribonucleotidyl transferase" 2)
   ("the template-independent enzyme TdT" 2) ("Tdt" 1)
   ("parent-specific TDT" 1) ("than standard TDT" 1)
   ("the immature leukemic marker TdT" 1)))
 ("UP:P04054"
  (("phospholipase" 59) ("phospholipase A 2" 31) ("Phospholipase A2" 6)
   ("Phospholipase A 2" 5) ("Group Ib" 5) ("Phospholipase" 4) ("PLA2G1B" 3)
   ("Group IB" 2) ("IIa secretory phospholipase A 2" 2)
   ("The isozyme group IIa secretory phospholipase A 2" 2)))
 ("UP:P04062"
  (("GLUC" 35) ("Glu-C" 32) ("Gluc" 20) ("GluC" 5) ("GLuc" 3) ("GBA" 2)
   ("glucocerebrosidase" 2) ("gLUC" 1)))
 ("UP:P04066" (("fucosidase" 3) ("-fucosidase" 1) ("FUCA1" 1)))
 ("UP:P04070" (("PROC" 80) ("Proc" 20) ("proc" 14) ("pROC" 3) ("proC" 1)))
 ("UP:P04075"
  (("ALDOA" 17) ("aldolase A" 4) ("Aldoa" 1) ("ALDA" 1)
   ("fructose-bisphosphate" 1) ("Fructose-bisphosphate aldolase A" 1)
   ("Aldolase A" 1)))
 ("UP:P04080" (("C91" 33) ("CST6" 2) ("CSTB" 1)))
 ("UP:P04083"
  (("p35" 348) ("Annexin A1" 111) ("ANXA1" 53) ("P35" 31) ("annexin 1" 8)
   ("p35 protein" 8) ("annexin A1" 4) ("P35 protein" 2) ("Annexin I" 2)
   ("p35−" 2) ("annexin I" 1) ("Anxa1" 1) ("annexin-1" 1)
   ("the baculoviral caspase inhibitor P35" 1)
   ("the baculoviral caspase inhibitor p35" 1) ("endocytotic factor ANXA1" 1)
   ("p35-" 1) ("its neuronal cyclin-like activator p35" 1)
   ("its neuronal activator p35" 1) ("Annexin-1" 1)))
 ("UP:P04085"
  (("PDGF" 2142) ("PDGFA" 103) ("PDGF-A" 94) ("PDGF-" 20)
   ("derived growth factor A" 11) ("Pdgf-a" 7) ("exogenous PDGF" 4)
   ("coexpressed PDGFA" 3) ("platelet-derived growth factor α polypeptide" 3)
   ("platelet-derived growth factor alpha polypeptide" 1) ("dimeric PDGF" 1)
   ("Pdgfa" 1) ("PDGF (BB) protein" 1) ("PDGF—a" 1)))
 ("UP:P04090"
  (("of pregnancy" 437) ("RLN2" 175) ("hypertensive disorder of pregnancy" 5)
   ("RLN2 protein" 4) ("hypertensive disorders of pregnancy" 4)
   ("a positive history of pregnancy" 3) ("the 20th week of pregnancy" 2)
   ("the predominant hormone of pregnancy" 2)
   ("the last trimester of pregnancy" 2) ("a history of pregnancy" 2)
   ("intrahepatic cholestasis of pregnancy (ICP)" 2)
   ("hypertensive diseases of pregnancy" 2)
   ("an unintentional end of pregnancy" 1) ("the latter half of pregnancy" 1)
   ("progressive nature of pregnancy" 1) ("the antiapoptotic RLN2" 1)
   ("the hormonal milieu of pregnancy" 1)
   ("elective terminations of pregnancy" 1) ("of pregnancy (ICP)" 1)
   ("hypertensive disease of pregnancy" 1) ("a unique disease of pregnancy" 1)
   ("the late period of pregnancy" 1) ("the late stage of pregnancy" 1)
   ("the late stages of pregnancy" 1)))
 ("UP:P04114"
  (("apoB" 47) ("APOB" 44) ("apolipoprotein B" 23) ("ApoB" 22)
   ("Apolipoprotein B" 2) ("apolipoprotein B-100" 1)))
 ("UP:P04118"
  (("CLPs" 21) ("pCLPS" 5) ("lentiviral expression vector pCLPS" 2)))
 ("UP:P04141"
  (("GM-CSF" 1139) ("CSF" 529) ("colony-stimulating factor" 257)
   ("colony stimulating factor" 170) ("CSF2" 141)
   ("granulocyte-macrophage colony-stimulating factor" 91)
   ("granulocyte-macrophage colony stimulating factor" 39) ("GMCSF" 29)
   ("granulocyte–macrophage colony-stimulating factor" 10) ("Csf" 8) ("Csf2" 8)
   ("colony–stimulating factor" 5) ("colony-stimulating factor (GMCSF)" 3)
   ("CsF" 3) ("artificial CSF" 3)
   ("a bone resorptive macrophage colony-stimulating factor" 3)
   ("Granulocyte-macrophage colony-stimulating factor" 2)
   ("significantly more GM-CSF" 2) ("ice-cold artificial CSF" 2)
   ("Colony stimulating factor" 2) ("Sargramostim" 2)
   ("the viral envelope protein induced macrophage colony-stimulating factor"
    2)
   ("colony-stimulating factor (MCSF)" 1) ("Exogenous GM-CSF" 1) ("-CSF" 1)
   ("10 5 γ-irradiated B16 GM-CSF" 1)
   ("Granulocyte–macrophage colony-stimulating factor" 1)
   ("Colony-stimulating factor" 1) ("GM-CSF-" 1) ("colonystimulating factor" 1)
   ("colony stimulating factor (MCSF)" 1) ("GM—CSF" 1)))
 ("UP:P04144" (("N2-3" 4) ("N2–3" 2)))
 ("UP:P04150"
  (("glucocorticoid receptor" 249) ("glucocorticoid receptor (GR)" 56)
   ("NR3C1" 27) ("Glucocorticoid Receptor" 11) ("GRL" 9)
   ("Glucocorticoid receptor" 6) ("nuclear receptor subfamily 3" 6)
   ("Glucocorticoid Receptor (GR)" 3) ("Nr3c1" 3)
   ("member 1 (glucocorticoid receptor)" 1) ("P04150" 1)
   ("the Hsp90 client glucocorticoid receptor" 1)))
 ("UP:P04155"
  (("pS2" 603) ("TFF1" 381) ("Tff1" 57) ("PS 2" 25) ("trefoil factor 1" 11)
   ("Trefoil factor 1" 4) ("TFF-1" 3) ("TFF1 (Trefoil factor 1) protein" 3)
   ("TFF1 (trefoil factor 1) protein" 2) ("TFF1-" 1)
   ("The recombinant adenovirus-expressing TFF1" 1) ("Tff1-" 1)
   ("pS2 protein" 1) ("protein pS2" 1)))
 ("UP:P04156"
  (("PrP" 1350) ("PRNP" 111) ("PrP-" 82) ("Prnp" 73) ("PrP protein" 7)
   ("-PrP" 4) ("p27–30" 3) ("lumenal PrP" 2)
   ("immature and mature glycosylated PrP" 2) ("less mature PrP" 2)
   ("full length wild type (WT) Syrian hamster PrP" 2) ("pRP" 2)
   ("soluble cellular PrP" 1) ("pPrP" 1) ("cellular PrP" 1) ("Prnp–" 1)
   ("lumenal Sec- PrP" 1) ("than Ctm PrP" 1) ("immature PrP" 1)
   ("transmissible PrP" 1) ("lumenal full length Sec PrP" 1)
   ("the disease-associated PrP" 1) ("mostly Sec PrP" 1) ("mostly Ntm PrP" 1)
   ("almost uniquely Sec PrP" 1) ("PrP indicating that PrP’s" 1)
   ("the C-terminal 200-227 amino acids of PrP that encompass" 1)
   ("than PrP ( xref )" 1) ("the normal cellular PrP" 1) ("than the WT PrP" 1)
   ("WT PrP's" 1) ("–PrP" 1)))
 ("UP:P04170" (("RD1" 8)))
 ("UP:P04179"
  (("SOD2" 565) ("Sod2" 95) ("Mn-SOD" 54) ("sod2" 47) ("SOD2 protein" 5)
   ("superoxide dismutase 2, mitochondrial" 5) ("upper SOD2" 1)
   ("than the wild-type SOD2" 1) ("acetylation mimetic mutant SOD2 K68Q" 1)
   ("mature SOD2" 1)))
 ("UP:P04180" (("LCAT" 6))) ("UP:P04181" (("OAT" 1)))
 ("UP:P04183"
  (("TK1" 744) ("TK1 protein" 50) ("thymidine kinase 1" 28)
   ("Thymidine kinase 1" 13) ("TK-1" 7) ("Cellular TK1" 3)
   ("TK1 (25 kDa) protein" 2) ("the subsequent incubation period TK1" 1)
   ("TK1 peptide" 1) ("tetrameric human thymidine kinase 1" 1)))
 ("UP:P04198"
  (("MYCN" 2304) ("N-Myc" 368) ("N-myc" 60) ("MYCN−" 56) ("Mycn" 53)
   ("MYCN protein" 47) ("N-MYC" 32) ("N-Myc protein" 31) ("NMYC" 15)
   ("n-myc" 14) ("n-Myc" 10) ("Nmyc" 8) ("nMyc" 8) ("n-MYC" 5) ("MycN" 4)
   ("normal MYCN" 2) ("more MYCN" 2) ("overexpressed MYCN" 2) ("than MYCN" 1)
   ("v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog"
    1)
   ("N-Myc-" 1) ("N-myc protein" 1) ("N-Myc (MYCN)" 1) ("MYCN-" 1) ("mycn" 1)
   ("Ser (54) of n-myc ( xref , 2.7-fold of control at day 1, p<0.05)" 1)))
 ("UP:P04201"
  (("MAS" 75) ("MAs" 36) ("pediatric MAs" 14) ("mAs" 7) ("mAS" 3)
   ("nearly all pediatric MAs" 2) ("Broadband triple resonance MAS" 1)
   ("58 (10%) pediatric MAs" 1)))
 ("UP:P04206"
  (("rheumatoid factor" 41) ("rheumatoid factor (RF)" 2)
   ("Rheumatoid factor" 1)))
 ("UP:P04216"
  (("Thy-1" 206) ("CD90" 137) ("Thy1" 71) ("THY-1" 12) ("thy1" 7) ("THY1" 6)
   ("Thy-1 protein" 4) ("the antifibrotic gene Thy-1" 2) ("-CD90" 2)
   ("mouse monoclonal anti-fibroblast antigen THY-1" 1)
   ("the mesenchymal marker CD90" 1)))
 ("UP:P04220"
  (("BOT" 42) ("bot" 10) ("Bot" 3) ("14 cm mucinous BOT" 2) ("mucinous BOT" 2)
   ("15 mucinous BOT" 1) ("seven mucinous BOT" 1) ("western bot" 1)))
 ("UP:P04222" (("PSORS1" 11))) ("UP:P04229" (("NC2" 7)))
 ("UP:P04233"
  (("LC3-II" 982) ("CD74" 197) ("major histocompatibility complex" 149)
   ("LC3B-II" 108) ("MHC-II" 78) ("Ii" 24)
   ("major histocompatibility complex (MHC)" 17) ("LC3-II protein" 17)
   ("topoisomerase-II" 14) ("LC3–II" 11) ("class II invariant chain" 4)
   ("more LC3-II" 4) ("mTORC2 slightly increases LC3-II" 3)
   ("Topoisomerase-II" 2) ("the autophagosome-associated protein LC3-II" 2)
   ("CD74-" 1) ("autophagosome-associated LC3-II" 1)
   ("torin1 partially decrease LC3-II" 1) ("further increased LC3-II" 1)
   ("LC3B-II protein" 1) ("the autophagic marker LC3B-II" 1)
   ("the
autophagic vacuole marker LC3-II"
    1)
   ("the autophagosomal form LC3-II" 1) ("More LC3-II" 1)
   ("Major histocompatibility complex (MHC)" 1)
   ("Major histocompatibility complex" 1)
   ("the well-established autophagic marker LC3-II" 1)
   ("the autophagic marker LC3-II" 1)
   ("the autophagosome-associated LC3-II" 1)))
 ("UP:P04234"
  (("TCR-ζ" 7) ("T-cell-receptor" 4) ("T3D" 3) ("CD3D" 1)
   ("T-cell-receptor-" 1)))
 ("UP:P04252" (("VHB" 5)))
 ("UP:P04259" (("CK6" 36) ("KRT6B" 6) ("keratin 6B" 2)))
 ("UP:P04264"
  (("K-RTA" 175) ("keratin 1" 50) ("K −1" 38) ("k 1" 32) ("k  1" 31)
   ("KRT1" 27) ("keratin-1" 26) ("K –1" 20) ("K  1" 16) ("k  −1" 15) ("K 1" 12)
   ("Ck1" 7) ("Keratin 1" 5) ("cytokeratin 1" 4) ("CK-1" 4) ("Keratin1" 4)
   ("k −1" 4) ("keratin1" 4) ("KRT1 protein" 4) ("Krt1" 3) ("K-RTA peptide" 3)
   ("-k 1" 2) ("smaller k  −1" 2)
   ("an energetically favorable +0.104 kcal mol −1 K −1" 1) ("K-Rta" 1)
   ("K
1"
    1)
   ("an unrealistic k  1" 1) ("more K-RTA" 1)
   ("KSHV latent-lytic switch K-RTA" 1) ("Cytokeratin 1" 1)
   ("the exponential function:where k 1" 1)))
 ("UP:P04271"
  (("S100B" 59) ("S100β" 35) ("S100b" 3) ("S100B-" 2) ("S100B protein" 2)
   ("S100beta" 2) ("UC S100B" 1) ("fetal cortisol and maternal/fetal S100B" 1)
   ("respective UC S100B" 1)))
 ("UP:P04275"
  (("vWF" 347) ("von" 114) ("von Willebrand factor" 72) ("VWF" 72) ("Von" 36)
   ("Von Willebrand Factor" 12) ("von Willebrand Factor" 10)
   ("Von Willebrand factor" 7) ("vwf" 4) ("von Willebrand factor (VWF)" 3)
   ("endothelial-cell-specific marker vWF" 2) ("exogenous vWF" 2)
   ("von
 Willebrand factor"
    1)
   ("soluble vWF" 1) ("Von Willebrand Factor (VWF)" 1) ("particular vWF" 1)
   ("the vascular marker vWF" 1)))
 ("UP:P04278"
  (("ABP" 214) ("SHBG" 178) ("sex hormone binding globulin" 10)
   ("sex hormone-binding globulin" 9) ("sex hormone binding globulin (SHBG)" 4)
   ("Abp" 4) ("Sex hormone-binding globulin" 3)
   ("sex hormone-binding globulin (SHBG)" 2) ("sex hormone–binding globulin" 2)
   ("Sex hormone binding globulin" 1) ("given ABP" 1) ("ABP-" 1)))
 ("UP:P04279" (("inhibins" 12) ("SGI" 11) ("Inhibins" 3) ("pSGI" 1)))
 ("UP:P04280"
  (("PM" 1847) ("PMF" 615) ("pM" 445) ("pm" 79) ("PMs" 39) ("pRB1" 20)
   ("PMFs" 16) ("Pm" 8) ("pM-" 5) ("pMS" 4) ("ppm" 3)
   ("both chronic- and blast-phase PMF" 2) ("whose PMF" 2) ("10 pM" 1)
   ("secondary PMF" 1)))
 ("UP:P04350" (("Tubb4" 6) ("TUBB5" 4) ("TUBB4" 1)))
 ("UP:P04377" (("cupredoxin" 4))) ("UP:P04382" (("FRD" 1)))
 ("UP:P04387" (("gal80" 6) ("Gal80" 4) ("GAL80" 1)))
 ("UP:P04406"
  (("GAPDH" 7526) ("3-phosphate dehydrogenase" 51) ("GAPD" 41) ("hGAPDH" 41)
   ("glyceraldehyde" 35) ("gapdh" 16) ("Glyceraldehyde" 12) ("Gapdh" 12)
   ("GAPDH protein" 11) ("the internal control GAPDH" 4)
   ("3-phosphate dehydrogenase (GAPDH)" 4)
   ("the internal control gene GAPDH" 3) ("mouse monoclonal GAPDH" 3)
   ("-GAPDH" 3) ("glyceraldehyde-" 2) ("P04406" 2) ("using GAPDH" 2)
   ("respective GAPDH" 2) ("GAPDH (CST)" 2) ("Upper GAPDH" 2)
   ("overexpressed GAPDH" 2) ("internal housekeeping gene GAPDH" 2)
   ("their respective GAPDH" 2) ("internal reference GAPDH" 2)
   ("mouse monoclonal anti GAPDH" 2) ("the internal reference GAPDH" 1)
   ("an internal control gene GAPDH" 1) ("posttranslational GAPDH" 1)
   ("GAPDH-" 1) ("nascent GAPDH" 1)
   ("nuclear S -nitrosylated/sulphonated GAPDH" 1)
   ("A dominant-negative mutant GAPDH" 1) ("GAPDH (CWBIO)" 1)
   ("internal control mouse GAPDH" 1) ("pGAPDH" 1)
   ("monoclonal primary mouse anti-human GAPDH" 1) ("—GAPDH (CT)" 1)
   ("—GAPDH" 1) ("“GAPDH\"" 1) ("its own GAPDH" 1)
   ("approximately 0.75 μM total GAPDH" 1) ("intrinsic GAPDH" 1) ("hGapdh" 1)
   ("−3-phosphate dehydrogenase (GAPDH)" 1) ("−3-phosphate dehydrogenase" 1)
   ("genomic GAPDH" 1) ("pre-developed Taqman assay reagent mouse GAPDH" 1)
   ("internal control GAPDH" 1) ("its internal reference GAPDH" 1) ("GapDH" 1)
   ("O-GlcNAcylated GAPDH" 1) ("subsequently causes GAPDH" 1)))
 ("UP:P04424" (("ASL" 14) ("argininosuccinate lyase" 2) ("Asl" 1)))
 ("UP:P04440" (("HLA-DPB1" 4)))
 ("UP:P04480" (("CAA" 825) ("-CAA" 42) ("CAA−" 7) ("CAA CAA" 5)))
 ("UP:P04485" (("ICP22" 13)))
 ("UP:P04494" (("E19" 55) ("than E16–E19 ( xref )" 1)))
 ("UP:P04506" (("Sigma1" 8) ("Sigma 1" 3) ("than Sigma1.2" 1)))
 ("UP:P04527" (("GP62" 10)))
 ("UP:P04585"
  (("gag-pol" 47) ("Gag-pol" 11) ("GAG-POL" 2) ("GAG-Pol" 1)
   ("retroviral gag-pol" 1) ("pgag-pol" 1)))
 ("UP:P04601" (("plated" 57) ("lated" 9) ("P04601" 1)))
 ("UP:P04626"
  (("HER2" 27291) ("ErbB2" 6060) ("ERBB2" 3462) ("HER-2" 3071) ("neu" 2533)
   ("Her2" 2039) ("ErbB-2" 752) ("Her-2" 619) ("erbB2" 513)
   ("human epidermal growth factor receptor 2" 504) ("Neu" 479)
   ("HER2 protein" 341) ("erbB-2" 307) ("HER2-" 286) ("HER2−" 158)
   ("c-erbB2" 157) ("Human epidermal growth factor receptor 2" 133)
   ("pHER2" 114) ("neu gene" 113) ("Erbb2" 100) ("neu protein" 94)
   ("c-ErbB2" 91) ("pERBB2" 52) ("overexpressed HER2" 48) ("ErbB2 protein" 41)
   ("pErbB2" 39) ("p-HER2" 38) ("ERBB-2" 33) ("ERBB2-" 24) ("Her2-" 23)
   ("sErbB2" 23) ("HER-2 protein" 21) ("ERBB2 protein" 20) ("neu-" 17)
   ("NEU" 17) ("-HER2" 17) ("ErbB2-" 13) ("-ErbB2" 13) ("Her2neu" 13)
   ("overexpressed Her2" 13) ("cerbB2" 12) ("p-ErbB2" 11) ("ErbB−2" 11)
   ("Herstatin" 10) ("overexpressed ERBB2" 10) ("P-HER2" 10)
   ("overexpressed HER-2" 10) ("NGL" 9) ("overexpressed ErbB2" 9) ("C-erbB2" 9)
   ("manual HER2/ neu" 9) ("central HER2" 8) ("local HER2" 8) ("than HER2" 7)
   ("c-ERBB2" 7) ("Her2 protein" 7) ("basolateral ErbB2" 7)
   ("exogenous HER2" 7) ("Her2−" 6) ("ERBB2−" 6) ("more HER2" 6)
   ("p185 ErbB-2" 6) ("cErbB2" 6) ("APICAL ErbB2" 6) ("P-ErbB2" 6) ("Erb-B2" 5)
   ("exogenous ErbB2" 5) ("apical ErbB2" 5) ("erbB2-" 5) ("ERbB2" 5)
   ("HER2–" 4) ("her2" 4) ("p-ERBB2" 4) ("herstatin" 4) ("membranous HER2" 4)
   ("Local HER2" 4) ("pHER-2" 4) ("overexpressed HER2/ neu" 4) ("Neu gene" 3)
   ("rabbit monoclonal anti-phospho ErbB2" 3) ("overexpressed ERBB-2" 3)
   ("Her2Neu" 3) ("HER-2-" 3) ("Overexpressed ERBB2" 3)
   ("human epidermal growth factor receptor 2 protein" 3) ("p-HER2 protein" 3)
   ("Neu protein" 3) ("ErbB-2 protein" 3) ("overexpressed ERBB2 protein" 3)
   ("-erbB2" 3) ("P-erbB2" 3) ("c-Erb-B2" 3) ("soluble herstatin" 3)
   ("overexpressed HER2/ neu protein" 3) ("HER2 (NEU)" 2) ("particular HER2" 2)
   ("human epidermal growth factor receptor 2 (HER2) protein" 2)
   ("ErbB2 (NDL)" 2)
   ("dually targets human epidermal growth factor receptor 2" 2) ("p-erbB2" 2)
   ("Her2–" 2) ("HRG decreased ErbB2 protein" 2) ("−ErbB2" 2)
   ("constitutively overexpressed ErbB2" 2) ("overexpressed human ErbB2" 2)
   ("local and central HER2" 2) ("confirmatory HER2" 2)
   ("their preferential dimerization partner HER2" 2)
   ("molecularly target ErbB2" 2) ("CD340" 2) ("heterogeneous ErbB2" 2)
   ("ErbB2 molecule" 2) ("targeting HER2" 2) ("mature ErbB2" 2)
   ("than WT HER2" 2) ("human epidermal growth factor receptor 2" 2)
   ("local laboratory HER2" 2) ("Overexpressed HER2" 2) ("soluble HER2" 2)
   ("intense globular HER2" 2)
   ("human epidermal growth factor receptor 2 (Her2/ErbB2) protein" 2)
   ("protein decreased total HER2 protein" 2)
   ("The National Comprehensive Cancer Network HER2" 2) ("erb-B-2" 2)
   ("functional HER-2" 2) ("either total or phosphorylated HER2" 2)
   ("strong ErbB2" 2) ("erb-b2" 2) ("a weak phospho-Her-2" 2)
   ("an unambiguous diffuse 3+ HER-2" 2) ("the re localized apical ErbB2" 2)
   ("TYROSINE 1139 ON APICAL ErbB2" 2) ("BASOLATERAL ErbB2" 2)
   ("functional ErbB2" 2) ("peptidomimetic HERP5 and protein HER2" 2)
   ("pathologically overexpressed HER-2" 2) ("17q21 region around HER2" 2)
   ("the transmembranous human epidermal growth factor receptor 2" 2)
   ("erbB2 protein" 2) ("Gastric HER2" 2)
   ("strong basal/lateral membranous HER2" 2)
   ("esophageal adenocarcinoma HER-2" 2) ("strong membranous HER-2" 2)
   ("Strong membranous HER-2" 2) ("c-erbB2 protein" 2)
   ("amplification around ERBB2" 2) ("HER2 protein (IHC)" 2)
   ("Manual HER2/ neu" 2) ("nonspecific HER2/ neu" 2)
   ("possibly target HER2" 2) ("an MMTV promoter-driven rat-ErbB2" 2)
   ("HER2 molecule" 2) ("infrequent HER2" 2) ("Her-2−" 2) ("Equivocal HER2" 2)
   ("ER(-) PR(-) HER2" 2) ("a previously unreported ERBB2 mutation G1075V" 1)
   ("these tumors typically lack HER2" 1) ("kinase-defective ERBB2" 1)
   ("Neu-" 1) ("prior immunohistochemical Her2" 1) ("ERBB-2-" 1)
   ("the cellular HER2" 1) ("a soluble truncated HER2" 1) ("“HER2”" 1)
   ("composite low ErbB2" 1) ("than targeting HER2" 1) ("ERBB2 (YRI)" 1)
   ("NEU-" 1) ("long-term treated tumors reduced pHER2" 1) ("perbB2" 1)
   ("the pivotal oncogene HER2" 1) ("stably overexpressed human ErbB2" 1)
   ("selectively targets HER-2" 1) ("conditional Erbb2" 1) ("-c-ErbB2" 1)
   ("the associated HER2" 1) ("diverse HER2" 1) ("than Her2" 1) ("c-erbb2" 1)
   ("-Neu" 1) ("the IHC/FISH-positive HER2" 1) ("5 IHC/FISH-positive HER2" 1)
   ("than the wild type HER2" 1) ("than HER2-" 1)
   ("locus-specific identifier ERBB2" 1) ("routine local and central HER2" 1)
   ("an accurate central HER2" 1) ("inaccurate local HER2" 1)
   ("excluded equivocal HER2" 1) ("all available local HER2" 1)
   ("the dual low HER2" 1) ("signals showed HER2" 1) ("than either Her2 +/-" 1)
   ("simultaneous high ERBB2" 1) ("than wild-type HER2" 1) ("monomeric HER2" 1)
   ("total and phosphorylated HER2" 1) ("mammary epithelium-targeted HER2" 1)
   ("-neu" 1) ("p185 ErbB-2 protein" 1)
   ("than ErbB2 that are upstream of PI3K regulating the LMO4 distal promoter"
    1)
   ("overexpressing ErbB2" 1) ("intact ErbB2" 1) ("“p95-HER2”" 1)
   ("our inducible chimeric ErbB2" 1) ("dominant-negative ErbB-2" 1)
   ("heterodimerized ErbB-2" 1) ("the adverse prognostic marker ERBB2" 1)
   ("than ErbB-2" 1) ("membrane-associated ErbB-2" 1) ("Apical ErbB2" 1)
   ("apical (over-expressed) ErbB2" 1) ("apical over-expressed ErbB2" 1)
   ("Basolateral ErbB2" 1) ("the apical ErbB2" 1) ("10-fold more p185 HER-2" 1)
   ("the classic markers ERBB2" 1) ("C-ERBB2" 1) ("than the ErbB2" 1)
   ("NEU gene" 1) ("reliable HER2" 1) ("\"HER2\"" 1) ("the one hand HER2’s" 1)
   ("an ectopically expressed chimeric HER2" 1) ("suggested HER2’s" 1)
   ("we first expressed Her2" 1) ("P-Her2" 1) ("a chimeric HER2" 1)
   ("selectively targets HER2" 1) ("-NEU" 1) ("HER2 that blocks it's" 1)
   ("than ErbB2" 1) ("currently available total HER2" 1)
   ("simultaneous high HER2" 1) ("weak HER2" 1) ("than the HER2" 1)
   ("a previously FDA-approved HER2" 1) ("2,4-dinitrophenyl-labeled HER2" 1)
   ("complete membranous HER2/ neu" 1) ("highly-amplified ErbB2" 1)
   ("the ER-negative ERBB2" 1) ("only three tumors expressed HER2" 1)
   ("-Her2" 1) ("Monoclonal Mouse Anti-Human c-erbB2" 1) ("than HER2(−)" 1)
   ("cellular HER2" 1) ("only full-length HER2" 1) ("kinase intact ErbB2" 1)
   ("monomeric or dimeric HER2" 1) ("whose tumors overexpressed HER2" 1)
   ("only 70% HER2" 1) ("than Her2 (HR = 1.375, 95%CI: 1.133–1.947)" 1)
   ("than erbB2 (HR = 1.375, 95%CI: 1.133–1.947 P = 0.004)" 1)))
 ("UP:P04628"
  (("Wnt1" 343) ("wnt" 131) ("Wnt-1" 76) ("WNT1" 63) ("WNT-1" 16) ("Wnt1-" 14)
   ("Wnt1 protein" 7) ("wnt1" 6)
   ("wingless-type MMTV integration site family" 5)
   ("Wingless-type MMTV integration site family" 4) ("wnt-1" 3)
   ("strong Wnt-1" 2) ("Wnt1 peptide" 2) ("the mesencephalic marker Wnt1" 1)
   ("exogenous Wnt1" 1) ("glioma-derived Wnt1" 1)
   ("the well-studied canonical WNT1" 1)))
 ("UP:P04629"
  (("TrkA" 886) ("tyrosine kinase receptor" 549) ("MTC" 393) ("TRK" 126)
   ("NTRK1" 83) ("Trk" 43) ("trk" 36)
   ("a transmembrane tyrosine kinase receptor" 24) ("pTrkA" 20) ("TRKA" 14)
   ("sporadic MTC" 11) ("metastatic MTC" 8) ("Trk-A" 7) ("NTRK" 5)
   ("pTrkA peptide" 5) ("tyrosine kinase receptor (RTK)" 4)
   ("a 185-kDa transmembrane tyrosine kinase receptor" 4) ("trkA" 3)
   ("Tyrosine kinase receptor" 3) ("tyrosine kinase receptor protein" 3)
   ("tyrosine kinase
receptor"
    3)
   ("a 185 kDa transmembrane tyrosine kinase receptor" 3)
   ("the transmembrane tyrosine kinase receptor" 2)
   ("metastatic sporadic MTC" 2)
   ("a 185-kD transmembrane tyrosine kinase receptor" 2)
   ("large-diameter neurotrophic tyrosine kinase receptor" 2)
   ("the most commonly overexpressed tyrosine kinase receptor" 2)
   ("overexpressed tyrosine kinase receptor" 2)
   ("a membrane-associated tyrosine kinase receptor" 2)
   ("para-follicular C-cell-derived MTC" 1) ("MEN 2–related MTC" 1)
   ("a few MTC" 1) ("17 telomerase-negative MTC" 1) ("39 sporadic MTC" 1)
   ("the 21 telomerase-positive sporadic MTC" 1) ("Sporadic MTC" 1)
   ("the 39 sporadic MTC" 1) ("TrK" 1) ("sporadic and inherited MTC" 1)
   ("incurable MTC" 1)
   ("the HER2/neu transmembrane tyrosine kinase receptor" 1)
   ("the neurotrophic receptor TrkA" 1)
   ("a particular tyrosine kinase receptor" 1)
   ("an alternate tyrosine kinase receptor" 1)
   ("the dimeric tyrosine kinase receptor" 1)
   ("tyrosine kinase receptor (TKR)" 1)
   ("the transmembrane tyrosine
kinase receptor"
    1)
   ("tyrosine
kinase receptor"
    1)
   ("the latter tyrosine kinase receptor" 1)))
 ("UP:P04632"
  (("30K" 12) ("Capn4" 5) ("calpain regulatory subunit" 5) ("30k" 3) ("CDPs" 2)
   ("CAPN4" 2)))
 ("UP:P04637"
  (("p53" 132684) ("TP53" 15411) ("p53 protein" 3348) ("P53" 2498)
   ("tumor suppressor p53" 883) ("p53 family" 599) ("Tp53" 325) ("p53-" 299)
   ("functional p53" 234) ("p53 peptide" 222) ("-p53" 186) ("p53DD" 137)
   ("p53−" 121) ("TP53 protein" 116) ("TRP53" 106) ("p-p53" 73) ("wtTP53" 68)
   ("tumor protein p53" 59) ("P53 protein" 59) ("overexpressed p53" 58)
   ("pp53" 52) ("p53 molecule" 38) ("exogenous p53" 31) ("TP53-" 31)
   ("Tumor suppressor p53" 29) ("than p53" 28) ("normal p53" 23)
   ("disruptive TP53" 22) ("tetrameric p53" 21) ("a functional p53" 20)
   ("tp53" 20) ("aberrant p53" 20) ("lack functional p53" 18)
   ("non-functional p53" 17) ("stromal p53" 17) ("P53−" 16)
   ("dysfunctional p53" 15) ("cellular p53" 14)
   ("tumor suppressor p53 protein" 14) ("intact p53" 13) ("defective p53" 11)
   ("than wild-type p53" 10) ("dominant-negative p53" 10) ("p-53" 10)
   ("Tumor protein p53" 10) ("oncomorphic p53" 9) ("chronic p53" 9)
   ("DyLight 650-labeled p53" 8) ("“p53”" 8) ("exogenous wild-type p53" 8)
   ("strong p53" 8) ("spontaneous p53" 8) ("excessive p53" 8)
   ("nonfunctional p53" 7) ("soluble p53" 7) ("pro-apoptotic p53" 7)
   ("Tp53 protein" 7) ("the entire p53 family" 7) ("p53 (mutp53) protein" 7)
   ("latent p53" 7) ("phosphoprotein p53" 6) ("p53 family protein" 6)
   ("targeting p53" 6) ("Functional p53" 6) ("P-p53" 6) ("monomeric p53" 6)
   ("functional P53" 6) ("intact TP53" 6) ("nucleoplasmic p53" 6)
   ("than WT p53" 6) ("a dysfunctional p53" 6) ("–p53" 6)
   ("strong nuclear p53" 6) ("p53 Protein" 6) ("P04637" 5)
   ("Exogenous wild-type p53" 5) ("tumor-associated mutant p53" 5)
   ("P53 peptide" 5) ("oncomorphic TP53" 5) ("a dominant-negative p53" 5)
   ("p53 (1–57) peptide" 5) ("non functional p53" 4) ("than TP53" 4)
   ("basal p53" 4) ("the functional p53" 4) ("both total and acetylated p53" 4)
   ("p53 (mtp53) protein" 4) ("cellular tumor antigen p53" 4)
   ("Tetrameric p53" 4) ("both primary p53" 4) ("mouse monoclonal p53" 4)
   ("less p53 protein" 4) ("Spontaneous p53" 4) ("overexpressed p53 protein" 4)
   ("quantitative immunoluminometric p53" 4) ("P53-" 4) ("Genomic p53" 4)
   ("abnormal TP53" 4) ("Nucleolar ubiquitylated p53" 4)
   ("nondisruptive TP53" 4) ("we first knocked down p53" 4)
   ("p53-WT protein" 4) ("normal TP53" 4) ("p53 peptide (SQETFSDLWKLLPEN)" 4)
   ("Cellular tumor antigen p53" 3) ("new p53" 3)
   ("enhancer/promoter-bound p53" 3) ("lacked functional p53" 3)
   ("stress-induced p53" 3) ("dominant-negative truncated p53" 3)
   ("TP53 peptide" 3) ("the p53's" 3) ("expressing wt p53" 3) ("null p53" 3)
   ("coexpressed wild-type p53 protein" 3) ("the tetrameric p53" 3)
   ("a largely nonfunctional p53" 3) ("genome-wide p53" 3)
   ("Mouse monoclonal antibodies anti- p53" 3) ("crucial p53" 3)
   ("p53(1-57) molecule" 3) ("agarose-conjugated mouse monoclonal p53" 3)
   ("targeting TP53" 3) ("total cellular p53" 3) ("just p53" 3)
   ("dominant-negative TP53 R270H" 3)
   ("an at least partially functional p53 protein" 3)
   ("a temperature-sensitive p53" 3) ("expressing mutant p53" 3)
   ("nucleolar p53" 3) ("naturally-processed p53 protein" 3)
   ("cumulative p53" 3) ("a dominant-negative mini p53 protein" 3)
   ("dramatically less p53 protein" 2) ("immunoreactive p53" 2)
   ("functional and non-functional p53" 2) ("New p53" 2)
   ("the well-documented apoptotic inducer p53" 2) ("adequate IARC TP53" 2)
   ("robust p53-" 2) ("P53 V157D -overexpressed P53  −/−" 2) ("P53 family" 2)
   ("an oncomorphic p53 protein" 2) ("a highly-stable p53 protein" 2)
   ("soft tissue sarcomas found positive p53" 2) ("Exogenous p53" 2)
   ("very little detectable p53" 2) ("IHC p53" 2)
   ("transcriptional factor p53" 2) ("p53DD protein" 2)
   ("mouse monoclonal anti p53" 2) ("hardly co-IP p53" 2) ("P53 Protein" 2)
   ("increased neuronal p53" 2) ("proficient p53" 2)
   ("cancer-associated MUT TP53" 2) ("“P53”" 2) ("“TP53”" 2)
   ("ChIP-competent p53" 2) ("previously characterized p53" 2)
   ("The only Drosophila homolog of p53" 2) ("exogenous mutant p53" 2)
   ("overexpressed YFP-tagged p53" 2) ("exogenous TP53" 2)
   ("exogenous p53-R280K" 2)
   ("the oncologically relevant transcription factor p53" 2)
   ("a plasmid encoding flag-tagged p53 protein" 2)
   ("serine-46-phosphorylated p53" 2) ("a well established genotoxic p53" 2)
   ("Nutlin-treated p53 +/+" 2) ("isogenic HCT116 p53 +/+" 2)
   ("Than the Canonical Tumor Suppressor p53" 2)
   ("aberrantly expressed/activated p53" 2) ("Isogenic p53" 2)
   ("antioncogenic protein p53" 2)
   ("treated cancer cells H1299 and HCT 116 TP53 −/−" 2) ("more p53 protein" 2)
   ("functional
p53"
    2)
   ("p53
protein"
    2)
   ("strongly binding mutant p53" 2)
   ("A small interfering RNA (siRNA) duplex targeting p53" 2)
   ("human cancers lack functional p53" 2) ("dimeric p53" 2) ("primary p53" 2)
   ("-P53" 2) ("a pseudo-wild-type p53" 2)
   ("functional and nonfunctional TP53" 2) ("overexpressed wild type p53" 2)
   ("Chronic p53" 2) ("cytoplasmic small vesicular p53" 2)
   ("null or wild-type P53" 2) ("ATM decreased p53" 2)
   ("dominant-negative p53 R175H" 2) ("concomitant poor-prognostic TP53" 2)
   ("an isogenic system -/+ p53" 2)
   ("a Trifluoroacetic acid (TFA)-p53 peptide" 2) ("-p53 peptide" 2)
   ("less frequent p53" 2) ("than the GOF p53" 2)
   ("Pirh2 selectively targets tetrameric p53" 2)
   ("a dominant-negative mutant p53" 2) ("particular p53" 2)
   ("shorter construct p53" 2) ("gliomas frequently lack p53" 2)
   ("pBabe-hygro DD p53 expressing dominant-negative p53" 2)
   ("down much more mutant p53" 2) ("transiently-expressed p53" 2)
   ("than native p53 in the H1299 system" 2) ("than full-length p53" 2)
   ("p53
                    protein"
    2)
   ("Normal p53" 2)
   ("a phospho-mimetic
                            S392D mutant p53 protein"
    2)
   ("the pro-apoptotic protein p53" 2) ("expressed p53" 2)
   ("heterogeneous p53" 2) ("a fluorescently-tagged p53" 2)
   ("p53(367–393) peptide" 2) ("longer His-tagged p53(361–393) peptide" 2)
   ("p53(361–393) peptide" 2) ("p53(ΔC30) protein" 2) ("p53 (rp53) protein" 2)
   ("overexpressed activated p53" 2) ("non-genotoxically overexpressed p53" 2)
   ("exotic p53" 2) ("viral p53" 2) ("switchable p53" 2)
   ("p53 ( xref ; xref ) p53" 2)
   ("stress-responsive tumor suppressor p53 protein" 2)
   ("its well-characterized substrate p53" 2) ("a negative or weak p53" 2)
   ("p53 (residues 351–382) peptide" 2) ("the tetrameric mutant p53" 2)
   ("“weak” p53" 2) ("p53Exon2-" 2) ("we first knocked-down p53" 2)
   ("chromatin associated p53" 2) ("chromatin-associated p53" 2)
   ("Strong p53" 2) ("a potential p53" 2) ("a functional P53" 2)
   ("report only epithelial p53" 2) ("strongly positive p53" 2)
   ("Strongly positive p53" 2)
   ("so many posttranslational modifications target p53" 2)
   ("previously known p53" 2) ("than native p53" 2)
   ("Atheronal-Misfolded p53" 2) ("expressing wild-type p53" 2)
   ("codon 72-polymorphic p53" 2) ("the intense and diffuse (≥ 60%) p53" 2)
   ("concordant p53" 2) ("evident mono-ubiquitinated p53" 2)
   ("harbored disruptive TP53" 2) ("nondisruptive mutant TP53" 2)
   ("either nondisruptive or wild type TP53" 2) ("Tetinducible p53" 2)
   ("an endogenously-expressed mutant p53" 2)
   ("the last 30 amino acids of p53" 2) ("intense p53" 2)
   ("proapoptotic p53" 2) ("stage 3 ESC increased p53 protein" 2)
   ("dysfunctional TP53" 2) ("further deleting TP53" 2) ("DeltaNp63alpha" 2)
   ("focal or weak p53" 2) ("only one sebaceoma showed uniform p53" 2)
   ("most cancer cells lack p53" 2) ("weak p53" 2)
   ("adriamycin-treated p53 −/−" 2) ("Focal weak nuclear p53" 2)
   ("mimics three hydrophobic amino acids of p53" 2) ("the cellular p53" 2)
   ("less total p53" 2)
   ("the Hsp70/Hsp90-containing complex first assists p53" 2)
   ("similar cumulative p53" 2) ("namely 2 μg/ml mouse anti-human p53" 2)
   ("dominant-negative mini p53 protein" 2) ("endogeneous wild-type p53" 2)
   ("ER stress-induced p53 protein" 2) ("TP53protein" 2)
   ("a temperature-sensitive p53 protein" 2) ("absent p53" 2)
   ("extensive TRP53" 2) ("obvious TRP53" 2) ("Most TRP53" 2)
   ("otherwise wild-type p53" 2) ("The well-known tumor suppressor p53" 2)
   ("than the p53[+]" 2) ("only mutant p53 protein" 2) ("Tumor Protein p53" 2)
   ("Wild Type p53" 2) ("a dominant-negative p53 peptide" 2)
   ("the pro-apoptotic tumor protein p53" 2) ("almost all p53 protein" 1)
   ("expressed temperature-sensitive p53" 1) ("the stress-induced p53" 1)
   ("representative most mutant p53" 1) ("two dominant negative (DN) p53" 1)
   ("whose TP53" 1) ("the first 13 amino acids of p53" 1)
   ("the N-terminal 13 amino acids of p53 (Δ2–13 and Δ4–13)" 1)
   ("the N-terminal 43 amino acids of p53" 1) ("a non functional p53" 1)
   ("a non-functional p53" 1) ("the non-functional p53" 1)
   ("the non functional p53" 1) ("a predicted functional p53" 1)
   ("the pre-eminent tumor suppressor p53" 1)
   ("‘oscillatory’ any single-cell p53" 1) ("the monotonic p53" 1)
   ("monotonic p53" 1) ("its isogenic p53" 1) ("many new p53" 1)
   ("genuine p53" 1) ("the 149 potential new p53" 1) ("the usual p53" 1)
   ("219 potential new p53" 1) ("less p53" 1)
   ("its isogenic derivative HCT116 p53" 1)
   ("the dominant-negative human TP53  R175H" 1) ("endogenous soluble p53" 1)
   ("soluble or aggregated p53" 1)
   ("Both cell lines internalized DyLight 650-labeled p53" 1)
   ("1 µM DyLight 650-labeled p53" 1) ("DyLight 650-labeled recombinant p53" 1)
   ("recombinant exogenous wild-type p53" 1)
   ("intracellular soluble wild-type p53" 1) ("pTP53" 1)
   ("than TP53 that reduce p53 activity" 1)
   ("the previously unreported P53 V157D" 1) ("highly cooperative p53" 1)
   ("Cooperation increases p53's" 1) ("the cellular tumor suppressor p53" 1)
   ("endogenous cellular p53" 1) ("Nutlin 3-treated HCT116 p53  +/+" 1)
   ("the isogenic p53  +/+" 1) ("two potential p53" 1) ("mutational p53" 1)
   ("posses mutational p53" 1) ("than WT p53 ( xref )" 1)
   ("acute myeloid leukemia ( xref ) support p53" 1)
   ("total and phosphorylated p53" 1) ("each oncomorphic p53" 1)
   ("alternate p53" 1) ("aberrant stromal p53" 1) ("Stromal p53" 1)
   ("this TP53" 1) ("p53 (TP53) protein" 1) ("instead regulated p53" 1)
   ("SD-treated RNC p53 −/−" 1) ("p53 transcriptional activity switches p53" 1)
   ("the remaining functionally intact p53" 1)
   ("approximately 10 fold less p53 protein" 1) ("p53, p16 expression" 1)
   ("a conditional p53" 1) ("than p53DD" 1) ("fewer p53" 1)
   ("than wild-type p53 (>125%)" 1) ("soluble p53 protein" 1)
   ("a possible p53-" 1) ("either functional or non-functional p53" 1)
   ("intact or inactivated TP53" 1) ("normal circumstances cellular p53" 1)
   ("in turn targets p53" 1) ("residual normal p53" 1)
   ("Total, native and denatured p53" 1) ("The mouse monoclonal p53" 1)
   ("mitochondrial monomeric p53" 1) ("dominant-negative mutant p53" 1)
   ("a mitochondrially targeted monomeric p53" 1)
   ("over-produced mutant p53" 1) ("oligomeric p53" 1)
   ("exogenous and endogenous p53" 1)
   ("the homo-tetrameric transcription factor p53" 1)
   ("newly-synthesised p53" 1) ("the high basal p53" 1)
   ("fully functional p53" 1) ("partly overlaps p53's" 1)
   ("partly overlaps p53" 1) ("the tumor suppressor p53's" 1) ("most TP53" 1)
   ("even Histidine-tagged p53 protein" 1) ("only p53 protein" 1)
   ("the heat stress-induced p53" 1) ("a p53's" 1)
   ("Mitochondrially targeted p53" 1) ("targeted p53" 1)
   ("Premature senescent WS MSCs expressed more p53" 1)
   ("The tumor suppressive transcription factor p53" 1)
   ("keratinocytes UV-induced p53" 1) ("UV-irradiated p53 -/-" 1)
   ("the differential p53" 1)
   ("than wild-type p53 (~30% vs ~24% Annexin V + , P = 0.032)" 1)
   ("the ubiquitous tumor suppressor TP53" 1) ("heterozygous p53" 1)
   ("immediate p53" 1) ("immediate direct p53" 1) ("particular—called p53" 1)
   ("an N-terminally intact p53" 1) ("some functional p53" 1)
   ("further stabilized p53" 1) ("these pro-apoptotic p53" 1)
   ("tetracycline–regulatable P53" 1) ("required functional P53" 1)
   ("Ash2L abrogated P53's" 1) ("Ash2L abrogated P53" 1) ("had lost p53's" 1)
   ("trophoblastic p53" 1) ("The pro-apoptotic transcription factor p53" 1)
   ("its isogenic counterpart HCT-116 p53 −/−" 1)
   ("skin wart–associated papillomaviruses leave p53" 1)
   ("genotoxic stress p53" 1)
   ("strong
p53"
    1)
   ("around TP53" 1) ("only p53 K305N" 1) ("any potential p53" 1)
   ("The p53's" 1) ("the pro-apoptotic proteins p53" 1)
   ("The pivotal role p53" 1) ("expressing p53" 1)
   ("exogenous wild-type tumor suppressor gene p53" 1)
   ("immunoprecipitable p53" 1) ("the more desirable scenario p53" 1)
   ("most mouse p53" 1) ("a nonfunctional TP53" 1)
   ("The monoclonal mouse anti-human p53" 1)
   ("a typical tumor suppressor p53" 1) ("nonfunctional mutated p53" 1)
   ("the
monomeric p53"
    1)
   ("Given p53’s" 1) ("Given p53" 1) ("residual WT p53" 1)
   ("exogenous WT p53" 1) ("exogenous therapeutic WT p53" 1)
   ("wild- type TP53" 1) ("directly target p53" 1) ("the proximal p53" 1)
   ("the isogenic p53" 1) ("potential p53" 1)
   ("the diphosphorylated tetrameric p53" 1)
   ("Recent evidence strongly support p53" 1) ("potential TP53" 1)
   ("the monomeric p53 L344P" 1) ("extreme p53" 1) ("Abnormal p53" 1)
   ("than 50% colon cancers display inactivated p53" 1)
   ("constantly target p53" 1) ("specifically target p53" 1)
   ("further refining p53" 1) ("than p53 25,26,53,54 ( xref )" 1)
   ("than wild type p53" 1) ("germline wild- type TP53" 1)
   ("than p53 peptide" 1)
   ("than a p53 peptide (residues 16-27, K  i = 1.2 μM)" 1) ("distinct p53" 1)
   ("well-characterized p53" 1) ("acute p53" 1) ("‘chronic’ p53" 1)
   ("PCa tumors expressed less Tp53" 1) ("a less extent p53" 1)
   ("Alongside canonical p53" 1) ("evaluating p53's" 1)
   ("The approximately 172 kb Spectrum Orange P53" 1) ("more p53" 1)
   ("the classic p53" 1) ("those harboring functional p53" 1)
   ("than wild-type P53" 1)
   ("than p53 deacetylated by wild-type HDAC1 in vitro and in vivo" 1)
   ("IAV infection increases p53" 1) ("oxidative stress and mutant p53" 1)
   ("wild-type TP53 expressing either dominant-negative p53" 1)
   ("non-transcriptional p53" 1) ("the exogenous p53 family" 1)
   ("BrCa subtypes expressing wt p53" 1)
   ("than those harbouring wild-type p53" 1)
   ("Multiple well-established p53" 1) ("Non-canonical p53" 1)
   ("Canonical p53" 1) ("the RAD6-MDM2 complex synergistically targets p53" 1)
   ("the p21  CDKN1A and mdm2 mRNAs which then allows p53's" 1)
   ("p53 and masks p53's" 1) ("E. coli -expressed recombinant p53 protein" 1)
   ("The bacteria specifically target p53" 1) ("a possible p53" 1)
   ("previously described p53" 1) ("crucial p53's" 1)
   ("a unique germline TP53 point mutation" 1)
   ("the C-terminal Lysines of p53" 1) ("the latter study p53" 1)
   ("analyzed p53 's" 1) ("antagonized p53 's" 1)
   ("the isogenic HCT116 p53 +/+" 1) ("UV-irradiated HCT116 p53 +/+" 1)
   ("the first 60 amino acids of p53" 1)
   ("the first 60 amino acids of p53 that interact with Taz2" 1)
   ("than non-phosphorylated p53 1-39 ( xref )" 1) ("proficient wt p53" 1)
   ("TPA-treated G3Terc −/− p53 −/−" 1) ("TPA-treated G3Terc −/− p53 +/−" 1)
   ("the associated AUC p53" 1) ("functionally distinct p53" 1)
   ("a heterozygous mutant Tp53" 1) ("P53DD" 1)
   ("human tumors lack functional p53" 1)
   ("than TP53 containing proline [C]" 1)
   ("Human papillomavirus (HPV) specifically targets p53" 1)
   ("the first 105 amino acids of human p53 (GST-p53)" 1)
   ("than the wt p53 protein" 1) ("down less p53" 1)
   ("pro-apoptotic protein p53" 1) ("no functional p53" 1)
   ("toxic and induced p53" 1) ("the three major TP53" 1)
   ("the ubiquitous p53 protein" 1) ("cancerous p53" 1)
   ("the previously unrescuable p53 cancer mutant
                    P152L"
    1)
   ("exogenous NTD125 stabilized p53" 1) ("had completely inactivated p53" 1)
   ("A functional p53" 1) ("showed either normal or overexpressed p53" 1)
   ("at least p53" 1) ("than p53 ( xref ; xref )" 1) ("mitotic p53  +/+" 1)
   ("isogenic p53  +/+" 1)
   ("specifically
                            target p53"
    1)
   ("Too much p53" 1) ("the stress-responsive p53" 1)
   ("whose tumors expressed p53" 1) ("than monomeric p53" 1)
   ("Oligomerized p53" 1) ("several C-terminal lysines of p53" 1)
   ("the pivotal role p53" 1) ("RPL11 predominantly controls p53" 1)
   ("Residual stable p53" 1) ("directly target human p53" 1)
   ("this immortal phenotype lacks p53" 1)
   ("integrin αvβ3 inactivated vascular cell p53" 1)
   ("fluorescently-tagged p53" 1) ("we first measured p53" 1)
   ("un-phosphorylated p53" 1) ("the 116 N-terminal amino acids of p53" 1)
   ("421-detectable p53" 1) ("bacterial p53" 1) ("than p53(ΔC30)" 1)
   ("than the p53(ΔC30) protein" 1)
   ("The key lysines of p53 that are ubiquitinated by Mdm2" 1)
   ("the well-defined roles p53" 1) ("such canonical p53" 1)
   ("Stress-induced p53" 1) ("a nonfunctional p53" 1)
   ("radiation-induced total mitochondrial p53" 1)
   ("the stress-induced p53 protein" 1) ("Cellular p53" 1)
   ("human cells lack functional p53" 1) ("increases p53’s" 1)
   ("binding and masking p53's" 1) ("continuous p53" 1)
   ("SCYL1-BP1 stabilized functional p53" 1) ("pro-melanogenic p53" 1)
   ("immunopositive wild-type p53" 1)
   ("the DNA-binding-deficient p53 mutant R175H" 1) ("”" 1)
   ("transcriptionally functional p53" 1) ("directly target TP53" 1)
   ("missing TP53" 1) ("Poly-ubiquitination primarily targets p53" 1)
   ("the consequent unfolded p53" 1) ("The His-SUMO1-conjugated p53 protein" 1)
   ("than intact TP53 [ xref ]" 1) ("Endothelial p53" 1) ("endothelial p53" 1)
   ("vascular p53" 1) ("existent p53" 1) ("lacks fully functional p53" 1)
   ("the reactive p53" 1) ("than those lacking p53 (t 1/2 = 4.01 h)" 1)
   ("MDM2 out-competed excess p53" 1)
   ("Only four contiguous amino acids of p53" 1)
   ("only 10 tumours expressed mutant p53" 1)
   ("had less bioactivity enhanced pp53" 1) ("most pp53" 1) ("pp53 protein" 1)
   ("than Pro 72 -p53 ( xref and Fig. S1 G)" 1)
   ("than those expressing Pro 72 -p53" 1) ("p53ΔDBD-" 1)
   ("mouse mammary cells knocked-out p53" 1) ("60%–70% aberrant TP53" 1)
   ("Steels et al. identified aberrant TP53" 1)
   ("than the SUMO-1/2/3 modified p53 ( xref )" 1) ("than SUMOylated p53" 1)
   ("most p53" 1) ("a genome-wide scale p53" 1) ("only high-confidence p53" 1)
   ("only partial dysfunctional p53 protein" 1) ("isotopically-labeled p53" 1)
   ("tetrameric full-length p53" 1) ("The tetrameric tumor suppressor p53" 1)
   ("a partially functional p53" 1) ("d-flow–induced p53" 1)
   ("the endothelial p53" 1) ("subsequent p53" 1)
   ("d-flow–mediated endothelial p53" 1)
   ("the lysines of p53 that have been identified for sumoylation and neddylation"
    1)
   ("uncommon and wild-type P53" 1) ("than control p53  (-/-)" 1)
   ("than p53  (-/-)" 1) ("exogenous WT P53" 1) ("epithelial p53" 1)
   ("lacks functional p53" 1) ("blocking pro-apoptotic p53" 1)
   ("relative TP53-" 1) ("than wt p53" 1) ("so many important p53" 1)
   ("the intrinsic p53's" 1) ("the intrinsic p53" 1)
   ("GRIM-19 increased p53" 1) ("the functionally-impaired p53 protein" 1)
   ("a temperature-insensitive mutant p53" 1) ("the nucleoplasmic p53" 1)
   ("γ-irradiated HCT116 p53 +/+" 1)
   ("recognized naturally-processed p53 protein" 1) ("that p53's" 1)
   ("the interconnected p53" 1) ("most tissues p53" 1)
   ("The stress-activated p53" 1) ("Dominant-negative p53" 1)
   ("functionally inactivated p53" 1) ("disruptive p53" 1)
   ("the nondisruptive TP53 mutation R175H" 1) ("Disruptive TP53" 1)
   ("WT p53’s" 1) ("expressing mutant p53-R273H" 1)
   ("the C-terminal 30 amino acids of p53" 1)
   ("the p53 peptide solely targets p53" 1)
   ("the last 30 amino acids of the human p53" 1)
   ("the last 38 amino acids (Δ356–393) of p53" 1)
   ("expressed functional p53" 1) ("defective or deleted p53" 1)
   ("K373/K382-acetylated p53" 1) ("than unfolded p53" 1)
   ("35 S-met-labeled p53" 1) ("than p53(73βaa1–54)" 1) ("than p53 (1–363)" 1)
   ("mutant p53’s" 1) ("only mutant p53" 1) ("prototypical TP53" 1)
   ("an investigational AmpliChip p53" 1) ("these canonical p53" 1)
   ("two well-recognized p53" 1) ("a p53’s" 1) ("Dox-induced exogenous TP53" 1)
   ("several new p53" 1) ("most cancers lack functional p53" 1)
   ("wild type functional p53" 1) ("homozygous wild type TP53" 1)
   ("amino acids of p53" 1) ("UV-induced DNA damage p53" 1) ("a strong p53" 1)
   ("conditional bitransgenic inducible p53" 1) ("the regulatory p53" 1)
   ("transcriptional p53" 1) ("stress-accumulated mitochondrial p53 protein" 1)
   ("than pulsed p53" 1) ("a heterozygous p53 point mutation" 1)
   ("adherent p53 +/+" 1) ("likely affected p53's" 1)
   ("than those containing mutated or attenuated p53" 1) ("p53-(DO)" 1)
   ("its proposed transcriptional upstream regulator p53" 1)
   ("specifically targets p53" 1)
   ("overexpression studies first associated p53" 1)
   ("dominant-negative TP53" 1) ("in fact human p53" 1)
   ("than dimethylated p53 (see below and xref )" 1) ("very little p53" 1)
   ("than wild-type p53 ( xref )" 1) ("two canonical p53" 1) ("GOF p53’s" 1)
   ("than the natural p53 peptide [ xref ]" 1)
   ("than p53 (e.g., E2F1, YY1, RB, ribosomal proteins) that explain" 1)
   ("undetectable p53" 1) ("than TP53 -72P" 1)
   ("expressing mutant p53 protein" 1) ("radiation-activated p53" 1)
   ("e.g. ΔCt p53" 1) ("the well-studied canonical p53 protein" 1)
   ("than mammalian full-length p53" 1) ("orthologous p53" 1)
   ("simultaneously both p53" 1) ("isogenic p53" 1) ("functional TP53" 1)
   ("tumoral p53" 1) ("cells displayed p53" 1) ("immunodetectable TRP53" 1)
   ("TRP53 protein" 1) ("DNA-damage–induced p53" 1) ("a few p53" 1)
   ("E6 continually targets p53" 1) ("the well-known tumor suppressor p53" 1)
   ("than phospho-p53 ( xref )" 1) ("less phospho-p53" 1)
   ("those bearing defective p53" 1) ("the transcriptional factors p53" 1)
   ("than full-length p53
[ xref , xref ]"
    1)
   ("heterozygous TP53" 1) ("the homozygous TP53" 1) ("apoptotic p53" 1)
   ("the canonical p53" 1) ("a normal p53" 1) ("only p53 R175H" 1)
   ("namely p53 R175H" 1) ("whose p53" 1)
   ("than the p53 peptide (amino acids 13 to 29, which constitutes the MDM2 binding motif)"
    1)
   ("endogenous basal p53" 1) ("a dual PI3K-mTOR inhibitor increases TP53" 1)
   ("namely both p53" 1)))
 ("UP:P04732" (("MTD" 129) ("MT-1E" 17) ("than its MTD" 1)))
 ("UP:P04733" (("MT1F" 6) ("MTIF" 1))) ("UP:P04745" (("AMY-1" 2)))
 ("UP:P04792"
  (("Hsp27" 2256) ("HSP27" 2101) ("HSPB1" 1286) ("Hsp-27" 229) ("HspB1" 219)
   ("Hsp25" 104) ("pHSP27" 38) ("p-HSP27" 37) ("hsp27" 29) ("HSP25" 27)
   ("HSPB1 protein" 26) ("hsp25" 23) ("Hsp27 protein" 15) ("HSP27 protein" 14)
   ("pHsp27" 10) ("HSP-27" 7) ("heat shock protein beta-1" 7) ("CMT2F" 6)
   ("HSPB1−" 5) ("overexpressed HSPB1" 5) ("hspb1" 5) ("Hsp27 peptide" 4)
   ("heat shock protein beta 1" 4) ("HSPB1 Protein" 4)
   ("overexpressed Hsp27" 4) ("Hsp 27" 4) ("tubular HSP27" 4) ("-HSP27" 4)
   ("Hsp27-" 3) ("HSPB1-" 3) ("stromal Hsp27" 3) ("than the wild type HspB1" 3)
   ("exogenous recombinant phosphorylated-HSP27" 3) ("HSP 27" 3)
   ("Hsp-27 protein" 3) ("p-Hsp27" 3) ("HSP-27 protein" 3)
   ("their stromal Hsp27" 2) ("soluble Hsp27" 2) ("Soluble Hsp27" 2)
   ("Stromal Hsp27" 2) ("the stromal Hsp27" 2) ("Heat shock protein beta-1" 2)
   ("Exogenous recombinant phosphorylated- HSP27" 2) ("HSPB1 molecule" 2)
   ("Hsp25+Hsp70-" 2) ("weak HSP27" 2) ("strong HSP27" 2)
   ("cells displayed HSP27" 2) ("Efficient Hsp25" 2)
   ("enhanced Hsp27 protein" 2) ("Tubular cell HSP27" 2)
   ("than wild-type HSPB1 [ xref , xref ]" 1)
   ("still stimulated cellular pHsp27" 1) ("hsp 27" 1)
   ("its transcriptional target Hsp27" 1) ("than the Hsp27 peptide" 1)
   ("down singly S78 phosphorylated Hsp27" 1) ("p-HSPB1" 1)
   ("further confirming HSPB1" 1) ("cellular and secreted Hsp27" 1)
   ("Strong stromal Hsp27" 1) ("than the wild type HspB1 ( xref )" 1)
   ("-HSPB1" 1) ("The exogenous recombinant phosphorylated-HSP27" 1)
   ("phosphorylated-HSP27/total HSP27" 1) ("elect HSPB1" 1) ("renal HSP27" 1)
   ("systemic HSP27" 1) ("original HSP27" 1) ("heat shock 27 kDa protein" 1)
   ("P-Hsp27" 1) ("heat shock 27kDa protein 1" 1) ("exogenous HSPB1" 1)
   ("expressing wild-type HSPB1" 1) ("monomeric and dimeric HSPB1" 1)
   ("transiently-induced Hsp27" 1) ("soluble HSPB1" 1)
   ("sequestered exogenous HSPB1" 1) ("only wildtype Hsp27" 1)
   ("both mock-phosphorylated Hsp27 and wildtype Hsp27" 1)
   ("than 3xS/D Hsp27 (r≈20nm; day 5)" 1)
   ("large (200 kDa – 800 kDa) dormant Hsp27" 1) ("exogenous HSP27" 1)
   ("Hsp25-" 1) ("the most Hsp27" 1) ("MGO modification made Hsp27" 1)
   ("than Hsp27-WT ( xref )" 1) ("heat shock 27kD protein 1" 1) ("HSPB-1" 1)
   ("phosphorylated-to-total HSP27" 1) ("elevated tubular HSP27" 1)
   ("cortical HSP27" 1) ("six times more Hsp27" 1) ("Hspb1" 1)))
 ("UP:P04798"
  (("CYP1A1" 313) ("pyrene" 120) ("cytochrome P450 1A1" 11) ("Cyp1a1" 9)
   ("Cytochrome P450 1A1" 1) ("pyrene (BPDE)" 1)))
 ("UP:P04807" (("HKB" 2))) ("UP:P04808" (("RLN1" 11) ("Relaxin 1" 1)))
 ("UP:P04815" (("SII" 22)))
 ("UP:P04818"
  (("TS" 2398) ("TYMS" 929) ("thymidylate synthase" 182) ("T/S" 98)
   ("Thymidylate synthase" 42) ("TS protein" 29) ("ts" 29) ("TMS" 28) ("Ts" 22)
   ("thymidylate synthase (TS)" 21) ("thymidylate synthetase" 20) ("Tyms" 12)
   ("TYMS protein" 9) ("Thymidylate synthetase" 8) ("-TS" 5)
   ("thymidylate synthase ( TS )" 4) ("pTS" 4) ("Tyms protein" 4)
   ("aberrant intratumoral TYMS" 4) ("TS-" 3) ("a favourable TS-5" 3)
   ("intratumoral aberrant TYMS" 3) ("Thymidylate synthase (TS)" 2) ("TSER" 2)
   ("mouse monoclonal thymidylate synthase" 2)
   ("thymidylate synthetase (TS)" 2) ("missing TS-3" 2) ("TS molecule" 2)
   ("genetic TYMS" 2) ("thymidylate synthase protein" 2)
   ("the chemotherapeutic target TYMS" 2) ("the favourable TS-5" 2)
   ("aberrant TYMS" 2) ("Tms" 1) ("the available TS protein" 1)
   ("Bacterial TS" 1) ("TS (AATCCGTCGAGCAGAGTT)" 1)
   ("Thymidylate synthase ( TYMS )" 1) ("a functional TS" 1) ("only TS 5" 1)
   ("the relevant T/S" 1) ("Thymidylate Synthetase" 1)
   ("The favourable TS-5" 1) ("natural-log transformed T/S" 1) ("TS Protein" 1)
   ("the available TYMS" 1) ("the polymorphic TYMS' s" 1)
   ("the polymorphic TYMS" 1) ("the clear Ts" 1) ("than normal TYMS" 1)
   ("normal TYMS" 1) ("experimental TS" 1)))
 ("UP:P04839"
  (("NOX2" 461) ("Nox2" 165) ("gp91 phox" 89) ("gp91" 23) ("gp91phox" 21)
   ("CYBB" 16) ("NOX-2" 15) ("gp91 PHOX" 14) ("Cybb" 7) ("functional NOX2" 6)
   ("gp91  phox" 3) ("NADPH oxidase 2" 3)
   ("neutrophil-restricted functional NOX2" 2) ("a functional gp91phox" 2)
   ("Gp91" 2) ("Gp91phox" 2)
   ("phagocytic NADPH oxidase catalytic subunit gp91 phox" 2) ("Nox-2" 2)
   ("particular Nox2" 1) ("non-functional NOX2" 1)
   ("macrophage-restricted functional NOX2" 1) ("NOX2-" 1)
   ("The classic NOX2" 1) ("Nox2-" 1) ("Nox2 protein" 1)))
 ("UP:P04843"
  (("RPN1" 18) ("Ribophorin-1" 3) ("Ribophorin 1" 1) ("Ribophorin I" 1)))
 ("UP:P04844" (("RPN2" 147) ("ribophorin II" 7))) ("UP:P04899" (("GNAI2" 26)))
 ("UP:P04920"
  (("anion exchanger" 12) ("SLC4A2" 5) ("AE2" 2) ("anion exchanger 2" 2)))
 ("UP:P04921" (("GPC" 17) ("GPD" 13) ("pGPD" 4)))
 ("UP:P04930"
  (("sharp" 510) ("Sharp" 28) ("shARP" 10) ("the bimodal transition sharp" 1)
   ("“sharp”" 1) ("even more sharp" 1)
   ("rare focal right parietal occipital sharp" 1)
   ("An electroencephalogram revealed right hemispheric sharp" 1)))
 ("UP:P04957"
  (("LICs" 76) ("BCR-ABL-positive LICs" 2) ("dormant LICs" 2) ("viable LICs" 2)
   ("MLL-AF9-driven LICs" 1) ("quiescent LICs" 1)
   ("the most aggressive LICs" 1)))
 ("UP:P04958" (("tetanus toxin" 5) ("TeNT" 4) ("Tetanus toxin" 2)))
 ("UP:P04971"
  (("BX" 356) ("an Olympus microscope BX51" 1) ("BX-" 1) ("an Olympus BX41" 1)
   ("Bx" 1)))
 ("UP:P04993"
  (("hope" 311) ("Hope" 80) ("new hope" 9) ("HOPE" 5) ("the ultimate hope" 3)
   ("a new hope" 2) ("the foremost hope" 1)
   ("obesity give considerable hope" 1) ("offer new hope" 1)))
 ("UP:P05004" (("interferon-alpha2" 2))) ("UP:P05013" (("IFNA6" 1)))
 ("UP:P05014" (("IFNA4" 9) ("IFN-α4" 2)))
 ("UP:P05019"
  (("IGF-1" 2596) ("IGF-I" 1350) ("IGF1" 803) ("IGF-1-" 131) ("IGFI" 81)
   ("IGF-1–" 42) ("Igf-1" 25) ("insulin-like growth factor I" 21)
   ("IGF-1 protein" 13) ("-IGF-1" 12) ("Igf1" 8) ("exogenous IGF-I" 7)
   ("normal IGF1" 4) ("than IGF1" 3) ("Insulin-like growth factor I" 3)
   ("IGF I" 3) ("exogenous IGF-1" 3) ("free mitogenic IGF-1" 3)
   ("0 nM external IGFI" 2) ("than IGF-1" 2) ("igf-1" 2)
   ("insulin like growth factor 1" 2) ("the bioavailable IGF-1" 2)
   ("IGF1 (CA)" 2) ("low–normal IGF1" 1) ("IGF1 (CEU)" 1)
   ("ALPCO kits separate IGF1" 1) ("IGF-I molecule" 1) ("IGF1-" 1) ("IGF–I" 1)
   ("IGF-I-" 1) ("Insulin like growth factor 1" 1) ("bioavailable IGF-1" 1)
   ("-IGF-I" 1) ("basal IGF-1" 1) ("H226B-K-Ras cells produced more IGF-1" 1)))
 ("UP:P05023" (("ATP1A1" 18) ("α1-subunit-" 4) ("α1-subunit" 3) ("Atp1a1" 2)))
 ("UP:P05026" (("ATP1B1" 17))) ("UP:P05046" (("SBA" 3)))
 ("UP:P05048"
  (("UBX" 12) ("Ubx" 3) ("UBX protein" 2) ("ultrabithorax" 1)
   ("Ultrabithorax" 1)))
 ("UP:P05060" (("CHGB" 19))) ("UP:P05062" (("ALDOB" 1)))
 ("UP:P05067"
  (("APP" 919) ("γ-secretase" 271) ("AICD" 219) ("app" 171)
   ("precursor protein" 149) ("AD1" 90) ("sAPP" 72) ("aPP" 50) ("APPs" 20)
   ("pAPP" 18) ("γ-Secretase" 8) ("precursor protein (APP)" 7)
   ("Amyloid beta A4 protein" 5) ("γ–secretase" 2)
   ("the causative proteins APP" 2) ("subsequent AICD" 2) ("excessive AICD" 2)
   ("sAPPalpha" 2) ("PI3K decreased APP" 2) ("AD1 peptide" 2) ("soluble APP" 2)
   ("App" 2) ("Precursor Protein (APP)" 1) ("Precursor Protein" 1) ("P05067" 1)
   ("exogenous AICD" 1) ("the c-terminal 31 amino acids of APP (c31)" 1)
   ("larger membrane-bound precursor protein" 1) ("precursor protein (GP)" 1)
   ("classic TCR-induced AICD" 1) ("APP-" 1) ("larger precursor protein" 1)
   ("than AD1" 1) ("the 50 cytoplasmic amino acids of APP" 1) ("AD-1" 1)
   ("the respective tEGFR ATP K  m  app" 1)))
 ("UP:P05089" (("arginase-1" 11) ("arginase 1" 9)))
 ("UP:P05090" (("APOD" 27) ("Apolipoprotein D" 2)))
 ("UP:P05091"
  (("ALDH2" 99) ("Aldh2" 26) ("ALDH2 protein" 3) ("Aldh2 protein" 1)
   ("than ALDH2" 1)))
 ("UP:P05093"
  (("CYP17A1" 230) ("CYP17" 72) ("cytochrome P450c17" 5) ("CYP17-" 4)
   ("Cyp17" 2) ("cytochrome P450 17A1" 2) ("CYP17A1 protein" 1)
   ("intratumoral CYP17A1" 1) ("Cyp17a1" 1)))
 ("UP:P05100"
  (("TAG" 493) ("-TAG" 7) ("‘TAG’" 4) ("–TAG" 2) ("less TAG" 1)
   ("for instance TAG 3 TTAG 3 T" 1)))
 ("UP:P05106"
  (("αIIbβ3" 360) ("ITGB3" 115) ("CD61" 55) ("integrin beta 3" 7)
   ("normal αIIbβ3" 6) ("GPIIIa" 5) ("Itgb3" 4) ("integrin beta3" 3)
   ("integrin beta-3" 2) ("megakaryocytic specific surface antigen CD61" 2)
   ("expressing αIIbβ3" 1)))
 ("UP:P05107" (("CD18" 214) ("ITGB2" 44) ("integrin beta 2" 5) ("Itgb2" 1)))
 ("UP:P05108"
  (("SCC" 2814) ("CYP11A1" 53) ("oesophageal SCC" 42) ("cervical SCC" 30)
   ("esophageal SCC" 20) ("oropharyngeal SCC" 16)
   ("HPV-positive oropharyngeal SCC" 12) ("invasive SCC" 12)
   ("cutaneous SCC" 11) ("CYP11A" 9) ("vulval SCC" 8) ("scc" 8)
   ("cervical and oral SCC" 5) ("TSCC" 5) ("Scc" 5) ("laryngeal SCC" 3)
   ("sinonasal SCC" 3) ("high-risk oropharyngeal SCC" 3) ("Cyp11a1" 3)
   ("HNSCC" 3) ("the vulval SCC" 2) ("the oropharyngeal SCC" 2)
   ("hypopharyngeal SCC" 2) ("pulmonary SCC" 2) ("extrapulmonary SCC" 2)
   ("285 incident SCC" 2) ("Invasive SCC" 2) ("invasive (Met1) SCC" 2)
   ("well-differentiated SCC" 2) ("a primary hypopharyngeal SCC" 2)
   ("metastatic esophageal SCC" 2) ("a primary pulmonary SCC" 2)
   ("the 40 vulval SCC" 1) ("two vulval SCC" 1) ("the cervical SCC" 1)
   ("the 19 cervical SCC" 1) ("advanced cervical SCC" 1)
   ("high-risk (as defined by both selection criteria and comparative clinical outcomes) oropharyngeal SCC"
    1)
   ("early stage esophageal SCC" 1) ("HPV-driven SCC" 1)
   ("a single HPV-positive oropharyngeal SCC" 1) ("Oropharyngeal SCC" 1)
   ("highly aggressive SCC" 1) ("most SCC" 1) ("invasive cervical SCC" 1)
   ("Cervical SCC" 1) ("“CAV-SCC”" 1) ("paraffin-embedded cervical SCC" 1)
   ("Cyp11A1" 1) ("HPV-associated SCC" 1) ("associated SCC" 1)
   ("the well-differentiated SCC" 1) ("microinvasive, and invasive SCC" 1)
   ("microinvasive and invasive SCC" 1) ("microinvasive SCC" 1)
   ("isogenic SCC" 1) ("well-differentiated locally invasive SCC" 1)
   ("than SCC (Figure xref )" 1) ("an invasive SCC" 1) ("extragenital SCC" 1)
   ("had pathologically confirmed squamous SCC" 1)
   ("80 metastatic esophageal SCC" 1) ("35 (11.8%) esophageal SCC" 1)
   ("unresectable esophageal SCC" 1) ("primary-metastatic esophageal SCC" 1)
   ("Ras-driven SCC" 1) ("uterine cervical or anal SCC" 1)
   ("an anal or uterine cervical SCC" 1) ("an anal or cervical SCC" 1)
   ("the 25 pulmonary SCC" 1) ("invasive uterine cervical SCC" 1)
   ("invasive anal SCC" 1) ("an anal SCC" 1) ("a uterine cervical SCC" 1)
   ("the UV-induced SCC" 1) ("operable oesophageal SCC" 1)
   ("HPV-related oropharyngeal SCC" 1)))
 ("UP:P05109"
  (("CagA" 561) ("S100A8" 310) ("S100A8/A9" 185) ("CAGA" 104) ("cagA" 56)
   ("pCAGA" 35) ("CagA-" 16) ("-CagA protein" 10) ("S100A8/A9 protein" 6)
   ("S100A8 protein" 3) ("-CagA" 3) ("CagA, H 2 O 2 ," 2) ("S100a8" 2)
   ("Calgranulin A" 1) ("proinflammatory S100A8" 1)
   ("the corresponding isogenic cagA" 1) ("corresponding isogenic cagA" 1)
   ("its heterodimeric partner S100A8" 1) ("heterodimeric S100A8/A9" 1)
   ("the heterodimeric S100A8/A9" 1) ("calgranulin A" 1)))
 ("UP:P05111" (("Inhibin-A" 2) ("Inha" 1)))
 ("UP:P05112"
  (("IL-4" 2365) ("IL4" 200) ("interleukin-4" 54) ("interleukin 4" 20)
   ("Il4" 20) ("IL-4-" 3) ("exogenous IL-4" 3) ("IL-4 protein" 3) ("IL-4–" 2)
   ("Interleukin-4" 2) ("neither exogenous IL-4" 2)
   ("Both LPS/TNFα-treated IL-4" 2) ("monoclonal anti-human IL-4" 2)
   ("more IL-4" 2) ("IL–4" 1) ("Interleukin 4" 1) ("than IL-4" 1)
   ("particular IL-4" 1) ("systemic or local IL-4" 1)
   ("the prototypic
                    Th2 cytokine IL-4"
    1)
   ("The
                    prototypic Th2 cytokine IL-4"
    1)
   ("Il-4" 1) ("few reports linked IL-4" 1)))
 ("UP:P05113"
  (("IL-5" 613) ("TRF" 125) ("IL5" 23) ("Il5" 6) ("interleukin 5" 3)
   ("IL-5-" 2) ("than IL-5" 1) ("iL5" 1) ("Il-5" 1) ("interleukin-5" 1)))
 ("UP:P05114" (("HMG-14" 7) ("HMGN1 protein" 6) ("HMGN1" 4) ("HMG14" 3)))
 ("UP:P05120"
  (("PAI-2" 33) ("SERPINB2" 8) ("Serpinb2" 5) ("SerpinB2" 4)
   ("plasminogen activator inhibitor 2" 3) ("PAI2" 1)))
 ("UP:P05121"
  (("PAI-1" 7666) ("SERPINE1" 470) ("PAI" 310)
   ("plasminogen activator inhibitor-1" 206) ("PAI-1 protein" 111) ("PAI1" 108)
   ("Plasminogen activator inhibitor-1" 78)
   ("plasminogen activator inhibitor 1" 63) ("Serpine1" 31) ("nexins" 24)
   ("nexin" 19) ("Plasminogen activator inhibitor 1" 14) ("Nexin" 12)
   ("SerpinE1" 10) ("-PAI" 10) ("PAI-1 molecule" 10) ("PAI-1-" 9) ("Pai-1" 6)
   ("serpine1" 5) ("PAI-" 4) ("latent PAI-1" 4) ("UC PAI-1" 4)
   ("exogenous PAI-1" 3) ("Exogenous PAI-1" 3) ("Pai1" 3)
   ("plasminogen activator inhibitor–1" 3)
   ("the cardiovascular disease risk factor plasminogen activator inhibitor-1"
    3)
   ("serpine-1" 3) ("targeted PAI" 2) ("the profibrotic mediator PAI-1" 2)
   ("strong PAI-1" 2) ("Plasminogen activator-inhibitor-1" 2)
   ("endothelial plasminogen activator inhibitor" 2)
   ("consequently increase SERPINE1" 2) ("SERPINE-1" 2) ("available PAI-1" 2)
   ("−PAI-1" 2) ("the well-characterized TGF-β inducible gene PAI-1" 2)
   ("significantly more PAI-1" 1) ("epidemiological data linking PAI-1" 1)
   ("Matricellular (i.e., anchored) PAI-1" 1)
   ("the epidemiological data linking PAI-1" 1) ("ablates PAI-1's" 1)
   ("than nonglycosylated human PAI-1" 1) ("given PAI-1’s" 1) ("given PAI-1" 1)
   ("“PAI-1”" 1) ("“Plasminogen activator inhibitor-1”" 1)
   ("preoperative PAI-1" 1) ("very long half-life PAI-1" 1) ("the PAI-1’s" 1)
   ("–PAI-1" 1) ("PAI1-" 1) ("wild-type PAI-1’s" 1) ("that PAI-1’s" 1)
   ("the respective sorting nexins" 1) ("the PAI-1" 1)
   ("homozygous PAI-1 −/−" 1) ("endothelial PAI-1" 1)
   ("these miRNAs directly target PAI-1-3" 1)
   ("its principal inhibitor PAI-1" 1) ("log-transformed PAI-1" 1)
   ("Log-transformed PAI-1" 1) ("Nexins" 1) ("available matrix-bound PAI-1" 1)
   ("soluble PAI-1" 1) ("matrix-associated PAI-1" 1) ("excessive PAI-1" 1)
   ("the entire PAI-1" 1) ("than plasma PAI-1" 1)
   ("“plasminogen activator inhibitor-1″" 1) ("Serpin E1" 1)))
 ("UP:P05129"
  (("PKCγ" 253) ("PRKCG" 7) ("PKC-γ" 5) ("-PKCγ" 3)
   ("the classical isozyme PKC-γ" 1) ("PKC-gamma" 1) ("pPKCγ" 1)))
 ("UP:P05141" (("ANT2" 8) ("T3s" 5) ("T2s" 2)))
 ("UP:P05154"
  (("PCI" 222) ("PAI-3" 8) ("SERPINA5" 4)
   ("plasma serine protease inhibitor" 4) ("in-hospital PCI" 1)))
 ("UP:P05155"
  (("angioedema" 88) ("ACE inhibitor-associated angioedema" 43) ("SERPING1" 6)
   ("hereditary)" 5) ("HAE2" 4) ("hereditary angioedema" 3)
   ("acute ACE inhibitor-associated angioedema" 2) ("Serping1" 2)
   ("ACE-associated angioedema" 1) ("Angioedema" 1)
   ("this polymorphism and ACE inhibitor-associated angioedema" 1)
   ("the pathogenesis ACE inhibitor-associated angioedema" 1)
   ("the B 2 receptor and ACE inhibitor-associated angioedema" 1)
   ("Hereditary angioedema" 1) ("had never developed angioedema" 1)
   ("angiotensin-converting enzyme (ACE) inhibitor-associated angioedema" 1)))
 ("UP:P05156" (("CFI" 28) ("FIs" 10) ("I/F" 8) ("F-I" 7) ("F–I" 2) ("KAF" 1)))
 ("UP:P05160"
  (("fibrin" 229) ("perivillous fibrin" 2) ("partially-degraded fibrin" 1)
   ("three-dimensional fibrin" 1)))
 ("UP:P05161"
  (("ISG15" 370) ("Isg15" 96) ("ISG15 ubiquitin-like modifier" 10)
   ("ISG15 protein" 6) ("ubiquitin-like protein ISG15" 4) ("ISG15-" 1)
   ("UCRP" 1)))
 ("UP:P05162" (("GAL2" 9)))
 ("UP:P05164"
  (("MPO" 200) ("myeloperoxidase" 52) ("Myeloperoxidase" 15)
   ("myeloperoxidase (MPO)" 11)
   ("The phagocytic enzyme myeloperoxidase (MPO)" 2)
   ("FFA increased doubled plasma MPO" 1)))
 ("UP:P05165" (("PCCA" 6))) ("UP:P05177" (("CYP1A2" 71) ("cyp1a2" 1)))
 ("UP:P05178" (("CYP2C6" 2)))
 ("UP:P05181"
  (("CYP2E1" 173) ("Cytochrome P450 2E1" 7) ("cytochrome P450 2E1" 6)
   ("Cyp2E1" 4) ("CYP2E" 3) ("subfamily E" 2) ("cyp2e1" 2)
   ("particular CYP2E1" 1)))
 ("UP:P05186" (("ALPL" 9))) ("UP:P05187" (("PLAP" 57)))
 ("UP:P05198"
  (("eIF2α" 995) ("p-eIF2α" 26) ("eIF-2α" 20) ("P-eIF2α" 12) ("p-eIF2" 7)
   ("the phosphomimetic eIF2α S51D" 3) ("eIF2alpha" 3) ("EIF2S1" 3)
   ("p-eIF2α protein" 2) ("eIF-2α protein" 2) ("Eif2s1" 2) ("making eIF2α" 1)
   ("an intact eIF2α" 1) ("peIF2α" 1) ("eIF-2alpha" 1)
   ("phosphorylation-mimetic (eIF2αS51D) eIF2α" 1)))
 ("UP:P05204" (("HMG-17" 2) ("HMGN2" 1))) ("UP:P05221" (("nucleoplasmin" 7)))
 ("UP:P05230"
  (("FGF1" 832) ("fgf1" 120) ("FGF-1" 31) ("aFGF" 23)
   ("fibroblast growth factor 1" 19) ("endothelial cell growth factor" 12)
   ("fibroblast growth factor-1" 9) ("Fgf1" 6) ("FGF1 molecule" 6)
   ("endothelial cell growth factor (ECGF)" 4) ("exogenous FGF1" 3)
   ("acidic fibroblast growth factor" 3) ("FGF1-" 2)
   ("the neurotrophic agent fibroblast growth factor-1" 2)
   ("The weak Cy3-FGF1" 2) ("ECGF" 1) ("RNAi abrogated FGF1-" 1)
   ("FGF1 (WT)" 1) ("HBGF-1" 1) ("than FGF1 ( xref )" 1)
   ("the dimerized labeled wild type FGF1" 1) ("surface-bound Cy3-FGF1" 1)
   ("canonic member FGF1" 1) ("canonic FGF1" 1) ("the canonic FGF1" 1)))
 ("UP:P05231"
  (("IL-6" 10267) ("IL6" 1096) ("anti-β" 1012) ("CDF" 160) ("anti–β" 151)
   ("interleukin 6" 123) ("Il6" 91) ("Anti-β" 71) ("Il-6" 54)
   ("IL-6 protein" 37) ("Interleukin 6" 29) ("exogenous IL-6" 24) ("IL-6-" 22)
   ("il-6" 16) ("than IL-6" 7) ("-IL-6" 6) ("cellular IL-6" 6) ("Anti–β" 5)
   ("more IL-6" 5) ("exogenous IL6" 5) ("autocrine IL-6" 5)
   ("their own IL-6" 5) ("IL -6" 5) ("interleukins-6" 4) ("pIL-6" 4)
   ("soluble IL-6" 3) ("GC-MSCs-derived IL-6" 3) ("particular IL-6" 3)
   ("SCF (50 ng/ml) + IL-3 (20 ng/ml) + IL-6" 3) ("IL-6–" 3) ("pCDF" 3)
   ("pro-inflammatory interleukin 6" 3) ("The atherogenic cytokine IL-6" 2)
   ("IL6 protein" 2)
   ("the pivotal breast cancer stem cells growth factor Interleukin 6" 2)
   ("IL−6" 2) ("the basic statistical analysis IL-6" 2)
   ("a strong positive IL-6" 2) ("80 percent less IL-6" 2)
   ("systemic pro-inflammatory cytokines IL-6" 2) ("intact IL-6" 2)
   ("an IL-6" 2) ("healthy and produced IL-6" 2) ("the hypergeometric CDF" 2)
   ("The elevated systemic IL-6" 1) ("hyporesponsive IL-6-" 1)
   ("the elevated systemic IL-6" 1) ("a homolog of cellular IL-6" 1)
   ("Cellular IL-6" 1) ("100-fold more IL-6" 1)
   ("cell growth-associated IL-6" 1) ("microenvironmetal IL-6" 1)
   ("Autocrine IL-6" 1) ("immunoreactive IL-6" 1) ("alternative CDF" 1)
   ("the carcinogenetic inflammatory cytokine IL-6" 1) ("P05231" 1)
   ("minimal IL-6" 1) ("IL6-" 1) ("the normal IL-6" 1)
   ("secreted less IL-6 protein" 1) ("10 times more IL-6" 1)
   ("AS2 cells produced autocrine IL-6" 1) ("“hyper-IL6”" 1)
   ("allogeneic APCs produced significantly more IL-6 protein" 1)
   ("Th17-promoting inflammatory IL-6" 1) ("LPS produced ∼50% less IL-6" 1)
   ("fewer IL-6-" 1) ("the calpain-overexpressing cells produced more IL-6" 1)
   ("Exogenous IL-6" 1) ("than IL-6 ( xref )" 1) ("strong IL-6" 1)
   ("pro-inflammatory IL-6" 1)))
 ("UP:P05305"
  (("ET-1" 359) ("endothelin-1" 104) ("endothelin" 34) ("EDN1" 22) ("ET-1-" 21)
   ("Endothelin-1" 18) ("endothelin 1" 14) ("Endothelin 1" 9) ("ET1" 6)
   ("Endothelin" 2) ("endothelin-1–" 2) ("ET-1–" 1) ("Edn1" 1)
   ("ET-1 protein" 1)))
 ("UP:P05316" (("Fur4" 2))) ("UP:P05339" (("RCSB" 21) ("rcsb" 1)))
 ("UP:P05362"
  (("ICAM-1" 1729) ("ICAM1" 104) ("intercellular adhesion molecule-1" 75)
   ("intercellular adhesion molecule 1" 47) ("CD54" 22) ("Icam1" 16)
   ("ICAM-1 protein" 16) ("soluble ICAM-1" 13)
   ("Intercellular adhesion molecule-1" 8)
   ("Intercellular adhesion molecule 1" 3)
   ("human and mouse soluble adhesion molecules ICAM-1" 3)
   ("The murine soluble recombinant ICAM-1" 3) ("monoclonal ICAM-1" 2)
   ("Endothelial ICAM-1" 2) ("soluble intercellular adhesion molecule 1" 2)
   ("LPS treated HUVECs over-expressing ICAM-1" 2) ("targeted ICAM-1 3" 2)
   ("ICAM-1–" 1) ("intercellular adhesion molecule ICAM-1" 1)
   ("Recombinant mouse soluble ICAM-1" 1) ("recombinant soluble ICAM-1" 1)
   ("the secreted soluble ICAM-1" 1)
   ("GFP-tagged full-length transmembrane ICAM-1" 1)
   ("isogenic virions either lacking or bearing host-derived ICAM-1" 1)
   ("hyperoxia expressed less ICAM-1" 1) ("Soluble ICAM-1" 1)
   ("autologous ICAM-1" 1) ("than ICAM-1" 1) ("endothelial ICAM-1" 1)))
 ("UP:P05386" (("RPLP1" 1))) ("UP:P05387" (("rplp2" 2) ("RPLP2" 2)))
 ("UP:P05388"
  (("ribosomal protein" 670) ("RPLP0" 103) ("Ribosomal Protein" 44)
   ("Rplp0" 15) ("Ribosomal protein" 12)
   ("ribosomal
protein"
    3)
   ("ribosomal protein (RP)" 2) ("60S acidic ribosomal protein P0" 2)
   ("an internal control RPLP0" 1) ("RPLP0-" 1)))
 ("UP:P05392" (("BL13" 4)))
 ("UP:P05408" (("c-terminal peptide" 2) ("c-terminal peptide (CKHLKMTRP)" 1)))
 ("UP:P05411" (("v-Jun" 6) ("v-jun" 5) ("v-JUN" 1)))
 ("UP:P05412"
  (("c-Jun" 6292) ("AP1" 819) ("cJun" 592) ("c-jun" 465) ("JUN" 354)
   ("c-JUN" 237) ("activator protein-1" 165) ("p-c-Jun" 146)
   ("activator protein 1" 145) ("activator protein" 121) ("C-Jun" 83)
   ("C-JUN" 80) ("c-Jun protein" 73) ("cJUN" 67) ("Ap-1" 29) ("pc-Jun" 19)
   ("Activator Protein-1" 16) ("Activator protein-1" 15) ("Ap1" 13)
   ("P-c-Jun" 12) ("AP1-" 11) ("p-cJun" 11) ("Activator Protein 1" 10)
   ("overexpressed c-Jun" 9) ("Activator protein 1" 8) ("pc-JUN" 7)
   ("exogenous c-Jun" 6) ("Activator Protein" 6) ("activator protein (AP)" 6)
   ("c-Jun-" 6) ("p-c-JUN" 5) ("Transcription factor AP-1" 4) ("C-jun" 4)
   ("activator protein-1-" 4) ("pAP1" 4) ("c-Jun (Δ2–123, TAM-67) protein" 3)
   ("Activator protein" 3) ("c-Jun molecule" 3) ("c-jun-" 3) ("p-c-jun" 3)
   ("a dominant-negative mutant c-Jun" 3) ("overexpressed cJun" 3)
   ("heterodimeric activator protein-1" 2) ("phospho-null c-Jun" 2)
   ("The sequence-specific transcription factor c-Jun" 2)
   ("un-phosphorylated c-Jun" 2) ("NFATC1-associated protein JUN" 2)
   ("t-phosphorylated c-Jun" 2) ("Non-phosphorylated c-Jun" 2)
   ("Activator protein (AP)" 2) ("the transcriptional factor c-Jun" 2)
   ("c-Jun peptide" 2) ("particular c-Jun" 2)
   ("total and phosphorylated c-Jun" 2) ("pJUN" 2) ("dominant-negative cJUN" 2)
   ("dominant-negative c-Jun" 2) ("its natural activator protein" 2)
   ("the nucleoplasmic AP-1 family transcription factor c-Jun" 2)
   ("an alternate mechanism not involving c-Jun" 1)
   ("either flag-tagged c-Jun" 1) ("PTHrP increased c-Jun" 1)
   ("c-JUN protein" 1) ("SP600125 decreased phosphorylated c-Jun" 1)
   ("abnormal p-c-Jun" 1) ("pcJun" 1) ("P05412" 1)
   ("the ATP dependent nucleosome remodeler SNF-2-related CREB-binding protein activator protein (SRCAP)"
    1)
   ("activator protein (SRCAP)" 1) ("-c-Jun" 1)
   ("the probe-associated c-Jun" 1) ("probe-associated c-Jun protein" 1)
   ("the AP1 transcriptional complex component c-Jun" 1)
   ("the transcriptional factor AP1" 1)
   ("a well-characterized dominant negative c-Jun" 1) ("ROS increased c-Jun" 1)
   ("activator protein-" 1) ("basal c-Jun" 1) ("than c-Jun" 1)
   ("UV-irradiation c-Jun" 1) ("We first tested JUN" 1)
   ("-activator protein 1" 1) ("P-c-jun" 1) ("intact AP1" 1)
   ("c-jun protein" 1) ("basic c-Jun" 1)
   ("the pleiotropic AP-1 transcription factor c-Jun" 1) ("exogenous c-jun" 1)
   ("Dominant-negative c-Jun" 1) ("a dominant-negative c-Jun" 1)
   ("EpCAM decreased phosphorylated c-Jun" 1) ("p-JUN" 1) ("-C-JUN" 1)
   ("c–jun" 1) ("than wild-type c-Jun ( xref )" 1) ("than c-Jun [ xref ]" 1)))
 ("UP:P05413"
  (("FABP3" 8) ("muscle and heart" 5) ("Fabp3" 1)
   ("the oxidative tissues muscle and heart" 1)))
 ("UP:P05451"
  (("REG" 38) ("ICRF" 19) ("reg" 8) ("PSPs" 3) ("reg–" 2) ("pSpS" 2)))
 ("UP:P05452" (("T/N" 24) ("TNA" 1))) ("UP:P05453" (("Sup35" 1)))
 ("UP:P05455"
  (("SSBs" 430) ("SSB" 175) ("ssb" 17) ("La autoantigen" 14)
   ("radiation-induced SSBs" 3) ("sublethal SSBs" 2) ("SS-B" 2)
   ("laser-induced SSBs" 1) ("essentially pure SSBs" 1)
   ("these neurons equally repair SSBs" 1) ("significantly less (∼40%) SSBs" 1)
   ("cellular SSBs" 1) ("000 fold more SSBs" 1) ("than SSBs" 1)
   ("than E.coli ssb" 1) ("the thermostable ssb" 1)
   ("the isoform better (to the theoretical maximum of 50%) so T.Aq ssb" 1)
   ("ssbs" 1) ("frank DNA SSBs" 1)))
 ("UP:P05457" (("GSI" 246) ("GSIs" 55) ("GSI-" 2))) ("UP:P05460" (("PSU" 6)))
 ("UP:P05461" (("SID" 27)))
 ("UP:P05463"
  (("epsilon" 189) ("Epsilon" 2) ("epsilon (PRKCE)" 2)
   ("than a specified epsilon" 1) ("-epsilon" 1)))
 ("UP:P05496" (("ATP5G1" 1)))
 ("UP:P05533" (("Ly6" 45) (NIL 3) ("ly6" 2) ("LY6" 2)))
 ("UP:P05534"
  (("HLA-A*2402" 20) ("HLA-A24" 9) ("HLA-A24–" 3) ("HLA-A*2402–" 2)))
 ("UP:P05538"
  (("subregions" 61) ("smaller subregions" 2)
   ("small mesenchymal subregions" 2) ("two nigral subregions" 1)
   ("the hippocampal subregions" 1) ("HLA-DQB2" 1)
   ("both hippocampal subregions" 1) ("Ten anatomical subregions" 1)
   ("Subregions" 1)))
 ("UP:P05543" (("TBG" 10) ("thyroxine binding globulin" 1)))
 ("UP:P05546"
  (("serpin family" 18) ("heparin cofactor II" 7) ("LS2" 5) ("SERPIND1" 3)
   ("SERPIN family" 3) ("Serpind1" 1)))
 ("UP:P05547" (("Troponin I" 2)))
 ("UP:P05549"
  (("AP-2" 487) ("AP2" 360) ("AP-2α" 301) ("TFAP2A" 36) ("TFAP2" 14)
   ("AP2α" 10) ("AP-2α protein" 8) ("AP-2 transcription factor" 5)
   ("activator protein 2" 4) ("Ap2" 4) ("AP-2 protein" 4)
   ("overexpressed AP-2α" 2) ("AP2 µ" 2) ("Heterotetrameric AP2" 2)
   ("AP-2 molecule" 2) ("most AP2" 1) ("the transcriptional factor AP-2" 1)
   ("Activating enhancer-binding protein-2" 1)
   ("the well-characterized tetramer AP2" 1) ("AP2alpha" 1) ("AP-2 µ" 1)
   ("Ap-2" 1) ("than AP2" 1) ("tfap2a" 1)))
 ("UP:P05556"
  (("CD29" 181) ("ITGB1" 80) ("integrin beta 1" 45) ("MSK1/2" 13)
   ("integrin beta-1" 5) ("p-MSK1/2" 5) ("Integrin beta-1" 4) ("Itgb1" 2)
   ("Integrin beta 1" 2) ("-CD29" 1) ("CD29-" 1) ("integrin beta1" 1)))
 ("UP:P05584" (("ovomucoid" 2)))
 ("UP:P05656" (("SACC" 71) ("solid SACC" 1) ("Sacc" 1)))
 ("UP:P05661"
  (("MHC" 1427) ("pMHC" 61) ("MHC molecule" 10) ("-MHC" 5) ("pMHC molecule" 2)
   ("MHC peptide" 2) ("the appropriate MHC" 1) ("canonical MHC" 1)
   ("hypertrophic hearts underwent canonical MHC" 1)
   ("antigenic peptide-bound MHC" 1)))
 ("UP:P05675" (("cAMP phosphodiesterase" 5))) ("UP:P05759" (("pS37" 2)))
 ("UP:P05771"
  (("PKCβ" 800) ("PRKCB" 46) ("Prkcb" 31) ("PRKCB2" 19)
   ("protein kinase C beta" 14) ("pPKCβ" 4) ("Prkcb2" 4) ("PKC beta" 3)
   ("PKC-beta" 3) ("the classical isoform PKCβ" 3)
   ("the CMV promoter–driven PRKCB2" 2) ("live neurons redistributed PKCβ" 2)
   ("the Classical Isoform PKCβ" 2) ("PKCB" 1)
   ("preferentially targets PKCβ" 1)
   ("activated PKCβ 2 that binds to spectrin's" 1) ("PRKCB1" 1)))
 ("UP:P05783"
  (("K18" 384) ("CK18" 272) ("cytokeratin 18" 57) ("KRT18" 49)
   ("keratin 18" 43) ("cytokeratin-18" 33) ("CK-18" 19) ("Cytokeratin 18" 14)
   ("pCK18" 13) ("CK18 protein" 11) ("Cytokeratin-18" 4) ("more CK18" 3)
   ("Krt18" 3) ("KGM expressed very weak CK18" 2) ("keratin-18" 2)
   ("epithelial CK18" 2) ("the epithelial cytokeratin 18" 2) ("Keratin 18" 2)
   ("less pCK18" 2) ("the epithelial keratin 18" 1) ("k18" 1)
   ("The cellular CK18" 1) ("CK18-" 1)
   ("luminal epithelial cytokeratin 18" 1)))
 ("UP:P05787"
  (("CK8" 171) ("cytokeratin 8" 41) ("KRT8" 41) ("keratin 8" 18) ("CK8−" 11)
   ("keratin-8" 10) ("Keratin 8" 9) ("Krt8" 8) ("Cytokeratin 8" 6) ("CK 8" 4)
   ("k  8" 3) ("widespread cytokeratin 8" 2) ("mouse monoclonal CK8" 2)
   ("Keratin 8 (TROMA)" 2) ("particular KRT8" 1) ("CK8-" 1)
   ("the mammary specific marker Keratin 8 (TROMA)" 1) ("Ck8" 1)))
 ("UP:P05814"
  (("β-casein" 76) ("βCasein" 1) ("Complementary duplex β-casein" 1)))
 ("UP:P05819" (("CBA" 34) ("pCBA" 9))) ("UP:P05820" (("CMA" 48) ("pCMA" 4)))
 ("UP:P05825" (("FEP" 13) ("fepA" 1)))
 ("UP:P05831" (("inCB" 10) ("bigger islets inCB1R −/−" 1)))
 ("UP:P05839" (("ExC" 1)))
 ("UP:P05937"
  (("calbindin" 49) ("CALB1" 8) ("calbindin D28" 5) ("Calbindin" 3)
   ("Calbindin D28" 2)))
 ("UP:P05976"
  (("isoform" 5966) ("Isoform" 109) ("the predominant isoform" 71)
   ("shorter isoform" 24) ("longest isoform" 20) ("longer isoform" 13)
   ("The predominant isoform" 9) ("larger isoform" 7)
   ("the mesenchymal isoform" 5) ("a special isoform" 5) ("isoform-" 5)
   ("the placental isoform" 4) ("the soluble isoform" 4) ("-isoform" 4)
   ("a predominant isoform" 4) ("a soluble isoform" 4)
   ("the cancer-associated isoform" 4) ("a dominant-negative isoform" 3)
   ("an atypical isoform" 3) ("a unique isoform" 3)
   ("the most widely-expressed isoform" 3) ("the principal isoform" 3)
   ("shortest isoform" 3) ("the most consistently expressed isoform" 3)
   ("a putative allelic isoform" 2) ("an exon-4-truncated isoform" 2)
   ("a secreted heterodimeric isoform" 2) ("mature isoform" 2)
   ("the most divergent isoform" 2) ("the vascular isoform" 2)
   ("smallest isoform" 2) ("a proteolytically-cleaved isoform" 2)
   ("a putatively neoplastic-specific isoform" 2)
   ("most frequently expressed isoform" 2)
   ("the 40 kDa antagonistic isoform" 2) ("mesenchymal isoform" 2)
   ("the most neutral isoform" 2) ("—a unique isoform" 2)
   ("the alternatively spliced soluble isoform" 2) ("smaller isoform" 2)
   ("the most abundantly expressed isoform" 2)
   ("the neuronal-specific isoform" 2) ("one predominant isoform" 2)
   ("the unique isoform" 2) ("targeted isoform" 2)
   ("the phosphomimetic (S401D) isoform" 2) ("the most predominant isoform" 2)
   ("the brain-predominant isoform" 2)
   ("the most well-characterized isoform" 2) ("A predominant isoform" 2)
   ("a physiologically relevant isoform" 2) ("the only myosin II isoform" 2)
   ("Myosin II isoform" 2) ("longest muscle-specific isoform" 2)
   ("slower migrating phosphorylated isoform" 1) ("The latter isoform" 1)
   ("the β II isoform" 1) ("the cardiac-specific isoform" 1)
   ("unique isoform" 1) ("a single un-phosphorylated isoform" 1)
   ("basic isoform" 1) ("phospho-isoform" 1)
   ("the most parsimonious isoform" 1) ("the antagonistic isoform" 1)
   ("this membrane-associated isoform" 1) ("the respective isoform" 1)
   ("largest isoform" 1) ("an alternate isoform" 1)
   ("An exon 10-skipped isoform" 1)
   ("the most ubiquitously expressed isoform" 1) ("pro-apoptotic isoform" 1)
   ("the latter isoform" 1) ("pathogenic isoform" 1) ("The former isoform" 1)
   ("the PML III isoform" 1) ("the pro-apoptotic isoform" 1)
   ("a pro-apoptotic isoform" 1) ("the ancestral isoform" 1)
   ("the basic isoform" 1)
   ("than the endogenously expressed isoform ( xref )" 1)
   ("its full-length parent isoform" 1) ("the most relevant isoform" 1)
   ("the optimal isoform" 1) ("another classical isoform" 1)
   ("the atypical isoform" 1) ("slowest isoform" 1)
   ("The most abundant alternatively-spliced isoform" 1)
   ("a mesenchymal isoform" 1) ("this peculiar isoform" 1)
   ("this atypical isoform" 1) ("This latter isoform" 1)
   ("alternate-spliced isoform" 1) ("its long muscle-specific isoform" 1)))
 ("UP:P05981"
  (("hepsin" 12) ("transmembrane protease" 10) ("HPN" 3)
   ("A potential transmembrane protease" 1) ("serine protease hepsin" 1)
   ("Hepsin" 1)))
 ("UP:P05997" (("type V" 10) ("COL5A2" 2))) ("UP:P06013" (("VSG" 4)))
 ("UP:P06019" (("MUR" 1))) ("UP:P06028" (("GPB" 1)))
 ("UP:P06104"
  (("RAD6" 253) ("Rad6" 218) ("RAD6 molecule" 12) ("RAD6-" 10) ("RAD6–" 10)
   ("Rad6 protein" 8) ("rad6" 6) ("RAD6 protein" 1)))
 ("UP:P06105" (("HX" 98) ("Hx" 28))) ("UP:P06114" (("APCC" 1)))
 ("UP:P06126"
  (("CD1a" 84) ("a polypeptide" 57) ("A polypeptide" 5) ("CD1a−" 2)
   ("p115 revealed a polypeptide" 1) ("CD1a-" 1)))
 ("UP:P06127"
  (("CD5" 474) ("CD5-" 4) ("CD5 peptide" 3) ("CD5 protein" 2)
   ("significantly fewer PKCβII-containing CD11b + CD5" 1) ("-CD5" 1)
   ("raft-associated CD5" 1) ("the tailless mutant CD5" 1)
   ("the 471-amino acid-long wild-type CD5 protein" 1) ("pCD5" 1)))
 ("UP:P06132" (("UPD" 60) ("pUPD" 2) ("somatic UPD" 1) ("X. Somatic UPD" 1)))
 ("UP:P06133" (("UGT2B4" 1)))
 ("UP:P06171" (("MycA" 10) ("Myc1" 3) ("myc1" 1) ("myca" 1) ("MYC1" 1)))
 ("UP:P06213"
  (("IR" 11207) ("insulin receptor" 964) ("INSR" 684) ("I/R" 344) ("InsR" 183)
   ("IRs" 123) ("ir" 83) ("INSR-B" 69) ("Insulin receptor" 60)
   ("insulin receptor (IR)" 37) ("-IR" 35) ("IR-" 34) ("renal IR" 28)
   ("cerebral I/R" 23) ("Insulin Receptor" 22) ("8Gy" 18) ("INSRs" 14)
   ("-insulin receptor" 11) ("insulin receptor (INSR)" 10) ("IR peptide" 10)
   ("insulin-receptor" 9) ("I-R" 7) ("INSR protein" 7) ("HCV-associated IR" 6)
   ("severe IR" 6) ("IR protein" 5) ("focal cerebral I/R" 4) ("irs" 3)
   ("INS-R" 3) ("overexpressed Drosophila insulin receptor" 3)
   ("postoperative IR" 3) ("the IR593" 3) ("cellular IR" 2)
   ("a classical IR" 2) ("species specific secondary antibodies IR" 2)
   ("more INSR" 2) ("renal I/R" 2) ("Insulin Receptor (IR)" 2)
   ("these essential cell processes exhibited increased IR" 2)
   ("significantly more IR" 2) ("medical IR" 2)
   ("hMSH5 required at least 5 Gy IR" 2) ("autosomal dominant severe IR" 2)
   ("homologous IR" 2) ("myocardial I/R" 2)
   ("total and phosphorylated insulin receptor" 2)
   ("significantly reduced homodimeric INSR" 2) ("homodimeric INSR" 2)
   ("Fab 83-7-complexed IR310" 2) ("the IR310" 2) ("than IR ( xref )" 1)
   ("–IR" 1) ("than IR (10 Gy)" 1) ("p-IR" 1) ("the intact insulin receptor" 1)
   ("“IR”" 1) ("more IR" 1) ("the HCV-associated IR" 1)
   ("“insulin receptor”" 1) ("HHF5" 1) ("CD220" 1) ("cardiac IR" 1)
   ("intestinal IR" 1)
   ("insulin
receptor"
    1)
   ("membrane-associated IR" 1) ("than before IR" 1) ("The mature IR" 1)
   ("extreme IR" 1) ("systemic IR" 1) ("Recently cell autonomous IR" 1)
   ("primary IR" 1) ("XRT" 1) ("IR (VDRC)" 1) ("INSR molecule" 1)
   ("Myocardial I/R" 1) ("Focal cerebral I/R" 1) ("moderate-high HOMA IR" 1)
   ("hybrid INSRs" 1) ("therapeutic IR" 1) ("pINSR" 1)
   ("The mature human insulin receptor (IR)" 1) ("IR—" 1)
   ("Insulin receptor (IR)" 1) ("-ir" 1) ("strong pS6 IR" 1) ("weak pS6 IR" 1)
   ("the ciliary body (CB, xref ) no IRs" 1) ("than IR" 1)
   ("the homodimeric INSR" 1) ("the Fab 83-7 bound IR310" 1)
   ("an Fab-complexed IR593" 1) ("Fab-complexed IR593" 1) ("The IR593" 1)
   ("the insulin-complexed IR593" 1) ("human-insulin-bound IR310" 1)
   ("the L1–CR–L2– (FnIII-1)–αCT(704–719) homodimeric construct IR593" 1)
   ("the L1–CR construct IR310" 1) ("P-IR" 1)
   ("than control cells post IR ( xref 2C)" 1)))
 ("UP:P06239"
  (("Lck" 3027) ("LCK" 353) ("LSK" 136) ("lck" 84) ("Lck protein" 10)
   ("p56-Lck" 7) ("p56lck" 5) ("Lck(1–120) protein" 4) ("Lck-" 4)
   ("lck protein" 2) ("p56LCK" 2) ("donor-derived CD45.2 LSK" 2)
   ("raft-associated Lck" 2)
   ("Lymphocyte cell-specific protein-tyrosine kinase" 2) ("LcK" 2)
   ("either proximal Lck" 2) ("functional Lck" 1) ("Y505F suppressed LCK" 1)
   ("The exogenous Lck" 1) ("less Lck" 1)
   ("the peripheral membrane protein Lck" 1) ("p56 Lck" 1)
   ("the plasma membrane-associated Lck" 1) ("–Lck" 1)
   ("raft-associated pY394 Lck" 1) ("cellular Lck" 1)
   ("Virtually all pY394 Lck" 1) ("lipid raft-associated Lck" 1)
   ("total and phosphorylated Lck" 1) ("no further activated Lck" 1)
   ("more Lck" 1) ("the C-terminal tyrosine of Lck" 1) ("available Lck" 1)
   ("inhibitory (Y505) tyrosines of Lck" 1) ("normal LSK" 1)
   ("Pax5-expressing GFP + LSK" 1) ("the proximal kinase Lck" 1)
   ("the TCR proximal kinase Lck" 1) ("the TCR proximal Src kinase Lck" 1)))
 ("UP:P06241"
  (("Fyn" 3135) ("FYN" 138) ("FYN-" 37) ("SYN" 35) ("fyn" 30) ("SLK" 14)
   ("PAG/Cbp" 10) ("Fyn protein" 8) ("pFyn" 7) ("c-Fyn" 6) ("-Fyn" 5)
   ("Src-like kinase" 5) ("-SLK" 5) ("Fyn-" 4) ("raft-associated Fyn" 3)
   ("a catalytically inert Fyn (FynK296M) protein" 3)
   ("the auto-tyrosine-phosphorylated Fyn" 3)
   ("the GEM-associated transmembrane adaptor proteins PAG/Cbp" 2) ("–Fyn" 2)
   ("associated Fyn" 2)
   ("cultured HeLa cells showed barely detectable activated Fyn" 2)
   ("CD5-associated Fyn" 2) ("the postsynaptic protein Fyn" 2)
   ("the negative regulatory tyrosine of Fyn" 1) ("α6β4-associated Fyn" 1)
   ("the integrin-associated Src family kinase Fyn" 1)
   ("than wth Fyn (Fig. S1)" 1) ("than kinase-dead Fyn ( xref A)" 1)
   ("neuronal Fyn" 1) ("Dominant-negative (DN)-Fyn" 1) ("that Fyn's" 1)
   ("dominant-negative Fyn K299M" 1) ("cellular Fyn" 1)
   ("CD3 associated Fyn" 1) ("nonraft associated Fyn" 1)
   ("Fyn (FynK296M) protein" 1) ("dysfunctional Fyn" 1) ("MGC45350" 1)
   ("p59-FYN" 1) ("Given Fyn" 1) ("dominant negative (DN) Fyn" 1)
   ("than Fyn in Jurkat cells ( xref )" 1) ("the C-terminal tyrosine of Fyn" 1)
   ("total cellular Fyn" 1)
   ("the negative regulatory tyrosine (Tyr 531 ) of Fyn" 1)
   ("particular Fyn" 1) ("a few Fyn" 1)))
 ("UP:P06244" (("pKA1" 1)))
 ("UP:P06276"
  (("Che-1" 343) ("BCHE" 28) ("cholinesterase" 24) ("Che1" 15)
   ("Che-1 protein" 9) ("butyrylcholinesterase" 9) ("-Che-1" 3)
   ("pseudocholinesterase (PCH)" 2) ("cellular Che-1" 2)
   ("Butyrylcholinesterase" 2) ("pseudocholinesterase" 1) ("Cholinesterase" 1)
   ("than Che-1" 1) ("exogenous Che-1" 1)))
 ("UP:P06280" (("GALA" 32) ("GLA" 20) ("Gla" 5) ("gla" 1)))
 ("UP:P06305"
  (("PH" 1265) ("pH" 708) ("PH-" 8) ("PH protein" 4) ("spontaneous PH" 4)
   ("hypoxic PH" 4) ("reversed established PH" 3) ("The actual cytosolic pH" 2)
   ("severe PH" 2) ("30 partially reversed PH" 2) ("experimental PH" 2)
   ("partially reversed established PH" 2) ("PH (TT)" 1)
   ("fluorescent Btk PH" 1) ("less severe hypoxia-induced PH" 1)
   ("the experimental PH" 1) ("–PH" 1) ("ph" 1)
   ("Nox4 attenuated experimental PH" 1) ("reversed PH" 1)
   ("generations 2, 3, and 4 developed less severe PH" 1) ("idiopathic PH" 1)
   ("‘PH’" 1) ("developed PH" 1) ("irreversible PH" 1) ("Irreversible PH" 1)
   ("either primary or secondary PH" 1)))
 ("UP:P06307"
  (("CCK" 485) ("CCK8" 99) ("cholecystokinin" 12) ("ccK" 2)
   ("the sole tyrosine of CCK" 2)
   ("the sole tyrosine of the octapeptide hormone cholecystokinin (CCK 8 )" 1)
   ("Cholecystokinin" 1)))
 ("UP:P06331" (("IGHV4-34" 24) ("IGHV4-34-" 1))) ("UP:P06340" (("HLA-DOA" 3)))
 ("UP:P06396"
  (("gelsolin" 200) ("GSN" 17) ("Gelsolin" 16)
   ("actin-depolymerizing factor" 13) ("GELSOLIN" 1)))
 ("UP:P06400"
  (("Rb" 6449) ("pRb" 4712) ("RB" 3759) ("pRB" 2854) ("RB1" 2487) ("Rb1" 608)
   ("PRB" 214) ("RB protein" 201) ("Rb protein" 200) ("pRb protein" 66)
   ("RB1 protein" 48) ("un-phosphorylated Rb" 33) ("bilateral RB" 30)
   ("p-pRb" 29) ("ppRB" 28) ("-Rb" 23) ("pRB protein" 23) ("-pRb" 22)
   ("p-Rb" 21) ("–RB" 13) ("BD" 13) ("p-RB" 12) ("unilateral RB" 12)
   ("retinoblastoma-associated protein" 10) ("Rb−" 10) ("Rb-" 10)
   ("tumor suppressor retinoblastoma protein" 10) ("pp110" 10) ("-RB" 8)
   ("P-Rb" 8) ("pRB1" 8) ("ppRb" 7) ("sporadic Rb" 7) ("-pRb protein" 6)
   ("only un-phosphorylated Rb" 5) ("only mono-phosphorylated Rb" 5)
   ("Rb1 protein" 5) ("weak Rb" 4) ("functional pRB" 4)
   ("sporadic unilateral RB" 4) ("than pRb" 4) ("Rb peptide" 4)
   ("The complete RB1" 4) ("RB1-" 4) ("pRb peptide" 4) ("functional RB" 3)
   ("pRB peptide" 3) ("p-pRB" 3) ("than Rb" 3) ("heritable RB" 3) ("pure Rb" 3)
   ("pRb-" 3) ("functional pRb" 3) ("mouse monoclonal anti pRB" 3)
   ("strong Rb" 2) ("intact Rb" 2) ("diffuse strong Rb" 2)
   ("nonfunctional RB" 2) ("a functional pRb" 2)
   ("the transcriptional repressor pRb" 2) ("non-heritable RB" 2)
   ("Retinoblastoma-associated protein" 2)
   ("no detectable un-phosphorylated Rb" 2) ("Un-phosphorylated Rb" 2)
   ("parental MEFs expressing endogenous wild type Rb" 2)
   ("progressive hypo-phosphorylated Rb" 2) ("P-RB" 2) ("RB Protein" 2)
   ("complete RB1" 2) ("targeted RB1" 2) ("more frequent Rb1" 2)
   ("hereditary RB" 2) ("the pure Rb" 2)
   ("the E2F transcriptional repressor pRb" 2) ("chromosome 13q around RB1" 2)
   ("Intense pRB" 2) ("than RB1 (3.8 ± 8.09)" 2)
   ("cell lines retaining functional RB" 2) ("a defective Rb" 2)
   ("pRb, flag-tagged Cyclin D1," 2) ("Monoclonal Rb" 2)
   ("using Spectrum Orange-labeled RB1" 2) ("clinically applicable RB1" 2)
   ("sporadic and familial Rb" 2) ("bilateral or unilateral RB" 2) ("RB-" 2)
   ("retinoblastomas generally lack Rb" 2) ("lentiviral Rb" 2) ("stromal Rb" 2)
   ("the repressive pocket proteins Rb" 2) ("Adipose RB1" 2) ("residual RB" 1)
   ("than total Rb ( xref ) suggesting a decrease in cyclin D complex activity"
    1)
   ("intestinal phospho-RB" 1) ("p35 diminished phospho-Ser807/811 Rb" 1)
   ("phosphomimetic RB" 1) ("Under-phosphorylated pRb" 1)
   ("the commercially available SALSA MLPA P047 RB1" 1)
   ("HAUSP showed endogenous Rb" 1) ("un-phosphorylated pRb" 1)
   ("constitutively mono-phosphorylating Rb" 1)
   ("Parental MEFs expressing endogenous Rb" 1)
   ("contained un-phosphorylated Rb" 1) ("control un-phosphorylated ΔCdk Rb" 1)
   ("We first detected hyper-phosphorylated Rb" 1)
   ("the cell cycle use un-phosphorylated Rb" 1) ("under-phosphorylated Rb" 1)
   ("intact RB" 1) ("exogenous RB" 1) ("showed RB’s" 1)
   ("pRb, interactions between the three proteins" 1)
   ("specific amino acids of Rb that must be dephosphorylated" 1)
   ("pRb, both" 1) ("Rb (retinoblastoma) protein" 1)
   ("isolated unilateral RB" 1) ("than the pRb" 1) ("the pRb's" 1)
   ("total and phosphorylated Rb" 1) ("the functional pRB" 1)
   ("NHEJ-competent WT RB1" 1) ("patient RB31" 1) ("patient RB18" 1)
   ("some unilateral RB" 1) ("inversely control RB" 1)
   ("bilateral and unilateral RB" 1) ("unilateral and bilateral RB" 1)
   ("unilateral and bilateral Rb" 1) ("32 bilateral RB" 1) ("p105RB" 1)
   ("intact pRb" 1) ("pRB, E2F1" 1) ("associated pRB" 1)
   ("ectopically-expressed pRb" 1) ("probably helps RB" 1) ("-pRB" 1)
   ("than RB" 1) ("the most severe bilateral RB" 1) ("only unilateral RB" 1)
   ("pRb (BD)" 1) ("parental RB1" 1) ("three intragenic RB1" 1) ("acute RB" 1)
   ("than RB1" 1) ("than the wild-type pRb protein (Figure xref )" 1)
   ("E2F-1- associated pRB" 1)
   ("pRB, the form of pRB known to be hypophosphorylated" 1)
   ("the cellular Rb" 1) ("nearly all cancer types Rb" 1)
   ("expressing wild-type Rb" 1) ("functional RB protein" 1)
   ("origin-bound Rb" 1) ("normal and mutated RB1" 1) ("a normal Rb" 1)
   ("pRb, HA -tagged Ub," 1) ("EBNA3C directly targets pRb" 1)
   ("sporadic RB" 1) ("the bilateral non-hereditary RB" 1)
   ("non-familial bilateral (BnH) RB" 1) ("the two bilateral RB" 1)
   ("Bilateral RB" 1)
   ("both agents downregulated total and phosphorylated RB" 1)
   ("directly binding and sequestering Rb" 1) ("functional Rb" 1)
   ("account RB1’s" 1) ("sporadic non-hereditary Rb" 1)
   ("the sporadic and familial Rb" 1) ("either sporadic Rb" 1)
   ("sporadic or familial Rb" 1) ("bilateral Rb" 1) ("eight intronic RB1" 1)
   ("unilateral and unifocal RB" 1) ("familial unilateral RB" 1)
   ("sporadic bilateral RB" 1) ("had sporadic unilateral RB" 1) ("rb" 1)
   ("nonfunctional RB1" 1) ("further implicating Rb" 1) ("adipose pRb" 1)
   ("than RB-wt (cleavage-sensitive RB) in β-catenin–deficient LIM1899 cells"
    1)
   ("pRB, transcriptional regulators that establish" 1)))
 ("UP:P06401"
  (("PR" 6517) ("progesterone" 1128) ("progesterone receptor" 1075) ("PgR" 659)
   ("PR-B" 258) ("PGR" 231) ("pRS" 186) ("PR−" 151) ("PRs" 122) ("PR-" 111)
   ("progesterone receptor (PR)" 67) ("p-Rb" 56) ("Progesterone" 53)
   ("Progesterone receptor" 39) ("PgR-" 30) ("Progesterone Receptor" 22)
   ("Pr" 21) ("-PR" 16) ("pPR" 16) ("p-RB" 11) ("P/R" 9) ("progesteron" 7)
   ("than progesterone" 6) ("Progesterone receptors" 6)
   ("progesterone receptor (PGR)" 4) ("PR–" 4) ("PR-B protein" 3)
   ("stromal PR" 3) ("progesterone receptor ( PGR )" 3)
   ("progesterone receptor-" 3) ("whose tumors lack PR" 3) ("progesterone-" 3)
   ("pgR" 2) ("PgR protein" 2)
   ("this method ready antibodies Monoclonal Mouse Anti-Human Progesterone Receptor Clone PgR"
    2)
   ("PR–B" 2) ("anatomic PR" 2) ("Pr(DE | data) Pr" 2)
   ("Mouse monoclonal anti-human ER and anti-human PR" 2) ("more PR" 2)
   ("epithelial PR" 2) ("PGR−" 2) ("progesterone (PR)" 2) ("one durable PR" 2)
   ("than PgR" 2) ("292 potential PR" 1) ("an ongoing PR" 1) ("PR protein" 1)
   ("transcriptionally competent PR" 1) ("“P/R”" 1)
   ("the virus-encoded aspartic PR" 1) ("transcriptionally incompetent PgR" 1)
   ("the first 164 amino acids of PR-B" 1) ("pp-RB" 1) ("than a PR" 1)
   ("HindIII/XhoI-linearized pRS426" 1) ("that progesterone's" 1)
   ("Progesteron" 1) ("a functional progesterone" 1)
   ("progesterone receptor protein" 1) ("than PR" 1) ("“progesterone”" 1)
   ("pRS-" 1) ("Progesterone Receptor (PR)" 1) ("P-PR" 1) ("HIV-1 PR’s" 1)
   ("PgR−" 1) ("that progesterone’s" 1) ("PR (PGR)" 1)
   ("the end of pregnancy “functional” progesterone" 1)))
 ("UP:P06454"
  (("proTα" 229) ("ProTα" 148) ("proTα-" 28) ("PTMA" 26) ("ProTα protein" 14)
   ("prothymosin" 8) ("Prothymosin alpha" 5) ("prothymosin alpha" 5)
   ("ProTα-" 4) ("its immunoreactive decapeptide proTα" 4) ("ProTα peptide" 4)
   ("Prothymosin" 3) ("than ProTα" 2) ("a possible proTα" 1)))
 ("UP:P06484" (("G-G" 27) ("G–G" 7) ("-G-G" 1)))
 ("UP:P06487" (("G–I" 21) ("G-I" 6) ("GIS" 2) ("GIs" 1) ("g–i" 1)))
 ("UP:P06492" (("Vmw65" 4) ("Vmw65 protein" 3)))
 ("UP:P06493"
  (("Cdk1" 2859) ("CDK1" 2112) ("Cdc2" 563) ("cdc2" 447) ("CDC2" 321)
   ("cdk1" 250) ("cyclin-dependent kinase 1" 86) ("pCDK1" 70) ("pCdc2" 19)
   ("pCDC2" 15) ("p-CDK1" 14) ("cdk-1" 13) ("CDKN1" 11) ("p-cdc2" 10)
   ("CDC-2" 10) ("Cyclin-dependent kinase 1" 9) ("cdc-2" 9) ("cdc2 protein" 8)
   ("Cdkn1" 8) ("Cdk1-" 8) ("-CDK1" 7) ("monomeric CDK1" 7) ("p34cdc2" 6)
   ("fluorescent Cdk1" 6) ("pcdc2" 6) ("mitotic Cdk1" 6) ("p34 cdc2" 5)
   ("cyclin dependent kinase 1" 5) ("than Cdk1" 4) ("CDC2 protein" 4)
   ("centrosomal Cdk1" 4) ("Cdk-1" 3) ("p-cdk1" 3) ("CDK1 protein" 3)
   ("p34 Cdc2" 3) ("cyclin-dependent kinase-1" 3) ("monomeric Cdk1" 3)
   ("CDK1 molecule" 3) ("mitotic kinase CDK1" 2) ("targeting CDK1" 2)
   ("cyclin–dependent kinase 1" 2) ("p-CDC2" 2) ("Cyclin dependent kinase 1" 2)
   ("CDK-1" 2) ("yellow fluorescent Cdk1" 2)
   ("release Y15/T14 phosphorylated monomeric CDK1" 2)
   ("the mitotic kinases CDK1" 2) ("overactive Cdk1" 2)
   ("the principle mitotic kinase CDK1" 2) ("the main mitotic kinase CDK1" 1)
   ("cellular Cdk1" 1) ("Cyclin B 1-bound Cdk1" 1) ("the commercial Cdk1" 1)
   ("CdK1" 1) ("the chief mitotic kinase Cdk1" 1)
   ("centrosome-associated Cdk1" 1) ("the mitotic CDK1" 1)
   ("Cyclin-dependent kinase-1" 1) ("just Cdk1" 1)
   ("the mitotic kinase cdc2" 1) ("the mitotic CDK family member Cdc2" 1)
   ("the mitotic kinase Cdk1" 1) ("using immune-isolated Cdk1" 1)
   ("the fluorescent Cdk1" 1) ("fluorescent Cdk1–1N" 1)
   ("wild-type fluorescent Cdk1" 1) ("CDK1-" 1) ("cdc28a" 1) ("Mitotic Cdk1" 1)
   ("monomeric (free) CDK1" 1) ("the three twice-phosphorylated CDK1" 1)
   ("Cdc 2" 1) ("compensatory Cdk1" 1) ("slower migrating cdk1" 1)
   ("cyclin B1-associated cdk1" 1) ("the mitotic kinase CDK1" 1)
   ("Cdc2 (PSTAIR)" 1) ("Cdc2-" 1) ("P-Cdk1" 1) ("the mitotic CDK Cdk1" 1)
   ("CDk1" 1)))
 ("UP:P06494" (("p185neu" 3)))
 ("UP:P06545"
  (("DNA binding protein" 141) ("a sequence-specific DNA binding protein" 6)
   ("DNA binding protein (DEDD)" 3)
   ("human basic helix-loop-helix DNA binding protein" 1)
   ("a relatively poor DNA binding protein" 1)))
 ("UP:P06576" (("ATP5B" 17) ("ATP synthase subunit beta, mitochondrial" 1)))
 ("UP:P06595" (("AP-5" 4))) ("UP:P06616" (("ER-a" 5)))
 ("UP:P06643" (("HBE4" 8))) ("UP:P06701" (("SIR3" 6) ("Sir3" 5) ("siR3" 2)))
 ("UP:P06702"
  (("S100A9" 170) ("Calprotectin" 23) ("calprotectin" 9) ("S100A9-" 3)
   ("S100a9" 2) ("S100 calcium binding protein A9" 1) ("homodimeric S100A9" 1)
   ("MRP14" 1) ("mrp14" 1) ("s100a9" 1) ("S100-A9" 1)))
 ("UP:P06703"
  (("PRA" 264) ("PR-A" 111) ("S100A6" 7) ("intact PRA" 5)
   ("than intact PRA ( xref , right graph)" 1) ("than PR-A (SGK1, FKBP5)" 1)
   ("S100a6" 1) ("S100A6 protein" 1)))
 ("UP:P06722" (("PRV" 2)))
 ("UP:P06725" (("pp65" 43) ("pP65" 3) ("pp65 (UL83) protein" 1) ("UL83" 1)))
 ("UP:P06726" (("protein pp71" 6) ("pp71" 5) ("pp71 protein" 4) ("Pp71" 1)))
 ("UP:P06727" (("APOA4" 11) ("apolipoprotein A4" 2) ("ApoA4" 1) ("apoA-IV" 1)))
 ("UP:P06729"
  (("CD2" 243) ("cD2" 208) ("CD2-" 29) ("SRBC" 24) ("CD2 peptide" 5)
   ("SRBCs" 2) ("pcD2" 2) ("sRBCs" 1) ("than the CD2 peptide" 1)))
 ("UP:P06730"
  (("p-eIF4E" 301) ("eIF4E1" 141)
   ("eukaryotic translation initiation factor 4E" 85)
   ("cap-binding protein" 73) ("EIF4E" 39) ("Eif4e" 15) ("peIF4E" 11)
   ("p-eIF4E protein" 10) ("mRNA cap-binding protein" 9)
   ("Eukaryotic translation initiation factor 4E" 8) ("p-eIF4E1" 7) ("eIF4e" 6)
   ("P-eIF4E" 6) ("HHT primarily targets p-eIF4E" 3)
   ("the translational repressors eukaryotic translation initiation factor 4E"
    3)
   ("excessive eIF4E1" 2) ("p-eIF4e" 2)
   ("the prototypic cap-binding protein" 2)
   ("an authentic cap-binding protein" 2) ("eIF-4e" 2)
   ("p-eIF4E ( xref ) protein" 1) ("NF-κB-driven eIF4E1" 1)
   ("directly target p-eIF4E" 1) ("most p-eIF4E" 1)
   ("potentially sequestering EIF4E" 1)))
 ("UP:P06731"
  (("carcinoembryonic antigen" 60) ("CEACAM" 37) ("CeA" 14)
   ("carcinoembryonic antigen (CEA)" 6) ("Carcinoembryonic antigen" 4)
   ("CEACAM5" 3)))
 ("UP:P06732"
  (("creatine" 95) ("creatine kinase" 82) ("MCK" 21) ("M-type" 5)
   ("P-creatine" 3) ("Creatine" 3) ("Creatine kinase" 3)
   ("hypoxia-inducible factor 1-α ( xref ) muscle-specific human sarcomeric mitochondrial creatine kinase"
    2)
   ("muscle-specific human sarcomeric mitochondrial creatine kinase" 2)
   ("creatine kinase (MCK)" 2) ("creatine kinase protein" 2) ("CKM" 1)
   ("Ckm" 1)))
 ("UP:P06733"
  (("MBP-1" 127) ("alpha-enolase" 110) ("ENO1" 59) ("pPH" 44) ("enolase 1" 14)
   ("MBP-1 protein" 11) ("Alpha-enolase" 9) ("MBP1" 5)
   ("alpha-enolase protein" 5) ("exogenous MBP-1" 4) ("Enolase 1" 2)
   ("minimal alpha-enolase" 2) ("NNE" 2) ("Eno1" 1)
   ("healthy PBMCs alpha-enolase" 1) ("Mbp1" 1) ("MPB-1" 1)
   ("the exogenous MBP-1 protein" 1)))
 ("UP:P06734"
  (("CD23" 85) ("FCER2" 16) ("CD23a" 13) ("Blast 2" 12) ("BLAST 2" 6)
   ("FcεRII" 3) ("sCD23" 2) ("CD11b + CD5 +/low CD43 + CD21 −/low CD23" 1)
   ("cd23" 1)))
 ("UP:P06744"
  (("AMF" 235) ("GPI" 126) ("PGI" 85) ("pHi" 54) ("phi" 22) ("PHI" 11)
   ("autocrine motility factor" 8) ("GPi" 8) ("phosphoglucose isomerase" 7)
   ("glucose-6-phosphate isomerase" 4) ("autocrine motility factor (AMF)" 3)
   ("exogenous AMF" 3)
   ("previously identified phosphoglucose isomerase (PGI)" 2)
   ("phosphoglucose isomerase (PGI)" 2) ("endothelial PGI" 2) ("Phi" 2)
   ("Phosphoglucose isomerase" 2) ("natural PGI" 2) ("basal PGI" 2)
   ("their basal pHi" 1) ("GPI molecule" 1) ("pHI" 1) ("-GPI" 1) ("GpI" 1)
   ("glucose phosphate isomerase (GPI)" 1) ("glucose phosphate isomerase" 1)
   ("Exogenous AMF" 1) ("neuroleukin (NLK)" 1) ("neuroleukin" 1)
   ("than natural PGI 2" 1)))
 ("UP:P06746" (("POLB" 43) ("DNA polymerase beta" 15) ("polymerase beta" 4)))
 ("UP:P06748"
  (("NPM" 1440) ("NPM1" 879) ("nucleophosmin" 168) ("Nucleophosmin" 46)
   ("pNPM" 21) ("NPM1-" 9) ("NPM protein" 9) ("nucleophosmin (NPM)" 8)
   ("pNPM1" 7) ("NPM1 protein" 5) ("NPM-" 4) ("numatrin" 3) ("Npm" 3)
   ("the multifunctional chaperone nucleophosmin" 3)
   ("nucleolar phosphoprotein B23" 2)
   ("a mutated polybasic region relocalizes NPM1" 2) ("targeted NPM1" 2)
   ("targeting NPM" 2) ("residual NPM" 2) ("nucleolar NPM" 2) ("p-NPM" 2)
   ("we first silenced NPM" 2) ("overexpressed NPM" 2) ("exogenous NPM" 2)
   ("Overexpressed NPM" 2) ("normal NPM" 1) ("CR revealed NPM1" 1)
   ("nucleolar protein NPM" 1) ("the nucleolar protein NPM" 1)
   ("the nucleolar protein nucleophosmin (NPM)" 1) ("NO38" 1)
   ("demonstrated strong cytoplasmic NPM" 1) ("NPM (NPM)" 1) ("-NPM" 1)
   ("the multifunctional NPM" 1) ("the nucleolar marker NPM1" 1) ("P-NPM" 1)
   ("most NPM" 1) ("so overexpressed NPM" 1)
   ("the normally nucleolar protein nucleophosmin (NPM)" 1)))
 ("UP:P06750"
  (("agglutinin" 53) ("Agglutinin" 3) ("RCAs" 3) ("VVA" 1)
   ("Agglutinin (HPA)" 1) ("agglutinin (WGA)" 1)))
 ("UP:P06753"
  (("TPM3" 35) ("tropomyosin 3" 10) ("TM5" 3) ("TPM3-" 2) ("Tropomyosin 3" 1)
   ("NEM1" 1)))
 ("UP:P06756" (("CD51" 169) ("ITGAV" 80) ("ItgaV" 3) ("Itgav" 1)))
 ("UP:P06781" (("Rho2" 8))) ("UP:P06784" (("Ste7" 2) ("Ste7-" 2) ("STE7" 2)))
 ("UP:P06795" (("Abcb1b" 15) ("mdr1b" 4)))
 ("UP:P06808"
  (("RV" 555) ("-RV" 13) ("RV-" 3) ("RV protein" 2) ("isogenic PKCθ RV" 2)
   ("RV–" 1) ("the most variable RV protein" 1) ("–RV" 1)
   ("a GFP-expressing bicistronic RV" 1)))
 ("UP:P06850"
  (("CRH" 121) ("corticotropin-releasing hormone" 4)
   ("corticotropin releasing hormone" 2) ("Placental CRH" 2)
   ("placental CRH" 1)))
 ("UP:P06855" (("PNK" 177) ("PNK (NEB)" 2)))
 ("UP:P06858"
  (("lipoprotein" 476) ("LPL" 176) ("lipoprotein lipase" 26)
   ("lipoprotein (HDL)" 19) ("lipoprotein (LDL)" 18) ("Lipoprotein" 16)
   ("lipoprotein lipase (LPL)" 3) ("LipoProtein" 2) ("Lpl" 2)
   ("very low-density lipoprotein (VLDL)" 1) ("lipoprotein (VLDL)" 1)
   ("LPL protein" 1) ("increased placental LPL" 1)
   ("lipoprotein lipase ( LPL )" 1) ("Lipoprotein lipase" 1)
   ("a major toxic lipoprotein" 1) ("a highly toxic lipoprotein" 1)))
 ("UP:P06864"
  (("β-gal" 744) ("β-Gal" 261) ("βGal" 190) ("βgal" 58) ("β-GAL" 16)
   ("-β-gal" 3) ("β-gal-" 3) ("-βgal" 2) ("associated β-Gal" 2)
   ("senescence-associated β-gal" 1) ("pβ-Gal" 1) ("β−gal" 1) ("βGAL" 1)
   ("p-βgal" 1)))
 ("UP:P06865" (("hexa" 35) ("Hexa" 3) ("HEXA" 3) ("hexa-" 1)))
 ("UP:P06870" (("KLK1" 6) ("kallikrein 1" 1)))
 ("UP:P06886"
  (("TSST-1" 23) ("toxic shock syndrome toxin 1" 5) ("syndrome toxin 1" 4)))
 ("UP:P06903" (("negative regulator of transcription" 9)))
 ("UP:P06949" (("1-C" 41) ("1–C" 4) ("1−C" 1)))
 ("UP:P06956" (("recombinase Cre" 2)))
 ("UP:P06961" (("cca" 23) ("CCa" 5) ("-cca" 2))) ("UP:P06983" (("POPE" 3)))
 ("UP:P06990" (("HSDs" 2))) ("UP:P07041" (("pHH3" 30) ("p-HH3" 7) ("HH3" 5)))
 ("UP:P07050" (("pIII" 4)))
 ("UP:P07052"
  (("PRRs" 139) ("innate PRRs" 1) ("many classic PRRs" 1) ("Bona fide PRRs" 1)
   ("diverse PRRs" 1)))
 ("UP:P07059" (("DENA" 8)))
 ("UP:P07093"
  (("SERPINE2" 8) ("PN1" 2) ("glia-derived nexin" 2) ("Serpine2" 1)
   ("plasminogen activator inhibitor type 1)" 1)))
 ("UP:P07098"
  (("GL" 153) ("pGL" 8) ("gL" 7) ("gastric type" 6) ("dietary GL" 6) ("Gl" 3)
   ("LIPF" 3) ("HLAL" 2) ("pGl" 2) ("anaplastic GL" 2) ("recurrent GL's" 1)
   ("recurrent GL" 1) ("high dietary GL" 1)))
 ("UP:P07099"
  (("EPHX1" 103) ("COS1" 51) ("mEH" 42) ("Microsomal epoxide hydrolase" 5)
   ("microsomal epoxide hydrolase" 3) ("EPHX" 3) ("epoxide hydrolase 1" 3)
   ("Ephx1" 1)))
 ("UP:P07101"
  (("TH" 517) ("Th" 417) ("T helper" 197) ("hTH" 96) ("TH-" 10) ("HtH" 8)
   ("-pTH" 4) ("phTH" 3) ("nigral TH-" 2) ("striatal TH" 2) ("pTH" 2)
   ("a strong TH" 2) ("TH protein" 2) ("T Helper" 2)
   ("T
                helper"
    1)
   ("TH−" 1)))
 ("UP:P07108" (("DBI" 12) ("diazepam binding inhibitor" 1)))
 ("UP:P07141" (("mCSF1" 1))) ("UP:P07148" (("LFABP" 2) ("FABPL" 1)))
 ("UP:P07167" (("VirA" 25)))
 ("UP:P07195"
  (("LDHB" 11) ("LDH-B" 3) ("lactate dehydrogenase B" 3)
   ("lactate dehydrogenase B (LDHB)" 1)))
 ("UP:P07196"
  (("NEFL" 9) ("NFL" 8) ("NF-L" 6) ("neurofilament light polypeptide" 2)
   ("NFl" 1) ("NF68" 1)))
 ("UP:P07197" (("NFM" 31) ("NF-M" 30) ("NEFM" 5) ("Nef3" 2)))
 ("UP:P07199" (("CENP-B" 34) ("CENPB" 1) ("the inner centromeric CENP-B" 1)))
 ("UP:P07202"
  (("TPO" 444) ("Tpo" 69) ("thyroid peroxidase" 12) ("TPO protein" 5)
   ("TPO-" 2) ("the favorable TPO" 1)))
 ("UP:P07203"
  (("GPx1" 78) ("GPX1" 77) ("glutathione peroxidase 1" 25) ("GPx-1" 15)
   ("GPX-1" 14) ("Glutathione Peroxidase 1" 2) ("GPX-1 protein" 1)))
 ("UP:P07204"
  (("thrombomodulin" 35) ("THROMBO" 13) ("thrombomodulin (TM)" 5)
   ("Thrombomodulin" 4) ("THBD" 4) ("endothelial thrombomodulin" 2)
   ("Thbd" 2)))
 ("UP:P07205" (("PGK2" 2)))
 ("UP:P07225"
  (("pS21" 26) ("pros" 9) ("PROS" 9) ("PS25" 8) ("PROs" 3) ("Pros" 2)
   ("PROS1" 1) ("proS" 1)))
 ("UP:P07237"
  (("protein disulfide isomerase" 22) ("P4HB" 10)
   ("Protein disulfide isomerase" 4) ("disulfide isomerase" 2)
   ("protein disulfide isomerase (PDI)" 2)
   ("Protein disulfide isomerase (PDI)" 1) ("PDIA1" 1)
   ("new protein disulfide isomerase (PDI)" 1)))
 ("UP:P07238"
  (("LC" 2004) ("P-LC" 59) ("Lc" 21) ("-LC" 5) ("lc" 3) ("MagNa Pure LC" 2)
   ("LC–" 1) ("single peripheral P-LC" 1) ("most P-LC" 1) ("targeted LC" 1)
   ("LC-" 1) ("online reversed-phase nanoscale capillary LC" 1) ("lc-" 1)
   ("an Eksigent NANO LC" 1)))
 ("UP:P07273" (("dst1" 2) ("Dst1" 1))) ("UP:P07274" (("PFY1" 1)))
 ("UP:P07288"
  (("PSA" 4021) ("prostate-specific antigen" 164)
   ("prostate specific antigen" 100) ("PsA" 59) ("PSA protein" 40)
   ("prostate specific antigen (PSA)" 32)
   ("prostate-specific antigen (PSA)" 31) ("preoperative PSA" 14)
   ("Prostate-specific antigen" 7) ("Prostate specific antigen" 6)
   ("pre-operative PSA" 5) ("preoperative serum PSA" 5)
   ("community-based PSA" 4) ("Kallikrein 3" 3) ("than PSA" 3) ("PSAs" 3)
   ("substantial PSA" 3) ("higher pre-operative free PSA" 2) ("annual PSA" 2)
   ("underwent PSA" 2) ("Prostate-specific antigen (PSA)" 2)
   ("prostate and breast cancer and undergoes annual PSA" 2) ("regular PSA" 2)
   ("pSA" 2) ("postoperative PSA" 2)
   ("pre-operative prostate specific antigen (PSA)" 2)
   ("the AR-V high cases showed less PSA" 2) ("asymptomatic PSA" 2)
   ("the archetypal prostate gene PSA" 2) ("than Serum PSA" 2) ("“poor” PSA" 2)
   ("the preoperative PSA" 2) ("exosomal PSA" 1)
   ("previously documented elevated serum PSA" 1) ("cellular PSA" 1)
   ("PSA (GPLGVR)" 1) ("higher preoperative PSA" 1)
   ("an elevated post-operative PSA" 1)
   ("preoperative prostate-specific antigen (PSA)" 1)
   ("the sensitive yet diagnostically unspecific biomarker prostate-specific antigen (PSA)"
    1)
   ("a postoperative serum PSA" 1) ("Previously described PSA" 1)
   ("a well-established AR target gene product PSA" 1) ("minimal PSA" 1)
   ("Postoperative PSA" 1) ("more PSA" 1)
   ("Exogenous IGF-I enhanced R1881-induced PSA" 1) ("only preoperative PSA" 1)
   ("basal PSA" 1) ("a lower median pre-operative PSA" 1)
   ("elevated pre-operative PSA" 1) ("postoperative prechemotherapy PSA" 1)
   ("benign PSA (BPSA)" 1) ("Preoperative serum PSA" 1) ("than serum PSA" 1)
   ("at least one PSA" 1)))
 ("UP:P07305" (("H10" 87) ("H1F0" 9) ("h10" 2) ("H1.0" 1)))
 ("UP:P07306" (("CLEC4H1" 1) ("Asgr1" 1)))
 ("UP:P07307" (("Asgr2" 15) ("ASGR2" 9) ("CLEC4H2" 1)))
 ("UP:P07315" (("crystallin" 155) ("Crystallin" 4)))
 ("UP:P07327" (("alpha polypeptide" 25) ("ADH1A" 2)))
 ("UP:P07332" (("Fe/S protein" 52) ("FES" 46) ("Fe-S" 7)))
 ("UP:P07333"
  (("CSF-1R" 339) ("DFG" 338) ("CSF1R" 82) ("CSFR" 36) ("c-fms" 30) ("fms" 27)
   ("FMS" 24) ("M-CSFR" 16) ("CD115" 15) ("Fms" 12)
   ("colony stimulating factor receptor" 10) ("CSF-1 receptor" 9) ("c-Fms" 9)
   ("c-FMS" 8) ("colony stimulating factor-1 receptor" 5) ("CSF1 receptor" 5)
   ("M-CSF-R" 4) ("Colony stimulating factor-1 receptor" 3)
   ("the homologous CSF-1R D802V" 2) ("“DFG”" 2) ("M-CSFr" 2) ("Csf1r" 1)
   ("‘DFG’" 1) ("DFG-" 1) ("autocrine CSF-1R" 1) ("'DFG'" 1) ("C-FMS" 1)
   ("functional CSF1R" 1) ("colony stimulating factor receptor (MCSFR)" 1)))
 ("UP:P07339"
  (("cathepsin D" 196) ("Cathepsin D" 82) ("Cath-D" 60) ("CTSD" 46)
   ("cathepsin-D" 4) ("cathepsin D protein" 4) ("cathepsin D (CTSD)" 2)
   ("than cathepsin D" 1) ("Cathepsin-D" 1)
   ("cathepsin
D"
    1)
   ("Cathepsin D (CTD)" 1) ("Ceroid-Lipofuscinosis" 1)))
 ("UP:P07355"
  (("AnxA2" 215) ("ANXA2" 66) ("protein I" 31) ("Annexin A2" 17)
   ("annexin A2" 6) ("Annexin II" 5) ("annexin-2" 4) ("annexin II" 4)
   ("Anxa2" 2) ("annexin 2" 2) ("The lipid raft associated AnxA2" 1)
   ("AnxA2 protein" 1) ("This surface-localized AnxA2" 1)))
 ("UP:P07357" (("C8A" 3))) ("UP:P07358" (("C8B" 2)))
 ("UP:P07359"
  (("CD42b" 36) ("GP1BA" 6) ("Glycoprotein Ib" 2) ("GpIba" 2) ("GP1B" 1)
   ("Platelet glycoprotein Ib alpha chain precursor" 1)))
 ("UP:P07384"
  (("μ-calpain" 199) ("calpain 1" 63) ("Calpain 1" 7) ("μ-Calpain" 5)
   ("μcalpains" 1) ("μcalpain" 1)))
 ("UP:P07385"
  (("CrmA" 70) ("crmA" 11) ("SPI2" 3) ("the cowpox viral protein CrmA" 2)
   ("the viral serpin CrmA" 2) ("CRMA" 1) ("Serpin2" 1)))
 ("UP:P07437" (("TUBB" 29)))
 ("UP:P07451"
  (("CA-3" 489) ("CA3" 74) ("muscle specific" 31) ("carbonic anhydrase 3" 3)
   ("Muscle specific" 2) ("muscle specific protein" 2)
   ("5-AAC TTG A CC GT A AAA G CA GGT ATT CA-3" 1) ("“muscle specific”" 1)
   ("hippocampal area CA3" 1)))
 ("UP:P07464"
  (("GAT" 814) ("-GAT" 50) ("gat" 10) ("pGAT" 6)
   ("the T7 polymerase hexahistidine-GST expression vector pGAT2" 1)
   ("a central GAT" 1)
   ("5-TTG TAC TTA AGT TTA TTG  C T A  GC A CAC TTA CAG ATG GAT-3" 1)))
 ("UP:P07476"
  (("involucrin" 353) ("IVL" 45) ("Involucrin" 32) ("Ivl" 8)
   ("involucrin ( IVL)" 3)
   ("the superbasal layer differentiation marker involucrin" 2)
   ("involucrin-" 1) ("involucrin (INV)" 1) ("expressing IVL" 1)))
 ("UP:P07477"
  (("trp1" 43) ("TRP1" 25) ("PRSS1" 17) ("trp1-" 3) ("trypsin 1" 2)
   ("Trp1" 2)))
 ("UP:P07478"
  (("serine 2" 25) ("Serine 2" 9) ("trypsin-2" 2) ("PRSS2" 2) ("trypsin 2" 1)))
 ("UP:P07492"
  (("gastrin-releasing peptide" 9) ("gastrin-releasing peptide (GRP)" 1)
   ("Gastrin-releasing peptide" 1)))
 ("UP:P07510" (("CHRNG" 1))) ("UP:P07518" (("subtilisin" 44) ("Subtilisin" 2)))
 ("UP:P07550"
  (("ADRB2" 48) ("β2-AR" 44) ("β2AR" 32) ("β2-adrenergic receptor" 15)
   ("B2AR" 12) ("beta2-adrenergic receptor" 5) ("beta 2 adrenergic receptor" 4)
   ("b2AR" 2) ("the inactive HA-tagged chimeric β2-adrenergic receptor" 1)))
 ("UP:P07560" (("Sec4" 154) ("SEC4" 4) ("-Sec4" 4) ("sec4" 3)))
 ("UP:P07584" (("astacin" 1)))
 ("UP:P07585"
  (("decorin" 386) ("Decorin" 177) ("DCN" 41) ("Decorin protein" 6)
   ("stromal Decorin" 4) ("Dcn" 3) ("soluble decorin" 3)
   ("monomeric decorin" 2) ("exogenous decorin" 1) ("than decorin" 1)
   ("the decorin’s" 1) ("average 4.61 times less DCN" 1)
   ("the profound effect decorin" 1) ("exogenous soluble decorin" 1)
   ("Soluble decorin" 1)))
 ("UP:P07593" (("yST" 1)))
 ("UP:P07602" (("PSAP" 197) ("component C" 10) ("PSA-P" 2) ("prosaposin" 1)))
 ("UP:P07647" (("SeV" 295) ("SeV-" 3) ("seV" 2)))
 ("UP:P07650"
  (("TTG" 731) ("tTG" 384) ("-TTG" 38)
   ("the active site cysteine of tTG (PDB accession # 3S3J)" 1)
   ("-GCT GAA GCA ATC AGG GC  A AAA ACT AGA AGT ATG TTG-3" 1)
   ("A A AA TTG" 1)))
 ("UP:P07686" (("HEXB" 1)))
 ("UP:P07711"
  (("CTSL" 169) ("MEP" 79) ("CATL" 50) ("cathepsin L" 44) ("pMEP" 5)
   ("cathepsin L (CTSL)" 4) ("Cathepsin L" 3) ("CTSL1" 2) ("Cathepsin-L" 2)
   ("cathepsin L1" 1) ("CATHEPSIN L" 1)))
 ("UP:P07737"
  (("Pfn1" 263) ("PFN1" 150) ("profilin I" 20) ("Profilin1" 8) ("Profilin-1" 7)
   ("profilin-1" 4) ("overexpressed Pfn1" 3) ("Profilin I" 3)
   ("ectopically expressed phosphomimetic PFN1" 3)
   ("PP1Cα bound more phosphomimetic PFN1" 2) ("the phosphomimetic PFN1" 2)
   ("Pfn1-" 1) ("profilin 1" 1) ("specifically control PFN1's" 1)
   ("specifically control PFN1" 1) ("cellular PFN1" 1) ("particular PFN1" 1)))
 ("UP:P07741" (("APRT" 2) ("adenine phosphoribosyltransferase" 1)))
 ("UP:P07745" (("patatin" 17))) ("UP:P07751" (("alpha-II-spectrin" 3)))
 ("UP:P07766"
  (("OKT3" 185) ("CD3ε" 82) ("CD3e" 14) ("CD3-ε" 10) ("CD3E" 10) ("OKT3-" 2)
   ("Cd3e" 2) ("1μg/ml soluble OKT3" 1) ("-CD3ε" 1) ("CD3ε-" 1)
   ("soluble OKT3" 1)))
 ("UP:P07773" (("CATA" 2)))
 ("UP:P07788" (("pig" 55) ("PIG" 32) ("pIG" 9) ("Pig" 6)))
 ("UP:P07790" (("CoTC" 5)))
 ("UP:P07814"
  (("pars" 29) ("aminoacyl-tRNA" 28) ("PARS" 17) ("QARS" 8)
   ("Aminoacyl-tRNA" 2) ("EPRS" 1)))
 ("UP:P07819"
  (("invertase" 6) ("Invertase" 4) ("The internal invertase" 1)
   ("the external invertase" 1)))
 ("UP:P07858"
  (("cathepsin B" 428) ("Cathepsin B" 95) ("CTSB" 31) ("cathepsin-B" 22)
   ("Cathepsin-B" 6) ("cathepsin B-" 4) ("strong cathepsin B" 4)
   ("overexpressed cathepsin B" 3) ("intact cathepsin B" 2)
   ("cathepsin B (CTSB)" 2) ("Cathepsin B ( CTSB )" 1)))
 ("UP:P07900"
  (("HSP90alpha" 111) ("HSP90AA1" 45) ("HSPCA" 5) ("Hsp86" 3) ("Hsp90AA1" 2)
   ("HSPC1" 1) ("HSP90A" 1)))
 ("UP:P07902" (("GALT" 121) ("GalT" 16)))
 ("UP:P07910"
  (("hnRNPC" 5) ("HNRNPC" 2)
   ("heterogeneous nuclear ribonucleoproteins C1/C2" 1)))
 ("UP:P07911"
  (("THP" 25) ("UMOD" 5) ("uromodulin" 3)
   ("the renal tubular protein uromodulin" 1)))
 ("UP:P07935" (("Vega" 9) ("VEGA" 7)))
 ("UP:P07942"
  (("laminin-1" 43) ("LAMB1" 20) ("Laminin-1" 6) ("Laminin B1" 1) ("Lamb1" 1)))
 ("UP:P07945" (("resolvase" 20)))
 ("UP:P07947"
  (("c-Yes" 367) ("YES1" 107) ("c-yes" 7) ("apical membrane c-Yes" 1)
   ("than c-Yes from uninfected cells (0 time point)" 1) ("RTKS" 1)))
 ("UP:P07948"
  (("Lyn" 2139) ("SU6656" 360) ("LYN" 263) ("p56 Lyn" 93) ("lyn" 17)
   ("Lyn protein" 11) ("p53 Lyn" 10) ("-Lyn" 7) ("p-LYN" 6) ("Lyn-" 5)
   ("complete Lyn" 2) ("SU6656 (EMD)" 2) ("just Lyn" 2) ("overexpressed Lyn" 2)
   ("a single potential LYN" 2) ("than p56 Lyn ( xref left)" 1)
   ("a phosphomimetic mutant p56 Lyn Y32E" 1) ("pLYN" 1)
   ("specifically target Lyn" 1) ("effectively target Lyn" 1)
   ("perinuclear Lyn" 1) ("LYN−" 1) ("Su6656" 1) ("selectively target Lyn" 1)
   ("than Lyn" 1)))
 ("UP:P07949"
  (("RET" 984) ("Ret" 36) ("c-Ret" 7) ("intense RET" 2)
   ("than RET in non-solid tumors [ xref ]" 1)))
 ("UP:P07951" (("TPM2" 1) ("NEM4" 1)))
 ("UP:P07954"
  (("FH" 415) ("F/H" 23) ("LRCC" 17) ("fumarate hydratase" 15) ("pFH" 8)
   ("Fumarate hydratase" 4) ("-F/H" 4) ("f–h" 3) ("functional FH" 3)
   ("Fumarase" 2) ("f-h" 2) ("fumarase" 1) ("than FH (n = 5)" 1) ("FH-" 1)
   ("a strong FH" 1) ("the very strong FH" 1)
   ("account bilateral disease and newer FH" 1) ("Q A L Q HPY V QR FH" 1)
   ("‘FH’" 1) ("computed Absolute LRCC" 1) ("the absolute LRCC" 1)
   ("A detailed FH" 1)))
 ("UP:P07978" (("PP2B" 63)))
 ("UP:P07988"
  (("SP-B" 160) ("surfactant" 77) ("Surfactant" 11) ("SPB" 8)
   ("Surfactant protein B" 6) ("Sftpb" 5) ("SPBs" 4) ("mitotic SPBs" 3)
   ("SP-B protein" 2) ("SFTPB" 2) ("surfactant protein B" 1)
   ("pulmonary surfactant" 1)))
 ("UP:P07992"
  (("ERCC1" 950) ("Ercc1" 37) ("ERCC-1" 13) ("ERCC1 protein" 11) ("ercc1" 11)
   ("-ERCC1" 8) ("very few control cells displayed ERCC1" 3) ("normal ERCC1" 3)
   ("RAD10" 2) ("ercc1 protein" 2) ("ercc-1" 1) ("than ERCC1" 1)
   ("normal and aberrant ERCC1" 1) ("aberrant ERCC1" 1)))
 ("UP:P07996"
  (("TSP-1" 544) ("THBS1" 160) ("TSP1" 135) ("thrombospondin 1" 27)
   ("Thrombospondin 1" 7) ("TSP-1 protein" 7) ("Tsp-1" 6) ("Thbs1" 6)
   ("TSP1 protein" 3) ("Tsp1" 3) ("tsp-1" 3) ("cellular TSP-1" 3) ("THBS" 2)
   ("THBS-1" 2)
   ("the antiangiogenic and proapoptotic glycoprotein thrombospondin 1" 2)
   ("associated TSP1" 1) ("thrombospondin1" 1) ("exosomal TSP-1" 1)))
 ("UP:P07998"
  (("RNase A" 1224) ("RNAse A" 214) ("ribonuclease A" 69) ("Rnase A" 19)
   ("Ribonuclease A" 13) ("RNase A (USB)" 5) ("QIAGEN" 5) ("RNASE1" 3)
   ("eosinophil-associated RNase1" 2) ("RNase1" 1) ("USB" 1)))
 ("UP:P08019"
  (("SGA" 71) ("children born SGA" 4) ("short children born SGA" 2)
   ("adults born SGA" 1) ("born SGA" 1)))
 ("UP:P08034"
  (("Cx32" 45) ("Gjb1" 11) ("connexin 32" 11) ("X-linked)" 10) ("connexin32" 6)
   ("GJB1" 5) ("Connexin 32" 4) ("Cx32 protein" 3)
   ("axonal Charcot–Marie–Tooth neuropathy" 2) ("undetectable Cx32" 2)
   ("Connexin-32" 2) ("Charcot–Marie–Tooth neuropathy" 1) ("connexin-32" 1)
   ("32kDa" 1)))
 ("UP:P08047"
  (("Sp1" 4687) ("SP1" 785) ("SP-1" 123) ("sp1" 122)
   ("transcription factor Sp1" 89) ("Sp1 protein" 72) ("Sp-1" 32)
   ("transcription factor SP1" 27) ("-Sp1 peptide" 20) ("Sp1-" 13) ("-Sp1" 9)
   ("Transcription factor Sp1" 6) ("the transcriptional factor Sp1" 5)
   ("the cellular transcription factor Sp1" 4) ("Thr739-Sp1 peptide" 4)
   ("rabbit monoclonal anti-human ERα clone SP1" 4) ("SP1 protein" 3)
   ("mitotic Sp1" 3) ("Sp1 peptide" 3) ("overexpressed SP1 protein" 3)
   ("transcriptional factor Sp1" 3) ("Sp1 molecule" 3) ("exogenous Sp1" 2)
   ("SP-1-" 2)
   ("Sp1
 protein"
    2)
   ("the ubiquitous cellular transcription factor Sp1" 2)
   ("electrophoresed proteins revealed Sp1" 2) ("Strong sp1" 2)
   ("the ubiquitous transcription factor Sp1" 2) ("the exogenous Sp1" 2)
   ("Mitotic phospho-Sp1" 2) ("the mitotic Sp1" 2) ("mouse tumorigenic SP1" 2)
   ("the α-helical spacer peptide SP1" 1)
   ("the ubiquitous transcriptional activator SP1" 1)
   ("the trans-criptional activator Sp1" 1) ("Exogenous Sp1" 1)
   ("the 785 amino acids of Sp1" 1) ("in turn causes Sp1" 1)
   ("the ubiquitous nuclear factor Sp1" 1) ("functional Sp1" 1) ("SP1-" 1)
   ("the secondary transcription factor SP1" 1) ("sp1 protein" 1) ("pSp1" 1)
   ("the ubiquitous transcription factor SP1" 1) ("than Sp1" 1)
   ("mitotic phospho-Sp1" 1) ("the strong transcriptional activator Sp1" 1)
   ("at least Sp1" 1)))
 ("UP:P08048" (("ZFY" 5)))
 ("UP:P08064" (("cytochrome b558" 7) ("Cytochrome b558" 2)))
 ("UP:P08069"
  (("IGF-1R" 2649) ("IGF1R" 2279) ("IGF-IR" 1021) ("Igf1r" 203) ("IGFR" 105)
   ("insulin-like growth factor 1 receptor" 100) ("IGF-I receptor" 63)
   ("IGF1 receptor" 43) ("IGF1-R" 39) ("IGFIR" 39) ("IGF-1R protein" 21)
   ("IGF1R protein" 19) ("p-IGF1R" 18)
   ("Insulin-like growth factor 1 receptor" 17) ("pIGF-IR" 17) ("pIGF-1R" 17)
   ("insulin-like growth factor I receptor" 9) ("-IGF1R" 9) ("pIGFR" 9)
   ("IGF-IR-" 8) ("IGF-IR protein" 7) ("overexpressed IGF1R" 7)
   ("Insulin like Growth Factor 1-Receptor" 6) ("IGF-I Receptor" 6)
   ("IGF-1R-" 5) ("pIGF1R" 5) ("Igf-1r" 5) ("IGF-IRs" 4)
   ("miR-375 directly targets IGF1R" 4) ("IGF1R molecule" 4) ("P-IGF1R" 4)
   ("p-IGFR" 3) ("Insulin-like growth factor I receptor" 3) ("dual IGF-1R" 3)
   ("alternatively mouse anti human IGF-IR" 3) ("Igf1R" 2)
   ("ligand-phosphorylated insulin-like growth factor I receptor" 2)
   ("igf-1r" 2) ("overexpressed IGF-1R" 2) ("expressing IGF1R" 2)
   ("targeting IGF1R" 2) ("Insulin like growth factor I receptor" 2)
   ("than targeting IGF-1R" 2) ("specifically target IGF-IR" 2)
   ("a chimeric IGF-1R" 2) ("total cellular IGF1R" 2) ("Igf-1R" 2) ("igf1r" 1)
   ("than cytoplasmic Igf1r in cells with initially high cell surface Igf1r" 1)
   ("lethal outcome regardless IGF1R" 1) ("than IGF1R" 1) ("than IGF-1R" 1)
   ("IGF-1-R" 1) ("insulin like growth factor I receptor" 1)
   ("mature IGF-1R" 1) ("p-IGF-IR" 1) ("IGF–1R" 1)
   ("dominant-negative PKC δ expressed markedly less IGF-1R protein" 1)
   ("more IGF-1R" 1) ("Mature IGF-1R" 1) ("-IGF-IR" 1)
   ("Insulin like growth factor 1 receptor" 1)
   ("resveratrol (i) mainly targets IGF-1R" 1)
   ("resveratrol specifically targets IGF-1R" 1)
   ("the heterotetrameric transmembrane protein IGF1R protein" 1) ("IgF1-R" 1)
   ("IgF1R" 1) ("investigational agents targeting IGF1R" 1) ("than IGF-IR" 1)
   ("iGFR" 1) ("somewhat less IGF-IR protein" 1) ("than the IGF-1R" 1)
   ("IGFI receptor" 1) ("homodimeric IGF-1R" 1)
   ("than 30 anticancer drugs targeting IGF-1R" 1) ("functional IGF-1R" 1)))
 ("UP:P08074"
  (("LCR" 99) ("LCRs" 14) ("the distal β-globin locus control region LCR" 2)))
 ("UP:P08076" (("StrR" 1)))
 ("UP:P08100"
  (("Rho family" 1017) ("RHO family" 12) ("rho family" 4)
   ("Rho family protein" 2) ("Rho  family" 1)))
 ("UP:P08103" (("BMK" 11)))
 ("UP:P08118"
  (("MSMB" 35) ("Msmb" 12) ("PSP94" 4) ("microseminoprotein beta" 2)
   ("microseminoprotein" 1)))
 ("UP:P08123" (("COL1A2" 110) ("Col1a2" 16) ("Col1A2" 11)))
 ("UP:P08133"
  (("p70" 482) ("AnxA6" 196) ("P70" 58) ("ANXA6" 49) ("p-p70" 9)
   ("Annexin A6" 7) ("annexin A6" 7) ("pp70" 2) ("Ribosomal S6 kinase p70" 2)
   ("annexin 6" 2) ("AnxA6-expressing invasive tumor cells AnxA6" 1)
   ("than mTOR independent P70" 1) ("than 100 μM P70" 1) ("Annexin 6" 1)))
 ("UP:P08134"
  (("RhoC" 2241) ("RHOC" 22) ("dnRhoC" 20) ("rhoC" 19) ("caRhoC" 18)
   ("RhoC protein" 17) ("Ras homolog family member C" 3) ("RhoC-" 2)
   ("miR-106b directly targets RhoC" 2) ("-RhoC" 2)
   ("dominant-negative RhoC" 2) ("than wild-type RhoC" 2)
   ("the pro-metastatic RhoC" 1) ("Rhoc" 1) ("RHO-C" 1)
   ("These results convincingly position RhoC" 1) ("Dominant-negative RhoC" 1)
   ("total GDP/GTP-bound RhoC" 1)
   ("the metastasis-associated small GTPase RhoC" 1) ("the residual RhoC" 1)
   ("than RhoC" 1)))
 ("UP:P08138"
  (("NGFR" 124) ("p75NTR" 32) ("NGF receptor" 29)
   ("nerve growth factor receptor" 26) ("NGF-R" 15) ("CD271" 9)
   ("low-affinity nerve growth factor receptor" 9) ("Ngfr" 3)
   ("nerve growth factor receptor (NGFR)" 2) ("Nerve growth factor receptor" 1)
   ("Low-affinity nerve growth factor receptor" 1)))
 ("UP:P08151"
  (("GLI1" 1114) ("Gli1" 793) ("GLI" 219) ("Gli" 150) ("GLI1 protein" 42)
   ("gli1" 37) ("glioma-associated oncogene" 15) ("Gli-1" 9) ("Gli1 protein" 6)
   ("GLI protein" 5) ("Glioma-associated oncogene" 4) ("gli" 3) ("than GLI1" 3)
   ("exogenous GLI1" 3) ("Gli1 peptide" 3) ("exogenous Gli1" 2)
   ("exogenous Gli1 protein" 2) ("GLI1-" 2) ("Gli protein" 2)
   ("Phospho-mimetic Gli1" 2) ("-GLI1" 1) ("Gli1-" 1) ("than GLI1 silencing" 1)
   ("more GLI1" 1) ("Exogenous GLI1" 1) ("exogenous transfected GLI1" 1)
   ("exogenous and endogenous human GLI1" 1) ("The canonical GLI" 1)
   ("the previously identified GLI" 1) ("Gli-1 protein" 1)))
 ("UP:P08155" (("KRH" 30) ("-KRH" 1) ("fresh low glucose KRH" 1)))
 ("UP:P08172" (("CHRM2" 6)))
 ("UP:P08174"
  (("CD55" 154) ("DAF" 146) ("daf" 28) ("DAF-2" 22) ("Daf" 12)
   ("DAF protein" 10) ("decay accelerating factor" 6) ("soluble DAF" 2)
   ("apical surface protein DAF" 2) ("excess soluble DAF" 1) ("daf-" 1)
   ("peripheral leukocyte CD55" 1)))
 ("UP:P08183"
  (("ABCB1" 863) ("MDR1" 658) ("mdr1" 70) ("MDR-1" 65)
   ("multidrug resistance protein 1" 18) ("Abcb1" 15) ("MDR1 protein" 7)
   ("multidrug resistance 1" 7) ("Mdr1" 5) ("ABCB1-" 5) ("ABCB1 protein" 3)
   ("pMDR1" 3) ("ATP-binding cassette sub-family B member 1" 2)
   ("P-glycoprotein 1" 2) ("abcb1" 2) ("overexpressing ABCB1" 1) ("mdr-1" 1)
   ("more MDR1" 1) ("than ABCB1" 1) ("its MDR-associated target gene ABCB1" 1)
   ("membranous ABCB1" 1) ("strong ABCB1 protein" 1)))
 ("UP:P08185"
  (("cortisol" 117) ("CBG" 72) ("SERPINA6" 59) ("pCBG" 14) ("Cortisol" 6)
   ("SERPINA6-" 2) ("corticosteroid binding globulin" 1)
   ("corticosteroid-binding globulin" 1) ("the parent gene SERPINA6" 1)
   ("adrenal cortisol" 1) ("UC cortisol" 1) ("maternal cortisol" 1)))
 ("UP:P08191" (("FimH" 97) ("–FimH" 35) ("fimH" 7)))
 ("UP:P08195"
  (("SLC3A2" 35) ("Slc3A2" 7) ("4F2" 4) ("CD98hc" 4)
   ("4F2 cell-surface antigen heavy chain" 1)
   ("solute carrier family 3 member 2" 1) ("Slc3a2" 1)))
 ("UP:P08235"
  (("MR" 601) ("MCR" 147) ("MLR" 118) ("Mr" 35)
   ("mineralocorticoid receptor" 14) ("MR-(RR)" 9) ("allogeneic MLR" 5)
   ("MR-" 4) ("structural MR" 4) ("the restrictive HIV-2 envelope MCR" 2)
   ("a relevant MCR" 2) ("a particular MR" 1) ("differential MR-" 1)
   ("Correct Mr" 1) ("only PACS-2 MR" 1) ("-MCR" 1) ("reliable MR" 1)
   ("the paramagnetic MR" 1) ("pMR" 1) ("Representative 1 H MR" 1)
   ("One-dimensional (1D) 1 H MR" 1) ("Mineralocorticoid Receptor (MR)" 1)
   ("Mineralocorticoid Receptor" 1) ("smallest MCR" 1)))
 ("UP:P08236"
  (("GUSB" 148) ("-glucuronidase" 28) ("glucuronidase" 21)
   ("beta-glucuronidase" 8) ("GusB" 3) ("Glucuronidase" 3) ("Gusb" 2)
   ("GUSb" 1) ("Beta-glucuronidase" 1)))
 ("UP:P08237" (("PFKM" 32) ("Pfk-1" 5) ("PFK-1" 5)))
 ("UP:P08238"
  (("Hsp90" 2433) ("HSP90β" 77) ("hsp90" 50) ("Hsp 90" 39) ("Hsp90 protein" 30)
   ("Hsp90β" 27) ("HSP90AB1" 14) ("HSP 90" 8) ("Hsp90 molecule" 7) ("Hsp90-" 6)
   ("Hsp90 (MEEVD)" 4) ("Hsp90-beta" 3) ("dimeric Hsp90" 2) ("MEEVD" 2)
   ("Hsp90
protein"
    2)
   ("targeting Hsp90" 2) ("IKKα-associated Hsp90" 2) ("Hsp90ab1" 1)
   ("specifically targets Hsp90" 1) ("directly contrast Hsp90" 1) ("-Hsp90" 1)
   ("less Hsp90" 1) ("non-phosphorylatable Hsp90" 1)
   ("tyrosine phosphorylatable Hsp90" 1) ("functional Hsp90" 1)
   ("particular Hsp90" 1) ("more Hsp90" 1)
   ("the well-characterized chaperone Hsp90" 1) ("Hsp90AB1" 1)))
 ("UP:P08240" (("SRα" 16) ("pSRα" 8) ("SRPR" 4) ("SRalpha" 1)))
 ("UP:P08243" (("ASNS" 20)))
 ("UP:P08246"
  (("NE" 1764) ("HNE" 828) ("HLE" 90) ("neutrophil elastase" 27) ("ELA2" 7)
   ("human leukocyte elastase" 5) ("ELANE" 3) ("neutrophil elastase (HNE)" 3)
   ("the outer NE" 2) ("human leukocyte elastase (HLE)" 2) ("acute NE" 2)
   ("an immortalized esophageal epithelial cell line NE2" 1)
   ("MMR-proficient HeLa NE" 1) ("NE protein" 1)))
 ("UP:P08247"
  (("synaptophysin" 113) ("Synaptophysin" 15) ("SYP" 14) ("Syp" 2)
   ("presynaptic synaptophysin" 1)
   ("the pre-synaptic marker Synaptophysin (SYP)" 1) ("Synaptophysin (SYP)" 1)
   ("synaptophysin (SYP)" 1) ("synapto" 1)))
 ("UP:P08253"
  (("MMP-2" 2409) ("MMP2" 1292) ("TBE1" 80) ("matrix metalloproteinase-2" 72)
   ("matrix metalloproteinase 2" 49) ("Mmp2" 18) ("mmp2" 16) ("MMP 2" 11)
   ("gelatinase A" 10) ("MMP-2 protein" 10) ("Matrix metalloproteinase-2" 9)
   ("stromal MMP-2" 7) ("Matrix metalloproteinase 2" 6)
   ("matrix metallopeptidase 2" 4) ("S1P selectively increases MMP-2" 3)
   ("72 kDa type IV collagenase" 2) ("Stromal MMP-2" 2)
   ("specifically knockdown MMP-2" 2) ("less MMP-2" 2)
   ("Matrix metallopeptidase 2" 2) ("-MMP-2" 2)
   ("both latent and activated MMP-2" 2)
   ("the latent 72 kDa type IV collagenase" 2) ("Matrix Metalloproteinase-2" 2)
   ("MMP-2-" 2) ("central and stromal MMP-2" 1)
   ("further downregulated MMP-2" 1) ("MMP2-" 1)
   ("than MMP-2 in HEK293/A 1 R cells" 1) ("mouse monoclonal MMP2" 1)
   ("mature MMP-2" 1) ("The soluble gelatinases MMP-2" 1) ("Cellular MMP-2" 1)
   ("MMP- 2" 1) ("further activated MMP2" 1)
   ("than MMP-2 in differentiated human macrophages based on mRNA levels" 1)
   ("ERK-1 and ERK-2 secreted significantly less pro- and active MMP2" 1)
   ("functional MMP2" 1) ("its transcriptional target MMP2" 1)
   ("further upregulated MMP-2" 1)))
 ("UP:P08254"
  (("MMP3" 799) ("MMP-3" 638) ("Stromelysin-1" 40) ("stromelysin-1" 21)
   ("matrix metalloproteinase-3" 19) ("MMP 3" 18) ("stromelysin" 17)
   ("Mmp3" 12) ("matrix metalloproteinase 3" 12)
   ("matrix metallopeptidase 3" 10) ("MMP3 protein" 8) ("stromelysin 1" 5)
   ("SL-1" 4) ("MMP3 (stromelysin-1) protein" 3) ("MMP3-" 3) ("pMMP3" 2)
   ("MMP-3-" 2) ("MMP-3 protein" 2) ("MMP-3–" 2)
   ("Matrix metalloproteinase-3" 2) ("Stromelysin" 1) ("targeting gene MMP3" 1)
   ("detectible MMP3" 1) ("Matrix metalloproteinase 3" 1)
   ("The rs679620 A MMP3" 1) ("MMP3, MMP10, and cathepsin K (CTSK)" 1)
   ("exogenous MMP-3" 1)))
 ("UP:P08263"
  (("GSTA1" 53) ("GST-A1" 5) ("glutathione S-transferase A1" 2) ("Gsta1" 1)))
 ("UP:P08294"
  (("extracellular" 5304) ("Extracellular" 285) ("SOD3" 48) ("EXTRACELLULAR" 6)
   ("diverse extracellular" 5) ("phosphorylated-extracellular" 3) ("EcSOD" 3)
   ("particular extracellular" 2) ("primarily extracellular" 2)
   ("‘extracellular’" 2) ("extracellular (EC)" 2) ("“extracellular”" 2)
   ("recently extracellular" 1) ("only extracellular" 1)
   ("completely extracellular" 1) ("distinctive extracellular" 1)
   ("generally extracellular" 1) ("largely extracellular" 1) ("ecSOD" 1)
   ("predominantly extracellular" 1)
   ("Alcian Blue highlighted extracellular" 1) ("subsequent extracellular" 1)
   ("extracellular polypeptide" 1) ("pleiotropic extracellular" 1)
   ("mostly extracellular" 1) ("non-covalently associated extracellular" 1)
   ("complete extracellular" 1) ("whereby extracellular" 1)
   ("numerous biologically key extracellular" 1) ("Also extracellular" 1)))
 ("UP:P08311"
  (("CG" 1034) ("C/G" 142) ("cathepsin" 70) ("CATG" 39) ("cathepsin G" 15)
   ("-CG" 10) ("CGTP" 7) ("CTSG" 7) ("the central C/G" 6) ("pCG" 4)
   ("Cathepsin" 4) ("Cg" 3) ("-CATG" 2) ("cathepsin-G" 2)
   ("Typical CG (CGTP)" 1) ("Cystitis glandularis" 1)
   ("intestinal CG (CGIT)" 1) ("cystitis glandularis" 1) ("only one CG" 1)
   ("strong motifs CATG" 1) ("two more canonical CG" 1)
   ("the most efficient cathepsin" 1) ("only 15 CG" 1)))
 ("UP:P08317" (("CEF4" 2)))
 ("UP:P08318" (("pp150" 15) ("the viral Cyclin A2 substrate pp150" 2)))
 ("UP:P08331" (("CPDB" 3))) ("UP:P08353" (("ICP34.5" 5)))
 ("UP:P08393" (("Vmw110" 6)))
 ("UP:P08397"
  (("UPS" 725) ("PBGD" 61) ("HMBS" 40) ("porphobilinogen deaminase" 18)
   ("porphobilinogen deaminase (PBGD)" 6) ("Hmbs" 4)
   ("hydroxymethylbilane synthase" 3) ("Hydroxymethylbilane synthase" 3)
   ("one patient developed two UPS" 2) ("Hydroxymethylbilane" 2)
   ("Porphobilinogen deaminase" 2) ("UPS-" 1)
   ("many known low-abundance canonical UPS" 1)
   ("porphobilinogen deaminase (PBDA)" 1)
   ("Porphobilinogen deaminase (PBGD)" 1) ("PBG-D" 1)))
 ("UP:P08457" (("STATx" 5)))
 ("UP:P08473"
  (("polypeptides" 970) ("NEP" 427) ("CD10" 231) ("neprilysin" 171) ("SFE" 27)
   ("SFEs" 25) ("Neprilysin" 11) ("Polypeptides" 10)
   ("neutral endopeptidase" 7) ("neutral endopeptidase (NEP)" 6) ("CALLA" 5)
   ("EPN" 4) ("CD10-" 3) ("metalloendopeptidase" 3) ("mouse monoclonal NEP" 3)
   ("membrane metalloendopeptidase" 3) ("Stromal CD10" 3)
   ("Both cyclin D1-positive undifferentiated endometrial sarcomas showed diffuse strong CD10"
    3)
   ("patchy CD10" 2) ("surgical specimens showed patchy CD10" 2)
   ("neprilysin (NEP)" 2) ("approximately 4000 polypeptides" 2)
   ("Neutral endopeptidase 24.11" 2) ("overexpressed human neprilysin" 2)
   ("consistently lacked substantial CD10" 2)
   ("both cyclin D1 positive UES-U showed diffuse strong CD10" 2)
   ("mutant resin-bound GST-BRCA2 DBD polypeptides" 2) ("neprilysin ( MME )" 1)
   ("at least some co-migrating polypeptides" 1) ("Neutral endopeptidase" 1)
   ("the polypeptides having molecular" 1) ("CD10−" 1)
   ("covalently conjugates SUMO polypeptides" 1)
   ("longer TEN domain polypeptides" 1) ("stromal CD10" 1)
   ("here lack polypeptides" 1)
   ("the wild-type and mutated resin-bound GST-BRCA2 recombinant polypeptides"
    1)))
 ("UP:P08476" (("INHBA" 22) ("EDF" 1)))
 ("UP:P08478"
  (("AEI" 96) ("pAla" 3)
   ("patient A (a male born in 1979) both demonstrated AEI" 2)))
 ("UP:P08487"
  (("phospholipase C-γ1" 11) ("phospholipase Cγ-1" 3)
   ("Phospholipase C-γ1" 2)))
 ("UP:P08493"
  (("MGP" 9) ("Mgp" 4) ("matrix Gla protein (MGP)" 2) ("mgP" 2)
   ("matrix Gla protein" 1)))
 ("UP:P08497" (("AECA" 1)))
 ("UP:P08514"
  (("CD41" 73) ("GPIIb" 64) ("ITGA2B" 15) ("GpIIb" 4) ("CD41+CD42b-" 3)
   ("G-T-A" 2) ("HPA-3" 2) ("Rat monoclonal anti–mouse CD41" 2)
   ("CD41+CD42b−" 1) ("ITGAB" 1)))
 ("UP:P08519"
  (("LPA" 1067) ("apo(a)" 232) ("Lp(a)" 79) ("Apo(a)" 24) ("LPA-" 23)
   ("Apolipoprotein(a)" 7) ("apolipoprotein(a)" 6)
   ("the unique glycoprotein apolipoprotein(a)" 2) ("absolute plasma Lp(a)" 1)
   ("exogenous LPA" 1) ("–LPA" 1)))
 ("UP:P08537" (("TUBA" 6) ("TubA" 2))) ("UP:P08541" (("UGT2B" 17)))
 ("UP:P08546" (("UL54" 2)))
 ("UP:P08559" (("PDHA1" 11) ("somatic form" 3) ("p-PDHA1" 1)))
 ("UP:P08567" (("pleckstrin" 27) ("Pleckstrin" 25) ("PLEK" 5)))
 ("UP:P08571"
  (("CD14" 967) ("CD14−" 5) ("Functional CD14" 2) ("CD14-" 2) ("pCD14" 2)
   ("-CD14" 1) ("pure CD14" 1) ("approximately 50% CD14" 1)
   ("the monocytic cell maturation marker CD14" 1)))
 ("UP:P08572"
  (("αvβ5" 315) ("COL4A2" 30) ("Col4a2" 3) ("only integrin αvβ5" 2)
   ("exclusively use integrin αvβ5" 1) ("col4a2" 1)
   ("monoclonal mouse anti- αvβ5" 1)))
 ("UP:P08574" (("CYC1" 8) ("cytochrome c1" 2) ("Cyc1" 1)))
 ("UP:P08575"
  (("LCA" 200) ("CD45RO" 166) ("T200" 67) ("Ptprc" 17)
   ("leukocyte common antigen" 10) ("CD45RB" 9) ("PTPRC" 7) ("-CD45RO" 3)
   ("p53 and cyclin D1and potentiated LCA’s" 1) ("further enhanced LCA’s" 1)
   ("further enhanced LCA" 1) ("The naive CD4 + CD45RO" 1)
   ("hypomorphic mutations cause LCA" 1)))
 ("UP:P08579"
  (("SNRPB2" 3) ("small nuclear ribonucleoprotein polypeptide B" 1)))
 ("UP:P08581"
  (("MET" 10480) ("c-Met" 5363) ("c-MET" 1364) ("met" 1072) ("c-met" 330)
   ("cMET" 159) ("p-MET" 137) ("MET protein" 116) ("pMET" 97)
   ("hepatocyte growth factor receptor" 89) ("cMet" 78) ("MeT" 71) ("HGFR" 56)
   ("HGF receptor" 48) ("p-c-Met" 43) ("P-MET" 41) ("c-Met protein" 40)
   ("C-Met" 35) ("C-MET" 27) ("MET-" 26) ("p-cMet" 21) ("c-MET protein" 20)
   ("−met" 19) ("p-c-MET" 12) ("c-met protein" 10) ("overexpressed c-Met" 9)
   ("overexpressed MET" 8) ("hepatocyte growth factor receptor (HGFR)" 6)
   ("-MET" 6) ("CMET" 6) ("HGF-R" 6) ("HGF/SF receptor" 6) ("targeted c-Met" 5)
   ("p-c-met" 5) ("Targeted c-Met" 4) ("targeting MET" 4) ("HGFR protein" 4)
   ("targeting c-Met" 4) ("HGF Receptor" 3) ("Mets" 3)
   ("Hepatocyte growth factor receptor" 3) ("soluble c-Met" 3)
   ("overexpressed MET protein" 3) ("total and phosphorylated MET protein" 3)
   ("membranous MET" 3) ("functional c-Met" 3) ("overexpressed c-MET" 3)
   ("faster MET" 2) ("“MET”" 2) ("scatter factor receptor" 2) ("c-MET-" 2)
   ("somatic MET" 2) ("sustained peripheral endosomal c-Met" 2)
   ("The human mesothelial cell line MeT-5A" 2)
   ("Two recurrent germline mutations (as these SNPs are potentially functional) MET- N375S"
    2)
   ("c-Met-" 2) ("predominant cytoplasmic MET" 2) ("strong MET" 2)
   ("soluble MET" 2) ("targeted MET" 2) ("targeting human MET" 2)
   ("virtually no phospho-c-Met" 2) ("c-Met molecule" 2)
   ("than c-Met ( xref )" 2) ("hepatocyte growth factor receptor (MET)" 2)
   ("mouse monoclonal anti human c-MET" 2) ("prominent MET" 2)
   ("phosphorylated-MET protein" 2)
   ("its hetrodimeric tyrosine kinase receptor MET" 2) ("Further, MET" 1)
   ("subsequently targets MET" 1) ("exogenous MET" 1)
   ("our results made c-Met" 1) ("than 4 designated c-Met" 1)
   ("than 3 designated c-Met" 1) ("‘MET’" 1)
   ("a heavy isotope-labeled MET peptide" 1) ("MET peptide" 1)
   ("the transformed human mesothelial cell line MeT-5A" 1)
   ("An important intermediary connecting MET" 1) ("p-MET protein" 1)
   ("very little MET" 1) ("the transiently overexpressed MET" 1)
   ("possible MET" 1) ("mets" 1) ("“HGF Receptor”" 1) ("“c-met”" 1)
   ("less total MET" 1) ("less pMET" 1) ("P08581" 1)
   ("a differential c-MET-" 1) ("CAV1 accelerated HGF-induced c-Met" 1)
   ("This mature c-Met" 1) ("perinuclear endosomal c-Met" 1)
   ("nuclear-proximal activated c-Met" 1)
   ("the untransformed mesothelial cell line MeT-5A" 1) ("the MET -WT" 1)
   ("than MET -Y1253D (Figure xref )" 1) ("than WT MET" 1)
   ("In contrast MET -Y1253D" 1) ("than MET" 1)
   ("HGF
receptor"
    1)
   ("more MET" 1) ("EMT termed MET" 1)
   ("damnacanthal directly targets c-Met" 1) ("damnacanthal targets c-Met" 1)
   ("MET, compared to the extensive studies of EMT" 1)
   ("whose tumors overexpressed MET" 1) ("c-Met (MET)" 1) ("than c-Met" 1)
   ("healthy mice expressed low MET" 1) ("“c-Met”" 1) ("“HGFR”" 1)
   ("“hepatocyte growth factor receptor”" 1) ("intact c-MET" 1)
   ("specifically target MET" 1) ("most met" 1) ("the latter met" 1)
   ("immature c-Met" 1) ("cMet-" 1) ("than c-Met [ xref ]" 1) ("cmet" 1)
   ("pc-Met" 1) ("Most met" 1) ("than c-MET" 1) ("miR-155-based c-Met" 1)
   ("strong P-MET" 1) ("C-met" 1) ("c-met-" 1) ("aberrant MET" 1)
   ("a functional MET" 1) ("phospho-MET protein" 1)))
 ("UP:P08582" (("melanotransferrin" 1)))
 ("UP:P08588" (("RHR" 130) ("ADRB1" 20) ("a statistic RHR" 1) ("ADRB1-" 1)))
 ("UP:P08590" (("myosin light chain 3" 3) ("MYL3" 2) ("Myl3" 2)))
 ("UP:P08603"
  (("CFH" 160) ("complement factor H" 18) ("Halofuginone" 13)
   ("complement factor H (CFH)" 2)
   ("the soluble regulator complement factor H" 2) ("HF2" 1)))
 ("UP:P08620"
  (("FGF4" 118) ("HST1" 39) ("Fgf4" 12) ("fibroblast growth factor 4" 7)
   ("FGF-4" 5) ("fgf4" 5) ("HSTF-1" 1) ("HST-1" 1)))
 ("UP:P08621"
  (("SNP1" 22) ("U1-70K" 9) ("SNRNP70" 7) ("U1-70K protein" 3) ("SNRP70" 2)))
 ("UP:P08631"
  (("Hck" 1836) ("HCK" 37) ("hck" 16) ("hematopoietic cell kinase" 10)
   ("Hck protein" 8) ("p59 Hck" 4) ("Hck-" 3) ("-Hck" 3)
   ("Hematopoietic cell kinase" 2) ("hCK" 2) ("at least p56/p59 hck" 1)
   ("virion-associated Hck" 1) ("associated Hck" 1) ("than wild-type Hck" 1)
   ("hematopoietic cell kinase (HCK)" 1) ("-HcK⋀OR" 1) ("HcK" 1) ("P08631" 1)
   ("the previously identified binding partner Hck" 1) ("than Hck" 1)
   ("Both exogenous and endogenous Hck" 1)))
 ("UP:P08637"
  (("CD16" 357) ("FcγRIIIa" 19) ("FCGR3A" 14) ("FcγRIIIA" 7) ("CD16-" 2)
   ("CD16−" 1)))
 ("UP:P08645" (("RAS3" 2)))
 ("UP:P08648"
  (("α5β1" 397) ("ITGA5" 177) ("fibronectin receptor" 52) ("CD49e" 21)
   ("integrin alpha 5" 6) ("VLA-5" 6) ("alpha polypeptide)" 5) ("Itga5" 4)
   ("Integrin Alpha 5" 3) ("inte-grin" 1) ("whereby integrin α5β1" 1)
   ("the major fibronectin receptor" 1) ("Fibronectin receptor" 1)
   ("α5β1(HH)" 1) ("VLA5" 1)))
 ("UP:P08651"
  (("NFI-C" 308) ("NFI-C protein" 14) ("Nfic" 6) ("NFIC" 5) ("NFI-C-" 3)
   ("NF-I" 1) ("exogenous NFI-C" 1)))
 ("UP:P08659"
  (("luciferase" 17557) ("Luciferase" 4370) ("Luc" 2367) ("luc" 1762)
   ("Dual-Luciferase" 429) ("LUC" 361) ("dual-luciferase" 263) ("-luc" 145)
   ("-Luc" 141) ("Dual-luciferase" 136) ("-luciferase" 118) ("pLuc" 108)
   ("luciferases" 98) ("-LUC" 31) ("FL" 30) ("pLUC" 25)
   ("luciferase protein" 19) ("Luc-" 10) ("-Luciferase" 9)
   ("luciferase (FL)" 7) ("p-LUC" 7) ("–luciferase" 5) ("Dual luciferase" 4)
   ("dual luciferase" 3) ("P-luc" 3)
   ("the internal control renilla luciferase" 3) ("Luc (PL)" 3)
   ("lentiviral firefly luciferase" 3)
   ("various promoter-driven firefly luciferase" 2)
   ("A thymidine kinase promoter-driven secreted gaussia luciferase" 2)
   ("a HSP70 promoter-driven secreted cypridina luciferase" 2)
   ("SV40 promoter-driven secreted cypridina luciferase" 2)
   ("HSP70 promoter-driven secreted cypridina luciferase" 2)
   ("the internal control Renilla luciferase" 2)
   ("NQO1-ARE-dependent luciferase" 2) ("DUAL-LUCIFERASE" 2)
   ("Dual Luciferase" 2) ("luciferase-" 2) ("robust luciferase" 2)
   ("the internal reference renilla luciferase" 2) ("dual-Luciferase" 2)
   ("the dual luciferase" 2)
   ("LEF/TCF-responsive promoter Topflash luciferase" 2)
   ("TSA induced both the HRE-luc" 2) ("targeted luciferase" 2)
   ("luciferase (Luc) protein" 2) ("an irrelevant firefly luciferase" 2)
   ("the intact luciferases" 2) ("luciferase (LL)" 2) ("Luc (KL)" 2)
   ("luciferase (RL)" 2)
   ("ETS-1-inducing miR-222 promoter-driven luciferase" 2)
   ("telomeric luciferase" 2) ("negligible luciferase" 2) ("DLR" 2)
   ("Coexpressed firefly ( Photinus pyralis ) luciferase" 2)
   ("lentiviral pseudoparticles encoding luciferase" 2)
   ("pGL3 basic firefly luciferase" 2) ("fl" 2)
   ("3Kb DKK1 promoter-driven luciferase" 1) ("a dual luciferase" 1)
   ("The dual luciferase" 1)
   ("an internal control plasmid coding Renilla luciferase" 1) ("-Luc2P" 1)
   ("human leukaemic cell line K562-luc" 1) ("luciferase (GLUC)" 1)
   ("expressing Renilla luciferase" 1) ("NFAT-driven luciferase" 1)
   ("NFAT promoter-driven luciferase" 1) ("lentiviral luciferase" 1)
   ("Dual–Luciferase" 1) ("p21 promoter-driven luciferase" 1)
   ("luciferase (LUC)" 1) ("the relevant luciferase" 1)
   ("the Dual Luciferase" 1) ("bioluminescent luciferase" 1)
   ("basal luciferase" 1) ("DUAL-Luciferase" 1)
   ("a BMAL1-promoter-driven luciferase (BLP)" 1) ("Luciferase (LUC)" 1)
   ("an internal ribosome entry site-driven Renilla luciferase" 1)
   ("traditional luciferase" 1) ("Luciferases" 1) ("DUAL-luciferase" 1)
   ("dual Gaussia luciferase" 1) ("a lentiviral firefly luciferase" 1)
   ("LUCIFERASE" 1) ("PPRE driven luciferase" 1)
   ("mouse GST-ARE-dependent firefly luciferase" 1) ("Additionally LCC6 luc" 1)
   ("the internal control luciferase" 1)
   ("the cyclin promoter-specific driven luciferase" 1)
   ("subsequently produced less luciferase" 1)
   ("luciferase (AACUUACGCUGAGUACUUCGA)" 1)
   ("Brazilian C. distinctus luciferase" 1)
   ("all homologous and heterologous click beetle luciferase" 1)
   ("The optimal luciferase" 1) ("Co-transfected Renilla luciferase" 1)
   ("using homemade dual luciferase" 1) ("than HRE-luc ( xref )" 1)
   ("a dicistronic Renilla luciferase (RL)" 1) ("chimeric luciferase" 1)
   ("only firefly luciferase" 1) ("using pGL3 basic luciferase" 1)
   ("using TRE-driven luciferase" 1) ("–luc" 1) ("luciferase (CTR)" 1)
   ("only NF-κB luciferase" 1) ("STAT3-driven luciferase" 1)
   ("functional luciferase" 1)))
 ("UP:P08670"
  (("vimentin" 2838) ("Vimentin" 599) ("Vim" 244) ("VIM" 189)
   ("the mesenchymal marker vimentin" 29) ("soluble vimentin" 15) ("Vim-" 10)
   ("VIMENTIN" 9) ("the mesenchymal marker Vimentin" 8)
   ("mesenchymal marker vimentin" 7) ("vim" 6) ("vimentin protein" 5)
   ("mesenchymal marker Vimentin" 5) ("the mesenchymal markers vimentin" 5)
   ("the mesenchymal protein vimentin" 5) ("insoluble vimentin" 4)
   ("Soluble Vimentin" 4) ("vimentin (VIM)" 4)
   ("the EMT signature mesenchymal marker protein vimentin" 4)
   ("overexpressed vimentin" 4) ("the mesenchymal adhesion protein vimentin" 3)
   ("vimentin ( VIM )" 3) ("Vimentin (VIM)" 3)
   ("mesenchymal intermediate filament vimentin" 2)
   ("very little soluble vimentin" 2)
   ("the mesenchymal and neural marker Vimentin" 2) ("Vimentin ( VIM )" 2)
   ("mouse monoclonal vimentin" 2) ("-VIM" 2)
   ("the signature mesenchymal protein vimentin" 2) ("strong human vimentin" 2)
   ("commercially available recombinant human Vim" 2) ("Vim protein" 2)
   ("less vimentin" 2) ("mCherry fluorescent protein–fused vimentin" 2)
   ("mesenchymal cell marker Vimentin" 2) ("expressing vimentin" 2)
   ("endothelial vimentin" 1) ("the intermediary filament protein vimentin" 1)
   ("the intermediary filament vimentin" 1) ("mesenchymal markers VIM" 1)
   ("increased soluble vimentin" 1) ("almost no detectable soluble vimentin" 1)
   ("the mesenchymal-specific marker vimentin" 1) ("mesenchymal vimentin" 1)
   ("VIM (vimentin) protein" 1) ("p-vimentin" 1)
   ("cytoplasmic mesenchymal marker vimentin" 1)
   ("the mesenchymal marker VIM" 1) ("the mesenchymal proteins vimentin" 1)
   ("mesenchyme-associated vimentin" 1)
   ("the signature EMT phenotypic marker vimentin" 1)
   ("The mesenchymal marker vimentin" 1) ("intact vimentin" 1)
   ("The phosphomimetic Vim" 1) ("the unphosphorylatable mutated Vim S39A" 1)
   ("previously shown( xref ) WT Vim" 1) ("no soluble vimentin" 1)
   ("Soluble vimentin" 1) ("filamentous vimentin" 1) ("VIM−" 1)
   ("Plk1-treated vimentin" 1) ("some Plk1-treated vimentin" 1)
   ("mesenchymal marker protein Vimentin" 1) ("vim−" 1) ("vimentin-" 1)))
 ("UP:P08678" (("CYR1" 10)))
 ("UP:P08684"
  (("CYP3A4" 83) ("CYP3A" 24) ("cytochrome P450 3A4" 5) ("Cyp3a4" 2)
   ("CYP3A4 protein" 2)))
 ("UP:P08686" (("subfamily A" 15) ("CYP21A2" 6) ("CYP21" 1)))
 ("UP:P08688" (("PA2" 31)))
 ("UP:P08697" (("SERPINF2" 3) ("alpha2-antiplasmin" 1) ("PLI" 1)))
 ("UP:P08700"
  (("IL-3" 1115) ("interleukin-3" 109) ("IL3" 89)
   ("hematopoietic growth factor" 24) ("Interleukin-3" 21) ("interleukin 3" 20)
   ("IL-3–" 4) ("Interleukin 3" 3) ("exogenous IL-3" 2) ("Il-3" 2)
   ("exogenous Interleukin 3" 2) ("hematopoietic growth  factor" 1)
   ("supplemental IL-3" 1) ("soluble IL-3" 1) ("IL-3-" 1)))
 ("UP:P08707"
  (("CI" 16020) ("Ci" 98) ("pCI" 54) ("CI-" 3) ("95% CI’s" 3) ("soluble CI" 3)
   ("a protective CI" 2) ("exact CI" 2) ("wider CI" 2) ("acute CI" 2)
   ("exact 95% CI" 2) ("a one-sided 95% CI" 1) ("its 95% CI using Woolf's" 1)
   ("A functional CI" 1) ("respective 95% CI" 1)
   ("than the GFP siRNA's CI (0.5)" 1)
   ("an exact Blyth-Still-Casella 95% CI" 1) ("the 95% exact CI" 1)
   ("the upper CI" 1) ("a relatively wide 95% CI" 1)))
 ("UP:P08708" (("S17" 75) ("RPS17" 12)))
 ("UP:P08709" (("factor VII" 63) ("SPCA" 18) ("Factor VII" 8)))
 ("UP:P08711" (("B Protein" 1))) ("UP:P08724" (("pBR1" 6) ("BR1" 6)))
 ("UP:P08725" (("BR2" 9)))
 ("UP:P08727"
  (("K19" 222) ("cytokeratins" 179) ("CK19" 156) ("KRT19" 39)
   ("cytokeratin 19" 37) ("CK 19" 27) ("CK-19" 17) ("cytokeratin-19" 15)
   ("keratin 19" 11) ("Keratin 19" 8) ("Cytokeratin 19" 7) ("Cytokeratins" 6)
   ("Ck19" 6) ("Krt19" 5) ("keratin-19" 5) ("myoepithelial cytokeratins" 4)
   ("DEDD-associated cytokeratins" 2) ("cytokeratins (CK)" 2)
   ("Cytokeratin-19" 2) ("than CK19 in epithelial cells" 1)
   ("than CK19 (CD3/CD19 500×, CD16 40,000×, CD14 300×)" 1)
   ("primitive cytokeratins" 1)))
 ("UP:P08729"
  (("CK7" 77) ("SCL" 37) ("cytokeratin 7" 31) ("KRT7" 15) ("Krt7" 13)
   ("scL" 10) ("CK-7" 10) ("keratin 7" 4) ("CK7−" 4) ("Cytokeratin 7" 3)
   ("SCL-" 2) ("the primary monoclonal antibodies (DAKO, Glostrup) CK7" 2)
   ("weak patchy CK7" 1) ("highly clonogenic Krt7" 1) ("“scL”" 1)
   ("absent CK7" 1) ("biliary membrane marker CK7" 1)))
 ("UP:P08754" (("GNAI3" 2)))
 ("UP:P08758"
  (("Annexin V" 2502) ("annexin V" 1052) ("Annexin-V" 406) ("AnnexinV" 319)
   ("annexin-V" 162) ("annexinV" 79) ("BD" 51) ("ANXA5" 17) ("Annexin V-" 12)
   ("annexin V-" 7) ("-annexin V" 4) ("Annexin-5" 4) ("-Annexin V" 3)
   ("Alexa Fluor 488-conjugated annexin V protein" 3)
   ("0.5% Alexa 594–conjugated annexin V" 2)
   ("imatinib showed increased Annexin V" 2) ("annexin v" 2) ("−Annexin-V" 2)
   ("Alexa-Fluor 488-conjugated Annexin-V" 2) ("Annexin–V" 2)
   ("AlexaFluor 488-conjugated annexin V" 2) ("annexin-5" 2) ("AnnexinV-" 2)
   ("Annexin V+/PI−" 2) ("Alex Fluor 647-conjugated Annexin V" 2)
   ("sixfold less Annexin V" 2) ("Annexin-V-" 1)
   ("Alexa 594–conjugated annexin V" 1)
   ("Alexa Fluor-488-conjugated Annexin V" 1)
   ("the lipophilic dye Annexin V" 1) ("Annexin v" 1) ("-Annexin-V" 1)
   ("annexin V protein" 1) ("Annexin V (BD)" 1) ("Anxa5" 1)
   ("Pacific blue Annexin V" 1) ("Alexa Fluor 488-conjugated annexin V" 1)
   ("an optical Annexin-V" 1) ("neglectable annexin V" 1) ("annexin 5" 1)
   ("AnnexinV+PI-" 1) ("Percent annexin V" 1) ("Annexin V (FITC)" 1)
   ("a fluorescent dye-conjugated annexin V" 1)))
 ("UP:P08763" (("Mod" 23) ("mod" 17) ("-mod" 2) ("mOD" 2)))
 ("UP:P08767" (("F protein" 24) ("infective F protein" 2)))
 ("UP:P08779"
  (("K16" 141) ("KRT16" 12) ("keratin 16" 3) ("nucleosomal H4 K16" 2)
   ("k16" 1)))
 ("UP:P08798" (("pSV" 263) ("pSV-" 16) ("PsV" 4) ("psV" 3)))
 ("UP:P08799" (("myosin II heavy chain" 5))) ("UP:P08815" (("NTX" 18)))
 ("UP:P08833"
  (("IGFBP1" 107) ("IGFBP-1" 36)
   ("insulin-like growth factor-binding protein-1" 6) ("Igfbp1" 4)
   ("IGFBP 1" 2) ("IGF binding protein 1" 2)
   ("Insulin-like growth factor-binding protein 1" 2)
   ("IGF binding protein-1" 1) ("igfbp-1" 1)))
 ("UP:P08842"
  (("STS" 937) ("STSs" 105) ("P-STS" 6) ("steroid sulfatase" 6) ("STS-" 3)
   ("sequential childhood STS" 2) ("non-metastasizing STSs" 2) ("Most STSs" 1)
   ("malignant STS" 1) ("genetically complex STS" 1)
   ("PTEN-positive and PTEN-negative STSs" 1)
   ("undifferentiated pleomorphic STS" 1) ("metastatic STS" 1)))
 ("UP:P08865"
  (("37LRP" 36) ("laminin receptor" 27) ("laminin receptor 1" 2)
   ("bacterial recombinant 37LRP" 2) ("RPSA" 1) ("laminin receptor 1 (RSSA)" 1)
   ("this major laminin receptor" 1) ("LAMR1" 1)
   ("His-tag-fused recombinant 37LRP" 1)))
 ("UP:P08882"
  (("B10" 122) ("b10" 2) ("an allogeneic LC B10" 1) ("syngeneic B10" 1)))
 ("UP:P08887"
  (("IL-6R" 277) ("IL-6Rα" 100) ("IL6R" 83) ("IL6Rα" 11) ("gp80" 11)
   ("IL-6RA" 11) ("IL6 receptor" 8) ("CD126" 5) ("IL6-R" 4) ("soluble IL-6R" 4)
   ("IL6-Rα" 3) ("The soluble IL-6Rα" 2) ("soluble IL6 receptor" 2)
   ("IL-6Ra" 2) ("Il6r" 2) ("Interleukin 6 Receptor" 2)
   ("interleukin 6 receptor" 2) ("soluble IL-6Rα" 2) ("the soluble IL-6R" 2)
   ("the soluble receptor (s) IL-6Rα" 1) ("Il6ra" 1)))
 ("UP:P08908" (("5-HT 1A" 22) ("5-HT1A receptor" 3) ("5-HT1A" 3) ("HTR1A" 1)))
 ("UP:P08912" (("CHRM5" 3))) ("UP:P08913" (("ADRA2A" 23)))
 ("UP:P08922"
  (("ROS" 13362) ("ROS1" 1289) ("Ros" 181) ("cellular ROS" 54) ("ROS-" 25)
   ("ROS1 protein" 24) ("exogenous ROS" 14) ("c-ros oncogene 1" 13)
   ("c-ros" 10) ("excessive ROS" 10) ("ROS1-" 7) ("ROS protein" 6)
   ("more ROS" 4) ("targeting ROS" 4) ("the cellular ROS" 4) ("Ros1" 4)
   ("harmful ROS" 4) ("c-Ros" 3) ("lower intracellular ROS" 3) ("acute ROS" 3)
   ("less ROS" 3) ("peroxisomal ROS" 3) ("Cellular ROS" 2) ("maximal ROS" 2)
   ("the stress-induced intracellular ROS" 2) ("total cellular ROS" 2)
   ("selectively increases ROS" 2) ("We first measured mitochondrial ROS" 2)
   ("Excessive ROS" 2) ("dark-adapted ROS" 2)
   ("more specific or more potent ROS1" 2) ("C-ros oncogene 1" 2)
   ("receptor tyrosine kinase c-ros oncogene 1" 2)
   ("specifically target ROS1 protein" 2) ("α-LA-induced ROS" 2)
   ("the excessive ROS" 2) ("Peroxisomal ROS" 2) ("toxic ROS" 2)
   ("the toxic ROS" 2) ("the dark-adapted ROS" 2) ("a highly reactive ROS" 2)
   ("electron transport chain-generated ROS" 2) ("basal ROS" 2)
   ("significantly more ROS" 2) ("intra-cellular ROS" 2)
   ("these publications identified increased cellular ROS" 2)
   ("BCR and CD40 signaling further increase ROS" 2) ("c-ROS" 2)
   ("Exogenous ROS" 1) ("chronic elevated cellular ROS" 1)
   ("in turn increases ROS" 1) ("extra-cellular ROS" 1) ("subtle ROS" 1)
   ("androgen-induced cellular ROS" 1) ("than cytosolic ROS" 1)
   ("the major ROS" 1) ("more toxic ROS" 1) ("mitochondrial-derived ROS" 1)
   ("These mitochondrial-derived ROS" 1) ("25%–55% more ROS" 1)
   ("the basal ROS" 1)
   ("KSHV-infected HMVEC-d cells produced 2–3-fold more ROS" 1)
   ("increased basal ROS" 1) ("The Influenza A virus induced ROS" 1)
   ("residual ROS" 1) ("ROS (LROS)" 1) ("a reciprocal ROS" 1)
   ("both exogenous and endogenous ROS" 1) ("RoS1" 1) ("the harmful ROS" 1)
   ("CRC cells produced more ROS" 1) ("most ROS" 1) ("elevated cellular ROS" 1)
   ("increased cellular ROS" 1) ("Both exogenous and endogenous ROS" 1)
   ("microvascular ROS" 1) ("a major ROS" 1) ("more cellular ROS" 1)
   ("confocal ROS" 1) ("distinct ROS" 1) ("detrimental ROS" 1)
   ("detachment-induced ROS" 1) ("a relatively long-lived ROS" 1)
   ("intercellular ROS" 1) ("ROS (DHR)" 1) ("cellular and mitochondrial ROS" 1)
   ("a prototypical ROS" 1) ("injurious ROS" 1)
   ("HC-fed WT mice produced ~25% more ROS" 1)
   ("many different cellular ROS" 1)
   ("The principal biologically-produced free radical ROS" 1)
   ("the carboxyl terminal 466 amino acids of ROS" 1)
   ("the carboxyl terminal 421 amino acids of ROS" 1)
   ("antimycin A induced ROS" 1) ("than the TNF-induced ROS" 1)
   ("cell adhesion increased ROS" 1) ("particular ROS" 1)
   ("the dominant ROS" 1) ("aberrant ROS" 1) ("radiation-induced ROS" 1)
   ("Further increased ROS" 1) ("Our previous research identified ROS" 1)
   ("mitchondrial ROS" 1) ("renal ROS" 1) ("SIRT3 decreased ROS" 1)
   ("produced less ROS" 1) ("other cellular ROS" 1)))
 ("UP:P08962"
  (("CD63" 275) ("Lysosomal-associated membrane protein 3" 2)
   ("the late endosomal marker CD63" 2) ("CD63 protein" 2)
   ("the late endosomal maker protein CD63" 2) ("the exosomal markers CD63" 2)
   ("CD63-" 1) ("granulophysin" 1) ("-CD63" 1) ("exogenous CD63 protein" 1)
   ("the late endosomal/lysosomal marker CD63" 1)
   ("lysosomal-associated marker CD63" 1) ("LAMP-3" 1)))
 ("UP:P08986" (("IMM" 45))) ("UP:P08993" (("H2B1" 10)))
 ("UP:P08997" (("mSA" 8)))
 ("UP:P08F94"
  (("PKD3" 247) ("fibrocystin" 16) ("Pkhd1" 9) ("PKHD1" 1)
   ("the cystic kidney disease gene Pkhd1" 1)))
 ("UP:P09005" (("Spi2.1" 4)))
 ("UP:P09012" (("U1A" 13) ("MUD1" 5) ("SNRPA" 2) ("Mud1" 1)))
 ("UP:P09016" (("HOXD4" 2))) ("UP:P09017" (("HOXC4" 1) ("Hoxc4" 1)))
 ("UP:P09038"
  (("FGF2" 1496) ("bFGF" 1177) ("FGF-2" 648)
   ("basic fibroblast growth factor" 349) ("b-FGF" 82) ("fgf2" 60)
   ("fibroblast growth factor 2" 54) ("fibroblast growth factor-2" 28)
   ("Fgf2" 19) ("fgf-2" 12)
   ("basic fibroblast
growth factor"
    9)
   ("Basic fibroblast growth factor" 7) ("FGFb" 5) ("bFgf" 4)
   ("exogenous FGF-2" 3) ("exogenous FGF2" 2) ("PDAC described FGF2" 2)
   ("both exogenous FGF2" 2) ("FGF2-" 2) ("FGF2 protein" 2)
   ("basic fibroblast growth factor-" 2) ("−FGF2" 2) ("-FGF2" 1)
   ("exogenous bFGF" 1) ("underwent bFGF" 1)
   ("than LMW FGF2 (Dunham-Ems et al , xref )" 1) ("intranuclear FGF2" 1)
   ("than FGF2" 1) ("particular FGF2" 1) ("its primary FGF2" 1)
   ("Significantly less bFGF" 1)
   ("the basic FGF (bFGF) alternatively named FGF2" 1) ("particular FGF-2" 1)
   ("SU5402 indicated FGF2" 1)))
 ("UP:P09067" (("HOXB5" 6) ("Hoxb5" 5) ("HoxB5" 1))) ("UP:P09081" (("PRD4" 1)))
 ("UP:P09086" (("Oct-2" 22) ("POU2F2" 3)))
 ("UP:P09089" (("ZEN" 77) ("Zen" 57) ("zen" 1)))
 ("UP:P09104"
  (("NSE" 69) ("ENO2" 47) ("neuron-specific enolase" 24) ("neuronal)" 14)
   ("neuron specific enolase" 8) ("enolase 2" 5) ("Enolase 2" 2)
   ("neuron-specific enolase (NSE)" 2) ("enolase 2 (gamma" 2)
   ("than matched NSE" 1) ("Neuronal)" 1) ("Eno2" 1)))
 ("UP:P09110" (("ACAA" 5) ("-ACAA" 2) ("ACAA1" 1))) ("UP:P09111" (("hdcB" 9)))
 ("UP:P09131" (("SLC10A3" 1))) ("UP:P09132" (("SRP19" 5)))
 ("UP:P09155" (("Rnd" 109) ("RnD" 6) ("RND" 3))) ("UP:P09169" (("ompT" 1)))
 ("UP:P09172"
  (("DBH" 151) ("DBM" 11) ("Dbh" 4)
   ("dopamine beta-hydroxylase (dopamine beta-monooxygenase)" 2)
   ("Dopamine Beta-Hydroxylase" 2) ("dopamine beta-hydroxylase" 1)
   ("Dopamine-Beta-Hydroxylase" 1)))
 ("UP:P09184" (("Vsr" 1))) ("UP:P09208" (("dINR" 4) ("INRA" 3) ("dInR" 2)))
 ("UP:P09210"
  (("GSTA2" 12) ("Gsta2" 2) ("glutathione S-transferase alpha 2" 1)))
 ("UP:P09211"
  (("GSTP1" 577) ("GSTp" 145) ("GSTP1-1" 49) ("GSTP1-" 20) ("GSTP" 15)
   ("GST-P" 7) ("glutathione S-transferase pi 1" 4)
   ("Glutathione S-transferase P" 4) ("Gstp1" 3) ("GST3" 2) ("GSTp protein" 2)
   ("glutathione S-transferase Pi 1" 1)))
 ("UP:P09228" (("cst2" 1) ("Cystatin SA" 1))) ("UP:P09229" (("OCI" 44)))
 ("UP:P09232" (("P-Rb" 26) ("P–Rb" 5) ("P-RB" 3) ("P-Rb protein" 2)))
 ("UP:P09234" (("SNRPC" 3)))
 ("UP:P09237"
  (("MMP-7" 954) ("MMP7" 822) ("matrilysin" 46)
   ("matrix metalloproteinase-7" 15) ("MMP7 protein" 13)
   ("matrix metalloproteinase 7" 11) ("Mmp7" 10) ("pMMP-7" 9)
   ("Matrix metalloproteinase 7" 5) ("MMP-7 protein" 5)
   ("Matrix metalloproteinase-7" 4) ("WP transcriptional targets MMP7" 2)
   ("Matrilysin" 2) ("significantly less MMP7" 2) ("than MMP7" 1) ("matrin" 1)
   ("Matrix Metalloproteinase 7" 1)))
 ("UP:P09238"
  (("MMP-10" 153) ("MMP10" 107) ("SL2" 23) ("matrix metalloproteinase 10" 14)
   ("stromelysin 2" 5) ("MMP 10" 3) ("exogenous MMP-10" 2) ("MMP-10 protein" 2)
   ("than MMP-10" 1) ("Sts2" 1) ("stromelysin-2" 1)))
 ("UP:P09255" (("IE63" 5)))
 ("UP:P09267"
  (("epithelial membrane protein-2" 5)
   ("lysosome-associated membrane protein-2" 3) ("membrane protein-2" 3)))
 ("UP:P09285"
  (("cAMP-regulated neuronal phosphoprotein 32" 1) ("phosphoprotein 32" 1)))
 ("UP:P09310" (("IE62" 2)))
 ("UP:P09326"
  (("CD48" 93) ("BCM1" 23) ("Blast 1" 10) ("CD4/8" 2)
   ("the micrometastatic cell line BCM1" 1)))
 ("UP:P09327" (("Villin 1" 2)))
 ("UP:P09341"
  (("CXCL1" 377) ("GRO" 55) ("Cxcl1" 43) ("Gro" 22) ("MGSA" 13) ("Gro1" 9)
   ("GRO-1" 5) ("GRO1" 5) ("more total CXCL1 protein" 2) ("CXCL1 protein" 2)
   ("GROa" 2) ("the chemotactic cytokine CXCL1" 2) ("CXCL1 (KC)" 2)
   ("the viral CXCL1" 1) ("cxcl1" 1) ("than CXCL1" 1)
   ("than the neutrophil chemoattractant CXCL1 ( xref ; xref )" 1) ("pGRO" 1)
   ("GRO peptide" 1) ("Cxcl1 (KC)" 1)))
 ("UP:P09346" (("KP" 160) ("than KP (1.762 ± 17.187)" 1)))
 ("UP:P09382"
  (("Gal-1" 387) ("gal-1" 123) ("HPL" 99) ("HBL" 79) ("GAL1" 65)
   ("galectin-1" 35) ("LGALS1" 32) ("Galectin-1" 22) ("pLGALS1" 12) ("hPL" 12)
   ("Gal1" 6) ("intrinsic Gal-1" 3) ("GAL-1" 2) ("galectin1" 2)
   ("exogenous Gal-1" 1) ("HIF-1 directly targets Gal-1" 1)
   ("Functional gal-1" 1) ("gal1" 1) ("GAL1-" 1)))
 ("UP:P09415" (("BL22" 1)))
 ("UP:P09417"
  (("QDPR" 3) ("dihydropteridine reductase" 2)
   ("quinoid dihydropteridine reductase (QDPR)" 2)
   ("quinoid dihydropteridine reductase" 2)))
 ("UP:P09426"
  (("histone H1" 474) ("Histone H1" 107) ("Histone H1 (NEB)" 2)
   ("larger protein Histone H1" 2) ("exogenous histone H1" 1)
   ("fluorescent Histone H1 protein" 1) ("Histone H1 protein" 1)
   ("-Histone H1" 1) ("The repressive histone H1" 1)))
 ("UP:P09429"
  (("HMGB1" 1665) ("HMGB-1" 84) ("HMGB1 protein" 21)
   ("high mobility group box 1" 17) ("High mobility group box 1" 12)
   ("HMGB1-" 4) ("high mobility group box 1 protein" 4)
   ("high mobility group protein B1" 4) ("HMGB1 peptide" 4) ("HMG1" 3)
   ("HMGB-1 protein" 3) ("high mobility group box 1 (HMGB1) protein" 2)
   ("conditional knockout HMGB1" 2) ("High mobility group box 1 protein" 2)
   ("HMG-1" 2) ("Hmg1" 2) ("exogenous HMGB1" 2)
   ("significantly greater overall total HMGB1" 2) ("more HMGB1" 2)
   ("HMGB1 secreted very little HMGB1" 2) ("robust nuclear HMGB1" 2)
   ("barely detectable nuclear HMGB1" 2) ("Tumor cells exploit HMGB1's" 1)
   ("-HMGB1" 1) ("than the full-length HMGB1" 1) ("functional HMGB1" 1)
   ("amino acids of HMGB1" 1) ("“cyt-HMGB1”" 1)
   ("p53 −/− HCT116 cells rapidly increase cytosolic HMGB1" 1)
   ("very little HMGB1" 1) ("LMB-treated cells retained nuclear HMGB1" 1)
   ("cells showed prominent nuclear HMGB1" 1)
   ("average significantly more HMGB1" 1)))
 ("UP:P09430" (("TP1" 11))) ("UP:P09435" (("Ssa3" 1)))
 ("UP:P09455" (("CRBP1" 15) ("CRBP" 2) ("cellular retinol binding protein" 1)))
 ("UP:P09466"
  (("PEG" 579) ("GD" 227) ("gD" 185) ("Gd" 57) ("GDF" 12) ("GDFs" 6)
   ("viral gD" 6) ("The soluble HSV-1 gD" 3) ("the soluble gD" 2) ("PAEP" 2)
   ("PEGs" 2) ("This heterobifunctional PEG" 1) ("10% DMSO/90% PEG400" 1)
   ("10% (v/v) PEG8000" 1) ("6% (v/v) PEG4000" 1) ("a few GD" 1)
   ("glycodelin" 1)))
 ("UP:P09467"
  (("FBP1" 102) ("fructose-1,6-bisphosphate" 8)
   ("Fructose-1,6-bisphosphatase 1" 2) ("fructose-1,6-bisphosphatase 1" 2)
   ("Fbp1" 1)))
 ("UP:P09471" (("GNAO1" 2) ("Gαo" 1)))
 ("UP:P09486"
  (("ON" 1268) ("SPARC" 220) ("osteonectin" 13) ("Sparc" 8) ("‘ON’" 4)
   ("Osteonectin" 4) ("“ON”" 4)
   ("secreted protein acidic and rich in cysteine" 4) ("“TET-ON”" 2)
   ("BM-40" 1) ("P09486" 1) ("-ON" 1) ("a perpetual ON" 1)
   ("NAC reduced ON1910" 1)))
 ("UP:P09488"
  (("GSTM1" 168) ("Gstm1" 12) ("H-B" 5) ("GSTm1" 3)
   ("glutathione S-transferase M1" 2) ("GSTM1-" 1)))
 ("UP:P09491" (("TM2" 14)))
 ("UP:P09493" (("TPM1" 63) ("tpm1" 2) ("Tpm1" 1) ("tropomyosin-1" 1)))
 ("UP:P09496" (("clathrin light chain A" 5) ("LCa" 2)))
 ("UP:P09497" (("LCB" 5) ("CLTB" 4) ("light chain B" 1)))
 ("UP:P09525" (("Annexin IV" 2) ("protein II" 1) ("ANXA4" 1) ("Protein II" 1)))
 ("UP:P09529" (("INHBB" 37) ("Inhbb" 3) ("inhbb" 2)))
 ("UP:P09534" (("VG1" 6) ("Vg1" 2)))
 ("UP:P09543" (("CNP" 155) ("CNPase" 19) ("CNP-" 6)))
 ("UP:P09544"
  (("IRPs" 49) ("IRP" 36) ("Wnt2" 27) ("secreted growth factor" 19) ("WNT2" 9)
   ("Wnt-2" 5) ("a multifunctional secreted growth factor" 2) ("WNT-2" 1)))
 ("UP:P09564" (("CD7" 26) ("Cd7" 14) ("-Cd7" 1)))
 ("UP:P09598" (("phospholipase c" 5)))
 ("UP:P09599"
  (("SMase" 26) ("exogenous SMase" 17) ("sphingomyelinases" 9) ("SMases" 6)
   ("Smase" 3) ("the Mg 2+ -dependent neutral SMases" 2)
   ("Neutral sphingomyelinases" 2) ("Exogenous SMase" 2)
   ("the neutral (n)Smase" 1) ("bacterial SMase" 1) ("a bacterial SMase" 1)))
 ("UP:P09601"
  (("HO-1" 1824) ("HMOX1" 336) ("heme oxygenase-1" 167) ("HO" 136) ("Ho" 56)
   ("HO-1 protein" 46) ("Hmox1" 45) ("HO1" 41) ("HMOX-1" 32)
   ("hemeoxygenase-1" 20) ("Heme oxygenase-1" 20) ("Heme Oxygenase-1" 10)
   ("NRF2-associated MARE  HMOX1" 3) ("proangiogenic HO-1" 3)
   ("the well-studied NRF2 target gene HMOX1" 2) ("HO-1-" 2) ("ho-1" 2)
   ("heme oxygenase-1 protein" 2) ("immunoreactive HO-1" 2)
   ("BACH1-associated MARE  HMOX1" 1) ("particular HO-1" 1)
   ("the vasculoprotective enzyme HO-1" 1) ("further implicating HO-1" 1)
   ("HO-" 1) ("Ho-1" 1)))
 ("UP:P09603"
  (("M-CSF" 409) ("CSF1" 158) ("CSF-1" 149) ("MCSF" 29)
   ("macrophage colony-stimulating factor 1" 4) ("M-CSF-" 3) ("Csf1" 2)
   ("macrophage colony–stimulating factor 1" 2)
   ("exogenous or coexpressed CSF-1" 1) ("exogenous CSF-1" 1)))
 ("UP:P09615" (("Wingless" 56) ("wingless" 38) ("soluble wingless" 2)))
 ("UP:P09616" (("HLY" 16)))
 ("UP:P09619"
  (("PDGFRβ" 1840) ("PDGFR-β" 287) ("PDGFRB" 234) ("PDGFRb" 123)
   ("p-PDGFRβ" 50) ("Pdgfrβ" 17) ("pPDGFR-β" 16)
   ("platelet-derived growth factor receptor beta" 15) ("Pdgfrb" 12)
   ("PDGFR-b" 12) ("platelet derived growth factor receptor beta" 11)
   ("PDGFRbeta" 10) ("PDGFR-beta" 6) ("PDGF-Rβ" 6) ("p-PDGFR-β" 5)
   ("pPDGFRβ" 4) ("Stromal PDGFRβ" 4) ("Stromal and perivascular PDGFRβ" 4)
   ("Pdgfr-b" 3) ("non-malignant stromal PDGFRβ" 3) ("PDGFR-β-" 3)
   ("stromal PDGFRβ" 2) ("CD140b" 2) ("PDGFRβ protein" 2) ("vascular PDGFRβ" 2)
   ("functional PDGFRβ" 2) ("high stromal PDGFRβ" 2) ("Perivascular PDGFRβ" 2)
   ("more intense PDGFR-β" 2) ("intermediate or high PDGFR-β" 2)
   ("PDGFR-β protein" 2) ("Soluble PDGFRβ" 1) ("particular PDGFRβ" 1)
   ("higher stromal PDGFRβ" 1) ("49.9% less total PDGFRβ" 1)
   ("mature PDGFRβ" 1) ("potentially target PDGFR-β" 1)
   ("tumor stromal PDGFRβ" 1) ("PDGFR-b-" 1) ("-PDGFRβ" 1)
   ("platelet-derived growth factor
receptor beta"
    1)))
 ("UP:P09622" (("DLD" 14) ("dihydrolipoyl" 1)))
 ("UP:P09629"
  (("HOXB7" 530) ("homeobox B7" 6) ("HOXB7 protein" 5)
   ("overexpressed HOXB7" 2) ("HoxB7" 1) ("than HOXB7" 1)
   ("than wild type HOXB7 ( xref )" 1) ("than the wild type HOXB7" 1)))
 ("UP:P09630" (("Hoxc6" 10) ("HOXC6" 9)))
 ("UP:P09650" (("rMCP-1" 42) ("exogenous human rMCP-1" 1)))
 ("UP:P09651"
  (("hnRNPA1" 330) ("heterogeneous nuclear ribonucleoprotein A1" 10)
   ("HnRNPA1" 8) ("HNRNPA1" 6) ("Heterogeneous nuclear ribonucleoprotein A1" 2)
   ("Hnrnpa1" 2) ("hnRNPA1 protein" 2) ("P09651" 1)
   ("the phospho-mimetic hnRNPA1" 1) ("most cellular hnRNPA1" 1)
   ("at least 20 members termed hnRNPA1" 1)))
 ("UP:P09661" (("SNRPA1" 1)))
 ("UP:P09668"
  (("CTSH" 9) ("cathepsin H" 6) ("cathepsin H (CTSH)" 1) ("ACC5" 1)
   ("Cathepsin H" 1)))
 ("UP:P09669" (("COX6C" 1) ("Cox6c" 1)))
 ("UP:P09681"
  (("GIP" 26) ("glucose-dependent insulinotropic polypeptide" 3)
   ("Glucose-dependent insulinotropic polypeptide" 1)
   ("glucose-dependent insulinotropic polypeptide (GIP)" 1)))
 ("UP:P09683" (("SCT" 56) ("pSCT" 4) ("secretin" 3)))
 ("UP:P09693" (("CD3G" 1)))
 ("UP:P09758" (("Trop-2" 115) ("TROP2" 4) ("TACSTD2" 3) ("that Trop-2's" 1)))
 ("UP:P09769"
  (("neutrophils" 3057) ("Fgr" 172) ("Neutrophils" 145) ("FGR" 30)
   ("apoptotic neutrophils" 29) ("primary neutrophils" 20) ("SRC2" 11)
   ("fgr" 9) ("GC-MSCs-primed neutrophils" 7)
   ("CalDAG-GEFI–null neutrophils" 6) ("pre-apoptotic neutrophils" 6)
   ("normal neutrophils" 5) ("chemotactic neutrophils" 3)
   ("intact neutrophils" 3) ("more neutrophils" 3)
   ("the adherent neutrophils" 3) ("adherent human neutrophils" 3)
   ("adiponectin-treated neutrophils" 2) ("Apoptotic neutrophils" 2)
   ("Primary neutrophils" 2) ("human primary neutrophils" 2)
   ("UV-irradiated neutrophils" 2) ("GC-MSCs-activated neutrophils" 2)
   ("pro-tumoural neutrophils" 2)
   ("only Ly6G + tumour-associated neutrophils" 2)
   ("MMP-9–positive neutrophils" 2) ("inflammatory neutrophils" 2)
   ("Rac2-T17N treated neutrophils" 2) ("Rac1-T17N treated neutrophils" 2)
   ("Rac1-T17N-treated neutrophils" 2) ("than neutrophils" 2)
   ("Peripheral Blood Neutrophils" 2) ("tumor-associated neutrophils" 2)
   ("patient CalDAG-GEFI–null neutrophils" 2)
   ("SH in-vitro treated neutrophils" 2) ("Such apoptotic neutrophils" 2)
   ("synovial fluid neutrophils" 2)
   ("biopsies showed sparse infiltrating neutrophils" 1)
   ("D57N-expressing Rac2 neutrophils" 1)
   ("intact COX-2-expressing neutrophils" 1) ("COX-2-expressing neutrophils" 1)
   ("peritoneal neutrophils" 1) ("Peritoneal neutrophils" 1)
   ("human blood primary neutrophils" 1) ("lysed primary neutrophils" 1)
   ("negligible and activated Fgr" 1)
   ("UV-irradiated apoptotic and aged apoptotic human neutrophils" 1)
   ("residual neutrophils" 1) ("naive bone marrow neutrophils (NN)" 1)
   ("neutrophils (NN)" 1) ("tumor-associated neutrophils (TAN)" 1)
   ("treated neutrophils" 1) ("neutrophils (MPO)" 1)
   ("previously unpolarized neutrophils" 1) (">98% viable neutrophils" 1)
   ("neutrophils (PMN)" 1)
   ("mice showed increased parenchymal lung neutrophils" 1)
   ("identified triple-positive MET expressing neutrophils" 1)
   ("apoptotic or dead neutrophils" 1) ("naive neutrophils" 1)
   ("primary tumor-attracted inflammatory neutrophils" 1)
   ("Tumor-associated neutrophils" 1) ("senescent neutrophils" 1)
   ("treated primary human neutrophils" 1)
   ("Rac1 conditional knock-out mouse neutrophils" 1)
   ("resting adherent neutrophils" 1)
   ("the Rac2-T17N-pretreated neutrophils" 1)
   ("control GFP-Tat-pretreated neutrophils" 1) ("adherent neutrophils" 1)
   ("Maternal circulating neutrophils" 1)
   ("pulmonary and bronchoalveolar lavage neutrophils" 1)
   ("than wild-type neutrophils ( xref )" 1)
   ("previously activated neutrophils" 1)
   ("FITC-conjugated carboxyp21 peptide–treated neutrophils" 1)
   ("peripheral neutrophils" 1) ("granulocytic neutrophils" 1)
   ("than 1×10 9 /L neutrophils" 1) ("systemic inflammation neutrophils" 1)
   ("FITC-positive neutrophils" 1) ("colonic pSTAT3+ and CXCR2+ neutrophils" 1)
   ("septic neutrophils" 1) ("healthy neutrophils" 1)
   ("LAD-derived CalDAG-GEFI–null neutrophils" 1)
   ("nearly all normal neutrophils" 1) ("CalDAG- GEFI–null neutrophils" 1)
   ("The LAD-derived CalDAG-GEFI–null neutrophils" 1)
   ("the intra-tumoral neutrophils" 1) ("a few neutrophils" 1)
   ("gelsolin null neutrophils" 1) ("normoxic neutrophils" 1)
   ("SH treated neutrophils" 1) ("The pre-apoptotic neutrophils" 1)
   ("The apoptotic neutrophils" 1)
   ("confocal microscopy apoptotic neutrophils" 1)
   ("At least 50 pre-apoptotic neutrophils" 1) ("Viable neutrophils" 1)))
 ("UP:P09837"
  (("WAP" 158) ("whey acidic protein" 14) ("whey acidic protein (WAP)" 1)))
 ("UP:P09848" (("LCT" 16))) ("UP:P09852" (("ToxR" 4)))
 ("UP:P09871" (("C1S" 5)))
 ("UP:P09874"
  (("PARP-1" 6844) ("PARP1" 3299) ("ARTD1" 367) ("PARP-1 protein" 120)
   ("Parp1" 60) ("PARP1 protein" 40) ("Parp-1" 26) ("ADPRT" 19)
   ("ARTD1 peptide" 12) ("ADP-ribosyltransferase diphtheria toxin-like 1" 11)
   ("PARP 1" 11) ("Poly [ADP-ribose] polymerase 1" 9) ("nucleolar PARP-1" 6)
   ("PARP-1 Molecule" 6) ("-PARP-1" 5) ("More PARP-1" 4)
   ("overexpressed PARP-1" 4) ("Stable lentiviral PARP1" 4) ("parp1" 4)
   ("-PARP1" 3) ("ARTD1 protein" 3) ("overexpressed mouse ARTD1" 3)
   ("PARP1-" 3) ("PARP-1 protein (Biomol)" 3) ("more PARP-1" 3)
   ("more PARP1" 3) ("PARP-1 molecule" 3) ("SUMO-2/3-modified PARP-1" 2)
   ("the region around PARP1" 2) ("TAC-treated hearts showed PARP1" 2)
   ("less PARP1" 2) ("Finally PARP-1 or mutant PARP-1" 2)
   ("nearly full-length PARP-1" 2) ("highly pure full-length PARP-1" 2)
   ("functional PARP-1" 2) ("Intense nuclear PARP1" 2) ("Nucleolar PARP-1" 1)
   ("that PARP-1's" 1) ("ARTD1−" 1) ("Interestingly PARP1 Val762Ala" 1)
   ("PARP-1–" 1) ("than the core PARP-1 protein ( xref , lane 1)" 1)
   ("than PARP-1" 1) ("mitochondrial-specific PARP1" 1)
   ("intra-mitochondrial PARP1" 1) ("intact PARP-1" 1) ("Most PARP-1" 1)
   ("Previously parylated PARP-1" 1) ("previously un-parylated PARP-1" 1)
   ("PARP1 which is mediated by CHFR's" 1) ("microglial PARP-1" 1)
   ("The chromatin-associated enzyme PARP1" 1) ("given PARP-1" 1) ("P-Pol" 1)
   ("PARP-1 (BD)" 1) ("exogenous PARP-1" 1) ("auto-PARylated PARP1" 1)
   ("than full-length PARP-1 ( xref )" 1)
   ("at least one free DNA end activated PARP-1" 1)
   ("These findings directly link PARP1" 1) ("DDB2-associated PARP1" 1)))
 ("UP:P09877" (("GPF" 10) ("gpf" 1)))
 ("UP:P09884"
  (("malformations" 306) ("congenital malformations" 26)
   ("vascular malformations" 20) ("skeletal malformations" 7)
   ("cortical malformations" 7) ("cerebral cavernous malformations" 5)
   ("POLA1" 4) ("craniofacial malformations" 4) ("capillary malformations" 4)
   ("cardiac and aortic arch malformations" 4)
   ("other major structural malformations" 3)
   ("inherited glomuvenous malformations" 3) ("Vascular malformations" 3)
   ("severe congenital malformations" 3) ("arteriovenous malformations" 3)
   ("severe malformations" 3) ("the cuticular malformations" 3)
   ("Malformations" 3) ("genital malformations" 3)
   ("polymerase (DNA directed)" 3) ("cardiac malformations" 2) ("POLA" 2)
   ("heterogeneous cardiac malformations" 2)
   ("life number five showed bilateral multicystic venous lymphatic malformations"
    2)
   ("bilateral multicystic malformations" 2)
   ("combined-type vascular malformations" 2)
   ("severe complex cortical malformations" 2)
   ("other vascular malformations" 2) ("Lymphatic malformations (LM)" 2)
   ("human arteriovenous malformations" 2)
   ("brain arteriovenous malformations" 2) ("human vascular malformations" 2)
   ("Cerebral cavernous malformations" 2) ("severe skeletal malformations" 2)
   ("embryonal malformations" 2) ("well-defined cardiac malformations" 2)
   ("Focal cortical malformations" 2) ("complex craniofacial malformations" 2)
   ("severe kidney malformations" 2) ("Congenital Malformations (ECLAMC)" 2)
   ("specific congenital malformations" 2) ("severe brain malformations" 2)
   ("had structural malformations" 2) ("The cardiac malformations" 2)
   ("the severe malformations" 1) ("additional severe malformations" 1)
   ("the ROCK1 gene and human cardiac malformations" 1)
   ("human cardiac malformations" 1) ("severe inner ear malformations" 1)
   ("focal malformations" 1) ("various congenital malformations" 1)
   ("venous malformations" 1) ("These urogenital malformations" 1)
   ("the underlying lymphovascular malformations" 1)
   ("these lymphovascular malformations" 1)
   ("vascular or lymphatic malformations" 1)
   ("severe lymphovascular malformations" 1) ("lymphovascular malformations" 1)
   ("fronto-centrally predominant malformations" 1)
   ("these complex cortical developmental malformations" 1)
   ("Complex cortical malformations" 1) ("PolA" 1)
   ("postnatal malformations" 1) ("head and neck lymphatic malformations" 1)
   ("Brain arteriovenous malformations" 1)
   ("Brain arteriovenous malformations (BAVM)" 1)
   ("eight surgically resected human brain arteriovenous malformations" 1)
   ("human and mutant mice vascular malformations" 1)
   ("capillary malformation–arteriovenous malformations" 1)
   ("severe mitochondrial ultrastructural malformations" 1)
   ("no clinically inapparent malformations" 1)
   ("congenital anatomic malformations" 1) ("some congenital malformations" 1)
   ("common congenital malformations" 1)
   ("fast-flow arteriovenous malformations (AVM)" 1)
   ("human cerebral cavernous malformations" 1) ("vertebral malformations" 1)
   ("urogenital malformations" 1)
   ("nonsyndromic focal cortical malformations" 1) ("Focal malformations" 1)
   ("similar skeletal malformations" 1) ("Skeletal malformations" 1)
   ("the vascular malformations" 1)
   ("capillary, venous, lymphatic, and arteriovenous malformations" 1)
   ("multiple congenital malformations" 1)
   ("significant congenital malformations" 1)
   ("anogenital and renal malformations" 1) ("biliary malformations" 1)
   ("associated malformations" 1) ("lacks vascular malformations" 1)
   ("The patchy skin vascular malformations" 1)
   ("only capillary vascular malformations" 1)
   ("cutaneous vascular malformations" 1)
   ("these two anatomical malformations" 1)
   ("capillary malformation-arterial venous malformations" 1)
   ("severe tracheal cartilage malformations" 1) ("fetal malformations" 1)))
 ("UP:P09912"
  (("IFI6" 177) ("6–16" 15) ("6-16" 3) ("IFI6 protein" 2) ("G1P3" 2)))
 ("UP:P09913" (("ISG54" 48) ("IFIT2" 17) ("Ifit2" 1) ("ISG-54" 1)))
 ("UP:P09914"
  (("IFIT1" 130) ("ISG56" 42) ("ifit1" 3) ("IFIT1 protein" 1)
   ("Interferon-induced protein with tetratricopeptide repeats 1" 1)
   ("tetratricopeptide repeats 1" 1)))
 ("UP:P09917"
  (("5LO" 82) ("ALOX5" 38) ("5-lipoxygenase" 22) ("Alox5" 19)
   ("5-Lipoxygenase" 8) ("arachidonate 5-lipoxygenase" 4) ("5-LO" 1)))
 ("UP:P09919"
  (("granulocyte colony-stimulating factor" 61) ("CSF3" 36)
   ("Granulocyte colony-stimulating factor" 11) ("GCSF" 9)
   ("granulocyte colony stimulating factor" 8)
   ("colony stimulating factor 3" 5) ("Csf3" 2)
   ("Granulocyte colony stimulating factor" 2) ("Filgrastim" 1)))
 ("UP:P09923"
  (("intestinal alkaline phosphatase" 45)
   ("intestinal alkaline phosphatase (CIP)" 3)
   ("intestinal alkaline phosphatase (CIAP)" 2)
   ("intestinal alkaline phosphatase (IAP)" 1)))
 ("UP:P09936"
  (("UCH-L1" 250) ("UCHL1" 140) ("Uchl1" 47) ("PGP9.5" 20) ("PGP 9.5" 6)
   ("UCH-L1 protein" 4) ("Ubiquitin C-terminal Hydrolase L1" 2) ("P09936" 1)
   ("much fewer Uchl1" 1) ("the neuronal marker PGP9.5" 1)))
 ("UP:P09950" (("CyD1" 4)))
 ("UP:P09958"
  (("pace" 141) ("Furin" 63) ("furin" 61) ("FUR" 53) ("fur" 45) ("FURIN" 5)
   ("an accelerated pace" 3) ("Pace" 3) ("faster pace" 2)
   ("a markedly accelerated pace" 1) ("its own pace" 1)
   ("faster pace than isogenic cells expressing" 1)))
 ("UP:P09959" (("MBF" 22) ("Swi6" 7)))
 ("UP:P09960" (("leukotriene A4 hydrolase" 4) ("LTA4H" 3)))
 ("UP:P09972" (("ALDOC" 12) ("Aldolase C" 2) ("aldolase C" 1)))
 ("UP:P09978"
  (("sphingomyelinase" 35) ("HLB" 10) ("Sphingomyelinase" 9)
   ("Exogenous Sphingomyelinase" 2)))
 ("UP:P09979" (("pHYG" 5) ("hyg" 1) ("pHYG-" 1)))
 ("UP:P0A1X5"
  (("SSc" 1620) ("early stage limited cutaneous SSc" 2)
   ("early stage diffuse cutaneous SSc" 2) ("progressive SSc" 2)
   ("only three SSc" 2) ("diffuse cutaneous SSc" 1)
   ("either limited cutaneous SSc" 1) ("had diffuse cutaneous SSc" 1)
   ("most SSc" 1) ("limited cutaneous (lc) SSc" 1)
   ("diffuse cutaneous (dc)SSc" 1)))
 ("UP:P0A247" (("VirB" 3) ("virB" 2)))
 ("UP:P0A2T7" (("catabolite activator protein" 1)))
 ("UP:P0A372" (("Cry1-2" 1))) ("UP:P0A3H1" (("HbS" 8) ("HBs" 7)))
 ("UP:P0A3R9"
  (("MMC" 829) ("NCS" 333) ("neocarzinostatin" 93)
   ("neocarzinostatin (NCS)" 19) ("Neocarzinostatin" 14) ("NCS-" 14)
   ("the radiomimetic drug neocarzinostatin (NCS)" 7)
   ("the radiomimetic drug neocarzinostatin" 7) ("NCs" 6) ("pNCS" 6) ("MMC-" 4)
   ("Neocarzinostatin (NCS)" 3)
   ("neocarzinostatin
                            (NCS)"
    3)
   ("the radiomimetic dsDNA-cleaving agents neocarzinostatin (NCS)" 2)
   ("the DSB-inducing radiomimetic compound neocarzinostatin" 2)
   ("the radiomimetic neocarzinostatin" 2) ("a radiomimetic drug NCS" 2)
   ("the radiomimetic DNA DSB agent neocarzinostatin
                            (NCS)"
    2)
   ("treated 1.2 µM MMC" 2) ("the radiomimetic drug NCS" 2)
   ("IR-mimetic NCS" 2) ("than MMC in high MGMT-expressing MCF-7 cells" 1)
   ("than MMC (Figure xref )" 1) ("−NCS" 1)
   ("the radiomimetic drug Neocarzinostatin (NCS)" 1)))
 ("UP:P0A3W8" (("single-strand DNA binding protein" 15)))
 ("UP:P0A434" (("OPD" 18) ("the Geriatric Medicine OPD" 1)))
 ("UP:P0A4Y5" (("TRex" 20) ("TREx" 15))) ("UP:P0A565" (("ESAT-6" 3)))
 ("UP:P0A5K1" (("MMPs1" 1)))
 ("UP:P0A5L9" (("Nat" 80) ("NATs" 33) ("nat" 3) ("adjacent NATs" 1)))
 ("UP:P0A6Y8" (("SEG" 20) ("seg" 3))) ("UP:P0A6Z2" (("Hsc66" 1)))
 ("UP:P0A7A9" (("PPA" 42) ("Ppa" 4) ("Idiopathic PPA" 1)))
 ("UP:P0A7B5" (("proB" 2))) ("UP:P0A7R5" (("NUSE" 4)))
 ("UP:P0A850"
  (("TF" 1921) ("TF protein" 20) ("trigger factor" 16) ("pTF" 16)
   ("a given TF" 3) ("included at least one TF" 3) ("TF-" 3) ("targeted TF" 2)
   ("an important ERα-associated TF" 2) ("than one TF" 2) ("–TF" 1)
   ("monocytic TF" 1) ("endothelial TF" 1) ("immunoreactive ( xref ) TF" 1)
   ("the classical TF" 1) ("each key TF" 1) ("This aberrant TF" 1)
   ("subsequent TF" 1) ("these leukocyte-associated TF" 1)
   ("its cis-regulatory TF" 1) ("diverse TF" 1) ("at least one TF" 1)
   ("a TF’s" 1) ("candidate synergistic TF" 1) ("a TF's" 1)
   ("tissue plasminogen activator (CV 3.5%) ( xref ) Soluble TF" 1)
   ("soluble TF" 1) ("this particular TF" 1) ("a possible interacting TF" 1)
   ("a genome-wide TF" 1) ("an essential TF" 1)
   ("a putative intermediary TF" 1)))
 ("UP:P0A8M0"
  (("TSS" 1906) ("TSS-" 36) ("more distant upstream TSS" 2)
   ("CTCF binding around TSS" 2) ("around TSS" 2)
   ("an annotated protein-coding gene TSS" 2) ("a single major TSS" 2)
   ("the genuine TSS" 2) ("the exact TSS" 2) ("almost only one TSS" 1)
   ("The most frequent TSS" 1) ("TSS (CAGACT)" 1) ("the classic p21 TSS" 1)
   ("MCF10A around TSS" 1) ("the major TSS" 1)
   ("the distribution around TSS" 1)))
 ("UP:P0A8N3" (("HERC" 1)))
 ("UP:P0A955"
  (("HGA" 62) ("pediatric and young adult HGA" 2) ("thalamic or spinal HGA" 2)
   ("pediatric HGA" 2) ("All midline pediatric HGA" 1)
   ("143 pediatric HGA" 1)))
 ("UP:P0A978" (("CSPG" 9))) ("UP:P0A9E9" (("NSR" 2)))
 ("UP:P0A9K9" (("FKBP-type peptidyl-prolyl cis-trans isomerase slyD" 2)))
 ("UP:P0A9M0" (("Lon" 16) ("lon" 2)))
 ("UP:P0A9X9"
  (("CSPs" 163) ("the bacterial CSPs" 10) ("bacterial CSPs" 10)
   ("largest CSPs" 4) ("larger CSPs" 3) ("Widespread CSPs" 1)
   ("quantitatively more subtle CSPs" 1) ("than bacterial CSPs" 1)
   ("the aforementioned CSPs" 1) ("substantial CSPs" 1) ("Local CSPs" 1)))
 ("UP:P0AA16" (("k-MT" 86) ("KMT" 7) ("K-MT" 4) ("unstable k-MT" 1)))
 ("UP:P0AA22" (("EBR" 21))) ("UP:P0AA25" (("Trx-1" 2) ("FIPA" 1)))
 ("UP:P0AAG5" (("pMDL" 9) ("MDL" 5))) ("UP:P0ABH9" (("LOPD" 3)))
 ("UP:P0AC05" (("fl-AR" 61) ("FL-AR" 45) ("FL-AR-" 1) ("fl-AR protein" 1)))
 ("UP:P0ACB2" (("NCF" 3))) ("UP:P0ACF8" (("CUR" 4))) ("UP:P0ACH5" (("MARA" 4)))
 ("UP:P0ACV2" (("DDG" 3) ("ddG" 2)))
 ("UP:P0AD51"
  (("pY" 2148) ("pY-" 15) ("pY peptide" 8) ("the central pY" 6)
   ("the phosphospecific antibody pY418" 2) ("-pY" 1)
   ("the pY+1 Leu of the HER2 pY 1248" 1)
   ("endogenously expressed Src pY215" 1)))
 ("UP:P0AE74" (("Citrate carrier" 2)))
 ("UP:P0AEG4" (("DSF" 65) ("shorter DSF" 4)))
 ("UP:P0AEW6"
  (("GSK" 329) ("pGSK" 116) ("p-GSK" 6) ("GSK-" 3) ("pGsk" 2)
   ("GSK protein" 2)))
 ("UP:P0AEY8"
  (("CMR" 14)
   ("slightly decreased (L858R cells, xref ) (E746-A750 del cells, xref ) CMR"
    1)))
 ("UP:P0AFI9" (("pERM" 8) ("P-ERM" 6))) ("UP:P0AFN2" (("PspC" 5) ("pSPC" 2)))
 ("UP:P0AFR0" (("RSSA" 22))) ("UP:P0AFV4" (("MEPs" 13) ("mEps" 9)))
 ("UP:P0AFY6" (("SBMA" 230))) ("UP:P0AG63" (("NEAA" 113)))
 ("UP:P0AG82"
  (("phos" 178) ("Phos" 15)
   ("rapamycin-treated HIV/MPTEC demonstrated attenuated phos" 2) ("phos-" 1)
   ("PHOS" 1)))
 ("UP:P0AGH5" (("SapC" 117))) ("UP:P0C0E4" (("Ras-like GTPase" 15)))
 ("UP:P0C0L4"
  (("SLPs" 13) ("C4A" 5) ("C4B" 3) ("C4a" 1) ("C4S" 1) ("two adjacent SLPs" 1)
   ("two predicted adjacent SLPs" 1) ("10 potential SLPs" 1)))
 ("UP:P0C0L5" (("C4b" 9))) ("UP:P0C0L7" (("ProP" 6)))
 ("UP:P0C0P6"
  (("NPs" 178) ("neuropeptide" 40) ("NPS" 32) ("targeted NPs" 3)
   ("Mix-Matrix–capped NPs" 2) ("a 5S rDNA (5S) ( xref ) NPS" 1)
   ("very few NPs" 1) ("the PLGA micellar NPs" 1)))
 ("UP:P0C0S5"
  (("H2AFZ" 33) ("H2AZ" 18) ("histone H2A.Z" 8) ("Histone H2A.Z" 5)
   ("member Z" 1)))
 ("UP:P0C0S8" (("HIST1H2AM" 2) ("member N" 1) ("HIST1H2AL" 1)))
 ("UP:P0C0X0" (("pS33" 15))) ("UP:P0C175" (("TS12" 23)))
 ("UP:P0C187" (("DII" 1)))
 ("UP:P0C1B3"
  (("TAA" 459) ("-TAA" 13) ("a well-known fibrogenic chemical TAA" 1)
   ("a universal TAA" 1) ("Mice given TAA" 1)
   ("All the p38 α F/F and p38 αΔ hep mice given TAA" 1)
   ("all p38 αΔ hep mice given TAA" 1) ("given TAA" 1) ("mice given TAA" 1)))
 ("UP:P0C1G0"
  (("deoxyguanosine kinase ( DGUOK )" 1) ("deoxyguanosine kinase" 1)))
 ("UP:P0C1V1" (("HLD" 1))) ("UP:P0C1Z0" (("Fas2" 6) ("Axonal Fas2" 1)))
 ("UP:P0C1Z6" (("FB1" 7))) ("UP:P0C210" (("PRT" 7) ("pRt" 1)))
 ("UP:P0C2A4"
  (("G-1" 317) ("G1-S" 287) ("G1–S" 64) ("G–1" 2) ("G1−S" 1) ("G−1" 1)))
 ("UP:P0C2E9" (("PFOA" 15) ("PFO" 2)))
 ("UP:P0C2P0" (("blasticidin-S-deaminase" 2)))
 ("UP:P0C2T3"
  (("adhesins" 42) ("bacterial adhesins" 4) ("the staphylococcal adhesins" 2)
   ("other bacterial adhesins" 2) ("key adhesins" 2) ("Neisserial adhesins" 1)
   ("Certain bacterial adhesins" 1)))
 ("UP:P0C2W1" (("FBXO45" 163))) ("UP:P0C585" (("WX" 17)))
 ("UP:P0C5Y9" (("H2A histone family" 6) ("-H2A histone family" 2)))
 ("UP:P0C648"
  (("MP" 836) ("a Takara DNA thermal cycler MP" 2) ("mp" 2) ("Mp" 1)
   ("than the MP ( xref ) suggesting" 1)))
 ("UP:P0C6B2" (("gp33" 26))) ("UP:P0C6D1" (("IRGB" 1)))
 ("UP:P0C6N0" (("BARF1" 12) ("the epithelial-specific latent BARF1" 1)))
 ("UP:P0C6P2" (("EFB" 1))) ("UP:P0C6U2" (("PP1a" 34)))
 ("UP:P0C6V4" (("M pro" 1)))
 ("UP:P0C781"
  (("Vpx" 171) ("vpx" 10) ("Vpx protein" 3) ("the G2-arrest incompetent Vpx" 2)
   ("than Vpx ( xref ; xref ; xref )" 1) ("homologous HIV-2, and SIV Vpx" 1)
   ("primate lentiviral Vpx protein" 1)))
 ("UP:P0C788" (("vOX2" 2)))
 ("UP:P0C796" (("N protein" 205) ("n protein" 2) ("-N protein" 1)))
 ("UP:P0C7M7" (("ACSM4" 7))) ("UP:P0C7P0" (("CISD3" 5)))
 ("UP:P0C7Q2" (("ARMS2" 7))) ("UP:P0C864" (("DANCR" 8)))
 ("UP:P0C869" (("PLA2G4B" 7)))
 ("UP:P0C8P8" (("thiostrepton" 65) ("Thiostrepton" 9)))
 ("UP:P0C911" (("alpha-toxin" 2)))
 ("UP:P0C929"
  (("bin" 231) ("Bin" 31) ("BIN" 9) ("intragenic bin" 1)
   ("the outermost bin" 1) ("a particular bin" 1) ("largest LDSelect bin" 1)))
 ("UP:P0C952" (("HtTA" 17))) ("UP:P0CAT3" (("TDI" 33)))
 ("UP:P0CB53" (("Dpr" 9) ("DPR" 2) ("dpR" 2)))
 ("UP:P0CE72"
  (("Ocm" 104) ("OM" 64) ("OCM1" 13) ("OCM" 9) ("Oncomodulin" 7)
   ("oncomodulin" 7) ("chronic OM" 6) ("chronic and recurrent OM" 2)
   ("a highly penetrant chronic suppurative OM" 2)
   ("a chronic suppurative OM" 2) ("recurrent or chronic OM" 2)
   ("Chronic and recurrent OM" 1) ("acute OM" 1)))
 ("UP:P0CF52" (("KDM7B" 2)))
 ("UP:P0CG07" (("SCR-1" 4) ("SCR1" 2) ("Scr-1" 1) ("sCR1" 1)))
 ("UP:P0CG29" (("GSTT2" 1))) ("UP:P0CG34" (("Tb15" 6) ("TMSL8" 4)))
 ("UP:P0CG37"
  (("cryptic" 550) ("Cryptic" 10) ("a new cryptic" 2) ("an adjacent cryptic" 2)
   ("“cryptic”" 2) ("an exonic cryptic" 2) ("potential cryptic" 1)))
 ("UP:P0CG40" (("Sp9" 8) ("SP9" 1))) ("UP:P0CG47" (("UBB" 2) ("UBIQ" 1)))
 ("UP:P0CG48"
  (("UBC" 412) ("poly-ubiquitin" 137) ("Ubc" 48) ("UbC" 21)
   ("lysine-6-linked poly-ubiquitin" 2) ("lysine-48-linked poly-ubiquitin" 2)
   ("Poly-ubiquitin" 2) ("cyclin B. Characteristic poly-ubiquitin" 2)
   ("canonical UBC" 1) ("primary UBC" 1) ("tested 15 micropapillary UBC" 1)
   ("micropapillary UBC" 1) ("purely or predominantly micropapillary UBC" 1)
   ("we first identified HER2 amplified UBC" 1)
   ("the HER2 non-amplified group showed mostly conventional UBC" 1)
   ("metastasizing UBC" 1) ("metastasizing primary UBC" 1)
   ("DNA-damage-induced poly-ubiquitin" 1) ("Eligible UBC" 1)
   ("conventional lysine-48-linked poly-ubiquitin" 1)
   ("non-conventional lysine-6-linked poly-ubiquitin" 1)
   ("this unconventional poly-ubiquitin" 1) ("superficial and invasive UBC" 1)
   ("superficial UBC" 1) ("incident UBC" 1) ("52 primary UBC" 1)))
 ("UP:P0CG63" (("polyUb" 83) ("UBI4" 1) ("homogenous K48-polyUb" 1)))
 ("UP:P0CG70" (("UBI" 32) ("ubi" 9)))
 ("UP:P0CG83"
  (("polyubiquitins" 7) ("lysine 48 (K48)-linked polyubiquitins" 2)
   ("RIP Lys-48-linked polyubiquitins" 1) ("Lys-63-linked polyubiquitins" 1)))
 ("UP:P0CH08" (("Ubi-1" 14)))
 ("UP:P0CI75"
  (("BirA" 132) ("its microbial orthologue BirA" 3)
   ("the bacterial biotin ligase BirA" 3)
   ("the myc-tagged bacterial biotin ligase BirA" 1)))
 ("UP:P0CJ46" (("actin-1" 4))) ("UP:P0CJ68" (("HN1" 1)))
 ("UP:P0CJ72" (("HN5" 163))) ("UP:P0CJ73" (("HN6" 2)))
 ("UP:P0CL48" (("FOXA" 38)))
 ("UP:P0CL70" (("CLA" 161) ("-CLA" 3) ("recipient CLA" 1) ("Dietary CLA" 1)))
 ("UP:P0CS93" (("Gao" 65) ("GAO" 2))) ("UP:P0CT70" (("KD4" 4) ("pKD4" 1)))
 ("UP:P0CW71" (("Mcp-1" 10) ("Mcp1" 10)))
 ("UP:P0CW91" (("RadA" 25) ("RadA protein" 4) ("archeal RadA" 2)))
 ("UP:P0CW95"
  (("CAG" 2938) ("cag" 209) ("-CAG" 74) ("shorter CAG" 14) ("Cag" 11)
   ("longer CAG" 9) ("The bi-allelic CAG" 5) ("longer AR CAG" 4) ("-cag" 4)
   ("the bi-allelic CAG" 3) ("fewer CAG" 3) ("shorter AR CAG" 3)
   ("a polymorphic CAG" 3) ("CAg" 2) ("Shorter CAG" 2)
   ("the polymorphic CAG" 2) ("bi-allelic CAG" 1) ("similar bi-allelic CAG" 1)
   ("harboring highly polymorphic CAG" 1) ("Longer CAG" 1) ("extreme CAG" 1)
   ("an absolute CAG" 1) ("a highly polymorphic CAG" 1) ("Shorter AR CAG" 1)
   ("the highly polymorphic CAG" 1) ("unstable CAG" 1) ("polymorphic CAG" 1)
   ("‘CAG'" 1) ("caG" 1) ("CAG-" 1) ("cAG" 1)
   ("the polymorphic androgen receptor CAG" 1) ("Longer AR CAG" 1)
   ("the long fetal AR CAG" 1) ("longest CAG" 1) ("a relatively long CAG" 1)
   ("the relatively short CAG" 1) ("28 or less CAG" 1) ("15 or fewer CAG" 1)))
 ("UP:P0CX12" (("Cos2" 1)))
 ("UP:P0CX23" (("L18a" 3) ("large ribosomal subunit protein L18a" 2)))
 ("UP:P0CY07" (("HMLalpha1" 1))) ("UP:P0DH90" (("FRI" 1)))
 ("UP:P0DH95" (("calmodulin1" 1))) ("UP:P0DI07" (("GD1a" 1)))
 ("UP:P0DI81"
  (("TRAPPC2" 3) ("SEDT" 2) ("TRS20" 1) ("SEDL" 1)
   ("Spondyloepiphyseal dysplasia" 1)))
 ("UP:P0DI83" (("Rab34" 7) ("RaH" 2) ("RAB34" 1)))
 ("UP:P0DJ88" (("TccP" 4) ("TCCP" 2))) ("UP:P0DJI3" (("inCD" 1)))
 ("UP:P0DJI8"
  (("SAA" 37) ("SAA1" 24) ("serum amyloid A" 14) ("Saa1" 2)
   ("Serum amyloid A" 2) ("the acute phase protein SAA1" 1)))
 ("UP:P0DJI9" (("SAA2" 6) ("Saa2" 2)))
 ("UP:P0DJX1" (("L4-22K" 38) ("L4-22K-" 3)))
 ("UP:P0DL10" (("TD1" 12) ("pTD1" 1))) ("UP:P0DM58" (("SOV" 58)))
 ("UP:P0DMB6" (("VT1" 10))) ("UP:P0DMC3" (("Ela" 66)))
 ("UP:P0DMI3"
  (("hTR" 826) ("phTR" 3) ("coexpressed hTR" 3) ("-hTR" 3)
   ("full length in vitro -transcribed hTR" 2) ("pull-down more hTR" 2)
   ("hTR molecule" 2) ("more hTR" 1) ("than wild-type hTR ( xref )" 1)))
 ("UP:P0DML2"
  (("PL" 760) ("PL peptide" 35) ("CSH1" 14) ("pl" 8) ("Csh1" 8)
   ("placental lactogen" 6) ("chorionic somatomammotropin hormone 1" 4)
   ("pL" 3) ("-PL" 3) ("lactogen" 3) ("Pl" 1) ("than PL" 1)))
 ("UP:P0DML3" (("C-SH2" 182) ("cSH2" 177) ("CSH2" 5)))
 ("UP:P0DMR3" (("SCA8" 2)))
 ("UP:P0DMV8"
  (("HSP70-1" 39) ("hsp70.1" 13) ("HSP70.1" 7) ("Hspa1a" 3) ("HspA1A" 2)
   ("Hsp70.1" 1)))
 ("UP:P0DMV9" (("HSP70-2" 1))) ("UP:P10045" (("BxN" 4)))
 ("UP:P10070"
  (("GLI2" 217) ("Gli2" 156) ("gli2" 15) ("Gli2 protein" 7) ("GLI2 protein" 2)
   ("GLI family zinc finger 2" 2) ("overexpressing GLI2" 1)))
 ("UP:P10071"
  (("DNA-binding protein" 241) ("GLI3" 41) ("PAPA" 40) ("Gli3" 30) ("GLI3R" 13)
   ("a sequence-specific DNA-binding protein" 10) ("Gli-3" 3)
   ("Gli3 protein" 3) ("a ubiquitous DNA-binding protein" 2)
   ("a transcriptionally incompetent DNA-binding protein" 2)
   ("the microtubule-associated transcription factor GLI3" 2)
   ("a multi-functional DNA-binding protein" 2)
   ("a single-strand telomeric DNA-binding protein" 2)
   ("the same sequence-specific DNA-binding protein" 1)
   ("a sequence-specific DNA-binding
                            protein"
    1)
   ("DNA-binding
                            protein"
    1)
   ("ACLS" 1) ("a potential DNA-binding protein" 1)
   ("a heterotrimeric single-stranded (ss) DNA-binding protein" 1)))
 ("UP:P10082" (("PYY" 11) ("peptide YY" 2) ("Peptide YY" 1)))
 ("UP:P10092" (("CALCB" 2)))
 ("UP:P10109"
  (("cycloheximide" 2435) ("CHX" 594) ("Cycloheximide" 260)
   ("cycloheximide (CHX)" 207) ("Cycloheximide (CHX)" 11) ("ADX" 8) ("chx" 5)
   ("the translational inhibitor cycloheximide (CHX)" 4)
   ("the translational inhibitor cycloheximide" 4) ("ADX-" 3)
   ("cycloheximide (VWR)" 2)
   ("protein translational inhibitor cycloheximide" 2)
   ("translational inhibitor cycloheximide" 2) ("FDX1" 1) ("than CHX" 1)))
 ("UP:P10114"
  (("Rap2" 68) ("Rap2a" 11) ("RAP2A" 6) ("GTPγs" 6) ("Rap2A" 5)
   ("monoclonal mouse Rap2" 2) ("rap2" 1)))
 ("UP:P10124"
  (("PPG" 18) ("secretory granule" 13) ("proteoglycan 1" 8)
   ("secretory granule protein" 3) ("serglycin (SRGN)" 3) ("SRGN" 2)
   ("serglycin" 1)))
 ("UP:P10144"
  (("granzyme B" 318) ("C11" 162) ("GzmB" 156) ("GrB" 129) ("grB" 58)
   ("Granzyme B" 44) ("C-11" 42) ("CspB" 17) ("c11" 9) ("Grb" 7) ("Gzmb" 6)
   ("GZMB" 4) ("sect" 4) ("GRB" 3) ("CGL1" 2)
   ("the associated cytotoxic molecule granzyme B" 2) ("gzmb" 2) ("Sect" 1)
   ("–C11" 1) ("exogenous GzmB" 1) ("lymphocyte protease" 1)
   ("exogenous GrB" 1)))
 ("UP:P10145"
  (("IL-8" 4478) ("NaF" 2703) ("CXCL8" 1144) ("IL8" 830) ("interleukin-8" 206)
   ("NAF" 120) ("interleukin 8" 54) ("Interleukin-8" 40) ("IL-8 protein" 21)
   ("il-8" 17) ("NAP-1" 17) ("-CXCL8" 10) ("cxcl8" 8) ("more IL-8" 6)
   ("CXCL8 protein" 6) ("CXCL-8" 5) ("Interleukin 8" 5) ("Il-8" 3)
   ("HK-EPEC-treated Sigirr-deficient Caco-2 cells released three-fold more IL-8"
    3)
   ("particular interleukin-8" 3) ("overexpressed IL-8" 3)
   ("the chemotactic and angiogenic factor IL8" 2) ("particular CXCL-8" 2)
   ("subsequent IL-1β-induced IL-8" 2)
   ("abundant chemotactic chemokine IL-8" 2) ("mucosal IL-8" 2)
   ("flammatory chemokine CXCL8" 2) ("targeting IL8" 2) ("pIL-8" 1)
   ("NCI-H292 cells produced markedly more IL-8" 1) ("markedly more IL-8" 1)
   ("The IB3 cells produced markedly more IL-8" 1) ("IL8 protein" 1)
   ("than IL8 ( p < 0.05)" 1) ("genes neighboring IL8" 1)
   ("a chemotactic CXCL8" 1) ("much more IL-8" 1)
   ("NSCLC cell lines produced much more IL-8" 1) ("than IL-8 (p < 0.001)" 1)
   ("NSCLC cell lines produced more IL-8" 1) ("both basal and induced CXCL8" 1)
   ("the 1-NP-induced CXCL8" 1) ("CXCL8-" 1)
   ("two classical NF- κ B target genes IL-8" 1)
   ("Short hairpin-mediated IL-8" 1) ("additional exogenous IL8" 1)
   ("both cytologically benign and malignant NAF" 1)
   ("additionally increase IL-8" 1) ("than IL-8" 1) ("less IL-8" 1)
   ("viable CXCL8" 1) ("maximal IL-8" 1) ("NAP-1 protein" 1) ("than NAF" 1)
   ("Axin ΔRGS produced significantly less IL-8" 1)
   ("pancreatic cancer exogenous IL-8" 1) ("IL8-" 1)))
 ("UP:P10146" (("TCA-3" 101)))
 ("UP:P10147"
  (("CCL3" 275) ("Ccl3" 8) ("macrophage inflammatory protein-1α" 8)
   ("CCL3 protein" 4) ("MIP1-α" 3) ("MIP-1alpha" 3) ("Mip1α" 2) ("MIP1a" 1)
   ("inflammatory protein-1" 1)))
 ("UP:P10148"
  (("JE" 137) ("normal JE" 3) ("the original JE" 2) ("the regenerative JE" 1)
   ("the normal JE" 1)))
 ("UP:P10152" (("angiogenin-1" 2)))
 ("UP:P10153"
  (("RNASE2" 12) ("eosinophil-derived neurotoxin" 3) ("edn" 1)
   ("eosinophil derived neurotoxin" 1)))
 ("UP:P10155" (("TROVE2" 4) ("Ssa2" 4) ("Ro60" 1)))
 ("UP:P10163" (("protein N1" 9)))
 ("UP:P10176"
  (("cytochrome c oxidase subunit VIII" 5) ("COX8" 5) ("Cox8a" 3) ("COX8A" 3)))
 ("UP:P10183" (("NAHR" 32) ("Recurrent NAHR" 1))) ("UP:P10225" (("VHS" 43)))
 ("UP:P10228"
  (("pUL44" 21) ("UL44" 8) ("the viral protein UL44" 2)
   ("viral protein pUL44" 2) ("viral proteins pUL44" 2)
   ("early viral protein pUL44" 1)))
 ("UP:P10238" (("ICP27" 15)))
 ("UP:P10242"
  (("MYB" 1592) ("Myb" 577) ("myb" 255) ("c-Myb protein" 112) ("cMYB" 44)
   ("MYB protein" 14) ("cMyb" 6) ("Myb protein" 4) ("c–Myb protein" 3)
   ("myb-" 3) ("C-Myb protein" 2) ("residual c-Myb protein" 2) ("Strong Myb" 2)
   ("the normal c-Myb protein" 2) ("The exogenous c-Myb protein" 2) ("Myb-" 1)
   ("longer MYB" 1) ("the previously identified Myb" 1)
   ("than the endogenous c-Myb protein" 1) ("the original MYB" 1)
   ("MYB (MYB)" 1)))
 ("UP:P10243"
  (("MYBL1" 8) ("myb-like protein 1" 7) ("MybL1" 5) ("than MYBL1 [ xref ]" 1)
   ("AMYB" 1)))
 ("UP:P10244"
  (("B-Myb" 139) ("MYBL2" 45) ("B-myb" 36) ("B-MYB" 34) ("b-myb" 17)
   ("b-Myb" 2) ("b-MYB" 1) ("Mybl2" 1) ("bMyb" 1) ("BMYB" 1)
   ("particular B-myb" 1)))
 ("UP:P10253"
  (("GAA" 1050) ("-GAA" 70) ("G-A-A" 12) ("the perfect site TTCN 3 GAA" 2)
   ("TTC(T/C)N(G/A)GAA" 2)
   ("a palindromic consensus sequence TTC(N) 2-4 GAA" 2) ("“TTC-GAA”" 1)
   ("consensus DNA-sequence TTC(C/T)N(G/A)GAA" 1) ("TTC(C/T)N(G/A)GAA" 1)))
 ("UP:P10266"
  (("RT" 6197) ("RNase H" 255) ("integrase" 138) ("RT-" 43) ("RNase H-" 20)
   ("Integrase" 17) ("rt" 17) ("RT−" 17) ("RT protein" 15)
   ("the viral integrase" 10) ("RNAse H" 8) ("Rnase H" 7) ("integrase (IN)" 7)
   ("preoperative RT" 6) ("pelvic RT" 6) ("integrase activity" 5) ("−RT" 5)
   ("integrase protein" 5) ("Human Synaptic Plasticity RT" 4)
   ("RNase H (NEB)" 4) ("post-operative RT" 3) ("RT peptide" 3) ("RT–" 3)
   ("than HIV-1 RT" 3) ("RT (ABI)" 3) ("thoracic RT" 3) ("ribonuclease H" 2)
   ("viral RT" 2) ("the viral integrase (IN)" 2)
   ("preoperative total dose RT" 2) ("definitive RT" 2)
   ("exclusive external beam RT" 2) ("Integrase Activity" 2) ("–RT" 2)
   ("total RNA underwent RT" 2) ("the commercially available RT" 2)
   ("feline immunodeficiency virus (FIV) RT" 2) ("-RT" 2)
   ("the viral RNase H" 2) ("using Superscript TM II Rnase H" 1)
   ("the viral enzyme integrase (IN)" 1)
   ("stringent milk buffer xref 1 hour RT" 1) ("the viral RT" 1)
   ("SYBR Green universal master mix and Multiscript RT" 1)
   ("96 well format RT" 1) ("Superscript™ III RT" 1) ("ribonuclease H-" 1)
   ("prototypical RT's" 1) ("prototypical RT" 1) ("than RT" 1)
   ("actually given RT" 1) ("Ditiotreitol, RNAseOUT and SuperScript II RT" 1)
   ("RNase
                    H"
    1)
   ("external RT" 1) ("functional integrase" 1)
   ("HIV-1–derived retroviral vector–carrying wild-type integrase" 1)
   ("a catalytically active viral integrase" 1) ("viral integrase (IN)" 1)
   ("a commercially available RT" 1)
   ("than the wild-type RT in the presence" 1) ("the RT’s" 1)
   ("than wild-type RT [ xref ]" 1) ("than the wild-type RT" 1)
   ("than AMV RT" 1) ("the retroviral RT" 1) ("than the HIV-1 RT [ xref ]" 1)
   ("the prototype foamy virus (PFV) RT" 1)
   ("than the AMV RT (2.3 × 10 −4  versus 1.0 × 10 −5 )" 1)
   ("than feline immunodeficiency virus (FIV) RT [ xref ]" 1)
   ("feline leukemia virus (FeLV) RT" 1) ("than the AMV RT" 1)
   ("than the Moloney MLV (Mo-MLV) RT [ xref , xref , xref ]" 1)
   ("therapeutic RT" 1) ("RNase H–" 1) ("using Superscript™ II RT" 1)
   ("the viral integrase protein" 1) ("definite RT" 1)))
 ("UP:P10275"
  (("AR" 34351) ("KD" 6306) ("androgen receptor" 1598) ("AR protein" 688)
   ("androgen receptor (AR)" 289) ("Ar" 179) ("Androgen receptor" 157)
   ("Androgen Receptor" 123) ("-KD" 78) ("AR-" 73) ("-AR" 47) ("ARv567es" 37)
   ("overexpressed AR" 30) ("functional AR" 28) ("P-AR" 27) ("AR (CAG)" 21)
   ("a functional AR" 16) ("androgen receptor ( AR )" 15) ("pKD" 14) ("pAR" 13)
   ("Androgen receptor (AR)" 10) ("Androgen Receptor (AR)" 9)
   ("classical AR" 9) ("KD protein" 8) ("AR Protein" 8) ("exogenous AR" 7)
   ("AR−" 7) ("Tfm" 7) ("epithelial AR" 7) ("tfm" 7) ("stromal AR" 6)
   ("HUMARA" 6) ("-AR protein" 6) ("intense nuclear AR" 6) ("AR(DBD)" 6)
   ("NR3C4" 5) ("intact AR" 5) ("KD molecule" 5) ("AR (GGC)" 5)
   ("the normal AR" 5) ("androgen receptor (AR) protein" 4) ("targeting AR" 4)
   ("androgen receptor-" 4) ("Functional AR" 4) ("normal AR" 4)
   ("AR peptide" 4) ("overexpressed wild type full length AR" 4)
   ("promiscuously mutant AR" 3) ("TFM" 3) ("than AR" 3)
   ("AR protein (ARFL)" 3) ("“KD”" 3) ("substantial AR" 3)
   ("a low MW form around 120 KD" 3) ("mouse monoclonal AR" 3) ("AR(AB)" 2)
   ("AR (AR)" 2) ("Successful (>80%) KD" 2) ("previously confirmed AR" 2)
   ("prostatic epithelial AR" 2) ("an intact AR" 2) ("acute KD" 2)
   ("androgen receptor (LAR)" 2) ("PAR-3 KD's" 2) ("extensive AR" 2)
   ("transiently silence AR" 2) ("genetic or pharmacological AR" 2)
   ("AR24Q protein" 2) ("the canonical androgen receptor" 2)
   ("17-AAG-disrupting AR protein" 2) ("17-AAG-degradating AR protein" 2)
   ("CaP expressed functional AR" 2) ("some residual AR" 2) ("strong Ar" 2)
   ("robust KD" 2) ("AR molecule" 2) ("exogenous AR protein" 2)
   ("overexpressed AR protein" 2)
   ("Stably overexpressed wild type full length AR" 2)
   ("the conditional Mdmx KD" 2) ("all well-studied AR" 2)
   ("a similarly sized N-terminal truncated AR protein" 2) ("around AR" 2)
   ("only partial KD" 2) ("Androgen Receptor Protein" 2)
   ("360A-treated ATR KD" 2) ("endogenously-expressed AR" 2)
   ("hypersensitive AR" 2) ("AR (GGN)" 2) ("lentiviral-mediated KD" 2)
   ("the classical AR" 2) ("such massive AR" 2) ("complete AR−" 2)
   ("Epithelial AR" 2) ("the pathogenic AR" 2) ("the phospho-mimetic ATR KD" 2)
   ("the epithelial AR" 2) ("intratumoral AR" 2)
   ("The investigators found very weak AR" 2) ("fetal AR" 2)
   ("ER(-) HER2(-) AR" 2) ("the IHC profiles ER(-) HER2(3+) AR" 2)
   ("only 58% AR" 2) ("PKG-Iβ enhanced AR's" 1) ("cytokine-treated GLIS3 KD" 1)
   ("the cellular KD" 1) ("orthotopic AR" 1) ("“AR339”" 1)
   ("the promiscuously mutant AR" 1)
   ("androgen
receptor (AR)"
    1)
   ("androgen
receptor"
    1)
   ("AR+/ER−" 1) ("strong AR" 1) ("RUNX2 influenced AR’s" 1) ("“AR”" 1)
   ("than the wild-type AR (110 kDa subtype)" 1) ("a few AR" 1)
   ("authentic AR" 1) ("systemic AR" 1)
   ("kidney proximal or distal epithelial AR" 1) ("the AR’s" 1)
   ("4-folds more AR protein" 1) ("a classical mouse AR" 1)
   ("coregulator-mediated AR" 1) ("PCa stromal AR" 1)
   ("insoluble AR protein" 1) ("Normal AR" 1) ("publically available AR" 1)
   ("barely detectable AR" 1)
   ("a transcriptionally incompetent
AR"
    1)
   ("fewer AR" 1) ("functional androgen receptor (AR)" 1) ("The dimeric AR" 1)
   ("exogenous GFP-tagged AR" 1) ("approximately 72% KD" 1)
   ("highly conserved amino acids of AR (Lys-563, Val-564 and Arg-568)" 1)
   ("p-AR" 1) ("simultaneous KD" 1) ("the exogenous Y267F mutant AR" 1)
   ("than full length AR ( xref )" 1)
   ("than endogenous AR in vector control cells ( xref )" 1)
   ("than full length AR" 1) ("those distinct AR" 1) ("aberrant AR" 1)
   ("AR-V7 (Figure xref and xref ) further indicating full-length AR's" 1)
   ("AR-V7 (Figure xref and xref ) further indicating full-length AR" 1)
   ("silent AR" 1) ("diverse AR" 1)
   ("androgen
 receptor"
    1)
   ("the androgen receptor’s" 1) ("the well-characterized 110-kD AR protein" 1)
   ("androgen receptor(AR)" 1) ("the dominant-negative Csk KD" 1)
   ("the dominant-negative Src KD" 1) ("the promiscuous receptor AR-V716M" 1)
   ("Rak KD1 and Rak KD3" 1) ("CNV around AR" 1) ("experiments examined AR" 1)
   ("antiandrogen-bound AR" 1) ("Given AR's" 1) ("Given AR" 1)
   ("the previously identified AR" 1) ("functional androgen receptor" 1)
   ("severe AR" 1) ("The patients developed AR" 1)
   ("AR (bottom panel) protein" 1) ("most AR protein" 1) ("P10275" 1)
   ("than the full length AR" 1) ("effectively target AR" 1)
   ("longer AR (CAG)" 1) ("endogenously-expressed wild-type AR" 1)
   ("exogenously-expressed wild-type AR" 1) ("a dominant-negative AR" 1)
   ("efficient KD" 1) ("non-toxic AR" 1) ("a normal AR" 1)
   ("lack functional androgen receptor" 1) ("slower migration AR" 1)
   ("transcriptionally incompetent AR" 1) ("lentiviral-mediated EZH2 KD" 1)
   ("monovalent KD" 1) ("cooperative AR" 1)
   ("43 high-grade ductal carcinoma in situ cases expressed androgen receptor"
    1)
   ("triple negative breast cancer cases co-expressed androgen receptor" 1)
   ("had evaluable androgen receptor" 1) ("the stromal AR" 1)
   ("the prostate epithelial AR" 1) ("The relative AR (CAG)" 1)
   ("than GGA3 KD ( xref )" 1) ("Mild Cav1 KD" 1) ("the region around AR" 1)
   ("deprive AR" 1) ("360A-treated Ct KD" 1) ("other transformed AR" 1)
   ("Strikingly NS KD" 1) ("A robust NS KD" 1)
   ("We first established stable NS KD" 1) ("prostate epithelial AR" 1)
   ("the polymorphic androgen receptor (AR)" 1) ("than those involving AR" 1)
   ("the androgen receptor's" 1) ("tumor-suppressive AR" 1)
   ("Androgen receptor protein" 1) ("KD−" 1) ("KD-" 1) ("differential AR" 1)
   ("the well-studied AR" 1) ("less AR" 1)
   ("a hyperactive androgen receptor" 1) ("whose AR" 1)
   ("a hyperactive androgen receptor (AR)" 1) ("than AR IHC in MA tumors" 1)
   ("1 µg/mL mouse monoclonal anti AR" 1)))
 ("UP:P10276"
  (("RARα" 544) ("RARA" 294) ("retinoic acid receptor alpha" 19)
   ("PLZF-RARα" 12) ("retinoic" 11) ("Retinoic" 10) ("RAR-α" 7)
   ("targeting RARA" 4) ("RARalpha" 4) ("Retinoic acid receptor alpha" 2)
   ("Quantitative proteomics link RARA" 2) ("NR1B1" 2) ("RARα protein" 2)
   ("functional RARα" 2) ("RAR-alpha" 2) ("RARA protein" 1)
   ("retinoic acid receptor alpha (RARA)" 1) ("RARa" 1) ("PLZF-RARalpha" 1)
   ("retinoic acid receptor alpha ( RARA )" 1) ("Rarα" 1)))
 ("UP:P10286"
  (("calcitonin gene-related peptide" 8)
   ("calcitonin gene-related peptide (CGRP)" 1)))
 ("UP:P10301" (("p23" 241) ("P23" 17) ("RRAS" 11) ("p23 (ABR)" 1)))
 ("UP:P10323"
  (("ACR" 144) ("urinary ACR" 6) ("AcR" 4) ("recurrent ACR" 1)
   ("the urinary ACR" 1) ("transiently elevated urinary ACR" 1)
   ("sex-specific ACR" 1) ("Urinary ACR" 1)))
 ("UP:P10351" (("RY" 16) ("Ry" 5)))
 ("UP:P10371" (("HisA" 22) ("-HisA" 4) ("hisA" 1))) ("UP:P10383" (("OTU" 21)))
 ("UP:P10395"
  (("v-myc" 20) ("v-Myc" 17) ("the parental v-Myc" 1) ("V-Myc" 1) ("V-MYC" 1)))
 ("UP:P10398"
  (("Araf" 123) ("A-Raf" 75) ("ARAF" 65) ("araf" 50) ("DAraf1" 50) ("A-RAF" 26)
   ("PKs" 13) ("Araf protein" 5) ("pKS" 3) ("ARAF1" 2) ("than A-Raf" 2)
   ("favourable PKs" 2) ("more Araf" 2) ("PKS" 1) ("than Araf" 1)
   ("mitochondrion-associated A-Raf" 1)
   ("the N-terminal 153 amino acids of A-Raf" 1)
   ("the N-terminal 186 amino acids of A-Raf" 1) ("A-raf" 1)
   ("the favourable PKs" 1) ("than wild-type Araf" 1)))
 ("UP:P10410" (("HMK" 5)))
 ("UP:P10412"
  (("H1.4" 6) ("histone H1b" 3) ("H1e" 2) ("HIST1H1E" 2) ("Hist1H1E" 1)
   ("histone H1.4" 1) ("Histone H1b" 1)))
 ("UP:P10415"
  (("Bcl-2" 10335) ("BCL2" 1693) ("BCL-2" 1415) ("Bcl2" 1041) ("bcl-2" 504)
   ("Bcl-2 protein" 176) ("pBcl-2" 40) ("bcl2" 35) ("BCL-2 protein" 29)
   ("Bcl2 protein" 25) ("BCL2 protein" 21) ("bcl -2" 17) ("-Bcl-2" 16)
   ("Bcl-2 peptide" 16) ("Bcl-2−" 13) ("than Bcl-2" 11)
   ("antiapoptotic Bcl-2" 10) ("bcl-2 protein" 10) ("bcl–2" 10)
   ("overexpressed Bcl-2" 7) ("Bcl - 2" 7) ("Bcl-2-" 7) ("Bcl-2 molecule" 7)
   ("-Bcl2" 6) ("-Bcl-2ΔTM" 6) ("BcL-2" 5) ("-BCL2" 5) ("BCl2" 5) ("BCl-2" 5)
   ("antiapoptotic BCL2" 4) ("BcL2" 4) ("homologous BCL-2" 4) ("Bcl- 2" 4)
   ("BCL -2" 3) ("BCL2-" 3) ("Kaposi sarcoma-associated herpesvirus Bcl-2" 3)
   ("an intact BCL2" 3) ("expressing Bcl-2" 3)
   ("overexpressed Bid reversed Bcl-2" 2) ("“pan-Bcl-2”" 2) ("Bcl -2" 2)
   ("overexpressing Bcl-2" 2) ("a mutant viral Bcl-2 (M11 AAA) protein" 2)
   ("BCL2−" 2) ("BCL-2-" 2) ("−Bcl2" 2) ("Bcl2 (B-cell lymphoma 2) protein" 2)
   ("Bcl2 (Fig. xref ) protein" 2) ("its transcriptional target Bcl-2" 2)
   ("the functional BCL2" 2) ("BCL 2" 2) ("the prosurvival protein Bcl-2" 2)
   ("the prosurvival members Bcl-2" 2) ("antiapoptotic BCL-2" 2)
   ("the pro-apoptotic protein Bcl-2" 2) ("than Bcl-2 (Figure xref )" 2)
   ("at least one homolog of Bcl-2" 2) ("overexpressed bcl-2" 2)
   ("the respective Bcl-2 molecule" 2) ("The typical Bcl-2" 2)
   ("70% less Bcl-2 protein" 2) ("overexpressed anti-apoptotic protein BCL2" 2)
   ("total and phosphorylated Bcl-2" 2)
   ("overexpressed Bid reversed Bcl-2's" 1) ("The antiapoptotic BCL-2" 1)
   ("the prosurvival gene BCL2" 1) ("Bcl2-" 1)
   ("the mutant viral Bcl-2 protein" 1) ("Bcl-2 (M11 AAA) protein" 1)
   ("Stably-transfected Bcl-2" 1) ("P10415" 1)
   ("than Bcl-2 from interphase cells ( xref )" 1) ("than wt Bcl-2" 1)
   ("than unmodified Bcl-2 ( xref )" 1) ("very little unmodified Bcl-2" 1)
   ("than wildtype (wt) Bcl-2" 1) ("than wildtype Bcl-2" 1) ("Bcl-2 (AAA)" 1)
   ("than wild-type Bcl-2" 1) ("bcl- 2" 1) ("the Bcl-2’s" 1)
   ("the prosurvival proteins Bcl-2" 1) ("bcl -2–" 1)
   ("uniformly 15 N-labeled Bcl-2" 1) ("the prosurvival molecule Bcl-2" 1)
   ("over-expressing protein Bcl-2" 1) ("western blot Bcl-2 protein" 1)
   ("nuclear compartment-associated Bcl-2" 1) ("less BCL-2" 1)
   ("three or more BCL2" 1) ("pro-apoptotic proteins Bcl-2" 1)
   ("the antiapoptotic Bcl-2" 1) ("pro-apoptotic multidomain Bcl-2" 1)
   ("the available Bcl-2" 1) ("both total and phospho(Ser70) Bcl-2" 1)
   ("than Bcl-2 ( xref C, left)" 1) ("expressing b5-BCL-2" 1) ("Bcl-2–" 1)
   ("bcl-2-" 1) ("antiapoptotic Bcl2" 1) ("the prosurvival factor BCL2" 1)
   ("The principal mammalian pro-apoptotic Bcl-2 protein" 1)
   ("simultaneously overexpressed bcl-2" 1)
   ("the otherwise anti-apoptotic factor Bcl-2" 1)
   ("the pro-apoptotic Bax and pro-survival molecule Bcl-2" 1)
   ("myocardial pro-survival Bcl-2" 1) ("than one Bcl-2 molecule" 1)
   ("Bambi increased Bcl-2" 1)
   ("the pro-apoptotic gene TRAIL and anti-apoptotic gene Bcl-2" 1)
   ("functional Bcl-2" 1) ("the only other dimeric Bcl-2 protein" 1)
   ("more Bcl2" 1) ("intact Bcl-2" 1) ("Bcl−2" 1)
   ("a pro-apoptotic Bcl-2 protein" 1) ("cellular Bcl-2" 1) ("intense Bcl-2" 1)
   ("pro-apoptotic Bax and anti-apoptotic Bcl-2" 1)
   ("multidomain antiapoptotic BCL-2" 1)))
 ("UP:P10451"
  (("OPN" 686) ("osteopontin" 304) ("Osteopontin" 78)
   ("secreted phosphoprotein 1" 8) ("osteopontin (OPN)" 5) ("OPN protein" 5)
   ("Osteopontin (OPN)" 4) ("Secreted phosphoprotein 1" 4)
   ("Immunoreactive Osteopontin" 2) ("FGF-2 increased osteopontin" 2)
   ("osteopontin (OP)" 1) ("soluble OPN" 1) ("Soluble human OPN protein" 1)
   ("OPN-" 1) ("Osteopontin protein" 1) ("expressed significantly less OPN" 1)
   ("SPP-1" 1)))
 ("UP:P10486"
  (("HSR" 500) ("an adequate HSR" 4) ("the proteotoxic stress-induced HSR" 3)
   ("developed HSR" 2) ("a history carboplatin HSR" 1) ("more HSR" 1)
   ("newly developed HSR" 1) ("a history HSR" 1)
   ("a prior history developed HSR" 1) ("patients developed carboplatin HSR" 1)
   ("mild-to-moderate HSR" 1) ("experience moderate-to-severe HSR" 1)
   ("developed carboplatin HSR" 1) ("a proper HSR" 1)))
 ("UP:P10487" (("RCI" 35) ("non-invasive RCI" 1)))
 ("UP:P10515"
  (("DLAT" 114) ("dihydrolipoamide S-acetyltransferase" 2)
   ("dihydrolipoamide S-acetyltransferase (DLAT)" 1)
   ("specific lipoylated lysines of endogenous cellular DLAT" 1)
   ("endogenous cellular DLAT" 1)))
 ("UP:P10519" (("SKG" 8))) ("UP:P10523" (("sAgs" 1) ("SAgs" 1)))
 ("UP:P10586" (("LAR" 69) ("PTPRF" 4) ("lar" 3) ("presynaptic LAR" 2)))
 ("UP:P10588" (("EAR2" 14) ("NR2F6" 8) ("Nr2f6" 7)))
 ("UP:P10589"
  (("Coup-TFI" 86) ("COUP-TFI" 27) ("NR2F1" 12) ("Nr2f1" 8) ("Group F" 6)
   ("group F" 2) ("the transcriptional repressors Nr2f1" 2)
   ("that Coup-TFI's" 1) ("Coup-TFI protein" 1)))
 ("UP:P10593" (("O-6" 6)))
 ("UP:P10599"
  (("thioredoxin" 362) ("Trx" 262) ("TRX" 54) ("TXN" 16) ("Thioredoxin" 14)
   ("thioredoxins" 9) ("TRX-" 3) ("thioredoxin (TXNIP)" 3) ("Thioredoxins" 3)
   ("trx" 3) ("Trx protein" 3) ("thioredoxin protein" 2) ("TrX" 2)
   ("exogenous Trx" 2) ("pTRX" 2) ("thioredoxin ( TXN )" 2)
   ("thioredoxin (TXN)" 2) ("thioredoxin (TRX)" 1)
   ("the active site cysteines of thioredoxin" 1) ("bacterial Trx" 1)
   ("Txn" 1)))
 ("UP:P10600" (("TGFB3" 12))) ("UP:P10602" (("RNAP" 29)))
 ("UP:P10606" (("COX5B" 1) ("Cox5b" 1)))
 ("UP:P10619" (("GSLs" 72) ("GSL" 23) ("CTSA" 1) ("cathepsin A" 1)))
 ("UP:P10620"
  (("MGST1" 2) ("microsomal glutathione S-transferase 1" 2) ("Mgst1" 2)))
 ("UP:P10622" (("AX" 152) ("UV-induced γH 2 AX" 1)))
 ("UP:P10632" (("CYP2C8" 6) ("polypeptide 8" 2)))
 ("UP:P10635"
  (("etc." 876) ("CYP2D6" 82) ("ETC." 12) ("subfamily D" 6) ("Etc." 4)
   ("central neural system etc." 2) ("the Pol III promoter elements etc." 2)
   ("atrial septal and ventricular septal defects etc." 2)
   ("intestinal crypt cells etc." 2) ("CYP2D" 1) ("functional ETC." 1)
   ("secondary structure calculation etc." 1)
   ("release thromboxane A 2 etc." 1)))
 ("UP:P10636"
  (("tau" 3473) ("Tau" 579) ("MAPT" 160) ("p-tau" 104) ("tau protein" 88)
   ("FTDP-17" 47) ("t-tau" 34) ("pTau" 33) ("isoform 4" 26) ("TAU" 26)
   ("microtubule-associated protein tau" 24) ("mutant tau" 24)
   ("Tau protein" 18) ("microtubule associated protein tau" 13)
   ("abnormal tau" 12) ("microtubule-associated protein Tau" 9) ("p-Tau" 9)
   ("tau-" 9) ("pathologic tau" 9) ("tubulin-associated tau" 9)
   ("insoluble tau" 8) ("tau molecule" 8) ("detergent insoluble tau" 8)
   ("PHF tau" 7) ("microtubule associated protein Tau" 5)
   ("paired helical filament tau" 5) ("tau peptide" 5)
   ("Microtubule-associated protein tau" 4) ("PHF-tau" 4)
   ("pre-phosphorylated tau" 3) ("-tau" 3) ("pathogenic tau" 3)
   ("Monomeric tau protein" 2) ("soluble tau" 2)
   ("perinuclear accumulated tau" 2) ("filamentous tau" 2) ("than MAPT" 2)
   ("longest human tau" 2) ("exogenous human full length tau" 2)
   ("normal tau" 2) ("total insoluble tau" 2)
   ("insoluble AD2-stained hyperphosphorylated paired helical filament tau" 2)
   ("helical filament tau" 2) ("oligomeric tau" 2) ("pathogenic p-tau" 2)
   ("raft-associated Tau" 2) ("detergent insoluble (FA, lane 2) tau" 2)
   ("Detergent Insoluble Tau" 2) ("fibrillar tau" 2) ("Pathological Tau" 2)
   ("Tau Protein" 2) ("JNK directly targets tau" 2)
   ("bind tubulin-associated tau" 2) ("PHF-Tau" 2)
   ("the neuronal microtubule-associated protein tau" 1) ("Isoform 4" 1)
   ("that tau's" 1) ("pre-phosphorylated tau protein" 1)
   ("GSK-3β pre-phosphorylated tau" 1) ("pre-assembled tau" 1)
   ("phosphorylated monomeric tau" 1) ("Phosphorylated monomeric tau" 1)
   ("monomeric tau" 1) ("the neuronal markers Tau (MAPT)" 1) ("Tau (MAPT)" 1)
   ("intracellular neurofibrillary tau protein" 1)
   ("exogenous c31/APP/352PHP tau or AICD/352PHP tau" 1) ("Mutant tau" 1)
   ("we first co-transfected tau" 1) ("study tau’s" 1)
   ("than tau containing the N terminus" 1) ("than Tau-WT" 1)
   ("normal soluble tau" 1) ("exogenous tau" 1) ("than mouse tau" 1)
   ("Ab708 detected strong tau" 1) ("Soluble tau" 1)
   ("especially aberrant p-tau" 1) ("endogenous soluble tau" 1) ("clear tau" 1)
   ("aberrant tau" 1) ("neuronal p-tau" 1) ("abnormal tau protein" 1)
   ("spherical tau" 1) ("pathological tau" 1) ("considerable aggregated tau" 1)
   ("abnormal toxic tau" 1) ("potentially toxic tau" 1)
   ("pathological tau protein" 1) ("Normal tau" 1) ("aggresomal tau" 1)
   ("microtubule-associated protein tau (MAPT)" 1) ("the next oncoming tau" 1)
   ("insoluble 0N3R or 2N4R tau" 1) ("abnormal and aggregated tau" 1)
   ("than total human E1 tau (Fig.  xref A–D)" 1) ("disease-relevant tau" 1)
   ("abnormal Tau" 1) ("Significantly more Tau" 1)))
 ("UP:P10639" (("TxN1" 6) ("TXN1" 3)))
 ("UP:P10644" (("PRKAR1A" 32) ("CNC1" 1)))
 ("UP:P10645"
  (("CgA" 156) ("CHGA" 31) ("SPI" 21) ("cga" 13) ("pancreastatin" 7)
   ("vasostatin I" 6) ("CgA protein" 4) ("catestatin" 4) ("Pancreastatin" 3)
   ("CgA molecule" 3) ("CGa" 2) ("Vasostatin I" 2) ("-cga" 2) ("SPI peptide" 2)
   ("SPi" 2) ("Chromogranin-A" 2) ("CgA peptide" 1)
   ("metastases expressed less CgA" 1)
   ("the predominant 75-80 kDa CgA protein" 1) ("SPI-" 1) ("P10645" 1)))
 ("UP:P10646"
  (("LacI" 179) ("EPI" 73) ("lacI" 42) ("TFPI" 34)
   ("tissue factor pathway inhibitor" 8) ("LacI protein" 3) ("pLacI" 3)
   ("tissue factor pathway inhibitor (TFPI)" 1) ("alveolar TFPI" 1)))
 ("UP:P10674" (("fasciclin-1" 9))) ("UP:P10696" (("ALP-1" 2)))
 ("UP:P10720" (("PF4V1" 5)))
 ("UP:P10721"
  (("Kit" 30042) ("KIT" 5223) ("c-kit" 1942) ("c-KIT" 1046) ("c-Kit" 821)
   ("CD117" 543) ("the RNeasy Mini Kit" 304) ("Kit (QIAGEN)" 139)
   ("QIAGEN" 138) ("cKIT" 135) ("RNeasy Mini Kit" 94)
   ("the QIAamp DNA Mini Kit" 80) ("Mini Kit" 78) ("using RNeasy Mini Kit" 62)
   ("an RNeasy Mini Kit" 61) ("KIT protein" 53) ("C-KIT" 42) ("PBT" 39)
   ("Qiagen" 38) ("C-kit" 34) ("BD" 34) ("the QIAamp DNA Blood Mini Kit" 32)
   ("pBT" 29) ("the Dual Luciferase Reporter Assay Kit" 26) ("ATCC" 26)
   ("c-kit protein" 25) ("cKit" 24) ("the miRNeasy Mini Kit" 23)
   ("the High Pure RNA Isolation Kit" 21) ("the Qiagen RNeasy Mini Kit" 20)
   ("the RNeasy Micro Kit" 19) ("the Dual Luciferase Assay Kit" 19)
   ("QIAamp DNA Mini Kit" 18) ("Kit (ABI)" 17) ("C-Kit" 17)
   ("the RNeasy Mini Kit (QIAGEN)" 14) ("the Dual Luciferase Kit" 14)
   ("a QIAamp DNA Mini Kit" 14) ("the LightShift Chemiluminescent EMSA Kit" 13)
   ("DAKO" 13) ("QIAgen" 13) ("stem cell factor receptor" 12)
   ("the RNeasy® Mini Kit" 12)
   ("the High Pure PCR Template Preparation Kit" 12)
   ("Qiagen RNeasy Mini Kit" 12) ("using miRNeasy Mini Kit" 12)
   ("using QIAamp DNA Mini Kit" 11) ("using Qiagen RNeasy Mini Kit" 11)
   ("the High Capacity cDNA Archive Kit" 11) ("the RNeasy mini Kit" 11)
   ("RNeasy Micro Kit" 10) ("the High-Capacity cDNA Archive Kit" 10)
   ("Nucleic Acid Kit" 10) ("c-KIT protein" 10) ("Kit (BD)" 10)
   ("Kit (GATK)" 9) ("Kit (EMD)" 9) ("AllPrep DNA/RNA Mini Kit" 8)
   ("miRNeasy Mini Kit" 8) ("a miRNeasy Mini Kit" 8) ("Kit (KPL)" 8)
   ("using QIAamp DNA Micro Kit" 8) ("ckit" 8) ("CKIT" 8) ("Kit (MBL)" 8)
   ("a QIAamp DNA Blood Mini Kit" 8) ("the PureLink RNA Mini Kit" 8)
   ("the ultraView Universal DAB Detection Kit" 8)
   ("a High Capacity cDNA Archive Kit" 8) ("the DNA Blood Mini Kit" 8)
   ("pKIT" 7) ("a QIAmp DNA Mini Kit" 7) ("-Kit" 7)
   ("the QIAamp DNA Micro Kit" 7) ("All Total Nucleic Acid Isolation Kit" 7)
   ("a RNeasy Mini Kit" 7) ("the QIAamp Viral RNA Mini Kit" 6)
   ("an RNeasy Micro Kit" 6) ("Rneasy Mini Kit" 6)
   ("High Pure RNA Isolation Kit" 6) ("RNeasy mini Kit" 6)
   ("a High Pure RNA Isolation Kit" 6)
   ("the ECL Western Blotting Detection Kit" 6) ("the QIAamp DNA mini Kit" 6)
   ("the QiaAmp DNA Mini Kit" 6) ("RNEasy Mini Kit" 6) ("KIT-" 6)
   ("a QIAamp DNA Micro Kit" 6) ("an miRNeasy Mini Kit" 6) ("Kit (DAKO)" 6)
   ("the RecoverAll™ Total Nucleic Acid Isolation Kit" 6)
   ("the Subcellular Protein Fractionation Kit" 6)
   ("a Dual Luciferase Reporter Assay Kit" 6) ("Kit (TOYOBO)" 6)
   ("Kit (TAKARA)" 6) ("the QIAmp DNA Blood Mini Kit" 6)
   ("overexpressed c-kit" 6) ("RNeasy Lipid Tissue Mini Kit" 6)
   ("LightShift Chemiluminescent EMSA Kit" 6) ("c-Kit protein" 5)
   ("QIAamp DNA Blood Mini Kit" 5) ("a Caspase-3 Colorimetric Assay Kit" 5)
   ("RNeasy® Mini Kit" 5) ("Kit (PBL)" 5) ("Plasmid Mini Kit" 5)
   ("the RNeasy™ Mini Kit" 5) ("RNAqueous Mini Kit" 5) ("Kit (ABM)" 5)
   ("Mini Kit (QIAGEN)" 5) ("Dual Luciferase Reporter Assay Kit" 5)
   ("strong KIT" 5) ("Kit–" 5) ("an ECL Western Blotting Kit" 4)
   ("The RNeasy Mini Kit" 4) ("the PureLink™ RNA Mini Kit" 4) ("Kit (KAPA)" 4)
   ("Kit-" 4) ("the RNAqueous-Micro Kit" 4) ("RNA Mini Kit" 4)
   ("the Light Shift Chemiluminescent EMSA Kit" 4)
   ("an AllPrep DNA/RNA/Protein Mini Kit" 4)
   ("the EasySep Mouse Mammary Stem Cell Enrichment Kit" 4)
   ("Pure Link Hipure Plasmid Filter Maxiprep Kit" 4) ("Kit (BESTBIO)" 4)
   ("the QiaAmp DNA mini Kit" 4) ("the QIAamp RNA Blood Mini Kit" 4)
   ("Kit (SIDANSAI)" 4) ("Micro Kit" 4) ("Total Nucleic Acid Isolation Kit" 4)
   ("QuikChange® II Site-Directed Mutagenesis Kit" 4)
   ("ultra VIEW SISH Detection Kit" 4)
   ("ultra VIEW Universal DAB Detection Kit" 4)
   ("the High Pure RNA Paraffin Kit" 4) ("Western Blotting Detection Kit" 4)
   ("the SNaPshot Multiplex Kit" 4) ("QIAamp DNA Micro Kit" 4)
   ("Universal RNA Purification Kit" 4)
   ("the ATCC Universal Mycoplasma Detection Kit" 4) ("the RNA Mini Kit" 4)
   ("Kit (KIT)" 4) ("using PureLink RNA Mini Kit" 4)
   ("the Dual Luciferase Reporter Kit" 4) ("Micro BCA Protein Assay Kit" 4)
   ("the CellTiter-Glo Luminescent Cell Viability Assay Kit" 4)
   ("the ECL Western Blotting Kit" 4) ("Kit (OMEGA)" 4)
   ("the Bicinchoninic Acid Protein Assay Kit" 4) ("QIAamp® DNA Mini Kit" 4)
   ("the CpGenome Universal DNA Modification Kit" 4)
   ("a LightShift Chemiluminescent EMSA Kit" 4) ("the QIAamp® DNA Mini Kit" 4)
   ("the High Pure RNA isolation Kit" 4) ("High Capacity cDNA Archive Kit" 4)
   ("ProteoExtract Subcellular Proteome Extraction Kit" 4)
   ("using QIAmp DNA Blood Mini Kit" 4) ("using Micro BSA Protein Assay Kit" 4)
   ("the AdEasy Viral Titer Kit" 4) ("its soluble receptor c-kit" 4)
   ("Subcellular Proteome Extraction Kit" 4) ("using QIAmp DNA Mini Kit" 4)
   ("DNA Micro Kit" 4) ("a Blood Mini Kit" 4) ("an RNeasy mini Kit" 4)
   ("a DNA blood Mini Kit" 4) ("a High-Capacity cDNA Archive Kit" 4)
   ("an RNeasy Fibrous Tissue Mini Kit" 4) ("the Mini RNA Isolation II Kit" 4)
   ("the Western Breeze Immunodetection Kit" 4)
   ("the Absolutely RNA Miniprep Kit" 4) ("Kit (VWR)" 4)
   ("the RNEasy Mini Kit" 4) ("Kit (AMV)" 4) ("SCFR" 3)
   ("the QIAGEN RNeasy Mini Kit" 3) ("c-KIT-" 3) ("ONE-HOUR IP-Western Kit" 3)
   ("the LightShift™ Chemiluminescent EMSA Kit" 3) ("using RNeasy® Mini Kit" 3)
   ("an RNeasy Mini Kit (QIAGEN)" 3)
   ("High Pure PCR Template Preparation Kit" 3) ("AllPrep DNA/RNA Micro Kit" 3)
   ("Agilent RNA Pico 6000 LabChip Kit" 3) ("the Qiagen QIAamp DNA Mini Kit" 3)
   ("the DAKO Histology FISH Accessory Kit" 3)
   ("the Agilent Human Genome Microarray Kit 244A" 3)
   ("The QIAamp DNA Mini Kit" 3)
   ("using RecoverAll Total Nucleic Acid Isolation Kit" 3)
   ("the Quick Change-site-directed mutagenesis Kit" 3) ("Kit (WGA)" 3)
   ("using CelLytic Nuclear Extraction Kit" 3) ("soluble c-kit" 3)
   ("Kit (TUNEL)" 3) ("the REPLI-g Mini Kit" 3)
   ("LIVE Green Reactive Oxygen Species Detection Kit" 3)
   ("Dual Luciferase Kit" 3)
   ("the Low RNA Input Fluorescent Linear Amplification Kit" 3)
   ("the RNAqueous Kit" 3) ("DNA Mini Kit" 3) ("CD117 (KIT)" 3)
   ("the ABI Prism SNaPshot Multiplex Kit" 3) ("USB" 3)
   ("the UltraView Universal Dab Detection Kit" 3)
   ("High-Capacity cDNA Archive Kit" 3)
   ("an ABI PRISM SNaPshot Multiplex Kit" 3)
   ("v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog" 3)
   ("CD117-" 3) ("Brilliant II SYBR Green qPCR Master Mix Kit" 3)
   ("the Amino Allyl MessageAmp II aRNA Amplification Kit" 2)
   ("the Fluorometric ATP Assay Kit" 2)
   ("the Ultra Tech Detection System Kit" 2)
   ("All™ Total Nucleic Acid Isolation Kit" 2)
   ("the Supersignal Detection Kit" 2) ("the Dual Luc Kit" 2)
   ("the InviTrap Spin Cell RNA Mini Kit" 2) ("Fab Preparation Kit" 2)
   ("Universal cDNA Synthesis Kit" 2) ("illustra RNAspin Mini Kit" 2)
   ("the UltraClean™ Microbial DNA Isolation Kit" 2)
   ("using SuperSignal Western Pico or Femto ECL Kit" 2)
   ("Visualizer Western Blot Detection Kit" 2)
   ("the AllPrep DNA/RNA Mini Kit" 2)
   ("a JC‐1 Mitochondrial Membrane Potential Detection Kit" 2)
   ("the VECTASTAIN® Universal Elite ABC Kit" 2)
   ("the Micro BCA™ Protein Assay Kit" 2)
   ("the AllPrep DNA/RNA/Protein Mini Kit" 2) ("a Total RNA Mini Kit" 2)
   ("Tissue DNA isolation kit or QIAamp DNA Mini Kit" 2)
   ("The LightShift Chemiluminescent EMSA Kit" 2) ("RNeasy Mini Spin Kit" 2)
   ("a Subcellular Protein Fractionation Kit" 2)
   ("using ApoLive-Glo Multiplex Assay Kit" 2)
   ("the Bicinchoninic Acid (BCA) Protein Assay Kit" 2) ("Kit (USB)" 2)
   ("the Fluor de Lys-Green HDAC Assay Kit" 2)
   ("the HDAC Fluorimetric Assay/Drug Discovery Kit" 2)
   ("using RNAqueous Isolation Kit" 2) ("stem cell growth factor receptor" 2)
   ("using QIAGEN RNeasy Mini Kit" 2)
   ("MAPK/ERK pathway-specific Cignal SRE Reporter (luc) Kit" 2)
   ("The Universal R.T.U. Vectastain Elite ABC Kit" 2)
   ("a CellTiter96 Aqueous Non-Radioactive Cell Proliferation Assay (MTS) Kit"
    2)
   ("A Caspase-3 Colorimetric Assay Kit" 2)
   ("the Histofine SAB-PO (M) Immunohistochemical Staining Kit" 2)
   ("using RecoverAll Total Nucleic Acid isolation Kit" 2)
   ("the Oligotex mRNA Mini Kit (QIAGEN)" 2)
   ("a commercially available RNA High Pure Kit" 2) ("RNeazy Mini Kit" 2)
   ("the Vectastain Universal Quick Kit and DAB Peroxidase Substrate Kit" 2)
   ("using QIAamp DNA FFPE Mini Kit" 2) ("the MasterAmp Extra-Long PCR Kit" 2)
   ("the commercially available AxyPrep Blood Genomic DNA Miniprep Kit" 2)
   ("The Trevigen HT Universal 96-well PARP Assay Kit" 2)
   ("a Purelink™ RNA Mini Kit" 2) ("using PureLink Genomic DNA Mini Kit" 2)
   ("Ultraview Universal DAB Detection Kit" 2)
   ("AllPrep DNA/RNA/Protein Mini Kit" 2)
   ("using EuroGold Total RNA Mini Kit" 2) ("using QIAGEN Rnasy Mini Kit" 2)
   ("RecoverAll Total Nucleic Acid Isolation Kit" 2) ("a Plasmid Mini Kit" 2)
   ("a Immobilon™ Western Chemiluminescent Kit" 2)
   ("the Blood Mini Isolation Kit" 2)
   ("the Geneclean Turbo Nucleic Acid Purification Kit" 2)
   ("the Roche High Pure RNA Paraffin Kit" 2)
   ("a Total RNA Isolation Classic Kit" 2) ("the Immun-Star Western C Kit" 2)
   ("the American Type Tissue Culture (ATCC) Universal Mycoplasma Detection Kit"
    2)
   ("Trans-Lentiviral Packaging Kit" 2) ("a PrimeSTAR Mutagenesis Basal Kit" 2)
   ("Oligotex mRNA Mini Kit" 2) ("Agilent RNA 6000 Nano Kit" 2)
   ("using bicinchoninic acid (BCA) Protein Assay Kit" 2)
   ("total and phosphorylated KIT" 2) ("the DIG Northern Starter Kit" 2)
   ("ECL Western Blotting Detection Kit" 2) ("the RNeasy Mini Kit" 2)
   ("the Quantitative Telomerase Detection Kit" 2)
   ("the Blood Genomic Prep Mini Spin Kit" 2) ("a Qiagen Micro Kit" 2)
   ("the Apoptotic/Necrotic/Healthy Cells Detection Kit" 2)
   ("the V5-HIS Directional TOPO Cloning Kit" 2)
   ("the QIAshreder and RNeasy Mini Kit" 2)
   ("the Thermo Scientific LightShift Chemiluminescent EMSA Kit" 2)
   ("QiaAmp DNA Blood Mini Kit" 2) ("the Dual reporter luciferase assay Kit" 2)
   ("exogenous c-kit" 2)
   ("using commercial kit GFX™ PCR DNA and Gel Purification Kit" 2)
   ("an RNEasy Mini Kit" 2) ("the Tiangen DNA Mini Kit" 2)
   ("a HDAC Fluorometric Activity Assay Kit" 2)
   ("a using ONE-HOUR Western Basic Kit" 2)
   ("employing QIAamp® DNA Mini Kit" 2)
   ("the RecoverAll™ Total nucleic Acid Isolation Kit" 2) ("TUNEL KIT" 2)
   ("using miRCURY LNA™ Universal RT microRNA PCR Kit" 2) ("Kit (EXIQON)" 2)
   ("Kit (LDH)" 2) ("QIAGEN RNAEasy Mini Kit" 2)
   ("the Universal Tyrosine Kinase Assay Kit" 2) ("the AllPrep Mini Kit" 2)
   ("a SYBR® Premix Ex Taq™ ii (Perfect Real Time) Kit" 2)
   ("QIAamp DNA FFPE Tissue Kit and QIAamp DNA Mini Kit" 2)
   ("the InviTrap Spin Tissue RNA Mini Kit" 2)
   ("using QIAamp DNA Blood Mini Kit" 2)
   ("Chemiluminescent HRP Antibody Detection Kit" 2)
   ("The Kinase-Glo Luminescent Kinase Assays Kit" 2)
   ("using rapid homogenization spin-column Qiasheredder and RNeasy mini KIT"
    2)
   ("using High Capacity cDNA Reverse Transcription Kit" 2)
   ("the Simply RNA Maxwell Total RNA Purification Kit" 2)
   ("the Lactate Colorimetric Assay Kit" 2)
   ("Universal Alkaline Phosphatase Red Detection Kit" 2)
   ("the CellTiter 96 AQueous One Solution Cell Proliferation Assay Kit" 2)
   ("Universal Mini Kit" 2) ("a commercially available QIAmp Kit" 2)
   ("the Pico Pure DNA Extraction Kit" 2)
   ("the Histology FISH Accessory Kit" 2)
   ("the HT Universal Chemiluminescent PARP Assay Kit" 2)
   ("using M.O.M. Basic Kit" 2) ("an L-Amino Acid Assay Kit" 2)
   ("the ViraPower™ Lentiviral Support Kit" 2)
   ("the pPACKH1 Lentiviral Packaging Kit" 2)
   ("using Gentra Puregene Buccal Cell Kit" 2) ("a QIAgen RNeasy Mini Kit" 2)
   ("the ATP Bioluminescent Somatic Cell Assay Kit" 2)
   ("the Zero Blunt PCR Cloning Kit" 2) ("the Dual Glo Luciferase Assay Kit" 2)
   ("Cell Mini Kit" 2) ("LumiGLO Peroxidase Chemiluminescent Substrate Kit" 2)
   ("using Micro BCA TM Protein Assay Kit" 2)
   ("the Immobilon Chemiluminescent Substrate Kit" 2)
   ("the SensoLyte Homogeneous AMC Caspase-3/7 Assay Kit" 2)
   ("using AllPrep DNA/RNA Mini Kit" 2)
   ("the SIRT3 Fluorimetric Drug Discovery Kit" 2)
   ("SIRT1 Fluorimetric Drug Discovery Kit" 2)
   ("the SIRT3 Fluorimetic Drug Discovery Kit" 2)
   ("the High Capacity DNA Archive Kit" 2)
   ("the Secrete-Pair™ Dual Luminescence Assay Kit" 2)
   ("a colorimetric 5-bromo-2-deoxyuridine (BrdU) Cell Proliferation ELISA Kit"
    2)
   ("the commercial QIAmp DNA Kit" 2)
   ("The RNeasy Mini Kit RNA Extraction Kit" 2) ("Qiagen Mini Kit" 2)
   ("QIAmp DNA Blood Mini Kit" 2) ("a luminescent ATP Detection Kit" 2)
   ("JC-1 Mitochondrial Membrane Potential Detection Kit" 2)
   ("RNeasy Mini Kit (QIAGEN)" 2)
   ("the Agilent Total RNA Isolation Mini Kit" 2)
   ("using ProteoExtract Subcellular Proteome Extraction Kit" 2)
   ("using Nuclear Extract commercial Kit" 2)
   ("using High Pure RNA Paraffin Kit" 2)
   ("the OneArray Amino Allyl aRNA Amplification Kit" 2)
   ("a ProFound Mammalian Co-Immunoprecipitation Kit" 2) ("RNEASY MINI KIT" 2)
   ("Spin Universal RNA Mini Kit" 2) ("a Universal RNA Purification Kit" 2)
   ("Pure Kit" 2) ("the Agilent qPCR NGS Library Quantification Kit" 2)
   ("the Multiplex PCR Kit" 2) ("the Invisorb Spin Tissue Mini Kit" 2)
   ("the CellTiter 96 Aqueous Assay Kit" 2) ("KIT molecule" 2)
   ("full size dimeric KIT" 2) ("the Amaxa Mouse Neural Stem Cell Kit" 2)
   ("a cell Titer Aqueous Assay Kit" 2) ("Femto Chemiluminescent Kit" 2)
   ("a “negative” KIT D816V" 2)
   ("a SIRT1 or SIRT3 Fluorimetric Activity Assay/Drug Discovery Kit" 2)
   ("a SIRT5 Fluorimetric Activity Assay/Drug Discovery Kit" 2)
   ("normal c-KIT" 2) ("the genomic DNA purification mini Kit" 2)
   ("the In Vitro Vascular Permeability Assay Kit" 2)
   ("a ChargeSwitch® gDNA Mini Tissue Kit" 2)
   ("a NAD/NADH Quantitation Colorimetric Kit" 2)
   ("stem cell factor receptor (KIT)" 2) ("RNAqueous—Micro Kit" 2)
   ("using REPLI-g Mini Kit" 2) ("The Cells-to-cDNA II Kit" 2)
   ("the Visualizer Western Blot Detection Kit" 2) ("the Allprep Micro Kit" 2)
   ("All TM Total Nucleic Acid Isolation Kit" 2)
   ("ECL Western Blotting Substrate Kit" 2)
   ("High Pure PCR product purification Kit" 2)
   ("using UltraView Universal DAB Detection Kit" 2)
   ("the QiagenRNeasy Mini Kit" 2)
   ("Caspase-3/CPP32 activity Colorimetric Assay Kit" 2)
   ("coomassie brilliant blue staining Kit" 2) ("miRNeasy/Protect Mini Kit" 2)
   ("an OptiView DAB IHC Detection Kit" 2)
   ("the kit QIAamp DNA Blood Mini Kit" 2)
   ("a high-capacity cDNA Archive Kit" 2)
   ("using Universal cDNA Synthesis Kit" 2) ("RNAqueous Micro Kit" 2)
   ("weak cytoplasmic c-kit" 2) ("soluble c-kit protein" 2)
   ("a Western Breeze Chromogenic Western Blot Immunodetection Kit" 2)
   ("the SuperScript® III First Strand cDNA Synthesis Kit" 2)
   ("using QIAamp DNA Mini KIT" 2)
   ("using commercial PRMTs Chemiluminescent Assay Kit" 2)
   ("the QiaAMP DNA Mini Kit" 2)
   ("MACH 4 Universal HRP-Polymer Detection Kit" 2)
   ("the Immun-Star Western Kit" 2) ("a DNA Mini Kit" 2) ("Lactic Acid Kit" 2)
   ("the SIRT1 Direct Fluorescent Screening Assay Kit" 2)
   ("the CpGenomeTM Turbo Bisulfide Modification Kit" 2)
   ("using High Capacity cDNA Archive Kit" 2) ("the Immobilon Western Kit" 2)
   ("the GDH Activity Colorimetric Assay Kit" 2)
   ("the Agilent RNA 6000 Nano Kit" 2) ("A QIAamp DNA Blood Mini Kit" 2)
   ("the Sirt1 Direct Fluorescent Screening Assay Kit" 2)
   ("the RNeasy Lipid Tissue Mini Kit" 2)
   ("The Cignal NF-κB Reporter Luciferase Kit" 2)
   ("using QIAamp RNA Blood Mini Kit" 2) ("SNaPshot™ Multiplex Kit" 2)
   ("a Qiagen RNeasy Mini Kit" 2) ("Dual Luminescence Assay Kit" 2)
   ("the Absolutely RNA miRNA Kit" 2)
   ("using OptiView DAB IHC Detection Kit" 2)
   ("the UltraSensitive TM SP Kit" 2)
   ("the All‐prep DNA/RNA/miRNA Universal Kit" 2)
   ("a PureLink Viral RNA/DNA Mini Kit" 2)
   ("the Chemiluminescent Peroxidase Substrate-3 Kit" 2)
   ("using Total RNA Mini Kit" 2) ("the miRNeasy MINI KIT" 2)
   ("Pico Chemiluminescent Substrate Kit" 2)
   ("using RNeasy Mini Preparation Kit" 2) ("-Micro Kit" 2)
   ("RecoverAll™ Total Nucleic Acid Isolation Kit" 2)
   ("using Universal RNA purification Kit" 2)
   ("CellTiter-Glo Luminescent Cell Viability Assay Kit" 2)
   ("the QuikChange multi-site-directed mutagenesis Kit" 2)
   ("a Low RNA Input Fluorescent Linear Amplification Kit" 2)
   ("Prep Micro mRNA Purification Kit" 2) ("a QIAmp DNA Blood Mini Kit" 2)
   ("the CellLytic NuCLEAR Extraction Kit" 2)
   ("the QIAGEN DNA Blood Mini Kit" 2) ("the Qiagen Mini RNA Extraction Kit" 2)
   ("the Biovision Colorimetric Assay Kit" 2) ("the Rneasy mini Kit" 2)
   ("FoxO3a EZ-TFA Transcription Factor Assay Chemiluminescent Kit" 2)
   ("using RecoverAll™ Total Nucleic Acid Isolation Kit" 2)
   ("+ Dual Link System-HRP Kit" 2) ("the soluble c-kit" 2)
   ("the CellTiter 96 Aqueous One Solution Cell Proliferation Assay Kit" 2)
   ("Dual Labeled Polymer Kit" 2) ("CD117 (KIT) protein" 2)
   ("a ReadyPrep™ Sequential Extraction Kit" 2)
   ("an Amino Allyl MessageAmp™ II aRNA Amplification Kit" 2)
   ("using Dual Luciferase Assay Kit" 2) ("a Dual Luciferase Reporter Kit" 2)
   ("strong (3+) KIT" 2) ("the Adeno-X Viral Purification Kit" 2)
   ("the Illustra RNAspin mini Kit" 2)
   ("the Caspase-3 Fluorescent Assay Kit" 2) ("Escort™ IV Transfection Kit" 2)
   ("a ProteoExtract Subcellular Proteome Extraction Kit" 2)
   ("a commercial QuantiChrom Calcium Assay Kit" 2)
   ("the Neural Tissue Dissociation Kit" 2) ("Pico Chemiluminescent Kit" 2)
   ("using Qiagen RNAeasy Mini Kit" 2) ("the RNeasy Mini KIT" 2)
   ("overexpressed KIT" 2) ("RNAqueous Kit" 2) ("using Rneasy Mini Kit" 2)
   ("the QIAGEN® Multiplex PCR Kit" 2) ("RNeasy Mini Prep Kit" 2)
   ("the Immun-Star HRP Chemiluminescent Kit" 2)
   ("the ProteoExtract Subcellular Proteome Extraction (S-PEK) Kit" 2)
   ("RNeasy Lipid Tissue and QIAamp DNA Mini Kit" 2)
   ("an ECL Western blot Kit" 2) ("a Catalyzed Signal Amplification Kit" 2)
   ("the RNeasy lipid tissue Mini Kit" 2)
   ("the pCR- Blunt II-TOPO Expression Kit" 2) ("the RNeasy Lipid Mini Kit" 2)
   ("the column-based RNeasy Kit" 2) ("diabetic rats expressed c-kit" 2)
   ("the Cell Titer 96 Aqueous One Solution Cell Proliferation Assay Kit" 2)
   ("the Oligotex RNeasy Mini Kit" 2) ("Pico Pure Kit" 2)
   ("the Cellular DNA Flow Cytometric Analysis Kit" 2)
   ("the High Pure PCR Product Purification Kit" 2)
   ("the ULS aRNA Fluorescent Labeling Kit" 2)
   ("a Bicinchoninic Acid Assay Kit" 2)
   ("the Caspase-9 Colorimetric Activity Assay Kit" 2)
   ("the RecoverALL Total Nucleic Acid Isolation Kit" 2)
   ("a QuantiChrom Peroxide Assay colorimetric Kit" 2)
   ("an EnzyChrom Lactate Assay colorimetric Kit" 2) ("QIAmp DNA Mini Kit" 2)
   ("a DNA Blood Mini Kit" 2) ("Nonradioactive Akt Kinase Assay Kit" 2)
   ("the EZ1 RNA Universal Tissue Kit" 2) ("the Magna ChIP A Kit" 2)
   ("the QIAmp DNA Mini Kit" 2)
   ("Upstate Bio-technology or ChapionChIP One-Day Kit" 2)
   ("an In-Gel Tryptic Digestion Kit" 2) ("the Absolutely RNA Microprep Kit" 2)
   ("the SNaPshot® Multiplex Kit" 2) ("the immature markers CD117" 2)
   ("the MagNA Pure Compact RNA Isolation Kit" 2)
   ("the RecoverALL™ Total Nucleic Acid Isolation Kit" 2)
   ("the Senescent Cells Histochemical Staining Kit" 2)
   ("a Dual Luciferase Assay Kit" 2)
   ("using Superscript™ II Rnase H Reverse Transcriptase Kit" 2)
   ("the QIAGEN Multiplex PCR Kit" 2) ("Spin Cell Mini Kit" 2)
   ("the Qiagen Mini Kit" 2) ("the Promege Dual Luciferase Kit" 2)
   ("the Matchmaker One-Hybrid Kit" 2) ("using Aurum Total RNA Mini Kit" 2)
   ("using QIAshredder and RNeasy Mini Kit" 2)
   ("using RecoveryAll™ Total Nucleic Acid isolation Kit" 2)
   ("The RNAeasy Mini Kit" 2) ("using QIAGEN DNA Mini Kit" 2)
   ("The FITC-Conjugated Monoclonal Active Caspase-3 antibody apoptosis Kit" 2)
   ("the CpGenomic DNA modification Kit" 2) ("the QIAmp® DNA Micro Kit" 2)
   ("using RNAqueous® Micro
                    Kit"
    2)
   ("using CellTiter 96 Aqueous One Solution Cell Proliferation Assay Kit" 2)
   ("the enzyme-linked immunosorbent assay (ELISA)-based chemiluminescent NF-κB Binding Assay Kit"
    2)
   ("the ProteoExtract Subcellular Proteosome Extraction Kit" 2)
   ("RNAeasy Mini Kit" 2)
   ("the RNeasy
                    Mini Kit"
    2)
   ("Qiaprep Spin Mini Kit" 2) ("Zero Blunt TOPO PCR Cloning Kit" 2)
   ("the High Pure Viral RNA Kit" 2)
   ("the ultra View Universal DAB Detection Kit" 2)
   ("a commercial Sphingosine Kinase Activity Assay Kit" 2)
   ("the Chemagic DNA Blood Kit" 2)
   ("the Agilent Oligo CGH Hybridization Kit" 2)
   ("the colorimetric BCA Protein Assay Kit" 2)
   ("the Chemiluminescent Detection Kit" 2)
   ("using CelLytic NuCLEAR Extraction Kit" 2) ("DNA Mini M48 Kit" 2)
   ("the GFX Micro Plasmid Prep Kit" 2) ("using RNeasy Micro Kit" 2)
   ("Turbo Nucleic Acid Purification Kit" 2)
   ("using ECL Advance (or ECL) Western Blotting Detection Kit" 2)
   ("Kit (QAIGEN)" 2) ("using Chemilumicent Kit" 2) ("QiAamp DNA Mini Kit" 2)
   ("QIAamp Viral RNA Mini Kit" 2) ("cDNA Archive Kit" 2)
   ("the chemiluminescent blotting Substrate Kit" 2)
   ("TaqMan Universal PCR Master Mix Kit" 2)
   ("the ApoAlert Caspase-3 Colorimetric Assay Kit" 2)
   ("the RNAeasy Lipid Tissue Mini Kit" 2)
   ("Caspase-3/CPP32 Fluorometric Assay Kit" 2)
   ("a Brilliant SYBR® Green QPCR Core Reagent Kit" 2)
   ("using Agilent RNA 6000 Pico Kit" 2)
   ("the Power Vision+ poly-HRP IHC Kit" 2)
   ("chromogenic detection UltraViewTMUniversal DAB Detection Kit" 2)
   ("the Qiagen AllPrep DNA/RNA Mini Kit" 2) ("TIANpure Mini Plasmid Kit" 2)
   ("the Brilliant II Sybr Green QRT–PCR Master Mix Kit" 2)
   ("the RPA III RNase Protection Assay Kit" 2)
   ("the Dual Luciferase Reporter Assay System Kit" 2)
   ("the QuikChange® II XL Site-Directed Mutagenesis Kit" 2)
   ("the LightShift Chemiluminescent Kit" 2)
   ("a High Pure PCR Product Purification Kit" 2) ("a Rneasy Mini Kit" 2)
   ("in Vitro Vascular Permeability Assay Kit" 2)
   ("the Chemiluminescent LightShift Assay Kit" 2) ("the RNAeasy® Mini Kit" 2)
   ("the DNeasy Blood and Tissue kit or QIAamp DNA Blood Mini Kit" 2)
   ("chemiluminescent electrophoretic mobility shift analysis (EMSA) Kit" 2)
   ("the QCM™ 24-Well Colorimetric Cell Migration Assay Kit" 2)
   ("the High-Prostate canceracity cDNA Archive Kit" 2)
   ("the ProteoExtract Subcellular Proteome Extraction Kit" 2)
   ("polyvalent secondary antibody KIT" 2) ("Perfectly Blunt Cloning Kit" 2)
   ("VWR" 2) ("Rneasy Micro Kit" 2)
   ("Magnetic Chromatin Immunoprecipitation Kit" 2)
   ("the PCRExtract Mini Kit" 2) ("the GelExtract Mini Kit" 2)
   ("a commercial KIT" 2)
   ("the QuickChange R II Site-Directed Mutagenesis Kit" 2)
   ("Cell Titer 96-Aqueous Assay Kit" 2)
   ("the Fluorescent DNA Quantitation Kit" 2) ("p-c-Kit" 2)
   ("the QIAmp DNA mini Kit" 2)
   ("using CytoSelect 96-well Cell Migration Kit" 2)
   ("High Pure Isolation Kit" 2) ("Cignal NFκB Reporter (GFP) Kit" 2)
   ("a High Pure RNA Paraffin Kit" 2) ("the High Pure RNA Tissue Kit" 2)
   ("the RNAeasy Mini Kit" 2) ("the High-Capasity cDNA Archive Kit" 2)
   ("the ZR Plasmid Miniprep Classic Kit" 2)
   ("the Cytometric Bead Array Mouse Inflammation Kit" 2)
   ("the pcDNA™3.1 Directional TOPO® Expression Kit" 2) ("Turbo DNAase Kit" 2)
   ("using DeadEnd TM Colorimetric TUNEL System Kit" 2)
   ("the Upstate (Millipore) ChIP Kit" 2)
   ("Cathepsin B Activity Fluorometric Assay Kit" 2)
   ("Qiagen DNA Mini blood Kit" 2) ("using Chemiluminescent Detection Kit" 2)
   ("BrightStar BioDetect Kit" 2)
   ("BrightStar Psoralen-Biotin Nonisotopic Labeling Kit" 2)
   ("the Universal Mycoplasma Detection Kit" 2)
   ("An Absolutely RNA Miniprep Kit" 2)
   ("the Ilustra blood genomic Prep Mini spin Kit" 2)
   ("a commercially available ChIP Assay Kit" 2)
   ("using QuiAmp DNA Mini Kit" 2) ("miRNEasy Mini Kit" 2)
   ("the high-capacity cDNA archive Kit" 2)
   ("using QIAGEN miRNeasy Mini Kit" 2)
   ("a SIRT1 Fluorimetric Drug Discovery Kit" 2)
   ("the immature cell surface marker c-Kit" 2)
   ("the ERE Cignal Reporter Assay Kit" 2) ("RNeasy Fibrous Tissue Mini Kit" 2)
   ("the Dual luciferase Reporter Kit" 2)
   ("the CellTitre 96 Aqueous One Solution Cell Proliferation Assay Kit" 2)
   ("a CellTitre 96 Aqueous One Solution Cell Proliferation Assay Kit" 2)
   ("the TNT Quick-coupled Transcription/Translation Kit" 2)
   ("QuikChange® II XL Site-Directed Mutagenesis Kit" 2)
   ("the colorimetric BrdU ELISA Kit" 2) ("the Qiagen Multiplex PCR Kit" 2)
   ("the detergent-compatible BCA™ Protein Assay Kit" 2)
   ("the CD117 magnetic MicroBeads Kit" 2) ("a Naive B Cell Isolation Kit" 2)
   ("CellTiter 96® AQueous One Solution Cell Proliferation Assay Kit" 2)
   ("Tissue Mini Kit" 2) ("Turbo Dicer siRNA Generation Kit" 2)
   ("using RNeasy Lipid Tissue Mini Kit" 2)
   ("the High Pure FFPE RNA miRNA Isolation Kit" 2)
   ("the commercially available QIAamp DNA Blood Mini Kit" 2)
   ("the Amaxa Human Dermal Fibroblast Nucleofector Kit" 2)
   ("using Brilliant II SYBR Green qRT-PCR Master Mix Kit" 2)
   ("using QuikChange® II Site-Directed Mutagenesis Kit" 2)
   ("Viral NA Small Volume Kit" 2)
   ("EdU CellCycle 488-Red (7-AAD) Assay Kit" 2) ("the QIAmp DNA Micro Kit" 2)
   ("Optiview DAB IHC Detection Kit" 2) ("using Turbo DNA-free Kit" 2)
   ("the Ilustra™ blood genomic Prep Mini spin Kit" 2)
   ("malachite green-based PP2A Immunoprecipitation Phosphatase Assay Kit" 2)
   ("the M.O.M. Basic Kit" 2) ("the Bioluminescent ATP Determination Kit" 2)
   ("homozygous and heterozygous KIT" 2)
   ("the ULS RNA Fluorescent Labeling Kit" 2) ("the MEGAclear Kit" 2)
   ("An RNeasy Mini Kit" 2) ("using LightShift Chemiluminescent EMSA Kit" 2)
   ("the Dual Luciferase Assay System Kit" 2)
   ("the COMET Assay rReagent Kit" 1) ("nonfunctional c-Kit" 1)
   ("a Qiagen DNA Mini Extraction Kit" 1) ("only KIT D816V" 1)
   ("the Kappa Robust PCR Kit" 1) ("Qiagen miRNeasy Mini Kit" 1)
   ("the AMAXA Basic Nucleofector Kit" 1)
   ("immunofluorescence-based PathScan® Apoptosis and Proliferation Multiplex IF Kit"
    1)
   ("here cross-inhibited c-KIT-" 1) ("using In-gel Tryptic Digestion Kit" 1)
   ("an AllPrep DNA/RNA Mini Kit" 1) ("a Qiagen RNEasy Mini Kit" 1)
   ("Super-Sensitive Detection Kit" 1) ("the EZ1 RNA Cell Mini Kit" 1)
   ("using Qiagen Blood and Cell Culture DNA Mini Kit" 1)
   ("PE-conjugated Monoclonal Active Caspase-3 Antibody Apoptosis Kit" 1)
   ("a Bicinchoninic Acid Kit" 1) ("Western Blotting Kit" 1)
   ("i-genomic CTB DNA Extraction Mini Kit" 1)
   ("Dual Link Horseradish Peroxidase Kit" 1)
   ("the SuperScript™ III Platinum® SYBR® Green Two-Step RT-qPCR Kit" 1)
   ("the Immun-Star WesternC Chemiluminescent Detection Kit" 1)
   ("Femto Chemiluminescent Substrate Kit" 1) ("using miRNeasy Micro Kit" 1)
   ("ECL Advanced Western Blot detection Kit" 1)
   ("the Light Shift® Chemiluminescent EMSA Kit" 1)
   ("Western Blot Detection Kit" 1) ("a miRNeasy Mini Kit (QIAGEN)" 1)
   ("Zero Blunt PCR Cloning Kit" 1) ("than KIT" 1)
   ("PhosphoPlus p44/p42 MAPK (ERK1/2) (Thr202/Tyr204) Antibody Kit" 1)
   ("QuickChange® II Site-Directed Mutagenesis Kit" 1)
   ("the Renilla-Firefly Luciferase Dual Assay Kit" 1)
   ("Enzyme-linked Immunosorbent Assay Kit" 1)
   ("a CellTiter-Glo Luminescent Cell Viability Assay Kit" 1)
   ("the only c-Kit peptide" 1) ("c-Kit peptide" 1)
   ("the BioVision Caspase 3 Fluorometric Assay Kit" 1)
   ("Universal cDNA Synthesis Kit (EXIQON)" 1) ("divergent KIT" 1)
   ("a Lactate Colorimetric Assay Kit" 1)
   ("Hexokinase Colorimetric Assay Kit" 1) ("Optical Kit" 1)
   ("the ultra View DAB Universal Detection Kit" 1)
   ("Universal Mycoplasma Detection Kit" 1)
   ("the Qiagen Allprep DNA/RNA Mini Kit" 1)
   ("16 robotic system and DNA IQ™ Casework Pro Kit" 1)
   ("a commercially available Cy™ Dye Termination Kit" 1)
   ("an Agilent RNA 6000 Nano Assay Kit" 1)
   ("Chemiluminescent Detection ECL Kit" 1) ("the Ultra Vision LP Kit" 1)
   ("the Thermo Scientific LightShift Chemiluminescent RNA EMSA Kit" 1)
   ("an iView DAB Universal Kit" 1) ("a Chemiluminescent EMSA Kit" 1)
   ("the CytoSelect 96-Well Cell Transformation Assay Kit" 1)
   ("SIRT2 Direct Fluorescent Screening Assay Kit" 1)
   ("SIRT1 Direct Fluorescent Screening Assay Kit" 1)
   ("a RecoverAll Total Nucleic Acid Isolation Kit" 1)
   ("the RNeasy Mini Kit(QIAGEN)" 1)
   ("using Caspase-3 Colorimetric Assay Kit" 1) ("the Genomic DNA Mini Kit" 1)
   ("a commercially available CycLex SIRT1/Sir2 Deacetylase Fluorometric Assay Kit"
    1)
   ("Mini Kit (Qiagen) according the manufacturer’s" 1)
   ("the OptiView universal DAB Detection Kit" 1)
   ("than the patient group not expressing CD117 in fibroblast-like stromal cells"
    1)
   ("Ab-Match Universal Kit" 1) ("both total and phosphorylated KIT" 1)
   ("AllPrep DNA/RNA Mini Kit (QIAGEN)" 1)
   ("KAPA Sybr Fast universal qPCR Kit" 1) ("–c-kit" 1) ("robust KIT" 1)
   ("Cell-to-cDNA II Kit" 1) ("basic Nucleofector Kit" 1)
   ("the NEB Next Ultra RNA Library Prep Kit" 1)
   ("patients indeed only bear wild type KIT" 1) ("frequently KIT D816V" 1)
   ("The EnVision FLEX Mini Kit" 1)
   ("using Subcellular Protein Fractionation Kit" 1)
   ("using PrimeSTAR Mutagenesis Basal Kit" 1)
   ("the Secrete-Pair TM Dual Luminescence Assay Kit" 1)
   ("Agilent Gene Expression Hybridization Kit" 1) ("neoplastic KIT" 1)
   ("the QIAamp DNA Mini Kit (QIAGEN)" 1) ("indirectly target KIT" 1)
   ("TAKARA" 1)
   ("the commercial One-Color Microarray-Based Gene Expression Analysis (version 5.5) Kit"
    1)
   ("An Agilent Enzymatic Labeling Kit" 1) ("the Puregene Buccal Cell Kit" 1)
   ("the kit Qiagen RNeasy Mini Kit" 1) ("GATK" 1)
   ("A Caspase 3 Fluorometric Protease Assay Kit (MBL)" 1)
   ("a QIAGEN RNeasy Mini Kit" 1) ("PRMTs Chemiluminescent Assay Kit" 1)
   ("using Amplite TM Universal Fluorimetric Kinase Assay Kit" 1)
   ("an RNA prep pure Plant Kit" 1) ("QIAamp Micro Kit" 1)
   ("JC-10 Mitochondrial Membrane Potential Assay Kit" 1)
   ("the Qiagen RNeasy Mini Kit (QIAGEN)" 1)
   ("using BD Cytometric Bead Array (CBA) Human Inflammatory Cytokines Kit" 1)
   ("a DNA Blood Mini Kit (QIAGEN)" 1) ("The Ultra Vision LP Kit" 1)
   ("Taq Man Fast Universal Kit" 1)
   ("PrimeScript 1st Strand cDNA Synthesis Kit (TAKARA)" 1)
   ("the RNeasy Mini Preparation Kit (QIAGEN)" 1)
   ("monoclonal mouse IgG1 anti-human c-KIT" 1) ("c-kit+/sca1-" 1)
   ("c-kit+/Sca1-" 1) ("C-kit+/Sca1-" 1) ("a Promega Dual Luciferase Kit" 1)
   ("cellular Kit" 1) ("serum soluble c-kit" 1) ("functional KIT" 1)
   ("the Agilent Low RNA Input Linear Amplification Kit" 1)
   ("TCF/LEF Cignal Reporter Assay Kit" 1) ("the RNeasy™ Mini Kit (QIAGEN)" 1)
   ("the Atlas™ Glass Fluorescent Labeling Kit" 1)
   ("using MagAttract DNA Mini M48 Kit" 1) ("using RNeasy Mini Kit (QIAGEN)" 1)
   ("a Pure gene DNA Extraction Kit" 1) ("a Basic Nucleofector Kit" 1)
   ("c-kit (KIT)" 1) ("RPA III Ribonuclease Protection Assay Kit" 1)
   ("the RecoverAll Total Nucleic Acid Isolation Kit" 1)
   ("using High Pure RNA Isolation Kit" 1)
   ("the Qiagen QIAamp DNA Micro Kit" 1) ("The Bio-Rad Western Blot Kit" 1)
   ("QAIGEN RNeasy Mini Kit" 1)
   ("the Magna ChIP A Chromatin Immunoprecipitation Kit" 1) ("AMV" 1)
   ("a quantitative Telomerase Detection Kit" 1)
   ("QCM™24-Well Fluorimetric Cell Migration Array Kit" 1)
   ("HotStar Taq® Master Mix Kit" 1)
   ("the Tandem-E PSA ImmunoEnzyMetric Assay Kit" 1)
   ("Subcellular Protein Fractionation Kit" 1)
   ("commercially available Annexin V–FITC Apoptosis Detection Kit" 1)
   ("c-Kit-" 1) ("the Qiagen Blood DNA Mini Kit" 1)
   ("PCR Kit (Clontech, Mountain View, CA) according the manufacturer's" 1)
   ("Amersham ECL Advance Western Blotting Detection Kit" 1)
   ("PKH26 Red Fluorescent Cell Linker Kit" 1)
   ("an RNeasy Plant Mini Kit (QIAGEN)" 1)
   ("the QIAamp DNA Blood Mini Kit (QIAGEN)" 1) ("QIAGEN DNA Blood Mini Kit" 1)
   ("the RNeasy© Mini Kit" 1) ("human c-kit" 1) ("the QIAGEN DNA Mini Kit" 1)
   ("Qiagen QIAamp DNA Blood Mini Kit" 1)
   ("a commercial AcycloPrime™-FP SNP Detection Kit" 1)
   ("RNAeasy Mini Qiagen Kit" 1) ("Dual Luciferase Assay Kit" 1)
   ("the OxiSelect™ Oxidative DNA Damage ELISA Kit" 1)
   ("the Agilent SureSelect Human All Exon Kit" 1)
   ("PKH26 Red Fluorescent Cell Linker Kit and PKH2 Green Fluorescent Phagocytic Cell Linker Kit"
    1)
   ("here showed normal KIT" 1) ("a promisingly strong KIT" 1)
   ("The Affymetrix One-round in vitro transcription (IVT) RNA Amplification Kit"
    1)
   ("the commercially available BRAF Pyro Kit (QIAGEN)" 1)
   ("the Agilent QuikChange II XL Site-Directed Mutagenesis Kit" 1)
   ("CD117 protein" 1) ("Proto-oncogene c-KIT" 1)
   ("QIAamp® DNA Blood Mini Kit" 1)
   ("Enzyme-Linked Immunosorbent Assay (ELISA) Kit" 1)
   ("ECL Advance Western Blotting Detection Kit" 1)
   ("the Colloidal Blue Staining Kit" 1) ("Colloidal Blue Staining Kit" 1)
   ("the CytoSelect 96-Well In Vitro Tumor Sensitivity Assay (Soft Agar Colony Formation) Kit"
    1)
   ("the EnVision TM IHC Detection System Kit" 1)
   ("Healthy Cell Quantitation Kit" 1)
   ("The nonradioactive cell proliferation MTS Assay Kit" 1)
   ("Amino AllylMessageAmp™ II aRNA Amplification Kit" 1)
   ("a universal RNA Purification Kit" 1) ("Kit (ATCC)" 1)
   ("an APOPCYTO Caspase-3 Colorimetric Assay Kit" 1)
   ("the Amino Ally MessageAmp aRNA Kit" 1)
   ("Fluorescent NAD/NADH Detection Kit" 1)
   ("the colorimetric MethylFlash Methylated DNA Quantification Kit" 1)
   ("the Invitrogen PureLink PCR Micro Kit" 1)
   ("than CD117 alone in the metastatic tumours" 1)
   ("the Universal DakoCytomation LSAB + Kit" 1) ("no homozygous KIT" 1)
   ("heterozygous KIT" 1)))
 ("UP:P10733" (("Severin" 1)))
 ("UP:P10735" (("TKO" 306) ("-TKO" 79) ("‘TKO’" 1)))
 ("UP:P10745" (("retinoid" 237) ("Retinoid" 9)))
 ("UP:P10747"
  (("CD28" 1539) ("anti-CD28" 383) ("YMNM" 28) ("Cd28" 24)
   ("soluble anti-CD28" 22) ("-CD28" 19) ("CD28-" 13)
   ("2 μg/ml soluble anti-CD28" 4) ("CD28 peptide" 2) ("Anti-CD28" 2)
   ("the costimulatory receptor CD28" 2) ("0.5 µg/ml soluble anti-CD28" 2)
   ("the co-stimulatory receptor CD28" 2) ("Soluble anti-CD28" 2)
   ("mouse monoclonal anti-human CD28" 2) ("than wild-type CD28" 1)
   ("cell-stimulatory CD28" 1) ("than ICOS YMNM" 1) ("naive DO11 CD28 +/+" 1)
   ("the co-stimulatory molecule CD28" 1)))
 ("UP:P10767" (("HST2" 32) ("FGF6" 5)))
 ("UP:P10768" (("ESD" 10) ("FGH" 3) ("Esd" 2)))
 ("UP:P10809"
  (("HSP60" 108) ("Hsp60" 67) ("HSPD1" 18) ("hsp60" 12) ("GroEL" 8)
   ("heat shock protein 60" 7) ("chlamydial Hsp60" 4) ("Rubisco" 4)
   ("Hsp60 protein" 3) ("HSP-60" 3) ("-hsp60" 1)
   ("bacterial
Hsp60 protein"
    1)
   ("the chlamydial Hsp60" 1) ("HSP 60" 1) ("bacterial Hsp60" 1)))
 ("UP:P10826"
  (("RAR-β" 205) ("RARB" 97) ("RARβ" 77) ("RAR-beta" 6)
   ("Retinoic acid receptor-beta" 1) ("retinoic acid receptor beta ( RARB )" 1)
   ("retinoic acid receptor beta" 1) ("RARbeta" 1)))
 ("UP:P10827" (("THRA" 72) ("THRA-" 1))) ("UP:P10828" (("THRB" 7)))
 ("UP:P10845" (("BOTOX" 2) ("BNA" 2)))
 ("UP:P10889" (("macrophage inflammatory protein-2" 12)))
 ("UP:P10894" (("PLCβ1" 106) ("PLCβ1 protein" 3) ("phospholipase C-β1" 2)))
 ("UP:P10896"
  (("RA" 5490) ("-RA" 20) ("seropositive RA" 16) ("ACPA-positive RA" 13)
   ("RA-" 9) ("incident RA" 7) ("severe RA" 5) ("autoantibody-positive RA" 5)
   ("anti-CCP-positive and anti-CCP-negative RA" 3) ("Ra" 2) ("erosive RA" 2)
   ("confirmed incident or prevalent RA" 2) ("definite RA" 2)
   ("327 seropositive RA" 2) ("RA (JRA)" 2) ("well-established/chronic RA" 1)
   ("experimental RA" 1) ("than PP2 + RA" 1) ("early erosive RA" 1)
   ("included 132 incident RA" 1) ("rheumatoid factor-positive RA" 1)
   ("rheumatoid factor-positive and rheumatoid factor-negative RA" 1)
   ("seropositive or seronegative RA" 1) ("72 Caucasian RA" 1)
   ("449 Caucasian RA" 1) ("functional RA" 1) ("‘RA’" 1)
   ("ACPA-positive and ACPA-negative RA" 1) ("3,929 seropositive RA" 1)
   ("289 seropositive RA" 1) ("only seropositive RA" 1) ("Definite RA" 1)
   ("than RA" 1) ("exogenous RA" 1) ("RA (STRA)" 1)
   ("genome-wide significance P  RA" 1) ("less RA" 1) ("subsequent RA" 1)
   ("developed RA" 1)))
 ("UP:P10909"
  (("CLU" 502) ("clusterin" 99) ("CLI" 87) ("Clusterin" 56) ("apoJ" 45)
   ("CLU protein" 29) ("ApoJ" 20) ("Secretory clusterin" 16) ("p-CLU" 10)
   ("apolipoprotein J" 8) ("Cl-I" 7) ("APO J" 4) ("clu" 3)
   ("overexpressed CLU" 3) ("Clusterin (CLU)" 3)
   ("both intracellular full-length pre-secretory clusterin" 2) ("pCLU" 2)
   ("Secretory Clusterin" 2) ("secretory clusterin" 2) ("Clu" 2)
   ("basal CLU" 2) ("SGP-2" 2) ("endogenous cellular CLU" 2)
   ("clusterin (CLU) protein" 1) ("high basal CLU" 1) ("Clusterin protein" 1)
   ("the mature CLU protein" 1)))
 ("UP:P10911" (("Dbl" 314) ("DBL" 15) ("dbl" 9) ("Dbl protein" 5) ("Dbl-" 4)))
 ("UP:P10912"
  (("GHR" 340) ("GH receptor" 67) ("growth hormone receptor" 39) ("GHRs" 25)
   ("growth hormone receptor (GHR)" 6) ("GH RECEPTOR" 4) ("the mature GHR" 3)
   ("Growth hormone receptor" 2) ("growth hormone receptor (GR)" 2)
   ("exogenous GHR" 2) ("mature GHR" 2) ("the mature (130kD) GHR" 2)
   ("the architypal GH receptor" 1) ("dimeric GHRs" 1) ("monomeric GHR" 1)
   ("exogenous GHRs" 1) ("total mature GHR" 1) ("GH binding protein" 1)
   ("GH receptor (GHR)" 1)))
 ("UP:P10914"
  (("IRF1" 291) ("IRF-1" 242) ("interferon regulatory factor 1" 19)
   ("interferon regulatory factor-1" 9) ("IRF-1 protein" 4) ("IRF1 protein" 3)
   ("Interferon regulatory factor-1" 3) ("Interferon regulatory factor 1" 3)
   ("irf1" 2) ("viral interferon regulatory factor-1" 2) ("-IRF1" 1)
   ("Irf-1" 1) ("viral interferon regulatory factor 1" 1) ("Irf1" 1)
   ("minimal IRF-1" 1) ("interferon regulatory factor–1" 1)))
 ("UP:P10915" (("HAPLN1" 14) ("CRTL1" 5)))
 ("UP:P10916" (("MLC2v" 7) ("MYL2" 3)))
 ("UP:P10923" (("OP" 195) ("E. coli strain OP50" 1)))
 ("UP:P10971" (("HL-33" 6)))
 ("UP:P10997" (("IAPP" 10) ("islet amyloid polypeptide" 4) ("amylin" 1)))
 ("UP:P11021"
  (("GRP78" 1346) ("BiP" 201) ("HSPA5" 66) ("Bip" 41) ("GRP78 protein" 22)
   ("Grp78" 21) ("glucose-regulated protein" 20) ("BiPs" 12) ("BiPS" 10)
   ("bip" 9) ("grp78" 7) ("Glucose-regulated protein" 7) ("-HSPA5" 6)
   ("BiP protein" 6) ("Hspa5" 5) ("78 kDa glucose-regulated protein" 3)
   ("GRP-78" 3) ("78 kDa glucose-regulated protein" 3)
   ("Immunoreactive HSPA5" 2)
   ("namely cell surface glucose-regulated protein" 2) ("more GRP78" 2)
   ("the ER-resident HSP70 family member HSPA5" 2) ("GRP 78" 2)
   ("78 kDa glucose-regulated protein" 2) ("membrane-associated GRP78" 2)
   ("cell membrane-associated GRP78" 2) ("intact GRP78 protein" 2)
   ("78 kDa glucose-regulated protein" 1) ("exogenous and endogenous GRP78" 1)
   ("immunoglobulin heavy chain-binding protein" 1) ("-BiP" 1)
   ("antiapoptotic BiP" 1)))
 ("UP:P11030"
  (("ODN" 699) ("more STAT3-decoy ODN" 2) ("the complementary ODN" 2)
   ("ODN-" 1) ("STAT3-decoy ODN's" 1)))
 ("UP:P11039" (("pETM" 15))) ("UP:P11040" (("ets" 84)))
 ("UP:P11047" (("LAMC1" 19))) ("UP:P11049" (("CD37" 3)))
 ("UP:P11055" (("Myh3" 1))) ("UP:P11075" (("SEC7" 1)))
 ("UP:P11077" (("mu1" 3) ("Mu1" 1))) ("UP:P11086" (("PNMT" 17)))
 ("UP:P11087" (("Cola1" 2))) ("UP:P11089" (("FLA" 63)))
 ("UP:P11137"
  (("MAP2" 188) ("MAP-2" 55) ("microtubule-associated protein 2" 34)
   ("microtubule-associated protein-2" 12) ("Map2" 9)
   ("all three neuronal markers MAP2" 4) ("the neuronal marker MAP2" 3)
   ("the neuronal markers MAP2" 3)
   ("the dendritic marker microtubule-associated protein 2" 2) ("MAP2C" 2)
   ("MAP2c" 1) ("three neuronal markers MAP2" 1) ("neuronal marker MAP2" 1)
   ("Microtubule-associated protein 2" 1)))
 ("UP:P11141" (("hsp-6" 2) ("HSP-6" 1)))
 ("UP:P11142"
  (("Hsc70" 247) ("HSC70" 129) ("HSPA8" 60) ("Hsp73" 15) ("hsc70" 5)
   ("HSPA8 protein" 3)
   ("HSC70 (also known as HSPA8, Hsp70-8 and HSP73) protein" 2) ("HSP73" 2)
   ("LAP-1" 2) ("Hspa8" 2) ("HSc70" 1) ("the stress-induced proteins HSC70" 1)
   ("Hspa8 protein" 1)))
 ("UP:P11146" (("HSC2" 9))) ("UP:P11147" (("HSC4" 1)))
 ("UP:P11150"
  (("HL" 1378) ("LIPC" 65) ("hepatic lipase" 11) ("nodular sclerosis HL" 4)
   ("classical HL" 4) ("hepatic lipase ( LIPC )" 3) ("EBV-associated HL" 3)
   ("776 EBV-negative HL" 2) ("HL (MCHL)" 2) ("Classical HL" 2) ("hl" 2)
   ("EBV-negative HL" 2) ("hepatic type" 1) ("nodular sclerosing HL" 1)
   ("hepatic lipase (LIPC)" 1) ("EBV-positive HL" 1)
   ("the nodular sclerosis HL" 1) ("lymphocyte predominant HL" 1)
   ("other classical HL" 1) ("the classical HL" 1) ("287 EBV-positive HL" 1)
   ("Nodular sclerosis HL (NSHL)" 1) ("HL (NSHL)" 1) ("HL-" 1) ("P-HL" 1)
   ("735 eligible HL" 1) ("473 classical HL" 1) ("Hepatic lipase" 1)
   ("non-HIV-related HL" 1) ("EBV-associated HIV-HL" 1) ("lipase C" 1)))
 ("UP:P11155" (("pPDK1" 38) ("p-PDK1" 14) ("pPdk1" 3)))
 ("UP:P11161"
  (("EGR2" 23) ("Krox-20" 17) ("Egr2" 14) ("Krox20" 10) ("Egr-2" 8)
   ("krox20" 4) ("KROX20" 2) ("EGR-2" 2) ("early growth response protein 2" 2)
   ("early growth response 2" 1) ("egr2" 1)))
 ("UP:P11166"
  (("GLUT1" 651) ("Glut1" 142) ("GLUT-1" 115) ("Glut-1" 62) ("GLUT" 55)
   ("Gtr1" 20) ("SLC2A1" 17) ("GLUTs" 9) ("GLUT1 protein" 9)
   ("Glut1 protein" 8) ("GluT1" 4) ("glut1" 3) ("heterogeneous GLUT1" 2)
   ("the GLUT1-positive human breast cancer specimens displayed generally homogenous GLUT1"
    2)
   ("epithelial GLUT1" 2) ("gtr1" 2) ("GluTs" 2) ("GLUT-1-" 2) ("than Gtr1" 1)
   ("more GLUT1" 1) ("a well-characterized HIF-1 target glut1" 1)
   ("double-Flag-tagged Glut1" 1)))
 ("UP:P11168"
  (("Glut2" 33) ("SLC2A2" 24) ("Glut 2" 22) ("GLUT2" 16) ("glut2" 1)
   ("GluT2" 1)))
 ("UP:P11169" (("SLC2A3" 7)))
 ("UP:P11171"
  (("band 4.1" 28) ("EPB41" 10) ("protein 4.1" 6) ("EL1" 3) ("Band 4.1" 3)
   ("P4.1" 2) ("erythrocyte membrane protein band 4.1" 2)))
 ("UP:P11172" (("OPRT" 83) ("UMPS" 2) ("UMP synthase" 1) ("Oprt" 1)))
 ("UP:P11177" (("PDHB" 21) ("pDHB" 5)))
 ("UP:P11182"
  (("pDBT" 9) ("DBT" 3) ("dbT" 2) ("dbt" 2)
   ("the centromeric low copy vector pDBT" 1)))
 ("UP:P11184"
  (("relaxin" 63) ("Relaxin" 3) ("the human LGR8 both the relaxin" 1)))
 ("UP:P11215"
  (("CD11b" 666) ("MAC-1" 25) ("Cd11b" 15) ("CD11B" 12) ("ITGAM" 10)
   ("Itgam" 6) ("CD11b protein" 3) ("CD11b-" 2)
   ("than MAC-1 established in 1985" 1)))
 ("UP:P11216" (("PYGB" 6))) ("UP:P11217" (("PYGM" 1)))
 ("UP:P11226"
  (("MBL" 204) ("MBPC" 78) ("MBL2" 10) ("MBL2-" 2) ("mannose-binding lectin" 1)
   ("Mannose-binding lectin" 1) ("mannose binding lectin" 1) ("pMBL" 1)))
 ("UP:P11229"
  (("acetylcholine receptor" 13) ("aneural acetylcholine receptor" 2)
   ("CHRM1" 1)))
 ("UP:P11233"
  (("RalA" 3446) ("RAL" 176) ("RALA" 99) ("RalA protein" 18)
   ("dominant-negative RalA protein" 2) ("membrane-associated RalA" 2)
   ("at least partially targets RalA" 2)
   ("the C-terminal 30 amino acids of RalA" 1) ("RAL-" 1) ("membranous RAL" 1)
   ("study RAL's" 1) ("far-western assay human RalA" 1) ("“sh-RalA”" 1)
   ("than the parent activated RalA79L" 1)
   ("the C-terminal 30 amino acids of RalA (RalBP1-RalA)" 1) ("RALS" 1)
   ("Ras-driven PDAC tumor cells RalA" 1)
   ("the last 30 amino acids of RalA (RalBP1-RalA, constitutively active due to membrane anchorage by the RalA sequence)"
    1)
   ("dominant-negative (DN)–RalA" 1) ("–RalA" 1)))
 ("UP:P11234"
  (("RalB" 1705) ("RALB" 77) ("RalB protein" 10) ("RalB(S198A) protein" 3)
   ("RalB peptide" 2) ("phosphomimetic RalB" 2) ("membrane-associated RalB" 2)
   ("than RALB" 1) ("“sh-RalB”" 1) ("than RalB" 1)))
 ("UP:P11245" (("aac2" 1)))
 ("UP:P11274"
  (("BCR" 2646) ("Bcr" 704) ("bcr" 35) ("BcR" 30)
   ("breakpoint cluster region" 27) ("Bcr peptide" 13) ("BCR-" 8)
   ("distal BCR" 5) ("BCR−" 5) ("pBCR" 3) ("a functional BCR" 3)
   ("Breakpoint Cluster Region" 3) ("breakpoint cluster region (BCR)" 3)
   ("normal BCR" 2) ("the major breakpoint cluster region" 2) ("-BCR" 2)
   ("a monoclonal BCR" 2) ("the first 902 or 927 amino acids of BCR" 1)
   ("functional BCR" 1) ("proximal BCR" 1) ("Breakpoint cluster region" 1)
   ("Bcr–" 1) ("the Cap II BCR" 1) ("less BCR" 1) ("no more BCR" 1)
   ("than BCR crosslinking" 1) ("smaller BCR" 1)))
 ("UP:P11277" (("SPTB" 148) ("recurrent SPTB" 2)))
 ("UP:P11279"
  (("lysosomal" 1774) ("LAMP1" 217) ("LAMP-1" 156) ("CD107a" 109) ("Lamp1" 104)
   ("Lysosomal" 48) ("Lamp-1" 19) ("lysosomal protein" 18)
   ("subsequent lysosomal" 5) ("lysosome associated membrane protein 1" 4)
   ("Lamp1-" 2) ("lysosome-associated membrane protein 1" 2)
   ("excessive lysosomal" 2) ("the late endosomal/lysosomal marker Lamp1" 2)
   ("late endosomal/ lysosomal marker protein Lamp-1" 2)
   ("defective lysosomal" 2) ("lysosomal protein (RILP)" 2)
   ("an essential lysosomal protein" 1) ("the mature lysosomal" 1)
   ("the late endosomal/lysosomal molecule LAMP-1" 1)
   ("their potential lysosomal" 1) ("a conserved self-digestive lysosomal" 1)
   ("proliferative lysosomal" 1)
   ("the late endosomal/lysosomal marker LAMP1" 1)
   ("the late endosomal marker LAMP-1" 1) ("a stable line expressing Lamp1" 1)
   ("autophagic lysosomal" 1) ("its efficient lysosomal" 1)
   ("late endosomal-lysosomal marker LAMP-1" 1)))
 ("UP:P11308"
  (("ERG" 2022) ("ERG protein" 20) ("pERG" 10) ("homogeneous ERG" 4) ("ERG-" 3)
   ("Erg" 2) ("non-recordable ERG" 2) ("the homogenous ERG" 2) ("ERG+/PTEN-" 2)
   ("than ERG (Figure  xref )" 1) ("-ERG" 1) ("expressing ERG" 1)))
 ("UP:P11309"
  (("Pim-1" 1128) ("Pim1" 440) ("PIM1" 414) ("LY-294002" 133) ("PIM-1" 57)
   ("Pim-1 protein" 35) ("pim-1" 8) ("overexpressed PIM1" 7)
   ("LY-294002 (LY)" 3) ("serine/threonine-protein kinase Pim-1" 2)
   ("-Pim-1" 2) ("than PIM1" 2) ("Pim1-" 2) ("Pim1 protein" 2) ("pim1" 2)
   ("PIM1 protein" 2) ("pim-1-" 1) ("P11309" 1) ("triple Pim1  −/−" 1)
   ("PIM 1" 1)))
 ("UP:P11310"
  (("MCAD" 99) ("systemic MCAD" 8) ("severe MCAD" 4) ("more systemic MCAD" 1)))
 ("UP:P11314" (("SIGMA 2" 1)))
 ("UP:P11346" (("DRaf-1" 6) ("dRAF" 2) ("DRAF" 1)))
 ("UP:P11362"
  (("FGFR1" 5020) ("Fgfr1" 95) ("FGFR-1" 82)
   ("fibroblast growth factor receptor 1" 65) ("pFGFR1" 51)
   ("FGFR1 protein" 35) ("FLG" 16) ("fibroblast growth factor receptor-1" 12)
   ("FGFR1-" 6) ("FGFR 1" 6) ("strong pFGFR1" 4) ("weak pFGFR1" 4)
   ("more intense FGFR1" 4) ("fgfr1" 3) ("pFGFR1 protein" 3) ("intact FGFR1" 3)
   ("a strong pFGFR1" 2) ("a weak pFGFR1" 2)
   ("significantly more nuclear FGFR1" 2) ("the most FGFR1" 2)
   ("dominant-negative FGFR1" 2) ("than FGFR1" 2) ("Membranous FGFR1" 2)
   ("chimeric FGFR1" 2) ("available FGFR1" 1) ("P11362" 1)
   ("the cytoplasmatic pFGFR1" 1)
   ("18 revealed membranous activated pFGFR1 protein" 1)
   ("representative FGFR1" 1) ("flt2" 1) ("at least 4 FGFR1" 1)
   ("at least four FGFR1" 1) ("exongenous wild type FGFR1" 1)
   ("105 biochemically-screened kinases FGFR1" 1)
   ("approximately neutral FGFR1" 1)
   ("than FGFR1 indicating that it may use a different endocytic mechanism than FGFR1"
    1)
   ("The second-ranked network implicated FGFR1" 1) ("epithelial Fgfr1" 1)
   ("five or more FGFR1" 1) ("classical FGFR1" 1)
   ("activated chimeric FGFR1" 1)))
 ("UP:P11369" (("Long INterspersed Element-1s" 2)))
 ("UP:P11387"
  (("Top1" 278) ("TOP1" 85) ("DNA topoisomerase I" 19) ("mild Top1" 2)
   ("DNA Topoisomerase 1" 1) ("top1" 1) ("stalled Top1" 1)))
 ("UP:P11388"
  (("TOP2A" 643) ("TOP2" 14) ("Top2" 8) ("top2" 3) ("TOP2A protein" 2)
   ("Top2a" 2) ("normal TOP2A" 1) ("Top2A" 1)))
 ("UP:P11413"
  (("G6PD" 844) ("glucose-6-phosphate dehydrogenase" 67)
   ("Glucose-6-phosphate dehydrogenase" 13) ("g6pd" 12) ("G6PD protein" 6)
   ("G6pd" 5) ("-G6PD" 3) ("G-6PD" 2)))
 ("UP:P11433" (("Cdc24" 11))) ("UP:P11437" (("AvrA" 12) ("avrA" 1)))
 ("UP:P11441" (("Ubl4A" 94))) ("UP:P11455" (("N-term" 123) ("N-Term" 3)))
 ("UP:P11464" (("PSG1" 1)))
 ("UP:P11473"
  (("VDR" 1379) ("Vdr" 106) ("VDR protein" 11) ("-VDR" 10)
   ("vitamin D3 receptor" 5) ("NR1I1" 4) ("most VDR" 2) ("functional VDR" 2)
   ("exogenous VDR" 2) ("exogenous wild type VDR" 2)
   ("than inApc min/+ Vdr +/+" 2)
   ("Biodesign International #B65860G (Saco ME) VDR" 1)
   ("at least one ligand-activated VDR" 1) ("VDR-" 1)
   ("than those ofApc min/+ Vdr +/+" 1)))
 ("UP:P11474"
  (("ERRα" 331) ("ESRRA" 14) ("myocardial ERRα" 5) ("Nr3b1" 4) ("NR3B1" 3)
   ("Estrogen Related Receptor alpha" 3) ("overexpressed ERRα" 2)
   ("myocardial ERRα protein" 2) ("ERRα protein" 2)
   ("Estrogen related receptor alpha" 2) ("KO decreased myocardial ERRα" 2)
   ("ERRalpha" 1)))
 ("UP:P11487"
  (("FGF3" 17) ("FGF-3" 16) ("Fgf3" 6) ("fibroblast growth factor 3" 4)
   ("INT2" 1)))
 ("UP:P11491" (("Pho8" 2)))
 ("UP:P11498"
  (("pyruvate" 2190) ("PCB" 127) ("Pyruvate" 82) ("PCBs" 65)
   ("pyruvate (GIBCO)" 12) ("pCbS" 10) ("coplanar PCBs" 9) ("Coplanar PCBs" 4)
   ("GIBCO" 3) ("non-ortho-substituted coplanar PCBs" 3) ("pyruvate (PAN)" 3)
   ("exogenous pyruvate" 2) ("supplemental sodium pyruvate" 2)
   ("cell permeable pyruvate" 2) ("pyruvate (PEP)" 1)
   ("10% fetal bovine serum, penicillin/streptomycin and sodium pyruvate" 1)
   ("10% fetal bovine serum and sodium pyruvate" 1) ("pyruvate (PA)" 1)
   ("pyruvate (LONZA)" 1) ("processing excessive pyruvate" 1)
   ("pyruvate (MP)" 1) ("the ubiquitous metabolite pyruvate" 1)))
 ("UP:P11509" (("CYP2A6" 37)))
 ("UP:P11511"
  (("aromatase" 766) ("CYP19" 157) ("CYP19A1" 145) ("ARO" 143)
   ("androstenedione" 81) ("aromatase activity" 53) ("Aromatase" 44)
   ("TTTA" 17) ("Aromatase activity" 13) ("Cyp19" 10) ("aromatase protein" 9)
   ("-androstenedione" 5) ("estrogen synthase" 3) ("Cyp19a1" 3)
   ("only weak (1+) aromatase" 2) ("cytochrome P450 19A1" 2) ("CYP19 TTTA" 2)
   ("adrenal-derived androstenedione" 1) ("CYP19 (TTTA)" 1)
   ("CYP19 TTTA(11–13)" 1) ("Aromatase protein" 1)
   ("premenopausal women aromatase" 1) ("local aromatase" 1) ("p450arom" 1)))
 ("UP:P11532"
  (("DMD" 152) ("dystrophin" 21) ("DMD−" 9) ("Dystrophin" 2)
   ("a complete DMD" 1)))
 ("UP:P11542" (("LG4" 1)))
 ("UP:P11586"
  (("MTHFD1" 33) ("methylenetetrahydrofolate dehydrogenase" 8)
   ("formyltetrahydrofolate synthetase" 2)
   ("methenyltetrahydrofolate cyclohydrolase" 1)))
 ("UP:P11597"
  (("CETP" 78) ("cholesteryl" 10) ("cholesteryl ester transfer protein" 8)
   ("cholesteryl ester transfer protein (CETP)" 1) ("Cholesteryl" 1)
   ("cholesteryl ester transfer protein ( CETP )" 1)))
 ("UP:P11598" (("Q-2" 3))) ("UP:P11632" (("NHP6A" 1)))
 ("UP:P11678"
  (("EPX" 8) ("eosinophil peroxidase" 3) ("eosinophil peroxidase (EPO)" 1)))
 ("UP:P11684"
  (("CCSP" 151) ("Up1" 61) ("CC10" 32) ("doxycycline-treated CCSP" 7)
   ("Scgb1a1" 5) ("Up1 molecule" 2) ("uteroglobin" 2)
   ("never Clara cell marker CCSP" 1)))
 ("UP:P11686"
  (("SPC" 133) ("SP-C" 77) ("SpC" 32) ("surfactant protein C" 18) ("SFTPC" 16)
   ("SPCs" 9) ("Sp5" 7) ("Sftpc" 5) ("pSPC" 4)
   ("the ATII-cell-specific surfactant protein C" 2) ("sftpc" 2)
   ("the alveolar type 2 cell-specific marker SP-C" 2) ("Spc" 2)
   ("Surfactant Protein C" 2) ("the alveolar SP-C" 2)
   ("the Clara cell marker CC10 and type II cell marker surfactant protein C"
    2)
   ("SP-C protein" 1) ("surfactant Protein C" 1)))
 ("UP:P11712" (("CYP2C9" 144) ("polypeptide 9" 3) ("CYP2C9-" 1)))
 ("UP:P11717"
  (("IGF2R" 117) ("CI-MPR" 24) ("IGF-II receptor" 23) ("IGF-2R" 21)
   ("CIMPR" 16) ("CI-M6PR" 13) ("soluble IGF2R" 2) ("IGF2R protein" 2)
   ("IGF-2R protein" 2) ("CSF soluble IGF2R" 1) ("IGF2 receptor" 1)
   ("-IGF2R" 1)))
 ("UP:P11734" (("LM8" 2))) ("UP:P11746" (("Mcm1" 7)))
 ("UP:P11764" (("pilE" 1))) ("UP:P11766" (("FDH" 118) ("ADH5" 1)))
 ("UP:P11792" (("Sch9" 18) ("SCH9" 5) ("sch9" 2)))
 ("UP:P11802"
  (("CDK4" 3252) ("Cdk4" 507) ("cdk4" 460) ("cyclin-dependent kinase 4" 94)
   ("cdk-4" 44) ("cyclin dependent kinase 4" 25) ("CDK4 protein" 25)
   ("Cyclin-dependent kinase 4" 12) ("overexpressed CDK4" 11) ("CDK4-" 9)
   ("CDK-4" 7) ("Cdk4-" 7) ("-CDK4" 5) ("cyclin-dependent kinase-4" 4)
   ("cdk4 protein" 4) ("Cyclin dependent kinase 4" 3) ("CdK4" 3)
   ("Cyclin-dependent kinase-4" 3) ("immunoreactive cdk4" 2) ("CDk4" 2)
   ("mouse monoclonal anti-human CDK4" 2) ("Overexpressed CDK4" 2) ("cdk4-" 2)
   ("sporadic breast cancers overexpressed CDK4" 2)
   ("such hyperactive p21/p27-unbound CDK4" 1) ("than endogenous CDK4" 1)
   ("the active phosphorylated cyclin D1/3-bound CDK4" 1)
   ("than CDK4 bound to T57D p21 ( xref )" 1) ("Cdk4 protein" 1)
   ("more cdk4" 1) ("CdK-4" 1) ("less CDK4" 1) ("than CDK4" 1)
   ("CDK4 (GAGATTACTTTGCTGCCTTAA)" 1) ("authentic cdk-4" 1) ("Cdk4 (CST)" 1)
   ("cdks4" 1) ("finally glutamate Glu144 CDK4" 1) ("-Cdk4" 1)
   ("a physiologic Cdk4-" 1)))
 ("UP:P11831"
  (("SRF" 420) ("serum response factor" 67) ("serum response factor (SRF)" 4)
   ("strong SRF" 2) ("CIDER associated SRF" 1) ("Serum response factor" 1)
   ("-SRF" 1)))
 ("UP:P11836" (("MS4A1" 9))) ("UP:P11837" (("NIMA" 26)))
 ("UP:P11880" (("MRA" 52))) ("UP:P11890" (("Hsp23" 1)))
 ("UP:P11895" (("HOK" 46)))
 ("UP:P11908" (("PRPS2" 61) ("phosphoribosyl pyrophosphate synthetase 2" 10)))
 ("UP:P11912"
  (("IgA" 177) ("Igα" 81) ("Mb1" 76) ("mb-1" 30) ("CD79a" 23) ("mb1" 13)
   ("MB1" 8) ("Cd79a" 7) ("CD79A" 6) ("Ig-α" 5) ("normal IgA" 1) ("pMB1" 1)
   ("the Ig-associated protein Ig-α" 1) ("Ig–α" 1) ("focal CD79a" 1)))
 ("UP:P11916" (("RCR" 20)))
 ("UP:P11926"
  (("paralogue" 123) ("ornithine decarboxylase" 31)
   ("ornithine decarboxylase (ODC)" 6) ("a functional paralogue" 4)
   ("the somatic paralogue" 2) ("Ornithine decarboxylase" 2)
   ("a previously isolated paralogue" 1) ("ornithine decarboxylase 1" 1)))
 ("UP:P11940"
  (("PABPC1" 157) ("PABP1" 27) ("poly(A)-binding protein" 15)
   ("poly(A)-binding protein (PABP)" 6) ("cytoplasmic 2" 6)
   ("Poly(A)-Binding Protein" 1) ("Poly(A)-binding protein" 1)))
 ("UP:P11970" (("PC-B" 4))) ("UP:P11978" (("Sir4" 3) ("SIR4" 3) ("siR4" 2)))
 ("UP:P12004"
  (("PCNA" 11319) ("proliferating cell nuclear antigen" 291)
   ("proliferating cell nuclear antigen (PCNA)" 91) ("PCNA protein" 47)
   ("-PCNA" 44) ("PCNAs" 26) ("Proliferating cell nuclear antigen" 20)
   ("PCNA-" 18) ("Pcna" 17) ("overexpressed PCNA" 9) ("–PCNA" 9)
   ("PCNA Protein" 8) ("trimeric PCNA" 7) ("exogenous PCNA" 7)
   ("chromatin-associated PCNA" 7) ("than PCNA" 6) ("soluble PCNA" 4)
   ("pcna" 3) ("pCNA" 3) ("than unmodified PCNA" 3) ("Exogenous PCNA" 3)
   ("a canonical PCNA" 2) ("defective PCNA" 2)
   ("proliferating cell nuclear antigen (PCNA) protein" 2)
   ("potentially new PCNA" 2) ("unmodifiable PCNA" 2) ("PCNA molecule" 2)
   ("FLAG-tagged modifiable WT PCNA" 2) ("the pET28/FLAG-PCNA-WT/HA- PCNA" 2)
   ("Proliferating cell nuclear antigen (PCNA)" 2) ("two functional PCNA" 2)
   ("homotrimeric PCNA" 2) ("the heterotrimeric Sulfolobus PCNA" 2)
   ("monomeric PCNA" 2) ("the homotrimeric PCNA" 2)
   ("residual monoubiqutinated PCNA" 2) ("Mouse monoclonal anti PCNA" 2)
   ("membrane-associated PCNA" 2)
   ("NKp44-Ig-coated beads precipitated soluble PCNA" 2) ("Soluble PCNA" 2)
   ("partially His Ub-modified PCNA" 2)
   ("The resultant monoubiquitinated PCNA" 2)
   ("its potential interaction partner PCNA" 2) ("a functional PCNA" 2)
   ("than the native PCNA" 1) ("more PCNA" 1)
   ("Red Fluorescent Protein (RFP)-PCNA" 1) ("than those expressing PCNA-WT" 1)
   ("those expressing exogenous PCNA-WT" 1) ("the indicated exogenous PCNA" 1)
   ("than unmodified PCNA (Supplementary Figure S6)" 1)
   ("than unmodified PCNA (Figure  xref , xref )" 1) ("PCNA (CST)" 1)
   ("PCNA (DAKO)" 1) ("elongated hLigI initially contacts PCNA" 1)
   ("The heterotrimeric PCNA" 1) ("the ring-shaped homotrimeric PCNA" 1)
   ("the multi-ubiquitinated proteins proliferating cell nuclear antigen (PCNA)"
    1)
   ("sequentially access PCNA" 1) ("exogenous recombinant PCNA" 1)
   ("the more plastic human PCNA" 1) ("a monomeric PCNA protein" 1)
   ("soluble, transfected, or endogenous PCNA" 1)
   ("NKp44-Ig-coated beads precipitated native PCNA" 1)
   ("soluble PCNA protein" 1) ("prominent PCNA" 1)
   ("Spartan preferentially binds ubiquitylated PCNA" 1) ("archaeal PCNA" 1)
   ("P12004" 1) ("its auxiliary protein PCNA" 1)
   ("the auxiliary protein proliferating cell nuclear antigen (PCNA)" 1)
   ("than unmodified PCNA suggesting" 1) ("than PCNA [ xref , xref ]" 1)
   ("HGFL increased chromatin-bound PCNA" 1) ("loaded PCNA" 1)
   ("The homotrimeric ring PCNA" 1)))
 ("UP:P12018" (("VpreB" 2)))
 ("UP:P12019"
  (("phosphodiesterase-1" 2) ("Phosphodiesterase 1" 2)
   ("phosphodiesterase 1" 2)))
 ("UP:P12020"
  (("sialoprotein" 39) ("Sialoprotein" 6) ("sialoprotein (BSP)" 5)
   ("Sialoprotein (BSP)" 2)))
 ("UP:P12021" (("apomucin" 4)))
 ("UP:P12023"
  (("AG" 2457) ("A-G" 66) ("pAG" 8) ("canonical AG" 5)
   ("Metabion International AG" 4) ("‘AG’" 4) ("AG-" 2) ("\"GU-AG\"" 2)
   ("-AG" 2) ("the heterozygous AG" 2) ("A–G" 2) ("nearby AG" 2)
   ("a canonical AG" 2) ("AG18735(RTS)" 2)
   ("CTT TCC AGG GAG G T G TGG CCT GGG CG and CGC CCA GGC CAC A CC TCC CTG GAA AG"
    1)
   ("“AG”" 1) ("-GAA GTA GGT TCC A G T AGT AAT GAA GTG GGC TCC AG-3" 1)
   ("JAK inhibitor AG490" 1) ("the dispensable upstream AG" 1)
   ("a neighboring AG" 1) ("orthologous AG" 1) ("neighboring AG" 1)
   ("explanatory AG" 1) ("the wild allele G. Genotype AG" 1)
   ("The heterozygous genotype AG" 1) ("heterozygous genotype AG" 1)))
 ("UP:P12034" (("FGF5" 26) ("Fgf5" 12)))
 ("UP:P12035"
  (("K 3" 33) ("CK3" 13) ("k  3" 8) ("K  3" 2) ("keratin 3" 2) ("k 3" 2)
   ("the positively corneal epithelial-specific marker CK3" 2) ("k  −3" 1)))
 ("UP:P12036"
  (("NFH" 35) ("NF-H" 8) ("NEFH" 3)
   ("the terminally differentiated neuronal marker neurofilament heavy polypeptide"
    2)
   ("neurofilament heavy polypeptide" 2) ("Nefh" 2)
   ("The arctic phosphatase treatment dephosphorylated NFH" 1)))
 ("UP:P12074" (("COX6A1" 1)))
 ("UP:P12081" (("histidyl-tRNA synthetase" 5) ("HARS protein" 2) ("HARS" 1)))
 ("UP:P12104" (("FABP2" 3) ("IFABP" 2) ("Fabp2" 1) ("fabp2" 1)))
 ("UP:P12107" (("collagen XI" 4) ("COL11A1" 3) ("type XI" 1)))
 ("UP:P12109" (("type VI" 6) ("COL6A1" 6) ("Col6a1" 2)))
 ("UP:P12110" (("COL6A2" 1))) ("UP:P12111" (("COL6A3" 16)))
 ("UP:P12235"
  (("SLC25A4" 2) ("Adenine nucleotide translocator 1" 2) ("P12235" 1)))
 ("UP:P12236" (("ANT3" 1)))
 ("UP:P12259" (("factor V" 34) ("Factor V" 17) ("coagulation factor V" 5)))
 ("UP:P12268"
  (("IMPDH2" 290) ("inosine monophosphate dehydrogenase 2" 8)
   ("cellular IMPDH2" 3) ("partially knockdown IMPDH2" 1)
   ("completely knockdown IMPDH2" 1)))
 ("UP:P12270"
  (("TPR" 731) ("Tpr" 398) ("TPRs" 142) ("TPR protein" 25) ("tpr" 17)
   ("Tpr protein" 10) ("coexpressed TPR protein" 2) ("roughly 14 TPRs" 1)
   ("adjacent TPRs" 1) ("nucleoporin Tpr's" 1)))
 ("UP:P12271" (("CRALBP" 4)))
 ("UP:P12272"
  (("PTHrP" 581) ("PTHLH" 35) ("parathyroid hormone-related protein" 18)
   ("Parathyroid hormone-related protein" 8)
   ("parathyroid hormone related protein" 8) ("the osteolytic factor PTHrP" 2)
   ("intermittent PTHrP" 1) ("PTHrp" 1)
   ("-parathyroid hormone-related protein" 1) ("more PTHrP" 1)
   ("exogenous PTHrP" 1)))
 ("UP:P12273"
  (("GCDFP15" 36) ("GCDFP-15" 12) ("prolactin-induced protein" 7)
   ("gross cystic disease fluid protein 15" 6)
   ("cystic disease fluid protein-15" 3)
   ("gross cystic disease fluid protein-15" 3)
   ("prolactin-inducible protein" 2)
   ("than GCDFP-15 (92 vs. 78% for overall positivity)" 1)))
 ("UP:P12277" (("CKB" 2)))
 ("UP:P12314"
  (("CD64" 23) ("IGFR1" 19) ("IGFR-1" 12) ("Fcgr1" 9) ("FcRI" 6) ("FCGR1a" 4)
   ("Fc fragment of IgG" 3) ("IGF-R1" 3) ("high affinity Ia" 2) ("FCGR1" 2)
   ("FCGR1A" 1)))
 ("UP:P12318"
  (("FCGR2A" 36) ("FcγRIIa" 32) ("FcγRIIA" 10) ("FCGR2" 5)
   ("the phagocytic Fc-gamma receptor FcγRIIa" 1) ("FCGR2a" 1)))
 ("UP:P12319" (("FCER1A" 28)))
 ("UP:P12356"
  (("p21 protein" 773) ("p21 proteins" 81) ("p21 Protein" 10) ("P21 protein" 8)
   ("-p21 protein" 7) ("overexpressed UCA1 reduced p21 protein" 2)
   ("functional p21 protein" 2) ("point-mutated ras p21 proteins" 2)
   ("An unstable or altered p21 protein" 2)
   ("acutely increase exogenous p21 protein" 1) ("P21 protein-" 1)
   ("the p21 protein induced by HDAC shRNAs" 1) ("exogenous p21 proteins" 1)
   ("particular p21 proteins" 1) ("Aberrant p21 proteins" 1)
   ("most p21 protein" 1) ("intact p21 protein" 1)))
 ("UP:P12370" (("CDK-A" 10))) ("UP:P12383" (("TPE1" 1)))
 ("UP:P12412" (("SHEP" 67))) ("UP:P12427" (("DAM" 1)))
 ("UP:P12428" (("BW" 74) ("bw" 1))) ("UP:P12429" (("ANXA3" 8) ("ANX3" 1)))
 ("UP:P12524" (("L-MYC" 42) ("MYCL" 28) ("L-Myc" 14) ("MYCL1" 14) ("L-myc" 2)))
 ("UP:P12532" (("CKMT1A" 1) ("CKMT1B" 1)))
 ("UP:P12544"
  (("HFs" 20) ("granzyme A" 5) ("Granzyme A" 4) ("all lesional HFs" 2)
   ("normal HFs" 2) ("senescent HFs" 1)))
 ("UP:P12608" (("IRPA" 1))) ("UP:P12611" (("WHI2" 4)))
 ("UP:P12630" (("BAR-1" 1))) ("UP:P12639" (("UL29" 31)))
 ("UP:P12643"
  (("BMP-2" 308) ("BMP2" 134) ("Bmp2" 39) ("bone morphogenetic protein 2" 25)
   ("bone morphogenetic protein-2" 14) ("BMP-2-" 6)
   ("Bone morphogenetic protein 2" 3) ("Bone morphogenetic protein-2" 2)
   ("the latter instance BMP-2" 1)))
 ("UP:P12644"
  (("BMP4" 348) ("BMP-4" 63) ("bone morphogenetic protein 4" 11) ("Bmp4" 5)
   ("exogenous BMP4" 2) ("bone morphogenetic protein-4" 1) ("bmp4" 1)))
 ("UP:P12645" (("BMP-3" 5))) ("UP:P12685" (("Trk1" 1) ("TRK1" 1)))
 ("UP:P12688" (("Ypk1" 2))) ("UP:P12694" (("MSU" 22) ("BCKDHA" 2)))
 ("UP:P12706" (("INS1" 45) ("Ins1" 3) ("ins1" 1)))
 ("UP:P12707" (("Ins2" 11) ("INS2" 5) ("ins2" 1)))
 ("UP:P12724"
  (("ECP" 12) ("RNASE3" 10) ("eosinophil cationic protein" 4) ("Ecp" 1)))
 ("UP:P12755"
  (("Ski" 546) ("SKI" 60) ("Ski protein" 20) ("SKi" 7)
   ("Ski (491-728) protein" 7) ("ski" 7) ("Ski (1-491) protein" 6) ("c-Ski" 3)
   ("overexpressed Ski" 2) ("the associated Ski" 1)))
 ("UP:P12757"
  (("SnoN" 337) ("SNO" 233) ("SKIL" 7) ("-SnoN" 3) ("SkiL" 3)
   ("Ski-related protein" 2)
   ("the nuclear transcriptional co-repressor SnoN" 2) ("Skil" 2) ("SNO-" 1)
   ("whereby all SNO" 1) ("than wt SnoN in the nucleus" 1) ("SnoN-" 1)
   ("SnoN protein" 1)))
 ("UP:P12763" (("asialofetuin" 13) ("Asialofetuin" 2)))
 ("UP:P12791" (("Cyp2b10" 6) ("cyp2b10" 3)))
 ("UP:P12804" (("prothrombinase" 4)))
 ("UP:P12814"
  (("α-actinin" 145) ("α-actinin-1" 7) ("ACTN1" 4) ("α-Actinin1" 2)
   ("α-actinin protein" 2) ("sarcomeric α-actinin" 1) ("alpha-actinin-1" 1)))
 ("UP:P12821"
  (("ACE" 389) ("converting enzyme" 79) ("angiotensin-converting enzyme" 29)
   ("angiotensin converting enzyme" 20) ("-converting enzyme" 7)
   ("converting enzyme (TACE)" 6) ("Angiotensin-converting enzyme" 3)
   ("Angiotensin converting enzyme" 3) ("dcp-1" 2) ("converting enzyme-" 2)
   ("-converting enzyme (TACE)" 2)
   ("the abundance-based coverage estimator model ACE" 1)
   ("angiotensin-converting enzyme (ACE)" 1)
   ("“tumor necrosis factor-alpha-converting enzyme”" 1) ("DCP-1" 1)
   ("angiotensin converting enzyme (ACE)" 1)))
 ("UP:P12830"
  (("E-cadherin" 17359) ("CDH1" 2911) ("Cdh1" 2776) ("E-cad" 641)
   ("E-Cadherin" 546) ("Ecad" 423) ("ECAD" 248) ("E-cadherin protein" 147)
   ("e-cadherin" 139) ("E-Cad" 104) ("E-cadherins" 49)
   ("epithelial cadherin" 40) ("soluble E-cad" 31) ("membranous E-cadherin" 26)
   ("-Ecad" 21) ("–E-cadherin" 16) ("cdh1" 16) ("E-CADHERIN" 15)
   ("E-cadherin molecule" 14) ("Cdh1-" 12) ("E-CAD" 11) ("CDH1 protein" 10)
   ("Epithelial cadherin" 10) ("junctional E-cadherin" 10)
   ("soluble E-cadherin" 9) ("intact E-cadherin" 9) ("cadherin 1" 8)
   ("CD324" 8) ("-CDH1" 7) ("Ecadherin" 7)
   ("extensively N-glycosylated E-cadherin" 7) ("intact e-cadherin" 7)
   ("dominant-negative E-cadherin" 6) ("serum soluble E-cad" 6)
   ("Soluble E-Cadherin" 6) ("E-Cadherin protein" 6) ("than E-cadherin" 5)
   ("cadherin-1" 5) ("E-cad molecule" 5) ("exogenous Cdh1" 5)
   ("more E-cadherin" 5) ("ECad" 4) ("Epithelial Cadherin" 4) ("Cadherin-1" 4)
   ("E-cadherin-" 4) ("-Cdh1" 3) ("the mature E-cadherin" 3) ("E–cadherin" 3)
   ("surface-bound E-cadherin" 3) ("overexpressed E-cadherin" 3) ("“CDH1”" 3)
   ("“E-cadherin”" 3) ("uvomorulin" 3) ("Cdh1 protein" 3) ("Ecad molecule" 3)
   ("strong E-cadherin" 3) ("directly targets CDH1" 3)
   ("epithelial E-cadherin" 3) ("miR-9 directly targets CDH1" 3)
   ("E-cadherin peptide" 3) ("the junctional E-cadherin" 2)
   ("consistent membranous E-cadherin" 2)
   ("significantly brighter E-cadherin" 2) ("strong continuous E-cadherin" 2)
   ("-ECad" 2)
   ("the parental 76NE6 cells display strong membranous E-cadherin" 2)
   ("more CDH1" 2) ("the lentiviral vector pWZL Blast mouse E-cadherin" 2)
   ("E-cad protein" 2)
   ("c-erbB2 signalling (i.e., commenced the EMT process) still expressed surface-bound E-cadherin"
    2)
   ("functional E-cadherin" 2) ("Transcriptional E-cad" 2)
   ("transcriptional E-cadherin" 2) ("CAM 120/80" 2) ("cdh1 protein" 2)
   ("tailless Ecad" 2) ("We first expressed wild-type E-cadherin" 2)
   ("Monoclonal anti-human E-cadherin" 2) ("siRNA reduced E-cadherin’s" 2)
   ("endogeous E-cadherin" 2) ("endogenous junctional E-cadherin" 2)
   ("Strong membranous E-cadherin" 2)
   ("paired normal tissue specimens all demonstrated diffuse strong membranous E-cadherin"
    2)
   ("decreased membranous E-cadherin" 2) ("Similarly punctate E-cadherin" 2)
   ("total cellular E-cadherin" 2) ("intense E-cadherin" 2) ("pCDH1" 2)
   ("the membranous E-cadherin" 2) ("residual E-cadherin" 2)
   ("a more aggressive subline expressing dominant negative E-Cadherin" 2)
   ("normal E-cadherin" 2) ("Cadherin 1" 2)
   ("Par-6α (H-90)∶sc-25525 (rabbit polyclonal; Santa Cruz; 1∶10) E-cadherin"
    2)
   ("tumoral e-cadherin" 2) ("Weak E-cadherin" 2) ("ECAD molecule" 2)
   ("the homotypic cell adhesion molecule E-cadherin" 2)
   ("considerable E-cadherin" 2) ("fluorescent E-cadherin" 2)
   ("more junctional E-cadherin" 2) ("the intact E-cadherin" 2)
   ("specifically control E-cadherin" 2) ("immature E-cad" 2)
   ("few human E-cadherin" 2) ("particular E-cadherin" 2)
   ("an approximately similar cytoplasmic E-cadherin" 2)
   ("Strong E-cadherin" 2)
   ("homotypic cell-cell adhesion molecule E-cadherin" 2)
   ("DECMA-1 bound both intact E-cadherin" 2) ("a tailless E-cadherin" 1)
   ("rat monoclonal anti-mouse E-cadherin" 1) ("the epithelial E-cadherin" 1)
   ("E-cadherin–" 1) ("An intact E-cadherin" 1)
   ("Epithelial-specific marker E-cadherin" 1) ("the soluble E-cadherin" 1)
   ("lack membrane bound intact E-cadherin" 1)
   ("less membrane-bound E-cadherin" 1) ("membrane-bound intact E-cadherin" 1)
   ("Cdh1 (FZR)" 1) ("control Cdh1’s" 1) ("than Cdh1" 1)
   ("typically lack E-cadherin" 1)
   ("the tight junctional protein E-cadherin" 1)
   ("the transmembrane E-cadherin" 1) ("EMT-associated protein E-cadherin" 1)
   ("residual APC/C CDH1" 1) ("exogenous CDH1" 1) ("solely APC/C CDH1" 1)
   ("E-cadherin (DSLLVFDY)" 1) ("than E-cadherin in many tumors" 1)
   ("EMT expressing E-cadherin" 1) ("epithelial-specific E-cadherin" 1)
   ("abnormal E-cadherin" 1) ("the non-adhesive E-cadherin" 1)
   ("than E-cadherin in parental epithelial cells" 1) ("CDH1-" 1)
   ("Mouse monoclonal E-cadherin" 1) ("transmembrane E-cadherin" 1)
   ("junctional adhesion protein E-cadherin" 1) ("homophilic E-cadherin" 1)
   ("APC CDH1 ’s" 1) ("one potential target E-cadherin" 1)
   ("Functional E-cadherin" 1) ("the homologous CDH1" 1)
   ("a dominant-negative E-cadherin" 1) ("Soluble E-cad" 1)
   ("Most epithelial tumors loose E-cad" 1) ("The Soluble E-Cadherin" 1)
   ("Soluble E-cadherin" 1) ("the so-called CDH1" 1)
   ("membranous epithelial marker E-cadherin" 1)
   ("the invasive marker E-cadherin" 1) ("-E-cadherin" 1)
   ("only junctional E-cadherin" 1) ("the exogenous Cdh1" 1) ("Ecad–" 1)
   ("cellular Ecad" 1) ("junctional Ecad" 1) ("oligomeric Ecad" 1)
   ("ECADHERIN" 1) ("mouse monoclonal E-cadherin" 1)
   ("very little E-cadherin" 1) ("significantly less E-cadherin" 1)
   ("Very little E-cadherin" 1) ("the APC/C auxiliary protein Cdh1" 1)
   ("the auxiliary subunit Cdh1" 1)
   ("than extensively N-glycosylated E-cadherin ( xref )" 1) ("−E-cad" 1)
   ("the epithelial homotypic adhesion molecule E-cadherin" 1)
   ("plakoglobin increased E-cadherin" 1) ("“sh-Ecad”" 1) ("UVO" 1)
   ("the key metastasis-suppressing protein E-cadherin" 1)
   ("the mitotic ubiquitin ligase APC/C Cdh1" 1) ("almost no E-cadherin" 1)
   ("a phosphorylated-Thr32/Ser36-containing Cdh1 peptide" 1)
   ("Cdh1 peptide" 1) ("continuous E-cadherin" 1) ("that ECAD’s" 1)
   ("p120-ctn reversed ECAD’s" 1) ("E-cadherin (ECAD)" 1)
   ("typical membrane-bound E-cadherin" 1) ("than normal E-cadherin" 1)
   ("The homotypic cellular adhesion molecule E-cadherin" 1)
   ("membranous (normal/functional) E-cadherin" 1) ("aberrant E-cadherin" 1)
   ("absent E-cadherin" 1) ("considerably less E-cadherin" 1)
   ("the extensively studied classical cadherin E-cadherin" 1)
   ("differentiated and dedifferentiated thyroid tumors found E-cadherin" 1)
   ("had intact e-cadherin" 1) ("e–cadherin" 1) ("redistributing E-cadherin" 1)
   ("less E-cadherin" 1) ("more immobile E-cadherin" 1)
   ("downregulated junctional E-cadherin" 1) ("their junctional E-cadherin" 1)
   ("reduced junctional E-cadherin" 1) ("had reduced junctional E-cadherin" 1)
   ("considerably less junctional E-cadherin" 1) ("Uvomorulin" 1)
   ("the mitotic ubiquitin ligase APC Cdh1" 1)
   ("display prominent E-cadherin" 1) ("than non-acetylated CDH1" 1)
   ("insoluble E-cadherin" 1) ("dominant-negative E-cadherin (EC)" 1)
   ("substantial E-cadherin" 1) ("the decreased PM-associated E-cadherin" 1)
   ("larger-scale lateral E-cadherin" 1) ("intentional E-cadherin" 1)
   ("around E-cadherin" 1) ("exocyst-associated E-cadherin" 1)
   ("nascent E-cadherin" 1) ("dominant-negative (DN)-E-cad" 1) ("-E-cad" 1)
   ("disrupted functional E-cadherin" 1)
   ("activated Rac disrupted functional E-cadherin" 1)
   ("the last 45 amino acids of E-cadherin" 1) ("E-cadherin−" 1)
   ("the intercellular molecule E-cadherin" 1)
   ("junction-associated E-cadherin" 1) ("pure E-cadherin protein" 1)
   ("the major epithelial cadherin" 1) ("soluble cytosolic E-cadherin" 1)
   ("the classical E-cadherin" 1) ("Mouse monoclonal anti E-cadherin" 1)
   ("only partially ablate Cdh1" 1) ("ductal carcinoma E-cadherin" 1)
   ("intact E-cad" 1) ("tubular cytoplasmic E-cadherin" 1)
   ("previously shown E-Cadherin" 1) ("Wnt3 increased E-cadherin" 1)
   ("fewer E-cadherin" 1) ("bound both intact E-cadherin" 1)
   ("both intact E-cadherin" 1) ("cell surface bound intact E-cadherin" 1)))
 ("UP:P12868" (("End1" 5) ("the immortalized endocervical cell line End1" 1)))
 ("UP:P12872" (("MLN" 31))) ("UP:P12877" (("BL6" 71)))
 ("UP:P12882" (("myosin-1" 24) ("Myosin-1" 5) ("Myh1" 1) ("MYH1" 1)))
 ("UP:P12883"
  (("MyHC" 43) ("MYH7" 14) ("MyH7" 3) ("Myh7" 2) ("distal 1" 2)
   ("distal
 1"
    1)))
 ("UP:P12890" (("AEII" 1)))
 ("UP:P12931"
  (("Src" 14110) ("c-Src" 3713) ("SRC" 1184) ("src" 419) ("cSrc" 105)
   ("c-src" 75) ("SRC1" 67) ("Src protein" 59) ("Src-" 49) ("c-SRC" 44)
   ("SRCs" 43) ("-Src" 38) ("c-Src protein" 33) ("pSRC" 22) ("pp60 c-src" 19)
   ("SRC protein" 17) ("pp60 c-Src" 14) ("p-cSrc" 11) ("cellular Src" 10)
   ("C-Src" 9) ("radiation-activated SRC" 8) ("C-src" 6)
   ("Radiation-activated SRC" 6) ("Src molecule" 5) ("pc-Src" 5) ("p-c-Src" 5)
   ("a dominant-negative Src" 5) ("dominant-negative c-Src" 5)
   ("dominant-negative Src" 5) ("p60 Src" 5) ("src-" 4) ("Src peptide" 4)
   ("-c-Src" 4) ("p-SRC" 4) ("sRC" 4) ("C-SRC" 4) ("than Wild-type Src" 4)
   ("c-Src-" 3) ("p-src" 3) ("SRC peptide" 3) ("Cellular Src" 3) ("Src-1" 3)
   ("targeting Src" 3) ("dominant-negative kinase-deficient or -deleted Src" 2)
   ("exogenous active c-Src" 2) ("overexpressed c-Src" 2)
   ("pre-existing Src" 2) ("pp60c-Src" 2) ("more Src" 2) ("potential Src-" 2)
   ("Dominant-negative c-Src" 2) ("constitutively active viral Src" 2)
   ("dominant negative (DN)Src" 2) ("normal cellular Src" 2)
   ("particular SRC" 2) ("integrin-associated c-Src" 2) ("c-Src molecule" 2)
   ("than c-Src" 2) ("kinase-defective (KD) Src" 2) ("kinase-defective Src" 2)
   ("sRCs" 2) ("than Src" 2) ("Overexpressed Src" 2) ("p60Src" 2)
   ("Silibinin treatment (30–90 µM) strongly decreased phospho-Src" 2)
   ("strong Src" 2) ("effectively folds Src" 2)
   ("ectopically-expressed WT Src" 2) ("than wild-type Src" 1)
   ("neonatal Src" 1) ("-src" 1) ("“total” Src" 1)
   ("integrin-associated Src" 1) ("Exogenous Src" 1) ("than Src ( xref B)" 1)
   ("than Src in vitro ( xref )" 1) ("“Src”" 1)
   ("possible common pathways src" 1) ("“MDA-MB-231-Src”" 1) ("p60 src" 1)
   ("residual Src" 1) ("more total Src" 1)
   ("NCOA1 nuclear receptor coactivator 1" 1) ("than c-Src [ xref ]" 1)
   ("hyperactive Src" 1) ("given Src" 1) ("src protein" 1)
   ("radiation-induced SRC" 1) ("the viral homolog of SRC" 1) ("avian c-Src" 1)
   ("EphB1-associated Src protein" 1) ("further elucidating Src's" 1)
   ("further elucidating Src" 1) ("the mitochondria-associated Src" 1)
   ("that Src's" 1) ("exogenous c-Src" 1) ("pSrc" 1)
   ("further implicating Src" 1) ("than cSrc in prostate cancer" 1)
   ("than the tyrosine kinase Src" 1) ("foremost SRC" 1) ("largest sRC" 1)
   ("than Src in vitro" 1) ("particular c-Src" 1) ("diminished Src's" 1)
   ("~two-fold more Src" 1) ("–Src" 1)
   ("nonmyristoylated (G2E) active (Y416F Y527F) chicken Src" 1)
   ("Strong Src" 1) ("a mutant (T338I ) chicken ( Gallus gallus) src" 1)
   ("downstream dysregulated proteins suggested Src" 1)
   ("the invasion-associated protein kinase Src" 1)
   ("than kinase active Src" 1) ("than kinase-dead Src ( xref and xref )" 1)
   ("than wt or activated Src ( xref )" 1)))
 ("UP:P12955"
  (("PEPD" 238) ("prolidase" 3) ("strong PEPD" 2) ("peptidase D" 2)
   ("peptidase D (PEPD)" 1) ("prolidase (PEPD)" 1)))
 ("UP:P12956"
  (("XRCC6" 90) ("KU70" 36) ("ku70" 7) ("ML8" 5) ("G22P1" 3)
   ("ATP-dependent DNA helicase 2 subunit 1" 2) ("KU-70" 1)))
 ("UP:P12980" (("LYL1" 2))) ("UP:P12995" (("DANS" 6)))
 ("UP:P13006"
  (("glucose oxidase" 64) ("Glucose oxidase" 3) ("GOD" 2)
   ("glucose oxidase (GO)" 2)))
 ("UP:P13010"
  (("Ku80" 292) ("Ku86" 119) ("KU80" 82) ("XRCC5" 54) ("Ku80 protein" 4)
   ("ku80" 3) ("KARP-1" 3) ("ATP-dependent DNA helicase 2 subunit 2" 3)
   ("Ku80 (also referred to as Ku86) protein" 2) ("KU86" 2) ("80KD)" 2)
   ("Ku86 protein" 2) ("XRCC5-" 2) ("433–732 amino acids of Ku86 protein" 1)))
 ("UP:P13049" (("LPK" 23)))
 ("UP:P13051"
  (("UNG" 805) ("Ung" 124) ("uracil-DNA glycosylase" 55) ("UNG1" 54)
   ("uracil–DNA glycosylase" 23) ("UNG protein" 18) ("pUNG" 12) ("Ung1" 5)
   ("selective monofunctional uracil-DNA glycosylase" 4)
   ("uracil–DNA glycosylase (UDG)" 3) ("ung1" 3) ("UNG1 protein" 2)
   ("TaqMan® Universal Master Mix II no UNG" 2)
   ("Universal PCR Master Mix NoAmpErase UNG" 2) ("a cellular UNG" 2)
   ("using TaqMan Universal PCR Master Mix No AmpErase UNG" 2) ("Ung-" 2)
   ("10 μl Taqman Universal PCR Master Mix No AmpErase UNG" 2) ("pure UNG" 2)
   ("the single-strand–specific monofunctional uracil-DNA glycosylase" 2)
   ("the TaqMan Universal PCR MasterMix No AmpErase UNG" 2)
   ("the NC-associated UNG protein" 1) ("pemetrexed treated UNG" 1)
   ("targeting UNG" 1) ("UNG1-" 1) ("the major uracil-DNA glycosylase" 1)
   ("the single-strand–specific uracil-DNA glycosylase" 1)))
 ("UP:P13056"
  (("group C" 100) ("Group C" 38) ("group C (XPC) protein" 11) ("NR2C1" 5)
   ("group C protein" 4) ("group C protein (XPC)" 2) ("group C (XPC)" 2)
   ("orphan nuclear receptor TR2" 2)))
 ("UP:P13073"
  (("cytochrome c oxidase subunit IV" 22) ("COX4I1" 22) ("COX4" 10) ("Cox4" 6)
   ("Cox4i1" 5) ("COX-4" 5) ("Cox-4" 5)))
 ("UP:P13082"
  (("STR" 472) ("SPH" 27) ("Sph" 11) ("sph" 5) ("Autosomal STR" 2)
   ("external STR" 1) ("the autosomal STR" 1) ("the original STR" 1)
   ("a highly polymorphic STR" 1)))
 ("UP:P13134" (("Kex2" 1)))
 ("UP:P13164"
  (("IFITM1" 7) ("9–27" 2) ("9-27" 1)
   ("interferon induced transmembrane protein 1" 1) ("CD225" 1)))
 ("UP:P13196"
  (("synthase 1" 33) ("ALAS" 6) ("ALAS1" 4) ("Synthase 1" 4)
   ("the homologous 3-hydroxy-3-methylglutaryl CoA synthase 1" 3)
   ("δ-aminolevulinic acid synthase 1" 2)))
 ("UP:P13208" (("S6B" 54) ("S6b" 3) ("sarafotoxin" 2) ("Sarafotoxin" 1)))
 ("UP:P13232"
  (("IL-7" 764) ("IL7" 39) ("interleukin-7" 9) ("IL-7-" 4) ("Interleukin-7" 4)
   ("exogenous IL-7" 2) ("fully glycosylated simian IL-7" 1)
   ("the lymphopoietic cytokine IL-7" 1)))
 ("UP:P13236"
  (("CCL4" 89) ("pACT2" 51) ("MIP1β" 25) ("Lag1" 9) ("LAG-1" 8) ("CCl4" 7)
   ("Lag-1" 6) ("Ccl4" 5) ("-Lag1" 2) ("MIP-1beta" 2)
   ("neuroprotective CCL4" 1)))
 ("UP:P13243" (("TSR" 90) ("Tsr" 1) ("tsr" 1)))
 ("UP:P13259" (("pCT" 6) ("pCt" 3) ("PCT-1" 1)))
 ("UP:P13262" (("mSp1" 17) ("Msp1" 1))) ("UP:P13267" (("POLIII" 5)))
 ("UP:P13284"
  (("GILT" 27) ("IFI30" 3) ("lysosomal thiol reductase" 2)
   ("the critical endolysosomal reductase GILT" 1)
   ("lysosomal thiol reductase (GILT)" 1)
   ("lysosomal thiol reductase ( GILT )" 1)))
 ("UP:P13304"
  (("RI" 754) ("RIA" 53) ("Ri" 10) ("RI-" 9) ("RI–" 3) ("commercial RIA" 2)
   ("rI" 1) ("the CA 125 II RIA" 1) ("RI−" 1) ("-RI" 1)))
 ("UP:P13310"
  (("VS" 181) ("laryngeal squamous cell carcinoma tissues VS" 4)
   ("sporadic VS" 2) ("primary VS" 1)))
 ("UP:P13319"
  (("DAS" 120) ("DAs" 57) ("Das" 33) ("das" 13) ("pediatric DAs" 2)
   ("the DAS28" 1) ("DaS" 1) ("15 cerebral DAs" 1) ("10 cerebral DAs" 1)))
 ("UP:P13349"
  (("myogenic" 265) ("Myf5" 11) ("MYF5" 7) ("Myf-5" 2) ("MYF-5" 2)
   ("their normal myogenic" 1)))
 ("UP:P13378" (("HOXD8" 3) ("homeobox D8" 1)))
 ("UP:P13379" (("LY1" 3) ("Ly1" 3)))
 ("UP:P13385"
  (("Cripto" 225) ("Cripto-1" 13) ("TDGF1" 7) ("soluble Cripto" 3)
   ("teratocarcinoma-derived growth factor-1" 2)
   ("teratocarcinoma-derived growth factor 1" 1) ("Tdgf1" 1)
   ("exogenous Cripto" 1) ("excess soluble Cripto" 1) ("cripto" 1)))
 ("UP:P13387" (("CER" 16) ("-CER" 3))) ("UP:P13388" (("Xmrk" 47) ("xmrk" 1)))
 ("UP:P13395"
  (("spectrin" 547) ("Spectrin" 29) ("spectrin-" 14) ("spectrin protein" 13)
   ("-spectrin" 3) ("more spectrin" 2) ("Heteromeric spectrin" 2)
   ("the cuticular plate marker spectrin" 2) ("spectrin–" 1)
   ("the total membrane-associated spectrin" 1) ("β-heavy spectrin" 1)
   ("smaller size β spectrin" 1) ("intracytoplasmic spectrin" 1)
   ("avian spectrin" 1)))
 ("UP:P13415" (("PIA" 26))) ("UP:P13438" (("TPBPA" 2)))
 ("UP:P13473"
  (("LAMP2" 182) ("Lamp2" 18) ("LAMP-2" 13) ("CD107b" 3) ("lamp2" 3)
   ("the late endosomal/lysosomal marker LAMP2" 2) ("LAMP2-" 1)))
 ("UP:P13475" (("3-F" 8))) ("UP:P13477" (("immE6" 18) ("ImmE6" 1)))
 ("UP:P13485" (("pTaG3" 9) ("TaG3" 4)))
 ("UP:P13489"
  (("pri" 373) ("PRi" 56) ("RAI" 38) ("Rai" 36) ("pri-" 32)
   ("ribonuclease inhibitor" 24) ("Ribonuclease Inhibitor" 19) ("Pri" 13)
   ("Ribonuclease inhibitor" 9) ("Pri-" 4) ("RNH" 3)
   ("placental ribonuclease inhibitor" 2) ("pRi" 1)
   ("ribonuclease/angiogenin inhibitor 1" 1) ("PRI" 1)))
 ("UP:P13497"
  (("PCP" 130) ("pCp" 7) ("PcP" 4) ("pCP" 1) ("BMP1" 1)
   ("Procollagen C-proteinase" 1) ("defective PCP" 1)))
 ("UP:P13498"
  (("p22phox" 253) ("cytochrome" 88) ("p22-PHOX" 30) ("CYBA" 27)
   ("cytochrome-" 18) ("p22-phox" 8) ("p22phox protein" 6) ("Cytochrome" 6)
   ("colonic cytochrome P4503A" 2) ("cytochrome b-245" 2) ("Cytochrome-" 1)))
 ("UP:P13500"
  (("MCP-1" 1178) ("CCL2" 858) ("HC11" 72)
   ("monocyte chemoattractant protein-1" 49) ("CCL-2" 45) ("Ccl2" 34)
   ("monocyte chemotactic protein-1" 34)
   ("monocyte chemoattractant protein 1" 15)
   ("monocyte chemotactic protein 1" 12) ("MCP-1 protein" 8)
   ("Monocyte Chemotactic Protein 1" 4)
   ("Monocyte chemoattractant protein-1" 4)
   ("Monocyte chemotactic protein-1" 2)
   ("0.05 µM showed significantly decreased CCL2" 2)
   ("Additionally OVCXCR2 increased CCL2" 1) ("ccl2" 1) ("CCl2" 1)
   ("mononuclear chemoattractant MCP-1" 1)
   ("the ERα/ERβ-positive mouse mammary epithelial cell line HC11" 1)
   ("MCP—1" 1)))
 ("UP:P13501"
  (("CCL5" 834) ("RANTES" 399) ("-RANTES" 60) ("Rantes" 17) ("Ccl5" 14)
   ("CCL5 protein" 9) ("CCL-5" 7) ("RANTES-" 4) ("Ccl5 (RANTES)" 4)
   ("rather decreased 1-AP-induced CCL5" 2) ("both basal and induced CCL5" 2)
   ("CCL5 (RANTES)" 2) ("the antiviral chemokine CCL5" 1)
   ("1-AP-induced CCL5" 1) ("abluminal CCL5" 1)))
 ("UP:P13514" (("LSP" 39)))
 ("UP:P13521"
  (("SN" 533) ("Sn" 13) ("sn" 4) ("SGII" 4) ("secretogranin II" 4)
   ("secretogranin-2" 2) ("the ipsilateral SN" 2) ("secretoneurin (SN)" 2)
   ("secretoneurin" 2)))
 ("UP:P13528" (("UNC-86" 1)))
 ("UP:P13533" (("MYH6" 9) ("Myh6" 5) ("myosin heavy chain 6" 1)))
 ("UP:P13559" (("XV" 19)))
 ("UP:P13569"
  (("CFTR" 1869) ("cystic fibrosis transmembrane conductance regulator" 34)
   ("CFTR protein" 24) ("normal CFTR" 19)
   ("cystic fibrosis transmembrane conductance regulator (CFTR)" 13)
   ("functional CFTR" 6) ("ABCC7" 5) ("cAMP-dependent chloride channel" 5)
   ("Cystic fibrosis transmembrane conductance regulator" 4) ("more CFTR" 4)
   ("defective CFTR" 3) ("immature CFTR" 3)
   ("Dab2 depletion dramatically increases CFTR's" 2)
   ("Dab2 depletion dramatically increases CFTR" 2)
   ("mature and immature wild-type (WT) CFTR" 2) ("mature CFTR" 2)
   ("immature and mature CFTR" 2) ("targeted CFTR" 2)
   ("export-competent wild-type CFTR" 2)
   ("Hsp27 selectively targets F508del CFTR" 2) ("the normal CFTR" 2)
   ("productive CFTR" 2)
   ("the COOH-terminal 330 amino acids of human CFTR (amino acids 1,151–1,480)"
    1)
   ("the COOH-terminal 10 amino acids of human CFTR (CFTRwt; see xref B)" 1)
   ("immature core-glycosylated CFTR" 1) ("nonfunctional CFTR" 1)
   ("dysfunctional CFTR" 1) ("even wild-type CFTR" 1)
   ("Defective or absent CFTR" 1) ("c-Cbl enhanced CFTR's" 1)
   ("the mature CFTR" 1) ("CFTR-" 1) ("nascent CFTR" 1)
   ("both mature and immature CFTR" 1)
   ("Monoclonal antibodies targeted CFTR's" 1)
   ("Monoclonal antibodies targeted CFTR" 1)
   ("immature and mature wild-type CFTR" 1) ("less CFTR" 1)
   ("Mature wild-type CFTR protein" 1) ("a functional CFTR" 1)))
 ("UP:P13582"
  (("EA" 1028) ("Ea" 24) ("Nef-expressing EA" 2)
   ("called Evolutionary Action EA" 2) ("-EA" 2) ("Human endothelial EA" 1)
   ("ectopically Nef-expressing EA" 1) ("Endothelial EA" 1)
   ("endothelial EA" 1) ("control (HI) Ea" 1) ("-infected endothelial EA" 1)
   ("Confluent EA" 1) ("The immortalized vascular EC line EA" 1)
   ("the immortalized human EC line EA" 1) ("34 participants developed EA" 1)
   ("human endothelial EA" 1)))
 ("UP:P13584" (("CYP4B1" 12)))
 ("UP:P13586"
  (("Scc1" 204) ("Scc1 molecule" 2) ("the so-called “kleisin” subunit Scc1" 2)
   ("neither nonphosphorylatable Scc1" 1) ("nonphosphorylatable Scc1" 1)))
 ("UP:P13587" (("ena1" 2)))
 ("UP:P13591"
  (("NCAM" 485) ("CD56" 248) ("neural cell adhesion molecule" 17) ("Ncam1" 13)
   ("N-CAM" 13) ("NCAM1" 10) ("associated NCAM" 2)
   ("neural cell adhesion molecule (NCAM)" 2) ("the neuronal marker Ncam1" 1)
   ("detergent-insoluble NCAM" 1) ("soluble NCAM" 1) ("the soluble NCAM's" 1)
   ("the soluble NCAM" 1) ("only full-length NCAM" 1)
   ("Neural cell adhesion molecule" 1) ("neural cell adhesion molecule 1" 1)
   ("CD56-" 1)))
 ("UP:P13598"
  (("ICAM-2" 15) ("Icam2" 6) ("ICAM2" 4)
   ("intercellular adhesion molecule 2" 1)))
 ("UP:P13611"
  (("versican" 53) ("VCAN" 36) ("PG-M" 24) ("Versican" 20) ("PGM protein" 4)
   ("VCAN protein" 2) ("versican proteoglycan" 1) ("CSPG2" 1)))
 ("UP:P13612"
  (("ITGA4" 25) ("CD49d" 16) ("VLA4" 13) ("CD49D" 5) ("integrin alpha 4" 5)
   ("Itga4" 1)))
 ("UP:P13631"
  (("RARγ" 51) ("RAR-γ" 14) ("RARG" 5) ("retinoic acid receptor gamma" 4)
   ("RAR-gamma" 3) ("than RARγ" 1)))
 ("UP:P13639"
  (("elongation" 3121) ("transcriptional elongation" 100) ("eEF2" 92)
   ("EF2" 90) ("EEF2" 43) ("Elongation" 37) ("elongation factor 2" 32)
   ("EF-2" 22) ("productive elongation" 11)
   ("HIV transcriptional elongation" 10) ("ductal elongation" 9)
   ("translational elongation" 8) ("elongation factor-2" 8)
   ("axonal elongation" 7) ("MYB transcriptional elongation" 7) ("Ef2" 6)
   ("the transcriptional elongation" 5) ("efficient elongation" 5)
   ("eukaryotic translation elongation factor 2" 5) ("p-eEF2" 4)
   ("ELONGATION" 4) ("aberrant elongation" 3)
   ("aberrant transcriptional elongation" 3)
   ("general transcriptional elongation" 3) ("ribosomal elongation" 3)
   ("RNAPII transcriptional elongation" 2) ("Elongation factor 2" 2)
   ("preferential elongation" 2) ("genome-wide transcriptional elongation" 2)
   ("a clear elongation" 2) ("fatty acyl elongation" 2)
   ("Pol II transcriptional elongation" 2) ("dorsal elongation" 2)
   ("A fission yeast translational elongation factor 2" 2)
   ("endothelial elongation" 2)
   ("Neuronal architecture and neurite elongation" 2)
   ("RNAPII-transcriptional elongation" 2) ("mediolateral elongation" 2)
   ("HIV-1 transcriptional elongation" 2)
   ("Tat-dependent and Tat-independent transcriptional elongation" 2)
   ("affected transcriptional elongation" 2)
   ("Enhanced HIV transcriptional elongation" 2) ("differential elongation" 2)
   ("telomerase-catalyzed elongation" 2) ("a progressive elongation" 2)
   ("Inefficient elongation" 2) ("the subsequent elongation" 1)
   ("productive transcription elongation" 1) ("eEF-2" 1)
   ("exaggerated cellular elongation" 1)
   ("Pol II mediated transcriptional elongation" 1)
   ("RNA polymerase II transcriptional elongation" 1)
   ("similarly impact chain elongation" 1) ("delayed ductal elongation" 1)
   ("corneal epithelial cell elongation" 1)
   ("posttranscriptional elongation" 1)
   ("RNAP II transcriptional elongation" 1) ("NFκBp50-driven MYB elongation" 1)
   ("the murine MYB gene transcriptional elongation" 1)
   ("Tat increased elongation" 1)
   ("NFκBp50, p65 and MYB SLR polyU transcriptional elongation" 1)
   ("murine MYB transcriptional elongation" 1)
   ("finally productive transcriptional elongation" 1) ("‘elongation’" 1)
   ("productive transcriptional elongation" 1)
   ("we first induced telomere elongation" 1)
   ("dendrites display dynamic elongation" 1)
   ("full transcriptional elongation" 1) ("proper elongation" 1)
   ("than transcription elongation" 1) ("the efficient elongation" 1)
   ("an efficient viral transcript elongation" 1)
   ("viral transcript elongation" 1) ("complete elongation" 1)
   ("the subsequent primer elongation" 1)
   ("PRC1 complexes hamper transcriptional elongation" 1)
   ("neural tube elongation" 1) ("processive elongation" 1)
   ("cellular transcriptional elongation" 1)
   ("normal transcriptional elongation" 1)
   ("disease-associated transcriptional elongation" 1)
   ("Transcriptional elongation" 1)
   ("control metazoan transcriptional elongation" 1)
   ("specific transcriptional elongation" 1)
   ("effectively supports HIV transcription elongation" 1)
   ("other similarly predicted mutations elicited telomere elongation" 1)
   ("TAT MEDIATED TRANSCRIPTIONAL ELONGATION" 1)
   ("its productive elongation" 1) ("bipolar cell elongation" 1)
   ("force-induced elongation" 1) ("a preferential elongation" 1)
   ("Ductal elongation" 1) ("the processive elongation" 1)
   ("sequential chain elongation" 1)
   ("template-independent primer elongation" 1) ("their aberrant elongation" 1)
   ("the global translation elongation" 1)))
 ("UP:P13640" (("MT1G" 2) ("MT-1G" 1)))
 ("UP:P13645"
  (("K10" 108) ("keratin 10" 46) ("CK10" 22) ("keratin-10" 15)
   ("cytokeratin 10" 11) ("KRT10" 3) ("Cytokeratin 10" 3) ("k10" 3) ("KPP" 2)
   ("Krt10" 2) ("Keratin 10" 2) ("keratin10" 2)
   ("the suprabasal cell marker K10" 1) ("mouse monoclonal K10" 1)
   ("had at least K10" 1)))
 ("UP:P13646" (("CK13" 16) ("KRT13" 5) ("keratin 13" 4) ("k1-3" 1)))
 ("UP:P13647"
  (("CK5" 389) ("keratins" 93) ("KRT5" 80) ("cytokeratin 5" 62)
   ("keratin 5" 36) ("Krt5" 25) ("CK 5" 18) ("EBS2" 16) ("Keratin 5" 13)
   ("CK5−" 10) ("CK5-" 8) ("cytokeratin-5" 6) ("-CK5" 6) ("Cytokeratin 5" 5)
   ("Ck5" 4) ("suprabasal keratins" 4) ("overexpressed keratins" 4)
   ("the suprabasal keratins" 2) ("cytokeratin5" 2)
   ("the squamous epithelial marker Krt5" 2) ("Keratins" 2)
   ("the proximal site EBS2" 2) ("keratin-5" 2) ("rabbit monoclonal CK5" 2)
   ("CK-5" 1) ("brain metastases showed rare CK5" 1) ("KRT5-" 1)
   ("Cytokeratin5" 1) ("the basic type II cytokeratin CK5" 1)))
 ("UP:P13648"
  (("laminae" 8) ("basal laminae" 3) ("Laminae" 3)
   ("the internal and external elastic laminae" 2) ("the basal laminae" 2)
   ("Lamin-A" 1) ("elastic laminae" 1)))
 ("UP:P13667" (("ERp72" 9) ("PDIA4" 6) ("Pdia4" 2) ("ERp72 (ER)" 1)))
 ("UP:P13670" (("CHB" 231) ("cirrhotic CHB" 5) ("younger cirrhotic CHB" 1)))
 ("UP:P13674"
  (("P4HA1" 191) ("prolyl 4-hydroxylase" 7) ("alpha polypeptide I" 5)
   ("P4HA1 protein" 2) ("Prolyl 4-Hydroxylase" 2)
   ("The schematic showing P4HA1" 1)
   ("than P4HA1 in malignant prostate cancer tissues and cell lines ( xref )"
    1)
   ("Prolyl 4-hydroxylase" 1)))
 ("UP:P13686" (("ACP5" 39) ("Acp5" 4)))
 ("UP:P13688"
  (("CEACAM1" 360) ("CEACAM1-" 9) ("βGP" 5)
   ("Carcinoembryonic antigen-related cell adhesion molecule 1" 4)
   ("CEACAM 1" 3) ("Ceacam1" 1)))
 ("UP:P13693"
  (("TCTP" 196) ("TPT1" 7) ("translationally controlled tumor protein" 3)
   ("translationally controlled tumor protein (TCTP)" 3) ("HRF" 2) ("pTCTP" 2)
   ("TCTP protein" 1) ("Fortilin" 1) ("Histamine Releasing Factor" 1)))
 ("UP:P13709"
  (("FSH" 155) ("follicle stimulating hormone" 11) ("exogenous FSH" 2)
   ("follicle stimulating hormone (FSH)" 1) ("FSH-" 1)))
 ("UP:P13716"
  (("delta-" 90) ("Delta-" 53) ("delta–" 8) ("ALAD" 2) ("Delta–" 1)
   ("delta−" 1) ("aminolevulinate" 1)))
 ("UP:P13725"
  (("OSM" 646) ("oncostatin M" 56) ("Oncostatin M" 30) ("OSm" 17)
   ("oncostatinM" 7) ("Osm" 5) ("Oncostatin M (OSM)" 4) ("exogenous OSM" 2)
   ("oncostatin M (OSM)" 2) ("OncostatinM" 2) ("oncostatin M (OM)" 1)
   ("longer median OSm" 1)))
 ("UP:P13726"
  (("tissue factor" 55) ("thromboplastin" 19) ("tissue factor (TF)" 4)
   ("Tissue factor" 4) ("coagulation factor III" 2)
   ("placental thromboplastin" 1) ("sub endothelial tissue factor (TF)" 1)
   ("the connective tissue factor" 1) ("sub-endothelial tissue factor" 1)
   ("Tissue factor (TF)" 1)))
 ("UP:P13747" (("HLA-E" 42) ("HLA–E" 3))) ("UP:P13748" (("Patra" 1)))
 ("UP:P13761" (("DR7" 1))) ("UP:P13762" (("HLA-DRB4" 14) ("DR beta 4" 1)))
 ("UP:P13771" (("mUb" 91) ("MuB" 6))) ("UP:P13792" (("PhoP" 3)))
 ("UP:P13796"
  (("L-plastin" 167) ("L-plastin peptide" 19) ("plastin 2" 2) ("LCP1" 1)
   ("P13796" 1)))
 ("UP:P13797" (("plastin 3" 2)))
 ("UP:P13798" (("AARE" 23) ("OPH" 13) ("aPH" 1) ("APEH" 1)))
 ("UP:P13800" (("IEP" 2))) ("UP:P13804" (("GA2" 7)))
 ("UP:P13805"
  (("TNT" 308) ("TNTs" 122) ("-TNT" 2) ("tubular TNTs" 1)
   ("the green-labeled TNT" 1)
   ("a typical B721.221-derived H-RasG12V-labeled TNT" 1)
   ("the red-labeled TNT" 1) ("TNNT1" 1)))
 ("UP:P13807"
  (("GYS1" 78) ("GYS" 6) ("glycogen synthase 1" 6)
   ("significantly knockdown GYS1" 2) ("p-GYS" 1)
   ("the so-called muscle GYS1" 1)))
 ("UP:P13833" (("RMLC" 11) ("p-RMLC" 5))) ("UP:P13856" (("Rsr1" 1)))
 ("UP:P13864"
  (("UIM" 181) ("a functional UIM" 1) ("functional UIM" 1) ("-UIM" 1)))
 ("UP:P13866" (("SGLT1" 7) ("SLC5A1" 5) ("NAGT" 3) ("SGLT-1" 2)))
 ("UP:P13902" (("INO4" 5)))
 ("UP:P13928" (("ANXA8" 6) ("Anxa8" 4) ("annexin A8" 3) ("Anxa 8" 1)))
 ("UP:P13929"
  (("(beta" 149) ("MSE" 65) ("(Beta" 41) ("muscle)" 32) ("Mse" 12) ("(BETA" 5)
   ("mse" 2) ("paraspinal muscle)" 2) ("suggestive association (beta" 1)
   ("ENO3" 1) ("Eno3" 1) ("pectoral muscle)" 1)
   ("using senescence-associated (beta" 1) ("smooth, and striated muscle)" 1)
   ("typically rabbit muscle)" 1) ("circular muscle)" 1)
   ("both mucosal and cutaneous (beta" 1)))
 ("UP:P13942" (("COL11A2" 2))) ("UP:P13945" (("ADRB3" 20)))
 ("UP:P13963"
  (("replication protein" 145) ("Replication Protein" 22)
   ("Replication protein" 16) ("the viral replication protein" 2)
   ("replication
                    protein"
    1)))
 ("UP:P13971" (("Sok" 1) ("SOK" 1))) ("UP:P13984" (("RAP30" 3) ("GTF2F2" 2)))
 ("UP:P13985" (("HRES-1" 86) ("HRES1" 4)))
 ("UP:P13987"
  (("min −1" 401) ("CD59" 51) ("MIN" 49) ("min -1" 30) ("min-1" 10)
   ("min –1" 4) ("min–1" 3)
   ("the glycophosphatidylinositol (GPI)-linked receptor CD59" 2)
   ("approximately 1.8 Gy min −1" 1) ("substrate transformed min −1" 1)
   ("approximately 1 Gy min −1" 1)))
 ("UP:P13995" (("MTHFD2" 17))) ("UP:P14018" (("T6-4" 3)))
 ("UP:P14057"
  (("nuclear factor 1" 6) ("nuclear factor I" 5) ("Nuclear factor I" 2)
   ("Nuclear factor 1" 1)))
 ("UP:P14060" (("HSD3B1" 6) ("HSD3b1" 1))) ("UP:P14061" (("HSD17B1" 10)))
 ("UP:P14080" (("PPII" 34))) ("UP:P14083" (("LOV" 5) ("Lov" 2)))
 ("UP:P14095" (("CINC-1" 1))) ("UP:P14108" (("ORF67" 9)))
 ("UP:P14136"
  (("GFAP" 1426) ("glial" 896) ("glial fibrillary acidic protein" 113)
   ("glial fibrillary acidic protein (GFAP)" 36) ("Glial" 19)
   ("GFAP protein" 11) ("Glial fibrillary acidic protein" 8) ("GFAP-" 7)
   ("the astrocytic marker GFAP" 7) ("strong GFAP" 5)
   ("monoclonal anti-human GFAP" 5)
   ("the astroglial marker glial fibrillary acidic protein" 2)
   ("sporadic glial" 2) ("occasional GFAP" 2)
   ("the astrocytic lineage-specific marker GFAP" 2) ("a tailless GFAP" 2)
   ("the astrocytic marker protein glial fibrillary acidic protein (GFAP)" 2)
   ("more variable and patchy GFAP" 2)
   ("the astrocytic intracellular marker glial fibrillary acidic protein (GFAP)"
    1)
   ("admixed mature glial" 1) ("neoplastic glial" 1) ("Gfap" 1)
   ("than glial" 1) ("the following GFAP, Iba1," 1)
   ("the mature glial marker GFAP" 1)
   ("an astrocytic differentiation marker GFAP" 1)
   ("distinct glial fibrillary acidic Protein (GFAP)" 1)
   ("glial fibrillary acidic Protein" 1) ("GFAP (DAKO)" 1) ("GFAP−" 1)
   ("the astroglial cell marker GFAP" 1) ("The astroctyic marker GFAP" 1)
   ("the astrocytic cell marker protein GFAP" 1)
   ("astrocytic differentiation marker protein GFAP" 1) ("astrocytic GFAP" 1)
   ("fibrillary acidic protein" 1) ("the human GFAP, 1:1000," 1)
   ("either astrocytic glial fibrillary acidic protein (GFAP)" 1)
   ("Primary glial" 1)))
 ("UP:P14138"
  (("ET3" 11) ("Et 3" 9) ("EDN3" 7) ("ET-3" 3) ("endothelin-3" 3) ("pET3" 2)))
 ("UP:P14142" (("GT2" 5))) ("UP:P14150" (("GEN" 27) ("pGEN" 1)))
 ("UP:P14151"
  (("CD62L" 147) ("L-selectin" 58) ("SELL" 21) ("Sell" 11) ("Leu-8" 4)
   ("Fluorecent-activated sell" 3) ("lnHR" 2) ("LnHR" 2) ("“Leu-8”" 2)
   ("only 30–40% expressed CD62L" 2) ("Christian Sell" 1)
   ("leukocyte adhesion molecule 1" 1) ("Soluble Sell" 1) ("CD62l" 1)
   ("sell" 1) ("CD62L−" 1)))
 ("UP:P14163" (("hAPP" 37)))
 ("UP:P14174"
  (("MIF" 404) ("macrophage migration inhibitory factor" 16) ("GIF" 11)
   ("MIF protein" 7)))
 ("UP:P14207" (("FOLR2" 9)))
 ("UP:P14209" (("CD99" 257) ("MIC2" 3) ("CD99-" 1)))
 ("UP:P14210"
  (("HGF" 7587) ("SF" 775) ("hepatocyte growth factor" 427)
   ("scatter factor" 78) ("Hepatocyte growth factor" 74)
   ("hepatocyte growth factor (HGF)" 68) ("Hgf" 60) ("SFs" 56) ("Sf" 23)
   ("HGF protein" 20) ("HGF-" 16) ("exogenous HGF" 13) ("radial SFs" 7)
   ("hepatocyte growth  factor" 4) ("Scatter factor" 4)
   ("hepatocyte growth factor (HGFR)" 4) ("HGF molecule" 3)
   ("Hepatocyte growth factor (HGF)" 3) ("‘HGF’" 3)
   ("hepatocyte growth factor (EMD)" 2) ("SF=1−" 2)
   ("mechanical stretch induced HGF" 2) ("SF-" 2) ("only minimal HGF" 2)
   ("inflammatory SF" 2) ("hepatocyte growth factor-" 1) ("bona fide HGF" 1)
   ("than HGF" 1) ("than active HGF" 1)
   ("Mature
 HGF"
    1)
   ("than the SF" 1) ("endogenously-produced HGF" 1)
   ("endogenously-expressed HGF" 1) ("either exogenous HGF" 1)
   ("Neither exogenous HGF" 1) ("peripheral SFs" 1)
   ("dorsal and ventral SFs" 1) ("autocrine HGF" 1)
   ("ARQ-197 almost blocked HGF’s" 1) ("ARQ-197 almost blocked HGF" 1)
   ("than HGF ( xref )" 1) ("approximately 70ng/mL HGF" 1)
   ("supplemental HGF" 1) ("than 0.30 ng/ml HGF (data not shown)" 1)
   ("stromal HGF" 1) ("mature HGF" 1) ("the vector SF91" 1)
   ("Quantikine Human HGF" 1) ("specifically targets HGF" 1) ("more HGF" 1)
   ("scatter factor (SF)" 1) ("-HGF" 1) ("than murine HGF" 1) ("Mature HGF" 1)
   ("the previous study xref HGF" 1) ("local HGF" 1) ("intrinsic HGF" 1)
   ("respectively (5'-3') HGF" 1) ("AXL decreased HGF’s" 1)
   ("AXL decreased HGF" 1)))
 ("UP:P14212" (("HIFa" 1) ("HIF-a" 1)))
 ("UP:P14222"
  (("P1" 1651) ("perforin" 76) ("P1-" 21) ("P1 peptide" 20) ("PF" 10)
   ("pfp" 10) ("Perforin" 8) ("PFP" 7) ("pFP" 5) ("P1−" 2)
   ("previously named P1" 2) ("around P1" 2) ("Pfp" 2)
   ("Ion Torrent adapters P1" 1) ("the proximal P1" 1) ("respective P1" 1)
   ("less perforin" 1) ("Cdc6-transformed P1" 1) ("shorter P1" 1)
   ("Stat1/3 directly controls promoter P1" 1)))
 ("UP:P14269" (("pX" 106)))
 ("UP:P14299"
  (("ADP-ribosyltransferase" 86) ("ADP-ribosyl-transferase" 9) ("pADPr" 5)
   ("ADPr" 5)))
 ("UP:P14300" (("dRag" 5)))
 ("UP:P14306"
  (("IC" 751) ("pIC" 3) ("ic" 1) ("–IC" 1) ("only N1-IC T2512A" 1)
   ("the IC30" 1)))
 ("UP:P14314" (("PRKCSH" 11))) ("UP:P14316" (("IRF2" 29)))
 ("UP:P14317"
  (("HCLS1" 306) ("Hcls1" 16) ("HCLS1 protein" 11) ("HCLS1-" 3)
   ("granulocytes showed abundant HCLS1" 2)
   ("hematopoietic cell–specific Lyn substrate 1" 2)
   ("congenital neutropenia HCLS1" 1)
   ("the
hematopoietic-specific HAX1-binding partner HCLS1"
    1)))
 ("UP:P14324" (("FDPS" 3) ("farnesyl pyrophosphate synthase" 2) ("Fdps" 1)))
 ("UP:P14359" (("Sna3" 1)))
 ("UP:P14373"
  (("TRIM27" 65) ("TRIM27 protein" 3) ("RET finger protein (RFP)" 1)
   ("RET finger protein" 1) ("Trim27" 1)))
 ("UP:P14384" (("CPM" 18)))
 ("UP:P14410"
  (("SI" 464) ("si" 327) ("Si" 271) ("siGFP" 46) ("siEGFP" 25) ("S I" 23)
   ("sucrase-isomaltase" 10) ("si-" 2) ("a Personal Densitometer SI" 2)
   ("siGFP-" 1) ("sucrase" 1)))
 ("UP:P14415" (("ATP1B2" 8) ("beta 2 polypeptide" 4) ("AMOG" 2)))
 ("UP:P14416"
  (("DRD2" 165) ("dopamine receptor D2" 12) ("dopamine D2 receptor" 12)
   ("Dopamine Receptor D2" 4) ("Dopamine D2 receptor" 3) ("D2DR" 1)))
 ("UP:P14543"
  (("nid-1" 136) ("NID" 37) ("Nid-1" 21) ("nidogen-1" 16) ("nidogen" 12)
   ("entactin" 8) ("nidogens" 7) ("intact nid-1" 2) ("NID1" 1)
   ("around 1–2 nM nid-1" 1) ("soluble nid-1" 1) ("than nid-1" 1)
   ("Nidogens" 1)))
 ("UP:P14550"
  (("arm" 3558) ("Arm" 299) ("ARM" 83) ("-arm" 11) ("a chromosomal arm" 9)
   ("p-arm" 8) ("aldo-keto reductase family 1" 6) ("the experimental arm" 6)
   ("tethering arm" 5) ("arm (STD)" 4) ("the transcriptional arm" 4)
   ("“arm”" 4) ("the PLX4720-treated arm" 4) ("the contralateral arm" 3)
   ("the upper arm" 3) ("the apoptotic arm" 3) ("homologous arm" 3)
   ("chromosomal arm" 3) ("linking arm" 3) ("arm (HR)" 3) ("arm (IR)" 3)
   ("arm (SR)" 3) ("the same chromosomal arm" 2) ("The antiapoptotic arm" 2)
   ("the 11q chromosomal arm" 2) ("targeting arm" 2) ("arm (CP)" 2)
   ("upper arm" 2) ("the conditional arm" 2) ("an artificial lever arm" 2)
   ("the genotypic arm" 2) ("AKR1A1" 2) ("an additional therapeutic arm" 2)
   ("longer tether arm" 2) ("improper chromosome arm" 2)
   ("premature chromosome arm" 2) ("The nonoxidative arm" 2)
   ("the oxidative arm" 2) ("the repressive (Reverb) arm" 2)
   ("the recipient chromosome arm" 2) ("arm-" 2) ("more Arm" 1)
   ("a flexible arm" 1) ("a key arm" 1) ("a specific chromosomal arm" 1)
   ("the Australian arm" 1) ("the concurrent trastuzumab arm" 1)
   ("anti-apoptotic adaptive arm" 1) ("this innate arm" 1)
   ("The non-oxidative arm" 1) ("the non-oxidative arm" 1)
   ("the 20q chromosomal arm" 1) ("the entire arm" 1)
   ("the indirect inhibition arm" 1) ("The homologous arm" 1)
   ("more whole arm" 1) ("the specific chromosomal arm" 1)
   ("experimental arm" 1) ("the experimental arm (CPS)" 1) ("whose 5p arm" 1)
   ("the degradative arm" 1)
   ("the experimental
arm"
    1)
   ("a whole chromosomal arm" 1) ("a mitogenic arm" 1) ("a metabolic arm" 1)
   ("the dominant arm" 1) ("oxidative arm" 1) ("This flexible long arm" 1)
   ("the flexible GFP-bearing arm" 1) ("the circular lagging arm" 1)
   ("present here another arm of p53's" 1) ("either experimental arm" 1)
   ("the last Arm" 1) ("the observational arm" 1)
   ("a structurally distinct arm" 1) ("the innate arm" 1)
   ("the left homologous arm" 1) ("the double-layer regulatory arm" 1)
   ("each experimental arm" 1)
   ("two different timescales—a slow positive transcriptional arm" 1)
   ("the definitive RT arm" 1) ("the proapoptotic arm" 1)
   ("other chromosomal arm" 1) ("the helical arm" 1)
   ("the immunohistochemical reference arm" 1)
   ("the so-called dimerization arm" 1) ("rhizomelic arm" 1)
   ("each respective arm" 1) ("the contra lateral arm" 1)
   ("the complete p-arm" 1) ("just one linker arm" 1) ("only one linker arm" 1)
   ("some entire chromosomal arm" 1) ("a few entire chromosomal arm" 1)
   ("the adaptive arm" 1) ("the protective arm" 1) ("any chromosomal arm" 1)
   ("the immunosuppressive arm" 1) ("the 8p chromosomal arm" 1)
   ("each chromosomal arm" 1) ("the DMSO-treated arm" 1) ("aRM" 1)
   ("A prospective arm" 1)))
 ("UP:P14555" (("PLA2G2A" 23) ("sPLA2" 1) ("sPLA2s" 1)))
 ("UP:P14585" (("Lin12" 5) ("LIN-12" 2)))
 ("UP:P14598"
  (("p47 phox" 292) ("p47phox" 212) ("Ncf1" 44) ("p47 PHOX" 38)
   ("chronic granulomatous disease" 14) ("NCF1" 6) ("p47-phox" 3)
   ("the recessive chronic granulomatous disease" 2) ("p47 phox protein" 2)
   ("–p47 phox" 2) ("membrane-associated p47 phox" 1)
   ("phospho-p47 PHOX protein" 1) ("ncf1" 1)))
 ("UP:P14616" (("INSRR" 4))) ("UP:P14617" (("IRRs" 15)))
 ("UP:P14618"
  (("PKM2" 1071) ("PKM" 118) ("Pkm2" 19) ("PK3" 4) ("-PKM2" 4)
   ("than wild type PKM2 ( xref , k  cat : 0.5 s −1 , wild type k  cat : 2–4 s −1 )"
    1)
   ("than wild type PKM2 (20 μM)" 1) ("pyruvate kinase muscle isozyme" 1)
   ("less PKM2" 1)
   ("pilocytic astrocytoma samples expressed approximately 66–77% PKM2" 1)
   ("PKM2-" 1) ("pK3" 1)))
 ("UP:P14621" (("ACYP2" 10)))
 ("UP:P14625"
  (("gp96" 113) ("GRP94" 35) ("HSP90B1" 34) ("Gp96" 11) ("endoplasmin" 6)
   ("GRP-94" 6) ("TRa1" 4) ("Grp94" 4) ("Tra1" 4)
   ("Heat shock protein 90 kDa beta member 1" 3) ("HSP90b1" 2)
   ("the entire gp96" 1) ("94 kDa glucose-regulated protein" 1) ("grp94" 1)))
 ("UP:P14635"
  (("cyclin B1" 3196) ("Cyclin B1" 1313) ("CCNB1" 332) ("CyclinB1" 285)
   ("cyclinB" 62) ("CyclinB" 43) ("cyclinB1" 33) ("Cyclin B1 protein" 28)
   ("cyclin B1 protein" 25) ("Ccnb1" 11) ("fluorescent cyclin B1" 6)
   ("cyclin
 B1"
    5)
   ("total and phosphorylated Cyclin B1" 4) ("than cyclin B1" 3)
   ("strong cyclin B1" 2) ("expressing nondegradable cyclin B1" 2)
   ("-cyclin B1" 2) ("proportionately more high molecular weight CyclinB1" 2)
   ("nondegradable Cyclin B1" 2) ("Ccnb1 (TTTAAA)" 2)
   ("overexpressed cyclin B1" 2) ("much less cyclin B1" 2) ("cyclin B1-" 2)
   ("mitotic cyclin B1" 2) ("CCNB" 2) ("CCNB1 protein" 2)
   ("cyclin B1 (AACCGGTCCGAAACCGTCGACATGTCGCATCACCATCACCATCACGGCTCGATGGCGCTCCGAGTCACGCGTAACTCGAAAATTAATGCTGAAAATAAAGCGAAAATCAACATGGCAGGCGCCAAGCGCGTTCCTACGGCACCGGCGGCAACCTCCAAACCCGGGCTGAGGCCAAGAACAGCTCTTGGGGACATTGGTAACAAAGTCAGTGAACAGCTACAGGCCAAAATGCCTATGAAAAAAGAAGCAAAACCTTCAGCTACCGGTAAAGTCATTGATAAAAAACTACCAAAACCTCTTGAAAAGGTACCTATGCTGGTGCCAGTGCCAGTGTCTGAGCCAGTGCCAGAGCCAGAACCTGAGCCAGAACCTGAGCCTGTTAAAGAAGAAAAACTTTCGCCTGAGCCTATTTTGGTTGATACTGCTAGCAATA)"
    2)
   ("cyclin B1–" 2) ("than Cyclin B1[1–200]" 1) ("–Cyclin B1" 1)
   ("mitotic Cyclin B1" 1) ("total cellular CyclinB1" 1) ("ccnb1" 1)
   ("Non-degradable Cyclin B1" 1) ("excessive cyclin B1" 1)
   ("intranuclear cyclin B1" 1) ("than the endogenous cyclin B1 protein" 1)
   ("EYFP" 1) ("the first 86 amino acids of cyclin B1" 1)
   ("nondegradable cyclin B1" 1) ("coexpressed fluorescent cyclin B1" 1)
   ("cyan fluorescent cyclin B1" 1) ("expressed Vif showed CyclinB1" 1)
   ("the mitotic cyclin B1" 1) ("pre-ubiquitinated radiolabeled cyclin B1" 1)
   ("the N-terminal 124 amino acids of wild-type human cyclin B1 (AACCGGTCCGAAACCGTCGACATGTCGCATCACCATCACCATCACGGCTCGATGGCGCTCCGAGTCACGCGTAACTCGAAAATTAATGCTGAAAATAAAGCGAAAATCAACATGGCAGGCGCCAAGCGCGTTCCTACGGCACCGGCGGCAACCTCCAAACCCGGGCTGAGGCCAAGAACAGCTCTTGGGGACATTGGTAACAAAGTCAGTGAACAGCTACAGGCCAAAATGCCTATGAAAAAAGAAGCAAAACCTTCAGCTACCGGTAAAGTCATTGATAAAAAACTACCAAAACCTCTTGAAAAGGTACCTATGCTGGTGCCAGTGCCAGTGTCTGAGCCAGTGCCAGAGCCAGAACCTGAGCCAGAACCTGAGCCTGTTAAAGAAGAAAAACTTTCGCCTGAGCCTATTTTGGTTGATACTGCTAGCAATA)"
    1)
   ("a gradual cyclin B1" 1) ("a second distinguishable cyclin B1 protein" 1)))
 ("UP:P14651" (("HOXB3" 125))) ("UP:P14652" (("HOXB2" 3)))
 ("UP:P14653" (("HOXB1" 12) ("Hoxb1" 6)))
 ("UP:P14672"
  (("GLUT4" 257) ("Glut4" 33) ("GLUT4 protein" 3) ("SLC2A4" 2) ("GLUT-4" 2)
   ("GluT4" 1) ("Slc2a4" 1)))
 ("UP:P14679"
  (("tyr" 273) ("TYR" 154) ("tyrosinase" 125) ("Tyrosinase" 26)
   ("phospho-tyr" 1)))
 ("UP:P14681" (("KSS1" 2))) ("UP:P14734" (("FKH" 31) ("fkh" 6)))
 ("UP:P14735"
  (("IDE" 23) ("insulin-degrading enzyme" 9)
   ("insulin-degrading enzyme (IDE)" 1) ("insulin degrading enzyme" 1)))
 ("UP:P14736" (("Rad4" 15) ("RAD4" 1) ("rad4" 1)))
 ("UP:P14750"
  (("HCA" 227) ("HCAs" 52) ("hCAS" 3) ("60 typical HCAs" 2) ("hCas" 2)
   ("intact HCAs" 2) ("classical HCA" 1) ("largest HCA" 1)))
 ("UP:P14756" (("LASB" 2))) ("UP:P14770" (("CD42a" 5) ("GPIX" 2)))
 ("UP:P14778"
  (("IL-1R" 111) ("IL-1R1" 36) ("IL1R1" 31) ("IL1R" 12) ("IL1Rs" 12)
   ("Il1r1" 4) ("interleukin 1 receptor type 1" 4) ("a soluble IL-1R" 2)
   ("using soluble recombinant IL-1R" 2) ("IL-1R1 protein" 1)))
 ("UP:P14780"
  (("MMP-9" 2921) ("MMP9" 1567) ("matrix metalloproteinase-9" 79) ("Mmp9" 70)
   ("matrix metalloproteinase 9" 54) ("pMMP-9" 28) ("MMP 9" 16)
   ("Matrix metalloproteinase-9" 13) ("gelatinase B" 10)
   ("92 kDa type IV collagenase" 5) ("MMP-9 protein" 5) ("MMP9 protein" 4)
   ("MMP-9-" 4) ("matrix metallopeptidase 9" 3) ("latent MMP-9" 3) ("Gelb" 3)
   ("than MMP-9" 2) ("mmp9" 2) ("surface-localized MMP-9" 2)
   ("placental MMP-9" 2) ("the invasive marker MMP-9" 2)
   ("markedly more MMP-9" 1) ("matrix metalloproteinase 9 (MMP-9) protein" 1)
   ("MMP- 9" 1) ("their unique matrix metalloproteinase-9" 1)
   ("than MMP9 [ xref ]" 1) ("mature MMP-9" 1) ("exogenous activated MMP-9" 1)
   ("increased RV myocardial MMP-9" 1) ("in turn anchors MMP-9" 1)
   ("92-kDa gelatinase" 1) ("Matrix metalloproteinase 9" 1)
   ("AKT2 increased MMP-9" 1) ("more MMP-9" 1)))
 ("UP:P14784"
  (("CD122" 40) ("IL2RB" 20) ("IL-2RB" 15)
   ("the strong candidate gene IL2RB" 2)))
 ("UP:P14832" (("CPR1" 1))) ("UP:P14836" (("p41" 29) ("P41" 4)))
 ("UP:P14859"
  (("Oct-1" 143) ("POU2F1" 39) ("octamer-binding transcription factor 1" 6)
   ("POU class 2 homeobox 1" 5)))
 ("UP:P14866" (("hnRNPL" 12) ("HNRNPL" 4) ("HNRPL" 4)))
 ("UP:P14867" (("GABRA1" 1)))
 ("UP:P14868" (("DARS" 4) ("aspartyl-tRNA synthetase" 1)))
 ("UP:P14902"
  (("IDO" 421) ("Indo" 46) ("indoleamine 2,3-dioxygenase" 16)
   ("indoleamine 2,3-dioxygenase (IDO)" 6) ("3-dioxygenase" 4)
   ("Indoleamine 2,3-dioxygenase" 4) ("Ido" 3)
   ("indoleamine 2,3 dioxygenase" 2) ("IDO protein" 2) ("indo" 2)
   ("Tat-induced immunosuppressive IDO" 1)
   ("indoleamine-2,3-dioxygenase (IDO)" 1) ("indoleamine-2,3-dioxygenase" 1)
   ("IDO1" 1)))
 ("UP:P14905" (("CBS-2" 10))) ("UP:P14906" (("pTL1" 8) ("Ptl1" 1)))
 ("UP:P14920" (("D-amino acid oxidase" 3)))
 ("UP:P14921"
  (("ETS1" 1092) ("Ets-1" 1077) ("Ets1" 1024) ("ETS-1" 726) ("pETS1" 21)
   ("ETS1 protein" 20) ("ets-1" 14) ("ETS-1 protein" 8) ("Ets-1 molecule" 8)
   ("VPAA" 6) ("Ets-1 protein" 6) ("than ETS1" 5) ("Ets1 protein" 5) ("ets1" 5)
   ("p-ETS-1" 4) ("ETS1-" 4) ("ETS1(T38A) protein" 2) ("viral Ets-1" 2)
   ("shortest Ets-1 protein" 2) ("the archetypal Ets protein Ets-1" 2)
   ("p-Ets-1" 2) ("P-ETS-1" 1) ("the TCRα enhancer-bound Ets1" 1) ("Ets1-" 1)
   ("exogenous wild-type ETS1" 1) ("diabetes-induced activated Ets-1" 1)
   ("a dominant-negative ETS1 (DN-ETS1) protein" 1)
   ("ETS1 (DN-ETS1) protein" 1) ("exogenous wild-type ETS1 protein" 1)
   ("in turn target Ets1" 1) ("around Ets-1" 1) ("directly target ETS-1" 1)
   ("than ETS1 ( p < 0.0001; χ 2 )" 1)
   ("than ETS1 ( p = 0.0024 for Jurkat, p < 0.0001 for K562 and HeLa; χ 2 )"
    1)))
 ("UP:P14922" (("Cyc8" 1)))
 ("UP:P14923"
  (("plakoglobin" 344) ("Plakoglobin" 96) ("JUP" 17) ("DP-3" 14)
   ("junctional plakoglobin" 11) ("γ-catenins" 8) ("plakoglobin protein" 6)
   ("gamma-catenin" 2) ("plasma membrane associated plakoglobin" 2) ("DP3" 1)
   ("decreasing junctional plakoglobin" 1)
   ("the remaining junctional plakoglobin" 1) ("dp3" 1)
   ("few high-grade samples highly expressed Plakoglobin" 1)
   ("protein called gamma-catenin" 1)))
 ("UP:P14927" (("UQCRB" 1))) ("UP:P14940" (("adh" 24) ("Adh" 2)))
 ("UP:P14998" (("agnoprotein" 12) ("AgNO" 9)))
 ("UP:P15000"
  (("S-tag" 30) ("small t antigen" 28) ("small t antigen (ST)" 2)
   ("S-tags" 1)))
 ("UP:P15006"
  (("mCRC" 945) ("metachronous mCRC" 21) ("synchronous mCRC" 16)
   ("chemorefractory mCRC" 4) ("metachronous and synchronous mCRC" 2)
   ("metachronous or synchronous mCRC" 2) ("the biologically worst mCRC" 2)
   ("had synchronous mCRC" 1)
   ("histologically proven synchronous or metachronous mCRC" 1)
   ("synchronous or metachronous mCRC" 1)
   ("synchronous and metachronous mCRC" 1) ("5-FU-treated mCRC" 1)
   ("13 pulmonary mCRC" 1)))
 ("UP:P15009" (("HS4" 44)))
 ("UP:P15018"
  (("LIF" 1055) ("leukemia inhibitory factor" 75)
   ("leukemia inhibitory factor (LIF)" 15) ("Leukemia inhibitory factor" 13)
   ("hLIF" 4) ("LIF−" 4) ("LIF protein" 3)
   ("Leukemia inhibitory factor (LIF)" 3) ("lif" 2) ("Exogenous LIF protein" 2)
   ("LIF-" 2) ("Hilda" 1) ("−LIF" 1) ("–LIF" 1) ("LiF" 1) ("exogenous LIF" 1)
   ("Exogenous LIF" 1) ("Lif" 1) ("more LIF" 1)
   ("leukemia inhibitory factor ( LIF )" 1) ("Immunoreactive LIF" 1)))
 ("UP:P15036"
  (("ETS2" 529) ("Ets2" 436) ("Ets-2" 202) ("ETS-2" 59) ("ETS2 protein" 14)
   ("Ets2 protein" 6) ("Ets2-" 4) ("ets2" 4)
   ("the transcriptional factor Ets2" 3)
   ("the immortalized human astrocytes overexpressing Ets2" 2)
   ("dominant-negative Ets2" 2) ("-Ets2" 2) ("stromal Ets2" 1) ("c-Ets-2" 1)
   ("than Ets-2" 1) ("flag-tagged Ets2" 1) ("the major Ets2" 1) ("c-ets-2" 1)
   ("exogenous ETS2" 1) ("Ets-2 protein" 1) ("the dissimilar roles ETS2" 1)))
 ("UP:P15042" (("PDEC" 1)))
 ("UP:P15054"
  (("v-Src" 964) ("V-Src" 11) ("v-SRC" 4) ("exongenous v-Src" 2)
   ("a temperature-sensitive v-Src" 1) ("v-Src protein" 1)))
 ("UP:P15056"
  (("BRAF" 24184) ("B-RAF" 1727) ("B-Raf" 1408) ("Braf" 560) ("BRaf" 230)
   ("B-raf" 184) ("BRAF protein" 101) ("BRAF-" 70) ("b-Raf" 43) ("B-Raf1" 22)
   ("FLAG-BRAF" 17) ("“BRAF”" 9) ("v-Raf murine sarcoma viral oncogene" 8)
   ("Braf protein" 8) ("b-RAF" 8) ("BRAF peptide" 8) ("p-B-Raf" 8)
   ("B-Raf protein" 8) ("BRAF molecule" 6) ("braf" 4)
   ("a highly aggressive BRAF" 4) ("serine/threonine-protein kinase B-Raf" 3)
   ("”" 3) ("overexpressed BRAF" 3) ("than BRAF" 3) ("p-B-Raf1" 3)
   ("“parental” B-RAF V600E" 2) ("preoperative BRAF" 2) ("definitive BRAF" 2)
   ("b-raf" 2) ("Most BRAF" 2) ("whose melanomas carried BRAF  V600K" 2)
   ("serine/threonine-protein kinase B-Raf (BRAF)" 2) ("B-RAF ”" 2)
   ("the most common somatic BRAF" 2) ("than BRAF V600E" 2) ("B-raf (BRAF)" 2)
   ("preoperative BRAF V600E" 2) ("more BRAF" 2)
   ("expressed V600E/R509H BRAF" 2) ("P94" 2)
   ("The recurrent BRAF driver mutation V600E" 2) ("upfront BRAF" 2)
   ("human exogenous BRAF" 2) ("genomic B-Raf" 2) ("distinct B-Raf" 2)
   ("normal Braf" 2) ("p-BRAF" 2) ("than wild-type BRAF" 2)
   ("specifically target BRAF V600E" 2) ("fewer BRAF" 2)
   ("six other therapeutically-targetable signaling molecules- BRAF" 2)
   ("B-RAF protein" 2) ("BRAF inhibited Y472C BRAF’s" 2)
   ("Serine/threonine-protein kinase B-Raf" 2)
   ("the four most recurrent melanoma nucleotide substitutions included BRAF"
    2)
   ("bRaf" 2) ("Concurrent BRAF" 2) ("concurrent BRAF" 2)
   ("than BRAF(V600E)" 1) ("secondary B-RAF point mutations" 1)
   ("monomeric B-RAF V600E" 1) ("secondary BRAF" 1) ("normal BRAF" 1)
   ("Therapeutically-targetable BRAF" 1)
   ("the recently-discovered BRAF V600E" 1)
   ("v-Raf Murine sarcoma viral oncogene" 1) ("“b-raf”" 1)
   ("a particular BRAF" 1) ("TTM reduced soft agar growth BRAF V600E" 1)
   ("namely B-Raf V600E" 1) ("oncogenically mutant BRAF" 1)
   ("namely V600E mutant B-Raf" 1) ("two arbitrarily chosen BRAF V600E" 1)
   ("discordant BRAF" 1) ("classical BRAF V600E" 1)
   ("bilateral lobes showed BRAF" 1) ("normal BRaf" 1)
   ("previously received BRAF" 1) ("very aggressive BRAF V600E" 1)
   ("targeting BRAF V600E" 1) ("reliable BRAF" 1) ("sub-clonal BRAF" 1)
   ("vemurafenib-treated BRAF" 1) ("monomeric BRAF" 1)
   ("1 unusual BRAF point mutation" 1) ("exogenous BRAF" 1)
   ("both the exogenous BRAF V600E" 1) ("than the BRAF" 1) ("avian b-raf" 1)
   ("b-Raf protein" 1) ("Only two BRAF" 1) ("overexpressing wild type BRAF" 1)
   ("than BRAF (44 vs 12%; p=0.002)" 1) ("one HP both a BRAF V600E" 1)
   ("than B-Raf" 1) ("-B-Raf" 1) ("than mutant BRAF ( xref )" 1)
   ("nearly twofold more BRAF protein" 1) ("BRAF (MB)" 1) ("the BRAF's" 1)
   ("the custom-made BRAF" 1)
   ("the serine/threonine-specific protein kinase BRAF" 1)
   ("selectively target BRAF V600E" 1) ("sporadic BRAF" 1)
   ("concurrent V600E BRAF" 1) ("Braf-" 1) ("pBRAF" 1)
   ("expressed appreciably less BRAF" 1) ("concurrent BRAF V600E" 1)
   ("potential circulating B-RAF" 1) ("-BRAF" 1)
   ("than those expressing wt BRAF ( xref )" 1)
   ("expressing kinase-deficient BRAF" 1)
   ("the further downstream-located BRAF" 1)
   ("than BRAF 600 or 601 ( xref )" 1) ("B-Raf–" 1)
   ("exogenous wild-type BRAF" 1) ("exogenous B-RAF V600E" 1)
   ("especially B-RAF V600E" 1) ("usually BRAF V600E" 1)
   ("conditionally-targeted Braf" 1)))
 ("UP:P15059" (("B13R" 1))) ("UP:P15064" (("RasG" 16)))
 ("UP:P15066" (("JUND1" 1)))
 ("UP:P15085"
  (("CPA" 80) ("cPA" 60) ("CpA" 4) ("cpA" 2) ("CPA-1" 1)
   ("Carboxypeptidase A" 1) ("the A 1 R agonist CPA" 1)
   ("the selective A 1 R agonist CPA" 1) ("carboxypeptidase A" 1) ("CPA1" 1)))
 ("UP:P15086" (("CPB" 35) ("pCPB" 1))) ("UP:P15088" (("CPA3" 1)))
 ("UP:P15090"
  (("FABP4" 90) ("Fabp4" 5) ("fatty acid binding protein 4" 4)
   ("fatty acid-binding protein 4" 3) ("A-FABP" 2)
   ("adipocyte-type fatty acid–binding protein" 1)))
 ("UP:P15104"
  (("GS" 1128) ("-GS" 215) ("Gs" 101) ("glutamine synthetase" 28) ("Glul" 28)
   ("GLUL" 22) ("G s" 20) ("gs" 8) ("P-GS" 7) ("Glutamine Synthetase" 7)
   ("glutamine synthetase (GS)" 6) ("Glutamine Synthetase (GS)" 5)
   ("tumor-wide GS" 4) ("Glutamine synthetase" 3) ("Gs protein" 3) ("p-GS" 3)
   ("its transcriptional targets glutamine synthetase (GS)" 2) ("pGS" 2)
   ("G s -protein" 2) ("a favourable GS" 1) ("glutamate-ammonia ligase" 1)
   ("its downstream transcriptional targets Glutamine Synthetase (GS)" 1)
   ("a few GS" 1) ("the known prognostic marker GS" 1)
   ("glutamine synthetase (GC)" 1)))
 ("UP:P15108" (("Hsc82" 1)))
 ("UP:P15121"
  (("1B1" 38) ("aldose reductase" 14) ("AKR1B1" 4)
   ("the monoclonal anti-CSB antibody 1B1" 2) ("-1B1" 1)
   ("mouse monoclonal 1B1" 1)))
 ("UP:P15144"
  (("AP-MS" 177) ("APN" 139) ("APM" 98) ("CD13" 68) ("AP–MS" 18)
   ("aminopeptidase N" 10) ("ANPEP" 3) ("CD13 (ANPEP)" 2) ("gp150" 2)
   ("two complementary AP-MS" 1) ("two distinct AP-MS" 1)
   ("reciprocal AP-MS" 1) ("that APN’s" 1) ("CD13−" 1) ("Reciprocal AP-MS" 1)
   ("efficient and robust AP-MS" 1)))
 ("UP:P15151"
  (("PVR" 234) ("Pvr" 13) ("PVs" 11) ("poliovirus receptor" 6)
   ("experimental PVR" 4) ("CD155" 2) ("very severe PVR" 1)
   ("more severe PVR" 1) ("a very severe PVR" 1) ("developed PVR" 1)
   ("pre-operative PVR" 1) ("progressive PVR" 1) ("severe PVR" 1)
   ("PVR (TPVR)" 1) ("polio virus receptor" 1)))
 ("UP:P15153"
  (("Rac2" 665) ("RAC2" 204) ("GX" 112) ("small G protein" 99)
   ("small G-protein" 50) ("rac2" 3) ("Agilent GeneSpring GX" 2) ("RAC2-" 1)
   ("Rac2-" 1) ("a striatal-specific small G protein" 1)
   ("this particular small G protein" 1)))
 ("UP:P15156" (("CASP" 47) ("pCASP" 8)))
 ("UP:P15160"
  (("hemoglobin" 381) ("Hemoglobin" 22) ("fetal hemoglobin" 11)
   ("corpuscular hemoglobin (MCH)" 4) ("Fetal hemoglobin" 4)
   ("corpuscular hemoglobin" 2) ("mildly increased fetal hemoglobin" 2)
   ("diagnostic hemoglobin" 1) ("fetal hemoglobin (HPFH)" 1)))
 ("UP:P15169" (("Cpn" 2))) ("UP:P15170" (("GSPT1" 3) ("GST1" 2)))
 ("UP:P15172"
  (("MyoD" 240) ("myod" 33) ("MYOD" 29) ("MYOD1" 19) ("Myod1" 13)
   ("myogenic differentiation 1" 9) ("ERMS" 9) ("myoD" 8) ("MyoD1" 4)
   ("myo D" 4) ("MyoD-" 3) ("Myo D" 3) ("expressed MyoD" 3)
   ("metastatic ERMS" 2)
   ("the basic helix-loop-helix transcription factor MyoD" 2)
   ("MyoD protein" 2) ("-MyoD" 1) ("Myf3" 1) ("previously published MyoD" 1)
   ("myoblast determination protein" 1) ("Myo-D" 1) ("particular MYOD1" 1)))
 ("UP:P15173"
  (("MYOGENIN" 116) ("myogenin" 93) ("Myogenin" 43) ("MYOG" 8)
   ("MYOGENIN protein" 3) ("Myog" 2)
   ("than wild-type MYOGENIN ( P <0.05, xref )" 1)
   ("the muscle-specific transcription factor myogenin" 1)))
 ("UP:P15175" (("cathelin" 1))) ("UP:P15210" (("IT" 374) ("IT-" 1)))
 ("UP:P15216" (("EGF2" 3))) ("UP:P15224" (("OS1" 18) ("poor OS1" 2)))
 ("UP:P15225" (("OS3" 60)))
 ("UP:P15248"
  (("IL-9" 46) ("IL9" 16) ("interleukin-9" 5) ("Interleukin-9" 4)
   ("interleukin 9" 1) ("Hp40" 1)))
 ("UP:P15259" (("PGAM2" 137) ("PGAM2 protein" 3)))
 ("UP:P15260"
  (("IFNGR1" 72) ("IFNGR" 6) ("IFNγR1" 3) ("IFNγR" 3) ("ifngr1" 2)
   ("interferon gamma receptor 1" 2) ("interferon gamma receptor" 2)))
 ("UP:P15268"
  (("SPM" 431) ("SPMs" 36) ("developed SPM" 26) ("spm" 8)
   ("non tobacco-associated SPM" 4) ("4 developed SPMs" 3)
   ("tobacco-associated SPM" 2) ("tobacco-associated SPMs" 2)
   ("non-tobacco-associated SPM" 1) ("the 110 (8.0%) patients developed SPM" 1)
   ("very few SPMs" 1) ("had tobacco-associated SPM" 1)
   ("109 (8.6%) patients developed SPM" 1) ("a simultaneous SPM" 1)
   ("109 developed SPMs" 1) ("35 developed SPMs" 1) ("81 developed SPMs" 1)))
 ("UP:P15286"
  (("DIV" 237) ("div" 34) ("dIV" 30) ("fluke" 24) ("Fluke" 2)
   ("postnatal age DIV" 2) ("Div" 1) ("further 6 DIV" 1) ("a lucky fluke" 1)))
 ("UP:P15289" (("AsA" 3) ("asA" 2)))
 ("UP:P15291"
  (("polypeptide 1" 66) ("B4GALT1" 11)
   ("named lamina associated polypeptide 1" 2)
   ("lamina-associated polypeptide 1" 2)))
 ("UP:P15309"
  (("aCPPs" 12) ("aCPP" 8) ("ACPP" 5) ("prostatic acid phosphatase" 5)))
 ("UP:P15311"
  (("ezrin" 391) ("Ezrin" 203) ("P81" 58) ("pEzrin" 17) ("EZR" 16) ("p81" 12)
   ("endothelial ezrin" 3) ("EZRIN" 3) ("VIL2" 3) ("EZR-" 2) ("P-ezrin" 2)
   ("ezrin protein" 2) ("the apical protein ezrin" 2)
   ("apical surface-associated protein ezrin" 2) ("p-Ezrin" 1) ("ezrin-" 1)
   ("its principal component ezrin" 1) ("particular ezrin" 1)))
 ("UP:P15320" (("shLA" 2)))
 ("UP:P15328" (("FRα" 4) ("FOLR1" 2) ("folate receptor 1" 2)))
 ("UP:P15336"
  (("ATF2" 835) ("ATF-2" 181) ("CREB2" 73) ("CREB-2" 19)
   ("activating transcription factor 2" 14) ("ATF2 protein" 8)
   ("ATF-2 protein" 7) ("p-ATF2" 6) ("-ATF2" 5)
   ("activating transcription factor-2" 5) ("Atf2" 5) ("CREB 2" 4)
   ("Activating transcription factor-2" 3) ("P-ATF2" 3) ("ATF2 peptide" 3)
   ("the residual nuclear ATF2" 3) ("CREB2 protein" 3) ("CREB2-" 1)
   ("p-ATF-2" 1) ("the sequence-specific transcriptional activator ATF2" 1)
   ("dominant-negative ( dn ) ATF2" 1)
   ("subcellular biochemical fractionation revealed increased ATF2" 1)
   ("Creb2" 1) ("Atf-2" 1)))
 ("UP:P15340" (("protamine" 44) ("Protamine" 1)))
 ("UP:P15370"
  (("eg" 210) ("EG" 147) ("pEG" 27) ("-EG" 8) ("similarly cut pEG(KT)" 2)
   ("pEG(KT)" 1) ("the bait vector pEG202" 1) ("pathological findings eg" 1)))
 ("UP:P15374" (("UCHL3" 1) ("UCH-L3" 1)))
 ("UP:P15382" (("KCNE1" 16) ("ISK" 6) ("Isk-related family" 2) ("LQT5" 1)))
 ("UP:P15391"
  (("CD19" 756) ("Cd19" 29) ("CD19-" 6) ("CD19 protein" 4) ("-CD19" 2)
   ("CD19+CD27-" 2) ("CD19+CD38+IgD−" 1)))
 ("UP:P15407"
  (("Fra-1" 865) ("FRA1" 303) ("FOSL1" 170) ("Fra1" 94) ("FRA-1" 78)
   ("Fosl1" 41) ("fra-1" 41) ("FRA-1 protein" 16) ("Fosl-1" 10)
   ("Fra-1 protein" 9) ("pro-mesenchymal FRA1" 4) ("fra1" 4)
   ("Fos-related antigen-1" 4) ("FosL1" 3) ("targeting FRA1" 3)
   ("FOSL1 protein" 3) ("pFra-1" 3) ("Moderate-to-strong nuclear FRA1" 2)
   ("the invasive front exhibited strong FRA1" 2) ("FRA1-" 2) ("p-Fra-1" 2)
   ("overexpressed Fra-1" 2) ("His-tagged-recombinant Fra-1" 2)
   ("the epithelial FRA1" 1) ("several mesenchymal and epithelial FRA1" 1)
   ("several pro-mesenchymal FRA1" 1) ("fos-related antigen 1" 1) ("FOSl1" 1)
   ("fosl1" 1)))
 ("UP:P15408"
  (("Fra-2" 228) ("FRA2" 65) ("Fosl2" 59) ("Fra2" 19) ("FOSL2" 9) ("Fra 2" 7)
   ("FRA-2" 4) ("fra-2" 2) ("FosL2" 2) ("fra2" 1)))
 ("UP:P15428"
  (("15-PGDH" 267) ("HPGD" 26) ("15-hydroxyprostaglandin dehydrogenase" 22)
   ("15-PGDH protein" 6) ("15-hydroxyprostaglandin dehydrogenase (PGDH)" 1)
   ("the degradative enzyme 15-PGDH" 1)))
 ("UP:P15436"
  (("Pol3" 16) ("DNA polymerase III" 6) ("POL3" 2)
   ("The classical DNA polymerase III" 1)))
 ("UP:P15456" (("Crb" 128) ("crb" 10) ("cRb" 3)))
 ("UP:P15498"
  (("Vav1" 2634) ("Vav" 817) ("vav" 176) ("VAV1" 143) ("Vav-1" 57) ("vav1" 32)
   ("Vav1 protein" 29) ("a new Vav1" 8) ("VAV" 7) ("Vav protein" 4)
   ("Vav1 Protein" 4) ("Vav-" 3) ("co-expressing wild-type Vav1" 3)
   ("functional Vav" 2) ("Vav1-" 2) ("Dominant-negative Vav1" 2)
   ("specifically target either Vav1" 2) ("FL" 2) ("Vav1 (FL)" 2) ("QFPFKE" 2)
   ("the cellular Vav" 1) ("potential Vav" 1) ("targeting Vav1" 1)
   ("exogenous Vav1" 1) ("dominant-negative Vav1" 1) ("DRM-associated Vav1" 1)
   ("vav-" 1) ("33 available Vav" 1) ("cellular Vav1" 1)
   ("the parental Vav1" 1)
   ("the N-terminal acidic region tyrosines of Vav1 (Y142, Y160, and Y174)" 1)
   ("VAV1-" 1)))
 ("UP:P15502"
  (("elastin" 210) ("Elastin" 14) ("ELN" 9) ("elastin protein" 5)
   ("Williams-Beuren syndrome" 3) ("substantial elastin" 3)
   ("Abnormal elastin" 2) ("elastin ( ELN )" 1) ("tropoelastin" 1)
   ("Williams–Beuren syndrome" 1)))
 ("UP:P15509"
  (("GM-CSFRα" 229) ("CD116" 10) ("GMRα" 6) ("GM-CSFRα Protein" 2) ("CSF2RA" 2)
   ("GM-CSFRα protein" 1)))
 ("UP:P15513" (("MMB" 93) ("MMI" 9) ("MMF" 3) ("given MMF" 2) ("MMG" 2)))
 ("UP:P15514"
  (("AREG" 770) ("amphiregulin" 552) ("Amphiregulin" 55) ("Areg" 21)
   ("amphiregulin (AREG)" 12) ("amphiregulin ( AREG )" 9)
   ("amphiregulin (AR)" 4) ("basal amphiregulin" 4) ("AREG-" 3)
   ("AREG protein" 3) ("AREG (SFIHA)" 2) ("exogenous AREG" 2) ("SDGF" 1)
   ("basal-level autocrine amphiregulin" 1) ("amphiregulin-" 1)
   ("exogenous amphiregulin" 1) ("more amphiregulin" 1)))
 ("UP:P15516"
  (("PB" 854) ("Pb" 62) ("pB" 30) ("PB-" 27) ("pb" 19) ("whose PB" 3)
   ("normal PB" 2) ("pPB" 1) ("postoperative PB" 1) ("periodic PB" 1)
   ("complete PB" 1) ("randomly chosen PB" 1)))
 ("UP:P15522" (("whey protein" 75) ("Whey protein" 2) ("whey protein–" 1)))
 ("UP:P15529"
  (("CD46" 406) ("TLX" 65) ("membrane cofactor protein" 10)
   ("complement regulatory protein" 10) ("Tailless" 3)
   ("recombinant (r) soluble CD46" 2) ("TLX protein" 1) ("Tlx" 1)
   ("a fluorescein isothiocyanate–labeled monoclonal mouse antihuman CD46" 1)
   ("viral proteins binding CD46" 1)))
 ("UP:P15531"
  (("NDPK-A" 159) ("NME1" 47) ("Nm23-H1" 30) ("Nm23" 26) ("nm23" 13)
   ("nucleoside diphosphate kinase A" 13) ("NM23" 11) ("Nm23 protein" 8)
   ("NM23-H1" 2) ("NM-23" 2) ("nm23-H1" 2) ("nm23H1" 1)))
 ("UP:P15533" (("Trim30" 51) ("TRIM30" 1)))
 ("UP:P15538" (("Cyp11B1" 2) ("Cyp11b1" 1) ("CYP11B1" 1)))
 ("UP:P15559"
  (("NQO1" 1592) ("NQO-1" 64) ("NAD(P)H:quinone oxidoreductase 1" 47)
   ("hNQO1" 16) ("NAD(P)H: quinone oxidoreductase 1" 15) ("NQO1 protein" 13)
   ("-NQO1" 3) ("targeting NQO1" 3) ("NQO1-" 3)
   ("the classical NRF2 target NQO1" 2) ("Overexpressed NQO1" 2)
   ("stably knock-down NQO1" 2) ("than NQO1" 1) ("hNQO1-" 1) ("“NQO1”" 1)
   ("revealed significantly lower basal and induced NQO1" 1)
   ("a missense hypomorphic NQO1" 1) ("NQO1−" 1)))
 ("UP:P15586" (("GNS" 141))) ("UP:P15597" (("vIRF" 5) ("v-IRF" 1)))
 ("UP:P15636" (("API" 40) ("API-" 1) ("the RESTful API" 1)))
 ("UP:P15692"
  (("VEGF" 9132) ("VEGF-A" 1294) ("vegf" 412) ("VEGFA" 270) ("VPF" 83)
   ("VEGF protein" 64) ("Vegf" 40) ("exogenous VEGF" 27)
   ("endothelial growth factor" 23) ("VEGFa" 22)
   ("vascular endothelial growth factor A" 21)
   ("vascular endothelial growth factor-A" 20) ("Vegfa" 18) ("Vegf-A" 15)
   ("vascular permeability factor" 14) ("VEGF-" 11) ("VEGF121" 8)
   ("Vascular endothelial growth factor-A" 7)
   ("Vascular endothelial growth factor A" 6) ("soluble VEGF" 5) ("Vegf-a" 4)
   ("residual VEGF" 3) ("the rapidly growing vegf 5" 3)
   ("Vascular permeability factor" 3) ("a new VEGF" 3) ("than VEGF-A" 3)
   ("bioavailable VEGF" 3) ("VEGF-A–" 3) ("preoperative serum VEGF" 2)
   ("significantly less VEGF" 2)
   ("vascular endothelial growth factor A ( VEGFA )" 2)
   ("vSMC-associated VEGF" 2) ("the bioavailable VEGF" 2)
   ("catalytically release angiogenesis-inducing VEGF" 2)
   ("targeting VEGF-A" 2) ("dimeric VEGF" 2) ("overexpressed VEGF" 2)
   ("neither exogenous human VEGF" 2) ("more VEGF" 2)
   ("TRAIL showed significantly less VEGF" 2) ("VEGF-A protein" 2)
   ("less VEGF-A" 2) ("previously determined VEGF" 1) ("VegfA" 1)
   ("less VEGF" 1) ("Too much VEGF-A" 1) ("secreted more VEGF" 1)
   ("small cell lung cancer (SCLC) cell lines produced more VEGF" 1)
   ("than VEGF (p < 0.001)" 1) ("local VEGF" 1) ("-VEGF" 1) ("vegfa" 1)
   ("vEGF" 1) ("inflamed gingival tissue sections (gingivitis) VEGF" 1)
   ("residual VEGF protein" 1) ("epithelial-derived human (h) VEGF" 1)
   ("soluble VEGF-A" 1) ("soluble VEGF protein" 1)
   ("soluble (bioavailable) human VEGF" 1)
   ("the interior expressed significantly less VEGF" 1)
   ("endothelial growth factor (EGF)" 1) ("hypertrophic cartilage VEGF" 1)
   ("endothelial VEGF" 1) ("targeted VEGF" 1)
   ("exogenous and endogenous BMSC-derived VEGF" 1) ("less VEGFA" 1)
   ("the previously identified VEGF" 1) ("VEGF-A-" 1) ("stromal VEGF" 1)
   ("Endothelial growth factor" 1) ("further reduced VEGF" 1)))
 ("UP:P15699" (("INTA" 1))) ("UP:P15703" (("Bgl2" 9) ("internal Bgl2" 1)))
 ("UP:P15729" (("GTR" 10) ("patients underwent GTR" 2)))
 ("UP:P15735" (("PHKG2" 13))) ("UP:P15750" (("p-ULK" 15) ("pULK" 3)))
 ("UP:P15776"
  (("HE" 378) ("HE-" 5) ("the characteristic HE" 2)
   ("pseudomyogenic (epithelioid sarcoma-like) HE" 1) ("9 pseudomyogenic HE" 1)
   ("antibody HE172" 1) ("the respective HE" 1) ("the correspondent HE" 1)
   ("the International HE" 1)))
 ("UP:P15796" (("hIL-2" 6)))
 ("UP:P15813"
  (("CD1d" 276) ("CD1d-" 3) ("CD1d molecule" 2) ("CD1d antigen" 2)))
 ("UP:P15814" (("IgL1" 3) ("Igl 1" 2) ("IGLL1" 1)))
 ("UP:P15822" (("Hivep1" 5) ("HIVEP1" 1)))
 ("UP:P15840" (("M.SssI" 9) ("the bacterial DNA methyltransferase M.SssI" 2)))
 ("UP:P15848"
  (("ARSB" 10) ("arylsulfatase B ( ARSB )" 3) ("arylsulfatase B" 2)))
 ("UP:P15863" (("Pax1" 3) ("PAX1" 2)))
 ("UP:P15880" (("RPS2" 5) ("RpS2" 1) ("ribosomal protein S2" 1)))
 ("UP:P15882"
  (("NC" 2715) ("N/C" 85) ("N-C" 59) ("CHN" 38) ("N-C-" 15) ("CHN1" 8)
   ("respective NC" 7) ("n/c" 7) ("nc" 5) ("NC-" 5) ("-NC" 5) ("N–C" 2)
   ("the miR-34a (+) NC and miR-34a (–) NC" 2) ("NC (NC)" 2) ("N c" 2)
   ("n c" 2) ("Chimerin 1" 2) ("n-chimaerin" 1) ("the mitotic blocker NC" 1)
   ("than LV-miR-222i NC" 1)
   ("the miR-34a (+) NC + PKCε (+) NC and miR-34a (–) NC + PKCε (–) NC" 1)
   ("than NC" 1) ("than the NC" 1) ("N  c" 1)))
 ("UP:P15884"
  (("TCF4" 842) ("TCF-4" 641) ("Tcf4" 157) ("Tcf-4" 35)
   ("transcription factor 4" 22) ("dominant-negative TCF4" 11)
   ("TCF-4 protein" 9) ("E2-2" 8) ("TCF4-" 8) ("Tcf4 peptide" 6)
   ("TCF4 protein" 5) ("TCF 4" 4) ("targeting TCF4" 3)
   ("a dominant-negative TCF4" 2) ("expressed GST-tagged TCF-4" 2) ("-TCF-4" 2)
   ("a dominant negative (DN) TCF-4" 2) ("XIAP directly binds TCF4" 2)
   ("ITF2" 2) ("dominant-negative TCF4 (DN-TCF4) protein" 1)
   ("TCF4 (DN-TCF4) protein" 1) ("ITF-2" 1) ("associated Tcf4" 1)
   ("the dominant-negative TCF4 protein" 1) ("dominant negative (DN) TCF4" 1)
   ("Tcf4-" 1) ("a recurrent TCF4" 1) ("residual TCF4" 1)))
 ("UP:P15904"
  (("pCR" 759) ("PCr" 30) ("pcR" 5) ("PcR" 3) ("predictive pCR" 2)
   ("less pCR" 2) ("pCR-" 2) ("The expression construct pCR3" 1)))
 ("UP:P15907" (("ST6Gal I" 2)))
 ("UP:P15917"
  (("LF" 262) ("LEF" 159) ("lethal factor" 15) ("lf" 5) ("Lef" 2)
   ("LEF protein" 1)))
 ("UP:P15918"
  (("NBD" 256) ("Rag1" 88) ("RAG1" 69) ("NBD peptide" 16) ("RAG-1" 8)
   ("Rag-1" 5) ("rag1" 3) ("homogeneous DBD-NBD" 1) ("the central NBD" 1)))
 ("UP:P15923"
  (("Tcf3" 214) ("TCF3" 165) ("transcription factor 3" 22) ("TCF-3" 19)
   ("-Tcf3" 14) ("Tcf-3" 11) ("Tcf3 protein" 5)
   ("dominant-negative Xenopus TCF-3" 1)))
 ("UP:P15924"
  (("DP" 1145) ("DPI" 324) ("dpi" 250) ("DSP" 173) ("desmoplakin" 67) ("Dp" 39)
   ("desmoplakin (DP)" 9) ("plakin" 5) ("Desmoplakin" 4)
   ("HIV-associated DSP" 3) ("DP protein" 3) ("dPI" 2) ("DP molecule" 2)
   ("the membrane permeable and reversible cross-linker DSP" 1) ("than DP" 1)
   ("than one DP molecule" 1) ("the desmosomal linker protein desmoplakin" 1)
   ("Most DP" 1) ("DP-" 1) ("the cell-permeable cross-linker DSP" 1)))
 ("UP:P15927"
  (("RPA32" 392) ("RPA2" 374) ("RPA34" 33) ("pRPA32" 28) ("pRPA2" 2)
   ("defective pRPA32" 2)
   ("replication
                    protein A (RPA) subunit RPA2"
    2)
   ("soluble RPA2" 1) ("replication protein A2" 1)
   ("than those expressing wild-type RPA32 ( xref )" 1)))
 ("UP:P15941"
  (("MUC1" 2236) ("EMA" 111) ("γ-catenin" 101) ("KL-6" 61) ("PEMs" 58)
   ("pUM" 57) ("Muc1" 53) ("mucin 1" 43) ("MUC-1" 28) ("PEM" 24)
   ("MUC1 protein" 16) ("MUC1-CT" 15) ("Pem" 13) ("Mucin 1" 10) ("mucin-1" 9)
   ("Pum" 5) ("muc-1" 5) ("Mucin-1" 4) ("cell surface–associated mucin 1" 4)
   ("muc1" 4) ("mucin 1 (MUC1) protein" 3) ("cytoplasmic tail-deleted MUC1" 3)
   ("the desmosomal protein γ-catenin" 3) ("episialin" 2) ("PUM" 2)
   ("Epithelial mucin-1" 2) ("MUC1−" 2) ("CD227" 2) ("CA 15-3" 2) ("EMA−" 2)
   ("the 24 primary EMA" 2) ("MUC1-" 2) ("overexpressed MUC1" 2)
   ("miR-145 directly targets MUC1" 2) ("strong cytoplasmic MUC1" 2)
   ("Muc-1" 2) ("DF3" 2) ("Mucin1" 2) ("MUC1 peptide" 2)
   ("HDAC11-overexpressing PEMs" 1) ("the aberrantly overexpressed MUC1" 1)
   ("the exogenous MUC1" 1) ("MUC1 molecule" 1) ("gp91 phox -null PEM" 1)
   ("gp91 phox -null PEMs" 1) ("hMUC1" 1) ("Krebs von den Lungen-6" 1)
   ("muc-1-" 1) ("re-distributed apical MUC1" 1)
   ("the aforementioned MUC1" 1)))
 ("UP:P15954" (("COX7C" 8))) ("UP:P15963" (("P74" 18)))
 ("UP:P15976"
  (("GATA1" 338) ("GATA-1" 262) ("Gata1" 18) ("Gata-1" 4)
   ("GATA binding protein 1" 3) ("GATA-1 protein" 2) ("GATA1 protein" 2)
   ("Gf1" 2) ("GATA−1" 2) ("erythroid transcription factor" 1)
   ("3-times more GATA1" 1) ("pGF1" 1) ("than GATA-1 (data not shown)" 1)
   ("GATA1 (GCCTCCAGAG)" 1) ("late stage erythroid maturation GATA-1" 1)))
 ("UP:P15992" (("HSP26" 1)))
 ("UP:P16035"
  (("TIMP-2" 201) ("TIMP2" 72) ("tissue inhibitor of metalloproteinase 2" 3)
   ("exogenous TIMP-2" 2) ("tissue inhibitor of metalloproteinases 2" 2)
   ("Tissue Inhibitor of Metalloproteinase 2" 2) ("metalloproteinases 2" 1)))
 ("UP:P16047" (("TGF-β3" 80)))
 ("UP:P16050"
  (("15-LOX-1" 71) ("ALOX15" 47) ("12-LOX" 45) ("12/15-lipoxygenase" 3)
   ("arachidonate 15-lipoxygenase" 2)))
 ("UP:P16066" (("NPRA" 5) ("natriuretic peptide receptor" 2)))
 ("UP:P16070"
  (("CD44" 5134) ("Cd44" 58) ("NLS" 51) ("heparan sulfate proteoglycan" 29)
   ("CD44-" 26) ("HA-CD44" 24) ("CD44−" 15) ("-CD44" 10) ("CD44 antigen" 7)
   ("CD44 protein" 6) ("MIC4" 5) ("than CD44" 5) ("CD44 molecule" 4)
   ("heparan sulfate proteoglycan (HSPG)" 3) ("The soluble CD44" 2)
   ("CD44 Protein" 2) ("APC-H7-conjugated CD44" 2)
   ("Heparan sulfate proteoglycan" 2) ("CD-44" 2) ("hCD44" 1) ("pCD44" 1)
   ("a distinctive CD44" 1) ("The most widely expressed CD44" 1) ("P16070" 1)
   ("CD44 (APC)" 1) ("Soluble CD44" 1)
   ("the BRG1 transcriptional target CD44" 1) ("weak NLS" 1) ("CD44 (HCAM)" 1)
   ("the well-studied cell-surface receptor CD44" 1) ("CD44+/CD24-" 1)
   ("than the CD44" 1) ("thymic CD44" 1) ("fewer memory-phenotype CD44" 1)
   ("Spi2A developed fewer memory-phenotype CD44" 1) ("less CD44" 1)
   ("soluble CD44" 1)))
 ("UP:P16083"
  (("NQO2" 14) ("NRH:quinone oxidoreductase 2" 5) ("QR2" 1) ("Nqo2" 1)))
 ("UP:P16090" (("gp100" 17) ("gp100 protein" 3) ("GP100" 2)))
 ("UP:P16099"
  (("TMD" 381) ("TMD peptide" 28) ("tmd" 7) ("TMD Peptide" 6)
   ("the upper TMD" 1) ("whose TMD" 1)))
 ("UP:P16104"
  (("H2AX" 2310) ("γH2AX" 2282) ("γ-H2AX" 1579) ("histone H2AX" 293)
   ("-H2AX" 192) ("H2ax" 106) ("histone H2A.X" 64) ("p-H2AX" 36) ("pH2AX" 34)
   ("H2AFX" 25) ("γH2Ax" 21) ("Histone H2A.X" 16) ("member X" 12)
   ("γH2AX protein" 8) ("intense γ-H2AX" 6) ("H2AX protein" 5) ("-γH2AX" 5)
   ("histone H2Ax" 5) ("γ-H2Ax" 4) ("histone H2AX peptide" 4)
   ("extensive γH2AX" 4) ("Immuno-fluorescent γH2AX" 4) ("gammaH2AX" 4)
   ("H2AXs" 4) ("intense γH2AX" 3) ("γH2AX peptide" 3)
   ("H2A histone family member X" 3) ("γ−H2AX" 3) ("H2Ax" 2)
   ("UV-induced γH2AX" 2) ("basal UV-induced γH2AX" 2)
   ("gamma-photon radiation-induced γ-H2AX" 2)
   ("Mouse monoclonal anti-phospho-histone γ-H2AX" 2) ("γH2AX-" 2)
   ("spontaneous γH2AX" 2)
   ("Serous intraepithelial and invasive carcinomas exhibited more intense γ-H2AX"
    2)
   ("monoclonal anti-phospho H2AX" 2)
   ("mouse monoclonal anti-phospho-Histone γ-H2AX" 2)
   ("chromatin-associated histone H2AX" 2) ("H2AX-" 2) ("Primary γ-H2AX" 2)
   ("nucleosomal H2AX" 2)
   ("diplotene spermatocytes display persistant autosomal γ-H2AX" 2)
   ("Autosomal γ-H2AX" 2) ("-γH2Ax" 2) ("almost no detectable γ-H2AX" 2)
   ("γ–H2AX" 2) ("strong γH2AX" 2) ("Chromatin-associated H2AX" 1)
   ("UV irradiation induced γH2AX" 1) ("γ-H2AX protein" 1) ("basal γ-H2AX" 1)
   ("induced substantial γH2Ax" 1) ("p-γH2AX" 1) ("P-H2AX" 1) ("local γH2AX" 1)
   ("p-Histone H2A.X" 1) ("histone H2AX (UBI)" 1) ("mouse monoclonal γ-H2AX" 1)
   ("early neural development γH2AX" 1) ("expressing FLAG-tagged H2AX" 1)
   ("less total γH2AX protein" 1) ("than γH2AX" 1)
   ("oxLDL exposure immunoreactive γ-H2AX" 1) ("immunoreactive γ-H2AX" 1)
   ("almost no γ-H2AX" 1) ("minimal γ-H2AX" 1)))
 ("UP:P16109" (("CD62P" 44) ("CD62p" 8)))
 ("UP:P16112"
  (("aggrecan" 122) ("Aggrecan" 19) ("ACAN" 11) ("AGC1" 5) ("AGGRECAN" 3)
   ("Acan" 1) ("the chondrogenic differentiation marker aggrecan" 1)
   ("20-fold less aggrecan" 1) ("the key anabolic gene aggrecan" 1)))
 ("UP:P16114" (("RNS" 139) ("RNs" 19) ("much less RNs" 1) ("RNS-" 1)))
 ("UP:P16118"
  (("6-phosphofructo-2-kinase" 12) ("PFKFB1" 9)
   ("fructose-2,6-bisphosphatase" 4)))
 ("UP:P16144"
  (("ITGB4" 137) ("β4-integrin" 7) ("CD104" 3) ("integrin-beta4" 2)
   ("integrin beta 4" 1) ("Itgb4" 1) ("ITGB4 protein" 1) ("upper ITGB4" 1)))
 ("UP:P16150"
  (("CD43" 95) ("SPNs" 84) ("CD43 (SPN)" 3) ("CD43-" 1)
   ("in fact solid SPNs" 1)))
 ("UP:P16152"
  (("CBR" 161) ("CBR1" 16) ("pCBR" 5) ("carbonyl reductase 1" 2)
   ("than CBR" 1)))
 ("UP:P16157"
  (("ankyrin" 460) ("ANK1" 85) ("Ankyrin" 35) ("ankyrin-1" 15)
   ("erythrocyte ankyrin" 11) ("ankyrin 1" 8) ("ankyrin1" 3)
   ("ankyrin (ANK)" 3) ("intact erythrocyte ankyrin" 2)
   ("125 I-labeled intact erythrocyte ankyrin" 2) ("ankyrin molecule" 2)
   ("125 I-labeled intact ankyrin" 2)
   ("Mouse monoclonal erythrocyte ankyrin" 2) ("ankyrin R" 2) ("Ank1" 2)
   ("intact ankyrin" 1) ("ANKYRIN" 1) ("typical ankyrin" 1)
   ("21 successive ankyrin (ANK)" 1) ("central ankyrin" 1)))
 ("UP:P16163" (("UO" 18))) ("UP:P16219" (("sCAD" 35) ("sCADs" 2) ("SCAD" 1)))
 ("UP:P16220"
  (("CREB1" 279) ("cAMP response element binding protein" 29) ("pCREB1" 13)
   ("cAMP-response element binding protein" 9)
   ("cAMP responsive element binding protein 1" 6) ("CREB-1" 6)
   ("CREB1 protein" 6) ("p-CREB1" 3) ("p-CREB-1" 3)
   ("cAMP response element binding protein (CREB)" 2)
   ("the sub-networks centred around CREB1" 2)
   ("cAMP-response
element binding protein"
    2)
   ("Creb1" 2) ("cAMP-response element binding protein (CREB)" 1)
   ("the top 21 most significant sub-networks centred around CREB1" 1)
   ("CREB1-" 1) ("than CREB1" 1)))
 ("UP:P16223"
  (("TKIs" 3347) ("TKI" 3129) ("EGFR-TKI" 810) ("-TKIs" 14)
   ("irreversible TKIs" 9) ("-TKI" 8) ("irreversible EGFR-TKI" 6)
   ("a clinically relevant c-Met TKI" 5) ("EGFR TKI's" 4) ("EGFR–TKI" 4)
   ("a dual TKI" 4) ("TKi" 4) ("reversible EGFR-TKI" 3) ("reversible TKIs" 3)
   ("reversible TKI" 3) ("targeted TKIs" 3) ("dual TKIs" 3) ("EGFR TKI’s" 2)
   ("available TKIs" 2) ("a reversible TKI" 2) ("more recent TKIs" 2)
   ("that TKI’s" 2) ("irreversible TKI" 2) ("Most available TKIs" 2)
   ("our dual Mer/Flt3 TKI" 2) ("orally bioavailable c-Met TKI" 2)
   ("a reversible ATP-competitive TKI" 2) ("currently approved EGFR TKIs" 2)
   ("clinically-available TKIs" 1) ("a reversible EGFR-TKI" 1)
   ("even fourth generation TKIs" 1) ("another irreversible EGFR-TKI" 1)
   ("a major EGFR-TKI" 1) ("selective TKI’s" 1) ("two or more TKIs" 1)
   ("had failed EGFR TKIs" 1) ("clinically-available EGFR TKIs" 1)
   ("than TKIs alone in vitro" 1) ("in contrast reversible TKI" 1)
   ("bur reversible TKI" 1) ("Irreversible TKI" 1)
   ("small molecule irreversible and reversible TKIs" 1)
   ("an irreversible TKI" 1) ("upfront EGFR TKI" 1)
   ("still no effective TKI" 1) ("at least one second-generation TKI" 1)
   ("two reversible TKIs" 1) ("typical EGFR TKIs" 1)
   ("the irreversible EGFR-TKI" 1) ("MET–EGFR TKIs (SU11274 plus erlotinib)" 1)
   ("an irreversible EGFR-TKI" 1) ("The clinically relevant TKI" 1)
   ("at least six MET TKIs" 1)
   ("orally available anilinoquinazoline small molecule ATP-mimetic TKIs" 1)
   ("classical c-Met TKI" 1) ("an anti-IGF-IR/InsR dual TKI" 1)
   ("the irreversible dual EGFR/ErbB2 TKI" 1) ("perioperative TKI" 1)
   ("an investigational EGFR TKI" 1) ("clinically available EGFR TKIs" 1)
   ("generally no effective TKIs" 1) ("“+TKI”" 1)
   ("received palliative EGFR-TKI" 1) ("more recent FLT3 TKI" 1)
   ("most TKIs" 1) ("a relevant well-tolerated TKI" 1) ("TKI-" 1)
   ("another irreversible TKI" 1) ("the so-called second-generation TKIs" 1)))
 ("UP:P16233"
  (("PTL" 127) ("spontaneous PTL" 2) ("PNLIP" 1) ("further all PTL" 1)))
 ("UP:P16234"
  (("PDGFRα" 2102) ("PDGFR" 1446) ("PDGFRA" 1200) ("PDGFR-α" 352)
   ("CD140a" 161) ("Pdgfrα" 147) ("Pdgfr-a" 89) ("PDGFR-A" 71)
   ("PDGF receptors" 56) ("platelet-derived growth factor receptor alpha" 33)
   ("pPDGFR" 30) ("PDGFR-" 16) ("PDGFRa" 14) ("Pdgfra" 14) ("PDGFRα-" 13)
   ("stromal PDGFRα" 12) ("platelet derived growth factor receptor alpha" 11)
   ("PDGFRalpha" 11) ("PDGFRα protein" 10)
   ("derived growth factor receptor-alpha" 8) ("PDGFR-alpha" 6) ("PDGFR-a" 6)
   ("PDGF Receptors" 4) ("PDGFR-A protein" 3) ("-PDGFRα" 3)
   ("platelet-derived growth factor receptor alpha (PDGFRA)" 3)
   ("monomeric PDGFRα" 3) ("p-PDGFR-α" 3)
   ("Platelet-derived growth factor receptor alpha" 2)
   ("Overexpressed PDGFR" 2) ("exogenous PDGFRα" 2) ("than PDGFRα" 2)
   ("PDGFRα-D842V protein" 2) ("PDGFR-alpha peptide" 2) ("PDGF-Rα" 2)
   ("PDGFR-a(D842V) protein" 2)
   ("-platelet-derived growth factor receptor alpha" 2)
   ("monoclonal anti–human PDGFRα" 2)
   ("platelet-derived growth factor α receptor" 2) ("stromal PDGFR" 2)
   ("mouse monoclonal anti-human PDGFR-α" 2) ("dimerized PDGF receptors" 1)
   ("intragenic mutations target PDGFRA" 1)
   ("Platelet derived growth factor receptor alpha" 1)
   ("than Pdgfrα ( xref )" 1) ("potentially target PDGFR-α" 1)
   ("quantum dot (Qdot) nanocrystal conjugated-Pdgfr-a" 1)
   ("a human alveolar rhabdomyosarcoma cell line (Rh5) efficiently knocked down PDGFR-A"
    1)
   ("Somatic PDGFRA" 1) ("a dominant-negative PDGFR" 1) ("PDGFR—a" 1)
   ("exclusively targets PDGFRα" 1) ("major PDGFRα" 1) ("than PDGFRA" 1)
   ("intact PDGFR" 1) ("stromal PDGF receptors" 1) ("than PDGFRα ( xref )" 1)
   ("Platelet Derived Growth Factor Receptor Alpha" 1) ("CD140a-" 1)
   ("than CD140a" 1) ("PDGFRA protein" 1) ("very little PDGFRα" 1)
   ("alpha-receptor" 1) ("targets stromal PDGFRα" 1) ("P-PDGFRa" 1)
   ("P-platelet-derived growth factor receptor alpha" 1)))
 ("UP:P16253" (("3A3" 2)))
 ("UP:P16260" (("GDC" 21) ("SLC25A16" 1) ("Graves disease autoantigen" 1)))
 ("UP:P16274" (("IFAs" 1)))
 ("UP:P16278"
  (("β-galactosidase" 1497) ("β-Galactosidase" 122)
   ("Senescence-associated β-galactosidase" 84)
   ("senescence-associated β-galactosidase" 52) ("beta-galactosidase" 49)
   ("SA-beta-gal" 41) ("Beta-galactosidase" 15) ("Beta-Galactosidase" 15)
   ("beta-galactosidase activity" 13)
   ("senescence-associated beta-galactosidase" 10)
   ("Senescence-Associated β-Galactosidase" 10) ("beta-Galactosidase" 10)
   ("-β-galactosidase" 8) ("SA-beta-Gal" 7)
   ("the senescence-associated β-galactosidase" 6)
   ("senescence-associated (SA)-β-galactosidase" 6)
   ("Senescence-associated betagalactosidase" 6) ("betagalactosidase" 5)
   ("GLB1" 5) ("senescence associated β-galactosidase" 5)
   ("senescent-associated β-galactosidase" 4)
   ("Senescent-associated β-galactosidase" 4) ("beta galactosidase" 3)
   ("targeting β-galactosidase" 3)
   ("the
accompanying elevated senescence-associated beta-galactosidase"
    3)
   ("we first performed senescence-associated beta-galactosidase" 3)
   ("senescence associated β–galactosidase" 3)
   ("Senescence-associated beta-galactosidase" 2) ("β-galactosidase protein" 2)
   ("using senescence-associated β-galactosidase" 2) ("SA-Beta-Gal" 2)
   ("Beta galactosidase" 2) ("CAPE showed moderate positive β-galactosidase" 2)
   ("senescence associated beta-galactosidase activity" 2)
   ("a senescence-associated β-Galactosidase" 2)
   ("Bacterial β-galactosidase" 2) ("Beta-galactosidase activity" 2)
   ("β−galactosidase" 2) ("-β-Galactosidase" 2)
   ("the senescence-associated acidic β-Galactosidase" 2) ("β–galactosidase" 2)
   ("senescence-associated beta-galactosidase activity" 2)
   ("the Senescence-associated β-galactosidase" 1)
   ("the ubiquitous acidic β-galactosidase" 1)
   ("Senescence-associated acidic β-galactosidase" 1)
   ("the internal control beta-galactosidase" 1)
   ("bacterial β-galactosidase" 1) ("β-galactosidase (SABG)" 1)
   ("beta-Galactosidase activity" 1) ("radiation-induced SA-beta-gal" 1)
   ("the Senescence-Associated β-galactosidase" 1)))
 ("UP:P16284"
  (("PECAM-1" 826) ("PECAM1" 27) ("CD-31" 21)
   ("platelet endothelial cell adhesion molecule" 12) ("PECAM-1 protein" 8)
   ("Pecam1" 7) ("Platelet endothelial cell adhesion molecule" 5)
   ("5 μg/ml Alexa 488–conjugated PECAM-1" 2)
   ("blood vessels showed strong PECAM-1" 2) ("soluble PECAM-1" 1)
   ("Alexa-conjugated PECAM-1.3" 1) ("simply sequestering PECAM-1" 1)
   ("Pecam-1" 1) ("the vascular marker PECAM-1" 1)
   ("young (8wk) PECAM-1 -/-" 1)))
 ("UP:P16298" (("PPP3CB" 6)))
 ("UP:P16300" (("LBLs" 28) ("both parental LBLs" 3)))
 ("UP:P16320"
  (("ORF" 1557) ("-ORF" 9) ("targeted ORF" 6) ("the entire ORF" 5)
   ("the nonstructural protein ORF" 2) ("Human full-length ERα Ultimate ORF" 2)
   ("The entire ORF" 2) ("a new ORF" 2) ("largest ORF" 2) ("the intact ORF" 2)
   ("a complete ORF" 2) ("the respective ORF" 2)
   ("the retroviral pQXIP/ THBS1 ORF" 2) ("successful ORF" 2)
   ("alternative ORF" 2) ("the first methionine of the ORF" 1)
   ("the longest-annotated ORF" 1)
   ("longest detected Met-initiated putative ORF" 1)
   ("Human snail homolog 2 ( Drosophila ) (SNAI2/SLUG, NM_003068) cDNA ORF" 1)
   ("than one ORF" 1) ("the correct ORF" 1) ("the valid ORF" 1)
   ("longer ORF" 1) ("the complete ORF" 1) ("complete ORF" 1)
   ("Ultimate ORF" 1) ("a given ORF" 1)
   ("stably expressed 597 sequence-validated kinase ORF" 1)
   ("The complete ORF" 1) ("at least one ORF" 1) ("each viral ORF" 1)))
 ("UP:P16333"
  (("Nck" 396) ("Nck1" 299) ("NCK" 21) ("NCK1" 15) ("Nck-1" 9) ("Nck-" 4)
   ("nck" 3) ("Nck1-" 3) ("more Nck" 2) ("SH3 adaptor protein" 1)))
 ("UP:P16343" (("de4" 2) ("DE4" 1))) ("UP:P16383" (("GCF" 22)))
 ("UP:P16389" (("Kv1.2" 9) ("kv1.2" 3)))
 ("UP:P16401"
  (("H1.5" 250) ("histone H1.5" 18) ("HIST1H1B" 3) ("Histone H1.5" 2)))
 ("UP:P16402" (("HIST1H1D" 8) ("H1.3" 7) ("histone H1.3" 3) ("H1d" 2)))
 ("UP:P16403"
  (("H1.2" 321) ("histone H1.2" 13) ("H1c" 9) ("H1.2 protein" 2)
   ("Histone H1.2" 2) ("nonphosphorylatable H1.2" 1)))
 ("UP:P16410"
  (("cytotoxic" 3250) ("CTLA-4" 692) ("CTLA4" 174) ("Cytotoxic" 86)
   ("CD152" 39) ("more cytotoxic" 17) ("less cytotoxic" 10)
   ("cytotoxic protein" 5) ("the most cytotoxic" 4)
   ("significantly less cytotoxic" 4) ("More Cytotoxic" 4) ("Ctla4" 3)
   ("CD152-" 2) ("soluble CTLA-4" 2) ("The differential cytotoxic" 2)
   ("maximal cytotoxic" 2) ("or less cytotoxic" 2)
   ("a potentially cytotoxic protein" 2) ("synergistic cytotoxic" 2)
   ("overexpressed CTLA-4" 2) ("surface-bound CTLA-4" 2)
   ("any artificial cytotoxic" 1) ("concentrations showed no cytotoxic" 1)
   ("a protective cytotoxic" 1) ("Ctla-4" 1) ("the more dramatic cytotoxic" 1)
   ("-CD152" 1) ("Only full-length CTLA-4" 1) ("Synergistic cytotoxic" 1)
   ("their intrinsic cytotoxic" 1) ("than cytotoxic" 1)
   ("exerted substantial cytotoxic" 1) ("potent synergistic cytotoxic" 1)
   ("CYTOTOXIC" 1) ("prominent cytotoxic" 1) ("efficient cytotoxic" 1)
   ("TBII became cytotoxic" 1) ("viral injection showed no clear cytotoxic" 1)
   ("indirect cytotoxic" 1) ("even more cytotoxic" 1)
   ("no obvious cytotoxic" 1) ("potential cytotoxic" 1)
   ("its potential cytotoxic" 1) ("Possible cytotoxic" 1)
   ("two broad cytotoxic" 1) ("the increased surface-bound CTLA-4" 1)
   ("the negative co-stimulatory molecule CTLA-4" 1)
   ("produced significant differential cytotoxic" 1)
   ("yielded synergistic cytotoxic" 1) ("significantly more cytotoxic" 1)))
 ("UP:P16415" (("Zfp36" 14)))
 ("UP:P16422"
  (("EpCAM" 798) ("Ep-CAM" 83) ("CD326" 63) ("EPCAM" 36) ("EGP" 35)
   ("epithelial cell adhesion molecule" 31) ("TACSTD1" 21) ("EpCam" 8)
   ("pEGP" 7) ("Epithelial cell adhesion molecule" 7)
   ("soluble urinary EpCAM" 4) ("Trop-1" 4) ("CD326 (ESA)" 3)
   ("recombinant soluble extracellular EpCAM" 3)
   ("the intestinal epithelium marker EpCAM" 2) ("than EpCAM" 2) ("KSA" 2)
   ("urinary EpCAM" 2) ("EGP40" 2)
   ("Recombinant soluble extracellular EpCAM" 2) ("EpCaM" 2)
   ("a distinct EpCAM" 1) ("EpCAM-" 1) ("Epcam" 1)
   ("recombinant soluble EpCAM" 1) ("the residual CD326" 1) ("GA733-2" 1)))
 ("UP:P16435" (("POR" 20) ("por" 11) ("Por" 6) ("p450R" 1)))
 ("UP:P16442" (("ABO" 80) ("a transferase" 5)))
 ("UP:P16444" (("MDP" 115) ("MDP-" 5)))
 ("UP:P16450" (("GERD" 133) ("no associated GERD" 1)))
 ("UP:P16452" (("Epb42" 2))) ("UP:P16454" (("ail" 1) ("AIL" 1)))
 ("UP:P16455"
  (("MGMT" 5399) ("MGMT protein" 87) ("Mgmt" 40) ("-MGMT" 23)
   ("-methylguanine DNA methyltransferase (MGMT)" 15)
   ("O-6-methylguanine-DNA methyltransferase" 11)
   ("-methylguanine DNA methyltransferase" 11)
   ("-methylguanine DNA methyltransferase ( MGMT )" 10)
   ("methylguanine DNA methyltransferase" 10) ("mgmt" 10) ("MGMT-" 4)
   ("than WT MGMT" 4) ("a methylated promoter showed high-level MGMT" 3)
   ("MGMT molecule" 3) ("overexpressed MGMT" 3)
   ("miR-221/222 directly target MGMT" 2)
   ("resected BM retained concordant MGMT" 2) ("absent MGMT" 2)
   ("a homogeneous MGMT" 2) ("than MGMT" 2)
   ("O-6-methylguanine-DNA methyltransferase (MGMT)" 2) ("MGMT ”" 1) ("”" 1)
   ("O-6-methylguanine-DNA methyltransferase ( MGMT )" 1)
   ("concordant low MGMT" 1) ("than a siRNA targeting Mgmt (Figure xref )" 1)
   ("the potential role MGMT" 1) ("defective MGMT" 1)
   ("The multivariate Cox proportional hazard model showed MGMT" 1)
   ("the 3 parental MGMT" 1)
   ("CD133-positive glioma cultures highly expressed MGMT" 1)))
 ("UP:P16462" (("LKT" 38) ("Lkt" 1)))
 ("UP:P16471"
  (("prolactin receptor" 51) ("PrlR" 38) ("Prolactin receptor" 5) ("PrlRs" 4)
   ("pPrlR" 4) ("PRLr" 3) ("prolactin receptor (PRLR)" 2) ("PRLRs" 2)))
 ("UP:P16473"
  (("Tshr" 36) ("thyrotropin" 11) ("TSH-R" 10)
   ("thyroid-stimulating hormone receptor" 5) ("TSHR" 5)
   ("thyrotropin receptor" 2) ("AICAR-treated Tshr  -/-" 2)
   ("thyroid stimulating hormone receptor (TSHR)" 2)
   ("thyroid stimulating hormone receptor" 2)))
 ("UP:P16499" (("cGMP-specific" 2) ("PDE6A" 1)))
 ("UP:P16501" (("somatomedin" 3))) ("UP:P16519" (("PCSK2" 11)))
 ("UP:P16520" (("GNB3" 16))) ("UP:P16525" (("Tus" 1)))
 ("UP:P16551" (("Raf-A" 1))) ("UP:P16552" (("Raf-B" 3)))
 ("UP:P16581"
  (("E-selectin" 146) ("E-Selectin" 101) ("SELE" 29) ("ELAM-1" 11)
   ("E-selectin (SELE)" 3) ("soluble E-selectin" 2) ("E-Selectin protein" 1)
   ("selectin E" 1) ("CD62E" 1) ("e-selectin" 1) ("Sele" 1)
   ("Soluble E-selectin" 1)))
 ("UP:P16591" (("tyrosine kinase-3" 52) ("FER" 4) ("FER-" 1)))
 ("UP:P16599" (("rTNF" 1))) ("UP:P16603" (("NCP1" 1)))
 ("UP:P16615"
  (("SERCA2" 36) ("ATP2A2" 18) ("Serca2" 7)
   ("sarcoplasmic/endoplasmic reticulum calcium ATPase 2" 2)
   ("Serca2 protein" 1)))
 ("UP:P16655" (("DDs" 22)))
 ("UP:P16662"
  (("2B7" 171) ("UGT2B7" 22) ("far less 2B7 protein" 2) ("than 2B7" 2)
   ("mammary gland-distributed 2B7" 1) ("than 2B7 expressed in COS-1 cells" 1)
   ("2B7 protein" 1) ("lanes 3 and 2 contained equal microsomal 2B7" 1)
   ("non-Src-phosphorylated 2B7" 1)))
 ("UP:P16671"
  (("thrombospondin receptor" 9) ("GP4" 5) ("CD36 molecule" 5)
   ("platelet collagen receptor" 3) ("fatty acid translocase" 2)
   ("a major platelet collagen receptor" 1) ("Platelet collagen receptor" 1)
   ("GPIV" 1)))
 ("UP:P16755" (("UL13" 15))) ("UP:P16767" (("UL36" 12)))
 ("UP:P16769"
  (("UDG" 174) ("UDGs" 31) ("Uracil-DNA glycosylase" 4)
   ("Uracil–DNA glycosylase" 3) ("Uracil-DNA glycosylase (UDG)" 1)
   ("UDG (NEB)" 1) ("at least four UDGs" 1)))
 ("UP:P16776" (("UL5" 16)))
 ("UP:P16788"
  (("UL97" 24) ("pUL97" 8) ("UL97 protein" 3) ("the viral kinase pUL97" 2)
   ("viral kinase pUL97" 1)))
 ("UP:P16860" (("BNP" 52) ("proBNP" 36) ("NPPB" 12) ("Nppb" 8)))
 ("UP:P16870"
  (("CPE" 140) ("carboxypeptidase E" 3) ("HSV-2-induced CPE" 3)
   ("Carboxypeptidase E" 2) ("extensive CPE" 2) ("showed complete CPE" 2)
   ("HSV-1-associated CPE" 2) ("complete CPE" 1)
   ("IFN-α showed extensive CPE" 1) ("functional CPE" 1) ("‘CPE’" 1)
   ("a single-round replication-defective HIV-1-induced CPE" 1)
   ("carboxypeptidase E (CPE)" 1)))
 ("UP:P16871"
  (("CD127" 201) ("IL-7R" 121) ("IL7R" 41) ("IL-7r" 14) ("Il7r" 8)
   ("interleukin-7 receptor" 8) ("Interleukin-7 receptor" 3)
   ("IL-7-receptor" 2) ("IL7 receptor" 2) ("Cd127" 1)
   ("Approximately 70% sorted IL-7R" 1) ("IL-7R-" 1) ("-IL-7R" 1)))
 ("UP:P16885"
  (("PLCγ2" 364) ("PLC-γ2" 270) ("PLCg2" 97) ("PLCG2" 18) ("p-PLCγ2" 12)
   ("phospholipase C-γ2" 5) ("phospholipase Cγ2" 5) ("PLCγ2-" 2)
   ("phospholipase Cgamma" 2) ("PLCg2 molecule" 2) ("P16885" 1)
   ("phospholipase Cγ2" 1) ("total and phosphorylated PLCγ2" 1)
   ("than PLCγ2" 1)))
 ("UP:P16892" (("Fus3" 5))) ("UP:P16905" (("pKAR1" 4)))
 ("UP:P16914" (("ELAV" 20) ("elav" 11) ("Elav" 4) ("Elav-" 1)))
 ("UP:P16922" (("REDD" 2)))
 ("UP:P16930" (("Fah" 15) ("fumarylacetoacetate hydrolase" 3) ("FAAs" 1)))
 ("UP:P16949"
  (("oncoprotein" 2205) ("stathmin" 1073) ("STMN1" 678) ("Stathmin" 272)
   ("stathmin1" 184) ("Stathmin 1" 122) ("Stmn1" 110) ("STATHMIN" 90)
   ("Stathmin1" 44) ("Op18" 32) ("oncoprotein 18" 30) ("stathmin protein" 28)
   ("stathmin 1" 14) ("OP18" 14) ("STMN-1" 13) ("Oncoprotein" 10)
   ("the viral oncoprotein" 9) ("PR22" 8) ("Oncoprotein 18" 7)
   ("metablastin" 7) ("a multifunctional oncoprotein" 6) ("stathmin-" 6)
   ("a viral oncoprotein" 5) ("targeted oncoprotein" 4) ("STMN1 protein" 4)
   ("viral oncoprotein" 3) ("op18" 3) ("this viral oncoprotein" 3)
   ("a bona fide oncoprotein" 3) ("a potential oncoprotein" 3)
   ("the major oncoprotein" 3) ("the principal oncoprotein" 3)
   ("a Golgi apparatus-associated oncoprotein" 3) ("stmn1" 3)
   ("stathmin (KIS)" 3) ("One particular oncoprotein" 2)
   ("overexpressed Stathmin" 2) ("Stathmin protein" 2)
   ("a bacterial oncoprotein" 2) ("the viral Src oncoprotein" 2)
   ("Strong STATHMIN" 2) ("the efficient Stathmin 1" 2) ("LAP18" 2)
   ("Leukemia-associated phosphoprotein p18" 2)
   ("another cellular oncoprotein" 2) ("a given oncoprotein" 2)
   ("a chimeric oncoprotein" 2)
   ("a transcriptional co-activator oncoprotein" 2) ("prosolin" 2)
   ("the v-Jun viral oncoprotein" 2) ("a well-characterized oncoprotein" 2)
   ("19 showed weak (1+) STMN1" 2) ("STMN1 molecule" 2)
   ("a leukemogenic fusion oncoprotein" 2) ("stathmin1 in MKN-45 cell’s" 1)
   ("stathmin1 protein" 1) ("than endogenous stathmin" 1)
   ("The principal Epstein–Barr virus (EBV) oncoprotein" 1)
   ("the relevant oncoprotein" 1) ("an alternate oncoprotein" 1)
   ("the particular oncoprotein" 1) ("This major oncoprotein" 1) ("pP19" 1)
   ("the ‘immortalizing’ adenoviral oncoprotein" 1)
   ("the main viral oncoprotein" 1) ("the principal EBV oncoprotein" 1)
   ("p-OP18" 1) ("the Tax viral oncoprotein" 1) ("The viral Tax oncoprotein" 1)
   ("the well-known metastasis-promoting oncoprotein" 1)
   ("the relevant Ras oncoprotein" 1) ("a weak oncoprotein" 1)
   ("a powerful oncoprotein" 1) ("oncoprotein-" 1) ("exogenous stathmin" 1)
   ("an important cellular oncoprotein" 1)
   ("The mucin 1 (MUC1) transmembrane oncoprotein" 1) ("this oncoprotein’s" 1)
   ("the viral E6 oncoprotein" 1) ("viral E6 oncoprotein" 1)
   ("the viral oncoprotein E1A" 1) ("un-phosphorylated STMN-1" 1)
   ("given stathmin's" 1) ("given stathmin" 1)))
 ("UP:P16989" (("ZONAB" 16) ("CSDA" 11)))
 ("UP:P17010" (("ZFX" 203) ("Zfx" 7) ("ZFX protein" 3)))
 ("UP:P17023" (("ZNF19" 1))) ("UP:P17026" (("ZNF22" 1)))
 ("UP:P17027" (("ZNF23" 2) ("ZNF23 protein" 1))) ("UP:P17029" (("ZKSCAN1" 13)))
 ("UP:P17050" (("NAGA" 3)))
 ("UP:P17066" (("HSPA6" 15) ("Hsp70B'" 8) ("Hsp70B’" 2) ("HSPA6 protein" 2)))
 ("UP:P17081"
  (("TC10" 155) ("RAS-like" 7) ("RhoQ" 5) ("188 amino acids of TC10" 1)
   ("TC10 (KKH)" 1) ("RHOQ" 1)))
 ("UP:P17096"
  (("HMGA1" 248) ("Hmga1" 9) ("HMG-I(Y)" 5) ("HMGA1b" 4) ("HMGA1a" 4)
   ("-HMGA1" 2) ("HMGIY" 1) ("high mobility group AT-hook 1" 1) ("HMGA1c" 1)))
 ("UP:P17097" (("ZnF7" 32))) ("UP:P17152" (("PM1" 13) ("pM1" 2)))
 ("UP:P17174" (("GOT1" 54) (NIL 31) ("cCAT" 20) ("CCAT" 17)))
 ("UP:P17181"
  (("IFNAR1" 186) ("IFNAR" 84) ("IFNAR1 peptide" 22) ("interferon receptor" 18)
   ("IFNAR1-" 4) ("ifnar1" 2) ("Ifnar1" 2) ("IFNAR1 protein" 1) ("IFNαR1" 1)))
 ("UP:P17210" (("KHC" 11))) ("UP:P17213" (("BPI" 72)))
 ("UP:P17237" (("chemotactic peptide" 9)))
 ("UP:P17252"
  (("PKCα" 3542) ("PKC-α" 258) ("PRKCA" 80) ("PKAca" 54) ("-PKCα" 28)
   ("PKC-alpha" 22) ("PKCα protein" 22) ("dominant-negative PKCα" 15)
   ("PKCalpha" 10) ("PKCa" 9) ("PRKACA" 8) ("PKCα peptide" 7)
   ("myocardial PKCα" 7) ("a dominant-negative PKCα" 6) ("PKCα-" 5)
   ("exogenous PKCα" 3) ("PKCα molecule" 3) ("overexpressed PKCα" 3)
   ("PKCα
molecule"
    2)
   ("than full-length PKCα" 2) ("than PKCα" 2) ("Lentiviral PKCα" 2)
   ("endometrial adenocarcinoma exhibited aberrant PKCα" 2) ("stromal PKCα" 2)
   ("the ERK1/2/MAPK-related protein PRKACA" 2)
   ("e.g. cAMP-activatable PKCα" 2) ("Prkca" 2) ("PKCA" 1)
   ("total and phosphorylated PKCα" 1) ("miR-203-resistant PKCα" 1)
   ("functional PKCα" 1) ("than PKCα in vitro" 1)
   ("the classical isozyme PKC-α" 1) ("Dominant-negative PKCα" 1)
   ("classical PKCα" 1) ("PKCα protein (FFTRGQPVLTPPDQLVIA)" 1)
   ("parental myocardial PKCα" 1) ("intact PKCα" 1)
   ("activity-constrained intact PKCα" 1) ("RACK1-associated PKCα" 1)
   ("perinuclear Golgi PKCα" 1) ("membrane-associated PKCα" 1)))
 ("UP:P17255" (("TFP1" 2)))
 ("UP:P17275"
  (("JunB" 739) ("JUNB" 216) ("Jun-B" 14) ("junB" 12) ("JUN-B" 7) ("p-JunB" 4)
   ("stably overexpressed JUNB" 2) ("overexpressed JUNB" 2) ("pJunB" 2)
   ("regions around JUNB" 2) ("than JunB ( xref ; xref )" 1)))
 ("UP:P17281" (("glycoprotein 120" 26)))
 ("UP:P17282" (("p6 Gag" 19) ("p6 Gag protein" 4)))
 ("UP:P17286"
  (("viral protein U" 8) ("Viral protein U" 3) ("Viral Protein U" 3)))
 ("UP:P17287"
  (("protein Vpr" 29) ("the viral protein Vpr" 3)
   ("its accessory protein Vpr" 2) ("the viral transcription protein Vpr" 2)
   ("the HIV-1 accessory protein Vpr" 2)
   ("Human immunodeficiency virus type 1 encoded viral protein Vpr" 1)
   ("the viral auxiliary protein Vpr" 1)
   ("The human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr" 1)
   ("HIV viral protein VPR" 1) ("protein VPR" 1)
   ("a HIV-1 viral protein Vpr" 1) ("the viral accessory protein Vpr" 1)
   ("HIV-1 accessory protein Vpr" 1)))
 ("UP:P17301"
  (("collagen receptor" 36) ("ITGA2" 35) ("CD49b" 34) ("-CD49b" 4)
   ("membranous proteins CD49b" 3) ("integrin alpha 2" 2) ("GpIa" 1)))
 ("UP:P17302"
  (("Cx43" 864) ("ODD" 59) ("GJA1" 45) ("cx43" 43) ("connexin 43" 36)
   ("gap junction protein" 27) ("CX43" 17) ("Cx43 peptide" 10)
   ("Cx43 protein" 9) ("connexin-43" 6) ("ODDD" 6) ("43kDa" 5)
   ("overexpressed Cx43" 5) ("Connexin 43" 4) ("pTyr of Cx43" 3)
   ("targeted wt Cx43" 3) ("43kDa protein" 3) ("coexpressed wt Cx43" 2)
   ("effectively repair ODD" 2)
   ("positively charged amino acids of Cx43 (for example, residues in the cytoplasmic loop)"
    1)
   ("than wt Cx43 (86 and 63%, respectively)" 1)
   ("the last 20 amino acids of Cx43" 1)
   ("the terminal 16 amino acids of Cx43" 1)
   ("the COOH-terminal 23 amino acids of Cx43 that is induced" 1)
   ("Immunoaffinity-purified Cx43" 1) ("immunoaffinity-purified Cx43" 1)
   ("only Cx43 protein" 1) ("Gja1" 1) ("CX-43" 1)))
 ("UP:P17309" (("RIII" 8)))
 ("UP:P17323" (("lipopeptide" 18) ("lipopeptides" 7)))
 ("UP:P17342" (("NPR3" 29) ("NPR-C" 2)))
 ("UP:P17405"
  (("ASM" 468) ("ASMase" 94) ("acid sphingomyelinase" 13) ("normal ASM" 3)
   ("Acid sphingomyelinase" 2) ("sphingomyelin phosphodiesterase" 1)
   ("acid sphingomyelinase (ASM)" 1)))
 ("UP:P17473"
  (("ie" 226) ("IE" 221) ("immediate early" 150) ("iE" 95) ("IE protein" 3)
   ("Ie" 1) ("immediate early (IE)" 1) ("Immediate early" 1) ("viral IE" 1)))
 ("UP:P17480"
  (("UBF" 245) ("upstream binding factor" 12) ("UBF1" 6) ("UBTF" 3)
   ("upstream binding factor (UBF)" 2) ("Upstream binding factor (UBF)" 2)
   ("UBF-1" 2) ("nucleolar marker proteins Upstream binding factor (UBF)" 1)
   ("Upstream binding factor" 1) ("cellular UBF" 1)
   ("upstream binding factor-1" 1) ("estrogen profoundly increases UBF" 1)
   ("upstream binding factor 1" 1)))
 ("UP:P17481" (("HOXB8" 9))) ("UP:P17482" (("HOXB9" 122) ("Homeobox B9" 3)))
 ("UP:P17483" (("HOXB4" 18) ("HoxB4" 2))) ("UP:P17489" (("YA" 36)))
 ("UP:P17499" (("VP39" 1)))
 ("UP:P17509" (("HOXB6" 22) ("HU2" 6) ("HOXB6 protein" 2) ("homeobox B6" 1)))
 ("UP:P17516" (("AKR1C4" 3)))
 ("UP:P17535"
  (("JunD" 882) ("JUND" 42) ("Jun D" 24) ("Jun-D" 11) ("p-JunD" 10) ("junD" 6)
   ("JunD protein" 3) ("-JunD" 2) ("further implicating JunD" 1) ("JUN D" 1)
   ("possible JunD" 1)))
 ("UP:P17538" (("CTRB1" 8))) ("UP:P17540" (("sMtCK" 2)))
 ("UP:P17542"
  (("TAL1" 664) ("TAL1 protein" 10) ("Tal1" 7) ("we first expressed TAL1" 3)
   ("The basic helix-loop-helix (bHLH) protein TAL1" 2) ("Tal-1" 1) ("TAL-1" 1)
   ("stem cell protein" 1) ("the representative TAL1" 1)
   ("virtually all TAL1" 1) ("previously characterized TAL1" 1)))
 ("UP:P17544" (("ATF7" 7) ("ATFa" 1)))
 ("UP:P17549"
  (("BPH" 584) ("symptomatic BPH" 6) ("symptomatic progressive BPH" 2)
   ("virtually all BPH" 1) ("incident BPH" 1) ("727 incident BPH" 1)
   ("Incident BPH" 1)))
 ("UP:P17555" (("Srv2" 7) ("SRV2" 1)))
 ("UP:P17568"
  (("B18" 5) ("NDUFB7" 5) ("-B18" 5) ("18kDa" 2) ("b18" 1) ("B18)" 1)))
 ("UP:P17586"
  (("pUL38" 88) ("UL38" 23) ("UL38 protein" 4)
   ("the HCMV viral protein UL38" 1)))
 ("UP:P17600"
  (("synapsin I" 13) ("SYN1" 3) ("the presynaptic protein synapsin I" 2)
   ("the pre-synaptic marker synapsin I" 1)
   ("The
presynaptic marker synapsin I"
    1)
   ("the synaptic vesicle phosphoprotein synapsin I" 1)))
 ("UP:P17608" (("Ryh1" 10) ("ryh1" 3))) ("UP:P17609" (("ypT2" 2)))
 ("UP:P17612" (("PKAca" 51) ("PKA-Cα" 6) ("PKAca protein" 3)))
 ("UP:P17643"
  (("Tyrp1" 55) ("TRP" 47) ("TYRP1" 22) ("tyrosinase-related protein 1" 11)
   ("gp75" 2) ("several nonselective TRP" 1)
   ("the melanosomal cargo protein Tyrp1" 1) ("Tyrosinase-related protein 1" 1)
   ("TYRP-1" 1)))
 ("UP:P17651" (("COR" 531) ("Cor" 10) ("cor" 8) ("“COR”" 1)))
 ("UP:P17655"
  (("m-calpain" 110) ("calpain 2" 6) ("Calpain 2" 2) ("m-calpain protein" 1)
   ("CAPN2" 1)))
 ("UP:P17661"
  (("desmin" 101) ("DES" 87) ("Des" 78) ("des" 73) ("Desmin" 11) ("DESMIN" 2)
   ("des(biotin,TAMRA)-peptide" 1)))
 ("UP:P17664"
  (("nef" 637) ("protein Nef" 55) ("NEF" 39) ("negative factor" 33) ("nef-" 5)
   ("The accessory protein Nef" 3) ("The HIV-1 accessory protein Nef" 3)
   ("NEF PROTEIN" 3) ("a totally inactivated nef" 2)
   ("the HIV-1 accessory protein Nef" 2) ("nef peptide" 2)
   ("the accessory protein Nef" 2)
   ("control cells showed minimal (< 2%) NEF" 2) ("defective nef" 2)
   ("The viral accessory protein Nef" 1) ("the viral accessory protein Nef" 1)
   ("particularly HIV-1 nef" 1)
   ("The human immunodeficiency virus type 1 (HIV-1) accessory protein Nef" 1)
   ("NeF" 1) ("a functional nef" 1) ("the original defective nef" 1)
   ("a defective nef" 1) ("The accessory viral protein Nef" 1)
   ("The HIV viral protein Nef" 1) ("Negative factor" 1)
   ("the pathogenetic protein Nef" 1) ("a dominant negative factor" 1)
   ("a transcriptional dominant negative factor" 1)
   ("HIV-1 accessory protein Nef" 1) ("The lentiviral accessory protein Nef" 1)
   ("viral protein Nef" 1) ("than HIV-1Δ nef" 1) ("biological effects nef" 1)
   ("Given nef ‘s" 1) ("Given nef" 1) ("an inherent negative factor" 1)
   ("intact nef" 1) ("replication competent nef" 1)
   ("The HIV accessory protein Nef" 1) ("The viral protein Nef" 1)
   ("the viral protein Nef" 1)))
 ("UP:P17676"
  (("C/EBPβ" 1190) ("lip" 386) ("enhancer binding protein" 28) ("CEBPB" 24)
   ("NF-IL6" 21) ("C/EBPβ protein" 14) ("C/EBPb" 8) ("NF-IL-6" 8)
   ("CCAAT/enhancer binding protein beta" 7) ("Lip" 6) ("lower lip" 6)
   ("overexpressed C/EBPβ 3" 6) ("Enhancer Binding Protein" 5)
   ("exogenous C/EBPβ 3" 5) ("-C/EBPβ" 5)
   ("liver-enriched inhibitory protein" 4) ("LiP" 4)
   ("CCAAT/enhancer-binding protein beta" 3) ("nonsyndromic cleft lip" 3)
   ("C/EBPb protein" 3) ("Nonsyndromic or isolated cleft lip" 3)
   ("liver-enriched inhibitory protein (LIP)" 3)
   ("the embryonic mouse upper lip" 2) ("the upper lip" 2)
   ("transcription factor 5" 2) ("pC/EBPβ" 2) ("the normal lip" 2)
   ("the upper rhombic lip" 2) ("Nonsyndromic cleft lip" 2) ("normal lip" 2)
   ("C/EBPβ-" 2) ("C/EBPβ (LAP)" 2) ("C/Ebpb" 1) ("mainly cleft lip" 1)
   ("transiently decrease C/EBPβ" 1) ("Enhancer binding protein" 1)
   ("the embryonic lip" 1) ("human breast carcinogenesis made C/EBPβ" 1)
   ("NFIL-6" 1) ("short upper lip" 1) ("very negligible C/EBPβ" 1)
   ("enhancer-binding protein-beta" 1) ("bilateral cleft lip" 1)
   ("more C/EBPβ 3" 1) ("no exogenous C/EBPβ 3" 1) ("the exogenous C/EBPβ 3" 1)
   ("directly study C/EBPβ" 1) ("C/EBP-beta" 1)
   ("dental agenesis, or cleft lip" 1) ("EBP-β" 1) ("lip (CL)" 1)
   ("the rhombic lip" 1) ("C/EBPbeta" 1) ("Enhancer Binding Protein-" 1)))
 ("UP:P17677"
  (("GAP43" 14) ("GAP-43" 10) ("growth-associated protein" 6)
   ("growth associated protein 43" 4) ("pp46" 1) ("at least GAP43" 1)
   ("N-terminal 20 amino acids (MLCCMRRTKQVEKNDEDQKI) of growth associated protein 43 (Gap43)"
    1)
   ("Gap43" 1)))
 ("UP:P17684" (("cont" 93) ("Cont" 33) ("CONT" 5)))
 ("UP:P17693" (("HLA-G" 112) ("soluble HLA-G" 1)))
 ("UP:P17706"
  (("PTPN2" 161) ("TC-PTP" 85) ("TC45" 49) ("TCPTP" 12) ("Ptpn2" 2)
   ("PTPN2-" 1)))
 ("UP:P17707"
  (("AMD" 288) ("aMD" 18) ("Amd1" 8) ("efficient AMD" 2) ("than AMD" 1)
   ("macular edema-associated AMD" 1)))
 ("UP:P17717" (("Ugt2b5" 4))) ("UP:P17722" (("defensin 1" 2)))
 ("UP:P17735"
  (("Tat" 8844) ("TAT" 1043) ("Tat protein" 543) ("tat" 199) ("pTat" 39)
   ("Tat-" 33) ("TAT protein" 27) ("pTAT" 25) ("TAT peptide" 17)
   ("Tat peptide" 15) ("-TAT" 12) ("the viral Tat protein" 10) ("tat-" 10)
   ("exogenous Tat" 10) ("soluble Tat" 7) ("TAT-Y211F peptide" 6)
   ("the viral transactivator Tat" 5) ("HIV-Tat protein" 5) ("Exogenous Tat" 4)
   ("TAT protein (RRRQRRKKRG)" 4) ("The viral protein Tat" 3) ("tat protein" 3)
   ("the viral transactivating protein Tat" 3) ("exogenous expressed Tat" 3)
   ("the exogenous Tat" 3) ("soluble TAT" 3) ("HIV-1-TAT protein" 3)
   ("extra-cellular Tat" 3) ("The first 48 amino acids of Tat" 2)
   ("diverse Tat" 2) ("more Tat protein" 2) ("Tat (1–72) peptide" 2)
   ("Tat (a key HIV t rans a ctivator of t ranscription) protein" 2)
   ("exogenous HIV-1 Tat protein" 2)
   ("a highly pure toxin-free recombinant Tat" 2) ("Tat (14–16-kDa) protein" 2)
   ("a soluble Tat" 2) ("the viral proteins Tat" 2) ("the soluble TAT" 2)
   ("viral Tat protein" 2) ("than wild-type Tat" 2)
   ("The viral transactivator Tat" 2) ("the multipotent HIV-1 protein Tat" 2)
   ("HIV-1 neurotoxic protein Tat" 2)
   ("the viral transactivating Tat protein" 2) ("newly-synthesized Tat" 2)
   ("TAG TGC GCC AGA TCT CTA TA C TC A CGC GCA ACC TAT" 2)
   ("coexpressed Tat" 2) ("recombinant viral Tat protein" 2)
   ("the viral transcription factor Tat" 2)
   ("vesicular stomatitis virus (VSV)-pseudotyped lentiviral Tat" 2)
   ("HIV-1 viral protein Tat" 2) ("exogenous HIV-1 Tat" 1)
   ("viral protein Tat" 1) ("the amino-terminal 13 amino acids of Tat" 1)
   ("Finally HIV-1 Tat" 1) ("The soluble Tat protein" 1)
   ("its neurotoxic Tat protein" 1) ("than subtype B Tat [ xref ]" 1)
   ("Interestingly subtype C Tat protein" 1) ("salivary tat" 1) ("HIV-1 Tat" 1)
   ("the viral HIV TAT" 1) ("highly pure toxin-free Tat" 1) ("-Tat" 1)
   ("The viral protein HIV-1 Tat" 1) ("than clade C Tat" 1)
   ("most cases Tat" 1)
   ("isoform selective antagonistic RACK peptide (δV1-1)TAT" 1)
   ("a polyvalent protein adaptor and positioned Tat" 1)
   ("cyclin T1 around Tat" 1)
   ("than Tat truncated at the second exon (Tat72)" 1) ("than Tat" 1)
   ("functional Tat" 1) ("exogeneous HIV-1 Tat" 1)
   ("The viral regulatory protein Tat" 1)
   ("HIV viral regulatory protein Tat" 1) ("exogenous recombinant Tat" 1)
   ("than Tat released from Tat-expressing astrocytic cells ( xref )" 1)
   ("that Tat’s" 1) ("tyrosine aminotransferase" 1) ("exactly Tat" 1)
   ("Recently TAT peptide" 1) ("viral transactivator protein Tat" 1)
   ("a functional Tat" 1) ("the viral protein Tat" 1) ("new Tat" 1)
   ("the residual Tat" 1) ("residual Tat" 1) ("than wild-type Tat (lane 5)" 1)
   ("81–86 amino acids of Tat protein" 1)
   ("the viral trans-activator protein Tat" 1)
   ("the N-terminal 35 amino acids of Tat" 1) ("Non-mutated Tat (WT)" 1)
   ("than the WT Tat" 1)
   ("than untagged Tat (Fig. xref , compare lanes 3 and 4)" 1) ("that Tat's" 1)
   ("Tat (KKCCFHCQVCFITK)" 1) ("HIV viral protein Tat" 1)
   ("around HIV-1 Tat" 1) ("effectively impaired Tat’s" 1)))
 ("UP:P17752" (("tryptophan 5-monooxygenase" 9) ("TPH1" 1)))
 ("UP:P17813"
  (("CD105" 95) ("endoglin" 39) ("Eng" 18) ("ENG" 10) ("Endoglin" 4)
   ("-CD105" 2) ("CD105-" 1)))
 ("UP:P17844"
  (("Ddx5" 177) ("DDX5" 53) ("RNA helicase p68" 18) ("68kD)" 2)
   ("cellular Ddx5" 1) ("most Ddx5" 1)))
 ("UP:P17858" (("Pfkl" 1)))
 ("UP:P17861"
  (("XBP1" 402) ("XBP1s" 199) ("XBP-1" 94) ("X-box-binding protein 1" 15)
   ("X-box binding protein 1" 14) ("XBP1s protein" 14) ("Xbp1" 12) ("Xbp-1" 4)
   ("XBP1s Protein" 4) ("XBP1 protein" 3) ("x-box binding protein 1" 3)
   ("more XBP1s" 2) ("-XBP1" 2) ("X-box binding protein-1" 2)
   ("total, spliced, and unspliced XBP-1" 2)
   ("a specific ER stress-induced protein X-box-binding protein 1" 2)
   ("overexpressed XBP1s" 2) ("X-box-binding protein-1" 2)
   ("the previously described XBP1" 1) ("total and spliced XBP1" 1)
   ("SIRT1 increased XBP1s" 1) ("exogenous XBP1s" 1)))
 ("UP:P17885" (("BimA" 1))) ("UP:P17923" (("NFI-A" 28) ("NFI-A-" 2)))
 ("UP:P17927"
  (("CR1" 225) ("CD35" 7) ("notably CXCR4, CCR5, CCR6, and CX 3 CR1" 2)
   ("cr1" 1) ("un-mutated CR1" 1)))
 ("UP:P17928" (("CAL1" 1)))
 ("UP:P17931"
  (("galectin-3" 388) ("Gal-3" 325) ("Galectin-3" 170) ("gal-3" 86)
   ("LGALS3" 28) ("Mac2" 17) ("galactoside-binding protein" 7) ("GAL3" 6)
   ("Gal-3 protein" 5) ("gal3" 5) ("Galectin3" 4) ("targeting Gal-3" 4)
   ("-galactoside-binding protein" 4) ("Gal3" 4) ("Lgals3" 3) ("galectin 3" 2)
   ("laminin binding protein" 2) ("MAC2" 2)
   ("over-expressing three Gal-3 fragments Gal-3" 2) ("intact Gal-3" 2)
   ("L-31" 1) ("galectin-3-" 1) ("galectin3" 1)
   ("originally display no expression galectin-3" 1)))
 ("UP:P17936"
  (("IGFBP3" 355) ("insulin-like growth factor binding protein 3" 23)
   ("IGF-BP3" 14) ("Igfbp3" 10)
   ("insulin-like growth factor binding protein-3" 8)
   ("IGF binding protein 3" 5)
   ("Insulin like growth factor binding protein 3" 3)
   ("IGF-binding protein 3" 2)
   ("Insulin-like growth factor binding protein-3" 2)
   ("generated less IGFBP3" 1) ("TS cells produced more IGFBP3" 1)
   ("binding protein 53" 1) ("IGF BP3" 1)))
 ("UP:P17947"
  (("SPI1" 68) ("transcription factor PU.1" 24) ("spi-1" 14) ("Spi-1" 13)
   ("SPI-1" 10) ("spi1" 3) ("spi 1" 1) ("SPi-1" 1) ("SPI 1" 1)))
 ("UP:P17948"
  (("FRT" 226) ("VEGFR1" 219) ("Flt-1" 214) ("Flt1" 172) ("FLT1" 62)
   ("VEGFR-1" 54) ("FLT" 39) ("FLT-1" 27)
   ("vascular endothelial growth factor receptor 1" 10) ("pFRT" 10)
   ("VEGF-R1" 7) ("Flt" 4) ("pFLT" 4) ("flt-1" 4) ("vegfr1" 2)
   ("soluble VEGFR1" 2) ("alternately transcribed soluble Flt1" 2) ("Vegfr1" 2)
   ("VEGFR1 protein" 2) ("Frt" 2) ("overexpressing Flt-1" 1)
   ("a functional Flt-1" 1) ("Flt-1 protein" 1) ("than Flt1" 1) ("Flt 1" 1)
   ("the abovementioned soluble Flt-1" 1) ("soluble Flt-1" 1) ("-VEGFR1" 1)
   ("flt1" 1)))
 ("UP:P17967" (("TRG1" 21)))
 ("UP:P17974" (("EGL" 51) ("Egl" 1) ("the cerebellar EGL" 1)))
 ("UP:P17978" (("VGH" 12)))
 ("UP:P17980"
  (("TBP-1" 163) ("TBP1" 6) ("PSMC3" 6) ("TBP-1 protein" 5) ("-TBP-1" 5)
   ("Tat-binding protein 1" 4) ("tbp-1" 3) ("Psmc3" 2)
   ("Tat-Binding Protein 1" 2) ("PSMc3" 1) ("exogenous TBP-1" 1)
   ("than TBP-1" 1)))
 ("UP:P17987"
  (("TCP1" 7) ("TCP-1" 7) ("CCT1" 6) ("T-complex protein 1" 3)
   ("t-complex 1" 2) ("CCTA" 2) ("T-complex 1" 2) ("Cct1" 1)
   ("TCP-1 (CCT)" 1)))
 ("UP:P18010" (("IpaA" 3) ("ipaA" 1)))
 ("UP:P18031"
  (("PTP1B" 876) ("PTP-1B" 231) ("PTPN1" 23) ("PTP1B protein" 8)
   ("overexpressed PTP1B" 4) ("Ptp1b" 3) ("Protein-tyrosine phosphatase-1B" 2)
   ("protein-tyrosine phosphatase-1B" 2) ("protein-tyrosine phosphatase 1B" 2)
   ("copious previous data using overexpressed PTP1B" 2)
   ("protein tyrosine phosphatase, non-receptor type 1" 2)
   ("the catalytic cysteine of PTP1B ( xref )" 1) ("-PTP1B" 1)
   ("the catalytic cysteine of PTP1B" 1) ("than PTP1B" 1) ("PTP1b" 1)))
 ("UP:P18047" (("SPIKE" 1)))
 ("UP:P18054" (("ALOX12" 17) ("platelet 12-LOX" 4) ("AlOX12" 1)))
 ("UP:P18056" (("HOC" 25) ("hoc" 15) ("Hoc" 2) ("mitotic HOC-7" 1)))
 ("UP:P18065"
  (("IGFBP2" 1270) ("IGFBP-2" 1093) ("exogenous IGFBP-2" 26) ("BP2" 23)
   ("IGFBP-2s" 16) ("Igfbp2" 14)
   ("insulin-like growth factor binding protein 2" 11)
   ("IGF binding protein 2" 10) ("IGFBP2 protein" 7) ("igfbp-2" 7)
   ("IGFBP2-" 6) ("Exogenous IGFBP-2" 5) ("IGFBP-2 protein" 3)
   ("Insulin like growth factor binding protein 2" 2) ("whose blood IGFBP2" 2)
   ("the exogenous recombinant IGFBP2" 2) ("intrinsic IGFBP2" 2)
   ("the extrinsic IGFBP2" 2)
   ("insulin-like growth factor-binding protein 2" 2)
   ("preoperative plasma IGFBP-2" 2)
   ("insulin-like growth factor binding protein-2" 2)
   ("overexpressed IGFBP2" 2) ("IGFBP2 molecule" 2)
   ("insulin like growth factor binding protein 2" 2)
   ("overexpressed IGFBP-2" 2) ("predominantly either IGFBP2" 1)
   ("serial dynamic plasma IGFBP-2" 1) ("enough exogenous IGFBP-2" 1)
   ("overweight or obese serum IGFBP-2" 1) ("than human IGFBP-2 ( xref )" 1)
   ("monomeric human IGFBP-2" 1) ("less IGFBP2" 1) ("–BP2" 1)
   ("membrane-associated IGFBP-2" 1)))
 ("UP:P18074"
  (("XPD" 777) ("ERCC2" 306) ("EM9" 98) ("XPD-" 40)
   ("xeroderma pigmentosum group D" 12)
   ("excision repair cross-complementing rodent repair deficiency" 10)
   ("ercc2" 10) ("XPD protein" 8) ("Ercc2" 4) ("ERCC2-" 3) ("ERCC2 (XPD)" 3)
   ("xeroderma pigmentosum complementary group D" 3) ("”" 3)
   ("complementation group 2" 3) ("Xeroderma Pigmentosum group D ( XPD )" 2)
   ("“ERCC2”" 2) ("Xeroderma pigmentosum group D" 2)
   ("xeroderma pigmentosum complementary group D (XPD)" 2) ("apo-XPD" 2)
   ("TFIIH p80" 1) ("Xeroderma Pigmentosum group D" 1)
   ("xeroderma pigmentosum group D ( XPD )" 1)
   ("Xeroderma Pigmentosum complementary group D" 1) ("XPD ”" 1)
   ("“ERCC2/XPD\"" 1) ("Excision Repair Cross-complementation group 2" 1)
   ("complementation group 2 (XPD)" 1)))
 ("UP:P18075"
  (("BMP7" 113) ("Bmp7" 2) ("Bone Morphogenetic Protein-7" 2)
   ("Bone morphogenetic protein-7" 2) ("osteogenic protein-1" 1)
   ("bone morphogenetic protein-7" 1)))
 ("UP:P18077"
  (("RPL35A" 10) ("L35A" 4) ("RPL35a" 3) ("ribosomal protein L35a" 2)))
 ("UP:P18084" (("ITGB5" 15))) ("UP:P18085" (("ARF2" 7) ("Arf4" 3) ("ARF4" 2)))
 ("UP:P18089" (("ADRA2B" 2))) ("UP:P18103" (("FANC" 65)))
 ("UP:P18124" (("RPL7" 8) ("rpL7" 2))) ("UP:P18126" (("EGb" 1)))
 ("UP:P18131"
  (("Pol" 1434) ("pol" 976) ("POL" 145) ("P-pol" 8) ("overexpressed pol" 3)
   ("Pol µ" 3) ("either irrelevant HIV pol" 2) ("Pol-" 1) ("stalled RNA pol" 1)
   ("than Pol" 1) ("POl" 1)))
 ("UP:P18146"
  (("EGR1" 741) ("Egr1" 137) ("early growth response" 50)
   ("early growth response 1" 45) ("Early growth response" 5) ("egr1" 4)
   ("EGR1 protein" 2) ("early growth response (EGR) protein" 2)
   ("Early growth response 1" 2) ("Egr1 protein" 1)
   ("early growth response protein-1" 1) ("—early growth response 1" 1)
   ("exogenous EGR1" 1) ("mild EGR1" 1) ("early growth response (EGR)" 1)))
 ("UP:P18153" (("D-7" 3)))
 ("UP:P18168" (("pSer" 851) ("SER" 36) ("pSER" 6) ("pSer–" 2) ("PSer" 1)))
 ("UP:P18177" (("TcdB" 3))) ("UP:P18181" (("blast-1" 3)))
 ("UP:P18195" (("PiB" 39) ("pIB" 8) ("than PiB" 1)))
 ("UP:P18206"
  (("vinculin" 860) ("mV" 364) ("MV" 326) ("Vinculin" 117) ("VCL" 61)
   ("pMV" 14) ("vinculin-" 4) ("vinculin molecule" 3) ("around −250 mV" 2)
   ("strong vinculin" 2) ("mv" 2) ("Mouse monoclonal anti vinculin" 2)
   ("-vinculin" 1) ("the FA-associated protein vinculin" 1)
   ("the resting potential around −40 mV" 1) ("around −40 mV" 1)
   ("vinculin ( VCL )" 1) ("than wild-type MV [ xref ]" 1)
   ("both the pathogenic wild-type MV" 1) ("VINCULIN" 1) ("mV (VZ)" 1)
   ("Vinculin (VCL)" 1) ("the focal complex protein vinculin" 1)
   ("approximately 0 mV" 1) ("than −370 mV ( xref )" 1) ("cellular vinculin" 1)
   ("very small vinculin" 1) ("fluorescent vinculin" 1)))
 ("UP:P18283"
  (("GPX2" 13) ("GPX-2" 13) ("glutathione peroxidase 2" 4) ("Gpx2" 3)))
 ("UP:P18289" (("JRA" 5) ("Jra" 4) ("jra" 1)))
 ("UP:P18301" (("STCs" 4) ("stanniocalcin" 4) ("Stanniocalcin" 1)))
 ("UP:P18302" (("drebrins" 2)))
 ("UP:P18405" (("SRD5A1" 18) ("steroid-5-alpha-reductase" 4)))
 ("UP:P18428"
  (("LBP" 42) ("chronic LBP" 1) ("lipopolysaccharide binding protein" 1)
   ("its intact LBP" 1)))
 ("UP:P18431" (("zw3" 12) ("Zw3" 8) ("SGG" 5) ("sgg" 3) ("Sgg" 1)))
 ("UP:P18433" (("RPTPα" 17) ("RPTP-α" 2) ("monomeric RPTPα" 1) ("rPTPα" 1)))
 ("UP:P18440" (("N-acetyltransferase 1" 5)))
 ("UP:P18464"
  (("etc" 240) ("mesangial expansion etc" 1) ("mechanical force etc" 1)))
 ("UP:P18488" (("EMS" 22)))
 ("UP:P18491" (("EMC" 64) ("Primary EMC" 2) ("∼20% confluent EMC" 1)))
 ("UP:P18502"
  (("PTC" 2927) ("Ptc" 133) ("FVPTC" 90) ("primary PTC" 27)
   ("recurrent PTC" 27) ("NFVPTC" 27) ("solitary PTC" 11) ("TCPTC" 9)
   ("metastatic PTC" 8) ("classic PTC" 7) ("classical PTC" 7)
   ("follicular variant PTC" 6) ("BRAF-negative PTC" 6) ("BRAF-positive PTC" 5)
   ("BRAF-positive and BRAF-negative PTC" 5)
   ("BRAF V600E mutation-positive PTC" 4) ("Hedgehog receptor" 4)
   ("aggressive PTC" 4) ("PTC (TCPTC)" 3) ("PTC-" 3) ("adjacent PTC" 3)
   ("extensive PTC" 3) ("these mice developed PTC" 3)
   ("104 (18.3%) BRAF mutation-positive PTC" 2) ("progressive PTC" 2)
   ("than BRAF-negative PTC" 2) ("BRAF V600E -negative PTC" 2)
   ("more aggressive PTC" 2) ("primary and recurrent PTC" 2)
   ("Recurrent PTC" 2) ("multifocal PTC" 2) ("all mice developed PTC" 2)
   ("a genuine PTC" 2) ("structural PTC" 2) ("the follicular variant PTC" 1)
   ("than PTC" 1) ("the TERT promoter mutation-positive PTC" 1)
   ("follicular variant PTC (FVPTC)" 1) ("PTC (FVPTC)" 1) ("PTC (CPTC)" 1)
   ("ATC and BRAF mutation-positive PTC" 1)
   ("30 (63.3%) C228T mutation-positive PTC" 1)
   ("56 (3.6%) follicular variant PTC" 1) ("hedgehog receptor" 1)
   ("than PTC [ xref ; xref ]" 1) ("thyroidectomy revealed multifocal PTC" 1)
   ("the most aggressive PTC" 1) ("the BRAF-positive PTC" 1) ("sporadic PTC" 1)
   ("multinodular goiter PTC" 1) ("less aggressive PTC" 1) ("only 12 PTC" 1)
   ("the multinodular goiter PTC" 1) ("insular PTC" 1) ("the metastatic PTC" 1)
   ("infiltrative metastatic PTC" 1) ("Middle Eastern PTC" 1)
   ("than thousand PTC" 1) ("than 1000 PTC" 1) ("only 21 PTC" 1)
   ("the more favorable well-differentiated primary PTC" 1)
   ("more aggressive recurrent PTC" 1) ("their primary PTC" 1)
   ("all the primary PTC" 1) ("54 recurrent PTC" 1) ("the same primary PTC" 1)
   ("most primary PTC" 1) ("the primary PTC" 1) ("those primary PTC" 1)
   ("405 Italian PTC" 1) ("therapeutic PTC" 1) ("confluent PTC" 1)
   ("BRaf CA mice developed PTC" 1) ("AGGRESSIVE PTC" 1) ("Most FVPTC" 1)
   ("than solitary PTC" 1) ("the BRAF aggressive PTC" 1) ("less FVPTC" 1)
   ("BRAF mutation-positive PTC" 1) ("94 (24.8%) follicular variant PTC" 1)
   ("PTC−" 1)))
 ("UP:P18509"
  (("PACAP" 40) ("PACAP-38" 6) ("PACAP-" 4)
   ("pituitary adenylate cyclase–activating polypeptide (PACAP)" 2)
   ("pituitary adenylate cyclase–activating polypeptide" 1)
   ("pituitary adenylate cyclase activating polypeptide (PACAP)" 1)
   ("pituitary adenylate cyclase activating polypeptide" 1)
   ("pituitary adenylate cyclase-activating polypeptide (PACAP)" 1)
   ("pituitary adenylate cyclase-activating polypeptide" 1)))
 ("UP:P18510"
  (("IL1RN" 69) ("IL-1ra" 50) ("iRap" 39) ("IL-1Ra" 34) ("IL1Ra" 23)
   ("IL-1RN" 22) ("IL-1RA" 12) ("IL1ra" 6) ("IL1RA" 5) ("Il1rn" 5)
   ("anakinra" 2) ("interleukin 1 receptor antagonist" 2)
   ("Interleukin 1 receptor antagonist" 2) ("IL1Ra protein" 1)))
 ("UP:P18512" (("KK1" 29)))
 ("UP:P18537"
  (("Frizzled" 205) ("frizzled" 85) ("Frizzled (Fz) protein" 2)
   ("Frizzled (FZD)" 1) ("the serpentine receptor Frizzled" 1)))
 ("UP:P18564" (("ITGB6" 5))) ("UP:P18569" (("EGT" 13)))
 ("UP:P18577" (("RHC" 19) ("rhe" 1)))
 ("UP:P18583"
  (("son" 89) ("SON" 16) ("Son" 6) ("-son" 4) ("the son’s" 2) ("her son’s" 1)))
 ("UP:P18612" (("KIN1" 1)))
 ("UP:P18615"
  (("RD" 708) ("just achieved RD" 3) ("Mittal RD" 2)
   ("causes recurrent and tractional RD" 1)
   ("traumatic, tractional, exudative or iatrogenic RD" 1)
   ("a primary rhegmatogenous RD" 1) ("experimental RD" 1) ("“RD”" 1)
   ("The embryonal rhabdomysarcoma cell line RD" 1)
   ("the human embryonal rhabdomyosarcoma cell line RD" 1)
   ("embryonal RMS cell line RD" 1)))
 ("UP:P18616" (("Rpb1" 32) ("RPII" 7))) ("UP:P18621" (("L17" 7) ("RPL17" 2)))
 ("UP:P18627"
  (("FDC" 28) ("LAG3" 13) ("Lag3" 6) ("LAG-3" 5) ("activation gene-3" 1)))
 ("UP:P18642" (("ImpB" 2)))
 ("UP:P18669"
  (("PGAM1" 43) ("phosphoglycerate mutase 1" 3)
   ("Phosphoglycerate mutase 1" 2)))
 ("UP:P18681" (("CIII" 6) ("Ciii" 1)))
 ("UP:P18754"
  (("RCC1" 221) ("Rcc1" 45) ("cell cycle regulatory protein" 32)
   ("regulator of chromosome condensation 1" 5) ("Chc1" 4)
   ("a key cell cycle regulatory protein" 4) ("CHC1" 3)
   ("at least one regulator of chromosome condensation
1"
    2)
   ("regulator of chromosome condensation
1"
    2)
   ("the chromatin-associated guanine nucleotide exchange factor RCC1" 2)
   ("a well-known cell cycle regulatory protein" 2) ("chc1" 1) ("rcc1" 1)))
 ("UP:P18759" (("SNAREs" 41)))
 ("UP:P18773"
  (("EST" 417) ("est" 2) ("A further five EST" 1)
   ("approximately 13,000 EST" 1) ("currently only 11 human EST" 1)
   ("10 better quality EST’s" 1)))
 ("UP:P18780" (("TERC" 446) ("late generation (G4) TERC" 1)))
 ("UP:P18827"
  (("CD138" 309) ("syndecan-1" 205) ("Syndecan-1" 149) ("SDC" 75) ("SDC1" 46)
   ("SDCs" 20) ("sdc" 15) ("CD138-" 6) ("Sdc" 5) ("syndecan-1 molecule" 3)
   ("sporadic weak nuclear syndecan-1" 2) ("Syndecan1" 1)
   ("The effluent containing non-labeled CD138" 1)
   ("than the native syndecan-1" 1) ("functional syndecan-1" 1)
   ("syndecan 1" 1) ("continuously treated pre-sorted CD138" 1)
   ("the characteristic surface antigen CD138" 1)))
 ("UP:P18846"
  (("ATF1" 34) ("ATF-1" 14) ("CREB1-associated protein ATF1" 2)
   ("activating transcription factor 1" 2)
   ("activating transcription factor-1" 1) ("Atf1" 1)))
 ("UP:P18847"
  (("ATF3" 643) ("ATF-3" 19) ("Atf3" 16)
   ("activating transcription factor 3" 8) ("stress-induced ATF3" 6)
   ("cancer-associated ATF3" 6) ("ATF3 protein" 6) ("Cancer-associated ATF3" 4)
   ("ATF3 peptide" 3) ("activating transcription factor 3 (ATF3) protein" 3)
   ("Activating transcription factor 3" 2) ("41 previously known ATF3" 1)
   ("the potential ATF3" 1) ("pro-apoptotic ATF3" 1)
   ("HIS-FLAG-tagged WT ATF3" 1)))
 ("UP:P18848"
  (("ATF4" 776) ("ATF-4" 50) ("activating transcription factor 4" 36)
   ("Activating transcription factor 4" 6) ("Atf4" 4) ("−ATF4" 4)
   ("ATF-4 protein" 4) ("ATF4 protein" 4) ("ATF4-" 1) ("P-ATF4" 1)
   ("Activating transcription factor 4 (ATF4) protein" 1)))
 ("UP:P18850"
  (("ATF6" 244) ("activating transcription factor 6" 27) ("Atf6" 9) ("ATF6α" 5)
   ("ATF-6" 1) ("Activating transcription factor 6" 1) ("ATF6a" 1)
   ("basic leucine zipper transcription factor ATF6" 1)))
 ("UP:P18851" (("Ste4" 2)))
 ("UP:P18858" (("LIG1" 80) ("DNA ligase I" 46) ("DNA ligase 1" 7) ("Lig1" 3)))
 ("UP:P18859"
  (("mito" 89) ("Mito" 81) ("subunit F6" 13) ("CF6" 5) ("ATP5J" 4) ("Atp5" 3)
   ("ATP5" 2)))
 ("UP:P18887"
  (("XRCC1" 6110) ("XRCC1 protein" 114) ("Xrcc1" 113) ("XRCC1 peptide" 28)
   ("the conservative XRCC1" 9) ("XRCC1-" 6) ("p-XRCC1" 6)
   ("X-ray repair cross complementing 1" 5) ("DNA repair protein XRCC1" 5)
   ("-XRCC1" 5) ("“XRCC1”" 4) ("P-XRCC1" 3) ("”" 3) ("than wild-type XRCC1" 2)
   ("pThr519-XRCC1 peptide" 2)
   ("X-ray repair cross complementing 1 (XRCC1) protein" 2) ("XRCC1 ”" 2)
   ("the ancestral XRCC1" 2) ("polymorphic variant wt XRCC1 Arg194Trp" 2)
   ("conservative XRCC1" 2)
   ("Similarly Heale et al. , and Parlanti et al. detected XRCC1" 2)
   ("p18887" 2) ("XRCC1 (X-ray repair cross- complementing gene 1) protein" 2)
   ("than full-length XRCC1 ( xref )" 1)
   ("Nonsynonymous XRCC1 polymorphisms Arg399Gln, Arg194Trp, and Arg280His" 1)
   ("susceptible XRCC1" 1) ("distinct XRCC1" 1)
   ("The transfected exogenous XRCC1" 1)
   ("further transcriptionally regulated XRCC1" 1) ("“XRCC1\"" 1)
   ("the cellular XRCC1" 1) ("than non-phosphorylated XRCC1 [ xref , xref ]" 1)
   ("the triple mutant XRCC1 S518A" 1) ("functional XRCC1" 1) ("XRCC1 (BER)" 1)
   ("that XRCC1’s" 1) ("the conservative XRCC1 protein" 1)
   ("than the conservative XRCC1 (after 60 s versus 120 s, respectively, shown in red)"
    1)
   ("partially complement XRCC1" 1) ("inefficient XRCC1" 1)
   ("XCC1 deficient EM9 CHO expressing polymorphic XRCC1" 1)))
 ("UP:P18889" (("pORF1" 5))) ("UP:P18899" (("FSP" 10)))
 ("UP:P18961" (("YPK2" 5))) ("UP:P19012" (("KRT15" 1) ("keratin 15" 1)))
 ("UP:P19013"
  (("K 4" 26) ("keratin 4" 23) ("KRT4" 6) ("k  4" 5) ("pCK4" 4) ("CK4" 3)
   ("Cyk4" 3) ("K  4" 2) ("Keratin 4" 2) ("k  −4" 1)))
 ("UP:P19021" (("PHMs" 8) ("PHM" 7)))
 ("UP:P19022"
  (("N-cadherin" 3488) ("CDH2" 230) ("N-Cadherin" 103) ("N-cad" 85) ("BD" 38)
   ("NCAD" 37) ("N-cadherin protein" 34) ("Cdh2" 33) ("Ncad" 22)
   ("N-cadherins" 17) ("N-CADHERIN" 17) ("N-Cadherins" 9)
   ("the mesenchymal marker N-cadherin" 6) ("overexpressed N-cadherin" 5)
   ("N-cadherin-" 5) ("N-Cad" 4) ("mesenchymal marker N-cadherin" 4)
   ("mesenchymal markers N-cadherin" 4)
   ("the mesenchymal markers N-cadherin" 4) ("Soluble N-cadherin" 3)
   ("N-Cadherin protein" 3) ("than N-cadherin" 3)
   ("mesenchymal markers CDH2" 3) ("neural cadherin" 3)
   ("overexpressed CDH2" 3) ("surface-expressed N-cadherin" 2)
   ("targeted CDH2" 2) ("Neural cadherin" 2)
   ("a constitutively-expressed N-cadherin" 2)
   ("the mesenchymal adhesion protein N-cadherin" 2) ("a strong N-Cadherin" 2)
   ("-N-cadherin" 2) ("junctional N-cadherin" 2) ("n-cadherin" 1)
   ("This multicomponent complex anchors N-cadherin" 1)
   ("even more N-cadherin" 1) ("almost no N-cadherin" 1)
   ("the mesenchymal markers CDH2" 1)
   ("The mesenchymal cell adhesion protein N-cadherin" 1) ("N-cadherin (BD)" 1)
   ("mesenchymal cell marker N-cadherin" 1)
   ("mesenchyme-associated N-cadherin" 1)
   ("the residual full-length N-cadherin" 1)
   ("the actin-associated protein N-cadherin" 1) ("N-CAD" 1)
   ("pseudoglandular and canalicular periods N-cadherin" 1) ("N-cadherin–" 1)
   ("The residual N-cadherin" 1) ("N–cadherin" 1)
   ("any membranous N-cadherin" 1) ("N-cadh" 1)
   ("the aforementioned N-cadherin" 1) ("the mesenchymal marker CDH2" 1)
   ("angiomatous meningioma expressed N-cadherin" 1) ("Ncadherin" 1)
   ("the mesenchymal proteins N-Cadherin" 1)
   ("0.1 µg/mL mouse monoclonal anti N-cadherin" 1)))
 ("UP:P19075" (("TSPAN8" 8))) ("UP:P19087" (("GNAT2" 3)))
 ("UP:P19099" (("aldosterone synthase" 4) ("Cyp11b2" 4) ("CYP11B2" 3)))
 ("UP:P19105"
  (("RLC" 150) ("myosin RLC" 10) ("monophosphomimetic RLC-T18A" 5)
   ("diphosphomimetic RLC-T18D" 2) ("phosphomimetic RLC T18D" 1)
   ("nonphosphorylatable RLC-T18A" 1) ("phosphomimetic RLC-T18D" 1)))
 ("UP:P19158" (("Ira2" 29) ("ira2" 26) ("GLC4" 23) ("IRA2" 5)))
 ("UP:P19174"
  (("PLCγ1" 717) ("PLC-γ1" 159) ("PLCG1" 32) ("Cγ1" 17) ("PLC-g1" 16)
   ("-Cγ1" 14) ("PLC-gamma1" 12) ("PLCg1" 10) ("Plcγ1" 8) ("PLCγ-1" 7)
   ("p-PLCγ1" 3) ("PLCgamma" 3) ("PLCγ1 protein" 3)
   ("phospholipase C-gamma1" 3) ("PLC1" 2) ("p-PLC-γ1" 2) ("PLCγ1-" 2)
   ("at least PLCγ1" 1) ("centrosomal PLCγ1" 1) ("P19174" 1) ("PLCG1-" 1)
   ("mature V H DJ H -Cδ and V H DJ H -Cγ1" 1) ("particular PLCγ1" 1)
   ("cellular PLCγ1" 1) ("pPLC-γ1" 1) ("-PLCγ1" 1)))
 ("UP:P19194" (("VP3" 7)))
 ("UP:P19196"
  (("invasin" 72) ("invasins" 21) ("a streptococcal invasin" 2) ("invasin-" 2)
   ("The primary meningococcal invasins" 2)
   ("the fungal Als3 and Ssa1 invasins" 1) ("a poor invasin" 1)
   ("a specific bacterial invasin" 1)))
 ("UP:P19212"
  (("pink" 93) ("AMR" 93) ("Pink" 8) ("PINK" 7) ("a functional AMR" 2)
   ("pink-" 1) ("The highly conserved endocytic AMR" 1) ("PINK-" 1)))
 ("UP:P19217" (("OST" 36) ("OST-" 1)))
 ("UP:P19220"
  (("O6-methylguanine DNA methyltransferase" 5)
   ("O6-methylguanine-DNA-methyltransferase" 1)))
 ("UP:P19224" (("UGT1A6" 9) ("Ugt1a6" 1)))
 ("UP:P19235"
  (("EpoR" 463) ("EPO-R" 81) ("erythropoietin receptor" 51) ("EPOR" 49)
   ("Epo receptor" 39) ("EpoR protein" 11) ("Erythropoietin receptor" 7)
   ("Epo-R" 5) ("EpoR peptide" 4) ("pEpoR" 4) ("-EPO-R" 2)
   ("the homodimeric EPOR" 1) ("a respective truncated EpoR" 1) ("more EpoR" 1)
   ("cellular EpoR" 1)))
 ("UP:P19237" (("slow)" 8) ("TNNI1" 1)))
 ("UP:P19254" (("BGC" 75) ("the human gastric carcinoma cells BGC823" 1)))
 ("UP:P19256" (("CD58" 24) ("LFA-3" 2) ("Ag 3" 1)))
 ("UP:P19320"
  (("VCAM-1" 1145) ("vascular cell adhesion molecule-1" 53) ("VCAM1" 50)
   ("Vcam1" 13) ("CD106" 5) ("L1-CAM" 5)
   ("Vascular cell adhesion molecule–1" 4) ("VCAM-1–" 3) ("VCAM-1 protein" 3)
   ("soluble L1-CAM" 3) ("-CD106" 2) ("strong VCAM-1" 2) ("VCAM-1-" 1)
   ("endogenous endothelial VCAM-1" 1)
   ("the vascular cell adhesion molecule VCAM-1" 1)
   ("Recombinant soluble seven-domain human VCAM-1" 1)
   ("vascular cell adhesion protein 1" 1)))
 ("UP:P19338"
  (("nucleolin" 673) ("NCL" 140) ("Nucleolin" 90) ("nucleolin protein" 8)
   ("nucleolin (NCL)" 4) ("nucleolin ( NCL )" 1)
   ("the nucleolar protein nucleolin" 1) ("P19338" 1)))
 ("UP:P19367"
  (("hexokinase 1" 15) ("Hexokinase 1" 12) ("HK I" 2)
   ("the essential glycolytic enzyme hexokinase 1" 2) ("Hexokinase-1" 2)
   ("hexokinase-1" 2)))
 ("UP:P19382" (("SNA" 21)))
 ("UP:P19387" (("RPB3" 3) ("RNA polymerase II subunit 3" 2) ("POLR2C" 1)))
 ("UP:P19388" (("POLR2E" 10) ("RPB5" 3) ("the next upstream gene POLR2E" 1)))
 ("UP:P19397" (("CD53" 2) ("Cd53" 1))) ("UP:P19404" (("NDUFV2" 3)))
 ("UP:P19419"
  (("Elk-1" 1472) ("ELK1" 422) ("Elk1" 209) ("ELK-1" 140) ("elk-1" 42)
   ("p-ELK1" 21) ("Elk-1 protein" 16) ("Elk1 protein" 7)
   ("extranuclear Elk-1" 5) ("Elk1-" 4) ("overexpressed Elk-1" 4)
   ("Overexpressed Elk-1" 4) ("latent Elk-1" 4) ("targeting human ELK1" 3)
   ("significant extranuclear T417 + Elk-1" 2) ("targeting ELK1" 2)
   ("the ternary complex transcription factor ELK-1" 2)
   ("the ternary complex factor Elk-1" 1) ("ElK-1" 1) ("-Elk-1" 1)
   ("further study ELK1" 1) ("extranuclear T417 + Elk-1" 1)
   ("remarkable Elk-1" 1) ("extranuclear Elk-1 protein" 1)
   ("phospho-Elk-1 (pElk-1) protein" 1) ("ELK1 protein" 1)
   ("several independent experiments more Elk-1" 1)
   ("dimerization-defective Elk-1" 1) ("directly target Elk-1" 1)))
 ("UP:P19429"
  (("cardiac troponin I" 18) ("TNNI3" 3) ("Tnni3" 3) ("Tnnc1" 2)
   ("Cardiac troponin I" 2) ("TNNC1" 1)))
 ("UP:P19438"
  (("TNFR1" 493) ("TNFR-I" 115) ("TNF-R1" 66) ("TNFR-1" 47) ("TNFRSF1A" 37)
   ("TNFRI" 20) ("Tnfr1" 14) ("TNF-R" 13)
   ("tumor necrosis factor receptor 1" 12) ("TNF-RI" 6) ("Tnfrsf1a" 4)
   ("p55-TNFR" 3) ("Tumor necrosis factor receptor 1" 2)
   ("lack functional TNFR-I" 1) ("The normal TNFR-1" 1) ("TNFR1 protein" 1)
   ("TNFRSF1a" 1) ("Soluble TNF-R1" 1)))
 ("UP:P19440" (("GGT" 745) ("-GGT" 47) ("GGT1" 13) ("‘GGT’" 1) ("Ggt1" 1)))
 ("UP:P19447"
  (("ERCC3" 41) ("XPB" 21) ("TFIIH p89" 3) ("complementation group 3" 2)
   ("Rad25" 1) ("complementation group 3 (XPB)" 1)))
 ("UP:P19453" (("SAA3" 2)))
 ("UP:P19474"
  (("SSAs" 125) ("Ssa1" 107) ("SSA1" 33) ("-Ssa1" 11) ("TRIM21" 10) ("Ro52" 10)
   ("ssa1" 8) ("Ro/SSA" 3) ("SS-A" 3) ("autoantigenic Ro/SSA" 2)
   ("-Ssa1 protein" 2) ("human colonic SSAs" 1)
   ("E3 ubiquitin-protein ligase TRIM21" 1) ("than SSAs (9.4%, 3/32)" 1)
   ("than SSAs ( p < 0.05)" 1) ("tripartite motif containing 21" 1)
   ("most SSA1" 1) ("the phosphomimetic mutant ssa1-T36E" 1)
   ("the nonphosphorylatable mutant ssa1-T36A" 1) ("RO52" 1)))
 ("UP:P19484" (("TFEB" 417) ("transcription factor EB" 3) ("pTFEB" 1)))
 ("UP:P19524"
  (("Myo2" 217) ("myo2" 56) ("Myo-2" 12) ("myo-2" 3)
   ("Sec4 potentially places Myo2" 1)))
 ("UP:P19525"
  (("PKR" 538) ("EIF2AK2" 20) ("protein kinase R" 18)
   ("double-stranded RNA-activated protein kinase" 13) ("overexpressed PKR" 6)
   ("p-EIF2AK2" 5) ("pPKR" 4) ("RNA-dependent protein kinase" 4)
   ("over-activated PKR" 3) ("Protein kinase R" 3) ("Over-activated PKR" 2)
   ("double-stranded RNA-activated protein kinase (PKR) protein" 2)
   ("Protein Kinase R" 2)
   ("double-stranded RNA-activated protein kinase (PKR)" 2) ("PRKR" 2)
   ("PKR-" 2) ("protein kinase R-" 2) ("protein kinase R (PKR)" 1)
   ("the over-activated PKR" 1)
   ("Double-stranded RNA-activated protein kinase" 1)
   ("RNA-dependent protein kinase (PKR)" 1) ("total or phosphorylated PKR" 1)
   ("total and phosphorylated PKR" 1) ("Protein Kinase R (PKR)" 1)))
 ("UP:P19526"
  (("HSCs" 1872) ("HSC" 1342) ("normal HSCs" 23) ("quiescent HSCs" 23)
   ("quiescent HSC" 17) ("primary HSC" 13) ("primary HSCs" 11)
   ("Primary HSC" 9) ("proliferating HSCs" 5) ("phenotypic HSCs" 4)
   ("human primary HSCs" 4) ("functional HSCs" 4) ("-HSCs" 3) ("HSC protein" 3)
   ("Primary HSCs" 3) ("FUT1" 3) ("normal HSC" 3) ("targeting HSCs" 3)
   ("phenotypic HSC" 2) ("primitive HSCs" 2) ("immunophenotypic HSCs" 2)
   ("lymphoid-competent HSCs" 2) ("most HSCs" 2) ("the Quiescent HSC" 2)
   ("phenotypic LT-HSCs" 2) ("H 2 O 2 -induced senescent HSCs" 2)
   ("fewer proliferated HSCs" 2) ("LPS-treated HSCs" 2)
   ("CD34+ primary HSCs" 2) ("Normal HSC" 2) ("clonal HSC" 2)
   ("cultured primary HSC" 2) ("dl312-treated HSC" 2) ("V12rac1-treated HSC" 2)
   ("MDM2-null HSCs" 2) ("MEF/ELF4-null HSCs" 2)
   ("MEF/ELF4-null long-term reconstituting HSCs" 2)
   ("the less p53 activated HSCs" 2) ("umbilical HSCs" 2)
   ("phenotypically defined Shp2 heterozygous HSCs" 2)
   ("passage #3 primary HSCs" 2) ("a normal HSC" 2)
   ("the conditional CXCR4 KO HSCs" 1) ("IGFBP2-null HSCs" 1) ("Normal HSCs" 1)
   ("than 5% HSCs" 1) ("recently described preleukemic HSCs" 1)
   ("myeloid leukemic HSCs" 1) ("aberrant HSCs" 1) ("the SEA-treated HSCs" 1)
   ("the primary HSCs" 1) ("than quiescent LT-HSCs ( xref )" 1)
   ("the actual HSCs" 1) ("one or more HSCs" 1)
   ("approximately 10,000 distinct HSCs" 1) ("approximately 10,000 HSCs" 1)
   ("than LT-HSCs ( xref )" 1) ("Short-term (ST)-HSCs" 1) ("rat primary HSC" 1)
   ("than HSCs" 1) ("most immature long-term reconstituting HSCs" 1)
   ("PDGF produced significantly fewer Ki67 + HSCs" 1) ("functional HSC" 1)
   ("STAT5-null HSCs" 1) ("the primary HSC" 1) ("Rat primary HSC" 1)
   ("the multipotent HSC" 1) ("than normal HSCs ( xref )" 1)
   ("p53-null HSCs" 1) ("than wild type HSCs ( xref )" 1) ("Puma null HSCs" 1)
   ("MEF/ELF4 double-null HSCs" 1) ("Necdin-null HSCs" 1) ("Gfi-1 null HSCs" 1)
   ("umbilical cord HSCs" 1) ("Umbilical cord HSCs" 1)
   ("10 nM siRNA duplex HSC" 1) ("reduced bone marrow phenotypic HSCs" 1)
   ("fewer HSC" 1)
   ("particular, Dnmt3a-null, Tet2-null and Tet2-haploinsufficient HSCs" 1)
   ("SIT-treated CD34 high HSC" 1)))
 ("UP:P19532"
  (("TFE3" 156) ("transcription factor E3" 3) ("TFE-3" 3) ("TFE3-" 2)
   ("strong nuclear TFE3" 1) ("TFE3 protein" 1)))
 ("UP:P19538" (("Cubitus interruptus" 8)))
 ("UP:P19544"
  (("WT1" 1338) ("Wilms tumor" 47) ("WT1 protein" 45) ("WT-1" 31) ("_WT" 19)
   ("Wt1" 18) ("Wilms tumor 1" 15) ("wt1" 4) ("_wt" 4) ("Wt1 protein" 4)
   ("The mesothelial markers WT1" 2) ("the epicardial marker WT1" 2)
   ("Wilms tumor (WT)" 1) ("a leukaemia-associated mutant WT1 protein" 1)
   ("WT1-" 1) ("RhoA_WT" 1) ("Wilms tumor 1 protein" 1)
   ("epithelial predominant Wilms tumor (WT)" 1) ("Wilms tumor protein" 1)
   ("undetectable endogenous WT1 protein" 1)
   ("epithelial-predominant Wilms tumor (WT)" 1) ("a sporadic Wilms tumor" 1)
   ("these findings link WT1’s" 1)))
 ("UP:P19560"
  (("Gag-Pol" 64) ("Gag–Pol" 1) ("pGag-Pol" 1)
   ("retroviral proteins Gag-Pol" 1)))
 ("UP:P19563" (("VIF" 10)))
 ("UP:P19582" (("TDM" 36) ("HOM" 1) ("spinal TDM" 1)))
 ("UP:P19592" (("ISS" 238))) ("UP:P19622" (("EN2" 4) ("en2" 2) ("En2" 1)))
 ("UP:P19623" (("spermidine synthase" 1) ("Sps1" 1)))
 ("UP:P19634"
  (("NHE1" 198) ("Nhe1" 9) ("NHE-1" 6) ("solute carrier family 9" 3)
   ("Na+/H+" 2) ("SLC9A1" 1)))
 ("UP:P19651" (("SH1" 29) ("SHI" 6) (NIL 1) ("consecutive SH1" 1)))
 ("UP:P19652" (("orosomucoid 2" 2) ("ORM2" 1) ("alpha-1-acid glycoprotein" 1)))
 ("UP:P19655" (("REB" 16))) ("UP:P19657" (("PMA2" 1)))
 ("UP:P19661" (("Bac-7" 4))) ("UP:P19711" (("GP33" 5)))
 ("UP:P19784" (("CSNK2A2" 3) ("CK2a2" 1)))
 ("UP:P19793" (("RxR" 11) ("RXRA" 9) ("NR2B1" 2) ("Rxr" 1)))
 ("UP:P19801"
  (("amine oxidase" 23) ("Kao" 16) ("ABP1" 9) ("Abp1" 3) ("KAO" 1)
   ("diamine oxidase" 1)))
 ("UP:P19823"
  (("ITIH2" 5) ("Itih2" 3) ("inter-alpha-trypsin inhibitor heavy chain 2" 1)))
 ("UP:P19827" (("ITIH1" 10) ("H1p" 2)))
 ("UP:P19835"
  (("CEL" 350) ("BAL" 207) ("BaL" 97) ("cel" 43) ("Cel" 12) ("-BaL" 11)
   ("Bal" 9) ("raw CEL" 5) ("cholesterol esterase" 4) ("BAL protein" 4)
   ("The raw CEL" 2) ("CEL (PC)" 2) ("Affymetrix raw CEL" 1)
   ("Hypotonic cel" 1) ("The original CEL" 1)
   ("Affymetrix expression microarrays raw CEL" 1) ("either raw CEL" 1)
   ("Raw CEL" 1) ("process all the Cel" 1) ("all experimental CEL" 1)
   ("Original CEL" 1) ("HIV-1 R5-tropic BaL" 1) ("the mini BAL" 1)
   ("raw cel" 1) ("the subsequent analysis six CEL" 1)))
 ("UP:P19838"
  (("NFKB1" 743) ("Ebp1" 419) ("EBP1" 335) ("E-BP1" 97) ("nfkb1" 37)
   ("ebp1" 26) ("NFkB1" 23)
   ("kappa light polypeptide gene enhancer in B-cells 1" 11)
   ("kappa light polypeptide gene" 8) ("Nfkb1" 6) ("EBP-1" 4) ("NFkBp50" 3)
   ("NFKB1 protein" 2) ("NF-kappaB1" 1) ("exogenous ebp1" 1)
   ("reported previously ( xref ) Ebp1" 1)
   ("the last 79 C-terminal amino acids of Ebp1 (amino acid 293–372)" 1)
   ("EBP1 protein" 1)))
 ("UP:P19875"
  (("HSF" 184) ("CXCL2" 76) ("Cxcl2" 71) ("pHSF" 3) ("Hsf" 3) ("than HSF" 1)
   ("cxcl2" 1) ("than CXCL2" 1) ("hsf" 1) ("CXCL2-" 1) ("Grob" 1)
   ("primary HSF" 1)))
 ("UP:P19876" (("CXCL3" 13) ("Cxcl3" 3)))
 ("UP:P19878"
  (("p67 phox" 203) ("NCF2" 88) ("p67phox" 70) ("Ncf2" 9) ("p67 PHOX" 5)
   ("neutrophil cytosolic factor 2" 5) ("–p67 phox" 3) ("-p67 phox" 1)
   ("p67-phox" 1) ("neutrophil cytosol factor 2" 1)))
 ("UP:P19883"
  (("FS" 210) ("FST" 202) ("fs" 24) ("Fst" 16) ("activins" 15) ("Activins" 10)
   ("follistatin" 8) ("Follistatin" 7) ("Fs" 5) ("fS" 3)
   ("CCR5-tropic HIV-1 vif FS" 2) ("whose SNPs showed both high FST" 2)
   ("FST protein" 2) ("cellular FST" 1) ("Follistatin (FST)" 1)))
 ("UP:P19940" (("sIgG" 16))) ("UP:P19952" (("HS12" 2)))
 ("UP:P19953" (("HS15" 6) ("HS15 (BASF)" 2)))
 ("UP:P19957"
  (("PI3" 1000) ("ESI" 301) ("PI-3" 285) ("SKALP" 5) ("PI3-" 2) ("elafin" 2)
   ("ESI-" 1) ("consequent dysregulated PI3" 1) ("-PI3" 1)
   ("peptidase inhibitor 3" 1) ("pi3" 1)))
 ("UP:P19971"
  (("TP" 644) ("thymidine phosphorylase" 57) ("T-P" 47) ("Tp" 18)
   ("Thymidine phosphorylase" 7) ("TxP" 5) ("thymidine phosphorylase (TP)" 4)
   ("TYMP" 2) ("thymidine phosphorylase protein" 2)
   ("mouse monoclonal thymidine phosphorylase" 2)
   ("platelet-derived endothelial cell growth factor" 2)
   ("exogenous recombinant TP" 1) ("proangiogenic TP" 1)
   ("thymidine phosphorylase ( TP )" 1)
   ("Platelet-derived endothelial cell growth factor" 1) ("pT-P" 1)))
 ("UP:P20009"
  (("BR" 400) ("Br" 47) ("br" 15) ("the seminal BR" 1) ("The pivotal BR" 1)
   ("the pivotal BR" 1) ("BR-" 1) ("case BR282" 1)))
 ("UP:P20020" (("ATP2B1" 4))) ("UP:P20023" (("CR2" 52) ("CD21" 47) ("Cr2" 2)))
 ("UP:P20036" (("HLA-DPA1" 12))) ("UP:P20039" (("DR-5" 1)))
 ("UP:P20041" (("PGA" 98) ("pga" 2)))
 ("UP:P20042"
  (("eIF2B" 48) ("EIF2" 18) ("eukaryotic translation initiation factor 2" 12)
   ("Eukaryotic translation initiation factor 2" 2) ("EIF2B" 2)
   ("translational initiation factor eIF2B" 1)))
 ("UP:P20051" (("ura4" 3))) ("UP:P20052" (("Pho80" 1)))
 ("UP:P20061"
  (("TCI" 73) ("protein R" 54) ("viral protein R" 26) ("Viral protein R" 18)
   ("HIV-1 viral protein R" 11) ("TC-1" 9)
   ("Human immunodeficiency virus type 1 (HIV-1) viral protein R" 4)
   ("The viral protein R" 4) ("Viral Protein R" 3) ("Protein R" 3)
   ("the regulatory viral protein R" 3)
   ("Extracellular human immunodeficiency virus type type 1 (HIV-1) viral protein R"
    2)
   ("The HIV-1 accessory protein viral protein R" 2)
   ("HIV-1 Viral protein R" 2) ("the viral protein R" 2)
   ("The HIV-1 viral protein R" 2) ("study HIV-1 viral protein R" 2)
   ("a 5-mm cryogenically-cooled TCI" 1)))
 ("UP:P20062"
  (("macrocytic anemia" 6) ("the associated macrocytic anemia" 2)
   ("transcobalamin II" 2) ("TCN2" 1)))
 ("UP:P20073"
  (("ANXA7" 297) ("SNX" 25) ("annexin A7" 5) ("Anxa7" 4) ("ANXA7 protein" 4)
   ("ANXA7-" 2) ("The RB-associated ANXA7" 1) ("synexin" 1) ("Annexin A7" 1)))
 ("UP:P20132"
  (("SDS" 8660) ("SDs" 121) ("SDH" 112) ("SDS-" 20) ("SDS protein" 9)
   ("SDS–" 5) ("-SDS" 4) ("sds" 3) ("finally 50μl 3x SDS" 2)
   ("10 ml SE buffer (75 mM NaCl, 24 mM EDTA pH 8.0) 500 μl SDS" 2)
   ("overnight using 10% SDS" 1)
   ("than two SDs from the empty vector control" 1) ("infrequently ≥2 SDs" 1)
   ("the strong detergent SDS" 1) ("homologous SDs" 1)
   ("65°C overnight using 1% SDS" 1)))
 ("UP:P20138" (("CD33" 163) ("CD33 molecule" 4) ("CD33-" 3) ("CD33−" 1)))
 ("UP:P20142"
  (("PGC" 298) ("PGCs" 170) ("pGC" 70) ("pepsinogen" 15) ("pepsinogen C" 7)
   ("PGC protein" 4) ("Pepsinogen C" 3) ("immature pre-gonadal PGCs" 2)
   ("pepsinogen-" 1) ("Pepsinogen" 1)
   ("testicular and ovarian cKIT + PGCs" 1)))
 ("UP:P20151"
  (("prostatic" 976) ("KLK2" 110) ("Prostatic" 29) ("kallikrein 2" 3)
   ("tissue kallikrein" 2) ("Human glandular kallikrein 2" 2) ("KLK-2" 2)
   ("separately isolated de novo primary prostatic" 1) ("Kallikrein 2" 1)
   ("23 benign prostatic" 1) ("benign prostatic" 1)))
 ("UP:P20154" (("Lin-11" 4) ("Lin11" 2) ("lin-11" 2)))
 ("UP:P20155" (("SPINK2" 1)))
 ("UP:P20160"
  (("heparin" 1307) ("synergizes" 477) ("Heparin" 143) ("Synergizes" 16)
   ("heparin-binding protein" 5) ("heparin-" 4) ("Heparin-" 2)
   ("non-genotoxic oxidative stress synergizes" 1)
   ("whose inhibition synergizes" 1)
   ("simultaneous JNK and BTK inhibition synergizes" 1) ("−heparin" 1)
   ("than heparin" 1) ("the BH3 mimetic ABT-737 synergizes" 1)
   ("only TG2 and TG1 bind heparin" 1) ("heparin binding protein" 1)))
 ("UP:P20226"
  (("TBP" 697) ("TFIID" 193) ("TATA-box binding protein" 12)
   ("TATA-box binding protein (TBP)" 4) ("Tbp" 4)
   ("TATA-box-binding protein" 3) ("canonical TFIID" 2)
   ("TATA-box-binding protein (TBP)" 2) ("the internal control TBP" 2)
   ("mouse monoclonal TATA Binding Protein TBP" 2) ("TBP protein" 2)
   ("P20226" 1) ("TATA-Box binding protein" 1) ("than TBP" 1)
   ("the respective TFIID" 1) ("TATA-box binding protein ( TBP )" 1)
   ("±2 kb around TFIID" 1) ("TFIID (TBP)" 1)))
 ("UP:P20228"
  (("GADA" 20) ("glutamate decarboxylase" 5) ("-GADA" 3) ("G-added" 1)))
 ("UP:P20241" (("NRG" 126) ("neuregulin family" 7)))
 ("UP:P20248"
  (("cyclin A" 2805) ("cyclin A2" 649) ("Cyclin A" 564) ("Cyclin A2" 447)
   ("CCNA2" 223) ("CyclinA" 90) ("cyclinA" 81) ("cyclin-A" 59) ("CyclinA2" 16)
   ("Ccna2" 15) ("cyclinA2" 14) ("CCNA" 9) ("cyclin A-" 7) ("-cyclin A" 7)
   ("Cyclin A2 protein" 5) ("exogenous cyclin A" 4)
   ("nondegradable cyclin A" 3) ("2 μg/mL mouse monoclonal cyclin A" 3)
   ("overexpressed cyclin A" 2) ("Nondegradable Cyclin A" 2)
   ("cyclin A protein" 2) ("cyclin-A-" 2)
   ("the non-degradable mutant cyclin A" 2) ("non-degradable cyclin A" 2)
   ("CYCLIN A" 2) ("primary Cyclin A2" 2) ("Cyclin-A" 2)
   ("cyclin A2 protein" 2) ("cytochemical cyclin A" 2) ("CYCLINA2" 2)
   ("cyclin-A2" 2) ("-Cyclin A" 2) ("coexpressed cyclin A" 2)
   ("the N-terminal 196 amino acids of Cyclin A2" 2)
   ("total cellular cyclin A" 2) ("indestructible cyclin A" 1)
   ("variable cyclin A" 1) ("somatic cyclin A" 1)
   ("immediately targets cyclin A" 1) ("the exogenous cyclin A" 1)
   ("maternal cyclin A" 1) ("cyclin-A protein" 1) ("cellular Cyclin A2" 1)
   ("four specific lysines of cyclin A" 1) ("than cyclin A ( xref )" 1)
   ("than cyclin A" 1) ("-cyclin A2" 1) ("cyclin A–" 1) ("cyclin A (CCNA)" 1)
   ("than cyclin A (1–165; xref )" 1)
   ("cyclin
A"
    1)
   ("endoplasmic reticulum-associated non-degraded cyclin A2" 1)
   ("the total cellular cyclin A" 1)
   ("its subsequent downstream target CCNA2" 1)))
 ("UP:P20264" (("POU3F3" 2) ("brain 1" 1)))
 ("UP:P20265" (("BRN2" 86) ("POU3F2" 7) ("Brn2" 5)))
 ("UP:P20273" (("CD22" 45) ("CD2-2" 1))) ("UP:P20274" (("mp18" 26)))
 ("UP:P20290" (("BTF3" 4)))
 ("UP:P20292"
  (("flap" 218) ("-flap" 34) ("ALOX5AP" 17)
   ("5-lipoxygenase activating protein" 6) ("Flap" 5) ("FLAP" 4) ("‘flap’" 2)
   ("“flap”" 2) ("arachidonate 5-lipoxygenase activating protein" 2)
   ("than the DNA flap ( xref , compare lanes 1-7 with 8-14; xref )" 1)
   ("arachidonate 5-lipoxygenase-activating protein" 1)
   ("relatively large-sized skin flap" 1) ("the dorsal flap" 1)
   ("the raised flap" 1)))
 ("UP:P20309" (("CHRM3" 3)))
 ("UP:P20333"
  (("TNFR2" 564) ("TNFRSF1B" 14) ("TNF-R2" 13) ("TNFR-2" 9) ("TNFRII" 9)
   ("Tnfrsf1b" 5) ("TNFR-II" 3) ("tumor necrosis factor receptor 2" 3)
   ("TNFR2 protein" 3) ("Tnfr2" 3) ("so active TNFR2" 1) ("than TNFR2" 1)
   ("Soluble TNFR2" 1) ("over-expressing TNFR2" 1)
   ("Tumor necrosis factor receptor superfamily member 1B" 1) ("TnfRII" 1)
   ("than TNFR2-WT ( xref )" 1)))
 ("UP:P20336" (("RAB3A" 4) ("Rab3A" 1)))
 ("UP:P20337" (("RAB3B" 8) ("Rab3b" 5)))
 ("UP:P20338"
  (("Rab4" 198) ("rab4" 64) ("Rab4A" 2) ("Rab4-" 2) ("Rab4a" 2)
   ("a dominant-negative Rab4" 1) ("-Rab4" 1) ("Rab 4" 1) ("RAB4A" 1)))
 ("UP:P20339"
  (("Rab5" 1031) ("Rab5A" 65) ("rab5" 39) ("RAB5" 38) ("RAB5A" 12)
   ("dominant-negative Rab5" 8) ("Rab5Q79L" 4) ("Rab5-" 3) ("most Rab5" 3)
   ("peripheral Rab5" 3) ("Rab 5" 2) ("-Rab5" 2) ("Rab5a" 2)
   ("membrane-associated Rab5" 2) ("the endocytic marker Rab5" 2)
   ("than Rab5A (see xref )" 1) ("Rab5CA" 1) ("the endocytic protein Rab5" 1)
   ("–Rab5" 1)))
 ("UP:P20340" (("Rab6" 103) ("Rab6A" 18) ("rab6" 2) ("RAB6" 1) ("RAB6A" 1)))
 ("UP:P20352" (("CF3" 2)))
 ("UP:P20366"
  (("substance P" 31) ("NKA" 9) ("TAC1" 7) ("Substance P" 5)
   ("TAC1 (tachykinin, precursor 1) protein" 4) ("substance P (SP)" 3)
   ("its preferential ligand substance P (SP)" 2) ("neurokinin A" 1)
   ("Tac1" 1)))
 ("UP:P20371" (("pCAG" 49)))
 ("UP:P20382" (("MCH" 66) ("Nei" 4) ("nei" 2) ("NEI" 1)))
 ("UP:P20393"
  (("preadipocytes" 165) ("NR1D1" 87) ("group D" 55) ("Group D" 34) ("EAR1" 12)
   ("HWP" 12) ("group D ( XPD )" 8) ("Preadipocytes" 7)
   ("preadipocytes (HWP)" 7) ("nuclear receptor subfamily 1" 5)
   ("group D (XPD)" 4)
   ("group
D"
    2)
   ("The omental preadipocytes" 2)
   ("subcutaneous and mesenteric preadipocytes" 2) ("EAR1 protein" 2)
   ("brown preadipocytes" 2) ("DHT-treated omental preadipocytes" 1)
   ("omental preadipocytes" 1) ("the adherent preadipocytes" 1)
   ("human subcutaneous, mesenteric and omental preadipocytes" 1)
   ("murine HIB1B brown preadipocytes" 1)
   ("pioglitazone-treated preadipocytes" 1)
   ("primary human visceral preadipocytes" 1)
   ("Human visceral preadipocytes" 1) ("visceral preadipocytes" 1)
   ("the isolated and expanded human subcutaneous preadipocytes" 1)))
 ("UP:P20396" (("TRH" 7) ("pTRH" 2) ("Thyrotropin releasing hormone" 1)))
 ("UP:P20482"
  (("cap’n’collar" 6) ("cap'n'collar" 4) ("“cap‘n’collar”" 3)
   ("cap‘n’collar" 3) ("cnc" 3) ("Cap’n’collar" 2) ("cap'n’collar" 1)
   ("cap'n'collar (CNC)" 1) ("Cnc" 1)))
 ("UP:P20487" (("CHEF" 8))) ("UP:P20584" (("PaCa" 144)))
 ("UP:P20585"
  (("MSH3" 426) ("hMSH3" 173) ("MRP1" 160) ("Mrp1" 83) ("Msh3" 27) ("mSH3" 13)
   ("DuP" 9) ("MSH3-R796W protein" 3) ("A chimeric hMSH3" 2) ("msh3" 2)
   ("than hMSH3" 2) ("MSh3" 1) ("MSH3-" 1)))
 ("UP:P20591"
  (("MxA" 66) ("MX1" 46) ("P20591" 2) ("MxA protein" 2)
   ("myxovirus resistance protein 1" 1) ("Macromedia FreeHand MXa" 1) ("MXa" 1)
   ("the antiviral protein MxA" 1)))
 ("UP:P20592"
  (("MX2" 24) ("Mx2" 10) ("MXA" 4) ("homolog of murine" 4) ("around MX2" 2)))
 ("UP:P20594"
  (("GCB" 361) ("GCB-" 23) ("NPRB" 4) ("Another notable GCB" 1)
   ("normal GCB" 1) ("only 1/3 GCB" 1)))
 ("UP:P20604" (("SIT4" 13) ("Sit4" 7) ("sit4" 1)))
 ("UP:P20618" (("HC5" 32) ("beta type" 3) ("Psmb1" 2)))
 ("UP:P20645" (("M6PR" 16) ("mannose-6-phosphate receptor" 14)))
 ("UP:P20665" (("PIV" 12) ("piv" 1)))
 ("UP:P20671" (("member G" 8) ("H2A/g" 1) ("member G (ARHG)" 1)))
 ("UP:P20690" (("depactin" 9)))
 ("UP:P20700"
  (("lamin B1" 212) ("lamins" 139) ("lamin" 114) ("Lamin B1" 52) ("Lamin" 22)
   ("Lamins" 9) ("Lmn" 8) ("LMN" 7) ("LMNB1" 6) ("LMNs" 5)
   ("mature lamin B1" 2) ("8D1-positive lamin B1" 2) ("LAMIN" 1)
   ("nuclear envelope–associated lamin B1" 1)
   ("the 8D1-positive mature lamin B1" 1)
   ("total and mature lamin B1 protein" 1) ("lamin B1 protein" 1)
   ("the remaining 8D1-positive lamin B1" 1) ("LMNB" 1)))
 ("UP:P20701"
  (("LFA-1" 449) ("CD11a" 49) ("ITGAL" 22) ("CD11A" 9) ("LFA-1-" 4)
   ("lymphocyte function-associated antigen 1" 2)
   ("Lymphocyte function-associated antigen 1" 1)
   ("quiescent or activated LFA-1" 1) ("symmetric LFA-1" 1)
   ("very weak, and activated LFA-1" 1)))
 ("UP:P20702"
  (("CD11c" 236) ("CD11c-" 6) ("Cd11c" 5) ("ITGAX" 4) ("-CD11c" 2)
   ("CD11C" 1)))
 ("UP:P20711"
  (("DDC" 87) ("ddC" 28) ("DOPA decarboxylase" 6) ("dopa decarboxylase" 5)
   ("-ddC" 3) ("AADC" 2) ("Dopa decarboxylase" 1)))
 ("UP:P20713" (("arylsulfatase" 2))) ("UP:P20718" (("CSPC" 54)))
 ("UP:P20719"
  (("HOXA5" 164) ("HoxA5" 60) ("Hoxa5" 7) ("HoxA5 protein" 2)
   ("HOXA5 protein" 1)))
 ("UP:P20723" (("SED" 13))) ("UP:P20724" (("ALE" 2))) ("UP:P20742" (("PZP" 6)))
 ("UP:P20749"
  (("Bcl-3" 110) ("BCL-3" 101) ("BCL3" 43) ("BCL-3-" 6)
   ("the transcriptional co-activator Bcl-3" 5) ("Bcl3" 5) ("Bcl3 protein" 4)
   ("Bcl-3 protein" 2) ("B-cell CLL/lymphoma 3" 1) ("BCl3" 1) ("bcl3" 1)))
 ("UP:P20760"
  (("IgG2a" 214) ("IgG 2a" 32) ("IgG2a molecule" 3)
   ("Dylight 488-conjugated goat anti-mouse IgG2a" 2)
   ("Alexa Fluor 546-conjugated goat anti-mouse IgG2a" 2)
   ("Monoclonal mouse IgG2a" 1) ("mouse monoclonal IgG2a" 1)))
 ("UP:P20774"
  (("osteoglycin" 13) ("OGN" 2) ("oif" 1) ("Osteoglycin" 1) ("mimecan" 1)))
 ("UP:P20783"
  (("NT-3" 62) ("neurotrophic factor" 57) ("neurotrophin-3" 7)
   ("neurotrophic factor (GDNF)" 6) ("Ntf3" 6)
   ("glial-cell-derived neurotrophic factor (GDNF)" 2) ("neurotrophin 3" 2)
   ("Neurotrophin-3" 2) ("Nerve growth factor 2" 2)
   ("yet another neurotrophic factor" 1)))
 ("UP:P20784" (("rol-6" 10)))
 ("UP:P20794"
  (("MAK" 43) ("male germ cell-associated kinase" 1)
   ("male germ cell associated kinase" 1)))
 ("UP:P20800" (("EDN2" 22) ("ET-2" 1)))
 ("UP:P20807"
  (("Ncl" 6) ("Calpain 3" 5) ("NCL1" 4) ("NCL-1" 4) ("ncl" 3) ("LGMD2A" 3)
   ("calpain 3" 2) ("LGMD2" 1) ("CAPN3" 1) ("NCl" 1) ("Ncl-1" 1)))
 ("UP:P20809"
  (("IL-11" 365) ("IL11" 13) ("interleukin-11" 6) ("interleukin 11" 3)
   ("gastric epithelial cells IL-11" 2) ("Exogenous IL-11" 2)
   ("Interleukin-11" 2) ("Endometrial IL-11" 2)
   ("the osteolytic factor IL-11" 1)))
 ("UP:P20810"
  (("calpastatin" 181) ("calpain inhibitor" 119) ("Calpastatin" 7)
   ("calpastatin peptide" 5) ("Calpain inhibitor" 4) ("calpastatin-" 4)
   ("Calpain Inhibitor" 2) ("a cell-permeable calpain inhibitor" 2)
   ("calpain inhibitor protein" 2) ("a cell permeable calpastatin peptide" 2)
   ("calpastatins" 2) ("a membrane-permeable calpain inhibitor" 2)
   ("a cell permeable calpain inhibitor" 1)
   ("1 uM cell permeable calpastatin peptide" 1) ("synovial calpastatin" 1)
   ("Calpastatin-" 1)))
 ("UP:P20813" (("CYP2B6" 26) ("CYP2B" 4) ("Cyp2B" 2) ("cyp2b" 1)))
 ("UP:P20815" (("CYP3A5" 29)))
 ("UP:P20823"
  (("TCF-1" 165) ("TCF1" 74) ("transcription factor 1" 72) ("Tcf1" 51)
   ("HNF1A" 49) ("Tcf-1" 47) ("transcription factor-1" 33)
   ("hepatocyte nuclear factor" 9) ("HNF1α" 8) ("HNF1" 4) ("HNF-1" 4)
   ("hepatocyte nuclear factor 1" 4) ("TCF-1 protein" 3)
   ("Transcription Factor-1" 3) ("Hnf-1" 2)
   ("The pituitary-specific transcription factor 1" 2)
   ("The ubiquitous octamer transcription factor-1" 2) ("MODY3" 2)
   ("Hepatocyte nuclear factor" 1) ("“HNF1”" 1) ("Transcription factor 1" 1)
   ("TCF-1-" 1)))
 ("UP:P20826" (("steel factor" 11) ("SLF" 1) ("Steel factor" 1)))
 ("UP:P20827"
  (("ephrinA1" 83) ("ephrin-A1" 52) ("EFNA1" 20) ("ephrin A1" 7)
   ("Ephrin-A1" 6) ("EphrinA1" 4) ("soluble ephrinA1" 1) ("Ephrin A1" 1)
   ("a soluble recombinant ephrinA1" 1) ("soluble ephrin-A1" 1)))
 ("UP:P20839" (("IMPDH1" 8)))
 ("UP:P20848"
  (("ARGs" 29) ("SERPINA2" 4) ("SERPINA2 protein" 3) ("the primary ARGs" 2)))
 ("UP:P20849" (("type IX" 5) ("COL9A1" 2) ("Col9a1" 1)))
 ("UP:P20851" (("beta chain" 13) ("C4BPB" 2))) ("UP:P20861" (("FANG" 6)))
 ("UP:P20908" (("COL5A1" 26) ("collagen type V alpha 1" 1)))
 ("UP:P20916"
  (("myelin-associated glycoprotein" 5) ("Myelin-associated glycoprotein" 1)
   ("myelin-associated glycoprotein (MAG)" 1)))
 ("UP:P20929"
  (("NEB" 366) ("pNEB" 5) ("nebulin" 4) ("NEBs" 3)
   ("cyclin B1/B2 double knockdown cells underwent NEB" 1)
   ("cyclin B2 knockdown cells underwent NEB" 1) ("H2B underwent NEB" 1)
   ("either histone H2B or NLS-cyclin B1-CFP underwent NEB" 1) ("Nebulin" 1)))
 ("UP:P20930"
  (("filaggrin" 45) ("Flg" 21) ("Filaggrin" 1)
   ("the late differentiation marker filaggrin" 1)))
 ("UP:P20933"
  (("AGA" 1064) ("-AGA" 34) ("aga" 11) ("A-G-A" 9) ("AGA AGA" 7)
   ("14 children born AGA" 2) ("A–G–A" 1)))
 ("UP:P20936"
  (("GTPase" 2389) ("gap" 1047) ("RASA1" 353) ("p120RasGAP" 293)
   ("GTPase-activating protein" 202) ("GTPase activating protein" 133)
   ("GTPase-activating" 129) ("p120GAP" 122) ("GTPase activating" 93)
   ("Gap" 52) ("GTPase activating protein (GAP)" 35) ("Rasa1" 33)
   ("GTPase-activating protein (GAP)" 29) ("p120 GAP" 17) ("P120RasGAP" 16)
   ("p120 RasGAP" 8) ("GTPase Activating Protein" 6)
   ("RAS p21 protein activator" 4) ("RASA1 protein" 4)
   ("Ras p21 protein activator" 4) ("p120 RasGAP protein" 4) ("‘gap’" 3)
   ("the predominant RAS GTPase activating protein" 3) ("RASA" 3)
   ("p120RasGAP protein" 3) ("Ras GTPase activating protein 1" 2)
   ("recombinative gap" 2) ("RasA" 2) ("The residual gap" 2)
   ("GTPase–activating protein" 2) ("increased endothelial p120RasGAP" 2)
   ("p120 RASGAP" 2) ("“gap”" 2) ("gap (DG)" 2) ("robust gap" 2)
   ("the capillary gap" 1) ("the lateral gap" 1) ("a sandal gap" 1)
   ("GTPase
activating"
    1)
   ("the diagnostic gap" 1) ("directly target RASA1" 1) ("cellular RASA1" 1)
   ("a huge gap" 1) ("GTPAse" 1) ("gap-" 1) ("This major gap" 1) ("rasa1" 1)
   ("an internal gap" 1) ("dominant-negative p120RasGAP" 1) ("p120RasGAP-" 1)
   ("a traditional NER gap" 1) ("a large spectral band gap" 1) ("p120-GAP" 1)))
 ("UP:P20937" (("Ly49" 10) ("Ly49A" 1)))
 ("UP:P20941"
  (("PHD" 369) ("PHDs" 120) ("pDC" 84) ("PDC" 70) ("PhD" 41)
   ("prolyl hydroxylase" 36) ("Prolyl hydroxylase" 2) ("PHD-" 2)
   ("commercially available PDC" 1) ("prolyl hydroxylase (PHD)" 1)
   ("PHD protein" 1)))
 ("UP:P20959"
  (("IGFBP-3" 585) ("exogenous IGFBP-3" 3) ("IGFBP-3 protein" 3) ("-IGFBP-3" 3)
   ("insulin-like growth factor-binding protein 3" 2)
   ("Insulin-like growth factor–binding protein 3" 2)
   ("insulin-like growth factor–binding protein 3" 2)
   ("proapoptotic IGFBP-3" 2) ("The retroviral expression plasmid IGFBP-3" 2)))
 ("UP:P20962" (("PTMS" 2)))
 ("UP:P20963"
  (("CD247" 46) ("CD3ζ" 32) ("CD3Z" 20) ("CD3-zeta" 3) ("CD3 zeta chain" 3)
   ("CD3zeta chain" 2) ("CD3zeta" 1)))
 ("UP:P21108" (("PRPS1L1" 1))) ("UP:P21114" (("AT-I" 3)))
 ("UP:P21127" (("CDC2L1" 10) ("cdk11" 8) ("Cdk11" 1) ("CDK11-p58" 1)))
 ("UP:P21128" (("Pp11" 1))) ("UP:P21141" (("LII" 5)))
 ("UP:P21144"
  (("LMS" 188) ("retroperitoneal LMS" 3) ("non-retroperitoneal LMS" 2)
   ("Only two LMS" 1) ("the retroperitoneal LMS" 1)
   ("well-differentiated LMS" 1) ("Retroperitoneal LMS" 1)))
 ("UP:P21145" (("Mal" 30) ("mal" 16) ("mal-" 1)))
 ("UP:P21169" (("spec" 25) ("SPEC" 24) ("Spec" 24))) ("UP:P21190" (("Ime1" 2)))
 ("UP:P21217"
  (("LE" 209) ("Le" 124) ("FUT3" 17) ("weak membrane FUT3" 4)
   ("fucosyltransferase 3" 3) ("treated LE" 1)
   ("than LE ( p = 0.02, paired t-test)" 1) ("than LE (Fig xref )" 1)
   ("than LE ( p = 0.04, paired t-test)" 1) ("construct Le2" 1)))
 ("UP:P21218" (("PorB" 121) ("porB" 1)))
 ("UP:P21243"
  (("polycomb repressive complex 2" 66) ("Polycomb repressive complex 2" 38)
   ("PRC-2" 2)))
 ("UP:P21246"
  (("PTN" 78) ("HB-GAM" 14) ("pleiotrophin" 7) ("pTN" 6)
   ("pleiotrophin (PTN)" 5) ("Pleiotrophin" 3) ("OSF-1" 2) ("Ptn" 2)
   ("heparin-binding growth-associated molecule" 1)))
 ("UP:P21266" (("GSTM3" 10) ("Gstm3" 4) ("GSTm3" 2) ("GSTM3-" 2) ("GST5" 1)))
 ("UP:P21272" (("SFB" 109) ("pSFB" 5) ("SFB-" 3)))
 ("UP:P21281" (("ATP6V1B2" 5)))
 ("UP:P21300" (("Akr1b7" 6) ("Akr1b7 protein" 1)))
 ("UP:P21332" (("oligo-1,6-glucosidase" 1)))
 ("UP:P21333"
  (("FlnA" 368) ("filamin A" 212) ("filamin" 136) ("FLNa" 136)
   ("Filamin A" 133) ("FLNA" 57) ("filamin A peptide" 9) ("FL-N" 7)
   ("Filamin" 6) ("Fln" 6) ("filaminA" 4) ("FLNa peptide" 3) ("Flna" 2)
   ("filamin
A"
    2)
   ("pFLNA" 2) ("exogenous FlnA" 1)
   ("cardiac mitral valvular dystrophy associated FlnA–G288R" 1)
   ("a dominant-negative filamin A" 1) ("ABP-280" 1)))
 ("UP:P21341" (("pAIB" 2))) ("UP:P21344" (("Sens" 7) ("SENs" 2) ("SENS" 2)))
 ("UP:P21347" (("Pep-1" 4)))
 ("UP:P21359"
  (("NF1" 3913) ("Nf1" 927) ("neurofibromin" 364) ("NFI" 307)
   ("NF1 protein" 129) ("Neurofibromin" 45) ("NF-1" 37) ("neurofibromin 1" 29)
   ("nf1" 27) ("Neurofibromin 1" 15) ("NFI protein" 8) ("NF1-" 6)
   ("classic NF1" 6) ("functional NF1" 6) ("NF1 molecule" 5)
   ("segmental NF1" 4) ("MiR-193b Directly Targets NF1" 4)
   ("functional neurofibromin" 3) ("Nf1-" 2) ("than NF1" 2) ("targeting NF1" 2)
   ("Nf1 protein (neurofibromin)" 1) ("characteristic NF1" 1) ("NF 1" 1)
   ("atypical NF1" 1) ("heterozygous (1N) NF1" 1) ("heterozygous NF1" 1)
   ("experimental NF1" 1) ("at least two other NF1" 1) ("genetic NF1" 1)
   ("more NF1" 1) ("unpredictable NF1" 1) ("ubiquitous NF1" 1)
   ("the previously published NF1" 1) ("than NFI that also participate" 1)
   ("very little NFI protein" 1) ("null NF1" 1) ("pediatric NF1" 1)))
 ("UP:P21397"
  (("MAOA" 78) ("MAO-A" 57) ("monoamine oxidase A" 15) ("Maoa" 2)
   ("MAOA protein" 1)))
 ("UP:P21399"
  (("IRP1" 126) ("IRP-1" 2) ("IRP1 protein" 2)
   ("the bifunctional iron regulatory protein 1" 2)
   ("iron regulatory protein 1" 2)))
 ("UP:P21439" (("MDR3" 8) ("ABCB4" 7) ("MDR2" 5) ("GBD1" 2)))
 ("UP:P21447" (("Abcb1a" 18) ("Mdr1a" 2) ("mdr1a" 2)))
 ("UP:P21452" (("NK-2R" 6) ("TACR2" 2) ("NK2R" 1) ("SKR" 1)))
 ("UP:P21453"
  (("S1P 1" 291) ("S1PR1" 199) ("S1P1" 16) ("S1P receptor 1" 8)
   ("sphingosine-1-phosphate receptor 1" 5) ("EDG-1" 4)
   ("sphingosine-1-phosphate receptor-1" 2) ("S1pr1" 1)
   ("functional S1PR1" 1)))
 ("UP:P21462"
  (("fMLP" 695) ("FPR1" 69) ("FPR" 45) ("fMLP receptor" 31) ("FPRs" 7)
   ("fMLP-" 7) ("the chemotactic factor fMLP" 1) ("more FPR1" 1)
   ("one or more FPRs" 1)))
 ("UP:P21465"
  (("BS3" 58) ("Previously defined E2F1-binding site BS3" 2)
   ("a previously identified E2F1-binding site BS3" 2)))
 ("UP:P21506" (("Kox1" 3))) ("UP:P21519" (("MAM" 47)))
 ("UP:P21542" (("CARE" 22) ("the INSTITUTIONAL ANIMAL CARE" 1)))
 ("UP:P21549"
  (("SPT" 87) ("PH1" 4) ("AGT1" 2) ("pSPT" 2) ("developed SPT" 1)
   ("alanine-glyoxylate aminotransferase" 1) ("entire SPT" 1)
   ("aerodigestive tract SPT" 1) ("the entire SPT" 1)))
 ("UP:P21554"
  (("CB 1" 72) ("CNR1" 59) ("CB1" 44) ("CNR" 42) ("cannabinoid receptor 1" 3)
   ("Cb1" 2) ("Cnr1" 2) ("“CNR”" 1)))
 ("UP:P21578"
  (("YFP" 2343) ("yellow fluorescent protein" 105) ("-YFP" 72) ("EYFP" 37)
   ("YFP-" 25) ("pYFP" 20) ("YFP protein" 17)
   ("yellow fluorescent protein (YFP)" 6) ("YC" 6)
   ("yellow fluorescent protein (EYFP)" 5) ("–yellow fluorescent protein" 3)
   ("YN" 3) ("Yellow Fluorescent Protein" 3) ("-yellow fluorescent protein" 2)
   ("fluorescent protein YFP" 2) ("The triple YFP" 2) ("monoclonal YFP" 2)
   ("Yellow fluorescent protein" 2) ("a functional YFP" 2) ("targeted YFP" 2)
   ("pEYFP" 2) ("yellow fluorescent protein (SYFP)" 1) ("YFP (VN)" 1)
   ("YFP (VC)" 1)
   ("yellow fluorescent
protein"
    1)
   ("CMR1-NTD  (1–17 3) -YFP or CMR1-NLS-WD40  (174–522)  -YFP" 1)
   ("YFP (EYFP)" 1) ("both ARQC(65)-YFP and HttQC(72)-YFP" 1)
   ("Htt exon 1(72)-YFP or HttQC(72)-YFP" 1)
   ("ARN127(65)-YFP or ARQC(65)-YFP" 1)
   ("Htt exon 1(72)-YFP and HttQC(72)-YFP" 1)
   ("Previously described murine YFP" 1) ("a proviral plasmid encoding YFP" 1)
   ("expressed both the YFP" 1) ("a fluorescent YFP" 1) ("pYFP-" 1)
   ("reconstituted fluorescent YFP" 1)))
 ("UP:P21579"
  (("synaptotagmin 1" 12) ("SYT1" 10) ("Syt1" 10) ("synaptotagmin-1" 1)
   ("the fungal specific Sec7-domain protein Syt1" 1)))
 ("UP:P21580"
  (("A20" 1047) ("TNFAIP3" 207) ("Tnfaip3" 19) ("A20 protein" 12) ("a20" 3)
   ("tumor necrosis factor alpha-induced protein 3" 3)
   ("zinc finger protein A20" 3) ("regulated A20" 3) ("expressing A20" 2)
   ("less A20" 1)))
 ("UP:P21583"
  (("stem cell factor" 259) ("KITLG" 167) ("stem cell factor (SCF)" 35)
   ("KIT ligand" 29) ("Stem Cell Factor" 25) ("Stem cell factor" 12)
   ("c-Kit ligand" 10) ("Kit ligand" 9) ("c-kit ligand" 9) ("c-KIT ligand" 9)
   ("Kitlg" 7) ("kit ligand" 6) ("Stem Cell Factor (SCF)" 5) ("SCF family" 3)
   ("an essential stem cell factor" 2) ("exogenous c-Kit ligand" 2)
   ("stem cell factor
(SCF)"
    2)
   ("a bona fide stem cell factor" 1) ("KIT ligand (SCF)" 1)
   ("KITLG ( SCF )" 1) ("KIT ligand ( KITLG )" 1) ("Stem Cell factor" 1)))
 ("UP:P21589"
  (("CD73" 75) ("NT5" 9) ("NT5E" 6)
   ("mesenchymal stem/stromal cell (MSC) marker CD73" 5) ("-CD73" 2)))
 ("UP:P21651" (("Mer2" 1))) ("UP:P21672" (("RNR3" 3)))
 ("UP:P21673"
  (("spermine" 56) ("SSAT" 25) ("ssat" 10) ("Spermine" 6)
   ("exogenous spermine" 2)))
 ("UP:P21675"
  (("TAF1" 31) ("TAFII250" 6) ("TAF-1" 4) ("CCGs" 2)
   ("TATA box binding protein (TBP)-associated factor" 1) ("250KDa" 1)
   ("Taf1" 1)))
 ("UP:P21678" (("cII" 38))) ("UP:P21695" (("GPD1" 3)))
 ("UP:P21709"
  (("Eph" 76) ("ephrin receptor" 18) ("EPH" 17) ("EPHA1" 10) ("EphA1" 7)
   ("Ephrin receptor" 6) ("eph" 4) ("ephA1" 1) ("largest Eph" 1)))
 ("UP:P21711" (("MIX1" 7) ("Mix1" 2)))
 ("UP:P21728"
  (("DRD1" 2) ("dopamine D1 receptor" 2) ("dopamine receptor D1" 1)))
 ("UP:P21730" (("C5aR" 5) ("CD88" 1)))
 ("UP:P21731" (("thromboxane A2 receptor" 1)))
 ("UP:P21741"
  (("MDK" 47) ("Mdk" 38) ("Midkine" 5) ("midkine" 4) ("MK1" 3)
   ("midkine ( MK )" 1) ("ARAP" 1) ("pMDK" 1)))
 ("UP:P21754" (("Zp3" 4) ("ZP3" 3)))
 ("UP:P21757" (("MSR1" 10) ("macrophage scavenger receptor 1" 3) ("SCARA1" 1)))
 ("UP:P21781"
  (("KGF" 612) ("FGF7" 178) ("keratinocyte growth factor" 53) ("FGF-7" 11)
   ("fibroblast growth factor 7" 10) ("Fgf7" 9) ("KGF-" 6)
   ("Keratinocyte growth factor" 5) ("fibroblast growth factor-7" 3)
   ("KGF protein" 3)
   ("fibroblast growth
factor 7"
    2)
   ("exogenous KGF" 2) ("Keratinocyte growth factor (KGF)" 1)
   ("keratinocyte growth factor (KGF)" 1)
   ("the irrelevant control growth factor FGF7" 1)))
 ("UP:P21796"
  (("VDAC" 300) ("VDAC1" 101) ("VDAC protein" 5) ("31HL" 3) ("Vdac1" 2)
   ("Porin 31HL" 2) ("voltage-dependent anion-selective channel protein 1" 2)
   ("hVDAC1" 1) ("Monomeric VDAC" 1) ("P21796" 1)
   ("the mitochondrial resident porin VDAC" 1)))
 ("UP:P21802"
  (("FGFR2" 3553) ("KGFR" 374) ("FGFR-2" 337) ("Fgfr2" 127) ("FGFR2-IIIb" 104)
   ("fibroblast growth factor receptor 2" 102) ("FGFR2-IIIc" 60) ("Bek" 51)
   ("K-sam" 34) ("keratinocyte growth factor receptor" 22) ("fgfr2" 20)
   ("FGFR2 protein" 18) ("KGF-R" 9) ("pFGFR2" 9) ("FGFR2-" 7)
   ("fibroblast growth factor receptor-2" 4) ("KGFR protein" 4) ("BEK" 3)
   ("than Fgfr2" 3) ("epithelial FGFR2-IIIb" 3)
   ("keratinocyte growth factor receptor (KGFR)" 3) ("FGFR2 molecule" 3)
   ("FGFR2−" 3) ("FGFR-2 protein" 2)
   ("fibroblast growth
factor receptor 2"
    2)
   ("p-FGFR2" 2) ("targeting FGFR2" 2) ("a soluble FGFR2" 2)
   ("than FGFR2 S252W" 2) ("consequent KGFR" 2) ("beK" 2)
   ("exogenous FGFR2-IIIb" 1) ("bi-allelic FGFR2 K660N" 1) ("human FGFR2 ’s" 1)
   ("than MEFs expressing FGFR2 S252W" 1) ("KSAM" 1) ("-FGFR2" 1)
   ("than FGFR2 reported here (per allele)" 1) ("than FGFR2 (HR = 1.28)" 1)
   ("than FGFR2" 1) ("fgfr2-" 1) ("overexpressing KGFR" 1) ("FGFR2-IIIC" 1)
   ("both FGFR2’s" 1) ("the pathological KGF receptor KGFR" 1)))
 ("UP:P21810"
  (("biglycan" 28) ("BGN" 18) ("Bgn" 7) ("Biglycan" 4) ("biglycan protein" 1)))
 ("UP:P21813" (("ChEA" 3))) ("UP:P21815" (("IBSP" 9)))
 ("UP:P21817" (("CcO" 7) ("mHS1" 6) ("CCO" 3)))
 ("UP:P21822" (("TSE" 65) ("coronal T2–weighted TSE" 1)))
 ("UP:P21823" (("TAS" 103) ("Tas" 1))) ("UP:P21833" (("EG-1" 1)))
 ("UP:P21834" (("eg2" 1)))
 ("UP:P21837" (("CRYs" 9) ("Crys" 4) ("crys" 3) ("CRYS" 1)))
 ("UP:P21854" (("CD72" 321) ("CD72 protein" 3)))
 ("UP:P21860"
  (("HER3" 2356) ("ErbB3" 1218) ("ERBB3" 657) ("erbB3" 286) ("Her3" 167)
   ("HER-3" 143) ("ErbB-3" 123) ("Erbb3" 93) ("pHER3" 64) ("pErbB3" 41)
   ("erbB-3" 31) ("P-HER3" 27) ("HER3 protein" 12) ("p-Her3" 12) ("p-ERBB3" 9)
   ("HER3-" 7) ("ErbB3 protein" 6) ("ERBB3 protein" 6) ("p-HER3" 6)
   ("erbB3 protein" 5) ("p-erbB3" 4) ("−ErbB3" 4) ("pHER-3" 4) ("P-erbB3" 3)
   ("rabbit monoclonal anti-phospho ErbB3" 2) ("-HER3" 2) ("monomeric HER3" 2)
   ("lapatinib decreased P-HER3" 2) ("overexpressed ErbB3" 2) ("less HER3" 2)
   ("−HER3" 2) ("ERbB3" 2) ("than erbB-3" 1)
   ("exogenous rhEcad/Fc demonstrated enhanced phospho-HER3" 1)
   ("Receptor tyrosine-protein kinase erbB-3" 1) ("functional ERBB3" 1)
   ("particular HER3" 1) ("than ERBB3" 1) ("ErbB3-" 1)
   ("the ectopically overexpressed ErbB3" 1) ("apical ErbB3" 1) ("than HER3" 1)
   ("the p85-associated pHER3" 1) ("\"HER3\"" 1) ("six tyrosines of ErbB3" 1)
   ("than ErbB-3-" 1) ("ErbB-3-" 1)))
 ("UP:P21912"
  (("IP" 4098) ("pGL4" 514) ("IPs" 489) ("iPS" 234) ("SDHB" 50)
   ("sinonasal IPs" 15) ("-pGL4" 9) ("Ip" 7) ("reciprocal IP" 6)
   ("sinonasal IP" 4) ("Reciprocal IP" 4) ("the sinonasal IPs" 3)
   ("a minimal promoter luciferase reporter vector pGL4.23" 2)
   ("the reciprocal IP" 2)
   ("Co-transfected empty Renilla luciferase reporter pGL4" 2)
   ("gynecological IPs" 2) ("PGl4" 2) ("biochemical IP" 2) ("sequential IP" 1)
   ("secondary IP" 1) ("Confirmatory IPs" 1)
   ("multiple recurrence sinonasal IPs" 1) ("both sinonasal IPs" 1)
   ("only 0.02% IP" 1) ("more IPs" 1) ("Sequential IP" 1)
   ("two sequential IPs" 1) ("subsequent IPs" 1)
   ("Germline heterozygous SDHB" 1) ("IP-" 1)
   ("urothelial, and unclassified IPs" 1) ("digestive IPs" 1)
   ("digestive IP" 1) ("the gynecological IPs" 1) ("Our stringent IP" 1)
   ("pGl4" 1) ("Bidirectional IP’s" 1) ("Bidirectional IP" 1)))
 ("UP:P21917" (("DRD4" 109) ("dopamine receptor D4" 6) ("DRD4-" 1)))
 ("UP:P21918"
  (("dopamine" 604) ("Dopamine" 37) ("dopamine-" 4) ("DRD5" 3)
   ("total striatal dopamine" 2) ("peripheral dopamine" 1)
   ("striatal dopamine" 1) ("24-h urinary dopamine" 1)))
 ("UP:P21926"
  (("CD9" 302) ("MIC3" 42) ("MRP-1" 7) ("CD9-" 7) ("CD9 antigen" 3)
   ("doxycycline-treated CD9-" 1) ("concurrent CD9" 1)))
 ("UP:P21941" (("CMP" 45) ("CMP-" 4) ("cartilage matrix protein" 1)))
 ("UP:P21953" (("BCKDHB" 1)))
 ("UP:P21964"
  (("COMT" 552) ("catechol" 37) ("COMT-" 35) ("MB-COMT" 16)
   ("catechol-O-methyltransferase" 11) ("Catechol" 6) ("COMT protein" 5)
   ("catechol-" 3) ("Catechol-O-methyltransferase" 3) ("Catechol-" 2)
   ("underexpressing COMT" 2) ("Catechol O-methyltransferase" 2)
   ("Catechol-O-methyltransferase (COMT)" 1)
   ("the predominant protein being MB-COMT" 1) ("that COMT's" 1)))
 ("UP:P21980"
  (("TGC" 722) ("TGM2" 164) ("TGCs" 117) ("-TGC" 55)
   ("tissue transglutaminase" 28) ("transglutaminase 2" 15)
   ("transglutaminase-2" 10) ("TGM-2" 7) ("TGM2 protein" 5)
   ("Tissue transglutaminase" 4) ("Transglutaminase 2" 3) ("viable TGCs" 2)
   ("Cys-coding TGC" 2) ("parietal TGC" 2) ("transglutaminase-2 protein" 2)
   ("most TGM2" 1) ("membrane-associated TGM2" 1)
   ("Csh1 mRNA-positive parietal TGCs" 1) ("2.3.2.13" 1)))
 ("UP:P22001"
  (("potassium channel" 70) ("Kv1.3" 43) ("potassium channel protein" 5)
   ("KCNA3" 4)
   ("hyperpolarization-activated cyclic nucleotide-gated potassium channel" 4)
   ("Potassium channel" 2)))
 ("UP:P22003" (("BMP5" 77) ("bone morphogenetic protein 5" 2) ("BMP-5" 1)))
 ("UP:P22004"
  (("BMP6" 10) ("Bmp6" 9) ("BMP-6" 9) ("bone morphogenetic protein 6" 3)
   ("BMP 6" 1) ("Bmp6 protein" 1)))
 ("UP:P22033"
  (("mut" 1873) ("MCM" 767) ("MUT" 692) ("Mut" 542) ("-mut" 112) ("p-mut" 101)
   ("MCM protein" 23) ("Mcm" 15) ("mut-" 13) ("Mut protein" 5) ("-Mut" 2)
   ("pMUT" 2) ("-mut3" 2) ("-mut2" 2) ("-mut1" 2) ("insufficient MCM" 2)
   ("efficient MCM" 2) ("Mut-" 2) ("subsequent MCM" 2) ("“Mut6”" 2) ("mcM" 1)
   ("”" 1) ("PMut" 1) ("In contrast TERT p-mut" 1) ("mut—" 1) ("silent mut" 1)
   ("targeting MCM" 1) ("hexametric MCM" 1)
   ("disease-associated Mut #4 C61G" 1) ("UTR mut146" 1)))
 ("UP:P22058" (("d −1" 8) ("d -1" 6) ("D -1" 1) ("d  −1" 1)))
 ("UP:P22059" (("OSBP" 13)))
 ("UP:P22061"
  (("PCMT1" 146) ("protein-L-isoaspartate (D-aspartate) O-methyltransferase" 6)
   ("mouse monoclonal PCMT1" 2)))
 ("UP:P22069" (("onconase" 15) ("Onconase" 1)))
 ("UP:P22079" (("LPO" 16) ("SpO" 11) ("SPO" 8) ("lactoperoxidase" 4)))
 ("UP:P22083"
  (("transfectants" 2576) ("Transfectants" 79) ("SSEA-1" 18)
   ("-transfectants" 10) ("mock or miR-control transfectants" 8) ("Ssea-1" 8)
   ("TRANSFECTANTS" 4)
   ("SIRT5-overexpressing and silenced stable transfectants" 2)
   ("Stable Grm1 -melanocytic transfectants" 2)
   ("Quer-treated transfectants" 2)
   ("previously described stable transfectants" 2)
   ("PC3-2/Mock and PC3-2/β5 transfectants" 2)
   ("PC3-2/Mock (n=195 cells) transfectants" 2) ("PC3-2/Mock transfectants" 2)
   ("expressing MDA-MB-435/mock and MDA-MB-435/β4 transient transfectants" 1)
   ("subsequent transfectants" 1) ("Positive and stable transfectants" 1)
   ("CD99-overexpressing transfectants" 1) ("the ST3 Gal III transfectants" 1)
   ("its RhoC-overexpressing transfectants" 1) ("The latter transfectants" 1)
   ("the resultant stable transfectants" 1)
   ("DKK3‐overexpressing transfectants" 1) ("GFP-positive transfectants" 1)
   ("most sparse transfectants" 1) ("parental and mock transfectants" 1)
   ("only ∼11.8% transfectants" 1) ("The resultant transfectants" 1)
   ("than control transfectants ( xref B)" 1)
   ("these Twist-overexpressing transfectants" 1)
   ("control (GFP) transfectants" 1)
   ("the respective Hyal1 or HAS3 transfectants" 1)
   ("the transfectants, which was consistent with the localization of DNMT1 in the nucleus (Figure xref )"
    1)
   ("RA-treated IRF + transfectants" 1)
   ("DMSO treated control transfectants" 1)
   ("DMSO-treated control transfectants" 1)
   ("its E1A/vector-stable transfectants" 1)
   ("than the wild-type Robo4 transfectants ( xref )" 1)
   ("p53-overexpressing transfectants" 1) ("than their NC transfectants" 1)))
 ("UP:P22087"
  (("fibrillarin" 44) ("Fibrillarin" 17) ("FBL" 9)
   ("the nucleolar marker fibrillarin" 1) ("Fibrillarin (FBL)" 1)))
 ("UP:P22102"
  (("pairs" 845) ("PRGs" 17) ("coexpressed gene pairs" 4) ("AIRS" 4)
   ("coexpressed pairs" 3) ("GART" 3) ("metachronous pairs" 2) ("airs" 2)
   ("the so-called PRGs" 2) ("most pairs" 2)
   ("mouse-human orthologous pairs" 2) ("84,233 orthologous intron pairs" 2)
   ("the discordant L/R pairs" 2) ("the 23 matched evaluable pairs" 2)
   ("several identified synergistic drug pairs" 1)
   ("these two independent isogenic cell line pairs" 1)
   ("heterozygous breeding pairs" 1) ("the isogenic pairs" 1)
   ("25 dizygotic twin (DZs) pairs" 1)
   ("the CML-specific weakly coexpressed gene pairs" 1)
   ("all possible cis methylation and expression pairs" 1)
   ("discordant read pairs" 1) ("334 avuncular pairs" 1)
   ("23,169,177 unique pairs" 1) ("true-positive gene pairs" 1)
   ("mature cell pairs" 1) ("than 10 discordant mate pairs" 1)
   ("10 discordant mate pairs" 1) ("the genome-wide gene pairs" 1)
   ("several other key PRGs" 1) ("the duplicate pairs, a Mendelian error," 1)
   ("two syngeneic pairs" 1) ("duplicate genotypic pairs" 1)
   ("artifactual pairs" 1)
   (">500 unselected colorectal normal-tumor matched pairs" 1)
   ("synchronous colorectal cancer pairs" 1)
   ("the 10 synchronous cancer pairs" 1)
   ("the orthologous mouse-human pairs" 1)
   ("putative miRNA:mRNA functional pairs" 1) ("synergistic TF pairs" 1)
   ("the various homologous and heterologous complementation pairs" 1)
   ("most gene pairs" 1) ("the unique bait–prey protein pairs" 1)
   ("the −A/+T, −C/+G, −G/+C and −T/+A symmetric pairs" 1) ("helical pairs" 1)
   ("AIRs" 1) ("one or more relative pairs" 1)
   ("53 possible microRNA/mRNA pairs" 1) ("primary-recurrent pairs" 1)
   ("divergent gene pairs" 1) ("These divergent gene pairs" 1)
   ("other nearby discordant pairs" 1) ("isogenic pairs" 1)))
 ("UP:P22105" (("TNXB" 3) ("TNX" 1))) ("UP:P22175" (("NCPs" 5)))
 ("UP:P22204" (("Dbf2" 9) ("Dbf-2" 1)))
 ("UP:P22223"
  (("pCAD" 7) ("P-cadherins" 6) ("placental cadherin" 4) ("cadherin 3" 2)))
 ("UP:P22234"
  (("ADE2" 63) ("PAIS" 11) ("Ade2" 7) ("paics" 7) ("PAICS" 7) ("PAIs" 4)
   ("ade2" 3) ("Ade2 protein" 2) ("the nutritional reporter genes ADE2" 1)))
 ("UP:P22266"
  (("esterase" 55) ("esterase (NSE)" 6) ("esterase (MSE)" 3) ("Esterase" 2)
   (">95% positive nonspecific esterase" 2) ("esterase (CAE)" 1)
   ("Esterase (ANAE)" 1) ("-esterase" 1)))
 ("UP:P22301"
  (("IL-10" 2711) ("IL10" 358) ("Il10" 113) ("interleukin-10" 28)
   ("interleukin 10" 20) ("IL10-" 19) ("IL-10–" 10) ("Interleukin 10" 8)
   ("Interleukin-10" 7) ("more IL-10" 6) ("viral IL-10" 4) ("cellular IL-10" 4)
   ("IL-10 protein" 3) ("IL-10-" 3) ("substantially more IL-10" 3)
   ("less IL-10" 2) ("Immunoregulatory cytokine interleukin-10" 2)
   ("exogenous IL10" 2) ("pIL-10" 2) ("IFN-β–treated mDC produced IL-10" 2)
   ("the pleiotropic cytokine IL-10" 2) ("relatively more IL-10" 1)
   ("TT genotype produced less anti-inflammatory cytokine IL-10" 1)
   ("girls produced less IL-10" 1) ("Il-10" 1)
   ("significantly ( p < 0.001) less IL-10" 1)
   ("IFN-β produced significantly less ( p < 0.001) IL-10" 1)
   ("an anti–IFN-β Ab produced significantly ( p < 0.01) less IL-10" 1)
   ("elevated spontaneous IL-10" 1) ("the immunosuppressive IL-10" 1)
   ("SLE patients produced less IL-10" 1)))
 ("UP:P22303"
  (("AChE" 144) ("acetylcholinesterase" 18) ("AchE" 5)
   ("acetyl-cholinesterase" 2)))
 ("UP:P22304"
  (("IDs" 442) ("IDSs" 44) ("IDS" 35) ("Ids" 28) ("ids" 4) ("pIDS" 3)
   ("an entire self-reliant IDS" 2) ("unique Refseq IDs" 2)
   ("14,622 unique rat RefSeq DNA IDs" 2) ("only one IDS" 1)
   ("the distinct IDSs" 1) ("334 unique tumor sample IDs" 1)
   ("13,262 unique Entrez gene IDs" 1) ("15,714 unique Entrez gene IDs" 1)
   ("165 unique human entrez gene IDs" 1) ("151 unique Entrez Gene IDs" 1)
   ("5,022 unique protein IDs" 1)))
 ("UP:P22307" (("SCP2" 64)))
 ("UP:P22309"
  (("UGT1A1" 140) ("UGT1A" 43) ("UGT1A1-" 1) ("than the UGT1A1" 1)
   ("the homozygous variant genotype UGT1A1" 1)))
 ("UP:P22314"
  (("UBA" 128) ("UBE1" 47) ("Uba1" 44) ("-Uba1" 18)
   ("ubiquitin activating enzyme E1" 16) ("Ube1" 9) ("-UBE1" 6) ("UbA" 2)
   ("ube1" 2) ("UbE1" 2) ("Uba" 1)))
 ("UP:P22324" (("APF" 46) ("apf" 1)))
 ("UP:P22330"
  (("GF" 284) ("GF−" 7) ("P-GF" 5) ("gf" 5) ("GF (Sef) protein" 2)))
 ("UP:P22336" (("Rfa1" 8)))
 ("UP:P22352" (("GPX3" 11) ("glutathione peroxidase 3" 10) ("Gpx3" 7)))
 ("UP:P22362" (("I-309" 19) ("CCL1" 8) ("TCA3" 8) ("Ccl1" 3)))
 ("UP:P22389" (("VIc" 2)))
 ("UP:P22392"
  (("NM" 1729) ("NME2" 89) ("NME/NM23 nucleoside diphosphate kinase 2" 5)
   ("NM23-H2" 5) ("NDPK-B" 4) ("pNM" 4) ("NM23B" 2) ("NME2-" 1) ("“NM”" 1)
   ("nucleoside diphosphate kinase B" 1)))
 ("UP:P22401" (("ORF66" 9)))
 ("UP:P22413" (("PrLZ" 115) ("PC-1" 75) ("ENPP1" 20)))
 ("UP:P22415"
  (("USF-1" 416) ("USF1" 221) ("Usf1" 67) ("USF1 protein" 4)
   ("USF-1 peptide" 4) ("than WT USF-1" 2) ("DSP showed identical USF-1" 2)
   ("UV-induced DNA damage USF1" 1) ("viable Usf1" 1)
   ("the ubiquitous stress sensor USF1" 1) ("Upstream stimulatory factor-1" 1)
   ("than WT USF-1 ( xref , lane 7)" 1) ("bacterially expressed USF-1" 1)
   ("expressed USF-1" 1) ("FCHL" 1) ("pUSF-1" 1)))
 ("UP:P22426" (("CbI" 2))) ("UP:P22434" (("PDE1" 7)))
 ("UP:P22455"
  (("FGFR4" 1669) ("FGFR-4" 110) ("fibroblast growth factor receptor 4" 33)
   ("Fgfr4" 21) ("FGFR4 protein" 15) ("Src/Shc" 5) ("fgfr4" 3) ("FGFR4-" 2)
   ("Plasmids encoding human prototypic FGFR4" 2) ("Prototypic FGFR4" 2)
   ("Quantitative FGFR4" 2) ("fgfr4 protein" 2) ("dominant-negative Fgfr4" 1)
   ("shorter FGFR4" 1) ("the dominant FGFR4" 1)
   ("than FGFR4 in presence of KLB" 1) ("further supports FGFR4" 1)
   ("successful FGFR4" 1) ("than FGFR4 [ xref ]" 1)))
 ("UP:P22459" (("KCNA4" 9) ("Kv1.4" 1)))
 ("UP:P22460" (("KCNA5" 13) ("Kv1.5" 6) ("KCNA5 protein" 1)))
 ("UP:P22466"
  (("GAL" 68) ("galanin" 55) ("GalN" 48) ("-GalN" 25) ("pGAL" 6) ("Galanin" 4)
   ("GMAP" 2) ("GAL-" 1)))
 ("UP:P22468" (("GDL" 2))) ("UP:P22488" (("IFs" 76) ("ifS" 1)))
 ("UP:P22492" (("H1t" 4))) ("UP:P22510" (("HS3" 12) ("-HS3" 1)))
 ("UP:P22528" (("SPRR1B" 1)))
 ("UP:P22544" (("BH1" 298) ("BH1-" 6) ("the divergent BH1" 1)))
 ("UP:P22557"
  (("synthase 2" 66) ("ASB" 19) ("ASB protein" 4)
   ("the homologous Acetyl-CoA Synthase 2" 3) ("Synthase 2" 2)
   ("amniotic prostaglandin-endoperoxidase synthase 2" 2)
   ("synthase 2 (CAD)" 1) ("ALAS2" 1)))
 ("UP:P22570"
  (("FDXR" 8) ("ferredoxin reductase" 6)
   ("a bacterial oxygenase-coupled nicotinamide adenine dinucleotide (NADH)-dependent ferredoxin reductase"
    3)))
 ("UP:P22607"
  (("FGFR3" 3912) ("ACH" 150) ("ACh" 146) ("Ach" 128) ("AcH" 118)
   ("fibroblast growth factor receptor 3" 66) ("Fgfr3" 64) ("FGFR3 protein" 28)
   ("acH" 16) ("FGFR-3" 15) ("mature FGFR3" 11) ("FgfR3" 6)
   ("overexpressed FGFR3" 4) ("-FGFR3" 4) ("the mature FGFR3" 3)
   ("than FGFR3" 3) ("than ACH" 3) ("FGFR3 peptide" 2)
   ("estrogen increased newly synthesized ACh" 2) ("intense FGFR3" 2)
   ("\"FGFR3\"" 2) ("targeting oncogenic FGFR3" 2)
   ("the fully glycosylated mature 130 kDa FGFR3" 2)
   ("non-point-mutated FGFR3" 2) ("ACh molecule" 2) ("more FGFR3" 1)
   ("FGFR  3" 1) ("fibroblast growth factor receptor-3" 1)
   ("the HTLV-1 proviral clone ACH" 1) ("transmembrane FGFR3" 1)
   ("the homologous FGFR3" 1) ("Heterozygous ACH" 1)
   ("dominant-negative FGFR3" 1) ("overexpressing FGFR3" 1) ("fgfr3" 1)
   ("the 120 kDa immature FGFR3" 1) ("monomeric and cross-linked FGFR3" 1)
   ("the mature 130 kDa FGFR3" 1) ("than wt FGFR3" 1) ("ACH-" 1)
   ("The autonomic nervous system releases ACh" 1) ("FGFR3-" 1)
   ("both normal FGFR3" 1) ("non-neuronal ACh" 1) ("than wild-type FGFR3" 1)
   ("monomeric and cross-linked mutant FGFR3" 1) ("the immature FGFR3" 1)
   ("than Ach" 1) ("than FGFR3 (49.2%)" 1)))
 ("UP:P22612"
  (("cAMP-dependent" 126) ("cAMP dependent" 7) ("PRKACG" 4)
   ("Camp-dependent" 1)))
 ("UP:P22618"
  (("IGF" 1071) ("insulin-like growth factor" 358) ("IGFs" 222)
   ("insulin-like growth factor-1" 163) ("Insulin-like growth factor" 38)
   ("Insulin-like growth factor-1" 20) ("insulin like growth factor-1" 17)
   ("IGF-" 13) ("insulin-like growth factor (IGF)" 7)
   ("insulin-like  growth factor-1" 2) ("insulin-like growth factor-1 (IGF)" 1)
   ("insulin-like-growth factor" 1) ("Igf" 1)
   ("insulin–like growth factor" 1)))
 ("UP:P22625" (("TUC" 1)))
 ("UP:P22626"
  (("hnRNPA2" 169) ("HNRNPA2B1" 29) ("hnRNPA2 protein" 27) ("2/B1" 9)
   ("hnRNPA2B1" 3) ("hnRNPB1" 3)
   ("Heterogeneous nuclear ribonucleoproteins A2/B1" 2)
   ("heterogeneous nuclear ribonucleoprotein A2/B1" 2) ("HNRNPa2B1" 2)))
 ("UP:P22629"
  (("streptavidin" 1724) ("Streptavidin" 287) ("BD" 52) ("streptavidin-" 5)
   ("streptavidin (DAKO)" 4) ("StreptAvidin" 3)
   ("carbocyanin 2-conjugated streptavidin" 3)
   ("fluorescent dye-conjugated streptavidin" 2)
   ("fluorescent conjugated streptavidin" 2)
   ("Alexa Fluor 647-conjugated streptavidin" 2)
   ("Alexa Fluor 594-conjugated streptavidin" 2)
   ("4°C. Magnetic Dynabeads M-280 Streptavidin" 2) ("streptavidin protein" 2)
   ("Alexa 488-conjugated streptavidin" 2)
   ("Cy3 equivalent dye-conjugated streptavidin" 2)
   ("the surface adhered streptavidin" 1)
   ("AlexaFluor 488-conjugated streptavidin" 1)
   ("commercially available streptavidin" 1) ("the classical streptavidin" 1)
   ("streptavidin (SA)" 1) ("Cy3- or Alexa 647-conjugated streptavidin" 1)
   ("the 605 nm quantum dot-conjugated streptavidin" 1)
   ("quantum dot-conjugated streptavidin" 1)
   ("A quantum dot-conjugated streptavidin" 1) ("fluorescent streptavidin" 1)
   ("streptavidin (BD)" 1) ("Alexa Fluor® Fluorescent Streptavidin" 1)))
 ("UP:P22637"
  (("cholesterol oxidase" 6) ("Cholesterol oxidase" 2) ("CHO-B" 1) ("CHOD" 1)))
 ("UP:P22669" (("cellulase" 2)))
 ("UP:P22670" (("RFX1" 9) ("Rfx1" 5) ("EFC" 1)))
 ("UP:P22676" (("calretinin" 25) ("Calretinin" 18)))
 ("UP:P22680"
  (("CYP7A1" 140) ("Cyp7a1" 3) ("CYP7" 3) ("family 7" 3) ("Cyp7A1" 3)
   ("CYP7A1 protein" 2) ("cholesterol 7-alpha-hydroxylase" 1) ("cyp7a1" 1)))
 ("UP:P22681"
  (("c-Cbl" 2941) ("CBL" 782) ("c-CBL" 251) ("pCBL" 37) ("c-cbl" 30)
   ("Casitas B-lineage lymphoma" 25) ("c-Cbl protein" 17) ("c-CBL protein" 12)
   ("cCbl" 10) ("C-Cbl" 5) ("p-c-Cbl" 4) ("E3 ubiquitin-protein ligase CBL" 4)
   ("Cbl2" 3) ("c-Cbl peptide" 3) ("CBL protein" 3)
   ("Casitas B-lineage Lymphoma" 3) ("overexpressed wild-type c-Cbl" 3)
   ("overexpressed HA-tagged c-Cbl" 3)
   ("this parental plasmid pAlterMax-c- CBL" 3) ("-c-Cbl" 2)
   ("c-Cbl molecule" 2) ("-CBL" 2) ("overexpressed c-Cbl" 2) ("RNF55" 2)
   ("the endocytic adaptors c-Cbl" 1)
   ("the activated endocytic effectors c-Cbl" 1) ("cardiac c-Cbl" 1)
   ("CD38-driven c-Cbl" 1)
   ("the PP2-upregualted CD38-associated proteins c-Cbl" 1)
   ("near-to perfect EGFR homeostasis c-Cbl" 1) ("c-Cbl–" 1)
   ("a nonfunctional c-Cbl" 1) ("at least some c-Cbl" 1) ("particular c-Cbl" 1)
   ("the CBL’s" 1) ("c–Cbl" 1) ("C-CBL" 1)))
 ("UP:P22692"
  (("IGFBP4" 41) ("IGFBP-4" 7) ("Igfbp4" 3)
   ("insulin-like growth factor-binding protein 4" 1)
   ("insulin-like growth factor binding protein 4" 1)))
 ("UP:P22694" (("PRKACB" 6))) ("UP:P22695" (("UQCRC2" 3)))
 ("UP:P22696" (("ESS1" 8) ("Ess1" 2)))
 ("UP:P22711" (("tin" 7) ("TIN" 5) ("Tin" 4) ("tinman" 1)))
 ("UP:P22728" (("visinin" 4)))
 ("UP:P22732"
  (("GLUT5" 8) ("SLC2A5" 2) ("fructose transporter" 2) ("Glut5" 1)
   ("GluT5" 1)))
 ("UP:P22735" (("transglutaminase 1" 10) ("TGM1" 7) ("TgK" 2) ("Tgm1" 1)))
 ("UP:P22736"
  (("Nur77" 453) ("NR4A1" 37) ("HMR" 34) ("Nur77 protein" 10)
   ("orphan nuclear receptor TR3" 5) ("NGFI-B" 4) ("NuR77" 4) ("NUR77" 3)
   ("NAK1" 3) ("Nur77-" 2) ("Nr4a1" 2) ("NAK1-" 2) ("nur77" 1)))
 ("UP:P22748"
  (("CA-4" 129) ("CA4" 13) ("colchicine, CA-4 and iso -amino CA-4" 2)))
 ("UP:P22749" (("granulysin" 1) ("Lag2" 1) ("GNLY" 1)))
 ("UP:P22753"
  (("SIN" 63) ("sin" 41) ("Sin" 26) ("siN" 6) ("-sin" 2) ("−sin" 1)))
 ("UP:P22810" (("orthodenticle" 2))) ("UP:P22816" (("pMyD" 5) ("MyD" 1)))
 ("UP:P22830"
  (("FECH" 27) ("Ferrochelatase" 4) ("ferrochelatase" 3)
   ("erythropoietic protoporphyria (EPP)" 2) ("protoporphyria" 2)
   ("ferrochelatase ( FECH )" 1) ("erthropoietic protoporphyria" 1)))
 ("UP:P22888"
  (("luteinizing hormone receptor" 14) ("LHCGR" 14) ("Lhcgr" 3)
   ("luteinizing hormone receptor (LHR)" 3)
   ("Luteinizing hormone receptor" 1)))
 ("UP:P22894"
  (("HNC" 404) ("MMP8" 138) ("MMP-8" 75) ("Clg1" 10) ("HNCs" 4) ("Mmp8" 3)
   ("neutrophil collagenase" 2) ("the so-called neutrophil collagenase" 2)
   ("cetuximab treated HNC" 1) ("proMMP8" 1) ("matrix metalloproteinase 8" 1)
   ("lysine and glutamic acid (K87E) in exon 2 of MMP8" 1)
   ("preclinical HNC" 1)))
 ("UP:P22897"
  (("MMR" 2190) ("MMR protein" 80) ("CD206" 64) ("Mrc1" 61)
   ("mannose receptor" 24) ("defective MMR" 12) ("MRC1" 8)
   ("at least one MMR protein" 6) ("intact MMR" 5) ("mrc1" 4)
   ("canonical MMR" 2) ("proficient MMR" 2) ("initially intact MMR" 2)
   ("macrophage mannose receptor" 2) ("human mannose receptor" 2)
   ("noncanonical MMR" 2) ("successful MMR" 2)
   ("either canonical or non-canonical MMR" 1) ("normal MMR" 1)
   ("vs proficient MMR" 1) ("Mrc1 protein" 1) ("the relevant MMR protein" 1)
   ("the two respective MMR" 1) ("These chromatin-associated MMR" 1)
   ("chromatin-associated MMR protein" 1) ("post-replicative MMR" 1)
   ("11 (54.5%) mucinous carcinomas showed absent MMR protein" 1) ("MMR+" 1)
   ("a defective MMR" 1) ("mannose receptor (MR)" 1) ("MMR-" 1)))
 ("UP:P22914" (("CRYGS" 1)))
 ("UP:P22922" (("antitrypsin" 25) ("-antitrypsin" 14)))
 ("UP:P22936" (("Apn1" 2) ("APN1" 1)))
 ("UP:P22981" (("LET-60" 27) ("LET-60 protein" 3) ("LET-60 (RAS)" 2)))
 ("UP:P23019" (("HbA" 151) ("Maternal HbA" 2) ("hBA" 1)))
 ("UP:P23023" (("DSX" 17))) ("UP:P23024" (("TCPA" 3)))
 ("UP:P23025"
  (("XPA" 1090) ("XPA protein" 28) ("XP-A" 16) ("the UV-induced XPA" 12)
   ("UV-induced XPA" 6) ("Xeroderma pigmentosum group A" 5) ("Xpa" 3)
   ("overexpressed mutated XPA" 3) ("dimeric XPA" 2) ("than XPA" 2)
   ("UV-damage induced XPA" 2)
   ("Xeroderma pigmentosum group A protein (XPA)" 2) ("more XPA" 2)
   ("available nuclear XPA" 1) ("associated cellular XPA" 1)
   ("two last amino acids of the XPA" 1) ("“XPA\"" 1) ("XPA-" 1)
   ("We first co-expressed XPA" 1)))
 ("UP:P23050" (("v-fos" 3) ("v-Fos" 1) ("v-FOS" 1)))
 ("UP:P23058" (("SLP" 20) ("an adjacent SLP" 2)))
 ("UP:P23107" (("Hph" 14) ("HPH" 4) ("HPh" 3) ("hph" 1)))
 ("UP:P23109" (("AMPD1" 1)))
 ("UP:P23141"
  (("REH" 36) ("TGH" 9) ("CE1" 8) ("ACAT" 7)
   ("The third E/R -positive leukemic cell line REH" 1)))
 ("UP:P23142"
  (("fibulin-1" 10) ("FBLN1" 9) ("fibulin 1" 5) ("Fbln1" 4) ("Fibulin-1" 1)))
 ("UP:P23193"
  (("TFs" 1781) ("TCEA1" 8) ("key TFs" 5) ("TFS" 5) ("the key TFs" 4)
   ("basic domain TFs" 3) ("TFIIS" 3)
   ("transcription elongation factor A (SII) TCEA1" 3)
   ("known and novel TFs" 3) ("breast cancer groups together many TFs" 2)
   ("5 key TFs" 2) ("genes share more TFs" 2) ("these associated TFs" 2)
   ("known cell-cycle-related TFs" 2) ("just 15 TFs" 2) ("the major TFs" 2)
   ("targeted TFs" 2) ("potential TFs" 2) ("one or more down-stream TFs" 2)
   ("the former three TFs" 2) ("new TFs" 2) ("the two most prominent TFs" 1)
   ("primary TFs" 1) ("streptavidin-S-FLAG (SFB) triple-tagged TFs" 1)
   ("Most TFs" 1) ("several lipogenic TFs" 1) ("the few TFs" 1)
   ("247 sequence-specific TFs" 1) ("causal TFs" 1)
   ("at least 2 different TFs" 1) ("regulatory TFs" 1) ("2 or more TFs" 1)
   ("known pancreatic regulatory TFs" 1)
   ("previously unrecognized pancreatic regulatory TFs" 1)
   ("the respective driving
TFs"
    1)
   ("driving
TFs"
    1)
   ("contained approximately six TFs" 1) ("two or more TFs" 1)
   ("Synergistic TFs" 1) ("key SRC-associated TFs" 1) ("possibly other TFs" 1)
   ("The immediate-early TFs" 1)
   ("some previously described BRCA1 interacting/recruiting TFs" 1)
   ("sequence-specific DNA binding TFs" 1) ("one or more other TFs" 1)
   ("these latter three TFs" 1) ("most TFs" 1) ("still other TFs" 1)
   ("exogenous TFs" 1) ("than individual TFs" 1) ("crucial TFs" 1)))
 ("UP:P23207" (("pOAD" 5))) ("UP:P23214" (("OAC" 51) ("OAc" 20) ("Oac" 5)))
 ("UP:P23219"
  (("COX-1" 756) ("PTGS1" 129) ("PGHS-1" 64) ("cyclooxygenase-1" 25)
   ("Cyclooxygenase-1" 19) ("COX-1 protein" 13) ("COX 1" 5)
   ("prostaglandin-endoperoxide synthase 1" 4) ("Ptgs1" 3) ("than COX-1" 3)
   ("functional COX-1" 2) ("Cyclooxygenase 1" 2)
   ("Prostaglandin-endoperoxide synthase 1" 2) ("COX-1-" 2)
   ("predominantly COX-1 protein" 1) ("“COX-1”" 1)
   ("prostaglandin-endoperoxide synthase-1" 1)
   ("the placental tissue sections COX-1 protein" 1) ("functional PTGS1" 1)
   ("more or less inhibited COX-1" 1) ("cyclooxygenase 1" 1)))
 ("UP:P23229" (("CD49f" 282) ("ITGA6" 77) ("CD49f-" 1) ("ITGA6B" 1)))
 ("UP:P23246"
  (("PSF" 52) ("SFPQ" 28) ("pSF" 2) ("SFPQ (PSF)" 2) ("a theoretical PSF" 1)))
 ("UP:P23258" (("TUBG1" 57) ("tubg1" 1)))
 ("UP:P23280" (("carbonic anhydrase VI" 2) ("carbonic anhydrase 6" 1)))
 ("UP:P23284"
  (("PPIB" 28) ("cyclophilin B" 22) ("Cyclophilin B" 8) ("CyPB" 4) ("Cyps" 2)))
 ("UP:P23287" (("CMP1" 1))) ("UP:P23295" (("NORs" 17) ("mitotic NORs" 9)))
 ("UP:P23297"
  (("S100" 398) ("S100A" 20) ("S100 protein" 7) ("S100A1" 3) ("-S100A" 2)
   ("s100" 2) ("S100a protein" 2) ("S100a1" 1) ("S100a" 1) ("S100 (DAKO)" 1)
   ("−S100" 1) ("-S100" 1)))
 ("UP:P23315" (("TrpE" 8) ("trpE" 1))) ("UP:P23321" (("MSP1" 11)))
 ("UP:P23327" (("HRC" 15) ("HRc" 4)))
 ("UP:P23341"
  (("Apt" 31) ("apt" 25) ("APT" 12) ("most apt" 1) ("ApT" 1) ("more apt" 1)
   ("less apt" 1)))
 ("UP:P23352" (("KAL1" 81) ("KAL" 8) ("anosmin-1" 6) ("Anosmin-1" 4)))
 ("UP:P23360" (("TAXI" 1))) ("UP:P23367" (("MutL" 53) ("mutL" 12)))
 ("UP:P23368"
  (("me2" 278) ("ME2" 222) ("ABTS" 45) ("Me2" 12) ("overexpressed ME2" 4)
   ("malic enzyme 2" 4) ("mE2" 2) ("much less ME2" 1) ("ME2 protein" 1)))
 ("UP:P23378" (("GLDC" 1)))
 ("UP:P23396"
  (("RPS3" 506) ("ribosomal protein S3" 20) ("rpS3" 9) ("RPS3 protein" 8)
   ("RpS3" 2) ("these conditions given modest residual phosphorylated RPS3" 2)
   ("the multifunctional roles RPS3" 1) ("cellular RPS3" 1)))
 ("UP:P23409" (("MRF4" 8))) ("UP:P23434" (("GCSh" 14) ("GCSH" 1)))
 ("UP:P23435" (("Cbln1" 9) ("cerebellin" 4) ("Cerebellin 1 precursor" 1)))
 ("UP:P23440" (("MPB" 15)))
 ("UP:P23443"
  (("S6K1" 2557) ("p70S6K" 1664) ("p70S6K1" 318) ("RPS6KB1" 241) ("p70s6k" 240)
   ("p-p70S6K" 203) ("P70S6K" 201) ("p70S6" 165) ("p70 S6K1" 61) ("p-S6K1" 61)
   ("p-P70S6K" 56) ("P-S6K" 44) ("S6Ks" 41) ("-p70S6K" 39) ("p-S6K" 37)
   ("pS6K1" 35) ("p-p70s6k" 33) ("p70S6k" 32) ("70-kD" 30) ("p-p70S6K1" 24)
   ("pp70S6K" 21) ("P70S6K1" 20) ("pP70S6K" 17) ("P-S6K1" 13) ("p-p70S6" 11)
   ("S6k1" 10) ("P70S6" 10) ("P-p70S6K" 7) ("p70S6K protein" 7) ("p-p70S6k" 6)
   ("S6KS" 5) ("Rps6kb1" 4) ("-S6K1" 4) ("p-p70S6K protein" 4) ("P70s6k" 4)
   ("S6K1 protein" 4) ("-P70S6K" 4) ("than S6K1" 3)
   ("rabbit monoclonal anti-phospho S6K1" 3) ("S6K1-" 2)
   ("phospho/total- P70S6K" 2)
   ("S6K1(1–421, T412E,
PDK1 activated) protein"
    2)
   ("p70S6K1 protein" 2) ("p70 S6K1 protein" 2) ("exogenous S6K1" 2)
   ("an exogenous S6K1" 2) ("ribosomal protein S6 kinase beta-1" 2)
   ("pp70S6" 1) ("total or phosphorylated p70S6K" 1) ("pp70S6k" 1)
   ("the FL772-bound S6K1" 1) ("pp70s6k" 1) ("more p70s6k" 1) ("70-KD" 1)
   ("hyperactive S6K1" 1) ("than the known substrate p70S6K" 1)
   ("the translational activator S6K1" 1) ("p70S6k1" 1)
   ("the ribosomal kinase p70S6" 1) ("than the wild-type S6K1 ( xref )" 1)
   ("S6K-1" 1) ("a separate S6K1" 1)
   ("than its upstream kinase p70S6K ( xref )" 1) (NIL 1)
   ("P70S6K protein" 1)))
 ("UP:P23458"
  (("JAK1" 1421) ("Jak1" 449) ("pJAK1" 28) ("Jak-1" 21) ("JAK-1" 20)
   ("Janus kinase 1" 14) ("JAK1-" 12) ("JAK1 protein" 10) ("pJak1" 7)
   ("Jak1 protein" 6) ("p-Jak1" 5) ("the exogenous JAK1" 2)
   ("recurrent JAK1" 2) ("tubulointerstitial Jak-1" 2)
   ("the patient-expressed JAK1-V658F" 2) ("expressing JAK1-WT" 2)
   ("Jak1 Protein" 2) ("janus kinase 1" 1) ("classic JAK1" 1)
   ("particular JAK1" 1) ("functional Jak1" 1)
   ("than the patient-derived JAK1-V658F" 1) ("monomeric Jak1" 1)
   ("The IL-6, IL-10, and IL-22 receptors predominantly use JAK1" 1)
   ("p-JAK1" 1) ("healthy PBMC Jak1" 1)))
 ("UP:P23467" (("VE-PTP" 31) ("PTPRB" 27) ("PtpB" 7) ("RPTPβ" 4)))
 ("UP:P23468"
  (("PTPRD" 31) ("RPTPδ" 2) ("PTPRD protein" 2)
   ("Receptor-type tyrosine-protein phosphatase delta" 1)))
 ("UP:P23469" (("PTPRE" 2))) ("UP:P23470" (("PTPRG" 10) ("RPTP gamma" 1)))
 ("UP:P23471" (("PTPRZ1" 105) ("Ptprz1" 56) ("PTPRZ" 9)))
 ("UP:P23490" (("loricrin" 62) ("Lor" 13) ("LOR" 12) ("Loricrin" 5)))
 ("UP:P23497" (("Sp100" 17) ("SP100" 2)))
 ("UP:P23508"
  (("MCC" 1069) ("MCCs" 43) ("MCC peptide" 11) ("Mcc" 10)
   ("mutated in colorectal cancers" 8) ("metastatic MCC" 7)
   ("the concurrent MCC" 2) ("-MCC" 2) ("ependymal MCCs" 2)
   ("the crystallographically-characterized MCC" 1) ("MCC protein" 1)
   ("epidermal MCCs" 1) ("Typical MCC" 1) ("locally treated MCC" 1)
   ("metastasized MCC" 1) ("most MCCs" 1) ("than MCC" 1)
   ("histologically proven MCC" 1) ("continuous MCC" 1) ("much more MCC" 1)))
 ("UP:P23510"
  (("OX40L" 66) ("TNFSF4" 18) ("OX40 ligand" 3) ("OX40L protein" 1)
   ("OX4OL" 1)))
 ("UP:P23511"
  (("NF-YA" 131) ("NFYA" 30) ("nuclear transcription factor Y" 7) ("Nf-ya" 6)))
 ("UP:P23515" (("OMgp" 2) ("OMG" 1) ("oligodendrocyte myelin glycoprotein" 1)))
 ("UP:P23526"
  (("SAH hydrolase" 6) ("SAHH" 5) ("AHCY" 2) ("adenosylhomocysteinase" 1)
   ("S-adenosylhomocysteine hydrolase" 1)))
 ("UP:P23528"
  (("CFL-1" 458) ("CFL1" 391) ("cofilin-1" 247) ("Cofilin-1" 84) ("CFL" 49)
   ("cofilin1" 26) ("phosphorylatable CFL-1" 15) ("cofilin 1" 9)
   ("CFL1 protein" 7) ("p-CFL" 5) ("Cofilin1" 4) ("CFl-1" 3)
   ("over-expressed phosphorylatable CFL-1" 3)
   ("Stealth siRNA duplex targeting cofilin 1" 2) ("p-cofilin-1" 2)
   ("cofilin1-" 2) ("Cfl1" 2) ("CFL-1–" 1) ("cofilin 1 protein" 1)
   ("targeting cofilin 1" 1) ("cofilin-1 protein" 1) ("cfl1" 1) ("p-CFL1" 1)
   ("phosphorylatable wild-type CFL-1" 1) ("pCFL" 1)
   ("serine-3 phosphorylatable wild-type CFL-1" 1)
   ("exogenous wild-type CFL-1" 1)))
 ("UP:P23560"
  (("BDNF" 522) ("brain-derived neurotrophic factor" 58)
   ("brain-derived neurotrophic factor (BDNF)" 17)
   ("brain derived neurotrophic factor" 9)
   ("brain derived neurotrophic factor (BDNF)" 7) ("Bdnf" 7)
   ("Brain-derived neurotrophic factor" 5) ("BDNF protein" 3) ("mature BDNF" 2)
   ("brain-derived neurotrophic
factor (BDNF)"
    2)
   ("Brain derived neurotrophic factor" 1)
   ("brain-derived neurotrophic
factor"
    1)
   ("the neurotrophic factors brain-derived neurotrophic factor (BDNF)" 1)
   ("the neurotrophic factors brain-derived neurotrophic factor" 1)))
 ("UP:P23582" (("C-type natriuretic peptide" 4) ("NPPC" 2)))
 ("UP:P23588"
  (("eukaryotic translation initiation factor 4B" 5) ("EIF4B" 5) ("peIF4B" 2)
   ("eIF4b" 1)))
 ("UP:P23594" (("Pph21" 1) ("pph21" 1))) ("UP:P23645" (("BIB" 10) ("bib" 3)))
 ("UP:P23654" (("NRT" 15) ("Nrt" 5) ("the basolateral marker Nrt" 2)))
 ("UP:P23658" (("ced-1" 12) ("CED-1" 10))) ("UP:P23677" (("ITPKA" 19)))
 ("UP:P23724" (("PTS1" 10)))
 ("UP:P23743" (("DGKα" 184) ("DGKa" 3) ("Dgka" 1) ("DGKA" 1)))
 ("UP:P23748" (("MIH1" 2) ("Mih1" 2)))
 ("UP:P23759" (("PAX7" 41) ("Pax7" 18) ("paired box 7" 2)))
 ("UP:P23760"
  (("PAX3" 785) ("Pax3" 258) ("PAX3 protein" 8) ("paired box 3" 6)
   ("Pax3 protein" 3) ("PAX3-" 2) ("overexpressed PAX3" 2)
   ("PAX3 (GAAACACCGUGCCGUCAGU)" 1) ("PAX 3" 1) ("heterozygous PAX3" 1)
   ("even lower PAX3" 1) ("exogenous PAX3" 1)))
 ("UP:P23761" (("vac" 17) ("Vac" 16) ("VAC" 3)))
 ("UP:P23763" (("VAMP1" 6) ("VAMP-1" 3)))
 ("UP:P23769"
  (("GATA2" 156) ("GATA-2" 52) ("GATA binding protein 2" 6) ("gata2" 5)
   ("Gata2" 4) ("GATA-binding protein 2" 3) ("negligible GATA2" 1)))
 ("UP:P23771"
  (("GATA3" 3522) ("Gata3" 164) ("GATA3 protein" 44)
   ("GATA binding protein 3" 36) ("weak GATA3" 6) ("Weak GATA3" 3)
   ("a representative GATA3" 2) ("normal proliferating keratinocytes GATA3" 2)
   ("231-Empty lacked nuclear GATA3" 2)
   ("the mammary luminal transcription factor GATA3" 2)
   ("weak and focal moderate GATA3" 2) ("p-GATA3" 2) ("stromal GATA3" 2)
   ("an immunocompetent model, and human GATA3" 2)
   ("T helper (Th)-2 lineage-specific transcription factor GATA3" 1)
   ("than the full-length GATA3 in the same cells (Figure  xref C)" 1)
   ("GATA3-" 1) ("12-fold more Gata3" 1) ("a dominant-negative GATA3" 1)
   ("exogenous GATA3" 1) ("-GATA3" 1) ("epidermal GATA3" 1)
   ("epithelial GATA3" 1) ("GATA3 (AAGGATGCCA)" 1)))
 ("UP:P23786" (("Cpt1" 16) ("CPT2" 1))) ("UP:P23789" (("XRE" 16)))
 ("UP:P23799"
  (("TLR" 1215) ("TLR-" 8) ("intracytoplasmic TLR" 1) ("most TLR" 1)))
 ("UP:P23801" (("PE38" 6)))
 ("UP:P23825"
  (("GATA-3" 891) ("GATA-3 protein" 24) ("-GATA-3" 4)
   ("those individuals contained significantly less GATA-3 protein" 1)
   ("the haematopoietic transcription factor GATA-3" 1)
   ("weakly assist GATA-3" 1) ("the transcriptional factor GATA-3" 1)))
 ("UP:P23827" (("ETI" 5)))
 ("UP:P23834"
  (("DH" 639) ("DH−" 1) ("E. coli DH5" 1) ("DH (GEF)" 1) ("DH-" 1)))
 ("UP:P23835" (("TetO" 159) ("tetO" 87))) ("UP:P23848" (("MOR" 23)))
 ("UP:P23872" (("ecE" 10))) ("UP:P23893" (("POPC" 31)))
 ("UP:P23895"
  (("EB" 281) ("EB (TFEB)" 4) ("pEB-" 3) ("approximately 15% EB" 2) ("pEB" 1)))
 ("UP:P23915" (("FLO" 48) ("Flo" 26) ("flo" 1)))
 ("UP:P23919" (("DTYMK" 18) ("DTYMK protein" 1) ("CDC8" 1)))
 ("UP:P23921"
  (("RRM1" 257) ("RRM" 201) ("RR1" 16) ("cladribine" 15) ("RRM1 peptide" 3)
   ("ribonucleotide reductase large subunit" 3) ("74 underwent RRM" 2)
   ("RIR1" 2) ("RR-1" 2) ("underwent RRM" 1)
   ("1, 2, or 3 live births used RRM" 1)
   ("than RRM1 in all experiments ( xref , xref ; xref )" 1)
   ("Ribonucleosidediphosphate reductase large subunit" 1) ("rir1" 1)
   ("Cladribine" 1) ("the entire RRM" 1) ("aberrant RRM1" 1)))
 ("UP:P23925" (("MglB" 2))) ("UP:P23938" (("NGP" 43) ("NG1" 3)))
 ("UP:P23942" (("RDS" 36) ("PRPH" 4)))
 ("UP:P23945"
  (("FSHR" 30) ("FSH receptor" 3) ("Fshr" 3)
   ("follicle stimulating hormone receptor" 2)
   ("the functional FSH receptor" 1)))
 ("UP:P23946"
  (("chymase" 130) ("Chymase" 2) ("CYH" 2)
   ("the pharmaceutically relevant drug target chymase" 1)))
 ("UP:P23975"
  (("Net1" 424) ("noradrenaline" 14) ("norepinephrine transporter" 4)
   ("Net1 protein" 3) ("Net1-" 2) ("norepinephrine transporter (NET)" 1)
   ("total and phosphorylated Net1" 1) ("SLC6A2" 1)
   ("the last 18 amino acids of human Net1 (C-RRARDKALSGGKRKETLV)" 1)
   ("noradrenaline, the non-selective β-adrenoceptor agonist isoprenaline,"
    1)))
 ("UP:P23988" (("PAG-C" 1)))
 ("UP:P24001"
  (("NK4" 158) ("IL-32" 91) ("IL32" 5) ("Nk4" 4) ("Interleukin-32" 2)
   ("interleukin-32" 2) ("HGF-antagonistic NK4" 1)))
 ("UP:P24022" (("LAF" 1))) ("UP:P24043" (("LAMA2" 18)))
 ("UP:P24056" (("SP44" 51))) ("UP:P24067" (("BIP2" 6) ("bip2" 1)))
 ("UP:P24071" (("CD89" 1) ("IgA Fc receptor" 1)))
 ("UP:P24097" (("protein Rev" 6) ("The viral protein Rev" 1)))
 ("UP:P24130" (("FUSE" 13) ("pFUSE" 5))) ("UP:P24146" (("GS4" 8)))
 ("UP:P24158"
  (("ACPA" 164) ("serine proteinase" 37) ("PR3" 27) ("PR-3" 10)
   ("proteinase 3" 5) ("PR-3 protein" 3) ("PRTN3" 2)
   ("The neutrophilic and monocytic proteinase 3" 2)
   ("the neutrophilic enzyme proteinase 3" 2) ("pPR3" 2) ("PR3–" 1)))
 ("UP:P24186"
  (("ADS" 56) ("Ade" 49) ("ADs" 43) ("ade" 39) ("AdE" 12) ("ADE" 9) ("-Ade" 5)
   ("these potent transcriptional ADs" 2) ("pads" 2) ("AdS" 2) ("−Ade" 2)
   ("the left and right mammary fat pads" 1) ("Ade (QDO)" 1) ("–Ade" 1)
   ("-ade" 1)))
 ("UP:P24219" (("sIgL" 11) ("siGL" 1))) ("UP:P24276" (("RLD1" 3)))
 ("UP:P24298" (("gpt" 5))) ("UP:P24310" (("Cox7a1" 3)))
 ("UP:P24347"
  (("ST3" 63) ("MMP-11" 10) ("MMP11" 9) ("stromelysin-3" 3) ("stromelysin 3" 2)
   ("mmp11" 1)))
 ("UP:P24348" (("LET-23" 7))) ("UP:P24384" (("Prp22" 3)))
 ("UP:P24385"
  (("cyclin D1" 11268) ("CCND1" 2853) ("cyclin D1b" 515) ("CyclinD1" 430)
   ("cyclinD1" 272) ("cyclin D 1" 250) ("Ccnd1" 205) ("cyclin D1 protein" 117)
   ("CCND1 protein" 34) ("CYCLIN-D1" 27) ("-CCND1" 26) ("Cyclin-D1" 25)
   ("CYCLIN D1" 22) ("CCND1-" 21) ("cyclin D 1 protein" 15)
   ("targeting cyclin D1" 14) ("cyclin D1b protein" 11) ("CyclinD1 protein" 10)
   ("overexpressed cyclin D1" 10) ("cyclin D1" 8) ("cyclin D1b" 7)
   ("CCND1 peptide" 6) ("Overexpressed cyclin D1" 4) ("cyclin D1 molecule" 4)
   ("than CCND1" 4) ("BCL1" 3) ("“CCND1”" 3) ("“cyclin D1”" 3)
   ("targeting cyclinD1" 3) ("cyclin D1-" 3) ("CCND1b" 3)
   ("mouse monoclonal anti-human cyclin D1" 3) ("diffuse strong cyclin D1" 3)
   ("PRAD1" 2) ("than cyclin D1" 2) ("-cyclin D1" 2)
   ("targeting human cyclin D1" 2) ("intense nuclear cyclin D1" 2)
   ("targeted cyclin D1" 2) ("cyclin D1 (MBL)" 2)
   ("overexpressed cyclin D 1" 2) ("potentially target CCND1" 2)
   ("cyclin D1-T286R protein" 2) ("CYCLIN-D1 protein" 2)
   ("only focal cyclin D1" 2) ("cyclin D1–" 2) ("ccnd1" 2)
   ("focal (<20%) cyclin D1" 2) ("strong nuclear cyclin D1" 2)
   ("Strong cyclin D1" 2)
   ("all 12 YWHAE-FAM22 ESS demonstrated diffuse (≥70%) moderate-to-strong nuclear cyclin D1"
    2)
   ("–cyclin D1" 1) ("these results not only highlight cyclin D1" 1)
   ("MMTV-driven cyclin D1" 1) ("particular cyclin D1" 1)
   ("merely use CyclinD1" 1) ("miR-21-regulated cyclin D1" 1)
   ("than oncogenic transcript factor CCND1" 1)
   ("The 1–155 amino acids of cyclin D1" 1) ("extranuclear cyclin D1" 1)
   ("less cyclin D1" 1) ("more cyclin D1" 1) ("analysis revealed cyclin D1" 1)
   ("specifically targets human cyclin D1" 1)
   ("cell cycle regulatory cyclin D1" 1) ("expressing cyclin D1b" 1)
   ("shorter isoform cyclin D1b" 1)
   ("than cyclin D1b in tumor tissues ( p  < 0.0001)" 1)
   ("expressing cyclin D1" 1) ("a more intense cytoplasmic cyclin D1" 1)
   ("employed mammary gland targeted cyclin D1" 1) ("exogenous cyclin D1" 1)
   ("phospho-RB (Ser807/811) (Cell Signaling Technology) rabbit antibodies, and anti-human cyclin D1 (MBL)"
    1)
   ("exponentially growing cells (S48) mostly contained cyclin D1" 1)
   ("ectopically-expressed cyclin D1" 1) ("than cyclinD1" 1)
   ("coexpressing cyclin D1" 1) ("tumoral cyclin D1" 1)
   ("miR-503 specifically targets CCND1" 1)
   ("these microRNAs truly target CCND1" 1)
   ("than wild-type cyclin D1 protein under anoikic conditions ( xref , lane 6 versus lane 8; data not shown)"
    1)
   ("than wild-type cyclin D1 under anchorage-independent conditions" 1)
   ("the resultant cyclin D1b protein" 1) ("than wild-type cyclin D1" 1)
   ("CCND1 (HPAC)" 1) ("driven cyclin D1" 1) ("fewer CCND1" 1)
   ("Spectrum Orange-labeled CCND1" 1) ("Cyclind1" 1)
   ("flag-tagged cyclin D1" 1) ("an intensive cyclin D1" 1) ("BCL-1" 1)
   ("than cyclin D1( CCND1 )" 1) ("overexpressing cyclin D1" 1)
   ("specifically targets CCND1" 1) ("CyclinD1-" 1) ("exogenous cyclin D1b" 1)
   ("than cyclin D1 [ xref ]" 1) ("than cyclin D1b" 1) ("major cyclin D1" 1)
   ("phospho-cyclin D1 protein" 1) ("cyclin D1−" 1) ("about possible CCND1" 1)
   ("available cyclin D1" 1) ("exogenous wild type cyclin D1" 1)
   ("targeting CyclinD1" 1) ("a spatially heterogeneous cyclin D1" 1)
   ("further validated cyclin D1" 1) ("Spry1 increased cyclin D1 protein" 1)))
 ("UP:P24386" (("TCD" 65) ("CHM" 30) ("normal and high TCD" 2)))
 ("UP:P24387" (("CRHBP" 5)))
 ("UP:P24390" (("KDELR1" 2) ("KDEL receptor 1" 1) ("kdelr1" 1)))
 ("UP:P24394"
  (("IL-4R" 50) ("IL4R" 20) ("Il4ra" 4) ("CD124" 4) ("IL4RA" 3)
   ("Interleukin 4 receptor" 1)))
 ("UP:P24434" (("1-l" 4) ("u54" 1))) ("UP:P24435" (("2-l" 3)))
 ("UP:P24446" (("U69" 1))) ("UP:P24462" (("CYP3A7" 9)))
 ("UP:P24468" (("COUP-TFII" 127) ("NR2F2" 33) ("Nr2f2" 7)))
 ("UP:P24492" (("Diptericin" 6) ("diptericin" 6)))
 ("UP:P24522"
  (("GADD45A" 142) ("Gadd45" 126) ("Gadd45a" 96) ("GADD45a" 26)
   ("growth arrest and DNA-damage-inducible" 9) ("gadd45a" 8) ("gadd45" 7)
   ("Growth arrest and DNA-damage-inducible" 3) ("GADD45 family" 2)
   ("Gadd45a protein" 1)))
 ("UP:P24530"
  (("EDNRB" 84) ("EtBr" 72) ("Et-Br" 6) ("EdnrB" 3) ("endothelin B receptor" 2)
   ("Ednrb" 2) ("membrane impermeable EtBr" 1)))
 ("UP:P24534" (("EEF1B2" 1) ("eEF1b" 1) ("eEF1B" 1)))
 ("UP:P24539" (("mitochondrial F0 complex" 1))) ("UP:P24549" (("AHD2" 4)))
 ("UP:P24557" (("TBXAS1" 46) ("TXAS" 10) ("TXS" 4) ("Cyp5A1" 1) ("TXs" 1)))
 ("UP:P24583" (("PKC1" 3))) ("UP:P24588" (("AKAP79" 4)))
 ("UP:P24592" (("IGFBP6" 9) ("Igfbp6" 1)))
 ("UP:P24593"
  (("IGFBP-5" 58) ("IGFBP5" 52)
   ("insulin-like growth factor-binding protein-5" 4) ("igfbp-5" 3)
   ("Insulin-like growth factor-binding protein-5" 1)
   ("insulin-like growth factor–binding protein-5" 1)))
 ("UP:P24618" (("GRM" 3) ("grm" 2))) ("UP:P24643" (("pp90" 11)))
 ("UP:P24653" (("ORF3" 9) ("ORF3 protein" 4)))
 ("UP:P24666"
  (("LMW-PTP" 120) ("ACP1" 30) ("overexpressed LMW-PTP" 4) ("”" 1)
   ("LMWPTP" 1)))
 ("UP:P24694"
  (("hpf" 197) ("HPF" 119) ("HPFs" 56) ("than 5/50 HPF" 1)
   ("than 10/50 HPF (n = 36)" 1) ("either mitotic rate >5/10 HPFs" 1)))
 ("UP:P24723" (("PRKCH" 34) ("PKC-η" 7) ("protein kinase C eta" 1)))
 ("UP:P24752" (("ACAT1" 6)))
 ("UP:P24781"
  (("Xbra" 30) ("bra" 14) ("BRA" 10) ("XBRA" 4) ("XBra" 3)
   ("the pan-mesodermal marker XBra" 1) ("Bra" 1)))
 ("UP:P24789" (("VIM1" 1))) ("UP:P24791" (("pME" 28) ("pMe" 2)))
 ("UP:P24821"
  (("tenascin-C" 110) ("HXB" 40) ("Tenascin-C" 33) ("JI" 16) ("GMEM" 5)
   ("hexabrachion" 3) ("tenascin­C" 3) ("Ji" 2) ("tenascin-c" 2) ("pHXB" 2)))
 ("UP:P24844" (("MYL9" 10) ("LC20" 3)))
 ("UP:P24855"
  (("DNase I" 879) ("DNAse I" 99) ("QIAGEN" 15) ("deoxyribonuclease I" 15)
   ("DNase1" 14) ("Deoxyribonuclease I" 7) ("deoxyribonuclease 1" 2)
   ("Ambion Turbo RNA-free DNase I" 2) ("clear DNase I" 1)
   ("digital DNase I" 1) ("a random DNase I" 1) ("available DNase I" 1)
   ("Quantitative DNase I" 1)))
 ("UP:P24860" (("cycB1" 14) ("CycB1" 5)))
 ("UP:P24863" (("cyclin C" 16) ("CCNC" 8) ("Cyclin C" 5) ("CycC" 1)))
 ("UP:P24864"
  (("cyclin E1" 882) ("CCNE1" 843) ("cyclin E1 protein" 44) ("pCCNE1" 22)
   ("uCCNE1" 12) ("less cyclin E1" 5) ("Ccne1" 4) ("overexpressed cyclin E1" 3)
   ("cyclin E1-" 2) ("CcnE" 1) ("miR-34a directly targets CCNE1" 1)
   ("human-specific pluripotent splicing variant pCCNE1" 1)
   ("non invasive MCF-7 cells downregulated cyclin E1" 1)
   ("only full-length cyclin E1" 1)))
 ("UP:P24869" (("Clb2" 14) ("the mitotic cyclin Clb2" 1) ("CLB2" 1)))
 ("UP:P24903" (("subfamily F" 2) ("CYP2F1" 2)))
 ("UP:P24928"
  (("POLR2A" 32) ("220kDa" 2) ("RPB1" 2) ("RNA II Polypeptide A" 1)))
 ("UP:P24941"
  (("CDK2" 3761) ("Cdk2" 2733) ("cdk2" 694) ("cyclin-dependent kinase 2" 90)
   ("CDK-2" 32) ("cdk-2" 27) ("pCDK2" 23) ("CDK2 protein" 16)
   ("CDK2 peptide" 14) ("Cdk2 protein" 14) ("cyclin dependent kinase 2" 13)
   ("-CDK2" 11) ("Cyclin-dependent kinase 2" 11)
   ("cyclin-dependent kinase-2" 9) ("cdk2 protein" 7) ("monomeric CDK2" 6)
   ("monomeric Cdk2" 6) ("p-CDK2" 5) ("the monomeric CDK2" 5) ("Cdk-2" 4)
   ("P24941" 4) ("cyclin dependent kinase-2" 3)
   ("the doubly-phosphorylated CDK2 peptide" 3) ("a kinase-defective Cdk2" 3)
   ("Cdk2-" 3) ("dominant-negative CDK2" 3) ("than Cdk2" 2)
   ("its associated cyclin dependent kinase 2" 2) ("the monomeric CDK2’s" 2)
   ("monomeric unphosphorylated CDK2" 2) ("Monomeric CDK2" 2)
   ("Cyclin dependent kinase 2" 2) ("cdK2" 2)
   ("We first expressed HA-tagged cdk2" 2) ("CDK2-" 2)
   ("kinase-defective Cdk2" 2) ("P-CDK2" 2) ("cellular CDK2" 2)
   ("CDK2 Protein" 2) ("Cyclin-dependent kinase 2 (CDK2) protein" 2)
   ("membrane-associated Cdk2" 2) ("a dominant-negative cdk2" 1)
   ("newly born CDK2" 1) ("–cyclin-dependent kinase 2" 1)
   ("the canonical Cdk2" 1) ("exogenous Cdk2" 1)
   ("sequestering monomeric CDK2" 1) ("the inactive monomeric CDK2" 1)
   ("the unphosphorylated monomeric CDK2" 1) ("the original CDK2" 1)
   ("than CDK2 ( xref )" 1) ("The resultant CDK2" 1) ("the only reason Cdk2" 1)
   ("-Cdk2" 1) ("pcdk2" 1) ("this specific lysine of cdk2" 1)
   ("functional Cdk2" 1) ("normal proliferating cells cyclin E/ CDK2" 1)
   ("hyperactive Cdk2" 1) ("contained ~2-fold more Cdk2" 1)
   ("dominant-negative Cdk2" 1) ("Cdk2–" 1) ("–CDK2" 1)
   ("a dominant-negative CDK2" 1) ("-cdk2" 1) ("CdK2" 1)))
 ("UP:P25008"
  (("CLND" 49) ("prophylactic CLND" 3) ("only underwent CLND" 1)
   ("29 underwent prophylactic CLND" 1) ("25 underwent therapeutic CLND" 1)
   ("a bilateral CLND" 1) ("a unilateral CLND" 1)
   ("extensive unilateral lymphadenopathy underwent bilateral CLND" 1)
   ("All patients underwent unilateral CLND" 1) ("underwent routine CLND" 1)))
 ("UP:P25024"
  (("CXCR1" 133) ("IL8RA" 10) ("IL-8 activated both the CXCR1" 1)
   ("CXCR-1" 1)))
 ("UP:P25025"
  (("CXCR2" 558) ("IL8RB" 7) ("CXCR2 protein" 5)
   ("invasive cell growth conditions use CXCR2" 1) ("Cxcr2" 1) ("CD182" 1)))
 ("UP:P25042" (("roX1" 1)))
 ("UP:P25050" (("Saimiri transformation-associated protein" 1)))
 ("UP:P25054"
  (("APC" 6548) ("APCs" 347) ("Apc" 294) ("APC protein" 78)
   ("adenomatous polyposis coli protein" 16) ("allogeneic APCs" 13) ("-APC" 10)
   ("APC-" 9) ("functional APC" 6)
   ("adenomatous polyposis coli protein (APC)" 6) ("protein APC" 6)
   ("than APC" 5) ("apc" 5) ("APC (adenomatous polyposis coli) protein" 5)
   ("APC molecule" 5) ("DP-2" 4) ("normal APC" 4) ("lateral membrane APC" 4)
   ("professional APCs" 4) ("VSV-G–tagged APC" 3) ("intact APC" 3)
   ("regulatory APCs" 3) ("apical APC" 2) ("Overexpressed APC" 2) ("APC–" 2)
   ("anti-p-p38-MAPK(pT180/pY182)-PE-Cy7, and anti-pERK1/2(pT202/pY205)-APC" 2)
   ("splenic APC" 2) ("the entire APC" 2) ("a particular APC" 2)
   ("functional adenomatous polyposis coli protein" 2)
   ("GSK3 inhibition slowed APC's" 2) ("inflammatory APCs" 2) ("Apc-" 2)
   ("fully competent APCs" 2) ("neighboring lateral membrane APC" 2)
   ("allogeneic APC" 2) ("either allogeneic APCs" 2)
   ("Gr-1/Ly6C-G (RB6-8C5)-APC-Cy7 and CD117 (ACK45)-APC" 2)
   ("irradiated allogeneic APCs" 2) ("professional APC" 2)
   ("K562-derived HLA-A2 artificial APC" 2) ("K562-based artificial APC" 2)
   ("conditionally inactivated APC" 2) ("apical membrane-associated APC" 1)
   ("most APC protein" 1) ("Essentially no APC" 1) ("than other APCs" 1)
   ("Exogenous truncated APC" 1) ("human APC’s" 1) ("the professional APCs" 1)
   ("human APC's" 1) ("primary APCs" 1) ("mature APC" 1)
   ("mitomycin C-treated C57BL/6 APCs" 1) ("resident APCs" 1)
   ("neighboring APCs" 1) ("stimulatory APCs" 1)
   ("F(ab’) Fragment Goat-anti-rabbit-IgG (H+L)-APC" 1)
   ("an un-methylated APC promoter 1A" 1) ("GSK3β and CKI decreased APC" 1)
   ("distinct APC" 1) ("residual APC" 1) ("Purified mitotic APC" 1)
   ("isolated residual APC" 1) ("tumours harboured both an APC" 1)
   ("protein Apc" 1) ("defective APC" 1) ("p53-expressing APCs" 1)
   ("allogeneic T cell–depleted APCs" 1) ("normal functional APC" 1)
   ("somatic APC" 1) ("a new APC" 1) ("wild- type APC" 1)))
 ("UP:P25063"
  (("CD24" 2218) ("CD24-" 40) ("CD24−" 26) ("than CD24" 2) ("-CD24" 2)
   ("a prominent CD24" 1)
   ("the cancer stem cell-associated membrane protein CD24" 1)
   ("CD24 protein" 1) ("Heat Stable Antigen (HSA)" 1) ("the immature CD24" 1)
   ("A siRNA duplex targeting CD24" 1) ("targeting CD24" 1)
   ("1,000 secondary non-CD29 high CD24" 1)))
 ("UP:P25067"
  (("FECD" 46) ("COL8A2" 9) ("collagen type VIII alpha 2" 1)
   ("atypical sporadic FECD" 1)))
 ("UP:P25090" (("LXA" 137) ("FPR-2" 10) ("FPRL1" 4) ("FPR2" 3)))
 ("UP:P25092"
  (("GUCY2C" 78) ("STAR" 61) ("Gucy2c" 13) ("pSTAR" 2)
   ("Guanylyl cyclase C" 2)))
 ("UP:P25098"
  (("GRK2" 135) ("βARK1" 104) ("bark" 24) ("βARK1 protein" 10) ("GRK-2" 6)
   ("G-protein coupled receptor kinase 2" 3) ("ADRBK1" 2)
   ("beta-adrenergic receptor kinase 1" 2)
   ("G-protein-coupled receptor kinase 2" 2)
   ("G-protein-coupled receptor kinase" 2)
   ("G-protein–coupled receptor kinase-2" 2) ("membrane-associated GRK2" 2)
   ("A robust βARK1" 1) ("the classical GRK2" 1)
   ("G protein-coupled receptor kinase GRK2" 1)
   ("G-protein–coupled receptor kinase" 1)))
 ("UP:P25100" (("ADRA1A" 10)))
 ("UP:P25101" (("EDNRA" 19) ("endothelin A receptor" 2) ("EdnrA" 1)))
 ("UP:P25103"
  (("SPR" 516) ("NK-1R" 48) ("TACR1" 11) ("NK1 receptor" 6)
   ("neurokinin-1 receptor" 1)))
 ("UP:P25105"
  (("PAFR" 175) ("platelet-activating factor receptor" 6) ("-PAFR" 2)
   ("PAF receptor" 2) ("Platelet activating factor receptor" 1)
   ("platelet activating factor receptor" 1)))
 ("UP:P25106"
  (("CXCR7" 773) ("CXCR7 protein" 22) ("CXCR7 peptide" 11) ("RDC1" 2)
   ("robust nuclear CXCR7" 2) ("CXCR7-" 1) ("Cxcr7" 1)
   ("chemokine orphan receptor 1" 1) ("GPR159" 1)))
 ("UP:P25116"
  (("PAR1" 757) ("PAR-1" 471) ("Par1" 38) ("thrombin receptor" 33) ("Par-1" 19)
   ("F2R" 12) ("endothelial PAR1" 7) ("par-1" 3) ("functional PAR1" 2)
   ("proteinase-activated receptor 1" 2) ("we first used PAR1" 2)
   ("PAR-1 Peptide" 2) ("PAR1-" 2) ("par1" 2) ("the major thrombin receptor" 1)
   ("endothelial proteinase-activated receptor 1" 1) ("Cortical PAR-1" 1)))
 ("UP:P25147" (("InlB" 9))) ("UP:P25158" (("OSK" 3)))
 ("UP:P25162"
  (("SBD" 261) ("than the DnaK SBD previously reported" 1)
   ("bacterial SLX1-SLX4 SBD" 1)))
 ("UP:P25189"
  (("MPP" 215) ("MPPs" 22) ("MPZ" 5) ("myelin protein zero" 3) ("raw MPP" 2)
   ("Mpz" 1) ("Quantitative MPP" 1)))
 ("UP:P25205"
  (("holoenzyme" 694) ("MCM3" 259) ("Mcm3" 10) ("the RNA pol II holoenzyme" 3)
   ("pol II holoenzyme" 2) ("a heterotrimeric holoenzyme" 2)
   ("a dimeric holoenzyme" 2) ("holoenzyme (RNAPII)" 2) ("MCM3 protein" 2)
   ("MCM-3" 2) ("RNA pol II holoenzyme" 1) ("Its tetrameric holoenzyme" 1)
   ("the dimeric G6PD holoenzyme" 1) ("RNAPII" 1) ("mcm3" 1)
   ("an ABC heterotrimeric holoenzyme" 1) ("the entire holoenzyme" 1)
   ("more APC/C holoenzyme" 1) ("MCM-3 protein" 1) ("a trimeric holoenzyme" 1)
   ("Holoenzyme" 1) ("tetrameric holoenzyme" 1)))
 ("UP:P25208"
  (("NFYB" 135) ("NF-YB" 49) ("Hap3" 2) ("E2F1 directly targets NFYB" 1)
   ("HAP3" 1)))
 ("UP:P25225" (("n-3" 274) ("N-3" 12) ("dietary n-3" 3)))
 ("UP:P25226" (("N 5" 31) ("–n 5" 6) ("n 5" 1) ("-N 5" 1) ("N  5" 1)))
 ("UP:P25241"
  (("REs" 1100) ("noncanonical REs" 11) ("the functional REs" 6)
   ("Canonical REs" 4) ("one or more p53 REs" 3)
   ("both canonical and noncanonical REs" 3) ("potential p53 REs" 3)
   ("its PGC-1 β weak REs" 2) ("weak p53 REs" 2) ("the seedless REs" 2)
   ("all three seedless REs" 2) ("strong full-site REs and ¾-site REs" 2)
   ("strong REs" 2) ("noncanonical consensus ¾-site REs" 2)
   ("the two weak MDM2 REs" 2) ("potential target REs" 2)
   ("many noncanonical ½- and ¾-site REs" 2)
   ("the noncanonical and canonical REs" 2) ("noncanonical ¾-site REs" 2)
   ("canonical REs" 2) ("two noncanonical ¾-site REs" 2)
   ("Noncanonical ¾-Site REs" 2) ("polymorphic REs" 2)
   ("previously established p53 REs" 2) ("three potential REs" 2)
   ("Co-localised KLF4 and p53 REs" 2) ("the potential REs" 1)
   ("repressive p53 REs" 1) ("the non-p53-occupied REs" 1)
   ("the ‘seedless’ REs" 1) ("the associated p53 REs" 1)
   ("miR-associated REs" 1) ("well-established REs" 1)
   ("15 candidate miR-associated p53 REs" 1)
   ("the predicted miR-associated p53 REs" 1) ("miRNA-associated REs" 1)
   ("selected miR-associated REs" 1) ("Truly functional REs" 1)
   ("the weak full-site REs" 1) ("noncanonical ½- and ¾-site REs" 1)
   ("apparently noncanonical ¾-site REs" 1) ("the noncanonical ½-site REs" 1)
   ("other closely-spaced full-sized p53 REs" 1)
   ("widely-separated full-size REs" 1) ("functional and nonfunctional REs" 1)
   ("the canonical and noncanonical REs" 1)
   ("the strong canonical full-site REs" 1)
   ("strong (p21-5′ and TIGAR-spacer) full-site REs" 1)
   ("actually ¾-site REs" 1) ("The noncanonical REs" 1) ("weak target REs" 1)
   ("weak full-site REs" 1) ("these noncanonical REs" 1)
   ("significantly stronger REs" 1) ("sequence-specific REs" 1)
   ("Perinuclear REs" 1) ("classical p53 REs" 1) ("putative polymorphic REs" 1)
   ("most functional REs" 1) ("seven polymorphic p53 REs" 1)
   ("most polymorphic REs" 1) ("the repeat-associated REs" 1)
   ("these repeat-associated p53 REs" 1) ("whose p53 REs" 1)
   ("these repeat-associated REs" 1)
   ("p53 target canonical and noncanonical REs" 1)
   ("the well-established p53 REs" 1) ("p53 and KLF4 only needs REs" 1)
   ("weak non-canonical REs" 1) ("both strong canonical p53 REs" 1)
   ("weak non-canonical p53 REs" 1) ("appropriate REs" 1)))
 ("UP:P25295" (("TUG1" 202) ("exogenous RNAi TUG1" 1)))
 ("UP:P25301" (("Rad57" 10) ("RAD57" 1))) ("UP:P25302" (("Swi4" 1)))
 ("UP:P25310" (("ACM" 59)))
 ("UP:P25311"
  (("zinc-binding" 110) (NIL 9) ("Zinc-binding" 4) ("zinc-binding protein" 3)
   ("two transcriptional adaptor zinc-binding" 2) ("zinc–binding" 2)
   ("AZGP1" 2) ("zags" 1) ("Zinc-Binding" 1)))
 ("UP:P25325"
  (("MST" 244) ("Mst" 27) ("MSTs" 10) ("pMST" 9) ("pMst" 3)
   ("3-mercaptopyruvate sulfurtransferase" 2) ("mST" 1)))
 ("UP:P25328" (("p91" 14) ("P91" 4)))
 ("UP:P25331" (("EH" 135) ("the skeletal EH" 1) ("separate EH" 1)))
 ("UP:P25340" (("ERG4" 1))) ("UP:P25353" (("NPP1" 4)))
 ("UP:P25356" (("BPH1" 44))) ("UP:P25369" (("Lsb5" 1)))
 ("UP:P25391" (("LAMA" 5) ("LAMA1" 1) ("Lama" 1)))
 ("UP:P25440" (("BRD2" 18) ("Brd2" 3) ("than Brd2" 1) ("RNF3" 1) ("RING3" 1)))
 ("UP:P25445"
  (("CD95" 1159) ("APO-1" 40) ("TNFRSF" 34) ("Fas protein" 24)
   ("FAS protein" 11) ("Apo-1" 10) ("CD95 protein" 8) ("Fas1" 6) ("CD95-" 5)
   ("TNFRSF6" 5) ("FA-S" 2) ("fas protein" 2) ("overexpressed WT CD95" 2)
   ("overexpressing WT CD95" 2) ("very little CD95" 2) ("cd95" 1) ("APO–1" 1)
   ("Fas cell surface death receptor" 1)
   ("than CD95 involved in the cross-talk" 1) ("DMM-treated cells CD95" 1)
   ("oligomerized CD95" 1)))
 ("UP:P25478" (("GPO" 1)))
 ("UP:P25490"
  (("DU145" 2380) ("YY1" 956) ("Du145" 97) ("YY-1" 63) ("Yin Yang 1" 44)
   ("YY1 protein" 17) ("Yin Yang1" 5) ("exogenous YY1" 4)
   ("YY1 transcription factor" 4) ("parental DU145" 4) ("UCRBP" 3) ("NF-E1" 3)
   ("targeting YY1" 2)
   ("the multifunctional transcription regulator Yin Yang 1" 2)
   ("PTEN-expressing DU145" 2) ("the transcriptional factor YY1" 2)
   ("the isogenic DU145" 2) ("yy1" 2) ("pure YY1 protein" 2)
   ("the repressive transcriptional factor YY1" 1) ("DU145-" 1) ("YY1-" 1)
   ("tumorigenic DU145" 1) ("isogenic DU145" 1) ("than DU145" 1)
   ("Lentiviral YY1" 1) ("Pim1-expressing DU145" 1) ("-YY1" 1) ("pure YY1" 1)
   ("Du145 (ATCC)" 1) ("hypoxic DU145" 1)
   ("the multifunctional transcription factor YY1" 1)))
 ("UP:P25491"
  (("MAS5" 90) ("Ydj1" 36) ("ydj1" 3) ("YDJ1" 2)
   ("using Affymetrix MAS5.0" 1)))
 ("UP:P25604" (("VPS23" 1))) ("UP:P25623" (("Syp1" 1)))
 ("UP:P25646" (("PPP2" 9)))
 ("UP:P25685"
  (("Hsp40" 69) ("hsp40" 41) ("DNAJB1" 11) ("HSP40" 11) ("Sis1" 6) ("siS1" 1)
   ("heat shock protein 40" 1) ("than Hsp40" 1)))
 ("UP:P25705"
  (("isoform 1" 256) ("alpha subunit" 123) ("isoform 2" 116)
   ("ATP synthase" 94) ("·ATP" 46) ("-ATP synthase" 15) ("ATP5A" 5)
   ("Isoform 2" 5) ("H+ transporting" 5) ("Isoform 1" 4)
   ("isoform 1 protein" 4) ("ATP5A1" 3) ("H+ Transporting" 3)
   ("binding protein-associated factor 2N isoform 1" 3)
   ("mitochondrial F1 complex" 3) ("ATP synthase peptide" 3)
   ("the entire isoform 1" 2) ("slower migrating isoform 1" 2)
   ("ATP synthase subunit alpha, mitochondrial" 2) ("Alpha subunit" 2)
   ("substrate SBS ·GSK-3β(p)·ATP and inhibitor SBS ·GSK-3β(p)·ATP" 2)
   ("sterol regulatory element-binding protein isoform 2" 2)
   ("longer isoform 1" 1) ("Atp5a1" 1) ("than isoform 2" 1)
   ("than isoform 1" 1) ("ORM" 1) ("alpha subunit 1" 1)
   ("mainly p120ctn isoform 1" 1)))
 ("UP:P25713"
  (("MT-3" 74) ("MT3" 25) ("MT-3 protein" 6) ("metallothionein 3" 3)))
 ("UP:P25774" (("CTSS" 4) ("ctss" 4) ("Cathepsin S" 3)))
 ("UP:P25786"
  (("HC2" 18) ("proteasome (prosome" 6) ("alpha type" 4) ("Psma1" 4)
   ("PSMA1" 4) ("proteasome (Prosome" 2)
   ("proteasome subunit alpha type-1" 1)))
 ("UP:P25787" (("HC3" 10) ("PSMA2" 2) ("hC3" 1)))
 ("UP:P25788" (("PSMA3" 23) ("HC8" 19) ("hc8" 1)))
 ("UP:P25789" (("PSMA4" 5) ("HC9" 1)))
 ("UP:P25791"
  (("LMO2" 109) ("Lmo2" 12) ("LIM domain only 2" 2) ("Lmo2 protein" 2)
   ("LIM domain Only 2" 1)))
 ("UP:P25800" (("LMO1" 146) ("LIM domain only 1" 7) ("around LMO1" 1)))
 ("UP:P25848"
  (("protein kinase" 4217) ("protein kinase (AMPK)" 234) ("Protein Kinase" 121)
   ("Protein kinase" 48) ("protein kinase (PKA)" 29)
   ("protein kinase (JNK)" 15) ("protein kinase (PKR)" 13)
   ("protein kinase (PKG)" 10) ("Rho-associated protein kinase (ROCK)" 7)
   ("Protein Kinase (AMPK)" 7) ("PIKK" 7)
   ("a serine/threonine-specific protein kinase" 6) ("protein kinase (ERK)" 6)
   ("Protein Kinase (MAPK)" 5) ("protein kinase (PIKK)" 5)
   ("protein kinase (ROCK)" 4) ("protein kinase (ATM)" 4)
   ("Protein
Kinase"
    4)
   ("protein kinase-" 4) ("a potential serine protein kinase" 3)
   ("A comprehensive protein kinase" 3) ("a major protein kinase" 3)
   ("the zeta-chain-associated protein kinase" 3)
   ("a dual specificity protein kinase" 2) ("protein  kinase" 2)
   ("a multifunctional protein kinase" 2)
   ("a conservative serine/threonine (S/T) protein kinase" 2)
   ("drugable protein kinase" 2)
   ("protein
kinase"
    2)
   ("a large ubiquitous and evolutionary conserved protein kinase" 2)
   ("major protein kinase" 2) ("70-kDa ribosomal S6 protein kinase" 2)
   ("DNA-dependent protein kinase" 2) ("a homonymous Ser/Thr protein kinase" 2)
   ("the ribosomal S6 protein kinase" 2)
   ("the oncogenic MAPKK-like protein T-cell-originated protein kinase (TOPK)"
    2)
   ("an ancillary protein kinase" 2) ("protein kinase (ATR)" 2)
   ("at least one protein kinase" 2)
   ("omnipresent dsRNA-dependent protein kinase (PKR)" 2) ("a unique PIKK" 2)
   ("the cytoplasmic tyrosine kinase ζ-chain-associated protein kinase" 2)
   ("extracellular-signal-regulated protein kinase" 2)
   ("protein kinase ( AMPK )" 2) ("protein kinase (MAPK)" 2)
   ("a ubiquitous serine–threonine protein kinase" 2)
   ("Rho-associated protein kinase" 2)
   ("Zeta-chain-associated protein kinase" 2) ("protein kinase (DAPK)" 1)
   ("The p160–Rho-associated coiled-coil–containing protein kinase (ROCK)" 1)
   ("a ubiquitous protein kinase" 1) ("Protein Kinase (PKR)" 1)
   ("Rho-associated serine-threonine protein kinase (ROCK)" 1)
   ("an antiapoptotic protein kinase" 1)
   ("an important pathogenic protein kinase" 1) ("protein kinase (PDK)" 1)
   ("UV-induced AMP-activated protein kinase (AMPK)" 1)
   ("rhoA-associated protein kinase (ROCK)" 1)
   ("a ubiquitous Ser-/Thr-specific protein kinase" 1)
   ("a monomeric serine-threonine protein kinase" 1)
   ("a potential protein kinase" 1) ("a typical protein kinase" 1)
   ("-protein kinase" 1) ("viral lytic protein kinase" 1)
   ("protein kinase (ZIPK)" 1) ("highly pleiotropic protein kinase" 1)
   ("protein kinase (PKC)" 1) ("a heterotrimeric Ser/Thr protein kinase" 1)
   ("The heterotrimeric AMP-activated protein kinase (AMPK)" 1)
   ("the Rho-associated protein kinase" 1) ("protein kinase (MNK)" 1)
   ("than one protein kinase" 1)
   ("its main effector Rho-associated Coil-containing Protein Kinase" 1)
   ("The major protein kinase" 1) ("the cellular protein kinase" 1)
   ("protein kinase (CDK)" 1) ("phase-specific protein kinase" 1)
   ("virtual protein kinase" 1)
   ("a well-studied serine and threonine protein kinase" 1)
   ("caspase-like apoptosis-regulatory protein kinase" 1)
   ("a protein kinase that regulates the cell's" 1)
   ("the downstream pathway Rho-associated protein kinase (ROCK)" 1)
   ("the effector pathway Rho-associated protein kinase (ROCK)" 1)
   ("protein kinase (DMPK)" 1)
   ("its downstream effector Rho-associated protein kinase (ROCK)" 1)))
 ("UP:P25861" (("GAPC" 3))) ("UP:P25867" (("eff" 10) ("EFF" 7) ("pEFF" 2)))
 ("UP:P25874"
  (("UCP" 65) ("UCP1" 58) ("UCPs" 25) ("Ucp1" 25) ("uncoupling protein" 15)
   ("huDHFR/NADPH/ UCP1015" 1) ("uncoupling protein 1" 1)
   ("uncoupling protein (UCP)" 1) ("troglitazone increased Ucp1" 1)
   ("UCP1 protein" 1)))
 ("UP:P25929" (("NPY1R" 16))) ("UP:P25940" (("COL5A3" 2)))
 ("UP:P25942"
  (("CD40" 759) ("Bp50" 26) ("TNFRSF5" 5) ("CD40 protein" 2) ("CD40-" 2)
   ("Human soluble CD40" 2) ("soluble CD40" 2)
   ("its classical receptor CD40" 1) ("less CD40" 1) ("Cd40" 1)))
 ("UP:P25963"
  (("IκBα" 3416) ("NFKBIA" 456) ("IκB-α" 357) ("IkBα" 136) ("kappaB" 95)
   ("KappaB" 76) ("pIκBα" 71) ("IκBα protein" 56) ("p-IκBα" 41) ("I-κBα" 25)
   ("IkappaBalpha" 18) ("NFKB1A" 17) ("MAD3" 16) ("IkBa" 15) ("P-IκBα" 14)
   ("-IκBα" 10) ("NFkBIA" 5) ("Nfkbia" 5) ("ikBα" 5) ("-IκBα protein" 4)
   ("IκBα molecule" 4) ("Iκbα" 3) ("dominant-negative IκBα" 3) ("ikba" 3)
   ("new IκBα" 3) ("IκB-α-" 3) ("iKBα" 3) ("p-IκB-α" 3) ("pIkBa" 2)
   ("cellular IκB-α" 2) ("NFKBIA protein" 2) ("p-IkBa" 2)
   ("the classical inhibitors IκBα" 2)
   ("1,25D increased both total and phosphorylated IκBα" 2)
   ("NFKBIA (IκBα) protein" 2) ("a dominant-negative IκBα" 2)
   ("the classical substrate IkBα" 1) ("-IκB-α" 1) ("NFKBI" 1) ("pIκB-α" 1)
   ("a point mutation which abrogates IκBα’s" 1) ("NF-kBIA" 1)
   ("slightly greater p-IkBa" 1) ("phospho-IκBα protein" 1)
   ("significantly less IκBα protein" 1) ("pIkBα" 1)
   ("Non-phosphorylated IkBα" 1) ("immunoreactive IκBα" 1)
   ("cytoplasmic immunoreactive IκBα" 1) ("IκBα-" 1) ("the latter case IκBα" 1)
   ("exogenous IκBα" 1) ("Regulatory IkBα" 1) ("foremost NFKBIA" 1)
   ("total and phosphorylated IκBα" 1) ("Ikbα" 1) ("than IκBα" 1)
   ("this dominant-negative IκBα" 1)))
 ("UP:P25974" (("CG4" 2))) ("UP:P26006" (("ITGA3" 11) ("CD49c" 3) ("Itga3" 1)))
 ("UP:P26007" (("Integrin-α6" 14)))
 ("UP:P26010" (("ADMIDAS" 4) ("ITGB7" 2) ("integrin-β7" 2)))
 ("UP:P26012" (("beta 8" 11) ("ITGB8" 9))) ("UP:P26016" (("furin1" 1)))
 ("UP:P26022" (("Pentraxin 3" 3) ("pentraxin 3" 2))) ("UP:P26023" (("GSG" 12)))
 ("UP:P26038"
  (("moesin" 293) ("MSN" 26) ("FERM" 14) ("Moesin" 12) ("Msn" 7)
   ("heat-treated moesin" 2) ("p-moesin" 2)))
 ("UP:P26045" (("PTPH1" 170) ("PTPN3" 4) ("PTPH1 protein" 2)))
 ("UP:P26196" (("RCK" 209) ("DDX6" 63) ("Rck" 11) ("rck" 1)))
 ("UP:P26232" (("catenin (cadherin-associated protein)" 11) ("CTNNA2" 2)))
 ("UP:P26292" (("ISP" 32)))
 ("UP:P26295" (("DNases" 3) ("DNAses" 2) ("mitochondrial-targeted DNases" 1)))
 ("UP:P26358"
  (("aim" 3891) ("DNMT1" 1895) ("DNMT" 349) ("DNMTs" 304) ("Dnmt1" 256)
   ("DNA methyltransferase" 240) ("Aim" 163) ("DNA methyltransferase 1" 68)
   ("AIM" 55) ("pDnmt1" 39) ("DNMT1 protein" 29) ("Dnmt" 22)
   ("The primary aim" 10) ("the primary aim" 9) ("DNMT1 peptide" 9)
   ("DNA methyltransferase ( MGMT )" 7) ("A secondary aim" 6)
   ("DNA-methyltransferases" 5) ("pDNMT1" 5) ("a secondary aim" 5)
   ("the ultimate aim" 4) ("Dnmt1 protein" 4) ("The ultimate aim" 3)
   ("Our primary aim" 3) ("DNA methyltransferase 1 (DNMT1) protein" 3)
   ("pDNMT" 3) ("whose aim" 3) ("our primary aim" 3) ("The principal aim" 2)
   ("Our secondary aim" 2) ("DNA methyltransferase (DNMT)" 2)
   ("The major aim" 2) ("DNMT-1" 2) ("palliative aim" 2) ("Less DNMT1" 2)
   ("phosphatase-treated DNMT1" 2) ("DNA (cytosine-5)-methyltransferase 1" 2)
   ("DNA-methyltransferase activity" 2)
   ("These innovative therapeutic approaches aim" 1) ("A major aim" 1)
   ("A principal aim" 1) ("The second major aim" 1) ("meaningful aim" 1)
   ("possibly other DNMTs" 1) ("Most vaccines aim" 1) ("our major aim" 1)
   ("the DNMT's" 1) ("the primary Dnmt" 1) ("curative aim" 1)
   ("The original aim" 1) ("The pivotal aim" 1) ("an attractive aim" 1)
   ("one possible aim" 1) ("than DNMT1" 1)
   ("the different cellular DNA-methyltransferases" 1) ("the principal aim" 1)
   ("Our principal aim" 1) ("The central aim" 1) ("a curative aim" 1)
   ("the major aim" 1) ("foremost aim" 1) ("The subsequent aim" 1)
   ("The secondary aim" 1) ("a dual aim" 1) ("than the Dnmt1" 1)
   ("the three major DNMTs" 1) ("three major DNMTs" 1)
   ("than wild-type DNMT1" 1) ("total cellular DNMT1" 1) ("after DNMT1’s" 1)
   ("than methylated DNMT1" 1) ("total cellular DNMTs" 1)
   ("DNA
                methyltransferase"
    1)
   ("DNA
                        methyltransferase"
    1)
   ("DNA methyltransferase (MGMT)" 1) ("our principal aim" 1)
   ("a major aim" 1)))
 ("UP:P26367"
  (("Pax6" 491) ("PAX6" 311) ("Pax6 protein" 8) ("Pax-6" 6) ("aniridia" 3)
   ("PAX-6" 2) ("overexpressed Pax6 protein" 2) ("Aniridia" 2)
   ("paired box 6" 2) ("aN2" 2) ("Paired box protein" 1) ("pax6" 1)
   ("the repressive effect Pax6" 1) ("ectodermal marker PAX6" 1)))
 ("UP:P26368"
  (("U2AF65" 128) ("U2AF-65" 8) ("the splicing accessory factor U2AF-65" 1)))
 ("UP:P26378"
  (("HuD" 148) ("HuD protein" 17) ("HuD-" 4) ("ELAVL4" 2) ("HuD Protein" 2)))
 ("UP:P26415" (("NI4" 1))) ("UP:P26439" (("HSD3B2" 18) ("3β-HSD" 1)))
 ("UP:P26440"
  (("IVD" 247) ("IVDs" 45) ("Human lumbar IVD" 3)
   ("than Grade II IVDs (p=0.047, n=3 or 4, respectively)" 1)
   ("a histologically non-degenerate IVD" 1) ("normal and degenerative IVD" 1)
   ("the lumbar IVDs" 1) ("normal IVDs" 1) ("The healthy IVD" 1)
   ("isovaleryl-CoA dehydrogenase" 1)))
 ("UP:P26441"
  (("CNTF" 222) ("ciliary neurotrophic factor" 22)
   ("Ciliary neurotrophic factor" 3) ("pCNTF" 3)
   ("ciliary neurotrophic factor (CTNF)" 1) ("CNTF-" 1)
   ("ciliary neurotrophic factor (CNTF)" 1)))
 ("UP:P26447"
  (("S100A4" 357) ("FSP-1" 45) ("FSP1" 26) ("Fsp1" 13) ("MTS1" 9) ("CAPL" 5)
   ("Fsp-1" 5) ("metastasin" 4) ("p9Ka" 3)
   ("the mesenchymal marker protein S100A4" 3) ("calvasculin" 2) ("pMTS1" 2)
   ("S100a4" 1) ("S100A4 protein" 1)))
 ("UP:P26448" (("Bub2" 11) ("BUB2" 1)))
 ("UP:P26461"
  (("AIs" 48) ("A–I" 11) ("A-I" 8)
   ("The intronic genomic DNA fragments A–I" 1)))
 ("UP:P26572" (("MGAT" 2)))
 ("UP:P26583" (("HMGB2" 76) ("HMG2" 5) ("HMGB2 protein" 1) ("HMG-2" 1)))
 ("UP:P26599"
  (("PTB" 624) ("PTBP1" 86) ("polypyrimidine tract binding protein" 15)
   ("PTB2" 8) ("Polypyrimidine tract binding protein 1" 6) ("PTB-" 5)
   ("PTB-1" 4) ("polypyrimidine tract binding protein (PTB)" 3) ("hnRNPI" 3)
   ("PTB4" 3) ("cardiac polypyrimidine tract binding protein (PTB)" 2)
   ("Polypyrimidine tract binding protein" 1) ("ptbp1" 1) ("spontaneous PTB" 1)
   ("Ptb" 1) ("PTB protein" 1) ("PTB−" 1)))
 ("UP:P26640" (("VARS" 2))) ("UP:P26641" (("EEF1G" 4)))
 ("UP:P26651"
  (("tristetraprolin" 20) ("Tristetraprolin" 10) ("TIS11" 8)
   ("tristetraprolin (TTP)" 3) ("Tis11" 2) ("tristetraprolin (TPP)" 1)
   ("Nup475" 1) ("G0S24" 1)))
 ("UP:P26675"
  (("SOS" 401) ("Son of Sevenless" 29) ("Son of sevenless" 16)
   ("son of sevenless" 12) ("son-of-sevenless" 5) ("son-of-sevenless (SOS)" 3)
   ("pSOS" 3) ("Son-of-sevenless" 2) ("son-of-sevenless (Sos) protein" 2)
   ("Son-of-Sevenless (SOS)" 1) ("Son-of-Sevenless" 1)
   ("Son of Sevenless (SOS)" 1) ("SON OF SEVENLESS" 1) ("\"SOS\"" 1)
   ("the next step SOS" 1)))
 ("UP:P26678" (("PLN" 29) ("Pln" 10) ("phospholamban" 9)))
 ("UP:P26696" (("MPK-1" 11) ("Mpk1" 7) ("mpk-1" 2))) ("UP:P26699" (("GpG" 22)))
 ("UP:P26715" (("NKG2A" 21) ("NKG2" 6) ("Klrc1" 2)))
 ("UP:P26718"
  (("NKG2D" 499) ("NKG2D molecule" 2) ("Klrk1" 2) ("NKG2D–" 1)
   ("soluble NKG2D" 1) ("CD314" 1)))
 ("UP:P26748"
  (("scaffolding protein" 551)
   ("scaffolding
protein"
    7)
   ("a multifunctional scaffolding protein" 4)
   ("a ubiquitous scaffolding protein" 4) ("a modular scaffolding protein" 2)
   ("a central scaffolding protein" 2)
   ("Another ErbB-associated scaffolding protein" 2)
   ("a poorly-studied scaffolding protein" 2)
   ("a neuronal scaffolding protein" 2)
   ("a multi-functional scaffolding protein" 2)
   ("a rather large scaffolding protein" 2)
   ("The caveolar scaffolding protein" 2) ("a trivalent scaffolding protein" 2)
   ("scaffolding protein molecule" 2) ("a synaptic scaffolding protein" 2)
   ("a well-known scaffolding protein" 2)
   ("a membrane-associated cytoskeletal scaffolding protein" 1)
   ("a critical postsynaptic scaffolding protein" 1)
   ("multi-functional scaffolding protein" 1)
   ("an essential scaffolding protein" 1)
   ("the major post-synaptic density (PSD) scaffolding protein" 1)
   ("a key scaffolding protein" 1)))
 ("UP:P26755" (("RFA" 14) ("RfA" 2) ("rfa" 1))) ("UP:P26795" (("p2b" 1)))
 ("UP:P26829" (("NDH" 2)))
 ("UP:P26842"
  (("CD27" 370) ("T14" 124) ("tumor necrosis factor receptor superfamily" 23)
   ("S152" 3) ("senescent CD27" 3)
   ("Tumor necrosis factor receptor superfamily" 2) ("CD27-" 1)
   ("an irrelevant scrambled control GFP + CD4 + CD27" 1)
   ("human senescent CD27" 1) ("the senescent CD27" 1) ("Senescent CD27" 1)
   ("TNFRSF7" 1)))
 ("UP:P26843" (("pEF4" 1))) ("UP:P26885" (("FKBP-2" 20) ("FKBP2" 15)))
 ("UP:P26902" (("DPPA" 2)))
 ("UP:P26927"
  (("MSP" 1592) ("pMSP" 21) ("quantitative MSP" 9) ("-MSP" 8) ("MSPs" 7)
   ("macrophage-stimulating protein" 5) ("Duplex MSP" 4)
   ("hepatocyte growth factor-like protein" 4) ("qualitative MSP" 4)
   ("Quantitative MSP" 3) ("traditional MSP" 2)
   ("real-time quantitative MSP" 2) ("weakly adherent MSP" 2)
   ("macrophage-stimulating protein (MSP)" 2)
   ("the original or modified MSP" 2) ("classic MSP" 2)
   ("using traditional MSP" 1) ("Quantitative SYBR Green MSP" 1)
   ("than MSP [ xref ]" 1) ("a Sybr green-based quantitative MSP" 1)
   ("Macrophage-stimulating protein" 1) ("macrophage stimulating protein" 1)
   ("mostly Caucasian and used Quantitative MSP (QMSP)" 1)
   ("than classical gel-based MSP" 1) ("classical gel-based MSP" 1)
   ("the original MSP" 1) ("than MSP [ xref - xref ]" 1)
   ("previously reported MSP" 1) ("than conventional MSP" 1)
   ("quantitative MSP (QMSP)" 1) ("Macrophage Stimulating Protein" 1)))
 ("UP:P26951"
  (("IL-3R" 104) ("CD123" 81) ("IL-3Rα" 8) ("IL3RA" 3) ("IL3Rα" 2)
   ("CD123-" 1)))
 ("UP:P26975" (("phoN" 2)))
 ("UP:P26992" (("CNTFR" 15) ("ciliary neurotrophic factor receptor" 3)))
 ("UP:P27010" (("OL2" 4)))
 ("UP:P27037"
  (("ACVR2A" 14) ("type IIa" 13) ("type IIA" 8) ("ACVR2" 4) ("Type IIA" 3)
   ("Type IIa" 3) ("activin receptor type IIA" 2)
   ("adult skeletal myosin heavy chain type IIA" 1)))
 ("UP:P27080" (("ABT" 196) ("ABT-" 4)))
 ("UP:P27087"
  (("MTB" 426) ("Mtb" 66) ("cell-associated MTB" 6) ("viable MTB" 4)
   ("virulent MTB" 3) ("virulent Mtb" 2) ("killing intracellular MTB" 2)
   ("MTB-" 1) ("avirulent Mtb" 1)
   ("significantly fewer viable intracellular MTB" 1)
   ("all cell-associated MTB" 1)))
 ("UP:P27091" (("GBB" 2))) ("UP:P27105" (("STOM" 2)))
 ("UP:P27134"
  (("carbonic anhydrase" 27) ("Carbonic anhydrase" 4)
   ("Carbonic Anhydrase" 1)))
 ("UP:P27144" (("AK3" 5) ("AK4" 4) ("ak3" 1)))
 ("UP:P27169"
  (("PON1" 101) ("PON" 54) ("K45" 43) ("Pon" 20) ("paraoxonase 1" 10)
   ("Paraoxonase 1" 2)))
 ("UP:P27186" (("DNA primase" 6))) ("UP:P27217" (("Scrb" 4)))
 ("UP:P27253" (("SBM" 10))) ("UP:P27298" (("p–RLC" 1)))
 ("UP:P27338" (("MAO-B" 10) ("MAOB" 7) ("monoamine oxidase B" 2)))
 ("UP:P27348" (("YWHAQ" 22) ("protein HS1" 5)))
 ("UP:P27352"
  (("IF" 1315) ("INF" 60) ("intrinsic factor" 15) ("inf" 7) ("dual IF" 6)
   ("IF protein" 6) ("indirect IF" 5) ("IF-" 4) ("used dual IF" 2)
   ("Dual IF" 2) ("perinucleolar p53- Ser 15 P IF" 2) ("nearly confluent IF" 2)
   ("Indirect IF" 2) ("rather uniform IF" 2) ("strong ATM-S1981 P IF" 2)
   ("confocal IF" 1) ("Inf" 1) ("Confocal IF" 1) ("Representative IF" 1)
   ("Original IF" 1) ("had very intense p53 Ser 15 P IF" 1) ("intense IF" 1)
   ("the CS-treated cultures expressed ATM-S1981 P or γH2AX IF" 1)
   ("a type II simple epithelial IF" 1)))
 ("UP:P27358" (("RZ" 12))) ("UP:P27359" (("TRAFs" 67)))
 ("UP:P27361"
  (("ERK1" 1274) ("Erk1" 299) ("ERK 1" 175) ("ERK-1" 172) ("ERT2" 72)
   ("p-ERK1" 51) ("Erk-1" 40) ("pERK1" 38) ("p44 MAPK" 34) ("MAPK3" 31)
   ("Erk 1" 17) ("extracellular signal-regulated kinase 1" 13)
   ("extracellular signal-regulated kinase-1" 10) ("ERK1 protein" 10)
   ("extracellular-signal-regulated kinase 1" 8) ("ERt2" 8)
   ("mitogen-activated protein kinase 3" 6)
   ("Extracellular signal-regulated kinase 1" 5) ("p44-MAPK" 5) ("-Erk1" 5)
   ("Ert2" 5) ("Erk1 protein" 4) ("than ERK1" 4) ("p-ERK1 protein" 3)
   ("phospho-ERK1 protein" 3) ("ERK 1 protein" 2) ("-ERK1" 2)
   ("extracellular
signal-regulated kinase 1"
    2)
   ("p44 Erk1" 2) ("a dominant-negative Erk1" 2)
   ("p-ERK1 (IRS for HCC vs. nonneoplastic liver: 4.04±0.67 vs. 1.20±0.33, P<0.001) protein"
    1)
   ("P27361" 1)
   ("than phospho-ERK1 (pp44) in both resting and simulated H- ras MCF10A and DLD-1 cells"
    1)
   ("p44 ERK1" 1) ("extracellular signal regulated kinase 1" 1) ("p44mapk" 1)
   ("-extracellular signal-regulated kinase 1" 1) ("ERK-1 protein" 1)
   ("erk 1" 1) ("p44MAPK" 1) ("microtubule-associated protein-2 kinase" 1)
   ("than ERK1 (Fig. xref , lane 2)" 1)
   ("Extracellular signal-regulated kinase-1" 1) ("pERK-1" 1)
   ("than knocking-down ERK1" 1)
   ("extracellular signal–regulated kinase 1" 1)))
 ("UP:P27369" (("Cys-R" 1))) ("UP:P27384" (("GpC" 1)))
 ("UP:P27387"
  (("XX" 194) ("xx" 5) ("“XX”" 4) ("genotypically not female XX" 2) ("Xx" 1)
   ("pXX" 1)))
 ("UP:P27388" (("XXII" 2))) ("UP:P27389" (("XVIII" 11)))
 ("UP:P27391" (("XXX" 11) ("xxx" 7) ("Xxx" 1)))
 ("UP:P27392" (("Protein S" 7) ("XVI" 6)))
 ("UP:P27448"
  (("MARK3" 64) ("C-TAK1" 7) ("PAR1A" 4) ("Mark3" 2) ("Par1A" 2) ("cTAK1" 2)
   ("PAR1a" 2) ("MARK-3" 1) ("c-Tak1" 1) ("c-TAK1" 1) ("Par1a" 1)))
 ("UP:P27469" (("G0s2" 4) ("G0/G1switch 2" 2) ("G0S2" 2)))
 ("UP:P27482"
  (("CLP" 252) ("CL/P" 144) ("unilateral right CL/P" 4) ("nonsyndromic CLP" 3)
   ("nonsyndromic CL/P" 2) ("syndromic CL/P" 2) ("unilateral left CL/P" 2)
   ("bilateral CL/P" 2) ("unilateral CL/P" 1)
   ("Nonsyndromic or isolated (without other associated abnormalities) CL/P" 1)
   ("Most CL/P" 1)))
 ("UP:P27487"
  (("CD26" 139) ("DPP4" 13) ("dipeptidyl peptidase IV" 9) ("DPP-4" 6)
   ("dipeptidyl peptidase 4" 2) ("CD26 protein" 2) ("six times more CD26" 1)
   ("Dipeptidyl peptidase IV" 1) ("DPP IV" 1)))
 ("UP:P27512" (("mCD40" 5))) ("UP:P27523" (("C-Ab" 21)))
 ("UP:P27536"
  (("PO" 1305) ("po" 17) ("PO (RPLPO)" 4) ("Po" 2)
   ("Acidic ribosomal phosphoprotein PO" 2) ("multi" 2) ("PO (MULTI)" 2)
   ("-PO" 1) ("human acidic ribosomal phosphoprotein PO (RPLPO)" 1)
   ("RPLPO" 1)))
 ("UP:P27539" (("GDF1" 6) ("Gdf1" 1)))
 ("UP:P27540"
  (("ARNT" 492) ("HIF-1β" 126) ("Arnt" 113) ("aryl" 44) ("HIF1β" 22)
   ("aryl hydrocarbon receptor nuclear translocator" 21) ("ARNT protein" 6)
   ("ARNT Protein" 4)
   ("aryl hydrocarbon receptor nuclear translocator (ARNT)" 3) ("than ARNT" 1)
   ("Aryl" 1) ("Aryl hydrocarbon receptor nuclear translocator" 1)
   ("-HIF-1β" 1) ("aryl-" 1) ("HIF-1β protein" 1)))
 ("UP:P27544"
  (("CerS1" 238) ("LASS1" 36) ("LASS1 (CCT)" 6) ("ceramide synthase 1" 5)
   ("LASS1 (CGT)" 4) ("LAG1" 2) ("CERS1" 1) ("Cers1" 1) ("CerS1 protein" 1)))
 ("UP:P27559"
  (("SO 2" 26) ("–SO 2" 3) ("-SO 2" 2) ("a distinct lowered SO 2" 1)))
 ("UP:P27560" (("SO 3" 16) ("-SO 3" 2) ("–SO 3" 1)))
 ("UP:P27614" (("carboxypeptidase S" 1))) ("UP:P27622" (("tagC" 1)))
 ("UP:P27623"
  (("GCTs" 201) ("primary GCTs" 5) ("nearly all adult GCTs" 4)
   ("almost all morphologically identified adult-type GCTs" 1)
   ("primary and recurrent GCTs" 1) ("eight primary GCTs" 1)
   ("The 13 recurrent GCTs" 1) ("13 recurrent GCTs" 1) ("testicular GCTs" 1)
   ("the ovarian GCTs" 1) ("mice developed GCTs" 1)))
 ("UP:P27635" (("QM" 98) ("the original QM" 2)))
 ("UP:P27636" (("CDC15" 5) ("Cdc15" 2)))
 ("UP:P27658" (("COL8A1" 30) ("type VIII" 10)))
 ("UP:P27661" (("H2A.X" 293) ("p-H2A.X" 9) ("-H2A.X" 6)))
 ("UP:P27686" (("Mhr1" 2)))
 ("UP:P27694"
  (("RPA70" 156) ("RPA1" 36) ("single stranded DNA binding protein" 8)
   ("replication protein A1" 1)))
 ("UP:P27695"
  (("APE1" 1731) ("apex" 161) ("APEX1" 98) ("APEX" 61) ("Ref-1" 51) ("APE" 37)
   ("Ref1" 34) ("REF1" 31) ("APE1 protein" 29) ("Hap1" 24) ("Apex" 15)
   ("AP endonuclease 1" 8) ("APE-1" 8) ("HAP1" 6) ("targeting APE1" 4)
   ("pAPEX" 3) ("redox factor 1" 3) ("the intact APE1" 3)
   ("the orthologous zebrafish APE1" 2) ("APEX nuclease" 2) ("ref-1" 2)
   ("Ape1 protein" 2) ("Ape1" 2) ("non-acetylatable APE1" 2)
   ("exogenous APE1" 2) ("APEX1 protein" 2) ("transcriptional factors Hap1" 2)
   ("the cochlear apex" 2) ("APE1–" 2) ("ref 1" 1)
   ("we first examined APE1’s" 1) ("we first examined APE1" 1)
   ("residual endogenous APE1 protein" 1) ("x-ray crystallographic APE1" 1)
   ("The first 33 N-terminal amino acids of APE1" 1)
   ("than the full-length APE1" 1) ("cellular APE1" 1)
   ("than the intact APE1" 1) ("intact APE1" 1)
   ("the dual function protein Ref1" 1) ("ref1" 1)
   ("the non-acetylatable APE1" 1) ("more APE1" 1) ("redox factor-1" 1)
   ("NΔ33 abolished APE1’s" 1)
   ("RR APE1 ( xref ) indicating that acetylation enhances APE1’s" 1)
   ("the apurinic-apyrimidinic endonuclease APEX2" 1) ("HAP1 (GCG)" 1)
   ("the exact AMC emission apex" 1) ("APX" 1) ("Apex1" 1)))
 ("UP:P27701"
  (("CD82" 298) ("KAI1" 119) ("ia4" 7) ("ST6" 3) ("CD82-" 2) ("KAI-1" 2)))
 ("UP:P27705" (("Mig-1" 5)))
 ("UP:P27707"
  (("-deoxycytidine" 312) ("deoxycytidine" 293) ("dCK" 59)
   ("deoxycytidine kinase" 11) ("DCK" 7) ("Deoxycytidine" 3)
   ("-deoxycytidine (DAC)" 3) ("-deoxycytidine (AZA)" 2) ("-Deoxycytidine" 2)
   ("deoxycytidine (AZA)" 1) ("deoxycytidine kinase (DCK)" 1)))
 ("UP:P27708"
  (("dihydroorotase" 13) ("CaD protein" 8) ("CAD protein" 7)
   ("dihydroorotase (CAD)" 1) ("dihydroorotase protein" 1)
   ("Dihydroorotase" 1)))
 ("UP:P27760" (("antigene" 6))) ("UP:P27784" (("Ccl6" 2) ("CCL6" 1)))
 ("UP:P27796" (("FOX3" 5) ("Fox3" 2)))
 ("UP:P27797"
  (("CALR" 244) ("calreticulin" 53) ("calregulin" 11) ("Calreticulin" 10)
   ("CRTC" 9) ("endoplasmic reticulum called calreticulin" 1) ("Calregulin" 1)
   ("the ER resident calreticulin" 1)))
 ("UP:P27809" (("MNT1" 2)))
 ("UP:P27814"
  (("NK1.1" 83) ("-NK1.1" 3) ("Klrb1c" 2) ("NK1.1-" 1)
   ("thymic and splenic NK1.1" 1)))
 ("UP:P27815" (("cAMP-specific" 8)))
 ("UP:P27816"
  (("MAP4" 194) ("p-MAP4" 13) ("Map4" 10)
   ("Microtubule-associated protein 4" 6)
   ("microtubule-associated protein 4" 3) ("map4" 2)
   ("microtubule associated protein 4" 2)))
 ("UP:P27824" (("calnexin" 188) ("Calnexin" 45) ("CANX" 3) ("CALNEXIN" 1)))
 ("UP:P27825" (("CNE1" 168) ("CNE1-" 3) ("LMP1-negative cell line CNE1" 1)))
 ("UP:P27918"
  (("CFP" 971) ("PFC" 276) ("-CFP" 18) ("CFP-" 15) ("the rat medial PFC" 5)
   ("pCFP" 5) ("P/FC" 4) ("the medial PFC" 2)
   ("the human and monkey DLPFC and rat medial PFC" 2) ("Postnatal PFC" 2)
   ("the postmortem dorsal lateral PFC (DLPFC)" 2) ("medial PFC" 2) ("–CFP" 2)
   ("CFP–" 2) ("ventrolateral PFC" 2) ("super-enhanced CFP" 2)
   ("monkey DLPFC and rat medial PFC" 1)
   ("than control CFP ( P value 0.009)" 1) ("primary PFC" 1)
   ("pRetro-X-tight(puro)-Pak2(L106F)-CFP" 1) ("than CFP" 1)))
 ("UP:P27930"
  (("IL1R2" 17) ("IL-1R2" 9) ("Il1r2" 8) ("interleukin 1 receptor" 6)
   ("Interleukin 1 receptor" 2)))
 ("UP:P27986"
  (("PIK3R1" 911) ("pik3r1" 31) ("Pik3r1" 29) ("pik3R1" 10) ("p85alpha" 2)
   ("P27986" 1) ("p85-alpha" 1) ("PIK3R1 protein" 1) ("GRB1" 1)
   ("than PIK3R1" 1) ("PiK3r1" 1)
   ("expressed nonphosphorylatable mutant PIK3R1" 1)))
 ("UP:P28013"
  (("Chi 2" 56) ("chi 2" 13) ("Chi  2" 4) ("Chi-2" 4) ("chi2" 3) ("chi-2" 2)
   ("CHI 2" 2) ("Chi2" 1)))
 ("UP:P28026"
  (("Wnt8" 11) ("XWnt8" 8) ("Xwnt-8" 7) ("Xwnt8" 5) ("wnt8" 3) ("Wnt-8" 2)
   ("the ventrolateral mesodermal marker XWnt8" 1) ("xWnt8" 1) ("XWnt-8" 1)))
 ("UP:P28039" (("AOAH" 10)))
 ("UP:P28062"
  (("JMP" 181) ("LMP7" 13) ("PSMB8" 3) ("the statistical software JMP" 1)
   ("the statistical packages JMP" 1)))
 ("UP:P28065" (("LMP2" 62) ("LMP2-" 5) ("PSMB9" 2) ("Ring1/2" 2) ("β1i" 1)))
 ("UP:P28066" (("PSMA5" 3) ("proteasome subunit alpha type 5" 3) ("Psma5" 2)))
 ("UP:P28067" (("DMA" 144) ("The Monascus secondary metabolite DMA" 2)))
 ("UP:P28068" (("DMB" 15) ("HLA-DMB" 2)))
 ("UP:P28069"
  (("Pit-1" 173) ("PIT1" 10) ("POU1F1" 9) ("Pit1" 4)
   ("POU class 1 homeobox 1" 2) ("pit-1" 1)
   ("the critical lineage-determining factor Pit1" 1)))
 ("UP:P28070" (("PSMB4" 25) ("HsN3" 2) ("HN3" 2) ("PROS26" 1)))
 ("UP:P28072" (("PSMB6" 34))) ("UP:P28074" (("PSMB5" 10) ("Psmb5" 4)))
 ("UP:P28092" (("Wnt7" 5) ("wnt7" 2))) ("UP:P28148" (("TBP-2" 4)))
 ("UP:P28157" (("HuPO" 4) ("HUPO" 1)))
 ("UP:P28161" (("GSTM2" 7) ("glutathione S-transferase mu 2" 1) ("Gstm2" 1)))
 ("UP:P28178"
  (("protein kinase 2" 46) ("PKBR1" 13) ("PkbR1" 9) ("pkbR1" 4)
   ("ribosomal S6 protein kinase 2" 3)
   ("stress-activated c-Jun N-terminal protein kinase 2" 2)))
 ("UP:P28221" (("HTR1D" 2)))
 ("UP:P28222"
  (("S12" 137) ("5-HT 1B" 39) ("5-HT1B" 4) ("HTR1B" 1) ("5-HT1B receptor" 1)
   ("htr1b" 1)))
 ("UP:P28223"
  (("5-HT 2A" 40) ("HTR2A" 37) ("5-HT2A receptor" 3) ("5-HT2A" 2) ("HTR2" 1)
   ("HTR2A-" 1)))
 ("UP:P28288" (("PMP70" 18) ("ABCD3" 6))) ("UP:P28293" (("VSP" 7)))
 ("UP:P28300"
  (("LOX" 785) ("lox" 379) ("Lox" 135) ("5-LOX" 64) ("lysyl oxidase" 31)
   ("Lysyl oxidase" 6) ("pLOX" 6) ("“two-lox”" 3)
   ("BRaf CA mice heterozygous forPten lox" 3) ("-LOX" 3) ("“one-lox”" 2)
   ("Lysyl oxidase (LOX)" 1) ("cisplatin-treated Lox" 1) ("LOX protein" 1)))
 ("UP:P28301" (("rrg" 3))) ("UP:P28304" (("quinone oxidoreductase-1" 39)))
 ("UP:P28321" (("MGH" 158)))
 ("UP:P28324"
  (("ELK4" 223) ("Elk4" 3) ("ELK4-" 1)
   ("the cancer-associated ETS transcription factor ELK4" 1)))
 ("UP:P28325"
  (("CST5" 111) ("CST5 protein" 8) ("cystatin D" 6) ("Cystatin D" 4)))
 ("UP:P28328" (("PEX2" 3) ("pEX2" 1)))
 ("UP:P28329"
  (("ChAT" 94) ("ChAt" 25) ("choline acetyltransferase" 16) ("CHAT" 9)
   ("choline acetyltransferase (CHAT)" 5) ("Chat" 2)
   ("Choline Acetyltransferase" 1)))
 ("UP:P28330" (("long chain" 54) ("LCAD" 15) ("ACADL" 3) ("Long chain" 2)))
 ("UP:P28331"
  (("NDUFS1" 6) ("NADH–ubiquinone oxidoreductase 75 kDa subunit" 6)
   ("Ndufs1" 3)))
 ("UP:P28332" (("ADH6" 1)))
 ("UP:P28335"
  (("5-HT 2C" 210) ("HTR2C" 30) ("5-hydroxytryptamine receptor 2C" 2)
   ("5-HT2C" 1)))
 ("UP:P28336" (("NMBR" 5)))
 ("UP:P28340" (("POLD1" 57) ("pold1" 1) ("Pold1" 1)))
 ("UP:P28347"
  (("TEAD1" 256) ("Tead1" 21) ("transcription factor 1-3" 4)
   ("TEAD1 protein" 2) ("peripapillary chorioretinal degeneration" 1)))
 ("UP:P28356" (("HOXD9" 3)))
 ("UP:P28358"
  (("HOXD10" 99) ("Hox" 75) ("hox" 9) ("Hox protein" 4) ("phox" 1)
   ("HoxD10" 1)))
 ("UP:P28360" (("MSX1" 41) ("Msx1" 8) ("msh homeobox 1" 2)))
 ("UP:P28370" (("SMARCA1" 13) ("Snf2l" 6) ("SNF2L" 2)))
 ("UP:P28467" (("ACEA" 45))) ("UP:P28472" (("GABRB3" 6)))
 ("UP:P28482"
  (("ERK2" 2498) ("Erk2" 618) ("MAPK1" 373) ("ERK-2" 146) ("p42 MAPK" 44)
   ("pERK2" 44) ("p-ERK2" 27) ("extracellular signal-regulated kinase 2" 16)
   ("mitogen-activated protein kinase 1" 14) ("ERK 2" 13) ("ERK2 protein" 10)
   ("Erk2 protein" 8) ("ERK2-CA" 7) ("Mitogen-activated protein kinase 1" 6)
   ("Erk-2" 6) ("ERK2 molecule" 6) ("MAPK1 protein" 5) ("MAPK2" 4) ("Mapk1" 4)
   ("pERK-2" 4) ("MAPK 1" 3) ("pure ERK2" 3) ("MAP kinase 1" 3) ("P28482" 2)
   ("pMAPK1" 2) ("p42-MAPK" 2) ("ERK/2" 2) ("Erk2 peptide" 2) ("P42 MAPK" 2)
   ("erk2" 2) ("exogenous ERK2" 1) ("especially ERK2 protein" 1)
   ("Mitogen activated protein kinase 1" 1)
   ("mitogen-activated protein kinase 2" 1) ("lentiviral ERK2" 1)
   ("than wild type ERK2 ( xref )" 1) ("different lentiviral ERK2" 1)
   ("p-p42 MAPK" 1) ("p42mapk" 1) ("ERK2-" 1) ("ERK-2 protein" 1) ("p-ERK/2" 1)
   ("phospho-ERK2/total ERK2" 1) ("dominant-negative ERK2 K52R" 1)
   ("mitogen-activated protein kinase-1" 1) ("than Erk2" 1)
   ("dual phosphorylated (pp)ERK2" 1) ("than ERK-2" 1) ("–ERK2" 1)))
 ("UP:P28493" (("PR5" 8)))
 ("UP:P28562"
  (("MKP-1" 1164) ("DUSP1" 808) ("MKP1" 366) ("Mkp-1" 68) ("Dusp1" 59)
   ("VH1" 24) ("mitogen-activated protein kinase phosphatase-1" 18)
   ("MKP-1 protein" 17) ("dual specificity phosphatase 1" 14) ("Mkp1" 10)
   ("MAP kinase phosphatase-1" 9) ("dual specificity phosphatase-1" 9)
   ("DUSP1 protein" 6) ("MKP1 protein" 6) ("dusp1" 5)
   ("Dual specificity phosphatase 1" 4) ("CL100" 4)
   ("total and phosphorylated MKP-1 protein" 4) ("overexpressed MKP-1" 4)
   ("p-MKP-1" 4) ("mouse monoclonal MKP-1" 3)
   ("Mitogen-activated protein kinase phosphatase-1" 3)
   ("non-functional MKP-1" 3) ("MAP kinase phosphatase 1" 3)
   ("endothelial MKP-1" 2) ("the residual MKP1" 2) ("weak and diffuse MKP-1" 2)
   ("the low steady state immunoreactive MKP-1" 2)
   ("Dual specificity phosphatase-1" 2) ("pDUSP1" 2) ("MKP-1-" 1)
   ("radiation-induced MKP1" 1) ("pMKP1" 1)
   ("miR-101 directly targets DUSP1" 1)
   ("both total and phosphorylated MKP-1 protein" 1)
   ("Occasional and faint cytoplasmic MKP-1" 1)
   ("mitogen activated protein kinase phosphatase-1" 1)
   ("three major MKP-1's" 1) ("three major MKP-1" 1)
   ("Lentiviral-expressed MKP-1" 1) ("Viral infusions increased Mkp-1" 1)
   ("exogenous MKP-1" 1) ("DUSP-1" 1)))
 ("UP:P28584" (("Trk2" 1))) ("UP:P28586" (("Lectin I" 3)))
 ("UP:P28615" (("HNO" 18)))
 ("UP:P28617"
  (("methionine aminopeptidase" 2) ("MetAP" 2) ("the online software MetaP" 2)
   ("MetaP" 2)))
 ("UP:P28628"
  (("SIPS" 189) ("particular SIPS" 2) ("The radiation-induced SIPS" 2)
   ("Radiation-induced SIPS" 1)))
 ("UP:P28676" (("GCL" 140) ("GCAs" 6) ("pGCL" 3)))
 ("UP:P28698"
  (("MZF-1" 112) ("MZF1" 80) ("myeloid zinc finger 1" 6) ("MZF-1 protein" 3)
   ("overexpressed MZF-1" 3) ("Myeloid zinc finger 1" 2)))
 ("UP:P28702"
  (("retinoid X receptor" 49) ("retinoid X receptor (RXR)" 9)
   ("Retinoid X receptor" 5) ("RXRB" 4) ("Retinoid X receptor (RXR)" 1)
   ("retinoid X receptor-" 1) ("Retinoid X Receptor Beta" 1)
   ("Retinoid X Receptor" 1)))
 ("UP:P28707" (("Sba1" 8) ("Sba1 (= yeast p23) molecule" 2)))
 ("UP:P28715"
  (("ERCC5" 58) ("Cockayne syndrome" 29) ("complementation group G" 5)
   ("complementation group G (XPG)" 2) ("ERCC5 protein" 2)
   ("Cockayne syndrome (CS)" 2)
   ("The structure-specific endonuclease xeroderma pigmentosum complementation group G (XPG)"
    1)))
 ("UP:P28749"
  (("p107" 446) ("RBL1" 50) ("p107 protein" 10) ("Rbl1" 8) ("P107" 7)
   ("RBL-1" 4) ("retinoblastoma-like 1" 4) ("the leukemic cell line RBL-1" 2)
   ("-p107" 2) ("their transcriptional inhibitor p107" 1)
   ("very little p107" 1)))
 ("UP:P28799"
  (("GRN" 196) ("progranulin" 15) ("PGRN" 5) ("granulin" 5) ("Progranulin" 4)
   ("GRNs" 4) ("Granulin" 3) ("pGRN" 2) ("progranulin (PGRN)" 1)
   ("the essential CNS growth factor progranulin" 1) ("available GRN" 1)
   ("functional GRN" 1)))
 ("UP:P28819" (("ADCs" 116) ("small-sized ADCs" 1))) ("UP:P28821" (("PABC" 4)))
 ("UP:P28827" (("RPTPμ" 5) ("PTPRM" 2) ("Ptprm" 1))) ("UP:P28829" (("BYR2" 1)))
 ("UP:P28838" (("LAP3" 1))) ("UP:P28845" (("HSD11B1" 21) ("HSD11" 2)))
 ("UP:P28867" (("PKCD" 5) ("conjugated peptide PKCD2" 1)))
 ("UP:P28906"
  (("CD34" 2150) ("CD34-" 20) ("CD34 antigen" 7) ("CD34−" 3)
   ("significantly less CD34" 3) ("-CD34" 3) ("coexpressed CD34" 3)
   ("the panendothelial cell marker CD34" 2) ("using human Indirect CD34" 1)
   ("CD34 (FITC)" 1) ("the panendothelial marker CD34" 1)
   ("more mature CD34" 1)))
 ("UP:P28907"
  (("CD38" 954) ("CD38-" 20) ("CD38−" 16) ("Lyn-associated CD38" 2)
   ("CD38 protein" 2) ("more intense CD38" 2) ("so little basal CD38" 1)
   ("further upregulating astrocyte-CD38" 1)))
 ("UP:P28908"
  (("CD30" 310) ("KI1" 20) ("TNFRSF8" 7) ("CD30−" 2)
   ("only full-length CD30" 1) ("CD30-" 1)))
 ("UP:P28957" (("Vhs" 4) ("approximately 52,900 Vhs" 1)))
 ("UP:P29016" (("CD1b" 16) ("B polypeptide" 5)))
 ("UP:P29017" (("CD1c" 16) ("CD1c−" 1) ("BDCA-1" 1) ("C polypeptide" 1)))
 ("UP:P29033"
  (("Cx26" 215) ("hisD" 14) ("HisD" 11) ("connexin 26" 6) ("GJB2" 4)
   ("chimeric Cx26" 2) ("functional Cx26" 1)
   ("GJIC-deficient chimeric Cx26" 1)))
 ("UP:P29034" (("S100A2" 167) ("-S100A2" 1) ("S100A2-" 1)))
 ("UP:P29074"
  (("MeG" 79) ("-MeG" 50) ("-meG" 43) ("meG" 34) ("than O  6 -MeG" 1)))
 ("UP:P29082" (("SOR" 6))) ("UP:P29083" (("TFIIEα" 3)))
 ("UP:P29084" (("TFIIEβ" 3) ("Gtf2e2" 1)))
 ("UP:P29120"
  (("Nec-1" 153) ("PCSK1" 13) ("prohormone convertase 1" 8) ("NEC1" 3)
   ("Nec1" 3)))
 ("UP:P29122" (("PCSK6" 3) ("Pcsk6" 1) ("PACE4" 1))) ("UP:P29144" (("TPP2" 2)))
 ("UP:P29166" (("cpi" 21) ("CPI" 13) ("a monofunctional CPI" 1)))
 ("UP:P29202" (("HS2" 31)))
 ("UP:P29218" (("IMP-1" 160) ("IMPA1" 2) ("IMP-1 protein" 1)))
 ("UP:P29241" (("NADase" 3) ("the major NADase" 2)))
 ("UP:P29274" (("ADORA2A" 10) ("ADORA2" 1)))
 ("UP:P29275" (("ADORA2B" 37) ("Adora2b" 1)))
 ("UP:P29279"
  (("CTGF" 1207) ("CCN2" 653) ("connective tissue growth factor" 103)
   ("Ctgf" 17) ("Connective tissue growth factor" 17)
   ("connective tissue growth factor (CTGF)" 15)
   ("connective-tissue growth factor" 7)
   ("connective tissue growth factor ( CTGF )" 5) ("CCN2 (CTFG)" 3)
   ("the fibrogenic mediator CTGF" 2) ("CCN2 protein" 2)
   ("intracellular dimeric CTGF" 2) ("targeting CCN2" 2)
   ("the pro-fibrotic marker CCN2" 2)
   ("connective-tissue growth factor (CTGF)" 1)
   ("the well-characterized Yap target CTGF" 1) ("NRG1 increased CTGF" 1)
   ("its known profibrotic effects CCN2" 1)
   ("Connective Tissue Growth Factor CTGF" 1)
   ("Adenoviral siRNA sequence CCAAGCCTATCAAGTTTGA targeting CCN2" 1)
   ("Exogenous CCN2" 1) ("exogenous CCN2" 1) ("membranous CCN2" 1)))
 ("UP:P29295" (("Hrr25" 6) ("-Hrr25" 4) ("hrr25" 3)))
 ("UP:P29311" (("BMH1" 13) ("Bmh1" 11) ("bmh1" 8)))
 ("UP:P29317"
  (("EphA2" 1015) ("ephrin" 73) ("ephrins" 31) ("EPHA2" 30) ("Ephrin" 27)
   ("pEphA2" 17) ("EphA2 protein" 13) ("p-EphA2" 9) ("Ephrins" 8) ("EcK" 4)
   ("EphA2 (SA)" 4) ("overexpressed EphA2" 3) ("Wild Type EphA2" 2)
   ("dimerized EphA2" 2) ("functional EphA2" 2) ("the more EphA2" 1)
   ("ephrins (EPH)" 1) ("Ser-897-phosphorylated EphA2" 1) ("eck" 1)))
 ("UP:P29320"
  (("HEK" 2038) ("EPHA3" 27) ("ETK" 27) ("EphA3" 15) ("Etk" 15) ("HEKs" 4)
   ("HEK-" 3) ("pETK" 3) ("adjacent HEK" 2) ("neighboring HEK" 1)
   ("noncancerous HEK-293T" 1) ("parental HEK" 1)))
 ("UP:P29322" (("EphA8" 15) ("EPHA8" 3) ("“EEK”" 1) ("EEK" 1)))
 ("UP:P29323"
  (("EphB2" 243) ("EPHB2" 21) ("Drt" 2) ("the exogenous EphB2" 1)
   ("neuronal EphB2" 1)))
 ("UP:P29327" (("hEN" 2) ("HeN" 1)))
 ("UP:P29337"
  (("BCC" 559) ("histologically proven BCC" 4)
   ("superficial and infiltrative BCC" 3)
   ("histologically proven invasive BCC" 2) ("than BCC" 2) ("cutaneous BCC" 2)
   ("a nodular BCC" 1) ("Nodular BCC" 1) ("nodular BCC" 1)
   ("Eastern European BCC" 1) ("364 new BCC" 1) ("Sporadic BCC" 1)
   ("genotyping additional Icelandic BCC" 1)
   ("an additional 903 Icelandic BCC" 1) ("Cutaneous BCC" 1)
   ("about 2600 available self-reported BCC" 1) ("300 self-reported BCC" 1)
   ("300 incident BCC" 1) ("HH-driven BCC" 1)))
 ("UP:P29349" (("CSW" 2) ("csw" 1)))
 ("UP:P29350"
  (("SHP-1" 862) ("SHP-1 protein" 22) ("PTPN6" 7)
   ("SHP-1 (SHP-1 C453S) protein" 3) ("HCPs" 3) ("SH-PTP1" 2) ("PTP1C" 2)
   ("PTP-1C" 2) ("only seven (35%) positive SHP-1" 1) ("shp-1" 1)
   ("bivalent HCPs" 1) ("shPTP1" 1)))
 ("UP:P29353"
  (("Shc" 2236) ("SHC" 303) ("SHC1" 204) ("ShcA" 85) ("Shc1" 64)
   ("Shc protein" 57) ("Shc-1" 53) ("shc-1" 26) ("shc" 22) ("shC" 20)
   ("pShc" 11) ("shcA" 5) ("p-SHC" 3) ("P-p66Shc" 3) ("SHC protein" 3)
   ("ShcA protein" 3) ("Shc-1 protein" 2) ("more ShcA" 2)
   ("Tyr239/240-phosphorylated ShcA" 2) ("Shc-" 2) ("SHC1-" 2)
   ("control SHC004" 1) ("-Shc1" 1) ("shorter p52 Shc" 1) ("ShC1" 1)
   ("p-Shc" 1) ("residual Shc protein" 1) ("that Shc's" 1)
   ("the phosphorylated tyrosine of Shc" 1) ("SHC-1" 1) ("a SHC’s" 1)
   ("shc-" 1) ("than Shc" 1) ("the exogenous Shc" 1)))
 ("UP:P29355" (("Sem5" 4) ("SEM-5" 2) ("Sem5 protein" 1)))
 ("UP:P29366" (("Bem1" 7) ("BEM1" 1)))
 ("UP:P29371" (("TACR3" 16) ("NK-3R" 6) ("HH11" 5) ("NKR" 3)))
 ("UP:P29372"
  (("AAG" 1472) ("MPG" 234) ("aag" 43) ("-AAG" 41) ("AAGOE" 23) ("AAG AAG" 19)
   ("AAg" 12) ("N-methylpurine DNA glycosylase" 5) ("A-A-G" 5) ("pig11" 5)
   ("N-methylpurine-DNA glycosylase" 3)
   ("N-methylpurine-DNA glycosylase (MPG)" 2) ("ANPG" 1) ("-aag" 1) ("A–A-G" 1)
   ("almost no AAG" 1) ("AAG (MPG)" 1) ("PIG11" 1)))
 ("UP:P29373"
  (("CRABP2" 9) ("CRABP-II" 5) ("cellular retinoic acid–binding protein II" 2)
   ("cellular retinoic acid binding protein 2" 2)))
 ("UP:P29375"
  (("KDM5A" 20) ("JARID1A" 16) ("Retinoblastoma binding protein 2" 5)
   ("Jarid1a" 2) ("JARID1a" 1)))
 ("UP:P29376" (("LTK" 36) ("TYK1" 1)))
 ("UP:P29380" (("CC1" 138) ("expressed mature markers CC1" 1) ("-CC1" 1)))
 ("UP:P29391" (("Ftl1" 3)))
 ("UP:P29400" (("alpha 5" 23) ("COL4A5" 4) ("Alpha 5" 2)))
 ("UP:P29401"
  (("TK" 1534) ("tk" 23) ("pTK" 16) ("tsK" 11) ("transketolase" 7) ("TK-" 5)
   ("TK protein" 4) ("the particular TK" 3) ("Tk" 3) ("transketolase (TKT)" 2)
   ("targeted TK" 2) ("driving TK" 2) ("“TK”" 2) ("-TK" 2) ("Transketolase" 1)
   ("VEGFR2 TK (cediranib)" 1) ("the TK" 1) ("”" 1) ("a hyperactive TK" 1)
   ("Fusion TK's" 1)))
 ("UP:P29447" (("TRX-C" 2)))
 ("UP:P29459"
  (("IL12A" 76) ("IL-12A" 13) ("interleukin 12" 8) ("Interleukin 12" 5)
   ("p35)" 3) ("more interleukin 12" 2) ("Il12a" 2) ("P35)" 1)))
 ("UP:P29460"
  (("IL-12p40" 91) ("IL12B" 75) ("P40)" 37) ("p40)" 11) ("IL-12p40–" 10)
   ("IL-12B" 5) ("Il12p40" 3) ("−p40)" 2) ("Il12b" 1) ("most IL-12p40–" 1)
   ("subunit p40" 1) ("less IL-12p40" 1)))
 ("UP:P29461" (("protein-tyrosine phosphatase-2" 4)))
 ("UP:P29465" (("KIT2" 8)))
 ("UP:P29466"
  (("caspase-1" 369) ("Caspase-1" 135) ("caspase 1" 35) ("CASP1" 27)
   ("procaspase-1" 20) ("caspases-1" 8)
   ("apoptosis-related cysteine peptidase" 8) ("Caspase1" 3) ("Caspase 1" 3)
   ("inflammasome-associated caspase-1" 2) ("Casp1" 2) ("P29466" 1)
   ("the inflammatory CASP1" 1) ("functional caspase-1" 1)
   ("inflammatory caspases-1" 1) ("caspases−1" 1)))
 ("UP:P29474"
  (("eNOS" 4514) ("NOS3" 302) ("endothelial NOS" 22) ("eNOS protein" 18)
   ("nitric oxide synthase 3" 11) ("p-eNOS" 5) ("phosphodefective eNOS" 4)
   ("-eNOS" 3) ("eNOS eNOS" 3) ("the cell membrane-associated eNOS" 2)
   ("Nos3" 2) ("eNos" 2) ("Endothelial NOS" 2) ("aspirin-acetylated eNOS" 2)
   ("phospho-mimetic S116D eNOS" 2) ("Endothelial nitric oxide synthase 3" 2)
   ("a monoclonal antibodyto eNOS" 2) ("NOS3 protein" 1)
   ("dysfunctional eNOS" 1) ("associated eNOS" 1) ("eNOS,  xref" 1)
   ("P-eNOS" 1) ("nitric oxide synthase-3" 1)
   ("the phospho-mimetic eNOS protein" 1) ("Nitric oxide synthase 3" 1)
   ("caveolar-localized endothelial NOS" 1)
   ("phosphodefective (S1177A) eNOS" 1) ("Quiescent eNOS" 1)
   ("hyperactive eNOS" 1)))
 ("UP:P29475" (("nNOS" 83) ("NOS1" 67) ("neuronal NOS" 17) ("nNOS-" 1)))
 ("UP:P29484" (("TCPS" 29) ("rigid TCPS" 2)))
 ("UP:P29508"
  (("SCCs" 684) ("SCCAs" 31) ("SCCA" 26) ("SERPINB3" 13) ("cervical SCCs" 12)
   ("T4a" 8) ("cutaneous SCCs" 6) ("invasive SCCs" 4) ("Serpin B3" 4)
   ("UV-induced SCCs" 3) ("oesophageal SCCs" 3) ("autochthonous SCCs" 2)
   ("human primary SCCs" 2) ("human cutaneous SCCs" 2)
   ("well-differentiated SCCs" 2) ("neonatal UVB-induced SCCs" 2)
   ("esophageal SCCs" 2) ("serpin B3" 2) ("metastatic cutaneous SCCs" 2)
   ("squamous cell carcinoma antigen-1" 2) ("primary oesophageal SCCs" 2)
   ("just 14% SCCs" 2) ("a small group uterine cervical SCCs" 2)
   ("some cervical and anal SCCs" 2) ("anal SCCs" 2)
   ("UV-induced mouse SCCs" 2) ("primary SCCs" 1) ("cervical and oral SCCs" 1)
   ("HPV-positive oropharyngeal SCCs" 1) ("Serpinb3" 1)
   ("squamous cell carcinoma antigen 1" 1) ("aggressive SCCs" 1)
   ("this xenograft cutaneous SCCs" 1) ("than oral SCCs" 1) ("SCCs (PDSCC)" 1)
   ("Lkb1  +/− mice developed SCCs" 1) ("transplantation-induced SCCs" 1)
   ("either spontaneous SCCs" 1) ("FAK-expressing SCCs" 1)
   ("FA associated SCCs" 1) ("serpinB3" 1) ("the 17 cervical SCCs" 1)
   ("the 3 cervical SCCs" 1) ("than SCCs" 1)
   ("the Pten cKO mice developed SCCs" 1)
   ("HPV+ oropharyngeal and cervical SCCs" 1)
   ("nearly all HPV-associated cervical and oral SCCs" 1)
   ("transformed and metastatic murine SCCs" 1) ("uterine cervical SCCs" 1)
   ("uterine cervical and anal SCCs" 1) ("cervical and anal SCCs" 1)
   ("the 15 anal SCCs" 1) ("15 invasive anal SCCs" 1)
   ("resected mouse cutaneous SCCs" 1) ("UV-induced skin SCCs" 1)
   ("overt SCCs" 1)))
 ("UP:P29523" (("MALP" 38))) ("UP:P29558" (("SCR2" 8) ("RBMS1" 3)))
 ("UP:P29590"
  (("PML" 2777) ("promyelocytic leukemia" 205) ("Pml" 67) ("PML protein" 54)
   ("promyelocytic" 53) ("RING finger protein" 52)
   ("acute promyelocytic leukemia" 38) ("promyelocytic leukemia protein" 33)
   ("PMLIV" 28) ("acute promyelocytic leukemia (APL)" 21) ("PMLs" 21)
   ("promyelocytic leukemia protein (PML)" 17) ("TRIM19" 12)
   ("promyelocytic leukemia protein (PML) protein" 7)
   ("promyelocytic leukemia (PML) protein" 7) ("Promyelocytic leukemia" 5)
   ("promyelocytic leukemia (PML)" 5) ("Promyelocytic leukemia protein" 4)
   ("Acute promyelocytic leukemia (APL)" 3)
   ("the acute promyelocytic leukemia (APL)" 3) ("Promyelocytic" 3)
   ("exogenous PML" 3) ("Promyelocytic leukemia (PML) protein" 2)
   ("acute promyelocytic leukemia (APML)" 2)
   ("predominantly acute promyelocytic leukemia" 2) ("defective PML" 1)
   ("protein PML" 1) ("ProMyelocytic" 1) ("specific cysteines of PML" 1)
   ("than promyelocytic leukemia [ xref ]" 1)
   ("than acute promyelocytic leukemia (APL)" 1) ("than wild-type PML" 1)
   ("PML–" 1) ("newly diagnosed acute promyelocytic leukemia (APL)" 1)
   ("that PML’s" 1) ("reduced PML’s" 1)
   ("relapsed/refractory acute promyelocytic leukemia (APL)" 1)
   ("dysfunctional PML" 1) ("very faint PML" 1)
   ("the promyelocytic leukemia–associated protein Pml" 1) ("protein Pml" 1)
   ("the growth-suppressive promyelocytic leukemia protein (PML)" 1)
   ("childhood acute promyelocytic leukemia (APL)" 1)
   ("particular acute promyelocytic leukemia" 1) ("the original PML" 1)
   ("PP8675" 1) ("RNF71" 1)
   ("Both trials excluded PML/RARα positive acute promyelocytic leukemia" 1)))
 ("UP:P29597"
  (("TYK2" 852) ("Tyk2" 305) ("tyrosine kinase 2" 54) ("Tyrosine kinase 2" 12)
   ("Tyk-2" 7) ("TYK2 protein" 6)
   ("the intronic variant IVS22+112T (higher frequency with SVR) TYK2 -2256A"
    4)
   ("TYK-2 protein" 2) ("tyk2" 2)
   ("The autoimmunity-associated TYK2 variants TYK2 I684S" 1)
   ("further support TYK2" 1) ("TYK-2" 1)))
 ("UP:P29622"
  (("PI4" 143) ("regional PI4" 7) ("kallistatin" 4) ("global PI4" 4)
   ("SERPINA4" 2) ("the global PI4" 2) ("PIPKIγ-generated local PI4" 1)
   ("the local PI4" 1) ("local PI4" 1) ("global cellular PI4" 1)
   ("cellular PI4" 1)))
 ("UP:P29675" (("SF3" 7) ("sf3" 7))) ("UP:P29692" (("EEF1D" 13) ("EF-1δ" 1)))
 ("UP:P29728" (("OAS2" 3) ("oas2" 2))) ("UP:P29742" (("CHC" 122) ("pCHC" 1)))
 ("UP:P29754" (("AT1a" 1))) ("UP:P29760" (("GAII" 33)))
 ("UP:P29762" (("CRABP1" 35)))
 ("UP:P29769"
  (("micrococcal nuclease" 173) ("Micrococcal nuclease" 24)
   ("micrococcal nuclease (NEB)" 2)))
 ("UP:P29782" (("STRE" 3)))
 ("UP:P29820" (("Rot" 36) ("ROT" 35) ("prot" 2) ("the regular ROT" 1)))
 ("UP:P29822"
  (("place" 115) ("LACE" 13) ("Lace" 4) ("lace" 1)
   ("a local tumoural recurrence took place" 1)))
 ("UP:P29832" (("IE3" 16) ("Ies3" 7)))
 ("UP:P29965"
  (("CD40L" 364) ("CD154" 361) ("CD40 ligand" 53) ("CD40LG" 27)
   ("hyper-IgM syndrome" 6) ("Recombinant soluble CD40L" 4) ("CD40L-" 3)
   ("soluble (s)CD40L" 2) ("CD40L protein" 2) ("TNFSF5" 1) ("given CD40L" 1)
   ("the multipotent immunomodulator CD40L" 1)
   ("either multimeric human CD154" 1) ("using either soluble CD40L" 1)
   ("Soluble CD40 ligand" 1) ("HIGM1" 1) ("CD40 Ligand" 1) ("soluble CD40L" 1)
   ("Human recombinant soluble CD40L" 1) ("gp39" 1) ("Human chimeric CD154" 1)
   ("chimeric CD154" 1) ("less CD154" 1) ("hCD40L" 1)))
 ("UP:P29966" (("MACS" 411) ("MARCKS" 64) ("p-MARCKS" 9) ("pMACS" 7)))
 ("UP:P29972"
  (("AQP1" 46) ("aquaporin-1" 9) ("Aquaporin-1" 4)
   ("aquaporin 1 (Colton blood group)" 3) ("aquaporin-1 protein" 2)
   ("Aqp1" 2)))
 ("UP:P29973" (("CNGA1" 99) ("rp49" 2) ("CNG1" 2) ("pCNCG" 1)))
 ("UP:P29992" (("GNA11" 47))) ("UP:P30005" (("U47" 34)))
 ("UP:P30008"
  (("SIR" 239) ("SIR protein" 1) ("the formal adjusted SIR" 1)
   ("a statistically significant overall invasive breast cancer SIR" 1)
   ("pSIR" 1)))
 ("UP:P30038"
  (("ALDH4" 4) ("aldehyde dehydrogenase 4 family member A1" 4) ("ALDH4A1" 2)))
 ("UP:P30040" (("ERP29" 11) ("endoplasmic reticulum protein 29" 2)))
 ("UP:P30041"
  (("Prdx6" 38) ("peroxiredoxin 6" 13) ("24 kDa protein" 6)
   ("peroxiredoxin-6" 3) ("peroxiredoxin-6 protein" 3) ("Prdx6 protein" 2)
   ("1-Cys peroxiredoxin" 2) ("peroxiredoxin6" 1) ("Peroxiredoxin 6" 1)
   ("24 KDa protein" 1) ("24 kDa protein" 1)))
 ("UP:P30042" (("GT335" 8)))
 ("UP:P30043"
  (("FR" 150) ("F/R" 33) ("FLR" 24) ("fr" 5) ("BLVRB" 3) ("Fr" 2)
   ("CDK6-dependent cell growth made FR" 1) ("Hirsch FR’s" 1)
   ("NADPH-flavin reductase" 1) ("Blvrb" 1)))
 ("UP:P30044"
  (("Alu" 940) ("ALU" 24) ("PRDX5" 6) ("alu" 2) ("repetitive Alu" 2)
   ("intronic Alu" 2) ("the proximal and distal Alu" 1)
   ("thioredoxinreductase" 1) ("the abundant genomic Alu" 1)
   ("particular Alu" 1) ("complementary Alu" 1) ("the repetitive Alu" 1)
   ("peroxiredoxin 5" 1) ("many other highly-related Alu" 1)
   ("breakpoints around Alu" 1) ("the intronic Alu" 1)
   ("numerous intragenic Alu" 1) ("the individual Alu ’s" 1) ("exonic Alu" 1)
   ("the 13 exonic Alu" 1) ("-ALU (AAAAT)" 1) ("-ALU" 1) ("Alu-" 1)))
 ("UP:P30046"
  (("D-DT" 251) ("DDT" 86) ("ddCt" 27) ("ddCT" 13) ("DDCt" 10) ("-DDT" 9)
   ("D-dopachrome tautomerase" 7) ("−ddCt" 4) ("−ddCT" 3) ("D-DTs" 2)
   ("-ddCt" 2) ("ectopically-expressed D-DT" 1) ("adenoviral D-DT" 1)
   ("the biologic function(s) D-DT" 1) ("-DDCt" 1) ("−DDCt" 1)))
 ("UP:P30048"
  (("peroxiredoxin 3" 20) ("PRDX3" 19) ("peroxiredoxin III" 3)
   ("peroxiredoxin-3" 2) ("Peroxiredoxin III" 2)))
 ("UP:P30049" (("delta subunit" 9) ("ATP5D" 1) ("Atp5d" 1)))
 ("UP:P30050" (("Rpl12" 1))) ("UP:P30075" (("cHS4" 1)))
 ("UP:P30084" (("short chain" 15))) ("UP:P30085" (("C-K" 5) ("UCK" 3)))
 ("UP:P30086"
  (("RKIP" 3502) ("pRKIP" 90) ("HCNP-pp" 74) ("ATCC" 44) ("PEBP1" 29)
   ("RKIP protein" 26) ("Raf kinase inhibitor protein" 21) ("PEBP" 18)
   ("HCNP" 14) ("PEBP-1" 13) ("Raf kinase inhibitor protein (RKIP)" 9)
   ("Phosphatidylethanolamine binding protein 1" 6) ("pRKIP peptide" 4)
   ("rabbit monoclonal anti-human RKIP" 3) ("overexpressed RKIP" 3)
   ("RAF kinase inhibitor protein" 2)
   ("phosphatidylethanolamine binding protein 1" 2)
   ("miR-27a directly targets RKIP" 2) ("PEBPs" 2) ("Overexpressed RKIP" 2)
   ("p-RKIP" 2) ("RKIP (ATCC)" 2) ("pEbp1" 2) ("BXB bypasses RKIP's" 1)
   ("review RKIP’s" 1) ("particular HCNP" 1)
   ("phosphatidylethanolamine binding protein1" 1) ("15 N-Enriched RKIP" 1)
   ("pRKIP protein" 1)))
 ("UP:P30101"
  (("ERp57" 162) ("PDIA3" 17) ("overexpressed ERp57" 6) ("Erp57" 6) ("58kDa" 3)
   ("GRP58" 3) ("ERP60" 1) ("ER-60" 1) ("P30101" 1) ("ERP57" 1)))
 ("UP:P30153" (("PPP2R1A" 22) ("PR65A" 7))) ("UP:P30154" (("PPP2R1B" 72)))
 ("UP:P30196" (("EPIC" 129)))
 ("UP:P30203"
  (("t 1/2" 170) ("t  1/2" 114) ("T 1/2" 26) ("CD6" 14) ("T  1/2" 3) ("cd6" 3)
   ("shorter T 1/2" 1) ("accelerated AC t  1/2" 1)))
 ("UP:P30260"
  (("Cdc27" 194) ("CDC27" 77) ("cdc27" 7)
   ("the C-terminal 20 amino acids of Cdc27" 1)
   ("the antigenic Cdc27 peptide" 1) ("Cdc27 peptide" 1)))
 ("UP:P30273" (("FcRγ" 24) ("FCER1G" 2)))
 ("UP:P30279"
  (("cyclin D2" 682) ("CCND2" 585) ("Ccnd2" 14) ("cyclin D2 protein" 6)
   ("CYCLIN D2" 2) ("a viral homolog of cellular cyclin D2" 2)
   ("associated
                    cyclin D2"
    2)
   ("total cellular
                    cyclin D2"
    2)
   ("ccnd2" 1) ("phosphodeficient CCND2" 1) ("Ccnd2-" 1) ("than cyclin D2" 1)))
 ("UP:P30281"
  (("cyclin D3" 638) ("CCND3" 266) ("Ccnd3" 6) ("CCND3 protein" 5)
   ("CYCLIN D3" 4) ("cyclin D3 protein" 2) ("than CCND3" 2)
   ("CYCLIN D3 protein" 2) ("cyclin D3-" 1) ("at least cyclin D3" 1)))
 ("UP:P30283" (("CLB5" 1)))
 ("UP:P30291"
  (("Wee1" 630) ("WEE1" 190) ("wee1" 33) ("Wee-1" 6) ("Wee1A" 5)
   ("Wee1 protein" 2) ("Wee1-" 2) ("the mitotic regulator Wee1" 1)
   ("miR-16 directly targets Wee1" 1) ("pWEE1" 1) ("-Wee1" 1)))
 ("UP:P30304"
  (("CDC25A" 700) ("Cdc25A" 435) ("cdc25A" 83) ("cdc25a" 62)
   ("CDC25A protein" 30) ("Cdc25a" 18) ("cdc25a protein" 8)
   ("Cdc25A protein" 6) ("cell division cycle 25A" 4) ("-CDC25A" 2)
   ("cdc25 A" 2) ("Cdk1-cyclin B1-phosphorylated Cdc25A" 1) ("CDC25a" 1)
   ("CDc25a" 1) ("Cdc25 A" 1) ("further establishing CDC25A" 1)
   ("a functional CDC25A" 1)))
 ("UP:P30305"
  (("Cdc25B" 148) ("CDC25B" 108) ("cdc25b" 10) ("cdc25B" 7) ("Cdc25b" 4)
   ("centrosome-associated Cdc25B" 2)
   ("the FoxM1 transcriptional target cdc25b" 2) ("Cdc25B protein" 2)
   ("than Cdc25B" 1) ("Cdc25B (DSGFCLDS)" 1) ("both centrosomal Cdc25B" 1)
   ("centrosomal Cdc25B" 1)))
 ("UP:P30307"
  (("Cdc25C" 702) ("CDC25C" 169) ("cdc25C" 64) ("Cdc25c" 34) ("cdc25c" 29)
   ("Cdc25C peptide" 10) ("Cdc25C protein" 7) ("pCDC25C" 6) ("CDC25c" 6)
   ("p-Cdc25C" 4) ("cdc25 c" 4) ("p-CDC25C" 3) ("Cell division cycle 25C" 3)
   ("-pCDC25C" 2) ("the mitotic phosphatase Cdc25C" 2)
   ("the intermediary CDC25C" 2) ("cell division cycle 25C" 2)
   ("nuclear mitotic Cdc25C" 2) ("the dual phosphatase Cdc25C" 2)
   ("mitotic Cdc25C" 2) ("hyperphosphorylated mitotic Cdc25C" 2) ("p-cdc25C" 2)
   ("dual specificity phosphatase cdc25C" 2) ("CDC25c protein" 2) ("pCdc25c" 2)
   ("the dual-specific phosphatase Cdc25C" 1)
   ("Ser-216-phosphorylated Cdc25C" 1)
   ("The dual-specific phosphatase Cdc25C" 1) ("both mitotic Cdc25C" 1)
   ("decreased hyperphosphorylated mitotic Cdc25C" 1)
   ("Vpr preferentially targets Cdc25C" 1) ("pcdc25C" 1) ("pCdc25C" 1)))
 ("UP:P30310" (("Cdc25-2" 6))) ("UP:P30363" (("L-asparaginase" 7)))
 ("UP:P30365" (("NI2" 5)))
 ("UP:P30405"
  (("CypD" 285) ("cyclophilin D" 49) ("Cyclophilin D" 16) ("CyPD" 6) ("cypD" 3)
   ("the essential regulatory PTP component CypD" 2)
   ("the Essential Regulatory PTP Component CypD" 2) ("PPIF" 1)))
 ("UP:P30408" (("TAAL6" 10) ("Taal6" 7) ("TM4SF1" 3)))
 ("UP:P30411" (("B2R" 78) ("BDKRB2" 31) ("Efficient B2R" 2)))
 ("UP:P30419"
  (("long form" 134) ("NMT1" 5) ("nmt1" 4) ("long form (LF)" 2)
   ("than the long form ( xref )" 2)))
 ("UP:P30420" (("TEG" 11))) ("UP:P30431" (("JG" 22) ("pJG" 12)))
 ("UP:P30511" (("HLA-F" 5)))
 ("UP:P30518"
  (("DI1" 13) ("arginine vasopressin receptor 2" 6)
   ("vasopressin V2 receptor" 6) ("DIR" 4) ("DI1 peptide" 4) ("V2R" 1)
   ("dI1" 1)))
 ("UP:P30519" (("HO-2" 15) ("HMOX2" 1)))
 ("UP:P30520"
  (("ADSS" 33) ("adenylosuccinate synthase" 2)
   ("adenylosuccinate synthase ( ADSS )" 1)))
 ("UP:P30530"
  (("AXL" 1116) ("Axl" 241) ("AXL protein" 13) ("pAXL" 7)
   ("AXL receptor tyrosine kinase" 6) ("p-AXL" 3)
   ("overexpressed wild type AXL" 3) ("than AXL" 2) ("targeting AXL" 2)
   ("the epithelial-to-mesenchymal transition (EMT)–associated receptor tyrosine kinase (RTK) AXL"
    1)
   ("AxL" 1) ("less pAXL" 1) ("slightly more abundant pAXL" 1)
   ("a kinase dead AXL disrupted AXL’S" 1) ("P-AXL" 1)))
 ("UP:P30531" (("GABA)" 14)))
 ("UP:P30532"
  (("CHRNA5" 44) ("Chrna5" 2)
   ("neuronal acetylcholine receptor subunit alpha-5" 1)))
 ("UP:P30533"
  (("RAP" 271) ("Rap" 150) ("receptor-associated protein" 23)
   ("receptor–associated protein" 7) ("receptor associated protein" 5)
   ("intermediate or high RAP" 4) ("RAP protein" 4)
   ("–receptor-associated protein (RAP)" 3)
   ("a soluble N -ethylmaleimide–sensitive factor attachment protein receptor–associated protein"
    2)
   ("receptor associated protein (TTRAP)" 2) ("RAP peptide" 2)
   ("–receptor-associated protein" 1) ("LRPAP1" 1) ("successful RAP" 1)
   ("the complete RAP" 1) ("Rap-" 1)
   ("receptor-associated protein (GABARAP)" 1)
   ("receptor-associated protein (RAP)" 1) ("evident RAP" 1)))
 ("UP:P30536"
  (("benzodiazepine receptor" 4) ("the peripheral benzodiazepine receptor" 3)))
 ("UP:P30542" (("ADORA1" 5) ("adenosine A1 receptor" 3)))
 ("UP:P30550"
  (("GRP-R" 205) ("GRPR" 62) ("GG" 18)
   ("gastrin-releasing peptide receptor" 12) ("functional GRP-R" 2)
   ("stably-transfected GRP-R" 1)))
 ("UP:P30556"
  (("AGTR1" 63) ("AT1BR" 10) ("angiotensin II receptor type 1" 4) ("Agtr1" 2)))
 ("UP:P30559"
  (("oxytocin receptor" 23) ("OXTR" 15) ("OTR" 12)
   ("oxytocin receptor ( OXTR )" 2) ("oxytocin receptor (OXTR)" 1)))
 ("UP:P30566"
  (("AMPs" 63) ("adsl" 17) ("adenylosuccinate lyase" 7)
   ("classical mammalian AMPs" 1) ("frog skin-derived AMPs" 1)
   ("amphibian skin AMPs" 1) ("ADSL" 1)))
 ("UP:P30577" (("Chs2" 1))) ("UP:P30578" (("Chs3" 1)))
 ("UP:P30613" (("LLC-PK1" 32) ("PKLR" 13) ("Pklr" 2)))
 ("UP:P30622"
  (("Restin" 182) ("CLIP-170" 116) ("CLIP170" 9) ("CLIP1" 5) ("RSN" 3)
   ("targeting Restin" 2) ("restin" 1)
   ("the microtubule plus-end tracking-associated protein CLIP170" 1)))
 ("UP:P30626"
  (("v19" 30) ("Sri" 14) ("SRI" 8) ("v19 (IBM)" 4) ("V19" 2) ("IBM" 1)
   ("SPSS v19.0" 1) ("Sorcin" 1) ("sorcin" 1) ("CP22" 1)))
 ("UP:P30690" (("PorB" 125) ("porB" 1))) ("UP:P30711" (("GSTT1" 103)))
 ("UP:P30740"
  (("EI" 61) ("Lei" 21) ("SERPINB1" 12) ("Ei" 4) ("Serpinb1" 4) ("LEI" 3)
   ("leukocyte elastase inhibitor" 1) ("lei" 1)))
 ("UP:P30744" (("sdAb" 6)))
 ("UP:P30750"
  (("ABC" 1379) ("ABC-" 9) ("ABC protein" 8) ("tertiary Vector ABC" 2)
   ("the Ultra-sensitive ABC" 2) ("“ABC”" 2)))
 ("UP:P30793"
  (("GTPCH I" 128) ("pGCH" 8) ("GTP cyclohydrolase I" 7) ("GCH1" 2)
   ("GTP cyclohydrolase I (GTPCH)" 1) ("GTPCH I protein" 1)))
 ("UP:P30825"
  (("ERR" 103) ("amino acid transporter" 34)
   ("ecotropic retroviral receptor" 7) ("SLC7A1" 4) ("slc7a1" 3) ("Slc7a1" 3)
   ("neutral amino acid transporter" 2)
   ("the mouse basic amino acid transporter" 1) ("cat-1" 1) ("Cat-1" 1)))
 ("UP:P30837" (("ALDH1B1" 1))) ("UP:P30838" (("ALDH3A1" 34) ("ALDH3" 1)))
 ("UP:P30843" (("PmrA" 2)))
 ("UP:P30872" (("SSTR1" 3) ("somatostatin receptor 1" 1)))
 ("UP:P30874" (("SSTR2" 12) ("somatostatin receptor 2" 3)))
 ("UP:P30876" (("POLR2B" 1)))
 ("UP:P30924"
  (("SBE" 272) ("SBE (GGCT)" 3) ("pSBE" 2) ("potentially functional SBE" 1)
   ("the functional SBE" 1) ("a functional SBE" 1) ("the authentic SBE" 1)))
 ("UP:P30926" (("CHRNB4" 19))) ("UP:P30953" (("\\or" 2)))
 ("UP:P30968"
  (("GnRHR" 123) ("GNRHR" 46) ("GnRHRs" 20) ("GnRH receptor" 11)
   ("gonadotropin-releasing hormone receptor" 5) ("GnRHR-" 4)
   ("overexpressed GnRHRs" 2) ("GnRH-R" 1)
   ("gonadotropin releasing hormone receptor" 1)))
 ("UP:P30988"
  (("CTR" 270) ("Ctr" 94) ("ctr" 32) ("CTR peptide" 21)
   ("calcitonin receptor" 5) ("their respective age-matched CTR" 3) ("CTR-" 2)
   ("CALCR" 2) ("calcitonin receptor ( CTR )" 2)))
 ("UP:P30989" (("NTSR1" 61) ("NTSR1 protein" 5)))
 ("UP:P30990"
  (("NT" 1166) ("nt" 721) ("NTS" 167) ("NN" 100) ("NMN" 99) ("neurotensin" 89)
   ("Nt" 61) ("tail peptide" 23) ("NTS1" 10) ("nN" 6)
   ("photoactivatable NMN" 3) ("nn" 3) ("-NMN" 2) ("a canonical nt" 2)
   ("than 200 nt" 2) ("around 85 nt" 2) ("typically 20-40 nt" 2)
   ("fluorescence-labeled exogenous NMN" 1) ("nts" 1) ("-NTS" 1)
   ("Neurotensin (NTS)" 1) ("Neurotensin" 1) ("PTEN-expressing DU145 NT" 1)
   ("NTS-" 1) ("than 3 nt" 1) ("than 1 nt" 1) ("approximately 140 nt" 1)
   ("this exogenous NMN" 1) ("p-NT" 1) ("at least 6 nt" 1)))
 ("UP:P31009" (("SOP" 3) ("the local SOP" 1)))
 ("UP:P31025"
  (("TLC" 171) ("preparative TLC" 2) ("LCN1" 2) ("two-dimensional TLC" 1)
   ("lipocalin 1" 1) ("Analytical TLC" 1)))
 ("UP:P31040"
  (("FP" 568) ("F/P" 197) ("SDHA" 61) ("subunit A" 21) ("Sdha" 11) ("sdha" 4)
   ("succinate dehydrogenase complex" 4) ("DTA" 4) ("fp" 3) ("FP (ECFP)" 3)
   ("the sigmoidal dose-dependent FP" 2) ("flavoprotein (Fp)" 2)
   ("Succinate dehydrogenase complex" 2)
   ("succinate dehydrogenase complex subunit A" 2)
   ("a transmembrane-oriented glutamate receptor subunit A" 2)
   ("endogenous fluorescent protein mcherry-conjugated ubi-STAT3 FP" 1)
   ("-FP" 1) ("subunit A (SDHA)" 1) ("FP-" 1)))
 ("UP:P31069" (("KCH" 1))) ("UP:P31080" (("dINR" 4) ("dInR" 2)))
 ("UP:P31097" (("OC1" 16) ("OC-1" 1)))
 ("UP:P31112" (("Hepa" 23) ("HEPA" 6) ("hepa" 3) ("HepA" 1)))
 ("UP:P31142" (("SSEA" 58)))
 ("UP:P31146" (("Coro1A" 76) ("coronin 1A" 4) ("Coro1a" 3) ("Coronin-1A" 2)))
 ("UP:P31150" (("GDIs" 50) ("GDI1" 4)))
 ("UP:P31151" (("S100A7" 70) ("psoriasin" 31) ("Psoriasin" 2) ("S100A7c" 1)))
 ("UP:P31152" (("ERK4" 5) ("MAPK4" 2)))
 ("UP:P31153" (("MAT2A" 11) ("methionine adenosyltransferase 2A" 3)))
 ("UP:P31169" (("KIN2" 1))) ("UP:P31213" (("SRD5A2" 18)))
 ("UP:P31226" (("SAX" 3) ("pSAX" 1))) ("UP:P31237" (("ACO" 2) ("Aco" 1)))
 ("UP:P31249" (("HOXD3" 10) ("HOX4A" 1)))
 ("UP:P31260" (("HOXA10" 103) ("HoxA10" 1)))
 ("UP:P31267" (("HOXA6" 2) ("homeobox A6" 2) ("HoxA6" 1)))
 ("UP:P31268" (("HOXA7" 141) ("HoxA7" 1)))
 ("UP:P31269"
  (("HOXA9" 186) ("Hoxa9" 13) ("homeobox A9" 6) ("Homeobox A9" 3) ("HoxA9" 3)
   ("tumor-suppressive p16  INK4a  homeobox A9" 2) ("HOXA9-" 1) ("hoxA9" 1)))
 ("UP:P31271" (("Hoxa13" 3) ("HOXA13" 1)))
 ("UP:P31273" (("Hoxc8" 29) ("HOXC8" 20) ("Hoxc-8" 7)))
 ("UP:P31274" (("HOX3B" 1) ("HOXC9" 1))) ("UP:P31275" (("HOXC12" 1)))
 ("UP:P31276" (("HOXC13" 4) ("homeobox C13" 2) ("Homeobox C13" 1)))
 ("UP:P31277" (("D11" 76) ("HOXD11" 6) ("d11" 1) ("D11 of aPP’s" 1)))
 ("UP:P31292" (("Wnt-10" 1)))
 ("UP:P31314" (("HOX11" 39) ("TLX1" 33) ("Hox11" 2) ("TCL3" 1)))
 ("UP:P31320" (("PKA regulatory subunit" 8) ("pKAR" 3)))
 ("UP:P31323" (("PRKAR2B" 8) ("Prkar2b" 1)))
 ("UP:P31327" (("carbamoyl-phosphate synthase 1" 2)))
 ("UP:P31350"
  (("RRM2" 419) ("RR2" 18) ("Rrm2" 6) ("RIR2" 2) ("more RRM2" 2)
   ("RRM2 protein" 1) ("expressing wild type RRM2" 1)
   ("than endogenous RRM2 ( xref )" 1) ("rr2" 1)))
 ("UP:P31358" (("CD52" 14) ("HE5" 1))) ("UP:P31364" (("Pou2" 1) ("POU2" 1)))
 ("UP:P31371"
  (("FGF9" 207) ("GAF" 9) ("Fgf9" 6) ("FGF-9" 3)
   ("the mesothelial fibroblast growth factor 9" 2)
   ("fibroblast growth factor 9" 1) ("than FGF9" 1) ("fgf9" 1)))
 ("UP:P31383" (("Tpd3" 3))) ("UP:P31397" (("MAP3" 4) ("Map3" 1)))
 ("UP:P31431"
  (("SDC4" 55) ("syndecan-4" 38) ("Sdc4" 8) ("syndecan 4" 3) ("syndecan4" 2)
   ("SDC4-" 1) ("Syndecan-4" 1)))
 ("UP:P31483"
  (("TIA-1" 145) ("TIA1" 24) ("TIA-1 protein" 14) ("TiA-1" 4)
   ("The Translational Silencer TIA-1" 2) ("TIA-1–" 1)
   ("the apoptosis-associated protein TIA-1" 1)
   ("the translational repressor protein TIA-1" 1)))
 ("UP:P31504" (("hunchback" 3) ("“hunchback”" 1))) ("UP:P31512" (("FMO2" 2)))
 ("UP:P31513" (("FMO3" 20) ("flavin containing monooxygenase 3" 4)))
 ("UP:P31539" (("Hsp104" 4) ("HSP104" 1)))
 ("UP:P31543" (("HSP100" 5) ("Hsp100" 1))) ("UP:P31629" (("HIVEP2" 2)))
 ("UP:P31639" (("SGLT2" 9) ("SLC5A2" 1)))
 ("UP:P31641" (("taurine)" 3) ("SLC6A6" 1))) ("UP:P31644" (("GABRA5" 3)))
 ("UP:P31645"
  (("SERT" 200) ("SLC6A4" 33) ("5-HTT" 5) ("serotonin)" 3)
   ("ER-resident CFP-tagged SERT" 1) ("solute carrier family 6 member 4" 1)))
 ("UP:P31689" (("DNAJA1" 3) ("HDJ2" 2) ("HDJ-2" 1)))
 ("UP:P31748" (("v-Akt" 16) ("v-AKT" 3) ("V-AKT" 2)))
 ("UP:P31749"
  (("AKT1" 4440) ("Akt1" 3719) ("Akt-1" 178) ("PKB α" 44) ("p-AKT1" 43)
   ("pAKT1" 38) ("-Akt1" 36) ("AKT-1" 23) ("Akt1 protein" 17)
   ("AKT1 protein" 16) ("Akt1-" 11) ("Akt/protein" 10) ("AKT1-" 10)
   ("AKT/protein" 9) ("AKT1(1–443) protein" 8) ("than AKT1" 7)
   ("RAC-alpha serine/threonine-protein kinase" 7) ("cAkt" 7) ("c-Akt" 6)
   ("-AKT1" 5) ("MiRNA-149 directly targets AKT1" 4) ("AKt1" 4)
   ("Akt-1 protein" 4) ("akt/protein" 3) ("akt1" 3)
   ("overexpressed mutant AKT1" 3) ("overexpressed active AKT1" 3)
   ("PKB alpha" 2) ("monoclonal phosphorylated-AKT1" 2) ("AKT1 molecule" 2)
   ("RAC-alpha serine/threonine-protein kinase (AKT)" 2) ("hyperactive Akt1" 2)
   ("both ectopically overexpressed Akt1" 2) ("overexpressed Akt1" 2)
   ("the ventral tegmental area AKT1" 2)
   ("unphosphorylatable T308D/S473D Akt1" 2)
   ("HA-tagged dominant-negative AKT1" 2)
   ("green fluorescent protein (GFP)-tagged dominant-negative AKT1" 2)
   ("dominant-negative Akt1" 2) ("commercial recombinant Akt1" 2)
   ("Akt-1(CA)" 2) ("antimigratory kinase AKT1" 2) ("the intrinsic Akt1" 2)
   ("P-AKT1" 2) ("than wild type AKT1" 1) ("exogenous AKT1 Q79K" 1)
   ("only one AKT1" 1) ("P31749" 1) ("residual AKT1" 1) ("-Akt-1" 1)
   ("than the constitutive active Akt1 (data not shown)" 1)
   ("preferentially target Akt1" 1) ("c-AKT" 1) ("AKT1protein" 1)
   ("PKB-alpha" 1) ("a commercially available AKT1 protein" 1)
   ("Monomeric AKT1(1–443) protein" 1) ("more AKT1" 1)
   ("dominant-negative AKT1" 1) ("Akt–1" 1) ("than Akt1" 1)
   ("the previously identified Akt1" 1) ("further evidence Akt1" 1)
   ("co-expressing Akt1" 1) ("dominant-negative murine Akt1" 1)
   ("than Akt1 ( xref )" 1) ("than AKT1 ( xref )" 1)
   ("Protein kinase B-alpha" 1)))
 ("UP:P31751"
  (("Akt2" 1767) ("AKT2" 1406) ("-Akt2" 32) ("Akt-2" 31) ("p-AKT2" 24)
   ("pAkt2" 23) ("Akt 2" 7) ("pAKT2" 6) ("-AKT2" 6) ("AKT-2" 6) ("new AKT2" 4)
   ("AKT2 protein" 3) ("Akt2 protein" 3) ("saline-infused Akt2" 3)
   ("targeted Akt-2" 2) ("targeted AKT2" 2) ("PKB beta" 2) ("AKT 2" 2)
   ("overexpressed Akt2" 2) ("Akt2-" 2)
   ("pcDNA3.1-myc-HisA(-)-Akt1 and pcDNA3.1-myc-HisA(-)-Akt2" 1)
   ("overactive Akt2" 1) ("p-Akt2" 1) ("than Akt2" 1)
   ("pro-metastatic pAkt2" 1) ("Additionally AKT2 protein" 1)
   ("than Akt2 in MDA-MB231 cells" 1) ("flag-tagged Akt2" 1) ("AKT2-" 1)
   ("than AKT2" 1)))
 ("UP:P31785"
  (("Il2rg" 50) ("IL2RG" 32) ("CD132" 22) ("γC" 14)
   ("interleukin-2 receptor gamma" 4) ("p64" 2) ("Rag2 null γC" 1) ("IL-2Rg" 1)
   ("IL2Rg" 1) ("Il2RG" 1) ("P64" 1) ("IL2rg" 1) ("Il2Rg" 1)))
 ("UP:P31787" (("ACB" 5))) ("UP:P31802" (("NARP" 4) ("Narp" 2)))
 ("UP:P31809" (("MHVR" 3)))
 ("UP:P31895" (("COOH" 1238) ("COOH-" 12) ("-COOH" 6) ("−COOH" 2) ("–COOH" 2)))
 ("UP:P31908" (("HOXA" 151)))
 ("UP:P31937" (("3-hydroxyisobutyrate dehydrogenase" 2)))
 ("UP:P31939"
  (("AICAR" 1076) ("ATIC" 31) ("AICAR-" 14)
   ("5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"
    4)
   ("AICar" 4)
   ("cell permeable short-chain C6 ceramide and AMPK activator AICAR" 2)
   ("AMPK pharmacologic activators AICAR" 2) ("Aicar" 2)
   ("the pharmacologic AMPK activators AICAR" 1)
   ("5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC)"
    1)
   ("the AMP-mimetic AICAR" 1) ("AMP mimetic AICAR" 1)
   ("the AMP mimetic AICAR" 1) ("that AICAR's" 1) ("IMP cyclohydrolase" 1)
   ("ATIC-" 1) ("AICAr" 1)))
 ("UP:P31941" (("APOBEC3A" 14)))
 ("UP:P31942" (("heterogeneous nuclear ribonucleoprotein H3" 3) ("HNRNPH3" 1)))
 ("UP:P31943"
  (("hnRNPH" 7) ("HNRNPH" 3) ("HNRNPH1" 1) ("HNRPH" 1) ("HNRPH1" 1)
   ("Heterogeneous nuclear ribonucleoprotein H" 1)))
 ("UP:P31944" (("CASP14" 3) ("caspase 14" 3) ("caspase-14" 2)))
 ("UP:P31946" (("YWHAB" 16)))
 ("UP:P31947"
  (("SFN" 873) ("sFn" 97) ("HME1" 81) ("14-3-3 sigma" 17) ("stratifin" 17)
   ("14-3-3sigma" 9) ("sFN" 9) ("Stratifin" 7) ("-SFN" 3)
   ("a mouse monoclonal anti 14-3-3 sigma" 2) ("available sFn" 2)
   ("Stratifin (SFN)" 1) ("immunoreactive stratifin" 1) ("14–3-3 sigma" 1)
   ("the available sFn" 1) ("Stratifin ( SFN )" 1)))
 ("UP:P31948"
  (("HOP" 121) ("STIP1" 38) ("Hop" 18) ("Sti1" 5) ("hop" 4) ("StIP1" 2)
   ("TPR2A" 1) ("than STIP1" 1) ("STI1" 1)))
 ("UP:P31949"
  (("S100A11" 107) ("A11" 77) ("S100a11" 5)
   ("S100 calcium binding protein A11" 3) ("a11" 2) ("“A11”" 1)))
 ("UP:P31965" (("petF" 1)))
 ("UP:P31994"
  (("Fc-receptor" 8) ("FcγRIIb" 5) ("the salvage neonatal Fc-receptor" 4)
   ("FcγRIIB" 3) ("Fcgr2b" 2) ("the only human Fc-receptor" 2) ("CDw32" 1)))
 ("UP:P31997" (("CD66b" 13) ("CEACAM8" 4)))
 ("UP:P32004"
  (("S10" 542) ("S10 protein" 2)
   ("the mitotic marker phospho-histone H3 S10" 2)
   ("neural cell adhesion molecule L1" 2)))
 ("UP:P32019" (("75KD" 1) ("75kD" 1)))
 ("UP:P32119"
  (("trichostatin A" 391) ("Trichostatin A" 233) ("PRX2" 165)
   ("trichostatin A (TSA)" 116) ("PRDX2" 63) ("Trichostatin A (TSA)" 44)
   ("Torin" 27) ("peroxiredoxin 2" 12) ("torin" 11) ("TORIN" 8) ("Prdx2" 4)
   ("Trichostatin A (TAS)" 3) ("Peroxiredoxin 2" 3) ("peroxiredoxin-2" 2)
   ("classic HDAC inhibitor trichostatin A (TSA)" 2) ("peroxiredoxin2" 2)
   ("TrichoStatin A" 1) ("significantly more PRDX2 protein" 1)
   ("PRDX2 protein" 1) ("than PRDX2" 1)
   ("Trichostatin
A"
    1)
   ("thiol-specific antioxidant protein" 1)
   ("trichostatin A
(TSA)"
    1)
   ("thioredoxin peroxidase 1" 1) ("neuronal PRX2" 1)))
 ("UP:P32121"
  (("β-arrestin2" 258) ("β-arrestin-2" 88) ("arrestin-2" 63) ("ARR2" 20)
   ("ARR 2" 8) ("Arrestin-2" 7) ("β-arrestin-2-" 6) ("-Arrestin-2" 5)
   ("Arrestin2" 2) ("arrestin2" 2) ("β-arrestin2 protein" 1)
   ("phospho/total- β-arrestin2" 1) ("than full-length β-arrestin2" 1)
   ("no obvious nuclear β-arrestin2" 1) ("exogenous arrestin-2" 1)
   ("P32121" 1)))
 ("UP:P32189" (("glycerol kinase" 1))) ("UP:P32194" (("pg1" 13) ("pG1" 3)))
 ("UP:P32196" (("pg3" 2) ("pG3" 2))) ("UP:P32197" (("elastases" 2)))
 ("UP:P32239" (("Cckbr" 2) ("CCKBR" 2) ("CCK2R" 1)))
 ("UP:P32240" (("Prostaglandin E2 receptor" 1))) ("UP:P32242" (("Otx1" 20)))
 ("UP:P32243"
  (("OTX2" 238) ("Otx2" 66) ("OTX2-" 10) ("orthodenticle homeobox 2" 2)
   ("otx2" 1)))
 ("UP:P32245"
  (("MC4R" 32) ("melanocortin 4 receptor" 11) ("Mc4r" 6)
   ("Melanocortin 4 Receptor" 5) ("common BMI associated gene MC4R" 1)))
 ("UP:P32246" (("CCR1" 25) ("Ccr1" 2)))
 ("UP:P32247"
  (("bombesin" 18) ("Bombesin" 4) ("-Bombesin" 3) ("bombesin (BBS)" 2)
   ("bombesin like receptor 3" 1)))
 ("UP:P32248"
  (("CCR7" 283) ("Evi1" 12) ("Ccr7" 10) ("CCR7-" 2) ("-CCR7" 2)
   ("significantly less CCR7" 2) ("ccr7" 1)
   ("mIL-4 DCs expressed significantly more CCR7" 1) ("CCR7−" 1)))
 ("UP:P32249" (("Ebi2" 1))) ("UP:P32252" (("RasB" 30) ("rasB" 3) ("rASB" 2)))
 ("UP:P32253" (("RasC" 6))) ("UP:P32254" (("RasS" 3)))
 ("UP:P32270" (("DDA" 15) ("ddA" 1) ("Sud" 1))) ("UP:P32286" (("SEGA" 7)))
 ("UP:P32297"
  (("CHRNA3" 82) ("neuronal acetylcholine receptor subunit alpha-3" 1)
   ("alpha polypeptide 3" 1)))
 ("UP:P32298" (("GRK4" 10)))
 ("UP:P32302" (("CXCR5" 216) ("cxcr5" 61) ("BLR1" 7)))
 ("UP:P32314" (("FOXN2" 24) ("HTLF" 2)))
 ("UP:P32320"
  (("CDA" 231) ("cytidine deaminase" 52) ("cytidine deaminase (CDA)" 2)
   ("Cda" 1) ("CdA" 1) ("defective CDA" 1)))
 ("UP:P32321" (("DCTD" 4))) ("UP:P32327" (("pYC2" 4)))
 ("UP:P32329" (("proprotein convertase" 8) ("YAP3" 2)))
 ("UP:P32334" (("Msb2" 13))) ("UP:P32338" (("RME-1" 4)))
 ("UP:P32377"
  (("MDD" 280)
   ("than MDD (for example, dementia, psychotic illness, bipolar disorder, adjustment disorder)"
    1)))
 ("UP:P32383" (("phospholipase C1" 4))) ("UP:P32418" (("SLC8A1" 5) ("NCX1" 2)))
 ("UP:P32455"
  (("GBP1" 229) ("GBP-1" 177) ("interferon-inducible" 26)
   ("guanylate binding protein 1" 4) ("-GBP1" 3)
   ("interferon-inducible protein" 2) ("Gbp1" 2)
   ("Guanylate binding protein 1" 2) ("Guanylate Binding Protein 1" 2)
   ("Interferon-inducible" 1) ("perijunctional GBP-1" 1)))
 ("UP:P32456" (("GBP2" 5) ("Gbp2" 1))) ("UP:P32457" (("Cdc3" 3)))
 ("UP:P32458" (("Cdc11" 1)))
 ("UP:P32468" (("septin" 37) ("Cdc12" 3) ("SEPTIN" 2) ("CDC12" 1)))
 ("UP:P32473" (("pdb1" 1)))
 ("UP:P32478" (("PIR2" 17) ("the previously described PIR2" 1)))
 ("UP:P32496" (("RPN12" 1))) ("UP:P32507" (("mpH" 4)))
 ("UP:P32517" (("US1" 20))) ("UP:P32519" (("ELF1" 15) ("ElF1" 3) ("Elf1" 2)))
 ("UP:P32554"
  (("SH" 482) ("sh" 332) ("Sh" 54) ("-SH" 19) ("sh-" 4) ("–SH" 2)
   ("adjacent SH" 2) ("the unique -SH" 1) ("the IBTK -shRNA SH2407H3" 1)
   ("whose SH" 1) ("SH protein" 1)))
 ("UP:P32567" (("pAP1" 11))) ("UP:P32581" (("IME2" 3)))
 ("UP:P32598" (("Glc7" 5)))
 ("UP:P32600"
  (("Tor2" 76) ("tor2" 75) ("TOR2" 8) ("previously isolated tor2-L2048S" 2)
   ("the previously isolated TORC1 mutant tor2-L2048S" 1)))
 ("UP:P32607" (("Rtg1" 1))) ("UP:P32608" (("Rtg2" 1)))
 ("UP:P32609" (("Vac1" 5))) ("UP:P32644" (("helicase 1" 13) ("Ecm32" 1)))
 ("UP:P32660" (("dNf1" 1)))
 ("UP:P32745" (("somatostatin receptor 3" 5) ("SSTR3" 2)))
 ("UP:P32754" (("HPD" 6) ("4-hydroxyphenylpyruvate dioxygenase" 1)))
 ("UP:P32767" (("KAP122" 1))) ("UP:P32768" (("FLO1" 26) ("Flo1" 18)))
 ("UP:P32771" (("SFA" 86) ("MNs displayed SFA" 1)))
 ("UP:P32780"
  (("general transcription factor IIH (TFIIH)" 2)
   ("general transcription factor IIH" 2) ("62kDa" 2) ("62KDa" 1)))
 ("UP:P32795" (("yme1" 2)))
 ("UP:P32797" (("Cdc13" 29) ("cdc13" 8) ("CDC13" 1)))
 ("UP:P32798" (("COT1" 37) ("Cot1" 7) ("COT-1" 3))) ("UP:P32816" (("GLD" 12)))
 ("UP:P32831" (("NgR1" 6) ("basal NgR1" 3))) ("UP:P32836" (("GSP2" 9)))
 ("UP:P32849" (("rev-2" 1) ("Rev-2" 1)))
 ("UP:P32856" (("STX2" 41) ("Stx2" 2) ("EPM" 1))) ("UP:P32867" (("Sso1" 1)))
 ("UP:P32891" (("DLD1" 538) (NIL 9) ("the colorectal cell line DLD1" 1)))
 ("UP:P32895" (("pRPS" 27) ("PrPs" 4)))
 ("UP:P32926"
  (("Dsg3" 419) ("PVA" 12) ("Desmoglein 3" 10) ("desmoglein 3" 3) ("DSG3" 2)
   ("the uppermost cell layers lack Dsg3" 2) ("Dsg3 protein" 2)
   ("exogenous human Dsg3" 2) ("further lacked Dsg3" 1)
   ("an ectodomain-deleted Dsg3" 1)))
 ("UP:P32927" (("Csf2rb" 7) ("CD131" 4) ("CSF2RB" 1)))
 ("UP:P32929" (("CTH" 44) ("CGL" 22)))
 ("UP:P32939" (("Ypt7" 4) ("YPT7" 1) ("ypt7" 1)))
 ("UP:P32940" (("ETC" 125) ("ETC protein" 3) ("no functional ETC" 2)))
 ("UP:P32942" (("ICAM-3" 28) ("αLβ2" 14) ("ICAM3" 3) ("CD50" 3)))
 ("UP:P32944" (("Swe1" 63) ("swe1" 21) ("SWE1" 2))) ("UP:P32954" (("CCI" 138)))
 ("UP:P32969" (("RPL9" 1))) ("UP:P32970" (("TNFSF7" 22) ("CD70" 4)))
 ("UP:P32971"
  (("CD30L" 34) ("TNFSF8" 9) ("CD30 ligand" 6) ("soluble CD30 ligand" 2)))
 ("UP:P33032" (("MC2" 13) ("Mc5r" 2)))
 ("UP:P33076"
  (("CIITA" 139) ("Mhc" 5) ("CIITA protein" 4) ("class II transactivator" 3)
   ("MHC class II transactivator" 2) ("MHC2TA" 2)
   ("class II transactivator (CIITA)" 1) ("Class II transactivator" 1)))
 ("UP:P33121" (("ACSL1" 18))) ("UP:P33125" (("Hsp82" 19)))
 ("UP:P33148"
  (("C-cadherin" 98) ("EP-cadherin" 5) ("C-cadherin protein" 4)
   ("C-cadherin–" 2) ("a chimeric tailless C-cadherin" 1)))
 ("UP:P33151"
  (("VE-cadherin" 1267) ("vascular endothelial cadherin" 28) ("VEC" 27)
   ("VE-Cadherin" 25) ("Vec" 23) ("Cdh5" 15) ("vec" 14) ("CD144" 13)
   ("VE-cadherin peptide" 12) ("cadherin 5" 11) ("CDH5" 11)
   ("vascular endothelial-cadherin" 8) ("Vascular endothelial cadherin" 4)
   ("VE–cadherin" 3) ("VEC-" 3) ("pVE-cadherin" 2)
   ("both total and phosphorylated VE-cadherin" 2) ("around VE-cadherin" 2)
   ("VECadherin" 2) ("Lentiviral expression vectors pLOC RHPN2 and pLOC VEC" 1)
   ("HUVECs demonstrated cell surface VE-cadherin" 1) ("Cd144" 1)
   ("particular VE-cadherin" 1) ("The transmembrane VE-cadherin" 1)
   ("MCF-7 spheroids showed intact VE-cadherin" 1)
   ("appropriate VE-cadherin" 1)
   ("the endothelial-specific gene VE-cadherin" 1) ("VE-cadherin-" 1)
   ("we first immunoprecipitated VE-cadherin" 1) ("than VE-cadherin" 1)
   ("VE-cadherin protein" 1)))
 ("UP:P33154"
  (("PR1" 164) ("PR-1" 15)
   ("than TSU-PR1 cells transfected with vector control" 1) ("Pr1" 1)))
 ("UP:P33157" (("PR2" 30)))
 ("UP:P33164" (("PDR" 151) ("pDR" 26) ("the Laotian PDR" 1)))
 ("UP:P33176"
  (("KIF5B" 97) ("KNS" 5) ("kinesin-1 heavy chain" 2) ("UKHC" 1) ("KIF5b" 1)
   ("the last KIF5B" 1)))
 ("UP:P33206" (("Fkh1" 35) ("fkh1" 16))) ("UP:P33226" (("TORC" 50)))
 ("UP:P33228" (("RecT" 4))) ("UP:P33238" (("Mx protein" 2)))
 ("UP:P33241" (("LSP1" 178) ("LSP-1" 4) ("lymphocyte-specific protein 1" 3)))
 ("UP:P33260" (("CYP2C18" 2))) ("UP:P33261" (("CYP2C19" 18)))
 ("UP:P33277"
  (("Ras-GTPase activating protein" 18) ("Ras-GTPase-activating protein" 3)
   ("Ras–GTPase-activating protein" 1)))
 ("UP:P33297" (("Rpt-5" 2))) ("UP:P33301" (("Xrs2" 9) ("Xrs2 protein" 3)))
 ("UP:P33306" (("Bck2" 4) ("bck2" 3))) ("UP:P33307" (("Cse1" 1)))
 ("UP:P33313" (("CNS1" 6)))
 ("UP:P33316"
  (("dUTPase" 31) ("dUTP pyrophosphatase" 3) ("a viral dUTPase" 2) ("DUT" 2)
   ("P33316" 1) ("DUTP pyrophosphatase" 1)))
 ("UP:P33328" (("Snc2" 15) ("snc2" 10) ("SNC2" 7))) ("UP:P33362" (("OSMF" 1)))
 ("UP:P33378" (("PLCb" 3))) ("UP:P33402" (("guanylate cyclase 1" 2)))
 ("UP:P33423" (("S9B" 8))) ("UP:P33449" (("BMR" 31) ("than predicted BMR" 1)))
 ("UP:P33452" (("sIgA" 5) ("dysfunctional sIgA" 1)))
 ("UP:P33519" (("Rana" 4) ("rana" 1)))
 ("UP:P33527"
  (("member 1" 102) ("ABCC1" 70) ("Member 1" 12)
   ("multidrug resistance-associated protein" 11) ("member 1 protein" 9)
   ("multidrug resistance-associated protein 1" 6) ("Abcc1" 3)
   ("the peroxisomal ATP-binding cassette (ABC) transporter subfamily D member 1 protein"
    3)
   ("Multidrug Resistance-associated Protein 1" 1)
   ("sub-family C (CFTR/MRP)" 1)
   ("Multidrug resistance-associated protein" 1)))
 ("UP:P33552"
  (("Cks2" 104) ("CKS2" 67) ("CDC28 protein kinase regulatory subunit 2" 8)))
 ("UP:P33579" (("pLPC" 45) ("pLpC" 1)))
 ("UP:P33627"
  (("α6-tubulin" 84) ("a pseudo-phosphorylated α6-tubulin" 2)
   ("than α6-tubulin" 1)))
 ("UP:P33681"
  (("CD80" 424) ("B7" 131) ("CD80 protein" 4) ("targeting CD80" 2) ("-CD80" 2)
   ("T cell co-stimulatory molecule CD80" 2)
   ("the costimulatory molecules CD80" 1) ("B7-" 1) ("“FL_CD80”" 1)))
 ("UP:P33699" (("ExoT" 2))) ("UP:P33700" (("ExoU" 46) ("exoU" 15)))
 ("UP:P33727" (("Asb" 33))) ("UP:P33748" (("Msn2" 1)))
 ("UP:P33749" (("Msn4" 3))) ("UP:P33778" (("member F" 1) ("HIST1H2BB" 1)))
 ("UP:P33881" (("EagI" 3)))
 ("UP:P33897"
  (("ALD" 98) ("ABCD1" 23) ("adrenoleukodystrophy" 5) ("Ald" 5) ("ALDP" 4)
   ("ABCD1 protein" 3) ("sub-family D member 1" 2) ("ABCD1 protein (ALDP)" 2)
   ("adrenoleukodystrophy protein (ALDP)" 2) ("Abcd1" 1)))
 ("UP:P33908" (("class 1A" 32) ("Class 1A" 10) ("MAN1A1" 2)))
 ("UP:P33947" (("KDELR2" 3) ("KDELR2-" 2)))
 ("UP:P33969"
  (("BRs" 104) ("multiple nearby BRs" 1) ("Only 143 STAT3 BRs" 1)
   ("more BRs" 1)))
 ("UP:P33981"
  (("SP600125" 1466) ("Mps1" 245) ("TTK" 32) ("MPS1" 15) ("PyT" 9) ("MPS-1" 8)
   ("Mps1 protein" 4)
   ("the reversible ATP-competitive JNK inhibitor SP600125" 4)
   ("SP600125 (JNK)" 3) ("Mps-1" 3) ("SP600125-" 2) ("SP600125 (SP)" 2)
   ("TTK protein kinase" 2) ("the ATP-competitive JNK inhibitor SP600125" 2)
   ("the mitotic kinase Mps1" 2) ("than 20 μM SP600125" 1)
   ("Only JNK1/2 inhibitor SP600125" 1) ("than SP600125" 1)))
 ("UP:P33991"
  (("MCM4" 143) ("Mcm4" 55) ("NKCD" 17) ("Mcm4 protein" 3)
   ("subsequent time points progressively more Mcm4" 1) ("very little Mcm4" 1)
   ("Mcm4-" 1)))
 ("UP:P33992"
  (("MCM-5" 87) ("MCM5" 81) ("Mcm5" 20) ("mcm5" 2) ("MCM-5 protein" 2)))
 ("UP:P33993"
  (("MCM7" 891) ("Mcm7" 137) ("Mcm2" 136) ("Mcm2-" 3) ("overexpressed MCM7" 3)
   ("p-MCM7" 2) ("exogenous MCM7" 2) ("Representative MCM7" 2)
   ("Mcm2 protein" 2) ("the nonphosphorylatable mutant MCM7 Y600F" 1)
   ("Lyn-mediated MCM7 Y600 phosphorylation increases MCM7’s" 1)
   ("than those expressing MCM7 Y600F ( xref )" 1)
   ("a phosphomimetic mutant MCM7 Y600E" 1) ("MCM7 protein" 1)
   ("around MCM7" 1) ("MCM7-" 1) ("Mcm7-" 1) ("MCM7 (and MCM2) protein" 1)
   ("in vitro -transcribed and –translated MCM7" 1)))
 ("UP:P34041"
  (("IgH" 190) ("Igh" 186) ("IGH" 148) ("IGH@" 10) ("igh" 7) ("igh-" 3)
   ("a representative Igh" 2) ("the entire Igh" 2) ("normal IGH" 1)
   ("than IGH" 1)))
 ("UP:P34056" (("Tcfap2a" 2)))
 ("UP:P34059" (("chondroitinase" 10) ("Chondroitinase" 1)))
 ("UP:P34060" (("MF2" 7))) ("UP:P34090" (("CMF" 127) ("pCMF" 7)))
 ("UP:P34096" (("Rab1" 37) ("RasB1" 23) ("RNASE4" 8)))
 ("UP:P34101"
  (("protein kinase 1" 88) ("coiled-coil-containing protein kinase 1" 2)
   ("phosphatidylinositol (3,4,5)-triphosphate (PIP3)–dependent protein kinase 1"
    2)
   ("rho-associated coiled-coil protein kinase 1" 2)
   ("extracellular-signal-regulated protein kinase 1" 1)
   ("Rho-associated coiled-coil protein kinase 1" 1)))
 ("UP:P34102" (("protein kinase 3" 2))) ("UP:P34121" (("coactosin" 5)))
 ("UP:P34130" (("NTF4" 8) ("NT-4" 5) ("neurotrophin-4" 3) ("nt4" 2) ("NT4" 2)))
 ("UP:P34136" (("HMGB" 13))) ("UP:P34144" (("Rac1A" 1)))
 ("UP:P34145" (("rac1b" 31) ("most cases (i.e. 80%) rac1b" 1)))
 ("UP:P34149" (("RacC" 2))) ("UP:P34169" (("GOBP" 11)))
 ("UP:P34200" (("MOPC" 27))) ("UP:P34218" (("Sas3" 6)))
 ("UP:P34358" (("CED-7" 3) ("ced-7" 2)))
 ("UP:P34609" (("JNK-interacting protein" 1))) ("UP:P34688" (("dpy-7" 1)))
 ("UP:P34722"
  (("cPKC" 80) ("a representative T cell–expressed cPKC" 2) ("mature cPKC" 2)
   ("catalytically competent cPKC" 1)))
 ("UP:P34727" (("Arf family" 18) ("ARF family" 10)))
 ("UP:P34730" (("Bmh2" 9) ("bmh2" 6) ("BMH2" 6)))
 ("UP:P34741"
  (("SDC2" 87) ("syndecan-2" 65) ("Syndecan-2" 3) ("Sdc2" 2) ("syndecan 2" 2)
   ("Syndecan 2" 2) ("syndecans-2" 2) ("syndecan2" 1)))
 ("UP:P34761" (("Whi3" 1)))
 ("UP:P34774" (("ORF57" 25) ("immediate-early lytic protein ORF57" 1)))
 ("UP:P34788" (("PFL" 4)))
 ("UP:P34796"
  (("PGI2" 64) ("PGI-2" 18) ("-PGI2" 3) ("the vascular protector PGI2" 1)))
 ("UP:P34810"
  (("CD68" 262) ("CD68-" 4) ("microglial marker CD68" 3) ("CD68 protein" 2)
   ("primary lesions expressed significantly more inflammatory cell markers CD68"
    2)
   ("CD-68" 1)))
 ("UP:P34820" (("OP2" 2)))
 ("UP:P34887" (("CYP" 84) ("cyclo" 20) ("Cyclo" 7) ("-CYP" 4)))
 ("UP:P34896"
  (("SHMT1" 76) ("SHMT" 25) ("14 kDa protein" 9)
   ("serine hydroxymethyltransferase" 7) ("shMT1" 5) ("Shmt1" 3)
   ("Serine hydroxymethyltransferase" 3) ("cSHMT" 2) ("shmt1" 2) ("SHMTs" 2)
   ("serine hydroxymethyltransferase (SHMT)" 2) ("14 kDa protein" 1)))
 ("UP:P34897"
  (("SHMT2" 61) ("Shmt2" 3) ("shmt2" 2) ("-SHMT2" 2) ("SHMT2 protein" 2)
   ("than SHMT2" 1)))
 ("UP:P34913"
  (("EPHX2" 4) ("epoxide hydrolase 2" 2) ("SEH" 1)
   ("soluble epoxide hydrolase" 1)))
 ("UP:P34914" (("Eph2" 2)))
 ("UP:P34925"
  (("RYK" 245) ("Ryk" 9) ("receptor-like tyrosine kinase" 8)
   ("glue-tagged RYK" 4) ("receptor-like tyrosine kinase ( RYK )" 1)
   ("Receptor-like tyrosine kinase" 1)))
 ("UP:P34927" (("MHL1" 2)))
 ("UP:P34931"
  (("HSPA1L" 38) ("an additional homologous heat shock gene HSPA1L" 1)))
 ("UP:P34932" (("HSPA4" 1)))
 ("UP:P34947" (("GRK5" 222) ("GRK5-" 4) ("potential GRK5" 2)))
 ("UP:P34972" (("CB2" 19) ("CB 2" 16) ("cNR2" 1))) ("UP:P34981" (("pTRHR" 2)))
 ("UP:P34995"
  (("EP1 receptor" 51) ("PTGER1" 8) ("Prostaglandin E receptor 1" 2)
   ("prostaglandin E receptor 1" 2) ("42kD" 1) ("42Kd" 1)))
 ("UP:P34997" (("NLRs" 27)))
 ("UP:P34998"
  (("CRH-R1" 36) ("CRHR1" 17) ("corticotropin releasing hormone receptor 1" 2)
   ("myometrial CRH-R1s" 1) ("CRH-R1s" 1)))
 ("UP:P35006" (("ORF62" 3)))
 ("UP:P35030"
  (("brain)" 88) ("serine 3" 24) ("trypsin IV" 7) ("PRSS3" 5) ("Serine 3" 5)
   ("mesotrypsin" 2) ("normal brain)" 1) ("the normal brain)" 1)))
 ("UP:P35052" (("glypican-1" 8) ("GPC1" 3)))
 ("UP:P35070"
  (("BTC" 383) ("betacellulin" 65) ("βTC" 15) ("Betacellulin" 6)
   ("beta cellulin" 5) ("exogenous betacellulin" 4) ("Betacellulin (BTC)" 2)
   ("the INSM1-positive cell line βTC-1" 1) ("primary or advanced BTC" 1)
   ("sporadic BTC" 1) ("betacellulin (BTC)" 1) ("extrahepatic BTC" 1)
   ("beta-cellulin" 1) ("mature BTC" 1)))
 ("UP:P35080"
  (("profilin" 48) ("PFN2" 7) ("profilin-2" 7) ("Profilin" 5) ("Pfn2" 2)
   ("profilin II" 1)))
 ("UP:P35125" (("pTRE2" 5) ("Tre2" 4) ("USP6" 2) ("TRE2" 1)))
 ("UP:P35127" (("UCH" 139))) ("UP:P35143" (("gpdA" 4)))
 ("UP:P35210" (("Spt23" 1)))
 ("UP:P35212" (("37kDa" 4) ("Cx37" 2) ("approximately 37kDa" 1)))
 ("UP:P35218"
  (("cava" 87) ("CA5" 74) ("cava (IVC)" 4)
   ("the thoracic inferior vena cava" 1) ("The abdominal inferior vena cava" 1)
   ("caudal vena cava" 1) ("the abdominal aorta and vena cava" 1)))
 ("UP:P35219" (("Carp" 2) ("CALS" 1) ("carp" 1)))
 ("UP:P35221"
  (("αE-catenin" 154) ("CTNNA1" 16) ("alpha-catenin" 8) ("α-catenins" 7)
   ("Ctnna1" 3) ("Alpha-catenin" 1) ("targeted αE-catenin" 1)
   ("Alpha-E-catenin" 1)))
 ("UP:P35222"
  (("β-catenin" 32709) ("CTNNB1" 1781) ("β-Catenin" 1303) ("beta-catenin" 1256)
   ("β-catenin protein" 402) ("Ctnnb1" 304) ("β−catenin" 96) ("P-β-catenin" 90)
   ("beta catenin" 76) ("Beta-catenin" 73) ("βcatenin" 67)
   ("membranous β-catenin" 47) ("β-Catenin protein" 44) ("β–catenin" 43)
   ("β-CATENIN" 33) ("BD" 30) ("ctnnb1" 28) ("p-β-catenin" 23)
   ("β-catenins" 20) ("p-β-Catenin" 19) ("beta-catenin protein" 15)
   ("β-catenin peptide" 14) ("the Ser37/Thr41-non-phosphorylated β-catenin" 13)
   ("VE-cadherin–associated β-catenin" 13) ("CTNNB" 12) ("–β-catenin" 12)
   ("overexpressed β-catenin" 11) ("exogenous β-catenin" 11) ("-β-catenin" 10)
   ("β-cateninS" 10) ("membrane-associated β-catenin" 10)
   ("the Ser37/Thr41-non-phosphorylated β-catenin protein" 10)
   ("CTNNB1 protein" 9) ("soluble β-catenin" 8) ("β-catenin-" 7)
   ("abnormal β-catenin" 6) ("β-catenin–" 5) ("normal β-catenin" 5)
   ("Beta catenin" 5) ("a strong and diffuse nucleocytoplasmic β-catenin" 4)
   ("Homozygous CTNNB1" 4) ("ERC-resident β-catenin" 4) ("β-catenin (ABC)" 4)
   ("strong nuclear and cytoplasmic β-catenin" 4) ("than β-catenin" 3)
   ("centrosomal β-catenin" 3) ("beta- catenin" 3) ("-β-Catenin" 3)
   ("functional β-catenin" 3) ("most β-catenin" 3) ("cellular β-catenin" 3)
   ("junctional β-catenin" 3)
   ("Ser37/Thr41-non-phosphorylated β-catenin protein" 3)
   ("intact β-catenin" 3) ("the junctional protein β-catenin" 3)
   ("soluble beta-catenin" 3) ("nascent β-catenin" 3) ("catenin beta 1" 3)
   ("nuclear-associated β-catenin" 3) ("exogenous mutant β-catenin" 3)
   ("than wild-type β-catenin" 2)
   ("the lateral membrane-associated β-catenin" 2)
   ("A high membranous β-catenin" 2) ("intense nuclear β-catenin" 2)
   ("lack strong nuclear β-catenin" 2) ("free cystolic β-catenin" 2)
   ("exogenous CTNNB1" 2) ("only membranous β-catenin" 2) ("βCatenin" 2)
   ("immunohistochemistry showed weak cytoplasmic β-catenin" 2)
   ("overexpressed nuclear β-catenin" 2) ("monoclonal β-catenin" 2)
   ("betacatenin" 2) ("the stem cell renewal factor β-catenin" 2)
   ("an increased perinuclear β-catenin" 2)
   ("typical honeycomb cell surface β-catenin" 2)
   ("total cellular β-catenin" 2) ("distinct β-catenin" 2)
   ("clone #79 weak β-catenin" 2) ("clear β-catenin" 2)
   ("exogenous or endogenous β-catenin" 2)
   ("the transcriptional co-activator βcatenin" 2)
   ("JS-K accumulated cellular β-catenin" 2)
   ("Monoclonal mouse anti-activated β-catenin" 2)
   ("AJ associated β-catenin" 2) ("dense β-catenin" 2)
   ("no exogenous β-catenin" 2) ("the multifunctional molecule β-catenin" 2)
   ("membranous beta-catenin" 2) ("SSA showed normal β-catenin" 2)
   ("signaling competent β-catenin" 2) ("TCF-associated β-catenin" 2)
   ("endogenous Ser37/Thr41-non-phosphorylated β-catenin protein" 2)
   ("The Ser37/Thr41-non-phosphorylated β-catenin" 2)
   ("very little β-catenin" 2)
   ("mitotic cell division GSK3-phosphorylated β-catenin" 2)
   ("far lower amounts β-catenin" 2) ("normally targets β-catenin" 2)
   ("non-degradable β-catenin" 2) ("total or phosphorylated β-catenin" 2)
   ("the exogenous mutant β-catenin" 2) ("cytoplasm-associated β-catenin" 2)
   ("the predominantly membrane bound beta-catenin" 2) ("residual β-catenin" 2)
   ("junctional CTNNB1" 2) ("the transcriptional co-activator β-catenin" 2)
   ("more β-catenin" 2) ("the subcellular localized β-catenin" 2)
   ("LoVo cells followed β-catenin" 2) ("cytoplasmatic β-catenin" 2)
   ("efficiently knocked-down β-catenin" 2)
   ("the SOX2-associated protein β-catenin" 2)
   ("sedentary lifestyle, and tumor CTNNB1" 2) ("the soluble β-catenin" 1)
   ("Ras-expressing mouse keratinocytes β-catenin" 1)
   ("associated β-catenin" 1) ("particular β-catenin" 1)
   ("High membranous β-catenin" 1) ("More β-catenin protein" 1)
   ("than CTNNB1 affecting different pathways" 1)
   ("capsular penetration and moderate/low nuclear β-catenin" 1)
   ("its associated protein β-catenin" 1) ("predominantly M/C β-catenin" 1)
   ("the other showed predominant C/N β-catenin" 1)
   ("total and non-phosphorylated β−catenin" 1) ("heterozygous β−catenin" 1)
   ("exogenous wild-type β−catenin" 1) ("beta-catenin beta-catenin" 1)
   ("Beta-catenin protein" 1) ("Very little phospho-S33/S37/T41 β-catenin" 1)
   ("centrosomal phospho-S33/S37/T41 β-catenin" 1)
   ("HA-ubiquitin–bound β-catenin" 1)
   ("than β-catenin phosphorylated by GSK3β/CK1 ( xref , B and C, lane 2)" 1)
   ("only membrane β-catenin" 1) ("several pro-invasive β-catenin" 1)
   ("bona fide CTNNB1" 1) ("functional CTNNB1" 1)
   ("nonphosphorylatable mutant β-catenin" 1) ("a normal β-catenin" 1)
   ("the nonphosphorylatable mutant 4 β-catenin" 1)
   ("Immunohistochemical cytoplasmic and nuclear β-catenin" 1)
   ("a less intense β-catenin" 1) ("beta-catenin-" 1)
   ("VE-cadherin-associated β-catenin" 1)
   ("the stem cell self-renewal factor β-catenin" 1)
   ("abnormal expression membranous β-catenin" 1)
   ("plasmalemmal (and hence eNOS-associated) β-catenin" 1)
   ("the membranous β-catenin" 1) ("pro-fibrotic β-catenin" 1)
   ("dermal fibroblast nuclear β-catenin" 1) ("p-βcatenin" 1)
   ("key β-catenin" 1) ("Total and “activated” β-catenin" 1)
   ("generally targets nuclear β-catenin" 1)
   ("at least 10 known or candidate β-catenin" 1) ("lenti-viral β-catenin" 1)
   ("consequently releases β-catenin" 1)
   ("an exogenous wild type β-catenin protein" 1)
   ("Wnt-associated β-catenin" 1) ("available β-catenin" 1)
   ("exogenous wild type β-catenin" 1)
   ("photoactivatable-GFP-tagged β-catenin" 1)
   ("F-TrCP-Ecad preferentially targets soluble nuclear/cytosolic β-catenin" 1)
   ("the membrane-associated β-catenin" 1)
   ("the \"non-degradable\" β-catenin S37A" 1)
   ("than the wild-type β-catenin [ xref ]" 1)
   ("Membrane-associated β-catenin" 1) ("using primary β-catenin" 1)
   ("Exogenous β-catenin protein" 1) ("virus-transformed B-cells β-catenin" 1)
   ("the transcriptional machinery β-catenin" 1) ("non-junctional β-catenin" 1)
   ("plasma membrane associated β-catenin" 1)
   ("Non-sequestered free β-catenin" 1) ("Cby-14-3-3–bound β-catenin" 1)
   ("This constantly targets β-catenin" 1) ("2-fold more β-catenin" 1)
   ("intranuclear β-catenin" 1) ("very little free β-catenin" 1)
   ("significantly more β-catenin" 1) ("monomeric β-catenin" 1)
   ("much more β-catenin" 1) ("COOH-terminal flag-tagged β-catenin" 1)
   ("precisely controls β-catenin" 1)
   ("the former exhibiting nuclear β-catenin" 1)
   ("exhibiting nuclear β-catenin" 1) ("exosome-associated β-catenin" 1)
   ("the exosome-associated β-catenin" 1) ("the total cellular β-catenin" 1)
   ("at least one β-catenin" 1)
   ("N-terminal phosphorylation normally targets β-catenin" 1)
   ("further stabilizing β-catenin" 1) ("Substantial β-catenin" 1)
   ("or more β-catenin" 1) ("The mouse monoclonal anti-human β-catenin" 1)
   ("the phosphomimic Y564E β-catenin" 1)
   ("the TCF transcriptional co-factor β-catenin" 1)
   ("cytoplastic β-catenin" 1) ("cadherin-associated β-catenin" 1)
   ("the associated β-catenin" 1) ("otherwise targets β-catenin" 1)
   ("total and phosphorylated β-catenin" 1) ("than β-catenin ( xref )" 1)
   ("membrane-associated CTNNB1" 1) ("most Ctnnb1" 1)
   ("dominant-stable CTNNB1" 1) ("immature Ctnnb1" 1)
   ("a normal membranous β-catenin" 1)
   ("Immunocytochemical staining found β-catenin" 1)
   ("subsequently targets β-catenin" 1) ("the available β-catenin" 1)
   ("possibly other β-catenin" 1) ("Membranous beta-catenin" 1)
   ("active cellular β-catenin" 1)
   ("than median β-catenin immunostaining ( xref )" 1)
   ("Exogenous β-catenin" 1) ("than wt beta-catenin ( xref )" 1)
   ("targeting β-catenin" 1) ("ectopically overexpressed β-catenin" 1)
   ("displayed membrane-associated β-catenin" 1) ("CTNB1" 1)
   ("the hereditary mutation V832M efficiently binds β-catenin" 1)
   ("postsynaptic β-catenin" 1) ("some residual β-catenin" 1)
   ("a strong β-catenin" 1) ("potential β-catenin" 1)
   ("6-His-tagged full-length β-catenin" 1)
   ("overexpressed 6-His-tagged β-catenin" 1)
   ("cell membrane associated β-catenin" 1)
   ("β-catenin 552-to-total β-catenin" 1)
   ("transcriptional active β-catenin" 1)
   ("invasive carcinomas nuclear beta-catenin" 1)
   ("intraepithelial neoplasia nuclear beta-catenin" 1)
   ("both intestinal β-catenin" 1) ("β-Catenins" 1)
   ("intracytosolic and intranuclear β-catenin" 1)
   ("the subsequent total β-catenin" 1) ("sequential total β-catenin" 1)
   ("We first immunoprecipitated β-CATENIN" 1)
   ("an exogenous stabilized mutant β-catenin" 1)
   ("demonstrated AR constitutively shuttles β-Catenin" 1)
   ("Proportionally less β-Catenin" 1) ("cellular β-Catenin" 1)
   ("exon-3–mutated β-catenin" 1) ("the basolateral protein β-catenin" 1)
   ("The basolateral marker β-catenin" 1)
   ("the basolateral marker β-catenin" 1)
   ("the transcriptional modulator β-catenin" 1)))
 ("UP:P35225"
  (("IL-13" 685) ("IL13" 139) ("interleukin-13" 8) ("Il13" 8) ("IL-13-" 6)
   ("IL13-" 4) ("interleukin 13" 2) ("Il-13" 2)
   ("monoclonal anti-human IL-13" 2) ("Interleukin 13" 1) ("IL-13 protein" 1)
   ("CLP T H 0 cells produced significantly less IL-13" 1) ("than IL-13" 1)))
 ("UP:P35226"
  (("Bmi1" 1055) ("BMI1" 644) ("Bmi-1" 391) ("BMI-1" 352) ("PCGF4" 30)
   ("Bmi1 protein" 14) ("BMI1 protein" 11) ("bmi-1" 7) ("BMI-1 protein" 5)
   ("bmi1" 4) ("-BMI1" 3) ("targeted Bmi1" 2)
   ("the stem cell self-renewal regulator BMI1" 1)
   ("miR-203 maybe target Bmi1" 1)
   ("The polycomb group transcriptional modifier Bmi1" 1)
   ("self-renewal factor BMI-1" 1) ("BMI-1-" 1) ("Pcgf4" 1) ("PCGF4-" 1)
   ("-PCGF4" 1) ("overexpressing ectopic Bmi-1" 1) ("–Bmi1" 1)
   ("the phosphorylation mimetic Bmi1-S316D protein" 1)
   ("Bmi1-S316D protein" 1)))
 ("UP:P35227"
  (("PCGF2" 24) ("MEL18" 8) ("PCGF2-" 2) ("MEL-18" 1) ("-PCGF2" 1)))
 ("UP:P35228"
  (("iNOS" 1896) ("NOS2" 463) ("iNOS protein" 47) ("NO synthase" 43)
   ("inducible NO synthase" 23) ("inducible NOS" 21) ("NOS2A" 20)
   ("endothelial NO synthase" 16) ("iNos" 14) ("NOS2 protein" 10)
   ("the endothelial NO synthase" 6) ("iNOS-" 5)
   ("neuronal (n) specific NO synthase" 4) ("iNOs" 4) ("NO synthase (NOS)" 3)
   ("the prooxidative inducible NO synthase" 2)
   ("both endothelial NO synthase" 2) ("neuronal NO synthase" 2)
   ("siRNA decreased iNOS protein" 2) ("the ectopically-expressed NOS2" 2)
   ("-NOS2_Flag_SalI" 2) ("basal NOS2" 1) ("respiratory epithelial NOS2" 1)))
 ("UP:P35230" (("RegIIIβ" 1))) ("UP:P35231" (("REG3" 4)))
 ("UP:P35232"
  (("PHB" 224) ("prohibitin" 54) ("Prohibitin" 13) ("Phb" 3) ("phb" 3)
   ("PROHIBITIN" 3) ("-Prohibitin" 1) ("pHB" 1)))
 ("UP:P35236"
  (("HePTP" 64) ("PTPN7" 7) ("LC-PTP" 2) ("than HePTP" 1) ("HEPTP" 1)))
 ("UP:P35237" (("pTis" 21) ("PTI" 6) ("SERPINB6" 2) ("Serpinb6" 1) ("PI6" 1)))
 ("UP:P35240"
  (("NF2" 545) ("Merlin" 299) ("Nf2" 159) ("merlin" 53) ("SCH" 35)
   ("MERLIN" 16) ("neurofibromin 2" 12) ("Neurofibromin 2" 6) ("p-NF2" 4)
   ("merlin protein" 4) ("Merlin protein" 3) ("Neurofibromin2" 2) ("Nf2-" 1)
   ("Schwannomin" 1) ("schwannomin" 1)))
 ("UP:P35241" (("radixin" 62) ("Radixin" 20) ("RDX" 11)))
 ("UP:P35243" (("recoverin" 1) ("Recoverin" 1)))
 ("UP:P35244" (("RPA14" 13) ("RPA3" 6) ("Rpa3" 1)))
 ("UP:P35247" (("PSPD" 72) ("SP-D" 8) ("surfactant protein D" 2)))
 ("UP:P35249" (("RFC4" 26) ("Rfc4" 12) ("rfc4" 2) ("Rfc-4" 2)))
 ("UP:P35250"
  (("Rfc2" 40) ("RFC2" 25) ("Rfc2 peptide" 3) ("rfc2" 2) ("Rfc-2" 2)))
 ("UP:P35251" (("Rfc1" 19) ("rfc1" 5)))
 ("UP:P35268" (("RPL22" 13) ("EAP" 5) ("ribosomal protein L22" 3) ("Rpl22" 2)))
 ("UP:P35269" (("TFIIF" 27) ("RAP74" 4) ("BTF4" 2) ("74kDa" 1) ("GTF2F1" 1)))
 ("UP:P35270" (("SPRs" 2))) ("UP:P35288" (("OPB" 4)))
 ("UP:P35318"
  (("AM" 1320) ("ADM" 527) ("ADMs" 11) ("adrenomedullin" 10) ("ADM protein" 5)
   ("AM (AM)" 5) ("Ratiometric Fura-2 AM" 3)
   ("Ca 2+ -sensitive fluorescent dye Fluo-3 AM" 2)
   ("containing fluorescent dye Calcein AM" 2)
   ("the ratiometric indicator Fura-2 AM" 1) ("therapeutically target ADM" 1)
   ("Adrenomedullin" 1) ("around ADM" 1) ("Kras-driven ADM" 1)
   ("mutant Kras-driven ADM" 1) ("their associated ADMs" 1)
   ("the associated ADM" 1) ("the pure ADMs" 1) ("associated ADM" 1)
   ("control mice showed extensive ADM" 1) ("Adm" 1)
   ("asymptomatic HIV+ and non-infected (i.e. healthy) AM" 1)
   ("clinically relevant human AM" 1) ("“ADM”" 1) ("-AM" 1)
   ("the statistical algorithm ADM-2" 1)))
 ("UP:P35321" (("Sprr1a" 13) ("SPRR1A" 3)))
 ("UP:P35326" (("SPRR2A" 108) ("Sprr2a" 1))) ("UP:P35336" (("pectinase" 2)))
 ("UP:P35346" (("SSTR5" 20)))
 ("UP:P35354"
  (("COX-2" 12593) ("COX2" 1144) ("PTGS2" 1033) ("Cox-2" 776)
   ("cyclooxygenase-2" 494) ("COX-2 protein" 177) ("Cyclooxygenase-2" 158)
   ("Cox2" 88) ("cyclooxygenase 2" 80) ("PGHS2" 62) ("COX 2" 59)
   ("prostaglandin-endoperoxide synthase 2" 41) ("Cyclooxygenase 2" 38)
   ("−COX2" 34) ("Ptgs2" 32) ("PGHS-2" 23) ("PTGS-2" 18)
   ("cyclo-oxygenase 2" 15) ("pCOX2" 14) ("cox-2" 12) ("COX2 protein" 11)
   ("Cox-2 protein" 9) ("−COX-2" 9) ("cervical COX-2" 9)
   ("cyclo-oxygenase-2" 7) ("Strong COX-2" 6) ("normal COX-2" 5)
   ("strong COX-2" 4) ("overexpressed COX-2" 4) ("-COX-2" 4) ("“COX-2”" 4)
   ("Cyclo-oxygenase-2" 4) ("COX-2-" 3) ("COX-2 (74 kDa) protein" 3)
   ("only one homogenous COX-2 protein" 3) ("renal medullary COX-2" 3)
   ("adenoviral COX-2 or siRNA COX-2" 3) ("cyclooxygenase2" 2)
   ("the studied endometrial tumor samples expressed COX2" 2)
   ("resting neutrophils yielded virtually no COX-2" 2)
   ("mature COX-2 protein" 2) ("Cox-2-" 2) ("“cyclooxygenase-2”" 2)
   ("selectively target COX2" 2) ("“Cyclooxygenase-2”" 2)
   ("“Cyclooxygenase 2”" 2) ("1.14.99.1" 2) ("PTGS2-" 2) ("renal COX-2" 2)
   ("Stromal COX-2" 2) ("cyclooxy-genase-2" 2)
   ("the immunohistological COX-2" 2) ("Cox 2" 2)
   ("Distinct perinuclear COX-2" 2) ("some nonspecific COX-2" 2)
   ("preeclamptic women expressed significantly more COX-2" 2)
   ("Cyclooxygenase2" 2) ("less Cox-2" 2) ("COX2-" 2)
   ("increased cervical COX-2" 2) ("the highly invasive COX-2" 2)
   ("Representative COX-2" 2) ("Prostaglandin-endoperoxide synthase 2" 2)
   ("Representative COX2" 2) ("moderate and strong COX-2" 2) ("COX-2–" 2)
   ("strong PGHS2" 2) ("PGHS2 protein" 2) ("than COX-2 ( xref )" 1) ("PTGs2" 1)
   ("ischemic PC induced COX-2" 1) ("-PTGS2" 1)
   ("glycosylation mature COX-2" 1) ("overexpressing COX-2" 1)
   ("intrinsic COX-2" 1) ("than COX-2" 1)
   ("the intestinal AC tumours expressed COX-2" 1) ("“PTGS-2”" 1) ("“PTGS2”" 1)
   ("“cyclooxygenase 2”" 1) ("expressing no COX-2" 1) ("weak COX-2" 1)
   ("expressing strong COX-2" 1) ("The functional PTGS2" 1)
   ("both basal COX-2" 1) ("immunoreactive COX-2 protein" 1)
   ("Epithelial and stromal COX-2" 1) ("sevenfold more COX-2 protein" 1)
   ("produced significantly more COX-2 protein" 1)
   ("normal mammary epithelium COX-2" 1) ("the cells P34-expressing COX-2" 1)
   ("the strong perinuclear COX-2" 1) ("functional COX-2" 1)
   ("the osmoinducible gene Cox2" 1) ("than PGHS-2 ( xref  A )" 1)
   ("than PGHS-2" 1) ("Plumbagin treated COX-2" 1) ("than COX-2 regulating" 1)
   ("a stimulatory role COX-2" 1) ("the homozygous COX-2" 1) ("\"PTGS2\"" 1)
   ("\"COX-2\"" 1) ("COX 2 protein" 1) ("IFNγ increased COX-2" 1) ("ptgs2" 1)
   ("\"cyclooxygenase 2\"" 1) ("cox2" 1)
   ("RKO-siHIPK2 cells induced efficient COX-2" 1) ("more COX-2 protein" 1)
   ("the proinflammatory COX-2" 1) ("robust COX-2" 1)))
 ("UP:P35362" (("opsin" 12) ("Opsin" 1) ("opsin-" 1)))
 ("UP:P35367"
  (("histamine" 300) ("Histamine" 30) ("HRH1" 15)
   ("than histamine [ xref , xref - xref ]" 1)
   ("than 200 pg/µL histamine ( xref )" 1)))
 ("UP:P35368" (("ADRA1B" 3)))
 ("UP:P35372"
  (("OPRM1" 16) ("mu-opioid receptor" 5) ("mu opioid receptor" 4) ("MOP" 2)))
 ("UP:P35373"
  (("angiotensin type 1 receptor" 1) ("angiotensin type 1 receptor" 1)))
 ("UP:P35398"
  (("RORα" 82) ("RORA" 25) ("Rorα" 6) ("NR1F1" 2) ("Rora" 2) ("RORα-" 2)
   ("RAR-related orphan receptor A" 1) ("RORa" 1)))
 ("UP:P35408"
  (("EP4" 151) ("EP4 receptor" 19) ("PTGER4" 17)
   ("Prostaglandin E receptor 4" 2) ("EP4 Receptor" 2)))
 ("UP:P35442"
  (("TSP-2" 24) ("THBS2" 22) ("TSP2" 3) ("Thbs2" 2) ("Thrombospondin 2" 1)))
 ("UP:P35443" (("TSP4" 7) ("Thbs4" 4) ("THBS4" 3) ("thrombospondin-4" 3)))
 ("UP:P35452" (("HOXD12" 1))) ("UP:P35453" (("HOXD13" 9)))
 ("UP:P35460" (("Ly6f" 6))) ("UP:P35461" (("Ly6G" 84) ("Ly6g" 1)))
 ("UP:P35462" (("DRD3" 3)))
 ("UP:P35498" (("SCN1A" 35) ("Nac1" 2) ("NAC1" 2) ("SCN1" 1)))
 ("UP:P35499" (("Scn4a" 36) ("SCN4A" 27) ("-Scn4a" 1)))
 ("UP:P35511" (("PAL" 11)))
 ("UP:P35520"
  (("CBS" 206) ("cbs" 3) ("cystathionine-beta-synthase" 2)
   ("the archetypal CBS" 1) ("cystathionine beta-synthase ( CBS )" 1)
   ("cystathionine beta-synthase" 1)))
 ("UP:P35527" (("KRT9" 1) ("keratin 9" 1)))
 ("UP:P35544" (("FUB1" 2) ("FuB1" 1)))
 ("UP:P35548"
  (("MSX2" 186) ("Msx2" 33) ("MSX2 protein" 3) ("Msh homeobox 2" 2) ("HOX8" 1)
   ("osteoblastic transcription factor Msx2" 1) ("msh homeobox 2" 1)
   ("msx2" 1)))
 ("UP:P35552"
  (("RPPA" 603) ("Proteomic RPPA" 2) ("the semi-quantitative RPPA" 1)
   ("experimental RPPA" 1)))
 ("UP:P35555"
  (("FBN1" 129) ("fibrillin-1" 122) ("Marfan syndrome" 36) ("Fibrillin-1" 11)
   ("Fbn1" 10) ("fibrillin 1" 9) ("FBN1 protein" 6) ("fibrillin-1 protein" 1)
   ("Marfan syndrome (MFS)" 1) ("FBN" 1) ("WMS" 1)
   ("definitive Marfan syndrome" 1)
   ("the dominant connective tissue disease Marfan syndrome" 1)))
 ("UP:P35556"
  (("fibrillin-2" 7) ("FBN2" 7) ("congenital contractural arachnodactyly" 1)
   ("fibrillin 2" 1)))
 ("UP:P35557" (("GCK" 29) ("glucokinase" 28) ("less glucokinase" 1)))
 ("UP:P35558"
  (("PEPCK1" 281) ("PEPCK" 138) ("PCK1" 61) ("pck1" 28) ("Pck1" 22)
   ("phosphoenolpyruvate carboxykinase 1" 6) ("Pepck1" 3)
   ("overexpressed PEPCK1" 3) ("Phosphoenolpyruvate carboxykinase 1" 2)
   ("UBR5-associated PEPCK1" 2) ("PEPCK1 protein" 2) ("PEPCK-C" 1) ("Pepck" 1)
   ("the UBR5-associated PEPCK1" 1) ("than wild type PEPCK1 ( xref )" 1)))
 ("UP:P35567" (("CDK1A" 2) ("cdc2a" 1)))
 ("UP:P35568"
  (("IRS-1" 2344) ("IRS1" 1812) ("insulin receptor substrate 1" 143)
   ("insulin receptor substrate-1" 93) ("Irs1" 56) ("GG" 46)
   ("IRS-1 protein" 28) ("IRS1 protein" 23) ("Insulin receptor substrate 1" 22)
   ("pIRS-1" 22) ("-IRS-1" 18) ("pIRS1" 14) ("IRS 1" 12)
   ("Insulin receptor substrate-1" 11) ("p-IRS1" 7) ("irs1" 4)
   ("IRS-1 peptide" 3) ("insulin-receptor substrate-1" 3)
   ("Insulin-receptor substrate 1" 3) ("IRS1 peptide" 3) ("IRS-1–" 2)
   ("overexpressed Arg 972 IRS-1" 2) ("pIrs1" 2) ("a strong nuclear IRS-1" 2)
   ("Irs-1" 2) ("“Insulin receptor substrate-1”" 2)
   ("miR-126 directly targets IRS-1" 2) ("total and phosphorylated IRS-1" 2)
   ("than those carrying wild type IRS-1" 1) ("abnormal IRS1" 1)
   ("largest IRS1" 1) ("in turn targets IRS1" 1) ("Irs1 protein" 1)
   ("even total IRS-1" 1) ("“IRS-1”" 1) ("just some baseline Irs1" 1)
   ("available IRS-1" 1) ("than IRS-1" 1) ("than IRS1 ( xref )" 1) ("-IRS1" 1)
   ("less IRS-1" 1) ("genetic predisposition around IRS1" 1)
   ("phospho-IRS1 peptide" 1)))
 ("UP:P35573" (("glycogen debranching enzyme" 3) ("AGL" 2) ("GDE" 1)))
 ("UP:P35575"
  (("G6Pase" 24) ("glucose-6-phosphatase" 24) ("G6PT" 17) ("G6pase" 10)
   ("G6pc" 10) ("G6Pc" 3) ("G6PC" 2)
   ("Glucose-6-phosphatase catalytic subunit" 1) ("G-6-Pase" 1)))
 ("UP:P35579"
  (("NMMHCIIA" 84) ("MYH9" 65) ("myosin 9" 5) ("myosin-9" 4) ("Myosin-9" 3)
   ("MyH9" 2) ("Myh9" 2) ("NMHC-IIA" 1)))
 ("UP:P35580"
  (("myosin 10" 2) ("MYH10" 2) ("MHC-IIB" 1) ("heavy polypeptide 10" 1)))
 ("UP:P35589" (("synaptobrevin" 1)))
 ("UP:P35590"
  (("Tie1" 91) ("TIE1" 6) ("transmembrane Tie1" 1) ("the transmembrane Tie1" 1)
   ("TIE" 1)))
 ("UP:P35606" (("COPB2" 8) ("beta’-COP" 1)))
 ("UP:P35609" (("alpha-actinin2" 20) ("Alpha-actinin2" 4) ("ACTN2" 1)))
 ("UP:P35610"
  (("STAT" 2404) ("pSTAT" 1997) ("STATs" 565) ("Stat" 378) ("pStat" 259)
   ("JAK-STAT" 258) ("Stats" 73) ("stats" 54) ("Jak-Stat" 45) ("Jak-STAT" 45)
   ("JAK–STAT" 33) ("stat" 22) ("STAT protein" 21) ("STAT (PIAS)" 8)
   ("P-STAT" 7) ("STATs (PIAS)" 6) ("Stat molecule" 5) ("STATS" 5) ("SOAT1" 4)
   ("“stats”" 4) ("-stat" 4) ("Stat protein" 4) ("STAT-" 3) ("STAT molecule" 3)
   ("Jak–STAT" 3) ("Stat-" 3) ("p-STAT" 2) ("using Vassar Stats" 2)
   ("“splico-stat”" 2) ("the predominant STAT protein" 2)
   ("the principal activated STAT protein" 2) ("Dimerized STATs" 2)
   ("most Stats" 2) ("JAK-Stat" 2) ("than STATs" 1) ("the respective STATs" 1)
   ("The dimerized STAT" 1) ("a proximal STAT" 1) ("a distal STAT" 1)
   ("the statistical package stat" 1) ("than one STAT protein" 1)
   ("most STATs" 1) ("Most STATs" 1) ("-pSTAT3" 1) ("Jak–Stat" 1)
   ("DNA binding competent STAT" 1) ("p-STATs" 1)
   ("the PTPRT substrate pSTAT3" 1) ("cellular STATs" 1)
   ("the phosphorylated tyrosine of one STAT" 1) ("the given STAT" 1)
   ("the associated STAT molecule" 1) ("increased pSTAT1" 1)
   ("increased pStat3" 1) ("latent STATs" 1) ("three potential Stat-" 1)
   ("low glandular pSTAT3" 1) ("-STAT" 1) ("expressed pSTAT3" 1)))
 ("UP:P35611"
  (("α-adducin" 281) ("ADD1" 8) ("P-α-adducin" 2) ("alpha-adducin" 1)))
 ("UP:P35612" (("β-adducin" 23) ("P-β-adducin" 3)))
 ("UP:P35613"
  (("CD147" 206) ("BSG" 85) ("EMMPRIN" 84) ("basigin" 11) ("BASIGIN" 6)
   ("extracellular matrix metalloproteinase inducer" 5) ("m+6" 5) ("5F7" 3)
   ("M+6" 1)))
 ("UP:P35615"
  (("CL1" 393) ("than its parental cell line CL1-0" 1)
   ("its parental cell line CL1-0" 1)))
 ("UP:P35625"
  (("TIMP3" 327) ("TIMP-3" 74) ("Timp3" 10)
   ("tissue inhibitor of metalloproteinases 3" 3) ("SFD" 2)
   ("Tissue inhibitor of metalloproteinases 3" 2) ("than TIMP3" 1)))
 ("UP:P35626" (("receptor kinase 2" 11) ("GRK3" 5))) ("UP:P35635" (("7B2" 2)))
 ("UP:P35637"
  (("TLS" 1052) ("FUS" 245) ("UV radiation-induced TLS" 3) ("UV-induced TLS" 2)
   ("defective TLS" 2) ("pol ι-related error-prone TLS" 2) ("optimal TLS" 2)
   ("efficient TLS" 2) ("The pol ι-involved error-prone TLS" 1)
   ("the pol ι-mediated TLS" 1) ("Efficient TLS" 1) ("the normal FUS" 1)
   ("UV-induced Pol η-mediated TLS" 1) ("replicative TLS" 1)
   ("PCNA/Rad18-dependent TLS" 1) ("separate TLS" 1)
   ("the more error-prone TLS" 1) ("intact TLS" 1) ("subsequent TLS" 1)))
 ("UP:P35638"
  (("CHOP" 1196) ("DDIT3" 120) ("GADD153" 56) ("Chop" 39)
   ("C/EBP homologous protein" 24) ("Gadd153" 17) ("transcript 3" 15)
   ("CHOP protein" 14) ("CHOP10" 9) ("C/EBP-homologous protein" 6)
   ("the pro-apoptotic gene CHOP" 6) ("Ddit3" 5)
   ("CCAAT/enhancer-binding protein homologous protein" 4)
   ("the pro-apoptotic transcription factor CHOP" 4) ("GADD 153" 3)
   ("C/EBP homologous protein (CHOP)" 3) ("gadd153" 3)
   ("C/EBP-homologous protein (CHOP)" 3) ("targeting GADD153" 3)
   ("CCAAT/enhancer-binding protein homologous protein (CHOP)" 2)
   ("C/EBP Homologous Protein" 2) ("Transcript 3" 2) ("less CHOP" 2)
   ("expressed nuclear CHOP" 2) ("Chop10" 2)
   ("Human Leukocyte Antigen-B associated Transcript 3" 2) ("uterine DDIT3" 1)
   ("The ER stress pathway-associated transcription factor CHOP" 1)
   ("DDIT3 ( CHOP )" 1) ("DLBCL treated CHOP" 1)
   ("CCAAT/enhancer binding protein homologous protein" 1)
   ("DNA-damage-inducible transcript 3" 1)
   ("the UPR-responsive transcriptional factor CHOP" 1)
   ("pro-apoptotic CHOP" 1) ("The pro-apoptotic gene CHOP" 1)
   ("the pro-apoptotic gene C/EBP homologous protein (CHOP)" 1)
   ("Exogenous CHOP" 1) ("the wild type flag-tagged CHOP protein" 1) ("DDIT" 1)
   ("proapoptotic CHOP" 1)))
 ("UP:P35658"
  (("protein can" 714) ("NUP214" 119) ("putative oncogene" 34) ("Nup214" 26)
   ("CaN" 6) ("the viral protein can" 5) ("soluble Nef protein can" 2)
   ("Cain" 2) ("Protein can" 2) ("the classical ERα protein can" 1)
   ("a given intact protein can" 1) ("N214" 1) ("total cellular protein can" 1)
   ("the nucleolar-associated p19 ARF protein can" 1) ("a given protein can" 1)
   ("almost no endogenous BRCA1 protein can" 1) ("The viral protein can" 1)
   ("only full-length MDMX protein can" 1) ("A viral protein can" 1)
   ("a ubiquitous and nonaltered protein can" 1)
   ("an associated nucleoporin Nup214" 1) ("more HDM2 protein can" 1)
   ("residual ATR protein can" 1)))
 ("UP:P35659"
  (("DEK" 396) ("Dek" 20) ("DEK protein" 9) ("DEK proto-oncogene" 2)
   ("RNAi-based therapeutic DEK" 2) ("invasive carcinomas expressed DEK" 1)))
 ("UP:P35663" (("CYL" 15) ("CYL1" 8) ("pCYL" 3)))
 ("UP:P35670" (("ATP7B" 12) ("PWD" 3)))
 ("UP:P35680"
  (("HNF1B" 121) ("transcription factor 2" 29) ("Tcf2" 19) ("TCF2" 13)
   ("transcription factor-2" 5)
   ("basic leucine zipper transcription factor 2" 4) ("HNF1β" 3)
   ("caudal-related homeobox transcription factor 2" 3)
   ("caudal type homeobox transcription factor 2" 2)
   ("the basic leucine zipper transcription factor 2" 2) ("MODY5" 2)
   ("the caudal type homeobox transcription factor 2" 2)
   ("hepatocyte nuclear factor-1β" 1)))
 ("UP:P35711" (("SOX5" 50) ("Sox5" 2) ("Sox-5" 1)))
 ("UP:P35712" (("SOX6" 18) ("Sox6" 4))) ("UP:P35713" (("SOX18" 3)))
 ("UP:P35716" (("SOX11" 47) ("Sox11" 5) ("SOX11−" 2)))
 ("UP:P35728" (("Mpe1" 1)))
 ("UP:P35729" (("Rat2" 43) ("rat2" 5) ("normal Rat2" 1)))
 ("UP:P35749" (("MYH11" 17) ("SM-MHC" 5) ("SMMHC" 2)))
 ("UP:P35754"
  (("glutaredoxin" 16) ("glutaredoxins" 6) ("GRX" 4) ("GLRX" 2) ("Glrx" 2)
   ("GRX-" 2) ("Glutaredoxins" 1)))
 ("UP:P35761" (("ESK" 2)))
 ("UP:P35790"
  (("CKI" 544) ("Cks" 269) ("CKIs" 233) ("pCHK" 139) ("EK" 90) ("Chk" 43)
   ("Cks protein" 26) ("CHK" 25) ("pChk" 13) ("CK-I" 10) ("choline kinase" 5)
   ("CKS" 3) ("choline kinase alpha" 2) ("another centrosomal CKI" 2)
   ("proteins called CKIs" 1) ("at least one CKI" 1) ("p-CHK" 1)
   ("CKI-ε (WT)" 1)
   ("the nuclear transport protein KPNA2 and cytoplasmic/nuclear expression pCHK1"
    1)
   ("appropriate CKIs" 1) ("than the other two CKIs" 1) ("Choline kinase" 1)
   ("-CHK" 1) ("“Chk3”" 1) ("CKI-" 1) ("ethanolamine kinase" 1) ("chk" 1)))
 ("UP:P35805" (("L-MYC2" 3)))
 ("UP:P35813"
  (("PPM1A" 287) ("PPM1A protein" 8) ("protein phosphatase 1A" 2)
   ("protein phosphatase-1a" 2) ("Protein phosphatase 1A" 1) ("PPM1a" 1)))
 ("UP:P35817" (("BDF1" 2)))
 ("UP:P35820"
  (("PSC" 284) ("both adult affected family members developed PSC" 1)
   ("332 Scandinavian PSC" 1) ("FLLL32-treated PSC" 1) ("stromal PSC" 1)))
 ("UP:P35823" (("a-protein" 2)))
 ("UP:P35858"
  (("ALS" 892) ("labile" 184) ("labile protein" 54) ("IGFALS" 28)
   ("insulin-like growth factor binding protein" 24) ("sporadic ALS" 15)
   ("ALs" 8) ("more labile" 5) ("als" 3)
   ("insulin-like growth factor binding protein (IGFBP)" 2)
   ("sporadic amyotrophic lateral sclerosis ALS" 2) ("sporadic ALS (SALS)" 2)
   ("both sporadic and familial ALS" 2) ("heat-labile protein" 2)
   ("sporadic human ALS" 1) ("Als" 1) ("so-called sporadic ALS" 1)
   ("Possible ALS" 1) ("Probably laboratory-supported ALS" 1) ("most ALS" 1)
   ("proportionately more ALs" 1) ("more ALs" 1) ("less labile" 1)
   ("the ALS’s" 1) ("242 sporadic ALS" 1) ("Most ALS" 1) ("-labile" 1)
   ("acid labile subunit (ALS)" 1) ("acid labile subunit" 1)
   ("The Northwestern sporadic ALS" 1) ("probable or definite ALS" 1)
   ("established sporadic ALS" 1)))
 ("UP:P35869"
  (("AhR" 947) ("AHR" 474) ("aryl hydrocarbon receptor" 122) ("Ahr" 14)
   ("AhR protein" 12) ("arylhydrocarbon receptor" 10)
   ("Aryl hydrocarbon receptor" 9) ("aryl hydrocarbon receptor (AHR)" 6)
   ("aHR" 5) ("overexpressed AHR" 3) ("Aryl Hydrocarbon Receptor" 2)
   ("absent AHR" 2) ("a strong and homogeneous cytoplasmic AHR" 2)
   ("a weak cytoplasmic and nuclear AHR" 2) ("functional AHR" 2)
   ("a stably expressed recombinant chimeric AhR" 1) ("Ah receptor" 1)
   ("residual AhR" 1) ("arylhydrocarbon receptor (AHR)" 1)
   ("a functional AhR" 1)))
 ("UP:P35875"
  (("PARPs" 92) ("the major PARPs" 1) ("Poly [ADP-ribose] polymerase" 1)
   ("bona fide PARPs" 1)))
 ("UP:P35900"
  (("CK20" 93) ("protein it" 43) ("KRT20" 18) ("cytokeratin 20" 16)
   ("CK20−" 6)))
 ("UP:P35914" (("HMGCL" 3) ("HMG-CoA lyase" 1)))
 ("UP:P35916"
  (("VEGFR-3" 65) ("VEGFR3" 64) ("FLT4" 60)
   ("vascular endothelial growth factor receptor 3" 8) ("P-VEGFR3" 5)
   ("Flt-4" 4) ("Flt4" 3) ("flt4" 2) ("VEGF-R3" 2) ("VEGFR3 protein" 2)
   ("Vegfr3" 1) ("FMS-like tyrosine kinase 4" 1)))
 ("UP:P35950" (("LDLa" 9)))
 ("UP:P35968"
  (("VEGFR2" 1722) ("VEGFR-2" 726) ("KDR" 575) ("Flk-1" 125) ("pVEGFR2" 62)
   ("VEGF-R2" 38) ("VEGFR2 protein" 28) ("p-VEGFR2" 16) ("VEGFr2" 15)
   ("Flk1" 15) ("vascular endothelial growth factor receptor 2" 14) ("Kdr" 11)
   ("Vegfr2" 10) ("Vascular endothelial growth factor receptor-2" 9)
   ("FLK-1" 5) ("-VEGFR-2" 4) ("flk1" 4) ("-VEGFR2" 4) ("–VEGFR2" 4)
   ("fetal liver kinase-1" 2) ("vegfr2" 2) ("Upstate and phospho KDR" 2)
   ("FLK1" 2) ("functional VEGFR2" 2) ("VEGFR2 ( KDR )" 2)
   ("VEGFR-2 ( KDR )" 2) ("specifically ablate Vegfr2" 2) ("flk-1" 2)
   ("VEGFR 2" 1) ("VEGFR2–" 1) ("overnight starvation KDR" 1) ("CD309" 1)
   ("Cediranib primarily targets VEGFR2" 1) ("soluble VEGFR2" 1)
   ("than VEGFR2 (data not published)" 1)
   ("kinase insert domain receptor (KDR)" 1)
   ("kinase insert domain receptor" 1)
   ("Recombinant soluble vascular endothelial growth factor receptor 2" 1)
   ("total and phosphorylated VEGFR2" 1) ("chimeric VEGFR-2" 1)
   ("chimeric VEGFR-2 (CKR)" 1) ("non-chimeric VEGFR-2" 1)
   ("Chimeric VEGFR-2 (CKR)" 1) ("Vegfr-2" 1) ("VEGFR2-" 1)))
 ("UP:P35984" (("E1B 19K" 2))) ("UP:P35998" (("PSMC2" 10) ("ATPase 2" 4)))
 ("UP:P36009" (("DHR2" 49))) ("UP:P36021" (("SLC16a2" 14)))
 ("UP:P36035" (("Jen1" 4))) ("UP:P36037" (("Ufd3" 6) ("UFD3" 1)))
 ("UP:P36077" (("sulphiredoxin" 1))) ("UP:P36084" (("Mud2" 1)))
 ("UP:P36108" (("Vps2" 1))) ("UP:P36117" (("Art6" 1)))
 ("UP:P36193" (("drosocin" 5) ("Drosocin" 2)))
 ("UP:P36222"
  (("oligomers" 1748) ("YKL-40" 165) ("CHI3L1" 111) ("Oligomers" 23)
   ("YKL40" 6) ("soluble oligomers" 5) ("oligomers (PMO)" 4)
   ("oligomers (PPMO)" 4) ("larger oligomers" 4)
   ("chitinase-3-like protein 1" 3) ("longer oligomers" 3)
   ("soluble Aβ oligomers" 3) ("Soluble Amyloid-β oligomers" 2)
   ("than oligomers" 2) ("A1-mini and Hdm2-ABD form discrete oligomers" 2)
   ("β-strand-rich oligomers" 2) ("only small oligomers" 2)
   ("YKL-40 protein" 2) ("rapidly form SDS-resistant 8S oligomers" 2)
   ("highly polymerized oligomers" 2) ("soluble misfolded protein oligomers" 2)
   ("smaller oligomers" 2) ("exogenous human Aβ oligomers" 2)
   ("the respective human Aβ oligomers" 2) ("Soluble Aβ oligomers" 2)
   ("ChI3L1" 2) ("CHI3L1 protein" 2) ("junctional oligomers" 1)
   ("than Aβ oligomers" 1) ("radioactively-labeled (+52/+60) oligomers" 1)
   ("A few oligomers" 1)
   ("the mesenchymal subtype marker chitinase-3-like protein 1" 1)
   ("unstable oligomers" 1) ("random oligomers" 1)
   ("clear any toxic Aβ oligomers" 1) ("β-strand-rich protein oligomers" 1)
   ("Hdm2/Arf bimolecular oligomers" 1)
   ("higher order bimolecular oligomers" 1)
   ("these unprecedented bimolecular oligomers" 1)
   ("β-strand-rich bi-molecular oligomers" 1)
   ("β-strand-rich bimolecular oligomers" 1)
   ("larger (NMR-invisible) bi-molecular oligomers" 1)
   ("smallest (NMR-observable) oligomers" 1) ("small and large oligomers" 1)
   ("than the corresponding oligomers of the wild type HspB1 ( xref , xref )"
    1)
   ("antisense miR-23 locked nucleic acid (LNA) oligomers" 1)
   ("Rad52 revealed ring-shaped oligomers" 1) ("still form oligomers" 1)
   ("maybe mono oligomers" 1) ("self-limited oligomers" 1)
   ("distinct oligomers" 1)
   ("high molecular weight (~130 kDa) tetrameric VDAC1 oligomers" 1)
   ("competitive wild type oligomers" 1) ("soluble endogenous Aβ oligomers" 1)
   ("the small-intermediate oligomers" 1)
   ("rapidly forms SDS-resistant oligomers" 1)
   ("the mesenchymal subtype marker YKL-40" 1) ("toxic Aβ oligomers" 1)
   ("secretory CHI3L1 protein" 1) ("Chi3l1" 1) ("secretory CHI3L1" 1)))
 ("UP:P36344" (("GJ" 6)))
 ("UP:P36382"
  (("Gja5" 5) ("CX40" 5) ("GJA5" 4) ("Cx40" 3) ("connexin 40" 3)
   ("connexin-40" 2) ("Connexin-40" 1)))
 ("UP:P36383" (("Cx45" 10)))
 ("UP:P36402"
  (("TCF7" 41) ("transcription factor 7" 9) ("T-cell factor-1" 3) ("Tcf7" 2)
   ("Transcription factor 7" 1)))
 ("UP:P36405" (("Arl3" 3))) ("UP:P36406" (("TRIM23" 13) ("Trim23" 1)))
 ("UP:P36417" (("GBF" 2))) ("UP:P36501" (("SCNA" 37) ("-SCNA" 2)))
 ("UP:P36507"
  (("MEK2" 676) ("MAP2K2" 34) ("MEK2 peptide" 14) ("MKK2" 7) ("MEK-2" 6)
   ("MEK 2" 5) ("mek-2" 3) ("than MEK2" 1) ("MEK2 (MEKDD)" 1) ("p-MEK-2" 1)))
 ("UP:P36542" (("ATP5c" 1)))
 ("UP:P36544"
  (("SH-SY5Y" 1800) ("ATCC" 19) ("CHRNA7" 15) (NIL 9)
   ("neuronal acetylcholine receptor subunit alpha-7" 3)
   ("wt p53-expressing SH-SY5Y" 2) ("SH-SY5Y-" 1)
   ("Transformed neuroblastoma cell lines–in particular SH-SY5Y" 1)
   ("IL-1β-treated SH-SY5Y" 1) ("Confluent SH-SY5Y" 1)
   ("ERα-positive neuroblastoma cell SH-SY5Y" 1) ("80% confluent SH-SY5Y" 1)
   ("the dopaminergic neuroblastoma cell line SH-SY5Y" 1)
   ("The parental human NB SH-SY5Y" 1) ("the LRRK2-overexpressing SH-SY5Y" 1)))
 ("UP:P36551"
  (("Cox" 4178) ("COX" 709) ("pCOX" 36) ("cox" 34) ("using Cox’s" 6)
   ("multivariate Cox's" 6) ("COX-" 5) ("using Cox's" 4) ("the Cox's" 3)
   ("the multivariate Cox's" 2) ("The multivariate Cox's" 2) ("CPX" 2)
   ("multivariable Cox" 2) ("Cox-" 2) ("The Cox's" 2)
   ("the multivariable Cox" 2) ("step wise forward Cox's" 1) ("the Cox’s" 1)
   ("Both univariant and multivariant Cox’s" 1) ("the fitted Cox's" 1)
   ("A multivariate Cox’s" 1) ("using stepwise Cox's" 1) ("a stepwise Cox’s" 1)
   ("Multivariate α proportional Cox" 1)
   ("propensity-score–weighted multivariable Cox" 1) ("–Cox" 1)
   ("the classical multivariate Cox" 1) ("two multivariable Cox" 1)
   ("multivariable Cox's" 1) ("Multivariate Cox's" 1) ("All univariable Cox" 1)
   ("The univariate Cox's" 1) ("using univariate Cox's" 1)
   ("the multivariate Cox’s" 1) ("a multivariate Cox’s" 1)
   ("the univariate Cox’s" 1) ("Multivariate Cox’s" 1) ("COX protein" 1)
   ("weighted Cox’s" 1)))
 ("UP:P36575"
  (("arrestin-3" 31) ("ARR3" 11) ("Carr" 2) ("pure arrestin-3" 1)
   ("Arrestin-3" 1)))
 ("UP:P36578" (("RPL1" 2) ("RpL1" 2) ("RPL4" 1) ("Rpl4" 1)))
 ("UP:P36615" (("Csk1" 11)))
 ("UP:P36639"
  (("MTH1" 254) ("overexpressed MTH1" 2)
   ("subsequently either overexpressed or suppressed MTH1" 1)
   ("either stably overexpressed MTH1" 1) ("NUDT1" 1)))
 ("UP:P36643" (("pilin" 2))) ("UP:P36776" (("Lonp1" 1)))
 ("UP:P36871" (("pPGM1" 4) ("phosphoglucomutase 1" 1) ("PGM1" 1)))
 ("UP:P36873"
  (("PP1c" 319) ("PP1γ" 200) ("PP1C" 62) ("PP1G" 13) ("gamma isoform" 9)
   ("-PP1c" 6) ("PPP1CC" 5) ("PP1gamma" 2) ("proteins called PP1c" 2)
   ("ppp1cc" 1)))
 ("UP:P36888"
  (("FLT3" 5403) ("STK1" 91) ("FMS-like tyrosine kinase 3" 44) ("Flt-3" 27)
   ("CD135" 27) ("FLT3-" 25) ("FLT-3" 23) ("fms-like tyrosine kinase 3" 16)
   ("Fms-like tyrosine kinase 3" 15) ("FLT3 protein" 13) ("Flk2" 9) ("Flk-2" 5)
   ("p-FLT3" 5) ("FLT3 (571-993) protein" 4) ("Fl cytokine receptor" 4)
   ("P-FLT3" 3) ("flk2" 3) ("Fms related tyrosine kinase 3" 3) ("FLK2" 3)
   ("FLK-2" 2) ("pFLT3" 2) ("only FLT3 point mutation" 2)
   ("the total and phosphorylated FLT3" 2) ("STK1 protein" 2)
   ("STK1 (25 kDa) protein" 2) ("targeting FLT3" 2)
   ("fms-related tyrosine kinase-3" 2) ("FLT-3-" 2) ("FLT3 molecule" 2)
   ("EGCG specifically targets mutant FLT3" 1) ("than FLT3 ( xref )" 1)
   ("than FLT3" 1) ("in contrast FLT3 point mutation" 1)
   ("the 150 kDa-sized FLT3 protein" 1) ("aberrant FLT3" 1) ("than FLT3-WT" 1)
   ("specifically target FLT3" 1) ("doubly-mutated FLT3" 1) ("flt-3" 1)
   ("FLT3–" 1)))
 ("UP:P36894"
  (("BMPR1A" 56) ("BMPR-1A" 15) ("BMPR-IA" 12) ("ALK3" 7) ("ALK-3" 2)
   ("Bmpr-Ia" 2) ("BMPRIA" 2)))
 ("UP:P36895" (("BMPR" 71) ("Bmpr" 5)))
 ("UP:P36896"
  (("ALK-4" 22) ("ALK4" 20) ("ACVR1B" 19) ("Alk4" 13) ("type Ib" 11)
   ("SKR-2" 3) ("Type Ib" 2) ("ActR-IB" 1)))
 ("UP:P36897"
  (("type I receptor" 310) ("Tgfbr1" 174) ("ALK5" 128) ("TGFBRI" 85)
   ("TGFBR1" 68) ("Alk5" 44) ("TβR-I" 38) ("Type I receptor" 8) ("TbetaRI" 7)
   ("ALK-5" 6) ("ALK 5" 4) ("TGFBR" 4) ("TGFBR1-" 3)
   ("activin receptor–like kinase 5" 3)
   ("transforming growth factor beta receptor 1" 3)
   ("the predominant type I receptor" 2) ("cells showed split ALK 5" 1)
   ("-Alk5" 1) ("TGFBRI-" 1) ("activin receptor-like kinase 5" 1)
   ("type I
receptor"
    1)
   ("Alk-5" 1)))
 ("UP:P36915" (("HSR1" 2) ("hsr" 2) ("hSR" 2)))
 ("UP:P36941"
  (("LTβR" 76) ("TNFR superfamily" 41) ("LT-βR" 7) ("LTβR protein" 2)
   ("the oligomerized LTβR" 1) ("LTBR" 1) ("TNFR3" 1)
   ("TNFR superfamily (TNFRSF)" 1)))
 ("UP:P36952"
  (("maspin" 270) ("Maspin" 167) ("SERPINB5" 36) ("PI5" 17) ("PI-5" 17)
   ("the
stage-specific colorectal cancer biomarker SERPINB5"
    2)
   ("Maspin-" 2) ("SerpinB5" 1) ("than maspin" 1)
   ("its antiangiogenic effect Maspin" 1)))
 ("UP:P36955"
  (("derived factor" 68) ("SERPINF1" 15) ("-derived factor" 5) ("Serpinf1" 3)
   ("SERPIN F1" 2) ("derived factor (SDF)" 1)))
 ("UP:P36956"
  (("SREBP-1" 200) ("SREBP1" 142) ("SREBP-1c" 72) ("SREBF1" 72) ("SREBP1c" 57)
   ("Srebp1" 18) ("sterol regulatory element binding protein 1" 8)
   ("sterol regulatory element-binding protein 1" 7) ("Srebp1c" 6)
   ("SREBP1a" 6) ("SREBP-1a" 6) ("SREBP-1 protein" 6) ("SREBP1C" 5)
   ("sterol regulatory element binding transcription factor 1" 5) ("Srebf1" 4)
   ("sterol regulatory element-binding protein-1" 4)
   ("sterol regulatory element binding protein-1" 3)
   ("Sterol regulatory element binding protein-1" 2)
   ("the master lipogenic regulator SREBP1c" 2) ("Srebp-1" 2)
   ("the
                            key lipogenic activator SREBP-1c"
    2)
   ("sterol regulatory element–binding protein 1" 2)
   ("lower intrinsic SREBP-1" 2)
   ("Sterol regulatory element-binding protein-1" 2)
   ("Sterol regulatory element-binding transcription factor 1" 1)
   ("flag-tagged active SREBP1c" 1) ("mature SREBP1c" 1) ("srebf1" 1)
   ("Mature SREBP1" 1) ("this mature SREBP-1" 1)
   ("the first 403 amino acids of SREBP1c" 1)
   ("the pivotal transcription factor SREBP-1c" 1)
   ("sterol regulatory element–binding protein-1" 1)))
 ("UP:P36957" (("DLTs" 37) ("DLST" 6) ("febrile neutropenia DLTs" 1)))
 ("UP:P36959" (("GMPR" 3) ("guanosine monophosphate reductase" 1)))
 ("UP:P36969" (("GPX4" 20) ("glutathione peroxidase 4" 1)))
 ("UP:P36978" (("SNAP25b" 1))) ("UP:P36980" (("CFHL2" 3) ("CFHR2" 1)))
 ("UP:P37023"
  (("ALK1" 70) ("Alk1" 29) ("ALK-1" 9) ("activin receptor-like kinase 1" 7)
   ("ACVRL1" 5) ("Mouse monoclonal antihuman ALK1" 2) ("Acvrl1" 2)
   ("than the ALK1" 1) ("ACVRLK1" 1)))
 ("UP:P37041"
  (("GnRH-I" 73) ("than GnRH-I in these cells" 1) ("than GnRH-I" 1)))
 ("UP:P37059" (("HSD17B2" 20) ("HSD17" 3)))
 ("UP:P37088"
  (("αENaC" 65) ("αENaC protein" 9) ("SCNN1A" 5) ("at least αENaC protein" 1)))
 ("UP:P37108" (("SRP14" 1))) ("UP:P37112" (("AMA" 1)))
 ("UP:P37137" (("LIM5" 9))) ("UP:P37167" (("actophorin" 13)))
 ("UP:P37173"
  (("TGFBR2" 372) ("Tgfbr2" 103) ("TβR-II" 10) ("TGFBR2 protein" 2)
   ("transforming growth factor beta receptor II" 2) ("TbetaRII" 2)
   ("TGF beta receptor type II" 2)
   ("the constitutively active dimeric TGFBR2" 1)
   ("TGF-beta receptor type-2" 1)
   ("transforming growth factor beta receptor II (TGFBRII)" 1)))
 ("UP:P37198" (("Nup62" 20) ("NUP62" 3) ("nucleoporin 62" 3)))
 ("UP:P37231"
  (("PPARγ" 2298) ("PPARG" 308) ("PPAR-γ" 281) ("Pparγ" 143)
   ("PPARγ protein" 47) ("peroxisome proliferator-activated receptor gamma" 37)
   ("Pparg" 36) ("PPARg" 15) ("PPARgamma" 13) ("PPAR-gamma" 10)
   ("peroxisome proliferator activated receptor gamma" 8) ("receptor gamma" 8)
   ("PPARG2" 5) ("NR1C3" 4)
   ("peroxisomal proliferator-activated receptor gamma" 4)
   ("the adipogenic transcription factor PPARγ" 4)
   ("peroxisome proliferator activated receptor gamma (PPARG)" 3)
   ("coexpressed PPARγ" 3) ("Monoclonal PPARγ" 2)
   ("Peroxisome proliferator activated receptor gamma" 2)
   ("peroxisome proliferator–activated receptor gamma" 2)
   ("the therapy-relevant PPARG" 1)
   ("peroxisome proliferator-activated receptor gamma (PPARG)" 1)
   ("the key adipogenic transcription factor PPAR-gamma" 1) ("-PPARγ" 1)
   ("adipogenic PPARG2" 1) ("proliferator-activated receptor gamma" 1)
   ("PPAR–γ" 1) ("PPARG-" 1) ("cytoplasmatic PPARγ" 1) ("Pparg2" 1)
   ("PPARG (PP)" 1) ("appropriate Pparγ" 1) ("canonical Pparγ" 1)
   ("than WT Pparγ" 1)))
 ("UP:P37268"
  (("SS" 839) ("ss" 94) ("pSS" 64) ("SS-" 23) ("FDFT1" 14) ("SQS" 9) ("“SS”" 4)
   ("squalene synthase" 4) ("farnesyl-diphosphate farnesyltransferase 1" 3)
   ("Laminar SS" 2) ("”" 1) ("laminar SS" 1) ("a laminar SS" 1) ("-SS" 1)
   ("monophasic SS" 1)))
 ("UP:P37269" (("PYS" 8)))
 ("UP:P37275"
  (("ZEB1" 1440) ("Zeb1" 294) ("Zeb-1" 79) ("ZEB-1" 40)
   ("zinc finger E-box binding homeobox 1" 17) ("ZEB1 protein" 13) ("Zeb" 11)
   ("TCF8" 10) ("zeb1" 5) ("deltaEF1" 5) ("TCF-8" 5) ("AREB6" 5) ("DeltaEF1" 4)
   ("ZEB 1" 3) ("transcriptional repressor ZEB1" 3)
   ("the transcriptional repressor ZEB1" 3) ("Zeb1 protein" 2) ("zeb-1" 2)
   ("Zinc finger E-box binding homeobox 1" 2)
   ("293T cells expressing SFB-tagged ZEB1" 1)
   ("the epithelial-mesenchymal transition (EMT) transcription factor Zeb1" 1)
   ("the epithelial-to-mesenchymal transition (EMT)-related TF ZEB1" 1)
   ("the E-cadherin transcriptional repressors ZEB1" 1)
   ("than ZEB1 (Fig. xref , right)" 1) ("transcriptional suppressor ZEB1" 1)
   ("its transcriptional suppressor Zeb-1" 1) ("zfhx1a" 1)
   ("the p73 transcriptional repressor ZEB1" 1) ("-ZEB1" 1) ("ZeB1" 1)
   ("miR-130b directly targets ZEB1" 1)
   ("the E-cadherin transcriptional repressor ZEB1" 1)))
 ("UP:P37279" (("PACs" 1)))
 ("UP:P37287"
  (("paroxysmal nocturnal hemoglobinuria" 2)
   ("paroxysmal nocturnal hemoglobinuria (PNH)" 1)))
 ("UP:P37303" (("TAs" 58) ("T-A" 31) ("flat and depressed TAs" 1) ("T–A" 1)))
 ("UP:P37330"
  (("pMSG" 16) ("MSG" 12) ("MSGs" 3) ("a frequently inactivated MSG" 1)))
 ("UP:P37338" (("CSIR" 4))) ("UP:P37340" (("NORE" 2) ("Nore" 1)))
 ("UP:P37370" (("verprolin" 19) ("Verprolin" 3)))
 ("UP:P37379"
  (("-synuclein" 44) ("synuclein" 37) ("Synuclein" 2) ("synucleins" 1)))
 ("UP:P37471" (("Diva" 47) ("DIVA" 38) ("DiVa" 12) ("DiVa (BD)" 2)))
 ("UP:P37524" (("Noc" 72) ("noc" 25) ("NOC" 10)))
 ("UP:P37650"
  (("BCSC" 209) ("potently co-induces BCSC" 1) ("attractive BCSC" 1)))
 ("UP:P37737" (("FATC" 34)))
 ("UP:P37743"
  (("hpi" 707) ("HPI" 91) ("at least 120 hpi" 3) ("at least 10 HPI" 2)
   ("than 24 hpi ( xref )" 1)))
 ("UP:P37802" (("TAGLN2" 3)))
 ("UP:P37818"
  (("arginase" 128) ("Arginase" 17) ("-arginase" 4)
   ("the binuclear manganese metalloenzyme arginase" 1)
   ("endothelial arginase" 1)))
 ("UP:P37837"
  (("TAL" 44) ("pTAL" 21) ("transaldolase" 11) ("TALDO" 5) ("TALDO1" 1)))
 ("UP:P37840"
  (("α-synuclein" 398) ("alpha-synuclein" 115) ("SNCA" 113) ("α-Synuclein" 16)
   ("alpha-Synuclein" 8) ("α-synuclein protein" 7) ("Alpha-synuclein" 6)
   ("ALPHA-SYNUCLEIN" 4) ("α–synuclein" 3)
   ("the family-PD-linked genes PARK-1" 2) ("PARK-1" 2) ("PARK1" 2)
   ("SNCA protein" 2) ("insoluble fibrillar α-synuclein" 2)
   ("fibrillar α-synuclein" 1) ("oligomeric alpha-synuclein" 1)
   ("presynaptic α-synuclein" 1) ("α-synuclein-" 1) ("NACP" 1)))
 ("UP:P37842" (("mC" 82) ("-mC" 2))) ("UP:P37872" (("ORF23" 1)))
 ("UP:P37954"
  (("UVR" 278) ("DiNa" 1) ("epidemiological data linking UVR" 1)
   ("solar UVR" 1)))
 ("UP:P37955" (("sPLA" 97) ("SPla/Ryanodine receptor (SPRY)" 1) ("SPla" 1)))
 ("UP:P38022" (("ROCR" 5))) ("UP:P38029" (("Spi2" 1)))
 ("UP:P38093" (("FlbA" 1))) ("UP:P38114" (("TBS-1" 1)))
 ("UP:P38152" (("Ctp1" 2)))
 ("UP:P38159" (("RBMX" 103) ("HNRNPG" 26) ("HNRNP G" 5) ("hnRNPG" 4)))
 ("UP:P38203" (("SNP3" 18))) ("UP:P38207" (("APN2" 7) ("Apn2" 6)))
 ("UP:P38212" (("rCR1" 2))) ("UP:P38262" (("siF2" 2)))
 ("UP:P38283" (("Sli15" 1))) ("UP:P38297" (("Fzo1" 1)))
 ("UP:P38337" (("shG1" 3) ("SHG1" 1)))
 ("UP:P38339"
  (("RhoGAP" 363) ("Rho-GAP" 70) ("RhoGAPs" 36)
   ("the associated p190 Rho-GAP" 2) ("a unique RhoGAP" 2) ("rhoGAP" 2)
   ("other well-characterized RhoGAPs" 1) ("RhoGap" 1)
   ("two neuronal RhoGAPs" 1)))
 ("UP:P38370" (("OAR" 2)))
 ("UP:P38398"
  (("BRCA1" 36349) ("BRCA1 protein" 684) ("IRIS" 652) ("BRCA1-" 274)
   ("iris" 72) ("pBRCA1" 46) ("4P" 42) ("IRIS peptide" 36)
   ("functional BRCA1" 29) ("BRCA-1" 19) ("intact BRCA1" 14) ("4p" 13)
   ("HCC1937B" 13) ("BRCA1 peptide" 11) ("Iris" 9) ("-BRCA1" 9)
   ("exogenous BRCA1" 8) ("–BRCA1" 6) ("dysfunctional BRCA1" 5)
   ("a functional BRCA1" 5) ("than BRCA1" 5) ("less BRCA1" 4)
   ("BRCA1 (breast cancer associated 1) protein" 4) ("BRCA1(R71G) protein" 4)
   ("BRCA1 Protein" 4) ("abnormal BRCA1" 4)
   ("BRCA1 (Breast Cancer 1) protein" 3) ("Ser1423-BRCA1 peptide" 3)
   ("p-BRCA1" 3) ("deleterious BRCA1" 3) ("normal BRCA1" 3)
   ("polymorphic BRCA1" 3) ("tumors expressed normal BRCA1" 3)
   ("a known pathogenic BRCA1" 2) ("concordant BRCA1 protein" 2)
   ("moderate or strong BRCA1" 2) ("a dysfunctional BRCA1" 2)
   ("genomic BRCA1" 2) ("exogenous BRCA1 protein" 2)
   ("the exogenous expressed BRCA1" 2)
   ("using monoclonal MS110 Ab-1 anti- BRCA1" 2) ("dominant-negative BRCA1" 2)
   ("the PP1-binding motif-deleted BRCA1 protein" 2) ("epigenetic BRCA1" 2)
   ("efficient BRCA1" 2) ("proficient BRCA1" 2) ("other possible BRCA1" 2)
   ("the subsequent BRCA1" 2) ("defective BRCA1" 2)
   ("the highly susceptible BRCA1" 2) ("“BRCA1”" 2) ("single somatic BRCA1" 2)
   ("targeting either BRCA1" 2) ("the predominant BRCA1" 2) ("Dual BRCA1" 2)
   ("almost no endogenous BRCA1" 2) ("larger wild-type BRCA1 protein" 2)
   ("pBRCA1 protein" 2) ("BRCA1(M18T) protein" 2)
   ("exogenous wild-type BRCA1" 2) ("indeed functionally relevant BRCA1" 2)
   ("potential BRCA1" 2) ("1000 distinct cancer-associated BRCA1" 2)
   ("medullary tumors BRCA1" 2) ("chromatin-associated BRCA1" 2)
   ("Functional BRCA1" 2) ("total and phosphorylated BRCA1" 2)
   ("Cardiac BRCA1" 2) ("a deleterious BRCA1" 2) ("overexpressed BRCA1" 2)
   ("Genetic or epigenetic BRCA1" 2) ("a hypomorphic BRCA1 protein" 2)
   ("all showed intact BRCA1" 2) ("Abnormal BRCA1" 2) ("the central BRCA1" 2)
   ("The less successful BRCA1" 1) ("Specifically six BRCA1" 1)
   ("around 44 BRCA1" 1) ("the parental BRCA1" 1)
   ("we first stably reconstituted wild-type BRCA1" 1) ("only 5 BRCA1-" 1)
   ("full-length exogenous BRCA1" 1) ("exogenous full-length BRCA1" 1)
   ("The commercial BRCA1" 1) ("given BRCA1’s" 1) ("given BRCA1" 1)
   ("associated BRCA1" 1) ("further identified BRCA1" 1) ("BRCA1GFP" 1)
   ("Cellular BRCA1" 1) ("the HR-associated repair factor BRCA1" 1)
   ("miR-638 directly targets BRCA1" 1) ("even less BRCA1" 1)
   ("the available BRCA1" 1) ("less BRCA1 protein" 1) ("the latter BRCA1" 1)
   ("one or more BRCA1" 1) ("multiple normal BRCA1" 1)
   ("N-terminal 198 amino acids of BRCA1" 1)
   ("the transcriptional role BRCA1" 1) ("partially-silenced BRCA1-" 1)
   ("The mutational and truncated BRCA1" 1) ("non-functional BRCA1" 1)
   ("764 distinct BRCA1" 1) ("RNaseH1-expressing BRCA1-" 1) ("robust BRCA1" 1)
   ("these twelve (9/12, 75.0%) triple negative BRCA1" 1)
   ("triple negative BRCA1" 1)
   ("the amino-terminal 304 amino acids of human BRCA1 (Ab-1, Catalog Number OP92, Calbiochem, Dermstadt, Germany)"
    1)
   ("RNF53" 1) ("most BRCA1" 1)
   ("meeting eligibility criteria underwent BRCA1" 1)
   ("immunoreactive BRCA1" 1)
   ("the N-terminal 304 amino acids of BRCA1 ( xref )" 1) ("a new BRCA1" 1)
   ("8 distinct BRCA1" 1) ("than the wild-type BRCA1 (the third well)" 1)
   ("linking BRCA1" 1) ("than the endogenous BRCA1 protein" 1)
   ("than the endogenous BRCA1 protein ( xref )" 1)
   ("Hereditary breast and ovarian cancer susceptibility gene product BRCA1" 1)
   ("very convoluted brown iris" 1) ("a web-based BRCA1" 1) ("around BRCA1" 1)
   ("a strong BRCA1" 1) ("the abnormal BRCA1" 1) ("Normal BRCA1" 1)
   ("two normal ovarian surface epithelial cell lines (HOSE-E6E7 and HOSE-27) BRCA1-wild type"
    1)
   ("nuclear:cytoplasmic BRCA1" 1) ("a robust DNA-damage-induced BRCA1" 1)
   ("the cytoplasm suppressed BRCA1’s" 1) ("focal nuclear BRCA1" 1)
   ("only 186 BRCA1" 1) ("only one BRCA1-" 1) ("targeting BRCA1" 1)
   ("genotoxic stress BRCA1" 1) ("The exogenous BRCA1" 1) ("Exogenous BRCA1" 1)
   ("expressing mutant BRCA1" 1) ("non-degradable BRCA1" 1)
   ("the molecular mechanisms underlying BRCA1’s" 1) ("amino acids of BRCA1" 1)
   ("exactly BRCA1" 1) ("than BRCA1 [ xref ]" 1)
   ("low EZH2/low pAkt-1/high nuclear pBRCA1" 1)
   ("Concomitant high EZH2/high pAkt-1/low nuclear pBRCA1" 1)
   ("Akt-1 decreased EZH2-induced BRCA1" 1) ("perinuclear BRCA1 protein" 1)
   ("late S phase BRCA1" 1) ("the resultant BRCA1 protein" 1)
   ("9 distinct BRCA1" 1) ("a known deleterious BRCA1" 1)
   ("most known BRCA1" 1) ("H2A affected previously well-documented BRCA1" 1)
   ("the polymorphic BRCA1 -V11A" 1) ("Given BRCA1's" 1) ("Given BRCA1" 1)
   ("than 1000 distinct cancer-associated BRCA1 [MIM 113705]" 1)
   ("than BRCA1 ( xref )" 1)
   ("than BRCA1 ( xref , OR for BRCA2 =11.4, 95% CI: 9.8-13.2)" 1)
   ("BRCA1/2 (CIMBA)" 1) ("almost all BRCA1" 1)
   ("epigenetically-silenced BRCA1" 1) ("Polymorphic BRCA1" 1)
   ("cellular BRCA1" 1) ("a few additional BRCA1" 1) ("”" 1)
   ("at least 43 amino acids of the BRCA1 protein" 1)
   ("28 amino acids of the BRCA1 protein" 1)
   ("the highly penetrant cancer susceptibility gene BRCA1" 1)
   ("systematically less BRCA1" 1) ("there are 38 BRCA1" 1)
   ("sporadic BRCA1" 1) ("than BRCA1 [ xref , xref - xref ]" 1)
   ("showed equivocal BRCA1" 1) ("a BRCA1's" 1)
   ("a 646 kb region around BRCA1" 1) ("germinal BRCA1" 1)
   ("ATR signaling (but not Chk1 signaling) strikingly further sensitized BRCA1-"
    1)
   ("P38398" 1)))
 ("UP:P38432"
  (("coil" 415) ("coilin" 27) ("a random coil" 19) ("random coil" 10)
   ("Coil" 7) ("coil peptide" 3) ("Coilin" 2) ("p80-coilin" 2)
   ("coilin protein" 2) ("COIL" 1) ("a built-in flexible body coil" 1)
   ("-coil" 1) ("34% random coil" 1) ("than a random coil" 1)
   ("a classical random coil" 1) ("a hormonal coil" 1) ("an entropic coil" 1)))
 ("UP:P38435" (("GGCX" 1))) ("UP:P38467" (("ORF64" 3)))
 ("UP:P38473" (("ORF61" 31) ("ORF61 protein" 1)))
 ("UP:P38484"
  (("AF-1" 273) ("IFNγR2" 258) ("AF1" 173) ("interferon-γ" 167)
   ("Interferon-γ" 29) ("IFNGR2" 15) ("AF-1 protein" 10) (NIL 7)
   ("AF1 molecule" 3) ("AF1 deletion mutant" 3) ("ifngr2" 2) ("intact AF-1" 2)
   ("defective AF-1" 2) ("the amino terminal AF1" 2) ("-IFNγR2" 1)
   ("the C-terminal 20 amino acids of IFNγR2" 1) ("IFNγR2 protein" 1)
   ("ER-α36 lacks both the AF-1" 1)))
 ("UP:P38555" (("Ypt31" 4) ("YPT31" 1)))
 ("UP:P38567" (("PH20" 2) ("Spam1" 1) ("SPAM1" 1)))
 ("UP:P38570" (("CD103" 150) ("ITGAE" 6) ("CD103-" 3) ("functional CD103" 1)))
 ("UP:P38571" (("LIPA" 28) ("LiPA" 13) ("Lal" 6))) ("UP:P38572" (("UP1a" 5)))
 ("UP:P38588" (("HMC" 35))) ("UP:P38606" (("ATP6V1A" 5)))
 ("UP:P38622" (("RCK1" 3))) ("UP:P38631" (("GSC1" 4)))
 ("UP:P38646"
  (("mortalin" 159) ("mot-2" 131) ("mtHSP70" 32) ("mtHsp70" 14) ("HSPA9" 13)
   ("Mot-2" 12) ("MOT" 10) ("MoT" 7) ("Mortalin" 6) ("mot-2 protein" 6)
   ("mot" 6) ("mortalin protein" 4) ("Grp75" 2) ("HSPA9B" 2)
   ("Less mortalin" 2) ("the soluble matrix chaperonin mtHsp70" 1)
   ("less mortalin" 1) ("PBP74" 1) ("More mot-2" 1) ("GRP75" 1)
   ("full-length mortalin’s" 1)))
 ("UP:P38691" (("KSP1" 4))) ("UP:P38715" (("GRE3" 3)))
 ("UP:P38766" (("RRM3" 44) ("Rrm3" 1))) ("UP:P38823" (("DMA1" 2)))
 ("UP:P38850" (("Esc4" 2)))
 ("UP:P38856" (("yap1801" 3) ("YAP1801" 2) ("Yap1801" 1)))
 ("UP:P38872" (("PFS1" 44))) ("UP:P38876" (("PTH1" 1)))
 ("UP:P38888" (("Mnl1" 1)))
 ("UP:P38919"
  (("isoform 3" 75) ("eIF4AIII" 12) ("DEAD box protein" 7) ("Isoform 3" 5)
   ("EIF4A3" 1) ("than p120ctn isoform 3" 1)))
 ("UP:P38936"
  (("p21" 24626) ("WAF1" 2207) ("CDKN1A" 1950) ("CIP1" 1450) ("Cip1" 1251)
   ("cip1" 716) ("waf1" 682) ("Waf1" 580) ("P21" 464) ("Cdkn1a" 180)
   ("WAF" 132) ("waf" 84) ("p21 peptide" 84) ("-p21" 60) ("cip1 protein" 60)
   ("Waf" 56) ("cyclin-dependent kinase inhibitor 1" 43) ("sdi1" 37)
   ("P21CIP1" 37) ("Waf1 protein" 35) ("p21-" 33) ("Waf-1" 25) ("CDKN1a" 25)
   ("p21–" 25) ("waf-1" 10) ("WAF1 protein" 8) ("functional p21" 8)
   ("CDKN1A protein" 7) ("Sdi1" 6) ("Waf–1" 6) ("Cip-1" 6)
   ("very little p21" 5) ("WAF-1" 5) ("Cip1 protein" 5)
   ("the p53 transcriptional target p21" 5) ("p-21" 4) ("p21 molecule" 4)
   ("SDI1" 3) ("Cdkn1A" 3) ("than CDKN1A" 3) ("cip-1" 3) ("than p21" 3)
   ("cdkn1a" 3) ("overexpressed p21" 3) ("p21 peptide (RQTSMTDFYHSKR)" 3)
   ("p21 (WAF1/CIP1) protein" 3) ("chromosome 6p21.3-p21.2" 3)
   ("CDK-interacting protein 1" 3) ("WAF1 (hereafter p21) protein" 3)
   ("Waf-1 protein" 2) ("transcriptional activation ofp21 Cip1" 2)
   ("the most well-studied default p53 target genes CDKN1A" 2) ("-p21.1" 2)
   ("CDKN1A-" 2) ("MiR-17 directly targets p21-3" 2)
   ("the established senescence-associated marker p21" 2) ("P38936" 2)
   ("more p21" 2) ("anti-p53 (DO-1) anti-RelA/p65 (C-20) anti- p21" 2)
   ("demonstrated less p21" 2) ("revealed less p21" 2) ("senescent p21-" 2)
   ("barely detectable p21" 2) ("significantly more p21 CIP1" 2)
   ("defective p21" 2) ("exogenous p21" 2)
   ("the known p53 transcriptional targets p21" 2) ("p21 (141–160) peptide" 2)
   ("various p21 peptide" 2) ("p21 (CDKN1A, Waf1 or Cip1) protein" 2)
   ("around P21" 2) ("than p21 ( xref )" 2) ("noncytoplasmic p21" 2)
   ("the pleiotropic cell cycle protein p21" 2) ("-p21.2" 2)
   ("the multifunctional protein p21" 2) ("mouse monoclonal anti-p21 WAF1" 2)
   ("flag-tagged p21" 2) ("p21 (but not PUMA) protein" 2)
   ("Custom siRNA duplex targeting human p21" 2)
   ("an irrelevant HA-tagged p21 CIP1" 1) ("than one p21 molecule" 1)
   ("than wt p21" 1) ("Additional multi-phosphorylated p21" 1)
   ("the p53/p73-inducible cell cycle regulator p21" 1) ("CAP20" 1)
   ("targeted human p21" 1) ("the well-established p53 target P21-5" 1)
   ("the isogenic cell line HCT116 p21 -/-" 1)
   ("the consecutive progesterone-induced transitory p21" 1)
   ("contained more (2-fold) p21" 1) ("“CDKN1A”" 1) ("CIP2A increased p21" 1)
   ("p21 (KRRQTSMTDFYHSKRRLIFSRQIKIWFQNRRMKWKK)" 1)
   ("the parental HCT 116 p21 +/+" 1) ("WS-MSC p53i expressed less p21" 1)
   ("than p21(wt)" 1) ("than p21(T140V)" 1) ("p21(wt) protein" 1)
   ("nuclear and cytoplasmic cell-associated p21" 1)
   ("miR-17 directly targets p21-3" 1) ("exogenous Cables1 increased p21" 1)
   ("non-phosphorylable human CDKN1A mutants T80A" 1)
   ("UV-irradiation CDKN1A" 1) ("the exogenous wild type p21 Waf1 protein" 1)
   ("the strong p21-5" 1)
   ("variant p21 cip1 expressed 21.9% more p21 cip1 protein" 1) ("CDKN1A ”" 1)
   ("”" 1) ("the p53 transcriptional target CDKN1A" 1)
   ("its well-established target p21" 1) ("high-expressed p21" 1)
   ("the p53 transcriptionaly target p21" 1)
   ("the circadian expression ofp21 CIP1" 1)
   ("FOXP3 still lack detectable p21" 1) ("P-CIP1" 1)
   ("another
                        senescence-associated CDK inhibitor p21 Waf1"
    1)
   ("residual p21 Cip1" 1) ("particular p21" 1) ("p-p21" 1) ("than the p21" 1)
   ("its transcriptional target p21" 1) ("epidermal p21" 1)
   ("shorter lifespan observed inparkin P21" 1)
   ("than wild-type p21 ( xref , xref )" 1) ("“p21”" 1)
   ("MMC-treated p21 +/+" 1) ("MMC-treated HCT116 p21 −/−" 1)
   ("immunoreactive p21" 1) ("serum withdrawal induced p21" 1) ("p21−" 1)
   ("The exogenous p21" 1) ("increased cytocymic p21" 1) ("cellular p21" 1)
   ("showed minimal p21" 1) ("new p21" 1) ("no functional p21" 1)
   ("further confirming p21" 1) ("a functional p21" 1) ("most p21" 1)
   ("than the full-length p21" 1) ("WAF1protein" 1) ("shorter p21 peptide" 1)
   ("targeting human p21" 1) ("-p21.31" 1) ("mouse monoclonal p21" 1)
   ("its downstream transcriptional target p21" 1) ("than wild type p21" 1)
   ("Waf1-" 1) ("the transcriptional activation ofp21 CIP1" 1)))
 ("UP:P38953" (("Rad55" 11) ("RAD55" 1))) ("UP:P39001" (("UME6" 4)))
 ("UP:P39009" (("Dun1" 13) ("DUN1" 1)))
 ("UP:P39019"
  (("RPS19" 96) ("S19" 85) ("Diamond-Blackfan anemia" 12) ("Rps19" 10)
   ("RpS19" 7) ("Diamond–Blackfan anemia" 6) ("rpS19" 2)
   ("Diamond-Blackfan anemia (DBA)" 2) ("RPS19-" 1)))
 ("UP:P39023"
  (("RpL3" 14) ("RPL3" 7) ("overexpressed RpL3" 3) ("ribosomal protein L3" 2)
   ("Rpl3" 2) ("ribosomal subunit RPL3" 1)))
 ("UP:P39059" (("COL15A1" 1)))
 ("UP:P39060"
  (("endostatin" 156) ("KNO" 9) ("Endostatin" 8) ("COL18A1" 7)
   ("than the native endostatin [ xref , xref ]" 1) ("type XVIII" 1)))
 ("UP:P39137" (("ROCE" 2))) ("UP:P39207" (("Ndk1" 4)))
 ("UP:P39224" (("MSP3" 1))) ("UP:P39458" (("nitrate reductase" 2)))
 ("UP:P39524" (("Drs2" 1)))
 ("UP:P39656" (("AGER1" 30) ("AGER1 protein" 4) ("OST48" 1)))
 ("UP:P39658" (("DNs" 174)))
 ("UP:P39687"
  (("member A" 37) ("pp32" 9) ("Anp32a" 6) ("PHAP1" 3) ("ANP32A" 2)
   ("member A (RHOA)" 2) ("member A ( RHOA )" 1) ("ANP32A protein" 1)))
 ("UP:P39705" (("nup60" 1)))
 ("UP:P39717" (("Gpb2" 3) ("gpb2" 2) ("GPB2" 2) ("GPB-2" 1)))
 ("UP:P39736" (("BX42" 1))) ("UP:P39743" (("Rvs167" 8) ("RVS167" 1)))
 ("UP:P39748"
  (("FEN1" 507) ("Fen1" 64) ("flap endonuclease 1" 25) ("MF1" 24) ("Fen-1" 24)
   ("FEN-1" 16) ("Flap endonuclease 1" 12) ("Fen-1 protein" 9)
   ("FEN1 protein" 6) ("RAD2" 5) ("FEN1 molecule" 4) ("flap endonuclease-1" 2)
   ("Fen1 protein" 2) ("Fen-1 molecule" 2)
   ("the structure-specific flap endonuclease FEN1" 1)
   ("flap structure-specific endonuclease 1" 1)
   ("than Fen1 ( xref and data not shown)" 1) ("than Fen1" 1)
   ("the aspartic acid in position 5 of Fen1's" 1)
   ("the aspartic acid in position 5 of Fen1" 1) ("Non-methylated FEN1" 1)
   ("Rad2" 1)))
 ("UP:P39769" (("php" 4))) ("UP:P39784" (("PCF" 1)))
 ("UP:P39795" (("TREC" 13))) ("UP:P39814" (("Top-I" 1)))
 ("UP:P39877" (("Group V" 5) ("PLA2G5" 1)))
 ("UP:P39880"
  (("Cux" 14) ("Cux-1" 5) ("CCAAT displacement protein" 2) ("CUX" 2)))
 ("UP:P39900"
  (("ME" 847) ("HME" 487) ("MMP-12" 66) ("hME" 44) ("MMP12" 39) ("pME" 30)
   ("metalloelastase" 11) ("parental HME" 3) ("Mmp12" 2)
   ("macrophage elastase" 2) ("independently generated isogenic HME" 2)
   ("ovarian ME180" 2) ("even 1:64-diluted ME" 1)
   ("macrophage metalloelastase" 1)
   ("The human isogenic hTERT-immortalized mammary epithelial cell lines HME +/+"
    1)
   ("the parental HME" 1) ("MMP12 protein" 1) ("ME-" 1)))
 ("UP:P39905"
  (("ATF" 208) ("GDNF" 84) ("glial cell line-derived neurotrophic factor" 11)
   ("Glial cell line–derived neurotrophic factor (GDNF)" 3)
   ("glial cell line–derived neurotrophic factor" 3)
   ("glial cell line derived neurotrophic factor" 2) ("Gdnf" 2)
   ("Glial cell line–derived neurotrophic factor" 1)
   ("Glial cell line-derived neurotrophic factor" 1) ("Atf" 1)
   ("Glial cell line derived neurotrophic factor" 1) ("pATF" 1)))
 ("UP:P39935" (("Tif4631" 1))) ("UP:P39962" (("Yck3" 4)))
 ("UP:P39979" (("DNT" 4))) ("UP:P39985" (("Pol5" 1)))
 ("UP:P39993" (("Gea2" 2))) ("UP:P40038" (("Pcl6" 5)))
 ("UP:P40061" (("Avo3" 1))) ("UP:P40066" (("Gle2" 8) ("Gle2 protein" 3)))
 ("UP:P40069" (("kap123" 2))) ("UP:P40072" (("slx8" 4) ("Slx8" 3) ("SLX8" 1)))
 ("UP:P40075" (("SCS2" 2) ("the software SCS2.6" 1)))
 ("UP:P40091" (("PEA2" 16))) ("UP:P40096" (("NCB1" 2)))
 ("UP:P40126"
  (("TRP2" 52) ("dCt" 27) ("dCT" 24) ("Trp-2" 23) ("DCT" 21) ("Dct" 15)
   ("TYRP2" 11) ("dopachrome tautomerase" 8) ("tyrosinase-related protein 2" 6)
   ("DCt" 6) ("TYRP-2" 6) ("TRP-2" 5) ("-dopachrome tautomerase" 3)
   ("-Dopachrome tautomerase" 2) ("Dopachrome tautomerase" 2) ("-dCt" 2)
   ("tyrosinase-related protein-2" 2) ("dCTs" 2) ("exosomal TYRP2" 1)
   ("—dCT" 1)))
 ("UP:P40136"
  (("EF" 530) ("pEF" 239) ("E-F" 41) ("E–F" 5) ("Cya" 2)
   ("the tamoxifen-treated EF" 1) ("tamoxifen-treated EF" 1)))
 ("UP:P40140" (("NG3" 1)))
 ("UP:P40145" (("ADCY8" 3) ("Adcy8" 2) ("adenylate cyclase 8" 1) ("AC8" 1)))
 ("UP:P40186" (("pCL7" 1) ("Pcl7" 1)))
 ("UP:P40189"
  (("gp130" 749) ("IL-6 receptor" 221) ("IL6ST" 43) ("glycoprotein 130" 32)
   ("soluble IL-6 receptor" 24) ("gp-130" 17) ("Gp130" 12) ("gp130 peptide" 10)
   ("the soluble IL-6 receptor" 8) ("IL-6 receptor-" 7) ("CD130" 7)
   ("gp130 protein" 7) ("interleukin 6 signal transducer" 4)
   ("residual gp130" 3) ("soluble gp130" 3)
   ("a 50-kDa soluble IL-6 receptor" 2) ("membrane glycoprotein 130" 2)
   ("a soluble IL-6 receptor" 2)
   ("soluble IL-6Rα (sIL-6Rα) binding cell-surface glycoprotein 130" 2)
   ("the soluble IL-6
 receptor"
    1)
   ("IL-6
 receptor"
    1)
   ("recombinant soluble human IL-6 receptor" 1)))
 ("UP:P40197" (("GP5" 17) ("CD42d" 1)))
 ("UP:P40198" (("CEACAM3" 76) ("CEACAM 3" 5)))
 ("UP:P40199" (("NCA" 119) ("CEACAM6" 22) ("CD66c" 1) ("CEACAM-6" 1)))
 ("UP:P40204" (("SNP2" 13) ("snp2" 2)))
 ("UP:P40205"
  (("NCYM" 213) ("NCYM protein" 29) ("Overexpressed NCYM" 2)
   ("a probable NCYM protein" 1)))
 ("UP:P40222" (("TXLNA" 5)))
 ("UP:P40225"
  (("mL" 4065) ("thrombopoietin" 68) ("M/L" 24) ("Thrombopoietin" 19)
   ("THPO" 16) ("thrombopoietin (TPO)" 8) ("MPL ligand" 3)
   ("approximately 0.5 mL" 2) ("Thrombopoietin (TPO)" 2)
   ("approximately 14 mL" 2) ("thrombopoietin-" 2)
   ("approximately
1 mL"
    2)
   ("Approximately 10 mL" 1) ("Approximately 2 mL" 1) ("Around 0.8 mL" 1)
   ("approximately 2 mL" 1) ("Approximately 32 mL" 1) ("a further 0.5 mL" 1)
   ("approximately 1 mL" 1) ("approximately 10 mL" 1) ("approximately 30 mL" 1)
   ("Approximately 5 mL" 1)))
 ("UP:P40227" (("CCT6" 11) ("Cct6" 6) ("CCT6A" 3)))
 ("UP:P40238"
  (("MPL" 410) ("Mpl" 307) ("thrombopoietin receptor" 14) ("TPOR" 13)
   ("immature Mpl" 9) ("CD110" 7) ("mature:immature Mpl" 6) ("mature Mpl" 5)
   ("Mpl protein" 5) ("mpl" 5) ("Aberrant Mpl" 4) ("core-glycosylated Mpl" 4)
   ("MPL-" 2) ("exosomal Mpl" 1) ("more Mpl" 1) ("surface immature Mpl" 1)
   ("new Mpl" 1) ("The newly-arrived Mpl" 1) ("ER core-glycosylated Mpl" 1)
   ("both immature and mature Mpl" 1) ("TpoR" 1)))
 ("UP:P40259"
  (("Igβ" 23) ("CD79B" 5) ("CD79b" 3) ("IGB" 3) ("Ig–β" 1) ("B29" 1)))
 ("UP:P40261"
  (("Nnmt" 174) ("NNMT" 24) ("Nicotinamide N-methyltransferase" 2)
   ("Nnmt protein" 1)))
 ("UP:P40305" (("IFI27" 65) ("ISG12" 10)))
 ("UP:P40306" (("LMP10" 6) ("PSMB10" 3) ("MECL1" 1)))
 ("UP:P40313"
  (("Ctrl" 348) ("CTRL" 156) ("ctrl" 144) ("chymotrypsin-like" 80)
   ("Chymotrypsin-like" 4) ("-Ctrl" 4) ("Ctrl-" 2) ("ctrl-" 1) ("than Ctrl" 1)
   ("-ctrl" 1) ("CTRL-" 1)))
 ("UP:P40335" (("Pep8" 1)))
 ("UP:P40337"
  (("VHL" 1813) ("pVHL" 918) ("vhl" 110) ("von Hippel-Lindau" 62)
   ("von Hippel-Lindau protein" 36) ("VHL protein" 34)
   ("von Hippel-Lindau tumor suppressor protein" 18)
   ("von Hippel-Lindau tumor suppressor" 18) ("Von Hippel-Lindau" 15)
   ("von Hippel-Lindau (VHL) protein" 15) ("von Hippel Lindau" 14)
   ("von Hippel-Lindau (VHL)" 14) ("von Hippel–Lindau" 11) ("pVHL protein" 10)
   ("von Hippel–Lindau protein" 9) ("vHL" 9) ("Vhl" 9) ("Von Hippel Lindau" 5)
   ("Von Hippel-Lindau protein" 5) ("von Hippel-Lindau ( VHL )" 4)
   ("Von-Hippel Lindau" 3) ("von Hippel Lindau protein" 3)
   ("von Hippel–Lindau tumor suppressor" 3) ("exogenous pVHL" 3)
   ("overexpressed VHL" 3) ("von Hippel Lindau protein (VHL)" 3)
   ("pVHL (VHL)" 2) ("VHL-" 2) ("Von Hippel-Lindau (pVHL) protein" 2)
   ("Von Hippel Lindau protein" 2) ("expressing HA-tagged pVHL" 2)
   ("Exogenously-expressed pVHL" 2) ("exogenous wild-type VHL" 2) ("VHL(WT)" 2)
   ("pVHL peptide" 2) ("strong pVHL" 2) ("Von-Hippel Lindau (VHL)" 1)
   ("a mutated nonfunctional VHL protein" 1) ("a functional VHL" 1)
   ("Von–Hippel Lindau" 1) ("Von Hippel Lindau ( VHL )" 1)
   ("functional pVHL" 1) ("defective VHL" 1) ("hypoxia-associated pVHL" 1)
   ("pVHL, which are" 1) ("von Hippel-Lindau protein (VHL)" 1)
   ("functional VHL" 1) ("slower migrating HA-human VHL" 1)
   ("pVHL, E3 ligase ( xref )" 1)
   ("pVHL, which contains E3 ligase activity that tags HIF1α for proteasomal degradation [ xref ]"
    1)))
 ("UP:P40338" (("mVHL" 4)))
 ("UP:P40347"
  (("PTPase" 123) ("protein tyrosine phosphatase activity" 8)
   ("Protein tyrosine phosphatase activity" 2)
   ("a non-transmembrane PTPase" 1)))
 ("UP:P40417" (("RL" 281) ("pRL" 6) ("-RL" 1) ("RL-" 1)))
 ("UP:P40424"
  (("PBX1" 207) ("Pbx1" 10) ("Pre-B-cell leukemia transcription factor 1" 4)
   ("Pre-B-cell leukemia homeobox 1" 1)))
 ("UP:P40425" (("PBX2" 2))) ("UP:P40426" (("Pbx3" 4) ("PBX3" 1)))
 ("UP:P40429"
  (("RPL13A" 79) ("RPL13a" 14) ("ribosomal protein L13a" 7) ("Rpl13a" 4)
   ("-RPL13a" 1) ("rpl13a" 1) ("Ribosomal Protein L13A" 1)))
 ("UP:P40450" (("BNR1" 1))) ("UP:P40468" (("TAO3" 9)))
 ("UP:P40529" (("age2" 1))) ("UP:P40537" (("ULP2" 1)))
 ("UP:P40577" (("mnd2" 68) ("Mnd2" 22))) ("UP:P40578" (("MGA2" 3)))
 ("UP:P40602" (("APG" 107))) ("UP:P40631" (("MLH" 7) ("pMLH" 1)))
 ("UP:P40688" (("SWA" 1)))
 ("UP:P40692"
  (("MLH1" 2166) ("hMLH1" 790) ("HNPCC" 304) (NIL 35) ("MLH1 protein" 25)
   ("hMLH1 protein" 13) ("MLH-1" 8) ("HMLH1" 4) ("atypical HNPCC" 3)
   ("most HNPCC" 2) ("DNA mismatch repair protein MLH1" 2)
   ("medullary (4/5, 80%) carcinomas showed negative/weak MLH1" 2)
   ("nonpolyposis type 2)" 2) ("the heterodimeric partner MLH1" 2)
   ("a possible HNPCC" 1) ("the conservative substitution MLH1 Asn38Ser" 1)
   ("nonpolyposis type 2 (E. coli)" 1)
   ("the hereditary cancer syndrome HNPCC" 1) ("minimal hMLH1" 1) ("MLH1-" 1)
   ("than MLH1 protein in the cell ( xref )" 1) ("classical HNPCC" 1)
   ("chromatin-associated MLH1" 1) ("This comprised absent MLH1" 1) ("hMLh1" 1)
   ("a defective MLH1" 1) ("hMLH1-" 1)))
 ("UP:P40763"
  (("STAT3" 30767) ("Stat3" 6911) ("pSTAT3" 1309) ("p-STAT3" 751)
   ("STAT-3" 440) ("signal transducer and activator of transcription 3" 391)
   ("pStat3" 322) ("p-Stat3" 251) ("STAT3 protein" 232) ("Stat-3" 221)
   ("P-STAT3" 185) ("Signal transducer and activator of transcription 3" 136)
   ("Stat3C" 99) ("Stat3 protein" 69) ("p-STAT-3" 62) ("-STAT3" 48)
   ("STAT3-" 39) ("Stat3 peptide" 21) ("pSTAT-3" 20) ("stat3" 17)
   ("STAT3 molecule" 11) ("STAT3−" 11) ("dominant-negative STAT3" 10)
   ("Stat3 molecule" 9) ("total and phosphorylated STAT3" 9) ("P-Stat3" 9)
   ("dominant-negative Stat3" 9) ("functional STAT3" 8) ("p-STAT3 protein" 8)
   ("STAT3 peptide" 6) ("monoclonal mouse anti-human STAT3" 6) ("than STAT3" 6)
   ("normal STAT3" 5) ("targeted Stat3" 4) ("dominant-negative STAT3-Y705F" 4)
   ("acute-phase response factor" 4) ("MiR-124 directly targets STAT3" 4)
   ("constitutively-activated Stat3" 4) ("Stat3 (TTATCAA)" 4)
   ("monoclonal mouse anti-human Stat3" 4) ("pStat3 protein" 4)
   ("dominant-negative Stat3 Y705F" 4) ("Endometrial pSTAT3" 4)
   ("exogenous wild-type STAT3" 3) ("-Stat3" 3) ("particular STAT3" 3)
   ("total and activated STAT3" 3) ("STAT3 (GAS)" 3)
   ("Dominant-negative STAT3" 3) ("acute-phase response factor (APRF)" 3)
   ("APRF" 3) ("Dimerized STAT3" 3) ("Stat3-" 3) ("STAT-3 protein" 3)
   ("those expressing less Stat3" 3) ("Stat3C-" 3) ("–STAT3 protein" 2)
   ("–STAT3" 2) ("overactive STAT3" 2)
   ("the small molecule STAT3 inhibitor LLL12 ( xref ) completely abrogated phospho-STAT3"
    2)
   ("expressing wild-type STAT3" 2) ("rabbit monoclonal p-STAT3" 2)
   ("specifically lack STAT3" 2) ("total and activated Stat3" 2)
   ("monoclonal mouse anti-human phosphotyrosine STAT3" 2)
   ("specifically targets STAT3" 2) ("stat-3" 2) ("targeted Mt STAT3" 2)
   ("signal transducer and activator of transcription 3 (STAT3) protein" 2)
   ("insoluble STAT3" 2)
   ("the acute phase response signal transducer and activator of transcription 3"
    2)
   ("strong active p-Stat3" 2) ("Constitutively Overactive p-Stat3" 2)
   ("UMUC3 parental cells activated STAT3" 2) ("associated STAT3" 2)
   ("Similarly phosphorylated STAT3" 2) ("‐STAT3" 2)
   ("Signal transducer and activator of transcription 3 protein" 2)
   ("total or phosphorylated STAT3" 2) ("p-STAT3 (CST)" 2) ("Stat-3 protein" 2)
   ("IL-6 or gp-130 decreased persistently active STAT3" 2)
   ("AGS gastric epithelial cells display constitutively active STAT3" 2)
   ("the soluble factor- and contact- dependent STAT3" 2)
   ("monoclonal mouse anti-human phosphotyrosine Stat3" 2)
   ("significantly less active STAT3" 2) ("a moderate or low level pSTAT3" 2)
   ("IL-6 driven STAT3" 2) ("weak pStat3" 2)
   ("monoclonal mouse anti–human STAT3" 2) ("defective STAT3" 2)
   ("strong STAT3" 2) ("Substantial STAT3" 2)
   ("Transcriptionally Competent STAT3" 2) ("sporadic P-STAT3" 2)
   ("specifically targets human STAT3" 2) ("selectively targets STAT3" 2)
   ("IL-6 increased phosphorylated and total STAT3" 2)
   ("constitutively-activated STAT3" 2) ("strong pStat3" 2)
   ("intense pStat3" 2) ("a bona fide Stat3" 2) ("Stat3 Protein" 2)
   ("PTPMeg2 directly targets STAT3" 2) ("basal STAT3" 2)
   ("strong nuclear pSTAT3" 2) ("astrocytic STAT3" 2) ("Cardiac STAT3" 2)
   ("overexpressed STAT3" 2) ("Minimal pSTAT3" 2)
   ("than endogenous STAT3 ( xref B)" 1)
   ("both exogenous and endogenous STAT3" 1) ("a functional Stat3" 1)
   ("miR-125b directly targets STAT3" 1)
   ("both total and phosphorylated STAT3" 1) ("targeting STAT3" 1)
   ("total cellular STAT3" 1) ("four times more STAT3" 1)
   ("than pSTAT3 ( xref )" 1) ("STAT3 (or USF2) protein" 1)
   ("phospho-STAT3 protein" 1) ("more pSTAT3" 1)
   ("phosphotyrosine of constitutively activated STAT3 in many human cancer cell lines"
    1)
   ("cellular STAT3" 1) ("global STAT3" 1) ("relatively less phospho-STAT3" 1)
   ("exogenous denatured Stat3" 1) ("than serine p-STAT-3" 1)
   ("STAT3 (TTCTGGGAA)" 1) ("the entire STAT3" 1) ("neural STAT3" 1)
   ("proximal Stat3" 1) ("pharmacologically target STAT3" 1)
   ("transcriptional factor STAT3" 1) ("two well-known STAT3" 1)
   ("Aberrant STAT3" 1) ("these dimeric STAT3" 1)
   ("squamous carcinoma STAT3" 1) ("pSTAT3 protein" 1)
   ("HGF/c-Met–dependent STAT3" 1) ("Overactive p-Stat3" 1)
   ("These findings made STAT3" 1) ("the essential role STAT3" 1)
   ("resultant STAT3" 1) ("18 possible STAT3" 1) ("Hyperactive STAT3" 1)
   ("sham infected animals displayed minimal phospho-STAT3" 1)
   ("Dimeric STAT3" 1) ("a FLAG-tagged dominant-negative Stat3" 1)
   ("a dominant-negative mutant Stat3" 1)
   ("mitochondrially-restricted STAT3" 1)
   ("transcriptionally-competent nuclear STAT3" 1)
   ("the acetylation-defective STAT3" 1) ("the acetylation-proficient STAT3" 1)
   ("that STAT3’s" 1) ("linking STAT3" 1)
   ("undetectable phospho-tyrosine or phospho-serine STAT3" 1) ("STAT-3–" 1)
   ("dasatinib increased pSTAT3" 1) ("its transcriptional co-factor STAT3" 1)
   ("retroviral constitutively active (CA) STAT3" 1) ("than pSTAT3(Y705)" 1)
   ("exogenous Stat3" 1) ("cellular Stat3" 1) ("latent Stat3" 1)
   ("The differential Stat3" 1)
   ("monoclonal mouse anti–human phosphotyrosine STAT3" 1)
   ("persistently-activated STAT3" 1) ("activated dimeric STAT3" 1)
   ("epithelial Stat3" 1) ("than Stat3 (89–90 KDa)" 1)
   ("associated Stat3 protein" 1) ("adenovirus dominant STAT3" 1)
   ("conditionally inactivated STAT3" 1) ("most STAT3" 1)
   ("Transcriptionally relevant STAT3" 1)
   ("transcriptionally-relevant STAT3" 1) ("more STAT3" 1) ("STAT3 (WT)" 1)
   ("Nanog-associated Stat-3" 1) ("Quiescent Stat3" 1)
   ("the p300 transcriptional factor and serine pSTAT3" 1) ("less p-STAT3" 1)
   ("20% less p-STAT3" 1) ("a dominant-negative STAT3 protein" 1)
   ("significantly more pStat3" 1) ("previously identified Stat3" 1)
   ("Differentially expressed genes included several previously identified Stat3"
    1)
   ("Further implicating Stat3" 1) ("pro-inflammatory STAT3" 1)
   ("two tyrosines (Y640, Y657) of STAT3" 1)
   ("intense nuclear phospho-Stat3" 1) ("the intense nuclear phospho-STAT3" 1)
   ("monomeric STAT3" 1) ("detectable monomeric STAT3" 1)
   ("systemic factors increase p-STAT3" 1) ("excessive p-STAT3" 1)
   ("Lentiviral transcriptional reporter vectors pGreenFire- STAT3" 1)
   ("STAT3–" 1) ("generated megakaryocyte/platelet-specific STAT3" 1)
   ("Megakaryocytes/platelet-specific STAT3" 1)
   ("The total and phosphorylated STAT3" 1)
   ("The present findings further support STAT3" 1) ("Low glandular pSTAT3" 1)
   ("CBE" 1) ("instead phosphorylated STAT3" 1) ("most cancers STAT3" 1)))
 ("UP:P40797" (("PNUT" 2) ("Pnut" 1)))
 ("UP:P40818"
  (("USP8" 323) ("UBPY" 15) ("USP8 protein" 2) ("targeting USP8" 2)))
 ("UP:P40843"
  (("esculentin-1a" 29) ("longer peptide esculentin-1a" 1)
   ("the first 20 amino acids of esculentin-1a (isolated from the skin of Pelophylax lessonae/ridibundus , formerly known as Rana esculenta )"
    1)))
 ("UP:P40851" (("AXL-1" 5)))
 ("UP:P40855"
  (("housekeeping gene" 842) ("housekeeping gene ( GAPDH )" 5)
   ("Housekeeping gene" 5) ("housekeeping gene (GAPDH)" 3)
   ("housekeeping gene (ACTB)" 3) ("an internal housekeeping gene" 2)
   ("a non-regulated ribosomal housekeeping gene" 2)
   ("at least one housekeeping gene" 2) ("HK33" 2)
   ("housekeeping gene ( GAPDH)" 2) ("the proper housekeeping gene" 2)
   ("internal control housekeeping gene" 1) ("housekeeping gene (HKG)" 1)
   ("PMPI" 1) ("a housekeeping gene’s" 1) ("a secondary housekeeping gene" 1)
   ("the β-actin internal control housekeeping gene" 1)
   ("a cellular housekeeping gene" 1)))
 ("UP:P40856" (("Sap185" 1)))
 ("UP:P40879"
  (("SLC26A3" 35) ("Dra" 24) ("CLD" 20) ("DRA" 11)
   ("congenital chloride diarrhea (CLD)" 5) ("solute carrier family 26" 4)
   ("congenital chloride diarrhea" 2)
   ("the major apical anion exchanger DRA" 1) ("functional SLC26A3" 1)
   ("than CLD (12%)" 1)))
 ("UP:P40925" (("MDH1" 34) ("malate dehydrogenase 1" 5)))
 ("UP:P40926" (("MDH2" 1))) ("UP:P40931" (("V-MPL" 4)))
 ("UP:P40933"
  (("IL-15" 672) ("IL15" 12) ("Il15" 10) ("interleukin-15" 7)
   ("readily secretable IL-15" 2) ("Interleukin-15" 2) ("interleukin 15" 2)
   ("-IL-15" 1) ("muscle-derived IL-15" 1) ("exercise-induced IL-15" 1)
   ("IL-15-" 1)))
 ("UP:P40937" (("Rfc5" 11) ("RFC5" 10) ("rfc5" 2) ("Rfc-5" 2)))
 ("UP:P40938" (("RFC3" 11) ("Rfc3" 8) ("rfc3" 3) ("Rfc-3" 2)))
 ("UP:P40939" (("TPα" 6) ("HADHA" 4) ("HADH" 3)))
 ("UP:P40967"
  (("PMEL" 21) ("Pmel17" 10) ("fibrillar PMEL" 5) ("SILV" 4)
   ("unprocessed non-fibrillar PMEL" 2)
   ("the early-stage melanosomal protein Pmel17" 2) ("non-fibrillar PMEL" 1)
   ("non-fbrillar PMEL" 1) ("premelanosome protein" 1)
   ("the premelanosomal protein Pmel17" 1)))
 ("UP:P40969" (("CSL-1" 1))) ("UP:P40987" (("CIN1" 54)))
 ("UP:P40995" (("RAL1" 1)))
 ("UP:P41002"
  (("Cyclin F" 214) ("cyclin F" 66) ("FBXO1" 3) ("CCNF" 2) ("Cyclin-F" 1)
   ("doxycycline-repressible Cyclin F" 1) ("exogenous Cyclin F" 1)
   ("Cyclin F protein" 1) ("the first 30-40 amino acids of Cyclin F" 1)
   ("FLAG-HA-tagged Cyclin F" 1) ("centrosomal Cyclin F" 1)))
 ("UP:P41026" (("SipA" 43) ("SipA protein" 4) ("a functional SipA" 2)))
 ("UP:P41027" (("SipC" 31)))
 ("UP:P41046" (("CCF" 106) ("cleaved and intact CCF2" 1)))
 ("UP:P41057" (("S-36" 1)))
 ("UP:P41064"
  (("Aurora-A" 1492) ("INSR-A" 53) ("aurora-A" 29) ("Aurora-A protein" 23)
   ("the mitotic kinase Aurora-A" 5) ("overexpressed Aurora-A" 4)
   ("Aurora-A ( AURKA )" 3) ("functional Aurora-A" 2)
   ("SIRT2 increased Aurora-A protein" 2) ("-Aurora-A" 1)
   ("centrosomal Aurora-A" 1) ("detectable strong Aurora-A" 1)
   ("normal Aurora-A" 1)))
 ("UP:P41091" (("than 52kDa" 1) ("52kDa" 1) ("52KDa" 1)))
 ("UP:P41134"
  (("ID" 2142) ("Id1" 404) ("ID1" 147) ("Id-1" 121) ("Id" 97)
   ("Id1 protein" 11) ("inhibitor of differentiation 1" 5) ("TMJ ID" 4)
   ("ID-1" 3) ("exogenous Id1" 3) ("approval ID" 3) ("ID-" 3)
   ("intronic ID 5" 2) ("Id1-" 2) ("COSMIC ID" 2) ("a unique UNIGENE ID" 2)
   ("autism or more severe ID" 2) ("Approval ID" 2)
   ("Inhibitor of differentiation 1" 2) ("ID (GO)" 2)
   ("the BMP transcriptional target Id1" 2) ("strong Id1" 2)
   ("Representative Public ID" 1) ("a unique cell ID" 1) ("id1" 1)
   ("The approval ID" 1) ("personal ID" 1) ("Exogenous Id-1" 1)
   ("A unique ID" 1) ("inhibitor of DNA binding 1" 1) ("TMJ disc ID" 1)
   ("Id protein" 1) ("the approval ID" 1) ("available fromtheir GEO ID" 1)
   ("DNA-binding protein inhibitor ID-1" 1) ("“ID”" 1) ("The IIumina ID’s" 1)
   ("The transcriptional inhibitor Id1" 1) ("EMBL-EBI ID’s" 1)))
 ("UP:P41143" (("OPRD1" 4) ("opioid receptor delta 1" 1)))
 ("UP:P41145" (("OPRK1" 2))) ("UP:P41146" (("NOPr" 26)))
 ("UP:P41157" (("FLI" 155)))
 ("UP:P41159"
  (("leptin" 1381) ("OB" 504) ("Leptin" 210) ("obs" 135) ("Lep" 120) ("OBs" 83)
   ("LEP" 44) ("OBS" 11) ("O/B" 11) ("leptin-" 7) ("exogenous leptin" 3)
   ("monoclonal rabbit anti- leptin" 3) ("the anorectic hormone leptin" 2)
   ("Primary OBs" 2) ("Obs" 1) ("leptin ( LEP )" 1)
   ("our studies strongly support Leptin" 1) ("Ob" 1)
   ("lacks functional leptin" 1) ("primary OBs" 1) ("These primary OBs" 1)
   ("intracerebroventricular leptin" 1) ("disrupted leptin's" 1)
   ("intraperitoneal leptin" 1)
   ("rapamycin reduced both the intracellular leptin" 1) ("consecutive OB" 1)
   ("other consecutive OB" 1) ("two consecutive OB" 1)
   ("these well-characterized OB" 1) ("hypothalamic leptin" 1)))
 ("UP:P41161"
  (("ERM" 377) ("eRMS" 62) ("E/R/M" 32) ("ETV5" 28) ("Etv5" 19) ("p-ERM" 8)
   ("Erm" 5) ("ERM protein" 5) ("erm" 2) ("P-ERM" 2) ("ERM-" 2) ("pE/R/M" 2)
   ("the actin-cytoskeleton-related ERM" 2) ("the major ERM" 1)
   ("the dominant ERM" 1)))
 ("UP:P41162"
  (("MetS" 650) ("ETV3" 25) ("METs" 22) ("PE1" 10) ("METS" 6)
   ("mitogenic Ets transcriptional suppressor" 1)))
 ("UP:P41180"
  (("CaSR" 74) ("CASR" 25) ("calcium sensing receptor" 16) ("CaSR protein" 4)
   ("HHC" 3)))
 ("UP:P41181" (("aquaporin-2" 5) ("AQP2" 2) ("Aquaporin 2" 1)))
 ("UP:P41182"
  (("BCL6" 1211) ("corepressors" 330) ("BCL-6" 117) ("Bcl-6" 84) ("Bcl6" 55)
   ("BCL6 protein" 21) ("transcriptional corepressors" 14) ("BCL6−" 11)
   ("bcl6" 11) ("Corepressors" 10) ("BCL6+/pSTAT6−" 6)
   ("the transcriptional repressor BCL6" 4) ("cellular BCL6" 4)
   ("B-cell CLL/lymphoma 6" 4) ("atypical corepressors" 4)
   ("B-Cell Lymphoma 6 protein" 3) ("dominant-negative BCL6" 3)
   ("BCL-6 protein" 2) ("BCL6+/pSTAT6-" 2) ("-BCL6" 2) ("Bcl-6 protein" 2)
   ("bcl-6" 2) ("negative coregulatory factors termed corepressors" 2)
   ("a few corepressors" 2) ("only five genes— BCL6" 2)
   ("its potential corepressors" 1) ("Bcl6 protein" 1)
   ("the transcriptional co-repressor BCL-6" 1)
   ("various transcriptional corepressors" 1) ("BCL6-" 1)
   ("general transcriptional corepressors" 1)
   ("the transcriptional repressor BCL-6" 1) ("further suppressed BCL6" 1)
   ("Quantitative immunohistochemistry revealed elevated BCL6" 1)
   ("The transcriptional repressor BCL6" 1) ("Exogenous corepressors" 1)
   ("Other transcriptional corepressors" 1) ("these atypical corepressors" 1)
   ("less BCL6" 1) ("The GC-specific transcriptional repressor BCL6" 1)
   ("the GC B cell-specific transcriptional repressor BCL6" 1)
   ("the transcriptional repressor Bcl6" 1)))
 ("UP:P41208"
  (("CETN2" 9) ("centrin 2" 9)
   ("the centriolar protein enhanced GFP (EGFP)-human centrin 2" 2)))
 ("UP:P41212"
  (("Tel" 242) ("TEL" 212) ("ETV6" 164) ("tel" 8) ("-TEL" 5) ("Tel-1" 5)
   ("ETV6 (TEL)" 3) ("than Tel" 2) ("Tel−" 1) ("-tel" 1) ("pTEL" 1)))
 ("UP:P41217" (("MRC" 251) ("CD200" 43) ("Mox1" 3) ("OX-2" 3)))
 ("UP:P41218" (("MNDA" 3))) ("UP:P41219" (("peripherin" 6)))
 ("UP:P41220"
  (("RGS2" 21) ("RGS-2" 21) ("Rgs2" 15)
   ("regulator of G protein signaling 2" 3)
   ("regulator of G-protein signaling 2" 2)))
 ("UP:P41221"
  (("Wnt5a" 344) ("Wnt-5a" 203) ("Wnt5A" 176) ("WNT5A" 55) ("WNT-5a" 2)
   ("overexpressed Wnt5A" 2) ("cellular Wnt5A" 2) ("than Wnt5A" 1)
   ("exogenous Wnt5a" 1) ("wnt5a" 1)
   ("the well-established non-canonical Wnt ligand Wnt5a" 1)
   ("non-canonical Wnt5a" 1) ("than Wnt-5a" 1)
   ("than Wnt-5a in 293 cells ( xref )" 1) ("particular WNT5A" 1)
   ("the non-canonical Wnt-5a" 1) ("WNT5a" 1) ("the noncanonical Wnt5a" 1)))
 ("UP:P41222" (("L-PGDS" 278) ("PTGDS" 2) ("LPGDS" 2)))
 ("UP:P41223" (("BUD31" 191) ("BUD31 peptide" 10) ("EDG-2" 1)))
 ("UP:P41225" (("SOX3" 2) ("panhypopituitarism" 2) ("Sox3" 1)))
 ("UP:P41226"
  (("Ube2" 26) ("UBE2" 10) ("UBE1L" 4) ("UbE2" 2) ("UBA7" 2) ("Ube1L" 1)))
 ("UP:P41229"
  (("SMCX" 131) ("KDM5C" 11) ("JARID1C" 7) ("SMCX protein" 7)
   ("overexpressed SMCX" 6) ("Jarid1c" 2) ("normal SMCX" 2)
   ("Overexpressed SMCX" 2) ("AT rich interactive domain 1C" 2)
   ("Both exogenous and endogenous SMCX" 1) ("exogenous SMCX" 1)
   ("transiently overexpressed SMCX" 1) ("X-linked (mouse)" 1)
   ("Smcy homolog" 1)))
 ("UP:P41231" (("P2Y2" 78) ("P2RY2" 1) ("ATPγs" 1)))
 ("UP:P41235"
  (("HNF4α" 265) ("HNF4A" 40) ("HNF4" 28) ("HNF-4" 16) ("HNF-4α" 10)
   ("Hnf4α" 9) ("HNF4α protein" 8) ("HNF4a" 5)
   ("hepatocyte nuclear factor 4 alpha" 5) ("HNF4alpha" 4) ("Hnf4a" 4)
   ("hepatocyte nuclear factor 4" 4) ("hepatocyte nuclear factor-4α" 4)
   ("hepatocyte nuclear factor 4alpha" 3) ("hepatocyte nuclear factor 4a" 2)
   ("The hepatocyte-associated transcription factor HNF4" 2) ("MODY1" 1)
   ("HNF4α-" 1) ("Hepatocyte nuclear factor 4" 1) ("NR2A1" 1)
   ("soluble HNF-4" 1)))
 ("UP:P41236" (("PPP1R2" 9)))
 ("UP:P41238"
  (("apolipoprotein B mRNA editing enzyme" 14) ("APOBEC1" 7)
   ("Apolipoprotein B mRNA editing enzyme" 3) ("APOBEC-1" 2)))
 ("UP:P41240"
  (("SFKs" 1113) ("Src kinase" 993) ("CSK" 345) ("src kinase" 91)
   ("SRC kinase" 48) ("cSrc kinase" 16) ("the predominant SFKs" 4)
   ("Src kinase protein" 3) ("CSK protein" 2) ("Src kinase (UBI)" 1)
   ("exogenous Src kinase" 1) ("the relevant Src kinase" 1) ("ice-cold CSK" 1)
   ("essential SFKs" 1) ("key SFKs" 1) ("endogenous A-419259-sensitive SFKs" 1)
   ("SRC kinase protein" 1) ("directly target Src kinase" 1) ("SFKs-" 1)
   ("receptor-associated SFKs" 1) ("Most SFKs" 1) ("pCSK" 1)
   ("functional Src kinase" 1) ("Src kinase-" 1)
   ("a dominant–negative C-terminal Src kinase (CSK)" 1) ("Src kinase (CSK)" 1)
   ("whose B cell SFKs" 1) ("the activation loop tyrosine of the SFKs" 1)
   ("membrane-associated SFKs" 1)
   ("Purified baculovirus-expressed human Src kinase" 1)))
 ("UP:P41241" (("mCSK" 2))) ("UP:P41242" (("NTK" 59)))
 ("UP:P41252"
  (("IRS" 701) ("pIRS" 34) ("IRSs" 32) ("p-IRS" 4) ("P-IRS" 2) ("IRS-" 1)
   ("IARS" 1) ("IRS protein" 1)))
 ("UP:P41261" (("HBII" 5))) ("UP:P41271" (("NBL1" 7) ("NO3" 1) ("no3" 1)))
 ("UP:P41273" (("4-1BBL" 22) ("TNFSF9" 3))) ("UP:P41274" (("CD137L" 4)))
 ("UP:P41279"
  (("COT" 208) ("p38 MAPKs" 67) ("MAP3K8" 50) ("Cot" 36) ("Tpl2" 10)
   ("mitogen-activated protein kinase kinase kinase 8" 9)
   ("mitogen-activated protein kinase kinase kinase 8 (COT)" 5) ("Map3k8" 4)
   ("TPL2" 3) ("Tpl-2" 3) ("COT protein" 3) ("pCOT" 2) ("Map3K8" 2) ("E-S-T" 2)
   ("MAP3K8 (COT)" 1) ("Tumor Progression Locus 2" 1) ("COT/TPL2" 1)
   ("P-E-S-T" 1) ("Tumor progression locus 2" 1)))
 ("UP:P41376" (("RH4" 15) ("Rh4" 11))) ("UP:P41387" (("TBB" 83)))
 ("UP:P41439" (("FOLR3" 1)))
 ("UP:P41440"
  (("RFC" 482) ("RFC1" 64) ("SLC19A1" 4) ("reduced folate carrier 1" 4)
   ("solute carrier family 19 member 1" 3) ("RF-C" 1) ("The canonical RFC" 1)
   ("three alternative RFC" 1) ("RFC protein" 1) ("the canonical RFC1" 1)
   ("heteropentameric RFC" 1)))
 ("UP:P41441" (("HopF" 6) ("Hopf" 2)))
 ("UP:P41444"
  (("FGF" 1170) ("Fgf" 76) ("fgf" 21) ("basic FGF" 15) ("FGF-" 12)
   ("Basic FGF" 5) ("−FGF" 3) ("4 ng/ml human basic FGF" 2) ("autocrine FGF" 2)
   ("10 ng/ml basic FGF" 2) ("10 ng/ml basic FGF" 2) ("20 ng/ml basic FGF" 2)
   ("the mitogen basic FGF" 2) ("embryonic FGF" 2) ("4 ng/ml basic FGF" 2)
   ("Exogenous FGF" 2) ("50 ng/mL basic FGF" 2) ("20ng/ml basic FGF" 2)
   ("1 ng/ml basic FGF" 1) ("There are 18 known fgf" 1)
   ("at least 18 different FGF" 1) ("exogenous FGF" 1) ("the immediate FGF" 1)
   ("endometrial stromal cells release FGF" 1) ("At least 18 FGF" 1)))
 ("UP:P41476" (("RNA ligase" 40)))
 ("UP:P41478" (("p15" 404) (NIL 66) ("P15" 65) ("-p15" 11) ("–p15" 5)))
 ("UP:P41567" (("EIF1" 4) ("eIF1" 2) ("Eif1" 1)))
 ("UP:P41586" (("ADCYAP1R1" 2))) ("UP:P41587" (("VIPR2" 2) ("Vipr2" 1)))
 ("UP:P41594"
  (("mGluR5" 497) ("Grm5" 27) ("S 1126" 18) ("mGluR5 peptide" 12) ("GRM5" 5)
   ("neuronal mGluR5" 3) ("directly impacts mGluR5" 2)
   ("than mGluR5 ( xref )" 1)))
 ("UP:P41595" (("5-HT2B receptor" 15)))
 ("UP:P41597"
  (("CCR2" 183) ("Ccr2" 2) ("CCR2b" 1) ("-CCR2" 1) ("CCR-2" 1) ("CCR2B" 1)))
 ("UP:P41732"
  (("A-15" 33) ("A15" 30) ("TSPAN7" 3) ("Tetraspanin 7" 2) ("a15" 1)
   ("TM4SF2" 1) ("Tspan7" 1)))
 ("UP:P41741" (("TUB2" 4) ("tub2" 4) ("Tub2" 1)))
 ("UP:P41743"
  (("PKCι" 1386) ("PRKCI" 148) ("Prkci" 31) ("ι/λ" 15) ("PKCι protein" 8)
   ("PKCι-" 6) ("targeting PKCι" 6) ("PKCi" 4) ("protein kinase C iota" 3)
   ("prkci" 3) ("exogenous PKCι" 2) ("particular PKCι" 2)
   ("less PKCι protein" 2) ("PKCι peptide" 2) ("targeting PRKCI" 2)
   ("functional PKCι" 2) ("atypical PKCι" 2) ("strong PKCι" 2)
   ("the closely related atypical PKCι" 1) ("Atypical PKCι" 1)
   ("Dominant-negative PKCι" 1) ("more PRKCI" 1) ("FLAG-epitope–tagged PKCι" 1)
   ("phorbol ester-insensitive atypical PKCι" 1)))
 ("UP:P41753"
  (("heat shock 70 kDa protein" 2) ("—heat shock 70 kDa protein" 1)
   ("Heat shock 70 kDa protein" 1)))
 ("UP:P41803" (("B20" 25) ("b20" 1))) ("UP:P41818" (("Glc8" 1) (NIL 1)))
 ("UP:P41832" (("Bni1" 2))) ("UP:P41855" (("PF2" 3)))
 ("UP:P41885" (("RBF1" 1) ("Rbf1" 1)))
 ("UP:P41932" (("PAR-5" 9) ("par-5" 4) ("PAR5" 3) ("Par5" 2) ("par5" 1)))
 ("UP:P41957" (("CED-9" 12) ("ced-9" 2)))
 ("UP:P41964" (("drosomycin" 7) ("Drosomycin" 6)))
 ("UP:P41968" (("MC3" 14) ("MC3R" 3)))
 ("UP:P41970" (("ELK3" 11) ("Elk3" 8) ("ELK-3" 1) ("Elk-3" 1)))
 ("UP:P42081" (("CD86" 300) ("-CD86" 3) ("“FL_CD86”" 1)))
 ("UP:P42092" (("CGED" 1))) ("UP:P42126" (("DCI" 33) ("stimuli termed DCI" 2)))
 ("UP:P42127"
  (("agouti signaling protein" 5) ("agouti signaling protein (ASIP)" 3)
   ("Agouti signaling protein" 1)))
 ("UP:P42166" (("TP5" 8) ("TMPO" 3) ("Thymopoietin" 1) ("P42166" 1)))
 ("UP:P42174" (("MP50" 5)))
 ("UP:P42191" (("pRSK" 28) ("p-RSK" 13) ("P-RSK" 6)))
 ("UP:P42195" (("PECs" 38) ("micro-dissected PECs" 2)))
 ("UP:P42201"
  (("P-selectin" 125) ("p-selectin" 9) ("P-selectins" 1)
   ("soluble circulating P-selectin" 1)))
 ("UP:P42212"
  (("GFP" 21415) ("green" 3319) ("Green" 3142)
   ("green fluorescent protein" 728) ("-GFP" 360) ("GFP-" 157)
   ("green fluorescent protein (GFP)" 120) ("green fluorescent" 108)
   ("pGFP" 107) ("BC" 107) ("FL" 93) ("gfp" 82) ("GFP protein" 78)
   ("Green Fluorescent Protein" 34) ("GREEN" 33)
   ("Green fluorescent protein" 23) ("Gfp" 19) ("–GFP" 13) ("p30 II -GFP" 11)
   ("HTLV-1 p30 II -GFP" 8) ("Green Fluorescent" 7) ("functional GFP" 7)
   ("GFP−" 7) ("GFP molecule" 6) ("targeting GFP" 6) ("Green (SG)" 6)
   ("Green protein" 6) ("than GFP" 5) ("a photoactivatable GFP" 4)
   ("Green fluorescent" 4) ("CMV-HTLV-1 p30 II -GFP" 4)
   ("Green protein (KGN)" 4) ("green (CBG)" 4) ("strong GFP" 3)
   ("curcumin or AG490 revealed green" 3) ("the functional GFP" 3)
   ("mouse monoclonal GFP" 3) ("Green protein (KGC)" 3)
   ("Green Fluorescent Protein (GFP)" 3) ("coexpressed GFP" 3) ("fl" 3)
   ("photoactivatable GFP" 3) ("Monoclonal GFP" 3) ("dual color GFP" 2)
   ("green fluorescent protein–" 2) ("Green fluorescent protein-" 2)
   ("the fluorescent dye SYBR Green" 2) ("green fluorescent-" 2)
   ("pGL-St nef(−) GFP or pGL-Ec nef(−) GFP" 2) ("soluble p53 GFP" 2)
   ("a HSP70 promoter-driven GFP" 2) ("HSP70 promoter-driven GFP" 2)
   ("overexpressed GFP" 2) ("Overexpressed GFP" 2)
   ("monomeric green fluorescent protein" 2) ("a fluorescent GFP" 2)
   ("a MyiQ thermal cycler and SYBR green" 2) ("just GFP" 2)
   ("fluorescent GFP" 2) ("Adenovirus-driven GFP" 2)
   ("the control adenoviral green fluorescent protein (GFP)" 2)
   ("Universal SYBR green" 2) ("significantly less GFP protein" 2)
   ("the CMV-HTLV-1 p30 II -GFP" 2) ("green (MTG)" 2) ("Green (TAKARA)" 2)
   ("–green fluorescent protein (GFP)" 2) ("pGFP-" 2)
   ("a TCF optimal promoter (TOP)–destabilized GFP" 2) ("exogenous GFP" 2)
   ("mitochondria-targeted photoactivable GFP" 2)
   ("a mitochondrial matrix–targeted photoactivable green fluorescent protein"
    2)
   ("The lentiviral expression vectors pLenti6-V5-UbC GFP" 2)
   ("adenoviral GFP" 2) ("HCMV-driven GFP" 2)
   ("All conventional confocal GFP" 2)
   ("lysosomal-associated membrane protein (Lamp1)-GFP" 2)
   ("green fluorescent protein ( GFP )" 2)
   ("the same vector-only–expressing GFP" 2) ("a functional GFP" 2)
   ("a choral green fluorescent protein" 2) ("Green (USB)" 2)
   ("chimeric GFP" 2) ("termed B idirectional- E F1α- GFP" 2) ("more GFP" 2)
   ("mouse monoclonal anti-enhanced green fluorescent (EGFP)" 2) ("GFP–" 1)
   ("the retroviral vector pLZRS-p120-internal ribosomal entry site (IRES)-GFP"
    1)
   ("the Green’s" 1) ("The Green’s" 1)
   ("pGL-St nef (−) GFP and pGL-Ec nef (−) GFP" 1)
   ("the commercial LSI EGFR Dual-Color Probe-Hyb Set (Vysis/Abbott Molecular, IL) LSI EGFR Spectrum Orange/Cep-7 Spectrum Green"
    1)
   ("“GFP”" 1) ("The internal membrane-anchored GFP" 1) ("insufficient GFP" 1)
   ("visible green" 1) ("2 or more green" 1) ("the visible green" 1)
   ("two homologous yet non-functional GFP" 1) ("Brilliant SYBR green" 1)
   ("the LSI D7S522 (7q31) Spectrum Orange and chromosome 7 centromere (CEP7) Spectrum Green"
    1)
   ("Transfected EPCs appeared green" 1) ("HIV-1 LTR driven GFP protein" 1)
   ("adenovirus-driven GFP" 1)
   ("green
fluorescent protein"
    1)
   ("expressing GFP" 1) ("the retrovirus-expressing GFP" 1)
   ("mitochondrially targeted GFP" 1) ("targeted GFP" 1) ("a few GFP" 1)
   ("the organic dye malachite green" 1) ("Functional GFP" 1)
   ("the p30 II -GFP" 1) ("either CMV-HTLV-1 p30 II -GFP" 1)
   ("The p30 II -GFP" 1) ("a fully functional GFP" 1) ("endothelial GFP" 1)
   ("three or more green" 1) ("vertical dotted green" 1)
   ("–green fluorescent protein" 1) ("retroviral GFP" 1) ("C53-GFP protein" 1)
   ("pPin1(S16E)-GFP or pPin1(S16A)-GFP" 1)
   ("its mutants Pin1(S16E)-GFP or Pin1(S16A)-GFP" 1)
   ("than GFP (29 kDa) in cells transfected with pEGFP C2-IFNγR2" 1)
   ("than IFNγR2 wild type -GFP" 1) ("previously described GFP" 1)
   ("the adenoviral backbone expressed GFP" 1)
   ("triple mutant cultures expressed GFP" 1)
   ("mitochondrial matrix–targeted photoactivable GFP (PAGFP)" 1)
   ("a single focal plane GFP" 1)
   ("D-luciferin-based click beetle green (CBG)" 1)
   ("than those expressing GFP ( xref )" 1) ("green fluorescent protein-" 1)
   ("-UTR chimeric GFP" 1) ("residual GFP protein" 1)
   ("live murine CMV (MCMV)–GFP" 1) ("GFP (EGFP)" 1) ("than BC" 1)
   ("viral marker GFP" 1) ("The very intense green" 1)
   ("the internal control GFP" 1) ("the chimeric GFP" 1) ("the bulky GFP" 1)
   ("Green (FAM)" 1) ("JAK2 showed three green" 1) ("Green (ABI)" 1)
   ("green (ABI)" 1) ("SRC-1  −/− uterine fragments expressing GFP" 1)
   ("expressing membrane-targeted GFP" 1) ("green (ROX)" 1)
   ("Douglas Green’s" 1) ("Cellular green" 1) ("than the GFP" 1)
   ("green (ICG)" 1) ("dim green" 1)
   ("the commercially available CEP10 Spectrum Green" 1) ("soluble GFP" 1)
   ("green (GFP)" 1)
   ("the commercial LSI EGFR Spectrum Orange/CEP7 Spectrum Green" 1)
   ("We first introduced GFP" 1) ("separate two green" 1)
   ("Green Fluorescent Protein(GFP)" 1) ("GFP‐" 1) ("intense green" 1)
   ("non-functional GFP" 1) ("a functional green fluorescent protein (GFP)" 1)
   ("green fluorescent (EGFP)" 1) ("GREEN (ENZO)" 1)))
 ("UP:P42224"
  (("STAT1" 3037) ("Stat1" 336) ("STAT-1" 131) ("pSTAT1" 126) ("uSTAT1" 64)
   ("p-STAT1" 45) ("pStat1" 40)
   ("signal transducer and activator of transcription 1" 33)
   ("STAT1 protein" 30) ("Stat-1" 26) ("stat1" 12) ("pSTAT-1" 10) ("STAT1-" 8)
   ("P-STAT1" 7) ("p-Stat1" 7)
   ("Signal transducer and activator of transcription 1" 7)
   ("rabbit monoclonal STAT-1" 2) ("a dominant-negative STAT1" 2)
   ("rabbit monoclonal p-STAT1" 2) ("strong pStat1" 2) ("-STAT1" 2)
   ("Stat1 protein" 2) ("WT SHP2 decreased basal and induced pSTAT1" 2)
   ("dominant-negative STAT1" 1) ("total and phosphorylated STAT1" 1)
   ("than phosphorylated STAT1" 1) ("the homologous STAT1 protein" 1)
   ("potential STAT1" 1) ("the basal STAT1-" 1) ("virtually no pStat1" 1)
   ("ISGF-3" 1)))
 ("UP:P42226"
  (("STAT6" 1703) ("Stat6" 319) ("pSTAT6" 64) ("STAT-6" 29)
   ("STAT6 protein" 25) ("p-STAT6" 14)
   ("signal transducer and activator of transcription 6" 11)
   ("Signal transducer and activator of transcription 6" 4) ("-STAT6" 3)
   ("P-STAT6" 3) ("STAT6 (pSTAT6) protein" 3) ("Stat6 protein" 2) ("Stat6-" 2)
   ("we first stably knocked down STAT6" 2) ("hSTAT6" 2)
   ("anti-phospho(Tyr694)-STAT5 and anti-phospho(Tyr641)-STAT6" 2) ("hStat6" 1)
   ("–Stat6" 1) ("than STAT6" 1) ("STAT6-" 1)
   ("pSTAT6 (phosphorylated form of STAT6) protein" 1)
   ("the STAT6 protein’s" 1)))
 ("UP:P42229"
  (("STAT5" 3522) ("STAT5A" 1220) ("Stat5a" 895) ("Stat5" 734) ("STAT5a" 262)
   ("pSTAT5" 195) ("p-STAT5" 55) ("Stat5a protein" 26) ("pSTAT5A" 24)
   ("STAT5 protein" 20) ("Stat5 protein" 15) ("P-STAT5" 13) ("pSTAT5a" 9)
   ("signal transducer and activator of transcription-5" 8) ("-STAT5" 5)
   ("Stat5A" 5) ("stat5a" 5) ("STAT5 molecule" 4) ("only FL Stat5a" 4)
   ("overexpressed STAT5A" 3) ("STAT5A protein" 3)
   ("signal transducer and activator of transcription 5A" 3)
   ("Stat5a (Nuc-Stat5a) protein" 3) ("Stat5-" 2)
   ("The phospho-mimetic variants (S→D) STAT5 S725D" 2) ("STAT5-" 2)
   ("yet Δ5 Stat5a" 2) ("than FL Stat5a" 2) ("only Δ5 Stat5a" 2) ("STAT5A-" 2)
   ("than STAT5A" 2) ("targeted either Stat5a" 2) ("modest pSTAT5" 2)
   ("cellular Stat5" 2) ("Stat5a-" 2) ("potential STAT5" 1)
   ("particular STAT5" 1) ("at least one STAT5 molecule" 1)
   ("more FL Stat5a" 1) ("more Δ5 Stat5a" 1) ("only full-length Stat5a" 1)
   ("tetrameric STAT5" 1) ("hyperactive STAT5" 1) ("particular STAT5A" 1)
   ("precisely Stat5" 1) ("phosphorylation-competent Stat5" 1)
   ("pcDNA-CMV-WT Stat5a" 1) ("only STAT5A S710F" 1)
   ("sorafenib and IPI-926 decreased active pSTAT5" 1)
   ("IPI-926 and sorafenib decreased both total STAT5 and active pSTAT5" 1)
   ("SHH increased pSTAT5" 1)
   ("whose biopsy specimens showed significant constitutively activated STAT5"
    1)
   ("STAT5a-" 1) ("a library containing STAT5" 1)
   ("than STAT5 in erythroid cells that may be important in the pathogenesis of PV"
    1)
   ("stat5" 1) ("dominant-negative STAT5A" 1)
   ("the transcriptional factor STAT5A" 1) ("“G-CSF→p-Stat5”" 1)
   ("slightly less p-STAT5" 1) ("total and phospho STAT5" 1) ("pstat5" 1)
   ("STAT-5a" 1) ("undetectable Stat5 protein" 1)
   ("Signal transducer and activator of transcription-5" 1)
   ("than STAT5a in prostate cancer and breast cancer cell lines [ xref , xref ]"
    1)))
 ("UP:P42261"
  (("GluR1" 52) ("glutamate receptor" 46) ("GRIA1" 10)
   ("the metabotropic glutamate receptor" 5) ("glutamate receptor 1" 5)
   ("GluA1" 4) ("Glutamate receptor" 2) ("Glutamate receptor 1" 2)
   ("metabotropic glutamate receptor" 2)
   ("a metabotropic glutamate receptor" 2) ("Glutamate Receptor 1" 2)
   ("GLUR1" 1) ("Gria1" 1) ("its neuronal substrate GluR1" 1) ("GluR-A" 1)))
 ("UP:P42262"
  (("GluR2" 131) ("glutamate receptor 2" 3) ("postsynaptic GluR2" 1)
   ("the postsynaptic marker GluR2" 1) ("Glutamate receptor 2" 1) ("GLUR2" 1)))
 ("UP:P42263" (("GluR3" 5) ("GRIA3" 2) ("Glutamate receptor 3" 1)))
 ("UP:P42286" (("thr" 115) ("THR" 6)))
 ("UP:P42307" (("S3B" 164) ("S3b" 5) ("Supplemental Figure S3B" 1)))
 ("UP:P42322" (("CnB1" 1)))
 ("UP:P42327"
  (("ADH" 347) ("pure ADH" 13) ("ADH protein" 3) ("Pure ADH" 2)
   ("the most highly expressed Class I ADH" 2) ("either pure ADH" 1)
   ("at least some pure ADH" 1) ("the pure ADH" 1) ("At least some pure ADH" 1)
   ("pADH" 1) ("more ADH" 1)))
 ("UP:P42330"
  (("AKR1C3" 154) ("PGFS" 7) ("HSD17B5" 5) ("homogeneous AKR1C3" 2)
   ("AKR1C3 protein" 2) ("DD3" 2)))
 ("UP:P42331" (("ARHGAP25" 8))) ("UP:P42334" (("BCRC" 21)))
 ("UP:P42336"
  (("PIK3CA" 11132) ("p110α" 3070) ("phosphoinositide 3-kinase" 741)
   ("PI3Kα" 313) ("catalytic subunit of PI3K" 212) ("nSH2" 169) ("PI3Ki" 156)
   ("phosphoinositide-3 kinase" 118) ("phosphoinositide 3" 85) ("Pik3ca" 56)
   ("p110-α" 52) ("PIK3CA-" 47) ("P110α" 33) ("phosphoinositide 3 kinase" 32)
   ("Phosphoinositide 3-kinase" 31) ("p110α protein" 27)
   ("Phosphoinositide 3" 23) ("PIK3CA protein" 19) ("p110-alpha" 15)
   ("Phosphoinositide-3 kinase" 13) ("Pi3k" 13) ("p110alpha" 10) ("p110CAAX" 9)
   ("p110α-" 7) ("5-bisphosphate 3-kinase" 7) ("PI3K-alpha" 5)
   ("phosphoinositide-3-kinase-catalytic-alpha" 5) ("p110α peptide" 5)
   ("PI3K-α" 4) ("PI3Kα protein" 4) ("NSH2" 4) ("p110α molecule" 4)
   ("than p110α" 3) ("PIK3Ca" 3) ("Phosphoinositide 3 kinase" 3) ("pik3ca" 3)
   ("phosphoinositide 3-kinase-" 3) ("class I A p110α" 2)
   ("than MCF-7 PIK3CA" 2) ("pi3k" 2) ("more PIK3CA" 2) ("P42336" 2)
   ("the commonly-expressed PIK3CA mutant H1047R" 2) ("phosphoinositide 3-" 2)
   ("“phosphoinositide 3-kinase”" 2) ("p110-α protein" 2) ("avian p110α" 2)
   ("the avian p110α" 2) ("Endothelial p110α" 2) ("targeting PI3Kα" 2)
   ("phosphoinositide 3–kinase" 2) ("Complete PIK3CA" 2)
   ("a prototypic PIK3CA" 2) ("more p110α E545K" 2) ("than wildtype p110α" 1)
   ("a somatic PIK3CA" 1) ("Catalytic subunit of PI3K" 1) ("genomic PIK3CA" 1)
   ("than PIK3CA [ xref ]" 1) ("had significantly more p110α" 1)
   ("phosphoinositide3-kinase" 1) ("especially PI3K p110α" 1)
   ("class I A PI3K isoform p110α" 1) ("normal PIK3CA" 1)
   ("the respective PI3Ki" 1)
   ("Phosphoinositide
3-kinase"
    1)
   ("”" 1) ("than the WT p110α" 1)
   ("phosphoinositide-3-kinase catalytic alpha polypeptide" 1)
   ("isogenic mutant PIK3CA" 1) ("than the PIK3CA" 1)
   ("than the low-risk PIK3CA" 1) ("“PIK3CA”" 1)
   ("monomeric p85α-bound p110α" 1) ("representative PIK3CA" 1) ("PIk3CA" 1)
   ("than mutant PIK3CA" 1) ("our own PIK3CA" 1) ("the complete PI3Kα" 1)
   ("These considerations made PI3Kα" 1) ("P110-alpha" 1) ("PI3Kalpha" 1)
   ("phosphoinositide 3 kinase-" 1) ("exogenous p110α" 1)
   ("the last C-terminal amino acid (N1068K) of the PIK3CA protein" 1)
   ("cardiac phosphoinositide 3-kinase" 1) ("than p110α E545K ( xref )" 1)
   ("a cancer cell line expressing p110α E545K" 1)
   ("the key catalytic subunit of PI3K" 1)))
 ("UP:P42338"
  (("p110β" 1920) ("iSH2" 248) ("PI3Kβ" 126) ("PIK3CB" 76) ("p110β peptide" 9)
   ("targeted p110β" 4) ("PIK3Cb" 3) ("p110 beta" 3) ("P110β" 3) ("PI3-Kβ" 2)
   ("-iSH2" 2) ("p110β-" 2) ("p110β protein" 2)
   ("baculovirally-expressed PI3Kβ" 2) ("Pik3cb" 1) ("than p110β" 1)
   ("p110beta" 1) ("than wild-type p110β" 1) ("-p110β" 1)
   ("than wild-type p110β in the presence of pY 2" 1)
   ("than the wild-type p110β ( xref C)" 1) ("PI3Kbeta" 1)))
 ("UP:P42345"
  (("mTOR" 54902) ("mammalian target of rapamycin" 1210) ("FRAP" 564)
   ("p-mTOR" 515) ("MTOR" 318) ("mTor" 180) ("Akt-mTOR" 161)
   ("mTOR protein" 116) ("mechanistic target of rapamycin" 115)
   ("Mammalian target of rapamycin" 93) ("FRAP1" 92) ("pmTOR" 81)
   ("PI3K-mTOR" 78) ("mTORC" 74) ("m-TOR" 25) ("mTOR-" 24) ("P-mTOR" 21)
   ("-mTOR" 18) ("pMTOR" 15) ("-Akt-mTOR" 8) ("overexpressed phospho-mTOR" 8)
   ("Mechanistic target of rapamycin" 7) ("–mTOR" 6) ("Akt-mTor" 6)
   ("overexpressed mTOR" 6) ("than mTOR" 5)
   ("serine/threonine protein kinase mTOR" 5) ("Akt–mTOR" 5)
   ("-mammalian target of rapamycin" 5) ("RAFT1" 4)
   ("mammalian target of rapamycin (MTOR)" 3) ("MTOR protein" 3)
   ("mTOR (FRAP)" 3) ("“mTOR”" 3) ("-MTOR" 3) ("pMtor" 3) ("p-mTor" 3)
   ("mammalian target of rapamycin (mTOR) protein" 3) ("the canonical mTOR" 2)
   ("pmTor" 2) ("non-synonymous MTOR point mutations" 2)
   ("reduced plasmatic FRAP" 2)
   ("FKBP12-rapamycin complex-associated protein" 2) ("P42345" 2)
   ("some weak and scattered pmTOR" 2) ("hyperactive mTOR" 2) ("spinal mTOR" 2)
   ("more p70s6k binding mTOR" 2) ("classical mammalian target of rapamycin" 2)
   ("p-MTOR" 2)
   ("the translational regulators mammalian target of rapamycin" 2)
   ("Overexpressed FRAP" 2) ("otherwise constitutively active FRAP" 2)
   ("mammalian target of rapamycin protein" 2)
   ("mammalian target of rapamycin-" 2)
   ("the serine/threonine-specific protein kinase mTOR" 2) ("mTOR molecule" 2)
   ("overall phospho-mTOR/Total mTOR" 2) ("p-mammalian target of rapamycin" 2)
   ("phospho-mTOR (p-mTOR) protein" 2) ("P-mTor" 2) ("Representative FRAP" 1)
   ("binding mTOR's" 1) ("The mTOR's" 1) ("PI3K–mTOR" 1)
   ("further downstream mTOR" 1) ("substantial p-mTOR" 1)
   ("the “total” mTOR" 1) ("than mTOR (5.10E–06 M and 6.71E–06 M)" 1)
   ("linking mTOR" 1) ("total and phosphorylated mTOR" 1) ("neuronal mTOR" 1)
   ("Synaptic
mTOR"
    1)
   ("mechanistic
target of rapamycin"
    1)
   ("mammalian
target of rapamycin"
    1)
   ("both total and phosphorylated (activated) mTOR" 1)
   ("dysfunctional mTOR" 1) ("Total and phosphorylated mTOR" 1) ("Mtor" 1)
   ("than sorted mTOR" 1) ("Almost all documented mTOR" 1) ("MTORC" 1)
   ("dual wavelength FRAP" 1) ("the canonical mTor" 1) ("no detectible mTOR" 1)
   ("up more mTOR" 1) ("than inhibiting mTOR" 1) ("dominant-negative mTOR" 1)
   ("mTOR ( MTOR )" 1) ("two distinct mTOR" 1) ("only one mTOR" 1) ("Frap1" 1)
   ("more mTOR" 1) ("—mammalian target of rapamycin" 1)
   ("specifically target mTOR" 1) ("nucleoplasmic FRAP" 1) ("nucleolar FRAP" 1)
   ("preferentially binds mTOR" 1) ("an alternative mTOR" 1)
   ("the well-established downstream effector mTOR" 1) ("peripheral mTOR" 1)
   ("less mTOR" 1) ("two major mTOR" 1) ("prefrontal mTOR" 1) ("dual mTOR-" 1)
   ("hypothalamic mTOR" 1) ("RAPT1" 1) ("MTOR-" 1)
   ("3HOI-BA-01 suppressed mTOR’s" 1)))
 ("UP:P42356" (("PIK4" 1))) ("UP:P42357" (("HAL" 17) ("HiS" 2)))
 ("UP:P42364" (("scAA" 1))) ("UP:P42544" (("ORF9" 2)))
 ("UP:P42566"
  (("Eps15" 211) ("EPS15" 52) ("eps15" 12) ("Eps15 peptide" 6)
   ("protein Eps15" 5) ("the accessory protein Eps15" 2)
   ("epidermal growth factor receptor substrate 15" 1)))
 ("UP:P42568" (("AF9" 124) ("MLLT3" 7))) ("UP:P42573" (("CED-3" 13)))
 ("UP:P42574"
  (("caspase-3" 7620) ("caspase 3" 2908) ("Caspase-3" 1333) ("CASP3" 538)
   ("Caspase 3" 404) ("caspase3" 188) ("Sca-1" 137) ("caspases-3" 100)
   ("Sca1" 93) ("Casp3" 56) ("Caspase3" 51) ("BD" 49) ("caspase-3 protein" 30)
   ("SCA1" 23) ("CASPASE 3" 22) ("CPP32" 21) ("casp3" 20) ("CASP-3" 14)
   ("caspase- 3" 11) ("uterine CASP3" 11) ("CASPASE-3" 9) ("Casp 3" 8)
   ("mature caspase-3" 6) ("Casp-3" 6) ("more caspase-3" 5) ("-caspase 3" 5)
   ("caspase 3 protein" 5) ("caspases3" 5) ("Caspases-3" 4)
   ("total and cleaved caspase-3" 4) ("caspase-3 peptide" 4)
   ("less caspase 3" 3) ("uterine caspase-3" 3) ("than wild-type caspase-3" 3)
   ("CASPASE3 protein" 3) ("rabbit α-cleaved caspase-3" 3) ("–caspase 3" 2)
   ("Caspase-3-" 2)
   ("10A L2 acinar structures expressed activated caspase-3" 2) ("-caspase3" 2)
   ("caspase-3-" 2) ("Caspase-3 peptide" 2)
   ("combined treatment increased activated caspase-3" 2)
   ("Caspase3 protein" 2) ("CASPASE3" 2)
   ("monoclonal IgG rabbit anti-Active Caspase 3" 2)
   ("proteolytically mature caspase 3" 2) ("than caspase-3" 2)
   ("caspase 3 (BD)" 2) ("caspase 3–" 2) ("the mature caspase-3" 2)
   ("CASP3 protein" 2) ("intense activated caspase-3" 2)
   ("the pro-apoptotic protein caspase-3" 2) ("caspase3 protein" 2)
   ("pro-apoptotic gene caspase-3" 2) ("proteolytically process caspase-3" 2)
   ("the genetically-engineered CASP3" 2) ("the premature CASP3" 2)
   ("the catalytic site cysteine of caspase-3" 1) ("particular Caspase-3" 1)
   ("the potential tocolytic enzyme CASP3" 1) ("cleaved uterine CASP3" 1)
   ("Our previously published mouse uterine CASP3" 1) ("deceive Caspase-3" 1)
   ("pure Caspase-3" 1) ("-Caspase 3" 1)
   ("apoptotic-related factors Caspase 3" 1) ("Non-cleaved caspase-3" 1)
   ("sca-1" 1) ("CASPASE 3-" 1) ("The cell-permeable caspase-3" 1)
   ("activated antigenic caspase-3" 1) ("-caspase-3" 1)
   ("the effector pro-apoptotic molecule caspase 3" 1)
   ("siRNA increased cleaved CASP3" 1)
   ("significantly less active caspase-3" 1) ("a more rapid caspase 3" 1)
   ("sca1" 1) ("a functional caspase-3" 1) ("functional caspase-3" 1)
   ("caspase 3-" 1) ("Caspase- 3" 1) ("exogenous caspase-3" 1)
   ("caspase-3 (DEVD)" 1) ("than caspase-3 ( xref )" 1) ("Mature caspases-3" 1)
   ("than wild-type caspase-3 (unpublished data)" 1)
   ("the wild-type TAT-HA–tagged caspase-3" 1)
   ("a TAT-HA–tagged mutated caspase-3" 1) ("TAT-HA–tagged caspase-3" 1)
   ("apical caspase-8 and effector caspase-3" 1) ("more caspase 3" 1)
   ("casp-3" 1) ("caspases−3" 1) ("Cpp32" 1) ("mainly p24 caspase-3" 1)
   ("monoclonal anti-caspase-9 and anti-cleaved caspase-3" 1)
   ("mature caspase 3" 1) ("-Sca1" 1) ("pro-apoptotic factor Caspase 3" 1)
   ("pro-apoptotic cleaved caspase-3" 1)
   ("subsequent executioner caspase-3" 1)))
 ("UP:P42575"
  (("caspase-2" 480) ("Caspase-2" 155) ("CASP2" 40) ("caspase 2" 38)
   ("caspases-2" 29) ("neural precursor cell expressed" 14) ("ICH-1" 7)
   ("Caspases-2" 4) ("Neural precursor cell Expressed" 3) ("procaspase-2" 2)
   ("Ich-1" 2) ("particular CASP2" 2) ("exogenous Caspase-2" 2)
   ("catalytically-dead (C320A) Caspase-2" 2) ("than procaspase-2" 1)
   ("Nedd2" 1) ("pro-apoptotic regulative CASP2" 1)
   ("mitochondrial-related caspase-2" 1) ("proapoptotic caspase-2" 1)))
 ("UP:P42658" (("DPP6" 5)))
 ("UP:P42677"
  (("RPS27" 154) ("overexpressed RPS27" 2) ("metallopanstimulin-1" 2)
   ("a nearly complete elimination RPS27" 1) ("Ribosomal Protein S27" 1)))
 ("UP:P42679"
  (("CTK" 20) ("MATK" 8) ("Csk homologous kinase" 4) ("HYL" 1)
   ("Csk homologous kinase (CHK)" 1)))
 ("UP:P42680" (("TEC" 53) ("than the TEC" 1)))
 ("UP:P42681"
  (("Rlk" 250) ("Rlk protein" 12) ("Txk" 10) ("TXK" 4) ("rlk" 2) ("TxK" 2)
   ("only Rlk protein" 1) ("RLK" 1)))
 ("UP:P42684"
  (("ARGs" 66) ("ARG" 57) ("arg" 51) ("ABL2" 20) ("Abl2" 5) ("ABL2 (ARG)" 3)))
 ("UP:P42685" (("Rak" 165) ("FRK" 25) ("RAK" 4) ("Frk" 3)))
 ("UP:P42688" (("SRK2" 1)))
 ("UP:P42694" (("HELZ" 154) ("Helicase with zinc finger" 1)))
 ("UP:P42695" (("CAPD3" 15) ("NCAPD3" 3) ("subunit D3" 1)))
 ("UP:P42696" (("RBM34" 1)))
 ("UP:P42701"
  (("IL12RB1" 35) ("IL-12Rβ1" 23) ("IL-12R" 3) ("IL12R" 2) ("IL-12Rβ1–" 2)
   ("IL-12RB1" 2) ("IL12rb1" 2) ("IL-12RB" 1)))
 ("UP:P42702"
  (("LIFR" 73) ("LIF receptor" 26) ("leukemia inhibitory factor receptor" 6)
   ("LIF Receptor" 4) ("LIFR-" 1) ("LIF receptor (LIFR)" 1)))
 ("UP:P42704" (("GP130" 43) ("LRPPRC" 16) ("LRP130" 1)))
 ("UP:P42737"
  (("BCA2" 388) ("BCA2 protein" 32) ("Ten new BCA2" 2) ("Ten unique BCA2" 2)
   ("than BCA2" 1)))
 ("UP:P42738" (("CM1" 250)))
 ("UP:P42751"
  (("CycD1" 225) ("cycD1" 54) ("CYCD1" 8) ("pCyclinD1" 1) ("–CycD1" 1)
   ("-CycD1" 1)))
 ("UP:P42753"
  (("cyclinD3" 29) ("CyclinD3" 18) ("CycD3" 11) ("CyclinD3 protein" 1)))
 ("UP:P42765"
  (("T1" 1312) ("pT1" 48) ("T1-" 19) ("coronal T1" 2) ("ACAA2" 1)
   ("faster growing GIST-T1" 1) ("-T1.10" 1) ("contrast-enhanced T1" 1)
   ("Urinary bladder carcinoma stage T1" 1)))
 ("UP:P42766" (("L35" 4)))
 ("UP:P42768"
  (("WASp" 470) ("WASP" 123) ("WAS" 66) ("wasp" 25)
   ("Wiskott Aldrich Syndrome protein" 8) ("Wasp" 6) ("wasP" 3)
   ("neural WASP" 2) ("WASP-" 1) ("neural (N)-WASp" 1) ("-WASp" 1)
   ("Wiskott Aldrich Syndrome Protein" 1) ("Most wasp" 1)))
 ("UP:P42771"
  (("p16" 4084) ("p16 INK4a" 1129) ("p14ARF" 618) ("p16 INK4A" 494)
   ("Ink4a" 422) ("INK4A" 286) ("INK4a" 256) ("P16" 239) ("p16INK4a" 146)
   ("p16 Ink4a" 142) ("Cdkn2a" 107) ("P14ARF" 91) ("p16INK4A" 72) ("p14Arf" 65)
   ("p16 ink4a" 54) ("p16ink4a" 43) ("p16−" 42) ("p16 protein" 39)
   ("p16  INK4A" 33) ("p16  INK4a" 29) ("p16Ink4a" 20) ("p16 INK4" 20)
   ("p16-" 20) ("p14ARF protein" 19) ("p16 Ink4A" 17) ("p16  Ink4a" 17)
   ("CDK4i" 17) ("ink4a" 14) ("p16 INK4a protein" 11) ("CDKN2a" 11)
   ("Ink4A" 11) ("p16 INK4A protein" 10) ("P14ARF protein" 7) ("ink4A" 7)
   ("p16INK4" 5) ("p16-INK4a" 5) ("P16 ink4a" 4) ("more frequent P16" 4)
   ("p14Arf protein" 4) ("GR decreased expression ofp16 INK4a" 4)
   ("p16  Ink4A" 3) ("p16 Ink4" 3) ("P16 INK4A" 3) ("p16INK4A protein" 3)
   ("p16 -protein" 3) ("overexpressed p16" 3) ("functional p16 INK4a" 3)
   ("residual p16" 3) ("Ink4a-" 3) ("INk4A" 3) ("p16 ink4" 2) ("p16 (WT)" 2)
   ("MP displayed strong diffuse p16" 2) ("weak p16" 2)
   ("diffuse strong p16" 2)
   ("Twenty-nine percent (4/14) malignant phyllodes showed diffuse strong p16"
    2)
   ("more positive p16" 2) ("p16  INK4" 2) ("the previous p16" 2)
   ("p16 (EMD)" 2) ("p16 ink4A" 2) ("p16 INK4a peptide" 2)
   ("exogenous p16 INK4a" 2) ("functional p16" 2)
   ("the senescence-associated markers p16 INK4a" 2) ("p16 INK4 protein" 2)
   ("multiple tumor suppressor 1" 2)
   ("the CDK4/CDK6-specific inhibitor INK4A" 1)
   ("All benign Brenner tumors expressed p16" 1) ("EGFR-driven Cdkn2a −/−" 1)
   ("overexpressing p16" 1) ("Acute suppression ofp16 Ink4a" 1)
   ("acute suppression ofp16 INK4A" 1)
   ("only two samples expressed p16 INK4a" 1)
   ("than non-degenerate discs expressed p16 INK4a" 1) ("P16ink4a" 1)
   ("amino acids of p14ARF" 1) ("basal p16 INK4A" 1) ("p16INk4a" 1)
   ("than p16 (-)" 1) ("P16-" 1) ("CDK4I" 1) ("P16–" 1) ("exogenous p14ARF" 1)
   ("similarly expressed WT p14ARF" 1) ("human p14ARF’s" 1)
   ("Subsequent loss ofp16 INK4A" 1) ("nucleic p16 INK4a" 1)
   ("p16ink4a protein" 1) ("cyoplasmic p16 INK4A" 1) ("exogenous p16" 1)
   ("p16 INK4a staining showed positive Spearman’s" 1) ("−p14ARF" 1)
   ("those lacking functional Ink4a" 1) ("compartmental p16" 1)
   ("primary Ink4A" 1) ("senescence-associated protein p16" 1)
   ("VGPs showed significantly less p16" 1)
   ("Only 3/17 VGP melanomas showed any detectable nuclear p16" 1)
   ("IHC-abnormal p16" 1) ("abnormal p16" 1)
   ("negative predictive value using p16" 1)))
 ("UP:P42772"
  (("CDKN2B" 432) ("p15 INK4B" 74) ("Cdkn2b" 58) ("p15 Ink4B" 35)
   ("p15  INK4B" 31) ("INK4B" 28) ("p15 INK4b" 20) ("INK4b" 18) ("Ink4b" 11)
   ("p15Ink4b" 11) ("p15 Ink4b" 10) ("p15ink4b" 8) ("p15INK4B" 6)
   ("p15INK4b" 4) ("P15INK4b" 4) ("ink4b" 3) ("MTS2" 3) ("CDKN2B-" 3)
   ("a cooperative tumor suppressor role forp15 INK4B" 2)
   ("The nearby CDKN2B" 2) ("p15ink4b protein" 2) ("p15 INK4B protein" 2)
   ("P15 INK4B" 2) ("cdkn2b" 1) ("A modest upregulation ofp15 INK4B" 1)
   ("ps15" 1) ("MTS-2" 1) ("p15  INK4b" 1) ("pMTS2" 1)))
 ("UP:P42773"
  (("Ink4c" 79) ("CDKN2C" 71) ("INK4c" 23) ("Cdkn2c" 12) ("p18Ink4c" 6)
   ("Ink4c protein" 3) ("ink4c" 2) ("p18INK4C" 1)
   ("compensatory regulation betweenp16 Ink4a andp18 Ink4c" 1)
   ("inhibits CDK4)" 1) ("cyclin-dependent kinase inhibitor 2C (p18" 1)
   ("p18INK4c" 1)))
 ("UP:P42830" (("CXCL5" 36) ("Cxcl5" 8) ("LIX" 1))) ("UP:P42857" (("Nsg1" 1)))
 ("UP:P42858"
  (("HD" 2004) ("HTT" 150) ("huntingtin" 122) ("Huntingtin" 51)
   ("Huntington disease" 29) ("Huntington's Disease" 14)
   ("huntingtin protein" 13) ("classical HD" 9) ("huntingtin (HTT)" 7)
   ("HTT protein" 6) ("Huntington’s Disease" 5) ("HD protein" 5)
   ("Huntingtin protein" 3) ("Huntingtin (Htt) protein" 3) ("Classical HD" 2)
   ("normal and mutated huntingtin (HTT)" 2) ("the HD" 2)
   ("further increases mutant HTT" 2)
   ("cationic lipid transfection reagents Fugene HD" 2)
   ("huntingtin (Htt) protein" 2) ("several preclinical HD" 1) ("-HD" 1)
   ("Huntingtin (HTT)" 1) ("than the HD ( xref )" 1)
   ("The disease-associated huntingtin protein" 1)
   ("the neurodegenerative disease proteins huntingtin (HTT)" 1)
   ("the first 171 amino acids of human Huntingtin containing 18 or 82 polyglutamine"
    1)))
 ("UP:P42862" (("GpIa" 1))) ("UP:P42863" (("GPIb" 38) ("GpIb" 4)))
 ("UP:P42892" (("endothelin-converting enzyme-1" 6)))
 ("UP:P42898"
  (("MTHFR" 602) ("methylenetetrahydrofolate reductase" 43)
   ("Methylenetetrahydrofolate reductase" 11)
   ("methylenetetrahydrofolate reductase (MTHFR)" 7)
   ("methylenetetrahydrofolate reductase ( MTHFR )" 3)
   ("methylenetetrahydrofolate reductase protein" 2) ("MTHFR-" 2)
   ("a pharmacogenetic marker MTHFR" 1)
   ("5,10-methylenetetrahydrofolate reductase (NADPH)" 1)))
 ("UP:P42927" (("Serpin1" 1)))
 ("UP:P42992"
  (("VT" 316) ("incident VT" 8) ("−VT" 1) ("malignant VT" 1)
   ("VT (ie without environemental risk factors) (< 50 years) VT" 1)
   ("idiopathic VT" 1) ("pVT" 1)))
 ("UP:P43003" (("GLAST" 6) ("SLC1A3" 5) ("GLAST1" 2) ("EAAT1" 2) ("EA6" 1)))
 ("UP:P43004"
  (("EAAT2" 4) ("GLT-1" 4) ("excitatory amino-acid transporter-2" 2)
   ("Glt1" 1)))
 ("UP:P43005" (("EAAC1" 5) ("SLC1A1" 4) ("EAAT3" 3)))
 ("UP:P43007" (("SLC1A4" 2)))
 ("UP:P43021"
  (("nodal" 1095) ("Nodal" 469) ("“nodal” protein" 4) ("nodal-" 3)
   ("autocrine nodal" 3) ("recombinant mature human Nodal" 2)
   ("strong (3+; Figure xref ) Nodal" 2) ("primary nodal" 2)
   ("distinct nodal" 2) ("“nodal”" 1) ("the same proliferative nodal" 1)
   ("Primary nodal" 1) ("13 primary nodal" 1)
   ("simultaneously targets various critical nodal" 1) ("pathological nodal" 1)
   ("functional nodal" 1) ("distinct nodal-" 1)))
 ("UP:P43026"
  (("GDF5" 26) ("Growth differentiation factor 5" 3)
   ("growth differentiation factor 5" 1)))
 ("UP:P43034"
  (("MDS" 1275) ("LIS1" 92) ("classical MDS" 4)
   ("histologically-confirmed MDS" 4) ("primary MDS" 2) ("aggressive MDS" 2)
   ("“AML/MDS”" 1) ("therapy-related MDS" 1)
   ("del(5q) MDS and non-del(5q) MDS" 1) ("LIS1 protein" 1)
   ("primary and secondary MDS" 1)))
 ("UP:P43080" (("pGCAP" 4) ("pGCAP1" 1) ("GUCA" 1)))
 ("UP:P43082"
  (("HEL" 346) ("ATCC" 16) ("Alexa Fluor 647–conjugated HEL" 2)
   ("HEL (ATCC)" 1)))
 ("UP:P43088" (("FP receptor" 10) ("prostaglandin F receptor" 3)))
 ("UP:P43115"
  (("PGE" 79) ("EP3" 53) ("PTGER3" 20) ("pGE" 9) ("EP3 receptor" 7)
   ("Prostaglandin E Receptor 3" 3) ("prostaglandin E receptor 3" 3)))
 ("UP:P43116"
  (("EP2 receptor" 21) ("PTGER2" 1) ("prostaglandin E receptor 2" 1)))
 ("UP:P43121"
  (("CD146" 128) ("MCAM" 36) ("melanoma cell adhesion molecule" 3)
   ("MUC18" 1)))
 ("UP:P43146" (("DCC" 509) ("netrin receptor DCC" 2) ("dCC" 2) ("Dcc" 1)))
 ("UP:P43155"
  (("CRAT" 32) ("carnitine acetyltransferase protein" 3)
   ("the previously reported CRAT" 2) ("carnitine acetyltransferase" 1)
   ("carnitine O-acetyltransferase" 1)))
 ("UP:P43220"
  (("GLP1R" 27) ("GLP-1 receptor" 10) ("GLP-1R" 10)
   ("glucagon-like peptide 1 receptor" 6) ("than the GLP-1 receptor" 1)
   ("Glp1r" 1)))
 ("UP:P43235"
  (("Cathepsin K" 22) ("cathepsin K" 20) ("CTSK" 10) ("catK" 4)
   ("CATHEPSIN K" 2) ("Cathepsin K (CTSK)" 1)))
 ("UP:P43243"
  (("Matrin 3" 14) ("MATR3" 3) ("matrin 3" 2) ("Matrin3" 1) ("Matrin-3" 1)
   ("matrin-3" 1)))
 ("UP:P43246"
  (("MSH2" 2711) ("hMSH2" 1067) ("Msh2" 67) ("MSH2 protein" 60)
   ("mutS homolog 2" 13) ("msh2" 12) ("hMSH2 protein" 10) ("MSH2(WT)" 10)
   ("MSH2-" 9) ("monomeric MSH2" 6)
   ("MSH2
protein"
    5)
   ("hMSH2-" 4) ("–hMSH2" 4) ("exogenous MSH2" 3) ("HMSH2" 3)
   ("overexpressed MSH2" 3) ("MutS homolog 2" 3) ("MSH2(P622L) protein" 3)
   ("mSH2" 2) ("mutS homolog 2 (MSH2) protein" 2)
   ("inherited defective MSH2" 2) ("-hMSH2" 2)
   ("The parental Hec59 cells lack detectable MSH2 protein" 2)
   ("medullary (4/5, 80%) carcinoma cases showed negative/weak MSH2" 2)
   ("ATM and ATR kinases directly target homologous recombination factors Nbs1 and Rad52 and mismatch repair factor Msh2"
    2)
   ("exogenous MSH2 protein" 1) ("the resulting monomeric MSH2" 1)
   ("more MSH2" 1) ("MSH6KO MEFs MSH2’s" 1) ("more monomeric MSH2" 1)
   ("carried defective MSH2" 1) ("At least 175 germline MSH2" 1)
   ("functional hMSH2" 1) ("substantially more MSH2" 1)
   ("than MSH2(WT) ( xref )" 1) ("MSH2(K393M) protein" 1)
   ("3 showed absent MSH2" 1) ("absent MSH2" 1) ("than MSH2" 1) ("than Msh2" 1)
   ("residual MSH2" 1)))
 ("UP:P43250" (("GRK6" 5))) ("UP:P43251" (("biotinidase" 2) ("BTD" 2)))
 ("UP:P43268"
  (("PEA3" 479) ("ETV4" 95) ("E1AF" 11) ("Etv4" 10) ("PEA3 protein" 5)
   ("ETV4 protein" 3)))
 ("UP:P43298" (("TMK1" 13))) ("UP:P43307" (("SSR1" 101)))
 ("UP:P43313"
  (("activating protein" 180) ("activating protein (GAP)" 10)
   ("Activating Protein" 8) ("activating protein (GSAP)" 4)
   ("activating protein (LAP)" 3) ("activating protein (SCAP)" 3)
   ("-activating protein" 3) ("activating protein (AP)" 2)
   ("Activating protein" 2) ("ACTIVATING PROTEIN" 1)))
 ("UP:P43320"
  (("punctate" 858) ("Punctate" 15) ("weak punctate" 4) ("distinct punctate" 3)
   ("wortmannin caused unusual punctate" 2) ("less punctate" 2)
   ("The characteristic 293 cell LMP1 punctate" 2)
   ("A characteristic punctate" 2) ("the characteristic punctate" 2)
   ("a typical punctate" 2) ("discontinuous punctate" 2)
   ("Riplet decreased RIG-I punctate" 1) ("more punctate" 1)
   ("the cytoplasmic TBC1D3-positive punctate" 1) ("brown punctate" 1)
   ("MYC became punctate" 1) ("the CMV9 system showed more punctate" 1)
   ("only few non-specific punctate" 1) ("‘punctate’" 1) ("typical punctate" 1)
   ("this distribution became more punctate" 1)
   ("the EGFR-positive punctate" 1)
   ("relatively small (~1–2 µm diameter) circular punctate" 1)
   ("a more intense punctate" 1) ("relatively small punctate" 1)))
 ("UP:P43332" (("SNF" 299) ("Snf" 5) ("SNF-" 2)))
 ("UP:P43351"
  (("RAD52" 990) ("Rad52" 496) ("DNA repair protein" 194) ("RAD52 protein" 29)
   ("rad52" 19) ("Rad52 protein" 12) ("monomeric Rad52" 7)
   ("less DNA repair protein" 3) ("an essential DNA repair protein" 2)
   ("chromatin-associated RAD52" 2)
   ("the most well-known DNA repair protein" 2)
   ("the major DNA repair protein" 2) ("pure RAD52" 2)
   ("cellular DNA repair protein" 2) ("RAD52 homolog" 2)
   ("phosphotyrosine mimetic RAD52" 2) ("DNA Repair Protein" 2)
   ("the novel chromosomal DNA repair protein" 1)
   ("a cellular DNA repair protein" 1) ("than Rad52 ( xref )" 1)
   ("than unmodified RAD52" 1) ("recombinant tyrosine-phosphomimetic RAD52" 1)
   ("The homologous recombination factor Rad52" 1)))
 ("UP:P43354"
  (("Nurr1" 220) ("NOT" 75) ("NR4A2" 21) ("Nurr1 protein" 9) ("Nr4a2" 5)
   ("NURR1" 3) ("NURR1-" 2) ("than the full-length Nurr1 protein" 1)
   ("than the full-length Nurr1" 1)
   ("than full-length Nurr1 (approximately 10% of the hTH promoter activity)"
    1)))
 ("UP:P43355" (("MAGE-A1" 123)))
 ("UP:P43356" (("MAGE-A2" 91) ("than MAGE-A2" 1)))
 ("UP:P43357" (("MAGE-A3" 56) ("MAGEA3" 7) ("MAGE3" 2) ("MAGE-A3 protein" 2)))
 ("UP:P43358" (("MAGE-A4" 10) ("MAGEA4" 1))) ("UP:P43360" (("MAGE-A6" 1)))
 ("UP:P43364" (("MAGE-A11" 10) ("MAGE11" 4) ("MAGE-11" 2) ("MAGEA11" 1)))
 ("UP:P43378"
  (("MEG2" 13) ("PTPN9" 9) ("Meg2" 4)
   ("protein tyrosine phosphatase, non-receptor type 9" 1)))
 ("UP:P43403"
  (("ZAP-70" 389) ("ZAP70" 240) ("Zap-70" 92) ("BD" 46) ("Zap70" 36)
   ("ZAP-70 peptide" 4) ("P-ZAP-70" 3) ("ZAP-70 (BD)" 2)
   ("than Zap70 [ xref ]" 1) ("phospho-ZAP-70's" 1) ("total cellular ZAP-70" 1)
   ("the latter cells ZAP70" 1)))
 ("UP:P43405"
  (("Syk" 1601) ("SYK" 389) ("syk" 25) ("spleen tyrosine kinase" 22)
   ("Syk-" 14) ("Spleen tyrosine kinase" 11) ("P-SYK" 5) ("pSyk" 4)
   ("Syk molecule" 3) ("overexpressed Syk" 2) ("expressing Syk" 2)
   ("fibrinogen-adherent syk" 1) ("c-Cbl strictly targets Syk" 1)
   ("the Igα-associated Syk" 1)
   ("Y519/520 showed approximately twofold more Y519/520 phospho-Syk" 1)
   ("BCR-associated Syk" 1) ("the activation loop tyrosine of Syk ( xref )" 1)
   ("Tyr525/526-phospho Syk" 1) ("spleen tyrosine kinase (SYK)" 1)))
 ("UP:P43487" (("RanBP1" 43) ("soluble RanBP1" 1)))
 ("UP:P43489" (("TNFRSF4" 1)))
 ("UP:P43490"
  (("nicotinamide" 674) ("NAMPT" 314) ("Nampt" 210) ("Nicotinamide" 57)
   ("nicotinamide (NAM)" 55) ("visfatin" 41)
   ("nicotinamide phosphoribosyltransferase" 34) ("PBEF" 19)
   ("Nicotinamide phosphoribosyltransferase" 12)
   ("nicotinamide phosphoribosyltransferase (NAMPT)" 8) ("Visfatin" 7)
   ("PBEF1" 6) ("Nicotinamide (NAM)" 4) ("Biomol" 4)
   ("cellular nicotinamide" 3) ("PBEF (NAMPT)" 3) ("NAMPT protein" 3)
   ("Nicotinamide (NAA)" 2)
   ("the essential NAD + biosynthesis enzyme nicotinamide phosphoribosyltransferase (NAMPT)"
    2)
   ("overexpressed Nampt" 2) ("Nampt (eNampt) protein" 2)
   ("mammals predominantly use nicotinamide" 2) ("nicotinamide (BIOMOL)" 2)
   ("pre-B-cell colony-enhancing factor" 1)
   ("an exogenously overexpressed Nampt" 1) ("exogenous expressed Nampt" 1)
   ("cellular Nampt" 1) ("H247E expressed more NAMPT protein" 1)
   ("Pre-B-cell colony-enhancing factor (PBEF)" 1)
   ("Pre-B-cell colony-enhancing factor" 1)
   ("mammals directly use nicotinamide" 1) ("enzyme defective (W247A) NAMPT" 1)
   ("Nicotinamide phosphoribosyltransferase (NAMPT)" 1)))
 ("UP:P43534" (("Mol2" 4))) ("UP:P43565" (("Rim15" 5)))
 ("UP:P43568" (("CDK activating kinase" 4) ("CDK activating kinase (CAK)" 2)))
 ("UP:P43585" (("PHM1" 1))) ("UP:P43602" (("Rog3" 1)))
 ("UP:P43621" (("Ret2" 2)))
 ("UP:P43626"
  (("two domains" 352) ("Two domains" 9) ("long cytoplasmic tail" 5)
   ("at least two domains" 3) ("CL-42" 3) ("47.11" 2)
   ("the last two domains" 2)
   ("than the other two domains in the closed conformation" 1)
   ("The latter two domains" 1)))
 ("UP:P43629"
  (("three domains" 132) ("Cl2" 9) ("cl2" 7) ("KIR3DL1" 6) ("NKB1" 5)
   ("CL-2" 5) ("cl-2" 5) ("cl2-" 2) ("at least three domains" 1)
   ("Three domains" 1)))
 ("UP:P43630"
  (("cl5" 43) ("CL5" 40) ("-cl5" 16) ("the junctional CL5" 2) ("CL5 protein" 2)
   ("around CL5" 1) ("CL-5" 1)))
 ("UP:P43652"
  (("AFM" 285) ("alba" 3) ("This high-speed AFM" 2)
   ("the previously published Dmc1 AFM" 1) ("the previously reported AFM" 1)
   ("a spherical AFM" 1) ("Ngo et al., applied high-speed AFM" 1) ("Alba" 1)
   ("their respective AFM" 1)))
 ("UP:P43657"
  (("G-protein coupled" 195) ("P2RY5" 22) ("LPAR6" 13)
   ("the vasoconstrictive G-protein coupled receptors (GPCRs) 5-hydroxytryptamine type 1B"
    2)
   ("P2Y5" 1) ("G-Protein coupled" 1) ("purinergic receptor P2Y" 1)
   ("Purinergic Receptor P2Y" 1)))
 ("UP:P43681" (("CHRNA4" 14))) ("UP:P43686" (("PSMC4" 10) ("TBP7" 6)))
 ("UP:P43694"
  (("GATA4" 322) ("Gata4" 122) ("GATA-4" 54) ("Gata4 protein" 6)
   ("transcription factor GATA-4" 5) ("GATA4 protein" 4)
   ("GATA binding protein 4" 3) ("cardiac markers GATA4" 2)
   ("the cardiogenic factor GATA4" 1) ("GATA-4-" 1)
   ("endodermal marker GATA4" 1)))
 ("UP:P43699"
  (("TITF-1" 174) ("NKX2-1" 160) ("TTF1" 98)
   ("thyroid transcription factor-1" 34) ("Nkx2-1" 27)
   ("thyroid transcription factor 1" 25) ("TITF-1 protein" 14) ("Ttf1" 8)
   ("Thyroid transcription factor 1" 6) ("TITF1" 6)
   ("Thyroid transcription factor-1" 3) ("NK2 homeobox 1" 2) ("BHC" 2)
   ("TTF1−" 1)))
 ("UP:P44321" (("T-Ag" 131)))
 ("UP:P44683"
  (("ROX" 229) ("Rox" 56) ("rox" 3) ("Absolute Blue SYBER Green ROX" 2)
   ("the internal size standard Genescan 400HD ROX" 1)))
 ("UP:P45168"
  (("SPBP" 128) ("exogenous SPBP" 2) ("the transcriptional coregulator SPBP" 1)
   ("less SPBP" 1)))
 ("UP:P45378" (("TNNT3" 3)))
 ("UP:P45379" (("cTnT" 125) ("cTNT" 4) ("TNNT2" 3) ("CMH2" 1) ("Tnnt2" 1)))
 ("UP:P45403" (("CycK" 5))) ("UP:P45405" (("CYCL" 3)))
 ("UP:P45452"
  (("collagenase" 882) ("MMP-13" 685) ("MMP13" 348) ("Collagenase" 51)
   ("matrix metalloproteinase-13" 10) ("collagenase-3" 10)
   ("matrix metalloproteinase 13" 9) ("MMP13 protein" 8)
   ("either 1 mg/ml crude collagenase" 5) ("matrix metallopeptidase 13" 4)
   ("exogenous collagenase" 4) ("MMP13 (active MMP13) protein" 3) ("Mmp13" 3)
   ("collagenase 3" 3) ("Matrix metalloproteinase 13" 3) ("than MMP-13" 3)
   ("bacterial collagenase" 3) ("MMP-13 protein" 3) ("collagenase protein" 3)
   ("the stereotypical secreted collagenase" 2) ("“collagenase”" 2)
   ("type IV clostridial collagenase" 2) ("an interstititial collagenase" 2)
   ("0.3% bacterial collagenase" 2) ("Matrix metalloproteinase-13" 2)
   ("0.25% clostridial collagenase" 2) ("the predominant collagenase" 2)
   ("collagenase molecule" 2) ("The results further support MMP13" 1)
   ("a nonelastolytic collagenase" 1) ("collagenase (GIBCO)" 1) ("-MMP-13" 1)
   ("Bacterial collagenase" 1)
   ("the major
 collagenase"
    1)
   ("MMP 13" 1) ("crude bacterial collagenase" 1)
   ("exogenous bacterial collagenase" 1)
   ("the most abundantly-expressed collagenase" 1)))
 ("UP:P45589" (("CP12" 2))) ("UP:P45632" (("PMMs" 38) ("PMM" 30)))
 ("UP:P45709" (("CCDB" 2))) ("UP:P45844" (("ABCG1" 33) ("Abcg1" 1)))
 ("UP:P45880" (("VDAC2" 36))) ("UP:P45916" (("ORF50" 74) ("ORF50-" 1)))
 ("UP:P45951"
  (("ref" 1112) ("refs" 315) ("Ref" 266) ("REFS" 6)
   ("the bicinchoninic acid method– ref" 1) ("Ref-" 1)
   ("the open source statistical package R version 3.0.1 ref" 1) ("−ref" 1)))
 ("UP:P45954" (("ACADSB" 1) ("short/branched chain" 1)))
 ("UP:P45973"
  (("HP1α" 74) ("heterochromatin protein 1" 54) ("Drosophila)" 16) ("CBX5" 4)
   ("Heterochromatin Protein 1" 4) ("Heterochromatin protein 1" 4)
   ("HP1-alpha" 3) ("respective binding proteins heterochromatin protein 1" 2)
   ("chromatin-associated HP1α" 2) ("drosophila)" 1) ("Cbx5" 1)))
 ("UP:P45974"
  (("USP5" 25) ("isopeptidase" 20) ("IsoT" 17) ("isopeptidase T" 7) ("isoT" 5)
   ("Isopeptidase T" 1)))
 ("UP:P45975" (("histone H3K9 methyltransferase" 3)))
 ("UP:P45983"
  (("JNK1" 1071) ("JNK-1" 118) ("MAPK8" 34) ("Jnk1" 23) ("p-JNK1" 9)
   ("P-JNK1" 9) ("jnk1" 8) ("JNK1-" 2) ("–JNK1" 2)
   ("mitogen-activated protein kinase 8" 2) ("than JNK1 ( xref )" 1)
   ("P45983" 1) ("JNK1 protein" 1) ("SAPK1" 1)
   ("The stress-activated kinase JNK1" 1) ("pJNK1" 1) ("SAPK1c" 1)
   ("Jnk1 peptide" 1) ("than JNK1" 1)))
 ("UP:P45984"
  (("JNK" 7672) ("JNK2" 726) ("phospho-JNK" 171) ("JNK-2" 34) ("JNK-" 26)
   ("jnk2" 20) ("MAPK9" 19) ("JNk-2" 14) ("-JNK" 9) ("JNK2 protein" 9)
   ("P-JNK2" 9) ("FL" 9) ("fl" 8) ("exogenous JNK" 3) ("Jnk2" 3) ("-JNK2" 2)
   ("−JNK" 2) ("Stress-activated protein kinase JNK2" 2)
   ("overexpressed JNK2" 2) ("JNK protein" 2) ("“JNK”" 1) ("JNK2-" 1)
   ("JNK–" 1) ("stress-activated JNK" 1) ("than JNK2" 1) ("p-JNK2" 1)
   ("–JNK" 1) ("either overexpressed or endogenous components confirmed JNK" 1)
   ("a non-degradable JNK" 1) ("the stress-activated kinase JNK" 1)
   ("MAPK 9" 1) ("pJNK2" 1) ("JNK (FL)" 1) ("Co-precipitated JNK2" 1)
   ("than JNK [ xref ]" 1)))
 ("UP:P45985"
  (("MKK4" 265) ("kinase-1" 227) ("SEK1" 93) ("MAP2K4" 35)
   ("mitogen-activated protein kinase kinase 4" 20) ("MEK4" 16) ("MKK-4" 15)
   ("3-phosphoinositide-dependent kinase-1" 5) ("p-MKK4" 4) ("MKK4-" 4)
   ("JNKK1" 3) ("JNKK" 3) ("Rho-associated kinase-1" 3) ("-SEK1" 3)
   ("overexpressed MKK4" 2) ("MAP kinase kinase-4" 2) ("Sek1" 2)
   ("Mitogen-activated protein kinase kinase 4" 1)
   ("glucose deprivation–activated SEK1" 1) ("amino acids of MKK4" 1)))
 ("UP:P46013"
  (("Ki67" 3457) ("MKI67" 80) ("ki67" 56) ("KI67" 32) ("Ki67-" 7) ("mKi67" 7)
   ("Mki67" 5) ("Ki67 protein" 3) ("more prominent Ki67" 2)
   ("monoclonal Ki67" 2) ("ki67 protein" 2) ("the international Ki67" 2)
   ("the International Ki67" 2) ("-Ki67" 2) ("virtually absent Ki67" 2)
   ("significantly less Ki67" 2) ("less Ki67" 2)
   ("the ubiquitous proliferation marker Ki67" 2) ("homogeneous Ki67" 2)
   ("high percent Ki67" 1) ("Residual Ki67" 1) ("Percent residual Ki67" 1)
   ("than Ki67" 1) ("robust Ki67" 1) ("MKi67" 1) ("the geometric Ki67" 1)
   ("Antigen KI-67" 1) ("subtle Ki67" 1)))
 ("UP:P46019" (("PHK" 19) ("PhK" 5) ("PHKA2" 2) ("phK" 2) ("PYK" 1) ("Pyk" 1)))
 ("UP:P46020"
  (("phosphorylase kinase" 19) ("PHKA1" 3)
   ("phosphorylase
kinase"
    1)))
 ("UP:P46060"
  (("SD" 3824) ("RanGAP1" 272) ("Sd" 25) ("S D" 12) ("RANGAP1" 9) ("sd" 8)
   ("pSD" 4) ("Sd protein" 3) ("average percent +/- SD" 1)
   ("than the experimental SD" 1) ("the experimental SD" 1) ("RanGap1" 1)
   ("than −2 SD" 1) ("new SD" 1) ("than 0.36 SD" 1) ("than 0.2 SD" 1)
   ("Ran GTPase-activating protein 1" 1) ("B -factors at least one SD" 1)
   ("than 3 SD" 1)))
 ("UP:P46063" (("RECQ1" 25) ("RecQ1" 16) ("RECQL" 14) ("RecQL" 5)))
 ("UP:P46084" (("HA1" 108) ("targeting vector HA1" 2)))
 ("UP:P46087"
  (("NOL1" 10) ("120kDa" 2) ("the nucleolar marker NOL1" 1)
   ("approximately 120KDa" 1) ("120KDa" 1)))
 ("UP:P46089" (("Gpr3" 2)))
 ("UP:P46091" (("GPR1" 15) ("GPR-1" 13) ("gpr1" 1) ("Gpr1" 1)))
 ("UP:P46092" (("GPR-2" 4))) ("UP:P46093" (("GPR4" 8) ("GPR4-" 3)))
 ("UP:P46098" (("5-HT" 259) ("5-HT-" 2) ("5-HT3A" 2) ("HTR3A" 1)))
 ("UP:P46100"
  (("ATRX" 438) ("RAD54" 181) ("ATRX protein" 14) ("RAD54 protein" 10)
   ("hRad54" 3) ("hRAD54" 2) ("the last 50 amino acids of ATRX" 1)
   ("HsRAD54" 1)))
 ("UP:P46108"
  (("Crk" 407) ("CRK" 307) ("CRK-II" 145) ("CrkII" 142) ("crk" 83)
   ("Crk-II" 17) ("p-Crk-II" 16) ("CrkII protein" 3) ("Crk protein" 3)
   ("than Crk" 1) ("phosphodeficient CRK-II" 1)))
 ("UP:P46109"
  (("CRKL" 449) ("CrkL" 319) ("pCRKL" 24) ("Crk-L" 13) ("Crkl" 5) ("p-CRKL" 5)
   ("CrkL-" 5) ("exogenous CRKL" 4) ("CRKL protein" 2) ("P-CRKL" 2)
   ("Abnova" 2) ("overexpressed CRKL" 2) ("an exogenous recombinant CRKL" 2)
   ("exogenous wild-type CRKL" 2) ("p-CrkL" 1) ("CrKL" 1) ("CrkL peptide" 1)
   ("internal control Crk-L" 1) ("mouse monoclonal CrkL (ABNOVA)" 1)
   ("recombinant exogenous CRKL" 1)))
 ("UP:P46150" (("DMoesin" 6))) ("UP:P46195" (("GUK" 4) ("GuK" 1)))
 ("UP:P46320" (("CELF" 31))) ("UP:P46321" (("LICR" 6)))
 ("UP:P46369" (("THCA" 9)))
 ("UP:P46379"
  (("G-3" 1339) ("Bat3" 247) ("Bag6" 86) ("BAT3" 65) ("g-3" 49) ("BAG6" 39)
   ("HLA-B-associated transcript 3" 5) ("Bat3KD1-" 2) ("Bat3-" 2)
   ("overexpressed Bag6" 2) ("C(A/T)(T/A)G-3" 1) ("G–3" 1) ("than Bag6" 1)))
 ("UP:P46415" (("GFD" 54) ("solely 15 kDa GFD" 1)))
 ("UP:P46439" (("GSTM5" 24) ("Gstm5" 1)))
 ("UP:P46459" (("NSF" 43) ("NSFs" 19))) ("UP:P46461" (("NSF1" 2)))
 ("UP:P46527"
  (("p27" 8700) ("p27 Kip1" 2030) ("p27 kip1" 1003) ("p27 KIP1" 547)
   ("CDKN1B" 443) ("p27Kip1" 387) ("Kip1" 313) ("p27 protein" 150) ("p-p27" 83)
   ("p27kip1" 67) ("p27KIP1" 57) ("P27" 51)
   ("cyclin-dependent kinase inhibitor p27" 50) ("kip1" 42)
   ("p27 kip1 protein" 36) ("p27 Kip1 protein" 31) ("Cdkn1b" 20)
   ("p27  Kip1" 19) ("-p27" 14) ("p27 Kip1 peptide" 14) ("P27 kip1" 12)
   ("p27Kip1 protein" 10) ("cyclin dependent kinase inhibitor p27" 10)
   ("p27KIP" 10) ("cyclin-dependent kinase inhibitor 1B" 9)
   ("p27 KIP1 protein" 9) ("p-p27 kip1" 8) ("intact p27" 7) ("P-p27 Kip1" 7)
   ("overexpressed p27" 7) ("Kip1 protein" 7) ("P27kip1" 6)
   ("total cellular p27 kip1" 4) ("p27-" 4) ("P27 Kip1" 4) ("p27−" 3)
   ("P27Kip1" 3) ("P-p27" 3) ("-p27 KIP1" 3)
   ("overexpressed HA-tagged human p27 protein" 2) ("kip-1" 2) ("Cdkn1B" 2)
   ("p27 Kip1 (T-p27 Kip1 ) protein" 2) ("more p27 protein" 2)
   ("cellular p27" 2) ("the postmitotic marker p27 Kip1" 2) ("than p27" 2)
   ("a new cell-permeable Pim-1 inhibitory p27 Kip1 peptide" 2)
   ("PIRH2 instead targets nuclear and cytoplasmic p27" 2)
   ("We first simply overexpressed p27" 2) ("These post-translational p27" 2)
   ("NEDD4 increased cytoplasmic p27" 2) ("almost no detectable p27" 2)
   ("robust nuclear p27" 2) ("Skp2 increased nuclear and cytoplasmic p27" 2)
   ("p27 molecule" 2) ("transiently expressed exogenous p27" 2)
   ("the Fbxl12-expressing cells p27" 1) ("CDKN1b" 1) ("unstable p27" 1)
   ("“Skp2-p27”" 1) ("transiently overexpressed HA-tagged human p27 protein" 1)
   ("significantly more p27 kip1" 1)
   ("p210 Bcr-Abl WT transfected cells showed similar p27 kip1" 1)
   ("less (5- to 10-fold) p27" 1) ("its possible downstream target p27 kip1" 1)
   ("radical cystectomy demonstrated more p27" 1)
   ("than endogenous mouse
p27"
    1)
   ("basal p27 Kip1" 1) ("most prognostic studies scored p27" 1)
   ("AKT1 not only mislocalizes p27" 1) ("the exogenous p27" 1)
   ("than p27 KIP1" 1) ("1,25D-treated myeloid leukemia cells p27 Kip1" 1)
   ("whose tumors expressed p27" 1)
   ("the BRCA1-associated cell-cycle inhibitor p27" 1)
   ("so small high grade p27" 1)
   ("10 carboxyl-terminal amino acids of the human p27 Kip1 peptide containing the Thr 198 residue (T198wt)"
    1)
   ("The one-dimensional sequence around p27 Kip1" 1) ("K IP1" 1)
   ("endongenous p27" 1) ("bacterial expression p27" 1)
   ("than wild type p27 (Figure xref , compare lanes 1 and 3)" 1)
   ("the resultant mutant p27 protein" 1) ("much more p27 Kip1" 1)
   ("more p27 Kip1" 1) ("relatively little endogenous p27 Kip1" 1)
   ("most p27" 1) ("the ER decreased p27" 1) ("-p27 Kip1" 1) ("–p27" 1)))
 ("UP:P46531"
  (("Notch1" 1735) ("NOTCH1" 994) ("NICD" 594) ("Notch-1" 359) ("Notch 1" 78)
   ("NEXT" 52) ("Notch1 protein" 22) ("ICN" 12) ("notch1" 5) ("Notch1-" 5)
   ("notch 1" 4) ("NOTCH 1" 4) ("NICD protein" 4) ("pNICD" 3)
   ("Notch 1 protein" 3) ("Notch-1 intracellular domain (NICD)" 3)
   ("Notch-1 intracellular domain" 3) ("Notch1 (ICN)" 3) ("the NICD3" 3)
   ("NICD peptide" 3) ("overexpressed Notch1" 3) ("than NOTCH1" 2)
   ("minimal Notch 1" 2)
   ("Notch1 (intracellular domain [ICD] of Notch [NICD]) protein" 2)
   ("NOTCH1 protein" 2) ("phospho-tyrosine-associated Notch-1" 2)
   ("detected phospho-tyrosine-associated Notch-1" 2) ("Notch1 peptide" 2)
   ("NOTCH1-" 1) ("Notch-1 protein" 1) ("Notch1 (NICD)" 1) ("NOTCH-1" 1)
   ("N3-NEXT protein" 1) ("less Notch 1 protein" 1) ("most NOTCH1" 1)
   ("TAN1" 1) ("the endothelial-associated Notch1" 1)
   ("the closely-related Notch1" 1)))
 ("UP:P46607" (("GL2" 99) ("pGL2" 6) ("-GL2" 4)))
 ("UP:P46640" (("ATk1" 2) ("ATK1 (AKTKD)" 1) ("ATK1" 1)))
 ("UP:P46663" (("B1R" 6) ("bradykinin receptor B1" 3) ("BDKRB1" 2)))
 ("UP:P46695"
  (("IER3" 199) ("IER3 protein" 12) ("IEX-1" 9) ("Ier3" 3) ("IEX1" 1)
   ("IEX-1L" 1) ("functional IER3" 1)))
 ("UP:P46721" (("solute carrier organic anion transporter family" 2)))
 ("UP:P46734"
  (("MKK3" 396) ("MAP2K3" 13) ("MEK3" 5)
   ("mitogen-activated protein kinase kinase 3" 4)
   ("serial intercrossing MKK3 −/−" 2) ("MKK3-" 1)))
 ("UP:P46736" (("Brcc36" 2)))
 ("UP:P46776" (("L27A" 13) ("RPL27a" 3) ("L27a" 1)))
 ("UP:P46777"
  (("RPL5" 234) ("RpL5" 8) ("RPL5-" 6) ("ribosomal protein L5" 4)
   ("exogenous RPL5" 1) ("Rpl5" 1)))
 ("UP:P46778" (("L21" 7) ("RPL21" 6)))
 ("UP:P46779" (("L28" 7) ("rpL28" 4) ("ribosomal protein L28" 4)))
 ("UP:P46781"
  (("RPS9" 118) ("ribosomal protein S9" 4) ("rps9" 2) ("nucleolar RPS9" 2)
   ("Nucleolar RPS9" 2) ("40S ribosomal protein S9" 1)))
 ("UP:P46782" (("RPS5" 1))) ("UP:P46783" (("RPS10" 3)))
 ("UP:P46821"
  (("MAP1B" 49) ("MAP1b" 7) ("microtubule-associated protein-1B" 4) ("Map1b" 3)
   ("Microtubule-associated protein 1B" 1) ("MAP-1B" 1)))
 ("UP:P46828" (("CCPA" 5))) ("UP:P46841" (("MMPIs" 1)))
 ("UP:P46867" (("Klp5" 1))) ("UP:P46875" (("kinesin-3" 2)))
 ("UP:P46888" (("USPC" 8))) ("UP:P46903" (("NatA" 9)))
 ("UP:P46904" (("NatB" 4)))
 ("UP:P46917" (("GGAA" 75) ("-GGAA" 3) ("more GGAA" 1)))
 ("UP:P46934"
  (("NEDD4" 374) ("Nedd4" 314) ("NEDD4-1" 309) ("Nedd4-1" 96) ("-NEDD4-1" 12)
   ("developmentally down-regulated 4" 9)
   ("neural precursor cell expressed developmentally down-regulated protein 4"
    9)
   ("Nedd4 protein" 6) ("NEDD-4-1" 6) ("NEDD4 protein" 5)
   ("the exogenous NEDD4-1" 2) ("exogenous NEDD4-1" 2)
   ("a non-degradable NEDD4" 2) ("NEDD4-1 protein" 1) ("NEDD4–1" 1)
   ("the fresh resin-bound ubiquitinated Nedd4" 1)
   ("the resin-bound ubiquitinated Nedd4" 1) ("resin-bound Nedd4" 1)))
 ("UP:P46937"
  (("YAP" 8853) ("YAP1" 3065) ("Yap" 1433) ("Yap1" 358) ("YAP2" 312)
   ("YAP65" 234) ("YAP protein" 142) ("pYAP" 57) ("Yap2" 51)
   ("YAP1 protein" 47) ("Yes-associated protein 1" 46) ("p-YAP1" 39)
   ("pYap" 25) ("Yap protein" 23) ("p-YAP" 20) ("YAP-1" 18) ("yap1" 12)
   ("yes-associated protein 1" 9) ("YAP-" 8)
   ("the transcriptional co-activator YAP" 8) ("YAP65 protein" 7)
   ("Yes-Associated Protein 1" 7) ("targeting YAP" 7) ("junctional YAP" 7)
   ("transcriptional coactivator Yap1" 7) ("YAP65 peptide" 6)
   ("strong nuclear YAP" 6) ("Yes-associated protein-1" 5) ("p-Yap" 5)
   ("P46937" 5) ("Yap1 protein" 5) ("pYAP1" 4) ("differential YAP1" 4)
   ("the transcriptional co‐activator YAP1" 4)
   ("transcriptional coactivator YAP1" 4) ("strong YAP" 4)
   ("the transcriptional co-activator YAP1" 4) ("phospho-Yap protein" 4)
   ("-YAP" 3) ("overexpressed constitutively active YAP" 3)
   ("exogenous YAP1 S127A" 3) ("Yes Associated Protein 1" 3)
   ("overexpressed YAP" 2) ("the same vector-expressing YAP" 2)
   ("simultaneous nuclear and cytosolic YAP1" 2)
   ("total and phosphorylated YAP1" 2) ("Phospho-mimetic YAP" 2)
   ("more YAP protein" 2) ("total and phosphorylated YAP" 2)
   ("targeting YAP1" 2) ("than YAP" 2) ("very weak YAP" 2)
   ("further knockdown YAP1" 2) ("exogenous YAP1" 2)
   ("colonic adenocarcinoma tissues expressed strong nuclear and cytoplasmic YAP"
    2)
   ("weak cytoplasmic YAP" 2) ("nucleolar YAP" 2) ("Lentiviral YAP" 2)
   ("an even greater extent YAP-S127A" 2) ("We first created mutant YAP" 2)
   ("overexpressed Yap" 2) ("transcriptional co-activators YAP" 2)
   ("a few basal cells display predominant nuclear Yap1 protein" 2)
   ("the transcriptional co-factor Yap1" 2) ("-YAP1" 2) ("YAP2 protein" 2)
   ("phospho-Yap (inactive) protein" 2) ("strong YAP1" 2) ("Yap65" 2)
   ("P-Yap" 2) ("the transcriptional co-activator Yap" 2)
   ("yes associated protein 1" 2)
   ("the COOH-terminal 10 amino acids of YAP65 ( xref B, YAPwt)" 1)
   ("the COOH-terminal 10 amino acids of YAP65 (YAPwt)" 1)
   ("The transcriptional co-activator YAP" 1) ("than YAP1" 1) ("Yap-" 1)
   ("two previously reported Yap" 1)
   ("Both favorable and unfavorable histology specimens expressed YAP1" 1)
   ("the mitotic phosphorylation controls YAP’s" 1)
   ("the mitotic phosphorylation controls YAP" 1) ("phospho-mimetic YAP" 1)
   ("The Yes-associated protein YAP" 1)
   ("age-matched normal ovarian tissues YAP" 1) ("absent YAP1" 1)
   ("that YAP’s" 1) ("50 nmol/l duplex YAP-1" 1) ("Yap−" 1)
   ("transcriptional co-activator YAP" 1) ("simultaneous YAP" 1)
   ("Exogenous wild type YAP" 1) ("a predominant nuclear YAP" 1)
   ("same exogenous YAP1-S127A" 1) ("exogenous YAP1-S127A" 1)
   ("than YAP1 [ xref ]" 1) ("potential YAP" 1)
   ("Yes-associated protein 1 (YAP)" 1) ("ductal YAP" 1)
   ("transcriptional coactivators YAP" 1)
   ("The transcriptional co-factor YAP" 1) ("than siRNAs targeting YAP" 1)
   ("un-phosphorylated YAP" 1) ("than wild-type YAP" 1)
   ("than YAP1 ( xref , xref )" 1) ("than the cytoplasmic YAP1" 1)
   ("phospho-YAP1 (p-YAP1) protein" 1) ("Our findings further support YAP’s" 1)
   ("Our findings further support YAP" 1) ("Yes associated protein 1" 1)
   ("CHX returned Yap protein" 1) ("exogenous Yap" 1) ("flag-tagged YAP" 1)))
 ("UP:P46939" (("utrophin" 13) ("utr" 5) ("UTRN" 2)))
 ("UP:P46940"
  (("IQGAP1" 963) ("IQ motif containing GTPase activating protein 1" 6)
   ("Iqgap1" 4) ("IQGAP1 protein" 3)
   ("lentiviral shRNA set targeting mouse IQGAP1" 2)
   ("targeting mouse IQGAP1" 2) ("less IQGAP1" 2) ("IQGAP-1" 2)
   ("more IQGAP1" 1) ("avian IQGAP1" 1)
   ("Ras GTPase-activating-like protein IQGAP1" 1) ("P195" 1)))
 ("UP:P46944" (("Trs85" 1)))
 ("UP:P46952"
  (("HAD" 208) ("Haao" 3) ("3-hydroxyanthranilate-3,4-dioxygenase" 2)
   ("HAAO" 2) ("severe HAD" 2) ("HAD resembling Parkinson’s" 1)))
 ("UP:P46976" (("G/N1" 6) ("glycogenin 1" 2)))
 ("UP:P46977" (("B5" 153) ("TMC" 50) ("tmc" 1) ("STT3A" 1) ("TMC-" 1)))
 ("UP:P46979" (("ETP" 158) ("ETP-" 1))) ("UP:P47027" (("Dpb11" 6) ("DPB11" 4)))
 ("UP:P47035" (("Cfi1" 2))) ("UP:P47041" (("Bit61" 5) ("bit61" 2)))
 ("UP:P47110" (("Pol32" 19) ("POL32" 3)))
 ("UP:P47156" (("Jhd2" 8) ("Jhd2 protein" 2))) ("UP:P47170" (("SEA1" 1)))
 ("UP:P47171" (("HPC1" 14))) ("UP:P47190" (("pMT3" 3) ("pmT3" 1)))
 ("UP:P47234" (("lacY" 1))) ("UP:P47244" (("pF" 58)))
 ("UP:P47710" (("Csn1" 14) ("CASA" 5)))
 ("UP:P47712"
  (("cPLA 2" 277) ("cPLA2α" 84) ("cytosolic phospholipase A 2" 14)
   ("PLA2G4A" 14) ("cytosolic phospholipase A2" 14) ("lysophospholipase" 10)
   ("cPLA2" 8) ("p-cPLA 2" 6) ("cPLA 2 protein" 4)
   ("Cytosolic phospholipase A 2" 4)))
 ("UP:P47735" (("HAE" 5)))
 ("UP:P47736"
  (("Rap1GAP" 258) ("Rap1GAPII" 6) ("Rap1-GAP" 5) ("Rap1GAP protein" 4)
   ("RAP1GAP" 3) ("Rap1Gap" 2)))
 ("UP:P47755" (("alpha 2" 32) ("Alpha 2" 2))) ("UP:P47756" (("CAPZB" 28)))
 ("UP:P47794" (("CycE" 67) ("cycE" 4))) ("UP:P47813" (("eIF4" 8) ("EIF1AX" 7)))
 ("UP:P47835"
  (("S1B" 233) ("S1b" 26) ("s1b" 3) ("Supplemental Figure S1B" 2) ("s1B" 2)
   ("Supplemental Figure S1b" 1)))
 ("UP:P47870" (("GABRB2" 12)))
 ("UP:P47871"
  (("GCGR" 108) ("GGR" 28) ("glucagon receptor" 15) ("GCGR protein" 2)
   ("glucagon receptor (GCGR)" 2) ("defective GGR" 1)))
 ("UP:P47872" (("secretin receptor" 1))) ("UP:P47874" (("OMP" 29)))
 ("UP:P47895" (("ALDH1A3" 6) ("member A3" 2) ("aldh1a3" 1) ("ALDH6" 1)))
 ("UP:P47900" (("P2Y1" 28) ("P2RY1" 3)))
 ("UP:P47902"
  (("CDX1" 12) ("Cdx1" 5)
   ("the intestine-specific transcription factor CDX1" 2)))
 ("UP:P47914" (("RPL29" 7)))
 ("UP:P47928"
  (("Id4" 316) ("ID4" 40) ("Inhibitor of differentiation 4" 2)
   ("the BRCA 1 transcriptional suppressor ID4" 1) ("id4" 1)
   ("inhibitor of DNA binding 4" 1) ("inhibitor of differentiation 4" 1)))
 ("UP:P47929"
  (("gal-7" 123) ("galectin-7" 120) ("Galectin-7" 7) ("PIG1" 6) ("Gal-7" 6)
   ("LGALS7" 6) ("GAL7" 6)
   ("the pro-apoptotic galectin family member LGALS7" 2)
   ("MCF-7 stable transfectants expressing exogenous gal-7" 1)))
 ("UP:P47938" (("DHD" 34)))
 ("UP:P47944"
  (("MT4" 56) ("MT-4" 42) ("The HTLV-1-transformed T cell line MT4" 1)))
 ("UP:P47974"
  (("glucocorticoids" 370) ("Glucocorticoids" 48) ("palmitoyltransferase" 24)
   ("TIS11d" 3) ("ZFP36L2" 2) ("systemic glucocorticoids" 2) ("Tis11d" 2)
   ("immunomodulatory glucocorticoids" 1)
   ("ovarian adenocarcinoma cells glucocorticoids" 1)
   ("adrenal glucocorticoids" 1) ("Brf2" 1) ("given glucocorticoids" 1)))
 ("UP:P47985" (("Rieske iron-sulfur polypeptide 1" 2) ("UQCRFS1" 1)))
 ("UP:P47988" (("TEA1" 1)))
 ("UP:P47989"
  (("XO" 131) ("xanthine oxidase" 67) ("XDH" 11) ("XD" 11)
   ("xanthine
                    oxidase"
    2)
   ("XOR" 1) ("xanthine dehydrogenase" 1) ("Xanthine oxidase" 1)))
 ("UP:P47992" (("ATAC" 31) ("AT-AC" 7) ("-ATAC" 3) ("lymphotactin" 2)))
 ("UP:P48023"
  (("FasL" 2025) ("APL" 484) ("Fas ligand" 226) ("CD95L" 139) ("FASL" 72)
   ("Fas-L" 57) ("sFasL" 31) ("CD95 ligand" 20) ("FASLG" 15) ("FAS ligand" 14)
   ("Fas-ligand" 12) ("soluble Fas ligand" 11) ("APLs" 10) ("CD178" 8)
   ("Spa" 7) ("fas ligand" 5) ("soluble FasL" 5) ("FAS-ligand" 5)
   ("FasLigand" 4) ("TNFSF6" 4) ("-Fas ligand" 4) ("SpA" 3) ("spa" 3)
   ("soluble Fas-L" 3) ("fully developed APL" 3) ("FasL protein" 3)
   ("previously reported APL" 2) ("previously untreated APL" 2)
   ("the synthetic leucine zipper soluble CD95 ligand" 2)
   ("soluble recombinant human FasLigand" 2) ("Fasl" 2) ("apl" 2)
   ("exogenous FASL" 2) ("FasL-" 2) ("CD95L molecule" 2) ("pediatric APL" 2)
   ("ERα-mediated MMP3 expression increases soluble FasL" 2) ("FasL (PE)" 1)
   ("soluble CD95L" 1) ("soluble FasLigand" 1) ("Fas ligand-" 1)
   ("the characteristic APL" 1) ("CD95L-" 1)
   ("protein-protein interactions around FasL" 1)
   ("increases endothelial FasL" 1) ("microgranular variant APL" 1)
   ("oligoclonal APL" 1) ("Myc developed APL" 1)
   ("than FasL in OVCAR3 cells ( xref )" 1) ("Soluble FasL" 1) ("FAS-L" 1)))
 ("UP:P48025" (("Sykb" 13) ("stably and efficiently knockdown Sykb" 2)))
 ("UP:P48029" (("SLC6A8" 8))) ("UP:P48047" (("OSCP" 1) ("ATP5O" 1)))
 ("UP:P48048"
  (("Potassium inwardly-rectifying channel" 1) ("ROMK1" 1)
   ("potassium inwardly-rectifying channel" 1)))
 ("UP:P48050" (("HIR" 4) ("Kir2.3" 1)))
 ("UP:P48051" (("BIR1" 31) ("KCNJ6" 1) ("-BIR1" 1)))
 ("UP:P48052" (("CPA2" 5) ("extrapancreatic CPA2" 2)))
 ("UP:P48058" (("GLUR4" 1) ("GluR4" 1) ("GRIA4" 1)))
 ("UP:P48059"
  (("PINCH-1" 133) ("PINCH" 132) ("pinch" 20) ("PINCH1" 17) ("PINCH protein" 5)
   ("LIMS1" 3) ("Pinch" 3) ("PINCH-1 protein" 3) ("Lims1" 2)
   ("rectal cancer PINCH" 1)))
 ("UP:P48060"
  (("GLIPR1" 127) ("Glipr1" 39) ("GLIPR" 3)
   ("glioma pathogenesis-related protein 1" 3)))
 ("UP:P48061"
  (("CXCL12" 2337) ("SDF-1" 888) ("SDF1" 286)
   ("stromal cell-derived factor-1" 41) ("SDF-1a" 25) ("Cxcl12" 24)
   ("CXCL1/2" 23) ("CXCL12-" 21) ("stromal cell-derived factor 1" 20)
   ("derived factor-1" 13) ("SDF-1 protein" 8) ("cxcl12" 8)
   ("exogenous CXCL12" 7) ("CXCL12 protein" 6)
   ("stromal cell derived factor-1" 6) ("Sdf-1" 5)
   ("stromal derived factor-1" 5) ("chemokine 12" 5)
   ("stromal cell–derived factor 1" 3) ("Stromal cell-derived factor-1" 3)
   ("CXCL-12" 2) ("stromal cell derived factor 1" 2)
   ("stromal cell–derived factor-1" 2)
   ("the pro-cell migratory inflammatory chemokine CXCL12" 2)
   ("exogenous SDF-1" 2) ("Autocrine CXCL12" 2) ("soluble CXCL12" 2)
   ("the prototypic lymphocyte chemokine CXCL12" 2)
   ("our previous studies SDF1" 1) ("SDF1-" 1) ("more SDF-1 protein" 1)
   ("Stromal cell–derived factor 1" 1) ("local SDF1" 1) ("SDF-1–" 1)
   ("colonic carcinoma cells producing CXCL12" 1)
   ("adherent and non-adherent CXCL12" 1) ("autocrine CXCL12" 1)
   ("thymic SDF-1" 1) ("treated −/+ 10nM CXCL12" 1)
   ("the prototypic chemokine CXCL12" 1)))
 ("UP:P48065" (("SLC6A12" 5) ("BGT1" 4)))
 ("UP:P48067" (("glycine)" 39) ("Glycine)" 3)))
 ("UP:P48146"
  (("neuropeptides" 65) ("their bioactive neuropeptides" 2) ("Neuropeptides" 2)
   ("sensory neuropeptides" 1)))
 ("UP:P48147"
  (("PE" 2224) ("Prep" 198) ("prep" 164) ("PEP" 75) ("-PE" 63) ("pREP" 20)
   ("Pe" 19) ("PE-" 16) ("severe PE" 14) ("PREP" 9) ("pPEP" 8)
   ("oligopeptidase" 7) ("mild PE" 4) ("prolyl endopeptidase" 2)
   ("2100 Agilent Bioanalyser and mRNA library prep" 2)
   ("using Direct-zol RNA Mini Prep" 2) ("the fresh mouse bone marrow prep" 2)
   ("the mild and severe PE" 1) ("RNeasy mini prep" 1) ("pRep" 1)
   ("plasmid pREP10" 1) ("PE/P" 1)
   ("pSTAT5 (pTyr694)-AF488, and pSTAT6 (pY641)-PE" 1) ("our stringent Pe" 1)
   ("the GenElute Blood genomic DNA kit mini prep" 1) ("both severe PE" 1)
   ("both the severe PE" 1) ("the severe PE" 1)))
 ("UP:P48163" (("me1" 157) ("ME1" 56) ("malic enzyme 1" 6) ("Me1" 5)))
 ("UP:P48165"
  (("50kDa" 8) ("CAE" 5) ("50KDa" 1) ("protein around 50kDa" 1) ("GJA8" 1)
   ("50kDA" 1)))
 ("UP:P48169" (("GABRA4" 4)))
 ("UP:P48200"
  (("IRP2" 77) ("element binding protein" 51)
   ("element binding protein (CREB)" 17) ("IREB2" 10)
   ("iron responsive element binding protein 2" 3)
   ("Element Binding protein (CREB)" 3) ("IRP-2" 2) ("Irp2" 2)
   ("element binding protein (RREB)" 2)
   ("the sterol regulatory element binding protein" 2) ("IRP2 protein" 2)
   ("element Binding Protein (SPBP)" 2) ("Element Binding Protein" 2)
   ("the sterol regulatory element binding protein (SREBP)" 2)
   ("Element Binding protein" 1)
   ("sterol regulatory element binding protein (SREBP)" 1)
   ("element Binding Protein" 1)))
 ("UP:P48230" (("TM4SF4" 1))) ("UP:P48307" (("TFPI2" 12) ("TFPI-2" 10)))
 ("UP:P48357"
  (("leptin receptor" 73) ("Ob-R" 47) ("OB-R" 34) ("Db" 21)
   ("leptin receptors" 16) ("Leptin receptor" 5) ("OBR" 5)
   ("a functional leptin receptor" 4) ("soluble leptin receptors" 3)
   ("Leptin receptors" 3) ("soluble Leptin receptors" 2) ("Leptin Receptors" 2)
   ("Lepr db mice lack functional leptin receptors" 1) ("Ob-R protein" 1)
   ("functional leptin receptors" 1) ("global leptin receptor" 1)
   ("leptin receptor ( LEPR)" 1)))
 ("UP:P48380" (("RFX3" 2) ("Rfx3" 2)))
 ("UP:P48426"
  (("PtdIns" 906) ("PIP4K2A" 88) ("PIPKI" 22)
   ("phosphatidylinositol-4-phosphate 5-kinase" 18) ("Ptdins" 4)
   ("vesicle associated PtdIns3P" 2) ("PtdIns-" 2)
   ("than the PIP4K2A  +/−" 1)))
 ("UP:P48431"
  (("SOX2" 1417) ("Sox2" 912) ("sox2" 110) ("Sox2 protein" 23) ("Sox-2" 12)
   ("SOX-2" 3) ("SOX2 protein" 3) ("SOX 2" 3) ("sox2 protein" 3)
   ("than SOX2" 2) ("Sox 2" 2) ("SRY-box 2" 2)
   ("the neural stem cell self-renewal factors SOX2" 1) ("SOX2-" 1) ("sox2−" 1)
   ("expressed less SOX2" 1) ("stably knockdown SOX2" 1)
   ("ectopically-expressed lentiviral Sox2" 1) ("four distinct Sox2" 1)
   ("lentiviral Sox2" 1) ("Lentiviral Sox2" 1) ("exogenous SOX2" 1)))
 ("UP:P48436"
  (("SOX9" 746) ("Sox9" 404) ("SOX9 protein" 9) ("Sox-9" 5) ("Sox9-" 5)
   ("sox9" 3) ("SOX-9" 2) ("eight subregions—within 1.4 Mb around SOX9" 2)
   ("both interpretable SOX9" 2) ("exogenous SOX9" 2) ("SOX 9" 1)
   ("SRY-box 9" 1) ("distal lung factor Sox9" 1) ("sox-9" 1)))
 ("UP:P48443" (("RXRG" 6)))
 ("UP:P48444"
  (("COPD" 1634) ("severe COPD" 18) ("very severe COPD" 6)
   ("severe/very severe COPD" 3) ("mild-to-moderate COPD" 3) ("ARCN1" 2)
   ("previously diagnosed COPD" 2) ("at least moderate COPD" 2) ("COPD (CS)" 1)
   ("mild undiagnosed COPD" 1) ("ever-smoking COPD" 1)))
 ("UP:P48449"
  (("LSS" 176) ("OSC" 18) ("lanosterol synthase (LSS)" 2)
   ("lanosterol synthase" 1)))
 ("UP:P48454" (("PPP3CC" 12))) ("UP:P48505" (("CR6" 1)))
 ("UP:P48506"
  (("GCLC" 211) ("Gclc" 20) ("GCLc" 18) ("gclc" 10)
   ("gamma-glutamylcysteine synthetase" 7)
   ("glutamate-cysteine ligase catalytic subunit" 7)
   ("glutamate–cysteine ligase catalytic subunit" 3) ("GCLC protein" 3)
   ("-GCLC" 1) ("glutamate-cysteine ligase catalytic subunit ( GCLC )" 1)))
 ("UP:P48507"
  (("GCLM" 110) ("Gclm" 34) ("GCLm" 15) ("gclm" 6) ("GCLM protein" 1)
   ("glutamate-cysteine ligase modifier subunit (GCLM)" 1)
   ("glutamate-cysteine ligase modifier subunit" 1)))
 ("UP:P48509" (("CD151" 160) ("RA-PH" 83) ("CD151 protein" 2)))
 ("UP:P48516" (("DSG" 115))) ("UP:P48539" (("PEP-19" 9) ("PCP4" 2)))
 ("UP:P48544" (("CisR" 42) ("Kir3.4" 6) ("cisR" 2) ("GIRK4" 1)))
 ("UP:P48546" (("GIPR" 4) ("GIP receptor" 1))) ("UP:P48549" (("Kir3.1" 1)))
 ("UP:P48551"
  (("IFNAR2" 98) ("IFNR" 13) ("IFNAR2-" 5) ("ifnar2" 2) ("interferon (alpha" 2)
   ("IFNαR2" 1)))
 ("UP:P48552"
  (("RIP140" 124) ("NRIP1" 66) ("nuclear receptor-interacting protein 1" 10)
   ("nuclear receptor interacting protein 1" 4)
   ("receptor-interacting protein 140" 3)
   ("the transcriptional corepressor RIP140" 1)))
 ("UP:P48553"
  (("TRAPPC10" 2) ("palate associated transmembrane protein 1" 2)
   ("transmembrane protein 1" 2)))
 ("UP:P48556" (("S14" 176) ("PSMD8" 1) ("Rpn12" 1)))
 ("UP:P48590" (("fushi tarazu" 7)))
 ("UP:P48594"
  (("SCCA2" 14) ("SERPINB4" 12) ("-SCCA2" 3) ("Serpinb4" 1) ("serpinB4" 1)))
 ("UP:P48596" (("PU" 73)))
 ("UP:P48634" (("BAT2" 8) ("Bat2" 1) ("around BAT2" 1)))
 ("UP:P48637"
  (("GSS" 65) ("GSs" 44) ("glutathione synthetase" 10)
   ("glutathione synthase (GS)" 4) ("glutathione synthase" 4)
   ("glutathione synthetase (GSS)" 1) ("previously published GSs" 1)
   ("GSH synthetase" 1) ("Gss" 1)))
 ("UP:P48643" (("CCT5" 5))) ("UP:P48645" (("NMU" 12)))
 ("UP:P48651"
  (("PSSA" 34) ("PTDSS1" 4) ("PSS1" 3) ("phosphatidylserine synthase 1" 3)))
 ("UP:P48664" (("EAAT4" 1) ("SLC1A6" 1))) ("UP:P48668" (("KRT6C" 1)))
 ("UP:P48676" (("IF3" 4)))
 ("UP:P48681"
  (("NES" 1196) ("Nestin" 397) ("nestin" 209) ("NEs" 85) ("NES-" 71)
   ("NESTIN" 27) ("NES peptide" 14) ("a functional NES" 10)
   ("the neuroepithelial filament nestin" 4) ("a highly efficient NES" 3)
   ("a weak NES" 2) ("the neural stem/progenitor cell marker nestin" 2)
   ("a given NES" 2) ("a Functional NES" 2) ("the intrinsic NES" 2)
   ("a discernable NES" 2) ("an intrinsic NES" 2)
   ("the neural progenitor filament nestin" 2) ("Nestin-" 2)
   ("both neural progenitor markers Nestin" 2)
   ("neural progenitor gene Nestin" 2) ("Nestin protein" 2)
   ("The canonical NES" 2) ("the classical leucine-rich NES" 1)
   ("a classical leucine-rich NES" 1) ("several functional NES" 1)
   ("several potential NES" 1) ("a conditional NES" 1) ("the adjacent NES" 1)
   ("a potential NES" 1) ("functional NES" 1) ("biologically functional NES" 1)
   ("than NES 1" 1) ("at least two putative NES" 1)
   ("We first fractionated NEs" 1) ("highly positive NES" 1)
   ("nonspecific Nestin" 1) ("its functional NES" 1) ("typical NES" 1)
   ("a defective NES" 1) ("both intrinsic NES" 1) ("a genuine NES" 1)
   ("the neuronal marker nestin" 1)
   ("Neural precursor and stem cell marker NES" 1) ("an intact NES" 1)
   ("crude NEs" 1) ("Crm1-recognizeable NES" 1) ("An intrinsic NES" 1)
   ("nes" 1) ("the cytoskeletric protein nestin" 1) ("NES (LPPLERLTLDS)" 1)
   ("a suboptimal NES" 1) ("An experimental NES" 1) ("234 experimental NES" 1)
   ("the experimental NES" 1) ("experimental NES" 1) ("an experimental NES" 1)
   ("experiments identified both a functional leucine-rich NES" 1)
   ("the highly efficient NES" 1) ("the more prominent NES" 1)
   ("a classical Crm1-dependent NES" 1)))
 ("UP:P48723" (("60kDa" 4) ("STCH" 3) ("60KD" 2) ("60kD" 2) ("HSPA13" 1)))
 ("UP:P48728" (("AMT" 81)))
 ("UP:P48729"
  (("CK1α" 513) ("CKIα" 47) ("CSNK1A1" 42) ("Csnk1a1" 9) ("CK-Iα" 3)
   ("CK1α peptide" 3) ("CK1-alpha" 2) ("CSNK1a1" 1) ("CK1α protein" 1)))
 ("UP:P48730" (("CSNK1D" 17) ("Csnk1d" 16) ("CKiD" 13) ("CK1delta" 1)))
 ("UP:P48735" (("IDH2" 322) ("Idh2" 5) ("IDH2-" 2)))
 ("UP:P48736"
  (("p110γ" 964) ("PI3Kγ" 673) ("PIK3CG" 53) ("PI3-Kγ" 5)
   ("heterodimeric PI3Kγ" 4) ("monomeric p110γ" 3) ("p110γ protein" 3)
   ("heterodimeric and monomeric PI3Kγ" 2)
   ("fluorescent heterodimeric PI3Kγ" 2)
   ("This compound selectively targets p110γ" 2) ("myocardial p110γ" 2)
   ("PI3Kgamma" 2) ("fluorescent PI3Kγ" 1) ("catalytic subunit gamma" 1)
   ("P48736" 1) ("p110 gamma" 1) ("no functional PI3Kγ" 1)
   ("endothelial p110γ" 1) ("cardiac p110γ" 1)
   ("Cardiac phosphoinositide 3-kinase p110γ" 1) ("a functional PI3Kγ" 1)
   ("25 fold more p110γ" 1) ("243-fold more p110γ" 1)
   ("at least 73-fold more p110γ" 1) ("mainly target p110γ" 1)
   ("PI3Kγ protein" 1)))
 ("UP:P48739" (("PITPNB" 6))) ("UP:P48740" (("MASP1" 1)))
 ("UP:P48741" (("HSP70B" 15) ("Hsp70B" 1)))
 ("UP:P48742" (("LIM1" 39) ("Lhx1" 16) ("Lim1" 4) ("lim1" 1) ("LHX1" 1)))
 ("UP:P48745"
  (("NOV" 196) ("Nov" 25) ("CCN3" 15) ("NOV protein" 4) ("Ccn3" 3)
   ("protein NOV homolog (NOV)" 2) ("We first ectopically reexpressed NOV" 2)
   ("protein NOV homolog" 1)))
 ("UP:P48751" (("AE3" 48)))
 ("UP:P48775" (("TDO" 6) ("TPH2" 4) ("tryptophan 2,3-dioxygenase" 1)))
 ("UP:P48784" (("hFOB" 40)))
 ("UP:P48788"
  (("type 2B" 13) ("FAST)" 5) ("fast)" 4) ("Fast)" 2) ("troponin I-" 2)
   ("troponin I" 2)))
 ("UP:P48960" (("seven-transmembrane" 33) ("CD97" 15)))
 ("UP:P48987" (("ATO" 466) ("than ATO" 1)))
 ("UP:P48995" (("TRPC1" 37) ("TRPC 1" 8) ("TRPC1 protein" 2) ("TRPC1-" 1)))
 ("UP:P49005" (("POLD2" 4)))
 ("UP:P49006"
  (("MLP" 81) ("-MLP" 4) ("pMLP" 4)
   ("puromycin-selectable shRNA vector MLP" 1)))
 ("UP:P49019" (("HCA 3" 14) ("GPR109B" 3) ("HM74" 1)))
 ("UP:P49023"
  (("paxillin" 2104) ("Paxillin" 210) ("PXN" 39) ("p-Paxillin" 5)
   ("pPaxillin" 5) ("-paxillin" 4) ("p-paxillin" 4) ("paxillin-" 4)
   ("P-paxillin" 2) ("punctate peripheral paxillin" 2)
   ("red fluoresecent protein (RFP)-paxillin" 2) ("intact  paxillin" 1)
   ("ppaxillin" 1) ("-Paxillin" 1) ("more paxillin" 1)
   ("the focal contact-associated protein paxillin" 1) ("paxillin (PXN)" 1)
   ("prominent paxillin" 1) ("very small paxillin" 1)))
 ("UP:P49054" (("EMM" 13))) ("UP:P49107" (("pSIN" 20) ("pSin" 12)))
 ("UP:P49116" (("TR4" 22) ("NR2C2" 5) ("testicular receptor 4" 2)))
 ("UP:P49137"
  (("MK2" 801) ("MAPKAPK2" 102) ("MAPK-activated protein kinase 2" 24)
   ("MAPK-activated protein kinase-2" 17) ("MAPKAP kinase 2" 13)
   ("MAPKAP-K2" 10) ("MAPKAPK-2" 7) ("MAP kinase-activated protein kinase 2" 6)
   ("MAPKAP kinase-2" 6) ("-MK2" 4) ("dominant-negative MK2" 4) ("p-MK2" 3)
   ("MAPKAP Kinase 2" 3) ("Mapkapk2" 3) ("MK2 protein" 3) ("MAPKAP K2" 2)
   ("MapkapK2" 2) ("pMAPKAPK2" 2) ("MK2-" 2) ("the adenoviral wild-type MK2" 2)
   ("Mk2" 2)
   ("than MK2 immunoprecipitated from arsenite-treated cells [ xref ]" 1)
   ("MAPKAPk2" 1) ("pMK2" 1)))
 ("UP:P49146" (("NPY2R" 1)))
 ("UP:P49177" (("transducin" 47) ("Transducin" 3) ("-transducin" 3)))
 ("UP:P49189" (("ALDH9A1" 4)))
 ("UP:P49207" (("L34" 4) ("RPL34" 3) ("RpL34" 1)))
 ("UP:P49221" (("TGM4" 8) ("TGP" 2)))
 ("UP:P49238"
  (("CX3CR1" 98) ("Cx3cr1" 14) ("fractalkine receptor" 3) ("V28" 1)))
 ("UP:P49257"
  (("ERGIC53" 18) ("ERGIC-53" 14) ("LMAN1" 2) ("gp58" 1)
   ("mannose-binding" 1)))
 ("UP:P49277" (("Dp5" 1))) ("UP:P49278" (("DPX" 53)))
 ("UP:P49279"
  (("SLC11A1" 6) ("NRAMP1" 2)
   ("natural resistance-associated macrophage protein 1" 1) ("Slc11a1" 1)))
 ("UP:P49281" (("divalent metal transporter 1" 7))) ("UP:P49283" (("MVL" 6)))
 ("UP:P49286"
  (("MTNR1B" 63) ("melatonin receptor 1B" 5) ("Melatonin receptor 1B" 3)))
 ("UP:P49312" (("TIS" 16) ("-TIS" 6)))
 ("UP:P49321"
  (("NASP" 30) ("termed ‘testicular’ NASP" 2)
   ("nuclear autoantigenic sperm protein (NASP)" 1)
   ("nuclear autoantigenic sperm protein" 1)))
 ("UP:P49326" (("FMO5" 2)))
 ("UP:P49327"
  (("FASN" 475) ("fatty acid synthase" 107) ("Fasn" 15)
   ("Fatty acid synthase" 10) ("fatty acid synthase (FAS)" 6)
   ("fatty acid synthase (FASN)" 5) ("FASN protein" 2) ("fasn" 1)
   ("fatty-acid synthase" 1) ("plasma membrane-associated FASN" 1)
   ("fatty acid synthase ( FASN )" 1)))
 ("UP:P49330" (("RGG" 41))) ("UP:P49331" (("GTFs" 10)))
 ("UP:P49336"
  (("CDK8" 103) ("Cdk8" 4) ("cdk8" 3) ("cyclin-dependent kinase-8" 3)
   ("cyclin-dependent kinase 8" 1)))
 ("UP:P49347" (("conB" 4))) ("UP:P49354" (("FNTA" 1)))
 ("UP:P49366"
  (("DS" 572) ("DHS" 256) ("ds" 92) ("Ds" 36) ("dS" 23)
   ("deoxyhypusine synthase" 2) ("pDS" 1)
   ("the electroporation protocol DS112" 1) ("the program DS112" 1)
   ("FLT3-ITD-specific DHS" 1) ("a weak DHS" 1) ("Ds-" 1)))
 ("UP:P49368" (("CCT3" 45) ("CCTG" 11) ("Tric" 6) ("“CCTG”" 2)))
 ("UP:P49406" (("MRPL19" 36)))
 ("UP:P49407"
  (("β-arrestin-1" 181) ("ARRB1" 24) ("β-arrestin1" 18) ("ARR" 12)
   ("overexpressed beta-arrestin" 2) ("beta-arrestin" 2) ("arr1" 2) ("ARR1" 2)
   ("specifically target β-arrestin-1" 1)))
 ("UP:P49411" (("EFTu" 1)))
 ("UP:P49418"
  (("amphiphysin" 26) ("Amphiphysin" 9) ("Amph" 9) ("amphiphysin peptide" 4)
   ("-ampH" 1) ("ampH" 1) ("P49418" 1)))
 ("UP:P49419" (("EPD" 15) ("PDEs" 13) ("invasive EPD" 2) ("ALDH7A1" 1)))
 ("UP:P49427"
  (("Cdc34" 202) ("CDC34" 49) ("Ubch3" 7) ("UbcH3" 7) ("UBE2R1" 6)
   ("cell division cycle 34" 2) ("than unconjugated CDC34" 1)))
 ("UP:P49441" (("INPP1" 1)))
 ("UP:P49448"
  (("GLUD2" 3) ("Glutamate dehydrogenase 2" 2)
   ("glutamate dehydrogenase 2" 2)))
 ("UP:P49450"
  (("CENP-A" 387) ("CENPA" 55) ("CenpA" 16) ("CENP-A protein" 8)
   ("new CENP-A" 6) ("Cenp-A" 5) ("centromere protein A" 2)
   ("targeting CENPA" 2) ("Centromere protein A" 2) ("than CENP-A" 1)
   ("pCenp-A" 1)))
 ("UP:P49454"
  (("CENP-F" 67) ("CENPF" 21) ("Cenp-F" 16) ("centromere protein F" 9)
   ("weak CENP-F" 2) ("strong CENP-F" 1) ("Mitosin" 1) ("CenpF" 1)))
 ("UP:P49458" (("SRP9" 3)))
 ("UP:P49459"
  (("RAD6A" 221) ("RAD6A–" 73) ("UBE2A" 6) ("HR6A" 5) ("Rad6A" 4) ("RAD6A-" 2)
   ("RAD6A protein" 2) ("HHR6A" 2) ("Rad6a" 1) ("hHr6A" 1) ("Hr6a" 1)
   ("the catalytic cysteine of RAD6A" 1)))
 ("UP:P49585"
  (("CTA" 437) ("-CTA" 23) ("PCYT1A" 3) ("C-t" 2) ("–CTA" 1) ("‘CTA’" 1)))
 ("UP:P49588" (("AARS" 2))) ("UP:P49589" (("CARS" 28)))
 ("UP:P49593" (("PPM1F" 5) ("POPX2" 3))) ("UP:P49598" (("PP2Ca" 1)))
 ("UP:P49617" (("LAPC" 54))) ("UP:P49619" (("DGKG" 3)))
 ("UP:P49639"
  (("Hoxa1" 105) ("HOXA1" 60) ("HoxA1" 5) ("homeobox A1" 4) ("-Hoxa1" 2)
   ("at least two Hoxa1" 1)))
 ("UP:P49640" (("Evx1" 1)))
 ("UP:P49642" (("primase" 56) ("P49" 22) ("p49" 17) ("p49-" 5) ("PRIM1" 4)))
 ("UP:P49643" (("PRIM2" 13)))
 ("UP:P49662"
  (("TX" 1935) ("caspase-4" 179) ("Tx" 30) ("CASP4" 30) ("caspase 4" 10)
   ("Caspase-4" 7) ("targeting caspase-4" 3) ("caspase-11" 3)
   ("caspase-4 protein" 2) ("procaspase-4" 2) ("tx" 1) ("Caspase 4" 1)
   ("TX-" 1) ("the inflammatory caspase-4" 1) ("particular caspase-4" 1)
   ("pro-apoptotic ER stress marker CHOP and ER stress-specific caspase CASP4"
    1)))
 ("UP:P49674"
  (("casein kinase 1" 104) ("CSNK1E" 81) ("CKIε" 35) ("Casein kinase 1" 5)
   ("underexpressed genes CSNK1E" 3) ("Csnk1e" 2)
   ("casein kinase 1 epsilon" 2)))
 ("UP:P49675" (("StAR" 44) ("pStAR" 2) ("StAR protein" 1)))
 ("UP:P49682"
  (("CXCR3" 83) ("MIGR" 48) ("MigR" 19) ("MiGR" 6) ("Cxcr3" 5) ("Migr" 4)
   ("retroviral vector MigR1" 1)))
 ("UP:P49685" (("GPR15" 20))) ("UP:P49703" (("ARL4D" 2)))
 ("UP:P49711"
  (("CTCF" 1424) ("CCCTC-binding factor" 20) ("CTCF protein" 17)
   ("11-zinc finger protein" 8) ("CCCTC binding factor" 5) ("cellular CTCF" 4)
   ("CCCTC-binding factor(CTCF)" 3) ("CCCTC binding factor (CTCF)" 3)
   ("CCCTC-binding factor (CTCF)" 3) ("than CTCF" 2)
   ("transcriptional repressor CTCF" 2) ("overexpressed CTCF" 2)
   ("the multifunctional nuclear factor CTCF" 2) ("precisely CTCF" 1)
   ("the ubiquitous epigenetic regulator and insulator protein CTCF" 1)
   ("exogenous CTCF" 1) ("the multifunctional protein CTCF" 1)
   ("the transcriptional insulator protein CTCF" 1) ("complete CTCF" 1)))
 ("UP:P49715"
  (("C/EBPα" 610) ("CEBPA" 143) ("C/EBPα protein" 128)
   ("CCAAT/enhancer-binding protein alpha" 10)
   ("CCAAT/enhancer binding protein alpha" 4) ("C/EBP-alpha" 3)
   ("C/EBP alpha" 3) ("C/EBPa" 2) ("-C/EBPα" 2) ("C/EBPalpha" 2)
   ("expressing C/EBPα" 1) ("overexpressing C/EBPα" 1) ("exogenous C/EBPα" 1)))
 ("UP:P49716"
  (("CEBPD" 133) ("CCAAT/enhancer binding protein delta" 4) ("C/EBPdelta" 3)
   ("Exogenous CEBPD" 1) ("-CEBPD" 1)))
 ("UP:P49720" (("PSMB3" 11))) ("UP:P49721" (("PSMB2" 3) ("Psmb2" 2)))
 ("UP:P49736" (("MCM-2" 84) ("CCNL1" 6))) ("UP:P49739" (("XMCM3" 1)))
 ("UP:P49746" (("TSP3" 4) ("THBS3" 1)))
 ("UP:P49747"
  (("collagen-1" 42) ("COMP" 12) ("comp" 1)
   ("Cartilage oligomeric matrix protein" 1) ("Collagen-1" 1)))
 ("UP:P49748" (("VLCAD" 7))) ("UP:P49750" (("YLPM1" 2)))
 ("UP:P49753" (("ACOT2" 29))) ("UP:P49754" (("Vps41" 18) ("vps41" 1)))
 ("UP:P49755" (("TMP21" 13) ("TMED10" 11)))
 ("UP:P49757"
  (("Numb" 394) ("NUMB" 19) ("numb" 14) ("Numb-" 10) ("Numb protein" 1)
   ("The endocytic adaptor Numb" 1)
   ("the conserved endocytic adaptor protein Numb" 1)))
 ("UP:P49758" (("RGS6" 4)))
 ("UP:P49759" (("CLK" 29) ("Clk" 26) ("CLK1" 15) ("P49759" 2)))
 ("UP:P49760" (("CLK2" 10) ("Clk2" 1))) ("UP:P49761" (("CLK3" 6)))
 ("UP:P49763" (("PGF" 54))) ("UP:P49765" (("VEGFB" 18) ("VEGFb" 1)))
 ("UP:P49767"
  (("VEGF-C" 412) ("VEGFC" 31) ("VEGF-C Protein" 6)
   ("vascular endothelial growth factor C" 5)
   ("Vascular endothelial growth factor-C" 3)
   ("The lymphangiogenic factor VEGF-C" 2)
   ("the potent pro-lymphangiogenic factor VEGFC" 2)
   ("the potent pro-lymphangiogenic factor vascular endothelial growth factor C"
    2)
   ("VEGF-C protein" 1)))
 ("UP:P49768"
  (("PS1" 180) ("presenilin" 31) ("PSEN1" 19) ("presenilin 1" 15)
   ("Presenilin 1" 12) ("PS 1" 12) ("Presenilin" 6) ("Presenilin1" 5)
   ("presenilin1" 2) ("AD3" 1)))
 ("UP:P49770" (("EIF2B2" 1)))
 ("UP:P49771"
  (("Flt3" 581) ("FL" 448) ("FLT3L" 78) ("FLT3 ligand" 55) ("Flt3 ligand" 40)
   ("Flt3L" 29) ("Flt3 protein" 16) ("Flt3-L" 15) ("fl" 14) ("exogenous FL" 14)
   ("FLT3 ligand (FL)" 4) ("Exogenous FL" 4) ("flt3" 3)
   ("Flt3 ligand protein" 3) ("FMS-related tyrosine kinase 3 ligand" 3)
   ("soluble FL" 2) ("FLt3-L" 2) ("We first knocked down Flt3" 2) ("Flt3-" 2)
   ("the low-glycosylated FL" 1) ("FL protein" 1) ("extrinsic Flt3L" 1)
   ("extrinsic FL" 1) ("Flt3 ligand (FL)" 1) ("Soluble FL" 1) ("FLT3L-" 1)
   ("added exogenous FL" 1)))
 ("UP:P49773" (("HINT1" 87) ("Hint1" 79) ("HINT1 protein" 10)))
 ("UP:P49786" (("BCCP" 4))) ("UP:P49788" (("TIG1" 12) ("RARRES1" 4)))
 ("UP:P49789"
  (("FHIT" 140) ("FRA3B" 88) ("FHIT protein" 10) ("underexpressed FHIT" 10)
   ("fragile histidine triad" 4) ("fragile site FRA3B" 4)
   ("common fragile site FRA3B" 2) ("the common fragile site FRA3B" 2)
   ("Fhit" 2) ("FRA3B ( FHIT )" 1) ("fragile histidine triad protein" 1)))
 ("UP:P49790"
  (("Nup153" 65) ("nucleoporin 153" 5) ("NUP153" 4) ("nucleoporin NUP153" 3)
   ("nucleoporin Nup153" 2) ("Nucleoporin Nup153" 2)))
 ("UP:P49792"
  (("RanBP2" 309) ("Nup358" 40) ("RANBP2" 28) ("Ran Binding Protein 2" 4)
   ("RAN binding protein 2" 2) ("E3 SUMO-protein ligase RANBP2" 2) ("p270" 2)))
 ("UP:P49795" (("GAIP" 3))) ("UP:P49796" (("RGS3" 4)))
 ("UP:P49798" (("RGS4" 13)))
 ("UP:P49802" (("RGS7" 10) ("rgs-7" 4) ("RGS-7" 3)))
 ("UP:P49809" (("EGL-10" 8) ("egl-10" 2) ("Egl-10" 1)))
 ("UP:P49810"
  (("Ad5eGFP" 69) ("PSEN2" 19) ("presenilin 2" 6) ("Presenilin 2" 4)
   ("intact Ad5eGFP" 1)))
 ("UP:P49815"
  (("TSC2" 3713) ("tuberin" 756) ("Tsc2" 402) ("Tuberin" 41)
   ("tuberous sclerosis 2" 27) ("TSC2 protein" 18) ("p-TSC2" 17) ("pTSC2" 12)
   ("tuberin protein" 12) ("TSC-2" 11) ("Tuberous sclerosis 2" 8) ("TSC2-" 7)
   ("P-TSC2" 6) ("tuberin peptide" 6) ("p-Tsc2" 5) ("-TSC2" 5)
   ("Tuberous Sclerosis 2" 5) ("targeting TSC2" 4) ("tsc2" 3)
   ("overexpressed TSC2" 3) ("overexpressing TSC2" 2) ("functional TSC2" 2)
   ("TSC2 peptide" 2) ("than tuberin" 2) ("membrane-associated tuberin" 2)
   ("robust tuberin protein" 2) ("the immediately upstream regulator TSC2" 1)
   ("−TSC2" 1) ("directly phosphorylates/inactivates TSC2" 1)
   ("particular TSC2" 1) ("Homozygous Tsc2 −/−" 1) ("–TSC2" 1) ("less TSC2" 1)
   ("increases TSC2’s" 1) ("physically sequestering tuberin" 1)
   ("than wild-type tuberin" 1) ("S939/S981 affected tuberin's" 1)
   ("AKT (but not RSK) directly controls tuberin's" 1)
   ("AKT (but not RSK) directly controls tuberin" 1)
   ("AKT directed tuberin's" 1) ("cellular TSC2" 1) ("more TSC2" 1)))
 ("UP:P49821" (("NDUFV1" 3)))
 ("UP:P49840"
  (("GSK3α" 291) ("GSK3-α" 15) ("p-GSK3α" 4) ("than GSK3α" 3) ("P-GSK3α" 3)
   ("GSK3α-" 2) ("GSK-3alpha" 2) ("pGSK3-α" 2)
   ("glycogen synthase kinase 3 alpha" 2) ("than GSK3α in oral tumor tissue" 1)
   ("GSK-3a" 1)))
 ("UP:P49841"
  (("GSK3β" 6248) ("GSK-3β" 4648) ("glycogen" 451) ("GSK3B" 361)
   ("GSK-3 β" 292) ("GSK-3α" 284) ("GSK3-β" 271) ("p-GSK3β" 123)
   ("GSK3beta" 116) ("-GSK3β" 81) ("GSK-3beta" 75) ("p-GSK-3β" 64)
   ("Glycogen" 60) ("pGSK3β" 52) ("pGSK-3β" 44)
   ("glycogen synthase kinase 3 beta" 35) ("GSK3β protein" 24) ("GSK3b" 21)
   ("Glycogen synthase kinase 3 beta" 16) ("Gsk3b" 16) ("GSK-3β protein" 16)
   ("GSk-3β" 12) ("glycogen synthase kinase-3 beta" 11) ("P-GSK3β" 10)
   ("GSK3β-" 10) ("GSK3-beta" 8) ("GSK-3b" 8) ("Gsk-3β" 7) ("–GSK3β" 6)
   ("gsk3b" 4) ("exogenous GSK3β" 4) ("-glycogen synthase kinase 3 beta" 4)
   ("GSK3β (KD)" 4) ("GSK-3β-" 3) ("GSK-3β (hrGSK-3β) protein" 3)
   ("than GSK-3α" 3) ("cardiac glycogen" 3) ("GSK-3α–" 3) ("pGSK3b" 2)
   ("total and phosphorylated GSK-3β" 2) ("p-GSK3-β" 2)
   ("exogenous constitutively active GSK3β" 2) ("Acute GSK-3α" 2)
   ("exogenous GSK3-β" 2) ("an overactive GSK3β" 2)
   ("rabbit monoclonal total GSK3β" 2)
   ("constitutively active monomeric RFP (mRFP)–GSK3β" 2)
   ("the residual GSK-3β" 2) ("Non-phosphorylated GSK3-β" 2)
   ("retroviral GSK3β" 2) ("endothelial GSK-3β" 2) ("P-GSK-3β" 2)
   ("GSK3β (CA)" 2) ("GSK3β (WT)" 2) ("dominant-negative GSK3β" 2)
   ("GSK-3 β protein" 2) ("rabbit monoclonal p-GSK3β" 2)
   ("the pelletable GSK-3β" 1) ("Given GSK-3β’s" 1) ("Given GSK-3β" 1)
   ("oxidative stress-activated GSK3β" 1) ("The stress-induced GSK3β" 1)
   ("ultra-pure glycogen" 1) ("gsk-3β" 1) ("abnormal GSK3B" 1) ("GSK-3 β-" 1)
   ("preferentially target active GSK3β" 1) ("phospho-GSK-3β/total GSK-3β" 1)
   ("Non-phosphorylated GSK-3β" 1) ("p-GSK-3β protein" 1) ("than GSK3β" 1)
   ("more GSK3β" 1) ("the highly homologous GSK-3β" 1) ("exogenous GSK-3β" 1)
   ("Enogenous GSK-3β" 1) ("GSK-3β–" 1)
   ("the ubiquitous serine/threonine kinase GSK3β" 1) ("GSK–3α" 1)
   ("very little poly-ubiquitinated GSK-3β" 1) ("basal GSK-3β" 1)
   ("targeting GSK3β" 1) ("-GSK-3α" 1) ("excessive GSK3β" 1)
   ("than GSK-3α in normal PBMC and nPC" 1) ("than GSK-3α (Fig. xref )" 1)
   ("EDD impaired GSK-3β's" 1)
   ("the only common amino acids of GSK-3β(p) that interact with the peptides"
    1)
   ("GSK3-β protein" 1) ("GSK-3 beta" 1) ("Ser-9-phosphorylated GSK3β" 1)
   ("than GSK3β (WT) ( xref , lane 2 and 3)" 1)
   ("a well-characterized Akt substrate GSK3β" 1)
   ("Immunohistochemical staining revealed GSK3β" 1)
   ("namely ypT, ypN, ypM and resection category revealed GSK3B" 1)
   ("in turn inactivated GSK3β" 1) ("the dominant-negative GSK3β" 1)
   ("the pivotal cellular kinase GSK3β" 1) ("cardiac GSK-3α" 1)))
 ("UP:P49842" (("RP1" 11) ("STK19" 2) ("rp1" 1)))
 ("UP:P49848"
  (("TAF6" 91) ("80 kD" 23) ("Taf6" 16) ("approximately 80 kD" 2)
   ("negative control oligonucleotides showed strong TAF6" 2)
   ("a protein around 80 kD" 2) ("a distinct TAF6" 2) ("80 KD" 1) ("80 kD" 1)))
 ("UP:P49862" (("kallikrein 7" 6) ("Klk7" 1) ("kallikrein-7" 1)))
 ("UP:P49880"
  (("ecdysone receptor" 9) ("EcR" 3) ("pEcR" 2)
   ("the functional ecdysone receptor" 1)
   ("a functional ecdysone receptor" 1)))
 ("UP:P49888" (("STE" 27) ("SULT1E1" 6) ("estrogen sulfotransferase" 1)))
 ("UP:P49895" (("DIO1" 1)))
 ("UP:P49901"
  (("MCs" 354) ("neoplastic MCs" 38) ("MCSs" 4) ("atypical MCs" 4)
   ("mature MCs" 3) ("clonal MCs" 3) ("human cord blood-derived MCs" 2)
   ("connective tissue MCs" 2) ("Effluent-derived MCs" 2)
   ("human primary MCs" 2) ("patient derived neoplastic MCs" 2)
   ("immature MCs" 2) ("the neoplastic MCs" 2) ("the mature RasGRP4 + MCs" 2)
   ("all examined mature MCs" 2)
   ("Omental and peritoneal effluent-derived MCs" 1) ("Mouse peritoneal MCs" 1)
   ("than WT MCs" 1) ("human PD-patient-derived MCs" 1)
   ("KIT D816V negative neoplastic MCs" 1) ("the normal MCs" 1)
   ("These neoplastic MCs" 1) ("peritoneal MCs" 1)))
 ("UP:P49902" (("NT5C2" 6))) ("UP:P49903" (("SPs" 7) ("SEPHS1" 2) ("SpS" 2)))
 ("UP:P49908"
  (("Wang" 742) ("WANG" 42) ("SEP" 13) ("selenoprotein P" 3) ("SEPP1" 2)
   ("Shaomeng Wang's" 1) ("‘Wang’" 1) ("JD Wang's" 1)))
 ("UP:P49913"
  (("LL-37" 113) ("hCAP-18" 14) ("hCAP18" 11) ("LL-37 peptide" 10) ("c-AMP" 8)
   ("than LL-37" 1)))
 ("UP:P49914"
  (("MTHFS" 9) ("methenyltetrahydrofolate synthetase" 1)
   ("5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)"
    1)))
 ("UP:P49915"
  (("GMPs" 58) ("GMPS" 27) ("normal GMPs" 2) ("glutamine amidotransferase" 2)))
 ("UP:P49916"
  (("LIG3" 153) ("DNA ligase III" 78) ("DNA Ligase III" 17) ("Lig3" 14)
   ("Lig III" 11) ("DNA ligase 3" 4) ("tightly bound DNA ligase III" 2)
   ("than DNA Ligase III (Additional file xref )" 1)
   ("their respective interaction partners DNA Ligase III" 1)))
 ("UP:P49917"
  (("ATP-dependent" 373) ("DNA repair enzyme" 185) ("LIG4" 89)
   ("DNA ligase IV" 44) ("Lig4" 38) ("ATP dependent" 21) ("DNA Ligase IV" 16)
   ("ligase IV" 13) ("Ligase IV" 8) ("DNA ligase 4" 4)
   ("a suicide cellular DNA repair enzyme" 2)
   ("an ubiquitous DNA repair enzyme" 2) ("the primary DNA repair enzyme" 1)
   ("a ubiquitous DNA repair enzyme" 1) ("bifunctional ATP-dependent" 1)
   ("diverse ATP-dependent" 1)))
 ("UP:P49918"
  (("KIP2" 228) ("CDKN1C" 138) ("Kip2" 76) ("kip2" 17) ("p57Kip2" 7)
   ("KIP2 protein" 6) ("p57KIP2" 5) ("CDKN1C protein" 3) ("Cdkn1c" 2)
   ("namely p27 Kip1 and p57 Kip2" 2)
   ("heterozygous or homozygous null mutations inp57 Kip2" 1)
   ("than p27 KIP1 and p57 KIP2" 1) ("cdkn1c" 1) ("P49918" 1)
   ("flag-tagged CDKN1C" 1) ("P57KIP2" 1)))
 ("UP:P49933" (("pg4" 5) ("pg 4" 1)))
 ("UP:P49934" (("pG5" 32) ("pg5" 19) ("PG5" 4)))
 ("UP:P49959"
  (("Mre11" 701) ("MRE11" 601) ("mre11" 144) ("MRE11A" 39) ("MRE11 protein" 14)
   ("hMre11" 11) ("hMRE11" 7) ("Mre11-" 6) ("Mre11 protein" 6)
   ("meiotic recombination 11 homolog A" 3) ("-MRE11" 2) ("Mre11a" 1)
   ("the characteristic Mre11" 1) ("functional Mre11" 1)
   ("the final 13 amino acids of Mre11" 1)
   ("the final 76 amino acids of Mre11" 1)
   ("than full length Mre11 ( xref )" 1)
   ("the C-terminal 76 amino acids of Mre11 (Mre11 c76aa )" 1)
   ("approximately matches Mre11" 1)))
 ("UP:P49961" (("CD39" 5)))
 ("UP:P50052"
  (("AT2" 42) ("type 2 receptor" 30) ("type 2 receptor (PILR)" 3)
   ("polygonal AT2" 3) ("Type 2 receptor" 1) ("AGTR2" 1)))
 ("UP:P50053" (("KHK" 2))) ("UP:P50108" (("MNN10" 1)))
 ("UP:P50135" (("HMT" 86) ("HMTs" 53) ("respective HMTs" 1)))
 ("UP:P50148"
  (("GNAQ" 159) ("GaQ" 54) ("Gαq" 52)
   ("guanine nucleotide–binding protein alpha-q" 3) ("Gαq/11" 3)
   ("guanine nucleotide–binding protein alpha-q (GNAQ)" 2) ("GNAQ protein" 2)
   ("the somatic GNAQ" 1) ("Gαq protein" 1)))
 ("UP:P50213" (("IDH3A" 4))) ("UP:P50219" (("HLXB9" 3)))
 ("UP:P50221" (("MEOX1" 146) ("mesenchyme homeobox 1" 1) ("Meox1" 1)))
 ("UP:P50222"
  (("MEOX2" 204) ("Meox2" 12) ("Gax" 3) ("Mesenchyme homeobox 2" 2)
   ("mesenchyme homeobox 2" 1) ("than MEOX2 ( xref )" 1)))
 ("UP:P50225"
  (("SULT1A1" 60) ("1A1" 60) ("S/TP" 12) ("1a1" 2) ("pS/TP" 2)
   ("Sulfotransferase 1A1" 1) ("p-S/TP" 1)))
 ("UP:P50226" (("1A2" 15) ("SULT1A2" 1)))
 ("UP:P50281"
  (("MT1-MMP" 1319) ("MMP14" 173) ("MMP-14" 92) ("MT1-MMP protein" 35)
   ("MMP14 protein" 15) ("exogenous MT1-MMP" 4) ("Mmp14" 3) ("MT1MMP" 3)
   ("overexpressed MT1-MMP" 3) ("MT1-MMP molecule" 3) ("mmp14" 2)
   ("membrane-type-1 matrix metalloproteinase" 2) ("active cellular MT1-MMP" 2)
   ("membrane-type matrix metalloproteinase 1" 2)
   ("Membrane-type matrix metalloproteinase 1" 2)
   ("Granulocyte colony-stimulating factor increased MT1-MMP protein" 1)
   ("-MT1-MMP" 1) ("possible MT1-MMP" 1) ("Given MT1-MMP's" 1)
   ("Given MT1-MMP" 1) ("either directly target MT1-MMP" 1)
   ("strong epithelial MT1-MMP" 1) ("neuronal MMP-14" 1)
   ("the essential collagenase MT1-MMP" 1)))
 ("UP:P50301" (("Sam1" 2))) ("UP:P50302" (("SAM2" 2)))
 ("UP:P50336" (("Ppo" 109) ("-Ppo" 2))) ("UP:P50395" (("GDI2" 3)))
 ("UP:P50402"
  (("EMD" 1068) ("emerin" 68) ("STA" 59) ("EDMD" 9) ("Emerin" 2) ("-EMD" 1)))
 ("UP:P50406" (("5-HT 6" 113)))
 ("UP:P50416" (("CPT1a" 8) ("CPT1A" 6) ("Cpt1a" 5) ("CPT-I" 1)))
 ("UP:P50440" (("AGAT" 18) ("GATM" 1)))
 ("UP:P50443"
  (("SLC26A2" 17) ("homozygous SLC26A2" 2) ("DTDST" 1)
   ("sulfate transporter" 1)))
 ("UP:P50445" (("Rux" 3))) ("UP:P50452" (("PI8" 1) ("SERPINB8" 1)))
 ("UP:P50453"
  (("CAP3" 10) ("pI9" 6) ("Serpinb9" 1) ("PI9" 1) ("SERPINB9" 1) ("cap3" 1)
   ("Cap3" 1) ("PI-9" 1)))
 ("UP:P50454"
  (("pCBP2" 44) ("RAA" 9) ("SERPINH1" 7) ("Serpinh1" 4) ("HSP47" 2) ("CBP2" 1)
   ("pIG14" 1) ("RaA" 1) ("Serpin H1" 1)))
 ("UP:P50458" (("LHX2" 9) ("Lhx2" 1)))
 ("UP:P50461" (("Csrp3" 3) ("muscle LIM protein" 1)))
 ("UP:P50466" (("AER" 52))) ("UP:P50476" (("Xhox3" 1)))
 ("UP:P50479"
  (("rIL" 123) ("RIL" 102) ("-RIL" 12) ("PDLIM4" 3) ("RIL protein" 3)
   ("E. coli BL21 (DE3) Gold or BL21 (DE3) RIL" 2) ("pRIL" 2) ("RIL-" 1)))
 ("UP:P50500" (("IRO" 3)))
 ("UP:P50502"
  (("HIP" 52) ("Hsc70-interacting protein" 21)
   ("Hsc70-interacting protein (CHIP)" 4) ("‘HIP’" 2)
   ("Hsc70 interacting protein" 2) ("HIP protein" 1)
   ("-Hsc70-interacting protein" 1)))
 ("UP:P50519" (("SCF1" 3) ("SCF-1" 1)))
 ("UP:P50539" (("MXI1" 7) ("Mxi1" 4) ("Mxd2" 1)))
 ("UP:P50542"
  (("PEX5" 127) ("p-PEX5" 3) ("PEX5 peptide" 3) ("PTS1 receptor" 2)))
 ("UP:P50548"
  (("ERF" 95) ("PE2" 37) ("pE2" 6) ("erf" 3) ("Basal ERF" 2)
   ("ERF (CACCGAGAAAGAAGGATGGA)" 1) ("Ets2 repressor factor" 1)))
 ("UP:P50549"
  (("ETV1" 410) ("ER81" 104) ("Etv1" 49) ("Er81" 7) ("ETV1 protein" 4)
   ("immunohistochemical analysis all showed strong nuclear ETV1" 2)
   ("-ETV1" 2) ("the GIST-lineage-related transcription factor ETV1" 2)))
 ("UP:P50552"
  (("VASP" 137) ("vasodilator" 87) ("vasodilator-stimulated phosphoprotein" 12)
   ("Vasp" 10) ("p-VASP" 4) ("vasodilator-stimulated phosphoprotein (VASP)" 2)
   ("an endothelial vasodilator" 1) ("a predominant vasodilator" 1)
   ("a primary vasodilator" 1) ("a pure vasodilator" 1)
   ("Vasodilator-stimulated phosphoprotein" 1) ("an acute vasodilator" 1)
   ("ER-β-associated uterine vasodilator" 1) ("Vasodilator" 1)
   ("vasodilator stimulated phosphoprotein" 1)))
 ("UP:P50553"
  (("Ascl1" 97) ("ASCL1" 22) ("ASH1" 10) ("Ascl1 protein" 4) ("hASH1" 3)
   ("ASCL1 protein" 2) ("the neuronal lineage factor ASCL1" 1) ("Ascl1-" 1)))
 ("UP:P50570"
  (("Dyn2" 339) ("DYn-2" 69) ("dynamin 2" 39) ("DNM2" 31) ("Dynamin 2" 24)
   ("dynamin2" 19) ("dynamin-2" 11) ("Dyn 2" 8) ("Dynamin2" 4)
   ("heavy DYn-2" 2) ("DYn-2-" 1) ("Dnm2" 1)))
 ("UP:P50579" (("MetAP2" 44) ("METAP2" 5)))
 ("UP:P50591"
  (("TRAIL" 4634) ("TL2" 153) ("TNFSF10" 62)
   ("TNF-related apoptosis-inducing ligand" 50) ("Trail" 37) ("Apo2L" 21)
   ("soluble TRAIL" 12) ("TRAIL protein" 12) ("Apo-2L" 11)
   ("TNF-related apoptosis inducing ligand" 7) ("TRAIL-" 7)
   ("TNF-related apoptosis-inducing ligand (TRAIL)" 6)
   ("recombinant soluble TRAIL" 5)
   ("T. Brunner, Konstanz, Germany, and leucine zipper-tagged TRAIL" 3)
   ("Recombinant soluble TRAIL" 2)
   ("a soluble biologically active recombinant human TRAIL" 2)
   ("the pro-apoptotic TNF-family ligand TRAIL" 2)
   ("the recombinant soluble TRAIL" 2) ("serum-soluble TRAIL" 2)
   ("soluble recombinant TRAIL" 2) ("Tnfsf10" 1)
   ("Soluble recombinant human TRAIL" 1) ("Trail-" 1) ("making TRAIL" 1)
   ("TNF-related apoptosis-inducing ligand–" 1)
   ("Recombinant human soluble TRAIL" 1) ("than TRAIL" 1)
   ("The soluble recombinant human TRAIL" 1) ("APO-2L" 1)
   ("the pro-apoptotic factor TRAIL" 1)
   ("the Foxo3a pro-apoptotic target genes TRAIL" 1) ("either soluble TRAIL" 1)
   ("HA-tagged soluble TRAIL" 1) ("the soluble TRAIL" 1)
   ("TNF-related apoptosis inducing ligand (TRAIL)" 1)
   ("soluble human recombinant TRAIL" 1) ("the biologic agent TRAIL" 1)))
 ("UP:P50607" (("Tub" 51) ("TUB" 33)))
 ("UP:P50613"
  (("Cdk7" 400) ("CAK" 235) ("CDK7" 202) ("cdk7" 13) ("CAKs" 9)
   ("than CDK7 in HCT116 cells" 2) ("Serine/Threonine Protein Kinase 1" 2)
   ("Cak" 2) ("Cak1" 2) ("chromatin-associated Cdk7" 2) ("A Universal CAK" 2)
   ("a universal CAK" 2) ("a physiologic CAK" 2)
   ("almost all cyclin H-bound CDK7" 1) ("than CDK7" 1)
   ("the only known CAK" 1) ("CAK1" 1) ("cyclin-dependent kinase 7" 1)
   ("TFIIH-associated CDK7" 1) ("cell-cycle–independent kinase CDK7" 1)
   ("trimeric Cdk7" 1) ("TFIIH-associated Cdk7" 1)
   ("its potential activator Cdk7" 1) ("its own unique CAK" 1)
   ("than Cdk7 in metazoan cells ( xref )" 1)))
 ("UP:P50616" (("Tob" 21) ("Tob1" 6) ("TOB1" 5) ("toB" 2)))
 ("UP:P50617" (("DEN" 176))) ("UP:P50736" (("YPDA" 4)))
 ("UP:P50747" (("HLCS" 201) ("holocarboxylase synthetase" 2)))
 ("UP:P50748"
  (("rod" 246) ("Rod" 18) ("ROD" 8) ("a polyionic rod" 2)
   ("a central α-helical rod" 1) ("pROD" 1) ("a semi-flexible rod" 1)
   ("a rigid hollow rod" 1) ("KNTC1" 1) ("gram-negative rod" 1)
   ("a 7-nm-wide helical rod" 1)))
 ("UP:P50749"
  (("RASSF2" 284) ("RASSF2 protein" 2) ("fluorescent RASSF2" 1) ("Rassf2" 1)))
 ("UP:P50750"
  (("CDK9" 1179) ("Cdk9" 292) ("cdk9" 80) ("TAK" 69) ("Tak" 24)
   ("cyclin-dependent kinase 9" 22) ("Ctk1" 8) ("tak" 5)
   ("overexpressed kinase-inactive CDK9 mutant D167N" 4) ("CDK9 protein" 4)
   ("CDK-9" 2) ("than Cdk9" 2) ("cyclin dependent kinase 9" 2) ("pTAK" 2)
   ("less CDK9" 2) ("Cyclin-dependent kinase 9" 1)
   ("the dominant-negative CDK9 mutant D167N" 1) ("both CDK9's" 1) ("CDK9-" 1)
   ("phosphatase-treated recombinant CDK9" 1) ("chromatin-associated Cdk9" 1)
   ("CDK9_HUMAN" 1)))
 ("UP:P50756" (("CycE1" 1))) ("UP:P50851" (("Bgl" 237) ("LBA" 11)))
 ("UP:P50854"
  (("RS" 577) ("pRS" 91) ("PRs" 20) ("RIBE" 15) ("-RS" 2)
   ("the parental RT112 and BGJ398 RS" 1) ("consequent RS" 1)
   ("empty vector pRS314" 1)))
 ("UP:P50863" (("SalA" 37))) ("UP:P50895" (("Lu" 241) ("Qingxian Lu" 1)))
 ("UP:P50897" (("Ppt1" 13))) ("UP:P50914" (("L14" 21) ("RPL14" 1)))
 ("UP:P50947" (("pho23" 9) ("PHO23" 2))) ("UP:P50990" (("Cct8" 1) ("CCT8" 1)))
 ("UP:P50991" (("SRB" 230) ("CCT4" 7)))
 ("UP:P50993"
  (("migraine" 592) ("Migraine" 29) ("typical migraine" 8) ("ATP1A2" 3)
   ("clinic-based migraine" 2) ("“migraine”" 2) ("hemiplegic migraine" 2)
   ("Typical migraine" 2) ("chronic migraine" 2) ("migraine, 146 regions" 1)
   ("incident migraine" 1) ("migraine Familial Hemplegic Migraine (FHM)" 1)
   ("self-reported migraine" 1) ("alpha 2 polypeptide" 1)
   ("menstrual migraine" 1) ("phase–associated migraine" 1)
   ("migraine (5 of 13) using a Fisher’s" 1) ("probable migraine" 1)
   ("familial hemiplegic migraine" 1)))
 ("UP:P50995" (("ANX11" 1))) ("UP:P51003" (("PAPOLA" 1)))
 ("UP:P51091" (("ANS" 64) ("only 11.3 μM ANS" 1) ("more ANS" 1)))
 ("UP:P51109" (("DFR" 1))) ("UP:P51114" (("Fxr1" 75) ("FXR1" 33) ("Fxr1-" 8)))
 ("UP:P51116" (("FXR2" 3)))
 ("UP:P51124" (("MET1" 4) ("granzyme M" 2) ("Granzyme M" 2) ("GZMM" 1)))
 ("UP:P51148" (("Rab5C" 59) ("RaB5C" 1)))
 ("UP:P51149"
  (("Rab7" 280) ("RAB7" 85) ("Rab7A" 24) ("rab7" 15) ("RAB7A" 10) ("RAB7-" 2)
   ("-Rab7" 2) ("Rab7-" 2) ("RAB-7" 2)
   ("shorter fragment (Armus 1–169 ) modestly activated Rab7" 2)
   ("than RAB7" 1) ("functional Rab7" 1) ("phagosome associated Rab7" 1)
   ("phagosomal Rab7" 1) ("rab7-" 1)))
 ("UP:P51151"
  (("Rab9" 55) ("Rab9A" 3) ("more Rab9 protein" 1) ("Rab9 protein" 1)
   ("rab9" 1)))
 ("UP:P51153" (("Rab13" 6) ("RAB13" 1))) ("UP:P51157" (("RAB28" 1)))
 ("UP:P51159"
  (("RAB27a" 8) ("RAB27A" 6) ("RAB27" 4) ("member RAS oncogene family" 3)
   ("Rab27" 2) ("member RAS oncogene family (RAN)" 1) ("Rab27A" 1)
   ("RaB27" 1)))
 ("UP:P51160" (("PDE6C" 2)))
 ("UP:P51161"
  (("GT" 929) ("G/T" 217) ("ileal" 55) ("Gt" 24) ("-GT" 9) ("pGT" 5)
   ("a malignant gastrointestinal GT" 4) ("ROSA" 3)
   ("the heterozygous genotype G/T" 3) ("CTC  CA A TGT CCC CTC AAG  GT" 2)
   ("g/t" 2) ("the Heterozygous Genotype G/T" 2) ("a malignant GT" 1)
   ("a benign soft tissue GT" 1) ("benign soft tissue GT" 1)
   ("AGACCGGACGACAGGCC(C/ G )AC(C/ G )CTC(C/ A )GT" 1) ("GT-" 1) ("Ileal" 1)
   ("Rosa" 1) ("gT" 1) ("heterozygous genotype G/T" 1)
   ("the heterozygous rs17849071 G/T" 1)))
 ("UP:P51168" (("Liddle syndrome" 11)))
 ("UP:P51170"
  (("gamma subunit" 12) ("the associated FcγRI gamma subunit" 1)
   ("a regulatory gamma subunit" 1)))
 ("UP:P51178"
  (("phospholipase C" 327) ("PLCD1" 50) ("Phospholipase C" 29) ("PLCδ1" 12)
   ("phospholipase C (PLC)" 8) ("phospholipase C delta 1" 2) ("Plcd1" 2)
   ("PLCD1 protein" 2) ("PLC-δ1" 1) ("phospholipase C-" 1)))
 ("UP:P51348" (("SYH" 1))) ("UP:P51397" (("Death Associated Protein" 1)))
 ("UP:P51407" (("rPP2A" 7)))
 ("UP:P51449"
  (("RORγt" 210) ("Rorc" 83) ("RORC" 46) ("Rorγt" 30)
   ("RAR-related orphan receptor C" 2) ("-Rorc" 1) ("RORgamma" 1)))
 ("UP:P51450" (("Thor" 2)))
 ("UP:P51451"
  (("BLK" 618) ("Blk" 307) ("BLK protein" 20) ("overexpressed Blk" 7)
   ("the third amino acid of BLK" 2) ("blk" 2)
   ("the second amino acid of BLK" 1) ("BLK-" 1) ("the homeostatic BLK" 1)
   ("BLK (YF)" 1)))
 ("UP:P51452"
  (("DUSP3" 227) ("VHR" 132) ("Dusp3" 84) ("VHR protein" 11)
   ("Vaccinia H1-related (VHR)" 3) ("Vaccinia H1-related" 1)
   ("the atypical dual specificity phosphatase DUSP3" 1) ("study DUSP3’s" 1)))
 ("UP:P51460" (("INSL3" 10) ("Insl3" 8) ("relaxin-like factor" 1)))
 ("UP:P51472" (("B23" 133) ("b23" 1) ("the nucleolar antigen B23" 1)))
 ("UP:P51486"
  (("arrestin-1" 12) ("arrestin1" 3) ("Arrestin-1" 2)
   ("pure fluorescently labeled arrestin-1" 1) ("than arrestin-1" 1)))
 ("UP:P51504" (("PT-17" 1)))
 ("UP:P51511" (("MMP15" 23) ("MT2-MMP" 10) ("MMP-15" 5)))
 ("UP:P51512"
  (("MMP-16" 33) ("MMP16" 26) ("MT3-MMP" 24)
   ("matrix metalloproteinase-16" 1)))
 ("UP:P51513"
  (("NOVA1" 29) ("RNA binding protein nova 1" 4) ("Nova1" 3) ("NOVA-1" 1)))
 ("UP:P51521" (("OVO" 14) ("ovo" 12) ("Svb" 2)))
 ("UP:P51526"
  (("IFN" 2874) ("IFN-" 228) ("IFN protein" 3) ("pIFN" 3) ("the primary IFN" 2)
   ("at least one IFN" 2) ("IFN, IP-10, and type III IFN" 1)
   ("efficient IFN" 1) ("type III IFN’s" 1) ("exogenous IFN" 1)))
 ("UP:P51530"
  (("Dna2" 271) ("DNA2" 79) ("dna2" 58) ("Dna2 protein" 3)
   ("DNA replication helicase 2 homolog (yeast)" 2) ("DNA2-" 1)
   ("nuclease defective Dna2" 1)))
 ("UP:P51531"
  (("BRM" 64) ("Brm" 57) ("SMARCA2" 26) ("Brahma" 23) ("hBRM" 18) ("BrM" 17)
   ("matrix associated" 13) ("SWI/SNF related" 5) ("-Brm" 5)
   ("actin dependent regulator of chromatin" 4) ("subfamily a" 3) ("hBrm" 3)
   ("Brahma (BRM)" 1) ("a facultative-enhanced matrix associated" 1)
   ("brahma" 1) ("BAF190" 1)
   ("SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"
    1)))
 ("UP:P51532"
  (("BRG1" 809) ("Brg1" 153) ("SMARCA4" 48) ("BRG-1" 22) ("BRG1 protein" 6)
   ("Brg-1" 3) ("-BRG1" 2) ("SmarcA4" 1)
   ("the typical enhancer-associated gene SMARCA4" 1)
   ("a typical enhancer-associated gene SMARCA4" 1)
   ("SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"
    1)
   ("defective BRG1" 1) ("TAC-treated hearts showed Brg1" 1)))
 ("UP:P51553" (("IDH3G" 28))) ("UP:P51571" (("SSR4" 2)))
 ("UP:P51572"
  (("BAP31" 75) ("Bap31" 9) ("B-cell receptor-associated protein 31" 5)
   ("B-cell Receptor-associated Protein 31" 4) ("BCAP31" 2) ("P51572" 2)))
 ("UP:P51575"
  (("purinergic receptor P2X" 7) ("ligand-gated ion channel" 4) ("P2X1" 3)
   ("the purinergic receptor P2X4" 1)))
 ("UP:P51580" (("TPMT" 10) ("thiopurine methyltransferase" 4)))
 ("UP:P51582" (("P2Y4" 6) ("P2P" 3)))
 ("UP:P51587"
  (("BRCA2" 14950) ("BRCA2 protein" 317) ("Brca2" 257) ("FANCD1" 118)
   ("brca2" 28) ("BRCA2-" 23) ("BRCA2 peptide" 18) ("functional BRCA2" 12)
   ("than BRCA2" 8) ("Avian Brca2" 6) ("Brca2 protein" 5) ("BRCA2 Protein" 4)
   ("-BRCA2" 3) ("FancD1" 3) ("the intact BRCA2 protein" 3)
   ("FANCD1 protein" 3) ("BRCA2 (WT)" 2) ("chromatin-associated BRCA2" 2)
   ("The defective BRCA2" 2) ("a “minimal” BRCA2 protein" 2) ("avian Brca2" 2)
   ("functional BRCA2 protein" 2) ("BRCA2 molecule" 2) ("a minimal BRCA2" 2)
   ("the multifunctional gene BRCA2" 2) ("Previously reported BRCA2" 2)
   ("defective BRCA2 protein" 1) ("BRCA2 (Genbank P51587) protein" 1)
   ("P51587" 1) ("one previously known BRCA2" 1) ("a strong inherent BRCA2" 1)
   ("the final 156 amino acids of the BRCA2 protein" 1)
   ("the entire BRCA2 protein" 1) ("BRCA2 (AAGAAGAATGCAGGTTTAATA)" 1)
   ("entire BRCA2 protein" 1) ("Functional BRCA2" 1) ("brca2-" 1)
   ("Only BRCA2 Y42C" 1) ("Defective BRCA2" 1) ("normal BRCA2 protein" 1)
   ("the breast cancer-associated tumor suppressor BRCA2" 1)
   ("we first bound BRCA2" 1) ("intact BRCA2" 1) ("invasive BRCA2" 1)
   ("–BRCA2" 1) ("that BRCA2's" 1) ("defective BRCA2" 1) ("Given BRCA2’s" 1)
   ("Given BRCA2" 1) ("the C-terminal ~200 amino acids of BRCA2 (C-ter)" 1)
   ("purified intact BRCA2 protein" 1) ("no identifiable BRCA2" 1)
   ("probably not BRCA2" 1) ("otherwise full-length BRCA2" 1)
   ("than full length BRCA2" 1) ("“micro-BRCA2”" 1)
   ("otherwise intact BRCA2" 1) ("ovarian tumor suppressor BRCA2" 1)
   ("than those reporting lower BRCA2" 1) ("key cellular BRCA2" 1)))
 ("UP:P51589" (("subfamily J" 2) ("CYP2J2" 1)))
 ("UP:P51591"
  (("RR" 1861) ("“RR”" 4) ("than the pooled RR (5.16, 95% CI = 4.16–6.40)" 2)
   ("PFM(N/S)o(S/N)ooRR(N/S)RR" 2) ("highly variable RR" 2)
   ("the objective RR" 1) ("Rr" 1)
   ("than the RR reported by us in 2003 ( xref )" 1) ("RR-" 1) ("rr" 1)
   ("good RR" 1)))
 ("UP:P51606" (("AGE" 410) ("AGE−" 5) ("RENBP" 1) ("A chronic AGE" 1)))
 ("UP:P51608"
  (("MeCP2" 144) ("RTTs" 38) ("MECP2" 18) ("Mecp2" 3) ("MeCP2 protein" 3)
   ("Methyl-CpG binding protein" 2) ("MECp2" 2) ("MeCP-2 protein" 2)
   ("fewer RTTs" 1) ("progressively fewer RTTs" 1)))
 ("UP:P51610"
  (("HCF-1" 500) ("hcf-1" 198) ("HCFC1" 27) ("HCF" 13) ("host cell factor 1" 8)
   ("HCF-1 protein" 5) ("HCF1" 3) ("the closely associated protein HCFC1" 2)
   ("HCF-1-" 1) ("more HCF-1" 1)))
 ("UP:P51617"
  (("IRAK1" 368) ("IRAK" 67) ("Irak1" 12) ("IRAKs" 6)
   ("IL-1R-associated kinase 1" 3) ("IL-1R–associated kinase 1" 2) ("P51617" 1)
   ("IRAK1-" 1) ("exogenously-expressed IRAK1" 1)))
 ("UP:P51636"
  (("CAV2" 205) ("Cav" 95) ("cav-2" 70) ("caveolin-2" 58) ("CAV-2" 39)
   ("caveolin 2" 28) ("Cav-2" 21) ("cav" 19) ("Cav2" 17) ("Caveolin-2" 13)
   ("Caveolin 2" 10) ("CAV2–" 4) ("Cav-" 3) ("CaV" 2)
   ("longer construct Cav" 2) ("longer peptide Cav" 2) ("than CAV2" 1)))
 ("UP:P51648" (("ALDH3A2" 1)))
 ("UP:P51654"
  (("SGBS" 41) ("Glypican-3" 19) ("GPC3" 17) ("Glypican 3" 15) ("sGB" 5)
   ("glypican-3" 4) ("Gpc3" 4) ("glypican 3" 4)
   ("mitoinhibitory protein GPC3" 2) ("sGBs" 1)
   ("mitoinhibitory protein glypican 3" 1)))
 ("UP:P51659" (("HSD17B4" 40) ("Hsd17b4" 4) ("multifunctional protein 2" 3)))
 ("UP:P51665" (("PSMD7" 21) ("MOV34" 5) ("Mov34" 4)))
 ("UP:P51668"
  (("SFT" 109) ("UbcH5a" 64) ("UbcH5" 47) ("UBCH5" 46) ("UBE2D1" 40)
   ("Ubc5" 18) ("UBC5" 12) ("UBC4/5" 10) ("Ubc5a" 10) ("UBE2D" 8) ("UbcH5A" 7)
   ("Ubc5A" 4) ("a right suprarenal SFT" 3) ("Ubc4/5" 3) ("Ubch5" 2)
   ("Ube2D" 2) ("pararenal SFT" 1) ("a well-encapsulated pararenal SFT" 1)
   ("a well-encapsulated SFT" 1) ("renal or pararenal SFT" 1)
   ("Pararenal SFT" 1) ("UBC5a" 1) ("UBCh5" 1) ("the homologous UBE2D1" 1)
   ("intracranial SFT" 1) ("metastatic SFT" 1)
   ("a meningeal malignant SFT" 1)))
 ("UP:P51670" (("MIP1γ" 1)))
 ("UP:P51671" (("Eotaxin" 87) ("eotaxin" 76) ("CCL11" 22)))
 ("UP:P51674" (("GPM6A" 9) ("glycoprotein M6A" 7) ("GPM6" 3)))
 ("UP:P51677" (("CCR3" 31)))
 ("UP:P51681"
  (("CCR5" 1154) ("CCR5-" 12) ("Ccr5" 7) ("C-C chemokine receptor type 5" 6)
   ("CCR5 protein" 2) ("macrophage-tropic CCR5" 2) ("-CCR5" 1)
   ("Macrophage tropic viruses primarily use CCR5" 1) ("CD195" 1)))
 ("UP:P51684" (("DCR2" 4) ("C-C chemokine receptor type 6" 2) ("BN-1" 1)))
 ("UP:P51685"
  (("Ccr8" 8) ("C-C chemokine receptor type 8" 2) ("P51685" 1) ("CCR8" 1)))
 ("UP:P51686" (("Ccr9" 8) ("CCR9" 1)))
 ("UP:P51689"
  (("ASD" 684) ("idiopathic ASD" 2) ("non-syndromic ASD" 1)
   ("the prototypical ASD" 1)))
 ("UP:P51690" (("ASE" 52) ("FoxH1/Smad2/3 binding sites" 2) ("CDPX1" 1)))
 ("UP:P51692"
  (("STAT5b" 637) ("STAT5B" 557) ("Stat5b" 395) ("Stat5b protein" 8)
   ("STAT5b protein" 6) ("dominant-negative STAT5b" 4) ("-STAT5b" 3)
   ("STAT5b peptide" 3) ("pSTAT5b" 3) ("Stat5B" 2) ("STAT5B-" 2)
   ("undetectable STAT5B" 1) ("exogenous STAT5b" 1) ("overexpressing STAT5b" 1)
   ("signal transducer and activator of transcription 5B" 1)
   ("dominant-negative STAT5B" 1) ("the dominant-negative STAT5B protein" 1)
   ("STAT5B protein" 1) ("the highly homologous Stat5b" 1)
   ("targeting STAT5b" 1)))
 ("UP:P51693" (("APLP1" 10))) ("UP:P51784" (("USP11" 44)))
 ("UP:P51787" (("KCNQ1" 71) ("LQT1" 7) ("Kcnq1" 3) ("KQT-like subfamily" 2)))
 ("UP:P51788" (("ClC2" 2) ("CLC-2" 1) ("ClC-2" 1)))
 ("UP:P51790"
  (("ClC3" 4) ("chloride channel 3" 2) ("clcn3" 1) ("Clc-3" 1) ("ClC-3" 1)))
 ("UP:P51793" (("chloride channel 4" 7) ("CLCN4" 1)))
 ("UP:P51795"
  (("proteinuria" 262) ("severe proteinuria" 8) ("Proteinuria" 4)
   ("heavy proteinuria" 3) ("massive proteinuria" 3) ("overt proteinuria" 3)
   ("diabetic proteinuria" 2)
   ("significantly less angiotensin II-induced proteinuria" 2) ("XRN" 2)
   ("ClC5" 2) ("The described mouse model showed early heavy proteinuria" 1)
   ("lack spontaneous proteinuria" 1)
   ("the patient developed heavy proteinuria" 1)
   ("experimental proteinuria" 1)))
 ("UP:P51797" (("CLCN6" 1))) ("UP:P51798" (("CLCN7" 8)))
 ("UP:P51800" (("CLCNKA" 1)))
 ("UP:P51805"
  (("6.3" 424) ("Sex" 105) ("plexin" 62) ("Plexin" 30) ("Plexin-A3" 7)
   ("PLXNA3" 4) ("Plexin A3" 3) ("6.3 µ" 2)
   ("using Sequential Oligogenic Linkage Analysis Routines (SOLAR) version 6.3"
    2)
   ("PLEXIN" 1) ("−6.3" 1) ("6.3–" 1) ("Sex-" 1) ("PLXN4" 1)))
 ("UP:P51809"
  (("VAMP7" 19) ("Ti-VAMP" 11) ("the late endocytic SNARE protein VAMP7" 2)
   ("SYBL1" 1) ("the late endosomal/lysosomal v-SNARE Ti-VAMP" 1) ("Vamp7" 1)))
 ("UP:P51810"
  (("OA1" 14) ("GPR143" 13)
   ("the pre-melanosomal G-protein–coupled receptor OA1" 1)
   ("exogenously expressed pre-melanosomal markers OA1" 1)))
 ("UP:P51811" (("XK" 10) ("K-X" 5)))
 ("UP:P51812"
  (("RSK2" 1305) ("RSK2 protein" 23) ("ribosomal S6 kinase 2" 20)
   ("RPS6KA3" 18) ("RSKs" 15) ("RSK2-" 5) ("MAPKAP-K1b" 4) ("Rsk2" 4)
   ("pRSK2" 4) ("RskS" 2) ("p-RSK2" 2) ("functional RSK2" 2)
   ("each bacterial-expressed RSK2 protein" 2)
   ("either bacterial-expressed RSK2" 2) ("RSK-2" 2)
   ("dominant-negative RSK2" 2) ("pp90rsk2" 1) ("Rps6ka3" 1)
   ("commercially available active RSK2" 1) ("RsK2" 1) ("RSK 2" 1)
   ("HA-RSK2" 1) ("Dominant-negative RSK2" 1) ("the disruptive effect RSK2" 1)
   ("The suppressive effect RSK2" 1)))
 ("UP:P51813"
  (("BMX" 228) ("Bmx" 44) ("pBMX" 5) ("bMx" 2) ("a dominant-negative BMX" 2)
   ("BMX protein" 2)))
 ("UP:P51817" (("PrkX" 1)))
 ("UP:P51825" (("FEL" 5) ("AFF1" 4) ("AF4 family" 2)))
 ("UP:P51826" (("AFF3" 7) ("Laf4" 4) ("LAF4" 1))) ("UP:P51828" (("ADCY7" 2)))
 ("UP:P51843"
  (("group B" 150) ("Group B" 76) ("CALGB" 22) ("NR0B1" 5) ("DAX1" 5)
   ("Group B (CALGB)" 5) ("Dax-1" 4) ("DAX-1" 4) ("NROB1" 4)
   ("group B (XPB)" 3) ("DAX-1-" 2) ("metastatic group B" 2)
   ("Group B (CALBG)" 2) ("nuclear receptor subfamily 0" 1) ("Dax1" 1)
   ("Nr0b1" 1)))
 ("UP:P51853"
  (("BL" 1149) ("pBL" 8) ("the predominant EGFR BL" 4) ("a latent BL" 4)
   ("the internal BL" 3) ("Recent BL" 2) ("EBV-positive BL" 2)
   ("the external BL" 2) ("endemic BL" 2) ("gene expression-defined BL" 2)
   ("than either BL" 2) ("Bl" 2) ("primary BL" 2) ("redundant BL" 2)
   ("the previously identified 667-PLTP BL" 2) ("bl" 1) ("internal BL" 1)
   ("normal sporadic BL" 1) ("pediatric and adult BL" 1) ("than classic BL" 1)
   ("classic BL" 1) ("BL (BCLU)" 1) ("most BL" 1) ("29 primary BL" 1)
   ("fully phenocopy human BL" 1)))
 ("UP:P51854" (("TKTL1" 3))) ("UP:P51857" (("AKR1D1" 4)))
 ("UP:P51858"
  (("HDGF" 6) ("hepatoma-derived growth factor" 3)
   ("Hepatoma-derived growth factor" 2)))
 ("UP:P51861" (("CDR1" 8))) ("UP:P51862" (("Rom2" 2)))
 ("UP:P51875" (("GOA-1" 6))) ("UP:P51878" (("CASP5" 10)))
 ("UP:P51884"
  (("LUM" 14) ("Lum" 5) ("lumican" 2) ("LDC" 2) ("Lumican ( LUM )" 1)
   ("Lumican" 1)))
 ("UP:P51885" (("LCN" 12) ("lcn" 1))) ("UP:P51888" (("Prelp" 1)))
 ("UP:P51911"
  (("CNN1" 18) ("calponin 1" 5) ("Calponin 1" 1) ("basic calponin" 1)))
 ("UP:P51946"
  (("cyclin H" 59) ("p37" 27) ("P37" 10) ("CycH" 8) ("CCNH" 6) ("Cyclin H" 3)
   ("cycH" 2) ("cyclinH" 2)))
 ("UP:P51948" (("MNAT1" 3)))
 ("UP:P51955"
  (("Nek2" 332) ("Nek2A" 49) ("NEK2" 9) ("Nek2 protein" 8) ("NEK2A" 8)
   ("exogenous Nek2" 4) ("Nek2A protein" 3)
   ("the centrosomal kinase Nek2 protein" 2) ("overexpressed Nek2" 2)
   ("mouse monoclonal Nek2" 1) ("Nek2a" 1) ("NLK1" 1)))
 ("UP:P51956" (("Nek3" 14)))
 ("UP:P51957" (("NEK4" 6) ("serine/threonine-protein kinase 2" 5)))
 ("UP:P51959"
  (("G 0" 727) ("Cyclin G1" 159) ("cyclin G1" 142) ("CCNG1" 33)
   ("overexpressed cyclin G1" 25) ("Ccng1" 6)
   ("cyclin
 G1"
    6)
   ("miR-132/-212 potentially targets cyclin G1" 3)
   ("Cyclin
 G1"
    2)
   ("CyclinG1" 2) ("cyclinG1" 2) ("—Cyclin G1" 1) ("-G 0" 1)
   ("accelerated G 0" 1) ("pCCNG" 1)))
 ("UP:P51965" (("UBE2E1" 20) ("UbcH6" 16) ("Ube2e1" 3) ("UbE2E1" 2)))
 ("UP:P51984"
  (("cAMP-response element-binding protein" 2)
   ("cAMP-response element–binding protein" 2)
   ("c-AMP response element binding protein (CREB)" 1)
   ("c-AMP response element binding protein" 1)))
 ("UP:P51991" (("hnRNPA3" 4) ("hnRPA3" 2))) ("UP:P51996" (("Ypt32" 5)))
 ("UP:P52042" (("BCD" 10) ("Bcd" 1)))
 ("UP:P52067" (("FSR" 15) ("the authors measured basal FSR" 2)))
 ("UP:P52093" (("PFR" 31))) ("UP:P52119" (("PASI" 24) ("more severe PASI" 2)))
 ("UP:P52183"
  (("transglutaminase" 22) ("Transglutaminase" 2) ("transglutaminase (TG)" 1)))
 ("UP:P52198"
  (("Rnd2" 65) ("RND2" 12) ("Rho family GTPase 2" 6) ("ARHN" 1)
   ("the last 11 C-terminal amino acids of Rnd2" 1)
   ("the first six N-terminal amino acids of Rnd2" 1)))
 ("UP:P52209"
  (("PGD" 248) ("exogenous PGD" 2) ("“PGD”" 1) ("developed grade 3 PGD" 1)
   ("phosphogluconate dehydrogenase" 1)))
 ("UP:P52272"
  (("HNRNPM" 4) ("heterogeneous nuclear ribonucleoprotein M" 4) ("HNRPM" 4)
   ("hnRNPM" 2)))
 ("UP:P52292" (("KPNA2" 190) ("KPNA2 protein" 6)))
 ("UP:P52294" (("karyopherin" 38) ("Karyopherin" 3)))
 ("UP:P52298" (("CBP20" 6) ("20KD" 2) ("20kD" 1)))
 ("UP:P52304" (("polo" 92) ("Polo" 60) ("“polo”" 2)))
 ("UP:P52306"
  (("SmgGDS" 325) ("SmgGDS protein" 4) ("smgGDS" 1) ("Rap1GDS1" 1)))
 ("UP:P52321" (("SPRD" 2)))
 ("UP:P52333"
  (("JAK3" 466) ("Jak3" 331) ("JAK-3" 22) ("Janus kinase 3" 16)
   ("Jak3 protein" 5) ("-JAK3" 3) ("than JAK3" 3) ("Jak-3" 2)
   ("leukemic JAK3" 2) ("Jak3-" 1) ("a catalytically intact JAK3" 1)
   ("JAK3 protein" 1) ("pJAK3" 1) ("p-JAK3" 1)))
 ("UP:P52348" (("U29" 8))) ("UP:P52377" (("UL9" 12) ("viral protein UL9" 2)))
 ("UP:P52380" (("U12" 16) ("U12-" 1))) ("UP:P52382" (("U51" 1)))
 ("UP:P52387" (("U50" 1))) ("UP:P52429" (("DGKε" 4)))
 ("UP:P52434"
  (("polymerases" 386) ("RPB8" 27) ("non-classical polymerases" 5) ("POLR2H" 3)
   ("the non-classical polymerases" 3) ("these non-classical polymerases" 3)
   ("damage-tolerant polymerases" 3) ("Polymerases" 2)
   ("DNA damage-tolerant polymerases" 2)
   ("some non thermostable polymerases" 2) ("Retroviral polymerases" 2)
   ("classical polymerases" 2) ("Damage-tolerant polymerases" 2)
   ("Pol II and Pol III polymerases" 1)
   ("both Pol II and Pol III polymerases" 1)
   ("normal processive polymerases" 1)
   ("the same time binding non-classical polymerases" 1)
   ("separate polymerases" 1) ("the damage-tolerant polymerases" 1)))
 ("UP:P52441" (("U33" 4)))
 ("UP:P52451" (("CB1R" 84) ("GFP-HA–tagged CB1R" 1) ("GFP-HA-tagged CB1R" 1)))
 ("UP:P52465" (("U34" 6))) ("UP:P52473" (("U44" 40)))
 ("UP:P52488"
  (("PIP2" 403) (NIL 7) ("PIP2 peptide" 2) ("PIP2-" 2) ("polyvalent PIP2" 1)
   ("essential PIP2" 1)))
 ("UP:P52550" (("A-Myb" 15)))
 ("UP:P52564"
  (("MKK6" 347) ("MEK6" 5) ("MAP2K6" 4) ("overexpressed MKK6" 3)
   ("an MMTV-driven active MKK6" 2) ("MAPKK6" 1) ("MKK6 protein" 1)))
 ("UP:P52565"
  (("RhoGDI" 352) ("RhoGDI-1" 87) ("RhoGDI1" 43) ("Rho-GDI" 39) ("ARHGDIA" 12)
   ("RhoGDI protein" 9) ("Rho GDP dissociation inhibitor alpha" 4)
   ("Rho GDI1" 3) ("exogenous RhoGDI" 2) ("targeting RhoGDI" 2)
   ("weak and diffuse RhoGDI" 2) ("RhoGDI-1 molecule" 2) ("Rho-GDI protein" 1)
   ("Arhgdia" 1) ("arhgdia" 1) ("benign tumors RhoGDI" 1)
   ("RhoGDI-1 peptide" 1)
   ("threonine but not serine-phosphorylated RhoGDI-1" 1) ("Rho–GDI" 1)
   ("Rho-GDI α" 1)))
 ("UP:P52566"
  (("RhoGDI2" 299) ("ARHGDIB" 14) ("Rho GDI2" 6) ("RhoGDI2 protein" 5)
   ("LyGDI" 2) ("Rho GDP Dissociation Inhibitor Beta" 1)))
 ("UP:P52575" (("IFR" 3))) ("UP:P52580" (("pIRL" 1)))
 ("UP:P52594" (("Rab family" 45) ("HRB" 5))) ("UP:P52597" (("HNRNPF" 4)))
 ("UP:P52625"
  (("pATM" 319) ("p-ATM" 115) ("P-ATM" 23) ("-pATM" 4)
   ("immunofluorescence included γHistone H2AX (pSer139) (Cell Signaling Technologies) pATM"
    2)
   ("very little pATM" 2) ("representative pATM" 1) ("p–ATM" 1)))
 ("UP:P52626"
  (("path" 534) ("Path" 38) ("PATH" 8) ("shortest path" 8) ("Golden path" 3)
   ("the medial perforant path" 3) ("an irreversible path" 2)
   ("the evolutionary path" 2) ("a clear path" 1) ("a new path" 1)
   ("the optical path" 1) ("the diffusive path" 1)
   ("The optimal approval path" 1) ("an unexpected evolutionary path" 1)
   ("faster path" 1) ("a two-pronged signaling path" 1) ("an alternate path" 1)
   ("the diagonal path" 1) ("an appropriate path" 1)
   ("a more flexible
path"
    1)
   ("the anatomic path" 1) ("evolutionary path" 1) ("the major path" 1)
   ("thermodynamically well-defined path" 1) ("a novel regulatory path" 1)
   ("a new regulatory path" 1) ("shorter path" 1)
   ("the dominant evolutionary path" 1) ("the APP amyloidogenic path" 1)
   ("the clathrin-mediated endocytic path" 1) ("a less aggressive path" 1)
   ("a more productive path" 1) ("the available path" 1)
   ("a single evolutionary path" 1) ("the realized evolutionary path" 1)
   ("a curvilinear path" 1) ("the indirect path" 1) ("its potential path" 1)
   ("an aggressive path" 1)))
 ("UP:P52630"
  (("STAT2" 394) ("Stat2" 20) ("pSTAT2" 7) ("p-STAT2" 5) ("STAT-2" 5)
   ("P-STAT2" 5) ("P113" 3)
   ("signal transducer and activator of transcription 2" 3) ("STAT2 protein" 1)
   ("IFNα-treated Huh7 cells STAT2" 1) ("specifically target STAT2" 1)))
 ("UP:P52655"
  (("TFIIA" 15) ("glucose regulated protein" 12)
   ("Glucose regulated protein" 1)))
 ("UP:P52657" (("12kDa" 1))) ("UP:P52665" (("BudR" 5) ("BUdR" 1)))
 ("UP:P52667" (("ESTR" 1)))
 ("UP:P52697" (("pGL" 158) ("pGL-" 6) ("pGl" 2) ("pgL" 1)))
 ("UP:P52701"
  (("mismatch" 1434) ("MSH6" 1022) ("hMSH6" 381) ("p160" 151) ("Mismatch" 71)
   ("Msh6" 37) ("MSH6 protein" 10) ("-hMSH6" 9) ("msh6" 7) ("-mismatch" 3)
   ("P160" 3) ("GTBP" 2) ("we first silenced MSH6" 2)
   ("a primary/metastasis mutational mismatch" 1)
   ("the essential hMLH1 mismatch" 1) ("mutS homolog 6" 1)
   ("than one mismatch [ xref ]" 1) ("an intentional mismatch" 1)
   ("at least one mismatch" 1) ("a defective MSH6" 1)
   ("only one crypt demonstrated a type 2 (20%) mismatch" 1)
   ("the p53 protein overexpression (−)/p53 mutation (+) mismatch" 1)
   ("mismatch (MMR)" 1) ("even one mismatch" 1) ("than one mismatch" 1)
   ("two absent MSH6" 1) ("absent MSH6" 1) ("yeast MSH6’s" 1)
   ("the π-stacking Phe of MSH6" 1) ("hMSH6(PAAP)" 1) ("more hMSH6" 1)
   ("mismatch-" 1)))
 ("UP:P52732"
  (("Eg5" 218) ("KIF11" 24) ("Kif11" 3) ("the plus-end-directed kinesin Eg5" 2)
   ("mitotic kinesin Eg5" 2) ("the mitotic motor Eg5" 1) ("EG5" 1)
   ("the mitotic kinesin Eg5" 1) ("end–directed bipolar kinesin Eg5" 1)
   ("The plus-end-directed MT motor Eg5" 1)))
 ("UP:P52735"
  (("Vav2" 763) ("VAV2" 253) ("Vav2 protein" 6) ("overexpressed Vav2" 4)
   ("guanine nucleotide exchange factor VAV2" 3)
   ("guanine nucleotide exchange factor Vav2" 3) ("overexpressed Vav2-Y172F" 3)
   ("Vav2-" 2) ("less (50%) Vav2" 1) ("than CA VAV2" 1) ("particular Vav2" 1)
   ("dominant-negative VAV2" 1) ("40% more Vav2" 1)))
 ("UP:P52739" (("ZNF131" 3))) ("UP:P52743" (("ZNF137" 2)))
 ("UP:P52746" (("ZNF142" 1)))
 ("UP:P52747"
  (("ZNF143" 161) ("SBF" 10) ("Staf" 2) ("ZNF143 protein" 2) ("ZNF143-" 1)))
 ("UP:P52756" (("H37" 27) ("RBM5" 5))) ("UP:P52757" (("CHN2" 35)))
 ("UP:P52758" (("P14.5" 3))) ("UP:P52788" (("SMS" 136) ("SMs" 11)))
 ("UP:P52789"
  (("HK-2" 440) ("HK II" 118) ("hexokinase 2" 41) ("Hexokinase 2" 19)
   ("HKII" 14) ("HK-II" 13) ("HXK2" 6) ("hexokinase-2" 4) ("Hexokinase-2" 3)
   ("hexokinase2" 2) ("hxk2" 1) ("The human proximal tubule cell line HK-2" 1)
   ("The immortalized human kidney proximal tubular cell line HK-2" 1)
   ("1 immortalized normal kidney proximal tubule epithelial cell line HK-2" 1)
   ("nonmalignant immortalized renal cell line HK-2" 1)))
 ("UP:P52790" (("HK3" 16))) ("UP:P52798" (("ephrin A4" 1) ("EFNA4" 1)))
 ("UP:P52799"
  (("EphrinB" 41) ("EFNB2" 10) ("ephrinB2" 10) ("ephrinB" 6) ("ephrin-B2" 4)
   ("Efnb2" 2)))
 ("UP:P52803" (("EFNA5" 7) ("ephrin-A5" 7) ("ephrinA5" 5)))
 ("UP:P52823"
  (("STC1" 11) ("STC" 4) ("pSTC" 2) ("Stanniocalcin 1" 1)
   ("stanniocalcin 1" 1)))
 ("UP:P52824" (("DGKθ" 3))) ("UP:P52848" (("NDST1" 6)))
 ("UP:P52867" (("PMT5" 1) ("pMT5" 1)))
 ("UP:P52895"
  (("AKR1C2" 25) ("DD2" 17) ("type III)" 14) ("ddH2" 13) ("DD2 peptide" 5)
   ("Type III)" 3) ("than the DD2 peptide ( xref )" 1)))
 ("UP:P52907" (("CAPZA1" 37)))
 ("UP:P52926"
  (("HMGA2" 563) ("Hmga2" 43) ("Lipo" 30) ("high mobility group AT-hook 2" 16)
   ("HMGA2 protein" 15) ("lipo" 14) ("LiPO" 5) ("HMGI-C" 2)
   ("miR-98 Directly Targets HMGA2" 2)
   ("The architectural transcription factor high mobility group AT-hook 2" 2)
   ("lipo-" 2) ("High mobility group AT-hook 2" 2) ("HMGIC" 1)
   ("the self-renewal marker HMGA2" 1)))
 ("UP:P52945" (("PDX-1" 18) ("Pdx-1" 13) ("GSF" 6) ("IPF1" 4) ("IUF1" 2)))
 ("UP:P52948"
  (("Nup98" 196) ("NUP98" 20) ("Nup96" 7) ("nucleoporin Nup98" 4) ("Adar2" 1)))
 ("UP:P52951" (("GBX2" 15) ("Gbx2" 2) ("gastrulation brain homeobox 2" 1)))
 ("UP:P52952"
  (("Nkx2.5" 202) ("NKX2-5" 114) ("Nkx2-5" 63) ("NKX2.5" 16) ("NKX2–5" 7)
   ("CSX" 7) ("NKX2-5 protein" 3)
   ("the cardiac specific homeobox transcription factor Nkx2.5" 2) ("Nkx2–5" 2)
   ("Csx" 1) ("CSX1" 1) ("Nkx 2.5" 1) ("nkx2.5" 1)))
 ("UP:P52954" (("Lbx1" 4) ("LBX1" 1))) ("UP:P53004" (("BVR" 1)))
 ("UP:P53007"
  (("CTP" 114) ("P-CTP" 7) ("flexible CTP" 1) ("“CTP”" 1) ("pCTP" 1)))
 ("UP:P53041" (("protein phosphatase 5" 18) ("PPP5C" 2)))
 ("UP:P53065" (("TAD1" 136) ("TAD1-" 4) ("the entire TAD1" 1)))
 ("UP:P53096" (("Hos2" 2) ("HOS2" 2))) ("UP:P53118" (("ROG-1" 1)))
 ("UP:P53124" (("pCL10" 4))) ("UP:P53148" (("Spc105" 3)))
 ("UP:P53165" (("Sgf73" 3))) ("UP:P53197" (("Hct1" 1)))
 ("UP:P53281" (("Lsb1" 2))) ("UP:P53304" (("SLI-1" 3)))
 ("UP:P53309" (("yap1802" 7) ("Yap1802" 2)))
 ("UP:P53346" (("oncostatin-M" 12) ("oncostatin-M (OSM)" 2)))
 ("UP:P53350"
  (("Plk1" 6047) ("PLK1" 3505) ("Polo-like kinase 1" 205) ("PLK-1" 147)
   ("polo-like kinase 1" 143) ("PLK" 121) ("PLKs" 73) ("Plks" 50)
   ("Polo-like kinase" 32) ("Plk" 31) ("polo-like kinase" 30) ("Polo-like" 28)
   ("PLK1 protein" 28) ("Plk1 protein" 27) ("Plk-1" 26)
   ("Polo-like kinase-1" 23) ("pLK" 21) ("polo-like" 13)
   ("polo-like kinase-1" 13) ("the mitotic kinase Plk1" 11) ("plk1" 8)
   ("overexpressed PLK1" 8) ("the mitotic kinase PLK1" 7) ("Plk1-" 7)
   ("nondegradable Plk1" 7) ("mitotic Plk1" 5)
   ("the mitotic polo-like kinase" 3) ("-Plk1" 3) ("Polo like kinase 1" 3)
   ("the mitotic Polo-like kinase 1" 3) ("Plk 1" 3)
   ("targeting Polo-like kinase-1" 3) ("Polo-Like" 3) ("overexpressed Plk1" 3)
   ("kinase defective Plk1" 2) ("FLAG-PLK1 termed PLK1" 2)
   ("pro-mitotic PLKs" 2)
   ("the HES6-associated cell cycle regulator polo-like kinase 1" 2)
   ("the mitotic regulator polo-like kinase" 2)
   ("the pro-mitotic kinases polo-like kinase-1" 2)
   ("the centrosomal and mitotic kinase
polo-like kinase 1"
    2)
   ("flag-tagged Plk1" 2) ("the mitotic kinase Polo-like" 2)
   ("rectal tumour PLK1" 2) ("functional Plk1" 2) ("overexpressed PLK-1" 2)
   ("Overexpressed PLK1" 2) ("analogue-sensitive Plk1" 2)
   ("the mitotic kinase Polo-like kinase (PLK)" 2) ("targeting PLK1" 2)
   ("pololike kinase 1" 2) ("similarly localized active Plk1" 2)
   ("polo like kinase 1" 2) ("the Mitotic Kinase Plk1" 2)
   ("miR-100 directly targets PLK1" 2)
   ("the mitotic kinase polo-like kinase 1" 2) ("residual Plk1 protein" 1)
   ("a mitotic cofactor turns Plk1" 1)
   ("GSK461364A effectively targets PLK1" 1) ("the centrosomal Plk1" 1)
   ("at least four distinct PLKs" 1) ("the most targeted PLK" 1)
   ("targeted PLK" 1) ("BRCA2-associated Plk1" 1) ("the Plk1" 1) ("PlK1" 1)
   ("subcellular compartment Plk1" 1) ("mitotic kinase PLK1" 1)
   ("the peripheral PLK1" 1) ("centrosomal Plk1" 1) ("STPK13" 1)
   ("mitotic regulator Plk1" 1) ("preferentially anchor Plk1" 1)
   ("both total and activated PLK1 protein" 1) ("the original Plk1" 1)
   ("3-MB-PP1-treated Plk1" 1) ("dominant-negative Plk1" 1) ("P53350" 1)
   ("the only role Plk1" 1) ("Papillary carcinoma overexpressed PLK1" 1)
   ("than wild-type Plk1" 1) ("Nondegradable Plk1" 1) ("than Plk1" 1)
   ("than Plk1 ( xref B)" 1) ("we first pharmacologically inhibited PLK1" 1)
   ("Polo-like kinase (PLK)" 1) ("centrosomal PLK1" 1)
   ("polo-like kinase ( PLK )" 1) ("Polo-like Kinase-1" 1)
   ("the mitotic control gene PLK1" 1) ("the ciliary Plk1" 1)
   ("the relevant Plk1" 1) ("constitutively target Plk1" 1)))
 ("UP:P53355"
  (("DAPK1" 462) ("DAPK" 300) ("DAPK-1" 70)
   ("death-associated protein kinase" 17)
   ("death-associated protein kinase-1" 10)
   ("death-associated protein kinase 1" 7)
   ("death associated protein kinase 1" 7) ("Dapk1" 4)
   ("Death Associated Protein kinase 1" 3) ("overexpressed DAPK1" 3)
   ("death-associated
protein kinase-1"
    3)
   ("death associated protein kinase" 2)
   ("death-associated protein kinase (DAPK)" 2)
   ("Death associated protein kinase 1" 2) ("we first overexpressed DAPK1" 1)
   ("DAPK1-" 1) ("Death associated protein kinase" 1) ("DAPK-1-" 1)))
 ("UP:P53365" (("POR1" 6) ("Arfaptin-2" 3) ("Por1" 1)))
 ("UP:P53371" (("tub1" 2)))
 ("UP:P53384"
  (("Nbp35" 12) ("NBP35" 8) ("NBP" 6) ("E. coli)" 4) ("only human NBP35" 1)))
 ("UP:P53396"
  (("ACLY" 331) ("ACL" 20) ("ATP citrate lyase" 12) ("ACLY protein" 10)
   ("ATP-citrate synthase" 3) ("than the ACLY" 1)
   ("ATP citrate lyase (ACLY)" 1) ("pATPCL" 1) ("aCl" 1) ("aCL" 1)))
 ("UP:P53420"
  (("alpha 4" 36) ("Alpha 4" 4) ("COL4A4" 3)
   ("gamma-aminobutyric acid A receptor subunit alpha 4" 2)))
 ("UP:P53421"
  (("Hsp72" 1319) ("Hsp72 protein" 12) ("pleural fluid Hsp72" 6) ("hsp72" 5)
   ("exogenous Hsp72" 4) ("Exogenous Hsp72" 2) ("adenoviral vector Hsp72" 2)
   ("functional Hsp72" 2)
   ("than N-terminus Hsp72 ( xref , lanes 4 through 9)" 2)
   ("than N-terminus Hsp72" 2) ("viable mesothelial cells release Hsp72" 1)
   ("exogenous human Hsp72" 1) ("Hsp72 (TKDNNLLGREFELSG)" 1)
   ("equimolar full length Hsp72" 1)
   ("than the N-terminus Hsp72 (amino acids 1to 430)" 1)
   ("than the N-terminus Hsp72 ( xref , lanes 6 through 13)" 1)
   ("than Hsp72 that are evident in differentiated 5YHSP72.1 neuron-like cells that affect"
    1)))
 ("UP:P53441" (("cTn" 8))) ("UP:P53496" (("act1-1" 1)))
 ("UP:P53518" (("CSSC" 3)))
 ("UP:P53539"
  (("FosB" 172) ("FOSB" 20) ("fosB" 12) ("Fos-B" 3) ("FosB protein" 2)
   ("FOS-B" 1) ("Fosb" 1)))
 ("UP:P53567" (("CEBPG" 18)))
 ("UP:P53582" (("MAP 1" 2) ("methionine aminopeptidase 1" 1) ("METAP1" 1)))
 ("UP:P53597" (("SUCLG1" 1))) ("UP:P53599" (("Ssk2" 5)))
 ("UP:P53602"
  (("MVD" 486) ("tumor-associated MVD" 2)
   ("CD34-determined intratumoral MVD" 1) ("Intratumoral MVD" 1) ("MVDs" 1)
   ("sporadic tumors MVD" 1)))
 ("UP:P53611" (("RABGGTB" 5)))
 ("UP:P53618" (("β-COP" 29) ("βCOP" 5) ("COPB1" 3) ("more β-COP" 2)))
 ("UP:P53621" (("COPA" 5))) ("UP:P53629" (("ARE2" 27) ("ARE-2" 10)))
 ("UP:P53634"
  (("Cathepsin C" 7) ("CTSC" 6) ("CATHEPSIN C" 1) ("cathepsin C" 1)))
 ("UP:P53667"
  (("LIMK1" 628) ("LIMK" 200) ("LIMK-1" 23) ("LIM kinase 1" 18)
   ("LIMK1 protein" 12) ("Limk1" 11) ("pLIMK" 11) ("LIM-kinase 1" 5)
   ("LIM domain kinase 1" 5) ("overexpressed LIMK1" 5) ("LIMK1-" 3)
   ("p-LIMK1" 3) ("Lim domain kinase 1" 2) ("LIMK 1" 2)
   ("dominant-negative Limk1" 2) ("exogenous LIMK-1" 2)
   ("LIMK1 and BMPR-II inhibited LIMK1's" 1) ("pLIMK1" 1)))
 ("UP:P53671" (("LIMK2" 450) ("P-LIMK2" 3) ("LIMK-2" 2) ("LIMK 2" 1)))
 ("UP:P53675" (("cHC" 71) ("CH–C" 2))) ("UP:P53676" (("P47A" 8) ("-P47A" 1)))
 ("UP:P53687" (("Hst3" 3))) ("UP:P53688" (("Hst4" 8)))
 ("UP:P53701"
  (("HCCs" 698) ("EpCAM(−)/K19(−) HCCs" 29) ("EpCAM(+)/K19(+) HCCs" 14)
   ("primary HCCs" 5) ("almost all HCCs" 4) ("most HCCs" 3)
   ("11/64 (17.2%) EpCAM(−)/K19(−) HCCs" 2)
   ("EpCAM(−)/K19(−) HCCs and EpCAM(+)/K19(+) HCCs" 2) ("than HCCs" 2)
   ("hMLH1-negative HCCs" 2) ("MGMT-negative and -positive HCCs" 2)
   ("10 months developed well-differentiated HCCs" 2) ("synchronous HCCs" 1)
   ("spontaneous HCCs" 1) ("β-Catenin-negative HCCs" 1)
   ("C/N-β-catenin-positive HCCs" 1) ("N/C β-catenin-positive HCCs" 1)
   ("only 7% HCCs" 1) ("morphologically pure HCCs" 1)
   ("both EpCAM(−)/K19(−) HCCs and EpCAM(+)/K19(+) HCCs" 1)
   ("than EpCAM(−)/K19(−) HCCs ( P <0.001 for both)" 1)
   ("than EpCAM(−)/K19(−) HCCs and EpCAM(+)/K19(+) HCCs ( P  = 0.032 and P  = 0.002, respectively)"
    1)
   ("than EpCAM(−)/K19(−) HCCs ( P  = 0.001 and P  = 0.005, respectively)" 1)
   ("than advanced HCCs" 1)
   ("the CB+ HCCs ( xref ) compared to the para-tumoral tissues" 1)
   ("20-paired clinical HCCs" 1) ("metastatic HCCs" 1) ("larger HCCs" 1)
   ("K19-positive HCCs" 1) ("non-β-catenin-mutated HCCs" 1)
   ("the five fibrolamellar HCCs" 1) ("invasive HCCs" 1)
   ("the remaining five hMLH1-negative HCCs" 1) ("hMLH1-positive HCCs" 1)
   ("10 hMLH1-negative HCCs" 1) ("MGMT-negative HCCs" 1) ("Most HCCs" 1)
   ("Those YAP1-positive HCCs" 1) ("both primary HCCs" 1)
   ("most human HCCs" 1)))
 ("UP:P53708" (("ITGA8" 3) ("Itga8" 3))) ("UP:P53741" (("Bre5" 4)))
 ("UP:P53778"
  (("p38γ" 219) ("MAPK12" 10) ("MAPK1/2" 4) ("SAPK3" 3) ("p38gamma" 1)
   ("P53778" 1) ("ERK6" 1)))
 ("UP:P53779"
  (("JNKs" 187) ("JNK3" 36) ("JNK-3" 3) ("MAPK10" 3) ("JNK3 protein" 2)
   ("pro-apoptotic molecule JNKs" 2) ("P-JNKs" 1) ("jnk3" 1)))
 ("UP:P53794" (("Smit" 5) ("SMIT" 4) ("SLC5A3" 3)))
 ("UP:P53801" (("PBF" 52) ("Pbf" 1)))
 ("UP:P53804" (("tetratricopeptide repeat domain 3" 4) ("TTC3" 2)))
 ("UP:P53805"
  (("RCAN1" 313) ("MCIP1" 5) ("DSCR1" 5) ("RCAN1 protein" 4)
   ("Regulator of calcineurin 1" 4) ("overexpressed RCAN1" 2)
   ("insoluble RCAN1" 2) ("Adapt78" 1)))
 ("UP:P53814" (("SMTN" 6) ("smoothelin" 4) ("SMOOTHELIN" 2)))
 ("UP:P53816"
  (("H-rev107" 113) ("HREV107" 19) ("PLA2G16" 19) ("H-REV107" 10)
   ("H-rev107 protein" 4) ("pH-rev107" 4) ("H-rev107 (FL) protein" 3)
   ("HRASLS3" 3) ("HREV107 protein" 2) ("H-rev107 (FL)" 1) ("PLA2G16-" 1)))
 ("UP:P53822" (("Cos1" 18))) ("UP:P53844" (("PITP" 1)))
 ("UP:P53847" (("Dsl1" 4))) ("UP:P53848" (("FASC" 1)))
 ("UP:P53903" (("PGA2" 4))) ("UP:P53917" (("FAR11" 3) ("Far11" 1)))
 ("UP:P53940" (("Apj1" 2))) ("UP:P53950" (("VAC7" 1)))
 ("UP:P53968" (("Crz1" 2)))
 ("UP:P53985"
  (("Solute carrier family 16" 3) ("SLC16A1" 2) ("solute carrier family 16" 2)
   ("monocarboxylate transporter 1" 1)))
 ("UP:P53990" (("Hist1" 3) ("HIST1" 2))) ("UP:P53992" (("SEC24C" 6)))
 ("UP:P53999"
  (("PC4" 142) (NIL 17) ("SUB1" 9) ("positive cofactor 4" 6) ("PC4-" 2)
   ("the transcriptional positive coactivator PC4" 1)
   ("the transcriptional co-activator PC4" 1) ("“PC4”" 1)))
 ("UP:P54075" (("PAFc" 7))) ("UP:P54098" (("POLG" 36) ("polg" 33) ("POLG1" 3)))
 ("UP:P54105" (("pICln" 2) ("CLNS1A" 1)))
 ("UP:P54108" (("crisp3" 2) ("CRISP3" 1)))
 ("UP:P54132"
  (("BLM" 2211) ("BLM protein" 20) ("BLM-" 11) ("BLM peptide" 9) ("p-BLM" 3)
   ("pBLM" 3) ("IR induced less BLM" 2) ("either normal BLM" 2)
   ("a normal BLM" 2) ("An essential BLM" 2)
   ("than wild-type BLM in G1 cells ( xref )" 1)
   ("E. coli –expressed and -purified MBP-tagged BLM" 1)
   ("Bloom syndrome protein" 1) ("replicational stress causes BLM" 1)
   ("the N-terminal 660 amino acids of BLM" 1) ("particular BLM" 1)))
 ("UP:P54136"
  (("RAR" 515) ("RARs" 248) ("RARS" 22) ("Retinoic acid receptors" 6)
   ("RAR protein" 3) ("the poor prognosis-associated RARs" 2) ("pRAR" 1)
   ("previously characterized functional RAR" 1) ("arginyl-tRNA synthetase" 1)
   ("the prognosis-associated RARs" 1)))
 ("UP:P54198" (("HIRA" 47) ("hIR" 17) ("HIRA protein" 3)))
 ("UP:P54212" (("DCA" 161) ("DCA-" 1))) ("UP:P54216" (("Aldo1" 1)))
 ("UP:P54227" (("LAG" 3)))
 ("UP:P54252"
  (("autosomal dominant" 563) ("ataxin-3" 66) ("Autosomal dominant" 17)
   ("Ataxin-3" 13) ("SCA3" 11) ("Cerebral autosomal dominant" 9) ("ataxin 3" 7)
   ("MJD" 7) ("spinocerebellar ataxia type 3" 7) ("Autosomal Dominant" 5)
   ("cerebral autosomal dominant" 5) ("Cerebral Autosomal Dominant" 4)
   ("the NOTCH3 gene cause cerebral autosomal dominant" 2) ("ATXN3" 2)
   ("a progressive autosomal dominant" 1)
   ("cause cerebral autosomal dominant" 1)
   ("the stroke and dementia disorder cerebral autosomal dominant" 1)
   ("a rare autosomal dominant" 1)
   ("aggregate-associated deubiquitinase ataxin-3" 1)
   ("cerebral arteriopathy autosomal dominant" 1)
   ("CADASIL Cerebral autosomal dominant" 1) ("Ataxin 3" 1)))
 ("UP:P54253"
  (("ATXN1" 92) ("ataxin-1" 34) ("Atxn1" 7) ("ATXN1 protein" 4) ("ataxin 1" 1)
   ("ATXN1-" 1)))
 ("UP:P54257" (("huntingtin-associated protein 1" 5)))
 ("UP:P54259"
  (("Atrophin-1" 8) ("atrophin-1" 8) ("DRPLA" 5) ("Atrophin" 2) ("ATN1" 1)
   ("atrophin" 1)))
 ("UP:P54274"
  (("TRF1" 711) ("TRF1 protein" 37) ("TERF1" 33) ("PIN2" 19)
   ("telomeric repeat binding factor 1" 4) ("cellular TRF1" 2)
   ("the telomeric TRF1" 2) ("Telomeric repeat binding factor 1" 2)
   ("the major TRF1" 2) ("TRF-1" 2) ("telomeric TRF1" 1)))
 ("UP:P54277" (("hPMS1" 50) ("PMS1" 22) ("hPMS1-" 3) ("Pms1" 2) ("pms1" 1)))
 ("UP:P54278"
  (("PMS2" 591) ("MutLα" 219) ("hPMS2" 84) ("mismatch repair protein" 45)
   ("PMS2 protein" 12) ("hPMS2 protein" 8) ("PMS2-" 7)
   ("at least one mismatch repair protein" 3) ("Pms2" 3) ("hPMS2-" 3)
   ("mismatch repair endonuclease PMS2" 2) ("MUTLα" 2) ("absent PMS2" 2)
   ("PMS2CL" 2) ("MutLα protein" 2)
   ("the most abundantly expressed mismatch repair
protein"
    1)
   ("mismatch repair
protein"
    1)
   ("monomeric PMS2" 1) ("the chromatin-associated PMS2" 1)
   ("Mismatch repair protein" 1)))
 ("UP:P54284" (("CACNB3" 6) ("beta 3 subunit" 2)))
 ("UP:P54289" (("CACNA2D1" 13) ("mHS3" 2)))
 ("UP:P54296"
  (("M protein" 54) ("paraproteins" 13) ("paraprotein" 9) ("M-protein" 6)
   ("Paraproteins" 2) ("M protein molecule" 2) ("the viral M protein" 1)
   ("m protein" 1)))
 ("UP:P54309" (("Siz" 2)))
 ("UP:P54315" (("pancreatic lipase related protein 1" 4)))
 ("UP:P54350" (("WEE" 2) ("pWEE" 1))) ("UP:P54360" (("FJ" 12) ("Fj" 7)))
 ("UP:P54368"
  (("ODC-AZ" 16) ("OAZ1" 4) ("ODC–AZ" 3) ("Oaz1" 2) ("Oaz" 2)
   ("antizyme 1" 1)))
 ("UP:P54479" (("zur" 3) ("Zur" 2))) ("UP:P54535" (("ARTP" 66)))
 ("UP:P54577"
  (("yrs" 258) ("YTS" 4) ("TyrRS" 4) ("YARS" 2) ("only 3.33 yrs" 1) ("YRs" 1)
   ("tyrosyl-tRNA synthetase" 1)))
 ("UP:P54578" (("USP14" 145) ("Usp14" 2) ("defective USP14" 1)))
 ("UP:P54609" (("CDC–48" 1))) ("UP:P54619" (("PRKAG1" 13)))
 ("UP:P54623" (("Cnn" 15) ("CNN" 5))) ("UP:P54631" (("SCW" 3)))
 ("UP:P54637" (("PTPC" 87) ("PTPc" 11)))
 ("UP:P54646"
  (("AMP-activated" 306) ("LKB1-AMPK" 132) ("PRKAA2" 89) ("Prkaa2" 9)
   ("AMPKa2" 8) ("LKB1–AMPK" 6) ("-AMP-activated" 3) ("Hmgcr" 2)))
 ("UP:P54652"
  (("HSPA2" 153) ("HSPA2 protein" 16) ("strong HSPA2" 4) ("HSPA2 peptide" 3)
   ("a spotty HSPA2" 2) ("Strong HSPA2" 2)))
 ("UP:P54672" (("APMA" 38)))
 ("UP:P54673"
  (("PI3-K" 856) ("PI3Ks" 754) ("PI3-Kinase" 75) ("PI3Kinase" 33) ("PI3 K" 28)
   ("PI3kinase" 25) ("PtdIns3K" 15) ("PI3 K" 10) ("PI3-Ks" 9) ("PI3Kinases" 5)
   ("PI-3-K" 5) ("PI3-K-" 4) ("PI-3kinase" 3) ("class I A PI3Ks" 2)
   ("PI3-K–" 2) ("p-PI3-K" 2) ("PtdIns 3-kinase" 2) ("PI3 K" 2)
   ("expressed PI3Ks" 2) ("the inflammatory PI3Ks" 2) ("distinct PI3Ks" 2)
   ("a nonconventional PI3-K–" 1) ("pPI3-K" 1) ("PI3ks" 1)
   ("their respective full-length PI3Ks" 1)
   ("the ubiquitous growth-linked PI3Ks" 1) ("only class I PI3Ks" 1)
   ("than PI3Ks (for further discussion, see supplemental Results)" 1)
   ("the two predominant PI3-K" 1) ("the predominant PI3-K" 1) ("Key PI3Ks" 1)
   ("one or more PI3Ks" 1) ("P-I3Kinase" 1) ("the distinct PI3Ks" 1)))
 ("UP:P54674" (("PIK2" 2))) ("UP:P54681" (("RatioA" 2)))
 ("UP:P54687" (("BCAT1" 5) ("Bcat1" 1) ("bcat1" 1)))
 ("UP:P54707" (("Na+/K+ transporting" 3) ("sodium/potassium ATPase" 3)))
 ("UP:P54709" (("ATP1B3" 1)))
 ("UP:P54725"
  (("yeast homolog" 128) ("hHR23a" 127) ("hHR23A" 38) ("RAD23A" 10)
   ("HHR23A" 9) ("nucleotide excision repair protein" 4) ("hHR23A protein" 2)
   ("RAD23" 2) ("the bacterial uvrC nucleotide excision repair protein" 2)
   ("than hHR23A ( xref )" 1) ("pure hHR23A" 1) ("than hHR23A" 1)))
 ("UP:P54727"
  (("RAD23B" 60) ("hHR23B" 36) ("HHR23B" 4) ("HR23B" 3) ("hHR23b" 2)
   ("Rad23b" 1) ("Rad23B" 1)))
 ("UP:P54753" (("EphB3" 14) ("EPHB3" 10) ("HEK2" 3)))
 ("UP:P54756"
  (("pBSK" 27) ("EPHA5" 12) ("brain-specific kinase" 3) ("BSK" 2) ("EphA5" 1)))
 ("UP:P54760" (("EphB4" 12) ("EPHB4" 7) ("HTK" 1)))
 ("UP:P54762"
  (("EphB1" 186) ("Elk" 157) ("ELK" 24) ("EPHB1" 15) ("pEPHB1" 2)
   ("overexpressed WT Elk" 2) ("-Elk" 1) ("ElK" 1) ("pELK" 1)
   ("dominant-negative EphB1-Y594F" 1) ("than WT Elk" 1)
   ("than wild-type (WT) Elk" 1)))
 ("UP:P54764" (("EphA4" 62) ("EPHA4" 11) ("SEK" 7) ("EPH receptor A4" 2)))
 ("UP:P54792" (("DVL" 102) ("dvl" 1) ("a dominant-negative DVL" 1)))
 ("UP:P54803" (("GalC" 10) ("GALC" 1) ("-GalC" 1)))
 ("UP:P54819"
  (("AK2" 16) ("Ak2" 3) ("Adenylate kinase 2" 2) ("adenylate kinase 2" 2)))
 ("UP:P54821"
  (("Prx1" 127) ("PRX1" 23) ("PRRX1" 7) ("Prrx1" 4) ("targeting Prx1" 2)
   ("Prx1 peptide" 2) ("Prx1 protein" 1)))
 ("UP:P54824" (("Xp54" 4)))
 ("UP:P54826" (("GAS1" 42) ("gas 1" 7) ("gas1" 5) ("GAS 1" 1)))
 ("UP:P54829"
  (("step" 7240) ("striatum" 403) ("Step" 277) ("STEP" 206)
   ("an essential step" 111) ("the homolateral striatum" 7)
   ("a pivotal step" 7) ("filtering step" 7) ("a subsequent step" 7)
   ("a vital step" 7) ("a proximal step" 6) ("a preliminary step" 5)
   ("An essential step" 5) ("This latter step" 5) ("-STEP" 4) ("PTPN5" 4)
   ("antigen retrieval step" 4) ("loading-step" 4) ("reversal step" 3)
   ("essential step" 3) ("the subsequent step" 3)
   ("a heat-induced antigen retrieval step" 3) ("the most proximal step" 3)
   ("the intermediary step" 3) ("a post-endocytic step" 3)
   ("an essential proximal step" 2) ("an intermediary step" 2)
   ("the first exploratory step" 2) ("the physical step" 2)
   ("each subsequent step" 2) ("an indispensable step" 2)
   ("the pivotal step" 2) ("The antigen retrieval step" 2) ("one more step" 2)
   ("a very proximal step" 2) ("An antigen retrieval step" 2)
   ("the first tumor suppressive step" 2) ("this latter step" 2)
   ("a secondary step" 2) ("The antigen retriewal step" 2)
   ("a slow internal step" 2) ("-step" 2) ("a more proximal step" 2)
   ("Striatum" 2) ("striatum (STR)" 2) ("secondary step" 2)
   ("a translational step" 2) ("a mandatory step" 2) ("PTPN-5" 2)
   ("the dorsal striatum" 2) ("the first observable step" 2)
   ("an obvious step" 2) ("a first preliminary step" 2)
   ("the first biochemical step" 2)
   ("a relatively harsh antigen retrieval step" 2) ("the essential step" 2)
   ("the latter step" 2) ("The latter step" 1) ("The intermediary step" 1)
   ("a first exploratory step" 1) ("an additional chromatographic step" 1)
   ("each exocytotic step" 1) ("a crucial proximate step" 1)
   ("the preanalytical step" 1) ("the preparative step" 1)
   ("a pre-requisite step" 1) ("than full-length STEP ( xref ; xref )" 1)
   ("biologically and clinically relevant step" 1) ("an operative step" 1)
   ("a BH3-domain-dependent step" 1)
   ("a high temperature antigen retrieval step" 1)
   ("the post-translational step" 1) ("a post-transcriptional step" 1)
   ("viral step" 1) ("a pivotal and required step" 1)
   ("a strong hyperpolarizing step" 1) ("an early mitotic step" 1)
   ("the included optional step" 1) ("a principal step" 1)
   ("the first pivotal step" 1) ("a unimolecular step" 1)
   ("earliest etiologic step" 1) ("an important preliminary step" 1)
   ("an associative
step"
    1)
   ("the anion-exchange step" 1) ("a potentially valuable step" 1)
   ("a sequential step" 1)
   ("the
hypotonic step"
    1)
   ("the proximal step" 1) ("untreated contralateral striatum" 1)
   ("the ultimate step" 1) ("a consecutive step" 1)
   ("this last filtering step" 1) ("the antigen retrieval step" 1)
   ("the metaplastic step" 1) ("the dramatic step" 1)
   ("the Mre11 nucleolytic step" 1) ("A subsequent step" 1)
   ("ventral striatum" 1) ("the preleukemic step" 1)
   ("the initial relevant step" 1) ("posttranscriptional step" 1)
   ("The first analytical step" 1) ("One essential step" 1)
   ("A principal step" 1) ("The former step" 1) ("a key intermediary step" 1)
   ("“one-step”" 1) ("a previously uncharacterized step" 1)
   ("the precise step" 1) ("The subsequent step" 1)
   ("the next investigational step" 1) ("manually drawn around striatum" 1)
   ("a compulsory step" 1) ("the translational step" 1)
   ("each elementary step" 1) ("a steepest descent step" 1)
   ("a key etiological step" 1) ("a rational step" 1) ("a nucleolytic step" 1)
   ("this manual step" 1) ("an ill-defined step" 1) ("this essential step" 1)
   ("an antigen retrieval step" 1) ("the multiplex step" 1)
   ("an important pathogenetic step" 1) ("the apical step" 1)
   ("the post-transcriptional step" 1) ("a considerable step" 1)
   ("a heat-induced epitope retrieval step" 1) ("another essential step" 1)
   ("a separate step" 1) ("this endocytic step" 1)
   ("the transcriptional step" 1) ("a relatively slow unimolecular step" 1)
   ("the same biochemical step" 1) ("the last washing step" 1)
   ("A pivotal step" 1) ("the distal step" 1) ("an early pivotal step" 1)
   ("the relevant step" 1) ("the major anaplerotic step" 1)))
 ("UP:P54840" (("GYS2" 11))) ("UP:P54841" (("kreisler" 1)))
 ("UP:P54845" (("NRL" 13) ("Nrl" 3)))
 ("UP:P54849"
  (("TMP" 53) ("epithelial membrane protein 1" 5) ("Emp1" 4) ("EMP-1" 3)
   ("EMP1" 3) ("Epithelial membrane protein 1" 2)))
 ("UP:P54851"
  (("EMP2" 271) ("Epithelial membrane protein 2" 3)
   ("epithelial membrane protein 2" 2)))
 ("UP:P54855" (("UGT2B15" 50) ("polypeptide B15" 3)))
 ("UP:P54868" (("HMGCS2" 26) ("HMG-CoA synthase" 5)))
 ("UP:P54873"
  (("synthase" 518) ("Synthase" 116) ("synthase (PGHS)" 7)
   ("synthase (PTGS)" 6) ("HMGS" 5) ("synthase (PGIS)" 5) ("-synthase" 4)
   ("synthase (MTR)" 4) ("synthase (TXAS)" 4) ("synthase (TS)" 3)
   ("synthase (SMS)" 3) ("thromboxane A synthase" 2) ("synthase (HAS)" 2)
   ("Synthase (TS)" 2) ("Fatty Acid Synthase (FAS)" 2) ("synthase ( PTGIS )" 2)
   ("synthase (CBS)" 2) ("synthase peptide" 2) ("microsomal PGE2 synthase" 2)
   ("synthase (GS)" 2) ("synthase (PKS)" 2) ("Synthase (NOS)" 2)
   ("synthase (PGFS)" 2) ("synthase (HMGCS)" 1) ("synthase ( NANS )" 1)
   ("Synthase (FAS)" 1) ("Fatty Acid Synthase" 1)
   ("thromboxane A 2 synthase (TXAS)" 1) ("synthase ( PGES )" 1)
   ("synthase ( MTR )" 1)
   ("the pseudouridine synthase that alters the ribosome's" 1)))
 ("UP:P54886" (("member A1" 24))) ("UP:P54909" (("TRBD" 92)))
 ("UP:P54920" (("NAPA" 2))) ("UP:P54964" (("REX2" 60) ("Rex2" 5)))
 ("UP:P54968" (("IL-R1" 3) ("ILR1" 2))) ("UP:P54998" (("SoxC" 3)))
 ("UP:P55000"
  (("MDM" 803) ("MDMs" 601) ("M-DM" 69) ("Mdm" 32) ("primary MDMs" 16)
   ("peritoneal M-DM" 10) ("primary MDM" 9) ("Nef-treated MDMs" 6)
   ("BFA-treated MDMs" 4) ("than MDMs" 4) ("Peritoneal M-DM" 4)
   ("rNef-treated MDMs" 3) ("cirrhotic peritoneal M-DM" 3) ("normal MDMs" 2)
   ("MDMs protein" 2) ("HIV-1-infected/activated MDM" 2)
   ("mock-infected MDM" 1) ("CXCL8-treated MDM" 1)
   ("CXCL8-treated HIV-1-infected MDM" 1) ("than GM-CSF MDMs [ xref ]" 1)
   ("than MDMs (  xref )" 1) ("than MDMs ( xref  )" 1) ("only one MDM" 1)
   ("than untreated MDMs ( xref )" 1) ("mdm" 1) ("whose MDM" 1)
   ("zidovudine-treated HIV-1-infected MDM" 1) ("mature MDMs" 1)
   ("Nef-treated MDM" 1) ("this hypothesis primary MDMs" 1)
   ("human inflammatory MDMs" 1) ("both MDM’s" 1)
   ("isolated peritoneal M-DM" 1) ("the peritoneal M-DM" 1)))
 ("UP:P55001" (("MFAP2" 19)))
 ("UP:P55008"
  (("G 1" 2461) ("Iba1" 88) ("-G 1" 33) ("–G 1" 24) ("Iba-1" 16) ("AIF1" 14)
   ("IBA-1" 12) ("IBA1" 9) ("Aif1" 4) ("AIF-1" 3)
   ("the microglial marker IBA-1" 2) ("G  1" 2) ("aif1" 2) ("Iba1-" 2)
   ("the microglial marker Iba1" 2) ("than G 1" 1)
   ("Allograft Inflammatory Factor 1" 1) ("normal G 1" 1) ("Aberrant G 1" 1)
   ("the G 1 , S" 1) ("ionized calcium-binding adapter molecule 1" 1)))
 ("UP:P55010"
  (("eIF5" 72) ("EIF5" 5) ("eukaryotic translation initiation factor 5" 1)
   ("eight times more eIF5" 1)))
 ("UP:P55011" (("NKCC1" 2) ("SLC12A2" 1)))
 ("UP:P55017"
  (("NaCl" 17998) ("NaCL" 42) ("NCC" 39) ("Nacl" 34) ("NaCl (TBS)" 9)
   ("SLC12A3" 4) ("ice-cold 0.9% NaCl" 3)
   ("cold physiologial salt solution (PSS) 118 mmol/l NaCl" 2) ("NaCl-" 2)
   ("a linear gradient 0.05–0.4 M NaCl" 1) ("approximately 50 mM NaCl" 1)
   ("hyperosmotic NaCl" 1) ("than simple random sampling NCC 3" 1)
   ("the mildly dissociative NaCl" 1) ("NCCT" 1)))
 ("UP:P55036"
  (("AF" 1358) ("S5a" 216) ("A-F" 52) ("lone AF" 30) ("A–F" 22)
   ("aminoflavone" 8) ("Aminoflavone" 6) ("PSMD4" 5) ("Lone AF" 4) ("AF-" 3)
   ("AF protein" 2) ("-AF488" 2) ("s5a" 1) ("Intrinsic proteasomal S5a" 1)
   ("RPN10" 1) ("A−F" 1) ("common sporadic AF" 1) ("sporadic AF" 1)
   ("2,517 incident AF" 1) ("pSTAT4 (pY693)-AF647" 1)
   ("pSTAT3 (pY705)-AF488" 1) ("-AF647" 1) ("MCB1" 1)))
 ("UP:P55040"
  (("GEM" 208) ("GEMs" 171) ("pGEM" 169) ("KIR" 101) ("Gem" 18) ("Kir" 14)
   ("gem" 10) ("GEM-" 5) ("pGem" 5) ("GeM" 4) ("buoyant GEMs" 2)
   ("Triton-insoluble GEMs" 2) ("“KIR”" 1) ("Nf1 preclinical GEM" 1)
   ("only male Nf1 GEM" 1) ("only female Nf1 GEM" 1) ("GEM protein" 1)
   ("than Gem" 1) ("a defective KIR" 1) ("well-defined GEM" 1) ("kir" 1)
   ("a functional KIR" 1)))
 ("UP:P55042"
  (("RAD" 271) ("RRAD" 243) ("-RAD" 9) ("RAD peptide" 4) ("pRAD" 3)
   ("the mTORC1 inhibitor RAD001" 2)))
 ("UP:P55055"
  (("LXRβ" 77) ("NR1H2" 10) ("group H" 5) ("NERI" 4) ("Neri" 3) ("Group H" 3)
   ("LXRB" 2) ("liver X receptor-beta" 1) ("using NERI's" 1)
   ("than LXRβ ( xref )" 1)))
 ("UP:P55056" (("APOC4" 5) ("ApoC4" 2) ("apolipoprotein C-IV" 1)))
 ("UP:P55058"
  (("PLTP" 253) ("Phospholipid transfer protein" 3)
   ("phospholipid transfer protein" 3) ("intranuclear PLTP" 1)
   ("phospholipid transfer protein (PLTP)" 1) ("that PLTP's" 1)))
 ("UP:P55060" (("CSE1L" 4) ("Exp2" 3) ("exp2" 2) ("Xpo2" 1)))
 ("UP:P55061"
  (("BI-1" 4) ("Bax inhibitor 1" 4) ("TEGT" 2) ("Bis-1" 2) ("TMBIM6" 1)
   ("BI1" 1)))
 ("UP:P55064"
  (("Aquaporin 5" 5) ("AQP5" 4) ("AQP-5" 3) ("Aquaporin-5" 2) ("Aqp5" 1)))
 ("UP:P55072"
  (("VCP" 745) ("TERA" 156) ("tera" 8) ("TeRAS" 7) ("TeRas" 7)
   ("VCP protein" 5) ("TERA protein" 2) ("overexpressed myc-tagged VCP" 2)
   ("overexpressed VCP" 2) ("valosin containing protein" 1) ("Given VCP's" 1)
   ("Given VCP" 1) ("VCP-" 1) ("transiently overexpressed VCP" 1)))
 ("UP:P55073" (("DIO3" 9) ("Dio3" 2)))
 ("UP:P55075"
  (("FGF8" 218) ("Fgf8" 30) ("FGF-8" 13) ("strong FGF8" 2)
   ("androgen-induced growth factor" 2) ("fgf8" 2)
   ("fibroblast growth factor 8" 2) ("exogenous Fgf8" 1)))
 ("UP:P55084" (("TPβ" 28) ("Hadhb" 1)))
 ("UP:P55085"
  (("PAR-2" 255) ("PAR2" 28) ("Par2" 8) ("F2RL1" 4) ("F2rl1" 2)
   ("proteinase-activated receptor 2" 1) ("Cortical PAR-2" 1)
   ("cortical PAR-2" 1) ("1.5 μM polymerized tubulin rescued PAR-2’s" 1)
   ("1.5 μM polymerized tubulin rescued PAR-2" 1) ("par2" 1)))
 ("UP:P55087"
  (("AQP4" 3) ("aquaporin-4" 1) ("Aquaporin-4" 1) ("aquaporin 4" 1)))
 ("UP:P55089" (("urocortin" 6))) ("UP:P55103" (("INHBC" 4)))
 ("UP:P55107" (("BIP" 40) ("Gdf10" 2))) ("UP:P55145" (("ARMET" 8)))
 ("UP:P55160"
  (("Hem-1" 173) ("Hem-1 peptide" 6) ("hematopoietic protein 1" 3) ("HEM-1" 2)
   ("Versatile Hem-1" 2) ("Hem1" 2) ("residual Hem-1" 1) ("separate Hem-1" 1)))
 ("UP:P55196"
  (("afadin" 127) ("AF6" 11) ("Afadin" 9) ("intestinal epithelial afadin" 2)
   ("MLLT4" 2)))
 ("UP:P55197" (("MLLT10" 22) ("AF10" 18)))
 ("UP:P55198" (("MLLT6" 6) ("AF17" 1)))
 ("UP:P55199" (("ELL" 140) ("ell" 30) ("ells" 27) ("ELL-" 10) ("ELL1" 2)))
 ("UP:P55201"
  (("bromodomain-containing protein" 18) ("BRPF1" 7)
   ("Bromodomain-containing protein" 1) ("140kD" 1)))
 ("UP:P55209" (("NAP1L1" 9) ("HnRPs" 2)))
 ("UP:P55210"
  (("caspase-7" 336) ("CASP7" 174) ("caspase 7" 104) ("Caspase-7" 79)
   ("Caspase 7" 22) ("caspase7" 7) ("Casp7" 4) ("MCH3" 2)
   ("the pro-apoptotic factor caspase-7" 2) ("caspase-7 protein" 2)
   ("miR-106b directly targets caspase-7" 2) ("than Caspase-7" 1)
   ("-caspase 7" 1) ("further affecting pro-apoptotic factor caspase-7" 1)
   ("pro-apoptotic factor caspase-7" 1) ("P55210" 1) ("CMH-1" 1) ("Mch3" 1)
   ("ICE-LAP3" 1)))
 ("UP:P55211"
  (("caspase-9" 1801) ("caspase 9" 575) ("Caspase-9" 145) ("CASP9" 130)
   ("Casp9" 70) ("Caspase 9" 50) ("caspases-9" 17) ("caspase9" 9)
   ("CASPASE 9" 7) ("p-caspase-9" 7) ("procaspase3" 5) ("caspase-9-" 4)
   ("Mch6" 3) ("caspase 9-" 3) ("ICE-LAP-6" 2) ("Apaf-3" 2)
   ("total and cleaved caspase-9" 2) ("original caspase-9" 2)
   ("apical caspase-9" 2) ("a functional Casp9" 2)
   ("the pro-apoptotic caspase-9" 2)
   ("pCDNA3-Flag-dominant negative caspase 9" 1) ("caspase-9 protein" 1)
   ("subsequent caspase-9" 1) ("CASPASE 9-" 1) ("caspase 9 (LEHD)" 1)
   ("the apical caspase-9" 1) ("Mature caspase-9" 1) ("Pro-apoptotic CASP9" 1)
   ("only p35 caspase-9" 1) ("the mitochondrial-dependent caspase 9" 1)
   ("very little caspase-9" 1) ("Caspases-9" 1) ("caspase-9–" 1) ("MCH6" 1)
   ("than CASP9" 1) ("25-fold more CASP9" 1) ("G-Rh2-induced caspase-9" 1)))
 ("UP:P55212"
  (("caspase-6" 77) ("CASP6" 46) ("caspase 6" 12) ("Caspase-6" 8)
   ("caspases-6" 3) ("Casp6" 2) ("Caspase 6" 1)))
 ("UP:P55241"
  (("SH2" 1638) (NIL 53) ("SH2-" 26) ("SH2 protein" 10) ("-SH2" 7)
   ("intact SH2" 3) ("potential SH2" 2) ("the regulatory SH2" 2) ("–SH2" 2)
   ("the aforementioned SH2" 1) ("a classical SH2" 1) ("classical SH2" 1)
   ("Intact SH2" 1) ("Most SH2" 1) ("nearly every human SH2" 1)
   ("the associated SH2" 1) ("one possible SH2" 1) ("possible SH2" 1)
   ("adjacent SH2" 1)))
 ("UP:P55248" (("SH4" 19) ("sh4" 15) ("Sh4" 1)))
 ("UP:P55263"
  (("AK" 367) ("adenosine kinase" 7) ("Adk" 6) ("ADK" 5) ("AK-" 2)
   ("erminal F AK (CNTF)" 1) ("AK (CNTF)" 1) ("Ak" 1)))
 ("UP:P55265" (("ADAR1" 124) ("ADAR" 15) ("Adar" 3)))
 ("UP:P55268" (("LAMS" 1)))
 ("UP:P55273"
  (("CDKN2D" 26) ("p19 INK4D" 20) ("p19 INK4d" 10) ("INK4D" 9) ("p19 Ink4d" 3)
   ("Cdkn2d" 2) ("p19ink4d" 2) ("ink4d" 2) ("INK4d" 2) ("p19INK4" 2)
   ("p19INK4D" 1) ("Ink4d" 1)))
 ("UP:P55283" (("R-cadherins" 22) ("CDH4" 10) ("cadherin 4" 1)))
 ("UP:P55285"
  (("cadherin-6" 6) ("K-cadherin" 5) ("CDH6" 4) ("cadherin 6" 3) ("P55285" 1)
   ("Cdh6" 1)))
 ("UP:P55286" (("cadherin-8" 5) ("CDH8" 4) ("cadherin 8" 1)))
 ("UP:P55287"
  (("CDH11" 222) ("cadherin-11" 146) ("cadherin 11" 45) ("Cadherin-11" 21)
   ("OB-cadherin" 11) ("OB-Cadherin" 3) ("osteoblast cadherin" 2)
   ("cadherin-11 (UTR)" 2) ("Cadherin 11" 2) ("the mesenchymal cadherin-11" 2)
   ("cadherin-11 protein" 1) ("CAD11" 1) ("intact CDH11" 1) ("Cdh11" 1)
   ("CDH11 protein" 1)))
 ("UP:P55289" (("CDH12" 3) ("cadherin 12" 1)))
 ("UP:P55290"
  (("CDH13" 135) ("T-cadherin" 26) ("cadherin 13" 9) ("H-cadherin" 6)
   ("T-Cadherin" 3) ("Cadherin 13" 2) ("cadherin-13" 1)))
 ("UP:P55291" (("cadherin 15" 4) ("M-cadherin" 3) ("CDH15" 1)))
 ("UP:P55316"
  (("Qin" 30) ("Foxg1" 13) ("BF1" 4) ("BF-1" 3) ("QIN" 1) ("FoxG1" 1)
   ("Fkh2" 1) ("FOXG1" 1) ("qin" 1)))
 ("UP:P55317"
  (("FOXA1" 1595) ("Foxa1" 29) ("forkhead box A1" 19) ("FOXA1 protein" 11)
   ("FOXA1-" 9) ("Forkhead box A1" 4) ("targeting FOXA1" 4)
   ("transcription factor-3a" 4) ("HNF-3-alpha" 3)
   ("pGIPZ lentiviral shRNAmir targeting FOXA1" 2) ("excessive FOXA1" 2)
   ("concomitantly overexpressed FOXA1" 2) ("overexpressed FOXA1" 2)
   ("HNF3α" 2) ("ER(-) AR(+) FOXA1" 2)
   ("the IHC signature ER(-) AR(+) FOXA1" 2) ("ESR1 (-) AR (+) FOXA1" 2)
   ("than FOXA1 (e.g. in LNCaP+shFOXA1 or DU145+AR cells)" 1)
   ("Too much FOXA1" 1) ("the differential FOXA1" 1) ("HNF3A" 1)
   ("residual FOXA1" 1) ("differential FOXA1" 1) ("than FOXA1" 1)
   ("HNF-3A" 1)))
 ("UP:P55318" (("FOXA3" 18) ("Foxa3" 11) ("FoxA3" 5) ("forkhead box A3" 4)))
 ("UP:P55320" (("GIH" 5) ("pGIH" 1))) ("UP:P55321" (("MIH" 9)))
 ("UP:P55327" (("TPD52" 16) ("tumor protein D52" 3)))
 ("UP:P55344" (("LIM2" 48) ("MP17" 1) ("MP19" 1) ("Lim2" 1)))
 ("UP:P55345" (("PRMT2" 2) ("hMT1" 1))) ("UP:P55347" (("pREP1" 2) ("PREP1" 1)))
 ("UP:P55735"
  (("Sec13" 8) ("SEC13 protein" 5) ("SEC13" 4) ("Sec13 protein" 2)))
 ("UP:P55769" (("NHP2L1" 13))) ("UP:P55771" (("PAX9" 19)))
 ("UP:P55773"
  (("CCL23" 18) ("MIP-3" 8) ("macrophage inflammatory protein-3" 2)
   ("MIP3" 1)))
 ("UP:P55774"
  (("Parc" 11) ("PARC" 9) ("DC-CK1" 2) ("CCL18" 2) ("AMAC1" 2) ("‘Parc’" 2)))
 ("UP:P55786" (("NPEPPS" 2)))
 ("UP:P55789"
  (("Hippo" 1726) ("HSS" 217) ("augmenter of liver regeneration" 2) ("ERV1" 1)
   ("GFER" 1) ("hepatopoietin" 1)))
 ("UP:P55791" (("nociceptin" 4)))
 ("UP:P55795" (("hnRNPH2" 4) ("Hnrnph2" 1) ("HNRNPH2" 1)))
 ("UP:P55809" (("OXCT1" 2) ("SCOT" 2)))
 ("UP:P55822" (("SH3BGR" 5) ("SH3BGR protein" 2)))
 ("UP:P55824" (("FAF" 5) ("Faf" 2)))
 ("UP:P55851"
  (("UCP2" 91) ("GG" 11) ("uncoupling protein 2" 8) ("UCP-2" 6) ("Ucp2" 3)
   ("Mitochondrial uncoupling protein 2" 3)
   ("mitochondrial uncoupling protein 2" 2) ("UCP 2" 1) ("a viable GG" 1)))
 ("UP:P55852" (("Smt3" 17) ("SUM1" 4) ("-Smt3" 1)))
 ("UP:P55853"
  (("SUMO" 1866) ("Sumo" 57) ("small ubiquitin-related modifier" 23)
   ("sumo" 16) ("SUMOs" 15) ("-SUMO" 12) ("SUMO protein" 8)
   ("small ubiquitin-related modifier (SUMO)" 3) ("most SUMO" 1) ("new SUMO" 1)
   ("SUMO-" 1) ("pSUMO" 1)))
 ("UP:P55854" (("SUMO3" 50) ("Sumo2" 7) ("-SUMO3" 1)))
 ("UP:P55884"
  (("eIF3b" 75) ("eukaryotic translation initiation factor 3" 11) ("EIF3B" 6)
   ("eIF3η" 4) ("eukaryotic translation initiation factor 3 subunit B" 2)
   ("eIF3b protein" 1)))
 ("UP:P55895"
  (("Rag2" 233) ("RAG2" 48) ("rag2" 21) ("RAG-2" 3) ("Rag  2" 1)
   ("RAG2 protein" 1)))
 ("UP:P55899"
  (("α-chain" 148) ("FcRn" 8) ("neonatal Fc receptor" 2) ("FCGRT" 2)
   ("alpha-chain" 1) ("α–chain" 1)))
 ("UP:P55906" (("MP78" 1)))
 ("UP:P55916"
  (("UCP3" 44) ("uncoupling protein 3" 6) ("Ucp3" 3)
   ("mitochondrial uncoupling protein 3" 2)))
 ("UP:P55954" (("C-CO 2" 4)))
 ("UP:P55957"
  (("Bid" 2316) ("tBid" 1171) ("BID" 1024) ("tBID" 400) ("truncated Bid" 46)
   ("Bid peptide" 28) ("Bid protein" 22)
   ("BH3 interacting domain death agonist" 18) ("pBid" 16) ("BID peptide" 14)
   ("BH3-interacting domain death agonist" 14) ("tBid protein" 10)
   ("BID protein" 7) ("truncated BID" 6) ("Truncated Bid" 5) ("t-Bid" 4)
   ("Truncated BID" 4) ("Pro-apoptotic Bid" 4) ("overexpressed Bid" 3)
   ("intact Bid" 3) ("Bid molecule" 3) ("-Bid" 3)
   ("the pro-apoptotic protein Bid" 3) ("tBID molecule" 3)
   ("proapoptotic Bid" 3) ("BID-" 3) ("than BID" 2) ("nonfunctional Bid" 2)
   ("than tBid" 2) ("the pro-apoptotic Bcl-2 protein Bid" 2)
   ("Proapoptotic BH3 interacting domain death agonist" 2)
   ("the well-established caspase 8 substrate Bid" 2)
   ("than Bid +/+ ( xref )" 2) ("ptBid" 2)
   ("the Bcl-2 pro-apoptotic BH3 single-domain protein Bid" 2)
   ("commercial caspase-8-cleaved Bid" 2) ("fluorescent Bid" 2)
   ("Intact Bid" 1) ("intact (∼25 kD) Bid" 1) ("fluorescent Bid peptide" 1)
   ("than the BID peptide" 1) ("the pro-apoptotic molecule BID" 1)
   ("proapoptotic BID" 1) ("Bax accelerated tBid" 1) ("external tBid" 1)
   ("pro-apoptotic protein Bid" 1) ("pro-apoptotic Bid" 1)
   ("the traditional cytosolic caspase-8 substrate BID" 1)
   ("than full-length Bid" 1) ("‘empty' vector Bid" 1) ("tBid molecule" 1)
   ("than Bid" 1) ("The pro-apoptotic Bcl-2 protein Bid" 1)
   ("whose product tBid" 1) ("the Bcl-2 family pro-apoptotic protein Bid" 1)
   ("P55957" 1) ("the pro-apoptotic protein BID" 1) ("than free tBID" 1)
   ("intact tBID" 1) ("intact BID" 1)
   ("the pro-apoptotic Bcl-2 family member Bid" 1) ("that BID's" 1)
   ("clearly place Bid" 1) ("examined Bid's" 1)
   ("The human pro-apoptotic protein tBid" 1)
   ("the human pro-apoptotic protein tBid" 1) ("Bid-" 1)
   ("pro-apoptotic BID protein" 1)))
 ("UP:P55965" (("TRG" 107) ("pTRG" 8) ("a favorable TRG" 1)))
 ("UP:P55981" (("VacA" 30) ("vacA" 11) ("vacuolating cytotoxin A" 7)))
 ("UP:P56134" (("subunit f" 5))) ("UP:P56159" (("Gfra1" 63) ("GFRA1" 11)))
 ("UP:P56177" (("DLX1" 2)))
 ("UP:P56178"
  (("DLX5" 128) ("Dlx5" 44) ("DLX5 protein" 6) ("distal-less homeobox 5" 2)))
 ("UP:P56179" (("DLX6" 7) ("Dlx6" 2) ("DLX6 protein" 2)))
 ("UP:P56180" (("PTEN2" 17) ("TPTE" 1)))
 ("UP:P56181" (("NDUFV3" 6) ("10kDa" 2)))
 ("UP:P56182" (("RRP1" 1) ("NNP-1" 1)))
 ("UP:P56192"
  (("MARs" 43) ("MaRS" 2) ("nucleolar MARs" 2)
   ("methionyl-tRNA synthetase ( MARS )" 2) ("methionyl-tRNA synthetase" 1)
   ("different potential MARs" 1)))
 ("UP:P56199" (("ITGA1" 126) ("CD49a" 4) ("Itga1" 3) ("integrin alpha 1" 1)))
 ("UP:P56202" (("CTSW" 2) ("cathepsin W" 1)))
 ("UP:P56211"
  (("cAMP-regulated phosphoprotein" 4) ("19kDa" 3) ("ARPP-19" 3) ("Arpp19" 1)
   ("cAMP-regulated phosphoprotein 19" 1)
   ("cAMP-regulated phosphoprotein-19" 1)
   ("cAMP-regulated phosphoprotein-" 1)))
 ("UP:P56224" (("Taiji" 1))) ("UP:P56264" (("caerulein" 65) ("Caerulein" 6)))
 ("UP:P56270"
  (("MAZ" 111) ("Maz" 62) ("pMAZ" 9)
   ("Myc-associated zinc-finger protein (MAZ)" 2)
   ("Myc-associated zinc-finger" 1)))
 ("UP:P56279" (("TCL1A" 17) ("oncogene TCL1" 2))) ("UP:P56282" (("POLE2" 3)))
 ("UP:P56377"
  (("X-linked" 223) ("mental retardation" 216)
   ("mental retardation protein (FMRP)" 8) ("severe mental retardation" 7)
   ("mental retardation protein" 7) ("X-Linked (ATRX)" 6) ("x-linked" 5)
   ("mild mental retardation" 5) ("mental retardation (MR)" 5)
   ("mental retardation (MRX)" 4) ("nonsyndromic mental retardation" 3)
   ("psychosis and premorbid mild mental retardation" 2)
   ("X-linked nonsyndromic mental retardation" 2)
   ("profound mental retardation" 2)
   ("the Fragile X mental retardation protein (FMRP)" 2)
   ("cytoplasmic fragile X mental retardation" 2)
   ("mental retardation (XMLR)" 2) ("X-Linked" 2)
   ("Down syndrome-related mental retardation" 1) ("a severe X-linked" 1)
   ("fragile X mental retardation" 1)
   ("Moderate-to-severe mental retardation" 1) ("X-linked (SPRX)" 1)
   ("fragile X mental retardation protein (FMRP)" 1)
   ("the fragile X mental retardation protein (FMRP)" 1) ("AP1S2" 1)
   ("Fragile X mental retardation protein (FMRP)" 1)
   ("the fragile X mental retardation protein" 1)))
 ("UP:P56381" (("ATP5E" 1)))
 ("UP:P56385" (("subunit E" 11) ("ATP5I" 2) ("subunit e" 1)))
 ("UP:P56470"
  (("GAL4" 621) ("Gal4" 620) ("Gal-4" 12) ("GAL-4" 12) ("Gal4-" 10) ("-GAL4" 8)
   ("gal4" 7) ("GAL4 protein" 6) ("-Gal4" 5) ("LGALS4" 3) ("GAL4-" 3)
   ("pGal4" 2) ("Gal 4" 1) ("galectin-4" 1)))
 ("UP:P56524"
  (("HDAC4" 2449) ("HDAC4 protein" 64) ("histone deacetylase 4" 34)
   ("Histone deacetylase 4" 9) ("-HDAC4" 8) ("HDAC-4" 4) ("HDAC4-" 4)
   ("Hdac4" 3) ("brachydactyly-mental retardation syndrome" 2)
   ("associated HDAC4" 2) ("an especially strong HDAC4" 2)
   ("miR-125a-5p directly targets HDAC4" 2) ("pHDAC4 protein" 2) ("HD4" 2)
   ("strong HDAC4" 2) ("allosterically binding HDAC4" 2)
   ("physical exercise revealed HDAC4" 1) ("miR-200a directly targets HDAC4" 1)
   ("Subcelluar HDAC4" 1) ("miRNAs specifically target HDAC4" 1)
   ("Cartilage specific miR-140 directly targets HDAC4 3" 1)
   ("Exogenous HDAC4" 1) ("pHDAC4" 1) ("very little HDAC4 protein" 1)
   ("than HDAC4" 1) ("bacterial HDAC4" 1) ("lentiviral HDAC4" 1)
   ("most HDAC4" 1)))
 ("UP:P56528" (("I19" 9))) ("UP:P56530" (("P-V" 129) ("P-v" 1)))
 ("UP:P56537"
  (("eIF6" 7) ("EIF3a" 5) ("The ribosome-associated factor eIF6" 1)))
 ("UP:P56539"
  (("caveolin" 941) ("caveolin-3" 48) ("Caveolin" 39) ("Cav3" 26) ("CAV3" 25)
   ("caveolin-" 14) ("Caveolin-3" 13) ("caveolin protein" 11) ("Cav-3" 5)
   ("the muscle-specific caveolin-3" 4) ("caveolin 3" 3) ("cav-3" 3)
   ("caveolin molecule" 3) ("the principal caveolin" 2) ("more caveolin" 2)
   ("More intense caveolin" 2) ("muscle-specific Caveolin-3" 2) ("CAV-3" 2)
   ("dynamic caveolin" 2) ("Caveolin 3" 1) ("dermal fibroblasts caveolin" 1)
   ("muscle-specific caveolin-3" 1) ("LQT9" 1) ("M-caveolin" 1)))
 ("UP:P56545"
  (("CtBP2" 590) ("CTBP2" 21) ("RIBEYE" 4) ("presynaptic CtBP2" 2)
   ("the monomeric CtBP2" 2) ("monomeric CtBP2" 2) ("Ribeye" 2)
   ("the presynaptic marker CtBP2" 1) ("intact CtBP2" 1)
   ("than wt CtBP2 (Fig. xref )" 1) ("than H6-CtBP2 (top panel)" 1)
   ("than CtBP2" 1) ("than the wt CtBP2" 1) ("Flag-HA-tagged CtBP2" 1)))
 ("UP:P56556" (("B14" 21) ("B14 protein" 4) ("b14" 3) ("14kDa" 3) ("B14)" 2)))
 ("UP:P56557" (("TMEM50B" 2) ("C21orf4 protein" 2) ("C21orf4" 2)))
 ("UP:P56559" (("LAK" 26) ("ARL4C" 2))) ("UP:P56570" (("IFE-5" 27)))
 ("UP:P56579" (("SBL" 5)))
 ("UP:P56645"
  (("PER3" 34) ("Per3" 10) ("period circadian clock 3" 2) ("per3" 1)
   ("Per3-" 1)))
 ("UP:P56693"
  (("SOX10" 204) ("Sox10" 130) ("dom" 16) ("SOX10 protein" 5) ("sox10" 2)))
 ("UP:P56703"
  (("Wnt3" 108) ("WNT3" 54) ("Wnt-3" 8) ("WNT-3" 2) ("Wnt3 protein" 2)))
 ("UP:P56704"
  (("Wnt3a" 659) ("Wnt3A" 160) ("Wnt-3a" 145) ("WNT3A" 129)
   ("Wnt3a protein" 12) ("Wnt3a-" 4) ("wnt3a" 4) ("canonical Wnt3a" 3)
   ("WNT3A protein" 2) ("member 3A" 2) ("exogenous WNT3A" 2) ("Wnt3a−" 2)
   ("WNT3a" 1) ("Wnt3A-" 1) ("at least Wnt3a" 1) ("exogenously-added WNT3A" 1)
   ("Wnt-3a protein" 1) ("purified canonical Wnt3a" 1) ("exogenous Wnt3a" 1)
   ("than Wnt3a" 1)))
 ("UP:P56705"
  (("Wnt4" 77) ("WNT4" 51) ("Wnt-4" 10) ("wnt4" 2) ("WNT-4" 1)
   ("WNT4 protein" 1) ("-Wnt4" 1)))
 ("UP:P56706"
  (("WNT7B" 34) ("Wnt7b" 9) ("WNT-7b" 2) ("Wnt-7b" 2) ("WNT7B protein" 2)
   ("wnt7b" 2) ("WNT7b" 1) ("Wnt7B" 1)))
 ("UP:P56721"
  (("NSC" 398) ("COL" 202) ("embryonic NSC" 2) ("The immortalized human NSC" 1)
   ("1 μM NSC's" 1) ("the optimal COL" 1) ("both embryonic and adult NSC" 1)
   ("enhanced embryonic NSC" 1) ("embryonic and adult NSC" 1)
   ("sagittal NSC" 1)))
 ("UP:P56730" (("PRSS12" 1))) ("UP:P56746" (("claudin-15" 4) ("CLDN15" 1)))
 ("UP:P56747" (("claudin 6" 4) ("claudin-6" 4) ("CLDN6" 2)))
 ("UP:P56748" (("claudin-8" 5) ("CLDN8" 4)))
 ("UP:P56750" (("claudin-17" 27) ("claudin-17 protein" 1)))
 ("UP:P56817"
  (("BACE1" 185) ("BACE-1" 47) ("BACE1 protein" 16) ("Bace1" 3) ("BACE" 2)))
 ("UP:P56856" (("CLDN18" 4) ("Claudin-18" 2) ("claudin-18" 2)))
 ("UP:P56871" (("cisRA" 1)))
 ("UP:P56915"
  (("GSCs" 1271) ("than GSCs" 5) ("CPEB1-overexpressing GSCs" 4)
   ("infiltrative GSCs" 4) ("the wild-type STAT3-expressing GSCs" 3)
   ("viable GSCs" 2) ("UCN-01 efficiently kills GSCs" 2) ("most GSCs" 2)
   ("STAT3 mutant-expressing GSCs" 1) ("treated GSCs" 1) ("primary GSCs" 1)
   ("Primary GSCs" 1) ("perivascular GSCs" 1) ("quiescent (G0) GSCs" 1)
   ("10 5 GFP-expressing GSCs" 1) ("most low-sensitivity GSCs" 1)
   ("healthy GSCs" 1) ("Sema3C preferentially supports GSCs" 1)
   ("EGFRvIII + infiltrative GSCs" 1) ("than GSCs transfected with pcDNA3.1" 1)
   ("than GSCs transfected with nc-siRNA" 1) ("than GSCs (Figure xref )" 1)))
 ("UP:P56937" (("HSD17B7" 1)))
 ("UP:P56945"
  (("p130Cas" 415) ("BCAR1" 175) ("p130 CAS" 99) ("p130 Cas" 92) ("p130cas" 83)
   ("Crk-associated substrate" 21) ("p130CAS" 17) ("P130Cas" 8)
   ("p-p130 Cas" 5) ("P130CAS" 5) ("Crk-associated substrate (CAS)" 4)
   ("targeting human BCAR1" 3) ("mouse monoclonal BCAR1" 2)
   ("the subsequent phosphorylated p130Cas" 1) ("Artificial BCAR1" 1)
   ("BCAR1 protein" 1) ("P130 CAS" 1) ("than BCAR1" 1) ("P130cas" 1)))
 ("UP:P56975" (("NRG3" 18) ("Nrg3" 3) ("neuregulins-3" 1) ("neuregulin-3" 1)))
 ("UP:P57052" (("RBM11" 2)))
 ("UP:P57053" (("member S" 3) ("H2B histone family" 1)))
 ("UP:P57054" (("class P" 1)))
 ("UP:P57058" (("HUNK" 109) ("B19" 74) ("Hunk" 28) ("b19" 1) ("-B19" 1)))
 ("UP:P57059"
  (("SIK1" 251) ("SIK" 37) ("salt-inducible kinase" 9)
   ("salt inducible kinase" 4) ("Sik1" 4) ("salt-inducible kinase 1" 2)
   ("salt inducible kinase (SIK)" 2) ("SIK-1" 1) ("expressing sh SIK1" 1)
   ("SIK1-" 1) ("SNF1LK" 1) ("functional SIK1" 1) ("SIK1 (SIK)" 1)
   ("particular SIK1" 1)))
 ("UP:P57073" (("Sox8" 37)))
 ("UP:P57075" (("UBASH3A" 26) ("-UBASH3A" 3) ("Sts-2" 1)))
 ("UP:P57077" (("TAKl" 1)))
 ("UP:P57078" (("RIPK4" 6) ("Rip4" 5) ("RIP4" 4) ("DIK" 1)))
 ("UP:P57082" (("Tbx4" 2))) ("UP:P57087" (("JAM2" 3)))
 ("UP:P57103" (("NCX3" 2))) ("UP:P57105" (("OMP25" 19) ("SYNJ2BP" 1)))
 ("UP:P57170" (("BACa" 1))) ("UP:P57171" (("CysK" 5)))
 ("UP:P57181" (("FLiK" 14))) ("UP:P57182" (("FLIM" 105)))
 ("UP:P57219" (("NTH" 3))) ("UP:P57220" (("PriA" 1)))
 ("UP:P57266" (("PRS" 43) ("poor PRS" 1)))
 ("UP:P57276"
  (("ribonucleotide reductase" 108) ("Ribonucleotide reductase" 14)
   ("ribonucleotide reductase (RR)" 3) ("ribonucleotide reductase (RNR)" 2)
   ("The classical Ribonucleotide reductase" 1)))
 ("UP:P57298" (("MutT" 9) ("mutT" 3))) ("UP:P57347" (("LepB" 5)))
 ("UP:P57360" (("HNs" 2) ("hNS" 1))) ("UP:P57372" (("IMPase" 1)))
 ("UP:P57381" (("MFD" 2))) ("UP:P57384" (("GAP-A" 7)))
 ("UP:P57404"
  (("PK" 366) ("PK-" 3) ("immortalized PK" 2) ("the last PK" 2)
   ("insufficient PK" 2) ("the respective PK" 2) ("its favourable PK" 1)))
 ("UP:P57430"
  (("Rluc" 128) ("RLuc" 66) ("R-Luc" 7) ("RLUC" 3) ("RLuc-" 3) ("rLuc" 2)
   ("rluc" 2) ("rLUC" 1)))
 ("UP:P57437" (("PTSG" 5))) ("UP:P57453" (("DEAD" 118) ("“DEAD”" 1)))
 ("UP:P57459" (("NusA" 2)))
 ("UP:P57472"
  (("CM" 3477) ("PDT" 177) ("stromal CM" 11) ("LPS-treated BMSC-CM" 6)
   ("fatal CM" 2) ("primary CM" 2) ("sporadic CM" 2) ("typical CM" 2)
   ("pediatric CM" 2) ("the transformed cell CM" 2) ("the stromal CM" 2)
   ("than T CM" 2) ("than T CM ( xref )" 2) ("mTeSR1 or MEF complete CM" 2)
   ("homemade MEF CM" 2) ("fewer T CM" 2) ("-CM" 1) ("nonfamilial CM" 1)
   ("another GC-MSCs-derived CM" 1) ("approximately 76100 CM" 1)
   ("cytokine-treated CM" 1) ("each experimental CM" 1) ("either stromal CM" 1)
   ("R1881 and C1 stromal CM" 1) ("Stromal CM" 1) ("inhibited stromal CM" 1)
   ("neonatal rat CM" 1) ("than PDT" 1)
   ("than CM from control siRNA-treated cells ( xref , right panel)" 1)
   ("non-toxic THP-1 CM" 1) ("than CM" 1)
   ("LPS-treated human primary cultured BMSC-CM" 1) ("whereby T CM" 1)
   ("“CM4\"" 1) ("peripheral T CM" 1) ("Five hundred micro liters CM" 1)
   ("senescent CM" 1)))
 ("UP:P57487" (("endonuclease-1" 11) ("endonuclease1" 3)))
 ("UP:P57611" (("dnaB" 2)))
 ("UP:P57617" (("MutY" 4) ("MutY protein" 3) ("mutY" 2)))
 ("UP:P57631" (("HflK" 2)))
 ("UP:P57647"
  (("pit" 97) ("Pit" 5) ("pit (CCP)" 3) ("the olfactory pit" 1) ("PIT" 1)
   ("the endocytic pit" 1) ("the initial endocytic pit" 1)))
 ("UP:P57678" (("gemin4" 18) ("Gemin4" 4) ("comparatively little gemin4" 1)))
 ("UP:P57679" (("EVC" 7) ("evc" 7) ("Ellis van Creveld syndrome" 2)))
 ("UP:P57682" (("BKLF" 57) ("KLF3" 5) ("TEF-2" 1) ("KLf3" 1)))
 ("UP:P57723" (("PCBP4" 4)))
 ("UP:P57727"
  (("TMPRSS3 protein" 3) ("TMPRSS3" 2) ("transmembrane protease, serine 3" 2)))
 ("UP:P57730" (("ICEBERG" 5))) ("UP:P57735" (("Rab25" 20) ("RAB25" 2)))
 ("UP:P57739"
  (("claudin-2" 292) ("Claudin-2" 117) ("Cldn2" 24) ("CLDN2" 18)
   ("claudin 2" 17) ("claudin2" 6) ("Claudin 2" 2) ("claudin-2 protein" 2)
   ("less claudin-2" 1) ("Substantially less claudin2" 1)))
 ("UP:P57740" (("Nup107" 11) ("NUP107" 1)))
 ("UP:P57768" (("SNX16" 8) ("sorting nexin 16" 1)))
 ("UP:P57772"
  (("eukaryotic elongation factor" 21) ("SELB" 1)
   ("Eukaryotic elongation factor" 1)))
 ("UP:P57775"
  (("Fbxw4" 116) ("FBXW4" 53) ("SHFM3" 5) ("FBXW4 protein" 3) ("Dactylin" 2)
   ("Fbxw4 protein" 2) ("exogenous Fbxw4" 1)))
 ("UP:P58004"
  (("SESN2" 211) ("Sesn2" 74) ("sestrin 2" 35) ("Sestrin2" 30) ("Sestrin-2" 7)
   ("sestrin2" 7) ("sestrin-2" 5) ("Sestrin 2" 4) ("SESTRIN2" 4)
   ("exogenous SESN2" 2) ("expressing comparable SESN2" 1) ("Hi95" 1)
   ("cells indeed need Sestrin-2" 1) ("sestrin 2 protein" 1) ("HI95" 1)))
 ("UP:P58005" (("SESN3" 9) ("sestrin3" 8) ("Sesn3" 5) ("sestrin 3" 1)))
 ("UP:P58012"
  (("FOXL2" 57) ("Pinto" 7) ("Foxl2" 6) ("Forkhead Box L2" 2)
   ("the transcriptional factor FOXL2" 2) ("pinto" 1)))
 ("UP:P58108" (("AMPK-γ1" 7) ("–AMPK-γ1" 1))) ("UP:P58165" (("PMCA" 19)))
 ("UP:P58166" (("INHBE" 2)))
 ("UP:P58304"
  (("Chx10" 23) ("retinal neuronal marker Chx10" 2)
   ("the neural retinal transcription factor Chx10" 1)))
 ("UP:P58335" (("ANTXR2" 2)))
 ("UP:P58340" (("MLF1" 6) ("myeloid leukemia factor 1" 2)))
 ("UP:P58397" (("ADAMTS12" 3))) ("UP:P58400" (("Nrxn1" 82)))
 ("UP:P58417" (("NXPH1" 2))) ("UP:P58517" (("PI-4" 51)))
 ("UP:P58546" (("Mtpn" 2))) ("UP:P58658" (("C21orf63" 1)))
 ("UP:P58743"
  (("PREs" 82) ("preS" 4) ("PreS" 4) ("prestin" 4) ("Experimental PREs" 2)
   ("the experimental PREs" 2) ("than expected PREs ( xref )" 1)
   ("the unanticipated large experimental PREs" 1) ("The theoretical PREs" 1)))
 ("UP:P58753" (("TIRAP" 25)))
 ("UP:P58763"
  (("cKO" 289) ("CKO" 246) ("CKX" 19) ("-CKO" 18) ("cko" 4) ("-cKO" 2)
   ("Olympus CKX41" 1) ("Akt2 or Akt3 decreased proliferation ofPten cKO" 1)))
 ("UP:P58876" (("HIST1H2BD" 4))) ("UP:P59025" (("RTp1" 1)))
 ("UP:P59036" (("C21orf82" 1))) ("UP:P59044" (("NLRP6" 2)))
 ("UP:P59046" (("NLRP12" 5) ("Nlrp12" 2)))
 ("UP:P59047" (("mater" 32) ("Mater" 5)))
 ("UP:P59082"
  (("LFS" 456) ("34 TP53 -negative LFS" 2) ("classical LFS" 2)
   ("classic LFS" 2) ("LFS-" 1) ("shorter LFS" 1)
   ("five previously undiagnosed LFS" 1) ("both classic LFS" 1)))
 ("UP:P59103"
  (("DAOA" 36) ("D-amino acid oxidase activator" 5)
   ("d-amino acid oxidase activator" 3)))
 ("UP:P59169" (("HTR8" 4))) ("UP:P59276" (("NT2" 82)))
 ("UP:P59533" (("TAS2R38" 1))) ("UP:P59591" (("DAE" 40) ("'DAE'" 1)))
 ("UP:P59665"
  (("DEFA1" 29) ("HP-1" 15) ("HP2" 10) ("HP-1 protein" 3) ("dEF1" 2) ("HNP1" 1)
   ("HP1protein" 1)))
 ("UP:P59768" (("pGNG2" 2))) ("UP:P59772" (("EIS" 10) ("Eis" 3)))
 ("UP:P59901" (("ILT7" 5))) ("UP:P59998" (("20kDa" 1)))
 ("UP:P60006" (("APC15" 119) ("Apc15" 5) ("than APC15" 1)))
 ("UP:P60022"
  (("hBD1" 110) ("DEFB1" 89) ("beta 1" 36) ("beta defensin 1" 8) ("Beta 1" 6)
   ("HBD1" 3) ("hBD1 protein" 2) ("hBD-1" 2) ("BD1" 2) ("Beta defensin 1" 2)))
 ("UP:P60033"
  (("CD81" 378) ("SR-B1" 28) ("TAPA1" 2) ("1 μM permeable CD81" 2) ("CD81-" 1)
   ("CD81 antigen" 1) ("exogenous CD81" 1) ("complete CD81" 1)))
 ("UP:P60059" (("SEC61G" 8)))
 ("UP:P60174"
  (("TPI1" 10) ("TPI" 7) ("triosephosphate isomerase 1" 4)
   ("Triosephosphate isomerase 1" 1) ("tpi1" 1)))
 ("UP:P60201"
  (("myelin proteolipid protein" 6) ("PLP1" 6) ("Myelin proteolipid protein" 2)
   ("pPLP1" 1) ("-PLP1" 1)))
 ("UP:P60228"
  (("INT6" 143) ("EIF3E" 16)
   ("eukaryotic translation initiation factor 3 subunit E" 3) ("eIF3e" 3)
   ("Int6" 2)))
 ("UP:P60254" (("MCA" 149) ("MCa" 2) ("“MCA”" 2)))
 ("UP:P60321"
  (("NOS-2" 29) ("Nanos2 protein" 2) ("NANOS2" 2) ("NOS-2 protein" 1)
   ("Nanos2" 1)))
 ("UP:P60323" (("NANOS3" 10))) ("UP:P60413" (("KRTAP10.12" 7)))
 ("UP:P60468" (("SEC61B" 2) ("Sec61B" 1)))
 ("UP:P60484"
  (("PTEN" 33215) ("Pten" 3124) ("PTEN protein" 509) ("Akt/PKB" 359)
   ("phosphatase and tensin homolog" 339) ("pten" 238)
   ("phosphatase and tensin homolog (PTEN)" 82)
   ("Phosphatase and tensin homolog" 81) ("PTEN−" 51) ("pPTEN" 43)
   ("p-PTEN" 41) ("functional PTEN" 33) ("tensin homolog" 26) ("PTEN-" 23)
   ("PTEN1" 21) ("Pten protein" 21) ("PTEN molecule" 19) ("canonical PTEN" 19)
   ("pten-" 17) ("cellular PTEN" 12) ("Phosphatase and Tensin homolog" 11)
   ("normal PTEN" 11) ("PTEN peptide" 10) ("-PTEN" 10) ("MMAC1" 9)
   ("than PTEN" 9) ("−PTEN" 9) ("intact PTEN" 8)
   ("phosphatase and tensin homolog ( PTEN )" 8) ("exogenous PTEN" 7)
   ("overexpressed PTEN" 7) ("–PTEN" 6) ("pTen" 5)
   ("uninterpretable or equivocal PTEN" 5) ("heterogeneous PTEN" 5)
   ("targeted PTEN" 4) ("a functional PTEN" 4) ("Pten-" 4) ("Efficient PTEN" 4)
   ("genomic PTEN" 4) ("mouse monoclonal PTEN" 4) ("PTEN Protein" 4)
   ("miR-21-targeted PTEN" 3) ("expressing PTEN" 3)
   ("Phosphatase and tensin homolog (PTEN)" 3) ("dimeric PTEN" 3)
   ("targeting PTEN" 3) ("than wild-type PTEN" 3) ("targeting pten" 3)
   ("less PTEN" 3) ("PTEN (WT and mutants) protein" 3)
   ("phosphatase and tensin homolog (PTEN) protein" 3)
   ("lack functional PTEN" 2) ("percent PTEN" 2)
   ("phosphatase and tensin homolog protein (PTEN)" 2)
   ("uninterpretable PTEN" 2) ("discordant PTEN" 2)
   ("the dual protein and lipid phosphatase PTEN" 2)
   ("phosphatase and tensin homolog(PTEN) protein" 2) ("PTEN (WT)" 2)
   ("nucleic PTEN" 2) ("a phospho-mimetic PTEN" 2)
   ("non-phosphorylatable PTEN" 2) ("contained monomeric PTEN" 2)
   ("Monomeric PTEN" 2) ("intense PTEN" 2) ("Least intense (1+) PTEN" 2)
   ("longer PTEN protein" 2) ("nonfunctional PTEN" 2)
   ("miR-718 directly target PTEN" 2) ("miR-718 directly targets PTEN" 2)
   ("parallelly knockdown PTEN" 2) ("oxidative PTEN" 2) ("Absent PTEN" 2)
   ("directly targeted PTEN" 2) ("made PTEN protein" 2)
   ("negative or weak PTEN" 2) ("3.1.3.67" 2) ("“PTEN”" 2)
   ("either functional or mutated PTEN" 2)
   ("total and
phosphorylated PTEN protein"
    2)
   ("Phosphatase and tensin
homolog"
    2)
   ("tensin homolog (PTEN)" 2) ("PTEN (WTPTEN)" 2)
   ("simultaneously overexpressed PTEN" 2) ("a strong phospho-PTEN" 2)
   ("a weak PTEN" 2) ("a strong PTEN" 2) ("Many polycistronic PTEN" 2)
   ("a dynamic and reversible Pten" 2) ("showed heterogeneous PTEN" 2)
   ("background benign glands showed robust PTEN" 2)
   ("endogenous functional PTEN" 1) ("in contrast mutant PTEN" 1)
   ("classical PTEN" 1) ("the classical 403 amino acids of PTEN ( xref )" 1)
   ("a homozygous PTEN" 1) ("microvesicular PTEN" 1) ("exosomal PTEN" 1)
   ("immunoreactive PTEN" 1) ("than cells not expressing PTEN ( xref )" 1)
   ("benign nuclear PTEN" 1) ("epithelial PTEN" 1) ("the PTEN’s" 1)
   ("IHC, and null PTEN" 1) ("that PTEN's" 1) ("membrane associated PTEN" 1)
   ("surprisingly Pten protein" 1) ("we first depleted PTEN" 1)
   ("total and activated PTEN" 1) ("mutated in multiple advanced cancers 1" 1)
   ("P60484" 1) ("regular PTEN" 1) ("the relative “non-phospho” PTEN" 1)
   ("“phospho-PTEN”" 1) ("the dimeric PTEN" 1)
   ("monomeric conformation PTEN" 1) ("a dimeric PTEN" 1)
   ("positively link PTEN" 1) ("clinically relevant PTEN" 1)
   ("“phosphatase and tensin homolog/PTEN”" 1)
   ("Phosphatase and tensin homolog ( PTEN )" 1)
   ("miR-205 directly targets PTEN" 1) ("the 403-residue-long PTEN protein" 1)
   ("most PTEN" 1) ("directly targets PTEN" 1)
   ("the LCL nuclear and cytoplasmic fractionated proteins showed more nuclear PTEN"
    1)
   ("directly target PTEN" 1)
   ("the open conformational unphosphorylated PTEN" 1)
   ("the tumour suppressive gene PTEN" 1)
   ("Phosphatase and Tensin homolog (PTEN)" 1) ("less PTEN protein" 1)
   ("monomeric PTEN" 1) ("-Akt/PKB" 1) ("“phosphatase and tensin homolog”" 1)
   ("pTEN" 1) ("Phosphatase and tensin homolog (PTEN) protein" 1)
   ("the primary Pten" 1) ("Phosphatase and TENsin homolog" 1)
   ("phosphatase and TENsin homolog" 1) ("SPRY2 increased total PTEN" 1)
   ("phospho-PTEN protein" 1) ("the constitutively binding PTEN" 1)
   ("than phosphorylated PTEN ( xref )" 1) ("the oxidative PTEN" 1)
   ("employing purified PTEN" 1) ("Heterogeneous PTEN protein" 1)
   ("impaired PTEN's" 1) ("total and phosphorylated Akt/PKB" 1)
   ("regarding alternative PTEN" 1) ("less mutant PTEN" 1)
   ("normal, heterozygous and homozygous PTEN" 1) ("more PTEN" 1)
   ("Intragenic PTEN" 1) ("miR-21 directly targets PTEN" 1) ("intact Pten" 1)
   ("ATP-binding motifs impaired PTEN's" 1) ("further abolished PTEN's" 1)
   ("further abolished PTEN" 1) ("total and oxidized PTEN" 1) ("Akt/Pkb" 1)
   ("most pten" 1) ("The isogenic Pten +/+" 1) ("Akt/PKB–" 1)
   ("exogenous Myc-tagged PTEN" 1) ("This immunoreactive PTEN protein" 1)
   ("human genomic PTEN" 1) ("the classic tumor suppressor gene PTEN" 1)
   ("the “naive” PTEN" 1) ("the cerebellar PTEN protein" 1) ("than Pten" 1)
   ("than PTEN in DU145 cells (100 fold)" 1) ("pAkt/PKB" 1)
   ("than the WT PTEN protein (~54 kDa) in the MDA-MB-453 cell line (Figure xref )"
    1)
   ("than those possessing wild type PTEN" 1) ("the new Pten" 1)
   ("primary Pten" 1) ("separate PTEN" 1) ("PTEN (PTENCA)" 1)
   ("undetectable or low PTEN" 1)
   ("lipid species and protein binding domains control PTEN's" 1)
   ("than wt PTEN" 1) ("miR-21-sensitive PTEN" 1)
   ("TGFβ forces miR-21-targeted PTEN" 1) ("lysines of PTEN" 1)
   ("the non-infected cells showed PTEN" 1) ("intact genomic PTEN" 1)
   ("a robust PTEN" 1) ("miR-32 directly targets PTEN" 1)))
 ("UP:P60506" (("gp60" 6) ("Gp60" 1))) ("UP:P60508" (("syncytin 2" 3)))
 ("UP:P60510"
  (("PP4C" 113) ("PPP4C" 16) ("protein phosphatase 4" 14)
   ("protein phosphatase 4 catalytic subunit" 2) ("PPX" 1)))
 ("UP:P60520" (("GABARAPL2" 16) ("GEF2" 3) ("GATE-16" 2)))
 ("UP:P60568"
  (("IL-2" 2996) ("IL2" 294) ("interleukin-2" 113) ("interleukin 2" 47)
   ("Il2" 46) ("exogenous IL-2" 21) ("Interleukin-2" 11) ("IL-2-" 11)
   ("-IL-2" 10) ("T-cell growth factor" 7) ("IL-2–" 6) ("interleukin-2 (IL)" 4)
   ("fresh human interleukin-2" 3) ("IL-2 protein" 3) ("than IL-2" 2)
   ("less IL-2" 2)
   ("anti-CD28 (5 ug/ml soluble) antibodies, and PHA (1 ug/ml) + IL-2" 2)
   ("aldesleukin" 2) ("Interleukin 2" 2) ("exogenous interleukin-2" 2)
   ("proliferated and produced interleukin 2" 2)
   ("10 units/ml exogenous IL-2" 2) ("InterLeukin 2" 1)
   ("approximately 5-fold more IL-2" 1) ("WT Carma1 made IL-2" 1)
   ("fresh media + IL-2" 1) ("than IL2" 1) ("TMD produced less IL-2" 1)
   ("CD4T TMD cells produced less IL-2" 1)
   ("-HER/ ζ effectors underwent IL-2" 1) ("il2" 1) ("IL–2" 1)
   ("intact IL-2" 1) ("high environmental IL-2" 1)))
 ("UP:P60602" (("Romo1" 6) ("ROS modulator 1" 1)))
 ("UP:P60604" (("Ube2g2" 14) ("UBE2G2" 13) ("Ube2G2" 1) ("UbE2G2" 1)))
 ("UP:P60660" (("MYL6" 2))) ("UP:P60673" (("PFN3" 3) ("Pfn3" 1)))
 ("UP:P60704" (("APOBEC3" 113)))
 ("UP:P60709"
  (("β-actin" 4454) ("ACTB" 387) ("β-Actin" 362) ("beta-actin" 233)
   ("β-ACTIN" 37) ("β-actin protein" 28) ("Beta-actin" 23)
   ("β-actin ( ACTB )" 11) ("Beta-Actin" 10) ("ActB" 10) ("beta-Actin" 10)
   ("β–actin" 9) ("-β-actin" 7) ("Actin beta" 5) ("ACBT" 5)
   ("mouse monoclonal β-actin" 4) ("monoclonal mouse anti-human β-actin" 4)
   ("Actb" 3) ("β-actin peptide" 3) ("the internal control β-actin" 3)
   ("Internal standard β-actin" 3) ("Mouse monoclonal anti β-actin" 2)
   ("-beta-actin" 2) ("actin beta" 2) ("monoclonal β-actin" 2) ("BETA-ACTIN" 2)
   ("internal reference gene β-actin" 2) ("the relative β-actin" 2)
   ("monoclonal anti-chicken β-Actin" 2) ("the internal reference β-actin" 2)
   ("internal control beta-actin" 2) ("A monoclonal mouse β-Actin" 2)
   ("beta-actin (ACTB)" 2) ("The commercially available human ACTB" 2)
   ("P60709" 1) ("monoclonal β-Actin" 1) ("β-actin (ACTB)" 1)
   ("the internal reference gene β-actin" 1) ("β−Actin" 1)
   ("beta-actin protein" 1) ("respective β-actin" 1) ("β-Actin protein" 1)
   ("internal control β-actin" 1) ("the internal control β-actin ( ACTB )" 1)
   ("phospho-ACC (Ser79) overnight or monoclonal mouse anti β-actin" 1)
   ("yellow fluorescent protein (YFP)-Rabankyrin-5 and cyan fluorescent protein (CFP)-β-actin"
    1)
   ("β-Actin (ACTB)" 1) ("the internal β-actin" 1) ("β-actin ( ACBT )" 1)
   ("an internal reference gene β-actin" 1) ("its respective β-actin" 1)
   ("the internal gene β-actin" 1) ("β­actin protein" 1) ("β­actin" 1)))
 ("UP:P60763"
  (("RAC3" 407) ("Rac3" 280) ("RAC3 protein" 21) ("RAC 3" 11)
   ("Rac3 protein" 10) ("Rac 3" 3) ("RAC 3 protein" 2) ("rac3" 2)
   ("hyperactive Rac3" 1) ("than WT RAC3" 1)))
 ("UP:P60771" (("NT1" 14))) ("UP:P60842" (("EIF4A1" 12) ("eIF4A1" 2)))
 ("UP:P60844" (("BNIP" 6))) ("UP:P60866" (("RPS20" 69) ("Rps20" 1)))
 ("UP:P60880"
  (("SNAP25" 88) ("SUP" 72) ("Sup" 46) ("SNAP-25" 35) ("sup" 24)
   ("synaptosomal-associated protein" 6)
   ("Synaptosomal-associated protein 25" 5) ("SNAP25 protein" 3)
   ("the soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) protein SNAP25"
    2)
   ("pSUP" 2) ("the presynaptic protein SNAP25" 2) ("Intact SNAP25" 1)
   ("the viral sup" 1) ("Snap25" 1)))
 ("UP:P60891" (("Perceptive" 11) ("perceptive" 3) ("PRPS1" 2)))
 ("UP:P60893" (("G-protein coupled receptor 85" 2) ("SREB2" 1)))
 ("UP:P60896" (("DSS1" 191) ("DSS1 protein" 13) ("-DSS1" 4) ("SHFM1" 3)))
 ("UP:P60900" (("p27K" 81) ("PSMA6" 6) ("p27k" 2)))
 ("UP:P60903" (("S100A10" 4)))
 ("UP:P60953"
  (("Cdc42" 3949) ("cdc42" 334) ("CDC42" 308) ("Cdc42Hs" 249) ("Cdc42hs" 68)
   ("Cerione" 24) ("Cdc42-" 22) ("cell division cycle 42" 13)
   ("dominant-negative Cdc42" 12) ("Cdc42Hs molecule" 8) ("Cdc42 protein" 5)
   ("Cdc42Hs protein" 5) ("cdc42 protein" 5) ("Cdc-42" 3)
   ("Cell division cycle 42" 3) ("-Cdc42" 2) ("a distinct Cdc42" 2)
   ("the tripartite complex Cdc42" 2) ("a dominant-negative Cdc42" 2)
   ("CDC-42" 2) ("dominant-negative (DN) Cdc42" 2)
   ("titrated dominant-negative Cdc42" 2) ("Pak3 functionally links  Cdc42" 1)
   ("Cell division control protein 42 homolog" 1) ("Cdc42–" 1)
   ("Cdc42 activation yet total Cdc42" 1) ("the former activating Cdc42" 1)
   ("Cdc42 ( TTCAGCAATGCAGACAATTAA )" 1) ("than active Cdc42" 1)
   ("Hyperactive Cdc42" 1) ("more Cdc42" 1) ("the apical membrane Cdc42" 1)
   ("Professor Richard Cerione’s" 1)))
 ("UP:P60981" (("destrin" 7) ("destrin (ADF)" 1))) ("UP:P60983" (("GMFB" 2)))
 ("UP:P60985"
  (("Krtdap" 9) ("Keratinocyte differentiation associated protein" 1)))
 ("UP:P61006"
  (("MEL" 409) ("Mel" 333) ("mel" 77) ("Rab8" 56) ("Rab8a" 26) ("Rab8A" 1)
   ("RAB8" 1) ("“SK-Mel”" 1)))
 ("UP:P61009" (("SPCS3" 2))) ("UP:P61011" (("SRP54" 15)))
 ("UP:P61018" (("RAB4B" 1)))
 ("UP:P61019"
  (("Rab2A" 213) ("RAB2A" 6) ("Rab2" 4) ("Rab2A protein" 3)
   ("overexpressed Rab2A" 2)
   ("~3,000 breast cancer patients strongly link Rab2A" 1)
   ("than WT Rab2A" 1)))
 ("UP:P61020" (("Rab5B" 23) ("Rab5b" 6) ("RAB5B" 3) ("RAB5b" 1)))
 ("UP:P61024" (("CKS1B" 10) ("CKSHS1" 2))) ("UP:P61026" (("Rab10" 6)))
 ("UP:P61073"
  (("CXCR4" 4171) ("coreceptor" 321) ("CXCR4 protein" 55) ("Cxcr4" 20)
   ("CXCR4-" 19) ("CXC chemokine receptor" 11) ("SDF-1 receptor" 9) ("CD184" 8)
   ("a new coreceptor" 6) ("functional CXCR4" 4) ("CXCR-4" 3)
   ("mouse monoclonal anti CXCR4" 3) ("an essential coreceptor" 3) ("Fusin" 3)
   ("coexpressed CXCR4" 3) ("epithelial CXCR4" 3) ("CXCR4 molecule" 3)
   ("cxcr4" 2) ("a major viral coreceptor" 2) ("Cxcr4 protein" 2) ("LCR1" 2)
   ("heterozygous and homozygous CXCR4" 2) ("Coreceptor" 2) ("fusin" 1)
   ("the major coreceptor" 1) ("a classical coreceptor" 1) ("Cxcr-4" 1)
   ("CXCR4−" 1) ("CXCR 4" 1) ("the principal coreceptor" 1)
   ("a major coreceptor" 1) ("chondrogenic differentiation CXCR4" 1)
   ("intestinal epithelial expressed CXCR4" 1) ("heterozygous CXCR4" 1)
   ("p-CXCR4" 1) ("again increase CXCR4" 1) ("coreceptor-" 1)))
 ("UP:P61077"
  (("UbcH5c" 251) ("UBE2D3" 86) ("Ubch5c" 9) ("UBCH5c" 6) ("UbCH5c" 4)
   ("UbcH5C" 3) ("UBC5C" 2) ("UbCh5C" 2) ("UBcH5c" 2) ("orient UbcH5c" 1)
   ("Ubc5c" 1) ("the active site cysteine of UbcH5c" 1)))
 ("UP:P61081"
  (("UBC12" 39) ("UBE2M" 35) ("UBE2M protein" 20) ("ube2m" 15) ("Ubc12" 15)
   ("NEDD8-conjugating enzyme UBC12" 3)
   ("Dominant negative (DN) NEDD8 E2 ligase UBC12" 1)))
 ("UP:P61086"
  (("ubiquitin-protein ligase" 110) ("ubiquitin protein ligase" 55)
   ("UbE2K" 30) ("Ube2k" 13) ("LIG" 9) ("Ube2K" 5)
   ("ubiquitin–protein ligase" 4) ("lig" 4)
   ("a functional ubiquitin protein ligase" 2) ("UBE2K" 2)
   ("ubiquitin carrier protein" 1) ("ube2k" 1)))
 ("UP:P61088"
  (("UBC13" 289) ("Ubc13" 181) ("UBE2N" 72) ("UbcH13" 15) ("–UBE2N" 3)
   ("ube2n" 1) ("functional Ubc13" 1)))
 ("UP:P61092" (("Siah-1A" 160) ("-Siah-1A" 2)))
 ("UP:P61106"
  (("Rab14" 62) ("RAB14" 6) ("less Rab14 protein" 2) ("rab14" 2)
   ("Rab14 protein" 1)))
 ("UP:P61110" (("kidney androgen-regulated protein" 1)))
 ("UP:P61129" (("ZC3H6" 1))) ("UP:P61158" (("actin-related protein 3" 1)))
 ("UP:P61160" (("Arp2" 9) ("ActR2" 1) ("actin related protein 2" 1)))
 ("UP:P61163" (("centractin" 2) ("ACTR1A" 1) ("ActR1A" 1)))
 ("UP:P61201" (("COPS2" 17) ("TRIP15" 1)))
 ("UP:P61204" (("Arf3" 95) ("ARF3" 1) ("arf3" 1)))
 ("UP:P61221"
  (("ABCE1" 156) ("Rli1" 5) ("RLI" 2)
   ("ATP-binding cassette sub-family E member 1" 2) ("RLI1" 1) ("RLi" 1)))
 ("UP:P61224" (("Rap1B" 12) ("Rap1b" 6) ("RAP1B" 4)))
 ("UP:P61225" (("Rap2b" 4) ("Rap2B" 4))) ("UP:P61236" (("YPEL3" 5)))
 ("UP:P61244"
  (("max" 943) ("Max" 793) ("MAX" 472) ("Myc/Max" 37) ("pmaxGFP" 28)
   ("Max protein" 21) ("-max" 11) ("‘MAX'(PEI)" 5) ("pMAX" 4)
   ("Acute Tat treatment increases DAT V max" 4) ("MAX protein" 3)
   ("MYC associated factor X" 2) ("–Max" 2) ("ARTD1 increased V max" 1)
   ("its essential partner MYC associated factor X" 1)
   ("M . Achievable C  max" 1) ("its transcriptional partner Max" 1)
   ("‘MAX'" 1) ("a submaximal VO 2 max" 1) ("more Max" 1) ("the global max" 1)
   ("Tat decreased DAT V max" 1) ("than Max" 1) ("the statistic CCP max" 1)
   ("The statistic CCP max" 1) ("MaX" 1) ("MAX-" 1) ("maxGFP" 1) ("maX" 1)
   ("larger V max" 1) ("the obligatory transcriptional co-activator MAX" 1)))
 ("UP:P61247"
  (("S3A" 288) ("RPS3a" 223) ("S3a" 17) ("ribosomal protein S3a" 5) ("rpS3a" 4)
   ("S3A peptide" 4) ("RPS3a protein" 2) ("S3A protein" 2)
   ("the N-terminal 50 amino acids of RPS3a" 1) ("Supplemental Figure S3A" 1)))
 ("UP:P61254"
  (("RPL26" 240) ("L26" 31) ("rpL26" 8) ("ribosomal protein L26" 8) ("RpL26" 2)
   ("-RPL26" 2) ("Two MDM2 binding ribosomal proteins L26" 2)
   ("ribosomal proteins L26" 1)))
 ("UP:P61278"
  (("somatostatin" 49) ("SST" 35) ("Somatostatin" 9)
   ("the hypothalamic hormones somatostatin" 2) ("Sst" 1) ("sst" 1)))
 ("UP:P61289"
  (("REGγ" 618) ("Psme3" 63) ("PA28γ" 38) ("PSME3" 9) ("REGγ protein" 3)
   ("Immortalized REGγ +/−" 2) ("overexpressed REGγ-WT" 2)
   ("the proteasome-associated protein PA28γ" 2) ("REGgamma" 1)
   ("human genomic REGγ" 1) ("immortalized REGγ +/−" 1)))
 ("UP:P61296" (("HAND2" 1)))
 ("UP:P61313"
  (("L15" 52) ("ribosomal protein L15" 5) ("Ribosomal protein L15" 1)
   ("RPL15" 1)))
 ("UP:P61326"
  (("proliferation-associated" 71) ("Magoh" 9) ("MAGOH" 6)
   ("proliferation-associated protein" 5) ("Proliferation-associated" 1)))
 ("UP:P61328" (("FGF1/2" 2) ("FGF12" 1)))
 ("UP:P61353" (("L27" 19) ("RPL27" 4) ("Rpl27" 2)))
 ("UP:P61371"
  (("ISL-1" 241) ("Isl1" 45) ("Islet1" 19) ("Isl-1" 10) ("ISL1" 8)
   ("Aberrant ISL-1" 2) ("soft PMAs co-expressed Isl1" 1) ("ISL-1 protein" 1)
   ("ISl-1" 1) ("Islet-1" 1)))
 ("UP:P61457"
  (("PCD" 185) ("PHS" 91) ("pHs" 14) ("PHs" 3) ("the WT-ANXA7-induced PCD" 1)
   ("late (membrane permeabilization) PCD" 1) ("pcd" 1) ("neuronal PCD" 1)
   ("phS" 1)))
 ("UP:P61513"
  (("RPL37A" 15) ("Ribosomal protein L37a" 2) ("RPL37a" 1)
   ("ribosomal protein L37a" 1)))
 ("UP:P61586"
  (("RhoA" 19102) ("RHOA" 513) ("H12" 111) ("RhoA protein" 42) ("Rho-A" 39)
   ("rhoA" 22) ("RhoA-" 16) ("h12" 13) ("dominant-negative RhoA" 10)
   ("RHOA protein" 7) ("pRhoA" 6) ("overexpressed RhoA" 4)
   ("membrane-associated RhoA" 4) ("cellular RhoA" 4) ("soluble RhoA" 3)
   ("targeting RhoA" 3) ("RhoA molecule" 3) ("expressing RhoA" 3)
   ("constitutively-activated RhoA" 2) ("the only known RhoA" 2)
   ("significantly more GTP-bound RhoA" 2) ("significantly less active RhoA" 2)
   ("the dominant-negative mutant N19-RhoA" 2) ("overexpressed RhoA-WT" 2)
   ("cortical RhoA" 2) ("functional RhoA" 2) ("than RhoA ( xref )" 2)
   ("active soluble RhoA" 2) ("particulate-associated RhoA" 2)
   ("the COOH-terminal 20 amino acids of RhoA" 1) ("we first imaged RhoA" 1)
   ("than WT RhoA in the absence" 1) ("RhoA(GDP)" 1) ("intestinal RhoA" 1)
   ("RhoA or myosin light chain (MLC)" 1)
   ("the ectopically overexpressed RhoA-WT" 1)
   ("dominant-negative RhoA-T19N" 1) ("RHO-A" 1)
   ("simultaneously knockdown endogenous RhoA" 1)
   ("the 12 C-terminal amino acids of RhoA" 1)
   ("an enzyme-linked immunosorbent assay-based RhoA activation assay kit (Cytoskeleton, Denver, CO, USA) active RhoA"
    1)
   ("RhoA ( TAGGCTGTAACTACTTTATAA )" 1)
   ("the control dominant-negative RhoA" 1)
   ("35 S-Methionine-labeled RhoA protein" 1) ("extranuclear RhoA" 1)
   ("total cellular RhoA" 1) ("overexpressing RhoA" 1) ("potential RhoA-" 1)
   ("than RhoA" 1) ("RhoA, V14-RhoA (constitutively active mutant)," 1)
   ("transcriptome-wide profiling identified RHOA" 1)
   ("directly reposition h12" 1)))
 ("UP:P61587"
  (("Rnd3" 299) ("RhoE" 40) ("RND3" 35) ("Rnd3 peptide" 9) ("ARHE" 2)
   ("Rnd3 protein" 2)
   ("the last C-terminal ten amino acids of Rnd3 (232–241) that were phosphorylated on S240"
    1)))
 ("UP:P61601" (("NCALD" 7) ("neurocalcin delta" 1)))
 ("UP:P61604" (("HSPE1" 3) ("Hsp10" 1) ("EPF" 1)))
 ("UP:P61619" (("Sec61a" 2) ("SEC61A" 1))) ("UP:P61626" (("LYZ" 24) ("LZM" 4)))
 ("UP:P61647" (("St8sia6" 2)))
 ("UP:P61758"
  (("VBP1" 9) ("von Hippel-Lindau binding protein 1" 7) ("PFD3" 1)))
 ("UP:P61763" (("nsec1" 6)))
 ("UP:P61764" (("munc18-1" 14) ("Munc18" 9) ("munc18" 3)))
 ("UP:P61769"
  (("B2M" 199) ("β2-microglobulin" 54) ("β-2-microglobulin" 29)
   ("beta-2-microglobulin" 11) ("β2m" 11) ("B2m" 8) ("Beta-2-microglobulin" 5)
   ("β2microglobulin" 4) ("beta 2 microglobulin" 3) ("Beta 2 microglobulin" 3)
   ("beta2-microglobulin" 1)))
 ("UP:P61803" (("DAD1" 3) ("OST2" 2)))
 ("UP:P61812"
  (("TGF-β2" 214) ("TGFβ2" 142) ("TGFB2" 72) ("Tgfb2" 14)
   ("transforming growth factor beta 2" 6) ("TGF-β2 protein" 3)
   ("Transforming growth factor beta 2" 1) ("TGF-beta2" 1)))
 ("UP:P61872" (("ROL" 1))) ("UP:P61916" (("NPC2" 14)))
 ("UP:P61923" (("COPZ1" 7))) ("UP:P61925" (("PKIα" 5)))
 ("UP:P61927" (("RPL37" 63) ("L37" 2))) ("UP:P61952" (("GNG11" 7)))
 ("UP:P61956"
  (("SUMO-2" 367) ("polymeric SUMO-2" 3) ("small ubiquitin-like modifier 2" 2)
   ("SMT3 (suppressor of mif two 3" 2) ("monomeric SUMO-2" 1)
   ("His6-SUMO-2 protein" 1)))
 ("UP:P61962" (("Dcaf7" 15) ("WDR68" 3) ("DCAF7" 2)))
 ("UP:P61964"
  (("BIG3" 108) ("WDR5" 44) ("Wdr5" 21) ("WD repeat domain 5" 2)
   ("BIG3 protein" 2) ("WD repeat-containing protein 5" 1) ("Swd3" 1)))
 ("UP:P61966" (("AP1S1" 2)))
 ("UP:P61968"
  (("LMO4" 240) ("Lmo4" 13) ("LMO4 protein" 6)
   ("its known mammary gland binding partner LMO4" 1) ("Given LMO4’s" 1)
   ("Given LMO4" 1)))
 ("UP:P61970" (("NTF2" 12) ("Ntf2" 4)))
 ("UP:P61978"
  (("hnRNP K" 707) ("HNRNPK" 40) ("hnRNP K protein" 37) ("hnRNPK" 13)
   ("HnRNP K" 12) ("heterogeneous nuclear ribonucleoprotein K" 11)
   ("Heterogeneous nuclear ribonucleoprotein K" 7) ("hnRNP K peptide" 4)
   ("hnRNPk" 3) ("heterogeneous nuclear ribonucleoprotein K (HNRNPK)" 2)
   ("HNRPK" 2) ("down more hnRNP K" 2)
   ("the translational regulator hnRNP K" 1)))
 ("UP:P61981"
  (("B/Cdk1" 85) ("B/CDK1" 74) ("YWHAG" 18) ("B/cdk1" 12)
   ("the two mitotic kinases Aurora A and cyclin B/Cdk1" 2)
   ("than cyclin B/CDK1 in vitro ( xref A)" 1)
   ("the mitotic kinase cyclin B/Cdk1" 1)))
 ("UP:P62068" (("USP46" 187) ("overexpressed USP46" 3) ("Usp46" 2)))
 ("UP:P62070" (("RRAS2" 1) ("TC21" 1)))
 ("UP:P62081"
  (("RPS7" 139) ("ribosomal protein S7" 13) ("rpS7" 10)
   ("Ribosomal protein S7" 3) ("A small ribosomal subunit protein RPS7" 2)
   ("Rps7" 2) ("whose RPS7" 1) ("—ribosomal protein S7" 1)))
 ("UP:P62136"
  (("PP1α" 350) ("PP1A" 81) ("PPP1CA" 20) ("PP1α protein" 3) ("PPP1A" 3)
   ("PP1alpha" 2) ("than endogenous PP1α" 2)
   ("either exogenous or endogenous PP1A" 2)
   ("exogenous GFPBRCA1 and myc-tagged PP1α" 1) ("the exogenous PP1A" 1)))
 ("UP:P62140" (("PP1β" 134) ("PPP1CB" 5) ("PP1B" 3) ("PP1Beta" 1)))
 ("UP:P62158"
  (("CaM" 850) ("CAM" 625) ("calmodulin" 534) ("Calmodulin" 74) ("CALM" 66)
   ("CALM3" 41) ("CALM2" 27) ("-calmodulin" 24) ("CALM1" 14) ("pure CaM" 13)
   ("calmodulin-" 9) ("the distal CAM" 7) ("calmodulin protein" 5) ("CaM3" 4)
   ("CaM1" 3) ("melanoma adhesion molecule" 3) ("the upper CAM" 2)
   ("Mel-CAM" 2) ("pCAM" 2) ("-CaM" 2) ("pull-down pure bovine brain CaM" 2)
   ("Camb" 1) ("less calmodulin" 1) ("more calmodulin" 1) ("the intact CAM" 1)
   ("the bacterial
protein synthesis inhibitor CAM"
    1)
   ("calmodulin 1" 1) ("average 1.7 times less CALM3" 1) ("using pure CaM" 1)
   ("Pure CaM" 1) ("pre-menopausal ER(−) CAM" 1) ("pure bovine brain CaM" 1)
   ("distal CAM" 1)))
 ("UP:P62166" (("freq" 23) ("FREQ" 5)))
 ("UP:P62191"
  (("proteasome 26S subunit" 10)
   ("the TGN-localized secretory pathway calcium ATPase 1" 3) ("ATPase 1" 3)
   ("PSMC1" 2) ("pSmc1" 1)))
 ("UP:P62195"
  (("PSMC5" 12) ("ATPase 5" 4) ("p45/SUG" 1) ("SUG1" 1) ("TRIP1" 1)))
 ("UP:P62241" (("RPS8" 5) ("RpS8" 1)))
 ("UP:P62244" (("S15A" 25) ("Rps15a" 2) ("-S15A" 1)))
 ("UP:P62249" (("Rps16" 2))) ("UP:P62253" (("Ubc7" 16) ("UBC7" 3)))
 ("UP:P62256" (("UbcH2" 13) ("UBE2H" 5) ("Ubc8" 5)))
 ("UP:P62258" (("YWHAE" 35) ("YWHAE-" 2) ("P62258" 1)))
 ("UP:P62263"
  (("RPS14" 188) ("ribosomal protein S14" 10)
   ("5q-syndrome-associated RPS14" 2) ("rpS14" 1)))
 ("UP:P62266" (("RPS23" 63) ("S23" 37)))
 ("UP:P62269"
  (("S18" 88) ("RPS18" 11) ("ribosomal protein S18" 10)
   ("Ribosomal protein S18" 3) ("viable RASSF6-expressing S18" 2) ("Rps18" 1)))
 ("UP:P62273" (("S29" 18) ("RPS29" 3) ("Rps29" 2)))
 ("UP:P62277" (("S13" 85) ("RPS13" 3) ("ribosomal protein S13" 2)))
 ("UP:P62280" (("S11" 100) ("RPS11" 1))) ("UP:P62304" (("snrpe" 1)))
 ("UP:P62306" (("SMF" 16) ("SNRPF" 8))) ("UP:P62312" (("LSM6" 2)))
 ("UP:P62314" (("SmD1" 2))) ("UP:P62316" (("snrpd2" 1)))
 ("UP:P62324"
  (("BTG1" 137) ("translocation gene 1" 16) ("Btg1" 3)
   ("associated lymphoid tissue lymphoma translocation gene 1" 2)
   ("Mucosa-associated lymphoid tissue lymphoma translocation gene 1" 2)))
 ("UP:P62328"
  (("FX" 229) ("fx" 10) ("thymosin" 3) ("thymosin beta-4" 3)
   ("Thymosin beta-4" 3) ("Personal Molecular Imager FX" 2)
   ("Rac1CA induced typical FX" 1)
   ("the Kodak In-Vivo Multispectral System FX" 1)))
 ("UP:P62330"
  (("ARF6" 804) ("Arf6" 393) ("ARF6-" 3) ("Arf6-" 3) ("ARF6 (WT)" 2)
   ("total cellular Arf6" 2) ("dominant-inhibitory ARF6" 2) ("ARF6 protein" 1)
   ("HA-tagged dominant-inhibitory ARF6-T27N" 1)))
 ("UP:P62332" (("rARF6" 6)))
 ("UP:P62333" (("ATPase 6" 3) ("PSMC6" 3) ("Psmc6" 1)))
 ("UP:P62380" (("stud" 6) ("TRPs" 4) ("Stud" 3) ("TLF" 1)))
 ("UP:P62424"
  (("rpL7a" 44) ("TRUP" 8) ("rpL7a protein" 5) ("L7a" 4)
   ("ribosomal protein L7a" 3) ("RPL7A" 2) ("L7A" 1)))
 ("UP:P62487" (("Rpb7" 2)))
 ("UP:P62490"
  (("Rab11" 609) ("dominant-negative Rab11" 4)
   ("expressing dominant-negative Rab11" 3) ("-Rab11" 2)
   ("traffic using Rab11" 2) ("mitotic Rab11" 1) ("significantly more Rab11" 1)
   ("GFP-tagged dominant negative (DN) Rab11" 1) ("Rab11 (ERC)" 1) ("Rab11-" 1)
   ("subapical Rab11" 1) ("rab11" 1)))
 ("UP:P62491"
  (("Rab11a" 105) ("RAB11" 47) ("Rab11A" 8) ("Rab-11" 5) ("rab-11" 5)
   ("the peripherally associated GTPase RAB11" 2) ("Rab 11" 2) ("RAB11A" 2)
   ("RAB11a" 1) ("than Rab11a" 1)))
 ("UP:P62495" (("eRF1" 4) ("RF1" 2) ("ETF1" 1)))
 ("UP:P62508"
  (("ESRRG" 4) ("Esrrg" 4) ("estrogen related receptor gamma" 2)
   ("estrogen-related receptor gamma" 1) ("ERR3" 1)))
 ("UP:P62555" (("protein-G" 96) ("Protein-G" 35) ("Protein–G" 1)))
 ("UP:P62556" (("SopA" 11))) ("UP:P62558" (("SopB" 95) ("sopB" 9)))
 ("UP:P62583" (("Vps74" 3)))
 ("UP:P62633"
  (("CNBP" 14) ("cellular nucleic acid binding protein" 3) ("ZNF9" 1)))
 ("UP:P62701" (("RPS4X" 6) ("SCAR" 6))) ("UP:P62714" (("PPP2CB" 12)))
 ("UP:P62736"
  (("αSMA" 202) ("α-actin" 189) ("ACTA2" 82) ("SMA" 17) ("alpha-actin" 14)
   ("alpha-SMA" 12) ("Acta2" 11) ("α-Actin" 7) ("αSMA protein" 5)
   ("SMA protein" 4) ("α–actin" 4) ("α-ACTIN" 3) ("α-actin (SMA)" 3)
   ("Alpha-actin" 2) ("mouse monoclonal αSMA" 2)
   ("actin, alpha 2, smooth muscle, aorta" 1) ("cardiac alpha-actin" 1)))
 ("UP:P62745"
  (("RhoB" 3071) ("RHOB" 68) ("CINCCKVL" 52) ("rhoB" 30) ("RhoB protein" 17)
   ("overexpressed myc-tagged RhoB" 3)
   ("The primary monoclonal mouse anti-human RhoB" 2)
   ("Fluorescent CINCCKVL" 2) ("–CINCCKVL" 1) ("expressing RhoB" 1)
   ("functional RhoB" 1) ("these results strongly highlight RhoB" 1)))
 ("UP:P62750" (("RPL23A" 2) ("RpL23a" 1)))
 ("UP:P62753"
  (("S6" 3769) ("ribosomal protein S6" 320) ("RPS6" 262) ("rpS6" 222)
   ("pS6" 170) ("S6 protein" 82) ("p-S6" 62) ("p-rpS6" 47) ("pRPS6" 28)
   ("p-RPS6" 23) ("P-S6" 21) ("the ribosomal S6 protein" 17)
   ("ribosomal S6 protein" 10) ("Rps6" 9) ("RpS6" 9) ("ribosomal S6" 8)
   ("-S6" 7) ("phospho-Ser240/244-ribosomal S6 protein" 5)
   ("the ribosomal subunit S6" 4) ("phospho-S6 protein" 4)
   ("ribosomal protein
S6"
    4)
   ("Supplemental Figure S6" 3) ("phosphorylated-S6 protein" 3)
   ("phospho-ribosomal S6" 2)
   ("the epidermal growth factor receptor (EGFR)/PI3K p110α/phosphorylated ribosomal S6 protein"
    2)
   ("p-RpS6" 2) ("namely phosphorylated/activated (p)-ribosomal protein S6" 2)
   ("-ribosomal protein S6" 2) ("the small ribosomal subunit protein S6" 2)
   ("13/14 (93%) p-p70S6K, and 11/12 (83%) p-rpS6" 2)
   ("the phosphorylated ribosomal S6 protein" 2) ("S6-" 2)
   ("anti-phosphorylated (S235/236) ribosomal S6 protein" 2)
   ("online supplementary table S6" 1) ("phosphorylated ribosomal S6" 1)
   ("Figure S6.1" 1) ("phospho-S6(Ser235/6) protein" 1)
   ("ribosomal subunit S6" 1) ("residual pRPS6" 1)
   ("phosphorylated ribosomal S6 protein" 1) ("P-RPS6" 1)
   ("whose S6 protein" 1)
   ("ribosomal
protein S6"
    1)
   ("a mouse monoclonal recognizing total S6 protein" 1)
   ("the last 32 amino acids of 40S ribosomal protein S6" 1)))
 ("UP:P62756" (("inter-alpha-trypsin inhibitor" 3)))
 ("UP:P62760" (("VSNL1" 14) ("Vsnl1" 5)))
 ("UP:P62805"
  (("histone H4" 508) ("histone 4" 49) ("Histone H4" 32) ("Histone 4" 14)
   ("histone H4 peptide" 6) ("HIST1H4C" 3) ("HIST1H4A" 3) ("HIST1H4K" 3)
   ("HIST1H4B" 2) ("-histone H4" 2) ("exogenous substrate histone H4" 2)
   ("new histone H4" 2) ("histone 4 (H4) peptide" 2) ("Histone H4 peptide" 2)
   ("monoclonal primary antibody anti-acetyl histone H4" 2)
   ("the first 23 amino acids of histone 4" 1) ("histone H4 protein" 1)
   ("HIST1H4I" 1) ("HIST1H4" 1) ("than histone H4" 1) ("HIST1H4E" 1)))
 ("UP:P62807" (("HIST1H2BE" 2) ("H2BFG" 1))) ("UP:P62811" (("WDNM1" 7)))
 ("UP:P62820"
  (("Rab1A" 185) ("Ypt1" 21) ("RAB1A" 3) ("ypT1" 2) ("heart-specific Rab1A" 1)
   ("ypt1" 1) ("RAB1a" 1) ("RAB1" 1)))
 ("UP:P62826"
  (("RAN" 24) ("GTPase Ran" 23) ("ARA24" 8) ("GTPase RAN" 3) ("−RAN" 1)))
 ("UP:P62829"
  (("RPL23" 45) ("ribosomal protein L23" 5) ("RpL23" 3) ("Rpl23" 3)))
 ("UP:P62834"
  (("Rap1A" 145) ("Rap1a" 132) ("RAP1A" 35) ("Rap-1A" 5) ("Rap1A peptide" 3)
   ("Rap1a-" 2) ("dominant-negative 17N Rap1a" 1)))
 ("UP:P62837"
  (("UbcH5b" 96) ("Ubc4" 77) ("UBE2D2" 67) ("UbcH5B" 40) ("UBC4" 6) ("Ubc5B" 4)
   ("UBCH5b" 4) ("UbcH5-B" 2) ("than UbcH5b [ xref ]" 1)
   ("than UBE2D2(UbcH5B)" 1) ("UbcH4" 1)))
 ("UP:P62841"
  (("S15" 229) ("RPS15" 49) ("monoclonal rabbit anti-p53 S15" 3) ("s15" 3)
   ("Ribosomal Protein S15" 1) ("S15-" 1)))
 ("UP:P62847" (("RPS24" 13) ("S24" 2))) ("UP:P62851" (("S25" 34) ("RPS25" 3)))
 ("UP:P62854"
  (("S26" 106) ("RPS26" 7) ("low metastatic S26" 2) ("ribosomal protein S26" 2)
   ("especially around S26" 1)))
 ("UP:P62857" (("RPS28" 10))) ("UP:P62873" (("Gnb1" 1)))
 ("UP:P62875" (("POLR2L" 1)))
 ("UP:P62877"
  (("RBX1" 348) ("Rbx 1" 6) ("Rbx-1" 5) ("RING-box 1" 2) ("binding RBX1’s" 2)
   ("Ring-box 1" 2) ("ring-box 1" 1) ("cullin-associated RBX1" 1)
   ("GLMN not only contacts RBX1’s" 1) ("GLMN not only contacts RBX1" 1)))
 ("UP:P62879"
  (("guanine nucleotide binding protein (G protein)" 2) ("GNB2" 1)))
 ("UP:P62888" (("RPL30" 38))) ("UP:P62891" (("L39" 2)))
 ("UP:P62899" (("L31" 7) ("RPL31" 1))) ("UP:P62906" (("RPL10A" 1)))
 ("UP:P62910"
  (("RPL32" 9) ("ribosomal protein L32" 7) ("Rpl32" 6) ("RpL32" 6) ("rpl32" 3)
   ("the housekeeping gene Ribosomal gene Rpl32" 2)
   ("60S ribosomal protein L32" 1) ("P62910" 1)))
 ("UP:P62913"
  (("RPL11" 488) ("RpL11" 35) ("Rpl11" 33) ("ribosomal protein L11" 16)
   ("rpL11" 6) ("Ribosomal Protein L11" 4) ("RPL11-" 4) ("RPL11 protein" 3)
   ("overexpressed RPL11" 2) ("NP40-soluble RPL11" 2) ("Exogenous RPL11" 2)
   ("co-precipitate RPL11" 1) ("the ribosomal subunit RPL11" 1)
   ("nucleolar Rpl11" 1) ("than Rpl11" 1)))
 ("UP:P62917" (("RPL8" 6)))
 ("UP:P62937"
  (("PPIA" 178) ("CyPA" 86) ("cyclophilin A" 82) ("CypA" 45)
   ("Cyclophilin A" 19) ("peptidylprolyl isomerase A" 14) ("Ppia" 6)
   ("peptidylprolyl isomerase A (PPIA)" 3) ("than CyPA" 1)
   ("the oxidative stress markers Keap1, Nrf2, and antioxidants PPIA" 1)
   ("extarcellular PPIA" 1)
   ("oxidative stress markers Keap1, Nrf2, and antioxidants PPIA" 1)
   ("CYCLOPHILIN A" 1) ("cyclophilin A (PPIA)" 1)))
 ("UP:P62942"
  (("FKBP12" 229) ("immunophilin" 20) ("immunophilin FKBP12" 14) ("FKBP-12" 10)
   ("FKBP12 protein" 4) ("12-kDa FK506-binding protein" 4)
   ("12 kDa FK506-binding protein" 3) ("FKBP12 protein (FKBP)" 3) ("FKBP1a" 1)
   ("PPIase FKBP1A" 1) ("FKBP1A" 1) ("FK506 binding protein 1A" 1)
   ("The macrolide antibiotic rapamycin selectively binds FKBP12" 1)
   ("Immunophilin" 1)))
 ("UP:P62945" (("L41" 20) ("RPL41" 4) ("hg12" 1)))
 ("UP:P62979" (("S27A" 20) ("RPS27A" 8) ("RPS27a" 8)))
 ("UP:P62987" (("L40" 61) ("UBA52" 5)))
 ("UP:P62993"
  (("Grb2" 3736) ("GRB2" 657) ("grb2" 90)
   ("growth factor receptor-bound protein 2" 51) ("Ash" 37) ("Grb-2" 35)
   ("Grb2 molecule" 18) ("Grb2-" 16) ("ASH" 16) ("adapter protein Grb2" 15)
   ("Growth factor receptor-bound protein 2" 14) ("Grb2 protein" 11)
   ("GRB2 protein" 10) ("than Grb2" 7)
   ("growth factor receptor–bound protein 2" 7) ("GRB-2" 5)
   ("Monomeric Grb2" 4) ("–Grb2" 3) ("adapter protein  Grb2" 2)
   ("tumor-associated protein growth factor receptor-bound protein 2" 2)
   ("-Grb-2" 2) ("adapter protein GRB2" 2) ("dimeric Grb2" 2)
   ("the dimeric Grb2" 2) ("growth factor receptor bound protein 2" 2)
   ("targeted Grb2" 2) ("the annual ASH" 2)
   ("growth factor receptor-bound protein 2 (Grb2) protein" 2)
   ("tumor-associated proteins GRB2" 2)
   ("the ubiquitous cytoplasmic adapter protein Grb2" 2) ("Grb2–" 2)
   ("The complete  adapter protein Grb2" 1) ("grb-2" 1)
   ("Grb2 (Growth factor receptor-binding protein 2) protein" 1)
   ("only GRB2 protein" 1) ("The dimeric adaptor protein Grb2" 1)
   ("than Grb2 such as IQGAP1, Crk and Sgk269" 1)
   ("the universal adaptor protein Grb2" 1)
   ("the ubiquitous adaptor protein Grb2" 1)
   ("The ubiquitous adaptor protein Grb2" 1) ("selectively knock-down Grb2" 1)
   ("fluorescent protein-tagged Grb2" 1) ("Only monomeric Grb2" 1)
   ("a monomeric Grb2" 1) ("than WT Grb2 ( xref )" 1) ("the dimeric WT Grb2" 1)
   ("mimetic Grb2 mutant Y160E" 1) ("monomeric and dimeric Grb2" 1)
   ("Dimeric Grb2" 1) ("homodimeric Grb2" 1)))
 ("UP:P62995" (("TRA2B" 17) ("Tra2b" 3) ("SFRS10" 2)))
 ("UP:P63000"
  (("Rac1" 14223) ("RAC1" 862) ("rac1" 157) ("Rac-1" 68) ("Rac1 protein" 49)
   ("Rac1-" 36) ("Ras-related C3 botulinum toxin substrate 1" 24)
   ("dominant-negative Rac1" 18) ("pRac1" 17) ("Rac1 peptide" 15)
   ("RAC1 protein" 8) ("-Rac1" 7) ("than Rac1" 5) ("expressing dn Rac1" 5)
   ("cryptococcal Rac1" 5) ("soluble Rac1" 4) ("the dominant-negative Rac1" 4)
   ("dominant-negative rac1" 4) ("microtubule-associated Rac1" 4)
   ("release less Rac1" 3) ("RAC-1" 3) ("–Rac1" 3) ("photoactivatable Rac1" 3)
   ("membrane-associated Rac1" 3) ("more Rac1" 3)
   ("the NH 2 -terminal 54 amino acids of Rac1" 3) ("less Rac1" 2)
   ("dominant-negative (DN) Rac1" 2) ("the dominant-negative mutants Rac1" 2)
   ("control photoinsensitive (PI) Rac1" 2) ("RAC1-" 2)
   ("overexpressed active rac1" 2) ("basal Rac1" 2)
   ("less membrane-bound Rac1" 2) ("dominant-inhibitory rac1" 2)
   ("Endothelial Rac1" 2) ("monoclonal Rac1" 2) ("functional Rac1" 2)
   ("dominant-negative mutant Rac1" 2) ("fungal RAC1" 2) ("p-Rac1" 2)
   ("dominant-negative  Rac1" 1)
   ("Hace1 preferentially targets NOXA1-associated Rac1" 1)
   ("released less Rac1" 1)
   ("down experiment revealed no detectable activated Rac1" 1)
   ("we first silenced Rac1" 1) ("soluble recombinant GDP-loaded Rac1" 1)
   ("photoactivatable GFP (PAGFP)-tagged Rac1" 1) ("total cellular Rac1" 1)
   ("a mouse monoclonal Rac1" 1) ("Dominant-negative 17N Rac1" 1)
   ("Rac1(PQ)" 1) ("active soluble Rac1" 1) ("non-SUMOylated Rac1" 1)
   ("than wild-type Rac1 ( xref )" 1) ("clearly more activated Rac1" 1)
   ("the highly homologous RAC family member RAC1" 1) ("Hyperactive Rac1" 1)
   ("consequently inactivated Rac1" 1)
   ("the first 17 amino acids of Rac1 that are involved in Stat3 binding" 1)
   ("amino acids of Rac1" 1) ("the 54 NH 2 -terminal amino acids of Rac1" 1)
   ("Rac1 151–164 amino acids of Rac1" 1) ("the appropriate Rac1" 1)
   ("This domain specifically only binds Rac1" 1)))
 ("UP:P63010"
  (("β2-adaptin" 8) ("β-adaptin" 7) ("AP2B1" 4) ("the precise β-adaptin" 2)
   ("P63010" 1)))
 ("UP:P63013" (("PMX" 33)))
 ("UP:P63027"
  (("VAMP2" 24) ("VAMP-2" 4)
   ("the vesicle-associated membrane protein VAMP2" 1)))
 ("UP:P63096" (("GNAI1" 4)))
 ("UP:P63098"
  (("type I)" 44) ("Type I)" 10) ("regulatory subunit B" 8) ("CNB" 5)
   ("PPP3R1" 2) ("papillary type I)" 1)
   ("congenital dyserythropoietic anemia type I)" 1) ("calcineurin B" 1)))
 ("UP:P63104" (("YWHAZ" 70) ("14-3-3zeta" 29)))
 ("UP:P63127"
  (("proteases" 2077) ("Proteases" 24) ("viral proteases" 6)
   ("cellular proteases" 3) ("chlamydial proteases" 3)
   ("ovarian tumor proteases" 3)
   ("calcium-activated neutral cysteine proteases" 2)
   ("cellular and viral proteases" 2) ("the key proteases" 2)
   ("cell surface-associated proteases" 2)
   ("the ovarian tumour proteases (OTU)" 2) ("proteases (OTU)" 2)
   ("essential proteases" 2) ("Some RNA viral proteases" 2)
   ("the A Disintegrin And Metalloproteinase Domains (ADAM) proteases" 2)
   ("lysomal proteases" 2) ("proteases (MJD)" 2)
   ("ubiquitous Ca 2+ -activated proteases" 2)
   ("at least 10 human ubiquitin-specific processing proteases" 2)
   ("secondary proteases" 2) ("the membrane-associated proteases" 2)
   ("alternative proteases" 2) ("Destructive proteases" 2)
   ("certain non-proteasomal proteases" 2) ("prominent proteases" 2)
   ("the ovarian tumor proteases" 2) ("distinct proteases" 2)
   ("the most highly expressed proteases" 2) ("all ERα-associated proteases" 2)
   ("virally-encoded proteases" 2) ("Sentrin/SUMO-specific proteases" 2)
   ("respective proteases" 2)
   ("at least six different SUMO-specific proteases" 2)
   ("nongenomic proteases" 1) ("soluble proteases" 1)
   ("proteolytic proteases" 1) ("tumor-associated proteases" 1)
   ("most cellular proteases" 1) ("retroviral proteases" 1)
   ("similar neuronal proteases" 1) ("Generally blood serum proteases" 1)
   ("major proteases" 1)
   ("secreted
bacterial proteases"
    1)
   ("bacterial proteases" 1) ("the cancer-associated proteases" 1)
   ("the most well-known proteases" 1) ("neutral cysteine proteases" 1)
   ("host cellular proteases" 1)
   ("the common proteases found in lysosomes, MG-132" 1)
   ("the common proteases found in lysosomes" 1) ("key lyososomal proteases" 1)
   ("FAK-associated proteases" 1) ("other pro-migratory/mitogenic proteases" 1)
   ("ovarian tumor-like proteases (OTU)" 1) ("two major proteases" 1)
   ("most serine proteases" 1) ("their associated proteases" 1)
   ("key proteases" 1) ("both invadopodia-associated proteases" 1)
   ("the major proteases" 1)
   ("than other well-known cancer-related proteases" 1)
   ("cell death proteases which cleave the cell's" 1)
   ("tumor cell-associated proteases" 1) ("aspartic proteases" 1)
   ("pericellular proteases" 1) ("no major proteases" 1)
   ("dimeric cysteine proteases" 1) ("viral and cellular proteases" 1)
   ("at least 26 proteases" 1) ("cation-dependent proteases" 1)))
 ("UP:P63128" (("p66 RT" 1)))
 ("UP:P63146"
  (("Rad6B" 211) ("rad6B" 27) ("RAD6B" 22) ("hHR6B" 7) ("UBE2B" 5)
   ("catalytically inert rad6B" 3) ("HR6B" 2) ("Rad6B protein" 2) ("HHR6B" 2)
   ("Rad6b" 1) ("hHr6B" 1) ("Hr6b" 1) ("catalytically inert Rad6B" 1)
   ("Catalytically inert Rad6B C88A" 1)))
 ("UP:P63151" (("PPP2R2A" 175) ("targeting PPP2R2A" 3) ("Ppp2r2a" 1)))
 ("UP:P63162" (("SMD" 32) ("SNRPN" 4)))
 ("UP:P63165"
  (("SUMO1" 1173) ("SUMO-1" 293) ("Sumo1" 25) ("-SUMO1" 8) ("SMT3" 6)
   ("exogenous SUMO1" 5) ("sentrin" 5) ("-SUMO-1" 4) ("Sentrin" 4)
   ("small ubiquitin-related modifier 1" 3) ("UBL1" 2) ("SUMO1 protein" 2)
   ("SUMO-1-" 2) ("pSMT3" 1) ("Pi-C1" 1) ("almost no SUMO-1" 1)
   ("than SUMO-1" 1) ("the mature SUMO1 protein" 1) ("SUMO1-" 1)))
 ("UP:P63167"
  (("DLC1" 826) ("PIN" 822) ("LC8" 174) ("PINs" 18) ("dynein light chain 1" 16)
   ("DYNLL1" 6) ("DLC1 protein" 5) ("a comprehensive PIN" 3)
   ("focal high-grade PIN" 2) ("Dynein light chain 1" 2) ("functional DLC1" 2)
   ("-DLC1" 2) ("dlc1" 2) ("well-established high-grade PIN" 2)
   ("than high grade PIN" 2) ("typical high grade PIN" 2) ("subtle PIN" 1)
   ("so LG and HG PIN" 1) ("homogenous PIN" 1) ("noise-driven PINs" 1)
   ("PIN (HGPIN)" 1) ("than DLC1" 1) ("DNCL1" 1) ("monomeric LC8" 1)
   ("homodimeric LC8" 1) ("almost all human PIN" 1) ("more LC8" 1)
   ("than ordinary high grade PIN" 1) ("ordinary high grade PIN" 1)
   ("than high grade PIN ( xref , xref – xref )" 1)
   ("than typical high grade PIN ( xref )" 1)))
 ("UP:P63168"
  (("mPIN" 69) ("mPINs" 12) ("subtle mPIN" 3) ("In fact more mPIN" 1)
   ("residual mPIN" 1)))
 ("UP:P63173" (("L38" 8) ("RPL38" 5) ("Rpl38" 1)))
 ("UP:P63208"
  (("Skp1" 343) ("SKP1" 224) ("–Skp1" 20)
   ("S-phase kinase-associated protein 1" 14) ("targeted SKP1" 4)
   ("S-phase kinase–associated protein 1" 4) ("skp1" 4) ("–SKP1" 2) ("SIII" 2)
   ("Skp 1" 1) ("p19Skp1" 1) ("-SKP1" 1) ("less SKP1" 1)))
 ("UP:P63220" (("S21" 79) ("s21" 4) ("RPS21" 2)))
 ("UP:P63241" (("eukaryotic translation initiation factor 5A" 1) ("EIF5A" 1)))
 ("UP:P63244"
  (("RACK1" 453) ("GNB2L1" 22) ("RACK-1" 11) ("Rack1" 9) ("RACK1 protein" 7)
   ("activated C-kinase" 6) ("receptor for activated C kinase" 4)
   ("Receptor for activated C kinase" 4)
   ("receptor for activated C kinase 1" 3)
   ("the tubulin-associated protein Rack1" 2) ("very little RACK1" 1)))
 ("UP:P63252"
  (("Kir2.1" 139) ("KCNJ2" 25) ("IRK1" 2)
   ("cardiac potassium channels Kir2.1" 1) ("LQT7" 1) ("KIR2.1" 1)))
 ("UP:P63261"
  (("ACTG" 13) ("γ-actin" 11) ("ACTG1" 6) ("Actg1" 2) ("ActG1" 1)
   ("gamma-actin" 1) ("P63261" 1)))
 ("UP:P63267" (("ACTG2" 1)))
 ("UP:P63279"
  (("Ubc9" 687) ("UBC9" 544) ("SUMO conjugating enzyme" 27) ("UBE2I" 25)
   ("SUMO-conjugating enzyme Ubc9" 12) ("Ubc-9" 6) ("UBE2I (UBC9)" 4)
   ("dominant-negative UBC9" 3) ("cells not expressing exogenous Ubc9" 2)
   ("dominant negative (DN) Ubc9" 2) ("ubc9" 1)
   ("ubiquitin-conjugating enzyme E2I" 1) ("Ube2I" 1) ("Ubc9 protein" 1)
   ("SUMO-E2-conjugating enzyme Ubc9" 1) ("SUMO conjugating enzyme UBC9" 1)
   ("the dominant-negative mutant DN UBC9" 1)
   ("the dominant-negative mutant UBC9" 1) ("SUMO–conjugating enzyme Ubc9" 1)))
 ("UP:P63313" (("TMSB10" 2))) ("UP:P63358" (("MKL" 34)))
 ("UP:P65486" (("mutA" 12))) ("UP:P66428" (("RS-15" 1)))
 ("UP:P67775"
  (("PP2Ac" 225) ("PP2A-C" 50) ("PP2AC" 41) ("PP2Cα" 26) ("PPP2CA" 22)
   ("–PP2Ac" 4) ("RP-C" 3) ("PP2Aα" 2) ("PP2As" 2)
   ("threonine-protein phosphatase" 1) ("Pp2a-c" 1)))
 ("UP:P67809"
  (("YB-1" 5386) ("YBX1" 601) ("YB-1 protein" 101) ("YB1" 97)
   ("Y-box binding protein-1" 47) ("Y-box binding protein 1" 44) ("P-YB-1" 38)
   ("YBX1 protein" 16) ("Y-box-binding protein-1" 13) ("pYB-1" 10)
   ("Y-box-binding protein 1" 9) ("CBF-A" 6) ("YBX-1" 6) ("YB-1 peptide" 6)
   ("CBFA" 4) ("dbpB" 3) ("YB-1 (HTRY)" 3)
   ("the transcriptional and translational regulator YB-1" 3) ("DbpB" 3)
   ("\"YB-1\"" 3) ("YB-1 (WT)" 2) ("The nucleic acid-binding protein YB-1" 2)
   ("intense YBX1" 2) ("strong YBX1" 2) ("more YB-1" 2)
   ("Y-box–binding protein-1" 2)
   ("The transcription/translation regulatory Y-box binding protein-1" 2)
   ("others previously identified Y-box binding protein 1" 2)
   ("only weak YB-1" 2) ("that YB-1’s" 2) ("Y-box transcription factor" 2)
   ("than the full length YB-1" 1) ("both total and phosphorylated YB-1" 1)
   ("the first 220 amino acids of YB-1" 1) ("NSEP-1" 1) ("YBX1-" 1) ("ybx1" 1)
   ("secretory YB-1" 1) ("YB-1–" 1) ("down less YBX1 protein" 1)
   ("flag-tagged YB-1" 1) ("YB1 protein" 1) ("intravesicular YB-1" 1)
   ("YB-1 (Y-box binding protein-1) protein" 1) ("P-YB1" 1)
   ("potential YBX1" 1) ("DNA-binding protein B" 1) ("monomeric YB-1" 1)
   ("almost every case YB-1" 1) ("P67809" 1) ("Yb1" 1)))
 ("UP:P67812" (("Sec11a" 1) ("Sec11A" 1)))
 ("UP:P67870" (("CSNK2B" 8) ("CK2b" 1))) ("UP:P67925" (("BRP" 1)))
 ("UP:P67936"
  (("TPM4" 42) ("tropomyosin 4" 5) ("tropomyosin alpha-4 chain" 2)
   ("TPM4 protein" 2) ("Tropomyosin 4" 1)))
 ("UP:P68030" (("γ-globin" 293) ("γglobin" 4) ("gamma-globin" 3)))
 ("UP:P68032"
  (("ACTC" 11) ("ACTC1" 4) ("Actc1" 3) ("actin, alpha, cardiac muscle 1" 1)
   ("-ACTC" 1)))
 ("UP:P68036"
  (("UbcH7" 133) ("UBE2L3" 117) ("UbCH7" 4) ("UBCH7" 3) ("Ubch7" 2)
   ("UBE2L3 protein" 2) ("Ube2L3" 1)))
 ("UP:P68104"
  (("eEF1A" 234) ("eEF1A1" 181) ("EEF1A1" 20) ("EF1A" 16) ("EF1a" 11)
   ("eEF1A protein" 7) ("elongation factor 1A" 6) ("eEF1" 5) ("Eef1a1" 3)
   ("relatively more eEF1A" 2) ("EEF1A" 1) ("no associated eEF1A protein" 1)
   ("pEF1A" 1) ("eukaryotic elongation factor 1A1" 1) ("pEF1a" 1)
   ("than eEF1A1 (data not shown)" 1) ("than eEF1A1" 1)
   ("Recently xref identified eEF1A" 1)))
 ("UP:P68106" (("FKBP12.6" 21) ("endothelial FKBP12.6" 1)))
 ("UP:P68133" (("ACTA" 8) ("Acta1" 7) ("ACTA1" 3) ("-ACTA" 1)))
 ("UP:P68193" (("Sra" 3))) ("UP:P68324" (("BHLF1" 1)))
 ("UP:P68347" (("pP38" 11))) ("UP:P68363" (("TUBA1B" 9) ("kα1" 6) ("Kα1" 1)))
 ("UP:P68366"
  (("α-tubulin" 1803) ("Tuba1" 26) ("α–tubulin" 9) ("TUBA4A" 7)
   ("polymerized α-tubulin" 6) ("α-tubulin protein" 5)
   ("monoclonal α-tubulin" 2) ("soluble α-tubulin" 2)
   ("Histone2B–eGFP and monomer red fluorescent protein (mRFP)-tagged α-tubulin"
    2)
   ("mouse-monoclonal α-tubulin" 2) ("mouse monoclonal α-tubulin" 2)
   ("mouse monoclonal anti-sea urchin acetylated α-tubulin" 2) ("tuba1" 1)
   ("unresolved α-tubulin" 1) ("Monoclonal α-tubulin" 1) ("around α-tubulin" 1)
   ("ciliary markers acetylated α-tubulin" 1) ("both soluble α-tubulin" 1)))
 ("UP:P68371" (("TUBB2C" 1)))
 ("UP:P68400"
  (("CK2α" 537) ("CSNK2A1" 8) ("CK2α protein" 4) ("targeting CK2α" 3)
   ("CK2A1" 2) ("mouse monoclonal CK2α" 2) ("monomeric CK2α" 1) ("CK2a1" 1)))
 ("UP:P68402" (("platelet-activating factor acetylhydrolase" 1)))
 ("UP:P68431" (("Hist1H3B" 2) ("HIST1H3B" 2) ("Histone H3.1" 1)))
 ("UP:P68543"
  (("UBXN2A" 202) ("UBXN2A protein" 6) ("overexpressed UBXN2A" 5) ("-UBXN2A" 5)
   ("MCF7-expressing UBXN2A" 1) ("Exogenous UBXN2A" 1)))
 ("UP:P68762" (("pHEF" 28) ("HEF" 4)))
 ("UP:P68871"
  (("β-globin" 268) ("HBB" 40) ("beta-globin" 24) ("βGlobin" 5)
   ("Beta-globin" 3) ("beta-globin protein" 1) ("β–globin" 1)
   ("the transcriptionally silent HBB" 1)))
 ("UP:P68970"
  (("PIX" 195) ("-pix" 37) ("pix" 27) ("Pix" 19) ("PIXs" 3) ("PIX-" 1)
   ("PIX protein" 1)))
 ("UP:P69169" (("g3p" 2))) ("UP:P69191" (("NDD" 3)))
 ("UP:P69208"
  (("HA" 11247) ("-HA" 128) ("HA-" 91) ("HA peptide" 38) ("pHA" 26)
   ("HA protein" 20) ("hA" 6) ("influenza A virus HA" 2)
   ("carboxy-terminal triple HA" 2) ("HA Peptide" 2) ("“dRAD6-HA”" 2)
   ("monoclonal anti HA" 2) ("polymeric HA" 2) ("mouse monoclonal HA" 2)
   ("HA–" 2) ("apical HA" 2) ("HA-WT protein" 2)
   ("TFAM(S177D)-HA and TFAM(S177A)-HA" 1) ("Ha" 1)
   ("pLenti-6.2/V5-DEST-HTLV-1 p30 II HA" 1) ("TMPRSS2-treated HA" 1) ("−HA" 1)
   ("than HA" 1) ("Profound mammalian HA" 1) ("a triple HA" 1)
   ("oligomeric HA" 1) ("than the HA-WT protein" 1)))
 ("UP:P69722"
  (("virion infectivity factor" 9) ("Virion infectivity factor" 2)
   ("virion infectivity factor (Vif) protein" 1)))
 ("UP:P69771" (("FTI-1" 17)))
 ("UP:P69776"
  (("MLPA" 892) ("-MLPA" 1) ("subsequent MLPA" 1) ("abnormal MLPA" 1)))
 ("UP:P69783" (("TRED" 23) ("pTRED" 1))) ("UP:P69891" (("HBG1" 7)))
 ("UP:P69892" (("HBG2" 8)))
 ("UP:P69905"
  (("HbA1" 112) ("α-globin" 16) ("alpha-globin" 4) ("HBA1" 3) ("HBA2" 3)
   ("HbA2" 1) ("hbA1" 1) ("hemoglobin subunit alpha" 1)))
 ("UP:P70032" (("Plx1" 75) ("than the unmodified Plx1" 1)))
 ("UP:P70062" (("xTcf3 protein" 5) ("xTcf3" 3) ("-xTcf3" 1)))
 ("UP:P70106" (("GCCs" 3))) ("UP:P70168" (("SCG" 93) ("scg" 6)))
 ("UP:P70213" (("Fv-1" 3) ("Fv1" 2))) ("UP:P70354" (("MSX3" 2)))
 ("UP:P70387" (("MR2" 3))) ("UP:P70694" (("AKR1C6" 3)))
 ("UP:P70753"
  (("LacZ" 1547) ("lacZ" 758) ("HTRZ" 22) ("LacZ-" 11) ("pLacZ" 10) ("-LacZ" 4)
   ("LAcZ" 4) ("-lacZ" 4) ("LacZ (HTRZ)" 2) ("lacZ-" 2) ("lacZ protein" 2)
   ("chimeric lacZ" 2) ("LacZ protein" 2) ("bacterial LacZ" 1)
   ("expressed less lacZ" 1) ("“LacZ”" 1)
   ("the more stringent promoter LacZ" 1) ("placZ" 1) ("LacZ, Ad-PIAS1," 1)))
 ("UP:P70918" (("HSPB" 52)))
 ("UP:P71049" (("SLR" 278) ("SLR-" 2) ("Only relative changes ≥0.6 SLR" 1)))
 ("UP:P71052" (("EPSC" 6))) ("UP:P71058" (("epsi" 2)))
 ("UP:P71828" (("GGT-1" 2))) ("UP:P72154" (("ORP" 5)))
 ("UP:P72292" (("ExoS" 11))) ("UP:P74155" (("Oxa1" 1)))
 ("UP:P75938" (("flax" 2))) ("UP:P75990" (("BLRP" 5)))
 ("UP:P76129" (("DOS" 22) ("dos" 10) ("Dos" 1))) ("UP:P76236" (("YEAI" 1)))
 ("UP:P76261" (("ADRB" 12))) ("UP:P76440" (("pRET" 3) ("preT" 1)))
 ("UP:P76446" (("RTN" 4)))
 ("UP:P76621" (("GAB" 32) ("pGAB" 1) ("GAB protein" 1)))
 ("UP:P77257" (("EGO" 1))) ("UP:P77319" (("HSCC" 47) ("HscC" 5)))
 ("UP:P77334" (("GMR" 77) ("GMR-" 2) ("pGMR" 2))) ("UP:P77650" (("PhdA" 1)))
 ("UP:P77814" (("OPA" 53)))
 ("UP:P78310"
  (("hCAR" 4) ("Coxsackievirus and adenovirus receptor (CAR)" 2)
   ("Coxsackievirus and adenovirus receptor" 2) ("CXADR" 1)))
 ("UP:P78314"
  (("SH3BP2" 94) ("phosphatidylinositols" 40) ("3BP2" 12) ("Sh3bp2" 2)
   ("3BP-2" 1) ("-phosphatidylinositols" 1)))
 ("UP:P78316" (("NOP14" 136) ("targeting NOP14" 2) ("RES4–25" 1)))
 ("UP:P78317"
  (("RNF4" 178) ("SNURF" 68) ("E3 ubiquitin ligase RNF4" 2)
   ("ring finger protein 4" 2) ("Slx5" 1) ("SLX5" 1) ("slx5" 1)
   ("three different dominant-negative RNF4" 1) ("functional RNF4" 1)
   ("Ring finger protein 4" 1) ("dominant-negative RNF4" 1) ("P78317" 1)))
 ("UP:P78318" (("IGBP1" 14) ("alpha-4" 2)))
 ("UP:P78324"
  (("SIRPα1" 81) ("BIT" 14) ("SIRPA" 9) ("SIRPalpha" 9) ("SIRP" 8) ("SIRPα" 8)
   ("signal regulatory protein" 5) ("SHP substrate 1" 3) ("siRPA" 2)
   ("SIRP-α1" 1) ("C2 mouse myotubes SIRPα1's" 1)
   ("the N-SH2 domain-specific PTPNS1" 1) ("PTPNS1" 1)))
 ("UP:P78325"
  (("MS2" 187) ("ADAM8" 8) ("Adam8" 6) ("-MS2" 4) ("MS2-" 4) ("ms2" 2)
   ("a disintegrin and metalloproteinase domain 8" 1)))
 ("UP:P78329" (("CYP4F2" 2)))
 ("UP:P78330" (("PSPH" 3) ("Phosphoserine phosphatase" 1)))
 ("UP:P78333" (("GPC5" 20) ("Glypican 5" 2) ("glypican 5" 2)))
 ("UP:P78334" (("GABRE" 3))) ("UP:P78337" (("PITX1" 37) ("BFT" 5) ("Pitx1" 3)))
 ("UP:P78344" (("eukaryotic translation initiation factor 4 gamma" 4)))
 ("UP:P78346" (("RPP30" 4)))
 ("UP:P78347"
  (("spin" 519) ("Spin" 132) ("BAP-135" 3) ("the paramagnetic spin" 3)
   ("GTF2I" 2) ("paramagnetic spin" 2) ("Paramagnetic spin" 1)
   ("actual MTSL spin" 1) ("The paramagnetic spin" 1) ("representative spin" 1)
   ("the subsequent spin" 1) ("unique spin" 1)))
 ("UP:P78352"
  (("PSD-95" 491) ("DLG" 275) ("PSD95" 136) ("Dlg" 106) ("DLG4" 21) ("Dlg4" 9)
   ("postsynaptic density protein 95" 9) ("PSD-95 protein" 7) ("dlg" 6)
   ("post-synaptic density protein" 6) ("postsynaptic marker PSD95" 4)
   ("the excitatory synaptic marker PSD95" 2)
   ("the synaptic scaffolding protein PSD95" 2) ("synaptic PSD-95" 2)
   ("the postsynaptic density protein PSD95" 1)
   ("the postsynaptic marker PSD95" 1) ("Postsynaptic density protein 95" 1)
   ("the synaptic marker PSD95" 1) ("the post-synaptic marker PSD-95" 1)
   ("the postsynaptic marker PSD95 postsynaptic density protein 95" 1)
   ("the postsynaptic organizing molecule PSD-95" 1) ("PSD-95-" 1)
   ("postsynaptic scaffolding protein Dlg" 1)
   ("postsynaptic density protein-95" 1) ("synaptosomal PSD-95" 1)
   ("DLG protein" 1) ("the N-terminal 222 amino acids of DLG" 1)
   ("the residual DLG" 1) ("the postsynaptic protein PSD-95" 1)))
 ("UP:P78356" (("PIP4K2B" 103) ("PIPKIIβ" 1)))
 ("UP:P78357" (("p190" 362) ("P190" 13) ("p190(1252) protein" 2) ("CNTNAP" 1)))
 ("UP:P78358" (("CTAG" 13) ("CTAg" 7))) ("UP:P78362" (("SRPK2" 27)))
 ("UP:P78363"
  (("chloroquine" 516) ("Chloroquine" 61) ("CQ" 29) ("FFM" 22)
   ("chloroquine (CQ)" 19) ("ATP-binding cassette transporter" 18)
   ("member 4" 14) ("Member 4" 12) ("Cq" 4) ("ABCR" 2)
   ("a pharmacologic inhibitor chloroquine" 2)
   ("the generic antimalarial agent chloroquine" 2)
   ("indirect autophagy inhibitor chloroquine (CQ)" 1) ("retinal-specific" 1)
   ("chloroquine-" 1) ("the lysosomotropic drug chloroquine" 1)
   ("the lysosomotropic agent chloroquine (CQ)" 1)))
 ("UP:P78364" (("PHC1" 5) ("Phc1" 3) ("Hph1" 3) ("EDR1" 2)))
 ("UP:P78367" (("Nkx3.2" 2) ("BapX1" 1) ("BAPX1" 1)))
 ("UP:P78368" (("casein kinase 1 gamma 2" 2) ("CSNK1G2" 1)))
 ("UP:P78369"
  (("claudin-10" 46) ("CLDN10" 29) ("Claudin 10" 6) ("claudin 10" 4)
   ("Claudin-10" 2) ("claudin-10 protein" 1) ("P78369" 1)))
 ("UP:P78371"
  (("CCT2" 28) ("chaperonin containing TCP1 (CCT)" 3)
   ("chaperonin containing TCP1" 3)))
 ("UP:P78380"
  (("OxLDL" 320) ("oxLDL" 316) ("ox-LDL" 285) ("LOX-1" 128) ("Ox-LDL" 35)
   ("LOX1" 11) ("OLR1" 6) ("oxidized low density lipoprotein receptor 1" 4)
   ("OxLDL-" 2) ("the atherogenic stimulus OxLDL" 2) ("p-LOX1" 2)
   ("lectin-like oxidized LDL receptor-1" 2) ("ox-LDL protein" 2)
   ("atherogenic stimulant OxLDL" 1)))
 ("UP:P78381"
  (("UGT" 87) ("UGTs" 64) ("the relevant UGT" 1)
   ("perinatal P0.5 male rat UGTs" 1)))
 ("UP:P78382" (("CMP-sialic acid transporter" 3) ("SLC35A1" 1)))
 ("UP:P78395"
  (("PRAME" 27) ("preferentially expressed antigen in melanoma" 1)))
 ("UP:P78396"
  (("cyclin A1" 720) ("Cyclin A1" 202) ("CCNA1" 149)
   ("overexpressed cyclin A1" 36) ("cyclin A1-" 8) ("cyclin A1 protein" 3)
   ("targeted cyclin A1" 2) ("CCNA1 protein" 2) ("CYCLIN A1" 1)
   ("whose tumors overexpressed cyclin A1" 1) ("“cyclin A1”" 1) ("Ccna1" 1)))
 ("UP:P78406" (("Rae1" 10))) ("UP:P78414" (("Irx1" 1)))
 ("UP:P78415" (("IRX3" 3) ("Irx3" 3) ("Iroquois homeobox 3" 2)))
 ("UP:P78417" (("GSTO1" 2) ("glutathione S-transferase omega 1" 1)))
 ("UP:P78423"
  (("CX3CL1" 297) ("fractalkine" 106) ("Fractalkine" 18) ("CX3CL1 protein" 7)
   ("Cx3cl1" 7) ("soluble CX3CL1" 5) ("cx3cl1" 3)
   ("a secreted protein called fractalkine" 2) ("FKN" 1)
   ("soluble CX3CL1 protein" 1)))
 ("UP:P78424" (("POU6F2" 1)))
 ("UP:P78426"
  (("Nkx6.1" 9) ("Family 6" 6) ("family 6" 3) ("NKX6-1" 2) ("Nkx6-1" 1)))
 ("UP:P78504"
  (("Jagged1" 236) ("JAG1" 225) ("Jagged-1" 122) ("Jag1" 111) ("Jag-1" 110)
   ("jagged-1" 68) ("JAGGED1" 38) ("Jagged 1" 28) ("jagged 1" 12)
   ("jagged1" 11) ("JAG-1" 3) ("endothelial-expressed JAGGED1" 3)
   ("JAG1 peptide (CDDYYYGFGCNKFCRPR)" 3) ("Jagged-1 peptide" 3)
   ("jagged 1 protein" 2) ("Jag1 protein" 2) ("Jagged1-" 2)
   ("Jagged1 protein" 1) ("jagged1 protein" 1)
   ("SiHa cell-overexpressing Jagged1" 1) ("endothelial-expressed Jagged1" 1)
   ("whose protein product JAG1" 1) ("JAG1 protein" 1) ("Jag-1 peptide" 1)
   ("somewhat increased Jag-1" 1) ("Jag1 peptide" 1)))
 ("UP:P78508" (("Kir4.1" 1)))
 ("UP:P78509" (("reelin" 56) ("Reelin" 32) ("RELN" 14)))
 ("UP:P78524" (("suppression of tumorigenicity 5" 3) ("ST5" 1)))
 ("UP:P78527"
  (("DNA-PKcs" 2014) ("DNA-PK" 1545) ("PRKDC" 141) ("DNA-PK CS" 103)
   ("DNA-PK cs" 75) ("DNA-dependent protein kinase catalytic subunit" 46)
   ("DNA–PK" 26) ("DNA-PK catalytic subunit" 22) ("DNAPKcs" 14)
   ("overexpressed DNA-PKcs" 11) ("-DNA-PK" 10) ("pDNA-PK" 7)
   ("DNA dependent protein kinase catalytic subunit" 6) ("DNA-Pkcs" 4)
   ("DNA-PKCS" 4)
   ("DNA-dependent protein
            kinase catalytic subunit"
    4)
   ("DNA-PKcs protein" 4) ("DNA–PKcs" 3) ("DNA-pK" 2) ("DNA-PK protein" 2)
   ("we first knocked down DNA-PKcs" 2) ("functional DNA-PK" 2)
   ("the co-associated DNA-PK" 2) ("monoclonal anti DNA-PKcs" 2)
   ("the heterotrimeric complex DNA-PK" 2) ("functional DNA-PKcs" 1)
   ("“HYRC”" 1) ("HYRC" 1) ("intrinsic DNA-PK" 1)
   ("PLK1 directly targets DNA-PKcs" 1) ("a functional DNA-PKcs" 1)
   ("chromatin-associated DNA-PKcs" 1) ("radiation-activated DNA-PK" 1)
   ("intact DNA-PKcs" 1) ("pDNA-PKcs" 1) ("absent DNA-PKcs" 1) ("DNA-PKCs" 1)
   ("break (DSB) repair heterotrimeric complex DNA-PK" 1) ("DNA-PKcs-" 1)))
 ("UP:P78536"
  (("TNF-α" 6911) ("TACE" 717) ("ADAM17" 675) ("ADAM-17" 81) ("TNF-α-" 35)
   ("Adam17" 29) ("TNF-α protein" 12) ("ADAM 17" 11) ("TACE-" 4)
   ("than TNF-α" 4) ("mature ADAM17" 4) ("exogenous TNF-α" 3)
   ("TACE protein" 3) ("ADAM17 protein" 2)
   ("PLK1 RNA interference down-Regulated Pam3CSK4-Induced TNF-α" 2)
   ("TNF-α-converting enzyme" 2) ("soluble ADAM17" 2)
   ("ADAM metallopeptidase domain 17" 2) ("elaborate TNF-α" 2)
   ("Aidoo et al. 2001 associated TNF-α" 2) ("T 735 A mutant TACE" 2)
   ("TNF–α" 2) ("TNF-α–" 2) ("TNF-α (TNF)" 2)
   ("the  trimeric TNF-α molecule" 1) ("TNF-α molecule" 1)
   ("all subsequent studies TNF-α" 1) ("T 735 A TACE" 1) ("than TACE" 1)
   ("bioactive TNF-α" 1) ("the principal HB-EGF sheddase ADAM17" 1)
   ("the most TNF-α" 1) ("the lesser frequent homozygous TNF-α" 1)
   ("soluble TNF-α" 1) ("amino-labeled ADAM17" 1)
   ("redox-sensitive cysteines within the extracellular region of mature ADAM17"
    1)))
 ("UP:P78539" (("Srpx" 1) ("SRPX" 1)))
 ("UP:P78540" (("ARG2" 113) ("arginase 2" 3) ("Arginase 2" 3)))
 ("UP:P78543"
  (("PC3" 3781) ("BTG2" 343) ("Btg2" 14) ("parental PC3" 8) ("PC3-" 4)
   ("BTG2 protein" 4) ("BTG family member 2" 3)
   ("shRNA-transduced parental PC3" 2)
   ("aggressive prostate cancer cell line PC3" 2) ("transformed PC3" 2)
   ("the pCMV-PDGF-B-transfected PC3" 2)
   ("neurogenic progenitor BTG family member 2" 2) ("PTEN-null PC3" 2)
   ("p53 null PC3" 1)
   ("The lower chamber contained DMEM/10% FBS/10 ug/ml collagen type I. Both the PC3"
    1)
   ("c-kit-expressing PC3" 1) ("further verity BTG2's" 1)
   ("further verity BTG2" 1)
   ("the prostate cancer metastasis-derived line PC3" 1)
   ("than PC3 (Fig. xref )" 1) ("metformin-treated PC3" 1)
   ("GC-4 treated PC3" 1) ("the antiproliferative BTG2 protein" 1)
   ("PTEN-negative PC3" 1) ("the homologous family member BTG2" 1)
   ("than PC3 ( xref )" 1) ("The only other c-MET positive cell line PC3" 1)
   ("p53-null PC3" 1) ("we first treated PC3" 1) ("pre-treated PC3" 1)
   ("M-110 and M-142 treated PC3" 1)
   ("than PC3
[ xref ]"
    1)))
 ("UP:P78545"
  (("ELF3" 163) ("ERT" 22) ("ESX" 17) ("ert" 10) ("Jen" 5) ("ESE-1" 5)
   ("ESE1" 4) ("Ese1" 2)
   ("the epithelial-specific Ets transcription factor ELF3" 2) ("ERT-" 2)
   ("ElF3" 1) ("Elf3" 1)))
 ("UP:P78549" (("NTH1" 16) ("NTHL1" 12) ("hNTH1" 1)))
 ("UP:P78552"
  (("IL13Rα1" 3) ("IL-13Rα1" 3) ("IL-13RA1" 1) ("IL13ra1" 1) ("IL13RA1" 1)))
 ("UP:P78556" (("CCL20" 77) ("LARC" 47) ("MIP3α" 15) ("Ccl20" 5) ("MIP3a" 2)))
 ("UP:P78560" (("RAIDD" 134) ("CRADD" 6) ("proapoptotic RAIDD" 1)))
 ("UP:P78562" (("pEX" 27) ("hyp" 27) ("Hyp" 4) ("HYP" 1)))
 ("UP:P78563"
  (("ADAR2 protein" 15) ("RNA-specific" 9) ("ADARB1" 8) ("RED1" 2)
   ("RNA-specific (ADAR)" 1)))
 ("UP:P79098" (("BAPN" 6))) ("UP:P79171" (("fAPN" 13)))
 ("UP:P79483" (("HLA-DRB3" 10) ("DR beta 3" 1))) ("UP:P79522" (("PRR/3" 5)))
 ("UP:P79701"
  (("K 2" 92) ("k 2" 43) ("k  2" 23) ("k  −2" 21) ("K  2" 6) ("larger k  −2" 2)
   ("-k 2" 2)))
 ("UP:P79741"
  (("PEs" 112) ("PES" 48) ("pescadillo" 11) ("-PEs" 9) ("Pescadillo" 8)
   ("exudative PEs" 1)))
 ("UP:P79799" (("MNP" 1))) ("UP:P79942" (("RM1" 3) ("RM1 (BM)" 1)))
 ("UP:P80024" (("pMY" 1)))
 ("UP:P80057"
  (("GSE" 2582) ("GEO Series accession number GSE50929" 2)
   ("the accession number GSE19642" 2) ("accession number GSE36827" 1)
   ("the accession number GSE37271" 1) ("accession number GSE40730" 1)
   ("accession number GSE17536" 1) ("GEO Series accession number GSE46642" 1)
   ("accession number GSE41322" 1) ("accession number GSE47379" 1)
   ("accession GSE46190" 1) ("the accession number GSE39136" 1)
   ("GEO Series accession number GSE37138" 1)
   ("GEO series accession number GSE44874" 1) ("accession number GSE33218" 1)
   ("accession number GSE52100" 1) ("accession number GSE47937" 1)
   ("accession number GSE48036" 1) ("the subseries GSE50721" 1)
   ("Accession number GSE10905" 1) ("accession number GSE8888" 1)
   ("submission number GSE50142" 1) ("accession number GSE39334" 1)
   ("using GSE3158" 1) ("accession number GSE47371" 1)
   ("the accession number GSE53394" 1) ("Accession GSE52627" 1)
   ("accession number GSE55483" 1) ("accession number GSE56363" 1)
   ("accession number GSE36526" 1) ("GEO Series accession number GSE50491" 1)
   ("accession number GSE52061" 1) ("accession number GSE55822" 1)
   ("superSeries GSE49415" 1) ("data series GSE53966" 1)
   ("accession number GSE57153" 1) ("the accession number GSE52232" 1)
   ("accession numbers GSE56898" 1) ("GEO accession number GSE52664" 1)
   ("GEO Series accession number GSE49941" 1)
   ("the accession number GSE57422" 1) ("the accession number GSE57724" 1)
   ("accession number GSE19027" 1) ("the GEO database GSE39645" 1)
   ("the gene expression Omnibus (GEO) database GSE54934" 1)
   ("the identifier GSE39955" 1) ("the accession number GSE44617" 1)
   ("GEO dataset GSE41271" 1) ("accession number GSE64007" 1)
   ("GEO series accession number GSE62454" 1) ("accession number GSE63072" 1)
   ("GEO accession number GSE58462" 1) ("GSE accession number GSE58199" 1)
   ("accession number GSE51709" 1) ("GEO accession GSE21140" 1)
   ("GEO number GSE52798" 1) ("accession number GSE64628" 1)
   ("the study ID GSE64293" 1) ("accession number GSE18328" 1)
   ("series accession number GSE63059" 1)
   ("GEO series accession number GSE47443" 1)
   ("GEO series accession number GSE56649" 1) ("accession number GSE54958" 1)
   ("accession number GSE64527" 1) ("accession GSE62455" 1)
   ("GEO accession number GSE66498" 1) ("accession number GSE61272" 1)
   ("accession number GSE67457" 1) ("accession number GSE52776" 1)
   ("the HumanMethylation450 dataset GSE34387" 1) ("accession GSE55521" 1)
   ("accession number GSE55275" 1) ("dataset GSE35988" 1)
   ("the series accession number GSE68655" 1) ("accession number GSE65815" 1)
   ("the accession number GSE71180" 1) ("accession number GSE13216" 1)
   ("GEO Series accession number GSE11627" 1) ("accession number GSE12761" 1)
   ("access number GSE14001" 1) ("accession number GSE15550" 1)
   ("Accession number GSE11581" 1) ("the accession number GSE15716" 1)
   ("accession number GSE15523" 1) ("accession number GSE14533" 1)
   ("accession number GSE16578" 1) ("accession number GSE18638" 1)
   ("the accession number GSE14489" 1) ("the accession number GSE12427" 1)
   ("the Gene Expression Omnibus accession number GSE19718" 1)
   ("data series accession number GSE18903" 1)
   ("the accession number GSE22123" 1) ("accession ID GSE21105" 1)
   ("dataset GSE4290" 1) ("Gene Expression Omnibus Dataset Series GSE12662" 1)
   ("GEO series accession number GSE23070" 1)
   ("Gene Expression Omnibus database accession number GSE24810" 1)
   ("series accession number GSE22035" 1) ("accession number GSE22101" 1)
   ("the accession number GSE23832" 1) ("the accession number GSE27112" 1)
   ("accession GSE20906" 1) ("accession number GSE26148" 1)
   ("accession number GSE18755" 1) ("the accession ID GSE28678" 1)
   ("accession GSE29230" 1) ("GEO Series accession number GSE25988" 1)
   ("accession number GSE30739" 1) ("GEO accession number GSE18457" 1)
   ("the accession number GSE26447" 1) ("superSeries GSE28008" 1)
   ("the NCBI gene Expression Omnibus () accession number GSE9686" 1)
   ("the GEO series accession GSE32612" 1) ("accession number GSE31294" 1)
   ("accession number GSE36593" 1)
   ("GEO databaseunder GEO accession number GSE32922" 1)
   ("accession number GSE32549" 1) ("accession number GSE5851" 1)
   ("accession GSE27692" 1) ("accession number GSE29745" 1)
   ("accession number GSE7899" 1) ("accession number GSE37459" 1)
   ("accession GSE37058" 1) ("accession number GSE34893" 1)
   ("GEO study GSE37919" 1) ("Accession Number GSE40130" 1)
   ("the accession number GSE36051" 1)
   ("GEO series accession number GSE41536" 1) ("accession number GSE39710" 1)
   ("the Gene Expression Omnibus (GEO) database GSE39645" 1)
   ("published microarray data GSE15641" 1) ("the accession number GSE37934" 1)
   ("the accession number GSE37314" 1) ("number GSE40577" 1)
   ("accession number GSE33968" 1) ("the identifier accession GSE41477" 1)))
 ("UP:P80075" (("MCP-2" 105) ("CCL8" 88) ("ccl8" 7) ("mcp-2" 6) ("MCP2" 1)))
 ("UP:P80098"
  (("CCL7" 10) ("MCP-3" 8) ("Ccl7" 4) ("monocyte chemotactic protein 3" 2)))
 ("UP:P80162" (("CXCL6" 36) ("chemotactic protein-2" 1)))
 ("UP:P80163" (("BTX" 58)))
 ("UP:P80188"
  (("LCN2" 187) ("NGAL" 11) ("lipocalin 2" 6) ("Lcn2" 6)
   ("neutrophil gelatinase-associated lipocalin" 5) ("Lipocalin 2" 3)
   ("neutrophil gelatinase-associated lipocalin (NGAL)" 2) ("Lipocalin-2" 1)
   ("LCN2 protein" 1) ("lipocalin2" 1)))
 ("UP:P80189"
  (("LZ" 196) ("-LZ" 6) ("LZ peptide" 5) ("lz" 2) ("Lz" 2)
   ("the authentic LZ" 2)))
 ("UP:P80192"
  (("MAP3K9" 6) ("MLK1" 4)
   ("mitogen-activated protein kinase kinase kinase 9" 1)))
 ("UP:P80195" (("PP-3" 5))) ("UP:P80217" (("Ifi35" 1)))
 ("UP:P80255" (("Hemerythrin" 2)))
 ("UP:P80297" (("MT1X" 72) ("metallothionein1X" 4) ("MT1x" 1)))
 ("UP:P80301" (("RTIs" 3))) ("UP:P80303" (("NEFA" 21) ("NEFAs" 17)))
 ("UP:P80355" (("COMs" 4)))
 ("UP:P80365"
  (("R-250" 100) ("Coomassie brilliant blue R-250" 8)
   ("Coomassie Brilliant Blue R-250" 6)
   ("0.5% Coomassie brilliant blue R-250" 3)
   ("0.25% Coomassie Brilliant Blue R-250" 3)
   ("0.5% (w/v) Coomassie brilliant blue R-250" 2)
   ("0.1% Coomassie Brilliant Blue R-250" 2)
   ("0.2% Coomassie brilliant blue R-250" 2)
   ("Coomassie Brilliant Blue R-250 (CBB)" 2) ("R-250 (CBB)" 2)
   ("1% Coomassie Brilliant Blue R-250" 1)
   ("0.1% Coomassie Brilliant blue R-250" 1)
   ("0.5% (w/v) Coomassie Brilliant Blue R-250" 1)
   ("0.25% Coomassie brilliant blue R-250" 1)
   ("0.1% Coomassie brilliant blue R-250" 1)))
 ("UP:P80370"
  (("DLK1" 28) ("Dlk1" 14) ("FA1" 8) ("Delta-1" 5) ("fetal antigen 1" 4)
   ("Pref-1" 1)))
 ("UP:P80403" (("AAI" 6) ("AA-I" 5) ("than AA-I [ xref ]" 1)))
 ("UP:P80426" (("TF1" 75))) ("UP:P80463" (("PHA" 392) ("PHA-" 9) ("PhA" 4)))
 ("UP:P80474" (("aminopeptidase" 57))) ("UP:P80509" (("hydrogenase" 6)))
 ("UP:P80511" (("CGRP" 74) ("CAGC" 13) ("S100A12" 11) ("S100A12 protein" 3)))
 ("UP:P80567"
  (("enterotoxin" 60) ("a bacterial enterotoxin" 2)
   ("Staphylococcal enterotoxin (SEE)" 1) ("bacterial enterotoxin" 1)))
 ("UP:P80569" (("Pisa" 37) ("PISA" 18)))
 ("UP:P80723"
  (("BASP1" 198) ("brain acid soluble protein 1" 2) ("soluble protein 1" 1)
   ("CAP23" 1) ("CAP-23" 1) ("The transcriptional corepressor BASP1" 1)))
 ("UP:P80884" (("AN1" 5) ("aN1" 2)))
 ("UP:P80888" (("hemocyanin" 7) ("Hemocyanin" 4) ("hemocyanin (KLH)" 2)))
 ("UP:P80892" (("TrxR" 34) ("tRXR" 10)))
 ("UP:P80936" (("TE" 970) ("classic type TE" 1) ("a Nikon Eclipse TE200" 1)))
 ("UP:P81133" (("SIM1" 8) ("Sim1" 2)))
 ("UP:P81172"
  (("hepcidin" 68) ("hEPCs" 58) ("hEPC" 15) ("Hepcidin" 10) ("HAMP" 9)
   ("pLTR" 6) ("Hamp" 3) ("H 2 O 2 -induced senescent hEPCs" 2)
   ("than hepcidin" 1)))
 ("UP:P81180" (("cyanovirin-N" 5) ("CV-N" 4)))
 ("UP:P81182"
  (("high density lipoprotein" 26) ("High density lipoprotein" 3)
   ("the antiatherogenic high density lipoprotein (HDL)" 2)
   ("high density lipoprotein (HDL)" 1)))
 ("UP:P81204"
  (("nuclease" 986) ("nuclease activity" 218) ("Nuclease" 66) ("-nuclease" 19)
   ("Nuclease Activity" 12) ("nuclease (ZFN)" 8) ("nuclease protein" 6)
   ("Micrococcal Nuclease" 6) ("microccocal nuclease" 5) ("nuclease (TALEN)" 4)
   ("nuclease (DSN)" 4) ("2.5U Micrococcal Nuclease" 2)
   ("CRISPR-associated nuclease" 2) ("a BRCA1-associated nuclease" 2)
   ("weak nuclease activity" 2) ("TALEN" 2) ("-Nuclease" 2) ("nuclease-" 2)
   ("the bacterial UvrABC nuclease" 2) ("200 U/ml microccocal nuclease" 2)
   ("exogenous nuclease" 2) ("25°C. Micrococcoal nuclease" 2)
   ("structure specific multi-functional nuclease" 2) ("Nuclease activity" 2)
   ("micrococal nuclease (NEB)" 1) ("the RNase III-type nuclease" 1)
   ("dimeric TALEN nuclease" 1) ("functional nuclease" 1)
   ("micrococal nuclease" 1) ("a structure-specific endo- and exo- nuclease" 1)
   ("MRN-associated nuclease activity" 1) ("extreme nuclease" 1)
   ("inherent nuclease activity" 1) ("using Transgenomic SURVEYOR nuclease" 1)
   ("the key nuclease" 1)))
 ("UP:P81242"
  (("NHE" 166) ("pNHE" 5) ("duplex NHE" 4) ("regulatory NHE" 1)
   ("the two complementary NHE" 1) ("the duplex NHE" 1)))
 ("UP:P81274" (("LGN" 35) ("GPSM2" 6) ("the contralateral LGN" 4)))
 ("UP:P81350" (("CP 5" 1))) ("UP:P81446" (("MLB" 52) ("MLA" 14)))
 ("UP:P81449" (("Tim11" 1))) ("UP:P81450" (("Atp18" 3)))
 ("UP:P81451" (("Atp19" 2)))
 ("UP:P81460"
  (("ConA" 65) ("Con A" 50) ("Concanavalin A" 18) ("conA" 7) ("Con A-" 3)
   ("ConA-" 1)))
 ("UP:P81461" (("Concanavalin-A" 2)))
 ("UP:P81534"
  (("HBD3" 31) ("beta-defensin 103" 5) ("than HBD3" 3) ("hBD3" 2)
   ("DEFB103B" 1) ("DEFB103A" 1)))
 ("UP:P81543"
  (("FDA" 895) ("the official FDA" 2) ("the FDA’s" 2) ("The official FDA" 1)
   ("the recent FDA" 1) ("The recent FDA" 1) ("the FDA's" 1)
   ("a commercial FDA" 1) ("relevant FDA" 1) ("there are eleven FDA" 1)
   ("a recent FDA" 1) ("recent FDA" 1)))
 ("UP:P81565" (("PLX" 105))) ("UP:P81602" (("DEFB" 5)))
 ("UP:P81605" (("DCD" 4))) ("UP:P81667" (("nV5" 20)))
 ("UP:P81706" (("Gsta" 6))) ("UP:P81713" (("WTI" 1)))
 ("UP:P81765" (("POI" 52))) ("UP:P81790" (("PF-3" 2)))
 ("UP:P81795" (("pp42" 5))) ("UP:P81877" (("SSBP2" 32) ("SSBP2 protein" 4)))
 ("UP:P81900" (("PKA RII" 5))) ("UP:P82014" (("dh1" 1) ("DH1" 1)))
 ("UP:P82094" (("TMF" 1) ("ARA160" 1)))
 ("UP:P82109"
  (("trypsin inhibitor" 248) ("Trypsin Inhibitor" 2)
   ("trypsin inhibitor (CTI)" 2) ("Trypsin inhibitor" 2)
   ("a physiological urinary trypsin inhibitor" 1)))
 ("UP:P82160"
  (("GFP-LC3" 433) ("GFP–LC3" 36) ("LC-3" 23) ("overexpressed GFP-LC3" 3)
   ("fewer GFP-LC3" 1) ("practically all the GFP-LC3" 1) ("LC-3-" 1)
   ("GFP-LC3-" 1) ("non-treated MHM, S4, and U2OS cells GFP-LC3" 1)))
 ("UP:P82279" (("CRB1" 2) ("Crb1" 1))) ("UP:P82290" (("CEC1" 28)))
 ("UP:P82475" (("IC2" 28))) ("UP:P82538" (("PPL1" 1)))
 ("UP:P82605" (("NIT" 33)))
 ("UP:P82612"
  (("phosphoglycerate mutase" 26) ("phosphoglycerate mutase (PGM)" 2)
   ("phosphoglycerate mutase (PGAM)" 1)))
 ("UP:P82664" (("MRPS10" 2))) ("UP:P82686" (("Peak2" 12)))
 ("UP:P82689" (("Peak5" 4))) ("UP:P82912" (("hCC-2" 1)))
 ("UP:P82932" (("MRPS6" 3)))
 ("UP:P82933"
  (("mitochondrial ribosomal protein S9" 6) ("28S ribosomal protein S9" 1)))
 ("UP:P82987" (("ADAMTSL3" 6)))
 ("UP:P83094" (("STIM" 13) ("stromal interaction molecule" 5) ("Stim" 1)))
 ("UP:P83101" (("GSK-3s" 1))) ("UP:P83105" (("HTRA4" 4)))
 ("UP:P83108"
  (("neurotoxins" 93) ("neurotoxin" 90)
   ("the well-characterized oxidative parkinsonian
neurotoxin"
    2)
   ("a selective dopaminergic neurotoxin" 2) ("soluble neurotoxins" 2)
   ("dopaminergic neurotoxins" 2) ("the most potent HIV viral neurotoxins" 2)
   ("viral and cellular neurotoxins" 1) ("cellular and viral neurotoxins" 1)
   ("Neurotoxins" 1) ("possible neurotoxins" 1) ("excitatory neurotoxins" 1)))
 ("UP:P83214" (("PO1" 10))) ("UP:P83215" (("PO3" 6)))
 ("UP:P83216" (("PO4" 96)))
 ("UP:P83369"
  (("Lsm11" 143) ("the first 40 amino acids of Lsm11" 1)
   ("the first 170 amino acids of Lsm11" 1)
   ("highly conserved amino acids of Lsm11 that are required for 3" 1)
   ("the N-terminal 170 amino acids of human Lsm11 that is active" 1)))
 ("UP:P83390" (("conotoxin" 2))) ("UP:P83430" (("PBD2" 1)))
 ("UP:P83440" (("unknown protein" 34))) ("UP:P83476" (("pTII" 8)))
 ("UP:P83507" (("MUPs" 2))) ("UP:P83646" (("Lp02" 18)))
 ("UP:P83672" (("PFA 1" 2))) ("UP:P83678" (("PHAP" 1)))
 ("UP:P83731" (("RPL24" 7) ("Rpl24" 1)))
 ("UP:P83762"
  (("CSM" 20) ("cSM" 19) ("BSM" 14) ("Csm" 3) ("submaxillary mucin (BSM)" 3)
   ("submaxillary mucin" 2) ("csm" 1)))
 ("UP:P83766" (("PB3" 2))) ("UP:P83767" (("bp2" 6) ("pbp2" 1)))
 ("UP:P83772"
  (("cRNA" 772) ("fluorescently-labeled cRNA" 2)
   ("purified cyanine 3-labelled cRNA" 1) ("subsequent cRNA" 1)
   ("resultant cRNA" 1)))
 ("UP:P83876" (("DIM1" 1))) ("UP:P83881" (("RPL36a" 3)))
 ("UP:P83916"
  (("heterochromatin" 600) ("HP1β" 72) ("pericentric heterochromatin" 34)
   ("CBX" 27) ("CBX1" 13) ("Cbx" 12) ("pericentromeric heterochromatin" 9)
   ("repressive heterochromatin" 6) ("Heterochromatin" 6)
   ("facultative heterochromatin" 6) ("M31" 3)
   ("Xi-facultative heterochromatin" 3)
   ("Senescence-associated heterochromatin" 2)
   ("the heterochromatic proteins HP1β" 2)
   ("XIST RNA and Xi facultative heterochromatin" 2)
   ("the centromeric heterochromatin" 2) ("intercalary heterochromatin" 2)
   ("heterochromatin (HC)" 1)
   ("indirectly impacts pericentric heterochromatin" 1)
   ("both facultative and constitutive heterochromatin" 1)
   ("the perinucleolar heterochromatin" 1)
   ("adjacent repressive heterochromatin" 1)
   ("the facultative heterochromatin" 1)
   ("H3K27me3-containing facultative heterochromatin" 1)
   ("pre-existing heterochromatin" 1) ("the pericentric heterochromatin" 1)
   ("the latter heterochromatin" 1) ("mouse pericentric heterochromatin" 1)
   ("Pericentric heterochromatin" 1) ("HP1β protein" 1)
   ("centromeric heterochromatin" 1)
   ("The murine pericentric heterochromatin" 1)
   ("a bona fide pericentric heterochromatin" 1)
   ("centric and pericentric heterochromatin" 1) ("centric heterochromatin" 1)
   ("heterochromatin (PCH)" 1) ("pericentric heterochromatin (PCH)" 1)
   ("specifically Xi-facultative heterochromatin" 1)
   ("the peripheral heterochromatin" 1) ("this repressive heterochromatin" 1)))
 ("UP:P83973" (("RSL" 26))) ("UP:P84004" (("PYF" 1)))
 ("UP:P84022"
  (("Smad3" 3746) ("SMAD3" 1415) ("SMAD-3" 67) ("Smad3 protein" 67)
   ("p-Smad3" 50) ("pSmad3" 30) ("smad3" 25) ("phospho-Smad3 protein" 21)
   ("SMAD3 protein" 20) ("P-Smad3" 19) ("Smad 3" 18)
   ("mothers against decapentaplegic homolog 3" 13) ("smad-3" 6) ("Smad-3" 6)
   ("Smad3-" 6) ("Smad3 molecule" 5) ("SMAD family member 3" 5) ("SMAD 3" 4)
   ("overexpressed Smad3" 4) ("MRTF-associated Smad3" 3) ("less SMAD3" 2)
   ("-SMAD3" 2) ("Mothers against decapentaplegic homolog 3" 2) ("Smad3(WT)" 2)
   ("MiR-23 directly targets Smad3" 2) ("Overexpressed Smad3" 2)
   ("TGF- β 1-phosphorylated Smad3 protein" 2) ("coexpressed Smad3" 2)
   ("mouse monoclonal Smad3" 2) ("targeting Smad3" 2) ("functional SMAD3" 1)
   ("than Smad3(WT)" 1) ("than WT Smad3 ( xref )" 1)
   ("than Smad3(WT) ( xref , left)" 1)
   ("exogenous TGF-β activated phosphorylated Smad3" 1)
   ("the TGF- β 1-phosphorylated Smad3 protein" 1)
   ("the TGF- β 1-induced phospho-Smad3 protein" 1)
   ("than wild-type Smad3 in yeast" 1) ("than wild-type Smad3 ( xref )" 1)
   ("MADH3" 1) ("-Smad3" 1) ("50% less Smad3 protein" 1)))
 ("UP:P84074" (("hippocalcin" 1)))
 ("UP:P84077"
  (("Arf1" 207) ("ARF1" 96) ("dominant-negative ARF1" 1)
   ("ADP-ribosylation factor-1" 1)))
 ("UP:P84085" (("Arf5" 11) ("ARF5" 4)))
 ("UP:P84089"
  (("mers" 85) ("mERS" 9) ("MERS" 4) ("mERs" 2) ("MERs" 1) ("-mers" 1)))
 ("UP:P84091" (("μ2-adaptin" 2)))
 ("UP:P84095" (("RhoG" 387) ("ARHG" 20) ("RHOG" 3) ("RhoG peptide" 1)))
 ("UP:P84098"
  (("L19" 50) ("RPL19" 20) ("ribosomal protein L19" 4)
   ("Ribosomal Protein L19" 3) ("Rpl19" 2)))
 ("UP:P84103"
  (("SRSF3" 28) ("SRp20" 7) ("SFRS3" 5)
   ("serine/arginine-rich splicing factor 3" 1)))
 ("UP:P84104" (("x16" 2)))
 ("UP:P84122"
  (("thrombin" 1421) ("Thrombin" 135) ("thrombin-" 4) ("thrombin molecule" 2)
   ("equimolar thrombin" 2) ("Thrombin-" 1) ("pure thrombin" 1)
   ("exogenous thrombin" 1) ("barrier-disruptive agent thrombin" 1)))
 ("UP:P84241" (("AKH" 3)))
 ("UP:P84243"
  (("H3 histone" 16) ("H3F3A" 15) ("histone H3.3" 9) ("H3f3b" 3)
   ("canonical H3 histone" 2) ("H3.3a" 2) ("H3F3B" 1) ("H3.3B" 1)))
 ("UP:P84292" (("hSP1" 7) ("hSp1" 4))) ("UP:P84444" (("Ccl21a" 1)))
 ("UP:P84445"
  (("ICP0" 203) ("ICP0 protein" 19) ("ICP0-" 4)
   ("viral E3 ubiquitin ligase ICP0" 2) ("the first 241 amino acids of ICP0" 1)
   ("the N-terminal 241 amino acids of ICP0 ( xref )" 1)))
 ("UP:P84568" (("pS3" 6))) ("UP:P84569" (("pS4" 6))) ("UP:P84570" (("pS5" 1)))
 ("UP:P84571"
  (("p-S6" 385) ("P-S6" 187) ("p-S6 protein" 3) ("p-s6" 3)
   ("Intense (grade 2 and 3) p-S6" 2) ("PS6" 2) ("p-S6–" 1)))
 ("UP:P84590"
  (("hirudin" 52) ("repetitive hirudin" 2) ("Hirudin" 2)
   ("Repetitive hirudin" 2)))
 ("UP:P84618" (("RCA2" 2))) ("UP:P84621" (("HDLc" 3)))
 ("UP:P84641" (("circ" 4))) ("UP:P84719" (("PS3" 5)))
 ("UP:P84730" (("LRR" 242) ("LRRs" 40))) ("UP:P84731" (("pS15" 85)))
 ("UP:P84813" (("PT-1" 7)))
 ("UP:P84821"
  (("LSL" 504) ("LSL-" 56) ("pLSL" 3)
   ("the transcriptional termination LSL" 1)))
 ("UP:P84838"
  (("outer membrane protein" 23)
   ("the Chlamydia major outer membrane protein (MOMP)" 1)
   ("an integral outer membrane protein" 1)))
 ("UP:P84855" (("MUP" 36)))
 ("UP:P84996"
  (("exon" 23345) ("Exon" 1064) ("the last exon" 46) ("the entire exon" 17)
   ("targeted exon" 15) ("coding exon" 14) ("largest exon" 9) ("EXON" 7)
   ("-exon" 7) ("an alternative exon" 7) ("distal coding exon" 6)
   ("the relevant exon" 6) ("a unique first exon" 6) ("the complete exon" 5)
   ("the 9th exon" 5) ("the last coding exon" 5) ("the alternative exon" 5)
   ("exon-" 5) ("Proximal coding exon" 4) ("at least one exon" 4)
   ("the unique exon" 4) ("non-coding exon" 3) ("low-scoring exon" 3)
   ("the 20th exon" 3) ("subsequent exon" 3) ("at least one new exon" 3)
   ("a particular exon" 3) ("only one exon" 3) ("largest coding exon" 3)
   ("than one exon" 3) ("a central exon" 3) ("A new exon" 3) ("the new exon" 3)
   ("a cassette-type alternative exon" 2) ("a complete exon" 2)
   ("the 9th and 20th exon" 2) ("proximal and distal coding exon" 2)
   ("proximal coding exon" 2) ("the intact exon" 2) ("a remote exon" 2)
   ("the last AR exon" 2) ("an alternative GATA-3 distal exon" 2)
   ("an alternative distal upstream exon" 2) ("the 34th exon" 2)
   ("targeting EGFR exon" 2) ("included alternative exon" 2)
   ("a physiological alternative splicing around exon" 2)
   ("largest BRCA1 exon" 2) ("the particular exon" 2) ("the 4th exon" 2)
   ("Kurian et al. performed targeted exon" 2)
   ("intronic sequence deletions around MET exon" 2)
   ("three probands deletions encompassed at least exon 1" 2)
   ("the most abundantly expressed -2 exon" 2) ("The entire exon" 2)
   ("the previous exon" 2) ("its neighboring exon" 2) ("a new exon" 2)
   ("IHC based EGFR exon" 2) ("the 16th exon" 2) ("one adjacent exon" 2)
   ("a typical human exon" 2) ("an internal exon" 2) ("targeting exon" 2)
   ("the upstream alternative exon" 2) ("only exon 10A" 2) ("The last exon" 2)
   ("the most distal non-coding exon" 2) ("the last MYB exon" 2)
   ("Agilent SureSelect All Exon" 2) ("the previously identified exon" 2)
   ("the respective exon" 2) ("the 2nd exon" 2) ("at least one BARD1 exon" 2)
   ("the subsequent exon" 2) ("the previous exon 1" 2)
   ("respectively carry co-incident JAK2 exon" 2) ("homozygous JAK2 exon" 2)
   ("co-transcriptional exon" 2) ("new exon" 2) ("the primordial exon 5" 2)
   ("the 11th exon" 2) ("the last 27th exon" 2) ("encompassing AR exon" 2)
   ("a large internal exon" 2) ("The large internal exon" 2)
   ("the very large exon" 2) ("a rare exon" 2) ("the EDA alternative exon" 1)
   ("the neighboring exon" 1) ("the 29th exon" 1)
   ("Figure xref contained another alternative exon" 1)
   ("the Agilent SureSelect Human All Exon" 1) ("the orthologous AKT1m exon" 1)
   ("this particular exon" 1) ("than exon 19( xref )" 1)
   ("CTNNB1 (β-catenin) exon3" 1) ("than KRAS exon" 1)
   ("a productive V(D)J exon" 1) ("around exon 14" 1)
   ("no splicing defects around exon 14" 1) ("the 10th exon" 1)
   ("The CHEK1 alternative exon" 1) ("a key exon" 1)
   ("than the TRA2B poison exon (the TRA2A poison exon also has a much higher density of AGAA Tra2β binding sites than the TRA2B poison exon xref )"
    1)
   ("so any tested exon" 1) ("the last shared exon" 1) ("the 26th exon" 1)
   ("than KRAS exon 2" 1) ("ERa exon8" 1) ("the final exon’s" 1)
   ("targeted TP53 exon" 1) ("a subsequent exon" 1) ("a given exon" 1)
   ("the heterologous exon" 1) ("the adjacent exon" 1)
   ("than the known exon 10" 1) ("had normal exon" 1)
   ("than one exon (cases 7a and 10)" 1) ("the alternate 4B exon" 1)
   ("than exon" 1) ("the next downstream exon" 1) ("only MYB exon 9A" 1)
   ("each putative homologous exon" 1) ("an alternate exon \"22A\"" 1)
   ("an alternate fifth exon" 1) ("a putative alternate exon" 1)
   ("an adjacent exon" 1) ("the second last exon" 1)
   ("the first 14 amino acids of Htt exon 1" 1) ("the respective other exon" 1)
   ("the immediately upstream exon" 1) ("a neighboring exon" 1)
   ("The last investigated exon" 1) ("the most frequent exon" 1)
   ("The 6th exon" 1) ("hTERT exon1" 1) ("a heterologous exon" 1)
   ("the last RB1 exon" 1) ("the last known exon" 1) ("a unique exon" 1)
   ("the 38th exon" 1) ("the respective novel exon" 1) ("the normal exon" 1)
   ("a relatively short C-terminal exon" 1) ("than one p53 exon" 1)
   ("unique alternative exon 8A" 1) ("the space-delimited exon" 1)
   ("their last coding exon" 1) ("the exon's" 1) ("this new exon" 1)
   ("both the alternative exon" 1) ("the entire coding exon" 1)
   ("a potential novel tissue-specific exon" 1) ("every potential exon" 1)
   ("The alternative exon" 1) ("than exon 1" 1) ("the classical exon" 1)
   ("any particular exon" 1) ("an entire exon" 1)
   ("removed at least one exon" 1) ("a unique exon 7B" 1)))
 ("UP:P85008" (("defensin-1" 2)))
 ("UP:P85037" (("FOXK1" 46) ("MNF" 11) ("forkhead box K1" 7) ("FoxK1" 4)))
 ("UP:P85120" (("DAL" 4))) ("UP:P85298" (("BPGAP1" 7) ("ARHGAP8" 2)))
 ("UP:P85299"
  (("PRR5" 32) ("PROTOR" 7) ("Protor-1" 4) ("Protor1" 3)
   ("proline-rich protein 5" 3) ("PROTOR1" 2) ("Protor 1" 2) ("protor1" 1)
   ("protor-1" 1)))
 ("UP:P85498" (("AKTi" 426) ("Akti" 92) ("AktI" 18) ("AKT-I" 5) ("AKTI" 1)))
 ("UP:P85797" (("Ast1" 1))) ("UP:P85895" (("Ovt" 3)))
 ("UP:P85920"
  (("malate dehydrogenase" 14) ("malate dehydrogenase (MDH)" 1)
   ("-malate dehydrogenase" 1)))
 ("UP:P86254"
  (("MnSOD" 638) ("MnSOD protein" 12) ("FOXO3 transcriptional target MnSOD" 2)
   ("both total and acetylated MnSOD" 2) ("the lentiviral exogenous MnSOD" 1)
   ("MnSOD-" 1) ("MnSoD" 1)))
 ("UP:P86385" (("beta defensin" 9)))
 ("UP:P86498"
  (("keratin" 241) ("Keratin" 19) ("perinuclear keratin" 1) ("keratin-" 1)
   ("well-differentiated invasive keratin" 1) ("suprabasal (K1/K10) keratin" 1)
   ("a myoepithelial keratin" 1)))
 ("UP:P86516" (("carboxypeptidase" 12) ("Carboxypeptidase" 1)))
 ("UP:P86521" (("Lamp1A" 2))) ("UP:P86534" (("CLP2" 1)))
 ("UP:P86720" (("LANA2" 1) ("LANA-2" 1)))
 ("UP:P86791" (("Ccz1" 6) ("-Ccz1" 1)))
 ("UP:P86872" (("mRNP" 114) ("mRNP (ribonucleoprotein particle) protein" 4)))
 ("UP:P86911" (("SERCA" 98) ("The ER resident Ca 2+ ATPase SERCA-2" 2)))
 ("UP:P86981"
  (("SNP" 27244) ("an intronic SNP" 51) ("only one SNP" 44)
   ("at least one SNP" 36) ("a functional SNP" 31) ("a synonymous SNP" 23)
   ("a given SNP" 21) ("a nonsynonymous SNP" 20) ("the causal SNP" 19)
   ("a non-synonymous SNP" 13) ("SNP-" 13) ("a particular SNP" 13) ("snp" 12)
   ("“SNP”" 12) ("Only one SNP" 12) ("a new SNP" 11) ("the functional SNP" 10)
   ("specific nuclear protein" 10) ("An intronic SNP" 9)
   ("the associated SNP" 9) ("strongest associated SNP" 9)
   ("the original SNP" 9) ("a nearby SNP" 8) ("homozygous SNP" 8)
   ("an intergenic SNP" 8) ("a rare SNP" 8) ("the previously reported SNP" 7)
   ("a potentially functional SNP" 7) ("The associated SNP" 7)
   ("the new SNP" 6) ("-SNP" 6) ("one intronic SNP" 6)
   ("A nonsynonymous SNP" 6) ("a known synonymous SNP" 6)
   ("An intergenic SNP" 5) ("the relevant SNP" 5) ("this particular SNP" 5)
   ("another functional SNP" 5) ("the intronic SNP" 5)
   ("a genome-wide significant SNP" 5) ("than one SNP" 5)
   ("a synonymous coding SNP" 5) ("an associated SNP" 5)
   ("the nonsynonymous SNP" 5) ("The new SNP" 4) ("functional SNP" 4)
   ("the causative SNP" 4) ("a comprehensive SNP" 4) ("Functional SNP" 4)
   ("One functional SNP" 4) ("associated SNP" 4) ("A synonymous coding SNP" 4)
   ("the next most associated SNP" 4) ("the previously implicated SNP" 4)
   ("the trabecular vBMD-associated SNP" 4) ("genome-wide significant SNP" 3)
   ("an adjacent SNP" 3) ("SNP (CC)" 3) ("a causal SNP" 3) ("particular SNP" 3)
   ("a non-synonymous MMP3 45K>E SNP" 3) ("p-SNP" 3)
   ("the hypomorphic NQO1 SNP" 3) ("each autosomal SNP" 3)
   ("a nonsynonymous coding SNP" 3) ("a single intronic SNP" 3)
   ("genome-wide SNP" 3) ("This particular SNP" 3)
   ("a nearby heterozygous SNP" 3) ("coding SNP" 3)
   ("a previously described SNP" 3) ("SNP (BER)" 3)
   ("a previously unreported SNP" 3) ("a potential causal SNP" 3)
   ("highest associated SNP" 3) ("A synonymous SNP" 3)
   ("another unreported potentially functional SNP" 3)
   ("a frequent intronic SNP" 3) ("the primary SNP" 3)
   ("another genome-wide significant SNP" 3) ("a newly identified rare SNP" 2)
   ("the “causal” SNP" 2) ("the previously reported rs757978 SNP" 2)
   ("Another intergenic SNP" 2) ("the homozygous SNP" 2)
   ("a closely linked exonic SNP" 2)
   ("our 62 new loci contained at least one SNP" 2)
   ("the previously discovered T2D-associated TCF7L2 rs7903146 SNP" 2)
   ("A temozolomide-associated SNP" 2) ("this intronic SNP" 2)
   ("A comprehensive SNP" 2) ("the top associated SNP" 2) ("a causative SNP" 2)
   ("one unique SNP" 2) ("commonly associated SNP" 2) ("the respective SNP" 2)
   ("the randomly-selected SNP" 2) ("the most-associated SNP" 2)
   ("only one non-synonymous SNP" 2) ("the strongest MPN-associated SNP" 2)
   ("a possible undescribed SNP" 2) ("the rare SNP" 2)
   ("each informative SNP" 2) ("the SNP’s" 2) ("a novel functional SNP" 2)
   ("A suitable informative SNP" 2) ("This synonymous coding SNP" 2)
   ("a solitary SNP" 2) ("the particular SNP" 2) ("an infrequent SNP" 2)
   ("aggressive SNP" 2) ("any particular SNP" 2) ("the heterozygous C>T SNP" 2)
   ("at least one nonsynonymous SNP" 2) ("A common functional SNP" 2)
   ("8 interactive SNP" 2) ("One synonymous SNP" 2) ("One particular SNP" 2)
   ("the immediate downstream SNP" 2) ("The last SNP" 2) ("the last SNP" 2)
   ("a perfect proxy SNP" 2) ("This latter SNP" 2)
   ("The top associated rs1471403 SNP" 2) ("a nearby intergenic SNP" 2)
   ("an acetyl-coenzyme A carboxylase α (ACACA) SNP" 2)
   ("the T2D-associated SNP" 2) ("the intergenic SNP" 2)
   ("A nonsynonymous LRP5 SNP" 2) ("a common intronic SNP" 2)
   ("a previously reported synonymous SNP" 2) ("one non-synonymous SNP" 2)
   ("at least one significant SNP" 2) ("significantly associated SNP" 2)
   ("the exact functional SNP" 2) ("this SNP’s" 2) ("each SNP’s" 2)
   ("one synonymous SNP" 2) ("forward at least one SNP" 2)
   ("a representative associated SNP" 2) ("A further linked SNP" 2)
   ("Only one common (MAF > 0.05) SNP" 2) ("The intensive SNP" 2)
   ("a second adjacent SNP" 2) ("the non-synonymous SNP" 2)
   ("A non-synonymous SNP" 2) ("the other functional SNP" 2)
   ("an intergenic sentinel SNP" 2)
   ("the recently identified intronic G>A STAT3 SNP" 2)
   ("the recently identified G>A intronic SNP" 2) ("a true causal SNP" 2)
   ("the proximal SNP" 2) ("the only other genotyped SNP" 2)
   ("than the most significant genotyped SNP" 2) ("the most distant SNP" 2)
   ("the regulatory SNP" 2) ("APP intronic SNP" 2) ("each polymorphic SNP" 2)
   ("a frequent functional SNP" 2) ("an informative SNP" 2)
   ("a heterozygous A/G SNP" 2) ("a heterozygous C/G SNP" 2)
   ("The silent SNP" 2) ("one intronic vWF SNP" 2) ("The latter SNP" 2)
   ("The key SNP" 2)
   ("one
synonymous coding SNP"
    2)
   ("a previously implicated AGER SNP" 2)
   ("Our next most statistically significant SNP" 2)
   ("at least one other SNP" 2) ("Trabecular vBMD SNP" 2)
   ("this intronic ESR1 SNP" 2) ("The same nonsynonymous coding SNP" 2)
   ("a previously selected SNP" 2) ("the previously associated SNP" 2)
   ("the previously discovered MUC5B promoter SNP" 2) ("incomplete SNP" 2)
   ("the previously reported top SNP" 1) ("the intronic rs288979 SNP" 1)
   ("A rare SNP" 1) ("The ATR synonymous rs1802904 SNP" 1)
   ("a synonymous ATR SNP" 1) ("one significant or suggestive SNP" 1)
   ("a common heterozygous SNP" 1)
   ("only
one SNP"
    1)
   ("Only
one MHC SNP"
    1)
   ("the prognosis-associated SNP" 1) ("Another intronic SNP" 1)
   ("each risk-associated SNP" 1) ("400 kb windows around each SNP" 1)
   ("the KITLG p53-RE SNP’s" 1) ("at least one cancer GWAS SNP" 1)
   ("this regulatory SNP" 1) ("internal SNP" 1)
   ("the putative functional SNP" 1) ("This synonymous SNP" 1)
   ("the homozygous G SNP" 1) ("our associated SNP" 1)
   ("the neighboring SNP" 1) ("synonymous SNP" 1) ("SNP_A-" 1)
   ("at least one e-QTL SNP" 1)
   ("an expression-quantitative trait locus (e-QTL) SNP" 1)
   ("The maternal SNP" 1) ("The intronic SNP" 1)
   ("a single Illumina-designable SNP" 1) ("an Illumina-designable SNP" 1)
   ("a potential modifier SNP" 1) ("a more plausible causal SNP" 1)
   ("the nonsynonymous rs34550074G>A SNP" 1) ("A representative SNP" 1)
   ("the underlying functional SNP" 1) ("the next most-significant SNP" 1)
   ("One associated SNP" 1) ("at least 1 SNP" 1)
   ("than one probably functional SNP" 1) ("one probably functional SNP" 1)
   ("nonsynonymous SNP" 1) ("the previously identified C-to-T SNP" 1)
   ("each QT-associated SNP" 1) ("Cohort-specific SNP" 1)
   ("the stable dimorphic AR-E213(G/A) SNP" 1) ("gene-associated SNP" 1)
   ("non-coding SNP" 1) ("the former SNP" 1) ("a TP53 intronic SNP" 1)
   ("than the rs4149244 SNP" 1) ("a randomly-selected SNP" 1)
   ("a rare intronic SNP" 1) ("the newly identified synonymous SNP" 1)
   ("Only 1 SNP" 1) ("larger SNP" 1) ("than the FOXO3A rs12212067 SNP" 1)
   ("another yet unidentified causal SNP" 1) ("The causative SNP" 1)
   ("each SNP using Fisher’s" 1) ("Genome-Wide Human SNP" 1)
   ("the individual SNP’s" 1) ("the previously described promoter SNP" 1)
   ("a coding non-synonymous SNP" 1) ("the nominal SNP" 1)
   ("representative SNP" 1) ("one associated SNP" 1)
   ("had at least one other SNP" 1) ("these few SNP" 1) ("a constituent SNP" 1)
   ("previously reported SNP's" 1) ("previously reported SNP" 1)
   ("each SNP using Fisher's" 1) ("A functional SNP" 1)
   ("the other proposed functional SNP" 1) ("a universal CRC-related SNP" 1)
   ("A previously unreported SNP" 1) ("this rare SNP" 1)
   ("all informative SNP" 1) ("11 informative SNP’s" 1)
   ("11 informative SNP" 1) ("an at least one proxy SNP" 1)
   ("a candidate causal SNP" 1) ("a better candidate causal SNP" 1)
   ("a cancer risk-associated SNP" 1) ("the more frequent SNP" 1)
   ("the polymorphic rs2853669 SNP" 1) ("rs2736100 and rs10069690 SNP's" 1)
   ("A well-studied SNP" 1) ("any given SNP" 1) ("the SNP's" 1)
   ("each given SNP" 1) ("the next most strongly associated SNP" 1)
   ("than any genotyped or imputed SNP" 1) ("each SNP's" 1)
   ("the heterozygous SNP" 1) ("The intronic rs7044343 SNP" 1)
   ("a previously untested SNP" 1) ("one adjacent SNP" 1)
   ("an unknown rare SNP" 1) ("a frequent SNP" 1)
   ("a causally-associated SNP" 1) ("disease-relevant SNP" 1)
   ("a potential functional SNP" 1) ("an alternative SNP" 1)
   ("a neighboring SNP" 1) ("A pericentromeric SNP" 1)
   ("the synonymous Ex9+14G>A SNP" 1) ("the intronic IFNAR1 IVS1-22T>G SNP" 1)
   ("this nonsynonymous SNP" 1) ("a common nonsynonymous SNP" 1)
   ("eight interactive SNP" 1) ("each respective SNP" 1)
   ("an interactive SNP" 1) ("the raw SNP" 1) ("a heterozygous SNP" 1)
   ("known prostate cancer risk-associated SNP" 1)
   ("a synonymous or ‘silent' SNP" 1) ("1 non-synonymous SNP" 1)
   ("chromosomal SNP" 1) ("each chromosomal SNP" 1)
   ("another associated SNP" 1) ("The intronic rs34750 ERAP1 SNP" 1)
   ("the Australian cohort one SNP" 1) ("unique SNP" 1)
   ("another previously identified functional NFE2L2 SNP" 1)
   ("The NFE2L2 G(-686)A (rs35652124) SNP" 1)
   ("this potential functional SNP" 1) ("An informative heterozygous SNP" 1)
   ("A non synonymous SNP" 1) ("each biallelic SNP" 1) ("only four SNP" 1)
   ("at least one GW significant SNP" 1) ("a candidate functional SNP" 1)
   ("one silent SNP" 1) ("a nonconservative SNP" 1) ("this synonymous SNP" 1)
   ("the only IRF6 SNP" 1) ("a highly suggestive SNP" 1)
   ("This intronic SNP" 1) ("A non-synonymous coding SNP" 1)
   ("than each SNP" 1) ("the second exonic SNP" 1) ("The first exonic SNP" 1)
   ("extensive genome-wide gene-centric SNP" 1)
   ("than the original marker SNP ( xref )" 1) ("the exact SNP" 1)
   ("the associated G>C SNP" 1) ("The third most-associated SNP" 1)
   ("the second most-associated SNP" 1)
   ("a putatively functional coding SNP" 1) ("around 1 SNP" 1)
   ("just one SNP" 1) ("Another nearby SNP" 1) ("the only one SNP" 1)
   ("another functional or causal SNP" 1) ("-most SNP" 1)
   ("the maternal SNP" 1) ("another CBS functional SNP" 1)
   ("A previously unknown C/T SNP" 1) ("the true causative SNP" 1)
   ("the representative SNP" 1) ("the actual causal SNP" 1)
   ("using blood-derived SNP" 1) ("causal functional SNP" 1)
   ("a given SNP's" 1) ("a regulatory SNP" 1) ("No non-synonymous SNP" 1)
   ("Primary SNP" 1) ("The genome-wide significant SNP" 1) ("modest SNP" 1)
   ("A nonsynonymous common EGFR polymorphism R497K (G>A) (rs2227983) SNP" 1)
   ("the most significant DHEAS-associated SNP" 1)
   ("prostate cancer-associated rs6983267 SNP" 1)
   ("underwent high-density SNP" 1) ("relatively common synonymous SNP" 1)
   ("XRCC1 and XPD SNP’s" 1) ("these SNP’s" 1) ("a second associated SNP" 1)
   ("The synonymous rs1051730 SNP" 1)
   ("the previously reported rs2010963 SNP" 1) ("a separate SNP" 1)
   ("the well-studied p53 codon 72 (rs1042522) SNP" 1)
   ("DKK1 heterozygous SNP" 1) ("the most distal SNP41" 1)
   ("a previously identified SNP" 1) ("differential SNP" 1)
   ("Previous genome-wide SNP" 1) ("than single SNP" 1)
   ("strongest available proxy SNP" 1) ("an already known silent SNP" 1)
   ("an already described silent SNP" 1)
   ("The most significant intragenic SNP" 1) ("specific nuclear protein-" 1)
   ("than any individual SNP" 1) ("her associated SNP" 1) ("only 1 SNP" 1)
   ("The proximal SNP" 1) ("all possible SNP" 1)
   ("the non-synonymous rs2274223 SNP" 1) ("the RCC-associated SNP" 1)
   ("a common functional SNP" 1) ("the classic codon 72 (Arg/Pro) TP53 SNP" 1)
   ("than one significant SNP" 1) ("The validated somatic SNP" 1)
   ("a nominal SNP" 1) ("Only one novel SNP" 1) ("this last SNP" 1)
   ("inflammation-associated SNP" 1) ("minimal SNP" 1)
   ("The associated single SNP" 1) ("homozygous synonymous SNP" 1)
   ("a homozygous synonymous SNP" 1) ("a heterozygous synonymous SNP" 1)
   ("the originally associated SNP" 1) ("the T1D-associated SNP" 1)
   ("a low-frequency (1%≤MAF<5%) non-synonymous SNP" 1)
   ("a low-frequency non-synonymous SNP" 1) ("than the SNP" 1)
   ("the multiplicative SNP" 1) ("any SNP’s" 1) ("Thirteen SNP’s" 1)
   ("a synonomous SNP" 1) ("than any single SNP" 1) ("at least 1 other SNP" 1)
   ("The functional SNP" 1) ("the locus-specific SNP" 1)
   ("the previously reported SOX5 index SNP" 1)
   ("than the most significant SNP" 1)
   ("A previously identified lung cancer risk SNP" 1)
   ("the true causal
SNP"
    1)
   ("than a nearby SNP" 1) ("A 31st SNP" 1) ("–SNP" 1) ("the G(3780)A SNP" 1)
   ("directly link thep27 Kip1 -838C>A SNP" 1)
   ("a human tumour-associated MDM2 SNP" 1) ("the controversial −135G>C SNP" 1)
   ("a non-synonymous coding SNP" 1)
   ("commercially available Affymetrix 500K SNP" 1) ("a secondary SNP" 1)
   ("The identified cortical vBMD SNP" 1)
   ("than the originally identified SNP" 1) ("A nearby SNP" 1)
   ("each significant associated SNP" 1) ("the most likely functional SNP" 1)
   ("nearby SNP" 1) ("The most significant associated SNP" 1)
   ("the most strongly-associated SNP" 1) ("This single uncommon SNP" 1)
   ("the trait-associated SNP" 1) ("ten or more SNP" 1)
   ("≥10 consecutive SNP" 1) ("the exonic SNP" 1) ("Genome-wide SNP" 1)
   ("there remained one SNP" 1) ("monomorphic SNP" 1)))
 ("UP:P87284" (("SNA1" 2)))
 ("UP:P87377" (("BRAT" 55) ("brat" 16) ("Brat" 11) ("BRAt" 7)))
 ("UP:P89079"
  (("E4-ORF1" 192) ("E4-ORF1 protein" 43) ("expressing wt E4-ORF1 protein" 1)))
 ("UP:P90245"
  (("NIA" 45) ("NIB" 2) ("the mouse cDNA library NIA" 2) ("NIa" 1)))
 ("UP:P90489" (("MIR2" 21))) ("UP:P90666" (("IC-1" 1)))
 ("UP:P91620" (("pSIF" 6) ("SIF" 2) ("the parental vector pSIF" 1)))
 ("UP:P91664" (("dMax" 3)))
 ("UP:P91679"
  (("Yin" 68) ("yin" 19) ("YIN" 8)
   ("technical support, and Dr You-jia CAO and Jie YIN" 1)))
 ("UP:P91682" (("protein Smoothened" 1)))
 ("UP:P91685"
  (("mGluR" 774) ("phosphorylated mGluR5" 3)
   ("mGluR5(pT 1123 pS 1126 ) peptide" 2)
   ("the single-phosphorylated mGluR5(pS 1126 ) peptide" 2)
   ("mGluR5(pS 1126 ) peptide" 1) ("PrP C –mGluR5" 1) ("–mGluR5" 1)))
 ("UP:P91793" (("DEFA" 1))) ("UP:P91929" (("ND42" 2)))
 ("UP:P91943"
  (("TCF" 1587) ("dTCF" 12) ("TcF" 5) ("TCF (dnTCF) protein" 4) ("TCF-" 2)
   ("a dominant-negative TCF" 2) ("pBabe-hygro dominant-negative TCF" 2)
   ("dTcf" 1) ("than TCF" 1)))
 ("UP:P91953"
  (("HES" 95) ("hES" 46) ("Hes" 31)
   ("9 pseudomyogenic (epithelioid sarcoma-like) HEs" 1) ("HEs" 1)
   ("0.5 ml ice-cold HES" 1)))
 ("UP:P92172" (("DAF-7" 1))) ("UP:P92958" (("Snf1" 14) ("SnF1" 1)))
 ("UP:P92960"
  (("KC" 430) ("KC1" 18) ("suprabasal KC" 2) ("accession number KC330992" 1)
   ("psoriatic KC" 1)))
 ("UP:P92976" (("SS3" 4))) ("UP:P93015" (("pSPL3" 34)))
 ("UP:P93026" (("ELP" 70) ("elP" 2) ("macromolecular ELP" 1)))
 ("UP:P93280" (("CCMB" 6)))
 ("UP:P93331" (("N 1" 59) ("n 1" 11) ("n  1" 9) ("N  1" 7)))
 ("UP:P93332" (("N 3" 42) ("n 3" 2)))
 ("UP:P93472" (("LKB" 61) ("competent LKB" 2) ("LKB-" 1)))
 ("UP:P93762"
  (("HOX" 297) ("HOX protein" 10) ("H3K27me3 around four HOX" 1)
   ("proximal HOX" 1) ("three distal HOX" 1)))
 ("UP:P93766" (("MLO" 2))) ("UP:P93788" (("pp34" 1)))
 ("UP:P93825" (("ERS2" 8) ("ERS2 protein" 2) ("ERs2" 1)))
 ("UP:P93831" (("CLF" 11))) ("UP:P94111" (("SS1" 10)))
 ("UP:P94388" (("CAH" 36))) ("UP:P94416" (("HPRC" 7)))
 ("UP:P94464" (("sun" 359) ("sun-" 1) ("the tropical sun" 1) ("The sun's" 1)))
 ("UP:P94522" (("ABN" 32))) ("UP:P94583" (("RAPD" 7)))
 ("UP:P94854" (("CR3" 50) ("pCR3" 14)))
 ("UP:P95339"
  (("cyt" 488) ("Cyt" 170) ("CYT" 144) ("than human cyt" 2) ("CyT" 2)
   ("14 fungal cyt" 1) ("this fungal cyt" 1) ("functional cyt" 1)
   ("punctiform organelles preceded cyt" 1) ("caspase-8–driven cyt" 1)
   ("mouse monoclonal cyt" 1) ("“cyt”" 1) ("the apoptogenic protein Cyt" 1)))
 ("UP:P95477" (("PMSA" 10))) ("UP:P96199" (("USG" 4)))
 ("UP:P96454" (("NHLF" 105) ("hypoxic NHLF" 2)))
 ("UP:P96635"
  (("nick" 700) ("Nick" 67)
   ("terminal deoxunucleotidal transferase-mediated deoxyuridine 5-triphosphate nick"
    1)
   ("-nick" 1) ("‘nick’" 1) ("at least one nick" 1) ("this ligatable nick" 1)))
 ("UP:P96649" (("RAPI" 4)))
 ("UP:P96712"
  (("MDR" 876) ("pMDR" 3) ("the PI3K/Akt pathway significantly reverses MDR" 2)
   ("data-mining analytical approach MDR" 1)
   ("effectively reverse P-gp-mediated MDR" 1) ("nonparametric MDR" 1)
   ("either intrinsic or acquired MDR" 1) ("Exploratory MDR" 1)))
 ("UP:P96787" (("AR3" 281) ("AR-3" 3) ("pAR3" 1) ("AR3 protein" 1)))
 ("UP:P97346" (("GN25" 18))) ("UP:P97465" (("DOK" 41) ("Dok" 18)))
 ("UP:P97802" (("EF5" 14))) ("UP:P98009" (("CyaA" 17)))
 ("UP:P98066" (("TSG-6" 27) ("TNFAIP6" 17)))
 ("UP:P98072" (("enterokinase" 5) ("Enterokinase" 1)))
 ("UP:P98073" (("TMPRSS15" 2)))
 ("UP:P98077"
  (("SHC2" 45) ("Shc2" 23) ("the CNVs around SHC2" 2) ("-Shc2" 1) ("ShC2" 1)
   ("SCK" 1) ("ShcB" 1)))
 ("UP:P98082"
  (("Dab2" 498) ("DAB2" 28) ("disabled homolog 2" 8) ("Disabled2" 5)
   ("Homolog 2 (Drosophila)" 1) ("DAB2 protein" 1) ("dab2" 1)
   ("than Dab2 ( xref )" 1)
   ("monomeric phosphotyrosine-binding domain proteins Dab2" 1) ("more Dab2" 1)
   ("the endocytic adaptor Dab2" 1)))
 ("UP:P98088"
  (("MUC5AC" 315) ("TBM" 42) ("Muc5ac" 22) ("Muc5AC" 8) ("gastric mucin" 3)
   ("gastric mucin (PGM)" 3) ("Mucin 5AC" 2) ("MUC5" 1) ("MUC5Ac" 1)
   ("MUC-5AC" 1) ("pMUC5AC" 1) ("Muc-5ac" 1)))
 ("UP:P98095" (("fibulin-2" 19) ("Fibulin-2" 3) ("Fbln2" 1)))
 ("UP:P98153" (("DGCR2" 16)))
 ("UP:P98155"
  (("VLDLR" 196) ("VLDLr" 80) ("very low density lipoprotein receptor" 8)
   ("lipoprotein receptor" 7) ("the full-length VLDLR and type II VLDLR" 3)
   ("very low density lipoprotein receptor (VLDLR)" 2)
   ("very low density lipoprotein receptor ( VLDLR)" 2)
   ("Very low density lipoprotein receptor" 1)))
 ("UP:P98157"
  (("low-density lipoprotein receptor-related protein 1" 7)
   ("Low-density lipoprotein receptor-related protein 1" 3)
   ("low-density lipoprotein receptor-related protein 1" 2)))
 ("UP:P98159" (("NDL" 13)))
 ("UP:P98160"
  (("PLC" 974) ("perlecan" 76) ("HSPGs" 29) ("plc" 16) ("Plc" 8) ("Perlecan" 6)
   ("LG3" 5) ("PLC-" 4) ("PLC (GEF)" 2) ("-PLC" 2) ("endorepellin" 1)
   ("pLG3" 1)))
 ("UP:P98161"
  (("Pkd1" 169) ("polycystin-1" 28) ("Polycystin-1" 6)
   ("polycystin-1 peptide" 4) ("polycystin-1 protein" 2)))
 ("UP:P98163" (("YL" 39) ("yl" 7)))
 ("UP:P98164" (("megalin" 5) ("LRP2" 3) ("Megalin" 2)))
 ("UP:P98170"
  (("XIAP" 2547) ("MIHA" 101) ("XIAP protein" 32)
   ("X-linked inhibitor of apoptosis protein" 32)
   ("X-linked inhibitor of apoptosis" 23) ("XIAPs" 16) ("X-linked IAP" 13)
   ("X-linked inhibitor of apoptosis protein (XIAP)" 10) ("exogenous XIAP" 8)
   ("overexpressed XIAP" 7) ("Xiap" 7) ("BIRC4" 6) ("X-IAP" 5)
   ("X-linked inhibitor of apoptosis (XIAP)" 5) ("xIAP" 4) ("ILP" 4)
   ("X-linked IAP (XIAP)" 4) ("XIAP molecule" 3) ("MiHA" 2)
   ("inadvertent caspase activation XIAP" 1) ("than the full-length XIAP" 1)
   ("hILP" 1) ("-XIAP" 1) ("X-linked IAP ( XIAP )" 1)
   ("immortalized non-tumorigenic human hepatocyte cell line MIHA" 1)
   ("non-transformed rat small intestinal epithelial cell line IEC-6 and human non-tumorigenic liver cell line MIHA"
    1)
   ("the exogenous XIAP" 1) ("Membrane-associated XIAP" 1)
   ("The immortalized non-tumorigenic human hepatocyte cell line MIHA" 1)
   ("the nontumorigenic hepatocyte cell line MIHA" 1) ("the parental MIHA" 1)
   ("the immortalized non-tumorigenic hepatocyte cell line MIHA" 1)
   ("the strong caspases inhibitor XIAP" 1)
   ("monoclonal mouse anti-human XIAP" 1)
   ("x-linked inhibitor of apoptosis protein (XIAP)" 1)
   ("x-linked inhibitor of apoptosis protein" 1)))
 ("UP:P98171"
  (("p115" 351) ("RhoGAP4" 17) ("ARHGAP4" 4) ("targeting p115" 3) ("ArhGAP4" 2)
   ("Rhogap4" 2) ("p115-" 2)
   ("than p115 in MCF-7 cells stimulated by Fas receptor ligation" 1)
   ("USO1 also known as Golgi complex-associated protein p115" 1)
   ("—RhoGAP4" 1) ("P115" 1)))
 ("UP:P98172"
  (("EphrinB1" 211) ("ephrinB1" 33) ("EFNB1" 6) ("ephrin-B1" 4)
   ("the soluble form ephrinB1" 1) ("Given EphrinB1" 1)))
 ("UP:P98174" (("FGD1" 16) ("Rho/Rac GEF" 2))) ("UP:P98175" (("RBM10" 3)))
 ("UP:P98177"
  (("FOXO4" 419) ("FoxO4" 108) ("AFX" 26) ("Foxo4" 9) ("forkhead box O4" 8)
   ("HA-FOXO4" 6) ("FOXO4 protein" 3) ("Fox O4" 2) ("p-FoxO4" 2)
   ("overexpressed FOXO4" 2) ("FOXO4-" 1) ("Flag-FOXO4" 1) ("flag-FOXO4" 1)
   ("foxo4" 1) ("MLLT7" 1) ("FOXO4 (ARX)" 1) ("-FoxO4" 1)))
 ("UP:P98179"
  (("RBM3" 59) ("RNA binding motif protein 3" 6) ("RBM3 protein" 2)
   ("than RBM3" 1)))
 ("UP:P98185" (("SO4" 20))) ("UP:P98187" (("CYP4F8" 1)))
 ("UP:P98194"
  (("SPCA1" 241) ("type 2C" 17) ("ATP2C1" 3) ("BCPM" 2) ("Type 2C" 1)))
 ("UP:P98196" (("ATP11A" 18) ("type 11A" 2)))
 ("UP:P99999"
  (("cytochrome c" 3124) ("Cytochrome c" 197) ("cytochrome C" 193)
   ("Cytochrome C" 75) ("cyc" 57) ("CYCS" 31) ("Cyc" 13)
   ("exogenous cytochrome c" 13) ("CYC" 6)
   ("cytochrome c (MCC 88–103) peptide" 5)
   ("cytochrome
                    c"
    5)
   ("pellet-associated cytochrome c" 4) ("cytochrome C (CYCS)" 3)
   ("cytochrome c (MCC) peptide" 3) ("cytochrome c (PCC) peptide" 3)
   ("Cytochrome C (PCC) peptide" 2)
   ("the “leaky” extra-mitochondrial cytochrome c" 2)
   ("non-irradiated cells showed only mitochondrial cytochrome c" 2)
   ("a distinct cytochrome c" 2) ("cytochrome c molecule" 2)
   ("Exogenous Cytochrome c" 2) ("Monoclonal mouse anti–human cytochrome c" 2)
   ("cytochrome
                    C"
    2)
   ("cytochrome
                c"
    2)
   ("maximally releases cytochrome c" 2) ("most mitochondrial cytochrome c" 2)
   ("cYC" 2) ("more cytochrome C" 2) ("roughly docked bovine cytochrome c" 2)
   ("immunodetectable cytochrome c" 1) ("apoptogenic cytochrome c" 1)
   ("Cellular cytochrome c" 1) ("CyC" 1) ("completely release cytochrome c" 1)
   ("cytochrome c-" 1) ("fungal cytochrome c" 1)
   ("the apoptogenic proteins cytochrome C" 1)
   ("sequestering cytosolic proapoptotic Cytochrome c" 1)
   ("minimal cytochrome c" 1) ("in turn releases cytochrome c" 1)
   ("some residual cytochrome c" 1)
   ("a strikingly less cytosolic cytochrome c" 1) ("Cytochrome c-" 1)
   ("cytochrome
                        c"
    1)
   ("directly release cytochrome c" 1) ("most cytochrome C" 1) ("pCyc" 1)
   ("mitochondrion-associated cytochrome c" 1)
   ("Dexa-treated cells cytochrome c" 1) ("exogenous reduced cytochrome c" 1)))
 ("UP:P9WGI8" (("ShM1" 2)))
 ("UP:P9WGU0"
  (("pAb" 779) ("PAb" 244) ("pAbs" 61) ("PAB" 26) ("pAB" 19) ("PAbs" 4)
   ("pAb (Thr202/Tyr204) pAb" 3) ("pABs" 3)
   ("a phycoerythrin-conjugated secondary goat anti–mouse pAb" 2)
   ("pAb (SIGMA)" 2) ("pAb (BOD)" 2) ("Pab" 1) ("using PAb1801" 1)))
 ("UP:P9WGU1" (("PhoS1" 1))) ("UP:P9WIB1" (("PLCc" 1)))
 ("UP:P9WIE5" (("KatG" 4))) ("UP:P9WJC5" (("EspI" 2)))
 ("UP:P9WJD1" (("EspF" 7))) ("UP:P9WK25" (("malic enzyme" 19) ("MEZ" 2)))
 ("UP:P9WMK0" (("alpha-crystallin" 3) ("Alpha-crystallin" 2)))
 ("UP:P9WNE1" (("Fgd1" 12))) ("UP:P9WNQ5" (("ECCD-2" 11)))
 ("UP:P9WNV0" (("LigA" 14) ("ligA" 10) ("than LigA" 1)))
 ("UP:P9WNV4" (("LigB" 196) ("ligB" 14)))
 ("UP:P9WQ37"
  (("FACS" 3613) ("representative FACS" 3) ("A representative FACS" 1)
   ("Subsequent FACS" 1) ("We first use FACS" 1) ("subsequent FACS" 1)
   ("sox2 enhancer-based FACS" 1) ("E/sox2:EGFP-based FACS" 1)
   ("Sox2 enhancer-based FACS" 1) ("Representative FACS" 1)
   ("further separable using CD9 ectodomain-directed FACS" 1)))
 ("UP:P9WQB5" (("AhpD" 7))) ("UP:P9WQB7" (("AhpC" 3)))
 ("UP:P9WQB9" (("ADHD" 48) ("reported mild ADHD" 1)))
 ("UP:Q00005" (("PPP2R2B" 117) ("PPP2R2B-" 1)))
 ("UP:Q00022" (("ABA" 57) ("Aba" 3))) ("UP:Q00056" (("HOXA4" 4)))
 ("UP:Q00059"
  (("TFAM" 305) ("transcription factor A (TFAM)" 15)
   ("transcription factor A" 14) ("transcription factor-6" 10)
   ("TFAM protein" 4) ("mature TFAM" 4) ("mtTFA" 4)
   ("transcription factor A, mitochondrial" 4) ("Tfam" 3)
   ("transcription factor 6" 2) ("the phosphomimetic mutant TFAM" 2)
   ("TFAM precursor" 2) ("tfam" 2) ("the granular TFAM" 2)))
 ("UP:Q00094"
  (("ORF73" 97) ("viral latent protein ORF73" 2) ("latent ORF73" 1)))
 ("UP:Q00095" (("ORF74" 6))) ("UP:Q00138" (("ORF59" 43) ("ORF59 protein" 1)))
 ("UP:Q00266" (("MAT" 146) ("MAT1A" 17) ("pMAT" 16)))
 ("UP:Q00277" (("GPXs" 2)))
 ("UP:Q00325"
  (("PHC" 14) ("PHCs" 13) ("pHC" 3) ("PHc" 1)
   ("phosphate carrier protein, mitochondrial" 1)))
 ("UP:Q00326" (("myrosinase" 6))) ("UP:Q00341" (("HDLBP" 7) ("vigilin" 1)))
 ("UP:Q00362" (("Cdc55" 1)))
 ("UP:Q00403"
  (("IIB" 155) ("general transcription factor TFIIB" 6) ("IIB (TFIIB)" 4)
   ("IIB (MIIB)" 4) ("general transcription factor IIB" 2) ("GTF2B" 1)
   ("general transcription factor IIB (TFIIB)" 1)))
 ("UP:Q00526" (("CDK3" 20) ("Cdk3" 2)))
 ("UP:Q00534"
  (("CDK6" 2523) ("cdk6" 263) ("Cdk6" 210) ("cdk-6" 97) ("CDK6 protein" 55)
   ("cyclin-dependent kinase 6" 46) ("CDK-6" 10)
   ("Cyclin-dependent kinase 6" 8) ("overexpressed CDK6" 6) ("cdk6 protein" 6)
   ("p185 BCR-ABL -transformed Cdk6" 4) ("than cdk6" 3) ("pCDK6" 3)
   ("monoclonal CDK6" 2) ("than CDK6" 2) ("overexpressed wild-type CDK6" 2)
   ("cdk6-" 2) ("pre-existent CDK6" 2) ("CDK6 Protein" 2) ("Cdk-6" 2)
   ("the highly homologous enzyme CDK6" 2) ("Cdk6 protein" 1)
   ("than those containing only endogenous CDK6" 1) ("more cdk6 protein" 1)
   ("-CDK6" 1) ("Cyclin dependent kinase 6" 1) ("CDK6-" 1) ("Cdk6 (CST)" 1)
   ("adenoviral cdk6" 1) ("the adenoviral cdk6" 1)
   ("cyclin dependent kinase 6" 1) ("the previously demonstrated CDK6" 1)
   ("activation-competent Cdk6" 1)))
 ("UP:Q00535"
  (("CDK5" 690) ("Cdk5" 586) ("cdk5" 79) ("cyclin dependent kinase 5" 14)
   ("pCdk5" 4) ("cdk5−" 4) ("Cdk5 protein" 3) ("Cdk5-" 3) ("aberrant Cdk5" 2)
   ("The siRNA duplex targeting CDK5" 2) ("neuronal CDK5" 2) ("than Cdk5" 1)
   ("targeting CDK5" 1) ("Monomeric CDK5" 1) ("Cdk-5" 1)))
 ("UP:Q00536"
  (("PCTAIRE1" 202) ("PCTK1" 78) ("PCTAIRE" 7) ("PCTAIRE-1" 6)
   ("PCTAIRE1 protein" 3) ("Cdk16" 1) ("CDK16" 1) ("PCTAIRE protein" 1)))
 ("UP:Q00537" (("PCTAIRE2" 2)))
 ("UP:Q00577" (("PURα" 69) ("PURA" 20) ("targeting PURA" 3) ("Pura" 2)))
 ("UP:Q00586" (("FRQ" 1))) ("UP:Q00587" (("CDC42EP1" 1) ("MSE55" 1)))
 ("UP:Q00597"
  (("FANCC" 441) ("FAC" 88) ("FACs" 33) ("FANCC protein" 20) ("FA-C" 18)
   ("FANCC-" 3) ("Fanconi anemia group C protein (FANCC)" 2)
   ("Fanconi anemia group C protein" 2) ("a heterozygous FANCC" 1)))
 ("UP:Q00610"
  (("clathrin heavy chain" 85) ("CLTC" 23) ("clathrin heavy chain 1" 4)
   ("Clathrin heavy chain" 1) ("clathrin heavy chain-" 1)))
 ("UP:Q00613"
  (("HSF1" 1744) ("HSF-1" 106) ("hsf1" 97) ("Hsf1" 27)
   ("heat shock transcription factor 1" 21) ("HSF1 protein" 12)
   ("Heat Shock Factor" 11) ("p-HSF1" 5) ("Hsf-1" 5) ("HSF-1 protein" 4)
   ("pHSF1" 2) ("monomeric HSF1" 2)
   ("contained total and activated p-Ser326 HSF1" 2) ("HSF 1" 2) ("HSF1-" 2)
   ("Heat shock transcription factor 1" 2) ("hSF1" 2)
   ("the phosphomimetic mutant HSF1-S333E" 2) ("HSF-1-" 1)
   ("the transcriptional HSF1" 1) ("classic activated HSF1" 1)
   ("Inactive monomeric HSF1" 1) ("Previously characterized HSF1" 1)
   ("E1A transformed hsf1  −/−" 1) ("doxorubicin-treated hsf1  −/−" 1)
   ("hsf1-" 1)))
 ("UP:Q00653"
  (("p100" 853) ("NF-κB2" 186) ("Nfkb2" 90) ("NFKB2" 86) ("P100" 77)
   ("NFκB2" 34) ("p100 protein" 18) ("p-p100" 15) ("NF-kB2" 11) ("nfkb2" 10)
   ("LYT-10" 8) ("NFkB2" 6) ("NF-κB2 protein" 4) ("Nfκb2" 3) ("nf-kb2" 2)
   ("exogenous p52 stabilized p100" 2) ("cellular p100" 1) ("most p100" 1)
   ("NLS" 1) ("Fbxw7α constitutively targets p100" 1)
   ("Fbxw7α constitutively targets nuclear p100" 1) ("targeting p100" 1)
   ("alternate NF-κB2 p100 protein" 1)))
 ("UP:Q00680" (("lipid transfer protein" 8))) ("UP:Q00688" (("FKBP25" 1)))
 ("UP:Q00701" (("U11" 3))) ("UP:Q00714" (("v-erb" 16) ("V-erb" 3)))
 ("UP:Q00722" (("PLCβ2" 16) ("PLCb2" 1)))
 ("UP:Q00765" (("D5S346" 71) ("Dp1" 49) ("REEP5" 5) ("Dp1-" 1)))
 ("UP:Q00768" (("hsp56" 1)))
 ("UP:Q00791"
  (("vera" 218) ("vera (PV)" 56) ("Vera" 20) ("Vera (PV)" 4)
   ("nearly all polycythemia vera" 1) ("especially polycythemia vera" 1)
   ("essential thrombocytosis and polycythemia vera" 1)
   ("the chronic myeloproliferative neoplasm (cMPN) polycythemia vera (PV)" 1)
   ("namely polycythemia vera (PV)" 1)))
 ("UP:Q00796" (("SORD" 1) ("sorbitol dehydrogenase" 1)))
 ("UP:Q00839"
  (("hnRNP-U" 11) ("HNRNPU" 6) ("hnRNPU" 4) ("SAFA" 2) ("SAF-A" 2)
   ("scaffold attachment factor A" 2) ("Q00839" 1) ("HnRNPU" 1)
   ("Scaffold attachment factor A" 1)
   ("Heterogeneous nuclear ribonucleoprotein U" 1)))
 ("UP:Q00859"
  (("Mitogen Activated Protein Kinase" 15)
   ("mitogenactivated protein kinase" 4) ("MITOGEN ACTIVATED PROTEIN KINASE" 2)
   ("mitogen-activated-protein-kinase" 2)
   ("MITOGEN ACTIVATED PROTEIN KINASE (MAPK)" 1)
   ("mitogen-activated protein-kinase" 1)
   ("Mitogen Activated Protein Kinase (MAPK)" 1)
   ("mitogen- activated protein kinase" 1)))
 ("UP:Q00872"
  (("myosin binding protein C" 13) ("MYBPC1" 7)
   ("Cardiac myosin binding protein C" 4) ("myosin-binding protein C" 2)
   ("the SYPRO Ruby-stained myosin binding protein C" 2)))
 ("UP:Q00873" (("CYT-2" 73) ("Cyt2" 54) ("CYT2" 2))) ("UP:Q00887" (("PS34" 4)))
 ("UP:Q00934" (("PILR" 60)))
 ("UP:Q00942"
  (("TOP" 448) ("-TOP" 29) ("pTOP" 11) ("competent E. coli strain TOP10" 1)
   ("Escherichia coli strain TOP10" 1)
   ("chemically competent Escherichia coli strain TOP 10F" 1)))
 ("UP:Q00951"
  (("CytC" 27) ("cyt-c" 4) ("mitochondria-associated CytC" 2) ("Cyt-c" 1)))
 ("UP:Q00955"
  (("Acetyl Co-A Carboxylase" 3) ("acetylCoA carboxylase" 2)
   ("acetyl Co-A carboxylase" 1)))
 ("UP:Q00975" (("Biii" 6) ("CACNA1B" 2) ("Cav2.2" 1) ("BIII" 1) ("N type" 1)))
 ("UP:Q00978"
  (("ISGF3" 69) ("IRF9" 40) ("IRF-9" 6) ("Irf9" 2)
   ("interferon regulatory factor 9" 2)))
 ("UP:Q00987"
  (("MDM2" 15195) ("Mdm2" 6882) ("HDM2" 1532) ("Hdm2" 1002)
   ("MDM2 protein" 579) ("mdm2" 422) ("double minute 2" 228) ("HdmX" 186)
   ("Mdm2 protein" 152) ("hMDM2" 95) ("HDM-2" 95) ("hdm2" 92) ("hdmX" 83)
   ("mdm-2" 64) ("MDM2 peptide" 47) ("Mdm-2" 42) ("oncoprotein MDM2" 26)
   ("MDM2-" 26) ("MDM-2" 24) ("HDM2 protein" 18) ("than Mdm2" 12)
   ("double minute 2 protein" 11) ("HdmX protein" 11) ("pMDM2" 10)
   ("MDM2 molecule" 9) ("Hdmx" 9) ("-MDM2" 8) ("p-HDM2" 8) ("exogenous MDM2" 8)
   ("overexpressed MDM2" 7) ("-Mdm2" 7) ("hMDM2 protein" 7) ("HDM2-" 6)
   ("mdm2 protein" 5) ("p-MDM2" 5) ("-HDM2" 5) ("hDM2" 5) ("Mdm2-" 4)
   ("overexpressed HDM2" 4) ("MDM2 proto-oncogene" 4) ("P-MDM2" 4)
   ("mdm-2 protein" 4) ("MDM2 (P14ARF) protein" 3)
   ("E3 ubiquitin-protein ligase MDM2" 3) ("hyperactive MDM2" 3)
   ("co-precipitate MDM2" 3) ("than MDM2" 3) ("Bzd-bound MDM2" 3)
   ("double minute 2 (Mdm2) protein" 3) ("oncoprotein Mdm2" 3) ("DVPD" 3)
   ("Mdm2 (WT)" 3) ("MdM2" 3) ("“MDM2”" 2)
   ("the recurrent amplification around MDM2" 2) ("Mdm2 (Hdm2) protein" 2)
   ("specifically target MDM2" 2) ("a few hundred MDM2" 2) ("shorter MDM2" 2)
   ("potential MDM2" 2) ("Nutlin-3a-bound MDM2" 2)
   ("DyLight 549-labeled MDM2" 2) ("equimolar MDM2" 2)
   ("We first transfected MDM2" 2) ("overexpressed Mdm2" 2)
   ("Overexpressed Mdm2" 2) ("monomeric Mdm2" 2) ("Mdm-2 protein" 2)
   ("mutant nonfunctional Mdm2" 2) ("Mdm2 peptide" 2)
   ("only 17% (3 of 18)Mdm2 SNP309T/T p53 515A/+ tumors expressed Mdm2" 2)
   ("targeted HDM2" 2) ("MDM2 (FLAG)" 2) ("MDM2 (residues 208–242) peptide" 2)
   ("a monoclonal mouse Anti-Human MDM2 protein" 2) ("no discernable MDM2" 2)
   ("Hdm2 protein" 2) ("targeting HDM-2" 2) ("a dominant MDM2" 2)
   ("cellular MDM2" 2) ("MDM2 Protein" 2) ("very little MDM2 protein" 2)
   ("the N-terminal 220 amino acids of Mdm2" 1) ("than full–length Mdm2" 1)
   ("intact MDM2" 1) ("the RUNX1 motif-positive MDM2" 1)
   ("pro-apoptotic p53 and anti-apoptotic Mdm2" 1) ("the exogenous MDM2" 1)
   ("USP15 directly targets MDM2" 1)
   ("a fundamentally destabilized region around MDM2" 1) ("homodimeric MDM2" 1)
   ("dimeric
MDM2"
    1)
   ("much more MDM2" 1) ("E3-competent Mdm2" 1)
   ("the p53 transcriptional target Mdm2" 1) ("the natural MDM2" 1)
   ("MDM2
protein"
    1)
   ("directly target MDM2" 1) ("the RING abrogated MDM2's" 1)
   ("the RING abrogated MDM2" 1) ("amino acids of MDM2" 1) ("lidless MDM2" 1)
   ("lid-truncated MDM2" 1) ("namely p50 MDM2" 1)
   ("namely p90 MDM2 and p75 MDM2" 1) ("than wt MDM2 (Figure xref )" 1)
   ("that MDM2's" 1) ("hdm-2" 1) ("HDM-2 protein" 1)
   ("its principal regulator HDM2" 1) ("than wild type MDM2 ( xref )" 1)
   ("bacterial Mdm2" 1) ("than unphosphorylated MDM2 ( xref )" 1)
   ("functional Mdm2" 1)
   ("than wild-type Mdm2 in synchronous cell cycle release experiments ( xref )"
    1)
   ("The Mdm2 protein’s" 1) ("its principal antagonist Mdm2" 1) ("mdm-2-" 1)
   ("than wild-type Mdm2" 1) ("ligase activity–null Mdm2" 1)
   ("cellular Mdm2" 1) ("than full-length Mdm2 ( xref , right)" 1)
   ("overactive MDM2" 1) ("its predominant negative regulator Mdm2" 1)
   ("targeting MDM2" 1) ("nucleolar 90-kD MDM2" 1)
   ("The immunoreactive HDM2 protein" 1) ("-Hdm2" 1) ("Q00987" 1)
   ("the associated Hdm2" 1) ("The cellular MDM2 protein" 1)
   ("Hyperactive MDM2" 1) ("the MDM2’s" 1)
   ("The p53 transcriptional target MDM2" 1) ("reduced cellular MDM2" 1)
   ("the entire MDM2" 1) ("than MDM2 (>50 fold)" 1)))
 ("UP:Q00993" (("ARK" 28))) ("UP:Q00994" (("NADE" 3) ("BEX3" 1) ("Ngfrap1" 1)))
 ("UP:Q01042" (("immediate early protein" 2))) ("UP:Q01043" (("vCyclin" 5)))
 ("UP:Q01060" (("MPs" 40)))
 ("UP:Q01081"
  (("U2AF1" 48) ("U2AF35" 24) ("U2AF-35" 7) ("U2AF 35" 4)
   ("U2 small nuclear RNA auxiliary factor 1" 1)
   ("the essential splicing factor U2AF 35" 1)))
 ("UP:Q01082" (("SPTBN1" 12)))
 ("UP:Q01085"
  (("TIAR" 38) ("the translational inhibitor TIAR" 2) ("TIAL1" 2)
   ("TIA-1–related protein" 1)))
 ("UP:Q01094"
  (("E2F1" 8104) ("E2F" 3969) ("E2F-1" 803) ("E2f1" 121)
   ("transcription factor E2F1" 101) ("E2F1 protein" 100) ("e2f-1" 73)
   ("e2f1" 22) ("E2F1-" 17) ("E2F-" 15) ("E2F-1 peptide" 13) ("-E2F1" 11)
   ("E2F protein" 9) ("exogenous E2F1" 8) ("E2f-1" 6)
   ("E2F1 (dnE2F1) protein" 6)
   ("the sequence-specific transcription factors E2F1" 6)
   ("Transcription factor E2F1" 5) ("overexpressed E2F" 5)
   ("MiR-329 directly targets E2F1" 4) ("E2F peptide" 4) ("–E2F" 4)
   ("than wild-type E2F-1" 3) ("E2F-1–" 2)
   ("retinoblastoma-associated protein 1" 2) ("potential E2F1" 2)
   ("a representative activator E2F" 2) ("-E2F" 2)
   ("The pivotal transcription factor E2F1" 2)
   ("limited disease (LD) displayed weakly-expressed E2F1" 2)
   ("weak, moderate, and strong positive E2F1" 2) ("more E2F1" 2)
   ("the well-studied cell cycle regulator E2F" 2) ("the repressive E2F" 2)
   ("pRB-associated E2F1" 2) ("E2F-1-" 2) ("both E2F1's" 2)
   ("over-expressing E2F" 2) ("–E2F1" 2) ("monoclonal E2F1" 2)
   ("80-fold more E2F1" 1) ("exogenous E2F-1" 1) ("overexpressing E2F1" 1)
   ("proliferative E2F1" 1) ("normal and abnormal E2F1" 1)
   ("well-established G1/S E2F" 1) ("well-established E2F" 1)
   ("expressing E2F1" 1) ("other new E2F1" 1) ("nearly all the E2F" 1)
   ("targeting E2F1" 1) ("The characteristic E2F" 1) ("aberrant E2F1" 1)
   ("Given E2F1’s" 1) ("Given E2F1" 1) ("than E2F" 1)
   ("the transcriptional factor E2F-1" 1)
   ("differentiated cells many bona fide E2F1" 1)
   ("knockdown mitochondria-associated E2F" 1)
   ("mitochondria-associated E2F" 1) ("potential E2F" 1)
   ("the transcriptional factor E2F" 1) ("The transcriptional factor E2F1" 1)
   ("Exogenous E2F1" 1) ("normally pro-apoptotic E2F1" 1)
   ("bifunctional E2F1" 1) ("bona fide E2F" 1) ("than E2F-1 bound to pRB" 1)
   ("tightly binds E2F" 1) ("More available E2F1" 1)
   ("actively binding E2F-1" 1) ("exogenous E2F" 1)
   ("than E2F that specifically bind" 1)
   ("than the full-length E2F1 protein" 1) ("than the WT E2F1 protein" 1)
   ("normally flags E2F1" 1) ("most E2F1" 1)
   ("The C-terminal 70 amino acids of E2F1" 1) ("transcriptional E2F1" 1)
   ("the heterozygous E2F1" 1) ("heterozygous E2F1-R166H" 1)
   ("the R166H mutation cripples E2F1's" 1) ("Q01094" 1) ("than E2F1" 1)
   ("RB-associated E2F1" 1) ("pro-apoptotic E2F1" 1) ("stimulatory E2F1" 1)
   ("Stimulatory E2F1" 1) ("the relevant E2F" 1)))
 ("UP:Q01101"
  (("INSM1" 175) ("INSM1 protein" 14) ("Insm1" 10) ("IA1" 9)
   ("insulinoma-associated 1" 4) ("INSM-1" 2) ("IA-1" 2)
   ("Insm1 (insulinoma-associated-1) protein" 2)
   ("INSM1 (Cpep, 257-510 amino acids) protein" 1)))
 ("UP:Q01105"
  (("SET" 229) ("TAFI" 12) ("I2-PP2A" 11) ("TAF-I" 10) ("SET protein" 8)
   ("I2PP2A" 4) ("protein set" 4) ("protein SET" 2) ("PHAPII" 1)))
 ("UP:Q01113" (("IL9R" 2)))
 ("UP:Q01130"
  (("SC35" 89) ("SRSF2" 57) ("SC-35" 18)
   ("serine/arginine-rich splicing factor 2" 4) ("SC35 protein" 3)
   ("splicing factor SC35" 3) ("SFRS2" 2) ("Sc35" 1) ("sc35" 1) ("SRp30b" 1)))
 ("UP:Q01134" (("CKR" 21)))
 ("UP:Q01151"
  (("CD83" 112) ("the mature DC marker CD83" 2) ("CD83−" 1) ("Cd83" 1)))
 ("UP:Q01167"
  (("FOXK2" 637) ("ILF1" 5) ("FOXK2 protein" 5) ("Forkhead box K2" 4)
   ("the phosphomimetic form FOXK2" 2) ("potential direct FOXK2" 1) ("ILF" 1)
   ("instead compared wild-type FOXK2" 1) ("FoxK2" 1)))
 ("UP:Q01196"
  (("RUNX1" 1082) ("leukemia 1" 21) ("RUNX1 protein" 14)
   ("Runt-related transcription factor 1" 11) ("CBFA2" 6)
   ("overexpressed RUNX1" 5) ("leukemia 1 protein" 4) ("myeloid leukemia–1" 2)
   ("Runx-1" 1) ("an essentially full-length RUNX1 protein" 1) ("α-B" 1)
   ("runt-related transcription factor 1" 1)))
 ("UP:Q01201"
  (("RelB" 599) ("RELB" 64) ("Rel-B" 20) ("relB" 11) ("relb" 6)
   ("RelB protein" 3) ("Relb" 2) ("both basal and induced RelB" 1)
   ("very little RelB" 1) ("p52 preferentially binds RelB" 1)))
 ("UP:Q01268" (("NSm" 4))) ("UP:Q01279" (("mEGFR" 72) ("strong mEGFR" 2)))
 ("UP:Q01295"
  (("BRC" 1199) ("broad complex" 7) ("BRC peptide" 6) ("Broad complex" 6)
   ("aggressive BRC" 2) ("the highly aggressive BRC" 2) ("one or more BRC" 2)
   ("“BRC”" 2) ("the poorly and highly aggressive BRC" 1) ("internal BRC" 1)
   ("a previously described BRC" 1) ("the seemingly simple BRC" 1)
   ("fewer BRC" 1) ("adjacent BRC" 1) ("consecutive BRC" 1)
   ("a complete BRC" 1) ("five more weakly-bound BRC" 1) ("an entire BRC" 1)
   ("at least one BRC" 1) ("more BRC" 1)
   ("eight highly conserved internal BRC" 1) ("the very well conserved BRC" 1)
   ("the very well conserved BRCA2 BRC" 1)))
 ("UP:Q01344" (("IL-5Rα" 3) ("IL-5RA" 1)))
 ("UP:Q01362" (("FCER1B" 12) ("MS4A2" 7)))
 ("UP:Q01432" (("adenosine monophosphate deaminase 3" 3) ("AMPD3" 1)))
 ("UP:Q01438"
  (("GOF" 859) ("GoF" 24) ("the unequal GOF" 2) ("unequal GOF" 2)
   ("more GOF" 1) ("a new GOF" 1) ("resultant enhanced mutp53 GOF" 1)
   ("p53 mutations display unequal GOF" 1)
   ("the ensuing non cell-autonomous GOF" 1) ("cell non-autonomous GOF" 1)
   ("disruptive TP53 mutations GOF" 1) ("endothelial-specific GOF" 1)))
 ("UP:Q01449" (("MLC2a" 3) ("MYL7" 2) ("the chamber-specific marker MLC2a" 1)))
 ("UP:Q01453"
  (("DSS" 1001) ("PMP22" 183) ("shorter DSS" 20) ("DSS-" 9)
   ("significantly worse DSS" 6) ("longer DSS" 4) ("PMP22-" 4)
   ("peripheral myelin protein 22" 4) ("GAS-3" 3) ("a poor DSS" 2)
   ("internal standard DSS" 2) ("GAS3" 2) ("unfavorable DSS" 2)
   ("The exogenous myc-tagged PMP22" 1) ("well-defined PMP22-" 1)
   ("the last DSS" 1) ("Gas3" 1) ("external DSS" 1) ("pmp22" 1)
   ("the membrane permeable crosslinker DSS" 1) ("incipient DSS" 1)
   ("nearly identical DSS" 1) ("Pmp22" 1) ("gas3" 1) ("PMP-22" 1)
   ("than DSS" 1) ("adult and pediatric DSS" 1) ("“not-DSS”" 1) ("“DSS”" 1)))
 ("UP:Q01457" (("ABIC" 1)))
 ("UP:Q01459"
  (("CTB" 122) ("CTBs" 54) ("villous CTB" 2) ("normoxic CTBs" 1)
   ("Mononuclear CTBs" 1) ("mononuclear CTBs" 1) ("ctb" 1)))
 ("UP:Q01467" (("mRed" 15) ("mRED" 5)))
 ("UP:Q01469" (("FABP5" 10) ("Fabp5" 4)))
 ("UP:Q01484" (("ANK2" 13) ("ankyrin 2" 6) ("LQT4" 2) ("Ank2" 1)))
 ("UP:Q01501" (("PORN" 1))) ("UP:Q01518" (("CAP1" 17)))
 ("UP:Q01520" (("AS4" 2)))
 ("UP:Q01523" (("DEFA5" 6) ("defensin alpha 5" 1) ("defensin-5" 1)))
 ("UP:Q01534" (("TSPY" 31) ("TSPY protein" 3)))
 ("UP:Q01538"
  (("MTF-1" 7) ("Myt-1" 4) ("Myt 1" 3) ("myelin transcription factor 1" 3)))
 ("UP:Q01543"
  (("FLI1" 366) ("Fli1" 319) ("Fli-1" 116) ("FLI-1" 70) ("FLI1 protein" 3)
   ("fli1" 3) ("Fli1 protein" 3) ("than wild type Fli1" 1)
   ("the transcriptional repressor Fli1" 1)))
 ("UP:Q01581"
  (("HMGCS1" 38) ("HMGCS" 17) ("HMGCS1 protein" 3) ("Hmgcs1" 2) ("HMGCS1-" 1)))
 ("UP:Q01584" (("lipocalin" 10) ("lipocalins" 2) ("Lipocalin" 1)))
 ("UP:Q01592" (("deltaP" 5)))
 ("UP:Q01603"
  (("peroxidase" 4887) ("Peroxidase" 275) ("-peroxidase" 30) ("peroxidase-" 29)
   ("KPL" 27) ("ABC Ultrasensitive Peroxidase" 4) ("DAKO" 3) ("-Peroxidase" 3)
   ("antigen retrieval and endogenous peroxidase" 2)
   ("a commercial peroxidase" 2) ("a secondary peroxidase" 2)
   ("subsequent peroxidase" 2) ("Peroxidase-" 1) ("secondary peroxidase" 1)
   ("peroxidase (HRP)" 1) ("using peroxidase" 1)
   ("total p38 (sc-7149, Santa Cruz Biotech, USA) Secondary peroxidase" 1)
   ("peroxidase-(HRP)" 1) ("peroxidase–" 1) ("Endogeneous peroxidase" 1)
   ("a goat F(ab′)2 fragment anti-rabbit IgG (H + L)-peroxidase" 1)
   ("Secondary peroxidase" 1)))
 ("UP:Q01628" (("IFITM3" 4)))
 ("UP:Q01629" (("VSV" 1085) ("vsv" 5) ("VSV–" 3) ("VSV-" 3) ("Vsv" 1)))
 ("UP:Q01638" (("IL1RL1" 29) ("ST2L" 5)))
 ("UP:Q01650"
  (("SLC7A5" 50) ("LAT1" 7) ("Solute carrier family 7 member 5" 2)
   ("solute carrier family 7 member 5" 1) ("Slc7a5" 1)))
 ("UP:Q01658" (("NC2β" 1))) ("UP:Q01668" (("CACNA1D" 8)))
 ("UP:Q01718" (("MC2R" 26) ("Melanocortin 2 receptor" 7) ("ACTH receptor" 2)))
 ("UP:Q01726"
  (("MC1R" 417) ("melanocortin 1 receptor" 21) ("Mc1r" 14)
   ("melanocortin receptor 1" 4) ("MC1R protein" 2)
   ("melanocortin 1 receptor protein" 2)))
 ("UP:Q01740" (("FMO1" 1) ("Fmo1" 1)))
 ("UP:Q01780" (("Rrp6" 7) ("EXOSC10" 3) ("exosome component 10" 1)))
 ("UP:Q01811" (("NSS" 6))) ("UP:Q01813" (("PFKP" 14) ("PFKF" 1)))
 ("UP:Q01815"
  (("MBC" 738) ("sporadic MBC" 9) ("HER2-overexpressing MBC" 6)
   ("HER2-positive MBC" 4) ("sporadic and familial MBC" 2) ("Mbc" 1)
   ("histologically confirmed HER2-positive MBC" 1)
   ("the three Hispanic MBC" 1) ("the 97 BRCA2 -negative MBC" 1)
   ("BRCA2 -negative MBC" 1) ("Egyptian MBC" 1) ("BRCA2-associated MBC" 1)
   ("BRCA1/2-associated MBC" 1)
   ("BRCA-associated and non-BRCA-associated MBC" 1)
   ("BRCA mutation-associated MBC and non-BRCA mutation-associated MBC" 1)
   ("triple-negative MBC" 1)))
 ("UP:Q01826"
  (("SATB1" 1370) ("SATB1 protein" 13) ("SATB1-" 12)
   ("Special AT-rich sequence binding protein 1" 4)
   ("special AT-rich sequence binding protein 1" 3)
   ("The T-lineage-enriched chromatin organizer special AT-rich sequence binding protein 1"
    2)
   ("Satb1" 1) ("satb1" 1) ("examined SATB1's" 1)))
 ("UP:Q01831"
  (("XPC" 694) ("p125" 26) ("XP-C" 25) ("XPC protein" 7)
   ("XPC (Xeroderma pigmentosum group C) protein" 2) ("pp125" 2) ("XPC-" 2)
   ("XPCC" 1)))
 ("UP:Q01842" (("AOP" 72) ("Yan" 69) ("YAN" 4)))
 ("UP:Q01844"
  (("EWS" 912) ("EWSR1" 46) ("Ews" 37) ("Ewing sarcoma breakpoint region 1" 5)
   ("metastatic EWS" 2) ("metastatic, relapsed, or resistant EWS" 1)
   ("the first six amino acids of EWS (Δ22)" 1)))
 ("UP:Q01850" (("CDR2" 4) ("cdr2" 2))) ("UP:Q01851" (("POU4F1" 6)))
 ("UP:Q01860"
  (("Oct4" 1226) ("OCT4" 526) ("Oct-4" 151) ("octamer" 125) ("OCT4A" 117)
   ("POU5F1" 93) ("Pou5f1" 70) ("Oct4A" 67) ("OCT-4" 37) ("Oct4 protein" 35)
   ("Oct3" 33) ("Oct" 32) ("Oct-3" 7) ("Octamer" 6) ("Oct4A protein" 4)
   ("OCT-3" 4) ("OCT4 protein" 3) ("Oct4-" 3) ("Oct 4" 3) ("oct" 3)
   ("octamer protein" 3) ("octamer-binding protein 3" 3) ("pou5f1" 3)
   ("Oct4 peptide" 3) ("Exogenous OCT4" 2) ("OCT4-" 2) ("oct3" 2)
   ("DKK3 down‐regulated stem cell markers OCT4" 2)
   ("the pluripotency-associated marker Oct4" 2)
   ("the pluripotent transcription factor OCT4" 1) ("exogenous OCT4" 1)
   ("the pluripotent-associated gene Oct4" 1) ("Pou5F1" 1)
   ("Octamer-binding transcription factor 3" 1)
   ("DKK3 down‐regulated stem markers OCT4" 1)
   ("the pluripotency-associated factor Oct4" 1) ("OCTAMER" 1)
   ("considerably less Oct4" 1) ("than non-phosphorylated Oct4" 1)
   ("than Oct4-WT ( xref )" 1) ("fetal ovaries OCT4A" 1) ("OCT4A protein" 1)
   ("oct-4" 1) ("bona fide OCT4A" 1)
   ("the pluripotency self-renewal transcription factor OCT4A" 1)
   ("the pluripotency-associated transcription factor OCT4" 1)))
 ("UP:Q01883" (("RA17" 1))) ("UP:Q01892" (("Spi-B" 24) ("SPIB" 8) ("SpiB" 1)))
 ("UP:Q01939" (("Rpt-6" 4) ("Rpt6" 2)))
 ("UP:Q01954" (("BNC" 8) ("basonuclin" 3) ("basonuclin 1" 1) ("Basonuclin" 1)))
 ("UP:Q01955" (("COL4A3" 9) ("tumstatin" 4)))
 ("UP:Q01959"
  (("DAT" 277) ("DAT1" 47) ("dopamine transporter" 33) ("DAT protein" 14)
   ("DA transporter" 13) ("SLC6A3" 9)
   ("Acute Tat treatment increases plasma membrane DAT" 4)
   ("sodium-dependent dopamine transporter" 3) ("synaptic DAT" 3)
   ("Dopamine transporter 1" 2) ("DA transporter (DAT)" 2) ("dopamine)" 2)
   ("total cellular DAT" 1) ("acute synaptic DAT" 1)
   ("we first measured total cellular DAT protein" 1) ("dat" 1)))
 ("UP:Q01968" (("OCRL" 12) ("OCRL1" 4)))
 ("UP:Q01970" (("PLCβ3" 13) ("p-PLCβ3" 2) ("PLCB3" 2)))
 ("UP:Q01973" (("ROR-1" 2)))
 ("UP:Q01974" (("ROR2" 31) ("Ror2" 3) ("ROR2 protein" 2) ("ROR2-" 1)))
 ("UP:Q01989" (("JAR" 78)))
 ("UP:Q01995"
  (("transgelin" 117) ("TAGLN" 61) ("SM22" 52) ("SM22α" 16) ("SM22-" 10)
   ("Transgelin" 7) ("SMCC" 5) ("transgelin protein" 5)
   ("an actin-associated protein transgelin" 2)))
 ("UP:Q01IS8" (("CIN3" 147) ("more progressive CIN3" 1)))
 ("UP:Q01MB6"
  (("lectins" 39) ("growth/adhesion-regulatory lectins" 2)
   ("β-galactoside-specific lectins" 1) ("duct-specific lectins" 1)))
 ("UP:Q02067"
  (("Mash1" 33) ("mash1" 3) ("MASH1" 2)
   ("the pro-neuronal basic helix-loop-helix (bHLH) transcription factor Mash1"
    1)))
 ("UP:Q02078"
  (("MEF2" 519) ("MEF2A" 145) ("MEF2 family" 33)
   ("myocyte enhancer factor 2A" 9) ("MEF2-" 4) ("Mef2a" 3) ("mef2a" 2)
   ("RSRFC4" 2) ("MEF2A-" 2) ("the prosurvival transcription factors MEF2" 2)
   ("MEF2A protein" 2) ("than MEF2 ( xref and xref online)" 1) ("Mef2" 1)))
 ("UP:Q02080" (("MEF2B" 237) ("MEF2B protein" 3) ("xMEF2" 1)))
 ("UP:Q02083"
  (("PLT" 335) ("PLT-" 2) ("TRAP-6-activated PLT" 1) ("autologous PLT" 1)))
 ("UP:Q02086"
  (("SP2" 316) ("Sp2" 19) ("sp2" 13) ("Leica confocal microscope TCS SP2" 2)
   ("a laser-scanning confocal microscope Leica TCS SP2" 1)
   ("a Leica Confocal Scanning System (Exton, PA) TCS SP2" 1)
   ("Leica confocal microscopy SP2" 1)))
 ("UP:Q02094"
  (("rhesus blood group–associated glycoprotein" 1) ("RHAG" 1) ("RhAG" 1)))
 ("UP:Q02108" (("GUCY1A3" 9) ("Gucy1a3" 2))) ("UP:Q02127" (("DHODH" 14)))
 ("UP:Q02153" (("GUCY1B3" 7) ("Gucy1b3" 2)))
 ("UP:Q02156"
  (("PKCε" 2398) ("PKCɛ" 33) ("PKCepsilon" 26) ("PRKCE" 10) ("PKCε protein" 9)
   ("PKCε-" 6) ("-PKCε" 6) ("nPKCε" 4) ("PKCepsilon-" 3)
   ("overexpressed PKCε" 3) ("slower migrating PKCε" 2) ("healthy PKCε" 1)
   ("homozygous PKCε" 1) ("PKCE" 1)
   ("Anti-phospho-threonine (655) PKCη, and phospho-serine (729) PKCɛ" 1)
   ("atypical PKCε" 1) ("myocardial infarction patients expressed PKCε" 1)
   ("than WT PKCε ( xref , bottom panel)" 1)))
 ("UP:Q02161" (("RHD" 164) ("RHDs" 12))) ("UP:Q02192" (("BCA" 1098)))
 ("UP:Q02207" (("MFP" 28)))
 ("UP:Q02218"
  (("OGDH" 16) ("oxoglutarate dehydrogenase" 3)
   ("alpha-ketoglutarate dehydrogenase" 2)))
 ("UP:Q02223" (("BCM" 25) ("pBCM" 5) ("TNFRSF17" 3) ("bcm" 1)))
 ("UP:Q02224"
  (("CENP-E" 119) ("CENPE" 26) ("Cenp-E" 7)
   ("the plus-end-directed kinesin CENP-E" 2) ("centromere protein E" 2)
   ("Centromere-associated protein E" 2) ("CenpE" 1)))
 ("UP:Q02241"
  (("KIF23" 170) ("centralspindlin" 87) ("MKLP1" 83) ("MKlp1" 71) ("Mklp1" 13)
   ("Kinesin family member 23" 6) ("MKLP1-" 4) ("Centralspindlin" 4)
   ("mitotic kinesin-like protein 1" 2) ("MKLP-1" 2) ("Q02241" 1)
   ("the mitotic kinesin MKLP1" 1) ("Kif23" 1)))
 ("UP:Q02246"
  (("Tax1" 260) ("Tax-1" 5) ("CNTN2" 4) ("Tax1 protein" 3) ("TAX1" 1)
   ("contactin 2" 1) ("We first co-expressed Tax1" 1) ("tax1" 1)))
 ("UP:Q02248" (("Catnb" 5)))
 ("UP:Q02297"
  (("NRG1" 707) ("heregulin" 420) ("Nrg1" 208) ("neuregulin" 77)
   ("Heregulin" 64) ("neuregulin 1" 27) ("neuregulin-1" 26) ("Neuregulin" 19)
   ("heregulin (HRG)" 18) ("NDF" 12) ("Neuregulin-1" 11) ("Neuregulin 1" 9)
   ("nrg1" 6) ("soluble Nrg1" 5) ("axonal Nrg1" 5) ("neuregulin1" 5)
   ("neuregulins-1" 4) ("exogenous heregulin" 4) ("Neuregulin1" 4)
   ("transmembrane Nrg1" 3) ("heregulin-" 3) ("completely lack Nrg1" 2)
   ("the intragenic NRG1" 2) ("Heregulin (HRG)" 2) ("-heregulin" 1)
   ("NRG1 protein" 1) ("PNS development neuronal Nrg1" 1)
   ("glial growth factor" 1) ("Neu differentiation factor" 1)
   ("heregulin protein" 1) ("than NRG1 in T47D cells ( xref )" 1)
   ("neuroregulin" 1)))
 ("UP:Q02318" (("CYP27A1" 9) ("CP27" 2) ("family 27" 1)))
 ("UP:Q02322" (("mutB" 9)))
 ("UP:Q02338" (("BDH" 34) ("mitochondrial)" 33) ("BDH1" 1)))
 ("UP:Q02362"
  (("ICP4" 49) ("the immediate-early proteins ICP4" 3) ("ICP4 protein" 2)
   ("the essential immediate early viral transactivator ICP4" 1)))
 ("UP:Q02363"
  (("Id2" 325) ("ID2" 233) ("inhibitor of differentiation 2" 17)
   ("ID2 protein" 7) ("inhibitor of DNA binding 2" 2) ("overexpressed ID2" 2)
   ("Id2 protein" 2) ("Inhibitor of DNA Binding 2" 2) ("less ID2" 1)
   ("inhibitor of differentiation 2 (ID2) protein" 1)
   ("flag-tagged human ID2" 1) ("trichostatin A decreased Id2" 1)))
 ("UP:Q02386" (("ZNF45" 3)))
 ("UP:Q02388"
  (("dystrophic" 99) ("dominant and recessive" 92) ("type VII" 17)
   ("COL7A1" 11) ("Dominant and recessive" 5) ("Dystrophic" 3)
   ("epidermolysis bullosa" 3) ("Type VII" 2) ("epidermolysis bullosa (EB)" 2)
   ("epidermolysis bullosa (RDEB)" 2) ("aberrant dystrophic" 1)))
 ("UP:Q02395" (("mPcl2" 2))) ("UP:Q02399" (("PDPK" 4)))
 ("UP:Q02410"
  (("MINT1" 26) ("family A" 25) ("Family A" 16) ("x11" 3) ("Mint1" 2) ("X11" 2)
   ("mint1" 1) ("X11α" 1)))
 ("UP:Q02413"
  (("Dsg1" 308) ("DGI" 27) ("DSG1" 14) ("DG1" 14) ("desmoglein-1" 7)
   ("desmoglein 1" 4) ("dsg1" 3) ("Desmoglein-1" 2)
   ("the residual cleaved Dsg1" 2) ("the soluble Dsg1" 1) ("a soluble Dsg1" 1)
   ("than Dsg1" 1) ("Triton-insoluble Dsg1" 1)))
 ("UP:Q02415" (("KR" 389) ("KR protein" 3) ("“KR”" 2)))
 ("UP:Q02446"
  (("Sp4" 86) ("SP4" 39) ("sp4" 2) ("Sp4 protein" 1)
   ("rabbit monoclonal SP4" 1)))
 ("UP:Q02447"
  (("Sp3" 233) ("SP3" 94) ("transcription factor SP3" 4) ("Sp3 protein" 2)
   ("Sp-3" 1) ("Sp3 transcription factor" 1) ("sp3" 1) ("than the SP3" 1)
   ("than SP3" 1)))
 ("UP:Q02454"
  (("cytotoxin" 78) ("CTx" 67) ("cytotoxins" 15) ("cTX" 6) ("cardiotoxin" 5)
   ("cetuximab based CTx" 2) ("Cytotoxin" 2) ("the microglial cytotoxins" 2)
   ("the principal H. pylori cytotoxin" 1)
   ("an isolated bacterial cytotoxin" 1)))
 ("UP:Q02457" (("Tbf1" 4))) ("UP:Q02465" (("SPIA" 6)))
 ("UP:Q02487"
  (("Dsc2" 174) ("desmocollin" 14) ("DSC2" 7) ("Dsc2 protein" 5)
   ("desmocollin 2" 1) ("Desmocollin" 1)))
 ("UP:Q02535"
  (("Id3" 139) ("ID3" 18) ("Id3-" 6) ("Id3 protein" 5) ("Id-3" 3) ("id3" 1)))
 ("UP:Q02539"
  (("histone 1" 15) ("Histone 1" 3) ("HIST1H1A" 2) ("histone H1.1" 2)
   ("H1F1" 1) ("histone cluster 1" 1)))
 ("UP:Q02548"
  (("PAX5" 593) ("Pax5" 499) ("Pax-5" 4) ("PAX5 protein" 4) ("BSAP" 4)
   ("PAX-5" 2) ("B-cell-specific transcription factor" 2)
   ("naive STAT3 MUT B cells down-regulated PAX5" 1) ("PAX 5" 1)
   ("the possible PAX5" 1) ("specifically targets PAX5" 1)
   ("particular PAX5" 1) ("than PAX5" 1)))
 ("UP:Q02556"
  (("IRF8" 177) ("IRF-8" 25) ("interferon regulatory factor 8" 8) ("ICSBP" 6)
   ("interferon consensus sequence binding protein (ICSBP)" 1)
   ("interferon consensus sequence binding protein" 1)
   ("Interferon regulatory factor 8" 1)))
 ("UP:Q02575" (("NSCL" 22) ("NHLH1" 11) ("nescient helix-loop-helix 1" 1)))
 ("UP:Q02577"
  (("NHLH2" 68) ("HEN2" 2) ("We first immunoprecipitated NHLH2" 1)))
 ("UP:Q02629" (("Nup100" 1))) ("UP:Q02630" (("Nup116" 6)))
 ("UP:Q02641" (("CACNB1" 14)))
 ("UP:Q02643"
  (("GHRHR" 22) ("GHRH receptor" 6) ("the pituitary GHRHR" 1)
   ("growth hormone-releasing hormone receptor" 1)))
 ("UP:Q02651" (("Sma1" 11) ("SMA1" 1)))
 ("UP:Q02742" (("core 2" 8) ("Core 2" 4)))
 ("UP:Q02747" (("GUCA2A" 11) ("Guca2a" 6) ("guanylin" 6)))
 ("UP:Q02750"
  (("MEK1" 2460) ("MEK-1" 215) ("MAP2K1" 139) ("Mek1" 48) ("MKK1" 30)
   ("MEK 1" 17) ("MEK1 protein" 12) ("dominant-negative MEK1" 9)
   ("MAPK/ERK kinase 1" 7) ("p-MEK1" 7) ("MEK1-" 6) ("MAP kinase kinase 1" 5)
   ("-MEK1" 3) ("dominant-negative rabbit MEK1" 2)
   ("the dual specificity kinase MEK1" 2) ("MEK1(K175/362Q) protein" 2)
   ("lentiviral pHAGE-MEK1CA expressing MEK1-R4F" 2) ("than MEK1" 2)
   ("both exogenous and endogenous MEK1" 2) ("MAPKK 1" 2)
   ("overexpressed MEK-1" 2) ("MAP2K1 (YRI)" 1)
   ("acetyltransferases directly target MEK1" 1) ("a cupric setting MEK1" 1)
   ("MEK-1-" 1) ("recurrent MEK1 point mutations" 1)
   ("than MEK1 in colon cancer cells" 1) ("We first inactivated MEK1" 1)
   ("MAPK2K1" 1) ("pMEK1" 1) ("both exogenous and endogenous active MEK1" 1)
   ("FLAG-epitope-tagged MEK-1" 1)))
 ("UP:Q02763"
  (("Tie2" 95) ("TEK" 61) ("Tie-2" 17) ("TIE2" 16) ("TIE-2" 3)
   ("the transmembrane Tie2" 2) ("endothelial tyrosine kinase" 2) ("Tie2-" 1)))
 ("UP:Q02779" (("MLK2" 11) ("MAP3K10" 4)))
 ("UP:Q02790"
  (("FKBP52" 63) ("FKBP4" 5) ("FKBP59" 3) ("than FKBP52" 1) ("more FKBP52" 1)
   ("the highly homologous FKBP52" 1)))
 ("UP:Q02809" (("PLOD1" 4) ("LLH" 1) ("PLOD" 1)))
 ("UP:Q02817"
  (("MUC2" 58) ("MUC-2" 11) ("Muc2" 5) ("mucin2" 3) ("MUC2−" 2) ("Smuc" 2)
   ("mucin 2" 2) ("mucin 2" 1) ("mucin-2" 1) ("intestinal mucin" 1)))
 ("UP:Q02818"
  (("Nuc" 213) ("nuc" 31) ("NUC" 11) ("NUCB1" 4) ("nucleobindin 1" 4)
   ("immunoreactive Nuc" 2) ("“nuc”" 1)))
 ("UP:Q02833"
  (("RASSF7" 155) ("RASSF7 protein" 9) ("HRC1" 6) ("rassf7" 6) ("Rassf7" 4)
   ("C11orf13" 1)))
 ("UP:Q02878"
  (("RPL6" 246) ("RPL-6" 4) ("ribosomal protein L6" 3) ("RpL6" 2) ("Rpl6" 2)
   ("more RPL6" 1) ("both exogenous and endogenous RPL6" 1) ("rpl-6" 1)))
 ("UP:Q02880" (("TOP2B" 4)))
 ("UP:Q02928" (("family 4" 19) ("Family 4" 2) ("CYP4A11" 2) ("CYP4A2" 1)))
 ("UP:Q02930" (("CREB5" 7) ("cAMP responsive element binding protein 5" 1)))
 ("UP:Q02934" (("EGI" 5))) ("UP:Q02936" (("nHH" 13)))
 ("UP:Q02952"
  (("Gravin" 474) ("AKAP12" 31) ("gravin" 3) ("Gravin protein" 2)
   ("more Plk1 and phospho-T766 Gravin" 2) ("Akap12" 1)))
 ("UP:Q02962"
  (("PAX2" 827) ("Pax2" 249) ("Pax-2" 72) ("PAX2 protein" 25) ("PAX-2" 22)
   ("Pax-2 protein" 6) ("pAX2" 5) ("pPAX2" 4) ("Paired box 2" 3)
   ("robust PAX2" 2) ("monoclonal rabbit IgG anti-human PAX2" 2) ("Pax2-" 2)
   ("PAX2-" 1) ("Pax2 protein" 1) ("than Pax2" 1)))
 ("UP:Q02969" (("Pex25" 1))) ("UP:Q02978" (("OGC" 1)))
 ("UP:Q02985" (("CFHR3" 27) ("complement factor H–related 3" 2)))
 ("UP:Q03001"
  (("BPA" 266) ("DMH" 134) ("BPAG-1" 11) ("DST" 8) ("DMH-" 3)
   ("the hemidesmosomal components BPAG-1" 2) ("bullous pemphigoid antigen" 1)
   ("BPA-" 1) ("bullous pemphigoid antigen 1" 1)))
 ("UP:Q03013" (("GSTM4" 16) ("glutathione S-transferase mu 4" 2)))
 ("UP:Q03014"
  (("HEX" 56) ("HHEX" 46) ("Hex" 19) ("hex" 5) ("-HEX" 5) ("Hhex" 3) ("-Hex" 2)
   ("fluorescent dye HEX" 1) ("hEX" 1) ("neat HEX" 1)))
 ("UP:Q03026" (("APRI" 1))) ("UP:Q03042" (("cGK" 1)))
 ("UP:Q03052" (("Oct-6" 5) ("POU3F1" 1)))
 ("UP:Q03060"
  (("CREM" 14) ("ICER" 13) ("cAMP responsive element modulator" 2)
   ("an unacceptable ICER" 1)))
 ("UP:Q03063" (("Dig1" 1))) ("UP:Q03104" (("MSC1" 7) ("immortal MSC1" 2)))
 ("UP:Q03111"
  (("ENL" 133) ("MLL-ENL" 31) ("pENL" 2) ("–ENL" 2) ("MLL-ENL-" 2)
   ("bio-available ENL" 1) ("MLL–ENL" 1) ("MLLT1" 1)))
 ("UP:Q03112"
  (("MECOM" 13) ("Evi-1" 7) ("EVI-1" 5)
   ("ecotropic viral integration site 1" 4) ("evi-1" 3) ("MDS1-EVI1" 1)
   ("Prdm3" 1)))
 ("UP:Q03113" (("GNA12" 18) ("Galpha12" 1)))
 ("UP:Q03135"
  (("Cav-1" 4277) ("caveolin-1" 3162) ("CAV1" 2912) ("Cav1" 1795)
   ("cav-1" 1347) ("Caveolin-1" 513) ("CAV-1" 197) ("caveolin 1" 178)
   ("stromal Cav-1" 88) ("Cav-1 protein" 65) ("CAV" 61) ("Caveolin 1" 56)
   ("caveolin-1 protein" 45) ("caveolin1" 33) ("CAV1 protein" 21)
   ("cav-1 protein" 20) ("cav1" 18) ("fibroblastic Cav-1" 13)
   ("Stromal Cav-1" 11) ("-Cav-1" 11) ("epithelial Cav-1" 10) ("pCav1" 8)
   ("Cav1 protein" 7) ("Cav1 peptide" 7) ("overexpressed CAV1" 7)
   ("stromal Cav1" 7) ("endothelial caveolin-1" 6) ("Caveolin1" 6)
   ("-caveolin-1" 5) ("Cav-1 molecule" 4) ("overexpressed Cav-1" 4) ("CAV1-" 4)
   ("pCAV" 4) ("caveolins-1" 4) ("endothelial Cav-1" 3) ("caveolin-1-" 3)
   ("immortalized Cav1" 3) ("overexpressed caveolin-1" 3)
   ("targeting human Cav1" 3) ("Cav-1-" 3) ("proper caveolin-1" 3) ("CAV1–" 3)
   ("Overexpressed wild-type CAV1" 3)
   ("human atherosclerotic lesions expressed Cav-1" 2) ("stromal caveolin-1" 2)
   ("a plasma membrane-associated protein caveolin-1" 2)
   ("intra-vesicular CAV1" 2) ("triton-insoluble Cav-1" 2) ("typical Cav-1" 2)
   ("Caveolin-1 protein" 2) ("adenoviral encoding human caveolin-1" 2)
   ("membrane-associated caveolin-1" 2) ("a stromal Cav-1" 2)
   ("showed abundant stromal Cav-1" 2) ("CAVEOLIN-1" 2) ("Stromal Cav1" 2)
   ("human dermal fibroblasts cav-1" 2) ("uniformly 15 N- labeled Cav1" 2)
   ("cave-olin-1" 2) ("Cav-1–" 2)
   ("biologically active soluble Cav-1 protein" 2)
   ("epithelial or stromal caveolin-1" 2) ("CAV-1 protein" 2)
   ("the lipid raft-associated protein caveolin-1" 2) ("Cav1-" 1)
   ("secreted stromal Cav-1" 1) ("much more caveolin 1" 1)
   ("cross-linker most caveolin 1" 1) ("the two discordant cases Cav-1" 1)
   ("preclinical models Cav-1" 1) ("their associated protein caveolin-1" 1)
   ("developed early CAV" 1) ("pCAV1" 1)
   ("other antiviral innate immune molecules Cav-1" 1) ("still some Cav-1" 1)
   ("Radiation-induced caveolin-1-" 1) ("the caveolar protein caveolin-1" 1)
   ("the major caveolar structural protein caveolin-1" 1)
   ("caveolar structure protein caveolin-1" 1) ("exosomal CAV1" 1)
   ("Radiation-induced Cav-1" 1) ("endocytic protein caveolin-1" 1)
   ("triton-soluble Cav-1 protein" 1)
   ("raft-associated membrane protein caveolin-1" 1) ("new CAV1-" 1)
   ("targeting CAV1" 1) ("-Cav1" 1) ("further supporting Cav-1" 1)
   ("fluorescent CAV1" 1) ("Transiently overexpressed CAV1" 1)
   ("than nonphosphorylated Cav-1 [ xref ]" 1) ("exogenous CAV1" 1)
   ("increased cellular CAV1" 1) ("parenchymal Cav1" 1) ("mesenchymal Cav1" 1)
   ("intrinsic Cav1" 1) ("stromal-expressed Cav1" 1) ("fibroblastic Cav1" 1)
   ("showed strong Cav1" 1) ("the associated Cav1" 1)
   ("high membranous CAV1" 1) ("the raft-associated protein cav-1" 1)
   ("the raft-associated protein caveolin-1" 1)
   ("these studies no monomeric caveolin-1" 1)
   ("we first co-expressed caveolin-1" 1) ("less caveolin-1" 1)
   ("exogenous Cav-1" 1) ("low fibroblastic Cav-1" 1)
   ("plasma membrane-associated caveolin-1" 1) ("the peripheral Cav1" 1)
   ("exosomal Cav-1" 1) ("oligomerized CAV1" 1)
   ("wild type FoxO3a transcriptionally increases cav-1" 1)))
 ("UP:Q03164"
  (("myeloid" 1293) ("MLL" 1179) ("MLL1" 307) ("Myeloid" 84) ("mll1" 27)
   ("MLLs" 22) ("hTrx" 21) ("ALL1" 13) ("MLL1 protein" 8) ("MLL protein" 7)
   ("KMT2A" 4) ("ALL-1" 2) ("kmt2a" 2) ("chronic myeloid" 2)
   ("effectively bypass MLL" 2) ("donor-derived myeloid" 2) ("myeloid-" 1)
   ("N-terminal 1400 amino acids of MLL" 1) ("acute myeloid" 1) ("more MLL1" 1)
   ("MLL-" 1) ("these cells still bear myeloid" 1)
   ("immortalized human myeloid" 1) ("Mll1" 1) ("hTRX" 1)
   ("mitomycin C treated MLL  −/−" 1) ("HRX" 1) ("an innate myeloid" 1)
   ("Myeloid-" 1) ("Mac-1 + Gr-1 −/low immature myeloid" 1)
   ("inflammatory myeloid" 1) ("inhibitor-treated myeloid" 1)))
 ("UP:Q03167"
  (("TGFBR3" 23) ("transforming growth factor beta receptor 3" 2)
   ("betaglycan" 1)))
 ("UP:Q03169" (("TNFAIP2" 11)))
 ("UP:Q03181"
  (("nuc-1" 30) ("PPARβ" 17) ("PPARD" 16) ("Nuc-1" 5)
   ("the repressive nucleosome nuc-1" 3) ("PPARd" 2)
   ("The repressive nucleosome nuc-1" 1) ("PPARB" 1) ("NUC1" 1)
   ("peroxisome proliferator-activated receptor beta" 1) ("NUC-1" 1)))
 ("UP:Q03188"
  (("CENP-C" 76) ("centromere protein C" 6)
   ("the centromeric protein CENP-C" 2) ("Centromere protein C" 1)))
 ("UP:Q03198" (("PIIa" 129) ("pPIIa" 1)))
 ("UP:Q03206" (("CED-10" 51) ("ced-10" 20) ("CED-10 protein" 3)))
 ("UP:Q03209" (("p61" 14) ("P61" 2))) ("UP:Q03211" (("PELP" 2) ("pPELP" 1)))
 ("UP:Q03252"
  (("lamin B2" 42) ("LMNB2" 12) ("Lamin B2" 8) ("avian lamin B2" 1)))
 ("UP:Q03322" (("Tlg1" 2))) ("UP:Q03345" (("LIN-3" 1)))
 ("UP:Q03372"
  (("DR" 768) ("Gomez DR’s" 3) ("DR-" 2) ("proliferative DR" 2)
   ("96 patients developed DR" 1) ("severe DR" 1)))
 ("UP:Q03373" (("rsT2" 6)))
 ("UP:Q03393"
  (("pts" 263) ("PKG" 166) ("Pts" 38) ("PTS" 16) ("34 evaluable pts" 2)
   ("PTPS" 2) ("that PKG's" 1) ("EGFR-overexpressing pts" 1)
   ("the 34 evaluable pts" 1) ("14 evaluable KRAS mutant pts" 1)
   ("18 evaluable KRAS wild-type pts" 1) ("than liver 7 pts (17.5%)" 1)
   ("the 40 treated pts" 1) ("other/multiple metastatic (O/MM) pts" 1)
   ("EGFR-overexpressing MCRC pts" 1) ("PKG-" 1) ("than SIVcpz Pts" 1)))
 ("UP:Q03395" (("Rom" 11) ("rom" 5)))
 ("UP:Q03403"
  (("SP" 1579) ("Sp" 208) ("sp" 84) ("TFF2" 7) ("SP (RSV)" 5) ("-SP" 5)
   ("sml1" 3) ("TFF-2" 2) ("‘SP’" 1) ("Sp-" 1) ("The latter SP" 1)
   ("a Leica confocal scanner SP" 1) ("SP-" 1) ("substantial SP" 1)
   ("no distinct SP" 1) ("a microbial strain Streptomyces sp" 1)
   ("than SP (approximately equal to three folds)" 1) ("the SP's" 1)))
 ("UP:Q03405"
  (("uPAR" 1350) ("u-PAR" 155) ("MO3" 57) ("PLAUR" 27) ("soluble uPAR" 12)
   ("CD87" 11) ("uPAR-" 4) ("soluble u-PAR" 2) ("the available uPAR" 1)
   ("identified serum soluble uPAR" 1) ("than uPAR" 1)
   ("purified soluble uPAR" 1) ("uPAR protein" 1) ("-uPAR" 1)))
 ("UP:Q03426"
  (("MKs" 51) ("MVK" 19) ("mevalonate kinase" 6) ("immature MKs" 5)
   ("mevalonic aciduria" 4) ("mevalonate kinase (MK)" 2) ("-MKs" 2)
   ("most MKs" 2) ("Mevalonate kinase" 1) ("mature MKs" 1)))
 ("UP:Q03427" (("laminC" 2)))
 ("UP:Q03431"
  (("PTH1R" 33) ("PTHR1" 7) ("parathyroid hormone 1 receptor" 3) ("Pth1r" 1)))
 ("UP:Q03439" (("CAAC" 10)))
 ("UP:Q03468"
  (("CSB" 1123) ("ERCC6" 58) ("CSB protein" 25)
   ("chromatin remodeling factor" 22) ("functional CSB" 9) ("that CSB's" 3)
   ("RAD26" 3) ("a new chromatin remodeling factor" 3) ("soluble CSB" 2)
   ("the unique CSB" 2) ("the N-terminal 465 amino acids of CSB" 2)
   ("a Cockayne syndrome-associated mutant CSB protein" 2)
   ("CSB (Cockayne syndrome complementation B) protein" 2) ("ERCC6-" 2)
   ("FLAG-HA-tagged CSB" 2) ("intact CSB" 2)
   ("FLAG-HA-tagged chimeric CSB-eGFP, eGFP-PGBD3, or full-length CSB" 2)
   ("CKN2" 1) ("than CSB ( xref , xref )" 1)
   ("than cells not expressing CSB (CS1AN)" 1)
   ("than CSB (p-values of 5.2e-11 and 1.8e-7, respectively)" 1)
   ("a less efficient ERCC6" 1) ("the C-terminal 273 amino acids of CSB" 1)
   ("Cockayne syndrome B protein" 1) ("lack functional CSB" 1)
   ("than CSB in all cell lines" 1) ("intact CSB protein" 1)
   ("both the original CSB protein" 1)))
 ("UP:Q03518"
  (("TAP-1" 161) ("TAP1" 43) ("TAP-1 protein" 11) ("Psf1" 7) ("Tap1" 1)
   ("ABCB2" 1)))
 ("UP:Q03519" (("Psf2" 13) ("TAP2" 6) ("ABCB3" 3))) ("UP:Q03546" (("EAD" 1)))
 ("UP:Q03547"
  (("EAE" 361) ("secondary progressive EAE" 15) ("passive EAE" 2)
   ("somewhat counter-intuitive given reduced EAE" 1) ("Passive EAE" 1)
   ("chronic EAE" 1) ("acute EAE" 1) ("the immunized SJL mice developed EAE" 1)
   ("Secondary progressive EAE" 1) ("NOD secondary progressive EAE" 1)
   ("human SPMS and mouse secondary progressive EAE" 1)
   ("mouse secondary progressive EAE" 1)
   ("Bat3KD1-2D2 Th1 cells developed EAE" 1)
   ("All control-2D2 Th1 cell recipients developed EAE" 1)
   ("Bat3-overexpressing 2D2 Th1 recipient mice developed EAE" 1)))
 ("UP:Q03553" (("fiber protein" 6)))
 ("UP:Q03591" (("CFHL1" 69) ("CFHR1" 41) ("HFL1" 24) ("CFHR-1" 1)))
 ("UP:Q03600" (("INA-1" 6))) ("UP:Q03656" (("SRPK" 21)))
 ("UP:Q03692"
  (("type X" 29) ("COL10A1" 22) ("Type X" 9) ("Col10A1" 3) ("Col10a1" 2)))
 ("UP:Q03696" (("NgCAM" 1)))
 ("UP:Q03701"
  (("CBF" 249) ("CCAAT" 209) ("CTF2" 21) ("ccaat" 9) ("“Ap1/ccaat”" 3)
   ("CCAAT-binding factor" 2) ("the adipogenic transcription factor CCAAT" 1)
   ("pCBF" 1) ("CBF2" 1) ("CBF-" 1) ("Regional CBF" 1)
   ("the potential CCAAT" 1)))
 ("UP:Q03708" (("immE7" 17))) ("UP:Q03714" (("Usa1" 4)))
 ("UP:Q03833" (("Gis1" 1))) ("UP:Q03923" (("ZNF85" 1)))
 ("UP:Q03933"
  (("HSF2" 20) ("Heat shock transcription factor 2" 3)
   ("heat shock transcription factor 2" 1)))
 ("UP:Q03945" (("IpaB" 8))) ("UP:Q03946" (("IpaC" 4)))
 ("UP:Q03947" (("IpaD" 7) ("iPAD" 1))) ("UP:Q04118" (("PRG" 1)))
 ("UP:Q04205" (("tensin" 260) ("Tensin" 19) ("tensin protein" 5) ("TENsin" 3)))
 ("UP:Q04206"
  (("RelA" 5821) ("RELA" 463) ("Rela" 140) ("enhanceosome" 129) ("relA" 47)
   ("Rel-A" 46) ("RelA protein" 17) ("rela" 15) ("p-RelA" 14)
   ("RELA protein" 10) ("pRelA" 7) ("transcription factor p65" 6)
   ("targeting RelA" 5) ("p-RELA" 5) ("a functional enhanceosome" 4)
   ("-RelA" 3) ("RelA-" 2) ("much less RELA" 2)
   ("overexpressed wild-type RelA" 2) ("In contrast RelA S276A" 2)
   ("a transcriptional enhanceosome" 2) ("occasional nuclear RelA" 2)
   ("“enhanceosome”" 1) ("In contrast phosphorylated Rel-A" 1)
   ("exogenous RELA" 1) ("NFKB3" 1) ("RelA (BIOSOURCE)" 1) ("More RelA" 1)
   ("most RelA" 1) ("total promoter-associated RelA" 1)
   ("monomethylates chromatin-associated NF-κB RelA" 1)
   ("the NF-κB transcriptional enhanceosome" 1) ("exogenous RelA" 1)
   ("over-expressing either RelA" 1) ("than RelA" 1)
   ("the transcriptional enhanceosome" 1)
   ("the ribosome-associated ppGpp synthase RelA" 1) ("‘enhanceosome’" 1)))
 ("UP:Q04217" (("DHR1" 7))) ("UP:Q04323" (("UBXN1" 7)))
 ("UP:Q04377" (("Ddc2" 2) ("DDC2" 2)))
 ("UP:Q04396" (("phosphatidate phosphatase" 1)))
 ("UP:Q04412" (("Age1" 7) ("age-1" 1) ("AGE-1" 1)))
 ("UP:Q04440" (("C-TAD" 13)))
 ("UP:Q04446"
  (("GBE1" 8) ("branching enzyme 1" 1) ("glycogen branching enzyme" 1)))
 ("UP:Q04456"
  (("GES-1" 83)
   ("the immortalized normal gastric epithelial cell line GES-1" 2)
   ("The immortalized normal gastric mucosal epithelial cell line GES-1" 2)
   ("immortalized gastric epithelium cell lines GES-1" 2)
   ("human gastric epithelial cell line GES-1" 2)
   ("the normal gastric cell line GES-1" 2)
   ("an immortalized normal gastric epithelial cell line GES-1" 1)
   ("non-invasive gastric epithelial cell line GES-1" 1)
   ("Human gastric epithelial cells GES-1" 1)
   ("gastric epithelial cells GES-1" 1) ("normal GES-1" 1)
   ("10% fetal bovine serum and human gastric epithelium cell line GES-1" 1)
   ("the gastric epithelial cell line GES-1" 1)))
 ("UP:Q04511" (("Ufo1" 8) ("UFO1" 1)))
 ("UP:Q04547" (("US3" 11) ("the late protein kinase US3" 2)))
 ("UP:Q04554" (("VIS" 18)))
 ("UP:Q04609"
  (("PSMA" 176) ("PSM" 42) ("FOLH1" 22)
   ("prostate specific membrane antigen" 9) ("functional PSMA" 2) ("PS-MS" 1)))
 ("UP:Q04637"
  (("eIF4GI" 257) ("eIF4G1" 35) ("EIF4G1" 9) ("overexpressed eIF4GI" 3)
   ("polysome-associated eIF4GI" 2) ("P-eIF4GI" 2) ("functional eIF4GI" 1)
   ("PARK18" 1) ("TRIB2 (primers' sequences described in xref ) eIF4GI's" 1)
   ("translational initiation factor EIF4G1" 1)))
 ("UP:Q04656"
  (("MNK" 285) ("Mnk" 81) ("MC1" 41) ("MNK protein" 2) ("ATP7A" 2)
   ("that MNK's" 1) ("the other key MNK" 1)))
 ("UP:Q04666" (("rhL" 1)))
 ("UP:Q04671" (("OCA2" 40) ("P protein" 15) ("p protein" 1)))
 ("UP:Q04688" (("delG" 89)))
 ("UP:Q04695" (("CK17" 45) ("KRT17" 26) ("keratin 17" 13) ("keratin17" 2)))
 ("UP:Q04721"
  (("NOTCH2" 340) ("Notch2" 261) ("Notch 2" 20) ("Notch-2" 9)
   ("NOTCH2 protein" 5) ("Notch2 protein" 4) ("NOTCH2-" 3) ("NOTCH 2" 2)
   ("notch2" 2) ("notch 2" 2) ("Only two NOTCH2-" 1) ("than NOTCH2" 1)
   ("Notch 2 protein" 1) ("functional NOTCH2" 1)
   ("the last 426 amino acids of Notch2" 1) ("particular NOTCH2" 1)))
 ("UP:Q04724"
  (("TLE1" 269) ("Groucho" 41) ("TLE1 protein" 4)
   ("transcriptional repressor complex Groucho" 2) ("GRG1" 2)
   ("exogenous TLE1" 1) ("groucho" 1)
   ("The Groucho transcriptional corepressor TLE1 protein" 1)))
 ("UP:Q04725" (("TLE2" 2)))
 ("UP:Q04726" (("TLE3" 102) ("only non-ubiquitylated TLE3" 2)))
 ("UP:Q04727" (("TLE4" 13) ("Grg4" 5) ("Tle4" 1)))
 ("UP:Q04741" (("Emx1" 8) ("emx1" 2) ("EMX1" 1))) ("UP:Q04749" (("Avo2" 1)))
 ("UP:Q04756"
  (("hGFAP" 21) ("hGfap" 5) ("HGF activator" 4) ("HGF activator (HGFA)" 1)))
 ("UP:Q04759"
  (("PRKCQ" 83) ("Prkcq" 78) ("PKC-theta" 6) ("protein kinase C theta" 4)
   ("PKCtheta" 1) ("primary Prkcq" 1)))
 ("UP:Q04760" (("glyoxalase" 1)))
 ("UP:Q04771"
  (("ACVR1" 7) ("ALK2" 4) ("Acvr1" 2) ("activin receptor like kinase 2" 2)))
 ("UP:Q04790" (("IFNR1" 1)))
 ("UP:Q04828" ; fixed DHT
  (#+ignore("DHT" 2570) ("ddH" 169) ("AKR1C1" 43) ("AKR1c1" 18) #+ignore("DHT-" 12)
   ("Akr1c1" 8) #+ignore("DHT−" 6) ("dsD1" 4) #+ignore("–DHT" 2) ("-DHT" 1)
   ("the nonaromatizable DHT" 1)
   ("charcoal stripped (CS)-FBS + 1 nM DHT, and CS-FBS + 10 nM DHT" 1)
   ("exogenous DHT" 1) ("than DHT" 1) ("low intraprostatic DHT" 1)
   ("intraprostatic DHT" 1) ("10% charcoal-stripped serum (CSS) +/- 1nM DHT" 1)
   ("Aldo-keto reductase family 1 member C1" 1) ("than 1 nM DHT" 1)))
 ("UP:Q04837"
  (("single-stranded DNA-binding protein" 19) ("mtSSB" 14) ("SSBP" 5)
   ("single-stranded DNA binding protein 1" 2)
   ("single-stranded DNA-binding protein (SSB)" 1)))
 ("UP:Q04844" (("CHRNE" 3)))
 ("UP:Q04864"
  (("c-Rel" 1230) ("Rel" 579) ("c-REL" 270) ("REL" 205) ("cRel" 76) ("Crel" 74)
   ("rel" 56) ("c-rel" 53) ("c-Rel protein" 14) ("O-GlcNAcylated c-Rel" 12)
   ("cREL" 10) ("C-Rel" 9) ("crel" 8) ("RELs" 6) ("c-Rel-" 4)
   ("overexpressed c-REL" 4) ("c-Rel–" 3) ("REL protein" 3)
   ("inducibly expressed FLAG-tagged O-GlcNAcylated c-Rel" 2)
   ("overexpressed c-Rel" 2) ("overexpressed wild-type c-Rel" 2)
   ("exogenous c-Rel" 2)
   ("O-GlcNAcylated proteins showed O-GlcNAcylated c-Rel" 2) ("C-rel" 2)
   ("overexpressed c-rel" 2) ("either more Rel protein" 2) ("c-REL protein" 2)
   ("distinct c-Rel–" 1) ("We first suppressed endogenous c-Rel" 1)
   ("the highly transactivation-competent NF-κB subunit c-Rel" 1)
   ("than 31 c-Rel" 1) ("than c-Rel ( xref )" 1) ("Rel protein" 1)
   ("the last 63 amino acids of c-Rel (c-Rel 1-525 )" 1) ("than c-REL" 1)
   ("exogenously overexpressed c-REL" 1) ("TNF-α increased c-REL" 1)
   ("a 100x oil immersion objective lens and Axio Vision Rel" 1)))
 ("UP:Q04900" (("CD164" 2)))
 ("UP:Q04912"
  (("Ron" 583) ("RON" 166) ("MST1R" 8) ("Ron protein" 6) ("functional Ron" 2)
   ("macrophage stimulating 1 receptor" 2)
   ("P-macrophage-stimulating protein receptor" 2)
   ("macrophage-stimulating protein receptor" 2)
   ("the matched noncancerous tissues expressed mature Ron" 1) ("Ron−" 1)
   ("The carcinomas expressed exclusively mature functional Ron" 1) ("p-RON" 1)
   ("MSP receptor" 1)))
 ("UP:Q04917" (("YWHAH" 4)))
 ("UP:Q04941"
  (("PLP2" 170) ("pLP2" 25) ("-PLP2" 2) ("pPLP2" 1) ("Plp2" 1)
   ("the viral PLP2" 1)))
 ("UP:Q04965" (("hexon protein" 1))) ("UP:Q04968" (("OspA" 6)))
 ("UP:Q04IN8"
  (("pneumolysin" 5) ("pneumolysin (PLY)" 3)
   ("pneumococcal pneumolysin (PLO)" 1)))
 ("UP:Q05024" (("Tri1" 1))) ("UP:Q05029" (("BCH-1" 2)))
 ("UP:Q05047" (("SLS" 17)))
 ("UP:Q05048"
  (("50kD" 15) ("CSTF1" 15) ("cleavage stimulation factor" 6) ("CstF1" 4)
   ("approximately 50kD" 4) ("CstF-50" 2)
   ("cleavage stimulation factor subunit 1" 1)))
 ("UP:Q05066"
  (("SRY" 83) ("TDF" 29) ("sex determining region Y" 15) ("Sry" 12)
   ("sex Determining Region Y" 1)))
 ("UP:Q05084"
  (("P69" 40) ("BRCA1-overexpressing P69" 2) ("parental P69" 1)
   ("the AR-negative P69" 1) ("p69" 1)))
 ("UP:Q05086"
  (("E6AP" 468) ("E6-AP" 261) ("UBE3A" 66) ("Ube3A" 58)
   ("Angelman syndrome" 16) ("E6AP protein" 8) ("exogenous E6-AP" 4)
   ("-E6AP" 3) ("MiR-375 directly targets UBE3A" 2)
   ("the human papilloma virus (HPV) E6-associated cellular protein E6AP" 2)
   ("Q05086" 1) ("Cellular E6AP" 1) ("E6-AP protein" 1)
   ("the human cognitive disorder Angelman syndrome" 1)
   ("ubiquitin-ligase defective E6AP" 1)))
 ("UP:Q05129" (("EspB protein" 3) ("EspB" 1))) ("UP:Q05159" (("egr2b" 3)))
 ("UP:Q05193"
  (("dynamin 1" 21) ("DNM" 15) ("Dnm1" 12) ("DNM1" 10) ("Dynamin1" 9)
   ("dynamin1" 4) ("dynamin-1" 3) ("the endocytic GTPase dynamin1" 2)
   ("Dynamin 1" 1)))
 ("UP:Q05195"
  (("MAD" 163) ("Mad" 33) ("Mxd1" 10) ("mad" 9) ("protein Mad" 3)
   ("MAX dimerization protein 1" 2) ("protein MAD" 1) ("MAD protein" 1)
   ("MXD1" 1)))
 ("UP:Q05203" (("HAG" 5)))
 ("UP:Q05209"
  (("PTP-PEST" 326) ("PTPN12" 23) ("more PTP-PEST" 2)
   ("catalytically inactive and likely dominant negative–acting PTP-PEST C231S"
    1)))
 ("UP:Q05215" (("EGR4" 9))) ("UP:Q05293" (("E-78" 2)))
 ("UP:Q05309" (("TNP" 146) ("TNP-" 1))) ("UP:Q05315" (("CLC" 43) ("Clc" 10)))
 ("UP:Q05329" (("GAD2" 4) ("Gad65" 2) ("GAD65" 1)))
 ("UP:Q05342" (("ABE" 19) ("Abe" 1)))
 ("UP:Q05356"
  (("KS" 847) ("iatrogenic KS" 5) ("Ks" 3) ("syndromic KS" 2)
   ("Acquired immunodeficiency syndrome-associated KS" 2) ("classical KS" 2)
   ("severe KS" 2) ("autosomal KS" 2) ("autosomal recessive KS" 2)
   ("endemic KS" 1) ("complete KS" 1) ("ks" 1) ("systemic KS" 1)
   ("Endemic KS" 1) ("classic KS" 1) ("than iatrogenic KS" 1)))
 ("UP:Q05397"
  (("FAK" 12671) ("FRNK" 301) ("pp125 FAK" 249) ("-FAK" 99) ("FAK protein" 56)
   ("PTK2" 50) ("FAK-" 32) ("pp125FAK" 27) ("p125 FAK" 16) ("Ptk2" 14)
   ("FAK1" 9) ("p125 Fak" 9) ("p125FAK" 7) ("PtK2" 5) ("overexpressed FAK" 5)
   ("overexpressed  FAK" 4) ("Pro-null FAK" 4) ("FAK (FRNK)" 3)
   ("FRNK protein" 3) ("total and phosphorylated FAK" 2) ("Q05397" 2)
   ("hyperactive FAK" 2) ("un-phosphorylated FAK" 2)
   ("focal adhesion kinase 1" 2) ("FAK peptide" 2) ("–FAK" 2)
   ("Tyr-397–mutated FAK" 2)
   ("Adenoviral-mediated FAK expression rescues FAK" 2)
   ("v-Src–transformed FAK −/−" 2) ("FAK (Y576/577) protein" 2)
   ("dominant-negative FAK" 2) ("exogenous HA-tagged FAK" 2)
   ("dominant-negative FRNK" 2) ("a dominant-negative FAK protein" 2)
   ("dominant-negative FAK protein" 2)
   ("absent, low, moderate, and strong FAK" 2) ("than wt FAK" 2)
   ("focal adhesion kinase-1" 2) ("cytoskeleton-associated pp125 FAK" 1)
   ("Significantly less native pp125 FAK" 1)
   ("reversible, and native pp125 FAK" 1) ("intact pp125 FAK" 1)
   ("functional FAK" 1) ("p125Fak" 1) ("than FAK" 1)
   ("further activating FAK" 1) ("PF-228 demonstrated decreased p-Y397 FAK" 1)
   ("exogenous dominant negative FAK" 1) ("less FAK" 1)
   ("than tumour cell FAK in breast cancer" 1) ("endothelial FAK" 1)
   ("epidermal FAK" 1) ("than endogenous FAK ( xref )" 1) ("FAK (RTK)" 1)
   ("PF-228 confirmed FAK" 1) ("most FAK" 1) ("the nuclear FAK's" 1)
   ("than WT FAK ( xref )" 1) ("FAK (FAK)" 1) ("we first simulated FAK" 1)
   ("its immediate downstream targets FAK" 1) ("the phosphodeficient FAK" 1)
   ("Focal adhesion kinase-1" 1) ("the lamellipodial-associated FAK" 1)
   ("PTK2 (FAK)" 1) ("further implicating FAK" 1) ("exogenous FRNK" 1)
   ("more total FAK" 1) ("more FAK" 1) ("avian FAK" 1) ("pp125FAKs" 1)
   ("pp125FAK protein" 1) ("more FAK protein" 1) ("specifically targets FAK" 1)
   ("EGFR-associated FAK" 1) ("than wt FAK ( xref )" 1)
   ("expressing FAK E1015A" 1) ("than wild-type FAK" 1)
   ("further indicating FAK" 1)
   ("phosphorylated cleaved CDCP1 and β1 integrin-associated FAK" 1)
   ("regenerate active FAK" 1)))
 ("UP:Q05404" (("L-MYC1" 2) ("Mycl1A" 1))) ("UP:Q05437" (("Prx-1" 2)))
 ("UP:Q05469"
  (("hormone-sensitive" 55) ("HSL" 16) ("hormone sensitive lipase" 6)
   ("hormone-sensitive lipase" 4) ("hormone sensitive lipase (HSL)" 2)
   ("hormone-sensitive lipase (HSL)" 1) ("LIPE" 1)
   ("hormone-sensitive (AD)" 1)))
 ("UP:Q05487"
  (("ESTs" 302) ("subgroup A ESTs" 3) ("carboxylesterases" 2)
   ("at least two ESTs" 2) ("cellular carboxylesterases" 1)
   ("approximately 500 ESTs" 1)
   ("than 5 million human ESTs ( xref ; see also xref for details)" 1)
   ("publicly available breast cancer ESTs" 1)
   ("at least two independent ESTs" 1)))
 ("UP:Q05512" (("EMK" 1)))
 ("UP:Q05513"
  (("PRKCZ" 308) ("p42/44" 202) ("protein kinase C zeta" 12) ("Prkcz" 4)
   ("pp42/44" 4) ("protein kinase C zeta ( PRKCZ )" 2) ("p-p42/44" 2)
   ("PKC-zeta" 2) ("than PRKCZ ( xref )" 1) ("the dual effect PRKCZ" 1)
   ("PRKCZ peptide" 1)))
 ("UP:Q05516"
  (("PLZF" 164) ("ZBTB16" 7) ("promyelocytic leukemia zinc finger protein" 4)
   ("PLZF protein" 2) ("Zbtb16" 2)
   ("zinc finger and BTB domain containing 16" 2)
   ("monocytic leukemia zinc-finger protein (MOZ)" 1)
   ("leukemia zinc-finger protein" 1) ("PLZF-" 1)
   ("normal controls expressed significantly more PLZF" 1)
   ("promyelocytic leukemia zinc finger protein (PLZF)" 1)))
 ("UP:Q05519" (("SRSF11" 10) ("NET2" 1))) ("UP:Q05567" (("YSPL" 7)))
 ("UP:Q05586" (("NMDAR1" 7) ("GRIN1" 3) ("monoclonal antibodies NMDAR1" 2)))
 ("UP:Q05637"
  (("pHM6" 14) ("HA-tag-encoded mammalian expression vector pHM6" 2)))
 ("UP:Q05639" (("eEF1A2" 118) ("EEF1A2" 21) ("STN" 2) ("eEF1A2 molecule" 2)))
 ("UP:Q05652" (("PLL" 64) ("PLL-" 2)))
 ("UP:Q05655"
  (("PKCδ" 3451) ("PKC-δ" 211) ("PRKCD" 138) ("Prkcd" 25) ("PKCδ protein" 15)
   ("protein kinase C delta" 13) ("nPKCδ" 11) ("PKC-delta" 8) ("PKCdelta" 8)
   ("PRKCD protein" 5) ("a dominant-negative mutant PKCδ" 3) ("-PKCδ" 3)
   ("dominant-negative PKCδ" 3) ("particular PKCδ" 3) ("PKCδ-" 3)
   ("targeting PKCδ" 2) ("miR-26a directly targets PRKCD" 2)
   ("We first validated PKCδ" 1) ("than PKCδ" 1) ("nPKC-δ" 1)
   ("the pro-apoptotic PKCδ" 1) ("the membrane-associated PKCδ" 1) ("PKCδ–" 1)
   ("additional stress-induced changes push PKCδ" 1)
   ("dominant-negative PKC-δ" 1) ("the pro-apoptotic kinase PKCδ" 1)
   ("a dominant-negative PKCδ" 1)))
 ("UP:Q05682" (("CDM" 36) ("CALD1" 5) ("pCDM" 2)))
 ("UP:Q05695" (("Nile" 67) ("the fluorescent dye Nile" 1)))
 ("UP:Q05707" (("COL14A1" 4) ("type XIV" 3))) ("UP:Q05718" (("IGFBP-6" 6)))
 ("UP:Q05783" (("HMG-D" 1))) ("UP:Q05787" (("Hrd3" 1)))
 ("UP:Q05789" (("Atg38" 7)))
 ("UP:Q05823"
  (("RNASEL" 7) ("RNaseL" 2) ("ribonuclease L" 2)
   ("ribonuclease L ( RNASEL )" 1)))
 ("UP:Q05858"
  (("formin" 100) ("formins" 43) ("Formin" 16) ("formin molecule" 4)
   ("Formins" 3) ("formin protein" 3) ("the predominant formin" 1)))
 ("UP:Q05901" (("CHRNB3" 1)))
 ("UP:Q05923" (("DUSP2" 107) ("dual specificity protein phosphatase 2" 3)))
 ("UP:Q05925" (("EN1" 9) ("en1" 1) ("En1" 1)))
 ("UP:Q05932"
  (("FPGS" 91) ("folylpolyglutamate synthase" 2)
   ("Cox proportional hazards model considering FPGS" 1)))
 ("UP:Q05940"
  (("VMAT2" 17) ("monoamine" 14) ("vesicular monoamine transporter" 7)
   ("Monoamine" 6) ("VMAT" 2) ("VMAT2 protein" 1)))
 ("UP:Q05AK5" (("miRB" 16) ("MIRb" 3)))
 ("UP:Q05D60" (("CCDC67" 9) ("Deup1" 6)))
 ("UP:Q06033" (("H3P" 11) ("H3-P" 6) ("ITIH3" 4)))
 ("UP:Q06055" (("ATP synthase F" 1)))
 ("UP:Q06124"
  (("SHP2" 3397) ("Shp2" 2166) ("SHP-2" 1928) ("PTPN11" 990) ("Shp-2" 225)
   ("Ptpn11" 110) ("SHP2 protein" 41) ("shp-2" 39) ("Shp2 protein" 32)
   ("SHP2-" 16) ("ptpn11" 14) ("Shp-2 protein" 12) ("SHP-2 protein" 12)
   ("pSHP-2" 11) ("tyrosine-protein phosphatase non-receptor type 11" 10)
   ("Shp-2 molecule" 9) ("shp2" 9) ("Shp2 molecule" 8) ("PTP1D" 6)
   ("functional SHP-2" 6) ("SH-PTP2" 6)
   ("The ubiquitous non-receptor protein tyrosine phosphatase SHP2" 4)
   ("nonreceptor-type 11" 4) ("PTPN11-" 4) ("PTP-2c" 4) ("than WT SHP2" 3)
   ("Shp2D61Y-" 3) ("PTP-1D" 3) ("PECAM-1-associated SHP-2" 3) ("SHP-2-" 3)
   ("at least some SHP2" 3) ("overexpressed SHP2" 3) ("a functional Shp-2" 2)
   ("Strong SHP-2" 2) ("the classical PTP SHP2" 2) ("dominant-negative Shp2" 2)
   ("constitutively tyrosine phosphorylated and bound Shp2" 2) ("more Shp2" 2)
   ("dominant-negative SHP2" 2) ("further facilitating SHP2" 2) ("P-SHP2" 2)
   ("shP2" 2) ("-SHP-2" 1) ("the distinct SHP-2" 1)
   ("the SHP-2-coding gene PTPN11" 1) ("a functional SHP-2" 1)
   ("soluble SHP-2" 1) ("the most recurrent LS-associated SHP2 mutant Y279C" 1)
   ("residual Shp2" 1) ("activatable Shp2" 1) ("PTPN11 ”" 1) ("”" 1)
   ("also known as dominant-negative SHP2" 1) ("functional Shp-2" 1)
   ("further recruited SHP-2" 1) ("nonfunctional SHP-2" 1) ("only Shp-2 +/−" 1)
   ("PTP2C" 1) ("e.g. adhesion protein SHP2" 1) ("than wild-type PTPN11" 1)
   ("expressing mutant Shp2" 1) ("pSHP2" 1) ("more SHP2" 1)
   ("catalytically-deficient Shp2 C459S" 1) ("–SHP2" 1) ("SHPTP-2" 1)
   ("the entire SHP2" 1) ("than SHP2 ( xref )" 1)
   ("the nonphosphorylatable Y542F mutant Shp2" 1) ("that SHP2’s" 1)))
 ("UP:Q06136" (("DHSR" 1))) ("UP:Q06141" (("PAP1" 2)))
 ("UP:Q06142" (("Kap95" 3))) ("UP:Q06148" (("Nej1" 2)))
 ("UP:Q06156" (("Ycs4" 1)))
 ("UP:Q06180"
  (("MPTP" 217) ("mPTP" 111) ("mPTPs" 9) ("continual mPTP" 1)
   ("acute MPTP" 1)))
 ("UP:Q06187"
  (("Btk" 662) ("BTK" 115) ("ATK" 53) ("XLA" 27) ("BPK" 18)
   ("Bruton tyrosine kinase" 8) ("Btk-" 5) ("Atk" 4) ("Btk protein" 2)
   ("Immortalized Btk" 2) ("endogeneous Btk" 1) ("functional Btk" 1)
   ("the immortalized Btk" 1) ("ATk" 1) ("B-cell progenitor kinase" 1)
   ("this trimolecular arrangement Btk" 1)))
 ("UP:Q06190" (("PPP2R3" 1)))
 ("UP:Q06203"
  (("ATase" 106) ("Prat" 17) ("PRAT" 7) ("ATase protein" 4)
   ("pure recombinant human ATase" 2)
   ("phosphoribosyl pyrophosphate amidotransferase" 1)))
 ("UP:Q06210"
  (("fructose" 46) ("GFPT1" 9)
   ("glutamine-fructose-6-phosphate transaminase 1" 3)
   ("fructose-6-phosphate amidotransferase" 2) ("phospho-fructose" 1)))
 ("UP:Q06211" (("Mms1" 5)))
 ("UP:Q06259" (("DOC" 117) ("Doc" 82) ("doc" 6) ("DoC" 1)))
 ("UP:Q06265" (("Scl" 9) ("75kDa" 4) ("Rrp45" 1)))
 ("UP:Q06278"
  (("raloxifene" 185) ("AO" 121) ("Raloxifene" 16) ("Ao" 2)
   ("aldehyde oxidase 1" 2) ("aldehyde oxidase" 2) ("AOX1" 1) ("Aox1" 1)))
 ("UP:Q06283" (("Lyz2" 2))) ("UP:Q06304" (("aerolysin" 2) ("Aerolysin" 1)))
 ("UP:Q06323" (("PA28α" 19) ("PA28" 7) ("PSME1" 1))) ("UP:Q06324" (("MMR1" 2)))
 ("UP:Q06330"
  (("CBF1" 105) ("RBP-Jk" 96) ("CBF-1" 94) ("RBPJ" 50) ("RBP-J" 44)
   ("RBPjk" 10) ("RBPJK" 9) ("RBPJk" 8) ("RBP-Jk protein" 7) ("Suh" 7)
   ("Rbpj" 4)
   ("recombination signal binding protein for immunoglobulin kappa J region" 3)
   ("293T cells overexpressing CBF-1" 2) ("Rbpsuh" 2) ("RBPSUH" 2) ("Rbpjk" 1)
   ("an exogenous RBP-Jk protein" 1) ("RBP-jk" 1)
   ("the essential Rta cofactor and Notch effector RBP-Jk" 1)
   ("the DNA-binding transcriptional co-activator RBPJ" 1)
   ("Recombination signal binding protein for immunoglobulin kappa J region" 1)
   ("RBP-j" 1) ("CBF1-" 1) ("RBP-J κ" 1)))
 ("UP:Q06412" (("Tus1" 4)))
 ("UP:Q06413"
  (("MEF2C" 410) ("Mef2c" 10) ("MEF2c" 9) ("MEF2C-" 4) ("Mef2C" 2)
   ("cardiac transcription factor Mef2c" 2) ("MEF-2C" 1) ("cellular MEF2C" 1)
   ("than the MEF2C-WT" 1) ("than MEF2C-WT" 1) ("mef2c" 1)))
 ("UP:Q06416"
  (("POU5F1P1" 22) ("OTF3P1" 1) ("OTF3C" 1) ("POU5F1B" 1)
   ("around POU5F1P1" 1)))
 ("UP:Q06418"
  (("TIF" 212) ("SKY" 64) ("TIFs" 31) ("TYRO3" 21) ("Tyro3" 10) ("Dtk" 8)
   ("Tyro-3" 5) ("RSE" 3) ("Sky" 2) ("tyro3" 2) ("Rse" 1)
   ("Biotechnology Information Spectral Karyotyping SKY" 1) ("than 3 TIFs" 1)
   ("3 or more TIFs" 1) ("tif" 1)))
 ("UP:Q06455"
  (("ETO" 296) ("Eto" 85) ("ETO-" 15) ("Runx1t1" 5) ("RUNX1T1" 2)
   ("ETO protein" 2) ("MTG8" 1) ("“ETO”" 1)))
 ("UP:Q06481" (("APLP2" 4)))
 ("UP:Q06495"
  (("SLC34A1" 8) ("solute carrier family 34 (sodium phosphate)" 1) ("NPT2" 1)
   ("NAPI-3" 1) ("Npt2" 1)))
 ("UP:Q06520"
  (("catabolism" 483) ("STD" 51) ("Std" 30) ("SULT2A1" 21) ("Catabolism" 15)
   ("cellular catabolism" 4) ("std" 3) ("aerobic catabolism" 2)
   ("toxic catabolism" 2) ("the local catabolism" 2)
   ("Our results closely link matrix catabolism" 1)
   ("aerobic and anaerobic catabolism" 1)
   ("monoaminergic neurotransmitter catabolism" 1) ("its own catabolism" 1)
   ("dehydroepiandrosterone sulfotransferase" 1) ("aberrant catabolism" 1)
   ("further tissue catabolism" 1) ("their more efficient catabolism" 1)
   ("MYC -induced mouse liver tumors significantly increase both glucose and glutamine catabolism"
    1)))
 ("UP:Q06529"
  (("FC" 459) ("Fc" 184) ("fc" 19) ("pFC" 14) ("fC" 9) ("FC protein" 4)
   ("a morphologically unique FC" 2) ("a functional Fc" 1)))
 ("UP:Q06546"
  (("GABPA" 197) ("GA-binding protein transcription factor" 2)
   ("strong GABPA" 1) ("Nrf2a" 1) ("further subpartitioning GABPA" 1)))
 ("UP:Q06547" (("nuclear respiratory factor 2" 11) ("GABPB1" 6) ("GABPB" 3)))
 ("UP:Q06587"
  (("Ring1" 36) ("RING1" 25) ("RING1A" 8)
   ("The N-terminal canonical RING1" 2)))
 ("UP:Q06609"
  (("RAD51" 7255) ("Rad51" 3205) ("RecA" 534) ("HsRAD51" 493) ("hRad51" 329)
   ("HsRad51" 168) ("RAD51 protein" 165) ("hRAD51" 144)
   ("RAD51 recombinase" 85) ("Rad51 protein" 51) ("rad51" 29)
   ("RecA protein" 27) ("HsRad51 protein" 26) ("hRad51 protein" 19) ("recA" 16)
   ("Rad51-" 10) ("bacterial RecA" 10) ("Rad51 Protein" 8) ("–RAD51" 8)
   ("Rad51 (HsRad51) protein" 6) ("RAD51-" 4) ("defective RAD51" 4)
   ("a homolog of bacterial RecA protein" 4) ("exogenous RAD51" 4)
   ("RAD51 molecule" 4) ("monomeric RAD51" 3) ("chromatin-associated RAD51" 3)
   ("the Walker A box mutant HsRAD51" 3) ("rad51 protein" 3) ("HRad51" 3)
   ("the homologous recombinase RAD51" 2) ("the prototypical bacterial RecA" 2)
   ("a common ancestral RecA" 2) ("possible HsRAD51" 2) ("than RAD51" 2)
   ("HRAD51" 2) ("targeting RAD51" 2) ("RecA protein (NEB)" 2)
   ("monomeric Rad51" 2) ("exogenous WT Rad51" 2)
   ("the essential recombinase Rad51" 2) ("non-cleavable RAD51" 2)
   ("Non-Cleavable RAD51" 2) ("filamentous yeast Rad51" 2)
   ("the central homologous recombination factor RAD51" 2) ("-Rad51" 2)
   ("The telomeric RAD51" 2) ("the aberrant RAD51" 2)
   ("the homologous recombination (HR) protein RAD51" 2) ("Exogenous RAD51" 2)
   ("proper RAD51" 2)
   ("the key homologous recombination repair protein Rad51" 2)
   ("hRAD51 protein" 2) ("adenoviral RAD51" 2)
   ("prorecombinogenic protein RAD51" 2) ("than HsRAD51" 1)
   ("a paranemic RAD51" 1) ("HsRAd51" 1) ("HSRAD51" 1)
   ("than HsRAD51 [ xref , xref , xref ]" 1)
   ("its robust bacterial counterpart RecA" 1)
   ("miR-103/107 directly target RAD51" 1) ("we first immunodepleted RAD51" 1)
   ("than hRad51" 1) ("hRad51-" 1) ("RAD51A" 1) ("MRMV2" 1) ("-RAD51" 1)
   ("fork-associated S14A Rad51" 1) ("residual Rad51" 1)
   ("the critical homologous recombination (HR) protein RAD51" 1)
   ("the homologous recombination DNA repair protein RAD51" 1)
   ("than wild-type Rad51" 1) ("the homologous recombination factor RAD51" 1)
   ("filamentous yeast Rad51 protein" 1) ("Polymerized Rad51" 1)
   ("soluble nuclear RAD51" 1) ("the intrinsic RAD51" 1)
   ("fluorescent RAD51" 1) ("targeting active RAD51" 1)
   ("pro-recombinogenic RAD51 protein" 1) ("the bacterial RecA protein" 1)
   ("more RAD51" 1)
   ("the essential HR factor
                    RAD51"
    1)
   ("than wild type Rad51" 1) ("the bacterial recombinase RecA" 1)
   ("dsDNA-bound RecA" 1) ("than the RAD51 recombinase" 1)
   ("an ancestral RAD51-" 1) ("the key bacterial recombinase RecA" 1)
   ("acute toxicity and mut/het RAD51" 1) ("the exogenous RAD51" 1)
   ("the next RAD51 molecule" 1) ("toxic RAD51" 1) ("simply binding RAD51" 1)
   ("two adjacent RAD51" 1) ("than WT Rad51" 1)
   ("its well-studied bacterial homologue RecA" 1) ("even wild-type RAD51" 1)
   ("complete RAD51" 1) ("presynaptic RAD51" 1) ("HRad51 protein" 1)
   ("its bacterial homologue RecA" 1) ("than RecA" 1) ("neighboring RAD51" 1)
   ("archaeal RadA, and eukaryotic RAD51" 1) ("full-length archaeal RAD51" 1)
   ("IBR2-bound Rad51" 1) ("IBR2-bound RAD51" 1) ("functional RAD51" 1)
   ("the essential recombinase RAD51" 1)
   ("mitochondrially-localized Rad51" 1)))
 ("UP:Q06615" (("Xnot" 1))) ("UP:Q06623" (("Plo1" 10) ("plo1" 5)))
 ("UP:Q06639" (("Rsc3" 1)))
 ("UP:Q06643" (("LTB" 33) ("lymphotoxin-β" 13) ("LTβ" 7) ("LT-β" 2)))
 ("UP:Q06677" (("Swa2" 2) ("swa2" 1))) ("UP:Q06700" (("GCDA" 103)))
 ("UP:Q06710"
  (("PAX8" 448) ("Pax8" 39) ("PAX-8" 29) ("PAX8 protein" 8) ("Pax-8" 6)
   ("PAX 8" 4) ("A recent PAX8" 3) ("weak (1 to 2+/4+) PAX-8" 2)
   ("paired box 8" 1) ("a potential therapeutic target PAX8" 1) ("PAX8-" 1)
   ("pediatric thyroid cancers PAX8" 1)))
 ("UP:Q06721" (("RCA" 99) ("rA" 5)))
 ("UP:Q06787"
  (("Fmr1" 197) ("FMR1" 186) ("FMRP" 109) ("fragile X mental retardation 1" 7)
   ("a functional FMRP" 2) ("the fragile-X causative gene FMR1" 2)
   ("FMR1 protein" 2) ("Satisfactory FMR1" 1) ("FMRP-" 1)))
 ("UP:Q06796" (("RelC" 3))) ("UP:Q06797" (("BL1" 12)))
 ("UP:Q06819" (("SNU16" 60)))
 ("UP:Q06828"
  (("FM" 265) ("fM" 22) ("fibromodulin" 6) ("Fibromodulin" 4) ("Fm" 1)
   ("intravenous FM" 1) ("MitoTracker Deep-Red FM" 1)))
 ("UP:Q06830"
  (("Prdx1" 471) ("PRDX1" 401) ("PAG" 301) ("peroxiredoxin 1" 25)
   ("Peroxiredoxin 1" 16) ("PRDX1 protein" 13) ("overexpressed Prdx1" 4)
   ("peroxiredoxin1" 4) ("decameric PRDX1" 3) ("Peroxiredoxin-1" 2)
   ("membranous Prdx1" 2) ("equimolar Prdx1" 2) ("Prdx-1 protein" 2)
   ("a single tyrosine of PAG (Y 317 )" 1) ("primary PAG" 1)
   ("nearly all PAG" 1) ("The first methionine of PAG" 1) ("cellular PRDX1" 1)
   ("peroxiredoxin-1" 1) ("oxidative stress induced Prdx1" 1)
   ("Prdx1 protein" 1) ("than Prdx1 C172S ( xref )" 1) ("Prdx-1" 1)
   ("than Prdx1 −/−" 1) ("than Prdx1 +/+" 1)
   ("the Csk-docking tyrosine of PAG (Tyr 317 )" 1)))
 ("UP:Q06848" (("ANCA" 36) ("pANCA" 2) ("p-ANCA" 1)))
 ("UP:Q06851"
  (("cohesin" 622) ("Cohesin" 64) ("centromeric cohesin" 11)
   ("soluble cohesin" 2) ("the centromeric cohesin" 2) ("cohesin-" 1)
   ("chromatin-associated cohesin" 1) ("noncleavable cohesin" 1)
   ("containing nonphosphorylatable cohesin" 1) ("at least some cohesin" 1)
   ("that cohesin's" 1) ("total cellular cohesin" 1)))
 ("UP:Q06889"
  (("pilot" 471) ("Pilot" 83) ("Egr3" 35) ("EGR3" 21)
   ("The laboratories underwent rigorous pilot" 2) ("Egr-3" 2) ("egr3" 1)
   ("particular Egr3" 1)))
 ("UP:Q06945" (("SOX4" 164) ("Sox4" 7) ("miR-31 directly targets SOX4" 2)))
 ("UP:Q06JG5" (("16D10" 2))) ("UP:Q07002" (("PCTAIRE3" 2)))
 ("UP:Q07011"
  (("CD137" 53) ("4-1BB" 35) ("TNFRSF9" 14) ("4-1BB protein" 3)
   ("the costimulatory tumor necrosis factor superfamily receptor 4-1BB" 2)
   ("Tnfrsf9" 2)))
 ("UP:Q07020" (("RPL18" 6) ("L18" 5) ("l18" 1)))
 ("UP:Q07021"
  (("gC1qR" 257) ("C1QBP" 4) ("gC1qR protein" 4) ("gC1qR-" 2)
   ("q subcomponent binding protein" 1) ("mature gC1qR" 1)))
 ("UP:Q07065" (("CLIMP-63" 5) ("CKAP4" 1)))
 ("UP:Q07075"
  (("APA" 42) ("ENPEP" 5) ("glutamyl aminopeptidase" 3)
   ("aminopeptidase A" 1)))
 ("UP:Q07081" (("olfactomedin" 12)))
 ("UP:Q07108"
  (("aims" 736) ("CD69" 411) ("Aims" 197) ("AIMs" 154) ("AIMS" 32) ("EA1" 10)
   ("Cd69" 8) ("CD69-" 2) ("very recent years aims" 1) ("The latter aims" 1)
   ("the key aims" 1)
   ("the gated ‘red’ and ‘yellow’ populations expressed approximately 2.3 and 4.5 fold more CD69"
    1)
   ("predominantly Caucasian AIMs" 1) ("predominantly African AIMs" 1)
   ("acute myelogenous leukemia (AML) aims" 1) ("Secondary aims" 1)
   ("two major aims" 1) ("This cross-sectional study aims" 1)
   ("The major aims" 1) ("The primary aims" 1) ("Additional secondary aims" 1)
   ("the current explorative study aims" 1) ("This explorative study aims" 1)
   ("four major aims" 1) ("3 primary aims" 1) ("only 80 AIMs" 1)
   ("the PCa hormonal therapy aims" 1) ("The Mayo Clinic proposal aims" 1)
   ("The HALCyon programme aims" 1) ("the dual aims" 1) ("The dual aims" 1)
   ("Our primary aims" 1) ("The ultimate aims" 1)))
 ("UP:Q07121" (("MAOI" 6)))
 ("UP:Q07157"
  (("ZO-1" 981) ("ZO1" 50) ("zonula" 32) ("tight junction protein ZO-1" 18)
   ("ZO-1 protein" 8) ("Zonula Occludens" 5) ("Zonula" 5) ("TJP1" 4) ("Zo-1" 4)
   ("overexpressed recombinant full length ZO1" 3)
   ("zona occludens protein 1" 2) ("Zona occludens protein 1" 2)
   ("the kidney cortex strong ZO-1" 2) ("Zona occludens 1" 2)
   ("aPKCλwt display normal ZO-1" 1) ("monoclonal mouse ZO-1" 1) ("ZO-1-" 1)
   ("apical ZO-1" 1) ("the apicolateral tight junction marker ZO-1" 1)
   ("considerably more ZO-1" 1) ("considerably less ZO-1" 1) ("zo-1" 1)))
 ("UP:Q07162" (("prog" 2))) ("UP:Q07163" (("pTYB1" 7)))
 ("UP:Q07283"
  (("TCHH" 12) ("trichohyalin" 7) ("trichohyalin protein" 2) ("THL" 1)
   ("more trichohyalin" 1) ("Trichohyalin" 1) ("pTHL" 1)))
 ("UP:Q07325"
  (("MIG" 126) ("Mig" 114) ("mIgG" 105) ("pMIG" 50) ("CXCL9" 50) ("mIgGs" 4)
   ("mIg" 3) ("more CXCL9" 2)
   ("the 10 membrane-proximal amino acids of mammalian mIgG" 2)
   ("mIg molecule" 2) ("MIG-" 2) ("-MIG" 2) ("p-MIG" 1) ("pMIG-" 1)))
 ("UP:Q07326" (("pIGF" 64) ("PIGF" 7)))
 ("UP:Q07343" (("PDE4B" 55) ("PDE4B protein" 3) ("phosphodiesterase 4B" 2)))
 ("UP:Q07352"
  (("ZFP36L1" 101) ("Tis11b" 41) ("TIS11B" 15) ("ZFP36L1 protein" 2)
   ("TIS11b" 1)))
 ("UP:Q07407" (("FR1" 16))) ("UP:Q07436" (("EX" 156) ("Ex" 18) ("‘EX’" 8)))
 ("UP:Q07440" (("Bcl2a1a" 5))) ("UP:Q07444" (("NKG2E" 1)))
 ("UP:Q07507" (("DPT" 35) ("dpt" 5) ("DpT" 3))) ("UP:Q07532" (("IWR1" 1)))
 ("UP:Q07566" (("IpgD" 69) ("ipgD" 13)))
 ("UP:Q075B4"
  (("caspase 12" 49) ("caspase-12" 25) ("Caspase 12" 4) ("caspase12" 3)
   ("-caspase 12" 2) ("endoplasmic reticulum-associated caspase-12" 1)
   ("than the full-length caspase 12" 1) ("Caspase-12" 1)))
 ("UP:Q07627" (("b2a" 2)))
 ("UP:Q07654"
  (("TFF3" 28) ("trefoil factor 3" 4) ("intestinal trefoil factor" 2)
   ("Tff3" 2)))
 ("UP:Q07655" (("Whi4" 1)))
 ("UP:Q07666"
  (("Sam68" 648) ("KHDRBS1" 6) ("SAM68" 5) ("Sam68 molecule" 3) ("Sam68-" 2)
   ("at least Sam68" 1) ("cycloheximide treatment further implicating Sam68" 1)
   ("Sam68 protein" 1) ("p85α-SH3 bound less Sam68" 1)
   ("GST-Fyn-SH3 retained much more Sam68" 1) ("sam68" 1)))
 ("UP:Q07687" (("TES1" 50) ("DLX2" 8) ("Dlx2" 2))) ("UP:Q07698" (("ABCA" 4)))
 ("UP:Q07749" (("unc-60" 3) ("UNC-60" 2))) ("UP:Q07758" (("NODs" 1)))
 ("UP:Q07788"
  (("COS7" 344) ("Cos7" 86) ("PMA-treated COS7" 1)
   ("Only MET -transfected COS7" 1)))
 ("UP:Q07794" (("Rtt109" 33) ("rtt109" 7) (NIL 3)))
 ("UP:Q07812"
  (("Bax" 11516) ("BAX" 3370) ("bax" 669) ("Bax protein" 199)
   ("BAX protein" 83) ("BSI" 70) ("pro-apoptotic Bax" 39)
   ("the pro-apoptotic protein Bax" 33) ("Bax−" 26) ("bax protein" 22)
   ("Bax-" 19) ("Bax molecule" 17) ("pro-apoptotic protein Bax" 12)
   ("pro-apoptotic BAX" 10) ("monomeric Bax" 9) ("the pro-apoptotic Bax" 9)
   ("proapoptotic Bax" 9) ("pBax" 8) ("monomeric BAX" 8) ("proapoptotic BAX" 8)
   ("overexpressed Bax" 8) ("BAX-" 7) ("-Bax" 7) ("apoptosis regulator BAX" 7)
   ("-BAX" 6) ("the pro-apoptotic factor Bax" 5) ("cellular Bax" 5)
   ("Q07812" 5) ("intact Bax" 5) ("pro-apoptotic Bax protein" 4)
   ("the pro-apoptotic protein BAX" 4) ("the proapoptotic Bax" 4)
   ("membrane associated bax" 4) ("p-Bax" 4) ("the pro-apoptotic factor BAX" 4)
   ("detergent-soluble Bax" 4) ("Bax  protein" 3) ("soluble Bax" 3)
   ("N-terminally EGFP-tagged pro-apoptotic Bax" 3)
   ("the pro-apoptotic Bcl-2 family member Bax" 3) ("the pro-apoptotic BAX" 3)
   ("Yeast-expressing galactose-inducible Bax" 3)
   ("the proapoptotic BAX protein" 3) ("BAX peptide" 3) ("more Bax" 3)
   ("the pro-apoptotic BCL2 family protein BAX" 3) ("pro-apoptotic gene BAX" 2)
   ("the pro-apoptotic Bcl-2 family members Bax" 2) ("apoptotic BAX" 2)
   ("pro-apoptotic molecule Bax" 2) ("exogenous BAX" 2) ("soluble bax" 2)
   ("soluble monomeric bax" 2) ("purified monomeric human bax" 2)
   ("the both the BAX" 2) ("exclusively monomeric membrane-bound Bax" 2)
   ("the lysine-null Bax" 2) ("a lysine-null Bax" 2) ("than BAX" 2)
   ("respective human Bax" 2) ("its pro-apoptotic binding partner BAX" 2)
   ("the pro-apoptotic Bax protein" 2)
   ("mitochondrial-derived immunoprecipitated Bax" 2)
   ("the pro-apoptotic gene Bax" 2) ("Bax peptide" 2) ("Bax(P168A) protein" 2)
   ("the TRAIL-treated HCT116 Bax" 2) ("oligomerized BAX" 2)
   ("pro-apoptotic BAX protein" 2)
   ("N-terminal conformationally-activated BAX" 2) ("considerably less Bax" 2)
   ("less Bax" 2) ("conformationally-changed Bax" 2) ("monoclonal anti Bax" 2)
   ("the pro-apoptotic Bcl2 family protein Bax" 2)
   ("the Bcl-2 pro-apoptotic protein Bax" 2)
   ("high molecular weight oligomerized endogenous Bax" 2)
   ("light membrane-associated Bax" 2) ("than Bax" 2)
   ("mouse monoclonal Bax" 2) ("the apoptogenic Bax protein" 2)
   ("activated BH3-multidomain proapoptotic bax protein" 2)
   ("p53-depedent Bax" 2) ("a strong mitochondrial Bax" 2)
   ("strong mitochondrial Bax" 2) ("BAX−" 2)
   ("the pro-apoptotic Bcl2 family member Bax" 1)
   ("the NH 2 -terminal 19 amino acids of Bax" 1) ("most cases Bax" 1)
   ("the well-characterized p53 target genes BAX" 1)
   ("considerably less mitochondrion-associated BAX" 1)
   ("proapoptotic BAX protein" 1) ("14-3-3 associated Bax" 1)
   ("than Bax ( p < 0.01 vs. p < 0.05, xref )" 1) ("the soluble bax protein" 1)
   ("cytosolic monomeric Bax" 1) ("apoptotic Bax protein" 1) ("BaX" 1)
   ("the pro-apoptotic molecule Bax" 1) ("healthy cells Bax" 1)
   ("Yeast-expressing Bax" 1) ("pBax-" 1) ("stably membrane-bound Bax" 1)
   ("apoptosis identified two specific lysines of Bax that are critical" 1)
   ("genetically neither Bax-" 1)
   ("BCL-2 BH4 SAHB A co-precipitated native BAX" 1)
   ("pro-apoptotic member Bax" 1) ("pro-apoptotic factor BAX" 1)
   ("membrane-associated Bax" 1) ("oligomerized Bax" 1)
   ("The proapoptotic BAX" 1) ("the pro-apoptotic gene bax" 1)
   ("excess pro-apoptotic Bax" 1) ("than Bax in vitro" 1)
   ("the first 20 amino acids of Bax ( xref A)" 1)
   ("the last 21, 22, and 23 amino acids of Bax" 1)
   ("conformationally-altered Bax" 1) ("an exogenous BAX protein" 1)
   ("inactive monomeric BAX" 1) ("most Bax" 1) ("Most Bax" 1)
   ("The pro-apoptotic member Bax" 1) ("immunoprecipitable Bax" 1)
   ("the pro-apoptotic target gene BAX" 1) ("than wt Bax ( xref )" 1)
   ("associated Bax" 1) ("minimal Bax" 1) ("mitochondrial-bound Bax" 1)
   ("α-helical Bax" 1) ("exclusively MOMP-incompatible monomeric Bax" 1)
   ("previously ( xref , xref ) pE1B- BAX" 1) ("pro-apoptotoic Bax" 1)
   ("the pro-apoptotic gene BAX" 1) ("The pro-apoptotic protein Bax" 1)
   ("The pro-apoptotic Bax protein" 1) ("MOAP-1 activated less Bax" 1)
   ("HCT116 p53+/+ cells further confirming p53-dependent Bax" 1)
   ("BAX_HUMAN" 1) ("oligomeric Bax" 1) ("discrete Bax" 1)
   ("the pro-apoptotic Bcl-2 family proteins Bax" 1) ("healthy cells BAX" 1)
   ("pro-apoptotic bax" 1) ("the apoptogenic protein Bax" 1)
   ("down regulated pro-apoptotic protein Bax" 1) ("The pro-apoptotic Bax" 1)))
 ("UP:Q07817"
  (("Bcl-xL" 4556) ("Bcl-x L" 1826) ("BclXL" 1139) ("Bcl-XL" 743)
   ("BCL-xL" 557) ("Bcl-xl" 514) ("BCL-XL" 386) ("BCL2L1" 244) ("BclxL" 86)
   ("Bcl-xL protein" 61) ("Bcl-xs" 61) ("bcl-xL" 58) ("BclX" 51) ("BCLX" 48)
   ("Bcl-xS" 46) ("Bcl2l1" 44) ("Bcl-Xl" 39) ("BCLXL" 21) ("BcL-xL" 21)
   ("BCLxL" 18) ("Bcl2L" 14) ("Bcl-2L" 9) ("Bclx" 9) ("p-Bcl-xL" 8)
   ("Bcl-xL-" 7) ("overexpressed Bcl-x L" 6) ("overexpressed Bcl-xL" 6)
   ("BCL-XL protein" 6) ("BCL-xL protein" 6) ("-Bcl-xL" 6) ("Bcl-x protein" 6)
   ("Bcl-xl protein" 6) ("Cerulean BCL-xL" 5) ("Bcl-XL protein" 5) ("bclxl" 5)
   ("BcL-XL" 5) ("bcl-XL" 4) ("BCL2L" 4) ("overexpressing Bcl-x L" 4)
   ("Bcl-xL(ΔTM) protein" 3) ("Bclxl" 2) ("Overexpressed untagged Bcl-xL" 2)
   ("overexpressed untagged Bcl-xL" 2) ("Bcl-xS protein" 2)
   ("dual mutant Bcl-xL" 2) ("N-terminal-YFP-tagged Bcl-XL" 2) ("Bcl-Xs" 2)
   ("moderate-to-strong Bcl-xL" 2) ("than Bcl-XL" 2) ("BCL-xL-" 2)
   ("−Bcl-xL" 2) ("Bcl2L1" 2) ("targeting Bcl-xL" 2) ("antiapoptotic BCL2L1" 2)
   ("pBcl-xL" 2) ("Bcl-x L protein" 2) ("BClXL" 2)
   ("anti apoptotic proteins Bcl-XL" 2) ("than Bcl-xL" 2) ("targeted Bcl-xL" 2)
   ("Bcl-xL molecule" 2) ("-BCL-xL" 2)
   ("than those expressing wild-type Bcl-x L ( xref )" 1)
   ("the prosurvival Bcl-2 family protein Bcl-x L" 1) ("BclXL-" 1)
   ("e.g. Q207 Bcl-xl" 1) ("than wild type Bcl-x L" 1)
   ("stably overexpressed untagged Bcl-xL" 1) ("Bcl-XS" 1)
   ("principally contact BCL-xL" 1) ("monoclonal rabbit anti-human Bcl-xL" 1)
   ("SV40 TAg-transformed MEFs overexpressing Bcl-x L" 1)
   ("than Bcl-x L ( xref C)" 1)
   ("pro-apoptotic BAX and anti-apoptotic BCL-XL" 1)
   ("autophagic cells Bcl-xL" 1) ("the thymic Bcl2l1" 1)
   ("Antiapoptotic BCL-xL" 1) ("a chimeric BCL-xL protein" 1)
   ("than Bcl-xl (BH1 and BH2 region)" 1) ("shorter fragment Bcl-xs" 1)
   ("longer fragment Bcl-xl" 1) ("cellular Bcl-xL" 1) ("bcl-XS" 1)
   ("Both intact Bcl-xL" 1) ("than Bcl-XL it was" 1) ("BCL-Xs" 1)
   ("-Bcl-x L" 1) ("the differential Bcl-xL" 1) ("Bcl-2L1" 1)
   ("exogenous Bcl-x L" 1) ("directly target BCL-XL" 1)
   ("the N-terminal 28 amino acids of human Bcl-x L" 1)
   ("low-expressed Bcl-xL" 1) ("highly-expressed Bcl-xL" 1)))
 ("UP:Q07820"
  (("Mcl-1" 4923) ("MCL1" 655) ("MCL-1" 498) ("Mcl1" 219) ("Mcl-1 protein" 113)
   ("mcl-1" 19) ("MCL1 protein" 14) ("MCL-1 protein" 9) ("-Mcl-1" 4) ("mcl1" 4)
   ("targeting Mcl-1" 4) ("than Mcl-1" 3) ("the prosurvival factor MCL1" 3)
   ("much more MCL-1" 2) ("pMcl1" 2) ("Overexpressed Mcl-1" 2)
   ("acute ABT-199 treatment MCL-1" 2) ("this residual Mcl1" 2)
   ("the prosurvival Bcl-2 family member Mcl-1" 2) ("prosurvival Mcl-1" 2)
   ("the residual MCL1" 2) ("MCL-1 Protein" 2) ("antiapoptotic MCL1" 2)
   ("Mcl-1-" 1) ("Mcl1-" 1) ("expressing Mcl-1" 1)
   ("both DLD1 and Bid −/− MEFs expressed less Mcl-1" 1) ("than WT Mcl-1" 1)
   ("nondegradable MCL1" 1) ("more MCL1" 1)
   ("pro-apoptotic Bim and anti-apoptotic Mcl-1" 1)
   ("exogenous HA-tagged Mcl-1" 1) ("the classical proteasome target MCL-1" 1)
   ("pro-apoptotic Bax and anti-apoptotic Mcl-1" 1)
   ("only slightly more Mcl-1 protein" 1)
   ("both pro-apoptotic Bak and pro-survival Mcl-1" 1)
   ("similarly targets Mcl-1" 1) ("MCL1-" 1)))
 ("UP:Q07835" (("YxxF" 1))) ("UP:Q07837" (("SLC3A1" 3) ("D2H" 1)))
 ("UP:Q07864"
  (("pole" 405) ("POLE" 42) ("Pole" 5) ("the apical pole" 3)
   ("the basal pole" 3) ("POLE1" 2) ("the basolateral pole" 2) ("lower pole" 2)
   ("around either pole" 2) ("a distinct pole" 2) ("Polɛ" 2)
   ("the distal pole" 2) ("the entire basal pole" 1) ("an acentriolar pole" 1)
   ("the incorrect pole" 1) ("syncytial pole" 1) ("an apical pole" 1)
   ("one bacterial pole" 1) ("the upper pole" 1) ("the distal T cell pole" 1)))
 ("UP:Q07866" (("KLC1" 17) ("kinesin light chain 1" 3) ("KLC" 3)))
 ("UP:Q07869"
  (("PPARα" 334) ("PPAR" 227) ("PPARs" 75) ("PPARA" 16) ("Ppar" 13)
   ("PPAR-α" 9) ("peroxisome proliferator-activated receptor alpha" 9)
   ("peroxisome-proliferator-activated receptor" 7) ("PPAR-" 5) ("Pparα" 3)
   ("than PPARα" 1) ("PPARα protein" 1) ("NR1C1" 1) ("PPARalpha" 1)
   ("PPARα-" 1)))
 ("UP:Q07889"
  (("SOS1" 685) ("Sos1" 577) ("sos1" 81) ("Sos1 peptide" 46) ("SOS-1" 12)
   ("SOS1-" 5) ("SOS1 protein" 4) ("Sos-1" 3) ("SOS1 peptide" 2)
   ("cellular sos1" 2) ("SOS1 molecule" 2) ("than Sos1" 1)
   ("MEF increased sos1" 1) ("the SOS1's" 1) ("SOS-1 protein" 1)))
 ("UP:Q07890" (("SOS2" 38) ("Sos2" 3)))
 ("UP:Q07912"
  (("ACK1" 401) ("Ack1" 242) ("TNK2" 125) ("monoubiquitin" 74) ("Ac-K" 24)
   ("ACK-1" 18) ("Tnk2" 4) ("available pTyr284-Ack1" 4)
   ("mouse monoclonal TNK2" 2) ("ACK1 protein" 2) ("Ack1 protein" 1)))
 ("UP:Q07930" (("PML1" 5) ("Pml1" 1)))
 ("UP:Q07954"
  (("LRP1" 302) ("APR" 55) ("Apr" 8) ("Lrp1" 6) ("pLRP-ICD" 5)
   ("LRP1 molecule" 2) ("LRP1 protein" 2) ("LRP-ICD" 1)
   ("the first 409 amino acids of LRP1" 1) ("apr" 1) ("APR peptide" 1)))
 ("UP:Q07955"
  (("SF2" 466) ("SRSF1" 249) ("Asf1" 115) ("SRp30a" 89) ("ASF1" 74) ("asf1" 24)
   ("sf2" 7) ("serine/arginine-rich splicing factor 1" 5)
   ("the Ser/Arg-rich (SR) protein serine/arginine-rich splicing factor 1" 2)
   ("the serine/arginine-rich protein serine/arginine-rich splicing factor 1"
    2)
   ("Asf1 protein" 2) ("a new ASF1" 2) ("than SRSF1" 1)
   ("splicing factor, arginine/serine-rich 1" 1) ("Sf2" 1) ("SFRS1" 1)))
 ("UP:Q07957" (("USFs" 1)))
 ("UP:Q07960"
  (("p50RhoGAP" 136) ("ARHGAP1" 28) ("Cdc42GAP" 27) ("RhoGAP1" 4)
   ("CDC42GAP" 2) ("Rho GTPase activating protein 1" 2) ("p50rhoGAP" 1)
   ("Q07960" 1)))
 ("UP:Q07973" (("CYP24A1" 161) ("CYP24" 129) ("Cyp24A1" 1)))
 ("UP:Q07980" (("MLH2" 2) (NIL 1))) ("UP:Q07982" (("GFO" 1)))
 ("UP:Q07998" (("NTL" 16) ("ntl" 4))) ("UP:Q07CK6" (("M67" 17) ("m67" 13)))
 ("UP:Q08012" (("drk" 3) ("DRK" 3) ("Drk" 1)))
 ("UP:Q08043" (("alpha 3" 8) ("ACTN3" 3) ("Alpha 3" 1)))
 ("UP:Q08047" (("SBE1" 10)))
 ("UP:Q08050"
  (("FOXM1" 1698) ("FoxM1" 1172) ("Foxm1" 126) ("FOXM1 protein" 35) ("WIN" 15)
   ("HNF-3" 14) ("Forkhead Box M1" 13) ("Win" 13) ("Forkhead box M1" 11)
   ("FOXM1b" 9) ("forkhead box protein M1" 8) ("Foxm1b" 8) ("-FoxM1b" 8)
   ("HNF3" 7) ("win" 7) ("forkhead box M1" 5) ("FoxM1 protein" 5) ("FOXM1B" 5)
   ("trident" 4) ("FOXM1 Protein" 4) ("FoxM1B" 3) ("Forkhead box protein M1" 3)
   ("Foxm1 protein" 3) ("HFH-11" 3) ("overexpressed FoxM1" 3) ("FoxM1b" 3)
   ("Forkhead box M1 protein" 2) ("Trident" 2) ("exogenous FOXM1" 1)
   ("the well-characterized FOXM1" 1)
   ("mitotic transcriptional regulator FOXM1" 1) ("“win-win”" 1) ("“WIN”" 1)
   ("the transcriptional factor FoxM1" 1) ("we first found FoxM1" 1)
   ("competitive displacing FOXM1" 1) ("specifically target FOXM1" 1)
   ("the resultant FOXM1 protein" 1)))
 ("UP:Q08116"
  (("RGS1" 107) ("RGS1 protein" 8) ("cellular RGS1" 1) ("Negligible RGS1" 1)
   ("Rgs1" 1)))
 ("UP:Q08117"
  (("AEs" 213) ("AES" 16) ("serious AEs" 4)
   ("Amino-terminal enhancer of split (AES)" 4) ("most AEs" 2)
   ("Treatment-emergent and treatment-related AEs" 2)
   ("treatment-related serious AEs" 2) ("fatal AEs" 2) ("GRG" 2) ("Grg" 2)
   ("amino-terminal enhancer of split" 1)
   ("The only lapatinib-related serious AEs" 1) ("27 non-fatal serious AEs" 1)
   ("Fewer grade 3/4 AEs" 1) ("Amino-terminal enhancer of split" 1)
   ("Treatment-related serious AEs" 1)))
 ("UP:Q08168"
  (("HRP" 4405) ("-HRP" 44) ("HRP-" 12)
   ("secondary antibody anti rabbit-HRP" 12) ("DAKO" 10) ("HRP (DAKO)" 4)
   ("secondary antibody anti mouse-HRP" 4) ("secondary HRP" 4)
   ("secondary mAB anti-goat HRP" 3) ("the dual link system-HRP" 2)
   ("appropriate HRP" 2) ("the appropriate HRP" 2)
   ("The monoclonal anti-c-myc HRP" 2) ("EnVision + Dual Link System–HRP" 2)
   ("the secondary antibodies ECL anti-rabbit IgG HRP" 2)
   ("secondary antibody anti guinea pig-HRP" 2)
   ("secondary antibody anti rat-HRP" 2) ("HRP (DAB)" 2) ("‐HRP" 2)
   ("secondary goat anti- rabbit HRP" 2)
   ("the secondary antibodies goat anti mouse-HRP" 2)
   ("Goat α-Rabbit IgG (H+L)-HRP and Goat α-Mouse IgG (H+L)-HRP" 2) ("HrP" 1)
   ("Secondary HRP" 1) ("the respective HRP" 1) ("hrp" 1)
   ("secondary antibodies, anti-mouse and anti-rabbit HRP" 1)
   ("Dual Link System-HRP" 1) ("–HRP" 1)
   ("Secondary goat anti-rabbit and goat anti-mouse HRP" 1)
   ("respective HRP" 1) ("HRP–" 1) ("Secondary donkey anti-rabbit IgG HRP" 1)
   ("complementary HRP" 1)
   ("Monoclonal anti-Flag antibody and anti-Flag HRP" 1)))
 ("UP:Q08170" (("SFRS4" 3) ("SRSF4" 1) ("SRp75" 1)))
 ("UP:Q08174" (("PCDH1" 2))) ("UP:Q08176" (("MIM1" 7)))
 ("UP:Q08188" (("TGM3" 30) ("TGE" 4) ("Transglutaminase 3" 2) ("Tgm3" 1)))
 ("UP:Q08193"
  (("GAS5" 432) ("abnormal and dysregulated GAS5" 1) ("Gas5" 1)
   ("than full-length GAS5 (GAS5-FL)" 1)))
 ("UP:Q08209"
  (("CNA" 479) ("CNAs" 464) ("alpha isoform" 57) ("focal CNAs" 10) ("PPP3CA" 7)
   ("CNA-" 7) ("Recurrent CNAs" 4) ("protein phosphatase 2B" 3) ("pCALN" 2)
   ("Regions of Interest Encompassing Focal and Recurrent CNAs" 2)
   ("more CNAs" 2) ("recurrent CNAs" 2) ("focal amplification CNAs" 2)
   ("regional CNAs" 2) ("CNA (BC)" 2) ("CNA (MC)" 2) ("CALN" 2)
   ("the most common broad CNAs" 2) ("calcineurin A alpha" 2)
   ("their characteristic CNAs" 2) ("Alpha isoform" 2)
   ("especially small-sized CNAs" 2) ("a given CNA" 1)
   ("ranks many previously unrecognized CNAs" 1) ("any given CNA" 1)
   ("the genome-wide CNA" 1) ("centromeric CNA" 1) ("other telomeric CNA" 1)
   ("frequent focal length CNAs" 1) ("focal and whole arm CNAs" 1)
   ("significantly more frequent whole chromosome arm CNAs" 1)
   ("focal or targeted CNAs" 1) ("frequent focal CNAs" 1)
   ("than focal amplification CNAs ( BRAF mut/MSS p = 0.004, BRAF wt/MSS p = 0.03)"
    1)
   ("all cohorts focal deletion CNAs" 1) ("substantially fewer focal CNAs" 1)
   ("23.2 focal CNAs" 1) ("than amplification CNAs" 1) ("Continuous CNAs" 1)
   ("the major alpha isoform" 1) ("CnA" 1) ("The most frequent CNAs" 1)
   ("non-focal CNA" 1) ("protein phosphatase 3" 1) ("genome-wide CNAs" 1)
   ("genome-wide CNA" 1) ("the simultaneous subtype-specific CNAs" 1)
   ("genomic CNAs" 1) ("These major CNAs" 1)
   ("protein phosphatase 3 catalytic subunit alpha" 1) ("Genome-wide CNAs" 1)))
 ("UP:Q08211"
  (("DHX9" 53) ("RNA helicase A" 46) ("rHA" 3) ("RNA helicase A (RHA)" 2)
   ("overexpressed DHX9" 2) ("LKP" 1) ("dominant-negative truncated DHX9" 1)
   ("DDX9" 1)))
 ("UP:Q08214" (("Ntg2" 4)))
 ("UP:Q08231"
  (("THP1" 172) ("Monocytic cell line THP1" 2)
   ("myelomonocytic leukemia THP1" 1)
   ("The human monocytic leukemia cell line THP1" 1)))
 ("UP:Q08236" (("Avo1" 1)))
 ("UP:Q08257"
  (("quinone oxidoreductase" 130) ("quinone" 130) ("CRYZ" 29) ("-quinone" 4)
   ("quinone
oxidoreductase"
    1)
   ("Quinone Oxidoreductase" 1) ("Quinone oxidoreductase" 1) ("Quinone" 1)
   ("quinoneoxidoreductase" 1)))
 ("UP:Q08281" (("Sea2" 1))) ("UP:Q08289" (("CACNB2" 26)))
 ("UP:Q08334" (("IL10RB" 32) ("IL-10R2" 25) ("IL-10RB" 22) ("IL10RB-" 1)))
 ("UP:Q08345"
  (("DDR1" 67) ("discoidin domain receptor 1" 6) ("DDR1 protein" 3) ("TRKE" 3)
   ("discoidin domain receptor" 2)
   ("discoidin domain receptor tyrosine kinase 1" 2)))
 ("UP:Q08357"
  (("murine leukemia virus" 139) ("MLV" 75) ("SLC20A2" 25) ("Pit-2" 13)
   ("PiT2" 5) ("sodium-dependent phosphate transporter 2" 4) ("RAM-1" 3)
   ("Murine leukemia virus" 2) ("murine leukemia virus (MLV)" 2)
   ("murine leukemia virus (MMLV)" 2)
   ("solute carrier family 20 (phosphate transporter)" 1)
   ("amphotropic murine leukemia virus (MLV)" 1)
   ("amphotropic murine leukemia virus" 1) ("DLL- mutant N-tropic MLV" 1)
   ("Murine leukemia virus (MLV)" 1)))
 ("UP:Q08370" (("HRMA" 104) ("an aberrant HRMA" 2)))
 ("UP:Q08378" (("golgin-160" 123) ("Golgin-160" 30)))
 ("UP:Q08379"
  (("GM130" 341) ("GOLGA2" 16) ("Golgi matrix protein GM130" 9)
   ("-Golgi matrix protein GM130" 6) ("-GM130" 1)))
 ("UP:Q08380"
  (("90K" 14) ("galactoside-binding" 8) ("LGALS3BP" 7)
   ("Galectin-3-binding protein" 2) ("-galactoside-binding" 1)))
 ("UP:Q08397" (("LOXL1" 6)))
 ("UP:Q08426" (("EHHADH" 2) ("PBE" 2) ("Ehhadh" 1)))
 ("UP:Q08431"
  (("MFG-E8" 121) ("BA46" 20) ("MFGE8" 19) ("lactadherin" 3)
   ("milk fat globule" 3) ("MFG-E8 protein" 2) ("whose MFG-E8" 1)
   ("exogenous MFGE8" 1) ("HMFG" 1)))
 ("UP:Q08462" (("ADCY2" 3))) ("UP:Q08477" (("CYP4F3" 8)))
 ("UP:Q08481" (("PECAM" 43))) ("UP:Q08493" (("PDE4C" 1)))
 ("UP:Q08495" (("DMT" 3) ("much needed female-specific DMT" 1)))
 ("UP:Q08499" (("PDE4D" 40)))
 ("UP:Q08548" (("lysophospholipid acyltransferase" 1) ("AGPAT" 1)))
 ("UP:Q08554" (("DSC1" 3) ("desmocollin 1" 1)))
 ("UP:Q08601" (("metacaspase" 5)))
 ("UP:Q08605" (("GAGA" 10) ("GAGA factor" 2))) ("UP:Q08629" (("SPOCK1" 2)))
 ("UP:Q08641" (("Abp140" 5))) ("UP:Q08648" (("EP2" 127) ("EP-2" 5)))
 ("UP:Q08708" (("CD300C" 2)))
 ("UP:Q08722"
  (("IAPs" 253) ("CD47" 196) ("integrin-associated protein" 7)
   ("proteins called IAPs" 2) ("CD47 protein" 2) ("overexpressed IAPs" 2)
   ("cellular IAPs" 1) ("OA3" 1) ("than individual IAPs in vivo" 1)))
 ("UP:Q08752"
  (("CyP40" 141) ("Cyp40" 29) ("CYP40" 6) ("the cellular CyP40" 5)
   ("CyP40 protein" 5) ("Cyclophilin 40" 4) ("PPID" 1) ("cyclophilin 40" 1)))
 ("UP:Q08755" (("CL6" 18))) ("UP:Q08773" (("Isw2" 2)))
 ("UP:Q08828" (("adenylyl cyclase 1" 2))) ("UP:Q08830" (("Fgl1" 9) ("FGL1" 7)))
 ("UP:Q08881"
  (("Itk" 275) ("ITK" 22) ("T-cell kinase" 6) ("LYK" 5) ("itk" 2)
   ("than Itk" 1) ("Lyk" 1) ("a key T-cell kinase" 1)))
 ("UP:Q08886"
  (("Gbeta" 3) ("Gpb1" 3) ("GPB-1" 3) ("G-protein subunit" 2) ("gpb1" 2)
   ("GPB1" 2)))
 ("UP:Q08887" (("Ndd1" 3))) ("UP:Q08907" (("FIT3" 1)))
 ("UP:Q08921" (("tco89" 2))) ("UP:Q08924" (("ERE2" 37)))
 ("UP:Q08945"
  (("SSRP1" 133) ("T160" 40) ("nucleolar SSRP1" 4) ("SSRP1 protein" 3)
   ("structure specific recognition protein 1" 3)))
 ("UP:Q08966" (("Pcl8" 1))) ("UP:Q08969" (("GRE1" 5)))
 ("UP:Q08981" (("Acm1" 16)))
 ("UP:Q08999"
  (("p130" 625) ("p1–30" 195) ("RBL2" 120) ("Rbl2" 58) ("Rb2" 21) ("RB2" 21)
   ("P130" 7) ("retinoblastoma-like 2" 6) ("p130 (RBL2)" 5)
   ("Retinoblastoma-like 2" 4) ("RBL2 protein" 4) ("p1–30 peptide" 3)
   ("ample p130" 2) ("tetrameric p1–30" 2) ("genuine p1–30" 2)
   ("the antimitogenic p130" 2) ("p130 (MRYQHPPEYGAARP)" 2) ("p-p130" 1)
   ("rb2" 1) ("just hypophosphorylated p130" 1)))
 ("UP:Q08AH1" (("MACS1" 4) ("LAE" 1) ("ACSM1" 1))) ("UP:Q08AH3" (("MACS2" 9)))
 ("UP:Q08AM6" (("ArPIKfyve" 21) ("VAC14" 7) ("ArPIKFyve" 2)))
 ("UP:Q08DD1" (("ASA" 72)))
 ("UP:Q08DE6" (("aquaporin-3" 14) ("AQP-3" 4) ("Aquaporin-3" 1)))
 ("UP:Q08DY6" (("E2F-6" 3)))
 ("UP:Q09013"
  (("DMPK" 141) ("myotonic dystrophy protein kinase" 9)
   ("dystrophia myotonica protein kinase" 5)
   ("myotonic dystrophy protein kinase (DMPK)" 2)
   ("the cytoplasmic dimeric protein dystrophia myotonica protein kinase" 1)
   ("most DMPK" 1)))
 ("UP:Q09019" (("DMWD" 6)))
 ("UP:Q09020" (("PR4" 52) ("unlabeled duplex PR4" 1)))
 ("UP:Q09028"
  (("RbAp48" 155) ("RBBP4" 91) ("lin-53" 16) ("LIN-53" 7) ("LIN-53 protein" 3)
   ("retinoblastoma binding protein 4" 3) ("RbAP48" 3) ("cellular RBBP4" 2)
   ("Nurf55" 2) ("NURF55" 2) ("RbAp48 protein" 1)
   ("than RbAp48 in the absence of hormone" 1) ("Rbbp4" 1)))
 ("UP:Q09090"
  (("OspB" 136) ("ospB" 40) ("pOspB" 2)
   ("47 amino acids (44 - 91) of OspB" 1)))
 ("UP:Q09147" (("FR2" 5)))
 ("UP:Q09161"
  (("CBP80" 50) ("80kDa" 6) ("only one single band around 80kDa" 1)
   ("around 80kDa" 1) ("80KD" 1) ("a constitutively active form around 80kD" 1)
   ("80kD" 1)))
 ("UP:Q09163" (("preadipocyte factor 1" 3)))
 ("UP:Q09312" (("FBF" 88) ("basal FBF" 3))) ("UP:Q09323" (("GnT" 5) ("gNT" 1)))
 ("UP:Q09327" (("GnT-III" 1)))
 ("UP:Q09328" (("MGAT5" 4) ("Mgat5" 1) ("GnT-V" 1)))
 ("UP:Q09428"
  (("hyperglycemia" 587) ("Hyperglycemia" 58) ("Sur" 42) ("sur" 26)
   ("ABCC8" 24) ("SUR" 12) ("maternal hyperglycemia" 8) ("SUR1" 8)
   ("frank hyperglycemia" 4) ("chronic hyperglycemia" 3)
   ("sustained maternal hyperglycemia" 2) ("postprandial hyperglycemia" 2)
   ("resultant hyperglycemia" 2) ("stress-induced hyperglycemia" 2)
   ("mild hyperglycemia" 2) ("post-prandial hyperglycemia" 1)
   ("Maternal hyperglycemia" 1) ("Reversible hyperglycemia" 1)
   ("Mst1 prevented progressive hyperglycemia" 1)
   ("progressive hyperglycemia" 1)
   ("pancreatic β-cells developed progressive hyperglycemia" 1) ("PHHI" 1)
   ("than the hyperglycemia" 1) ("severe hyperglycemia" 1)
   ("the multiethnic Hyperglycemia" 1) ("treatment associated hyperglycemia" 1)
   ("hyperglycemia-" 1) ("High fat diet-induced hyperglycemia" 1)
   ("éthique de la recherche sur" 1)))
 ("UP:Q09433" (("thioredoxin1" 1)))
 ("UP:Q09470"
  (("potassium voltage-gated channel" 6) ("Potassium voltage-gated channel" 4)
   ("Kv1.1" 1) ("shaker-related subfamily" 1)))
 ("UP:Q09472"
  (("p300" 6317) ("EP300" 210) ("P300" 146) ("p300 HAT" 87) ("p300 protein" 75)
   ("histone acetyltransferase p300" 42) ("p300-" 12)
   ("Histone acetyltransferase p300" 5) ("p300 molecule" 5)
   ("p53-associated p300" 4) ("KAT3B" 3)
   ("the transcriptional co-activator p300" 3)
   ("p300
 protein"
    3)
   ("-p300" 3) ("P300 HAT" 3) ("its transcriptional co-activator p300" 2)
   ("p300 and CREB-Binding Protein (CBP)" 2) ("p300 (CBP)" 2)
   ("cellular p300" 2) ("transcriptional co-activator p300" 2) ("more p300" 1)
   ("The E1A-associated cellular p300" 1)
   ("the transcriptional coactivators/acetyltransferase p300" 1)
   ("transcriptional co-activator and histone acetyl transferase (HAT) p300" 1)
   ("significantly less p300" 1) ("the transcriptional coactivators p300" 1)
   ("–P300" 1) ("p300–" 1) ("EP300−" 1) ("significantly less p300 protein" 1)
   ("than p300" 1) ("p300HAT" 1) ("these p300’s" 1)
   ("a nearly full-length p300 protein" 1)
   ("Transcriptional co-activator p300" 1)
   ("the same transcriptional co-activator p300" 1)))
 ("UP:Q09510"
  (("MRLC" 123) ("myosin regulatory light chain" 19) ("p-MRLC" 6) ("-MRLC" 4)
   ("myosin regulatory light chain (MRLC)" 4)))
 ("UP:Q09553" (("PHAS-1" 18) ("PHAS-1 protein" 1)))
 ("UP:Q09630" (("mgL −1" 1)))
 ("UP:Q09666"
  (("AHNAK" 265) ("AHNAK protein" 11) ("Q09666" 2)
   ("the membrane-associated AHNAK" 1)
   ("the last 575 and 213 amino acids of AHNAK" 1)
   ("the COOH-terminal 998 amino acids of AHNAK ( xref )" 1)
   ("the last 998 amino acids of AHNAK (EGFP-C998)" 1)
   ("the last 213 amino acids of AHNAK (between positions 5431 and 5643)" 1)
   ("–AHNAK" 1)))
 ("UP:Q09811" (("Rqh1" 2) ("RQH1" 1) ("rEC9" 1))) ("UP:Q09815" (("pPK5" 2)))
 ("UP:Q09821" (("TP4" 2))) ("UP:Q09851" (("ADR" 460) ("Adr" 57) ("adr" 17)))
 ("UP:Q09912"
  (("PSI" 143) ("psi" 64) ("pSI" 4) ("Psi" 3) ("topical PSI" 2) ("pSi" 1)
   ("topical or intraperitoneal PSI" 1)))
 ("UP:Q09990" (("LIN-23" 2)))
 ("UP:Q09LL3"
  (("BBD" 176) ("proliferative BBD" 8) ("nonproliferative BBD" 4)
   ("non-proliferative BBD" 2) ("histologically ‘nonproliferative' BBD" 2)
   ("a major BBD" 1) ("the self-reported BBD" 1) ("10% proliferative BBD" 1)))
 ("UP:Q09MP3"
  (("RAD51AP2" 199) ("RAD51AP2 protein" 12) ("RAD51 Associated Protein 2" 3)
   ("the last 57 amino acids of RAD51AP2 (RAD51AP2-ΔC57)" 1)
   ("the last 92 amino acids of RAD51AP2" 1)
   ("the last 92 amino acids of RAD51AP2 (C92)" 1)))
 ("UP:Q0D2I5" (("HOM-TES-103" 8)))
 ("UP:Q0GE19" (("P7" 160) ("than P7" 1) ("postnatal day P7" 1)))
 ("UP:Q0H8C5" (("nsp1" 16) ("Nsp1" 3))) ("UP:Q0H8Z1" (("RNL" 10)))
 ("UP:Q0IES8" (("MAb21" 1))) ("UP:Q0IFL2" (("Pontin" 73) ("pontin" 9)))
 ("UP:Q0IH24"
  (("clamp" 1042) ("Clamp" 42) ("the hyperinsulinemic clamp" 9)
   ("hyperinsulinemic-euglycemic clamp" 8)
   ("a hyperinsulinemic-euglycemic clamp" 8) ("“clamp”" 7) ("CLAMP" 7)
   ("a euglycemic-hyperinsulinemic clamp" 4)
   ("Hyperinsulinemic-euglycemic clamp" 4)
   ("Euglycemic hyperinsulinemic clamp" 4) ("The bacterial clamp" 4)
   ("peptide nucleic acid-locked nucleic acid (PNA-LNA) PCR clamp" 3)
   ("a hyperglycemic clamp" 3) ("clamp protein" 3)
   ("hyperinsulinaemic clamp" 3) ("Hyperinsulinemic-Euglycemic Clamp" 2)
   ("a 4-hr hyperinsulinemic euglycemic clamp" 2) ("the euglycemic clamp" 2)
   ("Hyperglycemic clamp" 2) ("Euglycaemic clamp" 2) ("“rigid-clamp”" 2)
   ("underwent euglycemic-hyperinsulinemic clamp" 2)
   ("a 120-min hyperinsulinemic-euglycemic clamp" 2)
   ("a dual whole-cell voltage clamp" 1)
   ("A hyperinsulinemic-euglycemic clamp" 1)
   ("the hyperinsulinemic euglycemic clamp" 1)
   ("the peptide nucleic acid (PNA)-mediated PCR clamp" 1) ("-clamp" 1)
   ("a nontraumatic vascular clamp" 1) ("hyperglycemic clamp" 1)
   ("A 2-h euglycemic hyperinsulinemic clamp" 1)
   ("the euglycemic hyperinsulinemic clamp" 1)
   ("a 4-hr two-step hyperinsulinemic euglycemic clamp" 1)
   ("a 4-hour hyperinsulinemic euglycemic clamp" 1)
   ("the heterotrimeric clamp" 1)
   ("the heterotrimeric cell-cycle checkpoint clamp" 1)
   ("an evolutionarily-conserved ‘clamp’" 1) ("‘clamp’" 1)
   ("Hyperinsulinemic clamp" 1) ("the euglycemic-hyperinsulinemic clamp" 1)
   ("a 2-h (40 mU/m 2 per min) euglycemic-hyperinsulinemic clamp" 1)
   ("the hyperinsulinemic-euglycemic clamp" 1) ("the hyperglycaemic clamp" 1)
   ("the hyperglycemic clamp" 1) ("a 2-hour hyperglycemic clamp" 1)
   ("the trimeric PCNA clamp" 1) ("a microvascular clamp" 1)
   ("the peptide nucleic acid-locked nucleic acid polymerase chain reaction (PNA-LNA PCR) clamp"
    1)
   ("a euglycemic hyperinsulinemic clamp" 1)
   ("euglycemic-hyperinsulinemic clamp" 1)
   ("Peptide nucleic acid-locked nucleic acid PCR clamp" 1)
   ("peptide nucleic acid-locked nucleic acid PCR clamp" 1)
   ("a stereotactic clamp" 1) ("the dual electrode voltage clamp" 1)
   ("euglycemic hyperinsulinemic clamp" 1)
   ("the gold standard method euglycemic hyperinsulinemic clamp" 1)
   ("simultaneous whole cell patch clamp" 1)
   ("using euglycemic-hyperinsulinemic clamp" 1)))
 ("UP:Q0J8A4"
  (("p-p38" 267) ("pp38" 48) ("P-p38" 23) ("Pp38" 6) ("−p-p38" 2)
   ("the pro-apoptotic effector p-p38" 2) ("undetectable pp38" 2) ("“pp38”" 1)
   ("pro-apoptotic effector p-p38" 1)))
 ("UP:Q0JA75" (("Fc1" 6) ("FC1" 3)))
 ("UP:Q0JRZ9" (("FCHO2" 159) ("FCHO2 protein" 2) ("FCHO2-" 1)))
 ("UP:Q0KHY3" (("MeSH" 34) ("available MeSH" 1))) ("UP:Q0KIY6" (("MB2" 8)))
 ("UP:Q0NZX5" (("JT" 30))) ("UP:Q0P5A7" (("4E-BP-1" 18) ("p-4E-BP-1" 2)))
 ("UP:Q0P9X8" (("PEB1" 1))) ("UP:Q0PDM0" (("NS1a" 2)))
 ("UP:Q0PNE2" (("Elp6" 12) ("Atp1" 4) ("ATP1" 1))) ("UP:Q0Q469" (("NS8" 46)))
 ("UP:Q0QLE6" (("MII" 70) ("mII" 4))) ("UP:Q0QLF7" (("HNR" 5)))
 ("UP:Q0V7U7" (("LA-2" 3))) ("UP:Q0V7X4" (("FIT" 6)))
 ("UP:Q0V898" (("NelfE" 1)))
 ("UP:Q0VAF6" (("SYL" 6) ("syncollin" 5) ("Syncollin" 2)))
 ("UP:Q0VAP4" (("FANCA protein" 3))) ("UP:Q0VBL6" (("HIF3α" 3) ("HIF-3α" 2)))
 ("UP:Q0VCL6" (("NFI-B" 27) ("NFI-B-" 1)))
 ("UP:Q0VCR2" (("connexin40" 2) ("Connexin40" 1)))
 ("UP:Q0VD83" (("antipeptide" 8))) ("UP:Q0VD86" (("INCA1" 3)))
 ("UP:Q0VF96" (("JACOP" 1))) ("UP:Q0VG06" (("FAAP100" 24)))
 ("UP:Q0VGL1" (("C7orf59" 1))) ("UP:Q0VKZ4" (("ALKs" 6)))
 ("UP:Q0VZ41" (("ps8" 2))) ("UP:Q0W5A6" (("DHG" 2)))
 ("UP:Q0WL80" (("EBS1" 11) ("Ebs1" 4))) ("UP:Q0WML0" (("ALS1" 6)))
 ("UP:Q0WNR6" (("ARID5" 1))) ("UP:Q0WNZ5" (("MS3" 12)))
 ("UP:Q0WPU1" (("XII" 26) ("we first tested calpain inhibitor XII" 1)))
 ("UP:Q0WW26" (("γCOP" 3))) ("UP:Q0WX57" (("USP17" 1)))
 ("UP:Q0Z7S8" (("PERF" 3))) ("UP:Q0ZAQ8" (("PPARδ" 146)))
 ("UP:Q10318" (("DAD" 89)))
 ("UP:Q10417"
  (("mESC" 131) ("MeSC" 36) ("LIF/Stat3-dependent mESC" 2)
   ("mediated LIF/Stat3-dependent mESC" 1) ("The homozygous mutant mESC" 1)
   ("homozygous Shp2 null mutant mESC" 1) ("mESC-" 1)))
 ("UP:Q10459" (("MOM-2" 1)))
 ("UP:Q10471"
  (("GALNT2" 18) ("Galnt2" 8)
   ("polypeptide N-acetylgalactosaminyltransferase 2" 1)))
 ("UP:Q10472"
  (("polypeptide" 1536) ("GALNT1" 166) ("Polypeptide" 18)
   ("polypeptide (LMP)" 8) ("polypeptide (ELP)" 4)
   ("a cationic 86–101 amino acid polypeptide" 3)
   ("overexpressed C-terminal polypeptide" 3) ("polypeptide (TERT)" 3)
   ("a soluble ∼35 kD N-glycosylated polypeptide" 2)
   ("slower mobility polypeptide" 2) ("a relatively small polypeptide" 2)
   ("than the expected full-length polypeptide" 1)
   ("a soluble FZC18 polypeptide" 1)
   ("a multicomponent precursor polypeptide" 1)
   ("a monomeric E7 polypeptide" 1) ("polypeptide (DP)" 1)
   ("polypeptide ( YWHAZ )" 1)
   ("a bacterially expressed mouse full-length polypeptide" 1)
   ("expressed mouse full-length polypeptide" 1) ("polypeptide (STOP)" 1)
   ("polypeptide ( PDGFRA )" 1)
   ("the thermally responsive macromolecular carrier elastin-like polypeptide (ELP)"
    1)
   ("a soluble full length Vpr (1–96) polypeptide" 1)
   ("a disruptive BRC3/4 polypeptide" 1) ("an exogenous Mdmx polypeptide" 1)
   ("the mature amino-terminal polypeptide" 1) ("polypeptide (NEFM)" 1)
   ("PolyPeptide" 1)))
 ("UP:Q10477" (("pMC3" 4))) ("UP:Q10570" (("CPSF1" 13) ("160kDa" 2)))
 ("UP:Q10571"
  (("MN1" 143) ("MNi" 21) ("Mn1" 9) ("functional MN1" 2) ("MN1-" 2)
   ("overexpressed MN1" 2) ("the transcriptional co-activator MN1" 1)
   ("mN1" 1)))
 ("UP:Q10585" (("Spd1" 2))) ("UP:Q10587" (("TEF" 14) ("pTEF" 13)))
 ("UP:Q10589"
  (("cytometry" 13544) ("Cytometry" 841) ("tetherin" 473) ("BST-2" 140)
   ("Tetherin" 49) ("BST2" 49) ("cytometry (FCM)" 27) ("cytometry (FACS)" 16)
   ("CD317" 10) ("Bst2" 10) ("multiparametric flow cytometry" 9)
   ("subsequent flow cytometry" 6) ("Western blot and flow cytometry" 5)
   ("live cell flow cytometry" 5) ("cytometry (CFC)" 5)
   ("western blot and flow cytometry" 5) ("cytometry (FC)" 4)
   ("BD LSR II flow cytometry" 3) ("cytometry (BD)" 3)
   ("bone marrow stromal cell antigen 2" 3) ("quantitative flow cytometry" 3)
   ("artificial BST-2" 2) ("confocal miscroscopy and flow cytometry" 2)
   ("Western blot, and Flow Cytometry" 2)
   ("Homologous recombination repair and flow cytometry" 2)
   ("cytometry (IFC)" 2) ("Live Cell Flow Cytometry" 2)
   ("phosphospecific flow cytometry" 2) ("CYTOMETRY" 2)
   ("high-speed flow cytometry" 2) ("cytometry (MIFC)" 2)
   ("using BD LSR II flow cytometry" 2) ("Simultaneous flow cytometry" 2)
   ("Western blot, and phospho-flow cytometry" 1)
   ("independently target BST-2" 1) ("bi-parametric flow cytometry" 1)
   ("7-AAD-based flow cytometry" 1) ("only flow cytometry" 1)
   ("Cytometry (LCS)" 1) ("using flow cytometry" 1)
   ("fluorescent-activated flow cytometry" 1)
   ("surgically resected HCCs (n=17 patients, xref ) underwent single cell suspension and flow cytometry"
    1)
   ("Western blot, and flow cytometry" 1) ("Cytometry (FCM)" 1)
   ("specifically target human tetherin" 1)
   ("total and internalized tetherin" 1)
   ("the fluorescence-assisted flow cytometry" 1) ("than flow cytometry" 1)
   ("cytometry (GFP)" 1) ("Annexin V-FITC–based flow cytometry" 1)
   ("polychromatic flow cytometry" 1) ("dual color flow cytometry" 1)
   ("Live cell flow cytometry" 1)
   ("phosphospecific whole blood flow cytometry" 1)
   ("Polychromatic flow cytometry" 1)
   ("using Western blot and flow cytometry" 1) ("multi-parametric cytometry" 1)
   ("the OSU Comprehensive Cancer Center Analytical Cytometry" 1)
   ("Indirect analytic flow cytometry" 1) ("dual parameter flow cytometry" 1)
   ("multispectral imaging flow cytometry (MIFC)" 1)
   ("reliable flow cytometry" 1) ("The subsequent flow cytometry" 1)
   ("more complex flow cytometry" 1) ("fluorescent cytometry" 1)
   ("cytometry (FAC)" 1) ("Wantage SE (Becton Dickinson) Flow Cytometry" 1)
   ("the peripheral lymphocyte flow cytometry" 1)
   ("Representative flow cytometry" 1) ("Subsequent flow cytometry" 1)
   ("previously reported flow cytometry" 1) ("Cytometry (LSC)" 1)
   ("the routinely performed diagnostic flow cytometry" 1)
   ("a multiparametric flow cytometry" 1)))
 ("UP:Q10655" (("elt-2" 12))) ("UP:Q10656" (("Egl-15" 5) ("EGL-15" 3)))
 ("UP:Q10713" (("72 kD" 4) ("INPP5e" 2) ("INPP5E" 2) ("mPpa" 1)))
 ("UP:Q10749" (("MOC" 4)))
 ("UP:Q10757"
  (("angiotensin" 74) ("Angiotensin" 7) ("angiotensins" 4)
   ("at least four other angiotensins" 2)))
 ("UP:Q10902" (("internal NHR2" 2) ("NHR2" 2)))
 ("UP:Q10981"
  (("SE" 971) ("se" 120) ("SES" 101) ("Se" 38) ("FUT2" 10) ("Sec2" 5) ("sE" 2)
   ("adulthood—low SES" 1) ("normal esophageal SE" 1) ("actual SES" 1)
   ("cross-sectional SES" 1) ("convulsive SE" 1)))
 ("UP:Q10988" (("Uve1" 1)))
 ("UP:Q10992"
  (("SCA" 260) ("SCAs" 14) ("than SCA" 1) ("Sca" 1) ("sca" 1)
   ("sequence-based SCA" 1) ("homozygous SCA" 1) ("community-based SCA" 1)))
 ("UP:Q10993" (("SCB" 4)))
 ("UP:Q10998"
  (("CP1" 114) ("CP-1" 46) ("soluble CP1" 7) ("cp-1" 5) ("cp-1 protein" 3)
   ("CP3" 2) ("this soluble CP1" 1) ("soluble (Flag-CP1) CP1" 1)
   ("exogenous CP1" 1)))
 ("UP:Q10NQ9" (("nCBP" 4)))
 ("UP:Q11184"
  (("LET-756" 83) ("let-756" 2)
   ("a two-hybrid cDNA human library using LET-756" 1)))
 ("UP:Q11201" (("ST3GAL1" 6) ("ST3Gal I" 1)))
 ("UP:Q11203" (("ST3Gal III" 70) ("ST3GAL3" 12) ("ST3GalIII" 2)))
 ("UP:Q11206"
  (("STZ" 415) ("ST3GAL4" 21) ("ST3Gal IV" 19) ("St-4" 16) ("St3gal4" 7)
   ("Sat3" 4) ("ST3GAL IV" 1) ("STZ-" 1)
   ("STZ-induced diabetic animals STZ" 1)))
 ("UP:Q11207" (("PARP-2" 249) ("PARP-2 protein" 4) ("than purified PARP-2" 1)))
 ("UP:Q12018" (("Cdc53" 6))) ("UP:Q12031" (("ICL2" 4)))
 ("UP:Q12038" (("Sro7" 4)))
 ("UP:Q12050" (("ELG1" 83) ("Elg1" 19) ("elg1" 8) ("ELG1 protein" 4)))
 ("UP:Q12062" (("VBS" 4))) ("UP:Q12068" (("GRE2" 4) ("the potential GRE2" 1)))
 ("UP:Q12069" (("pUS9" 1))) ("UP:Q12100" (("RTK1" 5)))
 ("UP:Q12120" (("AFLP" 16))) ("UP:Q12140" (("BSC1" 4)))
 ("UP:Q12158" (("MCD1" 1) ("Mcd1" 1))) ("UP:Q12173" (("GAG-3" 138)))
 ("UP:Q12216" (("Siz2" 12))) ("UP:Q12224" (("Rlm1" 3)))
 ("UP:Q12236" (("PKH2" 3)))
 ("UP:Q12271"
  (("inp53" 75) ("Inp53" 2) ("inP53" 1) ("InP53" 1)
   ("fewer nephrons inp53 −/−" 1)))
 ("UP:Q12280" (("Cyk1" 1) ("IQG1" 1))) ("UP:Q12289" (("CRC1" 2)))
 ("UP:Q12329" (("hsp42" 7) ("HSP42" 5) ("Hsp42" 4))) ("UP:Q12403" (("ERP3" 2)))
 ("UP:Q12416"
  (("Whi5" 25) ("whi5" 5) ("Whi5 protein" 3) ("a functional Whi5" 1)))
 ("UP:Q12446" (("LAS17" 1))) ("UP:Q12477" (("Pcl9" 3)))
 ("UP:Q12505" (("shA3" 1))) ("UP:Q12511" (("PPP1" 9)))
 ("UP:Q12701" (("Ksg1" 9) ("ksg1" 4)))
 ("UP:Q12756" (("KIF1A" 24) ("kinesin family member 1A" 2)))
 ("UP:Q12768" (("KIAA0196" 8) ("strumpellin" 5) ("Strumpellin" 4)))
 ("UP:Q12769" (("Nup160" 1) ("NUP160" 1)))
 ("UP:Q12770"
  (("SCAP" 34) ("scap" 6) ("SCAPs" 3) ("Scap" 3) ("7/23 sporadic SCAP" 2)
   ("12/23 screened sporadic SCAP" 1) ("sporadic SCAPs" 1)))
 ("UP:Q12772"
  (("SREBP-2" 167) ("SREBP2" 58) ("SREBF2" 30) ("Srebf2" 6)
   ("sterol regulatory element binding protein 2" 2) ("Srebp2" 2)
   ("Sterol regulatory element-binding protein-2" 2)
   ("sterol regulatory element-binding protein-2" 2)
   ("endogenous mature SREBP-2" 2) ("Srebp-2" 1) ("SREBP-2 protein" 1)))
 ("UP:Q12774"
  (("ARHGEF5" 39) ("Rho guanine nucleotide exchange factor 5" 4) ("Ephexin3" 3)
   ("Arhgef5" 2) ("Dysfunctional ARHGEF5" 1)))
 ("UP:Q12778"
  (("FOXO1" 1345) ("FoxO1" 1213) ("Foxo1" 316) ("FKHR" 145)
   ("forkhead box" 115) ("Forkhead box" 79) ("FOXO-1" 32) ("FOXO1A" 24)
   ("Fkhr" 24) ("forkhead box O1" 23) ("p-FOXO1" 23) ("FOXO1a" 18)
   ("FoxO1a" 15) ("p-FoxO1" 14) ("FOXO1 protein" 13) ("FoxO1 protein" 11)
   ("Forkhead box protein O1" 11) ("forkhead box protein O1" 9)
   ("Forkhead Box" 7) ("-FoxO1" 6) ("Fox" 5) ("forkhead box protein" 4)
   ("forkhead in rhabdomyosarcoma" 4) ("p-FKHR" 4)
   ("Forkhead Box Protein O1" 4) ("Forkhead box O1" 3) ("“forkhead box”" 3)
   ("foxO1" 3) ("FOXO1 (FKHR)" 3) ("than FoxO1" 3) ("pFKHR" 2)
   ("intercompartmental FoxO1" 2) ("pFOXO1" 2) ("−FOXO1" 2)
   ("MiR-21-regulated FOXO1" 2) ("FoxO1A" 2)
   ("e. g. forkhead transcription factor FOXO1" 2)
   ("Reduced nuclear forkhead transcriptional factor Foxo1" 2)
   ("p-FoxO1 protein" 2) ("the forkhead transcriptional factor Foxo1" 2)
   ("Forkhead in rhabdomyosarcoma" 2) ("P-FOXO1" 2) ("phosphospecific FoxO1" 2)
   ("a transactivation-defective Foxo1" 2) ("WT Akt decreased FOXO1" 2)
   ("-FOXO1" 1) ("Foxo1a" 1) ("transcriptional factor FoxO1" 1) ("foxo1" 1)
   ("Nuclear predominant FOXO1" 1)
   ("the pro-apoptotic transcription factor FKHR" 1) ("Q12778" 1)
   ("than FoxO1 in β-cells" 1) ("transactivation-defective Foxo1" 1)))
 ("UP:Q12789"
  (("TFIIIC" 15) ("the pol III factor TFIIIC" 2)
   ("The core Pol III transcription factor TFIIIC" 1)))
 ("UP:Q12791"
  (("HSlo" 356) ("Slo" 109) ("hSlo" 28) ("BK channel" 24) ("KCNMA1" 15)
   ("Slo protein" 7) ("SLO" 6) ("subfamily M" 3) ("slo" 2)
   ("almost all the Slo" 2) ("HSlo protein" 2) ("exogenous Slo" 2) ("MaxiK" 1)
   ("than the wildtype HSlo ( xref )" 1) ("than wt HSlo" 1) ("HSlo-" 1)
   ("exogenous HSlo" 1)))
 ("UP:Q12792" (("PTK9" 3) ("TWF1" 2)))
 ("UP:Q12794"
  (("HYAL1" 73) ("Hyal1" 68) ("hyaluronidase" 60) ("HYAL-1" 52)
   ("Hyaluronidase-1" 11) ("Hyaluronidase" 8)
   ("the clinically relevant hyaluronidase Hyal1" 1) ("HYAL-1 protein" 1)
   ("hyaluronidase-1" 1)))
 ("UP:Q12797" (("BAH" 19) ("asparaginyl" 18) ("ASPH" 5) ("Bah" 1)))
 ("UP:Q12800" (("LSF" 119) ("expressing LSF" 2)))
 ("UP:Q12802"
  (("LBCs" 161) ("LBC" 121) ("AKAP-Lbc" 112) ("AKAP13" 37) ("Ht31" 22)
   ("Lbc" 12) ("Brx" 7) ("sporadic LBC" 4) ("LBCs (WRN)" 3) ("AKAP-13" 2)
   ("normal LBCs" 2) ("Exponentially growing LBCs" 2) ("sporadic LBCs" 2)
   ("sporadic invasive LBC" 2) ("hereditary LBC" 1) ("LBCs (WT)" 1)
   ("most LBCs" 1) ("pure LBC" 1)))
 ("UP:Q12805"
  (("EFEMP1" 23)
   ("EGF-containing fibulin-like extracellular matrix protein 1" 6)
   ("fibulin-3" 5) ("fibulin 3" 1) ("S1-5" 1)))
 ("UP:Q12809"
  (("hERG" 116) ("HERG" 60) ("KCNH2" 33) ("ERG1" 16) ("hERG1" 6)
   ("hERG peptide" 4) ("hERG protein" 4) ("Erg-1" 4) ("Kv11.1" 3)
   ("the Src-specific inhibitory peptide (Src40-58) similarly reduced both cloned hERG1"
    2)
   ("LQT2" 2) ("HERG protein" 2)))
 ("UP:Q12816" (("tro" 34) ("Tro" 12)))
 ("UP:Q12824"
  (("INI1" 221) ("hSNF5" 182) ("SMARCB1" 49) ("BAF47" 28) ("Ini1" 10)
   ("integrase interactor 1" 7) ("RDT" 5) ("cellular INI1" 3)
   ("sucrose nonfermenting" 2) ("InI1" 2)
   ("than the virally incorporated INI1 explaining the observed effects on HIIV-1 replication"
    1)
   ("Snf5" 1)))
 ("UP:Q12830"
  (("Bptf" 258) ("H3K4Me3" 21) ("BPTF" 10) ("NURF301" 8) ("FAC1" 4)
   ("bromodomain PHD finger transcription factor" 2) ("successful Bptf" 2)
   ("showed widespread Bptf" 1) ("maternal Bptf" 1) ("Bptf-" 1)))
 ("UP:Q12834"
  (("Cdc20" 2572) ("CDC20" 470) ("cdc20" 17) ("Cdc20 protein" 11) ("Cdc20-" 10)
   ("targeting subunit Cdc20" 4) ("-Cdc20" 3) ("centrosomal Cdc20" 3)
   ("Hyperactive Cdc20" 2) ("directly target Cdc20" 2)
   ("exogenous and endogenous Cdc20" 2) ("mitotic APC/C Cdc20" 2) ("p55CDC" 1)
   ("the mitotic APC/C activator Cdc20" 1) ("typically either CDC20" 1)
   ("than wild type Cdc20" 1) ("neuronal Cdc20" 1) ("the Cdc20" 1)
   ("than APC/C Cdc20 ( xref ; xref ; xref ; xref )" 1) ("most Cdc20" 1)
   ("less Cdc20" 1) ("this exogenous Cdc20" 1) ("–Cdc20" 1) ("-CDC20" 1)
   ("more CDC20" 1) ("MAD2 C stably embraces CDC20" 1)
   ("than Cdc20 ( xref )" 1)))
 ("UP:Q12837"
  (("class 4" 19) ("Brn3b" 11) ("POU domain" 10) ("POU4F2" 6)
   ("at least class 4" 2)))
 ("UP:Q12840" (("KIF5A" 21))) ("UP:Q12841" (("FSTL1" 5) ("Fstl1" 3) ("Frp" 1)))
 ("UP:Q12846"
  (("syntaxin-4" 28) ("Syntaxin-4" 18) ("syntaxin 4" 6) ("Syntaxin 4" 1)
   ("syntaxin4" 1)))
 ("UP:Q12849" (("GRSF1" 15))) ("UP:Q12851" (("MAP4K2" 4)))
 ("UP:Q12852" (("MAP3K12" 1)))
 ("UP:Q12857" (("NFI-L" 7) ("NFIA" 5) ("Nfia" 2)))
 ("UP:Q12860"
  (("CNTN-1" 155) ("gp135" 29) ("CNTN1" 19) ("contactin 1" 4)
   ("the apical marker gp135" 3) ("undetectable CNTN-1" 2)))
 ("UP:Q12866"
  (("MERTK" 6) ("c-mer proto-oncogene tyrosine kinase (MERTK)" 2)
   ("c-mer proto-oncogene tyrosine kinase" 1)))
 ("UP:Q12870" (("Tcf15" 2)))
 ("UP:Q12872" (("swap" 114) ("Swap" 3) ("a conformational swap" 1)))
 ("UP:Q12873"
  (("CHD3" 40) ("Chromodomain helicase DNA binding protein 3" 10) ("CHD3-" 2)
   ("Mi-2α" 2)))
 ("UP:Q12874" (("SF3A3" 3)))
 ("UP:Q12879"
  (("NMDA receptor" 124) ("NR2A" 40) ("GluN2A" 10) ("GRIN2A" 6) ("GluN2A-" 2)
   ("than GluN2A ( xref )" 1) ("NMDA Receptor" 1) ("NR2A protein" 1)
   ("Functional NMDA receptor" 1) ("NR2a" 1)))
 ("UP:Q12882"
  (("DPD" 183) ("DPYD" 125) ("dihydropyrimidine dehydrogenase" 41)
   ("Dihydropyrimidine dehydrogenase" 5) ("DPYD protein" 2)
   ("dihydropyrimidine dehydrogenase ( DPYD )" 2)
   ("mouse monoclonal dihydropyrimidine dehydrogenase" 2)
   ("dihydropyrimidine dehydrogenase (DPD)" 2)))
 ("UP:Q12884"
  (("fibroblast activation protein" 9)
   ("fibroblast activation protein (FAP)" 5)
   ("Fibroblast activation protein" 2) ("seprase" 1)))
 ("UP:Q12887" (("COX10" 7) ("cytochrome c oxidase assembly protein" 1)))
 ("UP:Q12888"
  (("53BP1" 4559) ("TP53BP1" 117) ("53BP1 protein" 76) ("53bp1" 56)
   ("p53 binding protein 1" 31) ("p53BP1" 30) ("p53-binding protein 1" 26)
   ("p-53BP1" 22) ("p53-binding protein-1" 9) ("p53bp1" 9)
   ("tumor suppressor p53 binding protein 1" 5) ("53BP1-" 4)
   ("TP53BP1 protein" 4) ("p53 Binding Protein 1" 4)
   ("P53-binding protein 1" 4) ("P53 binding protein 1" 3) ("targeted 53BP1" 3)
   ("P202" 2) ("mitotic 53BP1" 2) ("functional 53BP1" 2) ("p202" 2)
   ("An immunofluorescent 53BP1" 1) ("than wildtype 53BP1 ( xref )" 1)
   ("directly targets 53BP1" 1) ("Excessive 53BP1" 1) ("tightly-bound 53BP1" 1)
   ("most 53BP1" 1) ("mirror 53BP1's" 1) ("miR-200b/429 mediated 53BP1 ’s" 1)
   ("than 53BP1" 1) ("distinct 53BP1" 1) ("oligomeric 53BP1" 1)
   ("oligomerized 53BP1" 1) ("an aspartate of 53BP1" 1) ("intact 53BP1" 1)
   ("exogenous DNA damage 53BP1" 1) ("P53BP1" 1)
   ("soluble nuclear proteins 53BP1" 1) ("HU-treated 53BP1 +/+" 1)
   ("untransfected cells little residual 53BP1 protein" 1)
   ("than 53BP1 (T 0  = 77±7 s, τ 1  = 310±60 s)" 1)
   ("simultaneously impact both 53BP1" 1)))
 ("UP:Q12889" (("OGP" 4)))
 ("UP:Q12891" (("HYAL2" 65) ("HYAL2-" 1) ("hyaluronidase 2" 1) ("LUCA2" 1)))
 ("UP:Q12893" (("PL6" 8) ("pl6" 3) ("pL6" 1) ("TMEM115" 1)))
 ("UP:Q12899"
  (("TRIM26" 2)
   ("tripartite
motif containing 26"
    1)))
 ("UP:Q12905" (("NF45" 135) ("ILF2" 16)))
 ("UP:Q12906"
  (("NF90" 287) ("ILF3" 31) ("NFAR" 10)
   ("interleukin enhancer binding factor 3" 6)
   ("interleukin enhancer-binding factor 3" 3)
   ("nuclear factor associated with dsRNA" 2) ("NF90 (terminal) protein" 2)
   ("NFAR1" 2) ("DRBP76" 2)
   ("exogenous Myc-tagged NF90 (terminal) protein" 1)))
 ("UP:Q12908"
  (("ASBT" 6) ("apical sodium dependent bile acid transporter (ASBT)" 2)
   ("apical sodium dependent bile acid transporter" 2)))
 ("UP:Q12912" (("LRMP" 4)))
 ("UP:Q12913"
  (("DEP-1" 239) ("CD148" 182) ("PTPRJ" 9) ("overexpressed DEP-1" 4)
   ("Density-enhanced phosphatase-1" 2) ("whose DEP-1" 1)))
 ("UP:Q12918" (("NKR-P1" 1)))
 ("UP:Q12923"
  (("PTPN13" 234) ("PTPL1" 224) ("FAP1" 8) ("PTPBAS" 6) ("FAP-1" 6) ("PTP1E" 4)
   ("PTPN13 protein" 4) ("PTPLE" 3) ("Fap1" 3) ("nearly undetectable PTPN13" 2)
   ("exhibited nearly absent PTPN13 protein" 2) ("hPTP1E" 2)
   ("only wildtype PTPN13" 1) ("cellular PTPN13" 1)
   ("both exogenous and endogenous PTPL1" 1)))
 ("UP:Q12926"
  (("hub" 631) ("Hub" 42) ("the central hub" 32) ("hub protein" 22)
   ("“hub”" 13) ("a central hub" 10) ("‘hub’" 7) ("a major hub" 7)
   ("a regulatory hub" 6) ("‘hub’ molecule" 4) ("HuB" 4) ("central hub" 4)
   ("hub molecule" 4)
   ("a previously unreported transcriptional activity hub" 3)
   ("a convergent hub" 2) ("huB" 2)
   ("a publically available breast cancer expression hub" 2) ("HUB" 2)
   ("a multivalent phosphorylation-dependent signaling hub" 2)
   ("a transcriptional activity hub" 2) ("the major regulatory hub" 2)
   ("the prominent central hub" 2) ("The central ‘hub’" 2)
   ("a key regulatory hub" 1) ("a key regulatory ‘hub’ protein that" 1)
   ("‘hub’ protein that" 1) ("hub’ protein" 1) ("the transparent needle hub" 1)
   ("a central “hub”" 1) ("a functional ‘hub'" 1) ("‘hub'" 1)
   ("a multifunctional hub protein" 1) ("a key hub" 1) ("'hub'" 1)
   ("a multivalent signaling hub" 1) ("a multivalent hub" 1)
   ("a major “hub”" 1) ("a pivotal control hub" 1)
   ("an important convergent hub" 1) ("the most convergent hub" 1)
   ("Embryonic-Lethal Abnormal Vision" 1) ("Abnormal Vision" 1)
   ("central “hub”" 1)))
 ("UP:Q12929"
  (("Eps8" 566) ("EPS8" 26) ("eps8" 24) ("Emerald-tagged mouse Eps8" 6)
   ("Eps8 protein" 2) ("expressing Emerald-tagged mouse Eps8" 2)
   ("epidermal growth factor receptor pathway substrate 8" 2)
   ("immunoprecipitated wild type Emerald-tagged Eps8" 1)))
 ("UP:Q12931" (("Hsp75" 2) ("HSP75" 1)))
 ("UP:Q12933"
  (("TRAF2" 1489) ("TNF receptor-associated factor 2" 17)
   ("TNF receptor associated factor 2" 15) ("Traf2" 10) ("TRAF2-" 8)
   ("TRAF-2" 7) ("TNF receptor–associated factor 2" 4) ("TRAF2 protein" 3)
   ("overexpressed TRAF2" 3) ("dominant-negative TRAF2" 2)
   ("cIAP1/2-bound TRAF2" 2)
   ("a RING-deleted dominant-negative TRAF2 protein" 2) ("-TRAF2" 2)
   ("TNF-receptor-associated factor 2" 2)
   ("TNF receptor-associated factor TRAF2" 1) ("flag-tagged TRAF2" 1)
   ("very little endogenous TRAF2" 1) ("here revealed TRAF2" 1)))
 ("UP:Q12946" (("FOXF1" 6) ("Forkhead box F1" 2) ("FoxF1" 1)))
 ("UP:Q12947" (("FOXF2" 7) ("Freac-2" 2) ("forkhead box F2" 1)))
 ("UP:Q12948" (("Foxc1" 16) ("forkhead box C1" 6)))
 ("UP:Q12951" (("FoxI1" 4) ("FOXi1" 1)))
 ("UP:Q12955"
  (("ANK3" 60) ("ankyrin 3" 39) ("ank3" 6) ("Ank3" 4) ("ankyrin G" 2)
   ("Ankyrin 3" 1)))
 ("UP:Q12959"
  (("hDlg" 211) ("Dlg1" 205) ("SAP97" 184) ("DLG1" 47) ("hDLG" 24) ("Dlgh1" 8)
   ("large homolog 1" 6) ("SAP-97" 2) ("SAP97 protein" 2)
   ("overexpressed hDlg" 2) ("the basolateral polarity protein DLG1" 1)
   ("Q12959" 1) ("the common viral target Dlg1" 1)
   ("The membrane-associated scaffold molecule DLG1" 1) ("Dlg-1" 1)
   ("most cases hDlg" 1)))
 ("UP:Q12962" (("TAF10" 19) ("TAFII30" 2))) ("UP:Q12965" (("MYO1E" 1)))
 ("UP:Q12967"
  (("RalGDS" 86) ("RGDS" 54) ("RalGEFs" 45) ("RalGEF" 38) ("Ral-GEF" 33)
   ("RALGDS" 22) ("Ral-GDS" 11) ("targeted RalGEF" 3)
   ("Ral guanine nucleotide exchange factor" 3) ("RGDS peptide" 3)
   ("RalGDS (RBD)" 2) ("RGF" 1)
   ("Ral guanine nucleotide dissociation stimulator" 1) ("RalGDs" 1)))
 ("UP:Q12968"
  (("NFATc3" 180) ("NFAT4" 74)
   ("the prohypertrophic transcription factor NFATc3" 3)
   ("no detectable such immunoprecipitable NFATc3" 2) ("NF-AT4" 2) ("NFATx" 2)
   ("NFATC3" 1)))
 ("UP:Q12972" (("PPP1R8" 4)))
 ("UP:Q12974" (("PRL-2" 155) ("PRL2" 13) ("PRL-2 protein" 1)))
 ("UP:Q12979" (("ABR" 35) ("Abr" 13) ("MDB" 3) ("active BCR-related" 1)))
 ("UP:Q12980" (("MARE" 45) ("NPRL3" 1))) ("UP:Q12981" (("TRG8" 6) ("BNIP1" 3)))
 ("UP:Q12982" (("BNIP2" 28) ("BNIP-2" 11) ("NIP2" 3)))
 ("UP:Q12983"
  (("BNIP3" 361) ("Bnip3" 117) ("functional BNIP3" 2)
   ("L -glutamine withdrawal reduced mitophagy marker BNIP3" 2)
   ("proautophagic Bnip3" 2) ("FoxO3‐Driven Bnip3" 2) ("cardiac Bnip3" 1)
   ("Bnip3 protein" 1)))
 ("UP:Q12986" (("NFX1" 27)))
 ("UP:Q12988"
  (("protein 3" 262) ("protein-3" 50) ("Protein 3" 13) ("HspB3" 5)
   ("the nonstructural protein 3" 4) ("Protein-3" 4)
   ("Breast carcinoma-associated protein 3" 3)
   ("CDK5 kinase regulatory subunit-associated protein 3" 3)
   ("The TP53I3-tumor protein p53-inducible protein 3" 2) ("HSPB3" 2)
   ("The novel E2/ERα signalling regulator brefeldin A-inhibited guanine nucleotide-exchange protein 3"
    2)
   ("drug resistance-associated protein 3" 2)
   ("γ-complex-associated protein 3" 2)
   ("a
fluorescently-tagged end-binding protein 3"
    2)
   ("breast carcinoma-associated protein 3" 2)
   ("synpatonemal complex protein 3" 2) ("Nonstructural protein 3" 2)
   ("Partitioning-defective protein 3" 2)
   ("partitioning-defective protein 3" 2)
   ("the host Golgi adaptor protein acyl coenzyme A (acyl-CoA) binding domain protein 3"
    2)
   ("the Golgi adaptor acyl coenzyme A (acyl-CoA) binding domain protein 3" 2)
   ("tumor necrosis factor α-induced protein 3" 1)))
 ("UP:Q12996" (("Hat2" 7) ("hat2" 1) ("77kD" 1)))
 ("UP:Q12999"
  (("SAS" 1915) ("“SAS”" 3) ("the statistical software SAS" 2)
   ("the nonpolar SAS" 1) ("the statistical package SAS" 1)))
 ("UP:Q13002" (("GluR6" 3))) ("UP:Q13003" (("GRIK3" 1)))
 ("UP:Q13007"
  (("IL-24" 413) ("IL-24 protein" 25) ("mda-7" 12) ("MDA-7" 10) ("IL24" 9)
   ("Interleukin 24" 4) ("interleukin-24" 4) ("Il24" 4) ("C49A" 4)
   ("exogenous IL-24" 2) ("Interleukin-24" 2)
   ("approximately 35 μg/ml IL-24" 1) ("MDA7" 1)))
 ("UP:Q13009"
  (("Tiam1" 2269) ("TIAM1" 507) ("Ras-binding" 90) ("Tiam-1" 70)
   ("RAS-binding" 15) ("Tiam1 protein" 10) ("Tiam 1" 6) ("TIAM1 protein" 6)
   ("its associated C1199 Tiam1" 4)
   ("miR-29b directly targets tumor metastasis-related gene Tiam1" 4)
   ("exogenous TIAM1" 4) ("Tiam1-" 4) ("Tiam1 peptide" 3) ("Tiam1 molecule" 3)
   ("TIAM-1" 3) ("Tiam1 (WT)" 3) ("ankyrin-associated Tiam1" 2)
   ("the gross TIAM1" 2) ("ras-binding" 2) ("the nondegradable 4x595R TIAM1" 2)
   ("than Tiam1" 2) ("exogenous Tiam1" 2) ("The phospho-mimetic Tiam1" 2)
   ("Ras-binding protein" 2) ("stromal Tiam1" 2) ("Tiam 1 protein" 1)
   ("than Tiam1 isolated from nontransfected COS-7 cells grown in the presence of 5% FCS ( xref B, d, shaded bar)"
    1)
   ("-Tiam1" 1) ("soluble Tiam1" 1) ("more Tiam1" 1) ("Ras-Binding" 1)
   ("TIAM 1" 1) ("only total Tiam1" 1)))
 ("UP:Q13011" (("ECH1" 1))) ("UP:Q13015" (("AF1Q" 3) ("AF1q" 1)))
 ("UP:Q13017"
  (("p190B" 211) ("ARHGAP5" 4) ("p190B protein" 3) ("Arhgap5" 2) ("P190-B" 1)))
 ("UP:Q13018"
  (("PLA2R1" 122) ("phospholipase A2 receptor" 5) ("PLA2R1 protein" 3)
   ("phospholipase A2 receptor 1" 1)))
 ("UP:Q13021" (("BENE" 1))) ("UP:Q13023" (("mAKAP" 2) ("AKAP6" 2)))
 ("UP:Q13029" (("PRDM2" 83) ("RIZ1" 14) ("RIZ" 9) ("RIZ protein" 2) ("Riz" 1)))
 ("UP:Q13033" (("STRN3" 6) ("Strn3" 1)))
 ("UP:Q13042"
  (("anaphase-promoting complex" 96) ("Cdc16" 49) ("APC6" 47) ("CDC16" 19)
   ("Anaphase-promoting complex" 4) ("APC6 molecule" 3)
   ("anaphase-promoting
 complex"
    3)
   ("anaphase–promoting complex" 3) ("CUT9" 2)
   ("anaphase-promoting complex (APC)" 1) ("CDC16 homolog" 1) ("cdc16" 1)))
 ("UP:Q13043"
  (("STK4" 61) ("MST-1" 17) ("serine/threonine-protein kinase 4" 7)
   ("Mst-1" 1)))
 ("UP:Q13045"
  (("Fli-I" 106) ("FLII" 3) ("Fli" 2) ("than full length Fli-I ( xref )" 2)))
 ("UP:Q13049"
  (("TRIM32" 345) ("Trim32" 7) ("overexpressed TRIM32" 3) ("HT2A" 3)
   ("Tripartite motif protein 32" 2)
   ("the neuronal fate determinant TRIM32" 1)))
 ("UP:Q13057" (("Coenzyme A synthase" 2))) ("UP:Q13064" (("MKRN3" 9)))
 ("UP:Q13072" (("BAGE" 4)))
 ("UP:Q13075"
  (("NAIP" 20) ("BIRC1" 7) ("neuronal apoptosis inhibitory protein" 3)))
 ("UP:Q13077"
  (("TRAF1" 522) ("TNF receptor-associated factor 1" 8) ("most TRAF1" 2)
   ("TRAF-1" 2) ("Most TRAF1" 1) ("-TRAF1" 1) ("TRAF1-" 1)))
 ("UP:Q13085"
  (("ACC" 1989) ("ACC1" 155) ("acac" 93) ("ACACA" 80) ("acc" 56) ("-ACC" 47)
   ("ACAC" 27) ("Acc" 27) ("salivary ACC" 13) ("-acc" 8) ("ACC-" 8) ("–ACC1" 7)
   ("Acaca" 6) ("than ACC1" 6) ("late stage ACC" 4) ("-acac" 3)
   ("salivary gland ACC" 3) ("ACC molecule" 3) ("ACCalpha" 2)
   ("lipogenic enzyme ACC" 2) ("Acetyl-CoA carboxylase 1" 2) ("most ACC" 2)
   ("sinonasal ACC" 2) ("aCC" 1) ("60 salivary ACC" 1)
   ("all 167 salivary ACC" 1) ("fusion-negative ACC" 1)
   ("this uncommon epithelial tumor ACC" 1) ("at least 4 ACC" 1)
   ("ACC protein" 1) ("more ACC1" 1) ("progressive ACC" 1) ("recurrent ACC" 1)
   ("a few ACC" 1) ("-acC" 1) ("ACc" 1) ("acC" 1) ("paranasal sinus ACC" 1)
   ("Lacrimal gland ACC" 1) ("3 developed ACC" 1) ("apparently sporadic ACC" 1)
   ("developed ACC" 1)))
 ("UP:Q13087"
  (("PDIp" 180) ("PDIp protein" 21) ("Selectively-expressed PDIp" 2)
   ("the selectively-expressed human PDIp" 1) ("the residual PDIp" 1)
   ("the highly-pure PDIp protein" 1)))
 ("UP:Q13093" (("plasma)" 51) ("PLA2G7" 4) ("platelet-poor plasma)" 1)))
 ("UP:Q13094"
  (("SLP-76" 756) ("SLP76" 98)
   ("SH2 domain-containing leukocyte protein of 76 kDa" 5) ("SLP76 peptide" 4)
   ("Slp76" 3) ("SLP76 protein" 3) ("SLP-76 molecule" 2) ("more SLP-76" 1)
   ("lymphocyte cytosolic protein 2" 1) ("SLP-76-" 1)
   ("significantly less SLP-76" 1) ("the amino-terminal tyrosines of SLP-76" 1)
   ("LCP2" 1)))
 ("UP:Q13098"
  (("signalosome" 140) ("CSN1" 3) ("‘signalosome’" 3) ("Signalosome" 3)
   ("COPS1" 2) ("“signalosome”" 2) ("a unique signalosome" 1)))
 ("UP:Q13099" (("IFT88" 21) ("ift88" 8) ("Ift88" 5) ("Tg737" 1)))
 ("UP:Q13105"
  (("MIZ1" 12) ("MIZ-1" 11) ("Myc-interacting zinc finger protein 1" 2)
   ("ZBTB17" 2)))
 ("UP:Q13107"
  (("USP4" 643) ("unP" 30) ("USP4 protein" 6) ("UNP" 2)
   ("sh-RNA-resistant USP4" 2) ("188–302 amino acids of USP4" 1)
   ("exogenous Myc-tagged USP4" 1)))
 ("UP:Q13111"
  (("CAF" 214) ("pCAF" 10) ("CHAF1A" 3) ("at least one or more CAF" 2)
   ("More stringent CAF" 1) ("Histologically immature CAF" 1) ("than CAF" 1)
   ("mammary CAF" 1)))
 ("UP:Q13112"
  (("CAF-1 p60" 10) ("CHAF1B" 9) ("CHAF1B protein" 7) ("Chaf1b" 1)))
 ("UP:Q13114"
  (("TRAF3" 740) ("c-Raf-1" 51) ("Traf3" 7) ("TRAF3 molecule" 6) ("Triad3A" 4)
   ("TNF receptor associated factor 3" 4) ("less TRAF3" 2) ("Craf1" 2)
   ("c-Raf1" 2) ("TRAF3-" 2)
   ("tumor necrosis factor-receptor-associated factor 3 TRAF3" 1) ("Q13114" 1)
   ("c-RAF-1" 1) ("CAP-1" 1) ("Traf3-" 1)))
 ("UP:Q13115"
  (("DUSP4" 640) ("MKP2" 219) ("MKP-2" 138) ("TYP" 12) ("Dusp4" 8)
   ("DUSP4 protein" 6) ("MKP-2 protein" 5)
   ("mitogen-activated protein kinase phosphatase-2" 3) ("MKP2 protein" 3)
   ("Monoclonal MKP2" 2) ("tamoxifen increased MKP-2" 1)
   ("Dual specificity protein phosphatase 4" 1)
   ("dual specificity phosphatase 4" 1)))
 ("UP:Q13118"
  (("TIEG1" 209) ("KLF10" 7) ("TIEG" 3) ("-TIEG1" 2)
   ("Itch differentially targets TIEG1" 1) ("naive TIEG1 +/+" 1)))
 ("UP:Q13123"
  (("I  K" 119) ("RER" 31) ("RED" 28) ("IK" 14) ("I-K" 5) ("I–K" 4) ("pRER" 3)
   ("Ik" 2) ("a HeLa cell line expressing histone H2B–monomeric RED protein" 2)
   ("RER–" 2) ("the functional I  K" 1) ("RED protein" 1)))
 ("UP:Q13126"
  (("MTAP" 42) ("MTA phosphorylase" 8)
   ("methylthioadenosine phosphorylase" 8)))
 ("UP:Q13127"
  (("REST" 492) ("REST protein" 19) ("NRSF" 13)
   ("RE1-silencing transcription factor" 5)
   ("RE1 silencing transcription factor" 3) ("undetectable REST protein" 2)
   ("relative expression software tool REST" 2)
   ("RE1-silencing transcription factor (REST)" 1) ("pREST" 1)
   ("RE1 silencing transcription factor (REST)" 1)
   ("RE1 Silencing Transcription Factor (REST)" 1)
   ("RE1 Silencing Transcription Factor" 1)))
 ("UP:Q13129" (("RLF" 2)))
 ("UP:Q13131"
  (("AMPKα1" 311) ("AMPK-α1" 233) ("activated protein kinase" 176)
   ("PRKAA1" 55) ("Prkaa1" 13) ("-activated protein kinase" 10) ("AMPKα1-" 5)
   ("-activated protein kinase (AMPK)" 4) ("-AMPK-α1" 3) ("–AMPK-α1" 3)
   ("than AMPKα1" 3) ("Ampk1" 2) ("AMPK subfamily" 2) ("AMPKα1 protein" 2)
   ("AMPK1" 1)
   ("activated protein
kinase"
    1)
   ("-activated protein kinase(AMPK)" 1) ("Activated Protein kinase" 1)
   ("Activated protein kinase" 1) ("“ADP-activated protein kinase”" 1)))
 ("UP:Q13133"
  (("NR1H3" 9) ("liver X receptor alpha" 7) ("Nr1h3" 3) ("LXRA" 3)
   ("LXRalpha" 1)))
 ("UP:Q13136"
  (("protein tyrosine phosphatase" 491) ("LIP1" 108)
   ("protein tyrosine phosphatase (PTP)" 32)
   ("protein tyrosine phosphatase (SHP)" 23)
   ("Protein tyrosine phosphatase" 12) ("PPFIA1" 3)
   ("protein
tyrosine phosphatase"
    2)
   ("protein tyrosine phosphatase (TCPTP)" 2)
   ("Protein tyrosine phosphatase (PTP)" 2)
   ("namely protein tyrosine phosphatase 1B" 2) ("exogenous LIP1" 2)
   ("the 1,099-amino acid residue-long LIP1 protein" 2)
   ("a widely-expressed Src homology 2 (SH2) domain-containing protein tyrosine phosphatase (PTP)"
    2)
   ("a bacterial protein tyrosine phosphatase" 1)
   ("protein tyrosine
phosphatase"
    1)
   ("even less LIP1" 1) ("LIP1 protein" 1)
   ("a functional protein tyrosine phosphatase" 1)
   ("interacting protein (liprin)" 1)
   ("a dual specificity protein tyrosine phosphatase" 1)))
 ("UP:Q13137" (("Ndp52" 30) ("NDP52" 7) ("CALCOCO2" 4)))
 ("UP:Q13144" (("eIF2Bε" 20) ("EIF2B5" 1)))
 ("UP:Q13145" (("Bambi" 86) ("BAMBI" 33) ("NMA" 13)))
 ("UP:Q13148"
  (("TARDBP" 20) ("This pathological TARDBP" 1) ("TAR DNA binding protein" 1)))
 ("UP:Q13151"
  (("hnRNPA0" 8) ("heterogeneous nuclear ribonucleoprotein A0" 2)
   ("HNRNPA0" 1)))
 ("UP:Q13153"
  (("PAK1" 4337) ("Pak1" 2098) ("p-PAK1" 84) ("p21-activated kinase 1" 64)
   ("PAK1 protein" 45) ("pPak1" 27) ("PAK-1" 26) ("Pak1 protein" 19)
   ("P21-activated kinase 1" 17) ("PAK 1" 12) ("Pak-1" 11)
   ("p21 activated kinase 1" 10) ("Pak 1" 9) ("pPAK1" 7)
   ("p21-activated kinase-1" 7) ("p-21 activated kinase" 7)
   ("expressed PAK1" 6) ("P21-activated kinase-1" 5) ("-PAK1" 4)
   ("particular Pak1" 4) ("the ectopically expressed PAK1" 4)
   ("hyperactive PAK1" 3) ("Paks1" 3) ("PAK1-" 3) ("pak1" 2)
   ("Overexpressed PAK1" 2) ("noticeable upregulated PAK1" 2)
   ("overexpressed PAK1 WT and kinase-dead PAK1" 2) ("PAK1 molecule" 2)
   ("the ectopically expressed PAK1 protein" 2) ("expressed PAK1 protein" 2)
   ("P21 activated kinase 1" 2) ("FA-associated Pak1" 2)
   ("overexpressed activated Pak1" 2) ("Pak1 (KD)" 2) ("PAK-1 protein" 2)
   ("p-Pak1" 2) ("overexpressed PAK1" 2) ("αPAK" 1) ("the dimeric PAK1" 1)
   ("a monomeric PAK1" 1) ("targeting PAK1" 1) ("stress-induced Pak1" 1)
   ("strong positive PAK1" 1)
   ("other prognostic pathological markers demonstrated high PAK1" 1)
   ("dominant-negative PAK1" 1)
   ("the four-molecule PAK1/βPIX/GIT1/paxillin signaling module transiently targets PAK1"
    1)
   ("further activating PAK1" 1)
   ("JAK2-phosphorylation-deficient mutant PAK1 Y3F" 1)
   ("than PAK1 Y3F in MCF-7" 1) ("first 70 amino acids of PAK1" 1)
   ("This semi-open/semi-active PAK1" 1) ("phospho-PAK1/total PAK1" 1)
   ("that PAK1's" 1) ("P-PAK1" 1) ("TNFα showed increased p-PAK1" 1) ("αPak" 1)
   ("The constitutively expressed PAK1" 1) ("forcedly expressed PAK1" 1)
   ("p65PAK" 1) ("dimeric Pak1" 1) ("presumably dimeric Pak1" 1)
   ("the homologous Pak1" 1) ("the N-terminal 1–270 amino acids of Pak1" 1)
   ("tumor-associated phosphorylated Pak1" 1) ("-Pak1" 1)
   ("exogenous WT Pak1" 1) ("exogenous Pak1" 1)
   ("than PAK1 in human fibroblast based on Western blotting results" 1)
   ("credential PAK1" 1) ("than wild-type PAK1 ( xref )" 1)
   ("“p21 activated kinase 1”" 1) ("p21 activated kinase-1" 1)
   ("alternate PAK1" 1) ("80% less PAK1 protein" 1)))
 ("UP:Q13155"
  (("AIMP2" 240) ("overexpressed AIMP2" 2) ("JTV-1" 2)
   ("another transgenic line expressing AIMP2" 1) ("JTV1" 1)))
 ("UP:Q13158"
  (("FADD" 1065) ("procaspase-8" 392) ("protein FADD" 70)
   ("procaspase-8 protein" 33) ("Procaspase-8" 25) ("FADD molecule" 14)
   ("p-FADD" 12) ("pFADD" 9) ("Fadd" 8) ("-FADD" 7) ("procaspase-8 molecule" 6)
   ("FADD protein" 5) ("PROCASPASE-8" 4) ("the subsequent procaspase-8" 2)
   ("dimeric procaspase-8" 2) ("FAS-associated death domain protein" 2)
   ("exogenous FADD" 2)
   ("than the subsequent procaspase-8 autoprocessing ( xref )" 1)
   ("than the wild-type procaspase-8 protein" 1)
   ("FAS-associated death domain protein (FADD)" 1)
   ("the pro-apoptotic protein FADD" 1) ("Mort-1" 1)
   ("dominant-negative FADD" 1) ("the next procaspase-8 molecule" 1)
   ("than FADD ( xref E)" 1)
   ("than FADD in the TRAIL DISC isolated from all three cell lines ( xref ; xref D and 4E)"
    1)
   ("than FADD in the HMW TRAIL DISC ( xref E)" 1) ("than FADD in the DISC" 1)
   ("FADD-" 1) ("abrogated FADD's" 1) ("abrogated FADD" 1) ("MORT1" 1)
   ("residual p-FADD" 1)))
 ("UP:Q13162" (("PRDX4" 4) ("peroxiredoxin 4" 3) ("Prx4" 1)))
 ("UP:Q13163"
  (("MEK5" 276) ("MAP2K5" 8) ("MKK5" 2) ("Q13163" 1) ("MAPK/ERK kinase 5" 1)))
 ("UP:Q13164"
  (("ERK5" 768) ("BMK1" 105) ("pERK5" 31) ("Erk5" 12) ("-ERK5" 5)
   ("extracellular signal–regulated kinase 5" 4) ("Bmk1" 4)
   ("mitogen-activated protein kinase 7" 3) ("P-Erk5" 3) ("ERK5 protein" 3)
   ("extracellular signal-regulated kinase 5" 3) ("p-ERK5" 3)
   ("the oxidative stress marker P-Erk5" 2) ("MAPK7" 2)
   ("total and phosphorylated ERK5" 1) ("ERK 5" 1) ("a few ERK5" 1)
   ("dominant-negative (dn) ERK5" 1) ("cellular BMK1" 1)))
 ("UP:Q13177"
  (("PAK2" 930) ("Pak2" 509) ("p21-activated kinase 2" 7)
   ("Nef-associated PAK2" 5) ("-Pak2" 4) ("pPAK2" 3) ("Pak2 protein" 3)
   ("p-PAK2" 3) ("γ-Pak" 2) ("all cutaneous structures expressed Pak2" 2)
   ("PAk2" 1) ("Nef-associated PAK2 protein" 1) ("PAK2 protein" 1)
   ("p21 activated kinase 2" 1) ("γPak" 1) ("Pak 2" 1)))
 ("UP:Q13185"
  (("HP1γ" 47) ("CBX3" 10) ("HP1gamma" 2) ("chromobox protein homolog 3" 1)
   ("focal HP1γ" 1) ("HP-1γ" 1) ("the transcriptional repressor HP1γ" 1)))
 ("UP:Q13188"
  (("MST2" 470) ("Mst2" 203) ("STK3" 67) ("Mst-2" 12) (NIL 4) ("MST-2" 3)
   ("total or phosphorylated Mst-2" 3) ("Serine/threonine-protein kinase 3" 2)
   ("mst2" 2) ("nonphosphorylatable MST2-T117A" 2) ("Only Mst2 K473A" 1)
   ("serine/threonine kinase 3" 1) ("phosphomimetic MST2-T117D" 1)
   ("Akt phosphomimetic MST2-T117D" 1)))
 ("UP:Q13190" (("Syntaxin 5" 4) ("STX5" 3)))
 ("UP:Q13191"
  (("Cbl-b" 1183) ("CBLB" 27) ("cbl-b" 8) ("Cbl-b protein" 5) ("CBL-b" 5)
   ("the chimeric Cbl-b" 2) ("RNF56" 2) ("exactly Cbl-b" 1)
   ("its relative Cbl-b" 1) ("mature Cbl-b +/+" 1)
   ("mature splenic B cells Cbl-b" 1)))
 ("UP:Q13200" (("PSMD2" 14) ("Rpn1" 1) ("TRAP2" 1)))
 ("UP:Q13201"
  (("ECM" 4873) ("ECM protein" 43) ("abnormal ECM" 6) ("the vascular ECM" 5)
   ("ECM-" 4) ("exogenous ECM" 3) ("stromal ECM" 3) ("supportive ECM" 3)
   ("the local ECM" 2) ("fatal ECM" 2) ("a cell free bioactive ECM" 2)
   ("surface-bound ECM" 2) ("fibrotic ECM" 2) ("a collagenous ECM" 2)
   ("fluorescent ECM" 2) ("abnormal or ectopic ECM" 2) ("regular ECM" 2)
   ("a flexible ECM" 2) ("the aortic ECM" 2) ("the extensive ECM" 2)
   ("some implanted glioma cell lines form interstitial ECM" 2)
   ("aberrant ECM" 2) ("‘ECM’" 2) ("surface-associated ECM protein" 2)
   ("a more rigid ECM" 2) ("a more complex fibroblast-derived ECM" 2)
   ("natural ECM" 2) ("proteinaceous ECM" 2) ("the collagenous ECM" 2)
   ("“ECM”" 1) ("the insoluble ECM" 1) ("miR-206-mediated ECM" 1)
   ("‘organotypic’ 3D ECM" 1) ("complex fibrillar ECM" 1) ("biological ECM" 1)
   ("dynamic ECM" 1) ("tumor-associated ECM" 1) ("insoluble ECM" 1)
   ("than control ECM" 1) ("than ECM" 1) ("the submesothelial ECM" 1)
   ("Fluorescent ECM" 1) ("this discontinuous ECM" 1) ("the fibrotic ECM" 1)
   ("considerable ECM" 1) ("proteolytic ECM" 1) ("innate ECM" 1)
   ("fetal bovine serum ECM" 1) ("a rigid or dense ECM" 1)
   ("tumor-associated (late) 3D ECM" 1) ("the subendothelial ECM" 1)
   ("an exogenous ECM" 1) ("dense ECM" 1) ("The vascular ECM" 1)
   ("interconnected ECM" 1) ("incorrect ECM" 1) ("a robust ECM" 1)
   ("The normal ECM" 1) ("the stromal ECM" 1) ("their functional ECM" 1)
   ("a basal ECM" 1) ("focal ECM" 1)
   ("p21CIP1 knockdown exhibited aberrant ECM" 1) ("a three-dimensional ECM" 1)
   ("injectable ECM" 1) ("aortic ECM" 1) ("the otherwise impenetrable ECM" 1)
   ("fragmented collagenous ECM" 1) ("The dermal ECM" 1)
   ("the cross-linked collagenous ECM" 1) ("unsupportive hPSF ECM" 1)
   ("hESC-supportive ECM" 1) ("the unsupportive MF1×CD1 ECM" 1)
   ("the unsupportive hPSF ECM" 1)
   ("the unsupportive MF1×CD1 mouse feeder ECM" 1)))
 ("UP:Q13202" (("DUSP8" 13))) ("UP:Q13203" (("H protein" 14)))
 ("UP:Q13207"
  (("Tbx2" 252) ("TBX2" 15) ("Tbx2(1-301) molecule" 2) ("exogenous Tbx2" 2)
   ("Tbx2(84-301) protein" 2) ("Tbx2 protein" 2)
   ("the amino-terminal 83 amino acids of Tbx2" 1)
   ("inducible dominant-negative Tbx2" 1)))
 ("UP:Q13214" (("Sema3B" 3) ("SEMA3B" 3) ("SEMA5" 2)))
 ("UP:Q13216" (("ERCC8" 3) ("CSA protein" 3)))
 ("UP:Q13217"
  (("interferon-induced" 25) ("DNAJC3" 3) ("interferon-induced protein" 2)
   ("Interferon-induced" 1)))
 ("UP:Q13219"
  (("PAPPA" 81) ("PAPPA protein" 7) ("Pappa" 4) ("PAPP-A" 3)
   ("pregnancy-associated plasma protein A" 2)))
 ("UP:Q13224" (("NR2B" 106) ("GRIN2B" 30) ("NMDAR2B" 9) ("NR3" 1)))
 ("UP:Q13227"
  (("GPS2" 296) ("GPS2 protein" 5) ("G-protein pathway suppressor 2" 4)
   ("than GPS2" 1)))
 ("UP:Q13228" (("SELENBP1" 5)))
 ("UP:Q13231" (("chitotriosidase" 2) ("CHI3" 1))) ("UP:Q13232" (("NME3" 1)))
 ("UP:Q13233"
  (("MEKK1" 154) ("MAP3K1" 128) ("MEKK" 25)
   ("mitogen-activated protein kinase kinase kinase 1" 9) ("MEKK-1" 3)
   ("overexpressed MEKK1" 3) ("MEK kinase 1" 1)
   ("MAPK/ERK kinase kinase 1" 1)))
 ("UP:Q13237" (("PRKG2" 2)))
 ("UP:Q13239"
  (("SLAP" 425) ("Src-like" 54) ("SLAP protein" 5) ("src-like" 4) ("SLA" 2)
   ("SLA1" 1) ("“CDK/Src-like”" 1) ("the external stimuli SLAP" 1)))
 ("UP:Q13241" (("CD94" 30) ("NK cell receptor" 8) ("CD94/NKG2A" 7)))
 ("UP:Q13242" (("SFRS9" 3) ("SRSF9" 2) ("SRp30c" 1)))
 ("UP:Q13243" (("SRp40" 30) ("SRSF5" 8) ("SRp40 protein" 4) ("SrP40" 1)))
 ("UP:Q13247"
  (("SRSF6" 4) ("SFRS6" 3) ("the serine–arginine-rich (SR) protein SRSF6" 1)
   ("splicing factor, arginine/serine-rich 6" 1)))
 ("UP:Q13253"
  (("Noggin" 94) ("NOG" 50) ("noggin" 38) ("exogenous Noggin" 1) ("Nog" 1)))
 ("UP:Q13255"
  (("mGluR1" 123) ("mGlu1" 52) ("mGluR1a" 38) ("Grm1" 37) ("GRM1" 33)
   ("metabotropic glutamate receptor 1" 15) ("GRM1 protein" 1)))
 ("UP:Q13257"
  (("Mad2" 913) ("MAD2" 205) ("MAD2L1" 27) ("mad2" 21) ("Mad2-" 11) ("-Mad2" 5)
   ("most Mad2" 3) ("than wild type Mad2" 3) ("MAD2-" 3)
   ("undetectable Mad2" 3) ("Mad2 protein" 3) ("Mad2 molecule" 2)
   ("doxycycline-inducible and RNAi-resistant GFP-AID-tagged BubR1 or AID-YFP-tagged Mad2"
    2)
   ("substoichiometric Mad2" 2) ("further open Mad2 molecule" 1)
   ("than Mad2 ( xref )" 1) ("Mad2 of Cdc20’s" 1) ("avian Mad2" 1)))
 ("UP:Q13258" (("DP1 receptor" 2) ("prostaglandin D2 receptor" 2)))
 ("UP:Q13261"
  (("IL-15Rα" 19) ("IL-15Ra" 8) ("interleukin-15 receptor" 2) ("IL-15Rα-" 1)))
 ("UP:Q13263"
  (("KAP1" 597) ("KAP-1" 273) ("Kap1" 127) ("TRIM28" 108) ("pKAP-1" 47)
   ("TIF1β" 8) ("-KAP1" 8) ("Trim28" 4) ("KAP1 protein" 3) ("pKAP1" 3)
   ("the transcriptional repressor KAP1" 2)
   ("the transcriptional co-repressor KAP-1" 2) ("unphosphorylatable KAP-1" 1)
   ("the KAP1’s" 1) ("SUMOylation-defective KAP-1" 1)
   ("the transcriptional co-repressor KAP1" 1)
   ("heterochromatic factor KAP1" 1) ("phospho-KAP1 (824)-peptide" 1)
   ("KAP-1-" 1) ("the pleiotropic transcriptional corepressor Kap1" 1)
   ("exogenous Kap1" 1) ("Tif1β" 1) ("the transcriptional repressor KAP-1" 1)
   ("Krip1" 1)))
 ("UP:Q13268" (("protein D" 6) ("Protein D" 2)))
 ("UP:Q13275" (("SEMA3F" 24) ("Sema3F" 3)))
 ("UP:Q13277" (("syntaxin-3" 6) ("Syntaxin 3" 5) ("syntaxins-3" 1)))
 ("UP:Q13283"
  (("G3BP1" 685) ("G3BP" 21) ("G3BP1 protein" 4)
   ("resveratrol directly targets G3BP1" 2) ("G3BP-1" 2)
   ("Ras GTPase-activating protein-binding protein 1" 2)
   ("its translational target G3BP1" 1) ("some cancer cells made G3BP1" 1)))
 ("UP:Q13285"
  (("group A" 182) ("SF-1" 114) ("Group A" 66) ("steroidogenic" 41)
   ("group A (XPA)" 11) ("steroidogenic factor 1" 9) ("Steroidogenic" 6)
   ("nuclear receptor subfamily 5" 6) ("group A protein (FANCA)" 3)
   ("Steroidogenic factor 1" 3) ("group A ( XPA )" 3)
   ("group A (XPA) protein" 3) ("steroidogenic factor-1" 2) ("Group A (XPA)" 1)
   ("NR5A1" 1) ("SF-1 protein" 1)))
 ("UP:Q13286"
  (("Cln3" 135) ("-Cln3" 8) ("cln3" 6) ("CLN3" 6) ("Cln3 protein" 2)
   ("the endosomal/lysosomal membrane
protein-coding gene CLN3"
    2)
   ("residual Cln3" 1)))
 ("UP:Q13287" (("NMI" 88) ("killed NMI" 3) ("nmi" 2) ("than killed NMI" 1)))
 ("UP:Q13291"
  (("SLAM" 69) ("CD150" 32) ("SLAMF1" 7)
   ("signaling lymphocytic activation molecule family member 1" 5) ("Slamf1" 3)
   ("SLAM protein" 3) ("signaling lymphocytic activation molecule" 1)))
 ("UP:Q13296" (("MGB1" 7) ("Mammaglobin A" 1))) ("UP:Q13303" (("KCNAB2" 3)))
 ("UP:Q13304" (("GPR17" 3))) ("UP:Q13308" (("protein kinase 7" 6) ("PTK7" 3)))
 ("UP:Q13309"
  (("Skp2" 3469) ("SKP2" 866) ("Skp2 protein" 130)
   ("S-phase kinase-associated protein 2" 34) ("skp2" 22)
   ("F-box protein Skp2" 20) ("SKP2 protein" 16) ("-Skp2" 16)
   ("S-phase kinase associated protein 2" 10)
   ("S-phase kinase-associated protein-2" 7) ("FBXL1" 3)
   ("overexpressed Skp2" 2) ("p45SKP2" 2) ("F-box protein SKP2" 2)
   ("the key negative posttranslational regulator SKP2" 2)
   ("than wild-type Skp2" 2) ("exogenous Skp2" 2)
   ("S-phase kinase associated protein-2" 2) ("Skp2 Protein" 2) ("SKP2-" 1)
   ("particular Skp2" 1) ("than Skp2 ( P = 0.037)" 1)
   ("artificially overexpressed Skp2" 1) ("than Skp2" 1) ("Skp2-" 1)
   ("the phospho-mimetic Skp2" 1) ("the non-phosphorylatable Skp2" 1)
   ("cellular Skp2" 1) ("than the wt Skp2 in cytosol and nucleus ( xref )" 1)
   ("than the human Skp2 protein ( xref , right panel)" 1) ("SKp2" 1)
   ("Skp2 molecule" 1) ("FBL1" 1) ("much less Skp2" 1) ("namely SCF Skp2" 1)))
 ("UP:Q13310" (("PABPC4" 6) ("iPABP" 2) ("PABP4" 1) ("APP1" 1)))
 ("UP:Q13315"
  (("ATM" 18673) ("Atm" 787) ("ATM protein" 398)
   ("ataxia telangiectasia mutated" 201) ("ataxia telangiectasia" 172)
   ("ATM-" 136) ("Ataxia telangiectasia" 64) ("As-TM" 56) ("atm" 55)
   ("pATM" 47) ("Ataxia telangiectasia mutated" 45)
   ("ataxia telangiectasia mutated (ATM)" 42)
   ("Ataxia Telangiectasia Mutated" 40) ("ataxia telangiectasia-mutated" 39)
   ("Ataxia Telangiectasia" 37) ("functional ATM" 25)
   ("ataxia telangiectasia (AT)" 20) ("ATE" 13)
   ("ataxia telangiectasia-mutated (ATM)" 13) ("ATM−" 12) ("ates" 11)
   ("-ATM" 11) ("p-ATM" 10) ("Ataxia Telangiectasia Mutated (ATM)" 9)
   ("P-ATM" 8) ("ATM molecule" 7) ("residual ATM protein" 7)
   ("Ataxia telangiectasia-mutated" 6) ("defective ATM" 5)
   ("Ataxia Telangiectasia-mutated" 5) ("ataxia telangiectasia mutated-" 5)
   ("Ataxia Telangiectasia Mutated ( ATM )" 5) ("aberrant ATM" 5)
   ("Ataxia telangiectasia mutated (ATM)" 4)
   ("Ataxia Telangiectasia Mutated protein (ATM)" 4) ("ATM peptide" 4)
   ("aTM" 4) ("the apical kinase ATM" 4) ("overexpressed murine ATM" 4)
   ("lack functional ATM" 3) ("exogenous ATM" 3) ("A-T mutated" 3)
   ("Ataxia Telangiectasia-Mutated" 3) ("ATM serine/threonine kinase" 3)
   ("a partially functional ATM" 3) ("ate" 3) ("the residual ATM" 3)
   ("Ser 1981-phosphorylated ATM" 3)
   ("Ataxia Telangiectasia Mutated (ATM) protein" 3)
   ("Ataxia Telangiectasia mutated" 3) ("ATM (ATM-KD) protein" 3)
   ("neuronal ATM" 3) ("—ATM" 3) ("cellular ATM" 2)
   ("the DDR apical kinase ATM" 2) ("an active monomeric ATM" 2)
   ("namely serine/threonine protein kinase ATM" 2) ("hyperactive ATM" 2)
   ("Given ATM" 2) ("strong ATM" 2) ("serine 1981-phosphorylated ATM" 2)
   ("Granta-519 and UPN2 cell lines lack functional ATM" 2)
   ("ataxia telangiectasia-mutated ( ATM )" 2)
   ("ataxia telangiectasia mutated protein (ATM)" 2) ("more ATM" 2)
   ("normal ATM" 2) ("“ATM”" 2) ("strong ATM protein" 2)
   ("non-functional ATM" 2) ("a functional ATM" 2) ("this studying ATM’s" 1)
   ("than ATM [ xref ]" 1) ("–ATM" 1) ("genotoxic stress induced ATM" 1)
   ("IKK-associated ATM" 1)
   ("ataxia
telangiectasia mutated"
    1)
   ("ataxia telangiectasia mutated ( ATM )" 1)
   ("The apical stress sensor kinase ATM" 1) ("monomeric ATM" 1)
   ("a commercial ATM" 1) ("almost undetectable ATM protein" 1)
   ("peroxisomal ATM" 1) ("immunoreactive phospho-ATM" 1)
   ("the tiled region around ATM" 1) ("Exogenous ATM" 1) ("dimeric ATM" 1)
   ("genuine ATM" 1) ("Q13315" 1) ("ataxia telangiectasia mutated protein" 1)
   ("the defective ATM" 1) ("-ataxia telangiectasia mutated" 1)
   ("UV-irradiated ATM −/−" 1) ("primary ATM" 1)
   ("immunoreactive ATM protein" 1) ("A-T Mutated" 1) ("–Atm" 1)
   ("A-T mutated protein (ATM)" 1) ("The extranuclear ATM" 1)
   ("heterozygous Atm" 1) ("Intranuclear ATM protein" 1)
   ("Mitotically-activated ATM" 1) ("mitotically-activated ATM" 1)
   ("targeting ATM" 1) ("exogenous FLAG-tagged ATM" 1) ("exactly ATM" 1)
   ("than Atm  −/−" 1) ("the original ATM" 1) ("telo1" 1)
   ("than endogenous Atm using metaphase FISH" 1)
   ("D2889A, and Q2730P mutant dimeric human ATM" 1) ("nonfunctional ATM" 1)
   ("previously described ATM-" 1) ("our genomic ATM" 1) ("targeted ATM" 1)
   ("absent ATM protein" 1) ("that ATM’s" 1) ("Ataxia Telangiectasia (AT)" 1)
   ("non functional ATM" 1)
   ("most cells
ATM"
    1)
   ("A-T patients lack functional ATM" 1)
   ("Ataxia
Telangiectasia"
    1)
   ("Ataxia
Telangiectasia Mutated"
    1)
   ("vertebrates ATM's" 1) ("than ATM" 1) ("Ataxia telangiectasia-" 1)
   ("the chromatin-associated ATM" 1) ("key ATM" 1)
   ("functionally intact ATM" 1)))
 ("UP:Q13316"
  (("Dmp1" 338) ("DMP1" 175) ("Dmp1 protein" 12) ("DMP1 protein" 10)
   ("Dmp1 (RAX)" 8) ("dentin matrix protein 1" 5) ("Dmp-1" 4) ("DMP-1" 3)
   ("Dentin matrix protein 1" 2) ("Dmp1 ( xref ) suggesting that Dmp1’s" 1)))
 ("UP:Q13322"
  (("Grb10" 337) ("GRB10" 140) ("RSS" 20) ("RSSs" 17)
   ("growth factor receptor-bound protein 10" 11)
   ("growth factor receptor bound protein 10" 5) ("strong cryptic RSSs" 3)
   ("Grb10 protein" 3) ("than Grb10 ( xref )" 2) ("than Grb10" 2)
   ("GRB10 protein" 1) ("proximal 12/23 RSSs" 1) ("no strong cryptic RSSs" 1)
   ("grb10" 1) ("−RSS" 1) ("non-phosphorylatable Grb10" 1)
   ("more Grb10 protein" 1) ("increases Grb10’s" 1)
   ("HuR-associated Grb10" 1)))
 ("UP:Q13323"
  (("Bik" 212) ("BIK" 148) ("NBK" 31) ("Nbk" 20)
   ("the pro-apoptotic gene BIK" 1) ("-BIK" 1) ("Bik-" 1) ("BP4" 1)))
 ("UP:Q13324" (("CRHR2" 5))) ("UP:Q13325" (("IFIT5" 5)))
 ("UP:Q13326" (("SGCG" 1)))
 ("UP:Q13330"
  (("MTA1" 655) ("MTA-1" 20) ("MTA1 protein" 5) ("MTA1s" 3) ("Mta1" 3)
   ("Metastasis Associated 1" 2) ("metastasis associated 1" 2)
   ("MTA1s peptide" 2) ("the SOX2-associated protein Mta1" 2)
   ("exogenous MTA1" 1) ("a manual MTA-1" 1)
   ("the Beecher Instruments Manual Tissue Arrayer MTA-1" 1)))
 ("UP:Q13332" (("RPTPs" 20) ("RPTPσ" 10) ("RPTPsigma" 3) ("PTPRs" 1)))
 ("UP:Q13336" (("JK" 29) ("Ute" 8) ("pJK" 3))) ("UP:Q13342" (("SP140" 2)))
 ("UP:Q13347"
  (("TRIP-1" 122) ("subunit I" 34) ("EIF3I" 2) ("eIF3I" 2) ("36kDa" 2)
   ("eIF3i" 1) ("eIF3β" 1)))
 ("UP:Q13351" (("EKLF" 91) ("KLF1" 12) ("Klf1" 1)))
 ("UP:Q13352" (("ITGB3BP" 6) ("NRIF3" 2))) ("UP:Q13356" (("PPIL2" 5)))
 ("UP:Q13361" (("Mfap5" 5) ("MFAP5" 4) ("Magp2" 1)))
 ("UP:Q13362" (("PPP2R5C" 7)))
 ("UP:Q13363"
  (("CtBP1" 671) ("CtBP" 531) ("CtBP1 protein" 14) ("CTBP1" 12)
   ("CtBP protein" 3) ("transcriptional co-repressor CtBP1" 3)
   ("transcriptional corepressor CtBP" 3)
   ("transcriptional repressor EZH2 and co-repressor CtBP1" 1)
   ("the transcriptional corepressor CtBP" 1) ("than CtBP1" 1) ("CTBP" 1)
   ("Lentiviral expressed CtBP1" 1) ("the transcriptional co-repressor CtBP" 1)
   ("the 16 C-terminal amino acids of CtBP1 that are unique" 1)
   ("the transcriptional co-repressor CtBP1" 1)))
 ("UP:Q13368" (("MPP3" 33)))
 ("UP:Q13370" (("PDE3B" 49) ("phosphodiesterase 3B" 4)))
 ("UP:Q13371" (("PDCL" 10)))
 ("UP:Q13387" (("JIP2" 7) ("IB2" 3) ("MAPK8IP2" 1)))
 ("UP:Q13393"
  (("PLD1" 919) ("PLD-1" 34) ("phospholipase D1" 18) ("overexpressed PLD1" 8)
   ("PLD1-" 6) ("auto-regulatory PLD1" 2) ("than PLD1-S505Q" 1) ("than PLD1" 1)
   ("–PLD1" 1) ("PLD1 protein" 1)))
 ("UP:Q13402"
  (("myosin VIIA" 39) ("myosin VIIa" 16) ("Myo7a" 7) ("Myo7A" 5) ("MYO7A" 1)))
 ("UP:Q13404"
  (("UEV1A" 77) ("Uev1" 34) ("UEV1" 32) ("UBE2V1" 12) ("CROC1" 3)
   ("than UEV1A" 1) ("UBE2V" 1)))
 ("UP:Q13405" (("NOF" 2)))
 ("UP:Q13410"
  (("BT" 837) ("Btn1a1" 53) ("bT" 14) ("Bt" 8) ("BTN" 3) ("Btn" 2)
   ("98 developed BT" 2) ("unique bT" 1) ("btn" 1)
   ("transformed luminal cells BT474" 1) ("pBT" 1) ("subsequent BT" 1)))
 ("UP:Q13415" (("ORC1L" 5) ("HsOrc1" 2)))
 ("UP:Q13416"
  (("Orc2" 120) ("ORC2" 63) ("origin recognition complex" 29)
   ("origin recognition complex (ORC)" 21) (NIL 5) ("orc2" 3)
   ("origin recognition complex subunit 2" 3) ("Orc2 protein" 2) ("ORC2L" 1)))
 ("UP:Q13418"
  (("ILK" 743) ("ILKWT" 10) ("ILK1" 7) ("overexpressed ILK" 2) ("ILK-" 2)
   ("proper ILK" 2) ("Aberrant ILK" 1) ("Further inhibiting ILK" 1)
   ("the upstream-located β 1-integrin signalling pathway protein kinases ILK"
    1)
   ("ILK–" 1)))
 ("UP:Q13421"
  (("mesothelin" 347) ("MPF" 86) ("Mesothelin" 42) ("SMR" 7)
   ("mesothelin protein" 3) ("MSLN" 3) ("CAK-1" 2)
   ("expressed at least some mesothelin" 2) ("Smr" 1)))
 ("UP:Q13422"
  (("IKZF1" 125) ("Ikaros" 42) ("Ikzf1" 15) ("IKAROS" 5)
   ("IKAROS family zinc finger 1" 2)))
 ("UP:Q13423"
  (("nicotinamide nucleotide transhydrogenase (NNT)" 1) ("NNT" 1)
   ("nicotinamide nucleotide transhydrogenase" 1)))
 ("UP:Q13424" (("Snta1" 5) ("SNTA1" 4) ("Snt1" 1)))
 ("UP:Q13426"
  (("XRCC4" 211) ("Xrcc4" 12) ("repair in Chinese hamster" 7)
   ("X-ray repair complementing defective repair in Chinese hamster cells 4"
    1)))
 ("UP:Q13428" (("Treacher" 4) ("Tcof1" 2) ("TCOF1" 1)))
 ("UP:Q13432"
  (("Unc119" 236) ("UNC119" 25) ("HRG4" 7) ("Exogenous Unc119" 2)
   ("unc119" 1)))
 ("UP:Q13433"
  (("LIV-1" 298) ("ZIP6" 178) ("LIV-1 protein" 24) ("LIV1" 10) ("SLC39A6" 8)
   ("LIV-1 peptide" 5) ("ZIP6 protein" 4) ("zip6" 3)
   ("plasma-membrane-located ZIP6" 2) ("Zip6" 2)
   ("specifically LIV-1 protein" 2) ("overexpressing LIV-1 protein" 2)
   ("clinical samples significantly places ZIP6" 1) ("exogenous LIV-1" 1)))
 ("UP:Q13435" (("SAP145" 14) ("SF3B2" 1)))
 ("UP:Q13438" (("OS-9" 7) ("OS9" 1) ("Os9" 1)))
 ("UP:Q13439" (("p230" 20) ("P230" 2)))
 ("UP:Q13442" (("PDGFA associated protein 1" 2) ("PDAP1" 1)))
 ("UP:Q13443" (("ADAM9" 87) ("ADAMs" 79) ("ADAM-9" 24) ("Adam9" 2)))
 ("UP:Q13444"
  (("αvβ3" 616) ("ADAM15" 6) ("than αvβ3" 1) ("αvβ3-" 1) ("integrin αvβ3" 1)
   ("ADAM 15" 1)))
 ("UP:Q13449"
  (("lamp" 378) ("LAMP" 40) ("a germicidal lamp" 10) ("ultraviolet lamp" 3)
   ("an actual arc lamp" 2) ("A 365 nm UV lamp" 2)
   ("using long-wave ultraviolet (UV) lamp" 2) ("a UV germicidal lamp" 1)
   ("Lumencor Spectra 7
epifluorescent lamp"
    1)
   ("using 312 nm UV lamp" 1) ("LSAMP" 1) ("a U-RFL-T fluorescent lamp" 1)
   ("an incandescent lamp" 1) ("an ultraviolet lamp" 1)
   ("a germicidal UV lamp" 1) ("a germicidal ultraviolet lamp" 1)))
 ("UP:Q13451"
  (("FKBP5" 285) ("Fkbp5" 7) ("FK506 binding protein 5" 2)
   ("FK506-binding protein 5" 2)))
 ("UP:Q13454" (("TUSC3" 20) ("N33" 8)))
 ("UP:Q13459" (("MYO9B" 13) ("myosin IXB" 2)))
 ("UP:Q13464"
  (("ROCK1" 2272) ("ROCK-1" 170) ("ROCKI" 137) ("p160ROCK" 97) ("Rock1" 68)
   ("ROCK1 protein" 38) ("ROCK-I" 28) ("Rock-1" 22) ("p160 ROCK" 19)
   ("ROCK1-" 16) ("ROKβ" 11) ("ROCK1 molecule" 8) ("ROCK 1" 6)
   ("Rho-associated protein kinase 1" 6) ("ROCK-1 protein" 5) ("-ROCK1" 3)
   ("targeting ROCK1" 3) ("Rho-associated kinase ROCK1" 2)
   ("immunoprecipitated flag-tagged ROCKI protein" 2) ("ROCKI protein" 2)
   ("the Rho-associated protein kinase ROCK1" 2) ("fewer ROCK1-" 2)
   ("p160Rock" 2) ("monoclonal rabbit antibody ROCK-1" 2) ("p160-ROCK" 2)
   ("p160-ROCK1" 2) ("ROCK1 (GGUGAUUGGUAGAGGUGCA)" 1)
   ("than ROCK1 (p=0.01, n=3, xref )" 1) ("than ROCK1 [ xref ]" 1)
   ("a dominant negative (DN) ROCK1 molecule" 1)
   ("directly targets oncogene ROCK-1" 1) ("mouse monoclonal ROCK1" 1)
   ("exogenous ROCK1" 1) ("cellular ROCK1" 1) ("than ROCKI" 1)
   ("specifically target either ROCK1" 1)))
 ("UP:Q13467" (("FZD5" 14) ("Fzd5" 3) ("Frizzled-5" 1) ("Fzd-5" 1) ("Fz5" 1)))
 ("UP:Q13469"
  (("NFATc2" 601) ("NFAT1" 153) ("NFATs" 20) ("NFATC2" 17)
   ("overexpressed NFATc2" 4) ("Nfatc2" 3) ("-NFATc2" 3) ("NFATp" 3)
   ("NF-ATc2" 2) ("NFATc2 protein" 2) ("NFATc2(688–921) peptide" 2)
   ("NFATc2-" 1) ("Most NFATs" 1) ("NFAT1 protein" 1)))
 ("UP:Q13470" (("TNK1" 5))) ("UP:Q13472" (("TOP3" 4) ("TOP3A" 2)))
 ("UP:Q13477"
  (("Madcam1" 181) ("MAdCAM-1" 16)
   ("mucosal vascular addressin cell adhesion molecule 1" 8) ("MADCAM1" 5)
   ("mucosal addressin cell adhesion molecule 1" 4)
   ("Mucosal vascular addressin cell adhesion molecule 1" 2)
   ("endothelial MAdCAM-1" 1) ("soluble MAdCAM-1" 1) ("Madcam1 protein" 1)
   ("MadCAM-1" 1)))
 ("UP:Q13478" (("IL18R1" 16) ("Il18r1" 4)))
 ("UP:Q13480"
  (("Gab1" 1621) ("GAB1" 377) ("Gab-1" 17) ("Gab1 peptide" 14) ("GAB-1" 14)
   ("Grb2-associated binder 1" 8) ("Gab1 protein" 6) ("pGab1" 6) ("Gab1-" 3)
   ("Grb2-associated
binder-1"
    3)
   ("Grb2-associated binder-1" 3) ("Grb2 associated binder 1" 3)
   ("GRB2-associated binder 1" 3)
   ("heterozygous animals produced no live Gab1 −/−" 2) ("around GAB1" 2)
   ("growth factor receptor bound protein 2-associated protein 1" 2)
   ("GAB1 protein" 2) ("Grb2-associated binder 1 (Gab1) protein" 2)
   ("The N-terminal 300 amino acids of Gab1 (1–300)" 2) ("exogenous Gab1" 1)
   ("than wild-type Gab1 ( xref B)" 1) ("than Gab1" 1)
   ("embryonic and chimeric Gab1-" 1) ("p-Gab1" 1) ("GAB1-" 1) ("pGAB1" 1)
   ("less Gab1" 1)))
 ("UP:Q13485"
  (("Smad4" 1789) ("SMAD4" 787) ("DPC4" 54) ("Smad4 protein" 28) ("Smad 4" 24)
   ("smad4" 10) ("SMAD4 protein" 6) ("MADH4" 6) ("smad-4" 6) ("Smad-4" 5)
   ("Smad4−" 4) ("SMAD-4" 3) ("SMAD 4" 3) ("Smad 4 protein" 2) ("SMAD4-" 2)
   ("overexpressed Smad4" 2) ("coexpressed Smad4" 2) ("smad4 protein" 2)
   ("vehicle-treated mice retained Smad4" 2) ("Smad 4-" 1) ("less Smad4" 1)
   ("functional Smad4" 1) ("-Smad4" 1)
   ("four different retroviral short hairpin RNA (shRNA) Smad4" 1)
   ("proof Smad4's" 1) ("Smad4-" 1) ("than full-length SMAD4" 1) ("Madh4" 1)
   ("serum-deprivation-induced Smad4" 1) ("SMAD family member 4" 1)))
 ("UP:Q13488" (("TCIRG1" 4) ("normal TCIRG1" 1)))
 ("UP:Q13489"
  (("cIAP2" 226) ("cIAP-2" 161) ("API2" 112) ("BIRC3" 68) ("c-IAP2" 35)
   ("Birc3" 34) ("API-2" 22) ("c-IAP-2" 13)
   ("inhibitor of apoptosis protein 1" 8) ("birc3" 7) ("CIAP2" 6)
   ("inhibitor of apoptosis protein-1" 3)
   ("cellular inhibitor of apoptosis protein 1" 3) ("cIAP2 protein" 2)
   ("cIAP-2 protein" 2) ("baculoviral IAP repeat-containing 3" 2) ("c-iap2" 1)
   ("IAP-1" 1)))
 ("UP:Q13490"
  (("cIAP1" 317) ("c-IAP1" 235) ("cIAP-1" 219) ("API-1" 134) ("BIRC2" 56)
   ("c-IAP-1" 19) ("CIAP1" 13) ("cIAP1 protein" 7) ("Birc2" 5) ("IAP2" 5)
   ("c-IAP1 protein" 5)
   ("A synthetic IAP antagonist selectively targets c-IAP1" 2)
   ("overexpressed cIAP-1" 2) ("MIHB" 1) ("cIAP1-" 1)
   ("baculoviral IAP repeat-containing 2" 1) ("birc2" 1)
   ("specifically target c-IAP1" 1) ("–c-IAP1" 1) ("HIAP2" 1) ("cIap-1" 1)))
 ("UP:Q13491"
  (("GPM6B" 49) ("glycoprotein M6B" 5) ("Glycoprotein M6B" 4)
   ("GPM6B peptide" 3) ("the neuronal membrane glycoprotein M6B" 3)))
 ("UP:Q13492" (("PICALM" 14)))
 ("UP:Q13495" (("F18" 10) ("human commensal bacterial E. coli F18" 1)))
 ("UP:Q13496"
  (("MTM1" 7) ("myotubularins" 2) ("myotubularin" 2) ("CG2" 2)
   ("myotubularin 1" 1) ("Myotubularin" 1)))
 ("UP:Q13501"
  (("p62" 2293) ("SQSTM1" 512) ("Orca" 80) ("ORCA" 70) ("P62" 40)
   ("sequestosome 1" 27) ("p62 protein" 25) ("Sequestosome 1" 14) ("Sqstm1" 10)
   ("sequestosome-1" 7) ("p62-" 7) ("insoluble SQSTM1" 7)
   ("ubiquitin-binding protein p62" 6) ("insoluble p62" 5) ("sequestosome1" 4)
   ("Zip3" 3) ("the autophagic substrates p62" 2)
   ("p62 (sequestosome-1/SQSTM1) protein" 2) ("the autophagic substrate p62" 2)
   ("Sequestosome-1" 2) ("the autophagic adaptor p62" 2) ("p62/ZIP" 1)
   ("Exogenous p62" 1) ("smaller SQSTM1" 1) ("more p62 protein" 1)
   ("than p62" 1) ("cellular p62" 1) ("soluble p62" 1)
   ("p62(SQSTM1) protein" 1) ("SQSTM1-" 1) ("autophagic degradation p62" 1)
   ("more p62" 1) ("the autophagic adapter protein p62" 1)
   ("occasional small p62" 1) ("The autophagic adaptor p62" 1) ("-p62" 1)))
 ("UP:Q13503" (("MED21" 1)))
 ("UP:Q13505"
  (("MTX" 212) ("Metaxin 1" 7) ("Metaxin1" 2) ("Mtx" 1)
   ("chemotherapeutic agent MTX" 1) ("metaxin-1" 1) ("metaxin 1" 1)))
 ("UP:Q13506" (("NAB1" 6))) ("UP:Q13507" (("TRPC3" 124) ("more TRPC3" 1)))
 ("UP:Q13508" (("ART3" 3) ("Art3" 1)))
 ("UP:Q13509" (("TUBB3" 67) ("Tubb3" 3) ("beta-4" 2)))
 ("UP:Q13510"
  (("AC" 1881) ("Ac" 818) ("A–C" 211) ("A-C" 159) ("ac" 76) ("a–c" 64)
   ("a-c" 40) ("AC−" 19) ("acid ceramidase" 16) ("-AC" 15)
   ("Acid ceramidase" 12) ("Ac-" 7) ("ASAH1" 4) ("acid ceramidase (AC)" 3)
   ("aC" 3) ("–AC" 2) ("AC-" 2) ("whose tumor AC" 2) ("A-c" 2)
   ("peripheral AC" 2) ("papillary and solid AC" 2) ("CDC accelerated AC" 2)
   ("palliative AC" 2) ("normal AC" 2) ("benign AC" 1) ("their benign AC" 1)
   ("human genome sequence AC069148.6" 1) ("invasive mucinous and acinar AC" 1)
   ("A−C" 1) ("all Caucasian AC" 1) ("-Ac" 1) ("Figure  xref A a-c" 1)
   ("-ac" 1) ("the human BAC clone AC025164" 1) ("accelerated AC" 1)
   ("percent AC" 1) ("“AC”" 1) ("pAC" 1) ("whose planar AC" 1)))
 ("UP:Q13516"
  (("Olig2" 335) ("OLIG2" 59) ("olig2" 28) ("Oligo 2" 9) ("OLIG2 protein" 5)
   ("Olig2 protein" 1)
   ("the central nervous system-restricted transcription factor Olig2" 1)
   ("-Olig2" 1)))
 ("UP:Q13519"
  (("OFQ" 8) ("orphanin FQ" 3) ("prepronociceptin (PNOC)" 2) ("PNOC" 2)
   ("prepronociceptin" 1) ("Orphanin FQ" 1)))
 ("UP:Q13520" (("kidney specific" 3)))
 ("UP:Q13522"
  (("I1" 60) ("I 1" 17) ("i1" 5) ("i  1" 4)
   ("protein phosphatase inhibitor 1" 3) ("i -1" 2) ("i 1" 1) ("i  -1" 1)
   ("PPP1R1A" 1)))
 ("UP:Q13523" (("PRP4K" 132) ("PRPF4B" 3)))
 ("UP:Q13526"
  (("PIN1" 390) ("Pin-1" 20) ("NIMA-interacting 1" 7) ("PPIase Pin1" 6)
   ("Peptidyl-prolyl cis–trans isomerase NIMA-interacting 1" 5)
   ("trans isomerase NIMA-interacting 1" 4)
   ("peptidylprolyl cis/trans isomerase, NIMA-interacting 1" 3) ("“PIN1”" 2)
   ("PIN1 protein" 2) ("soluble PIN1" 2)
   ("“peptidylprolyl cis/trans isomerase, NIMA-interacting 1”" 1)
   ("peptidylprolyl cis/trans isomerase,
NIMA-interacting 1"
    1)))
 ("UP:Q13530" (("SERINC3" 1)))
 ("UP:Q13535"
  (("wortmannin" 1357) ("Wortmannin" 454) ("WM" 12) ("wortmannin (WM)" 10)
   ("Wortmannin (WN)" 4) ("we first used wortmannin" 3) ("Frp1" 2)
   ("Ataxia Telangiectasia and Rad3-Related protein" 1) ("than wortmannin" 1)
   ("ATR serine/threonine kinase" 1) ("than WM" 1) ("FRP1" 1)
   ("Wortmannin (WM)" 1) ("wortmannin-" 1)
   ("the classical PI3K inhibitor wortmannin" 1)))
 ("UP:Q13536" (("CROC4" 1)))
 ("UP:Q13541"
  (("4E-BP1" 2619) ("4EBP1" 1362) ("4E-BP" 420) ("p-4E-BP1" 253)
   ("p-4EBP1" 249) ("p4EBP1" 168) ("p4E-BP1" 107) ("EIF4EBP1" 52) ("-4EBP1" 50)
   ("4E-binding protein 1" 41)
   ("eukaryotic translation initiation factor 4E binding protein 1" 29)
   ("P-4EBP1" 24) ("4eBP1" 23) ("4EBP1 peptide" 20) ("P-4E-BP1" 19)
   ("eIF4E-binding protein 1" 16) ("4E-BP1 protein" 15) ("eIF4E-BP1" 12)
   ("PHAS-I" 9) ("the translational inhibitor 4E-BP1" 9) ("4EBP1 protein" 8)
   ("p-4EBP-1" 8) ("total and phosphorylated 4E-BP1" 7) ("4E–BP1" 6)
   ("eIF4E-BP-1" 6) ("4-EBP1" 5) ("4ebp1" 5)
   ("the translational repressor 4E-BP1" 5) ("4EB-P1" 4)
   ("total or phosphorylated (Thr37/46) 4E-BP1" 4) ("than 4E-BP1" 3)
   ("eIF4E–BP1" 3) ("eIF4EBP1" 3) ("the small translational repressor 4E-BP" 2)
   ("the translational regulator 4E-BP1" 2) ("strong nuclear 4EBP1" 2)
   ("strong cytoplasmic p4EBP1" 2) ("p-4EBP1 protein" 2)
   ("factor 4E Binding Protein 1" 2)
   ("the cap-dependent translation regulator 4E-BP1" 2)
   ("overexpressed p-4E-BP1" 2) ("4e-bp1" 2) ("than 4E-BP" 2)
   ("the previously characterized substrate 4E-BP" 2) ("p4E-BP1 protein" 2)
   ("a rabbit monoclonal phospho-4E-BP1" 2) ("4E-BP1-" 2)
   ("Western blots demonstrated decreased p-4E-BP1" 2) ("4E-BP1 (WT)" 2)
   ("the 4E-BP’s" 1)
   ("p4EBP1, downstream effectors of the mTOR kinase ( xref – xref )" 1)
   ("translational suppressor 4EBP1" 1) ("4eBp1" 1) ("p4eBp1" 1)
   ("phospho/total- 4EBP1" 1) ("p4E-BP" 1) ("p-4E-BP" 1)
   ("the cap-dependent translation inhibitor 4E-BP1" 1)
   ("than low p-4E-BP1 ( P < 0.01)" 1) ("than 4E-BP1 ( xref )" 1)
   ("Recently Imai et al. reported 4E-BP" 1) ("total cellular eIF4E-BP1" 1)
   ("p4EBP-1" 1) ("non-phosphorylatable 4E-BP(TA)" 1) ("than 4E-BP(WT)" 1)
   ("the phospho-mimetic 4E-BP(TE)" 1) ("p-EIF4EBP1" 1)
   ("more phospho-4E-BP" 1)
   ("the previously characterized dLRRK substrate 4E-BP" 1)
   ("the translational repressor 4EBP1" 1)
   ("rabbit monoclonal anti-phosphoThr37/46 4E-BP1" 1) ("4Ebp1" 1) ("P4EBP1" 1)
   ("particular 4E-BP1" 1) ("substantial 4E-BP1" 1)
   ("4E–binding protein 1" 1)))
 ("UP:Q13542" (("4E-BP2" 64) ("4EBP2" 10) ("Eif4ebp2" 1) ("p4EBP2" 1)))
 ("UP:Q13546"
  (("RIP1" 1524) ("RIPK1" 270) ("Ripk1" 73) ("Rip1" 31)
   ("receptor-interacting protein 1" 30) ("receptor interacting protein 1" 25)
   ("RIP-1" 8) ("receptor interacting protein-1" 7) ("RIPK" 6)
   ("Receptor-interacting protein 1" 5) ("prosurvival RIP1" 5)
   ("receptor-interacting protein-1" 4) ("RIP1-" 4) ("RIP1 protein" 4)
   ("Receptor-interacting serine/threonine-protein kinase 1" 3)
   ("programmed necrosis mediator RIP1" 3) ("TNFR1-associated RIP1" 3)
   ("Overexpressed RIP1" 2) ("targeting RIP1" 2) ("Rip-1" 2)
   ("More RIPK1 protein" 2) ("hyper-ubiquitinated RIP1" 1)
   ("the essential necrosome component RIP1" 1) ("kinase defective RIP1" 1)
   ("than RIP1" 1) ("monomeric RIP1" 1) ("more RIPK1" 1) ("RIPK1 protein" 1)))
 ("UP:Q13547"
  (("HDAC1" 5646) ("histone deacetylase 1" 127) ("Hdac1" 49) ("HDAC-1" 36)
   ("HDAC1 protein" 28) ("-HDAC1" 23) ("RPD3" 20) ("HDAC1-" 14)
   ("deacetylase 1" 7) ("virion-associated HDAC1" 7)
   ("Histone deacetylase 1" 6) ("“Fli1-p300-HDAC1”" 5) ("Deacetylase 1" 5)
   ("HD-1" 4) ("overexpressed HDAC1" 4) ("selectively target HDAC1" 3)
   ("than wild-type HDAC1" 3) ("–HDAC1" 2) ("than HDAC1" 2)
   ("histone deacetylase 1 (HDAC1) protein" 2)
   ("CHD4-associated NuRD subunits HDAC1" 2)
   ("the transcriptional repressor HDAC1" 2) ("less HDAC1" 2)
   ("the major transcriptional co-repressor HDAC1" 2)
   ("completely around HDAC1" 1) ("miR-449b directly targets HDAC1" 1)
   ("histone deacetylase-1" 1) ("cellular HDAC1" 1) ("at least HDAC1" 1)
   ("p53-associated acetylated HDAC1" 1) ("P53-associated HDAC1" 1)
   ("the transcriptional co-repressor HDAC1" 1) ("than HDAC1 (5% and 6%)" 1)
   ("HIV-1 virion-associated HDAC1" 1) ("virion-associated HDAC1 H141A" 1)
   ("HDACs-1" 1) ("significantly more HDAC1" 1)
   ("previously validated target HDAC1" 1) ("hdac1" 1)
   ("than wild type HDAC1" 1) ("the structurally highly-related HDAC1" 1)))
 ("UP:Q13554" (("CAMK2" 2) ("CAMK2B" 1)))
 ("UP:Q13555"
  (("CaMKII" 782) ("CaMK" 153) ("CamKII" 42) ("camkII" 3) ("CamK" 3)
   ("pCaMKII" 2) ("CAMK2G" 2)))
 ("UP:Q13557" (("CaMK2D" 1) ("CAMK2D" 1)))
 ("UP:Q13561" (("p50 dynamitin" 6) ("DCTN2" 2)))
 ("UP:Q13562"
  (("NeuroD1" 132) ("NeuroD" 92) ("β-2" 61) ("beta-2" 20) ("beta2" 19)
   ("NEUROD1" 4) ("Beta-2" 3) ("Beta2" 3) ("neuroD" 2) ("Neurod1" 2)
   ("neurogenic differentiation 1" 2) ("-beta2" 1) ("neuroD1" 1)))
 ("UP:Q13563" (("polycystin-2" 22) ("TRPP2" 15) ("polycystin" 1)))
 ("UP:Q13564" (("NAE1" 20) ("APPBP1" 3) ("Nae1" 2) ("APP-BP1" 1)))
 ("UP:Q13568"
  (("IRF5" 567) ("IRF-5" 13) ("IRF5 protein" 10)
   ("interferon regulatory factor 5" 6) ("Interferon regulatory factor 5" 4)
   ("dimeric IRF5" 2) ("irf5" 2) ("latent IRF5" 2)
   ("514 amino acids of IRF5" 1) ("The T7-His-tagged ΔN IRF5" 1)
   ("a static image latent IRF5" 1)))
 ("UP:Q13569"
  (("TDG" 352) ("hTDG" 41) ("thymine-DNA glycosylase" 8) ("hTDG protein" 4)
   ("Tdg" 3) ("thymine–DNA glycosylase (TDG)" 1) ("thymine–DNA glycosylase" 1)
   ("thymine-DNA glycosylase (TDG)" 1)))
 ("UP:Q13571" (("LAPTM5" 3)))
 ("UP:Q13572" (("inositol 1,3,4-trisphosphate 5/6-kinase" 3)))
 ("UP:Q13573"
  (("SKIP" 269) ("SNW1" 7) ("Skip" 5) ("overexpressed SKIP" 2)
   ("SKI-interacting protein" 2)))
 ("UP:Q13574"
  (("DGKζ" 301) ("than DGKζ" 2) ("DGKζ protein" 2) ("that DGKζ's" 1)))
 ("UP:Q13576" (("IQGAP2" 11)))
 ("UP:Q13586"
  (("STIM1" 328) ("stromal interaction molecule 1" 9) ("-STIM1" 5)
   ("STIM1 protein" 2) ("caveolar STIM1" 2) ("–STIM1" 1) ("STIM1-" 1)))
 ("UP:Q13588"
  (("Grap" 22) ("GRAP" 12) ("GRB2-related adaptor protein" 2)
   ("at least another adaptor Grap" 2)))
 ("UP:Q13591"
  (("Sema5A" 137) ("SEMA5A" 8) ("Sema5A protein" 3) ("Semaphorin 5A" 2)
   ("semaphorin 5A" 1)))
 ("UP:Q13595" (("TRA2A" 20) ("Tra2a" 2)))
 ("UP:Q13596" (("SNX1" 13) ("sorting nexin 1" 2))) ("UP:Q13601" (("KRR1" 1)))
 ("UP:Q13608" (("PEX6" 1)))
 ("UP:Q13609"
  (("LSD" 92) ("pLSD" 14) ("DNASE1L3" 3) ("an autosomal recessive LSD" 1)))
 ("UP:Q13610" (("PWP1" 7) ("pWP1" 2)))
 ("UP:Q13614"
  (("phosphatidylinositol-3" 169) ("phosphoinositide-3-phosphatase" 7)
   ("Phosphatidylinositol-3" 4) ("-phosphatidylinositol-3" 3) ("MTMR2" 2)
   ("the secondary messengers phosphatidylinositol-3" 1)
   ("the secondary lipid messenger phosphatidylinositol-3" 1)
   ("myotubularin-related protein 2" 1) ("phosphatidylinositol-3-" 1)))
 ("UP:Q13616"
  (("Cul1" 450) ("CUL1" 351) ("Cullin 1" 47) ("Cullin1" 24) ("cullin 1" 14)
   ("cullin1" 7) ("Cul1-" 6) ("CUL-1" 4) ("possible CUL1" 2)
   ("dominant-negative cullin 1" 2)
   ("The dominant-negative Flag-tagged Cul1" 1) ("dominant-negative Cul1" 1)
   ("a dominant-negative Cul1" 1) ("-CUL1" 1) ("a non-canonical Cul1" 1)
   ("previously assembled and neddylated CUL1" 1) ("MLN4924 treated CUL1" 1)
   ("cul1" 1) ("its associated CUL1" 1)))
 ("UP:Q13617"
  (("Cul2" 47) ("CUL2" 24) ("Cullin2" 13) ("Cullin 2" 12) ("cullin 2" 9)
   ("Cul2 protein" 3) ("CUL-2" 1)))
 ("UP:Q13618"
  (("CUL3" 263) ("Cul3" 260) ("Cullin 3" 25) ("cul3" 18) ("Cullin3" 13)
   ("Cul3 protein" 9) ("cullin 3" 7) ("-CUL3" 7) ("CULLIN3" 6)
   ("Imp-11 decreased HA 3 -CUL3" 2) ("the KEAP1-associated CUL3 protein" 2)
   ("exogenous CUL3" 1) ("CUL-3" 1) ("cullin3" 1) ("CUL3-" 1)
   ("CUL3 protein" 1)))
 ("UP:Q13619"
  (("CUL4A" 342) ("Cul4A" 206) ("Cul4a" 20) ("Cullin 4A" 10) ("cullin 4A" 9)
   ("cullin4A" 8) ("-CUL4A" 4) ("Cullin-4A" 3) ("CUL4A protein" 3)
   ("Cullin4A" 2) ("undetectable or low CUL4A" 2)
   ("Here both DN UBC12 and DN CUL4A" 1) ("CUl4A" 1)))
 ("UP:Q13620"
  (("CUL4B" 47) ("Cul4B" 17) ("Cullin 4B" 3) ("cullin 4B" 1) ("CUL4b" 1)))
 ("UP:Q13625"
  (("ASPP2" 556) ("p53BP2" 25) ("TP53BP2" 23) ("ASPP2 protein" 6) ("p53bp2" 5)
   ("ASPP2 peptide" 5) ("p53-binding protein-2" 3) ("53BP2" 3)
   ("p53BP2 peptide (EYPPYPPPPYPSG)" 2) ("p53 binding protein 2" 2) ("53bp2" 2)
   ("than wild type ASPP2" 1) ("too much ASPP2" 1)
   ("the pro-apoptotic factor ASPP2" 1)))
 ("UP:Q13627"
  (("DYRK1A" 530) ("Dyrk1a" 231) ("DYRK" 79) ("Dyrk1A" 9) ("DYRKs" 5)
   ("DYRK1a" 4) ("Dyrk1a (WT)" 2)
   ("Dual specificity tyrosine-phosphorylation-regulated kinase 1A" 2)
   ("DYRK1A protein" 2)))
 ("UP:Q13630" (("TSTA3" 2)))
 ("UP:Q13634" (("CDH18" 5) ("cadherin 18" 2) ("Cdh18" 2) ("cadherin-18" 1)))
 ("UP:Q13635"
  (("patch" 849) ("PTCs" 683) ("PTCH1" 379) ("homolog 1" 267) ("Ptch1" 163)
   ("Patch" 76) ("Patched" 60) ("PTCH" 50) ("patched" 50) ("Homolog 1" 33)
   ("Ptch" 32) ("NGACP" 22) ("Ubc9 basic patch" 12) ("homolog 1 (AKT)" 10)
   ("Patched (PTCH)" 8) ("PATCH" 8) ("ptch1" 5) ("patch (SP)" 5)
   ("homolog 1 (YES)" 4) ("the basic patch" 4)
   ("e.g. human homolog of patched" 4) ("NBCCS" 3) ("more aggressive PTCs" 3)
   ("targeting patch" 3) ("the preserved concave hydrophobic patch" 2)
   ("the preserved convex hydrophobic patch" 2) ("aggressive PTCs" 2)
   ("the conserved basic patch" 2) ("largest basic patch" 2) ("Most PTCs" 2)
   ("95 aggressive PTCs" 2) ("micro PTCs" 2) ("targeting Ptch1" 2)
   ("primary PTCs" 2) ("a polar surface patch" 2) ("patch-" 2)
   ("radiation-induced PTCs" 2) ("patched (PTCH)" 2) ("pre-apical patch" 2)
   ("most classic type PTCs" 1) ("locally aggressive PTCs" 1)
   ("classical variant PTCs" 1) ("most PTCs" 1) ("ptch" 1)
   ("this basic patch" 1) ("a bright fluorescent patch" 1) ("than PTCs" 1)
   ("37 consecutive classical PTCs" 1) ("37 consecutive PTCs" 1)
   ("obvious patch" 1) ("an aromatic ring patch" 1)
   ("30 consecutive classical PTCs" 1) ("The former included 42 PTCs" 1)
   ("smaller basic patch" 1) ("largest patch" 1) ("a basic patch" 1)
   ("adult sporadic PTCs" 1) ("Three classic PTCs" 1) ("large invasive PTCs" 1)
   ("the nucleosomal H2A/H2B acidic patch" 1) ("follicular variant PTCs" 1)
   ("126 (1.6%) follicular variant PTCs" 1)
   ("6 unencapsulated follicular variant PTCs" 1) ("both usual PTCs" 1)
   ("all consecutive unselected PTCs" 1) ("PATCHED" 1) ("all primary PTCs" 1)
   ("Only 2 PTCs" 1) ("the multinodular goiter PTCs" 1) ("five micro PTCs" 1)
   ("again only found Ptch1" 1) ("the Group II basic patch" 1)
   ("the KAKTLRK basic patch" 1) ("their primary PTCs" 1)
   ("treated cells remained patched" 1)
   ("the isoleucine-44-centered hydrophobic patch" 1) ("The basic patch" 1)
   ("potentially heritable PTCs" 1) ("a reddish patch" 1) ("few PTCs" 1)
   ("a contiguous patch" 1) ("invasive PTCs" 1)
   ("the respective diaromatic patch" 1) ("a diaromatic patch" 1)
   ("just PTCs" 1) ("well-differentiated PTCs" 1) ("376 solitary PTCs" 1)
   ("a single discreet patch" 1) ("senescent PTCs" 1)))
 ("UP:Q13636" (("RAB31" 13) ("Ras-associated protein RAB31" 2) ("Rab31" 1)))
 ("UP:Q13639" (("HTR4" 7) ("5-hydroxytryptamine receptor 4" 1) ("5-HT4" 1)))
 ("UP:Q13641" (("5T4" 1)))
 ("UP:Q13651"
  (("IL10RA" 41) ("IL-10R" 24) ("IL-10RA" 10) ("IL10R" 7) ("IL-10R1" 3)
   ("more IL-10R" 1)))
 ("UP:Q13671" (("RIN1" 45) ("Rin1" 7)))
 ("UP:Q13683"
  (("rabbit monoclonal anti-nicotinic acetylcholine receptor alpha 7" 3)
   ("ITGA7" 2) ("alpha 7" 2) ("Itga7" 1)))
 ("UP:Q13686" (("ABH" 12) ("ALKBH" 1)))
 ("UP:Q13696"
  (("crosslinker" 118) ("Crosslinker" 13) ("an ultraviolet crosslinker" 2)
   ("a thiol-cleavable homobifunctional chemical crosslinker" 2)
   ("the CL1000 Ultraviolet Crosslinker" 2)
   ("GS Gene Linker UV Chamber Crosslinker" 2) ("reversible crosslinker" 2)
   ("a membrane-impermeable crosslinker" 2)
   ("a CL-1000 ultraviolet crosslinker" 1)
   ("a CL-1000 Ultraviolet Crosslinker (UVP)" 1)
   ("a photo–activatable crosslinker" 1) ("permanent crosslinker" 1)
   ("a CL-1000 Ultraviolet crosslinker (UVP)" 1)
   ("a homobifunctional crosslinker" 1)
   ("a cell-permeable thio-cleavable crosslinker" 1)))
 ("UP:Q13698" (("CACNA1S" 4) ("CACN1" 2) ("Cacna1s" 1)))
 ("UP:Q13705"
  (("Actr-IIb" 6) ("ACVR2B" 4) ("ACTR-IIB" 3) ("Activin receptor type IIB" 3)
   ("ActRIIB" 3) ("ActR-IIB" 2) ("Actr-IIB" 1)))
 ("UP:Q13724" (("Gcs1" 1))) ("UP:Q13733" (("ATP1A4" 1)))
 ("UP:Q13740"
  (("ALCAM" 107) ("ALCAM protein" 3)
   ("activated leukocyte cell adhesion molecule" 2) ("ER(-) PR(-) ALCAM" 2)
   ("Activated leukocyte cell adhesion molecule" 1)))
 ("UP:Q13751" (("LAMB3" 32)))
 ("UP:Q13753" (("LAMC2" 57) ("laminin 5" 38) ("intact laminin 5" 2)))
 ("UP:Q13761"
  (("RUNX3" 690) ("Runx3" 44) ("RUNX3 protein" 25)
   ("runt-related transcription factor 3" 2) ("RUNX3 Protein" 2)
   ("runt related transcription factor 3" 1)
   ("the lineage-specific tumor suppressor RUNX3" 1) ("two normal RUNX3" 1)
   ("These studies highlight RUNX3's" 1)))
 ("UP:Q13765" (("NACA" 2)))
 ("UP:Q13772"
  (("ARA70" 43) ("NCOA4" 11) ("nuclear receptor coactivator 4" 8) ("RFGs" 5)
   ("ARA70 protein" 2) ("RFG" 2) ("Q13772" 1) ("“RFG”" 1)))
 ("UP:Q13790" (("APOF" 2)))
 ("UP:Q13794"
  (("PMA" 3284) ("Noxa" 989) ("NOXA" 368) ("PMAIP1" 61) ("PMA-" 13)
   ("Noxa peptide" 11) ("Noxa protein" 6) ("noxa" 5) ("-Noxa" 5) ("than PMA" 4)
   ("the pro-apoptotic protein NOXA" 4) ("NOXA protein" 4)
   ("the pro-apoptotic protein Noxa" 4) ("Pmaip1" 4) ("NOXA peptide" 3)
   ("the pro-apoptotic BH3-only proteins NOXA" 3)
   ("The recently described p53-dependent pro-apoptotic Bcl-2 family member Noxa"
    2)
   ("Noxa-" 2) ("protein NOXA" 2) ("pMA" 2)
   ("the artificial protein kinase C activator PMA" 2) ("protein Noxa" 2)
   ("phorbol-12-myristate-13-acetate-induced protein 1 (NOXA)" 2)
   ("the known pro-apoptotic protein PMAIP1 (NOXA)" 2)
   ("different apoptotic noxae" 2) ("noxae" 2)
   ("the pro-apoptotic binding partner Noxa" 1)
   ("seven independent untransduced p53-null PMA" 1)
   ("PMA-induced protein 1" 1)
   ("phorbol-12-myristate-13-acetate-induced protein 1" 1)
   ("the classic tumour promoter PMA" 1) ("PMAIP1 (NOXA)" 1)
   ("the pro-apoptotic target Noxa" 1) ("other apoptotic noxae" 1)
   ("the membrane soluble PMA" 1) ("specifically target Noxa" 1)
   ("PMAIP1 ( NOXA )" 1)))
 ("UP:Q13795" (("ARP" 68) ("ARFRP1" 4)))
 ("UP:Q13796" (("SHROOM2" 25) ("Shroom2" 2) ("shroom family member 2" 2)))
 ("UP:Q13797" (("ITGA9" 26) ("nearby ITGA9" 1)))
 ("UP:Q13813" (("NEAs" 1) ("SPTAN1" 1)))
 ("UP:Q13822"
  (("autotaxin" 39) ("ENPP2" 37) ("Autotaxin" 10) ("Enpp2" 4)
   ("ectonucleotide pyrophosphatase/phosphodiesterase family member 2" 3)
   ("autotaxin (ATX)" 1)))
 ("UP:Q13823" (("Ngp-1" 12))) ("UP:Q13825" (("AUH" 2)))
 ("UP:Q13829" (("TNFAIP1" 16))) ("UP:Q13835" (("PKP1" 35)))
 ("UP:Q13838" (("UAP56" 12) ("BAT1" 6)))
 ("UP:Q13867"
  (("BH" 694) ("BH molecule" 5) ("pBH" 3) ("100 BH" 1) ("BLMH" 1)
   ("than p85α BH" 1) ("Bh" 1)))
 ("UP:Q13873"
  (("BMPR-II" 160) ("BMPR2" 101) ("BMPRII" 79) ("BMPR-2" 55)
   ("overexpressed BMPR-II" 6) ("bone morphogenetic protein receptor type 2" 6)
   ("BMP type II receptor" 5) ("Bmpr2" 2) ("BMPRII protein" 2)
   ("potentially target BMPR2" 1) ("tailless BMPR-II" 1)
   ("BMPR-II (R873X) protein" 1) ("than BMPR2 mutations may also contribute" 1)
   ("BMP-RII" 1)))
 ("UP:Q13875"
  (("MOBP" 28) ("myelin-associated oligodendrocyte basic protein" 2)))
 ("UP:Q13882"
  (("Brk" 712) ("PTK6" 491) ("breast tumor kinase" 24)
   ("Breast tumor kinase" 23) ("BRK" 19) ("Protein tyrosine kinase 6" 14)
   ("PTK6 protein" 12) ("protein tyrosine kinase 6" 10) ("Brk protein" 10)
   ("protein-tyrosine kinase 6" 4) ("breast tumor kinase (BRK)" 3) ("-PTK6" 2)
   ("Immunohistochemical staining showed positive Brk" 2) ("brk" 1)
   ("membrane associated PTK6" 1)))
 ("UP:Q13885" (("TUBB2A" 1) ("TUBB2" 1) ("Tubb2" 1)))
 ("UP:Q13886" (("Klf9" 174) ("KLF9" 19) ("BTEB1" 2) ("“FLAG-Klf9”" 1)))
 ("UP:Q13887"
  (("KLF5" 626) ("Klf5" 150) ("KLF5 protein" 6) ("BTEB2" 3)
   ("We first knocked down KLF5" 2) ("exogenous KLF5" 2) ("IKLF" 2)
   ("than KLF5" 1) ("human dysplastic epithelia accumulated KLF5" 1)))
 ("UP:Q13888" (("GTF2H2" 2))) ("UP:Q13895" (("BYSL" 12) ("bystin" 2)))
 ("UP:Q13901" (("C1D" 1))) ("UP:Q13905" (("RapGEF1" 8) ("RAPGEF1" 3)))
 ("UP:Q13907"
  (("IDI1" 13)
   ("its transcriptional targets isopentenyl-diphosphate delta isomerase" 2)
   ("isopentenyl-diphosphate delta isomerase" 2)
   ("isopentenyl-diphosphate delta isomerase 1" 2) ("IDI1-" 1)
   ("Isopentenyl-diphosphate delta isomerase 1" 1)))
 ("UP:Q13936"
  (("CACNA1C" 87) ("LQT8" 9) ("Cacna1c" 4) ("alpha 1C subunit" 4) ("L type" 3)
   ("the Mendelian Timothy syndrome gene (LQT8) CACNA1C" 1) ("l type" 1)))
 ("UP:Q13938"
  (("caps" 145) ("CaPs" 74) ("CaPS" 48) ("CAPS" 46) ("Caps" 7)
   ("Pten null CaPs" 6) ("protective caps" 4) ("nucleolar caps" 3) ("-caps" 3)
   ("adhesive caps" 2) ("one or two 19S regulatory caps" 1)
   ("androgen ablation treated CaPs" 1) ("Nucleolar caps" 1)
   ("essential protective caps" 1) ("fibrous caps" 1)
   ("heterogeneous malignant CaPs" 1) ("the adhesive caps" 1)
   ("primary CaPs" 1) ("44 primary CaPs" 1) ("17 (59%) metastatic CaPs" 1)))
 ("UP:Q13950"
  (("Runx2" 812) ("RUNX2" 720) ("runx2" 97)
   ("Runt-related transcription factor 2" 14) ("Runx-2" 9)
   ("runt-related transcription factor 2" 8) ("runx2 protein" 8) ("RUNX-2" 8)
   ("Cbfa1" 7) ("Runx2 protein" 6) ("RunX2" 6) ("CCD1" 5) ("exogenous RUNX2" 5)
   ("runt-related transcription factor-2" 5) ("RUNX2 protein" 4)
   ("Runx2 molecule" 4) ("Runx2-" 3) ("osteoblastic RUNX2" 2)
   ("functional runx2" 2) ("Runt-related transcription factor-2" 2)
   ("exogenous Runx2" 1) ("-Runx2" 1) ("most RUNX2-" 1) ("RUNX2-" 1)
   ("OSF-2" 1) ("the lineage-specific transcription factor Runx2" 1)
   ("functional Runx2" 1) ("CBFA1" 1) ("Ccd1" 1)
   ("an important transcriptional factor called Runx2" 1) ("Runx 2" 1)))
 ("UP:Q13951"
  (("enhancers" 1411) ("CBFβ" 239) ("Enhancers" 55) ("ISE" 29) ("CBFB" 19)
   ("distal enhancers" 17) ("strong enhancers" 8) ("typical enhancers" 8)
   ("the distal enhancers" 7) ("transcriptional enhancers" 6)
   ("potential enhancers" 6) ("doubly-occupied enhancers" 4) ("ESE" 4)
   ("Exonic Splicing Enhancers" 4) ("composite enhancers" 3)
   ("“proto-enhancers”" 3) ("all five distal enhancers" 3)
   ("the intragenic enhancers" 2) ("multiple neuronal enhancers" 2)
   ("their own enhancers" 2) ("pre-established enhancers" 2)
   ("core binding factor beta" 2) ("individual p53-bound enhancers" 2)
   ("the proximal and distal enhancers" 2)
   ("these pre-established enhancers" 2) ("the five distal enhancers" 2)
   ("Exonic splicing enhancers" 2) ("core-binding factor subunit beta" 2)
   ("pre-existing enhancers" 1) ("had doubly-occupied enhancers" 1)
   ("their respective nearest TSSs revealed many more doubly-occupied enhancers"
    1)
   ("the doubly-occupied enhancers" 1)
   ("the doubly-occupied presumptive enhancers" 1)
   ("intronic (ISE) splicing enhancers" 1) ("more robust enhancers" 1)
   ("than the other 1,033 ERα-bound active enhancers" 1)
   ("than functional ERα-bound enhancers ( xref )" 1)
   ("MegaTrans-bound 1,333 ERα active enhancers" 1)
   ("classical RAR cis -bound enhancers" 1)
   ("the most potent functional enhancers" 1) ("their respective enhancers" 1)
   ("relevant enhancers" 1) ("distal ERα-bound enhancers" 1)
   ("all transcription factor-bound enhancers" 1) ("Distal enhancers" 1)
   ("our own predicted invasive enhancers" 1) ("multiple distal enhancers" 1)
   ("these distal enhancers" 1) ("candidate active enhancers" 1)
   ("enhancers, so-called A080" 1) ("adjacent enhancers" 1)
   ("exonic enhancers" 1) ("enhancers, nPE1" 1) ("weak enhancers" 1)
   ("distant enhancers" 1) ("-enhancers" 1) ("classical enhancers" 1)
   ("These distal enhancers" 1) ("Exonic enhancers" 1)
   ("pro-apoptotic enhancers" 1) ("tissue specific distal enhancers" 1)
   ("binding viral enhancers" 1) ("mid-hindbrain-specific enhancers" 1)
   ("lineage-specific enhancers" 1)))
 ("UP:Q13952"
  (("NF-Y" 368) ("NFYC" 13) ("NF-YC" 11) ("–NF-Y" 3)
   ("The heterotrimeric transcription factor NF-Y" 2) ("NF-Y (CHOP)" 2)
   ("the trimeric transcription factor NF-Y" 1)
   ("the trimeric transcription factor complex NF-Y" 1)))
 ("UP:Q13972"
  (("Cdc25" 496) ("RasGRF1" 313) ("CDC25" 164) ("cdc25" 59) ("Cdc25s" 34)
   ("RASGRF1" 29) ("guanine nucleotide releasing protein" 16)
   ("Cdc25 protein" 9) ("Rasgrf1" 7) ("guanine nucleotide-releasing protein" 5)
   ("RasGRF1 protein" 4) ("Ras-GRF1" 3) ("than RasGRF Cdc25" 1)
   ("residual full-length RasGRF1" 1) ("-Cdc25" 1)
   ("the mitotic inducer Cdc25" 1)))
 ("UP:Q13976" (("cGMP-dependent" 29) ("PRKG1" 10) ("cGMP dependent" 3)))
 ("UP:Q14004" (("CDK13" 7)))
 ("UP:Q14005"
  (("IL-16" 8) ("IL16" 7) ("the chemotactic factor IL-16" 2)
   ("interleukin-16" 1)))
 ("UP:Q14008" (("ch-TOG" 34) ("CKAP5" 21) ("CH-TOG" 11) ("chTOG" 1)))
 ("UP:Q14011"
  (("CIRBP" 143) ("CIRP" 13) ("pCIRBP" 2) ("CIRBP protein" 1)
   ("cold-induced CIRBP" 1) ("cold inducible RNA binding protein (CIRBP)" 1)
   ("cold inducible RNA binding protein" 1)))
 ("UP:Q14012" (("CaMKI protein" 2) ("CAMK1" 1)))
 ("UP:Q14028" (("GARP" 68) ("glutamic acid-rich protein" 4)))
 ("UP:Q14031"
  (("COL4A6" 10) ("alpha 6" 7) ("Alpha 6" 3)
   ("gamma-amino butyric acid A receptor subunit alpha 6" 2)))
 ("UP:Q14032"
  (("BAT" 613) ("BAAT" 4) ("pBat" 2) ("pBAT" 1) ("SIRT3-null BAT" 1)
   ("cold-induced BAT" 1) ("cold-activated BAT" 1)))
 ("UP:Q14050" (("IDD" 81) ("COL9A3" 3) ("IDDs" 2)))
 ("UP:Q14055"
  (("Med" 57) ("MED" 33) ("med" 29) ("COL9A2" 4)
   ("We first employed D283 Med" 2) ("employed D283 Med" 2)))
 ("UP:Q14088" (("Rab33A" 2))) ("UP:Q14094" (("CCNI" 2)))
 ("UP:Q14103"
  (("AUF1" 361) ("AUF-1" 46) ("AUF1 protein" 34) ("AUF1-" 5) ("hnRNPD" 3)
   ("heterogeneous nuclear ribonucleoprotein D" 2)
   ("the ubiquitous RNA-binding protein AUF1" 2) ("Auf1" 2)
   ("AU-rich element RNA binding protein 1" 2) ("HNRNPD" 1) ("37KD)" 1)))
 ("UP:Q14106" (("Tob2" 2))) ("UP:Q14108" (("SCARB2" 1)))
 ("UP:Q14112" (("nid-2" 16) ("Nid-2" 9) ("nidogen-2" 3)))
 ("UP:Q14114" (("apoER2" 2) ("Apoer2" 2) ("Lrp8" 1) ("APOER2" 1)))
 ("UP:Q14116"
  (("IL-18" 453) ("IL18" 17) ("IL-18 protein" 6) ("Il18" 3)
   ("interleukin 18" 3) ("interleukin-18" 3) ("pIL-18" 3) ("-IL-18" 3)
   ("Interleukin-18" 3) ("IL-18-" 2) ("ALT-E increased IL-18" 2) ("IGIF" 1)
   ("Secreted mature IL-18" 1) ("specifically release IL-18" 1)))
 ("UP:Q14117" (("DPYS" 26)))
 ("UP:Q14118"
  (("dystroglycan" 6) ("Dystroglycan 1" 4) ("dystroglycan 1" 4) ("a3a" 1)))
 ("UP:Q14119" (("DB1" 20) ("VEZF1" 5)))
 ("UP:Q14126"
  (("Dsg2" 236) ("HDGC" 156) ("DSG2" 12) ("desmoglein 2" 7) ("Dsg2 protein" 6)
   ("desmoglein-2" 4) ("Desmoglein 2" 3) ("Dsg2-" 2)
   ("disrupted normal Dsg2" 2) ("recurrent HDGC" 1)))
 ("UP:Q14129" (("DGCR6" 12))) ("UP:Q14134" (("TRIM29" 21) ("Trim29" 1)))
 ("UP:Q14135" (("VGLL4" 6)))
 ("UP:Q14137" (("Bop1" 10) ("BOP1" 7) ("the nucleolar protein Bop1" 1)))
 ("UP:Q14139" (("UBE4A" 9) ("the VCP/p97 accessory protein UBE4A" 1)))
 ("UP:Q14141" (("SEPT6" 9)))
 ("UP:Q14145"
  (("Keap1" 2200) ("KEAP1" 1235) ("sulforaphane" 329) ("INrf2" 163)
   ("Kelch-like ECH-associated protein 1" 135) ("Sulforaphane" 60)
   ("KEAP 1" 43) ("Keap1 protein" 36) ("KEAP 1 protein" 29)
   ("KEAP1 protein" 28) ("kelch-like ECH-associated protein 1" 27)
   ("Keap-1" 15) ("Kelch-like ECH associated protein 1" 14)
   ("Kelch-like ECH-associated protein-1" 14) ("keap1" 10) ("KEAP-1" 7)
   ("INrf2 protein" 6) ("Keap-1 protein" 5) ("functional KEAP1" 5)
   ("Kelch-Like ECH-Associated Protein 1" 4) ("Keap1-" 3)
   ("Kelch-like ECH-associated protein 1-" 3) ("sulforaphane (SFN)" 3)
   ("Keap1 molecule" 3) ("-Keap1" 3) ("overexpressed Keap1" 3)
   ("KELCH-like ECH-associated protein 1" 2)
   ("a nonfunctional KEAP1 protein" 2) ("KEAP1 molecule" 2)
   ("targeting KEAP1" 1) ("than ubiquitinated Keap1" 1) ("sulforaphane (SF)" 1)
   ("iNrf2" 1) ("BRD4 decreased KEAP1" 1)
   ("a more extensively ubiquitinated-Keap1 protein" 1)
   ("ubiquitinated-Keap1 protein" 1) ("absolute Keap1" 1) ("more KEAP1" 1)
   ("exogenous Keap1" 1) ("-KEAP1" 1) ("no functional KEAP1" 1)
   ("exogenous KEAP1" 1)))
 ("UP:Q14149"
  (("MORC3" 12) ("Morc3" 6) ("NXP-2" 3) ("ZCWCC3" 1) ("KIAA0136" 1)))
 ("UP:Q14151" (("SAFB2" 50) ("scaffold attachment factor B2" 8)))
 ("UP:Q14152" (("EIF3S10" 5) ("EIF3A" 2)))
 ("UP:Q14154" (("delE" 69) ("DelE" 4)))
 ("UP:Q14155"
  (("β-Pix" 221) ("βPIX" 148) ("ARHGEF7" 88) ("β-PIX" 72) ("COOL-1" 16)
   ("PAK-interacting exchange factor" 4) ("p85SPR" 4) ("Cool-1" 4) ("Cool1" 3)
   ("βPIX protein" 2) ("more β-Pix" 2) ("beta-PIX" 1) ("βPix" 1)
   ("p85Cool-1" 1)))
 ("UP:Q14156" (("EFR3A" 4)))
 ("UP:Q14157" (("UBAP2L" 1) ("Q14157" 1) ("NICE-4" 1)))
 ("UP:Q14160"
  (("SCRIB" 428) ("Scrib" 386) ("hScrib" 379) ("Scribble" 96) ("scribble" 57)
   ("hScrib protein" 7) ("hSCRIB" 5) ("HScrib" 5) ("scrib" 4)
   ("scribble protein" 4) ("-hScrib" 3) ("the basolateral protein scribble" 2)
   ("overexpressed hScrib" 2) ("Scribble-" 1)
   ("the basolateral determinant Scribble" 1) ("hSCRIB protein" 1) ("Q14160" 1)
   ("basolateral Scrib" 1) ("SCRIB-" 1) ("distinct SCRIB" 1)
   ("dysfunctional Scrib" 1)))
 ("UP:Q14161" (("GIT2" 37) ("KIAA0148" 19) ("CAT-2" 1)))
 ("UP:Q14162"
  (("SREC-I" 75) ("scavenger receptor expressed by endothelial cells" 3)
   ("SCARF1" 3) ("SREC-I-" 2) ("SREC" 2) ("SRECI" 1)))
 ("UP:Q14164"
  (("IKKε" 883) ("IKBKE" 340) ("IKKi" 88) ("IKK-i" 53) ("Ikbke" 13) ("Ikki" 10)
   ("IKKε-" 7) ("IKKε protein" 4) ("Ikappa-B kinase epsilon" 2)
   ("baculovirus-expressed recombinant IKKε" 2) ("IKK-epsilon" 2)
   ("the noncanonical IκB kinases (IKKs) IKKi" 2) ("-IKBKE" 1)
   ("Inhibitor of nuclear factor kappa-B kinase subunit epsilon" 1) ("IKKɛ" 1)
   ("Q14164" 1) ("K48 poly-Ub-activated IKKε" 1)
   ("its homologous kinase IKKε" 1) ("IKKE" 1) ("IKK epsilon" 1) ("IKKε–" 1)
   ("IKKepsilon" 1) ("potentially redundant IKK-i" 1) ("IKBKE protein" 1)
   ("IKKe" 1)))
 ("UP:Q14165" (("MLEC" 41) ("MLECs" 14) ("TNFR2-null MLEC" 2)))
 ("UP:Q14181" (("POLA2" 1)))
 ("UP:Q14183"
  (("DOC2A" 11)
   ("the brain-specific synaptic vesicle-associated protein DOC2A" 1)
   ("Doc2a" 1) ("the synaptic vesicle gene DOC2A" 1)))
 ("UP:Q14185"
  (("Dock180" 437) ("DOCK180" 216) ("DHR2c" 26) ("DOCK1" 25)
   ("Dock180 protein" 11) ("ced-5" 9) ("dedicator of cytokinesis 1" 7)
   ("-Dock180" 6) ("Dock1" 4) ("CED-5" 4) ("DOCK180 protein" 2)
   ("extrinsic Dock180" 2) ("smaller DHR2c" 1) ("Ced-5" 1)
   ("Junctional DOCK180" 1) ("CED5" 1)))
 ("UP:Q14186"
  (("TFDP1" 59) ("overexpressed TFDP1" 4) ("transcription factor DP-1" 2)))
 ("UP:Q14188" (("Tfdp2" 31) ("TFDP2" 10)))
 ("UP:Q14190" (("SIM2" 72) ("Sim2" 5)))
 ("UP:Q14191"
  (("WRN" 702) ("WRN protein" 92) ("-WRN" 1) ("nucleoplasmic WRN" 1)
   ("WRN-" 1)))
 ("UP:Q14192"
  (("FHL2" 137) ("DRAL" 83) ("FHL2 protein" 2) ("DRAL protein" 1)
   ("four and a half LIM domains 2" 1)))
 ("UP:Q14194"
  (("Drp1" 992) ("LCRMP-1" 147) ("CRMP1" 113) ("CRMP" 43) ("pCRMP" 21)
   ("CRMP-1" 16) ("LCRMP-1 (WT)" 5) ("Drp1 protein" 5)
   ("Dominant-negative Drp1 K38 E" 2) ("drp1" 2)
   ("expressing tetracycline-inducible WT Drp1" 1)
   ("further dephosphorylated Drp1" 1) ("exogenous recombinant Drp1" 1)
   ("collapsin response mediator protein 1" 1)))
 ("UP:Q14195" (("CRMP4" 211) ("CRMP4 protein" 4) ("pCRMP4" 1)))
 ("UP:Q14197" (("DS-1" 11) ("DS1" 1)))
 ("UP:Q14201"
  (("BTG3" 178) ("ANA" 44) ("BTG3 protein" 12) ("BTG3 peptide" 10) ("Btg3" 8)
   ("an exogenous myc-tagged BTG3" 1)))
 ("UP:Q14202" (("ZNF261" 13) ("ZMYM3" 8)))
 ("UP:Q14203"
  (("p150 Glued" 147) ("p150 glued" 59) ("BD" 49) ("p150Glued" 5)
   ("p150glued" 4) ("DCTN1" 1) ("BICD2-N simultaneously binds p150 Glued" 1)))
 ("UP:Q14206" (("RCAN2" 2)))
 ("UP:Q14207"
  (("NPAT" 224) ("The global histone expression regulator NPAT" 1)))
 ("UP:Q14209"
  (("E2F2" 612) ("E2f2" 11) ("E2F-2" 8) ("transcription factor E2F2" 7)
   ("E2F2-" 5) ("E2F transcription factor 2" 3) ("E2F2 protein" 2)
   ("miR-24-insensitive E2F2" 2) ("miR-218 directly targets E2F2" 1)))
 ("UP:Q14213" (("EBI3" 12))) ("UP:Q14232" (("EIF2B1" 2)))
 ("UP:Q14240"
  (("EIF4A2" 12) ("EIF4F" 5) ("EIF4A" 5)
   ("Eukaryotic translation initiation factor 4A" 1) ("Eif4a2" 1)
   ("eukaryotic initiation factor 4A-II" 1)))
 ("UP:Q14241" (("TCEB3" 4)))
 ("UP:Q14242"
  (("selectins" 19) ("PSGL-1" 5) ("PSGL1" 4)
   ("P-selectin glycoprotein ligand 1" 2) ("Selectins" 1)))
 ("UP:Q14244" (("MAP7" 13)))
 ("UP:Q14246"
  (("F4/80" 190) ("F4-80" 8) ("EMR1" 5) ("mucin-like" 5)
   ("mucin-like protein" 3) ("mucin-like peptide" 3) ("F4–80" 1) ("Emr1" 1)))
 ("UP:Q14247" (("CTTN" 159) ("EMS1" 6)))
 ("UP:Q14249"
  (("EndoG" 74) ("endoG" 73) ("endonuclease G" 30) ("Endo G" 22)
   ("Endonuclease G" 5) ("ENDOG" 5) ("significantly more nuclear endoG" 2)
   ("endog" 1) ("EndoG-" 1)))
 ("UP:Q14254"
  (("chromosome 17" 780) ("Flot-2" 235) ("ESA" 186) ("flotillin2" 82)
   ("flotillin-2" 76) ("Chromosome 17" 39) ("ESA peptide" 37)
   ("membrane component" 14) ("Flotillin-2" 13) ("Esa1" 9) ("Flot-2 protein" 7)
   ("flot-2" 7) ("flotillin 2" 6) ("Flotillin 2" 6)
   ("the entire chromosome 17" 4) ("Flotillin2" 4) ("flotillin2 protein" 4)
   ("chromosome
17"
    3)
   ("ESA (GPDR-ESA) peptide" 3) ("FLOT2" 2) ("-flotillin-2" 1)
   ("epidermal surface antigen" 1) ("chromosome 17 according manufacturer’s" 1)
   ("only one chromosome 17" 1) ("than the ESA peptide" 1)
   ("the raft-associated marker flotillin-2" 1)))
 ("UP:Q14257" (("E6BP" 1)))
 ("UP:Q14258"
  (("TRIM25" 351) ("TRIM25-" 10) ("TRIM25 protein" 8) ("EFP" 6) ("Trim25" 3)
   ("Efp" 3) ("exogenous TRIM25" 2) ("pEFP" 2)
   ("ectopically expressed TRIM25" 1) ("expressed TRIM25" 1)
   ("exogenous and endogenous TRIM25" 1)
   ("influenza Aviruses specifically target TRIM25" 1)))
 ("UP:Q14264" (("ERV3" 8)))
 ("UP:Q14289"
  (("Pyk2" 1084) ("PYK2" 189) ("PYK-2" 28)
   ("proline-rich tyrosine kinase 2" 25) ("Pyk-2" 22) ("PTK2B" 13)
   ("Proline-rich tyrosine kinase 2" 12) ("pyk2" 12) ("-Pyk2" 11) ("Pyk2-" 6)
   ("overexpressed Pyk2" 4) ("RAFTK" 4) ("calcium-dependent tyrosine kinase" 3)
   ("CAKβ" 3) ("FAK2" 2) ("Pyk2 protein" 2) ("Pyk2 (PKM)" 1)
   ("transiently overexpressed Pyk2" 1) ("CADTK" 1) ("PyK2" 1)
   ("homologous Pyk-2" 1) ("dominant-negative Pyk2-Y402F" 1)))
 ("UP:Q14314" (("FGL2" 2)))
 ("UP:Q14318" (("FKBP38" 38) ("mTOR-associated FKBP38" 1) ("FKBP8" 1)))
 ("UP:Q14331" (("FRG" 28)))
 ("UP:Q14332" (("Fzd2" 195) ("FZD2" 6) ("Frizzled2" 4) ("Frizzled-2" 2)))
 ("UP:Q14344" (("Gα13" 4) ("GNA13" 1) ("Gna13" 1)))
 ("UP:Q14353"
  (("GAMT" 17) ("guanidinoacetate methyltransferase" 4)
   ("guanidinoacetate methyltransferase ( GAMT )" 4)
   ("Guanidinoacetate methyltransferase" 1)))
 ("UP:Q14376" (("UDP-" 62) ("UDP–" 2))) ("UP:Q14392" (("LRRC32" 23)))
 ("UP:Q14393" (("GAS6" 85) ("Gas6" 64) ("Gas6 protein" 3) ("GAS6 protein" 2)))
 ("UP:Q14397" (("GCKR" 45))) ("UP:Q14416" (("metabotropic 2" 1)))
 ("UP:Q14432" (("PDE3A" 4))) ("UP:Q14435" (("GALNT3" 6)))
 ("UP:Q14444" (("CAPRIN1" 5) ("Caprin1" 2)))
 ("UP:Q14449"
  (("Grb14" 142) ("GRB14" 29) ("growth factor receptor-bound protein 14" 12)))
 ("UP:Q14451" (("GRB7" 68) ("Grb7" 50) ("B47" 6) ("Grb-7" 1)))
 ("UP:Q14457"
  (("Beclin 1" 1382) ("Beclin-1" 684) ("Beclin1" 547) ("BECN1" 339)
   ("beclin-1" 56) ("Becn1" 41) ("beclin 1" 33) ("beclin1" 29) ("Beclin" 23)
   ("Beclin1 protein" 14) ("BECLIN1" 11) ("Beclin 1" 11) ("Beclin-1 protein" 8)
   ("beclin" 5) ("Beclin 1 protein" 5) ("-Beclin1" 3) ("Beclin 1 peptide" 3)
   ("BECLIN 1" 3) ("low-expressed Beclin 1" 3) ("BECN1-" 2)
   ("cleavable wild-type Beclin 1" 2) ("exogenous Beclin 1" 2)
   ("flag-tagged Beclin 1" 2) ("Vps30" 2)
   ("essential autophagic gene Beclin1" 2) ("Beclin−" 1) ("BECN1−" 1)
   ("BCL2-expressing Becn1  +/+" 1) ("becn1" 1)
   ("the essential autophagy regulator BECN1" 1) ("down less Beclin-1" 1)
   ("1–150 amino acid of Beclin-1 (Fig. xref )" 1)
   ("The autophagic gene Beclin1" 1) ("VPS30" 1) ("-Beclin 1" 1)
   ("essential autophagic protein Beclin1" 1)
   ("the autophagy essential protein Beclin1" 1)
   ("autophagic gene Beclin1" 1)))
 ("UP:Q14469"
  (("Hes-1" 88) ("HES-1" 34) ("hairy and enhancer of split 1" 9)
   ("hes family bHLH transcription factor 1" 3) ("HRY" 1) ("Hes-1 protein" 1)))
 ("UP:Q14493"
  (("SLBP" 61) ("histone binding protein" 3)
   ("stem-loop binding protein (SLBP)" 2) ("stem-loop binding protein" 2)
   ("SLBP-" 1)))
 ("UP:Q14494"
  (("Nrf1" 275) ("NFE2L1" 9) ("Nuclear factor erythroid 2-related factor 1" 2)
   ("TCF11" 2) ("cytoprotective gene Nrf1" 1) ("negatively impacts Nrf1's" 1)
   ("negatively impacts Nrf1" 1)))
 ("UP:Q14498" (("CAPER" 1)))
 ("UP:Q14500"
  (("inhibitor 1" 102) ("Inhibitor 1" 24) ("Early Mitotic Inhibitor 1" 4)
   ("Kelch-like ECH-associated inhibitor 1" 2) ("Inhibitor 1 (SI)" 1)
   ("than inhibitor 1 ( xref )" 1)))
 ("UP:Q14508" (("HE4" 27)))
 ("UP:Q14511"
  (("NEDD9" 428) ("HEF1" 231) ("Nedd9" 20) ("NEDD9 protein" 10) ("CasL" 9)
   ("Fyn/Src" 7) ("CASL" 6) ("enhancer of filamentation 1" 4) ("Cas-L" 3)
   ("Enhancer of Filamentation 1" 3) ("Overexpressed NEDD9" 2)
   ("The prometastatic protein NEDD9" 2) ("NEDD9-" 2) ("Hef1" 1) ("HEF-1" 1)
   ("hEF1" 1) ("Nedd9 protein" 1) ("CAS-L" 1)))
 ("UP:Q14512" (("FGFBP1" 3))) ("UP:Q14517" (("FAT1" 40)))
 ("UP:Q14520"
  (("hyaluronan" 223) ("Hyaluronan" 20) ("exogenous hyaluronan" 2)
   ("hyaluronan (HA)" 1) ("peri-tumoral hyaluronan" 1)))
 ("UP:Q14524"
  (("SCN5A" 87) ("HB2" 20) ("Sss1" 6) ("hH1" 5) ("HH1" 4) ("LQT3" 2)
   ("P-HH1" 1) ("the cardiac sodium channel gene SCN5A" 1)))
 ("UP:Q14526"
  (("HIC1" 188) ("Hic1" 3) ("overexpressed HIC1" 2) ("HIC1 protein" 1)))
 ("UP:Q14527"
  (("HLTF" 285) ("HLTF protein" 3) ("hltf" 2) ("whose dsDNA region HLTF" 1)
   ("than the wild-type HLTF" 1)))
 ("UP:Q14534" (("SQLE" 29)))
 ("UP:Q14541"
  (("HNF4G" 9) ("HNF4γ" 4) ("NR2A2" 2) ("HNF4g" 1)
   ("hepatocyte nuclear factor 4-gamma" 1)))
 ("UP:Q14542" (("SLC29A2" 2) ("Ent2" 1))) ("UP:Q14554" (("PDIr" 5)))
 ("UP:Q14558" (("PRPSAP1" 2)))
 ("UP:Q14563"
  (("Sema3A" 120) ("Sema domain" 71) ("Semaphorin 3A" 56) ("sema domain" 19)
   ("SEMA3A" 19) ("Semaphorin3A" 13) ("“Sema domain”" 12) ("SEMA domain" 7)
   ("Semaphorin 3A-" 5)
   ("Sema
 domain"
    4)
   ("autocrine Sema3A" 2) ("semaphorin 3A" 1) ("Sema3A-" 1)))
 ("UP:Q14565"
  (("Dmc1" 122) ("DMC1" 50) ("-Dmc1" 4) ("DMC1 protein" 4) ("that Dmc1's" 1)
   ("Dmc1-" 1) ("Dmc1 protein" 1) ("dmc1" 1) ("DNA meiotic recombinase 1" 1)))
 ("UP:Q14566" (("Mcm6" 90) ("MCM6" 39) ("mcm6" 4)))
 ("UP:Q14571"
  (("ITPR2" 20) ("inositol 1,4,5-triphosphate receptor" 12) ("IP3R2" 2)))
 ("UP:Q14573" (("ITPR3" 6) ("IP3R-3" 3) ("IP3R3" 2) ("IP3R-3 protein" 2)))
 ("UP:Q14574"
  (("DSC" 56) ("Dsc" 19) ("Dscs" 9) ("DSCS" 3) ("desmocollin-3" 2) ("DSCs" 2)
   ("the experimental DSC" 1) ("Dsc protein" 1)))
 ("UP:Q14576" (("HuC" 4) ("ELAVL3" 1)))
 ("UP:Q14582" (("MXD4" 4) ("Mxd4" 3) ("Mad4" 3))) ("UP:Q14590" (("ZNF270" 1)))
 ("UP:Q14592" (("ZNF460" 7)))
 ("UP:Q14596"
  (("NBR1" 479) ("phosphomimetic NBR1" 5) ("Nbr1" 4)
   ("nonphosphorylable NBR1" 3) ("the autophagic receptors NBR1" 1)
   ("the late endosomal protein NBR1" 1)))
 ("UP:Q14623"
  (("IHH" 124) ("Ihh" 61) ("IHh" 33) ("Indian hedgehog" 9) ("normosmic IHH" 5)
   ("iHH" 3) ("indian hedgehog" 2)
   ("GNRHR mutations cause autosomal recessive IHH" 1) ("Incomplete IHH" 1)
   ("Complete IHH" 1)))
 ("UP:Q14624"
  (("gp120" 3819) ("Gp120" 69) ("gp120 protein" 45) ("gp120-" 11)
   ("an α 4 β 7 -reactive gp120" 11) ("soluble gp120" 7) ("“M-gp120”" 6)
   ("Viral Protein gp120" 4) ("gp120 (M-gp120) protein" 4) ("gp 120" 4)
   ("gp-120" 3) ("α 4 β 7 -reactive gp120" 3) ("GP120" 3) ("viral gp120" 3)
   ("gp120 molecule" 2) ("ITIH4" 2) ("exogenous gp120" 2) ("-gp120" 2)
   ("Viral gp120" 2) ("Soluble gp120" 2) ("recombinant viral envelope gp120" 2)
   ("CXCR4 tropic gp120" 2) ("very little gp120" 2) ("only HIV-1 gp120" 2)
   ("M-tropic gp120" 2) ("mock-treated gp120" 2) ("used soluble gp120" 1)
   ("highly α 4 β 7 -reactive gp120" 1) ("Additionally R880F gp120" 1)
   ("the viral gp120" 1) ("one or more gp120" 1) ("monomeric Env gp120" 1)
   ("The soluble Env derivative gp120" 1)
   ("the viral envelope (Env) surface subunit gp120" 1)
   ("any potentially carried-over gp120" 1)
   ("200 pM dual-tropic viral envelope protein gp120" 1)
   ("The viral protein gp120" 1) ("the viral envelope gp120" 1)
   ("The HIV-1 viral envelope protein gp120" 1) ("Gp120-" 1)
   ("viral envelope gp120" 1) ("The viral coat protein gp120" 1)
   ("another M-tropic gp120 protein" 1) ("than R5 tropic gp120" 1)
   ("R5 tropic gp120" 1) ("gp120 (HXB)" 1) ("X4 tropic gp120" 1)
   ("than HIV-1 gp120" 1) ("than free gp120" 1)
   ("than mock-treated gp120 (M-gp120; processed without the enzyme)" 1)
   ("virion-associated gp120" 1) ("gp120 (upto 4 µg/ml) protein" 1)))
 ("UP:Q14626" (("IL-11Rα" 21))) ("UP:Q14627" (("Il13ra2" 2)))
 ("UP:Q14641" (("INSL4" 4)))
 ("UP:Q14642"
  (("inositol polyphosphate-5-phosphatase" 8) ("40kD" 3) ("40KD" 2)
   ("INPP5A" 1)))
 ("UP:Q14643"
  (("IP3R" 129) ("ITPR1" 22) ("IP3R1" 21) ("IP3Rs" 14)
   ("inositol 1,4,5-trisphosphate receptor" 3)
   ("Inositol 1,4,5-trisphosphate receptor" 2) ("IP3R-1" 1)
   ("InsP3 receptor" 1) ("IP3R protein" 1)))
 ("UP:Q14644" (("RASA3" 5)))
 ("UP:Q14651" (("PLS1" 4) ("plastin 1" 2) ("I-plastin" 1)))
 ("UP:Q14653"
  (("IRF3" 1972) ("IRF-3" 395) ("interferon regulatory factor 3" 40)
   ("pIRF3" 13) ("IRF3-" 11) ("IRF3-5D protein" 8) ("-IRF3" 7)
   ("interferon regulatory factor-3" 7) ("IRF3 protein" 7) ("p-IRF3" 4)
   ("IRF-3 protein" 3) ("Interferon regulatory factor 3" 3) ("P-IRF3" 2)
   ("IRF3 (DLHISNSHPLSLC)" 2) ("pIRF-3" 2) ("cellular IRF-3" 2)
   ("viral interferon regulatory factor-3" 2) ("overexpressed IRF3" 2)
   ("hyper-ubiquitinated IRF3" 2) ("than IRF3" 1) ("Q14653" 1) ("more IRF3" 1)
   ("the cellular IRF3" 1) ("p-IRF-3" 1) ("dimeric ( D ) IRF-3" 1)
   ("than IRF-3" 1)
   ("two previously described IRF-3 mutants ( xref , xref ) 2A and 5A" 1)
   ("the divergent IRF3" 1) ("dimerized IRF3" 1) ("IRF3 (IBL)" 1)
   ("particular IRF3" 1) ("Interferon Regulatory Factor-3" 1)))
 ("UP:Q14654" (("KCNJ11" 64) ("Kir6.2" 15) ("KIR6.2" 3) ("Kcnj11" 3)))
 ("UP:Q14667" (("KIAA0100" 1)))
 ("UP:Q14669"
  (("ULF" 199) ("ULF protein" 3) ("TRIP12" 2) ("ARF called ULF" 1) ("-ULF" 1)))
 ("UP:Q14671" (("PUM1" 82) ("PUM1-" 1) ("pumilio homolog 1 (Drosophila)" 1)))
 ("UP:Q14674" (("ESPL1" 19) ("ESP1" 4) ("esp1" 2)))
 ("UP:Q14676"
  (("MDC1" 590) ("NFBD1" 426) ("Mdc1" 127)
   ("mediator of DNA damage checkpoint 1" 10)
   ("mediator of DNA damage checkpoint 1 (MDC1) protein" 4)
   ("Mediator of DNA damage checkpoint 1" 2) ("Mdc1-" 2) ("the NFBD1’s" 1)
   ("more MDC1" 1) ("that MDC1’s" 1) ("MDC1-" 1) ("800 amino acids of MDC1" 1)
   ("bicistronic vector pMC16 Mdc1" 1) ("than Mdc1" 1)
   ("Mediator of DNA damage checkpoint protein 1" 1)))
 ("UP:Q14677"
  (("epsinR" 13) ("epsinR peptide" 2) ("ENTH" 1) ("Q14677" 1) ("CLINT" 1)))
 ("UP:Q14678" (("Kank" 428) ("Kank protein" 6) ("less Kank" 2)))
 ("UP:Q14680"
  (("MELK" 181) ("MELK protein" 6)
   ("maternal embryonic leucine zipper kinase" 3)
   ("Maternal embryonic leucine zipper kinase" 2)
   ("Maternal embryonic leucine zipper kinase (MELK)" 1) ("KIAA0175" 1)))
 ("UP:Q14683"
  (("SMC1" 166) ("SMC1A" 68) ("Smc1" 27) ("-SMC1" 1) ("SMC1L1" 1) ("Smc1a" 1)))
 ("UP:Q14684" (("RRP1B" 1)))
 ("UP:Q14686"
  (("TRBP" 32) ("AIB3" 8) ("Ncoa6" 4) ("PPARS" 2) ("NCoA6" 2)
   ("NCOA6 nuclear receptor coactivator 6" 1) ("ASC-2" 1)))
 ("UP:Q14689" (("DIP2" 1)))
 ("UP:Q14691" (("GINS1" 6) ("GINS complex subunit 1" 3)))
 ("UP:Q14693"
  (("lipin-1" 35) ("Lipin 1" 32) ("Lpin1" 23) ("LPIN1" 11) ("lipin 1" 6)
   ("Lipin1" 3)))
 ("UP:Q14694" (("USP10" 561) ("Usp10" 3) ("USP10 protein" 1) ("usp10" 1)))
 ("UP:Q14696" (("MESDC2" 4))) ("UP:Q14697" (("GANAB" 1)))
 ("UP:Q14699" (("KIAA0084" 1)))
 ("UP:Q14703"
  (("S1P" 1707) ("site 1" 264) ("S1P-" 18) ("exogenous S1P" 15) ("Site 1" 14)
   ("site 1 protein" 14) ("SKI-1" 11) ("-S1P" 10) ("HDL-associated S1P" 9)
   ("–S1P" 2) ("Exogenous S1P" 2) ("cellular S1P" 2) ("autocrine S1P" 2)
   ("site-1 protease" 2) ("Bioactive S1P" 1) ("especially given S1P" 1)
   ("local S1P" 1) ("S-1-P" 1) ("so-called site 1" 1) ("particular S1P" 1)
   ("more S1P" 1) ("The HDL-associated S1P" 1)))
 ("UP:Q14714" (("KrasG" 18) ("KRasG" 6) ("SSPN" 1)))
 ("UP:Q14721"
  (("Kv2.1" 89) ("KCNB1" 8) ("Kv2.1 protein" 6) ("particular Kv2.1" 1)))
 ("UP:Q14722" (("KCNAB1" 9) ("beta member 1" 3))) ("UP:Q14738" (("PPP2R5D" 1)))
 ("UP:Q14739" (("LBR" 28)))
 ("UP:Q14746" (("LDLC" 106) ("LDLc" 3) ("actual LDLC" 1)))
 ("UP:Q14749" (("glycine N-methyltransferase" 5) ("GNMT" 4) ("Gnmt" 1)))
 ("UP:Q14761" (("LPAP" 6) ("PTPRCAP" 2)))
 ("UP:Q14764"
  (("LRP" 130) ("MVP" 45) ("MVPs" 10) ("Major Vault Protein" 7) ("mvp" 5)
   ("pLRP" 4) ("major vault protein" 4) ("major vault protein (MVP)" 2)
   ("Major Vault Protein (MVP)" 2) ("Major vault protein" 1)
   ("several intragenic MVPs" 1) ("inter-individual MVPs" 1)))
 ("UP:Q14765"
  (("STAT4" 392) ("Stat4" 18) ("STAT-4" 7) ("p-STAT4" 5) ("pSTAT4" 4)
   ("STAT4-" 3) ("signal transducer and activator of transcription 4" 2)
   ("Signal transducer and activator of transcription 4" 2) ("-STAT4" 1)
   ("two new STAT4" 1) ("New STAT4" 1)))
 ("UP:Q14766" (("LTBP" 7) ("LTBP1" 4) ("LTBP-1" 2)))
 ("UP:Q14767"
  (("LTBP2" 9) ("latent transforming growth factor beta binding protein 2" 3)))
 ("UP:Q14773" (("LW" 31) ("ICAM-4" 2) ("ICAM4" 1)))
 ("UP:Q14774" (("HLX1" 8) ("Hlx1" 1)))
 ("UP:Q14781"
  (("CBX2" 57) ("Cbx2" 3) ("chromobox homolog 2" 2)
   ("Polycomb Repressive Complex component CBX2" 2) ("-CBX2" 2)))
 ("UP:Q14789"
  (("giantin" 84) ("Giantin" 27) ("GOLGB1" 4) ("golgin B1" 3)
   ("Golgi integral membrane protein" 2)
   ("the cis-medial Golgi marker Giantin" 2)
   ("a Golgi resident protein giantin" 2) ("‘giantin’" 1)))
 ("UP:Q14790"
  (("caspase-8" 3900) ("caspase 8" 1145) ("CASP8" 1096) ("Caspase-8" 348)
   ("MACH" 197) ("CASPASE 8" 174) ("Caspase 8" 132) ("caspases-8" 64)
   ("FLICE" 63) ("CASPASE-8" 52) ("Casp8" 44) ("caspase8" 23) ("MaCH" 16)
   ("Caspase8" 12)
   ("caspase
 8"
    12)
   ("CASP8 protein" 10) ("caspase-8 protein" 10) ("caspase 8-" 6)
   ("membrane-associated caspase-8" 5) ("-caspase 8" 5) ("Mch5" 4) ("Flice" 4)
   ("Caspases-8" 4) ("apical caspases-8" 4) ("casp-8" 4)
   ("caspase 8 protein" 4) ("functional caspase-8" 3) ("mature caspase 8" 3)
   ("caspase 8 molecule" 3) ("CASP8 Protein" 2) ("accelerated caspase-8" 2)
   ("essentially all caspase-8" 2) ("heterotetrameric caspase-8" 2)
   ("available full-length caspase-8" 2) ("the major CASP8" 2)
   ("mitochondria-associated caspase-8" 2) ("mature caspase-8" 2)
   ("the apical caspase-8" 2) ("normal caspase-8" 2)
   ("proteolytically process human caspase-8" 2) ("exogenous caspase-8" 2)
   ("than wild-type caspase-8" 1) ("Fas featured active caspase-8" 1)
   ("CASPASE 8-" 1) ("the viral caspase-8" 1)
   ("fluorescently-labeled caspase-8" 1)
   ("Dimerized uncleavable chimeric caspase 8" 1) ("MCH5" 1)
   ("Caspase-8 protein" 1) ("only CASP8 D302H" 1)
   ("CP70 expressed less caspase 8 protein" 1)
   ("FLICE-associated huge protein (FLASH)-caspase 8" 1) ("-caspase-8" 1)
   ("monomeric un-processed caspase-8" 1) ("particular caspase-8" 1)
   ("subsequent caspase-8" 1) ("than caspase-8" 1) ("9-fold more caspase-8" 1)
   ("casp8" 1) ("monoclonal mouse anti-human caspase-8" 1) ("new CASP8" 1)
   ("most CASP8" 1) ("G-Rh2-promoted caspase-8" 1)))
 ("UP:Q147X3" (("putative)" 9)))
 ("UP:Q14807" (("KID" 126) ("KIF22" 3) ("Kif22" 2) ("Kid" 1)))
 ("UP:Q14814"
  (("MEF2D" 46) ("myocyte enhancer factor 2D" 5)
   ("Further strongly correlated differentially methylated genes included myocyte enhancer factor 2D"
    3)))
 ("UP:Q14831" (("mGluR7" 20) ("GRM7" 9) ("metabotropic 7" 1)))
 ("UP:Q14832" (("grm3" 2) ("GRM3" 1)))
 ("UP:Q14839"
  (("CHD4" 408) ("Mi-2β" 8) ("Mi2β" 4) ("CHD4 peptide" 2) ("Chd4" 1)
   ("epidermal Mi-2β" 1)))
 ("UP:Q14847"
  (("LASP-1" 124) ("LASP1" 16) ("LIM and SH3 protein 1" 6)
   ("LIM and SH3 domain protein 1" 4) ("lasp-1 protein" 2) ("Lasp1" 2)
   ("lasp-1" 1)))
 ("UP:Q14849" (("STARD3" 64) ("MLN64" 1))) ("UP:Q14863" (("POU6F1" 4)))
 ("UP:Q14865" (("ARID5B" 22))) ("UP:Q14896" (("Mybpc3" 5) ("MYBPC3" 4)))
 ("UP:Q14914" (("Ptgr1" 1)))
 ("UP:Q14916"
  (("SLC17A1" 8) ("solute carrier family 17 (sodium phosphate)" 1)))
 ("UP:Q14934"
  (("NFAT3" 198) ("NFATc4" 76) ("NFATC4" 4) ("functional NFAT3 (GGAAA)" 1)
   ("the available basal NFAT3" 1)))
 ("UP:Q14938" (("NFIX" 18) ("nuclear factor I/X" 5) ("Nfix" 2)))
 ("UP:Q14940" (("isoform 5" 2) ("Isoform 5" 1))) ("UP:Q14943" (("KIR3DS1" 5)))
 ("UP:Q14954" (("short cytoplasmic tail" 7) ("KIR2DS1" 1)))
 ("UP:Q14956" (("GPNMB" 198) ("apparent soluble GPNMB" 2)))
 ("UP:Q14957" (("GRIN2C" 5) ("NR2C" 2)))
 ("UP:Q14973" (("Ntcp" 56) ("NTCP" 4) ("SLC10A1" 2)))
 ("UP:Q14974" (("KPNB1" 3) ("KpNB1" 1))) ("UP:Q14978" (("Nopp140" 13)))
 ("UP:Q14980"
  (("NuMA" 111) ("NuMa" 9) ("NMP22" 6) ("NUMA1" 5) ("Numa" 4)
   ("the mitotic factor NuMA" 2) ("NUMA" 2)
   ("nuclear mitotic apparatus protein 1" 1)))
 ("UP:Q14982" (("OPCML" 29))) ("UP:Q14990" (("ODF1" 4)))
 ("UP:Q14994"
  (("constitutive androstane receptor" 5)
   ("constitutive androstane receptor (CAR)" 4) ("NR1I3" 2)
   ("Constitutive Androstane Receptor" 1)
   ("Constitutive androstane receptor" 1)))
 ("UP:Q14995" (("Reverbβ" 1) ("NR1D2" 1) ("Nr1d2" 1)))
 ("UP:Q14997" (("PSME4" 4) ("PA200" 3) ("Psme4" 2)))
 ("UP:Q14999" (("CUL7" 108) ("Cul7" 7) ("Cullin 7" 1)))
 ("UP:Q149N8" (("SHPRH" 11) ("shprh" 1))) ("UP:Q14BN4" (("SLMAP" 7)))
 ("UP:Q14C86" (("Gapex-5" 6) ("GAPVD1" 3) ("GAPex5" 1)))
 ("UP:Q14C87" (("TMEM132D" 3)))
 ("UP:Q14CB8"
  (("ARHGAP19" 2) ("the hematopoietic linage-specific Rho-GAP ARHGAP19" 1)))
 ("UP:Q14CN2" (("family member 4" 16))) ("UP:Q14CN4" (("KRT6" 4)))
 ("UP:Q14CS0" (("UBXN2B" 5)))
 ("UP:Q14CX7" (("C12orf30" 7) ("NAA25" 4) ("mdm20" 2) ("MDM20" 2) ("Mdm20" 1)))
 ("UP:Q14CZ8" (("HEPACAM" 6)))
 ("UP:Q14DG7" (("transmembrane protein 132B" 2) ("TMEM132B" 1)))
 ("UP:Q15003" (("NCAPH" 9) ("hCAP-H" 2) ("CAPH" 1)))
 ("UP:Q15004"
  (("PAF" 623) ("KIAA0101" 177) ("NS5ATP9" 85) ("KIAA0101 protein" 44)
   ("PAF15" 5) ("p15(PAF)" 4) ("-NS5ATP9" 3) ("p15PAF" 3) ("–PAF" 2)
   ("PCNA-associated factor" 2) ("overexpressed KIAA0101" 2) ("PAF-" 2)
   ("urinary PAF" 1) ("bacterially-expressed KIAA0101 protein" 1)))
 ("UP:Q15005" (("SPCS2" 1))) ("UP:Q15006" (("TTC35" 3)))
 ("UP:Q15011"
  (("HERP" 28) ("HERPUD1" 7) ("homocysteine-inducible" 3) ("MIF1" 2)
   ("“HERP”" 1) ("ubiquitin-like domain member 1" 1)
   ("endoplasmic reticulum stress–inducible" 1)))
 ("UP:Q15014" (("MRGX" 2) ("MORF4L2" 1))) ("UP:Q15018" (("KIAA0157" 1)))
 ("UP:Q15019"
  (("SEPTIN2" 69) ("SEPT2" 16) ("strong SEPTIN2" 2) ("septin 2" 2)
   ("septin-2" 2) ("Nedd5" 1) ("Septin 2" 1)))
 ("UP:Q15020" (("Tip110" 125) ("SART3" 7) ("overexpressed Tip110" 2)))
 ("UP:Q15021"
  (("bipartite" 218) ("hCAP-D2" 19) ("CNAP1" 11) ("bipartite protein" 3)
   ("the classic bipartite" 1) ("a classical bipartite" 1)
   ("the classical bipartite" 1) ("the putative non-classical bipartite" 1)
   ("classical bipartite" 1) ("CAP-D2" 1)
   ("the proximal centriole marker CNAP1" 1) ("CAPD2" 1) ("‘bipartite’" 1)
   ("non-SMC condensin I complex" 1)))
 ("UP:Q15022"
  (("SUZ12" 293) ("Suz12" 64) ("zeste 12" 17)
   ("a genome-wide shRNA library screen SUZ12" 2) ("strong SUZ12" 2)
   ("the essential PRC2 component Suz12" 2) ("zeste 12 protein" 1) ("JJAZ1" 1)
   ("weak SUZ12" 1)))
 ("UP:Q15024" (("Rrp42" 4)))
 ("UP:Q15025"
  (("TNIP1" 497) ("van" 447) ("ABIN-1" 231) ("Van" 131) ("ABIN" 24)
   ("ABIN1" 20) ("TNFAIP3 interacting protein 1" 14) ("tnip1" 10)
   ("ABIN-1 protein" 7) ("TNIP1 protein" 2) ("VAN" 2) ("Abin1" 2)
   ("depth soluble TNIP1" 1) ("our data clearly support TNIP1" 1)))
 ("UP:Q15027" (("ACAP1" 8) ("CENTB1" 7) ("Centaurin" 2) ("centaurin" 1)))
 ("UP:Q15029" (("EFTUD2" 17) ("116 kD" 4) ("eftud2" 1) ("116 kD" 1)))
 ("UP:Q15031" (("Leucyl tRNA synthetase" 3) ("leucyl tRNA synthetase" 3)))
 ("UP:Q15036" (("SNX17" 3)))
 ("UP:Q15038"
  (("Dazap2" 219) ("DAZAP2 protein" 7) ("Dazap2 protein" 7) ("DAZAP2" 6)
   ("expressed Dazap2" 2) ("DAZ-associated protein 2" 2) ("targeting Dazap2" 2)
   ("we first ectopically expressed Dazap2" 1)
   ("ectopically expressed Dazap2" 1)
   ("a small evolutionary conserved protein Dazap2" 1)
   ("the evolutionary conserved Dazap2 protein" 1)))
 ("UP:Q15042" (("KIAA0066" 6) ("RAB3GAP1" 1)))
 ("UP:Q15043" (("ZIP14" 8) ("Zip14" 3) ("SLC39A14" 1)))
 ("UP:Q15046" (("KARS" 8)))
 ("UP:Q15047"
  (("SET domain" 164) ("SETDB1" 124) ("ESET" 11) ("a functional SET domain" 2)
   ("the functional SET domain" 2) ("SetDB1" 2) ("SET domain bifurcated 1" 1)
   ("Histone-lysine N-methyltransferase SETDB1" 1) ("bifurcated 1" 1)))
 ("UP:Q15049" (("LVM" 61) ("log-transformed LVM" 3) ("MLC1" 1)))
 ("UP:Q15050"
  (("RRR" 21) ("rrs1" 6) ("pVHL termed RRR" 2) ("RRS1" 2) ("Rrs1" 1)
   ("-RRR" 1)))
 ("UP:Q15051" (("NPHP5" 52) ("Nphp5" 6) ("nphp5" 1) ("IQCB1" 1)))
 ("UP:Q15052"
  (("αPIX" 382) ("ARHGEF6" 12) ("α-Pix" 8) ("α-PIX" 8)
   ("Overexpressed wild-type αPIX" 4) ("αPIX-" 2) ("Cool-2" 1)))
 ("UP:Q15053" (("KIAA0040" 1))) ("UP:Q15054" (("POLD3" 122)))
 ("UP:Q15056" (("EIF4H" 8) ("eukaryotic translation initiation factor 4H" 1)))
 ("UP:Q15058"
  (("KIF14" 259)
   ("the more highly and frequently gained/amplified oncogene KIF14" 1)
   ("Kif14" 1) ("dyneins" 1) ("the last 166 amino acids of human KIF14" 1)))
 ("UP:Q15059" (("BRD3" 6) ("BRD3-" 1)))
 ("UP:Q15063"
  (("PN" 269) ("Postn" 238) ("pN" 45) ("periostin" 30) ("PN protein" 16)
   ("Periostin" 13) ("Pn" 9) ("POSTN" 7) ("periostin (PN)" 2) ("benign PN" 1)
   ("a benign PN" 1) ("Postn protein" 1) ("than three Pn" 1)))
 ("UP:Q15067"
  (("palmitoyl" 69) ("palmitoyl-" 5) ("Palmitoyl" 3) ("Aox" 2) ("AOX" 2)
   ("ACOX" 1) ("ACOX1" 1) ("Acox" 1)))
 ("UP:Q15070"
  (("hsa" 617) ("HSA" 303) ("Hsa" 18) ("HSA peptide" 7) ("hsa-" 2) ("HsA" 1)
   ("Hsa-" 1) ("the HSA21" 1)))
 ("UP:Q15075"
  (("EEA1" 552) ("EE" 362) ("EEA-1" 32) ("early endosome antigen 1" 18)
   ("“EE”" 3) ("ee" 3) ("pEE" 3) ("EEA1-" 3)
   ("early endosome antigen 1 protein" 2) ("the early endocytic marker EEA1" 1)
   ("the peripheral membrane protein EEA1" 1) ("“QQ477EE”" 1) ("-EEA1" 1)
   ("EEA1 protein" 1)))
 ("UP:Q15077" (("P2Y6" 6) ("P2RY6" 3)))
 ("UP:Q15078"
  (("cyclin-dependent kinase 5" 36) ("Cyclin-dependent kinase 5" 8)))
 ("UP:Q15080" (("NCF4" 25) ("p40phox" 10) ("Ncf4" 4) ("p40PHOX" 1)))
 ("UP:Q15084" (("PDIA6" 6) ("ERP5" 2)))
 ("UP:Q15109"
  (("RAGE" 399) ("AGER" 19) ("RAGE protein" 10)
   ("Recombinant human endogenous secretory RAGE" 2)
   ("endogenous secretory RAGE" 2) ("than RAGE" 1) ("soluble RAGE" 1)))
 ("UP:Q15111" (("PLCL1" 24) ("Plcl1" 2)))
 ("UP:Q15113" (("PCOLCE" 4) ("procollagen C-endopeptidase enhancer" 1)))
 ("UP:Q15116" (("pdcd1" 4) ("programmed cell death protein 1" 2) ("PDCD1" 1)))
 ("UP:Q15118"
  (("PDK-1" 328) ("Pdk1" 88) ("pyruvate dehydrogenase kinase 1" 15)
   ("phosphoinositide dependent kinase 1" 10) ("pPDK-1" 3)
   ("antitotal PDK-1" 2) ("pPdk1" 1) ("Q15118" 1)
   ("membrane-associated PDK-1" 1)))
 ("UP:Q15119"
  (("PDK2" 64) ("PDK-2" 60) ("PDK2s" 5) ("the primary PDK2" 4)
   ("pyruvate dehydrogenase kinase 2" 2) ("tentative kinase PDK2" 2) ("Pdk2" 2)
   ("the principal PDK2" 2) ("the so-called PDK2" 2)
   ("the previously elusive PDK2" 1)
   ("the hypothetical ghrelin-activated PDK2" 1) ("the so-called PDK-2" 1)
   ("previously putatively named PDK2" 1)))
 ("UP:Q15120" (("Pdk3" 2) ("PDK3" 1)))
 ("UP:Q15121"
  (("astrocytes" 4087) ("PEA-15" 1087) ("PED" 355) ("PEA15" 187)
   ("Astrocytes" 181) ("reactive astrocytes" 53) ("primary astrocytes" 42)
   ("normal astrocytes" 38) ("pPEA-15" 34) ("astrocytes (NHA)" 30)
   ("Phosphoprotein enriched in astrocytes" 17)
   ("primary human fetal astrocytes" 15) ("mature astrocytes" 15)
   ("human fetal astrocytes" 14) ("NHA" 14) ("Primary astrocytes" 10)
   ("phosphomimetic PEA-15" 8) ("immortalized human astrocytes" 7)
   ("phosphoprotein enriched in astrocytes" 7) ("Reactive astrocytes" 6)
   ("mock-transfected astrocytes" 5) ("human primary astrocytes" 5)
   ("PEA-15 protein" 5) ("nonphosphorylatable PEA-15" 5) ("-astrocytes" 4)
   ("pea-15" 4) ("GFAP-immunoreactive astrocytes" 4)
   ("primary cortical astrocytes" 4) ("37°C. Progenitor-derived astrocytes" 4)
   ("ASTROCYTES" 4) ("Pea-15" 4) ("transformed astrocytes" 3)
   ("phosphoprotein enriched in diabetes" 3) ("neoplastic astrocytes" 3)
   ("the primary astrocytes" 3) ("rat primary astrocytes" 3)
   ("BeclinCCP-positive astrocytes" 3)
   ("primary progenitor-derived astrocytes" 3) ("C6-originated astrocytes" 3)
   ("overexpressed PEA-15" 3) ("extracellular Vpr-treated astrocytes" 2)
   ("astrocytes (HA)" 2) ("Astrocytes (HA)" 2)
   ("the adherent GFP + -murine astrocytes" 2)
   ("conditionally immortal astrocytes" 2) ("human immortalized astrocytes" 2)
   ("human fetal astrocytes (HFA)" 2)
   ("larger tumors fromp16 Ink4a /Arf −/− astrocytes" 2)
   ("immortalized ( p53  −/− ) murine astrocytes" 2)
   ("more GFAP+ astrocytes" 2) ("Astrocytes (NHA)" 2)
   ("non-tumorigenic astrocytes" 2) ("Primary human fetal astrocytes" 2)
   ("astrocytes (NRA)" 2) ("primary human fetal astrocytes (PHFA)" 2)
   ("neighboring astrocytes" 2) ("primary human fetal astrocytes (HFA)" 2)
   ("sparse astrocytes" 2) ("the nonneoplastic astrocytes" 2)
   ("quiescent cortical astrocytes" 2) ("treated astrocytes" 2)
   ("a transformed astrocytes" 2) ("non-dysplastic astrocytes" 2)
   ("mouse primary astrocytes" 2) ("predominantly Gfap + astrocytes" 2)
   ("hippocampal astrocytes" 2) ("labeled BeclinCCP-positive astrocytes" 2)
   ("reporter-positive astrocytes" 2) ("optic nerve astrocytes" 2)
   ("FGF2 treated astrocytes" 2) ("human progenitor-derived astrocytes" 2)
   ("non-malignant fetal astrocytes" 2) ("fetal astrocytes" 2)
   ("Human Fetal Astrocytes" 2) ("gp120-triggered human fetal astrocytes" 2)
   ("Phosphoprotein enriched in astrocytes 15" 2) ("The adherent astrocytes" 2)
   ("astrocytes (PCRA)" 2) ("normoxia treated astrocytes" 2)
   ("Widespread Reactive Astrocytes" 2)
   ("GFAP/pS6 double-positive astrocytes" 2)
   ("Primary progenitor-derived astrocytes" 2)
   ("progenitor-derived astrocytes" 2)
   ("progenitor-derived astrocytes (PDA)" 2) ("C6-originated Astrocytes" 2)
   ("transduced mature p53 −/− astrocytes" 2) ("GFAP-expressing astrocytes" 2)
   ("mature cortical astrocytes" 2) ("Mature primary cortical astrocytes" 2)
   ("mature primary astrocytes" 2) ("PEA-15 molecule" 2)
   ("Normal astrocytes" 1) ("both normal astrocytes" 1)
   ("immortalized murine astrocytes" 1) ("immortalized astrocytes" 1)
   ("the immortalized murine astrocytes" 1) ("Immortalized mouse astrocytes" 1)
   ("virally-transduced astrocytes" 1)
   ("Ink4a/Arf -null cortical astrocytes" 1)
   ("parental p53-null mouse primary astrocytes" 1) ("p53-null astrocytes" 1)
   ("astrocytes (GFAP)" 1)
   ("RNAi-mediated depletion ofp18 INK4C inp16 INK4A -deficient primary astrocytes"
    1)
   ("The mock-transfected astrocytes" 1) ("the adjacent astrocytes" 1)
   ("mature GFAP+ astrocytes" 1) ("cultured human primary astrocytes" 1)
   ("poorly differentiated neoplastic astrocytes" 1) ("around PEA-15" 1)
   ("nearby astrocytes" 1)
   ("5×10 5 immortalized mBrEC and 5×10 5 human astrocytes" 1)
   ("The primary fetal astrocytes" 1) ("the primary human fetal astrocytes" 1)
   ("a recent study human fetal astrocytes" 1)
   ("HIV-1 Nef-treated primary fetal astrocytes" 1) ("15kD" 1)
   ("astrocytes (RNB)" 1) ("fetal brain astrocytes" 1)
   ("than normal astrocytes" 1) ("WT reactive astrocytes" 1)
   ("The reactive astrocytes" 1) ("Ischemic astrocytes" 1)
   ("EGFRvIII-expressing astrocytes" 1) ("transformed mouse astrocytes" 1)
   ("non-glucose treated control astrocytes" 1)
   ("glucose treated astrocytes" 1)
   ("the control non-glucose treated astrocytes" 1)
   ("human fetal brain astrocytes" 1) ("Ras-mediated transformed astrocytes" 1)
   ("phosphoprotein enriched in astrocytes 15" 1) ("than astrocytes" 1)
   ("p53−/− mouse neonatal astrocytes" 1)
   ("numerous BeclinCCP-positive astrocytes" 1)
   ("the occasional reactive astrocytes" 1)
   ("some reporter-positive astrocytes" 1) ("Primary cortical astrocytes" 1)
   ("EGFRvIII expression transformed p53-null astrocytes" 1)
   ("Pten-null astrocytes" 1) ("human primary fetal astrocytes (PFA)" 1)
   ("Progenitor-derived astrocytes (PDA)" 1) ("Human fetal astrocytes (HFA)" 1)
   ("human fetal astrocytes (NHA)" 1) ("normal astrocytes (NHA)" 1)
   ("primary human progenitor fetal astrocytes" 1)
   ("human progenitor derived fetal astrocytes (PDA)" 1)
   ("Human fetal astrocytes" 1) ("using primary human fetal astrocytes" 1)
   ("human optic nerve head astrocytes" 1) ("a few astrocytes" 1)
   ("protoplasmic astrocytes" 1) ("defensive genes Nqo1 and HO-1 astrocytes" 1)
   ("mainly reactive astrocytes" 1) ("gp120-treated cultured rat astrocytes" 1)
   ("Phosphoprotein enriched in diabetes" 1)
   ("lineage-restricted fibrous astrocytes" 1)
   ("mock- transfected astrocytes" 1) ("subsequent experiments astrocytes" 1)
   ("interleukin (IL)-1β-activated astrocytes" 1)
   ("tolerant LPS/LPS-stimulated astrocytes" 1) ("LPS-tolerant astrocytes" 1)
   (">99% pure astrocytes" 1) ("Vpr-treated astrocytes" 1)
   ("aNF-κB rescued primary astrocytes" 1) ("apoptotic and dead astrocytes" 1)
   ("predominantly GFAP+ astrocytes" 1) ("widespread reactive astrocytes" 1)
   ("similar atypical astrocytes" 1) ("FGFR3-TACC3–transformed astrocytes" 1)
   ("mitotic cells such astrocytes" 1) ("STAT3-mediated reactive astrocytes" 1)
   ("hypertrophic astrocytes" 1) ("whereby reactive astrocytes" 1)
   ("p38-overexpressing astrocytes" 1) ("HIV DNA-positive astrocytes" 1)
   ("primary immortalized human astrocytes" 1)
   ("non-transformed human astrocytes" 1) ("the normal astrocytes" 1)
   ("mature p53 −/− astrocytes" 1) ("p53 −/− cortical astrocytes" 1)
   ("most astrocytes" 1) ("Most astrocytes" 1)
   ("Most early-passage p53AKT astrocytes" 1) ("Q15121" 1)
   ("15 kDa phosphoprotein enriched in astrocytes" 1)
   ("murine cortical astrocytes" 1)))
 ("UP:Q15125" (("EBPs" 22))) ("UP:Q15126" (("PMK" 1)))
 ("UP:Q15131" (("CDK10" 2) ("cdk10" 1)))
 ("UP:Q15139"
  (("PKD" 597) ("PRKD1" 55) ("PKCμ" 38) ("protein kinase D" 29)
   ("protein kinase D1" 23) ("Protein Kinase D" 10) ("Protein kinase D" 5)
   ("autosomal recessive PKD" 5) ("pPKD" 4) ("protein kinase D (PKD)" 3)
   ("PKCmu" 2) ("The nonconventional PKC isoform PKD" 2) ("-PKD" 1) ("“PKD”" 1)
   ("Protein Kinase D (PKD)" 1)))
 ("UP:Q15147" (("PLCB4" 3)))
 ("UP:Q15149"
  (("PCN" 155) ("plectin" 21) ("PLEC" 1) ("Chemically-synthesized PCN" 1)
   ("PLEC1" 1) ("PCN-" 1) ("Plectin" 1)))
 ("UP:Q15154" (("PCM1" 97) ("PCM-1" 1)))
 ("UP:Q15165" (("PON2" 16) ("paraoxonase 2" 4)))
 ("UP:Q15170" (("TCEAL1" 1) ("pp21" 1)))
 ("UP:Q15181" (("PPase" 41) ("inorganic pyrophosphatase" 8)))
 ("UP:Q15185"
  (("PTGES3" 23) ("cPGES" 15) ("HSP90 co-chaperone" 6) ("cPGES protein" 2)))
 ("UP:Q15195" (("PrGA" 2))) ("UP:Q15198" (("PDGFRL" 12)))
 ("UP:Q15208"
  (("NDR1" 335) ("STK38" 218) ("serine/threonine kinase 38" 5)
   ("phosphomimetic mutant NDR1 3E" 3) ("NDR1 protein" 3) ("mitotic NDR1" 2)
   ("STK38 protein" 2) ("Ndr1" 1)))
 ("UP:Q15223"
  (("nectin-1" 140) ("Nectin-1" 22) ("HVEC" 10) ("PRR1" 3)
   ("poliovirus receptor-related protein 1" 3) ("nectin-1-" 3) ("CD111" 2)
   ("-nectin-1" 1) ("substantially more nectin-1" 1) ("HveC" 1) ("PVRL1" 1)))
 ("UP:Q15233"
  (("NonO" 104) ("NONO" 92) ("NonO protein" 23) ("p54nrb" 3) ("NONO protein" 2)
   ("non-POU domain containing, octamer-binding" 1)
   ("Non-POU domain-containing octamer-binding protein" 1)))
 ("UP:Q15238" (("pSG5" 304) ("PSG5" 3) ("pSG5-" 2)))
 ("UP:Q15256"
  (("PTP-SL" 118) ("PTPSL" 92) ("PTPRR" 5) ("PTPRQ" 5) ("PTPBR7" 3)))
 ("UP:Q15257" (("PPP2R4" 7)))
 ("UP:Q15262" (("RPTPκ" 2) ("RPTP-kappa" 2) ("PTPkappa" 1)))
 ("UP:Q15269" (("Pwp2" 9) ("Pwp2h" 4) ("pwp2h" 3))) ("UP:Q15274" (("QPRT" 7)))
 ("UP:Q15276"
  (("Rabaptin-5" 12) ("Rabaptin5" 8) ("rabaptin-5" 5) ("Rabep1" 4)
   ("Rabaptin 5" 3) ("RABEP1" 3) ("rabaptin5" 2) ("rabaptin" 1)))
 ("UP:Q15283" (("RASA2" 8)))
 ("UP:Q15286" (("Rab35" 15) ("RAB35" 2) ("Rab35-" 2)))
 ("UP:Q15287" (("RNPS1" 12) ("serine-rich domain" 6) ("Serine-rich domain" 3)))
 ("UP:Q15291" (("RbBP5" 24) ("RBBP5" 13) ("rbbp5" 3)))
 ("UP:Q15293" (("RCN1" 8)))
 ("UP:Q15303"
  (("ErbB4" 733) ("HER4" 575) ("ERBB4" 557) ("4ICD" 161) ("Erbb4" 110)
   ("erbB4" 73) ("Her4" 46) ("ErbB-4" 45) ("pErbB4" 29) ("HER-4" 19)
   ("ERBB4 protein" 9) ("pHER4" 8) ("Her-4" 7) ("ERBB4 intracellular domain" 7)
   ("erbB-4" 5) ("erbB4 protein" 4) ("P-HER4" 4) ("p-erbB4" 3)
   ("presynaptic Erbb4" 3)
   ("v-Erb-B erythroblastic leukemia viral oncogene homolog ERBB4" 3)
   ("HER4 protein" 2) ("postsynaptic Erbb4" 2) ("barely detectable ERBB4" 2)
   ("ErbB4 protein" 2) ("exogenous ERBB4" 2) ("ERBB4-" 2)
   ("an intrinsic ERBB4" 2) ("ErbB4-" 2)
   ("the ‘minimal’ isoform JM-b/CYT-2 ErbB4" 2) ("−HER4" 2)
   ("interneuronal Erbb4" 1) ("Erbb4 protein" 1) ("particular Erbb4" 1)
   ("undetectable ErbB4 protein" 1) ("mammary ERBB4" 1)
   ("here expressed HER4" 1) ("perinuclear 4ICD" 1)))
 ("UP:Q15306"
  (("IRF4" 300) ("IRF-4" 202) ("Irf-4" 10) ("Irf4" 4)
   ("Interferon Regulatory Factor 4" 4) ("IRF-4 protein" 3) ("IRF4-" 3)
   ("interferon regulatory factor 4" 3) ("–IRF-4" 2)
   ("Interferon regulatory factor 4" 2) ("LSIRF" 1) ("-Irf-4" 1)
   ("the plasmablastic marker IRF4" 1)))
 ("UP:Q15311"
  (("doxorubicin" 3892) ("RLIP76" 1054) ("Doxorubicin" 506) ("RalBP1" 371)
   ("RLIP76 protein" 39) ("doxorubicin-" 25) ("DOXO" 19)
   ("doxorubicin (DOX)" 15) ("RALBP1" 13)
   ("the chemotherapeutic drug doxorubicin" 12)
   ("the chemotherapeutic agent doxorubicin" 10) ("Doxorubicin (DXR)" 5)
   ("pegylated liposomal doxorubicin" 5) ("doxorubicin (DXR)" 5)
   ("the chemotherapeutic doxorubicin" 5) ("liposomal doxorubicin" 4)
   ("RalBP-1" 4) ("RLIP76-" 3) ("the genotoxic agent doxorubicin" 3)
   ("Doxorubicin (DOX)" 2) ("than doxorubicin" 2)
   ("the genotoxic chemotherapeutic agent doxorubicin" 2)
   ("using pegylated liposomal doxorubicin" 2)
   ("chemotherapeutic agent doxorubicin (DXR)" 2)
   ("the chemotherapeutic drug doxorubicin (DXR)" 2)
   ("genotoxic drug doxorubicin" 2) ("linking RLIP76" 2)
   ("undetectable RLIP76" 2) ("apparently homogenous RLIP76" 2) ("Ralbp1" 2)
   ("another genotoxic drug Doxorubicin" 2)
   ("the chemotherapeutic drug Doxorubicin" 2) ("doxorubicin (DRB)" 2)
   ("the chemotherapeutic agents doxorubicin" 2) ("modest doxorubicin-" 1)
   ("a chemotherapeutic agent doxorubicin" 1)
   ("the mercapturic acid pathway transporter protein RLIP76" 1)
   ("Doxorubicin-" 1) ("combined pegylated liposomal doxorubicin" 1)
   ("a somewhat lesser extent RalBP1" 1) ("RalBP1 protein" 1)
   ("the genotoxic drug doxorubicin" 1) ("cellular doxorubicin" 1)
   ("doxorubicin doxorubicin" 1) ("DOXO-" 1)
   ("chemotherapeutic drug doxorubicin" 1) ("DNP-SG ATPase" 1)
   ("H9c2 myoblasts xref sub-apoptotic doxorubicin" 1) ("toxic doxorubicin" 1)
   ("the multifunctional effector RalBP1" 1) ("RLIP1" 1)
   ("ralA binding protein 1" 1) ("dose-dense doxorubicin" 1) ("Doxo" 1)
   ("given doxorubicin" 1)))
 ("UP:Q15319"
  (("Pou4f3" 73) ("POU4F3" 17)
   ("than POU4F3 ( xref ; xref ; xref , xref )" 1)))
 ("UP:Q15326" (("ZMYND11" 4) ("BS69" 1)))
 ("UP:Q15327"
  (("ANKRD1" 39) ("Ankrd1" 6) ("ankyrin repeat domain 1" 3)
   ("cardiac ankyrin repeat protein" 3)
   ("ankyrin repeat domain 1 (cardiac muscle)" 2)
   ("namely Ankrd1 also known as cardiac ankyrin repeat protein" 1)))
 ("UP:Q15329"
  (("E2F5" 72) ("E2F-5" 12) ("E2f5" 4) ("transcription factor E2F5" 2)))
 ("UP:Q15334"
  (("Lgl1" 79) ("Lgl1 protein" 2) ("Hugl-1" 2) ("functional Lgl1" 1) ("LGL1" 1)
   ("LLGL1" 1)))
 ("UP:Q15345" (("MUF1" 1)))
 ("UP:Q15349"
  (("ribosomal protein S6 kinase" 160) ("RPS6KA2" 59) ("RSK3" 22) ("RSK-3" 5)
   ("ribosomal protein S6 kinase (RSK)" 4) ("90kD" 1) ("Rsk3" 1)
   ("-ribosomal protein S6 kinase" 1)))
 ("UP:Q15361"
  (("TTF-1" 307) ("TTF-I" 143) ("transcription termination factor I" 7)
   ("TTF-I protein" 6) ("either weak or undetectable TTF-1" 2)
   ("displayed strong TTF-1" 2) ("TTF-1−" 2) ("Ttf-1" 1)
   ("exogenous TTF-I" 1)))
 ("UP:Q15363" (("COPI" 115) ("TMED2" 1)))
 ("UP:Q15365" (("PCBP1" 5) ("pcbp1" 2) ("pCBP1" 2)))
 ("UP:Q15366"
  (("PCBP2" 53) ("poly(rC)-binding protein 2" 4) ("Q15366" 1) ("αCP-2" 1)))
 ("UP:Q15369"
  (("ElonginC" 17) ("EloC" 5) ("TCEB1" 3)
   ("transcription elongation factor B polypeptide 1" 2) ("Elongin-C" 1)
   ("elongin-C" 1) ("elonginC" 1)))
 ("UP:Q15370"
  (("ElonginB" 75) ("EloB" 11) ("elonginB" 4) ("Elongin-B" 3) ("TCEB2" 2)
   ("elongin-B" 1)))
 ("UP:Q15375" (("EphA7" 87) ("EPHA7" 28) ("EPH receptor A7" 3)))
 ("UP:Q15382"
  (("Rheb" 1550) ("RHEB" 108) ("Rheb2" 59) ("Ras homolog enriched in brain" 54)
   ("Rheb protein" 14) ("rheb" 9) ("ras homolog enriched in brain" 7)
   ("Rheb-" 7) ("functional Rheb" 6) ("GTP-binding protein Rheb" 5)
   ("ras homolog enriched in brain protein" 3)
   ("RAS homolog enriched in brain" 3) ("overexpressed Rheb" 2)
   ("Overexpressed Rheb" 2) ("Rheb PROTEIN" 2)
   ("than geranylgeranylated Rheb" 2) ("than recombinant Rheb" 1)
   ("than Rheb" 1) ("The proximal mTORC1 activator Rheb" 1) ("RheB" 1)
   ("even wild-type Rheb" 1) ("than endogenous Rheb" 1)
   ("than wild-type farnesylated Rheb (F-Rheb; data not shown)" 1)
   ("longer C-terminal Rheb" 1) ("any plasma membrane-associated Rheb" 1)
   ("2-DG reduced Rheb’s" 1) ("Rheb not only made Rheb" 1)
   ("the wildtype PRAK-treated Rheb" 1) ("we first determined Rheb's" 1)
   ("we first determined Rheb" 1)))
 ("UP:Q15386" (("KIAA10" 2)))
 ("UP:Q15388"
  (("Tom20" 79) ("TOM20" 56) ("TOMM20" 11) ("Tomm20" 5) ("tom20" 2)
   ("-Tom20" 1)))
 ("UP:Q15389"
  (("Angpt-1" 55) ("angiopoietin-1" 23) ("Ang-1" 23) ("Angpt1" 13)
   ("Angiopoietin-1" 9) ("ANGPT1" 7) ("angiopoietin 1" 7) ("angiopoietin1" 2)
   ("IQGAP1 abrogated Angiopoietin-1's" 1)
   ("IQGAP1 abrogated Angiopoietin-1" 1)))
 ("UP:Q15390" (("polyproline" 138))) ("UP:Q15391" (("P2RY14" 1)))
 ("UP:Q15392" (("DHCR24" 7) ("seladin-1" 2) ("Seladin-1" 1)))
 ("UP:Q15397" (("PUFA" 194) ("dietary PUFA" 3) ("HA-8" 3) ("KIAA0020" 2)))
 ("UP:Q15398"
  (("DLGAP5" 50) ("HURP" 31) ("DLG7" 9) ("Dap-5" 5)
   ("Disks large-associated protein 5" 1)))
 ("UP:Q15399"
  (("TIL" 221) ("TLR1" 76) (NIL 5) ("TIL-" 4) ("TLR1 protein" 1) ("TLR-1" 1)
   ("most autologous and allogeneic CD8 + tumor-specific TIL" 1)
   ("two different MART-1-reactive TIL" 1)))
 ("UP:Q15404" (("Rsu-1" 92) ("Ras suppressor protein 1" 2) ("RSU1" 1)))
 ("UP:Q15406"
  (("pRTR" 39) ("RTR" 13) ("GCNF" 6) ("NR6A1" 4)
   ("the episomal expression vector pRTR" 2)))
 ("UP:Q15413" (("RyR3" 71) ("RyR3 protein" 4)))
 ("UP:Q15417"
  (("calponin" 88) ("Calponin" 11) ("CALPONIN" 2) ("Calponin (CH)" 1)))
 ("UP:Q15418"
  (("RSK" 1036) ("RSK1" 706) ("Rsk" 39) ("RPS6KA1" 34) ("Rsk1" 18)
   ("p90 RSK1" 17) ("RSK-" 10) ("p90 Rsk-1" 9) ("p90 RSK-1" 8) ("rsk" 7)
   ("Ribosomal S6 kinase 1" 7) ("S6Kα1" 6) ("Ribosomal S6 Kinase 1" 6)
   ("p90RSK-1" 5) ("p90-RSK1" 5) ("p90S6K" 4)
   ("T359-S363-phosphorylated RSK" 3) ("MAPKAP-K1" 3) ("coexpressed S6Kα1" 2)
   ("ribosomal protein S6 kinase alpha-1" 2) ("p-RSK" 2) ("RSK-1" 2)
   ("pRSK1" 2) ("very little active phospho–Thr-573 RSK1" 2) ("pp90rsk1" 1)
   ("rsk1" 1) ("-RSK" 1) ("pRSK" 1) ("exogenous RSK1" 1) ("hyperactive RSK" 1)
   ("than RSK" 1) ("p90 Rsk1" 1) ("more phospho-RSK1" 1)))
 ("UP:Q15424"
  (("SAFB1" 366) ("SAFB" 40) ("het" 18) ("HET" 10)
   ("scaffold attachment factor B1" 7) ("Het" 4) ("hEts" 3) ("hET" 2)
   ("Scaffold attachment factor B1" 2)
   ("the transcriptional repressor SAFB1" 2) ("hETS" 1)))
 ("UP:Q15427" (("SF3B4" 7) ("SAP49" 2) ("49kDa" 2)))
 ("UP:Q15428" (("66kDa" 3) ("SF3a66" 3) ("66KDa" 1)))
 ("UP:Q15431" (("S/CP1" 9) ("CT8" 1))) ("UP:Q15434" (("SCR-3" 1)))
 ("UP:Q15435"
  (("Sds22" 56) ("sds22" 9) ("PP1R7" 3) ("Sds22 protein" 2) ("PPP1R7" 2)))
 ("UP:Q15436"
  (("homologues" 398) ("Homologues" 4) ("Sec23a" 4) ("retroviral homologues" 2)
   ("simpler eukaryal homologues" 2) ("Sec23A" 1) ("Sec23a-" 1)))
 ("UP:Q15437" (("SEC23B" 1)))
 ("UP:Q15438"
  (("cytohesin1" 3) ("Cytohesin1" 1) ("Cytohesin-1" 1) ("cytohesin-1" 1)))
 ("UP:Q15459" (("SF3A1" 7) ("120kD" 6)))
 ("UP:Q15464" (("sHB" 90) ("SHB" 30) ("Shb" 12) ("shB" 2) ("sHb" 1)))
 ("UP:Q15465"
  (("Shh" 457) ("SHH" 357) ("Sonic" 61) ("sonic hedgehog" 54)
   ("Sonic hedgehog" 53) ("sonic" 9) ("Shh protein" 5)
   ("Sonic hedgehog (SHH)" 4) ("sonic hedgehog (SHH)" 3) ("shh" 3) ("SHh" 2)
   ("exogenous Shh" 2) ("handy sonic" 2) ("SHH protein" 2)
   ("Sonic hedgehog ( SHH )" 1) ("Shh-" 1) ("fresh medium + Shh" 1)
   ("SONIC" 1)))
 ("UP:Q15466"
  (("SHP" 395) ("SHP protein" 23) ("small heterodimer partner" 20) ("NR0B2" 10)
   ("pSHP" 10) ("SHPs" 7) ("Shp" 7) ("SHP (FL)" 3) ("SHP-" 2)
   ("SHP and p53 decreased SHP" 2) ("Small heterodimer partner" 2)
   ("small heterodimer partner (SHP)" 1) ("p53 decreased SHP" 1) ("sHps" 1)))
 ("UP:Q15468"
  (("sIL" 322) ("SIL" 97) ("STIL" 24) ("sTILs" 15) ("sTIL" 6) ("Sil" 3)
   ("STILs" 2) ("at least one sTIL" 2) ("sIl" 2) ("“STILs”" 1)
   ("its soluble receptor sIL-6R" 1) ("soluble sIL-6R" 1)))
 ("UP:Q15475"
  (("SIX1" 74) ("Six1" 18) ("SIX1 protein" 13) ("SIX1-" 2) ("SIX homeobox 1" 2)
   ("The homeotic transcription factor Six1" 2)
   ("Sine oculis homeobox homolog 1" 2) ("functional SIX1" 1)))
 ("UP:Q15477" (("170A" 14) ("SKIV2L" 7) ("SKI2" 2)))
 ("UP:Q15493"
  (("RC" 222) ("rC" 33) ("GNL" 6) ("RC (ORC)" 2) ("the EEVPLY 90 GNL" 1)
   ("underwent RC" 1) ("Twelve patients (12%) underwent RC" 1) ("rc" 1)
   ("gluconolactonase (PGLS)" 1) ("gluconolactonase" 1)))
 ("UP:Q15517" (("CDSN" 1))) ("UP:Q15526" (("Surf1" 1) ("SURF1" 1)))
 ("UP:Q15527" (("Surf2" 1)))
 ("UP:Q15542"
  (("TAF5" 21) ("Taf5" 6) ("100kD" 3) ("approximately 100kD" 1) ("100KD" 1)))
 ("UP:Q15543" (("18kD" 1)))
 ("UP:Q15544" (("TAF11" 3) ("around 28kD" 1) ("28kD" 1)))
 ("UP:Q15545" (("55kD" 9))) ("UP:Q15546" (("MMD" 4) ("Mmd" 1)))
 ("UP:Q15554"
  (("TERF2" 63) ("telomeric repeat-binding factor 2" 8)
   ("telomeric repeat binding factor 2" 2)
   ("Telomeric
repeat-binding factor 2"
    2)))
 ("UP:Q15555" (("EB2" 3)))
 ("UP:Q15561" (("TEAD4" 192) ("TEAD4 protein" 2) ("Tead4" 1)))
 ("UP:Q15562"
  (("TEAD2" 35) ("Tead2" 11)
   ("its sequence-specific DNA binding partner Tead2" 1)))
 ("UP:Q15569"
  (("TESK1" 11) ("testicular protein kinase 1" 4) ("TESK 1" 2) ("Tesk1" 1)))
 ("UP:Q15572" (("110kD" 2) ("approximately 110kD" 1) ("TAF1C" 1) ("110KD" 1)))
 ("UP:Q15573"
  (("RNA polymerase I" 53) ("transcription factor SL1" 11) ("48kD" 4)
   ("approximately 48kD" 2)))
 ("UP:Q15582"
  (("TGFBI" 139) ("eBMD" 26) ("ig-h3" 20) ("CSD1" 5) ("calcaneal eBMD" 4)
   ("ig-h3 (TGFBI)" 3) ("exogenous TGFBI" 2) ("TGFBI protein" 2)
   ("higher QUS calcaneal eBMD" 2) ("β-Ig-H3" 1) ("Betaig-h3" 1)
   ("undetectable TGFBI" 1) ("calcaneal ultrasound eBMD" 1)
   ("Calcaneal eBMD" 1) ("transforming growth factor beta induced" 1)
   ("CDB1" 1)))
 ("UP:Q15583" (("Tgif1" 42) ("TGIF1" 12) ("further emphasizing Tgif1" 1)))
 ("UP:Q15596"
  (("TIF2" 361) ("SRC-2" 62) ("TIF-2" 39) ("NCOA2" 17)
   ("transcriptional intermediary factor 2" 5)
   ("nuclear receptor coactivator 2" 4) ("Ncoa2" 3) ("SRC-2 protein" 2)
   ("TIF2 protein" 2) ("-TIF2" 2) ("-SRC-2" 1)
   ("NCOA2 nuclear receptor coactivator 2" 1) ("exogenous TIF-2" 1)
   ("Q15596" 1) ("–TIF2" 1) ("NCoA2" 1) ("the intact TIF2" 1)))
 ("UP:Q15599" (("E3KARP" 8) ("NHERF2" 2) ("SLC9A3R2" 1)))
 ("UP:Q155Q3" (("DIXDC1" 146) ("Dixdc1" 27) ("lack appreciable Dixdc1" 2)))
 ("UP:Q15612"
  (("OR1Q1" 4) ("olfactory receptor family 1 subfamily Q member 1" 2)))
 ("UP:Q15628"
  (("TRADD" 270) ("TRADD protein" 3)
   ("transiently overexpressed receptor adaptor proteins TRADD" 2)
   ("overexpressed receptor adaptor proteins TRADD" 2)
   ("TNFRSF1A-associated via death domain (TRADD)" 1)
   ("TNFRSF1A-associated via death domain" 1)))
 ("UP:Q15629" (("TRAM" 32) ("Tram1" 7) ("TRAM1" 5)))
 ("UP:Q15631" (("TSN" 42) ("translin" 8) ("C3PO" 6)))
 ("UP:Q15633"
  (("TRBP2" 32) ("TARBP2" 11) ("LOQs" 8)
   ("a truncated dysfunctional TARBP2" 2)))
 ("UP:Q15637" (("mBBP" 1) ("splicing factor 1" 1)))
 ("UP:Q15642"
  (("CIP4" 6) ("Cdc42-interacting protein" 4) ("Trip10" 3) ("Cip4" 2)))
 ("UP:Q15643" (("TRIP230" 108) ("TRIP230 protein" 5) ("TRIP11" 3)))
 ("UP:Q15645"
  (("PCH" 31) ("pCH" 26) ("receptor interacting protein" 19)
   ("Receptor interacting protein" 2) ("receptor interacting protein (RIP)" 2)
   ("TRIP13" 1) ("nearly all the DAPI-bright PCH" 1)))
 ("UP:Q15646" (("OASL" 20)))
 ("UP:Q15648"
  (("TRAP220" 34) ("PPARBP" 12) ("mediator complex subunit 1" 4) ("DRIP205" 2)
   ("PPAR binding protein" 1) ("Mediator complex subunit 1" 1)))
 ("UP:Q15650" (("Asc1" 4)))
 ("UP:Q15652"
  (("JMJD1C" 47) ("Jmjd1c" 3) ("jmjd1c" 2) ("jumonji domain containing 1C" 2)
   ("Jumonji domain containing 1C" 1)))
 ("UP:Q15653"
  (("IκBβ" 65)
   ("nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor"
    8)
   ("NFKBIB" 4) ("ikbb" 3) ("NFκBIB" 3) ("IkBβ" 1) ("Nfkbib" 1)
   ("IκBβ protein" 1)))
 ("UP:Q15654" (("OIP-1" 115) ("TRIP6" 41) ("Trip6" 4)))
 ("UP:Q15669"
  (("TTF" 90) ("RhoH" 61) ("Ras homolog gene family" 16) ("Rhoh" 12)
   ("RHOH" 12) ("ras homolog gene family" 10) ("RhoH protein" 3)
   ("shorter median TTF" 2)
   ("a premature stop codon and non-functional RhoH protein" 1)
   ("than the prior TTF" 1) ("RAS homolog gene family" 1) ("shortest TTF" 1)))
 ("UP:Q15672"
  (("Twist" 1087) ("TWIST1" 661) ("Twist1" 591) ("TWIST" 455) ("twist" 116)
   ("CRS" 83) ("TWIST1 protein" 12) ("TWIST protein" 11) ("twist1" 9)
   ("TWIST-1" 8) ("TWISTs" 8) ("the helical twist" 5) ("overexpressed Twist" 5)
   ("Twist-1" 4) ("a slight left-handed twist" 4) ("a new twist" 3)
   ("a right-handed superhelical twist" 2)
   ("the EMT-associated transcription factor Twist" 2)
   ("overexpressed TWIST1" 2) ("monomeric N-terminally flag tagged Twist1" 1)
   ("helical twist" 1) ("Twist1 protein" 1) ("epithelial or stromal TWIST1" 1)
   ("Epithelial TWIST1" 1) ("-Twist" 1)
   ("the basic helix-loop-helix transcription factor Twist" 1)
   ("yet another twist" 1) ("H-Twist" 1) ("the super-helical twist" 1)
   ("a subtle right-handed super-helical twist" 1)
   ("the basic helix-loop-helix (bHLH) transcription factor Twist" 1)
   ("than Twist" 1)
   ("The basic helix-loop-helix (bHLH) transcription factor Twist" 1)
   ("a remarkable twist" 1) ("TWIST-" 1)
   ("relatively high-level TWIST protein" 1) ("The helical twist" 1)
   ("the overall superhelical twist" 1) ("TwistS" 1)))
 ("UP:Q15678"
  (("PTPN14" 368) ("pEZ" 14) ("PTPD2" 12) ("Pez" 5) ("PTPN14 protein" 4)
   ("-PTPN14" 3) ("overexpressed PTPN14" 2) ("PEZ" 1) ("PTPN14-" 1)
   ("ectopically-expressed WT YAP and PPxY-mutant PTPN14" 1)))
 ("UP:Q15691" (("MAPRE1" 35) ("Mapre1" 4) ("MAPRE1 protein" 2)))
 ("UP:Q15696" (("ZRSR2" 5))) ("UP:Q15697" (("AW1" 5) ("pAW1" 1)))
 ("UP:Q15714"
  (("TSC-22" 187) ("TSC22" 47) ("TSC-22-" 4) ("TSC22D1" 3)
   ("most Ad- TSC-22-" 1)))
 ("UP:Q15717"
  (("HuR" 1293) ("Hua" 26) ("HUR" 15) ("HuR protein" 14) ("Hu-antigen R" 9)
   ("overexpressed HuR" 8) ("Hur" 6) ("ELAV1" 4) ("-HuR" 4) ("hua" 3)
   ("Q15717" 2) ("elavL1" 2) ("HuR-" 1) ("Elavl1" 1) ("that HuR’s" 1)
   ("ElAVL1" 1) ("specifically target HuR" 1) ("ELAVL1" 1)
   ("exogenous HuR" 1)))
 ("UP:Q15722" (("BLT" 95) ("BLT1" 3) ("leukotriene B4 receptor" 3)))
 ("UP:Q15723" (("ELF2" 3) ("Nerf2" 2) ("Nerf1a" 1)))
 ("UP:Q15726"
  (("KiSS1" 85) ("KISS1" 13) ("kisspeptin" 7) ("KISS-1" 3) ("Metastin" 2)))
 ("UP:Q15735" (("INPP5" 2) ("PIPP" 2))) ("UP:Q15738" (("NSDHL" 4)))
 ("UP:Q15742"
  (("NAB2" 123) (NIL 81) ("Mader" 3) ("Nab2" 1)
   ("the transcriptional repressor NAB2" 1)))
 ("UP:Q15743" (("GPR68" 14) ("OGR1" 7) ("OGR1-" 1) ("Gpr68" 1)))
 ("UP:Q15744" (("C/EBP epsilon" 2) ("CEBPE" 1)))
 ("UP:Q15746"
  (("MLCK" 242) ("myosin light chain kinase" 60) ("MYLK" 22) ("KRP" 7)
   ("Myosin light chain kinase" 5) ("myosin light chain kinase (MLCK)" 5)
   ("-MYLK" 3) ("myosin light  chain kinase" 2)
   ("recently non-muscular myosin light chain kinase" 2) ("than MLCK" 1)
   ("than MLCK ( xref , xref )" 1) ("MYLK1" 1)
   ("Myosin light chain kinase (MLCK)" 1)
   ("cortactin directly and specifically binds endothelial cell myosin light chain kinase"
    1)
   ("kinase-related protein" 1) ("telokin" 1)))
 ("UP:Q15750"
  (("TAB1" 327) ("Tab1" 7) ("TAK1–binding protein 1" 4) ("TAB1-" 3)
   ("TAB1 protein" 3) ("TAK1-binding protein 1" 2) ("TAB-1" 2)
   ("TAK1 binding protein 1" 1) ("TAK1 Binding Protein 1" 1)
   ("heterozygous Tab1" 1) ("a noncanonical TAB1-" 1)))
 ("UP:Q15751" (("HERC1" 31)))
 ("UP:Q15758"
  (("SLC1A5" 53) ("ASCT2" 17) ("Slc1A5" 13) ("Slc1a5" 7) ("RDR" 6)
   ("the neutral amino acid transporter ASCT2" 2)
   ("both the exogenous and endogenous SLC1A5" 2)
   ("Solute carrier family 1 member 5" 2)))
 ("UP:Q15759"
  (("p-38" 24) ("MAPK11" 9) ("p38b" 7) ("P382" 7) ("p38-2" 2) ("Q15759" 1)
   ("SAPK2" 1)))
 ("UP:Q15761" (("NPY5R" 16)))
 ("UP:Q15762" (("CD226" 29) ("DNAM-1" 15) ("Cd226" 4) ("CD226 antigen" 2)))
 ("UP:Q15768" (("EFNB3" 7) ("ephrin-B3" 1))) ("UP:Q15777" (("MPPED2" 6)))
 ("UP:Q15782" (("CHI3L2" 1))) ("UP:Q15784" (("NEUROD2" 11) ("NeuroD2" 1)))
 ("UP:Q15785" (("TOMM34" 5)))
 ("UP:Q15788"
  (("SRC-1" 784) ("NCOA1" 41) ("Ncoa1" 32) ("F-SRC-1" 21) ("SRC-1 protein" 20)
   ("steroid receptor coactivator-1" 7) ("NcoA-1" 5)
   ("steroid receptor coactivator 1" 4)
   ("steroid receptor coactivator 1 protein" 2)
   ("The primary and stable SRC-1" 2) ("the endometriotic SRC-1" 2)
   ("an intact SRC-1" 2) ("intact SRC-1" 2)
   ("nuclear receptor coactivator 1" 1)
   ("the well-characterised steroid receptor co-activator SRC-1" 1)
   ("SRC-1-" 1) ("NCo-A1" 1) ("NCoA1" 1) ("NCoA-1" 1)
   ("the endometriotic 70-kDa SRC-1" 1)))
 ("UP:Q15796"
  (("Smad2" 1677) ("SMAD2" 418) ("P-Smad2" 91) ("pSmad2" 71) ("p-Smad2" 44)
   ("Smad 2" 34) ("SMAD-2" 23) ("smad-2" 22) ("pSMAD2" 19) ("smad2" 15)
   ("Smad2 protein" 12) ("p-SMAD2" 7) ("Smad2-" 7) ("-Smad2" 5) ("Smad-2" 4)
   ("hMAD2" 3) ("than Smad2" 3) ("SMAD 2" 3) ("than wild-type Smad2" 3)
   ("-SMAD2" 2) ("Smads2" 2) ("down more Smad2" 2)
   ("the phospho-mimetic Smad2" 2) ("the trimeric Smad2 protein" 1)
   ("SMAD family member 2" 1) ("differential Smad2" 1)
   ("Dominant negative (DN)-SMAD2" 1)
   ("assay revealed NLS-R attenuated RanBP3-mediated Smad2" 1)
   ("Quantitative Smad2" 1) ("RanBP3 increased Smad2" 1) ("intact Smad2" 1)
   ("hMAD-2" 1) ("MADR2" 1) ("than Smad2 in both LX-2 cells" 1)
   ("particular SMAD2" 1) ("the hypoactive P-Smad2" 1) ("P-Smad2 protein" 1)
   ("RBPMS increased Smad2-" 1) ("hMad2" 1)))
 ("UP:Q15797"
  (("BSP" 120) ("SMADs" 111) ("Bsp" 12) ("Smad 1" 8) ("Smad-1" 5) ("SMAD 1" 3)
   ("BSp" 3) ("hsMad1" 2) ("SMAD-1" 2) ("-Smad 1" 2)
   ("antagonistic or inhibitory SMADs" 1)
   ("mothers against decapentaplegic homolog 1" 1)))
 ("UP:Q157B2" (("PX" 305) ("Px" 35) ("px" 11) ("PX-" 1) ("‘PX’" 1)))
 ("UP:Q15811"
  (("intersectin" 17) ("Intersectin" 8) ("intersectin 1" 7) ("ITSN1" 4)
   ("ITSN" 4) ("intersectin1" 3) ("Itsn" 2) ("intersectin-1" 2)
   ("Intersectin 1" 1) ("Intersectin-1" 1)))
 ("UP:Q15813" (("hypoparathyroidism" 23) ("Kcs1" 4)))
 ("UP:Q15814" (("CFC" 301) ("TBCC" 5) ("normal CFC" 1)))
 ("UP:Q15818" (("NPTX1" 3) ("neuronal pentraxin 1" 2)))
 ("UP:Q15819"
  (("MMS2" 79) ("Mms2" 40) ("UEV" 19) ("UBE2V2" 8) ("Uev" 5) ("mms2" 1)
   ("MMS2–" 1)))
 ("UP:Q15825" (("CHRNA6" 1)))
 ("UP:Q15831"
  (("LKB1" 6389) ("STK11" 529) ("PJS" 289) ("Lkb1" 276) ("liver kinase B1" 64)
   ("LKB1 protein" 59) ("Liver kinase B1" 34) ("lkb1" 28) ("STK11 protein" 22)
   ("serine/threonine kinase 11" 16) ("Liver Kinase B1" 13) ("Stk11" 11)
   ("LKB1-" 11) ("LKB-1" 6) ("intact LKB1" 6) ("definite PJS" 6) ("p-LKB1" 4)
   ("LKb1" 3) ("functional LKB1" 3) ("Lkb-1" 3) ("fulfilling PJS" 3)
   ("strong LKB1" 2) ("stageII breast cancer showed moderately strong LKB1" 2)
   ("exogenous LKB1" 2) ("a few genes—such as STK11" 2)
   ("overexpressed LKB1" 2) ("Stk11 protein" 2) ("clearly less LKB1" 2)
   ("than the wild-type LKB1" 1) ("Serine/threonine kinase 11" 1)
   ("total or phosphorylated LKB1" 1) ("than LKB1 ( xref )" 1)
   ("lack functional LKB1" 1) ("genetically engineered mice implicated LKB1" 1)
   ("sporadic PJS" 1) ("than LKB1" 1) ("Significantly more LKB1" 1)
   ("almost all familial PJS" 1)
   ("germline pathogenic STK11 point mutations" 1) ("In contrast no LKB1" 1)))
 ("UP:Q15835" (("RK" 116) ("GRK1" 1)))
 ("UP:Q15836" (("CEB" 28) ("VAMP3" 17) ("Vamp3" 3) ("cellubrevin" 1)))
 ("UP:Q15843"
  (("NEDD8" 249) ("Nedd8" 148) ("-NEDD8" 11)
   ("ubiquitin-like protein Nedd8" 10) ("ubiquitin-like protein NEDD8" 8)
   ("-Nedd8" 5) ("nedd8" 5) ("NEDD8 peptide" 5)
   ("monomeric or multimeric Nedd8" 1) ("nearly all NEDD8" 1)
   ("K48 diGly-modified NEDD8" 1)))
 ("UP:Q15847" (("Afro" 24) ("Afro-" 2)))
 ("UP:Q15848"
  (("adiponectin" 388) ("ADIPOQ" 53) ("Adiponectin" 43) ("Adipoq" 6)
   ("Acrp30" 2) ("AdipoQ" 1) ("the antifibrotic mediator adiponectin" 1)
   ("we first selected LD-independent adiponectin" 1) ("than ADIPOQ" 1)))
 ("UP:Q15849" (("SLC14A2" 2)))
 ("UP:Q15853"
  (("USF2" 381) ("FIP" 48) ("USF-2" 38) ("USF2 protein" 9) ("CANNTG" 2)
   ("USF2 ( CANNTG )" 1) ("pUSF2" 1)))
 ("UP:Q15858" (("pN1" 30)))
 ("UP:Q15878" (("BII" 30) ("BII (TBII)" 1) ("CACNA1E" 1)))
 ("UP:Q15904"
  (("orf" 240) ("subunit 1" 44) ("16A" 44) ("ATP6AP1" 28) ("Orf" 7) ("CF2" 7)
   ("16a" 5) ("Subunit 1" 4) ("V-type proton ATPase subunit S1" 2)
   ("an immortal human mammary epithelial cell line 16A5" 1)))
 ("UP:Q15906" (("YL1" 6)))
 ("UP:Q15907" (("Rab11b" 10) ("Rab11B" 4) ("ypT3" 3)))
 ("UP:Q15910"
  (("EZH2" 4522) ("Ezh2" 333) ("enhancer of zeste homolog 2" 70)
   ("EZH2 protein" 40) ("Enhancer of zeste homolog 2" 28) ("BD" 27) ("EZH-2" 7)
   ("ezh2" 6) ("EZH2 peptide" 5) ("Ezh2 protein" 4) ("EZH2-" 3) ("pEzh2" 3)
   ("KMT6" 2) ("Zeste homolog 2" 2) ("pEZH2" 2)
   ("the Bim transcriptional repressor EZH2" 2) ("stably knockdown EZH2" 2)
   ("overexpressed NIPP1 redistributed EZH2" 2)
   ("The complete and truncated EZH2" 2) ("Kmt6" 2) ("lentiviral EZH2" 1)
   ("than EZH2 in control fibroblasts ( xref )" 1)
   ("than the EZH2-wt (Figure xref )" 1) ("than the EZH2-wt" 1)
   ("the acetylation-deﬁcient mimic EZH2-K348R" 1)
   ("Eight lysines (K10, K245, K309, K318, K344, K348, K472 and K735) of EZH2"
    1)
   ("zeste homolog 2" 1)
   ("the Polycomb Repressive Complex 2 (PRC2) member EZH2" 1)
   ("monoclonal EZH2(BD)" 1) ("associated EZH2" 1) ("cellular EZH2" 1)
   ("specifically target EZH2" 1) ("strong EZH2" 1) ("exogenous Ezh2" 1)))
 ("UP:Q15911"
  (("ZFHX3" 32) ("ATBF1" 4) ("Zfhx3" 2) ("Zinc finger homeobox 3" 1)
   ("zinc finger homeobox 3" 1)))
 ("UP:Q15915" (("Zic" 5) ("ZIC1" 5) ("ZIC" 1) ("Zic1" 1)))
 ("UP:Q15935" (("pT1" 216) ("than pT1 (n = 78, 62.9%)" 1) ("than pT1" 1)))
 ("UP:Q15937" (("pT7" 27) ("pT7CFE1-" 1)))
 ("UP:Q15942"
  (("zyxin" 249) ("Zyxin" 35) ("zyxin protein" 4) ("ZYX" 3) ("zyx" 2)
   ("ZYXIN" 1)))
 ("UP:Q15KG7"
  (("interleukins" 156) ("Interleukins" 10) ("inflammatory interleukins" 1)
   ("interleukins (IL)" 1)))
 ("UP:Q16082" (("HspB2" 107) ("HSPB2" 13) ("MKBP" 7) ("expressing HspB2" 1)))
 ("UP:Q16099" (("KA1" 70))) ("UP:Q16143" (("SNCB" 1)))
 ("UP:Q16181"
  (("SEPT7" 196) ("Sept7" 49) ("septin 7" 5) ("cdc10" 3) ("Cdc10" 3)
   ("residual SEPT7" 2) ("the pivotal septin subunit SEPT7" 2)
   ("almost no SEPT7" 1) ("SEPT7 protein" 1)))
 ("UP:Q16186"
  (("Rpn13" 43) ("arm 1" 18) ("ADRM1" 14) ("ARM1" 11) ("Rpn13 protein" 2)
   ("RPN13" 1) ("gp110" 1) ("Rpn13-" 1)
   ("the proteasome-associated ubiquitin receptor ADRM1" 1)))
 ("UP:Q16204"
  (("CCDC6" 224) ("TPCs" 106) ("CCDC6 protein" 35)
   ("coiled-coil domain containing 6" 2) ("CCDC6-" 1) ("the original TPCs" 1)
   ("defective CCDC6" 1)))
 ("UP:Q16222" (("UAP1" 7)))
 ("UP:Q16236"
  (("Nrf2" 14048) ("NFE2L2" 600) ("Nrf2 protein" 252) ("Nrf-2" 178)
   ("NRF-2" 150) ("pNrf2" 87) ("NF-E2-related factor 2" 70)
   ("nuclear factor erythroid 2-related factor 2" 49)
   ("Nuclear factor erythroid 2-related factor 2" 27)
   ("nuclear factor-erythroid 2-related factor 2" 25) ("P-Nrf2" 24)
   ("NF-E2–related factor 2" 18) ("NF-E2-related factor-2" 18)
   ("NFE2-related factor 2" 16) ("Nrf2-" 14)
   ("nuclear factor erythroid-2 related factor 2" 12) ("Nrf2 peptide" 11)
   ("NF-E2 related factor 2" 10)
   ("nuclear factor erythroid 2–related factor 2" 9)
   ("Nuclear factor erythroid-2-related factor 2" 9) ("Nrf2 Protein" 8)
   ("Nuclear factor-erythroid 2-related factor 2" 8)
   ("Nuclear factor erythroid-2 related factor 2" 8) ("overexpressed Nrf2" 7)
   ("-Nrf2" 6) ("erythroid related factor 2" 6) ("Nrf2 molecule" 6)
   ("nuclear factor erythroid 2-related factor" 6)
   ("nuclear factor erythroid 2-related factor-2" 6) ("Overexpressed Nrf2" 5)
   ("nuclear factor-erythroid-2-related factor 2" 5)
   ("nuclear factor, erythroid derived 2, like 2" 5)
   ("erythroid-derived 2, like 2" 5) ("erythroid derived 2, like 2" 4)
   ("Nuclear factor erythroid 2-related factor" 4) ("cardiac Nrf2" 4)
   ("Nrf2-WT peptide" 3) ("–NF-E2-related factor 2" 3)
   ("constantly targets Nrf2" 3) ("more Nrf2" 3)
   ("erythroid 2-related factor 2" 2) ("weak Nrf2" 2)
   ("S- (-)equol (10–250 nM) increases nuclear factor-erythroid 2-related factor 2"
    2)
   ("oxidative stress markers Nrf2" 2) ("transformed MSC expressing Nrf2" 2)
   ("a nontoxic Nrf2" 2) ("relatively less Nrf2" 2)
   ("–nuclear factor erythroid 2–related factor 2" 2) ("miR153 based Nrf2" 2)
   ("Nuclear factor erythroid 2–related factor 2" 2) ("oscillatory Nrf2" 2)
   ("targeted Nrf2" 2) ("Ser-40-phosphorylated Nrf2" 2) ("new Nrf2" 2)
   ("nuclear:cytoplasmic Nrf2" 2)
   ("Nuclear factor erythroid-2 related factor-2" 2)
   ("particularly haplotypes around NFE2L2" 2)
   ("previously described NFE2L2" 2) ("targeting Nrf-2" 2)
   ("targeting NFE2L2" 2) ("considerable P-Nrf2" 2) ("oxidative stress Nrf2" 2)
   ("–Nrf2" 2) ("HEBP1" 2)
   ("the oxidative stress response transcription factor Nrf2" 2)
   ("nuclear factor erythroid-2–related factor 2" 2)
   ("the nickel-treated Nrf2" 2) ("cytoprotective nuclear factor Nrf2" 2)
   ("Nuclear factor-erythroid 2–related factor 2" 2)
   ("the oxidative stress-responsive transcription factor Nrf2" 1)
   ("DHA increased Nrf2" 1)
   ("The basic leucine zipper (bZIP) transcription factor Nrf2" 1)
   ("than Nrf2-WT (IC 50 : 0.08 µ M vs. 0.11 µ M )" 1)
   ("Keap1-associated Nrf2" 1) ("oxidative stress marker Nrf2" 1)
   ("bona fide Nrf2" 1) ("renal Nrf2" 1) ("directly target Nrf2 3" 1)
   ("an artificial WT Nrf2 3" 1)
   ("H 2 O 2 induced miR153 directly targets Nrf2" 1) ("basal Nrf2" 1)
   ("Exogenous overexpressed Nrf2" 1)
   ("oxidative and electrophilic stress Nrf2" 1)
   ("particular interest given Nrf2's" 1) ("particular interest given Nrf2" 1)
   ("the newly-translated Nrf2" 1) ("less Nrf2" 1)
   ("nuclear factor erythroid-2-related factor 2" 1) ("NRf2" 1)
   ("Cytoplamic Nrf2" 1) ("uncontrolled Nrf2" 1)
   ("common SNPs around NFE2L2" 1) ("around NFE2L2" 1)
   ("miR-153 directly targets Nrf-2" 1)
   ("Nuclear factor-erythroid 2-related factor" 1)
   ("nuclear factor-erythroid 2-related factor" 1) ("nfe2l2" 1)
   ("the typical NFE2L2" 1) ("These reciprocal P-Nrf2" 1)
   ("the catalase mimetic Euk134 not only relocalized Nrf2" 1)
   ("smaller Nrf2" 1) ("functional Nrf2" 1) ("a functional Nrf2" 1)
   ("1 ppm-treated Nrf2 +/+" 1) ("than NRF-2" 1) ("than NRF-2(A)" 1)
   ("both STZ-treated Nrf2 +/+" 1) ("exogenous Nrf2" 1)
   ("benign ducts expressed low cytoplasmic Nrf2" 1)
   ("the transcriptional factor nuclear factor erythroid 2-related factor 2" 1)
   ("the protective Nrf2" 1) ("the cytoprotective Nrf2 protein" 1)
   ("the oxidative stress response transcription factor NFE2L2" 1)
   ("extravillous trophoblast expressed Nrf2" 1)
   ("than Nrf2 +/+ mice exposed" 1)
   ("gastroesophageal reflux activated Nrf2" 1) ("the Nrf2's" 1) ("Nrf2–" 1)))
 ("UP:Q16254"
  (("E2F4" 646) ("E2F-4" 104) ("E2f4" 22) ("transcription factor E2F4" 10)
   ("E2F4 protein" 5) ("repressive E2F4" 5) ("E2F-4 protein" 3)
   ("constitutively expressed repressive E2F4" 1) ("the repressive E2F4" 1)
   ("-E2F4" 1)))
 ("UP:Q16270"
  (("TAF" 173) ("TAFs" 103) ("IGFBP7" 55) ("IGFBP-7" 3)
   ("previously identified TAFs" 2) ("stromal TAFs" 2)
   ("insulin-like growth factor-binding protein 7" 2)
   ("the previously identified p53-interacting TAFs" 1) ("Taf" 1)
   ("independently-derived melanoma TAFs" 1)
   ("melanoma-patient-derived TAFs" 1) ("treated TAFs" 1)))
 ("UP:Q16288"
  (("NTRK3" 22) ("TrkC" 15) ("neurotrophic tyrosine kinase receptor type 3" 4)
   ("TRKC" 1) ("TrkC tyrosine kinase" 1)))
 ("UP:Q16342" (("PDCD2" 3) ("programmed cell death 2" 1)))
 ("UP:Q16352"
  (("InAs" 29) ("ina" 7) ("INA" 2) ("Nef5" 2) ("α-internexin" 1) ("Ina" 1)
   ("than InAs suggesting that MMA3 could be the primary toxic arsenic species ( xref ; xref ; xref ; xref )"
    1)))
 ("UP:Q16363" (("LAMA4" 3))) ("UP:Q16384" (("SS18-SSX1" 27) ("SSX1" 22)))
 ("UP:Q16385" (("SSX2" 183) ("-SSX2" 1)))
 ("UP:Q16394" (("EXT1" 16) ("TTV" 2) ("Ext1" 2))) ("UP:Q16397" (("EWS1" 2)))
 ("UP:Q16401" (("S5B" 84) ("S5b" 5) ("-S5B" 1) ("Supplemental Figure S5B" 1)))
 ("UP:Q16445" (("gabra6" 1) ("GABRA6" 1)))
 ("UP:Q16473" (("Xa" 101) ("a chromogenic substrate Spectrozyme Xa" 1)))
 ("UP:Q16478" (("GRIK5" 4) ("kainate 5" 2) ("Q16478" 1)))
 ("UP:Q16512"
  (("PKN" 72) ("PKN-1" 34) ("pkn-1" 32) ("PKN1" 25) ("PRK1" 4)
   ("PKN-1 protein" 2) ("Protein kinase N (PKN)" 1) ("Protein kinase N" 1)))
 ("UP:Q16513" (("PRK2" 61) ("PKN2" 14) ("pRK2" 2) ("-PRK2" 1)))
 ("UP:Q16514" (("TAF12" 7) ("Taf12" 1)))
 ("UP:Q16515" (("mdeg" 9) ("ACCN1" 9) ("degenerin" 1)))
 ("UP:Q16518"
  (("palmitate" 319) ("Palmitate" 26) ("-palmitate" 6)
   ("exogenous palmitate" 2)))
 ("UP:Q16520" (("BATF" 100) ("Batf" 9) ("B-ATF" 3) ("BATF protein" 1)))
 ("UP:Q16526"
  (("versa" 1447) ("Cry1" 476) ("CRY1" 29) ("cry1" 23) ("Versa" 6)
   ("CRY1 protein" 6) ("Cry1 protein" 5) ("Cry1-" 3)
   ("ER-α associated immunocomplexes or vice versa" 2) ("than vice versa" 2)
   ("Cryptochrome 1" 2) ("Western blot and vice versa" 2)
   ("BK viral infection and vice versa" 1)
   ("standard unfavorable characteristics and vice versa" 1)
   ("the monocytic cell line U937 and vice versa" 1) ("arrhythmic Cry1  −/−" 1)
   ("than Cry1 from control cells ( xref , xref )" 1)
   ("the circadian clock— Cryptochrome 1" 1) ("than one E3 and vice versa" 1)
   ("VERSA" 1) ("weak BPSs, and vice versa" 1)
   ("than vice versa (76% vs. 24% respectively)" 1) ("CRYPTOCHROME 1" 1)
   ("steric hindrance and vice versa" 1)))
 ("UP:Q16531"
  (("DDB1" 683) ("DNA binding protein 1" 25) ("DDB1-" 8) ("Ddb1" 6) ("-DDB1" 6)
   ("DNA damage-binding protein 1" 5) ("DDB1 protein" 4) ("xAP-1" 2)
   ("the associated DDB1" 1) ("xAP1" 1) ("the homo-trimeric protein DDB1" 1)
   ("ddb1" 1)))
 ("UP:Q16533"
  (("43KD" 1) ("43kD" 1) ("small nuclear RNA activating complex" 1)
   ("43Kd" 1)))
 ("UP:Q16534"
  (("HLFs" 16) ("hepatic leukemia factor" 2) ("adult primary HLFs" 2)
   ("hepatic leukemia factor (HLF)" 1) ("hepatic leukemia factor ( HLF )" 1)
   ("primary HLFs" 1)))
 ("UP:Q16537" (("PPP2R5E" 47))) ("UP:Q16538" (("GRCA" 4) ("GPR162" 1)))
 ("UP:Q16539"
  (("p38α" 2001) ("MAPK14" 185) ("p38α protein" 22) ("p38alpha" 11)
   ("p38 alpha" 10) ("P38α" 10) ("-p38α" 8) ("p38α-" 6) ("Mapk14" 5)
   ("mitogen-activated protein kinase 14" 5) ("p38α (9.0 mg/ml) protein" 3)
   ("the proapoptotic p38α" 3) ("This selectively ablates p38α" 2)
   ("Mitogen-activated protein kinase 14" 2) ("the pure p38α" 2) ("Q16539" 2)
   ("Mxi2" 2) ("p-p38α" 2) ("pure p38α" 1) ("SAPK2a" 1) ("p38α peptide" 1)
   ("UV B irradiation activated p38α" 1) ("the pro-apoptotic p38α" 1)
   ("potential MAPK14" 1) ("than p38α" 1)))
 ("UP:Q16543"
  (("EGFRvIII" 3270) ("Cdc37" 357) ("CDC37" 122) ("cdc37" 14) ("EGFRvIII-" 9)
   ("CdC37" 6) ("overexpressed EGFRvIII" 4) ("EGFRVIII" 4)
   ("EGFRvIII protein" 4) ("cell division cycle 37" 3) ("than EGFRvIII" 3)
   ("Hsp90 co-chaperone Cdc37" 3) ("genomic EGFRvIII" 2) ("Cdc37 protein" 2)
   ("Hsp90 chaperone protein kinase-targeting subunit" 2) ("p50CDC37" 2)
   ("the monomeric EGFRvIII" 1) ("-EGFRvIII" 1)
   ("even focally distributed EGFRvIII" 1) ("phenocopy EGFRvIII's" 1)
   ("surface-localized EGFRvIII" 1) ("cell-surface resident EGFRvIII" 1)
   ("the previously characterized EGFRvIII" 1) ("noninfiltrative EGFRvIII" 1)
   ("than EGFRvIII in GBM cells" 1) ("expressing EGFRvIII" 1)
   ("the exogenous Cdc37" 1) ("pre-dimerized EGFRvIII" 1)
   ("conclusive EGFRvIII" 1) ("Cell division cycle 37" 1)
   ("at least EGFRvIII" 1)))
 ("UP:Q16548"
  (("Bfl-1" 397) ("BCL2A1" 146) ("bfl-1" 102) ("Bcl2a1" 87) ("BFL-1" 32)
   ("Bcl2A1" 10) ("BFL1" 5) ("Bfl-1 protein" 4) ("BCL2A1 protein" 3)
   ("Bcl2-A1" 2) ("-Bfl-1" 2) ("Bfl1" 2) ("BCL2a1" 2) ("Bcl2A1-" 1) ("bfl1" 1)
   ("prosurvival Bfl-1" 1) ("BCL2-A1" 1)))
 ("UP:Q16549"
  (("LPC" 239) ("LPCs" 67) ("LPC-" 11) ("PC7" 8) ("transformed LPCs" 5)
   ("tumorigenic LPCs" 4) ("PC8" 3) ("pLPC" 2) ("all three transformed LPCs" 1)
   ("Indeed all transformed LPCs" 1) ("the transformed LPCs" 1) ("than LPC" 1)
   ("than 20:4 LPC ( xref D)" 1) ("respective LPCs" 1)))
 ("UP:Q16552"
  (("IL-17" 1362) ("IL-17A" 384) ("IL17A" 55) ("IL17" 27) ("IL-17a" 15)
   ("Il17" 7) ("more IL-17" 5) ("Il17a" 5) ("exogenous IL-17" 5)
   ("less IL-17" 4) ("il17" 3) ("IL-17 protein" 3) ("pathogenic IL-17" 2)
   ("Il17A" 2) ("their characteristic cytokine IL-17A" 2) ("the major IL-17" 2)
   ("IL17a" 1) ("interleukin 17A" 1) ("CD3-positive cells producing IL-17" 1)
   ("10–20-fold less IL-17A" 1) ("tuberculosis patients produced less IL-17" 1)
   ("IL-17A protein" 1) ("IL-17A-" 1) ("Il-17A" 1)
   ("post-septic animals expressed increased IL-17" 1)))
 ("UP:Q16553"
  (("tsA" 22) ("Sca-2" 7) ("TSA-1" 4) ("thymic shared antigen-1" 3) ("RIG-E" 2)
   ("SCA 2" 2) ("Spinocerebellar ataxia type 2" 2) ("Ly6E" 1) ("tsa" 1)))
 ("UP:Q16555"
  (("CRMP-2" 204) ("DPYSL2" 127) ("CRMP2" 99) ("pCRMP-2" 14) ("dpysl2" 13)
   ("response mediator protein" 7) ("collapsin response mediator protein 2" 7)
   ("pCRMP2" 7) ("collapsin response mediator protein-2" 6)
   ("CRMP-2 protein" 5) ("dihydropyrimidinase-related protein 2" 3)
   ("around DPYSL2" 3) ("Collapsin response mediator protein 2" 2)
   ("pCRMP-2 protein" 2) ("Dihydropyrimidinase-related protein 2" 1)
   ("Dpysl2" 1) ("p-CRMP2" 1) ("at least CRMP2" 1) ("Crmp2" 1)
   ("an essential neuronal protein CRMP-2" 1) ("observable CRMP-2" 1)))
 ("UP:Q16557" (("pSG3" 9) ("PSG3" 1))) ("UP:Q16560" (("HM1" 13)))
 ("UP:Q16566"
  (("CaMK4" 101) ("CaMKIV" 70) ("CAMK4" 8) ("CaMK4 protein" 3) ("CAMKIV" 1)
   ("than CaMK4" 1)))
 ("UP:Q16568"
  (("cART" 231) ("CART" 136) ("suppressive cART" 4) ("‘CART’" 3)
   ("efficient cART" 2) ("ongoing cART" 2) ("long-term suppressive cART" 1)
   ("CARTPT" 1)))
 ("UP:Q16570"
  (("heterozygotes" 756) ("chemokine receptor" 312) ("DARC" 64) ("FY" 35)
   ("Heterozygotes" 25) ("Chemokine receptor" 10) ("glycoprotein D" 3)
   ("atypical chemokine receptor" 2) ("heterozygotes (GT)" 2)
   ("a promiscuous CC chemokine receptor" 2) ("Chemokine Receptor" 2)
   ("the major chemokine receptor" 2) ("functional chemokine receptor" 1)
   ("the UV pre-treated heterozygotes" 1)
   ("the most frequently expressed chemokine receptor" 1)
   ("fewer heterozygotes" 1) ("23 fewer heterozygotes" 1)
   ("a predominant chemokine receptor" 1) ("Endothelial DARC" 1)
   ("a major chemokine receptor" 1) ("chemokine receptor (CCR)" 1)
   ("at least one chemokine receptor" 1) ("only 4 heterozygotes" 1)
   ("than heterozygotes" 1)))
 ("UP:Q16572" (("VAChT" 13) ("vesicular acetylcholine transporter" 1)))
 ("UP:Q16576"
  (("RbAp46" 401) ("RBBP7" 30) ("RbAP46" 4) ("RBBP7 protein" 2)
   ("exogenous RbAp46" 2) ("endogenously-expressed RbAp46" 1)
   ("RbAp46 protein" 1) ("Rbbp7" 1)))
 ("UP:Q16581" (("complement component 3a receptor 1" 2)))
 ("UP:Q16584"
  (("MLK3" 147) ("Src-homology" 49) ("src-homology" 9) ("PtK1" 8) ("MAP3K11" 6)
   ("mixed lineage kinase 3" 3) ("SRC-homology" 2) ("pMLK3" 2) ("Mlk3" 1)
   ("Ptk1" 1) ("particular MLK3" 1) ("mixed-lineage kinase 3" 1)))
 ("UP:Q16585" (("A3B" 164))) ("UP:Q16586" (("ADL" 42) ("SGCA" 1)))
 ("UP:Q16589"
  (("cyclin G2" 54) ("CCNG2" 17) ("Cyclin G2" 6) ("Ccng2" 2) ("CyclinG2" 1)))
 ("UP:Q16594" (("TAF9" 66) ("TAFII31" 6) ("TAF9-" 3) ("32kD" 1) ("Taf9" 1)))
 ("UP:Q16595"
  (("frataxin" 88) ("FRDA" 88) ("Frataxin" 21) ("X25" 16) ("FXN" 7)
   ("Friedreich ataxia" 6) ("x25" 2) ("frataxin-" 1)))
 ("UP:Q16600" (("MOK2" 6) ("ZNF239" 1))) ("UP:Q16602" (("CRLR" 1)))
 ("UP:Q16610" (("extracellular matrix protein 1" 7) ("ECM1" 2) ("Ecm1" 2)))
 ("UP:Q16611"
  (("Bak" 4194) ("BAK" 1361) ("BAK1" 210) ("bak" 59) ("Bak protein" 55)
   ("Bak1" 40) ("Bak−" 29) ("Bak peptide" 18) ("BAK molecule" 15)
   ("pro-apoptotic Bak" 12) ("BAK protein" 11) ("-Bak" 9)
   ("the pro-apoptotic protein Bak" 8) ("Bak molecule" 6) ("Bak-" 6)
   ("BAK peptide" 6) ("BAK1 protein" 5) ("BCL2-antagonist/killer 1" 5)
   ("monomeric BAK" 4) ("the pro-apoptotic protein BAK" 4) ("oligomeric BAK" 3)
   ("proapoptotic Bak" 3) ("the pro-apoptotic Bak" 3) ("oligomeric Bak" 3)
   ("targeted Bak" 3) ("neuronal Bak" 3) ("rabbit monoclonal anti BAK" 3)
   ("Bak  protein" 2) ("Bak Protein" 2)
   ("Bak protein (another  monoclonal antibody to the NH 2 terminus and the polyclonal, see Materials and Methods)"
    2)
   ("down more BAK" 2)
   ("faster migrating intra-molecularly cross-linked monomeric BAK protein" 2)
   ("solely monomeric BAK" 2) ("the total cellular Bak" 2)
   ("displaying optimal Bak" 2) ("BaK" 2) ("basal Bak" 2)
   ("pro-apoptotic molecule Bak" 2) ("functional Bak" 2)
   ("the homologous Bak" 2)
   ("the
                    pro-apoptotic Bak peptide"
    2)
   ("Bak
                    peptide"
    2)
   ("available Bak" 2) ("Pro-apoptotic Bak" 2) ("Bak (NT)" 2)
   ("activated pro-apoptotic Bak protein" 2)
   ("pro-apoptotic BH1-3-domain Bcl-2 family member Bak" 2) ("Q16611" 2)
   ("efficiently IP BAK" 2) ("proapoptotic BAK" 2) ("directly targets BAK1" 1)
   ("oligomerized prepore BAK" 1) ("BCL-X L sequestered oligomeric BAK" 1)
   ("associated BAK" 1) ("BH3-domain-exposed BAK" 1) ("e.g. E129-R576 Bak" 1)
   ("pro-apoptotic protein Bak" 1) ("pro-apoptotic protein BAK" 1) ("bak1" 1)
   ("The pro-apoptotic protein Bak" 1) ("shorter BAK peptide" 1)
   ("90% less Bak" 1) ("free monomeric Bak" 1) ("pro-apoptotic BAK" 1)
   ("pro-apoptotic Bcl-2 family member Bak" 1)
   ("the pro-apoptotic Bak protein" 1) ("pro-apoptotic protein BAK protein" 1)
   ("3× oligomeric Bak" 1) ("1×, 2× and 3× oligomeric Bak" 1) ("BAK_HUMAN" 1)
   ("than Bak" 1) ("this resident Bak protein" 1)
   ("phosphorylated/non-phosphorylated BAK" 1) ("less BAK" 1)
   ("native cellular BAK" 1)))
 ("UP:Q16612" (("C5orf13" 1)))
 ("UP:Q16613" (("AANAT" 3) ("serotonin N-acetyltransferase" 1)))
 ("UP:Q16617" (("Nkg7" 2)))
 ("UP:Q16619"
  (("CT-1" 133) ("CTF1" 12) ("cardiotrophin-1" 9) ("Cardiotrophin-1" 7)
   ("epithelial-cadherin" 2)))
 ("UP:Q16620"
  (("TrkB" 707) ("NTRK2" 35) ("trkB" 7) ("pTrkB" 5) ("TrKB" 2) ("nTrk2" 1)
   ("this interval more TrkB" 1) ("VC whole lysates more TrkB" 1)))
 ("UP:Q16621"
  (("NFE2" 76) ("NF-E2" 49) ("nuclear factor (erythroid-derived 2)" 22)
   ("erythroid 2" 21) ("Nfe2" 12) ("45kD" 10) ("p45 NF-E2" 5) ("45kDa" 4)
   ("Nuclear factor (erythroid-derived 2)" 4) ("Erythroid 2" 3)
   ("NFE2 protein" 3) ("45KD" 2) ("nuclear factor, erythroid 2" 2)
   ("approximately 45kD" 2) ("p45 NFE2" 1)
   ("erythroleukemic cell line K562 NFE2" 1) ("NF-E2-" 1)
   ("Nuclear factor, erythroid 2" 1) ("erythroid 2-" 1)))
 ("UP:Q16623"
  (("STX1A" 8) ("syntaxin 1A" 3) ("Syntaxin 1A" 1) ("STX1a" 1) ("Stx1A" 1)
   ("STX1" 1) ("Stx1" 1)))
 ("UP:Q16625"
  (("occludin" 353) ("Occludin" 32) ("OCLN" 15) ("Ocln" 7)
   ("endothelial occludin" 2) ("occludin protein" 1) ("Occludin ( OCLN )" 1)
   ("occludin (OCLN)" 1)))
 ("UP:Q16626" (("meas" 21) ("MEA" 5) ("MEAS" 3)))
 ("UP:Q16629" (("splicing factor 9G8" 6) ("SRSF7" 4)))
 ("UP:Q16630" (("CPSF6" 69) ("68kDa" 5)))
 ("UP:Q16633"
  (("OCA-B" 162) ("Oca-b" 6) ("POU2AF1" 4) ("overexpressed human OCA-B" 4)
   ("a bona fide OCA-B" 2) ("POU class 2 associating factor 1" 2) ("Bob-1" 1)))
 ("UP:Q16635"
  (("TAZ" 3364) ("Taz" 80) ("tafazzin" 79) ("4SA" 47) ("TAZ1" 46) ("pTAZ" 39)
   ("Taz1" 39) ("TAZ protein" 34) ("-TAZ" 17) ("overexpressed TAZ" 11)
   ("targeting TAZ" 4) ("Taz protein" 4) ("Tafazzin" 3) ("p-TAZ" 3)
   ("phospho-YAP (S127) (#4911, 1:1,000) TAZ" 3) ("Overexpressed TAZ" 3)
   ("TAZ molecule" 2) ("a major TAZ" 2) ("TAZ (wt) protein" 2)
   ("plasmids encoding flag-tagged wild-type TAZ" 2) ("exogenous TAZ-S89A" 2)
   ("TAZ-" 2) ("transcriptional coactivators TAZ" 2) ("-4SA" 1)
   ("a lot more TAZ" 1) ("–TAZ" 1) ("p300 Taz2" 1)
   ("a transcriptional co-activator TAZ" 1) ("Lats1/2-phosphorylated TAZ" 1)
   ("exogenous TAZ" 1) ("the YAP homologous protein TAZ" 1)))
 ("UP:Q16637" (("SMN2" 17) ("SMN1" 16)))
 ("UP:Q16643" (("developmentally regulated brain protein" 1)))
 ("UP:Q16644" (("3PK" 4) ("MAPKAPK3" 3) ("MK3 protein" 1)))
 ("UP:Q16647"
  (("PGIS" 190) ("PTGIS" 19) ("prostacyclin synthase" 9)
   ("prostaglandin I2 synthase" 1)))
 ("UP:Q16649"
  (("E4BP4" 53) ("NFIL3" 44)
   ("the bZIP transcriptional repressor gene E4BP4" 2) ("Nfil3" 1)))
 ("UP:Q16650" (("Tbr1" 14) ("TBR1" 4))) ("UP:Q16651" (("PRSS8" 2)))
 ("UP:Q16653"
  (("MOG" 82) ("myelin oligodendrocyte glycoprotein" 13) ("MOG peptide" 2)
   ("-myelin oligodendrocyte glycoprotein (MOG)" 1)
   ("-myelin oligodendrocyte glycoprotein" 1)))
 ("UP:Q16654"
  (("PDK4" 46) ("Pdk4" 16) ("pyruvate dehydrogenase kinase 4" 8) ("pdk4" 5)
   ("pPDK4" 3)))
 ("UP:Q16655"
  (("MART1" 86) ("melan-a" 63) ("Melan-a" 46) ("MART-1" 28) ("Melan-A" 25)
   ("MLANA" 13) ("melan-A" 6) ("MelanA" 5) ("Mart-1" 4) ("-melan-a (MASS)" 4)
   ("transformed G12V NRAS Melan-a" 2) ("-melan-a" 2)
   ("the tumour-associated antigen MART-1" 2) ("MART-1 protein" 2)
   ("mLANA" 1)))
 ("UP:Q16656" (("NRF-1" 41) ("Nrf-1" 6) ("nuclear respiratory factor 1" 3)))
 ("UP:Q16658"
  (("Fascin" 393) ("fascin" 51) ("Fascin protein" 21) ("FSCN1" 15) ("SNL" 9)
   ("the filopodia-associated signal protein fascin" 2) ("targeting Fascin" 2)
   ("fimbrin" 1) ("fscn1" 1) ("than Fascin that could contribute" 1)
   ("than Fascin" 1) ("FASCIN" 1)))
 ("UP:Q16659"
  (("ERK3" 15) ("MAPK6" 10) ("mitogen-activated protein kinase 6" 4) ("Erk3" 2)
   ("ErK3" 1)))
 ("UP:Q16661" (("GUCA2B" 4) ("uroguanylin" 2)))
 ("UP:Q16665"
  (("HIF-1α" 4677) ("HIF1α" 1508) ("HIF-1α protein" 167) ("HIF1A" 124)
   ("HIF1α protein" 58) ("HIF-1a" 57) ("hypoxia inducible factor" 38)
   ("HIF-1alpha" 25) ("Hif1α" 24) ("Hif-1a" 19) ("Hif-1α" 14) ("HIF1a" 12)
   ("Hypoxia inducible factor" 12) ("HIF-1α Protein" 12) ("HIF1-alpha" 11)
   ("overexpressed HIF-1α" 11) ("Hif1a" 10) ("HIF-1A" 8)
   ("hypoxia-inducible factor 1-alpha" 6) ("factor 1A" 5) ("-HIF-1α" 5)
   ("HIF1alpha" 4) ("HIF-1α-" 4) ("Hypoxia-inducible factor 1-alpha" 3)
   ("HIF1α (Hypoxia inducible factor-1α) protein" 3)
   ("hypoxia-inducible factor 1a" 3) ("functional HIF-1α" 3)
   ("hypoxia-inducible factor-1alpha" 3) ("Hypoxia inducible factor (HIF)" 3)
   ("coexpressed rescued HIF-1α" 3) ("Factor-1alpha" 3)
   ("Hypoxia-inducible factor-1alpha" 2)
   ("oxidative stress induced much less HIF-1α" 2)
   ("the transcriptional factor HIF1A" 2) ("intense HIF-1α" 2)
   ("previously described reduced HIF1α" 2) ("HIF-1a protein" 2)
   ("hypoxia inducible factor-1alpha (HIF-1alpha) protein" 2)
   ("hypoxia inducible factor-1alpha" 2) ("hypoxiainducible factor-1α" 2)
   ("hypoxia-inducible factor -1α" 2)
   ("SirT3-expressing cells stabilized HIF-1α protein" 2)
   ("hypoxia-inducible factor- 1α" 2) ("we first overexpressed HIF-1α" 2)
   ("the HIF1α’s" 1) ("HIF1α+USF2 expressed less HIF1α protein" 1)
   ("than HIF1α ( xref )" 1) ("-HIF1α" 1) ("HIF-1-alpha" 1)
   ("hypoxia inducible factor (HIF)" 1) ("undetectable HIF-1α" 1)
   ("targeting HIF1α" 1) ("rabbit monoclonal HIF-1α" 1)
   ("the archetypal hypoxia-regulated transcription factor Hif-1α" 1)
   ("than diffuse HIF-1α" 1)
   ("the less conservative Ser696Arg mutant HIF-1α" 1)
   ("significantly less hydroxylated HIF1α" 1)
   ("SIRT3 knock-down cells accumulated more HIF1α" 1) ("—HIF1α" 1)
   ("HIF1α peptide" 1) ("HIF-1α (TM)" 1) ("HIF-1α (DM)" 1)
   ("virtually no HIF1α protein" 1) ("enhanced HIF1α" 1) ("normoxic HIF1α" 1)
   ("normoxic Hep3B cells HIF-1α protein" 1) ("hif1A" 1)
   ("increased renal HIF-1α" 1)
   ("N-terminal lysines of HIF-1α enhancing its degradation" 1)))
 ("UP:Q16666"
  (("IFI16" 867) ("IFI16 protein" 108) ("IFI16 Protein" 4)
   ("Gamma-interferon-inducible protein 16" 3)
   ("Glucose Restriction-induced IFI16 Protein" 2) ("drives IFI16’s" 1)
   ("significantly less IFI16" 1) ("IFI16-" 1)))
 ("UP:Q16667"
  (("kinase-associated phosphatase (KAP)" 1)
   ("kinase-associated phosphatase" 1)))
 ("UP:Q16670" (("SRE" 187) ("SRE-" 4) ("sre" 2) ("Sre" 2)))
 ("UP:Q16671" (("Amhr2" 36) ("AMHR2" 2)))
 ("UP:Q16674"
  (("MIA" 220) ("CD-RAP" 79) ("Mia" 41) ("MIAs" 17) ("mia" 7)
   ("melanoma inhibitory activity" 5) ("nonmucinous MIA" 2)
   ("31 nonmucinous MIA" 2) ("1 mucinous MIA" 2)
   ("Melanoma inhibitory activity" 1) ("One mucinous MIA" 1)
   ("2 nonmucinous MIA" 1) ("mIAS" 1)
   ("melanoma inhibitory activity protein (MIA)" 1)))
 ("UP:Q16676" (("FOXD1" 4)))
 ("UP:Q16678"
  (("17β-estradiol" 579) ("CYP1B1" 293) ("17β-Estradiol" 33)
   ("-17β-estradiol" 9) ("Cyp1b1" 4)
   ("other membrane-resident 17β-estradiol" 3) ("17β–estradiol" 3) ("GLC3A" 2)
   ("exogenous 17β-estradiol" 1) ("than 17β-estradiol (6 vs.12 fold, xref )" 1)
   ("particular 17β-estradiol" 1) ("vs extranuclear 17β-estradiol" 1)
   ("than 17β-estradiol" 1) ("17β-estradiol-" 1) ("cytochrome P4501B1" 1)))
 ("UP:Q16690"
  (("DUSP5" 359) ("DUSP5 protein" 31) ("dusp5" 3) ("VH3" 3) ("HVH3" 2)
   ("than wild type DUSP5 protein" 2) ("than wild type DUSP5" 1)
   ("than WT DUSP5 protein" 1) ("hVH3" 1) ("Dusp5" 1)))
 ("UP:Q16696" (("Family 2" 28) ("family 2" 25)))
 ("UP:Q16706" (("Mannosidase II" 9) ("class 2A" 1) ("MAN2A1" 1)))
 ("UP:Q16718" (("ubiquinone reductase" 3) ("NDUFA5" 2)))
 ("UP:Q16719" (("KYNU" 1)))
 ("UP:Q16720"
  (("spinocerebellar ataxia" 29) ("X-linked 1" 2)
   ("the neurodegenerative disease spinocerebellar ataxia" 2)
   ("Spinocerebellar ataxia" 1)))
 ("UP:Q16739"
  (("glucosylceramide synthase" 7) ("UGCG" 4)
   ("glucosylceramide synthase (GCS)" 2) ("Glucosylceramide synthase" 2)
   ("ceramide glucosyltransferase" 1)))
 ("UP:Q16740" (("ClpP" 4)))
 ("UP:Q16760" (("DGKD" 23) ("diacylglycerol kinase delta" 2)))
 ("UP:Q16762" (("TST" 27) ("thiosulfate sulfurtransferase" 2)))
 ("UP:Q16763"
  (("UBE2S" 434) ("Ube2S" 10) ("UBE2s" 3) ("E2-EPF" 3) ("UBE2S protein" 2)
   ("tethering UBE2S’s" 1) ("-UBE2S" 1) ("Ube2S-" 1) ("Ube2s" 1)
   ("specifically assay E2 enzyme UBE2S" 1)))
 ("UP:Q16769"
  (("EC" 4746) ("QC" 838) ("SQC" 85) ("pEC" 11) ("passed QC" 10)
   ("vascular EC" 10) ("Qc" 9) ("pulmonary EC" 9) ("QPCT" 8)
   ("PRA-treated EC" 8) ("EC-" 8) ("EC (HUVEC)" 7) ("qc" 7)
   ("the vascular EC" 5) ("TNF-treated EC" 4) ("failed QC" 3)
   ("HPV E6/E7-immortalized dermal microvascular EC" 3) ("xenogeneic EC" 3)
   ("passed post-imputation QC" 3) ("Quantitative QC" 2)
   ("human arterial EC" 2) ("Ec" 2) ("adult saphenous vein EC (HSVEC)" 2)
   ("their respective EC" 2) ("-EC" 2) ("human lung microvascular EC" 2)
   ("surface-adherent EC" 2) ("mature EC" 2) ("stringent QC" 2)
   ("primary EC" 2) ("31 naturally senescent EC" 2) ("aortic EC" 2)
   ("EC (MLEC)" 2) ("HGF increased EC" 2) ("the most reliable EC" 2)
   ("their approximate EC" 2) ("two more QC" 1) ("passing QC" 1)
   ("PRA serum-treated EC" 1) ("peritubular capillary EC" 1)
   ("IFN-γ-pre-treated EC" 1) ("microvascular EC" 1)
   ("lymphatic microvascular EC" 1) ("EC (HSVEC)" 1) ("pQC" 1)
   ("underwent QC" 1) ("Qpct" 1) ("–EC" 1) ("Standard technical QC" 1)
   ("sufficient arterial EC" 1) ("liver sinusoidal EC (LSEC)" 1)
   ("some sinusoidal EC" 1) ("matched conditionally immortalized cardiac EC" 1)
   ("cardiac EC" 1) ("uterine EC" 1) ("870 new EC" 1)
   ("AR transcriptional activityin EC" 1) ("50–60% confluent EC" 1)
   ("normal vascular EC" 1) ("human aortic EC (AEC)" 1) ("ec" 1)
   ("solitary quiescent EC" 1) ("blood vascular EC (BEC)" 1)
   ("dysfunctional EC" 1) ("10 5 porcine aortic EC (PAE)" 1)
   ("nonadherent and surface-adherent EC" 1)
   ("Primary human aortic EC (HAE)" 1) ("even matrix-embedded xenogeneic EC" 1)
   ("“EC”" 1) ("the esophageal carcinoma cell line EC109" 1)
   ("lung vascular EC" 1) ("LPS-treated EC" 1) ("Berberine-treated EC" 1)
   ("Extensive QC" 1) ("senescent EC" 1) ("systemic EC" 1)
   ("79 genotyped variants failed QC" 1) ("nearly confluent EC" 1)
   ("iloprost-stimulated sparse EC" 1) ("Human pulmonary EC" 1)
   ("iloprost-stimulated pulmonary EC" 1) ("live pulmonary EC" 1)
   ("the following experiments nearly confluent pulmonary EC" 1)
   ("double-infected EC" 1) ("the EC's" 1) ("primary vascular EC" 1)
   ("aggressive EC" 1) ("invasive grade 3 EC" 1) ("EC (UK)" 1)
   ("The last three QC" 1) ("recurrent EC" 1) ("A single universal EC" 1)
   ("Vascular EC" 1)
   ("CIITA-transduced human dermal microvascular EC (HDMEC)" 1)
   ("94.5 percent passed QC" 1) ("ongoing QC" 1) ("“QC2”" 1) ("“QC1”" 1)
   ("deliberate QC" 1)))
 ("UP:Q16772"
  (("GSTa3" 2) ("glutathione S-transferase alpha 3" 2) ("Gsta3" 2)
   ("GSTA3" 1)))
 ("UP:Q16774"
  (("guanylate kinase" 26) ("GUK1" 5) ("GMK" 3) ("guanylate kinase (GUK)" 1)
   ("membrane-associated guanylate kinase" 1) ("GMP kinase" 1)
   ("Guanylate kinase" 1)))
 ("UP:Q16777"
  (("H2A" 1241) ("pH2A" 22) ("H2A protein" 4) ("H2A peptide" 4)
   ("chromatin-associated H2A" 2) ("canonical H2A" 2)
   ("than canonical H2A [ xref ]" 1) ("than H2A" 1)
   ("pericentric heterochromatic histone H2A" 1) ("HIST2H2AC" 1)))
 ("UP:Q16778"
  (("H2B" 960) ("H2b" 4) ("H2B protein" 3) ("pH2B" 2) ("m-cherry H2B" 2)
   ("−H2B" 2) ("the dominant-negative mutant H2B" 2) ("20-mutated H2B" 1)
   ("the first 15 amino acids of H2B" 1) ("intact H2B" 1)
   ("the first 37 amino acids of human H2B" 1) ("potential H2B" 1)))
 ("UP:Q16787" (("LAMA3" 39)))
 ("UP:Q16790"
  (("CA9" 310) ("CAIX" 221) ("CA-IX" 126) ("carbonic anhydrase 9" 26)
   ("Ca9" 24) ("carbonic anhydrase IX" 20) ("caix" 6)
   ("carbonic anhydrase 9 (CAIX)" 4) ("Carbonic anhydrase IX" 3)
   ("membranous CAIX" 3) ("CA-IX protein" 3)
   ("the robust HIF-1 α target gene CAIX" 2) ("case 3 showed modest CAIX" 2)
   ("Carbonic anhydrase 9" 2) ("CA-9" 2) ("Carbonic Anhydrase 9" 2) ("CA9-" 1)
   ("CA−IX" 1)))
 ("UP:Q16795" (("NDUFA9" 31) ("39kDa" 2) ("-NDUFA9" 1)))
 ("UP:Q16798" (("me3" 502) ("Me3" 49) ("-me3" 4) ("ME3" 2)))
 ("UP:Q16799" (("RTN1" 1))) ("UP:Q16816" (("PHKG1" 1)))
 ("UP:Q16821" (("PPP1R3" 5) ("PPP1R3A" 4)))
 ("UP:Q16822"
  (("PCK2" 8) ("Pck2" 5) ("phosphoenolpyruvate carboxykinase 2" 4)
   ("Phosphoenolpyruvate carboxykinase 2" 2)))
 ("UP:Q16825" (("PTPN21" 4)))
 ("UP:Q16827" (("PTPRO" 98) ("GLEPP1" 6) ("PTPU2" 1) ("PTPμ" 1)))
 ("UP:Q16828"
  (("DUSP6" 525) ("MKP-3" 352) ("MKP3" 200) ("Mkp3" 69) ("MKP-3 protein" 15)
   ("Dusp6" 10) ("mitogen-activated protein kinase phosphatase 3" 7)
   ("MAP kinase phosphatase 3" 4) ("Pyst1" 4) ("MAP Kinase Phosphatase 3" 4)
   ("PYST1" 3) ("dusp6" 3) ("MKP3 protein" 3) ("exogenous MKP-3" 1)))
 ("UP:Q16829" (("DUSP7" 48) ("MKP-X" 6)))
 ("UP:Q16831"
  (("UP" 159) ("UPP" 13) ("UPP1" 12) ("UP-" 11) ("UP protein" 4) ("“UP”" 3)
   ("Upp1" 3) ("pUP" 1)))
 ("UP:Q16832"
  (("DDR2" 184) ("-DDR2" 4) ("discoidin domain receptor 2" 2)
   ("cancer-associated DDR2 point mutations" 1)))
 ("UP:Q16836" (("SCHAD" 2))) ("UP:Q16849" (("IA2" 8)))
 ("UP:Q16850" (("LDM" 16) ("CYP51A1" 15) ("CYP51" 9)))
 ("UP:Q16851" (("UGP2" 2) ("UDP-glucose pyrophosphorylase" 2)))
 ("UP:Q16853"
  (("adipocytes" 1442) ("mature adipocytes" 61) ("Adipocytes" 25)
   ("primary adipocytes" 23) ("brown adipocytes" 9)
   ("human mature adipocytes" 8) ("smaller adipocytes" 5)
   ("visceral adipocytes" 4) ("8Br-cAMP–treated adipocytes" 3) ("SSAO" 3)
   ("visceral and subcutaneous adipocytes" 3)
   ("considered mature adipocytes" 3)
   ("caveolin/caveolae-deficient adipocytes" 2) ("AOC3" 2)
   ("vascular adhesion protein 1" 2) ("Brown Adipocytes" 2)
   ("adipocytes (BAT)" 2) ("human mammary adipocytes" 2)
   ("cancer-associated adipocytes (CAA)" 2) ("Co-cultivated adipocytes" 2)
   ("stromal adipocytes" 2) ("premature adipocytes" 2) ("obese adipocytes" 2)
   ("rat primary adipocytes" 2) ("fewer adipocytes" 2)
   ("In vitro cultured mature adipocytes" 2) ("no paucilocular adipocytes" 2)
   ("larger dysfunctional adipocytes" 1)
   ("pioglitazone-treated 3T3-L1 adipocytes" 1)
   ("parental 3T3-L1 adipocytes" 1) ("hypertrophic adipocytes" 1)
   ("abdominal adipocytes" 1)
   ("a lipid droplet protein expressed in mature adipocytes" 1)
   ("thermogenic adipocytes" 1) ("VAP-1" 1) ("normal adipocytes" 1)
   ("these mature adipocytes" 1) ("the adjacent adipocytes" 1)
   ("C-CM-treated adipocytes" 1) ("cancer-associated adipocytes" 1)
   ("both 3T3-L1-differentiated adipocytes" 1) ("intra-abdominal adipocytes" 1)
   ("well-adapted specialized adipocytes" 1) ("Cav-1-null adipocytes" 1)
   ("semicarbazide-sensitive amine oxidase" 1) ("only small adipocytes" 1)
   ("Mature adipocytes" 1) ("intramedullary adipocytes" 1)
   ("than adipocytes" 1) ("Primary adipocytes" 1)
   ("CL 316,243-stimulated rat adipocytes" 1) ("at least 500 adipocytes" 1)
   ("epididymal fat adipocytes" 1) ("isolated mature adipocytes" 1)
   ("brown (or “brite”) adipocytes" 1)
   ("paucilocular or multilocular adipocytes" 1)
   ("Ucp1-immunoreactive paucilocular adipocytes" 1)
   ("subcutaneous white adipocytes" 1)
   ("Ucp1-immunoreactive paucilocular iWAT adipocytes" 1)
   ("Brown adipocytes" 1) ("cultured subcutaneous adipocytes" 1)))
 ("UP:Q16854" (("DGUOK" 4)))
 ("UP:Q16873" (("LTC4S" 5) ("leukotriene C4 synthase" 2)))
 ("UP:Q16875"
  (("PFKFB3" 155) ("Pfkfb3" 6) ("PFK-2" 5) ("pfkfb3" 1)
   ("6-bisphosphatase 3" 1)))
 ("UP:Q16877" (("PFKFB4" 1)))
 ("UP:Q16878"
  (("CDO" 6) ("CDO1" 2) ("cysteine dioxygenase type 1" 2) ("Cdo" 1)))
 ("UP:Q16880" (("CGT" 425) ("-CGT" 27) ("pCGT" 19) ("Ugt8" 1)))
 ("UP:Q16881"
  (("TXNRD1" 15) ("thioredoxin reductase 1" 12) ("Txnrd1" 9) ("TrxR1" 5)
   ("TRR" 4) ("thioredoxin reductase 1, cytoplasmic" 2)))
 ("UP:Q16890" (("D53" 11) ("pd53" 2)))
 ("UP:Q16891"
  (("HMP" 21) ("mitofilin" 18) ("MINOS2" 12) ("p89" 7) ("Mitofilin" 6)
   ("a strong cleaved form p89" 2) ("inner membrane mitochondrial protein" 2)))
 ("UP:Q16927"
  (("VL" 99) ("VGs" 92) ("VH" 47) ("pVL" 19) ("-VL" 15) ("-VH" 7) ("Vh" 7)
   ("VH-" 2) ("the baculovirus recombination plasmid pVL1393" 1)
   ("the most telomeric VH" 1) ("arteriosclerotic VGs" 1)
   ("Undetectable HIV VL" 1) ("VL-" 1)))
 ("UP:Q16983" (("DHR" 65))) ("UP:Q16KE2" (("15A1" 1)))
 ("UP:Q16WA6"
  (("CBC" 430) ("asynchronous CBC" 8) ("radiation-induced CBC" 4)
   ("radiation-associated CBC" 3)
   ("ER-positive first cancer developed ER-negative asynchronous CBC" 2)
   ("ER-negative first breast cancer developed ER-negative asynchronous CBC" 2)
   ("developed CBC" 2) ("a radiation-associated CBC" 2) ("40% developed CBC" 1)
   ("Annual screening CBC’s" 1) ("Annual screening CBC" 1) ("the CBC's" 1)
   ("ER-positive first breast cancers developed ER-negative CBC" 1)
   ("ER-negative first cancer developed ER-negative asynchronous CBC" 1)
   ("subsequently developed CBC" 1)))
 ("UP:Q170J7" (("MOE" 56) ("-MOE" 2) ("Moe" 1)))
 ("UP:Q17239" (("serotonin receptor" 40) ("Serotonin receptor" 3)))
 ("UP:Q17339" (("GLD-1" 1))) ("UP:Q17381" (("PHA-4" 5) ("pha-4" 2)))
 ("UP:Q17389" (("Cul-1" 33))) ("UP:Q17390" (("cul-2" 1) ("Cul-2" 1)))
 ("UP:Q17778" (("DNAse II" 3))) ("UP:Q17R60" (("IMPG1" 14)))
 ("UP:Q17R89" (("RICH2" 5) ("Rich2" 4)))
 ("UP:Q17RS7"
  (("Gen" 67) ("GEN1" 37) ("gen" 12) ("Holliday junction resolvase" 3)))
 ("UP:Q17RW2" (("type XXIV" 7) ("0.01% bacterial protease type XXIV" 2)))
 ("UP:Q17RY0" (("CPEB4" 5))) ("UP:Q18409" (("RSP6" 1)))
 ("UP:Q185C5" (("EAM" 3))) ("UP:Q18PE1" (("dok-7" 2)))
 ("UP:Q19266"
  (("aPKC" 1064) ("P-aPKC" 5) ("strong aPKC" 2) ("soluble aPKC" 2)
   ("both total and activated aPKC" 2)
   ("than aPKC in both GBM6 and U251/EGFR cells ( xref )" 1)
   ("a kinase-defective aPKC" 1) ("an associated aPKC" 1) ("The apical aPKC" 1)
   ("cortical aPKC" 1) ("more aPKC protein" 1) ("aPKC protein" 1)))
 ("UP:Q19743" (("hIL-3" 3))) ("UP:Q197W8" (("TAN" 31)))
 ("UP:Q19MC2" (("SCRA" 3)))
 ("UP:Q19T08"
  (("chemotaxis" 2127) ("ECSM2" 217) ("Chemotaxis" 189) ("ECSM2 protein" 10)
   ("cellular chemotaxis" 8) ("optimal chemotaxis" 4) ("robust chemotaxis" 4)
   ("stimulated optimal A431 chemotaxis" 2)
   ("growth factor–driven chemotaxis" 2) ("growth  factor–driven chemotaxis" 2)
   ("defective chemotaxis" 2) ("proper chemotaxis" 2)
   ("peripheral neutrophil chemotaxis" 2)
   ("significantly less endothelial cell chemotaxis" 2)
   ("efficient chemotaxis" 2) ("showed significantly defective chemotaxis" 2)
   ("chemotaxis-" 2) ("expressing ECSM2" 2) ("the endogenous mature ECSM2" 2)
   ("mature ECSM2" 2) ("Endothelial cell-specific molecule 2" 2)
   ("endothelial cell-specific molecule 2" 2)
   ("even abrogated HGF-induced chemotaxis" 2)
   ("further inhibited chemotaxis" 2) ("both display directional chemotaxis" 2)
   ("GPCR-driven chemotaxis" 1) ("GPCR-mediated cellular chemotaxis" 1)
   ("respective vector controls exhibited chemotaxis" 1)
   ("significantly increase chemotaxis" 1)
   ("the exogenous CIK cell chemotaxis" 1)
   ("CaM T cells underwent chemotaxis" 1) ("inflammatory chemotaxis" 1)
   ("Hax1 shRNA A chemotaxis" 1) ("RhoA-depleted cells underwent chemotaxis" 1)
   ("ARHI decreased EGF-induced chemotaxis" 1) ("ECSCR" 1)
   ("hypoxia increased chemotaxis" 1) ("subsequent chemotaxis" 1)
   ("M-gp120-induced chemotaxis" 1) ("robust CXCL12-triggered chemotaxis" 1)))
 ("UP:Q1HG43" (("NIP" 4) ("DUOXA1" 1))) ("UP:Q1HG44" (("DuoxA2" 1)))
 ("UP:Q1HVB3"
  (("latent membrane protein-1" 5) ("Latent membrane protein-1" 2)))
 ("UP:Q1HVF6" (("gp25" 1)))
 ("UP:Q1HVF7"
  (("EBNA1" 83) ("nuclear antigen-1" 7) ("EBNA1 protein" 3) ("EBNA1 peptide" 3)
   ("Epstein-Barr nuclear antigen 1" 3) ("EBNA 1" 1)))
 ("UP:Q1HVG0"
  (("replication and transcription activator" 6)
   ("Replication and transcription activator" 3)
   ("replication and transcription activator (RTA)" 2)
   ("The viral replication and transcription activator (RTA)" 1)))
 ("UP:Q1HVG1" (("ZEB" 171) ("the transcriptional repressor ZEB" 2)))
 ("UP:Q1HVG4" (("EBNA3B" 11))) ("UP:Q1HVI8" (("EBNA-5" 4)))
 ("UP:Q1KMD3" (("HNRNPUL2" 1)))
 ("UP:Q1LZB6" (("caprin-1" 61) ("Caprin-1" 9) ("caprin-1 protein" 7)))
 ("UP:Q1M799" (("MCTs" 35))) ("UP:Q1MSJ5" (("CSPP" 3)))
 ("UP:Q1MX18" (("insC" 108) ("Insc" 8) ("InsC" 3) ("“5382insC”" 1)))
 ("UP:Q1PD51" (("VP40" 2))) ("UP:Q1PD52" (("VP35 protein" 6) ("VP35" 2)))
 ("UP:Q1PD62" (("VP24" 2))) ("UP:Q1PEI6" (("Far8" 2)))
 ("UP:Q1PSW8" (("mLin41" 3))) ("UP:Q1RMT8" (("IRAK-4" 11) ("IRAK-4–" 1)))
 ("UP:Q1RNF8"
  (("MRs" 138) ("mRS" 17) ("synergistic MRs" 3) ("synergistic top-level MRs" 2)
   ("key MRs" 1)))
 ("UP:Q1XH10" (("c10orf140" 1))) ("UP:Q20334" (("TnI-1" 6)))
 ("UP:Q20365" (("Rab33" 11) ("RAB33" 1)))
 ("UP:Q20679"
  (("LH" 574) ("-LH" 4) ("urinary LH" 2) ("LH-" 1)
   ("the helical sub-domain LH" 1) ("p21 termed LH" 1)))
 ("UP:Q21049" (("SYD-2" 5))) ("UP:Q22366" (("RIM" 34)))
 ("UP:Q23430" (("ins-7" 1))) ("UP:Q23551" (("unc-22" 1)))
 ("UP:Q23794" (("HMG I" 5) ("HMGI" 1))) ("UP:Q23808" (("AQP" 3)))
 ("UP:Q23894" (("CPRC" 4)))
 ("UP:Q23935" (("Tra" 37) ("tRA" 3) ("tra" 3) ("TRa" 1)))
 ("UP:Q23970"
  (("OSE" 318) ("normal OSE" 14) ("OSE (MOSE)" 3) ("overtly normal OSE" 3)
   ("no family history (NFH) OSE" 2) ("than OSE" 1) ("only mouse OSE" 1)
   ("transformed OSE" 1) ("metaplastic OSE" 1) ("The normal OSE" 1)
   ("both the normal OSE" 1)
   ("The Drosophila ovarian follicular epithelium and human OSE" 1)))
 ("UP:Q23989" (("QUA" 1)))
 ("UP:Q24008"
  (("INAD" 2) ("INAD (inactivation no afterpotential D) protein" 1)))
 ("UP:Q24020" (("Flightless I" 3) ("Flightless-I" 3)))
 ("UP:Q24087" (("MEI-9" 2))) ("UP:Q24106" (("hid" 84) ("Hid" 15)))
 ("UP:Q24139" (("comm" 6) ("Comm" 3) ("COMM" 3) ("personal comm" 1)))
 ("UP:Q24141" (("MEI-S332" 3))) ("UP:Q24145" (("shark" 2)))
 ("UP:Q24151" (("MRL" 24) ("dSTAT" 2) ("MRL-" 1) ("Stat92E" 1)))
 ("UP:Q24167" (("sima" 13) ("Sima" 6) ("SIMA" 5)))
 ("UP:Q24174"
  (("Ab" 2022) ("AB" 1577) ("ab" 1107) ("AB-" 87) ("-AB" 20)
   ("secondary Ab" 10) ("primary Ab" 8) ("pAb" 6)
   ("mouse anti-p63 monoclonal Ab" 6) ("monoclonal Ab" 5)
   ("HRP-conjugated secondary Ab" 5) ("the primary Ab" 4)
   ("the secondary Ab" 3) ("Monoclonal mouse anti-MBS Ab" 2)
   ("Anti-hemagglutinin (HA) monoclonal Ab" 2)
   ("rabbit anti-human Fn monoclonal Ab" 2)
   ("MAB 1935 mouse anti-human Fn monoclonal Ab" 2)
   ("A32 mouse anti-human Fn monoclonal Ab" 2) ("“AB”" 2)
   ("a horseradish peroxidase-conjugated anti-mouse, or anti-rabbit IgG secondary Ab"
    2)
   ("Alexa 594-labeled anti-mouse Ab" 2)
   ("fluorescently labeled secondary Ab" 2)
   ("monoclonal 4G10 anti-phosphotyrosine Ab" 2)
   ("mouse anti-Ub monoclonal Ab" 2) ("Scandinavian Gene Synthesis AB" 2)
   ("primary and secondary Ab" 2)
   ("anti-species-specific horseradish peroxidase-conjugated secondary Ab" 2)
   ("The fluorochrome-conjugated goat anti-human IgG1 Fc-specific secondary Ab"
    2)
   ("an anti-Fas monoclonal Ab" 2) ("monoclonal Ab 31E" 2)
   ("a monoclonal Ab" 2) ("rabbit monoclonal anti-HER2 Ab" 2)
   ("PE anti-human Fas (CD95) monoclonal Ab" 2)
   ("an FITC-tagged secondary Ab" 2) ("the irrelevant Ab" 1) ("the dual Ab" 1)
   ("monoclonal p53 Ab" 1) ("pAB" 1) ("basolateral AB" 1)
   ("the mouse monoclonal anti-PTEN ab" 1)
   ("the species-specific secondary Ab" 1)
   ("the appropriate horseradish-peroxidase-conjugated secondary Ab" 1)
   ("appropriate primary Ab" 1) ("the mouse monoclonal Ab" 1)
   ("the fluorochrome-conjugated rabbit anti-mouse IgG secondary Ab" 1)
   ("the anti-Fas monoclonal Ab" 1)
   ("1∶100 and Alexa-588 conjugated α-rabbit secondary Ab" 1)
   ("the fluorescent secondary Ab" 1)
   ("PE-conjugated anti-mouse secondary Ab" 1)
   ("biotin-conjugated secondary Ab" 1) ("fluorescently tagged secondary Ab" 1)
   ("the secondary anti-goat FITC Ab" 1) ("the appropriate secondary Ab" 1)
   ("Actin monoclonal mouse Ab" 1) ("the surface-bound Ab" 1)
   ("each primary Ab" 1) ("4°C. Biotin-conjugated secondary Ab" 1)
   ("500 ng/ml soluble anti-CD28 Monoclonal Ab" 1)
   ("the F(ab′) 2 goat anti-mouse IgG secondary Ab" 1)
   ("anti-CD2AP Ab and Alexa Fluor 647-conjugated anti-Cb1 Ab" 1) ("Ab-" 1)
   ("goat anti-rabbit Alexa-488 or anti-mouse Alexa-568 secondary Ab" 1)
   ("mouse monoclonal Ab" 1) ("than the C-2-10 Ab" 1)
   ("Secondary HRP-coupled Ab" 1) ("the specific primary Ab" 1)))
 ("UP:Q24179" (("SLH" 13))) ("UP:Q24192" (("RhoL" 7)))
 ("UP:Q24210" (("CAKI" 13)))
 ("UP:Q24246" (("SW" 343) ("the E. coli strain SW102" 1) ("sw" 1)))
 ("UP:Q24278" (("CNG" 372) ("-CNG" 7) ("CNG channel" 5) ("only PDGFR CNG" 1)))
 ("UP:Q24292"
  (("adherin" 5) ("loosened intercellular adherin" 2) ("adherin (MTDH)" 2)))
 ("UP:Q24298"
  (("shotgun" 68) ("SHG" 14) ("DE-cadherin" 7) ("Shotgun" 7) ("“shotgun”" 5)
   ("‘shotgun’" 1)))
 ("UP:Q24312" (("EWG" 4))) ("UP:Q24324" (("MAPK-K" 3)))
 ("UP:Q24352" (("GRD" 104)))
 ("UP:Q24418"
  (("NMR" 2086) ("paramagnetic NMR" 4) ("NMR, electron microscopy," 1)
   ("the observable NMR" 1) ("-NMR" 1) ("The paramagnetic NMR" 1)
   ("One-dimensional NMR" 1) ("Typical NMR" 1) ("Traditional NMR" 1)))
 ("UP:Q24472"
  (("RBF" 4) ("Retinoblastoma family protein" 3) ("overexpressing RBF" 1)))
 ("UP:Q24475" (("RPR" 3) ("rpr" 1) ("Rpr" 1))) ("UP:Q24488" (("ROR" 106)))
 ("UP:Q24522" (("SHS" 34) ("BUN" 28))) ("UP:Q24536" (("SSL" 8)))
 ("UP:Q24537" (("dSp1" 7) ("DSP1" 3))) ("UP:Q24558" (("TOS" 74)))
 ("UP:Q24570" (("pGRIM" 2))) ("UP:Q24573" (("DRI" 9)))
 ("UP:Q24JJ8" (("Glo3" 1))) ("UP:Q25019" (("ZW" 12)))
 ("UP:Q25132"
  (("LIM" 527) ("PDZ-LIM protein" 5) ("LIM protein" 3)
   ("reversion-induced LIM protein ( RIL )" 1) ("LIM protein ( RIL )" 1)
   ("only Pax LIM" 1) ("the human Reversion-Induced LIM protein (RIL)" 1)
   ("LIM protein (RIL)" 1) ("-LIM" 1)))
 ("UP:Q25381" (("LPM" 14) ("actin, muscle" 1)))
 ("UP:Q25520" (("Runt" 26) ("runt" 10) ("RUNT" 5)))
 ("UP:Q25540" (("DG2" 4) ("dG2" 4)))
 ("UP:Q25637" (("period circadian protein" 3))) ("UP:Q26061" (("ferritins" 7)))
 ("UP:Q26239" (("NP-1" 33) ("NP1" 1))) ("UP:Q26261" (("UNC5" 15)))
 ("UP:Q26263" (("DPN" 188) ("given DPN" 3))) ("UP:Q26417" (("OTX" 1)))
 ("UP:Q26474"
  (("LAC" 223) ("Lac" 5) ("pLAC" 5) ("primary LAC" 3) ("the 28 primary LAC" 2)
   ("acinar LAC" 2) ("malignant LAC" 2) ("than LAC" 1) ("solid LAC" 1)
   ("papillary LAC" 1) ("60 primary LAC" 1)))
 ("UP:Q26495"
  (("LO2" 111) ("The human nontumourigenic hepatocyte cell line LO2" 1)))
 ("UP:Q26657" (("ALX" 20))) ("UP:Q27174" (("T2b" 6)))
 ("UP:Q27297" (("DMR" 81)))
 ("UP:Q27350"
  (("SO" 638) ("anhydrous Na 2 SO" 12) ("SO (DMSO)" 1)
   ("using 2N H 2 SO 4" 1)))
 ("UP:Q27367" (("CRQ" 2))) ("UP:Q27368" (("dE2F" 22)))
 ("UP:Q27371" (("troponin" 31) ("Troponin" 6) ("cardiac troponin" 1)))
 ("UP:Q27403" (("gcm" 1)))
 ("UP:Q27450"
  (("cyclophilins" 22) ("at least six known human cyclophilins" 1)))
 ("UP:Q27571" (("nitric" 25) ("Nitric" 2)))
 ("UP:Q27934" (("Phyllopod" 2) ("PHYL" 1)))
 ("UP:Q28106" (("contactin-1" 17) ("Contactin-1" 1)))
 ("UP:Q28110" (("FcRII" 1)))
 ("UP:Q28256" (("GpIbα" 115) ("GPIbα" 33) ("overexpressed GpIbα" 5)))
 ("UP:Q287T7" (("FRs" 2))) ("UP:Q28894" (("CE4" 9)))
 ("UP:Q29458"
  (("GLs" 57) ("primary and recurrent GLs" 7) ("Gls" 6) ("anaplastic GLs" 3)
   ("recurrent GLs" 3) ("corresponding histological transformed GLs" 2)
   ("both primary and recurrent GLs" 1) ("10 recurrent GLs" 1)
   ("12 recurrent GLs" 1) ("6 recurrent GLs" 1)))
 ("UP:Q29980"
  (("MICB" 110) ("MHC class I polypeptide-related sequence B" 3)
   ("MICB molecule" 2)))
 ("UP:Q29983"
  (("MICA" 128) ("mica" 66) ("MICA molecule" 2)
   ("MHC class I polypeptide-related sequence A" 2) ("Mica" 2)
   ("the tumor-associated MICA" 2) ("the stress-related protein MICA" 2)))
 ("UP:Q29Q28" (("UTR-2" 9) ("-UTR-2" 4)))
 ("UP:Q29RF7" (("Pds5" 9) ("Pds5a" 4) ("Pds5A" 1) ("PDS5A" 1)))
 ("UP:Q29RI6" (("MO25α" 283) ("calcium-binding protein 39" 2)))
 ("UP:Q29RU9" (("pso" 74) ("Pso" 12) ("PSO" 6)))
 ("UP:Q29ST3" (("DrrA" 3) ("SidM" 3)))
 ("UP:Q2ET28" (("OspF" 140) ("ospF" 28) ("missing components linking OspF" 3)))
 ("UP:Q2HR71"
  (("vIRF-2" 189) ("vIRF-2 protein" 19) ("vIRF2" 1)
   ("the two-exon-encoded full-length vIRF-2 protein" 1)))
 ("UP:Q2HR73" (("vIRF4" 2))) ("UP:Q2HRC7" (("vIL-6" 171) ("vIL-6 protein" 3)))
 ("UP:Q2I0E5"
  (("int" 166) ("Int" 103) ("INT" 67) ("iNT" 6) ("-int" 4) ("Int−" 3)
   ("1.9 ml/(packyear*allele number) SE INT" 2)
   ("the non-transformed intestinal cell line Int" 2)
   ("both the non-transformed epithelial cell line Int" 2)
   ("non-growth termed M int" 2)))
 ("UP:Q2I0M5" (("RSPO4" 7))) ("UP:Q2J7L5" (("KRM" 2)))
 ("UP:Q2JTM7" (("RUVB1" 25) ("ruvb-1" 2) ("Ruvb1" 1)))
 ("UP:Q2KHM9" (("KIAA0753" 21)))
 ("UP:Q2KHT3" (("CLEC16A" 25) ("CLEC16a" 11) ("KIAA0350" 1)))
 ("UP:Q2KIR7" (("AAC" 615) ("-AAC" 32) ("T A TT AAC" 3) ("A-A-C" 1)))
 ("UP:Q2KJY2" (("Kif26b" 230) ("KIF26B" 5) ("Kif26b protein" 3)))
 ("UP:Q2LD37" (("KIAA1109" 1))) ("UP:Q2LK54" (("CL3" 27) ("Cl3" 7)))
 ("UP:Q2M1K9"
  (("ZNF423" 146) ("Zfp423" 14) ("the centrosomal proteins ZNF423" 1)
   ("NPHP14" 1) ("OAZ" 1)))
 ("UP:Q2M1P5" (("KIF7" 8))) ("UP:Q2M1V0" (("ISX" 4) ("PIX1" 1)))
 ("UP:Q2M1Z3" (("CdGAP" 4))) ("UP:Q2M2I3" (("FAM83E" 8)))
 ("UP:Q2M2I5" (("K24" 34) ("k24" 1))) ("UP:Q2M389" (("KIAA1033" 5)))
 ("UP:Q2M3C6" (("C15ORF27" 3)))
 ("UP:Q2M3G0"
  (("rhodamine" 545) ("Rhodamine" 185) ("ABCB5" 82) ("rhodamine-" 9)
   ("Rhodamine-" 5)
   ("the cell-permeable fluorescent calpain substrate bis-(CBZ-L-alanyl-L-alanine amide) Rhodamine"
    3)
   ("No nonspecific rhodamine" 2) ("rhodamine (TRITC)" 2) ("rhodamine–" 2)
   ("rhodamine (TAMRA)" 1) ("Rhodamine (TRITC)" 1)
   ("Secondary antibodies or Alexa Fluor 647-conjugated phalloidin/tetramethy rhodamine"
    1)
   ("-rhodamine" 1) ("ATP-binding cassette protein" 1)))
 ("UP:Q2M3R5"
  (("post" 13015) ("Post" 503) ("post-" 89) ("Post-" 7)
   ("the pentameric CRP post" 1) ("bladder at least 30 days post" 1)
   ("pathological study post" 1) ("POST" 1)))
 ("UP:Q2M3T9" (("HYAL4" 3))) ("UP:Q2M3X9" (("ZNF674" 2)))
 ("UP:Q2M5E4" (("RGS21" 3))) ("UP:Q2MHE4" (("HT1" 3) ("Ht1" 2) ("ht1" 1)))
 ("UP:Q2MJR0" (("Spred-3" 2)))
 ("UP:Q2MKA7"
  (("RSPO1" 62) ("RSpo1" 22) ("Rspo1" 8) ("pRSPO1" 4) ("RSPO1 protein" 3)))
 ("UP:Q2MV58" (("Tectonic1" 2) ("Tctn1" 1)))
 ("UP:Q2NKX8"
  (("PICH" 191) ("PICh" 73) ("ERCC6L" 4) ("Pich" 3) ("pPICH" 2)
   ("FLJ20105" 1)))
 ("UP:Q2NL67" (("PARP6" 3)))
 ("UP:Q2Q1W2"
  (("Trim71" 209) ("LIN-41" 10) ("TRIM71" 4) ("LIN41" 2) ("Trim71 protein" 2)))
 ("UP:Q2QAV0" (("TiO" 20))) ("UP:Q2QGD7" (("MGC11349" 2)))
 ("UP:Q2QKL5" (("pcS3" 1))) ("UP:Q2QL34" (("MLPH" 2)))
 ("UP:Q2TA46" (("mUb" 91) ("MuB" 7))) ("UP:Q2TAA5" (("GT8" 5)))
 ("UP:Q2TAK8" (("Mom-1" 2)))
 ("UP:Q2TAM9" (("TUSC1" 3) ("Tumor suppressor candidate 1" 1)))
 ("UP:Q2TAZ0"
  (("ATG2A" 13)
   ("a previously unstudied WD40 protein WDR45 (WIPI4) reciprocally bound ATG2A"
    1)))
 ("UP:Q2TB18" (("HT001" 1))) ("UP:Q2TB90" (("HKDC1" 14)))
 ("UP:Q2TBC4" (("C6orf49" 6))) ("UP:Q2TBH8" (("Zwint1" 1)))
 ("UP:Q2TWM1" (("pL1" 7) ("PL1" 4) ("pPL1" 1)))
 ("UP:Q2TXS4" (("PL2" 11) ("pL2" 2) ("pl2" 1))) ("UP:Q2UY09" (("COL28A1" 1)))
 ("UP:Q2V2M9" (("FHOD3" 3))) ("UP:Q2VIQ3" (("KIF4B" 1)))
 ("UP:Q2VPA4" (("CR1L" 2))) ("UP:Q2VPB7" (("beta5" 3) ("-beta5" 1)))
 ("UP:Q2VYF4" (("LETM2" 14))) ("UP:Q2WGJ6" (("KLHL38" 2)))
 ("UP:Q2WGN9" (("Gab2 like" 1))) ("UP:Q2Y2L9" (("mG" 14)))
 ("UP:Q2YD98" (("UVSSA" 3) ("a UV-sensitive syndrome protein UVSSA" 1)))
 ("UP:Q2YLF3" (("pRPA" 81) ("PrPA" 2))) ("UP:Q2YN11" (("RSH" 44)))
 ("UP:Q2YRB4" (("PDHs" 2))) ("UP:Q2YVZ4" (("SBI" 129)))
 ("UP:Q2YXC0" (("FLIPR" 6))) ("UP:Q2YY04" (("ARLs" 2)))
 ("UP:Q30134" (("DR8" 14))) ("UP:Q30154" (("HLA-DRB5" 4) ("DR beta 5" 2)))
 ("UP:Q30201"
  (("HFE" 97) ("hemochromatosis" 22) ("hereditary hemochromatosis" 6)
   ("the gastric cell line HFE145" 1)))
 ("UP:Q30NP4" (("PAX" 160) ("PAX protein" 7))) ("UP:Q31N27" (("ZDS" 1)))
 ("UP:Q326Z4" (("OspG" 62) ("ospG" 2)))
 ("UP:Q32LE3" (("centrin1" 3) ("centrin-1" 1))) ("UP:Q32M78" (("Hang" 2)))
 ("UP:Q32MQ0" (("ZNF750" 20))) ("UP:Q32MZ4" (("LRRFIP1" 18)))
 ("UP:Q32P28" (("prolyl 3-hydroxylase 1" 3))) ("UP:Q32P44" (("EML3" 1)))
 ("UP:Q32PJ7" (("tensin-4" 3) ("Tensin-4" 2) ("tensin4" 1)))
 ("UP:Q32SG3" (("Ig1" 7))) ("UP:Q330K2" (("NADH dehydrogenase" 25)))
 ("UP:Q33339" (("P93" 3) ("p93" 1))) ("UP:Q37001" (("Eto2" 6)))
 ("UP:Q37874" (("ORF45" 3))) ("UP:Q37976" (("PLY" 11)))
 ("UP:Q38167" (("DMP" 46)))
 ("UP:Q38424"
  (("ALT" 1067) ("telomerases" 43) ("normal ALT" 3) ("than ALT" 1)
   ("Telomerases" 1)))
 ("UP:Q38710"
  (("AS" 2036) ("secondary AS" 38) ("primary AS" 16) ("AS-" 11)
   ("primary and secondary AS" 5) ("Secondary AS" 4) ("radiation-induced AS" 4)
   ("the six primary AS" 3) ("nine secondary AS" 2) ("12 primary AS" 2)
   ("the 18 primary AS" 2) ("11 primary AS" 2) ("18 primary AS" 2)
   ("22 secondary AS" 2) ("the four secondary AS" 2) ("Primary AS" 2)
   ("both primary and secondary AS" 2) ("pAS" 1) ("largest absolute AS" 1)
   ("than the true AS" 1) ("pervasive AS" 1) ("a radiation-induced AS" 1)
   ("all primary AS" 1) ("lymphedema-associated AS" 1) ("soft tissue AS" 1)
   ("radiation-induced breast AS and post-lymphedema AS" 1)
   ("identified two distinct AS" 1) ("Eight radiation-induced AS" 1)
   ("the primary AS" 1) ("subsequently developed AS" 1)
   ("the radiation-induced AS" 1) ("10 secondary AS" 1)
   ("than AS (i.e. malignant fibrous histiocytoma)" 1) ("2 secondary AS" 1)
   ("the angiogenic phenotype radiation-induced AS" 1)
   ("MYC -amplified secondary AS" 1) ("secondary and primary AS" 1)
   ("the 12 secondary AS" 1) ("than AS" 1) ("12 secondary AS" 1)
   ("eight secondary AS" 1) ("a secondary breast AS" 1)))
 ("UP:Q38793"
  (("RBCs" 145) ("pRBCs" 5) ("any mature enucleated RBCs" 1)
   ("functional mature RBCs" 1) ("Non-internalized RBCs" 1)))
 ("UP:Q38822" (("shY2" 1))) ("UP:Q38830" (("BDL" 125) ("underwent BDL" 2)))
 ("UP:Q38833" (("Atg4" 6) ("ATG4" 3))) ("UP:Q38836" (("STK" 6)))
 ("UP:Q38846" (("ERS1" 16) ("ERs1" 1)))
 ("UP:Q38850" (("ATM-2" 9) ("ATM-2 peptide" 4))) ("UP:Q38861" (("XPB1" 2)))
 ("UP:Q38867" (("CYP4" 2))) ("UP:Q38885" (("SCY1" 1)))
 ("UP:Q38890" (("DEC" 19) ("DEC protein" 1))) ("UP:Q38919" (("ROP2" 1)))
 ("UP:Q38945" (("AHL" 1))) ("UP:Q38950" (("DF1" 19))) ("UP:Q38951" (("DF2" 1)))
 ("UP:Q38HL5" (("HOG" 1)))
 ("UP:Q38SD2"
  (("LRRK1" 504) ("LRRK1-" 2) ("the phosphomimic mutations LRRK1" 2)))
 ("UP:Q39023" (("Mpk3" 1))) ("UP:Q39085" (("DIM" 70)))
 ("UP:Q39089"
  (("PAC" 154) ("Pac" 47) ("pAC" 9) ("pAc" 2) ("pac" 1) ("than PAC" 1)
   ("than
                    PAC"
    1)))
 ("UP:Q39096" (("CID1" 5)))
 ("UP:Q39102"
  (("AAA" 1322) ("-AAA" 102) ("AAA protein" 4)
   ("CEM(5–7)-AAA and VKE(164–166)-AAA" 3)
   ("the corresponding protein accession number AAA73985" 1)
   ("KEW(165–167)-AAA and EWL-(166–168)-AAA" 1)
   ("than the wild-type protein and mutant EWL(166–168)-AAA" 1)
   ("mutants KDC(3–5)-AAA and DCE(4–6)-AAA" 1)
   ("EWL(166–168)-AAA and KEW(165–167)-AAA" 1)
   ("-DCE(4–6)-AAA and -KEW(165–167)-AAA" 1) ("especially DCE(4–6)-AAA" 1)
   ("KEW(165–167)-AAA and EWL(166–168)-AAA" 1)
   ("DCE(4–6)-AAA and KEW(165–167)-AAA" 1) ("“AAA”" 1) ("than AAA" 1)
   ("larger AAA's" 1) ("larger AAA" 1)))
 ("UP:Q39161" (("niR" 1))) ("UP:Q39214" (("RPM1" 7)))
 ("UP:Q39218" (("SATA" 22) ("SATa" 3) ("SatA" 1) ("Sata" 1)))
 ("UP:Q39231" (("SUC2" 1))) ("UP:Q39232" (("suc1" 10) ("Suc1" 4)))
 ("UP:Q39234" (("TGA3" 11))) ("UP:Q39250" (("ADF1" 5) ("AtADF1" 2)))
 ("UP:Q39601"
  (("HMG" 190) ("Proteus-associated HMG" 2) ("right-sided HMG" 2)
   ("showed left-sided HMG" 1)))
 ("UP:Q39693" (("INV3" 1))) ("UP:Q3B7T1" (("EDRF1" 5)))
 ("UP:Q3B7T3" (("Bean" 11)))
 ("UP:Q3BK13"
  (("MSI" 3712) ("MSI−" 14) ("MSIs" 8) ("sporadic MSI" 4)
   ("tumours showed MSI" 4) ("than MSI" 2) ("more MSI" 2) ("Msi" 2) ("MSI-" 2)
   ("msi" 1) ("tumors showed MSI" 1) ("Only two cases showed MSI" 1)
   ("widespread MSI" 1) ("colorectal MSI" 1)
   ("than MSI testing for detecting mutation rates of particular genes [ xref ]"
    1)
   ("a more recent study documented MSI" 1) ("‘MSI'" 1)))
 ("UP:Q3C1A6" (("gAPN" 29) ("GAP-N" 13)))
 ("UP:Q3EBD3" (("RH41" 20) ("alveolar RH41" 2))) ("UP:Q3HNM7" (("miNSC" 6)))
 ("UP:Q3IT46" (("GADD" 9)))
 ("UP:Q3IZ91" (("CCR" 28) ("cCR" 3) ("a promiscuous CCR" 2) ("ccr" 1)))
 ("UP:Q3KNS1" (("PTR" 10))) ("UP:Q3KNV8" (("PCGF3" 4)))
 ("UP:Q3KP31" (("Znf791" 4) ("ZNF791" 2)))
 ("UP:Q3KR16" (("MyoGEF" 191) ("PLEKHG6" 2))) ("UP:Q3KR37" (("GRAMD1B" 3)))
 ("UP:Q3L1D1" (("PDH" 233)))
 ("UP:Q3LIE5" (("manganese-dependent" 3) ("manganese dependent" 1)))
 ("UP:Q3LXA3"
  (("DAK" 5) ("bifunctional ATP-dependent dihydroxyacetone kinase" 1)
   ("ATP-dependent dihydroxyacetone kinase" 1)))
 ("UP:Q3MHD2" (("lsm12" 12) ("LSM12" 6))) ("UP:Q3MII6" (("OATL1" 1)))
 ("UP:Q3MIN7" (("RGL3" 2)))
 ("UP:Q3MIT2" (("PUS10" 7) ("proapoptotic PUS10" 2)))
 ("UP:Q3MSQ8" (("VLG" 11))) ("UP:Q3SX26" (("Trip-6" 6)))
 ("UP:Q3SXY7"
  (("LRIT3" 102) ("antisense LRIT3 C592Y 5" 1) ("sense LRIT3 C592Y 5" 1)
   ("antisense LRIT3 S494T 5" 1)))
 ("UP:Q3SXY8" (("Arl13b" 6) ("ARL13B" 2)))
 ("UP:Q3SY56" (("SP6" 139) ("Sp6" 14) ("a Leica confocal microscope SP6" 1)))
 ("UP:Q3SYC2" (("Mogat2" 4) ("Mgat2" 1))) ("UP:Q3SYG4" (("BBS9" 3)))
 ("UP:Q3SZE5" (("Mlc2v" 8) ("MLC-2v" 1))) ("UP:Q3SZP7" (("villin1" 3)))
 ("UP:Q3SZW1" (("TSK1" 4) ("TSSK1" 3))) ("UP:Q3T7C9" (("TSL" 4)))
 ("UP:Q3T906"
  (("subunits" 4529) ("-subunits" 40) ("Subunits" 21) ("ribosomal subunits" 21)
   ("targeting subunits" 17) ("40S ribosomal subunits" 7)
   ("two accessory subunits" 4) ("proteasomal subunits" 3)
   ("free ribosomal subunits" 3) ("small ribosomal subunits" 3)
   ("accessory subunits" 3) ("the ribosomal subunits" 3) ("most subunits" 3)
   ("the respective subunits" 3) ("two Golgi-processed mature subunits" 3)
   ("their associated subunits" 3) ("five homologous subunits" 3)
   ("known ribosomal subunits" 3) ("the other proteasomal subunits" 2)
   ("two possible α -subunits" 2) ("60S ribosomal subunits" 2)
   ("auxiliary subunits" 2) ("other intrinsic proteasomal subunits" 2)
   ("exogenous subunits" 2) ("vesicle-associated subunits" 2)
   ("whose subunits" 2) ("small and large ribosomal subunits" 2)
   ("homo- or hetero dimeric subunits" 2) ("specific tubular subunits" 2)
   ("associated subunits" 2) ("the most conservative subunits" 2)
   ("five possible subunits" 2) ("small (40S) ribosomal subunits" 2)
   ("the 40S ribosomal subunits" 2) ("cargo-specific subunits" 2)
   ("separate subunits" 2) ("the classical subunits" 2)
   ("the principal subunits" 2) ("smaller subunits" 2)
   ("their monomeric subunits" 2) ("longest subunits" 2)
   ("transactivation-competent subunits" 2) ("some essential subunits" 1)
   ("the constituent subunits" 1) ("more subunits" 1)
   ("both unique subunits" 1) ("mature small ribosomal subunits" 1)
   ("one or more subunits" 1) ("large mitoribosomal subunits" 1)
   ("immunoproteasomal subunits" 1) ("these latter subunits" 1)
   ("the 12 POL II subunits" 1) ("ancient subunits" 1)
   ("two essential subunits" 1) ("unique subunits" 1)
   ("at least three principal subunits" 1) ("the associated subunits" 1)
   ("these accessory subunits" 1) ("heterodimeric subunits" 1)
   ("the five non-essential subunits" 1) ("large and small ‘subunits’" 1)
   ("‘subunits’" 1) ("cytoplasmic 40S ribosomal subunits" 1)
   ("distal subunits" 1) ("its dimeric subunits" 1) ("dimeric subunits" 1)
   ("subunits, a regulatory subunit" 1) ("mature ribosomal subunits" 1)
   ("10 unique subunits" 1) ("a few subunits" 1) ("the basic subunits" 1)
   ("four paralogous subunits" 1) ("5 or fewer subunits" 1)
   ("two noncovalently associated subunits" 1) ("large:small subunits" 1)
   ("all 40S ribosomal subunits" 1)))
 ("UP:Q3TDK6" (("LZF" 3))) ("UP:Q3TDN0" (("ICB" 3)))
 ("UP:Q3UL97" (("pSM2" 39) ("PSM2" 21) ("PSM2 protein" 2)))
 ("UP:Q3ULA2" (("FWD1" 9) ("Fwd1" 2))) ("UP:Q3UMR0" (("Varp" 1)))
 ("UP:Q3URY0" (("MAR4" 2))) ("UP:Q3UYI5" (("rpm" 676) ("RPM" 177)))
 ("UP:Q3V5L5" (("MGAT5B" 1)))
 ("UP:Q3V6T2"
  (("GIV" 357) ("girdin" 121) ("Girdin" 32) ("GIV protein" 3)
   ("expressing siRNA-resistant GIV-WT" 3) ("that GIV's" 2)
   ("functionally intact GIV" 1) ("tyrosine phosphorylated GIV's" 1)))
 ("UP:Q3Y598" (("HNF-3γ" 1))) ("UP:Q3YBR2" (("TBRG1" 1) ("NIAM" 1)))
 ("UP:Q3ZB98" (("PMES-2" 4)))
 ("UP:Q3ZBF9"
  (("pyridoxal phosphate phosphatase (PDXP)" 2)
   ("Pyridoxal phosphate phosphatase" 1)
   ("pyridoxal phosphate phosphatase" 1)))
 ("UP:Q3ZK62"
  (("nsp2" 3)
   ("porcine reproductive and respiratory syndrome virus (PRRSV) nsp2" 2)))
 ("UP:Q3ZK64" (("nsP4" 2))) ("UP:Q3ZK65" (("NS26" 1)))
 ("UP:Q40170" (("TM4" 35) ("non-transformed TM4" 1) ("TM4-" 1)))
 ("UP:Q40504" (("FL1" 84))) ("UP:Q40505" (("FL2" 55) ("Fl2" 3)))
 ("UP:Q40588"
  (("ASO" 349) ("AAO" 162) ("ASO-" 6) ("a novel cell-permeable ASO" 2)))
 ("UP:Q40665"
  (("β-3-tubulin" 4) ("the neural proteins β-3-tubulin" 2) ("β3-tubulin" 1)))
 ("UP:Q40702" (("MADS" 12) ("MADs" 1))) ("UP:Q41188" (("GRP2" 1)))
 ("UP:Q41764" (("the maize vegetative ZmADF3" 1) ("ZmADF3" 1)))
 ("UP:Q41969" (("eIF2β" 22) ("eIF2β peptide (MSGDEMIFDPTMSKKKKKKKKP)" 1)))
 ("UP:Q42202" (("HAP4" 5) ("Hap4" 2)))
 ("UP:Q42371"
  (("TE1" 21) ("control siRNA-treated TE1" 2) ("Te1" 1)
   ("HER2-siRNA-treated TE1" 1)))
 ("UP:Q42376" (("LEA" 27) ("“LEA”" 2))) ("UP:Q42406" (("cyclophilin 1" 3)))
 ("UP:Q42536" (("pORA" 5))) ("UP:Q42611" (("mSOD1" 3)))
 ("UP:Q42971"
  (("enolase" 153) ("Enolase" 7) ("acid-treated enolase" 3) ("OSE1" 2)
   ("10 μg exogenous enolase" 1) ("enolase protein" 1) ("enolase (ENO)" 1)
   ("1 μg acid-treated enolase" 1) ("–enolase" 1)))
 ("UP:Q43348" (("VI-3" 13)))
 ("UP:Q43358"
  (("VIC" 223) ("Vic" 18) ("VIC-" 4) ("CSV" 4) ("csv" 3) ("−VIC" 1)
   ("fluorescent VIC" 1)))
 ("UP:Q43383" (("2A6" 3))) ("UP:Q43470" (("14-3-3b" 2)))
 ("UP:Q43725"
  (("CSC" 1941) ("p-CSC" 29) ("pCSC" 4) ("pCSC-" 3)
   ("the mammary gland and breast CSC" 2) ("potential CSC" 2) ("basal CSC" 1)
   ("Pin1 critically supports breast CSC" 1) ("metastatic CSC" 1)
   ("stationary CSC" 1) ("than p-CSC" 1) ("effectively target CSC" 1)
   ("Highly clonogenic CSC" 1) ("that targeting CSC's" 1)
   ("EGFR-negative CSC" 1)))
 ("UP:Q43880" (("thermolysin" 28) ("Thermolysin" 2)))
 ("UP:Q43931"
  (("MLE" 83) ("CatB" 17) ("catB" 5) ("Mle" 2) ("0.5×10 6 adherent MLE" 1)))
 ("UP:Q44587" (("NCCN" 95))) ("UP:Q44756" (("ORF36" 2) ("ORF36 protein" 1)))
 ("UP:Q45388" (("Tex" 18) ("TEX" 3))) ("UP:Q45877" (("HA70" 1)))
 ("UP:Q45878" (("HA17" 1))) ("UP:Q45XH8" (("HBG" 3) ("hbg" 2)))
 ("UP:Q46087"
  (("transposase" 100) ("transposase (SB)" 3) ("solitary PGBD3 transposase" 1)
   ("the intact transposase" 1)))
 ("UP:Q460N3" (("ARTD7" 4) ("PARP15" 1)))
 ("UP:Q460N5" (("ARTD8" 101) ("PARP14" 4) ("ARTD8-" 2)))
 ("UP:Q46203"
  (("MOMP" 544) ("subsequent MOMP" 4) ("Bax/Bak-dependent MOMP" 3)
   ("robust MOMP" 2) ("underwent MOMP" 1) ("MPT-driven MOMP" 1)
   ("even tough MOMP" 1) ("RFP-XIAP-induced MOMP" 1)
   ("cell free assays tethered Bax completely lacks tBID activated MOMP" 1)
   ("directly cause MOMP" 1) ("NOXA SAHB induced weak BAK-mediated MOMP" 1)))
 ("UP:Q46222"
  (("GSEA" 736) ("Subsequent GSEA" 1) ("using GSEA" 1) ("subsequent GSEA" 1)
   ("BROAD GSEA" 1) ("the regular GSEA" 1) ("the original GSEA" 1)))
 ("UP:Q46495" (("RBO" 12)))
 ("UP:Q46654"
  (("LSC" 444) ("than LSC" 4) ("the entire LSC" 2) ("than the P2 LSC" 2)
   ("Primary LSC" 2) ("primary LSC" 2) ("Residual LSC" 1) ("“LSC”" 1)
   ("than P2 LSC" 1) ("than (p<0.01, n = 3) the P2 LSC" 1)))
 ("UP:Q46669" (("CdtB" 8))) ("UP:Q46670" (("CdtC" 2)))
 ("UP:Q46790"
  (("PBL" 480) ("Pbl" 10) ("monomorphic PBL" 7) ("normal PBL" 2)
   ("autologous PBL" 2) ("autologous human CD3+ PBL" 2)
   ("one monomorphic PBL" 2) ("the treated and untreated PBL" 1)
   ("than unfractionated PBL" 1) ("Two monomorphic PBL" 1)
   ("12 monomorphic PBL" 1) ("Only two monomorphic PBL" 1)
   ("the 23 monomorphic PBL" 1) ("8 monomorphic PBL" 1)
   ("Two HIV negative patients developed PBL" 1) ("10 5 PBL's" 1)
   ("two autologous tetramer + /CD8 + PBL" 1)))
 ("UP:Q46897"
  (("case" 16616) ("Case" 937) ("the latter case" 78) ("CASE" 20)
   ("the former case" 16) ("a special case" 11) ("a strong case" 10)
   ("case-" 9) ("this latter case" 8) ("‘case'" 6) ("a sporadic case" 5)
   ("a unique case" 5) ("intriguing case" 4) ("the NF1-driven case" 4)
   ("An adequate case" 3) ("The latter case" 3) ("paradigmatic case" 3)
   ("‘case’" 3) ("the unique case" 3) ("deterministic case" 3)
   ("related case" 2) ("the one discordant case" 2)
   ("the pregnancy-associated case" 2) ("the single discordant case" 2)
   ("one special case" 2) ("One representative case" 2)
   ("a metachronous case" 2) ("Our one discordant case" 2) ("enrolled case" 2)
   ("one ROS1 FISH-positive case" 2) ("no FISH equivocal case" 2)
   ("the representative case" 2) ("the most well understood case" 2)
   ("no non-Jewish sporadic case" 2) ("mutation-negative case" 2)
   ("Potential case" 2) ("the curious case" 2) ("the PDGF-driven case" 2)
   ("one Her2-positive case" 2) ("the typical case" 2)
   ("A representative case" 2) ("a single immunoreactive case" 2)
   ("an additional sporadic case" 2) ("eligible case" 2)
   ("the very special case" 2) ("the deterministic case" 2)
   ("The former case" 1) ("a further single case" 1) ("a persuasive case" 1)
   ("one schizophrenic case" 1) ("the most contentious case" 1)
   ("each bilateral case" 1) ("3,523 EOBC incident case" 1)
   ("youngest available case" 1) ("the pediatric case" 1)
   ("a single leukaemic case" 1) ("the seminal foetal case" 1)
   ("Only few foetal case" 1) ("the special case" 1) ("Available case" 1)
   ("case–" 1) ("subsequent case" 1) ("“case”" 1)
   ("a unilateral sporadic case" 1) ("This latter case" 1)
   ("a hypothetical case" 1) ("one tumoral case" 1)
   ("the only aggressive case" 1) ("a typical case" 1)
   ("1 ROS1 FISH-positive case" 1) ("No FISH equivocal case" 1)
   ("each PIK3CA mutant‐positive and mutant‐negative case" 1)
   ("each PIK3CA mutation‐positive and mutation‐negative case" 1)
   ("one mucinous case" 1) ("an unusual case" 1) ("the Icelandic case" 1)
   ("one representative case" 1) ("hospital-based case" 1)
   ("the adenosquamous case" 1) ("the above-mentioned case" 1)
   ("This unique case" 1) ("the bilateral case" 1) ("a representative case" 1)
   ("the usual case" 1) ("case, firefly" 1) ("substantially more case" 1)
   ("An adopted sporadic case" 1) ("each potential case" 1)
   ("this unusual case" 1) ("The infiltrative case" 1)
   ("a few incidental case" 1) ("HER2-negative case" 1)
   ("an illustrative case" 1) ("26 menopausal case" 1)
   ("a single JAK2V617F-positive case" 1) ("a legitimate case" 1)
   ("a bipolar case" 1) ("each eligible case" 1) ("sparse case" 1)
   ("the particular case" 1) ("the same microglial case" 1)
   ("the homogeneous case" 1) ("a precedential case" 1)
   ("only one discordant case" 1) ("previously reported case" 1)
   ("only one single case" 1) ("another well-studied case" 1)
   ("a particularly tragic case" 1) ("a pediatric case" 1) ("lower case" 1)
   ("1 Canadian case" 1) ("A plausible case" 1)
   ("respect toin stochastic case" 1) ("No ER-positive case" 1)))
 ("UP:Q46DA4" (("hPSA" 5))) ("UP:Q47098" (("HpaI" 18)))
 ("UP:Q47129" (("FEAR" 8))) ("UP:Q47142" (("hCat" 1)))
 ("UP:Q47162" (("FCT" 2))) ("UP:Q47318" (("IUCC" 1)))
 ("UP:Q47454" (("pCOC" 2)))
 ("UP:Q47457"
  (("PCOS" 942) ("the obese PCOS" 4) ("the lean and obese PCOS" 3)
   ("obese PCOS" 3) ("the obese and lean PCOS" 2) ("the hirsute PCOS" 2)
   ("‘PCOS’" 1) ("obese and lean PCOS" 1) ("The obese PCOS" 1)
   ("lean and obese PCOS" 1) ("nondiabetic PCOS" 1)))
 ("UP:Q47WJ3"
  (("ICC" 938) ("unresectable ICC" 1) ("Sometimes bipolar ICC" 1)
   ("the above-described c-kit-IR ICC" 1) ("particular ICC" 1)
   ("significantly fewer Ano1-positive ICC" 1)))
 ("UP:Q48153" (("HHUA" 16)))
 ("UP:Q48211"
  (("LST" 44) ("20 non-granular LST" 2) ("especially granular type LST" 1)))
 ("UP:Q48271" (("CoPP" 41))) ("UP:Q48459" (("ORF13" 2)))
 ("UP:Q48899" (("MMPI" 1))) ("UP:Q48927" (("CMTM" 2)))
 ("UP:Q49124" (("MADH" 3))) ("UP:Q494W8" (("CHRFAM7A" 3)))
 ("UP:Q494X3" (("ZNF404" 3))) ("UP:Q495M3" (("SLC36A2" 6) ("PAT2" 1)))
 ("UP:Q495N2" (("PAT-3" 5))) ("UP:Q495T6" (("MMEL1" 24)))
 ("UP:Q495W5" (("FUT11" 3))) ("UP:Q495X7" (("TRIM60" 1)))
 ("UP:Q495Z4" (("C17orf65" 1)))
 ("UP:Q496J9"
  (("SV2C" 73) ("SV2C peptide" 2) ("than the SV2C peptide" 1)
   ("very little endogenous SV2C" 1) ("more SV2C" 1) ("than SV2C" 1)
   ("than SV2C 529–579 ( xref )" 1)))
 ("UP:Q496M5" (("PLK5" 3) ("Plk5" 2))) ("UP:Q496Y0" (("LONRF3" 1)))
 ("UP:Q49A26" (("GLYR1" 7))) ("UP:Q49A88" (("CCDC14" 24)))
 ("UP:Q49AM3" (("TTC31" 30) ("TTC31-" 1)))
 ("UP:Q49AN0"
  (("Cry2" 313) ("CRY2" 19) ("cry2" 16) ("Cry2 protein" 1)
   ("cryptochrome 2" 1)))
 ("UP:Q49MG5" (("MAP9" 50) ("ASAP" 24) ("Map9" 1) ("“ASAP”" 1)))
 ("UP:Q4AC94" (("C2CD3" 2)))
 ("UP:Q4AEG8"
  (("XYL" 11) ("Cytoseal XYL" 4) ("Richard-Allan Scientific Cytoseal XYL" 2)
   ("using Cytoseal XYL" 2) ("Cytoseal XYL (VWR)" 1) ("xyl" 1)))
 ("UP:Q4FZB7" (("Suv4-20h1" 9) ("SUV420H1" 3) ("Suv420h1" 1)))
 ("UP:Q4G0J3" (("LARP7" 11) ("LARP7 protein" 5)))
 ("UP:Q4G0N8" (("isoform 10" 1))) ("UP:Q4G0P3" (("HYDIN" 12)))
 ("UP:Q4G0X4" (("KCTD21" 3)))
 ("UP:Q4G163" (("Emi2" 148) ("the Emi2" 4) ("EMI2" 2) ("Fbx43" 1)))
 ("UP:Q4H3K6"
  (("fibroblast growth factor receptor" 86) ("FGF-R" 9)
   ("fibroblast growth factor receptor (FGFR)" 8) ("-FGF-R" 2)
   ("“fibroblast growth factor receptor”" 1)))
 ("UP:Q4J6C6" (("PREPL" 70) ("KIAA0436" 2))) ("UP:Q4JDL3" (("PTPN20A" 2)))
 ("UP:Q4KMP7" (("TBC1D10B" 3))) ("UP:Q4KMQ1" (("TprN" 5)))
 ("UP:Q4KMZ8" (("NKAIN1" 14))) ("UP:Q4KWH8" (("PLCH1" 1)))
 ("UP:Q4L235" (("U26" 4) ("AASDH" 1)))
 ("UP:Q4L2X2" (("ORF6" 15) ("Orf6" 10) ("orf6" 7))) ("UP:Q4LDG9" (("DNAL1" 1)))
 ("UP:Q4LDR2"
  (("CTXN3" 17) ("cortexin 3" 4) ("CTXN3 protein" 3)
   ("kidney and brain expressed protein" 2)))
 ("UP:Q4LE39" (("BCAA" 45) ("ARID4B" 2) ("BCAA-" 1) ("-BCAA" 1) ("SAP180" 1)))
 ("UP:Q4LE53" (("protein+" 1))) ("UP:Q4PRD2" (("LC2" 5)))
 ("UP:Q4R1J6" (("SU2" 2) ("su2" 1)))
 ("UP:Q4U0G1" (("CLASP" 88) ("CLASP molecule" 3)))
 ("UP:Q4U2R8"
  (("losartan" 35) ("Losartan" 14)
   ("Ang II type 1 receptor blocker losartan's" 1)))
 ("UP:Q4UDU8" (("HSP-90" 30) ("HSP-90-" 1)))
 ("UP:Q4UN85" (("TLC1" 14) ("Tlc1" 11))) ("UP:Q4V328" (("GRASP-1" 4)))
 ("UP:Q4VC05" (("BCL7A" 14) ("Bcl7a" 1)))
 ("UP:Q4VCS5"
  (("Amot" 537) ("AMOT" 66) ("angiomotin" 51) ("Angiomotin" 13)
   ("showed negligible Amot" 2) ("the junctional protein AMOT" 2)
   ("Amot protein" 1)))
 ("UP:Q4WB37"
  (("CSN" 497) ("Csn" 6) ("CSN-" 4) ("more CSN" 3) ("2-fold more CSN" 1)
   ("smaller CSN" 1) ("-CSN" 1)))
 ("UP:Q4WF61"
  (("side" 7228) ("Side" 67) ("only one side" 6)
   ("the contralateral control side" 3) ("SidE" 3) ("the far right side" 2)
   ("the bulky peptide side" 2) ("minimal in vivo side" 2)
   ("form both the side" 2) ("its amino terminal side" 2)
   ("the contralateral non-ischemic side" 2) ("possible negative side" 2)
   ("larger amino acid side" 2) ("bulky hydrophobic side" 1)
   ("detrimental long-term side" 1) ("most methyl side" 1)
   ("different antiangiogenic approaches side" 1)
   ("than the right side (24.2%, P < 0.0001)" 1)
   ("aromatic or large hydrophobic side" 1) ("the cathodal facing side" 1)
   ("human recombinant IGF1 alone causes side" 1) ("larger binding side" 1)
   ("bulky amino acid side" 1) ("three flexible solvent-exposed side" 1)
   ("The ridged side of APC3’s" 1) ("potentially severe autoimmune side" 1)
   ("respectively each side" 1)
   ("the N-terminal amino acid of a protein and lysine side" 1)
   ("radiation-induced late skin side" 1) ("late skin side" 1)
   ("one or more glutamate side" 1) ("severe physiological side" 1)
   ("taxanes often cause significant negative side" 1)
   ("generally only low-to-moderate severity side" 1)
   ("adverse bleeding side" 1) ("acute skin side" 1) ("there are side" 1)
   ("unnecessary therapy-related side" 1) ("only minor side" 1)
   ("amino acids of similar side" 1) ("shorter 7α alkyl side" 1)
   ("than one side" 1) ("the other flexible arginine or lysine side" 1)
   ("the mammary pads side" 1) ("SIDE" 1) ("often BIR3 side" 1)
   ("nucleophilic protein side" 1) ("the immediately opposite side" 1)))
 ("UP:Q4WXX9" (("PDCA" 20) ("advanced unresectable PDCA" 1)))
 ("UP:Q4ZG55"
  (("GREB1" 252) ("Greb1" 11) ("GREB-1" 9)
   ("growth regulation by estrogen in breast cancer 1" 4)
   ("previously described estrogen responsive genes GREB1" 2)
   ("GREB1 protein" 2)))
 ("UP:Q4ZJI4" (("nha1" 2) ("pNHA1" 1) ("NHEDC1" 1))) ("UP:Q4ZJY8" (("O12" 2)))
 ("UP:Q4ZJY9" (("O11" 2))) ("UP:Q500W7" (("PNT1" 5)))
 ("UP:Q50234" (("Maul" 8))) ("UP:Q502W7" (("CCDC38" 12)))
 ("UP:Q504Q3" (("USP52" 1) ("Pan2" 1))) ("UP:Q50777" (("USPs" 77)))
 ("UP:Q50925" (("Hao" 22))) ("UP:Q51061" (("GME" 11)))
 ("UP:Q51330"
  (("ofas" 27) ("the stochastic steady state solution ofas" 1) ("ofA" 1)))
 ("UP:Q51700" (("cytochrome oxidase" 21) ("Cytochrome oxidase" 2)))
 ("UP:Q51845" (("hemagglutinin A" 1))) ("UP:Q52078" (("FDM" 10)))
 ("UP:Q52106" (("MErT" 1))) ("UP:Q52488" (("HRPT" 2)))
 ("UP:Q52LA3" (("Lin52" 31) ("LIN52" 5) ("than Lin52" 1)))
 ("UP:Q52LD8" (("RFTN2" 2))) ("UP:Q52LJ0" (("FAM98B" 2)))
 ("UP:Q52LR7"
  (("EPC2" 57)
   ("telomerase-immortalized non-transformed diploid human esophageal keratinocytes EPC2"
    2)))
 ("UP:Q52LW3" (("ARHGAP29" 3))) ("UP:Q52PH6" (("Hog1" 23)))
 ("UP:Q53034"
  (("MPCs" 328) ("MPC" 62) ("MPc" 18) ("normal MPCs" 4)
   ("genuine embryonic MPCs" 1) ("artificial pancreatic MPCs" 1)))
 ("UP:Q53546" (("THS" 72) ("ThS" 18) ("hHsp" 15)))
 ("UP:Q53765" (("SoxE" 22) ("SoxE protein" 2)))
 ("UP:Q53957"
  (("streptolysin O" 5) ("streptolysin O (SLO)" 3) ("Streptolysin O" 1)))
 ("UP:Q53EL6"
  (("PDCD4" 407) ("Pdcd4" 221) ("programmed cell death 4" 15)
   ("programmed cell death protein 4" 10) ("Programmed Cell Death 4" 9)
   ("Programmed cell death 4" 7) ("Pdcd4 protein" 7) ("PDCD4 protein" 6)
   ("pdcd4" 6) ("PDCD4-" 4) ("the miR-21-mediated PDCD4-" 1)))
 ("UP:Q53EP0"
  (("fad104" 107) ("FAD104" 89) ("Fad104" 5) ("fndc3b" 2) ("FAD104-" 1)
   ("FAD104 protein" 1)))
 ("UP:Q53ET0"
  (("TORC2" 350) ("CRTC2" 202) ("CREB protein 2" 3) ("-TORC2" 3)
   ("CRTC2 protein" 3) ("TORC2 protein" 3) ("TorC2" 2) ("Torc2" 2) ("Crtc2" 1)
   ("Hyperactive or overexpressed CRTC2" 1) ("the key TORC2" 1)))
 ("UP:Q53EU6"
  (("MAG-1" 8) ("GPAT3" 5) ("glycerol-3-phosphate acyltransferase 3" 1)))
 ("UP:Q53EZ4"
  (("CEP55" 130) ("Cep55" 120) ("the spindle-associated Cep55" 1)
   ("Dimeric CEP55" 1)))
 ("UP:Q53F09" (("karyopherin-α" 1)))
 ("UP:Q53FA7"
  (("TP53I3" 54) ("Pig3" 8) ("Tumor protein p53-inducible protein 3" 2)
   ("Tp53I3" 1)))
 ("UP:Q53FZ2" (("SAH" 363) ("SAH peptide" 4) ("experimental SAH" 2)))
 ("UP:Q53G44" (("IFI44L" 4))) ("UP:Q53G59" (("KLHL12" 4)))
 ("UP:Q53GA4" (("IPL" 103) ("PHLDA2" 11) ("IsPL" 2) ("ipl" 1) ("Ipl" 1)))
 ("UP:Q53GD3" (("CTL4" 1)))
 ("UP:Q53GG5" (("PDLIM3" 15) ("weak cytoplasmic PDLIM3" 2)))
 ("UP:Q53GI3" (("ZNF394" 9))) ("UP:Q53GL0" (("CKIP1" 38) ("CKIP-1" 13)))
 ("UP:Q53GL7"
  (("ARTD10" 260) ("-ARTD10" 17) ("PARP10" 8)
   ("preliminary experiments ARTD10" 1) ("most ARTD10" 1)))
 ("UP:Q53GQ0" (("HSD17B12" 7) ("pKAR" 2)))
 ("UP:Q53GS7" (("Gle1" 20) ("GLE1" 1))) ("UP:Q53GS9" (("USP39" 9)))
 ("UP:Q53GT1" (("KLHL22" 54) ("KLHL22 protein" 7))) ("UP:Q53H12" (("mUlk" 4)))
 ("UP:Q53H47"
  (("Metnase" 337) ("Metnase protein" 16) ("SETMAR" 15) ("metnase" 3)
   ("than the wt Metnase" 2) ("pure recombinant wt Metnase" 1)
   ("explained Metnase’s" 1) ("Hsmar1" 1)))
 ("UP:Q53H76"
  (("NMD" 562) ("PLA1A" 7) ("minimal NMD" 2) ("canonical NMD" 1)
   ("enogenous NMD" 1) ("endogeneous NMD" 1)))
 ("UP:Q53HC0" (("CCDC92" 13))) ("UP:Q53HC5" (("Klhl26" 22)))
 ("UP:Q53HI1" (("UNC50" 124) ("-UNC50" 6) ("UNC50 protein" 5) ("Gea1p" 1)))
 ("UP:Q53HL2" (("Borealin" 16) ("CDCA8" 9) ("borealin" 4)))
 ("UP:Q53HV7"
  (("SMUG1" 381) ("FDG" 316)
   ("single-strand-selective monofunctional uracil-DNA glycosylase 1" 5)
   ("SMUG1 protein" 3) ("Smug1" 2) ("SMUG1-" 2) ("pSMUG1" 2) ("than SMUG1" 1)
   ("the less efficient SMUG1" 1)))
 ("UP:Q53QV2" (("LBH" 74) ("Lbh" 7) ("limb bud and heart development" 1)))
 ("UP:Q53R12" (("transmembrane 4 L six family member 20" 5) ("TM4SF20" 2)))
 ("UP:Q53RT3" (("TAPs" 19))) ("UP:Q53SF7" (("COBLL1" 6)))
 ("UP:Q53T94" (("TAF1B" 2) ("raf1b" 1))) ("UP:Q53TN4" (("CYBRD1" 5)))
 ("UP:Q53TS8" (("2SA" 35) ("-2SA" 1))) ("UP:Q54150" (("IpaJ" 2)))
 ("UP:Q54765" (("AAR" 32))) ("UP:Q54BM7" (("p-PKA" 1)))
 ("UP:Q54C71" (("Rac-GEF" 14) ("RacGEF" 13) ("a dendritic Rac-GEF" 1)))
 ("UP:Q54CD8" (("Hela" 217) ("HELA" 3) ("heterogeneous Hela" 1)))
 ("UP:Q54DE8" (("PSB" 15))) ("UP:Q54DP3" (("FSC-H" 5)))
 ("UP:Q54DU8" (("4EBPs" 14) ("the translational repressors 4EBPs" 1)))
 ("UP:Q54EH1"
  (("Epsin" 20) ("epsin" 14) ("pepsin" 12) ("epsins" 5) ("epsin protein" 4)))
 ("UP:Q54NP6" (("SNP-A" 54))) ("UP:Q54NU5" (("BTG" 15)))
 ("UP:Q54NZ7"
  (("ARBs" 41) ("ARB" 16) ("The new ARBs" 3) ("the new ARBs" 2)
   ("nearly three thousand (2 772) new ARBs" 1) ("arb" 1)))
 ("UP:Q54PQ4" (("AIMLESS" 4) ("Aimless" 1))) ("UP:Q54QB9" (("GacG" 8)))
 ("UP:Q54T48" (("UCH1" 14))) ("UP:Q54UC9" (("kinesin-1" 17) ("Kinesin-1" 1)))
 ("UP:Q54VC7" (("PITC" 2))) ("UP:Q54WH5" (("ElmoE" 4)))
 ("UP:Q54WX4"
  (("Aurora" 1379) ("aurora" 92) ("AurB" 9) ("pAurB" 4) ("AURORA" 3)
   ("phospho-Aurora" 2) ("AURK" 2)))
 ("UP:Q54X03" (("PMMA" 22))) ("UP:Q54YF2" (("AMPKa" 11)))
 ("UP:Q55034" (("GGPP" 39)))
 ("UP:Q55309" (("pAR" 168) ("par" 63) ("Par" 46) ("plasmid pAR20" 1)))
 ("UP:Q556G4" (("DoHH2" 12) ("We first treated DoHH2" 1)))
 ("UP:Q558K8" (("ICMT1" 7)))
 ("UP:Q55AX2" (("DOTA" 93) ("the bifunctional chelator DOTA" 1)))
 ("UP:Q55C49" (("GT-AG" 9) ("GT–AG" 2)))
 ("UP:Q55C77" (("GER" 150) ("pGER" 7) ("the neonatal GER" 2)))
 ("UP:Q55D99"
  (("PakA" 75) ("pakA" 34) ("pakA-" 9) ("PAKa" 2)
   ("nonphosphorylatable PakA" 1) ("phosphomimetic PakA" 1)))
 ("UP:Q55DL0" (("dhps" 21))) ("UP:Q55FQ9" (("LMPC" 3)))
 ("UP:Q55G45" (("Miro" 6) ("miro" 2) ("MIRO" 1))) ("UP:Q56110" (("OMPs" 21)))
 ("UP:Q56148"
  (("CPT" 1490) ("CPTs" 25) ("pCPT" 7) ("CPT-" 4)
   ("the apoptogenic drug CPT" 2) ("1 developed CPT" 1)))
 ("UP:Q56268" (("LeuB" 3) ("leuB" 1))) ("UP:Q562E7" (("WDR81" 1)))
 ("UP:Q562F6" (("SGOL2" 18) ("Sgo2" 16) ("centromeric Sgo2" 2)))
 ("UP:Q569H8"
  (("estrogen-related receptor alpha" 10)
   ("myocardial Estrogen-Related Receptor alpha" 2)
   ("Estrogen-Related Receptor alpha" 1)))
 ("UP:Q569K4" (("ZNF533" 13) ("ZNF385B" 11)))
 ("UP:Q56NI9"
  (("ESCO2" 11) ("Roberts syndrome" 4)
   ("previously called Norman Roberts syndrome" 2)))
 ("UP:Q56X52"
  (("IM" 875) ("late stage IM" 3) ("incomplete IM" 3) ("than IM" 2)
   ("Gastric IM" 2) ("IM-" 2) ("gastric IM" 1)
   ("the predominantly incomplete IM" 1) ("the predominantly complete IM" 1)
   ("Complete IM" 1) ("failed IM" 1) ("tightly binding inhibitor IM" 1)
   ("“IM”" 1)))
 ("UP:Q56YJ8" (("FMA" 9))) ("UP:Q570B4" (("EL4" 34)))
 ("UP:Q570C0" (("TIR-1" 1) ("TIR1" 1))) ("UP:Q570Y6" (("AtADF8" 2)))
 ("UP:Q57501" (("HPAC" 117))) ("UP:Q58187" (("Transcription factor E" 2)))
 ("UP:Q58378" (("PATs" 127) ("the now-identified PATs" 1)))
 ("UP:Q58379" (("POK" 19)))
 ("UP:Q58428" (("ARcs" 21) ("ARCs" 12) ("Most ARCs" 1)))
 ("UP:Q58559" (("RP-A" 51) ("focal RP-A" 2) ("nuclei showed RP-A" 2)))
 ("UP:Q588V7" (("TEB" 85) ("developmentally associated TEB" 2)))
 ("UP:Q58A45" (("PAN3" 5) ("Pan3" 1))) ("UP:Q58EX7" (("Plekhg4" 7)))
 ("UP:Q58FF8" (("HSP90AB2P" 3))) ("UP:Q58HK4" (("Qa-2" 6) ("Qa2" 2) ("qA2" 1)))
 ("UP:Q58HT5" (("diacylglycerol acyltransferase 2" 2)))
 ("UP:Q58WW2"
  (("NRIP" 279) ("ARCaP" 142) ("nuclear receptor interaction protein" 2)
   ("AR CaP" 1) ("ARCAP" 1) ("indirect interaction NRIP" 1) ("NRIP protein" 1)
   ("nuclear receptor interaction protein (NRIP)" 1)))
 ("UP:Q59111" (("GCTA" 76) ("G-C-T-A" 1)))
 ("UP:Q59119" (("CyA" 40) ("than low CyA" 1)))
 ("UP:Q59156"
  (("DNA polymerase I" 32) ("Poli" 11) ("the Poli’s" 1) ("poli" 1)))
 ("UP:Q59268" (("MGM" 8))) ("UP:Q59723" (("LINC" 14) ("Linc" 1) ("LINC-" 1)))
 ("UP:Q59966" (("SRPG" 1)))
 ("UP:Q59E55" (("NaB" 74) ("nAb" 15) ("nab" 15) ("NAb" 4) ("NaB-" 1)))
 ("UP:Q59EK9" (("RPIP8" 2))) ("UP:Q59H18" (("TNNI3K" 2)))
 ("UP:Q59HB0"
  (("p66Shc" 1383) ("p66shc" 238) ("p66Shc protein" 72) ("P66Shc" 5)
   ("Ser-36–phosphorylated p66Shc" 4) ("P66shc" 4)
   ("overexpressed Myc-tagged p66Shc" 3) ("the monomeric p66Shc" 3)
   ("dominant-negative mutant p66Shc" 2) ("overexpressing p66Shc‐S36A" 1)
   ("total cellular p66Shc" 1) ("the apparently opposite p66Shc" 1)
   ("β3-associated p66Shc" 1)))
 ("UP:Q5A762" (("MLT1" 3)))
 ("UP:Q5AQ33"
  (("heat shock transcription factor" 5)
   ("heat shock transcription factor (HSF)" 1)))
 ("UP:Q5B2E9" (("POD" 54) ("POX" 20) ("Pod" 11) ("pox" 5) ("Pox" 1)))
 ("UP:Q5B3U7" (("CsnB" 1))) ("UP:Q5BB99" (("Toa2" 1)))
 ("UP:Q5BEY7" (("ADB" 15))) ("UP:Q5BGR2" (("MESA" 79) ("Mesa" 19)))
 ("UP:Q5BIV9" (("SHO" 2) ("shO" 2)))
 ("UP:Q5BJF2" (("transmembrane protein 97" 2) ("TMEM97" 1)))
 ("UP:Q5BJF6"
  (("ODF2" 44) ("Cenexin" 13) ("cenexin" 3)
   ("Outer Dense Fiber of sperm tails 2" 2)))
 ("UP:Q5BJH7" (("YIF1B" 2))) ("UP:Q5BKX8" (("MURC" 1)))
 ("UP:Q5BKZ1" (("ZIRD" 25) ("ZNF326" 10)))
 ("UP:Q5BPS0"
  (("log2" 411) ("Log2" 49) ("-log2" 4) ("than log2(40)" 1)
   ("an robust multi-array average (RMA) normalization algorithm producing log2"
    1)
   ("absolute log2" 1) ("the vehicle treated log2" 1) ("log2-" 1)))
 ("UP:Q5CD77" (("Srf2" 1)))
 ("UP:Q5D1E8"
  (("MCPIP1" 118) ("using plasmid-expressed Flag-tagged MCPIP1" 2)
   ("MCPIP1 protein" 2) ("ZC3H12A" 1) ("MCPIP-1" 1)))
 ("UP:Q5D869" (("RPE1" 169))) ("UP:Q5E9P6" (("seipin" 7)))
 ("UP:Q5EB52"
  (("MEST" 21) ("Mest" 10) ("Peg1" 2) ("mesoderm specific transcript" 1)))
 ("UP:Q5EC55"
  (("anti" 1336) ("Anti" 61) ("‘anti’" 1) ("6.7×10 6 sheep anti" 1)
   ("“Anti-anti”" 1) ("-anti" 1)))
 ("UP:Q5EE01" (("C6orf173" 7) ("CENPW" 2) ("CENP-W" 1)))
 ("UP:Q5EG05"
  (("COP1" 554) ("copGFP" 82) ("Cop1" 60) ("COP" 53) ("Cop" 7) ("CopGFP" 4)
   ("COP-" 2) ("COP1 (WT)" 2) ("copGFP-" 1) ("fluorescent copGFP" 1)
   ("CARD16" 1) ("COP1 protein" 1)))
 ("UP:Q5FBB7"
  (("Sgo1" 365) ("hSgo1" 42) ("Sgo" 21) ("Sgo1 protein" 8) ("SGOL1" 6)
   ("Sgo1
 protein"
    6)
   ("Shugoshin 1" 6) ("SGO1" 5) ("hSgo1 (Shugoshin-like 1) protein" 3)
   ("Shugoshin-like 1" 2) ("SgoL1" 1) ("centromere-associated Sgo1" 1)))
 ("UP:Q5FBZ9" (("PMS1 protein homolog 1" 1))) ("UP:Q5FVE4" (("BGR" 1)))
 ("UP:Q5FWF4"
  (("ZRANB3" 234) ("AH2" 174) ("AH2 protein" 15) ("ZRANB3 protein" 3)
   ("exogenous AH2" 1)
   ("than ZRANB3 under these conditions (compare xref and xref and xref )" 1)
   ("than ZRANB3" 1)))
 ("UP:Q5FWF5" (("ESCO1" 10) ("Esco1" 1))) ("UP:Q5FWY4" (("XMCM6" 2)))
 ("UP:Q5FYA8" (("ARSH" 1))) ("UP:Q5FYB0" (("ASJ" 34)))
 ("UP:Q5FYB1" (("ASI" 6) ("member I" 2))) ("UP:Q5G4B7" (("266A" 7)))
 ("UP:Q5GH73" (("XKR6" 2))) ("UP:Q5H9F3" (("BcoRL1" 1)))
 ("UP:Q5H9I0" (("TFDP3" 49) ("TFDP3 protein" 5)))
 ("UP:Q5H9R7"
  (("regulatory subunit 3" 18) ("PP6R3" 9) ("SAPS3" 8) ("KIAA1558" 4)))
 ("UP:Q5HCN2" (("ICaR" 11))) ("UP:Q5HCR7" (("ClfB" 4)))
 ("UP:Q5HDD6" (("Hγ2" 2)))
 ("UP:Q5HEN9" (("v-Ras" 7) ("v-ras" 3) ("V-Ras" 2) ("v-RAS" 1)))
 ("UP:Q5HHM8" (("ClfA" 35))) ("UP:Q5HYA8" (("TMEM67" 1) ("MKS3" 1)))
 ("UP:Q5HYI8" (("RABL3" 7) ("Rabl3" 2))) ("UP:Q5HYK7" (("SH3D19" 2)))
 ("UP:Q5HZ36" (("GNC" 2))) ("UP:Q5HZZ6" (("MED8A" 5)))
 ("UP:Q5I2A0" (("Spi2A" 178) ("Serpina3g" 4))) ("UP:Q5IJ48" (("Crb2" 10)))
 ("UP:Q5J8M3" (("TMEM85" 1))) ("UP:Q5JPB2" (("ZNF831" 2)))
 ("UP:Q5JR12" (("PPM1J" 2))) ("UP:Q5JRA6" (("MIA3" 3)))
 ("UP:Q5JRX3"
  (("hMps1" 125) ("metalloprotease-1" 9) ("metalloprotease 1" 6)
   ("hMps1 protein" 2) ("MP-1" 1) ("hMPs1" 1) ("pMP-1" 1)))
 ("UP:Q5JS13" (("RalGPS1" 1))) ("UP:Q5JS54" (("PSMG4" 1)))
 ("UP:Q5JSH3" (("WDR44" 1)))
 ("UP:Q5JSL3"
  (("ACG" 348) ("-ACG" 26) ("A-C-G" 11) ("DOCK11" 5) ("Dock11" 2)
   ("Zizimin2" 1)))
 ("UP:Q5JSP0" (("FGD3" 3))) ("UP:Q5JT25" (("Rab41" 1)))
 ("UP:Q5JT82" (("KLF17" 7))) ("UP:Q5JTC6" (("AMER1" 9) ("FAM123B" 3)))
 ("UP:Q5JTD0" (("PilT" 3) ("pilT" 1)))
 ("UP:Q5JTV8" (("LAP1B" 169) ("TOR1AIP1" 4))) ("UP:Q5JUK2" (("TEB2" 2)))
 ("UP:Q5JUK3" (("slack" 13) ("Slack" 12) ("Frank Slack" 3)))
 ("UP:Q5JWF2" (("XLalphaS" 23) ("XLalphas" 4))) ("UP:Q5JY77" (("GASP1" 11)))
 ("UP:Q5JZY3" (("EPHA10" 1))) ("UP:Q5K651" (("SAMD9" 111) ("SAMD9 protein" 2)))
 ("UP:Q5KSL6" (("DGKK" 2))) ("UP:Q5KU26" (("SrCl" 23) ("SCARA4" 14)))
 ("UP:Q5LH66" (("MBE" 7))) ("UP:Q5M775" (("Nsp5" 3) ("NSPs" 2) ("NSP5" 2)))
 ("UP:Q5MIZ7" (("SMEK2" 5)))
 ("UP:Q5MJ70"
  (("Spy1" 361) ("Speedy/Ringo A2" 178) ("Speedy/Ringo" 41) ("ringo" 33)
   ("Speedy/Ringo protein" 7) ("Spy1 protein" 4) ("speedy" 3) ("Ringo" 3)
   ("ringo protein" 2)
   ("the previously reported mammalian Speedy/Ringo protein" 2)
   ("Recently p33 ringo" 1) ("Speedy/RINGO" 1) ("-Speedy/Ringo A2" 1)))
 ("UP:Q5MNZ6" (("WDR45L" 2)))
 ("UP:Q5MNZ9"
  (("puncta" 1405) ("WIPI1" 16) ("Puncta" 11) ("discrete puncta" 6)
   ("internal puncta" 5) ("fluorescent puncta" 4) ("LC3-positive puncta" 4)
   ("endosomal WASH-positive puncta" 3) ("ventral puncta" 3)
   ("cytoplasmatic puncta" 3) ("ATG18" 3) ("WIPI1 protein" 3)
   ("occasional puncta" 3) ("synaptophysin-mCherry-positive puncta" 2)
   ("‘puncta'" 2) ("GFP-WASH–positive puncta" 2) ("exocyst-positive puncta" 2)
   ("WASH-positive puncta" 2) ("cortactin-positive puncta" 2)
   ("pre- and post synaptic puncta" 2) ("immunofluorescent puncta" 2)
   ("autophagic puncta" 2) ("distinct puncta" 2) ("basal puncta" 2)
   ("very few puncta" 2) ("fewer p-ULK1 puncta" 2)
   ("∼60% more LANA-1 puncta" 2) ("more puncta" 2) ("autophagosomal puncta" 2)
   ("actin-associated intracellular puncta" 2) ("fluorescent LC3 puncta" 2)
   ("dominant-negative ARF6 puncta" 2) ("drawn around 250 puncta" 2)
   ("peripheral AP-1 puncta" 2) ("well-defined puncta" 2)
   ("red fluorescent puncta" 2) ("apical dendrite puncta" 2)
   ("fewer PSD-95 puncta" 2) ("intense puncta" 2) ("clearly fewer puncta" 2)
   ("internal 546-α-myc puncta" 2) ("fewer bassoon puncta" 2)
   ("GFP-LC3 autophagic puncta" 2) ("GFP‐LC3–positive puncta" 2)
   ("subcortical actin puncta" 1) ("cortical dAPC2 puncta" 1)
   ("cortical puncta" 1) ("caveolar puncta" 1) ("nearly all mCherry puncta" 1)
   ("F-actin–positive puncta" 1) ("WASH-positive endosomal puncta" 1)
   ("post-synaptic puncta" 1) ("GFP-fluorescent puncta" 1)
   ("these BirA*-CEP63/PCM1-positive puncta" 1)
   ("revealed more LC3 positive puncta" 1) ("LC3 immunofluorescent puncta" 1)
   ("the LC3-positive puncta" 1) ("generic LC3 puncta" 1)
   ("intracellular autophagic puncta" 1) ("autophagic intracellular puncta" 1)
   ("dendritic ADAM10 and PSD-95 puncta" 1) ("GFP-positive puncta" 1)
   ("dual diffraction-limited puncta" 1)
   ("cortactin-positive endosomal puncta" 1)
   ("F-actin/cortactin double-positive puncta" 1)
   ("LC3A positive autophagic puncta" 1) ("brown puncta" 1)
   ("rLGALS9-treated cells such LC3B puncta" 1) ("smaller puncta" 1)
   ("than any of the Axin puncta ( xref )" 1) ("largest APC + Axin puncta" 1)
   ("PAR1 endocytic puncta" 1) ("‘puncta’" 1) ("clear puncta" 1)
   ("Primordial E-cadherin puncta" 1) ("radial puncta" 1)
   ("The lamellal puncta" 1) ("dynamic puncta" 1)
   ("than four GFP-LC3B puncta" 1) ("formed prominent puncta" 1)
   ("the apical puncta" 1) ("apical “puncta”" 1) ("“puncta”" 1)
   ("apical dendrite anatomical puncta" 1) ("synaptic puncta" 1)
   ("than basal dendrite puncta (graph not shown, p < 0.05 in only 2 of 13 segments, N=17 neurons)"
    1)
   ("E-cadherin immunopositive cytoplasmic puncta" 1)
   ("the autophagic puncta" 1) ("LC3-GFP autophagic puncta" 1)
   ("immunopositive puncta" 1) ("Immunopositive puncta" 1)
   ("cells showed clearly discernible intracellular puncta" 1)
   ("the PDK1-positive apical puncta" 1)
   ("the puncta observed by confocal microscopy" 1)
   ("the PDK1-positive puncta" 1) ("the Rab11-positive puncta" 1)
   ("Nearly all Rab11-positive puncta" 1) ("PDK1-positive puncta" 1)
   ("most Raichu-Rac1-positive cytoplasmic puncta" 1)
   ("any apparent dendritic puncta" 1)
   ("both early autophagic (‘green+red‘) LC3B puncta" 1)
   ("protrusion-associated puncta" 1)))
 ("UP:Q5MZZ2"
  (("aCSF" 57) ("ACSF" 20) ("normal aCSF" 5) ("sterile ice-cold aCSF" 2)
   ("ice-cold aCSF" 1)))
 ("UP:Q5NCC9" (("GM16" 11) (NIL 1))) ("UP:Q5NUL3" (("GPR120" 3)))
 ("UP:Q5NV62" (("V3-4" 1))) ("UP:Q5NV92" (("V5-6" 4)))
 ("UP:Q5PEA9" (("SptP" 2) ("the TTSS bacterial effector SptP" 1)))
 ("UP:Q5PEB1" (("HilA" 1))) ("UP:Q5PHN0" (("SopE2" 24) ("sopE2" 13)))
 ("UP:Q5PP12" (("Agp24" 3))) ("UP:Q5PT55" (("SLC10A5" 1)))
 ("UP:Q5Q0B3" (("FLP1" 4) ("FLP1L1-" 1))) ("UP:Q5QJ38" (("TCHHL1" 3)))
 ("UP:Q5QJ74"
  (("EL" 1400) ("El" 55) ("EL protein" 49) ("EL-" 17) ("el" 5) ("pEL" 5)
   ("than EL" 5) ("less Bim EL" 4) ("-EL" 2) ("only Bim EL" 2)
   ("the pro-apoptotic protein BIM EL" 2) ("targeting BIM EL" 2)
   ("rapidly increase Bim EL" 1)
   ("the pro-apoptotic Bcl-2 family protein BIM EL" 1) ("than the EL" 1)
   ("than EL (full-length)" 1) ("than EL ( xref )" 1)
   ("the first 40, 45, or 70 amino acids of EL ( xref )" 1)
   ("the Universal Microplate Reader EL" 1)
   ("pro-apoptotic genes BID andBIM EL" 1) ("“76NE6-EL”" 1)))
 ("UP:Q5QN75" (("MAPKK1" 8))) ("UP:Q5QP82" (("dcaf10" 1)))
 ("UP:Q5QQ55"
  (("XT" 541) ("log(Xd/Xi)/log(Cd/Ci)xT" 1) ("xT" 1)
   ("Agilent SureSelect Human All Exon 50mb XT" 1)))
 ("UP:Q5RJ20" (("AP-2δ" 1))) ("UP:Q5RKV6" (("Mtr3" 6)))
 ("UP:Q5S007"
  (("LRRK2" 2267) ("LRRK2 protein" 26) ("Lrrk2" 8) ("pathogenic LRRK2" 7)
   ("PARK8" 4) ("LRRK2-" 3) ("leucine rich repeat kinase 2" 2) ("-LRRK2" 2)
   ("transiently overexpressed LRRK2-wild type" 2)
   ("overexpressed LRRK2-wild type" 2) ("than wild-type LRRK2" 2)
   ("than wild-type LRRK2 [ xref ]" 1) ("again kinase dead LRRK2" 1)
   ("the pathogenic LRRK2 mutants R1441C and G2019S" 1)
   ("phenocopy pathogenic LRRK2" 1) ("Pathogenic LRRK2" 1)
   ("our protein microarray analysis functionally links PD-associated LRRK2" 1)
   ("pathogenic G2019S-mutant LRRK2" 1) ("exogenous LRRK2" 1)))
 ("UP:Q5S2C3" (("KLK" 12))) ("UP:Q5S2C4" (("p125NAP1" 2)))
 ("UP:Q5S580" (("Sec31" 11) ("SEC31" 1)))
 ("UP:Q5SBP6"
  (("GDS" 47) ("guanyl-nucleotide exchange factor activity" 2)
   ("Gene Expression Omnibus GDS4386" 1)))
 ("UP:Q5SBP7" (("SEs" 38) ("the respective corrected SEs" 3)))
 ("UP:Q5SCB5"
  (("cyclinD" 75) ("CyclinD" 48) ("Cyclin-D" 26) ("cyclin-D" 22) ("CycD" 18)
   ("pCyclinD" 6) ("-cyclin-D" 1)))
 ("UP:Q5SF94" (("AAAP" 3))) ("UP:Q5SGD2" (("1L" 134) ("PPM1L" 4)))
 ("UP:Q5SNT2" (("SAMP1" 4) ("TMEM201" 2)))
 ("UP:Q5SQI0" (("ATAT" 4) ("MEC-17" 1)))
 ("UP:Q5SRH9"
  (("MCF7" 6964) ("parental MCF7" 16) ("MCF7 (ATCC)" 6) ("-MCF7" 5)
   ("BRCA1 competent MCF7" 5) ("ER-positive MCF7" 4) ("ERα-positive MCF7" 3)
   ("the parental MCF7" 3) ("the transformed MCF7" 3)
   ("The human epithelial mammary cell line MCF7" 2) ("than MCF7" 2)
   ("the parental cell line MCF7" 2) ("heterozygous MCF7" 2) ("MCF7-" 2)
   ("estrogen-treated MCF7" 2) ("cyclin D1-overexpressing MCF7" 2)
   ("siControl or siPBX1 treated MCF7" 2) ("less aggressive MCF7" 2)
   ("the pediatric osteosarcoma cell line U2OS or breast adenocarcinoma cell line MCF7"
    2)
   ("stable Ets1-expressing MCF7" 1) ("non-treated and 4-OHT-treated MCF7" 1)
   ("than the parental cell line MCF7 ( xref )" 1) ("both parental MCF7" 1)
   ("ERα-positive breast cancer lines MCF7" 1) ("the ER driven MCF7" 1)
   ("ER-positive breast cancer MCF7" 1)
   ("the well-characterized ER-positive breast cancer MCF7" 1)
   ("ER-positive breast cancer cells MCF7" 1) ("Parental MCF7" 1)
   ("ductal adenocarcinoma derived MCF7" 1)
   ("BRCA1 proficient cell lines MCF7" 1)
   ("Parental breast cancer cell lines ER + MCF7" 1)
   ("AF-sensitive ERα-positive MCF7" 1) ("than both MCF7" 1)
   ("BRCA1-expressing MCF7" 1) ("Her2/Neu-negative (HER2 − ) MCF7" 1)
   ("than MCF7 in MDA-MB-231 (Figure xref )" 1)
   ("than MCF7 (Figure  xref B)" 1)
   ("the telomerase-positive breast cancer cell line MCF7" 1) ("MCF7—" 1)
   ("similarly treated MCF7" 1)
   ("The human ER-positive breast cancer cells MCF7" 1)
   ("the ERα-positive cell lines MCF7" 1) ("p53-proficient MCF7" 1)
   ("the p53-positive breast cancer cell line MCF7" 1) ("Subconfluent MCF7" 1)
   ("the noninvasive breast cancer cell line MCF7" 1)
   ("ER-positive breast cancer cell lines MCF7" 1) ("treated MCF7" 1)
   ("than MCF7 ( xref )" 1)
   ("intermediate and high HER2 overexpressing MCF7" 1)
   ("culture both the MCF7" 1) ("the sporadic breast cancer cell line MCF7" 1)
   ("than the ER-positive MCF7" 1) ("the ER-positive MCF7" 1)
   ("estradiol-treated MCF7" 1) ("ErbB2-negative breast cancer cells MCF7" 1)))
 ("UP:Q5SRI9" (("MANEA" 1))) ("UP:Q5SS90" (("GM11992" 7)))
 ("UP:Q5SSG8" (("epiglycanin" 3))) ("UP:Q5SSJ5" (("HP1BP3" 6)))
 ("UP:Q5SW24" (("Dact2" 20))) ("UP:Q5SW79" (("CEP170" 7) ("Cep170" 3)))
 ("UP:Q5SW96"
  (("ARH" 67) ("LDLRAP1" 6) ("ARH peptide" 4)
   ("autosomal recessive hypercholesterolemia protein" 3)))
 ("UP:Q5SXH7" (("PLEKHS1" 3))) ("UP:Q5SXM2" (("SNAPC4" 6)))
 ("UP:Q5SXM8" (("Hep1" 98) ("HEP1" 18) ("hep1" 17)))
 ("UP:Q5T0D9" (("TPRG1L" 1)))
 ("UP:Q5T0N5" (("Toca-1" 163) ("toca1" 20) ("fnbp1l" 1) ("FNBP1L" 1)))
 ("UP:Q5T0T0" (("MARCH8" 3) ("c-MIR" 2) ("RNF178" 1)))
 ("UP:Q5T0W9"
  (("FAM83B" 405) ("FAM83B protein" 10) ("FAM83B-" 3)
   ("FAM83B-K230A protein" 2) ("efficient FAM83B-" 1)
   ("Subsequent analysis defined FAM83B" 1)))
 ("UP:Q5T124" (("SOC" 181) ("UBXN11" 9) ("pre-menopausal SOC" 2)))
 ("UP:Q5T160" (("RARSL" 3))) ("UP:Q5T1C6" (("CTMP" 4)))
 ("UP:Q5T1M5" (("wafl" 1))) ("UP:Q5T1Q4" (("SLC35F1" 1)))
 ("UP:Q5T1R4" (("KRC" 3) ("krc" 1)))
 ("UP:Q5T200" (("ZC3H13" 26) ("ZC3H13 protein" 2)))
 ("UP:Q5T230" (("UTF1" 9) ("Utf1" 4)))
 ("UP:Q5T280" (("CENP-32" 7) ("C9orf114" 2))) ("UP:Q5T292" (("c10orf128" 2)))
 ("UP:Q5T2D3" (("OTUD3" 12))) ("UP:Q5T2E6" (("C10orf76" 8)))
 ("UP:Q5T2R2" (("TPT" 178) ("TPRT" 9) ("TPT-" 4))) ("UP:Q5T2W1" (("PDZK1" 93)))
 ("UP:Q5T3F8" (("TMEM63B" 1))) ("UP:Q5T3U5" (("ABCC10" 7) ("MRP7" 5)))
 ("UP:Q5T442" (("alpha 12" 4)))
 ("UP:Q5T4F7" (("SFRP5" 25) ("Sfrp5" 1) ("sFRP5" 1)))
 ("UP:Q5T4H9" (("c10orf114" 1)))
 ("UP:Q5T4S7"
  (("UBR4" 27) ("UBR4 protein" 4)
   ("than the original UBR4 protein (5,183 residues)" 1) ("p600" 1)
   ("ubiquitin protein ligase E3 component n-recognin 4" 1)))
 ("UP:Q5T4W7" (("artemin" 1) ("ARTN" 1) ("EVN" 1)))
 ("UP:Q5T5C0" (("STXBP5" 38))) ("UP:Q5T5J6" (("Swt1" 7)))
 ("UP:Q5T5P2" (("SKT" 5) ("KIAA1217" 3))) ("UP:Q5T5X7" (("bEnd3" 1)))
 ("UP:Q5T619" (("ZNF648" 4)))
 ("UP:Q5T6S3"
  (("PHF19" 26) ("Phf19" 20) ("PCL3" 8) ("PHD finger protein 19" 1)
   ("a wild-type hairpin-resistant PHF19" 1)))
 ("UP:Q5T6X5" (("GPRC6A" 37) ("gprc6a" 3) ("Gprc6a" 1)))
 ("UP:Q5T764" (("IFIT1B" 2)))
 ("UP:Q5T7V8"
  (("SCYL1-BP1" 153) ("SCYL1-BP1 protein" 8) ("overexpressed SCYL1-BP1" 2)
   ("the exogenously overexpressed SCYL1-BP1" 1) ("exactly SCYL1-BP1" 1)
   ("exogenous SCYL1-BP1" 1)))
 ("UP:Q5T7W0" (("ZNF618" 1))) ("UP:Q5T9C9" (("PIP5KL1" 2)))
 ("UP:Q5T9L3" (("EVI" 47) ("GPR177" 41) ("WLS" 11) ("Evi" 2)))
 ("UP:Q5TA45" (("RC-68" 2) ("CPSF3L" 1))) ("UP:Q5TA77" (("LCE3B" 2)))
 ("UP:Q5TA78" (("LCE4A" 4)))
 ("UP:Q5TA89"
  (("Hes5" 155) ("HES5" 62) ("hes5" 4) ("split 5" 4) ("Hes-5" 2) ("BHLHB38" 2)
   ("HES-5" 1)))
 ("UP:Q5TAH2" (("isoform 11" 1))) ("UP:Q5TAP6" (("UTP14C" 10) ("UTP14c" 1)))
 ("UP:Q5TAT6" (("COL13A1" 2)))
 ("UP:Q5TAX3" (("Zcchc11" 7) ("ZCCHC11" 3) ("TUT4" 2)))
 ("UP:Q5TB30" (("DEPDC1" 2))) ("UP:Q5TBA9" (("Fry" 13)))
 ("UP:Q5TBB1" (("RNaseH2B" 1))) ("UP:Q5TC12" (("ATPAF1" 14)))
 ("UP:Q5TC63" (("GRTP1" 4) ("TBC1D6" 1))) ("UP:Q5TCH4" (("CYP4A22" 1)))
 ("UP:Q5TCQ9"
  (("MAGI-3" 100) ("MAGI3" 6) ("Magi-3" 2) ("exogenous MAGI-3" 2) ("Magi3" 1)))
 ("UP:Q5TCZ1"
  (("FISH" 7107) ("fish" 747) ("Tks5" 193) ("TKs" 123) ("FISH−" 46) ("Fish" 42)
   ("Tks" 31) ("FISH-" 25) ("-FISH" 14) ("tks5" 13) ("local FISH" 7)
   ("confirmatory FISH" 6) ("TKS5" 6) ("each locus-specific FISH" 4)
   ("than FISH" 4) ("Local FISH" 4) ("Representative FISH" 3)
   ("NPM immunofluorescent FISH" 3) ("successful FISH" 3) ("fatty fish" 3)
   ("using centromeric FISH" 2) ("discordant FISH" 2) ("normal FISH" 2)
   ("binary FISH" 2) ("triple FISH" 2) ("classic FISH" 2)
   ("cartilaginous fish" 2) ("TexRed)/CEN7q (FITC) Dual Color FISH" 2)
   ("IHC FISH" 2) ("concurrent EGFR FISH" 2) ("dual color FISH" 2) ("Tks-" 2)
   ("manual dual-color FISH" 2) ("uninterpretable FISH" 2)
   ("the unique adaptor protein Tks5" 2) ("unsuccessful FISH" 2)
   ("targeted FISH" 2) ("raw FISH" 2) ("subsequent FISH" 2)
   ("We first applied FISH" 2) ("Detailed FISH" 2) ("employed FISH" 2)
   ("differentially-labeled FISH" 1) ("Exemplary FISH" 1)
   ("centromeric FISH" 1) ("failed FISH" 1) ("Digital FISH" 1) ("IHC + FISH" 1)
   ("CEP3 (Spectrum Orange) (Abbot Molecular, Des Plaines, IL, USA) FISH" 1)
   ("Dual color FISH" 1) ("more positive FISH" 1)
   ("Sequential RNA/DNA double FISH" 1) ("abnormal FISH" 1)
   ("a commercially available FISH" 1) ("evaluable PTEN FISH" 1)
   ("raw or uncooked fish" 1) ("weak FISH" 1) ("Cartilaginous fish" 1)
   ("bony fish" 1) ("informative FISH" 1) ("ALK showed FISH" 1)
   ("discrete and robust FISH" 1) ("the previously described FISH" 1)
   ("the previously detected large FISH" 1) ("abnormally large ESR1 FISH" 1)
   ("the major FISH" 1) ("Dual color EGFR FISH" 1) ("2 commercial FISH" 1)
   ("a c-Met/CEN7p Dual Color FISH" 1)
   ("retained CTCs showed evaluable FISH" 1) ("conclusive FISH" 1)
   ("more frequently EGFR FISH" 1) ("the less severe fish" 1)
   ("than Tg( mitfa :BRAF V600E ) fish" 1) ("SH3PXD2A" 1)
   ("white and fatty fish" 1) ("previously described FISH" 1)
   ("the gold standard dual color FISH" 1) ("complete FISH" 1)
   ("telomeric FISH" 1) ("adequate MET FISH" 1)
   ("our precise single cell FISH" 1) ("three-dimensional FISH" 1)
   ("traditional FISH" 1) ("locus-specific interphase FISH" 1)
   ("the normal FISH" 1) ("underwent FISH" 1) ("a confirmatory FISH" 1)
   ("available EGFR FISH" 1) ("appropriate FISH" 1) ("fluorescent FISH" 1)
   ("most MYCN transgenic fish" 1) ("most other FISH" 1)
   ("a dual color FISH" 1) ("The commercially available dual-colour FISH" 1)
   ("ALK -negative FISH" 1) ("the original FISH" 1)
   ("a commercially two-color FISH" 1) ("A recent FISH" 1)
   ("sequential tri-colour FISH" 1) ("Sequential tri-colour FISH" 1)
   ("CEN7p Dual Color FISH" 1) ("the dual color break-apart FISH" 1)
   ("Bismar et al. used FISH" 1)))
 ("UP:Q5TDP6" (("LGS" 25))) ("UP:Q5TEJ8" (("Themis2" 94)))
 ("UP:Q5TGU0" (("TSPO2" 3)))
 ("UP:Q5TGZ0" (("MINOS1" 54) ("Mio10" 53) ("mio10" 17) ("MIO10" 3)))
 ("UP:Q5TH69" (("ARF-GEFs" 2))) ("UP:Q5TIA1" (("MEI-1" 13) ("MEI1" 3)))
 ("UP:Q5TJF3" (("Ring1A" 18))) ("UP:Q5TKA1" (("LIN9" 36) ("Lin9" 4)))
 ("UP:Q5TZA2" (("rootletin" 20) ("Rootletin" 5))) ("UP:Q5U5Q3" (("MEX3C" 1)))
 ("UP:Q5U5R9"
  (("HECTD2" 206) ("–HECTD2" 2) ("the first 40 amino acids of HECTD2" 1)
   ("40 amino acids of HECTD2 ( xref )" 1) ("HECTD2 protein" 1)
   ("targeted HECTD2" 1)))
 ("UP:Q5U651" (("RASIP1" 6) ("rain" 2) ("Raines" 1)))
 ("UP:Q5UAW9" (("GPR157" 3))) ("UP:Q5UCC4" (("INM" 49) ("INM protein" 3)))
 ("UP:Q5UE93" (("p87PIKAP" 2) ("PIK3R6" 1)))
 ("UP:Q5UPZ0"
  (("DNA ligase" 289) ("16°C overnight using T4 DNA ligase" 2)
   ("DNA ligase (NEB)" 1) ("DNA ligase (PROMEGA)" 1)))
 ("UP:Q5UQE6" (("DNA topoisomerase II" 41)))
 ("UP:Q5UQM2" (("Robin" 4) ("robin" 3)))
 ("UP:Q5UQP9" (("TBP-like" 2) ("TBP-like protein (TLP)" 1)))
 ("UP:Q5UZ65"
  (("puro" 749) ("Puro" 233) ("-puro" 129) ("PURO" 28) ("-Puro" 12)
   ("a functional puro" 2) ("—puro" 1) ("-PURO" 1)
   ("a lentiviral expression vector PGLV3/H1/GFP+ puro" 1)))
 ("UP:Q5VIR6" (("Vps53" 26))) ("UP:Q5VSL9" (("FAM40A" 23)))
 ("UP:Q5VST9" (("OBSCN" 1) ("obscurin" 1))) ("UP:Q5VT06" (("CAP350" 56)))
 ("UP:Q5VT25" (("MRCK" 53))) ("UP:Q5VT52" (("RPRD2" 2)))
 ("UP:Q5VT97" (("syde2" 1)))
 ("UP:Q5VTB9"
  (("RNF220" 9) ("RNF220 protein" 1)
   ("RNF220 (ring finger protein 220) protein" 1)
   ("ring finger protein 220" 1)))
 ("UP:Q5VTD9"
  (("Gfi-1B" 213) ("GFI1B" 22) ("GFI1b" 5) ("Gfi1b" 2) ("less Gfi-1B" 1)
   ("Gfi-1B protein" 1) ("Gfi1B" 1)))
 ("UP:Q5VTQ0"
  (("TTC39B" 5) ("Ttc39b" 4) ("tetratricopeptide repeat domain 39B" 1)))
 ("UP:Q5VTR2" (("RNF20" 126) ("hBRE1" 1) ("Bre1a" 1)))
 ("UP:Q5VTY9" (("HHAT" 62))) ("UP:Q5VU43" (("PDE4DIP" 6) ("myomegalin" 1)))
 ("UP:Q5VU92"
  (("DCAF12L1" 4)
   ("the cullin-associated WD domain-containing protein DCAF12L1" 1)))
 ("UP:Q5VUB5" (("FAM171A1" 1)))
 ("UP:Q5VV41" (("Ephexin4" 120) ("Ephexin 4" 2) ("ARHGEF16" 2) ("ephexin4" 1)))
 ("UP:Q5VV42"
  (("CDKAL1" 65) ("A37" 14)
   ("CDK5 regulatory subunit associated protein 1-like 1" 2)))
 ("UP:Q5VV43"
  (("neuronal migration" 196) ("proper neuronal migration" 8) ("KIAA0319" 6)
   ("Defective Neuronal Migration" 4) ("Neuronal Migration" 4)
   ("abnormal neuronal migration" 3) ("defective neuronal migration" 2)
   ("cortical neuronal migration" 2) ("proper cortical neuronal migration" 2)
   ("extensive neuronal migration" 2) ("radial neuronal migration" 1)
   ("successive neuronal migration" 1) ("normal neuronal migration" 1)
   ("robust neuronal migration" 1)
   ("radial glia directed neuronal migration" 1) ("Neuronal migration" 1)
   ("optimal GnRH neuronal migration" 1) ("basal neuronal migration" 1)))
 ("UP:Q5VV67"
  (("PRC" 101) ("PR-C" 8) ("Pprc1" 1) ("previously identified PRC" 1)))
 ("UP:Q5VVH5" (("IRAK1BP1" 13))) ("UP:Q5VVJ2" (("MYSM1" 4)))
 ("UP:Q5VVQ6" (("YOD1" 3))) ("UP:Q5VVX9" (("UBE2U" 32) ("UBE2U protein" 2)))
 ("UP:Q5VWG9"
  (("TAF3" 181) ("140 kD" 4) ("overexpressing murine TAF3" 2) ("-TAF3" 2)
   ("approximately 140kDa" 2) ("Taf3" 1)
   ("TATA binding protein associated factor 3" 1) ("140kDa" 1) ("140 KD" 1)))
 ("UP:Q5VWJ9" (("SNX30" 1)))
 ("UP:Q5VWK5"
  (("IL23R" 84) ("IL-23R" 77) ("IL-23 receptor" 11)
   ("interleukin 23 receptor" 3) ("IL23r" 1)))
 ("UP:Q5VWP3" (("CIPs" 1))) ("UP:Q5VWQ0" (("RSBN1" 3)))
 ("UP:Q5VWQ8"
  (("DAB2IP" 972) ("DAB2IP protein" 16) ("Dab2ip" 9) ("AIP-1" 4)
   ("weak DAB2IP" 2) ("DAB2-interacting protein" 2) ("Dab2IP" 1) ("DAB2IP-" 1)
   ("DAB2IP (KD)" 1) ("total and ubiquitinated DAB2IP" 1)))
 ("UP:Q5VWX1" (("SLM-1" 3) ("SLM1" 1))) ("UP:Q5VWZ2" (("LYPLAL1" 16)))
 ("UP:Q5VXI9" (("LIPN" 4))) ("UP:Q5VXJ0" (("LIPK" 4)))
 ("UP:Q5VY09" (("IER5" 1)))
 ("UP:Q5VY43" (("PEAR1" 34) ("Jedi" 6) ("MEGF12" 6)))
 ("UP:Q5VYV7"
  (("C20orf94" 19)
   ("a previously uncharacterized open reading frame C20orf94" 2)
   ("SLX4IP" 1)))
 ("UP:Q5VYX0" (("RNLS" 3))) ("UP:Q5VYY2" (("LIPM" 3)))
 ("UP:Q5VZF2" (("MBNL2" 1)))
 ("UP:Q5VZK9"
  (("capping protein" 46) ("LRRC16A" 11) ("CARMIL" 6) ("CARMIL protein" 2)))
 ("UP:Q5VZL5" (("ZNF262" 12)))
 ("UP:Q5VZM2" (("RagB" 106) ("RAGB" 4) ("Rag B" 1)))
 ("UP:Q5VZV1" (("METTL21C" 2))) ("UP:Q5W064" (("LIPJ" 2)))
 ("UP:Q5W5W9"
  (("endocrine" 1943) ("Endocrine" 63) ("endocrine-" 5)
   ("potential endocrine" 2) ("primary endocrine" 1)
   ("this classical endocrine" 1) ("ENDOCRINE" 1) ("new ‘endocrine’" 1)
   ("‘endocrine’" 1) ("-endocrine" 1) ("systemic endocrine" 1)
   ("The major endocrine" 1)))
 ("UP:Q5W7F2" (("SFC" 14))) ("UP:Q5WFT5" (("RASp" 1)))
 ("UP:Q5XG87" (("TRF4" 1)))
 ("UP:Q5XJA3"
  (("Mys" 44) ("mys" 6) ("MYs" 5) ("Mys protein" 2) ("very little Mys" 1)))
 ("UP:Q5XKP0" (("MIC1-3" 36))) ("UP:Q5XLA6" (("INCa" 6)))
 ("UP:Q5XPI4"
  (("KPC1" 38) ("just KPC1" 1) ("E3 ubiquitin-protein ligase RNF123" 1)))
 ("UP:Q5XUX0" (("FBXO31" 163) ("FBXO31-" 1)))
 ("UP:Q5XUX1" (("Fbxw9" 2) ("FBXW9" 1)))
 ("UP:Q5XVF0" (("CCG" 478) ("-CCG" 37))) ("UP:Q5XX13" (("FBXW10" 1)))
 ("UP:Q5XXA6"
  (("ANO1" 362) ("Ano1" 69) ("DOG-1" 6) ("ANO1-" 6) ("DOG1" 6)
   ("ANO1 protein" 5) ("TMEM16A" 4) ("Dog-1" 2)
   ("the 40–70 most C-terminal amino acids of ANO1" 1) ("ORAOV2" 1) ("TAOS2" 1)
   ("FLJ10261" 1)))
 ("UP:Q5Y7A7" (("DR13" 6))) ("UP:Q5YD75" (("LR1" 23)))
 ("UP:Q5YD76" (("LB3" 4)))
 ("UP:Q5ZC82"
  (("log" 4832) ("Log" 534) ("−log" 58) ("-log" 19) ("–log" 14) ("log (OR)" 11)
   ("—log" 8) ("the natural log" 7) ("log(OR)" 7) ("log(RR)" 7)
   ("natural log" 6) ("log-" 4) ("lower bound onby requiring that≥ log" 3)
   ("a nonlinear log" 2) ("−Log" 2) ("−log10" 2)
   ("log( p  i ) + Σ(1 - p  i ) log" 2) ("log(ACR)" 2) ("log(RTA)" 2)
   ("Clinical score=16.2x(Gleason score 7)+30.2x(Gleason score>7)+6.6x log" 1)
   ("an affinity at least one log" 1) ("approximately one log" 1)
   ("log (HR)" 1) ("all natural log" 1) ("log(HR)" 1) ("continuous log(ACR)" 1)
   ("log-transformed values using log" 1)
   ("a
                    minimum regional absolute average log"
    1)
   ("-log10Ki" 1) ("using natural log" 1) ("LOG" 1)))
 ("UP:Q5ZJ58" (("PIP5KIβ" 3)))
 ("UP:Q5ZLN5"
  (("TDP-43" 166) ("pTDP-43" 25) ("insoluble TDP-43" 2)
   ("the toxic disease protein TDP-43" 1) ("Pathological TDP-43" 1)))
 ("UP:Q5ZPR3"
  (("B7-H3" 136) ("costimulatory molecule" 67) ("B7-H3 protein" 12) ("B7H3" 4)
   ("the transfection control tumors showed strong B7-H3" 2) ("B7-H3-" 1)))
 ("UP:Q5ZU30"
  (("glucosyltransferase activity" 11) ("glucosyltransferase" 5)
   ("Glucosyltransferase" 1)))
 ("UP:Q60216" (("Tran" 24) ("tran" 7) ("tran-" 1)))
 ("UP:Q60477" (("aa1" 36) ("AA1" 13)))
 ("UP:Q60670" (("MSK" 149) ("Msk" 2) ("pMSK" 2) ("p-MSK" 1)))
 ("UP:Q60682" (("Ly49H" 1))) ("UP:Q60770" (("Munc18c" 30)))
 ("UP:Q60813" (("ADAM1" 1))) ("UP:Q60875" (("Lfc" 19)))
 ("UP:Q60L58" (("SIR-2.1" 72))) ("UP:Q60NC0" (("MEC-10" 3)))
 ("UP:Q60XS3" (("GPA-16" 6))) ("UP:Q60YN5" (("RFP1" 1)))
 ("UP:Q61091" (("mFZ8" 1)))
 ("UP:Q61093"
  (("CGD" 32) ("severe genetic condition CGD" 2)
   ("autosomal recessive CGD" 1)))
 ("UP:Q61146" (("OCL" 48) ("pagetic OCL" 5) ("Pagetic OCL" 2)))
 ("UP:Q61152" (("Flp1" 12))) ("UP:Q61158" (("Yrk" 10) ("YRK" 1)))
 ("UP:Q61282"
  (("AGC" 1251) ("-AGC" 53) ("'AGC'" 2) ("AGC-" 1)
   ("metastatic or relapsed AGC" 1) ("Predictive AGC" 1) ("“AGC”" 1)))
 ("UP:Q61468" (("mES" 25) ("MEs" 3) ("MeS" 2)))
 ("UP:Q61477" (("Dana" 2) ("DANA" 1)))
 ("UP:Q61572"
  (("MF" 803) ("MF-" 5) ("primary or secondary MF" 3) ("Mf" 3)
   ("a weak power frequency MF" 2) ("mF" 1) ("-MF" 1) ("1M-KCl-stripped MF" 1)
   ("MF-1" 1) ("JAK2V671F-positive MF" 1) ("JAK2V617F-positive MF" 1)
   ("co-existent MF" 1)))
 ("UP:Q61644"
  (("pacsin" 11) ("the additional caveolar proteins pacsin" 2) ("PACSIN" 2)))
 ("UP:Q61696" (("Hsp68" 2))) ("UP:Q61846" (("MPK38" 1)))
 ("UP:Q61850" (("BF-3" 2))) ("UP:Q61UC4" (("LIN-45" 15) ("LIN-45 (RAF)" 3)))
 ("UP:Q61W58" (("DAF-21" 4))) ("UP:Q62245" (("mSos1" 1)))
 ("UP:Q62401" (("CCL12" 1))) ("UP:Q62471" (("LCn-3" 1)))
 ("UP:Q62666" (("VAT" 47) ("abdominal VAT" 3))) ("UP:Q62671" (("DD5" 2)))
 ("UP:Q63035" (("pAVR" 4) ("AVR" 1))) ("UP:Q63064" (("RB7" 10)))
 ("UP:Q63135" (("rCrry" 2))) ("UP:Q63276" (("KAN-1" 24)))
 ("UP:Q63317" (("Ly6B" 3))) ("UP:Q63961" (("EDG" 7) ("Edg" 3)))
 ("UP:Q63HK5" (("TSHZ3" 11) ("Tshz3" 6))) ("UP:Q63HN8" (("ALO17" 2)))
 ("UP:Q63HR2" (("tensin-2" 5) ("TNS2" 3) ("tensin 2" 1) ("TENC1" 1)))
 ("UP:Q63ZK0" (("AMI" 36)))
 ("UP:Q63ZY3"
  (("coactivators" 762) ("transcriptional coactivators" 67) ("Coactivators" 9)
   ("siP" 5) ("CREB-regulating transcriptional coactivators" 4)
   ("essential coactivators" 3) ("a few coactivators" 2)
   ("both transcriptional coactivators" 2)
   ("the transcriptional coactivators" 2)
   ("other transcriptional coactivators" 2)
   ("generalized transcriptional coactivators" 2) ("classical coactivators" 2)
   ("binding transcriptional coactivators" 2) ("Most coactivators" 2)
   ("related transcriptional coactivators" 2)
   ("p300/CBP transcriptional coactivators" 2)
   ("CRTC transcriptional coactivators" 1)
   ("either transcriptional coactivators" 1)
   ("two closely related transcriptional coactivators" 1)
   ("its associated coactivators" 1) ("the potential coactivators" 1)
   ("other secondary coactivators" 1) ("multiple secondary coactivators" 1)
   ("KANK2" 1) ("various transcriptional coactivators" 1)
   ("additional transcriptional coactivators" 1)
   ("Transcriptional coactivators" 1)
   ("4ICD associated transcriptional coactivators" 1)
   ("The three transcriptional coactivators" 1)
   ("all these secondary coactivators" 1)
   ("classical transcriptional coactivators" 1)
   ("classical nuclear receptor coactivators" 1)
   ("cognate transcriptional coactivators" 1)
   ("defined transcriptional coactivators" 1) ("secondary coactivators" 1)))
 ("UP:Q64277" (("BP3" 4) ("BP-3" 3) ("–BP3" 1)))
 ("UP:Q64280" (("Lefty" 5) ("LEFTY" 5))) ("UP:Q64321" (("Th-POK" 2)))
 ("UP:Q64329" (("Ly49C" 9)))
 ("UP:Q64364" (("p19ARF" 211) ("p19Arf" 19) ("than p19ARF" 1)))
 ("UP:Q643R3" (("AGPAT7" 4) ("ETA)" 1)))
 ("UP:Q64735" (("Crry protein" 3) ("Crry" 2)))
 ("UP:Q64755" (("CPP" 273) ("–CPP" 4) ("targeted CPP" 2)))
 ("UP:Q64756" (("PMU" 1))) ("UP:Q64770" (("GAM1" 8) ("Gam1" 2)))
 ("UP:Q64897"
  (("core protein" 610) ("Core protein" 12) ("Core Protein" 10)
   ("soluble core protein" 4) ("an indispensable core protein" 2)
   ("CORE protein" 2) ("mature or more truncated HCV core protein" 2)
   ("mature core protein" 2) ("The HCV core protein" 1)
   ("this major core protein" 1) ("soluble HCV core protein" 1)
   ("the viral core protein" 1) ("The viral core protein" 1)
   ("a mature HCV core protein" 1)
   ("the initial five amino acids of the core protein" 1)))
 ("UP:Q64LD2" (("WDR25" 1))) ("UP:Q65372" (("ORF8" 1)))
 ("UP:Q658P3" (("TSAP6" 4))) ("UP:Q65943" (("E1B 55K" 1)))
 ("UP:Q659A1" (("ICE2" 36))) ("UP:Q659C4" (("LARP2" 5)))
 ("UP:Q66GS9" (("pCEP4" 37) ("CEP4" 11) ("CEP135" 6)))
 ("UP:Q66K14" (("TBC1D9B" 4) ("KIAA0676" 1)))
 ("UP:Q66K74" (("MAP1S" 7) ("BPY2IP1" 2)))
 ("UP:Q66K79" (("CPZ" 180) ("the antipsychotic drug CPZ" 1)))
 ("UP:Q66K89" (("E4F1" 13) ("transcription factor E4F1" 5)))
 ("UP:Q66LE6" (("PPP2R2D" 1))) ("UP:Q66T02" (("SYX" 3) ("Syx" 2)))
 ("UP:Q674R7" (("ATG9B" 3) ("sone" 1)))
 ("UP:Q674X7" (("kazrin" 3) ("Kazrin" 1)))
 ("UP:Q676U5"
  (("ATG16L1" 265) ("Atg16L1" 6) ("Atg16l1" 3) ("Apg16L" 2) ("ATG16L" 2)))
 ("UP:Q67FY2" (("B9L" 27))) ("UP:Q67ZM4" (("AtADF7" 1)))
 ("UP:Q680Q4"
  (("Siz1" 242) ("targeted Siz1" 2) ("siz1" 1) ("the respective Siz1" 1)
   ("SIZ1" 1)))
 ("UP:Q682S0" (("Rpt2" 9) ("RPT2" 1) ("proteasomal subunit Rpt2" 1)))
 ("UP:Q684P5" (("Rap1GAP2" 1))) ("UP:Q687X5" (("STEAP4" 2)))
 ("UP:Q68CJ9" (("CREB-H" 77) ("the key CREB-H" 1) ("CREB3L3" 1)))
 ("UP:Q68CL5" (("TPGS2" 1))) ("UP:Q68CM3" (("TCS2" 2)))
 ("UP:Q68CP9" (("ARID2" 17) ("Baf200" 4) ("BAF200" 1)))
 ("UP:Q68CQ4" (("DEF" 99) ("def" 12) ("pDEF" 3))) ("UP:Q68CQ7" (("GLT8D1" 1)))
 ("UP:Q68CZ1"
  (("type 5" 55) ("NPHP8" 23) ("Nphp8" 4) ("Type 5" 3) ("RPGRIP1L" 3)
   ("adeno-associated virus type 5" 2)))
 ("UP:Q68CZ2"
  (("tensin-3" 166) ("TNS3" 147) ("tensin 3" 6) ("Tensin-3" 6) ("Tensin 3" 5)
   ("Tns3" 2) ("less TNS3" 1)))
 ("UP:Q68CZ6" (("IT1" 222)))
 ("UP:Q68DA7"
  (("LD" 4339) ("strong LD" 227) ("complete LD" 58) ("perfect LD" 41)
   ("weak LD" 27) ("the strong LD" 11) ("modest LD" 9) ("pair-wise LD" 8)
   ("Strong LD" 7) ("FMN" 6) ("very strong LD" 5) ("a strong LD" 5)
   ("incomplete LD" 5) ("FMN1" 4) ("approximate LD" 4) ("only weak LD" 4)
   ("dense LD" 4) ("absolute LD" 4) ("strong pair-wise LD" 4)
   ("less extensive LD" 3) ("the extensive LD" 3) ("Complete LD" 3)
   ("extensive LD" 3) ("much less LD" 2) ("very weak LD" 2) ("minimal LD" 2)
   ("adherent Tet-On HEK293T LD" 2) ("an associated LD" 2)
   ("a traditional LD" 2) ("Pair-wise LD" 2) ("the pair-wise LD" 2)
   ("strong and complete LD" 2) ("TS 3′-UTR loci showed mild LD" 2)
   ("moderately strong LD" 2) ("successful LD" 2) ("relatively strong LD" 2)
   ("smaller LD" 2) ("nearly absolute LD" 2) ("Subsequent LD" 2)
   ("overall weak LD" 2) ("strong linkage LD" 2) ("the new LD" 2)
   ("No non-synonymous SNPs showing strong LD" 2) ("regional LD" 2)
   ("more extensive LD" 2) ("all the studied SNPs exhibited strong LD" 2)
   ("homogenous LD" 1) ("any demonstrable LD" 1) ("largely absent LD" 1)
   ("moderate-high LD" 1) ("substantial LD" 1) ("residual LD" 1)
   ("the strong pairwise LD" 1) ("classical LD" 1) ("near-perfect LD" 1)
   ("2 =0 indicating absent LD" 1) ("2 =1 indicating complete LD" 1)
   ("a distinct LD" 1) ("the informative LD" 1) ("submaximal LD" 1)
   ("The only nonsynonymous SNPs showing strong LD" 1) ("The extensive LD" 1)
   ("almost complete LD" 1) ("the very strong LD" 1)
   ("than 1 Mb displays high LD" 1) ("a complete LD" 1)
   ("The SNPs demonstrated strong LD" 1) ("-LD" 1) ("the global LD" 1)
   ("strong or moderate LD" 1) ("than the LD 50" 1) ("The associated LD" 1)
   ("the broad LD" 1) ("appreciable LD" 1) ("Such differential LD" 1)
   ("very modest LD" 1) ("shorter LD" 1) ("this survey showed strong LD" 1)
   ("using pair-wise LD" 1) ("a 340 kb strong LD" 1) ("local LD" 1)
   ("three distinct LD" 1) ("any distinct LD" 1)
   ("adjacent SNPs displaying weak LD" 1) ("its complete LD" 1)
   ("an extensive LD" 1) ("a substantial LD" 1) ("the more extensive LD" 1)
   ("“strong” LD" 1)
   ("complete
LD"
    1)
   ("previously association LD" 1) ("more LD" 1) ("the regional LD" 1)
   ("their regional LD" 1) ("the family-based linkage given LD" 1)
   ("The linkage given LD" 1) ("composite LD" 1) ("rs461155 showed weak LD" 1)
   ("rs11254 showed weak LD" 1) ("only modest LD" 1)
   ("the 214kb TGCT-associated LD" 1)))
 ("UP:Q68DK2" (("SPASTIZIN" 7))) ("UP:Q68DK7" (("MSL1" 54)))
 ("UP:Q68DV7" (("RNF43" 158) ("RNF43 protein" 2)))
 ("UP:Q68E01" (("INTS3" 9) ("integrator complex subunit 3" 3) ("int 3" 2)))
 ("UP:Q68EM7" (("Rich1" 10) ("RICH1" 7))) ("UP:Q68G74" (("LHX8" 25)))
 ("UP:Q68G75" (("LEMD1" 5) ("LEM domain containing 1" 2)))
 ("UP:Q68J47" (("Rh1" 57) ("RH1" 1)))
 ("UP:Q68Y29"
  (("protein 4" 109) ("Protein 4" 12) ("bone morphogenic protein 4" 4)
   ("polyadenylate-binding protein 4" 2)
   ("the canonical transient receptor potential protein 4" 2)
   ("the neuroretinal morphogenesis effector delta-like protein 4" 2)
   ("Bone Morphogenetic Protein 4" 2)))
 ("UP:Q69022"
  (("EBNA2" 69) ("nuclear antigen-2" 2) ("the viral nuclear antigen EBNA2" 1)))
 ("UP:Q69138" (("EBNA3A" 22) ("EBNA-3A" 2)))
 ("UP:Q69140"
  (("EBNA3C" 1018) ("Epstein-Barr nuclear antigen 3C" 3)
   ("EBNA2 driven EBNA3C" 1) ("EBNA3C-" 1) ("the flag-tagged EBNA3C" 1)
   ("the essential EBV latent antigen EBNA3C" 1) ("-EBNA3C" 1)))
 ("UP:Q69383" (("Krev-" 1) ("Krev" 1))) ("UP:Q693B1" (("KCTD11" 1)))
 ("UP:Q69489" (("gp105" 4))) ("UP:Q69548" (("U13" 3)))
 ("UP:Q69549" (("U14" 5))) ("UP:Q69553" (("U18" 10)))
 ("UP:Q69554" (("U19" 174))) ("UP:Q69555" (("U20" 47)))
 ("UP:Q69556" (("U21" 1))) ("UP:Q69557" (("U22" 4))) ("UP:Q69558" (("U23" 5)))
 ("UP:Q69559" (("U24" 7))) ("UP:Q69560" (("U32" 1)))
 ("UP:Q69565"
  (("U87" 1718) ("U87-" 6) ("commercial U87" 1)
   ("the mock-transfected glioma U87" 1) ("-U87" 1)
   ("JUNB siRNA-treated U87" 1) ("hUCBSC-treated U87" 1) ("than U87" 1)))
 ("UP:Q69577" (("LT1" 96))) ("UP:Q695T7" (("SLC6A19" 4) ("Hartnup disease" 2)))
 ("UP:Q69R21" (("AO4" 4)))
 ("UP:Q69YH5" (("Repo-Man" 55) ("Repo-Man protein" 4)))
 ("UP:Q69YQ0" (("SPECC1L" 1))) ("UP:Q6A162" (("KRT40" 10) ("keratin 40" 2)))
 ("UP:Q6A1I3" (("LAN" 32))) ("UP:Q6A333" (("Aly2" 2)))
 ("UP:Q6AWC2"
  (("bomb" 58) ("Bomb" 13) ("“bomb”" 7) ("WW domain-containing protein 2" 4)
   ("a dirty bomb" 2) ("WWC2" 1) ("dirty bomb" 1)))
 ("UP:Q6AZY7"
  (("CSR" 413) ("SCARA3" 12) ("complete CSR" 4) ("optimal CSR" 4)
   ("defective CSR" 3) ("ongoing CSR" 3) ("efficient CSR" 3) ("intact CSR" 2)
   ("undergoes spontaneous CSR" 2) ("partially defective CSR" 2) ("Csr" 1)
   ("intact or normal CSR" 1) ("patient P3 underwent negligible CSR" 1)
   ("underwent high-rate CSR" 1) ("spontaneous CSR" 1) ("the defective CSR" 1)
   ("tamoxifen-treated Rosa  +/ER-Cre  Atm  C/KDN mice underwent CSR" 1)))
 ("UP:Q6B0I6"
  (("JMJD2D" 167) ("KDM4D" 15) ("Jmjd2D" 5) ("JMJD2D protein" 3)
   ("the N-terminal 354 amino acids of JMJD2D" 1)))
 ("UP:Q6B0K9" (("HBM" 28)))
 ("UP:Q6BCY4" (("CYB5R2" 7) ("cytochrome b5 reductase 2" 1)))
 ("UP:Q6D067" (("BRG" 4))) ("UP:Q6D0W9" (("Cas3" 3)))
 ("UP:Q6DE87" (("xChk1" 3))) ("UP:Q6DFF5" (("Sox9b" 2) ("sox9b" 2)))
 ("UP:Q6DGB6" (("SMH" 3))) ("UP:Q6DHR0" (("R-Spondin1" 11)))
 ("UP:Q6DI22" (("hydroxyacyl" 3)))
 ("UP:Q6DJT9" (("PLAG1" 12) ("adenoma gene 1" 1))) ("UP:Q6DKE1" (("CycT" 5)))
 ("UP:Q6DKJ4" (("NXN" 6) ("Nucleoredoxin" 3) ("nucleoredoxin" 1)))
 ("UP:Q6DN12" (("Mctp2" 1)))
 ("UP:Q6DN90"
  (("GEP100" 104) ("BRAG2" 7) ("IQSEC1" 3) ("overexpressed GEP100" 3)
   ("than 50% overexpressed GEP100" 1)))
 ("UP:Q6DRL4" (("Treslin" 202) ("TRESLIN" 1)))
 ("UP:Q6DT37"
  (("CDC42BPG" 6) ("CDC42 binding protein kinase gamma" 6) ("MRCKγ" 1)))
 ("UP:Q6E213"
  (("WS" 280) ("WS protein" 4) ("HWS" 2) ("a non-classic WS" 1)
   ("the principal WS" 1)))
 ("UP:Q6E2N3" (("MON" 19))) ("UP:Q6EBC2" (("IL-31" 7)))
 ("UP:Q6EEV6" (("SUMO4" 4)))
 ("UP:Q6EIG7" (("Dectin-2" 16) ("superfamily member 10" 7) ("Dectin-2-" 3)))
 ("UP:Q6EMB2" (("stamp" 33) ("STAMP" 4) ("A composite stamp" 2)))
 ("UP:Q6EVK6" (("chr2" 25) ("Chr2" 4)))
 ("UP:Q6F0E4"
  (("TILs" 292) ("autologous TILs" 5)
   ("regulatory intratumoral and stromal TILs" 2) ("FOXP3+ regulatory TILs" 1)
   ("FOXP3 + regulatory TILs" 1) ("Tim-3 + PD-1 + double-positive TILs" 1)
   ("absent and present TILs" 1)))
 ("UP:Q6F0I2" (("TDK" 7))) ("UP:Q6F0L7" (("rpoB" 3)))
 ("UP:Q6F145" (("thyA" 3))) ("UP:Q6F149" (("HSP7" 1)))
 ("UP:Q6F159" (("TIG" 6))) ("UP:Q6F1D3" (("NFO" 5)))
 ("UP:Q6F1N5" (("RNC" 64) ("SD + Oxy-treated RNC" 1)))
 ("UP:Q6F5E8"
  (("leucine-rich repeat" 101) ("RGD motif" 93) ("Leucine-rich repeat" 10)
   ("leucine rich repeats" 5) ("the intact RGD motif" 2)
   ("leucine-rich repeat protein" 2) ("Leucine-Rich repeat" 2)
   ("its prototypical RGD motif" 1)
   ("leucine-rich
repeat"
    1)
   ("its unique RGD motif" 1) ("leucine-rich repeat (LRR)" 1)
   ("leucine rich repeats (LRR)" 1)))
 ("UP:Q6F8H8" (("TPM" 18))) ("UP:Q6FCU0" (("AAH" 48) ("precancerous AAH" 1)))
 ("UP:Q6FCX7" (("DPs" 8))) ("UP:Q6FFG4" (("DinB" 3)))
 ("UP:Q6FH11" (("HMOX1 protein" 6)))
 ("UP:Q6FHJ7" (("SFRP4" 13) ("sFRP4" 3) ("Sfrp4" 1)))
 ("UP:Q6FI13" (("histone 2" 13) ("Histone 2" 6) ("HIST2H2AA3" 5)))
 ("UP:Q6FI27" (("GSK3B protein" 6))) ("UP:Q6FIF0" (("ZFAND6" 2)))
 ("UP:Q6FX11" (("sec2-41" 1)))
 ("UP:Q6GFB3"
  (("ChIPs" 166) ("CHIPs" 4) ("sequential ChIPs" 2) ("The resultant ChIPs" 1)))
 ("UP:Q6GPH4"
  (("XAF1" 22) ("XIAP-associated factor 1" 3) ("xaf1" 2)
   ("the proapoptotic XAF1" 2) ("the pro-apoptotic factors XAF1" 2) ("XAF-1" 1)
   ("Xaf1" 1)))
 ("UP:Q6GPI1" (("chymotrypsin" 89) ("CTRB2" 7) ("Chymotrypsin" 3)))
 ("UP:Q6GQQ9"
  (("Cezanne" 237) ("cezanne" 43) ("OTUD7B" 39) ("overexpressed Cezanne" 3)
   ("deubiquitylase Cezanne" 3) ("OTU deubiquitinase 7B" 2)
   ("the ovarian tumour protease (OTU) DUB Cezanne" 2)))
 ("UP:Q6GTX8" (("LAIR-1" 9) ("leukocyte-associated Ig-like receptor 1" 2)))
 ("UP:Q6GYQ0" (("Garnl1" 1)))
 ("UP:Q6H8Q1"
  (("ABLIM2" 17) ("actin binding LIM protein family member 2" 2)
   ("actin binding LIM protein family" 1)))
 ("UP:Q6HA08" (("BB94" 29)))
 ("UP:Q6I7C2" (("polymerase-3" 5) ("only poly(ADP-ribose) polymerase-3" 1)))
 ("UP:Q6IA17"
  (("Sigirr" 159) ("SIGIRR" 3) ("Sigirr peptide" 2)
   ("we first assessed Sigirr" 2) ("Sigirr protein" 1)))
 ("UP:Q6IA69" (("NADSYN1" 8)))
 ("UP:Q6IA86"
  (("STATIP1" 93) ("ELP2" 33) ("Elp2" 15) ("STAT3-interacting protein 1" 2)
   ("STATIP1 protein" 1) ("over-expressing STATIP1" 1)))
 ("UP:Q6IAA8" (("LAMTOR1" 33) ("pdro" 1) ("Pdro" 1) ("p27RF-Rho" 1)))
 ("UP:Q6IBS0" (("TWF2" 1))) ("UP:Q6ICB0" (("PPPDE2" 3)))
 ("UP:Q6IE81"
  (("Jade-1" 470) ("Jade-1 protein" 3) ("overexpressed Jade-1" 2) ("JADE1" 2)
   ("PHF17" 1) ("Jade-1-" 1)))
 ("UP:Q6IEG0" (("SNRNP48" 2))) ("UP:Q6IFT4" (("RA-RhoGAP" 9)))
 ("UP:Q6IN85" (("SMEK1" 3))) ("UP:Q6IPR1" (("LYRM5" 4)))
 ("UP:Q6IPU0" (("CENP-P" 8))) ("UP:Q6IQ20" (("NAPE-PLD" 1)))
 ("UP:Q6IQ22" (("Rab12" 8)))
 ("UP:Q6IQ23"
  (("PLEKHA7" 149) ("very weak PLEKHA7" 2) ("exogenous human PLEKHA7" 1)))
 ("UP:Q6IQ55"
  (("TTBK2" 15) ("spinocerebellar ataxia 11" 4) ("Tau tubulin kinase 2" 2)
   ("SCA11" 1) ("tau tubulin kinase 2" 1)))
 ("UP:Q6ISB3"
  (("GRHL2" 77) ("BoM" 11) ("exogenous GRHL2" 1)
   ("than GRHL2 which are necessary for hTERT expression" 1)))
 ("UP:Q6ISU1"
  (("TCR" 4933) ("pTa" 133) ("TCR-" 42) ("pTA" 27) ("Tcr" 16) ("TcR" 11)
   ("Ptcra" 4) ("strong TCR" 3) ("a functional TCR" 3) ("PTCRA" 2)
   ("Defective TCR" 2) ("a unique TCR" 2) ("a minimal TCR" 1)
   ("defective TCR" 1) ("proficient TCR" 1) ("differential TCR" 1)
   ("low-intermediate strength TCR" 1) ("the clonotypic HY TCR" 1) ("tCr" 1)
   ("than TCR" 1)))
 ("UP:Q6IVY4"
  (("SSH" 35) ("pSSH" 10) ("slingshot homolog" 2) ("SSH protein" 1)))
 ("UP:Q6IWH7"
  (("LNCaP" 7207) ("LNCap" 130) ("LnCaP" 85) ("ATCC" 36) ("-LNCaP" 21)
   ("LNCAP" 17) ("LNCaP-" 10) ("LnCap" 8) ("LNCaP (ATCC)" 6) ("than LNCaP" 5)
   ("LnCAP" 4) ("the parental LNCaP" 3) ("LNcap" 3) ("parental LNCaP" 2)
   ("TGF-α-treated LNCaP" 2) ("sarcosine treated LNCaP" 2)
   ("overexpressing SREBP-1 LNCaP" 2)
   ("rat urogenital mesenchyme or bone marrow fibroblasts promoted LNCaP" 1)
   ("5 μmol/l GWARJD10-treated LNCaP" 1) ("subcutaneous LNCaP" 1)
   ("fast-growing LNCaP" 1) ("Mitotic LNCaP" 1) ("AR-positive LNCaP" 1)
   ("–LNCaP" 1)
   ("the poorly aggressive human prostate carcinoma cell line LNCaP" 1)
   ("the isogenic cell lines LNCaP" 1) ("its parental line LNCaP" 1)
   ("AR-expressing LNCaP" 1) ("androgen-sensitive transformed LNCaP" 1)
   ("The parental androgen-dependent LNCaP" 1)
   ("the parental androgen-dependent LNCaP" 1)
   ("Exponentially growing LNCaP" 1)
   ("the androgen-depenedent prostate cancer cell line LNCaP" 1)
   ("prostate cancer cell lines C-81/long passage LNCaP" 1)
   ("relapsed LNCaP" 1) ("Appropriately treated LNCaP" 1)
   ("non-metastatic LNCaP" 1) ("both AR-positive LNCaP" 1) ("Parental LNCaP" 1)
   ("10 6 treated LNCaP" 1) ("p53-functional LNCaP" 1)))
 ("UP:Q6J201" (("JP" 52) ("jp" 2) ("pJP" 1) ("the SMAC mimetic JP1584" 1)))
 ("UP:Q6J9G0"
  (("NOK" 62) ("human primary NOK" 4) ("rapamycin-treated NOK" 4)
   ("primary NOK" 2) ("STYK1" 1) ("rapamycin-treated human primary NOK" 1)
   ("rapamycin treated NOK" 1)))
 ("UP:Q6JBY9" (("CapZ" 13) ("CapZIP" 1) ("RCSD1" 1)))
 ("UP:Q6JQN1" (("ACAD10" 2))) ("UP:Q6JVE5" (("LCN12" 1)))
 ("UP:Q6K0P9" (("PYHIN1" 6) ("IFIX" 1)))
 ("UP:Q6KAS7" (("Zfp521" 214) ("overexpressed Zfp521" 2)))
 ("UP:Q6KC79"
  (("CdLS" 150) ("NIPBL" 35) ("“CdLS”" 2) ("“classical” CdLS" 2)
   ("CdLS protein" 1)))
 ("UP:Q6KCM7" (("mCSCs" 4) ("MCSCs" 1))) ("UP:Q6MEA7" (("Ndk2" 1)))
 ("UP:Q6MZP7" (("LIN54" 6) ("mip120" 1)))
 ("UP:Q6MZQ0"
  (("PRR5L" 89) ("Q6MZQ0" 6) ("FLJ14213" 3) ("PROTOR2" 2) ("Protor 2" 2)))
 ("UP:Q6MZW2" (("FSTL4" 2)))
 ("UP:Q6MZZ7" (("calpain-13" 2) ("calpain 13" 1) ("CAPN13" 1)))
 ("UP:Q6N021"
  (("TET2" 220) ("Tet2" 7) ("methylcytosine dioxygenase TET2" 3)
   ("tet methylcytosine dioxygenase 2" 2) ("TET oncogene family member 2" 2)
   ("tet2" 2)))
 ("UP:Q6N022" (("ODZ4" 22))) ("UP:Q6N063" (("OGFOD2" 1)))
 ("UP:Q6NH63"
  (("ACN" 254) ("ACN-" 2) ("finally 1× 100 μl 100% ACN" 1) ("pure ACN" 1)
   ("ice-cold ACN" 1)))
 ("UP:Q6NM25" (("UTR-5" 7))) ("UP:Q6NMD6" (("argos" 8)))
 ("UP:Q6NS38" (("ABH2" 13) ("ABH2-" 2)))
 ("UP:Q6NSN2" (("monoamine oxidase" 18) ("Monoamine oxidase" 2)))
 ("UP:Q6NSW7" (("NANOGP8" 32) ("NanogP8" 21) ("Nanogp8" 2) ("Nanog P8" 1)))
 ("UP:Q6NSZ9" (("ZNF498" 1))) ("UP:Q6NT76" (("HMBOX1" 5)))
 ("UP:Q6NTS2" (("BafA" 75) ("bafA" 5)))
 ("UP:Q6NUI2" (("glycerol-3-phosphate acyltransferase 2" 4) ("GPAT2" 2)))
 ("UP:Q6NUK1" (("Apc1" 31))) ("UP:Q6NUK4" (("REEP3" 3)))
 ("UP:Q6NUN9" (("Paris" 208) ("PARIS" 27) ("Paris Protein" 1) ("paris" 1)))
 ("UP:Q6NUP7" (("KIAA1622" 3))) ("UP:Q6NV75" (("PGR1" 19) ("GPR153" 2)))
 ("UP:Q6NW40" (("RGMB" 6))) ("UP:Q6NWY9" (("PRPF40B" 1)))
 ("UP:Q6NXG1"
  (("ESRP1" 270) ("Rbm35a" 19) ("Esrp1" 14)
   ("Epithelial splicing regulatory protein 1" 4) ("Esrp1 protein" 3)
   ("epithelial splicing regulatory protein" 1)))
 ("UP:Q6NXR4" (("Tti2" 9) ("TTI2" 1))) ("UP:Q6NXT1" (("ANKRD54" 1)))
 ("UP:Q6NYC1"
  (("phosphatidylserine" 321) ("phosphatidylserine (PS)" 25)
   ("Phosphatidylserine" 20) ("JMJD6" 12) ("Phosphatidylserine (PS)" 1)
   ("phosphatidylserine receptor" 1)
   ("the anionic lipid phosphatidylserine (PS)" 1)
   ("the monovalent acidic phosphatidylserine" 1)))
 ("UP:Q6NZ36"
  (("core complex" 989) ("FAAP20" 290) ("FAAP20 protein" 4)
   ("a canonical heterotrimeric PP2A core complex" 2)
   ("a reconstituted tetrameric PRC2 core complex" 2)
   ("the entire core complex" 1) ("subsequent FA core complex" 1)
   ("core complex-" 1) ("than one core complex" 1)
   ("Chromosome 1 open reading frame 86" 1)))
 ("UP:Q6NZI2"
  (("cavin-1" 157) ("PTRF" 124) ("cavin 1" 108) ("Cavin-1" 13) ("Cavin 1" 9)
   ("cavin1" 5) ("polymerase I and transcript release factor" 4)
   ("cavin 1 molecule" 3) ("Transcript Release Factor" 3)
   ("Monomeric cavin 1" 2) ("Cavin1" 1) ("cellular cavin 1" 1)
   ("targeted cavin-1" 1)))
 ("UP:Q6NZY7" (("CEP5" 3))) ("UP:Q6P050" (("FBXL22" 2)))
 ("UP:Q6P0D0" (("QK" 10))) ("UP:Q6P0E7" (("AP-2ε" 1)))
 ("UP:Q6P0N0" (("M18BP1" 87) ("KNL2" 1)))
 ("UP:Q6P179"
  (("ERAP2" 50) ("ERAP2 protein" 3)
   ("endoplasmic reticulum aminopeptidase 2" 2)))
 ("UP:Q6P1A2" (("C3F" 7)))
 ("UP:Q6P1J6"
  (("Plb1" 34) ("PLB1" 17) ("cryptococcal PLB1" 6) ("plb1" 4)
   ("cryptococcal Plb1" 4) ("phospholipase B1" 4) ("Cryptococcal PLB1" 2)
   ("the cryptococcal Plb1" 1)))
 ("UP:Q6P1J9"
  (("HRPT2" 16) ("CDC73" 6) ("homolog (S. cerevisiae)" 1) ("FIHP" 1)))
 ("UP:Q6P1K1" (("SLC48A1" 6))) ("UP:Q6P1K2" (("PMF1" 5)))
 ("UP:Q6P1M0" (("SLC27A4" 1)))
 ("UP:Q6P1N0"
  (("CC2D1A" 83) ("Freud1" 3) ("Aki-1" 2) ("Freud-1" 2) ("Aki1" 2)
   ("FREUD1" 1)))
 ("UP:Q6P1Q0"
  (("HCCR-1" 153) ("Overexpressed HCCR-1" 2)
   ("the strong oncoprotein HCCR-1" 1) ("Letmd1" 1)))
 ("UP:Q6P1X5" (("150kD" 2) ("150kDa" 2) ("TAF-2" 2) ("150KD" 1)))
 ("UP:Q6P2D0" (("zinc finger protein 1" 1))) ("UP:Q6P2D8" (("Xrra1" 1)))
 ("UP:Q6P2E9" (("Edc4" 2))) ("UP:Q6P2P2" (("PRMT9" 2)))
 ("UP:Q6P2Q9" (("PRPF8" 4))) ("UP:Q6P2S7" (("GNN" 5)))
 ("UP:Q6P3S1" (("DENND1B" 51))) ("UP:Q6P3S6" (("JFK" 2)))
 ("UP:Q6P3U7"
  (("RXRα" 321) ("RXRα protein" 11) ("a strong cytoplasmic RXRα" 2)
   ("-RXRα protein" 2) ("-RXRα" 1)))
 ("UP:Q6P3W6" (("NBPF10" 1))) ("UP:Q6P3W7" (("CVAK104" 3)))
 ("UP:Q6P4F7" (("ARHGAP11A" 9) ("KIAA0013" 1))) ("UP:Q6P4R8" (("NFRKB" 1)))
 ("UP:Q6P597" (("KLC3" 5) ("Kinesin Light Chain 2" 2)))
 ("UP:Q6P5W5" (("ZIP4" 114) ("SLC39A4" 1))) ("UP:Q6P5X7" (("Tmem71" 1)))
 ("UP:Q6P5Z2" (("PKN3" 3))) ("UP:Q6P7N7" (("TMEM81" 2)))
 ("UP:Q6P7W2" (("SB1" 12))) ("UP:Q6P8Z1" (("B-Myc" 1)))
 ("UP:Q6P988" (("NOTUM" 5) ("Notum" 2)))
 ("UP:Q6P9A2" (("Galntl4" 8) ("GALNTL4" 5))) ("UP:Q6P9F5" (("TRIM40" 2)))
 ("UP:Q6P9H4" (("CNK3" 3))) ("UP:Q6P9H5" (("IAN6" 4) ("gimap6" 2)))
 ("UP:Q6PCB5" (("RSBN1L" 1))) ("UP:Q6PCB7" (("SLC27A1" 4)))
 ("UP:Q6PCB8" (("EMB" 13))) ("UP:Q6PCD5" (("RFWD3" 12)))
 ("UP:Q6PCT2" (("FBXL19" 108))) ("UP:Q6PD62" (("CTR9" 12)))
 ("UP:Q6PEY0" (("beta 7" 22) ("25kDa" 9) ("approximately 25kDa" 2)))
 ("UP:Q6PEY1" (("TMEM88" 3)))
 ("UP:Q6PF39"
  (("AML" 6754) ("secondary AML" 26) ("primary AML" 22) ("pediatric AML" 12)
   ("relapsed AML" 9) ("cytogenetically normal AML" 7) ("-AML" 6)
   ("FLT3-ITD-associated AML" 6) ("relapsed or refractory AML" 6)
   ("therapy-related AML" 5) ("TSC-associated AML" 3) ("diagnostic AML" 3)
   ("Primary AML" 3) ("MLL-AF9-positive AML" 3) ("aggressive AML" 3)
   ("most AML" 3) ("withStat5 −/− leukemic cells developed AML" 3)
   ("cytogenetically normal (CN)-AML" 2) ("than FLT3 WT AML" 2) ("than AML" 2)
   ("Karyotypically Normal AML" 2) ("FLT3 mutational AML" 2)
   ("256 cytogenetically normal (CN-) AML" 2)
   ("advanced therapy-refractive AML" 2) ("renal AML" 2)
   ("either primary or secondary AML" 2) ("Core-Binding Factor (CBF) AML" 2)
   ("pI-pC-treated Cre + (∆/∆) donor cells developed AML" 2)
   ("MLL-AF9-induced AML" 2) ("relapsed FLT3-mutated AML" 2)
   ("a secondary AML" 2) ("overt AML" 2) ("concurrent AML" 2)
   ("miR-150+ MLL-AF9 leukemic cells developed AML" 2)
   ("MOZ-TIF2–induced AML" 2) ("responding AML" 2)
   ("healthy BMMb and FLT3 ITD AML" 2) ("healthy BM and FLT3 ITD AML" 2)
   ("an aggressive CD56 + AML" 2) ("aggressive disseminated AML" 2)
   ("an aggressive CD56 + monoblastic AML" 2)
   ("relapsed or refractory FLT3 mutated AML" 2) ("MLL-associated AML" 1)
   ("the AE9a-transduced IGFBP2 -null cells developed AML" 1)
   ("the secondary transplantable AML" 1) ("normal-karyotype secondary AML" 1)
   ("3 primary AML" 1) ("data available describing AML" 1)
   ("Cytogenetically normal (CN) AML" 1) ("newly-diagnosed AML" 1)
   ("relapsed or refractory FLT3-ITD AML" 1) ("FLT3-associated AML" 1)
   ("an otherwise prognostically favorable AML1/ETO- positive AML" 1)
   ("the non-APL AML" 1) ("the respective AML" 1) ("22 primary AML" 1)
   ("FLT-ITD driven AML" 1) ("FLT3-ITD driven AML" 1) ("FLT3-driven AML" 1)
   ("than ITD+ AML ( xref E)" 1) ("karyotypically normal (KN) AML" 1)
   ("cytogenetically normal (CN-) AML" 1) ("the BALB/c mice developed AML" 1)
   ("acute myeloid leukemia AML" 1) ("Only PAX2 mRNA expressing AML" 1)
   ("FLT3/ITD-positive AML" 1) ("all new AML" 1) ("27 developed AML" 1)
   ("the patient developed AML" 1) ("primary and secondary AML" 1)
   ("human primary AML" 1) ("88 evaluable BMMC AML" 1)
   ("clinically annotated diagnostic AML" 1) ("71 pediatric AML" 1)
   ("Sequence-based analysis identified 2 AML" 1)
   ("Thirty four diagnostic non-M3 AML" 1)
   ("nine PML-RARα + MYC animals developed AML" 1) ("than FLT3-ITD AML" 1)
   ("Acute Myeloid Leukemia 1" 1) ("newly-diagnosed de novo AML" 1)
   ("Pediatric AML" 1) ("four primary AML" 1) ("all the 3 primary AML" 1)
   ("relapsed FLT3-ITD-positive AML" 1) ("Secondary AML" 1)
   ("secondary (s) AML" 1) ("436 primary AML" 1) ("than renal AML" 1)
   ("fat-poor AML" 1) ("Renal AML" 1) ("Typical AML" 1) ("–AML" 1)
   ("Flt3ITD-driven AML" 1) ("Myc-driven AML" 1) ("MYC-driven AML" 1)
   ("HGF-expressing primary AML" 1) ("renal malignant AML" 1)
   ("The typical AML" 1) ("AML (EAML)" 1) ("typical renal AML" 1)
   ("MT2-driven AML" 1)
   ("MOZ-TIF2–transduced hematopoietic progenitors developed monoclonal or oligoclonal AML"
    1)
   ("eitherStat5 −/− orStat5 +/+ cells developed AML" 1)
   ("solely MOZ-TIF2–driven AML" 1) ("adult and pediatric AML" 1)
   ("an aggressive AML" 1) ("extramedullary AML" 1) ("aggressive CD56 + AML" 1)
   ("syngeneic MLL-AF9 AML" 1) ("three different primary AML" 1)
   ("Cryopreserved primary AML" 1)
   ("relapsed or refractory FLT3 -mutated AML" 1)))
 ("UP:Q6PFM0" (("PSR" 14)))
 ("UP:Q6PFW1"
  (("IP6K" 14) ("IP6 kinase" 3) ("IPS1" 3) ("the only yeast IP6 kinase" 1)))
 ("UP:Q6PGN9" (("PSRC1" 9) ("DDA3" 1)))
 ("UP:Q6PGP7" (("theS" 2) ("TheS" 1) ("SKI3" 1)))
 ("UP:Q6PGQ7"
  (("Bora" 334) ("Bora protein" 24) ("FLJ22624" 3) ("bora" 2)
   ("nondegradable Bora" 2) ("BORA" 1) ("Boras" 1)))
 ("UP:Q6PH81" (("C16orf87" 7))) ("UP:Q6PH85" (("DCUN1D2" 4)))
 ("UP:Q6PHR2" (("ULK3" 36) ("Ulk3" 6) ("exogenous ULK3" 2)))
 ("UP:Q6PI98" (("hIes6" 4) ("Ies6" 2) ("INO80C" 2)))
 ("UP:Q6PID8" (("KLHDC10" 4) ("kelch domain containing 10" 2)))
 ("UP:Q6PIL6" (("KCNIP4" 2) ("Kv channel interacting protein 4" 2)))
 ("UP:Q6PIU2" (("NCEH1" 5) ("Neutral cholesterol ester hydrolase 1" 3)))
 ("UP:Q6PIY7" (("Gld2" 59) ("ectopically-expressed Gld2" 2)))
 ("UP:Q6PIZ9"
  (("TRIM" 264) ("TRIM protein" 14) ("TRIM  molecule" 4) ("pp29/30" 2)))
 ("UP:Q6PJ61" (("Fbxo46" 17)))
 ("UP:Q6PJG6" (("FL" 68) ("BRAT1" 65) ("BRAT1 (FL)" 1) ("BAAT1" 1)))
 ("UP:Q6PJI9" (("WDR59" 3)))
 ("UP:Q6PJP8"
  (("SNM1A" 12) ("SNM1" 7) ("hSNM1" 5) ("hSNM1A" 2) ("KIAA0086" 1) ("PSO2" 1)
   ("DCLRE1A" 1) ("Snm1" 1)))
 ("UP:Q6PKG0"
  (("LARP1" 174) ("La-related protein 1" 3)
   ("La ribonucleoprotein domain family member 1" 3) ("LARP1 protein" 2)
   ("LARP family" 2) ("Q6PKG0" 1)))
 ("UP:Q6PL18" (("ATAD2" 37) ("ANCCA" 3))) ("UP:Q6PQQ4" (("BBM" 1)))
 ("UP:Q6PV68" (("SMZ" 6) ("a Stereotopic Microscope SMZ" 1)))
 ("UP:Q6Q0C0" (("TRAF7" 45) ("TNF receptor-associated factor 7" 6)))
 ("UP:Q6Q4D0" (("BRU1" 7) ("bru1" 2))) ("UP:Q6Q4G3" (("LVRN" 3)))
 ("UP:Q6Q759" (("SPAG17" 3))) ("UP:Q6Q788" (("APOA5" 21)))
 ("UP:Q6QHC5" (("DEGS2" 9)))
 ("UP:Q6QHF9" (("PAO" 61) ("Pao" 26) ("PaO" 14) ("pAo" 1)))
 ("UP:Q6QHK0" (("CHI" 21) ("Chi" 6) ("chi" 6))) ("UP:Q6QIA5" (("gp44" 1)))
 ("UP:Q6QLQ5" (("CATH" 2)))
 ("UP:Q6QNF4"
  (("HGFA" 5) ("hepatocyte growth factor activator" 3)
   ("Hepatocyte growth factor activator" 1)))
 ("UP:Q6QNY1" (("centrosome-associated protein" 15)))
 ("UP:Q6R325"
  (("VPg" 95) ("P1B" 9) ("P3C" 6) ("VPg protein" 2) ("protein 2A" 1)))
 ("UP:Q6R327"
  (("Rictor" 1233) ("rictor" 547) ("RICTOR" 323)
   ("rapamycin-insensitive companion of mTOR" 29) ("RICTOR-mTOR" 20)
   ("Rictor protein" 11) ("rictor protein" 3)
   ("rapamycin-insensitive companion of mTOR (RICTOR)" 2)
   ("Rapamycin-insensitive companion of mTOR" 2) ("−Rictor" 2)
   ("miR-491-3p directly targets Rictor" 2) ("Rictor-" 2)
   ("mTOR-associated Rictor" 2) ("the mTORC2-associated subunit rictor" 1)
   ("more precisely RICTOR" 1) ("6 times more RICTOR" 1) ("AVO3" 1)
   ("rictor-" 1) ("the mTORC2-associated protein rictor" 1) ("mAVO3" 1)))
 ("UP:Q6R4B4"
  (("glutathione-S-transferase" 89) ("Glutathione-S-transferase" 20)
   ("glutathione-S-transferase (GST)" 17) ("glutathione-S-transferase-" 3)
   ("Glutathione-S-transferases" 2) ("glutathione-S-transferase protein" 2)
   ("Bacterial glutathione-S-transferase (GST)" 1)))
 ("UP:Q6R4R6" (("CALD" 2))) ("UP:Q6R4R8" (("CalB" 3) ("CaLB" 1)))
 ("UP:Q6R4R9" (("calA" 10) ("CalA" 1)))
 ("UP:Q6R5J2"
  (("CON" 247) ("con" 147) ("Con" 128) ("CoN" 8) ("1-Con" 3) ("-Con" 1)
   ("Con-" 1)))
 ("UP:Q6R8J2" (("HEG" 47))) ("UP:Q6RFH5" (("WDR74" 9)))
 ("UP:Q6RSH7"
  (("VLPs" 128) ("VLP" 74) ("We first produced VSV-G pseudotyped HIV-1 VLP" 2)
   ("a few VLPs" 2) ("fluorescent VLPs" 1)
   ("the VSV-G pseudotyped noninfectious VLPs" 1)
   ("iodixinal gradient-purified GagPol VLPs" 1)))
 ("UP:Q6RVD6" (("SPATA8" 1))) ("UP:Q6RW13" (("AGTRAP" 2)))
 ("UP:Q6RYW5" (("OmpA" 19) ("OmpA−" 5))) ("UP:Q6S000" (("kinesin-6" 6)))
 ("UP:Q6S003" (("kinesin-4" 2)))
 ("UP:Q6S004" (("kinesin-13" 49) ("Kinesin-13" 5))) ("UP:Q6S591" (("JAG" 26)))
 ("UP:Q6S592" (("NuB" 6) ("nubbin" 1)))
 ("UP:Q6S5L8" (("shCD" 7) ("SHC4" 3) ("RALP" 1))) ("UP:Q6SJ96" (("TRF3" 9)))
 ("UP:Q6STE5"
  (("BAF60c" 131) ("BAF60C" 16) ("Baf60c" 8) ("BAF60c protein" 6)
   ("SMARCD3" 3)))
 ("UP:Q6SZW1"
  (("SARM1" 112) ("SARM" 5) ("pSARM" 4) ("1–12 amino acids of SARM1" 1)
   ("SAMD2" 1) ("Samd2" 1)))
 ("UP:Q6T1F6" (("BMT" 63) ("performed secondary BMT" 1) ("allogeneic BMT" 1)))
 ("UP:Q6T1X6" (("RMD" 1))) ("UP:Q6T4P5" (("LPPR3" 2) ("PRG2" 1)))
 ("UP:Q6T4R5" (("NHS" 779) ("NHs" 16)))
 ("UP:Q6T7B7"
  (("CTLs" 145) ("tumor-reactive CTLs" 2) ("tumour-reactive CTLs" 1)))
 ("UP:Q6T8E9"
  (("cyclinT1" 37) ("CyclinT1" 17)
   ("the phosphomimetic mutant cyclinT1 S564D" 1) ("—cyclinT1" 1)))
 ("UP:Q6TCH7" (("RKTG" 2) ("Raf kinase trapping to Golgi" 1)))
 ("UP:Q6TDP4" (("KLHL17" 2))) ("UP:Q6TDU7" (("CASC1" 4)))
 ("UP:Q6TEM9" (("MIRA" 12) ("Mira" 10) ("Misra" 4) ("MiRa" 1)))
 ("UP:Q6TFL4" (("DRE-1" 4) ("the neuronal protein KRIP6" 2) ("KRIP6" 2)))
 ("UP:Q6TGC4" (("PADI6" 2))) ("UP:Q6U736" (("neuropsin" 1)))
 ("UP:Q6U841" (("solute carrier family 4" 4)))
 ("UP:Q6U949" (("IGF-2" 80) ("igf-2" 1))) ("UP:Q6UB35" (("MTHFD1L" 3)))
 ("UP:Q6UB99" (("ANKRD11" 1))) ("UP:Q6UK63" (("pIRA" 10)))
 ("UP:Q6ULP2" (("aftiphilin" 6)))
 ("UP:Q6UN15"
  (("FIP1L1" 25) ("RHE" 9) ("FIP1" 6) ("FIP1L1-" 5)
   ("three-dimensional RHE" 1)))
 ("UP:Q6UUV7"
  (("transducers" 409) ("Transducers" 22) ("proximal transducers" 4)
   ("“transducers”" 3) ("bidirectional transducers" 2) ("distal transducers" 2)
   ("the distal transducers" 1) ("distal (i.e., Chk1/Chk2) “transducers”" 1)
   ("transcriptional transducers" 1)))
 ("UP:Q6UUV9"
  (("TORC1" 496) ("CRTC1" 82) ("CREB regulated transcription coactivator 1" 2)
   ("TORC-1" 2) ("MECT1" 2) ("miR-21-stimulated TORC1" 1)
   ("miR-21-activated TORC1" 1) ("CRTC1-" 1)))
 ("UP:Q6UVJ0" (("SAS6" 13) ("SASS6" 2) ("Sas6" 1)))
 ("UP:Q6UVK1"
  (("HMW-MAA" 7) ("CSPG4" 6)
   ("melanoma-associated chondroitin sulfate proteoglycan" 3)
   ("chondroitin sulfate proteoglycan 4" 3)
   ("chondroitin sulfate proteoglycan NG2" 3) ("Cspg4" 2)
   ("Melanoma chondroitin sulfate proteoglycan" 2) ("cspg4" 1)
   ("Chondroitin sulfate proteoglycan 4" 1)))
 ("UP:Q6UVM3" (("SLICK" 6))) ("UP:Q6UVW9" (("pilar" 3)))
 ("UP:Q6UVY6" (("Mox" 4) ("MOX" 3) ("mox" 3))) ("UP:Q6UW10" (("SPG" 18)))
 ("UP:Q6UW15" (("RegIIIγ" 1)))
 ("UP:Q6UW49"
  (("ESP" 169) ("esp" 12) ("the 1,10-PT-pretreated T. vaginalis ESP" 3)
   ("Esp" 2) ("than T. vaginalis ESP" 1)
   ("an aggressive breast cancer phenotype esp" 1)))
 ("UP:Q6UW60" (("PCSK4" 1))) ("UP:Q6UW68" (("TMEM205" 4)))
 ("UP:Q6UW88"
  (("epigen" 37) ("Epgn" 28) ("EPGN" 22) ("Epigen" 4) ("EpiGen" 2)
   ("epithelial mitogen" 1) ("EPG" 1)))
 ("UP:Q6UWB1"
  (("WSX-1" 14) ("IL-27R" 2) ("IL-27RA" 1) ("IL27Ra" 1) ("TCCR" 1)))
 ("UP:Q6UWE0" (("TSG101-associated ligase" 1)))
 ("UP:Q6UWL6"
  (("Neph3" 183) ("filtrin" 3) ("longest construct Neph3" 2) ("than Neph3" 1)
   ("KIRREL2" 1) ("Neph3 protein" 1)))
 ("UP:Q6UWP8" (("suprabasin" 5)))
 ("UP:Q6UWZ7"
  (("ABRA1" 28) ("CCDC98" 18) ("FAM175A" 12) ("ABRAXAS" 2)
   ("Abraxas protein" 1)))
 ("UP:Q6UX04" (("CWC27" 4)))
 ("UP:Q6UX06"
  (("OLFM4" 161) ("Olfactomedin 4" 19) ("Olfm4" 14) ("GW112" 2) ("olfm4" 1)))
 ("UP:Q6UX15" (("LAYN" 2) ("Layilin" 2) ("layilin" 1)))
 ("UP:Q6UX27"
  (("leukocytes" 1561) ("peripheral leukocytes" 36) ("Leukocytes" 34)
   ("polymorphonuclear leukocytes" 15) ("leukocytes (PBL)" 7)
   ("phagocytic leukocytes" 6) ("peritoneal leukocytes" 4)
   ("the peripheral leukocytes" 3) ("around attached leukocytes" 2)
   ("human primary leukocytes" 2) ("Peripheral Blood Leukocytes" 2)
   ("immunomodulatory leukocytes" 2) ("accessory non-malignant leukocytes" 2)
   ("circulating Mac1-negative leukocytes" 2)
   ("IL-22 expressing innate leukocytes" 2) ("mononuclear leukocytes" 2)
   ("peripheral vein blood leukocytes" 2)
   ("polymorphonuclear (PMN) leukocytes" 2)
   ("primary lesions contained significantly more leukocytes" 2)
   ("further activates/attracts other pro-inflammatory leukocytes" 2)
   ("some polymorphonuclear leukocytes" 2)
   ("around some adherent leukocytes" 2) ("around adherent leukocytes" 2)
   ("CalDAG-GEFI–null leukocytes" 2) ("clustered around adherent leukocytes" 1)
   ("tumor-associated leukocytes" 1) ("cryopreserved peritoneal leukocytes" 1)
   ("hepatitis B-seronegative donor leukocytes" 1)
   ("Human neutrophil polymorphonuclear leukocytes" 1) ("mucosal leukocytes" 1)
   ("More leukocytes" 1) ("few leukocytes" 1) ("inflammatory leukocytes" 1)
   ("extravasating inflammatory leukocytes" 1) ("fewer CD45 + leukocytes" 1)
   ("particular leukocytes" 1) ("the predominant airway leukocytes" 1)
   ("most leukocytes" 1) ("Most adherent leukocytes" 1)
   ("nonleukemic leukocytes" 1) ("peculiar leukocytes" 1)
   ("intact leukocytes" 1) ("isolated polymorphonuclear leukocytes" 1)
   ("chemokine receptor-expressing leukocytes" 1)
   ("NOX2 oxidase-expressing leukocytes" 1) ("Phagocytic leukocytes" 1)
   ("the normal leukocytes" 1) ("Normal leukocytes" 1)
   ("the transformed leukocytes" 1) ("mature leukocytes" 1)
   ("pro-inflammatory leukocytes" 1) ("the intact leukocytes" 1)
   ("ascitic leukocytes" 1) ("than leukocytes ( xref )" 1)
   ("resident leukocytes" 1)))
 ("UP:Q6UX46" (("FAM150B" 1))) ("UP:Q6UX53" (("METTL7B" 7)))
 ("UP:Q6UX71" (("PLXDC2" 1))) ("UP:Q6UX72" (("B3GNT9" 2)))
 ("UP:Q6UXB2" (("DMC" 9) ("CXCL17" 6)))
 ("UP:Q6UXD5" (("Sez6l2" 6) ("pSK" 3) ("psk" 3)))
 ("UP:Q6UXG2" (("EIG121" 25) ("KIAA1324" 1) ("EIG121 protein" 1)))
 ("UP:Q6UXH0" (("betatrophin" 1))) ("UP:Q6UXH9" (("ramp" 68) ("Ramp" 1)))
 ("UP:Q6UXI7" (("Vit" 60) ("vit" 14) ("VIT" 4))) ("UP:Q6UXI9" (("NPNT" 4)))
 ("UP:Q6UXL0" (("IL-20Rβ" 4) ("IL-20R2" 1)))
 ("UP:Q6UXM1" (("LRIG3" 6) ("LRIG3-" 1))) ("UP:Q6UXN8" (("Clec9a" 4)))
 ("UP:Q6UXN9" (("WDR82" 7) ("Wdr82" 3)))
 ("UP:Q6UXS9" (("CASP12" 22) ("Casp12" 5) ("uterine CASP12" 1)))
 ("UP:Q6UXT8" (("FAM150A" 1))) ("UP:Q6UXX9" (("Rspo2" 1)))
 ("UP:Q6UXY1" (("BAIAP2L2" 1))) ("UP:Q6UXY8" (("TMC5" 5)))
 ("UP:Q6UXZ4" (("UNC5D" 3) ("UNC5H4" 1))) ("UP:Q6UY11" (("DLK2" 1)))
 ("UP:Q6UYE1" (("DLEU7" 23))) ("UP:Q6V0I7" (("FAT4" 30) ("Fat4" 24)))
 ("UP:Q6V0L0" (("CYP26C1" 11) ("Cyp26c1" 5) ("subfamily C" 4)))
 ("UP:Q6V1X1" (("DPP8" 1)))
 ("UP:Q6VAB6"
  (("KSR-2" 6) ("Kinase suppressor of Ras 2" 2)
   ("kinase suppressor of Ras 2" 2) ("kinase suppressor of ras 2" 2)
   ("hKSR2" 1)))
 ("UP:Q6VMQ6"
  (("Ham" 422) ("HAM" 143) ("Hams" 26) ("p621" 21) ("ATF7IP" 15)
   ("F-12 HAM'S" 5) ("ham" 4) ("50% Ham’s" 3) ("DMEM Ham's" 3)
   ("serum-free Ham’s" 3) ("F12 Ham’s" 2) ("HAMS" 2) ("DMEM-Ham’s" 2)
   ("DMEM/F-12 Ham's" 2) ("modified Ham's" 1) ("50% DMEM/50% Ham's" 1)
   ("the latter containing DMEM Ham’s" 1) ("the latter containing DMEM Ham" 1)
   ("Modified Eagle Medium/ Ham’s" 1) ("1 ml Ham’s" 1)
   ("45% RPMI 1640/45% Ham's" 1) ("serum-free DMEM-Ham's" 1) ("50% Ham's" 1)
   ("F-12 Ham's" 1) ("F-12 HAM’s" 1) ("-Ham" 1) ("3:1 (v/v) Ham's" 1)
   ("80% DMEM-20% Ham's" 1) ("antibiotic-free Ham's" 1)
   ("than HAM (approximately 63% LSC, 34% TAC, <5% TDC; xref )" 1)
   ("a cellular HAM" 1) ("medium-Ham’s" 1) ("Nutrient F-12 Ham’s" 1)
   ("medium-Ham's" 1) ("DMEM-F12 Ham’s" 1) ("ice-cold Ham's" 1)
   ("ice-cold Ham" 1) ("serum-free Ham's" 1) ("Nutrient Mixture Ham’s" 1)
   ("MCAF1" 1) ("D-MEM + Ham's" 1) ("DMEM/F12 Ham's" 1) ("1:1 F12 Ham’s" 1)
   ("20% Ham's" 1)))
 ("UP:Q6VN20" (("RanBP10" 7))) ("UP:Q6VUC0" (("TFAP2E" 1)))
 ("UP:Q6VVB1" (("malin" 158) ("Malin" 9) ("EPM2B" 7) ("NHLRC1" 2)))
 ("UP:Q6VVX0" (("CYP2R1" 7) ("subfamily R" 3) ("cyp2R1" 1) ("Cyp2R1" 1)))
 ("UP:Q6VY07" (("PACS-1" 43) ("PACS1" 7) ("phosphofurin" 5)))
 ("UP:Q6W0C5" (("STELLAR" 2) ("stellar" 1) ("Stellar" 1)))
 ("UP:Q6W2J9" (("BCOR" 20) ("BCoR" 4) ("BcoR" 3) ("BcoR-" 1)))
 ("UP:Q6W3E5" (("GDPD4" 3)))
 ("UP:Q6W4X9" (("MUC6" 9) ("Muc6" 7) ("mucin 6" 2)))
 ("UP:Q6W5P4" (("GPR154" 3) ("NPSR1" 1)))
 ("UP:Q6W8W5"
  (("RM" 239) ("1-B" 41) ("the normoxic RM" 1) ("“RM”" 1) ("1–B" 1)
   ("Indian RM" 1)))
 ("UP:Q6WCQ1"
  (("RIP3" 523) ("RIP3 protein" 34) ("MP-RIP" 15) ("Rip3" 8) ("MPRIP" 5)
   ("MRIP" 3) ("M-RIP" 2) ("kinase-defective RIP3" 1)
   ("Commercially available human RIP3 protein" 1) ("−RIP3" 1)
   ("myosin phosphatase Rho interacting protein (MPRIP)" 1)
   ("myosin phosphatase Rho interacting protein" 1)))
 ("UP:Q6WG24" (("IL-4Rα" 15) ("IL4Rα" 1) ("IL-4Ralpha" 1)))
 ("UP:Q6WKZ4"
  (("RAB11FIP1" 16) ("Rab coupling protein" 2)
   ("RAB11 family interacting protein 1" 2)))
 ("UP:Q6WWW4" (("KAK" 5))) ("UP:Q6WY08" (("AAL" 6)))
 ("UP:Q6X4U4" (("SOSTDC1" 2))) ("UP:Q6X4W1" (("NELF" 76)))
 ("UP:Q6X7K1" (("WOX2" 2))) ("UP:Q6XE38" (("IIS" 71) ("IIs" 42) ("iis" 1)))
 ("UP:Q6XPR3" (("RPTN" 4) ("repetin" 2))) ("UP:Q6XPS3" (("TPIP" 2)))
 ("UP:Q6XR72" (("SLC30A10" 5))) ("UP:Q6Y7W6" (("GIGYF2" 1)))
 ("UP:Q6YBV0" (("SLC36A4" 7) ("PAT4" 2)))
 ("UP:Q6YBV1"
  (("ROA" 13) ("unilateral ROA" 4) ("bilateral knee ROA" 2)
   ("bilateral ROA" 1)))
 ("UP:Q6YHK3" (("CD109" 2))) ("UP:Q6YHU6" (("THADA" 26)))
 ("UP:Q6YNI5"
  (("NTD" 1084) ("NTD peptide" 11) ("NTD protein" 4) ("the intact NTD" 3)
   ("intact NTD" 3) ("the NTD's" 1) ("the entire NTD" 1)
   ("than p53 NTD ( K  d = 250 μM)" 1) ("crude his-PR-B NTD" 1)
   ("a fluorescent linear Ub-CyclinB NTD" 1)
   ("whose disruption causes NTD" 1)))
 ("UP:Q6YP21" (("KAT3" 7)))
 ("UP:Q6YZE2" (("GSA" 130) ("model-based GSA" 2) ("“GSA”" 1)))
 ("UP:Q6ZMB0" (("core 3 synthase" 3)))
 ("UP:Q6ZMG9" (("CerS6" 21) ("Cers6" 2) ("ceramide synthase 6" 2)))
 ("UP:Q6ZMJ2" (("SCARA5" 7))) ("UP:Q6ZMJ4" (("IL-34" 1)))
 ("UP:Q6ZMP0" (("THSD4" 28)))
 ("UP:Q6ZMQ8" (("AATK" 19) ("p35 binding protein" 4) ("AATYK" 2)))
 ("UP:Q6ZMR5"
  (("ECRG1" 85) ("TMPRSS11A" 7) ("transmembrane protease, serine 11A" 2)
   ("HESP" 1) ("ECRG1 protein" 1)))
 ("UP:Q6ZMT4" (("JHDM1D" 2) ("KDM7A" 2))) ("UP:Q6ZMV7" (("LEKR1" 5)))
 ("UP:Q6ZMV9" (("KIF6" 3))) ("UP:Q6ZMZ0" (("Rnf19b" 1)))
 ("UP:Q6ZN04" (("MEX3B" 1)))
 ("UP:Q6ZN17"
  (("LIN28B" 104) ("Lin28B" 28) ("Lin-28B" 9) ("Lin28b" 9)
   ("lin-28 homolog B" 2)))
 ("UP:Q6ZN18" (("AEBP2" 3))) ("UP:Q6ZN28" (("MACC1" 123)))
 ("UP:Q6ZN44"
  (("UNC5A" 139) ("UNC5A protein" 9) ("FANCC negatively impacts UNC5A's" 1)
   ("FANCC negatively impacts UNC5A" 1)
   ("the pro-apoptotic dependence receptor UNC5A" 1) ("UNC5H1" 1)))
 ("UP:Q6ZNA4"
  (("Arkadia" 362) ("RNF111" 8) ("Arkadia protein" 8)
   ("ring finger protein 111" 1) ("Rnf111" 1) ("exogenous Arkadia" 1)))
 ("UP:Q6ZNC4" (("ZNF704" 2))) ("UP:Q6ZNC8" (("Oact1" 3)))
 ("UP:Q6ZNE5"
  (("Atg14L" 128) ("ATG14" 27) ("ATG14L" 26) ("Atg14" 8)
   ("markedly less Atg14L" 1) ("Barkor" 1) ("BARKOR" 1) ("KIAA0831" 1)))
 ("UP:Q6ZNE9" (("RUFY4" 2))) ("UP:Q6ZQN5" (("FOXi2" 3)))
 ("UP:Q6ZQY3"
  (("ADC" 673) ("Adc" 8) ("oesophageal ADC" 6) ("poorly-differentiated ADC" 5)
   ("mucinous ADC" 2) ("invasive ADC" 2) ("than Adc" 2) ("Mucinous ADC" 1)
   ("than ADC" 1) ("Caucasian NSCLC ADC" 1) ("Caucasian ADC" 1)
   ("Invasive ADC" 1) ("radiologic ‘invasive’ ADC" 1)
   ("pathologically proven lung ADC" 1) ("Oesophageal ADC" 1) ("solid ADC" 1)
   ("“ADC”" 1) ("metastasized ADC" 1)))
 ("UP:Q6ZRQ5" (("MMS22L" 129) ("C6ORF167" 9) ("targeting MMS22L" 1)))
 ("UP:Q6ZRR9" (("DCDC5" 7)))
 ("UP:Q6ZRS2" (("SRCAP" 162) ("the entire SRCAP" 2) ("SRCAP protein" 2)))
 ("UP:Q6ZS10" (("CLEC17A" 3) ("prolectin" 2))) ("UP:Q6ZS11" (("RINL" 4)))
 ("UP:Q6ZS81" (("WDFY4" 68) ("WDFY family member 4" 7) ("WDFY4 protein" 1)))
 ("UP:Q6ZS82" (("R9AP" 5) ("RGS9BP" 1))) ("UP:Q6ZSM3" (("SLC16A12" 1)))
 ("UP:Q6ZSY5" (("PPP1R3F" 2)))
 ("UP:Q6ZSZ5"
  (("p114RhoGEF" 138) ("Junctional p114RhoGEF" 6) ("ARHGEF18" 3) ("GEF18" 2)))
 ("UP:Q6ZSZ6" (("TSHZ1" 9))) ("UP:Q6ZT07" (("TBC1D9" 1)))
 ("UP:Q6ZTA4" (("TNL" 15)))
 ("UP:Q6ZTQ3"
  (("RASSF6" 221) ("RASSF6 protein" 3)
   ("Ras association domain family member 6" 2)))
 ("UP:Q6ZU15" (("SEPT14" 2)))
 ("UP:Q6ZUJ8"
  (("phosphoinositide" 361) ("Phosphoinositide" 34) ("PIK3AP1" 9)
   ("the major phosphoinositide" 1) ("a distinct phosphoinositide" 1)))
 ("UP:Q6ZUT3"
  (("FRMD7" 128) ("FRMD7 protein" 13) ("Nys" 2) ("only full-length FRMD7" 1)
   ("RhoGDI-FLAG-tagged FRMD7" 1)))
 ("UP:Q6ZUX7" (("LHFPL2" 1))) ("UP:Q6ZV89" (("SH2D5" 1)))
 ("UP:Q6ZVD7" (("STOX1" 6) ("Storkhead box 1" 1)))
 ("UP:Q6ZVD8"
  (("PHLPP2" 289) ("Phlpp2" 62) ("PHLPPL" 60) ("PHLPP2 protein" 7)
   ("PH domain and leucine rich repeat protein phosphatase 2" 2) ("PHLPP/L" 2)
   ("Phlpp2 protein" 2) ("PHLPPL protein" 1) ("prominent PHLPP2" 1)))
 ("UP:Q6ZVM7" (("Tom1L2" 9) ("TOM1L2" 2)))
 ("UP:Q6ZVN8" (("JH" 162) ("pJH" 20) ("HJV" 4) ("hemojuvelin" 1)))
 ("UP:Q6ZW05" (("PTCHD4" 2)))
 ("UP:Q6ZW31"
  (("Rho GTPase" 529) ("the primary Rho GTPase" 4) ("an atypical Rho GTPase" 2)
   ("the predominant Rho GTPase" 2)
   ("the quantitatively predominant Rho GTPase" 1) ("syde1" 1)
   ("Rho GTPase protein" 1) ("SYDE1" 1)))
 ("UP:Q6ZW49"
  (("PAXIP1" 26) ("pTip" 12) ("PTIP" 5) ("PAX-interacting protein 1" 1)
   ("Paxip1" 1)))
 ("UP:Q6ZWB6" (("KCTD8" 2))) ("UP:Q6ZWH5" (("NEK10" 18)))
 ("UP:Q6ZWJ1" (("STXBP4" 3))) ("UP:Q6ZWK4" (("C1orf186" 1)))
 ("UP:Q6ZWL3" (("subfamily V" 2) ("CYP4V2" 1)))
 ("UP:Q6ZWT7" (("LPAAT" 106) ("LPAAT-" 2) ("MBOAT2" 1)))
 ("UP:Q6ZYL4"
  (("TTD" 90) ("trichothiodystrophy" 6) ("GTF2H5" 4) ("longer TTD" 1)
   ("Trichothiodystrophy" 1)))
 ("UP:Q700D2" (("JKD" 1)))
 ("UP:Q702N8"
  (("Xin" 31) ("xin" 9) ("XIRP1" 3) ("particularly pertinent xin" 2)
   ("XIN" 1)))
 ("UP:Q709F0" (("Acad11" 55))) ("UP:Q70CQ1" (("USP49" 6)))
 ("UP:Q70CQ2" (("USP34" 5))) ("UP:Q70CQ3" (("USP30" 4)))
 ("UP:Q70E73" (("Lamellipodin" 6) ("lamellipodin" 4)))
 ("UP:Q70EL3" (("USP50" 3))) ("UP:Q70EL4" (("USP43" 1)))
 ("UP:Q70IA6" (("Mob2" 17))) ("UP:Q70SY1" (("CREB3L2" 4) ("BBF2H7" 3)))
 ("UP:Q70UQ0" (("IKBIP" 1)))
 ("UP:Q70YC4"
  (("ZNF365" 41) ("zinc finger protein 365" 2) ("around ZNF365" 2)))
 ("UP:Q70Z35" (("PREX2" 11) ("P-Rex2" 6))) ("UP:Q712K3" (("UBC3B" 2)))
 ("UP:Q719H9" (("KCTD1" 197)))
 ("UP:Q719L8"
  (("CRCs" 1508) ("sporadic CRCs" 33) ("primary CRCs" 29)
   ("metastatic CRCs" 12) ("KRAS-positive CRCs" 9) ("aggressive CRCs" 7)
   ("all other incident CRCs" 6) ("CIMP-positive CRCs" 5) ("-negative CRCs" 4)
   ("incident CRCs" 4) ("76 primary CRCs" 3) ("KRAS mutation-positive CRCs" 3)
   ("454 primary CRCs" 2) ("MMR proficient CRCs" 2)
   ("microsatellite unstable CRCs" 2) ("included 293 primary CRCs" 2)
   ("PI3K-driven aggressive CRCs" 2) ("metachronous CRCs" 2) ("Most CRCs" 2)
   ("HER2/neu-positive CRCs" 2) ("hypoxic CRCs" 2) ("curative resected CRCs" 2)
   ("human BRAF-driven CRCs" 2) ("these 49 primary CRCs" 2) ("most CRCs" 2)
   ("an additional 222 sporadic CRCs" 2) ("3/4 late stage CRCs" 2)
   ("3/4 MSI-H late stage CRCs" 2) ("early and late stage sporadic MSI CRCs" 2)
   ("one-hundred and fifty-two primary CRCs" 2) ("Incident CRCs" 2)
   ("human metastatic CRCs" 2)
   ("sporadic and hereditary (HNPCC-associated) microsatellite instable CRCs"
    2)
   ("396 early stage primary CRCs" 1) ("90 localized primary CRCs" 1)
   ("virtually all CRCs" 1) ("virtually all metastatic CRCs" 1)
   ("the 515 primary CRCs" 1) ("all 9 primary CRCs" 1) ("Primary CRCs" 1)
   ("98 consecutive CRCs" 1) ("consecutive CRCs" 1)
   ("matched primary and metastatic CRCs" 1) ("the aggressive KRAS WT CRCs" 1)
   ("the aggressive KRAS G12mut CRCs" 1) ("Even KRAS WT CRCs" 1)
   ("node-positive CRCs" 1) ("HIF-2 α stromal-negative CRCs" 1)
   ("than unmethylated CRCs (25 vs 75%, respectively)" 1)
   ("HIF-2 α and CA9 stromal-positive CRCs" 1)
   ("MSI-positive early stage CRCs" 1) ("all primary CRCs" 1)
   ("we first examined primary invasive CRCs" 1)
   ("primary synchronous and metachronous CRCs" 1) ("than sporadic CRCs" 1)
   ("mucinous CRCs" 1) ("Lynch syndrome-derived CRCs" 1)
   ("TLR4-positive CRCs" 1) ("than CRCs" 1) ("newly diagnosed distal CRCs" 1)
   ("The 1420 sporadic CRCs" 1) ("Lynch syndrome-associated CRCs" 1)
   ("late stage MSI CRCs" 1) ("4 late stage MSI CRCs" 1)
   ("71(18.3%) sporadic CRCs" 1) ("71 sporadic CRCs" 1)
   ("99 MSI-High (MSI-H) sporadic CRCs" 1)
   ("Most Lynch Syndrome-associated CRCs" 1) ("PPARG -negative CRCs" 1)
   ("152 primary sporadic CRCs" 1) ("229 sporadic CRCs" 1)
   ("non-metastatic CRCs" 1) ("liver metastatic CRCs" 1)
   ("The best-defined mammalian CRCs" 1) ("135 human sporadic CRCs" 1)
   ("distal CRCs" 1) ("proximal CRCs" 1) ("distal MSI CRCs" 1)
   ("almost all HNPCC-associated CRCs" 1) ("FAP associated CRCs" 1)
   ("Most sporadic CRCs" 1) ("hereditary CRCs" 1) ("Sporadic CRCs" 1)
   ("multiple primary CRCs" 1) ("traditional pathway CRCs" 1)
   ("Lynch syndrome associated CRCs" 1) ("syndrome-associated CRCs" 1)
   ("than KRAS- wild-type CRCs ( xref ; xref ; xref ; xref ; xref )" 1)
   ("124 primary CRCs" 1) ("220 well-characterised CRCs" 1)))
 ("UP:Q71DI3" (("H3.2" 9) ("Histone H3.2" 1))) ("UP:Q71DR4" (("CNTF-Rα" 4)))
 ("UP:Q71F23"
  (("PBIP1" 13) ("CENP-U" 12) ("MLF1IP" 2) ("CENP-50" 1) ("KLIP1" 1)))
 ("UP:Q71F56" (("MED13L" 9)))
 ("UP:Q71G51"
  (("alpha-tubulin" 201) ("alpha tubulin" 17) ("Alpha-tubulin" 11)))
 ("UP:Q71RC2" (("LARP4" 2))) ("UP:Q71RS6" (("SLC24A5" 6) ("JSX" 1)))
 ("UP:Q71SY5" (("Med25" 114))) ("UP:Q71U07" (("tMSC" 42)))
 ("UP:Q71U36"
  (("brain-specific" 86) ("TUBA1A" 39) ("TUBA3" 14) ("Brain-specific" 7)
   ("brain-specific protein" 4) ("tuba1a" 2) ("“brain-specific”" 1)
   ("Foetal TUBA1A" 1)))
 ("UP:Q71UI9" (("H2Av" 14)))
 ("UP:Q71UM5"
  (("RPS27L" 208) ("exogenous expressed RPS27L" 2) ("MDM2 added RPS27L" 1)))
 ("UP:Q74HL8" (("Nfr2" 18) ("NFR2" 4) ("nfr2" 2))) ("UP:Q74Z26" (("nut-1" 22)))
 ("UP:Q74Z47" (("ppE1" 1))) ("UP:Q74ZA9" (("GSP1" 11)))
 ("UP:Q74ZB0" (("Mec3" 8) ("MEC3" 1)))
 ("UP:Q74ZJ6"
  (("Bro1" 128) ("BRO1" 13) ("Patch 2-deleted (ΔP2) GST-ALIX Bro1" 2)
   ("the CHMP4-noninteractive Y319F-I212D FLAG-ALIX Bro1" 1)))
 ("UP:Q74ZL3" (("MSC3" 8) ("immortal MSC3" 4)))
 ("UP:Q74ZW4" (("CaR1" 5) ("cAR1" 1))) ("UP:Q750Y3" (("DCN1" 8) ("Dcn1" 3)))
 ("UP:Q751E8"
  (("Pho85" 52) ("pho85" 4) ("-Pho85" 2)
   ("the stress-activated kinase Pho85" 1)))
 ("UP:Q752A3" (("Tof1" 2) ("TOF1" 1))) ("UP:Q752B8" (("Pol2" 25) ("POL2" 6)))
 ("UP:Q752H7" (("Sec61" 37) ("sec61" 4) ("SEC61" 1)))
 ("UP:Q752N9" (("cPSA" 3))) ("UP:Q752V4" (("Sec9" 8)))
 ("UP:Q752Y3" (("ALO" 1)))
 ("UP:Q753A0"
  (("karyopherin-βs" 3) ("karyopherin-β" 2) ("Karyopherin-β" 1) ("Los1" 1)))
 ("UP:Q753D9" (("pKH3" 35))) ("UP:Q753L9" (("Rrd1" 3)))
 ("UP:Q753V5" (("Rad5" 46) ("RAD5" 13) ("rad5" 3))) ("UP:Q753W3" (("Vps32" 2)))
 ("UP:Q754R5" (("Doa4" 1))) ("UP:Q755D0" (("Ceg1" 1)))
 ("UP:Q755K3" (("Atg16" 6))) ("UP:Q755Q0" (("Inp2" 1)))
 ("UP:Q755Q4" (("INP1" 5))) ("UP:Q755V9" (("ATG31" 2)))
 ("UP:Q755X2" (("ATG8 family" 11) ("atg8" 6)))
 ("UP:Q755Y0" (("AKR1" 6) ("Akr1" 2)))
 ("UP:Q756L2" (("Cln1" 3) ("CLN1" 2) ("cln1" 1))) ("UP:Q756P0" (("Nop1" 5)))
 ("UP:Q756X6" (("POB3" 2))) ("UP:Q757A7" (("Atg17" 14)))
 ("UP:Q757M7"
  (("silent information regulator 2" 85) ("sir2" 40)
   ("Silent information regulator 2" 10)
   ("the yeast transcriptional repressor silent information regulator 2" 3)
   ("The evolutionary conserved silent information regulator 2" 2)
   ("Silent information regulator 2 protein" 2)))
 ("UP:Q757N0" (("atp16" 1))) ("UP:Q757R0" (("Vac8" 4)))
 ("UP:Q757S1" (("URA3" 99) ("ura3" 54) ("URA3-" 2)))
 ("UP:Q757W2" (("yng2" 2) ("Yng2" 1))) ("UP:Q758M7" (("Sec23" 14)))
 ("UP:Q759A9" (("PYK1" 1))) ("UP:Q759D1" (("Rlp24" 3)))
 ("UP:Q759U5" (("PPM1" 2))) ("UP:Q759W1" (("RMT2" 2)))
 ("UP:Q75A44" (("Ldb17" 2) ("ldb17" 1))) ("UP:Q75A48" (("Atg9" 10) ("ATG9" 3)))
 ("UP:Q75AA7" (("Mph1" 4))) ("UP:Q75AL5" (("JHD1" 1)))
 ("UP:Q75B16" (("SEC24" 5) ("Sec24" 1))) ("UP:Q75B65" (("ATG20" 1)))
 ("UP:Q75BB3" (("αAR" 4))) ("UP:Q75BI6" (("Gal11" 2)))
 ("UP:Q75BY1" (("Rrd2" 3))) ("UP:Q75C43" (("ATG24" 1)))
 ("UP:Q75C78" (("Kar2" 5))) ("UP:Q75CM4" (("SBE2" 6)))
 ("UP:Q75CM8" (("TrR-1" 40) ("trr1" 36) ("TRR1" 11)))
 ("UP:Q75CZ5" (("MEF1" 4))) ("UP:Q75D34" (("Atg21" 2)))
 ("UP:Q75D77" (("PP4R2" 75) ("targeting subunit PP4R2" 2)))
 ("UP:Q75DB8"
  (("Mec1" 99) ("MEC1" 54) ("mec1" 10) ("mEC1" 5) (NIL 4) ("Mec1 (ATR)" 2)
   ("Mec1-" 2)))
 ("UP:Q75DK1" (("SEC14" 1))) ("UP:Q75DK7" (("MAP4K" 1)))
 ("UP:Q75E32" (("PP4R3" 11)))
 ("UP:Q75EP8" (("Spt6" 8) ("SPT6" 1) ("HIV-1 chromatin-associated Spt6" 1)))
 ("UP:Q75F10" (("srb2" 1))) ("UP:Q75F26" (("ATG29" 2)))
 ("UP:Q75J96" (("RAPGAP1" 1))) ("UP:Q75N03" (("Hakai" 84)))
 ("UP:Q75N90" (("FBN3" 3)))
 ("UP:Q75NE6"
  (("C13orf25" 41) ("c13orf25" 15) ("MIR17HG" 6) ("MIRH1" 3) (NIL 1)))
 ("UP:Q75T13" (("PGAP1" 2))) ("UP:Q75V66" (("ANO5" 1)))
 ("UP:Q75W54" (("EBM" 198))) ("UP:Q76E23" (("EIF4G" 2) ("EIF4G protein" 1)))
 ("UP:Q76I76" (("SSH2" 30))) ("UP:Q76L37" (("CP-r" 76) ("Cp-r" 1)))
 ("UP:Q76L83" (("ASXL2" 10))) ("UP:Q76LX8" (("ADAMTS13" 8)))
 ("UP:Q76M96" (("URB" 6) ("CCDC80" 3)))
 ("UP:Q76MJ5"
  (("IRE2" 31) ("the proximal IRE2" 2) ("Confocal microscope Leica DM IRE2" 1)
   ("Ire2" 1) ("IRE1b" 1)))
 ("UP:Q76MV0" (("B34" 2))) ("UP:Q76N89" (("NEDL1" 12) ("HECW1" 8)))
 ("UP:Q76NV1" (("DYRK1" 6) ("tyrosine-phosphorylation-regulated kinase 1" 3)))
 ("UP:Q76RF1" (("ORF71" 16))) ("UP:Q77ZF7" (("antigen-3" 1)))
 ("UP:Q79354" (("K29" 65) ("K29-" 4) ("-K29" 1) ("k29" 1)))
 ("UP:Q79360" (("K88" 21) ("than K88" 1))) ("UP:Q79BT1" (("SipB" 2)))
 ("UP:Q79FX8" (("HMA" 1))) ("UP:Q7CQE0" (("RPF" 25)))
 ("UP:Q7CRQ0" (("UDH" 37))) ("UP:Q7CXF0" (("ADE1" 1)))
 ("UP:Q7DMA9" (("pAS1" 16) ("Pas1" 1)))
 ("UP:Q7F613"
  (("RISC" 434) ("RISCs" 11) ("Risc" 2) ("pRISC" 2) ("the mature RISC" 1)
   ("miR-145-quided RISC" 1) ("the repressive RISC" 1)))
 ("UP:Q7K2D2" (("dynamitin" 29) ("Dynamitin" 1)))
 ("UP:Q7KM13"
  (("HEY" 226) ("VS-4718-treated sensitive HEY" 1)
   ("siRNA PEA-15-treated HEY" 1)))
 ("UP:Q7KNF2" (("roX2" 1))) ("UP:Q7KRY7" (("SMI" 139)))
 ("UP:Q7KTX8"
  (("BLI" 147) ("SU11274-treated H1975 xenograft tumour BLI" 1)
   ("noninvasive BLI" 1) ("We first optimized BLI" 1)))
 ("UP:Q7KZF4" (("SND1" 106) ("TDRD11" 1) ("a new SND1" 1)))
 ("UP:Q7KZI7"
  (("MARK2" 166) ("Mark2" 6) ("MARK2 protein" 3) ("Par1b" 3) ("MARK-2" 2)
   ("the only commercially available recombinant MARK2" 1) ("Par-1b" 1)
   ("par-1b" 1) ("that MARK2’s" 1)))
 ("UP:Q7KZN9" (("COX15" 3)))
 ("UP:Q7L099"
  (("RUFY3" 199) ("RIPX" 4) ("targeting RUFY3" 3) ("Singar1" 3)
   ("RUN and FYVE domain containing 3" 3) ("SINGAR1" 2) ("RUFY3 protein" 1)))
 ("UP:Q7L0J3" (("SV2A" 20)))
 ("UP:Q7L0Q8"
  (("RhoU" 319) ("RHOU" 7) ("Ras homolog family member U" 2) ("Wrch1" 2)
   ("dominant negative (DN) RhoU" 2) ("down significantly more RhoU" 2)
   ("Wrch-1" 2) ("than WT RhoU ( xref ; xref ; xref ; xref )" 1)
   ("physically links RhoU" 1)))
 ("UP:Q7L190" (("DPPA4" 3) ("developmental pluripotency associated 4" 1)))
 ("UP:Q7L1I2" (("SV2B" 8))) ("UP:Q7L1Q6" (("BZW1" 7) ("BZAP45" 6)))
 ("UP:Q7L1S5" (("CHST9" 7))) ("UP:Q7L1T6" (("CYB5R4" 1)))
 ("UP:Q7L1V2" (("MON1B" 2))) ("UP:Q7L1W4" (("LRRC8D" 7)))
 ("UP:Q7L266" (("crash" 14) ("Crash" 2) ("“crash”" 2)))
 ("UP:Q7L2E3" (("DHX30" 2))) ("UP:Q7L2H7" (("EIF3M" 6) ("GA17" 2) ("eIF3m" 1)))
 ("UP:Q7L2J0" (("BCDIN3" 6)))
 ("UP:Q7L2Z9" (("CENP-Q" 156) ("CENP-Q-" 3) ("CENP-Q protein" 2)))
 ("UP:Q7L3B6"
  (("CDC37L1" 11) ("its divergent N-terminus CDC37L1" 1) ("Harc" 1)))
 ("UP:Q7L3T8"
  (("prolyl" 312) ("Prolyl" 12) ("PARS2" 2) ("prolyl peptide" 1)
   ("-prolyl" 1)))
 ("UP:Q7L3V2"
  (("BH3-only protein" 376) ("a pro-apoptotic BH3-only protein" 4)
   ("a proapoptotic BH3-only protein" 4) ("a strong BH3-only protein" 2)
   ("the auxiliary BH3-only protein" 2) ("The only other BH3-only protein" 2)
   ("the major BH3-only protein" 2) ("the primary BH3-only protein" 2)
   ("the pro-apoptotic BH3-only protein" 2) ("a weak BH3-only protein" 1)
   ("a potent pro-apoptotic BH3-only protein" 1)
   ("yet another BH3-only protein" 1) ("a particular BH3-only protein" 1)
   ("than any individual BH3-only protein" 1) ("a given BH3-only protein" 1)
   ("another pro-apoptotic BH3-only protein" 1)
   ("a pro-apoptotic BCL2 family BH3-only protein" 1)
   ("an intact BH3-only protein" 1) ("a typical BH3-only protein" 1)
   ("The pro-apoptotic BH3-only protein" 1)))
 ("UP:Q7L513" (("FCRL1" 7) ("FCRL" 2)))
 ("UP:Q7L523"
  (("RagA" 99) ("Rags" 49) ("RAGA" 24) ("Rag A" 4)
   ("dominant-negative RagA" 1)))
 ("UP:Q7L576"
  (("CYFIP1" 90) ("SRA1" 7) ("cytoplasmic FMR1 interacting protein 1" 4)
   ("Sra-1" 2) ("CYFIP1 protein" 2) ("CYFIP1-" 1) ("p140Sra-1" 1)))
 ("UP:Q7L590"
  (("Mcm10" 251) ("MCM10" 29) ("Mcm10 protein" 4) ("-Mcm10 protein" 3)
   ("the nuclear soluble Mcm10" 2) ("Mcm10-" 2)
   ("an essential DNA replication factor Mcm10" 1) ("more Mcm10" 1)
   ("-Mcm10" 1)))
 ("UP:Q7L591" (("Dok-3" 9) ("DOK3" 1))) ("UP:Q7L5D6" (("Trc35" 2)))
 ("UP:Q7L5N1"
  (("CSN6" 127) ("COPS6" 13) ("Vpr interacting protein" 4)
   ("COP9 signalosome subunit 6" 3) ("Csn6" 3) ("hVIP" 2)))
 ("UP:Q7L5Y1"
  (("ENOSF1" 43) ("enolase superfamily member 1" 2) ("ENOSF1 protein" 1)))
 ("UP:Q7L5Y6" (("DET1" 9)))
 ("UP:Q7L5Y9" (("emp" 36) ("P-emp" 18) ("EMP" 4) ("Emp" 3)))
 ("UP:Q7L622"
  (("G2/M" 3596) ("G2/M-" 2) ("mock-infected cells reached G2/M" 1)
   ("a less robust G2/M" 1) ("a clear G2/M" 1)))
 ("UP:Q7L7L0"
  (("histone 3" 243) ("Histone 3" 48) ("H2a" 32) ("histone 3 protein" 4)
   ("27 Lys (K27) and 20 Lys (K20) of histone 3 (H3)" 1)))
 ("UP:Q7L7X3" (("MARKK" 22) ("TAOK1" 17) ("MARK kinase" 2) ("Mark kinase" 1)))
 ("UP:Q7L804" (("Rab11FIP2" 1)))
 ("UP:Q7L8A9"
  (("VASH1" 164) ("VASH" 3) ("VASH1 protein" 3) ("data showed VASH1" 2)
   ("exogenous VASH1" 1)))
 ("UP:Q7L8C5" (("SYT13" 1))) ("UP:Q7L985" (("LINGO2" 2)))
 ("UP:Q7L9L4"
  (("MOB1B" 16) ("Mob1A" 10) ("MOB kinase activator 1B" 3) ("MOBKL1A" 1)))
 ("UP:Q7LBC6" (("Jumonji domain" 4) ("jumonji domain" 4) ("KDM3B" 4)))
 ("UP:Q7LBE3" (("SLC26A9" 8)))
 ("UP:Q7LC44"
  (("AR-C" 24) ("Arg3.1" 9)
   ("activity-regulated cytoskeleton-associated protein" 4)))
 ("UP:Q7LDG7"
  (("RASGRP2" 41) ("RasGRP2" 41) ("RAS guanyl releasing protein 2" 4)
   ("Rasgrp2" 4) ("-RasGRP2" 2)))
 ("UP:Q7LG56"
  (("RRM2B" 166) ("p53R2" 34) ("P53R2" 13) ("RRM2b" 9) ("Rrm2b" 4)
   ("RRM2B protein" 1)))
 ("UP:Q7LGA3" (("HS2ST1" 1))) ("UP:Q7LXL5" (("XP-F" 1)))
 ("UP:Q7LZ31" (("lethal toxin" 13) ("lethal toxin (LT)" 1)))
 ("UP:Q7LZI5" (("US-1" 1))) ("UP:Q7M135" (("Lys-C" 71) ("Lys-C peptide" 4)))
 ("UP:Q7M2P1" (("TP3" 8)))
 ("UP:Q7M459"
  (("ATT" 607) ("Att" 63) ("att" 45) ("-ATT" 19) ("aTT" 16) ("-att" 1)))
 ("UP:Q7M4L6" (("Shf" 3) ("SHF" 3))) ("UP:Q7M713" (("TRb1" 1)))
 ("UP:Q7PKQ5" (("ACTN" 10))) ("UP:Q7PMT1" (("Exd" 3)))
 ("UP:Q7PT10" (("Hsp83" 28) ("Hsp83 protein" 3) ("Much more Hsp83 protein" 2)))
 ("UP:Q7PTL2"
  (("PKP" 9) ("the primary PKP" 2)
   ("a generally expressed epithelial and epidermal PKP" 1)))
 ("UP:Q7QG73" (("α-adaptin" 52) ("α-adaptin-" 5) ("alpha-adaptin" 1)))
 ("UP:Q7RTN6"
  (("STRADα" 405) ("STRAD" 158) ("STRADα protein" 4)
   ("STE20-related kinase adaptor alpha" 4) ("STRADα molecule" 2) ("STLK" 2)
   ("Strad" 1) ("N-terminally 6-His-tagged STRADα" 1)
   ("than full-length STRADα ( xref )" 1)
   ("the last six amino acids of STRADα (residues 426–431, including the WEF motif that interacts with MO25α, xref )"
    1)
   ("LYK5" 1)))
 ("UP:Q7RTP0" (("NIPA1" 4))) ("UP:Q7RTP6" (("MICAL3" 2)))
 ("UP:Q7RTR2"
  (("NLRC3" 131) ("Nlrc3" 71) ("nucleotide-binding oligomerization domain" 14)
   ("Nucleotide-binding oligomerization domain" 2)
   ("nucleotide-binding oligomerization domain (NOD)" 2)
   ("overexpressed NLRC3" 2) ("CLR16.2" 2)))
 ("UP:Q7RTS3" (("Ptf1a" 16) ("ptf1a" 3))) ("UP:Q7RTS9" (("dymeclin" 6)))
 ("UP:Q7RTU3" (("OLIG3" 5)))
 ("UP:Q7RTU7" (("SCXA" 8) ("the tendon-specific transcription factor SCXA" 3)))
 ("UP:Q7RTV0" (("INI" 14) ("InI" 2))) ("UP:Q7RTX0" (("T1R3" 1)))
 ("UP:Q7RTX1"
  (("TR1" 114) ("the uroepithelial cells T1R1" 2) ("T1R1" 2)
   ("taste receptor" 2) ("Tr1" 1)))
 ("UP:Q7RTX7" (("CATSPER4" 5))) ("UP:Q7RTX9" (("MCT1/4" 3)))
 ("UP:Q7RTY1" (("SLC16A9" 2))) ("UP:Q7RTY8" (("TMPRSS7" 1)))
 ("UP:Q7RY30" (("NMP1" 5))) ("UP:Q7RYI3" (("CRC2" 1)))
 ("UP:Q7S565"
  (("HPs" 85) ("hPS" 71) ("large left-sided HPs" 2) ("microvesicular HPs" 2)
   ("than HPs" 1) ("innocent HPs" 1) ("distal goblet cell HPs" 1)
   ("proximal goblet cell HPs" 1)
   ("than all HPs (mean 5.0 SD 2.7 mm vs. 3.2 SD 1.8 mm; P<0.001)" 1)))
 ("UP:Q7SX85" (("SOL" 6))) ("UP:Q7SXW4" (("POB" 24) ("-POB" 8)))
 ("UP:Q7SYN5" (("RXRE" 10))) ("UP:Q7SZI5" (("RAFTLIN" 2)))
 ("UP:Q7T0K5" (("mage" 6))) ("UP:Q7T6Y9" (("RNR2" 12)))
 ("UP:Q7TJL8" (("R-55" 2)))
 ("UP:Q7TQ95"
  (("ULN" 73) ("institutional ULN" 1) ("than 2.5 times ULN" 1)
   ("than 5 times ULN" 1)))
 ("UP:Q7TSN2"
  (("CLM" 172) ("bilobar CLM" 2) ("metachronous CLM" 1)
   ("previously undetected CLM" 1)))
 ("UP:Q7TYQ4" (("MBTB" 26))) ("UP:Q7VRD7" (("Skp" 25) ("SKP" 6) ("SKp" 1)))
 ("UP:Q7WDU0" (("PTLD" 30))) ("UP:Q7X2H8" (("CODA" 1)))
 ("UP:Q7X911" (("Sac6" 2) ("sac6" 2) ("SAC6" 2)))
 ("UP:Q7X9V2" (("chr13" 15) ("Chr13" 2) ("PIE-1" 1)))
 ("UP:Q7X9V3" (("Nsi" 21) ("NSI" 3) ("NSi" 1)))
 ("UP:Q7XA72"
  (("ABC transporter" 78) ("ABC transporter protein" 8)
   ("The prototypical ABC transporter" 2) ("respective ABC transporter" 1)
   ("a particular ABC transporter" 1) ("each respective ABC transporter" 1)))
 ("UP:Q7XDZ7" (("pT3" 127))) ("UP:Q7XJL2" (("GLR-2" 1)))
 ("UP:Q7XZU0" (("CFS" 93) ("the major CFS" 1))) ("UP:Q7Y0V7" (("GL26" 2)))
 ("UP:Q7Y4Y9" (("dNK" 4))) ("UP:Q7Z2D5" (("PRG-1" 2) ("LPPR4" 1)))
 ("UP:Q7Z2E3"
  (("APTX" 32) ("aprataxin" 15) ("Aprataxin" 6) ("aprataxin (APTX)" 1)))
 ("UP:Q7Z2H8" (("SLC36A1" 7)))
 ("UP:Q7Z2W4"
  (("ZAP" 3) ("zinc finger antiviral protein" 2) ("Zap" 2) ("ZC3HAV1" 2)
   ("ARTD13" 1)))
 ("UP:Q7Z2W7" (("TRPM8" 5)))
 ("UP:Q7Z2X4"
  (("PID1" 7) ("phosphotyrosine interaction domain containing 1" 2)))
 ("UP:Q7Z2Y5" (("NRK" 113))) ("UP:Q7Z2Y8" (("GVINP1" 2)))
 ("UP:Q7Z2Z1" (("TRCT" 90) ("TRCT-7A protein" 3) ("ticrr" 1) ("Ticrr" 1)))
 ("UP:Q7Z333" (("SETX" 77) ("senataxin" 3) ("Reciprocal SETX" 2)))
 ("UP:Q7Z353"
  (("HDX" 186) ("a unique HDX" 3)
   ("the most statistically significant (p<0.001) differential HDX" 2)
   ("Comprehensive differential HDX" 1) ("distinct HDX" 1)))
 ("UP:Q7Z3B1" (("NEGR1" 34) ("ntra" 3)))
 ("UP:Q7Z3B3"
  (("MSL1v1" 172) ("Nsl1" 3) ("NSL1" 2)
   ("the N-terminal 800 amino acids of MSL1v1" 1) ("KIAA1267" 1) ("CENP-36" 1)
   ("KANSL1" 1)))
 ("UP:Q7Z3B4" (("Nup54" 1)))
 ("UP:Q7Z3C6" (("Atg9a" 10) ("ATG9A" 4) ("mAtg9" 1)))
 ("UP:Q7Z3E1"
  (("TiPARP" 262) ("TCDD" 233) ("Tiparp" 38) ("TCDD-" 9) ("ARTD14" 2)
   ("than TCDD" 1) ("PARP7" 1) ("PARP-7" 1)))
 ("UP:Q7Z3F1" (("GPR155" 4))) ("UP:Q7Z3G6" (("PRICKLE2" 1)))
 ("UP:Q7Z3K6" (("MIER3" 2))) ("UP:Q7Z3S7" (("CACNA2D4" 1)))
 ("UP:Q7Z3T8" (("FYVE domain containing 16" 3) ("endofin" 2) ("ZFYVE16" 1)))
 ("UP:Q7Z3U7" (("Sf21" 8) ("SF21" 3) ("Mon2" 3)))
 ("UP:Q7Z3Z0" (("K25" 24) ("k25" 4))) ("UP:Q7Z3Z2" (("RD3" 6)))
 ("UP:Q7Z3Z3" (("PIWIL3" 6) ("Piwil3" 1)))
 ("UP:Q7Z3Z4"
  (("PIWI" 56) ("Piwi" 8) ("PIWIL4" 6) ("Piwi protein" 1)
   ("Piwi subfamily" 1)))
 ("UP:Q7Z401" (("DENND4A" 1))) ("UP:Q7Z406" (("MYH14" 2)))
 ("UP:Q7Z418" (("member 18" 7)))
 ("UP:Q7Z419" (("RNF144B" 1) ("Rnf144b" 1) ("IBRDC2" 1)))
 ("UP:Q7Z429" (("GRINA" 11)))
 ("UP:Q7Z434"
  (("MAVS" 717) ("IPS-1" 213) ("VISA" 31) ("Cardif" 18) ("MAVS protein" 15)
   ("mitochondrial antiviral signaling protein" 9) ("visa" 7) ("MAVS-" 6)
   ("cellular MAVS" 3) ("CARDIF" 3) ("overexpressed MAVS" 3)
   ("targeted both IPS-1" 2) ("mini MAVS" 2) ("Q7Z434" 2) ("VISA-" 2)
   ("overexpressed IPS-1" 2) ("an essential antiviral adaptor MAVS" 2)
   ("peroxisomal IPS-1" 1) ("very large MAVS" 1) ("viral infection MAVS" 1)
   ("Mini MAVS" 1) ("all other strains abrogated MAVS" 1)
   ("mitochondrial antiviral signaling protein (MAVS)" 1) ("IPS-1 protein" 1)
   ("than full-length MAVS ( xref )" 1)))
 ("UP:Q7Z444" (("HRAS-2" 3) ("ERAS" 2) ("HRAS2" 2)))
 ("UP:Q7Z449" (("CYP2U1" 1))) ("UP:Q7Z460" (("CLASP1" 20) ("Mast1" 1)))
 ("UP:Q7Z465" (("BNIP-Sα" 11)))
 ("UP:Q7Z494"
  (("NPHP3" 14) ("type 7" 5) ("Nphp3" 4) ("spinocerebellar atrophy type 7" 2)
   ("Type 7" 2)))
 ("UP:Q7Z4H4" (("ADM2" 3))) ("UP:Q7Z4H7" (("FAM29A" 1)))
 ("UP:Q7Z4H8" (("KDELC2" 2))) ("UP:Q7Z4I7" (("PINCH2" 7) ("PINCH-2" 5)))
 ("UP:Q7Z4J2" (("GLT6D1" 10))) ("UP:Q7Z4K8" (("TRIM46" 3)))
 ("UP:Q7Z4N2" (("TRPM1" 9) ("melastatin" 4) ("Trpm1" 2) ("Melastatin" 1)))
 ("UP:Q7Z4Q2" (("HEATR3" 38))) ("UP:Q7Z4V5" (("HRp2" 21)))
 ("UP:Q7Z4W1" (("XR" 153) ("XR (BCM)" 2)))
 ("UP:Q7Z553" (("MDGA2" 1) ("MAMDC1" 1)))
 ("UP:Q7Z569"
  (("IMP" 35) ("BRCA1-associated protein" 13) ("E3 ligase BRAP" 10) ("BRAP2" 8)
   ("Brap2" 5) ("BRCA1 associated protein" 4) ("IMPs" 3)
   ("Impedes Mitogenic Propagation (IMP)" 1)
   ("Impedes Mitogenic Propagation" 1)))
 ("UP:Q7Z570" (("ZNF804A" 5)))
 ("UP:Q7Z589" (("EMSY" 34) ("c11orf30" 10) ("EMSY protein" 5) ("C11orf30" 3)))
 ("UP:Q7Z5G4" (("GCP16" 1) ("GOLGA7" 1))) ("UP:Q7Z5H3" (("ARHGAP22" 31)))
 ("UP:Q7Z5J4" (("RAI1" 7)))
 ("UP:Q7Z5K2"
  (("Wapl" 37) ("WAPAL" 8) ("Wapal" 4) ("WAPL" 2) ("than WAPAL" 1) ("FOE" 1)))
 ("UP:Q7Z5L2" (("PSORT" 13))) ("UP:Q7Z5L7" (("Podocan" 5) ("podocan" 3)))
 ("UP:Q7Z5L9" (("IRF2BP2" 1))) ("UP:Q7Z5P9" (("MUC19" 6)))
 ("UP:Q7Z5Q5" (("POLN" 3))) ("UP:Q7Z5R6" (("RIAM" 31) ("PREL1" 1)))
 ("UP:Q7Z5Y6" (("BMP8A" 1))) ("UP:Q7Z5Y7" (("KCTD20" 75)))
 ("UP:Q7Z601" (("PGR2" 16)))
 ("UP:Q7Z624" (("CAMKMT" 6) ("chromosome 2 open reading frame 34" 2)))
 ("UP:Q7Z628"
  (("Net1A" 18) ("NET1" 3) ("Net1A protein" 2)
   ("an HA-epitope-tagged Net1A" 2)))
 ("UP:Q7Z695" (("ADCK2" 2)))
 ("UP:Q7Z698"
  (("Spred2" 195) ("Spred-2" 83) ("SPRED2" 77) ("SPRED2 protein" 3)
   ("Spred-2 protein" 2) ("spred2" 1) ("Spred2 protein" 1) ("Spred2-" 1)))
 ("UP:Q7Z699"
  (("SPRED1" 147) ("Spred1" 17) ("hSpred1" 9) ("Spred-1" 4) ("spred1" 2)
   ("SPRED-1" 2) ("SPRED1 protein" 1) ("curiously hSpred1 protein" 1)
   ("hSpred1 protein" 1)))
 ("UP:Q7Z6A9" (("BTLA" 5))) ("UP:Q7Z6B0" (("CCDC91" 2)))
 ("UP:Q7Z6B7"
  (("srGAP1" 168) ("srGAP1 protein" 4) ("Exogenous srGAP1" 1)
   ("particular srGAP1" 1)))
 ("UP:Q7Z6C1" (("Ep300" 33) ("EP300 protein" 3)))
 ("UP:Q7Z6E9"
  (("P2P-R" 156) ("P2P-R protein" 13) ("P2PR" 4) ("Rbbp6" 4)
   ("the Nuclear Receptor Signaling Atlas online databasethat P2P-R" 1)))
 ("UP:Q7Z6G8" (("EB-1" 19)))
 ("UP:Q7Z6J0" (("POSH" 96) ("plenty of SH3 domains" 2)))
 ("UP:Q7Z6J2"
  (("GRASP" 19) ("grasp" 11) ("GrASP" 4) ("a solid grasp" 2)
   ("a clear grasp" 1)))
 ("UP:Q7Z6J6" (("FRMD5" 5))) ("UP:Q7Z6K3" (("PTAR1" 4)))
 ("UP:Q7Z6K4" (("Nrarp" 15) ("NRARP" 6))) ("UP:Q7Z6K5" (("Arpin" 8)))
 ("UP:Q7Z6L1"
  (("TECPR1" 8) ("the previously unstudied TECPR1 protein" 2)
   ("TECPR1 protein" 2)))
 ("UP:Q7Z6M1" (("RABEPK" 2))) ("UP:Q7Z6V5" (("TAD2" 96) ("TAD2-" 2)))
 ("UP:Q7Z6W7" (("HSC3" 36)))
 ("UP:Q7Z6Z7"
  (("Mule" 222) ("HUWE1" 220) ("Huwe1" 109) ("ARF-BP1" 56) ("MULE" 23)
   ("Mcl-1 ubiquitin ligase E3" 15) ("HectH9" 14) ("Mcl" 10) ("HECTH9" 8)
   ("mcl" 7) ("HUWE1 protein" 6) ("mcL" 4) ("Arf-BP1" 3) ("Lasu1" 3) ("MCl" 3)
   ("ARF-binding protein 1" 2) ("UREB1" 2) ("ARF-Binding Protein 1" 2)
   ("HUWE1 peptide" 2) ("UBA and WWE domain containing 1" 1) ("mule" 1)
   ("Arf-Bp1" 1)))
 ("UP:Q7Z7A1"
  (("CEP-1" 87) ("Fan" 55) ("FAN" 17) ("fan" 16) ("cep-1" 8) ("centriolin" 7)
   ("Cntrl" 2) ("Cep-1" 2) ("reminiscent fan" 1)))
 ("UP:Q7Z7A4" (("PXK" 12) ("K(R)S(T) PXK" 2))) ("UP:Q7Z7C7" (("STRA8" 1)))
 ("UP:Q7Z7C8" (("TBN" 19) ("TAF8" 1) ("TbN" 1)))
 ("UP:Q7Z7D3" (("VTCN1" 8) ("B7-H4" 5))) ("UP:Q7Z7E8" (("UBE2Q1" 2)))
 ("UP:Q7Z7G0" (("ABI3BP" 3) ("TARSH" 2))) ("UP:Q7Z7G1" (("Clnk" 1)))
 ("UP:Q7Z7G8" (("COH1" 1) ("Chs1" 1))) ("UP:Q7Z7H8" (("MRPL10" 9)))
 ("UP:Q7Z7J9" (("CAMK2N1" 16) ("CAMK2N1-" 1))) ("UP:Q7Z7K6" (("CENPV" 1)))
 ("UP:Q801X7"
  (("galectins" 34) ("galectin" 20) ("Galectins" 6) ("Galectin" 6)))
 ("UP:Q804H7" (("SIX" 4))) ("UP:Q805B2" (("FGF8b" 17)))
 ("UP:Q80872" (("NS2A" 1))) ("UP:Q810D1" (("ChP2" 8) ("Chp2" 2)))
 ("UP:Q819Y5" (("PolIII" 4) ("polIII" 1))) ("UP:Q81JW1" (("ctrA" 2)))
 ("UP:Q81KI3"
  (("MoAb" 145) ("moAb" 53) ("500 ng ml −1 soluble anti-CD28 MoAb" 1)
   ("a chimaeric mouse/human MoAb" 1)))
 ("UP:Q81MS1" (("TGL" 5) ("TGase" 4))) ("UP:Q81SD1" (("SspH2" 2)))
 ("UP:Q81SZ9" (("RESA" 6))) ("UP:Q837U7" (("PTCA" 11)))
 ("UP:Q848S6" (("KPC" 88) ("nearly all KPC" 1))) ("UP:Q84JG5" (("HLL" 2)))
 ("UP:Q84JQ4" (("PRKC" 40) ("PRKC–" 2) ("PRKC-" 2)))
 ("UP:Q84JT7" (("ARID1" 4))) ("UP:Q84JU6" (("Hos1" 7) ("HOS1" 1)))
 ("UP:Q84LB2" (("prenyltransferase" 10) ("Prenyltransferase" 4)))
 ("UP:Q84LK0" (("ChM1" 1)))
 ("UP:Q84NC9" (("withvalues around 1e-20" 1) ("1e-20" 1)))
 ("UP:Q84TH4"
  (("Tra2" 139) ("TRA-2" 8) ("Transformer2" 3) ("Tra2 protein" 1)
   ("transformer2" 1)))
 ("UP:Q84UC7" (("BAC1" 10)))
 ("UP:Q84V25"
  (("EO" 72) ("QR" 11) ("Eo" 2) ("eo" 1) ("EO (AEO)" 1) ("EO (BEO)" 1)))
 ("UP:Q84VX0" (("RFS-1" 4))) ("UP:Q84WU4" (("GC3" 2)))
 ("UP:Q852M1" (("AO2" 1))) ("UP:Q852M2" (("AO3" 3))) ("UP:Q853W0" (("p206" 2)))
 ("UP:Q86A67"
  (("Aldo" 48) ("fructose-bisphosphate aldolase" 3) ("aldo" 1) ("ALDO" 1)))
 ("UP:Q86H98" (("CHMP4" 76) ("membrane-associated CHMP4" 2)))
 ("UP:Q86HN7" (("polo like kinase" 2)))
 ("UP:Q86IX6"
  (("bromodomain" 133) ("BD" 40) ("Bromodomain" 22)
   ("its resident bromodomain" 1)))
 ("UP:Q86MW9" (("SINA" 3) ("Sina" 1))) ("UP:Q86NG3" (("CpG6" 1)))
 ("UP:Q86PC9" (("TULP" 1))) ("UP:Q86PM2" (("KH" 326)))
 ("UP:Q86QI5"
  (("defensins" 20) ("defensin" 15) ("Defensins" 2) ("Defensin" 2)
   ("vaginal defensins" 1)))
 ("UP:Q86SE8" (("NPM2" 2))) ("UP:Q86SE9" (("PCGF5" 7) ("-PCGF5" 1)))
 ("UP:Q86SF2" (("GALNT7" 2))) ("UP:Q86SG2" (("DARP" 1) ("Ankrd23" 1)))
 ("UP:Q86SG3" (("DAZ4" 1))) ("UP:Q86SG4" (("C15orf21" 1)))
 ("UP:Q86SG5" (("S100A7A" 2)))
 ("UP:Q86SG6" (("NPHP9" 2) ("Jck" 2) ("Nphp9" 1)))
 ("UP:Q86SH2" (("ZAR1" 7) ("zygote arrest 1" 3) ("ZAR1 protein" 2)))
 ("UP:Q86SI9" (("CEI" 6) ("pCEI" 1))) ("UP:Q86SJ2" (("AMIGO2" 3)))
 ("UP:Q86SJ6"
  (("LAH" 55) ("Dsg4" 13) ("DSG4" 2) ("-Dsg4" 1) ("Dsg4 protein" 1)))
 ("UP:Q86SK9" (("sCD4" 16) ("Scd4" 1))) ("UP:Q86SM5" (("MRGPRG" 2)))
 ("UP:Q86SP6" (("Gpr149" 3))) ("UP:Q86SQ0" (("LL5β" 9)))
 ("UP:Q86SQ4" (("GPR126" 17))) ("UP:Q86SQ7" (("SDCCAG8" 14) ("NPHP10" 10)))
 ("UP:Q86SW4"
  (("Jurkat" 3598) ("JURKAT" 82) ("normal Jurkat" 4) ("jurkat" 2)
   ("the non-HTLV-1-associated leukemic T-cell line Jurkat" 2)
   ("the acute T cell leukemia lines Jurkat" 2) ("Lck-expressing Jurkat" 2)
   ("apoptotic Jurkat" 2) ("The human leukemic T-cell line Jurkat" 2)
   ("the acute lymphoblastic leukemia T-cell line Jurkat" 1)
   ("the non-HTLV-1-infected leukemic T-cell line Jurkat" 1)
   ("leukemic Jurkat" 1)
   ("the well-defined human T leukemic cell line Jurkat" 1)
   ("the human acute T cell leukemia cell line Jurkat" 1)
   ("the human leukemic T-cell line Jurkat" 1)
   ("The human leukemic T cell line Jurkat" 1)
   ("six stable Unc119-overexpressing Jurkat" 1)
   ("leukemic T cell line Jurkat" 1) ("than Jurkat" 1)
   ("LiCl-treated Jurkat" 1) ("acute T cell leukemia Jurkat" 1) ("Jurkat-" 1)
   ("The human mature T-cell leukemia cell lines Jurkat" 1)
   ("the T lymphoblastic leukemia/lymphoma cell line Jurkat" 1)))
 ("UP:Q86T03" (("TMEM55B" 1) ("transmembrane protein 55B" 1)))
 ("UP:Q86T24" (("ZBTB33" 7))) ("UP:Q86T65" (("DAAM2" 4)))
 ("UP:Q86T75" (("NBPF11" 1)))
 ("UP:Q86T82" (("USP37" 117) ("FLAG-HA-tagged USP37" 1)))
 ("UP:Q86T90" (("KIAA1328" 1))) ("UP:Q86T96" (("RNF180" 3)))
 ("UP:Q86TA1" (("MOBKL2b" 1))) ("UP:Q86TB9" (("PATL1" 2)))
 ("UP:Q86TC9" (("MYPN" 4) ("myopalladin" 2) ("Myopalladin" 1)))
 ("UP:Q86TD4" (("SRL" 140) ("Srl" 11) ("srl" 10) ("sarcalumenin" 1)))
 ("UP:Q86TG7"
  (("EDR" 19) ("PEG10" 10) ("peg10" 1) ("paternally expressed 10" 1)
   ("Paternally expressed 10" 1) ("microvascular EDR" 1)))
 ("UP:Q86TI0"
  (("TBC1D1" 8) ("TBC1" 8) ("TBC1 domain family member 1" 2) ("p-TBC1D1" 2)
   ("TbC1" 1)))
 ("UP:Q86TI2" (("DPP9" 16) ("dipeptidyl peptidase 9" 1)))
 ("UP:Q86TI4" (("WDR86" 1))) ("UP:Q86TJ2" (("ADA2B" 2)))
 ("UP:Q86TM3" (("CT26" 31) ("cagE" 14) ("CagE" 4)))
 ("UP:Q86TM6" (("Hrd1" 116) ("HRD1" 10) ("SYNOVIOLIN" 2) ("synoviolin" 2)))
 ("UP:Q86TX2" (("ACH2" 35) ("acH2" 2) ("ACOT1" 1) ("Acot1" 1)))
 ("UP:Q86U10" (("asparaginase" 14) ("Asparaginase" 1)))
 ("UP:Q86U42" (("PABPN1" 5) ("pAB2" 2) ("Poly(A)-binding protein II" 1)))
 ("UP:Q86U44" (("m6a" 3)))
 ("UP:Q86U70" (("CLIM2" 37) ("Clim2" 34) ("Ldb1" 16) ("NLI" 4) ("LDB1" 2)))
 ("UP:Q86U86"
  (("PB1" 271) ("PBRM1" 29) (NIL 17) ("BAF180" 4)
   ("two structurally-related PB1" 2)
   ("the influenza A virus polymerase subunit PB1" 1)))
 ("UP:Q86U90"
  (("ischemia" 1380) ("cerebral ischemia" 79) ("Ischemia" 35)
   ("myocardial ischemia" 23) ("focal cerebral ischemia" 13)
   ("transient focal cerebral ischemia" 11) ("acute ischemia" 10)
   ("renal ischemia" 7) ("focal ischemia" 4) ("cardiac ischemia" 4)
   ("Focal cerebral ischemia" 4) ("YrdC" 4)
   ("45 minute transient cerebral ischemia" 4) ("chronic ischemia" 3)
   ("placental ischemia" 3) ("Renal ischemia" 3)
   ("transient cerebral ischemia" 3) ("local ischemia" 2)
   ("cerebrovascular ischemia" 2) ("chronic myocardial ischemia" 2)
   ("warm ischemia" 2) ("subsequent tissue ischemia" 2)
   ("cerebral and myocardial ischemia" 2)
   ("middle cerebral artery occlusion-induced ischemia" 2) ("ischemia (CLI)" 2)
   ("global ischemia" 2) ("experimental cerebral ischemia" 2)
   ("exercise-induced cardiac ischemia" 2)
   ("model transient focal cerebral ischemia" 2)
   ("Transient focal cerebral ischemia" 2) ("transient focal ischemia" 1)
   ("40 min warm ischemia" 1) ("Resultant ischemia" 1)
   ("namely 1 min ischemia" 1)
   ("coronary artery disease reduced myocardial ischemia" 1)
   ("acute myocardial ischemia" 1) ("the herewith associated ischemia" 1)
   ("the subsequent ischemia" 1) ("tumor-associated ischemia" 1)
   ("30 min renal ischemia" 1) ("a segmental (∼70%) hepatic ischemia" 1)
   ("unilateral retinal ischemia" 1) ("total global ischemia" 1)
   ("severe ischemia" 1) ("uteroplacental ischemia" 1) ("vascular ischemia" 1)
   ("acute hindlimb ischemia" 1) ("Cerebral ischemia" 1)
   ("neuronal ischemia" 1) ("gross ischemia" 1) ("regional ischemia" 1)
   ("postnatal ischemia" 1) ("unilateral limb ischemia" 1) ("ischemia-" 1)
   ("acute hind limb ischemia" 1)))
 ("UP:Q86UC2" (("RSHL2" 1)))
 ("UP:Q86UE4"
  (("AEG-1" 378) ("MTDH" 52) ("metadherin" 12) ("astrocyte elevated gene-1" 8)
   ("Astrocyte elevated gene-1" 5) ("AEG-1 protein" 3) ("LYRIC" 3)
   ("Metadherin" 3) ("AEG-1 (MTDH)" 2) ("Membranous AEG-1" 1)
   ("metadherin (MTDH)" 1)))
 ("UP:Q86UE8" (("TLK2" 2) ("Tousled-like kinase 2" 1)))
 ("UP:Q86UF1"
  (("Pen" 91) ("pen" 89) ("penumbra" 26) ("pEN" 6) ("PEN" 5)
   ("the ischemic penumbra" 5) ("an apoptotic penumbra" 2)
   ("this ischemic penumbra" 1) ("ischemic penumbra" 1)))
 ("UP:Q86UG4"
  (("GST" 14321) ("GST protein" 96) ("GST-" 82) ("pGST" 35) ("-GST" 30)
   ("–GST" 7) ("bacterial GST" 4) ("GST–" 3) ("GST peptide" 3)
   ("GST Protein" 2) ("overexpressed GST-" 2) ("GDP-treated GST" 1)
   ("than the control GST protein" 1) ("ProFound Pull-Down GST Protein" 1)
   ("GST (GSTP)" 1) ("Dual GST" 1) ("associated GST" 1)
   ("amino (N)-terminal GST" 1) ("FLAG-hp53(ch)GST and myc -hp53(ch)GST" 1)
   ("FLAG-hp53(ch)GST, and FLAG-NLS-hp53(ch)GST" 1) ("than GST-S147P" 1)
   ("The amount bead-bound GST protein" 1) ("soluble GST" 1)
   ("than cad-GST ( xref B, lanes 1 and 2)" 1) ("soluble GST protein" 1)
   ("beads-linked GST" 1) ("than control GST" 1)
   ("the heterologous carrier protein GST" 1)))
 ("UP:Q86UK0" (("ABCA12" 3) ("member 12" 3))) ("UP:Q86UL3" (("zeta)" 10)))
 ("UP:Q86UL8" (("MAGI-2" 7) ("Magi-2" 1) ("MAGI-2 protein" 1) ("MAGI2" 1)))
 ("UP:Q86UP2" (("KTN1" 2)))
 ("UP:Q86UP3" (("ZFHX4" 14) ("zinc finger homeobox 4" 2)))
 ("UP:Q86UR1"
  (("NoxA1" 238) ("NOXA1" 41) ("NoxA1 protein" 3) ("Noxa1" 2)
   ("NADPH oxidase activator 1" 2) ("NOX activator 1" 1)))
 ("UP:Q86UR5" (("RIMS1" 2) ("RIM1" 1)))
 ("UP:Q86US8" (("EST1A" 21) ("SMG6" 7) ("Smg6" 2) ("SMG-6" 1) ("KIAA0732" 1)))
 ("UP:Q86UT6"
  (("NLRX1" 16) ("NLR family" 12) ("NLR family member X1" 2) ("Nlrx1" 1)
   ("NOD-like receptor X1" 1)))
 ("UP:Q86UU0" (("BCL9L" 14))) ("UP:Q86UU1" (("PHLDB1" 28)))
 ("UP:Q86UU5" (("GGN" 115) ("shorter GGN" 3) ("longer GGN" 1)))
 ("UP:Q86UU9" (("TAC4" 1))) ("UP:Q86UV5" (("USP48" 1) ("USP31" 1)))
 ("UP:Q86UW1" (("OSTα" 1))) ("UP:Q86UW6" (("N4BP2" 1)))
 ("UP:Q86UW7" (("CADPS2" 2))) ("UP:Q86UW9" (("DTX2" 1)))
 ("UP:Q86UX2" (("ITIH5" 60)))
 ("UP:Q86UX7"
  (("MIG-2" 17) ("kindlin-3" 11) ("URP2" 3) ("FERMT3" 3)
   ("fermitin family member 3" 3) ("defective kindlin-3" 1) ("kindlin 3" 1)))
 ("UP:Q86UY5" (("FAM83A" 81) ("FAM83A-" 1)))
 ("UP:Q86V15" (("CST" 305) ("SRG" 7) ("CASZ1" 4))) ("UP:Q86V21" (("AACS" 1)))
 ("UP:Q86V24"
  (("AdipoR2" 35) ("AdipoR2-" 2)
   ("than AdipoR2 in HUVEC (relative mRNA abundance [normalized against GAPDH]: AdipoR1=0.67±0.04; AdipoR2=0.31±0.03, P<0.01)"
    1)
   ("adiponectin receptor 2" 1)))
 ("UP:Q86V25"
  (("VASH2" 139) ("overexpressed VASH2" 2) ("Vasohibin 2" 2)
   ("vasohibin 2" 2)))
 ("UP:Q86V81" (("Aly" 33) ("ALY" 11) ("THOC4" 1) ("BeF" 1)))
 ("UP:Q86V85" (("GPR180" 1)))
 ("UP:Q86V86"
  (("Pim-3" 78) ("Pim3" 26) ("PIM-3" 21) ("PIM3" 12) ("Pim-3 protein" 1)))
 ("UP:Q86V88" (("Mdp1" 1))) ("UP:Q86V97" (("KBTBD6" 2)))
 ("UP:Q86VB7" (("CD163" 95) ("M130" 6) ("sCD163" 4)))
 ("UP:Q86VD1" (("MORC" 16) ("MORC1" 12))) ("UP:Q86VD9" (("SMP3" 1)))
 ("UP:Q86VI3" (("IQGAP3" 20)))
 ("UP:Q86VI4"
  (("LAPTM4B" 305) ("LAPTM4B protein" 5)
   ("lysosomal protein transmembrane 4 beta" 5)))
 ("UP:Q86VL8" (("SLC47A2" 1) ("MATE2" 1)))
 ("UP:Q86VP1"
  (("TAX1BP1" 182) ("Tax1bp1" 51) ("the paralogous protein Tax1bp1" 1)))
 ("UP:Q86VP3"
  (("PACS-2" 256) ("PACS-2S" 13) ("PACS-2 protein" 2)
   ("mAb 81-positive PACS-2" 2)))
 ("UP:Q86VP6"
  (("CAND1" 172) ("Cand1" 152) ("TIP120" 2) ("available CAND1" 1)
   ("that Cand1’s" 1) ("pure Cand1" 1)))
 ("UP:Q86VQ1" (("Glcci1" 4)))
 ("UP:Q86VQ6" (("TGR" 59) ("Txnrd3" 4) ("TGRs" 1)))
 ("UP:Q86VR2" (("Fam134c" 15))) ("UP:Q86VR8" (("Fjx1" 1)))
 ("UP:Q86VS8" (("Hook3" 1)))
 ("UP:Q86VW0" (("solo" 12) ("SOLO" 2) ("SESTD1" 1)))
 ("UP:Q86VW1"
  (("CT2" 25) ("Armenian hamster anti–MUC1-CT antibody CT2" 2) ("SLC22A16" 1)))
 ("UP:Q86VW2" (("GEFT" 21) ("p63RhoGEF" 3) ("Overexpressed GEFT" 2)))
 ("UP:Q86VX9" (("SAND1" 1))) ("UP:Q86VY4" (("TSPYL5" 2)))
 ("UP:Q86VY9" (("Tmem200a" 1))) ("UP:Q86VZ1" (("P2RY8" 3)))
 ("UP:Q86VZ5" (("Mob" 22) ("MOB" 8) ("SMS1" 8) ("protocol number MOB005" 1)))
 ("UP:Q86VZ6" (("JAZF1" 85))) ("UP:Q86W10" (("CYP4Z1" 13)))
 ("UP:Q86W47" (("KCNMB4" 37)))
 ("UP:Q86W56"
  (("PARG" 379) ("Parg" 8) ("pArg" 7) ("functional PARG" 3)
   ("exogenous PARG" 1) ("poly(ADP-ribose) glycohydrolase" 1)))
 ("UP:Q86W92" (("PPFIBP1" 6) ("Sgt2" 3))) ("UP:Q86WA8" (("LONP2" 1)))
 ("UP:Q86WB0"
  (("NIPA" 16) ("ZC3HC1" 4) ("ZC3HC1 (NIPA)" 1)
   ("nuclear interacting partner of ALK" 1)))
 ("UP:Q86WC4" (("OSTM1" 2)))
 ("UP:Q86WG3" (("BNIP-H" 213) ("Caytaxin" 4) ("ATCAY" 3)))
 ("UP:Q86WH2" (("RASSF3" 204) ("Rassf3" 2) ("ectogenic RASSF3" 1)))
 ("UP:Q86WI3" (("NLRC5" 18) ("Nlrc5" 1)))
 ("UP:Q86WJ1" (("CHD1L" 47) ("Alc1" 7) ("Chd1L" 1)))
 ("UP:Q86WN1" (("FCHSD1" 3))) ("UP:Q86WP2" (("GPBP1" 1)))
 ("UP:Q86WV1" (("SKAP1" 178) ("Skap1" 5) ("SKAP55" 4) ("SKAP-1" 2)))
 ("UP:Q86WV6" (("MITA" 28) ("TMEM173" 10) ("mista" 9)))
 ("UP:Q86WX3"
  (("AROS" 312) ("AROS protein" 17) ("Active regulator of SIRT1" 11)
   ("RPS19BP1" 5) ("AROS (active regulator of Sirt1) protein" 2)))
 ("UP:Q86X10" (("KIAA1219" 4) ("p170" 2) ("P170" 1)))
 ("UP:Q86X27" (("RalGPS2" 1))) ("UP:Q86X29" (("LSR" 275) ("Lisch" 44)))
 ("UP:Q86X45" (("LRRC6" 2))) ("UP:Q86X52" (("CHSY1" 5)))
 ("UP:Q86X55"
  (("CARM1" 383) ("PRMT4" 9)
   ("coactivator-associated arginine methyltransferase 1" 8) ("CARM-1" 6)
   ("coactivator associated arginine methyltransferase 1" 5)
   ("PRMT4 protein" 4) ("exogenous CARM1" 2) ("targeting human CARM1" 2)))
 ("UP:Q86X67" (("NUDT13" 1))) ("UP:Q86X76" (("NIT1" 18)))
 ("UP:Q86X95" (("CIR-1" 4) ("CIR1" 2) ("CBF1 interacting corepressor" 1)))
 ("UP:Q86XA0" (("METTL23" 2))) ("UP:Q86XF0" (("DHFR2" 3)))
 ("UP:Q86XI6"
  (("phosphatase-1" 66) ("Phosphatase-1" 13) ("PPP1R3B" 11) ("PTG" 6)
   ("Ppp1r3b" 5) ("phosphatase–1" 5)))
 ("UP:Q86XI8" (("LOC374920" 1))) ("UP:Q86XK2" (("FBXO11" 131) ("Fbxo11" 59)))
 ("UP:Q86XL3" (("LEM4" 3))) ("UP:Q86XN6" (("ZNF761" 2)))
 ("UP:Q86XP1"
  (("DGKH" 14) ("diacylglycerol kinase eta" 4)
   ("diacylglycerol kinase eta ( DGKH )" 1)))
 ("UP:Q86XP3" (("Subunit 8" 4) ("splicing factor 3b" 2) ("subunit 8" 1)))
 ("UP:Q86XP6"
  (("blot" 17420) ("Western blot" 3224) ("western blot" 1901) ("Blot" 1886)
   ("Western Blot" 494) ("WB" 166) ("Southern blot" 93) ("Northern blot" 79)
   ("the Western blot" 72) ("the western blot" 72) ("a Western blot" 41)
   ("a western blot" 39) ("northern blot" 38) ("The Western blot" 30)
   ("Western blot (WB)" 26) ("using Western blot" 20) ("using western blot" 12)
   ("The western blot" 12) ("A western blot" 12) ("western blot (WB)" 10)
   ("Southern Blot" 10) ("Northern Blot" 10) ("our western blot" 9)
   ("both Western blot" 9) ("A representative western blot" 8)
   ("a representative blot" 8) ("both western blot" 7)
   ("quantitative western blot" 6) ("Western Blot (WB)" 6)
   ("Our western blot" 5) ("A Western blot" 5) ("our Western blot" 5)
   ("the same Western blot" 5) ("BLOT" 5) ("ex vivo Western blot" 5)
   ("A representative Western blot" 4) ("2.3 Western blot" 4)
   ("a representative Western blot" 4) ("Blot (WB)" 4)
   ("quantitative Western blot" 4) ("the Northern blot" 3)
   ("anti-PTYR Western blot" 3) ("the Western Blot" 3)
   ("one representative blot" 3) ("Northern and western blot" 3)
   ("the Southern blot" 3) ("Both Western blot" 3) ("a Southern blot" 3)
   ("Conventional Western blot" 3) ("multiple tissue Northern blot" 2)
   ("This Southern blot" 2) ("Multiple Tissue Northern  blot" 2)
   ("Northern and Western blot" 2) ("western blot (IPW)" 2)
   ("Far-Western blot" 2) ("Far western blot" 2)
   ("Phosphorylation-Specific Western Blot" 2) ("Western and Northern Blot" 2)
   ("anti-STAT5 Western Blot" 2) ("southern blot" 2)
   ("calibrated Western blot" 2) ("IP western blot" 2)
   ("a representative western blot" 2) ("a northern blot" 2)
   ("subsequent western blot" 2) ("Representative blot" 2)
   ("cell lines Western blot" 2) ("NF-κB2/p100 western blot" 2)
   ("conventional western blot" 2) ("quantitative northern blot" 2)
   ("one Western blot" 2) ("Flag western blot" 2)
   ("an anti-Plk1 western blot" 2) ("Quantitative western blot" 2)
   ("PTEN western blot" 2) ("Our Western blot" 2) ("relative Western blot" 2)
   ("Uncropped western blot" 2) ("a poor p21 Western blot" 2)
   ("each western blot" 2) ("a standard Western blot" 2)
   ("than western blot" 2) ("conventional Western blot" 2) ("Preliminary WB" 2)
   ("Subsequent western blot" 2) ("LC3 western blot" 2) ("a Northern blot" 2)
   ("A Southern blot" 2) ("radioactive Southern blot" 2)
   ("anti-RAB7 western blot" 2) ("Stat3 western blot" 2)
   ("semiquantitative western blot" 2) ("Both Southern blot" 2)
   ("a simple western blot" 2) ("A Far Western blot" 2)
   ("Western blot protein" 2) ("a control western blot" 2)
   ("Small RNA Northern Blot" 2) ("A full-length western blot" 2)
   ("A typical Southern blot" 2) ("2.9 Western blot" 2)
   ("the previously described thioredoxin redox western blot" 2)
   ("CCN2 western blot" 2) ("2.5 Western blot" 2) ("Far Western Blot" 2)
   ("transferred nitrocellulose blot" 2) ("Erasable blot" 2)
   ("CF-KO MΦs buy Western blot" 2) ("multiple tissue Northern (MTN) blot" 1)
   ("this Northern blot" 1) ("anti-gp30/40 Western blot" 1)
   ("a Far-Western blot" 1) ("our Northern blot" 1)
   ("western
blot"
    1)
   ("using phosphorylation-specific Western blot" 1) ("using northern blot" 1)
   ("our original western blot" 1) ("The second western blot" 1)
   ("The first western blot" 1) ("2-D Western blot" 1) ("capillary blot" 1)
   ("a parallel western blot" 1) ("performing Southern blot" 1)
   ("the southwestern blot" 1) ("simultaneous western and southwestern blot" 1)
   ("using Western blot (WB)" 1) ("-blot" 1)
   ("the corresponding Western blot" 1) ("This Western blot" 1)
   ("this Western blot" 1) ("The same northern blot" 1) ("western Blot" 1)
   ("sequential western blot" 1) ("K1 cells Western blot" 1)
   ("an ubiquitin western blot" 1) ("the loading control Southern Blot" 1)
   ("All the western blot" 1) ("immunoprecipitation (IP)–Western blot" 1)
   ("4°C. Western blot" 1) ("each subsequent blot" 1)
   ("anti-Plk1 western blot" 1) ("phospho-p38 western blot" 1)
   ("an anti-p38α western blot" 1) ("An anti-Jak2 Western blot" 1)
   ("Complete western blot" 1) ("1 Western blot" 1) ("37°C. Western blot" 1)
   ("anti-EGFR western blot" 1) ("3 independent Western blot" 1)
   ("both ex vivo Western blot" 1) ("downstream western blot" 1)
   ("than Western blot" 1) ("supports western blot" 1)
   ("Important uncropped western blot" 1) ("Further western blot" 1)
   ("Each Western blot" 1) ("the representative blot" 1)
   ("ULK3FLAG western blot" 1) ("β-actin western blot" 1)
   ("a standard western blot" 1) ("using Western Blot" 1)
   ("Far-western blot" 1) ("blot, co-immunoprecipitation" 1)
   ("far-western blot" 1) ("all the Western Blot" 1)
   ("The HDAC5-specific Western blot" 1) ("blot, qRT-PCR" 1)
   ("Nrf2 western blot" 1) ("using Southern Blot" 1)
   ("subsequent Western blot" 1) ("corresponding Western blot" 1)
   ("δ-catenin Western blot" 1) ("these Western blot" 1)
   ("our previous western blot" 1) ("at least three Western blot" 1)
   ("Stat3 IP and GATA-1 western blot" 1)
   ("Four independent approaches—western blot" 1)
   ("the aforementioned Northern blot" 1) ("similar Southern blot" 1)
   ("One western blot" 1) ("A new blot" 1) ("blot protein" 1)
   ("the standard Western Blot" 1) ("A representative blot" 1)
   ("A typical Western blot" 1) ("the same western blot" 1)
   ("the same Northern blot" 1) ("We first conducted western blot" 1)
   ("a “Far-Western” blot" 1) ("parallel Western blot" 1)
   ("Parallel Western blot" 1) ("JAR cells both Northern blot" 1)
   ("mouse BRIT1 and anti-BRIT1 Western blot" 1) ("each Western Blot" 1)
   ("both Southern blot" 1) ("representative western blot" 1)
   ("An anti-PRMT1 western blot" 1) ("the p53 western blot" 1)
   ("each respective blot" 1) ("northern and western blot" 1)
   ("non-reducing western blot" 1) ("the Fast Western Blot" 1)
   ("Several Western blot" 1) ("the survivin western blot" 1)
   ("IP-Western blot" 1) ("the Northern Blot" 1) ("Baf53 western blot" 1)
   ("all Western blot" 1) ("Quantitative Western blot" 1)
   ("the Southwestern blot" 1) ("a satisfactory 18E6 Western blot" 1)
   ("A standard western blot" 1) ("the representative western blot" 1)
   ("only one western blot" 1) ("the pan-cadherin western blot" 1)
   ("a reciprocal Far-Western blot" 1) ("previous Western blot" 1)
   ("direct western blot" 1) ("mouse MDMX western blot" 1)
   ("mouse MDM2 western blot" 1) ("p53 western blot" 1) ("MDMX western blot" 1)
   ("the scanned Southern blot" 1) ("the aforementioned Western blot" 1)
   ("All Western blot" 1) ("using Northern blot" 1)
   ("an anti-RasGRP1 Western blot" 1) ("myc Western blot" 1)
   ("competitive western blot" 1) ("The repetitive blot" 1) ("GKN2" 1)
   ("a similar Western blot" 1) ("representative Western blot" 1)
   ("using both Southern blot" 1) ("the RhoA western blot" 1)
   ("SDS-PAGE protein samples Western blot" 1)
   ("combined immunoprecipitation-western blot" 1) ("Similar western blot" 1)
   ("a triangular blot" 1) ("Reciprocal immunoprecipitation-Western blot" 1)
   ("standard western blot" 1) ("30°C. Western blot" 1)
   ("the reciprocal immunoprecipitation-Western blot" 1)
   ("immunoprecipitation-Western blot" 1) ("a p53 Western blot" 1)
   ("a BRCA1 Western blot" 1) ("antiphosphotyrosine western blot" 1)
   ("The representative Western blot" 1) ("Typical Western blot" 1)
   ("a quantitative Western blot" 1) ("Anti-STAT3 western blot" 1)
   ("Western blot (IB)" 1) ("The southern blot" 1)))
 ("UP:Q86XQ3" (("CATSPER3" 7)))
 ("UP:Q86XR5" (("PRIMA-1" 209) ("PRIMA" 4) ("Prima-1" 3) ("PRIMA-" 1)))
 ("UP:Q86XS8" (("RNF130" 12) ("RNF130 protein" 3) ("Goliath" 3)))
 ("UP:Q86XT4" (("TRIM50" 136) ("Trim50" 27) ("TRIM50 protein" 2)))
 ("UP:Q86Y01"
  (("DELTEX1" 25) ("Deltex1" 15) ("Deltex-1" 3) ("DTX1" 2) ("Dtx1" 2)))
 ("UP:Q86Y07"
  (("VRK2" 125) ("VRK2A" 111) ("VRK2A protein" 7) ("VRK2 protein" 3)
   ("more VRK2A" 2)))
 ("UP:Q86Y22" (("COL23A1" 2)))
 ("UP:Q86Y26"
  (("nut" 64) ("NUT" 42) ("Nut" 11) ("whose mothers chew betel nut" 1)
   ("Approximately 600 million people chew Betel nut" 1)))
 ("UP:Q86Y33" (("Cdc20B" 5) ("CDC20B" 1) ("CDC20b" 1)))
 ("UP:Q86Y37" (("cac1" 19) ("Cac1" 7) ("CAC1" 4) ("CaC1" 3)))
 ("UP:Q86Y39" (("NDUFA11" 2)))
 ("UP:Q86Y97"
  (("SUV420H2" 125) ("Suv4-20h2" 9) ("Suv420h2" 4) ("SUV420H2 protein" 4)
   ("Suv4-20H2" 3) ("protein associations around SUV420H2" 1)))
 ("UP:Q86YB8" (("Ero1-Lβ" 5) ("Ero1B" 1) ("Ero1b" 1)))
 ("UP:Q86YC2"
  (("PALB2" 1390) ("Fanconi anemia" 245) ("Fanconi Anemia" 68) ("FANCN" 51)
   ("PALB2 protein" 31) ("Palb2" 29) ("partner and localizer of BRCA2" 16)
   ("Fanconi anemia (FA)" 12) ("PalB2" 7) ("fanconi anemia" 5)
   ("hereditary Fanconi anemia" 4) ("Fanconi anemia protein" 3)
   ("PALB2-T1030I protein" 2) ("FANCONI ANEMIA" 2) ("PALB2 (FANCN)" 2)
   ("Flag-HA-tagged PALB2" 2) ("exogenous PALB2" 2)
   ("exogenous murine Palb2" 2) ("monoallelic PALB2" 1)
   ("than PALB2 ( xref )" 1) ("simultaneous Fanconi anemia" 1)
   ("than wild-type PALB2 ( xref )" 1) ("PalB2 protein" 1)
   ("Fanconi Anemia (FA)" 1) ("Partner and localizer of BRCA2" 1)
   ("Partner and Localizer of BRCA2" 1) ("the recurrent Finnish PALB2" 1)
   ("the autosomal recessive disorders Fanconi Anemia" 1)
   ("the hereditary disease Fanconi anemia" 1) ("PALB2-" 1) ("less PALB2" 1)
   ("FLAG-HA-double tagged PALB2" 1)))
 ("UP:Q86YD1" (("PTOV1" 3)))
 ("UP:Q86YH6" (("candidate tumor suppressor protein" 3) ("PDSS2" 1)))
 ("UP:Q86YL7"
  (("podoplanin" 55) ("T1a" 20) ("PDPN" 13) ("T1A" 7) ("Podoplanin" 2)
   ("gp36" 2) ("the mesenchymal marker podoplanin" 1)))
 ("UP:Q86YM7" (("Homer1b" 1)))
 ("UP:Q86YN6"
  (("PGC-1β" 129) ("PGC1" 30) ("coactivator 1" 25) ("Synovial PGC-1β" 1)
   ("PGC1beta" 1) ("PPARGC1B" 1)))
 ("UP:Q86YP4" (("p66alpha" 2) ("GATAD2A" 1) ("Gatad2A" 1)))
 ("UP:Q86YR5"
  (("GPSM1" 21) ("AGS3" 2) ("soluble GPSM1 protein" 1) ("GPSM1 protein" 1)))
 ("UP:Q86YS6" (("Rab43" 15)))
 ("UP:Q86YT5" (("NACT" 105) ("twenty-two underwent NACT" 1)))
 ("UP:Q86YT6"
  (("MIB1" 430) ("MIB-1" 200) ("Mib1" 13) ("mib1" 5) ("overexpressed MIB1" 4)
   ("the monoclonal mouse Ab MIB-1" 2) ("Percent MIB-1" 2) ("MiB-1" 1)
   ("Mib-1" 1)))
 ("UP:Q86YT9"
  (("adhesion molecule" 317) ("intercellular adhesion molecule (ICAM)" 18)
   ("intercellular adhesion molecule" 7) ("adhesion molecule (ICAM)" 6)
   ("junctional adhesion molecule (JAM)" 5)
   ("another endothelial-specific adhesion molecule" 3)
   ("an epithelial adhesion molecule" 2) ("a basal adhesion molecule" 2)
   ("epithelial adhesion molecule" 2)
   ("the standard mesothelial markers intercellular adhesion molecule (ICAM)"
    2)
   ("a homotypic intercellular adhesion molecule" 2)
   ("soluble intercellular adhesion molecule (ICAM)" 2)
   ("a Ca2 + -dependent intercellular adhesion molecule" 2)
   ("an intercellular adhesion molecule" 2) ("Adhesion molecule" 2)
   ("a transmembrane adhesion molecule" 2)
   ("a synaptogenic adhesion molecule" 1)
   ("a calcium-dependent intercellular adhesion molecule" 1)
   ("homophilic adhesion molecule" 1) ("a key adhesion molecule" 1)))
 ("UP:Q86YV9"
  (("RU" 223) ("Ru" 34) ("rU" 2) ("approximately 250 RU" 2)
   ("approximately 600 RU" 2) ("HPS6" 1) ("Approximately 100 RU" 1)))
 ("UP:Q86YW9" (("MED12L" 2)))
 ("UP:Q86Z02"
  (("HIPK1" 31) ("homeodomain-interacting protein kinase 1" 9)
   ("homeodomain-interacting protein kinase" 8)
   ("Homeodomain-interacting protein kinase" 2)))
 ("UP:Q86Z14"
  (("KLB" 316) ("β-Klotho" 4) ("betaKlotho" 4) ("BetaKlotho" 2) ("KLB-" 2)
   ("BKL" 2) ("the transmembrane KLB" 1) ("than KLB" 1)
   ("betaKlotho (KLB)" 1)))
 ("UP:Q88E10" (("MCPs" 2))) ("UP:Q88FY4" (("NICE" 4)))
 ("UP:Q88ZS6" (("GNP" 74) ("GNP-" 3)))
 ("UP:Q89613"
  (("NS5A" 520) ("NS5A protein" 25) ("-NS5A" 8) ("Phe (Y334F) of NS5A" 2)
   ("Phe (Y129F) of NS5A" 2) ("NS5a" 1)))
 ("UP:Q89786" (("NS5B" 26)))
 ("UP:Q89894" (("Sm protein" 3) ("a typical Sm protein" 1)))
 ("UP:Q89A24" (("PITA" 24) ("pita" 1) ("Pita" 1))) ("UP:Q89QH2" (("FRC" 5)))
 ("UP:Q8AMB3"
  (("Tax protein" 59) ("the viral Tax protein" 3) ("The viral Tax protein" 2)
   ("the well-studied Tax protein" 1)
   ("the Human T-Lymphotropic Virus type 1 (HTLV-1) Tax protein" 1)
   ("the homologous Tax protein" 1)))
 ("UP:Q8AWH1"
  (("FoxA1" 641) ("FoxA1 protein" 3) ("soluble FoxA1" 2) ("more FoxA1" 1)
   ("the previously characterized ERα-associated pioneer factor FoxA1" 1)))
 ("UP:Q8AWZ0" (("HoxB8" 21)))
 ("UP:Q8AZL8" (("RdRP" 76) ("RdRPs" 17) ("right-handed RdRPs" 1)))
 ("UP:Q8BB12" (("NS0" 1))) ("UP:Q8BG22" (("mCLCA5" 5)))
 ("UP:Q8BG36" (("TERRA" 4))) ("UP:Q8BHF7" (("SAF" 3)))
 ("UP:Q8BPX9" (("CI1" 11))) ("UP:Q8BVW3" (("PUB" 10)))
 ("UP:Q8C025" (("DN4" 49)))
 ("UP:Q8C0T9"
  (("sacs" 58) ("Sacs" 15) ("SACs" 11) ("ovarian SACs" 2) ("tiny air sacs" 1)
   ("46 ovarian SACs" 1)))
 ("UP:Q8C145" (("‘ermelin’ protein" 3) ("ermelin" 2) ("‘ermelin’" 1)))
 ("UP:Q8C4V4" (("AFH" 15)))
 ("UP:Q8CAV0"
  (("ribonuclease" 137) ("Ribonuclease" 20) ("ribonuclease (PARN)" 2)
   ("a multi-functional ribonuclease" 2) ("the key ribonuclease" 1)))
 ("UP:Q8CGU1" (("cocoa" 6) ("CoCoA" 2))) ("UP:Q8CJ69" (("CV2" 13)))
 ("UP:Q8DV10" (("CAPP" 1)))
 ("UP:Q8FAD9" (("arginine deiminase" 2) ("Arginine deiminase" 1)))
 ("UP:Q8FVH5"
  (("aminotransferase" 75) ("aminotransferase (ALT)" 21)
   ("Aminotransferase" 2)))
 ("UP:Q8FZV0" (("CCRB" 1)))
 ("UP:Q8G6Z9" (("dipeptidase" 10) ("dipeptidase activity" 9)))
 ("UP:Q8GAI8" (("SAD" 51) ("pSAD" 2) ("typical SAD" 1)))
 ("UP:Q8GAJ0" (("MAO" 31) ("Mao" 2))) ("UP:Q8GBD3" (("GroES" 3)))
 ("UP:Q8GCB2"
  (("PEL" 409) ("the three extracavitary PEL" 1) ("The extracavitary PEL" 1)))
 ("UP:Q8GSQ1" (("dwarf" 10)))
 ("UP:Q8GTR4" (("LDA" 28) ("PU1" 5) ("pU-1" 1) ("Pu-1" 1)))
 ("UP:Q8GYJ3" (("ACK2" 8))) ("UP:Q8GYT9" (("SIS3" 77)))
 ("UP:Q8GZ17" (("SEB1" 1) ("Seb1" 1) ("SEB-1" 1))) ("UP:Q8H074" (("pT1-2" 13)))
 ("UP:Q8H0D3" (("CS6" 18)))
 ("UP:Q8H1F2"
  (("AtRGS1" 12) ("the conjoint 7TM/RGS-box Arabidopsis protein AtRGS1" 1)))
 ("UP:Q8HAE6" (("Dec" 60))) ("UP:Q8HZV4" (("δ-tubulin" 2)))
 ("UP:Q8I1F4" (("FIB" 42) ("fib" 7) ("Fib" 3)))
 ("UP:Q8I1I3"
  (("endophilin A" 4) ("Endophilin A" 4)
   ("the synaptic vesicle endocytosis protein Endophilin A" 2)))
 ("UP:Q8I2J4" (("PFN" 2))) ("UP:Q8I7X1" (("AGH" 1)))
 ("UP:Q8INB9" (("Dakt1" 3) ("dAkt" 2) ("dAKT" 1)))
 ("UP:Q8INM3"
  (("SLE" 2194) ("developed SLE" 2) ("than SLE" 1)
   ("reported Caucasian ancestry revealed 51 SLE" 1)
   ("the 1,610 Caucasian SLE" 1) ("1,610 Caucasian SLE" 1)
   ("the 124 chart-confirmed SLE" 1)
   ("46 medical record-confirmed female SLE" 1) ("late adult-onset SLE" 1)
   ("than adult-onset SLE" 1) ("again both active and inactive SLE" 1)
   ("Mendelian juvenile-onset SLE" 1) ("monogenic SLE" 1)))
 ("UP:Q8IS15" (("GEFI" 3))) ("UP:Q8IU29" (("OG" 106) ("-OG" 1)))
 ("UP:Q8IU54"
  (("IL-29" 157) ("IFN-λ1" 5) ("Interleukin-29" 3) ("IFNL1" 1)
   ("IFN-lambda1" 1) ("IFNλ1" 1)))
 ("UP:Q8IU57" (("IL-28R1" 18) ("IL28RA" 10) ("IFNLR1" 1)))
 ("UP:Q8IU60"
  (("Dcp2" 93) ("DCP2" 61) ("dcp2" 5) ("DCP2 protein" 4) ("P-DCP2" 2)
   ("the phosphodeficient Dcp2" 2) ("the phosphomimetic Dcp2" 2) ("p-DCP2" 1)
   ("smaller mammalian DCP2 protein" 1)
   ("the double-phosphodeficient Dcp2" 1)))
 ("UP:Q8IU80"
  (("TMPRSS6" 80) ("Tmprss6" 56) ("matriptase-2" 23) ("serine 6" 12)
   ("transmembrane protease, serine 6" 3) ("Matriptase-2" 1)))
 ("UP:Q8IU85" (("CAMK1D" 8))) ("UP:Q8IU99" (("CALHM1" 1)))
 ("UP:Q8IUA7" (("member 9" 12))) ("UP:Q8IUC4" (("RHPN2" 98) ("Rhophilin 2" 4)))
 ("UP:Q8IUC6"
  (("Tir" 27) ("TICAM1" 7) ("the bacterial effector Tir" 1)
   ("Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta"
    1)))
 ("UP:Q8IUD2" (("ELKS" 158) ("ELKS protein" 3)))
 ("UP:Q8IUD6"
  (("Riplet" 190) ("Riplet protein" 32) ("RNF135" 3)
   ("ectopically expressed Riplet" 3) ("targeted Riplet" 2)
   ("expressed Riplet" 2) ("Riplet-" 1) ("Reul" 1) ("REUL" 1)))
 ("UP:Q8IUF8"
  (("Mina" 2) ("roX" 1) ("MINA" 1) ("Myc induced nuclear antigen" 1)))
 ("UP:Q8IUG1" (("B2B" 2))) ("UP:Q8IUH3" (("DRB1" 108) ("DRB 1" 1)))
 ("UP:Q8IUH4" (("DHHC13" 2))) ("UP:Q8IUH5" (("ZDHHC17" 5) ("HIP14" 2)))
 ("UP:Q8IUH8" (("SPPL2C" 2)))
 ("UP:Q8IUI8"
  (("Myc-tagged" 621) ("myc-tagged" 399) ("p48" 75) ("MYC-tagged" 32)
   ("myc-tagged protein" 10) ("P48" 5) ("Myc-tagged protein" 3)
   ("myc–tagged" 1)))
 ("UP:Q8IUK5" (("PLXDC1" 4)))
 ("UP:Q8IUN9" (("HML" 8) ("CLEC10A" 1) ("the blood-specific Hml" 1) ("Hml" 1)))
 ("UP:Q8IUQ4"
  (("Siah-1" 214) ("SIAH1" 76) ("Siah1" 69) ("Siah 1" 8) ("Siah-1 protein" 5)
   ("SIAH1 protein" 2) ("seven in absentia homolog 1" 1)))
 ("UP:Q8IUR0" (("TRAPPC5" 2) ("TRS31" 1))) ("UP:Q8IUR6" (("C5orf41" 2)))
 ("UP:Q8IUX4" (("APOBEC3F" 47))) ("UP:Q8IUX7" (("AEBP1" 7)))
 ("UP:Q8IV04" (("TBC1D10C" 2))) ("UP:Q8IV08" (("PLD3" 1)))
 ("UP:Q8IV16" (("GPIHBP1" 2) ("LOC338328" 1))) ("UP:Q8IV56" (("PRR15" 1)))
 ("UP:Q8IV61"
  (("RasGRP3" 504) ("RASGRP3" 9) ("RasGRP3 protein" 5) ("CalDAG-GEFIII" 5)
   ("GRP3" 3) ("overexpressed RasGRP3" 2) ("previously shown RasGRP3" 1)
   ("Rasgrp3" 1)))
 ("UP:Q8IV63" (("VRK3" 5))) ("UP:Q8IV76" (("PASD1" 3)))
 ("UP:Q8IVA1"
  (("Purkinje cell protein 2" 2) ("pcp2" 1) ("GPSM4" 1) ("Pcp-2" 1)))
 ("UP:Q8IVB4" (("NHE9" 2))) ("UP:Q8IVD9" (("NUDCD3" 12)))
 ("UP:Q8IVF5" (("Tiam2" 15) ("STEF" 6) ("Stef" 1) ("TIAM2" 1)))
 ("UP:Q8IVF7" (("FMNL3" 68))) ("UP:Q8IVG5" (("SAMD9L" 4)))
 ("UP:Q8IVG9"
  (("HN" 316) ("H/N" 39) ("humanin" 5) ("Humanin" 4) ("HN protein" 4)
   ("HN-" 4)))
 ("UP:Q8IVH2" (("FOXP4" 1)))
 ("UP:Q8IVH8"
  (("MAP4K3" 6) ("mitogen-activated protein kinase kinase kinase kinase 3" 5)
   ("GLK" 3)))
 ("UP:Q8IVI9"
  (("inducer" 2325) ("NOSTRIN" 54) ("a strong inducer" 46)
   ("a weak inducer" 19) ("Inducer" 18) ("a well-known inducer" 12)
   ("a powerful inducer" 12) ("a major inducer" 8) ("a key inducer" 7)
   ("an apoptotic inducer" 5) ("a good inducer" 5) ("the major inducer" 4)
   ("an efficient inducer" 4) ("a classical apoptosis inducer" 3)
   ("a strong autophagy inducer" 3) ("a prototypic inducer" 3)
   ("a poor inducer" 3) ("strong inducer" 3) ("a typical inducer" 3)
   ("the primary inducer" 3) ("so far no other EMT inducer" 2)
   ("Similarly Cysteine-rich angiogenic inducer" 2)
   ("a positive transcriptional inducer" 2) ("a weak c-Fos inducer" 2)
   ("a therapeutic inducer" 2) ("TNF-related weak inducer" 2)
   ("a potent apoptotic inducer" 2) ("a translational inducer" 2)
   ("a classical inducer" 2) ("a well-described inducer" 2)
   ("a potent transcriptional inducer" 2) ("a very poor inducer" 2)
   ("nitric oxide synthase trafficker" 2) ("virtually every stress inducer" 2)
   ("a non-genotoxic inducer" 2) ("the strong oxidative stress inducer" 2)
   ("ribosomal stress inducer" 2) ("the nonselective apoptosis inducer" 2)
   ("a strong RSK activation inducer" 2) ("classical NF-κB inducer" 2)
   ("TNF-like weak inducer" 2) ("a more powerful inducer" 2)
   ("a canonical inducer" 2) ("a significantly less potent inducer" 2)
   ("a nonspecific apoptotic inducer" 2)
   ("a pharmacologic apoptosis inducer" 2) ("a strong NF-κB inducer" 2)
   ("Another robust inducer" 2) ("a mitotic inducer" 2)
   ("a highly efficient inducer" 2) ("a facultative inducer" 1)
   ("slower inducer" 1) ("a  strong inducer" 1) ("essential inducer" 1)
   ("The tumor necrosis factor (TNF) superfamily member TNF-like weak inducer"
    1)
   ("the apoptotic inducer" 1) ("a primary apoptotic inducer" 1)
   ("tumor necrosis factor-like weak inducer" 1) ("a strong Nrf2 inducer" 1)
   ("an oxidative-stress-induced chaperone inducer" 1)
   ("a well-characterized oxidative stress inducer" 1)
   ("stress-related inducer" 1) ("a more competent inducer" 1)
   ("classical apoptosis inducer" 1) ("a key potential upstream inducer" 1)
   ("a non-hypoxic inducer" 1) ("an oxidative stress inducer" 1)
   ("Tumor necrosis factor (TNF)-like weak inducer" 1)
   ("strong apoptosis inducer" 1) ("a well-recognized inducer" 1)
   ("a relevant inducer" 1) ("a crucial inducer" 1)
   ("a potential tumor inducer" 1) ("a very powerful inducer" 1)
   ("a common apoptotic inducer" 1) ("a rather poor inducer" 1)
   ("a previously established inducer" 1) ("an electrophilic inducer" 1)
   ("apoptotic inducer" 1) ("a known environmental inducer" 1)
   ("well-known inducer" 1) ("key inducer" 1) ("a very weak inducer" 1)
   ("the classical inducer" 1) ("strong leukemogenesis inducer" 1)
   ("a primary inducer" 1) ("faster inducer" 1)
   ("a significantly more
potent inducer"
    1)
   ("a unique inducer" 1) ("a principal inducer" 1) ("A possible inducer" 1)
   ("a more efficient inducer" 1) ("a possible apoptosis inducer" 1)
   ("a known intrinsic apoptotic inducer" 1) ("a third alternative inducer" 1)
   ("an alternate pathway inducer" 1) ("a non-oxidative inducer" 1)
   ("a possible inducer" 1) ("the key inducer" 1)))
 ("UP:Q8IVL0" (("NAV3" 1))) ("UP:Q8IVL1" (("NAV2" 2)))
 ("UP:Q8IVL6" (("protein B" 22) ("LEPREL2" 1)))
 ("UP:Q8IVN8" (("RPE-spondin" 1))) ("UP:Q8IVQ6" (("DHHC-21" 2)))
 ("UP:Q8IVS2"
  (("MT" 2667) ("mt" 145) ("MCT" 117) ("pMT" 67) ("Mt" 65) ("mT" 59)
   ("MCAT" 12) ("MT protein" 6) ("mtGFP" 6) ("mCAT" 5) ("mCT" 4)
   ("the thyroid hormone transporter MCT8" 1) ("an UBC9 phosphomimic mt" 1)
   ("pmT" 1) ("MCT protein" 1) ("EGFP-CLASP2–decorated lamella MT" 1) ("-mt" 1)
   ("than MOAP-1 MT" 1) ("Mt-" 1)))
 ("UP:Q8IVS8" (("GLYCTK" 1))) ("UP:Q8IVT2" (("mitotic spindle positioning" 2)))
 ("UP:Q8IVT5"
  (("KSR" 52) ("KSR1" 44) ("ksr1" 9) ("kinase suppressor of Ras 1" 5)
   ("KSR-1" 3) ("ksr" 2) ("Ksr" 1)))
 ("UP:Q8IVU9" (("c10orf107" 4))) ("UP:Q8IVW4" (("cdkl3" 1) ("CDKL3" 1)))
 ("UP:Q8IVY1" (("temp" 92) ("TEMP" 52) ("Temp" 7)))
 ("UP:Q8IW19"
  (("APLF" 38) ("Aprataxin and PNK-like factor" 1)
   ("aprataxin and PNKP like factor (APLF)" 1)
   ("aprataxin and PNKP like factor" 1)))
 ("UP:Q8IW35"
  (("modulators" 874) ("Modulators" 6) ("transcriptional modulators" 6)
   ("SERM" 4) ("potential modulators" 4) ("the epigenetic modulators" 4)
   ("modulators (SERM)" 3) ("modulators-" 3) ("pharmacologic modulators" 3)
   ("new modulators" 3) ("immune modulators" 3) ("epigenetic modulators" 3)
   ("the key modulators" 3) ("translational modulators" 3)
   ("monoaminergic modulators" 2) ("its proximal modulators" 2)
   ("multiple transcriptional modulators" 2) ("SERMs" 2)
   ("modulators (SERMS)" 2) ("the endocytic modulators" 1)
   ("possible downstream modulators" 1) ("possible direct modulators" 1)
   ("CEP97" 1) ("major modulators" 1)
   ("multiple hereditary and environmental modulators" 1)
   ("noncovalent modulators" 1) ("70 viral immune modulators" 1)
   ("secondary modulators" 1) ("well-characterized modulators" 1)
   ("most notably transcriptional modulators" 1) ("coherent modulators" 1)
   ("more efficient modulators" 1) ("several fibrinolytic modulators" 1)
   ("essential modulators" 1) ("versatile modulators" 1) ("fewer modulators" 1)
   ("the transcriptional modulators" 1) ("the essential modulators" 1)
   ("key modulators" 1) ("ubiquitous modulators" 1)
   ("essential transcriptional modulators" 1)
   ("novel steroidal estrogen receptor modulators (SERMS)" 1)
   ("post-translational modulators" 1) ("other genetic modulators" 1)
   ("genetic modulators" 1) ("secondary RNAi pathway modulators" 1)
   ("other extra cellular modulators" 1)))
 ("UP:Q8IW41"
  (("PRAK" 301) ("MK5" 112) ("PRAK(KM)" 2) ("overexpressed PRAK" 2)
   ("we first incubated PRAK" 1) ("PRAK protein" 1) ("than MK5" 1)))
 ("UP:Q8IW93" (("Ephexin2" 2) ("ARHGEF19" 1)))
 ("UP:Q8IWA4"
  (("Mfn1" 82) ("MFN1" 18) ("mitofusin" 17) ("mitofusin 1" 8) ("Mitofusin" 3)
   ("Mitofusin 1" 3)))
 ("UP:Q8IWA5" (("CTL2" 18) ("infectious CTL2" 1)))
 ("UP:Q8IWB1"
  (("danger" 138) ("“danger”" 2) ("the potential danger" 2)
   ("numerous exogenous and endogenous danger" 1) ("inflammatory danger" 1)
   ("physical danger" 1) ("Several potential endogenous danger" 1)
   ("so-called danger" 1) ("a potential danger" 1) ("'danger'" 1)
   ("microbial or sterile danger" 1)))
 ("UP:Q8IWB6" (("TEX14" 109) ("Tex14" 6) ("TEX14-" 3)))
 ("UP:Q8IWC1" (("Mdp3" 77) ("MAP7D3" 2))) ("UP:Q8IWE5" (("PLEKHM2" 1)))
 ("UP:Q8IWJ2" (("GCC185" 3)))
 ("UP:Q8IWL1" (("SPA" 49) ("SFTPA2" 3) ("SPA2" 2)))
 ("UP:Q8IWL2" (("SP-A" 34) ("SPA-1" 2) ("SFTPA1" 1)))
 ("UP:Q8IWL3" (("HSCB" 2))) ("UP:Q8IWL8" (("STH" 74) ("chronic STH" 1)))
 ("UP:Q8IWQ3"
  (("Serine/Threonine" 24) ("BRSK2" 21) ("SAD-A" 17) ("BrsK2" 1)
   ("SERINE/THREONINE" 1)))
 ("UP:Q8IWR1" (("TRIM59" 8))) ("UP:Q8IWT1" (("SCN4B" 1)))
 ("UP:Q8IWT3"
  (("Cul9" 194) ("CUL9" 69) ("Cul9 protein" 2) ("only one Cul9  +/+" 1)))
 ("UP:Q8IWT6" (("LRRC8A" 3) ("LRRC8" 2)))
 ("UP:Q8IWU2" (("LMTK2" 15) ("KPI-2" 2) ("BREK" 1)))
 ("UP:Q8IWU4" (("SLC30A8" 46) ("ZnT8" 5))) ("UP:Q8IWU5" (("SULF2" 10)))
 ("UP:Q8IWU6"
  (("HSulf-1" 111) ("SULF1" 8) ("Sulfatase1" 7) ("HSulf1" 4) ("sulfatase 1" 1)
   ("Extracellular sulfatase Sulf-1" 1)))
 ("UP:Q8IWU9" (("tryptophan hydroxylase 2" 2)))
 ("UP:Q8IWV1" (("LAX" 9) ("Lax" 5) ("lax" 4)))
 ("UP:Q8IWV2" (("Big2" 3) ("CNTN4" 1))) ("UP:Q8IWV7" (("UBR1" 6) ("Ubr1" 2)))
 ("UP:Q8IWV8" (("UBR2" 3))) ("UP:Q8IWW6" (("ArhGAP12" 9)))
 ("UP:Q8IWW8"
  (("hot" 1185) ("Hot" 171) ("mutational hot" 8) ("“hot”" 7) ("HOT" 6)
   ("these mutational hot" 2) ("‘hot’" 2) ("discrete transcriptional hot" 2)
   ("neovascular hot" 1) ("72°C. A hot" 1) ("discrete hot" 1)
   ("DyNAzyme™ II Hot" 1) ("no obvious hot" 1) ("a local hot" 1)
   ("Mutational hot" 1) ("p53 mutational hot" 1) ("vascular hot" 1)
   ("other genomic hot" 1) ("genomic hot" 1) ("previously described hot" 1)
   ("Pfu turbo hot" 1) ("the previously described mutational hot" 1)
   ("No MEN1 mutational hot" 1) ("the two somatic hot" 1)
   ("These mutational hot" 1)
   ("Samuels et al.  xref  three PIK3CA mutational hot" 1) ("two major hot" 1)
   ("The first-round amplification protocol used KOD Hot" 1)
   ("clinically relevant hot" 1)
   ("two previously characterized mutational hot" 1) ("intratumoral hot" 1)
   ("new hot" 1) ("functional hot" 1)
   ("three small in-frame indels affecting two mutational hot" 1)
   ("extensive and multifocal hot" 1) ("Regular hot" 1)
   ("the FTMap calculations finding strong hot" 1) ("the remote hot" 1)
   ("remote hot" 1) ("several mutational hot" 1) ("relevant hot" 1)
   ("dynamic hot" 1) ("These reactive hot" 1) ("a few hot" 1)
   ("the mutational hot" 1) ("the typical mutational hot" 1)
   ("all known mutational hot" 1)))
 ("UP:Q8IWX5" (("SGPP2" 1)))
 ("UP:Q8IWX8" (("calcium homeostasis endoplasmic reticulum protein" 1)))
 ("UP:Q8IWY4"
  (("matrix-bound" 33) ("matrix-bound protein" 5) ("Matrix-bound" 2)))
 ("UP:Q8IWZ3"
  (("mask" 341) ("Mask" 66) ("MASK1" 40) ("a binary mask" 9) ("‘mask’" 4)
   ("A binary mask" 3) ("the endocytic mask" 2) ("a digital mask" 2)
   ("“mask”" 2) ("“un-mask”" 1) ("a tumor-specific binary mask" 1)
   ("a two-dimensional binary mask" 1) ("binary mask" 1)
   ("the resulting binary mask" 1) ("the binary mask" 1) ("ANKHD1" 1)))
 ("UP:Q8IWZ6" (("BBS7" 2))) ("UP:Q8IWZ8" (("SF4" 4) ("sf4" 1)))
 ("UP:Q8IX03"
  (("Kibra" 47) ("KIBRA" 47) ("WWC1" 19) ("kibra" 3) ("Kibra protein" 3)))
 ("UP:Q8IX06" (("GOR" 2)))
 ("UP:Q8IX07"
  (("FOG1" 9) ("FOG-1" 8) ("FOG" 4) ("Fog1" 2) ("friend of GATA-1" 1)))
 ("UP:Q8IX12"
  (("CCAR1" 288) ("CAS" 219) ("CARP-1" 216) ("CARP-1 (651-759) protein" 7)
   ("CCAR1 protein" 6) ("DIS" 5) ("Dis" 4) ("CAS protein" 4) ("dis" 3)
   ("myc-His-tagged CARP-1" 3) ("myc-His-tagged wild-type CARP-1" 2)
   ("CARP-1 protein" 2) ("pCAS" 1) ("severe CAS" 1)
   ("Cell division cycle and apoptosis regulator 1" 1)
   ("Cell cycle and apoptosis regulatory protein 1" 1)
   ("expressing myc-His-tagged wild-type CARP-1" 1)
   ("CARP-1 (651-759 T667A ) protein" 1)
   ("myc-His-tagged CARP-1 (651-759) protein" 1) ("CARP1" 1)))
 ("UP:Q8IX90" (("Ska3" 23) ("Rama1" 20) ("SKA3" 3)))
 ("UP:Q8IXB1" (("ERdj5" 1))) ("UP:Q8IXH6" (("DOR" 31) ("DoR" 5)))
 ("UP:Q8IXH7"
  (("Th1" 659) ("TH1" 300) ("Th1-" 31) (NIL 22) ("trihydrophobin 1" 5)
   ("simultaneous high Th1" 1) ("another un-relevant point mutation TH1-Y5F" 1)
   ("NELF-C/D" 1) ("than WT Th1" 1) ("inflammatory Th1" 1)))
 ("UP:Q8IXI1" (("RHOT2" 2)))
 ("UP:Q8IXJ6"
  (("SIRT2" 1069) ("Sirt2" 370) ("SirT2" 27) ("sirtuin 2" 22) ("Sirtuin 2" 10)
   ("Sirt 2" 8) ("SIRT2 protein" 6) ("sirT2" 3) ("Sirt2 molecule" 3)
   ("SIRT2-" 2) ("SIRT 2" 2) ("disable Sirt2" 2) ("Sirt2 protein" 2)
   ("overexpressed SIRT2" 2) ("SIR2L" 1) ("than Sirt2" 1)
   ("the closely-related class III HDAC SIRT2" 1) ("Q8IXJ6" 1)
   ("that SIRT2’s" 1) ("ectopically overexpressed SIRT2" 1)))
 ("UP:Q8IXJ9"
  (("ASXL1" 122) ("Asxl1" 1) ("three cases both an ASXL1" 1)
   ("two cases showed both an ASXL1" 1)))
 ("UP:Q8IXK0" (("PHC2" 6) ("Phc2" 2) ("EDR2" 2))) ("UP:Q8IXL7" (("MSRB3" 23)))
 ("UP:Q8IXM3" (("BMRP" 2))) ("UP:Q8IXM6" (("NRM" 13)))
 ("UP:Q8IXQ6" (("ARTD9" 166) ("PARP9" 6) ("BAL1" 2)))
 ("UP:Q8IXR5" (("FAM178B" 2))) ("UP:Q8IXS6" (("PALM2" 3)))
 ("UP:Q8IXT5" (("RBM12B" 1))) ("UP:Q8IXU6" (("SLC35F2" 17)))
 ("UP:Q8IXV7" (("KLHDC8B" 8))) ("UP:Q8IXZ2" (("ZC3H3" 2)))
 ("UP:Q8IXZ3" (("SP8" 18) ("Sp8" 7))) ("UP:Q8IY18" (("SMC5" 6) ("Smc5" 4)))
 ("UP:Q8IY31" (("IFT20" 22))) ("UP:Q8IY34" (("PTR3" 4) ("pHT2" 1)))
 ("UP:Q8IY45" (("AMN1" 3) ("Amn1" 3))) ("UP:Q8IY49" (("MMD2" 2) ("Mmd2" 1)))
 ("UP:Q8IY57" (("YAF2" 42) ("-YAF2" 1) ("YAF2-" 1)))
 ("UP:Q8IY63" (("AmotL1" 91) ("AMOTL1" 15))) ("UP:Q8IY84" (("NIM1" 1)))
 ("UP:Q8IY92"
  (("SLX4" 796) ("MUS312" 24) ("BTBD12" 23) ("FANCP" 17) ("Slx4" 7) ("-SLX4" 3)
   ("SLX4 protein" 2) ("than SLX4" 1) ("slx4" 1)))
 ("UP:Q8IY95" (("TMEM192" 1))) ("UP:Q8IYB3" (("SRm160" 6)))
 ("UP:Q8IYB4" (("TRIP8b" 2) ("PXR2" 1)))
 ("UP:Q8IYB5" (("SMAP1" 7) ("Smap1" 3))) ("UP:Q8IYB8" (("Suv3" 3)))
 ("UP:Q8IYD8" (("FANCM" 355) ("FANCM protein" 7) ("most FANCM" 1)))
 ("UP:Q8IYH5" (("ZZZ3" 3))) ("UP:Q8IYI6" (("EXOC8" 5)))
 ("UP:Q8IYJ3" (("SLP1" 4) ("SYTL1" 1) ("Slp1" 1)))
 ("UP:Q8IYK4" (("GLT25D2" 1)))
 ("UP:Q8IYL9"
  (("TDAG8" 139) ("GPR65" 9) ("TDAG8-" 2)
   ("T-cell death-associated gene 8" 1)))
 ("UP:Q8IYM9"
  (("TRIM22" 132) ("Trim22" 23) ("Staf50" 1)
   ("the ancestral Platyrrhini TRIM22" 1)))
 ("UP:Q8IYN0" (("ZNF100" 1))) ("UP:Q8IYR2" (("SMYD4" 2)))
 ("UP:Q8IYR6" (("Tomoregulin-1" 2))) ("UP:Q8IYS5" (("OSCAR" 17)))
 ("UP:Q8IYT2" (("AFT" 7)))
 ("UP:Q8IYT3"
  (("CCDC170" 127) ("C6orf97" 72) ("CCDC170 protein" 2) ("C6orf97 protein" 2)))
 ("UP:Q8IYT4" (("KATNAL2" 14))) ("UP:Q8IYT8" (("ULK2" 79) ("Ulk2" 9)))
 ("UP:Q8IYU2" (("HACE1" 248) ("Hace1" 245) ("hace1" 11)))
 ("UP:Q8IYV9" (("OBF" 3)))
 ("UP:Q8IYW5"
  (("RNF168" 513) ("Rnf168" 140) ("Lentiviral Flag-HA–tagged RNF168" 1)
   ("E3 ubiquitin-protein ligase RNF168" 1) ("down more HIS-RNF168" 1)
   ("Rnf168 protein" 1)))
 ("UP:Q8IYX4" (("Dnd1" 10))) ("UP:Q8IZ02" (("LRRC34" 1)))
 ("UP:Q8IZ07" (("ANKRD13" 2))) ("UP:Q8IZ41" (("RASEF" 1)))
 ("UP:Q8IZ57"
  (("anlagen" 16) ("VMP" 7) ("the mammary anlagen" 3) ("subcortical anlagen" 1)
   ("the embryonic mammary gland anlagen" 1)
   ("the embryonic mouse mammary gland anlagen" 1)))
 ("UP:Q8IZ69"
  (("TRMT2A" 50) ("HTF9C" 2) ("Given TRMT2A's" 1) ("Given TRMT2A" 1)
   ("multivariable analysis TRMT2A" 1) ("targeting TRMT2A" 1)))
 ("UP:Q8IZD2" (("NKp44L" 88) ("MLL5" 1))) ("UP:Q8IZD4" (("DCP1B" 4)))
 ("UP:Q8IZD6" (("solute carrier family 22" 3)))
 ("UP:Q8IZD7" (("anti-Histone" 37) ("Anti-Histone" 6)))
 ("UP:Q8IZD9" (("DOCK3" 15) ("Dock3" 15) ("MOCA" 2)))
 ("UP:Q8IZF0"
  (("non-selective" 110) ("NALCN" 26) ("Non-selective" 4) ("NALCN protein" 2)))
 ("UP:Q8IZF3" (("GPR115" 2))) ("UP:Q8IZF4" (("Pgr" 6)))
 ("UP:Q8IZH2" (("XRN1" 9) ("Xrn1" 6)))
 ("UP:Q8IZI9" (("IL28B" 4) ("IFNλ" 2) ("Il28B" 1) ("IL-28B" 1)))
 ("UP:Q8IZJ0" (("IL-28A" 1)))
 ("UP:Q8IZJ1" (("UNC5B" 108) ("UNC5B protein" 2) ("UNC5H2" 1)))
 ("UP:Q8IZK6" (("MCOLN2" 2) ("TRPML2" 1)))
 ("UP:Q8IZL2" (("MAML2" 10) ("Maml2" 1)))
 ("UP:Q8IZL8"
  (("PELP1" 763) ("MNAR" 14) ("p-PELP1" 2) ("HMX3" 2)
   ("specifically targets PELP1" 1)
   ("2–3 fold more PELP1over endogenous PELP1" 1) ("pPELP1" 1)
   ("overnight using PELP1" 1)
   ("modulator of non-genomic activity of estrogen receptor" 1)))
 ("UP:Q8IZL9" (("c-crk" 32) ("c-Crk" 11) ("cell cycle related kinase" 1)))
 ("UP:Q8IZM8"
  (("melanoma-associated antigen" 11) ("melanoma associated antigen" 6)
   ("melanoma-associated antigens" 2) ("melanoma-associated antigen (MAGE)" 1)
   ("Melanoma-associated antigens" 1) ("Melanoma-associated antigen" 1)))
 ("UP:Q8IZN3" (("ZDHHC14" 1)))
 ("UP:Q8IZP0"
  (("Abi1" 129) ("v-Abl" 58) ("Abi-1" 31) ("E3B1" 22) ("e3b1" 20) ("ABI1" 13)
   ("v-ABL" 9) ("E3b1" 4) ("ABI-1" 3) ("v-abl" 2)
   ("the phosphorylated tyrosines of Abi1" 1)))
 ("UP:Q8IZP1"
  (("TBC1D3" 355) ("TBC1D3 protein" 6) ("PRC17" 1)
   ("the nucleocytoplasmic protein TBC1D3" 1)
   ("the C-terminal 50 amino acids of TBC1D3" 1)))
 ("UP:Q8IZP7" (("HS6ST3" 2)))
 ("UP:Q8IZQ1"
  (("WDFY3" 7) ("ALFY" 3) ("WD repeat and FYVE domain containing 3" 2)))
 ("UP:Q8IZQ8"
  (("Myocd" 61) ("myocardin" 31) ("MYOCD" 15) ("Myocardin" 11)
   ("myocardin protein" 1)))
 ("UP:Q8IZS5" (("OFCC1" 6))) ("UP:Q8IZT6" (("ASPM" 13)))
 ("UP:Q8IZU2" (("WDR17" 6)))
 ("UP:Q8IZU3"
  (("SYCP3" 174) ("SYCP3 protein" 5)
   ("the synaptonemal complex protein SYCP3" 1)
   ("The meiosis-specific synaptonemal complex protein SYCP3" 1)))
 ("UP:Q8IZU9" (("Neph2" 2) ("KIRREL3" 1)))
 ("UP:Q8IZW8"
  (("Cten" 222) ("TNS4" 219) ("CTEN" 172) ("cten" 95) ("Cten protein" 8)
   ("Cten Protein" 2) ("these findings closely link CTEN" 1)
   ("functional TNS4" 1) ("TNS4-" 1)))
 ("UP:Q8IZX4" (("210kDa" 2))) ("UP:Q8IZY2" (("ABCA7" 7)))
 ("UP:Q8J025" (("APCDD1" 7) ("Apcdd1" 4))) ("UP:Q8J1G7" (("Cin8" 1)))
 ("UP:Q8JFR5" (("Kita" 3))) ("UP:Q8JFZ2" (("GSTpi" 1)))
 ("UP:Q8JHZ8" (("Paladin" 10) ("PALADIN" 7))) ("UP:Q8JI28" (("XLR" 2)))
 ("UP:Q8JJ48" (("Frodo" 7))) ("UP:Q8JTG9" (("replicase" 2)))
 ("UP:Q8JTH0"
  (("glycoprotein" 1437) ("glycoproteins" 508) ("GP" 35) ("Glycoprotein" 29)
   ("P-glycoprotein" 26) ("vesicular stomatitis virus glycoprotein" 17)
   ("membrane-associated glycoproteins" 8) ("VSVG" 6)
   ("Vesicular Stomatitis Virus Glycoprotein" 5) ("Glycoproteins" 4)
   ("a dimeric glycoprotein" 4) ("a heterodimeric glycoprotein" 4)
   ("a multifunctional glycoprotein" 4) ("the viral glycoprotein" 4)
   ("previously unrecognized surface glycoprotein" 4) ("glycoprotein (GP)" 4)
   ("glycoprotein peptide" 4) ("a modular glycoprotein" 3)
   ("a membrane-associated glycoprotein" 3) ("glycoprotein (HRG)" 3)
   ("19 soluble secreted glycoproteins" 3) ("glycoprotein (AGP)" 3)
   ("a Disulfide-linked Dimeric Glycoprotein" 2)
   ("a disulfide-linked homodimeric glycoprotein" 2)
   ("Synaptic Vesicle (SV) glycoprotein 2" 2)
   ("a multifunctional epithelial glycoprotein" 2)
   ("a ubiquitous ECM glycoprotein" 2)
   ("heterodimeric transmembrane surface glycoproteins" 2)
   ("an adhesive glycoprotein" 2) ("heterodimeric surface glycoproteins" 2)
   ("a secretory glycoprotein" 2) ("immature and mature Mpl glycoprotein" 2)
   ("immature Mpl glycoprotein" 2) ("viral glycoproteins" 2)
   ("several viral related glycoproteins" 2) ("P-glycoproteins" 2)
   ("multifunctional glycoprotein" 2) ("viral surface glycoproteins" 2)
   ("a testicular glycoprotein" 2)
   ("a large molecular weight dimeric glycoprotein" 2)
   ("cytoprotective glycoprotein" 2)
   ("high-molecular-mass adhesive glycoproteins" 2)
   ("multifunctional cell adhesion glycoprotein" 2)
   ("a Vesicular Stomatitis Virus glycoprotein" 2)
   ("a matricellular glycoprotein" 2)
   ("the vesicular stomatitis virus glycoprotein" 2)
   ("a heterodimeric cell surface glycoprotein" 2)
   ("cell membrane-associated glycoprotein" 2) ("a pleiotropic glycoprotein" 2)
   ("these two viral receptor-binding glycoproteins" 2)
   ("large secretory glycoproteins" 2) ("heterodimeric glycoproteins" 2)
   ("encoding vesicular stomatitis virus glycoprotein" 2)
   ("a microfibril-associated glycoprotein" 2)
   ("a disulfide-linked  homodimeric lymphocyte-specific glycoprotein" 1)
   ("Vesicular stomatitis virus-glycoprotein" 1)
   ("a complement-regulatory glycoprotein" 1)
   ("CCR5-tropic HIV Envelope (Env) glycoprotein" 1)
   ("a cell membrane-associated glycoprotein" 1)
   ("Several key glycoproteins" 1) ("-glycoprotein" 1)
   ("a dimeric filament-forming 440 kDa glycoprotein" 1)
   ("the key glycoproteins" 1) ("the immature Mpl glycoproteins" 1)
   ("canonical vesicular stomatitis virus glycoprotein" 1)
   ("two virally-encoded glycoproteins" 1) ("O -linked glycoproteins" 1)
   ("heterodimeric cell surface glycoproteins" 1)
   ("an embryonic glycoprotein" 1) ("late lytic glycoprotein K8.1A" 1)
   ("epithelial glycoprotein (EGP)" 1)
   ("Vesicular stomatitis virus glycoprotein" 1)
   ("a large multifunctional glycoprotein" 1)
   ("virus-associated glycoprotein" 1) ("an ECM-associated glycoprotein" 1)
   ("the Rh blood group-associated glycoprotein (RHAG)" 1)
   ("the Vesicular Stomatitis Virus glycoprotein" 1)
   ("the viral G N and G C glycoproteins" 1) ("the viral glycoproteins" 1)
   ("newly produced viral G C glycoproteins" 1) ("soluble glycoproteins" 1)
   ("a cell-surface glycoprotein’s" 1) ("glycoprotein (VSVG)" 1)
   ("an extracellular matrix cell-adhesive glycoprotein" 1)
   ("isomeric glycoproteins" 1) ("an oligomeric glycoprotein" 1)
   ("an allergenic glycoprotein" 1) ("a secreted monomeric glycoprotein" 1)))
 ("UP:Q8JTH2"
  (("phosphoprotein" 852) ("phosphoproteins" 333) ("Phosphoprotein" 33)
   ("Phosphoproteins" 21) ("mitotic phosphoproteins" 9)
   ("a nucleolar phosphoprotein" 7) ("PhosphoProtein" 7)
   ("these mitotic phosphoproteins" 4) ("phosphoprotein  (SLP)" 3)
   ("overexpressed phosphoproteins" 3)
   ("src kinase–associated phosphoprotein (SKAP)" 2)
   ("at least one additional mTOR activity related phosphoprotein" 2)
   ("a cellular phosphoprotein" 2) ("a tetrameric nuclear phosphoprotein" 2)
   ("a membrane-associated phosphoprotein" 2)
   ("a multifunctional phosphoprotein" 2)
   ("Src kinase-associated phosphoprotein" 2)
   ("a ubiquitously expressed nucleolar phosphoprotein" 2)
   ("other cyclin D1/cdk4-dependent phosphoproteins" 2)
   ("a multifunctional nucleolar phosphoprotein" 2)
   ("the key phosphoprotein" 2) ("Mouse acidic ribosomal phosphoprotein" 2)
   ("Gab1-associated phosphoproteins" 2) ("nucleolar phosphoproteins" 2)
   ("a small (18 kD) ubiquitous phosphoprotein" 2)
   ("at least nine different unidentified phosphoproteins" 2)
   ("cAMP-regulated neuronal phosphoprotein" 2)
   ("Very little phosphoprotein" 1) ("Fyn-associated phosphoproteins" 1)
   ("lymphocyte phosphatase–associated  phosphoprotein" 1)
   ("a prominent phosphoprotein" 1)
   ("EB-associated tyrosine phosphoproteins" 1)
   ("779 unique phosphoproteins" 1) ("265 unique phosphoproteins" 1)
   ("the resultant quantile plot showed normally distributed phosphoproteins"
    1)
   ("phosphoprotein (KAPP)" 1) ("only two phosphoproteins" 1)
   ("Most phosphoproteins" 1) ("a major phosphoprotein" 1)
   ("This membrane-associated cytoplasmic phosphoprotein" 1)
   ("associated phosphoprotein" 1) ("a small presynaptic phosphoprotein" 1)
   ("approximately 150 phosphoproteins" 1)
   ("a multifunctional nuclear phosphoprotein" 1) ("10 key phosphoproteins" 1)
   ("ubiquitously expressed nucleolar phosphoprotein" 1)
   ("a new phosphoprotein" 1) ("rafts-associated phosphoproteins" 1)
   ("the most prominent phosphoprotein" 1) ("This oligomeric phosphoprotein" 1)
   ("a ubiquitous cytosolic phosphoprotein" 1)
   ("the housekeeping gene acidic ribosomal phosphoprotein (ARP)" 1)
   ("a pleiotropic phosphoprotein" 1)
   ("approximately 10,000 phosphoproteins" 1)))
 ("UP:Q8JTH3"
  (("MVNP" 132) ("nucleocapsid protein" 116) ("Nucleocapsid protein" 3)))
 ("UP:Q8JZM4"
  (("BRET" 212) ("-BRET" 2) ("secondary HTS BRET" 2)
   ("ABT-737 (1  μ M) significantly decreased BRET" 1)))
 ("UP:Q8K023" (("Akr1c18" 1))) ("UP:Q8K4J0" (("mARTs" 6) ("MART" 1)))
 ("UP:Q8KE49" (("thioredoxin-2" 2))) ("UP:Q8KEA4" (("TRX-1" 7)))
 ("UP:Q8KZR4" (("Taub" 3))) ("UP:Q8L3A9" (("PADI" 13)))
 ("UP:Q8L3X9" (("KAS" 2))) ("UP:Q8L7F7" (("Np62" 2) ("NP62" 2)))
 ("UP:Q8L7S8" (("RH3" 9) ("Rh3" 6) ("RH3 (AWGRFLHTNCHPFLA)" 3)))
 ("UP:Q8L840" (("Sgs1" 46) ("sgs1" 10) ("SGS1" 4)))
 ("UP:Q8L925"
  (("CRC" 12357) ("metastatic CRC" 146) ("sporadic CRC" 136) ("primary CRC" 69)
   ("incident CRC" 31) ("IYCC" 18) ("invasive CRC" 11)
   ("primary and metastatic CRC" 10) ("than CRC" 9) ("familiar CRC" 8)
   ("distal CRC" 8) ("proximal CRC" 8) ("the primary CRC" 7) ("CRC (IYCC)" 7)
   ("non-metastatic CRC" 6) ("hereditary CRC" 6) ("incident invasive CRC" 6)
   ("inflammation-associated CRC" 5) ("Incident CRC" 5) ("Primary CRC" 4)
   ("the sporadic CRC" 4) ("right-sided CRC" 4) ("liver metastatic CRC" 3)
   ("“CRC”" 3) ("247 primary CRC" 3) ("local CRC" 3) ("colorectal CRC" 3)
   ("population-based CRC" 3) ("chemorefractory CRC" 3)
   ("distant metastatic CRC" 3) ("HER2/neu-positive CRC" 3)
   ("locoregional CRC" 3) ("CRC (AYCC)" 3) ("stage III right-sided CRC" 3)
   ("most CRC" 3) ("Lynch syndrome-associated CRC" 3) ("-CRC" 3)
   ("any incident CRC" 3) ("metachronous CRC" 3)
   ("Lynch Syndrome-associated CRC" 3) ("mass sporadic CRC" 3)
   ("hereditary nonpolyposis CRC" 2) ("Metastatic CRC" 2)
   ("EGFR-expressing metastatic CRC" 2) ("parental and drug-resistant CRC" 2)
   ("V600E BRAF-expressing CRC" 2) ("any evident CRC" 2)
   ("virtually all metastatic CRC" 2) ("implemented population-based CRC" 2)
   ("KRAS wild-type metastatic CRC" 2) ("1186 metastatic CRC" 2)
   ("all incident CRC" 2) ("neoadjuvantly treated CRC" 2)
   ("anti-EGFR therapy-resistant CRC" 2) ("late clinical stage CRC" 2)
   ("paired primary and metastatic CRC" 2)
   ("wild-type KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue) metastatic CRC"
    2)
   ("PTEN -haploinsufficient CRC" 2) ("mismatch repair–proficient CRC" 2)
   ("selectively killing CRC" 2) ("therapy-refractory CRC" 2)
   ("hereditary Lynch syndrome-associated CRC" 2) ("MSI-H sporadic CRC" 2)
   ("developed CRC" 2) ("KRAS wt metastatic CRC" 2)
   ("colitis-associated CRC" 2) ("chemotherapy-refractory metastatic CRC" 2)
   ("previously localized CRC" 2) ("a primary CRC" 2) ("the metastatic CRC" 2)
   ("non selected sporadic CRC" 2) ("MMR-proficient CRC" 2)
   ("aggressive CRC" 2) ("CRc" 2) ("model human sporadic CRC" 1)
   ("ulcerative CRC" 1) ("advanced sporadic CRC" 1)
   ("potentially resectable CRC" 1) ("LGR carriers developed CRC" 1)
   ("a few hundred CRC" 1) ("primary and metastasized CRC" 1)
   ("Saudi Arabian CRC" 1) ("than primary CRC" 1) ("56 sporadic CRC" 1)
   ("invasive or metastatic KRAS-positive CRC" 1)
   ("sporadic MSI-H/CIMP+ CRC" 1) ("MSI-H/CIMP+ sporadic CRC" 1)
   ("DNA mismatch repair-proficient CRC" 1) ("the familiar CRC" 1)
   ("sporadic or familiar CRC" 1) ("histologically proven metastatic CRC" 1)
   ("the estimated new CRC" 1) ("Distant metastatic CRC" 1)
   ("nearly all (>90%) metastatic CRC" 1) ("Most sporadic CRC" 1)
   ("the 304 incident CRC" 1) ("304 incident invasive CRC" 1)
   ("494 incident CRC" 1) ("chemorefractory metastatic CRC" 1)
   ("almost all sporadic MSI-H CRC" 1) ("meta-static CRC" 1)
   ("especially metastatic CRC" 1) ("a SOX2 positive primary CRC" 1)
   ("The primary-metastatic CRC" 1) ("than CRC ( P ≤ 0.04)" 1)
   ("1645 primary CRC" 1) ("29 primary CRC" 1) ("FFPE primary CRC" 1)
   ("an activated YAP1 signature—activated YAP1 CRC (AYCC)" 1)
   ("refractory metastatic CRC" 1) ("The 103 sporadic CRC" 1)
   ("generally proximal CRC" 1) ("isogenic human SW48 CRC" 1)
   ("nonmetastatic CRC" 1) ("Unselected primary CRC" 1)
   ("prevalent HPV-associated CRC" 1) ("pathological confirmed CRC" 1)
   ("left-sided stage III CRC" 1) ("right-sided stage III CRC" 1)
   ("stage III Right-sided mIS-high CRC" 1) ("286 informative CRC" 1)
   ("147 (48.8%) carriers developed histologically confirmed CRC" 1)
   ("than CRC (6 patients)" 1) ("a dominant invasive CRC" 1)
   ("735 primary CRC" 1) ("orthotropic and heterotropic CRC" 1)
   ("sporadic MSS CRC" 1) ("sporadic MSI CRC" 1)
   ("MSI-stable and MSI-high CRC's" 1) ("MAP CRC's" 1) ("both sporadic CRC" 1)
   ("AURKA developed CRC" 1) ("more CRC" 1) ("a PTEN-positive CRC" 1)
   ("sporadic, hereditary and metastatic CRC" 1) ("specific sporadic CRC" 1)
   ("histologically confirmed metastatic CRC" 1)
   ("genetically confirmed Lynch syndrome-associated CRC" 1)
   ("metastasized CRC" 1) ("2126 incident CRC" 1) ("a metchronous CRC" 1)
   ("late stage CRC" 1) ("448 Middle Eastern CRC" 1)
   ("951 unselected sporadic CRC" 1)
   ("hereditary prostate cancer (HPC) reported CRC" 1)
   ("Lynch-associated CRC" 1) ("164 sporadic CRC" 1)
   ("the 314 consecutive CRC" 1) ("314 consecutive CRC" 1)
   ("primary sporadic CRC" 1) ("845 metastatic CRC" 1)
   ("36 patients developed CRC" 1) ("hereditary non-polyposis CRC" 1)
   ("unverified self-reported CRC" 1) ("pathology-confirmed CRC" 1)
   ("the 1001 sporadic CRC" 1) ("Sporadic CRC" 1) ("IBD-associated CRC" 1)
   ("very young CRC" 1) ("recurrent CRC" 1) ("the 553 incident CRC" 1)
   ("536/553 incident CRC" 1) ("525/553 incident CRC" 1) ("553 incident CRC" 1)
   ("the first primary CRC" 1) ("less aggressive CRC" 1)
   ("highly metastatic CRC" 1) ("the available 555 CRC" 1)
   ("All incident CRC" 1) ("22 incident CRC" 1)
   ("507/555 (91%) available CRC" 1) ("507 incident CRC" 1)
   ("Two hundred twenty-five incident CRC" 1) ("732 incident CRC" 1)
   ("gastrointestinal disorders—such as CRC" 1) ("147,000 new CRC" 1)
   ("than CRC exhibiting" 1) ("The HCCM-1544 human metastatic CRC" 1)
   ("characterise sporadic CRC" 1) ("no prognostic value ofO 6 -MGMTin CRC" 1)
   ("111 primary CRC" 1) ("1052 sporadic CRC" 1) ("almost all CRC" 1)
   ("than MSS CRC ( xref )" 1)
   ("than BRAF- wild-type CRC ( xref ; xref ; xref )" 1)
   ("than KRAS- wild-type CRC" 1) ("BRAF -wild-type/MSI-high CRC" 1)
   ("sporadic (3.90%, 17/436) CRC" 1) ("220,000 new CRC" 1)
   ("88 unselected sporadic CRC" 1)
   ("robust therapeutic strategies forBRAF V600E CRC" 1)
   ("a robust surrogate forBRAF V600E CRC" 1) ("21% metastatic CRC" 1)
   ("all sporadic CRC" 1) ("a sporadic CRC" 1)))
 ("UP:Q8LDW6" (("Endo3" 3))) ("UP:Q8LE98" (("ICR1" 11) ("-ICR1" 2)))
 ("UP:Q8LGG0"
  (("FK506 binding protein 12" 22) ("FK506-binding protein-12 (FKBP)" 1)
   ("FK506-binding protein-12" 1) ("FK506 binding protein-12" 1)))
 ("UP:Q8LGH4"
  (("Cullin 4" 14) ("cullin 4" 9) ("Cullin4" 4) ("cullin4" 2) ("Cullin 4-" 1)))
 ("UP:Q8LGI3" (("Dis2" 5))) ("UP:Q8LGU6" (("HBT" 9)))
 ("UP:Q8LK56"
  (("DME" 935) ("Met/Cys-free DME" 3) ("Cys/Met-free DME" 2)
   ("methionine/cysteine–free DME" 2) ("regular DME" 1) ("complete DME" 1)))
 ("UP:Q8LLV8" (("PLs" 18) ("pLS" 6))) ("UP:Q8LPQ9" (("Fpa" 1)))
 ("UP:Q8MH63" (("MLAs" 7))) ("UP:Q8MJW8" (("CCR4" 66)))
 ("UP:Q8MKI8" (("cRAD51" 32)))
 ("UP:Q8MP00"
  (("NPF" 188) ("NPFs" 37) ("a functional NPF" 4)
   ("the Rad51 presynaptic NPF" 2)))
 ("UP:Q8MQW8" (("SPRI" 4))) ("UP:Q8MSS1" (("LVA" 2))) ("UP:Q8MSU4" (("SYM" 1)))
 ("UP:Q8MUF9" (("cPLA" 1))) ("UP:Q8MXI4" (("p-MK2" 7) ("pMK2" 2)))
 ("UP:Q8MZR6" (("EH1" 46))) ("UP:Q8N0S6" (("CENP-L" 1)))
 ("UP:Q8N0U8" (("VKORC1L1" 4))) ("UP:Q8N0V5" (("GCNT2" 5)))
 ("UP:Q8N0W3" (("Fuk" 1)))
 ("UP:Q8N0W4" (("hLNX" 16) ("NLGN4" 4) ("NLGN4X" 2) ("neuroligin 4" 1)))
 ("UP:Q8N0X2" (("SPAG16" 2)))
 ("UP:Q8N0X4" (("CLB" 107) ("Clb" 14) ("the treated patients received CLB" 1)))
 ("UP:Q8N0Z2"
  (("stars" 31) ("STARS" 14) ("Stars" 11) ("ABRA" 10) ("‘stars’" 2)
   ("triple stars" 1) ("5 or more stars" 1) ("6 or more stars" 1) ("“Stars”" 1)
   ("an integrative genomic-based approach called ABRA" 1)))
 ("UP:Q8N0Z3" (("spice" 18) ("a dietary spice" 3)))
 ("UP:Q8N0Z6"
  (("TTC5" 112) ("Ttc5" 8) ("Strap" 7) ("tetratricopeptide repeat domain 5" 3)
   ("Tetratricopeptide repeat domain 5" 2)))
 ("UP:Q8N0Z9" (("VSIG10" 2)))
 ("UP:Q8N100" (("ATOH7" 47) ("Math5" 11) ("Atoh7" 1)))
 ("UP:Q8N103" (("TAGAP" 16)))
 ("UP:Q8N108"
  (("ER1" 102) ("MIER1" 31) ("early response 1" 6) ("mier1" 3) ("pER1" 1)
   ("“ER1”" 1)))
 ("UP:Q8N114" (("Scotin" 208) ("Scotin protein" 48)))
 ("UP:Q8N122"
  (("raptor" 1032) ("Raptor" 752) ("RAPTOR" 120) ("RPTOR" 117)
   ("regulatory-associated protein of mTOR" 40) ("raptor protein" 15)
   ("raptor molecule" 7) ("regulatory-associated protein of mTOR (RAPTOR)" 5)
   ("Raptor-" 3) ("Rptor" 3) ("KOG1" 3) ("than Raptor" 3)
   ("Regulatory-associated protein of mTOR" 2) ("-Raptor" 2)
   ("the essential partner protein raptor" 2)
   ("most likely representing monomeric Raptor" 2) ("KIAA1303" 2) ("Kog1" 2)
   ("less raptor" 1) ("−Raptor" 1) ("RAPTOR-" 1) ("RPTOR-" 1)
   ("regulatory associated protein of mTOR complex 1" 1)
   ("than nuclear raptor ( xref )" 1)
   ("a fully cdc2 non-phosphorylatable raptor" 1)
   ("the essential mTORC1 binding protein Raptor" 1)
   ("its associated RAPTOR" 1)))
 ("UP:Q8N126" (("Necl-1" 1) ("CADM3" 1))) ("UP:Q8N127" (("OR5AS1" 13)))
 ("UP:Q8N136" (("WDR69" 1)))
 ("UP:Q8N137"
  (("centrobin" 190) ("Centrobin" 10) ("any conspicuous centrobin" 2)
   ("strong centrobin" 2)))
 ("UP:Q8N138" (("ORMDL3" 87))) ("UP:Q8N139" (("member 6" 22)))
 ("UP:Q8N143" (("BCL6B" 138))) ("UP:Q8N144" (("Delta 3" 2) ("delta 3" 2)))
 ("UP:Q8N157"
  (("AHI1" 19) ("Jouberin" 10) ("Ahi1" 8)
   ("previously uncharacterized gene AHI1" 1)))
 ("UP:Q8N158" (("GPC2" 1)))
 ("UP:Q8N163" (("KIAA1967" 10) ("DBC-1" 6) ("CCAR2" 3)))
 ("UP:Q8N183" (("assembly factor 2" 2))) ("UP:Q8N187" (("CARF" 5)))
 ("UP:Q8N196" (("SIX5" 2))) ("UP:Q8N1B4" (("Vps52" 28) ("ARE-1" 4)))
 ("UP:Q8N1D0"
  (("antisense" 4145) ("Antisense" 158) ("antisense-" 11) ("-antisense" 8)
   ("SLC22A18AS" 4) ("antisense protein" 3)
   ("antisense (TCTTTCAACACGCAGGACAG)" 2) ("antisense–" 2)
   ("antisense molecule" 2) ("antisense (AS)" 1)
   ("single-stranded nucleic acids antisense" 1)
   ("its complementary antisense" 1) ("natural antisense" 1)
   ("antisense (GGAAGCTTATCAAAGTCCTCGGCCACA)" 1)
   ("antisense (GAGACAGGTTCCTTCATCAACTCC)" 1) ("Antisense (AS)" 1)
   ("its reverse complementary antisense" 1) ("possible antisense" 1)
   ("Antisense-" 1) ("pGEM4-distal and pGEM4-proximal antisense" 1)
   ("expressing CARP-1 antisense" 1)))
 ("UP:Q8N1E6" (("FBXL14" 2)))
 ("UP:Q8N1F7" (("NUP93" 3) ("nucleoporin 93" 2) ("Nup93" 2)))
 ("UP:Q8N1G0" (("ZNF687" 1))) ("UP:Q8N1G2" (("MTR-1" 19)))
 ("UP:Q8N1I0" (("Dock4" 100) ("DOCK4" 44) ("dedicator of cytokinesis 4" 3)))
 ("UP:Q8N1K5"
  (("Themis1" 205) ("THEMIS" 167) ("Themis" 7) ("Themis family" 2)
   ("lentiviral THEMIS" 1) ("-Themis1" 1)))
 ("UP:Q8N1L4" (("CYP4Z2P" 20)))
 ("UP:Q8N1L9" (("SARI" 116) ("less SARI" 1) ("BATF2" 1)))
 ("UP:Q8N1N4" (("CK7/8" 3))) ("UP:Q8N1N5" (("CRIPak" 4)))
 ("UP:Q8N1Q1" (("CA13" 1)))
 ("UP:Q8N1W1"
  (("RhoGEF" 106) ("RhoGEFs" 58) ("Rho guanine nucleotide exchange factor" 47)
   ("Rgnef" 13) ("p190RhoGEF" 12)
   ("Rho guanine nucleotide exchange factor (GEF)" 4) ("rhoGEF" 2)
   ("P190RhoGEF" 1) ("most RhoGEFs" 1) ("leukaemia-associated RhoGEF" 1)
   ("Rho guanine nucleotide exchange factor (ARHGEF)" 1) ("“RhoGEFs”" 1)))
 ("UP:Q8N1W2" (("ZNF710" 5)))
 ("UP:Q8N264"
  (("FilGAP" 246) ("ARHGAP24" 25) ("Rho GTPase activating protein 24" 4)
   ("-FilGAP" 3) ("RC-GAP72" 2) ("targeting human FilGAP" 2) ("Fil-GAP" 1)))
 ("UP:Q8N271"
  (("Prom2" 75) ("prom2" 55) ("SIRT5 prom2 ’s" 1) ("fluorescent Prom2" 1)))
 ("UP:Q8N2C7" (("UNC80" 29))) ("UP:Q8N2F6" (("SVH" 1)))
 ("UP:Q8N2I9" (("STK40" 7) ("Serine/threonine kinase 40" 2)))
 ("UP:Q8N2K1" (("UBE2J2" 2) ("Ube2j2" 1)))
 ("UP:Q8N2M8"
  (("splicing factor" 129) ("Splicing factor" 2)
   ("a well-characterized splicing factor" 2) ("SFRS16" 2)
   ("an essential splicing factor" 2)
   ("PTB-associated splicing factor (PSF)" 1) ("splicing factor (PSF)" 1)))
 ("UP:Q8N2Q7"
  (("neuroligin 1" 5) ("Nlgn1" 3) ("neuroligin-1" 2) ("nlgn1" 2)
   ("the synaptogenic adhesion molecule neuroligin-1" 1)
   ("Postsynaptic neuroligin 1" 1)))
 ("UP:Q8N2R0" (("OSR2" 3) ("Osr2" 1))) ("UP:Q8N2S1" (("LTBP4" 1)))
 ("UP:Q8N2U9" (("PQLC1" 15)))
 ("UP:Q8N2W9" (("PIASy" 301) ("PIASγ" 24) ("PIAS4" 11) ("Pias4" 2)))
 ("UP:Q8N2Z9"
  (("apoptosis-inducing" 387) ("Apoptosis-inducing" 10)
   ("Apoptosis-Inducing" 6) ("MHF1" 3) ("APITD1" 2) ("CENP-S" 1)
   ("the principal apoptosis-inducing protein" 1)
   ("apoptosis-inducing protein" 1)))
 ("UP:Q8N300" (("SVBP" 1))) ("UP:Q8N302" (("AGGF1" 1)))
 ("UP:Q8N328" (("PGBD3" 381) ("PGBD3 protein" 4))) ("UP:Q8N335" (("GPD1L" 1)))
 ("UP:Q8N344" (("MIER2" 1))) ("UP:Q8N350" (("c19orf26" 30)))
 ("UP:Q8N370" (("LAT4" 4))) ("UP:Q8N386" (("Mapa" 72)))
 ("UP:Q8N387" (("MUC15" 2))) ("UP:Q8N392" (("ARHGAP18" 3)))
 ("UP:Q8N3C0"
  (("p200" 17) ("P200" 17) ("RNA helicase family" 5) ("ASCC3" 3) ("pp200" 2)
   ("the previously described pp200" 1)))
 ("UP:Q8N3E9" (("PLCD3" 6))) ("UP:Q8N3I7" (("BBS5" 12)))
 ("UP:Q8N3J2"
  (("METTL4" 13) ("“methyltransferase like 4”" 2)
   ("methyltransferase like 4" 2)))
 ("UP:Q8N3J5" (("1K" 39) ("BDP" 2) ("Mg2+/Mn2+ dependent" 2)))
 ("UP:Q8N3J6" (("SynCAM 2" 2) ("Necl-3" 1) ("CADM2" 1)))
 ("UP:Q8N3J9" (("ZNF664" 6))) ("UP:Q8N3K9" (("CMYA5" 2)))
 ("UP:Q8N3P4" (("VPS8" 8)))
 ("UP:Q8N3R9"
  (("membrane protein" 545) ("PALS1" 111) ("Membrane Protein" 34)
   ("Stardust" 19) ("an Integral Membrane Protein" 8) ("Membrane protein" 7)
   ("a peripheral membrane protein" 6) ("MPP5" 4) ("membrane protein (LIME)" 4)
   ("a glycophosphatidylinositol (GPI)-linked membrane protein" 3)
   ("membrane protein (LMP)" 3)
   ("the late endosomal/lysosomal peripheral membrane protein" 2)
   ("A New Highly Conserved Peripheral Membrane Protein" 2)
   ("lysosome-associated membrane protein (LAMP)" 2)
   ("a viral membrane protein" 2)
   ("membrane
protein"
    2)
   ("a lysosomal-associated membrane protein" 2) ("Latent Membrane Protein" 2)
   ("The Epstein-Barr virus (EBV) encoded oncoprotein Latent Membrane Protein"
    2)
   ("an intestinal brush border membrane protein" 2)
   ("total crude membrane protein" 2)
   ("a stress-responsive membrane protein" 2)
   ("Lysosomal-associated membrane protein" 2)
   ("the apical polarity proteins Stardust" 2)
   ("a placental fusogenic membrane protein" 2)
   ("a peripherally associated membrane protein" 2)
   ("lysosome associated membrane protein" 2)
   ("the late endosome/lysosome marker lysosomal-associated membrane protein"
    2)
   ("this novel peripheral membrane protein" 1)
   ("an N-myristoylated peripheral membrane protein" 1)
   ("inner membrane protein" 1) ("cerebellar vermis membrane protein" 1)
   ("an associated membrane protein" 1) ("an inner membrane protein" 1)
   ("crude membrane protein" 1) ("basolateral membrane protein" 1)
   ("an endogenous apical membrane protein" 1) ("precisely PALS1" 1)
   ("likely monotopic membrane protein" 1)
   ("an integral inner membrane protein" 1) ("membrane Protein" 1) ("PALS1-" 1)
   ("junctional membrane protein" 1) ("possible membrane protein" 1)))
 ("UP:Q8N3U4"
  (("STAG2" 264) ("SA2" 208) ("STAG2-" 23) ("nonphosphorylatable SA2" 8)
   ("STAG2 protein" 6) ("exogenous SA2" 2)
   ("Containing Nonphosphorylatable SA2" 2) ("than SA2" 1)))
 ("UP:Q8N3V7" (("synaptopodin" 42) ("Synaptopodin" 7) ("SYNPO" 1)))
 ("UP:Q8N3X1" (("FNBP4" 4)))
 ("UP:Q8N3Y1"
  (("FBXW8" 123) ("Fbxw8" 15) ("F-box/WD repeat-containing protein 8" 1)
   ("FBXW6" 1)))
 ("UP:Q8N3Y7" (("Rdhe2" 7) ("RDHE2" 1))) ("UP:Q8N3Z6" (("ZCCHC7" 2)))
 ("UP:Q8N423" (("LIR-2" 9) ("ILT4" 9) ("LILRB2" 4) ("LIR2" 1)))
 ("UP:Q8N427" (("TXNDC3" 17) ("NME8" 1))) ("UP:Q8N434" (("SVOPL" 3)))
 ("UP:Q8N448" (("LNX2" 19) ("Lnx2" 2)))
 ("UP:Q8N456" (("leucine rich repeat containing 18" 1) ("LRRC18" 1)))
 ("UP:Q8N461" (("FBXL16" 2)))
 ("UP:Q8N474"
  (("sFRP1" 197) ("SFRP1" 121) ("FRP" 51) ("sFRP" 23) ("Sfrp1" 7)
   ("sFRP1 protein" 6) ("secreted frizzled-related protein 1" 5) ("SFRP1-" 3)
   ("SARP2" 2) ("secreted frizzled related protein 1" 2) ("sFRP protein" 2)
   ("sFRP-1" 2) ("SFRP-1" 1) ("d2-labeled FRP5" 1)))
 ("UP:Q8N485" (("Lft" 4) ("Lix1" 2)))
 ("UP:Q8N488"
  (("RYBP" 102) ("DEDAF" 7) ("RYBP-" 7) ("RING1 and YY1 binding protein" 1)
   ("-RYBP" 1)))
 ("UP:Q8N490" (("MR1" 21) (NIL 2) ("than MR1-1" 1)))
 ("UP:Q8N4C6"
  (("ninein" 45) ("NIN" 25) ("Ninein" 14) ("Nin" 4)
   ("two appendage-associated ninein" 1) ("asymmetrical division Ninein" 1)
   ("centrosomal ninein" 1)))
 ("UP:Q8N4C8" (("B55" 60) ("mink" 22) ("Mink" 5)))
 ("UP:Q8N4E4" (("PdCl2" 1) ("PDCL2" 1))) ("UP:Q8N4F7" (("RNF175" 2)))
 ("UP:Q8N4H5" (("TOM5" 4)))
 ("UP:Q8N4M1" (("solute carrier family" 31) ("Solute carrier family" 3)))
 ("UP:Q8N4N8" (("Kif2b" 14) ("KIF2B" 6)))
 ("UP:Q8N4Q1" (("MIA40" 2) ("CHCHD4" 1)))
 ("UP:Q8N4S9"
  (("TRiC" 182) ("tricellulin" 5) ("TriC" 2) ("TRIC" 2)
   ("Ultra-purified TRiC" 1) ("the co-translational interaction TRiC" 1)
   ("MARVELD2" 1)))
 ("UP:Q8N4T8" (("CBR4" 2))) ("UP:Q8N4V1" (("MMGT1" 2) ("TMEM32" 1)))
 ("UP:Q8N4X5" (("XB130" 120) ("xb130" 1)))
 ("UP:Q8N531" (("FBXL6" 1) ("FbxL6" 1))) ("UP:Q8N554" (("ZNF276" 2)))
 ("UP:Q8N556"
  (("MCF-10A" 1798) ("AFAP1" 30) (NIL 22) ("AFAP" 16) ("parental MCF-10A" 14)
   ("apoptotic MCF-10A" 2) ("immortalised human breast epithelial MCF-10A" 2)
   ("the KLF8-expressing Tet-on MCF-10A" 2) ("ERα-negative MCF-10A" 2)
   ("the isogenic cell line series MCF-10A" 2)
   ("non-tumorigenic human breast epithelial MCF-10A" 2)
   ("the nontumorigenic mammary epithelial cell line MCF-10A" 2)
   ("The non-transformed human breast epithelial cell line MCF-10A" 2)
   ("Non-transformed MCF-10A" 1)
   ("the non-transformed mammary epithelial cell line MCF-10A" 1)
   ("than both MCF-10A" 1) ("the normal MCF-10A" 1)
   ("immortalized breast epithelial cell line MCF-10A" 1)
   ("immortal non-tumorigenic cell line MCF-10A" 1)
   ("Exponentially growing MCF-10A" 1) ("human breast epithelial MCF-10A" 1)
   ("Immortalized breast epithelial cells MCF-10A" 1)
   ("immortalized human mammary epithelial cell line MCF-10A" 1)
   ("Breast epithelial MCF-10A" 1)
   ("the nontransformed human mammary cell line MCF-10A" 1)
   ("the spontaneously immortalized human mammary epithelial cell line MCF-10A"
    1)
   ("the ERα/PR-negative breast epithelial cell lines MCF-10A" 1)
   ("the isogenic MCF-10A" 1)
   ("spontaneously immortalized non-tumorigenic mammary epithelial MCF-10A"
    1)))
 ("UP:Q8N565" (("MREG" 6) ("melanoregulin" 3))) ("UP:Q8N567" (("ZCCHC9" 6)))
 ("UP:Q8N568" (("DCLK2" 4) ("CL2" 2)))
 ("UP:Q8N5A5"
  (("ZIP" 192) ("Zip" 58) ("zip" 53) ("pZIP" 3) ("ZGPAT" 2)
   ("the transcriptional repressor ZIP" 1) ("a universal zip" 1)
   ("the unique Zip" 1)))
 ("UP:Q8N5B7" (("LASS5" 1) ("Cers5" 1) ("CerS5" 1)))
 ("UP:Q8N5C6" (("SRBD1" 4) ("S1 RNA binding domain 1" 1)))
 ("UP:Q8N5C8" (("TAB3" 117) ("MAP3K7IP3" 3) ("TAB3 (CCTTCACCCATCAGTAATC)" 1)))
 ("UP:Q8N5F7" (("NKAP" 233)))
 ("UP:Q8N5H7"
  (("nsp3" 11) ("SHEP1" 7) ("nsP3" 6) ("NSP3" 5) ("SH2D3C" 5) ("SHEP-1" 1)))
 ("UP:Q8N5I2" (("ARRDC1" 1))) ("UP:Q8N5I3" (("KCNRG" 1)))
 ("UP:Q8N5U6" (("RNF10" 1))) ("UP:Q8N5V2" (("Ephexin1" 22) ("NGEF" 6)))
 ("UP:Q8N5X7" (("eIF4E3" 100) ("EiF4E3" 1))) ("UP:Q8N5Y2" (("MSL3" 24)))
 ("UP:Q8N5Z0" (("KAT2" 1)))
 ("UP:Q8N668" (("COMMD1" 123) ("Murr1" 12) ("MURR1" 2) ("COMMD1 protein" 2)))
 ("UP:Q8N680" (("ZBTB2" 3)))
 ("UP:Q8N682"
  (("DRAM" 191) ("DRAM1" 147) ("DRAM protein" 10)
   ("damage-regulated autophagy modulator" 6) ("Overexpressed DRAM" 3)
   ("exogenous DRAM1" 1) ("Damage-regulated autophagy modulator" 1)))
 ("UP:Q8N695"
  (("iodide" 2389) ("Iodide" 147) ("SLC5A8" 9) ("iodide (PI)" 3) ("iodide-" 2)
   ("SMCT1" 1)))
 ("UP:Q8N699"
  (("MYCT1" 80) ("Myc target 1" 3) ("MYCT1 protein" 1)
   ("than MYCT1 ( xref )" 1) ("myc target 1" 1)))
 ("UP:Q8N6C7" (("PGSF1" 4))) ("UP:Q8N6C8" (("LILRA3" 9)))
 ("UP:Q8N6D2" (("ring finger protein 182" 2)))
 ("UP:Q8N6F7"
  (("gal" 337) ("Gal" 172) ("-gal" 103) ("-Gal" 69)
   ("Senescence-associated β -gal" 4) ("gal-" 2) ("-gal4is" 2)
   ("andsal PE -gal4" 2) ("a fresh senescence-associated β -Gal" 1)
   ("the most intense β gal" 1) ("-gal4" 1)))
 ("UP:Q8N6G5" (("GalNacT2" 18) ("essentially no GalNacT2" 1)))
 ("UP:Q8N6K7" (("SAMD3" 2)))
 ("UP:Q8N6M6" (("apo" 432) ("Apo" 188) ("APO" 121) ("C9orf3" 10) ("apo-" 8)))
 ("UP:Q8N6N3"
  (("BAG" 38) ("bag" 24) ("a plastic bag" 3) ("Bag" 3) ("the capsular bag" 1)
   ("a separate dialysis bag" 1)))
 ("UP:Q8N6P7" (("IL22RA1" 62) ("IL-22R" 8) ("IL22RA1 protein" 3) ("IL22R" 2)))
 ("UP:Q8N6Q3"
  (("PRV1" 44) ("NB1" 7) ("HNa" 1) ("PRV-1" 1) ("HNA" 1) ("hNA" 1)))
 ("UP:Q8N6S4" (("ANKRD13C" 3))) ("UP:Q8N6T3" (("ArfGAP1" 8)))
 ("UP:Q8N6T7"
  (("SIRT6" 2383) ("Sirt6" 628) ("SIRT6 protein" 53) ("Sirtuin 6" 26)
   ("Sirt6 protein" 6) ("SirT6" 5) ("Sirt6 Protein" 4) ("SIRT6 molecule" 3)
   ("SIRT6 peptide" 3) ("Overexpressed Sirt6" 3) ("Immortalized SIRT6" 2)
   ("previously uncharacterized SIRT6" 2) ("total and phosphorylated SIRT6" 2)
   ("Nonphosphorylatable SIRT6" 2)
   ("the nonphosphorylatable S338A mutant SIRT6" 2)
   ("exogenous Flag-tagged SIRT6" 2) ("than SIRT6" 2)
   ("1 µg/ml and 1/500 monoclonal mouse anti-human SIRT6" 2) ("strong SIRT6" 2)
   ("than wild-type SIRT6" 1) ("neural SIRT6" 1) ("Sirt6-" 1) ("SIRT6-" 1)
   ("These results further support Sirt6" 1)))
 ("UP:Q8N6U8" (("RE2" 30))) ("UP:Q8N6Y1" (("PCDH20" 2)))
 ("UP:Q8N6Y2" (("LRRC17" 2)))
 ("UP:Q8N726"
  (("ARF" 2467) ("p14 ARF" 495) ("p14  ARF" 97) ("MLM" 39) ("ARF protein" 38)
   ("alternative reading frame" 23) ("p14 ARF protein" 23) ("p14 Arf" 19)
   ("ARF peptide" 8) ("tumor suppressor ARF" 8)
   ("alternative reading frame (ARF)" 6) ("tumor suppressor Arf" 6)
   ("Alternative Reading Frame" 5) ("P14 ARF" 5) ("ARF (26–44) peptide" 3)
   ("Alternative Reading Frame protein (ARF)" 3) ("–ARF" 3)
   ("Alternative Reading Frame (ARF) protein" 2)
   ("The post-transcriptional silencing ofp14 ARF" 2) ("exogenous ARF" 2)
   ("alternative reading frame protein" 2) ("followed byp14 ARF" 2)
   ("-p14 ARF" 2) ("P14 ARF protein" 1) ("its transcriptional target ARF" 1)
   ("functional ARF" 1) ("that ARF’s" 1) ("“super-INK4a/ARF”" 1)
   ("Nucleoplasmic ARF" 1) ("We first examinedp16 Ink4a andp14 ARF" 1)))
 ("UP:Q8N729" (("NPW" 1))) ("UP:Q8N766" (("KIAA0090" 4)))
 ("UP:Q8N7B1" (("HORMAD2" 1))) ("UP:Q8N7C3" (("TRIML2" 2)))
 ("UP:Q8N7H5" (("PAF1" 81) ("PD2" 13) ("pD2" 5))) ("UP:Q8N7M2" (("ZNF283" 5)))
 ("UP:Q8N7P3" (("CLDN22" 1)))
 ("UP:Q8N7Q3" (("zinc finger protein 676" 3) ("ZNF676" 1)))
 ("UP:Q8N883" (("ZNF614" 1)))
 ("UP:Q8N895"
  (("ZNF366" 180) ("zinc finger protein 366" 1)
   ("455–558 amino acids of ZNF366" 1)))
 ("UP:Q8N8A6" (("DDX51" 1)))
 ("UP:Q8N8D1" (("PDCD7" 5) ("programmed cell death 7" 3)))
 ("UP:Q8N8Q8" (("COX18" 7)))
 ("UP:Q8N8S7" (("Mena" 80) ("ENAH" 13) ("MENA" 10)))
 ("UP:Q8N8U9" (("HCV-2" 19) ("BMPER" 1))) ("UP:Q8N960" (("Cep120" 5)))
 ("UP:Q8N966" (("DHHC-22" 7))) ("UP:Q8N9B4" (("SARP" 14)))
 ("UP:Q8N9B5"
  (("JMY" 23) ("p53 cofactor" 6)
   ("junction mediating and regulatory protein" 2)))
 ("UP:Q8N9B8" (("RASGEF1A" 3)))
 ("UP:Q8N9I0" (("Synaptotagmin II" 4) ("Syt2" 3) ("SYT2" 1)))
 ("UP:Q8N9I9" (("Dtx3" 2)))
 ("UP:Q8N9M5" (("CBAP" 184) ("CBAP molecule" 3) ("TMEM102" 1)))
 ("UP:Q8N9N5"
  (("SMAR1" 272) ("p-SMAR1" 3) ("BANP" 1) ("the chromatin-associated SMAR1" 1)
   ("SMAR 1" 1)))
 ("UP:Q8N9N8"
  (("U87MG" 1203) ("the astrocytic cell line U87MG" 4) ("parental U87MG" 3)
   ("U87MG-" 2) ("Chaetocin-treated U87MG" 1) ("than parental U87MG" 1)
   ("EGFRvIII-expressing U87MG" 1) ("than U87MG" 1) ("PTEN-negative U87MG" 1)
   ("The adherent glioblastoma cell lines U87MG" 1)))
 ("UP:Q8N9R8" (("SCAI" 5) ("ScaI" 4) ("suppressor of cancer cell invasion" 2)))
 ("UP:Q8N9U0" (("TC2N" 5))) ("UP:Q8N9W5" (("pf22" 3)))
 ("UP:Q8NA29" (("NLS1" 56))) ("UP:Q8NA72" (("hPOC5" 7) ("hPOC5 protein" 1)))
 ("UP:Q8NAA4" (("ATG16L2" 18))) ("UP:Q8NAC3" (("IL-17RC" 1)))
 ("UP:Q8NAP3" (("ZBTB38" 9))) ("UP:Q8NAU1" (("Irisin" 4)))
 ("UP:Q8NB12" (("SMYD1" 1)))
 ("UP:Q8NB16"
  (("MLKL" 37) ("mixed lineage kinase domain-like" 6)
   ("mixed lineage kinase domain-like (MLKL)" 3)
   ("mixed lineage kinase domain-like protein (MLKL)" 3)
   ("the oligomerized MLKL" 1)
   ("Mixed lineage kinase domain-like protein (MLKL)" 1)
   ("Mixed lineage kinase domain-like" 1)))
 ("UP:Q8NB78" (("LSD2" 11))) ("UP:Q8NB90" (("SPATA5" 3)))
 ("UP:Q8NB91" (("FAB" 118) ("FANCB" 38) ("FancB" 3) ("FA-B" 1)))
 ("UP:Q8NBD8" (("TMEM229B" 2)))
 ("UP:Q8NBF2" (("NHL repeat containing 2" 8) ("Nhlrc2" 4)))
 ("UP:Q8NBF6" (("Avl9" 1) ("avl9" 1)))
 ("UP:Q8NBJ4"
  (("hepatocytes" 2957) ("Hepatocytes" 91) ("primary hepatocytes" 74)
   ("PHH" 31) ("normal hepatocytes" 28) ("hepatocytes (PHH)" 18)
   ("mouse primary hepatocytes" 15) ("mature hepatocytes" 13)
   ("Primary hepatocytes" 12) ("human primary hepatocytes" 9)
   ("Human primary hepatocytes" 6) ("apoptotic hepatocytes" 6)
   ("dysplastic hepatocytes" 5) ("HBx-expressing hepatocytes" 5)
   ("SV40-transformed hepatocytes" 5) ("Mouse primary hepatocytes" 4)
   ("Primary Hepatocytes" 4) ("inhibitor-treated hepatocytes" 4)
   ("transformed hepatocytes" 4) ("normal mature hepatocytes" 4)
   ("malignant hepatocytes" 3) ("hepatocytes (IHH)" 3) ("hepatocytes (HFD)" 3)
   ("Mature hepatocytes" 3) ("cholestatic hepatocytes" 3)
   ("than hepatocytes" 3) ("benign proliferative hepatocytes" 2)
   ("pericentral hepatocytes" 2) ("palmitate-treated hepatocytes" 2)
   ("rat primary hepatocytes" 2)
   ("human E2F1 inE2F1 +/− primary hepatocytes" 2)
   ("Immortalized Met murine hepatocytes" 2) ("the normal hepatocytes" 2)
   ("nonproliferative hepatocytes" 2) ("than normal hepatocytes" 2)
   ("IL-6-treated Hep3B hepatocytes" 2) ("quiescent hepatocytes" 2)
   ("neoplastic hepatocytes" 2) ("these premalignant hepatocytes" 2)
   ("protumoral hepatocytes" 2) ("Ras-transformed hepatocytes" 2)
   ("neonatal hepatocytes" 2)
   ("hydrodynamic gene delivery specifically targets mature hepatocytes" 2)
   ("immortalized human hepatocytes (IHH)" 2) ("parenchymal hepatocytes" 2)
   ("null hepatocytes" 2) ("postnatal hepatocytes" 2)
   ("TUNEL-positive hepatocytes" 2) ("centrilobular hepatocytes" 2)
   ("adult periportal hepatocytes" 2)
   ("adjacent non-transformed hepatocytes" 2) ("hepatocytes (HH)" 2)
   ("centrilobular (zone 3) hepatocytes" 2) ("hepatocytes (PMH)" 2)
   ("A3G-expressing hepatocytes" 1) ("mitotic hepatocytes" 1)
   ("arsenic-treated Chang human hepatocytes" 1)
   ("HCV infected primary hepatocytes" 1)
   ("HCV-infected primary hepatocytes" 1) ("these primary hepatocytes" 1)
   ("normal and transformed hepatocytes" 1)
   ("Cryoplateable primary human hepatocytes" 1)
   ("more physiological relevant freshly isolated rat primary hepatocytes" 1)
   ("PIMT S298A overexpressing primary hepatocytes" 1)
   ("Immortalized murine hepatocytes" 1) ("immortalized murine hepatocytes" 1)
   ("non-cancerous hepatocytes" 1) ("differentiated quiescent hepatocytes" 1)
   ("The primary hepatocytes" 1) ("dysplastic or transformed hepatocytes" 1)
   ("isolated apoptotic hepatocytes" 1)
   ("TERT-immortalized human fetal hepatocytes" 1)
   ("primarily target hepatocytes" 1) ("The normal hepatocytes" 1)
   ("preneoplastic and neoplastic hepatocytes" 1)
   ("well-differentiated tumor Phb1 -KO hepatocytes" 1)
   ("healthy hepatocytes" 1) ("well-differentiated hepatocytes" 1)
   ("Immortalized human hepatocytes (IHH)" 1) ("periportal hepatocytes" 1)
   ("dedifferentiate mature hepatocytes" 1) ("Viable hepatocytes" 1)
   ("MNAM-treated hepatocytes" 1) ("fetal hepatocytes" 1)
   ("primary hepatocytes using Qiagen's" 1) ("EGF-treated hepatocytes" 1)
   ("GOLPH2" 1) ("isolated human and mouse primary hepatocytes" 1)
   ("necrotic hepatocytes" 1) ("L-Pik3r1KO primary hepatocytes" 1)
   ("than 30 altered hepatocytes" 1)
   ("pre-malignant and malignant hepatocytes" 1)
   ("pX-expressing hepatocytes" 1)
   ("whose protein depletion rescued pX-expressing hepatocytes" 1)
   ("rescued pX-expressing hepatocytes" 1)
   ("miR-126-overexpressed hepatocytes" 1) ("non-cirrhotic hepatocytes" 1)
   ("Cd44 null hepatocytes" 1) ("CD44 null hepatocytes" 1)
   ("both human primary hepatocytes" 1) ("than primary mouse hepatocytes" 1)
   ("cultured primary hepatocytes" 1) ("37°C. Primary hepatocytes" 1)
   ("embryonic hepatocytes" 1) ("the primary hepatocytes" 1)
   ("wild type primary hepatocytes" 1) ("Yap -deficient primary hepatocytes" 1)
   ("than adjacent non-transformed hepatocytes ( xref B)" 1)
   ("occasional hepatocytes" 1) ("ChREBP-overexpressing hepatocytes" 1)
   ("both cultured primary hepatocytes" 1) ("Sirt6-null hepatocytes" 1)))
 ("UP:Q8NBJ5" (("GLT25D1" 1))) ("UP:Q8NBK3" (("SUMF1" 2)))
 ("UP:Q8NBL1" (("hCLP46" 42) ("Rumi" 2)))
 ("UP:Q8NBM4"
  (("UBAC2" 24)
   ("an uncharacterised UBA domain-containing polytopic protein UBAC2" 1)))
 ("UP:Q8NBN7" (("RDH13" 1)))
 ("UP:Q8NBP7"
  (("PC9" 488) ("PCSK9" 31) ("parental PC9" 3) ("the original PC9" 2)
   ("PC9-" 2) ("Proprotein convertase subtilisin/kexin type 9" 1)
   ("Parent PC9" 1) ("Pcsk9" 1) ("specifically target PCSK9" 1)
   ("viable PC9" 1)))
 ("UP:Q8NBQ7" (("AQP11" 1))) ("UP:Q8NBS3" (("SLC4A11" 2) ("Slc4a11" 1)))
 ("UP:Q8NBS9" (("TXNDC5" 15) ("thioredoxin domain containing protein 5" 1)))
 ("UP:Q8NBT2" (("SPBC24" 2) ("SPC24" 1) ("Spc24" 1)))
 ("UP:Q8NBW4" (("SLC38A9" 185) ("targeting SLC38A9" 2)))
 ("UP:Q8NBX0" (("SCCPDH" 1))) ("UP:Q8NC51" (("SERBP1" 1)))
 ("UP:Q8NC56" (("NET25" 3) ("LEM2" 1))) ("UP:Q8NC60" (("C4orf14" 1)))
 ("UP:Q8NCD3" (("HJURP" 25))) ("UP:Q8NCF5" (("NIP45" 2) ("Rad60" 1)))
 ("UP:Q8NCG5" (("CHST4" 1))) ("UP:Q8NCG7" (("DAGLB" 7)))
 ("UP:Q8NCM2" (("KCNH5" 26))) ("UP:Q8NCM8" (("Dync2h1" 1)))
 ("UP:Q8NCN4" (("RNF169" 3))) ("UP:Q8NCP5" (("ZBTB44" 4)))
 ("UP:Q8NCQ5" (("FBXO15" 3) ("Fbx15" 1) ("fbx15" 1)))
 ("UP:Q8NCU7" (("NLF1" 1))) ("UP:Q8NCW5" (("APOA1BP" 6)))
 ("UP:Q8ND04" (("Smg8" 1))) ("UP:Q8ND25" (("ZNRF1" 2)))
 ("UP:Q8ND30" (("PPFIBP2" 9))) ("UP:Q8ND56" (("LSm14A" 1)))
 ("UP:Q8ND71" (("IAN9" 9) ("gimap8" 7)))
 ("UP:Q8ND76" (("cyclin Y" 2) ("CCNY" 2) ("cyclin Y (CCNY)" 1)))
 ("UP:Q8ND83" (("SLAIN1" 1))) ("UP:Q8NDA8" (("HEATR7A" 4)))
 ("UP:Q8NDB2"
  (("Bank" 2289) ("bank" 933) ("BANK1" 307) ("Bank (PDB)" 55) ("bank (PDB)" 28)
   ("Bank (HSRRB)" 12) ("BANK" 11) ("Bank (KCLB)" 10) ("Bank (MBTB)" 10)
   ("Bank (TTB)" 6) ("Bank (DSHB)" 6) ("a central bank" 3)
   ("the Worldwide Protein Data Bank" 3) ("Bank (PBD)" 3) ("Bank (NYBB)" 3)
   ("Texas M.D. Anderson Cancer Center Thoracic Tissue Bank" 2) ("bank (TB)" 2)
   ("the Mayo Clinic Blood Bank" 2) ("residual sample bank" 2)
   ("Radiological and Medical Science (KIRMS) cell bank" 2)
   ("the Northern Ireland Tumour Bank" 2) ("Hospital tissue bank" 2)
   ("the M. D. Anderson Cancer Center Thoracic Tissue Bank" 2)
   ("Moorfields Hospital Eye Bank" 2) ("Bank (VAMC)" 2)
   ("the hospital blood bank" 2)
   ("Washington Gynecologic Oncology Tissue Bank" 2) ("Bank (BTB)" 2)
   ("the Biological Magnetic Resonance Data Bank" 2) ("Bank1" 2)
   ("BANK1 protein" 2) ("the Aberdeen colorectal tumour bank" 2)
   ("an accessible source bank" 2) ("the public cord blood bank" 2)
   ("the Canadian Ovarian Tissue Bank" 2) ("Biological Sciences Cell Bank" 2)
   ("the institutional tumor bank" 2) ("biomaterial bank" 2)
   ("B-cell scaffold protein with ankyrin repeats 1" 2)
   ("the Australian Mesothelioma Tissue Bank" 1)
   ("the Western Pennsylvania blood bank" 1)
   ("the Institutional Tissue Bank" 1) ("the First Hospital Tissue Bank" 1)
   ("an institutional tumor bank" 1) ("the Mayo Clinic lung tumor bank" 1)
   ("the respective cell bank" 1) ("the Italian Red Cross Blood Bank" 1)
   ("the Brazilian National Bank" 1)
   ("the Mayo Clinic Florida (MCF) Brain Bank" 1)
   ("the Mayo Clinic Florida Brain Bank" 1)
   ("the MD Anderson Gynecologic Cancer Translational Research Tissue Bank" 1)
   ("the nationwide Danish Pathology Data Bank" 1)
   ("DSMZ cell depository bank" 1) ("Iowa Gynecologic Oncology Tumor Bank" 1)
   ("the ovarian SPORE tissue bank" 1)
   ("the Imperial College Healthcare Tissue Bank" 1)
   ("the Neurological Tissue Bank" 1)
   ("Chronic Liver Disease Biological Sample Bank" 1)
   ("Typical Culture Preservation Commission Cell Bank" 1)
   ("Uppsala University Hospital Blood Bank" 1)
   ("The biological specimen bank" 1)
   ("the Massachusetts General Hospital Tumor Bank" 1)
   ("Texas Southwestern Medical School Tissue Bank" 1)
   ("our Ovarian Tumor Bank" 1) ("the regional tissue bank" 1)
   ("the National Neurological Research Specimen Bank (VAMC)" 1)
   ("Hospital Boston blood bank" 1) ("Mayo Clinic Jacksonville brain bank" 1)
   ("the Gynecologic Tissue Bank" 1) ("our institutional tumor bank" 1)
   ("the institutional Gynecologic Oncology Tumor Bank" 1)
   ("the institutional Tumor Bank" 1) ("the Laval Hospital tissue bank" 1)
   ("the Institutional Tumor Bank" 1) ("the same Thoracic Tissue Bank" 1)
   ("the COG Nucleic Acids bank" 1)
   ("California San Francisco Comprehensive Cancer Center Breast Oncology Program Tissue Bank"
    1)
   ("bank1" 1) ("the Gynecologic Cancer Tumor Bank" 1)
   ("the European Georges Pompidou hospital tumor bank" 1)
   ("the Cleveland Clinic Gene Bank" 1)
   ("the Memorial Sloan-Kettering Cancer Center (MSKCC) lung cancer tissue bank"
    1)
   ("Neurodegenerative Disorders brain bank" 1) ("Bank (QSBB)" 1)
   ("an IRB-approved gynecologic oncology tissue bank" 1)
   ("the Human Mammary Epithelial Cell Bank" 1) ("the Biological Bank" 1)
   ("centralized biomaterial bank" 1) ("FL" 1) ("BANK1-" 1) ("BANK1–" 1)))
 ("UP:Q8NDF8" (("Gld4" 31) ("PAPD5" 4))) ("UP:Q8NDN9" (("RCBTB1" 2)))
 ("UP:Q8NDV1" (("Sty" 41) ("STY" 9) ("S/T/Y" 1) ("ST6GALNAC3" 1)))
 ("UP:Q8NDV2" (("Gpr26" 1))) ("UP:Q8NDV3" (("SMC1B" 1)))
 ("UP:Q8NDV7" (("GW182" 66) ("TNRC6" 1) ("TNRC6A" 1) ("GW182 protein" 1)))
 ("UP:Q8NDX1"
  (("TICs" 549) ("TIC" 166) ("pTICs" 28) ("ovarian TICs" 23) ("pTIC" 7)
   ("basal TICs" 6) ("Ovarian TICs" 5) ("colorectal TICs" 3)
   ("Colorectal TICs" 2) ("murine ovarian TICs" 1) ("the ovarian TICs" 1)
   ("deadly ovarian TICs" 1) ("a synchronous TIC" 1) ("most TICs" 1)
   ("many mammary TICs" 1) ("Oct4-driven lung TICs" 1) ("residual pTICs" 1)
   ("a few pTICs" 1) ("chemotherapy-induced TICs" 1) ("EFA6B" 1)
   ("selectively target TICs" 1) ("‘TICs’" 1) ("bipotent TICs" 1)
   ("mammary TICs" 1) ("IKKα-dependent and IKKα-independent TICs" 1)
   ("defective TIC" 1)))
 ("UP:Q8NDX5"
  (("pH3" 108) ("PH3" 72) ("PHC3" 4) ("the mitotic pH3" 2) ("Phc3" 1)))
 ("UP:Q8NDX9" (("LY6G5B" 2)))
 ("UP:Q8NDZ4" (("Akt-induced" 31) ("AKT-induced" 27)))
 ("UP:Q8NE09" (("RGS22" 19) ("PRTD-NY2" 2))) ("UP:Q8NE22" (("MGC33648" 1)))
 ("UP:Q8NE62"
  (("CHD" 672) ("pCDH" 131) ("CDH" 131) ("incident CHD" 24)
   ("the lentiviral vector pCDH" 4) ("Cdh" 4) ("sporadic CHD" 4)
   ("Incident CHD" 3) ("fatal CHD" 3) ("the Lentiviral vector pCDH" 2)
   ("self-reported CHD" 1) ("the commonest cyanotic CHD" 1) ("severe CHD" 1)
   ("definite fatal CHD" 1) ("pcDH" 1) ("many familiar and sporadic CHD" 1)
   ("lentiviral vector pCDH" 1) ("403 incident CHD" 1) ("either fatal CHD" 1)
   ("210 incident CHD" 1) ("190 incident CHD" 1) ("only 10 CHD" 1)
   ("using incident CHD" 1) ("cdh" 1) ("“sporadic” CHD" 1) ("cyanotic CHD" 1)))
 ("UP:Q8NE65" (("ZNF738" 1))) ("UP:Q8NE79" (("BVES" 8)))
 ("UP:Q8NE86"
  (("mCU" 3) ("mitochondrial calcium uniporter" 2) ("mcU" 1)
   ("mitochondrial calcium uniporter (MCU)" 1)))
 ("UP:Q8NEA6" (("GLIS3" 137) ("Glis3" 2)))
 ("UP:Q8NEB5"
  (("PPAPDC1B" 2) ("HTPAP" 1)
   ("phosphatidic acid phosphatase type 2 domain containing 1B" 1)))
 ("UP:Q8NEB9"
  (("Vps34" 719) ("hVps34" 202) ("VPS34" 194) ("hVPS34" 46)
   ("vacuolar protein sorting 34" 35) ("PIK3C3" 21) ("Vps34 protein" 10)
   ("hVPS34-" 4) ("Atg14L-associated Vps34" 3) ("type-3" 2)
   ("the Beclin1-associated class III PI3K VPS34" 2)
   ("the primordial class III PI3K Vps34" 2) ("hVps34 protein" 2)
   ("Associated VPS34" 1) ("than the wild type Vps34" 1)
   ("flag-tagged Vps34" 1) ("Pik3c3" 1) ("hVps34–" 1)))
 ("UP:Q8NEC5"
  (("cation channel" 38) ("a prominent cation channel" 2)
   ("a calcium-permeable cation channel" 1) ("Cation channel" 1)
   ("a nonselective cation channel" 1)
   ("a Ca(2+)-permeable nonselective cation channel" 1)
   ("volume-regulatory hypertonicity-induced cation channel (HICC)" 1)
   ("tetrameric cation channel" 1)))
 ("UP:Q8NEC7" (("GSTCD" 13))) ("UP:Q8NEE6" (("FBXL13" 4)))
 ("UP:Q8NEG5" (("MEX" 4))) ("UP:Q8NEH6" (("MNS1" 1)))
 ("UP:Q8NEJ0" (("DUSP18" 1)))
 ("UP:Q8NEM0"
  (("MCPH1" 273) ("BRIT1" 246) ("MCPH1-" 13) ("Microcephalin" 7)
   ("microcephalin" 7) ("BRIT1 protein" 6) ("Mcph1" 4) ("microcephalin 1" 2)
   ("further assessing BRIT1's" 1) ("further assessing BRIT1" 1) ("Brit1" 1)
   ("functional BRIT1" 1)))
 ("UP:Q8NEM2" (("SHCBP1" 1)))
 ("UP:Q8NEM7" (("SAGA complex component" 3) ("FAM48A" 2)))
 ("UP:Q8NEN9" (("PDZK8" 3))) ("UP:Q8NEQ6" (("ERRF" 1)))
 ("UP:Q8NER1"
  (("TRPV1" 288) ("VR1" 4) ("TRPV1 protein" 2) ("TRPV-1" 1)
   ("functional TRPV1" 1) ("capsaicin receptor" 1)))
 ("UP:Q8NER5" (("ALK7" 10) ("ALK-7" 7) ("ACVR1C" 2) ("Alk7" 1)))
 ("UP:Q8NES3" (("LFNG" 1))) ("UP:Q8NEV8" (("EXPH5" 2)))
 ("UP:Q8NEV9" (("IL27" 9) ("IL-27p28" 1))) ("UP:Q8NEY1" (("Nav1" 66)))
 ("UP:Q8NEZ2" (("VPS37A" 3) ("HCRP1" 1)))
 ("UP:Q8NEZ3" (("ORF26" 5) ("WDR19" 3) ("WD repeat domain 19" 2)))
 ("UP:Q8NEZ4" (("MLL3" 31)))
 ("UP:Q8NEZ5" (("FBXO22" 4) ("FBxO22" 2) ("FBX22" 1)))
 ("UP:Q8NF50"
  (("DOCK8" 66) ("Dock8" 2) ("the CRK-associated Rac GEF DOCK8" 1)))
 ("UP:Q8NF64" (("hZimp7" 42) ("zmiz2" 1)))
 ("UP:Q8NF86"
  (("Eos" 122) ("EOS" 18) ("eos" 3) ("anti-Fas treated Eos" 3)
   ("soluble monomeric Eos" 2) ("Otherwise untreated Eos" 2)
   ("otherwise untreated Eos" 2) ("long-lived Eos" 2)
   ("otherwise untreated BAL Eos" 1) ("alveolar lavage (BAL) derived Eos" 1)
   ("than control Eos" 1) ("In vivo activated bronchoalvelolar (BAL) Eos" 1)))
 ("UP:Q8NF91"
  (("8B" 62) ("SYNE1" 40) ("Nesprin 1" 9) ("C6orf98" 2) ("nesprin-1" 2)
   ("Nesprin-1" 1) ("the clonally-derived 8B" 1) ("nesprin 1" 1)))
 ("UP:Q8NFA2" (("NoxO1" 56) ("NOXO1" 18) ("NOX organizer 1" 2)))
 ("UP:Q8NFD2" (("ANKK1" 1))) ("UP:Q8NFD5" (("ARID1B" 16)))
 ("UP:Q8NFF2" (("SLC24A4" 26))) ("UP:Q8NFF5" (("FAD1" 3) ("FAD1-" 1)))
 ("UP:Q8NFG4"
  (("BHD" 89) ("Bhd" 87) ("folliculin" 46) ("FLCN" 9) ("folliculin protein" 9)
   ("Folliculin" 3) ("bhd" 2) ("the ENU-treated Bhd  +/-" 1)
   ("more complex organisms folliculin" 1)))
 ("UP:Q8NFH5" (("NUP35" 1) ("nucleoporin 35" 1))) ("UP:Q8NFH8" (("REPS2" 11)))
 ("UP:Q8NFJ5"
  (("GPRC5A" 219) ("Gprc5a" 6) ("RAI3" 2) ("the associated GPRC5A" 2)
   ("the total and phosphorylated GPRC5A" 2) ("EGF-treated GPRC5A-WT" 1)))
 ("UP:Q8NFJ6" (("PROKR2" 20))) ("UP:Q8NFJ9" (("BBS1" 5)))
 ("UP:Q8NFM4" (("AC4" 1))) ("UP:Q8NFP4" (("MDGA1" 2)))
 ("UP:Q8NFP7" (("NUDT10" 1))) ("UP:Q8NFP9" (("NBEA" 5)))
 ("UP:Q8NFT8"
  (("BET" 105) ("DNER" 24) ("Bet" 3) ("the viral Bet protein" 2)
   ("Bet protein" 1)))
 ("UP:Q8NFU3" (("MDA-MB468" 84) ("KAT" 42) ("TSTD1" 1)))
 ("UP:Q8NFU5"
  (("IPMK" 170) ("exogenous IPMK" 4) ("inositol polyphosphate multikinase" 3)
   ("IPMK protein" 3) ("IMPK" 1)))
 ("UP:Q8NFU7" (("TET1" 413) ("TET1 protein" 24) ("Tet1" 16) ("LCx" 5)))
 ("UP:Q8NFW1" (("COL22A1" 3) ("type XXII" 3))) ("UP:Q8NFW8" (("CMAS" 37)))
 ("UP:Q8NFW9" (("MyRIP" 2) ("its associated protein MyRIP" 1)))
 ("UP:Q8NFX7" (("STXBP6" 5)))
 ("UP:Q8NFY4"
  (("Semaphorin6D" 21) ("Sema6D" 8) ("Semaphorin 6D" 2) ("SEMA6D" 2)))
 ("UP:Q8NFZ0"
  (("FBH1" 248) ("Fbh1" 6) ("FBXO18" 3) ("overexpressed FBH1" 3)
   ("exogenous FBH1" 2) ("FBH1 protein" 2)
   ("than wild-type FBH1 ( xref C) in non-irradiated cells demonstrating that this motif is critical for the in vivo ubiquitination of FBH1"
    1)
   ("than the PIP degron mutant FBH1 (and)" 1)))
 ("UP:Q8NFZ3" (("Y-linked" 3))) ("UP:Q8NFZ4" (("neuroligin 2" 1)))
 ("UP:Q8NFZ5"
  (("factor-κB" 548) ("Factor-κB" 26) ("factor–κB" 9) ("TNIP2" 3)
   ("factor—κB" 2) ("the ubiquitous and inducible nuclear factor-κB" 2)
   ("factor-κB (RANK)" 1)))
 ("UP:Q8NG06" (("TRIM58" 3)))
 ("UP:Q8NG08"
  (("HDHB" 146) ("HELB" 10) ("DNA helicase B" 7) ("DNA helicase B (HDHB)" 3)))
 ("UP:Q8NG27" (("Praja1" 3)))
 ("UP:Q8NG31"
  (("Knl1" 223) ("Blinkin" 134) ("KNL1" 125) ("blinkin" 38) ("–Knl1" 20)
   ("Knl-1" 11) ("CASC5" 10) ("AF15q14" 8) ("KNL-1" 8)
   ("The latter bound Knl1" 5) ("KNL1 protein" 3)
   ("the mitotic kinetochore protein Blinkin" 3) ("Knl1(150–250) peptide" 3)
   ("KIAA1570" 2) ("-Blinkin" 2) ("5-FAM–labeled synthetic peptide Knl1" 2)
   ("Casc5" 1) ("BUB-linking kinetochore protein" 1) ("hKNL1" 1) ("hSpc105" 1)
   ("d40" 1) ("pKnl1" 1)))
 ("UP:Q8NG35" (("BD5" 4))) ("UP:Q8NG41" (("NPBs" 12) ("NPB" 2) ("hL7" 1)))
 ("UP:Q8NG48" (("Lins" 2))) ("UP:Q8NG50" (("Rdm1" 1)))
 ("UP:Q8NG66" (("NEK11" 10) ("NEK11 protein" 1))) ("UP:Q8NG68" (("TTL" 2)))
 ("UP:Q8NG76" (("OR2T33" 1))) ("UP:Q8NG77" (("OR2T12" 1)))
 ("UP:Q8NG81" (("OR2M7" 4))) ("UP:Q8NG83" (("OR2M3" 2)))
 ("UP:Q8NGH5" (("OR56A1" 1) ("family 56" 1))) ("UP:Q8NGH8" (("OR56A4" 1)))
 ("UP:Q8NGP2" (("OR8J1" 3))) ("UP:Q8NGR1" (("family 13" 3)))
 ("UP:Q8NGS3" (("OR1J1" 2))) ("UP:Q8NGU1" (("Family 9" 1)))
 ("UP:Q8NGY1" (("subfamily Z" 4))) ("UP:Q8NH00" (("OR2T4" 1)))
 ("UP:Q8NHC5" (("family 5" 5) ("Family 5" 2))) ("UP:Q8NHC7" (("OR5BF1" 1)))
 ("UP:Q8NHC8" (("OR2T6" 2))) ("UP:Q8NHG7" (("SVIP" 2)))
 ("UP:Q8NHG8" (("ZNRF2" 2))) ("UP:Q8NHH9" (("ARL6IP2" 1)))
 ("UP:Q8NHJ6" (("ILT3" 9) ("LILRB4" 3) ("Lilrb4" 1)))
 ("UP:Q8NHL6"
  (("LILRB1" 31) ("LIR-1" 10) ("ILT-2" 8) ("pIRB" 8) ("miR7" 6) ("CD85j" 4)
   ("LIR1" 4) ("PIR-B" 3) ("PirB" 2) ("the parental minigene pIRB" 1)))
 ("UP:Q8NHM5" (("KDM2B" 18) ("FBXL10" 11))) ("UP:Q8NHP6" (("MOSPD2" 1)))
 ("UP:Q8NHP8" (("p76" 12) ("pp76" 3) ("P76" 3)))
 ("UP:Q8NHQ1" (("bite" 27) ("BiTE" 5) ("CEP70" 2)))
 ("UP:Q8NHQ8" (("RASSF8" 252) ("RASSF8 protein" 3) ("HOJ1" 3) ("Rassf8" 1)))
 ("UP:Q8NHR9" (("PFN4" 3))) ("UP:Q8NHU3" (("SMS2" 5) ("SGMS2" 3)))
 ("UP:Q8NHU6" (("TDRD7" 1))) ("UP:Q8NHV1" (("IAN7" 5) ("gimap7" 2)))
 ("UP:Q8NHV4"
  (("GCP-WD" 149) ("NEDD1" 10) ("centrosomal GCP-WD" 2)
   ("targeting factor GCP-WD" 2) ("the centrosomal marker NEDD1" 1)
   ("exogenous GCP-WD" 1) ("than GCP-WD" 1)
   ("a mitotic phosphoprotein GCP-WD" 1)))
 ("UP:Q8NHW3" (("MafA" 19) ("MAFA" 5) ("RIPE3b1" 1)))
 ("UP:Q8NHW4"
  (("macrophage inflammatory protein-1β" 3) ("CCL4L" 1) ("CCL4L2" 1)))
 ("UP:Q8NHX9" (("TPC2" 13) ("TPCN2" 7))) ("UP:Q8NHY0" (("SDA" 5)))
 ("UP:Q8NHY2"
  (("RFWD2" 8) ("RING finger and WD repeat domain 2" 3) ("Rfwd2" 1)))
 ("UP:Q8NHY6" (("ZFP28" 1)))
 ("UP:Q8NHZ8" (("CDC26" 28) ("Cdc26" 12) ("APC12" 1)))
 ("UP:Q8NI08" (("NCOA7" 6) ("AhR/ARNT" 2) ("AhR/Arnt" 1)))
 ("UP:Q8NI17"
  (("GPL" 46) ("CRL3" 12) ("IL31RA" 7) ("“GPL571”" 1) ("“GPL570”" 1)
   ("“GPL96”" 1) ("GEO platform GPL7541" 1)))
 ("UP:Q8NI27" (("Thoc2" 3)))
 ("UP:Q8NI35"
  (("Patj" 66) ("PATJ" 21) ("INADL" 15) ("Q8NI35" 1) ("PATJ-" 1)
   ("the Pals1-associated TJ protein Patj" 1)))
 ("UP:Q8NI36" (("WDR36" 42) ("WD repeat domain 36" 6) ("GLC1G" 4)))
 ("UP:Q8NI38" (("IκBδ" 10)))
 ("UP:Q8NI51"
  (("BORIS" 350) ("CTCFL" 8) ("BORIS protein" 4) ("CTCF paralog" 3)
   ("pBORIS" 2)))
 ("UP:Q8NI77" (("Kif18A" 3))) ("UP:Q8NI99" (("AGF" 9) ("Arp5" 1)))
 ("UP:Q8NJR2" (("Ure2" 1))) ("UP:Q8NTE1" (("LPDs" 7) ("systemic LPDs" 6)))
 ("UP:Q8PQ45" (("cap-like" 5))) ("UP:Q8QFP9" (("KSY" 1)))
 ("UP:Q8QMY9" (("glutaredoxin1" 1))) ("UP:Q8QZX0" (("SBK" 2)))
 ("UP:Q8R173" (("GODZ" 2))) ("UP:Q8R183" (("Tim-2" 11)))
 ("UP:Q8R2Z5" (("wARP" 7)))
 ("UP:Q8R4P5"
  (("DN" 2558) ("dn" 126) ("dN" 27) ("BTH" 5) ("-DN" 5) ("pDN" 5) ("DN-" 4)
   ("DN protein" 3) ("Dn" 2) ("3.3 DN30" 2) ("than DN" 1)
   ("the two IKKβ DN, either the IKKβ [S177S181≫AA]" 1) ("–DN" 1)
   ("most DN" 1)))
 ("UP:Q8R526" (("RKS" 1))) ("UP:Q8R550" (("Ruk" 156)))
 ("UP:Q8RUW5" (("pSMT" 5))) ("UP:Q8RVQ9" (("centromeric histone" 1)))
 ("UP:Q8RWD5" (("SCD-2" 6))) ("UP:Q8RWL0" (("del3" 19) ("Del3" 4)))
 ("UP:Q8RWZ1" (("scm" 2) ("Scm" 2))) ("UP:Q8RX87" (("RS6" 4) ("rS6" 2)))
 ("UP:Q8RXL7" (("ARL" 18) ("Arl" 1)))
 ("UP:Q8RXN0" (("Cof1" 146) ("COF1" 9) ("cof1" 2) ("Dye-labelled Cof1" 1)))
 ("UP:Q8RXN3" (("Cue1" 3)))
 ("UP:Q8S307" (("bis-2-" 4) ("Bis-2-" 3) ("Bis-2" 3) ("bis-2" 2)))
 ("UP:Q8S8F9" (("Pnc1" 3))) ("UP:Q8S8S1" (("Sse1" 8)))
 ("UP:Q8SQ41" (("PGB" 11)))
 ("UP:Q8SSW7"
  (("GEFs" 854) ("GefS" 6) ("most GEFs" 3) ("Ras-GEFs" 2)
   ("integrin-associated GEFs" 2) ("atypical GEFs" 2) ("the potential GEFs" 2)
   ("gefS" 2) ("membrane-associated GEFs" 1) ("Affinity-precipitated GEFs" 1)
   ("one or more GEFs" 1) ("adhesion-receptor-associated GEFs" 1)
   ("family atypical GEFs" 1) ("the classical GEFs" 1)
   ("the unconventional GEFs" 1) ("dominant-negative GEFs" 1)
   ("the relevant GEFs" 1)))
 ("UP:Q8ST83" (("pho" 27) ("Pho" 14) ("pHO" 2) ("PHO" 2)))
 ("UP:Q8SWV6" (("FIC" 1))) ("UP:Q8SX86" (("NTC" 115) ("NTC-" 4) ("-NTC" 2)))
 ("UP:Q8T115" (("HC4" 52)))
 ("UP:Q8T390" (("endo" 56) ("Endo" 54) ("endo-" 18)))
 ("UP:Q8T5C6"
  (("RXR" 311) ("RXRs" 23) ("-RXR" 2) ("pRXR" 2) ("‘RXR’" 1) ("“RXR”" 1)))
 ("UP:Q8T626"
  (("VA" 1956) ("USA" 152) ("DLT" 117) ("three DLT's" 1) ("pVA" 1)
   ("only 1 DLT" 1) ("VA (USA)" 1)))
 ("UP:Q8T6B9" (("HFP" 10)))
 ("UP:Q8TAA9"
  (("VANGL1" 44) ("Vangl1" 4) ("the planar cell polarity protein VANGL1" 2)))
 ("UP:Q8TAB7" (("CCDC26" 134) ("Ccdc26" 23) ("CCDC26 protein" 3)))
 ("UP:Q8TAD2" (("IL17D" 7))) ("UP:Q8TAD8" (("SNIP1" 6)))
 ("UP:Q8TAE8"
  (("CRIF1" 386) ("Crif1" 26) ("CR6-interacting factor 1" 23)
   ("CRIF1 protein" 7) ("the associated CRIF1" 2) ("Gadd45gip1" 1)))
 ("UP:Q8TAF3"
  (("UAF1" 83) ("WDR48" 24) ("Uaf-1" 24) ("almost full-length UAF1" 2)))
 ("UP:Q8TAG9"
  (("Sec15p" 26) ("EXOC6" 14) ("overexpressed Sec15p" 3) ("Sec15A" 1)))
 ("UP:Q8TAI7" (("RhebL1" 6) ("RHEBL1" 2))) ("UP:Q8TAK5" (("GABPB2" 4)))
 ("UP:Q8TAK6" (("Oligo 1" 9) ("OLIG1" 3) ("Olig1" 2)))
 ("UP:Q8TAM2" (("TTC8" 2))) ("UP:Q8TAM6" (("JN" 16)))
 ("UP:Q8TAP4" (("Lmo3" 6) ("LMO3" 6))) ("UP:Q8TAP9" (("ORF20" 1)))
 ("UP:Q8TAQ2" (("BAF170" 23) ("Baf170" 15) ("SmarcC2" 1) ("SMARCC2" 1)))
 ("UP:Q8TAQ5" (("ZNF420" 1) ("ATM and p53-Associated KZNF Protein" 1)))
 ("UP:Q8TAQ9" (("SUNC1" 4)))
 ("UP:Q8TAS1"
  (("KIS" 50) ("KIs" 2) ("kinase interacting with stathmin" 1) ("KiS" 1)
   ("KIST" 1)))
 ("UP:Q8TAT2" (("FGFBP3" 1))) ("UP:Q8TAT5" (("NEIL3" 1)))
 ("UP:Q8TAT6" (("Npl4" 16) ("NPLOC4" 14) ("NPL4" 5)))
 ("UP:Q8TAV4"
  (("SRO" 23) ("The heterozygous 1p-deleted SRO" 2) ("the 1p-deleted SRO" 2)))
 ("UP:Q8TAX0" (("odd" 79) ("Odd" 16)))
 ("UP:Q8TAX7" (("MG2" 15) ("Mg2" 4) ("MUC7" 1)))
 ("UP:Q8TAX9" (("GSDMB" 18) ("GSDML" 5))) ("UP:Q8TB24" (("Rin3" 2) ("RIN3" 1)))
 ("UP:Q8TB36" (("ganglioside" 31) ("GDAP1" 2) ("ganglioside-" 1)))
 ("UP:Q8TB45"
  (("DEPTOR" 1046) ("Deptor" 62) ("DEPDC6" 13) ("deptor" 5)
   ("DEPTOR peptide" 5) ("less Deptor" 2) ("DEPTOR protein" 2) ("Depdc6" 2)
   ("Dep domain containing mTOR interacting protein" 1)
   ("bound much less Deptor" 1) ("than wild type DEPTOR" 1)
   ("immune-purified DEPTOR" 1) ("CKI-treated DEPTOR" 1)
   ("β-TRCP specifically targets DEPTOR" 1) ("placental DEPTOR" 1)))
 ("UP:Q8TB52" (("FBXO30" 1)))
 ("UP:Q8TB72" (("PUM2" 35) ("Pum2" 6) ("than PUM2" 1)))
 ("UP:Q8TB92" (("Hmgcll1" 13)))
 ("UP:Q8TBB1" (("LNX1" 196) ("LNX" 8) ("Lnx1" 1)))
 ("UP:Q8TBC3" (("SHKBP1" 93) ("SH3KBP1 binding protein 1" 7) ("Sb1" 2)))
 ("UP:Q8TBC4" (("UBA3" 6) ("Uba3" 3))) ("UP:Q8TBE0" (("BAHD1" 2)))
 ("UP:Q8TBJ5"
  (("TOF" 562) ("ToF" 4) ("FEZF2" 2) ("pTOF" 2) ("non-syndromic TOF" 2)
   ("a further 209 TOF" 1) ("One hundred and forty-four Canadian TOF" 1)
   ("Canadian TOF" 1)))
 ("UP:Q8TBK2"
  (("SETD6" 159) ("overexpressed SETD6" 3) ("SETD6 protein" 2)
   ("exogenous SETD6" 1) ("SET domain containing 6" 1)))
 ("UP:Q8TBM7" (("FLJ13263" 1))) ("UP:Q8TBP0" (("TBC1D16" 1)))
 ("UP:Q8TBP6" (("mCFP" 10))) ("UP:Q8TBX8" (("PIP4K2C" 11)))
 ("UP:Q8TBY9" (("WDR66" 10))) ("UP:Q8TBZ3" (("WDR20" 25)))
 ("UP:Q8TBZ5" (("ZNF502" 1))) ("UP:Q8TC05" (("MDM1" 8) ("Mdm1" 2)))
 ("UP:Q8TC07" (("TBC1D15" 4) ("Rab7 GAP" 2))) ("UP:Q8TC20" (("cT3" 6)))
 ("UP:Q8TC41" (("IBR domain containing 1" 1))) ("UP:Q8TC44" (("WDR51B" 1)))
 ("UP:Q8TC59"
  (("PIWIL2" 207) ("Piwil2" 79) ("piwil2" 11) ("HILI" 5) ("-Piwil2" 5)
   ("Piwil2 protein" 4) ("mili" 3) ("Hili" 3) ("overexpressed Piwil2" 2)
   ("piwil2 protein" 2)))
 ("UP:Q8TC71" (("SPATA18" 1))) ("UP:Q8TC76" (("FAM110B" 9)))
 ("UP:Q8TC84" (("FANK1" 7))) ("UP:Q8TC92" (("ENOX1" 2)))
 ("UP:Q8TCB0"
  (("p44" 743) ("P44" 18) ("p44 protein" 8) ("IFI44" 3) ("Delta40p53" 2)
   ("pp44" 1) ("Ifi44" 1) ("-p44" 1)))
 ("UP:Q8TCB6" (("OR51E1" 2))) ("UP:Q8TCD6" (("phospho2" 2)))
 ("UP:Q8TCF1" (("ZFAND1" 4)))
 ("UP:Q8TCG1"
  (("CIP2A" 490) ("cip2A" 7) ("KIAA1524" 5) ("CIP2A protein" 4)
   ("cancerous Inhibitor of PP2A" 2) ("cancerous inhibitor of PP2A" 2)
   ("Cancerous inhibitor of PP2A" 2) ("Cancerous Inhibitor of PP2A" 1)
   ("p53 increased CIP2A" 1)))
 ("UP:Q8TCG2" (("PI4K2B" 1)))
 ("UP:Q8TCG5"
  (("Cpt1c" 34) ("cpt1c" 29) ("CPT1C" 2)
   ("carnitine palmitoyltransferase 1C" 1)
   ("BCR-ABL-transformed cells required Cpt1c" 1)))
 ("UP:Q8TCJ2" (("STT3B" 1))) ("UP:Q8TCN5" (("ZNF507" 2)))
 ("UP:Q8TCS8" (("PNPase" 9) ("PNPT1" 6))) ("UP:Q8TCT0" (("CERK" 2)))
 ("UP:Q8TCT1" (("Phospho1" 1) ("phospho1" 1))) ("UP:Q8TCT6" (("SPPL3" 1)))
 ("UP:Q8TCT8" (("SPPL2a" 5) ("IMP-3" 3)))
 ("UP:Q8TCT9"
  (("HM13" 6) ("signal peptide peptidase" 3) ("Signal peptide peptidase" 2)
   ("-hM13" 1) ("hM13" 1)))
 ("UP:Q8TCU4" (("ALMS1" 5))) ("UP:Q8TCU5" (("GRIN3A" 2)))
 ("UP:Q8TCU6" (("P-Rex1" 16) ("P-REX1" 11) ("PREX1" 4) ("Prex1" 2)))
 ("UP:Q8TCW7" (("ZPLD1" 18))) ("UP:Q8TCY5" (("B27" 394) ("B-27" 59)))
 ("UP:Q8TCY9" (("URG4" 126) ("URGCP" 125) ("URG4-" 1)))
 ("UP:Q8TD08"
  (("ERK8" 224) ("MAPK15" 159) ("ERK7" 6) ("pERK8" 5) ("MAPK15 protein" 4)
   ("soluble ERK8" 1)))
 ("UP:Q8TD10" (("MIPOL1" 1))) ("UP:Q8TD16" (("BICD2" 184) ("Bicd2" 1)))
 ("UP:Q8TD17" (("pp71" 9) ("P71" 2)))
 ("UP:Q8TD19" (("Nek9" 17) ("NEK9" 12) ("Nercc1" 1)))
 ("UP:Q8TD26" (("CHD6" 4))) ("UP:Q8TD30" (("ALT2" 101) ("AAT2" 1)))
 ("UP:Q8TD31"
  (("CCHCR1" 172) ("spongiosis expressed less CCHCR1" 2)
   ("the invasive front expressed CCHCR1" 2) ("the less CCHCR1" 1)
   ("The most intense CCHCR1" 1) ("CCHCR1 protein" 1)))
 ("UP:Q8TD33" (("SCGB1C1" 1))) ("UP:Q8TD46" (("CD200R" 2) ("HCRTR2" 1)))
 ("UP:Q8TD94" (("BTEB5" 1))) ("UP:Q8TDB6" (("DTX3L" 175) ("BBAP" 9)))
 ("UP:Q8TDC3" (("BRSK1" 38) ("SAD-B" 9) ("Brsk1" 2) ("BrsK1" 1)))
 ("UP:Q8TDD2"
  (("Osterix" 35) ("osterix" 21) ("SP7" 17) ("Sp7" 1)
   ("the previously known SP7" 1)))
 ("UP:Q8TDD5" (("TRPML3" 1) ("MCOLN3" 1)))
 ("UP:Q8TDF6"
  (("RasGRP4" 49) ("full-length normal RasGRP4" 1) ("normal RasGRP4" 1)))
 ("UP:Q8TDG4" (("HELQ" 164) ("HEL308" 3) ("helq" 1)))
 ("UP:Q8TDH9" (("MU" 203) ("Mu" 41) ("mU" 15) ("mu" 10)))
 ("UP:Q8TDI0" (("chromodomain helicase DNA binding protein 5" 3)))
 ("UP:Q8TDJ6" (("DMXL2" 2))) ("UP:Q8TDM6" (("DLG5" 10) ("KIAA0583" 2)))
 ("UP:Q8TDN4"
  (("Cables1" 171) ("cables" 86) ("CABLES1" 6)
   ("circumferential actin cables" 3) ("the normal cables" 1)
   ("straight radial cables" 1) ("pCables" 1) ("whose endogenous Cables1" 1)
   ("Cables1 protein" 1) ("showed only occasional actin cables" 1)
   ("the circumferential actin cables" 1)
   ("the subapical plane revealed typical circumferential actin cables" 1)
   ("Cables" 1)))
 ("UP:Q8TDQ0"
  (("Tim-3" 260) ("Tim3" 5) ("TIM3" 3) ("TIM-3" 2)
   ("a dysfunctional Tim-3" 1)))
 ("UP:Q8TDQ1" (("NK inhibitory receptor" 6))) ("UP:Q8TDQ7" (("GNPDA2" 10)))
 ("UP:Q8TDR0" (("MIP-T3" 2))) ("UP:Q8TDR2" (("STK35" 5)))
 ("UP:Q8TDR4" (("TCP10L" 1)))
 ("UP:Q8TDS4" (("GPR109A" 18) ("HM74a" 1) ("NIACR1" 1)))
 ("UP:Q8TDU6" (("TGR5" 8) ("TGR-5" 1))) ("UP:Q8TDV2" (("BTR" 34)))
 ("UP:Q8TDW0" (("LRRC8C" 1) ("fad158" 1)))
 ("UP:Q8TDW4" (("ST7L" 10) ("suppression of tumorigenicity 7 like" 1)))
 ("UP:Q8TDW5" (("SYTL5" 1)))
 ("UP:Q8TDW7" (("FAT3" 21) ("FAT tumor suppressor homolog 3" 3) ("Fat3" 3)))
 ("UP:Q8TDX7" (("Nek7" 17) ("NEK7" 1)))
 ("UP:Q8TDY2"
  (("RB1CC1" 304) ("FIP200" 271) ("ATG17" 7) ("KIAA0203" 5) ("Fip200" 1)
   ("cc1" 1)))
 ("UP:Q8TDZ2" (("Mical1" 22) ("Mical-1" 9) ("MICAL1" 8)))
 ("UP:Q8TE02" (("Elp5" 17) ("DERP6" 2) ("ELP5" 1)))
 ("UP:Q8TE04" (("PANK1" 99) ("PANK1 protein" 6) ("pantothenate kinase 1" 3)))
 ("UP:Q8TE12" (("lmx1.1" 1))) ("UP:Q8TE23" (("T1R2" 1)))
 ("UP:Q8TE49" (("Cezanne-2" 5))) ("UP:Q8TE54" (("SLC26A7" 1)))
 ("UP:Q8TE56" (("ADAMTS17" 1))) ("UP:Q8TE59" (("ADAMTS19" 1)))
 ("UP:Q8TE67" (("Eps8L3" 1))) ("UP:Q8TE68" (("Eps8L1" 1)))
 ("UP:Q8TE76" (("MORC4" 4) ("ZCWCC2" 1))) ("UP:Q8TE77" (("SSH3" 4)))
 ("UP:Q8TE85" (("SOM" 76) ("SOMs" 5) ("GRHL3" 3) ("grhl3" 1)))
 ("UP:Q8TEB7" (("GRAIL" 197) ("GRAIL protein" 7) ("Rnf128" 1)))
 ("UP:Q8TEB9" (("Rrp4" 2))) ("UP:Q8TEC5" (("SH3RF2" 1)))
 ("UP:Q8TED0" (("UTP15" 1))) ("UP:Q8TED1" (("GPX8" 2)))
 ("UP:Q8TEH3" (("DENND1A" 8) ("Connecdenn" 4)))
 ("UP:Q8TEK3"
  (("DOT1L" 351) ("Dot1L" 9) ("DOT1L-" 4) ("c-Myc-associated DOT1L protein" 1)
   ("DOT1L protein" 1)
   ("DOT1L
protein"
    1)
   ("potential oncogene
DOT1L"
    1)))
 ("UP:Q8TEM1" (("GP210" 1)))
 ("UP:Q8TEP8" (("CEP192" 49) ("Cep192" 16) ("at least some CEP192" 1)))
 ("UP:Q8TEQ6"
  (("gemin5" 145) ("Gemin5" 13) ("purified intact gemin5" 1)
   ("immunopurified intact gemin5" 1) ("Both intact gemin5" 1)))
 ("UP:Q8TEQ8" (("class O" 50) ("class O (FOXO)" 3) ("Class O" 1)))
 ("UP:Q8TER0" (("SNED1" 2)))
 ("UP:Q8TEU7" (("PDZ-GEF2" 11) ("PDZGEF2" 7) ("RapGEF6" 3) ("RAPGEF6" 1)))
 ("UP:Q8TEV9" (("SMCR8" 1)))
 ("UP:Q8TEW0"
  (("PARD3" 76) ("Baz" 40) ("Pard3" 32) ("Bazooka" 17)
   ("apical determinants Bazooka" 2) ("bazooka" 1)
   ("the apical polarity determinant PARD3" 1) ("PARD3-" 1) ("baz" 1)
   ("atypical PKC isotype-specific interacting protein" 1)))
 ("UP:Q8TEW8" (("PARD3B" 2)))
 ("UP:Q8TEX9"
  (("importin-4" 23) ("importin-4 protein" 3) ("Importin-4" 1)
   ("residual importin-4" 1) ("IPO4" 1)))
 ("UP:Q8TEY5" (("AIbZIP" 1) ("CREB3L4" 1) ("JAL" 1)))
 ("UP:Q8TEY7" (("USP33" 10) ("Usp33" 4))) ("UP:Q8TF05" (("PPP4R1" 1)))
 ("UP:Q8TF30"
  (("microtubules" 2129) ("Microtubules" 51) ("microtubules (MT)" 3)
   ("completely depolymerase spindle microtubules" 2)
   ("shorter cytoplasmic microtubules" 2)
   ("designate stabilized microtubules" 2) ("than microtubules" 1)
   ("targeting microtubules" 1) ("than non-treated microtubules" 1)
   ("than the control microtubules ( xref C, arrows)" 1)
   ("the outermost cortically associated central spindle microtubules" 1)))
 ("UP:Q8TF40" (("FNIP1" 6) ("folliculin interacting protein 1" 1)))
 ("UP:Q8TF42" (("STS-1" 6) ("Sts-1" 1))) ("UP:Q8TF47" (("ZFP90" 5)))
 ("UP:Q8TF62" (("ATP8B4" 1))) ("UP:Q8TF66" (("pLIB" 34)))
 ("UP:Q8TF68"
  (("NMP4" 5) ("CIZ" 2) ("Nuclear matrix transcription factor 4" 1)))
 ("UP:Q8TF71" (("Ta/T1" 10) ("Tat1" 9) ("TAT1" 6) ("pTa/T1" 5) ("tat1" 1)))
 ("UP:Q8TF72" (("SHROOM3" 2)))
 ("UP:Q8TF74"
  (("wire" 59) ("WICH" 15) ("wich" 7) ("Wire" 6) ("WIRE" 4) ("WIPF2" 4)
   ("20 µm-thick tungsten wire" 2)))
 ("UP:Q8TF76" (("haploid" 149) ("Haploid" 14) ("GSG2" 2)))
 ("UP:Q8TFU8" (("HA-CA" 2) ("hACA" 1))) ("UP:Q8THF6" (("MS-MS" 35)))
 ("UP:Q8U671"
  (("DHA" 793) ("placental DHA" 4) ("DHA-" 2) ("-DHA" 2) ("than DHA" 1)
   ("than DHA ( xref )" 1) ("Low placental DHA" 1)))
 ("UP:Q8UCD5" (("moDC" 66) ("MoDC" 13) ("immature moDC" 2) ("than moDC" 1)))
 ("UP:Q8UF86" (("UvrA" 5)))
 ("UP:Q8V5E0"
  (("pro" 8020) ("pro-" 568) ("PRO" 200) ("PRO-" 11) ("pro–" 5) ("‘pro’" 1)
   ("the defective pro–" 1) ("“pro-pro”" 1) ("only one pro-" 1)
   ("cellular pro-" 1)))
 ("UP:Q8VBY2" (("CAMKK" 9))) ("UP:Q8VC69" (("NKT" 424) ("NK-T" 2)))
 ("UP:Q8VE73"
  (("p185" 88) ("circulating soluble p185" 2) ("P185" 1) ("−p185" 1)))
 ("UP:Q8VHJ4"
  (("rat" 4696) ("Rat" 360) ("RAT" 8) ("rat protein" 2)
   ("a Brown Norway rat" 1) ("a live anesthetized rat" 1) ("RAt" 1)))
 ("UP:Q8VHV8" (("S-G2" 23) ("S–G2" 6) ("SG2" 1)))
 ("UP:Q8VIN1" (("PEBP2" 6) ("PEBP-2" 1)))
 ("UP:Q8VQF4" (("CDX" 92) ("CINC" 8) ("Cdx" 7)))
 ("UP:Q8VWN6"
  (("RFS" 1398) ("shorter RFS" 32) ("longer RFS" 19) ("poor RFS" 14)
   ("significantly worse RFS" 5) ("a statistically significant poor RFS" 4)
   ("more favorable RFS" 4) ("RFS (NPV)" 3) ("than the median RFS" 2)
   ("Bevacizumab (Bev) (yes/no) median RFS" 2) ("significantly poorer RFS" 2)
   ("post-operative RFS" 2) ("shorter median RFS" 2)
   ("significantly better RFS" 2) ("postoperative RFS" 1) ("Actuarial RFS" 1)
   ("a significantly worse 3 year RFS" 1) ("Cumulative 5-year RFS" 1)
   ("a significant poor RFS" 1) ("a significantly poorer RFS" 1)
   ("a favorable RFS" 1) ("more precisely assessed RFS" 1)
   ("HSP90 and PI3K-p110α predicted significantly worse RFS" 1)
   ("shortest RFS" 1) ("The poor RFS" 1)))
 ("UP:Q8VXV4" (("B16" 251) ("b16" 2))) ("UP:Q8VYR7" (("BOR1" 2)))
 ("UP:Q8VYX0"
  (("Gr1" 123) ("Gr-1" 110) ("GR1" 29) ("GR-1" 14) ("Gr1-" 3)
   ("the late myeloid markers GR-1" 1) ("Gr1−" 1) ("GR-1-" 1) ("Gr-1-" 1)
   ("a mature ckit lo Mac1 + Gr1" 1)))
 ("UP:Q8VZD4" (("Gpp" 14) ("GPP" 3))) ("UP:Q8VZF1" (("ACN1" 8)))
 ("UP:Q8W035" (("DFd" 5))) ("UP:Q8W191" (("HYH" 2)))
 ("UP:Q8W1E3" (("CDF1" 3) ("pCDF1" 1))) ("UP:Q8W1L6" (("mfp" 10) ("MFPs" 9)))
 ("UP:Q8W1Y3" (("KP1" 10) ("kp1" 5) ("kp1-" 2)))
 ("UP:Q8W257" (("PFI" 29) ("longer PFI" 1)))
 ("UP:Q8W4J9"
  (("HRT" 284) ("CHRT" 10) ("postmenopausal HRT" 2)
   ("sporadic breast cancer cases not using HRT" 2) ("new HRT" 1) ("CHRT-" 1)
   ("HRT (CHRT)" 1)))
 ("UP:Q8W4R3"
  (("RH30" 194) ("Rh30" 165) ("RH30-" 1) ("Alveolar RMS cell lines Rh30" 1)))
 ("UP:Q8WTE6" (("OR2" 1))) ("UP:Q8WTE7" (("OR1" 6)))
 ("UP:Q8WTK2" (("hexosaminidase" 2)))
 ("UP:Q8WTP8" (("AEN" 3) ("ISG20L1" 1) ("Isg20l1" 1)))
 ("UP:Q8WTQ7" (("GRK7" 1))) ("UP:Q8WTR2" (("SKRP1" 5) ("DUSP19" 2)))
 ("UP:Q8WTR7" (("ZFP100" 3))) ("UP:Q8WTS1" (("CGI-58" 3)))
 ("UP:Q8WTS6"
  (("Set9" 194) ("SET7/9" 159) ("SET7" 37) ("Set7" 8) ("Set7/9" 7) ("SET9" 6)
   ("KMT7" 5) ("overexpressed Set9" 4) ("Setd7" 2) ("SET7/9-" 1)))
 ("UP:Q8WTT0" (("BDCA2" 68) ("member C" 13) ("CD303" 1) ("DLEC" 1)))
 ("UP:Q8WTT2" (("NOC3L" 9)))
 ("UP:Q8WTV0"
  (("SR-BI" 34) ("SCARB1" 11) ("scavenger receptor class B" 5)
   ("scavenger receptor class B member 1" 4) ("Cla1" 3) ("Scarb1" 2) ("srb1" 2)
   ("SRBI" 1) ("SRB1" 1) ("SR-BI-" 1)))
 ("UP:Q8WTW4" (("TUSC4" 157) ("NPRL2" 62) ("TUSC4-" 1)))
 ("UP:Q8WTX9" (("ZDHHC1" 1))) ("UP:Q8WU17" (("Trc8" 7)))
 ("UP:Q8WU20"
  (("FRS2" 203) ("FRS2α" 142) ("p-FRS2" 14) ("p-FRS2α" 11)
   ("fibroblast growth factor receptor substrate 2" 8) ("pFRS2" 8) ("FRS-2" 7)
   ("FGFR substrate 2" 7) ("SNT1" 6) ("Frs2" 6) ("SNT" 3) ("P-FRS2" 3)
   ("FRS2α protein" 2) ("more p-FRS2α" 1) ("the immediate substrate FRS2α" 1)
   ("the immediate FGFR substrate FRS2α" 1)))
 ("UP:Q8WU67" (("ABHD3" 2))) ("UP:Q8WU79" (("SMAP2" 4) ("Smap2" 1)))
 ("UP:Q8WUA4" (("110kD)" 2)))
 ("UP:Q8WUA7"
  (("TBC1D22A" 68) ("TBC1 domain family member 22A protein" 3)
   ("TBC1 domain family member 22A" 1)))
 ("UP:Q8WUA8" (("Tsukushi" 25) ("Tsku" 9) ("TSK" 3) ("Tsk" 2) ("LRRC54" 1)))
 ("UP:Q8WUB2" (("HSU79274" 2))) ("UP:Q8WUD6" (("CPT-1" 8)))
 ("UP:Q8WUF5"
  (("iASPP" 424) ("iASPP protein" 7) ("protein iASPP" 3)
   ("overexpressed iASPP" 2) ("NKIP1" 2) ("PP1-binding Defective iASPP" 2)
   ("the last 15 amino acids of iASPP that could not" 1)
   ("both exogenous and endogenous iASPP" 1)))
 ("UP:Q8WUH2" (("TRAP-1" 1)))
 ("UP:Q8WUI4"
  (("HDAC7" 855) ("HDAC7 protein" 9) ("exogenous HDAC7" 5)
   ("histone deacetylase-7" 3) ("the exogenous HDAC7 protein" 1) ("-HDAC7" 1)))
 ("UP:Q8WUJ0" (("STYX" 2)))
 ("UP:Q8WUJ3"
  (("KIAA1199" 284) ("hyaluronan binding" 9) ("Hyaluronan binding" 2)
   ("a soluble hyaluronan binding protein" 2) ("marginal KIAA1199" 2)
   ("hyaluronan binding protein" 1)
   ("the first N-terminal 60 amino acids of KIAA1199" 1)))
 ("UP:Q8WUM0" (("NUP133" 1)))
 ("UP:Q8WUM4"
  (("ALIX" 698) ("Alix" 148) ("YPX" 11) ("PDCD6IP" 7) ("Hp95" 3)
   ("Alix protein" 3) ("programmed cell death 6-interacting protein" 3)
   ("ALG-2-interacting Protein X" 2) ("PDCD6IP protein" 2)
   ("membrane-associated ALIX" 1) ("ALIX-" 1)
   ("1A12, 1F7 and 3A9 monoclonal antibodies each specifically immunoblotted ALIX"
    1)
   ("Alix peptide" 1)))
 ("UP:Q8WUM9" (("SLC20A1" 3))) ("UP:Q8WUP2" (("Migfilin" 180) ("migfilin" 3)))
 ("UP:Q8WUT9" (("SLC25A43" 1))) ("UP:Q8WUU5" (("GATAD1" 2)))
 ("UP:Q8WUW1"
  (("HSPC300" 14) ("Hspc300" 2) ("smaller WRC constituent HSPC300" 2)
   ("BRK1" 1)))
 ("UP:Q8WUX1" (("SN2" 2)))
 ("UP:Q8WUY3" (("BMCC1" 233) ("PRUNE2" 11) ("BNIPXL" 6) ("KIAA0367" 3)))
 ("UP:Q8WUY9"
  (("DEPDC1B" 171) ("DEPDC1B protein" 8) ("overexpressed DEPDC1B protein" 4)
   ("BRCC3" 2) ("DEPDC1b" 1) ("than the DEPDC1B" 1)
   ("Cell-expressing DEPDC1B" 1)))
 ("UP:Q8WV07" (("ORAOV1" 1)))
 ("UP:Q8WV24"
  (("pleckstrin homology-like domain" 7) ("PHLDA1" 4)
   ("containing both the pleckstrin homology-like domain" 1)))
 ("UP:Q8WV28"
  (("homology" 4813) ("BCa" 346) ("SLP65" 279) ("BLNK" 211) ("BASH" 142)
   ("Homology" 124) ("linker protein" 46) ("structural homology" 29)
   ("extensive homology" 14) ("SLP-65" 13) ("homology (SH)" 13)
   ("homology (DH)" 11) ("cytoplasmic adapter protein" 10) ("invasive BCa" 8)
   ("strong homology" 7) ("the structural homology" 7)
   ("homology protein (CHOP)" 6) ("homology (PH)" 6)
   ("linker protein (BLNK)" 5) ("SLP65 (BLNK)" 5) ("homology (CH)" 4)
   ("weak homology" 4) ("-homology" 4) ("considerable homology" 4)
   ("muscle-invasive BCa" 4) ("homology (TH)" 4) ("functional homology" 4)
   ("structural and functional homology" 4)
   ("a multifunctional linker protein" 4) ("displays strong homology" 3)
   ("significant structural homology" 3) ("the high functional homology" 3)
   ("B-cell linker protein (BLNK)" 3)
   ("significant structural and functional homology" 3) ("homology (BH)" 3)
   ("homology protein (PTEN)" 3) ("substantial homology" 3)
   ("strong sequence homology" 3) ("the high structural homology" 3)
   ("exogenous BASH" 2) ("considerable sequence homology" 2)
   ("comparative homology" 2) ("the functional and structural homology" 2)
   ("its structural homology" 2) ("only 37% sequence homology" 2)
   ("reliable BCa" 2) ("Structural homology" 2)
   ("extensive structural homology" 2) ("a strong homology" 2)
   ("this apparent global homology" 2) ("no structural homology" 2)
   ("share at least 40% homology" 2) ("other hormonally-responsive BCa" 2)
   ("their primary homology" 2) ("roughly 58% amino acid homology" 2)
   ("the desmosomal linker protein" 2)
   ("Both isoforms 125a and 125b share perfect sequence homology" 2)
   ("p68 and p72 share remarkable homology" 2) ("a reliable homology" 2)
   ("perfect homology" 2) ("high local homology" 2) ("the strong homology" 2)
   ("no obvious homology" 2) ("the most homology" 2)
   ("the remarkable homology" 2) ("share no obvious sequence homology" 2)
   ("approximately 70% nucleotide homology" 2)
   ("functionally substitute SLP65" 2) ("than 80% homology" 2)
   ("the high structural and functional homology" 2) ("–BASH" 1)
   ("other previously identified proteins revealed homology" 1)
   ("The structural homology" 1) ("SH2 domains share less homology" 1)
   ("any obvious homology" 1)
   ("a testis cDNA library and contained 63% homology" 1)
   ("its strong homology" 1)
   ("β1, β3, and β5 integrin cytoplasmic tails share considerable sequence homology"
    1)
   ("the response element displays perfect human/rodent homology" 1)
   ("muscle invasive BCa" 1)
   ("the transcriptional repressor BTB and CNC homology" 1)
   ("share structural homology" 1)
   ("Both Id1 and Id4 share strong sequence homology" 1)
   ("nearly 100% amino acid sequence homology" 1)
   ("share at least 90% homology" 1) ("All PKCs share extensive homology" 1)
   ("the β-chain
 shares structural homology"
    1)
   ("The atypical PKC isozymes PKCι and PKCζ share ~72% sequence homology" 1)
   ("shared perfect homology" 1) ("the positional homology" 1)
   ("their positional homology" 1) ("strong structural homology" 1)
   ("than 98% sequence homology" 1) ("a triple-negative BCa" 1)
   ("the so-called MYC homology" 1) ("a 53% structural homology" 1)
   ("otherwise lack any significant homology" 1)
   ("shares close structural homology" 1) ("only 25% sequence homology" 1)
   ("Mouse monoclonal C/EBP homology protein (CHOP)" 1) ("homology (ECH)" 1)
   ("very little sequence homology" 1) ("an eighty percent homology" 1)
   ("Most BCa" 1) ("than BCa" 1) ("primary BCa" 1)
   ("approximately 70% homology" 1) ("B-cell linker protein" 1)
   ("TBK1 and IKKε share structural homology" 1)
   ("partial homology of Rta’s" 1)
   ("considerable tertiary structural homology" 1) ("than the homology" 1)
   ("serendipitous homology" 1) ("No genetic homology" 1)
   ("share considerable homology" 1) ("Less homology" 1)
   ("no extensive homology" 1) ("reliable homology" 1)
   ("approximately 60% homology" 1)
   ("PRL1 and PRL3 share high structural homology" 1) ("no strong homology" 1)
   ("the essential adaptor protein BLNK" 1) ("weak sequence homology" 1)
   ("MK and PTN display no obvious homology" 1) ("its extensive homology" 1)
   ("than 90% homology" 1) ("showed less homology" 1) ("exact homology" 1)
   ("absent sequence homology" 1) ("obvious sequence homology" 1)
   ("no structural or chemical homology" 1) ("complete homology" 1)
   ("conformational homology" 1) ("Extensive homology" 1)
   ("approximately 56% homology" 1) ("approximately 48% amino acid homology" 1)
   ("recently undergone expansion and share high sequence homology" 1)
   ("only 14% homology" 1) ("a 26 bp perfect homology" 1)
   ("These two proteins share considerable sequence homology" 1)
   ("Weak homology" 1) ("share significant structural homology" 1)
   ("the Akt family members share approximately 80% homology" 1)
   ("the tightly associated Dbl homology (DH)" 1)
   ("than 85% amino acid homology" 1)
   ("considerable cysteine-rich sequence homology" 1)
   ("similar weak homology" 1) ("than 48% sequence homology" 1) ("slp65" 1)
   ("Slp65" 1) ("ROCK1 and ROCK2 share considerable sequence homology" 1)
   ("available sequence homology" 1) ("high structural homology" 1)
   ("a centriolar linker protein" 1) ("HomologY" 1)
   ("All hnRNP family proteins share structural homology" 1)
   ("scant sequence homology" 1) ("shares at least 20% sequence homology" 1)
   ("approximately residues 55 and 230 displays particularly low homology" 1)
   ("an approximately 42% amino acid homology" 1) ("nonmuscle-invasive BCa" 1)
   ("obvious homology" 1) ("perfect nucleotide homology" 1)
   ("their structural homology" 1) ("than 90% sequence homology (> 100-bp)" 1)
   ("only 50% homology" 1) ("shares approximately 83% homology" 1)
   ("than 98% homology" 1) ("no considerable homology" 1)
   ("92 percent homology" 1) ("65 percent amino acid homology" 1)
   ("a structural homology" 1) ("than 60% overall sequence homology" 1)
   ("loose homology" 1) ("shared distant homology" 1) ("distant homology" 1)
   ("B-cell linker" 1) ("approximately 82% homology" 1)
   ("share high structural homology" 1) ("ERBB2-postitive BCa" 1)
   ("STAT-5α and STAT-5β share extensive homology" 1)
   ("Similar structural homology" 1)))
 ("UP:Q8WV41" (("SNX33" 7) ("sorting nexin 33" 2)))
 ("UP:Q8WV44"
  (("RINCK" 4) ("RING-finger protein that interacts with C kinase" 1)))
 ("UP:Q8WV83" (("FLJ22004" 3)))
 ("UP:Q8WVB6" (("CTF18" 16) ("Ctf18" 11) ("ctf18" 7) ("Chl12" 1)))
 ("UP:Q8WVC0" (("LEO1" 4) ("RDL" 3)))
 ("UP:Q8WVD3" (("NLK associated RING finger protein" 1)))
 ("UP:Q8WVE0" (("N6AMT2" 7))) ("UP:Q8WVE6" (("TMEM171" 2)))
 ("UP:Q8WVJ2" (("NUDCD2" 5)))
 ("UP:Q8WVJ9" (("Twist2" 34) ("TWIST2" 7) ("twist2" 2) ("Dermo1" 1)))
 ("UP:Q8WVK2" (("ry1" 1)))
 ("UP:Q8WVK7"
  (("SKA2" 21) ("Ska2" 2)
   ("spindle and kinetochore associated complex subunit 2" 2)
   ("SKA2 protein" 1)))
 ("UP:Q8WVM7" (("STAG1" 18) ("Stromal antigen 1" 2) ("more STAG1" 1)))
 ("UP:Q8WVN6" (("SECTM1" 1))) ("UP:Q8WVN8" (("UBE2Q2" 7)))
 ("UP:Q8WVP5" (("TNFAIP8L1" 1))) ("UP:Q8WVT3" (("TTC15" 5)))
 ("UP:Q8WVZ9" (("KBTBD7" 1))) ("UP:Q8WW22" (("DNAJA4" 6)))
 ("UP:Q8WW27" (("APOBEC4" 6)))
 ("UP:Q8WW38"
  (("zinc finger protein" 155) ("ZFPM2" 14) ("Zinc finger protein" 5)
   ("FOG2" 4) ("FOG-2" 3) ("Fog2" 3)
   ("a sequence-specific DNA binding C 2 H 2 zinc finger protein" 2)))
 ("UP:Q8WW43" (("APH1B" 3))) ("UP:Q8WW59" (("SPRYD4" 1)))
 ("UP:Q8WWA0"
  (("Intl" 19) ("Alpha Diagnostic Intl" 3) ("ITLN1" 1) ("Intelectin-1" 1)))
 ("UP:Q8WWF5" (("ZNRF4" 3))) ("UP:Q8WWG1" (("NRG4" 9) ("neuregulin-4" 1)))
 ("UP:Q8WWH4"
  (("ankyrin repeat" 110) ("Orf3" 29) ("Ankyrin repeat" 15)
   ("the viral E4 Orf3 protein" 2) ("Orf3 protein" 2) ("orf3" 2)
   ("ankyrin repeat protein" 2) ("E4 Orf3's" 1)))
 ("UP:Q8WWI5" (("CDw92" 1))) ("UP:Q8WWK9" (("LB1" 5) ("CKAP2" 4) ("TMAP" 4)))
 ("UP:Q8WWL7" (("CCNB3" 4)))
 ("UP:Q8WWM9"
  (("Hgb" 24) ("CYGB" 23) ("cytoglobin" 5) ("HGB" 4) ("pHGB" 2)
   ("Cytoglobin" 2) ("HgB" 1) ("hGB" 1)))
 ("UP:Q8WWN8" (("ARAP3" 24) ("Arap3" 3)))
 ("UP:Q8WWN9" (("IPCEF1" 3) ("PIP3E" 1)))
 ("UP:Q8WWP7" (("IMAP1" 6) ("gimap1" 2) ("imap38" 1)))
 ("UP:Q8WWQ0" (("PhIP" 22) ("PHIP" 9) ("PhiP" 3)))
 ("UP:Q8WWQ8"
  (("fell" 752) ("concurrent PDGFRA and KIT amplification fell" 1)
   ("the RMS energy gradient fell" 1)
   ("their actual known molecular mass fell" 1)
   ("all quantifiable
phosphopeptides (9320) fell"
    1)
   ("All resultant
phosphopeptides fell"
    1)
   ("whose theoretical mass fell" 1) ("arterial oxygen saturation fell" 1)
   ("survival just fell" 1) ("so each reaction fell" 1)
   ("AME-positive mice fell" 1) ("Most SNPs fell" 1)
   ("the ethnic groups fell" 1) ("underwent normal mitosis fell" 1)
   ("many potential associating partners fell" 1)
   ("neurological disease fell" 1) ("STAB2" 1)
   ("approximately 64% (approximately 15.5 Gbases) fell" 1)
   ("their first two principal components fell" 1) ("public databases fell" 1)
   ("the relative rate ( v / v  0 ) fell" 1) ("These focal gains fell" 1)))
 ("UP:Q8WWW0"
  (("RASSF1C" 585) ("NORE1A" 423) ("RASSF5" 321) ("NORE1" 91) ("RapL" 74)
   ("NORE1B" 73) ("Rassf1C" 56) ("NORE1A protein" 14) ("NORE1A peptide" 4)
   ("RASSF1C protein" 4) ("Maxp1" 2) ("negatively impacts RASSF1C" 1)
   ("RassF1C" 1) ("-NORE1A" 1) ("MAXP1" 1)))
 ("UP:Q8WWW8" (("GAB3" 3))) ("UP:Q8WWY3" (("PRPF31" 1)))
 ("UP:Q8WWY8" (("LIPH" 6))) ("UP:Q8WWZ3" (("EDARADD" 1)))
 ("UP:Q8WWZ4"
  (("ATP-binding cassette" 113) ("member 10" 7) ("ATP-Binding Cassette" 5)
   ("ATP-binding cassette (ABC)" 1)))
 ("UP:Q8WWZ7" (("ABCA5" 15) ("member 5" 12)))
 ("UP:Q8WX92" (("COBRA1" 51) ("NELF-B" 4)))
 ("UP:Q8WX93" (("palladin" 111) ("Palladin" 14) ("palladin protein" 1)))
 ("UP:Q8WX94" (("NLRP7" 2))) ("UP:Q8WXA3" (("RUFY2" 4)))
 ("UP:Q8WXA9" (("SFRS12" 1)))
 ("UP:Q8WXB1" (("METTL21A" 6) ("methyltransferase like 21A" 1)))
 ("UP:Q8WXD0" (("LGR8" 7) ("RXFP2" 3)))
 ("UP:Q8WXD2" (("secretogranin III" 4) ("Scg3" 1))) ("UP:Q8WXD5" (("si-P2" 3)))
 ("UP:Q8WXD9" (("caskin1" 1)))
 ("UP:Q8WXE1"
  (("ATRIP" 574) ("Atrip" 114) ("ATR-interacting protein" 19) ("-ATRIP" 15)
   ("ATRIP protein" 8) ("ATR interacting protein" 4)
   ("ATR Interacting Protein" 3) ("ATR-interacting protein (ATRIP)" 2)
   ("Atrip protein" 2) ("ATR Interacting Protein (ATRIP)" 2) ("ATRIP–" 2)
   ("25% residual WT ATRIP" 2) ("ATR interacting protein (ATRIP)" 1)
   ("the first 107 amino acids of Atrip" 1)
   ("E. coli -expressed Bid and His-MBP-fused Atrip" 1)
   ("ATR–interacting protein (ATRIP)" 1) ("ATR–interacting protein" 1)))
 ("UP:Q8WXF0" (("SRrp35" 2))) ("UP:Q8WXF1" (("pSp1" 8)))
 ("UP:Q8WXF7" (("Atl1" 12) ("Atl1 protein" 5) ("ATL1" 1)))
 ("UP:Q8WXF8" (("DEDD2" 33) ("FLAME3" 2)))
 ("UP:Q8WXG1"
  (("pDCs" 260) ("PDCs" 26) ("RSAD2" 5) ("IL-6-treated pDCs" 4) ("Rsad2" 4)
   ("human primary pDCs" 4) ("Viperin" 3) ("viperin" 2)
   ("fresh isolated human pDCs" 2) ("healthy donor pDCs" 1)
   ("allogeneic pDCs" 1) ("Cig5" 1) ("than pDCs" 1)))
 ("UP:Q8WXG6"
  (("MADD" 93) ("pMADD" 22) ("MADD-" 3) ("DENN" 3) ("the intact MADD" 2)
   ("differentially expressed in normal and neoplastic cells" 2)
   ("exogenous MADD" 1)))
 ("UP:Q8WXG9" (("mass1" 18)))
 ("UP:Q8WXH0" (("SYNE2" 24) ("Nesprin 2" 10) ("nesprin-2" 2)))
 ("UP:Q8WXI2" (("CNK2" 105) ("exogenous GFP-tagged CNK2" 1)))
 ("UP:Q8WXI3"
  (("ASB10" 208) ("ASB10 protein" 10) ("GLC1F" 6) ("glaucoma 1" 3)
   ("ASB10-" 1)))
 ("UP:Q8WXI7"
  (("MUC16" 455) ("CA125" 177) ("CA 125" 54) ("MUC16-" 3)
   ("dual-tagged 114 amino acids of carboxyl-terminal MUC16" 2) ("Muc16" 2)
   ("the functional cell-associated MUC16" 1)
   ("dual-epitope tagged 114 amino acids of carboxyl-terminal MUC16 in PC cells"
    1)
   ("normal CA125" 1) ("the ovarian tumor cell marker CA125" 1)
   ("than CA125" 1) ("an abnormal CA125" 1) ("followed abnormal CA125" 1)
   ("transvaginal ultrasonography and serum CA125" 1)))
 ("UP:Q8WXI8"
  (("MCL" 942) ("therapy-resistant MCL" 13) ("nonnodal MCL" 4)
   ("primary MCL" 4) ("aggressive MCL" 4) ("malignant MCL" 3)
   ("classical MCL" 3) ("superfamily member 8" 3) ("mPcl" 2) ("most MCL" 2)
   ("Aggressive MCL" 2) ("a few blastic MCL" 1)
   ("the remaining non-blastic MCL" 1) ("essentially all MCL" 1)
   ("non-blastic MCL" 1) ("blastic MCL" 1) ("the therapy-resistant MCL" 1)
   ("overt MCL" 1) ("even high-risk MCL" 1) ("17 typical MCL" 1)
   ("the reported CCND2 or CCND3 translocation-associated MCL" 1)
   ("virtually all MCL" 1) ("than MCL (Table xref )" 1) ("the primary MCL" 1)))
 ("UP:Q8WXI9"
  (("p66" 739) ("P66" 11) ("p66 protein" 4) ("p66β" 2)
   ("presumably mutant p66" 2) ("the first 440 amino acids of P66" 1)
   ("Gatad2B" 1) ("the C-terminal 11 amino acids of p66" 1)
   ("the N-terminal 144 amino acids of p66" 1) ("expressing full-length p66" 1)
   ("than the p66 22" 1)))
 ("UP:Q8WXK4" (("Asb12" 6))) ("UP:Q8WXS3" (("BAALC" 168)))
 ("UP:Q8WXS8" (("ADAMTS14" 21))) ("UP:Q8WXU2" (("DYX1C1" 5)))
 ("UP:Q8WXW3" (("CEP90" 1))) ("UP:Q8WXX5" (("DNAJC9" 7)))
 ("UP:Q8WXX7" (("AUTS2" 57) ("Auts2" 1)))
 ("UP:Q8WY07" (("CAT-3" 72) ("CAT3" 1)))
 ("UP:Q8WY41" (("NOS-1" 2) ("Nanos1" 2)))
 ("UP:Q8WY54" (("PPM1E" 11) ("POPX1" 4)))
 ("UP:Q8WY64" (("MYLIP" 5) ("Idol" 2))) ("UP:Q8WYA0" (("IFT81" 5)))
 ("UP:Q8WYA1" (("MOP9" 1) ("CLIF" 1)))
 ("UP:Q8WYA6" (("NaP" 29) ("NAP" 11) ("CTNNBL1" 9)))
 ("UP:Q8WYB5"
  (("MORF" 7) ("MoRF" 6) ("KAT6B" 1)
   ("monocytic leukemia zinc finger protein-related factor" 1)
   ("Monocytic leukemia zinc finger protein-related factor" 1)))
 ("UP:Q8WYH8" (("ING5" 181) ("inhibitor of growth protein 5" 3)))
 ("UP:Q8WYJ6" (("SEPT1" 1))) ("UP:Q8WYK0" (("CACH" 2)))
 ("UP:Q8WYK2"
  (("JDP2" 236) ("Jdp2" 85) ("JDP2 protein" 8) ("Jun dimerization protein 2" 4)
   ("Jundm2" 1) ("JDP-2" 1)))
 ("UP:Q8WYL5"
  (("SSH1L" 358) ("SSH1" 18) ("SSH-1L" 9) ("overexpressed SSH1L" 4)
   ("Ser-978–phosphorylated SSH1L" 2) ("-SSH1L" 2)
   ("donor and Alexa Fluor 568-labeled myc-tagged SSH1L" 1) ("SSH-1" 1)))
 ("UP:Q8WYN0"
  (("ATG4A" 4) ("cysteine peptidase" 3) ("ATG4a" 2) ("Atg4a" 1)
   ("cysteine
peptidase"
    1)))
 ("UP:Q8WYP3" (("RASSF4" 38) ("RIN2" 2) ("Rin2" 1))) ("UP:Q8WYP5" (("ELYS" 2)))
 ("UP:Q8WYQ5"
  (("DGCR8" 98) ("Dgcr8" 4) ("DiGeorge syndrome critical region gene 8" 4)
   ("DiGeorge syndrome critical region 8" 4) ("Pasha" 2)
   ("the essential miRNA processing factor DGCR8" 2)))
 ("UP:Q8WYR1" (("PIK3R5" 17) ("Pik3r5" 1))) ("UP:Q8WZ19" (("KCTD13" 6)))
 ("UP:Q8WZ42"
  (("titin" 67) ("TTN" 33) ("Titin" 8) ("cardiac titin" 4) ("TT-N" 4)
   ("-TT-N" 3) ("cardiac N2B titin" 2) ("cardiac titin’s" 2)
   ("human cardiac titin" 1) ("Cardiac titin" 1) ("connectin" 1)))
 ("UP:Q8WZ55" (("barttin" 1) ("Bartter syndrome" 1)))
 ("UP:Q8WZ64" (("ARAP2" 1))) ("UP:Q8WZ71" (("TMEM158" 2)))
 ("UP:Q8WZ73" (("RFFL" 2))) ("UP:Q8WZ74" (("CTTNBP2" 6)))
 ("UP:Q8WZ75"
  (("Robo4" 158) ("ROBO" 5) ("Robo4 (WT)" 5) ("Robo4 (MT)" 3) ("robo" 1)))
 ("UP:Q8WZA2" (("RapGEF4" 2) ("EPAC2" 1) ("RAPGEF4" 1)))
 ("UP:Q8WZA9" (("IRGQ" 1))) ("UP:Q8X077" (("PCA2" 3)))
 ("UP:Q8X225" (("HKMT" 4))) ("UP:Q8XKQ2" (("MglA" 2)))
 ("UP:Q8YGD0"
  (("exonuclease" 210) ("Exonuclease" 20) ("-exonuclease" 9)
   ("viral shutoff exonuclease" 4)
   ("the previously mentioned TREX1 exonuclease" 1)))
 ("UP:Q90243" (("LVI" 41))) ("UP:Q90257" (("ES1" 21)))
 ("UP:Q90259" (("zash1a" 1)))
 ("UP:Q90321" (("MKK" 204) ("the canonical MKK" 2) ("pMKK" 2)))
 ("UP:Q90334" (("ITR" 5))) ("UP:Q90472" (("Hoxd13" 2)))
 ("UP:Q90508" (("LV1" 11)))
 ("UP:Q90600" (("P104" 63) ("previously prepared P104" 2)))
 ("UP:Q90607" (("Semaphorin-3A" 1))) ("UP:Q90660" (("pITA" 3) ("ITA" 2)))
 ("UP:Q90743"
  (("amyloid" 358) ("Amyloid" 45) ("-amyloid" 9) ("amyloid peptide" 5)
   ("amyloid-" 3) ("-amyloid peptide" 3) ("parenchymal amyloid" 2)
   ("Amyloid-" 1) ("extraneuronal amyloid" 1) ("vascular amyloid" 1)
   ("typical amyloid" 1)))
 ("UP:Q90827" (("NEL" 14))) ("UP:Q90839" (("dickkopf3" 5)))
 ("UP:Q90932" (("NFI-X" 18) ("NFI-X-" 1)))
 ("UP:Q90WN5"
  (("CoREST" 392) ("coREST" 5) ("CoRest" 2) ("purified (His) 6 -CoREST1" 1)
   ("-CoREST1" 1)))
 ("UP:Q90WP7" (("pLR" 7) ("PLRs" 1))) ("UP:Q90Y63" (("GAP1" 18) ("Gap1" 3)))
 ("UP:Q90ZY6" (("TLK1B" 30) ("Tousled-like kinase 1B" 3)))
 ("UP:Q91048" (("KLG" 2))) ("UP:Q910A1" (("AMI-1" 60)))
 ("UP:Q91274" (("SDS1" 22)))
 ("UP:Q91280"
  (("UDP-glucuronosyltransferase" 17) ("UDP-glucuronosyltransferase (UGT)" 1)))
 ("UP:Q91474" (("shNF1" 16))) ("UP:Q91550" (("Ubp3" 7) ("UBP3" 2)))
 ("UP:Q91609" (("Xnr3" 6)))
 ("UP:Q91610"
  (("CHH" 72) ("Dhh1" 40) ("dhh1" 5) ("DHH1" 2) ("normosmic CHH" 1)))
 ("UP:Q91612" (("BHH" 2))) ("UP:Q91620" (("NR2" 10) ("Nr2" 6)))
 ("UP:Q91636" (("XKCM1" 20))) ("UP:Q91685" (("MIX2" 5)))
 ("UP:Q91695" (("HDM" 72) ("pHDM" 6) ("HDMs" 3) ("chronically-inhaled HDM" 1)))
 ("UP:Q91771"
  (("mm3" 41) ("tumor size reached 100 mm3" 1)
   ("the tumor volume reached 60–100 mm3" 1)))
 ("UP:Q91780" (("CyclinE1" 4) ("cyclinE1" 2)))
 ("UP:Q91783" (("kinesin-5" 6) ("Kinesin-5" 3))) ("UP:Q91819" (("EG2" 1)))
 ("UP:Q91820" (("PEG2" 2))) ("UP:Q91837" (("FSCN" 2)))
 ("UP:Q91848" (("siamois" 8) ("Siamois" 4)))
 ("UP:Q91854"
  (("β-TrCP" 918) ("β-TRCP" 542) ("TrCP" 145) ("β-Trcp" 145) ("-TrCP" 32)
   ("FBXW1" 4) ("beta-transducin repeat containing protein" 4) ("beta-TrCP" 3)
   ("β-TrCP-" 2) ("TrcP" 2) ("pβ-TrCP" 2) ("β -TrCP2" 2) ("-TrCP2" 2)
   ("β-TrcP" 2) ("continuously binding β-TrCP" 1) ("betaTrcp" 1) ("β-trCP" 1)
   ("whose endogenous β-TRCP" 1) ("–TrCP" 1) ("β−TrCP" 1) ("BetaTrCP" 1)
   ("target β-TRCP2" 1)))
 ("UP:Q91924" (("SLU" 4) ("Slu" 2)))
 ("UP:Q91974" (("Iκ-Bα" 10) ("i-κBα" 4) ("Iκ–Bα" 1)))
 ("UP:Q91998" (("Brn-3" 3)))
 ("UP:Q91V27"
  (("LN" 820) ("LN(AI)" 5) ("distant LN" 3)
   ("Monoclonal antibodies (mAbs) LN2B" 2) ("castration-resistant LN(AI)" 1)
   ("than classic LN" 1) ("classic LN" 1) ("one less LN" 1)
   ("NSC-87877 more potently inhibited LN229" 1) ("the PTEN-positive LN229" 1)
   ("-LN229" 1)))
 ("UP:Q91WP6" (("Serpina3n" 1))) ("UP:Q91Y25" (("FAM21" 3)))
 ("UP:Q91ZY8" (("Spring" 200) ("spring" 81) ("SPRING" 3)))
 ("UP:Q92010" (("ZF5" 24)))
 ("UP:Q92039" (("CYP1A" 8) ("cytochrome P-450 1A" 2)))
 ("UP:Q92050"
  (("Wnt5" 51) ("Wnt-5" 10) ("WNT5" 6)
   ("the noncanonical Wnt pathway protein Wnt5" 1) ("WNT-5" 1)))
 ("UP:Q920G3" (("Siglec F" 2))) ("UP:Q92161" (("cyclinA1" 5)))
 ("UP:Q92182" (("ST6Gal-I" 58))) ("UP:Q92185" (("ST8SIA1" 1)))
 ("UP:Q92186"
  (("ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" 3)
   ("STX" 2)))
 ("UP:Q92187" (("Pst" 165) ("Pst1" 3) ("pST" 3) ("pST1" 3) ("ST8SIA4" 2)))
 ("UP:Q92344" (("SMA-5" 4))) ("UP:Q923Y7" (("TA2" 15) ("pTA2" 2)))
 ("UP:Q92466"
  (("DDB2" 570) ("DDB2 protein" 4) ("DDB2-" 3) ("functional DDB2" 3)
   ("negligible endogenous DDB2" 2) ("N-terminal FLAG-HA-tagged human DDB2" 2)
   ("DNA damage binding protein 2" 2) ("DDB2‐" 1)))
 ("UP:Q92478" (("Ifnrg1" 1)))
 ("UP:Q92481"
  (("TFAP2B" 27) ("AP-2β" 11) ("AP2β" 3) ("AP-2B" 2) ("AP-2beta" 1)))
 ("UP:Q92482" (("AQP3" 1))) ("UP:Q92484" (("SMPDL3A" 2)))
 ("UP:Q92496" (("CFHR4" 4) ("CFHL4" 2)))
 ("UP:Q92499" (("DDX1" 144) ("DDX1 protein" 2) ("excessive DDX1" 1)))
 ("UP:Q924T7" (("Paul" 119))) ("UP:Q92502" (("DLC3" 5)))
 ("UP:Q92504" (("ZIP7" 8) ("KE4" 1) ("HKE4" 1)))
 ("UP:Q92506" (("Ring2" 20) ("RING2" 20)))
 ("UP:Q92508" (("MIB" 97) ("Mib" 14)))
 ("UP:Q92519" (("TRIB2" 8) ("Tribbles homolog 2" 5) ("tribbles homolog 2" 2)))
 ("UP:Q92520" (("FAM3C" 8))) ("UP:Q92522" (("H1FX" 1)))
 ("UP:Q92523" (("carnitine palmitoyltransferase 1B" 1)))
 ("UP:Q92526" (("CCT6B" 1)))
 ("UP:Q92529" (("shC3" 8) ("ShcC" 3) ("Shc3" 3) ("SHC3" 2) ("ShC3" 1)))
 ("UP:Q92530" (("PSMF1" 2))) ("UP:Q92535" (("class C" 23) ("Class C" 5)))
 ("UP:Q92536"
  (("HUVECs" 3086) ("HuVECs" 82) ("senescent HUVECs" 23)
   ("Confluent HUVECs" 15) ("HUVECS" 12) ("primary HUVECs" 8)
   ("overexpressed HUVECs" 6) ("SLC7A6" 6) ("Primary HUVECs" 5)
   ("the AGE-treated HUVECs" 4) ("TNF-α-treated HUVECs" 3)
   ("subconfluent HUVECs" 3) ("confluent HUVECs" 3) ("VEGF-A-treated HUVECs" 3)
   ("TNFα-treated HUVECs" 2) ("sSEMA4D treated HUVECs" 2)
   ("Caveolin-1 siRNA-treated HUVECs" 2) ("than HUVECs" 2)
   ("doxazosin-treated HUVECs" 2) ("both young and senescent HUVECs" 2)
   ("young and senescent HUVECs" 2) ("uninfected primary HUVECs" 2)
   ("VN-adherent HUVECs" 2) ("control-siRNA-treated HUVECs" 2)
   ("siRNA-treated HUVECs" 2) ("Bach1-overexpressing HUVECs" 2)
   ("doxorubicin treated HUVECs" 2) ("LAMP1-GFP–transfected HUVECs" 2)
   ("P125A-treated HUVECs" 2) ("Hypercholesterolemic-Treated HUVECs" 2)
   ("80%~90% confluent HUVECs" 2) ("talin siRNA–expressing HUVECs" 2)
   ("eNOS siRNA–treated HUVECs" 2) ("apoptotic HUVECs" 2) ("normal HUVECs" 2)
   ("Fully confluent HUVECs" 2) ("Tat-treated HUVECs" 2)
   ("The treated HUVECs" 1) ("tBHP-treated HUVECs" 1) ("The normal HUVECs" 1)
   ("than HUVECs transfected with a control siRNA ( xref )" 1)
   ("the control siRNA-treated HUVECs" 1) ("80–90% confluent HUVECs" 1)
   ("Senescent HUVECs" 1) ("normal primary HUVECs" 1)
   ("vehicle-treated HUVECs" 1) ("Approximately 10 7 HUVECs" 1)
   ("siYAP treated HUVECs" 1) ("AGE-treated HUVECs" 1) ("BSA-treated HUVECs" 1)
   ("metabolically viable HUVECs" 1) ("GFP–expressing HUVECs" 1)
   ("RFP-expressing HUVECs" 1) ("than control HUVECs" 1)
   ("AktVIII-treated HUVECs" 1) ("treated HUVECs" 1)
   ("p110α siRNA–treated HUVECs" 1) ("un-treated and IM-treated HUVECs" 1)
   ("un-treated HUVECs" 1) ("quiescent HUVECs" 1) ("VEGF-A treated HUVECs" 1)
   ("The primary HUVECs" 1) ("Subconfluent HUVECs" 1)
   ("febrile temperatures HUVECs" 1) ("scrambled siRNA–treated HUVECs" 1)
   ("LAT3" 1) ("used sparse HUVECs" 1) ("sparse HUVECs" 1)
   ("we first transfected HUVECs" 1) ("siRNA-treated HuVECs" 1)
   ("the colorless HuVECs" 1)))
 ("UP:Q92537" (("KIAA0247" 2))) ("UP:Q92538" (("GBF1" 199) ("GBF1 protein" 3)))
 ("UP:Q92539"
  (("lipin 2" 37) ("Lipin 2" 11) ("LPIN2" 3) ("lipin 2 protein" 3)
   ("lipin2 protein" 1)))
 ("UP:Q92540" (("SMG7" 23) ("EST1C" 4) ("SMG-7" 2) ("SMG7 protein" 2)))
 ("UP:Q92541" (("RTF1" 22) ("Rtf1" 3)))
 ("UP:Q92542" (("Nicastrin" 12) ("NCSTN" 4)))
 ("UP:Q92547"
  (("TopBP1" 1143) ("TOPBP1" 138) ("TopBp1" 7) ("pTopBP1" 6)
   ("Topoisomerase binding protein 1" 6)
   ("DNA topoisomerase II binding protein 1" 5)
   ("Topoisomerase Binding Protein 1" 5) ("TopBP1-" 2)
   ("the transcriptional co-factor TopBP1" 2) ("The residual TopBP1" 2)
   ("TopBP1 protein" 2) ("Topbp1" 2) ("ToPBP1" 2)
   ("DNA topoisomerase II-binding protein 1" 1)
   ("the acetylation-mimetic TopBP1" 1) ("seven lysines of TopBP1" 1)
   ("Q92547" 1)
   ("a triple-tagged (S-protein, FLAG and streptavidin binding peptide) TopBP1"
    1)
   ("than TOPBP1" 1) ("than TopBP1" 1)))
 ("UP:Q92551"
  (("IP6K1" 30) ("inositol hexakisphosphate kinase 1" 2) ("IHPK1" 1)))
 ("UP:Q92556"
  (("ELMO1" 621) ("Elmo1" 48) ("ELMO1 protein" 6) ("CED-12" 5)
   ("targeting ELMO1" 3) ("exogenous ELMO1" 3) ("-Elmo1" 2) ("−Elmo1" 1)
   ("amino acid of Elmo1" 1) ("intrinsic ELMO1" 1) ("endogeneous ELMO1" 1)))
 ("UP:Q92558" (("WAVE1" 9) ("Wave1" 2) ("WASF1" 1)))
 ("UP:Q92560"
  (("BAP1" 481) ("BAP1 protein" 6) ("overexpressed BAP1" 5)
   ("BRCA1 associated protein 1" 2)))
 ("UP:Q92562"
  (("SAC3" 44) ("polyphosphoinositide" 6) ("FIG4" 6)
   ("Polyphosphoinositide" 1)))
 ("UP:Q92563" (("Spock2" 1))) ("UP:Q92565" (("GFR" 121) ("MR-GEF" 2)))
 ("UP:Q92569"
  (("PIK3R3" 283) ("p55PIK" 121) ("p55γ" 88) ("-p55PIK" 30) ("pPIK3R3" 5)
   ("TLR9 signaling–associated molecule PIK3R3" 2) ("PIK3R3 protein" 2)
   ("N-terminal 24 amino acid of PIK3R3" 1)
   ("the N-terminal 24 amino acids of PIK3R3 (N24)" 1)
   ("we first identified PIK3R3" 1)))
 ("UP:Q92570"
  (("NR4A3" 4) ("Nr4a3" 4) ("Nor-1" 2) ("Neuron-derived orphan receptor 1" 2)
   ("NOR-1" 1) ("NOR1" 1)))
 ("UP:Q92574"
  (("TSC1" 1958) ("Tsc1" 403) ("hamartin" 197) ("tuberous sclerosis 1" 23)
   ("Hamartin" 14) ("TSC1 protein" 11) ("TSC1-" 9) ("TSC-1" 4)
   ("overexpressed TSC1" 3) ("strong TSC1" 2) ("exogenous TSC1 protein" 2)
   ("tsc1" 2) ("Tuberous sclerosis 1" 2) ("Tuberous Sclerosis 1" 2)
   ("p-TSC1" 2) ("monomeric TSC1" 1) ("than wild-type TSC1 (Fig.  xref C)" 1)
   ("than wild-type TSC1" 1)
   ("the two tumor suppressor genes TSC1 , which encodes the hamartin protein, and TSC2"
    1)
   ("than those lacking Tsc1" 1) ("previously characterized TSC1-" 1)))
 ("UP:Q92575" (("UbxD2" 4))) ("UP:Q92576" (("PHF3" 2)))
 ("UP:Q92581" (("isoform 6" 4)))
 ("UP:Q92583"
  (("C-C motif" 26) ("CCL17" 19) ("TARC" 11) ("C–C motif" 5)
   ("thymus and activation-regulated chemokine" 3) ("Ccl17" 1)))
 ("UP:Q92585"
  (("MAML1" 99) ("MAML-1" 14) ("Maml1" 12) ("MAML1 protein" 4)
   ("Dominant-negative MAML1" 1) ("a functional MAML1" 1)))
 ("UP:Q92597"
  (("NDRG1" 543) ("GC-4" 21) ("NDRG1 protein" 14) ("RTP" 11)
   ("N-myc downstream regulated gene 1" 10) ("p-NDRG1" 7)
   ("V5-NDRG1 protein" 6) ("N-Myc downstream regulated gene 1" 6) ("-NDRG1" 6)
   ("pNDRG1" 4) ("GC4" 4)
   ("N-myc downstream regulated gene 1 (NDRG1) protein" 3)
   ("V5-NDRG1 peptide" 2)
   ("Our previous gene expression data identified N-Myc downstream regulated gene 1"
    2)
   ("Monoclonal rabbit anti-human NDRG1" 1)))
 ("UP:Q92598"
  (("Hsp110" 11) ("HSPH1" 7) ("HSP110" 2) ("HSP105" 2) ("Hsp105" 1)))
 ("UP:Q92599" (("SEPT8" 2))) ("UP:Q92600" (("Caf40" 4) ("CNOT9" 2)))
 ("UP:Q92608"
  (("DOCK2" 125) ("Dock2" 9) ("KIAA0209" 1) ("endogeneous DOCK2" 1)))
 ("UP:Q92611" (("Edem1" 7) ("EDEM1" 5) ("EDEM" 2)))
 ("UP:Q92614" (("MYO18A" 2))) ("UP:Q92616" (("GCN1L1" 13) ("GCN1" 1)))
 ("UP:Q92618" (("ZNF516" 4) ("Znf516" 2)))
 ("UP:Q92619"
  (("HMHA1" 221) ("FL" 25) ("HMHA1 protein" 18) ("fl" 6) ("HMHA1 (FL)" 3)
   ("HA-1" 3) ("HMHA1 FL" 2) ("FL HMHA1" 1)))
 ("UP:Q92621" (("Nup205" 1)))
 ("UP:Q92622" (("Rubicon" 69) ("RUBICON" 17) ("Baron" 5) ("KIAA0226" 1)))
 ("UP:Q92626" (("PXDN" 2))) ("UP:Q92629" (("Sgcd" 1)))
 ("UP:Q92630"
  (("DYRK2" 422) ("overexpressed DYRK2" 4) ("regulated kinase 2" 3)
   ("DYRK2 protein" 2)
   ("dual specificity tyrosine phosphorylation regulated kinase 2" 2)
   ("Q92630" 1) ("triple tagged DYRK2" 1) ("intact DYRK2" 1)))
 ("UP:Q92633"
  (("LPAR1" 44) ("LPA receptor" 23) ("LPA1" 18) ("LPAR1 protein" 6) ("LPA 1" 2)
   ("mainly target LPAR1" 1)))
 ("UP:Q92637" (("FCGR1B" 3))) ("UP:Q92664" (("TFIIIA" 5) ("GTF3A" 2)))
 ("UP:Q92667"
  (("AKAP149" 176) ("D-AKAP1" 6) ("A-kinase" 6) ("S-AKAP84" 4) ("AKAP121" 3)
   ("AKAP1" 3) ("AKAP-149" 2)))
 ("UP:Q92673"
  (("sorLA" 244) ("SorLA" 28) ("LR11" 19) ("SORL1" 16) ("Ldlr" 10) ("gp250" 1)
   ("the sorLA’s" 1) ("sorL1" 1) ("sortilin-related receptor" 1)))
 ("UP:Q92674" (("CENP-I" 1) ("CenpI" 1))) ("UP:Q92686" (("RC3" 4) ("NRGN" 1)))
 ("UP:Q92692" (("nectin-2" 21) ("PVRL2" 8) ("CD112" 3) ("Nectin-2" 1)))
 ("UP:Q92729" (("FMI" 34)))
 ("UP:Q92730"
  (("Rnd1" 198) ("RND1" 5) ("Rho family GTPase 1" 4)
   ("the last 11 C-terminal amino acids of Rnd1 ( xref )" 1)
   ("the first 12 N-terminal amino acids of Rnd1 ( xref )" 1) ("Rnd1-" 1)))
 ("UP:Q92731"
  (("ERβ" 3569) ("ESR2" 569) ("ER-β" 289) ("ERbeta" 125) ("ERβ protein" 56)
   ("ER-beta" 39) ("ERB" 37) ("estrogen receptor beta" 34) ("LBD" 19)
   ("estrogen receptor 2" 11) ("ERβ-" 7) ("ErB" 7) ("functional ERβ" 5)
   ("strong ERβ" 3) ("erβ" 2) ("mouse monoclonal ER-β" 2) ("ERBs" 2)
   ("The resultant ERβ" 2) ("weak ERβ" 2) ("pERb" 2) ("erB" 2)
   ("anti-(pTyr 1118 )Dock7, anti-ErbB2, and anti-(pTyr 1112 )ErB2" 1)
   ("than ERβ ( xref 2)" 1) ("ER-beta protein" 1) ("ER-beta-" 1)
   ("the exogenous ERβ" 1)
   ("than the wild-type ERβ
[ xref , xref ]"
    1)
   ("than ERβ" 1) ("erbs" 1) ("differentiation-associated ERβ protein" 1)
   ("Q92731" 1) ("than ERβ [ xref ]" 1) ("Erβ" 1) ("Esr2" 1)
   ("effectively target ERβ" 1) ("ERβ(LBD)" 1) ("than ERβ (PC3-shERβ)" 1)
   ("ERβ−" 1) ("ER-β-" 1) ("ER-β protein" 1) ("the complete ERβ" 1)))
 ("UP:Q92733"
  (("RCC" 3535) ("papillary RCC" 77) ("pRCC" 69) ("PRCC" 64)
   ("metastatic RCC" 41) ("the primary RCC" 23) ("sporadic RCC" 9) ("CCRCC" 9)
   ("type II papillary RCC" 7) ("RCC (CCRCC)" 7) ("primary RCC" 6)
   ("Metastatic RCC" 5) ("Papillary RCC" 5) ("CS associated RCC" 3)
   ("42 papillary RCC (PRCC)" 3) ("sporadic clear-cell RCC" 3)
   ("the papillary RCC" 3) ("VHL-null RCC" 3) ("papillary, and clear RCC" 2)
   ("invasive RCC" 2) ("RCC (CRCC)" 2) ("type-1 papillary RCC" 2)
   ("most clear-cell RCC" 2) ("Xp11 translocation-associated RCC" 2)
   ("clear cell papillary RCC" 2) ("the corresponding primary RCC" 2)
   ("a metastatic RCC" 2) ("the primary heterogeneous RCC" 2)
   ("VHL null RCC" 2) ("than clear cell RCC" 2)
   ("clear cell papillary RCC and chromophobe RCC" 2) ("unfavorable RCC" 1)
   ("PTEN -deficient sporadic RCC" 1) ("advanced sporadic RCC" 1)
   ("hereditary RCC" 1) ("Hereditary Papillary RCC (HPRC)" 1)
   ("the largely HIF-2α driven clear cell RCC" 1)
   ("VHL deficient sporadic RCC" 1) ("type 2 papillary RCC" 1)
   ("ALK-associated RCC" 1) ("a previously reported VCL-ALK -positive RCC" 1)
   ("type-2 papillary RCC" 1) ("2 type-2 papillary RCC" 1)
   ("hereditary type-1 papillary RCC" 1) ("Most RCC" 1) ("a primary RCC" 1)
   ("the only non-metastatic RCC" 1) ("a pre-metastatic RCC" 1)
   ("this localized primary RCC" 1) ("TPRC" 1) ("17 (16.0%) papillary RCC" 1)
   ("than conventional or papillary RCC" 1) ("one papillary RCC" 1)
   ("all sporadic RCC" 1) ("most sporadic clear cell RCC" 1)
   ("poor-risk metastatic RCC" 1) ("pRCc" 1)
   ("than those seen conventional RCC" 1) ("than papillary RCC" 1)
   ("well-established Xp11 translocation RCC" 1) ("all papillary RCC" 1)
   ("the 6 papillary RCC" 1) ("The latter included 3 PSF-TFE3 RCC" 1)
   ("typical adult type RCC" 1) ("6 papillary RCC (PRCC)" 1)
   ("usual adult type RCC" 1) ("aggressive RCC" 1)
   ("even organ-confined RCC" 1) ("preclinical RCC" 1) ("nonmetastatic RCC" 1)
   ("progressive RCC" 1) ("than RCC" 1) ("node-positive RCC" 1)
   ("the pVHL-defective RCC" 1) ("pVHL-defective RCC" 1)
   ("type II (IRS 0.83 ± 1.38) papillary RCC" 1) ("18 papillary RCC" 1)
   ("22 papillary RCC" 1) ("papillary RCC type II papillary RCC" 1)
   ("type-1
hereditary papillary RCC"
    1)
   ("histologically proven RCC" 1)
   ("histopathologically confirmed incident RCC" 1)
   ("sporadic and hereditary RCC" 1) ("hereditary leiomyomatosis RCC" 1)))
 ("UP:Q92734"
  (("TRK-T3" 126) ("TFG" 69) ("TRK-fused gene" 3) ("TRK-T3 protein" 2)
   ("TFG-" 1)))
 ("UP:Q92736" (("ryanodine" 27) ("RyR2" 10) ("RYR2" 5) ("Ryanodine" 1)))
 ("UP:Q92738" (("RN-tre" 27) ("RN-Tre" 8) ("USP6NL" 2)))
 ("UP:Q92743"
  (("HTRA1" 152) ("HtrA1" 5) ("HtrA" 4) ("Htra1" 1) ("HTRA" 1) ("PRSS11" 1)
   ("the previously described HtrA1" 1)))
 ("UP:Q92747" (("41kDa" 10) ("Arpc1" 8) ("ARPC1A" 7)))
 ("UP:Q92748" (("SPOT14" 1))) ("UP:Q92750" (("TAF4b" 1)))
 ("UP:Q92752" (("TNR" 80) ("TNRs" 7))) ("UP:Q92753" (("RORB" 7) ("NR1F2" 1)))
 ("UP:Q92754"
  (("TFAP2C" 171) ("AP-2γ" 13) ("AP-2 Gamma" 1) ("TFAP2C protein" 1)))
 ("UP:Q92764" (("HA5" 54)))
 ("UP:Q92765"
  (("frizzled-related protein" 14) ("sFRP-3" 12)
   ("Frizzled-related protein" 11) ("FRZB" 4) ("Frizzled-related protein 1" 4)
   ("Fre" 2) ("wnts" 1) ("Frzb" 1)))
 ("UP:Q92766" (("RREB1" 50)))
 ("UP:Q92769"
  (("HDAC2" 3111) ("Hdac2" 173) ("HD2" 87) ("histone deacetylase 2" 32)
   ("HDAC2 protein" 12) ("Histone deacetylase 2" 8) ("HDAC-2" 6)
   ("HD2 peptide" 5) ("Absolute HDAC2" 4) ("epithelial HDAC2" 4)
   ("than HDAC2" 4) ("quantitative HDAC2" 2) ("Hdac2-" 2) ("pHDAC2" 1)
   ("only HDAC2 protein" 1) ("specifically target HDAC2" 1) ("intact HDAC2" 1)
   ("We first examined HDAC2" 1) ("-HDAC2" 1)))
 ("UP:Q92777"
  (("synapsin-2" 6)
   ("the synaptic vesicle-associated phosphoprotein synapsin-2" 4) ("SYN2" 2)
   ("SYNII" 1)))
 ("UP:Q92783" (("STAM" 67) ("STAM1" 5) ("STAM-1" 4) ("Stam1" 1) ("Stam" 1)))
 ("UP:Q92784" (("DPF3" 69) ("Dpf3" 41) ("DPF3 protein" 2)))
 ("UP:Q92785" (("Ubi-d4" 1)))
 ("UP:Q92786"
  (("Prox1" 79) ("PROX1" 5) ("Prox-1" 4) ("neuronal Prox1" 2) ("Prox1−" 2)
   ("PROX-1" 1) ("the lymphatic marker PROX1" 1)))
 ("UP:Q92793"
  (("CREBBP" 233) ("CREB-binding protein" 91) ("CREB binding protein" 58)
   ("Crebbp" 34) ("CREB-binding protein (CBP)" 29)
   ("CREB binding protein (CBP)" 10) ("CREB-Binding Protein" 4) ("KAT3A" 3)
   ("CREBBP ( CBP )" 3) ("CREBBP protein" 2) ("CREB Binding Protein" 2)
   ("CREB binding
protein"
    1)
   ("the CREBBP -mutated" 1)
   ("The transcriptional co-activator CREB binding protein" 1)
   ("Crebbp (HA)" 1) ("exogenous CREBBP" 1) ("defective CREBBP" 1)
   ("CREBBP−" 1)))
 ("UP:Q92794"
  (("MOZ" 292) ("moz" 12) ("MYST3" 8) ("KAT6A" 3) ("MOZ protein" 3) ("kat6a" 2)
   ("Monocytic leukemia zinc finger protein" 2) ("MOZ-" 2)
   ("monocytic leukemia zinc finger protein" 1)))
 ("UP:Q92796" (("SAP102" 3) ("DLG3" 3)))
 ("UP:Q92797" (("symplekin" 11) ("Symplekin" 8)))
 ("UP:Q927U4" (("GTCA" 25) ("-GTCA" 2)))
 ("UP:Q92800" (("EZH1" 24) ("Ezh1" 8) ("ezh1" 1)))
 ("UP:Q92805"
  (("Golgin-97" 15) ("golgin-97" 10) ("the late Golgi marker Golgin-97" 1)
   ("golgin subfamily a" 1)))
 ("UP:Q92813" (("deiodinase" 10) ("DIO2" 4) ("Dio2" 3)))
 ("UP:Q92817" (("p210" 113) ("P210" 3) ("envoplakin" 1) ("EVPL" 1)))
 ("UP:Q92819" (("HAS2" 94) ("hyaluronan synthase 2" 8)))
 ("UP:Q92820" (("conjugase" 31) ("GGH" 2)))
 ("UP:Q92823"
  (("Bravo" 8) ("NrCAM" 8) ("NRCAM" 4) ("neuronal cell adhesion molecule" 4)
   ("Nrcam" 3) ("BRAVO" 2) ("the E/sox2:EGFP-overexpressed transcript NrCAM" 1)
   ("NrCAM (NRCAM)" 1)))
 ("UP:Q92824" (("PC5" 13) ("PC6" 13) ("PCSK5" 8) ("Pcsk5" 3)))
 ("UP:Q92826"
  (("HOXB13" 238) ("Hoxb13" 5) ("overexpressed HOXB13" 3) ("HOXB13 protein" 2)
   ("HoxB13" 1)))
 ("UP:Q92828" (("Coronin2A" 2) ("IR10" 1)))
 ("UP:Q92830"
  (("GCN5" 376) ("histone acetyltransferase" 282) ("Gcn5" 38)
   ("histone acetyltransferase (HAT)" 25) ("gcn5" 11)
   ("Histone acetyltransferase" 10) ("histone acetyltransferase GCN5" 8)
   ("Histone Acetyltransferase" 4) ("hGCN5" 4) ("KAT2A" 3)
   ("a generic histone acetyltransferase" 2) ("Weak cytoplasmic GCN5" 2)
   ("Histone AcetylTransferase" 1) ("histone acetyltransferase Gcn5" 1)
   ("shorter 1-204 and 2-108 sub-domains bound GCN5" 1)
   ("the cellular histone acetyltransferase" 1)
   ("the principal histone acetyltransferase" 1) ("GCN5-" 1)
   ("the p/CAF homologous protein gcn5" 1)
   ("their respective histone acetyltransferase (HAT)" 1)))
 ("UP:Q92831"
  (("PCAF" 1190) ("CAFs" 717) ("P/CAF" 188) ("p/CAF" 131)
   ("p300/CBP-associated factor" 48) ("pCAF" 44) ("KAT2B" 14)
   ("histone acetyltransferase PCAF" 13) ("PCAF protein" 12)
   ("P300/CBP-associated factor" 11) ("primary CAFs" 10)
   ("p300/CBP associated factor" 9) ("p300/CBP-associated factor (PCAF)" 8)
   ("lysine acetyltransferase 2B" 5) ("histone acetyltransferase pCAF" 5)
   ("PCAF-" 5) ("pCAFs" 4) ("Pcaf" 4) ("Cav1-expressing CAFs" 4)
   ("immature CAFs" 3) ("P300/CBP-associated factor (PCAF)" 3)
   ("bona fide CAFs" 2) ("we first extracted CAFs" 2) ("exogenous PCAF" 2)
   ("P300/CBP associated factor" 1) ("CAV1-expressing CAFs" 1)
   ("IGFBP7-expressing CAFs" 1) ("KU60019-treated CAFs" 1)
   ("10-fold more CAFs" 1) ("the transcriptional co-activator PCAF" 1)
   ("flag-tagged p/CAF" 1) ("renal CAFs" 1)))
 ("UP:Q92833"
  (("Jumonji" 22) ("JARID2" 19) ("jumonji" 5) ("Jumonji protein" 2)
   ("AT rich interactive domain 2" 1) ("JMJ" 1) ("Jarid2" 1)))
 ("UP:Q92834" (("RP3" 5) ("RPGR" 2)))
 ("UP:Q92835"
  (("SHIP-1" 212) ("SHIP" 185) ("SHIP1" 94) ("INPP5D" 12) ("Ship1" 4)
   ("inositol-5'-phosphatase" 2) ("than SHIP-1" 1)
   ("inositol 5’ phosphatase" 1) ("cerulean-tagged SHIP" 1)))
 ("UP:Q92837" (("FRAT1" 9) ("FRAT-1" 3) ("Frat-1" 1)))
 ("UP:Q92838"
  (("EDA" 436) ("ED1" 19) ("EDA–" 13) ("HED" 8) ("ED-A" 6) ("EDA-A2" 4)
   ("ectodysplasin A" 3) ("EDA protein" 3) ("ectodysplasin" 2) ("anhidrotic" 2)
   ("the exogenous EDA" 2) ("EDA-" 1) ("EDA (EIIIA)" 1)))
 ("UP:Q92839"
  (("HAs" 18) ("HAS1" 13) ("Less pathogenic IAV HAs" 1) ("HA-S1" 1)))
 ("UP:Q92841"
  (("p72" 393) ("P72" 105) ("Ddx17" 72) ("DDX17" 60) ("-P72" 48) ("pp72" 14)
   ("p72 protein" 5) ("Ddx17-" 3) ("-p72" 3) ("total cellular Ddx17-" 2)
   ("the highly homologous helicase p72" 2)
   ("the highly homologous protein p72" 2) ("pp72 protein" 2) ("Q92841" 1)
   ("than p53 P72 (encoded by the C-allele)" 1) ("than p53 P72" 1)
   ("the highly homologous p72 (Ddx17) protein" 1) ("p72 (Ddx17) protein" 1)
   ("DdX17" 1)))
 ("UP:Q92843"
  (("Bcl-w" 438) ("BCLW" 15) ("BCL2L2" 13) ("BCL-w" 13) ("BclW" 10) ("BCL-W" 9)
   ("Bcl-w protein" 9) ("Bcl-W" 6) ("BCl-w" 3) ("Bclw" 2) ("-Bcl-w" 1)
   ("bcl-w" 1) ("bclw" 1) ("BCLw" 1)))
 ("UP:Q92844"
  (("TANK" 250) ("TRAF family member-associated NF-kappa-B activator" 6)))
 ("UP:Q92845" (("KIFAP3" 3) ("KAP3" 2)))
 ("UP:Q92847"
  (("GHSR" 12) ("ghrelin receptor" 4) ("ghrelin receptor (GHSR)" 3) ("GHS-R" 2)
   ("growth hormone secretagogue receptor type 1" 1)))
 ("UP:Q92851"
  (("caspase-10" 187) ("CASP10" 151) ("MCH4" 15) ("Caspase-10" 8)
   ("caspase 10" 6) ("the nearby caspase-10" 2)
   ("Both the original caspase-10" 2) ("original caspase-10" 2) ("caspase10" 2)
   ("the highly homologous caspase-10" 2) ("Caspase 10" 2)
   ("expressing caspase-10" 1) ("apoptosis-related cysteine protease" 1)
   ("only CASP10 V410I" 1)))
 ("UP:Q92854"
  (("Sema4D" 397) ("SEMA4D" 84) ("CD100" 43) ("Semaphorin 4D" 18)
   ("semaphorin 4D" 10) ("soluble Sema4D" 8) ("CD100 protein" 4)
   ("soluble SEMA4D" 3) ("Soluble SEMA4D" 2)))
 ("UP:Q92858"
  (("Math1" 76) ("ATOH1" 76) ("Atoh1" 39) ("Hath1" 5)
   ("The basic helix-loop-helix transcription factor Math1" 2)
   ("exogenous ATOH1" 2)
   ("the Class II basic helix-loop-helix (bHLH) transcription factor (TF) ATOH1"
    2)
   ("the prosensory bHLH transcription factor Atoh1" 1)))
 ("UP:Q92859" (("neogenin" 8) ("NEO1" 3) ("Ngn" 1)))
 ("UP:Q92870" (("APBB2" 17)))
 ("UP:Q92871" (("PMM1" 14) ("phosphomannomutase 1" 3) ("pmm1" 3)))
 ("UP:Q92876"
  (("Zymed" 473) ("ZYMED" 22) ("Zyme" 10) ("Klk6" 2) ("kallikrein 6" 2)
   ("SP59" 1) ("KLK6" 1) ("ZyMed" 1)))
 ("UP:Q92878"
  (("RAD50" 283) ("Rad50" 280) ("Rad50 protein" 18) ("hRAD50" 6) ("rad50" 6)
   ("double strand break repair protein" 3) ("DNA repair protein RAD50" 3)
   ("Rad50 molecule" 3) ("RAD50 protein" 2) ("-RAD50" 2) ("4 or more Rad50" 2)
   ("RAD50 homolog (S. cerevisiae)" 1) ("4 or more Rad50's" 1)))
 ("UP:Q92879"
  (("CUGBP1" 392) ("CELF1" 10) ("CUG-BP1" 8) ("hNab50" 2)
   ("un-phosphorylated CUGBP1" 2) ("most CUGBP1" 2) ("Cugbp1" 2)
   ("purified electrophoretically homogenous wild type CUGBP1" 1)
   ("CUGBP1 protein" 1)))
 ("UP:Q92882"
  (("OSF" 33) ("osteoclast stimulating factor 1" 3) ("OSTF1" 1)
   ("Osteoclast stimulating factor 1" 1)
   ("osteoclast stimulating factor 1 (OSF)" 1)))
 ("UP:Q92886"
  (("aka" 81) ("NEUROG1" 45) ("Ngn1" 18) ("Neurog1" 10) ("Neurogenin1" 6)
   ("neurogenin1" 4) ("the basic helix-loop-helix protein neurogenin1" 1)
   ("AKA" 1) ("ngn1" 1)))
 ("UP:Q92887"
  (("multidrug" 146) ("MRP2" 104) ("ABCC2" 30) ("Mrp2" 13) ("Multidrug" 7)
   ("multidrug resistance-associated protein 2" 6) ("multidrug-" 1)
   ("MRP2 protein" 1)))
 ("UP:Q92888"
  (("p115-RhoGEF" 19) ("p115 RhoGEF" 13) ("p115RhoGEF" 10) ("P115-RhoGEF" 2)))
 ("UP:Q92889"
  (("XPF" 156) ("ERCC4" 99) ("xeroderma pigmentosum" 73)
   ("Xeroderma pigmentosum" 29) ("Xeroderma Pigmentosum" 15)
   ("xeroderma pigmentosum (XP)" 12) ("XP" 9) ("Xeroderma pigmentosum (XP)" 4)
   ("xeroderma pigmentosum group F" 2) ("than XPF" 1) ("functional ERCC4" 1)
   ("XPF-" 1) ("complementation group F" 1)
   ("the photosensitive inherited disorder xeroderma pigmentosum (XP)" 1)
   ("the hereditary disease xeroderma pigmentosum (XP)" 1)))
 ("UP:Q92890" (("UFD1L" 14) ("UFD1" 4)))
 ("UP:Q92896"
  (("antiserum" 1350) ("Antiserum" 22) ("primary antiserum" 7) ("GLG1" 6)
   ("golgi glycoprotein 1" 4) ("antiserum (RTA)" 3) ("the primary antiserum" 3)
   ("a commercially available anti–IRF-4 antiserum" 2)
   ("diluted biotinylated secondary antiserum" 2)
   ("An irrelevant rabbit antiserum" 2)
   ("only one (GPLENVYESIKEMGL) (aa 255–269) effectively generated antiserum"
    2)
   ("1 μg monoclonal anti-p65 antiserum" 2)
   ("Anti-β-actin monoclonal antiserum" 2)
   ("mouse anti-Myc monoclonal antiserum" 2)
   ("Secondary fluorophore-conjugated antiserum" 2)
   ("polyclonal rabbit-α- meningococcal outer membrane protein (OMP) antiserum"
    2)
   ("irrelevant antiserum" 1)
   ("the phosphoserine 473 AKT/PKB–specific rabbit antiserum" 1)
   ("phosphoserine 473 AKT/PKB–specific rabbit antiserum" 1)
   ("The 9E10 monoclonal myc antiserum" 1)
   ("The appropriate horseradish peroxidase-labeled secondary antiserum" 1)
   ("the respective antiserum" 1)
   ("mouse monoclonal Ki67 (both from BD Biosciences, San Jose, CA) antiserum"
    1)
   ("the new antiserum" 1) ("the DO-1 monoclonal antiserum" 1)
   ("the specified primary antiserum" 1)
   ("Alexa fluor 594-labelled goat anti-rabbit IgG antiserum" 1)
   ("Our phospho-DUSP9/MKP-4-specific antiserum" 1)
   ("phosphospecific antiserum" 1) ("mouse-α-meningococcal antiserum" 1)
   ("polyclonal rabbit-α-meningococcal OMP antiserum" 1)))
 ("UP:Q92900"
  (("UPF1" 133) ("Upf1" 55) ("hUpf1" 17) ("Rent1" 2)
   ("approximately threefold more Upf1" 2) ("UPF-1" 1)))
 ("UP:Q92901" (("RPL3L" 1))) ("UP:Q92902" (("HPS" 65) ("HPS1" 2)))
 ("UP:Q92903"
  (("CDS" 417) ("CDs" 12) ("correspondent CDS" 3) ("cDs" 3)
   ("the complete CDS" 2) ("the entire CDS" 2) ("the respective human CDS" 1)))
 ("UP:Q92904" (("DAZL" 17) ("Dazl" 3) ("DAZL1" 1)))
 ("UP:Q92905"
  (("Jab1" 506) ("JAB1" 168) ("Csn5" 110) ("CSN5" 96) ("COPS5" 31) ("jab1" 9)
   ("COP9 signalosome complex" 7) ("COP9 signalosome subunit 5" 6)
   ("Jab1 protein" 5) ("Jun activation domain-binding protein 1" 5)
   ("smaller JAB1" 2) ("flag-tagged IKK2 and myc-tagged JAB1" 1)
   ("monomeric JAB1" 1) ("COP9 signalosome complex (CSN)" 1)))
 ("UP:Q92908"
  (("GATA6" 91) ("Gata6" 12) ("GATA-6" 5) ("GATA binding protein 6" 1)))
 ("UP:Q92911"
  (("NIS" 429) ("SLC5A5" 8) ("NIS protein" 3) ("sodium-iodide symporter" 3)
   ("overexpressed NIS" 2) ("sodium-iodide symporter (NIS)" 1)))
 ("UP:Q92913" (("FGF13" 6))) ("UP:Q92914" (("FGF11" 41) ("more FGF11" 1)))
 ("UP:Q92915" (("FGF14" 46) ("fibroblast growth factor 14" 3) ("SCA27" 1)))
 ("UP:Q92918"
  (("HPK1" 240) ("MAP4K1" 74) ("map4k1" 37)
   ("hematopoietic progenitor kinase" 6) ("pMAP4K1" 4)
   ("exogenous WT or kinase-dead HPK1" 2)
   ("mitogen-activated protein kinase kinase kinase kinase 1" 2)
   ("HPK1 protein" 1) ("HPK" 1) ("HPK-1" 1)))
 ("UP:Q92922"
  (("BAF155" 31) ("Baf155" 14) ("SMARCC1" 4) ("SmarcC1" 1) ("subfamily c" 1)
   ("Rsc8" 1)))
 ("UP:Q92925" (("smarcd2" 1))) ("UP:Q92930" (("Rab8b" 6)))
 ("UP:Q92932" (("IAR" 12) ("IA2β" 5) ("PTPRN2" 4) ("Ptprn2" 3)))
 ("UP:Q92934"
  (("BAD" 1749) ("Bad" 1628) ("bad" 154) ("pBAD" 113) ("BAD protein" 46)
   ("Bad protein" 41) ("p-BAD" 23) ("Bad peptide" 11)
   ("the pro-apoptotic protein BAD" 11) ("the pro-apoptotic protein Bad" 9)
   ("proapoptotic Bad" 5) ("-BAD" 5) ("the pro-apoptotic Bad protein" 3)
   ("the pro-apoptotic factor Bad" 3) ("pro-apoptotic protein Bad" 3)
   ("BAD (pBAD) protein" 3) ("the pro-apoptotic molecule BAD" 2)
   ("pro-apoptotic Bad" 2) ("the pro-apoptotic proteins Bad" 2)
   ("Overexpressed wild-type Bad" 2) ("BAD peptide" 2)
   ("raft-associated BAD" 2) ("pro-apoptotic Bcl-2 family member Bad" 2)
   ("mRNA expression both pro-apoptotic genes Bad" 2) ("pBad" 2)
   ("pBAD protein" 2) ("pBAD (serine-155) protein" 2)
   ("the pro-apoptotic proteins BAD" 2)
   ("The bcl-2-associated death promoter Bad" 1) ("the proapoptotic Bad" 1)
   ("the pro-apoptotic molecule Bad" 1)
   ("conditional and transient overexpression BAD" 1)
   ("pro-apoptotic
Bad"
    1)
   ("the AKT-downstream pro-apoptotic protein BAD" 1)
   ("the pro-apoptotic BAD" 1) ("Q92934" 1)
   ("the
 pro-apoptotic protein BAD"
    1)
   ("the pro-apoptotic Bcl-2 protein BAD" 1) ("the proapoptotic Bad protein" 1)
   ("the triple mutant Bad" 1) ("25% or more bad" 1) ("BAD-" 1)
   ("The BH3-only pro-apoptotic protein Bad" 1)
   ("the pro-apoptotic BCL2 family member BAD" 1)
   ("the pro-apoptotic BH3-only Bcl-2 family member Bad" 1) ("most BAD" 1)
   ("Almost no phosphorylated BAD" 1)
   ("than the endogenous human Bad ( xref )" 1) ("exogenous murine Bad" 1)
   ("the non-phosphorylatable S112A/S136A (AA) mutant murine Bad" 1)
   ("p-BAD protein" 1) ("Bcl-xL/Bcl-2–associated death promoter" 1) ("“bad”" 1)
   ("pro-apoptotic genes BAD" 1) ("Bad-" 1)
   ("the downstream pro-apoptotic target BAD" 1)
   ("the pro-apoptotic factors BAD" 1)))
 ("UP:Q92945"
  (("KSRP" 17) ("KH-type splicing regulatory protein" 5) ("KHSRP" 3)))
 ("UP:Q92947" (("GCDH" 6) ("gcd" 3) ("glutaryl-CoA dehydrogenase" 2)))
 ("UP:Q92949"
  (("FOXJ1" 24) ("Foxj1" 15) ("Myb preceded Foxj1" 2) ("FOXj1" 1) ("FoxJ1" 1)))
 ("UP:Q92953" (("Kv2.2" 5))) ("UP:Q92954" (("SZP" 2)))
 ("UP:Q92956"
  (("TNFRSF14" 34) ("HVEM" 12) ("herpesvirus entry mediator" 3) ("LIGHTR" 1)
   ("herpesvirus entry mediator (HVEM)" 1)))
 ("UP:Q92959"
  (("PGT" 18) ("SLCO2A1" 16) ("member 2A1" 2) ("prostaglandin transporter" 1)))
 ("UP:Q92963"
  (("Rit" 8) ("Rit1" 3) ("Ras-like protein expressed in many tissues" 3)
   ("RIT1" 2)))
 ("UP:Q92973"
  (("MIP-1" 16) ("macrophage inflammatory protein" 12) ("MIP1" 9) ("Mip1" 9)
   ("transportin 1" 5) ("TNPO1" 3) ("mip1" 2)))
 ("UP:Q92974"
  (("GEF-H1" 981) ("GEFH1" 141) ("ARHGEF2" 8) ("Weco -expressed GEF-H1" 2)
   ("dominant-negative GEF-H1" 1) ("GEF-H1 protein" 1) ("GEF–H1" 1)
   ("SDC-associated GEF-H1" 1) ("than wild type GEFH1" 1) ("arhgef2" 1)
   ("Arhgef2" 1)))
 ("UP:Q92979" (("EMG1" 8) ("C2F" 6))) ("UP:Q92982" (("Ninj1" 2)))
 ("UP:Q92985"
  (("IRF7" 377) ("pIRF7" 17) ("interferon regulatory factor 7" 12) ("IRF-7" 12)
   ("irf7" 5) ("interferon regulatory factor-7" 2) ("Q92985" 1) ("IRF7-" 1)
   ("Irf7" 1)))
 ("UP:Q92988" (("DLX4" 190) ("BP-1" 12) ("–DLX4" 2) ("−DLX4" 1)))
 ("UP:Q92990"
  (("media" 21867) ("Media" 886) ("complete media" 278) ("GLMN" 169)
   ("media (CM)" 95) ("USA" 41) ("normal media" 29) ("MEM" 26) ("ATCC" 26)
   ("appropriate media" 24) ("minimal media" 24) ("osteogenic media" 18)
   ("fresh culture media" 17) ("Neurobasal media" 17) ("basal media" 17)
   ("regular media" 16) ("GIBCO" 16) ("neurobasal media" 16) ("media (SFM)" 15)
   ("Gibco" 15) ("fresh complete media" 14) ("Media (DMEM)" 14)
   ("fresh serum-free media" 12) ("the appropriate media" 12)
   ("fresh growth media" 11) ("M9 minimal media" 10) ("Complete media" 9)
   ("media (GIBCO)" 9) ("minimum essential media" 9) ("Glmn" 9)
   ("endothelial basal media" 8) ("the aortic media" 8) ("media (DMEM)" 8)
   ("warm media" 8) ("viral media" 7) ("the complete media" 7)
   ("Minimum Essential Media (MEM)" 7) ("recurrent otitis media" 7)
   ("media (BEGM)" 7) ("SFM" 7) ("charcoal-stripped media" 6)
   ("charcoal stripped media" 6) ("50% Neurobasal Media" 6) ("media (ATCC)" 6)
   ("minimal assay media" 6) ("media (KSFM)" 6) ("experimental media" 5)
   ("fluorescent mounting media" 5) ("their respective media" 5)
   ("new media" 5) ("the conditional media" 5) ("chondrogenic media" 5)
   ("media (OM)" 5) ("aqueous media" 5) ("Media (STM)" 5) ("solid media" 5)
   ("media (LCM)" 5) ("media (SFEM)" 5) ("heavy media" 4) ("permanent media" 4)
   ("RPMI complete media" 4) ("minimal essential media (MEM)" 4)
   ("semisolid media" 4) ("nonselective media" 4)
   ("permanent mounting media" 4) ("the viral media" 4)
   ("RPMI 1640 complete media" 4)
   ("SuperMount permanent aqueous mounting media" 4)
   ("gp120-induced neurotoxic media" 4)
   ("Intestinal stroma-conditioned media" 4) ("“heavy” media" 4)
   ("media (PAA)" 4) ("aortic tunica media" 4)
   ("Roswell Park Memorial Institute (RPMI) 1640 media" 3) ("glomulin" 3)
   ("Minimum Essential Media" 3) ("Edinburgh minimal media" 3) ("media (GM)" 3)
   ("Human NeuroCult NS-A Basal media" 3) ("Vasculife Basal Media" 3)
   ("their respective growth media" 3) ("Smooth muscle cell basal media" 3)
   ("Roswell Park Memorial Institute (RPMI) media" 3) ("ice-cold HBSS media" 3)
   ("antibiotic-free complete media" 3) ("media (RPMI)" 3)
   ("minimum essential media (MEM)" 3) ("media (ICCM)" 3)
   ("fresh DMEM media" 3) ("complete or leucine-free media" 3)
   ("media (ASN)" 3) ("semisolid methylcellulose media" 3)
   ("the respective media" 3) ("synthetic complete media" 3)
   ("modified minimal media" 3) ("neuronal media" 3) ("semi-solid media" 3)
   ("Media (FM)" 3) ("fresh antibiotic free-transfection media" 3)
   ("complete neuronal media" 3) ("media (HFCM)" 3) ("media (SF)" 3)
   ("residual hESC media" 3) ("serum-free mammary epithelial growth media" 3)
   ("given media" 2) ("the normal media" 2)
   ("Faramount Aqueous Mounting Media" 2) ("media (NBA)" 2)
   ("fresh or conditioned media" 2) ("MEGM/DMEM-F12 complete media" 2)
   ("complete smooth muscle basal media" 2)
   ("Dulbecco Minimal Essential Media (DMEM)" 2)
   ("biliary epithelial cell culture media" 2) ("GVMs" 2)
   ("normoacidic and acidotic culture media" 2)
   ("serum free MCDB 153-LB basal media" 2) ("Neural basal media" 2)
   ("1:1 (v/v) DMEM:F12 (Ham) media" 2) ("media (YES)" 2)
   ("minimal sporulating liquid media" 2) ("fresh 1% serum-reduced media" 2)
   ("Experimental media" 2) ("media (DM)" 2)
   ("reconstituted alpha-minimum essential media" 2) ("media (TCM)" 2)
   ("ice-cold serum-free media" 2) ("Alpha Minimum Essential Media" 2)
   ("Vectashield Hard Mounting Media" 2) ("MammoCult Basal media" 2)
   ("Leu/Met-containing media" 2) ("media (KGM)" 2)
   ("neuronal induction media" 2) ("Neurobasal stem cell media" 2)
   ("the respective cell culture media" 2) ("media (FBS)" 2)
   ("chemically defined Essential 8 media" 2)
   ("fresh puromycin-containing media" 2) ("decidual media" 2)
   ("respective media" 2) ("Viral media" 2)
   ("phenol-red free neurobasal media (NBM)" 2)
   ("phenol red-free Minimum Essential Media (MEM)" 2)
   ("bronchial epithelial media" 2) ("the original media" 2)
   ("10 ml Waymouth complete media" 2)
   ("high-glucose (4.5 g/ml) DMEM (hDMEM) media" 2)
   ("fresh phenol-red free media" 2) ("A further 500 ml culture media" 2)
   ("200 μL RPMI-1640 complete media" 2) ("Neurobasal Media" 2)
   ("Heavy media" 2) ("fresh AIM-V media" 2)
   ("50% Percoll/50% Minimum Essential Media" 2)
   ("mammary epithelial growth media" 2) ("ice-cold media" 2)
   ("DAKO fluorescent mounting media" 2) ("proper media" 2)
   ("obligatory respiratory media" 2) ("media (EGM)" 2)
   ("minimal essential media (EMEM)" 2) ("The viral media" 2)
   ("the regular media" 2) ("contained endothelial cell basic media" 2)
   ("commercially available media" 2) ("MEDIA" 2)
   ("fresh normal growth media" 2) ("1 ml complete media" 2)
   ("Roswell Park Memorial Institute-1640 (RPMI-1640) (GIBCO-BRL, Bethesda MA) media"
    2)
   ("fresh complete DMEM media" 2) ("CaSki-dnRhoC-derived media" 2)
   ("The bottom wells contained basal media" 2)
   ("the aqueous mounting media" 2)
   ("a 1:1 DMEM/F12 (Invitrogen) basal media" 2)
   ("mammary epithelium growth media" 2) ("Minimal media" 2) ("“cold” media" 2)
   ("endothelial cell basal media" 2) ("using fluorescent mounting media" 2)
   ("these distinct media" 2) ("neurotoxic media" 2)
   ("a highly defined media called stem cell media (SCM)" 2)
   ("foetal calf serum-containing media" 2) ("respective basal media" 2)
   ("fresh MEM/F12 media" 2)
   ("intestinal extracellular matrix (stroma)-conditioned media" 2)
   ("neutral media" 2) ("mildly alkaline media" 2) ("viral otitis media" 2)
   ("hyperosmolar media" 2) ("treated media" 2)
   ("regular or osteogenic media" 2) ("48 h-conditioned media" 2)
   ("Media (NGM)" 2) ("media (SM)" 2)
   ("serum free prostate epithelial cell basal media" 2)
   ("morpholine propanol sulfonic acid (MOPS) minimal media" 2)
   ("phenol-red free (PRF) minimal essential media (MEM)" 2) ("media (ACM)" 2)
   ("Roswell Park Memorial Institute 1640 (RPMI-1640; Hyclone, USA) media" 2)
   ("fresh neuronal culture media" 2)
   ("a commercial preadipocyte differentiation media" 2)
   ("vectamount permanent mounting media" 2) ("Neurobasal serum-free media" 2)
   ("Aqueous Mounting Media" 2) ("minimal (synthetic) media" 2)
   ("synthetic minimal media" 2) ("stoichiometric GLMN" 2) ("more GLMN" 2)
   ("GLMN protein" 2) ("Glomulin (GLMN)" 2) ("Glomulin" 2)
   ("keratinocyte basal media" 2) ("Terrific Broth (TB) autoinduction media" 2)
   ("Fluorotech aqueous media" 2) ("Media (SFM)" 2)
   ("filtered lentiviral media" 2) ("supplemental media" 2)
   ("their respective complete media" 2) ("either complete media" 2)
   ("Dulbecco essential media" 2) ("aortic media" 2) ("patient remote media" 2)
   ("minimal essential media" 2) ("culture osteogenic differentiation media" 2)
   ("their basal media" 2) ("the aortic tunica media" 2)
   ("PrEC complete media" 2) ("than ATM media" 1)
   ("cancer-associated myofibroblast
media"
    1)
   ("the relevant media" 1)
   ("double-sided adhesive tape, and cell culture media" 1) ("media (FM)" 1)
   ("low external K + media" 1) ("adipogenic media" 1)
   ("warm infection media" 1) ("than conditioned media from control cells" 1)
   ("fresh RPMI media" 1) ("normal or serum-free media" 1)
   ("FLX treated media" 1) ("enough complete media" 1)
   ("fresh standard media" 1) ("Unconditioned complete media" 1)
   ("charcoal-stripped serum (CSS) media" 1) ("HDF basal media" 1)
   ("G418 (400 µg/ml) (Gibco) media" 1) ("the Neurobasal media" 1)
   ("fresh Wnt-conditioned media" 1) ("Astrocytes Basal Media" 1)
   ("acidotic media" 1) ("their respective normal culture media" 1)
   ("vehicle-containing media" 1)
   ("respective time points inhibitor-containing media" 1)
   ("differentiated multilayer cultures media" 1) ("fresh drug-free media" 1)
   ("Fresh 0.35% agarose media" 1) ("overnight balanced hypoxic media" 1)
   ("confluent media" 1) ("suprabasal media" 1) ("StemPro complete media" 1)
   ("non adherent serum free media" 1) ("8.5 ml complete media" 1)
   ("Minimum Essential Media (DMEM)" 1) ("give new media" 1)
   ("given new media" 1) ("intheir respective media" 1)
   ("fresh His-Ura-Leu- media" 1) ("steroid-free complete media" 1)
   ("The cholesteatomatous suppurative otitis media" 1)
   ("Fresh culture media" 1)
   ("5% charcoal dextran-treated FBS-containing media" 1)
   ("keratinocyte basal media (KBM)" 1)
   ("Roswell Park Memorial Institute 1640 (RPMI1640) cell growth media" 1)
   ("MOPS minimal media" 1) ("osteogenic and chondrogenic media" 1)
   ("more media" 1) ("collagen III treated cell conditioned media" 1)
   ("their respective complete culture media" 1)
   ("semisolid methyl cellulose media" 1) ("Media (ATCC)" 1)
   ("charcoal-stripped (CS) media" 1)
   ("10% heat-inactivated fetal bovine serum RPMI media" 1)
   ("using charcoal-stripped media" 1) ("viral particle-containing media" 1)
   ("the basal media" 1) ("the residual media" 1) ("400 μl complete media" 1)
   ("Waymouth complete media" 1) ("8% charcoal-stripped media" 1)
   ("5% charcoal-stripped media" 1) ("respective culture media" 1)
   ("control fetal membrane culture media" 1) ("respective growth media" 1)
   ("MOPS-based minimal media" 1) ("1X minimal essential media" 1)
   ("fresh 5% FBS media" 1) ("mock or complete media" 1)
   ("using Methocult semisolid media" 1) ("special media" 1)
   ("fresh SmGM-2 media" 1) ("the outer media" 1) ("the hypoxic media" 1)
   ("triplicate and fresh serum-free media" 1) ("Fresh serum-free media" 1)
   ("cryoprotective media" 1) ("Mammary Epithelial Growth Media" 1)
   ("the infectious media" 1) ("fresh full-growth media" 1)
   ("a pro-osteoblastic media" 1) ("full conditional media" 1)
   ("fresh culture/treatment media" 1) ("fresh phenol red-free media" 1)
   ("standard or low calcium media" 1) ("warm culture media" 1)
   ("the aforementioned media" 1) ("fresh maintenance media" 1)
   ("5 ml complete media" 1) ("M9 minimal salt media" 1)
   ("complete (estrogenic) media" 1) ("warm plain RPMI media" 1)
   ("prostate epithelium basal media" 1) ("public media" 1)
   ("fresh SABM media" 1) ("fresh standard culturing media" 1)
   ("Roswell Park Memorial Institute media (RPMI)" 1) ("OS media" 1)
   ("residual complete media" 1) ("2% FCS–endothelial cell basic media" 1)
   ("HMFCM" 1) ("media (HMFCM)" 1) ("neuronal maintenance media" 1)
   ("media (DME)" 1) ("terrific broth (TB) media" 1)
   ("fresh stem cell media" 1) ("vectashield aqueous mounting media" 1)
   ("media (WCM)" 1) ("charcoal treated media" 1) ("media (AM)" 1)
   ("DMEM/10% Fetal Bovine Serum media" 1) ("Minimal assay media" 1)
   ("the local media" 1) ("apocynin pre-treated conditioned media" 1)
   ("serum free neuronal media" 1)
   ("complete
media"
    1)
   ("the neurobasal media" 1) ("warm EGM-2 media" 1)
   ("15 NH 4 Cl-supplemented (Isotec) minimal media" 1)
   ("apical and basal compartment media" 1)
   ("pooled pre-conditioned minimal media" 1)
   ("pre-conditioned minimal media" 1) ("basic media" 1)
   ("either fresh growth media" 1) ("media (ME)" 1)
   ("pre-warmed complete media" 1) ("3-ml complete media" 1)
   ("steroid free media which partially activate MR's" 1)
   ("significantly neurotoxic conditioned media" 1)
   ("cell-free neurotoxic THP-1 media" 1) ("media (SCM)" 1)
   ("endothelial basal media (EBM)" 1) ("fresh cell media" 1)
   ("SC minimal media" 1) ("the treated media" 1)
   ("basal bronchial epithelial growth media (BEGM)" 1)
   ("serum-free Neurobasal media" 1) ("containing RPMI complete media" 1)
   ("Sf-900 II SFM media" 1) ("fresh starvation media" 1)
   ("the chromatographic media" 1) ("normoxic and hypoxic media" 1)
   ("pre-existing media" 1) ("half-complete media" 1)
   ("complete or serum-free media" 1)
   ("Mouse monoclonal anti-PKCα (MC5) hybridoma media" 1)
   ("than the regular media" 1) ("their respective basal media" 1)
   ("osteogenic differentiation media" 1) ("given regular media" 1)
   ("normal (“light”) media" 1) ("extracorporal media" 1) ("media (ELL)" 1)
   ("media (FL)" 1) ("compound- (or vehicle-) free media" 1)
   ("800 μL minimal media" 1) ("the osteogenic media" 1)
   ("both regular and osteogenic media" 1) ("regular and osteogenic media" 1)
   ("their respective recommended media" 1) ("the respective growth media" 1)
   ("astrocytic-conditioned media" 1)
   ("the resultant astrocytic-conditioned media" 1)
   ("the previously collected media" 1)
   ("5% double charcoal-stripped serum-containing media" 1)
   ("100 μl sterile complete media" 1) ("37°C. Complete media" 1)
   ("the stringent serum-free media" 1) ("fresh complete culture media" 1)
   ("Solid media" 1) ("recommended bronchial epithelial growth media (BEGM)" 1)
   ("at least 3 days phenol-red free media" 1) ("complete Media" 1)
   ("2% foetal bovin serum culture media" 1) ("media (CIM)" 1)
   ("a permanent mounting media" 1) ("fresh serum-supplemented growth media" 1)
   ("charcoal stripped serum supplemented media" 1)
   ("standard complete media" 1) ("fresh serum-containing media" 1)
   ("HIBERNATE™ A media" 1) ("bronchial epithelial growth media" 1)
   ("serum free-cold MEM media" 1) ("serum-free minimum essential media" 1)
   ("aqueous mounting media" 1) ("residual media" 1)
   ("the galactose inductive media" 1) ("DMEM complete media" 1) ("-GLMN" 1)
   ("charcoal stripped and dialyzed media" 1)
   ("1 µg/ml puromycin-containing complete media" 1)
   ("adipogenic or osteogenic media" 1) ("mock-immunodepleted media" 1)
   ("fetal bovine serum-free culture media" 1) ("given fresh culture media" 1)
   ("RPMI 1640 Complete media" 1) ("recurrent and persistent otitis media" 1)
   ("serum free-cold cell culture media" 1) ("1 mL complete media" 1)
   ("practically all environmental media" 1) ("charcoal-treated media" 1)
   ("ice-cold CO 2 -independent media" 1) ("fresh DMEM/10% FBS media" 1)
   ("Potential \"remote\" media" 1) ("bacterial conditioned media" 1)
   ("fresh cell culture media" 1) ("conditional media" 1)
   ("intermittent media" 1) ("subsequent media" 1) ("fresh full media" 1)
   ("media (SDM)" 1) ("media (NSC)" 1) ("inner media" 1)
   ("cytoprotective and cytokine-abundant stromal-conditioned media (SCM)" 1)
   ("Clonetics Skeletal Muscle Myoblast Cell System media" 1)
   ("containing complete media" 1) ("soft agar-containing media" 1)))
 ("UP:Q92993"
  (("Tip60" 1205) ("TIP60" 511) ("KAT5" 13) ("TIP60 protein" 10) ("tip60" 7)
   ("Tat interacting protein" 4) ("Tip60 protein" 2)
   ("a multifunctional histone acetyltransferase (HAT) Tip60" 2) ("HTATIP" 2)
   ("TiP60" 2) ("Tip60-" 2) ("a multifunctional acetyltransferase Tip60" 1)
   ("the transcriptional cofactor/acetyltransferase TIP60" 1)
   ("This interaction increases Tip60’s" 1)
   ("the DNA damage-associated TIP60" 1)))
 ("UP:Q92994" (("BrF" 11) ("BRF" 9) ("Brf" 2))) ("UP:Q92995" (("USP13" 117)))
 ("UP:Q92997" (("Dvl3" 61) ("DVL3" 43) ("Dvl-3" 6)))
 ("UP:Q93008"
  (("FAM" 923) ("USP9X" 202) ("Fam" 24) ("-FAM" 17) ("FAM-" 13) ("fam" 4)
   ("previously reported NUAK1 interactors USP9X" 2)
   ("the fluorescent dye FAM" 2) ("−FAM" 1) ("Dual-labeled FAM" 1)
   ("a fluorescent FAM" 1) ("Fam-" 1) ("FAM (5-carboxyfluorescein) molecule" 1)
   ("FAM (ABI)" 1) ("Ubiquitin specific peptidase 9, X-linked" 1)
   ("ubiquitin specific peptidase 9, X-linked" 1) ("Usp9x" 1)))
 ("UP:Q93009"
  (("HAUSP" 1123) ("USP7" 720) ("Hausp" 194) ("hausp" 120) ("HAUSP protein" 17)
   ("herpesvirus-associated ubiquitin-specific protease" 11) ("USP7 protein" 6)
   ("Usp7" 4) ("Herpesvirus-associated ubiquitin-specific protease" 3)
   ("herpesvirus-associated ubiquitin-specific protease (HAUSP)" 3)
   ("only one HAUSP molecule" 2) ("HAUSP molecule" 2)
   ("ubiquitin specific peptidase 7" 2) ("cellular USP7" 1)
   ("expresse less USP7" 1) ("-Hausp" 1) ("than WT USP7" 1)
   ("herpesvirus associated ubiquitin specific protease" 1)
   ("other potential HAUSP" 1) ("ING1-associated HAUSP" 1) ("USP7 (HAUSP)" 1)))
 ("UP:Q93033"
  (("AR-V7" 1100) ("AR-V7 protein" 13) ("undetectable AR-V7" 11) ("AR-V7–" 4)
   ("ectopically-expressed AR-V7" 2) ("than AR-V7 in VCaP cells" 1)
   ("The well-characterized AR-V7" 1)
   ("the clinically-relevant AR-V7 protein" 1) ("nearly equivalent AR-V7" 1)))
 ("UP:Q93034"
  (("Cul5" 144) ("CUL5" 109) ("Cullin 5" 26) ("Cullin-5" 14) ("Cullin5" 13)
   ("cullin 5" 5) ("cullin5" 3) ("Cul5 protein" 3) ("cellular cullin 5" 1)
   ("its associated CUL5" 1) ("VACM-1" 1)))
 ("UP:Q93038"
  (("DR3" 33) ("APO3" 17) ("LARD" 13) ("TNFRSF25" 9) ("DDR3" 4) ("Apo3" 4)
   ("TNFRSF12" 4) ("lard" 1) ("DR3-" 1)))
 ("UP:Q93045"
  (("SCG10" 18) ("STMN2" 7) ("Stmn2" 2)
   ("the neuronal growth-associated protein SCG10" 1)))
 ("UP:Q93052"
  (("LPP" 233) ("LPP protein" 14) ("LPPs" 12)
   ("LPP (Lipoma Preferred Partner) protein" 3)
   ("lipoma preferred partner" 1)))
 ("UP:Q93062"
  (("RBPMS" 288) ("Hermes" 20) ("hermes" 10) ("RBPMS protein" 9)
   ("RNA-binding protein with multiple splicing (RBPMS)" 2)
   ("RNA-binding protein with multiple splicing" 2)
   ("RNA binding protein with multiple splicing" 1)))
 ("UP:Q93063" (("EXT2" 24)))
 ("UP:Q93070"
  (("DO" 941) ("p62dok" 7) ("Dok1" 7) ("p62DOK" 7) ("dok1" 6) ("Art4" 4)
   ("p53 mouse anti-human monoclonal DO-1" 1)
   ("primary monoclonal antibodies DO-1" 1) ("particular Dok1" 1)
   ("p62Dok" 1)))
 ("UP:Q93074" (("OPA1" 55) ("MED12" 20) ("Med12" 12) ("TRAP230" 1)))
 ("UP:Q93083" (("mTFs" 6)))
 ("UP:Q93088"
  (("BHMT" 22) ("BHMT1" 2)
   ("betaine homocysteine methyltransferase ( BHMT )" 1)
   ("betaine homocysteine methyltransferase" 1)))
 ("UP:Q93096" (("PRL-1" 47) ("PTP4A1" 17)))
 ("UP:Q93097" (("WNT2B" 37) ("Wnt2b" 3) ("WNT13" 1) ("Wnt-13" 1) ("Wnt-2b" 1)))
 ("UP:Q93098" (("WNT8B" 4) ("Wnt8B" 1)))
 ("UP:Q93099"
  (("HGD" 155) ("hGO" 1)
   ("Konda et al., all the 19 depressed lesions harbored HGD" 1)
   ("only 3 HGD" 1) ("less HGD" 1)))
 ("UP:Q93100" (("PHKB" 10)))
 ("UP:Q93105"
  (("miR" 48053) ("MiR" 1172) ("miRs" 789) ("MiRs" 24) ("mIRS" 13) ("mirs" 12)
   ("mIR" 9) ("InR" 8) ("MIRs" 4) ("pMIR" 4) ("pMiR" 2)
   ("the mature miR molecule" 2) ("inR" 1)
   ("lentiviral scramble control miR" 1) ("at least one miR" 1)
   ("miR molecule" 1)
   ("miRs, Human TaqMan® MicroRNA Assays (Applied Biosystems, Carlsbad, California)"
    1)))
 ("UP:Q93134"
  (("RACK" 28) ("RACK peptide" 13) ("so far no RACK" 2)
   ("PKCδ specific antagonistic RACK peptide" 2) ("a unique RACK" 2)))
 ("UP:Q93MD2" (("resp" 129) ("RESP" 9) ("only 173 resp" 1)))
 ("UP:Q93NG3" (("DH-PH" 119) ("DH–PH" 36) ("–DH–PH" 1)))
 ("UP:Q93P60" (("MGS" 26))) ("UP:Q93PP8" (("RD2" 4)))
 ("UP:Q93Q23" (("MgTx" 33))) ("UP:Q93TJ5" (("HAPE" 2)))
 ("UP:Q93TU6" (("OCH" 31))) ("UP:Q93WC9" (("IPT3" 3)))
 ("UP:Q93YV0" (("LIS" 25))) ("UP:Q93Z01" (("inositol-3 kinase" 22)))
 ("UP:Q93ZB2"
  (("KO" 3718) ("-KO" 172) ("ko" 114) ("pKO" 7) ("Ko" 5) ("conditional KO" 3)
   ("targeted HCT116 p21 KO" 3) ("the global KO" 2)
   ("micronemal proteins MIC1 ko" 2) ("the T-cell-conditional IKKβ KO" 2)
   ("KO1" 2) ("genetic KO" 2) ("muscle-specific KO" 2) ("Homer triple KO" 1)
   ("AD-treated RSK2 KO" 1) ("the conditional KO" 1) ("-ko" 1) ("distal KO" 1)
   ("significantly more pronounced forMac-Tsc1 KO" 1) ("a conditional KO" 1)
   ("the adipose-specific raptor KO" 1) ("than KO" 1)
   ("conditional macrophage/neutrophil Rac1 -KO" 1)
   ("conditional neutrophil/macrophage KO" 1) ("only 1/12 Rac1 -KO" 1)
   ("The lentiviral vector pKO" 1) ("lentiviral vector pKO" 1)
   ("Two independently-derived IRS1 KO" 1)))
 ("UP:Q940U6"
  (("Flu" 135) ("FLU" 90) ("flu" 28) ("FLU peptide" 2) ("recent flu" 1)))
 ("UP:Q94420" (("MEL-26" 6))) ("UP:Q94465" (("G-to-C" 5)))
 ("UP:Q944A6" (("SNF4" 4) ("Snf4" 1))) ("UP:Q944C2" (("PLC5" 40)))
 ("UP:Q94503" (("CP6" 3))) ("UP:Q94504" (("CPRG" 3)))
 ("UP:Q94547" (("Not2" 7))) ("UP:Q945Q1" (("cys" 112) ("CYS" 44) ("CyS" 6)))
 ("UP:Q945T0" (("RalF" 3))) ("UP:Q94741" (("LO1" 7)))
 ("UP:Q94758" (("DLC" 42) ("DLC protein" 4) ("dlc" 1)))
 ("UP:Q947R4" (("GL1" 5) ("GL1 protein" 2))) ("UP:Q94901" (("Lark" 3)))
 ("UP:Q94918"
  (("DDD" 245) ("DDD peptide" 19) ("ddd" 9)
   ("DDD (PSLLSSEDNADDEVDTRPASFWETS)" 2) ("an intact DDD" 1) ("intact DDD" 1)
   ("than DDD" 1)))
 ("UP:Q94986" (("Rab3" 2))) ("UP:Q949T8" (("SML" 8))) ("UP:Q94A52" (("RH2" 2)))
 ("UP:Q94AT5" (("Ex2" 29) ("EX2" 25) ("ex2" 11))) ("UP:Q94AU2" (("Sec22" 5)))
 ("UP:Q94AW8" (("J 3" 2)))
 ("UP:Q94B35"
  (("HDR" 402) ("Clb6" 5) ("HDR protein" 4) ("successful HDR" 2)
   ("efficient HDR" 1) ("robust HDR" 1) ("defective HDR" 1)))
 ("UP:Q94BN0" (("BT2" 1))) ("UP:Q94BN2" (("SPMs" 48)))
 ("UP:Q94C74" (("SHM2" 2))) ("UP:Q94FB9" (("CTs" 8)))
 ("UP:Q94ID3" (("IPT1" 5))) ("UP:Q94KJ7" (("Vps33" 3) ("vps33" 1)))
 ("UP:Q95121" (("pigment epithelium-derived factor" 4)))
 ("UP:Q95LF0"
  (("IL13Rα2" 92) ("IL-13Rα2" 82)
   ("these Tgfbr1/Pten double conditional knockout (2cKO) mice over-expressed IL-13Rα2"
    1)))
 ("UP:Q95P08" (("HC1" 33)))
 ("UP:Q95P23"
  (("Ena" 60) ("ENT" 14) ("ENS" 4) ("ENM" 4) ("ENC" 1)
   ("Structure-based ENM" 1) ("ena" 1)))
 ("UP:Q95Q39" (("mAb7" 4))) ("UP:Q95Q95" (("let-363" 2)))
 ("UP:Q95RG8" (("git" 2) ("Git" 1)))
 ("UP:Q95RI5" (("Fax" 9) ("FAX" 2) ("fax" 1))) ("UP:Q95SX7" (("RTase" 6)))
 ("UP:Q95T12" (("FWE" 10) ("3L5" 1))) ("UP:Q95TN8" (("Greatwall" 6)))
 ("UP:Q95UN8" (("slpr" 2))) ("UP:Q95V55" (("dFOXO" 4) ("dFoxO" 2)))
 ("UP:Q95W85" (("HCCP" 31) ("HcRed" 14) ("HcRED" 1) ("pHcRed" 1)))
 ("UP:Q96242" (("AOS" 65) ("AOs" 6)))
 ("UP:Q96247" (("Aux" 2) ("aux" 2) ("AUX" 1))) ("UP:Q96288" (("STO" 2)))
 ("UP:Q96293" (("ACT8" 1))) ("UP:Q96301" (("SPY" 17)))
 ("UP:Q96303" (("pT2" 194) ("than pT2" 1))) ("UP:Q96321" (("Kapα1" 2)))
 ("UP:Q96502" (("Col2" 82) ("Col2 protein" 1))) ("UP:Q967F4" (("HMR-1" 1)))
 ("UP:Q968Y9" (("daf-2" 47) ("daf-2-" 1)))
 ("UP:Q969D9"
  (("TSLP" 190) ("thymic stromal lymphopoietin" 6)
   ("Thymic stromal lymphopoietin" 2) ("thymic stromal lymphopoietin (TSLP)" 2)
   ("the cytokine Thymic Stromal Lymphopoietin (TSLP)" 2) ("Lymphopoietin" 1)))
 ("UP:Q969E3" (("UCN3" 7) ("stresscopin" 1))) ("UP:Q969E8" (("TSR2" 1)))
 ("UP:Q969F0"
  (("fate" 1972) ("fated" 24) ("“fate”" 12) ("Fate" 10) ("the ultimate fate" 3)
   ("mitotic fate" 3) ("an astrocytic fate" 3) ("The precise fate" 2)
   ("neural fate" 2) ("the mesenchymal fate" 2) ("mesenchymal fate" 2)
   ("a proneoplastic fate" 2) ("the p38-independent post-endocytic fate" 2)
   ("the post-endocytic fate" 2) ("a multi-vulval fate" 2)
   ("the mitotic fate" 2) ("a differential biological fate" 2)
   ("the exact fate" 2) ("neuronal fate" 2)
   ("an osteogenic or adipogenic fate" 2) ("astrocytic fate" 2)
   ("post endocytic fate" 2)
   ("the previously described alternative endocytic fate" 2)
   ("the early endocytic fate" 2) ("the degradative fate" 2)
   ("The ultimate fate" 2) ("a neural fate" 1) ("a mesodermal fate" 1)
   ("neural or mesodermal fate" 1) ("the auditory fate" 1)
   ("one alternate fate" 1) ("a wide evolutionary fate" 1)
   ("an ectodermal fate" 1) ("a unique fate" 1)
   ("the EGF-induced biological fate" 1) ("ultimately phenotypic fate" 1)
   ("osteoblastic fate" 1) ("the biological fate" 1) ("whose fate" 1)
   ("the cardiac fate" 1) ("organismal fate" 1) ("the vulval fate" 1)
   ("a chondrogenic fate" 1) ("vulval fate" 1) ("a neuronal fate" 1)
   ("caudal fate" 1) ("regional fate" 1)
   ("the cardiac crescent and embryonic heart tube fated" 1)
   ("self-renewal and neurogenic fate" 1) ("a ductal fate" 1)
   ("its itinerary fate" 1) ("oligodendrocytic fate" 1) ("ultimate fate" 1)
   ("a myocytic fate" 1) ("some other degradative fate" 1) ("arterial fate" 1)
   ("its subsequent fate" 1) ("the same dual fate" 1)
   ("the posttranslational fate" 1) ("the endodermal fate" 1)))
 ("UP:Q969F2" (("NKD2" 5) ("Nkd2" 5)))
 ("UP:Q969F8" (("KISS1R" 30) ("GPR54" 26))) ("UP:Q969F9" (("HPS3" 2)))
 ("UP:Q969G2" (("LHX4" 11) ("LIM homeobox protein 4" 3) ("Lhx4" 2)))
 ("UP:Q969G3" (("SMARCE1" 149) ("BAF57" 14) ("Baf57" 8) ("SmarcE1" 1)))
 ("UP:Q969G5"
  (("cavin-3" 403) ("Cavin-3" 64) ("cavin 3" 51) ("Prkcdbp" 9) ("PRKCDBP" 6)
   ("Cavin 3" 5) ("cavin-3 protein" 5) ("C-kinase" 5) ("cavin3" 2)
   ("hSRBC" 1)))
 ("UP:Q969G6" (("RFK" 4) ("riboflavin kinase" 2)))
 ("UP:Q969G9"
  (("Nkd1" 181) ("NKD1" 60) ("Nkd" 34) ("Nkd1 protein" 15) ("nkd" 6) ("NKD" 4)
   ("NKd" 1) ("nkd1" 1) ("than Nkd1" 1) ("than wild-type Nkd1" 1)))
 ("UP:Q969H0"
  (("FBXW7" 811) ("Fbw7" 805) ("FBW7" 799) ("Fbxw7" 527) ("hCDC4" 15)
   ("SEL-10" 12) ("hCdc4" 10) ("FBW7 protein" 8)
   ("F-box and WD repeat domain containing 7" 7) ("hAgo" 6) ("Sel-10" 5)
   ("FBXW7-" 5) ("monomeric Fbw7" 5) ("Fbxw7 protein" 4) ("p-FBW7" 4)
   ("F-box/WD repeat-containing protein 7" 3) ("Fbxw7-" 2)
   ("Previously described Fbw7" 2) ("most Fbw7" 2)
   ("F-Box and WD repeat domain containing 7" 2) ("Dimerized Fbw7" 2)
   ("monomeric and dimerized Fbw7" 2) ("overexpressed tagged Fbw7" 2)
   ("a dominant-negative (DN) FBW7" 2) ("hAGO" 2) ("FBxw7" 1)
   ("than WT FBW7" 1) ("than wild-type FBW7" 1) ("FBXW7 protein" 1) ("Sel10" 1)
   ("dimerized Fbw7" 1) ("Dimerization-defective Fbw7" 1)
   ("than either Fbxw7  +/−" 1) ("nonfunctional SCF FBW7" 1)
   ("preformed pure SCF Fbxw7" 1) ("–Fbw7" 1)))
 ("UP:Q969H4" (("CNK1" 8) ("connector enhancer of KSR 1" 2)))
 ("UP:Q969H6" (("POP5" 2)))
 ("UP:Q969H8"
  (("IL-27" 179) ("IL-25" 21) ("Interleukin-25" 2) ("IL-27–" 2)
   ("interleukin 25" 1)))
 ("UP:Q969I3" (("GNAT" 4))) ("UP:Q969I6" (("ATA3" 2) ("NAT3" 1)))
 ("UP:Q969J2" (("ZNF307" 11))) ("UP:Q969J5" (("IL22RA2" 2) ("IL-22BP" 1)))
 ("UP:Q969K3" (("RNF34" 8))) ("UP:Q969L2" (("MAL2" 16)))
 ("UP:Q969L4" (("Lsm10" 3)))
 ("UP:Q969M7" (("UBE2F" 9) ("NCE2" 2) ("NEDD8 conjugating enzyme" 1)))
 ("UP:Q969N4" (("T/A 5" 4) ("TAR5" 1)))
 ("UP:Q969P0"
  (("keratinocytes" 6319) ("Keratinocytes" 203) ("primary keratinocytes" 147)
   ("epidermal keratinocytes" 62) ("normal keratinocytes" 60)
   ("basal keratinocytes" 53) ("immortalized keratinocytes" 41) ("HIGK" 39)
   ("HKC" 37) ("keratinocytes (HOK)" 30) ("Primary keratinocytes" 25)
   ("HFK" 21) ("keratinocytes (HFK)" 20) ("normal primary keratinocytes" 17)
   ("human epidermal keratinocytes" 16)
   ("normal human epidermal keratinocytes" 16)
   ("primary human epidermal keratinocytes" 14)
   ("Ras-expressing keratinocytes" 13) ("human primary keratinocytes" 11)
   ("transformed keratinocytes" 11) ("NHPK" 11) ("PHFK" 11)
   ("the epidermal keratinocytes" 10) ("confluent keratinocytes" 10)
   ("keratinocytes (NHEK)" 10) ("keratinocytes (NHOK)" 10)
   ("apoptotic keratinocytes" 9) ("immortalized human keratinocytes" 9)
   ("UVB-treated keratinocytes" 8) ("Lat-treated keratinocytes" 8)
   ("Ras-transformed keratinocytes" 7) ("mouse epidermal keratinocytes" 7)
   ("HPV16-immortalized keratinocytes" 7)
   ("normal human epidermal keratinocytes (NHEK)" 7) ("keratinocytes (PHFK)" 7)
   ("the primary keratinocytes" 6) ("Immortalized human keratinocytes" 6)
   ("Stat3 −/− primary keratinocytes" 6) ("keratinocytes (NHK)" 6)
   ("primary human esophageal keratinocytes" 6)
   ("Immortalized keratinocytes" 6) ("Epidermal keratinocytes" 6)
   ("suprabasal keratinocytes" 6) ("neighboring keratinocytes" 6)
   ("esophageal keratinocytes" 6) ("human interfollicular keratinocytes" 6)
   ("proliferative keratinocytes" 6) ("Human epidermal keratinocytes" 5)
   ("primary genital keratinocytes" 5)
   ("Normal human epidermal keratinocytes (NHEK)" 5)
   ("acroinfundibular keratinocytes" 5) ("keratinocytes (HKC)" 5)
   ("HPV16-immortalized human keratinocytes" 4) ("keratinocytes (NOK)" 4)
   ("Normal Human Epidermal Keratinocytes" 4) ("NHK" 4)
   ("the lesional keratinocytes" 4) ("ACAM-2000-infected keratinocytes" 4)
   ("interfollicular keratinocytes" 4) ("Normal keratinocytes" 4)
   ("Normal human epidermal keratinocytes" 3)
   ("Rho-expressing keratinocytes" 3) ("calcium-treated keratinocytes" 3)
   ("normal epidermal keratinocytes" 3) ("gingival keratinocytes" 3)
   ("hyperproliferative keratinocytes" 3) ("H-Ras transformed keratinocytes" 3)
   ("proliferating keratinocytes" 3) ("basal epidermal keratinocytes" 3)
   ("basal and suprabasal keratinocytes" 3)
   ("primary epidermal keratinocytes" 3) ("EWI-2" 3)
   ("UV-damaged keratinocytes" 3) ("Human primary keratinocytes" 3)
   ("primary esophageal keratinocytes" 3) ("granular keratinocytes" 3)
   ("senescencent human epidermal keratinocytes" 3)
   ("p110CAAX-overexpressing keratinocytes" 2)
   ("Ras-transformed Keratinocytes" 2)
   ("mock-infected primary keratinocytes" 2) ("hrHPV-positive keratinocytes" 2)
   ("using normal keratinocytes" 2) ("the basal keratinocytes" 2)
   ("epidermal growth factor-stimulated human epidermal keratinocytes" 2)
   ("immortalised human epidermal keratinocytes" 2)
   ("the C3-treated keratinocytes" 2) ("Keratinocytes (NHEK)" 2)
   ("MG132-treated keratinocytes" 2)
   ("Human neonatal Epidermal Keratinocytes" 2) ("E7-positive keratinocytes" 2)
   ("keratinocytes (PK)" 2) ("siRNA-treated keratinocytes" 2)
   ("most keratinocytes" 2) ("Human neonatal foreskin keratinocytes" 2)
   ("human papillomavirus type 16-immortalized human keratinocytes" 2)
   ("normal immortalized human keratinocytes (NIKS)" 2)
   ("undifferentiated gingival keratinocytes" 2)
   ("wound-edge basal keratinocytes" 2) ("leading-edge basal keratinocytes" 2)
   ("Stat3 fl/fl primary keratinocytes" 2)
   ("exogenous YFP-tagged SMAD2-expressing HaCaT keratinocytes" 2)
   ("Adult normal human epidermal keratinocytes" 2)
   ("the SIRT1-overexpressing primary keratinocytes" 2)
   ("Immortalized human foreskin keratinocytes" 2)
   ("SV40T-transformed human epidermal keratinocytes" 2)
   ("Spontaneously immortalized human keratinocytes" 2)
   ("primary normal human epidermal keratinocytes" 2)
   ("the nontumorigenic oral keratinocytes" 2)
   ("showed atypical proliferative keratinocytes" 2)
   ("immortalized and transformed keratinocytes" 2)
   ("than primary keratinocytes" 2) ("rat epithelial keratinocytes" 2)
   ("PVIgG-treated human keratinocytes" 2)
   ("Primary human epidermal keratinocytes" 2)
   ("lincRNA-p21-depleted keratinocytes" 2)
   ("UVB-treated mouse and human keratinocytes" 2)
   ("UVB-treated p53 knockdown keratinocytes" 2) ("keratinocytes (PFK)" 2)
   ("infected cervical keratinocytes" 2) ("subconfluent HaCaT keratinocytes" 2)
   ("late passage E6/7 keratinocytes" 2)
   ("immortalized FA patient keratinocytes" 2)
   ("HPV positive normal immortalized keratinocytes" 2)
   ("primary normal keratinocytes" 2)
   ("HPV 16 E6/E7-immortalized keratinocytes" 2)
   ("E6/E7-immortalized keratinocytes" 2)
   ("primary and immortalized keratinocytes" 2) ("adjacent keratinocytes" 2)
   ("20-hydroxycholecalciferol treated keratinocytes" 2)
   ("nontumorigenic HaCaT keratinocytes" 2)
   ("Adult human primary keratinocytes" 2) ("atypical keratinocytes" 2)
   ("specialized epithelial cells called keratinocytes" 2)
   ("the normal keratinocytes" 2) ("Normal Keratinocytes" 2)
   ("primary human epithelial keratinocytes" 2)
   ("primary keratinocytes (EK)" 2)
   ("undifferentiated primary human epidermal keratinocytes" 2)
   ("neonatal epidermal human keratinocytes" 2)
   ("non-transformed primary epidermal keratinocytes" 2)
   ("HaCaTs (data not shown) A431 parental and primary human oral keratinocytes (POK)"
    2)
   ("keratinocytes (POK)" 2) ("both suprabasal and basal keratinocytes" 2)
   ("preneoplastic keratinocytes" 2) ("siRhoA-treated keratinocytes" 2)
   ("transformed rat keratinocytes" 2) ("HeLa cervical tumour keratinocytes" 2)
   ("Tamoxifen-treated keratinocytes" 2) ("Mst1/Mst2-null keratinocytes" 2)
   ("non-cSCC primary epidermal keratinocytes" 2)
   ("Ras-expressing HaCaT-II-4 keratinocytes" 2)
   ("Normal human primary keratinocytes (NHPK)" 2)
   ("normal human primary keratinocytes (NHPK)" 2)
   ("p53  R175H transformed primary epidermal keratinocytes" 2)
   ("non-transformed esophageal keratinocytes" 2)
   ("normal primary human epidermal keratinocytes (HEK)" 2)
   ("HPV-16 immortalized foreskin keratinocytes" 2)
   ("cultured normal human epidermal keratinocytes (NHEK)" 2)
   ("Primary mouse and human epidermal keratinocytes" 2)
   ("CB-treated keratinocytes" 2)
   ("all three actin inhibitor-treated keratinocytes" 2)
   ("superficial differentiated keratinocytes" 2)
   ("non-tumorigenic HPV-immortalized keratinocytes" 2)
   ("Non-tumorigenic HPV16-immortalized keratinocytes" 2)
   ("keratinocytes (NOKSI)" 2) ("BrdU-positive keratinocytes" 2)
   ("both proliferative and differentiated keratinocytes" 2)
   ("keratinocytes (HPK)" 2) ("proliferative and migratory keratinocytes" 2)
   ("NTERT ( xref ) non-cancerous immortalized human keratinocytes" 2)
   ("non-transformed human keratinocytes" 2) ("keratinocytes (PMK)" 2)
   ("Primary Keratinocytes" 2) ("senescent keratinocytes" 2)
   ("Primary human ectocervical keratinocytes" 2)
   ("HPV-expressing keratinocytes" 2) ("Keratinocytes (HOK)" 2)
   ("hyperproliferative primary keratinocytes" 1)
   ("our Ras-expressing keratinocytes" 1)
   ("the murine Pam212 epidermal keratinocytes" 1)
   ("human epithelial keratinocytes" 1) ("these transformed keratinocytes" 1)
   ("mouse primary keratinocytes" 1)
   ("Parental 804G cells and HaCaT keratinocytes" 1)
   ("both normal and neoplastic keratinocytes" 1)
   ("normal cultured epidermal keratinocytes" 1)
   ("both human primary epidermal keratinocytes" 1)
   ("the immortalized keratinocytes" 1)
   ("E6-positive immortalized keratinocytes" 1)
   ("E6/E7- immortalized keratinocytes" 1)
   ("E7-immortalized human keratinocytes" 1) ("siTrio-treated keratinocytes" 1)
   ("siRNA- treated keratinocytes" 1) ("Pre-confluent keratinocytes" 1)
   ("KeratinocyteS" 1) ("keratinocytes (NIKS)" 1)
   ("multilayer keratinocytes" 1) ("many more keratinocytes" 1)
   ("dermal type I collagen–which keratinocytes" 1)
   ("sulforaphane-treated keratinocytes" 1) ("Adult primary keratinocytes" 1)
   ("Stat3 null keratinocytes" 1) ("normal and neoplastic keratinocytes" 1)
   ("than GM16 keratinocytes" 1)
   ("human gingival mucosal (GM) keratinocytes" 1)
   ("human gingival mucosal keratinocytes" 1) ("K14-positive keratinocytes" 1)
   ("cultured human epidermal keratinocytes" 1)
   ("normal human primary keratinocytes (NHEK)" 1)
   ("adjacent normal keratinocytes" 1)
   ("human epidermal keratinocytes (HEK)" 1) ("Primary keratinocytes (KN)" 1)
   ("interfollicular basal keratinocytes" 1)
   ("500 consecutive keratinocytes" 1)
   ("serum-stimulated quiescent (G 0 ) keratinocytes" 1)
   ("normally differentiating keratinocytes" 1) ("EGF-treated keratinocytes" 1)
   ("wild type immortalized keratinocytes" 1)
   ("Primary epidermal keratinocytes" 1)
   ("ACAM-2000-infected human and mouse keratinocytes" 1)
   ("two adherent keratinocytes" 1) ("adherent keratinocytes" 1)
   ("HPV16-transformed human keratinocytes" 1)
   ("TNF-α treated human foreskin keratinocytes" 1)
   ("AK23/mIgG-treated mouse keratinocytes" 1)
   ("PVIgG-treated cultured mouse and human keratinocytes" 1)
   ("AK23-treated mouse and human keratinocytes" 1)
   ("mitomycin C-treated mouse keratinocytes" 1)
   ("positive basal keratinocytes" 1)
   ("PVIgG-treated cultured HaCat keratinocytes" 1)
   ("epidermal keratinocytes (NHEK)" 1) ("UVB-treated mouse keratinocytes" 1)
   ("suprabasal differentiating keratinocytes" 1) ("than keratinocytes" 1)
   ("Confluent keratinocytes" 1)
   ("human immortalized and primary epidermal keratinocytes" 1)
   ("psoriatic keratinocytes" 1) ("the invasive keratinocytes" 1)
   ("late E6/E7 keratinocytes" 1) ("invasive E6/7-expressing keratinocytes" 1)
   ("primary human epidermal keratinocytes (NHEK)" 1)
   ("transformed human keratinocytes" 1) ("post-natal skin keratinocytes" 1)
   ("primary cutaneous keratinocytes" 1)
   ("primary and cancerous keratinocytes" 1)
   ("E6/E7 immortalized keratinocytes" 1)
   ("UVB-irradiated immortalized keratinocytes" 1)
   ("spontaneously immortalized HaCaT keratinocytes" 1)
   ("logarithmically growing HKC" 1)
   ("DNA-damaged human primary keratinocytes" 1) ("ATR siRNA-treated HKC" 1)
   ("UVB-treated HKC" 1) ("Immortalized human keratinocytes (IKC)" 1)
   ("keratinocytes (IKC)" 1) ("slightly fewer Ki67-positive keratinocytes" 1)
   ("than G3Terc −/− p53 +/+ keratinocytes" 1) ("DP-null keratinocytes" 1)
   ("adjacent basal keratinocytes" 1)
   ("these studies both immortalized human HaCaT keratinocytes" 1)
   ("both primary and immortalized epidermal keratinocytes" 1)
   ("β-cat–null mouse keratinocytes" 1)
   ("oncogenic Ras-expressing HaCaT-II-4 keratinocytes" 1)
   ("parental HaCaT keratinocytes" 1) ("non-invasive keratinocytes" 1)
   ("RAS-transformed human keratinocytes" 1)
   ("10 6 human primary keratinocytes" 1) ("than keratinocytes ( xref )" 1)
   ("the tumorigenic keratinocytes" 1) ("stable immortalized keratinocytes" 1)
   ("Previously described cdk4 and hTERT immortalized foreskin keratinocytes"
    1)
   ("anisomycin-treated keratinocytes" 1)
   ("human cervical
                            keratinocytes"
    1)
   ("human cervical keratinocytes" 1) ("human immortal HaCaT keratinocytes" 1)
   ("human immortalized gingival keratinocytes (HIGK)" 1)
   ("premalignant keratinocytes" 1)
   ("spontaneously immortalized keratinocytes" 1)
   ("primary mouse esophageal keratinocytes" 1)
   ("Normal esophageal keratinocytes" 1)
   ("Normal human epidermal keratinocytes (HEKA)" 1)
   ("growing primary normal human epidermal keratinocytes (NHEK)" 1)
   ("Primary normal human epidermal keratinocytes (NHEK)" 1)
   ("Non-malignant HPV-transformed keratinocytes" 1)
   ("the basal and suprabasal keratinocytes" 1)
   ("EGFR-treated keratinocytes" 1) ("oral and dermal keratinocytes" 1)
   ("primary murine dermal keratinocytes" 1) ("dermal keratinocytes" 1)
   ("exponentially growing asynchronous keratinocytes" 1)
   ("cultured neonatal human keratinocytes (NHK)" 1)
   ("freshly-isolated primary keratinocytes" 1)
   ("Freshly-isolated keratinocytes" 1)
   ("c-Met-expressing basal keratinocytes" 1)
   ("transgenic primary keratinocytes" 1) ("K5-positive basal keratinocytes" 1)
   ("matriptase-expressing keratinocytes" 1)
   ("Human neonatal foreskin keratinocytes (NHK)" 1)
   ("undifferentiated primary keratinocytes" 1)
   ("replication–activated suprabasal keratinocytes" 1)
   ("the untransfected primary keratinocytes" 1)
   ("HPV18 E1^E4-expressing HFK" 1) ("normal p53-positive keratinocytes" 1)
   ("Tamoxifen-treated Adam17flox/flox/CAG-Cre keratinocytes" 1)
   ("Tamoxifen-treated primary mouse keratinocytes" 1)
   ("FGF7-treated primary human keratinocytes" 1)
   ("Spontaneously immortalized keratinocytes" 1)
   ("Trypsin-treated keratinocytes" 1)
   ("TNF-treated tak1 -deficient keratinocytes" 1)
   ("spinal and granular layer keratinocytes" 1)
   ("only few X-Gal positive keratinocytes" 1)
   ("lesional psoriatic keratinocytes" 1)
   ("than normal primary keratinocytes" 1)
   ("all peritumoral normal keratinocytes" 1) ("keratinocytes (HEKA)" 1)
   ("Primary human epidermal keratinocytes (HEKA)" 1)
   ("BrdU-positive proliferating basal keratinocytes" 1)
   ("these HPV-immortalized keratinocytes" 1)
   ("HPV16- and HPV18- immortalized keratinocytes" 1)
   ("HPV-transformed keratinocytes" 1) ("HaCaT epidermal keratinocytes" 1)
   ("Ras-expressing E-cadherin-competent keratinocytes" 1)
   ("Ras-expressing human keratinocytes" 1)
   ("normal human primary keratinocytes" 1)
   ("Human primary epidermal keratinocytes" 1)
   ("differentiating suprabasal keratinocytes" 1)
   ("cutaneous HPV infected keratinocytes" 1) ("cutaneous keratinocytes" 1)
   ("human primary keratinocytes (HPK)" 1) ("embryonic keratinocytes" 1)
   ("normal human epidermal primary keratinocytes (NHEK)" 1)
   ("inhibitor-treated keratinocytes" 1)
   ("actin inhibitor-treated keratinocytes" 1) ("Lat–treated keratinocytes" 1)
   ("the basal, suprabasal and granular keratinocytes" 1)
   ("The inhibitor-treated keratinocytes" 1) ("Proliferative keratinocytes" 1)
   ("normal epithelial cervical keratinocytes" 1)
   ("non-tumorigenic HPV16-immortalized keratinocytes" 1)
   ("HRAS Q61L -transformed keratinocytes" 1)
   ("DMBA-transformed mouse keratinocytes" 1)
   ("PAI-1-deficient malignant keratinocytes" 1)
   ("non tumorigenic keratinocytes" 1)
   ("Spontaneously immortalized normal oral keratinocytes (NOKSI)" 1)
   ("surviving epidermal keratinocytes" 1)
   ("Primary Human Epidermal Keratinocytes" 1)
   ("normal human interfollicular keratinocytes" 1)
   ("external keratinocytes" 1) ("the IL-22-treated keratinocytes" 1)
   ("E.g. adult keratinocytes" 1) ("NTERT immortalized keratinocytes" 1)
   ("cultured human primary keratinocytes" 1)
   ("interfollicular epidermal keratinocytes" 1)
   ("the basal and squamous keratinocytes" 1)
   ("Foreskin-derived primary keratinocytes" 1)
   ("primary epidermal keratinocytes (PHK)" 1)
   ("pimozide-treated HPV31-positive keratinocytes" 1)
   ("-negative keratinocytes" 1)
   ("model normal, non-tumorigenic and cancerous keratinocytes" 1)))
 ("UP:Q969P5"
  (("atrogin-1" 22) ("MAFbx" 21) ("Atrogin-1" 20) ("Atrogin1" 4) ("FBXO32" 3)))
 ("UP:Q969P6" (("TOP1MT" 8)))
 ("UP:Q969Q1"
  (("IRF" 166) ("pIRF" 35) ("MURF1" 9) ("MuRF1" 8) ("Murf1" 4)
   ("IRF protein" 3) ("muscle-specific RING finger protein 1" 2)))
 ("UP:Q969Q4" (("ARL11" 3)))
 ("UP:Q969R5" (("L3MBTL2" 10) ("MAX-associated protein L3MBTL2" 2)))
 ("UP:Q969S2" (("Neh2" 207) ("Neh2 peptide" 50) ("NEIL2" 40) ("NEIL2-" 1)))
 ("UP:Q969S3" (("ZPR9" 3))) ("UP:Q969S8" (("HDAC10" 48) ("-HDAC10" 1)))
 ("UP:Q969T4" (("UBE2E3" 138) ("UbcH9" 4) ("a critical cysteine of UBE2E3" 1)))
 ("UP:Q969T9"
  (("Wbp2" 180) ("WBP2" 57) ("WBP-2" 6) ("cellular Wbp2" 2)
   ("exogenous Wbp2" 1) ("Wbp2 protein" 1) ("targeting Wbp2" 1)))
 ("UP:Q969U6" (("Fbw5" 3) ("FBXW5" 2) ("Fbxw5" 1))) ("UP:Q969V1" (("SLT" 7)))
 ("UP:Q969V4" (("TEKT1" 4))) ("UP:Q969V5" (("MUL1" 6) ("MULAN" 3)))
 ("UP:Q969V6"
  (("MKL1" 23) ("MRTF-A" 14) ("the transcriptional co-activator MKL1" 1)
   ("BSAC" 1)))
 ("UP:Q969W9"
  (("PMEPA1" 166) ("TMEPAI" 28) ("PMEPA1 protein" 2) ("PMEPA1-" 1)))
 ("UP:Q969X0" (("RILPL2" 2))) ("UP:Q969X1" (("TMBIM1" 1)))
 ("UP:Q969X5" (("ERGIC-32" 1))) ("UP:Q969X6" (("NAIC" 2) ("Cirhin" 2)))
 ("UP:Q969Y2" (("MSS1" 1))) ("UP:Q969Z4" (("RELT" 1)))
 ("UP:Q96A00" (("CPI-17" 14) ("PPP1R14A" 1))) ("UP:Q96A08" (("TSH2B" 1)))
 ("UP:Q96A25" (("TMEM106A" 2))) ("UP:Q96A29" (("member C1" 1)))
 ("UP:Q96A35" (("MRPL24" 1))) ("UP:Q96A44" (("SPSB4" 3)))
 ("UP:Q96A54" (("AdipoR1" 93) ("than AdipoR1" 1) ("AdipoR1-" 1)))
 ("UP:Q96A56"
  (("TP53INP1" 56) ("Tp53inp1" 4) ("stress induced protein" 3)
   ("environmental stress induced protein" 2)
   ("tumor protein p53-inducible nuclear protein 1" 2) ("TP53Inp1" 1)
   ("TEAP" 1) ("Tp53inp1 protein" 1)))
 ("UP:Q96A58" (("RERG" 20) ("rERG" 7)))
 ("UP:Q96A65"
  (("Sec8" 215) ("EXOC4" 33) ("exocyst complex component 4" 2)
   ("Exocyst complex component 4" 1) ("fluorescent protein-tagged Sec8" 1)
   ("-Sec8" 1)))
 ("UP:Q96A83" (("EMID2" 2)))
 ("UP:Q96AC1"
  (("Kindlin-2" 43) ("mig-2" 7) ("Mig-2" 3) ("kindlin-2" 3) ("PLEKHC1" 2)
   ("FERMT2" 2)))
 ("UP:Q96AC6" (("KIFC2" 6)))
 ("UP:Q96AD5"
  (("ATGL" 191) ("PNPLA2" 7) ("ATGL protein" 6)
   ("adipose triglyceride lipase" 3)
   ("patatin-like phospholipase domain containing 2" 1)))
 ("UP:Q96AE4" (("FBPs" 30) ("FUBP1" 16)))
 ("UP:Q96AG3" (("SLC25A46" 3) ("TB1" 3))) ("UP:Q96AG4" (("LRRC59" 1)))
 ("UP:Q96AH0"
  (("NABP1" 9) ("nucleic acid binding protein 1" 7) ("SSB2" 6) ("hSSB2" 1)
   ("OBFC2A" 1)))
 ("UP:Q96AJ1" (("CLUAP1" 7) ("Cluap1" 2)))
 ("UP:Q96AJ9" (("VTI1A" 26) ("Vti1a" 5)))
 ("UP:Q96AK3" (("APOBEC3D" 10) ("a3d" 1) ("than APOBEC3D" 1)))
 ("UP:Q96AP0"
  (("ACD" 83) ("PIP1" 59) ("pip1" 31) ("PIP1-" 2)
   ("severe phenotypes affecting neuroblast ACD" 1) ("possible ACD" 1)))
 ("UP:Q96AP7" (("endothelial cell adhesion molecule" 16) ("ESAM" 1)))
 ("UP:Q96AQ7" (("CIDEC" 11)))
 ("UP:Q96AT9"
  (("RPE" 1022) ("macular RPE" 2) ("the RPE’s" 2) ("-RPE" 2)
   ("Etoposide-treated RPE" 1) ("normal RPE" 1) ("RPEs" 1) ("migratory RPE" 1)
   ("RPE-" 1) ("primary RPE" 1) ("abnormal RPE" 1)))
 ("UP:Q96AV8"
  (("E2F7" 264) ("E2F-7" 162) ("E2F-7 protein" 2) ("E2f7" 2)
   ("the repressive E2F7" 1) ("a typical mammalian E2F7" 1) ("E2F7 (WT)" 1)
   ("the transcriptional repressor E2F7" 1)))
 ("UP:Q96AX2" (("RAB37" 4))) ("UP:Q96AX9" (("MIB2" 50) ("Mib2" 4)))
 ("UP:Q96AY2" (("EME1" 88) ("Eme1" 21) ("Mms4" 5) ("mms4" 2) ("MMS4" 1)))
 ("UP:Q96AY4" (("Ttc28" 3) ("Tprbk" 1))) ("UP:Q96AZ1" (("METTL21B" 6)))
 ("UP:Q96AZ6" (("snRNAs" 49) ("ISG20" 3) ("isg20" 2) ("the major snRNAs" 1)))
 ("UP:Q96B01"
  (("RAD51AP1" 282) ("RAD51AP1 protein" 4) ("PIR51" 4) ("Rad51AP1" 3)
   ("RAD51AP1-" 3) ("than RAD51AP1" 1) ("-RAD51AP1" 1)
   ("RAD51 associated protein 1" 1) ("Rad51ap1" 1)
   ("RAD51 Associated Protein 1" 1)))
 ("UP:Q96B02" (("Ube2w" 149) ("UBE2W" 11) ("Ube2W" 6) ("dimeric Ube2w" 1)))
 ("UP:Q96B18" (("Dact3" 9) ("DACT3" 1)))
 ("UP:Q96B26" (("P9" 71) ("Rrp43" 3) ("P9 peptide" 2) ("EXOSC8" 1) ("OIP2" 1)))
 ("UP:Q96B33" (("claudin-23" 1)))
 ("UP:Q96B36"
  (("PRAS40" 883) ("PRAS40-" 31) ("pPRAS40" 21) ("P-PRAS40" 9) ("p-PRAS40" 7)
   ("AKT1S1" 6) ("Pras40" 6) ("pras40" 3) ("PRAS40 peptide" 2) ("Q96B36" 1)))
 ("UP:Q96B42" (("TMEM18" 13))) ("UP:Q96B49" (("TOM6" 1)))
 ("UP:Q96B67" (("ARRDC3" 4)))
 ("UP:Q96B70" (("LENG9" 4) ("leukocyte receptor cluster member 9" 2)))
 ("UP:Q96B86" (("RGM" 3) ("RGM domain family" 2)))
 ("UP:Q96B97"
  (("CIN85" 979) ("SH3KBP1" 9) ("CIN85 protein" 6) ("HSB1" 6)
   ("the endocytic regulator protein CIN85" 3)
   ("the endocytic adaptor protein CIN85" 2) ("Q96b97" 1)
   ("associated CIN85" 1) ("CIN85-" 1)))
 ("UP:Q96BA8"
  (("OASIS" 7) ("Oasis" 5) ("CREB3L1" 2)
   ("old astrocyte specifically induced substance" 1)))
 ("UP:Q96BD0" (("SLCO4A1" 11) ("member 4A1" 1))) ("UP:Q96BD5" (("BHC80" 2)))
 ("UP:Q96BD6" (("Ssb1" 12) ("SPSB1" 7) ("the ribosomal Hsp70 Ssb1" 2)))
 ("UP:Q96BD8" (("SKA" 36) ("Ska" 9) ("SKA1" 2) ("Ska1" 1)))
 ("UP:Q96BF6" (("NACC2" 1))) ("UP:Q96BH3" (("HE12" 38) ("E1/2" 1)))
 ("UP:Q96BI1" (("SLC22A18" 4))) ("UP:Q96BI3" (("APH1A" 3)))
 ("UP:Q96BJ3" (("AIDA" 13))) ("UP:Q96BJ8" (("ELMO3" 2)))
 ("UP:Q96BK5"
  (("PinX1" 328) ("PinX1 protein" 10) ("PINX1" 5) ("nucleolar PinX1" 1)))
 ("UP:Q96BN2" (("TADA1" 1)))
 ("UP:Q96BR1"
  (("SGK3" 259) ("Sgk3" 12) ("SGK-3" 3) ("Sgk3-" 3) ("regulated kinase 3" 2)
   ("p-SGK3" 2) ("pSGK3" 1) ("CISK" 1)
   ("serum/glucocorticoid regulated kinase 3" 1)))
 ("UP:Q96BT3" (("CENP-T" 13) ("Cenp-T" 1)))
 ("UP:Q96BT7" (("tRNA methyltransferase" 3) ("ALKBH8" 3)))
 ("UP:Q96BW5"
  (("PTER" 35) ("pTER" 17) ("pter" 11) ("the shRNA-expressing vector pTER" 2)
   ("pTER-" 1)))
 ("UP:Q96BY2"
  (("MOAP-1" 107) ("MOAP1" 4) ("MOAP1 protein" 3) ("MAP-1" 2)
   ("MOAP-1 protein" 1)))
 ("UP:Q96BY6" (("Dock10" 3) ("DOCK10" 2) ("Zizimin3" 1)))
 ("UP:Q96BY7" (("ATG2B" 6)))
 ("UP:Q96BZ9" (("TBC1 domain family" 1) ("TBC1D20" 1)))
 ("UP:Q96C00" (("ZBTB9" 2) ("Zinc finger and BTB domain containing 9" 2)))
 ("UP:Q96C03" (("MiD49" 2) ("SMCR7" 1)))
 ("UP:Q96C10"
  (("RLR" 98) ("RLRs" 70) ("LGP2" 12) ("RIG-I-like receptor" 7) ("RLR-" 2)
   ("DHX58" 1) ("RIG–I–like receptor" 1)))
 ("UP:Q96C19" (("WEHI-231" 10))) ("UP:Q96C57" (("C12orf43" 15) ("FLJ12448" 2)))
 ("UP:Q96C86" (("Hsl1" 50) ("decapping enzyme" 14) ("-Hsl1" 1) ("DCPS" 1)))
 ("UP:Q96C90" (("PNG" 25) ("pNG" 11) ("png" 1))) ("UP:Q96C92" (("SDCCAG3" 4)))
 ("UP:Q96CA5" (("livin" 20) ("BIRC7" 16) ("ML-IAP" 5) ("Livin" 5)))
 ("UP:Q96CB8" (("INTS12" 7))) ("UP:Q96CD0" (("FBXL8" 1)))
 ("UP:Q96CF2" (("CHMP4C" 19) ("Chmp4C" 1)))
 ("UP:Q96CH1" (("GPR146" 5) ("Gpr146" 1)))
 ("UP:Q96CJ1"
  (("traits" 2295) ("Traits" 54) ("quantitative traits" 38)
   ("related traits" 23) ("anthropometric traits" 17) ("mesenchymal traits" 14)
   ("behavioral traits" 11) ("Eaf2" 10) ("hematological traits" 9)
   ("subclinical atherosclerosis traits" 8) ("autistic traits" 7)
   ("ovarian CSC-like traits" 7) ("metabolic traits" 6)
   ("the quantitative traits" 6) ("diabetes-related quantitative traits" 6)
   ("phenotypic traits" 5) ("related metabolic traits" 5) ("skeletal traits" 5)
   ("“traits”" 5) ("these anthropometric traits" 5)
   ("six anthropometric traits" 4) ("biological traits" 4)
   ("five subclinical atherosclerosis traits" 4)
   ("other complex quantitative traits" 3) ("GIANT" 3) ("glycaemic traits" 3)
   ("functional traits" 3) ("Quantitative traits" 3) ("age-sensitive traits" 3)
   ("obesity-related quantitative traits" 3) ("polygenic traits" 3)
   ("reproductive traits" 3) ("the hematological traits" 3)
   ("medically relevant quantitative traits" 3) ("cognitive traits" 3)
   ("T2D-related quantitative traits" 3) ("glycaemic quantitative traits" 3)
   ("the phenotypic traits" 2) ("genetic traits" 2)
   ("highly aggressive traits" 2) ("various metabolic traits" 2)
   ("related phenotypic traits" 2) ("neuropsychological traits" 2)
   ("related neuropsychological traits" 2) ("complex phenotypic traits" 2)
   ("hematologic traits" 2) ("diverse age-sensitive traits" 2)
   ("the binary traits" 2) ("concurrent downstream traits" 2)
   ("desirable traits" 2) ("any quantitative traits" 2)
   ("cortical circuitry causing autistic traits" 2)
   ("two quantitative traits" 2) ("all common EMR-linked binary traits" 2)
   ("miR-1207–induced stem cell-like traits" 2) ("prediabetic traits" 2)
   ("CVD-related quantitative traits" 2) ("relevant quantitative traits" 2)
   ("secondary and tertiary traits" 2) ("one or more traits" 2)
   ("nine quantitative traits" 2) ("various skeletal traits" 2)
   ("multiple functional traits" 2) ("malignancy-associated traits" 2)
   ("quantitative or qualitative traits" 2) ("other circadian traits" 2)
   ("Such hematological traits" 2)
   ("affective state-independent personality traits" 2)
   ("these quantitative traits" 2) ("both normal traits" 2)
   ("antecedent traits" 2) ("diabetogenic traits" 2)
   ("quantitative glycemic traits" 2)
   ("either continuous quantitative traits" 2) ("those quantitative traits" 2)
   ("other behavioral traits" 2) ("the evaluated hematological traits" 2)
   ("anthropometric and related metabolic traits" 2) ("polymorphic traits" 2)
   ("trans-diagnostic traits" 2) ("CHIRP" 2) ("Behavioral Autism Traits" 2)
   ("glycemic traits" 2) ("several endometabolic traits" 2)
   ("Endometabolic Traits" 2) ("bone microstructural traits" 2)
   ("electrocardiographic (ECG) traits" 2)
   ("the three anthropometric traits" 2) ("three anthropometric traits" 2)
   ("The anthropometric traits" 1) ("the anthropometric traits" 1)
   ("reading traits" 1) ("other complex cognitive traits" 1)
   ("cardiovascular traits" 1) ("aggressive traits" 1) ("Subclinical traits" 1)
   ("diverse biologic traits" 1) ("CLL several biological traits" 1)
   ("medically important quantitative traits" 1)
   ("associated malignant traits" 1) ("endocrine phenotypic traits" 1)
   ("cardiovascular and metabolic traits" 1)
   ("all neuropsychological traits" 1) ("many other cognitive traits" 1)
   ("various neuropsychological traits" 1)
   ("the examined behavioural traits" 1) ("many behavioural traits" 1)
   ("particular behavioural traits" 1) ("epithelial traits" 1)
   ("metabolism related quantitative traits" 1) ("heritable traits" 1)
   ("migratory and invasive traits" 1) ("other glycemic traits" 1)
   ("secondary traits" 1) ("all previously reported glycemic traits" 1)
   ("given cognitive traits" 1) ("the cognitive traits" 1)
   ("human complex quantitative traits" 1) ("malignant traits" 1)
   ("multiple transformed traits" 1) ("several age-sensitive traits" 1)
   ("two binary traits" 1) ("cell adhesion and gain mesenchymal traits" 1)
   ("multiple behavioral traits" 1) ("other associated molecular traits" 1)
   ("oncogenic
RAS-mediated pro-malignant traits"
    1)
   ("Many such malignant traits" 1)
   ("multiple
malignant traits"
    1)
   ("several KRAS-driven pro-malignant traits" 1)
   ("quantitative clinical traits" 1) ("major traits" 1)
   ("other pubertal traits" 1) ("typical quantitative traits" 1)
   ("Downstream transformation-associated traits" 1)
   ("multiple sub-clinical traits" 1) ("sub-clinical traits" 1)
   ("improved glycemic traits" 1) ("the other phenotypic traits" 1)
   ("continuous traits" 1) ("other biological traits" 1)
   ("oestrogen-dependent traits" 1) ("the aggressive traits" 1)
   ("the CVD-related quantitative traits" 1)
   ("CVD related quantitative traits" 1)
   ("at least five obesity related traits" 1)
   ("disease-associated quantitative traits" 1) ("other quantitative traits" 1)
   ("these Mendelian traits" 1) ("any phenotypic traits" 1)
   ("both biological traits" 1) ("the associated phenotypic traits" 1)
   ("heritable quantitative traits" 1) ("CHD-related quantitative traits" 1)
   ("pre-diabetic and diabetic traits" 1) ("categorical traits" 1)
   ("the M2 biological traits" 1) ("inherited skeletal traits" 1)
   ("the typical traits" 1) ("qualitative traits" 1)
   ("the following reproductive traits" 1)
   ("androgenic or reproductive traits" 1) ("These Mendelian traits" 1)
   ("complex behavioral traits" 1) ("related clinical traits" 1)
   ("eight clinically relevant hematological traits" 1)
   ("clinically related mendelian traits" 1)
   ("Type 2 diabetes–related quantitative traits" 1)
   ("only quantitative traits" 1) ("the psychological traits" 1)
   ("psychological traits" 1) ("these psychometric traits" 1)
   ("diagnosis-related traits" 1) ("other ophthalmic traits" 1)
   ("both quantitative traits" 1) ("Skeletal traits" 1)
   ("several phenotypic traits" 1) ("many other antecedent traits" 1)
   ("clinically relevant traits" 1) ("two clinically relevant traits" 1)
   ("concordant traits" 1) ("Other concordant traits" 1)
   ("related quantitative glycemic traits" 1)
   ("other medically relevant quantitative traits" 1)
   ("several quantitative traits" 1) ("related quantitative traits" 1)
   ("medically relevant traits" 1) ("epigenetic traits" 1)
   ("such clinicopathological traits" 1) ("right-censored traits" 1)
   ("diabetes-related intermediary traits" 1) ("the three broad traits" 1)
   ("bipolar traits" 1) ("other common behavioral traits" 1)
   ("Baseline clinicopathologic traits" 1) ("other clinicopathologic traits" 1)
   ("these hematologic traits" 1) ("other hematological traits" 1)
   ("multiple cardiometabolic traits" 1) ("the respective traits" 1)
   ("selectable traits" 1) ("genetically complex traits" 1)
   ("high level Notch activation exhibited tumor suppressive traits" 1)
   ("dysthymic and hyperthymic traits" 1)
   ("traits, produced three GW significant results on chromosomes 12 and 22 in the double minute 1 ( MDM1 )"
    1)
   ("exuberant, upbeat, over-energetic, and overconfident lifelong traits" 1)
   ("subclinical affective traits" 1)
   ("a few other
traits"
    1)
   ("several metabolic traits" 1) ("other metabolic traits" 1)
   ("relevant glycemic traits" 1) ("relevant quantitative glycemic traits" 1)
   ("baseline log-transformed traits" 1) ("the behavioral traits" 1)
   ("analyzed behavioral traits" 1) ("various psychiatric traits" 1)
   ("binary traits" 1) ("psychiatric traits" 1) ("normative traits" 1)
   ("traits (CHIRP)" 1) ("invasive traits" 1) ("greater autistic traits" 1)
   ("The heterogeneous phenotypical and molecular traits" 1)
   ("their associated traits" 1) ("demographic traits" 1)
   ("most quantitative traits" 1) ("often correlated quantitative traits" 1)
   ("miR-29b promoted mesenchymal traits" 1) ("gly-caemic traits" 1)
   ("glyacemic traits" 1) ("distinct phenotypic traits" 1)
   ("the subclinical atherosclerosis traits" 1)
   ("multiple autoimmune phenotypic traits" 1) ("multi-genetic traits" 1)
   ("self-reported migraine traits" 1)))
 ("UP:Q96CS3" (("UBXD8" 18) ("FAF2" 16) ("UbxD8" 10) ("ETEA" 1)))
 ("UP:Q96CS7" (("PLEKHB2" 1)))
 ("UP:Q96CV9"
  (("optineurin" 354) ("Optn" 221) ("OPTN" 81) ("Optineurin" 41)
   ("NEMO-Related Protein" 6) ("NEMO-related protein" 4) ("GLC1E" 3) ("optn" 3)
   ("FIP2" 3) ("FIP-2" 2) ("substantially less optineurin D474N" 2)
   ("E3-14.7K-interacting protein" 1) ("optineurin protein" 1)
   ("Nemo related protein" 1) ("optineurin ( OPTN )" 1)
   ("optineurin (OPTN)" 1)))
 ("UP:Q96CW1" (("AP2M1" 23)))
 ("UP:Q96CW5"
  (("γ-tubulin" 818) ("the centrosomal marker γ-tubulin" 5)
   ("centrosomal γ-tubulin" 4) ("γ–tubulin" 4) ("γ-tubulin protein" 4)
   ("centrosomal marker γ-tubulin" 3) ("more γ-tubulin" 2) ("GCP3" 2)
   ("mouse monoclonal γ-tubulin" 1) ("Cellular γ-tubulin" 1) ("TUBGCP3" 1)
   ("Spindle-associated γ-tubulin" 1) ("large and small γ-tubulin" 1)
   ("study γ-tubulin's" 1)))
 ("UP:Q96CX2" (("KCTD12" 10))) ("UP:Q96CX6" (("LRRC58" 1)))
 ("UP:Q96D03" (("REDD2" 10) ("DDIT4L" 3))) ("UP:Q96D09" (("GASP2" 9)))
 ("UP:Q96D21" (("Rhes" 79) ("striatal Rhes" 1)))
 ("UP:Q96D31" (("Orai1" 123) ("ORAI1" 54) ("caveolar Orai1" 7)))
 ("UP:Q96D37" (("proto-oncogene Vav" 3) ("VAV1 protein" 1)))
 ("UP:Q96D42"
  (("Tim-1" 203) ("HAVCR1" 16) ("TIM-1" 9) ("KIM-1" 7)
   ("hepatitis A virus cellular receptor 1" 3)
   ("the highly O-glycosylated membrane-protein hepatitis A virus cellular receptor 1"
    2)
   ("TIMs" 1) ("HAVcr1" 1)))
 ("UP:Q96D46" (("NMD3" 5))) ("UP:Q96D59" (("RNF183" 1)))
 ("UP:Q96D71"
  (("REPS1" 6) ("Reps1" 1) ("the highly homologous human protein REPS1" 1)))
 ("UP:Q96DA2" (("RAB39B" 5))) ("UP:Q96DA6" (("member 19" 2) ("DNAJC19" 1)))
 ("UP:Q96DB2"
  (("HDAC11" 320) ("HD11" 7) ("histone deacetylase 11" 4)
   ("less HDAC11 protein" 2) ("HDAC11 protein" 1)
   ("the haematopoietic cell line HD11" 1)))
 ("UP:Q96DB9"
  (("dysadherin" 89) ("Dysadherin" 17) ("FXYD5" 6) ("‘dysadherin'" 2)
   ("the in situ ductal carcinoma dysadherin" 1)
   ("lobular carcinoma dysadherin" 1)))
 ("UP:Q96DC9" (("OTUB2" 9) ("otubain2" 2) ("Q96DC9" 1)))
 ("UP:Q96DE5"
  (("APC16" 122) ("CENP-27" 7) ("-APC16" 1) ("that APC16’s" 1)
   ("chromosome 10 open reading frame 104" 1)))
 ("UP:Q96DF8" (("ES2" 118) ("parental ES2" 1)))
 ("UP:Q96DH6"
  (("MSI2" 62) ("Musashi-2" 11) ("Musashi 2" 2) ("Msi2" 1) ("Musashi2" 1)))
 ("UP:Q96DN2" (("URG11" 138) ("URG11 protein" 1))) ("UP:Q96DN6" (("MBD6" 1)))
 ("UP:Q96DP5" (("FMT" 17))) ("UP:Q96DR4" (("STARD4" 3)))
 ("UP:Q96DR7" (("SGEF" 49))) ("UP:Q96DR8" (("MUCL1" 1)))
 ("UP:Q96DS6" (("MS4A6E" 1))) ("UP:Q96DT0" (("GRIP-1" 30)))
 ("UP:Q96DT6" (("Atg4c" 3) ("ATG4C" 2) ("Atg4C" 1) ("ATG4c" 1)))
 ("UP:Q96DT7" (("ZBTB10" 47) ("zinc finger and BTB domain containing 10" 3)))
 ("UP:Q96DU3"
  (("NTB-A" 202) ("KALI" 12) ("NTB-A molecule" 8) ("activating NK receptor" 5)
   ("SLAMF6" 3) ("KALIb" 2) ("NTB-A–" 2) ("NK-T-B-antigen" 2)
   ("NTB-A Molecule" 2) ("Slamf6" 1)))
 ("UP:Q96DU7"
  (("ITPKC" 36) ("rs28493229" 26)
   ("inositol 1,4,5-trisphosphate 3-kinase C" 2)))
 ("UP:Q96DX5" (("ASB9" 1) ("Asb9" 1))) ("UP:Q96DX7" (("MC7" 2) ("TRIM44" 1)))
 ("UP:Q96DX8" (("RTP4" 2))) ("UP:Q96DY7" (("Mtbp" 151) ("MTBP" 73)))
 ("UP:Q96DZ1" (("XTP3-B" 5) ("ERLEC1" 1)))
 ("UP:Q96DZ5" (("CLIPR-59" 141) ("CLIP-170-related" 3) ("than CLIPR-59" 1)))
 ("UP:Q96E11" (("RRF" 1))) ("UP:Q96E14" (("RMI2" 3) ("BLAP18" 1)))
 ("UP:Q96E17" (("Rab3C" 5)))
 ("UP:Q96E22" (("NgBR" 134) ("than NgBR in IDC" 1)))
 ("UP:Q96E29" (("MTERFD1" 1) ("mTERF3" 1))) ("UP:Q96E39" (("RBMXL1" 1)))
 ("UP:Q96E52" (("Oma-1" 2)))
 ("UP:Q96E93"
  (("KLRG1" 344) ("2F1" 58) ("killer cell lectin-like receptor subfamily G" 6)
   ("Mafa" 3) ("Alexa Fluor 488-conjugated KLRG1" 2) ("more KLRG1" 1)
   ("naive CD4 + KLRG1" 1) ("mast cell function-associated antigen" 1)
   ("most KLRG1" 1)))
 ("UP:Q96EA4" (("spindly" 7) ("protein Spindly" 4)))
 ("UP:Q96EB1" (("Elp4" 11)))
 ("UP:Q96EB6"
  (("SIRT1" 18881) ("Sirt1" 2297) ("SirT1" 688) ("SIRT1 protein" 255)
   ("sirtuin 1" 151) ("hSIRT1" 144) ("Sir2p" 102) ("Sirtuin 1" 98)
   ("Sirt 1" 97) ("75SirT1" 92) ("SIRT 1" 48) ("Sirt1 protein" 35)
   ("SIRT1-" 26) ("Sirtuin1" 23) ("sirt1" 21) ("SIRT-1" 16) ("sirtuin1" 15)
   ("-SIRT1" 11) ("exogenous SIRT1" 10) ("overexpressed SIRT1" 9)
   ("cellular SIRT1" 8) ("Overexpressed SIRT1" 6) ("hSirT1" 6)
   ("silent mating type information regulator 2 homolog 1" 6) ("SIRT1−" 6)
   ("overexpressed Sirt1" 5) ("hSir2" 5) ("sirT1" 5)
   ("NAD-dependent deacetylase sirtuin-1" 4) ("phospho-mimetic SIRT1 S682D" 4)
   ("Sir2p protein" 4) ("Sirt1-" 3) ("SIRT1 STOP" 3) ("Sirt-1" 3)
   ("than SIRT1" 3) ("our previously identified SIRT1" 3) ("hSIRT1 protein" 3)
   ("overexpressed SIRT1 protein" 3) ("overexpressed cytoplasmic SIRT1" 3)
   ("SirT1s" 3) ("rabbit monoclonal anti-human SIRT1" 3)
   ("flag-tagged Sirt1" 2) ("glomerular Sirt1" 2)
   ("NAD-dependent deacetylase Sirtuin-1" 2)
   ("a minimally functional hSIRT1" 2) ("sirtuin 1 protein" 2)
   ("more SIRT1 protein" 2) ("“SIRT1”" 2) ("SIRTUIN 1" 2) ("SIRTUIN1" 2)
   ("the anti-SIRT1 2G1/F7 mouse monoclonal IgG 1 recognized SIRT1" 2)
   ("hypothalamic SIRT1" 2) ("the N-terminally intact SirT1" 2)
   ("Silent mating type information regulator 2 homolog 1" 2)
   ("normal, knocked down, or overexpressed SIRT1" 2)
   ("targeting human SirT1" 2) ("commercial SIRT1" 2)
   ("35 S-Methionine-labeled SIRT1 protein" 1) ("the SIRT1’s" 1) ("pSirt1" 1)
   ("renal tubular Sirt1" 1) ("renal Sirt1" 1) ("nude mice confirmed SIRT1" 1)
   ("than Sirt1 [ xref , xref , xref ]" 1)
   ("cardiac aging, and targeting Sirt1" 1) ("the Sirt1’s" 1)
   ("the possible role SIRT1" 1) ("a dominant-negative SIRT1 protein" 1)
   ("using soluble recombinant SIRT1" 1) ("other SIRT1's" 1)
   ("expressed exogenous wild-type SIRT1" 1) ("residual SIRT1" 1)
   ("healthy fibroblasts SIRT1" 1) ("Q96EB6" 1)
   ("We first knocked down SIRT1" 1) ("placental SIRT1" 1)
   ("mouse monoclonal SIRT1" 1) ("phosphorylation-mimetic SIRT1 S27D" 1)
   ("phosphorylation-mimetic SIRT1 S682D" 1) ("cortical SIRT1" 1)
   ("possible SIRT1" 1) ("that SIRT1's" 1)
   ("a human complementary DNA (cDNA) library using SIRT1" 1)
   ("endothelial SIRT1" 1)
   ("SIRT1
                            protein"
    1)
   ("transfection abolished SirT1's" 1) ("the broad SIRT1" 1)
   ("Flag-HA-tagged SIRT1" 1) ("histone-promoter-associated SIRT1" 1)
   ("functional SIRT1" 1) ("Our previous findings display SirT1" 1)
   ("the endogenous N-terminally intact SirT1" 1) ("We first examined SIRT1" 1)
   ("exogenous SIRT1 protein" 1) ("transfected exogenous SIRT1" 1)
   ("than endogenous mouse SIRT1" 1) ("than SIRT1 H363Y" 1) ("SIRT1 (AROS)" 1)
   ("the classical route SIRT1" 1) ("vascular SIRT1" 1)
   ("a dominant-negative SIRT1" 1) ("trimeric Sirt1" 1)
   ("the NAD-dependent deacetylase SIRT1" 1) ("pure SIRT1" 1)
   ("normal SIRT1" 1)))
 ("UP:Q96ED9" (("Hook2" 1) ("hook2" 1)))
 ("UP:Q96EE3" (("Seh1" 27) ("Nucleoporin Seh1" 2)))
 ("UP:Q96EF6" (("FBXO17" 3)))
 ("UP:Q96EK4" (("THAP11" 158) ("soluble THAP11" 1)))
 ("UP:Q96EK6" (("GNPNAT1" 1)))
 ("UP:Q96EN8"
  (("MCS" 170) ("HMCs" 36) ("MOS" 26) ("hMCs" 15) ("MOCOS" 3)
   ("Primary hMCs" 1) ("pMCS" 1)))
 ("UP:Q96EP0"
  (("RNF31" 169) ("HOIP" 74) ("The atypical E3 ubiquitin ligase RNF31" 3)
   ("ZIBRA" 2) ("ring finger protein 31" 2)))
 ("UP:Q96EP1"
  (("CHFR" 352) ("Chfr" 246) ("Chfr protein" 45) ("CHFR protein" 8)
   ("the CHFR's" 1) ("The P5L/I9H-specific interactor CHFR" 1)))
 ("UP:Q96EP5" (("DAZAP1" 50))) ("UP:Q96EQ8" (("RNF125" 5)))
 ("UP:Q96ES7" (("CCDC101" 1))) ("UP:Q96EU7" (("Cosmc" 10)))
 ("UP:Q96EV8"
  (("DTNBP1" 16) ("dysbindin-1" 9) ("dystrobrevin binding protein 1" 5)
   ("Dysbindin-1" 1)))
 ("UP:Q96EW2" (("HSPBAP1" 3)))
 ("UP:Q96EY1"
  (("hTid-1" 171) ("hTid" 46) ("Tid1" 29) ("Tid-1" 7) ("DNAJA3" 3)
   ("Tid1 protein" 2) ("TID1" 2) ("hTid1" 2) ("hTid1-" 1)))
 ("UP:Q96EY5" (("MVB12A" 3) ("CFBP" 1))) ("UP:Q96EY8" (("Cob" 1)))
 ("UP:Q96EZ4" (("MYEOV" 3) ("Myeloma overexpressed" 2)))
 ("UP:Q96EZ8" (("MSP58" 1)))
 ("UP:Q96F07"
  (("CYFIP2" 122) ("PIR121" 12) ("Cyfip2" 3) ("CYFIP2-" 2)
   ("Cytoplasmic FMR1 interacting protein 2" 2) ("Pir121" 1)
   ("CYFIP2 protein" 1)))
 ("UP:Q96F10" (("SSAT2" 6))) ("UP:Q96F15" (("IAN5" 109) ("gimap5" 2)))
 ("UP:Q96F24"
  (("NRBF2" 303) ("Nrbf2" 7) ("residual NRBF2" 2) ("NRBF2 protein" 2)
   ("exogenous NRBF2" 1)))
 ("UP:Q96F44" (("TRIM11" 133) ("tripartite motif containing 11" 1)))
 ("UP:Q96F46"
  (("IL-17RA" 19) ("IL-17R" 11) ("interleukin 17 receptor" 1)
   ("interleukin 17 receptor A" 1) ("IL17RA" 1)))
 ("UP:Q96F86" (("EDC3" 4)))
 ("UP:Q96FA3"
  (("Prism" 3404) ("PRISM" 784) ("prism" 87)
   ("the statistical software GraphPad Prism" 3)
   ("the Fluorescent Capillary System ABI PRISM" 2)
   ("the statistical software program GraphPad Prism" 2)
   ("the commercial programme GraphPad PRISM" 1) ("using GraphPad Prism" 1)
   ("GraphPad Prism4" 1) ("a hemicylindrical prism" 1)
   ("two-tailed GraphPad Prism" 1)
   ("the statistical software GraphPad Prism 5" 1)))
 ("UP:Q96FE5" (("Lingo-1" 5) ("LiNGO1" 1)))
 ("UP:Q96FE7"
  (("PIK3IP1" 3) ("Phosphoinositide-3-kinase interacting protein 1" 2)))
 ("UP:Q96FF9" (("CDCA5" 4)))
 ("UP:Q96FI4"
  (("NEIL1" 222) ("Neh1" 8) ("Neil1" 7) ("NEIL1 (NEB)" 5) ("NEIL1-" 2)
   ("the C-terminal-100 amino acids of NEIL1" 1)))
 ("UP:Q96FJ0"
  (("AMSH-LP" 6) ("STAMBPL1" 3)
   ("the homologous de-ubiquitinating enzyme AMSH-LP" 2)))
 ("UP:Q96FL8" (("SLC47A1" 16) ("multidrug and toxin extrusion protein 1" 4)))
 ("UP:Q96FL9" (("GALNT14" 2)))
 ("UP:Q96FM1" (("PERLD1" 13) ("PGAP3" 4) ("MGC9753" 1)))
 ("UP:Q96FQ6" (("S100A16" 1))) ("UP:Q96FS4" (("SIPA1" 3)))
 ("UP:Q96FT9" (("IFT43" 5))) ("UP:Q96FV9" (("THOC1" 7) ("THO1" 1)))
 ("UP:Q96FW1"
  (("OTUB1" 311) ("Otub1" 63) ("OTU domain" 20) ("Otub1 protein" 8)
   ("Otubain-1" 6) ("Otu1" 3) ("The catalytic cysteine of OTUB1" 2)
   ("ubiquitin aldehyde binding 1" 2) ("-OTUB1" 1) ("Q96FW1" 1)))
 ("UP:Q96FX8" (("PERP" 53) ("Perp" 4) ("perp" 1) ("PIGPC1" 1)))
 ("UP:Q96FZ5" (("CMTM7" 3) ("Cmtm7" 2)))
 ("UP:Q96FZ7" (("CHMP6" 64) ("VPS20" 3) ("Vps20" 2)))
 ("UP:Q96G01" (("BICD1" 9)))
 ("UP:Q96G23" (("LASS2" 3) ("ceramide synthase 2" 1)))
 ("UP:Q96G30" (("MRAP2" 2))) ("UP:Q96G61" (("NUDT11" 2)))
 ("UP:Q96G74"
  (("OTUD5" 103) ("DUBA" 25) ("deubiquitinating enzyme A" 3)
   ("OTUD5 protein" 1) ("Q96G74" 1)))
 ("UP:Q96G75" (("RMND5B" 1))) ("UP:Q96G91" (("P2Y11" 5) ("P2RY11" 1)))
 ("UP:Q96G97" (("BSCL2" 2))) ("UP:Q96GC6" (("ZF2" 11)))
 ("UP:Q96GC9" (("TMEM49" 21) ("VMP1" 14)))
 ("UP:Q96GD0"
  (("CIN" 1444) ("numerical CIN" 4) ("PDXP" 4) ("Cin" 3) ("‘structural’ CIN" 2)
   ("intercellular CIN" 2)
   ("41/57 (72%) BRAF mutant, and 74/90 (82%) BRAF wild type showing CIN" 2)
   ("typically lack CIN" 1) ("genome-wide CIN" 1) ("than grade I CIN" 1)
   ("survivable CIN" 1)))
 ("UP:Q96GD3" (("SCMH1" 3) ("Scmh1" 1)))
 ("UP:Q96GD4"
  (("Aurora-B" 171) ("AURKB" 107) ("ARK-2" 43) ("aurora-B" 37)
   ("Aurora kinase B" 29) ("Aurkb" 10) ("AIM1" 8) ("Ipl1" 5)
   ("aurora kinase B" 4) ("AIM-1" 4) ("AuroraB" 3)
   ("flag-tagged wild-type Aurora-B" 2) ("multipolar mitoses aurora-B" 1)
   ("Aurora Kinase B" 1) ("Aurora-1" 1) ("ARK2" 1) ("AIK2" 1) ("aurkb" 1)
   ("aurora-related kinase 2" 1)))
 ("UP:Q96GF1" (("RNF185" 2))) ("UP:Q96GG9" (("DCUN1D1" 10)))
 ("UP:Q96GM5" (("SMARCD1" 39) ("BAF60a" 11) ("Baf60a" 4) ("subfamily d" 2)))
 ("UP:Q96GN5"
  (("R 1" 50) ("R  1" 41) ("HR1" 25) ("CDCA7L" 21) ("Hr1" 5) ("JPO2" 3)
   ("d B A R D 1 R 1" 1)))
 ("UP:Q96GR2" (("bubblegum" 1))) ("UP:Q96GU1" (("page 5" 2)))
 ("UP:Q96GW9" (("MARS2" 4)))
 ("UP:Q96GX1"
  (("Tctn2" 30) ("TCTN2" 16) ("type 8" 11) ("Tectonic2" 10) ("Type 8" 2)))
 ("UP:Q96GX5"
  (("GW" 246) ("MASTL" 106) ("Gwl" 13) ("-GW" 5) ("gw" 4) ("pGW" 4) ("GWL" 3)
   ("that Gwl's" 1)))
 ("UP:Q96GX9" (("APIP" 2))) ("UP:Q96GY3" (("LIN37" 6) ("Lin37" 2)))
 ("UP:Q96H12" (("MSANTD3" 2))) ("UP:Q96H15" (("Tim-4" 4)))
 ("UP:Q96H22" (("CENP-N" 1))) ("UP:Q96H72" (("SLC39A13" 1)))
 ("UP:Q96H96" (("COQ2" 6))) ("UP:Q96HA1" (("POM121" 3) ("Pom121" 1)))
 ("UP:Q96HA7" (("NFKBIL2" 95) ("TONSL" 1))) ("UP:Q96HA9" (("PEX11G" 4)))
 ("UP:Q96HC4" (("enh" 11) ("Enh" 6) ("PDLIM5" 2)))
 ("UP:Q96HE7" (("Ero1-Lα" 6) ("Ero1L" 4)))
 ("UP:Q96HF1"
  (("SFRP2" 36) ("Sfrp-2" 10) ("sFRP2" 10) ("SFRP-2" 5)
   ("Secreted frizzled-related protein 2" 2)
   ("secreted frizzled-related protein 2" 2)))
 ("UP:Q96HH4" (("tmem169" 1))) ("UP:Q96HH6" (("TMEM19" 1)))
 ("UP:Q96HI0" (("SENP5" 34))) ("UP:Q96HJ3" (("CCDC34" 1)))
 ("UP:Q96HJ5" (("MS4A3" 4)))
 ("UP:Q96HL8"
  (("rays" 321) ("-rays" 44) ("Rays" 4) ("the Galactic Cosmic Rays" 3)
   ("cosmic rays" 3) ("-Rays" 2) ("UV rays" 2) ("SH3YL1" 2)
   ("In fact γ -rays" 1)))
 ("UP:Q96HN2" (("KIAA0828" 1))) ("UP:Q96HP0" (("DOCK6" 11) ("Dock6" 6)))
 ("UP:Q96HP8" (("TMEM176A" 1))) ("UP:Q96HR3" (("THRAP6" 1)))
 ("UP:Q96HS1"
  (("PGAM5" 191) ("hPGAM5" 21) ("phosphoglycerate mutase family member 5" 5)
   ("Pgam5" 1)))
 ("UP:Q96HU1"
  (("RabGAP-5" 19) ("SGSM3" 13) ("RabGAP5" 2) ("RabGap-5" 1)
   ("small G protein signaling modulator 3" 1)))
 ("UP:Q96HU8" (("DIRAS2" 3) ("diras2" 1)))
 ("UP:Q96HW7" (("INTS4" 5) ("Int4" 4))) ("UP:Q96HZ4" (("HES6" 230) ("Hes6" 3)))
 ("UP:Q96I15" (("SCLY" 1)))
 ("UP:Q96I23"
  (("prey" 625) ("prey protein" 44) ("Prey" 21) ("“prey”" 12)
   ("“prey” protein" 4) ("\"prey\"" 4) ("‘prey’ protein" 4) ("‘prey’" 3)
   ("prey peptide" 3) ("“Prey” protein" 2) ("“Prey”" 2)
   ("the respective prey protein" 2) ("a relatively long prey protein" 2)
   ("a representative biological prey" 2) ("log 2 -transformed prey" 1)
   ("prey
protein"
    1)
   ("a two-hybrid prey" 1) ("Most prey" 1) ("a peroxisomal prey" 1)
   ("the phagocytic prey" 1)))
 ("UP:Q96I24" (("FBP3" 80)))
 ("UP:Q96I25" (("RBM17" 8) ("SPF45" 6) ("RNA binding motif protein 17" 2)))
 ("UP:Q96I34" (("MYPT3" 1)))
 ("UP:Q96IF1"
  (("Ajuba" 325) ("JUB" 7) ("ajuba" 6) ("AJUBA" 3) ("JuB" 2)
   ("a nonphosphorylatable Ajuba" 2) ("Jub" 1) ("phosphomimetic Ajuba" 1)))
 ("UP:Q96IG2" (("FBXL20" 14) ("FBL2" 3)))
 ("UP:Q96IK0" (("transmembrane protein 101" 4) ("TMEM101" 1)))
 ("UP:Q96IK1" (("Bod1" 5) ("BOD1" 4))) ("UP:Q96IP4" (("FAM46A" 6)))
 ("UP:Q96IU2" (("ZBED3" 4)))
 ("UP:Q96IV0"
  (("fmk" 377) ("FMK" 234) ("PNGase" 36) ("-FMK" 21) ("-fmk" 18) ("PNgase" 6)
   ("Fmk" 4) ("Peptide-N" 3) ("10 μM Z-LE(OMe)HD(OMe)-FMK" 2)
   ("Z-Leu-Glu(OMe)-Thr-Asp(OMe)-fmk" 1) ("Z-LE(Ome)HD(Ome)-FMK (LEHD)" 1)
   ("NGly1" 1)))
 ("UP:Q96IW2" (("SHD" 5) ("Shd" 1))) ("UP:Q96IX5" (("Usmg5" 1)))
 ("UP:Q96IY4"
  (("CPU" 14) ("CPB2" 7) ("carboxypeptidase B2" 3) ("PCPB" 1) ("pCPB2" 1)))
 ("UP:Q96IZ0"
  (("Par-4" 368) ("PAWR" 17) ("Par-4 protein" 16) ("Par4" 8)
   ("a human T-ALL cell cDNA library using Par-4" 1)
   ("pro-apoptotic gene Par-4" 1) ("PAR 4" 1) ("par4" 1) ("Par4-" 1)))
 ("UP:Q96IZ7" (("RSRC1" 2))) ("UP:Q96J01" (("TEX1" 1)))
 ("UP:Q96J02"
  (("Itch" 484) ("ITCH" 331) ("itch" 44) ("pitch" 16) ("Itch/AIP4" 13)
   ("NaPP1" 7) ("helical pitch" 2) ("half helical pitch" 2)
   ("an intractable itch" 2) ("normal half helical pitch" 1)
   ("shorter helical pitch" 1) ("Itch-" 1)
   ("the enzymatically competent ITCH" 1) ("ITCH protein" 1) ("-Itch" 1)
   ("the ligase activity defective Itch" 1)))
 ("UP:Q96J65" (("MRP9" 3) ("ABCC1/2" 1))) ("UP:Q96J66" (("ABCC11" 1)))
 ("UP:Q96J84" (("Neph1" 3))) ("UP:Q96J88" (("EPSTI1" 1)))
 ("UP:Q96J92" (("WNK4" 4)))
 ("UP:Q96J94"
  (("PIWIL1" 61) ("piwil1" 15) ("Piwil1" 3) ("PIWIL1 protein" 2) ("Hiwi" 1)
   ("HIWI" 1)))
 ("UP:Q96JA1"
  (("LRIG1" 430) ("LRIG-1" 8) ("–LRIG1" 6) ("LRIG1 protein" 4)
   ("residual LRIG1" 2) ("inherent LRIG1" 1) ("soluble LRIG-1" 1)
   ("less LRIG1" 1) ("more LRIG1" 1) ("Lrig1" 1)))
 ("UP:Q96JB3" (("HIC2" 2)))
 ("UP:Q96JB5"
  (("LZAP" 245) ("Cdk5rap3" 5) ("CDK5RAP3" 1) ("most data highlights LZAP" 1)))
 ("UP:Q96JC1" (("Vps39" 1)))
 ("UP:Q96JC9" (("eaf-1" 45) ("EAF1" 7) ("EAF-1 protein" 2) ("EAF-1" 1)))
 ("UP:Q96JD6" (("testis specific protein" 3))) ("UP:Q96JE7" (("SEC16B" 2)))
 ("UP:Q96JE9"
  (("stop" 1311) ("Stop" 224) ("“stop”" 25) ("a premature stop" 5) ("MAP6" 2)
   ("Eventually cells stop" 1) ("no discernible effects onEF Stop" 1)
   ("premature translational stop" 1) ("‘stop’" 1) ("a temporary stop" 1)
   ("a Dual Luciferase Stop" 1) ("shorter telomeres stop" 1)))
 ("UP:Q96JF0" (("ST6GAL2" 1))) ("UP:Q96JG9" (("ZNF469" 16)))
 ("UP:Q96JH7" (("VCPIP1" 5) ("VCIP135" 2) ("deubiquitinating protein" 1)))
 ("UP:Q96JH8"
  (("Radil" 225) ("Radil-" 10) ("RADIL" 5) ("Radil protein" 4)
   ("than Radil ( xref )" 1)))
 ("UP:Q96JI7" (("SPG11" 5))) ("UP:Q96JJ3" (("ELMO2" 103) ("Elmo2" 1)))
 ("UP:Q96JJ6" (("JP4" 10) ("JPH4" 4))) ("UP:Q96JK2" (("WDR22" 3)))
 ("UP:Q96JK4" (("HHIPL1" 2))) ("UP:Q96JK9" (("MAML3" 2) ("Maml3" 1)))
 ("UP:Q96JN0" (("LCoR" 6))) ("UP:Q96JN8" (("NEURL4" 8)))
 ("UP:Q96JQ0" (("Fib1" 3) ("CDH19" 2) ("Dchs1" 1)))
 ("UP:Q96JQ5" (("MS4A4A" 1))) ("UP:Q96JS3" (("PGBD1" 1)))
 ("UP:Q96JT2" (("SLC45A3" 16) ("prostein" 4) ("Prostein" 1)))
 ("UP:Q96JW4" (("SLC41A2" 1))) ("UP:Q96JY0" (("MAEL" 1)))
 ("UP:Q96JY6"
  (("PDLIM2" 83) ("pdlim2" 4) ("PDZ and LIM domain 2" 1)
   ("exogenous PDLIM2" 1)))
 ("UP:Q96K58"
  (("ZNF668" 224) ("zinc finger protein 668" 7) ("ZNF668 protein" 6)
   ("ZNF668-" 6)
   ("a hypothetical protein (FLJ13479) later named zinc finger protein 668" 2)
   ("mediating ZNF668's" 1) ("FLJ13479" 1)))
 ("UP:Q96K76" (("USP47" 190) ("USP47-" 1))) ("UP:Q96K80" (("ZC3H10" 1)))
 ("UP:Q96K83"
  (("zinc finger protein 521" 2) ("Zinc finger protein 521" 2) ("lip3" 1)
   ("ZNF521" 1)))
 ("UP:Q96KA5" (("CLPTM1L" 457) ("CRR9" 19) ("CRR9p" 4) ("CLPTM1L protein" 2)))
 ("UP:Q96KB5"
  (("TOPK" 235) ("PBK" 25) ("pBK" 23) ("T-cell-originated protein kinase" 14)
   ("evaluable TOPK" 3) ("non-degradable TOPK" 2) ("PDZ binding kinase" 1)
   ("T-cell-originated protein kinase (TOPK)" 1) ("Pbk" 1)))
 ("UP:Q96KC2" (("Arl8" 2))) ("UP:Q96KF2" (("PRAC" 2)))
 ("UP:Q96KG7" (("MEGF10" 181) ("overexpressed MEGF10" 2) ("MEGF10 protein" 2)))
 ("UP:Q96KG9"
  (("TRAP" 664) ("SCYL1" 71) ("TRAP-" 6) ("CVAK90" 5)
   ("the osteoclastic biochemical markers TRAP" 2) ("the most TRAP" 2)
   ("NTKL" 2) ("TRAP peptide" 2) ("-TRAP" 1) ("than traditional TRAP" 1)
   ("traditional TRAP" 1) ("Previous real-time quantitative TRAP" 1)
   ("the traditional TRAP" 1) ("The traditional TRAP" 1)))
 ("UP:Q96KK3" (("delayed-rectifier" 2))) ("UP:Q96KN1" (("FAM84B" 8)))
 ("UP:Q96KN2" (("CN1" 3) ("cN1" 1))) ("UP:Q96KN8" (("HRLP5" 3)))
 ("UP:Q96KN9" (("Delta 4" 2)))
 ("UP:Q96KP1"
  (("Sec5" 642) ("EXOC2" 51) ("Sec5p" 6) ("exocyst complex component 2" 6)
   ("Sec5 protein" 3) ("sec5" 3) ("SEC5L1" 2) ("SEC5" 2) ("Sec5-" 1)
   ("a compensatory Sec5 point mutation" 1) ("Exocyst complex component 2" 1)))
 ("UP:Q96KP4" (("peptidase A" 2) ("CN2" 2) ("PepA" 1) ("CNDP2" 1)))
 ("UP:Q96KP6" (("Lind" 10) ("TNIP3" 1))) ("UP:Q96KQ4" (("ASPP1" 53)))
 ("UP:Q96KQ7"
  (("H3K9" 874) ("G9a" 498) ("G9A" 16) ("G9a-" 13) ("EHMT2" 7) ("KMT1C" 4)
   ("H3K9 peptide" 3) ("G9a protein" 3) ("whose G9a" 2)
   ("the repressive histone markers H3K9" 1) ("H3K9-" 1)
   ("its heterodimeric partner G9a" 1)))
 ("UP:Q96KR1" (("ZFR" 1)))
 ("UP:Q96KR4"
  (("GP63" 268) ("GP63 protein" 21) ("L. major GP63" 7)
   ("parasite-free soluble GP63" 1) ("soluble GP63" 1)))
 ("UP:Q96KS0" (("PHD1" 83) ("EGLN2" 2)))
 ("UP:Q96KS9" (("C8orf13" 82) ("FAM167A" 21) ("C8orf13-" 1)))
 ("UP:Q96L03" (("SPATA17" 2))) ("UP:Q96L12" (("CALR3" 1)))
 ("UP:Q96L15" (("Art5" 1)))
 ("UP:Q96L33" (("RhoV" 26) ("Wrch2" 1) ("–RhoV14" 1)))
 ("UP:Q96L34" (("MARK4" 34) ("Mark4" 5) ("Par1d" 1) ("MARK-4" 1)))
 ("UP:Q96L42" (("KCNH8" 21))) ("UP:Q96L58" (("polypeptide 6" 7)))
 ("UP:Q96L73" (("NSD1" 41) ("Nsd1" 4)))
 ("UP:Q96L91"
  (("p400" 389) ("EP400" 8) ("Ep400" 7) ("P400" 4) ("Swi2/Snf2" 3)
   ("p400 protein" 3) ("explaining p400’s" 1)))
 ("UP:Q96L92" (("SNX27" 3) ("sorting nexin 27" 1)))
 ("UP:Q96L93" (("KIF16B" 1)))
 ("UP:Q96L94" (("SNX22" 21) ("sorting nexin 22" 3))) ("UP:Q96L96" (("Mak" 9)))
 ("UP:Q96LA8" (("PRMT6" 31))) ("UP:Q96LB1" (("β-defensins" 4)))
 ("UP:Q96LB3" (("IFT74" 1))) ("UP:Q96LC7" (("Siglec-10" 2)))
 ("UP:Q96LC9"
  (("Bmf" 275) ("BMF" 218) ("Bmf peptide" 5) ("an overt BMF" 1)
   ("congenital BMF" 1) ("spontaneous BMF" 1) ("The progressive BMF" 1)
   ("overt BMF" 1)))
 ("UP:Q96LD4" (("GOA" 31) ("goa" 4) ("Goa" 2)))
 ("UP:Q96LD8" (("Nedp1" 20) ("NEDP1" 9) ("Den1" 1) ("SENP8" 1)))
 ("UP:Q96LI5" (("CNOT6L" 44) ("Ccr4b" 2)))
 ("UP:Q96LJ8" (("UBXN10" 105) ("Ubxn10" 4))) ("UP:Q96LM6" (("TSC2/1" 1)))
 ("UP:Q96LR5" (("UBE2E2" 8) ("Ube2e2" 1)))
 ("UP:Q96LR9"
  (("verge" 33) ("the anal verge" 25) ("anal verge" 2)
   ("the anocutaneous verge" 2)))
 ("UP:Q96LT7"
  (("C9orf72" 18) ("c9orf72" 4) ("chromosome 9 open reading frame 72" 2)))
 ("UP:Q96LT9"
  (("RNP" 700) ("RNPs" 426) ("ribonucleoprotein" 148) ("ribonucleoproteins" 67)
   ("Ribonucleoprotein" 13) ("ribonucleoprotein (RNP)" 7)
   ("the viral ribonucleoproteins" 4) ("small nucleolar ribonucleoproteins" 4)
   ("smaller RNPs" 4) ("cellular RNPs" 3) ("heterogeneous ribonucleoprotein" 3)
   ("the minimal TERT core RNP" 3)
   ("the influenza A virus ribonucleoprotein" 2) ("viral ribonucleoproteins" 2)
   ("Distinct RNPs" 2) ("other small Cajal body-specific RNPs" 2)
   ("a unique ribonucleoprotein" 2) ("membrane-associated RNPs" 2)
   ("the viral RNP" 2) ("a supraphysiologic RNP" 2) ("larger Staufen1 RNPs" 2)
   ("supraphysiologic RNPs" 2) ("dense Staufen1 RNPs" 2)
   ("normally shuttles ribonucleoproteins" 1)
   ("cellular ribonucleoprotein (RNP)" 1) ("the tandem-purified RNP" 1)
   ("these three distinct RNP" 1) ("its associated RNP" 1)
   ("namely viral RNP" 1) ("viral RNP" 1) ("than the full-length TERT RNP" 1)
   ("we first reconstituted TERT core RNPs" 1)
   ("Human and Tetrahymena minimal TERT+TER RNPs" 1) ("relevant eIF4E RNPs" 1)
   ("soluble cytosolic RNPs" 1) ("The most compositionally diverse RNPs" 1)
   ("subcellular RNPs" 1) ("similar-sized RNPs" 1) ("dense RNPs" 1)
   ("a super-dense RNP" 1) ("Staufen1 viral RNPs" 1) ("viral RNPs" 1)
   ("other cellular RNPs" 1)
   ("the previously characterized Staufen1 HIV-1-dependent RNPs" 1)
   ("immunoprecipitation-purified telomerase RNPs" 1)))
 ("UP:Q96LW4" (("PrimPol" 1))) ("UP:Q96LW9" (("ZNF323" 11)))
 ("UP:Q96M11" (("HLs" 58) ("relapsed and refractory HLs" 2) ("most HLs" 2)))
 ("UP:Q96M32" (("AK7" 1))) ("UP:Q96M61" (("MAGE-B18" 15)))
 ("UP:Q96M69" (("LRGUK" 9))) ("UP:Q96M96" (("FGD4" 4) ("frabin" 2)))
 ("UP:Q96M98" (("PACRG" 5))) ("UP:Q96ME1" (("Fbl18" 2) ("FBXL18" 2)))
 ("UP:Q96MF2" (("STAC3" 5)))
 ("UP:Q96MF7" (("MMS21" 12) ("NSMCE2" 9) ("mms21" 5) ("Mms21" 3) ("hMMS21" 1)))
 ("UP:Q96MG7" (("MAGE-G1" 48) ("NDNL2" 1) ("NSE3" 1)))
 ("UP:Q96MG8" (("PCMTD1" 1))) ("UP:Q96MH2" (("HEXIM2" 4)))
 ("UP:Q96MI9" (("CCP4" 58)))
 ("UP:Q96MM3" (("Rex1" 21) ("REX1" 9) ("ZFP42" 4) ("P-REX1" 2)))
 ("UP:Q96MM6" (("Hspa12b" 2)))
 ("UP:Q96MM7" (("heparan sulfate 6-O-sulfotransferase 2" 3) ("HS6ST2" 1)))
 ("UP:Q96MN2"
  (("NLRP4" 286) ("only one NLRP4" 2) ("Q96MN2" 1) ("Nlrp4" 1)
   ("NLRP4 protein" 1)))
 ("UP:Q96MR9" (("ZNF560" 2))) ("UP:Q96MS0" (("HGPS" 10)))
 ("UP:Q96MT1" (("rnf145" 2))) ("UP:Q96MT3" (("PRICKLE1" 4)))
 ("UP:Q96MT8" (("CEP63" 88) ("Cep63" 34)))
 ("UP:Q96MU7" (("Ythdc1" 1) ("Yt521" 1)))
 ("UP:Q96MU8" (("Kremen" 5) ("KREMEN1" 4))) ("UP:Q96MV8" (("ZDHHC15" 2)))
 ("UP:Q96MW5" (("Cog8" 8) ("COG8" 2))) ("UP:Q96MX0" (("CMTM3" 2)))
 ("UP:Q96MX6" (("WDR92" 3))) ("UP:Q96MZ4" (("c4orf39" 2)))
 ("UP:Q96N16"
  (("JAKMIP1" 6) ("Janus kinase and microtubule interacting protein 1" 5)))
 ("UP:Q96N28" (("SLMO1" 2))) ("UP:Q96N64" (("PWWP2A" 9)))
 ("UP:Q96N67"
  (("Dock7" 225) ("DOCK7" 85) ("Dock7 protein" 6) ("DOCK7 protein" 3)
   ("the atypical Dock180-related GEF Dock7" 1)
   ("the atypical Dock180-related guanine nucleotide exchange factor (GEF) Dock7"
    1)))
 ("UP:Q96N87" (("SLC6A18" 11) ("Xtrp2" 2)))
 ("UP:Q96N96" (("Asef2" 9) ("SPATA13" 1))) ("UP:Q96NB3" (("CCDC16" 1)))
 ("UP:Q96NC0" (("ZMAT2" 1))) ("UP:Q96ND0" (("C18orf19" 2)))
 ("UP:Q96NE9" (("FRMD6" 21) ("Frmd6" 1))) ("UP:Q96NK8" (("NeuroD6" 1)))
 ("UP:Q96NL0" (("RPIP9" 2))) ("UP:Q96NL3" (("ZNF599" 1)))
 ("UP:Q96NL6" (("SCLT1" 1)))
 ("UP:Q96NR8"
  (("rp53" 28) ("Rp53" 8) ("rp53 protein" 6) ("ethanethiol-treated rp53" 1)))
 ("UP:Q96NT5" (("SLC46A1" 4))) ("UP:Q96NW4" (("ANKRD27" 8)))
 ("UP:Q96NW7"
  (("LRRC7" 10) ("Densin-180" 4) ("the post-synaptic membrane LRRC7" 1)))
 ("UP:Q96NY7" (("CLIC6" 1)))
 ("UP:Q96NY8"
  (("nectins" 9) ("PVRL4" 2) ("poliovirus receptor-related 4" 2)
   ("Nectins" 1)))
 ("UP:Q96NY9"
  (("MUS81" 790) ("Mus81" 50) ("the structure-specific endonuclease MUS81" 3)
   ("cellular MUS81" 1) ("Chk1 directly controls MUS81" 1)
   ("the structure-specific DNA endonuclease MUS81" 1)))
 ("UP:Q96NZ9" (("PRAP1" 177) ("PRAP1 protein" 1))) ("UP:Q96P09" (("BIRC8" 7)))
 ("UP:Q96P11" (("NSUN5" 8))) ("UP:Q96P16" (("p15RS" 1)))
 ("UP:Q96P20"
  (("NLRP3" 170) ("NALP3" 46) ("Aii" 20) ("AII" 20) ("Nlrp3" 10)
   ("NLRP3 protein" 2) ("overexpressed NLRP3" 2) ("cryopyrin" 2) ("aII" 1)
   ("Cryopyrin" 1) ("overexpressed fluorescent NLRP3" 1)))
 ("UP:Q96P26" (("5’-Nucleotidase" 2) ("NT5C1B" 2)))
 ("UP:Q96P31" (("FCRL3" 21) ("FCRL3 molecule" 2))) ("UP:Q96P47" (("AGAP3" 3)))
 ("UP:Q96P48"
  (("ARAP1" 231) ("CENTD2" 6) ("overexpressed ARAP1" 2)
   ("perinuclear assocated ARAP1" 2) ("than wild type ARAP1" 1)
   ("the N-terminal 100 amino acids of ARAP1" 1)))
 ("UP:Q96P50" (("ACAP3" 8)))
 ("UP:Q96P53" (("Prof" 324) ("prof" 4) ("WDFY2" 1)))
 ("UP:Q96P69" (("GPR78" 1))) ("UP:Q96P70" (("importin 9" 3) ("Ipo9" 1)))
 ("UP:Q96P71" (("NECAB3" 3)))
 ("UP:Q96PC2" (("IP6K3" 5) ("than IP6K3 ( xref )" 1)))
 ("UP:Q96PD2"
  (("subline" 599) ("DCBLD2" 9) ("a stable DAB2IP-expressing subline" 3)
   ("a highly invasive A431-III subline" 2) ("a cellular subline" 2)
   ("its tumorigenic subline" 2) ("the CLDN4-expressing subline" 2)
   ("the vehicle-treated 7.2 subline" 2) ("The vehicle treated subline" 2)
   ("low-expressing LNCaP subline" 2) ("castration-resistant LNCaP subline" 2)
   ("its castration-resistant C4-2 subline" 2)
   ("The MDA-MB-231 lung metastatic subline" 2)
   ("the HCT116 p53−/− isogenic subline" 2)
   ("discoidin, CUB and LCCL domain containing 2" 2) ("a clonal subline" 2)
   ("the isogenic knockout subline HCT116-Bax −/−" 1)
   ("the metastatic subline" 1) ("A brain-tropic subline" 1)
   ("a brain-tropic subline" 1) ("An androgen-dependent clonal subline" 1)
   ("the vehicle-treated subline" 1)
   ("than the MIR2 subline obtained from in vitro treatment with the drug ( xref )"
    1)
   ("the parent MCF7 subline" 1) ("a metastatic subline" 1)
   ("the VCR-selected multidrug-tolerant KB/VCR subline" 1)
   ("The Dox-selected multidrug-tolerant K562/A02 subline" 1)
   ("the androgen-dependent LNCaP 104-S clonal subline" 1)
   ("the transformed subline" 1)
   ("its isogenic and osteotropic C4-2B subline" 1) ("Subline" 1)
   ("a highly metastatic subline" 1) ("a bioluminescent subline" 1)
   ("the castration-resistant LNCaP-CL1 subline" 1)
   ("its castration-resistant subline" 1) ("its isogenic subline" 1)
   ("Tat-expressing CHME5 cell subline" 1) ("its lung metastatic subline" 1)
   ("The 4175 metastatic subline" 1) ("respective drug resistant subline" 1)))
 ("UP:Q96PD4" (("IL-17F" 25) ("Il17f" 6) ("IL17F" 5) ("IL-17f" 3)))
 ("UP:Q96PD6" (("DC2" 7)))
 ("UP:Q96PD7" (("DGAT2" 12) ("diacylglycerol O-acyltransferase 2" 4)))
 ("UP:Q96PE1" (("GPR124" 1))) ("UP:Q96PE2" (("ARHGEF17" 3)))
 ("UP:Q96PE3" (("INPP4A" 20) ("INPP4" 2)))
 ("UP:Q96PG8"
  (("PUMA" 2505) ("Puma" 1382) ("BBC3" 75) ("PUMA protein" 46) ("puma" 45)
   ("bbc3" 20) ("p53 up-regulated modulator of apoptosis" 14)
   ("Puma protein" 12) ("Bbc3" 8) ("Puma peptide" 5)
   ("BCL2 binding component 3" 5) ("the pro-apoptotic gene PUMA" 3)
   ("than PUMA" 3) ("PUMA peptide" 3) ("BBC3 (PUMA)" 3) ("Puma-" 2)
   ("a triple mutant PUMA" 2) ("stably knockdown PUMA" 2)
   ("than wild type PUMA" 1) ("our biochemical assays excluded Puma" 1)
   ("p53 up-regulated modulator of apoptosis ( PUMA )" 1)
   ("pro-apoptotic BH3-only protein PUMA" 1) ("less PUMA" 1)
   ("the proapoptotic PUMA" 1) ("-Puma" 1)
   ("p53 up-regulated modulator of apoptosis (PUMA)" 1) ("particular Puma" 1)
   ("the pro-apoptotic protein PUMA" 1) ("pro-apoptotic target Puma" 1)
   ("the pro-apoptotic protein Puma" 1)
   ("the pro-apoptotic BH3-only protein Puma" 1)
   ("the apoptotic-related factor PUMA" 1) ("proapoptotic PUMA" 1)
   ("-PUMA" 1)))
 ("UP:Q96PH1"
  (("NADPH oxidase" 1429) ("Nox5" 184) ("NOX5" 84) ("NADPH oxidase (NOX)" 6)
   ("NADPH oxidase-" 5) ("the primary NADPH oxidase" 4) ("NADPH oxidase 5" 4)
   ("endothelial NADPH oxidase" 3) ("the phagocyte-derived NADPH oxidase" 3)
   ("nonphagocytic NADPH oxidase" 3) ("a predominant membrane NADPH oxidase" 2)
   ("a multimeric NADPH oxidase" 2) ("The classic NADPH oxidase" 2)
   ("a neuronal NADPH oxidase" 2) ("the phagocytic NADPH oxidase" 2)
   ("vascular Nox5" 1) ("vascular NADPH oxidase" 1)
   ("the so-called NADPH oxidase (NOX)" 1)))
 ("UP:Q96PJ5"
  (("FcRL4" 74) ("FCRL4" 13) ("HIV-1 viremic individuals FcRL4" 1)))
 ("UP:Q96PK6" (("CoAA" 8)))
 ("UP:Q96PL5"
  (("SC" 1484) ("sc" 209) ("Sc" 20) ("SceGFP" 15) ("tumour-associated SC" 6)
   ("normal SC" 4) ("basal SC" 1) ("SC-" 1) ("mammary SC" 1)
   ("mouse mammary epithelial SC" 1) ("epidermal SC" 1)))
 ("UP:Q96PM5"
  (("Pirh2" 611) ("Pirh2 protein" 14) ("PIRH2" 11) ("pirh2" 5)
   ("RING finger and CHY zinc finger domain-containing
protein 1"
    3)
   ("RCHY1" 2) ("p53-induced RING-H2 protein" 2) ("Rchy1" 2)
   ("p53-induced protein with a Ring-H2 domain" 1) ("than Pirh2" 1) ("ARNIP" 1)
   ("PirH2" 1)))
 ("UP:Q96PM9" (("Hzf" 5) ("HZF" 2) ("HZF protein" 2)))
 ("UP:Q96PN6"
  (("SAC" 1386) ("sac" 113) ("Sac" 92) ("absorptive" 10) ("hypercalciuria" 5)
   ("SacI" 5) ("sAC" 4) ("the mitotic SAC" 3) ("SAC protein" 2)
   ("aberrant SAC" 2) ("a functional SAC" 2) ("the presumptive yolk sac" 2)
   ("an intact SAC" 2) ("a dilated aortic sac" 2) ("the protective sac" 2)
   ("mitotic SAC" 2) ("soluble adenylyl cyclase" 2)
   ("a combined acidic buffer-based dynamic and static absorptive" 2)
   ("visceral yolk sac" 1) ("Hypercalciuria" 1) ("than SAC that contribute" 1)
   ("a dysfunctional SAC" 1) ("the aortic sac" 1) ("the testicular yolk sac" 1)
   ("the visceral yolk sac" 1) ("The parietal yolk sac" 1)
   ("An artificial air sac" 1) ("a dorsal air sac" 1) ("Mitotic SAC" 1)))
 ("UP:Q96PN7" (("RAPA" 52) ("Rapa" 18) ("TRERF1" 1) ("rapa" 1)))
 ("UP:Q96PP8" (("GBP-5" 9) ("guanylate-binding protein 5" 2)))
 ("UP:Q96PQ1" (("slg" 1))) ("UP:Q96PQ6" (("ZNF317" 1)))
 ("UP:Q96PQ7" (("KLHL5" 8))) ("UP:Q96PU4" (("UHRF2" 3)))
 ("UP:Q96PU5"
  (("Nedd4-2" 80) ("Nedd4L" 46) ("NEDD4-2" 41) ("NEDD4L" 30) ("Rsp5" 30)
   ("-NEDD4L" 6) ("RSP5" 2) ("NEDD4.2" 1)))
 ("UP:Q96PU8"
  (("QKI" 93) ("targeted QKI" 4) ("QKI protein" 2) ("protein Quaking (QKI)" 2)
   ("protein Quaking" 1)))
 ("UP:Q96PU9" (("ODF3" 1))) ("UP:Q96PX1" (("RNF157" 1)))
 ("UP:Q96PX8" (("TTM" 50) ("SLITRK1" 2))) ("UP:Q96PY5" (("FMNL2" 156)))
 ("UP:Q96PY6" (("NEK1" 12)))
 ("UP:Q96PZ7"
  (("CSMD1" 20) ("sushi" 3) ("CUB and sushi domain-containing protein 1" 3)
   ("Sushi" 1)))
 ("UP:Q96Q04" (("LMTK3" 4) ("lemur tyrosine kinase 3" 1)))
 ("UP:Q96Q05" (("NIBP" 1)))
 ("UP:Q96Q15"
  (("SMG1" 19) ("Smg1" 13) ("phosphatidylinositol 3-kinase-related kinase" 8)
   ("PIKK" 5) ("SMG-1" 2)
   ("phosphatidylinositol
3-kinase-related kinase"
    2)))
 ("UP:Q96Q27"
  (("Asb2" 177) ("Asb2 protein" 2) ("ASB2" 2) ("exogenous Asb2" 1)))
 ("UP:Q96Q40" (("Cdk15" 7)))
 ("UP:Q96Q42" (("ALS2" 21) ("Alsin" 16) ("Als2" 2)))
 ("UP:Q96Q83" (("DEPC1" 2))) ("UP:Q96Q89" (("KRMP1" 3) ("KIF20B" 1)))
 ("UP:Q96Q91" (("SBC5" 70))) ("UP:Q96QA5" (("GSDMA" 14)))
 ("UP:Q96QA6" (("YPEL2" 1)))
 ("UP:Q96QB1" (("DLC-1" 48) ("p122RhoGAP" 8) ("p122-RhoGAP" 1)))
 ("UP:Q96QC0"
  (("PNUTS" 59) ("PPP1R10" 1)
   ("the nuclear targeting PP1-associated protein PNUTS" 1) ("FB19" 1)))
 ("UP:Q96QD5" (("DEPDC7" 81)))
 ("UP:Q96QD8" (("SLC38A2" 10) ("SNAT2" 8) ("SAT2" 1)))
 ("UP:Q96QE3"
  (("ATAD5" 232) ("ATAD5 protein" 10) ("Atad5" 4)
   ("ATAD5 (p3×FLAG-ATAD5) protein" 3) ("than wild-type ATAD5 protein" 1)
   ("than wild-type ATAD5 ( xref , respectively)" 1)))
 ("UP:Q96QE4" (("LRRC37B" 2))) ("UP:Q96QF0" (("Rabin8" 2)))
 ("UP:Q96QF7" (("aCRC" 11) ("ACRC" 9)))
 ("UP:Q96QK1" (("VPS35" 30) ("Vps35" 8) ("VPS35 protein" 1) ("PARK17" 1)))
 ("UP:Q96QR1" (("HIN-1" 139) ("SCGB3A1" 2) ("Scgb3a1" 1)))
 ("UP:Q96QR8" (("PURB" 7)))
 ("UP:Q96QT4"
  (("TRPM7" 238) ("Trpm7" 3) ("given TRPM7’s" 1) ("given TRPM7" 1)
   ("exactly TRPM7" 1)))
 ("UP:Q96QT6" (("Pf1" 2) ("PF1" 2))) ("UP:Q96QU8" (("XPO6" 5)))
 ("UP:Q96QV1"
  (("HHIP" 66) ("Hhip" 16) ("hedgehog-interacting protein" 3)
   ("Hedgehog interacting protein" 1) ("hedgehog interacting protein" 1)))
 ("UP:Q96QZ0" (("Panx3" 1)))
 ("UP:Q96QZ7"
  (("MAGI-1" 41) ("Magi-1" 20) ("AIP3" 1) ("Q96QZ7" 1) ("BAP-1" 1)))
 ("UP:Q96R06"
  (("SPAG5" 153) ("Astrin" 10) ("astrin" 4) ("sperm-associated antigen 5" 4)
   ("SPAG5 protein" 2)))
 ("UP:Q96R27" (("OR2M4" 1))) ("UP:Q96R28" (("OR2M2" 1)))
 ("UP:Q96RD6" (("Px2" 2) ("PX2" 2))) ("UP:Q96RD7" (("PX1" 2) ("pannexin-1" 1)))
 ("UP:Q96RF0" (("SNX18" 6)))
 ("UP:Q96RI0"
  (("PAR-4" 239) ("PAR4" 100) ("overexpressed PAR-4" 2) ("PAR4 peptide" 2)))
 ("UP:Q96RI1"
  (("bar" 674) ("FXR" 504) ("BAR" 310) ("Bar" 254) ("farnesoid X receptor" 25)
   ("Fxr" 9) ("farnesoid X receptor (FXR)" 8) ("bile acid receptor" 6)
   ("Farnesoid X receptor" 5) ("a horizontal bar" 5) ("Farnesoid X Receptor" 5)
   ("BAR-" 3) ("a magnetic bar" 3) ("magnetic stirring bar" 2) ("Nr1h4" 2)
   ("NR1H4" 2) ("“bar”" 1) ("unique bar" 1) ("intestinal FXR" 1)
   ("Farnesoid X Receptor (FXR)" 1)
   ("Farnesoid
                            X Receptor"
    1)
   ("a thin apical bar" 1) ("Representative bar" 1) ("overexpressing FXR" 1)))
 ("UP:Q96RI8" (("TAAR6" 1))) ("UP:Q96RI9" (("TA3" 7)))
 ("UP:Q96RJ0"
  (("TA1" 8) ("Ta1" 3) ("a manual tissue arrayer TA1" 2) ("TAR1" 2)))
 ("UP:Q96RJ3"
  (("BR3" 108) ("Br3" 10) ("activating factor receptor" 8) ("BAFFR" 7)
   ("BAFF-R" 5) ("TNFRSF13C" 3) ("BAFF receptor" 2)
   ("its parental normal cell BR3" 2) ("-BR3" 1)))
 ("UP:Q96RK0" (("CIC" 188) ("Capicua" 4) ("CiC" 1) ("stem-like CIC's" 1)))
 ("UP:Q96RK4" (("BBS4" 4)))
 ("UP:Q96RL1"
  (("RAP80" 835) ("Rap80" 29) ("RAP80 protein" 15) ("UIMC1" 8)
   ("receptor-associated protein 80" 6) ("–RAP80" 6)
   ("BRCA1-A complex subunit RAP80" 2)
   ("ubiquitin interaction motif containing 1" 2) ("exogenous RAP80" 2)
   ("Receptor Associated Protein 80" 2)
   ("ectopically expressed Flag-HA-tagged RAP80" 1)))
 ("UP:Q96RN5" (("ARC105" 2)))
 ("UP:Q96RP3"
  (("SRP" 40) ("pSRP" 8) ("SRP protein" 3)
   ("the NCBI (National Center for Biotechnology Information) SRA (Sequence Read Archive) SRP045204"
    2)
   ("Bioproject accession number SRP043021" 1)
   ("the accession number SRP011927" 1)))
 ("UP:Q96RP9" (("GFM" 51) ("EFG" 11) ("pEFG" 1))) ("UP:Q96RQ3" (("MCCC1" 1)))
 ("UP:Q96RQ9" (("Lao" 10) ("FIG1" 1)))
 ("UP:Q96RR1"
  (("PEO1" 98) ("replisome" 72) ("parental PEO1" 4) ("IOSCA" 2)
   ("origin-independent replisome" 2) ("Replisome" 2)
   ("The paired high grade serous ovarian carcinoma cell lines PEO1" 1)))
 ("UP:Q96RR4"
  (("CaMKK" 387) ("CAMKK2" 22) ("CaMKK2" 5) ("CamKK" 4) ("CaMK2" 3) ("Camk2" 3)
   ("Calcium/calmodulin-dependent protein kinase kinase 2" 2) ("-CaMKK" 2)
   ("CaMKK-" 1)))
 ("UP:Q96RS0"
  (("TGS1" 5) ("NCoA6IP" 3) ("trimethylguanosine" 2)
   ("Trimethylguanosine synthase" 2) ("trimethylguanosine synthase" 1)))
 ("UP:Q96RS6" (("NUDCD1" 5)))
 ("UP:Q96RT1" (("Erbin" 174) ("ERBB2IP" 8) ("Erbin protein" 6) ("erbin" 2)))
 ("UP:Q96RT6" (("CTAGE1" 1))) ("UP:Q96RU2" (("USP28" 82) ("USP28 protein" 2)))
 ("UP:Q96RU3" (("–FBP17" 5) ("FBP17" 4) ("FNBP1" 3)))
 ("UP:Q96RU7"
  (("sink" 62) ("TRIB3" 35) ("“sink”" 10) ("SINK" 3) ("‘sink’" 2)
   ("a potential sink" 1) ("a local sink" 1)))
 ("UP:Q96RU8" (("TRIB1" 20) ("Skip1" 2) ("trib1" 2) ("Trib1" 1)))
 ("UP:Q96S15" (("WDR24" 3))) ("UP:Q96S21" (("RARL" 6)))
 ("UP:Q96S37" (("SLC22A12" 2))) ("UP:Q96S38" (("RPS6KC1" 4)))
 ("UP:Q96S42" (("NODAL" 27) ("Nodal protein" 8) ("NODAL protein" 2)))
 ("UP:Q96S53" (("TESK 2" 2) ("TESK2" 1)))
 ("UP:Q96S55" (("WRNIP1" 16) ("Werner helicase interacting protein 1" 1)))
 ("UP:Q96S59"
  (("RanBPM" 460) ("RANBP9" 6) ("Ran-binding protein M" 5)
   ("residual RanBPM protein" 2) ("RanBP9" 2) ("Ran-Binding Protein M" 2)
   ("RanBPM protein" 1) ("that RanBPM's" 1)))
 ("UP:Q96S79" (("RASL10B" 16) ("RASL10B protein" 1)))
 ("UP:Q96S94" (("CCNs" 2))) ("UP:Q96S96" (("PEBP4" 1)))
 ("UP:Q96S97" (("MYADM" 139) ("MYADM protein" 4)))
 ("UP:Q96S99"
  (("aPPD" 111) ("apoptosis inducing protein" 8) ("PLEKHF1" 6)
   ("that aPPD's" 1)))
 ("UP:Q96SB3"
  (("spinophilin" 201) ("neurabin II" 59) ("Spinophilin" 19) ("PPP1R9B" 6)
   ("Spinophilin protein" 2) ("Neurabin II" 1) ("Neurabin-2" 1)))
 ("UP:Q96SB4" (("SRPK1" 92) ("than WT SRPK1" 1)))
 ("UP:Q96SB8"
  (("SMC6" 13) ("structural maintenance of chromosomes protein 6" 3)
   ("Smc6" 2)))
 ("UP:Q96SD1"
  (("Artemis" 417) ("SCID" 190) ("severe combined immunodeficiency" 80)
   ("severe combined immunodeficiency (SCID)" 11) ("scid" 11)
   ("Severe combined immunodeficiency" 7) ("Scid" 7) ("Artemis-" 6)
   ("ARTEMIS" 4) ("Artemis protein" 4) ("Severe Combined Immunodeficiency" 3)
   ("overexpressed state Artemis" 3)
   ("classical severe combined immunodeficiency (SCID)" 1)
   ("autosomal recessive severe combined immunodeficiency (SCID)" 1)
   ("artemis" 1)))
 ("UP:Q96SI1" (("Kctd15" 7) ("KCTD15" 2))) ("UP:Q96SJ8" (("TSPAN" 3)))
 ("UP:Q96SL4" (("GPX7" 6) ("glutathione peroxidase 7" 2) ("Gpx7" 1)))
 ("UP:Q96SN7" (("Orai2" 13)))
 ("UP:Q96SN8"
  (("microcephaly" 148) ("Cep215" 30) ("CEP215" 26) ("CDK5RAP2" 17)
   ("primary microcephaly" 9) ("C48" 7) ("severe microcephaly" 5)
   ("extreme microcephaly" 4) ("Cdk5Rap2" 4) ("Microcephaly" 3)
   ("congenital microcephaly" 3) ("Primary microcephaly" 2)
   ("centrosomal Cep215" 2) ("cdk5rap2" 1) ("severe congenital microcephaly" 1)
   ("autosomal recessive primary microcephaly (MCPH)" 1)
   ("Primary microcephaly (MCPH)" 1) ("hereditary microcephaly" 1)
   ("autosomal recessive primary microcephaly" 1) ("-CEP215" 1)
   ("All four ATR/ATRIP patients displayed severe microcephaly" 1)
   ("Patient CV1720 displayed severe microcephaly" 1)
   ("extremely severe microcephaly" 1)))
 ("UP:Q96SR6" (("KS1" 1)))
 ("UP:Q96ST3"
  (("Sin3A" 350) ("Sin3a" 83) ("SIN3A" 77) ("Sin3A protein" 15)
   ("SIN3 homolog A" 4) ("SIN3a" 4) ("the transcriptional repressor Sin3A" 3)
   ("Sin3a protein" 2) ("transcriptional co-repressor Sin3A" 2)
   ("called SIN3A" 1) ("–Sin3A" 1) ("Sin3A-" 1) ("Sin-3A" 1)))
 ("UP:Q96SW2" (("CRBN" 46) ("cereblon" 4) ("CRBN-" 2) ("Cereblon" 1)))
 ("UP:Q96SZ5" (("ADO" 8) ("Ado" 7) ("ado" 2)))
 ("UP:Q96T23"
  (("RSF1" 11) ("Rsf-1" 9) ("remodeling and spacing factor 1" 1) ("HBXAP" 1)
   ("RSF-1" 1)))
 ("UP:Q96T37" (("OTT" 37) ("Ott" 13) ("RBM15" 1)))
 ("UP:Q96T49" (("Ppp1r16b" 1)))
 ("UP:Q96T51"
  (("rabip4" 156) ("Rabip4" 28) ("RUFY1" 11) ("than wild-type rabip4" 1)))
 ("UP:Q96T53"
  (("goat" 6011) ("Goat" 351) ("-goat" 12) ("10% normal goat" 6)
   ("the normal goat" 4) ("Control Chrome Pure goat" 2) ("normal goat" 2)
   ("Goat-" 2) ("Alexa Fluor 488-labeled rabbit-anti-goat" 2)
   ("5% normal goat" 2) ("goat-" 1) ("either normal goat" 1) ("–goat" 1)
   ("Alexa 594–conjugated goat" 1) ("2% normal goat" 1) ("secondary goat" 1)))
 ("UP:Q96T58" (("MINT" 108) ("SPEN" 17) ("SHARP" 13) ("Mint" 1)))
 ("UP:Q96T60"
  (("PNKP" 168) ("pnkp" 8) ("Pnkp" 4) ("phosphatase-defective PNKP" 1)))
 ("UP:Q96T68" (("SET2" 10) ("SETDB2" 1)))
 ("UP:Q96T76"
  (("MMS19" 126) ("Mms19" 30) ("mms19" 3) ("Efficient MMS19" 2) ("MET18" 2)
   ("MMS19 protein" 1)))
 ("UP:Q96T83" (("isoform 7" 1) ("SLC9A7" 1)))
 ("UP:Q96T88" (("UHRF1" 199) ("ICBP90" 2) ("NP95" 2) ("Np95" 1)))
 ("UP:Q96T91" (("GPA2" 5) ("gpa2" 1))) ("UP:Q96T92" (("IA6" 2) ("INSM2" 1)))
 ("UP:Q96TA1"
  (("MEG3" 195) ("FAM129B" 36) ("MINERVA" 11) ("Minerva" 7) ("Meg3" 4)
   ("-MEG3" 3) ("FAM129B protein" 3) ("the maternally-expressed genes MEG3" 2)
   ("“MINERVA”" 1)))
 ("UP:Q96TA2"
  (("PAMPs" 104) ("YME1L1" 2) ("their respective PAMPs" 1) ("innate PAMPs" 1)
   ("soluble PAMPs" 1) ("exogenous PAMPs" 1) ("Bacterial PAMPs" 1)
   ("microbial PAMPs" 1)))
 ("UP:Q96TC7" (("PTPIP51" 1))) ("UP:Q96X30" (("ENOA" 1)))
 ("UP:Q96X49" (("pACC" 49) ("p-ACC" 39) ("P-ACC" 15)))
 ("UP:Q97GB9" (("DSR" 9) ("pDSR" 2))) ("UP:Q980W9" (("LysM" 114)))
 ("UP:Q98146"
  (("vGPCR" 430) ("viral G protein-coupled receptor" 8)
   ("Viral G protein coupled receptor" 2)
   ("viral G-protein-coupled receptor" 2) ("these potential vGPCR" 1)
   ("vGPCR-" 1)))
 ("UP:Q98234" (("GSH-Px" 20))) ("UP:Q98325" (("MC159L" 1)))
 ("UP:Q98862" (("EHH" 46) ("than the EHH" 2) ("EHH (REHH)" 1)))
 ("UP:Q98867" (("TRα1" 61) ("TRα1 protein" 1))) ("UP:Q98925" (("IRF-2" 5)))
 ("UP:Q98931" (("Apolipoprotein E receptor-2" 3)))
 ("UP:Q98936" (("RPTPγ" 26) ("RPTPγ molecule" 2))) ("UP:Q98SP8" (("ePAB" 2)))
 ("UP:Q98TT6" (("4E-BP3" 3)))
 ("UP:Q99062"
  (("G-CSFR" 52) ("G-CSF receptor" 50) ("GCSFR" 25) ("CSF3R" 13) ("CD114" 4)
   ("GCSF receptor" 2)
   ("the C-terminal tyrosines of G-CSFR [ xref , xref , xref , xref , xref , xref – xref ]"
    2)
   ("G-CSF-R" 1)))
 ("UP:Q99075"
  (("HB-EGF" 919) ("HBEGF" 77) ("heparin-binding EGF-like growth factor" 60)
   ("pro-HB-EGF" 6) ("Heparin-binding EGF-like growth factor" 4)
   ("available HB-EGF" 4) ("heparin-binding-EGF" 3) ("Hbegf" 3)
   ("soluble HB-EGF" 3) ("specifically not HB-EGF" 2) ("the residual HB-EGF" 2)
   ("DTS" 2) ("than HB-EGF" 1) ("HB-EGF protein" 1) ("pro–HB-EGF" 1)
   ("The soluble HB-EGF" 1) ("Soluble HB-EGF" 1) ("simian HB-EGF" 1)))
 ("UP:Q99081"
  (("HEB" 28) ("TCF12" 4) ("E-box binding protein" 3) ("Tcf12" 3) ("Heb" 1)))
 ("UP:Q99102"
  (("MUC4" 633) ("tracheobronchial" 14) ("MUC4 protein" 13) ("Muc4" 11)
   ("mucin4" 8) ("mucin-4" 3) ("ASGP2" 2) ("mucin 4" 2)
   ("membrane-associated Muc4" 1) ("Mucin4" 1)))
 ("UP:Q99176" (("Vps37" 3) ("VPS37" 3))) ("UP:Q99217" (("AMG" 35) ("AMELX" 1)))
 ("UP:Q99250" (("SCN2A2" 15) ("SCN2A" 8) ("SCN2A1" 1)))
 ("UP:Q99259"
  (("GAD1" 102) ("pGAD" 35) ("GAD" 21) ("Glutamate decarboxylase 1" 4)
   ("GAD1 protein" 2) ("GAD67" 2) ("the yeast two-hybrid vector pGAD" 1)
   ("the commercially available GAD" 1)))
 ("UP:Q99260" (("Ypt6" 2) ("YPT6" 1) ("ypt6" 1)))
 ("UP:Q99417" (("MYCBP" 9) ("MYC binding protein" 1)))
 ("UP:Q99418"
  (("ARNO" 565) ("cytohesin-2" 200) ("Cytohesin-2" 18)
   ("ARF nucleotide binding site opener (ARNO)" 8) ("PSCD2" 4)
   ("ARF nucleotide binding site opener" 3)
   ("ARF nucleotide-binding site opener (ARNO)" 1)
   ("ARF nucleotide-binding site opener" 1) ("Cytohesin 2" 1) ("cytohesin 2" 1)
   ("ARNO (ARNO)" 1)))
 ("UP:Q99424" (("branched chain" 13) ("Branched chain" 1)))
 ("UP:Q99426"
  (("cofactors" 1282) ("transcriptional cofactors" 34) ("Cofactors" 8)
   ("cellular cofactors" 5) ("repressive cofactors" 5) ("distinct cofactors" 4)
   ("several transcriptional cofactors" 4)
   ("other transcriptional cofactors" 4) ("inorganic cofactors" 3)
   ("their associated cofactors" 3) ("essential cofactors" 3)
   ("the transcriptional cofactors" 3) ("nominal cofactors" 3)
   ("most cofactors" 3) ("possibly other cofactors" 2) ("diverse cofactors" 2)
   ("regulatory cofactors" 2) ("potentially several hundred cofactors" 2)
   ("E2F1 apoptotic transcriptional cofactors" 2) ("epigenetic cofactors" 2)
   ("non-canonical cofactors" 2) ("possible cofactors" 2)
   ("gene-specific transcriptional cofactors" 2) ("Viral Cofactors" 2)
   ("various transcriptional cofactors" 2)
   ("several associated protein cofactors" 2) ("other cellular cofactors" 2)
   ("potential cellular cofactors" 2) ("their regulatory cofactors" 2)
   ("affecting external cofactors" 2) ("these cellular cofactors" 2)
   ("The first essential cofactors" 1) ("its cellular cofactors" 1)
   ("multiple cellular cofactors" 1) ("numerous cellular cofactors" 1)
   ("alternate cofactors" 1) ("essential cellular cofactors" 1)
   ("Transcriptional cofactors" 1) ("Epigenetic cofactors" 1)
   ("Myc transcriptional cofactors" 1)
   ("essential AR transcriptional cofactors" 1)
   ("general transcriptional cofactors" 1) ("any possible cofactors" 1)
   ("p53 transcriptional cofactors" 1) ("some transcriptional cofactors" 1)
   ("its transcriptional cofactors" 1) ("these transcriptional cofactors" 1)
   ("several p53 transcriptional cofactors" 1) ("dietary cofactors" 1)
   ("many well-known cofactors" 1)
   ("Tcf/Lef family transcriptional cofactors" 1) ("the cellular cofactors" 1)
   ("cellular or viral cofactors" 1)
   ("secondary histone-modifying cofactors" 1)
   ("specific negative and positive cofactors" 1)
   ("target cellular cofactors" 1) ("stress-specific cofactors" 1)
   ("other distinct cofactors" 1) ("associated cofactors" 1)
   ("functionally distinctive cofactors" 1) ("various regulatory cofactors" 1)
   ("unique cofactors" 1) ("intranuclear transcription cofactors" 1)
   ("nucleolar cofactors" 1) ("additional cargo-associated dynein cofactors" 1)
   ("few cofactors" 1) ("many transcriptional cofactors" 1)
   ("alternative cofactors" 1) ("re-acquiring appropriate cofactors" 1)))
 ("UP:Q99435" (("NELL2" 3))) ("UP:Q99436" (("PSMB7" 5)))
 ("UP:Q99437" (("HATPL" 1) ("Atp6v0b" 1))) ("UP:Q99439" (("CNN2" 2)))
 ("UP:Q99442" (("Sec62" 48) ("hTP1" 17) ("SEC62" 4) ("SEC62 homolog" 3)))
 ("UP:Q99453"
  (("phox" 377) ("PHOX2B" 158) ("PHOX" 90) ("Phox" 19) ("Phox2b" 11)
   ("PHOX2B protein" 6) ("neuronal PHOX" 5) ("PHOX2b" 2)
   ("early neural differentiation marker PHOX2B" 2)
   ("a highly malignant Phox2b" 1) ("the sympathoadrenal marker Phox2b" 1)
   ("neural differentiation marker PHOX2B" 1) ("phox2b" 1)))
 ("UP:Q99459" (("CDC5L" 59)))
 ("UP:Q99460" (("non-ATPase" 12) ("PSMD1" 3) ("Psmd1" 2)))
 ("UP:Q99463"
  (("PP2" 2014) ("PP-2" 7) ("PP2−" 3) ("pP2" 3) ("pp2" 2)
   ("based retroviral expression vectors pP2" 2) ("than PP2" 1) ("Pp2" 1)
   ("PP2-" 1)))
 ("UP:Q99466"
  (("Notch4" 98) ("NOTCH4" 50) ("Notch 4" 31) ("Notch-4" 9)
   ("Notch 4 protein" 3) ("than NOTCH4 (data not shown)" 1) ("notch 4" 1)))
 ("UP:Q99467"
  (("radioprotective" 11) ("RP105" 3) ("CD180" 2) ("RP105 (BD)" 2)))
 ("UP:Q99469" (("STAC" 95) ("a particular STAC" 1)))
 ("UP:Q99471" (("MM-1" 90) ("PFDN5" 5) ("prefoldin 5" 1)))
 ("UP:Q99489" (("DDO" 7)))
 ("UP:Q99490"
  (("PIKE" 8) ("CENTG1" 5) ("phosphatidylinositol 3-kinase enhancer" 1)))
 ("UP:Q99496"
  (("Ring1B" 270) ("RNF2" 188) ("pDING" 102) ("Ding" 50) ("RING1B" 50)
   ("Rnf2" 13) ("pDING protein" 4) ("DING" 4) ("-Ring1B" 4) ("RING1B-" 3)
   ("Ring1B protein" 2) ("Ring1b" 2) ("Ring1B-" 1) ("RING1b" 1) ("RNF2-" 1)))
 ("UP:Q99497"
  (("DJ-1" 1301) ("PARK7" 20) ("DJ-1 protein" 5) ("than wild-type DJ-1" 4)
   ("Park7" 3) ("PARK-7" 2) ("Parkinson disease protein 7" 2) ("DJ1" 2)
   ("another PD-associated mutant DJ-1" 2) ("much more DJ-1" 2) ("more DJ-1" 2)
   ("its pathogenic mutant DJ-1" 2)
   ("parkin directly binds L166P mutant DJ-1" 2) ("DJ-1–" 1)
   ("exogenous wild-type DJ-1" 1)
   ("parkin selectively targets L166P mutant DJ-1" 1)))
 ("UP:Q99500"
  (("S1PR3" 8) ("S1pr3" 2) ("sphingosine-1-phosphate receptor 3" 2)
   ("EDG-3" 1)))
 ("UP:Q99501" (("Gar22" 1)))
 ("UP:Q99502"
  (("EYA" 20) ("EYA1" 15) ("Eya1" 3) ("Eya" 1) ("eya" 1) ("eya1" 1)))
 ("UP:Q99523" (("SORT1" 39) ("sortilin" 6)))
 ("UP:Q99527"
  (("GPR30" 288) ("GPER" 252) ("membrane estrogen receptor" 4)
   ("GPR30 (GPER)" 3) ("GPER−" 3) ("G-protein coupled estrogen receptor 1" 3)
   ("previously called GPR30" 2) ("expressed GPR30" 2) ("GPER protein" 2)
   ("no longer evident silencing GPER" 1)
   ("ERα-positive breast carcinomas given GPR30" 1) ("GPR30-" 1)
   ("possible GPER" 1) ("the transmembrane GPER" 1)))
 ("UP:Q99536" (("VAT1" 6))) ("UP:Q99538" (("LGMN" 1)))
 ("UP:Q99541"
  (("ADRP" 7) ("adipophilin" 2) ("perilipin 2" 2)
   ("adipose differentiation-related protein" 2)
   ("PPAR-regulatable target gene adipose differentiation-related protein (ADRP)"
    2)
   ("adipose differentiation-related protein (ADRP)" 2) ("Adipophilin" 2)))
 ("UP:Q99542"
  (("MMP1/9" 23) ("MMP-19" 5) ("MMP19" 3) ("targeted genes MMP1/9" 2)
   ("matrix metalloproteinase 19" 1)))
 ("UP:Q99543"
  (("N-terminally" 465) ("more N-terminally" 1)
   ("polybasic amino acids N-terminally" 1)))
 ("UP:Q99547" (("MPHOSPH6" 3))) ("UP:Q99549" (("MPP8" 1)))
 ("UP:Q99550" (("MPHOSPH9" 9)))
 ("UP:Q99551"
  (("mTERF" 4) ("MTERF" 3)
   ("mitochondrial transcription termination factor" 1)))
 ("UP:Q99558" (("MAP3K14" 53) ("map3k14" 8) ("Map3k14" 1)))
 ("UP:Q99567" (("Nup88" 11) ("NUP88" 2)))
 ("UP:Q99569" (("plakophilin" 8) ("p0071" 6) ("PKP4" 3)))
 ("UP:Q99570" (("Vps15" 118) ("PIK3R4" 23) ("VPS15" 3) ("less Vps15" 2)))
 ("UP:Q99571" (("P2rx4" 4))) ("UP:Q99572" (("P2X7" 12) ("P2X7-" 2)))
 ("UP:Q99574"
  (("SERPINI1" 27) ("neuroserpin" 8)
   ("neurodegenerative disease proteins superoxide dismutase-1, ataxin-3 and mutant neuroserpin"
    2)
   ("Serpini1" 1)))
 ("UP:Q99575" (("POP-1" 7) ("pop1" 3)))
 ("UP:Q99576"
  (("glucocorticoid" 485) ("Glucocorticoid" 34) ("GILZ" 4)
   ("glucocorticoid-" 3) ("TSC22 domain family protein 3" 3)
   ("glucocorticoid-induced leucine zipper (GILZ)" 3)
   ("glucocorticoid-induced leucine zipper" 2) ("a natural glucocorticoid" 1)
   ("TSC22D3" 1) ("glucocorticoid (GR)" 1)))
 ("UP:Q99578" (("RIN" 118))) ("UP:Q99581" (("FEV" 581) ("Pet1" 4) ("PET1" 1)))
 ("UP:Q99583"
  (("Mnt" 63) ("MNTs" 9) ("Myc antagonist Mnt" 3) ("Myc antagonist MNT" 2)
   ("MNT" 2)))
 ("UP:Q99584" (("S100A13" 1))) ("UP:Q99592" (("ZNF238" 15) ("RP58" 2)))
 ("UP:Q99593" (("TBX5" 127) ("Tbx5" 22))) ("UP:Q99594" (("TEAD3" 25)))
 ("UP:Q99598" (("TRAX" 12)))
 ("UP:Q99607"
  (("mEF" 62) ("ELF4" 13) ("elF4" 8) ("myeloid Elf-1-like factor" 2)
   ("than mEF ( xref )" 1)))
 ("UP:Q99608"
  (("Necdin" 120) ("NDN" 21) ("necdin" 5) ("Necdin protein" 2) ("NECDIN" 1)))
 ("UP:Q99611" (("SPS2" 5)))
 ("UP:Q99612"
  (("KLF6" 515) ("KLF6 protein" 21) ("klf6" 12) ("CPBP" 3)
   ("KLF6-4A protein" 3) ("KLF6-WT protein" 3)
   ("ductal breast tumor tissues expressed nuclear KLF6" 2) ("Zf9" 2)
   ("ZF9" 1)))
 ("UP:Q99613"
  (("eIF3c" 57) ("subunit C" 5) ("110kDa" 4) ("EIF3S8" 1)
   ("approximately 110kDa" 1) ("EIF3C" 1)))
 ("UP:Q99614" (("TPR1" 22))) ("UP:Q99615" (("TPR2" 64) ("DNAJC7" 1)))
 ("UP:Q99616" (("CCL13" 9) ("MCP-4" 3) ("member 13" 1)))
 ("UP:Q99618" (("C-8" 11) ("Tome-1" 1) ("cell division cycle associated 3" 1)))
 ("UP:Q99619" (("SPSB2" 5)))
 ("UP:Q99623"
  (("PHB2" 189) ("REA" 116) ("BaP" 41) ("BAP" 29) ("Rea" 19)
   ("PHB2 protein" 12) ("prohibitin 2" 8) ("ReA" 8) ("rea" 5) ("BAP protein" 4)
   ("repressor of estrogen receptor activity" 3) ("Intrinsic PHB2" 2)
   ("Phb2" 2) ("Prohibitin 2" 2) ("PROHIBITIN 2" 2) ("intrinsic PHB2" 1)
   ("REA protein" 1) ("prohibitin-2" 1)
   ("repressor of estrogen receptor activity (REA)" 1)
   ("Flag-PAK4-WT or Flag BAP" 1)))
 ("UP:Q99624" (("G17" 16) ("S N 1" 8) ("SN1" 4) ("SLC38A3" 1)))
 ("UP:Q99626"
  (("Cdx2" 220) ("CDX2" 102) ("CDX-2" 12) ("Cdx2 protein" 9) ("Cdx-2" 7)
   ("Cdx3" 2) ("the intestine-specific homeobox transcription factor CDX2" 2)
   ("CDX2−" 1) ("The caudal related homeobox gene CDX2" 1)
   ("a specificity control much less Cdx2" 1)))
 ("UP:Q99627" (("COP9" 22) ("Csn8" 3) ("CSN8" 2) ("COPS8" 2) ("Cop9" 2)))
 ("UP:Q99638" (("hRad9" 54) ("hRAD9" 6) ("RAD9A" 1)))
 ("UP:Q99640"
  (("PKMYT1" 24) ("MYT1" 10) ("Myt1 kinase" 5) ("-MYT1" 2) ("pkmyt1" 1)))
 ("UP:Q99643"
  (("pGL3" 2332) ("integral membrane protein" 154) ("PGL3" 46) ("pGL3-" 24)
   ("SDHC" 22) ("-pGL3" 8) ("pGl3" 3) ("pGL3–" 2)
   ("the basic luciferase reporter construct pGL3" 2) ("Pgl3" 2)
   ("a synaptic vesicle integral membrane protein" 2)
   ("the major integral membrane protein" 1)
   ("a homodimeric integral membrane protein" 1) ("ERE" 1) ("“pGL3”" 1)))
 ("UP:Q99645" (("pGLB" 20)))
 ("UP:Q99650" (("OSMR" 95) ("oncostatin M receptor" 3)))
 ("UP:Q99653" (("CHP" 15) ("Chp" 8) ("chp" 1) ("CHP1" 1)))
 ("UP:Q99661"
  (("MCAK" 1351) ("KIF2C" 74) ("mitotic centromere-associated kinesin" 14)
   ("mitotic centromere-associated kinesin (MCAK)" 9) ("KIF2C protein" 5)
   ("Kif2c" 4) ("mitotic centromere–associated kinesin (MCAK)" 4)
   ("exogenous MCAK" 4) ("mitotic centromere–associated kinesin" 3)
   ("MCAK protein" 3) ("the MCAK's" 2)
   ("Mitotic centromere-associated kinesin" 2)
   ("MCAK peptide (CMQLEEQASRQISS)" 2) ("centromeric pSer715-MCAK" 2)
   ("the centromere-associated kinesin-13 protein MCAK" 2)
   ("less centromeric MCAK" 2) ("phosphomimetic MCAK S621D" 1)
   ("the phosphomimetic MCAK variant S621D" 1) ("3.4 fold more MCAK S621A" 1)
   ("than WT MCAK" 1) ("the phosphomimetic MCAK S621D" 1)
   ("almost no phosphorylated MCAK" 1) ("the phosphomimic EEEEE MCAK" 1)
   ("phosphomimic (serine to glutamic acid) MCAK" 1) ("centromeric MCAK" 1)
   ("kinetochore-associated MCAK" 1) ("centrosomal MCAK" 1)
   ("centromeric phospho-Ser715 MCAK" 1) ("most MCAK S715E" 1)
   ("non-phosphorylatable MCAK" 1)
   ("the central spindle-associated pSer715-MCAK" 1)
   ("than MCAK S715A ( xref )" 1) ("GFP-His-tagged MCAK" 1)))
 ("UP:Q99665" (("IL12RB2" 10) ("IL-12RB2" 2) ("Il12rb2" 1)))
 ("UP:Q99674" (("CGR11" 24))) ("UP:Q99676" (("ZNF184" 3)))
 ("UP:Q99677" (("LPAR4" 5) ("GPR23" 1)))
 ("UP:Q99683"
  (("ASK1" 596) ("apoptosis signal-regulating kinase 1" 61) ("Ask1" 39)
   ("ASK-1" 36) ("MAP3K5" 19) ("apoptosis signal–regulating kinase 1" 7)
   ("ASK1 peptide" 5) ("apoptosis signal regulating kinase 1" 4)
   ("apoptosis signal-regulating kinase-1" 4)
   ("Apoptosis signal-regulating kinase 1" 4) ("ASK 1" 3) ("nonactive ASK1" 2)
   ("apoptosis signal regulating kinase-1" 2)
   ("oxidative stress–activated ASK1" 1) ("diabetic Ask1  −/−" 1) ("MEKK5" 1)))
 ("UP:Q99684"
  (("Gfi-1" 255) ("Gfi1" 144) ("GFI1" 132)
   ("Zinc-finger (ZF) transcriptional repressor Gfi-1" 1) ("functional Gfi1" 1)
   ("The transcriptional repressor Gfi1" 1)))
 ("UP:Q99685"
  (("MAGL" 73) ("Monoacylglycerol lipase" 12) ("monoacylglycerol lipase" 4)
   ("MGLL" 3) ("MAGL protein" 1)))
 ("UP:Q99689" (("FEZ1" 18)))
 ("UP:Q99697"
  (("RGS" 181) ("PITX2" 179) ("Pitx2" 16) ("RGS protein" 12)
   ("paired-like homeodomain transcription factor 2" 5) ("pitx2" 4)
   ("PITX2 protein" 3) ("we first transiently overexpressed PITX2" 2)
   ("overexpressed PITX2" 2) ("shortest RGS protein" 2)))
 ("UP:Q99698" (("LYST" 3)))
 ("UP:Q99700"
  (("ataxin 2" 154) ("ATXN2" 24) ("Ataxin 2" 3) ("ataxin-2" 3)
   ("normal ataxin 2" 3) ("Atx2" 1)
   ("even SCA2-length (>34Q) polyQ-expanded ataxin 2" 1)))
 ("UP:Q99704"
  (("Dok-1" 42) ("DOK1" 6) ("DOK-1" 4) ("Dok-1 peptide" 2) ("-Dok-1" 1)))
 ("UP:Q99705" (("mCHR" 4) ("MCHR1" 1))) ("UP:Q99706" (("KIR2DL4" 2)))
 ("UP:Q99707"
  (("MS" 6998) ("MTR" 117) ("mTR" 7) ("progressive MS" 6) ("acute MS" 6)
   ("clinically definite MS" 5) ("quantitative MS" 5)
   ("secondary progressive MS" 3) ("MS (RRMS)" 3) ("–MS" 3) ("pMS" 2)
   ("shBeta normoxic MS" 2) ("normoxic MS" 2) ("-MS" 2) ("definite MS" 2)
   ("primary or consecutive MS" 1) ("new MS" 1) ("subsequent MS" 1)
   ("the autoimmune neuroinflammatory disease MS" 1)
   ("100 primary progressive MS (PPMS)" 1) ("Clinically definite MS" 1)
   ("the other cortical MS" 1) ("primary progressive MS (PPMS)" 1)
   ("secondary progressive MS (SPMS)" 1)
   ("The MS cohort included 6 acute MS (AMS)" 1) ("large-scale mitotic MS" 1)
   ("Only definite MS" 1) ("all clinically definite MS" 1) ("possible MS" 1)
   ("probable MS" 1) ("Quantitative SILAC-based MS" 1) ("all analytical MS" 1)
   ("data-dependent MS" 1) ("sequential MALDI QqTOF MS" 1)
   ("quantitative SILAC-based MS" 1)
   ("5-methyltetrahydrofolate-homocysteine methyltransferase" 1)
   ("3 primary progressive MS (PPMS)" 1)
   ("5 secondary progressive MS (SPMS)" 1) ("Representative MS" 1)
   ("The global HX MS" 1) ("the raw MS" 1) ("Detailed MS" 1)
   ("two recent MS" 1) ("A hybrid ion trap-triple quadrupole (Q-Trap) MS" 1)))
 ("UP:Q99708"
  (("CtIP" 1121) ("rim" 198) ("SCKL2" 76) ("CtIP protein" 52) ("CTIP" 37)
   ("SCKL2 protein" 13) ("RBBP8" 12) ("the perinuclear rim" 9) ("Rim" 6)
   ("the neuroretinal rim" 3) ("the outer rim" 3) ("the neural rim" 3)
   ("retinoblastoma binding protein 8" 3) ("gingival rim" 2) ("Ctip" 2)
   ("the transcriptional corepressor CtIP" 2) ("the thin cortical rim" 2)
   ("the peripheral rim" 2) ("the pelvic rim" 2) ("exogenous murine CtIP" 2)
   ("COM1" 2) ("The serine-327-phosphorylated CtIP" 1) ("RBBP8/CtIP" 1)
   ("The corneoscleral rim" 1) ("a narrowed neuroretinal rim" 1)
   ("the peripheral F-actin rim" 1) ("a normal rim" 1)
   ("the polar and charged rim" 1) ("the corneal rim" 1) ("perinuclear rim" 1)
   ("a prominent rim" 1) ("The entire rim" 1) ("the upper rim" 1)
   ("the Pacific Rim" 1) ("rbbp8" 1) ("RBBP8/CTIP" 1) ("more CtIP protein" 1)
   ("than full-length CtIP" 1) ("than the full-length CtIP protein" 1)
   ("CtIP-" 1) ("The infra-orbital rim" 1) ("the infra-orbital rim" 1)
   ("a highly proliferative rim" 1)))
 ("UP:Q99714"
  (("CAMR" 9) ("amyloid-beta peptide" 9) ("HSD17B10" 4) ("ERAb" 2)
   ("hydroxyacyl-Coenzyme A dehydrogenase" 2)
   ("hydroxyacyl-Coenzyme A dehydrogenase (HAD)" 1)))
 ("UP:Q99715" (("COL12A1" 4) ("Col12A1" 1) ("Type XII" 1)))
 ("UP:Q99717" (("Smad5" 32) ("SMAD5" 22) ("MiR-155 directly targets SMAD5" 1)))
 ("UP:Q99720"
  (("Sigma" 13304) ("SIGMA" 174) ("sigma" 75) ("Sigma-" 16) ("Sigma–" 2)
   ("-Sigma" 2) ("sigma-" 1)))
 ("UP:Q99727" (("TIMP4" 10) ("TIMP-4" 3)))
 ("UP:Q99728"
  (("BARD1" 2027) ("BARD1 protein" 39) ("Bard1" 23) ("BARD1-" 23)
   ("BRCA1-associated RING domain protein 1" 7) ("“Q99728”" 4)
   ("BRCA1-associated ring domain protein 1" 3)
   ("BRCA1 associated RING domain 1" 3)
   ("the cytoplasmic homologous recombination marker BARD1" 2)
   ("still binding BARD1" 2) ("Q99728" 2) ("exogenous and endogenous BARD1" 2)
   ("breast cancer associated protein BARD1" 1) ("co-precipitate BARD1" 1)
   ("Only FL BARD1" 1) ("these data strongly support BARD1" 1)
   ("nearby BARD1" 1) ("We first analyzed BARD1" 1) ("bard1" 1)))
 ("UP:Q99731" (("CCL19" 74) ("MIP-3β" 12) ("Ccl19" 2) ("ccl19" 1) ("ccL19" 1)))
 ("UP:Q99732"
  (("simple" 1720) ("Simple" 131) ("LITAF" 18) ("simple relation" 2)
   ("than simple" 1) ("a simple" 1) ("most simple" 1)
   ("S6 (1∶100) (all Cell Signaling, Danvers, MA, USA) N-Histofine Simple" 1)
   ("a more simple" 1) ("than a simple" 1) ("SIMPLE" 1) ("more simple" 1)
   ("PIG7" 1)))
 ("UP:Q99733" (("NAP1L4" 8) ("nucleosome assembly protein 1-like 4" 2)))
 ("UP:Q99741"
  (("Cdc6" 1460) ("CDC6" 227) ("cdc6" 106) ("Cdc6 protein" 47) ("-Cdc6" 15)
   ("cell division cycle 6" 6) ("CDC6-" 4) ("Cdc6 molecule" 3)
   ("Cdc6 (cell division cycle 6) protein" 3) ("Cdc6 peptide" 2)
   ("functional Cdc6" 2) ("the monomeric Cdc6 protein" 2)
   ("Mouse monoclonal anti- Cdc6" 2) ("expressing Cdc6" 2) ("cdc6 protein" 2)
   ("fluorescent Cdc6" 1) ("CDC6 (cell division cycle 6" 1) ("hsCDC6" 1)
   ("exogenous Cdc6" 1) ("the residual Cdc6 protein" 1) ("tumorigenic Cdc6" 1)
   ("even wild-type cdc6" 1)))
 ("UP:Q99743" (("NPAS2" 30) ("Npas2" 7))) ("UP:Q99748" (("neurturin" 1)))
 ("UP:Q99750" (("MDFI" 3) ("I-mfa" 2)))
 ("UP:Q99755" (("PIP5KIα" 20) ("PIP5K1A" 7) ("PIP5K1α" 5)))
 ("UP:Q99757" (("Trx2" 9) ("TXN2" 5) ("thioredoxin 2" 2) ("Trx2 protein" 1)))
 ("UP:Q99758" (("member 3" 25) ("ABCA3" 22) ("ABCA3 protein" 1)))
 ("UP:Q99759"
  (("MEKK3" 31) ("MAP3K3" 6) ("Mekk3" 2) ("MEK kinase 3" 1)
   ("protein kinase kinase kinase 3" 1)))
 ("UP:Q99766" (("Fb" 9) ("F b" 6) ("f b" 2) ("pFb" 1) ("ATP5S" 1) ("−F b" 1)))
 ("UP:Q99767" (("MINT2" 12) ("APBA2" 1))) ("UP:Q99788" (("CMKLR1" 1)))
 ("UP:Q99797"
  (("mitochondrial intermediate peptidase (MIP)" 2)
   ("mitochondrial intermediate peptidase" 2) ("MIPEP" 1)))
 ("UP:Q99798" (("mitochondrial aconitase" 4)))
 ("UP:Q99801"
  (("NKX3.1" 592) ("Nkx3.1" 111) ("NKX3-1" 21) ("NKX3.1 protein" 13)
   ("Nkx 3.1" 11) ("Nkx3-1" 5) ("NK3 homeobox 1" 4) ("functional NKX3.1" 3)
   ("Nkx3.1 protein" 3) ("NKX3.1(1–183) peptide" 2) ("NKx3.1" 2)
   ("the single C-terminal tryptophan of NKX3.1" 1) ("cellular NKX3.1" 1)
   ("NKX3–1" 1)))
 ("UP:Q99807" (("coenzyme Q" 9) ("CAT5" 1)))
 ("UP:Q99808" (("equilibrative nucleoside transporter-1" 2) ("Ent1" 1)))
 ("UP:Q99811" (("Prrx2" 1)))
 ("UP:Q99814"
  (("HIF-2α" 934) ("HIF2α" 542) ("HIF2α protein" 29) ("EPAS1" 20)
   ("HIF-2α protein" 19) ("HIF2a" 7) ("HIF2α molecule" 4) ("HIF-2alpha" 3)
   ("overexpressed HIF-2α" 3) ("endothelial PAS domain protein 1" 3)
   ("functional HIF-2α" 2) ("than HIF2α" 1) ("EPAS-1" 1) ("-HIF-2α" 1)
   ("HIF2α-" 1) ("786-mock cells endogenous HIF2α" 1)
   ("These in vivo data support HIF-2α’s" 1)))
 ("UP:Q99816"
  (("TSG101" 437) ("Tsg101" 114) ("TSG101 protein" 31)
   ("tumor susceptibility gene 101" 19) ("FL" 5) ("cellular TSG101" 3)
   ("Vps23" 3) ("overexpressed TSG101" 2) ("TSG101 (FL)" 1)
   ("ectopically-expressed TSG101" 1) ("Tumor susceptibility gene 101" 1)
   ("tumor susceptibility gene 101 (TSG101) protein" 1)
   ("tumor susceptibility gene 101 protein" 1)))
 ("UP:Q99819" (("RhoGDI3" 2)))
 ("UP:Q99828"
  (("CIB1" 360) ("Kip" 158) ("KIP" 91) ("kinase interacting protein" 30)
   ("-kinase interacting protein" 4) ("KIPs" 1) ("Cib1" 1)
   ("exogenous p27 Kip" 1) ("calmyrin" 1)))
 ("UP:Q99832" (("CCT7" 14)))
 ("UP:Q99835"
  (("SMO" 330) ("Smo" 90) ("Smoothened" 52) ("smoothened" 17)
   ("Smoothened (SMO)" 12) ("smoothened (SMO)" 7) ("SMOH" 5)
   ("smoothened, frizzled class receptor" 1)
   ("the essential HH effector SMO" 1)
   ("the essential pathway effector smoothened (SMO)" 1) ("SMO-" 1)))
 ("UP:Q99836"
  (("MyD88" 478) ("MYD88" 60) ("Myd88" 15) ("MyD88 protein" 8) ("MyD88-" 5)
   ("normal MyD88" 1)))
 ("UP:Q99848" (("EBP2" 5) ("EBNA1BP2" 4) ("EBP-2" 4)))
 ("UP:Q99856"
  (("bright" 523) ("Bright" 277) ("DRX" 15) ("CD4 dim CD8 bright" 5)
   ("less bright" 3) ("“Bright”" 3) ("ARID3A" 3) ("‘bright’" 1)
   ("bright protein" 1) ("autophagosomes appeared bright" 1)
   ("the respective Bright" 1) ("“bright”" 1)))
 ("UP:Q99873"
  (("PRMT1" 351) ("protein arginine methyltransferase 1" 8) ("PRMT1 protein" 6)
   ("ANM1" 3) ("hMT2" 1) ("HRMT1L2" 1)))
 ("UP:Q99877" (("HIST1H2BN" 3))) ("UP:Q99880" (("HIST1H2BL" 2)))
 ("UP:Q99884"
  (("Prot" 92) ("prot" 14) ("PROT" 8) ("“Swiss-Prot”" 1) ("ProT" 1)))
 ("UP:Q99895" (("ctrC" 6) ("CTRC" 1)))
 ("UP:Q99928" (("GABRG3" 4) ("gamma 3" 1)))
 ("UP:Q99929" (("ASCL2" 3) ("Ascl2" 2) ("Ash2" 1))) ("UP:Q99932" (("SPAG8" 2)))
 ("UP:Q99933"
  (("BAG-1" 314) ("BAG-1S" 74) ("BAG-1 protein" 54) ("BAG1" 41) ("Bag-1" 33)))
 ("UP:Q99941" (("ATF6b" 1)))
 ("UP:Q99942"
  (("G16" 25) ("RNF5" 6) ("RMA1" 3) ("Q99942" 1) ("RING5" 1) ("Rma1" 1)))
 ("UP:Q99943"
  (("alpha)" 62) ("G15" 48) ("Alpha)" 8) ("Minimum Essential Medium Alpha)" 4)
   ("AGPAT1" 2) ("Agpat1" 1) ("-G15" 1) ("–G15" 1)))
 ("UP:Q99952" (("PTPN18" 350) ("PTPN18/" 2)))
 ("UP:Q99956"
  (("DUSP9" 150) ("MKP-4" 121) ("MAP kinase phosphatase 4" 2) ("Dusp9" 1)
   ("MKP4" 1)))
 ("UP:Q99958"
  (("FOXC2" 45) ("Foxc2" 18) ("FoxC2" 10) ("forkhead box protein C2" 1)))
 ("UP:Q99959"
  (("PKP2" 259) ("plakophilin 2" 3) ("Plakophilin 2" 2)
   ("The desmosomal armadillo protein plakophilin 2" 2) ("PKP2-" 1)
   ("plakophilin-2" 1)))
 ("UP:Q99961" (("endophilin A2" 17) ("SH3GL1" 3) ("Endophilin-A2" 1)))
 ("UP:Q99962"
  (("SH3GL2" 310) ("endophilin A1" 12) ("SH3GL2 protein" 7)
   ("targeting SH3GL2" 2) ("Endophilin A1" 1)
   ("the available wild-type SH3GL2" 1) ("exogenous SH3GL2" 1)))
 ("UP:Q99963"
  (("endophilin A3" 16) ("endophilin 3" 7) ("SH3GL3" 4) ("Endophilin-A3" 3)
   ("Endophilin A3" 2)))
 ("UP:Q99965" (("CT15" 3) ("ADAM2" 1)))
 ("UP:Q99966" (("CITED1" 2) ("Cited1" 1)))
 ("UP:Q99967"
  (("CITED2" 198) ("Cited2" 57) ("Mrg1" 10)
   ("the HIF-1α transcriptional inhibitor CITED2" 2) ("p35srj" 1)
   ("than the positive control Mrg1 (Bienvenu et al. 2010)" 1)))
 ("UP:Q99972"
  (("MYOC" 182) ("myocilin" 152) ("TIGR" 19) ("Myocilin" 19) ("TiGR" 13)
   ("GLC1A" 6) ("myocilin protein" 4) ("MYOC protein" 3)
   ("functional myocilin" 2) ("MYOCILIN" 2) ("most mutant MYOC" 1)
   ("the severe MYOC mutation Y437H" 1) ("Most mutant MYOC" 1)
   ("the severe MYOC mutant Y437H" 1) ("myocilin ( MYOC )" 1)))
 ("UP:Q99983" (("Osteomodulin" 1)))
 ("UP:Q99985"
  (("Sema3C" 155) ("SEMA3C" 4) ("Additional exogenous Sema3C" 2)
   ("exogenous Sema3C" 1) ("exogenous recombinant human Sema3C" 1)
   ("semaphorin 3C" 1)))
 ("UP:Q99986"
  (("VRK1" 424) ("VRK1 protein" 26) ("vaccinia-related kinase 1" 8)
   ("vaccinia-related kinase 1 (VRK1) protein" 3)
   ("Vaccinia-related kinase 1" 2) ("whose product targets VRK1" 1)))
 ("UP:Q99988"
  (("GDF15" 656) ("NSAID" 509) ("NAG-1" 209) ("MIC-1" 95) ("Nag-1" 90)
   ("PDF" 17) ("GDF-15" 14) ("NRG-1" 13)
   ("Growth differentiation factor 15" 12)
   ("macrophage inhibitory cytokine 1" 7)
   ("macrophage inhibitory cytokine-1" 6) ("MIC-1 protein" 4) ("-GDF15" 3)
   ("GDF15 protein" 3) ("growth/differentiation factor 15" 2) ("Gdf15" 2)
   ("PLAB" 2) ("Nag-1 protein" 2) ("NSAID-activated gene" 2) ("Nag1" 2)
   ("bacterial PDF" 1) ("pdf" 1) ("the highly-induced p53 gene GDF15" 1)
   ("NAG1" 1) ("THE ONLINE PDF" 1) ("PTGFB" 1) ("NSAID-" 1) ("-NSAID" 1)
   ("recent NSAID" 1) ("GDF 15" 1) ("the popular over-the-counter NSAID" 1)
   ("placental bone morphogenetic protein (PLAB)" 1)
   ("placental bone morphogenetic protein" 1) ("exogenous GDF15" 1)
   ("-MIC-1" 1) ("the mature MIC-1 protein" 1)))
 ("UP:Q99990" (("VGLL1" 2)))
 ("UP:Q99996"
  (("AKAP450" 73) ("AKAP9" 12) ("A-kinase anchor protein 450" 3) ("yotiao" 1)
   ("CG-NAP" 1) ("AKAP 450" 1) ("centrosomal AKAP450" 1) ("CG-Nap" 1)
   ("AKAP350" 1)))
 ("UP:Q99999" (("CSTs" 10) ("cerebroside sulfotransferase" 1)))
 ("UP:Q99JR5" (("AZ-1" 1))) ("UP:Q99K85" (("PSAT" 4)))
 ("UP:Q99LI5" (("Zfp281" 1)))
 ("UP:Q99MI6" (("IAN4" 87) ("IAN4 (METLQNVVTGGKKGGC)" 1)))
 ("UP:Q99NF2" (("JAC" 2))) ("UP:Q99PP2" (("TZF" 3)))
 ("UP:Q99PQ1" (("Trim12" 18))) ("UP:Q99R54" (("FMO" 6)))
 ("UP:Q9AEU2" (("GLY" 20))) ("UP:Q9AGC0" (("PFK" 20)))
 ("UP:Q9AGP8" (("DMG" 5)))
 ("UP:Q9AJS8"
  (("HCl" 1269) ("HCL" 472) ("relapsed or refractory HCL" 2)
   ("phenotypic HCL" 2) ("typical HCL" 1) ("Hcl" 1)
   ("10 m M Tris(hydroxymethyl)methylamine (Tris)-HCl" 1) ("-HCl" 1)
   ("finally no guanidine HCl" 1)
   ("immunohistological studies 5 BRAF -mutated HCL" 1)))
 ("UP:Q9ALZ8"
  (("CPEs" 14) ("minimal CPEs" 3) ("MV-Edm infection caused dramatic CPEs" 1)))
 ("UP:Q9AR07" (("JMT" 2))) ("UP:Q9AT76" (("FK1" 24)))
 ("UP:Q9AVL9" (("CS4" 74) ("mtl-1" 1))) ("UP:Q9BE45" (("IκBζ" 6)))
 ("UP:Q9BEG2" (("IL-12Rβ2" 1))) ("UP:Q9BKU4" (("Prohibitin1" 1)))
 ("UP:Q9BLM6" (("TM3" 5))) ("UP:Q9BPS0" (("VG2" 10)))
 ("UP:Q9BPU6" (("CRMP5" 1)))
 ("UP:Q9BPU9" (("MGC4093" 6) ("B9D2 protein" 3) ("B9D2" 2)))
 ("UP:Q9BPV8" (("P2Y13" 1))) ("UP:Q9BPW4" (("APOL4" 2)))
 ("UP:Q9BPW5" (("RASL11B" 2))) ("UP:Q9BPW8" (("NIPSNAP1" 3)))
 ("UP:Q9BPX3" (("hCAP-G" 16) ("NCAPG" 4)))
 ("UP:Q9BPX6" (("calc" 22) ("Calc" 14) ("CALC" 1)))
 ("UP:Q9BPY8"
  (("Hopx" 71) ("OB1" 32) ("HOPX" 7) ("HOP homeobox" 1)
   ("the cardiac maturation factor HOPX" 1) ("obs1" 1)))
 ("UP:Q9BPZ3" (("Paip2" 5)))
 ("UP:Q9BPZ7"
  (("SIN1" 77) ("mSin1" 69) ("Sin1" 51) ("SIN-1" 34) ("mSIN1" 25) ("sin1" 17)
   ("Sin 1" 12) ("stress-activated MAP kinase-interacting protein 1" 8)
   ("stress-activated map kinase-interacting protein 1" 4) ("MAPKAP1" 2)
   ("mitogen-activated protein kinase associated protein 1" 2) ("siN1" 1)
   ("MSIN1" 1) ("Mapkap1" 1)))
 ("UP:Q9BQ15"
  (("hSSB1" 98) ("telomere-associated hSSB1" 3) ("NABP2" 2) ("OBFC2B" 2)))
 ("UP:Q9BQ16" (("SPARC/Osteonectin" 1))) ("UP:Q9BQ50" (("Trex2" 6)))
 ("UP:Q9BQ51"
  (("PD-L2" 29) ("PDCD1LG2" 11) ("PDL2" 3) ("programmed death ligand 2" 2)
   ("pDL2" 2) ("PDL-2" 1)))
 ("UP:Q9BQ67" (("GRWD1" 194) ("Rrb1" 3) ("GRWD1 protein" 2) ("-GRWD1" 1)))
 ("UP:Q9BQ69" (("LRP16" 373) ("MacroD1" 1) ("exogenous LRP16" 1)))
 ("UP:Q9BQ70" (("TCF25" 39) ("Tcf25" 2) ("transcription factor 25" 2)))
 ("UP:Q9BQ83" (("SLX1" 91) ("GIYD1" 1) ("slx1" 1))) ("UP:Q9BQ87" (("TBL-1" 2)))
 ("UP:Q9BQ90" (("PEAS" 2))) ("UP:Q9BQ95" (("ECSIT" 241) ("ECSIT protein" 8)))
 ("UP:Q9BQA1"
  (("MEP50" 122) ("Mep50" 38) ("WDR77" 10) ("methylosome protein 50" 5)
   ("MEP50 protein" 5) ("seven-bladed β-propeller MEP50" 1)
   ("approaches revealed MEP50" 1) ("non-phosphorylatable MEP50" 1)
   ("WD45" 1)))
 ("UP:Q9BQA5"
  (("HiNF-P" 72) ("HINF-P" 3) ("exogenous HiNF-P" 2) ("MIZF" 2)
   ("Exogenous HiNF-P" 1)))
 ("UP:Q9BQB4"
  (("Sost" 95) ("sclerostin" 53) ("Sclerostin" 14) ("SOST" 8)
   ("exogenous sclerostin" 2) ("Exogenous Sclerostin" 2) ("basal Sost" 1)
   ("Sclerostin protein" 1) ("Exogenous sclerostin" 1)))
 ("UP:Q9BQB6"
  (("dithiothreitol" 1447) ("dithiothreitol (DTT)" 269) ("Dithiothreitol" 46)
   ("Dithiothreitol (DTT)" 16) ("VKORC1" 16)
   ("vitamin K epoxide reductase complex subunit 1" 4)))
 ("UP:Q9BQC6" (("MRP63" 1))) ("UP:Q9BQE3" (("TUBA1C" 4)))
 ("UP:Q9BQE4" (("SEPS1" 7) ("VIMP" 4) ("SELS" 1) ("selenoprotein S" 1)))
 ("UP:Q9BQF6" (("SENP7" 2)))
 ("UP:Q9BQG0"
  (("MYBBP1A" 79) ("Myb-binding protein 1A" 3) ("more MYBBP1A" 2)
   ("nucleolar protein Myb-binding protein 1A" 2)
   ("The nucleolar protein MYBBP1A" 1) ("the nucleolar protein MYBBP1A" 1)))
 ("UP:Q9BQG1" (("Syt3" 1)))
 ("UP:Q9BQI3"
  (("HCR" 24) ("HRI" 21) ("heme-regulated inhibitor" 6)
   ("heme regulated inhibitor" 3) ("pHCR" 2)))
 ("UP:Q9BQI9" (("NRIP2" 4))) ("UP:Q9BQN1" (("FAM83C" 8)))
 ("UP:Q9BQQ3"
  (("GRASP65" 150) ("65kDa" 8) ("65kDa protein" 4) ("had intact GRASP65" 2)
   ("GRASP65 protein" 2) ("GRASp65" 1)))
 ("UP:Q9BQR3"
  (("MPN" 1211) ("PRSS27" 14) ("sporadic MPN" 10) ("overt MPN" 5)
   ("JAK2 V617F-negative MPN" 4) ("sporadic and familial MPN" 3)
   ("JAK2  V617F -negative MPN" 3) ("unclassifiable MPN" 3) ("-negative MPN" 2)
   ("JAK2 V617F-positive MPN" 2) ("BCR–ABL1 -negative MPN" 2)
   ("JAK2V617F-positive MPN" 2) ("JAK2 -negative MPN" 2) ("MPN-" 2)
   ("JAK2V617F -negative Ph− MPN" 1) ("classic MPN" 1) ("120 classic MPN" 1)
   ("sporadic and unfiltered familial JAK2 -positive MPN" 1)
   ("two or more MPN" 1) ("the primary MPN" 1) ("V617F -negative MPN" 1)
   ("infrequently BCR-ABL1 -positive MPN" 1) ("a few MPN" 1)
   ("a chronic MPN" 1) ("a potential JAK2 V617F-negative MPN" 1)
   ("either chronic- or blast-phase MPN" 1) ("BCR-ABL1 -negative MPN" 1)
   ("an aggressive MPN" 1) ("the four JAK2V617F-negative MPN" 1)
   ("our JAK2V617F-positive patients developed overt MPN" 1)
   ("An evident MPN (PV)" 1) ("an overt MPN" 1) ("Marapsin" 1)
   ("the 109 informative MPN" 1) ("three unclassifiable MPN" 1)))
 ("UP:Q9BQS6" (("HSPB9" 3))) ("UP:Q9BQS7" (("CPL" 6) ("HepH" 1) ("pCPL" 1)))
 ("UP:Q9BQS8" (("FYCO1" 14) ("FYVE and coiled-coil domain containing 1" 2)))
 ("UP:Q9BQT8" (("SLC25A21" 2)))
 ("UP:Q9BQT9" (("CS3" 109) ("pCS3" 4) ("using Photoshop CS3" 2)))
 ("UP:Q9BR39" (("Jph2" 3))) ("UP:Q9BR76" (("Coro1B" 1) ("CORO1B" 1)))
 ("UP:Q9BRB3" (("Gpi1" 1))) ("UP:Q9BRD0" (("BUD13" 1)))
 ("UP:Q9BRF8" (("CSTP1" 1))) ("UP:Q9BRG1" (("EAP20" 1)))
 ("UP:Q9BRG2"
  (("NSP1" 425) ("NSP1 protein" 24) ("This chimeric NSP1" 2)
   ("coexpressed OSU NSP1" 2) ("its nonstructural protein NSP1" 2)
   ("rotaviral NSP1" 1) ("simian SA11-4F NSP1" 1) ("a nonfunctional NSP1" 1)
   ("available NSP1" 1)))
 ("UP:Q9BRI3" (("SLC30A2" 4))) ("UP:Q9BRJ2" (("MRPL45" 4)))
 ("UP:Q9BRJ9" (("Mesp1" 5) ("MESP1" 3)))
 ("UP:Q9BRK4" (("LAPSER1" 3) ("tumor suppressor 2" 3) ("Lzts2" 2)))
 ("UP:Q9BRK5" (("Cab45" 13) ("the Golgi resident protein Cab45" 1)))
 ("UP:Q9BRP0" (("Ovol2" 9))) ("UP:Q9BRP4" (("PAAF1" 5)))
 ("UP:Q9BRP8" (("PYM" 42) ("PYM-" 2) ("Pym" 1)))
 ("UP:Q9BRQ0"
  (("Pygo2" 133) ("PYGO2" 13) ("Pygo2 protein" 4) ("endogenic Pygo2" 2)
   ("endogenic Pygo2 protein" 1)))
 ("UP:Q9BRQ5" (("Orai3" 108) ("Orai-3" 2) ("functional Orai3" 2)))
 ("UP:Q9BRR0" (("ZKSCAN3" 16) ("ZNF306" 1)))
 ("UP:Q9BRR9"
  (("ArhGAP9" 215) ("10C" 63) ("Rho GTPase-activating protein 9" 4) ("10c" 4)
   ("ArhGAP9 protein" 4) ("−10C" 2) ("−10C>T" 1) ("ARHGAP9" 1)))
 ("UP:Q9BRS2" (("Riok1" 1))) ("UP:Q9BRS8" (("ACHN" 269) ("metastatic ACHN" 1)))
 ("UP:Q9BRT2" (("mNFI" 21) ("CBP6" 1)))
 ("UP:Q9BRT3"
  (("C17ORF37" 13) ("C17orf37" 11) ("MIEN1" 9) ("MIEN1 protein" 1)
   ("c17orf37" 1)))
 ("UP:Q9BRU9" (("UTP23" 3))) ("UP:Q9BRV3" (("SCP" 16)))
 ("UP:Q9BRV8" (("SIKE" 5) ("SIKE1" 1))) ("UP:Q9BRX5" (("Psf3" 3)))
 ("UP:Q9BRX9"
  (("Morg1" 218) ("Morg1-" 3) ("WDR83" 2) ("Wdr83" 1)
   ("the soluble protein Morg1" 1)))
 ("UP:Q9BRZ2" (("TRIM56" 2))) ("UP:Q9BS16" (("CENP-K" 1)))
 ("UP:Q9BS18" (("APC13" 9) ("Swm1" 7) ("Anapc13" 2) ("ANAPC13" 1) ("SWM1" 1)))
 ("UP:Q9BSA4" (("TTYH2" 1)))
 ("UP:Q9BSB4" (("ATG101" 11) ("Atg101" 3) ("C12orf44" 2)))
 ("UP:Q9BSC4" (("NOL10" 1)))
 ("UP:Q9BSD3"
  (("RHINO" 46) ("Rad9-Rad1-Hus1" 30) ("MGC13204" 9)
   ("9-1-1 complex-interacting protein RHINO" 1)))
 ("UP:Q9BSD7" (("NTPase" 4) ("NTPCR" 1)))
 ("UP:Q9BSE2" (("TMEM79" 15) ("transmembrane protein 79" 4)))
 ("UP:Q9BSE5" (("AGMAT" 1))) ("UP:Q9BSF8" (("BTBD10" 60)))
 ("UP:Q9BSG1"
  (("A1-5" 26) ("ZnF2" 7) ("zinc finger protein 2" 6) ("around ZnF2" 1)))
 ("UP:Q9BSH4" (("TACO1" 1))) ("UP:Q9BSH5" (("HDHD3" 11)))
 ("UP:Q9BSI4"
  (("TIN2" 171) ("TINF2" 115) ("TIN2 protein" 4)
   ("the telomere-associated protein TIN2" 1)))
 ("UP:Q9BSJ2" (("GCP2" 9) ("GCP-2" 8)))
 ("UP:Q9BSJ8" (("E-Syt1" 62) ("ESYT1" 4) ("E-SYT1" 2) ("FAM62A" 1)))
 ("UP:Q9BSK2" (("PNC1" 12)))
 ("UP:Q9BSL1" (("KPC2" 7) ("UBADC1" 1) ("UBAC1" 1)))
 ("UP:Q9BSM1" (("PCGF1" 11) ("NSPC1" 3) ("RNF68" 1) ("-PCGF1" 1)))
 ("UP:Q9BSQ5" (("CCM2" 34) ("ccm2" 31) ("Ccm2" 25) ("ccm2 protein" 2)))
 ("UP:Q9BST9" (("Rhotekin" 133) ("rhotekin" 57) ("-rhotekin" 1)))
 ("UP:Q9BSV6" (("TSEN34" 4))) ("UP:Q9BSW2" (("CRACR2A" 1)))
 ("UP:Q9BT22" (("MT-1" 8))) ("UP:Q9BT40" (("PPs" 25)))
 ("UP:Q9BT56" (("SPx" 1)))
 ("UP:Q9BT67" (("Ndfip1" 125) ("NDFIP1" 13) ("Ndfip1 protein" 2)))
 ("UP:Q9BT78"
  (("COP9 signalosome" 101) ("Csn4" 10) ("COP9 signalosome (CSN)" 7)
   ("COP9 Signalosome" 3) ("COPS4" 3)))
 ("UP:Q9BT81"
  (("Sox7" 129) ("SOX7" 6) ("underexpressed Sox7" 6) ("Sox 7" 1) ("Sox-7" 1)))
 ("UP:Q9BT92"
  (("tumor suppressor protein" 1203) ("Tumor suppressor protein" 6)
   ("tumor suppressor protein (RB)" 4) ("a classic tumor suppressor protein" 4)
   ("tumor
                        suppressor protein"
    4)
   ("TPMs" 4) ("a well-known tumor suppressor protein" 3)
   ("the alternate reading frame (Arf) tumor suppressor protein" 3)
   ("a haploinsufficient tumor suppressor protein" 2)
   ("a well-characterized tumor suppressor protein" 2)
   ("a prototypic tumor suppressor protein" 2)
   ("a key tumor suppressor protein" 2)
   ("reading frame (Arf) tumor suppressor protein" 2)
   ("a well-accepted tumor suppressor protein" 2)
   ("a functional tumor suppressor protein" 1)
   ("the tumor suppressor protein's" 1)
   ("the most well studied tumor suppressor protein" 1)
   ("a major tumor suppressor protein" 1)
   ("a multifunctional tumor suppressor protein" 1)
   ("intact tumor suppressor protein" 1)
   ("an antiproliferative (ARPO) tumor suppressor protein" 1)
   ("potential tumor suppressor protein" 1)
   ("tumor
                    suppressor protein"
    1)
   ("bona fide tumor suppressor protein" 1)
   ("a bona fide tumor suppressor protein" 1)
   ("a prominent tumor suppressor protein" 1)))
 ("UP:Q9BTA9" (("WAC" 2)))
 ("UP:Q9BTC0" (("DIDO1" 3) ("death inducer-obliterator 1" 1) ("DATF1" 1)))
 ("UP:Q9BTC8" (("MTA3" 17)))
 ("UP:Q9BTE0"
  (("EBS" 406) ("pEBS" 12) ("the suboptimal EBS" 4) ("a functional EBS" 3)
   ("Ebs" 3) ("other similar palindromic EBS" 2) ("only one EBS" 2)
   ("an optimal EBS" 2) ("palindromic EBS" 1) ("pEBs" 1)
   ("The putative palindromic EBS" 1) ("the palindromic EBS" 1)))
 ("UP:Q9BTE3" (("MCMBP" 22))) ("UP:Q9BTK6" (("PA1" 58)))
 ("UP:Q9BTM9" (("URM1" 1))) ("UP:Q9BTP7" (("FAAP24" 30) ("24kDa" 3)))
 ("UP:Q9BTT0" (("Anp32e" 3))) ("UP:Q9BTT6" (("Lano" 2) ("LRRC1" 1)))
 ("UP:Q9BTU6" (("PI4K2A" 1) ("PI4KII" 1)))
 ("UP:Q9BTV4" (("LumA" 9) ("lumA" 6) ("TMEM43" 3)))
 ("UP:Q9BTV5" (("MIR1" 12) ("Kaposi sarcoma associated herpesvirus MIR1" 1)))
 ("UP:Q9BTW9"
  (("β-tubulin" 582) ("β–tubulin" 7) ("SSD1" 6) ("the polymorphic gene SSD1" 2)
   ("mouse monoclonal anti-human β-tubulin" 2)
   ("neural specific class III β-tubulin" 2)
   ("polyclonal rabbit anti-class III β-tubulin" 2)
   ("mouse monoclonal anti-polycephalum myxamoebae β-tubulin" 2)
   ("β-tubulin (SIGMA)" 1) ("ssd1" 1)
   ("1 μg/ml or rabbit anti-class III β-tubulin" 1)
   ("immunoreactive β-tubulin" 1) ("mouse monoclonal anti β-tubulin" 1)
   ("Neuronal Class III β-tubulin" 1)))
 ("UP:Q9BTZ2" (("PSCD" 4))) ("UP:Q9BU19" (("AREBP" 2) ("ZNF692" 1)))
 ("UP:Q9BU23" (("LMF2" 1))) ("UP:Q9BU40" (("MgC1" 8)))
 ("UP:Q9BU61" (("2P1" 1))) ("UP:Q9BU64" (("CENP-O" 18)))
 ("UP:Q9BU89" (("deoxyhypusine hydroxylase" 6)))
 ("UP:Q9BUB5"
  (("MNK1" 154) ("Mnk1" 99) ("Mnk-1" 58) ("Mknk1" 4) ("MNK-1" 3) ("MNK1-" 2)
   ("MKNK1" 2) ("p-MNK1" 2) ("Thr197/202-phosphorylated Mnk1" 2)
   ("MAP kinase interacting serine/threonine kinase 1" 1) ("MnK1" 1)
   ("p-MNK-1" 1)
   ("MAP kinase-interacting serine/threonine-protein kinase 1" 1)))
 ("UP:Q9BUD6"
  (("extracellular matrix protein" 78)
   ("a major extracellular matrix protein" 2)
   ("Extracellular matrix protein" 2)
   ("the appropriate extracellular matrix protein" 1)
   ("extracellular matrix protein (ECM)" 1)))
 ("UP:Q9BUF5" (("TUBB6" 5) ("Tubb6" 2)))
 ("UP:Q9BUF7"
  (("Crb3" 135) ("CRB3" 9) ("the apical transmembrane protein Crb3" 7)
   ("the apical protein Crb3" 2) ("Crb-3" 1)))
 ("UP:Q9BUH6" (("XLS" 2) ("xLS" 2))) ("UP:Q9BUH8" (("BEGAIN" 1)))
 ("UP:Q9BUJ2"
  (("hnRPUL1" 141) ("HnRPUL1" 13) ("E1B-AP5" 6) ("HNRNPUL1" 3) ("hnRNPUL1" 1)
   ("FLJ12944" 1)))
 ("UP:Q9BUL8" (("PDCD10" 6) ("CCM3" 3))) ("UP:Q9BUL9" (("RPP25" 1)))
 ("UP:Q9BUM1" (("glucose 6 phosphatase" 4))) ("UP:Q9BUN1" (("ment" 1)))
 ("UP:Q9BUN8"
  (("Derlin-1" 8) ("Der1" 3) ("DERLIN" 2) ("derlin-1" 2) ("Derlin1" 1)
   ("the polytopic ER membrane protein Der1" 1)))
 ("UP:Q9BUP3"
  (("CC-3" 535) ("CC3" 185) ("Tip30" 78) ("TIP30" 74) ("cc-3" 24) ("cC3" 15)
   ("HTATIP2" 4) ("HIV-1 Tat interactive protein 2" 3)
   ("specifically target TIP30" 2) ("CC-3 protein" 1) ("than CC3" 1)))
 ("UP:Q9BUQ8" (("DDX23" 3)))
 ("UP:Q9BUR4"
  (("Cajal" 200) ("TCAB1" 157) ("WDR79" 18) ("WRAP53" 5)
   ("overexpressed TCAB1" 5) ("telomerase Cajal body protein 1" 2)
   ("overexpressed HA-tagged TCAB1" 2) ("WRAP53 protein" 1)
   ("Cajal which was associated with Auerbach’s" 1)
   ("stably overexpressed HA-tagged TCAB1" 1) ("Cajal (ICC)" 1)))
 ("UP:Q9BUU2" (("METTL22" 15) ("its associated methyltransferase METTL22" 1)))
 ("UP:Q9BUV8" (("RIP5" 5))) ("UP:Q9BUX1" (("CHAC1" 6)))
 ("UP:Q9BUZ4" (("TRAF4" 462)))
 ("UP:Q9BV20"
  (("MRDI" 138) ("MGC3207" 7) ("MRDI protein" 2) ("-MRDI" 2)
   ("mediator of RhoA-dependent invasion" 1)))
 ("UP:Q9BV40"
  (("v-SNARE" 27) ("EDB" 23) ("Endobrevin" 11) ("VAMP8" 6)
   ("v-SNARE protein" 4) ("a late endosomal/lysosomal v-SNARE" 2)
   ("the exocytic v-SNARE" 1) ("the secretory vesicle v-SNARE" 1)
   ("VAMP-8" 1)))
 ("UP:Q9BV47" (("DUSP24" 2))) ("UP:Q9BV57" (("ARD" 93) ("mtND" 5) ("mTND" 2)))
 ("UP:Q9BV68" (("RNF126" 224) ("RNF126 protein" 2) ("-RNF126" 1)))
 ("UP:Q9BV73"
  (("C-Nap1" 208) ("C-Nap1 protein" 11) ("Cep250" 2)
   ("exogenous full-length C-Nap1" 1) ("mouse monoclonal C-Nap1" 1)
   ("CEP250" 1) ("C-NAP1" 1)))
 ("UP:Q9BV81" (("TMEM93" 1)))
 ("UP:Q9BV86"
  (("NRMT" 63) ("METTL11a" 5) ("NRMT peptide" 2) ("C9orf32" 2) ("NTMT1" 1)
   ("a unique C-terminal NRMT peptide" 1)))
 ("UP:Q9BV90" (("SNRNP25" 42))) ("UP:Q9BV94" (("EDEM2" 1)))
 ("UP:Q9BVA1" (("TUBB2B" 27) ("Tubulin beta 2B class IIb" 2) ("Tubb2b" 1)))
 ("UP:Q9BVC3" (("DCC1" 3) ("DSCC1" 1)))
 ("UP:Q9BVC4"
  (("mLST8" 447) ("GβL" 69) ("-mLST8" 34) ("LST8" 23) ("GbL" 9) ("mlst8" 8)
   ("–mLST8" 7) ("Lst8" 6) ("mLST8 protein" 4) ("GbetaL" 3) ("LST8 homolog" 3)
   ("MLST8" 2) ("GBL" 2)))
 ("UP:Q9BVC5" (("ASW" 36)))
 ("UP:Q9BVG3"
  (("DEAR1" 305) ("Dear1" 55) ("DEAR1 protein" 4) ("that DEAR1’s" 1)
   ("Our data support DEAR1’s" 1) ("TRIM62" 1)))
 ("UP:Q9BVG8" (("KIFC3" 13))) ("UP:Q9BVG9" (("PSS2" 2)))
 ("UP:Q9BVI0"
  (("PHF20" 243) ("NZF" 43) ("PHF20 protein" 2) ("GLEA2" 2)
   ("glioma-expressed antigen 2" 2) ("Homodimeric PHF20" 1) ("TZP" 1)
   ("Phf20" 1)))
 ("UP:Q9BVJ6"
  (("UTP14a" 10) ("Utp14" 6) ("UTP14" 2) ("utp14a" 1) ("UTP14A" 1)))
 ("UP:Q9BVJ7" (("DUSP23" 4) ("VHZ" 3))) ("UP:Q9BVK2" (("ALG8" 1)))
 ("UP:Q9BVL2" (("NUPL1" 2) ("nucleoporin like 1" 2)))
 ("UP:Q9BVP2"
  (("NS" 2748) ("ns" 300) ("nucleostemin" 46) ("Nucleostemin" 22)
   ("NS protein" 16) ("NS-" 13) ("GNL3" 9) ("nucleostemin protein" 7)
   ("guanine nucleotide-binding protein-like 3" 5) ("pNS" 5) ("than NS" 4)
   ("the last 30 ns" 4) ("nucleostemin (NS)" 4) ("equilibrium around 4 ns" 3)
   ("primary NS" 2) ("Nucleostemin (NS)" 2) ("an equilibrium around 4 ns" 2)
   ("a sudden decrease around 9.5 ns" 2)
   ("the nucleolar GTP-binding protein nucleostemin (NS)" 2) ("nucleolar NS" 2)
   ("overexpressed NS" 2) ("Congenital NS" 2)
   ("The marked sebaceous hyperplasia observed NS" 2)
   ("the aforementioned nucleostemin" 2) ("two normal NS" 1)
   ("four independent normal NS" 1) ("Bacterial purified His-tagged NS" 1)
   ("nucleolar GTPase Nucleostemin (NS)" 1) ("a sudden increase around 7 ns" 1)
   ("an equilibrium around 5 ns" 1) ("a sudden decrease around 9 ns" 1)
   ("an equilibrium around 6 ns" 1) ("a sudden decrease around 7 ns" 1)
   ("a sudden increase around 7.5 ns" 1) ("a sudden decrease around 7.5 ns" 1)
   ("equilibrium around 6 ns" 1) ("classic NS" 1) ("cellular NS" 1)
   ("the last 80 ns" 1) ("around 17 ns" 1) ("mouse hippocampal NS" 1)
   ("postnatal wt SVZ NS" 1) ("E17.5 thalamic NS" 1) ("Wt postnatal SVZ NS" 1)
   ("GLI1 produced more NS" 1) ("than DT −dox NS" 1) ("-NS" 1)
   ("PTPN11, SOS1, KRAS and RAF1 typically cause NS" 1) ("more NS" 1)
   ("than NS ( xref )" 1) ("Guanine nucleotide binding protein-like 3" 1)
   ("the 302 recurrent NS" 1) ("congenital NS" 1) ("P30 NS47466" 1) ("“NS”" 1)
   ("than the wild-type NS" 1) ("intact NS" 1) ("fewer primary NS" 1)
   ("secondary NS" 1)))
 ("UP:Q9BVS5" (("TRMT61B" 3))) ("UP:Q9BVT8" (("TMUB1" 55)))
 ("UP:Q9BVW5" (("TIPIN" 33) ("Tipin" 8))) ("UP:Q9BW11" (("MXD3" 2) ("Mxd3" 1)))
 ("UP:Q9BW19" (("hSET" 3) ("KIFC1" 3) ("HSET" 1))) ("UP:Q9BW27" (("Nup85" 1)))
 ("UP:Q9BW61" (("DDA1" 5))) ("UP:Q9BW66" (("CINP" 16)))
 ("UP:Q9BW71" (("HIRIP3" 23))) ("UP:Q9BW83" (("IFT27" 6)))
 ("UP:Q9BW91" (("NUDT9" 1))) ("UP:Q9BWD1" (("p-acetyl-CoA" 1)))
 ("UP:Q9BWE0" (("REPIN1" 1)))
 ("UP:Q9BWF2" (("TRAIP" 141) ("TRAIP protein" 6) ("RNF206" 1)))
 ("UP:Q9BWF3" (("RBM4" 1))) ("UP:Q9BWG4" (("SSBP4" 1)))
 ("UP:Q9BWK5"
  (("MRI" 1125) ("MRIs" 23) ("cardiac MRI" 6) ("annual MRI" 4) ("MRI-" 4)
   ("Cardiac MRI" 4) ("contrast-enhanced T1-weighted MRI" 3) ("Annual MRI" 3)
   ("underwent annual MRI" 3) ("preoperative MRI" 2)
   ("annual mammography and breast MRI" 2) ("the postoperative MRI" 2)
   ("fetal MRI" 2) ("foetal MRI" 2) ("pre-operative MRI" 2)
   ("annual breast MRI" 2) ("had annual MRI" 2) ("contrast-enhanced MRI" 2)
   ("underwent repeated MRI" 2) ("normal MRI" 2) ("A new MRI" 2)
   ("Cerebral MRI" 2) ("abdominal MRI" 1) ("T1-weighted structural MRI" 1)
   ("MRI using Schneiderman's" 1) ("rectal MRI" 1) ("serial brain MRI" 1)
   ("Regular MRI" 1) ("Post-operative MRI" 1) ("MRI (DWI)" 1)
   ("Contrast-enhanced T1-weighted MRI" 1) ("the more precise MRI" 1)
   ("the fetal MRI" 1) ("The preoperative MRI" 1) ("typical MRI" 1)
   ("foetal brain MRI" 1) ("abnormal MRI" 1) ("this study underwent MRI" 1)
   ("dynamic contrast-enhanced MRI" 1)
   ("dynamic contrast-enhanced (DCE)-MRI" 1) ("-MRI" 1) ("recent MRI" 1)
   ("Serial MRI" 1) ("Preoperative MRI" 1) ("Pituitary MRI" 1)
   ("Ovarian MRI" 1) ("serial MRI" 1) ("Concurrent MRI" 1)
   ("bilateral breast MRI" 1) ("a normal preoperative brain MRI" 1)
   ("pre-operative brain MRI" 1) ("Cranial MRIs" 1)
   ("approximately 800 breast MRIs" 1) ("an annual breast MRI" 1)
   ("Structural MRI" 1) ("annual mammogram and breast MRI" 1)
   ("Atherosclerosis (MESA) performed cardiac MRI" 1)
   ("contrast-enhanced cranial MRI" 1)
   ("most frequently evaluated by contrast-enhanced cranial MRI" 1)
   ("postoperative MRI" 1) ("early postoperative MRI" 1)
   ("the functional MRI" 1) ("functional MRI" 1) ("a noninvasive MRI-" 1)
   ("the Austrian Stroke Prevention Study underwent MRI" 1) ("pelvic MRI" 1)
   ("The cerebral MRI" 1) ("A cervical-spinal MRI" 1) ("A new cerebral MRI" 1)
   ("Fetal MRI" 1) ("structural MRI" 1)
   ("both structural and functional MRI" 1) ("Emergent brain MRI" 1)
   ("physical examination and brain MRI" 1) ("regular bilateral breast MRI" 1)
   ("no suspicious proliferative lesions detectable using standard whole-body MRI"
    1)
   ("the cardinal MRI" 1) ("essentially normal MRI" 1)))
 ("UP:Q9BWQ8" (("LFG" 1))) ("UP:Q9BWT1" (("CDCA7" 2)))
 ("UP:Q9BWT6" (("Mnd1" 4) ("MND1" 2)))
 ("UP:Q9BWT7" (("CARMA3" 156) ("CARD10" 29) ("Carma3" 11) ("CARMA3-" 2)))
 ("UP:Q9BWU1"
  (("CDK11" 196) ("CDK19" 2) ("Cyclin-dependent kinase 11" 2) ("CDC2L6" 1)))
 ("UP:Q9BWV1"
  (("Boc" 57) ("BOC" 10) ("boc" 8) ("oncogene regulated" 3) ("-Boc" 2)
   ("cell adhesion associated" 2) ("Boc-" 2)))
 ("UP:Q9BWV2" (("SPATA9" 6))) ("UP:Q9BWW4" (("SSDP1" 4)))
 ("UP:Q9BWW8" (("APOL6" 2))) ("UP:Q9BWX1" (("PHF7" 2)))
 ("UP:Q9BWX5"
  (("gata5" 11) ("GATA5" 9) ("Gata5" 2) ("the mesendodermal marker gata5" 2)
   ("GATAs" 1) ("GATA5 (TCCTGGCATA)" 1)))
 ("UP:Q9BX59" (("TAPBPL" 1)))
 ("UP:Q9BX63"
  (("FANCJ" 1117) ("BRIP1" 642) ("FANCJ protein" 38) ("Brip1" 6) ("Fanc-J" 3)
   ("BRCA1 interacting protein C-terminal helicase 1" 2) ("than FANCJ" 2)
   ("BRIP1 protein" 2) ("sufficient residual FANCJ" 1) ("intact FANCJ" 1)
   ("functional FANCJ" 1) ("this study effectively decrease FANCJ" 1)
   ("BRIP1-" 1) ("BRCA1-bound and-unbound FANCJ" 1) ("the CPT-treated FANCJ" 1)
   ("exogenous FANCJ" 1) ("the very last amino acid of FANCJ" 1)))
 ("UP:Q9BX66" (("CAP" 205) ("CAP-" 3) ("SORBS1" 3) ("ponsin" 1)))
 ("UP:Q9BX67" (("JAM3" 7))) ("UP:Q9BX69" (("CARD6" 1)))
 ("UP:Q9BX73" (("TM2D2" 4) ("BLP1" 2))) ("UP:Q9BX74" (("TM2D1" 1)))
 ("UP:Q9BX79" (("FLJ12541" 1))) ("UP:Q9BX82" (("Erp1" 4) ("ERP1" 2)))
 ("UP:Q9BX95" (("SGPP1" 1))) ("UP:Q9BX97" (("PV1" 1) ("Fels" 1)))
 ("UP:Q9BXA6" (("SSTK" 1) ("TSSK6" 1))) ("UP:Q9BXA9" (("SALL3" 3)))
 ("UP:Q9BXB1" (("LGR4" 2))) ("UP:Q9BXB5" (("OSBPL10" 3)))
 ("UP:Q9BXC0" (("HCA1" 2))) ("UP:Q9BXC9" (("BBS2" 2)))
 ("UP:Q9BXD5" (("NPL" 8))) ("UP:Q9BXF6" (("Rip11" 1)))
 ("UP:Q9BXG8" (("Spz1" 2))) ("UP:Q9BXI2" (("SLC25A2" 1)))
 ("UP:Q9BXI3" (("CNI" 116) ("CNI-" 8)))
 ("UP:Q9BXI6" (("TBC1D10A" 16) ("TBC1D10" 3))) ("UP:Q9BXI9" (("C1QTNF6" 14)))
 ("UP:Q9BXJ9" (("Nath" 22) ("NATH" 8))) ("UP:Q9BXK1" (("KLF16" 2) ("BTEB4" 1)))
 ("UP:Q9BXK5" (("BCL2L13" 1)))
 ("UP:Q9BXL5"
  (("BMMCs" 174) ("NDR" 24) ("nontransgenic BMMCs" 3) ("BMMCS" 2)
   ("Kitl-stimulated nontransgenic BMMCs" 2) ("HEMGN" 2) ("primary BMMCs" 1)
   ("Ndr" 1) ("long-lived BMMCs" 1)))
 ("UP:Q9BXL6" (("CARMA2" 36) ("Carma2" 4) ("CARD14" 2) ("PSORS2" 2)))
 ("UP:Q9BXL7"
  (("CARMA1" 171) ("Carma1" 134) ("CARD11" 45) ("CARMA-1" 2) ("Carma1-" 2)
   ("PKCθ-phosphorylated CARMA1" 1) ("Caspase recruitment domain family" 1)))
 ("UP:Q9BXM0" (("PRXs" 14) ("periaxin" 5) ("Prxs" 2) ("Periaxin" 1)))
 ("UP:Q9BXM7"
  (("PINK1" 782) ("PINK1 protein" 22) ("hPINK1" 12)
   ("–PINK1 (112–581 amino acids) protein" 4) ("Pink1" 4) ("–PINK1" 2)
   ("PARK6" 2) ("pathogenic PINK1 G309D" 1)
   ("than PINK1-WT ( xref and Supplemental Figure S4B)" 1) ("-PINK1" 1)
   ("Park6" 1) ("PTEN induced putative kinase 1" 1)))
 ("UP:Q9BXN1"
  (("asporin" 19) ("ASPN" 17) ("AspN" 9) ("Aspn" 1)
   ("the atypical proteoglycan asporin" 1)
   ("the scarce glycoprotein asporin" 1)))
 ("UP:Q9BXN2"
  (("Dectin-1" 65) ("dectin-1" 11) ("CLEC7A" 2) ("Dectin-1-" 2) ("clec7a" 1)
   ("Clec7a" 1) ("superfamily member 12" 1)))
 ("UP:Q9BXP2" (("SLC12A9" 2))) ("UP:Q9BXP5" (("Serrate" 13) ("Ars2" 3)))
 ("UP:Q9BXR0" (("TGT" 602) ("-TGT" 42) ("TGT-" 8) ("‘TGT'" 3)))
 ("UP:Q9BXR5" (("TLR10" 17))) ("UP:Q9BXR6" (("CFHL5" 2)))
 ("UP:Q9BXS5" (("AP1M1" 1)))
 ("UP:Q9BXS6"
  (("NuSAP" 110) ("NUSAP1" 61) ("Nusap1" 2) ("prognostic and included NuSAP" 2)
   ("nucleolar and spindle associated protein 1" 2) ("NuSAP1" 2)))
 ("UP:Q9BXS9" (("SLC26A6" 1))) ("UP:Q9BXT4" (("tudor domain containing 1" 1)))
 ("UP:Q9BXT5" (("TEX15" 4))) ("UP:Q9BXU1" (("STK31" 2)))
 ("UP:Q9BXU7" (("USP26" 2) ("Usp26" 1)))
 ("UP:Q9BXW4" (("LC3C" 10) ("MAP1LC3C" 4))) ("UP:Q9BXW6" (("ORP1L" 1)))
 ("UP:Q9BXW9"
  (("FANCD2" 1653) ("Fancd2" 41) ("FANCD2 protein" 23) ("FA-D2" 17)
   ("FancD2" 13) ("FANCD2-L" 5)
   ("the minichromosome maintenance–associated FA factor FANCD2" 2)
   ("Fancd2 protein" 2) ("Successful FANCD2" 2) ("-FANCD2" 1)
   ("Chromatin-associated FANCD2" 1) ("FANCD2 (FARF)" 1) ("basal FANCD2" 1)
   ("than FANCD2 in cells (Figure xref )" 1) ("FANCD2−" 1) ("–FANCD2" 1)
   ("the completely negative FANCD2" 1)))
 ("UP:Q9BXY4"
  (("domain containing 2" 6) ("RSPO3" 3)
   ("cysteine-rich secretory protein LCCL domain containing 2" 2) ("Rspo3" 1)))
 ("UP:Q9BXY8" (("BEX2" 7)))
 ("UP:Q9BY08"
  (("ERP" 31) ("the frontal ERP" 1) ("Erp" 1) ("accession ERP001432" 1)))
 ("UP:Q9BY11"
  (("syndapin I" 5) ("PACSIN1" 4)
   ("protein kinase C and casein kinase substrate in neurons 1" 1)))
 ("UP:Q9BY12" (("SCAPER" 232) ("ZNF291" 5) ("exogenous SCAPER" 1)))
 ("UP:Q9BY19"
  (("MS4A4" 212) ("overexpressed MS4A4" 2) ("than MS4A4 ( xref )" 1)
   ("fluorescent protein–tagged MS4A4" 1)))
 ("UP:Q9BY21"
  (("GPR87" 154) ("GPR87 protein" 2) ("exogenous siRNA-resistant GPR87" 1)))
 ("UP:Q9BY27" (("DGCR6L" 3))) ("UP:Q9BY32" (("ITPA" 2)))
 ("UP:Q9BY41"
  (("HDAC8" 1418) ("α-SMA" 739) ("-HDAC8" 86) ("HDAC8–" 32)
   ("histone deacetylase 8" 8) ("α−SMA" 6) ("HDAC8 protein" 5) ("HDAC8-" 3)
   ("Hdac8" 3) ("“HDAC8”" 2) ("metal-bound HDAC8" 2) ("minimal α-SMA" 2)
   ("α–SMA" 2) ("mouse monoclonal anti-human α-SMA" 2)
   ("preferentially target HDAC8" 1) ("than HDAC8" 1) ("exogenous HDAC8" 1)
   ("the mesenchymal marker α-SMA" 1) ("that HDAC8's" 1)
   ("functional HDAC8" 1)))
 ("UP:Q9BY44"
  (("EIF2A" 19) ("eIF2a" 7) ("eIF2A" 4)
   ("Eukaryotic translation initiation factor 2A" 2) ("p-EIF2A" 2)))
 ("UP:Q9BY49"
  (("PECR" 9) ("peroxisomal trans-2-enoyl-coA reductase" 2)
   ("peroxisomal trans-2-enoyl-coA reductase ( PECR )" 1)))
 ("UP:Q9BY50" (("Sec11c" 1))) ("UP:Q9BY64" (("UGT2B28" 1)))
 ("UP:Q9BY66"
  (("HY" 98) ("SMCY" 8) ("HY peptide" 7) ("-HY peptide" 2) ("JARID1D" 2)
   ("KDM5D" 2) ("-HY" 1) ("−HY" 1)))
 ("UP:Q9BY67"
  (("CADM1" 177) ("SynCAM" 166) ("IGSF4" 9) ("cell adhesion molecule-1" 9)
   ("SynCAMs" 5) ("TSLC1" 4) ("Cell adhesion molecule 1" 4)
   ("cell adhesion molecule 1" 3) ("overexpressed SynCAM" 3)
   ("synaptic cell adhesion molecule" 2)
   ("intercellular cell adhesion molecule-1" 2)
   ("soluble intercellular cell adhesion molecule 1" 2)
   ("postsynaptic SynCAM" 2) ("IgSF4A" 1) ("Necl-2" 1) ("exogenous CADM1" 1)
   ("the intercellular cell adhesion molecule-1 protein" 1)
   ("cell adhesion molecule-1 protein" 1) ("than SynCAM" 1)
   ("synaptosomal SynCAM" 1) ("Cadm1" 1) ("nectin-like 2" 1)
   ("the synaptogenic adhesion molecule SynCAM" 1)))
 ("UP:Q9BY76"
  (("ANGPTL4" 120) ("Angptl4" 96) ("NL2" 7) ("angiopoietin like 4" 4)
   ("ARP4" 2) ("Angptl4 protein" 2)))
 ("UP:Q9BY77"
  (("p46" 60) ("SKAR" 9) ("P46" 4)
   ("S6K1 Aly/REF-like target protein (SKAR)" 2) ("S6K1 Aly/REF-like target" 2)
   ("p46-" 2) ("pp46" 1)))
 ("UP:Q9BY78" (("RNF26" 3)))
 ("UP:Q9BY84"
  (("DUSP16" 23) ("MKP-7" 16) ("Dual specificity phosphatase 16" 1)
   ("MAPK phosphatase-7" 1) ("MKP7" 1)))
 ("UP:Q9BYB0" (("SHANK3" 7) ("Shank3" 4)))
 ("UP:Q9BYC2"
  (("Scott" 68) ("aqueous hematoxylin/blue Scott's" 1)
   ("aqueous hematoxylin/blue Scott" 1)))
 ("UP:Q9BYC5" (("FUT8" 2) ("Fucosyltransferase 8" 2) ("Fut8" 1)))
 ("UP:Q9BYC8" (("L32" 17)))
 ("UP:Q9BYD1"
  (("RPL13" 16) ("L13A" 10) ("L13" 7) ("MRPL13" 4) ("L13a" 2) ("Rpl13" 1)
   ("ribosomal L13a protein" 1) ("L13a protein" 1)))
 ("UP:Q9BYE0" (("HES7" 3) ("Hes7" 1))) ("UP:Q9BYE2" (("TMPRSS13" 2)))
 ("UP:Q9BYE4" (("SPRR2G" 4)))
 ("UP:Q9BYE7" (("PCGF6" 5) ("MBLR" 2) ("-PCGF6" 1)))
 ("UP:Q9BYF1" (("ACE2" 105) ("cardiac ACE2" 3) ("soluble ACE2" 2) ("Ace2" 2)))
 ("UP:Q9BYG0" (("B3GNT5" 1)))
 ("UP:Q9BYG4" (("Par6γ" 6) ("PARD6G" 3) ("PAR6G" 1)))
 ("UP:Q9BYG5" (("Par6B" 34) ("PARD6B" 6) ("Par6b" 3) ("PAR6B" 1)))
 ("UP:Q9BYG8" (("Gsdmc" 46) ("GSDMC" 31) ("MLZE" 5)))
 ("UP:Q9BYH1" (("Sez6l" 2)))
 ("UP:Q9BYH8"
  (("mail" 51) ("NFKBIZ" 15) ("regular mail" 3) ("Brazilian mail" 1)))
 ("UP:Q9BYJ0" (("FGFBP2" 3) ("KSP37" 1)))
 ("UP:Q9BYJ4" (("TRIM34" 59) ("Trim34" 1)))
 ("UP:Q9BYK8"
  (("transcriptional coactivator" 385) ("PRIC285" 3)
   ("the E1A-associated cellular p300 transcriptional coactivator" 2)
   ("a cold-inducible transcriptional coactivator" 2)
   ("the nascent polypeptide-associated complex and coactivator alpha (NACA) transcriptional coactivator"
    2)
   ("a physiologic transcriptional coactivator" 2) ("PDIP1" 1)
   ("Transcriptional coactivator" 1)
   ("a crucial transcriptional coactivator" 1)
   ("This powerful transcriptional coactivator" 1)
   ("a key transcriptional coactivator" 1)))
 ("UP:Q9BYM8"
  (("RBCK1" 36) ("HOIL-1" 6) ("heme-oxidized IRP2 ubiquitin ligase 1" 4)
   ("RanBP-type and C3HC4-type zinc finger containing 1" 2) ("HOIL1" 1)))
 ("UP:Q9BYN0"
  (("SRXN1" 12) ("Srxn1" 5) ("sulfiredoxin 1" 4) ("Srx" 3)
   ("sulfiredoxin1" 1)))
 ("UP:Q9BYT3"
  (("STK33" 228) ("STK33 protein" 6) ("serine/threonine kinase 33" 1)
   ("less STK33" 1)))
 ("UP:Q9BYU1" (("PBX4" 2)))
 ("UP:Q9BYV1" (("AGT2" 2) ("alanine-glyoxylate aminotransferase 2" 2)))
 ("UP:Q9BYV2" (("MuRF" 15) ("TRIM54" 3) ("Murf3" 1)))
 ("UP:Q9BYV6" (("TRIM55" 9))) ("UP:Q9BYV8" (("testis specific" 3)))
 ("UP:Q9BYV9" (("BACH2" 162) ("Bach2" 121) ("Bach2-" 2)))
 ("UP:Q9BYW1"
  (("SLC2A11" 5)
   ("solute carrier family 2 (facilitated glucose transporter)" 2)))
 ("UP:Q9BYW2"
  (("HIF-1" 1832) ("SETD2" 370) ("Set2" 31) ("HIF-1 protein" 8) ("Setd2" 7)
   ("HIF 1" 7) ("HIF-1-" 4) ("targeting SETD2" 3) ("SETD2-" 3) ("-HIF-1" 2)
   ("NF-κB both positively and negatively fine-tuned HIF-1" 2)
   ("Huntingtin-interacting protein 1" 2)
   ("huntingtin-interacting protein 1" 2) ("HIF–1" 2)
   ("the hypoxia-responsive transcriptional factor HIF-1" 2) ("set2" 1)
   ("HYPB" 1) ("than HIF-1" 1) ("functional HIF-1" 1)))
 ("UP:Q9BYW3" (("DEFB126" 4)))
 ("UP:Q9BYX2"
  (("Armus" 215) ("TBC1D2" 4) ("associated Armus" 2) ("TBC1D2A" 2)
   ("Armus protein" 1)))
 ("UP:Q9BYX4"
  (("MDA5" 142) ("IFIH1" 58) ("MDA-5" 25)
   ("melanoma differentiation-associated gene 5" 13) ("Mda5" 10)
   ("interferon induced" 9) ("Mda-5" 5)
   ("melanoma differentiation-associated protein 5" 3) ("MDA5-" 1)
   ("interferon induced with helicase C domain 1" 1) ("Q9BYX4" 1)
   ("the enteroviral response gene IFIH1" 1)))
 ("UP:Q9BYZ6"
  (("P83" 4) ("Cancer 2" 3) ("DBC2" 3) ("RhoBTB2" 2) ("cancer 2" 1) ("p83" 1)))
 ("UP:Q9BYZ8" (("RELP" 2)))
 ("UP:Q9BZ11" (("ADAM33" 17) ("ADAM metallopeptidase domain 33" 1)))
 ("UP:Q9BZ29" (("DOCK9" 20) ("Zizimin1" 4) ("Dock9" 3)))
 ("UP:Q9BZ71" (("NIR1-" 1) ("NIR1" 1))) ("UP:Q9BZ72" (("PITPNM2" 2)))
 ("UP:Q9BZ95"
  (("WHSC1L1" 46) ("NSD3" 10)
   ("Wolf–Hirschhorn syndrome candidate 1-like 1" 3)))
 ("UP:Q9BZA7"
  (("PCDH11" 13) ("protocadherins" 7) ("protocadherin 11" 2) ("PCDH11X" 2)))
 ("UP:Q9BZA8" (("PCDH11Y" 2)))
 ("UP:Q9BZB8"
  (("CPEB1" 142) ("-CPEB1" 7)
   ("cytoplasmic polyadenylation element–binding protein" 1)
   ("cytoplasmic polyadenylation element binding protein 1" 1)))
 ("UP:Q9BZC1" (("BRUNOL4" 8))) ("UP:Q9BZC7" (("ABCA2" 21)))
 ("UP:Q9BZD4" (("hNuf2" 6) ("Nuf2" 5) ("NUF2" 2)))
 ("UP:Q9BZE0"
  (("NKL" 79) ("Glis2" 2) ("the zinc finger transcriptional repressor Glis2" 1)
   ("NKL–" 1)))
 ("UP:Q9BZE9" (("ASPSCR1" 26) ("UBXD9" 4) ("ASPL" 3) ("TUG" 3)))
 ("UP:Q9BZF2" (("OSBPL7" 1))) ("UP:Q9BZF3" (("OSBPL6" 1)))
 ("UP:Q9BZF9" (("Uaca" 2))) ("UP:Q9BZG8" (("DPH1" 1)))
 ("UP:Q9BZH6" (("WDR11" 20)))
 ("UP:Q9BZI1" (("IRX2" 30) ("IRX2 protein" 3) ("Irx2" 1)))
 ("UP:Q9BZI7" (("hUpf3B" 27) ("Upf3B" 25) ("Upf3b" 3)))
 ("UP:Q9BZJ0" (("CRN" 9))) ("UP:Q9BZJ4" (("Slc25a39" 1)))
 ("UP:Q9BZK7"
  (("TBLR1" 280) ("TBL1XR1" 44) ("Ira1" 34) ("ira1" 26)
   ("overexpressed nuclear TBLR1" 2) ("IRA1" 2) ("TBLR-1" 2) ("dc42" 1)
   ("more TBLR1" 1) ("TBL1XR1 protein" 1)))
 ("UP:Q9BZL1" (("UBL5" 2) ("Ubl5" 1)))
 ("UP:Q9BZL4"
  (("PPP1R12C" 98) ("protein phosphatase 1 regulatory subunit 12C" 6)
   ("overexpressed WT PPP1R12C" 2) ("MBS85" 2) ("than PPP1R12C" 1)))
 ("UP:Q9BZL6" (("PRKD2" 4))) ("UP:Q9BZM1" (("PLA2G12A" 2)))
 ("UP:Q9BZM3" (("GSH2" 2) ("GSX2" 1)))
 ("UP:Q9BZM5" (("ULBP-2" 35) ("ULBP2" 7) ("UL16 binding protein 2" 2)))
 ("UP:Q9BZM6"
  (("ULBP-1" 48) ("ULBP1" 31) ("ulbp1" 3) ("roughly 40-fold more ULBP1" 1)))
 ("UP:Q9BZP6" (("CHIA" 1)))
 ("UP:Q9BZQ4"
  (("NMNAT2" 166) ("nicotinamide mononucleotide adenylyltransferase 2" 3)))
 ("UP:Q9BZQ6" (("EDEM3" 3)))
 ("UP:Q9BZR6"
  (("NGR" 11) ("Nogo-66 receptor" 7) ("NgR" 1) ("nogo receptor" 1)))
 ("UP:Q9BZR8" (("BCL2L14" 12) ("Bcl-G" 3)))
 ("UP:Q9BZR9" (("GERP" 11) ("TRIM8" 4)))
 ("UP:Q9BZS1"
  (("FOXP3" 597) ("Foxp3" 561) ("FoxP3" 281) ("forkhead box P3" 21)
   ("Foxp3 protein" 12) ("IPEX" 7) ("Forkhead box P3" 4) ("FOXp3" 4)
   ("FoxP3 protein" 4) ("Forkhead Box P3" 3)
   ("transcriptional factor forkhead box P3" 2) ("FOXP3-" 2)
   ("each tyrosine of FOXP3" 1) ("FOXP3 protein" 1) ("Foxp3-" 1)
   ("the lineage-specific transcription factor Foxp3" 1)
   ("directly target FOXP3" 1) ("cellular Foxp3" 1) ("than wildtype Foxp3" 1)))
 ("UP:Q9BZV1"
  (("UBXD1" 107) ("UBXN6" 7) ("overexpressed mCherry-tagged UBXD1" 2)
   ("transiently overexpressed mCherry-tagged UBXD1" 1)))
 ("UP:Q9BZW2" (("SLC13A1" 1)))
 ("UP:Q9BZW8"
  (("2B4" 292) ("nail" 69) ("CD244" 54) ("SLAMF4" 2) ("2B4-" 1)
   ("2B4 molecule" 1) ("Nail" 1)))
 ("UP:Q9BZX2"
  (("uridine" 144) ("Uridine" 5) ("-uridine" 3) ("UCK2" 2) ("uridine-" 1)))
 ("UP:Q9BZZ2"
  (("sialoadhesin" 11) ("sialoadhesins" 3) ("Sialoadhesin" 2) ("Siglec-1" 1)))
 ("UP:Q9BZZ5"
  (("Api5" 186) ("API5" 23) ("FIF" 4) ("Api5-" 2) ("API-5" 2)
   ("apoptosis inhibitor-5" 2) ("Api5 protein" 1) ("aac11" 1)
   ("Apoptosis inhibitor-5" 1)))
 ("UP:Q9C000"
  (("NAC" 1297) ("neoadjuvant chemotherapy" 488)
   ("systemic lupus erythematosus" 179) ("NAc" 111)
   ("Systemic lupus erythematosus" 37) ("NaC" 33) ("NALP1" 29)
   ("Neoadjuvant chemotherapy" 24) ("CED-4" 10)
   ("systemic lupus erythematosus (SLE)" 9) ("NLRP1" 8)
   ("underwent neoadjuvant chemotherapy" 4)
   ("neoadjuvant chemotherapy (NAC)" 4) ("Neoadjuvant Chemotherapy" 4)
   ("cytotoxic-based neoadjuvant chemotherapy" 2)
   ("consecutively underwent neoadjuvant chemotherapy" 2)
   ("these 396 patients underwent neoadjuvant chemotherapy" 2)
   ("underwent NAC" 2) ("underwent primary neoadjuvant chemotherapy" 2)
   ("primary neoadjuvant chemotherapy" 2)
   ("dose-dense neoadjuvant chemotherapy" 2)
   ("Systemic lupus erythematosus (SLE)" 1)
   ("received pre-operative neoadjuvant chemotherapy" 1) ("exogenous NAC" 1)
   ("our discordant cases underwent NAC" 1)
   ("platinum based neoadjuvant chemotherapy" 1)
   ("3 HER2-positive patients underwent NAC" 1)
   ("histologically confirmed locally advanced cervical carcinoma (FIGO stage IB2-IIA at least 4 cm in diameter) underwent NAC"
    1)
   ("ced-4" 1) ("underwent neoadjuvant chemotherapy (RTX)" 1)
   ("all patients underwent neoadjuvant chemotherapy" 1) ("than NAC" 1)))
 ("UP:Q9C004" (("SPRY4" 428) ("Spry 4" 1)))
 ("UP:Q9C005" (("DPY30" 6) ("DPY-30" 1) ("hDPY-30" 1)))
 ("UP:Q9C009" (("Foxq1" 95) ("FOXQ1" 3))) ("UP:Q9C010" (("PKIB" 2)))
 ("UP:Q9C026" (("TRIM9" 5)))
 ("UP:Q9C030" (("TRIM6" 288) ("TRIM6-" 1) ("than TRIM6 ( xref )" 1)))
 ("UP:Q9C035"
  (("TRIM5α" 202) ("TRIM5" 151) ("Trim5" 50) ("TRIM5α protein" 4)
   ("tripartite motif-containing protein 5" 3) ("viral entry TRIM5α" 1)))
 ("UP:Q9C037" (("TRIM4" 24) ("TRIM4 (isoform 1) protein" 2)))
 ("UP:Q9C040" (("TRIM2" 1)))
 ("UP:Q9C056"
  (("GTX" 80) ("NKX6.1" 20) ("NKX6.1 protein" 5)
   ("STAT1(internal) GTX113010 and STAT1 (SH2) GTX113011" 1)))
 ("UP:Q9C075" (("K-23" 23) ("K23" 10) ("k23" 4) ("KRT23" 3)))
 ("UP:Q9C086" (("hIes2" 4) ("Ies2" 2) ("hIes2-" 1)))
 ("UP:Q9C0A6" (("SETD5" 1))) ("UP:Q9C0B1" (("FTO" 72) ("fTO" 2)))
 ("UP:Q9C0C2"
  (("TNKS1BP1" 131) ("TAB182" 8) ("TNKS1BP1 protein" 5)
   ("tankyrase 1 binding protein 1" 2)))
 ("UP:Q9C0C7"
  (("AMBRA1" 157) ("Ambra1" 84) ("AMBRA1-" 2) ("the AMBRA1’s" 1)
   ("Given Ambra1’s" 1) ("Given Ambra1" 1)
   ("the pro-autophagic protein AMBRA1" 1) ("DCAF3" 1)))
 ("UP:Q9C0C9" (("UBE2O" 6) ("E2-230K" 2) ("Ube2o" 1)))
 ("UP:Q9C0D0" (("PHACTR1" 52) ("Phosphatase and actin regulator 1" 1) ("”" 1)))
 ("UP:Q9C0D7" (("ZC3H12C" 11)))
 ("UP:Q9C0E2" (("Exportin 4" 7) ("exportin 4" 2) ("XPO4" 2)))
 ("UP:Q9C0E4" (("GRIP2" 2))) ("UP:Q9C0G0" (("ZNF407" 23)))
 ("UP:Q9C0H2" (("TTYH3" 1)))
 ("UP:Q9C0H5" (("Vilse" 71) ("crGAP" 4) ("CrGAP" 4) ("ARHGAP39" 2)))
 ("UP:Q9C0H9"
  (("p140" 21) ("pp140" 10) ("SNIP" 7) ("P140" 5) ("p140CAP" 3)
   ("SNIP protein" 2)))
 ("UP:Q9C0I1" (("MTMR12" 1))) ("UP:Q9C0I3" (("KIAA1680" 1)))
 ("UP:Q9C0J1" (("B3GNT4" 2)))
 ("UP:Q9C0J9"
  (("DEC2" 105) ("BHLHB3" 47) ("BHLHE41" 3) ("Dec2" 3) ("Sharp1" 2)
   ("Sharp-1" 2) ("the basic helix loop helix TF BHLHB3" 1)
   ("DEC2 protein" 1)))
 ("UP:Q9C0K0"
  (("BCL11B" 207) ("CTIP2" 141) ("Bcl11b" 11) ("Ctip2" 5)
   ("COUP-TF-interacting protein 2" 4) ("–CTIP2" 2)
   ("COUP-TF interacting protein" 1) ("COUP-TF Interacting Protein 2" 1)
   ("red fluorescent protein (RFP)–CTIP2" 1)))
 ("UP:Q9C0K1" (("SLC39A8" 7) ("ZIP8" 4) ("Zip8" 2)))
 ("UP:Q9C0K7" (("candidate 2" 6) ("Candidate 2" 1) ("STRADB" 1)))
 ("UP:Q9C1M7" (("DYn-1" 11) ("DYN-1" 2) ("Dyn1" 1)))
 ("UP:Q9C413" (("αTubulin" 6))) ("UP:Q9C4B4" (("CSG" 7)))
 ("UP:Q9C509" (("pSPL" 44) ("SPL" 34) ("Spl" 3) ("SPl" 2) ("SpL" 2)))
 ("UP:Q9C544"
  (("cm 3" 241) ("CM3" 7) ("than 1 cm 3" 2)
   ("their tumor volume reached approximately 0.2 cm 3" 1) ("Cm 3" 1)
   ("than 1.0 cm 3" 1) ("tumor volume reached 2 cm 3" 1)
   ("approximately 0.1 cm 3" 1) ("approximately 0.4 cm 3" 1)
   ("approximately 1 cm 3" 1) ("approximately 1 cm 3" 1)
   ("human ovarian cortex approximately 1 cm 3" 1)
   ("approximately 0.15 cm 3" 1) ("total tumor bulk reached 2 cm 3" 1)
   ("tumor volume reached 1.5 cm 3" 1)))
 ("UP:Q9C585" (("Ubp8" 16)))
 ("UP:Q9C5M0"
  (("DTC" 228) ("cytokeratin-positive DTC" 2) ("most DTC" 1)
   ("sporadic DTC" 1)))
 ("UP:Q9C5Q2" (("EEL" 21))) ("UP:Q9C5U0" (("CRE1" 5) ("Cre1" 1)))
 ("UP:Q9C5U8" (("Hdh" 137))) ("UP:Q9C826" (("SRE-1" 1)))
 ("UP:Q9C932" (("AnAc" 142))) ("UP:Q9C998" (("RPI-1" 20)))
 ("UP:Q9C9G4" (("Endo2" 1))) ("UP:Q9C9P4" (("Fab1" 11)))
 ("UP:Q9C9X6" (("BPC3" 100))) ("UP:Q9CA19" (("MS13" 71) ("Intense MS13" 2)))
 ("UP:Q9CA64" (("Pre3" 2))) ("UP:Q9CA67" (("ChlP" 1)))
 ("UP:Q9CA92"
  (("helicases" 124) ("other hexameric helicases" 2)
   ("the canonical helicases" 1) ("processive helicases" 1)
   ("eukaryotic replicative helicases" 1)))
 ("UP:Q9CAH0" (("RIP7" 4))) ("UP:Q9CAR7" (("HIR2" 2)))
 ("UP:Q9CLZ5" (("PUR" 34) ("Pur" 27) ("pur" 16) ("Pur-" 1)))
 ("UP:Q9CQX3" (("TPL" 38) ("the entire TPL" 2) ("the intact TPL" 2)))
 ("UP:Q9D1C8" (("CIIA" 135) ("-CIIA" 3)))
 ("UP:Q9D1F4" (("pPRAS" 22) ("PRAS" 6))) ("UP:Q9D1T5" (("G-90" 1)))
 ("UP:Q9D2N9" (("buff" 1))) ("UP:Q9D7Z6" (("Gob5" 4)))
 ("UP:Q9DBD0" (("ICA" 108) ("the proximal ICA" 1)))
 ("UP:Q9DC33" (("iBRAF" 13) ("these AKT-negative iBRAF" 1)))
 ("UP:Q9DD33"
  (("LMP2A" 384) ("LMP2a" 13) ("LMP2B" 5) ("LMP-2A" 5) ("LMP2A−" 4)
   ("pLMP2A" 2) ("targeted LMP2A" 2) ("LMP-2B" 2) ("LMP2a protein" 2)
   ("more LMP2A" 1)))
 ("UP:Q9DDY9" (("PABPII" 1)))
 ("UP:Q9DE33"
  (("septa" 51) ("the connective tissue septa" 4)
   ("connective tissue septa" 2)))
 ("UP:Q9DEB6" (("CdxA" 2))) ("UP:Q9DG36" (("GAP2" 5)))
 ("UP:Q9DGW5"
  (("MEQ" 179) ("mEq" 5) ("MEQ protein" 3) ("than MEQ" 2) ("meq" 1)))
 ("UP:Q9ENS0"
  (("thymidine kinase" 166) ("Thymidine kinase" 7) ("thymidine kinase (TK)" 5)
   ("viral thymidine kinase" 2) ("the viral thymidine kinase (TK)" 1)
   ("thymidine kinase ( TK )" 1)))
 ("UP:Q9EP95" (("FIZZ1" 4) ("Fizz1" 2) ("Retnla" 1)))
 ("UP:Q9EPB4"
  (("MaSCs" 47) ("MaSC" 26) ("bipotent MaSCs" 3) ("multipotent MaSC" 2)
   ("normal MaSCs" 1)))
 ("UP:Q9EPL5" (("MMP-1a" 62) ("MMP1a" 2) ("peri-tumoral MMP1a" 1)))
 ("UP:Q9EPL6" (("MMP-1b" 8) ("MMP1b" 2))) ("UP:Q9EQZ5" (("LTB4" 5)))
 ("UP:Q9EQZ6" (("Epac2" 14) ("Rapgef4" 1))) ("UP:Q9ER71" (("RhoT" 4)))
 ("UP:Q9ERA7"
  (("ERC" 132) ("the perinuclear ERC" 5) ("the juxtanuclear ERC" 3)))
 ("UP:Q9ERE4" (("GMx33" 2))) ("UP:Q9ES00" (("UFD2a" 5)))
 ("UP:Q9EUT9"
  (("limb" 400) ("Limb" 12) ("the distal limb" 11) ("lower limb" 3)
   ("the ischemic limb" 2) ("fresh mouse hind limb" 2)
   ("the expiratory descending limb" 1) ("severe limb" 1) ("frequent limb" 1)
   ("the critical receptive limb" 1) ("only one limb" 1)
   ("Proximal upper limb" 1) ("the entire limb" 1)))
 ("UP:Q9EZE7" (("EspC" 1))) ("UP:Q9F4F7" (("FFP" 2)))
 ("UP:Q9FCP2" (("PSSM" 29))) ("UP:Q9FDS1" (("Aldehyde dehydrogenase-1" 5)))
 ("UP:Q9FE20" (("PBS1" 45) ("a novel potential binding site PBS1" 1)))
 ("UP:Q9FFK8" (("NFXL2" 1))) ("UP:Q9FFX4" (("KNU" 2)))
 ("UP:Q9FFY3" (("VAS" 23))) ("UP:Q9FFZ1" (("PPH" 76) ("Crn1" 1) ("pph" 1)))
 ("UP:Q9FG35" (("TBR" 13) ("TbR" 2)))
 ("UP:Q9FG67"
  (("MAML" 42) ("the essential transcriptional coactivator MAML" 2)))
 ("UP:Q9FGN8" (("dyad" 13) ("a distinct prosurvival dyad" 1)))
 ("UP:Q9FGS4" (("QS" 46) ("qs" 2)))
 ("UP:Q9FI46"
  (("CRL" 796) ("CRL-" 8) ("FBXLs examined here form intact CRL" 1)
   ("unstable CRL" 1) ("distinct CRL" 1) ("applicable CRL" 1) ("dynamic CRL" 1)
   ("many well-studied CRL" 1) ("the highly divergent CRL" 1)
   ("superfluous and non-productive CRL" 1)))
 ("UP:Q9FI78"
  (("HCT" 745) ("Hct" 58) ("allogeneic HCT" 31) ("pHCT" 4)
   ("an allogeneic HCT" 3) ("underwent allogeneic HCT" 2)
   ("underwent first-time allogeneic HCT" 2) ("Allogeneic HCT" 2) ("HCT-" 1)
   ("undergone allogeneic HCT" 1)
   ("available FLT3 mutational testing received first-time allogeneic HCT" 1)
   ("first-time allogeneic HCT" 1) ("received allogeneic HCT" 1)
   ("the patients underwent myeloablative HCT" 1)
   ("The majority underwent myeloablative HCT" 1)))
 ("UP:Q9FIB6"
  (("MSA" 354) ("the structure-based MSA" 4) ("had possible MSA" 2)
   ("probable MSA" 2) ("sporadic MSA" 1) ("a secondary structure MSA" 1)))
 ("UP:Q9FII5" (("TdR" 44) ("-TdR" 12)))
 ("UP:Q9FIK0" (("phosphofructokinase 2" 3)))
 ("UP:Q9FIP9" (("Myc3" 25) ("myc3" 8))) ("UP:Q9FJ10" (("GATA1-6" 1)))
 ("UP:Q9FJ75" (("AT4" 1))) ("UP:Q9FJ93" (("CBF-4" 1)))
 ("UP:Q9FJV8" (("Mrn1" 1))) ("UP:Q9FKS0" (("UKL1" 1)))
 ("UP:Q9FKS4" (("Rad-3" 16) ("rad-3" 4)))
 ("UP:Q9FLB0" (("Rh18" 29) ("RH18" 9) ("embryonal RH18" 1) ("Rh18 (RMS)" 1)))
 ("UP:Q9FLT2" (("IP3K" 1))) ("UP:Q9FLU1" (("MID" 29)))
 ("UP:Q9FMA3"
  (("Pex5p" 5)
   ("the peroxisomal targeting signal 1 (PTS1) receptor protein Pex5p" 2)
   ("targeting signal 1 (PTS1) receptor protein Pex5p" 1)))
 ("UP:Q9FMF5" (("Rpt3" 3))) ("UP:Q9FMJ0" (("PI4K" 11)))
 ("UP:Q9FML4" (("LOB" 2))) ("UP:Q9FN48" (("STR3" 2)))
 ("UP:Q9FN69"
  (("pGL3" 51) ("GL3" 46)
   ("the standard promoter-testing monocistronic vector pGL3" 2)
   ("than pGL3" 1)))
 ("UP:Q9FNY2" (("DPB" 14))) ("UP:Q9FNY3" (("DPA" 22) ("Dpa" 1)))
 ("UP:Q9FNY7"
  (("8-oxoguanine-DNA glycosylase 1" 8) ("8-Oxoguanine-DNA glycosylase 1" 3)))
 ("UP:Q9FPW3" (("TBT" 4))) ("UP:Q9FQ04" (("AIN-1" 6)))
 ("UP:Q9FR53"
  (("TOR" 549) ("“mechanistic” TOR" 2) ("TOR-" 2) ("mechanistic TOR" 2)
   ("the genomic TOR" 1)
   ("Tor1 and Tor2 form two functionally distinct TOR" 1)))
 ("UP:Q9FRT9"
  (("leg" 212) ("Leg" 10) ("the contralateral leg" 3) ("the exocytic leg" 1)
   ("“leg”" 1) ("A1b" 1) ("the intense leg" 1)))
 ("UP:Q9FT36" (("TBA" 14))) ("UP:Q9FUH9" (("pY-1" 7) ("pY–1" 2)))
 ("UP:Q9FVC1" (("Svp" 4) ("SVp" 1) ("SVP" 1))) ("UP:Q9FVU0" (("CYB" 3)))
 ("UP:Q9FVU9" (("CSN5a" 1))) ("UP:Q9FW44" (("ADR1" 3)))
 ("UP:Q9FXA8" (("invA" 9) ("InvA" 1))) ("UP:Q9FY50" (("CL10" 2)))
 ("UP:Q9FY74" (("SR2" 19) ("sR2" 1))) ("UP:Q9FYB5" (("J1-1" 13)))
 ("UP:Q9FYH1" (("PCAT-1" 4))) ("UP:Q9G050" (("Vps4" 18) ("VP4" 2)))
 ("UP:Q9GLK0" (("TGase-1" 4) ("transglutaminase1" 1)))
 ("UP:Q9GNK5" (("PGRP-LC" 9))) ("UP:Q9GNL2" (("lin-14" 4)))
 ("UP:Q9GPQ8" (("RacL" 4) ("Racl" 3))) ("UP:Q9GSG9" (("Wiscott" 6)))
 ("UP:Q9GYU8" (("MBO" 15) ("MBO-" 1))) ("UP:Q9GZL7" (("WDR12" 13)))
 ("UP:Q9GZM7" (("Tinagl1" 1) ("Tinagl" 1) ("TINAGL1" 1)))
 ("UP:Q9GZM8"
  (("Nudel" 316) ("NDEL1" 16) ("Ndel1" 4) ("than those containing Nudel" 1)
   ("exogenous Nudel" 1) ("insufficient Nudel" 1) ("NUDEL" 1)))
 ("UP:Q9GZN2" (("TGIF2" 5))) ("UP:Q9GZN4" (("BSSP4" 1)))
 ("UP:Q9GZP0"
  (("PDGF-D" 175) ("I-EGF" 141) ("PDGFD" 36) ("Pdgf-d" 4) ("-PDGF-D" 3)
   ("derived growth factor-D" 2) ("process exogenous PDGF-D protein" 1)
   ("PDGF-D protein" 1) ("surface-bound 125 I-EGF" 1)))
 ("UP:Q9GZP1" (("NRSN2" 1)))
 ("UP:Q9GZP8" (("H2RSP" 3) ("chromosome 19 open reading frame 33" 3)))
 ("UP:Q9GZP9" (("Derlin-2" 8))) ("UP:Q9GZQ4" (("parental TGR1" 1) ("TGR1" 1)))
 ("UP:Q9GZQ8"
  (("LC3B" 426) ("MAP1LC3B" 99) ("LC3b" 16) ("tandem fluorescent LC3B" 4)
   ("fibroblastic LC3B" 4) ("Map1LC3B" 2) ("LC3B protein" 2)
   ("the autophagosomal marker LC3B" 2) ("the autophagic marker LC3B" 1)
   ("autophagic markers MAP1LC3B" 1) ("MAP1LC3B protein" 1)
   ("very little MAP1LC3B" 1) ("MAP1LC3b" 1) ("positive fibroblastic LC3B" 1)
   ("Positive fibroblastic LC3B" 1)))
 ("UP:Q9GZR1" (("SENP6" 5))) ("UP:Q9GZR5" (("ELOVL4" 1)))
 ("UP:Q9GZR7" (("DDX24" 194) ("DDX24 protein" 7) ("-DDX24" 1)))
 ("UP:Q9GZS1" (("PAF53" 3))) ("UP:Q9GZS3" (("SKI8" 8) ("WDR61" 6)))
 ("UP:Q9GZT4" (("SRR" 55) ("serine racemase" 2)))
 ("UP:Q9GZT5"
  (("WNT10A" 137) ("WNT10A-" 3) ("Wnt-10a" 1) ("Wnt10a-" 1) ("Wnt10a" 1)))
 ("UP:Q9GZT9"
  (("PHD2" 104) ("prolyl hydroxylase 2" 5) ("than PHD2 [ xref ]" 1) ("EGLN1" 1)
   ("the normoxic state PHD2" 1)))
 ("UP:Q9GZU1"
  (("TRPML1" 67) ("MCOLN1" 23) ("MLIV" 21) ("mucolipin 1" 3)
   ("TRPML1 peptide" 3) ("TRPML1 protein" 2) ("Q9GZU1" 1) ("ML4" 1)))
 ("UP:Q9GZU2" (("PEG3" 13) ("Peg3" 3) ("pEg3" 1) ("paternally expressed 3" 1)))
 ("UP:Q9GZU7" (("CTDSP1" 13) ("SCP1" 10) ("SCP1 protein" 1)))
 ("UP:Q9GZV1"
  (("Ankrd2" 352) ("Ankrd2 protein" 7) ("ARPP" 6)
   ("the designated canonical Ankrd2" 1) ("flag-tagged human Ankrd2" 1)
   ("subcellular compartment Ankrd2" 1)
   ("mutant Ser99Ala human flag-tagged Ankrd2" 1)))
 ("UP:Q9GZV3"
  (("CHT" 57) ("sequential TMZ CHT" 2) ("had undergone preoperative CHT" 1)))
 ("UP:Q9GZV4" (("EIF5A2" 5)))
 ("UP:Q9GZV5"
  (("WWTR1" 155) ("transcriptional coactivator with PDZ-binding motif" 15)
   ("Wwtr1" 12) ("Transcriptional coactivator with PDZ-binding motif" 6)
   ("transcriptional coactivator with PDZ-binding motif (TAZ)" 3)
   ("transcriptional coactivator with PDZ binding motif" 3)
   ("transcriptional coactivator with PDZ binding motif (TAZ)" 2)))
 ("UP:Q9GZV8" (("PRDM14" 26) ("the naive markers PRDM14" 2)))
 ("UP:Q9GZV9"
  (("FGF23" 29) ("FGF-23" 2) ("fibroblast growth factor 23" 2)
   ("a mouse FGF23" 1)))
 ("UP:Q9GZX5"
  (("ZBRK1" 184) ("ZNF350" 8) ("ZBRK1 (GZB)" 3) ("ZBRK1 (GDZ)" 2)
   ("the ZBRK1’s" 2) ("the transcriptional repressor ZBRK1" 2)))
 ("UP:Q9GZX6"
  (("IL-22" 544) ("IL22" 8) ("IL-22R1" 7) ("interleukin-22" 5)
   ("IL12B and IL12RB1 mutations secreted less IL-22" 1) ("pIL22" 1)
   ("Il22" 1)))
 ("UP:Q9GZX7"
  (("AID" 924) ("aid" 901) ("aicda" 43) ("Aid" 39) ("AICDA" 37)
   ("activation-induced cytidine deaminase" 24) ("AID-" 20) ("AID protein" 3)
   ("activation-induced cytidine deaminase (AID)" 3) ("a diagnostic aid" 3)
   ("-AID" 3) ("a functional AID" 1)
   ("activation induced cytidine deaminase" 1)
   ("the most valuable diagnostic aid" 1) ("alternate AID (AMP)" 1)
   ("virtually no AID" 1) ("the respective aicda  +/+" 1)
   ("a complex polygenic AID" 1) ("a vital aid" 1) ("less AID" 1)
   ("robustly targets AID" 1) ("the core RNA exosome robustly targets AID" 1)
   ("robust AID-" 1) ("the complete AID" 1) ("pAID" 1)
   ("both miR-155 and miR-361-5p directly target AID" 1) ("a visual aid" 1)))
 ("UP:Q9GZX9"
  (("tumor suppressor gene" 2757) ("TSGs" 556) ("TSG" 416)
   ("Tumor suppressor gene" 15) ("a key tumor suppressor gene" 14)
   ("a potential tumor suppressor gene" 14)
   ("a bona fide tumor suppressor gene" 12)
   ("a well-known tumor suppressor gene" 11)
   ("a haploinsufficient tumor suppressor gene" 9)
   ("tumor suppressor gene (TSG)" 8) ("key TSGs" 6) ("anti-oncogenes" 6)
   ("tumor
 suppressor gene"
    6)
   ("a major tumor suppressor gene" 6) ("Tsg" 5)
   ("insufficient tumor suppressor gene" 4) ("tsG" 4)
   ("a classic tumor suppressor gene" 4)
   ("the most frequently inactivated tumor suppressor gene" 4)
   ("tumor suppressor gene ( RB )" 4) ("a new tumor suppressor gene" 3)
   ("pTSG" 3) ("a classical tumor suppressor gene" 3)
   ("a well-established tumor suppressor gene" 3)
   ("tumor suppressor gene (CYLD)" 3)
   ("tumor suppressor
                gene"
    3)
   ("epigenetic TSG" 2) ("above-mentioned TSGs" 2)
   ("the major tumor suppressor gene" 2)
   ("the functional tumor suppressor gene" 2)
   ("a well-studied tumor suppressor gene" 2) ("pTSG-" 2)
   ("a prominent tumor suppressor gene" 2) ("antioncogenes" 2)
   ("The classical tumor suppressor gene" 2)
   ("a classical two-hit tumor suppressor gene" 2)
   ("an otherwise silent mutant tumor suppressor gene" 2)
   ("a strong tumor suppressor gene" 2) ("given tumor suppressor gene" 2)
   ("the most commonly inactivated tumor suppressor gene" 2)
   ("a gastric tumor suppressor gene" 2)
   ("at least one tumor suppressor gene (TSG)" 2)
   ("the endometrial tumor suppressor gene" 2)
   ("tumor suppressor gene ( APC )" 2) ("deliberate tumor suppressor gene" 2)
   ("a stress-induced tumor suppressor gene" 2)
   ("a multifunctional tumor suppressor gene" 2)
   ("the prototypical tumor suppressor gene" 2)
   ("a possible tumor suppressor gene" 2) ("the above-mentioned TSGs" 1)
   ("a well-documented tumor suppressor gene" 1) ("other possible TSGs" 1)
   ("MLN0128-treated TSGs" 1) ("primary TSG" 1) ("primary TSGs" 1)
   ("an archetypical tumor suppressor gene" 1)
   ("the senescence-associated tumor suppressor gene" 1)
   ("a typical tumor suppressor gene" 1)
   ("the well-characterized tumor suppressor gene" 1)
   ("potential deleted tumor suppressor gene" 1)
   ("HER2 cooperative tumor suppressor gene" 1)
   ("a ubiquitous tumor suppressor gene" 1) ("protein-coding TSGs" 1)
   ("a currently undruggable tumor suppressor gene" 1)
   ("than one tumor suppressor gene in breast tumors [ xref , xref ]" 1)
   ("the adenomatous polyposis coli ( Apc ) tumor suppressor gene" 1)
   ("a relevant tumor suppressor gene" 1) ("the key tumor suppressor gene" 1)
   ("possible TSG" 1) ("at least three TSG" 1)
   ("a meaningful tumor suppressor gene" 1)
   ("the adenomatous polyposis coli tumor suppressor gene ( APC )" 1)
   ("than one tumor suppressor gene" 1)
   ("a traditional tumor suppressor gene" 1) ("other known and novel TSGs" 1)
   ("further hypermethylated TSGs" 1)
   ("the prototypic tumor suppressor gene" 1)
   ("a vital tumor suppressor gene" 1) ("a potential TSG" 1)
   ("The adenomatous polyposis coli ( APC ) tumor suppressor gene" 1)
   ("an intestinal tumor suppressor gene" 1)))
 ("UP:Q9GZY6"
  (("lab" 1521) ("Lab" 948) ("NTAL" 139) ("LAB" 39) ("WBSCR5" 8) ("LAT2" 5)
   ("Lab (BDRL)" 5) ("lab (FHCRC)" 4) ("LaB" 3) ("NTAL protein" 2)
   ("worldwide only one lab" 2) ("the Congenital Defects Lab" 2)
   ("anatomic molecular pathology lab" 2)
   ("Health and Human Services Clinical Laboratory Improvement Amendments (CLIA)–compliant pathology lab"
    1)
   ("the late Korsmeyer lab" 1) ("Lat2" 1) ("the lab’s" 1)
   ("Eisen Lab (University of California, Berkeley, California, USA) using Pearson’s"
    1)
   ("lab (DFCI)" 1)))
 ("UP:Q9GZY8"
  (("MFF" 114) ("MFF protein" 5) ("Mff" 4) ("MFF-" 2) ("than 350 MFF-" 1)
   ("miR-593-5p directly targets MFF-3" 1) ("mitochondrial fission factor" 1)))
 ("UP:Q9GZZ0" (("HOXD1" 11))) ("UP:Q9GZZ1" (("San" 5580) ("san" 4) ("SAN" 2)))
 ("UP:Q9GZZ8"
  (("lacritin" 160) ("Lacritin" 22) ("“lacritin”" 4) ("LACRT" 3)
   ("intact mature lacritin" 1) ("lacritin-" 1)))
 ("UP:Q9H000" (("MKRN2" 2))) ("UP:Q9H013" (("ADAM19" 11)))
 ("UP:Q9H015" (("SLC22A4" 7) ("OCTN1" 4) ("neighboring SLC22A4" 1)))
 ("UP:Q9H040"
  (("Spartan" 598) ("DVC1" 29) ("SPRTN" 7) ("DVC1 protein" 3)
   ("exogenous Spartan" 3) ("SPARTAN" 2) ("‘Spartan’" 2)
   ("GST-FLAG-tagged Spartan" 1) ("Spartan protein" 1)
   ("SprT-like domain at the N terminus" 1)))
 ("UP:Q9H063"
  (("MAF1" 421) ("MAF1 protein" 25) ("Maf1" 6) ("maf1" 3) ("MAF1-" 2)))
 ("UP:Q9H074" (("Paip1" 12)))
 ("UP:Q9H081"
  (("hMis12" 39) ("Mis12" 36) ("MIS12" 4) ("its associated partner Mis12" 1)
   ("homolog (S. pombe)" 1)))
 ("UP:Q9H082" (("Rab33B" 2)))
 ("UP:Q9H093"
  (("NUAK2" 28) ("SNARK" 4) ("SNF1/AMP kinase-related kinase" 1) ("NuaK2" 1)))
 ("UP:Q9H0A0" (("NAT10" 1) ("hALP" 1))) ("UP:Q9H0A6" (("RNF32" 2)))
 ("UP:Q9H0B6" (("KLC2" 5)))
 ("UP:Q9H0C3" (("transmembrane protein 117" 2) ("TMEM117" 1)))
 ("UP:Q9H0C5" (("BTBD1" 1))) ("UP:Q9H0C8" (("ILKAP" 4)))
 ("UP:Q9H0D6" (("Xrn2" 1)))
 ("UP:Q9H0E2"
  (("IL-1RI" 27) ("Tollip" 13) ("TOLLIP" 3) ("Toll-interacting protein" 2)))
 ("UP:Q9H0E3" (("SAP130" 6))) ("UP:Q9H0E7" (("USP44" 25) ("-USP44" 1)))
 ("UP:Q9H0E9" (("BRD8" 1) ("Brd8" 1)))
 ("UP:Q9H0F5"
  (("RNF38" 125) ("RNF38 protein" 2) ("We first examined RNF38" 2)
   ("possible RNF38" 1) ("exogenous RNF38" 1) ("“RNF38”" 1)))
 ("UP:Q9H0F6" (("SHARPIN" 29) ("Sharpin" 2))) ("UP:Q9H0F7" (("ARL6" 6)))
 ("UP:Q9H0H3" (("KLHL25" 4)))
 ("UP:Q9H0H5"
  (("MgcRacGAP" 259) ("HsCyk" 174) ("CYK-4" 144) ("HsCYK" 79) ("RACGAP1" 32)
   ("RacGAP1" 14) ("significantly more CYK-4" 4) ("MgcRacGAP-" 3)
   ("MGCRacGAP" 2) ("HsCyk4" 2) ("Significantly more CYK-4" 2)
   ("overexpressed MgcRacGAP R386A" 2) ("Rac GTPase-activating protein 1" 2)
   ("Racgap1" 2) ("than MgcRacGAP" 1) ("phosphomimetic HsCyk-4" 1) ("Q9H0H5" 1)
   ("cyk-4" 1) ("male germ cell RacGAP" 1)))
 ("UP:Q9H0J4" (("QRICH2" 1))) ("UP:Q9H0J9" (("PARP1/2" 17) ("PARP12" 3)))
 ("UP:Q9H0K1"
  (("SIK2" 250) ("–SIK2" 8) ("salt-inducible kinase 2" 6) ("QIK" 6)
   ("salt inducible kinase 2" 3) ("Sik2" 3)))
 ("UP:Q9H0M0" (("WWP1" 93) ("AIP5" 20))) ("UP:Q9H0M4" (("ZCWPW1" 1)))
 ("UP:Q9H0N0" (("WTH3" 224) ("Rab6c" 7) ("WTH3 protein" 3) ("that WTH3 's" 1)))
 ("UP:Q9H0N5" (("PCBD2" 3)))
 ("UP:Q9H0P0" (("POMP" 45) ("Lupin" 4) ("NT5C3" 4))) ("UP:Q9H0R1" (("Mud" 1)))
 ("UP:Q9H0R4" (("HDHD2" 2) ("Hdhd2" 1)))
 ("UP:Q9H0R8" (("GABARAPL1" 18) ("Gabarapl1" 2) ("ATG8L" 1)))
 ("UP:Q9H0S4" (("DDX47" 3))) ("UP:Q9H0T7" (("RAB17" 3) ("Rab17" 2)))
 ("UP:Q9H0U3" (("MagT1" 5))) ("UP:Q9H0U4" (("Rab1b" 3) ("Rab1B" 1)))
 ("UP:Q9H0U9" (("TSPYL1" 1))) ("UP:Q9H0V1" (("TMEM168" 1)))
 ("UP:Q9H0W5" (("CCDC8" 48))) ("UP:Q9H0W8" (("Smg9" 1)))
 ("UP:Q9H0X9" (("OSBPL5" 1))) ("UP:Q9H0Y0" (("ATG10" 21) ("Atg10" 5)))
 ("UP:Q9H0Z9"
  (("RNPC1" 266) ("RBM38" 209) ("Rbm38" 5)
   ("these results strongly support RBM38's" 1)
   ("these results strongly support RBM38" 1) ("Most RNPC1" 1)))
 ("UP:Q9H147" (("DNTTIP1" 1))) ("UP:Q9H160" (("ING2" 16) ("p33ING2" 3)))
 ("UP:Q9H161" (("PFM" 41) ("Alx4" 1)))
 ("UP:Q9H165" (("BCL11A" 187) ("BCL11A protein" 2) ("Bcl11a" 2) ("CTIP1" 1)))
 ("UP:Q9H169" (("RB3" 8) ("STMN4" 2) ("Rb3" 1)))
 ("UP:Q9H171" (("ZBP1" 4) ("DLM-1" 3) ("ZBP-1" 2)))
 ("UP:Q9H172" (("subfamily G" 3) ("ABCG4" 2) ("sub-family G member 4" 2)))
 ("UP:Q9H173"
  (("MSS" 794) ("MSSs" 9) ("MSS-" 2) ("‘MSS'" 1) ("shorter MSS" 1) ("-MSS" 1)))
 ("UP:Q9H1A4" (("ANAPC1" 7) ("anaphase promoting complex subunit 1" 1)))
 ("UP:Q9H1C0" (("LPAR5" 2) ("GPR92" 1))) ("UP:Q9H1C3" (("GLT8D2" 1)))
 ("UP:Q9H1C4" (("UNC-93B" 19) ("UNC93B1" 7) ("UNC-93B–" 3)))
 ("UP:Q9H1D0" (("TRPV6" 39) ("cat-like" 1))) ("UP:Q9H1D9" (("POLR3F" 1)))
 ("UP:Q9H1E3"
  (("NUCKS1" 244) ("NUCKS1 protein" 24) ("NUCKS1-" 18) ("pNUCKS1" 7)))
 ("UP:Q9H1H9" (("KIF13A" 85) ("end–directed motor KIF13A" 1)))
 ("UP:Q9H1J1"
  (("Upf3" 32) ("hUpf3" 10) ("Upf3A" 4) ("UPF3a" 3) ("UPF3" 2) ("hUpf3A" 1)))
 ("UP:Q9H1J5" (("WNT8A" 7) ("Wnt-8a" 1)))
 ("UP:Q9H1J7"
  (("WNT5B" 19) ("Wnt5b" 14) ("WNT-5B" 14) ("WNT5b" 3) ("Wnt5B" 1)
   ("Wnt-5B protein" 1) ("Wnt-5B" 1)))
 ("UP:Q9H1K0"
  (("Rabenosyn-5" 9) ("110 kDa protein" 6) ("rabenosyn-5" 6)
   ("110 kDa protein" 4) ("Rabenosyn5" 3) ("the resultant 110 kDa protein" 1)
   ("Rabenosyn" 1) ("very little rabenosyn-5" 1)
   ("the bivalent FYVE domain effector rabenosyn-5" 1)))
 ("UP:Q9H1K1" (("ISCU" 8) ("Iscu" 1))) ("UP:Q9H1K4" (("GC2" 4)))
 ("UP:Q9H1M4" (("DEFB127" 3))) ("UP:Q9H1R3" (("MYLK2" 1)))
 ("UP:Q9H1U4" (("EGFL5" 1)))
 ("UP:Q9H1Y0"
  (("ATG5" 356) ("Atg5" 228) ("ASP" 117) ("atg5" 7) ("ATG-5" 5)
   ("autophagy protein 5" 4) ("Atg5 protein" 3) ("Atg-5" 3) ("ATG5 protein" 3)
   ("ATG5-" 2) ("DOX-treated cells not expressing ATG5" 1) ("-ATG5" 1)
   ("autophagy related 5" 1) ("Atg5-" 1) ("-Atg5" 1)))
 ("UP:Q9H1Y3" (("OPN3" 1)))
 ("UP:Q9H1Z8"
  (("ECRG4" 96) ("ECRG4 protein" 7)
   ("N-terminal His-tagged soluble ECRG4 protein" 1)))
 ("UP:Q9H204" (("MED28" 4)))
 ("UP:Q9H208"
  (("olfactory receptor" 11) ("olfactory receptor (OR)" 3)
   ("Olfactory receptor" 1)))
 ("UP:Q9H211"
  (("Cdt1" 1039) ("CDT1" 113)
   ("chromatin licensing and DNA replication factor 1" 9) ("hCdt1" 8)
   ("DNA replication factor" 8) ("cdt1" 7) ("Cdt1-" 6) ("soluble Cdt1" 5)
   ("chromatin-associated Cdt1" 4) ("overexpressed T7-Cdt1" 3)
   ("soluble Cdt1 protein" 2) ("Cdt1 protein" 2)
   ("pEF-FLAG-tagged geminin and pcDNA-HA-tagged Cdt1" 1)
   ("the soluble Cdt1" 1) ("all mitotic Cdt1" 1) ("-Cdt1" 1)
   ("an essential DNA replication factor" 1) ("than Cdt1" 1)))
 ("UP:Q9H213" (("APR-1" 13) ("apr-1" 3) ("MAGEH1" 3) ("APR1" 1)))
 ("UP:Q9H221" (("ABCG8" 5) ("Abcg8" 1)))
 ("UP:Q9H222" (("ABCG5" 6) ("Abcg5" 1)))
 ("UP:Q9H237" (("PPN" 2) ("PORCN" 2) ("porc" 1)))
 ("UP:Q9H239" (("MMP28" 12) ("matrix metallopeptidase 28" 3) ("MMP-28" 1)))
 ("UP:Q9H244" (("P2Y12" 64) ("P2RY12" 3))) ("UP:Q9H252" (("ERG2" 1)))
 ("UP:Q9H254" (("SPTBN4" 2))) ("UP:Q9H257" (("Card9" 123) ("CARD9" 24)))
 ("UP:Q9H269" (("Vps16" 9))) ("UP:Q9H270" (("pep5" 1)))
 ("UP:Q9H295"
  (("DCSTAMP" 5) ("TM7SF4" 2)
   ("dendrocyte expressed seven transmembrane protein" 1) ("FIND" 1)))
 ("UP:Q9H299" (("SH3BGRL3" 1))) ("UP:Q9H2A2" (("ALDH8A1" 13)))
 ("UP:Q9H2A3"
  (("Ngn2" 39) ("neurogenin 2" 6) ("Neurogenin2" 2) ("Neurogenin 2" 2)))
 ("UP:Q9H2A7" (("CXCL16" 7))) ("UP:Q9H2A9" (("CHST8" 11)))
 ("UP:Q9H2B2" (("SYT4" 1)))
 ("UP:Q9H2B4" (("solute carrier family 26 (sulfate transporter)" 1)))
 ("UP:Q9H2C0" (("GAN" 16) ("Gan" 9) ("GAN1" 5) ("GAN-1" 1)))
 ("UP:Q9H2C2" (("AR-V1" 52))) ("UP:Q9H2D6" (("TARA" 40)))
 ("UP:Q9H2E6"
  (("Sema6A" 102) ("and cytoplasmic domain" 27)
   ("transmembrane domain (TM)" 25) ("SEMA6A" 18) ("semaphorin 6A" 2)
   ("its transmembrane and cytoplasmic domain" 1)
   ("at least one transmembrane domain (TM)" 1)))
 ("UP:Q9H2F5" (("enhancer of polycomb homolog 1" 2)))
 ("UP:Q9H2G2" (("Ste20-related kinase" 5)))
 ("UP:Q9H2H9" (("SLC38A1" 8) ("solute carrier family 38" 3)))
 ("UP:Q9H2K2"
  (("TNKS2" 22) ("Tankyrase 2" 4)
   ("TRF1-interacting
ankyrin-related ADP-ribose polymerase 2"
    4)
   ("tankyrase-2" 3) ("PARP-5b" 3) ("ARTD6" 2) ("tankyrase 2" 1) ("Part6" 1)
   ("PARP5b" 1)))
 ("UP:Q9H2K8"
  (("KDs" 170) ("TAOK3" 39) ("K  D s" 9) ("K D s" 5) ("kDs" 2) ("KDS" 1)
   ("DPK" 1)))
 ("UP:Q9H2L5" (("Rassf4" 1))) ("UP:Q9H2M3" (("BHMT2" 3)))
 ("UP:Q9H2M9" (("RAB3GAP2" 1))) ("UP:Q9H2P0" (("ADNP" 9)))
 ("UP:Q9H2P9" (("diphthine synthase" 1))) ("UP:Q9H2R5" (("KLK15" 13)))
 ("UP:Q9H2S1" (("SK2" 104) ("KCa2.2" 2) ("systemic SK2" 1)))
 ("UP:Q9H2S6"
  (("TEM" 721) ("TCR-driven TEM" 28) ("chemokine-driven TEM" 26)
   ("tenomodulin" 11) ("transcellular TEM" 6) ("reduced TCR-driven TEM" 3)
   ("subsequent TEM" 2) ("complete TEM" 2) ("efficient TEM" 2)
   ("leukocyte paracellular TEM" 2) ("paracellular TEM" 2)
   ("the Vav inhibitor 6-thio-GTP reduced TCR-but not chemokine-driven TEM" 2)
   ("both chemokine-and TCR-driven TEM" 2) ("occasional TEM" 1)
   ("ultrastructural TEM" 1) ("Transcellular TEM" 1) ("Tenomodulin" 1)
   ("Vav and Rac both reduced TCR-driven TEM" 1)
   ("EHop-016 reduced TCR-driven TEM" 1) ("chemokine driven TEM" 1)
   ("Chemokine-driven TEM" 1)))
 ("UP:Q9H2S9" (("IKZF4" 8)))
 ("UP:Q9H2U1"
  (("DHX36" 38) ("DDX36" 2) ("ATP-dependent RNA helicase DHX36" 2) ("RHAU" 1)
   ("G4R1" 1) ("Q9H2U1" 1)))
 ("UP:Q9H2U2" (("PPA2" 6))) ("UP:Q9H2V7" (("SPNS1" 1)))
 ("UP:Q9H2W1" (("MS4A6" 1)))
 ("UP:Q9H2W2" (("Mixl1" 38) ("MIXL1" 33) ("MixL1" 18)))
 ("UP:Q9H2W6" (("mitochondrial ribosomal protein L46" 1)))
 ("UP:Q9H2X0"
  (("chordin" 29) ("Chordin" 5) ("the dorsal mesodermal marker chordin" 1)))
 ("UP:Q9H2X3" (("CLEC4M" 5) ("CD299" 2)))
 ("UP:Q9H2X6"
  (("HIPK2" 1620) ("homeodomain-interacting protein kinase-2" 16)
   ("homeodomain-interacting protein kinase 2" 15) ("HIPK2 protein" 14)
   ("Homeodomain-interacting protein kinase 2" 12)
   ("homeodomain interacting protein kinase 2" 9) ("Hipk2" 6)
   ("Homeodomain interacting protein kinase 2" 6) ("dysfunctional HIPK2" 4)
   ("the proapoptotic
homeodomain-interacting protein kinase-2"
    3)
   ("strong HIPK2" 2) ("Upper HIPK2" 2)
   ("Homeodomain-interacting protein kinase-2" 2)
   ("Stress-induced homeodomain-interacting protein kinase-2" 2)
   ("overexpressed HIPK2" 2) ("exogenous GFP-tagged HIPK2" 1)
   ("ADR-treated HIPK2" 1) ("than HIPK2" 1)
   ("the pro-apoptotic kinase HIPK2" 1) ("constitutive hypoxic HIPK2" 1)
   ("zinc-treated HIPK2" 1) ("only zinc-treated HIPK2" 1) ("HIPK-2" 1)))
 ("UP:Q9H2X9" (("SLC12A5" 1))) ("UP:Q9H300" (("PARL" 15)))
 ("UP:Q9H306" (("MMP27" 2) ("matrix metallopeptidase 27" 2)))
 ("UP:Q9H307" (("DRs" 30) ("Pnn" 3) ("PNN" 2) ("DRS" 2)))
 ("UP:Q9H313" (("TTYH1" 1))) ("UP:Q9H324" (("ADAMTS10" 1)))
 ("UP:Q9H334"
  (("FOXP1" 228) ("MFH" 49) ("Foxp1" 15) ("FoxP1" 9) ("soft tissue MFH" 5)
   ("its subfamily member Foxp1" 3) ("Overexpressed FOXP1" 3)
   ("Forkhead box protein P1" 2) ("Soft tissue MFH" 2) ("smaller FOXP1" 1)
   ("foxp1" 1) ("soft tissue MFH, liposarcomas, and bone MFH" 1)))
 ("UP:Q9H339" (("OR51B5" 1))) ("UP:Q9H361" (("PABPC3" 3)))
 ("UP:Q9H3C7" (("Dif-3" 5)))
 ("UP:Q9H3D4"
  (("p63" 2378) ("ΔNp63α" 983) ("TP63" 249) ("p51" 129) ("P63" 72)
   ("ΔNp63α protein" 17) ("p63 protein" 10) ("tumor protein 63" 9) ("P51" 7)
   ("tumor protein p63" 6) ("-ΔNp63α" 6) ("cusp" 5) ("overexpressed ΔNp63α" 4)
   ("than p63" 3) ("p63-" 3) ("phospho-ΔNp63α protein" 3) ("p-ΔNp63α" 3)
   ("ΔNP63α" 2) ("transformation-related protein 63" 2)
   ("the epidermal lineage-determining transcription factor p63" 2)
   ("ΔNp63α (WT)" 2) ("p51 protein" 2) ("a fully functional ΔNp63α" 2)
   ("ΔNp63α (ca. 64 kDa) protein" 2) ("Tumor Protein 63" 2)
   ("exogenous ΔNp63α" 2) ("antimetastatic TP63" 1)
   ("the non-malignant benign gland specific marker P63" 1)
   ("the well-differentiated P63" 1) ("Tp63" 1) ("mouse monoclonal TP63" 1)
   ("abluminal (both myoepithelial and basal cells) cell marker p63" 1)
   ("p73L" 1) ("Tetrameric p63" 1) ("Causative p63" 1)
   ("the key ectodermal transcription factor p63" 1)
   ("p-ΔNp63α/non-phosphorylated ΔNp63α" 1) ("P-ΔNp63α protein" 1)
   ("P-ΔNp63α" 1) ("distinct p63" 1) ("further implicating ΔNp63α" 1)
   ("the normal p63" 1) ("Notorious p63" 1)
   ("the mesiobuccal (anterior, cheek side) cusp" 1) ("P63-" 1)
   ("the new myoepithelial marker P63" 1)))
 ("UP:Q9H3E2" (("SNX25" 1))) ("UP:Q9H3F6" (("KCTD10" 2) ("MSTP028" 1)))
 ("UP:Q9H3G5" (("CPVL" 4)))
 ("UP:Q9H3H1" (("IPT" 118) ("soluble IPT" 3) ("Soluble IPT" 2) ("than IPT" 1)))
 ("UP:Q9H3H5"
  (("DPAGT1" 69) ("GPT" 5) ("intense DPAGT1" 2) ("Prominent DPAGT1" 2)))
 ("UP:Q9H3K2" (("MICS1" 1)))
 ("UP:Q9H3M0"
  (("KH1" 11) ("a lentiviral shRNA expression construct KH1" 2)
   ("the lentiviral shRNA vector KH1" 2) ("IK8" 1)))
 ("UP:Q9H3M7"
  (("TXNIP" 269) ("Txnip" 73) ("TXNIP protein" 13)
   ("thioredoxin-interacting protein" 8) ("VDUP-1" 4)
   ("thioredoxin interacting protein" 4)
   ("Vitamin D3 up-regulated protein 1" 3) ("VDUP1" 3)
   ("Thioredoxin interacting protein" 3) ("thioredoxin binding protein 2" 2)
   ("Thioredoxin-interacting protein" 2) ("thioredoxin binding protein-2" 2)
   ("essentially all the TXNIP" 1)))
 ("UP:Q9H3N1" (("TMX" 14))) ("UP:Q9H3N8" (("HRH4" 12) ("H4R" 11)))
 ("UP:Q9H3P2" (("NELF-A" 4)))
 ("UP:Q9H3P7"
  (("ACBD3" 195) ("GCP60" 2) ("the multifunctional protein ACBD3" 1)))
 ("UP:Q9H3R0"
  (("JMJD2C" 236) ("KDM4C" 42) ("GASC1" 6) ("JMJD2C protein" 5)
   ("jumonji domain containing 2C" 2) ("JHDM3C" 1)
   ("Jumonji domain containing 2C" 1) ("KIAA0780" 1)))
 ("UP:Q9H3R5" (("CENP-H" 2) ("CENP-H-" 1))) ("UP:Q9H3S1" (("Sema4A" 4)))
 ("UP:Q9H3S5" (("class M" 4) ("Class M" 1)))
 ("UP:Q9H3S7" (("HD-PTP" 146) ("HDPTP" 10) ("PTPN23" 5) ("-HD-PTP" 2)))
 ("UP:Q9H3U1" (("UNC45A" 132) ("UNC45A (DKAVEYGLIQPNQDGE)" 1)))
 ("UP:Q9H3U5" (("MFSD1" 5))) ("UP:Q9H3U7" (("Smoc2" 2)))
 ("UP:Q9H3Y0" (("R3HDML" 2))) ("UP:Q9H3Y6" (("SRMS" 2)))
 ("UP:Q9H3Z4" (("CLN4" 1)))
 ("UP:Q9H400"
  (("LIME" 221) ("LimE" 7) ("lime" 3) ("LIME protein" 2)
   ("the specific amino acids of LIME" 1) ("pLIME" 1)))
 ("UP:Q9H410" (("Dsn1" 33) ("c20orf172" 1)))
 ("UP:Q9H422"
  (("HIPK3" 8) ("homeodomain-interacting protein kinase 3" 4)
   ("homeodomain interacting protein kinase 3" 2) ("HipK3" 1)))
 ("UP:Q9H427" (("KCNK15" 1))) ("UP:Q9H444" (("CHMP4b" 9)))
 ("UP:Q9H461" (("FZD8" 4) ("Fz8" 1))) ("UP:Q9H467" (("CUEDC2" 5)))
 ("UP:Q9H469" (("Fbxl15" 2) ("FBXL15" 1)))
 ("UP:Q9H479" (("FN3K" 8) ("fructosamine 3 kinase" 2)))
 ("UP:Q9H488" (("POFUT1" 1) ("protein O-fucosyltransferase 1" 1)))
 ("UP:Q9H492" (("LC3A" 37) ("MAP1LC3A" 11) ("LC3a" 3)))
 ("UP:Q9H4A3" (("WNK1" 25) ("KDp" 4) ("PRKWNK1" 4)))
 ("UP:Q9H4A4"
  (("APBs" 143) ("APB" 130) ("undetectable APB" 2) ("few APBs" 2)
   ("than APBs in ALT cells" 1)))
 ("UP:Q9H4A5" (("GOLPH3L" 1)))
 ("UP:Q9H4A6" (("GOLPH3" 118) ("MIDAS" 32) ("MIDAS (ADMIDAS)" 1) ("GPP34" 1)))
 ("UP:Q9H4B4"
  (("PLK3" 78) ("Plk3" 38) ("FNK" 13) ("polo-like kinase 3" 4) ("CNK" 3)
   ("Polo-like kinase-3" 2) ("Fnk" 1) ("Polo-like kinase 3" 1)))
 ("UP:Q9H4B6"
  (("SAV1" 282) ("hWW45" 89) ("WW45" 74) ("Sav1" 57) ("SAV1 protein" 8)
   ("Salvador homolog 1" 7) ("ww45" 5) ("ww45 protein" 4) ("hWW45 protein" 4)
   ("Salvador homolog 1 protein" 4) ("protein salvador homolog 1" 2)))
 ("UP:Q9H4B7" (("TUBB1" 8))) ("UP:Q9H4D0" (("CS2" 123) ("pCS2" 32)))
 ("UP:Q9H4E5" (("TCL" 45) ("TCLs" 14) ("RhoJ" 3) ("angioimmunoblastic TCL" 1)))
 ("UP:Q9H4G4"
  (("GLIPR-2" 196) ("-GLIPR-2" 7) ("Overexpressed GLIPR-2" 4)
   ("overexpressed GLIPR-2" 4) ("C9orf19" 2) ("GAPR-1" 2)
   ("Stably Overexpressed GLIPR-2" 2)))
 ("UP:Q9H4H8" (("FAM83D" 63))) ("UP:Q9H4K1" (("RIBC2" 3)))
 ("UP:Q9H4L4" (("SENP3" 56) ("Ulp1" 14) ("Senp3" 6) ("ULP1" 3)))
 ("UP:Q9H4L7"
  (("SMARCAD1" 9)
   ("SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"
    2)))
 ("UP:Q9H4M3" (("Fbx44" 1)))
 ("UP:Q9H4M9"
  (("past" 1880) ("EHD1" 151) ("Past" 30) ("PAST" 3) ("EHD1-" 2)
   ("internal EHD1" 1) ("more intracellular EHD1" 1)))
 ("UP:Q9H4P4" (("Nrdp1" 30) ("NRDP1" 4) ("RNF41" 1)))
 ("UP:Q9H4W6" (("OE2" 3) ("EBF3" 2)))
 ("UP:Q9H4X1"
  (("RGC-32" 142) ("regulator of cell cycle" 109)
   ("a key regulator of cell cycle" 6) ("A dual regulator of cell cycle" 2)
   ("regulator of
 cell cycle"
    2)
   ("a crucial regulator of cell cycle" 1) ("RGC-32 protein" 1) ("RGCC" 1)))
 ("UP:Q9H4Z3" (("Pcif1" 2))) ("UP:Q9H553" (("ALG-2" 12)))
 ("UP:Q9H582" (("ZNF644" 5))) ("UP:Q9H583" (("HEATR1" 2)))
 ("UP:Q9H598"
  (("vesicular GABA transporter (VGAT)" 4) ("VGAT" 4)
   ("vesicular GABA transporter" 1)))
 ("UP:Q9H5I1" (("H3-K9" 26) ("SUV39H2" 7) ("Suv39h2" 6)))
 ("UP:Q9H5I5" (("PIEZO2" 1)))
 ("UP:Q9H5J4" ; removed lowercase face
  (#+ignore("face" 1157) ("LCE" 19) #+ignore("the inner face" 11) ("FACE" 7) ("ELOVL6" 6)
   ("a triangular face" 5) ("characteristic face" 5) ("Face" 4)
   ("the upper face" 4) ("the nucleoplasmic face" 4) ("the hydrophilic face" 3)
   ("triangular face" 3) ("the concave face" 3) ("-face" 2)
   ("the outer face" 2) ("the convex face" 2) ("lower face" 2)
   ("the ventral face" 1) ("the cytolic face" 1) ("a new face" 1)
   ("the external face" 1) ("the internal face" 1)
   ("The DNA-adjacent helical face" 1) ("survive face" 1)
   ("the concave front face" 1) ("pathobiological risk face" 1)
   ("ELOVL fatty acid elongase 6" 1) ("coarse face" 1)
   ("whose hydrophobic face" 1) ("anaplastic astrocytomas face" 1) ("“face”" 1)
   ("good face" 1) ("narrower ~34 Å face" 1) ("most women face" 1)
   ("the aortic endothelium en face" 1) ("the apical face" 1)
   ("their hydrophilic face" 1) ("The hydrophobic face of PTHLH's" 1)
   ("the cytoplasmatic face" 1) ("the symmetric kinase dimer face" 1)
   ("the polar face" 1)))
 ("UP:Q9H5J8" (("JOSD3" 2))) ("UP:Q9H5P4" (("PDZk7" 1)))
 ("UP:Q9H5Q4" (("TFB2M" 2) ("transcription factor B2" 2)))
 ("UP:Q9H5V7" (("Pegasus" 6) ("IKZF5" 1)))
 ("UP:Q9H5V8"
  (("CDCP1" 607) ("CDCP1 protein" 5) ("TRASK" 1) ("SIMA135" 1) ("CD318" 1)))
 ("UP:Q9H607" (("OCEL1" 4))) ("UP:Q9H611" (("PIF1" 13) ("Pif1" 9) ("pif1" 8)))
 ("UP:Q9H668" (("OBFC1" 19) ("STN1" 5) ("Stn1" 4))) ("UP:Q9H694" (("Bic-C" 2)))
 ("UP:Q9H6A9" (("pCX" 41) ("-PCX" 2) ("PCX" 1) ("Pcx" 1) ("pCx" 1)))
 ("UP:Q9H6B4" (("ACAM" 49) ("CLMP" 6))) ("UP:Q9H6E4" (("CCDC134" 1)))
 ("UP:Q9H6E5" (("TUT1" 1)))
 ("UP:Q9H6I2" (("SOX17" 37) ("Sox17" 31) ("sox17" 1)))
 ("UP:Q9H6K1" (("C6orf106" 8))) ("UP:Q9H6K4" (("OPA3" 7) ("“OPA3”" 1)))
 ("UP:Q9H6Q3"
  (("SLAP-2" 173) ("MARS" 17) ("SLAP-2 protein" 3) ("Sla2" 3) ("SLA2" 2)
   ("correctly position SLAP-2" 1) ("than wild-type SLAP-2" 1)
   ("than wild-type SLAP-2 ( xref C)" 1)))
 ("UP:Q9H6Q4" (("IOP1" 26) ("Nar1" 9))) ("UP:Q9H6R4" (("NOL6" 1)))
 ("UP:Q9H6S1" (("AZI2" 2))) ("UP:Q9H6S3" (("Eps8L2" 1)))
 ("UP:Q9H6T0"
  (("ESRP2" 36) ("Rbm35b" 17) ("Esrp2" 7) ("RBM35B" 4) ("than ESRP2" 1)))
 ("UP:Q9H6T3" (("RPAP3" 6))) ("UP:Q9H6U6" (("BCAS3" 5)))
 ("UP:Q9H6U8" (("ALG9" 5)))
 ("UP:Q9H6X2"
  (("receptor 1" 190) ("Receptor 1" 23) ("TEM8" 5) ("ANTXR1" 4)
   ("soluble rComplement Receptor 1" 3) ("human epidermal receptor 1" 2)
   ("The transmembrane protein Vascular Endothelial Growth Factor Receptor 1"
    2)
   ("–receptor 1" 2) ("soluble tumour necrosis factor-α receptor 1" 2)
   ("the heterodimeric IFN-γ receptor 1" 2) ("receptor 1 (TGFBRI)" 1)
   ("human soluble tumor necrosis factor (TNF) receptor 1" 1)
   ("anthrax toxin receptor" 1)))
 ("UP:Q9H6Y7" (("RNF167" 3)))
 ("UP:Q9H6Z4"
  (("RanBP3" 205) ("overexpressed RanBP3" 3) ("Ranbp3" 2)
   ("than the full-length RanBP3 ( xref )" 1)))
 ("UP:Q9H6Z9"
  (("PHD3" 474) ("EGLN3" 6) ("Lentiviral PHD3" 2) ("prolyl hydroxylase 3" 1)
   ("-PHD3" 1) ("epigenetic PHD3" 1)))
 ("UP:Q9H772" (("GREM2" 31) ("PRDC" 1)))
 ("UP:Q9H792"
  (("SgK269" 25) ("Peak1" 11) ("PEAK1" 2) ("than JH2-Peak1 ( xref )" 2)
   ("Sgk269" 1) ("-Peak1" 1)))
 ("UP:Q9H7B4"
  (("SMYD3" 170) ("Smyd3" 7) ("SET and MYND domain-containing protein 3" 2)))
 ("UP:Q9H7D0" (("Dock5" 5) ("DOCK5" 1))) ("UP:Q9H7E2" (("TDRD3" 2)))
 ("UP:Q9H7F4" (("TMEM185B" 1)))
 ("UP:Q9H7H1" (("Runx1" 190) ("RunX1" 1) ("runx1" 1)))
 ("UP:Q9H7L9" (("SDS3" 4) ("SUDS3" 3)))
 ("UP:Q9H7M9" (("Vista" 62) ("siSp1" 1))) ("UP:Q9H7N4" (("SCAF1" 3)))
 ("UP:Q9H7P6" (("MVB12B" 1)))
 ("UP:Q9H7S9"
  (("ZNF703" 237) ("zinc finger protein 703" 5) ("FLJ14299" 4)
   ("ZNF703 protein" 2) ("Zeppo1" 1)))
 ("UP:Q9H7T0" (("Sperm-associated" 2))) ("UP:Q9H7X7" (("RABL5" 1)))
 ("UP:Q9H7Z6"
  (("MOF" 253) ("hMOF" 28) ("MOF protein" 5) ("KAT8" 3) ("distinct MOF" 2)
   ("MYST1" 2) ("than MOF" 1) ("two distinct MOF" 1)))
 ("UP:Q9H7Z7"
  (("prostaglandin" 519) ("Prostaglandin" 62) ("mPGES-2" 7)
   ("-prostaglandin" 7) ("prostaglandin E synthase 2" 3)
   ("the predominant prostaglandin" 2) ("mPGES2" 2) ("mPGES-2 protein" 1)
   ("-Prostaglandin" 1) ("–prostaglandin" 1)))
 ("UP:Q9H814" (("PHAX" 3) ("RNA U" 2)))
 ("UP:Q9H816"
  (("hSNM1B" 186) ("Apollo" 32) ("hSNM1B protein" 5) ("DCLRE1B" 5)
   ("overexpressed hSNM1B" 4) ("SNM1B" 4)))
 ("UP:Q9H832" (("UBE2Z" 7) ("Ube2z" 2))) ("UP:Q9H840" (("Gemin7" 4)))
 ("UP:Q9H857" (("NT5DC2" 6))) ("UP:Q9H867" (("METTL21D" 26)))
 ("UP:Q9H8G2" (("Janicke" 1))) ("UP:Q9H8H0" (("NOL11" 2)))
 ("UP:Q9H8M7" (("protein CARP" 7))) ("UP:Q9H8N7" (("ZNF395" 2)))
 ("UP:Q9H8P0" (("SRD5A3" 1)))
 ("UP:Q9H8S9" (("MOB kinase activator 1A" 1) ("MOBKL1B" 1)))
 ("UP:Q9H8T0" (("FTS" 280)))
 ("UP:Q9H8V3"
  (("Ect2" 1279) ("ECT2" 513) ("ECT2 protein" 13) ("Ect2 protein" 11)
   ("pEct2" 6) ("Ect2 peptide" 3)
   ("epithelial cell transforming sequence 2 oncogene" 3) ("ECT2-" 2)
   ("very faint Ect2" 2) ("Ect2-" 2) ("significantly less cytoplasmic Ect2" 2)
   ("Exogenous Ect2" 2) ("Non degradable Ect2" 2) ("pECT2" 1) ("Q9H8V3" 1)
   ("very little Ect2" 1) ("less Ect2" 1) ("total cellular Ect2" 1)
   ("the central spindle–associated RhoGEF ECT2" 1)
   ("cortically localized/phospholipid-associated Ect2" 1)
   ("mutant Ect2 (C-term)" 1) ("abolished Ect2's" 1) ("decreased Ect2's" 1)
   ("Phosphorylated mitotic Ect2" 1)))
 ("UP:Q9H8Y8"
  (("55 kDa" 63) ("GRASP55" 23) ("55 kDa" 19) ("55 kDa" 13) ("55kDa" 3)
   ("Grasp55" 2) ("around 55 kDa" 2)
   ("the unrelated peripheral Golgi protein GRASP55" 1) ("55 KDa" 1)
   ("approximately 55 kDa" 1) ("than 55 kDa that were" 1)
   ("than 55 kDa ( xref ; xref )" 1) ("than 55 kDa" 1)))
 ("UP:Q9H900" (("Zwilch" 11) ("ZWILCH" 1))) ("UP:Q9H902" (("REEP1" 5)))
 ("UP:Q9H903" (("MTHFD2L" 1)))
 ("UP:Q9H910"
  (("L11" 317) ("l11" 5) ("exogenous L11" 3) ("nucleoplasmic L11" 2)
   ("the ribosomal proteins L11" 2) ("L11-" 1) ("the nucleolar L11" 1)
   ("Three ribosomal proteins L11" 1) ("L11 ( xref E) protein" 1)
   ("L11 protein" 1)))
 ("UP:Q9H920" (("RNF121" 71))) ("UP:Q9H936" (("GC-1" 49) ("GC-1 protein" 2)))
 ("UP:Q9H939" (("PSTPIP2" 4)))
 ("UP:Q9H944" (("tRFP" 64) ("-tRFP" 13) ("TRFP" 4)))
 ("UP:Q9H967" (("WDR76" 29))) ("UP:Q9H974" (("QTRTD1" 2)))
 ("UP:Q9H981" (("Arp8" 11) ("hArp8" 4) ("Arp8-" 1)))
 ("UP:Q9H987" (("SYNPO2L" 5))) ("UP:Q9H992" (("MARCH7" 2)))
 ("UP:Q9H993" (("C6orf211" 3))) ("UP:Q9H999" (("Pank3" 1)))
 ("UP:Q9H9A5" (("CNOT10" 2)))
 ("UP:Q9H9A7"
  (("75 kDa" 45) ("RMI1" 13) ("75 kDa" 9) ("75 kDa" 4) ("75 kDa protein" 4)
   ("approximately 75 kDa" 4) ("Blm" 4) ("a predicted size around 75 kDa" 1)
   ("around 75 kDa" 1) ("BLAP75" 1)))
 ("UP:Q9H9B1" (("EHMT1" 6) ("KMT1D" 3)))
 ("UP:Q9H9B4"
  (("TCC" 1059) ("-TCC" 55) ("TCC-" 9) ("invasive TCC" 2)
   ("locally invasive TCC" 2) ("GCC GCC CGA TTG CTT TAG CTT CC A AAT TCC" 2)
   ("deep invasive TCC" 2) ("superficial TCC" 2) ("his muscle-invasive TCC" 1)
   ("invasive (pTa/pT1) TCC" 1) ("developed detrusor muscle invasive TCC" 1)
   ("either detrusor muscle invasive TCC" 1) ("Invasive TCC" 1)
   ("reliable TCC" 1) ("CTG(C→G)AA(G→T)TCCTGA(C→A)TT(G→A)TCC" 1)
   ("muscle-invasive TCC" 1) ("only T1G3 TCC" 1) ("noninvasive TCC" 1)
   ("human invasive TCC" 1)))
 ("UP:Q9H9E1" (("ANKRA2" 11))) ("UP:Q9H9G7" (("Ago3" 3)))
 ("UP:Q9H9H4" (("Vps37b" 2) ("VPS37B" 1))) ("UP:Q9H9J4" (("USP42" 10)))
 ("UP:Q9H9L4" (("NSL2" 1))) ("UP:Q9H9P8" (("L2HGDH" 1)))
 ("UP:Q9H9Q2" (("COPS7B" 1)))
 ("UP:Q9H9Q4"
  (("XLF" 311) ("XLF protein" 6) ("XRCC4-like factor" 5) ("Cernunnos" 4)
   ("The C-terminal 60 amino acids of XLF" 2)
   ("the C-terminal 60 amino acids of XLF (amino acids 240–299)" 2)
   ("phosphorylation- defective XLF" 1)
   ("The C-terminal ∼70 amino acids of human XLF" 1)
   ("phosphorylation-defective XLF" 1) ("than either full-length XLF" 1)
   ("the C-terminal ∼50 amino acids of XLF" 1) ("NHEJ1" 1)))
 ("UP:Q9H9S0"
  (("Nanog" 1602) ("NANOG" 396) ("nanog" 23) ("Nanog protein" 19) ("hNANOG" 4)
   ("Nanog (3.0 ± 0.2-fold) protein" 3) ("dimeric wildtype:wildtype Nanog" 2)
   ("lentiviral Nanog" 2) ("Nanog homeobox (NANOG)" 2) ("Nanog homeobox" 2)
   ("endogenous dimeric wildtype:wildtype Nanog" 1)
   ("than dimeric wildtype:wildtype Nanog" 1) ("dimeric Nanog" 1)
   ("phosphoinsensitive T280A mutant Nanog" 1)
   ("phosphoinsensitive T200A mutant Nanog" 1) ("than wildtype Nanog" 1)
   ("the pluripotency-associated transcription factor Nanog" 1)
   ("pluripotency-associated transcription factor Nanog" 1)
   ("the self-renewal factor Nanog" 1) ("than NANOG" 1) ("pNANOG" 1)
   ("than Nanog" 1) ("Nanog-" 1)))
 ("UP:Q9H9S4" (("MO25β" 14) ("CAB39L" 1)))
 ("UP:Q9H9T3"
  (("elp3" 188) ("Elp3" 108) ("ELP3" 14) ("than either elp3" 4)
   ("than the elp3" 3) ("Elp3 protein" 2) ("Kat9" 2)))
 ("UP:Q9H9Y6" (("POLR1B" 3)))
 ("UP:Q9H9Z2"
  (("LIN28" 67) ("Lin28a" 50) ("LIN28A" 26) ("LIN28 protein" 7) ("Lin28A" 2)
   ("lin28" 2) ("Lin 28" 1)
   ("We first used His-tagged recombinant LIN28 protein" 1)))
 ("UP:Q9HA38"
  (("Wig-1" 157) ("WIG-1" 55) ("WIG1" 25) ("ZMAT3" 13) ("Wig-1 protein" 7)
   ("Wig1" 5) ("strong nuclear and negative cytoplasmic Wig-1" 4)
   ("several distinct Wig-1" 2)))
 ("UP:Q9HA47" (("UCK1" 1))) ("UP:Q9HA65" (("TBC1D17" 8)))
 ("UP:Q9HAB8" (("PPCs" 4) ("PPCS" 2)))
 ("UP:Q9HAC7" (("c7orf10" 6) ("C7orf10" 2)))
 ("UP:Q9HAF1" (("CENP-28" 2) ("Eaf6" 1) ("hEaf6" 1)))
 ("UP:Q9HAH7" ; changed to FBRS since that's more correct and added good FBS def
  (#+ignore("FBS" 17067) ("SFS" 48) #+ignore("10% charcoal-stripped FBS" 40)
   #+ignore("5% charcoal-stripped FBS" 34) ("GIBCO" 22) #+ignore("charcoal-stripped FBS" 20)
   ("FBS (GIBCO)" 12) ("charcoal stripped FBS" 12)
   ("10% charcoal stripped FBS" 10) ("FBS-" 10) ("normal FBS" 7) ("–FBS" 7)
   ("2.5% charcoal-stripped FBS" 6) ("5% charcoal stripped FBS" 5)
   ("1% charcoal-stripped FBS" 5) ("FBS (FBS)" 4)
   ("5% charcoal dextran-treated FBS" 4) ("than FBS" 4)
   ("5% charcoal–dextran-stripped (CDS) FBS" 4)
   ("10% dextran/charcoal-treated FBS" 4)
   ("charcoal stripped heat inactivated FBS" 4) ("2% charcoal stripped FBS" 4)
   ("10% charcoal-dextran sulfate-stripped FBS" 4) ("FBS (CSFBS)" 3)
   ("FBS (PAA)" 3) ("5% dextran-coated charcoal-stripped FBS" 3) ("−FBS" 3)
   ("10% charcoal-treated FBS" 3) ("-FBS" 3) ("10% ultra-low Ig FBS" 2)
   ("fresh DMEM/10% FBS" 2) ("charcoal-dextran-stipped FBS" 2)
   ("fresh 10% FBS" 2) ("treated FBS" 2) ("10% normal FBS" 2)
   ("dextran-treated FBS" 2) ("Charcoal/Dextran treated FBS" 2)
   ("charcoal-treated FBS" 2) ("FBS (PPA)" 2) ("FBS (LONZA)" 2)
   ("5% charcoal dextran FBS" 2) ("EMEM + 10% DCC-treated FBS" 2)
   ("5% dextran-coated charcoal-treated FBS" 2)
   ("2% charcoal dextran-treated FBS" 2) ("FBS (JRH)" 2)
   ("5% (v/v) charcoal filtered FBS" 2)
   ("phenol red-free IMEM/10% dextran-charcoal-treated FBS" 2)
   ("0.5% heat-inactivated charcoal-stripped FBS" 2)
   ("charcoal-stripped (low-estrogen) FBS" 2)
   ("containing 10% charcoal-stripped FBS" 2) ("5% DCC-treated FBS" 2)
   ("5% charcoal-dextran sulfate-stripped FBS" 2)
   ("endothelial growth medium (EGM-2) (Lonza) +5% FBS" 2) ("FBS (JRS)" 2)
   ("5% charcoal-treated FBS" 1) ("5% dextran/charcoal-stripped FBS" 1)
   ("5% dextran charcoal-stripped FBS" 1) ("saline (PBS) + 1% FBS" 1)
   ("10% heat-inactivated fetal bovine serum (FBS) -5% FBS" 1)
   ("warm IMDM+10% FBS" 1) ("10% charcoal stripped FBS (GIBCO)" 1)
   ("10% v/v dextran-charcoal stripped FBS" 1)
   ("5% charcoal-dextran-stripped FBS" 1)
   ("dextran-coated charcoal-treated FBS" 1)
   ("phenol red-free DMEM + 10% charcoal stripped FBS" 1)
   ("10% charcoal-dextran–treated FBS" 1) ("the DCC-treated FBS" 1)
   ("charcoal-dextran-stripped FBS" 1) ("8% charcoal-dextran–stripped FBS" 1)
   ("20% activated charcoal-stripped FBS" 1)
   ("1% charcoal dextran-treated FBS" 1)
   ("fresh RMPI/charcoal–dextran stripped FBS" 1)
   ("10% charcoal–treated FBS" 1)
   ("10% heat inactivated charcoal-stripped FBS" 1)
   ("4% dextran-coated charcoal-stripped FBS" 1)
   ("0.5% charcoal-stripped FBS" 1) ("10% charcoal-stripped FBS (PAA)" 1)
   ("FBS (CDSS)" 1) ("FBS (CSS)" 1)
   ("5% (v/v) dextran-coated charcoal-stripped FBS" 1) ("fresh DMEM-10% FBS" 1)
   ("containing charcoal-stripped FBS" 1)
   ("10% charcoal dextran-stripped FBS" 1) ("pure FBS" 1) ("only 0.5% FBS" 1)
   ("5% charcoal dextran-treated (CDT) FBS" 1)
   ("Both charcoal dextran-treated (CDT) FBS" 1)
   ("charcoal dextran-treated (CDT)-FBS" 1) ("fresh DMEM 10% FBS" 1)
   ("1% charcoal stripped FBS" 1) ("10% DCC-treated FBS" 1)
   ("charcoal filtered FBS" 1) ("Ten percent FBS" 1)
   ("5% charcoal dextran-treated FBS (CDFBS)" 1)
   ("phenol red free DMEM/F12 + 10% 6x charcoal stripped FBS (SFS)" 1)
   ("FBS (SFS)" 1) ("10% inactivated FBS" 1)
   ("10% charcoal dextran–treated FBS" 1)
   ("10% dextran-charcoal-treated FBS" 1) ("FBS (PBS)" 1) ("10% fetal FBS" 1)
   ("fresh RPMI1640/10% FBS" 1) ("only 0.1% FBS" 1)
   ("1% dextran charcoal-stripped (CS) FBS" 1) ("androgen-poor FBS" 1)
   ("DMEM-DCC-treated FBS" 1)
   ("5% dextran-coated charcoal (DCC)-treated FBS" 1)))
 ("UP:Q9HAJ7"
  (("SAP30L" 172) ("SAP30L protein" 18) ("SAP30L (1–120) protein" 4)
   ("than the wt SAP30L protein" 2) ("SAP30L-" 2)
   ("than the wt SAP30L protein ( xref )" 1) ("myc-his-tagged SAP30L" 1)))
 ("UP:Q9HAN9"
  (("NMNAT-1" 6) ("NMNAT1" 3)
   ("nicotinamide nucleotide adenylyltransferase 1" 3) ("Nmnat1" 1)))
 ("UP:Q9HAP2" (("MondoA" 164) ("Mlxip" 3) ("MondoA protein" 3) ("MLXIP" 1)))
 ("UP:Q9HAP6" (("Mals2" 2) ("Lin7b" 1)))
 ("UP:Q9HAS3" (("hCNT3" 11) ("SLC28A3" 1)))
 ("UP:Q9HAT1"
  (("1 like" 18) ("1 like protein" 4) ("1 Like" 2)
   ("palate transmembrane 1 like" 1)))
 ("UP:Q9HAT8" (("PELI2" 1)))
 ("UP:Q9HAU4"
  (("Smurf2" 207) ("SMURF2" 16) ("overexpressed Smurf2" 3) ("hSmurf2" 2)
   ("Smurf2–" 2) ("Smurf2 protein" 1) ("ectopically overexpressed Smurf2" 1)
   ("Smurf2-" 1)))
 ("UP:Q9HAU5" (("Upf2" 20) ("UPF2" 18) ("hUpf2" 11) ("Q9HAU5" 1)))
 ("UP:Q9HAV4"
  (("RanGTP" 39) ("XPO5" 9) ("exportin 5" 3) ("Exportin 5" 3) ("Exportin5" 1)
   ("RANGTP" 1)))
 ("UP:Q9HAV5"
  (("EDA2R" 40) ("EDA2R protein" 2) ("ectodysplasin A2 receptor" 2)))
 ("UP:Q9HAV7" (("GrpE" 2)))
 ("UP:Q9HAW0"
  (("EGCG" 1053) ("BRF2" 52) ("EGCG-" 5) ("B-related factor 2" 2) ("BRF-2" 2)))
 ("UP:Q9HAW4"
  (("Claspin" 221) ("claspin" 24) ("CLASPIN" 21) ("CLSPN" 8) ("Claspin-" 2)))
 ("UP:Q9HAW7" (("UGT1A7" 35))) ("UP:Q9HAW8" (("UGT1A10" 5)))
 ("UP:Q9HAW9" (("UGT1A8" 1))) ("UP:Q9HAY2" (("MAGE-F1" 4)))
 ("UP:Q9HAZ1" (("CLK4" 1)))
 ("UP:Q9HAZ2"
  (("Prdm16" 35) ("PRDM16" 16) ("MEL1" 7)
   ("the transcriptional co-activator PRDM16" 1) ("PR domain containing 16" 1)
   ("the brown cofactor Prdm16" 1)))
 ("UP:Q9HB03" (("Elovl3" 1))) ("UP:Q9HB09" (("BCL2L12" 9) ("Bcl2L12" 2)))
 ("UP:Q9HB19" (("TAPP2" 2))) ("UP:Q9HB21" (("TAPP1" 5)))
 ("UP:Q9HB55" (("CYP3A43" 12) ("family 3" 6) ("Family 3" 3)))
 ("UP:Q9HB58" (("SP110" 16))) ("UP:Q9HB63" (("NTN4" 8)))
 ("UP:Q9HB75"
  (("PIDD" 392) ("Pidd" 115) ("LRDD" 7) ("Pidd protein" 4) ("PIDD protein" 4)
   ("p53-induced death domain protein" 3) ("nonphosphorylatable PIDD" 3)
   ("non-phosphorylatable PIDD T788A" 1) ("pPIDD" 1)))
 ("UP:Q9HB90"
  (("RagC" 157) ("Rag C" 9) ("RRAGC" 8) ("rragc" 5)
   ("lysosome-associated recombinant RagC" 1) ("cellular RagC" 1)))
 ("UP:Q9HB96" (("FANCE" 41)))
 ("UP:Q9HBE1"
  (("PATZ1" 165) ("Patz1" 24) ("PATZ" 20) ("PATZ protein" 3)
   ("PATZ1 protein" 3) ("MAZR" 2) ("Patz1-" 1)))
 ("UP:Q9HBE4"
  (("IL-21" 920) ("IL21" 63) ("Il21" 8) ("Interleukin-21" 6) ("-IL-21" 6)
   ("IL-21 protein" 3) ("interleukin 21" 1) ("exogenous IL-21" 1)))
 ("UP:Q9HBE5"
  (("IL-21R" 82) ("IL21R" 35) ("a functional IL-21R" 2)
   ("a functional IL21R" 1)))
 ("UP:Q9HBF4" (("DFCP1" 15) ("SR3" 5) ("ZFYVE1" 3)))
 ("UP:Q9HBG4" (("ATP6V0A4" 1))) ("UP:Q9HBG6" (("IFT122" 1)))
 ("UP:Q9HBG7" (("Lys9" 54) ("lys9" 4) ("Ly9" 1)))
 ("UP:Q9HBH0" (("RIF" 13) ("rif" 13) ("Rif" 10) ("RHOF" 9) ("RhoF" 2)))
 ("UP:Q9HBH7" (("BEX1" 127) ("BEX-1" 1)))
 ("UP:Q9HBH9" (("MNK2" 86) ("Mnk2" 48) ("MKNK2" 2) ("MNK-2" 1) ("Mnk2-" 1)))
 ("UP:Q9HBI1" (("affixin" 10) ("β-parvin" 7) ("PARVB" 1)))
 ("UP:Q9HBI5" (("chromosome 3 open reading frame 14" 2) ("HT021" 1)))
 ("UP:Q9HBJ7" (("USP29" 3)))
 ("UP:Q9HBJ8" (("Tmem27" 10) ("collectrin" 1) ("Transmembrane protein 27" 1)))
 ("UP:Q9HBK9" (("AS3MT" 3)))
 ("UP:Q9HBL0"
  (("TNS1" 19) ("tensin-1" 18) ("TNS" 9) ("Tensin-1" 3) ("TNs" 1) ("tns1" 1)
   ("than tensin-1-3" 1)))
 ("UP:Q9HBL8"
  (("HSCARG" 120) ("Q9HBL8" 1) ("NMRAL1" 1)
   ("NmrA-like family domain-containing protein 1" 1)))
 ("UP:Q9HBM1" (("SPC25" 8) ("Spc25" 1)))
 ("UP:Q9HBM6"
  (("TAF9B" 47) ("TAF9b" 37) ("the highly homologous protein TAF9b" 2)))
 ("UP:Q9HBU6" (("ETNK1" 3) ("ethanolamine kinase 1" 3)))
 ("UP:Q9HBU9" (("pop2" 3) ("Pop2" 1))) ("UP:Q9HBV1" (("POPDC3" 1)))
 ("UP:Q9HBW0" (("LPAR2" 24) ("LPA2" 14) ("than LPAR2" 1) ("LPA-2" 1)))
 ("UP:Q9HBX8" (("Lgr6" 34) ("LGR6" 18)))
 ("UP:Q9HBX9" (("LGR7" 7) ("RXFP1" 6) ("relaxin family peptide receptor 1" 6)))
 ("UP:Q9HBY0" (("NOX3" 30) ("Nox3" 24) ("Nox3-" 1)))
 ("UP:Q9HBY8" (("SGK2" 11)))
 ("UP:Q9HBZ2"
  (("ARNT2" 7) ("aryl hydrocarbon receptor nuclear translocator 2" 3)))
 ("UP:Q9HC07" (("TMEM165" 1))) ("UP:Q9HC10" (("OTOF" 5)))
 ("UP:Q9HC16"
  (("APOBEC3G" 440) ("catalytic polypeptide-like 3G" 14) ("APOBEC-3G" 7)
   ("CEM15" 4) ("Apobec3G" 4) ("the host antiviral factor APOBEC3G" 2)
   ("functional APOBEC3G" 2) ("overexpressed APOBEC3G" 2)
   ("the antiviral protein APOBEC3G" 1)
   ("the important antiviral protein APOBEC3G" 1) ("APOBEC 3G" 1)
   ("antiviral APOBEC3G" 1)
   ("the retroviral complementary DNA deaminase APOBEC3G" 1) ("Arp9" 1)))
 ("UP:Q9HC21" (("DNC" 6) ("DNc" 6) ("dnc" 1)))
 ("UP:Q9HC23" (("PROK2" 29) ("prokineticin 2" 1)))
 ("UP:Q9HC24"
  (("TMBIM4" 24) ("Z protein" 7)
   ("the first 32 amino acids of TMBIM4 (MADPDPRYPRSSIEDDFNYGSSVASATVHIRM)"
    1)))
 ("UP:Q9HC29"
  (("NOD2" 515) ("Nod2" 18) ("CARD15" 13) ("NOD2 protein" 3) ("Blau" 2)
   ("NLRC2" 2) ("disease-associated NOD2" 1) ("the homozygous NOD2" 1)
   ("just NOD2" 1) ("NOD2-" 1)))
 ("UP:Q9HC35"
  (("EML4" 810) ("previously identified fusion partners EML4" 3) ("EML4-" 1)
   ("EML4–" 1) ("than EML4" 1) ("EML4 ”" 1) ("”" 1) ("EML4 protein" 1)
   ("had both the EML4" 1) ("a functional EML4" 1) ("the canonical EML4" 1)))
 ("UP:Q9HC52" (("CBX8" 5) ("chromobox homolog 8" 2) ("RC1" 2) ("Cbx8" 1)))
 ("UP:Q9HC56" (("Pcdh9" 2))) ("UP:Q9HC57" (("pS20" 35) ("WFDC1" 1)))
 ("UP:Q9HC62"
  (("SENP2" 405) ("Senp2" 10) ("axam" 3) ("SENP2 protein" 3) ("than SENP2" 3)
   ("than SENP2 ( xref )" 2) ("adenoviral SENP2" 2) ("SenP2" 1)
   ("sentrin-specific protease 2" 1) ("than SENP2 ( xref , bottom )" 1)
   ("-SENP2" 1)))
 ("UP:Q9HC73"
  (("CRLF2" 152) ("TSLPR" 15) ("TSLP receptor" 6) ("overexpressed CRLF2" 5)
   ("cysteine of CRLF2" 1) ("CRL2" 1)))
 ("UP:Q9HC77" (("CPAP" 23) ("CENPJ" 7) ("SCKL4" 2)))
 ("UP:Q9HC78"
  (("Zbtb20" 8) ("ZBTB20" 4) ("zinc finger and BTB domain containing 20" 4)))
 ("UP:Q9HC84" (("MUC5B" 40)))
 ("UP:Q9HC96"
  (("CAPN10" 38) ("calpain 10" 11) ("calpain-10" 5) ("Calpain-10" 3)
   ("Calpain 10" 2)))
 ("UP:Q9HC97" (("GPR35" 4))) ("UP:Q9HC98" (("Nek6" 117) ("NEK6" 3)))
 ("UP:Q9HCB6" (("SPON1" 16) ("spondin 1" 2))) ("UP:Q9HCC0" (("MCCB" 1)))
 ("UP:Q9HCC6" (("Hes4" 19) ("HES4" 15))) ("UP:Q9HCC8" (("GDPD2" 4)))
 ("UP:Q9HCC9"
  (("hLst2" 172) ("Non-ubiquitinylated hLst2" 2) ("hLst2 protein" 2)))
 ("UP:Q9HCD5"
  (("CIA" 249) ("acute CIA" 2) ("the so-called CIA" 1) ("Heterologous CIA" 1)))
 ("UP:Q9HCE1"
  (("MOV10" 10) ("homolog (mouse)" 5)
   ("testicular haploid expressed gene homolog (mouse)" 1)))
 ("UP:Q9HCE7"
  (("Smurf1" 551) ("SMURF1" 29) ("Smurf1 molecule" 5) ("smurf1" 4)
   ("Smurf1 protein" 2) ("Smurf1-" 1)
   ("Smad ubiquitination regulatory factor 1" 1)))
 ("UP:Q9HCF6" (("TRPM3" 2)))
 ("UP:Q9HCG1" (("F11" 115) ("-F11" 3) ("ZNF160" 3) ("f11" 1)))
 ("UP:Q9HCG8"
  (("NCMs" 20) ("NCM" 19) ("spliceosome-associated protein" 5) ("Cwc22" 5)))
 ("UP:Q9HCH5" (("SYTL2" 1))) ("UP:Q9HCI5" (("MAGEE1" 2)))
 ("UP:Q9HCI7" (("MSL2" 26) ("Msl2" 4))) ("UP:Q9HCJ1" (("ankylosis" 1)))
 ("UP:Q9HCJ2" (("LRRC4C" 4))) ("UP:Q9HCJ6" (("VAT1L" 5)))
 ("UP:Q9HCK4" (("axon guidance receptor" 4) ("ROBO2" 1)))
 ("UP:Q9HCK5" (("Ago4" 4)))
 ("UP:Q9HCK8" (("CHD8" 186) ("Chd8" 37) ("Duplin" 4)))
 ("UP:Q9HCL2" (("glycerol-3-phosphate acyltransferase" 8)))
 ("UP:Q9HCM2"
  (("PlexinA4" 15) ("Plexin-A4" 7) ("PLXNA4" 7) ("Plexin A4" 5)
   ("plexinA4" 1)))
 ("UP:Q9HCM3" (("KIAA1549" 111))) ("UP:Q9HCM7" (("FBRSL1" 2)))
 ("UP:Q9HCM9"
  (("Trim39" 85) ("TFP" 38) ("Tfp" 19) ("TRIM39" 4) ("monomeric TFP" 2)
   ("TfP" 1)))
 ("UP:Q9HCN2"
  (("p53AIP1" 80) ("P53AIP1" 10) ("TP53AIP1" 6)
   ("p53-regulated apoptosis-inducing protein 1" 6)))
 ("UP:Q9HCN4"
  (("XAB1" 24) ("XAB1 protein" 5) ("XPA binding protein 1" 4) ("than XAB1" 1)))
 ("UP:Q9HCN6"
  (("GPVI" 246) ("GP6" 30) ("glycoprotein VI" 7) ("soluble GPVI" 2)
   ("the activatory collagen receptor GPVI" 2)))
 ("UP:Q9HCN8" (("SDF2L1" 1)))
 ("UP:Q9HCR9" (("PDE11A" 12) ("phosphodiesterase 11A" 1)))
 ("UP:Q9HCS2" (("CYP4F12" 3))) ("UP:Q9HCS4" (("TCF7L1" 2)))
 ("UP:Q9HCS5" (("EPB41L4A" 3)))
 ("UP:Q9HCS7" (("XAB2" 3) ("XPA binding protein 2" 3)))
 ("UP:Q9HCT0" (("FGF22" 5) ("fibroblast growth factor 22" 3) ("FGF-22" 1)))
 ("UP:Q9HCU0" (("Tem1" 3) ("CD248" 1) ("endosialin" 1)))
 ("UP:Q9HCU4" (("CELSR2" 8)))
 ("UP:Q9HCU5"
  (("pre-B" 452) ("pre–B" 62) ("PRE-B" 7) ("Pre-B" 6) ("PREB" 4) ("pre-B-" 3)
   ("Sec12" 2) ("normal pre-B" 2) ("most pre-B-" 2) ("sec12" 1) ("PreB" 1)
   ("Pre–B" 1) ("malignant clonal pre-B" 1)))
 ("UP:Q9HCU8"
  (("p12" 228) (NIL 23) ("-p12" 14) ("p12 protein" 10)
   ("the mature p12 protein" 5) ("mature p12 protein" 2) ("POLD4" 1)))
 ("UP:Q9HCU9"
  (("BRMS1" 133) ("Breast cancer metastasis suppressor 1" 5)
   ("breast cancer metastasis suppressor 1" 4)))
 ("UP:Q9HCX3"
  (("ZNF304" 135) ("ZNF304 protein" 4)
   ("the transcriptional repressor ZNF304" 2)))
 ("UP:Q9HCY8"
  (("S100a14" 5) ("S100A14" 3) ("S100 calcium binding protein A14" 1)))
 ("UP:Q9HD15" (("SrAp" 66) ("Sra1" 5) ("SRAP" 4)))
 ("UP:Q9HD20" (("ATP13A1" 2)))
 ("UP:Q9HD23"
  (("HPT" 60) ("Secondary HPT" 2) ("Primary HPT" 2) ("primary HPT" 2)))
 ("UP:Q9HD26"
  (("CAL" 143) ("FIG" 91) ("cal" 23) ("Cal" 8) ("pCAL" 3)
   ("Fused in Glioblastoma" 3) ("GOPC" 2) ("FIG (GOPC)" 1)
   ("the first 412 amino acids of FIG" 1)
   ("the amino terminal 209 amino acids of FIG" 1)))
 ("UP:Q9HD34" (("ISD11" 1)))
 ("UP:Q9HD36"
  (("Bcl-B" 168) ("BCL2L10" 5) ("Bcl-B (Uniprot: Q9HD36) protein" 4)
   ("a viral Bcl-B" 2)
   ("soluble stable recombinant human Bcl-B (Uniprot: Q9HD36) protein" 1)))
 ("UP:Q9HD40" (("LP" 355) ("lp" 44) ("Lp" 15) ("SECs" 5) ("-LP" 3)))
 ("UP:Q9HD42" (("CHMP1" 2))) ("UP:Q9HD67" (("Myosin-X" 2)))
 ("UP:Q9HD89" (("resistin" 414) ("Resistin" 39) ("resistin-" 1)))
 ("UP:Q9HD90" (("Math3" 2) ("math3" 1)))
 ("UP:Q9HDB5" (("neurexin" 7) ("Nrxn3" 1) ("NRXN3" 1)))
 ("UP:Q9HDD0" (("HRASLS" 4))) ("UP:Q9HDS6" (("alpha3" 2)))
 ("UP:Q9HF51" (("Rho3" 4))) ("UP:Q9HFW2" (("Cla4" 6)))
 ("UP:Q9HIJ2" (("PGAM" 173) ("PGAM protein" 6) ("specifically target PGAM" 2)))
 ("UP:Q9HKT2"
  (("CTD" 1539) ("CTD peptide" 48) ("CTD(367–393) peptide" 3)
   ("overexpressed CTD" 2) ("the intact CTD" 2) ("the latter mechanism—CTD" 2)
   ("pCTD" 1) ("intact CTD" 1)
   ("than either the Pirh2 NTD or Pirh2 CTD ( xref )" 1)
   ("the basic CTD peptide" 1) ("initiation-competent RNAPII CTD" 1)))
 ("UP:Q9HN27" (("RFCA" 3))) ("UP:Q9HRE8" (("TPC" 82)))
 ("UP:Q9HW93" (("PCTC" 5)))
 ("UP:Q9I4E3"
  (("dimethylarginine dimethylaminohydrolase" 3)
   ("Dimethylarginine dimethylaminohydrolase" 1)))
 ("UP:Q9I7S8" (("Ade5" 1))) ("UP:Q9I8A3" (("BC8" 2)))
 ("UP:Q9I8W5"
  (("CML" 1542) ("CD34-positive CML" 3) ("atypical CML" 2)
   ("BCR-ABL-driven CML" 2) ("associated atypical CML" 2)
   ("the most primitive CML" 1) ("SCF increased CML" 1)
   ("these mice developed CML" 1)
   ("Pax5 -transduced bone marrow cells developed CML" 1)))
 ("UP:Q9IA03" (("FZ8" 5)))
 ("UP:Q9IAL9" (("ERβ2" 49) ("ERbeta2" 14) ("ER-β2" 7)))
 ("UP:Q9IAT6" (("delC" 193) ("deltaC" 1))) ("UP:Q9IJX4" (("protein 1A" 24)))
 ("UP:Q9INI2" (("NS-1" 34))) ("UP:Q9JI99" (("MSPP1" 3)))
 ("UP:Q9JIH2" (("Npap60" 4))) ("UP:Q9JII7" (("AIRAP" 2)))
 ("UP:Q9JJD0" (("Ronin" 1))) ("UP:Q9JKD9" (("ROG" 1)))
 ("UP:Q9JL19" (("NRC" 6))) ("UP:Q9JL26" (("FRL" 7)))
 ("UP:Q9JLB2" (("Pals1" 25)))
 ("UP:Q9JLM8"
  (("doublecortin–like kinase" 4) ("DCLK" 1)
   ("doublecortin-like
kinase"
    1)))
 ("UP:Q9JM04"
  (("Lgl" 127) ("LGL" 81) ("LGL2" 2) ("non-phosphorylatable Lgl" 2)
   ("EBV-positive LGL" 1) ("Lgl2" 1)))
 ("UP:Q9JMB7" (("miwi" 1))) ("UP:Q9JRN7" (("TLD" 7)))
 ("UP:Q9JTK4"
  (("LBPA" 41) ("negligible LBPA" 2) ("the late endosomal marker LBPA" 2)))
 ("UP:Q9K323"
  (("CEP" 621) ("pCEP" 89) ("pCep" 4) ("A green-labeled CEP" 2)
   ("centrosomal protein CEP104" 1) ("Spectrum Green-labeled CEP" 1)))
 ("UP:Q9KBR4" (("ABF" 2))) ("UP:Q9KWU4" (("pyruvate carboxylase" 3) ("PYC" 1)))
 ("UP:Q9L4Q7" (("PRDX" 2)))
 ("UP:Q9LDQ7"
  (("SAM" 560) ("pSAM" 8) ("-SAM" 4) ("pSam" 2) ("sequential SAM" 2)
   ("subsequent SAM" 1) ("SAM-" 1)))
 ("UP:Q9LDR4" (("FK" 252))) ("UP:Q9LDX3" (("UTR-4" 1)))
 ("UP:Q9LDY9" (("IJ" 3) ("I-J" 3)))
 ("UP:Q9LE81" (("IRE" 242) ("IRP1-associated IRE" 1) ("-IRE" 1)))
 ("UP:Q9LEZ3" (("BIM1" 26) ("Bim1" 11) ("Bim-1" 10)))
 ("UP:Q9LF61" (("RPT" 7) ("TBP developed significant RPT" 2)))
 ("UP:Q9LF80" (("GT3" 10) ("pGT3" 2))) ("UP:Q9LFE0" (("MDF" 3)))
 ("UP:Q9LFH6" (("LuL2" 10) ("Lul2" 1))) ("UP:Q9LFM5" (("thread" 27)))
 ("UP:Q9LFN7" (("shN2" 1))) ("UP:Q9LFQ9" (("Del2" 21) ("del2" 16) ("Del-2" 2)))
 ("UP:Q9LFS4" (("NIK1" 2))) ("UP:Q9LHE9" (("vIII-1" 2)))
 ("UP:Q9LHS9" (("RBE" 79))) ("UP:Q9LJR2" (("LEC" 124) ("mock-infected LEC" 1)))
 ("UP:Q9LJY0" (("PRKA" 4))) ("UP:Q9LK35" (("THE1" 1) ("the1" 1)))
 ("UP:Q9LKL2" (("Toc1" 1)))
 ("UP:Q9LLC6"
  (("SUV" 74) ("sUV" 40) ("SUVs" 13) ("Suv" 4) ("notable SUV" 1)
   ("the “average” SUV" 1)))
 ("UP:Q9LN63" (("BIS1" 12))) ("UP:Q9LNB6" (("Hop1" 5)))
 ("UP:Q9LNU1" (("CRSP" 2))) ("UP:Q9LPQ3" (("Bud1" 7)))
 ("UP:Q9LPT1" (("pRK5" 142) ("PRK5" 4) ("prK5" 2))) ("UP:Q9LQ55" (("CF1" 4)))
 ("UP:Q9LQ81" (("AtADF10" 2)))
 ("UP:Q9LQQ4" (("HTB-1" 10) ("HTB1" 8) ("htb1" 1))) ("UP:Q9LQR0" (("LBD1" 8)))
 ("UP:Q9LQU2" (("PCR1" 18))) ("UP:Q9LQU4" (("PCR2" 24)))
 ("UP:Q9LS48" (("Sg1" 7))) ("UP:Q9LT17" (("BBR" 100)))
 ("UP:Q9LT31" (("Vps9" 2))) ("UP:Q9LTB2" (("MmT" 9) ("MMT" 3)))
 ("UP:Q9LTG0"
  (("B2" 490) ("B2 protein" 5) ("-B2" 3) ("Montreal B2" 3) ("B2 (BCRP)" 2)
   ("fibrostenotic B2" 1) ("than 3 Å, and helix B2" 1)
   ("a mouse type II Alu-like SINE repetitive element B2" 1)
   ("130 consecutive B2" 1)))
 ("UP:Q9LU64" (("Apg8" 2) ("APG8" 1))) ("UP:Q9LUW0" (("LOX-5" 20)))
 ("UP:Q9LV87" (("Pep1" 1)))
 ("UP:Q9LVI9"
  (("dehydrogenase" 1337) ("dehydrogenase (GAPDH)" 160)
   ("dehydrogenase (LDH)" 89) ("Dehydrogenase" 46)
   ("dehydrogenase ( GAPDH )" 20) ("dehydrogenase (GDH)" 16)
   ("dehydrogenase (SDH)" 14) ("dehydrogenase (PDH)" 14)
   ("dehydrogenase (IMPDH)" 11) ("dehydrogenase (MCAD)" 10)
   ("dehydrogenase peptide" 9) ("dehydrogenase (LCAD)" 7)
   ("lactic dehydrogenase" 5) ("dehydrogenase (IDH)" 4)
   ("dehydrogenase (BCKDH)" 4)
   ("long-chain acyl coenzyme A dehydrogenase (LCAD)" 3)
   ("dehydrogenase protein" 3) ("lactic dehydrogenase (LDH)" 3)
   ("coenzyme A dehydrogenase (LCAD)" 3) ("dehydrogenase (VLCAD)" 3)
   ("short-chain acyl-coenzyme A dehydrogenase" 3)
   ("the mitochondrial enzyme succinic dehydrogenase" 2)
   ("Hydroxyl-coenzyme A dehydrogenase" 2)
   ("monoclonal anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH)" 2)
   ("long chain fatty acyl-CoA dehydrogenase (LCAD)" 2)
   ("dehydrogenase (OGDH)" 2)
   ("the oxidative 17β-hydroxysteroid dehydrogenase" 2)
   ("serum lactic dehydrogenase (LDH)" 2)
   ("The glioma-associated  xref  isocitrate dehydrogenase" 2)
   ("long-chain acyl coenzyme A dehydrogenase" 2) ("dehydrogenase (SDHA)" 2)
   ("hydroxyacyl-coenzyme A dehydrogenase (HADHA)" 1)
   ("dehydrogenase (HADHA)" 1) ("dehydrogenase ( GAPDH)" 1)
   ("the multimeric mammalian dehydrogenase complexes—pyruvate dehydrogenase (PDH)"
    1)
   ("human isovaleryl coenzyme A dehydrogenase" 1) ("dehydrogenase ( IDH )" 1)
   ("e.g. pyruvate dehydrogenase (PDH)" 1)
   ("bovine heart L-Lactic Dehydrogenase" 1) ("L-Lactic Dehydrogenase" 1)
   ("dehydrogenase (LD)" 1) ("dehydrogenase ( PGDH )" 1)
   ("very long chain acetyl CoA dehydrogenase (VLCAD)" 1)
   ("dehydrogenase ( SDH )" 1) ("bacterial Sdh and fumarate dehydrogenase" 1)
   ("glutamic dehydrogenase" 1) ("dehydrogenase (PHGDH)" 1)
   ("Dehydrogenase-" 1) ("dehydrogenase (LDHA)" 1)))
 ("UP:Q9LVM1" (("STA1" 1)))
 ("UP:Q9LW07"
  (("PG" 386) ("-PG" 8) ("the major PG" 2) ("the oral pathogenic PG" 2)
   ("40 archival PG" 1) ("other PG's" 1) ("superficial PG" 1)))
 ("UP:Q9LX14" (("UFC" 11))) ("UP:Q9LX33" (("FTA" 5)))
 ("UP:Q9LXG5" (("PrE2" 2))) ("UP:Q9LYU4" (("PBS-3" 5)))
 ("UP:Q9LZ78"
  (("SIM" 367) ("-SIM" 5) ("SIM-" 2) ("An unusual SIM" 2) ("a canonical SIM" 2)
   ("an obvious SIM" 1) ("The most well‑characterized SIM" 1)
   ("the unusual SIM" 1) ("this unusual SIM" 1) ("the SIM’s" 1)
   ("the noncanonical SIM" 1)))
 ("UP:Q9LZC3" (("MLS" 291) ("pure MLS" 1))) ("UP:Q9LZL3" (("pCS1" 2)))
 ("UP:Q9LZM8" (("RpL" 6) ("rpL" 2))) ("UP:Q9M040" (("PDC4" 1)))
 ("UP:Q9M0G9" (("Sta3" 3))) ("UP:Q9M158" (("trol" 2) ("Trol" 2)))
 ("UP:Q9M1H3" (("GCN4" 143) ("Gcn4" 7)))
 ("UP:Q9M1K3" (("siP21" 20) ("sip21" 12))) ("UP:Q9M1T1" (("AP-I" 2)))
 ("UP:Q9M291"
  (("CEF" 115) ("SR-A RSV transformed CEF" 9) ("v-Src transformed CEF" 6)
   ("Q64L-transformed CEF" 3) ("SR-A transformed CEF" 2)
   ("non-transformed CEF" 2) ("Akt-transformed CEF" 1) ("pCEF-" 1) ("pCEF" 1)
   ("primary CEF" 1) ("RSV transformed CEF" 1) ("SR-A RSV-transformed CEF" 1)))
 ("UP:Q9M2U1" (("OBP3" 1))) ("UP:Q9M345" (("sGC" 36)))
 ("UP:Q9M384"
  (("Scr" 240) ("SCR" 182) ("scr" 141) ("Scr-" 2) ("“SCR”" 2)
   ("786-mock SCR" 1)))
 ("UP:Q9M591" (("CRD1" 6))) ("UP:Q9M5P2" (("SC3" 5)))
 ("UP:Q9M658"
  (("MOM" 429) ("MOM protein" 9) ("MOM-" 2) ("an integral MOM" 1)
   ("the contiguous MOM" 1) ("a resident MOM protein" 1)
   ("another resident MOM protein" 1)))
 ("UP:Q9M682" (("AGK2" 18))) ("UP:Q9M7D0" (("AG9" 8)))
 ("UP:Q9M7Q4" (("Abf2" 1)))
 ("UP:Q9M8K6" (("MuTE" 12) ("MutE" 5) ("mute" 3) ("mutE" 1)))
 ("UP:Q9M8W7" (("GLR-1" 3) ("GLR1" 2)))
 ("UP:Q9M8Y0" (("SEC" 281) ("Analytical SEC" 2))) ("UP:Q9M9S6" (("UTR-3" 4)))
 ("UP:Q9MAC8" (("SS2" 4))) ("UP:Q9MAH0" (("PPC1" 63)))
 ("UP:Q9MBA1"
  (("cHL" 255) ("CHL" 5) ("briefly 622 cHL" 2) ("nodular sclerosis (NS) cHL" 1)
   ("primary cHL" 1) ("a representative primary cHL" 1) ("EBV-negative cHL" 1)
   ("EBV-positive cHL" 1) ("ChL" 1)))
 ("UP:Q9MZ06" (("FGF-BP1" 6))) ("UP:Q9MZL5" (("CAB2" 14)))
 ("UP:Q9MZL7" (("c-Ab1" 2))) ("UP:Q9N0V4" (("GSTM" 2)))
 ("UP:Q9NA13" (("iPLA" 9))) ("UP:Q9NB71" (("hiw" 1)))
 ("UP:Q9NBK5" (("TRC" 168) ("the Public TRC" 1) ("pTRC" 1)))
 ("UP:Q9NFL4" (("hCG" 71) ("intact hCG" 1) ("HCGs" 1) ("hCGs" 1)))
 #+ignore("UP:Q9NFL6" ; removed - tarantula
  (("HCC" 11953) ("primary HCC" 24) ("than HCC" 8) ("HBV-associated HCC" 8)
   ("recurrent HCC" 7) ("EpCAM(+)/K19(+) HCC" 7) ("metastatic HCC" 6)
   ("IFNAR2-positive HCC" 6) ("hypoxic HCC" 5) ("Most HCC" 4)
   ("unresectable HCC" 4) ("the metastatic HCC" 4) ("the HBV-associated HCC" 4)
   ("spontaneous HCC" 3) ("“HCC”" 3) ("well-differentiated HCC" 3)
   ("pure HCC" 3) ("human primary HCC" 3) ("HCC-" 3) ("HBV associated HCC" 3)
   ("poor-differentiated HCC" 3) ("alcohol-associated HCC" 3) ("largest HCC" 2)
   ("poorly-differentiated HCC" 2) ("hcc" 2) ("the HBV-positive HCC" 2)
   ("HBV-negative HCC" 2) ("46 HBV-negative HCC" 2)
   ("advanced unresectable HCC" 2) ("human viral HCC" 2)
   ("completely cure HCC" 2) ("aggressive HCC" 2) ("Fibrolamellar HCC" 2)
   ("chemically-induced HCC" 2) ("hepatitis B virus-associated HCC" 2)
   ("the primary HCC" 2) ("operable HCC" 2)
   ("Hepatitis B virus-positive HCC" 2) ("late primary HCC" 2)
   ("histological grades II–III HCC" 2) ("malignant HCC" 2)
   ("subcutaneous EGFR-positive HCC" 1) ("HCV-associated HCC" 1) ("new HCC" 1)
   ("the poorly-differentiated HCC" 1) ("hepatocytes showed enhanced HCC" 1)
   ("well-characterized human HCC" 1) ("EpCAM(−)/K19(−) HCC" 1)
   ("primary invasive HCC" 1) ("a few hundred HCC" 1)
   ("vascular invasive HCC" 1) ("CTNNB1 and SMO mutation-positive HCC" 1)
   ("the HBV-negative HCC" 1) ("110 HBV-positive HCC" 1)
   ("their primary HCC" 1) ("had only solitary HCC" 1)
   ("fresh frozen human HCC" 1) ("more HCC" 1)
   ("705 newly diagnosed incident HCC" 1) ("late stage HCC" 1)
   ("high pathologic grade HCC" 1) ("a low pathologic grade HCC" 1)
   ("highly malignant HCC" 1) ("Survivin-positive HCC" 1)
   ("an aggressive solitary HCC" 1) ("major HCC" 1)
   ("pathological primary HCC" 1) ("58 (93.1%) primary HCC" 1)
   ("the prolonged hypoxic HCC" 1) ("eventually multifocal HCC" 1)
   ("had primary HCC" 1) ("available HCC" 1) ("25 weeks developed HCC" 1)
   ("Developed HCC" 1) ("macrophage-driven HCC" 1) ("250 000 new HCC" 1)
   ("highly metastatic HCC" 1) ("solitary HCC" 1) ("a multinodular HCC" 1)
   ("Most human HCC" 1) ("than HCC compared to peritumour" 1)
   ("Ep-CAM-positive HCC" 1) ("Brazilian HCC" 1) ("asymptomatic HCC" 1)
   ("non-resectable HCC" 1) ("Non-resectable or metastatic HCC" 1)
   ("a well-differentiated HCC" 1) ("Tg mice developed spontaneous HCC" 1)
   ("core-induced spontaneous HCC" 1) ("finally 366 HCC" 1)
   ("These genetic HCC" 1) ("MYC-associated HCC" 1)
   ("female p21-HBx transgenic mice developed HCC" 1)
   ("than HCC compared to AFP, CEA or CA19-9" 1)
   ("histologically proven HCC" 1) ("than HCC (60% positive)" 1)
   ("10 metastatic HCC" 1) ("40 primary HCC" 1) ("most cases HCC" 1)
   ("tamoxifen negatively impacts HCC" 1) ("IL-17A-treated HCC" 1)
   ("proliferative HCC" 1) ("Snail-associated HCC" 1)
   ("the microenvironment around HCC" 1) ("overt HCC" 1)
   ("the non-recurrent HCC" 1) ("the recurrent HCC" 1) ("non-recurrent HCC" 1)
   ("the 35 recurrent HCC" 1) ("“HCC\"" 1) ("all 10 human primary HCC" 1)
   ("HBV-positive HCC" 1) ("more aggressive HCC" 1) ("almost all HCC" 1)
   ("authentic primary HCC" 1) ("than HCC ( xref and xref )" 1)
   ("most HCC" 1)))
 ("UP:Q9NHD5" (("span" 61) ("a broad span" 1) ("Span" 1)))
 ("UP:Q9NKV0" (("MLF" 16)))
 ("UP:Q9NNW7"
  (("Txnrd2" 31) ("thioredoxin reductase 2" 9) ("TXNRD2" 2)
   ("we first depleted Txnrd2" 2) ("TrxR2" 1)))
 ("UP:Q9NNX1" (("TUFT1" 1)))
 ("UP:Q9NNX6"
  (("DC-SIGN" 199) ("CD209" 19) ("nonintegrin" 11)
   ("DC-specific intercellular adhesion molecule-3-grabbing nonintegrin" 2)))
 ("UP:Q9NP08" (("HMX1" 4)))
 ("UP:Q9NP31"
  (("TSAd" 850) ("SH2D2A" 103) ("tsad" 19)
   ("T cell specific adapter protein" 10) ("Tsad" 6) ("TSAd protein" 3)
   ("TSAd molecule" 3) ("the immunoregulatory gene SH2D2A" 2)
   ("VEGF receptor–associated protein" 2) ("less TSAd" 1) ("exogenous TSAd" 1)
   ("the three C-terminal tyrosines of TSAd" 1)
   ("the three penultimate tyrosines (Y280,290,305 F) of TSAd (Fig. xref , lane 4)"
    1)
   ("the 20 C-terminal amino acids of murine TSAd" 1) ("intact TSAd" 1)
   ("VRAP" 1) ("TSAD" 1) ("the N-terminal 18 amino acids of TSAd" 1)
   ("the four C-terminal tyrosines (aa239–334) of TSAd" 1) ("sh2d2a" 1)))
 ("UP:Q9NP50" (("FAM60A" 135) ("FAM60A protein" 3)))
 ("UP:Q9NP55"
  (("spurt" 39) ("PLUNC" 31) ("pubertal growth spurt" 6) ("PLUNC family" 4)
   ("pubertal height growth spurt" 3) ("the pubertal growth spurt" 2)))
 ("UP:Q9NP56" (("PDE7B" 13) ("phosphodiesterase 7B" 2)))
 ("UP:Q9NP58" (("ABCB6" 31) ("ABCB6 protein" 6)))
 ("UP:Q9NP59"
  (("ferroportin" 29) ("SLC40A1" 9) ("Ferroportin" 2) ("Fpn1" 2) ("FPN1" 2)
   ("ferroportin-1" 1)
   ("solute carrier family 40 (iron-regulated transporter)" 1)))
 ("UP:Q9NP62" (("GCMa" 180) ("GCM1" 8) ("pGCMa" 3) ("Gcm1" 2) ("GcMa" 1)))
 ("UP:Q9NP66" (("HMG20A" 4) ("High mobility group 20A" 3)))
 ("UP:Q9NP70" (("ameloblastin" 3)))
 ("UP:Q9NP71"
  (("Mio" 186) ("ChREBP" 116) ("MIO" 10) ("chREBP" 10) ("ChREBP protein" 5)
   ("carbohydrate response element binding protein" 4) ("Mio protein" 2)
   ("carbohydrate responsive element binding protein" 2)
   ("Carbohydrate response element binding protein" 2) ("MLXIPL" 1)
   ("MLX interacting protein-like" 1)))
 ("UP:Q9NP72" (("Rab18" 2)))
 ("UP:Q9NP74" (("PALMD" 109) ("palmdelphin" 9) ("intact PALMD" 2)))
 ("UP:Q9NP77" (("Ssu72" 5) ("SSU72" 3))) ("UP:Q9NP78" (("ABCB9" 4)))
 ("UP:Q9NP79" (("VTA1" 8)))
 ("UP:Q9NP81" (("SARS M protein" 2) ("Sars2" 1) ("SARS2" 1)))
 ("UP:Q9NP84"
  (("Fn14" 407) ("Fn14 protein" 9) ("TNFRSF12A" 9) ("FN14" 7) ("Tnfrsf12a" 6)
   ("proper Fn14" 2) ("Endogenously-expressed Fn14" 2)
   ("smaller 94-aa Fn14 protein" 1) ("endogenously-expressed Fn14" 1)
   ("significantly more Fn14 protein" 1) ("TNFRSF12a" 1)))
 ("UP:Q9NP85" (("podocin" 36) ("Podocin" 15) ("NPHS2" 10)))
 ("UP:Q9NP87" (("POLM" 1))) ("UP:Q9NP91" (("SLC6A20" 1)))
 ("UP:Q9NP92" (("MRPS30" 10)))
 ("UP:Q9NP95" (("FGF20" 48) ("Fgf20" 33) ("FGF20 protein" 2) ("FGF-20" 1)))
 ("UP:Q9NP97" (("BLP" 39) ("DYNLRB1" 2) ("DNLC2A" 1)))
 ("UP:Q9NP99" (("TREM-1" 4) ("TREM1" 1)))
 ("UP:Q9NPA1" (("Kcnmb2" 3) ("KCNMB2" 1)))
 ("UP:Q9NPA2" (("MMP-25" 15) ("MT6-MMP" 1))) ("UP:Q9NPB1" (("MDN" 1)))
 ("UP:Q9NPB6"
  (("Par6" 406) ("Par6α" 175) ("PAR-6" 125) ("PAR6" 86) ("Par-6" 26)
   ("PAR-6 protein" 6) ("–Par6" 5) ("-Par6" 5) ("pard6a" 5) ("par-6" 3)
   ("Par6a" 3) ("Pard6a" 3) ("Pard6A" 3)
   ("confocal z-sectioning revealed PAR-6" 2) ("a dominant-negative Par6" 2)
   ("Par6 protein" 2) ("cellular Par6" 2) ("par6" 2) ("Par6A" 2) ("–PAR-6" 1)
   ("PARD6" 1) ("PAR6A" 1) ("Tip40" 1) ("exogenous wild-type Par6" 1)
   ("less Par6A" 1)))
 ("UP:Q9NPC2" (("KCNK9" 39) ("TASK-3" 4)))
 ("UP:Q9NPC4" (("Gb3 synthase" 15) ("globotriaosylceramide synthase" 1)))
 ("UP:Q9NPC6" (("calsarcin 1" 1))) ("UP:Q9NPC8" (("Six2" 6) ("SIX2" 4)))
 ("UP:Q9NPD3" (("Rrp41" 2)))
 ("UP:Q9NPD7" (("neuritin 1" 2) ("NRN1" 1) ("Nrn1" 1)))
 ("UP:Q9NPD8"
  (("UBE2T" 32) ("Ube2t" 26) ("than the endogenous Ube2t" 1) ("Ube2T" 1)))
 ("UP:Q9NPE3" (("NOP10" 10) ("Nop10" 3) ("NOLA3" 3)))
 ("UP:Q9NPF0" (("CD320" 21) ("8D6" 3) ("CD320 molecule" 2) ("Q9NPF0" 1)))
 ("UP:Q9NPF4" (("OSGEP" 2)))
 ("UP:Q9NPF5"
  (("EAF2" 216) ("DMAP1" 18) ("Dmap1" 13) ("EAF2 protein" 3) ("Swc4" 1)))
 ("UP:Q9NPF7" (("IL23A" 24) ("IL-23p19" 10) ("IL-23A" 3) ("IL-23 p19" 1)))
 ("UP:Q9NPG1" (("Fzd-3" 1) ("Fz3" 1)))
 ("UP:Q9NPG2"
  (("NGB" 127) ("Neuroglobin" 1) ("neuroglobin (NGB)" 1) ("neuroglobin" 1)))
 ("UP:Q9NPG3" (("UBN1" 3))) ("UP:Q9NPH0" (("ACP6" 14) ("Acp6" 1)))
 ("UP:Q9NPH2" (("hiPS" 32) ("INO1" 8) ("hIPS" 2)))
 ("UP:Q9NPH3" (("IL-1RAcP" 5) ("IL-1RAP" 2)))
 ("UP:Q9NPH5"
  (("Nox4" 848) ("NOX4" 547) ("Nox4 protein" 68) ("NADPH oxidase 4" 16)
   ("Nox4GFP" 10) ("NADPH oxidase-4" 4) ("intense Nox4" 4) ("NOX4-" 3)
   ("dominant-negative Nox4" 2) ("Nox4 peptide" 2) ("functional Nox4" 1)
   ("targeting Nox4" 1) ("Nox4-" 1) ("basal Nox4" 1) ("particular NOX4" 1)
   ("NOX-4" 1) ("Nox-4" 1)))
 ("UP:Q9NPH9"
  (("IL-26" 143) ("IL26" 6) ("Interleukin-26" 2) ("interleukin-26" 1)))
 ("UP:Q9NPI1"
  (("BRD7" 376) ("Brd7" 7) ("BRD7 protein" 4) ("overexpressing BRD7" 2)
   ("than endogenous BRD7 ( xref )" 1) ("BP75" 1) ("celtix-1" 1)
   ("bromodomain containing 7" 1)))
 ("UP:Q9NPI5" (("Nrk" 2))) ("UP:Q9NPI6" (("DCP1a" 14) ("DCP1A" 6) ("Dcp1a" 3)))
 ("UP:Q9NPI8" (("FANCF" 196) ("FANCF-" 2) ("than FANCF" 1)))
 ("UP:Q9NPJ1" (("MKKs" 33) ("MKKS" 2) ("their respective MKKs" 1)))
 ("UP:Q9NPJ3" (("THEM2" 2))) ("UP:Q9NPJ4" (("PNRC2" 1)))
 ("UP:Q9NPJ6" (("MED4" 4))) ("UP:Q9NPJ8" (("NXT2" 5)))
 ("UP:Q9NPL8" (("TIMMDC1" 2)))
 ("UP:Q9NPP4" (("Ipaf" 34) ("NLRC4" 7) ("iPAF" 3) ("IPAF" 2)))
 ("UP:Q9NPQ8" (("Ric-8A" 12) ("RIC8A" 1))) ("UP:Q9NPR2" (("SEMA4B" 1)))
 ("UP:Q9NPR9" (("Gpr108" 3))) ("UP:Q9NPZ5" (("GlcAT-S" 10)))
 ("UP:Q9NQ11"
  (("ATP13A2" 73) ("Probable cation-transporting ATPase 13A2" 2) ("PARK9" 1)))
 ("UP:Q9NQ25"
  (("CS1" 50) ("CRACC" 32) ("19A" 20) ("19a" 15) ("SLAMF7" 1) ("pCS1" 1)))
 ("UP:Q9NQ31"
  (("BCA3" 90) ("BCA3 protein" 5) ("A-kinase interacting protein 1" 1)
   ("AKIP1" 1)))
 ("UP:Q9NQ33" (("ASCL3" 2)))
 ("UP:Q9NQ34" (("TMEM9B" 27) ("targeting TMEM9B" 2)))
 ("UP:Q9NQ35" (("NRIP3" 10)))
 ("UP:Q9NQ36"
  (("signal peptide" 340) ("CUB domain" 27) ("SCUBE2" 7)
   ("signal peptide (NLSP)" 5) ("a classical signal peptide" 2)
   ("a weak signal peptide" 2) ("Signal peptide" 2)
   ("signal peptide (MGAPACALALCVAVAIVAGA)" 2)
   ("methionine of the fibronectin signal peptide" 1)
   ("signal peptide (MPLLLLLPLLWAGALA)" 1)
   ("an amino terminal hydrophobic signal peptide" 1)
   ("signal peptide (SP)" 1)))
 ("UP:Q9NQ38" (("SPINK5" 40) ("Spink5" 1))) ("UP:Q9NQ40" (("C20orf54" 7)))
 ("UP:Q9NQ48" (("LZTFL1" 1))) ("UP:Q9NQ55" (("pPAN" 3) ("PPAN" 2)))
 ("UP:Q9NQ66" (("PLCB1" 13)))
 ("UP:Q9NQ75" (("EFs" 12) ("CASS4" 3) ("Efs" 2) ("HEPL" 2)))
 ("UP:Q9NQ76"
  (("MEPE" 137) ("OF45" 120) ("Of45" 17) ("Mepe" 16)
   ("matrix extracellular phosphoglycoprotein (MEPE)" 1)
   ("matrix extracellular phosphoglycoprotein" 1) ("OF45s" 1)
   ("Matrix extracellular phosphoglycoprotein" 1)
   ("osteoblast/osteocyte factor 45" 1)))
 ("UP:Q9NQ87" (("HEYL" 27) ("HRT3" 5) ("HeyL" 4) ("Hrt3" 3)))
 ("UP:Q9NQ88"
  (("TIGAR" 425) ("TIGAR protein" 18) ("Tigar" 14)
   ("TP53-induced glycolysis and apoptosis regulator" 11) ("C12orf5" 6)
   ("TIGAR-" 1)
   ("TP53-induced glycolysis and apoptosis regulator ( TIGAR )" 1)))
 ("UP:Q9NQ90" (("ANO2" 1))) ("UP:Q9NQ92" (("COPR5" 1)))
 ("UP:Q9NQ94"
  (("ACF" 198) ("ACF complex" 7) ("rectal ACF" 7) ("colonic ACF" 3)
   ("only few ACF" 2)
   ("K-Ras LA2 /kdPKCι mice developed significantly fewer ACF" 2) ("A1CF" 2)
   ("rectal (and sigmoidal) ACF" 1)
   ("homozygous transgenic kdPKCι mice developed significantly fewer ACF" 1)
   ("the dysplastic ACF" 1)))
 ("UP:Q9NQB0"
  (("TCF7L2" 513) ("dnTCF" 56) ("T-cell factor 4" 8) ("dnTcf" 5) ("hTcf4" 4)
   ("T-cell factor-4" 4) ("than dnTCF" 1) ("Tcf7l2" 1)))
 ("UP:Q9NQC3" (("Nogo-B" 63) ("Nogo" 9) ("ASY" 6) ("RTN4" 6) ("Asy" 1)))
 ("UP:Q9NQC7"
  (("CYLD" 1321) ("Cyld" 81) ("CYLD protein" 21)
   ("deubiquitinating enzyme CYLD" 7) ("Cylindromatosis" 5)
   ("Cylindromatosis (CYLD)" 2) ("defective CYLD" 1)
   ("miR-181b-1 directly targets CYLD" 1) ("Cylindromatosis protein" 1)
   ("overexpressing WT CYLD" 1)))
 ("UP:Q9NQC8" (("IFT46" 1))) ("UP:Q9NQE9" (("HINT3" 1)))
 ("UP:Q9NQG5" (("RPRD1B" 1))) ("UP:Q9NQG7" (("HPS4" 1)))
 ("UP:Q9NQI0" (("VASA" 39) ("DDX4" 4) ("Vasa" 3) ("vasa" 2)))
 ("UP:Q9NQL2" (("RagD" 36) ("Rag D" 4) ("RAGD" 1)))
 ("UP:Q9NQP4" (("C-1" 42) ("c-1" 5) ("PFDN4" 4) ("C–1" 3)))
 ("UP:Q9NQR1"
  (("PR-Set7" 499) ("SET8" 261) ("Set8" 242) ("H4K20me1" 81)
   ("Set8 protein" 32) ("SETD8" 11) ("Pr-Set7" 4) ("KMT5A" 3)
   ("the non-degradable Set8" 2)
   ("Set8b ΔPIP2 expression initially increases H4K20me1" 2)
   ("Undetectable PR-Set7" 2) ("PR-Set7 protein" 2) ("PR-SET7" 2) ("KMT5a" 2)
   ("global H4K20me1" 1) ("nondegradable SET8" 1) ("SET8 protein" 1)
   ("than SET8" 1) ("exogenous SET8" 1)
   ("a GFP-tagged null or wild type PR-Set7" 1)
   ("Full length recombinant His-S-tagged PR-Set7" 1)))
 ("UP:Q9NQR9" (("G6PC2" 5)))
 ("UP:Q9NQS1"
  (("Aven" 221) ("Aven protein" 23) ("exogenous Aven" 2)
   ("expressing excess Aven" 1) ("AVEN" 1)))
 ("UP:Q9NQS3" (("Nectin-3" 1) ("PVRL3" 1)))
 ("UP:Q9NQS5"
  (("FFAs" 144) ("excessive FFAs" 1) ("than unsaturated FFAs" 1)
   ("fetal FFAs" 1)))
 ("UP:Q9NQS7"
  (("INCENP" 153) ("-INCENP" 49) ("inner centromere protein" 10)
   ("inner centromere protein (INCENP)" 1) ("Inner centromere protein" 1)))
 ("UP:Q9NQT4" (("Rrp46" 4)))
 ("UP:Q9NQT5"
  (("p10" 104) ("P10" 94) ("Rrp40" 42) ("Exosc3" 3)
   ("nonstructural protein p10" 2) ("p10 peptide" 2) ("targeted Rrp40" 1)))
 ("UP:Q9NQT8" (("KIF13B" 19) ("GAKIN" 3) ("kinesin family member 13B" 2)))
 ("UP:Q9NQU5" (("PAK6" 279) ("Pak6" 4) ("the PAK6’s" 1)))
 ("UP:Q9NQV6"
  (("Tris" 7385) ("tris" 295) ("TRIS" 82) ("Tris-" 9) ("tris-" 9) ("-tris" 5)
   ("Tris–" 2) ("ice-cold tris" 1) ("-Tris" 1)))
 ("UP:Q9NQV7" (("PRDM9" 5) ("115kDa" 3) ("around 115kDa" 1)))
 ("UP:Q9NQW6" (("ANLN" 10))) ("UP:Q9NQX0" (("PRDM6" 6)))
 ("UP:Q9NQX1" (("PRDM5" 4)))
 ("UP:Q9NQX3"
  (("GPH" 35) ("domain E" 34) ("gephyrin" 6) ("domain G" 3) ("Domain E" 3)
   ("pGPH" 1) ("Gephyrin" 1) ("gephyrin (GPHN)" 1) ("GPHN" 1)))
 ("UP:Q9NQX4" (("MYO5C" 1))) ("UP:Q9NQX7" (("ITM2C" 1)))
 ("UP:Q9NQZ3" (("DAz" 10) ("DAZ" 5) ("dAZ" 1))) ("UP:Q9NR00" (("C8orf4" 6)))
 ("UP:Q9NR09"
  (("Apollon" 101) ("Bruce" 32) ("BIRC6" 11) ("BRUCE" 4) ("apollon" 3)
   ("Birc6" 2) ("Apollon protein" 1)))
 ("UP:Q9NR12"
  (("LMP" 237) ("enigma" 64) ("ENIGMA" 25) ("Enigma" 11) ("LMPs" 5)
   ("PDLIM7" 5) ("serous LMP" 5) ("pLMP" 2) ("mucinous LMP" 2)
   ("a very little LMP" 1) ("a scientific enigma" 1)))
 ("UP:Q9NR19" (("AceCS" 3))) ("UP:Q9NR20" (("DYRK4" 2)))
 ("UP:Q9NR21" (("PARP11" 2))) ("UP:Q9NR22" (("PRMT8" 8)))
 ("UP:Q9NR23" (("GDF3" 5)))
 ("UP:Q9NR28"
  (("Smac" 600) ("SMAC" 138) ("DIABLO" 95) ("Smac/DIABLO" 86) ("Diablo" 52)
   ("pSMAC" 23) ("second mitochondria-derived activator of caspase" 17)
   ("mature Smac" 17) ("smac" 13) ("p-SMAC" 4) ("the peripheral SMAC" 3)
   ("Smac protein" 2) ("Second mitochondria-derived activator of caspase" 2)
   ("SMACs" 2) ("peripheral and distal SMAC" 2) ("distal SMAC" 2)
   ("peripheral SMAC" 2)
   ("second mitochondria-derived activator of caspase (SMAC)" 1)
   ("Smac/DIABLO protein" 1)
   ("some anticancer drugs selectively release Smac" 1)
   ("a plasmid encoding mature Smac" 1)
   ("the pro-apoptotic protein Smac/DIABLO" 1) ("diablo" 1)
   ("The proapoptotic Smac/DIABLO" 1)
   ("the F-actin-dependent peripheral pSMAC" 1)))
 ("UP:Q9NR30" (("DDX21" 15) ("RHII/Gu" 5))) ("UP:Q9NR31" (("SAR1" 1)))
 ("UP:Q9NR33" (("POLE4" 4))) ("UP:Q9NR34" (("MAN1C" 6) ("class 1C" 1)))
 ("UP:Q9NR45" (("NANS" 3))) ("UP:Q9NR46" (("SH3GLB2" 1)))
 ("UP:Q9NR48" (("ASH1L" 1))) ("UP:Q9NR50" (("EIF2B3" 1)))
 ("UP:Q9NR55" (("SNFT" 1)))
 ("UP:Q9NR56"
  (("MBNL1" 208) ("Exp" 137) ("exp" 131) ("pEXP" 19) ("EXP" 7) ("MBNL" 6)
   ("MBNL1 protein" 3) ("Mbnl1" 3) ("λ( t )=λ 0 ( t )exp" 2)
   ("λ(t)=λ 0 (t)exp" 2) ("an exponential distribution exp" 2) ("“Exp”" 1)))
 ("UP:Q9NR61"
  (("Dll4" 154) ("DLL4" 40) ("Delta4" 4) ("endothelial DLL4" 2)
   ("Endothelial DLL4" 2) ("dll4" 2) ("Dll-4" 2) ("Ad-driven soluble Dll4" 2)
   ("than Dll4" 1) ("delta4" 1) ("endothelial-specific Dll4" 1)
   ("soluble DLL4" 1)))
 ("UP:Q9NR63" (("CYP26B1" 6) ("subfamily B" 4)))
 ("UP:Q9NR71" (("nCDase" 195) ("neutral ceramidase" 4)))
 ("UP:Q9NR80"
  (("Asef" 150) ("ARHGEF4" 3) ("Asef protein" 2) ("Asef-" 2) ("Asef1" 1)))
 ("UP:Q9NR81"
  (("ARHGEF3" 63) ("XPLN" 17) ("Rho guanine nucleotide exchange factor 3" 1)
   ("STA3" 1) ("arhgef3" 1)))
 ("UP:Q9NR96"
  (("TLR9" 385) ("TLR-9" 17) ("Toll-like receptor 9" 17) ("Tlr9" 2)
   ("Toll-Like Receptor 9" 2) ("Toll-like receptor-9" 2)
   ("the viral DNA-sensing TLR9" 1) ("functional TLR9" 1)))
 ("UP:Q9NR97" (("TLR8" 132) ("TLR-8" 3) ("Tlr8" 1)))
 ("UP:Q9NRA0"
  (("SphK2" 195) ("sphingosine kinase 2" 7) ("overexpressed V5-SphK2" 4)
   ("Sphingosine kinase 2" 4) ("SPHK2" 3)))
 ("UP:Q9NRA1" (("PDGFC" 26)))
 ("UP:Q9NRA2" (("AST" 130) ("SLD" 47) ("SLC17A5" 2) ("smallest SLD" 1)))
 ("UP:Q9NRA8" (("4E-T" 7)))
 ("UP:Q9NRB3" (("carbohydrate sulfotransferase 12" 1)))
 ("UP:Q9NRC1" (("suppression of tumorigenicity 7" 3)))
 ("UP:Q9NRC6" (("SPTBN5" 4)))
 ("UP:Q9NRC8"
  (("SIRT7" 824) ("Sirt7" 244) ("SIRT7 protein" 9) ("SIR-T7" 6)
   ("overexpressed Sirt7" 4) ("SIR-T7 protein" 2) ("SIRT-7" 2) ("SirT7" 2)
   ("specifically target SIRT7" 1) ("Sirt7 protein" 1) ("SIRT 7" 1)
   ("–SIRT7" 1) ("considerable SIRT7 protein" 1)))
 ("UP:Q9NRC9" (("FDP" 8)))
 ("UP:Q9NRD0" (("F box only protein 8" 1) ("FBXO8" 1)))
 ("UP:Q9NRD1" (("Fbx6" 100) ("FBX6" 10) ("Fbxo6" 2) ("FBx6" 1) ("FBXO6" 1)))
 ("UP:Q9NRD5" (("PICK1" 12)))
 ("UP:Q9NRD8" (("Hudson" 43) ("DUOX2" 28) ("Duox2" 15) ("duox2" 1)))
 ("UP:Q9NRD9"
  (("forskolin" 482) ("Forskolin" 136) ("DUOX1" 104) ("Duox" 26) ("DUOX" 21)
   ("Duox1" 18) ("forskolin-" 8)
   ("nicotinamide adenine dinucleotide phosphate oxidase" 6)
   ("Topically-applied forskolin" 2) ("Forskolin-" 2) ("forskolin (FSK)" 1)
   ("nicotinamide adenine dinucleotide phosphate oxidase (NOX)" 1)
   ("forskolin (FO)" 1) ("lack functional DUOX1" 1)))
 ("UP:Q9NRE1" (("MMP26" 8) ("MMP-26" 6)))
 ("UP:Q9NRF2" (("SH2B1" 12) ("SH2-B" 9)))
 ("UP:Q9NRF9"
  (("p17" 318) ("P17" 19) ("p17 peptide" 11) ("p17 protein" 8)
   ("HIV-p17 protein" 2) ("p17-" 2) ("TLR1 or TLR2 ablated viral p17" 1)
   ("POLE3" 1)))
 ("UP:Q9NRG4"
  (("SMYD2" 77) ("SET and MYND domain containing 2" 11) ("Smyd2" 8)
   ("KMT3C" 2)))
 ("UP:Q9NRG9" (("achalasia" 4) ("Achalasia" 1) ("Aladin" 1)))
 ("UP:Q9NRH2" (("SNRK" 7))) ("UP:Q9NRH3" (("TUBG2" 7)))
 ("UP:Q9NRI5"
  (("DISC1" 383) ("dentate" 144) ("Disrupted in Schizophrenia 1" 5)
   ("disrupted in schizophrenia 1" 3) ("DISC1 peptide" 3) ("Disc1" 3)
   ("DISC1 protein" 2) ("the reciprocal DISC1" 1)))
 ("UP:Q9NRJ3" ; added cancer but didin't delete this
  (("MEC" 371) ("Mec" 30) ("pulmonary MEC" 10) ("primary and recurrent MEC" 6)
   ("both primary and recurrent MEC" 4) ("primary MEC" 3) ("mec" 3) ("meC" 2)
   ("normal MEC" 2) ("MeC" 1) ("immortal nontumorigenic human MEC" 1)
   ("12 primary MEC" 1) ("the highly EGFR-expressing ALDH1-positive MEC" 1)
   ("Pulmonary MEC" 1) ("the 21 pulmonary MEC" 1)
   ("Postoperative pathology showed low-grade MEC" 1)
   ("pathologically confirmed primary pulmonary MEC" 1)))
 ("UP:Q9NRJ7" (("PCDHB16" 2))) ("UP:Q9NRK6" (("ABCB10" 1)))
 ("UP:Q9NRL2"
  (("ACF1" 10) ("Acf1" 4) ("ATP-dependent chromatin remodeling protein" 3)
   ("intact ACF1" 1) ("BAZ1A" 1)))
 ("UP:Q9NRL3" (("Strn4" 1))) ("UP:Q9NRM0" (("SLC2A9" 14)))
 ("UP:Q9NRM1" (("enamelin" 1))) ("UP:Q9NRM6" (("CRL4" 575) ("CRL4-" 1)))
 ("UP:Q9NRM7"
  (("LATS2" 600) ("Lats2" 329) ("large tumor suppressor" 23)
   ("Lats2 protein" 18) ("KPM" 3) ("LATS2 protein" 3) ("p-LATS2" 2)
   ("large tumor suppressor (LATS)" 2) ("the exogenous Lats2 protein" 2)
   ("LATS (large tumor suppressor" 1) ("lats2" 1)
   ("“large tumor suppressor”" 1) ("persistent centrosomal Lats2" 1)
   ("the mitotic apparatus Lats2" 1) ("Large tumor suppressor" 1)))
 ("UP:Q9NRP7" (("FU" 109) ("Fu" 36) ("fu" 2) ("-FU" 2)))
 ("UP:Q9NRR3" (("CDC42SE2" 1) ("SPEC2" 1)))
 ("UP:Q9NRR4"
  (("Drosha" 445) ("DROSHA" 67) ("the RNase III Drosha" 4) ("Drosha protein" 3)
   ("ribonuclease III" 2) ("Drosha ribonuclease III" 2) ("RN3" 2)
   ("RNaseIII" 2) ("drosha" 1) ("Nuclear RNase III enzyme Drosha" 1)
   ("the nuclear RNase III enzyme Drosha" 1) ("ribonuclease-III" 1) ("P241" 1)
   ("RNase-III" 1) ("RNASEN" 1) ("the RNase III enzyme Drosha" 1)))
 ("UP:Q9NRR5" (("Ubqln4" 2)))
 ("UP:Q9NRS4"
  (("TMPRSS4" 70) ("TMPRSS4 protein" 3) ("Transmembrane protease, serine 4" 2)
   ("transmembrane protease, serine 4" 2)))
 ("UP:Q9NRS6" (("SNX15" 2))) ("UP:Q9NRV9" (("p22HBP" 17)))
 ("UP:Q9NRW1" (("RAB6B" 1)))
 ("UP:Q9NRW3" (("pBI" 14) ("A–3C" 4) ("APOBEC3C" 2) ("pBi" 1)))
 ("UP:Q9NRW4" (("DUSP22" 15))) ("UP:Q9NRW7" (("Vps45" 4)))
 ("UP:Q9NRX5" (("SERINC1" 10))) ("UP:Q9NRY2" (("Mise" 1)))
 ("UP:Q9NRY4"
  (("p190RhoGAP" 211) ("p190A" 174) ("ARHGAP35" 61) ("p190Rho-GAP" 12)
   ("P190RhoGAP" 4) ("GRLF1" 3) ("p190RhoGAPs" 3)
   ("glucocorticoid receptor DNA binding factor 1" 3) ("p190ARhoGAP" 2)
   ("p190A protein" 2) ("hyperactive p190A" 1) ("p190-RhoGAP" 1)
   ("the critical amino acids of p190A" 1) ("total or activated p190RhoGAP" 1)
   ("p190A-" 1)))
 ("UP:Q9NRY6" (("phospholipid scramblase 3" 1)))
 ("UP:Q9NRZ5"
  (("delta)" 13) ("1-acylglycerol-3-phosphate O-acyltransferase 4" 3)
   ("Delta)" 2)))
 ("UP:Q9NRZ9" (("HELLS" 4) ("PASG" 4) ("lymphoid-specific helicase" 1)))
 ("UP:Q9NS00" (("C1GALT1" 112) ("T-synthase" 1)))
 ("UP:Q9NS15" (("latent transforming growth factor beta binding protein 3" 5)))
 ("UP:Q9NS18" (("GLRX2" 1)))
 ("UP:Q9NS23"
  (("RASSF1A" 3321) ("RASSF1" 305) ("Rassf1" 69) ("Rassf1A" 45)
   ("RASSF1A protein" 41) ("Ras association domain family member 1" 6)
   ("Rassf1a" 5) ("consequent RASSF1A" 4) ("RassF1" 3) ("RASSF1a" 2)
   ("phospho-mimetic RASSF1A" 2) ("phospho-null RASSF1A" 2)
   ("the phospho-null RASSF1A" 2) ("RASSF1A (WT)" 2)
   ("ectopically-expressed RASSF1A" 1) ("Unfortunately only 17 RASSF1A" 1)
   ("than RASSF1A" 1) ("the 'classical' members RASSF1–6" 1)
   ("exogenous RASSF1A" 1) ("the phospho-null (T202A/S203A) RASSF1A" 1)
   ("the Ras-associated family member RASSF1A" 1)))
 ("UP:Q9NS25" (("SPANXB1" 2))) ("UP:Q9NS26" (("SPANX" 3) ("SPANXA1" 1)))
 ("UP:Q9NS28" (("RGS13" 3) ("RGS18" 2)))
 ("UP:Q9NS37"
  (("ZF" 180) ("CREBZF" 17) ("ZF protein" 6) ("an intact ZF" 4)
   ("the ZF histidines of the ZF 6–10" 1)))
 ("UP:Q9NS39" (("Red2" 2))) ("UP:Q9NS40" (("KCNH7" 2)))
 ("UP:Q9NS56" (("TOPORS" 29) ("Topors" 5) ("LUN" 4) ("lun" 1)))
 ("UP:Q9NS62"
  (("domain 1" 197) ("Domain 1" 14) ("BRCA1-associated RING domain 1" 9)
   ("domain 1 (DS)" 3) ("the cell cycle regulatory domain 1" 2)
   ("namely activation domain 1" 1)))
 ("UP:Q9NS64" (("RPRM" 114)))
 ("UP:Q9NS68"
  (("TROY" 171) ("trade" 46) ("TNFRSF19" 32) ("Trade" 4) ("TROY protein" 2)
   ("foreign trade" 1) ("TAJ" 1)))
 ("UP:Q9NS69" (("Tom22" 50) ("TOM22" 37) ("TOMM22" 4) ("TOM 22" 1)))
 ("UP:Q9NS71" (("GKN1" 2))) ("UP:Q9NS73" (("MBIP" 8)))
 ("UP:Q9NS75" (("CysLT2" 10) ("CYSLTR2" 6) ("CysLT 2 R" 5)))
 ("UP:Q9NS86" (("LANCL2" 8))) ("UP:Q9NS87" (("KIF15" 4)))
 ("UP:Q9NS91"
  (("RAD18" 1500) ("Rad18" 1229) ("Rad18 protein" 15) ("hRad18" 13)
   ("rad18" 10) ("RAD18 molecule" 9) ("RAD18–" 9) ("Rad18-" 5) ("hRAD18" 4)
   ("–Rad18" 4) ("UV-inducible RAD18" 3) ("overexpressed Rad18" 3) ("RAD18-" 2)
   ("X-ray-induced RAD18" 2) ("-Rad18 (WT)" 2) ("His-SUMO–tagged RAD18" 1)
   ("NBS1, BRCA1 or ATM exhibited robust RAD18" 1)
   ("only one homolog of RAD18" 1) ("a triple-tagged RAD18" 1) ("rAd18" 1)
   ("-Rad18" 1) ("than Rad18" 1)
   ("bacterial glutathione S -transferase (GST)–Rad18" 1) ("soluble Rad18" 1)
   ("than endogenous Rad18 (Rad18 dark)" 1)))
 ("UP:Q9NS98" (("SEMA3G" 1))) ("UP:Q9NSA0" (("SLC22A11" 8) ("SLC22A11-" 1)))
 ("UP:Q9NSA1"
  (("FGF21" 355) ("fibroblast growth factor 21" 9) ("Fgf21" 9)
   ("FGF21 protein" 3) ("defective FGF21" 3)))
 ("UP:Q9NSA3" (("ICAT" 70) ("CTNNBIP1" 5))) ("UP:Q9NSB2" (("HB4" 7)))
 ("UP:Q9NSB8" (("Homer2" 10)))
 ("UP:Q9NSC2" (("SALL1" 67) ("Sal1" 18) ("Sall1" 13)))
 ("UP:Q9NSC5" (("Homer3" 8))) ("UP:Q9NSD5" (("pGAT2" 1) ("SLC6A13" 1)))
 ("UP:Q9NSD9" (("FARSLB" 1)))
 ("UP:Q9NSE2"
  (("cis" 2674) ("CIs" 1057) ("CIS" 570) ("CISH" 529) ("SOCS" 435)
   ("suppressor of cytokine signaling" 53) ("cis-" 52) ("Cis" 51) ("G18" 33)
   ("SOCS protein" 9) ("multiple redundant cis" 8)
   ("suppressor of cytokine signaling (SOCS)" 5)
   ("Suppressor of cytokine signaling" 5) ("functional cis" 4) ("pCIS" 4)
   ("g18" 4) ("‘cis’" 3) ("the location-specific cis" 2)
   ("clearly potential cis" 2) ("associated 95% CIs" 2)
   ("numerous redundant cis" 2) ("The essential cis" 2) ("than cis" 2)
   ("appropriate cis" 2) ("CIs (FAS)" 2) ("strong cis" 2) ("essential cis" 2)
   ("a particular cis" 2) ("a single-protein phenotype at least one cis" 2)
   ("a conservative cis" 2) ("cytokine inducible SH2-containing protein" 2)
   ("possible cis" 2) ("incident CIS" 2) ("a ‘strong’ cis" 2)
   ("several key cis" 2) ("the classical cis" 2) ("a key cis" 2)
   ("A prominent cis" 2) ("a new putative distal cis" 2)
   ("several potential transcriptional cis" 2) ("a distal cis" 2)
   ("a new distal cis" 2) ("associated CIs" 2) ("a predicted viral SOCS" 2)
   ("successful CISH" 2) ("potential cis" 2) ("a strong cis" 2)
   ("In fact non-overlapping CIs" 1) ("the entire CIS" 1)
   ("The most frequently targeted CIS" 1) ("targeted CIS" 1)
   ("the most frequent CIS" 1) ("“cis”" 1) ("respective 95% CIs" 1)
   ("solitary CIS" 1) ("primary CIS" 1)
   ("equivocal or positive HER2/neu IHC results underwent HER2/neu CISH" 1)
   ("very wide CIs" 1) ("SOCSI" 1) ("wider CIs" 1) ("than CIS" 1)
   ("than CIS occurring" 1) ("the associated 95% CIs" 1) ("the broad CIs" 1)
   ("focal CIS" 1) ("exact CIs" 1) ("the intrinsically slow cis" 1)
   ("pure CIS" 1)))
 ("UP:Q9NSE4" (("IARS2" 1))) ("UP:Q9NSE7" (("ABCC13" 7)))
 ("UP:Q9NSI5" (("JAM4" 3))) ("UP:Q9NSI6" (("BRWD1" 3)))
 ("UP:Q9NSI8" (("SAMSN1" 4))) ("UP:Q9NSP4" (("CENP-M" 1)))
 ("UP:Q9NSU2"
  (("TREX1" 41) ("Trex1" 8) ("three prime repair exonuclease 1" 2)))
 ("UP:Q9NSV4"
  (("mDia" 187) ("mDia2" 130) ("DIAPH3" 36) ("mDIA" 6) ("mDia2 protein" 5)
   ("DRF3" 3)))
 ("UP:Q9NT62" (("ATG3" 47) ("Atg3" 19))) ("UP:Q9NT68" (("TENM2" 2) ("ODZ2" 1)))
 ("UP:Q9NT99" (("NGL-3" 4) ("hSM" 4)))
 ("UP:Q9NTG7"
  (("SIRT3" 3850) ("Sirt3" 1134) ("hSIRT3" 168) ("sir-2" 143) ("SirT3" 124)
   ("SIRT3 protein" 20) ("Sirtuin 3" 13) ("hSIRT3 protein" 11) ("pSIRT3" 10)
   ("sirtuin 3" 7) ("Sir-2" 6) ("intratumoral Sirt3" 5) ("sirtuin 3 (SIRT)" 5)
   ("Sirt3 protein" 4) ("SIRT 3" 3) ("peritumoral Sirt3" 3)
   ("intratumoral and peritumoral Sirt3" 3) ("Intratumoral Sirt3" 3)
   ("overexpressed full-length SIRT3" 3) ("overexpressed SIRT3" 3)
   ("targeting human SIRT3" 3) ("a latent hSIRT3" 2) ("flag-tagged SIRT3" 2)
   ("SIRT3 (green, xref ) protein" 2)
   ("a human lung cDNA library using full-length SIRT3" 2)
   ("a significantly higherfor SIRT3" 2)
   ("overexpressed epitope-tagged Sirt3" 2)
   ("nearly undetectable SIRT3 protein" 2) ("sirt3" 2)
   ("transfection SIRT3-targeted siRNA or adenovirus expressing SIRT3" 2)
   ("-SIRT3" 2)
   ("the NH 2 -terminal 25 amino acids of hSIRT3 (unpublished data)" 1)
   ("the NH 2 -terminal 25 amino acids of hSIRT3" 1)
   ("the last 15 amino acids of hSIRT3 (N-DLVQRETGKLDGPDK-C)" 1)
   ("Peritumoral Sirt3" 1) ("Ectopically-expressed SIRT3" 1)
   ("NAC treated SIRT3" 1) ("SIRT3-" 1) ("the significantly higherfor SIRT3" 1)
   ("than mitochondrial SIRT3" 1) ("a full-sized SIRT3" 1)
   ("using commercial human recombinant SIRT3" 1)
   ("only 6 demonstrated SIRT3" 1) ("the mature Sirt3 protein" 1)
   ("the mature Sirt3" 1) ("-Sirt3" 1) ("Given Sirt3 ’s" 1) ("Given Sirt3" 1)
   ("poorly-differentiated tumors expressed less SIRT3" 1)
   ("sirtuin (silent mating type information regulation 2" 1)))
 ("UP:Q9NTI2"
  (("ml −1" 2340) ("mL −1" 228) ("ml -1" 100) ("ML-1" 97) ("ml –1" 93)
   ("mL -1" 31) ("ml −1 protein" 6) ("GIBCO" 3) ("ml -1 (GIBCO)" 3) ("mL –1" 2)
   ("at least 4 IU ml −1" 2)
   ("than 40 ng ml −1 (even near the plasma IGFBP-2 levels)" 1)
   ("than 40 ng ml −1 ( xref )" 1) ("Treated and untreated ML-1" 1)
   ("a serum diagnostic PSA level <20 ng ml −1" 1) ("ATP8A2" 1) ("ML −1" 1)))
 ("UP:Q9NTI5"
  (("Pds5b" 89) ("as3" 32) ("AS-3" 15) ("AS3" 9) ("As3" 2)
   ("an intact genomic Pds5b" 1) ("APRIN" 1) ("PDS5B" 1)))
 ("UP:Q9NTJ3" (("SMC4" 23) ("hCAP-C" 1))) ("UP:Q9NTJ5" (("SACM1L" 3)))
 ("UP:Q9NTN9" (("SEMA4G" 2))) ("UP:Q9NTQ9" (("GJB4" 1)))
 ("UP:Q9NTX5" (("ECHDC1" 3))) ("UP:Q9NTX7" (("RNF146" 34) ("Iduna" 7)))
 ("UP:Q9NU19" (("TBC1D22B" 25)))
 ("UP:Q9NUB1" (("AceCS2" 24) ("AceCS2 peptide" 4) ("ACSS1" 2)))
 ("UP:Q9NUD5" (("ZCCHC3" 2)))
 ("UP:Q9NUD9"
  (("class V" 10) ("one representative class V peptide" 1)
   ("class V peptide" 1)))
 ("UP:Q9NUG6" (("PDRG1" 1))) ("UP:Q9NUI1" (("PDCR" 1)))
 ("UP:Q9NUM3" (("SLC39A9" 5))) ("UP:Q9NUN5" (("nESI" 2)))
 ("UP:Q9NUN7" (("PHCA" 1))) ("UP:Q9NUP1" (("CNO" 3)))
 ("UP:Q9NUP9"
  (("Lin-7C" 59) ("LIN7C" 9) ("MALS-3" 3) ("VELI3" 2) ("VELI-3" 1)))
 ("UP:Q9NUQ2" (("epsilon)" 6) ("Agpat5" 6))) ("UP:Q9NUQ3" (("TXLNG" 1)))
 ("UP:Q9NUT2" (("mABC1" 1) ("ABCB8" 1))) ("UP:Q9NUU7" (("DDX19A" 2)))
 ("UP:Q9NUV7" (("SPTLC3" 5) ("serine palmitoyltransferase" 5)))
 ("UP:Q9NUV9" (("IAN1" 62) ("gimap4" 7)))
 ("UP:Q9NUW8"
  (("TDP1" 129) ("tyrosyl–DNA phosphodiesterase 1" 5)
   ("tyrosyl-DNA phosphodiesterase 1" 5) ("Tdp1" 4)
   ("tyrosyl DNA phosphodiesterase 1" 4)))
 ("UP:Q9NUX5"
  (("POT1" 304) ("Pot1" 14) ("protection of telomeres 1" 10) ("POT1 protein" 4)
   ("hPOT1" 3) ("than enough protection of telomeres 1" 1)))
 ("UP:Q9NUY8" (("TBC1D23" 3))) ("UP:Q9NUZ1" (("ACOXL" 2)))
 ("UP:Q9NV23" (("THEDC1" 1)))
 ("UP:Q9NV35" (("MTH2" 18) ("MTH2 protein" 1) ("MutT homolog2" 1)))
 ("UP:Q9NV56" (("C20orf20" 42) ("MRGBP" 1)))
 ("UP:Q9NV58" (("Dorfin" 1) ("RNF19A" 1)))
 ("UP:Q9NV70" (("Sec3" 120) ("EXOC1" 28) ("SEC3" 4)))
 ("UP:Q9NV72" (("ZNF701" 2)))
 ("UP:Q9NV96" (("perifosine" 227) ("Perifosine" 41) ("perifosine-" 2)))
 ("UP:Q9NVA2" (("SEPT11" 6) ("septin 11" 4))) ("UP:Q9NVC3" (("SLC38A7" 8)))
 ("UP:Q9NVC6" (("MED17" 3) ("TRAP80" 1)))
 ("UP:Q9NVD7"
  (("actopaxin" 165) ("Actopaxin" 20) ("α-parvin" 4) ("CH-ILKBP" 3)
   ("the exogenous actopaxin" 1) ("α-Parvin" 1)))
 ("UP:Q9NVF7"
  (("FBXO28" 272) ("FBXO28 protein" 3) ("dominant-negative FBXO28" 2)))
 ("UP:Q9NVF9" (("ETNK2" 25))) ("UP:Q9NVH1" (("DnaJC11" 1)))
 ("UP:Q9NVH2" (("INTS7" 13)))
 ("UP:Q9NVI1"
  (("FANCI" 347) ("FANCI protein" 4) ("exogenous FANCI" 1) ("FANCi" 1)))
 ("UP:Q9NVI7" (("ATAD3A" 1))) ("UP:Q9NVJ2" (("Arl8b" 1)))
 ("UP:Q9NVK5" (("FGFR1OP2" 8))) ("UP:Q9NVM4" (("PRMT7" 12)))
 ("UP:Q9NVN3" (("Ric-8B" 2)))
 ("UP:Q9NVN8"
  (("GNL3L" 470) ("GNL3L protein" 11) ("than GNL3L" 4) ("the GNL3L’s" 2)
   ("more GNL3L" 1) ("GNL3L (HA)" 1)))
 ("UP:Q9NVP1" (("DDX18" 10)))
 ("UP:Q9NVP2"
  (("ASF1B" 49) ("Asf1b" 17) ("ASF1B protein" 2)
   ("expressing FLAG-tagged ASF1B" 1) ("ASF1b" 1)))
 ("UP:Q9NVQ4" (("FAIM" 10) ("fas apoptotic inhibitory molecule" 1)))
 ("UP:Q9NVV4" (("PAPD1" 2))) ("UP:Q9NVV5" (("AIG1" 8) ("-AIG1" 1)))
 ("UP:Q9NVV9"
  (("THAP1" 168) ("THAP1 protein" 4)
   ("some amino acids of the proapoptotic factor THAP1" 1)))
 ("UP:Q9NVW2"
  (("RLIM" 300) ("ring finger protein" 14)
   ("LIM domain interacting protein (RLIM)" 6) ("RNF12" 5)
   ("Ring finger protein" 5) ("RLIM protein" 3)
   ("E3 ubiquitin-protein ligase RLIM" 2) ("ring finger protein (RING)" 2)
   ("LIM domain interacting" 1) ("targeting RNF12" 1)
   ("the transcriptional activation o RLIM" 1)))
 ("UP:Q9NW08" (("POLR3B" 1)))
 ("UP:Q9NW38" (("FANCL" 303) ("pOG" 28) ("POG" 7) ("Fancl" 1)))
 ("UP:Q9NWB1" (("A2BP1" 10) ("Fox-1" 7) ("RBFOX1" 3) ("Fox1" 3) ("FOX1" 1)))
 ("UP:Q9NWB7" (("IFT57" 6))) ("UP:Q9NWF9" (("TRIAD3" 1) ("Triad3a" 1)))
 ("UP:Q9NWH9" (("SLTM" 4) ("modulator of estrogen induced transcription" 1)))
 ("UP:Q9NWM0"
  (("SMOX" 97) ("PAO1" 49) ("spermine oxidase" 5) ("spermine oxidase (SMOX)" 2)
   ("SMOX protein" 1) ("than P. aeruginosa PAO1" 1)
   ("the opportunistic pathogen P. aeruginosa PAO1" 1)))
 ("UP:Q9NWM8"
  (("22 kDa" 13) ("22 kDa protein" 2) ("22 KDa" 2) ("22 kDa" 1) ("22 kDa" 1)))
 ("UP:Q9NWQ8"
  (("Csk" 710) ("Csk-binding protein" 8)
   ("transmembrane adaptor protein PAG" 5) ("the PAG-associated Csk" 4)
   ("csk" 3) ("coexpressed Csk" 3) ("Csk protein" 2) ("Csk binding protein" 2)
   ("subsequently releases Csk" 1) ("the membrane-associated Csk" 1)
   ("more Csk protein" 1) ("membrane-associated Csk" 1)
   ("CSK binding protein (CBP)" 1) ("CSK binding protein" 1)
   ("the lipid raft-localized inhibitory receptor tyrosine kinase Csk" 1)
   ("than endogenous Csk" 1)))
 ("UP:Q9NWS1"
  (("PARI" 222) ("PARI protein" 6) ("C12orf48" 4)
   ("exogenously-expressed PARI" 2) ("flag-tagged PARI" 1)))
 ("UP:Q9NWS8" (("RMND1" 7) ("C6orf96" 1)))
 ("UP:Q9NWT1"
  (("PAK1IP1" 219) ("Mak11" 8) ("hPIP1" 2) ("Mak11 protein" 2)
   ("overexpressed PAK1IP1" 2) ("Pak1ip1" 2) ("PAK1IP1-" 1)
   ("PAK1IP1 protein" 1)))
 ("UP:Q9NWT6" (("FIH-1" 8))) ("UP:Q9NWT8" (("AKIP" 1)))
 ("UP:Q9NWV8"
  (("MERIT40" 42) ("NBA1" 15) ("C19orf62" 7) ("BABAM1" 7) ("HSPC142" 3)
   ("Mediator of Rap80 Interactions and Targeting 40 kD" 2)))
 ("UP:Q9NWW0" (("HCFC1R1" 1))) ("UP:Q9NWW9" (("HRASLS2" 9)))
 ("UP:Q9NWX5" (("Asb6" 1)))
 ("UP:Q9NWX6"
  (("foci" 14971) ("Foci" 170) ("metastatic foci" 48) ("IRIF" 47)
   ("discrete foci" 45) ("foci (IRIF)" 34) ("distinct foci" 24)
   ("foci (TIF)" 17) ("SAHF" 17) ("fibroblastic foci" 16) ("foci (SAHF)" 13)
   ("foci (ACF)" 13) ("subnuclear foci" 13)
   ("senescence-associated heterochromatin foci (SAHF)" 11)
   ("irradiation-induced foci" 9) ("radiation-induced foci (IRIF)" 8)
   ("telomeric foci" 8) ("perinuclear foci" 7) ("spontaneous foci" 6)
   ("more 53BP1 foci" 6) ("the metastatic foci" 6) ("endometriotic foci" 6)
   ("lung fibrotic foci" 6) ("fewer foci" 6)
   ("nondamage-associated RAD51 foci" 6) ("lung metastatic foci" 6)
   ("smaller foci" 6) ("dysplastic foci" 6)
   ("telomere dysfunction-induced foci" 6) ("microscopic foci" 5)
   ("residual γH2AX foci" 5) ("radiation-induced foci" 5) ("larger foci" 5)
   ("atypical foci" 5) ("Foci (ACF)" 5) ("squamous metaplasia foci" 5)
   ("senescence-associated heterochromatin foci" 4) ("residual γ-H2AX foci" 4)
   ("transformed foci" 4) ("residual RAD51 foci" 4)
   ("metaphase telomere dysfunction-induced foci" 4)
   ("the inflammatory foci" 4) ("dysplastic aberrant crypt foci" 4)
   ("the fibroblastic foci" 4) ("epileptogenic foci" 4) ("cellular foci" 4)
   ("more foci" 4) ("abnormally large PCNA foci" 4)
   ("extravasate and form metastatic foci" 3) ("prominent foci" 3)
   ("small and diffuse foci" 3) ("significantly more γH2AX foci" 3)
   ("adjacent foci" 3) ("hemorrhagic necrotic foci" 3) ("occasional foci" 3)
   ("viral DNA replication foci" 3) ("residual RAD51/γH2AX foci" 3)
   ("more cells formed nuclear foci" 3) ("heterochromatic foci" 3)
   ("characteristic foci" 3) ("the telomeric foci" 3)
   ("multiple microscopic foci" 3) ("NIH3T3-derived transformed foci" 3)
   ("visible foci" 3) ("pre-neoplastic foci" 3) ("foci (VNF)" 3)
   ("most foci" 3) ("a few foci" 3) ("multiple new foci" 3)
   ("multiple noncontiguous tumor foci" 3) ("the invasive tumor foci" 3)
   ("significantly fewer foci" 3) ("hemorrhagic foci" 3)
   ("IPF fibroblastic foci" 3) ("the few γH2AX foci" 3)
   ("progressively later replicating foci" 2) ("replicating foci" 2)
   ("mainly yellow foci" 2) ("ionizing radiation-induced foci" 2)
   ("RPA-positive foci" 2) ("the residual foci" 2) ("new malignant foci" 2)
   ("fluorescent foci" 2) ("p53-positive preneoplastic foci" 2)
   ("pulmonary metastatic foci" 2) ("3.5-fold more γ-H2AX foci" 2)
   ("very few foci" 2) ("tumor-associated foci" 2) ("very distinct foci" 2)
   ("the relatively primary foci" 2)
   ("microscopic extrahepatic metastatic foci" 2)
   ("significantly fewer focal adhesion foci" 2)
   ("virus revealed small foci" 2) ("transformed cell foci" 2)
   ("constitutive transcriptional repression foci" 2) ("even small foci" 2)
   ("discrete perinuclear foci" 2) ("radiogenic foci" 2)
   ("residual 53BP1-positive foci" 2) ("53BP1-positive foci" 2)
   ("established metastatic foci" 2)
   ("telomere dysfunction-induced foci (TIF)" 2)
   ("the non-lymphocytic stromal foci" 2) ("epithelial foci" 2)
   ("almost all BRCA1 foci" 2) ("The multifocal SRCC foci" 2)
   ("neuroglial overmigration foci" 2) ("preneoplastic foci" 2)
   ("viral replication foci" 2) ("less BRCA1 and Rad51 foci" 2)
   ("wt-Vav1 induced transformed foci" 2)
   ("involution-resistant neoplastic foci" 2) ("heterochromatic foci (SAHF)" 2)
   ("residual γH 2 AX foci" 2) ("radiation-induced residual γH 2 AX foci" 2)
   ("residual γH 2 AX positive repair foci" 2)
   ("53BP1-S1618D or 53BP1-T1609D-S1618D formed BRCA1-positive foci" 2)
   ("necrotic foci" 2) ("than five foci" 2) ("two or more tumor foci" 2)
   ("siRNA developed less tumour foci" 2) ("secondary tumour foci" 2)
   ("multiple 53BP1-positive foci" 2) ("than 10 foci" 2)
   ("fewer BRCA1 and BRCA2 repair foci" 2)
   ("senescence associated heterochromatic foci" 2) ("at least 3 foci" 2)
   ("Senescence-associated heterochromatin foci (SAHF)" 2)
   ("irradiation-induced RAD51 foci" 2) ("distinct subnuclear foci" 2)
   ("the Cct6-YFP perinuclear foci" 2)
   ("the juxtanuclear or peripheral cytoplasmic VHL foci" 2)
   ("perinuclear Cmr1 foci" 2)
   ("senescence-associated heterochromatic foci (SAHF)" 2)
   ("senescence associated heterochromatin foci (SAHF)" 2)
   ("the nucleolar eGFP-TopBP1 foci" 2) ("Dna2 subnuclear foci" 2)
   ("the lung metastatic foci" 2) ("postmitotic 53BP1 foci" 2)
   ("the peritoneal metastatic foci" 2) ("an invasive foci" 2)
   ("centrosomal foci" 2) ("mitotic DNA synthesis foci" 2)
   ("three or more foci" 2) ("irradiated cells showed pChk2T68 foci" 2)
   ("Subnuclear Foci" 2) ("Cajal Body-related subnuclear foci" 2)
   ("tightly-associated 53BP1 foci" 2) ("the associated foci" 2)
   ("large intranuclear foci" 2) ("all metastatic foci" 2) ("dense foci" 2)
   ("mainly RAD51C foci" 2) ("extra-nucleolar WRN foci" 2)
   ("GFP-expressing metastatic foci" 2) ("formed only microscopic foci" 2)
   ("peripheral foci" 2) ("less intense foci" 2)
   ("RK3E cells formed numerous transformed foci" 2)
   ("almost all BLM and p53 foci" 2) ("more BLM foci" 2) ("a few RAD51 foci" 2)
   ("few foci" 2) ("these distinctive foci" 2)
   ("senescence-associated DNA damage foci" 2)
   ("significantly ( P < 0.031) fewer RPA-positive foci" 2)
   ("essentially no distinct 53BP1 foci" 2) ("periportal foci" 2)
   ("senescence-induced heterochromatic foci (SAHF)" 2)
   ("less intense staining nuclear foci" 2) ("We first analyzed Rad51 foci" 2)
   ("chromatin-associated WRN foci" 2) ("3D fibroblastic foci" 2)
   ("so-called nuclear foci" 2) ("dense nuclear foci" 2)
   ("fluorescent γ -H2AX foci" 2) ("robust 53BP1 or γH2AX foci" 2)
   ("ductular tumor-like foci" 2) ("epileptic foci" 2)
   ("10-12 discrete foci" 2) ("RNA pol II foci" 2)
   ("20 or more centromere foci" 2) ("the late replication foci" 2)
   ("senescence-associated heterochromatic foci" 2) ("only sporadic foci" 2)
   ("70% ofShp2 hep−/− female mice developed visible foci" 2)
   ("both control andShp2 hep−/− groups developed visible hepatic tumor foci"
    2)
   ("HR-associated proteins form DNA damage-induced foci" 2)
   ("bacterial-induced actin foci" 2) ("smaller co-localized foci" 2)
   ("radiation-induced DNA damage foci" 2)
   ("radiation-induced γ-H2AX and 53BP1 foci" 2) ("foci (NF)" 2)
   ("only rare foci" 2) ("rare foci" 2) ("few γH2A.X foci" 2)
   ("very few γH2A.X foci" 2) ("Immunoflourescent foci" 2)
   ("DNA damage–induced immunoflourescent foci" 2) ("Most BRCA1 foci" 2)
   ("the cell lines formed characteristic Rad51 foci" 2) ("fibrotic foci" 2)
   ("nontelomeric RAD51 foci" 2)
   ("NS knockdown increases nontelomeric RAD51 foci" 2)
   ("AT cells accumulated most Rad51 foci" 2) ("even some foci" 2)
   ("form distinct foci" 2) ("individual discrete foci" 2)
   ("radiation-induced nuclear foci" 2) ("Inflammatory foci" 2)
   ("SC35-positive nuclear foci" 2) ("53BP1-positive DNA damage foci" 2)
   ("so-called radiation-induced foci" 2) ("inflammatory foci" 2)
   ("intranuclear foci" 2) ("ectopic epithelial foci" 2)
   ("invasive tumor foci" 2) ("The unusually brighter PCNA foci" 2)
   ("very numerous p-p53 foci" 2) ("spontaneously forms foci" 2)
   ("The resulting telomere dysfunction-induced foci" 2)
   ("fewer DNA repair foci" 2) ("immunofluorescent γH2AX foci" 2)
   ("Htt-positive foci" 2) ("the Fibroblastic Foci" 2)
   ("laser-induced DNA damage foci" 2) ("radiation-induced repair foci" 2)
   ("the large subnuclear foci" 2)
   ("over-sized host DNA damage response foci" 2)
   ("prominent subnuclear foci" 2) ("associated heterochromatin foci" 2)
   ("damage-induced subnuclear foci" 1) ("assembly subnuclear RAD51 foci" 1)
   ("damage-induced subnuclear RAD51 foci" 1) ("a few hRAD51 and BLM foci" 1)
   ("BS cells formed 2–2.5-fold more RAD51 foci" 1)
   ("than BLM/RAD51 foci (>30 per nucleus; xref f)" 1) ("BLM-positive foci" 1)
   ("The few BLM foci" 1) ("most (80–90%) BLM foci" 1)
   (">10 discernible foci" 1) ("The transformed foci" 1) ("Transformed foci" 1)
   ("These spontaneous foci" 1) ("the fibrotic foci" 1)
   ("these micrometastatic foci" 1) ("The metastatic foci" 1)
   ("residual 53BP1 foci" 1) ("Fewer foci" 1) ("many more foci" 1)
   ("Metastatic foci" 1) ("only small residual foci" 1) ("aggressive foci" 1)
   ("multicentric tumor foci" 1) ("the ribonuclear foci" 1) ("latent foci" 1)
   ("siMSH2 displayed UV-induced RPA foci" 1)
   ("mock-treated cells demonstrated increased gamma-H2AX foci" 1)
   ("UVR-induced preneoplastic foci" 1)
   ("than p53-positive preneoplastic foci" 1)
   ("these UVR-induced preneoplastic foci" 1) ("small mesenchymal foci" 1)
   ("one or more foci" 1) ("UAF1 contained 3.5-fold more γ-H2AX foci" 1)
   ("5 or more foci" 1) ("than 20 foci compared to ~20" 1) ("less foci" 1)
   ("whose foci" 1) ("genetically altered mucosal foci" 1)
   ("rapidly forms foci" 1) ("primary foci" 1)
   ("persistent heterochromatic foci" 1) ("independent histologic foci" 1)
   ("70% less foci" 1) ("HSV-1-infected viral foci" 1)
   ("UV-inducible RAD18 foci" 1) ("UV-induced CPD foci" 1)
   ("distinct senescence-associated heterochromatin foci" 1)
   ("significantly more radiation-induced 53BP1 foci" 1)
   ("repair-associated foci" 1) ("irradiation-induced γH2AX foci" 1)
   ("than six γH2AX foci" 1) ("form dysplastic foci" 1) ("adhesive foci" 1)
   ("mitotic γH2AX foci" 1) ("an average around six foci" 1)
   ("RECK-expressing metastatic foci" 1) ("γH2AX-positive foci" 1)
   ("Representative photomicrographs illustrating RAD51 foci" 1)
   ("radiation-induced RAD51 foci" 1)
   ("Representative photomicrographs illustrating γ-H2AX foci" 1)
   ("fewer 53BP1 foci" 1) ("the concurrent acinar foci" 1)
   ("had displayed fewer gamma-H2AX foci" 1) ("Microscopic foci" 1)
   ("subpial foci" 1) ("the malignant foci" 1) ("the three epithelial foci" 1)
   ("dysplastic and early invasive esophageal squamous cell cancer foci" 1)
   ("Adjacent foci" 1) ("multicentric foci" 1) ("gastric foci" 1)
   ("at least five Rad51 nuclear foci" 1) ("microscopic neoplastic foci" 1)
   ("discreet nuclear foci" 1) ("p85D showed both the IRS-1 cytosolic foci" 1)
   ("at least 3 different foci" 1) ("a few grade 2 budding/sprouting foci" 1)
   ("53BP1 protein forms prominent IRIF" 1)
   ("a pathologist identified neoplastic foci" 1) ("both preneoplastic foci" 1)
   ("aberrant foci" 1) ("pathologic lesions called fibroblast foci" 1)
   ("intense KU70/80 and DNA-PK cs foci" 1) ("formed intense foci" 1)
   ("Lung surface metastatic foci" 1) ("had more foci" 1)
   ("The most strongly labeled TPT or MXT treated cells displayed IF foci" 1)
   ("closely adjacent foci" 1) ("hybrid foci" 1)
   ("stable ionizing radiation-induced foci" 1) ("malignant foci" 1)
   ("residual IR-induced γ-H2AX foci" 1) ("the transformed foci" 1)
   ("than Rad51 foci" 1) ("forty-three fresh frozen PCa tissue foci" 1)
   ("significantly fewer infected foci" 1) ("infectious foci" 1)
   ("at least five 53BP1 foci" 1) ("the residual RAD51 foci" 1)
   ("only 12 foci" 1) ("an almost four times fewer RPA foci" 1)
   ("residual RAD51 and yH2AX foci" 1) ("hyperproliferative foci" 1)
   ("than 25 foci" 1)
   ("Significantly fewer β-HPV 5 and 8 E6 expressing HFKs formed BRCA1 foci" 1)
   ("focal SAHF" 1) ("RS-1-induced RAD51 foci" 1) ("associated RPA foci" 1)
   ("than five RPA staining foci" 1) ("five discrete foci" 1)
   (">10 discrete foci" 1) ("distinct metastatic foci" 1)
   ("six or more foci" 1) ("stress-induced cytoplasmic foci" 1)
   ("MG132-induced perinuclear foci" 1) ("Cmr1 perinuclear foci" 1)
   ("more necrotic foci" 1) ("CFP-PCNA-labeled replication foci" 1)
   ("multiple dysplastic foci" 1) ("nucleolar eGFP-TopBP1 foci" 1)
   ("the characteristic foci" 1) ("nucleolus-associated TopBP1 foci" 1)
   ("than the necklace-like foci formed by RNA pol I" 1)
   ("the nucleolar TopBP1 foci" 1) ("discrete subnuclear Dna2 foci" 1)
   ("subnuclear RPA foci" 1) ("nearly normal Dna2 foci" 1)
   ("subnuclear Rad51 foci" 1) ("cytokinesis displayed nuclear 53BP1 foci" 1)
   ("Previously 53BP1 foci" 1) ("genetic foci" 1)
   ("three or more obvious colocalization foci" 1)
   ("the foci, that was present in some of the cells" 1)
   ("paired primary foci" 1) ("less metastatic foci" 1)
   ("These so-called γH2AX foci" 1) ("than ten 53BP1 foci" 1)
   ("BO-1055 induced fewer γ-H2AX nuclear foci" 1) ("bilateral tumor foci" 1)
   ("still forms foci" 1) ("both primary foci" 1) ("the primary foci" 1)
   ("at least five FANCD2 or γH2AX foci" 1) ("inert cellular foci" 1)
   ("at least five phospho-Chk2 foci" 1)
   ("than three foci ( xref , and data not shown)" 1)
   ("the p53-positive foci" 1) ("distinct repair proficient nuclear foci" 1)
   ("tightly associated salt-resistant 53BP1 foci" 1)
   ("the X-ray-induced RAD18 foci" 1) ("The X-ray-induced foci" 1)
   ("discrete observable foci" 1) ("The fibrotic foci" 1)
   ("immunofluorescent foci" 1) ("intense RPA foci" 1) ("Few RPA foci" 1)
   ("large cell dysplastic foci" 1) ("approximately 30 foci" 1)
   ("cells showed MUS81 foci" 1)
   ("RAP80 delE81 demonstrated discernable foci" 1)
   ("59 high grade prostatic intraepithelial neoplasia (HGPIN) foci" 1)
   ("Radiation-induced foci" 1) ("irradiation developed visible RAD51C foci" 1)
   ("cells showed numerous RAD51C foci" 1) ("visible Rad51 foci" 1)
   ("microscopically visible RAD51 foci" 1)
   ("Visible microscopic Rad51 foci" 1) ("multiple discrete foci" 1)
   ("at least 2 foci" 1) ("replication-associated repair protein foci" 1)
   ("Many pathway components form subnuclear repair protein foci" 1)
   ("starvation displayed peripheral foci" 1) ("viral genome foci" 1)
   ("infiltrative tumor foci" 1) ("residual protein and pChk1 foci" 1)
   ("residual protein and 53BP1 foci" 1) ("than p53 foci" 1)
   ("stalled replication foci" 1) ("more RAD51 foci" 1)
   ("typical RAD51 and BRCA2 foci" 1) ("The perinuclear foci" 1)
   ("around five foci" 1) ("long-lived foci" 1)
   ("multiple discontinuous foci" 1) ("discontinuous foci" 1)
   ("senescence associated hetero-chromatin foci
                        (SAHF)"
    1)
   ("foci
                        (SAHF)"
    1)
   ("Few γ-H2AX foci" 1) ("than single foci in doxorubicin-treated cells" 1)
   ("NIH3T3 transformed foci" 1) ("10 or more foci" 1)
   ("indeed DNA damage foci" 1) ("a few XPF foci" 1)
   ("five representative replication foci" 1) ("obvious replication foci" 1)
   ("than twenty H2AX foci" 1) ("dystrophic calcific foci" 1)
   ("PRDX1 intense nuclear foci" 1) ("widespread foci" 1)
   ("WRN subsequently forms DNA damage-dependent foci" 1)
   ("WRN rapidly forms discrete nuclear foci" 1)
   ("than five nuclear foci staining" 1) ("than wild-type foci ( xref )" 1)
   ("DNA-damage-associated foci" 1) ("BEAS-2B developed distinct foci" 1)
   ("large distinct foci" 1) ("than control foci (p=0.26)" 1)
   ("often p53 foci" 1) ("more p53 foci" 1)
   ("the transformed cells form foci" 1) ("many residual γ-H2AX foci" 1)
   ("Vpr forms highly mobile nuclear foci" 1) ("more punctate foci" 1)
   ("form discrete DNA-damage-induced nuclear foci" 1)
   ("representative foci" 1) ("typical HR foci" 1) ("Foci (IRIF)" 1)
   ("newly arisen PCNA-only foci" 1) ("five distinct foci" 1)
   ("excised epileptic foci" 1) ("these proliferative foci" 1)
   ("discrete proliferative foci" 1) ("all atypical foci" 1)
   ("evident nuclear FANCD2 foci" 1) ("than two Aurora A foci ( xref )" 1)
   ("than two Aurora A foci ( xref , right)" 1) ("the two distinct foci" 1)
   ("than five Rad51 foci" 1) ("than one γH2AX foci" 1)
   ("one or more γH2AX foci" 1) ("morphologically transformed foci" 1)
   ("regenerative foci" 1) ("the typical juxtaposed RPA-PML foci" 1)
   ("RAD51 subnuclear foci" 1) ("nucleoplasmic foci" 1) ("strong foci" 1)
   ("fewer Dmc1/Rad51 foci" 1) ("persistent autosomal γ-H2AX foci" 1)
   ("the heterochromatic foci" 1) ("fewer DNA damage-induced foci" 1)
   ("colonic Aberrant Crypt Foci (ACF)" 1) ("the X-ray-induced γ-H2AX foci" 1)
   ("more γ-H2AX foci" 1) ("these so-called G1 foci" 1)
   ("subnuclear RAD51 foci" 1) ("than twenty 53BP1 foci" 1)
   ("more visible 53BP1 foci" 1) ("irradiation-induced foci (IRIF)" 1)
   ("Most BrdU foci" 1) ("rapidly forms nuclear foci (NF)" 1)
   ("residual foci" 1) ("the invasive foci" 1) ("than 10 γH2AX foci" 1)
   ("KE/N-Ras V12 mice developed abnormal lymphoproliferative foci" 1)
   ("lymphoplasmacytic foci" 1) ("largest invasive foci" 1)
   ("significantly more BRDU foci" 1) ("immunofluorescent BRDU foci" 1)
   ("local and distant foci" 1) ("PCNA associated replication foci" 1)
   ("Typically one or two BRCA1 foci" 1)
   ("Breast cancer–associated protein 1 (BRCA1) forms foci" 1)
   ("DNA repair-associated foci" 1) ("replication protein A (RPA) foci" 1)
   ("senescence-associated chromatin foci" 1) ("fibrotic foci (FF)" 1)
   ("UV-induced PCNA nuclear foci" 1) ("UV-induced Spartan WT foci" 1)
   ("the UV-induced Spartan foci" 1) ("four or more tumor foci" 1)
   ("contained dysplastic foci" 1) ("telomere-associated RAD51 foci" 1)
   ("nontelomeric (IDF, interstitial damage foci) damage foci" 1)
   ("radiation-induced Rad51 foci" 1) ("Discrete foci" 1) ("than 6 foci" 1)
   ("than 10 RAD51 foci" 1) ("the distinct foci" 1) ("innumerable foci" 1)
   ("DNA damage-associated nuclear foci" 1) ("at least 5 foci" 1)
   ("significantly fewer inflammatory foci" 1)
   ("CEP164-positive nuclear foci" 1) ("SC25/SRSF2-positive nuclear foci" 1)
   ("3–5 strong nuclear foci" 1) ("these new foci" 1)
   ("the lung inflammatory foci" 1) ("the granulomatous inflammatory foci" 1)
   ("more γH2AX foci" 1) ("Perinuclear foci" 1)
   ("small proliferating atypical cell foci" 1) ("Such micrometastatic foci" 1)
   ("proliferative foci" 1) ("the few RAD51 foci" 1)
   ("small metastatic foci" 1) ("γH2AX-positive nuclear foci" 1)
   ("RAD51/γH2AX-positive nuclear foci" 1) ("the major foci" 1)
   ("weak BrdU foci" 1) ("DNA synthesis–deficient PCNA foci" 1)
   ("the abnormally large PCNA foci" 1) (">10 fluorescent foci" 1)
   ("nearly no Rad51 foci" 1) ("the Rad51-associated protein BRCA1 foci" 1)
   ("p400-depleted cells present slightly more phospho-RPA foci" 1)
   ("several subnuclear foci" 1) ("53BP1-associated telomere foci" 1)
   ("than four foci at telomeres ( xref D)" 1)
   ("than four foci at telomeres" 1) ("than 10 DNA-damage foci" 1)
   ("CGRP revealed increased NE foci" 1)
   ("immunofluorescent γH2AX or 53BP1 foci" 1) ("bright circular foci" 1)
   ("than the SSBR foci ( xref )" 1) ("a few XRCC1 small foci" 1)
   ("a few XRCC1 foci" 1) ("mutant Htt-positive foci" 1) ("neighboring foci" 1)
   ("XRCC1 deficient cells accumulated more γH2AX foci" 1)
   ("EM-C12 cells accumulated more γH2AX foci" 1) ("HCV-NS5A-postitive foci" 1)
   ("than γH2AX foci" 1) ("the well-defined foci" 1) ("intra-tumoral foci" 1)
   ("all visible hnRNP C foci" 1) ("at least several distinct foci" 1)
   ("somewhat more foci" 1) ("RPA-associated nuclear foci" 1)
   ("UV-induced foci" 1) ("smaller hMSH6 foci" 1)
   ("significantly fewer hMSH6 foci" 1)
   ("significantly (p<0.001) fewer hMSH6 foci" 1)
   ("cells displayed FBH1 foci" 1) ("a new foci" 1)))
 ("UP:Q9NWZ3" (("IRAK4" 67))) ("UP:Q9NX01" (("DLP" 29)))
 ("UP:Q9NX02"
  (("Nbs1" 613) ("nbs1" 3) ("Nbs1 protein" 2) ("NLRP2" 2) ("residual Nbs1" 2)
   ("Pan1" 1) ("Nbs1 (MRN)" 1) ("no exogenous Nbs1" 1)))
 ("UP:Q9NX08" (("COMMD8" 1)))
 ("UP:Q9NX09"
  (("REDD1" 724) ("Redd1" 32) ("DDIT4" 27) ("transcript 4" 11)
   ("REDD1 protein" 10) ("REDD1 molecule" 8)
   ("REDD1 (also know as RTP801/Dig1/ DDIT4) protein" 3)
   ("non-immortalized REDD1" 2) ("RTP801" 2) ("than REDD1" 1)
   ("the two essential REDD1" 1) ("the N-terminal 84 amino acids of REDD1" 1)
   ("DNA-damage-inducible transcript 4" 1) ("REDD-1" 1)))
 ("UP:Q9NX14" (("NDUFB11" 1)))
 ("UP:Q9NX18"
  (("pGL2" 217) ("PGL2" 7) ("pgl2" 5) ("pGL2-" 4) ("Sdhaf2" 1) ("pGl2" 1)))
 ("UP:Q9NX24" (("NHP2" 10) ("NOLA2" 7) ("Nhp2 protein" 3) ("Nhp2" 2)))
 ("UP:Q9NX40" (("OCIA domain containing 1" 3) ("OCIAD1" 2)))
 ("UP:Q9NX46" (("ARH3" 18)))
 ("UP:Q9NX47" (("MARCH5" 39) ("mitochondrial ubiquitin ligase" 1)))
 ("UP:Q9NX52" (("NTFs" 1))) ("UP:Q9NX55" (("HYPK" 16)))
 ("UP:Q9NX58" (("LYAR" 7) ("LYAR (Ly-1 antibody reactive) protein" 2)))
 ("UP:Q9NX63" (("CHCHD3" 5) ("MINOS3" 4))) ("UP:Q9NX94" (("OPAL1" 8)))
 ("UP:Q9NXA8"
  (("SIRT5" 698) ("Sirt5" 320) ("SirT5" 9) ("sirt5" 5) ("SIRT5 protein" 3)
   ("SIRT5-" 2) ("sirtuin 5" 2)))
 ("UP:Q9NXB0" (("Mks1" 25) ("MKS1" 10) ("BBS13" 1))) ("UP:Q9NXC5" (("Mios" 1)))
 ("UP:Q9NXE4" (("nSMase3" 1))) ("UP:Q9NXE8" (("CCDC49" 2)))
 ("UP:Q9NXF8" (("ZDHHC7" 2)))
 ("UP:Q9NXG0"
  (("centrosomal protein" 71) ("an integral centrosomal protein" 3)
   ("a widespread centrosomal protein" 2)
   ("centrosomal
protein"
    1)))
 ("UP:Q9NXG6" (("PH4" 3) ("PHD4" 2) ("P4HTM" 1))) ("UP:Q9NXI6" (("RNF186" 17)))
 ("UP:Q9NXJ5" (("PGPEP1" 6))) ("UP:Q9NXK8" (("Fbxl12" 76) ("FBXL12" 15)))
 ("UP:Q9NXL9" (("MCM9" 1))) ("UP:Q9NXR1" (("NudE" 42) ("NDE1" 3)))
 ("UP:Q9NXR7" (("BRE" 45) ("BRCC45" 22) ("BRCC45 (BRE)" 1)))
 ("UP:Q9NXR8" (("ING3" 1))) ("UP:Q9NXS2" (("QPCTL" 3)))
 ("UP:Q9NXU5" (("ARL15" 8))) ("UP:Q9NXV2" (("KCTD5" 1)))
 ("UP:Q9NXV6"
  (("MG132" 5182) ("the proteasomal inhibitor MG132" 21) ("Mg132" 19)
   ("MG132 (EMD)" 9) ("proteasomal inhibitor MG132" 5) ("MG132 (MG)" 4)
   ("–MG132" 4) ("the proteosomal inhibitor MG132" 3)
   ("proteasomal degradation inhibitor MG132" 2)
   ("proteomic inhibitor MG132" 2) ("treated 10 μM MG132" 2) ("MG132-" 2)
   ("The proteasomal inhibitor MG132" 2)
   ("25 μM proteasomal inhibitor MG132" 2) ("Proteasomal inhibitor MG132" 1)
   ("mg132" 1) ("“dRad6-HA+MG132”" 1) ("than MG132" 1) ("-MG132" 1)))
 ("UP:Q9NXX6" (("NSE4a" 5))) ("UP:Q9NXZ1" (("SAGE" 252)))
 ("UP:Q9NXZ2"
  (("pHAGE" 38) ("the lentiviral expression vector pHAGE" 1)
   ("The lentiviral expression vector pHAGE" 1)))
 ("UP:Q9NY15" (("STAB1" 4) ("stab1" 1) ("stabilin 1" 1)))
 ("UP:Q9NY25" (("Clec5a" 5) ("CLEC5A" 3)))
 ("UP:Q9NY26" (("solute carrier family 39 (zinc transporter)" 2)))
 ("UP:Q9NY27" (("PPP4R2" 1))) ("UP:Q9NY30" (("BTG4" 2)))
 ("UP:Q9NY33" (("DPP3" 4) ("Dipeptidyl peptidase 3" 3)))
 ("UP:Q9NY46" (("SCN3A" 28))) ("UP:Q9NY47" (("CACNA2D2" 1)))
 ("UP:Q9NY57" (("STK32B" 1)))
 ("UP:Q9NY59"
  (("nSMase2" 209) ("overexpressed nSMase2" 4) ("smpd3" 3) ("NSMase2" 2)
   ("SMPD3" 1)))
 ("UP:Q9NY61"
  (("DED" 315) ("AATF" 254) ("DEDs" 115)
   ("apoptosis-antagonizing transcription factor" 3)
   ("DED (APGAAGGLARARSGLE)" 2)
   ("apoptosis antagonizing transcription factor" 2) ("DED protein" 2)
   ("nucleoplasmic endogenous AATF" 2)
   ("apoptosis antagonizing
transcription factor"
    1)
   ("the DED’s" 1) ("its incomplete DEDs" 1)
   ("harboring two highly homologous DEDs" 1)
   ("apoptosis antagonizing transcription factor ( AATF )" 1)
   ("their respective DEDs" 1) ("only one DED" 1) ("nearly all DEDs" 1)
   ("Apoptosis-antagonizing transcription factor" 1)
   ("apoptosis-antagonizing transcription factor (AATF)" 1)))
 ("UP:Q9NY65" (("TUBA8" 2))) ("UP:Q9NY97" (("B3GNT1" 1)))
 ("UP:Q9NYA1"
  (("SPHK1" 160) ("SphK1" 73) ("sphingosine kinase" 39) ("SphK" 30)
   ("sphingosine kinase 1" 25) ("SPK" 7) ("Sphingosine kinase 1" 6)
   ("Sphingosine kinase" 4) ("SPHK" 4) ("decidual SPHK1" 2) ("SPHK1 protein" 2)
   ("Sphingosine kinase-1" 2) ("SPHKs" 1) ("SPHK-1" 1) ("Sphk1" 1)))
 ("UP:Q9NYA4" (("MTMR4" 2)))
 ("UP:Q9NYB0"
  (("Rap1" 1472) ("Rap-1" 52) ("TERF2IP" 17) ("-TERF2IP" 13) ("hRap1" 9)
   ("Rap1-" 6) ("cellular Rap1" 2) ("Rap1 protein" 2)
   ("total activatable Rap1" 1) ("ice-cold 2x Rap1" 1) ("RAP-1" 1)
   ("membrane-associated Rap1" 1) ("this residual Rap1" 1)))
 ("UP:Q9NYB9" (("Abi-2" 6) ("ABI2" 2))) ("UP:Q9NYD6" (("HOXC10" 2)))
 ("UP:Q9NYF0"
  (("DACT1" 253) ("Dact1" 40) ("overexpressed DACT1" 6) ("Dact1 protein" 4)
   ("DACT1 protein" 4) ("Dapper1" 3) ("FRODO" 2) ("targeted DACT1" 2)
   ("Dpr1" 2)))
 ("UP:Q9NYF8"
  (("BCLAF1" 189) ("BTF" 4) ("BCLAF1-" 2) ("BclAF1" 1)
   ("sarcoma-associated herpes virus (KSHV) target BCLAF1" 1) ("BCLAF" 1)))
 ("UP:Q9NYG2" (("ZDHHC3" 3) ("DHHC 3" 1))) ("UP:Q9NYG5" (("ANAPC11" 9)))
 ("UP:Q9NYH9" (("UTP6" 2)))
 ("UP:Q9NYI0"
  (("pSD3" 12) ("PSD3" 5) ("Psd3" 3)
   ("Pleckstrin and Sec7 domain containing 3" 3)))
 ("UP:Q9NYJ7" (("delta3" 63) ("DLL3" 25) ("delta3-" 5) ("Delta3" 1)))
 ("UP:Q9NYJ8"
  (("TAB2" 315) ("MAP3K7IP2" 7) ("TAB2-" 3) ("MAP3K7IP2 protein" 2)
   ("mitogen-activated protein kinase kinase kinase 7 interacting protein 2" 2)
   ("targeting TAB2" 2) ("TAB2 protein" 2) ("TAB-2" 1) ("Tab2" 1) ("TAB 2" 1)))
 ("UP:Q9NYK1"
  (("TLR7" 145) ("TLR-7" 3) ("toll-like receptor 7" 3)
   ("Toll-like receptor-7" 3) ("Tlr7" 1) ("Toll-like receptor 7" 1)
   ("TLR7-" 1)))
 ("UP:Q9NYL2" (("MRK" 13) ("MLTK" 4) ("ZAK" 3)))
 ("UP:Q9NYL4" (("FKBP11" 11) ("FK506 binding protein 11" 2)))
 ("UP:Q9NYL5" (("Cyp39a1" 1))) ("UP:Q9NYM4" (("Gpr83" 2)))
 ("UP:Q9NYM9" (("BET1L" 11)))
 ("UP:Q9NYN1"
  (("RIS" 64) ("RIs" 26) ("RISs" 16) ("Both aberrant RIs" 2) ("unique RISs" 1)
   ("19,923 unique RIS" 1)))
 ("UP:Q9NYP7" (("ELOVL5" 9) ("ELOVL fatty acid elongase 5" 1)))
 ("UP:Q9NYP9" (("C21orf45" 1) ("C21Orf45" 1)))
 ("UP:Q9NYQ3" (("glycolate oxidase" 3) ("glycolate oxidase (GO)" 2)))
 ("UP:Q9NYQ7" (("CELSR" 3) ("Celsr" 1))) ("UP:Q9NYR8" (("RDH8" 2)))
 ("UP:Q9NYS7" (("WSB2" 2) ("WD repeat and SOCS box containing 2" 2)))
 ("UP:Q9NYT6" (("ZNF226" 1)))
 ("UP:Q9NYU2" (("UDP-glucose ceramide glucosyltransferase-like 1" 1)))
 ("UP:Q9NYV4"
  (("CDK12" 59) ("CDK1/2" 36) ("Cdk12" 30) ("Cdk1/2" 29) ("CRK7" 10)
   ("CRKRS" 6) ("pCDK1/2" 3) ("CDC2-related protein kinase 7" 3)
   ("the kinase-coding gene CDK12" 2) ("CDK1/2 that activates MYC's" 1)
   ("Overactive CDK1/2" 1) ("the associated Cdk1/2" 1)
   ("cyclin-dependent kinase 12" 1) ("arginine/serine-rich" 1)))
 ("UP:Q9NYV6"
  (("TIF-IA" 25) ("transcription initiation factor IA" 3) ("tifia" 2)))
 ("UP:Q9NYW0" (("TAS2R10" 3) ("Trb2" 1))) ("UP:Q9NYW4" (("TAS2R5" 1)))
 ("UP:Q9NYW5" (("TAS2R4" 1))) ("UP:Q9NYW6" (("TAS2R3" 1)))
 ("UP:Q9NYY1" (("IL-20" 24) ("IL20" 10) ("particular IL-20" 1)))
 ("UP:Q9NYY3"
  (("PLK2" 76) ("Plk2" 47) ("SNK" 11) ("Snk" 4) ("polo-like kinase 2" 4)
   ("Polo-like kinase 2" 2)))
 ("UP:Q9NYZ2" (("mitoferrin-1" 3) ("MFRN1" 2)))
 ("UP:Q9NYZ3" (("GTSE1" 13) ("B99" 2))) ("UP:Q9NYZ4" (("Siglec-8" 91)))
 ("UP:Q9NZ01"
  (("TER" 491) ("SC2" 36) ("a typical TER" 2) ("a characteristic TER" 2)
   ("than a typical TER" 1) ("the characteristic TER" 1)))
 ("UP:Q9NZ08"
  (("ERAP1" 188) ("endoplasmic reticulum aminopeptidase 1" 10)
   ("ERAP1 protein" 7) ("Endoplasmic reticulum aminopeptidase 1" 3)
   ("intense ERAP1" 2) ("the Australian and Norwegian ERAP1" 1)))
 ("UP:Q9NZ09" (("UBAP1" 5))) ("UP:Q9NZ20" (("group III" 29) ("Group III" 26)))
 ("UP:Q9NZ42" (("PSENEN" 3) ("PEN2" 2))) ("UP:Q9NZ43" (("Use1" 2)))
 ("UP:Q9NZ52"
  (("GGA3" 212) ("ARF binding protein 3" 6) ("GGA3 protein" 3)
   ("the first 298 amino acids of GGA3" 1)))
 ("UP:Q9NZ56"
  (("FMN2" 330) ("FMN2 protein" 52) ("exogenous FMN2 protein" 1) ("fmn2" 1)
   ("exogenous FMN2" 1) ("formin 2" 1)))
 ("UP:Q9NZ71"
  (("NHL" 941) ("RTEL1" 97) ("RTEL" 7) ("aggressive NHL" 6) ("RTEL1 protein" 2)
   ("The aggressive NHL" 2) ("relapsed NHL" 2) ("a rare NHL" 2) ("-NHL" 1)
   ("incident NHL" 1) ("high risk acute leukemia and stage IV NHL" 1)
   ("first primary NHL" 1) ("832 eligible NHL" 1) ("an aggressive NHL" 1)
   ("histologically confirmed incident NHL" 1) ("incident female NHL" 1)
   ("518 histologically confirmed incident NHL" 1)
   ("disseminated anaplastic lymphoma kinase (ALK)-negative anaplastic NHL"
    1)))
 ("UP:Q9NZ72" (("SCLIP" 132) ("STMN3" 6)))
 ("UP:Q9NZ81" (("TXR1" 48) ("proline rich 13" 3) ("PRR13" 2)))
 ("UP:Q9NZ94" (("NLGN3" 5) ("neuroligin 3" 2) ("NL3" 2)))
 ("UP:Q9NZA1" (("CLIC5" 2))) ("UP:Q9NZC2" (("TREM2" 2) ("Trem2" 1)))
 ("UP:Q9NZC3" (("miR16" 1)))
 ("UP:Q9NZC4"
  (("EHF" 25) ("ESE-3" 4) ("ETS homologous factor" 2) ("ESE3" 1)
   ("ets homologous factor" 1)))
 ("UP:Q9NZC7"
  (("WWOX" 453) ("WOX1" 125) ("Wwox" 20) ("WWOX protein" 11) ("p-WOX1" 3)
   ("–WWOX" 2) ("WW domain containing oxidoreductase" 2)
   ("overexpressed WOX1" 2) ("wwox" 1)))
 ("UP:Q9NZC9"
  (("SMARCAL1" 64) ("SMARCAL1 protein" 4) ("SMARCAL1 (HARP)" 1)
   ("the first 31 amino acids of SMARCAL1 ( xref ; xref ; xref ; xref ; xref )"
    1)))
 ("UP:Q9NZD1" (("GPRC5D" 6))) ("UP:Q9NZD4" (("ERAF" 2)))
 ("UP:Q9NZD8" (("SPG21" 2))) ("UP:Q9NZF1" (("PLAC8" 6)))
 ("UP:Q9NZG7" (("NINJ2" 5))) ("UP:Q9NZH0" (("GPRC5B" 2)))
 ("UP:Q9NZH6" (("Interleukin-23" 2))) ("UP:Q9NZH8" (("IL1F9" 5) ("Il1f9" 1)))
 ("UP:Q9NZI2" (("VABP" 1)))
 ("UP:Q9NZI5" (("NH32" 12) ("Grhl1" 4) ("GRHL1" 1) ("MGR" 1) ("mGR" 1)))
 ("UP:Q9NZI6" (("TFCP2L1" 12) ("Tfcp2L1" 4) ("LBP9" 1)))
 ("UP:Q9NZI7" (("LBP-1" 2) ("UBP1" 1)))
 ("UP:Q9NZI8"
  (("IMP1" 32) ("IGF2BP1" 13) ("CRD-BP" 3) ("Zipcode binding protein 1" 3)))
 ("UP:Q9NZJ0"
  (("Cdt2" 769) ("CDT2" 82) ("DCAF" 29) ("DTL" 13) ("Cdt2 protein" 10)
   ("L2DTL" 2) ("cdt2" 2) ("CUL4-associated factor (DCAF) CDT2" 1)
   ("this basal Cdt2" 1) ("exogenous siRNA-resistant Cdt2" 1)
   ("retinoic acid-regulated nuclear matrix-associated protein" 1)
   ("about five times more Cdt2 protein" 1) ("Cdt2-" 1)))
 ("UP:Q9NZJ5"
  (("PERK" 624) ("pERK" 25) ("p-PERK" 12) ("EIF2AK3" 8) ("P-PERK" 7) ("pErk" 6)
   ("Perk" 6) ("PERK protein" 4) ("PEK" 3)
   ("the ISR initiator and endoplasmic reticulum resident kinase PERK" 2)
   ("pPERK" 1) ("PERK-" 1)))
 ("UP:Q9NZJ7"
  (("MTCH1" 4)
   ("the pro-apoptotic mitochondrial outer membrane protein MTCH1" 3)))
 ("UP:Q9NZK5" (("ADA2" 3) ("candidate 1" 2) ("CECR1" 1)))
 ("UP:Q9NZK7" (("PLA2G2E" 16) ("group IIE" 4)))
 ("UP:Q9NZL3" (("ZNF224" 1) ("zinc finger protein 224" 1)))
 ("UP:Q9NZL4" (("HSPBP1" 1))) ("UP:Q9NZL6" (("RGL" 3) ("RGL1" 2) ("Rgl1" 2)))
 ("UP:Q9NZL9" (("MAT2B" 2)))
 ("UP:Q9NZM3"
  (("intersectin 2" 101) ("Intersectin 2" 21) ("SWAP" 16) ("SH3P18" 6)
   ("intersectin 2 protein" 5) ("ITSN2" 4)
   ("a previously reported partial cDNA designated SH3P18" 2)))
 ("UP:Q9NZM5"
  (("PICT1" 201) ("Pict1" 125) ("GLTSCR2" 6) ("PICT1-" 1) ("PICT1 protein" 1)
   ("exogenous Pict1" 1) ("expressed exogenous Pict1" 1) ("less PICT1" 1)))
 ("UP:Q9NZN1" (("MRX34" 5))) ("UP:Q9NZN3" (("EHD3" 10) ("ehd3" 1)))
 ("UP:Q9NZN4" (("EHD2" 50)))
 ("UP:Q9NZN5" (("LARG" 116) ("ARHGEF12" 12) ("leukemia-associated RhoGEF" 3)))
 ("UP:Q9NZN8" (("subunit 2" 42) ("CNOT2" 7) ("CCR4 associated factor 2" 1)))
 ("UP:Q9NZQ3"
  (("WISH" 203) ("SPIN90" 129) ("90 kDa" 52) ("SH3 protein" 16)
   ("WISH protein" 7) ("90 kDa" 7) ("90 kDa" 5) ("approximately 90 kDa" 3)
   ("overexpressed SPIN90" 2) ("DIP1" 2) ("90 kDa protein" 2) ("than WISH" 1)
   ("90
 kDa"
    1)
   ("SH3 protein interacting with Nck" 1) ("90 KDa" 1) ("around 90 kDa" 1)))
 ("UP:Q9NZQ7"
  (("PD-L1" 443) ("CD274" 126) ("PDL1" 46) ("B7-H1" 23) ("death ligand-1" 6)
   ("programmed death ligand 1" 4) ("PD-L1 protein" 3)
   ("programmed death ligand-1" 3) ("CD274 protein" 2)
   ("programmed cell death 1 ligand 1" 1) ("Cd274" 1) ("poor PD-L1" 1)
   ("polyvalent PD-L1" 1)
   ("post-transplant lymphoproliferative disorders (PTLD) expressed PD-L1" 1)
   ("the above-mentioned PD-L1" 1)
   ("only low-level 9p24.1 amplification expressed detectable cell surface PD-L1"
    1)
   ("EBV+ post-transplant lymphoproliferative disorders expressed detectable PD-L1"
    1)))
 ("UP:Q9NZQ9" (("actin-capping protein" 2)))
 ("UP:Q9NZR2" (("LRP1B" 10) ("Lrp1b" 5)))
 ("UP:Q9NZR4" (("visual system homeobox 1" 1)))
 ("UP:Q9NZU0"
  (("FLRT3" 35) ("targeting FLRT3" 3) ("FLRT3-" 2)
   ("Fibronectin leucine rich transmembrane protein 3" 2)))
 ("UP:Q9NZU5" (("LMCD1" 3) ("LIM and cysteine-rich domains protein 1" 2)))
 ("UP:Q9NZV1" (("CRIM1" 1))) ("UP:Q9NZV6" (("SEPX1" 2)))
 ("UP:Q9NZV8" (("pRK5" 19) ("KCND2" 2) ("Kv4.2" 1) ("RK5" 1)))
 ("UP:Q9NZW4"
  (("DPP" 97) ("DSPP" 33) ("Dpp" 15) ("dpp" 10)
   ("dentin sialophosphoprotein" 3) ("Dspp" 1) ("dentin sialoprotein" 1)))
 ("UP:Q9P031" (("BR22" 2)))
 ("UP:Q9P035"
  (("butyrate" 615) ("Butyrate" 45) ("butyrate (SB)" 7) ("-butyrate" 2)
   ("nicotinic acid or sodium butyrate" 1) ("butyrate-" 1)
   ("than butyrate" 1)))
 ("UP:Q9P0I2" (("TMEM111" 3) ("EMC3" 1)))
 ("UP:Q9P0J0"
  (("GRIM-19" 136) ("GRIM19" 4) ("overexpressed GRIM-19" 3)
   ("targeting GRIM-19" 3) ("NDUFA13" 2) ("Grim19" 1)))
 ("UP:Q9P0J1" (("PDP1" 1) ("PDP" 1)))
 ("UP:Q9P0J7"
  (("pCMF" 37) ("KCMF1" 5) ("FIGC" 2)
   ("non-hydrolysable phosphotyrosine analogue pCMF" 2) ("making pCMF" 1)))
 ("UP:Q9P0K1" (("ADAM22" 2))) ("UP:Q9P0K7" (("RAI14" 4)))
 ("UP:Q9P0K8" (("FOXJ2" 17) ("FoxJ2" 1)))
 ("UP:Q9P0L0" (("VAPA" 42) ("VAPA protein" 4)))
 ("UP:Q9P0L1" (("zinc finger protein 64" 2)))
 ("UP:Q9P0L2"
  (("MARK" 116) ("MARK1" 80) ("MARKs" 53) ("MARK-" 2) ("Mark1" 2)
   ("coexpressed MARKs" 2) ("p-MARK" 1) ("Par1c" 1) ("MARK-1" 1) ("PAR1c" 1)))
 ("UP:Q9P0M4" (("IL-17C" 12) ("CX2" 2))) ("UP:Q9P0M6" (("macroH2A2" 2)))
 ("UP:Q9P0N5" (("TMEM216" 1)))
 ("UP:Q9P0N9" (("TBC1D7" 170) ("total cellular TBC1D7" 2) ("more TBC1D7" 1)))
 ("UP:Q9P0R6" (("GSKIP" 8) ("GSK3B interacting protein" 1)))
 ("UP:Q9P0U1" (("TOM7" 2)))
 ("UP:Q9P0U3"
  (("SENP1" 381) ("Senp1" 14) ("SUMO1/sentrin specific peptidase 1" 2)
   ("overexpressed SENP1" 2)
   ("than SENP1 ( xref D, compare column 2, black bars with column 6, grey bars)"
    1)
   ("than SENP1" 1) ("than SENP1 ( xref )" 1) ("86-fold less SENP1" 1)
   ("7000-fold and 3200-fold more SENP1" 1)))
 ("UP:Q9P0U4"
  (("CpG" 4027) ("zinc finger" 932) ("Zinc finger" 130) ("CFP1" 33) ("UBZ" 27)
   ("CpG binding protein" 15) ("CpG-binding protein" 12) ("-CpG" 11) ("pCpG" 9)
   ("ubz" 8) ("zinc finger (UBZ)" 8) ("zinc finger (NZF)" 5)
   ("zinc finger (PLZF) protein" 4) ("PBZ" 4) ("CXXC1" 3)
   ("the last zinc finger" 3) ("CpG-" 2) ("hematopoietic zinc finger" 2)
   ("somatic CpG" 2) ("at least two CpG" 2) ("zinc finger ( PLZF ) protein" 2)
   ("ZINC finger" 2) ("zinc finger (PBZ)" 2) ("an intact zinc finger" 2)
   ("zinc finger peptide" 2) ("CpG (HCP)" 1) ("“CpG”" 1)
   ("hemi-methylated CpG" 1) ("a zinc finger’s" 1) ("the zinc finger’s" 1)
   ("zinc finger (ZF)" 1) ("the 12th and 13th zinc finger" 1)
   ("virtually every individual CpG" 1) ("the three major CpG" 1)
   ("CpG (ICP)" 1) ("The three most proximal CpG" 1) ("the 2nd zinc finger" 1)
   ("RING" 1) ("containing two consecutive CpG" 1)))
 ("UP:Q9P0V3" (("SH3BP4" 2))) ("UP:Q9P0W0" (("IFN-κ" 2)))
 ("UP:Q9P0W2"
  (("HMG20b" 280) ("HMG20b protein" 11) ("BRAF35" 5) ("HMG20B" 3) ("Hmg20b" 3)
   ("the cytokinetic regulator HMG20b" 1) ("Hmg20B" 1)))
 ("UP:Q9P0W5" (("SCHIP1" 6)))
 ("UP:Q9P0X4" (("CACNA1I" 7) ("alpha 1I subunit" 1)))
 ("UP:Q9P104" (("IRS 6" 6)))
 ("UP:Q9P121" (("NTM" 42) ("HNT" 5) ("neurotrimin" 3) ("HNt" 1)))
 ("UP:Q9P126" (("member B" 33) ("member B ( RGMB )" 1)))
 ("UP:Q9P1A6" (("DLGAP2" 13) ("disks large-associated protein 2" 1)))
 ("UP:Q9P1Q0" (("Vps54" 22)))
 ("UP:Q9P1Q5"
  (("family 1" 69) ("Family 1" 21) ("ras-associated domain family 1" 2)
   ("the consanguineous family 1" 2)))
 ("UP:Q9P1T7" (("HIC" 28) ("Hic" 2) ("HiC" 1))) ("UP:Q9P1U0" (("ZNRD1" 1)))
 ("UP:Q9P1W3" (("CSC1" 22) ("p-CSC1" 8) ("AG1478-treated CSC1" 1) ("CSC-1" 1)))
 ("UP:Q9P1W8" (("SIRPG" 1)))
 ("UP:Q9P1W9"
  (("PIM2" 140) ("Pim-2" 60) ("Pim2" 50) ("PIM-2" 28) ("pim2" 1) ("pim-2" 1)))
 ("UP:Q9P1Y5" (("nezha" 1)))
 ("UP:Q9P1Y6"
  (("KIAA1542" 10) ("PHRF1" 5) ("PHD and RING finger domains 1" 4)
   ("PHD and ring finger domains 1" 1)))
 ("UP:Q9P1Z0" (("ZBTB4" 8) ("Zbtb4" 1)))
 ("UP:Q9P1Z2" (("CALCOCO1" 6) ("CalCoCo1" 1))) ("UP:Q9P209" (("CEP72" 9)))
 ("UP:Q9P212"
  (("PLCE1" 655) ("phospholipase C epsilon 1" 18) ("PLCE1 protein" 15)
   ("Phospholipase C epsilon 1" 11) ("PLCε1" 10) ("pPLC" 10) ("NPHS3" 7)
   ("“PLCE1”" 3) ("“Phospholipase C epsilon 1”" 2) ("”" 1) ("PLCE" 1)
   ("Plce1" 1)))
 ("UP:Q9P218" (("COL20A1" 1))) ("UP:Q9P219" (("DAPPLE" 27)))
 ("UP:Q9P227" (("ARHGAP23" 3)))
 ("UP:Q9P232" (("Pang" 15) ("BIG 1" 10) ("Big1" 3) ("PANG" 1)))
 ("UP:Q9P242" (("NYAP2" 2) ("KIAA1486" 1)))
 ("UP:Q9P243" (("ZFAT1" 7) ("Zfat" 3)))
 ("UP:Q9P246" (("STIM2" 15) ("Stim2" 2))) ("UP:Q9P253" (("pep3" 1) ("Pep3" 1)))
 ("UP:Q9P255" (("zinc finger protein 492" 3) ("ZNF492" 1)))
 ("UP:Q9P258"
  (("RCC2" 237) ("TD-60" 177) ("RCC2-" 7) ("overexpressed RCC2" 2)
   ("TD-60 protein" 1)))
 ("UP:Q9P267" (("MBD5" 4))) ("UP:Q9P275" (("USP36" 3)))
 ("UP:Q9P278" (("FNIP2" 5) ("FNIPL" 1))) ("UP:Q9P283" (("SEMA5B" 1)))
 ("UP:Q9P287"
  (("BCCIP" 77) ("TOK1" 2) ("the BRCA2-associated protein BCCIP" 1)))
 ("UP:Q9P289"
  (("MST4" 116) ("MASK" 4) ("Mst4" 3) ("miR-4728-3p directly targets MST4" 1)))
 ("UP:Q9P2A4" (("ABI3" 3) ("Nesh" 1))) ("UP:Q9P2B2" (("FPRP" 151)))
 ("UP:Q9P2B4" (("CTTNBP2NL" 2))) ("UP:Q9P2B7" (("HMW" 97) ("HMW protein" 5)))
 ("UP:Q9P2D0"
  (("NB4" 434) ("IBTK" 82) ("IBtk" 61)
   ("inhibitor of Bruton tyrosine kinase" 1) ("leukemic cell lines NB4" 1)
   ("etoposide-treated NB4" 1) ("NSC606985-treated NB4" 1)))
 ("UP:Q9P2D1" (("CHD7" 45) ("IS3" 7) ("Chd7" 1)))
 ("UP:Q9P2D3" (("KIAA1414" 4) ("HEATR5B" 1))) ("UP:Q9P2E2" (("KIF17" 6)))
 ("UP:Q9P2E3" (("ZNFX1" 2)))
 ("UP:Q9P2E7"
  (("Pcdh10" 185) ("PCDH10" 2) ("protocadherin 10" 2) ("Pcdh10 protein" 2)
   ("Protocadherin 10" 1)))
 ("UP:Q9P2F6"
  (("ARHGAP20" 3) ("ArhGAP20" 2) ("Rho GTPase activating protein 20" 1)))
 ("UP:Q9P2G3" (("KLHL14" 6))) ("UP:Q9P2G4" (("mTrs120" 4)))
 ("UP:Q9P2H0" (("KIAA1377" 1)))
 ("UP:Q9P2I0" (("100kDa" 4) ("CPSF-100" 2) ("100KDa" 1) ("CPSF100" 1)))
 ("UP:Q9P2J3" (("KIAA1354" 2)))
 ("UP:Q9P2J5"
  (("leucyl-tRNA synthetase" 8) ("LARS" 5) ("Leucyl-tRNA synthetase" 1)))
 ("UP:Q9P2J9"
  (("protein phosphatase 2C" 6) ("magnesium-dependent" 4) ("PDP2" 4)
   ("magnesium dependent" 1)))
 ("UP:Q9P2K1"
  (("type 6" 12) ("MKS6" 5) ("Mks6" 4) ("CC2D2A" 3) ("Meckel syndrome" 3)
   ("the apical membrane calcium channel transient receptor potential vanilloid type 6"
    2)
   ("Type 6" 2) ("type 6" 1)))
 ("UP:Q9P2K3" (("RCOR3" 2))) ("UP:Q9P2K5" (("MEF-2" 3)))
 ("UP:Q9P2K6" (("KLHDC5" 1)))
 ("UP:Q9P2K8"
  (("GCN2" 300) ("Gcn2" 9) ("GCN2-" 4) ("exogenous GCN2" 2)
   ("GCN2 that regulate GCN2's" 1)))
 ("UP:Q9P2L0" (("WDR35" 1))) ("UP:Q9P2M4" (("TBC1D14" 5)))
 ("UP:Q9P2M7"
  (("CGNs" 141) ("pCGN" 58) ("CGN" 51) ("cingulin" 36) ("LK-treated CGNs" 8)
   ("Cingulin" 6) ("mature CGNs" 3) ("immature CGNs" 3) ("LK-treated CGN" 1)
   ("the junctional adaptor cingulin" 1) ("pCGN-" 1)))
 ("UP:Q9P2N4" (("ADAMTS9" 17) ("Adamts9" 1)))
 ("UP:Q9P2N6" (("si1" 35) ("Si1" 8) ("Rcd1" 1))) ("UP:Q9P2N7" (("KLHL13" 1)))
 ("UP:Q9P2P5" (("NEDL2" 3)))
 ("UP:Q9P2P6"
  (("STARD9" 227) ("STARD9 protein" 3)
   ("the first 387 amino acids of STARD9" 1) ("STARD9-" 1)))
 ("UP:Q9P2Q2" (("Frmd4a" 1)))
 ("UP:Q9P2R3"
  (("Rabankyrin-5" 189) ("Ankhzn" 5) ("Rabankyrin-5–" 3) ("ANKFY1" 3)
   ("-Rabankyrin-5" 1) ("the peripheral enlarged Rabankyrin-5" 1)))
 ("UP:Q9P2R6" (("RERE" 4))) ("UP:Q9P2R7" (("SUCLA2" 1)))
 ("UP:Q9P2T0" (("theG" 3)))
 ("UP:Q9P2U7"
  (("vGluT1" 15) ("the synaptic vesicle marker vGluT1" 2) ("VGlut1" 2)
   ("vesicular glutamate transporter 1" 1) ("vGlut1" 1)
   ("presynaptic marker vGluT1" 1)))
 ("UP:Q9P2W1" (("Hop2" 4)))
 ("UP:Q9P2W7"
  (("CD57" 28) ("HNK-1" 15) ("GlcAT-P" 10) ("NK-1" 2) ("hNK-1" 2)
   ("the senescence-associated marker CD57" 1)))
 ("UP:Q9P2X3" ; removed lowercase
  (#+ignore("impact" 9599) #+ignore("Impact" 431) #+ignore("the prognostic impact" 175) ("IMPACT" 85)
   ("the potential impact" 48) ("the biological impact" 47)
   ("a profound impact" 38) ("the possible impact" 35) ("prognostic impact" 30)
   ("Prognostic impact" 25) ("a strong impact" 24) ("minimal impact" 22)
   ("The prognostic impact" 22) ("no prognostic impact" 18)
   ("a dramatic impact" 15) ("a prognostic impact" 14) ("a modest impact" 12)
   ("the strong impact" 10) ("a minimal impact" 10) ("a potential impact" 9)
   ("more impact" 9) ("its prognostic impact" 9) ("a considerable impact" 9)
   ("a significant prognostic impact" 9) ("the global impact" 9)
   ("a possible impact" 8) ("the adverse impact" 8)
   ("their prognostic impact" 8) ("the negative prognostic impact" 8)
   ("the relative impact" 6) ("profound impact" 6) ("potential impact" 6)
   ("a favorable prognostic impact" 6) ("the subsequent impact" 6)
   ("the actual impact" 6) ("larger impact" 6) ("less impact" 6)
   ("its biological impact" 5) ("the poor prognostic impact" 5)
   ("a severe impact" 4) ("no obvious impact" 4) ("No prognostic impact" 4)
   ("a tremendous impact" 4) ("The dramatic impact" 4)
   ("a negative prognostic impact" 4) ("wider impact" 4)
   ("the profound impact" 4) ("favorable prognostic impact" 4)
   ("modest impact" 4) ("The potential impact" 4) ("a favorable impact" 4)
   ("the dual impact" 4) ("no discernible impact" 4) ("possible impact" 4)
   ("the simultaneous impact" 4) ("no discernable impact" 4)
   ("the significant prognostic impact" 3) ("their potential impact" 3)
   ("a huge impact" 3) ("an independent prognostic impact" 3)
   ("a negligible impact" 3) ("considerable impact" 3)
   ("INTRODUCTION TRANSLATIONAL IMPACT" 3) ("a noticeable impact" 3)
   ("the cooperative impact" 3) ("an immediate impact" 3) ("whose impact" 3)
   ("the detrimental impact" 3) ("the predictive impact" 3)
   ("a strong prognostic impact" 3) ("the favorable prognostic impact" 3)
   ("a more profound impact" 3) ("the adverse prognostic impact" 3)
   ("a global impact" 3) ("largest impact" 3) ("an adverse impact" 3)
   ("the pathogenic impact" 3) ("its potential impact" 3)
   ("phenotypical impact" 3) ("the modest impact" 3)
   ("the independent prognostic impact" 3) ("the combined prognostic impact" 3)
   ("The biological impact" 3) ("biological impact" 3) ("The strong impact" 3)
   ("an unfavorable impact" 3) ("-impact" 3) ("the collective impact" 3)
   ("negative prognostic impact" 3) ("their biological impact" 2)
   ("a differential prognostic impact" 2) ("the most impact" 2)
   ("stronger prognostic impact" 2) ("a synergistic impact" 2)
   ("its possible impact" 2) ("a relevant prognostic impact" 2)
   ("a clear prognostic impact" 2) ("a meaningful impact" 2)
   ("Global impact" 2) ("about prognostic impact" 2)
   ("an unfavourable impact" 2) ("controlled cortical impact" 2)
   ("the precise impact" 2) ("The synergistic impact" 2)
   ("negligible impact" 2) ("The specific phenotypic impact" 2)
   ("the economic impact" 2) ("the quantitative and qualitative impact" 2)
   ("subsequent impact" 2) ("the clear-cut prognostic impact" 2)
   ("limited prognostic impact" 2) ("biggest impact" 2)
   ("a single blunt impact" 2) ("had no prognostic impact" 2)
   ("an adverse prognostic impact" 2) ("a more severe impact" 2)
   ("The negative prognostic impact" 2) ("the potential prognostic impact" 2)
   ("the phenotypic impact" 2) ("translational impact" 2)
   ("the prognostic and predictive impact" 2)
   ("a substantial antagonistic impact" 2) ("a favourable impact" 2)
   ("potential prognostic impact" 2) ("The site-specific prognostic impact" 2)
   ("The poor prognostic impact" 2) ("a variable prognostic impact" 2)
   ("its phenotypic impact" 2) ("strong impact" 2)
   ("chemosensitizing impact" 2) ("adverse impact" 2)
   ("c-Rel prognostic impact" 2) ("The favourable prognostic impact" 2)
   ("significant prognostic impact" 2) ("its clinicopathological impact" 2)
   ("a physiological coherent impact" 2) ("the possible prognostic impact" 2)
   ("study prognostic impact" 2) ("the pathological impact" 2)
   ("the favorable impact" 2) ("the Global Impact" 2)
   ("the potential adverse prognostic impact" 2)
   ("MAPK phosphorylation TRANSLATIONAL IMPACT" 2) ("pathogenic impact" 2)
   ("Cumulative impact" 2) ("an emotional impact" 2) ("a detrimental impact" 2)
   ("an appreciable impact" 2) ("predictive impact" 2)
   ("the translational impact" 2)
   ("PgR-/p-Akt Ser 473 + phenotype showed less favorable impact" 2)
   ("strong adverse impact" 2) ("opposite prognostic impact" 2)
   ("different prognostic impact" 2) ("less favorable impact" 2)
   ("strong unfavorable impact" 2) ("the major behavioral impact" 2)
   ("The strong adverse prognostic impact" 2) ("the full biological impact" 2)
   ("the consistent significant negative prognostic impact" 2)
   ("the immediate impact" 2) ("a high prognostic impact" 2)
   ("Biologic impact" 2) ("its independent prognostic impact" 2)
   ("the conclusive impact" 2) ("The translational impact" 2)
   ("a consequent impact" 1) ("the obvious impact" 1)
   ("a specific and independent prognostic impact" 1)
   ("The high prognostic impact" 1) ("probable impact" 1)
   ("the beneficial prognostic impact" 1)
   ("The beneficial prognostic impact" 1) ("the psychological impact" 1)
   ("a less impact" 1) ("any additional prognostic impact" 1)
   ("revealed no obvious impact" 1) ("an unequivocal prognostic impact" 1)
   ("disparate prognostic impact" 1) ("transgenerational impact" 1)
   ("favorable impact" 1) ("consequent impact" 1) ("a predictable impact" 1)
   ("the considered prognostic impact" 1) ("the conformational impact" 1)
   ("the mechanical impact" 1) ("their respective impact" 1)
   ("obvious impact" 1) ("stronger pathophysiological impact" 1)
   ("clinically relevant impact" 1) ("strong prognostic impact" 1)
   ("a marginal impact" 1) ("a relevant impact" 1) ("any relevant impact" 1)
   ("its prognostic and predictive impact" 1)
   ("the diagnostic and therapeutic impact" 1) ("an indirect impact" 1)
   ("the true prognostic impact" 1) ("the interactive impact" 1)
   ("The previously described prognostic impact" 1)
   ("the potential biological impact" 1) ("its social impact" 1)
   ("xref others noted no significant prognostic impact" 1)
   ("an obvious impact" 1) ("a diagnostic impact" 1)
   ("a cell-autonomous impact" 1) ("a different predictive impact" 1)
   ("no profound impact" 1) ("substantially less impact" 1) ("a mild impact" 1)
   ("a very mild impact" 1) ("tremendous impact" 1) ("a more subtle impact" 1)
   ("a long lasting adverse and psychological impact" 1)
   ("had minimal impact" 1) ("the same biological impact" 1)
   ("The potential translational impact" 1)
   ("had statistically significant prognostic impact" 1) ("far less impact" 1)
   ("a major prognostic impact" 1) ("a serious impact" 1) ("smallest impact" 1)
   ("clinical prognostic impact" 1)
   ("a significant reproductive and metabolic impact" 1)
   ("high potential impact" 1) ("neutral impact" 1) ("a definitive impact" 1)
   ("the in vivo phenotypic and functional impact" 1)
   ("any prognostic impact" 1) ("possible biological impact" 1)
   ("a greater phenotypic impact" 1) ("the suppressive impact" 1)
   ("less dramatic impact" 1) ("a neutral impact" 1)
   ("viruses cause substantial ophthalmic impact" 1)
   ("The unfavorable impact" 1) ("significant translational impact" 1)
   ("the plausible impact" 1) ("this favorable prognostic impact" 1)
   ("the mutational impact" 1) ("had no evident impact" 1)
   ("no noticeable impact" 1) ("a limited prognostic impact" 1)
   ("a revolutionary impact" 1) ("the pivotal impact" 1)
   ("consecutive impact" 1) ("a much greater biological impact" 1)
   ("a pathophysiological impact" 1) ("their possible impact" 1)
   ("the subtle impact" 1) ("a distinct prognostic impact" 1)
   ("lesser prognostic impact" 1) ("imply no prognostic impact" 1)
   ("strongest prognostic impact" 1) ("phenotypic impact" 1)
   ("A potential impact" 1) ("The economic impact" 1)
   ("the frequent psychological impact" 1) ("had no discernable impact" 1)
   ("The Prognostic impact" 1) ("the quantitative impact" 1)
   ("worse prognostic impact" 1) ("significantly prognostic impact" 1)
   ("Viral impact" 1) ("viral impact" 1)
   ("A potential adverse prognostic impact" 1) ("its precise impact" 1)
   ("The respective biological impact" 1) ("relevant impact" 1)
   ("an enormous impact" 1) ("a much more profound impact" 1)
   ("its adverse impact" 1) ("independent prognostic impact" 1)
   ("The estimated economic impact" 1) ("no dramatic impact" 1)
   ("its consequent impact" 1) ("The actual impact" 1)
   ("a more immediate impact" 1) ("some potential impact" 1)
   ("the potential translational impact" 1) ("an undue impact" 1)
   ("an immediate profound impact" 1) ("marginal impact" 1)
   ("some synergistic impact" 1) ("its favourable impact" 1)
   ("a significant detrimental impact" 1) ("The adverse impact" 1)
   ("an essential impact" 1) ("far-reaching impact" 1)
   ("the predicted steric impact" 1) ("no appreciable impact" 1)
   ("residual impact" 1) ("the biologic impact" 1) ("The exact impact" 1)
   ("synergistic impact" 1) ("a strikingly discordant impact" 1)
   ("the cytostatic impact" 1) ("its relative impact" 1)
   ("greater relative impact" 1) ("the possible psychological impact" 1)
   ("its resultant impact" 1) ("a profound negative prognostic impact" 1)
   ("the 
global impact"
    1)
   ("a significant negative prognostic impact" 1)
   ("predictive and prognostic impact" 1) ("a tangible impact" 1)
   ("the predictive
                impact"
    1)
   ("a cumulative impact" 1) ("a greater biologic impact" 1)
   ("its profound impact" 1) ("Only minimal impact" 1) ("very modest impact" 1)
   ("any possible impact" 1) ("some biological impact" 1)
   ("The emotional impact" 1) ("the favourable impact" 1)
   ("the most clinically relevant impact" 1) ("the resultant impact" 1)
   ("the comparative impact" 1) ("a potential “negative” impact" 1)
   ("such a dramatic impact" 1) ("any meaningful impact" 1)
   ("as well predictive impact" 1) ("relatively less impact" 1)
   ("a strong unfavorable impact" 1) ("Such prognostic impact" 1)
   ("gender-dependent impact" 1) ("significant economic impact" 1)
   ("a cumulative detrimental impact" 1) ("a neglible impact" 1)
   ("unfavourable impact" 1) ("The adverse prognostic impact" 1)
   ("adverse prognostic impact" 1) ("the minimal impact" 1)
   ("The minimal impact" 1) ("a greater biological impact" 1)
   ("the long-term psychological impact" 1) ("an immune-mediated impact" 1)
   ("a quantitative impact" 1) ("the stimulatory impact" 1)
   ("the worldwide impact" 1) ("the overall global impact" 1)
   ("the emerging global impact" 1) ("optimal impact" 1)
   ("a dissymmetrical impact" 1) ("only marginal impact" 1)
   ("a benign impact" 1) ("no independent prognostic impact" 1)
   ("Both TP53 mutation status and gene expression subgroups demonstrated strong prognostic impact"
    1)
   ("vital impact" 1) ("any possible prognostic impact" 1)
   ("an independent predictive impact" 1) ("The potential prognostic impact" 1)
   ("pothential pathogenetic and clinical impact" 1)
   ("potential pathogenetic and clinical impact" 1)
   ("an estimated collective impact" 1) ("the respective impact" 1)
   ("great therapeutical impact" 1) ("its cell autonomous impact" 1)
   ("a distinct cell nonautonomous impact" 1)
   ("the same negative prognostic impact" 1)
   ("prognostic, and predictive impact" 1) ("a poor prognostic impact" 1)
   ("reported different prognostic impact" 1)
   ("the actual prognostic impact" 1) ("severe impact" 1)
   ("the exact impact" 1) ("its associated impact" 1)
   ("a markedly less severe impact" 1) ("slightly more robust impact" 1)
   ("no additional prognostic impact" 1) ("The precise impact" 1)
   ("a biological impact" 1) ("destructive impact" 1)
   ("than the collective impact" 1) ("a mouse model showed minimal impact" 1)
   ("the predictive and prognostic impact" 1)
   ("its negative prognostic impact" 1)))
 ("UP:Q9P2X7" (("Dec1" 9))) ("UP:Q9P2Y4" (("ZNF219" 4)))
 ("UP:Q9P2Y5"
  (("UVRAG" 313) ("UVRAG protein" 3) ("Vps34-associated UVRAG" 1)
   ("in turn lets UVRAG" 1) ("Uvrag" 1) ("Exogenous UVRAG" 1)
   ("further implicating UVRAG" 1)))
 ("UP:Q9P7J8" (("Gad8" 102) ("gad8" 20)))
 ("UP:Q9P885" (("CArG" 30) ("c-Arg" 1))) ("UP:Q9P8V0" (("Rho4" 1)))
 ("UP:Q9P8W3" (("ACEi" 1)))
 ("UP:Q9PT60" (("RLIP" 13) ("Rlip(RBD)" 6) ("Rlip" 3)))
 ("UP:Q9PT63" (("XMAP215" 15) ("XMAP215 protein" 3)))
 ("UP:Q9PTG8" (("Maskin" 3))) ("UP:Q9PTH3" (("IGFBP-2a" 40) ("igfbp-2a" 22)))
 ("UP:Q9PTN2" (("VDRA" 5))) ("UP:Q9PTQ4" (("UI" 59)))
 ("UP:Q9PTU5" (("cerb" 3) ("Cerb" 2) ("cErb" 1))) ("UP:Q9PU13" (("Spy1A" 2)))
 ("UP:Q9PVE4"
  (("TRβ1" 178) ("TRβ" 97) ("TRB" 4) ("thyroid hormone receptor-beta1" 2)))
 ("UP:Q9PVW8" (("RBL" 5) ("rbl" 2) ("pRBL" 2))) ("UP:Q9PWM6" (("HoxD9" 1)))
 ("UP:Q9PX69" (("Protein B1" 1))) ("UP:Q9QM72" (("endoprotease" 29)))
 ("UP:Q9QR69" (("NFAT/AP1" 2))) ("UP:Q9QSP4" (("nucleo-protein" 7)))
 ("UP:Q9QUH0" (("GLRX1" 1))) ("UP:Q9QVY3" (("Sar1" 9)))
 ("UP:Q9QXE4" (("Trp53inp1" 2))) ("UP:Q9QXG4" (("AceCS1" 9)))
 ("UP:Q9QXK9" (("RIBP" 7))) ("UP:Q9QXT9" (("ZFP354B" 3)))
 ("UP:Q9QXV1" (("MPC3" 17))) ("UP:Q9QXZ6" (("OATP-1" 3)))
 ("UP:Q9QY24"
  (("IFN-regulatory factors (IRF)" 2) ("IFN-regulatory factors" 1)))
 ("UP:Q9QYM5" (("RhoN" 11))) ("UP:Q9QYN5" (("rCD" 12)))
 ("UP:Q9QYR7" (("Acot3" 1))) ("UP:Q9QYW3" (("KL1" 2)))
 ("UP:Q9QZA1" (("PQR" 15))) ("UP:Q9QZK2" (("AND-34" 1)))
 ("UP:Q9R002" (("Ifi202" 1))) ("UP:Q9R016" (("NAIP5" 1)))
 ("UP:Q9R1S4" (("HTF" 4) ("pHTF" 1))) ("UP:Q9R210" (("Tcfeb" 5)))
 ("UP:Q9R237" (("JRP" 3))) ("UP:Q9R708" (("katA" 1)))
 ("UP:Q9RI12"
  (("protein kinase A" 270) ("protein kinase A (PKA)" 31)
   ("Protein kinase A" 10) ("e.g. cAMP-dependent protein kinase A" 2)
   ("-protein kinase A" 1)))
 ("UP:Q9RMZ4" (("reps" 4))) ("UP:Q9RPP2" (("pEEP" 6) ("EEP" 3)))
 ("UP:Q9RUW8" (("RSR" 85))) ("UP:Q9S1G8" (("SERD" 13)))
 ("UP:Q9S3K0" (("SOTA" 1)))
 ("UP:Q9S3Z2" (("O-acyltransferase activity" 2) ("O-acyltransferase" 2)))
 ("UP:Q9S5E2" (("dois" 3))) ("UP:Q9S746" (("HTH" 14) ("Hth" 3)))
 ("UP:Q9S775" (("chr6" 23) ("Chr6" 6)))
 ("UP:Q9S7C9"
  (("ESC" 517) ("Esc" 169) ("pESC" 15) ("EsC" 15) ("than all-L Esc(1-21)" 3)
   ("Esc(1-21) peptide" 2) ("ESC (ATCC)" 2) ("esc" 1)
   ("two independent Trim33-null ESC" 1)))
 ("UP:Q9S7H4"
  (("cm 2" 1017) ("CM2" 36) ("cm2" 30) ("CM 2" 10) ("cm²" 3)
   ("reached 0.6 cm 2" 1) ("each roughly 1–3 cm 2" 1) ("than 0.25 cm 2" 1)
   ("than 1.5 cm 2" 1) ("6-well 10 cm 2" 1) ("Approximately 1–3 cm 2" 1)))
 ("UP:Q9S7H8" (("Sid2" 1))) ("UP:Q9S7I0" (("TadA" 1)))
 ("UP:Q9S7I2" (("Air1" 1)))
 ("UP:Q9S7Q7"
  (("FLC" 151) ("circular muscle PDGFRα-ir FLC" 2)
   ("PDGFRα-immunoreactive (ir) FLC" 1)))
 ("UP:Q9S7U0" (("MIPS" 2))) ("UP:Q9S7W5" (("PTF1" 7) ("Ptf1" 1)))
 ("UP:Q9S7X6" (("TKV" 1))) ("UP:Q9S7Z8" (("PIN3" 122)))
 ("UP:Q9S850" (("Sox" 75) ("SOX" 61) ("Sox protein" 14) ("sox" 9)))
 ("UP:Q9SA27" (("RH36" 3))) ("UP:Q9SAF1" (("Dis1" 1)))
 ("UP:Q9SAK2" (("KSB" 1))) ("UP:Q9SB48" (("AR1" 11))) ("UP:Q9SB50" (("CLH" 6)))
 ("UP:Q9SB60" (("IPT4" 3))) ("UP:Q9SBJ1" (("PDK" 32)))
 ("UP:Q9SCS6" (("HR4" 5))) ("UP:Q9SCS7" (("h-R3" 22) ("HR3" 4)))
 ("UP:Q9SCS8" (("HR2" 27)))
 ("UP:Q9SCY0"
  (("PGM" 145) ("Ion Torrent PGM" 4) ("ion-torrent PGM" 2)
   ("Ion-Torrent PGM" 2) ("pPGM" 2) ("the Ion Torrent PGM" 1)))
 ("UP:Q9SD40" (("Sty1" 2))) ("UP:Q9SDN0" (("J20" 9)))
 ("UP:Q9SDW9"
  (("BSs" 153) ("potential p53 BSs" 4) ("many 'real' p53 BSs" 2)
   ("approximately two million putative p53 BSs" 1)
   ("~400,000 potential p53 BSs" 1)))
 ("UP:Q9SE43" (("rev" 483) ("-rev" 30) ("a fully functional rev" 1)))
 ("UP:Q9SF40"
  (("L1s" 40) ("Overexpressed HA-UCH L1s" 2)
   ("about 90 retrotransposition-competent L1s" 1) ("many new L1s" 1)
   ("all known intact L1s" 1)))
 ("UP:Q9SF47" (("PAH1" 10))) ("UP:Q9SHH0" (("CAT8" 1)))
 ("UP:Q9SI18" (("AT8" 72) ("the canonical AT8" 2)))
 ("UP:Q9SI56" (("TET1-3" 1))) ("UP:Q9SI85" (("PND4" 4)))
 ("UP:Q9SI96" (("HTB3" 4))) ("UP:Q9SIH2" (("Dot1" 3) ("DOT1" 1)))
 #+ignore("UP:Q9SIW2" ; added new chromatin def
  (("chromatin" 17706) ("Chromatin" 1179) ("telomeric chromatin" 49)
   ("repressive chromatin" 39) ("local chromatin" 33) ("CHROMATIN" 30)
   ("Soluble chromatin" 16) ("chromatin-" 16) ("silent chromatin" 14)
   ("mitotic chromatin" 14) ("dense chromatin" 13) ("cellular chromatin" 12)
   ("soluble chromatin" 12) ("chromatin protein" 10) ("nucleolar chromatin" 10)
   ("viral chromatin" 8) ("distinct chromatin" 7) ("DSB-proximal chromatin" 7)
   ("nascent chromatin" 6) ("permissive chromatin" 6)
   ("human telomeric chromatin" 6) ("the dense chromatin" 6)
   ("transcriptionally silent chromatin" 5) ("epigenetic chromatin" 5)
   ("Insoluble chromatin" 5) ("subsequent chromatin" 5)
   ("The soluble chromatin" 5) ("insoluble chromatin" 5)
   ("UV-damaged chromatin" 4) ("vesicular chromatin" 4)
   ("pericentromeric chromatin" 4) ("intact chromatin" 4)
   ("the repressive chromatin" 4) ("aberrant chromatin" 4)
   ("the soluble chromatin" 4) ("the local chromatin" 4)
   ("a repressive chromatin" 4) ("dynamic chromatin" 3)
   ("the permissive chromatin" 3) ("perinuclear chromatin" 3)
   ("extensive chromatin" 3) ("ribosomal chromatin" 3) ("regional chromatin" 3)
   ("senescence-associated chromatin" 3) ("the genome-wide chromatin" 3)
   ("little visible chromatin" 3) ("similarly open compacted chromatin" 3)
   ("competent chromatin" 2) ("maximal chromatin" 2) ("post-UV chromatin" 2)
   ("optimal UV-induced chromatin" 2)
   ("transcriptionally repressive chromatin" 2) ("immature chromatin" 2)
   ("Global chromatin" 2) ("A Bioruptor generated soluble chromatin" 2)
   ("global chromatin" 2) ("targeted chromatin" 2) ("genome-wide chromatin" 2)
   ("lamin-associated chromatin" 2) ("accessible chromatin" 2)
   ("accessible or repressive chromatin" 2)
   ("a well-characterized chromatin" 2) ("less pRPA32 chromatin" 2)
   ("euchromatic and hyperacetylated chromatin" 2) ("chromatin (DPC)" 2)
   ("“Chromatin”" 2) ("the ribosomal chromatin" 2) ("coarse chromatin" 2)
   ("PTEN-dependent chromatin" 2) ("the latter facilitating chromatin" 2)
   ("optimal chromatin" 2) ("Dynamic Chromatin" 2)
   ("both the crude chromatin" 2) ("promoters facilitated local chromatin" 2)
   ("nucleosomal chromatin" 2) ("Telomeric Chromatin" 2)
   ("the sheared soluble chromatin" 2) ("peripheral chromatin" 2)
   ("DNA methylation forms repressive chromatin" 2)
   ("mark pericentric chromatin" 2) ("the intact chromatin" 2)
   ("structural chromatin" 2) ("a SWI/SNF-related chromatin" 2)
   ("normal chromatin" 2) ("the unique chromatin" 2) ("abnormal chromatin" 2)
   ("the efficient chromatin" 2) ("previously condensed chromatin" 2)
   ("Specific repressive chromatin" 2)
   ("the P2p73 promoter undergoes substantial chromatin" 2)
   ("no extensive chromatin" 2) ("universal chromatin" 2)
   ("GR-induced dynamic chromatin" 2)
   ("Quantitative analysis MCP1-immunoprecipitated chromatin" 2)
   ("proper chromatin" 2) ("silent telomeric chromatin" 2)
   ("Co-precipitated chromatin" 2) ("the less-soluble dense chromatin" 2)
   ("150 mM NaCl-extractable chromatin" 2)
   ("a ChIP-on-ChIP approach wherein samples chromatin" 2)
   ("50 known and putative chromatin" 2) ("'bivalent' chromatin" 2)
   ("restrictive chromatin" 2) ("Permissive chromatin" 2)
   ("the detergent-insoluble chromatin" 2) ("the pericentromeric chromatin" 2)
   ("reaction-sheared chromatin" 2)
   ("transcriptional elongation (green) chromatin" 1)
   ("well-established chromatin" 1)
   ("this phenomenon further and identified chromatin" 1)
   ("the homogenous chromatin" 1) ("heterochromatic chromatin" 1)
   ("the entire chromatin" 1) ("transcriptionally competent chromatin" 1)
   ("the 15 functional chromatin" 1) ("histone H4-associated chromatin" 1)
   ("The resultant chromatin" 1)
   ("newly synthesized chromatin called nascent chromatin" 1)
   ("global and nascent chromatin" 1) ("phospho-H3S10-bound chromatin" 1)
   ("CS-MKP-1-bound chromatin" 1) ("several nucleolar chromatin" 1)
   ("sonicated nucleolar chromatin" 1)
   ("CTCF-associated higher-order chromatin" 1) ("its adjacent chromatin" 1)
   ("a distinct chromatin" 1)
   ("repressive
chromatin"
    1)
   ("YAP1 associated chromatin" 1) ("three-dimensional chromatin" 1)
   ("making chromatin" 1) ("the silent chromatin" 1)
   ("the dynamic chromatin" 1) ("other silent chromatin" 1)
   ("the perinuclear chromatin" 1) ("DSB-associated chromatin" 1)
   ("damage-proximal chromatin" 1)
   ("macroH2A1 and H3K9me2 repressive chromatin" 1)
   ("DSB-proximal repressive chromatin" 1) ("other repressive chromatin" 1)
   ("uniformly accessible chromatin" 1) ("break-proximal chromatin" 1)
   ("autosomal chromatin" 1) ("senescent chromatin" 1)
   ("a very complex chromatin" 1) ("non-permissive chromatin" 1)
   ("its subsequent chromatin" 1) ("non-nucleolar chromatin" 1)
   ("rounded granular chromatin" 1) ("new chromatin" 1) ("crude chromatin" 1)
   ("approximately 25 μg chromatin" 1) ("already-accessible chromatin" 1)
   ("accessible chromatin (DHS)" 1) ("weak enhancer/open chromatin" 1)
   ("distinct (15 or 7 HMM states) chromatin" 1)
   ("adjacently positioned yet often noncontiguous chromatin" 1)
   ("the resulting soluble chromatin" 1)
   ("the invasive and proliferative chromatin" 1)
   ("repressive H3K27me3 chromatin" 1) ("relatively inaccessible chromatin" 1)
   ("favorable chromatin" 1) ("The local chromatin" 1)
   ("leukemic TFs reprogram chromatin" 1) ("divergent chromatin" 1)
   ("the Swith/Sucrose Non-Fermentable chromatin" 1)
   ("the SWI/SNF ATPase-dependent chromatin" 1) ("both viral chromatin" 1)
   ("more compact chromatin" 1) ("conformational chromatin" 1)
   ("again no substantial chromatin" 1) ("cyclical chromatin" 1)
   ("the C-terminal 530 amino acids of the chromatin remodelling factor BRG1"
    1)
   ("given chromatin" 1) ("transcriptional repressive chromatin" 1)
   ("monitor local chromatin" 1) ("the epigenetic chromatin" 1)
   ("Non-immunoprecipitated chromatin" 1) ("no repressive chromatin" 1)
   ("than the 1/10 input chromatin (Figure xref , lanes 2 and 6)" 1)
   ("promoter-proximal chromatin" 1) ("“silent” chromatin" 1)
   ("formaldehyde-treated chromatin" 1) ("telomeric silent chromatin" 1)
   ("yeast silent chromatin" 1) ("delicate chromatin" 1)
   ("these crucial chromatin" 1) ("passive DNA lesion-dependent chromatin" 1)
   ("Passive chromatin" 1) ("a new chromatin" 1)
   ("hMSH2-hMSH6 catalyzed chromatin" 1) ("The sheared soluble chromatin" 1)
   ("Soluble HeLa chromatin" 1) ("interphase centromeric chromatin" 1)
   ("centromeric chromatin" 1) ("The residual chromatin" 1)
   ("restrictive higher-order chromatin" 1) ("one or more chromatin" 1)
   ("partly compensatory chromatin" 1) ("only ERK8 CHROMATIN" 1)
   ("the loose chromatin" 1) ("special nucleating chromatin" 1)
   ("transcription-coupled chromatin" 1) ("inaccessible chromatin" 1)
   ("substantial chromatin" 1) ("H2B-GFP-labeled chromatin" 1)
   ("H3K4me3-associated chromatin" 1) ("increased repressive chromatin" 1)
   ("pre-acetylated chromatin" 1) ("widespread chromatin" 1)
   ("500 mM NaCl-extractable chromatin" 1) ("salt-extractable chromatin" 1)
   ("less-soluble chromatin" 1) ("ATP-driven chromatin" 1)
   ("the sonicated soluble chromatin" 1) ("quiescent chromatin" 1)
   ("pericentric and telomeric chromatin" 1)
   ("soluble and insoluble chromatin" 1)
   ("a more stable heterochromatic repressive chromatin" 1)
   ("misshapen interphase chromatin" 1) ("Extensive chromatin" 1)
   ("the cellular chromatin" 1) ("the functional chromatin" 1)
   ("the H3K9me3 repressive chromatin" 1) ("unresolved chromatin" 1)
   ("The resulting insoluble chromatin" 1) ("uncut chromatin" 1)
   ("the otherwise condensed chromatin" 1)
   ("condensed yellow/green-colored chromatin" 1)
   ("loose red-colored chromatin" 1) ("a negative repressive chromatin" 1)
   ("larger chromatin" 1) ("unique chromatin" 1) ("their normal chromatin" 1)
   ("further implicating chromatin" 1) ("loose nuclear chromatin" 1)))
 ("UP:Q9SIZ8" (("RKP" 5))) ("UP:Q9SJF0" (("BD" 65) ("BSL2" 3) ("BSL2 (BD)" 2)))
 ("UP:Q9SJG8" (("ML2" 1)))
 ("UP:Q9SJJ3"
  (("PNF" 24) ("sciatic nerve PNF" 1) ("benign PNF" 1)
   ("2\" developed another PNF" 1)))
 ("UP:Q9SJM6" (("Sap4" 1)))
 ("UP:Q9SJX1" (("Hema-3" 23) ("HEMA3" 4) ("Hema3" 2) ("HEMA-3" 1)))
 ("UP:Q9SJY5" (("DiC1" 2))) ("UP:Q9SK47" (("TAT–3" 57) ("TAT-3" 19)))
 ("UP:Q9SK53" (("Col3" 5) ("COL3" 4))) ("UP:Q9SKN6" (("GATA1-3" 1)))
 ("UP:Q9SKQ0" (("CYP2" 1))) ("UP:Q9SKT3" (("aTSC1" 1)))
 ("UP:Q9SLA8" (("EnR" 2))) ("UP:Q9SLH3" (("RGA" 6))) ("UP:Q9SLN8" (("DBR" 1)))
 ("UP:Q9SM64" (("MnSOD1" 2))) ("UP:Q9SMJ4" (("ClaI" 66)))
 ("UP:Q9SNB4" (("LUX" 60) ("lux" 25) ("Lux" 20))) ("UP:Q9SPE5" (("GSNAP" 3)))
 ("UP:Q9SPK5" (("FHS" 138))) ("UP:Q9SR13" (("flK" 1) ("flk" 1)))
 ("UP:Q9SSN3" (("TIR" 103))) ("UP:Q9SSW0" (("ZF3" 4)))
 ("UP:Q9SSW1" (("ZF1" 10) ("an intact ZF1" 2))) ("UP:Q9SU13" (("FLA2" 1)))
 ("UP:Q9SUC3" (("MS5" 71) ("TDM1" 1) ("new MS5" 1))) ("UP:Q9SUM3" (("AR2" 35)))
 ("UP:Q9SUP1"
  (("oxidoreductase" 116) ("oxidoreductases" 16) ("oxidoreductase (WWOX)" 3)
   ("Oxidoreductase" 2)))
 ("UP:Q9SUR6" (("JR2" 2))) ("UP:Q9SVV9" (("ML3" 1))) ("UP:Q9SW18" (("CHLM" 1)))
 ("UP:Q9SX04" (("ROA2" 1))) ("UP:Q9SXA6" (("Endo1" 2)))
 ("UP:Q9SXS3" (("IFS" 60)))
 ("UP:Q9SXZ2"
  (("FT" 644) ("-FT" 22) ("regions around FT" 2) ("FT169A (ATM+) FT169A" 1)))
 ("UP:Q9SYB9" (("UNC" 162) ("unc" 36) ("Unc" 16) ("“UNC”" 1)))
 ("UP:Q9SYJ4" (("RS4" 67) ("RS-4" 33) ("acute leukemia RS4" 1)))
 ("UP:Q9SYL0" (("BT3" 1))) ("UP:Q9SYU4" (("pER10" 2)))
 ("UP:Q9SYZ0" (("EL2" 1))) ("UP:Q9SZ30" (("cyclase" 27)))
 ("UP:Q9SZD4" (("HLR" 1)))
 ("UP:Q9SZF7"
  (("SHR" 76) ("PDTC-treated SHR" 6) ("than untreated SHR" 1)
   ("prehypertensive 5-week-old SHR" 1) ("prehypertensive SHR" 1)))
 ("UP:Q9SZU7" (("HTL" 3)))
 ("UP:Q9T041"
  (("tor1" 188) ("Tor1" 172) ("TOR1" 17) ("Tor1-" 2) ("the analogous tor1" 1)
   ("TOR1 (HEAT)" 1)))
 ("UP:Q9T0D3" (("HSF7" 2)))
 ("UP:Q9T0I1" (("DNMT3" 16) ("DNA methyltransferase 3" 15)))
 ("UP:Q9T1Q7" (("4-1" 59) ("4–1" 29) ("4–1 µ" 1)))
 ("UP:Q9T1R6" (("3-2" 83) ("3–2" 22)))
 #+ignore("UP:Q9T1U6" ; fixed -- all defs for this protein were bad
  (("CGH" 936) ("proinsulin" 13) ("HTC-2" 7) ("EGFR-2" 6) ("Genome-Wide CGH" 2)
   ("intact proinsulin" 2) ("the Agilent Oligonucleotide Array-Based CGH" 1)
   ("Agilent CGH" 1)
   ("Agilent
                    Oligo Array CGH"
    1)
   ("bacterial artificial
                chromosome (BAC) array CGH"
    1)
   ("Agilent Oligonucleotide Array-Based CGH" 1)
   ("We first performed array CGH" 1)
   ("using Agilent Human Genome CGH Microarray 44K" 1)))
 ("UP:Q9T1V0" (("GPS" 159) ("GPS-" 1))) ("UP:Q9TQE0" (("DR9" 1)))
 ("UP:Q9TRM8" (("Rln" 1))) ("UP:Q9TSN7" (("Iα1" 12)))
 ("UP:Q9TTR7" (("COUP-TF2" 12)))
 ("UP:Q9TTR8" (("COUP-TF1" 4) ("COUP transcription factor 1" 2)))
 ("UP:Q9TTT8"
  (("COX IV" 80) ("Cox IV" 26) ("CoxIV" 26) ("COX-IV" 8) ("coxIV" 2)
   ("Cox IV protein" 2) ("-CoxIV" 1)))
 ("UP:Q9TU03"
  (("D4-GDI" 38) ("Rho GDP-dissociation inhibitor 2" 2)
   ("the homologous D4-GDI" 1)))
 ("UP:Q9TU27" (("IL-12p35" 4))) ("UP:Q9TUB5" (("AECC" 2)))
 ("UP:Q9TVC8" (("DQB1" 19))) ("UP:Q9U1H0" (("FET" 34)))
 ("UP:Q9U1H9" (("SBR" 72) ("histological grade SBR" 5)))
 ("UP:Q9U1K1" (("Spir" 2)))
 ("UP:Q9U2Q9"
  (("glycogen synthase kinase-3" 200) ("Glycogen synthase kinase-3" 53)
   ("glycogen synthase kinase–3" 2)))
 ("UP:Q9U4H5" (("AMX" 2))) ("UP:Q9U6V7" (("JDP" 9)))
 ("UP:Q9U6Y8"
  (("DsRed" 850) ("dsRed" 367) ("-dsRed" 46) ("dsRED" 27) ("DsRED" 16)
   ("-DsRed" 5) ("pDsRed" 5) ("pdsRed" 5) ("DSRed" 4) ("dsRed protein" 3)
   ("a fluorescent marker protein dsRed" 2) ("vesicular FYVE-dsRed" 2)
   ("the red fluorescent protein DsRed" 2) ("DsRed-" 2)
   ("mitochondrial-targeted dsRed" 2) ("DsRed (RFP)" 1) ("monomeric dsRed" 1)
   ("-dsRED" 1)
   ("the peroxisomal marker PTS1 (peroxisomal targeting sequence 1)-DsRed" 1)))
 ("UP:Q9U8P7" (("AQPA" 2)))
 ("UP:Q9U9A3"
  (("PP6C" 167) ("PP6c" 142) ("PP6c protein" 6) ("intense PP6c" 2)
   ("PP6C protein" 1)))
 ("UP:Q9U9R7" (("SNpc" 72)))
 ("UP:Q9UBB4"
  (("Ataxin-10" 132) ("ATXN10" 94) ("SCA10" 93)
   ("Spinocerebellar ataxia type 10" 11) ("ataxin 10" 8) ("Atxn10" 5)
   ("Ataxin 10" 3) ("Ataxin-10 protein" 2) ("spinocerebellar ataxia type 10" 2)
   ("ataxin-10" 1)))
 ("UP:Q9UBB5"
  (("demethylase" 434) ("MBD2" 359) ("demethylase activity" 121) ("Mbd2" 11)
   ("Demethylase" 10) ("MBD2 protein" 10) ("transcriptional repressors p66α" 2)
   ("p66α" 2) ("demethylase (LSD)" 2) ("an appropriate demethylase activity" 1)
   ("a probable histone demethylase" 1)))
 ("UP:Q9UBC0"
  (("family member 1" 24) ("Hnf6" 13) ("HNF6" 12) ("Onecut1" 6) ("ONECUT1" 4)
   ("HNF6A" 1) ("Hepatocyte nuclear factor 6" 1)
   ("hepatocyte nuclear factor 6" 1)))
 ("UP:Q9UBC2" (("Eps15R" 9) ("EPS15R" 2)))
 ("UP:Q9UBC3"
  (("DNMT3B" 450) ("DNMT3b" 62) ("Dnmt3b" 11) ("DNMT3B (DKO)" 3)
   ("exogenous DNMT3B" 2) ("DNMT3B protein" 2)))
 ("UP:Q9UBC9" (("SPRR3" 59))) ("UP:Q9UBD3" (("xcl2" 1)))
 ("UP:Q9UBD5" (("Orc3" 1)))
 ("UP:Q9UBD9"
  (("NR6" 60) ("CLCF1" 52) ("cardiotrophin-like cytokine factor 1" 8)
   ("CISS2" 4) ("exogenous human CLCF1" 1) ("NNT1" 1)))
 ("UP:Q9UBE0"
  (("SAE1" 75) ("AOS1" 6) ("Aos1" 5) ("SUMO activating enzyme subunit 1" 2)))
 ("UP:Q9UBE8"
  (("Nemo" 22) ("Nemo-like kinase" 8) ("nemo-like kinase" 6)
   ("Nemo-like kinase (NLK)" 4) ("nemo-like kinase (NLK)" 3) ("nemo" 2)
   ("NeMo" 2)))
 ("UP:Q9UBF1"
  (("MAGE-C2" 193) ("CT10" 20) ("MAGEC2" 2) ("MAGE-C2-" 2) ("than MAGE-C2" 1)
   ("ectopically expressed MAGE-C2" 1) ("expressed MAGE-C2" 1)))
 ("UP:Q9UBF2"
  (("coatomer
protein complex"
    4)
   ("COPG2" 2) ("coatomer protein complex" 1)))
 ("UP:Q9UBF6" ; changed "sensitive to apoptosis" to "sensitive to apoptosis gene protein" since that's the uniprot
  (#+ignore("sensitive to apoptosis" 73) ("RBX2" 39) ("more sensitive to apoptosis" 12)
   ("Rbx2" 5) ("RBX2 protein" 3)
   ("significantly more sensitive to apoptosis" 2)
   ("much less sensitive to apoptosis" 2) ("less sensitive to apoptosis" 1)
   ("even more sensitive to apoptosis" 1)
   ("the cells more sensitive to apoptosis" 1)
   ("the nearly 50% identical RBX2 protein" 1)
   ("cells less sensitive to apoptosis" 1)))
 ("UP:Q9UBF8" (("PI4KB" 93) ("phosphatidylinositol 4-kinase" 6)))
 ("UP:Q9UBF9" (("MYOT" 9) ("myotilin" 6) ("Myotilin" 5)))
 ("UP:Q9UBG0" (("UPARAP" 1) ("Endo180" 1))) ("UP:Q9UBG7" (("Rb PL" 24)))
 ("UP:Q9UBH6" (("X-receptor" 4) ("X-Receptor (FXR)" 2) ("X-Receptor" 1)))
 ("UP:Q9UBI1" (("COMMD3" 1)))
 ("UP:Q9UBI4" (("SLP-1" 86) ("just SLP-1" 1) ("stomatin-like protein 1" 1)))
 ("UP:Q9UBJ2"
  (("ABCD2" 109) ("ABCD2 protein" 4) ("ABCD2 protein (ALDRP)" 2) ("ALDRP" 2)))
 ("UP:Q9UBK2"
  (("PGC-1α" 689) ("PGC1α" 131) ("Ppargc1a" 30) ("PPARGC1A" 22)
   ("PGC-1α protein" 11)
   ("peroxisome proliferator-activated receptor gamma coactivator 1-alpha" 5)
   ("peroxisome proliferator–activated receptor γ coactivator 1α" 3)
   ("PGC-1alpha" 3) ("Pgc1" 2) ("PGC-1α-" 2)
   ("peroxisome proliferator-activated receptor γ coactivator 1α" 2)
   ("PPARγ-coactivator 1α" 2) ("pgc-1α" 1) ("exogenous PGC-1α" 1) ("Pgc-1α" 1)
   ("its previously reported substrate PGC1α" 1) ("Pgc1α" 1)
   ("PPRE-associated PGC-1α" 1) ("than PGC-1α" 1)))
 ("UP:Q9UBK5" (("DAP10" 22) ("KAP10" 1)))
 ("UP:Q9UBK8"
  (("MTRR" 65) ("methionine synthase reductase" 9)
   ("5-methyltetrahydrofolate-homocysteine methyltransferase reductase" 3)))
 ("UP:Q9UBK9" (("ART-27" 13) ("UXT" 11))) ("UP:Q9UBL0" (("TARPp" 2)))
 ("UP:Q9UBL3" (("Ash2L" 99) ("ASH2L" 67)))
 ("UP:Q9UBM4" (("OPT" 44) ("Opt" 6) ("pOPT" 4) ("oPT" 2) ("OPTC" 1)))
 ("UP:Q9UBM7"
  (("DHCR7" 9) ("7-dehydrocholesterol reductase" 4)
   ("Smith-Lemli-Opitz syndrome" 1)))
 ("UP:Q9UBN4"
  (("TRPC4" 192) ("endothelial TRPC4" 3) ("Endothelial TRPC4" 2)
   ("TRPC4 protein" 2)))
 ("UP:Q9UBN6"
  (("DcR2" 66) ("decoy receptor" 54) ("TRAIL-R4" 34) ("Dcr2" 5) ("TNFRSF10D" 3)
   ("decoy receptor 2" 3) ("Decoy receptor 2" 2) ("TRAIL receptor 4" 2)
   ("“decoy receptor”" 1) ("TRUNDD" 1) ("a soluble decoy receptor" 1)))
 ("UP:Q9UBN7"
  (("HDAC6" 4066) ("histone deacetylase 6" 96) ("HDAC6 protein" 38) ("HD6" 22)
   ("Histone deacetylase 6" 18) ("HDAC-6" 11) ("Hdac6" 7) ("HDAC6-" 3)
   ("-HDAC6" 2) ("overexpressed HDAC6" 2) ("cellular histone deacetylase 6" 2)
   ("Microtubule-associated histone deacetylase 6" 2)
   ("further strengthening HDAC6" 1) ("the autophagic pathway—via HDAC6" 1)
   ("than wild type HDAC6 in cells ( xref , compare Lane 3 and 4)" 1)
   ("exogenous HA-tagged HDAC6 protein" 1) ("detergent-insoluble HDAC6" 1)
   ("the HDAC6’s" 1) ("that HDAC6’s" 1) ("both HDAC6’s" 1) ("either HDAC6’s" 1)
   ("hdac6" 1) ("particular HDAC6" 1) ("defective HDAC6" 1)))
 ("UP:Q9UBP0" (("spastin" 8) ("Spastin" 7)))
 ("UP:Q9UBP4"
  (("DKK3" 221) ("DKK3 protein" 5) ("dickkopf" 4) ("DKK-3" 2) ("dickkopf 3" 2)
   ("Dickkopf 3" 1)))
 ("UP:Q9UBP5"
  (("HEY2" 20) ("Hey2" 18) ("HRT2" 5) ("Hrt2" 3) ("Herp1" 1) ("HERP1" 1)))
 ("UP:Q9UBP9" (("CED-6(GULP)" 3) ("CED-6" 2) ("GULP" 1)))
 ("UP:Q9UBQ0" (("VPS29" 1) ("Vps29" 1))) ("UP:Q9UBQ5" (("subunit 12" 1)))
 ("UP:Q9UBQ6" (("EXTL2" 6)))
 ("UP:Q9UBQ7"
  (("PH2" 12) ("Ph2" 7) ("pH2" 6) ("GRHPR" 1)
   ("postnatal Pkd1 heterozygous PH2" 1)))
 ("UP:Q9UBR2" (("CTSZ" 1)))
 ("UP:Q9UBR4"
  (("LIM-3" 24) ("LIM3" 7) ("LHX3" 2) ("Lim3" 2) ("lim3" 1) ("Lhx3" 1)))
 ("UP:Q9UBS0"
  (("S6K2" 228) ("RPS6KB2" 20) ("70kD" 2) ("70KD" 2) ("p70-beta" 2)))
 ("UP:Q9UBS3" (("ERdj4" 6) ("Erdj4" 2) ("DNAJB9" 2)))
 ("UP:Q9UBS4" (("HEDJ" 1)))
 ("UP:Q9UBS5"
  (("G-proteins" 197) ("GB1" 30) ("heterotrimeric G-proteins" 16) ("-GB1" 4)
   ("trimeric G-proteins" 2) ("classical signaling G-proteins" 2)
   ("other classical G-proteins" 2) ("diverse G-proteins" 2)
   ("S1PR-associated G-proteins" 2) ("the heterotrimeric G-proteins" 2)
   ("large heterotrimeric G-proteins" 1) ("the resin-bound GB1" 1) ("GB1-" 1)
   ("GABBR1" 1) ("the well-studied small G-proteins" 1)
   ("the quiescent heterotrimeric G-proteins" 1)
   ("heterotirmeric G-proteins" 1)))
 ("UP:Q9UBS8" (("ARA54" 35) ("RNF14" 1) ("ARA-54" 1) ("Q9UBS8" 1)))
 ("UP:Q9UBS9" (("CH1" 79) ("Ch1" 11) ("SUCO" 3)))
 ("UP:Q9UBT2" (("UBA2" 14) ("Uba2" 6))) ("UP:Q9UBT3" (("DKK4" 11) ("Dkk4" 1)))
 ("UP:Q9UBT6" (("DNA polymerase kappa" 7) ("POLK" 2) ("Polk" 2)))
 ("UP:Q9UBU2" (("Dkk2" 9) ("DKK2" 4))) ("UP:Q9UBU3" (("GHRL" 43)))
 ("UP:Q9UBU6" (("FAM8A1" 34)))
 ("UP:Q9UBU7"
  (("Dbf4" 23) ("ASK" 16) ("DBF4" 10) ("S-phase kinase" 10) ("DBf4" 1)
   ("pASK" 1)))
 ("UP:Q9UBU8"
  (("mortality factor 4-like protein 1" 7) ("MRG15" 6) ("Eaf3" 3) ("MORF4L1" 1)
   ("EAF3" 1)))
 ("UP:Q9UBU9" (("NXF1" 39) ("Nxf1" 5) ("Mex67" 3) ("NXF1-" 2)))
 ("UP:Q9UBV2"
  (("SEL1L" 62) ("FN2" 10) ("sel-1 suppressor of lin-12-like (C. elegans)" 2)))
 ("UP:Q9UBV4"
  (("WNT16" 38) ("Wnt-16" 11) ("WNT-16" 8) ("Wnt16" 7) ("wnt16" 2)))
 ("UP:Q9UBV8" (("PEF1" 11) ("pEF1" 3) ("peflin" 2)))
 ("UP:Q9UBW7"
  (("ZNF198" 336) ("MYM" 34) ("ZNF198 protein" 15) ("ZMYM2" 14) ("-ZNF198" 5)
   ("SCLL" 5) ("ZNF198-" 2) ("ZnF198" 2)))
 ("UP:Q9UBW8" (("COPS7A" 4) ("COP9 signalosome complex subunit 7a" 4)))
 ("UP:Q9UBX0" (("Hesx1" 11) ("aNF" 5) ("HESX1" 3) ("HesX1" 1)))
 ("UP:Q9UBX1" (("CTSF" 8))) ("UP:Q9UBX2" (("DUX4" 10)))
 ("UP:Q9UBX3" (("DIC" 309) ("strain DIC185" 1) ("SLC25A10" 1) ("DICs" 1)))
 ("UP:Q9UBX5" ; added emphysema definition
  (#+ignore("emphysema" 442) ("fibulin-5" 119) ("Fibulin-5" 34)
   ("pulmonary emphysema" 18) ("FBLN5" 10) ("Emphysema" 9)
   ("cigarette-smoke-induced pulmonary emphysema" 4)
   ("age-related emphysema" 3) ("fibulin 5" 3) ("UP50" 2)
   ("the smoke-exposed WT mice developed pulmonary emphysema" 2)
   ("the centrilobular emphysema" 2) ("more severe emphysema" 2)
   ("discernible emphysema" 2) ("subsequent emphysema" 2)
   ("experimental emphysema" 2)
   ("genetically determined pulmonary emphysema" 1) ("Pulmonary emphysema" 1)
   ("cigarette smoke-induced pulmonary emphysema" 1)
   ("early-onset pulmonary emphysema" 1) ("qualitative CT emphysema" 1)
   ("smoke-induced emphysema" 1) ("congenital emphysema" 1)
   ("severe emphysema" 1) ("self-reported emphysema" 1)))
 ("UP:Q9UBX7" (("HK11" 14))) ("UP:Q9UBX8" (("lactosylceramide synthase" 2)))
 ("UP:Q9UBY5"
  (("LPAR3" 45) ("endothelial differentiation" 14) ("LPA3" 10)
   ("Endothelial differentiation" 1)
   ("hemogenic endothelial differentiation" 1) ("LPA 3" 1)))
 ("UP:Q9UBY9" (("HSPB7" 48) ("HspB7" 1)))
 ("UP:Q9UBZ4" (("Ape2" 176) ("Ape2 protein" 9) ("APE2" 1)))
 ("UP:Q9UBZ9"
  (("REV1" 317) ("Rev1" 302) ("REV1 protein" 15) ("rev1" 5)
   ("functional Rev1" 3) ("REV1L" 1) ("—REV1" 1) ("significantly less Rev1" 1)
   ("than monoubiquitinated Rev1 (the ratio between non-ubiquitinated vs. monoubiquitinated form was increased in their FAAP20 immunoprecipitate compared to the Pre-IP extract; their xref , lanes 7 vs. 3)"
    1)
   ("REV1-" 1)))
 ("UP:Q9UD71"
  (("DARPP-32" 145) ("DARPP32" 97) ("PPP1R1B" 15) ("DARPP-32 protein" 5)
   ("pDARPP32" 4) ("exogenous and endogenous DARPP-32" 1) ("Darpp-32" 1)
   ("DARPP32 protein" 1)))
 ("UP:Q9UDR5" (("LKR" 16)))
 ("UP:Q9UDW1" (("ubiquinol-cytochrome c reductase" 2)))
 ("UP:Q9UDY2"
  (("ZO-2" 130) ("TJP2" 6) ("ZO2" 3) ("the junctional protein ZO2" 2)
   ("tight junction protein 2" 2) ("Q9UDY2" 1)))
 ("UP:Q9UDY6" (("RNF9" 1)))
 ("UP:Q9UDY8" (("MALT1" 304) ("Malt1" 12) ("MLT" 12) ("paracaspase" 3)))
 ("UP:Q9UEE5"
  (("thiazolidinediones" 32) ("Thiazolidinediones" 4) ("STK17A" 2)
   ("traditional thiazolidinediones" 2) ("DRAK1" 1) ("Stk17a" 1)))
 ("UP:Q9UEE9" (("CFDP1" 15)))
 ("UP:Q9UEF7"
  (("KL" 176) ("Klotho" 167) ("klotho" 10) ("Kl" 9) ("-Klotho" 7)
   ("immunohistochemical Klotho" 4) ("Klotho (KL)" 3) ("Klotho protein" 2)
   ("we first evaluated immunohistochemical Klotho" 2) ("soluble KL" 1)
   ("severe KL" 1) ("high immunohistochemical Klotho" 1)))
 ("UP:Q9UER7"
  (("Daxx" 407) ("DAXX" 401) ("hDaxx" 12) ("Daxx-" 11) ("DAXX protein" 5)
   ("the pro-apoptotic adaptor protein Daxx" 3) ("EAP1" 3) ("Daxx protein" 2)
   ("Death domain-associated protein 6" 2) ("cellular Daxx" 2)
   ("death domain-associated protein Daxx" 1)
   ("the pro-apoptotic molecule Daxx" 1) ("DAXX-" 1)))
 ("UP:Q9UEW3" (("Marco" 13) ("MARCO" 13) ("SCARA2" 1)))
 ("UP:Q9UEW8" (("SPAK" 5) ("STK39" 1)))
 ("UP:Q9UEY8" (("γ-adducin" 24) ("ADD3" 1))) ("UP:Q9UF11" (("Evt1" 1)))
 ("UP:Q9UF33" (("EphA6" 3) ("EPHA6" 3)))
 ("UP:Q9UF56" (("FBXL17" 92) ("the previously unstudied adaptor FBXL17" 1)))
 ("UP:Q9UFC0" (("LRWD1" 1))) ("UP:Q9UFD9" (("RIMBP3" 2)))
 ("UP:Q9UFF9" (("Calif" 106) ("CNOT8" 12) ("CAF2" 3) ("CALIF" 1) ("POP2" 1)))
 ("UP:Q9UG01" (("WIM" 3) ("Wim" 3))) ("UP:Q9UG22" (("IMAP2" 5)))
 ("UP:Q9UGC6" (("RGS17" 9) ("regulator of G-protein signaling 17" 2)))
 ("UP:Q9UGH3" (("SLC23A2" 26) ("slc23a2" 1) ("SVCT2" 1)))
 ("UP:Q9UGI0" (("ZRANB1" 30) ("TRABID" 5)))
 ("UP:Q9UGI6" (("KCa2.3" 202) ("SK3" 53) ("KCNN3" 9) ("SK3-" 2)))
 ("UP:Q9UGI8" (("TESS" 58) ("TEs" 53) ("TES" 35) ("Tes" 4) ("TESs" 1)))
 ("UP:Q9UGI9" (("PRKAG3" 27) ("AMPKG3" 4) ("prkag3" 1)))
 ("UP:Q9UGJ0" (("PRKAG2" 173) ("PRKAG2-" 15))) ("UP:Q9UGJ1" (("GCP4" 2)))
 ("UP:Q9UGK3" (("Brk substrate" 11) ("pBKS" 9) ("BKS" 1) ("STAP-2" 1)))
 ("UP:Q9UGL1"
  (("KDM5B" 250) ("Jarid1b" 86) ("JARID1B" 41) ("PLU-1" 7)
   ("lysine demethylase 5B" 5) ("AT rich interactive domain 1B" 3)
   ("strong KDM5B" 3) ("PLU1" 3) ("Kdm5b" 3) ("histone demethylase Jarid1b" 3)
   ("Plu-1" 2) ("KDM5B (PK)" 2) ("directly link KDM5B" 1)))
 ("UP:Q9UGM3" (("SALSA" 54) ("DMBT1" 4))) ("UP:Q9UGM5" (("Fetub" 8)))
 ("UP:Q9UGN4" (("IRp60" 2) ("CD300A" 1) ("CD300a" 1)))
 ("UP:Q9UGN5" (("PARP2" 110) ("ARTD2" 8) ("Parp-2" 2) ("Parp2" 2)))
 ("UP:Q9UGP4" (("LIMD1" 129) ("than LIMD1" 1))) ("UP:Q9UGP5" (("POLL" 1)))
 ("UP:Q9UGT4" (("SUSD2" 3))) ("UP:Q9UGU0" (("TCF20" 3)))
 ("UP:Q9UGV2" (("NDRG3" 2) ("N-myc downstream-regulated gene" 2) ("Ndrg3" 1)))
 ("UP:Q9UH17" (("APOBEC3B" 25))) ("UP:Q9UH65" (("SWAP-70" 21)))
 ("UP:Q9UH73"
  (("Ebf1" 204) ("EBF1" 93) ("EBF" 64) ("OE1" 7) ("EBF1-" 4)
   ("exogenous Ebf1" 1)))
 ("UP:Q9UH77" (("KLHL3" 1)))
 ("UP:Q9UH92" (("Mlx" 59) ("MLX" 3) ("centered around Mlx" 2)))
 ("UP:Q9UH99" (("SUN2" 4) ("Sun2" 1)))
 ("UP:Q9UHA4"
  (("MP1" 129) ("LAMTOR3" 10) ("coexpressed MP1" 4) ("MEK1 partner" 2)
   ("The previously described MMTV-cyclin D1 (no FLAG tag) line MP1" 2)
   ("-MP1" 1) ("\"MP1\"" 1)))
 ("UP:Q9UHB4" (("NR1" 116) ("gp120 increased total NR1" 1) ("-NR1" 1)))
 ("UP:Q9UHB6" (("EPLIN" 45) ("LIMA1" 4))) ("UP:Q9UHB7" (("AFF4" 27)))
 ("UP:Q9UHB9" (("SRP68" 1))) ("UP:Q9UHC1" (("MLH3" 9)))
 ("UP:Q9UHC6" (("CNTNAP2" 31) ("contactin associated protein-like 2" 3)))
 ("UP:Q9UHC7" (("MKRN1" 58)))
 ("UP:Q9UHC9" (("type C1" 23) ("Type C1" 11) ("NPC1L1" 11)))
 ("UP:Q9UHD0" (("IL19" 6) ("IL-19" 5)))
 ("UP:Q9UHD2"
  (("TBK1" 3887) ("Tbk1" 115) ("p-TBK1" 106) ("TANK-binding kinase 1" 69)
   ("TBK-1" 57) ("TBK1 protein" 33) ("NAK" 23) ("TANK binding kinase 1" 20)
   ("TBK1-" 20) ("overexpressed TBK1" 14) ("TANK-binding kinase-1" 14)
   ("most p-TBK1" 10) ("TANK-Binding Kinase 1" 10) ("targeted TBK1" 4)
   ("tbk1" 4) ("nearly full-length TBK1" 4) ("NAK protein" 3)
   ("TANK-binding Kinase 1" 3) ("TBK1 molecule" 3) ("Tank-binding kinase 1" 3)
   ("much less TBK1 protein" 3) ("Q9UHD2" 2) ("pTBK1" 2)
   ("hypo-ubiquitinated TBK1" 2) ("exogenous tagged TBK1" 2)
   ("targeted activated TBK1" 2) ("the atypical IκB kinase TBK1" 1)
   ("cellular p-TBK1" 1) ("most mitochondrial p-TBK1" 1) ("TBK-1-" 1)
   ("targeting TBK1" 1) ("the atypical IkB kinase family member TBK1" 1)
   ("the antiviral protein kinase TBK1" 1) ("ESCRT-I–associated TBK1" 1)
   ("more TBK1" 1) ("The protein-protein interaction network around TBK1" 1)
   ("an alternative TBK1-" 1) ("particular TBK1" 1) ("than TBK-1 ( xref )" 1)
   ("TBK1 (TANK-binding kinase 1) protein" 1) ("intact TBK1" 1)
   ("dimeric TBK1" 1)
   ("the chromosome 12q14 duplication strongly supports TBK1" 1)))
 ("UP:Q9UHD8" (("SEPT9" 33))) ("UP:Q9UHD9" (("UBQLN2" 7) ("hPlic2" 1)))
 ("UP:Q9UHE5"
  (("NAT8" 8) ("acetyltransferase 2" 7) ("N-acetyltransferase 8" 4)
   ("Given NAT8 ’s" 1) ("Given NAT8" 1)))
 ("UP:Q9UHE8" (("STEAP1" 1))) ("UP:Q9UHF0" (("TAC3" 15)))
 ("UP:Q9UHF1"
  (("EGFL7" 239) ("Egfl7" 40) ("vascular endothelial statin" 2) ("EGFl7" 2)))
 ("UP:Q9UHF3" (("acetyltransferase 1" 5) ("-acetyltransferase 1" 1)))
 ("UP:Q9UHF4" (("IL-20R1" 22) ("IL-20Rα" 3) ("IL-20RA" 2) ("IL20R1" 1)))
 ("UP:Q9UHF5" (("IL17B" 6) ("NIRF" 4) ("targeted NIRF" 2) ("Il17b" 1)))
 ("UP:Q9UHF7" (("TRPS1" 96))) ("UP:Q9UHG0" (("DCDC2" 6)))
 ("UP:Q9UHG3" (("Pcl1" 6) ("PCL1" 2) ("pCL1" 1)))
 ("UP:Q9UHH9"
  (("IP6K2" 171) ("the dominant-negative IP6K2" 2) ("recombinant IP6K2’s" 1)))
 ("UP:Q9UHI5" (("SLC7A8" 6)))
 ("UP:Q9UHI6"
  (("Gemin3" 207) ("gemin3" 17) ("DDX20" 12) ("DP103" 9) ("GEMIN3" 1)
   ("Ddx20" 1)))
 ("UP:Q9UHI7" (("solute carrier family 23 member 1" 4) ("SVCT1" 2)))
 ("UP:Q9UHI8" (("ADAMTS-1" 3) ("ADAMTS1" 2))) ("UP:Q9UHJ3" (("SFMBT1" 4)))
 ("UP:Q9UHJ6" (("SHK" 24) ("shPK" 2))) ("UP:Q9UHJ9" (("Frag1" 3) ("Frag-1" 2)))
 ("UP:Q9UHK0" (("NUFIP1" 1)))
 ("UP:Q9UHK6"
  (("AMACR" 16) ("alpha-methylacyl-CoA racemase" 3)
   ("Alpha-methylacyl-CoA racemase" 1) ("P504S" 1)
   ("alpha-methylacyl-CoA racemase (AMACR)" 1) ("“AMACR”" 1)))
 ("UP:Q9UHL9" (("GTF2IRD1" 3))) ("UP:Q9UHN1" (("POLG2" 1)))
 ("UP:Q9UHP3" (("USP21" 116) ("USP25" 6) ("–USP21" 6) ("Q9UHP3" 1)))
 ("UP:Q9UHP7" (("member D" 4) ("LLT1 molecule" 4) ("OCIL" 1) ("LLT1" 1)))
 ("UP:Q9UHQ4" (("BCAP29" 1))) ("UP:Q9UHR4" (("IRTKS" 170) ("BAIAP2L1" 42)))
 ("UP:Q9UHR5" (("SAP30BP" 1))) ("UP:Q9UHV2" (("SEI1" 46) ("SERTAD1" 4)))
 ("UP:Q9UHV5" (("RAPGEFL1" 2))) ("UP:Q9UHV7" (("MED13" 16) ("Med13" 1)))
 ("UP:Q9UHV8" (("LGALS13" 1))) ("UP:Q9UHV9" (("PFDN2" 4) ("PFD2" 1)))
 ("UP:Q9UHX1" (("PUF60" 1) ("SIAHBP1" 1))) ("UP:Q9UHX3" (("EMR2" 5)))
 ("UP:Q9UHZ2" (("MALAT1" 31) ("NEAT2" 28))) ("UP:Q9UI08" (("EVL" 8)))
 ("UP:Q9UI09" (("NDUFA12" 3))) ("UP:Q9UI10" (("EIF2B4" 4)))
 ("UP:Q9UI12" (("NBP1" 17)))
 ("UP:Q9UI14" (("PRA1" 10) ("yip3" 2) ("Rab acceptor 1" 1) ("Yip3" 1)))
 ("UP:Q9UI17" (("DMGDH" 3)))
 ("UP:Q9UI26" (("Imp-11" 55) ("-Imp-11" 10) ("importin-11" 8)))
 ("UP:Q9UI32"
  (("GA" 2258) ("G/A" 464) ("Ga" 89) ("GLS2" 58) ("GA-" 17)
   ("glutaminase 2" 10) ("Gls2" 10) ("-GA" 8) ("LGA" 6)
   ("overexpressed GLS2" 4) ("heterozygous G/A" 4) ("ga" 3) ("g/a" 3)
   ("a normal GA" 2) ("heterozygous variant GA" 1)
   ("-A CGTA G A TCAATG AGT AT T GA-3" 1)
   ("glycoprotein Ia/IIa (ITGA2) (chromosome 5q23-q31) 873 G/A" 1)
   ("Glutaminase 2" 1) ("the previous GA" 1) ("10 μM soluble GA" 1) ("-G/A" 1)
   ("individuals heterozygous GA" 1) ("prominent GA" 1) ("“GA”" 1) ("−GA" 1)))
 ("UP:Q9UI33"
  (("NaN" 360) ("Nan" 12) ("solid NaN" 2) ("NAN" 1) ("0.1% NaN3" 1)))
 ("UP:Q9UI36"
  (("DACH1" 503) ("DACH1 protein" 7) ("DACH" 5)
   ("a Ponasterone A inducible DACH1" 1) ("Dach" 1)
   ("whose tumors expressed DACH1" 1)))
 ("UP:Q9UI38" (("TSP50" 4))) ("UP:Q9UI40" (("SLC24A2" 2)))
 ("UP:Q9UI42" (("CPA4" 4))) ("UP:Q9UI46" (("DNAI1" 11)))
 ("UP:Q9UI47" (("CTNNA3" 12) ("CTNNA3 protein" 2)))
 ("UP:Q9UI95"
  (("MAD2L2" 163) ("Rev7" 17) ("REV7" 9) ("accessory subunit" 6) ("mad2l2" 3)
   ("nondegradable MAD2L2" 2)
   ("the NF- κ B Essential Modulator (NEMO or also termed IKK γ ) noncatalytic accessory subunit"
    2)
   ("Mad2B" 2) ("The first 141 amino acids of MAD2L2" 1) ("rev7" 1)
   ("than endogenous MAD2L2 ( xref )" 1)))
 ("UP:Q9UIA0"
  (("pleckstrin homology" 60) ("pleckstrin homology (PH)" 10) ("CYTH4" 4)
   ("–pleckstrin homology" 2) ("Pleckstrin homology" 1)))
 ("UP:Q9UIB8" (("CD84" 2))) ("UP:Q9UIC8" (("PPMT-1" 70) ("more PPMT-1" 1)))
 ("UP:Q9UID3" (("FFR" 40) ("Vps51" 15) ("Ffr" 10) ("FFR (ED)" 1) ("VPS51" 1)))
 ("UP:Q9UIF7"
  (("MUTYH" 74) ("MYH" 22) ("Mutyh" 8) ("mutyh" 8) ("hMYH" 3)
   ("MUTYH protein" 2) ("MYH-" 1)))
 ("UP:Q9UIF8" (("BAZ2B" 3)))
 ("UP:Q9UIF9" (("Tip5" 3) ("BAZ2A" 2) ("Baz2a" 2) ("KIAA0314" 1) ("TIP5" 1)))
 ("UP:Q9UIG0" (("WSTF" 18) ("BAZ1B" 8)))
 ("UP:Q9UIG5" (("PSORS1C1" 44) ("psoriasis susceptibility 1 candidate 1" 2)))
 ("UP:Q9UIG8"
  (("SLCO3A1" 67)
   ("solute carrier organic anion transporter family member 3A1" 3) ("3a1" 2)
   ("SLCO3A1 protein" 1) ("OATPD" 1) ("SLC21A11" 1) ("OATP3A1" 1)
   ("OATP-D" 1)))
 ("UP:Q9UII2" (("If1" 2))) ("UP:Q9UII4" (("HERC5" 13) ("Herc5" 9)))
 ("UP:Q9UII6" (("DUSP13" 1)))
 ("UP:Q9UIJ5"
  (("REC" 70) ("rec" 51) ("Rec" 33) ("ZDHHC2" 7) ("rEC" 2) ("“hyper-rec”" 1)))
 ("UP:Q9UIK4"
  (("DAPK2" 20) ("death-associated protein kinase 2" 1) ("Dapk2" 1)
   ("death associated protein kinase 2" 1)))
 ("UP:Q9UIK5" (("TMEFF2" 5))) ("UP:Q9UIL1" (("SCOC" 2)))
 ("UP:Q9UIL8" (("PHF11" 12) ("PHD finger protein 11" 4)))
 ("UP:Q9UIM3"
  (("Waf1/Cip1" 331) ("Waf1/CIP1" 100) ("WISp39" 11) ("Waf1/Cip1 protein" 5)
   ("mouse monoclonal anti-p21 Waf1/Cip1" 2)
   ("its transcriptional targets MDM2 and p21 Waf1/CIP1" 2)
   ("specifically p21 Waf1/CIP1" 1) ("only p21 Waf1/Cip1" 1)))
 ("UP:Q9UIQ6"
  (("LNPEP" 15) ("oxytocinase" 3) ("placental leucine aminopeptidase" 1)))
 ("UP:Q9UIS9" (("MBD1" 47))) ("UP:Q9UIU6" (("Six4" 20) ("SIX4" 1)))
 ("UP:Q9UIV1"
  (("CAF-1" 112) ("Caf1" 46) ("CAF1" 32) ("CNOT7" 9) ("Cnot7" 1) ("caf1" 1)
   ("than Caf1 ( xref , xref )" 1)))
 ("UP:Q9UIV8" (("SERPINB13" 6)))
 ("UP:Q9UIW2"
  (("plexin-A1" 5) ("Plexin A1" 4) ("plexinA1" 4) ("PlexinA1" 3)
   ("plexin A1" 3) ("Plexin-A1" 3) ("PlxnA1" 2) ("PLXNA1" 2)))
 ("UP:Q9UIX4"
  (("K13" 230) ("k13" 2) ("K13 protein" 2)
   ("herpes virus (KSHV, also known as Human Herpes virus 8)-encoded viral FLIP (Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein) K13"
    1)
   ("K13-" 1)))
 ("UP:Q9UJ14" (("GGT7" 1)))
 ("UP:Q9UJ41"
  (("Rabex-5" 104) ("Rabex5" 7) ("RabGEF1" 5) ("RABGEF1" 2)
   ("The well-characterized GEF Rabex5" 1)))
 ("UP:Q9UJ55" (("MAGEL2" 4) ("MAGE-L2" 2))) ("UP:Q9UJ68" (("MSRA" 10)))
 ("UP:Q9UJ70" (("NAGK" 1)))
 ("UP:Q9UJ71" ;fixed
  (#+ignore("fungi" 122) ("langerin" 101) ("Langerin" 65) ("CD207" 13)
   ("langerin protein" 2) ("most green fungi" 1) ("Langerin−" 1)
   ("functional langerin" 1) ("Fungi" 1)))
 ("UP:Q9UJ78" (("ZNF237" 4)))
 ("UP:Q9UJ83" (("HACL1" 2) ("2-hydroxyphytanoyl-CoA-lyase" 1)))
 ("UP:Q9UJ98" (("STAG3" 8))) ("UP:Q9UJ99" (("CDH22" 1)))
 ("UP:Q9UJA2" (("CLS" 105) ("approximately 15 CLS" 1)))
 ("UP:Q9UJA3" ; fixed
  (#+ignore("RECs" 52) ("MCM8" 7) ("KZ-41 treated irradiated RECs" 2)
   ("human primary RECs" 2)))
 ("UP:Q9UJC3"
  (("Hook1" 84) ("hook-1" 1) ("microtubule-associated Hook1" 1) ("HOOK1" 1)))
 ("UP:Q9UJC5" (("SH3BGRL2" 1))) ("UP:Q9UJD0" (("RIMS3" 1)))
 ("UP:Q9UJF2" (("RASAL2" 255) ("Rasal2" 46) ("functional Rasal2" 1)))
 ("UP:Q9UJM3"
  (("Mig6" 400) ("MIG6" 260) ("ERRFI1" 25) ("ERRFI" 17) ("Mig6 peptide" 15)
   ("RALT" 13) ("MIG6 protein" 13) ("MIG6 peptide" 5) ("Mig-6" 4)
   ("Mig6 protein" 3) ("ERBB receptor feedback inhibitor 1" 3)
   ("overexpressed Mig6" 2) ("MIG-6" 2) ("undetectable MIG6 protein" 2)
   ("MIG6 (RALT)" 2) ("longer Mig6 peptide" 2) ("less Mig6" 1) ("more Mig6" 1)
   ("Errfi1" 1)))
 ("UP:Q9UJM8" (("GOX" 19) ("GOx" 12) ("HAO1" 6))) ("UP:Q9UJP4" (("KLHL21" 1)))
 ("UP:Q9UJQ4"
  (("SALL4" 298) ("Sall4" 10) ("SALL4-" 2) ("the exogenous SALL4" 1)))
 ("UP:Q9UJS0"
  (("Citrine" 9) ("citrine" 7) ("Slc25a13" 5)
   ("solute carrier family 25 member 13" 5) ("SLC25A13" 3) ("citrin" 1)))
 ("UP:Q9UJT0" ;removed lowercase tube
  (#+ignore("tube" 2614) #+ignore("Tube" 118) #+ignore("the fallopian tube" 87) #+ignore("the neural tube" 65)
   #+ignore("fallopian tube" 51) #+ignore("the developing neural tube" 13) #+ignore("neural tube" 13)
   ("TUBE" 12) ("a separate tube" 8) ("the dorsal neural tube" 8)
   ("normal fallopian tube" 7) ("a new tube" 5) ("a conical tube" 5)
   ("the distal fallopian tube" 5) ("TUBE1" 4) ("tube (PMT)" 4)
   ("3 normal fallopian tube" 4) ("Fallopian tube" 3) ("capillary tube" 3)
   ("a 50 ml conical tube" 3) ("the chick neural tube" 3) ("Tube Protein" 3)
   ("an ice-cold tube" 2) ("trunk neural tube" 2) ("a 15 ml conical tube" 2)
   ("a capillary tube" 2) ("the endotracheal tube" 2)
   ("the left fallopian tube" 2) ("gastric tube" 2) ("the Fallopian tube" 2)
   ("the muscular tube" 2) ("the embryonic neural tube" 2)
   ("a 1.5 mL micro tube" 2) ("either fallopian tube" 1)
   ("All fallopian tube" 1) ("these fallopian tube" 1)
   ("a pre-chilled 15 ml conical tube" 1) ("the entire neural tube" 1)
   ("completely closed neural tube" 1) ("the early neural tube" 1)
   ("an orogastric tube" 1) ("an open neural tube" 1)
   ("comprised 8 normal fallopian tube" 1) ("the intramural fallopian tube" 1)
   ("the distal fallopian
tube"
    1)
   ("adult fallopian tube" 1)
   ("wider
tube"
    1)
   ("a 15 ml v-shaped tube" 1)
   ("One ethylenediaminetetraacetic acid (EDTA) sample tube" 1)
   ("8 normal fallopian tube" 1) ("a fresh collection tube" 1)
   ("An orogastric tube" 1) ("The orogastric tube" 1)
   ("a new micro centrifuge tube" 1) ("a cylindrical tube" 1)
   ("most primary fallopian tube" 1) ("the developing chick neural tube" 1)
   ("the 1/3 ventral neural tube" 1) ("HHIP1 electroporated neural tube" 1)
   ("a new conical tube" 1) ("only 3 fallopian tube" 1)
   ("the 3 fallopian tube" 1) ("3 fallopian tube" 1)
   ("The 3 normal fallopian tube" 1) ("early neural tube" 1)
   ("The left fallopian tube" 1) ("distal fallopian tube" 1)
   ("stained fallopian tube" 1) ("more fallopian tube" 1)
   ("significantly fewer fallopian tube" 1)
   ("histologically normal fallopian tube" 1)
   ("included distal fallopian tube" 1) ("each fallopian tube" 1)
   ("the gastric tube" 1) ("a 15-ml conical tube" 1)
   ("both the fallopian tube" 1) ("microscopic fallopian tube" 1)
   ("Occult fallopian tube" 1) ("Hh-dependent neural tube" 1)
   ("duodenal tube" 1) ("a duodenal tube" 1)
   ("A double-lumen nasogastric tube" 1) ("eight normal fallopian tube" 1)
   ("a 50-ml falcon conical tube" 1) ("chemotaxis or form capillary tube" 1)
   ("causes neural tube" 1) ("the tracheal tube" 1)
   ("fluid-filled fallopian tube" 1) ("primary fallopian tube" 1)
   ("tube, methanol (800 μL)" 1) ("TUBE1-" 1) ("15 mL conical tube" 1)
   ("15 ml conical tube" 1)))
 ("UP:Q9UJT1" (("TUBD1" 1))) ("UP:Q9UJT9" (("FBXL7" 8)))
 ("UP:Q9UJU2"
  (("lymphoid" 1437) ("LEF-1" 492) ("LEF1" 396) ("Lef-1" 74) ("Lymphoid" 36)
   ("Lef1" 29) ("LEF-1 protein" 18) ("lymphoid enhancer-binding factor 1" 11)
   ("lymphoid enhancer binding factor" 7) ("TLE/Groucho" 7) ("LEF-1–" 7)
   ("pLef-1" 4) ("lef1" 3) ("LEF1 protein" 2)
   ("the rest showed monomorphic lymphoid" 2) ("scarce lymphoid" 2)
   ("dominant-negative LEF-1" 2) ("normal lymphoid" 1)
   ("a cyclin D1–positive interstitial lymphoid" 1) ("tertiary lymphoid" 1)
   ("mature lymphoid" 1) ("transcriptional factor lymphoid" 1) ("LEF1-" 1)
   ("-lymphoid" 1) ("a preferential lymphoid" 1) ("Extra-nodular lymphoid" 1)
   ("Intra-nodular lymphoid" 1) ("the intra-glandular inflammatory lymphoid" 1)
   ("its transcriptional partner LEF1" 1)
   ("the Wnt pathway-associated proteins LEF-1" 1)
   ("Lymphoid enhancer binding factor" 1) ("lef-1" 1)
   ("the secondary lymphoid" 1) ("Epicardial lymphoid" 1)
   ("epicardial lymphoid" 1) ("lymphoid-" 1) ("mesodermal cells LEF-1" 1)
   ("ectodermal cells LEF-1" 1)))
 ("UP:Q9UJU3" (("ZNF112" 10)))
 ("UP:Q9UJU5"
  (("genesis" 573) ("FOXD3" 94) ("Foxd3" 58) ("Genesis" 8) ("GENESIS" 5)
   ("the ribosomal genesis" 2) ("aggressive molecular patho genesis" 2)
   ("multifocal genesis" 1) ("whose genesis" 1) ("“Genesis”" 1)
   ("osteoblastic bone lesion genesis" 1) ("HFH2" 1)
   ("robust multilineage cell genesis" 1)))
 ("UP:Q9UJU6" (("CMAP" 12) ("HIP-55" 1) ("SH3P7" 1)))
 ("UP:Q9UJV9" ; fixed
  (#+ignore("Abs" 805) ("ABS" 73) ("DDX41" 14) #+ignore("primary Abs" 10) #+ignore("appropriate Abs" 8)
   ("Secondary Abs" 8) ("abs" 6) ("secondary Abs" 4)
   ("RRX-conjugated Fab goat Abs" 4) ("Monoclonal Abs" 3)
   ("The secondary Abs" 3) ("peroxidase-coupled secondary Abs" 3)
   ("horseradish peroxidase-conjugated secondary Abs" 3) ("“ABS”" 3)
   ("two different primary Abs" 2) ("fluorescent secondary Abs" 2)
   ("HRP-conjugated secondary Abs" 2) ("available phospho-specific Abs" 2)
   ("anti-mouse IgG horseradish peroxidase-conjugated secondary Abs" 2)
   ("the following primary Abs" 2) ("anti-GAPDH rabbit monoclonal Abs" 2)
   ("anti-p62/SQSTM1 (D-3; sc28359) monoclonal Abs" 2)
   ("Alexa Fluor 488-conjugated goat anti-mouse and Alexa Fluor 568-conjugated goat anti-rabbit secondary Abs"
    2)
   ("Fab goat Abs" 2) ("Rhodamine Red X (RRX)-conjugated Fab goat Abs" 2)
   ("using pS52/pS33-specific Abs" 2) ("Goat anti-mouse secondary Abs" 2)
   ("Alexa 546 or 555 or 594 or 647 (red)-conjugated anti-rabbit and Alexa 488 (green)-conjugated anti-mouse secondary Abs"
    2)
   ("fluorescein-conjugated secondary Abs" 2)
   ("the following fluorescent Abs" 2) ("Infrared dye-labeled secondary Abs" 2)
   ("Alexa Fluor-conjugated secondary Abs" 2)
   ("rabbit (1:200 dilution) secondary Abs" 2) ("Primary Abs" 1)
   ("4°C. Secondary Abs" 1)
   ("Anti–mouse and anti–rabbit HRP-conjugated secondary Abs" 1)
   ("Alexa-conjugated secondary Abs" 1)
   ("Abcam (Abcam, Cambridge, UK) Fluorochrome-conjugated Alexa Fluor 488 and 546 secondary Abs"
    1)
   ("Primary and secondary Abs" 1) ("primary and secondary Abs" 1)
   ("all primary Abs" 1) ("commercially available monoclonal Abs" 1)
   ("commercially-available Abs" 1)
   ("their respective fluorescently labeled secondary Abs" 1)
   ("fluorescently labeled secondary Abs" 1) ("The two therapeutic Abs" 1)
   ("The following primary Abs" 1) ("Fluorochrome-conjugated monoclonal Abs" 1)
   ("appropriate isotypic control Abs" 1)
   ("IgG1 isotypic control (R&D Systems, Abbingdon, U.K.) Abs" 1)
   ("Alexa Fluor 488-conjugated goat anti-rat and Alexa Fluor 568-conjugated goat anti-rabbit or Alexa Fluor 488-conjugated goat anti-mouse and Alexa Fluor 568-conjugated goat anti-rabbit secondary Abs"
    1)
   ("flurochrome-conjugated secondary Abs" 1) ("conjugated secondary Abs" 1)
   ("monoclonal Abs" 1)
   ("Alexa Fluor 488-conjugated goat anti-rabbit secondary Abs" 1)
   ("using FITC-conjugated secondary Abs" 1)
   ("using AlexaFluor 488-conjugated goat Abs" 1)
   ("Monoclonal anti-u-PA and anti-u-PAR Abs" 1)
   ("The following commercially available Abs" 1)
   ("FITC-conjugated secondary Abs" 1) ("most anti-βTrCP1 polyclonal Abs" 1)
   ("appropriate HRP-conjugated secondary Abs" 1) ("Secondary ABs" 1) ("ABs" 1)
   ("goat anti-rabbit rhodamine or anti-mouse fluorescein-conjugated secondary Abs"
    1)
   ("mouse anti-Cav-1 and anti-Cav-2 primary Abs" 1) ("mouse monoclonal Abs" 1)
   ("Alexa-568-labeled GαM-Ig and Alexa-568-labeled GαR-Ig secondary Abs" 1)
   ("both latter Abs" 1) ("Appropriate anti-species secondary Abs" 1)
   ("fluorescein isothiocyanate (FITC)-conjugated goat anti mouse (GAM) secondary Abs"
    1)
   ("horseradish-peroxidase (HRP)-linked secondary Abs" 1)
   ("The bound primary Abs" 1) ("the primary Abs" 1)
   ("the respective primary Abs" 1)))
 ("UP:Q9UJW3" (("DNMT3L" 23) ("Dnmt3L" 1)))
 ("UP:Q9UJX2" (("APC8" 73) ("Cdc23" 14) ("CDC23" 5)))
 ("UP:Q9UJX3" (("APC7" 69) ("Apc7" 4))) ("UP:Q9UJX4" (("APC5" 27) ("Apc5" 8)))
 ("UP:Q9UJX5" (("APC4" 51) ("Apc4" 8) ("ANAPC4" 2)))
 ("UP:Q9UJX6"
  (("APC2" 695) ("ANAPC2" 55) ("a phosphomimetic APC2" 6)
   ("alanine blocked APC2's" 2) ("Both APC2's" 2)
   ("the cell-free-synthesized ANAPC2" 1)
   ("than those expressing Axin + APC2 ( xref )" 1)
   ("than wild-type APC2 ( xref )" 1) ("both APC2's" 1) ("fly APC2's" 1)))
 ("UP:Q9UJY1"
  (("H11" 116) ("HSPB8" 62) ("HspB8" 5) ("h11" 4) ("Hsp22" 2) ("HSP22" 1)
   ("1:100 monoclonal anti-EGFR antibody H11" 1)))
 ("UP:Q9UJY4"
  (("Golgi-associated" 42) ("γ-adaptin" 21) ("GGA2" 7) ("GGA2 protein" 4)
   ("Golgi–associated" 1)))
 ("UP:Q9UJY5" (("GGA1" 10))) ("UP:Q9UJZ1" (("StomL2" 2)))
 ("UP:Q9UK05"
  (("BMP9" 81) ("Bone morphogenetic protein 9" 3) ("exogenous BMP9" 1)
   ("Bmp9" 1)))
 ("UP:Q9UK12" (("ZNF222" 3))) ("UP:Q9UK17" (("Kv4.3" 21) ("KCND3" 5)))
 ("UP:Q9UK22" (("Fbx2" 6) ("NFB42" 4) ("FBXO2" 2)))
 ("UP:Q9UK32"
  (("RSK4" 391) ("RSK4 protein" 22) ("RPS6KA6" 9) ("overexpressed RSK4" 2)
   ("Rsk4" 1)))
 ("UP:Q9UK39" (("Nocturnin" 2) ("Ccrn4l" 1) ("S.cerevisiae)" 1)))
 ("UP:Q9UK41" (("hVPS28" 29) ("VPS28" 20))) ("UP:Q9UK45" (("LSM7" 1)))
 ("UP:Q9UK53"
  (("ING1" 364) ("ING1 protein" 9) ("p33ING1" 3) ("p33ING1b" 2) ("ing1" 2)
   ("Ing1" 1) ("ING1-" 1) ("Bacterial recombinant ING1 protein" 1)
   ("Src-associated ING1" 1)))
 ("UP:Q9UK59" (("DBR1" 1))) ("UP:Q9UK97" (("FBXO9" 3)))
 ("UP:Q9UK99" (("FBXO3" 5))) ("UP:Q9UKA1" (("FBXL5" 17)))
 ("UP:Q9UKA2" (("FBXL4" 1))) ("UP:Q9UKA4" (("AKAP220" 3) ("AKAP11" 2)))
 ("UP:Q9UKA8"
  (("RCAN3" 4) ("Dscr1l2" 3) ("Rcan3" 2) ("RCAN family member 3" 1)))
 ("UP:Q9UKA9" (("nPTB" 21) ("PTBP2" 5)))
 ("UP:Q9UKB1"
  (("βTrCP" 947) ("βTRCP" 174) ("FBXW11" 24) ("HOS" 24) ("βTrcp" 24) ("Hos" 9)
   ("endogenous βTrCP1" 3) ("βTrCP-" 2) ("βtrcp" 1)
   ("the well-studied ubiquitin ligase βTRCP" 1) ("Fbw11" 1)
   ("transiently-expressed βTrCP" 1) ("than βTrCP" 1) ("Fbxw11" 1)))
 ("UP:Q9UKB5" (("AJAP1" 22)))
 ("UP:Q9UKC9"
  (("FBXL2" 175) ("FLAG–HA-tagged FBXL2" 2) ("Fbxl2" 1)
   ("than wild-type FBXL2 ( xref )" 1)))
 ("UP:Q9UKD1" (("GMEB2" 1))) ("UP:Q9UKE5" (("TNIK" 11)))
 ("UP:Q9UKF2" (("ADAM30" 4))) ("UP:Q9UKF6" (("CPSF-73" 31) ("CPSF73" 4)))
 ("UP:Q9UKF7" (("Pitpnc1" 4) ("PITPNC1" 4)))
 ("UP:Q9UKG1"
  (("APPL1" 627) ("APPL" 129) ("APPL1 protein" 14) ("APPL protein" 8)
   ("overexpressed APPL1" 6) ("DCC-interacting protein 13-alpha" 2)
   ("APPL1-" 2) ("Multifunctional adaptor protein APPL1" 2)
   ("an endocytic adaptor APPL1" 1) ("the endocytic protein APPL1" 1)
   ("an endocytic protein APPL1" 1)))
 ("UP:Q9UKG9" (("CROT" 2) ("Crot" 1)))
 ("UP:Q9UKI2" (("Ub1" 9) ("CEP3" 6) ("CDC42EP3" 1)))
 ("UP:Q9UKI8"
  (("TLK1" 5) ("Tlk1" 4) ("Tousled like kinase 1" 3)
   ("tousled-like kinase 1" 1)))
 ("UP:Q9UKI9" (("POU2F3" 1))) ("UP:Q9UKJ5" (("CHIC2" 23) ("BTL" 8) ("btl" 6)))
 ("UP:Q9UKK3" (("PARP4" 7) ("vPARP" 2))) ("UP:Q9UKK6" (("Nxt1" 5) ("NXT1" 2)))
 ("UP:Q9UKK9" (("NUDT5" 1)))
 ("UP:Q9UKL0" (("Rcor1" 12) ("RCOR1" 4) ("RCOR" 3) ("RCoR1" 1)))
 ("UP:Q9UKL3"
  (("FLASH" 519) ("flash" 350) ("Flash" 156) ("CASP8AP2" 22) ("FlAsH" 15)
   ("FLASH-" 13) ("a temporary flash" 2) ("Flash (STF)" 2) ("than FLASH" 2)
   ("the UV flash" 1) ("the first 139 amino acid of FLASH" 1)
   ("the pro-apoptotic protein FLASH" 1)
   ("the SUMO acceptor lysine of FLASH" 1) ("“Super-Top-Flash”" 1)))
 ("UP:Q9UKL4" (("GJD2" 5) ("alpha 9" 3) ("Connexin 36" 3)))
 ("UP:Q9UKL6" (("PCTP" 9)))
 ("UP:Q9UKM7" (("MAN1B1" 4) ("class 1B" 3) ("Class 1B" 1)))
 ("UP:Q9UKM9" (("RALY" 76)))
 ("UP:Q9UKN1" (("MUC12" 11) ("cell surface associated" 3) ("MUC12 protein" 2)))
 ("UP:Q9UKN8" (("90kDa" 5))) ("UP:Q9UKP3" (("melusin" 4)))
 ("UP:Q9UKP4" (("ADAMTS7" 6))) ("UP:Q9UKP5" (("ADAMTS6" 3)))
 ("UP:Q9UKP6" (("GPR14" 14)))
 ("UP:Q9UKQ2" (("ADAM28" 4) ("MDC-L" 1) ("ADAM-28" 1) ("ADAM 28" 1)))
 ("UP:Q9UKS7" (("Helios" 15) ("IKZF2" 5) ("HELIOS" 2) ("helios" 1)))
 ("UP:Q9UKT4"
  (("EMI1" 219) ("Emi1" 202) ("-EMI1" 20) ("FBXO5" 17) ("Emi-1" 6) ("Fbxo31" 5)
   ("early mitotic inhibitor 1" 5) ("the mitotic regulator Emi1" 2)
   ("that EMI1’s" 1) ("Human EMI1’s" 1) ("shorter EMI1" 1) ("Emi1-" 1)
   ("the mitotic cell-cycle regulator Emi1" 1) ("Fbx5" 1)
   ("Early mitotic inhibitor 1" 1)))
 ("UP:Q9UKT5"
  (("Fbx4" 324) ("FBX4" 77) ("FBXO4" 20) ("Fbx4 protein" 4)
   ("exogenous Fbx4" 2) ("than the wild type Fbx4" 1)
   ("exogenous wild type Fbx4" 1)))
 ("UP:Q9UKT6" (("FBXL21" 7) ("Fbxl21" 5)))
 ("UP:Q9UKT7" (("Fbxl3" 47) ("FBXL3" 9)))
 ("UP:Q9UKT8" (("FBXW2" 12) ("FBW2" 2) ("Fbxw2" 1)))
 ("UP:Q9UKT9" (("IKZF3" 46) ("ZNFN1A3" 11) ("Ikzf3" 7) ("ikzf3" 1)))
 ("UP:Q9UKU0" (("ACS2" 25) ("ACSL6" 6) ("ACS2 peptide" 6)))
 ("UP:Q9UKU7" ; complicated -- unclear what the bare ones are, but others are inflammatory bowel disease or "identical-by-descent" regions of DNA
  (("IBD" 1089) ("pediatric IBD" 3) ("than 700 cM IBD" 2)
   ("both pediatric and adult IBD" 1) ("IBD-" 1)
   ("European descent identified additional IBD" 1) ("just coexistent IBD" 1)
   ("coexistent IBD" 1) ("overt IBD" 1) ("colonic IBD" 1)
   ("“any” colonic IBD" 1) ("active colonic IBD" 1)))
 ("UP:Q9UKU9" (("ANGPTL2" 1)))
 ("UP:Q9UKV0"
  (("HDAC9" 427) ("histone deacetylase 9" 9) ("MITR" 4) ("Hdac9" 3)
   ("Histone deacetylase 9" 3) ("all arterial beds strong HDAC9" 2)
   ("our new association around HDAC9" 1) ("-HDAC9" 1)))
 ("UP:Q9UKV3" ;fixed
  (#+ignore("acini" 1325) #+ignore("acinus" 180) #+ignore("Acini" 47) #+ignore("mammary acini" 23)
   #+ignore("Acinus" 21) #+ignore("mature acini" 18) #+ignore("mammary epithelial acini" 17)
   #+ignore("normal acini" 7) #+ignore("larger acini" 5) #+ignore("aberrant acini" 4)
   #+ignore("smaller acini" 4) #+ignore("epithelial acini" 4)
   #+ignore("differentiated mammary epithelial acini" 3) #+ignore("normoxic acini" 3)
   #+ignore("hypoxic acini" 3) #+ignore("parental MCF-10A acini" 3) #+ignore("Normal acini" 2)
   #+ignore("normal mammary acini" 2) #+ignore("uniform polar acini" 2)
   #+ignore("IgG-treated 10A cont acini" 2) #+ignore("IgG-treated 10A L2 acini" 2)
   #+ignore("LOXL2-expressing acini" 2) #+ignore("abnormal acini" 2)
   #+ignore("the typical pancreatic acinus" 2)
   #+ignore("Three-Dimensional Culture Assays-MCF10A Cells Form Acini" 2)
   #+ignore("regressed mouse prostate glandular acini" 2)
   #+ignore("phenotypically normal acini" 2) #+ignore("quiescent acini" 2) ("ACINUS" 2)
   ("cleaved caspase-3–positive acini" 2) ("mature 3D acini" 2)
   ("the mature acini" 2) ("less circular acini" 2)
   ("HER2-overexpressing acini" 2) ("misshapen acini" 2)
   ("large and misshapen acini" 2) ("highly proliferative acini" 2)
   ("properly formed mammary acini" 2)
   ("β-catenin induced multi-lobular acini" 2) ("multi-lobular acini" 2)
   ("polarized epithelial acini" 2)
   ("the less aggressive BRC cells generated acini" 1)
   ("those aberrant acini" 1) ("most acini" 1) ("Glandular acini" 1)
   ("DMSO-treated 10A cont acini" 1) ("aberrant mammary acini" 1)
   ("than 10A cont acini" 1) ("at least 20 acini" 1)
   ("multiple mammary acini" 1) ("than the control acini" 1)
   ("polarized spherical acini" 1) ("at least 100 distinct acini" 1)
   ("the primary acinus" 1)
   ("around RB-proficient ErbB2 over expressing acini" 1)
   ("RB-proficient and RB-deficient cells generated spherical acini" 1)
   ("around benign normal appearing prostate acini" 1)
   ("three-dimensional polarized acini" 1) ("three-dimensional breast acini" 1)
   ("the benign prostate acini" 1)
   ("percent cleaved caspase-3 positive acini" 1)
   ("than control MCF10A acini" 1)
   ("ζ cells generated atypical ductal hyperplasia (ADH)-like acini" 1)
   ("the 10A.Vec cells produced normal acini" 1)
   ("only MCF10A EGFR -DEL cells formed acini" 1) ("At least 200 acini" 1)
   ("a salivary gland acinus" 1) ("an epithelial acinus" 1)
   ("ER-Akt–expressing acini" 1) ("Bcl-2–expressing acini" 1)
   ("MCF-10A mammary acini" 1) ("These cells display aberrant acini" 1)
   ("cultured mammary epithelial acini" 1) ("4-HT-treated Raf:ER acini" 1)
   ("multicellular epithelial acini" 1) ("Only one or two acini" 1)
   ("salubrinal-treated ErbB2 acini" 1) ("salubrinal-treated CA-ErbB2 acini" 1)
   ("the three-dimensional (3D) acini" 1) ("three-dimensional mammary acini" 1)
   ("discohesive acini" 1) ("control cell lines formed typical acini" 1)
   ("the neoplastic acini" 1) ("less complex acini" 1)
   ("single-layered acini" 1) ("percent filled acini" 1)
   ("hypoxia-treated acini" 1) ("human mammary epithelial acini" 1)
   ("resembled parental MCF-10A acini" 1) ("than control acini" 1)
   ("entire acini" 1) ("more acini" 1) ("caerulein treated acini" 1)
   ("most morphologically normal acini" 1) ("both immature and mature acini" 1)
   ("infected mature (day 18) acini" 1) ("at least 100 acini" 1)
   ("invasive acini" 1) ("treated acini" 1)
   ("5-day-old HER2-overexpressing acini" 1) ("circular acini" 1)
   ("the filled HER2-overexpressing acini" 1) ("relatively small acini" 1)
   ("At least 10 acini" 1) ("multilobular acini" 1) ("still spherical acini" 1)
   ("coherent acini" 1) ("the abnormal acini" 1) ("large misshapen acini" 1)
   ("highly proliferative and disorganised acini" 1)
   ("ICI 182,780 allowed E2-treated acini" 1) ("neighboring acini" 1)))
 ("UP:Q9UKV5"
  (("gp78" 332) ("E3 ubiquitin protein ligase" 43) ("AMFR" 39)
   ("AMF receptor" 4) ("gp78 protein" 2)
   ("a cell surface transmembrane E3 ubiquitin protein ligase" 2)
   ("gp78 (AMFR)" 2)
   ("E3
ubiquitin protein ligase"
    1)
   ("autocrine motility factor receptor (AMFR)" 1)
   ("autocrine motility factor receptor" 1)
   ("autocrine mobility factor receptor" 1) ("Insig-associated gp78" 1)
   ("yet another AMF receptor" 1)))
 ("UP:Q9UKV8"
  (("Ago2" 648) ("AGO2" 267) ("slicer" 31) ("Argonaute 2" 23) ("hAgo2" 18)
   ("Slicer" 9) ("Argonaute-2" 7) ("Argonaute2" 7) ("argonaute 2" 6)
   ("Ago2 protein" 6) ("EIF2C2" 5) ("Ago2-" 4) ("ago2" 4) ("argonaute2" 3)
   ("the special slicer" 2) ("Argonaute 2 protein" 2) ("than Ago2" 1)
   ("ARGONAUTE 2" 1) ("the miRNA-associated protein Ago2" 1) ("‘slicer’" 1)
   ("most Ago2 protein" 1)))
 ("UP:Q9UKW4"
  (("Vav3" 664) ("VAV3" 45) ("Vav3 protein" 20) ("overexpressed Vav3" 2)
   ("the homologous Vav3 protein" 1) ("normal Vav3" 1) ("vav3" 1)))
 ("UP:Q9UKW6" (("Elf5" 32) ("ELF5" 2) ("Elf5 protein" 2)))
 ("UP:Q9UKX2"
  (("myosin heavy chain IIA" 13) ("MHCIIA" 11) ("myosin 2" 4) ("MYH2" 2)
   ("myosin heavy chain 2" 2) ("myosin heavy chain IIA (NMMHCIIA)" 1)
   ("MYH2A" 1) ("Myosin 2" 1)))
 ("UP:Q9UKX5" (("alpha 11" 4) ("ITGA11" 2)))
 ("UP:Q9UKX7" (("Nup50" 5) ("NUP50" 2)))
 ("UP:Q9UKZ1"
  (("C40" 19) ("DNA polymerase B possible subunit 11" 2) ("C2ORF29" 1)
   ("subunit 11" 1)))
 ("UP:Q9UL01" (("DSE" 27))) ("UP:Q9UL12" (("sarcosine dehydrogenase" 1)))
 ("UP:Q9UL15" (("BAG5" 34)))
 ("UP:Q9UL16"
  (("CCDC19" 137) ("CCDC19 protein" 3)
   ("the nasopharyngeal epithelium specific protein CCDC19" 1)))
 ("UP:Q9UL17"
  (("T-bet" 352) ("TBX21" 73) ("Tbx21" 29) ("TBET" 6) ("t-bet" 5) ("T-bet-" 3)
   ("Tbet" 2) ("intraglomerular T-bet" 2) ("Both intraglomerular T-bet-" 1)
   ("than T-bet in memory CD4 T cells" 1) ("T-bet protein" 1)))
 ("UP:Q9UL18"
  (("Ago1" 79) ("ago1" 7) ("Argonaute-1" 5) ("Argonaute 1" 4)
   ("protein Argonaute-1" 3) ("AGO1" 3) ("-Ago1" 2) ("argonaute 1" 2)))
 ("UP:Q9UL19"
  (("TIG3" 11)
   ("The tumor suppressive gene retinoic acid receptor responder 3" 2)
   ("retinoic acid receptor responder 3" 2) ("RARRES3" 1)))
 ("UP:Q9UL25" (("Rab21" 143) ("Rab21-" 7) ("RAB21" 2)))
 ("UP:Q9UL26" (("Rab22A" 1) ("Rab22" 1) ("Rab22a" 1)))
 ("UP:Q9UL33" (("TRAPPC2L" 1))) ("UP:Q9UL40" (("JAZ" 1)))
 ("UP:Q9UL41" (("MA3" 11) ("mas5" 4) ("Mas5" 2) ("MA3-" 1)))
 ("UP:Q9UL46"
  (("PSME2" 3) ("PA28β" 1)
   ("the interferon-inducible proteasome-associated activator PSME2" 1)))
 ("UP:Q9UL49" (("Cha" 5) ("pCHA" 3) ("CHA" 1))) ("UP:Q9UL51" (("HCN2" 18)))
 ("UP:Q9UL54" (("TAO2" 13) ("TAOK2" 6))) ("UP:Q9UL58" (("ZNF215" 1)))
 ("UP:Q9UL62" (("TRPC 5" 3) ("TRP5" 1) ("trp5" 1) ("Trp5" 1) ("TRPC5" 1)))
 ("UP:Q9UL63"
  (("Mkln1" 5) ("MKLN1" 3) ("Muskelin 1" 3) ("muskelin 1" 2) ("Muskelin" 1)))
 ("UP:Q9UL68" (("Myt1l" 2))) ("UP:Q9ULA0" (("aspartyl aminopeptidase" 1)))
 ("UP:Q9ULB1" (("neurexin-1" 1))) ("UP:Q9ULB4" (("CDH9" 3)))
 ("UP:Q9ULC3" (("RAB23" 6) ("Rab23" 3)))
 ("UP:Q9ULC4"
  (("MCT-1" 540) ("MCT-1 protein" 18) ("MCTS1" 4)
   ("the mimetic ERK-phosphorylated MCT-1" 2)
   ("the intrinsic and ectopic MCT-1" 1) ("intrinsic MCT-1" 1)
   ("endogenic MCT-1" 1)))
 ("UP:Q9ULC5" (("ACSL5" 39))) ("UP:Q9ULC6" (("peptidyl arginine deiminase" 3)))
 ("UP:Q9ULC8" (("ZDHHC8" 36)))
 ("UP:Q9ULD2"
  (("MTUS1" 2) ("mitochondrial tumor suppressor 1 (MTUSI)" 1)
   ("mitochondrial tumor suppressor 1" 1)
   ("Mitochondrial tumor suppressor 1" 1) ("mtus1" 1)))
 ("UP:Q9ULD8" (("Elk2" 1))) ("UP:Q9ULE3" (("DENND2A" 1)))
 ("UP:Q9ULE6" (("PALD1" 2))) ("UP:Q9ULF5" (("ZIP10" 8)))
 ("UP:Q9ULG1"
  (("INO80" 204) ("Ino80" 28) ("INO80-" 7) ("INO80 protein" 5) ("Ino80-" 3)))
 ("UP:Q9ULG6" (("Ccpg1" 4) ("CCPG1" 2)))
 ("UP:Q9ULH0" ; removed lowercase arms
  (#+ignore("arms" 1649) ("ARMS" 632) ("aRMS" 110) ("Arms" 18) ("experimental arms" 11)
   ("ARMs" 6) ("Kidins220" 6) ("PAX3/7-FOXO1-positive ARMS" 4)
   ("distinct arms" 4) ("“arms”" 4) ("KidIns220" 3) ("invasive arms" 3)
   ("PAX3/7-FOXO1-negative ARMS" 2) ("the homologous arms" 2)
   ("two homologous arms" 2) ("both the innate and adaptive arms" 2)
   ("mitotic chromosome arms" 2) ("8q chromosomal arms" 2)
   ("target called Kidins220" 2)
   ("underwent different chemotherapy treatment arms" 2) ("chromosomal arms" 2)
   ("flanking duplex arms" 2) ("two major arms" 2) ("heterologous arms" 2)
   ("further 2 ARMS" 2) ("than Scorpion ARMS" 2)
   ("the sequential and concurrent arms" 1) ("upper arms" 1)
   ("divergent arms" 1) ("the two therapeutic arms" 1)
   ("both therapeutic arms" 1) ("high accuracy PAX3/7-FOXO1-positive ARMS" 1)
   ("one fusion-negative (RH18) ARMS" 1) ("the essential arms" 1)
   ("than their single agent arms" 1) ("late treatment arms" 1)
   ("using ARMS" 1) ("than one chemotherapy arms" 1) ("7 weeks entire arms" 1)
   ("proximal and distal arms" 1) ("the three major arms" 1)
   ("longer regressed arms" 1) ("two essential arms" 1)
   ("EMD1214063 (6 mg/kg) twice weekly treatment arms" 1)
   ("compared at least two arms" 1) ("both experimental arms" 1)
   ("these chromosomal arms" 1) ("the aversive open arms" 1)
   ("homologous arms" 1) ("flexible spacer arms" 1)
   ("all human chromosomal arms" 1) ("down two distinct arms" 1)
   ("almost entire chromosome arms" 1) ("both major arms" 1)
   ("acceptable ARMS" 1) ("at least two arms" 1) ("ovarian arms" 1)
   ("whose arms" 1) ("previously described IF-dependent arms" 1)
   ("these two regulatory arms" 1) ("regulatory arms" 1)
   ("innate and adaptive arms" 1) ("these distinct arms" 1) ("distal arms" 1)
   ("All experimental arms" 1) ("disproportionately short arms" 1)
   ("invasive or metastatic ARMS" 1) ("both regulatory arms" 1)
   ("the innate or adaptive arms" 1) ("metastatic aRMS" 1)
   ("fusion-negative aRMS" 1) ("the innate and adaptive arms" 1)
   ("two symmetric linker arms" 1) ("completely lacks DNA linker arms" 1)
   ("50% involved more chromosomal arms" 1) ("both chromosomal arms" 1)
   ("specific chromosomal arms" 1) ("the individual chromosomal arms" 1)
   ("KIAA1250" 1) ("S-SCAM directly binds ARMS" 1)
   ("ankyrin repeat-rich membrane spanning protein" 1) ("than ARMS" 1)))
 ("UP:Q9ULH1"
  (("ASAP1" 130) ("BD" 14) ("PAG2" 5) ("ARF GTPase-activating protein 1" 4)
   ("DDEF1" 3)))
 ("UP:Q9ULH4" (("fibronectin type III" 26) ("FNIII" 4)))
 ("UP:Q9ULH7" (("MKL2" 22) ("MRTF-B" 15))) ("UP:Q9ULI1" (("KIAA1239" 1)))
 ("UP:Q9ULI3" (("HEG1" 78) ("Heg1" 63) ("heg" 17) ("HeG" 1)))
 ("UP:Q9ULI4" (("KIF26A" 4) ("Kif26a" 2) ("kinesin family member 26A" 1)))
 ("UP:Q9ULJ6"
  (("hZimp10" 150) ("ZMIZ1" 36) ("Zimp10" 31) ("Miz" 16) ("hZimp10 protein" 6)
   ("a potential hZimp10" 4) ("overexpressed hZimp10" 3)
   ("exogenous hZimp10" 3) ("zmiz1" 2) ("zinc finger MIZ-type containing 1" 1)
   ("MIZ" 1)))
 ("UP:Q9ULK0" (("GRID1" 4))) ("UP:Q9ULK4" (("MED23" 2)))
 ("UP:Q9ULK5"
  (("VANGL2" 26) ("Vangl2" 24) ("strabismus" 11) ("Strabismus" 9) ("Vang" 3)
   ("VANG" 2) ("divergent strabismus" 2) ("Stbm" 2)
   ("Bilateral strabismus" 1)))
 ("UP:Q9ULK6" (("RNF150" 4))) ("UP:Q9ULL1" (("PLEKHG1" 2)))
 ("UP:Q9ULL4" (("Plexin B3" 28) ("PLXNB3" 2) ("plexin-B3" 2)))
 ("UP:Q9ULM3" (("YEATS2" 12)))
 ("UP:Q9ULM6" (("Ccr4a" 9) ("CNOT6" 5) ("cytoplasmic deadenylase" 3)))
 ("UP:Q9ULP0" (("NDRG4" 2))) ("UP:Q9ULQ0" (("FAM40B" 32)))
 ("UP:Q9ULQ1" (("TPC1" 94)))
 ("UP:Q9ULR3" (("protein phosphatase 1H" 2) ("PPM1H" 1)))
 ("UP:Q9ULR5" (("PAIP2B" 1))) ("UP:Q9ULS5" (("TMCC3" 1)))
 ("UP:Q9ULT6" (("ZNRF3" 13) ("particular ZNRF3" 1)))
 ("UP:Q9ULT8" (("HECT" 273) ("Hect" 1) ("hect" 1) ("HECT-" 1)))
 ("UP:Q9ULU4" (("ZMYND8" 1))) ("UP:Q9ULV0" (("myosin Vb" 7) ("MYO5B" 1)))
 ("UP:Q9ULV1"
  (("vasculature" 1386) ("FZD4" 49) ("Vasculature" 35)
   ("the pulmonary vasculature" 31) ("intratumoral vasculature" 14)
   ("new vasculature" 13) ("the lymphatic vasculature" 7)
   ("the intratumoral vasculature" 5) ("perfusable vasculature" 5)
   ("lymphatic vasculature" 5) ("the uterine vasculature" 5)
   ("normal vasculature" 4) ("pulmonary vasculature" 4)
   ("tumor-associated vasculature" 3) ("the coronary vasculature" 3)
   ("the cerebral vasculature" 3) ("the local vasculature" 3)
   ("30-μm–sized intratumoral vasculature" 3) ("the normal vasculature" 3)
   ("human pulmonary vasculature" 3) ("arterial vasculature" 3)
   ("an intratumoral vasculature" 2) ("The lymphatic vasculature" 2)
   ("the embryonic vasculature" 2) ("the placental vasculature" 2)
   ("a distinct intravasation-sustaining intratumoral vasculature" 2)
   ("the primary vasculature" 2) ("the cranial vasculature" 2)
   ("foetal vasculature" 2) ("SScPAH pulmonary vasculature" 2)
   ("the choroidal vasculature" 2) ("the endothelial vasculature" 2)
   ("a quiescent vasculature" 2) ("the inefficient tumour vasculature" 2)
   ("the excessive vasculature" 2)
   ("an intravasation-supporting intratumoral vasculature" 1)
   ("perfusable intratumoral vasculature" 1)
   ("an intravasation-sustaining intratumoral vasculature" 1)
   ("B cells around tumor vasculature" 1)
   ("the developing coronary vasculature" 1)
   ("the glioblastoma-associated vasculature" 1) ("aberrant vasculature" 1)
   ("a more normal vasculature" 1) ("prominent vasculature" 1)
   ("delicate vasculature" 1)
   ("the spatial relationships around vasculature" 1) ("around vasculature" 1)
   ("the study pathologist (MMB) identified visible vasculature" 1)
   ("the poor vasculature" 1) ("disorganized embryonic vasculature" 1)
   ("cancer-associated vasculature" 1)
   ("mice display decreased coronary vasculature" 1)
   ("the vascular vasculature" 1) ("embryonic vasculature" 1)
   ("placental vasculature" 1)
   ("a permeable intravasation-sustaining vasculature" 1)
   ("robust angiogenic vasculature" 1)
   ("the entire intratumoral vasculature" 1)
   ("the highly permeable angiogenic vasculature" 1)
   ("a VEGF-dependent angiogenic vasculature" 1)
   ("a distinct intratumoral vasculature" 1) ("the limbal vasculature" 1)
   ("peripheral (lobar) cerebral vasculature" 1) ("the dermal vasculature" 1)
   ("the peripheral vasculature" 1) ("the adult pulmonary vasculature" 1)
   ("cranial vasculature" 1) ("the VEGF-C-induced lymphatic vasculature" 1)
   ("the systemic vasculature" 1) ("their own vasculature" 1)
   ("the sinusoidal vasculature" 1) ("post-capillary vasculature" 1)
   ("capillary pulmonary vasculature" 1) ("This choroidal vasculature" 1)
   ("some ciliary vasculature" 1) ("the pulmonary or systemic vasculature" 1)
   ("the fetal vasculature" 1) ("well-developed vasculature" 1)
   ("the hypoxia-exposed pulmonary vasculature" 1)
   ("an incomplete vasculature" 1) ("the portal vasculature" 1)
   ("the ovine placental vasculature" 1) ("the maternal vasculature" 1)
   ("the maternal systemic vasculature" 1) ("the entire vasculature" 1)
   ("the tracheal vasculature" 1) ("nearby vasculature" 1)
   ("the arterial vasculature" 1) ("the mature vasculature" 1)
   ("the functional vasculature" 1) ("the post-natal vasculature" 1)
   ("post-developmental quiescent vasculature" 1)
   ("both systemic and pulmonary vasculature" 1)))
 ("UP:Q9ULV4"
  (("Coro1C" 176) ("coronin-1C" 124) ("Coronin-1C" 5) ("CRN2" 2)
   ("trimeric Coro1C" 1) ("Coro1C (GCACAAGACUGGUCGAAUU)" 1)
   ("Coro1C (CCGUUGAAUUAAUUACGUA)" 1)))
 ("UP:Q9ULV5" (("HSF4" 1)))
 ("UP:Q9ULV8"
  (("Cbl-c" 269) ("CBLC" 198) ("Cbl-3" 11) ("Cbl-C" 9) ("Cbl-c protein" 5)
   ("cbl-c" 4) ("a new Cbl-c" 4) ("RNF57" 3) ("CBL-c" 2) ("potential Cbl-c" 2)
   ("Cbl proto-oncogene C" 1) ("overexpressing CBLC" 1)
   ("exogenous wild type CBLC" 1) ("CBLC protein" 1) ("CBL-3" 1)
   ("the last 124 amino acids of Cbl-c" 1) ("soluble Cbl-c" 1) ("CBl-c" 1)))
 ("UP:Q9ULW0"
  (("TPX2" 211) ("targeting protein for Xklp2" 3) ("TPX2 protein" 3)
   ("minimal detectable TPX2 protein" 2) ("targeting protein for XKlp2" 1)
   ("Tpx2" 1)))
 ("UP:Q9ULW2" (("FZD10" 9))) ("UP:Q9ULW5" (("Rab26" 3)))
 ("UP:Q9ULX5" (("BFP" 54)))
 ("UP:Q9ULX6"
  (("HA95" 195) ("HAP95" 3) ("the chromatin-associated protein HA95" 1)
   ("nuclear matrix–associated protein HA95" 1) ("NAKAP95" 1)))
 ("UP:Q9ULX7" (("pCA14" 2))) ("UP:Q9ULX9" (("MafF" 13) ("MAFF" 10) ("Maff" 1)))
 ("UP:Q9ULY5"
  (("Mincle" 17) ("member E" 4) ("superfamily member 9" 4) ("Clec4e" 1)))
 ("UP:Q9ULZ1" (("Apelin" 1) ("APLN" 1)))
 ("UP:Q9ULZ2"
  (("STAP-1" 2) ("STAP1" 2) ("Signal-transducing adaptor protein 1" 2)))
 ("UP:Q9ULZ3"
  (("TMS1" 51) ("ASCs" 36) ("AsCs" 29) ("PYCARD" 15)
   ("than AsCs ( P <0.001)" 1) ("multipotent ASCs" 1) ("than ASCs" 1)
   ("CARD5" 1)))
 ("UP:Q9ULZ9"
  (("MT4-MMP" 10) ("MMP17" 1) ("matrix metalloproteinase-17" 1) ("MMP-17" 1)))
 ("UP:Q9UM00" (("TMCO1" 41) ("transmembrane and coiled-coil domains 1" 2)))
 ("UP:Q9UM07"
  (("PADI4" 316) ("HL60" 313) ("PAD4" 115) ("Peptidylarginine deiminase 4" 4)
   ("peptidyl arginine deiminase 4" 3) ("the promyeloblastic leukemia HL60" 2)
   ("peptidylarginine deiminase 4" 2) ("PADI4 (CS)" 2)
   ("Peptidylarginine deiminase IV" 2)
   ("the human pro-monomyeloleucocytic cell line HL60" 1) (NIL 1)
   ("the previously reported PADI4" 1) ("treated HL60" 1)))
 ("UP:Q9UM11" (("fzr" 6) ("Fzr" 3) ("FZR1" 2) ("FZR" 1)))
 ("UP:Q9UM13"
  (("APC10" 254) ("ANAPC10" 13) ("Apc10/Doc1" 7) ("Apc10" 5)
   ("the C-terminal 66 amino acids of APC10" 1)
   ("the N-terminal 82 amino acids of APC10" 1)))
 ("UP:Q9UM19" (("HPCAL4" 3))) ("UP:Q9UM21" (("MGAT4A" 1)))
 ("UP:Q9UM47"
  (("Notch3" 2362) ("NOTCH3" 1374) ("Notch-3" 128) ("Notch3 protein" 46)
   ("NOTCH3 protein" 33) ("Notch 3" 28) ("Notch3 peptide" 19) ("notch3" 8)
   ("NOTCH 3" 3) ("Notch3-" 3) ("notch 3" 3) ("a functional Notch3" 2)
   ("membrane-associated Notch3" 2) ("Notch3 molecule" 2)
   ("Total cellular NOTCH3" 2) ("coexpressed NOTCH3" 2) ("potential NOTCH3" 1)
   ("directly target NOTCH 3" 1) ("Notch-3 protein" 1)
   ("the contrary Notch3" 1) ("Hyperactive Notch3" 1)
   ("normal brain vascular tissue Notch-3" 1) ("immediate NOTCH3" 1)
   ("normoxic Notch3  +/+" 1) ("than Notch3 ( xref )" 1)
   ("than wildtype NOTCH3" 1) ("than mutant NOTCH3 ( xref )" 1)
   ("excessive NOTCH3" 1)))
 ("UP:Q9UM54" (("Myo6" 4) ("MYO6" 2))) ("UP:Q9UM63" (("Zac1" 2) ("PLAGL1" 2)))
 ("UP:Q9UM73"
  (("ALK" 8283) ("anaplastic lymphoma kinase" 137) ("Alk" 115)
   ("ALK protein" 86) ("ALK-" 59) ("pALK" 37) ("Anaplastic lymphoma kinase" 32)
   ("-ALK" 19) ("–ALK" 13) ("anaplastic lymphoma kinase (ALK)" 10) ("p-ALK" 6)
   ("CD246" 5) ("e.g. ALK I1250T" 4) ("ALK tyrosine kinase receptor" 3)
   ("anaplastic lymphoma kinase ( ALK )" 3)
   ("Mouse monoclonal anti-human ALK" 2) ("noncircumferential ALK" 2)
   ("the two most frequent ALK" 2) ("a prospective ALK" 2)
   ("lymphoma kinase" 2) ("perinuclear ALK" 2)
   ("the mouse monoclonal anti-human CD246" 2) ("ALK (pALK) protein" 2)
   ("glutamic acid (G1201E) of ALK" 2)
   ("two novel missense heterozygous ALK point mutations" 2)
   ("targeting Alk" 2) ("anaplastic lymphoma receptor tyrosine kinase" 1)
   ("metastatic ALK" 1) ("most ALK-" 1) ("Anaplastic lymphoma kinase (ALK)" 1)
   ("scored nuclei showed split ALK" 1) ("the ALK -rearranged" 1)
   ("disomic ALK" 1) ("target not only aberrant ALK" 1) ("intact ALK" 1)
   ("”" 1) ("Non-rearranged ALK" 1)
   ("The dual anaplastic lymphoma kinase (ALK)" 1) ("directly target ALK" 1)
   ("Mouse monoclonal anti-human CD246" 1) ("than ALK" 1)
   ("the previously well-characterized neuroblastoma-associated ALK mutants K1062M and F1174L"
    1)
   ("than the wild-type ALK ( xref )" 1)
   ("The neuroblastoma-associated ALK mutants K1062M and F1174L" 1)
   ("phenylalanine (L1198F) of ALK" 1)
   ("the neuroblastoma-associated ALK mutants K1062M and F1174L" 1)
   ("a commercially available ALK" 1) ("–anaplastic lymphoma kinase" 1)
   ("ALK (ALKWT)" 1) ("the previously generated human ALK F1174L" 1)
   ("the previously verified constitutively active ALK mutations ALK F1174L" 1)
   ("the previously characterised ALK F1174S" 1)))
 ("UP:Q9UM81" (("PTPσ" 4) ("protein-tyrosine-phosphatase" 1)))
 ("UP:Q9UM82" (("SPATA2" 4)))
 ("UP:Q9UMD9" (("BPAG-2" 13) ("COL17A1" 6) ("BPAG2" 1) ("type XVII" 1)))
 ("UP:Q9UMF0" (("ICAM5" 2) ("TLCN" 1))) ("UP:Q9UMQ3" (("BARX2" 4) ("Barx2" 1)))
 ("UP:Q9UMR2" (("DDX19" 20))) ("UP:Q9UMR3" (("TBX20" 3)))
 ("UP:Q9UMR5" (("PPT2" 4)))
 ("UP:Q9UMR7" (("superfamily member 6" 4) ("C-type lectin domain family 4" 1)))
 ("UP:Q9UMS4" (("PRP19" 186) ("PRPF19" 2)))
 ("UP:Q9UMS6"
  (("myopodin" 245) ("Myopodin" 16) ("SYNPO2" 1)
   ("S225 and T272 ( xref A, S225AT272A) further decreased nuclear myopodin"
    1)))
 ("UP:Q9UMW8" (("USP18" 20) ("Usp18" 4) ("UBP43" 1)))
 ("UP:Q9UMX0" (("UBQLN1" 2) ("ubiquilin 1" 2)))
 ("UP:Q9UMX1"
  (("SUFU" 44) ("SuFu" 25) ("Sufu" 22) ("SUFUH" 7) ("overexpressed SUFU" 2)
   ("Similarly, Sufu" 1) ("sufu" 1)))
 ("UP:Q9UMX3" (("Bok" 28) ("BOK" 9) ("bok" 1)))
 ("UP:Q9UMX9" (("SLC45A2" 40) ("MATP" 32)))
 ("UP:Q9UMY4" (("SNX12" 103) ("sorting nexin 12" 3) ("overexpressed SNX12" 2)))
 ("UP:Q9UMZ2" (("γ-synergin" 4))) ("UP:Q9UN30" (("SCML1" 1)))
 ("UP:Q9UN36"
  (("NDRG2" 310) ("N-myc downstream-regulated gene 2" 9) ("NDRG2 protein" 2)
   ("NDRG2-" 1) ("HIF-1α and p53 transactional activated NDRG2" 1)))
 ("UP:Q9UN37" (("VPS4A" 69) ("VPS4" 4) ("very little VPS4A" 1)))
 ("UP:Q9UN79" (("Sox13" 1))) ("UP:Q9UN86" (("G3BP2" 12)))
 ("UP:Q9UNA0"
  (("ADAMTS5" 33) ("ADAMTS-5" 8) ("aggrecanase 2" 1)
   ("the A disintegrin and metalloproteinase (ADAM) protein family member ADAMTS5"
    1)))
 ("UP:Q9UNA1" (("Graf" 25) ("ARHGAP26" 9) ("GRAF" 7)))
 ("UP:Q9UNA4"
  (("Pol I" 298) ("pol I" 90) ("POLI" 25) ("DNA polymerase iota" 4) ("polI" 2)
   ("PolI" 1) ("transcription-competent pol I" 1) ("specifically RNA Pol I" 1)
   ("pPOLI" 1)))
 ("UP:Q9UNC0" (("K65" 36))) ("UP:Q9UND3" (("morpheus" 5) ("Morpheus" 2)))
 ("UP:Q9UNE0"
  (("DL" 206) ("dL" 136) ("dl" 18) ("EDAR" 8) ("Edar" 2) ("ED3" 1)
   ("cellular DL" 1)))
 ("UP:Q9UNE7" ; removed "chip" and "Chromatin immunoprecipitation" and defined the bio-method instead
  (#+ignore("ChIP" 9690) #+ignore("chip" 2371) #+ignore("Chromatin immunoprecipitation" 2317)
   #+ignore("chromatin immunoprecipitation" 2099) ("CHIP" 1552)
   #+ignore("Chromatin Immunoprecipitation" 918) ("Chip" 350) ("Stub1" 187) ("ChiP" 20)
   ("sequential ChIP" 17) ("CHiP" 12) ("quantitative ChIP" 11)
   ("Sequential ChIP" 9) ("CHIP protein" 9) ("the bionic airway chip" 8)
   ("genome-wide chromatin immunoprecipitation" 6) ("STUB1" 5)
   ("overexpressed CHIP" 5) ("Quantitative ChIP" 4)
   ("Chromatin ImmunoPrecipitation" 4) ("-CHIP" 4) ("the microfluidic chip" 4)
   ("Quantitative Chromatin Immunoprecipitation" 4)
   ("CHROMATIN IMMUNOPRECIPITATION" 4)
   ("we first performed chromatin immunoprecipitation" 3)
   ("overexpressed Stub1" 3) ("ChIP-" 3) ("a sequential ChIP" 3)
   ("Quantitative chromatin immunoprecipitation" 3) ("ChIP protein" 3)
   ("an Agilent DNA-1000 chip" 3) ("the primary ChIP" 3) ("CHIP molecule" 3)
   ("genome-wide Chromatin Immunoprecipitation" 3) ("classical ChIP" 3)
   ("chromatin Immunoprecipitation" 3)
   ("Dual cross-linking chromatin immunoprecipitation" 3)
   ("comparative ChIP" 2) ("traditional ChIP" 2)
   ("previously published p53 ChIP" 2) ("UNC Agilent chip" 2)
   ("differential ChIP" 2)
   ("chromatin
 immunoprecipitation"
    2)
   ("a previous ChIP" 2) ("an Agilent Bioanalyzer Nano Chip" 2)
   ("Chromatin immunoprecipitation (CHIP)" 2) ("the Constitutional Chip" 2)
   ("an Agilent HPLC chip" 2)
   ("Chromatin
immunoprecipitation"
    2)
   ("recent genome-wide chromatin immunoprecipitation" 2)
   ("a μParaflo™ microfluidic chip" 2) ("chIP" 2) ("a bionic airway chip" 2)
   ("ChIp" 2) ("quantitative chromatin immunoprecipitation" 2)
   ("performed quantitative chromatin immunoprecipitation" 2)
   ("A custom-built DNA single nucleotide polymorphism (SNP) chip" 2)
   ("Chromatin immunoprecipipation" 2) ("primary ChIP" 2) ("Sequential CHIP" 2)
   ("the Agilent 44 K human genome CGH microarray chip" 2) ("Agilent chip" 2)
   ("the sequential double ChIP" 2)
   ("using Affymetric U133plus2.0 gene chip" 2)
   ("targeted chromatin immunoprecipitation" 2) ("chip (GE)" 2)
   ("Preliminary ChIP" 2) ("local ChIP" 2)
   ("the Genome-Wide Human SNP Array 6.0 chip" 2)
   ("a 12.765 Fluidigm digital chip" 2)
   ("sequential chromatin immunoprecipitation" 2)
   ("STIP1 homology and U box-containing protein 1" 2) ("both regular ChIP" 1)
   ("The complete ChIP" 1) ("a genome-wide chip" 1)
   ("Chromatin  immunoprecipitation" 1)
   ("an Agilent Bioanalyzer RNA 6000 Nano chip" 1)
   ("chromatin immunoprecipitation" 1) ("the multiplex ChIP" 1)
   ("the Agilent SureSelect Human All Exon v4 chip" 1) ("CHIP-" 1)
   ("using Agilent Gene Chip" 1) ("Targeted LSD1 ChIP" 1)
   ("the custom-designed diagnostic chip" 1)
   ("serial pairwise two-step ChIP" 1) ("genomic chip" 1)
   ("the Illumina cardiovascular disease (IBC) chip" 1)
   ("the HSP90-associated E3 ligase CHIP" 1) ("our sequential ChIP" 1)
   ("Carboxy terminus of HSP70-interacting protein" 1)
   ("The sequential ChIP" 1) ("CHIP which binds to CHIP’s" 1)
   ("The PDMS microfluidic chip" 1) ("a working biomimetic airway chip" 1)
   ("this designed microfluidic chip" 1) ("this microfluidic chip" 1)
   ("the bionic lung chip" 1) ("a bionic lung chip" 1)
   ("a fabricated bionic airway chip" 1) ("“organ-on-chip”" 1)
   ("The microfluidic chip" 1) ("The digital chip" 1)
   ("the Fluidigm digital chip" 1)
   ("a nitrilotriacetic acid (NTA) sensor chip" 1)
   ("chromatin
immunoprecipitation"
    1)
   ("resultant ChIP" 1) ("E3 ubiquitin–protein ligase CHIP" 1)
   ("a QuantStudio 3D Digital PCR 20K Chip" 1) ("Non-normalized ChIP" 1)
   ("recent ChIP" 1) ("metabolic chip" 1) ("normal ChIP" 1) ("regular ChIP" 1)
   ("the previously reported Affymetrix 3k BOAC custom DNA chip" 1)
   ("a sequential chromatin immunoprecipitation" 1)
   ("used sequential chromatin immunoprecipitation" 1) ("telomeric ChIP" 1)
   ("-chip" 1) ("Time-resolved quantitative ChIP" 1) ("We first used ChIP" 1)
   ("the Agilent Human 44K array chip" 1)
   ("The chaperone-associated ubiquitin ligase CHIP" 1)
   ("targeted anti-cyclin D1 ChIP" 1) ("These quantitative ChIP" 1)
   ("Dual cross-linking ChIP" 1) ("Chromatin Immunoprecipitation-" 1)
   ("both strong c-Myc and sp1 ChIP" 1)
   ("the Affymetrix Genome-Wide Human SNP Array 6.0 chip" 1)
   ("approximately 600 pangenomic HIF-2 ChIP" 1) ("“re-ChIP”" 1)
   ("genome-wide Myc ChIP" 1) ("Several genome-wide ChIP" 1) ("–CHIP" 1)
   ("the automatic “lab-on-a-chip”" 1) ("“lab-on-a-chip”" 1)
   ("microfluidic chip" 1) ("HSP70-associated E3 ligase CHIP" 1)
   ("than one chip" 1) ("than an early generation chip used previously" 1)
   ("repetitive ChIP" 1) ("we first used ChIP" 1)))
 ("UP:Q9UNF0" (("PACSIN2" 10) ("syndapin2" 2)))
 ("UP:Q9UNF1" (("MAGED2" 2) ("hepatocellular carcinoma associated protein" 1)))
 ("UP:Q9UNG2" (("TL6" 13) ("TNFSF18" 12) ("GITRL" 2)))
 ("UP:Q9UNH5"
  (("Cdc14A" 214) ("CDC14A" 5) ("Cdc14A protein" 4) ("Cdc14A(PD)" 2)
   ("expressing Myc-tagged Cdc14A" 1) ("cdc14" 1) ("Cdc14A-" 1)))
 ("UP:Q9UNH7" (("SNX6" 8))) ("UP:Q9UNI1" (("ELA1" 5) ("Ela1" 1)))
 ("UP:Q9UNI6" (("DUSP12" 7))) ("UP:Q9UNK0" (("Syntaxin 8" 6)))
 ("UP:Q9UNK4" (("splash" 2)))
 ("UP:Q9UNK9"
  (("Angel1" 142) ("Angel1 protein" 10) ("overexpressed Angel1 protein" 4)
   ("angel1" 1) ("the exogenous Angel1 protein" 1) ("ANGEL1" 1)))
 ("UP:Q9UNL4"
  (("ING4" 140) ("more ING4 protein" 2) ("ING4 protein" 1) ("less ING4" 1)))
 ("UP:Q9UNM6"
  (("PSMD13" 32) ("26S proteasome non-ATPase regulatory subunit 13" 3)))
 ("UP:Q9UNN4" (("ALF" 204) ("Spontaneous ALF" 1) ("GTF2A1L" 1)))
 ("UP:Q9UNN5" (("FAF1" 38) ("FAF1 protein" 3) ("FAF-1" 2)))
 ("UP:Q9UNN8"
  (("EPCR" 67) ("PROCR" 7) ("endothelial protein C receptor" 4) ("EPCR-" 3)
   ("protein C receptor" 2) ("CD201" 2)))
 ("UP:Q9UNQ0"
  (("ABCG2" 912) ("BCRP" 347) ("MRX" 45)
   ("breast cancer resistance protein" 29) ("ABCG2 protein" 14) ("ABCG2−" 11)
   ("ABCP" 4) ("functional ABCG2" 4) ("Bcrp1" 4)
   ("breast cancer resistance protein (BCRP)" 3) ("MXR" 3) ("BCRP protein" 3)
   ("pMRX" 3) ("Abcg2" 3) ("BCRP1" 2) ("3.6 Functional ABCG2" 2) ("ABCG2-" 2)
   ("Given BCRP's" 1) ("Given BCRP" 1) ("Breast cancer resistance protein" 1)
   ("further suggesting ABCG2" 1) ("Cancer Resistance Protein" 1)))
 ("UP:Q9UNQ2" (("DIMT1" 25) ("Dimt1" 1)))
 ("UP:Q9UNS1"
  (("TIMELESS" 17) ("hTim" 4) ("the circadian protein TIMELESS" 1)))
 ("UP:Q9UNS2" (("COPS3" 6)))
 ("UP:Q9UNU6" (("CYP8B1" 5) ("family 8" 4) ("Cyp8b1" 2)))
 ("UP:Q9UNW1" (("MINPP1" 2)))
 ("UP:Q9UNW8"
  (("G2A" 107) ("G2 accumulation" 7) ("GPR132" 3) ("G2A-" 1) ("Gpr132" 1)
   ("G2a" 1)))
 #+Ignore("UP:Q9UNW9" ; removed "ANOVA" "ANOVAs" and made bio-method
  (("ANOVA" 5097) ("ANOVAs" 33) ("SPSS" 12) ("Anova" 4)
   ("Nonparametric ANOVA" 4) ("ANOVA (ANOVA)" 4) ("the parametric ANOVA" 2)
   ("the two-tailed Student' t-test or one-way ANOVA" 2) ("A global ANOVA" 2)
   ("using SPSS" 2) ("a two-tailed ANOVA" 2) ("MANOVA" 2) ("ANOVA (MANOVA)" 2)
   ("a non-parametric ANOVA" 2) ("nonparametric ANOVA" 2)
   ("nonparametric one-way ANOVA" 2) ("a multifactorial ANOVA" 2)
   ("nonparametric Kruskal-Wallis ANOVA" 1) ("the parametric one-way ANOVA" 1)
   ("a factorial two-way ANOVA" 1) ("factorial ANOVA" 1)
   ("the nonparametric Kruskal-Wallis ANOVA" 1) ("A nonparametric ANOVA" 1)
   ("Kruskal-Wallis non-parametric ANOVA" 1)
   ("a non-parametric one-way ANOVA" 1) ("the PRKCA global omnibus ANOVA" 1)
   ("An initial global omnibus ANOVA" 1) ("parametric ANOVA" 1)
   ("one-way parametric ANOVA" 1) ("ANOVA (SPSS)" 1) ("Separate ANOVA" 1)
   ("logistic regression and one-way ANOVA" 1)
   ("Non-parametric Kruskal-Wallis ANOVA" 1) ("nova2" 1)
   ("non-parametric Kruskal-Wallis ANOVA" 1) ("ANOVA using Fisher’s" 1)
   ("than two groups one-way ANOVA" 1) ("using one-sided ANOVA" 1)
   ("one-sided ANOVA" 1) ("done earlier using one-way ANOVA" 1)
   ("parametric one way ANOVA" 1) ("ANOVA using the Student Neuman-Keul's" 1)
   ("using one-way factorial ANOVA" 1) ("multifactorial ANOVA" 1)
   ("the S.E.M. A one-way ANOVA" 1) ("linear polynomial ANOVA" 1)
   ("ANOVA using Fisher's" 1)))
 ("UP:Q9UNX4" (("WDR3" 3))) ("UP:Q9UNY4" (("TTF-2" 11) ("TTF2" 4)))
 ("UP:Q9UNZ2" (("NSFL1C" 1)))
 ("UP:Q9UP38"
  (("FZD1" 125) ("Wnt receptor" 23) ("Frizzled homolog 1" 5) ("Fzd1" 3)
   ("WNT receptor" 2) ("Frizzled 1" 1) ("Fzd-1" 1) ("wnt receptor" 1)))
 ("UP:Q9UP52" (("TFR2" 14) ("transferrin receptor 2" 2)))
 ("UP:Q9UP65" (("PLA2G4C" 5))) ("UP:Q9UP79" (("ADAMTS8" 6)))
 ("UP:Q9UP83" (("COG5" 1))) ("UP:Q9UPE1" (("STK23" 1)))
 ("UP:Q9UPI3"
  (("CCT" 1264) ("CCT-" 64) ("-CCT" 63) ("FLVCR2" 1) ("CCT (MMM)" 1)))
 ("UP:Q9UPM6" (("Lhx6" 2) ("Lhx6-" 1)))
 ("UP:Q9UPN3" (("ACF7" 17) ("MACF1" 10))) ("UP:Q9UPN4" (("Cep131" 2)))
 ("UP:Q9UPN7"
  (("PP6R1" 15) ("regulatory subunit 1" 11) ("SAPS1" 3)
   ("SAPS domain family" 3)))
 ("UP:Q9UPN9"
  (("TRIM33" 405) ("TIF1γ" 287) ("Trim33" 17)
   ("Tripartite motif containing 33" 5) ("TRIM33 molecule" 5) ("PTC7" 2)
   ("RFG7" 2) ("TIF1γ protein" 2) ("Ectodermin" 1)))
 ("UP:Q9UPP1" (("PHF8" 222) ("using bacterially-expressed PHF8" 2)))
 ("UP:Q9UPQ0" (("LIMCH1" 8) ("LIM and calponin homology domains 1" 2)))
 ("UP:Q9UPQ4" (("MAIR" 1))) ("UP:Q9UPQ7" (("PDZRN3" 1)))
 ("UP:Q9UPQ9" (("TNRC6B" 9))) ("UP:Q9UPR0" (("PLCL2" 37)))
 ("UP:Q9UPR3" (("Smg5" 38) ("SMG5" 8) ("EST1B" 4) ("Smg5-" 2) ("SMG-5" 1)))
 ("UP:Q9UPR5" (("NCX2" 2)))
 ("UP:Q9UPS6" (("SET1B" 1) ("SETD1B" 1) ("Setd1B" 1)))
 ("UP:Q9UPT5"
  (("Exo70" 809) ("EXOC7" 10) ("exo70" 10) ("Exo70 protein" 3)
   ("exogenous Exo70" 2)
   ("RNA interference (RNAi)–resistant wild-type or mutated (PI4,5P 2 -binding deficient) rat Exo70"
    2)
   ("dimeric Exo70" 1) ("than the full-length Exo70" 1)
   ("the first 99 amino acids of Exo70 ( xref ; Supplemental Figure S2A)" 1)))
 ("UP:Q9UPT6" (("JIP3" 33) ("JIP-3" 3) ("JIP3 protein" 2) ("MAPK8IP3" 1)))
 ("UP:Q9UPT9" (("USP22" 11))) ("UP:Q9UPU3" (("SORCS3" 1)))
 ("UP:Q9UPU5" (("USP24" 157) ("USP24 protein" 9) ("Functional USP24" 1)))
 ("UP:Q9UPU9"
  (("SAMD4A" 14) ("SMG" 13) ("sMG" 8) ("SMGs" 4) ("at least one SMG" 2)))
 ("UP:Q9UPV0"
  (("CEP164" 161) ("Cep164" 45) ("cep164" 15) ("CEP164 protein" 7)))
 ("UP:Q9UPV9" (("TRAK1" 2))) ("UP:Q9UPW0" (("FOXJ3" 2) ("FoxJ3" 1)))
 ("UP:Q9UPW5" (("CCP1" 14) ("Ccp1" 2) ("ccp1" 2)))
 ("UP:Q9UPW6" (("SATB2" 35) ("SATB homeobox 2" 3)))
 ("UP:Q9UPW8" (("UNC13a" 5) ("UNC13A" 3)))
 ("UP:Q9UPX8"
  (("SHANK2" 4) ("Shank2" 1) ("SH3 and multiple ankyrin repeat domains 2" 1)))
 ("UP:Q9UPY3"
  (("Dicer" 869) ("DICER" 189) ("DICER1" 121) ("Dicer1" 103) ("dicer" 29)
   ("Dicer protein" 24) ("endoribonuclease Dicer" 9)
   ("the RNase III enzyme Dicer" 5) ("Dicer-" 4) ("dicer1" 4) ("Dicer-1" 3)
   ("endoribonuclease DICER" 3) ("a second RNase III Dicer" 2) ("dicer-1" 2)
   ("directly target Dicer1" 2)
   ("adding exogenous miR-200c mimic increases Dicer protein" 2)
   ("hypomorphic Dicer" 2)
   ("let-7 directly targets miRNA-processing enzyme Dicer" 2)
   ("cellular Dicer" 1) ("specifically targets human Dicer" 1)
   ("FLAG-epitope-tagged Dicer" 1) ("less Dicer" 1)
   ("the second RNase III enzyme Dicer" 1) ("the Dicer's" 1)
   ("acute hypoxia exposure decreased Dicer1" 1) ("Dicer1 protein" 1)
   ("substantial Dicer" 1) ("insufficient Dicer" 1)
   ("miR-29a directly target Dicer" 1)
   ("The human RNase III-type nuclease Dicer" 1) ("Dicer1-" 1)
   ("recombinant human RNase III Dicer protein" 1)
   ("variation nearby DICER1" 1)))
 ("UP:Q9UPY5"
  (("SLC7A11" 105) ("xCT" 32) ("Slc7a11" 19)
   ("cystine/glutamate transporter" 3) ("solute carrier family 7 member 11" 2)
   ("X-CT" 1)))
 ("UP:Q9UPY6" (("WAVE3" 9) ("WASF3" 5)))
 ("UP:Q9UPY8"
  (("EB3" 124) ("fluorescently-tagged EB3" 3) ("-EB3" 2) ("fluorescent EB3" 2)
   ("edge HUVECs expressing fluorescent EB3" 1) ("invasive EB3" 1)
   ("fluorescent-tagged EB3" 1)))
 ("UP:Q9UPZ3" (("HPS5" 1))) ("UP:Q9UPZ9" (("Ick" 3) ("ick" 1) ("ICK" 1)))
 ("UP:Q9UQ07" (("MOK" 2)))
 ("UP:Q9UQ13"
  (("SHOC2" 347) ("Shoc2" 197) ("SUR-8" 14) ("SHOC2 protein" 9)
   ("Shoc2 protein" 9) ("Sur-8" 3) ("genomic SHOC2" 3) ("Shoc2-" 1)))
 ("UP:Q9UQ16" (("DNM3" 45) ("dynamin 3" 3)))
 ("UP:Q9UQ26" (("RIMS2" 3) ("regulating synaptic membrane exocytosis 2" 2)))
 ("UP:Q9UQ35"
  (("SRRM2" 6) ("serine/arginine repetitive matrix 2" 4) ("SRm300" 2)
   ("SRM300" 2)))
 ("UP:Q9UQ49" (("NEU3" 1)))
 ("UP:Q9UQ52" (("CNTN6" 5) ("neural adhesion molecule" 3)))
 ("UP:Q9UQ72" (("PSG11" 2))) ("UP:Q9UQ80" (("PA2G4" 9) ("Pa2g4" 1)))
 ("UP:Q9UQ84"
  (("hEXO1" 224) ("Exo1" 152) ("EXO1" 150) ("Exonuclease I" 40)
   ("exonuclease I" 31) ("exonuclease 1" 26) ("ExoI" 13) ("Hex1" 10) ("exo1" 7)
   ("Exonuclease 1" 6) ("hEXOI" 4) ("EXOI" 3) ("Exo1-" 2)
   ("double-strand hydrolytic activity Exo1" 2)
   ("the more processive nucleases EXO1" 1) ("around 1 ng hEXO1" 1)
   ("4°C. Approximately 400 ng recombinant hEXO1" 1)))
 ("UP:Q9UQ88" (("CDC2L2" 8) ("CDK11A" 4)))
 ("UP:Q9UQ90" (("PGN" 91) ("SPG7" 1)))
 ("UP:Q9UQB3"
  (("CTNND2" 132) ("δ-Catenin" 39) ("Ctnnd2" 7) ("NPRAP" 4)
   ("targeting zebrafish ctnnd2" 4) ("ctnnd2" 4) ("Neurojungin" 1)))
 ("UP:Q9UQB8"
  (("IRSp53" 236) ("IRS-58" 199) ("BAIAP2" 10) ("BAI1-associated protein 2" 6)
   ("IRS-58 protein" 2) ("IRSp53/58" 2) ("Baiap2" 2)
   ("brain-specific angiogenesis inhibitor 1-associated protein 2" 2)
   ("IRS-58–" 1) ("IRS58" 1)))
 ("UP:Q9UQB9" (("AURKC" 11)))
 ("UP:Q9UQC2"
  (("Gab2" 499) ("GAB2" 309) ("Gab2 protein" 9) ("GRB2-associated binder 2" 3)
   ("GAB2 protein" 2) ("Gab-2" 2) ("p-GAB2" 1) ("Grb2-associated binder 2" 1)
   ("pTyr (YxxM) of Gab2" 1) ("exogenous wild type GAB2 (FLAG)" 1)
   ("GAB2 (FLAG)" 1) ("exogenous wild type GAB2" 1)))
 ("UP:Q9UQC9"
  (("monolayers" 1212) ("hCLCA2" 102) ("chloride channel" 69) ("Monolayers" 50)
   ("CaCC" 21) ("adherent monolayers" 18) ("CLCA2" 18) ("family member 2" 17)
   ("calcium activated" 8) ("subconfluent monolayers" 5)
   ("confluent monolayers" 5) ("endothelial monolayers" 5)
   ("Confluent monolayers" 4) ("chloride channel protein" 4)
   ("family member 2 (RASSF2) protein" 3) ("MDCK II monolayers" 2)
   ("Subconfluent monolayers" 2)
   ("an easily detected transmembrane chloride channel" 2)
   ("calcium activated protein" 2) ("intestinal monolayers" 2)
   ("sham serum-treated monolayers" 2) ("epithelial monolayers" 2)
   ("Chloride channel" 2) ("the resultant monolayers" 2)
   ("FN-coated mixed self-assembled monolayers" 2)
   ("mostly self-assembled monolayers" 2) ("mixed self-assembled monolayers" 2)
   ("the endothelial monolayers" 2) ("either adhered monolayers" 2)
   ("contact-inhibited monolayers" 1) ("Polarized epithelial monolayers" 1)
   ("subconfluent cell monolayers" 1) ("nearly confluent monolayers" 1)
   ("the confluent monolayers" 1) ("fresh cell monolayers" 1)
   ("the treated monolayers" 1) ("the normoxic monolayers" 1)
   ("an integral chloride channel" 1)
   ("cultured human dermal microvascular endothelial cell (HDMEC) monolayers"
    1)
   ("human endothelial monolayers" 1) ("produced monotonous monolayers" 1)
   ("hCLCA2 protein" 1) ("Snapwells supporting resistive monolayers" 1)
   ("resistive monolayers" 1) ("epithelial chloride channel" 1)
   ("form well-differentiated monolayers" 1)
   ("spontaneously differentiating Caco-2 monolayers" 1)
   ("Adherent monolayers" 1) ("Dry monolayers" 1)
   ("subconfluent cellular monolayers" 1)
   ("the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) chloride channel"
    1)
   ("Calcium activated" 1) ("60% confluent monolayers" 1)
   ("Epithelial monolayers" 1) ("cytokine treated monolayers" 1)
   ("Conﬂuent monolayers" 1) ("than 2D monolayers" 1) ("Mature monolayers" 1)
   ("self-assembled monolayers" 1) ("the adherent monolayers" 1)))
 ("UP:Q9UQD0" (("pN4" 3)))
 ("UP:Q9UQE7"
  (("SMC3" 170) ("BAM" 89) ("Smc3" 7) ("bam" 1)
   ("structural maintenance of chromosomes 3" 1) ("CSPG6" 1) ("-SMC3" 1)))
 ("UP:Q9UQF2"
  (("IB1" 10) ("JNK-interacting protein-1 (JIP1) peptide" 3)
   ("JNK-interacting protein-1" 2) ("MAPK8IP1" 1)))
 ("UP:Q9UQK1" (("protein targeting to glycogen" 4) ("PPP1R3C" 2)))
 ("UP:Q9UQL6"
  (("HDAC5" 920) ("myotube" 74) ("HDAC5 protein" 7) ("Myotube" 7) ("HDAC-5" 7)
   ("histone deacetylase 5" 5) ("HDAC5-" 3) ("P-HDAC5" 3) ("Hdac5" 2)
   ("HDAC-5 protein" 2) ("endogenous striatal HDAC5" 2)
   ("than WT HDAC5 ( xref )" 2) ("the only known HDAC5" 2)
   ("human-GST-fused HDAC5" 2) ("unique HDAC5" 1) ("pHDAC5" 1)
   ("than endogenous HDAC5 in COS7 cells" 1)
   ("than WT HDAC5 in cultured cells ( xref )" 1) ("striatal HDAC5" 1)
   ("HDAC5 (1–550) protein" 1) ("-HDAC5" 1)))
 ("UP:Q9UQM7" (("CAMK2A" 3) ("Camk2a" 2)))
 ("UP:Q9UQN3" (("CHMP2B" 1) ("Chmp2b" 1))) ("UP:Q9UQP3" (("TNN" 29)))
 ("UP:Q9UQQ1" (("NAALADL1" 1)))
 ("UP:Q9UQQ2"
  (("SH2B3" 112) ("Lnk" 94) ("lnk" 91) ("LNK" 28) ("lnK" 7)
   ("five times fewer lnk" 1) ("Lnk protein" 1) ("SH2B adaptor protein 3" 1)))
 ("UP:Q9UQR1" (("ZBP-89" 182) ("ZBP-89 protein" 2) ("ZNF-148" 1)))
 ("UP:Q9UQV4"
  (("LAMP3" 108) ("LAMP3 protein" 6)
   ("Lysosomal associated membrane protein 3" 2)))
 ("UP:Q9UR66"
  (("NDPK" 33) ("nucleoside diphosphate kinase" 12)
   ("nucleoside diphosphate kinase (NDPK)" 1)))
 ("UP:Q9URY2"
  (("Alp7" 125) ("alp7" 15) ("the NES-defective alp7-" 1) ("alp7-" 1)
   ("the centrosomal transforming acidic coiled-coil (TACC) protein Alp7" 1)))
 ("UP:Q9USX1" (("aminopeptidase 1" 2))) ("UP:Q9UUB4" (("Ad-E7" 3)))
 ("UP:Q9UUZ9" (("pTRA" 9))) ("UP:Q9UW86" (("phosphoprotein phosphatase 1" 2)))
 ("UP:Q9UWF8" (("cPKA" 12))) ("UP:Q9UWR6" (("GFPs" 7) ("FGS" 1)))
 ("UP:Q9V3E7"
  (("ALI" 125) ("Ali" 36) ("healthy ALI" 1) ("human airway epithelial ALI" 1)
   ("sepsis-associated ALI" 1) ("aseptic ALI" 1) ("“aseptic” ALI" 1) ("ALi" 1)
   ("ali" 1)))
 ("UP:Q9V3L1"
  (("sFL" 49) ("sFL protein" 5)
   ("intracellular mature virions (IMV) harbours sFL" 2)
   ("the low-glycosylated sFL" 1)))
 ("UP:Q9V3Q6" (("dTak1" 3)))
 ("UP:Q9V464"
  (("dASF1" 69) ("histone chaperone Asf1" 8) ("histone chaperone ASF1" 7)
   ("“dAsf1”" 2) ("dAsf1" 2)))
 ("UP:Q9V4A7" (("plexin-B" 9) ("Plexin-B" 2)))
 ("UP:Q9V4P1" (("anillin" 212) ("Anillin" 37) ("anillin protein" 2)))
 ("UP:Q9V535" (("Tsu" 2)))
 ("UP:Q9V5Z7" (("DRIP" 12) ("aquaporins" 2) ("Aquaporins" 1)))
 ("UP:Q9V629" (("cuff" 125) ("Cuff" 1) ("a pneumatic cuff" 1)))
 ("UP:Q9V726" (("CPSF" 11))) ("UP:Q9V751" (("attB" 36)))
 ("UP:Q9V853" (("Smurf" 13) ("Smurfs" 3) ("smurf" 1)))
 ("UP:Q9V9J3" (("Src42A" 5))) ("UP:Q9V9W8" (("PYGO" 5) ("Pygo" 1)))
 ("UP:Q9VA38"
  (("Wts" 78) ("wts" 28) ("WTs" 7) ("wtS" 3) ("than WTs" 1) ("Wts protein" 1)
   ("WTS" 1)))
 ("UP:Q9VA70" (("slab" 29) ("Slab" 1)))
 ("UP:Q9VB08"
  (("SCE" 337) ("spontaneous SCE" 12)
   ("small interfering RNA abrogated IR-induced SCE" 2)
   ("IR abrogated IR-induced SCE" 2) ("normal SCE" 2)
   ("normal S-phase-associated SCE" 1) ("FANCD2 increased SCE" 1)))
 ("UP:Q9VC27"
  (("NCT" 960) ("study NCT01087333" 1) ("inunder number NCT00579774" 1)))
 ("UP:Q9VC36" (("polybromo" 1))) ("UP:Q9VC57" (("ATL" 263)))
 ("UP:Q9VCR6" (("Sav" 72) ("SAV" 10) ("sav" 6)))
 ("UP:Q9VCX1" (("loco" 87) ("Loco" 13))) ("UP:Q9VCY8" (("AdipoR" 1)))
 ("UP:Q9VEI3" (("SLL" 60))) ("UP:Q9VEN1" (("filamin-A" 1)))
 ("UP:Q9VEZ5" (("ird5" 6) ("Ird5" 1) ("ird5 (IKK)" 1)))
 ("UP:Q9VF87" (("CYFIP" 43))) ("UP:Q9VFX1" (("WntD" 2)))
 ("UP:Q9VHH9" (("KDM2" 3))) ("UP:Q9VI93" (("RN" 64) ("Rn" 10)))
 ("UP:Q9VIF5" (("DEL" 216) ("-DEL" 27)))
 ("UP:Q9VIL0" (("BrU" 7) ("BRU" 6) ("bru" 2)))
 ("UP:Q9VIP7" (("BWA" 126) ("bwa" 3) ("short read aligner BWA" 3)))
 ("UP:Q9VIP8" (("VLS" 51) ("VSL" 6) ("the primary VLS" 1)))
 ("UP:Q9VIW3" (("RanGAP" 8))) ("UP:Q9VKD7" (("ZUC" 1)))
 ("UP:Q9VKJ9" (("LGD" 143) ("HER-2-positive LGD" 1))) ("UP:Q9VKN7" (("IAL" 4)))
 ("UP:Q9VLC0" (("SCAT" 18))) ("UP:Q9VMJ7" (("LID" 11)))
 ("UP:Q9VN14" (("contactin" 1))) ("UP:Q9VNJ5" (("DISP" 1)))
 ("UP:Q9VPC0" (("PITSLRE" 1))) ("UP:Q9VPQ6" (("ush" 2) ("USH" 1)))
 ("UP:Q9VQH2" (("dual oxidase" 5))) ("UP:Q9VS50" (("ECO" 19) ("eco" 4)))
 ("UP:Q9VSR3" (("orb2" 2))) ("UP:Q9VVT2" (("Indy" 1)))
 ("UP:Q9VVX0" (("GEM2" 3)))
 ("UP:Q9VWE0"
  (("cytokine receptor" 284) ("Cytokine Receptor" 4)
   ("just one cytokine receptor" 2) ("the chimeric cytokine receptor" 2)
   ("a chimeric cytokine receptor" 2) ("an exogenous cytokine receptor" 2)
   ("a transmembrane cytokine receptor" 1)
   ("this archetypal cytokine receptor" 1) ("Cytokine receptor" 1)))
 ("UP:Q9VWU1" (("PSH" 2))) ("UP:Q9VXE5" (("MBT" 18) ("mbt" 2)))
 ("UP:Q9VXG8" (("MEI-41" 1) ("Mei-41" 1) ("mei-41" 1)))
 ("UP:Q9VXN9" (("PGRP-LE" 1))) ("UP:Q9VYS4" (("WISP" 6)))
 #+ignore("UP:Q9VZF4" ; fixed
  (("ago" 1350) ("Ago" 57) ("AGO" 31) ("than 20 years ago" 9)
   ("than a decade ago" 7) ("Ago protein" 7) ("a few years ago" 7)
   ("almost two decades ago" 5) ("than 10 years ago" 4)
   ("nearly two decades ago" 4) ("ovarian tumors nearly eight years ago" 3)
   ("than three decades ago" 3) ("than two decades ago" 3)
   ("nearly 20 years ago" 2) ("first noticed nearly 20 years ago" 2)
   ("Nearly 20 years ago" 2) ("non-consanguineous parents 21 years ago" 2)
   ("phosphoprotein enriched in astrocytes-15 (PEA-15) almost 20 years ago" 2)
   ("than 30 years ago" 2) ("nearly 30 years ago" 2)
   ("nearly eight years ago" 2) ("discovered almost 20 years ago" 2)
   ("place approximately 40,000 years ago" 2) ("around 23,000 years ago" 2)
   ("than 440 million years ago" 2) ("more common few decades ago" 2)
   ("than 25 years ago" 2) ("than 30 years ago ( xref )" 2)
   ("cisplatin/carboplatin resistant ovarian cell lines almost 10 years ago" 2)
   ("their existence nearly 30 years ago" 2)
   ("first introduced almost 50 years ago" 2) ("occurred centuries ago" 2)
   ("already decades ago" 2) ("than 6 months ago" 2) ("than 40 years ago" 2)
   ("almost 20 years ago" 2) ("than five years ago" 2)
   ("identified nearly 25 years ago" 2)
   ("their first primary nearly 15 years ago" 2)
   ("Grb2 nearly two decades ago" 2) ("than 60 years ago" 2)
   ("a few generations ago" 2) ("ERE duplex solved nearly two decades ago" 2)
   ("ubiquitin-mediated protein degradation nearly 30 years ago" 2)
   ("approximately 20 years ago" 2) ("prostate cancer almost 15 years ago" 2)
   ("than six months ago" 1) ("than 800,000 years ago [ xref ]" 1)
   ("than 25 years ago" 1) ("approximately 40 years ago" 1)
   ("annual personal income 10 years ago" 1) ("xref almost 25 years ago" 1)
   ("than thirty years ago" 1) ("than 50 years ago" 1) ("than 30 years ago" 1)
   ("-AGO" 1) ("than a century ago" 1)
   ("than thirty years ago in Drosophila" 1)
   ("arisen around 85,000 years ago" 1)
   ("around 23,000 (CI: 17,000 - 40,000) years ago" 1)
   ("vascular cells nearly 20 years ago" 1) ("a few decades ago" 1)
   ("nearly three decades ago" 1) ("than 30 years ago [ xref ]" 1)
   ("than 1300 years ago" 1) ("than 6 months ago (LGC, London, UK)" 1)
   ("than two decades ago [ xref ]" 1) ("cast almost 300 years ago" 1)
   ("few years ago" 1) ("first described nearly 50 years ago" 1)
   ("than ten years ago" 1) ("a technique developed several years ago" 1)
   ("almost 15 years ago" 1) ("approximately 3,400 years ago" 1)
   ("xref almost two decades ago" 1) ("than 40 years ago ( xref )" 1)
   ("a decade or more
ago"
    1)
   ("than 17 years ago" 1) ("almost 20 yr ago" 1)
   ("than two decades ago ( xref – xref )" 1)
   ("an existing classifier developed several years ago" 1)
   ("Theodor Boveri hypothesized nearly 100 years ago" 1)
   ("than a decade ago [ xref ]" 1) ("than 15 years ago" 1)
   ("an uncommon tumor 20 years ago" 1) ("-Ago" 1)
   ("First described almost fifty years ago" 1)
   ("than 25 years ago ( xref )" 1) ("first described almost 50 years ago" 1)
   ("available just 20 years ago" 1) ("than 15 years ago [ xref ]" 1)
   ("successfully use slides prepared 7 years ago" 1)
   ("than 10 generations ago" 1) ("only seven years ago" 1)
   ("than a century ago in the kidney" 1) ("than 70 years ago" 1)
   ("than 43 million years ago" 1) ("pediatric RT fourteen years ago" 1)
   ("a point made many years ago" 1) ("almost 70 years ago" 1)
   ("than 50 years ago ( xref )" 1) ("almost nine decades ago" 1)
   ("the only Ago protein" 1)
   ("diverged approximately one billion years ago" 1)))
 ("UP:Q9W0K0" (("JIP-1" 4) ("JNK-interacting protein 1" 2)))
 ("UP:Q9W0K4" (("BAB2" 3)))
 ("UP:Q9W0K7"
  (("BAB" 11) ("bric-a-brac" 5) ("Bric-a-brac" 3) ("Bric-a-Brac" 2) ("bab" 1)))
 #+ignore("UP:Q9W0Y6" ; fixed
  (("pain" 1287) ("neuropathic pain" 57) ("chronic pain" 52) ("severe pain" 50)
   ("Pain" 35) ("abdominal pain" 32) ("chronic pelvic pain" 11)
   ("inflammatory pain" 10) ("pelvic pain" 7) ("pain (LBP)" 7)
   ("musculoskeletal pain" 6) ("Neuropathic pain" 4)
   ("inflammatory and neuropathic pain" 4) ("postoperative pain" 3)
   ("orofacial pain" 3) ("orofacial inflammatory pain" 3)
   ("spontaneous pain" 3) ("Chronic pain" 3) ("Severe pain" 3)
   ("experiencing severe pain" 3) ("the patients reported severe pain" 3)
   ("HIV-1 induced neuropathic pain" 2) ("DSP-associated neuropathic pain" 2)
   ("skeletal pain" 2) ("symptomatic pain" 2) ("experimental pain" 2)
   ("high maximal pain" 2) ("facial pain" 2) ("the extreme pain" 2)
   ("extreme pain" 2) ("Orofacial Inflammatory Pain" 2)
   ("CFA-induced orofacial inflammatory pain" 2) ("included cardiac pain" 2)
   ("behavioral pain" 2) ("Acute pain" 2) ("pleuritic chest pain" 2)
   ("formalin-induced pain" 2) ("neuropathic and inflammatory pain" 2)
   ("moderate or severe pain" 2) ("chronic widespread pain" 2)
   ("discogenic pain" 2) ("mechanical evoked pain" 2)
   ("capsaicin-induced inflammatory pain" 2)
   ("acute and chronic neuropathic pain" 2) ("uncontrolled pain" 2)
   ("atypical chest pain" 2) ("MS-associated chronic pain" 2)
   ("acute and chronic pain" 1) ("acute or chronic physical pain" 1)
   ("associated neuropathic pain" 1) ("severe acute back pain" 1)
   ("non-cyclic pelvic pain" 1) ("joint and muscular pain" 1)
   ("retro-orbital pain" 1) ("PAIN" 1) ("high maximum postoperative pain" 1)
   ("Maximum postoperative pain" 1) ("intractable pain" 1)
   ("Secondary outcomes addressed normalized maximal pain" 1)
   ("Maximum and minimum postoperative pain" 1)
   ("low (≤3/10) maximum postoperative pain" 1)
   ("increased acute postoperative pain" 1) ("Postoperative pain" 1)
   ("thoracic pain" 1) ("skeletal-associated pain" 1)
   ("right-sided chest pain" 1) ("a valid pain" 1)
   ("the orofacial inflammatory pain" 1) ("chronic neuropathic pain" 1)
   ("Chronic inflammatory pain" 1) ("Orofacial inflammatory pain" 1)
   ("extensive pain" 1) ("cancer metastatic pain" 1) ("Inflammatory pain" 1)
   ("Chronic Pain" 1) ("occasional abdominal pain" 1)
   ("NF-κB-mediated inflammatory pain" 1)
   ("Increased neuropathic and inflammatory pain" 1)
   ("IL8-251T/A (OR=2.43, 95% CI=1.3, 4.7, P <0.009) significantly predicted severe pain"
    1)
   ("severe and persistent pain" 1) ("nociceptive pain" 1)
   ("pure neuropathic pain" 1) ("the distal pain" 1) ("TMJ pain" 1)
   ("the worst imaginable pain" 1)
   ("neuropathic, inflammatory and incisional pain" 1)
   ("chronic inflammatory pain" 1) ("operative site pain" 1)
   ("severe pelvic pain" 1) ("the minimum possible pain" 1) ("focal pain" 1)
   ("severe paroxysmal pain" 1) ("the documented musculoskeletal pain" 1)
   ("Cancer-related chronic pain" 1) ("intermittent joint pain" 1)
   ("serious eye pain" 1) ("other musculoskeletal pain" 1)
   ("reproducible pain" 1) ("severe bone pain" 1) ("non-cardiac chest pain" 1)
   ("the associated pain" 1) ("pleural chest pain" 1) ("craniofacial pain" 1)))
 ("UP:Q9W123" (("POF" 1))) ("UP:Q9W1K5" (("SESN" 7) ("pSESN" 1)))
 ("UP:Q9W1M7"
  (("phosphatidylinositol" 818) ("Phosphatidylinositol" 63)
   ("phosphatidylinositol-" 50) ("phosphatidylinositol (PI)" 6)
   ("-phosphatidylinositol" 4) ("phosphatidylinositol (GPI)" 3)
   ("pure phosphatidylinositol" 2) ("Phosphatidylinositol-" 2)
   ("VPS34 only uses phosphatidylinositol" 1)
   ("The un-phosphorylated phosphatidylinositol (PI)" 1)
   ("Phosphatidylinositol (PI)" 1)))
 ("UP:Q9W4E2"
  (("RG" 160) ("Rg" 51) ("neocortical RG" 4) ("human neocortical RG" 2)
   ("-RG" 1) ("human and mouse neocortical RG" 1) ("rG" 1) ("than RG37" 1)))
 ("UP:Q9W4S7"
  (("DM" 1220) ("MYC protein" 478) ("Myc protein" 151) ("Dm" 30) ("dMyc" 25)
   ("myc protein" 14) ("dm" 7) ("pDM" 5) ("DM-" 5) ("-DM" 3)
   ("an abnormal MYC protein" 2) ("Leica confocal laser microscope DM" 2)
   ("synchronous DM" 2) ("metachronous DM" 2) ("MYC Protein" 2)
   ("the BRAF mutation-positive melanoma cell line DM440" 1) ("pDm" 1)
   ("cellular DM" 1) ("“DM”" 1) ("insulinopenic type 1 DM" 1)
   ("so too much MYC protein" 1)
   ("digital micrograph software program 1.7.1 Digital Micrograph DM" 1)
   ("pDM-" 1) ("the cellular Myc protein" 1)))
 ("UP:Q9W4Y2"
  (("Han" 797) ("HAN" 41) ("han" 2) ("Han-" 1)
   ("1742 unrelated ethnic Chinese Han" 1) ("the local Han" 1)))
 ("UP:Q9W596" (("Futsch" 72) ("futsch" 8)))
 ("UP:Q9W5D4"
  (("TW" 31) ("pTW" 2)
   ("than TW (IC 50  = 45.0 μM) which does not have this unit" 1)))
 ("UP:Q9W5E0" (("SUV4-20" 8) ("Suv4-20" 3)))
 ("UP:Q9W669"
  (("ERβ1" 286) ("ER-β1" 34) ("ERbeta1" 30) ("a few co-expressed ERβ1" 2)))
 ("UP:Q9W6F9"
  (("WIF-1" 148) ("Wif-1" 55) ("A representative Wif-1" 2)
   ("Wnt inhibitory factor 1" 1)))
 ("UP:Q9W6V6" (("Ten1" 2) ("TEN1" 2)))
 ("UP:Q9W704"
  (("RIPA" 2354) ("ice-cold RIPA" 3) ("Ripa" 3) ("RIPA protein" 2)))
 ("UP:Q9W747" (("DRL" 3))) ("UP:Q9W7E9" (("Sst2" 1)))
 ("UP:Q9WJJ2" (("JM-B" 80) ("JM-b" 10) ("a crucial JM-B" 2)))
 ("UP:Q9WTR1" (("GRC" 12))) ("UP:Q9WU81" (("CI2" 1)))
 ("UP:Q9WUI0" ; removed mix
(
 #|("mix" 6449) ("Mix" 5994) ("TaqMan Universal PCR Master Mix" 68)
   ("Mix (ABI)" 64) ("MIX" 35) ("Universal PCR Master Mix" 24)
   ("TaqMan Fast Universal PCR Master Mix" 22)
   ("TaqMan Universal Master Mix" 18) ("Taqman Universal PCR Master Mix" 17)
   ("Mix (TOYOBO)" 15) ("Universal Master Mix" 14) ("Mix (QIAGEN)" 13)
   ("TaqMan universal PCR master mix" 11)
   ("the Taqman Universal PCR Master Mix" 10)
   ("the TaqMan Universal PCR Master Mix" 10)
   ("using TaqMan Universal PCR Master Mix" 9)
   ("TaqMan Universal PCR master mix" 8) ("Taqman Universal Master Mix" 8)
   ("using TaqMan Universal Master Mix" 8)
   ("the TaqMan Universal PCR master Mix" 8)
   ("TaqMan® Universal PCR Master Mix" 8) ("Universal PCR master mix" 7)
   ("1× TaqMan Universal PCR master mix" 7)
   ("the ABsolute QPCR SYBR green mix" 6) ("TaqMan universal PCR Master Mix" 6)
   ("universal PCR master mix" 6) ("QIAGEN" 6) ("mix-" 5)
   ("ViraPower Lentiviral Packaging Mix" 5)
   ("FastStart Universal SYBR Green Master mix" 4)
   ("a universal PCR Master Mix" 4)
   ("the ABI SNaPshot Multiplex Ready Reaction Mix" 4)
   ("the FastStart Universal SYBR Green Master mix" 4)
   ("Absolute QPCR SYBR Green Mix" 4)
   ("using TaqMan Universal PCR master mix" 4)
   ("SYBR Green Universal PCR Master Mix" 4) ("2X Universal Master Mix" 4)
   ("1 Universal TaqMan Master Mix and 1xTaqMan probe/primer mix" 4)
   ("the FastStart Universal SYBR Green Master Mix" 4)
   ("5  μ L TaqMan Universal PCR Master Mix" 4)
   ("a TaqMan Universal PCR Master Mix" 4)
   ("ViraPower Lentivrial packaging mix" 4)
   ("1X Brilliant SYBR Green QPCR Master Mix" 4)
   ("using Taqman Universal Master Mix" 4)
   ("MISSION® Lentiviral Packaging Mix" 4) ("Fast Universal PCR Master Mix" 4)
("using Brilliant III Ultra-Fast QPCR Master Mix" 4)|#
("MML" 4)
   ("1X TaqMan Universal PCR Mast Mix" 4) ("mix (VWR)" 4)
   ("Taqman Universal PCR master mix" 3)
   ("1× TaqMan fast universal master mix" 3) ("mix (ABI)" 3)
   ("FastStart Universal SYBR Green Master Mix" 3) ("a heterogeneous mix" 3)
   ("Universal PCR TaqMan Master Mix" 3) ("TaqMan Fast Universal Master mix" 3)
   ("Brilliant SYBR Green QPCR Master Mix" 3)
   ("1 X TaqMan® universal PCR master mix" 3)
   ("1X TaqMan Universal PCR Master Mix" 3)
   ("a TaqMan universal PCR master mix" 3) ("Taqman Universal PCR Mix" 3)
   ("the HotStar Taq Master Mix" 3) ("a quantitative PCR mix" 3)
   ("2.5 µL 2X Universal Master Mix" 3) ("Lentiviral Packaging Mix" 3)
   ("employed TaqMan Genotyping PCR Master Mix" 3) ("Mix (NEB)" 3)
   ("using Brilliant SYBER Green QPCR Master Mix" 3)
   ("FastStart Universal SYBR Green master mix" 2)
   ("Brilliant III SYBR Green master mix" 2)
   ("TaqMan® Universal PCR fast Master Mix" 2)
   ("10 µL universal PCR master mix" 2) ("10 µL universal PCR Master Mix" 2)
   ("the Brilliant II SYBR Green QPCR Master Mix" 2) ("simultaneous mix" 2)
   ("1× ABsolute SYBR fluorescein mix" 2)
   ("p53- mouse anti-human monoclonal supernatant antibodies mix-" 2)
   ("the fluorescent dye SYBR Green Master Mix" 2)
   ("the Virapower lentiviral packaging mix" 2)
   ("1% antibiotic-antimycotic mix" 2)
   ("The Mission Lentiviral packaging mix" 2) ("TaqMan Universal master mix" 2)
   ("using 1× TaqMan Universal PCR Master Mix" 2)
   ("using High Capacity cDNA reverse transcriptase and TaqMan® FastUniversal PCR Master Mix"
    2)
   ("KAPA SYBR FAST Universal 2× qPCR Master Mix" 2)
   ("TaqMan® Fast Universal PCR Master Mix" 2)
   ("the Brilliant II SYBR Green QPCR master mix" 2)
   ("the Mission lentiviral packaging mix" 2)
   ("SNaPshot multiplex ready reaction mix" 2)
   ("the TaqMan Universal PCR Master mix" 2)
   ("Universal SYBR Green Master Mix" 2)
   ("1 Universal TaqMan Master Mix and 1×TaqMan probe/primer mix" 2)
   ("using miRCURY LNA™ universal cDNA synthesis Kit and miRCURY LNA™ SYBR Green master mix"
    2)
   ("Chemiluminescent Blue Ranger Marker Mix" 2)
   ("using Taqman Universal PCR Master Mix" 2) ("Mix(ABI)" 2)
   ("Ix TaqMan Universal PCR Master Mix" 2)
   ("AccuPower 2× Greenstar qPCR Master Mix" 2)
   ("Taq-Man universal PCR master mix" 2)
   ("the TaqMan Universal PCR master mix" 2) ("the ABsolute QPCR Mix" 2)
   ("1× QIAGEN Multiplex PCR Master Mix" 2)
   ("using SYBR Green Universal Master Mix" 2)
   ("the Brilliant SYBR Green QRT-PCR 1-Step Master Mix" 2)
   ("using Mission Lentiviral Packaging Mix" 2) ("mix (SIGMA)" 2)
   ("the TaqMAN Fast Universal PCR Master Mix" 2)
   ("using Universal TaqMan Master Mix" 2)
   ("2.5 μl TaqMan Universal PCR Master Mix" 2) ("a similar ethnic mix" 2)
   ("Brilliant II qRT-PCR master mix" 2) ("2x Absolute Q-PCR mix" 2)
   ("ABsolute Blue QPCR SYBR Green Low ROX Mix" 2)
   ("TM lentiviral packaging mix" 2)
   ("SYBR-Green Fast Universal PCR Master Mix" 2)
   ("Universal SYBER green mix" 2) ("using Universal SYBR green mix" 2)
   ("6.25 μl TaqMan Universal PCR Master Mix" 2) ("ice-cold mineral oil mix" 2)
   ("50 μl TaqMan® Universal Master Mix" 2)
   ("using TaqMan One-Step Universal Master Mix" 2)
   ("Brilliant II SYBR QPCR Low ROX Master Mix" 2)
   ("Brilliant III Ultra-fast SYBR Green QPCR Master Mix" 2)
   ("using TaqMan® Brilliant II QPCR Master Mix" 2)
   ("ice-cold click reaction mix" 2) ("MISSION lentiviral packaging mix" 2)
   ("Exilent SYBR Green master mix" 2)
   ("a customer developed dual-color mix" 2)
   ("quantitative real-time PCR Sybr Green qPCR Master MIX" 2)
   ("containing TaqMan Universal PCR Master Mix" 2)
   ("the commercial HRM PCR Master Mix" 2)
   ("Each 10 ml amplification reaction volume contained 1X Taqman Universal Master Mix"
    2)
   ("a 2X real- time PCR master mix" 2) ("a mitotic kinase mix" 2)
   ("2× Taqman Universal Master Mix" 2) ("Universal Taqman PCR master mix" 2)
   ("TaqMan Universal Master PCR Mix" 2)
   ("Each 10 mL amplification reaction volume contained 1X Taqman Universal Master Mix"
    2)
   ("MEM Essential Vitamin Mix" 2) ("10 μL 2× Brilliant II QPCR Master Mix" 2)
   ("the Taqman universal PCR master mix" 2)
   ("Taqman Universal Fast Master Mix" 2) ("SYBR Green Universal Master Mix" 2)
   ("TagMan Universal PCR Master Mix" 2)
   ("the 2X TaqMan Universal Master Mix" 2) ("Brilliant II PCR mix" 2)
   ("an antibiotic-antimycotic mix" 2)
   ("SNaPshot Multiplex Ready Reaction mix" 2)
   ("Taqman universal master mix" 2) ("Taqman 2X Universal PCR Master Mix" 2)
   ("1 ul TaqMan Universal PCR Master Mix" 2)
   ("2× SYBR Universal PCR Master Mix" 2)
   ("TaqMan® 2× Universal PCR Master Mix" 2)
   ("the TaqMan Universal Master Mix" 2)
   ("an MJ research thermal cycler system and SYBER Green QPCR Master Mix" 2)
   ("the ViraPower™ Lentiviral Packaging Mix" 2)
   ("Brilliant II QRT-PCR master mix" 2)
   ("the TaqMan Fast Universal PCR Master Mix" 2)
   ("Brilliant SYBR Green QPCR Master mix" 2)
   ("SNaPshot Multiplex Ready Reaction Mix" 2)
   ("using ABsolute SYBR Green ROX mix" 2)
   ("2× TaqMan Universal PCR Master Mix" 2) ("mix (PI)" 2)
   ("2x Taqman Universal Master Mix" 2) ("ABsolute Blue qPCR SYBR Green Mix" 2)
   ("using brilliant Q-PCR master mix" 2)
   ("TaqMan Fast Universal Master Mix" 2) ("SYBR green–based master mix" 2)
   ("the ABI TaqMan Fast Universal PCR master mix" 2)
   ("1 μl TaqMan Universal PCR Master Mix" 2)
   ("Taqman® Universal PCR Master Mix" 2)
   ("the TaqMan universal PCR master mix" 2)
   ("a TaqMan 2X Universal PCR Master Mix" 2)
   ("Brilliant SYBR green master mix" 2)
   ("RT 2 Real-Time SYBR green/ROX quantitative PCR Master Mix" 2)
   ("the ViraPower Lentiviral packaging mix" 2)
   ("SYBR Green qPCR Supermix-UDG universal PCR Master Mix" 2)
   ("TaqMan® universal PCR master mix" 2) ("mix (QIAGEN)" 2)
   ("TaqMan universal master mix and TaqMan primer mix" 2)
   ("the TaqMan® Universal PCR Master Mix" 2)
   ("0.7× Qiagen® PCR HotStar Taq Master Mix" 2)
   ("using Universal PCR Master Mix" 2) ("the TaqMan Abgene universal mix" 2)
   ("the Absolute Blue QPCR SYBRGreen Rox mix" 2)
   ("1x TaqMan Universal Master Mix" 2) ("internal calibration mix" 2)
   ("TaqMAN Universal PCR Master Mix" 2)
   ("the Applied Biosystems Taqman Universal PCR Master Mix" 2)
   ("Taqman Fast Universal PCR Master Mix" 2)
   ("1.5 ul 2XTaqMan universal PCR master mix" 2)
   ("Brilliant III Ultra-Fast SYBR Green qPCR Master mix" 2)
   ("1 x Taqman® Universal PCR Master Mix" 2)
   ("5 μL 2x TaqMan® Universal PCR Master Mix" 2)
   ("the Absolute QPCR SYBR green mix" 2) ("GoTaq Colorless Master Mix" 2)
   ("a TaqMan Universal Fast PCR Master Mix" 2)
   ("the QIAGEN Multiplex PCR Master Mix" 2) ("Absolute SYBR Green ROX Mix" 2)
   ("Lentiviral packaging mix" 2)
   ("using Brilliant II Fast Syber Green Master Mix" 2)
   ("50 ml TaqMan Universal PCR Master Mix" 2)
   ("using FastStart Universal SYBR Green master mix" 2)
   ("Universal SYBR Green Master (Rox) SYBR Green PCR Master Mix" 2)
   ("the ViraPower Lentiviral Packaging Mix" 2)
   ("using Brilliant II SYBR® Green qPCR Master Mix" 2)
   ("Brilliant SYBR Green Master Mix" 2)
   ("complete mini protease inhibitor mix" 2)
   ("using TaqMan Fast Universal 2× PCR Master Mix" 2)
   ("the TaqMan 2× universal master mix" 1)
   ("Universal PCR Master Mix (ABI)" 1)
   ("FastStart SYBR green Universal Master mix" 1)
   ("using Brilliant III Ultra-Fast SYBR® Green QPCR Master Mix" 1)
   ("TaqMan Universal PCR Master Mix (ABI)" 1)
   ("using TaqMan Fast Universal Master Mix" 1)
   ("the Trans-Lentiviral packaging mix" 1) ("a 1∶1 mix of DME and Ham’s" 1)
   ("using Taqman Universal PCR master mix" 1)
   ("The modified 2x TaqMan universal Master Mix" 1)
   ("MISSION Lentiviral Packaging Mix" 1)
   ("mix and Taqman Universal PCR Master Mix (ABI)" 1) ("Mml" 1)
   ("Brilliant II QPCR Master Mix" 1) ("a heterogenous mix" 1)
   ("Taqman FAST universal PCR Master Mix" 1)
   ("TaqMan(R) Fast Universal PCR Master Mix" 1)
   ("TaqMan Universal PCR Master mix" 1)
   ("an antibody-coated magnetic bead mix" 1) ("a very heterogeneous mix" 1)
   ("Sigma Mission Lentivaral packaging mix" 1)
   ("the Agilent Spike-in RNA mix" 1) ("1x Universal TaqMan Master Mix" 1)
   ("the TaqMan Universal PCR Master Mix(ABI)" 1)
   ("2× TaqMan® Universal Master Mix (ABI)" 1)
   ("using TaqMan Universal PCR Master Mix or SYBR Green PCR Master Mix" 1)
   ("antibiotic-antimycotic mix" 1) ("the ABsolute QPCR SYBR Green Mix" 1)
   ("Brilliant II SYBR Green QPCR master mix" 1)
   ("TNT quick-coupled transcription/translation system (Promega, Madison, WI, USA) master mix"
    1)
   ("a pre-made mix" 1) ("using Taqman Universal master mix" 1)
   ("Mission™ Lentiviral Packaging Mix" 1)
   ("Mission TM Lentiviral Packaging Mix" 1) ("This artificial “mix”" 1)
   ("“mix”" 1) ("2x Brilliant II SYBR Green QPCR master mix" 1)
   ("thermal mix" 1) ("the quantitative PCR (QPCR) master mix" 1)
   ("primer/probe mix and TaqMan Fast Universal PCR Master Mix" 1)
   ("1.5μL TaqMan Universal Master Mix" 1) ("Toyobo" 1)
   ("12.5 μl Brilliant SYBR Green QPCR Master Mix" 1)
   ("two-fold QuantStudio 3D Digital PCR Master Mix" 1)
   ("GATCAGTT TaqMan Universal PCR master mix" 1)
   ("1× TaqMan Universal PCR Master Mix" 1) ("mML" 1)
   ("the secondary antibody mix" 1) ("the universal mix" 1)
   ("Universal Master Mix (ABI)" 1) ("the lentiviral packaging mix" 1)
   ("Universal Fast Real-Time Master Mix" 1)
   ("brilliant SYBR Green QPCR Master Mix" 1)
   ("50% SYBR GREEN universal PCR Master Mix" 1)
   ("225 nM, and 1× Universal Master Mix" 1) ("“Mix”" 1)
   ("5.0 μl 2× TaqMan Universal Master Mix" 1)
   ("12.5 μl TaqMan Universal PCR Master Mix" 1)
   ("the TaqMan Fast Universal PCR Master mix" 1)
   ("1× Brilliant QPCR master mix" 1) ("a TaqMan® Universal PCR Master Mix" 1)
   ("MEM nonessential amino acid mix (NEAA)" 1) ("mix (NEAA)" 1)
   ("internal control vector mix" 1)
   ("the SNaPshot Multiplex Ready Reaction Mix (ABI)" 1)
   ("the Applied Biosystems universal master mix" 1)
   ("1x TaqMan Universal PCR master mix" 1)
   ("2X TaqMan Universal PCR Master Mix" 1) ("a different racial mix" 1)
   ("Universal Master mix" 1) ("the entire mix" 1)
   ("the HRP-Streptavidin-Chemiluminescent reaction mix" 1)
   ("6 μl TaqMan Universal PCR Master Mix" 1)
   ("GeneJuice transfection reagent/serum-free medium/DNA mix" 1)
   ("each primer pair and Power SYBR Green PCR Master Mix or TaqMan Universal PCR Master Mix"
    1)
   ("Mix (SERVA)" 1) ("1× TaqMan universal PCR master mix" 1)
   ("1xTaqMan Universal PCR Master Mix" 1)
   ("1x TaqMan® Universal PCR Master Mix (ABI)" 1)
   ("the TaqMan Universal PCR Mix" 1) ("an equimolar mix" 1)
   ("using FastStart Universal SYBR green (ROX) master mix" 1)
   ("the resultant hybridization mix" 1)
   ("the kit-supplied 1st Strand Master Mix" 1) ("a good mix" 1)
   ("Applied Biosystems and Taqman Fast-Advanced master mix" 1)
   ("a TaqMan fast universal PCR master mix" 1)
   ("the Universal PCR Master Mix" 1) ("4X New KASPar Reaction Mix" 1)
   ("the respective probe/primer mix" 1)))
 ("UP:Q9WUK6" (("ZFP238" 1)))
 ("UP:Q9WVF9"
  (("LCL1" 96) ("EBV-transformed LCL1" 1)
   ("EBV transformed lymphoblastoid LCL1" 1)
   ("EBV transformed B cell line LCL1" 1)
   ("an EBV transformed cell line LCL1" 1)))
 #+ignore("UP:Q9WXE6" ; removed line
  (("line" 7550) ("LINE" 689) ("Line" 158) ("the parental line" 68)
   ("-line" 22) ("JY" 14) ("severe line" 10) ("line-" 9)
   ("the diagonal line" 7) ("parental line" 5) ("inducible line" 5)
   ("its parental line" 5) ("exponential line" 4) ("“Germ-Line”" 4)
   ("the MCF7 parental line" 4) ("subsequent line" 3) ("urothelial line" 3)
   ("“line”" 3) ("a novel subclonal line" 3) ("the C10 parental line" 2)
   ("the mid-dorsal line" 2) ("the lateral dorsal axillary line" 2)
   ("the MDA-parental line" 2) ("a horizontal line" 2)
   ("the passage-matched parental line" 2) ("a white vertical line" 2)
   ("an AR-positive line" 2) ("a fibroblastic line" 2)
   ("the human mammary line" 2) ("ELR" 2) ("-Line" 2)
   ("smallest congenic line" 2) ("a straight horizontal line" 2)
   ("the germinal line" 2)
   ("the parental (p53 deficient) H1299 cell inducible line" 2)
   ("intense line" 2) ("a V600E B-RAF-homozygous parental line" 2)
   ("One receptor-positive line" 2) ("sensitive parental line (HP)" 2)
   ("telomerase-expressing human retinal pigment epithelial cells (RPE-hTERT) cells—a non-transformed line"
    2)
   ("the central venous line" 1) ("its wild-type parental line" 1)
   ("A robust line" 1) ("the floxed reverted line" 1)
   ("untreated parental line" 1) ("parental line’s" 1) ("an astrocytic line" 1)
   ("straight, segmented, or freehand line" 1) ("The diagonal line" 1)
   ("The parental line" 1) ("the thymic line" 1) ("associated line" 1)
   ("the left lateral axillary line" 1) ("line—" 1)
   ("the derived isogenic line" 1) ("a worthwhile line" 1)
   ("the lateral line" 1)
   ("the
LAPC4 parental line"
    1)
   ("a convenient line" 1) ("spontaneously immortal line" 1)
   ("its V600E  BRAF parental line" 1) ("even more advanced line" 1)
   ("characteristic LINE" 1) ("an almost horizontal line" 1)
   ("an AR-negative line" 1) ("a vertical line" 1) ("perfect line" 1)
   ("the same parental line" 1) ("background-corrected line" 1)
   ("The sensitive parental line" 1) ("an indirect line" 1)
   ("the TGR parental line" 1) ("radial arterial line" 1)
   ("a representative line" 1) ("each VARSPLIC line" 1) ("a VARSPLIC line" 1)
   ("A strong line" 1) ("the mid-clavicular line" 1)
   ("the uniform diagonal line" 1) ("a less well-differentiated line" 1)
   ("the only consomic line" 1) ("an imaginary horizontal line" 1)
   ("the MDA-MB-468 parental line" 1) ("a possible line" 1)
   ("thePten L/L conditional line" 1) ("an intravenous line" 1) ("–line" 1)
   ("a fuzzy line" 1) ("the corresponding parental line" 1)
   ("the laser-damaged line" 1)
   ("the observed inhomogeneous and homogeneous line" 1) ("an MDCK II line" 1)
   ("an immortalized human astrocytic line" 1) ("the afferent line" 1)
   ("trastuzumab parental line" 1) ("a non-transformed line" 1)
   ("the drug sensitive parental line" 1) ("a separate line" 1)
   ("their parental line" 1) ("The unbroken vertical line" 1)
   ("the horizontal line" 1)))
 ("UP:Q9WXI7" (("CRR" 7))) ("UP:Q9WYW0" (("Sir2Tm" 55)))
 ("UP:Q9X2F4" (("TMG" 20))) ("UP:Q9X3X2" (("UBM" 33)))
 ("UP:Q9X697" (("VDCC" 8)))
 ("UP:Q9X713" (("p-S" 152) ("P-S" 50) ("p­S" 4) ("strong p-S" 1)))
 ("UP:Q9XB14" (("DMBA" 233) ("\"DMBA\"" 1) ("given DMBA" 1)))
 ("UP:Q9XEX4" (("DESA" 7))) ("UP:Q9XF43" (("CUT-1" 1)))
 ("UP:Q9XGI7"
  (("CLN" 60) ("pCLN" 1) ("metastasized CLN" 1)
   ("prelaryngeal, pretracheal, and paratracheal CLN" 1)
   ("particularly clinically or radiographically abnormal CLN" 1) ("Cln" 1)))
 ("UP:Q9XGW1" (("PNH" 1))) ("UP:Q9XHH2" (("LC1" 1)))
 ("UP:Q9XI33" (("shn-1" 3))) ("UP:Q9XIA9" (("Bre1" 5) ("BRE1" 1)))
 ("UP:Q9XIP8" (("CDI" 12))) ("UP:Q9XQ94" (("GLN" 30)))
 ("UP:Q9XRX5" (("HHLA3" 1))) ("UP:Q9XTJ4" (("NHR3" 2)))
 ("UP:Q9XTR1"
  (("CDK4/6" 673) ("cdk4/6" 68) ("Cdk4/6" 48) ("-CDK4/6" 3) ("CDK4/6-" 2)
   ("Cdk4/6-" 2) ("CDk4/6" 1)))
 ("UP:Q9XVV3"
  (("nuclear hormone receptor" 131) ("nuclear hormone receptor-" 3)))
 ("UP:Q9XWE9" (("LAGR-1" 1))) ("UP:Q9XWP6" (("SPR-5" 5)))
 ("UP:Q9XYZ5"
  (("PIC" 326) ("pPIC" 14) ("P-PIC" 9) ("pic" 7) ("the viral PIC" 5) ("Pic" 4)
   ("−20°C. Complete PIC" 2) ("the viral dsRNA analog PIC" 2)
   ("the so-called PIC" 1) ("larger 43S translation PIC" 1)))
 ("UP:Q9XZ71" (("TNTs" 81) ("Troponin T" 3)))
 #+ignore("UP:Q9Y0A7" ; removed bad def -- need to add "region of interest"
  (("ROI" 391) ("AMOs" 12) ("a constant circular ROI" 2)
   ("a nucleoplasmic ROI" 2) ("the entire ROI" 1) ("at least 10 ROI" 1)
   ("the selected circular ROI" 1) ("the dorsal amygdala ROI" 1)
   ("The dorsal amygdala ROI" 1) ("The ventral amygdala ROI" 1)
   ("the equatorial ROI" 1) ("A circular ROI" 1)))
 ("UP:Q9Y0T3" (("CTxB" 11) ("CtxB" 8))) ("UP:Q9Y1C1" (("EMAP" 1)))
 ("UP:Q9Y210"
  (("TRPC6" 503) ("TRPC6 protein" 4) ("nascent TRPC6" 2) ("-TRPC6" 1)
   ("pulmonary smooth muscle cells TRPC6" 1) ("trpc6" 1) ("FSGS2" 1)))
 ("UP:Q9Y216" (("myotubularin related protein 7" 3) ("Mtmr7" 2)))
 ("UP:Q9Y219"
  (("Jagged-2" 53) ("JAG2" 43) ("Jagged2" 24) ("Jag2" 10) ("jagged 2" 4)
   ("JAG2 protein" 2) ("Jagged 2" 1) ("than JAG2" 1)))
 ("UP:Q9Y222"
  (("hDMP1" 14) ("DMTF1" 4) ("Dmtf1" 3) ("hDMP1 protein" 3)
   ("weak (1+) hDMP1" 2)))
 ("UP:Q9Y223" (("GNE" 65) ("the intrinsic GNE" 2) ("faster Ras GNE" 1)))
 ("UP:Q9Y224"
  (("CLE" 28) ("the retroviral vector pCLE" 4) ("pCLE" 4) ("C14orf166" 4)
   ("stochastic CLE" 2)))
 ("UP:Q9Y228" (("TRAF3IP3" 2)))
 ("UP:Q9Y230"
  (("Tip48" 34) ("TIP48" 24) ("RUVBL2" 9) ("TIP49b" 4) ("RuvBL2" 2)
   ("Reptin52" 2) ("Tip49b" 1) ("ruvbl2" 1)))
 ("UP:Q9Y231" (("FUT9" 6))) ("UP:Q9Y232" (("CDYL1" 2)))
 ("UP:Q9Y233" (("PDE10A" 3))) ("UP:Q9Y235" (("APOBEC2" 13)))
 ("UP:Q9Y237" (("Par14" 2)))
 ("UP:Q9Y239"
  (("NOD1" 120) ("Nod1" 28) ("NLRC1" 2) ("NOD1-" 2) ("CARD4" 1)
   ("SHIP-1 specifically increases NOD1" 1)))
 ("UP:Q9Y242"
  (("SC1" 210) ("TCF19" 7) ("that SC1's" 3) ("given SC1's" 1) ("given SC1" 1)
   ("direct SC1's" 1)))
 ("UP:Q9Y243" ; removed pervanadate
  (("Akt3" 878) ("AKT3" 588) #+ignore("pervanadate" 243) ("Akt-3" 23)
   ("Pervanadate" 20) ("overexpressed Akt3" 5) ("PKB γ" 4) ("Akt 3" 4)
   ("pervanadate (PV)" 3) ("PKB gamma" 2) ("pAKT3" 2) ("pervanadate-" 2)
   ("-Akt3" 2) ("Akt3-" 2) ("the unspecific  PTP inhibitor pervanadate" 1)
   ("AKT 3" 1) ("the strong tyrosine phosphatase inhibitor pervanadate (PV)" 1)
   ("the resultant Akt3" 1) ("Akt3 protein" 1) ("AKT3 protein" 1)))
 ("UP:Q9Y248" (("PFS2" 36) ("GINS2" 1))) ("UP:Q9Y250" (("LZTS1" 6)))
 ("UP:Q9Y251"
  (("HPA" 202) ("heparanase" 97) ("HPSE" 69) ("latent heparanase" 15)
   ("HEPARANASE" 14) ("Hpa1" 4) ("exogenous heparanase" 3) ("Heparanase" 3)
   ("HPA1" 3) ("exogenous HPSE" 2) ("Hpse" 1)
   ("particularly latent (65 kDa) heparanase" 1) ("latent HPSE" 1)
   ("exogenous latent heparanase" 1) ("roles exogenous heparanase" 1)
   ("recombinant human latent heparanase" 1) ("heparanase (HPSE)" 1)))
 ("UP:Q9Y252" (("RNF6" 182) ("overexpressed RNF6" 4) ("exogenous RNF6" 1)))
 ("UP:Q9Y253"
  (("PolH" 149) ("XPV" 68) ("PolH protein" 11) ("RAD30" 5) ("Rad30" 5)
   ("rad30" 1) ("Rad30 (yeast homolog of Polη) protein" 1) ("polH" 1)
   ("exogenous PolH protein" 1)))
 ("UP:Q9Y256" (("Rce1" 101) ("Rce1-" 14) ("RCE1" 12)))
 ("UP:Q9Y258" (("eotaxin-3" 87) ("IMAC" 53) ("Eotaxin-3" 29) ("-IMAC" 6)))
 ("UP:Q9Y259" (("Chkl" 2) ("CHKB" 2)))
 ("UP:Q9Y261"
  (("FOXA2" 411) ("Foxa2" 86) ("forkhead box A2" 14) ("Hnf-3β" 11) ("FoxA2" 9)
   ("FOXA2 protein" 4) ("HNF3β" 3) ("Forkhead Box A2" 2) ("HNF-3β" 2)
   ("Hnf3β" 1) ("than wild-type FOXA2 ( xref )" 1)
   ("ectopically-expressed wild type FOXA2" 1) ("HNF3B" 1)))
 ("UP:Q9Y262" (("EIF3L" 1))) ("UP:Q9Y263" (("PLAA" 10)))
 ("UP:Q9Y264" (("ANGPT4" 4) ("angiopoietin 4" 1)))
 ("UP:Q9Y265"
  (("TIP49a" 32) ("Pontin52" 31) ("RUVBL1" 11) ("Rvb1" 2) ("RuvBL1" 2)
   ("Tip49a" 1)))
 ("UP:Q9Y266"
  (("NUDC" 25) ("NudC" 3)
   ("the cytoplasmic dynein-associated protein NudC" 2)))
 ("UP:Q9Y271"
  (("CysLT1" 46) ("CysLT 1" 35) ("cysteinyl leukotriene receptor 1" 8)
   ("cysLT 1" 1) ("CysLTR1" 1)))
 ("UP:Q9Y272" ;removed dexamethasone
  (#+ignore("dexamethasone" 1139) #+ignore("Dexamethasone" 111) ("DEX" 45) ("RASD1" 15)
   ("Ras-related protein" 8) ("dexamethasone (DEX)" 4)
   ("ras-related protein" 2) ("Dex" 2)
   ("the non-genotoxic drug dexamethasone" 1) ("dexamethasone-" 1)
   ("pro-osteogenic dexamethasone" 1)
   ("hMSC Differentiation Basal Medium-Osteogenic containing dexamethasone" 1)
   ("-dexamethasone" 1) ("Dexras1" 1) ("RAS-related protein" 1)))
 ("UP:Q9Y274" (("ST3GAL6" 10)))
 ("UP:Q9Y275"
  (("BAFF" 109) ("activating factor" 75) ("activating factor (BAFF)" 10)
   ("BLyS" 5) ("TALL-1" 4) ("-activating factor" 4) ("TNFSF13B" 3)
   ("activating factor (BAF)" 3)
   ("a novel transcriptional activating factor" 2) ("Tnfsf13b" 1)
   ("tnfsf13b" 1) ("A major activating factor" 1) ("TALL1" 1)
   ("autocrine BAFF" 1)
   ("the prosurvival factor B cell activating factor (BAFF)" 1)))
 ("UP:Q9Y276" (("BCS1L" 1))) ("UP:Q9Y279" (("VSIG4" 5)))
 ("UP:Q9Y281"
  (("cofilin-2" 10) ("Cofilin-2" 2) ("Cofilin2" 2) ("cofilin2" 1) ("CFL2" 1)))
 ("UP:Q9Y283"
  (("inv" 115) ("INV" 77) ("NPHP2" 20) ("Inv" 17) ("inversin" 6) ("Nphp2" 4)
   ("Inversin" 3) ("“Inv”" 1) ("nphp2" 1)))
 ("UP:Q9Y285" (("FARSLA" 1)))
 ("UP:Q9Y286"
  (("p75/AIRM1" 47) ("AIRM1" 34) ("GT1b" 15)
   ("adhesion inhibitory receptor molecule 1" 4) ("p75/AIRM1 molecule" 2)))
 ("UP:Q9Y287" (("ITM2B" 4))) ("UP:Q9Y291" (("S33" 499) ("MRPS33" 1)))
 ("UP:Q9Y294"
  (("ASF1A" 137) ("Asf1a" 26) ("histone chaperone ASF1A" 5) ("ASF1a" 2)))
 ("UP:Q9Y295" (("developmentally regulated GTP binding protein 1" 3)))
 ("UP:Q9Y296"
  (("TRAPPC4" 112) ("trafficking protein particle complex 4" 6) ("synbindin" 3)
   ("TRS23" 1)))
 ("UP:Q9Y297"
  (("β-TRCP1" 241) ("βTrCP1" 170) ("β-TrCP1" 100) ("BTRC" 59) ("Fbw1a" 46)
   ("β-Trcp1" 23) ("βTrCP1 protein" 11) ("β-TrCP1 protein" 7) ("bTRCP" 4)
   ("BTRCP" 4) ("β-TRCP1 protein" 3) ("beta-TrCP1" 3) ("β-TrCP-1" 2)
   ("overexpressed βTrCP1" 2)
   ("the destruction motif Asp32, Ser33, Gly34, and Ser37 directly bind beta-TrCP1"
    2)
   ("flag-tagged Fbw1a" 1) ("β-Trcp1 protein" 1) ("bTrCP" 1)))
 ("UP:Q9Y2A0" (("TP53TG1" 1))) ("UP:Q9Y2A7" (("Hem-2" 8) ("Nap125" 6)))
 ("UP:Q9Y2A9"
  (("transmembrane protein 3" 9)
   ("fibronectin-leucine-rich transmembrane protein 3" 2) ("B3GNT3" 1)))
 ("UP:Q9Y2B2" (("PIGL" 1))) ("UP:Q9Y2B5" (("VPS9D1" 1)))
 ("UP:Q9Y2C2" (("UST" 4)))
 ("UP:Q9Y2C4" (("EXOG" 22) ("exog" 1) ("the mitochondrial-specific EXOG" 1)))
 ("UP:Q9Y2C5" (("SLC17A4" 3))) ("UP:Q9Y2C9" (("TLR6" 66) ("TLR-6" 2)))
 ("UP:Q9Y2D1"
  (("ATF5" 29) ("activating transcription factor 5" 2)
   ("Activating transcription factor 5" 1) ("than its paralog ATF5" 1)))
 ("UP:Q9Y2D4" (("Sec15B" 1))) ("UP:Q9Y2D9" (("ZNF652" 21)))
 ("UP:Q9Y2E4" (("KIAA0934" 1)))
 ("UP:Q9Y2E6" (("DTX4" 114) ("Dtx4" 2) ("Q9Y2E6" 1)))
 ("UP:Q9Y2E8" (("SLC9A8" 1))) ("UP:Q9Y2F5" (("ICE1" 12) ("ICEs1" 5)))
 ("UP:Q9Y2G1" (("MRF" 6))) ("UP:Q9Y2G2" (("TUCAN" 37) ("CARD8" 7)))
 ("UP:Q9Y2G4" (("diversin" 7))) ("UP:Q9Y2G9" (("SBNO2" 51)))
 ("UP:Q9Y2H1" (("NDR2" 6) ("STK38L" 1) ("Ndr2" 1)))
 ("UP:Q9Y2H2"
  (("INPP5F" 133) ("overexpressed INPP5F" 2) ("INPP5F protein" 2)
   ("Inpp5f" 1)))
 ("UP:Q9Y2H5" (("PLEKHA6" 1)))
 ("UP:Q9Y2H6" (("HUGO" 45) ("FNDC3" 12) ("fndc3a" 1)))
 ("UP:Q9Y2I1"
  (("antisera" 797) ("IR1" 165) ("I-1" 78) ("Antisera" 34) ("IRAS" 22)
   ("-IR1" 19) ("i-1" 18) ("Nischarin" 10) ("primary antisera" 9)
   ("The primary antisera" 4) ("the appropriate antisera" 3) ("than IR1" 3)
   ("Texas red–conjugated secondary antisera" 2) ("the primary antisera" 2)
   ("secondary antisera" 2)
   ("secondary antibodies goat anti-mouse or goat anti-rabbit antisera" 2)
   ("commercially available antisera" 2) ("available antisera" 2)
   ("secondary biotin-conjugated goat anti-mouse IgG antisera" 2)
   ("The following secondary antisera" 2) ("irrelevant antisera" 2)
   ("Commercial antisera" 1) ("i–1" 1) ("I–1" 1)
   ("The following primary antisera" 1) ("the resultant antisera" 1)
   ("a nonspecific antisera" 1)
   ("The pSTAT1 and pSTAT5 monoclonal antibodies and pJAK2, pSTAT3 and JAK2 antisera"
    1)
   ("I1R" 1) ("three different commercially available cdk-4 antisera" 1)
   ("Primary antisera" 1) ("a rabbit monoclonal H3 K56Ac specific antisera" 1)
   ("Monoclonal antisera" 1) ("than the cyclin D1a antisera" 1)
   ("Peroxidase-conjugated secondary antisera" 1)
   ("using species-specific secondary antisera" 1)
   ("The phosphospecific antisera" 1) ("phosphospecific antisera" 1)
   ("novel commercially available antisera" 1)
   ("anti-RNAPII-CTDa monoclonal antisera" 1) ("the crude antisera" 1)
   ("a hybrid IR1" 1)
   ("using anti-pVHL antibody and anti–rabbit AlexaFluor-conjugated antisera"
    1)
   ("their respective antisera" 1) ("mouse monoclonal antisera" 1)))
 ("UP:Q9Y2I2" (("NTNG1" 4)))
 ("UP:Q9Y2I6"
  (("NLP" 16) ("Nlp" 3) ("Ninein-like protein" 2) ("ninein-like protein" 2)
   ("NINL" 1)))
 ("UP:Q9Y2I7"
  (("PIKfyve" 104) ("PIKFYVE" 30) ("phosphoinositide kinase" 13)
   ("PIKfyve protein" 4) ("the general endocytic regulator PIKfyve" 1)
   ("the non-phosphorylatable S318A mutant PIKfyve" 1) ("p235" 1) ("PIP5K3" 1)
   ("FAB1" 1)))
 ("UP:Q9Y2J2" (("EPB41L3" 68) ("DAL-1" 3) ("4.1B" 1) ("DAL1" 1)))
 ("UP:Q9Y2J4"
  (("AMOTL2" 113) ("AmotL2" 15) ("overexpressed AMOTL2 protein" 3)
   ("AMOTL2 protein" 2) ("the first 100 amino acids of AMOTL2" 2)
   ("the first 307 amino acids of AMOTL2" 1)
   ("the first 307 amino acids of AMOTL2 ( xref )" 1)))
 ("UP:Q9Y2J8" (("PAD2" 2)))
 ("UP:Q9Y2K1"
  (("ZBTB1" 134) ("Zbtb1" 14)
   ("the UBZ4 domain-containing transcriptional repressor ZBTB1" 1)))
 ("UP:Q9Y2K2"
  (("SIK3" 18) ("QSK" 5) ("Sik3" 2) ("KIAA0999" 2) ("SIK3 (QSK)" 1)))
 ("UP:Q9Y2K3" (("MYH15" 10) ("MYH15 protein" 2) ("heavy polypeptide 15" 2)))
 ("UP:Q9Y2K6" (("USP20" 7)))
 ("UP:Q9Y2K7"
  (("KDM2A" 187) ("FBXL11" 8) ("JHDM1A" 5) ("KDM2A-" 2)
   ("35 S-Methionine-labeled KDM2A" 1)))
 ("UP:Q9Y2L1" (("Rrp44" 1))) ("UP:Q9Y2L5" (("KIAA1012" 2)))
 ("UP:Q9Y2L6" (("FRMD4B" 5))) ("UP:Q9Y2L8" (("ZKSCAN5" 7)))
 ("UP:Q9Y2L9" (("LRCH1" 6)))
 ("UP:Q9Y2M0"
  (("replication/repair" 5) ("FANCD2/FANCI-associated nuclease 1 protein" 3)
   ("FANCD2/FANCI-associated nuclease 1" 2)))
 ("UP:Q9Y2M5" (("KLHL20" 3)))
 ("UP:Q9Y2N7" ; removed normoxia, but haven't found new ontology
  (#+ignore("normoxia" 770) #+ignore("normoxia-" 8) ("IPAS" 6) #+ignore("Normoxia" 4) ("IPAs" 2)
   ("HIF3A" 1)))
 ("UP:Q9Y2P5"
  (("BACs" 88) ("BACS" 4) ("most nonmucinous BACs" 1) ("Schematic BACs" 1)
   ("Polymorphic BACs" 1) ("Circular BACs" 1)))
 ("UP:Q9Y2P8" (("RCL1" 3)))
 ("UP:Q9Y2Q0"
  (("Class I" 387) ("Class I-" 6) ("CLASS I" 4)
   ("viral infectivity or downmodulate CD4 and MHC Class I" 2)
   ("mature Class I" 2) ("typical Class I" 1) ("immature Class I" 1)))
 ("UP:Q9Y2Q3" (("GSTK1" 2) ("glutathione S-transferase kappa 1" 1)))
 ("UP:Q9Y2Q5" (("LAMTOR2" 1)))
 ("UP:Q9Y2R2"
  (("PTPN22" 145) ("LYP" 28) ("Lyp" 11)
   ("protein tyrosine phosphatase, non-receptor type 22" 4) ("lyp" 4)
   ("ofnear PTPN22" 2) ("LyP" 1)))
 ("UP:Q9Y2R4" (("DDX52" 4))) ("UP:Q9Y2S0" (("POLR1D" 2) ("RPA16" 1)))
 ("UP:Q9Y2S7" (("Poldip2" 1)))
 ("UP:Q9Y2T1"
  (("Axin2" 340) ("AXIN2" 288) ("axin2" 25) ("Conductin" 11) ("conductin" 10)
   ("Axin 2" 7) ("Axil" 4) ("overexpressed Axin2" 3) ("Axin-like protein" 2)
   ("N-terminal flag-tagged Axin2" 2) ("AXIN2 protein" 2)
   ("The epithelial-mesenchymal transition (EMT) promoter and Wnt target gene Axin2"
    2)
   ("AXIN-2" 2) ("than FL Conductin in SW480 cells" 1)
   ("N-terminal flag-tagged mouse Axin2" 1) ("AXIS inhibition protein 2" 1)
   ("a human placental cDNA library repeatedly recovered Axin2" 1) ("Axin2-" 1)
   ("the well-established Wnt target gene Axin2" 1)))
 ("UP:Q9Y2U5" (("MEKK2" 53) ("MAP3K2" 10) ("Mekk2" 7)))
 ("UP:Q9Y2U8" (("MAN1" 161) ("LEMD3" 8) ("MAN1 molecule" 2)))
 ("UP:Q9Y2U9" (("LCP" 20))) ("UP:Q9Y2V2" (("CARHSP1" 1)))
 ("UP:Q9Y2V3" (("RX" 28) ("the motif (R/K)XX(R/K)N(R/K)XAAXX(S/C)RX" 2)))
 ("UP:Q9Y2W1"
  (("THRAP3" 120) ("TRAP150" 6)
   ("thyroid hormone receptor–associated protein 3" 3)
   ("thyroid hormone receptor-associated protein 3" 2)
   ("its homologous binding partner THRAP3" 1) ("Trap150" 1)))
 ("UP:Q9Y2W2" (("SIPP1" 6) ("WW domain binding protein 11" 2) ("WBP11" 1)))
 ("UP:Q9Y2W7"
  (("DREAM" 254) ("Dream" 2) ("the E2F4/p130-containing DREAM" 2) ("dream" 2)
   ("-DREAM" 1)))
 ("UP:Q9Y2X0" (("MED16" 4) ("Thrap5" 1)))
 ("UP:Q9Y2X7"
  (("GIT1" 132) ("GIT-1" 10) ("Git1" 5) ("CAT-1" 3) ("GIT1 protein" 2)
   ("the postsynaptic adaptor protein GIT1" 2) ("more GIT1" 1)))
 ("UP:Q9Y2X8" (("UBE2D4" 2))) ("UP:Q9Y2Y0" (("BART1" 12)))
 ("UP:Q9Y2Y1" (("RPC11" 2)))
 ("UP:Q9Y2Y4" (("repressor of GATA" 3) ("Zbtb32" 2)))
 ("UP:Q9Y2Y9" (("KLF13" 4) ("FKLF2" 1) ("BTEB3" 1)))
 ("UP:Q9Y2Z0" (("SUGT1" 2)))
 ("UP:Q9Y2Z2" (("the homologous proteins Mto1" 2) ("Mto1" 2)))
 ("UP:Q9Y2Z9" (("q10" 1)))
 ("UP:Q9Y314"
  (("NOSIP" 15)
   ("endothelial nitric oxide synthase interacting protein (NOSIP)" 2)
   ("nitric oxide synthase interacting protein" 2)))
 ("UP:Q9Y316" (("MeMo" 8) ("MEMo" 6) ("MEMO" 5) ("CGI-27" 2) ("Memo" 2)))
 ("UP:Q9Y328"
  (("protein p19" 7) ("The tomato bushy stunt virus protein p19" 1)))
 ("UP:Q9Y330" (("G10" 197) ("g10" 2) ("the non-adjacent G10" 1)))
 ("UP:Q9Y333" (("LSM2" 6) ("Lsm2" 1))) ("UP:Q9Y343" (("SNX24" 2)))
 ("UP:Q9Y345" (("SLC6A5" 4))) ("UP:Q9Y365" (("STARD10" 3)))
 ("UP:Q9Y371"
  (("Bif-1" 17) ("SH3GLB1" 3) ("BIF1" 2) ("Endophilin B1" 2)
   ("Bax-interacting factor 1" 1) ("Bif1" 1)))
 ("UP:Q9Y375" (("assembly factor 1" 22) ("NDUFAF1" 1)))
 ("UP:Q9Y376"
  (("MO25" 78) ("CAB39" 54) ("protein MO25" 7) ("calcium binding protein 39" 3)
   ("protein Mo25" 1) ("directly targets CAB39" 1) ("CAB39 protein" 1)))
 ("UP:Q9Y383" (("LUC7L2" 19)))
 ("UP:Q9Y385"
  (("J-1" 11) ("ubiquitin-conjugating enzyme E2" 10) ("UBE2J1" 5)
   ("Ube2j1" 1)))
 ("UP:Q9Y397" (("DHHC9" 5))) ("UP:Q9Y399" (("MRPS2" 4)))
 ("UP:Q9Y3A3" (("PREI3" 3))) ("UP:Q9Y3A5" (("SBDS" 19)))
 ("UP:Q9Y3A6" (("TMED5" 1))) ("UP:Q9Y3B2" (("CsL4" 1)))
 ("UP:Q9Y3C5"
  (("RNF11" 445) ("neuronal RNF11" 6) ("Rnf11" 5) ("Rnf11(YA)" 2)
   ("Neuronal RNF11" 2) ("overexpressed RNF11" 2) ("RNF11-" 1)
   ("demonstrated neuronal RNF11" 1)))
 ("UP:Q9Y3C6" (("PPIases" 35)))
 ("UP:Q9Y3D0" (("CIA2B" 103) ("FAM96B" 13) ("CIA2B-" 2) ("MIP18" 1)))
 ("UP:Q9Y3D2" (("CBS1" 5) ("CBS-1" 3) ("MSRB2" 1)))
 ("UP:Q9Y3D6"
  (("Fis1" 29) ("FIS1" 10) ("hFis1" 3) ("fission 1" 2) ("Fission 1" 1)))
 ("UP:Q9Y3E1" (("HRp3" 11) ("HRP-3" 2))) ("UP:Q9Y3E5" (("Bit1" 3)))
 ("UP:Q9Y3F4" (("STRAP" 14) ("UNRIP" 8)))
 ("UP:Q9Y3I0" (("focal adhesion-associated protein" 10) ("C22orf28" 1)))
 ("UP:Q9Y3I1" (("FBXO7" 6) ("FBX" 4) ("Fbx7" 2) ("Fbxo7" 1)))
 ("UP:Q9Y3L3" (("3BP1" 29) ("SH3 domain binding protein 1" 7)))
 ("UP:Q9Y3L5" (("Rap2c" 36) ("rap2c" 2) ("junction-associated Rap2c" 2)))
 ("UP:Q9Y3M2"
  (("Cby" 389) ("CBY1" 148) ("Cby1" 69) ("C22orf2" 29) ("cBy" 24)
   ("Chibby1" 13) ("Cby protein" 9) ("Cby1-" 4) ("Cby1 protein" 4)
   ("beta catenin antagonist" 3) ("Cby1 Protein" 2) ("CBY1 protein" 2)
   ("than nuclear Cby" 2) ("exogenous Cby" 2) ("Chibby1 protein" 1) ("CBY" 1)))
 ("UP:Q9Y3M8"
  (("StarD13" 137) ("Rho GTPase activating protein" 16) ("STARD13" 5)
   ("Rho GTPase activating protein (GAP)" 2)
   ("Rho-GTPase activating protein" 1)))
 #+ignore("UP:Q9Y3P4" (("pTaG" 38) ("pTag" 9) ("pTAG" 1))) ; removed this bad def
 ("UP:Q9Y3P8"
  (("SIT" 202) ("gp30/40" 181) ("gp30/ 40" 6) ("gp30/ 40 molecule" 3)
   ("gp30/40 molecule" 3) ("possibly  syk protein tyrosine kinases SIT" 1)
   ("SIT1" 1)))
 ("UP:Q9Y3P9" (("GAPCenA" 22) ("TBC1D11" 21))) ("UP:Q9Y3Q0" (("NAALAD2" 5)))
 ("UP:Q9Y3Q3" (("TMED3" 1))) ("UP:Q9Y3Q4" (("HCN4" 17)))
 ("UP:Q9Y3Q7" (("ADAM18" 3))) ("UP:Q9Y3R4" (("neu2" 1)))
 ("UP:Q9Y3R5" (("DOPEY2" 1))) ("UP:Q9Y3S1" (("WNK2" 4)))
 ("UP:Q9Y3T9"
  (("NIR" 195) ("nucleoplasmic NIR" 7) ("exogenous NIR" 2)
   ("Nucleoplasmic NIR" 2) ("Novel INHAT Repressor" 2) ("NOC2L" 1)
   ("an EGF ligand-conjugated fluorescent NIR" 1) ("cellular NIR" 1)
   ("the genomic NIR" 1) ("NIR protein" 1) ("endogenous nucleoplasmic NIR" 1)
   ("nucleolar NIR" 1) ("novel INHAT repressor" 1)))
 ("UP:Q9Y3U8" (("L36" 4))) ("UP:Q9Y3V2" (("RSUME" 1)))
 ("UP:Q9Y3Y4" (("Pygo1" 2)))
 ("UP:Q9Y3Z3"
  (("SAMHD1" 102) ("Samhd1" 9) ("dNTPase" 3) ("antiviral protein SAMHD1" 1)
   ("cellular SAMHD1" 1) ("the antiviral protein SAMHD1" 1)
   ("SAM domain and HD domain 1" 1)))
 ("UP:Q9Y446"
  (("PKP3" 244) ("PKP3 protein" 8) ("desmosomal PKP3" 2) ("Plakophilin 3" 2)
   ("the desmosomal plaque protein PKP3" 1) ("exogenous full-length PKP3" 1)
   ("Exogenous PKP3" 1)))
 ("UP:Q9Y448" (("SKAP" 162) ("SKAP-" 1)))
 ("UP:Q9Y450" (("HBS1L" 94) ("HBS1" 4) ("HBS1L–" 1)))
 ("UP:Q9Y458" (("TBX22" 1))) ("UP:Q9Y462" (("ZnF5" 22) ("ZnF4" 1)))
 ("UP:Q9Y463"
  (("Mirk" 102) ("Dyrk1B" 34) ("DYRK1B" 17) ("Mirk protein" 8)
   ("overexpressed Mirk" 3) ("targeting Mirk" 2)))
 ("UP:Q9Y466"
  (("nuclear receptor subfamily" 13) ("Group E" 11) ("NR2E1" 9) ("group E" 7)
   ("nuclear
                receptor subfamily"
    4)
   ("group E (FANCE) protein" 3) ("group E (XPE)" 2)
   ("Nuclear receptor subfamily" 1)))
 ("UP:Q9Y467" (("SALL2" 204) ("Sall2" 27) ("SALL2 protein" 4) ("SALL2-" 1)))
 ("UP:Q9Y468"
  (("L3MBTL1" 48) ("L3MBTL" 5) ("L3MBTL1 protein" 3)
   ("RBPJ-associated protein L3MBTL3" 2) ("L3MBT" 1)))
 ("UP:Q9Y478" (("PRKAB1" 12)))
 ("UP:Q9Y483"
  (("Pcl2" 13) ("MTF2" 3) ("Mtf2" 2)
   ("metal response element binding transcription factor 2" 1) ("PCL2" 1)))
 ("UP:Q9Y484" (("WD repeat domain" 15) ("WDR45" 9) ("WIPI4" 2)))
 ("UP:Q9Y487" (("ATP6V0A2" 1)))
 ("UP:Q9Y490"
  (("talin" 695) ("talin1" 59) ("Talin" 53) ("TLN1" 13) ("Talin1" 6)
   ("talin-1" 5) ("Similarly native talin" 2) ("Talin 1" 2) ("talin 1" 2)
   ("talin1-" 2) ("Talin-1" 1) ("talin-" 1) ("“talin”" 1) ("residual talin1" 1)
   ("intact talin" 1) ("TLN" 1)))
 ("UP:Q9Y496" (("Kif3a" 6) ("KIF3A" 2) ("KIF3" 2) ("Kif3" 1)))
 ("UP:Q9Y4A5"
  (("TRRAP" 161) ("Trrap" 5) ("TRRAP protein" 2)
   ("MYC TAD indeed contacts TRRAP" 1)))
 ("UP:Q9Y4A8" (("Nrf3" 59) ("Nrf3 protein" 3) ("NRF3" 3) ("NFE2L3" 2)))
 ("UP:Q9Y4A9" (("subfamily H" 1))) ("UP:Q9Y4B4" (("ARIP4" 4) ("RAD54L2" 3)))
 ("UP:Q9Y4B5" (("MTCL1" 4)))
 ("UP:Q9Y4B6"
  (("DCAF1" 360) ("VPRBP" 145) ("VprBP" 46) ("DCAF-1" 18)
   ("dimeric CRL4 DCAF1" 3) ("less DCAF1" 2) ("shorter DCAF1 peptide" 2)
   ("Vpr-interacting protein (VIP)" 1) ("Vpr-interacting protein" 1)
   ("intact VPRBP" 1) ("DCAF1 protein" 1) ("Vpr targets VPRBP's" 1)
   ("monomeric CRL4 DCAF1" 1) ("DCAF1 peptide" 1) ("exogenous DCAF1" 1)))
 ("UP:Q9Y4C1"
  (("JMJD1A" 19) ("KDM3A" 15) ("JHDM2A" 4) ("Jhdm2a" 2)
   ("jumonji domain containing 1A" 1) ("JHMD2A" 1) ("Jmjd1a" 1) ("JHDM2a" 1)
   ("Jumonji domain containing 1A" 1) ("Jhmd2a" 1)))
 ("UP:Q9Y4C8" (("Rbm19" 3) ("RBM19" 3)))
 ("UP:Q9Y4D1" (("Daam1" 88) ("-Daam1" 16) ("DAAM1" 4) ("morphogenesis 1" 4)))
 ("UP:Q9Y4D2" (("diacylglycerol lipase" 1)))
 ("UP:Q9Y4D7" (("PlexinD1" 21) ("plexin-D1" 4)))
 ("UP:Q9Y4E1" ; fixed CSC to be "cancer stem cells"
  (#+ignore("CSCs" 1849) #+ignore("gastric CSCs" 4) #+ignore("ovarian CSCs" 4) #+ignore("mammary CSCs" 3)
   ("KIAA0592" 3) ("specifically kill CSCs" 2)
   ("CD44(+) CD24(-) breast CSCs" 2) ("the few CSCs" 2)
   ("one or more self-renewing CSCs" 2)
   ("Salinomycin selectively kills CSCs" 1)
   ("protein kinase C α (PKCα) specifically targets CSCs" 1)
   ("mouse and human mammary CSCs" 1) ("Aldh-positive CSCs" 1)
   ("CD44(+)/CD24(-/low) CSCs" 1) ("diverse CSCs" 1)
   ("triptolide predominantly targets CSCs" 1) ("primary CSCs" 1)
   ("the rare CSCs" 1) ("both more CSCs" 1)
   ("a FAK inhibitor preferentially targets tumor-initiating CSCs" 1)
   ("“CSCs”" 1) ("selectively targets CSCs" 1) ("colorectal CSCs" 1)
   ("mouse lymphoma and human acute myeloid leukemia CSCs" 1)
   ("highly metastatic CSCs" 1) ("hepatocellular CSCs" 1)
   ("EMT-associated CSCs" 1) ("pre-committed resident CSCs" 1)
   ("Resident CSCs" 1) ("relative pure human CSCs" 1)))
 ("UP:Q9Y4E5" ;removed "receptors"
(
 #|("receptors" 12150) ("Receptors" 112) ("their respective receptors" 38)
   ("MCLR" 36) ("LPAR" 16) ("hormonal receptors" 15)
   ("heterodimeric receptors" 12) ("costimulatory receptors" 9)
   ("targeted receptors" 9) ("soluble receptors" 8)
   ("the available receptors" 7) ("-receptors" 6) ("viral receptors" 6)
   ("other hormonal receptors" 5) ("available receptors" 5)
   ("the respective receptors" 5) ("phagocytic receptors" 5)
("dimeric receptors" 5) ("IGF1R/IR heterodimeric receptors" 5)
|#
("ZNF451" 5)
   ("stimulatory receptors" 4) ("monomeric receptors" 4)
   ("Soluble receptors" 4) ("fibronectin endocytic receptors" 4)
   ("more receptors" 4) ("olfactory receptors" 4)
   ("preformed homodimeric receptors" 4) ("nicotinic receptors" 4)
   ("endometrial receptors" 4)
   ("Overexpressed IGF1R and IR form IGF1R/IR heterodimeric receptors" 4)
   ("NHR" 3) ("endocytic receptors" 3) ("Neuronal Receptors" 3)
   ("the endometrial receptors" 3) ("g-coupled receptors" 3)
   ("serpentine receptors" 3) ("putative costimulatory receptors" 3)
   ("overexpressed receptors" 3) ("opsonic receptors" 3)
   ("two essential receptors" 2) ("whose receptors" 2)
   ("presynaptic receptors" 2) ("a few receptors" 2)
   ("three therapeutically relevant receptors" 2) ("bifunctional receptors" 2)
   ("Soluble
 receptors"
    2)
   ("endothelin A (ET A ) receptors and endothelin B (ET B ) receptors" 2)
   ("one or more co-stimulatory receptors" 2) ("homodimeric receptors" 2)
   ("dimerized receptors" 2) ("plasma membrane associated receptors" 2)
   ("mechanosensitive receptors" 2) ("transmembrane dimeric receptors" 2)
   ("RECEPTORS" 2) ("both muscarinic and nicotinic receptors" 2)
   ("mature receptors" 2) ("Overexpressed receptors" 2)
   ("respective receptors" 2) ("the olfactory receptors" 2)
   ("various costimulatory receptors" 2) ("muscarinic cholinergic receptors" 2)
   ("cell membrane activatory receptors" 2)
   ("several neuronal nicotinic cholinergic receptors" 2)
   ("several essential receptors" 2) ("24 different heterodimeric receptors" 2)
   ("the possible receptors" 2) ("one or more receptors" 2)
   ("endogenous or exogenous homodimeric receptors" 2)
   ("co-stimulatory receptors" 2) ("TNF soluble receptors" 2) ("“receptors”" 2)
   ("Ligand-bound dimeric receptors" 2) ("membrane associated receptors" 2)
   ("seven transmembrane serpentine receptors" 2)
   ("transmembrane heterodimeric receptors" 2) ("their classical receptors" 2)
   ("Lysosomally targeted receptors" 2) ("the costimulatory receptors" 2)
   ("longer receptors" 2) ("Homologous receptors" 2)
   ("cholinergic receptors" 2) ("bivalent receptors" 2)
   ("Olfactory receptors" 2) ("Dimeric receptors" 2)
   ("the specific phagocytic receptors" 2) ("non-opsonic receptors" 2)
   ("internal receptors" 2) ("their Respective Receptors" 2)
   ("four homologous receptors" 2) ("receptors (AR)" 2) ("receptors (GPCR)" 2)
   ("other homodimeric receptors" 1) ("different constituent receptors" 1)
   ("newly made receptors" 1) ("postsynaptic ionotropic receptors" 1)
   ("multiple hormonal receptors" 1) ("metabotropic receptors" 1)
   ("these ubiquitous receptors" 1)
   ("the
 engineered soluble receptors"
    1)
   ("dimeric (or oligomeric) receptors" 1) ("associated receptors" 1)
   ("extranuclear receptors" 1)
   ("metalloprotease-generated soluble receptors" 1)
   ("variant-derived soluble receptors" 1) ("60 novel soluble receptors" 1)
   ("fibronectin matrix endocytic receptors" 1) ("unusual receptors" 1)
   ("JAK3-associated receptors" 1) ("multiple immunoregulatory receptors" 1)
   ("the oligomerized receptors" 1) ("receptors (TKR)" 1) ("receptors-" 1)
   ("receptors (PR)" 1)
   ("broad-repertoire high-fidelity selective autophagic receptors" 1)
   ("related endocytic receptors" 1) ("membranous receptors" 1)
   ("neurotrophic receptors" 1) ("inhibitory immunoregulatory receptors" 1)
   ("few receptors" 1) ("cancer-associated receptors" 1)
   ("homomeric receptors" 1) ("neuronal receptors" 1)
   ("hybrid heterodimeric receptors" 1)
   ("constitutively dimerized receptors" 1) ("muscarinic (mAChRs) receptors" 1)
   ("heteromeric receptors" 1) ("membrane-associated receptors" 1)
   ("autophagic receptors" 1) ("the plasma membraneous receptors" 1)
   ("the latter receptors" 1) ("immune-related receptors" 1)
   ("the dimerized receptors" 1) ("Neuronal nicotinic cholinergic receptors" 1)
   ("These soluble receptors" 1) ("multiple costimulatory receptors" 1)
   ("surface-localized receptors" 1) ("four unique receptors" 1)
   ("synergistic receptors" 1) ("some neuronal receptors" 1)
   ("EGF-Rh–occupied receptors" 1) ("various immunomodulatory receptors" 1)
   ("other membrane-associated receptors" 1) ("many olfactory receptors" 1)
   ("all olfactory receptors" 1) ("their associated receptors" 1)
   ("its pro-apoptotic receptors" 1) ("antagonistic receptors" 1)
   ("tumor-associated receptors" 1) ("Co-stimulatory receptors" 1)
   ("contractile cerebrovascular receptors" 1)
   ("Several costimulatory receptors" 1) ("alternate receptors" 1)
   ("ciliary receptors" 1) ("sensory receptors" 1)
   ("at least 24 different heterodimeric receptors" 1)
   ("other activatable receptors" 1) ("accessory receptors" 1)
   ("QD-EGF-bound receptors" 1) ("fewer receptors" 1)
   ("the classical receptors" 1) ("two homologous receptors" 1)
   ("receptors (SB)" 1) ("IGF1-dependent heterodimeric receptors" 1)
   ("essential receptors" 1) ("trimeric receptors" 1)
   ("receptors, PP1 phosphatase [ xref ]," 1) ("the pre-bound receptors" 1)
   ("serotonergic receptors" 1) ("G12/13-coupled receptors" 1)
   ("all total and phosphorylated receptors" 1)
   ("the total or phosphorylated receptors" 1)
   ("certain phagocytic receptors" 1) ("non-specific phagocytic receptors" 1)
   ("Phagocytic receptors" 1) ("extracellular matrix-associated receptors" 1)
   ("oligomerized receptors" 1) ("α and β heterodimeric receptors" 1)
   ("potential receptors" 1) ("apical receptors" 1) ("receptors (PRR)" 1)
   ("“death-receptors”" 1) ("one or more MCLR" 1)
   ("active dimeric receptors" 1) ("receptors, G proteins," 1)
   ("intron-free olfactory receptors" 1) ("the mutant dimeric receptors" 1)
   ("other costimulatory receptors" 1) ("the serpentine receptors" 1)))
 ("UP:Q9Y4E6" (("trag" 7) ("Trag" 2)))
 ("UP:Q9Y4E8"
  (("R-Smads" 206) ("Usp15" 73) ("R-SMADs" 27) ("R-SMADS" 3)
   ("the key R-Smads" 2)))
 ("UP:Q9Y4F1"
  (("Farp1" 267) ("postsynaptic Farp1" 7) ("FARP1" 6) ("overexpressed Farp1" 5)
   ("Farp1 protein" 2) ("chondrocyte-derived ezrin-like protein" 1)
   ("Postsynaptic Farp1" 1)))
 ("UP:Q9Y4G2" (("PLEKHM1" 7) ("Plekhm1" 3) ("plekhm1" 2)))
 ("UP:Q9Y4G6" (("talin2" 11) ("TLN2" 4) ("talin-2" 1) ("Talin2" 1)))
 ("UP:Q9Y4G8"
  (("PDZ-GEF1" 212) ("CNrasGEF" 137) ("Rapgef2" 103) ("PDZGEF1" 10)
   ("Rapgef2 protein" 4) ("CNrasGEF protein" 4) ("intact Rapgef2" 2)
   ("nRapGEP" 2) ("PDZ GEF1" 2) ("exogenous Rapgef2" 1) ("KIAA0313" 1)))
 ("UP:Q9Y4H2"
  (("IRS-2" 1232) ("IRS2" 578) ("IRS-2 protein" 25) ("Irs2" 22)
   ("insulin receptor substrate-2" 18) ("IRS2 protein" 6) ("IRS-2 molecule" 5)
   ("Insulin receptor substrate-2" 3) ("Intrinsic IRS-2" 2)
   ("the dominant IRS-2" 2) ("Strong cytoplasmic IRS-2" 2)
   ("rabbit monoclonal IRS-2" 2) ("Three distinct IRS-2" 2)
   ("Minimal copy region analysis pinpoints IRS2" 2)
   ("more total IRS2 protein" 1) ("these cells or more IRS2 protein" 1)
   ("Irs-2" 1) ("than other IRS-2 staining patterns ( P < 0.001)" 1)))
 ("UP:Q9Y4H4" (("GPSM3" 2)))
 ("UP:Q9Y4I1"
  (("myosin V" 41) ("myosin Va" 26) ("MYO5a" 1) ("MYO5" 1) ("Myosin V" 1)
   ("MYO5A" 1)))
 ("UP:Q9Y4I5" (("MTL5" 1)))
 ("UP:Q9Y4K0"
  (("LOXL2" 214) ("LOXL2 protein" 7) ("lysyl oxidase-like 2" 5)
   ("Lysyl oxidase-like 2" 4) ("Lysyl oxidase homolog 2" 4)
   ("lysyl oxidase like 2" 2)))
 ("UP:Q9Y4K1" (("absent in melanoma 1" 1)))
 ("UP:Q9Y4K3"
  (("TRAF6" 1615) ("Traf6" 82) ("TNF receptor-associated factor 6" 31)
   ("TNF receptor associated factor 6" 14) ("TRAF6 protein" 6)
   ("overexpressed TRAF6" 4) ("dominant-negative TRAF6" 3)
   ("Dominant-negative (DN)-TRAF6" 3) ("less TRAF6 protein" 3) ("more TRAF6" 3)
   ("than wild-type TRAF6" 2) ("E3 ubiquitin-protein ligase TRAF6" 2)
   ("TRAF-6" 1) ("Traf-6" 1) ("-TRAF6" 1) ("much more TRAF6" 1)))
 ("UP:Q9Y4K4"
  (("MAP4K5" 7) ("Kinase Homologous to SPS1/STE20" 2)
   ("kinase homologous to SPS1/STE20" 1)))
 ("UP:Q9Y4L1" ; removed hypoxia
(
 #|("hypoxia" 7253) ("Hypoxia" 588) ("severe hypoxia" 60)
   ("chronic hypoxia" 33) ("neonatal hypoxia" 21) ("intermittent hypoxia" 20)
   ("hypoxia-" 16) ("acute hypoxia" 14) ("intratumoral hypoxia" 10)
   ("local hypoxia" 9) 
 |#
 ("ORP150" 9) ("HYOU1" 8) ("intermittent hypoxia (IH)" 8)
   ("continuous hypoxia" 8) ("Intermittent hypoxia" 7) ("mild hypoxia" 7)
   ("Intratumoral hypoxia" 6) ("GRP170" 6) ("hypobaric hypoxia" 5)
   ("subsequent hypoxia" 4) ("mimetic hypoxia" 4) ("systemic hypoxia" 4)
   ("Neonatal hypoxia" 4) ("extreme hypoxia" 3) ("Chronic hypoxia" 3)
   ("Severe hypoxia" 3) ("antiangiogenesis-induced intratumoral hypoxia" 3)
   ("tumor cells usually causes hypoxia" 3) ("than hypoxia" 3)
   ("modest hypoxia" 3) ("cellular hypoxia" 3) ("hypoxia (SH)" 3)
   ("both acute and chronic hypoxia" 2) ("hypoxia up-regulated protein 1" 2)
   ("focal hypoxia" 2) ("overnight intermittent hypoxia" 2)
   ("more severe hypoxia" 2) ("anemia-induced hypoxia" 2) ("Chronic Hypoxia" 2)
   ("acute exposure hypoxia" 2) ("widespread hypoxia" 2) ("only 4h hypoxia" 2)
   ("the associated hypoxia" 2) ("ischemic hypoxia" 2)
   ("acute tissue hypoxia" 2) ("HYPOXIA" 2) ("Intratumoural hypoxia" 1)
   ("regional hypoxia" 1) ("linking hypoxia" 1) ("Myocardial hypoxia" 1)
   ("local (pericellular) hypoxia" 1)
   ("tumor blood vessel formation increases intratumoral hypoxia" 1)
   ("the chronic hypoxia" 1) ("tumor-associated hypoxia" 1)
   ("modest (0.5% O 2 ) hypoxia" 1) ("acute and prolonged hypoxia" 1)
   ("the acute hypoxia" 1) ("this instance acute hypoxia" 1)
   ("a long existing chronic hypoxia" 1) ("the excessive hypoxia-" 1)
   ("than hypoxia alone in PDL cells" 1)
   ("Glucose withdrawal and transient hypoxia" 1) ("even exploit hypoxia" 1)
   ("commonly face hypoxia" 1) ("Severe intratumoural hypoxia" 1)
   ("non-necrosis associated hypoxia" 1) ("acute intrapartum hypoxia" 1)
   ("an acute hypoxia" 1) ("perinatal hypoxia" 1) ("Acute hypoxia" 1)
   ("pericellular hypoxia" 1) ("chronic hypoxia (CH)" 1)
   ("whose products sense hypoxia" 1)
   ("systemic or localised tissue hypoxia" 1) ("hypoxia—" 1)
   ("Tumoral hypoxia" 1) ("underperfusion-associated hypoxia" 1)
   ("temporary hypoxia" 1) ("nightly intermittent hypoxia (IH)" 1)
   ("sublethal hypoxia" 1) ("placental hypoxia" 1) ("Such local hypoxia" 1)
   ("persistent placental hypoxia" 1)))
 ("UP:Q9Y4L5" (("Rabring7" 204) ("RNF115" 4)))
 ("UP:Q9Y4P1" (("ATG4B" 30) ("protease ATG4b" 4) ("ATG4b" 3)))
 ("UP:Q9Y4P3" (("TBL2" 1)))
 ("UP:Q9Y4P8" (("WIPI2" 19) ("phosphoinositide interacting 2" 3)))
 ("UP:Q9Y4R8" (("HCLK2" 8) ("hCLK2" 4)))
 #+ignore("UP:Q9Y4U1" (("with homocystinuria" 4))) ; removed this synonym
 ("UP:Q9Y4W2" (("ribosome biogenesis factor" 9) ("Las1L" 1)))
 ("UP:Q9Y4X1" (("UDP glucuronosyltransferase 2 family" 3) ("complex locus" 1)))
 ("UP:Q9Y4X3" ; fixed ILC
(
 #|("ILC" 336) ("ILCs" 83) ("pleomorphic ILC" 35) ("classic ILC" 31)
   ("PILC" 30) 
|#
("CCL27" 10) ("pleomorphic ILCs" 7) ("classical ILC" 5)
   ("classic ILCs" 4) ("concurrent ILC" 4) ("metastatic ILC" 3)
   ("the classic ILC" 3) ("classic and pleomorphic ILCs" 3)
   ("16 pleomorphic ILC" 3) ("classic and pleomorphic ILC" 3) ("pure ILC" 2)
   ("had bilateral ILC" 2) ("than classic ILC" 2) ("Pleomorphic ILC" 2)
   ("than ILC" 2) ("at least two ILC" 1) ("unilateral concurrent ILC" 1)
   ("bilateral ILC" 1) ("bilateral LCIS +/− ILC" 1) ("the pleomorphic ILCs" 1)
   ("the classic and pleomorphic ILCs" 1) ("Classic and pleomorphic ILC" 1)
   ("20 classic ILC" 1) ("20 classical ILC" 1) ("a classical ILC" 1)
   ("a classical type ILC" 1) ("classical ILCs" 1) ("classical type ILC" 1)
   ("22 classic ILC" 1) ("most ILC" 1)))
 ("UP:Q9Y4X4" (("KLF12" 13) ("Klf12" 2)))
 ("UP:Q9Y4X5" ; removed "homolog of"
  (#+ignore("homolog of" 430) ("HHARI" 72) ("ARI" 30) ("Ariadne" 8) ("ARi" 7)
   ("Homolog of" 4) ("the cellular homolog of" 3) ("cellular homolog of" 2)
   ("the functional homolog of" 1) ("a structural and functional homolog of" 1)
   ("the human cellular homolog of" 1) ("ariadne" 1)
   ("a cellular homolog of" 1)))
 ("UP:Q9Y4Y9" (("LSM5" 34) ("the confocal laser mikroscope LSM5" 1)))
 ("UP:Q9Y4Z0" (("GRPs" 1)))
 ("UP:Q9Y4Z2"
  (("Ngn3" 15) ("NGN3" 11) ("ngn3" 11) ("NEUROG3" 3) ("Neurogenin3" 1)))
 ("UP:Q9Y508" (("RNF114" 7) ("ZNF313" 4) ("ring finger protein 114" 3)))
 ("UP:Q9Y512" (("SAM50" 37) ("TRG3" 35) ("Sam50" 1)))
 ("UP:Q9Y519" (("TMEM184B" 13))) ("UP:Q9Y520" (("KIAA1096" 3)))
 ("UP:Q9Y543" (("Hes2" 16) ("HES2" 15))) ("UP:Q9Y547" (("IFT25" 10)))
 ("UP:Q9Y561" (("Lrp12" 1))) ("UP:Q9Y566" (("Shank1" 1) ("SHANK1" 1)))
 ("UP:Q9Y570"
  (("PME-1" 6) ("PPME-1" 6) ("PPME1" 4)
   ("protein phosphatase methylesterase 1" 3)))
 ("UP:Q9Y572"
  (("RIPK3" 65) ("Ripk3" 10) ("receptor-interacting protein 3" 7)
   ("the necroptosis-associated kinase RIPK3" 1)))
 ("UP:Q9Y574" (("ASB4" 1))) ("UP:Q9Y575" (("Asb3" 2) ("ASB3" 1)))
 ("UP:Q9Y576" (("Asb1" 4)))
 ("UP:Q9Y577"
  (("RBCC" 43) ("TRIM17" 34) ("Tripartite motif containing 17" 2)
   ("Trim17" 1)))
 ("UP:Q9Y581" (("INSL6" 4)))
 ("UP:Q9Y592" (("coiled-coil domain containing 41" 2) ("CCDC41" 1)))
 ("UP:Q9Y597" (("KCTD3" 1))) ("UP:Q9Y5A7" (("NuB1" 20) ("NUB1" 3)))
 ("UP:Q9Y5B0" (("FCP1" 16) ("CTDP1" 3))) ("UP:Q9Y5B8" (("NME7" 2)))
 ("UP:Q9Y5B9" (("hSpt16" 102) ("SUPT16H" 7))) ("UP:Q9Y5C1" (("ANGPTL3" 2)))
 ("UP:Q9Y5E4" (("PCDHB5" 2))) ("UP:Q9Y5E8" (("PCDHB15" 1)))
 ("UP:Q9Y5H4" (("PCDHGA1" 1))) ("UP:Q9Y5J1" (("UTP18" 2)))
 ("UP:Q9Y5J3"
  (("HEY1" 82) ("Hey1" 82) ("HEY-1" 41) ("HRT1" 14) ("Hrt1" 7) ("Herp2" 6)
   ("Hey-1" 5) ("hairy/enhancer-of-split related with YRPW motif 1" 3)
   ("HESR1" 1)))
 ("UP:Q9Y5J5" (("PHLDA3" 3))) ("UP:Q9Y5K1" (("SPO11" 13) ("Spo11" 11)))
 ("UP:Q9Y5K2" (("KLK4" 10)))
 ("UP:Q9Y5K3"
  (("beta isoform" 33) ("the well-known beta isoform" 2) ("Beta isoform" 1)))
 ("UP:Q9Y5K5" (("UCH37" 23) ("UCHL5" 17) ("Uch37" 4) ("UCH37-" 3)))
 ("UP:Q9Y5K6"
  (("CD2AP" 396) ("CD2AP protein" 4) ("CD2AP-" 4) ("cd2ap" 3)
   ("inadequate CD2AP" 1) ("Q9y5k6" 1) ("than CD2AP" 1)))
 ("UP:Q9Y5L0" (("TNPO3" 24)))
 ("UP:Q9Y5L2" (("HIG2" 9) ("C7orf68" 1) ("HIG-2" 1)))
 ("UP:Q9Y5L4" (("TIMM13" 5) ("Timm13" 4)))
 ("UP:Q9Y5M8"
  (("B subunit" 154) ("the regulatory B subunit" 6)
   ("a regulatory B subunit" 5) ("A and a regulatory B subunit" 3)
   ("signal recognition particle receptor" 2)
   ("a tissue specificity regulatory B subunit" 2) ("SRPRB" 1)
   ("a third regulatory B subunit" 1) ("a variable regulatory B subunit" 1)
   ("the appropriate B subunit" 1)))
 ("UP:Q9Y5N1" (("HRH3" 30)))
 ("UP:Q9Y5N6" (("ORC6" 10) ("Orc6" 8) ("ORC6 protein" 3) ("ORC6L" 1)))
 ("UP:Q9Y5P2" (("RPMI8226" 37)))
 ("UP:Q9Y5P4" ;fixed
(
 #|("lipids" 1753) ("Lipids" 129) ("caveolar membrane-specific lipids" 2)
   ("using exogenous radiolabeled lipids" 2)
   ("binding stress-inducible phosphoinositide (PI) signaling lipids" 2)
   ("anionic PIP2 lipids" 2) ("anionic membrane lipids" 2)
   ("the anionic POPS lipids" 2) ("fluorescent membrane lipids" 1)
 |#
 ("COL4A3BP" 1)
   ("monovalent
PS lipids"
    1)
   ("than spirochete lipids" 1)
   ("entirely and simply exchange plasma membrane lipids" 1)
   ("stress-inducible phosphatidylinositol monophosphate (PtIn-MP) signaling lipids"
    1)
   ("pulmonary surfactant lipids" 1) ("particularly PC lipids" 1)
   ("the neutral DMPC lipids" 1)))
 ("UP:Q9Y5Q0" (("FADS3" 1)))
 ("UP:Q9Y5Q3"
  (("Mafb" 268) ("MAFB" 36) ("MafB" 12) ("Mafb protein" 12)
   ("exogenous Mafb" 2) ("that Mafb’s" 1)))
 ("UP:Q9Y5Q8" (("transcription factor IIIC" 4) ("63 kD" 1)))
 ("UP:Q9Y5Q9" (("TFIIIC102" 1)))
 ("UP:Q9Y5R2" (("MT5-MMP" 12) ("MMP-24" 5) ("Mmp24" 2)))
 ("UP:Q9Y5R6" (("DMRT1" 27) ("DMRT1-" 1)))
 ("UP:Q9Y5R8" (("TRAPPC1" 3) ("Bet5" 2))) ("UP:Q9Y5S1" (("TRPV2" 2)))
 ("UP:Q9Y5S2" (("CDC42BPB" 3)))
 ("UP:Q9Y5S8"
  (("oxidase" 725) ("Nox1" 663) ("NOX1" 438) ("NOX" 316) ("Nox" 148)
   ("Oxidase" 48) ("NOX-1" 35) ("Nox1 protein" 13) ("NADPH oxidase 1" 12)
   ("Nox1-" 9) ("NOX1-" 8) ("NOx" 8) ("oxidase (COX)" 5) ("Nox-1" 5)
   ("oxidase (LOX)" 4) ("NOX (arNOX) protein" 4) ("oxidase (NOX)" 4)
   ("a mitogenic oxidase" 3) ("Nox 1" 3) ("vascular NOX1" 3) ("NOX protein" 3)
   ("the classic NOX" 2) ("NOX 1" 2) ("functional oxidase" 1)
   ("the respiratory burst oxidase" 1) ("homozygous Nox1" 1)
   ("an authentic oxidase" 1) ("–oxidase" 1)
   ("seven homologous members termed NOX-1" 1) ("than NOX1" 1)
   ("vascular NOX1 oxidase and NOX2 oxidase" 1) ("than the NOX2 oxidase" 1)
   ("oxidase-" 1) ("especially NOX2 oxidase" 1) ("perceive Nox1" 1)))
 ("UP:Q9Y5S9" (("Y14" 100) ("RBM8A" 2) ("Y14-" 1) ("RBM8B" 1)))
 ("UP:Q9Y5T4" (("MCJ" 2)))
 ("UP:Q9Y5T5" (("Usp16" 169) ("USP16" 31) ("most Usp16" 1)))
 ("UP:Q9Y5U4" (("INSIG2" 13) ("Insig-2" 1)))
 ("UP:Q9Y5U5"
  (("tumor necrosis factor receptor" 56) ("GITR" 24) ("TNFRSF18" 21)
   ("Tumor necrosis factor receptor" 9)))
 ("UP:Q9Y5U8" (("BRP44L" 1))) ("UP:Q9Y5U9" (("IER3IP1" 2)))
 ("UP:Q9Y5V3" (("MAGED1" 7) ("NRAGE" 5) ("MAGE-D1" 5)))
 ("UP:Q9Y5W3"
  (("KLF2" 238) ("KLF" 102) ("Klf2" 20) ("KLF protein" 10) ("LKLF" 2)
   ("endothelial KLF2" 2) ("klf2" 2) ("KLF peptide" 2) ("KLF2-" 2)
   ("this particular KLF" 1) ("previously unidentified KLF" 1)
   ("KLF peptide (KLFGTSGQKT)" 1)))
 ("UP:Q9Y5W5"
  (("WIF1" 138) ("Wnt inhibitory factor-1" 17) ("Wif1" 5)
   ("Wnt-inhibitory factor" 4) ("WIF1-" 4) ("WNT inhibitory factor 1" 3)))
 ("UP:Q9Y5W8" (("SNX13" 1)))
 ("UP:Q9Y5X1"
  (("SNX9" 28) ("sorting nexin 9" 4) ("sorting-nexin9" 4) ("snx9" 2)
   ("Sorting nexin 9" 2)))
 ("UP:Q9Y5X3" (("SNX5" 138) ("sorting nexin 5" 3) ("SNX5 protein" 2)))
 ("UP:Q9Y5X4" (("NR2E3" 138) ("RNR" 82) ("exogenous NR2E3" 1)))
 ("UP:Q9Y5X9"
  (("EDL" 91) ("LIPG" 10) ("endothelial lipase" 4) ("Lipg" 2)
   ("Endothelial lipase" 1) ("basal or exercised EDL" 1)
   ("than the more glycolytic EDL" 1) ("the more glycolytic EDL" 1)
   ("Basal or exercised EDL" 1)))
 ("UP:Q9Y5Y2" (("Cfd1" 3) ("CFD1" 2)))
 ("UP:Q9Y5Y4"
  (("Th2" 1291) ("CRTH2" 34) ("TH2" 29) ("Th2-" 22) ("DP2 receptor" 6)
   ("antagonistic Th2" 2) ("predominant Th2" 1) ("th2" 1) ("TH2 peptide" 1)
   ("experimental Th2" 1)))
 ("UP:Q9Y5Y6"
  (("matriptase" 370) ("Matriptase" 134) ("HAI" 35) ("Hai" 11) ("MT-SP1" 7)
   ("ST14" 4) ("hai" 4) ("cleaved cell-associated Matriptase" 2)
   ("The cell-associated Matriptase" 1)
   ("Cell-associated cleaved Matriptase" 1) ("St14" 1) ("TADG15" 1)
   ("−HAI" 1)))
 ("UP:Q9Y5Y7"
  (("hAR" 82) ("LYVE-1" 75) ("LYVE1" 8) ("Lyve-1" 8)
   ("hyaluronic acid receptor" 4) ("hAR protein" 4) ("LYVE 1" 4)
   ("the lymphatic endothelium-specific marker LYVE-1" 2) ("Lyve1" 1)
   ("hAR121Q protein" 1) ("the lymphatic molecular marker LYVE1" 1)))
 ("UP:Q9Y5Y9"
  (("voltage-gated" 85) ("SCN10A" 70) ("sodium channel" 46) ("pN3" 15)
   ("voltage gated" 14) ("Voltage-gated" 3) ("Scn10a" 2)
   ("the cardiac sodium channel" 1) ("the major cardiac sodium channel" 1)))
 ("UP:Q9Y5Z0" (("AS-p21" 1))) ("UP:Q9Y5Z4" (("soul" 6) ("HEBP2" 2)))
 ("UP:Q9Y5Z7" (("HCF-2" 28) ("HCF-2 protein" 3) ("HCFC2" 1)))
 ("UP:Q9Y5Z9" (("TERE1" 3)))
 ("UP:Q9Y600"
  (("CSD" 576) ("CSD peptide" 25) ("CSD protein" 2) ("PCAP" 2)
   ("the dimeric CSD" 2) ("even extensively α-helical CSD" 2)
   ("The respective CSD" 1) ("a membrane-embedded β-stranded CSD" 1)
   ("a fully α-helical CSD" 1) ("than the isolated CSD ( xref )" 1)))
 ("UP:Q9Y603"
  (("TEL2" 131) ("Tel2" 91) ("ETV7" 28) ("tel2" 2) ("alanine of Tel2’s" 1)
   ("alanine of Tel2" 1)))
 ("UP:Q9Y608" (("LRRFIP2" 11) ("another homologous human protein LRRFIP2" 1)))
 ("UP:Q9Y613" (("FHOD1" 8))) ("UP:Q9Y616" (("IRAK3" 7) ("IRAK-M" 1)))
 ("UP:Q9Y617" (("PSAT1" 23)))
 ("UP:Q9Y618"
  (("SMRT" 797) ("NCOR2" 40) ("SMRT protein" 8) ("p-SMRT" 8) ("NcoR2" 5)
   ("the transcriptional co-repressor SMRT" 3) ("SMRT-" 2) ("than SMRT" 1)
   ("NcoR2 (SMRT)" 1)
   ("silencing mediator of retinoic acid and thyroid hormone receptor" 1)
   ("The distinct SMRT" 1) ("N-CoR2" 1) ("the late phase SMRT" 1)))
 ("UP:Q9Y619" (("HHH" 1))) ("UP:Q9Y620" (("RAD54B" 14) ("Rad54b" 3)))
 ("UP:Q9Y624"
  (("JAM-A" 275) ("JA" 30) ("KATs" 24) ("Jcam" 17) ("JCam" 8)
   ("TJ-associated JAM-A" 4) ("JCaM" 4) ("JAM-A–" 2) ("F11R" 2)
   ("the C-terminal 25 amino acids of JAM-A" 1)
   ("tight-junction–associated JAM-A" 1) ("junction-associated JAM-A" 1)
   ("dimerized JAM-A" 1) ("rotor JA25.5" 1) ("JAMA" 1)))
 ("UP:Q9Y625" (("Gpc6" 2) ("glypican 6" 1) ("GPC6" 1)))
 ("UP:Q9Y646" (("LDP" 33))) ("UP:Q9Y651" (("SOX21" 3)))
 ("UP:Q9Y653" (("GPR56" 171) ("Gpr56" 8) ("-GPR56" 1)))
 ("UP:Q9Y657"
  (("OCR" 300) ("basal OCR" 26) ("the basal OCR" 5) ("the maximal OCR" 3)
   ("higher basal OCR" 2) ("β-lap-induced OCR" 1) ("a robust OCR" 1)
   ("non-mitochondrial OCR" 1) ("Cells normally increase OCR" 1)
   ("the live cell OCR" 1) ("a significantly increased basal OCR" 1)
   ("both basal OCR" 1) ("hypoxia/reoxygenation reduced basal OCR" 1)
   ("the ATP synthesis-linked OCR (OXPHOS)" 1) ("residual OCR" 1)
   ("Four basal OCR" 1)))
 ("UP:Q9Y666" (("SLC12A7" 1))) ("UP:Q9Y678" (("COPG1" 2)))
 ("UP:Q9Y679" (("AUP1" 4))) ("UP:Q9Y692" (("GMEB1" 1)))
 ("UP:Q9Y694" (("NLT" 40) ("SLC22A7" 3) ("the migratory NLT" 2) ("OAT2" 1)))
 ("UP:Q9Y696"
  (("CLIC4" 150) ("CLIC4 protein" 8)
   ("Chloride intracellular channel protein 4" 3)
   ("chloride intracellular channel 4" 1)))
 ("UP:Q9Y697" (("ISCs" 37) ("NFS1" 5) ("Nfs1" 2) ("cysteine desulfurase" 1)))
 ("UP:Q9Y698" (("CACNG2" 2) ("gamma subunit 2" 1)))
 ("UP:Q9Y6A2" (("CYP46A1" 4) ("CYP46" 2)))
 ("UP:Q9Y6A5" (("TACC3" 336) ("Eric-1" 12) ("ERIC-1" 1)))
 ("UP:Q9Y6A9" (("SPCS1" 2))) ("UP:Q9Y6B2" (("EID1" 36) ("EID1 protein" 4)))
 ("UP:Q9Y6B6" (("andD" 10) ("Sar1b" 3)))
 ("UP:Q9Y6C2"
  (("EM" 1127) ("EMILIN" 6) ("than T EM" 4) ("Emi" 2) ("emi" 1)
   ("virtually all EM" 1) ("Raw EM" 1) ("employed EM" 1)
   ("than CD8 + T EM ( xref )" 1) ("than T EM ( n = 3; xref )" 1)
   ("the shorter-lived T EM" 1)))
 ("UP:Q9Y6C5" (("PTCH2" 12) ("Ptc2" 8) ("Patched 2" 1) ("Ptch2" 1)))
 ("UP:Q9Y6C9" (("MIMP" 35) ("Mtch2" 11) ("MTCH2" 10)))
 ("UP:Q9Y6D0" (("sElk" 33) ("sELK" 3))) ("UP:Q9Y6D5" (("BIG2" 18)))
 ("UP:Q9Y6D6" (("brefeldin" 123) ("Brefeldin" 93) ("ARFGEF1" 2)))
 ("UP:Q9Y6D9"
  (("MAD1" 427) ("Mad1" 198) ("MAD1L1" 40) ("Mad-1" 18) ("mad1" 11)
   ("MAD1 protein" 4) ("MAD1 (mitotic arrest deficient" 1) ("MAD-1" 1)
   ("dominant-negative AKT affected MAD1" 1)))
 ("UP:Q9Y6E0" (("STK24" 16) ("MST3" 9)))
 ("UP:Q9Y6E2" (("BZW2" 10) ("previously termed BZW2" 1)))
 ("UP:Q9Y6E7"
  (("SIRT4" 754) ("Sirt4" 30) ("residual SIRT4" 2)
   ("than SIRT4 (Fig. xref and xref )" 1) ("SirT4" 1)
   ("candidate transcription factors regulating SIRT4" 1)))
 ("UP:Q9Y6F1" (("PARP3" 110) ("PARP-3" 12) ("hPARP-3" 3) ("PARP3 protein" 1)))
 ("UP:Q9Y6F6" (("MRVI1" 21) ("IRAG" 1))) ("UP:Q9Y6F8" (("CDY1" 1)))
 ("UP:Q9Y6F9" (("Wnt6" 10) ("WNT6" 10) ("Wnt-6" 1)))
 ("UP:Q9Y6G9" (("LiC1" 3) ("LIC1" 1)))
 ("UP:Q9Y6H5" (("synphilin-1" 7) ("Synphilin-1" 2)))
 ("UP:Q9Y6H6" (("KCNE3" 2)))
 ("UP:Q9Y6H8" (("GJA3" 15) ("Cx46" 2) ("connexin 46" 1)))
 ("UP:Q9Y6I3" (("epsin1" 10) ("Epsin1" 6) ("Epsin-1" 5) ("epsin 1" 5)))
 ("UP:Q9Y6I4"
  (("USP3" 143) ("Usp3" 120) ("USP3 protein" 3) ("-Usp3<tm1" 2)
   ("that USP3’s" 1) ("USP3-" 1)))
 ("UP:Q9Y6I7" (("Wsb1" 1) ("SWIP1" 1))) ("UP:Q9Y6I8" (("PXMP4" 3)))
 ("UP:Q9Y6J0"
  (("CABIN1" 61) ("calcineurin inhibitor" 15) ("CAIN" 6) ("Cabin-1" 5)
   ("calcineurin binding protein 1" 2) ("cabin1" 2) ("Calcineurin Inhibitor" 2)
   ("Calcineurin inhibitor" 1) ("calcineurin inhibitor (CNI)" 1)
   ("calcineurin inhibitor protein" 1)))
 #+ignore("UP:Q9Y6J3" ; fixed
  (("dams" 107) ("diabetic dams" 14) ("nondiabetic wild-type dams" 5)
   ("the diabetic dams" 2) ("nondiabetic Ask1  −/− dams" 2)
   ("diabetic wild-type dams" 2) ("diabetic Ask1  −/− dams" 2)
   ("treated dams" 1)))
 ("UP:Q9Y6J6" (("KCNE2" 32) ("KCNE2 protein" 5) ("LQT6" 3)))
 ("UP:Q9Y6J8" (("MK-STYX" 1)))
 ("UP:Q9Y6K1"
  (("DNMT3A" 438) ("DNMT3a" 103) ("Dnmt3a" 29) ("Dnmt3A" 2)
   ("DNA (cytosine-5-)-methyltransferase 3 alpha" 2)))
 ("UP:Q9Y6K5" (("OAS3" 4))) ("UP:Q9Y6K8" (("AK5" 7)))
 ("UP:Q9Y6K9"
  (("NEMO" 1612) ("IKKγ" 776) ("FIP3" 218) ("pip2" 45) ("IKBKG" 20)
   ("IKK-gamma" 19) ("ip1" 18) ("IP1" 13) ("NEMO protein" 11) ("IP2" 9)
   ("NEMO-" 6) ("IKKγ (NEMO)" 5) ("ip2" 4) ("Ikkγ" 3) ("ikbkg" 3)
   ("endosome-associated FIP3" 3) ("NF-kappa-B essential modulator" 2)
   ("functional NEMO" 2) ("IKKg" 2) ("incontinentia pigmenti" 2)
   ("the essential regulatory sub-unit IKKγ" 2) ("kinase gamma" 2)
   ("IKKγ protein" 2) ("the associated regulatory subunit IKKγ (NEMO)" 2)
   ("exogenous NEMO" 1) ("intact NEMO" 1)
   ("the first 106 amino acids of IKKγ" 1)
   ("the ubiquitin binding domain abrogated NEMO's" 1)
   ("the ubiquitin binding domain abrogated NEMO" 1) ("IKKγ–" 1)
   ("than IKKγ-WT" 1) ("significantly bind NEMO" 1)
   ("an essential regulatory subunit NEMO" 1) ("than unmodified NEMO" 1)
   ("the essential regulatory subunit NEMO" 1)))
 ("UP:Q9Y6L6"
  (("SLCO1B1" 18) ("OATP1B1" 3)
   ("the organic anion-transporting polypeptide OATP1B1" 1)))
 ("UP:Q9Y6M1"
  (("IGF2BP2" 98) ("IMP2" 4) ("IGF2BP2 protein" 4) ("overexpressed IGF2BP2" 3)
   ("IMP-2" 2)))
 ("UP:Q9Y6M5" (("solute carrier family 30 (zinc transporter)" 1) ("ZnT1" 1)))
 ("UP:Q9Y6M7" (("SLC4A7" 23)))
 ("UP:Q9Y6M9" (("B22" 27) ("NDUFB9" 2) ("b22" 1)))
 ("UP:Q9Y6N3" (("family member 3" 13))) ("UP:Q9Y6N6" (("LAMC3" 3)))
 ("UP:Q9Y6N7"
  (("Robo1" 308) ("ROBO1" 18) ("Roundabout" 13) ("Robo1 protein" 5)
   ("strong candidate genes—including ROBO1" 1)))
 ("UP:Q9Y6N8" (("CDH10" 5) ("cadherin 10" 1))) ("UP:Q9Y6N9" (("USH1C" 2)))
 ("UP:Q9Y6P5"
  (("SESN1" 27) ("sestrin1" 21) ("Sestrin1" 15) ("Sesn1" 11) ("Sestrin 1" 3)
   ("Sestrin-1" 3) ("sestrin 1" 2) ("PA26" 2) ("antioxidative sestrin1" 1)
   ("Ses-trin1" 1)))
 ("UP:Q9Y6Q1" (("calpain-6" 1) ("calpain 6" 1) ("Calpain 6" 1)))
 ("UP:Q9Y6Q2" (("SALF" 5) ("STON1" 1))) ("UP:Q9Y6Q5" (("AP1M2" 2)))
 ("UP:Q9Y6Q6" ; removed "rank" and "loss of heterozygosity" as synonyms
(#|("rank" 4387) ("LOH" 2035) ("loss of heterozygosity" 861)|#
 ("RANK" 536)
   ("Rank" 282) ("Loss of heterozygosity" 123)
   ("loss of heterozygosity (LOH)" 79) ("FEO" 58) ("copy-neutral LOH" 20)
   ("Loss of Heterozygosity" 18) ("FEO-" 15) ("TNFRSF11A" 13)
   ("RANK protein" 12) ("frequent loss of heterozygosity" 9) ("PDB2" 9)
   ("the adaptive rank" 5) ("copy-neutral loss of heterozygosity" 5)
   ("Loss of heterozygosity (LOH)" 5) ("copy neutral LOH" 5) ("somatic LOH" 5)
   ("genome-wide LOH" 5) ("Loss Of Heterozygosity" 5)
   ("copy neutral loss of heterozygosity" 4) ("simultaneous LOH" 4)
   ("the frequent loss of heterozygosity (LOH)" 3) ("chromosomal region 1" 3)
   ("soluble RANK" 3) ("copy number-neutral loss of heterozygosity" 3)
   ("frequent LOH" 3) ("’rank’" 3) ("complete LOH" 3)
   ("copy-neutral loss of heterozygosity (LOH)" 2) ("Loh" 2)
   ("17% displayed copy neutral TP53 loss of heterozygosity" 2)
   ("Copy-neutral loss of heterozygosity" 2) ("the stochastic LOH" 2)
   ("concurrent LOH" 2) ("use either two-tailed Wilcoxon signed rank" 2)
   ("two-tailed Wilcoxon sum rank" 2) ("low genomic LOH" 2) ("minimal LOH" 2)
   ("allelic loss of heterozygosity" 2)
   ("these three cases underwent loss of heterozygosity" 2)
   ("chromosomal allelic loss of heterozygosity (LOH)" 2)
   ("copy neutral loss of heterozygosity (LOH)" 2)
   ("“loss of heterozygosity”" 2) ("NFKB activator" 2)
   ("ER negative and showed loss of heterozygosity (LOH)" 2)
   ("the second allele or copy neutral loss of heterozygosity" 2)
   ("a possible BRCA1 loss of heterozygosity (LOH)" 2)
   ("frequently undergoes loss of heterozygosity" 2) ("pLOH" 2)
   ("BALB/c- Trp53 +/− females showed frequent loss of heterozygosity" 2)
   ("found infrequent LOH" 1) ("The adaptive rank" 1)
   ("than the loss of heterozygosity that is observed with other classical tumour suppresser genes"
    1)
   ("Most LOH" 1) ("at least one informative marker showed LOH" 1)
   ("Copy-neutral LOH" 1) ("preferential LOH" 1) ("Adaptive Rank" 1)
   ("a potential loss of heterozygosity" 1)
   ("using non-parametric Mann-Whitney U rank" 1)
   ("subsequent loss of heterozygosity" 1) ("Frequent LOH" 1)
   ("sub-chromosomal LOH" 1) ("tumors displayed TP53 LOH" 1)
   ("LOH or CN LOH (93%)" 1) ("nonparametric Wilcoxon rank" 1) ("more LOH" 1)
   ("stochastic LOH" 1) ("Complete LOH" 1)
   ("the somatic loss of heterozygosity (LOH)" 1)
   ("chromosomal loss of heterozygosity (LOH)" 1)
   ("A nonparametric Wilcoxon Rank" 1) ("A two-tailed Wilcoxon signed rank" 1)
   ("the two-tailed
Wilcoxon signed rank"
    1)
   ("underwent chromosome 11p15 LOH" 1)
   ("somatic (n=3) TP53 mutations underwent LOH" 1) ("the widespread LOH" 1)
   ("little genome-wide LOH" 1) ("the two-sided Mann–Whitney rank" 1)
   ("a somatic loss of heterozygosity (LOH)" 1)
   ("than loss of heterozygosity ( xref ; xref )" 1)
   ("non-parametric Wilcoxon Sign Rank" 1)
   ("somatic TP53 mutation usually experience loss of heterozygosity (LOH)" 1)
   ("frequent loss of heterozygosity (LOH)" 1) ("than RANK" 1)
   ("SNP/CGH array technology demonstrated large segmental LOH" 1)
   ("concurrent TP53 LOH" 1) ("the four nonparametric linear rank" 1)
   ("traditional nonparametric rank" 1)
   ("three other non-parametric linear rank" 1)
   ("three other nonparametric linear rank" 1) ("prospective LOH" 1)
   ("recurrent loss of heterozygosity" 1) ("demonstrable LOH" 1)
   ("a frequent loss of heterozygosity" 1)
   ("Human tumors often display loss of heterozygosity" 1)
   ("stromal somatic LOH" 1)
   ("these tumors underwent loss of heterozygosity (LOH)" 1)
   ("than 50% loss of heterozygosity in 71 microdissected tumors" 1)
   ("A transformed rank" 1) ("CD265" 1) ("than wild-type RANK" 1)
   ("expressing wild-type RANK" 1)
   ("loss of
                heterozygosity"
    1)
   ("accelerated loss of heterozygosity" 1) ("a two-sided log rank" 1)
   ("the frequent loss of heterozygosity" 1)
   ("mitotic recombination causes loss of heterozygosity" 1)
   ("no obvious LOH" 1) ("the Kruskal Wallis rank" 1) ("Kruskal Wallis rank" 1)
   ("the nonphosphorylatable residues Asp32 and Gly34 rank" 1)
   ("cancers often display loss of heterozygosity (LOH)" 1)
   ("grade 2 breast tumours often display loss of heterozygosity" 1)
   ("One-tailed Wilcoxon signed rank" 1) ("region-wide LOH" 1) ("“LOH”" 1)
   ("copy number neutral loss of heterozygosity (LOH)" 1)
   ("TRAF family member-associated NFKB activator (TANK)" 1)
   ("Cox proportional hazard regression, and Kaplan-Meier log rank" 1)
   ("somatic loss of heterozygosity" 1)))
 ("UP:Q9Y6Q9"
  (("AIB1" 910) ("SRC-3" 319) ("SRC3" 226) ("AIB-1" 45) ("AIB1 protein" 35)
   ("NCOA3" 33) ("overexpressed AIB1" 22) ("SRC-3 protein" 21) ("NCoA" 19)
   ("ACTR" 13) ("p/CIP" 6) ("pCIP" 5) ("SRC3-" 2) ("aib1" 2)
   ("Receptor-associated coactivator 3" 2) ("Gal4-DBD-tagged AIB1" 2)
   ("more AIB1" 1)
   ("SRC-3
protein"
    1)
   ("-SRC-3" 1) ("NCOA3 nuclear receptor coactivator 3" 1)
   ("nuclear receptor coactivator 3" 1) ("NcoA" 1) ("mitotic cells AIB1" 1)
   ("mitotic AIB1" 1) ("Ncoa3" 1) ("Aib1" 1)))
 ("UP:Q9Y6R0" (("Numbl" 8) ("NUMBL" 1)))
 ("UP:Q9Y6R1"
  (("SLC4A4" 6) ("sodium bicarbonate cotransporter" 3) ("SLC4A5" 1)))
 ("UP:Q9Y6R4"
  (("MTK1" 263) ("MEKK4" 77) ("MAP3K4" 18)
   ("mitogen-activated protein kinase kinase kinase 4" 6) ("MTK1 protein" 2)
   ("HER3 and IRS-1 strongly links MTK1" 1) ("specifically targets MTK1" 1)))
 ("UP:Q9Y6U3" (("SCIN" 1) ("scinderin" 1))) ("UP:Q9Y6V0" (("PCLO" 1)))
 ("UP:Q9Y6V7" (("DDX49" 1)))
 ("UP:Q9Y6W3" (("CALPAIN7" 3) ("calpain 7" 2) ("CAPN7" 1)))
 ("UP:Q9Y6W5"
  (("WAVE2" 311) ("Wave2" 30) ("than WAVE2" 4) ("WASF2" 3)
   ("than WAVE2 downstream of Rac" 1)))
 ("UP:Q9Y6W6" (("MKP-5" 27) ("DUSP10" 22) ("MKP5" 3)))
 ("UP:Q9Y6W8"
  (("ICOS" 341) ("Icos" 11) ("target cell-stimulatory receptor ICOS" 3)
   ("AILIM" 3) ("ICOS (FITC)" 2)
   ("another B7 type co-stimulatory factor ICOS" 2)
   ("Inducible T-cell COStimulator (ICOS)" 1)
   ("Inducible T-cell COStimulator" 1) ("ICOS-" 1)))
 ("UP:Q9Y6X0"
  (("SEB" 43) ("SETBP1" 5) ("SET binding protein" 2)
   ("SET binding protein 1" 1) ("pSEB" 1)))
 ("UP:Q9Y6X1" (("SERP1" 2)))
 ("UP:Q9Y6X2"
  (("PIAS3" 461) ("PIAS3 protein" 4) ("-PIAS3" 4) ("PIAS-3" 2) ("Pias3" 2)))
 ("UP:Q9Y6X3" (("SCC4" 65) ("MAU2" 2))) ("UP:Q9Y6X6" (("Myo16" 2)))
 ("UP:Q9Y6X8" (("Afp" 18) ("ZHX2" 2)))
 ("UP:Q9Y6X9"
  (("MORC2" 348) ("p-MORC2" 10) ("MORC2 protein" 3) ("ZCWCC1" 2) ("KIAA0852" 2)
   ("ZCW3" 1)))
 ("UP:Q9Y6Y0"
  (("NS1-BP" 133) ("IVNS1ABP" 5) ("influenza virus NS1A binding protein" 5)
   ("ARA3" 5) ("NS1-BP protein" 3)))
 ("UP:Q9Y6Y1"
  (("CAMTA1" 103) ("calmodulin binding transcription activator 1" 1)))
 ("UP:Q9Y6Y8" (("P125A" 56) ("Q9Y6Y8" 1)))
 ("UP:Q9Y6Y9" (("MD-2" 214) ("MD2" 16) ("LY96" 12) ("the normal MD-2" 1)))
 ("UP:Q9Y812" (("Cnp1" 2))) ("UP:Q9Y815" (("RSV2" 1)))
 ("UP:Q9Y884" (("SKH1" 1))) ("UP:Q9Y942" (("TFB" 2)))
 ("UP:Q9YAC7"
  (("pan" 1740) ("Pan" 223) ("PAN" 182) ("pan-" 23) ("“pan”" 7)
   ("Currently no pan-" 1) ("‘pan’" 1)))
 ("UP:Q9YC75" (("topoisomerase" 185) ("Topoisomerase" 21)))
 ("UP:Q9YCL9" (("CAS4" 5))) ("UP:Q9YCV1" (("RNP2" 6) ("RNP-2" 4)))
 ("UP:Q9YF79" (("RNP1" 6) ("RNP-1" 5))) ("UP:Q9YGY0" (("AXN" 2) ("Axn" 2)))
 ("UP:Q9YHY6" (("EG7" 10))) ("UP:Q9Z0D3" (("REP3" 1)))
 ("UP:Q9Z0E0" (("norbin" 6))) ("UP:Q9Z0F3" (("BOO" 3)))
 ("UP:Q9Z0K9"
  (("amelogenin" 8) ("Amelogenin" 6) ("amelogenins" 2)
   ("amelogenin ( AMELX )" 1)))
 ("UP:Q9Z0N1" (("Eif2s3x" 1)))
 ("UP:Q9Z0S9" (("-PrA" 15) ("PrA" 7) ("pRA" 4) ("Pra1" 3) ("pRaf1" 1)))
 ("UP:Q9Z0V6" (("Prx3" 4))) ("UP:Q9Z1B5" (("MAD2a" 1)))
 ("UP:Q9Z1B8" (("mPCl1" 5) ("mPcl1" 5))) ("UP:Q9Z1N6" (("FRP4" 1)))
 ("UP:Q9Z1X0" (("mILC" 6)))
 ("UP:Q9Z214" (("HOMER" 70) ("both motifs genome-wide using HOMER" 2)))
 ("UP:Q9Z2A9" (("GGL" 4) ("“GGL”" 1))) ("UP:Q9Z2F5" (("BARS-50" 4) ("BARS" 1)))
 ("UP:Q9Z330" (("DNA methyltransferase I" 5))) ("UP:Q9Z426" (("pTSO" 1)))
 ("UP:Q9Z6U5" (("Pmp21" 3))) ("UP:Q9ZAA7" (("GCDC" 51)))
 ("UP:Q9ZAG3" (("Lima" 13) ("lima" 1))) ("UP:Q9ZHI2" (("PhAc" 2)))
 ("UP:Q9ZNB7" (("ALG" 1))) ("UP:Q9ZNT3" (("AtADF5" 1)))
 ("UP:Q9ZNV5"
  (("ATC" 1140) ("-ATC" 40) ("ATc" 24) ("−ATc" 1)
   ("mice developed rapidly lethal ATC" 1) ("orthotopic ATC" 1)))
 ("UP:Q9ZNX9"
  (("IgE" 742) ("monomeric IgE" 23) ("Monomeric IgE" 7) ("SigE" 3)
   ("monoclonal IgE" 2) ("Non-specific monomeric IgE" 2)
   ("a monoclonal anti-DNP IgE" 2) ("plasmatic IgE" 2) ("mature IgE" 2)
   ("cytokinergic IgE" 1) ("nonspecific monomeric IgE" 1) ("−IgE" 1)
   ("Exogenous IgE" 1) ("peanut-specific IgE" 1) ("milk-specific IgE" 1)
   ("local IgE" 1)))
 ("UP:Q9ZP19" (("PpoI" 21)))
 ("UP:Q9ZPE7" (("exo" 33) ("EXO" 33) ("Exo" 30) ("exo-" 12) ("N-EXO" 1)))
 ("UP:Q9ZQ88" (("UPS4" 1))) ("UP:Q9ZR12" (("LRF1" 1)))
 ("UP:Q9ZRZ8" (("RH28" 13))) ("UP:Q9ZSB5" (("Ubp10" 3)))
 ("UP:Q9ZSD6" (("LLA" 6))) ("UP:Q9ZSK3" (("AtADF4" 3)))
 ("UP:Q9ZSK4" (("ADF3" 18))) ("UP:Q9ZSL6" (("sIgD" 29)))
 ("UP:Q9ZSS6"
  (("TD" 628) ("TD peptide" 6) ("than E2F3 TD" 1)
   ("We first tested binding ofE2F1 TD" 1) ("paralogous ‘activating’ E2F TD" 1)
   ("most TD" 1) ("almost all type 2 TD" 1) ("the neonatal lethal TD" 1)
   ("project number TD2724" 1)))
 ("UP:Q9ZTS2" (("PFLP" 1))) ("UP:Q9ZU50" (("GABP" 200)))
 ("UP:Q9ZUS0" (("HTB5" 10))) ("UP:Q9ZUT3" (("Als3" 12) ("ALS3" 5) ("als3" 2)))
 ("UP:Q9ZV43" (("chr8" 36) ("Chr8" 5))) ("UP:Q9ZWC6" (("ATB" 7) ("ATB-" 1)))
 ("UP:Q9ZWQ9" (("FLSs" 269) ("arthritic FLSs" 5) ("treated control FLSs" 1)))
 ("UP:SL-9902" (("GPI-anchor" 3)))
 ("UP:SL-9904" (("single-pass" 58) ("massive single-pass" 2)))
 ("UP:V9HW48" (("S115" 5)))
 ("UP:V9VHH0"
  (("mCherry" 1097) ("-mCherry" 93) ("mcherry" 28) ("mCherry protein" 13)
   ("mCherry-" 11) ("mCHERRY" 3) ("the red fluorescent protein mCherry" 2)
   ("the fluorescent protein mCherry" 2) ("mCherry (CTL)" 2)
   ("the red fluorescent mCherry protein" 2) ("fluorescent mCherry protein" 2)
   ("the fluorescent proteins mCherry" 1)
   ("the red-fluorescent protein mCherry" 1)
   ("the fluorescent mCherry protein" 1)))
 ("UP:W0G7P8" (("S318" 14)))
 ("UP:W1WMX0" (("mannitol" 110) ("Mannitol" 4) ("-mannitol" 2)))
 ("UP:W1XQY5" (("C20" 178) ("c20" 5) ("than C20" 1) ("longer C20" 1)))
 ("UP:W2SUG2" (("CV-1" 99))) ("UP:W2TEH5" (("TrR" 3) ("Trr" 1) ("trr" 1)))
 ("UP:W4VSC2" (("peptide 1" 29) ("Peptide 1" 11) ("than Peptide 1" 1)))
 ("V600EBRAF" (("V600EBRAF" 3)))
 ("XFAM:PF00009" (("Elongation factor Tu GTP-binding domain" 1)))
 ("XFAM:PF00011"
  (("Hsp20" 79) ("Hsp20 peptide" 36) ("Hsp20 (SLSFVDEPILHGKVHAKFVE)" 2)
   ("Hsp20 (IAVK)" 1) ("Hsp20 (GHFSVLLDVKHFSPEEKAIV)" 1)))
 ("XFAM:PF00011.19"
  (("HSP20" 122) ("HSP20 protein" 13) ("overexpressed HSP20 protein" 4)))
 ("XFAM:PF00017"
  (("sh2" 98) ("SH2 Domain" 68) ("Sh2" 33) ("SH2 Domains" 6) ("sh2-" 6)
   ("SH2
Domain"
    2)
   ("-sh2" 1)))
 ("XFAM:PF00018" (("SH3 Domain" 23) ("SH3 Domains" 8)))
 ("XFAM:PF00038"
  (("intermediate filaments" 147) ("intermediate filament" 113)
   ("intermediate filament (IF) protein" 9) ("Intermediate filaments" 4)
   ("a ubiquitous mesenchymal intermediate filament" 2)
   ("around intermediate filaments" 2)
   ("native filamentous keratin (Krt) intermediate filaments" 2)
   ("intermediate filament family" 2) ("intermediate filament (IF)" 1)))
 ("XFAM:PF00038.19"
  (("filaments" 4211) ("filament" 2641) ("Filaments" 43) ("Filament" 31)
   ("cortical actin filaments" 17) ("filament (NPF)" 16)
   ("pre-assembled tau filaments" 16) ("pre-assembled filaments" 12)
   ("helical nucleoprotein filaments" 10) ("paired helical filaments" 8)
   ("the RAD51 presynaptic filament" 7) ("paired helical filaments (PHF)" 6)
   ("helical filaments" 6) ("irregular filaments" 6) ("‘filaments’" 6)
   ("the presynaptic filament" 5) ("the filament's" 4)
   ("a helical nucleoprotein filament" 4) ("the helical filament" 4)
   ("fewer filaments" 3) ("RAD51 presynaptic filaments" 3)
   ("perijunctional actin filaments" 3) ("filopodial actin filaments" 3)
   ("filament (ULF)" 3) ("the nucleoprotein filament's" 3) ("filament-" 3)
   ("dense actin filaments" 2) ("the photoactivated fluorescent filaments" 2)
   ("Intermediary filaments" 2) ("an intermediary filament" 2)
   ("either empty or contained very few linear actin filaments" 2)
   ("Alexa 594-labeled actin filaments" 2) ("bare or saturated filaments" 2)
   ("an essential actin filament" 2) ("insoluble vimentin filaments" 2)
   ("myosin II filaments" 2)
   ("a helical nucleoprotein
filament"
    2)
   ("these proteins form hetero-oligomeric filaments" 2) ("larger filaments" 2)
   ("Pre-assembled filaments" 2) ("a left-handed filament" 2)
   ("these proteins form helical filaments" 2)
   ("a Dmc1-DNA helical filament" 2) ("the helical filaments" 2)
   ("paired helical filament" 2) ("the sarcomeric filaments" 2)
   ("the cortical actin filaments" 2) ("a presynaptic filament" 2)
   ("otherwise apparently bare filaments" 2)
   ("the helical RAD51 nucleoprotein filaments" 2) ("bipolar filaments" 2)
   ("apical actin filaments" 2) ("short independently nucleated filaments" 2)
   ("mostly irregular filaments" 2) ("the irregular filaments" 2)
   ("loosely associated filaments" 2) ("newly polymerized actin filaments" 2)
   ("than RAD51 filaments" 2) ("thinner peri-junctional actin filaments" 2)
   ("neuronal paired helical filaments" 2)
   ("forms insoluble filamentous aggregates termed paired helical filaments" 2)
   ("the mature filament" 2) ("typical 10-nm filaments" 2)
   ("intranuclear filaments" 2) ("Rad51 presynaptic filament" 2)
   ("“old” actin filaments" 2) ("oligomeric filaments" 1)
   ("transmembranous cadherins and actin filaments" 1)
   ("a hypothetical nucleoprotein filament (NPF)" 1)
   ("intermediary filaments" 1) ("than partially decorated filaments" 1)
   ("than bare or saturated filaments [ xref , xref , xref , xref – xref ]" 1)
   ("heterogeneous filaments" 1) ("more cortical actin filaments" 1)
   ("transverse actin filaments" 1) ("short cortical filaments" 1)
   ("short cortical actin filaments" 1) ("most septin filaments" 1)
   ("significantly fewer filaments" 1)
   ("groups presented well-formed branch-like actin filaments" 1)
   ("the pre-assembled filaments" 1)
   ("phosphorylated pre-assembled tau filaments" 1)
   ("both pre-phosphorylated tau filaments" 1)
   ("straight and paired-helical filaments" 1)
   ("than 80 dsDNA filaments formed in the presence of calcium and ATP" 1)
   ("left-handed helical filaments" 1)
   ("ScDmc1 predominantly or exclusively forms right-handed filaments" 1)
   ("only right-handed filaments" 1) ("the given filament's" 1)
   ("very long filaments" 1) ("Helical filaments" 1)
   ("a more flexible filament" 1) ("visible filaments" 1)
   ("more rigid filaments" 1)
   ("the protein can form left-handed helical filaments" 1)
   ("apparently full-length filaments" 1)
   ("The RecA homologs form helical filaments" 1)
   ("both cortical actin filaments" 1) ("well-defined filaments" 1)
   ("soluble untagged SPCA1-L2-C1 and actin filaments" 1)
   ("Polymerized actin filaments" 1) ("helical RAD51–DNA filaments" 1)
   ("The RAD51 presynaptic filament" 1) ("helical presynaptic filament" 1)
   ("The resultant actin filaments" 1) ("than control filaments" 1)
   ("than the control filaments ( xref )" 1)
   ("Right-handed double helical filaments" 1) ("than those filaments" 1)
   ("the recombinogenic Rad51-ssDNA filament" 1)
   ("canonical RAD51 helical filaments" 1)
   ("helical dsDNA-RAD51 nucleoprotein filaments" 1)
   ("Cortical actin filaments" 1)
   ("we first polymerized and tethered DY647-labelled actin filaments" 1)
   ("surface-tethered Oregon-green (OG) labelled filaments" 1)
   ("RhoA-driven actomyosin filament" 1) ("more filaments" 1)
   ("RecA and RAD51 not only form ATP-dependent filaments" 1)
   ("forms right-handed helical nucleoprotein filaments" 1)
   ("the pre-formed fluorescent RAD51-dsDNA filaments" 1)
   ("sub-cortical actin filaments" 1) ("a discontinuous filament" 1)
   ("the fluorescent nucleoprotein filaments" 1)
   ("relatively few actin filaments" 1) ("produced irregular filaments" 1)
   ("very few filaments" 1)
   ("a recombination-competent nucleoprotein filament" 1)
   ("a right-handed helical protein filaments" 1)
   ("than filaments covering dsDNA" 1)
   ("myosin II-containing actin filaments" 1) ("linking actin filaments" 1)
   ("the RAD51 presynaptic filaments" 1) ("RAD51 presynaptic filament" 1)
   ("a right-handed helical filament" 1)
   ("RAD51 helical nucleoprotein filament" 1) ("discontinuous filaments" 1)
   ("around M-lines, and thin filaments" 1)
   ("The bare and decorated filaments" 1)
   ("enriched cortical actin filaments" 1) ("shorter filaments" 1)
   ("the HsRad51/dsDNA complex forms stiff and stable filaments" 1)
   ("discontinuous short filaments" 1) ("sufficiently long filaments" 1)
   ("EV/CIHPs displayed brightly fluorescent actin filaments" 1)
   ("Nef/CIHP displayed scanty actin filament" 1)
   ("forms hyperstable filaments" 1) ("showed similar irregular filaments" 1)
   ("shorter actin filaments" 1)
   ("the α -SMA immunopositive actin filaments" 1)
   ("a bone-associated filament" 1) ("very short filaments" 1)
   ("TAU typical cytoplasmic filaments" 1) ("“old” filaments" 1)
   ("most hRad51–dsDNA nucleoprotein filaments" 1)
   ("Ristic et al. ( xref ) report more regular filaments" 1)
   ("‘irregular’ filaments" 1) ("than RecA filaments" 1)
   ("a right-handed helical nucleoprotein filament" 1)
   ("a flexible filament" 1) ("very long (>10 kb) continuous filaments" 1)
   ("Instead each nucleoprotein filament" 1) ("perinuclear K8 filaments" 1)
   ("presynaptic Rad51 filaments" 1)))
 ("XFAM:PF00047"
  (("Ig" 1253) ("IG" 123) ("Igs" 54) ("mouse monoclonal Ig" 2) ("less Ig" 2)
   ("soluble B7.1 Ig" 2) ("mouse anti-human CD24 monoclonal Ig" 2)
   ("rabbit anti-human CD44 monoclonal Ig" 2)
   ("horseradish peroxidase secondary antibody anti-mouse IG" 2)
   ("Anti-ssDNA, anti-nRNP, and anti-Histone Ig’s" 1) ("10–20-fold more Ig" 1)
   ("Ig-" 1) ("using AlexaFluor 488-conjugated Abs specific rabbit Ig" 1)
   ("a control nonspecific rabbit Ig" 1) ("-Ig" 1)
   ("the Immpress Universal reagent anti-mouse/rabbit Ig" 1) ("Igµ" 1)))
 ("XFAM:PF00051"
  (("kringle" 22) ("kringle domain" 14) ("kringle domains" 8) ("kringles" 3)
   ("Kringle" 3) ("Kringle domains" 2) ("Kringle domain" 2)))
 ("XFAM:PF00067"
  (("cytochrome P450" 101) ("CYP" 91) ("P450" 52) ("cyP" 39) ("CYPs" 28)
   ("cytochrome p450" 17) ("Cytochrome P450" 14) ("cytochrome P450s" 6)
   ("p450" 3) ("CYP family" 3) ("Cyp" 2) ("cytochrome P450 family" 2)
   ("Cytochrome p450" 2) ("CyP" 2) ("P450s" 1) ("pCYP" 1)))
 ("XFAM:PF00069"
  (("kinase domain" 8387) ("kinase domains" 1020) ("TKD" 99) ("-TKD" 57)
   ("protein kinase domain" 56) ("kinase domain (KD)" 46)
   ("kinase
domain"
    31)
   ("protein kinase domains" 20) ("kinase domain (TKD)" 19)
   ("Kinase domain" 17) ("kinase domain (CTK)" 6) ("kinase domain (VM)" 6)
   ("kinase domain (NTK)" 4) ("kinase  domain" 3)
   ("kinase domain (2GS2) protein" 3) ("kinase domain (PTKD)" 3)
   ("kinase domain (CTD)" 3) ("kinase domains (NTKD)" 3)
   ("an FLAG-tagged minimal ERBB2 kinase domain" 2) ("kinase domain (CTKD)" 2)
   ("kinase domain (NTKD)" 2)
   ("a highly homologous kinase
domain"
    2)
   ("the atypical kinase domain" 2) ("the globular kinase domain" 2)
   ("a typical kinase domain" 2) ("a predominant middle kinase domain" 2)
   ("the respective kinase domains" 2)
   ("two unique functional kinase domains" 2) ("“pseudo-kinase domain”" 2)
   ("the subsequent kinase domain" 2) ("an internal kinase domain" 1)
   ("their respective intracellular kinase domains" 1)
   ("kinase domains (TKD)" 1) ("binding both the AKT kinase domain" 1)
   ("homologous ATP kinase domains" 1) ("the essential kinase domain" 1)
   ("the phosphorylated tyrosine (Y 1234/1235) of the Met kinase domain" 1)
   ("a typical serine/threonine kinase domain" 1) ("than FLT3 -TKD" 1)
   ("a strong kinase domain" 1) ("than the kinase domain (KD)" 1)
   ("their respective kinase domains" 1)
   ("than the kinase domain (Figure xref B)" 1) ("Protein kinase domains" 1)
   ("The monomeric (V948R) gefitinib/erlotinib resistant double mutant (L858R+T790M) EGFR kinase domain"
    1)
   ("than the untethered kinase domain ( xref )" 1) ("kinase domain-" 1)
   ("6 secondary inactive kinase domains" 1)
   ("the kinase domain, which includes positively charged residues Lys 723, Lys729, Lys 863, and Lys867"
    1)
   ("characteristic split tyrosine kinase domains" 1)
   ("C-terminal kinase domain’s" 1) ("monomeric kinase domains" 1)
   ("–Kinase domain" 1) ("the six-histidine-tagged c-Src kinase domain" 1)
   ("500 nM six-histidine-tagged c-Src kinase domain" 1)
   ("associated Hck kinase domains" 1) ("a bilobal kinase domain" 1)))
 ("XFAM:PF00093" (("VWC" 2)))
 ("XFAM:PF00102"
  (("protein-tyrosine phosphatase" 40) ("protein-tyrosine phosphatases" 5)
   ("Protein-tyrosine phosphatases" 4) ("protein–tyrosine phosphatase (PTP)" 3)
   ("Protein-tyrosine phosphatase" 2) ("protein–tyrosine phosphatase" 2)
   ("protein-tyrosine phosphatase (PTP)" 1)))
 ("XFAM:PF00123" (("peptide hormone" 34) ("peptide hormones" 23)))
 ("XFAM:PF00153"
  (("mitochondrial carrier" 6) ("mitochondrial carrier family" 2)))
 ("XFAM:PF00162"
  (("phosphoglycerate kinase" 25) ("Phosphoglycerate kinase" 1)))
 ("XFAM:PF00167"
  (("Fibroblast growth factor" 43) ("Fibroblast growth factors" 35)
   ("Fibroblast growth factor (FGF)" 1)))
 ("XFAM:PF00168" (("C2 Domain" 1)))
 ("XFAM:PF00170"
  (("bZIP transcription factor" 19) ("bZIP transcription factors" 11)
   ("bZip transcription factor" 7)
   ("a basic redox-sensitive bZIP transcription factor" 3)
   ("bZiP transcription factor" 3) ("bZip transcription factors" 2)
   ("dimeric bZIP transcription factors" 1)))
 ("XFAM:PF00179"
  (("ubiquitin-conjugating enzyme" 215) ("ubiquitin-conjugating enzymes" 103)
   ("ubiquitin conjugating enzyme" 97) ("ubiquitin conjugating enzymes" 38)
   ("ubiquitin–conjugating enzyme" 13) ("Ubiquitin-conjugating enzymes" 6)
   ("ubiquitin conjugating
enzyme"
    3)
   ("Ubiquitin conjugating enzyme" 2) ("ubiquitin-conjugating enzyme family" 2)
   ("Ubiquitin-Conjugating enzyme" 2) ("ubiquitin–conjugating enzyme (UBC)" 2)
   ("at least two ubiquitin conjugating enzymes" 2)
   ("Ubiquitin-conjugating enzyme" 2)
   ("a presumptive E2 ubiquitin-conjugating enzyme" 1)
   ("the active site cysteine of an E2 ubiquitin-conjugating enzyme forming an E2~Ub conjugate"
    1)
   ("SCF-associated E2 ubiquitin-conjugating enzyme" 1)
   ("the library target human E1, E2 and E3 ubiquitin-conjugating enzymes" 1)
   ("one or more E2 ubiquitin conjugating enzymes" 1)
   ("ubiquitin conjugating enzyme (UBC)" 1)))
 ("XFAM:PF00212.16"
  (("ANP" 40) ("Myocardial ANP protein" 1) ("ANP protein" 1)
   ("the hypertrophic marker ANP" 1)))
 ("XFAM:PF00224" (("Pk" 17)))
 ("XFAM:PF00226" (("DNAJ" 10) ("DNAJ family" 5) ("DnaJ" 5) ("DNAJs" 3)))
 ("XFAM:PF00227"
  (("proteasome subunits" 81) ("proteasome subunit" 14)
   ("most 26S proteasome subunits" 2) ("Proteasome subunit" 1)
   ("Proteasome subunits" 1) ("cardiac proteasome subunits" 1)))
 ("XFAM:PF00231" (("ATP Synthase" 15)))
 ("XFAM:PF00245"
  (("alkaline phosphatase" 799) ("Alkaline phosphatase" 79)
   ("alkaline phosphatase (AP)" 20) ("alkaline phosphatase (ALP)" 19)
   ("alkaline phosphatase (CIAP)" 10) ("SEAP" 9)
   ("alkaline phosphatase (SEAP)" 9) ("alkaline phosphatases" 4)
   ("placental alkaline phosphatase" 4)
   ("human placental alkaline phosphatase" 4) ("Alkaline phosphatase (AP)" 3)
   ("an intense alkaline phosphatase" 3) ("Alkaline phosphatase (ALP)" 3)
   ("thermosensitive alkaline phosphatase" 3)
   ("the enterocytic differentiation marker alkaline phosphatase" 3)
   ("alkaline phosphatase-" 2)
   ("the Ventana IHC Multimer alkaline phosphatase" 2)
   ("the osteoblastic markers alkaline phosphatase (AP)" 2)
   ("alkaline phosphatase (SAP)" 2) ("alkaline phosphatase (NEB)" 2)
   ("BMMSCs showed minimal alkaline phosphatase" 2)
   ("alkaline phosphatase (CIP)" 2) ("dual alkaline phosphatase" 2)
   ("Alkaline phosphatase–" 1)
   ("the intestinal differentiation markers alkaline phosphatase (AP)" 1)
   ("the enterocytic differentiation markers sucrose-isomaltase (SI,) alkaline phosphatase (AP)"
    1)
   ("alkaline phosphatase (BALP)" 1) ("alkaline phosphatase (ALKP)" 1)
   ("alkaline phosphatase–" 1)))
 ("XFAM:PF00250"
  (("forkhead domain" 44) ("Forkhead domain" 4) ("forkhead domains" 3)))
 ("XFAM:PF00269.18"
  (("SASP" 514) ("SASPs" 70) ("SIRT1 accelerated and enhanced SASP" 2)
   ("Radiation-induced SASPs" 2) ("This p21-depedent SASP" 1)
   ("the radiation-induced SASPs" 1)))
 ("XFAM:PF00302"
  (("chloramphenicol acetyltransferase" 24)
   ("chloramphenicol acetyltransferase (CAT)" 3)
   ("-chloramphenicol acetyltransferase (CAT)" 1)
   ("-chloramphenicol acetyltransferase" 1)
   ("a LTR promoter-driven reporter gene chloramphenicol acetyltransferase (CAT)"
    1)
   ("Chloramphenicol acetyltransferase" 1)))
 ("XFAM:PF00307"
  (("CH" 956) ("ch" 87) ("-CH=CH" 14) ("-CH" 7) ("Ch" 2) ("–CH" 2)
   ("Fas-agonistic antibody CH11" 1) ("the modulatory CH" 1)
   ("IgM clone CH11" 1) ("CH-" 1)))
 ("XFAM:PF00335"
  (("tetraspanin" 71) ("tetraspanins" 67) ("tetraspanin family" 24)
   ("Tetraspanins" 16) ("Tetraspanin" 5) ("tetraspannin" 4)
   ("tetraspanin protein" 3)))
 ("XFAM:PF00350"
  (("dynamin" 325) ("Dynamin" 31) ("dynamins" 11)
   ("coexpressed dynamin-K44A" 3) ("Dynamin family" 3)
   ("dominant-negative dynamin" 2) ("dynamin family" 2) ("dynamin-" 2)
   ("the endocytic protein dynamin" 1) ("Dynamins" 1)))
 ("XFAM:PF00375.16" (("SDF" 25) ("pSDF" 8) ("sdf" 1)))
 ("XFAM:PF00395.18" (("SLH" 13)))
 ("XFAM:PF00397"
  (("WW" 1390) ("WW protein" 2) ("“WW”" 2) ("ww" 1) ("pWW" 1) ("-WW" 1)
   ("‘WW’" 1) ("its unique WW" 1)))
 ("XFAM:PF00418"
  (("tubulin-binding" 15) ("tubulin binding" 6) ("tubulin-binding protein" 2)))
 ("XFAM:PF00424.16"
  (("Rev" 1032) ("REV" 210) ("Rev protein" 30) ("pREV" 17) ("REV protein" 10)
   ("pRev" 10) ("Rev-" 4) ("REV (GAGTTCTTGAACAGGCAGCTG)" 2) ("Rev’s" 2)
   ("Rev's" 1) ("traffic Rev" 1) ("-Rev" 1) ("retroviral Rev protein" 1)))
 ("XFAM:PF00446"
  (("gonadotropin-releasing hormone" 32)
   ("Gonadotropin-releasing hormone" 12)))
 ("XFAM:PF00454"
  (("PI3K" 26332) ("phosphatidylinositol 3-kinase" 1253) ("PI3-kinase" 645)
   ("PI-3K" 357) ("PI 3-kinase" 344) ("PI(3)K" 325)
   ("phosphatidylinositol-3-kinase" 210) ("Phosphatidylinositol 3-kinase" 78)
   ("PI3K-" 54) ("phosphatidylinositol 3-kinases" 47) ("PI3K family" 41)
   ("PI 3-kinases" 39) ("PI3k" 36)
   ("phosphatidylinositol-4,5-bisphosphate 3-kinase" 29) ("pPI3K" 25)
   ("p-PI3K" 25) ("phosphatidylinositide 3-kinase" 24)
   ("Phosphatidylinositol-3-kinase" 24) ("Phosphatidylinositol 3-kinases" 21)
   ("PI3K protein" 17) ("PI(3)Ks" 12) ("PI3K molecule" 10) ("PI3-kinases" 10)
   ("phosphatidylinositol 3-kinase family" 9) ("PI3-kinase family" 8)
   ("phosphatidylinositol-3-kinases" 7) ("-PI3K" 4)
   ("phosphatidylinositol 3-kinase (PIK)" 4)
   ("phosphatidylinositol 3-kinase (PI3K) family" 3) ("Pi3K" 3)
   ("Phosphatidylinositide 3-kinase" 3)
   ("phosphatidylinositol
3-kinase"
    3)
   ("phosphatidylinositol
 3-kinases"
    3)
   ("Class I A PI3K" 3) ("the dominant-negative PI3K" 3)
   ("PI3K family protein" 2) ("PI3K–" 2) ("PI3K-H1407R protein" 2)
   ("just PI3K" 2) ("an essential PI3-kinase" 2)
   ("phosphatidylinositide
3-kinase"
    2)
   ("a dominant-negative mutant PI3K" 2) ("targeting PI3K" 2) ("PI3-kinase-" 2)
   ("phosphatidylinositol 3-kinase (PI3-K) family" 2) ("a weak PI3K" 2)
   ("class I A PI 3-kinase" 2) ("than PI3K" 2)
   ("phosphatidylinositide 3-kinases" 2) ("pI3K" 2)
   ("-phosphatidylinositol 3-kinase" 2)
   ("phosphatidylinositol 3-kinase protein" 2) ("PI 3-kinase's" 1)
   ("the multimeric class III PI3K" 1)
   ("an endogenously expressed RTK-sensitive class I A PI3K" 1)
   ("an otherwise intact PI3K molecule" 1) ("less PI3K" 1)
   ("centrosomal PI3K" 1) ("our approach directly links PI3K" 1)
   ("Phosphatidylinositol-4,5-bisphosphate 3-kinase" 1)
   ("than just PI3K [ xref ]" 1) ("monomeric p85 α  PI3K" 1) ("PI(3)K-" 1)
   ("“PI 3-kinase”" 1) ("“phosphatidylinositol 3-kinase”" 1)
   ("a heterodimeric class IA PI3K" 1) ("monocytic U937 cells PI3K" 1)
   ("a nonclassic PI3K" 1) ("The lone type 1B PI3K" 1) ("P-PI3K" 1)
   ("heterodimeric p85α/p110 class IA PI3K" 1) ("\"PI3K\"" 1) ("more PI3K" 1)
   ("less PI 3-kinase" 1) ("Class I A PI 3-kinase" 1) ("especially HR PI3K" 1)
   ("than E545K PI3K in HER2-overexpressing cells" 1)
   ("the IRS2-associated PI3K" 1) ("the IRS1-associated PI3K" 1)
   ("Purified PI3K's" 1) ("the essential role PI3K" 1)
   ("directly target PI3K" 1) ("dominant-negative PI3K" 1)
   ("dominant-negative PI-3K" 1) ("than the PI3K" 1) ("than PI3-kinase" 1)
   ("phosphatidylinositol 3–kinase" 1) ("“PI3K”" 1)
   ("the classical upstream PKC regulators PI3K" 1)
   ("Rapamycin indirectly targets PI3K" 1) ("targeted PI3K" 1)))
 ("XFAM:PF00469"
  (("Nef" 6787) ("Nefs" 347) ("pNef" 3) ("primate lentiviral Nefs" 2)
   ("Primate lentiviral Nefs" 1) ("than HIV-1 Nefs" 1)
   ("all contemporary HIV-1 O Nefs" 1) ("the dimeric Nefs" 1)
   ("previously discussed subtype E Nefs" 1) ("discussed subtype E Nefs" 1)
   ("Remarkably subtype E Nefs" 1)))
 ("XFAM:PF00474.15" (("SSF" 29))) ("XFAM:PF00478" (("IMPDH" 49)))
 ("XFAM:PF00498"
  (("FHA" 491) ("FHA protein" 2) ("soluble FHA" 2)
   ("both surface-associated FHA" 1) ("than FHA ( xref )" 1)))
 ("XFAM:PF00501" (("AMP binding" 33)))
 ("XFAM:PF00503"
  (("G-alpha" 3) ("G-protein alpha subunit" 3) ("G alpha" 2)
   ("G-protein alpha subunits" 2) ("the stimulatory G-protein alpha subunit" 1)
   ("The heterotrimeric G-protein alpha subunit" 1) ("G-protein alpha" 1)
   ("G protein alpha" 1)))
 ("XFAM:PF00509.16"
  (("hemagglutinin" 319) ("haemagglutinin" 41) ("hemagglutinin (HA)" 33)
   ("Hemagglutinin" 16) ("hemagglutinin peptide" 11)
   ("hemagglutinin (HA) protein" 7) ("haemagglutinin (HA)" 7)
   ("hemagglutinins" 5) ("hemagglutinin (HA) peptide" 5)
   ("the viral hemagglutinin" 4) ("hemagglutinin protein (HA)" 4)
   ("overexpressed hemagglutinin (HA)" 3)
   ("overexpressed haemagglutinin (HA)" 3) ("influenza A hemagglutinin" 3)
   ("anti–Influenza A hemagglutinin (HA)" 2)
   ("Filamentous hemagglutinin (FHA)" 2) ("haemoagglutinin" 1)
   ("-hemagglutinin" 1) ("Hemagglutinin-" 1)
   ("the amino
terminal hemagglutinin"
    1)))
 ("XFAM:PF00510.16" (("COX-3" 15) ("COX3" 1)))
 ("XFAM:PF00516"
  (("envelope glycoprotein gp120" 37)
   ("the viral envelope glycoprotein gp120" 3)))
 ("XFAM:PF00517.15"
  (("gp41" 832) ("gp41 protein" 12) ("Gp41" 10) ("gp41 peptide" 3) ("pgp41" 3)
   ("gp41-" 2) ("the nearly entire wild-type (wt) gp41" 2)
   ("HIV gp41 protein’s" 1) ("the viral gp41 protein" 1) ("GP41" 1)
   ("HIV-gp41 protein" 1) ("the virus-associated gp41" 1)
   ("virus-associated gp41" 1) ("virus associated gp41" 1) ("than wt gp41" 1)
   ("viral gp41" 1) ("the viral gp41" 1)))
 ("XFAM:PF00518.15"
  (("E6" 4736) ("E6 protein" 260) ("e6" 34) ("E6s" 29) ("E6-" 16)
   ("viral E6" 6) ("the viral oncoprotein E6" 5) ("HPV-E6 protein" 4)
   ("E6 (HPV-E6) protein" 4) ("viral oncoproteins E6" 3)
   ("viral oncoprotein E6" 3) ("E6's" 3) ("cutaneous HPV23 E6" 3)
   ("overexpressed hrHPV E6" 2) ("overexpressed HPV E6" 2) ("abrogated E6" 2)
   ("the viral proteins E6" 2)
   ("proteins adenoviral E1A and papillomavirus E6" 2) ("virally-encoded E6" 2)
   ("The viral E6 protein" 2) ("than E6" 2) ("the E6's" 2)
   ("the respective E6" 2) ("we first expressed 3 β-HPV E6" 2)
   ("human papilloma virus type 16 viral protein E6" 2) ("only HPV E6-" 1)
   ("intra-lesional E6" 1) ("the viral E6" 1) ("viral protein E6" 1)
   ("their respective E6" 1) ("their viral oncoproteins E6" 1) ("Viral E6" 1)
   ("HR α-HPV E6’s" 1) ("specifically β-HPV 5 and 8 E6" 1)
   ("the viral oncoproteins E6" 1) ("than HPV-16 E6 ( xref )" 1)
   ("The viral oncoprotein E6" 1) ("selectively and individually silence E6" 1)
   ("two viral oncoproteins HPV E6" 1) ("Viral oncoproteins HPV E6" 1)
   ("day E6.5" 1) ("The viral oncoproteins E6" 1) ("correspondingly less E6" 1)
   ("more E6" 1) ("each respective E6 protein" 1) ("Indeed HPV23 E6" 1)
   ("HIPK2 mainly targets HPV23 E6" 1) ("Viral E6 protein" 1)
   ("the absolute E6" 1) ("Additionally HPV 5 and 8 E6" 1)
   ("immortalized keratinocytes expressing HPV16 E6" 1)
   ("The two viral proteins E6" 1) ("the major viral proto-oncogene E6" 1)
   ("We first used HPV-E6" 1)
   ("stable vIL-6-expressing endothelial cells E6" 1)
   ("2 representative clones E6" 1) ("representative clones E6" 1)
   ("HPV viral E6" 1)))
 ("XFAM:PF00522.16"
  (("Vpr" 5953) ("vpr" 312) ("Vpr protein" 111) ("VPR" 58) ("Vpr’s" 24)
   ("Vpr-" 20) ("Vpr's" 18) ("soluble Vpr" 14) ("exogenous Vpr" 11)
   ("virion-associated Vpr" 5) ("-Vpr" 5) ("Vpr molecule" 4) ("Vprs" 4)
   ("HIV-1 virion-associated Vpr" 3) ("soluble extracellular Vpr" 3)
   ("exogenous recombinant Vpr" 2) ("FLAG-epitope-tagged HIV-1 Vpr" 2)
   ("VprS" 2) ("endogenously expressed proviral Vpr" 2)
   ("Hsp70 preferentially target Vpr" 2) ("less Vpr" 2)
   ("either HA-tagged sooty mangabey Vpr" 2)
   ("artificially sequestering Vpr" 2) ("targeting Vpr" 2)
   ("the viral gene vpr" 2) ("the viral proteins Vpr" 2) ("Very little Vpr" 1)
   ("at least some Vpr protein" 1) ("Exogenous Vpr" 1)
   ("residual exogenous Vpr" 1) ("the role exogenous Vpr" 1)
   ("than HIV-1 Vpr ( xref ; xref )" 1) ("NGF blocked Vpr’s" 1)
   ("blocked Vpr’s" 1) ("both virion-associated Vpr" 1)
   ("the relatively abundant virion-associated Vpr protein" 1)
   ("the HIV-1 virion-associated Vpr" 1) ("these adverse Vpr" 1) ("pVpr" 1)
   ("The human immunodeficiency virus type 1 (HIV-1) accessory gene vpr" 1)
   ("than Vpr(Q65R)" 1) ("the viral gene product Vpr" 1)
   ("soluble Vpr protein" 1) ("the virion-associated Vpr" 1)
   ("the potential Vpr's" 1) ("sooty mangabey Vpr" 1)
   ("G2 arrest-competent sooty mangabey Vpr" 1) ("than the full-length Vpr" 1)
   ("than endogenously expressed Vpr" 1) ("the enigmatic Vpr protein" 1)
   ("a likely primarily “extracellular” Vpr" 1) ("pVPR" 1)))
 ("XFAM:PF00525.16"
  (("crystallin" 174) ("crystallins" 13) ("Crystallin" 6)
   ("crystallin ( CRYZ )" 2) ("Crystallins" 2)))
 ("XFAM:PF00531" ; fixed the tradd and fadd definitions to include these synonyms
  (("death domain" 387) ("death domains" 24) ("death domain (DD)" 20)
   ("DEATH domain" 11) ("Fas-associated death domain (FADD)" 9)
   ("Death Domain" 9) ("death domain protein (FADD)" 8)
   ("death domain protein" 8) ("Fas-associated death domain protein (FADD)" 5)
   ("“death domain”" 5) ("death domain (TRADD)" 4) ("Death Domain (DD)" 4)
   ("Death Domains" 3) ("the so-called death domain" 2)
   ("TNF-receptor associated death domain (TRADD)" 2)
   ("the Fas-associated death domain protein (FADD)" 2)
   ("death domain protein (TRADD)" 2) ("death domain (TRADD) protein" 2)
   ("the TNFR-associated death domain (TRADD) protein" 2)
   ("the adaptor protein Fas-associated death domain (FADD)" 2)
   ("an atypical death domain" 2) ("death domain (RAIDD)" 2)
   ("adaptor protein Fas-associated death domain (FADD)" 2)
   ("Fas-associated death domain" 2)
   ("TNFα receptor 1–associated death domain protein" 2)
   ("TNFR-associated death domain  (TRADD)" 1)
   ("the adapter protein Fas-associated death domain (FADD)" 1)
   ("death domain protein (MADD)" 1)
   ("the adaptor protein Fas-associated death domain protein (FADD)" 1)
   ("FAS-associated death domain (FADD)" 1) ("death domain (FADD)" 1)
   ("TNFR1-associated death domain protein (TRADD)" 1)
   ("the adapter molecule Fas-associated death domain (FADD)" 1)
   ("the Fas-associated death domain (FADD) protein" 1)
   ("death domain (FADD) protein" 1)
   ("the downstream signaling adaptor molecules Fas-associated death domain (FADD)"
    1)
   ("TNF receptor-associated death domain (TRADD) protein" 1)
   ("the essential cytoplasmic death domain" 1)
   ("the adaptor molecule Fas-associated death domain protein (FADD)" 1)
   ("tumor necrosis factor receptor type 1-associated DEATH domain (TRADD)" 1)
   ("the adaptor proteins TNFRI-associated death domain (TRADD)" 1)
   ("the BH3 amphipathic α-helical death domain" 1) ("Death domain" 1)
   ("the TNFR-associated death domain protein (TRADD)" 1)))
 ("XFAM:PF00551" (("formyl transferase" 3) ("formyl transferase (GARFT)" 1)))
 ("XFAM:PF00567"
  (("Tudor domain" 245) ("Tudor domains" 83) ("tudor domains" 10)
   ("tudor domain" 6) ("Tudor domain (TD)" 3) ("Tudor domain (TTD)" 3)
   ("TUDOR domains" 1)))
 ("XFAM:PF00569" (("ZZ" 75) ("ZZ-" 1)))
 ("XFAM:PF00577.18" (("usher" 4) ("ushers" 1) ("Usher" 1)))
 ("XFAM:PF00611.21" (("FCH" 6) ("fch" 2)))
 ("XFAM:PF00612"
  (("IQ" 313) ("iQ" 8) ("IQs" 3) ("especially verbal IQ" 2) ("a Bio-Rad IQ5" 1)
   ("16 robotic system and DNA IQ" 1) ("Subnormal IQ" 1)
   ("the DAS nonverbal IQ" 1) ("IQ-" 1) ("verbal IQ" 1)
   ("low-to-normal IQs" 1)))
 ("XFAM:PF00613.18" (("PI3KA" 4) ("PI3Ka" 2)))
 ("XFAM:PF00616"
  (("GAP" 1546) ("GAPs" 510) ("GAP protein" 26) ("GAP (srGAP) family" 3)
   ("most other cells M-phase GAP" 2) ("GAP family" 2) ("“GAP”" 2)
   ("a highly-conserved GAP" 2) ("bifunctional Ras and Rap GAPs" 2) ("pGAP" 1)
   ("GAP’s" 1) ("many potential GAPs" 1) ("the catalytic arginine of GAP" 1)
   ("at least 39 TBC domain–containing Rab GAPs" 1)
   ("the GAPs capable of blocking Shiga toxin transport" 1)
   ("at least six different Rabs and Rab GAPs" 1) ("the respective GAP" 1)
   ("a few GAPs" 1)))
 ("XFAM:PF00620"
  (("RhoGAP" 529) ("RhoGAPs" 54) ("RhoGAP protein" 18) ("RhoGAP family" 5)
   ("rhoGAP protein" 3) ("rhoGAP" 2) ("than 80 RhoGAPs" 1) ("RhoGap" 1)
   ("The RhoGAP's" 1)))
 ("XFAM:PF00658.16" (("PABP" 101) ("PABPs" 3)))
 #+ignore("XFAM:PF00661.19" ; removed matrix/matrices
  (("matrix" 8639) ("matrices" 1284) ("Matrix" 608) ("BD" 209)
   ("matrix protein" 126) ("matrixes" 43) ("Matrices" 26) ("matrix (ECM)" 19)
   ("matrix (PWM)" 15) ("matrix (PSSM)" 12) ("matrices (ECM)" 9)
   ("the nucleolar matrix" 7) ("matrix (MA)" 7) ("the interstitial matrix" 6)
   ("nucleolar matrix" 6) ("matrixes (PWM)" 6) ("Progressive Matrices" 6)
   ("matrix protein (MA)" 5) ("a three-dimensional collagen matrix" 5)
   ("a three-dimensional matrix" 5) ("a provisional matrix" 5)
   ("matrix (M) protein" 5) ("three-dimensional matrices" 5) ("Matrix (SAM)" 5)
   ("“matrix”" 4) ("the insoluble matrix" 4) ("insoluble matrix" 4)
   ("a fibrous matrix" 4) ("matrix-" 4) ("Matrix (BD)" 4)
   ("the fluorescent gelatin matrix" 4) ("the stable collagenous matrix" 4)
   ("the provisional matrix" 4) ("Matrix (PSFM)" 4) ("HPC" 4)
   ("polymerized collagen matrix" 4) ("a compliant matrix" 4)
   ("a soluble matrix protein" 3) ("the pericentriolar matrix" 3)
   ("matrix (CDM)" 3) ("matrices (CDM)" 3) ("matrix (GDM)" 3)
   ("pre-assembled matrix" 3) ("dense matrix" 3) ("a 2-dimensional matrix" 3)
   ("matrices (PWM)" 3) ("Matrix (PWM)" 3) ("the submesothelial matrix" 3)
   ("fluorescent gelatin matrix" 3) ("our late 3D matrices" 3)
   ("programming matrix" 3) ("collagenous matrix" 3)
   ("Standard Progressive Matrices" 3) ("rigid matrices" 3)
   ("its organic matrix" 3) ("most matrices" 3) ("a provisional ECM matrix" 3)
   ("the collagenous matrix" 2) ("pathology-associated matrix" 2)
   ("all time points together, data matrices" 2) ("sparse matrix" 2)
   ("three-dimensional collagen matrices" 2)
   ("4.6 Cell culture/cell made matrix" 2) ("Cell made matrix" 2)
   ("biological matrices" 2) ("cell made matrix" 2)
   ("two universal array matrices" 2) ("the mesangial matrix" 2)
   ("the ventral undersurface “matrix”" 2) ("traditional matrices" 2)
   ("invasive matrix" 2) ("the extracellular lamellar lipid–protein matrix" 2)
   ("Matrix-" 2) ("Pre-assembled Fibronectin Matrix" 2)
   ("pre-assembled fibronectin matrices" 2)
   ("pre-assembled fibronectin matrix" 2) ("a robust fibronectin matrix" 2)
   ("ectracellular matrix" 2) ("A numerical matrix" 2) ("matrices (PSWM)" 2)
   ("the online TCGA data matrix" 2) ("excellular matrix" 2) ("matrix (PCM)" 2)
   ("a three-dimensional collagen-1 matrix" 2) ("the nigral matrix" 2)
   ("a diagonal matrix" 2) ("more matrix" 2) ("the subjacent stromal matrix" 2)
   ("mature Gag proteins p17 matrix (MA)" 2) ("the stress-released matrix" 2)
   ("mesangial matrix" 2) ("a rigid matrix" 2)
   ("a floating three-dimensional (3D) collagen matrix" 2)
   ("the interstitial collagen-rich submesothelial matrix" 2)
   ("subendothelial matrix" 2) ("late stage stromal matrices" 2)
   ("matrix molecule (MSCRAMM)" 2) ("matrix (OCT)" 2)
   ("three-dimensional (3D) collagen matrices" 2)
   ("the connective tissue matrix" 2) ("matrices (DCCM)" 2)
   ("the membrane-associated matrix (MA) protein" 2) ("matrix molecule" 2)
   ("a more fibrous matrix" 2) ("the available matrix" 2)
   ("3-dimensional matrices" 2) ("a loose connective tissue matrix" 2)
   ("a mechanically rigid matrix" 2) ("a translucent matrix" 2)
   ("subsequent matrix" 2) ("three-dimensional extracellular matrices" 2)
   ("a fibrillar matrix" 2) ("positional weight matrices" 2)
   ("a genome-wide identity-by-state (IBS) matrix" 2)
   ("in vivo mesenchymal matrices" 2) ("matrix (AF2240-M) protein" 2)
   ("periportal fibrotic matrix" 2) ("a bony matrix" 2) ("‘matrix'" 2)
   ("a generic job-exposure matrix" 2)
   ("a positional frequency matrix (PFM)" 2) ("matrix (PFM)" 2)
   ("a binary adjacency matrix" 2) ("a binary matrix" 2) ("soft matrices" 2)
   ("ultra-low attachment matrix" 2) ("matrices (PSSM)" 2)
   ("Three-dimensional polymerized collagen matrices" 2)
   ("both compliant and rigid matrices" 2)
   ("an ill-defined basement membrane matrix" 2)
   ("exogenous basement membrane matrix" 2)
   ("polymerized collagen or three-dimensional matrices" 1)
   ("the established collagenous matrix" 1) ("MATRIX" 1)
   ("the three-dimensional gel matrix" 1) ("the macromolecular matrix" 1)
   ("underlying interstitial matrix" 1) ("A genome-wide matrix" 1)
   ("an adequate matrix" 1) ("the endometrial cell matrix" 1)
   ("a fibrillar collagen matrix" 1) ("profuse FN matrix" 1)
   ("fibrillar matrices" 1) ("Improper matrix" 1)
   ("the all-atom mass-weighted covariance matrix" 1)
   ("anti-Myc monoclonal antibodies and anti-HA affinity matrix" 1)
   ("the cell made matrix" 1) ("treated and untreated matrix" 1)
   ("a robust Fn matrix" 1) ("native cell made matrix" 1)
   ("a
 three-dimensional collagen matrix"
    1)
   ("the dermal or provisional matrix" 1)
   ("thicker trabecular bone matrices" 1) ("the lamellar lipid matrix" 1)
   ("a lamellar lipid–protein matrix" 1) ("the provisional bone matrix" 1)
   ("the typical matrices" 1)
   ("three-dimensional (3D) extracellular matrices" 1) ("Nucleolar matrix" 1)
   ("pre-assembled matrices" 1) ("the pre-assembled matrix" 1)
   ("fluorescently labeled pre-assembled fibronectin matrices" 1)
   ("a visible matrix" 1) ("The pair-wise correlation matrix" 1)
   ("matrix degrading metalloproteases's (MMP)" 1)
   ("the mass-weighted Hessian matrix" 1)
   ("a 2-dimensional gene-patient tumor sample association matrix" 1)
   ("a 100 µM-thick collagen matrix" 1) ("myxocollagenous(n=7) matrix" 1)
   ("abundant Alcian blue–positive mucinous matrix" 1)
   ("an abundant Alcian blue–positive matrix" 1)
   ("an abundant mucinous matrix Image 1A" 1) ("a polymeric matrix" 1)
   ("these predictive scoring matrices" 1) ("Diagonal covariance matrices" 1)
   ("the positional weight matrices" 1) ("nigral matrix" 1)
   ("extracellular connective tissue matrices (ECM)" 1)
   ("a secretive matrix protein" 1) ("sparse weighted adjacency matrices" 1)
   ("a laminin-rich fibrillar matrix" 1) ("this biological matrix" 1)
   ("the subendothelial matrix" 1) ("vehicle-treated matrices" 1)
   ("stress-released matrices" 1) ("the LY294002-treated released matrix" 1)
   ("the nested stress-released matrix" 1) ("a stress-released matrix" 1)
   ("the stress-released 3D collagen matrix" 1) ("DOC insoluble matrix" 1)
   ("–matrix" 1) ("a rigid or dense collagen matrix" 1) ("a flexible matrix" 1)
   ("flexible matrices" 1) ("collagenous matrices" 1) ("the organic matrix" 1)
   ("a provisional fibrin–fibronectin matrix" 1)
   ("3-dimensional collagen matrix" 1) ("late 3D matrices" 1)
   ("tumor-associated matrices" 1) ("tumor-associated 3D matrices" 1)
   ("Resultant 3D matrices" 1) ("the resultant \"late\" matrices" 1)
   ("self-derived 3D matrices" 1)
   ("Early and late three-dimensional matrices" 1)
   ("3-dimensional basement membrane matrix" 1)
   ("BBK32 or anastellin treated matrices" 1) ("matrices (MEEC)" 1)
   ("extracelluar matrices" 1) ("both cell-extra cellular matrix" 1)
   ("dense matrices" 1) ("the insoluble DNA matrix" 1)
   ("freshly made α-CHCA matrix" 1) ("the collagenous matrices" 1)
   ("overnight using anti-HA affinity matrix" 1) ("provisional matrix" 1)
   ("the Jacobian matrix" 1) ("matrix (MA) protein" 1)
   ("than one matrix molecule" 1) ("sparse transition matrices" 1)
   ("heavily cross-linked interstitial matrix" 1)
   ("highly cross-linked interstitial matrix" 1) ("fibrous matrix" 1)
   ("a less dense matrix" 1) ("the composite LD correlation matrix" 1)
   ("a numerical data matrix" 1) ("progressive matrix" 1)
   ("pathophysiological matrix" 1) ("matrix (IBA)" 1) ("flexible matrix" 1)
   ("three-dimensional collagen-I matrix" 1) ("peroxisomal matrix protein" 1)
   ("the peroxisomal matrix" 1) ("a peroxisomal matrix protein" 1)
   ("the basic matrix" 1) ("the host germinal matrix" 1)
   ("associated DNA binding site position weight matrices" 1)
   ("positional frequency matrices" 1) ("a symmetric weight matrix" 1)
   ("fluorescently-labeled fibronectin/gelatin matrix" 1)
   ("other glomeruli mesangial matrix" 1) ("Mesangial matrix" 1)
   ("the intercellular matrix" 1) ("the subjacent matrix" 1)
   ("homogenization (decoupling of proteins from nucleic acids) insoluble matrix"
    1)
   ("robust extracellular FN matrix" 1) ("near-physiological matrices" 1)
   ("than normal matrix" 1) ("than matrices derived from Cav1KO fibroblast" 1)
   ("matrix (BD)" 1) ("the cell-associated matrix" 1)
   ("swollen and pale matrix" 1) ("more rigid matrices" 1)
   ("a complex fibrous matrix" 1) ("96-well flat-bottom Matrix" 1)
   ("the cartilaginous matrix" 1) ("the Hessian matrix" 1)
   ("the viral matrix (MA)" 1) ("a three-dimensional (3D) matrix" 1)
   ("pericentriolar matrix (PCM)" 1) ("the pericentriolar matrix (PCM)" 1)
   ("the spindle pole–specific pericentriolar matrix" 1)
   ("larger expression matrix" 1) ("a mouse coronal brain matrix" 1)
   ("an artificial collagen matrix" 1) ("cortactin-positive matrix" 1)
   ("degraded fluorescent gelatin matrix" 1) ("a fibrous collagen matrix" 1)
   ("poly-Lys-coated matrices" 1) ("Only two matrices" 1) ("viral matrix" 1)
   ("a non-directional adjacency matrix" 1) ("all symmetric matrices" 1)
   ("the granulomatous matrix" 1) ("the principal matrix protein" 1)
   ("a 3-dimensional matrix" 1) ("a 3-dimensional Matrigel matrix" 1)
   ("much less matrix" 1) ("DOC-insoluble fibronectin matrix" 1)
   ("diagonal variance matrix" 1) ("Spectral compensation matrices" 1)
   ("a PAS-positive matrix" 1) ("pathological matrix" 1)
   ("the optimal sieving matrix" 1) ("cell-extra-cellular matrix" 1)
   ("3D fibrillar collagen matrices" 1) ("a capillary matrix" 1)
   ("a physiologically relevant matrix" 1)
   ("polymerized type I collagen matrices" 1)
   ("polymerized collagen matrices" 1)
   ("the type I collagen-rich fibrotic matrix" 1)
   ("both compliant and rigid collagen matrices" 1)
   ("three-dimensional (3D) matrices" 1)))
 #+ignore("XFAM:PF00668.18" ; removed condensation
  (("condensation" 1675) ("condensations" 40) ("Condensation" 32)
   ("premature chromatin condensation" 7) ("mitotic chromosome condensation" 7)
   ("mesenchymal condensation" 7) ("premature chromosome condensation (PCC)" 7)
   ("premature chromosome condensation" 6) ("condensation (PCC)" 6)
   ("mitotic condensation" 5) ("mitotic chromatin condensation" 3)
   ("subsequent chromatin condensation" 2) ("mesenchymal cell condensation" 2)
   ("the lateral condensation" 2) ("Premature chromatin condensation" 2)
   ("typical nuclear condensation" 2)
   ("the apoptosis-associated chromatin condensation" 2)
   ("characteristic chromatin condensation" 2)
   ("premature chromosomes condensation" 2)
   ("preceded TNF/CHX-induced nuclear condensation" 2)
   ("premature condensation" 1) ("cells showed nuclear condensation" 1)
   ("The latter highlighting increased chromatin condensation" 1)
   ("the pipette-mediated cell deformation caused chromatin condensation" 1)
   ("condensation (CC)" 1) ("the characteristic DNA condensation" 1)
   ("embryonic mesenchymal condensation" 1) ("e.g. chromosome condensation" 1)
   ("e.g. nuclear condensations" 1) ("Mesenchymal condensation" 1)
   ("improper DNA condensation" 1) ("premature chromatin condensation (PCC)" 1)
   ("attached cells showed frequent DNA condensation" 1)
   ("mitosis showed normal chromosome condensation" 1)
   ("mesenchymal condensations" 1)
   ("BGLF4-induced premature chromosome condensation" 1)
   ("visible chromatin condensation" 1) ("marginal chromatin condensation" 1)
   ("mitotic chromosomal condensation" 1) ("dense chromatin condensation" 1)
   ("preceded chromatin condensation" 1)))
 ("XFAM:PF00680"
  (("RNA-dependent RNA polymerase" 24) ("RNA-dependent RNA polymerases" 2)))
 ("XFAM:PF00691" (("OMPA" 39)))
 ("XFAM:PF00691.18" (("OmpA" 19) ("OmpA protein" 5)))
 ("XFAM:PF00747"
  (("ssDNA binding" 99) ("ssDNA-binding" 69) ("ssDNA binding protein" 19)
   ("ssDNA-binding protein" 12)
   ("ssDNA
binding protein"
    2)
   ("yet displays significantly reduced ssDNA binding" 2)
   ("ssDNA
binding"
    1)))
 ("XFAM:PF00775" (("dioxygenases" 18) ("dioxygenase" 12)))
 ("XFAM:PF00788"
  (("rheumatoid arthritis" 646) ("Rheumatoid arthritis" 59)
   ("Rheumatoid Arthritis" 42) ("EIRA" 40) ("rheumatoid arthritis (RA)" 11)
   ("Ras association (RalGDS/AF-6) domain" 11) ("Rheumatoid Arthritis (RA)" 2)
   ("seronegative rheumatoid arthritis" 1)
   ("rheumatoid
 arthritis"
    1)
   ("severe juvenile rheumatoid arthritis" 1)))
 ("XFAM:PF00791.18" (("ZU5" 1)))
 ("XFAM:PF00800"
  (("photodynamic therapy" 16) ("Photodynamic therapy" 3)
   ("photodynamic
therapy"
    1)))
 ("XFAM:PF00803"
  (("3A" 882) ("3a" 324) ("-3A" 14) ("3A protein" 8) ("-3a" 7)
   ("non-phosphorylatable NDR1 3A" 2) ("3AS" 1) ("−3A" 1) ("3aS" 1)
   ("Full-length Y47D3A" 1) ("Q9U2C5/ Y47D3A" 1) ("poliovirus 3A’s" 1)
   ("hepatitis A virus 3A" 1) ("enteroviral 3A" 1)))
 ("XFAM:PF00804"
  (("syntaxin" 14) ("Syntaxin" 3) ("syntaxins" 2) ("Syntaxins" 1)))
 ("XFAM:PF00817.18" (("IMS" 29))) ("XFAM:PF00823.17" (("PPE" 20)))
 ("XFAM:PF00846"
  (("hantavirus nucleocapsid protein" 7) ("hantavirus nucleocapsid" 7)
   ("Hantavirus nucleocapsid" 4)))
 ("XFAM:PF00847" (("aP2" 44) ("the adipogenic markers aP2" 1)))
 ("XFAM:PF00853"
  (("Runt domain" 31) ("Runt domains" 11) ("runt domain" 7)
   ("Runt domain (RD)" 1) ("RUNT domain" 1)))
 ("XFAM:PF00855" (("WWP" 9) ("pWWP" 4)))
 ("XFAM:PF00858.22"
  (("ASC" 428) ("ASc" 2) ("ASC (PYCARD)" 2) ("human subcutaneous ASC" 1)
   ("multipotent ASC" 1) ("AS-C" 1) ("fluorescent ASC" 1)))
 ("XFAM:PF00902" (("TatC" 3)))
 ("XFAM:PF00936"
  (("BMC" 58) ("BMCs" 4) ("higher lumbar spine BMC" 3) ("regional BMC" 3)
   ("regional or whole body BMC" 1) ("Regional BMC" 1) ("femoral neck BMC" 1)
   ("cortical BMC" 1)))
 ("XFAM:PF00940"
  (("DNA-dependent RNA polymerase" 5) ("DNA-dependent RNA polymerases" 3)))
 ("XFAM:PF00956.16" (("NAP" 10) ("NAPs" 3)))
 ("XFAM:PF00965"
  (("tissue inhibitor of metalloproteinase" 33)
   ("tissue inhibitor of metalloproteinase (TIMP)" 7)
   ("Tissue inhibitor of metalloproteinase" 6)
   ("Tissue inhibitor of metalloproteinase (TIMP)" 1)
   ("tissue inhibitor of metalloproteinase-" 1)))
 ("XFAM:PF00995.21" (("Sec1" 2)))
 ("XFAM:PF00996"
  (("GDP dissociation inhibitors" 22) ("GDP dissociation inhibitor" 7)
   ("GDP dissociation inhibitor (GDI)" 5) ("GDP Dissociation Inhibitor" 4)))
 ("XFAM:PF01007.18" (("IRK" 9) ("pIRK" 6)))
 ("XFAM:PF01012" (("ETF" 14) ("Etf" 1)))
 ("XFAM:PF01086"
  (("clathrin light chain" 11) ("clathrin light chains" 3)
   ("Clathrin light chain" 2)))
 ("XFAM:PF01092.17" (("S6e" 1)))
 ("XFAM:PF01102"
  (("glycophorin A" 31) ("Glycophorin A" 8) ("Glycophorin A (GPA)" 1)))
 ("XFAM:PF01103"
  (("surface antigens" 75) ("surface antigen" 67) ("surface antigen (ESA)" 1)))
 ("XFAM:PF01107" (("MPs" 39) ("mP" 10)))
 ("XFAM:PF01126" (("Heme oxygenase" 15) ("Heme oxygenases" 2)))
 ("XFAM:PF01131" (("DNA Topoisomerase" 3))) ("XFAM:PF01135.17" (("PCMT" 191)))
 ("XFAM:PF01152"
  (("globin" 178) ("-globin" 37) ("Globin" 20) ("globins" 5)
   ("-globin protein" 4) ("GLOBIN" 3) ("a specific nervous system globin" 2)
   ("globin ( HBG )" 1)))
 ("XFAM:PF01161"
  (("phosphatidylethanolamine-binding" 15)
   ("phosphatidylethanolamine-binding protein (PEBP)" 5)
   ("Phosphatidylethanolamine-binding" 4)
   ("Phosphatidylethanolamine-binding protein" 4)
   ("phosphatidylethanolamine-binding protein" 3)))
 ("XFAM:PF01187"
  (("macrophage migration inhibitory factor (MIF)" 11)
   ("Macrophage migration inhibitory factor (MIF)" 3)))
 ("XFAM:PF01207" (("dUs" 2)))
 ("XFAM:PF01230"
  (("HIT" 75) ("pHIT" 10)
   ("the two consecutive prospective multicenter trials HIT" 1)))
 ("XFAM:PF01237" (("oxysterol binding" 1)))
 ("XFAM:PF01250"
  (("Ribosomal protein S6" 13) ("Ribosomal Protein S6" 2)
   ("ribosomal protein s6" 1)))
 ("XFAM:PF01285.16" (("TEA" 75) ("Tea" 4) ("TEA-" 1)))
 ("XFAM:PF01293"
  (("phosphoenolpyruvate carboxykinase" 18)
   ("phosphoenolpyruvate carboxykinase (PEPCK)" 2)
   ("the essential gluconeogenic enzymes phosphoenolpyruvate carboxykinase (PEPCK)"
    1)
   ("the key gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK)"
    1)))
 ("XFAM:PF01300" (("telomere recombination" 46)))
 ("XFAM:PF01335"
  (("death effector domain" 79) ("death effector domains" 36)
   ("death effector domain (DED)" 14) ("death effector domains (DED)" 3)
   ("death effector domain (DED) protein" 3)
   ("death effector domains (DEDs) family" 2)
   ("the so-called death effector domain (DED)" 2)
   ("death effector domain (DED)" 1)))
 ("XFAM:PF01352.25" (("KRAB" 72) ("KRAB-" 3)))
 ("XFAM:PF01369"
  (("Sec7 domain" 139) ("Sec7 domains" 24) ("Sec7 domain protein" 4)))
 ("XFAM:PF01390"
  (("Sea" 22) ("the Caspian Sea" 4)
   ("the eastern and western Mediterranean Sea" 1)))
 ("XFAM:PF01390.18" (("SEA" 135)))
 ("XFAM:PF01398.19" (("JAMM" 23) ("JAB" 7) ("JAMM family" 2) ("JAMMs" 1)))
 ("XFAM:PF01403.17"
  (("Sema" 123) ("sema" 12) ("SEMAs" 7) ("SEMA" 5) ("Sema family" 2)))
 ("XFAM:PF01413"
  (("C4" 498) ("c4" 21) ("-C4" 3) ("dihedral angles C4" 1)
   ("preparative C4" 1)))
 #+ignore("XFAM:PF01423" ; changed to LSm because that's correct for the protein -- added "LSM for the microscope
  (("LSM" 1447) ("a confocal microscope LSM" 2)
   ("a Zeiss Confocal Laser Microscope LSM" 2)
   ("a Zeiss confocal microscope LSM" 2)
   ("a confocal laser-scanning microscope LSM" 2) ("a confocal LSM" 2)
   ("a Zeiss confocal LSM" 2) ("confocal microscope LSM510" 1)
   ("a confocal microscope LSM510" 1) ("a Leica confocal LSM" 1)
   ("confocal LSM" 1) ("Confocal Microscope LSM" 1) ("than LSM" 1)
   ("confocal microscope Zeiss LSM" 1)
   ("a Leica confocal
LSM"
    1)))
 ("XFAM:PF01452" (("Rotavirus non-structural" 1)))
 ("XFAM:PF01454" (("MAGE family" 38)))
 ("XFAM:PF01454.17"
  (("MAGE" 378) ("MAGEs" 66) ("Mage" 6) ("the TRIM28-associated MAGEs" 5)
   ("the related TRIM28-associated MAGE" 2) ("the type II ubiquitous MAGEs" 2)
   ("cancer-testis antigen and type II ubiquitous MAGEs" 1)
   ("typically bound at least two different MAGEs" 1)))
 ("XFAM:PF01472.18" (("PUA" 9) ("pUAS" 2)))
 ("XFAM:PF01496.17" (("V-ATPase" 26) ("V-ATPases" 2)))
 ("XFAM:PF01535.18" (("PPR" 27)))
 ("XFAM:PF01542"
  (("Hepatitis C virus core protein" 3) ("Hepatitis C virus core" 2)
   ("hepatitis C virus core protein" 1) ("hepatitis C virus core" 1)))
 ("XFAM:PF01554" ;removed mate
  (#|("mate" 101) ("mates" 52) ("Mate" 29) ("mates (FVB)" 4)
   ("at least 10 fusion mates" 2)
   ("the pre-transformed Y187/pACT2 normalized universal human Mate" 1)
|#   
("MATE" 1)
   ("than their wild type litter mates which would agree with ASPP2 contributing"
    1)
   ("at least 10 different mate" 1) ("than control litter mates [ xref ]" 1)))
 ("XFAM:PF01581.14" (("Farps" 1))) ("XFAM:PF01582.18" (("TIR" 83) ("TIRs" 11)))
 ("XFAM:PF01585.21" (("G-patch" 1)))
 ("XFAM:PF01603"
  (("B56" 97) ("B56 family" 8) ("B56s" 3) ("overexpressed B56 protein" 3)
   ("B56 protein" 2) ("-B56γ3" 1)))
 ("XFAM:PF01612" (("3’–5’ exonuclease" 3) ("3'-5' exonuclease" 1)))
 ("XFAM:PF01627.21" (("HPT" 56) ("pHPT" 35) ("hpt" 12)))
 ("XFAM:PF01634.16" (("HisG" 12) ("hisG" 1)))
 ("XFAM:PF01636.21" (("APH" 183) ("Aph" 9) ("aPH" 1)))
 ("XFAM:PF01652"
  (("eukaryotic initiation factor 4E" 172)
   ("Eukaryotic initiation factor 4E" 9) ("Eukaryotic Initiation Factor 4E" 2)
   ("the latter negatively regulating eukaryotic initiation factor 4E" 2)
   ("eukaryotic initiation factor 4e" 1)))
 ("XFAM:PF01666" (("Dx" 78) ("DX" 53)))
 ("XFAM:PF01683"
  (("EBs" 346) ("chlamydial EBs" 6) ("infectious EBs" 4) ("external EBs" 2)
   ("eB" 2) ("−EBs" 2) ("total cell-associated EBs" 1)
   ("the total cell-associated EBs" 1)
   ("internalized EBs/total cell-associated EBs" 1) ("around EBs" 1)
   ("Chlamydial EBs" 1) ("drug-treated EBs" 1) ("the chlamydial EBs" 1)
   ("Secondary EBs" 1)))
 ("XFAM:PF01694.20" (("rhomboid" 14)))
 ("XFAM:PF01705"
  (("CX" 350) ("Cx" 98) ("CX (9–39) CX" 7) ("-CX" 2) ("than Cx" 1)
   ("the consensus sequence Cx2Cx(9–39)Cx(1–3)Hx(2–3)Cx2Cx(4–48)Cx2C" 1)
   ("the signature RING motif CX 2 CX (9–39) CX (1–3) HX (2–3) C/HX 2 CX (4–48) CX 2 C"
    1)
   ("Cx-" 1)))
 ("XFAM:PF01749.18" (("IBB" 21))) ("XFAM:PF01758.14" (("SBF" 9)))
 ("XFAM:PF01770" (("reduced folate carrier" 12) ("Reduced folate carrier" 1)))
 ("XFAM:PF01782" (("Rimm" 8))) ("XFAM:PF01844.21" (("HNH" 6)))
 ("XFAM:PF01846" (("FF" 248) ("–FF" 1) ("fFS" 1) ("the program FF120" 1)))
 ("XFAM:PF01870.16" (("HJC" 5) ("HJCS" 2) ("Hjc" 1) ("hjc" 1)))
 ("XFAM:PF01877"
  (("RNA-binding" 345) ("RNA-binding protein" 139) ("RNA-Binding" 15)
   ("RNA-Binding Protein" 8) ("RNA–binding" 7) ("RNA–binding protein" 5)
   ("RNA-binding peptide" 2) ("a multifunctional RNA-binding protein" 2)
   ("RNA-binding protein (TRBP)" 2) ("RNA-binding protein (RBP)" 2)
   ("another well-conserved RNA-binding protein" 1)
   ("a neuronal-specific RNA-binding protein" 1)))
 ("XFAM:PF01878" (("Eves" 1) ("Eve" 1)))
 ("XFAM:PF01888.15"
  (("cBid" 127) ("cBID" 24) ("cBID protein" 1) ("less cBid" 1)))
 ("XFAM:PF02002.15" (("TFIIE" 29))) ("XFAM:PF02005" (("TRM" 57)))
 ("XFAM:PF02014.14" (("reeler" 13))) ("XFAM:PF02019.16" (("WIF" 14)))
 ("XFAM:PF02020"
  (("W2" 93) ("Clustal W2" 2) ("the intramolecularly packed W2's" 1)))
 ("XFAM:PF02026" (("RyRs" 42)))
 ("XFAM:PF02026.14" (("RyR" 101) ("RyRs" 68) ("RyR protein" 2) ("RyR–" 1)))
 ("XFAM:PF02044" (("BBS" 215) ("BBS family" 4) ("BBS-" 3) ("BBS peptide" 2)))
 ("XFAM:PF02082"
  (("transcriptional regulator" 974) ("transcriptional regulators" 642)
   ("APTR" 204) ("Transcriptional Regulators" 10)
   ("Transcriptional regulators" 9) ("transcriptional regulator ( APTR )" 7)
   ("exogenous APTR" 4)
   ("transcriptional
 regulators"
    3)
   ("a global transcriptional regulator" 3)
   ("A few transcriptional regulators" 3)
   ("the Th17 lineage–specific transcriptional regulator" 2)
   ("exogenous full length APTR" 2) ("exogenous sense-strand APTR" 2)
   ("putative HCF-1-associated transcriptional regulators" 2)
   ("a potential transcriptional regulator" 2)
   ("viral transcriptional regulator" 2)
   ("possible transcriptional regulators" 2)
   ("the predominant transcriptional regulators" 2)
   ("transcriptional
                regulator"
    2)
   ("previously identified hTERT transcriptional regulators" 1)
   ("whose downstream transcriptional regulators" 1) ("The exogenous APTR" 1)
   ("a vital transcriptional regulator" 1)
   ("most transcriptional regulators" 1)
   ("potentially other transcriptional regulators" 1)
   ("viral transcriptional regulators" 1)
   ("potential common transcriptional regulators" 1)
   ("than one transcriptional regulator" 1)
   ("the actual transcriptional regulators" 1)
   ("sophisticated pleiotrophic transcriptional regulators" 1)
   ("these protooncogenic transcriptional regulators" 1)
   ("a multifunctional transcriptional regulator" 1)
   ("regulatory circuits around transcriptional regulators" 1)
   ("a sequence-specific transcriptional regulator" 1)
   ("“transcriptional regulators”" 1)
   ("Classic transcriptional regulators" 1)))
 ("XFAM:PF02099.15" (("Josephin" 3) ("Josephins" 3)))
 ("XFAM:PF02106.13"
  (("Fanconi" 63) ("Fanconi's" 2) ("the Fanconi's" 1) ("Fanconi’s" 1)
   ("a hemolytic anemia called Fanconi's" 1)
   ("a hemolytic anemia called Fanconi" 1) ("Fanconi C" 1)))
 ("XFAM:PF02138" (("Beach" 40)))
 ("XFAM:PF02146.15"
  (("Sir2" 561) ("SIR2" 111) ("Sir2 protein" 21) ("SIR2 family" 12)
   ("Sir2 family" 10) ("SIR-2" 8) ("siR2" 4)
   ("Sir2 ( s ilent i nformation r egulator 2) family" 3) ("SIR2 protein" 3)
   ("Sir2 (silent information regulator 2) family" 3) ("bacterial Sir2" 2)
   ("Sir2 (Silent Information Regulator-2) family" 2)
   ("so-called SIR2 family" 2) ("Thermotoga maritime Sir2" 2)
   ("the bacterial class III member Sir2" 1)))
 ("XFAM:PF02155.13" (("GCRs" 86) ("GCR" 14)))
 ("XFAM:PF02159"
  (("oestrogen receptor" 387) ("Oestrogen receptor" 53)
   ("oestrogen receptors" 30) ("oestrogen receptor (ER)" 15)
   ("Oestrogen receptor-" 7) ("Oestrogen receptors" 5) ("Oestrogen Receptor" 4)
   ("oestrogen receptor-" 4) ("oestrogen receptors (ER)" 4)
   ("the hormonal receptor oestrogen receptor" 2)
   ("the classical oestrogen receptors" 2)
   ("the classic oestrogen receptors" 2) ("than oestrogen receptor" 1)
   ("than oestrogen receptor (ER)" 1) ("Oestrogen receptor (ER)" 1)))
 ("XFAM:PF02175.14" (("SRB" 279)))
 ("XFAM:PF02180"
  (("BH4" 329) ("BH4 peptide" 7) ("a noncanonical anti-apoptotic BH4" 1)
   ("the α-helical BH4 peptide" 1)))
 ("XFAM:PF02185.14" (("HR1" 23)))
 ("XFAM:PF02188" (("GoLoco motif" 38) ("GoLoco motifs" 7)))
 ("XFAM:PF02194.13"
  (("PXA" 307) ("PXAs" 68) ("5 treated adult recurrent or progressive PXAs" 2)
   ("BRAF V600E-positive PXAs" 2) ("the 12 BRAF V600E-positive grade II PXA" 2)
   ("BRAF V600E-positive PXA" 2) ("more PXA" 1)
   ("the BRAF V600E-positive grade II PXAs" 1)
   ("the remaining four BRAF V600E-positive PXA" 1)
   ("the BRAF V600E-positive PXA" 1) ("unequivocal grade II PXA" 1)
   ("differentiating less aggressive PXAs" 1) ("classic low grade PXA" 1)))
 ("XFAM:PF02205.18" (("WH2" 7)))
 ("XFAM:PF02234"
  (("cyclin dependent kinase inhibitor" 46)
   ("cyclin dependent kinase inhibitors" 35)
   ("Cyclin-dependent kinase inhibitor" 31)
   ("Cyclin-Dependent Kinase inhibitor" 8)
   ("Cyclin-dependent kinase inhibitors" 5)
   ("cyclin dependent kinase inhibitor (CDKI)" 3)
   ("cyclin dependent
kinase inhibitor"
    2)
   ("cyclin dependent
kinase inhibitors"
    1)
   ("Cyclin dependent kinase inhibitor" 1)))
 ("XFAM:PF02246"
  (("viral oncogene" 289) ("viral oncogenes" 71) ("viral oncogene ( KRAS)" 8)
   ("viral oncogene (MYC)" 2) ("a pivotal viral oncogene" 1)
   ("viral
                            oncogenes"
    1)
   ("Viral oncogene" 1) ("this unusual viral oncogene" 1)
   ("selectively targets viral oncogenes" 1)
   ("significantly more often Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene ( KRAS)"
    1)
   ("Viral oncogenes" 1)
   ("v-erb-b2 erythroblastic leukaemia viral oncogene" 1)))
 ("XFAM:PF02267" (("ADP-ribosyl cyclase" 14)))
 ("XFAM:PF02273" (("acyl transferase" 21) ("acyl transferase (LCAT)" 3)))
 ("XFAM:PF02277"
  (("phosphoribosyltransferase" 47) ("phosphoribosyltransferase (HPRT)" 11)
   ("Phosphoribosyltransferase" 4) ("phosphoribosyltransferase ( HPRT )" 3)
   ("nicotinic acid phosphoribosyltransferase" 2)
   ("phosphoribosyltransferase (OPRT)" 1)
   ("phosphoribosyltransferase (NAMPT)" 1)
   ("Phosphoribosyltransferase (HPRT)" 1)))
 ("XFAM:PF02338.17"
  (("OTU" 22) ("OTUs" 4) ("The catalytic cysteine of OTU" 1)))
 ("XFAM:PF02348" (("cytidylyltransferase" 4)))
 ("XFAM:PF02365.13" (("NAM" 651) ("NAm" 6) ("Nam" 2)))
 ("XFAM:PF02366.16" (("PMT" 46) ("pMTS" 12) ("PMTs" 4) ("3 internal PMT" 1)))
 ("XFAM:PF02375.15" (("JmjN" 7))) ("XFAM:PF02376" (("Cut" 74)))
 ("XFAM:PF02377.13"
  (("Dvl" 179) ("DVL" 117) ("Dishevelled" 93) ("dishevelled" 55)
   ("dishevelled (Dsh) protein" 9) ("Dvl protein" 9) ("Dishevelled protein" 7)
   ("Dvls" 6) ("DVLs" 5) ("dishevelled protein" 4) ("Dishevelled (DVL)" 4)
   ("Dvl family" 4) ("Dishevelled (Dsh/Dvl) family" 3)
   ("Dishevelled (Dvl) protein" 3) ("dvl" 1) ("DISHEVELLED" 1)))
 ("XFAM:PF02382" (("RTX" 61)))
 ("XFAM:PF02434.14"
  (("Fringe" 51) ("fringe" 4) ("Lunatic Fringe" 4) ("Fringe family" 3)
   ("termed Lunatic Fringe" 1) ("quite uniform fringe" 1)))
 ("XFAM:PF02441.17"
  (("flavoprotein" 24)
   ("a relatively small (106 amino acids) fluorescent flavoprotein" 2)
   ("flavoproteins" 2)))
 ("XFAM:PF02458"
  (("transferase" 1520) ("transferases" 303) ("-transferase" 264)
   ("-transferase (GST)" 97) ("Transferase" 66) ("transferase (OGT)" 29)
   ("-transferases" 28) ("transferase (HAT)" 27) ("Transferases" 27)
   ("transferase (HPRT)" 14) ("transferase (CAT)" 9) ("Transferase (SSAT)" 8)
   ("Transferase (HHAT)" 7) ("-transferases (GST)" 7)
   ("Cell-permeable C3 transferase" 6) ("transferase (OPRT)" 6)
   ("transferase (TDT)" 6) ("cell permeable C3 transferase" 4)
   ("transferase (HGPRT)" 4) ("Transferase (MGMT)" 4)
   ("transferase ( COMT )" 3) ("transferases (DNMT)" 3)
   ("transferase (MGMT)" 3) ("Transferase ( GAMT)" 3)
   ("-transferase (GST) protein" 3) ("cell-permeable C3 transferase" 2)
   ("transferase (COMT)" 2) ("the cell permeable inhibitor C3 transferase" 2)
   ("Golgi resident polypeptide N-acetylgalactosamine (GalNAc)-transferases (GALNT)"
    2)
   ("-transferases (GALNT)" 2) ("-Transferase" 2)
   ("a membrane permeable C3 transferase" 2)
   ("at least 3DNAmethyl transferases" 2)
   ("a cell-permeable Clostridium botulinum C3 transferase" 2)
   ("transferase ( HPRT )" 2)
   ("O -linked β- N -acetylglucosamine transferase" 2)
   ("the so-called GCN5-related N-acetyl transferases" 2)
   ("membrane-permeable C3 transferase" 1)
   ("the internal standard hypoxanthine guanine phosphoribosyl transferase (HGPRT)"
    1)
   ("Cell-permeable RhoA inhibitor C3 transferase" 1) ("–transferase" 1)
   ("transferase (FT)" 1)))
 ("XFAM:PF02462.13"
  (("opacity" 39) ("opacities" 37) ("GGO" 9) ("Opacity" 2) ("opacity (GGO)" 2)
   ("an essentially homogenous opacity" 2) ("Opacities" 1)
   ("pleural opacity" 1) ("the phase-variable opacity" 1)
   ("vision-threatening corneal opacity" 1) ("corneal opacity" 1)
   ("the corneal opacity" 1)
   ("Chest X-rays showed non-specific hazy opacities" 1)
   ("A 1.5 cm nodular opacity" 1)))
 ("XFAM:PF02469.20" (("fasciclin" 3))) ("XFAM:PF02474.13" (("Noda" 6)))
 ("XFAM:PF02485"
  (("Branch" 242) ("Branches" 8) ("Branch (UTMB)" 5) ("Branch (CBDB)" 4)
   ("Branch (NIMH)" 4) ("Biological Resources Branch" 3)
   ("Collective Invasion Branches" 2) ("the Pediatric Branch" 2)
   ("the Biometric Research Branch" 2)
   ("the National Cancer Institute Biological Testing Branch" 1)
   ("Health Statistics Reproductive Statistics Branch" 1)))
 ("XFAM:PF02486"
  (("replication initiation factors" 12) ("replication initiation factor" 2)
   ("mostly host replication initiation factors" 1)))
 ("XFAM:PF02498.15" (("bron" 1)))
 ("XFAM:PF02517"
  (("ABI" 3016) ("Abi" 27) ("ABI’s" 4) ("ABI's" 4) ("the thermal cycler ABI" 2)
   ("an ABI" 2) ("ABi" 2) ("an ABI’s" 1) ("using ABI's" 1) ("using ABI" 1)
   ("the ABI3100" 1) ("using ABI’s" 1)))
 ("XFAM:PF02518"
  (("HSP90" 1736) ("HSPCs" 286) ("HSPC" 101) ("pHSP90" 10)
   ("BCR-ABL-expressing HSPCs" 4) ("phenotypic HSPCs" 2) ("HSP90 protein" 2)
   ("at least one HSPC" 2) ("human BCR-ABL-expressing HSPCs" 2) ("HSP90s" 2)
   ("postnatal HSPCs" 1) ("human leukemic HSPCs" 1) ("than normal HSPCs" 1)
   ("lineage negative (Lin − ) multipotent bone marrow cKit + Sca1 + (KSL) HSPCs"
    1)
   ("donor-derived GFP + CD34 + HSPCs" 1) ("fewer HSPCs" 1) ("HSP90’s" 1)
   ("associated endogenous HSP90" 1)))
 ("XFAM:PF02531.14" (("pSAD" 41) ("PSAD" 1)))
 ("XFAM:PF02597" (("This family" 75)))
 ("XFAM:PF02608.12" (("Bmp" 24) ("bmp" 3) ("Bmps" 1)))
 ("XFAM:PF02691"
  (("VacA" 34) ("vacA" 11) ("the bacterial protein VacA" 2)
   ("VacA protein" 2)))
 ("XFAM:PF02711"
  (("E4" 468) ("E4 protein" 21) ("vIL-6-expressing cells E4" 5)
   ("mouse monoclonal anti-p73 antibody E4" 3) ("the adenoviral protein E4" 2)
   ("representative clones E4" 1)))
 ("XFAM:PF02735"
  (("KU" 347) ("Ku" 334) ("Ku protein" 6) ("nucleolar Ku" 3)
   ("the heterodimeric DNA binding complex Ku" 2) ("ku" 2) ("KU-" 2)
   ("than KU" 1)))
 ("XFAM:PF02759.17"
  (("Run" 56) ("RUN" 12) ("Runs" 9) ("Run's" 2) ("a Run's" 1)))
 ("XFAM:PF02760.13" (("HIN" 185) ("Hin" 124) ("hINs" 8)))
 ("XFAM:PF02793.20"
  (("HRM" 590) ("-HRM" 6) ("HRm" 5) ("rapidly developed HRM" 2)
   ("Developed Full HRM" 2) ("recurrent mutation HRM" 2) ("HRM-" 1)))
 ("XFAM:PF02811.17" (("PHP" 40) ("pHP" 1))) ("XFAM:PF02820" (("Mbt" 17)))
 ("XFAM:PF02824.19" (("TGS" 28))) ("XFAM:PF02825.18" (("WWE" 11)))
 ("XFAM:PF02829" (("3H" 471) ("3h" 112) ("-3H" 7)))
 ("XFAM:PF02888"
  (("calmodulin-binding domain" 15) ("calmodulin-binding domains" 2)))
 ("XFAM:PF02900"
  (("LigB" 230) ("ligB" 14) ("LigB protein" 11) ("dividing LigB7" 1)
   ("smaller LigB protein" 1)))
 ("XFAM:PF02916" (("DNA polymerase processivity factor" 15)))
 ("XFAM:PF02972.12"
  (("phycoerythrin" 254) ("Phycoerythrin" 34) ("Phycoerythrin (PE)" 9)
   ("phycoerythrin-" 4) ("phycoerythrin (PE)" 4) ("-phycoerythrin" 3)
   ("the fluorescent dye phycoerythrin" 2)))
 ("XFAM:PF02973"
  (("sialidase" 20) ("Sialidase" 7) ("sialidases" 4)
   ("plasma membrane-associated sialidases" 1) ("bacterial sialidases" 1)))
 ("XFAM:PF02996.15"
  (("prefoldin" 26) ("prefoldins" 11) ("prefoldin family" 6) ("Prefoldin" 4)
   ("Prefoldins" 1) ("an unconventional prefoldin protein" 1)
   ("prefoldin protein" 1)))
 ("XFAM:PF03034.13" (("PSS" 15))) ("XFAM:PF03059.14" (("NAS" 13)))
 ("XFAM:PF03062.17" (("MBOATs" 1)))
 ("XFAM:PF03068"
  (("PAD" 141) ("atherosclerotic PAD" 7) ("pAd" 4) ("pAD" 2)
   ("symptomatic PAD" 2) ("Pad" 1) ("age-related atherosclerotic PAD" 1)
   ("Atherosclerotic PAD" 1) ("both asymptomatic and symptomatic PAD" 1)
   ("PADs" 1)))
 ("XFAM:PF03071.13" (("GnTi" 2) ("GntI" 1))) ("XFAM:PF03076.12" (("GP3" 3)))
 ("XFAM:PF03094.13" (("MLO" 2)))
 ("XFAM:PF03125.16" (("SRE" 221) ("SREs" 13) ("sre" 2) ("Sre" 2)))
 ("XFAM:PF03137.18" (("OATPs" 1))) ("XFAM:PF03152" (("Ufd1" 14)))
 ("XFAM:PF03164.12" (("Mon1" 4) ("MON1" 2)))
 ("XFAM:PF03214.11" (("RGP" 117) ("RGPs" 1)))
 ("XFAM:PF03249.11"
  (("TSA" 2608) ("TSAs" 112) ("TSA-" 5) ("TSA (WAKO)" 2) ("than TSA" 1)
   ("than TSA ( xref )" 1) ("the hydroxamic acid pan-HDAC inhibitor TSA" 1)
   ("sporadic TSA" 1) ("SPS-associated TSA" 1)))
 ("XFAM:PF03253" (("UT" 622) ("uT" 4) ("UTs" 1)))
 ("XFAM:PF03255.12" (("ACCA" 13) ("pACCA" 4) ("-ACCA" 1)))
 ("XFAM:PF03283.11" (("PAE" 73) ("wtEGFR-expressing PAE" 1)))
 ("XFAM:PF03317.11"
  (("ELF" 33) ("elF" 7) ("Elf" 6) ("elf" 3) ("ElF" 1) ("eLF" 1)))
 ("XFAM:PF03331.11" (("LpxC" 5) ("the bacterial deacetylase LpxC" 2)))
 ("XFAM:PF03357.19" (("ESCRT-III" 53) ("Snf7" 6)))
 ("XFAM:PF03366.14" (("YEATS" 3)))
 ("XFAM:PF03374.12"
  (("ANT" 223) ("ANTs" 4) ("ANT protein" 2)
   ("than ANT (15/50 or 30.0%, 95% CI 17%-42%)" 1)))
 ("XFAM:PF03377" (("avirulence" 7) ("‘avirulence’" 3)))
 ("XFAM:PF03409"
  (("transmembrane glycoprotein" 362) ("transmembrane glycoproteins" 58)
   ("transmembrane glycoprotein family" 12)
   ("a highly heterogeneous transmembrane glycoprotein" 2)
   ("transmembrane glycoproteins family" 2)
   ("multifunctional transmembrane glycoproteins" 1)))
 ("XFAM:PF03421.14" (("YopJ" 4)))
 ("XFAM:PF03480"
  (("dCTP" 378) ("P-dCTP" 56) ("-dCTP" 16) ("P-dCTP (ICN)" 5)
   ("less efficiency dCTP" 2) ("dCTPs" 2) ("−dCTP" 1)
   ("α-labeled 32 P-dCTP (ICN)" 1) ("ICN" 1) ("than dCTP (~2.5-fold)" 1)))
 ("XFAM:PF03494.11" (("β-APP" 10) ("βAPP" 1)))
 ("XFAM:PF03507.11"
  (("CagA" 635) ("cagA" 61) ("CagA protein" 44) ("bacterial CagA protein" 3)
   ("a bacterial protein CagA" 2) ("more intracellular CagA" 1)
   ("the cancer-associated effector CagA" 1) ("isogenic mutant strains cagA" 1)
   ("than CagA" 1)))
 ("XFAM:PF03508.11" (("connexin43" 27) ("Connexin43" 5)))
 ("XFAM:PF03514.12" (("Gras" 1)))
 ("XFAM:PF03523"
  (("Macrophage Scavenger Receptor" 2) ("macrophage scavenger receptor" 1)))
 ("XFAM:PF03527" (("RHS" 139)))
 ("XFAM:PF03583.12"
  (("LIP" 123) ("overexpressed LIP" 7) ("smaller isoform LIP" 3) ("pLIP" 2)
   ("the 20 kDa liver-enriched transcriptional inhibitory protein LIP" 2)
   ("smaller LIP protein" 1) ("LIP protein" 1)))
 ("XFAM:PF03595"
  (("voltage-dependent anion channel" 49)
   ("voltage-dependent anion channel (VDAC)" 25)
   ("voltage-dependent anion channels" 11)
   ("voltage-dependent anion channel protein" 4)
   ("Voltage-dependent anion channel" 1)
   ("the so-called voltage-dependent anion channel (VDAC)" 1)))
 ("XFAM:PF03615.13" (("GCM" 7)))
 ("XFAM:PF03629"
  (("SASA" 198) ("apolar SASA" 6) ("polar SASA" 6) ("SASAs" 4)
   ("larger SASA" 1)))
 ("XFAM:PF03634" (("TCP" 55))) ("XFAM:PF03645.11" (("Tctex-1" 1)))
 ("XFAM:PF03646"
  (("Flag" 5467) ("Flag peptide" 84) ("pFlag" 72) ("Flag-" 64) ("-Flag" 33)
   ("pFLAG" 11) ("Mouse monoclonal anti Flag" 2) ("monoclonal anti Flag" 2)
   ("Flag peptide (DYKDDDDK)" 2) ("overexpressed Flag" 2) ("Flag (SIGMA)" 1)
   ("an amino terminal Flag" 1) ("Flag protein" 1) ("pFlag-" 1)
   ("ChIP-grade Flag" 1)))
 ("XFAM:PF03646.13"
  (("FLAG" 6508) ("-FLAG" 330) ("FLAG peptide" 252) ("pFLAG" 155) ("FLAG-" 60)
   ("pFlag" 18) ("FLAG protein" 8) ("FLAG–" 5) ("monoclonal FLAG" 2)
   ("triple FLAG" 2) ("exogenous hTERT WT -FLAG" 1) ("–FLAG" 1)
   ("a C-terminal triple FLAG" 1) ("a triple FLAG" 1)
   ("Est1(1-13)/GFP(S65T)/Est1(290-699)-FLAG" 1)
   ("1-13)/hEST1C(2-236)/Est1(290-699)-FLAG" 1)
   ("1-13)/hEST1B(25-262)/Est1(290-699)-FLAG" 1)
   ("Est1(1-13)/hEST1A(551-785)/Est1(290-699)-FLAG" 1)
   ("expressing EV or km23-1- FLAG" 1) ("exogenous FLAG" 1)))
 ("XFAM:PF03742" (("PETN" 2)))
 #+ignore("XFAM:PF03759.11" ; removed lower-case "prone
  (("prone" 1256) ("more prone" 94) ("less prone" 34) ("Prone" 5)
   ("highly cancer prone" 4) ("prone family" 3) ("much more prone" 3)
   ("more error prone" 2) ("no more tumor prone" 2) ("mice more tumor-prone" 2)
   ("more tumour prone" 2) ("relatively less prone" 2)
   ("the cells more prone" 2) ("the intestinal epithelium tumor prone" 1)
   ("considerably more prone" 1) ("a fibronectin matrix less prone" 1)
   ("HDAC4 KO mice more prone" 1) ("T cells more prone" 1)
   ("atherosclerotic lesion prone" 1) ("more tumor-prone" 1)
   ("the organism more cancer prone" 1) ("Tau mutants most prone" 1)
   ("mildly tumor prone" 1) ("tumor cells more prone" 1) ("males more prone" 1)
   ("significantly less prone" 1)
   ("numerous fragile genomic sequences prone" 1) ("a subgroup less prone" 1)
   ("presumable prone" 1) ("these less prone" 1)
   ("Pten heterozygous mice prone" 1) ("slightly more prone" 1)
   ("the cells less prone" 1) ("previously published regions prone" 1)
   ("more tumor prone" 1) ("most prone" 1) ("those most prone" 1)
   ("cardiovascular disease-prone" 1) ("men more prone" 1)
   ("the very first population prone" 1) ("much less prone" 1)
   ("ovariectomy made female rats more prone" 1) ("a fragile gene prone" 1)
   ("are less prone" 1) ("4-fold more error prone" 1)
   ("relatively error prone" 1) ("far less prone" 1)
   ("particularly more prone" 1) ("an aggressive HNSCC phenotype prone" 1)
   ("cells more prone" 1) ("cancer cells less prone" 1)
   ("aggressive skin cancer prone" 1) ("the WAT depot most prone" 1)
   ("the activated Rac1 became more prone" 1) ("RAD51 more prone" 1)
   ("cancers less prone" 1)))
 ("XFAM:PF03770" (("IPK" 6)))
 #+ignore("XFAM:PF03772" ; removed
  (("competence" 339) ("transcriptional competence" 6) ("Competence" 4)
   ("self-renewal competence" 4) ("mitotic competence" 4)
   ("the transcriptional competence" 4) ("‘competence’" 3)
   ("reproductive competence" 3) ("invasive competence" 2)
   ("chemotactic competence" 2) ("translational competence" 1)
   ("“competence”" 1) ("immunological competence" 1) ("Migratory competence" 1)
   ("the biological competence" 1) ("social competence" 1)
   ("oligodendrocytic lineage competence" 1)
   ("whose in vivo myelination competence" 1)
   ("their transcriptional competence" 1) ("its transcriptional competence" 1)
   ("increased self-renewal competence" 1)
   ("enhanced self-renewal competence" 1) ("visuospatial competence" 1)
   ("low translational competence" 1)))
 ("XFAM:PF03792.11" (("PBC" 200) ("PBCs" 27) ("cirrhotic PBC" 5)))
 ("XFAM:PF03803" (("Scramblase" 1))) ("XFAM:PF03824.14" (("Nico" 8)))
 ("XFAM:PF03843.11" (("Slp" 21) ("slp" 3)))
 ("XFAM:PF03856.11" (("Sun" 445) ("SUN" 30)))
 ("XFAM:PF03866.11" (("Hap" 68) ("HAP" 23) ("hap" 16) ("HAp" 8)))
 ("XFAM:PF03867.12" (("Ftz" 5)))
 ("XFAM:PF03924"
  (("chase" 540) ("Chase" 125) ("chases" 4) ("chase peptide" 4) ("-chase" 2)))
 ("XFAM:PF03968.12" (("Osta" 1))) ("XFAM:PF03970.11" (("UL37" 5)))
 ("XFAM:PF03992" (("ABM" 12) ("Abm" 1))) ("XFAM:PF04045.12" (("p34Arc" 1)))
 ("XFAM:PF04051.14" (("TRAPP" 26) ("TRAPP family" 4)))
 ("XFAM:PF04065.13" (("Not3" 5))) ("XFAM:PF04072.12" (("LCM" 169) ("L-CM" 5)))
 ("XFAM:PF04079.14"
  (("condensin" 97) ("Condensin" 42) ("condensins" 1) ("Condensins" 1)))
 ("XFAM:PF04085.12" (("MREC" 32)))
 ("XFAM:PF04093.10" (("mRed" 30) ("mRED" 10)))
 ("XFAM:PF04103.13"
  (("CD20" 335) ("all 3 expressed strong CD20" 1) ("CD20−" 1)))
 ("XFAM:PF04127.13"
  (("DFP" 87) ("DFPs" 4) ("4-amino-substituted DFP" 1) ("the 4-amino DFP" 1)))
 ("XFAM:PF04137" (("Ero1" 12)))
 ("XFAM:PF04159.11"
  (("NB" 1637) ("NBs" 651) ("pNB" 20) ("unfavorable NB" 4)
   ("the subcutaneous xenograft models ofALK F1174L -mutated NB" 2)
   ("aggressive NB" 2) ("a previously untreated localized NB" 2)
   ("larger “parental” PML NBs" 2) ("high-risk aggressive NB" 2)
   ("most (60–90%) PML NBs" 1) ("the integrating vector pNB1308" 1)
   ("Unfavorable NBs" 1) ("progressive and resistant NB" 1)
   ("the International NB" 1) ("favorable NB" 1) ("sporadic NB" 1)
   ("fewer PML NBs" 1) ("PML NB" 1) ("many fewer PML NBs" 1) ("even PML NBs" 1)
   ("PML NB's" 1) ("larger parental PML NBs" 1) ("meta-static NB" 1)
   ("therapy-resistant aggressive NBs" 1)))
 ("XFAM:PF04177.10" (("TAP42" 4))) ("XFAM:PF04180.12" (("LTV" 1)))
 ("XFAM:PF04203" (("Sortase" 1))) ("XFAM:PF04204" (("Hypotonic stress" 2)))
 ("XFAM:PF04247.10" (("siRB" 16) ("siRb" 6))) ("XFAM:PF04300.11" (("FBA" 8)))
 ("XFAM:PF04555.11"
  (("XhoI" 682) ("xhoI" 9) ("-XhoI" 3) ("XhoI ( CTCGAG )" 1) ("XHoI" 1)))
 ("XFAM:PF04564"
  (("U-box" 298) ("U-box domain" 76) ("U-box domains" 28) ("U-box protein" 6)
   ("U-Box" 5) ("the minimal U-box domain" 3) ("U-box family" 3) ("U-box-" 2)
   ("U-boxes" 2) ("a monomeric E4B U-box domain" 2)
   ("only one U-box protein" 1) ("previously characterized U-box domains" 1)))
 ("XFAM:PF04721" (("AW" 38) ("aWS" 1))) ("XFAM:PF04790.11" (("sarcoglycan" 2)))
 ("XFAM:PF04806" (("EspF" 5)))
 ("XFAM:PF04826.11" (("arm 2" 16) ("armadillo-like" 3)))
 ("XFAM:PF04832.10"
  (("SOUL" 125) ("SOUL molecule" 13) ("SOUL peptide" 3) ("SOUL protein" 2)))
 ("XFAM:PF04833" (("COBRA" 155))) ("XFAM:PF04844.11" (("ovate" 1)))
 ("XFAM:PF04877.10"
  (("hairpins" 207) ("two independent lentiviral hairpins" 2) ("Hairpins" 2)
   ("the central helical hairpins" 2)
   ("using retroviral or lentiviral hairpins" 1) ("helical hairpins" 1)
   ("form helical hairpins" 1) ("short artificial hairpins" 1)
   ("CTG hairpins" 1) ("lentiviral tet-inducible short hairpins" 1)))
 ("XFAM:PF04886" (("Pt" 211) ("elemental Pt" 1)))
 ("XFAM:PF04927.10" (("SMP" 104) ("SMPs" 6) ("pSMP" 5)))
 ("XFAM:PF04938.10" (("SIP1" 90) ("SIP-1" 15) ("sip-1" 1)))
 #+ignore("XFAM:PF04942" ; fixed cholangiocarcinoma
  (("CC" 3135) ("cholangiocarcinoma" 455) ("CCs" 108)
   ("cholangiocarcinomas" 89) ("Cholangiocarcinoma" 45) ("cc" 33) ("ECC" 24)
   ("EHCC" 21) ("IHCC" 17) ("“CC”" 13) ("intrahepatic cholangiocarcinoma" 12)
   ("-CC" 12) ("CC-" 9) ("Cc" 8) ("intrahepatic CC" 6) ("p-CC" 5)
   ("Intrahepatic cholangiocarcinoma (ICC)" 4)
   ("extrahepatic cholangiocarcinomas (ECC)" 3)
   ("a moderately differentiated intrahepatic cholangiocarcinoma" 3)
   ("sporadic intrahepatic cholangiocarcinoma (SIC)" 3) ("–CC" 3) ("‘CC’" 3)
   ("intrahepatic and perihilar cholangiocarcinomas" 3) ("CC family" 3)
   ("a poorly differentiated intrahepatic cholangiocarcinoma" 2)
   ("liver-fluke associated cholangiocarcinoma" 2)
   ("intrahepatic cholangiocarcinomas" 2) ("than ECC" 2)
   ("70 intrahepatic cholangiocarcinomas (ICC)" 2)
   ("irresectable, recurrent or metastatic CC" 2)
   ("intraheaptic cholangiocarcinoma" 2)
   ("intrapancreatic cholangiocarcinomas" 2)
   ("perihilar cholangiocarcinomas" 2) ("extra-hepatic cholangiocarcinomas" 2)
   ("intrahepatic and extrahepatic cholangiocarcinomas" 2)
   ("unresectable and recurrent CC" 2) ("extrahepatic CC (EHCC)" 2)
   ("intrahepatic CC (IHCC)" 2) ("hilar extrahepatic cholangiocarcinoma" 2)
   ("Intrahepatic CC (ICC)" 1)
   ("surgically resected intrahepatic cholangiocarcinomas" 1)
   ("intrahepatic cholangiocarcinoma (ICC)" 1) ("than their CC" 1)
   ("sporadic intrahepatic cholangiocarcinoma" 1)
   ("extrahepatic cholangiocarcinoma (EHCC)" 1)
   ("62 intrahepatic cholangiocarcinoma (ICC)" 1) ("than ECC ( p =0.018)" 1)
   ("57 extrahepatic cholangiocarcinomas (ECC)" 1) ("most CC" 1) ("Most CC" 1)
   ("mutated homozygous variant CC" 1) ("invasive CC" 1)
   ("significantly less stage III CC" 1) ("nonmetastatic CC" 1)
   ("only stage I–III CC" 1) ("extrahepatic cholangiocarcinomas" 1)
   ("intrahepatic Cholangiocarcinoma" 1) ("cholangiocarcinoma (CCA)" 1)
   ("the common ornamental plant CC" 1) ("homozygous CC" 1)
   ("almost all cholangiocarcinomas" 1) ("“GG”/”CC”" 1)
   ("ACTCAAGCTTC ATG TCT GAC CAG GAG GCA AA A CC 3" 1)
   ("advanced intrahepatic CC" 1) ("extra-pancreatic cholangiocarcinomas" 1)
   ("extra-hepatic CC" 1) ("cholangiocarcinoma (CC)" 1)
   ("extra-hepatic cholangiocarcinoma" 1)
   ("1 (33%) perihillar cholangiocarcinoma" 1) ("the wild genotype CC" 1)
   ("distal EHCC" 1) ("intrahepatic cholangiocarcinoma (IHCCA)" 1)
   ("a few CC" 1) ("distal cholangiocarcinomas" 1)))
 ("XFAM:PF04949"
  (("transcriptional activator" 846) ("transcriptional activators" 248)
   ("transcriptional activator protein" 4)
   ("a weak transcriptional activator" 4)
   ("transcriptional
activator"
    4)
   ("a well-characterized heterotrimeric transcriptional activator" 3)
   ("sequence-specific transcriptional activators" 3)
   ("a strong transcriptional activator" 2) ("transcriptional activator-" 2)
   ("“transcriptional activator”" 1) ("a global transcriptional activator" 1)
   ("strong transcriptional activators" 1)
   ("the immediate-early transcriptional activators" 1)
   ("the Yes-associated protein (YAP) transcriptional activator" 1)
   ("further recruiting other transcriptional activators" 1)
   ("other stress-induced transcriptional activators" 1)
   ("sequence-specific DNA binding transcriptional activators" 1)
   ("a classical transcriptional activator" 1)
   ("these two strong transcriptional activators" 1)
   ("an archetypal transcriptional activator" 1)
   ("two or more different transcriptional activators" 1)))
 ("XFAM:PF04957.10" (("RMFs" 21) ("RMF" 13)))
 ("XFAM:PF04968" (("chord" 3) ("chicken spinal chord" 1) ("CHORD" 1)))
 ("XFAM:PF04972" (("BON" 47)))
 ("XFAM:PF04982.11"
  (("HPPs" 99) ("HPP" 42) ("most human HPPs" 1) ("most HPPs" 1)))
 ("XFAM:PF05002" (("SGS" 2)))
 ("XFAM:PF05028" (("poly(ADP-ribose) glycohydrolase (PARG)" 20)))
 ("XFAM:PF05039" (("agouti" 14) ("Agouti" 10)))
 ("XFAM:PF05052.10" (("MERE" 4)))
 ("XFAM:PF05058.10"
  (("ActA" 31) ("acta" 27) ("Acta" 3) ("the listerial protein ActA" 2)))
 ("XFAM:PF05062"
  (("rich domain" 271) ("rich domains" 58) ("rich domain (CRD)" 10)
   ("-rich domain" 9) ("rich domain (PRD)" 6) ("-rich domains" 3)))
 ("XFAM:PF05092.10" (("PIF" 38) ("PIF (PDK1-interacting fragment) peptide" 4)))
 ("XFAM:PF05170" (("aSMA" 1)))
 ("XFAM:PF05204" (("homing endonuclease" 15) ("homing endonucleases" 1)))
 ("XFAM:PF05210" (("sprouty" 47) ("SPROUTY" 3)))
 ("XFAM:PF05316.10" (("var1" 2))) ("XFAM:PF05321.9" (("Hha" 18)))
 ("XFAM:PF05326.9" (("SVA" 16)))
 ("XFAM:PF05383"
  (("La" 1293) ("Las" 25) ("lumen area" 12) ("La protein" 3)
   ("Active Cdc42 increased cumulative lumen area" 1)
   ("the patent lumen area" 1)))
 ("XFAM:PF05384"
  (("DEGs" 372) ("synergistic DEGs" 4)
   ("Doxorubicin + TNF⍺ synergistic DEGs" 2) ("Basal-specific DEGs" 1)
   ("DegS" 1) ("Synergistic DEGs" 1) ("the synergistic DEGs" 1)
   ("Doxo+TNF⍺ synergistic DEGs" 1) ("the 15 synergistic DEGs" 1)
   ("the twelve validated synergistic DEGs" 1)
   ("synergistic up-regulated DEGs" 1)))
 ("XFAM:PF05389.10" (("MECA" 8)))
 ("XFAM:PF05472.9"
  (("ter" 102) ("Ter" 17) ("TERs" 11) ("tER" 6) ("pter" 4) ("p-ter" 4)))
 ("XFAM:PF05498.9" (("RalF" 3)))
 ("XFAM:PF05508.9" (("Ran-binding" 12) ("Ran-binding protein" 5)))
 ("XFAM:PF05522"
  (("metallothionein" 73) ("metallothioneins" 10) ("metallothionein (MT)" 7)
   ("Metallothionein" 5) ("Metallothioneins" 4) ("metallothionein protein" 3)))
 ("XFAM:PF05556.9" (("calsarcin" 2)))
 ("XFAM:PF05557"
  (("mitotic checkpoint" 399) ("mitotic checkpoints" 12)
   ("Mitotic checkpoint" 2) ("a leaky mitotic checkpoint" 1)
   ("“mitotic checkpoint”" 1)))
 ("XFAM:PF05622"
  (("hook" 117) ("Hook" 34) ("the electrostatic hook" 11) ("hooks" 5)
   ("‘hook'" 3) ("Hooks" 2) ("using s-shaped hooks" 1)))
 ("XFAM:PF05630.9" (("NPP1" 2)))
 ("XFAM:PF05693"
  (("glycogen synthase" 416) ("Glycogen synthase" 49)
   ("glycogen synthase (GS)" 6) ("glycogen synthase (GYS)" 2)
   ("glycogen synthase peptide" 2)
   ("glycogen
synthase"
    1)
   ("glycogen synthase (MGS)" 1)))
 ("XFAM:PF05710"
  (("coiled coil" 207) ("coiled coils" 17) ("coiled coil protein" 6)
   ("Rho-associated coiled coil" 3) ("a dimeric coiled coil" 2)
   ("Coiled Coil" 2) ("a parallel dimeric coiled coil" 2)
   ("a Rho-associated coiled coil" 2) ("dimeric coiled coil" 1)
   ("a three-stranded coiled coil" 1) ("alpha helix-based coiled coils" 1)
   ("a promiscuous DNA-binding domain and kinesin-like coiled coils" 1)
   ("smallest designed coiled coil" 1)))
 ("XFAM:PF05725" (("FNIP" 1))) ("XFAM:PF05732.9" (("repl" 8)))
 ("XFAM:PF05755.10" (("Refs" 38) ("REF" 37) ("REFs" 2)))
 ("XFAM:PF05760" (("IER" 1))) ("XFAM:PF05766.10" (("Ning" 5) ("ning" 3)))
 ("XFAM:PF05773" (("RWD" 5))) ("XFAM:PF05871.10" (("ESCRT-II" 15)))
 ("XFAM:PF05911.9" (("FPP" 64) ("than FPP" 2)))
 ("XFAM:PF05916.9" (("Sld5" 11))) ("XFAM:PF05925" (("IpgD" 97) ("ipgD" 14)))
 ("XFAM:PF05925.10" (("IpgD" 65) ("ipgD" 13) ("pIpgD" 5)))
 ("XFAM:PF05946.10" (("TCPA" 3))) ("XFAM:PF06064.9" (("GAM" 17) ("Gam" 1)))
 ("XFAM:PF06068.11"
  (("Tip49" 32) ("TIP49" 17) ("the MYC transcriptional cofactors TIP49" 2)))
 ("XFAM:PF06079" (("apyrase" 86) ("Apyrase" 9)))
 ("XFAM:PF06083" (("interleukin 17" 2) ("Interleukin 17" 2)))
 ("XFAM:PF06100.9" (("MCRA" 77) ("MCRAs" 2))) ("XFAM:PF06160.10" (("Ezra" 2)))
 ("XFAM:PF06188.10" (("hRPE" 37)))
 ("XFAM:PF06209" (("cofactor of BRCA1 (COBRA1)" 7)))
 ("XFAM:PF06227"
  (("poxvirus" 25) ("poxviruses" 13) ("poxvirus family" 7) ("Poxviruses" 2)
   ("Poxvirus" 1) ("yet several poxviruses" 1)))
 ("XFAM:PF06271.10" (("RDD" 20)))
 ("XFAM:PF06376.10" (("AGP" 49) ("AgP" 13) ("AGP-" 1)))
 ("XFAM:PF06391.11" (("Mat1" 35) ("MAT1" 13) ("pMAT1" 9)))
 ("XFAM:PF06428.9" (("Sec2p" 1))) ("XFAM:PF06456" (("Arfaptins" 1)))
 ("XFAM:PF06462.10"
  (("propeller" 178) ("propellers" 55) ("Propeller" 16) ("Propellers" 2)
   ("a seven-bladed propeller" 1)))
 ("XFAM:PF06511.9" (("IpaD" 7) ("iPAD" 2)))
 ("XFAM:PF06516.9"
  (("Nups" 51) ("NUPs" 49) ("Nup" 33) ("NUP" 13)
   ("the Nested Universal Primer A NUP" 1)))
 ("XFAM:PF06581.10" (("p31Comet" 2)))
 ("XFAM:PF06586.9" (("TRAK" 4) ("TRAKs" 2))) ("XFAM:PF06610.11" (("alae" 4)))
 ("XFAM:PF06684" (("amino acid synthesis" 4)))
 ("XFAM:PF06725"
  (("3D" 3680) ("3d" 73) ("using Intelligent Imaging Innovations 3D" 6)
   ("3D-" 5) ("3D (PROMALS)" 4) ("cytokine-treated 3D" 3) ("compliant 3D" 3)
   ("Organotypic 3D" 2) ("the so-called 3D" 2) ("3DS" 2)
   ("the phospho-mimetic mutant 3D" 2) ("the ImageJ Iterative Deconvolve 3D" 1)
   ("mesenchymal 3D" 1) ("Representative 3D" 1) ("lack rigid 3D" 1)
   ("The wild and mutated 3D" 1) ("the viral polymerase 3D" 1)
   ("comprehensive 3D" 1) ("quantitative 3D" 1) ("a novel organotypic 3D" 1)
   ("The resulting tomographic 3D" 1) ("cytokine treated 3D" 1)
   ("a chemically inert 3D" 1) ("z-projected 3D" 1)
   ("iterative deconvolution 3D" 1) ("rigid 3D" 1) ("the available 3D" 1)
   ("mature Caco-2 3D" 1) ("subsequent 3D" 1)))
 ("XFAM:PF06816" (("Nod" 51)))
 ("XFAM:PF06816.11"
  (("NOD" 465) ("NOD-" 7) ("STZ-induced diabetic NOD" 3)
   ("Six-week-old female non-obese-diabetic/severe-combined-immunodeficient NOD"
    1)))
 ("XFAM:PF06872"
  (("EspG" 137) ("espG" 40) ("pEspG" 14) ("EspGs" 4)
   ("Alternatively EHEC EspG" 1) ("more total EspG" 1)
   ("permeabilized cells indicated EspG" 1)))
 ("XFAM:PF06875.9" (("PRF" 32) ("pRF" 4) ("Prf" 3) ("PrF" 1)))
 ("XFAM:PF06920.11" (("DHR-2" 33))) ("XFAM:PF07042.9" (("TRFA" 4)))
 ("XFAM:PF07093.9" (("SGT1" 12) ("Sgt1" 1))) ("XFAM:PF07178" (("TRAL" 1)))
 ("XFAM:PF07194"
  (("P2" 1488) ("p2" 117) ("polyproline motif" 29) ("P2-" 5) ("P2’s" 5)
   ("polyproline motifs" 4) ("more P2" 2) ("PI(3)P and PI(3,4)P2" 2) ("-P2" 2)
   ("smaller PI(3,4)P2" 1) ("PI(3,4)P2 and PI(4,5)P2" 1)
   ("both PI (3, 4, 5) P3 and PI (4, 5) P2" 1) ("PI(3)P and PI(4,5)P2" 1)
   ("PI 3 K (by, for example, p21 Ras ) PtdIns(3,4,5) P3/PtdIns(3,4)P2" 1)
   ("PtdIns-(3,4,5)P3 and PtdIns(3,4)P2" 1)))
 ("XFAM:PF07277.9" (("SapC" 117)))
 ("XFAM:PF07348.10" (("SYD" 13) ("syd" 2) ("Syd" 1)))
 ("XFAM:PF07417.10"
  (("CRLs" 140) ("Crl" 19) ("Six-8-week-old female athymic Crl" 1)
   ("the prototypic “SCF” (SKP1-CUL1-F-box protein) CRLs" 1)))
 ("XFAM:PF07467"
  (("blips" 4) ("BLiP" 3) ("“blip”" 1) ("blip" 1) ("“blips”" 1)))
 ("XFAM:PF07491"
  (("phosphatase inhibitors" 935) ("phosphatase inhibitor" 756)
   ("Phosphatase Inhibitor" 91) ("Phosphatase inhibitor" 25)
   ("Phosphatase inhibitors" 11)
   ("phosphatase
inhibitors"
    3)
   ("phosphatase Inhibitor" 2) ("phosphatase inhibitor (PAO)" 2)
   ("a generic Ser/Thr phosphatase inhibitor" 2)
   ("phosphatase
inhibitor"
    1)
   ("–phosphatase inhibitors" 1) ("generic Ser/Thr phosphatase inhibitors" 1)
   ("Generic Ser/Thr phosphatase inhibitors" 1)))
 ("XFAM:PF07507"
  (("wave" 841) ("waves" 270) ("Wave" 46) ("Sequential Waves" 8) ("Waves" 5)
   ("sequential waves" 4) ("the second mitotic wave" 4)
   ("a synchronous wave" 4) ("intercellular Ca 2+ waves" 4) ("“wave”" 3)
   ("the neurogenic wave" 3) ("neurogenic wave" 3)
   ("the intense heat stress-induced early wave" 2) ("slower wave" 2)
   ("non-ionizing electromagnetic waves" 2) ("‘wave’" 2)
   ("ventral F-actin waves" 2) ("ventral F-actin-based waves" 2)
   ("two main transcriptional waves" 2) ("intricate oscillation waves" 2)
   ("electrical slow waves" 2) ("wave (RR)" 2) ("a massive wave" 1) ("wave-" 1)
   ("an evanescent wave" 1) ("early post-natal waves" 1) ("smaller wave" 1)
   ("Intense heat stress-induced early wave" 1)
   ("intense heat stress-induced early wave" 1) ("subsequent waves" 1)
   ("periodic waves" 1)
   ("Electroencephalogram (EEG) revealed multifocal spike wave" 1)
   ("ventral ARF6/actin waves" 1) ("two separate waves" 1)
   ("the first transcriptional wave" 1)
   ("the stimulus-specific transcriptional waves" 1) ("a secondary wave" 1)
   ("the first sizable wave" 1) ("spontaneous electric slow waves" 1)
   ("the subsequent waves" 1) ("the subsequent wave" 1)
   ("the retinal neurogenic wave" 1)
   ("the subsequent retinal differentiation wave" 1)
   ("the resulting evanescent wave" 1) ("the secondary wave" 1)
   ("the spatiotemporal wave" 1)
   ("than the major waves of NER that occur in normal cells" 1)
   ("reduced A wave" 1) ("slight and short waves" 1)
   ("the late (postincision) wave" 1) ("the next R wave (RR)" 1)
   ("intercellular waves" 1)))
 ("XFAM:PF07507.9"
  (("WAVE" 209) ("WAVEs" 8) ("WAVE protein" 2) ("‘WAVE'" 2)
   ("the Transgenomic WAVE" 1) ("than WAVE" 1)))
 ("XFAM:PF07508"
  (("recombinase" 929) ("recombinases" 71) ("Recombinase" 16)
   ("recombinase protein" 9) ("Recombinases" 3)
   ("a Pdx1 promoter-driven Cre recombinase" 2)
   ("a conditional Cre recombinase" 2)
   ("the bacterial RecA and eukaryotic RAD51 recombinases" 1)
   ("K6a-driven cre recombinase" 1) ("a retroviral cre recombinase" 1)
   ("a circular plasmid encoding Cre recombinase" 1)
   ("polymerized Rad51 recombinase" 1) ("both the archaeal recombinase" 1)
   ("proteins called recombinases" 1)
   ("the bacterial class 1 integron recombinase" 1)
   ("the essential Rad51 recombinase" 1)
   ("myeloid cells specific lysozyme 2 promoter-driven Cre recombinase" 1)))
 ("XFAM:PF07525"
  (("SOCS box" 173) ("SOCS boxes" 4) ("viral SOCS box" 1)
   ("the viral SOCS box" 1)))
 ("XFAM:PF07537" (("CAMs" 86) ("CaMs" 1))) ("XFAM:PF07583.9" (("PSC2" 1)))
 ("XFAM:PF07702" (("UTRa" 1)))
 ("XFAM:PF07715"
  (("plugs" 323) ("plug" 277) ("Plug" 19) ("Plugs" 16) ("a vaginal plug" 7)
   ("the hemostatic plug" 3) ("organotypic plugs" 2) ("the vaginal plug" 2)
   ("subcutaneous VEGF-supplemented Matrigel plugs" 2)
   ("cervical mucus plug" 2) ("an observable plug" 1)
   ("three separate plugs" 1) ("plug-" 1) ("vascular plug" 1)))
 ("XFAM:PF07729" (("FCD" 20) ("FCDs" 8))) ("XFAM:PF07742" (("BTG family" 4)))
 ("XFAM:PF07765.10" (("KIP1" 68) ("Kip-1" 11) ("Kip−1" 5)))
 ("XFAM:PF07860.9"
  (("CCD" 683) ("Digital CCD" 4) ("pCCD" 4) ("CCDs" 4)
   ("a Sony DFW-X710 Fire Wire 1/3″-type progressive SCAN IT CCD" 2)
   ("Wire 1/3-inch type progressive SCAN IT CCD" 2)
   ("monochrome digital CCD" 2)))
 ("XFAM:PF07885"
  (("ion channels" 232) ("ion channel" 152) ("ion channel protein" 10)
   ("Ion channels" 9) ("Ca 2+ and Mg 2+ permeable ion channels" 2)
   ("most ion channels" 2) ("Ion channel" 1)
   ("Transient receptor potential canonical‐6 (TRPC6) ion channels" 1)
   ("the better-established G-protein-dependent GPCR-activated ion channels" 1)
   ("a ubiquitous potassium ion channel" 1)
   ("mGluR1-mediated cation-permeable ion channel" 1)
   ("any volume-sensitive ion channels" 1) ("more calcium ion channels" 1)))
 ("XFAM:PF07894" (("DUF1669" 66)))
 ("XFAM:PF07897"
  (("ear" 553) ("ears" 170) ("Ear" 43) ("EAR" 7) ("cystic inner ears" 2)
   ("fleshy ears" 2) ("Ears" 1) ("The contralateral ear" 1)
   ("the contralateral ear" 1) ("bilateral ears" 1)
   ("ototoxic damaged mammalian inner ear" 1) ("large dysplastic ears" 1)
   ("recurrent ear" 1)))
 ("XFAM:PF07931" (("CPTs" 30) ("CpT" 6) ("Cpt" 3)))
 ("XFAM:PF07960.9" (("CBP4" 1))) ("XFAM:PF07968" (("leukocidin" 1)))
 ("XFAM:PF07974"
  (("EGF-like domains" 57) ("EGF-like domain" 49) ("EGF like domains" 3)
   ("almost all the EGF like domains" 2)
   ("their respective EGF-like domains" 1)
   ("shorter extracellular EGF-like domain" 1)))
 ("XFAM:PF07996.9" (("T4SS" 51)))
 ("XFAM:PF08045.9"
  (("Cdc14" 101) ("Cdc14 family" 6) ("Cdc14s" 2) ("than S. cerevisiae Cdc14" 1)
   ("the nucleolar phosphatase Cdc14" 1)))
 ("XFAM:PF08194"
  (("DiM" 73) ("Bcl-xL/Mcl1-deficient cells reduced DiM" 1) ("“DiM”" 1)
   ("RKO cells accelerated DiM" 1) ("Myc-dependent DiM" 1)
   ("than DiM ( xref G)" 1) ("cells underwent DiM" 1) ("DIMs" 1)))
 ("XFAM:PF08249" (("mastoparan" 1)))
 ("XFAM:PF08260.9" (("kinins" 2) ("kinin" 2))) ("XFAM:PF08321.10" (("ppp5" 1)))
 ("XFAM:PF08374.9"
  (("protocadherin" 24) ("protocadherin family" 5) ("Protocadherins" 2)
   ("Protocadherin" 1)))
 ("XFAM:PF08376.8" (("NIT" 36) ("pNIT" 4)))
 ("XFAM:PF08384.8"
  (("NPP" 104) ("pNPP" 103) ("-NPP" 7) ("p-NPP" 5) ("NPP-" 3)
   ("the small artificial substrate pNPP" 3)
   ("both a
small molecule chromogenic substrate p NPP"
    1)
   ("the artificial substrate pNPP" 1)))
 ("XFAM:PF08387.8" (("FBD" 12)))
 ("XFAM:PF08397.9" (("IMD" 115) ("IMD (IRSp53/MIM homology domain) family" 3)))
 ("XFAM:PF08416"
  (("phosphotyrosine-binding domain" 27) ("phosphotyrosine binding domain" 22)
   ("phosphotyrosine-binding domains" 18) ("phosphotyrosine binding domains" 8)
   ("phosphotyrosine-binding domain (PTB)" 2)))
 ("XFAM:PF08434" (("CLCA" 8) ("CLCA family" 4)))
 ("XFAM:PF08441" (("integrin alpha" 7) ("Integrin alpha" 3)))
 ("XFAM:PF08450.10" (("SGL" 5) ("pSGL" 1)))
 ("XFAM:PF08524" (("rRNA processing" 117)))
 ("XFAM:PF08573.8"
  (("SAE2" 173) ("Sae2" 65) ("sae2" 10) ("Sae2 protein" 3) ("SAE2 protein" 3)))
 ("XFAM:PF08574.8" (("IWR1" 1)))
 ("XFAM:PF08591" (("ribonucleotide reductase inhibitor" 22)))
 ("XFAM:PF08641.10" (("Mis14" 9) ("Mis14 family" 6)))
 ("XFAM:PF08675"
  (("RNA-binding domain" 72) ("RNA binding domain" 25)
   ("RNA-binding domains" 23) ("RNA binding domains" 6)
   ("RNA-binding domain (RBD)" 4) ("RNA-binding domain (TRBD)" 4)
   ("RNA-binding domains (RBD)" 3) ("RNA binding domain (TRBD)" 2)
   ("RNA-binding domain (RRM)" 2) ("sequence-specific RNA binding domains" 2)
   ("RNA binding domain (CTD)" 1)))
 ("XFAM:PF08736"
  (("Fas" 1889) ("Fa" 36) ("Fas-" 17) ("soluble Fas" 3)
   ("an antagonistic Fas" 2) ("than Fas" 1)))
 ("XFAM:PF08736.9"
  (("FA" 2991) ("FAs" 670) ("FA protein" 42) ("robust FAs" 14) ("pFA" 12)
   ("FA family" 6) ("larger FAs" 3) ("integrin β1–positive robust FAs" 3)
   ("the robust FAs" 3) ("mApple-paxillin-labeled FAs" 2) ("mature FA" 2)
   ("peripheral FAs" 2) ("the integrin β1–positive FAs" 2)
   ("the integrin β1–positive robust FAs" 2) ("integrin β1–positive FAs" 2)
   ("vinculin-positive FAs" 2) ("the paxillin-positive FAs" 2) ("fewer FA" 1)
   ("these structures became more mature and organized elongated FAs" 1)
   ("around FAs" 1) ("biallelic BRCA1 mutations cause FA" 1)
   ("long-lived FA" 1) ("FA (FFA)" 1) ("fetal FA" 1)
   ("the most predominant FA" 1)
   ("ErbB2-positive invasive breast cancer cells FA" 1) ("smaller FAs" 1)
   ("the broad mature FAs" 1) ("Mature FAs" 1) ("exhaustive FA" 1)
   ("Exhaustive multivariate FA" 1) ("β1-positive robust FAs" 1)
   ("2.2 such robust FAs" 1) ("paxillin-positive FAs" 1) ("‘typical' FA" 1)
   ("very young FA" 1) ("force-dependent FAs" 1) ("the FA's" 1)))
 ("XFAM:PF08771"
  (("rapamycin-binding domain" 16) ("Rapamycin-binding domain" 1)
   ("rapamycin–binding domain" 1)))
 ("XFAM:PF08777"
  (("RNA-binding motif" 18) ("RNA-binding motifs" 14) ("RNA binding motif" 7)
   ("RNA-binding motif (ARM)" 3) ("RNA-binding motif protein" 3)
   ("RNA binding motifs" 3)))
 ("XFAM:PF08815"
  (("Nuclear Receptor Coactivators" 10) ("receptor coactivators" 4)
   ("Nuclear receptor coactivators" 1) ("receptor coactivator" 1)))
 ("XFAM:PF08832"
  (("steroid receptor coactivator" 59) ("steroid receptor coactivators" 31)
   ("steroid receptor coactivator (SRC) family" 6)
   ("steroid receptor coactivator family" 5)
   ("steroid receptor coactivator (SRC)
family"
    4)
   ("Steroid receptor coactivator" 4)
   ("steroid receptor coactivator family (SRC)" 2)
   ("Steroid Receptor coactivator" 2) ("Steroid receptor coactivators" 1)
   ("steroid receptor coactivator-" 1)))
 ("XFAM:PF08841.8"
  (("DDR" 3513) ("DDRs" 44) ("DDR protein" 15) ("UV DDR" 13)
   ("the UV-induced DDR" 4) ("UV-induced DDR" 4) ("a robust DDR" 4)
   ("proficient DDR" 3) ("DDR family" 2) ("UV induced DDR" 2)
   ("Extranuclear E 2 -dependent DDR" 2) ("the classical DDR" 2)
   ("the infection-associated DDR" 2) ("a growth suppressive DDR" 1)
   ("a growth-suppressive DDR" 1) ("the ATM/Chk2-dependent DDR" 1)
   ("a modest DDR" 1) ("the UV DDR" 1) ("UV-induced Tip60-mediated DDR" 1)
   ("an apical DDR protein" 1)
   ("than DDR directly from parental lines ( xref )" 1)
   ("its associated DDR" 1) ("replication stress-mediated DDR" 1)
   ("the observed massive DDR" 1) ("the ATM-associated DDR" 1)
   ("an ATM-centric DDR" 1) ("the optimal DDR" 1) ("optimal DDRs" 1)
   ("This more robust DDR" 1) ("classical DDR" 1) ("radiation-induced DDR" 1)))
 ("XFAM:PF08842.8" (("mfas" 2))) ("XFAM:PF08912" (("Rho-binding" 72)))
 ("XFAM:PF08919"
  (("F-actin binding" 52) ("F-actin binding protein" 9) ("F-Actin Binding" 8)
   ("than F-actin binding" 1) ("the relative F-actin binding" 1)))
 ("XFAM:PF08934" (("Rb C-terminal domain" 5)))
 ("XFAM:PF08990"
  (("Docking" 228) ("Dockings" 2) ("Flexible Docking" 1) ("Docking (IFD)" 1)))
 ("XFAM:PF09027" (("GTPase binding" 44) ("GTPase-binding" 20)))
 ("XFAM:PF09030" (("CREB binding" 22) ("CREB-binding" 4) ("p-CREB binding" 3)))
 ("XFAM:PF09057" (("second mitochondria-derived activator of caspases" 11)))
 ("XFAM:PF09068" (("EF-hand" 28) ("EF-hands" 3) ("–EF-hand" 1)))
 ("XFAM:PF09121" (("tower" 35) ("Tower" 30) ("“tower”" 1)))
 ("XFAM:PF09145" (("ubiquitin-associated" 25) ("Ubiquitin-associated" 4)))
 ("XFAM:PF09213" (("m3" 49) ("m3s" 3))) ("XFAM:PF09247" (("TBP binding" 9)))
 ("XFAM:PF09340.8" (("NuA4" 41)))
 ("XFAM:PF09357" (("RTECs" 11) ("proximal RTECs" 2)))
 ("XFAM:PF09403.8" (("FadA" 80) ("fadA" 14))) ("XFAM:PF09462.8" (("Mus7" 3)))
 ("XFAM:PF09532" (("FDF" 1))) ("XFAM:PF09626.8" (("DHC" 48) ("DHCs" 1)))
 ("XFAM:PF09730" (("BicD" 17) ("BicD molecule" 2)))
 ("XFAM:PF09793"
  (("Ad" 2228) ("Alzheimer disease" 87) ("Ad-" 37) ("Ads" 11)
   ("replication-competent Ad" 8) ("Alzheimer disease (AD)" 3)
   ("Alzheimer diseases" 3) ("replication-incompetent serotype 5/3 Ad" 3)
   ("the minimal promoter Ad" 1) ("than Ad-WT" 1)
   ("than individual Ad alone in both cells (Fig.  xref a)" 1)
   ("GFP-expressing Ad" 1) ("The replication-incompetent Ad" 1)
   ("Replication-competent Ad" 1)
   ("Alzheimer
                        disease"
    1)
   ("than either Ad" 1)
   ("Alzheimer
                    disease"
    1)
   ("sporadic Alzheimer disease (AD)" 1)))
 ("XFAM:PF10136"
  (("site-specific recombinase" 4) ("Site-specific recombinase" 1)
   ("site-specific recombinases" 1)))
 ("XFAM:PF10158"
  (("tumour suppressor" 1804) ("tumour suppressors" 223)
   ("tumour suppressor protein" 98) ("Tumour suppressor" 11)
   ("a potential tumour suppressor" 9)
   ("tumour
                        suppressor"
    5)
   ("a classical tumour suppressor" 4) ("tumour suppressor (VHL)" 3)
   ("“tumour suppressor”" 2) ("a haploinsufficient tumour suppressor" 2)
   ("a multifunctional tumour suppressor" 2)
   ("a well-defined tumour suppressor" 2) ("intuitive tumour suppressors" 2)
   ("a universal tumour suppressor" 1) ("a possible tumour suppressor" 1)
   ("nuclear-associated tumour suppressor" 1)
   ("potential tumour suppressors" 1)
   ("an ‘unconventional’ tumour suppressor" 1)
   ("a gastric-specific tumour suppressor" 1)
   ("a colorectal tumour suppressor" 1)))
 ("XFAM:PF10165.7" (("RIC-8" 12) ("ric-8" 7) ("Ric-8" 5)))
 ("XFAM:PF10167.7" (("NEP" 458) ("NEP protein" 21) ("pNEP" 1)))
 ("XFAM:PF10183" (("ESSs" 17))) ("XFAM:PF10214.7" (("Rrn6" 1)))
 ("XFAM:PF10275.7" (("Otubain" 2) ("Otubains" 2)))
 ("XFAM:PF10276"
  (("zinc-finger domain" 79) ("zinc-finger domains" 16)
   ("an exceptional zinc-finger domain" 2)
   ("a unique ubiquitin-binding zinc-finger domain" 2)
   ("a probable DNA-binding zinc-finger domain" 1)))
 ("XFAM:PF10318.7" (("SRH" 9))) ("XFAM:PF10319.7" (("SRJ" 50)))
 ("XFAM:PF10376.7" (("Mei5" 1))) ("XFAM:PF10377.7" (("Atg11" 2) ("atg11" 1)))
 ("XFAM:PF10401" (("Interferon-regulatory factor 3" 2)))
 ("XFAM:PF10450.7" (("POC1" 1))) ("XFAM:PF10452.7" (("Tco89" 7)))
 ("XFAM:PF10477.7" (("eIF4E-T" 7)))
 ("XFAM:PF10567"
  (("RNA recognition motif" 29) ("RNA recognition motifs" 26)
   ("RNA recognition motif (RRM)" 11)))
 ("XFAM:PF10609.7" (("para" 159) ("Para" 6) ("para-" 5)))
 ("XFAM:PF10624" (("tRAS" 1))) ("XFAM:PF10627.7" (("CSGE" 72)))
 ("XFAM:PF10684.7" (("BDM" 17)))
 ("XFAM:PF10747.7" (("siRas" 34) ("than siRas" 1)))
 ("XFAM:PF10764.7"
  (("GIN" 87) ("GINS" 78) ("gin" 3) ("progressive GIN" 1) ("Gin" 1)))
 ("XFAM:PF11058.6"
  (("Ral" 524) ("Rals" 15) ("ral" 5) ("Ral family" 3) ("than Ral" 1)))
 ("XFAM:PF11073" (("NSs" 25) ("NSs protein" 13)))
 ("XFAM:PF11132.6" (("sPLA" 194) ("SPla" 2))) ("XFAM:PF11388" (("dotA" 9)))
 ("XFAM:PF11397.6"
  (("GlcNAc" 250) ("-GlcNAc" 187) ("GlcNac" 3)
   ("Mouse monoclonal anti-O-linked GlcNAc" 3) ("GlcNAc-" 1)
   ("indeed O -GlcNAc" 1) ("more heavily O -GlcNAc" 1)
   ("potentially O -GlcNAc" 1) ("less O -GlcNAc" 1)))
 ("XFAM:PF11409" (("Smad anchor for receptor activation (SARA)" 4)))
 ("XFAM:PF11430.6"
  (("EGL-1" 8) ("egl-1" 6) ("the pro-apoptotic gene egl-1" 1) ("Egl1" 1)))
 ("XFAM:PF11434"
  (("chips" 1075) ("Chips" 82) ("CHIPS" 6) ("chips (GE)" 3)
   ("Agilent Human miRNA microarray version 3 chips" 3)
   ("microfluidic chips" 2) ("Agilent chips" 2)
   ("using genome-wide SNP chips" 1) ("most genotyping chips" 1)
   ("Agilent High Sensitivity DNA Chips" 1)
   ("the commercial genotyping chips" 1) ("the 12 chips, 10,012" 1)
   ("“chips”" 1) ("the Agilent 44K chips" 1) ("genome-wide chips" 1)))
 ("XFAM:PF11466.6" (("Doppel" 5))) ("XFAM:PF11493.6" (("TSP9" 2)))
 ("XFAM:PF11522.6" (("PIK1" 3) ("Pik1" 3)))
 ("XFAM:PF11535"
  (("calcium binding" 63) ("calcium-binding" 61) ("calcium binding protein" 11)
   ("Calcium binding" 8) ("Calcium Binding" 2)
   ("28 kDa neuronal calcium binding protein" 2)))
 ("XFAM:PF11542.6" (("Mdv1" 5))) ("XFAM:PF11565.6" (("PorB" 121) ("porB" 1)))
 ("XFAM:PF11581.6" (("argos" 8))) ("XFAM:PF11610.6" (("Ste5" 8)))
 ("XFAM:PF11624.6" (("m157" 1))) ("XFAM:PF11626.6" (("TRF2IP" 3)))
 ("XFAM:PF11700" (("ATG22" 2)))
 ("XFAM:PF11725"
  (("pathogenicity factor" 13) ("a critical viral pathogenicity factor" 2)))
 ("XFAM:PF11778.6" (("SID" 30) ("siD" 1)))
 ("XFAM:PF11987" (("IF-2" 5) ("translation initiation factor 2" 4)))
 ("XFAM:PF12041" (("della" 17) ("Dellas" 2)))
 ("XFAM:PF12182"
  (("bacterial lipoprotein (BLP)" 2) ("bacterial lipoproteins" 2)
   ("bacterial lipoprotein" 1)))
 ("XFAM:PF12273.6" (("RCR" 23) ("rCRS" 1)))
 ("XFAM:PF12398"
  (("receptor serine/threonine kinases" 9)
   ("receptor serine/threonine kinase" 3)))
 ("XFAM:PF12407"
  (("homeobox" 202) ("Homeobox" 41) ("homeobox (ZEB)" 9) ("homeobox protein" 9)
   ("homeobox ( ZEB ) family" 4) ("homeobox (HOX) protein" 3)
   ("homeobox (CRX)" 2) ("homeobox family" 2)
   ("Lentiviral Human Nanog Homeobox" 1)
   ("myeloid ecotropic insertion site homeobox" 1)))
 ("XFAM:PF12445.6" (("FliC" 9))) ("XFAM:PF12448.6" (("Milton" 23)))
 ("XFAM:PF12455.6"
  (("dynactin" 309) ("Dynactin" 11) ("comparable strong dynactin" 2)))
 ("XFAM:PF12456"
  (("inositol phosphatase" 36) ("inositol phosphatase (SHIP)" 9)
   ("inositol phosphatase (SHIP) family" 4) ("inositol phosphatases" 3)
   ("-inositol phosphatase" 2) ("“lipid/phosphatidyl-inositol phosphatase”" 1)
   ("an insect-derived salivary inositol phosphatase" 1)))
 ("XFAM:PF12474.6" (("PKK" 9)))
 ("XFAM:PF12483"
  (("E3 ligase" 3773) ("E3 ubiquitin ligase" 2662) ("ubiquitin ligase" 2539)
   ("E3 ligases" 1051) ("ubiquitin ligases" 798) ("E3 ubiquitin ligases" 594)
   ("E3-ubiquitin ligase" 168) ("E3-ubiquitin ligases" 37)
   ("Ubiquitin ligase" 28) ("E3 Ubiquitin Ligase" 20) ("Ubiquitin ligases" 16)
   ("E3 ligase family" 10) ("E3 ubiquitin ligase family" 8)
   ("ubiquitin
ligase"
    8)
   ("E3
ligases"
    5)
   ("E3
ubiquitin ligase"
    5)
   ("ubiquitin ligase protein" 4)
   ("The Deltex (DTX)-3-like E3 ubiquitin ligase" 4)
   ("an artificial E3 ubiquitin ligase" 3) ("ubiquitin ligase family" 3)
   ("E3 ubiquitin ligase protein" 3) ("the potential E3 ligase" 3)
   ("at least two ubiquitin ligases" 2) ("a multifunctional E3 ligase" 2)
   ("yet another ubiquitin ligase" 2) ("typical E3 ubiquitin ligases" 2)
   ("a microtubule-associated ubiquitin E3 ligase" 2) ("possible E3 ligases" 2)
   ("well-designed engineered ubiquitin ligase" 2)
   ("the most well-characterized oncogenic E3 ligase" 2)
   ("a histone-H2A-specific ubiquitin ligase" 2) ("E3 ligase (VHL)" 2)
   ("a massive E3 ligase" 2) ("the predominant ubiquitin ligase" 2)
   ("an authentic E3 ligase" 2) ("a FA-associated E3 ubiquitin ligase" 2)
   ("the well-studied and established E3 ligases" 2)
   ("an associated E3 ubiquitin ligase" 2) ("Most E3 ubiquitin ligases" 2)
   ("the heterodimeric ubiquitin ligase" 2) ("an exogenous E3 ligase" 2)
   ("Cul4a-associated factor-1(DCAF-1) E3 ubiquitin ligase" 2)
   ("a minimal Siz1 E3 ligase" 2) ("multimeric ubiquitin ligase" 2)
   ("A possible E3 ubiquitin ligase" 2) ("the exact E3 ligase" 2)
   ("the only currently known E3 ligase" 2) ("potential E3 ligases" 2)
   ("at least three different ubiquitin ligases" 2)
   ("the predominant E3 ligase" 2) ("chaperone-associated E3 ligases" 2)
   ("a unique E3 ligase" 2) ("a heterodimeric E3 ligase" 2)
   ("the potential E3 ligases" 2) ("these and the relevant E3 ligase" 2)
   ("a well-studied E3 ubiquitin ligase" 2) ("E3 ligase molecule" 2)
   ("the principal p53 ubiquitin ligase" 2)
   ("a relatively inefficient E3 ubiquitin ligase" 2)
   ("E3 Ubiquitin Ligases" 2) ("a classical E3 ubiquitin ligase" 2)
   ("at least five E3 ubiquitin ligases" 1)
   ("a stress-activated E3 ubiquitin ligase" 1)
   ("an as-yet-unidentified E3 ligase" 1)
   ("the viral encoded ubiquitin ligase" 1)
   ("a pleiotropic E3 ubiquitin ligase" 1)
   ("chaperone-associated ubiquitin ligase (CHIP)" 1) ("largest E3 ligase" 1)
   ("Ubiquitin ligase protein" 1)
   ("muscle-specific protein ubiquitin ligases" 1)
   ("the relevant ubiquitin ligase" 1) ("their respective ubiquitin ligases" 1)
   ("a currently unidentified E3 ubiquitin ligase" 1)
   ("well-designed engineered ubiquitin ligases" 1)
   ("two artificial IR/IGF-1R-targeted ubiquitin ligases" 1)
   ("a WWP2-associated E3 ligase" 1) ("a histone-H2A-specific E3 ligase" 1)
   ("the principal ubiquitin ligases" 1) ("HSP90-associated E3 ligases" 1)
   ("an HSP90-associated E3 ubiquitin ligase" 1)
   ("muscle-specific ubiquitin ligases" 1)
   ("ubiquitin
ligases"
    1)
   ("E3 ubiquitin
ligase"
    1)
   ("Deltex (DTX)-3-like E3 histone ubiquitin ligase" 1)
   ("several RING finger-dependent ubiquitin E3 ligases" 1)
   ("than 1000 E3 ligases" 1) ("several atypical E3 ligases" 1)
   ("this peroxisomal E3 ligase" 1)
   ("cellular Cullin2/5-containing E3 ubiquitin ligase" 1)
   ("nducible E3 ligase" 1) ("the prototypic p53 E3 ligase" 1)
   ("this mitotic ubiquitin ligase" 1) ("the mitotic E3 ubiquitin ligase" 1)
   ("only nine human SCF ubiquitin ligases" 1)
   ("chaperone-associated ubiquitin ligases" 1)
   ("the chaperone-associated ubiquitin ligase" 1)
   ("the above-mentioned E3 ligases" 1)
   ("parkin-associated ubiquitin ligase" 1)
   ("the Cullin 4a-based E3 ubiquitin ligase" 1) ("Most E3 ligases" 1)
   ("there additional E3 ligases" 1)
   ("E3 ubiquitin
                            ligases"
    1)
   ("its nucleoplasmic ubiquitin ligase" 1)
   ("a more effectivep53 ubiquitin ligase" 1)
   ("the principal E3 ubiquitin ligase" 1)
   ("the most complex ubiquitin ligase" 1) ("monomeric E3 ligases" 1)
   ("heterodimeric E3 ligases" 1) ("homodimeric E3 ligases" 1)
   ("these monomeric E3 ligases" 1)
   ("their respective cullin-based E3 ligases" 1)
   ("a bacterial E3 ubiquitin ligase" 1)
   ("an estimated 600 potential E3 ubiquitin ligases" 1)
   ("potential SUMO E3 ligases" 1)
   ("monomeric and dimeric CRL4 DCAF1 E3 ligases" 1)
   ("possible ISG15 E3 ligases" 1) ("a CUL4A/DDB1-containing E3 ligase" 1)
   ("indeed cullins E3 ligases" 1) ("possibly other related E3 ligases" 1)
   ("well-characterized E3 ligases" 1) ("an atypical ubiquitin ligase" 1)
   ("the predominant E3 ubiquitin ligase" 1)
   ("the predominant and critical E3 ubiquitin ligase" 1)
   ("the probable E3 ligase" 1) ("The predominant E3 ubiquitin ligase" 1)
   ("than one E3 ligase" 1) ("other potential E3 ligases" 1)
   ("another potential E3 ligase" 1) ("largest E3 ubiquitin ligase family" 1)
   ("subsequent E3 ligase" 1) ("most other E3 ligases" 1)
   ("inherent E3 ligase" 1) ("the unique E3 ubiquitin ligase" 1)
   ("other heterodimeric E3 ligases" 1) ("most E3 ligases" 1)
   ("a previously identified E3 ligase" 1) ("a few E3 ligases" 1)
   ("other nucleolar ubiquitin ligases" 1) ("the relevant E3 ligase" 1)
   ("a well-ordered Vif E3 ligase" 1)
   ("DFFA-like effector A (CIDEA)–dependent E3-ubiquitin ligase" 1)))
 ("XFAM:PF12542"
  (("pre-mRNA splicing factor" 11) ("pre-mRNA splicing factors" 3)))
 ("XFAM:PF12561" (("Taga" 1)))
 ("XFAM:PF12567.6"
  (("CD45" 1149) ("CD45−" 15) ("CD45-" 4) ("CD45 molecule" 4) ("CD45 (APC)" 3)
   ("-CD45" 3) ("CD45 family" 3) ("the congenic markers CD45" 2)
   ("only ∼12% expressed CD45" 2) ("CD45 protein" 2) ("-CD45.1" 1)
   ("antileukocyte surface marker CD45" 1)
   ("The hematological cell marker CD45" 1) ("CD-45" 1) ("CD45 (PTPRC)" 1)
   ("All AME-positive mice expressed CD45.2" 1) ("most CD45" 1)
   ("CD45+CD20−" 1) ("CD45+CD11b+Ly6G-" 1)
   ("the haematopoietic marker CD45" 1)))
 ("XFAM:PF12598"
  (("T-box transcription factor" 26) ("T-box transcription factors" 2)))
 ("XFAM:PF12598.6" (("Tbx" 10) ("Tbx family" 7) ("TBX family" 3) ("TBX" 2)))
 ("XFAM:PF12610"
  (("suppressor of cytokine signalling" 6)
   ("suppressor of cytokine signalling (SOCS) family" 2)
   ("Suppressor of cytokine Signalling" 1)))
 ("XFAM:PF12610.6" (("SOCS" 435) ("pSOCS" 4)))
 ("XFAM:PF12689"
  (("acid phosphatase" 51) ("acid phosphatase (TRAP)" 29) ("TRACP" 10)
   ("Acid phosphatase" 5) ("acid phosphatases" 4)
   ("acid phosphatase (TRACP)" 4)
   ("the typical osteoclast enzyme tartrate resistant acid phosphatase (TRAP)"
    1)))
 ("XFAM:PF12711" (("kinesin motor" 17) ("kinesin motors" 2)))
 ("XFAM:PF12721" (("RHIM" 28) ("Rhim" 2)))
 ("XFAM:PF12812" (("PDZ-like domain" 23)))
 ("XFAM:PF12815"
  (("CTDs" 32) ("Nonsyndromic CTDs" 1) ("non-syndromic CTDs" 1)))
 ("XFAM:PF12845.5" (("TBD" 46) ("TBDs" 1)))
 ("XFAM:PF12907" (("zinc binding" 33) ("Zinc binding" 3)))
 ("XFAM:PF12998" (("ING" 100) ("INGs" 14) ("ING-" 1) ("ing" 1)))
 ("XFAM:PF13202"
  (("EF hand" 34) ("EF hands" 19) ("EF  hand" 3)
   ("a potential calcium-binding EF hand" 2) ("EF Hand" 2)
   ("classical EF hands" 1) ("metal-bound EF hands" 1)))
 ("XFAM:PF13424"
  (("tetratricopeptide repeat" 29) ("tetratricopeptide repeats" 25)
   ("tetratricopeptide repeat (TPR)" 6) ("tetratricopeptide repeats (TPR)" 3)
   ("Tetratricopeptide repeat" 1) ("Tetratricopeptide Repeat" 1)))
 ("XFAM:PF13513" (("HEAT-like repeats" 5) ("HEAT-like repeat" 2)))
 ("XFAM:PF13650" (("aspartyl protease" 4) ("aspartyl proteases" 2)))
 ("XFAM:PF13728.4"
  (("TRAF" 223) ("TRAFs" 89) ("TRAF family" 23) ("the potential TRAF" 3)
   ("TRAF family protein" 2) ("TRAF's" 1) ("most other TRAFs" 1)))
 ("XFAM:PF13731.4" (("WXL" 1) ("pWXL" 1)))
 ("XFAM:PF13769"
  (("virulence factor" 123) ("virulence factors" 92)
   ("bacterial virulence factors" 6) ("Virulence factors" 3)
   ("a pleiotropic virulence factor" 2)
   ("a specific bacterial virulence factor" 2) ("viral virulence factors" 2)
   ("The best-characterised bacterial virulence factors" 1)
   ("Microbial virulence factors" 1)
   ("a well-known traditional virulence factor" 1)
   ("bacterial virulence factor" 1)))
 ("XFAM:PF13796"
  (("sensor" 2442) ("sensors" 974) ("Sensor" 45) ("sensor protein" 34)
   ("a nucleolar stress sensor" 9) ("“sensor”" 9) ("‘sensor’" 8)
   ("“sensors”" 8) ("-sensor" 7) ("an oxidative stress sensor" 6)
   ("a novel nucleolar stress sensor" 5) ("sensor molecule" 4)
   ("fluorescent PtdIns-3,4,5-P 3 sensors" 3) ("Sensors" 3)
   ("a nonspecific pathogen sensor" 3) ("essential sensors" 3) ("\"sensor\"" 3)
   ("a previously established kinetochore-targeted
Aurora B sensor"
    3)
   ("characterized noncanonical (that is, non-PKA) cAMP sensor" 2)
   ("a pivotal energy sensor" 2) ("a cytoplasmic viral RNA sensor" 2)
   ("a mitochondria-targeted fluorescent protein sensor" 2) ("‘sensors’" 2)
   ("a fluorescent Ca 2+ sensor" 2) ("viral nucleic acid sensors" 2)
   ("pro-apoptotic sensors" 2) ("pSensor" 2)
   ("the neuronal calcium sensor family" 2) ("sensor family" 2)
   ("the principal sensors" 2) ("two nutritional sensors" 2)
   ("a crucial cytoplasmic bacterial sensor" 2)
   ("interdependent stress sensors" 2)
   ("the fluorescent PtdIns-3,4,5-P 3 sensor" 1)
   ("Another pivotal oxygen sensor" 1) ("a plethysmographic sensor" 1)
   ("possibly other sensors" 1) ("a previously described sensor" 1)
   ("a fluorescent sensor" 1) ("viral RNA sensors" 1) ("a rectal sensor" 1)
   ("Cytosolic retinoic acid-inducible gene 1 (RIG-I)/melanoma differentiation-associated protein 5 (MDA5) sensors"
    1)
   ("cellular nucleic acid sensors" 1) ("These nucleic acid sensors" 1)
   ("an exquisite sensor" 1) ("an oxidative sensor" 1)
   ("The described impedance-based sensor" 1)
   ("a UV-induced DNA damage sensor protein" 1)
   ("a directional migration sensor" 1) ("the electronic sensors" 1)
   ("featuring microelectronic sensors" 1) ("a principal stress sensor" 1)
   ("a well-recognized sensor" 1) ("a nutritional sensor" 1)
   ("an autophagic flux sensor" 1) ("an essential cellular stress sensor" 1)
   ("electrical sensors" 1) ("fluorescent sensors" 1)
   ("nucleic acid sensors" 1) ("a pivotal sensor" 1)
   ("a principal intracellular energy sensor" 1) ("an essential sensor" 1)
   ("a possible sensor" 1) ("a digital sensor" 1)
   ("the most conserved proximal sensor" 1)
   ("a previously characterized cAMP FRET sensor" 1) ("viral sensors" 1)
   ("an internal O 2 sensor" 1) ("few DNA damage sensors" 1)
   ("microelectronic sensors" 1) ("transcriptional sensors" 1)
   ("three proximal sensors" 1) ("3 proximal sensors" 1)
   ("the previous sensors" 1)
   ("A previously
designed Plk1 phosphorylation sensor"
    1)
   ("each ER proximal sensor" 1) ("a pleiotropic molecular sensor" 1)
   ("an early-activated sensor" 1)))
 ("XFAM:PF13841" (("beta-defensins" 9) ("beta-defensin" 9)))
 ("XFAM:PF13862" (("BCIP" 65)))
 ("XFAM:PF13864"
  (("calmodulin-binding" 17) ("Calmodulin-binding" 5)
   ("calmodulin-binding peptide (CBP)" 3) ("Calmodulin-binding peptide" 2)
   ("calmodulin-binding protein" 1)))
 ("XFAM:PF13868.4" (("TPH" 1)))
 ("XFAM:PF13894" (("C2H2-type zinc fingers" 9) ("C2H2-type zinc finger" 7)))
 ("XFAM:PF13941.4" (("MutL" 104) ("mutL" 24)))
 ("XFAM:PF13972.4" (("TetR" 50) ("tetR" 8)))
 ("XFAM:PF14047" (("DCRs" 10) ("dCR" 8) ("DcRs" 3) ("DcR" 1)))
 ("XFAM:PF14047.4"
  (("DCR" 131) ("DCRs" 10) ("pDCR" 4) ("DcRs" 1) ("pDCR-" 1)
   ("FISH+/mutation- obtained favorable DCR" 1)))
 ("XFAM:PF14098.4" (("SspI" 11))) ("XFAM:PF14324" (("PINIT" 58)))
 ("XFAM:PF14412.4" (("AHH" 5)))
 ("XFAM:PF14531" (("kinase like" 3) ("kinase like protein" 2)))
 ("XFAM:PF14531.4"
  (("kinase-like" 37) ("kinase-like family" 12) ("Kinase-like" 2)
   ("kinase-like protein (MAPK)" 2)
   ("also known as microtubule-associated serine/threonine kinase-like (MASTL)"
    2)
   ("microtubule-associated serine threonine kinase-like" 1)
   ("kinase-like (MASTL)" 1) ("-kinase–like" 1) ("kinase–like" 1)))
 ("XFAM:PF14564"
  (("membrane binding" 173) ("membrane-binding" 36) ("Membrane Binding" 6)
   ("membrane binding protein" 3) ("Membrane binding" 2)
   ("membrane-binding protein" 2) ("the weak membrane binding" 1)))
 ("XFAM:PF14566"
  (("inositol hexakisphosphate" 6) ("exogenous inositol hexakisphosphate" 2)))
 ("XFAM:PF14704.4" (("derm" 1))) ("XFAM:PF14811.4" (("TPD" 1)))
 ("XFAM:PF14820.4" (("SPRR2" 19) ("Sprr2" 10)))
 ("XFAM:PF14848"
  (("DNA-binding domain" 1744) ("DNA-binding domains" 239)
   ("DNA-binding domain (DBD)" 111)
   ("DNA-binding
domain"
    5)
   ("the sequence-specific DNA-binding domain" 4)
   ("a characteristic DNA-binding domain" 3)
   ("homologous DNA-binding domains" 2) ("a heterologous DNA-binding domain" 2)
   ("well-conserved DNA-binding domain" 2)
   ("a central sequence-specific well conserved DNA-binding domain" 2)
   ("functional sequence-specific DNA-binding domain" 2)
   ("DNA-binding domain (DB)" 2) ("a junction-specific DNA-binding domain" 2)
   ("a central sequence-specific DNA-binding domain" 2)
   ("a characteristic zinc-containing DNA-binding domain" 2)
   ("sequence-specific DNA-binding domains" 2)
   ("a characteristic winged helix-turn-helix DNA-binding domain" 2)
   ("any recognizable DNA-binding domain" 2) ("a basic DNA-binding domain" 1)
   ("its centrally located sequence-specific DNA-binding domain (DBD)" 1)
   ("three domains (1) N-terminal transactivation domain (2) central DNA-binding domain"
    1)
   ("its basic DNA-binding domain" 1) ("the respective DNA-binding domains" 1)
   ("a highly-conserved DNA-binding domain" 1)
   ("its central sequence-specific DNA-binding domain" 1)
   ("the central sequence-specific DNA-binding domain (DB)" 1)
   ("identifiable DNA-binding domains" 1) ("customizable DNA-binding domain" 1)
   ("its sequence-specific DNA-binding domain" 1)
   ("DNA-binding domains (DBD)" 1) ("DNA-binding domain (BD)" 1)
   ("their respective DNA-binding domains" 1)
   ("the central core sequence-specific DNA-binding domain" 1)
   ("separate higher-affinity DNA-binding domain" 1)
   ("whose Gal4 DNA-binding domain" 1)
   ("an evolutionary conserved DNA-binding domain" 1)
   ("a basic DNA-binding domain (BD)" 1)
   ("a homologous high-mobility group (HMG) DNA-binding domain" 1)))
 ("XFAM:PF14920"
  (("MDM2 binding" 157) ("Mdm2 binding" 66) ("MDM2-binding" 41)
   ("Mdm2-binding" 5) ("Mdm2 binding protein (MTBP)" 4)
   ("Mdm2-binding protein" 3) ("nearly no MDM2 binding" 1)
   ("possible MDM2 binding" 1) ("parkin increased Mdm2 binding" 1)))
 ("XFAM:PF14944.4" (("TCRP1" 117) ("TCRP1 protein" 1)))
 ("XFAM:PF14957" (("Cdc42 effector" 17) ("Cdc42 effectors" 12)))
 ("XFAM:PF14959.4" (("GSAP-16" 9) ("GSAP16" 3)))
 ("XFAM:PF14998"
  (("transcription regulators" 134) ("transcription regulator" 122)
   ("several EMT-associated transcription regulators" 3)
   ("bZIP bi-directional transcription regulators" 2)
   ("transcription regulator protein" 2)
   ("a potential transcription regulator" 2)
   ("the Maf basic leucine zipper (bZIP) transcription regulators" 2)
   ("the germ cell less (GCL) transcription regulator" 1)
   ("a stress-responsive transcription regulator" 1)
   ("essential transcription regulators" 1)))
 ("XFAM:PF15146" (("Fanconi anemia-associated" 1)))
 ("XFAM:PF15152.4"
  (("kisspeptin" 7) ("kisspeptins" 4) ("Kisspeptins" 1)
   ("kisspeptins (KP)" 1)))
 ("XFAM:PF15196" (("Harakiri" 1)))
 ("XFAM:PF15198" (("dexamethasone-induced" 28) ("Dexamethasone-induced" 1)))
 ("XFAM:PF15228"
  (("death-associated" 17) ("Death-associated" 10) ("Death-Associated" 3)
   ("death-associated protein" 1) ("death–associated" 1)))
 ("XFAM:PF15234" (("Linker for Activation of T-cells" 1)))
 ("XFAM:PF15240.4"
  (("Pro-rich" 9) ("PRO-RICH" 2) ("pro-rich" 1) ("prolinerich" 1)))
 ("XFAM:PF15347"
  (("phosphoprotein associated with glycosphingolipid-enriched" 3)))
 ("XFAM:PF15365" (("PNRC" 2))) ("XFAM:PF15392.4" (("Joubert" 21)))
 ("XFAM:PF15454.4" (("LAMTOR" 12))) ("XFAM:PF15460.4" (("SAS4" 4) ("Sas4" 1)))
 ("XFAM:PF15613.4" (("WHIM2" 6)))
 ("XFAM:PF15715.3"
  (("PAF" 679) ("PAFs" 4) ("the prototypic chemoattractant PAF" 1)))
 ("XFAM:PF15718.3" (("MNR" 2))) ("XFAM:PF15917.3" (("piezo" 17) ("Piezo" 4)))
 ("XFAM:PF16095" (("CoR" 8))) ("XFAM:PF16135.3" (("JAS" 4)))
 ("XFAM:PF16183" (("kinesin-associated" 1))) ("XFAM:PF16213.3" (("DCB" 27)))
 ("XFAM:PF16374"
  (("the Gram-negative pathogenic bacterial effector Cif" 2) ("Cif" 2)
   ("Cycle inhibiting factor (Cif)" 1)))
 ("XFAM:PF16453"
  (("PH Domain" 16) ("H domain" 4) ("PH DOMAIN" 3)
   ("PH
 Domain"
    1)
   ("H domains" 1)))
 ("XFAM:PF16455"
  (("ubiquitin-binding domain" 114) ("ubiquitin-binding domains" 66)
   ("ubiquitin binding domain" 47) ("ubiquitin binding domains" 32)
   ("ubiquitin-binding domain (UBD)" 16)
   ("most other ubiquitin binding domains" 2)
   ("an unusual ubiquitin-binding domain" 2)
   ("ubiquitin binding domains (UBD)" 2)
   ("their respective ubiquitin-binding domains" 2) ("UBAN" 1)
   ("ubiquitin-binding domain (UBAN)" 1) ("ubiquitin binding domain (UBD)" 1)
   ("its unique ubiquitin-binding domain" 1)
   ("ubiquitin-binding domain (UBA)" 1)))
 ("XFAM:PF16469" (("NPA" 62))) ("XFAM:PF16516" (("CC2-LZ" 4)))
 ("XFAM:PF16534" (("ULD" 72) ("ULD-" 2) ("its helical ULD" 1)))
 ("XFAM:PF16649.3" (("IL23" 19) ("Il23" 1)))
 ("XFAM:PF16739"
  (("caspase recruitment domain" 18) ("caspase recruitment domain (CARD)" 13)
   ("caspase recruitment domains" 10) ("caspase recruitment domain protein" 3)
   ("Caspase recruitment domain (CARD)" 1) ("Caspase recruitment domain" 1)
   ("caspase recruitment domain (ASC)" 1)
   ("caspase recruitment domains (CARD)" 1)))
 ("XFAM:PF16796"
  (("microtubule binding" 119) ("microtubule-binding" 100)
   ("microtubule-binding protein" 31) ("microtubule binding protein" 14)
   ("Microtubule-binding" 3) ("Microtubule binding" 3)
   ("microtubule
binding"
    1)
   ("Microtubule Binding" 1)))
 ("XFAM:PF17027" (("Histone-fold" 1) ("histone-fold" 1)))
 ("XFAM:PF17063.3" (("PSM4" 1))) ("XFAM:PF17073.3" (("Saf-A" 1)))
 ("XFAM:PF17076.3" (("SBE2" 6))) ("XFAM:PF17077.3" (("mSAP1" 2)))
 ("XFAM:PF17082.3" (("Spc29" 2)))
 ("brafv"
  (("BRAFV" 888) ("BRafV" 6) ("BrafV" 4) ("exogenous BRAFV600E" 2) ("bRafV" 2)
   ("exogenous human BRAFV600E" 1)))))
